Query	RS_Number	R2	GWAS_Trait	P_value	PMID
rs10000180	rs2868708	0.947759526633184	Lymphocyte count	3e-11	34469753
rs10000180	rs2868708	0.947759526633184	White blood cell count	1e-09	30595370
rs10000180	rs6831339	0.944449338790164	High density lipoprotein cholesterol levels	9e-09	34887591
rs10000180	rs116142917	0.867157229106754	Lymphocyte count	7e-18	32888494
rs10000180	rs6823199	0.851400957981542	Pulse pressure	4e-14	30224653
rs10000180	rs13111599	0.844390984736921	HDL cholesterol levels	3e-09	32203549
rs10000180	rs13111599	0.844390984736921	Apolipoprotein A1 levels	4e-08	32203549
rs10000180	rs6535419	0.831837550147235	Pulse pressure	6e-10	30578418
rs10000180	rs11099563	0.779205617331924	High density lipoprotein cholesterol levels	3e-11	34887591
rs10000180	rs28528763	0.762574386491188	White blood cell count	7e-12	32888494
rs10000180	rs4302451	0.709357927829245	Eosinophil counts	2e-09	30595370
rs10000180	rs35895091	0.6717868098693	Cardiovascular disease	1e-07	30595370
rs10000180	rs7662402	0.650726530315339	Brain morphology (MOSTest)	3e-08	35164939
rs10010659	rs10010659	1	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs10032000	rs10010659	0.947974788143136	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs10036895	rs10036895	1	Breast cancer	2e-12	34290314
rs10038651	rs38033	0.994152413933807	Blood protein levels	0	30072576
rs10038651	rs27293	0.983332329233094	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs10038651	rs27293	0.983332329233094	Diastolic blood pressure	3e-11	35762941
rs10038651	rs1423357	0.971026140541252	General cognitive ability	9e-06	29844566
rs10038651	rs2432142	0.959466198494439	Neutrophil count	2e-14	32888493
rs10038651	rs2432142	0.959466198494439	White blood cell count	1e-11	32888493
rs10038651	rs7705093	0.936789208980476	Birdshot chorioretinopathy	2e-09	24957906
rs10038651	rs2910686	0.847099019457154	Neutrophil count	4e-14	32888493
rs10038651	rs2910686	0.847099019457154	Psoriasis	2e-08	23143594
rs10038651	rs2910686	0.847099019457154	Ankylosing spondylitis	5e-17	23749187
rs10038651	rs2910686	0.847099019457154	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs10038651	rs2927608	0.843861702435685	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs10038651	rs2927608	0.843861702435685	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs10038651	rs2927608	0.843861702435685	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs10038651	rs38029	0.783315372693566	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs10038651	rs2617439	0.763279003676691	Neutrophil count	8e-11	32888494
rs10038651	rs2549797	0.752282800212888	Systolic blood pressure	7e-07	33230300
rs10038651	rs2549797	0.752282800212888	Diastolic blood pressure	1e-14	33230300
rs10038651	rs2549797	0.752282800212888	Diastolic blood pressure	3e-11	33230300
rs10038651	rs2549797	0.752282800212888	Systolic blood pressure	4e-09	33230300
rs10038651	rs2549782	0.751030791193721	Systolic blood pressure	6e-07	33230300
rs10038651	rs2549782	0.751030791193721	Diastolic blood pressure	1e-14	33230300
rs10038651	rs2549782	0.751030791193721	Diastolic blood pressure	3e-11	33230300
rs10038651	rs2549782	0.751030791193721	Systolic blood pressure	5e-09	33230300
rs10038651	rs1056893	0.750405625800376	Systolic blood pressure	1e-06	33230300
rs10038651	rs1056893	0.750405625800376	Diastolic blood pressure	7e-15	33230300
rs10038651	rs1056893	0.750405625800376	Diastolic blood pressure	2e-11	33230300
rs10038651	rs1056893	0.750405625800376	Systolic blood pressure	7e-09	33230300
rs10038651	rs2549794	0.749257390940066	Crohn's disease	1e-10	21102463
rs10038651	rs2549794	0.749257390940066	Systolic blood pressure	1e-07	33230300
rs10038651	rs2549794	0.749257390940066	Diastolic blood pressure	1e-15	33230300
rs10038651	rs2549794	0.749257390940066	Diastolic blood pressure	2e-12	33230300
rs10038651	rs2549794	0.749257390940066	Systolic blood pressure	4e-10	33230300
rs10038651	rs1363907	0.744674357439087	Crohn's disease	4e-16	26192919
rs10038651	rs1363907	0.744674357439087	Ulcerative colitis	4e-06	26192919
rs10038651	rs1363907	0.744674357439087	Inflammatory bowel disease	5e-15	26192919
rs10038651	rs1363907	0.744674357439087	Inflammatory bowel disease	6e-13	23128233
rs10038651	rs1363907	0.744674357439087	Inflammatory bowel disease	1e-10	28067908
rs10038651	rs1363907	0.744674357439087	Crohn's disease	1e-14	28067908
rs10038651	rs716848	0.716478990237484	Neutrophil percentage of white cells	2e-09	32888494
rs10038651	rs4869313	0.703354216602425	Pediatric autoimmune diseases	9e-08	26301688
rs10038651	rs1559359	0.696477735761092	Diastolic blood pressure	7e-10	34594039
rs10038651	rs2548532	0.673250754112324	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs10038651	rs4869314	0.648934612992059	Arthritis (juvenile idiopathic)	3e-09	33106285
rs10038651	rs4869314	0.648934612992059	Neutrophil count	1e-10	34594039
rs10038651	rs4869314	0.648934612992059	White blood cell count	2e-07	30595370
rs10038651	rs1974871	0.624169190249793	Granulysin levels	5e-13	34648354
rs10038651	rs27660	0.620960998866173	Coronary artery disease	3e-08	35915156
rs10038651	rs1019503	0.619076944732003	Systolic blood pressure	2e-06	33230300
rs10038651	rs1019503	0.619076944732003	Diastolic blood pressure	2e-14	33230300
rs10038651	rs1019503	0.619076944732003	Diastolic blood pressure	4e-11	33230300
rs10038651	rs1019503	0.619076944732003	Systolic blood pressure	1e-08	33230300
rs10038651	rs3096168	0.611862403097564	Aspartate aminotransferase levels	8e-12	33547301
rs10039322	rs33321	0.64458633450473	Height	1e-19	34594039
rs10039322	rs832540	0.6143514104912	Coronary artery disease	2e-08	29212778
rs10044354	rs38033	0.994152413933807	Blood protein levels	0	30072576
rs10044354	rs27293	0.983332329233094	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs10044354	rs27293	0.983332329233094	Diastolic blood pressure	3e-11	35762941
rs10044354	rs1423357	0.971026140541252	General cognitive ability	9e-06	29844566
rs10044354	rs2432142	0.959466198494439	Neutrophil count	2e-14	32888493
rs10044354	rs2432142	0.959466198494439	White blood cell count	1e-11	32888493
rs10044354	rs7705093	0.936789208980476	Birdshot chorioretinopathy	2e-09	24957906
rs10044354	rs2910686	0.847099019457154	Neutrophil count	4e-14	32888493
rs10044354	rs2910686	0.847099019457154	Psoriasis	2e-08	23143594
rs10044354	rs2910686	0.847099019457154	Ankylosing spondylitis	5e-17	23749187
rs10044354	rs2910686	0.847099019457154	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs10044354	rs2927608	0.843861702435685	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs10044354	rs2927608	0.843861702435685	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs10044354	rs2927608	0.843861702435685	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs10044354	rs38029	0.783315372693566	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs10044354	rs2617439	0.763279003676691	Neutrophil count	8e-11	32888494
rs10044354	rs2549797	0.752282800212888	Systolic blood pressure	7e-07	33230300
rs10044354	rs2549797	0.752282800212888	Diastolic blood pressure	1e-14	33230300
rs10044354	rs2549797	0.752282800212888	Diastolic blood pressure	3e-11	33230300
rs10044354	rs2549797	0.752282800212888	Systolic blood pressure	4e-09	33230300
rs10044354	rs2549782	0.751030791193721	Systolic blood pressure	6e-07	33230300
rs10044354	rs2549782	0.751030791193721	Diastolic blood pressure	1e-14	33230300
rs10044354	rs2549782	0.751030791193721	Diastolic blood pressure	3e-11	33230300
rs10044354	rs2549782	0.751030791193721	Systolic blood pressure	5e-09	33230300
rs10044354	rs1056893	0.750405625800376	Systolic blood pressure	1e-06	33230300
rs10044354	rs1056893	0.750405625800376	Diastolic blood pressure	7e-15	33230300
rs10044354	rs1056893	0.750405625800376	Diastolic blood pressure	2e-11	33230300
rs10044354	rs1056893	0.750405625800376	Systolic blood pressure	7e-09	33230300
rs10044354	rs2549794	0.749257390940066	Crohn's disease	1e-10	21102463
rs10044354	rs2549794	0.749257390940066	Systolic blood pressure	1e-07	33230300
rs10044354	rs2549794	0.749257390940066	Diastolic blood pressure	1e-15	33230300
rs10044354	rs2549794	0.749257390940066	Diastolic blood pressure	2e-12	33230300
rs10044354	rs2549794	0.749257390940066	Systolic blood pressure	4e-10	33230300
rs10044354	rs1363907	0.744674357439087	Crohn's disease	4e-16	26192919
rs10044354	rs1363907	0.744674357439087	Ulcerative colitis	4e-06	26192919
rs10044354	rs1363907	0.744674357439087	Inflammatory bowel disease	5e-15	26192919
rs10044354	rs1363907	0.744674357439087	Inflammatory bowel disease	6e-13	23128233
rs10044354	rs1363907	0.744674357439087	Inflammatory bowel disease	1e-10	28067908
rs10044354	rs1363907	0.744674357439087	Crohn's disease	1e-14	28067908
rs10044354	rs716848	0.716478990237484	Neutrophil percentage of white cells	2e-09	32888494
rs10044354	rs4869313	0.703354216602425	Pediatric autoimmune diseases	9e-08	26301688
rs10044354	rs1559359	0.696477735761092	Diastolic blood pressure	7e-10	34594039
rs10044354	rs2548532	0.673250754112324	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs10044354	rs4869314	0.648934612992059	Arthritis (juvenile idiopathic)	3e-09	33106285
rs10044354	rs4869314	0.648934612992059	Neutrophil count	1e-10	34594039
rs10044354	rs4869314	0.648934612992059	White blood cell count	2e-07	30595370
rs10044354	rs1974871	0.624169190249793	Granulysin levels	5e-13	34648354
rs10044354	rs27660	0.620960998866173	Coronary artery disease	3e-08	35915156
rs10044354	rs1019503	0.619076944732003	Systolic blood pressure	2e-06	33230300
rs10044354	rs1019503	0.619076944732003	Diastolic blood pressure	2e-14	33230300
rs10044354	rs1019503	0.619076944732003	Diastolic blood pressure	4e-11	33230300
rs10044354	rs1019503	0.619076944732003	Systolic blood pressure	1e-08	33230300
rs10044354	rs3096168	0.611862403097564	Aspartate aminotransferase levels	8e-12	33547301
rs10051637	rs1423357	0.989117246955643	General cognitive ability	9e-06	29844566
rs10051637	rs2432142	0.977438422526603	Neutrophil count	2e-14	32888493
rs10051637	rs2432142	0.977438422526603	White blood cell count	1e-11	32888493
rs10051637	rs38033	0.972558135425505	Blood protein levels	0	30072576
rs10051637	rs27293	0.961806622146123	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs10051637	rs27293	0.961806622146123	Diastolic blood pressure	3e-11	35762941
rs10051637	rs7705093	0.954811653883142	Birdshot chorioretinopathy	2e-09	24957906
rs10051637	rs2910686	0.866173660807361	Neutrophil count	4e-14	32888493
rs10051637	rs2910686	0.866173660807361	Psoriasis	2e-08	23143594
rs10051637	rs2910686	0.866173660807361	Ankylosing spondylitis	5e-17	23749187
rs10051637	rs2910686	0.866173660807361	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs10051637	rs2927608	0.862870657763637	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs10051637	rs2927608	0.862870657763637	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs10051637	rs2927608	0.862870657763637	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs10051637	rs2617439	0.777600953884442	Neutrophil count	8e-11	32888494
rs10051637	rs2549797	0.770886617418682	Systolic blood pressure	7e-07	33230300
rs10051637	rs2549797	0.770886617418682	Diastolic blood pressure	1e-14	33230300
rs10051637	rs2549797	0.770886617418682	Diastolic blood pressure	3e-11	33230300
rs10051637	rs2549797	0.770886617418682	Systolic blood pressure	4e-09	33230300
rs10051637	rs2549782	0.769628040951725	Systolic blood pressure	6e-07	33230300
rs10051637	rs2549782	0.769628040951725	Diastolic blood pressure	1e-14	33230300
rs10051637	rs2549782	0.769628040951725	Diastolic blood pressure	3e-11	33230300
rs10051637	rs2549782	0.769628040951725	Systolic blood pressure	5e-09	33230300
rs10051637	rs1056893	0.768999595936297	Systolic blood pressure	1e-06	33230300
rs10051637	rs1056893	0.768999595936297	Diastolic blood pressure	7e-15	33230300
rs10051637	rs1056893	0.768999595936297	Diastolic blood pressure	2e-11	33230300
rs10051637	rs1056893	0.768999595936297	Systolic blood pressure	7e-09	33230300
rs10051637	rs2549794	0.763525069522698	Crohn's disease	1e-10	21102463
rs10051637	rs2549794	0.763525069522698	Systolic blood pressure	1e-07	33230300
rs10051637	rs2549794	0.763525069522698	Diastolic blood pressure	1e-15	33230300
rs10051637	rs2549794	0.763525069522698	Diastolic blood pressure	2e-12	33230300
rs10051637	rs2549794	0.763525069522698	Systolic blood pressure	4e-10	33230300
rs10051637	rs38029	0.761309667285776	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs10051637	rs1363907	0.758899321161546	Crohn's disease	4e-16	26192919
rs10051637	rs1363907	0.758899321161546	Ulcerative colitis	4e-06	26192919
rs10051637	rs1363907	0.758899321161546	Inflammatory bowel disease	5e-15	26192919
rs10051637	rs1363907	0.758899321161546	Inflammatory bowel disease	6e-13	23128233
rs10051637	rs1363907	0.758899321161546	Inflammatory bowel disease	1e-10	28067908
rs10051637	rs1363907	0.758899321161546	Crohn's disease	1e-14	28067908
rs10051637	rs716848	0.730564547010637	Neutrophil percentage of white cells	2e-09	32888494
rs10051637	rs4869313	0.720033903728809	Pediatric autoimmune diseases	9e-08	26301688
rs10051637	rs1559359	0.713681374544672	Diastolic blood pressure	7e-10	34594039
rs10051637	rs2548532	0.686071197025612	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs10051637	rs4869314	0.666535924332783	Arthritis (juvenile idiopathic)	3e-09	33106285
rs10051637	rs4869314	0.666535924332783	Neutrophil count	1e-10	34594039
rs10051637	rs4869314	0.666535924332783	White blood cell count	2e-07	30595370
rs10051637	rs1974871	0.640338183234995	Granulysin levels	5e-13	34648354
rs10051637	rs1019503	0.635726414243418	Systolic blood pressure	2e-06	33230300
rs10051637	rs1019503	0.635726414243418	Diastolic blood pressure	2e-14	33230300
rs10051637	rs1019503	0.635726414243418	Diastolic blood pressure	4e-11	33230300
rs10051637	rs1019503	0.635726414243418	Systolic blood pressure	1e-08	33230300
rs10051637	rs27660	0.632595139746782	Coronary artery disease	3e-08	35915156
rs10051637	rs3096168	0.628338499552842	Aspartate aminotransferase levels	8e-12	33547301
rs10055160	rs1168404	0.698759514927663	Blood urea nitrogen levels	5e-09	31152163
rs10055224	rs702689	0.766957491436935	Vertex-wise sulcal depth	2e-22	34910505
rs10055224	rs10061757	0.754302740913889	Height	4e-30	30595370
rs10055224	rs96844	0.738376409161938	Type 2 diabetes	5e-08	30297969
rs10055224	rs96844	0.738376409161938	Height	4e-33	36224396
rs10055224	rs9292122	0.706430203310568	Prostate cancer	5e-09	33398198
rs10055224	rs33320	0.623783869185502	Height	9e-14	36224396
rs10055224	rs2257505	0.617862609763219	Height	8e-192	36224396
rs1005577	rs2430691	0.611790589532881	Height	4e-44	36224396
rs10058476	rs2617439	0.975955243907605	Neutrophil count	8e-11	32888494
rs10058476	rs2549794	0.966455168294426	Crohn's disease	1e-10	21102463
rs10058476	rs2549794	0.966455168294426	Systolic blood pressure	1e-07	33230300
rs10058476	rs2549794	0.966455168294426	Diastolic blood pressure	1e-15	33230300
rs10058476	rs2549794	0.966455168294426	Diastolic blood pressure	2e-12	33230300
rs10058476	rs2549794	0.966455168294426	Systolic blood pressure	4e-10	33230300
rs10058476	rs38029	0.963808057391398	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs10058476	rs1363907	0.961223582953732	Crohn's disease	4e-16	26192919
rs10058476	rs1363907	0.961223582953732	Ulcerative colitis	4e-06	26192919
rs10058476	rs1363907	0.961223582953732	Inflammatory bowel disease	5e-15	26192919
rs10058476	rs1363907	0.961223582953732	Inflammatory bowel disease	6e-13	23128233
rs10058476	rs1363907	0.961223582953732	Inflammatory bowel disease	1e-10	28067908
rs10058476	rs1363907	0.961223582953732	Crohn's disease	1e-14	28067908
rs10058476	rs716848	0.930970982853388	Neutrophil percentage of white cells	2e-09	32888494
rs10058476	rs2548532	0.868182037227223	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs10058476	rs27660	0.799263720150241	Coronary artery disease	3e-08	35915156
rs10058476	rs1423357	0.798197239422085	General cognitive ability	9e-06	29844566
rs10058476	rs2432142	0.781422714392652	Neutrophil count	2e-14	32888493
rs10058476	rs2432142	0.781422714392652	White blood cell count	1e-11	32888493
rs10058476	rs38033	0.779648251036857	Blood protein levels	0	30072576
rs10058476	rs27293	0.769397939382987	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs10058476	rs27293	0.769397939382987	Diastolic blood pressure	3e-11	35762941
rs10058476	rs7705093	0.762891107700031	Birdshot chorioretinopathy	2e-09	24957906
rs10058476	rs4869313	0.701024883558502	Pediatric autoimmune diseases	9e-08	26301688
rs10058476	rs2927608	0.700035757023862	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs10058476	rs2927608	0.700035757023862	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs10058476	rs2927608	0.700035757023862	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs10058476	rs2910686	0.69773100285104	Neutrophil count	4e-14	32888493
rs10058476	rs2910686	0.69773100285104	Psoriasis	2e-08	23143594
rs10058476	rs2910686	0.69773100285104	Ankylosing spondylitis	5e-17	23749187
rs10058476	rs2910686	0.69773100285104	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs10058476	rs1559359	0.638495633388354	Diastolic blood pressure	7e-10	34594039
rs10058476	rs1974871	0.629541482008549	Granulysin levels	5e-13	34648354
rs10058476	rs2549797	0.621933048962999	Systolic blood pressure	7e-07	33230300
rs10058476	rs2549797	0.621933048962999	Diastolic blood pressure	1e-14	33230300
rs10058476	rs2549797	0.621933048962999	Diastolic blood pressure	3e-11	33230300
rs10058476	rs2549797	0.621933048962999	Systolic blood pressure	4e-09	33230300
rs10058476	rs2549782	0.62092667055493	Systolic blood pressure	6e-07	33230300
rs10058476	rs2549782	0.62092667055493	Diastolic blood pressure	1e-14	33230300
rs10058476	rs2549782	0.62092667055493	Diastolic blood pressure	3e-11	33230300
rs10058476	rs2549782	0.62092667055493	Systolic blood pressure	5e-09	33230300
rs10058476	rs1056893	0.62042415556713	Systolic blood pressure	1e-06	33230300
rs10058476	rs1056893	0.62042415556713	Diastolic blood pressure	7e-15	33230300
rs10058476	rs1056893	0.62042415556713	Diastolic blood pressure	2e-11	33230300
rs10058476	rs1056893	0.62042415556713	Systolic blood pressure	7e-09	33230300
rs10061757	rs10061757	1	Height	4e-30	30595370
rs10061757	rs832540	0.77112510815175	Coronary artery disease	2e-08	29212778
rs10061757	rs33321	0.723553643086261	Height	1e-19	34594039
rs1006408	rs2224797	0.802008776817847	Red blood cell count	5e-08	30595370
rs1006408	rs2224797	0.802008776817847	Mean corpuscular hemoglobin	3e-09	30595370
rs10067659	rs13189973	0.942266842813238	Lymphocyte count	2e-16	32888493
rs10067659	rs2548499	0.628928344100221	Lymphocyte count	9e-14	32888494
rs10077945	rs1423357	0.992450509010109	General cognitive ability	9e-06	29844566
rs10077945	rs2432142	0.975757614544948	Neutrophil count	2e-14	32888493
rs10077945	rs2432142	0.975757614544948	White blood cell count	1e-11	32888493
rs10077945	rs38033	0.970919827723568	Blood protein levels	0	30072576
rs10077945	rs27293	0.965110458048628	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs10077945	rs27293	0.965110458048628	Diastolic blood pressure	3e-11	35762941
rs10077945	rs7705093	0.95813228400691	Birdshot chorioretinopathy	2e-09	24957906
rs10077945	rs2910686	0.867857904204483	Neutrophil count	4e-14	32888493
rs10077945	rs2910686	0.867857904204483	Psoriasis	2e-08	23143594
rs10077945	rs2910686	0.867857904204483	Ankylosing spondylitis	5e-17	23749187
rs10077945	rs2910686	0.867857904204483	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs10077945	rs2927608	0.864545796001235	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs10077945	rs2927608	0.864545796001235	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs10077945	rs2927608	0.864545796001235	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs10077945	rs2617439	0.775647304033654	Neutrophil count	8e-11	32888494
rs10077945	rs2549797	0.772602160735554	Systolic blood pressure	7e-07	33230300
rs10077945	rs2549797	0.772602160735554	Diastolic blood pressure	1e-14	33230300
rs10077945	rs2549797	0.772602160735554	Diastolic blood pressure	3e-11	33230300
rs10077945	rs2549797	0.772602160735554	Systolic blood pressure	4e-09	33230300
rs10077945	rs2549782	0.771343929701745	Systolic blood pressure	6e-07	33230300
rs10077945	rs2549782	0.771343929701745	Diastolic blood pressure	1e-14	33230300
rs10077945	rs2549782	0.771343929701745	Diastolic blood pressure	3e-11	33230300
rs10077945	rs2549782	0.771343929701745	Systolic blood pressure	5e-09	33230300
rs10077945	rs1056893	0.770715657153161	Systolic blood pressure	1e-06	33230300
rs10077945	rs1056893	0.770715657153161	Diastolic blood pressure	7e-15	33230300
rs10077945	rs1056893	0.770715657153161	Diastolic blood pressure	2e-11	33230300
rs10077945	rs1056893	0.770715657153161	Systolic blood pressure	7e-09	33230300
rs10077945	rs2549794	0.766153877185298	Crohn's disease	1e-10	21102463
rs10077945	rs2549794	0.766153877185298	Systolic blood pressure	1e-07	33230300
rs10077945	rs2549794	0.766153877185298	Diastolic blood pressure	1e-15	33230300
rs10077945	rs2549794	0.766153877185298	Diastolic blood pressure	2e-12	33230300
rs10077945	rs2549794	0.766153877185298	Systolic blood pressure	4e-10	33230300
rs10077945	rs38029	0.763932918014473	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs10077945	rs1363907	0.761520260744161	Crohn's disease	4e-16	26192919
rs10077945	rs1363907	0.761520260744161	Ulcerative colitis	4e-06	26192919
rs10077945	rs1363907	0.761520260744161	Inflammatory bowel disease	5e-15	26192919
rs10077945	rs1363907	0.761520260744161	Inflammatory bowel disease	6e-13	23128233
rs10077945	rs1363907	0.761520260744161	Inflammatory bowel disease	1e-10	28067908
rs10077945	rs1363907	0.761520260744161	Crohn's disease	1e-14	28067908
rs10077945	rs716848	0.733159832579098	Neutrophil percentage of white cells	2e-09	32888494
rs10077945	rs4869313	0.721428092325927	Pediatric autoimmune diseases	9e-08	26301688
rs10077945	rs1559359	0.715194158152253	Diastolic blood pressure	7e-10	34594039
rs10077945	rs2548532	0.688433352750199	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs10077945	rs4869314	0.668193050039165	Arthritis (juvenile idiopathic)	3e-09	33106285
rs10077945	rs4869314	0.668193050039165	Neutrophil count	1e-10	34594039
rs10077945	rs4869314	0.668193050039165	White blood cell count	2e-07	30595370
rs10077945	rs1974871	0.641748507801945	Granulysin levels	5e-13	34648354
rs10077945	rs1019503	0.637486653902393	Systolic blood pressure	2e-06	33230300
rs10077945	rs1019503	0.637486653902393	Diastolic blood pressure	2e-14	33230300
rs10077945	rs1019503	0.637486653902393	Diastolic blood pressure	4e-11	33230300
rs10077945	rs1019503	0.637486653902393	Systolic blood pressure	1e-08	33230300
rs10077945	rs27660	0.634738715017868	Coronary artery disease	3e-08	35915156
rs10077945	rs3096168	0.63007435664691	Aspartate aminotransferase levels	8e-12	33547301
rs10079030	rs150621	0.905798350695151	Appendicular lean mass	5e-12	31761296
rs10079030	rs2098713	0.768373952997737	Telomere length	3e-06	24795349
rs10079030	rs757720522	0.646556267923001	Appendicular lean mass	3e-11	31761296
rs10102628	rs4413755	0.851443399348283	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs10103694	rs4413755	0.939868447282679	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs10112410	rs4413755	0.91935912958042	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs10113779	rs751680	0.715069862123934	Insomnia	7e-09	35835914
rs10113779	rs1059592	0.713241925763196	Type 2 diabetes	2e-08	32541925
rs10113779	rs6558173	0.640486990411114	Type 2 diabetes	7e-10	32541925
rs10127737	rs10465746	0.755176480935108	Obesity-related traits	8e-06	23251661
rs10127737	rs11580836	0.728502136328118	Body mass index	2e-09	36581621
rs10128996	rs2695294	0.888787074767771	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs10128996	rs2695295	0.888091051606141	Serum levels of protein NAAA	1e-68	35078996
rs10128996	rs2695295	0.888091051606141	Serum levels of protein SMPDL3A	8e-86	35078996
rs10128996	rs2559856	0.886582183859769	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs10128996	rs3809260	0.877479547403208	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs10128996	rs2559851	0.818042871162199	Cathepsin F levels	2e-96	34648354
rs10128996	rs2559851	0.818042871162199	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs10128996	rs2559850	0.704491725271537	Serum levels of protein CTSH	1e-19	35078996
rs10128996	rs2559850	0.704491725271537	Vitamin C levels	6e-20	33203707
rs10128996	rs2559850	0.704491725271537	Cathepsin L2 levels	1e-24	34648354
rs10128996	rs2559850	0.704491725271537	Islet amyloid polypeptide levels	1e-49	34648354
rs10128996	rs2559850	0.704491725271537	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs10139435	rs4902352	0.621311693888621	Insulin levels	4e-06	34304350
rs10139435	rs4902352	0.621311693888621	Insulin levels	3e-07	34304350
rs10142533	rs10147992	0.988021380595423	White blood cell types	1e-08	21738478
rs10145845	rs7359095	0.617421055762594	Height (standard GWA)	5e-10	37106081
rs10155746	rs9469872	0.981604063837387	HDL cholesterol levels	3e-11	36333282
rs10155746	rs11755393	0.974561201443731	Body mass index	3e-26	29273807
rs10155746	rs11755393	0.974561201443731	Systemic lupus erythematosus	2e-12	33493351
rs10155746	rs11755393	0.974561201443731	Systemic lupus erythematosus	2e-06	33493351
rs10155746	rs11755393	0.974561201443731	Systemic lupus erythematosus	1e-07	33493351
rs10155746	rs11755393	0.974561201443731	Systemic lupus erythematosus	2e-08	19838195
rs10155746	rs11755393	0.974561201443731	Body mass index	4e-55	36581621
rs10155746	rs9366863	0.971282761779199	Adult body size	9e-33	32376654
rs10155746	rs9366863	0.971282761779199	Body mass index	2e-44	30595370
rs10155746	rs6941110	0.963384015555291	Sex hormone-binding globulin levels	5e-27	36653534
rs10155746	rs9462030	0.948746627471001	Red cell distribution width	5e-25	32888493
rs10155746	rs9469857	0.944104454508827	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs10155746	rs2764208	0.943367431586326	Systemic lupus erythematosus	7e-06	24871463
rs10155746	rs2814949	0.934440238758833	Essential hypertension (time to event)	9e-09	32589924
rs10155746	rs9469899	0.932097064065512	Prostate cancer (advanced)	2e-06	29892016
rs10155746	rs9469899	0.932097064065512	Prostate cancer	5e-09	29892016
rs10155746	rs9469899	0.932097064065512	Prostate cancer	8e-11	33398198
rs10155746	rs9469899	0.932097064065512	Hand grip strength	3e-15	29691431
rs10155746	rs9469899	0.932097064065512	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs10155746	rs9469899	0.932097064065512	Graves' disease	4e-10	34594039
rs10155746	rs9469899	0.932097064065512	Coronary artery disease	1e-11	36474045
rs10155746	rs9469899	0.932097064065512	Predicted visceral adipose tissue	2e-20	31501611
rs10155746	rs9469899	0.932097064065512	Medication use (thyroid preparations)	2e-09	31015401
rs10155746	rs9469899	0.932097064065512	Medication use (thyroid preparations)	3e-10	34594039
rs10155746	rs2744944	0.925116506190188	Hypothyroidism	3e-10	34594039
rs10155746	rs2744944	0.925116506190188	High density lipoprotein cholesterol levels	3e-86	34887591
rs10155746	rs2744944	0.925116506190188	Multi-trait sex score	7e-22	37277458
rs10155746	rs2263329	0.905904652793002	HDL cholesterol	6e-35	34594039
rs10155746	rs2263329	0.905904652793002	HDL cholesterol levels	8e-43	32203549
rs10155746	rs2263329	0.905904652793002	High density lipoprotein cholesterol levels	2e-52	34887591
rs10155746	rs9296128	0.898487501657524	Hip circumference adjusted for BMI	4e-13	34021172
rs10155746	rs111868030	0.883246673003766	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs10155746	rs9368830	0.858889728052394	HDL cholesterol	4e-21	30275531
rs10155746	rs9368828	0.829580586381156	Body mass index	1e-34	34594039
rs10155746	rs6912327	0.821799118277441	Fasting insulin	5e-06	33402679
rs10155746	rs6912327	0.821799118277441	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs10155746	rs112283401	0.797632475374964	Red cell distribution width	4e-27	30595370
rs10155746	rs2744973	0.776764350925639	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs10155746	rs2744973	0.776764350925639	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs10155746	rs2744973	0.776764350925639	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs10155746	rs2744973	0.776764350925639	Multi-trait sex score	6e-20	37277458
rs10155746	rs6940215	0.629052143064024	Insomnia	2e-10	35835914
rs10155746	rs6940215	0.629052143064024	Insomnia	1e-13	35835914
rs10155746	rs6940215	0.629052143064024	Hip circumference adjusted for BMI	8e-10	34021172
rs10155746	rs6940215	0.629052143064024	Multi-trait sex score	2e-23	37277458
rs10155746	rs6940215	0.629052143064024	Multi-trait sex score	4e-23	37277458
rs10155746	rs6457796	0.620160002772668	Insomnia	1e-08	30804565
rs10155746	rs6457796	0.620160002772668	Plateletcrit	9e-11	32888494
rs10155746	rs6457796	0.620160002772668	Systemic lupus erythematosus	3e-22	33272962
rs10155746	rs6457796	0.620160002772668	Body mass index	5e-13	30108127
rs10155746	rs6457796	0.620160002772668	Body mass index	1e-14	26426971
rs10155746	rs6457796	0.620160002772668	Educational attainment	5e-19	35361970
rs10155746	rs9689160	0.602238532153143	Lung function (forced vital capacity)	3e-14	36914875
rs10169662	rs12617371	0.927768587652167	Immature fraction of reticulocytes	8e-18	32888494
rs10169662	rs777587	0.906727434265082	Proteoglycan 3 levels	6e-29	34648354
rs10169662	rs777587	0.906727434265082	Pappalysin-1 levels	1e-25	34648354
rs10169662	rs2463097	0.886208150041541	White blood cell count	3e-26	30595370
rs10169662	rs10199672	0.873013832309699	Height	6e-12	34594039
rs10169662	rs10199672	0.873013832309699	Height	2e-12	31562340
rs10169662	rs2593620	0.867916455389481	Serum levels of protein PRG3	5e-14	35078996
rs10169662	rs2421200	0.845725496995561	Neutrophil count	1e-26	32888493
rs10169662	rs2421200	0.845725496995561	Neutrophil count	1e-25	32888493
rs10169662	rs11685226	0.797886318621621	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs10169662	rs11685226	0.797886318621621	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs10169662	rs1177308	0.789396693288283	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs10169662	rs1177308	0.789396693288283	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs10169662	rs7558954	0.785642134365076	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs10169662	rs10169482	0.771936516750139	C-reactive protein levels	4e-09	33462484
rs10169662	rs2950269	0.73131160696503	Eosinophil side fluorescence	3e-18	37596262
rs10169662	rs12616433	0.724628854423223	Eosinophil forward scatter	4e-13	37596262
rs10169662	rs12616433	0.724628854423223	Eosinophil side scatter	2e-18	37596262
rs10176712	rs4602255	0.714055369975712	Breast cancer	2e-09	32424353
rs10184314	rs6723298	0.683598235513149	Smoking initiation	2e-12	36477530
rs10184314	rs2194492	0.662110225047124	Educational attainment	9e-09	35361970
rs10184314	rs13020443	0.653611154462777	Type 2 diabetes	3e-11	32541925
rs10207408	rs6723298	0.680581352924382	Smoking initiation	2e-12	36477530
rs10207408	rs2194492	0.660437398912968	Educational attainment	9e-09	35361970
rs10207408	rs13020443	0.650600188391662	Type 2 diabetes	3e-11	32541925
rs1021282	rs7545078	0.631370562224004	Smoking initiation	2e-09	36477530
rs10223902	rs13232536	0.813130103547723	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10223902	rs4355658	0.756636531731059	Height	3e-13	36224396
rs10223902	rs12539962	0.752825951204815	Colorectal cancer	3e-08	36539618
rs10225983	rs4304220	0.86512188941046	Height	2e-14	36224396
rs10225983	rs4355658	0.816950225861042	Height	3e-13	36224396
rs10225983	rs13232536	0.613426149347321	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10225983	rs12539962	0.600428418698391	Colorectal cancer	3e-08	36539618
rs10234724	rs4304220	0.800562800710204	Height	2e-14	36224396
rs10234724	rs4355658	0.75054337367693	Height	3e-13	36224396
rs10234724	rs13232536	0.614303762628834	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10236342	rs12539962	0.873098954518342	Colorectal cancer	3e-08	36539618
rs10236342	rs13232536	0.698702434329049	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10236342	rs7806956	0.661910188807342	Esophageal squamous cell carcinoma	3e-07	37673066
rs10236342	rs4355658	0.652579817767507	Height	3e-13	36224396
rs10252756	rs4304220	0.781825664000285	Height	2e-14	36224396
rs10252756	rs4355658	0.752922453297189	Height	3e-13	36224396
rs10252756	rs12539962	0.619170157766953	Colorectal cancer	3e-08	36539618
rs10263665	rs12701798	0.751118823587448	Medication use (calcium channel blockers)	1e-08	34594039
rs10263665	rs7811577	0.722398197972242	Medication use (calcium channel blockers)	2e-09	34594039
rs10263665	rs2960826	0.632562789342949	Mean corpuscular hemoglobin	4e-08	34594039
rs10263665	rs2960826	0.632562789342949	Mean corpuscular volume	4e-12	34594039
rs10263665	rs1104888	0.613051947309518	Mean corpuscular volume	2e-17	32888493
rs10263665	rs1104888	0.613051947309518	Mean corpuscular hemoglobin	4e-12	30595370
rs10271009	rs4304220	0.794826548361593	Height	2e-14	36224396
rs10271009	rs4355658	0.744795805940287	Height	3e-13	36224396
rs10271009	rs13232536	0.609256170194389	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10276377	rs4304220	0.86512188941046	Height	2e-14	36224396
rs10276377	rs4355658	0.816950225861042	Height	3e-13	36224396
rs10276377	rs13232536	0.613426149347321	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10276377	rs12539962	0.600428418698391	Colorectal cancer	3e-08	36539618
rs10282443	rs4304220	0.866545648270098	Height	2e-14	36224396
rs10282443	rs4355658	0.816997126874272	Height	3e-13	36224396
rs10282443	rs13232536	0.614657395717792	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10282443	rs12539962	0.601759792635005	Colorectal cancer	3e-08	36539618
rs1030831	rs337277	0.922929386480613	Metabolite peak levels (QI10992)	3e-52	35995766
rs1030831	rs337277	0.922929386480613	Metabolite peak levels (QI4667)	7e-18	35995766
rs1030831	rs337277	0.922929386480613	Metabolite peak levels (QI4708)	1e-21	35995766
rs1030831	rs337277	0.922929386480613	Metabolite peak levels (QI5169)	7e-57	35995766
rs1030831	rs7655841	0.740426658729122	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1037147	rs337277	0.928245698738428	Metabolite peak levels (QI10992)	3e-52	35995766
rs1037147	rs337277	0.928245698738428	Metabolite peak levels (QI4667)	7e-18	35995766
rs1037147	rs337277	0.928245698738428	Metabolite peak levels (QI4708)	1e-21	35995766
rs1037147	rs337277	0.928245698738428	Metabolite peak levels (QI5169)	7e-57	35995766
rs1037147	rs7655841	0.736955197068572	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs10408535	rs1138888	0.753634651272917	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs10408535	rs1138888	0.753634651272917	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs10408535	rs4802157	0.734032440262898	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs10408535	rs2355433	0.6180509248216	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs10408535	rs2355433	0.6180509248216	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs10408535	rs2355433	0.6180509248216	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs10411926	rs3848597	0.938393868898731	Prostate cancer	3e-06	34981446
rs10430949	rs1467510	0.863241656370862	Platelet distribution width	1e-14	32888494
rs10430949	rs12276109	0.768271882653643	Severe COVID-19 infection	6e-08	36662838
rs10434708	rs1974871	0.916669349652752	Granulysin levels	5e-13	34648354
rs10434708	rs4869314	0.904823271627218	Arthritis (juvenile idiopathic)	3e-09	33106285
rs10434708	rs4869314	0.904823271627218	Neutrophil count	1e-10	34594039
rs10434708	rs4869314	0.904823271627218	White blood cell count	2e-07	30595370
rs10434708	rs2549782	0.85010077253848	Systolic blood pressure	6e-07	33230300
rs10434708	rs2549782	0.85010077253848	Diastolic blood pressure	1e-14	33230300
rs10434708	rs2549782	0.85010077253848	Diastolic blood pressure	3e-11	33230300
rs10434708	rs2549782	0.85010077253848	Systolic blood pressure	5e-09	33230300
rs10434708	rs2549797	0.85008721562494	Systolic blood pressure	7e-07	33230300
rs10434708	rs2549797	0.85008721562494	Diastolic blood pressure	1e-14	33230300
rs10434708	rs2549797	0.85008721562494	Diastolic blood pressure	3e-11	33230300
rs10434708	rs2549797	0.85008721562494	Systolic blood pressure	4e-09	33230300
rs10434708	rs1056893	0.847874009087815	Systolic blood pressure	1e-06	33230300
rs10434708	rs1056893	0.847874009087815	Diastolic blood pressure	7e-15	33230300
rs10434708	rs1056893	0.847874009087815	Diastolic blood pressure	2e-11	33230300
rs10434708	rs1056893	0.847874009087815	Systolic blood pressure	7e-09	33230300
rs10434708	rs4869313	0.829026994780015	Pediatric autoimmune diseases	9e-08	26301688
rs10434708	rs1559359	0.821332617036965	Diastolic blood pressure	7e-10	34594039
rs10434708	rs2910686	0.803215586138696	Neutrophil count	4e-14	32888493
rs10434708	rs2910686	0.803215586138696	Psoriasis	2e-08	23143594
rs10434708	rs2910686	0.803215586138696	Ankylosing spondylitis	5e-17	23749187
rs10434708	rs2910686	0.803215586138696	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs10434708	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs10434708	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs10434708	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs10434708	rs1019503	0.728940392110976	Systolic blood pressure	2e-06	33230300
rs10434708	rs1019503	0.728940392110976	Diastolic blood pressure	2e-14	33230300
rs10434708	rs1019503	0.728940392110976	Diastolic blood pressure	4e-11	33230300
rs10434708	rs1019503	0.728940392110976	Systolic blood pressure	1e-08	33230300
rs10434708	rs3096168	0.723409651088165	Aspartate aminotransferase levels	8e-12	33547301
rs10434708	rs1423357	0.704924641235886	General cognitive ability	9e-06	29844566
rs10434708	rs2432142	0.691024795840694	Neutrophil count	2e-14	32888493
rs10434708	rs2432142	0.691024795840694	White blood cell count	1e-11	32888493
rs10434708	rs38033	0.685525237258851	Blood protein levels	0	30072576
rs10434708	rs27293	0.67549231404753	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs10434708	rs27293	0.67549231404753	Diastolic blood pressure	3e-11	35762941
rs10434708	rs7705093	0.666760272686482	Birdshot chorioretinopathy	2e-09	24957906
rs10434709	rs1974871	0.917411194226669	Granulysin levels	5e-13	34648354
rs10434709	rs4869314	0.904083249088078	Arthritis (juvenile idiopathic)	3e-09	33106285
rs10434709	rs4869314	0.904083249088078	Neutrophil count	1e-10	34594039
rs10434709	rs4869314	0.904083249088078	White blood cell count	2e-07	30595370
rs10434709	rs2549782	0.849350553468495	Systolic blood pressure	6e-07	33230300
rs10434709	rs2549782	0.849350553468495	Diastolic blood pressure	1e-14	33230300
rs10434709	rs2549782	0.849350553468495	Diastolic blood pressure	3e-11	33230300
rs10434709	rs2549782	0.849350553468495	Systolic blood pressure	5e-09	33230300
rs10434709	rs2549797	0.849336335969296	Systolic blood pressure	7e-07	33230300
rs10434709	rs2549797	0.849336335969296	Diastolic blood pressure	1e-14	33230300
rs10434709	rs2549797	0.849336335969296	Diastolic blood pressure	3e-11	33230300
rs10434709	rs2549797	0.849336335969296	Systolic blood pressure	4e-09	33230300
rs10434709	rs1056893	0.847125009318234	Systolic blood pressure	1e-06	33230300
rs10434709	rs1056893	0.847125009318234	Diastolic blood pressure	7e-15	33230300
rs10434709	rs1056893	0.847125009318234	Diastolic blood pressure	2e-11	33230300
rs10434709	rs1056893	0.847125009318234	Systolic blood pressure	7e-09	33230300
rs10434709	rs4869313	0.828204193776253	Pediatric autoimmune diseases	9e-08	26301688
rs10434709	rs1559359	0.822029787505849	Diastolic blood pressure	7e-10	34594039
rs10434709	rs2910686	0.802434624025319	Neutrophil count	4e-14	32888493
rs10434709	rs2910686	0.802434624025319	Psoriasis	2e-08	23143594
rs10434709	rs2910686	0.802434624025319	Ankylosing spondylitis	5e-17	23749187
rs10434709	rs2910686	0.802434624025319	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs10434709	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs10434709	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs10434709	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs10434709	rs1019503	0.728311499553418	Systolic blood pressure	2e-06	33230300
rs10434709	rs1019503	0.728311499553418	Diastolic blood pressure	2e-14	33230300
rs10434709	rs1019503	0.728311499553418	Diastolic blood pressure	4e-11	33230300
rs10434709	rs1019503	0.728311499553418	Systolic blood pressure	1e-08	33230300
rs10434709	rs3096168	0.722779873820606	Aspartate aminotransferase levels	8e-12	33547301
rs10434709	rs1423357	0.704136975909934	General cognitive ability	9e-06	29844566
rs10434709	rs2432142	0.690245044619686	Neutrophil count	2e-14	32888493
rs10434709	rs2432142	0.690245044619686	White blood cell count	1e-11	32888493
rs10434709	rs38033	0.684757433951945	Blood protein levels	0	30072576
rs10434709	rs27293	0.67472868610218	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs10434709	rs27293	0.67472868610218	Diastolic blood pressure	3e-11	35762941
rs10434709	rs7705093	0.66601105887613	Birdshot chorioretinopathy	2e-09	24957906
rs1044158	rs58588820	0.886563365759467	Total cholesterol levels	1e-09	34887591
rs1044158	rs58588820	0.886563365759467	Total cholesterol levels	8e-11	34887591
rs1044158	rs6547629	0.797132405616496	Height	3e-09	36224396
rs10452626	rs55763431	1	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs10452626	rs9689694	0.998201794182664	Right hippocampal volume (head)	6e-11	37337106
rs10452626	rs9689694	0.998201794182664	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs10452626	rs9689694	0.998201794182664	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs10452626	rs9689694	0.998201794182664	Left hippocampal volume (head)	6e-12	37337106
rs10452626	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs10452626	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs10452626	rs9383843	0.994608621917206	Migraine	1e-09	35115687
rs10452626	rs10872645	0.99281581932217	Blood protein levels	2e-86	30072576
rs10452626	rs9688867	0.991946733398874	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs10452626	rs9688867	0.991946733398874	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs10452626	rs9688809	0.991946733398874	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs10452626	rs10872653	0.991920973218723	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs10452626	rs34337297	0.988337309266227	Serum levels of protein LRP11	3e-161	35078996
rs10452626	rs14314	0.97680053310452	Macular thickness	3e-19	30535121
rs10452626	rs14314	0.97680053310452	Vertex-wise sulcal depth	7e-17	34910505
rs10452626	rs14314	0.97680053310452	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs10452626	rs14314	0.97680053310452	Left hippocampal volume (body)	7e-15	37337106
rs10452626	rs14314	0.97680053310452	Left subiculum volume (body)	1e-14	37337106
rs10452626	rs9322193	0.952199474125302	Lung cancer	1e-07	27393504
rs10452626	rs4039600	0.908526761368909	Adenine levels	1e-11	35347128
rs10452626	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-08	37844115
rs10452626	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-06	37844115
rs10452626	rs4380763	0.641447984668751	Subcortical volume (min-P)	1e-11	32665545
rs10452626	rs11155671	0.630994895975767	Testicular germ cell tumor	2e-09	28604728
rs10452626	rs80147756	0.616065401687589	HippSubfield lh volume subiculum-head	3e-10	33875891
rs10452626	rs4421206	0.60846358923055	Brain morphology (min-P)	4e-11	32665545
rs10452626	rs9505982	0.60194342559747	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs10461616	rs702689	0.766957491436935	Vertex-wise sulcal depth	2e-22	34910505
rs10461616	rs10061757	0.754302740913889	Height	4e-30	30595370
rs10461616	rs96844	0.738376409161938	Type 2 diabetes	5e-08	30297969
rs10461616	rs96844	0.738376409161938	Height	4e-33	36224396
rs10461616	rs9292122	0.706430203310568	Prostate cancer	5e-09	33398198
rs10461616	rs33320	0.623783869185502	Height	9e-14	36224396
rs10461616	rs2257505	0.617862609763219	Height	8e-192	36224396
rs10461976	rs150621	0.907332468494907	Appendicular lean mass	5e-12	31761296
rs10461976	rs2098713	0.768373952997737	Telomere length	3e-06	24795349
rs10461976	rs757720522	0.646556267923001	Appendicular lean mass	3e-11	31761296
rs1046395	rs2617439	0.975955243907605	Neutrophil count	8e-11	32888494
rs1046395	rs2549794	0.961193140232331	Crohn's disease	1e-10	21102463
rs1046395	rs2549794	0.961193140232331	Systolic blood pressure	1e-07	33230300
rs1046395	rs2549794	0.961193140232331	Diastolic blood pressure	1e-15	33230300
rs1046395	rs2549794	0.961193140232331	Diastolic blood pressure	2e-12	33230300
rs1046395	rs2549794	0.961193140232331	Systolic blood pressure	4e-10	33230300
rs1046395	rs38029	0.956803843587467	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1046395	rs1363907	0.955977326243215	Crohn's disease	4e-16	26192919
rs1046395	rs1363907	0.955977326243215	Ulcerative colitis	4e-06	26192919
rs1046395	rs1363907	0.955977326243215	Inflammatory bowel disease	5e-15	26192919
rs1046395	rs1363907	0.955977326243215	Inflammatory bowel disease	6e-13	23128233
rs1046395	rs1363907	0.955977326243215	Inflammatory bowel disease	1e-10	28067908
rs1046395	rs1363907	0.955977326243215	Crohn's disease	1e-14	28067908
rs1046395	rs716848	0.925835004803164	Neutrophil percentage of white cells	2e-09	32888494
rs1046395	rs2548532	0.863102716291506	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1046395	rs27660	0.792612137147841	Coronary artery disease	3e-08	35915156
rs1046395	rs1423357	0.791999999549796	General cognitive ability	9e-06	29844566
rs1046395	rs2432142	0.781422714392652	Neutrophil count	2e-14	32888493
rs1046395	rs2432142	0.781422714392652	White blood cell count	1e-11	32888493
rs1046395	rs38033	0.779648251036857	Blood protein levels	0	30072576
rs1046395	rs27293	0.764843083380488	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1046395	rs27293	0.764843083380488	Diastolic blood pressure	3e-11	35762941
rs1046395	rs7705093	0.756862075784525	Birdshot chorioretinopathy	2e-09	24957906
rs1046395	rs4869313	0.696693539406121	Pediatric autoimmune diseases	9e-08	26301688
rs1046395	rs2927608	0.695733491798993	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1046395	rs2927608	0.695733491798993	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1046395	rs2927608	0.695733491798993	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1046395	rs2910686	0.693437004912761	Neutrophil count	4e-14	32888493
rs1046395	rs2910686	0.693437004912761	Psoriasis	2e-08	23143594
rs1046395	rs2910686	0.693437004912761	Ankylosing spondylitis	5e-17	23749187
rs1046395	rs2910686	0.693437004912761	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1046395	rs1559359	0.634397774088865	Diastolic blood pressure	7e-10	34594039
rs1046395	rs1974871	0.62547349925666	Granulysin levels	5e-13	34648354
rs1046395	rs2549797	0.617911931130549	Systolic blood pressure	7e-07	33230300
rs1046395	rs2549797	0.617911931130549	Diastolic blood pressure	1e-14	33230300
rs1046395	rs2549797	0.617911931130549	Diastolic blood pressure	3e-11	33230300
rs1046395	rs2549797	0.617911931130549	Systolic blood pressure	4e-09	33230300
rs1046395	rs2549782	0.616909157198462	Systolic blood pressure	6e-07	33230300
rs1046395	rs2549782	0.616909157198462	Diastolic blood pressure	1e-14	33230300
rs1046395	rs2549782	0.616909157198462	Diastolic blood pressure	3e-11	33230300
rs1046395	rs2549782	0.616909157198462	Systolic blood pressure	5e-09	33230300
rs1046395	rs1056893	0.616408442039816	Systolic blood pressure	1e-06	33230300
rs1046395	rs1056893	0.616408442039816	Diastolic blood pressure	7e-15	33230300
rs1046395	rs1056893	0.616408442039816	Diastolic blood pressure	2e-11	33230300
rs1046395	rs1056893	0.616408442039816	Systolic blood pressure	7e-09	33230300
rs1046396	rs1423357	0.986582188778059	General cognitive ability	9e-06	29844566
rs1046396	rs2432142	0.974916129078884	Neutrophil count	2e-14	32888493
rs1046396	rs2432142	0.974916129078884	White blood cell count	1e-11	32888493
rs1046396	rs38033	0.970108159431638	Blood protein levels	0	30072576
rs1046396	rs27293	0.95935531279904	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1046396	rs27293	0.95935531279904	Diastolic blood pressure	3e-11	35762941
rs1046396	rs7705093	0.952440391942808	Birdshot chorioretinopathy	2e-09	24957906
rs1046396	rs2910686	0.862551276632618	Neutrophil count	4e-14	32888493
rs1046396	rs2910686	0.862551276632618	Psoriasis	2e-08	23143594
rs1046396	rs2910686	0.862551276632618	Ankylosing spondylitis	5e-17	23749187
rs1046396	rs2910686	0.862551276632618	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1046396	rs2927608	0.859243120310723	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1046396	rs2927608	0.859243120310723	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1046396	rs2927608	0.859243120310723	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1046396	rs2617439	0.774567530845851	Neutrophil count	8e-11	32888494
rs1046396	rs2549797	0.767740036377871	Systolic blood pressure	7e-07	33230300
rs1046396	rs2549797	0.767740036377871	Diastolic blood pressure	1e-14	33230300
rs1046396	rs2549797	0.767740036377871	Diastolic blood pressure	3e-11	33230300
rs1046396	rs2549797	0.767740036377871	Systolic blood pressure	4e-09	33230300
rs1046396	rs2549782	0.766487603000068	Systolic blood pressure	6e-07	33230300
rs1046396	rs2549782	0.766487603000068	Diastolic blood pressure	1e-14	33230300
rs1046396	rs2549782	0.766487603000068	Diastolic blood pressure	3e-11	33230300
rs1046396	rs2549782	0.766487603000068	Systolic blood pressure	5e-09	33230300
rs1046396	rs1056893	0.765862225407113	Systolic blood pressure	1e-06	33230300
rs1046396	rs1056893	0.765862225407113	Diastolic blood pressure	7e-15	33230300
rs1046396	rs1056893	0.765862225407113	Diastolic blood pressure	2e-11	33230300
rs1046396	rs1056893	0.765862225407113	Systolic blood pressure	7e-09	33230300
rs1046396	rs2549794	0.760566583990644	Crohn's disease	1e-10	21102463
rs1046396	rs2549794	0.760566583990644	Systolic blood pressure	1e-07	33230300
rs1046396	rs2549794	0.760566583990644	Diastolic blood pressure	1e-15	33230300
rs1046396	rs2549794	0.760566583990644	Diastolic blood pressure	2e-12	33230300
rs1046396	rs2549794	0.760566583990644	Systolic blood pressure	4e-10	33230300
rs1046396	rs38029	0.758351361592127	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1046396	rs1363907	0.755952126251859	Crohn's disease	4e-16	26192919
rs1046396	rs1363907	0.755952126251859	Ulcerative colitis	4e-06	26192919
rs1046396	rs1363907	0.755952126251859	Inflammatory bowel disease	5e-15	26192919
rs1046396	rs1363907	0.755952126251859	Inflammatory bowel disease	6e-13	23128233
rs1046396	rs1363907	0.755952126251859	Inflammatory bowel disease	1e-10	28067908
rs1046396	rs1363907	0.755952126251859	Crohn's disease	1e-14	28067908
rs1046396	rs716848	0.727752798904229	Neutrophil percentage of white cells	2e-09	32888494
rs1046396	rs4869313	0.716446590591708	Pediatric autoimmune diseases	9e-08	26301688
rs1046396	rs1559359	0.710379112149872	Diastolic blood pressure	7e-10	34594039
rs1046396	rs2548532	0.682907675260646	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1046396	rs4869314	0.663737274588875	Arthritis (juvenile idiopathic)	3e-09	33106285
rs1046396	rs4869314	0.663737274588875	Neutrophil count	1e-10	34594039
rs1046396	rs4869314	0.663737274588875	White blood cell count	2e-07	30595370
rs1046396	rs1974871	0.637172121989015	Granulysin levels	5e-13	34648354
rs1046396	rs1019503	0.633253451798911	Systolic blood pressure	2e-06	33230300
rs1046396	rs1019503	0.633253451798911	Diastolic blood pressure	2e-14	33230300
rs1046396	rs1019503	0.633253451798911	Diastolic blood pressure	4e-11	33230300
rs1046396	rs1019503	0.633253451798911	Systolic blood pressure	1e-08	33230300
rs1046396	rs27660	0.62917039288261	Coronary artery disease	3e-08	35915156
rs1046396	rs3096168	0.625855028057329	Aspartate aminotransferase levels	8e-12	33547301
rs10465746	rs10465746	1	Obesity-related traits	8e-06	23251661
rs10465746	rs11580836	0.958206121290169	Body mass index	2e-09	36581621
rs10468026	rs1436958	0.947755297512776	IgG glycosylation	9e-06	23382691
rs10468026	rs2162062	0.850945433367305	Height	2e-13	35831902
rs10468026	rs933807	0.804794994510953	Fat-free mass	6e-06	30593698
rs10468026	rs933807	0.804794994510953	Fat-free mass	2e-07	30593698
rs10468026	rs933807	0.804794994510953	Fat-free mass	8e-11	30593698
rs10468026	rs7178540	0.712613048087985	Height	1e-31	36224396
rs10468026	rs11635977	0.69535777334501	Height	2e-25	36224396
rs10468026	rs72749770	0.682034505645725	Low density lipoprotein cholesterol levels	9e-10	32493714
rs10468026	rs72749770	0.682034505645725	Apolipoprotein B levels	2e-09	32203549
rs10468026	rs7162536	0.681067646685777	Height	4e-29	34594039
rs10468026	rs7178424	0.67498341409126	Height	6e-09	20881960
rs10468026	rs7178424	0.67498341409126	Height	6e-13	35831902
rs10468026	rs7178424	0.67498341409126	Height	3e-251	36224396
rs10468026	rs17271431	0.672521139679184	Height	2e-11	34594039
rs10468026	rs17205463	0.67196290396146	Serum levels of protein IGF1	8e-08	27329260
rs10468026	rs17205463	0.67196290396146	Appendicular lean mass	4e-43	33097823
rs10468026	rs17205463	0.67196290396146	Height	2e-35	30595370
rs10468026	rs731820	0.65892666142705	Height	2e-13	31562340
rs10468026	rs731820	0.65892666142705	Height	2e-12	35831902
rs10468026	rs12901247	0.613450813023664	Insular cortex volume	4e-06	31530798
rs10471991	rs9292122	0.94087782231902	Prostate cancer	5e-09	33398198
rs10471991	rs702689	0.758883235021304	Vertex-wise sulcal depth	2e-22	34910505
rs10473040	rs150621	0.875561361138986	Appendicular lean mass	5e-12	31761296
rs10473040	rs2098713	0.84604889354728	Telomere length	3e-06	24795349
rs10473040	rs757720522	0.719529950911137	Appendicular lean mass	3e-11	31761296
rs1047635	rs835341	0.923955030937436	Ascending aorta distensibility (MTAG)	8e-09	35922433
rs1047635	rs946155	0.769810037136581	Glutathione peroxidase 7 levels (GPX7.8345.27.3)	2e-61	29875488
rs10476696	rs38033	0.999162681066456	Blood protein levels	0	30072576
rs10476696	rs27293	0.97999228379099	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs10476696	rs27293	0.97999228379099	Diastolic blood pressure	3e-11	35762941
rs10476696	rs1423357	0.975919904087271	General cognitive ability	9e-06	29844566
rs10476696	rs2432142	0.964327802988691	Neutrophil count	2e-14	32888493
rs10476696	rs2432142	0.964327802988691	White blood cell count	1e-11	32888493
rs10476696	rs7705093	0.931957252721942	Birdshot chorioretinopathy	2e-09	24957906
rs10476696	rs2910686	0.850310000763992	Neutrophil count	4e-14	32888493
rs10476696	rs2910686	0.850310000763992	Psoriasis	2e-08	23143594
rs10476696	rs2910686	0.850310000763992	Ankylosing spondylitis	5e-17	23749187
rs10476696	rs2910686	0.850310000763992	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs10476696	rs2927608	0.847058111515012	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs10476696	rs2927608	0.847058111515012	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs10476696	rs2927608	0.847058111515012	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs10476696	rs38029	0.787278648176305	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs10476696	rs2617439	0.767153184851051	Neutrophil count	8e-11	32888494
rs10476696	rs2549797	0.755492244818526	Systolic blood pressure	7e-07	33230300
rs10476696	rs2549797	0.755492244818526	Diastolic blood pressure	1e-14	33230300
rs10476696	rs2549797	0.755492244818526	Diastolic blood pressure	3e-11	33230300
rs10476696	rs2549797	0.755492244818526	Systolic blood pressure	4e-09	33230300
rs10476696	rs2549782	0.754240112881046	Systolic blood pressure	6e-07	33230300
rs10476696	rs2549782	0.754240112881046	Diastolic blood pressure	1e-14	33230300
rs10476696	rs2549782	0.754240112881046	Diastolic blood pressure	3e-11	33230300
rs10476696	rs2549782	0.754240112881046	Systolic blood pressure	5e-09	33230300
rs10476696	rs1056893	0.753614886022533	Systolic blood pressure	1e-06	33230300
rs10476696	rs1056893	0.753614886022533	Diastolic blood pressure	7e-15	33230300
rs10476696	rs1056893	0.753614886022533	Diastolic blood pressure	2e-11	33230300
rs10476696	rs1056893	0.753614886022533	Systolic blood pressure	7e-09	33230300
rs10476696	rs2549794	0.753116885568819	Crohn's disease	1e-10	21102463
rs10476696	rs2549794	0.753116885568819	Systolic blood pressure	1e-07	33230300
rs10476696	rs2549794	0.753116885568819	Diastolic blood pressure	1e-15	33230300
rs10476696	rs2549794	0.753116885568819	Diastolic blood pressure	2e-12	33230300
rs10476696	rs2549794	0.753116885568819	Systolic blood pressure	4e-10	33230300
rs10476696	rs1363907	0.748522295507647	Crohn's disease	4e-16	26192919
rs10476696	rs1363907	0.748522295507647	Ulcerative colitis	4e-06	26192919
rs10476696	rs1363907	0.748522295507647	Inflammatory bowel disease	5e-15	26192919
rs10476696	rs1363907	0.748522295507647	Inflammatory bowel disease	6e-13	23128233
rs10476696	rs1363907	0.748522295507647	Inflammatory bowel disease	1e-10	28067908
rs10476696	rs1363907	0.748522295507647	Crohn's disease	1e-14	28067908
rs10476696	rs716848	0.720289188810334	Neutrophil percentage of white cells	2e-09	32888494
rs10476696	rs4869313	0.70607864510372	Pediatric autoimmune diseases	9e-08	26301688
rs10476696	rs1559359	0.69936734724382	Diastolic blood pressure	7e-10	34594039
rs10476696	rs2548532	0.676718762605027	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs10476696	rs4869314	0.65200696765962	Arthritis (juvenile idiopathic)	3e-09	33106285
rs10476696	rs4869314	0.65200696765962	Neutrophil count	1e-10	34594039
rs10476696	rs4869314	0.65200696765962	White blood cell count	2e-07	30595370
rs10476696	rs1974871	0.62687278502461	Granulysin levels	5e-13	34648354
rs10476696	rs27660	0.624108110262596	Coronary artery disease	3e-08	35915156
rs10476696	rs1019503	0.62228716114171	Systolic blood pressure	2e-06	33230300
rs10476696	rs1019503	0.62228716114171	Diastolic blood pressure	2e-14	33230300
rs10476696	rs1019503	0.62228716114171	Diastolic blood pressure	4e-11	33230300
rs10476696	rs1019503	0.62228716114171	Systolic blood pressure	1e-08	33230300
rs10476696	rs3096168	0.615033212060043	Aspartate aminotransferase levels	8e-12	33547301
rs1048135	rs6705511	0.685022729478207	Self-reported math ability	4e-09	30038396
rs1048135	rs6705511	0.685022729478207	Self-reported math ability (MTAG)	3e-10	30038396
rs1048135	rs34276187	0.679315484413304	Highest math class taken (MTAG)	2e-08	30038396
rs10493744	rs11580836	0.944718411083462	Body mass index	2e-09	36581621
rs10493744	rs10465746	0.926824374678406	Obesity-related traits	8e-06	23251661
rs10504930	rs6471393	0.70796486467486	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs10507832	rs2224797	0.885629366833941	Red blood cell count	5e-08	30595370
rs10507832	rs2224797	0.885629366833941	Mean corpuscular hemoglobin	3e-09	30595370
rs1053982	rs1053982	1	Severe COVID-19 infection	9e-06	36662838
rs1053982	rs2227169	0.975137801378867	Severe COVID-19 infection	4e-13	36662838
rs1053982	rs6000172	0.957434234185563	Severe COVID-19 infection	1e-07	36662838
rs1053982	rs4821461	0.939017742744797	Severe COVID-19 infection	4e-06	36662838
rs1053982	rs5756090	0.829738922000518	Severe COVID-19 infection	4e-08	36662838
rs1053983	rs1053982	0.999136130388745	Severe COVID-19 infection	9e-06	36662838
rs1053983	rs2227169	0.975981995481602	Severe COVID-19 infection	4e-13	36662838
rs1053983	rs6000172	0.958262581217764	Severe COVID-19 infection	1e-07	36662838
rs1053983	rs4821461	0.939831751060412	Severe COVID-19 infection	4e-06	36662838
rs1053983	rs5756090	0.83045632798574	Severe COVID-19 infection	4e-08	36662838
rs1057232	rs3965185	0.934422671808517	High-density lipoprotein levels (MTAG)	4e-11	36376304
rs1057610	rs2076435	0.984891737705927	Inguinal hernia	2e-08	35022708
rs1057610	rs2076435	0.984891737705927	Inguinal hernia	2e-09	35022708
rs1057610	rs2076438	0.862455433763165	Coronary artery disease	3e-08	33020668
rs1057610	rs2235642	0.860390732975651	Coronary artery disease	8e-06	29212778
rs1059307	rs1173416	0.927425296898331	Height	2e-59	36224396
rs1059307	rs2842611	0.881596570575011	High density lipoprotein cholesterol levels	5e-09	34887591
rs1059307	rs9450288	0.838155103295504	Height	2e-10	36224396
rs1060870	rs1060870	1	Serum metabolite levels	1e-11	33031748
rs1060870	rs1060870	1	Serum metabolite levels	1e-15	33031748
rs1060870	rs6698740	0.99837959677725	Beta-hydroxyisovalerate levels	1e-13	35347128
rs1060870	rs6685187	0.992718344958297	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs1060870	rs2338201	0.976674389399637	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs1060870	rs2338201	0.976674389399637	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs1060870	rs2338201	0.976674389399637	Dodecadienoate (12:2) levels	7e-15	36635386
rs1060870	rs11204914	0.967857694680128	Carnitine C9 levels	1e-13	35995766
rs1060870	rs11204914	0.967857694680128	Metabolite peak levels (QI6204)	1e-32	35995766
rs1060870	rs11204914	0.967857694680128	Metabolite peak levels (QI6252)	2e-32	35995766
rs1060870	rs10788817	0.955118175630483	Serum metabolite levels	3e-13	24625756
rs1060870	rs10788817	0.955118175630483	Metabolite peak levels (QI2718)	5e-18	35995766
rs1060870	rs10788817	0.955118175630483	3-hydroxylaurate levels	2e-12	36635386
rs1060870	rs10788817	0.955118175630483	Tetradecadienoate (14:2) levels	8e-17	36635386
rs1060870	rs7542137	0.837849309538796	Beta-hydroxyisovalerate levels	3e-11	35050183
rs1060870	rs7542137	0.837849309538796	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs1060870	rs7542137	0.837849309538796	3-hydroxysebacate levels	2e-10	36635386
rs1060870	rs7523082	0.830111634377863	Metabolite peak levels (QI9845)	2e-14	35995766
rs1060870	rs2130525	0.813195501359851	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs1060870	rs10888445	0.811301269656331	Beta-hydroxyisovalerate levels	5e-13	36635386
rs1060870	rs7541453	0.805530116888108	Serum metabolite levels	2e-16	33031748
rs1060870	rs7541453	0.805530116888108	Serum metabolite levels	2e-16	33031748
rs1060870	rs7541453	0.805530116888108	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs1060870	rs2999545	0.796288418067819	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs1060870	rs2279501	0.780339085259768	Serum metabolite levels	3e-14	33031748
rs1060870	rs3007711	0.757510557106821	Electrodermal activity	9e-06	25387706
rs1060870	rs2999541	0.756603012838021	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs1060870	rs1038747	0.659917878784084	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs1061115	rs942810	0.826417442779154	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs1061115	rs942810	0.826417442779154	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs1061115	rs942810	0.826417442779154	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs1061115	rs942810	0.826417442779154	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs1061115	rs942810	0.826417442779154	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs1061115	rs942810	0.826417442779154	N6-methyllysine levels (advanced age)	2e-11	37118062
rs1061115	rs1739	0.791184530001579	Metabolite peak levels (QI7389)	3e-91	35995766
rs1061115	rs1737	0.79052092506806	Arginine levels	3e-24	35995766
rs1061115	rs6584194	0.714764094670979	Metabolite peak levels (QI9680)	2e-135	35995766
rs1061115	rs6584194	0.714764094670979	Metabolite peak levels (QI8984)	5e-11	35995766
rs1061115	rs6584194	0.714764094670979	X-24736 levels	3e-13	36635386
rs1061115	rs4488133	0.647871178429367	Serum metabolite levels	2e-281	23093944
rs1061115	rs4488133	0.647871178429367	Serum metabolite levels	1e-27	23093944
rs1061115	rs4488133	0.647871178429367	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs1061115	rs4488133	0.647871178429367	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs1061115	rs4488133	0.647871178429367	Urine X-12112 levels in chronic kidney disease	0	37277652
rs1061115	rs4488133	0.647871178429367	X-12093 levels	1e-48	24816252
rs1061115	rs4488133	0.647871178429367	X-12092 levels	0	24816252
rs1061115	rs7072216	0.644360086086941	Metabolite levels	8e-15	21931564
rs1061115	rs7072216	0.644360086086941	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs1061115	rs10883083	0.636804130463775	N2-acetyl,N6-methyllysine levels	0	35347128
rs1061115	rs10883083	0.636804130463775	X-12112 levels	0	35347128
rs1061115	rs10883083	0.636804130463775	Arginine levels	1e-16	35347128
rs1061115	rs10883083	0.636804130463775	Metabolite peak levels (QI8972)	2e-124	35995766
rs1061115	rs10883083	0.636804130463775	Metabolite peak levels (QI5171)	8e-96	35995766
rs1061115	rs2147896	0.636804130463775	Urinary metabolites (H-NMR features)	3e-164	24586186
rs1061115	rs2147896	0.636804130463775	Urinary metabolites (H-NMR features)	8e-30	24586186
rs1061115	rs2147896	0.636804130463775	Urinary metabolites (H-NMR features)	2e-55	24586186
rs1061115	rs2147896	0.636804130463775	Urinary metabolites (H-NMR features)	6e-19	24586186
rs1061115	rs2147896	0.636804130463775	Urinary metabolites (H-NMR features)	4e-34	24586186
rs1061115	rs2147896	0.636804130463775	Trimethylamine levels	4e-144	33283231
rs1061115	rs2147896	0.636804130463775	Serum metabolite levels	1e-15	33031748
rs1061115	rs2147896	0.636804130463775	Serum metabolite levels	4e-226	33031748
rs1061115	rs2147896	0.636804130463775	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs1061115	rs2147896	0.636804130463775	Urinary metabolite levels in chronic kidney disease	0	31959995
rs1061115	rs2147896	0.636804130463775	Urinary metabolite levels in chronic kidney disease	0	31959995
rs1061115	rs2147896	0.636804130463775	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs1061115	rs2147896	0.636804130463775	N6-methyllysine levels	3e-198	33437055
rs1061115	rs2147896	0.636804130463775	N6-methyllysine levels	0	35347128
rs1061115	rs2147896	0.636804130463775	N-methylpipecolate levels	0	35050183
rs1061115	rs2147896	0.636804130463775	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs1061115	rs2147896	0.636804130463775	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs1061115	rs2147896	0.636804130463775	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs1061115	rs2147896	0.636804130463775	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1061115	rs2147896	0.636804130463775	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs1061115	rs2147896	0.636804130463775	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1061115	rs2147896	0.636804130463775	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1061115	rs2147896	0.636804130463775	X-12092 levels	4e-191	27073872
rs1061115	rs2147896	0.636804130463775	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs1061115	rs2147896	0.636804130463775	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs1061115	rs2147896	0.636804130463775	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs1061115	rs2147896	0.636804130463775	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs1061115	rs2147896	0.636804130463775	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs1061115	rs2147896	0.636804130463775	N6-methyllysine levels (advanced age)	5e-25	37118062
rs1061115	rs2147896	0.636804130463775	X-12112 levels	0	36635386
rs1061115	rs2147896	0.636804130463775	N6-methyllysine levels	0	36635386
rs1061115	rs2147896	0.636804130463775	N6,N6-dimethyllysine levels	0	36635386
rs1061115	rs2147896	0.636804130463775	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs1061115	rs2147896	0.636804130463775	N2-acetyl,N6-methyllysine levels	0	36635386
rs1061115	rs10786415	0.636804130463775	N6,N6-dimethyllysine levels	0	35347128
rs1061115	rs10786415	0.636804130463775	N-methylpipecolate levels	0	35347128
rs1061115	rs10786415	0.636804130463775	X-25810 levels	4e-11	36635386
rs1061115	rs942814	0.636804130463775	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs1061115	rs4539242	0.63608190548852	Urinary metabolites (H-NMR features)	2e-20	24586186
rs1061115	rs4539242	0.63608190548852	X-24809 levels	4e-67	33177712
rs1061115	rs4539242	0.63608190548852	X-24983 levels	8e-59	33177712
rs1061115	rs4539242	0.63608190548852	X-12112 levels	4e-63	33177712
rs1061115	rs4539242	0.63608190548852	N-methylpipecolate levels	3e-12	33177712
rs1061115	rs4539242	0.63608190548852	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs1061115	rs4539242	0.63608190548852	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs1061115	rs4539242	0.63608190548852	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs1061115	rs4539242	0.63608190548852	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs1061115	rs4539242	0.63608190548852	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs1061115	rs4539242	0.63608190548852	N6-methyllysine levels (advanced age)	5e-25	37118062
rs1061115	rs4539242	0.63608190548852	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs1061115	rs7905265	0.633763404987537	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs1061115	rs7905265	0.633763404987537	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs1061115	rs7905265	0.633763404987537	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs1061115	rs7905265	0.633763404987537	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1061115	rs7905265	0.633763404987537	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs1061115	rs7905265	0.633763404987537	N6,N6-dimethyllysine levels	2e-132	35995766
rs1061115	rs7905265	0.633763404987537	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs1061115	rs10786414	0.622106358939571	ADMA levels	5e-18	35995766
rs1061115	rs942813	0.618558871740077	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs1061115	rs3830025	0.615971772128578	Resting-state network 3 amplitude (blood oxygenation level dependent) (Attention)	2e-08	36462729
rs1061115	rs3830025	0.615971772128578	Resting-state network 20 amplitude (blood oxygenation level dependent) (Precuneal default mode network)	1e-08	36462729
rs1061115	rs11598867	0.611006299471268	Urinary metabolites	1e-307	26352407
rs1061115	rs45523432	0.60993939880059	Resting-state network 9 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs10698992	rs10698992	1	von Willebrand factor A domain-containing protein 2 levels	9e-13	34648354
rs10734259	rs4353250	0.998726597476597	Insulin-like growth factor 1 levels	2e-14	33462484
rs10734259	rs4353250	0.998726597476597	Amyloid A serum levels	2e-51	21124955
rs10734259	rs4150575	0.635173936837598	Imidazole lactate levels	1e-10	36635386
rs10735002	rs9739162	0.632265291295675	Neurofibrillary tangles	3e-06	28322283
rs10735079	rs1859336	0.746740146023313	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10735079	rs6489882	0.745125805537863	Chronic lymphocytic leukemia	5e-08	28165464
rs10735079	rs11066452	0.729558509457063	Blood protein levels	6e-08	30072576
rs10735079	rs4767027	0.713295231427556	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10735079	rs2057778	0.712291996249232	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10735079	rs2057778	0.712291996249232	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10735079	rs2057778	0.712291996249232	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10735079	rs1131476	0.690627990592484	Systemic lupus erythematosus	1e-09	33272962
rs10735079	rs2660	0.690627990592484	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10735079	rs2660	0.690627990592484	COVID-19 (critical illness vs population)	3e-15	37198478
rs10738078	rs9366863	0.99518383438223	Adult body size	9e-33	32376654
rs10738078	rs9366863	0.99518383438223	Body mass index	2e-44	30595370
rs10738078	rs9469872	0.972068593056418	HDL cholesterol levels	3e-11	36333282
rs10738078	rs11755393	0.965100699216519	Body mass index	3e-26	29273807
rs10738078	rs11755393	0.965100699216519	Systemic lupus erythematosus	2e-12	33493351
rs10738078	rs11755393	0.965100699216519	Systemic lupus erythematosus	2e-06	33493351
rs10738078	rs11755393	0.965100699216519	Systemic lupus erythematosus	1e-07	33493351
rs10738078	rs11755393	0.965100699216519	Systemic lupus erythematosus	2e-08	19838195
rs10738078	rs11755393	0.965100699216519	Body mass index	4e-55	36581621
rs10738078	rs2814949	0.957889170407418	Essential hypertension (time to event)	9e-09	32589924
rs10738078	rs6941110	0.955495512234789	Sex hormone-binding globulin levels	5e-27	36653534
rs10738078	rs2744944	0.948442138716483	Hypothyroidism	3e-10	34594039
rs10738078	rs2744944	0.948442138716483	High density lipoprotein cholesterol levels	3e-86	34887591
rs10738078	rs2744944	0.948442138716483	Multi-trait sex score	7e-22	37277458
rs10738078	rs9462030	0.936178098219259	Red cell distribution width	5e-25	32888493
rs10738078	rs9469857	0.931559336823595	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs10738078	rs2764208	0.930821929239406	Systemic lupus erythematosus	7e-06	24871463
rs10738078	rs2263329	0.928977396476005	HDL cholesterol	6e-35	34594039
rs10738078	rs2263329	0.928977396476005	HDL cholesterol levels	8e-43	32203549
rs10738078	rs2263329	0.928977396476005	High density lipoprotein cholesterol levels	2e-52	34887591
rs10738078	rs9469899	0.919693061740305	Prostate cancer (advanced)	2e-06	29892016
rs10738078	rs9469899	0.919693061740305	Prostate cancer	5e-09	29892016
rs10738078	rs9469899	0.919693061740305	Prostate cancer	8e-11	33398198
rs10738078	rs9469899	0.919693061740305	Hand grip strength	3e-15	29691431
rs10738078	rs9469899	0.919693061740305	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs10738078	rs9469899	0.919693061740305	Graves' disease	4e-10	34594039
rs10738078	rs9469899	0.919693061740305	Coronary artery disease	1e-11	36474045
rs10738078	rs9469899	0.919693061740305	Predicted visceral adipose tissue	2e-20	31501611
rs10738078	rs9469899	0.919693061740305	Medication use (thyroid preparations)	2e-09	31015401
rs10738078	rs9469899	0.919693061740305	Medication use (thyroid preparations)	3e-10	34594039
rs10738078	rs111868030	0.904463140684286	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs10738078	rs9296128	0.883088766449055	Hip circumference adjusted for BMI	4e-13	34021172
rs10738078	rs9368830	0.881441344085563	HDL cholesterol	4e-21	30275531
rs10738078	rs9368828	0.85016499862766	Body mass index	1e-34	34594039
rs10738078	rs6912327	0.812709712702608	Fasting insulin	5e-06	33402679
rs10738078	rs6912327	0.812709712702608	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs10738078	rs2744973	0.795213980400978	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs10738078	rs2744973	0.795213980400978	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs10738078	rs2744973	0.795213980400978	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs10738078	rs2744973	0.795213980400978	Multi-trait sex score	6e-20	37277458
rs10738078	rs112283401	0.79012008233362	Red cell distribution width	4e-27	30595370
rs10738078	rs6940215	0.632530070230836	Insomnia	2e-10	35835914
rs10738078	rs6940215	0.632530070230836	Insomnia	1e-13	35835914
rs10738078	rs6940215	0.632530070230836	Hip circumference adjusted for BMI	8e-10	34021172
rs10738078	rs6940215	0.632530070230836	Multi-trait sex score	2e-23	37277458
rs10738078	rs6940215	0.632530070230836	Multi-trait sex score	4e-23	37277458
rs10738078	rs6457796	0.62350918368825	Insomnia	1e-08	30804565
rs10738078	rs6457796	0.62350918368825	Plateletcrit	9e-11	32888494
rs10738078	rs6457796	0.62350918368825	Systemic lupus erythematosus	3e-22	33272962
rs10738078	rs6457796	0.62350918368825	Body mass index	5e-13	30108127
rs10738078	rs6457796	0.62350918368825	Body mass index	1e-14	26426971
rs10738078	rs6457796	0.62350918368825	Educational attainment	5e-19	35361970
rs10738078	rs205262	0.607740723311523	Body mass index	2e-09	26961502
rs10738078	rs205262	0.607740723311523	Walking pace	4e-10	33128006
rs10738078	rs205262	0.607740723311523	Body mass index	8e-13	30108127
rs10738078	rs205262	0.607740723311523	Body mass index	2e-09	25673413
rs10738078	rs205262	0.607740723311523	Body mass index	2e-14	26426971
rs10738078	rs205262	0.607740723311523	BMI in non-smokers	3e-07	28443625
rs10738078	rs205262	0.607740723311523	BMI in non-smokers	6e-09	28443625
rs10738078	rs205262	0.607740723311523	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs10738078	rs205262	0.607740723311523	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs10738078	rs205262	0.607740723311523	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs10738078	rs205262	0.607740723311523	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs10738078	rs205262	0.607740723311523	Gastroesophageal reflux disease	1e-10	34187846
rs10738078	rs205262	0.607740723311523	Body mass index	3e-10	25673413
rs10738078	rs205262	0.607740723311523	Body mass index	2e-10	25673413
rs10738078	rs205262	0.607740723311523	ICD10 M54: Dorsalgia	2e-12	35110524
rs10738078	rs9689160	0.602879024088245	Lung function (forced vital capacity)	3e-14	36914875
rs1073909	rs4304220	0.780004782058467	Height	2e-14	36224396
rs1073909	rs4355658	0.753671849015617	Height	3e-13	36224396
rs1073909	rs12539962	0.617205983020552	Colorectal cancer	3e-08	36539618
rs10744788	rs1557866	1	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10744788	rs1293767	0.897639450963228	Adult asthma	2e-06	27611488
rs10744788	rs1293767	0.897639450963228	Adult asthma	9e-07	27611488
rs10744788	rs6489882	0.64174960194697	Chronic lymphocytic leukemia	5e-08	28165464
rs10744788	rs1859336	0.61982849623932	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10744788	rs10744789	0.610025075807648	Vitamin D levels or COVID-19 (MTAG)	5e-12	37212302
rs10744788	rs4767027	0.6033381828865	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10744788	rs2057778	0.600481748899161	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10744788	rs2057778	0.600481748899161	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10744788	rs2057778	0.600481748899161	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1074541	rs61798917	0.802209546528422	Height	2e-10	30595370
rs10754258	rs10922531	0.976788333372122	Serum metabolite levels	2e-69	33031748
rs10754258	rs12729558	0.854119448847423	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs10754258	rs12120164	0.836211989037498	Metabolite peak levels (QI2146)	1e-26	35995766
rs10754258	rs7530513	0.801995937541185	Height	8e-11	35831902
rs10754258	rs7530513	0.801995937541185	Imidazole lactate levels	8e-166	36635386
rs10754258	rs12144640	0.801995937541185	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10754258	rs7532151	0.795672189909118	Imidazole lactate levels	9e-12	33177712
rs10754258	rs10801699	0.794034661780289	X-23639 levels	2e-10	36635386
rs10754258	rs1409152	0.791704915401043	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs10754258	rs1409152	0.791704915401043	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs10754258	rs10801690	0.771812104537756	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs10754258	rs9787133	0.744909097458032	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10754258	rs2765527	0.697105459432103	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs10754258	rs2810876	0.602522511686679	Imidazole lactate levels	2e-122	35347128
rs10754258	rs10801696	0.600100197784114	Imidazole lactate levels	3e-195	35050183
rs10754323	rs7551732	0.96281076739399	Height	6e-20	25282103
rs10754323	rs7551732	0.96281076739399	Gamma glutamyl transferase levels	5e-08	33339817
rs10754323	rs6699417	0.953310227746126	Height	5e-09	20881960
rs10754323	rs6699417	0.953310227746126	Height	2e-11	35831902
rs10754323	rs6699417	0.953310227746126	Height	1e-300	36224396
rs10754323	rs6699417	0.953310227746126	Height	1e-300	36224396
rs10754323	rs1002436	0.850237303677952	Red blood cell count	4e-22	32888493
rs10754323	rs1002436	0.850237303677952	Alanine aminotransferase levels	6e-11	33547301
rs10754323	rs1002436	0.850237303677952	Aspartate aminotransferase levels	1e-20	33547301
rs10754323	rs1002436	0.850237303677952	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs10754323	rs12145712	0.755946913646055	Pulse pressure	1e-10	35762941
rs10754323	rs10922476	0.685218632673379	Corneal resistance factor	4e-17	33311554
rs10754323	rs12145922	0.683818140293292	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs10754323	rs12145922	0.683818140293292	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs10754323	rs3806340	0.683818140293292	Corneal resistance factor (MTAG)	3e-18	35446358
rs10754323	rs3806340	0.683818140293292	Height	1e-12	35831902
rs10754323	rs3806340	0.683818140293292	Height	7e-17	36224396
rs10754323	rs3806340	0.683818140293292	Height	3e-47	36224396
rs10774672	rs1131476	0.976342544700373	Systemic lupus erythematosus	1e-09	33272962
rs10774672	rs2660	0.976342544700373	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10774672	rs2660	0.976342544700373	COVID-19 (critical illness vs population)	3e-15	37198478
rs10774672	rs4767027	0.951726831848586	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10774672	rs2057778	0.950549370357402	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10774672	rs2057778	0.950549370357402	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10774672	rs2057778	0.950549370357402	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10774672	rs11066452	0.933134734626807	Blood protein levels	6e-08	30072576
rs10774672	rs1859336	0.900390277067598	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10774672	rs6489882	0.884084259897555	Chronic lymphocytic leukemia	5e-08	28165464
rs10774672	rs6489867	0.632895290629283	COVID-19 (critical illness vs population)	1e-09	33307546
rs10774673	rs4767027	0.998784898959227	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10774673	rs2057778	0.995145751016778	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10774673	rs2057778	0.995145751016778	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10774673	rs2057778	0.995145751016778	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10774673	rs11066452	0.979619645350248	Blood protein levels	6e-08	30072576
rs10774673	rs1131476	0.96915037922071	Systemic lupus erythematosus	1e-09	33272962
rs10774673	rs2660	0.96915037922071	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10774673	rs2660	0.96915037922071	COVID-19 (critical illness vs population)	3e-15	37198478
rs10774673	rs1859336	0.941123970400008	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10774673	rs6489882	0.922072395810244	Chronic lymphocytic leukemia	5e-08	28165464
rs10774673	rs6489867	0.644148176759179	COVID-19 (critical illness vs population)	1e-09	33307546
rs10774673	rs1557866	0.604099218670206	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10774674	rs4767027	0.998784898959227	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10774674	rs2057778	0.995145751016778	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10774674	rs2057778	0.995145751016778	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10774674	rs2057778	0.995145751016778	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10774674	rs11066452	0.979619645350248	Blood protein levels	6e-08	30072576
rs10774674	rs1131476	0.96915037922071	Systemic lupus erythematosus	1e-09	33272962
rs10774674	rs2660	0.96915037922071	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10774674	rs2660	0.96915037922071	COVID-19 (critical illness vs population)	3e-15	37198478
rs10774674	rs1859336	0.941123970400008	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10774674	rs6489882	0.922072395810244	Chronic lymphocytic leukemia	5e-08	28165464
rs10774674	rs6489867	0.644148176759179	COVID-19 (critical illness vs population)	1e-09	33307546
rs10774674	rs1557866	0.604099218670206	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10774675	rs11066452	0.980998662390018	Blood protein levels	6e-08	30072576
rs10774675	rs4767027	0.964496962465119	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10774675	rs2057778	0.960948248715801	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10774675	rs2057778	0.960948248715801	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10774675	rs2057778	0.960948248715801	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10774675	rs1859336	0.942511086854102	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10774675	rs1131476	0.935458048583063	Systemic lupus erythematosus	1e-09	33272962
rs10774675	rs2660	0.935458048583063	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10774675	rs2660	0.935458048583063	COVID-19 (critical illness vs population)	3e-15	37198478
rs10774675	rs6489882	0.923376606105867	Chronic lymphocytic leukemia	5e-08	28165464
rs10774675	rs6489867	0.642704708871745	COVID-19 (critical illness vs population)	1e-09	33307546
rs10774676	rs1859336	0.978691366159255	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10774676	rs6489882	0.959030608000617	Chronic lymphocytic leukemia	5e-08	28165464
rs10774676	rs11066452	0.956270720216932	Blood protein levels	6e-08	30072576
rs10774676	rs4767027	0.935214098408885	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10774676	rs2057778	0.931730526952282	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10774676	rs2057778	0.931730526952282	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10774676	rs2057778	0.931730526952282	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10774676	rs1131476	0.906864550391553	Systemic lupus erythematosus	1e-09	33272962
rs10774676	rs2660	0.906864550391553	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10774676	rs2660	0.906864550391553	COVID-19 (critical illness vs population)	3e-15	37198478
rs10774676	rs6489867	0.666172377421599	COVID-19 (critical illness vs population)	1e-09	33307546
rs10774676	rs1557866	0.615024933981508	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10774677	rs1859336	0.975186189981633	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10774677	rs11066452	0.957519470518283	Blood protein levels	6e-08	30072576
rs10774677	rs6489882	0.95556930413665	Chronic lymphocytic leukemia	5e-08	28165464
rs10774677	rs4767027	0.936505640728186	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10774677	rs2057778	0.933020694946016	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10774677	rs2057778	0.933020694946016	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10774677	rs2057778	0.933020694946016	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10774677	rs1131476	0.908103664474967	Systemic lupus erythematosus	1e-09	33272962
rs10774677	rs2660	0.908103664474967	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10774677	rs2660	0.908103664474967	COVID-19 (critical illness vs population)	3e-15	37198478
rs10774677	rs6489867	0.666809863749544	COVID-19 (critical illness vs population)	1e-09	33307546
rs10774677	rs1557866	0.612777654562198	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10774678	rs1859336	0.78313246590338	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10774678	rs6489882	0.767821674164035	Chronic lymphocytic leukemia	5e-08	28165464
rs10774678	rs11066452	0.765336730909018	Blood protein levels	6e-08	30072576
rs10774678	rs4767027	0.748499318846651	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10774678	rs2057778	0.745518033668252	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10774678	rs2057778	0.745518033668252	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10774678	rs2057778	0.745518033668252	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10774678	rs1131476	0.723279181849947	Systemic lupus erythematosus	1e-09	33272962
rs10774678	rs2660	0.723279181849947	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10774678	rs2660	0.723279181849947	COVID-19 (critical illness vs population)	3e-15	37198478
rs10778139	rs2695294	0.897824522284684	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs10778139	rs2695295	0.897123784668255	Serum levels of protein NAAA	1e-68	35078996
rs10778139	rs2695295	0.897123784668255	Serum levels of protein SMPDL3A	8e-86	35078996
rs10778139	rs2559856	0.895607221985702	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs10778139	rs3809260	0.886459574661448	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs10778139	rs2559851	0.826728923901985	Cathepsin F levels	2e-96	34648354
rs10778139	rs2559851	0.826728923901985	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs10778139	rs2559850	0.712615956725164	Serum levels of protein CTSH	1e-19	35078996
rs10778139	rs2559850	0.712615956725164	Vitamin C levels	6e-20	33203707
rs10778139	rs2559850	0.712615956725164	Cathepsin L2 levels	1e-24	34648354
rs10778139	rs2559850	0.712615956725164	Islet amyloid polypeptide levels	1e-49	34648354
rs10778139	rs2559850	0.712615956725164	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs10782310	rs9505982	0.980716184918063	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs10782310	rs11155671	0.951343373510539	Testicular germ cell tumor	2e-09	28604728
rs10782310	rs4380763	0.938010641837427	Subcortical volume (min-P)	1e-11	32665545
rs10782310	rs1934534	0.937235198073709	Pain (pleiotropy)	2e-08	37844115
rs10782310	rs1934534	0.937235198073709	Pain (pleiotropy)	2e-06	37844115
rs10782310	rs80147756	0.895306574107862	HippSubfield lh volume subiculum-head	3e-10	33875891
rs10782310	rs4421206	0.890890144223553	Brain morphology (min-P)	4e-11	32665545
rs10782310	rs9688452	0.871659279563147	Brainstem global volume Whole-brainstem	1e-11	33875891
rs10782310	rs9688452	0.871659279563147	aseg lh volume VentralDC	2e-10	33875891
rs10782310	rs9322194	0.832125774643244	Brainstem volume	2e-11	31636452
rs10782310	rs10872649	0.824895964504778	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs10782310	rs10872649	0.824895964504778	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs10782310	rs10872649	0.824895964504778	Right hippocampal volume (body)	1e-10	37337106
rs10782310	rs7752089	0.791610759245346	Brain morphology (MOSTest)	2e-31	35164939
rs10782310	rs9285521	0.709688495914519	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs10782310	rs12526675	0.618789461340845	Brain morphology (MOSTest)	7e-22	32665545
rs10782310	rs9688809	0.611240465621125	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs10782310	rs34337297	0.608321091519963	Serum levels of protein LRP11	3e-161	35078996
rs10782310	rs10872645	0.607547431542733	Blood protein levels	2e-86	30072576
rs10782310	rs14314	0.606480666587824	Macular thickness	3e-19	30535121
rs10782310	rs14314	0.606480666587824	Vertex-wise sulcal depth	7e-17	34910505
rs10782310	rs14314	0.606480666587824	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs10782310	rs14314	0.606480666587824	Left hippocampal volume (body)	7e-15	37337106
rs10782310	rs14314	0.606480666587824	Left subiculum volume (body)	1e-14	37337106
rs10782310	rs55763431	0.606218031185672	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs10782310	rs9322193	0.605647741700794	Lung cancer	1e-07	27393504
rs10782310	rs9689694	0.605105609337406	Right hippocampal volume (head)	6e-11	37337106
rs10782310	rs9689694	0.605105609337406	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs10782310	rs9689694	0.605105609337406	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs10782310	rs9689694	0.605105609337406	Left hippocampal volume (head)	6e-12	37337106
rs10782310	rs9383843	0.603778485093603	Migraine	1e-09	35115687
rs10782310	rs2095375	0.603223183151797	Serum metabolite levels	1e-20	33031748
rs10782310	rs2095375	0.603223183151797	Serum metabolite levels	1e-20	33031748
rs10782310	rs10872653	0.601005294777978	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs10782310	rs9688867	0.60062795747081	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs10782310	rs9688867	0.60062795747081	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs10782311	rs9505982	0.979927768489878	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs10782311	rs11155671	0.950516039277173	Testicular germ cell tumor	2e-09	28604728
rs10782311	rs4380763	0.937180330973596	Subcortical volume (min-P)	1e-11	32665545
rs10782311	rs1934534	0.936404127085362	Pain (pleiotropy)	2e-08	37844115
rs10782311	rs1934534	0.936404127085362	Pain (pleiotropy)	2e-06	37844115
rs10782311	rs80147756	0.894535116365142	HippSubfield lh volume subiculum-head	3e-10	33875891
rs10782311	rs4421206	0.890137224398519	Brain morphology (min-P)	4e-11	32665545
rs10782311	rs9688452	0.870882499799949	Brainstem global volume Whole-brainstem	1e-11	33875891
rs10782311	rs9688452	0.870882499799949	aseg lh volume VentralDC	2e-10	33875891
rs10782311	rs9322194	0.830099863085902	Brainstem volume	2e-11	31636452
rs10782311	rs10872649	0.822727394248239	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs10782311	rs10872649	0.822727394248239	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs10782311	rs10872649	0.822727394248239	Right hippocampal volume (body)	1e-10	37337106
rs10782311	rs7752089	0.790978602815098	Brain morphology (MOSTest)	2e-31	35164939
rs10782311	rs9285521	0.707905277472995	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs10782311	rs12526675	0.618471341987703	Brain morphology (MOSTest)	7e-22	32665545
rs10782311	rs9688809	0.612746521054461	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs10782311	rs34337297	0.609817159032248	Serum levels of protein LRP11	3e-161	35078996
rs10782311	rs10872645	0.609043040014755	Blood protein levels	2e-86	30072576
rs10782311	rs14314	0.607980797010718	Macular thickness	3e-19	30535121
rs10782311	rs14314	0.607980797010718	Vertex-wise sulcal depth	7e-17	34910505
rs10782311	rs14314	0.607980797010718	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs10782311	rs14314	0.607980797010718	Left hippocampal volume (body)	7e-15	37337106
rs10782311	rs14314	0.607980797010718	Left subiculum volume (body)	1e-14	37337106
rs10782311	rs55763431	0.607711821173533	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs10782311	rs9322193	0.607151516168313	Lung cancer	1e-07	27393504
rs10782311	rs9689694	0.60659668264236	Right hippocampal volume (head)	6e-11	37337106
rs10782311	rs9689694	0.60659668264236	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs10782311	rs9689694	0.60659668264236	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs10782311	rs9689694	0.60659668264236	Left hippocampal volume (head)	6e-12	37337106
rs10782311	rs9383843	0.605267741408443	Migraine	1e-09	35115687
rs10782311	rs2095375	0.604711082891199	Serum metabolite levels	1e-20	33031748
rs10782311	rs2095375	0.604711082891199	Serum metabolite levels	1e-20	33031748
rs10782311	rs10872653	0.602487776322173	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs10782311	rs9688867	0.602119439819922	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs10782311	rs9688867	0.602119439819922	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs10782313	rs9505982	0.981521114237293	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs10782313	rs11155671	0.952121540301606	Testicular germ cell tumor	2e-09	28604728
rs10782313	rs4380763	0.938780783294933	Subcortical volume (min-P)	1e-11	32665545
rs10782313	rs1934534	0.938004707854127	Pain (pleiotropy)	2e-08	37844115
rs10782313	rs1934534	0.938004707854127	Pain (pleiotropy)	2e-06	37844115
rs10782313	rs80147756	0.896069929690804	HippSubfield lh volume subiculum-head	3e-10	33875891
rs10782313	rs4421206	0.891656380188532	Brain morphology (min-P)	4e-11	32665545
rs10782313	rs9688452	0.872407889146716	Brainstem global volume Whole-brainstem	1e-11	33875891
rs10782313	rs9688452	0.872407889146716	aseg lh volume VentralDC	2e-10	33875891
rs10782313	rs9322194	0.831449985828714	Brainstem volume	2e-11	31636452
rs10782313	rs10872649	0.824172586735062	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs10782313	rs10872649	0.824172586735062	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs10782313	rs10872649	0.824172586735062	Right hippocampal volume (body)	1e-10	37337106
rs10782313	rs7752089	0.792355720872261	Brain morphology (MOSTest)	2e-31	35164939
rs10782313	rs9285521	0.709093662601313	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs10782313	rs12526675	0.619529392907988	Brain morphology (MOSTest)	7e-22	32665545
rs10782313	rs9688809	0.611742031996952	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs10782313	rs34337297	0.60881933159645	Serum levels of protein LRP11	3e-161	35078996
rs10782313	rs10872645	0.608045518738903	Blood protein levels	2e-86	30072576
rs10782313	rs14314	0.606980259714711	Macular thickness	3e-19	30535121
rs10782313	rs14314	0.606980259714711	Vertex-wise sulcal depth	7e-17	34910505
rs10782313	rs14314	0.606980259714711	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs10782313	rs14314	0.606980259714711	Left hippocampal volume (body)	7e-15	37337106
rs10782313	rs14314	0.606980259714711	Left subiculum volume (body)	1e-14	37337106
rs10782313	rs55763431	0.606715512761234	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs10782313	rs9322193	0.606148548385683	Lung cancer	1e-07	27393504
rs10782313	rs9689694	0.60560218616743	Right hippocampal volume (head)	6e-11	37337106
rs10782313	rs9689694	0.60560218616743	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs10782313	rs9689694	0.60560218616743	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs10782313	rs9689694	0.60560218616743	Left hippocampal volume (head)	6e-12	37337106
rs10782313	rs9383843	0.604274456800207	Migraine	1e-09	35115687
rs10782313	rs2095375	0.603718703073772	Serum metabolite levels	1e-20	33031748
rs10782313	rs2095375	0.603718703073772	Serum metabolite levels	1e-20	33031748
rs10782313	rs10872653	0.601499010261186	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs10782313	rs9688867	0.601124670472321	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs10782313	rs9688867	0.601124670472321	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs10782317	rs10872649	0.989580275418258	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs10782317	rs10872649	0.989580275418258	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs10782317	rs10872649	0.989580275418258	Right hippocampal volume (body)	1e-10	37337106
rs10782317	rs7752089	0.941955548405786	Brain morphology (MOSTest)	2e-31	35164939
rs10782317	rs1934534	0.885761489020097	Pain (pleiotropy)	2e-08	37844115
rs10782317	rs1934534	0.885761489020097	Pain (pleiotropy)	2e-06	37844115
rs10782317	rs4380763	0.884972676867036	Subcortical volume (min-P)	1e-11	32665545
rs10782317	rs11155671	0.868890805763332	Testicular germ cell tumor	2e-09	28604728
rs10782317	rs9322194	0.851595664895741	Brainstem volume	2e-11	31636452
rs10782317	rs80147756	0.847214111964368	HippSubfield lh volume subiculum-head	3e-10	33875891
rs10782317	rs4421206	0.835211712249642	Brain morphology (min-P)	4e-11	32665545
rs10782317	rs9505982	0.825745495074193	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs10782317	rs9688452	0.811374141589593	Brainstem global volume Whole-brainstem	1e-11	33875891
rs10782317	rs9688452	0.811374141589593	aseg lh volume VentralDC	2e-10	33875891
rs10782317	rs9285521	0.726959159290808	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs10782317	rs12526675	0.718917408153635	Brain morphology (MOSTest)	7e-22	32665545
rs10782317	rs2342764	0.677036072131889	Cortical thickness	1e-08	34560273
rs10782317	rs56103941	0.644185131094788	Right presubiculum volume (head)	4e-08	37337106
rs10782317	rs12523793	0.608433542190109	Subcortical volume (MOSTest)	4e-24	32665545
rs10782317	rs12523793	0.608433542190109	C-reactive protein levels	3e-08	35459240
rs10782317	rs12523793	0.608433542190109	C-reactive protein levels (MTAG)	2e-08	36376304
rs10782317	rs11155662	0.602334465173527	Vertex-wise cortical thickness	2e-09	34910505
rs10782318	rs56103941	0.973412410976144	Right presubiculum volume (head)	4e-08	37337106
rs10782318	rs12523793	0.945593160295147	Subcortical volume (MOSTest)	4e-24	32665545
rs10782318	rs12523793	0.945593160295147	C-reactive protein levels	3e-08	35459240
rs10782318	rs12523793	0.945593160295147	C-reactive protein levels (MTAG)	2e-08	36376304
rs10782318	rs11155662	0.932791684423517	Vertex-wise cortical thickness	2e-09	34910505
rs10782318	rs12526675	0.880420091747059	Brain morphology (MOSTest)	7e-22	32665545
rs10782318	rs2342764	0.817296375078241	Cortical thickness	1e-08	34560273
rs10782318	rs58189451	0.757967659960784	Drinks per week	1e-09	36477530
rs10782318	rs9285521	0.748800690210512	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs10782318	rs7752089	0.660973659659061	Brain morphology (MOSTest)	2e-31	35164939
rs10782318	rs9322194	0.660365372102505	Brainstem volume	2e-11	31636452
rs10782318	rs11155675	0.643725136494538	Brain region volumes	3e-09	31676860
rs10782318	rs1125	0.639396755277668	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs10782318	rs1125	0.639396755277668	Vertical cup-disc ratio	8e-14	34077760
rs10782318	rs10872649	0.635303856503861	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs10782318	rs10872649	0.635303856503861	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs10782318	rs10872649	0.635303856503861	Right hippocampal volume (body)	1e-10	37337106
rs10782318	rs9371201	0.633544352640454	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs10782318	rs4421206	0.613528318453828	Brain morphology (min-P)	4e-11	32665545
rs10783618	rs920778	0.736945590822114	Haemorrhoidal disease	7e-10	33888516
rs10783836	rs10876993	0.810873258602291	Celiac disease or Rheumatoid arthritis	4e-06	21383967
rs10783836	rs7979246	0.808239848311935	interferon-related traits	9e-07	33104735
rs10783836	rs7979246	0.808239848311935	Height	3e-145	36224396
rs10783836	rs701006	0.789580107179451	Multiple sclerosis	1e-30	31604244
rs10783836	rs1633360	0.756890428330532	Rheumatoid arthritis	1e-07	30423114
rs10783836	rs1633360	0.756890428330532	Rheumatoid arthritis	9e-08	30423114
rs10783836	rs1633360	0.756890428330532	Rheumatoid arthritis	7e-08	24390342
rs10783836	rs1633360	0.756890428330532	Rheumatoid arthritis	1e-07	24390342
rs10783836	rs1678527	0.709084311349984	Mean corpuscular hemoglobin	5e-08	30595370
rs10786414	rs10786414	1	ADMA levels	5e-18	35995766
rs10786414	rs7905265	0.984249179966026	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs10786414	rs7905265	0.984249179966026	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs10786414	rs7905265	0.984249179966026	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs10786414	rs7905265	0.984249179966026	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786414	rs7905265	0.984249179966026	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs10786414	rs7905265	0.984249179966026	N6,N6-dimethyllysine levels	2e-132	35995766
rs10786414	rs7905265	0.984249179966026	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs10786414	rs10883083	0.980137084776573	N2-acetyl,N6-methyllysine levels	0	35347128
rs10786414	rs10883083	0.980137084776573	X-12112 levels	0	35347128
rs10786414	rs10883083	0.980137084776573	Arginine levels	1e-16	35347128
rs10786414	rs10883083	0.980137084776573	Metabolite peak levels (QI8972)	2e-124	35995766
rs10786414	rs10883083	0.980137084776573	Metabolite peak levels (QI5171)	8e-96	35995766
rs10786414	rs2147896	0.980137084776573	Urinary metabolites (H-NMR features)	3e-164	24586186
rs10786414	rs2147896	0.980137084776573	Urinary metabolites (H-NMR features)	8e-30	24586186
rs10786414	rs2147896	0.980137084776573	Urinary metabolites (H-NMR features)	2e-55	24586186
rs10786414	rs2147896	0.980137084776573	Urinary metabolites (H-NMR features)	6e-19	24586186
rs10786414	rs2147896	0.980137084776573	Urinary metabolites (H-NMR features)	4e-34	24586186
rs10786414	rs2147896	0.980137084776573	Trimethylamine levels	4e-144	33283231
rs10786414	rs2147896	0.980137084776573	Serum metabolite levels	1e-15	33031748
rs10786414	rs2147896	0.980137084776573	Serum metabolite levels	4e-226	33031748
rs10786414	rs2147896	0.980137084776573	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs10786414	rs2147896	0.980137084776573	Urinary metabolite levels in chronic kidney disease	0	31959995
rs10786414	rs2147896	0.980137084776573	Urinary metabolite levels in chronic kidney disease	0	31959995
rs10786414	rs2147896	0.980137084776573	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs10786414	rs2147896	0.980137084776573	N6-methyllysine levels	3e-198	33437055
rs10786414	rs2147896	0.980137084776573	N6-methyllysine levels	0	35347128
rs10786414	rs2147896	0.980137084776573	N-methylpipecolate levels	0	35050183
rs10786414	rs2147896	0.980137084776573	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs10786414	rs2147896	0.980137084776573	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs10786414	rs2147896	0.980137084776573	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs10786414	rs2147896	0.980137084776573	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786414	rs2147896	0.980137084776573	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs10786414	rs2147896	0.980137084776573	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786414	rs2147896	0.980137084776573	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786414	rs2147896	0.980137084776573	X-12092 levels	4e-191	27073872
rs10786414	rs2147896	0.980137084776573	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs10786414	rs2147896	0.980137084776573	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs10786414	rs2147896	0.980137084776573	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs10786414	rs2147896	0.980137084776573	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs10786414	rs2147896	0.980137084776573	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs10786414	rs2147896	0.980137084776573	N6-methyllysine levels (advanced age)	5e-25	37118062
rs10786414	rs2147896	0.980137084776573	X-12112 levels	0	36635386
rs10786414	rs2147896	0.980137084776573	N6-methyllysine levels	0	36635386
rs10786414	rs2147896	0.980137084776573	N6,N6-dimethyllysine levels	0	36635386
rs10786414	rs2147896	0.980137084776573	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs10786414	rs2147896	0.980137084776573	N2-acetyl,N6-methyllysine levels	0	36635386
rs10786414	rs10786415	0.980137084776573	N6,N6-dimethyllysine levels	0	35347128
rs10786414	rs10786415	0.980137084776573	N-methylpipecolate levels	0	35347128
rs10786414	rs10786415	0.980137084776573	X-25810 levels	4e-11	36635386
rs10786414	rs942814	0.980137084776573	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs10786414	rs4539242	0.979318746105715	Urinary metabolites (H-NMR features)	2e-20	24586186
rs10786414	rs4539242	0.979318746105715	X-24809 levels	4e-67	33177712
rs10786414	rs4539242	0.979318746105715	X-24983 levels	8e-59	33177712
rs10786414	rs4539242	0.979318746105715	X-12112 levels	4e-63	33177712
rs10786414	rs4539242	0.979318746105715	N-methylpipecolate levels	3e-12	33177712
rs10786414	rs4539242	0.979318746105715	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs10786414	rs4539242	0.979318746105715	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs10786414	rs4539242	0.979318746105715	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs10786414	rs4539242	0.979318746105715	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs10786414	rs4539242	0.979318746105715	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs10786414	rs4539242	0.979318746105715	N6-methyllysine levels (advanced age)	5e-25	37118062
rs10786414	rs4539242	0.979318746105715	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs10786414	rs7072216	0.967019331933946	Metabolite levels	8e-15	21931564
rs10786414	rs7072216	0.967019331933946	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs10786414	rs4488133	0.962170440812522	Serum metabolite levels	2e-281	23093944
rs10786414	rs4488133	0.962170440812522	Serum metabolite levels	1e-27	23093944
rs10786414	rs4488133	0.962170440812522	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs10786414	rs4488133	0.962170440812522	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs10786414	rs4488133	0.962170440812522	Urine X-12112 levels in chronic kidney disease	0	37277652
rs10786414	rs4488133	0.962170440812522	X-12093 levels	1e-48	24816252
rs10786414	rs4488133	0.962170440812522	X-12092 levels	0	24816252
rs10786414	rs11598867	0.917769318527455	Urinary metabolites	1e-307	26352407
rs10786414	rs7096654	0.916766750396093	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs10786414	rs7096654	0.916766750396093	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs10786414	rs7096654	0.916766750396093	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs10786414	rs7096654	0.916766750396093	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs10786414	rs942813	0.893349287706096	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs10786414	rs6584194	0.875807525056515	Metabolite peak levels (QI9680)	2e-135	35995766
rs10786414	rs6584194	0.875807525056515	Metabolite peak levels (QI8984)	5e-11	35995766
rs10786414	rs6584194	0.875807525056515	X-24736 levels	3e-13	36635386
rs10786414	rs942810	0.763578976385505	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs10786414	rs942810	0.763578976385505	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs10786414	rs942810	0.763578976385505	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs10786414	rs942810	0.763578976385505	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs10786414	rs942810	0.763578976385505	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs10786414	rs942810	0.763578976385505	N6-methyllysine levels (advanced age)	2e-11	37118062
rs10786414	rs4345897	0.711103368286863	Urinary metabolites (H-NMR features)	2e-19	24586186
rs10786414	rs4345897	0.711103368286863	Urinary metabolites (H-NMR features)	4e-12	24586186
rs10786414	rs4345897	0.711103368286863	Metabolite levels	2e-91	23281178
rs10786414	rs4345897	0.711103368286863	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	4e-25	37118062
rs10786414	rs4345897	0.711103368286863	N6,N6-dimethyllysine levels (elderly offspring)	4e-17	37118062
rs10786414	rs4345897	0.711103368286863	N6-methyllysine levels (elderly offspring)	1e-41	37118062
rs10786414	rs4345897	0.711103368286863	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs10786414	rs4345897	0.711103368286863	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs10786414	rs4345897	0.711103368286863	N6-methyllysine levels (advanced age)	6e-22	37118062
rs10786414	rs2182169	0.683069303240752	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-23	37118062
rs10786414	rs2182169	0.683069303240752	N6,N6-dimethyllysine levels (elderly offspring)	3e-16	37118062
rs10786414	rs2182169	0.683069303240752	N6-methyllysine levels (elderly offspring)	7e-40	37118062
rs10786414	rs2182169	0.683069303240752	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs10786414	rs2182169	0.683069303240752	N6,N6-dimethyllysine levels (advanced age)	4e-09	37118062
rs10786414	rs2182169	0.683069303240752	N6-methyllysine levels (advanced age)	1e-21	37118062
rs10786414	rs6584192	0.679529439874728	Metabolite levels	4e-33	23823483
rs10786414	rs6584192	0.679529439874728	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs10786414	rs6584192	0.679529439874728	N6,N6-dimethyllysine levels (elderly offspring)	2e-16	37118062
rs10786414	rs6584192	0.679529439874728	N6-methyllysine levels (elderly offspring)	3e-41	37118062
rs10786414	rs6584192	0.679529439874728	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs10786414	rs6584192	0.679529439874728	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs10786414	rs6584192	0.679529439874728	N6-methyllysine levels (advanced age)	6e-22	37118062
rs10786414	rs2147895	0.671141879997435	Hydroxyhexadecanoylcarnitine levels	9e-19	35888728
rs10786414	rs2147895	0.671141879997435	Plasma arginine levels in chronic kidney disease	7e-13	37277652
rs10786414	rs2147895	0.671141879997435	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-24	37118062
rs10786414	rs2147895	0.671141879997435	N6,N6-dimethyllysine levels (elderly offspring)	7e-17	37118062
rs10786414	rs2147895	0.671141879997435	N6-methyllysine levels (elderly offspring)	2e-39	37118062
rs10786414	rs2147895	0.671141879997435	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs10786414	rs2147895	0.671141879997435	N6,N6-dimethyllysine levels (advanced age)	2e-09	37118062
rs10786414	rs2147895	0.671141879997435	N6-methyllysine levels (advanced age)	4e-21	37118062
rs10786414	rs2182168	0.665982801981419	Urine X-22162 levels in chronic kidney disease	3e-13	37277652
rs10786414	rs2182168	0.665982801981419	Arginine levels	1e-17	36635386
rs10786414	rs11189591	0.615034960672417	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs10786414	rs11189591	0.615034960672417	N6,N6-dimethyllysine levels (elderly offspring)	1e-16	37118062
rs10786414	rs11189591	0.615034960672417	N6-methyllysine levels (elderly offspring)	1e-40	37118062
rs10786414	rs11189591	0.615034960672417	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs10786414	rs11189591	0.615034960672417	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs10786414	rs11189591	0.615034960672417	N6-methyllysine levels (advanced age)	6e-22	37118062
rs10786414	rs1739	0.612235846770023	Metabolite peak levels (QI7389)	3e-91	35995766
rs10786414	rs1737	0.611531473653635	Arginine levels	3e-24	35995766
rs10786415	rs10883083	1	N2-acetyl,N6-methyllysine levels	0	35347128
rs10786415	rs10883083	1	X-12112 levels	0	35347128
rs10786415	rs10883083	1	Arginine levels	1e-16	35347128
rs10786415	rs10883083	1	Metabolite peak levels (QI8972)	2e-124	35995766
rs10786415	rs10883083	1	Metabolite peak levels (QI5171)	8e-96	35995766
rs10786415	rs2147896	1	Urinary metabolites (H-NMR features)	3e-164	24586186
rs10786415	rs2147896	1	Urinary metabolites (H-NMR features)	8e-30	24586186
rs10786415	rs2147896	1	Urinary metabolites (H-NMR features)	2e-55	24586186
rs10786415	rs2147896	1	Urinary metabolites (H-NMR features)	6e-19	24586186
rs10786415	rs2147896	1	Urinary metabolites (H-NMR features)	4e-34	24586186
rs10786415	rs2147896	1	Trimethylamine levels	4e-144	33283231
rs10786415	rs2147896	1	Serum metabolite levels	1e-15	33031748
rs10786415	rs2147896	1	Serum metabolite levels	4e-226	33031748
rs10786415	rs2147896	1	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs10786415	rs2147896	1	Urinary metabolite levels in chronic kidney disease	0	31959995
rs10786415	rs2147896	1	Urinary metabolite levels in chronic kidney disease	0	31959995
rs10786415	rs2147896	1	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs10786415	rs2147896	1	N6-methyllysine levels	3e-198	33437055
rs10786415	rs2147896	1	N6-methyllysine levels	0	35347128
rs10786415	rs2147896	1	N-methylpipecolate levels	0	35050183
rs10786415	rs2147896	1	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs10786415	rs2147896	1	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs10786415	rs2147896	1	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs10786415	rs2147896	1	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786415	rs2147896	1	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs10786415	rs2147896	1	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786415	rs2147896	1	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786415	rs2147896	1	X-12092 levels	4e-191	27073872
rs10786415	rs2147896	1	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs10786415	rs2147896	1	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs10786415	rs2147896	1	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs10786415	rs2147896	1	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs10786415	rs2147896	1	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs10786415	rs2147896	1	N6-methyllysine levels (advanced age)	5e-25	37118062
rs10786415	rs2147896	1	X-12112 levels	0	36635386
rs10786415	rs2147896	1	N6-methyllysine levels	0	36635386
rs10786415	rs2147896	1	N6,N6-dimethyllysine levels	0	36635386
rs10786415	rs2147896	1	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs10786415	rs2147896	1	N2-acetyl,N6-methyllysine levels	0	36635386
rs10786415	rs10786415	1	N6,N6-dimethyllysine levels	0	35347128
rs10786415	rs10786415	1	N-methylpipecolate levels	0	35347128
rs10786415	rs10786415	1	X-25810 levels	4e-11	36635386
rs10786415	rs942814	1	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs10786415	rs4539242	0.999168439367004	Urinary metabolites (H-NMR features)	2e-20	24586186
rs10786415	rs4539242	0.999168439367004	X-24809 levels	4e-67	33177712
rs10786415	rs4539242	0.999168439367004	X-24983 levels	8e-59	33177712
rs10786415	rs4539242	0.999168439367004	X-12112 levels	4e-63	33177712
rs10786415	rs4539242	0.999168439367004	N-methylpipecolate levels	3e-12	33177712
rs10786415	rs4539242	0.999168439367004	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs10786415	rs4539242	0.999168439367004	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs10786415	rs4539242	0.999168439367004	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs10786415	rs4539242	0.999168439367004	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs10786415	rs4539242	0.999168439367004	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs10786415	rs4539242	0.999168439367004	N6-methyllysine levels (advanced age)	5e-25	37118062
rs10786415	rs4539242	0.999168439367004	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs10786415	rs7072216	0.986739800087918	Metabolite levels	8e-15	21931564
rs10786415	rs7072216	0.986739800087918	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs10786415	rs7905265	0.98425257612078	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs10786415	rs7905265	0.98425257612078	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs10786415	rs7905265	0.98425257612078	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs10786415	rs7905265	0.98425257612078	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786415	rs7905265	0.98425257612078	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs10786415	rs7905265	0.98425257612078	N6,N6-dimethyllysine levels	2e-132	35995766
rs10786415	rs7905265	0.98425257612078	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs10786415	rs4488133	0.981812255561224	Serum metabolite levels	2e-281	23093944
rs10786415	rs4488133	0.981812255561224	Serum metabolite levels	1e-27	23093944
rs10786415	rs4488133	0.981812255561224	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs10786415	rs4488133	0.981812255561224	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs10786415	rs4488133	0.981812255561224	Urine X-12112 levels in chronic kidney disease	0	37277652
rs10786415	rs4488133	0.981812255561224	X-12093 levels	1e-48	24816252
rs10786415	rs4488133	0.981812255561224	X-12092 levels	0	24816252
rs10786415	rs10786414	0.980137084776573	ADMA levels	5e-18	35995766
rs10786415	rs11598867	0.936646612426462	Urinary metabolites	1e-307	26352407
rs10786415	rs942813	0.912957270246383	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs10786415	rs7096654	0.899514581295609	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs10786415	rs7096654	0.899514581295609	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs10786415	rs7096654	0.899514581295609	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs10786415	rs7096654	0.899514581295609	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs10786415	rs6584194	0.894241137013551	Metabolite peak levels (QI9680)	2e-135	35995766
rs10786415	rs6584194	0.894241137013551	Metabolite peak levels (QI8984)	5e-11	35995766
rs10786415	rs6584194	0.894241137013551	X-24736 levels	3e-13	36635386
rs10786415	rs942810	0.780636275950061	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs10786415	rs942810	0.780636275950061	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs10786415	rs942810	0.780636275950061	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs10786415	rs942810	0.780636275950061	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs10786415	rs942810	0.780636275950061	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs10786415	rs942810	0.780636275950061	N6-methyllysine levels (advanced age)	2e-11	37118062
rs10786415	rs4345897	0.725228481314342	Urinary metabolites (H-NMR features)	2e-19	24586186
rs10786415	rs4345897	0.725228481314342	Urinary metabolites (H-NMR features)	4e-12	24586186
rs10786415	rs4345897	0.725228481314342	Metabolite levels	2e-91	23281178
rs10786415	rs4345897	0.725228481314342	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	4e-25	37118062
rs10786415	rs4345897	0.725228481314342	N6,N6-dimethyllysine levels (elderly offspring)	4e-17	37118062
rs10786415	rs4345897	0.725228481314342	N6-methyllysine levels (elderly offspring)	1e-41	37118062
rs10786415	rs4345897	0.725228481314342	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs10786415	rs4345897	0.725228481314342	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs10786415	rs4345897	0.725228481314342	N6-methyllysine levels (advanced age)	6e-22	37118062
rs10786415	rs2182169	0.696769770391045	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-23	37118062
rs10786415	rs2182169	0.696769770391045	N6,N6-dimethyllysine levels (elderly offspring)	3e-16	37118062
rs10786415	rs2182169	0.696769770391045	N6-methyllysine levels (elderly offspring)	7e-40	37118062
rs10786415	rs2182169	0.696769770391045	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs10786415	rs2182169	0.696769770391045	N6,N6-dimethyllysine levels (advanced age)	4e-09	37118062
rs10786415	rs2182169	0.696769770391045	N6-methyllysine levels (advanced age)	1e-21	37118062
rs10786415	rs6584192	0.69318459578308	Metabolite levels	4e-33	23823483
rs10786415	rs6584192	0.69318459578308	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs10786415	rs6584192	0.69318459578308	N6,N6-dimethyllysine levels (elderly offspring)	2e-16	37118062
rs10786415	rs6584192	0.69318459578308	N6-methyllysine levels (elderly offspring)	3e-41	37118062
rs10786415	rs6584192	0.69318459578308	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs10786415	rs6584192	0.69318459578308	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs10786415	rs6584192	0.69318459578308	N6-methyllysine levels (advanced age)	6e-22	37118062
rs10786415	rs2147895	0.684785652644244	Hydroxyhexadecanoylcarnitine levels	9e-19	35888728
rs10786415	rs2147895	0.684785652644244	Plasma arginine levels in chronic kidney disease	7e-13	37277652
rs10786415	rs2147895	0.684785652644244	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-24	37118062
rs10786415	rs2147895	0.684785652644244	N6,N6-dimethyllysine levels (elderly offspring)	7e-17	37118062
rs10786415	rs2147895	0.684785652644244	N6-methyllysine levels (elderly offspring)	2e-39	37118062
rs10786415	rs2147895	0.684785652644244	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs10786415	rs2147895	0.684785652644244	N6,N6-dimethyllysine levels (advanced age)	2e-09	37118062
rs10786415	rs2147895	0.684785652644244	N6-methyllysine levels (advanced age)	4e-21	37118062
rs10786415	rs2182168	0.679416289117702	Urine X-22162 levels in chronic kidney disease	3e-13	37277652
rs10786415	rs2182168	0.679416289117702	Arginine levels	1e-17	36635386
rs10786415	rs11189591	0.627750392434333	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs10786415	rs11189591	0.627750392434333	N6,N6-dimethyllysine levels (elderly offspring)	1e-16	37118062
rs10786415	rs11189591	0.627750392434333	N6-methyllysine levels (elderly offspring)	1e-40	37118062
rs10786415	rs11189591	0.627750392434333	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs10786415	rs11189591	0.627750392434333	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs10786415	rs11189591	0.627750392434333	N6-methyllysine levels (advanced age)	6e-22	37118062
rs10786415	rs1739	0.622481884535144	Metabolite peak levels (QI7389)	3e-91	35995766
rs10786415	rs1737	0.621776150568137	Arginine levels	3e-24	35995766
rs10786419	rs942810	0.894452225515259	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs10786419	rs942810	0.894452225515259	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs10786419	rs942810	0.894452225515259	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs10786419	rs942810	0.894452225515259	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs10786419	rs942810	0.894452225515259	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs10786419	rs942810	0.894452225515259	N6-methyllysine levels (advanced age)	2e-11	37118062
rs10786419	rs6584194	0.803973293406584	Metabolite peak levels (QI9680)	2e-135	35995766
rs10786419	rs6584194	0.803973293406584	Metabolite peak levels (QI8984)	5e-11	35995766
rs10786419	rs6584194	0.803973293406584	X-24736 levels	3e-13	36635386
rs10786419	rs1739	0.741770557897811	Metabolite peak levels (QI7389)	3e-91	35995766
rs10786419	rs1737	0.741053823533149	Arginine levels	3e-24	35995766
rs10786419	rs4488133	0.723647555047583	Serum metabolite levels	2e-281	23093944
rs10786419	rs4488133	0.723647555047583	Serum metabolite levels	1e-27	23093944
rs10786419	rs4488133	0.723647555047583	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs10786419	rs4488133	0.723647555047583	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs10786419	rs4488133	0.723647555047583	Urine X-12112 levels in chronic kidney disease	0	37277652
rs10786419	rs4488133	0.723647555047583	X-12093 levels	1e-48	24816252
rs10786419	rs4488133	0.723647555047583	X-12092 levels	0	24816252
rs10786419	rs10883083	0.721017680244017	N2-acetyl,N6-methyllysine levels	0	35347128
rs10786419	rs10883083	0.721017680244017	X-12112 levels	0	35347128
rs10786419	rs10883083	0.721017680244017	Arginine levels	1e-16	35347128
rs10786419	rs10883083	0.721017680244017	Metabolite peak levels (QI8972)	2e-124	35995766
rs10786419	rs10883083	0.721017680244017	Metabolite peak levels (QI5171)	8e-96	35995766
rs10786419	rs2147896	0.721017680244017	Urinary metabolites (H-NMR features)	3e-164	24586186
rs10786419	rs2147896	0.721017680244017	Urinary metabolites (H-NMR features)	8e-30	24586186
rs10786419	rs2147896	0.721017680244017	Urinary metabolites (H-NMR features)	2e-55	24586186
rs10786419	rs2147896	0.721017680244017	Urinary metabolites (H-NMR features)	6e-19	24586186
rs10786419	rs2147896	0.721017680244017	Urinary metabolites (H-NMR features)	4e-34	24586186
rs10786419	rs2147896	0.721017680244017	Trimethylamine levels	4e-144	33283231
rs10786419	rs2147896	0.721017680244017	Serum metabolite levels	1e-15	33031748
rs10786419	rs2147896	0.721017680244017	Serum metabolite levels	4e-226	33031748
rs10786419	rs2147896	0.721017680244017	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs10786419	rs2147896	0.721017680244017	Urinary metabolite levels in chronic kidney disease	0	31959995
rs10786419	rs2147896	0.721017680244017	Urinary metabolite levels in chronic kidney disease	0	31959995
rs10786419	rs2147896	0.721017680244017	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs10786419	rs2147896	0.721017680244017	N6-methyllysine levels	3e-198	33437055
rs10786419	rs2147896	0.721017680244017	N6-methyllysine levels	0	35347128
rs10786419	rs2147896	0.721017680244017	N-methylpipecolate levels	0	35050183
rs10786419	rs2147896	0.721017680244017	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs10786419	rs2147896	0.721017680244017	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs10786419	rs2147896	0.721017680244017	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs10786419	rs2147896	0.721017680244017	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786419	rs2147896	0.721017680244017	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs10786419	rs2147896	0.721017680244017	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786419	rs2147896	0.721017680244017	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786419	rs2147896	0.721017680244017	X-12092 levels	4e-191	27073872
rs10786419	rs2147896	0.721017680244017	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs10786419	rs2147896	0.721017680244017	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs10786419	rs2147896	0.721017680244017	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs10786419	rs2147896	0.721017680244017	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs10786419	rs2147896	0.721017680244017	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs10786419	rs2147896	0.721017680244017	N6-methyllysine levels (advanced age)	5e-25	37118062
rs10786419	rs2147896	0.721017680244017	X-12112 levels	0	36635386
rs10786419	rs2147896	0.721017680244017	N6-methyllysine levels	0	36635386
rs10786419	rs2147896	0.721017680244017	N6,N6-dimethyllysine levels	0	36635386
rs10786419	rs2147896	0.721017680244017	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs10786419	rs2147896	0.721017680244017	N2-acetyl,N6-methyllysine levels	0	36635386
rs10786419	rs10786415	0.721017680244017	N6,N6-dimethyllysine levels	0	35347128
rs10786419	rs10786415	0.721017680244017	N-methylpipecolate levels	0	35347128
rs10786419	rs10786415	0.721017680244017	X-25810 levels	4e-11	36635386
rs10786419	rs942814	0.721017680244017	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs10786419	rs4539242	0.720300199638966	Urinary metabolites (H-NMR features)	2e-20	24586186
rs10786419	rs4539242	0.720300199638966	X-24809 levels	4e-67	33177712
rs10786419	rs4539242	0.720300199638966	X-24983 levels	8e-59	33177712
rs10786419	rs4539242	0.720300199638966	X-12112 levels	4e-63	33177712
rs10786419	rs4539242	0.720300199638966	N-methylpipecolate levels	3e-12	33177712
rs10786419	rs4539242	0.720300199638966	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs10786419	rs4539242	0.720300199638966	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs10786419	rs4539242	0.720300199638966	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs10786419	rs4539242	0.720300199638966	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs10786419	rs4539242	0.720300199638966	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs10786419	rs4539242	0.720300199638966	N6-methyllysine levels (advanced age)	5e-25	37118062
rs10786419	rs4539242	0.720300199638966	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs10786419	rs7072216	0.719548907319516	Metabolite levels	8e-15	21931564
rs10786419	rs7072216	0.719548907319516	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs10786419	rs7905265	0.707836747897726	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs10786419	rs7905265	0.707836747897726	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs10786419	rs7905265	0.707836747897726	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs10786419	rs7905265	0.707836747897726	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs10786419	rs7905265	0.707836747897726	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs10786419	rs7905265	0.707836747897726	N6,N6-dimethyllysine levels	2e-132	35995766
rs10786419	rs7905265	0.707836747897726	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs10786419	rs942813	0.705676070159062	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs10786419	rs10786414	0.704539671539013	ADMA levels	5e-18	35995766
rs10786419	rs11598867	0.669147554308533	Urinary metabolites	1e-307	26352407
rs10786419	rs7096654	0.640398503413721	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs10786419	rs7096654	0.640398503413721	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs10786419	rs7096654	0.640398503413721	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs10786419	rs7096654	0.640398503413721	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs10788818	rs10788817	0.9041234489166	Serum metabolite levels	3e-13	24625756
rs10788818	rs10788817	0.9041234489166	Metabolite peak levels (QI2718)	5e-18	35995766
rs10788818	rs10788817	0.9041234489166	3-hydroxylaurate levels	2e-12	36635386
rs10788818	rs10788817	0.9041234489166	Tetradecadienoate (14:2) levels	8e-17	36635386
rs10788818	rs11204914	0.899082385950951	Carnitine C9 levels	1e-13	35995766
rs10788818	rs11204914	0.899082385950951	Metabolite peak levels (QI6204)	1e-32	35995766
rs10788818	rs11204914	0.899082385950951	Metabolite peak levels (QI6252)	2e-32	35995766
rs10788818	rs6685187	0.872784859102275	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs10788818	rs6698740	0.870541492551078	Beta-hydroxyisovalerate levels	1e-13	35347128
rs10788818	rs2999541	0.869192556763488	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs10788818	rs1060870	0.869019136781835	Serum metabolite levels	1e-11	33031748
rs10788818	rs1060870	0.869019136781835	Serum metabolite levels	1e-15	33031748
rs10788818	rs3007711	0.865435150931007	Electrodermal activity	9e-06	25387706
rs10788818	rs2338201	0.858228576807792	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs10788818	rs2338201	0.858228576807792	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs10788818	rs2338201	0.858228576807792	Dodecadienoate (12:2) levels	7e-15	36635386
rs10788818	rs2130525	0.76681111583574	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs10788818	rs2999545	0.763002145840676	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs10788818	rs2279501	0.745608733191036	Serum metabolite levels	3e-14	33031748
rs10788818	rs7542137	0.727526502913203	Beta-hydroxyisovalerate levels	3e-11	35050183
rs10788818	rs7542137	0.727526502913203	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs10788818	rs7542137	0.727526502913203	3-hydroxysebacate levels	2e-10	36635386
rs10788818	rs7523082	0.724824975483423	Metabolite peak levels (QI9845)	2e-14	35995766
rs10788818	rs10888445	0.721906097655227	Beta-hydroxyisovalerate levels	5e-13	36635386
rs10788818	rs7541453	0.717540969590584	Serum metabolite levels	2e-16	33031748
rs10788818	rs7541453	0.717540969590584	Serum metabolite levels	2e-16	33031748
rs10788818	rs7541453	0.717540969590584	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs10788818	rs1038747	0.631480517634904	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs10788818	rs10494270	0.628342854734155	Nonaylcarnitine levels	5e-13	26068415
rs10788818	rs9943221	0.621804820717404	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs10788820	rs2999541	1	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs10788820	rs3007711	0.995783742126405	Electrodermal activity	9e-06	25387706
rs10788820	rs2130525	0.892194099916733	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs10788820	rs7542137	0.84454600981745	Beta-hydroxyisovalerate levels	3e-11	35050183
rs10788820	rs7542137	0.84454600981745	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs10788820	rs7542137	0.84454600981745	3-hydroxysebacate levels	2e-10	36635386
rs10788820	rs10788817	0.78803489023865	Serum metabolite levels	3e-13	24625756
rs10788820	rs10788817	0.78803489023865	Metabolite peak levels (QI2718)	5e-18	35995766
rs10788820	rs10788817	0.78803489023865	3-hydroxylaurate levels	2e-12	36635386
rs10788820	rs10788817	0.78803489023865	Tetradecadienoate (14:2) levels	8e-17	36635386
rs10788820	rs11204914	0.784189575914813	Carnitine C9 levels	1e-13	35995766
rs10788820	rs11204914	0.784189575914813	Metabolite peak levels (QI6204)	1e-32	35995766
rs10788820	rs11204914	0.784189575914813	Metabolite peak levels (QI6252)	2e-32	35995766
rs10788820	rs6685187	0.760111553400485	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs10788820	rs6698740	0.75804274474034	Beta-hydroxyisovalerate levels	1e-13	35347128
rs10788820	rs1060870	0.756603012838021	Serum metabolite levels	1e-11	33031748
rs10788820	rs1060870	0.756603012838021	Serum metabolite levels	1e-15	33031748
rs10788820	rs2338201	0.747081739629544	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs10788820	rs2338201	0.747081739629544	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs10788820	rs2338201	0.747081739629544	Dodecadienoate (12:2) levels	7e-15	36635386
rs10788820	rs2279501	0.727270447289022	Serum metabolite levels	3e-14	33031748
rs10788820	rs56000812	0.682084106322215	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs10788820	rs56078223	0.679952879480075	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs10788820	rs56078223	0.679952879480075	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs10788820	rs10494270	0.670503454851672	Nonaylcarnitine levels	5e-13	26068415
rs10788820	rs9943221	0.663785006203325	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs10788820	rs2999545	0.662705733796985	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs10788820	rs7523082	0.630553122298745	Metabolite peak levels (QI9845)	2e-14	35995766
rs10788820	rs10888445	0.627400974162425	Beta-hydroxyisovalerate levels	5e-13	36635386
rs10788820	rs7541453	0.624707223046545	Serum metabolite levels	2e-16	33031748
rs10788820	rs7541453	0.624707223046545	Serum metabolite levels	2e-16	33031748
rs10788820	rs7541453	0.624707223046545	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs10788820	rs1038747	0.618799228812066	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs10788820	rs6684312	0.612169241811288	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs10789854	rs603646	0.762567141668481	High density lipoprotein cholesterol levels	3e-08	34887591
rs10789854	rs498547	0.647397941853912	General risk tolerance (MTAG)	4e-09	30643258
rs10789858	rs10891301	0.653687906000921	Pyruvate dehydrogenase protein X component, mitochondrial levels	1e-18	34648354
rs10789858	rs2276390	0.641661606270848	Waist-hip ratio	6e-28	30239722
rs10789858	rs603646	0.614665345130516	High density lipoprotein cholesterol levels	3e-08	34887591
rs10790175	rs4938354	0.929526539637245	Proprotein convertase subtilisin/kexin type 7 levels	3e-295	36168886
rs10790175	rs1794116	0.850314818376164	Protein CASC4 levels	5e-13	34648354
rs10790175	rs1794116	0.850314818376164	Asialoglycoprotein receptor 1 levels	7e-18	34648354
rs10790175	rs171052	0.839811282552638	Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)	1e-38	35870639
rs10790175	rs2622935	0.652122037777389	Serum levels of protein CASC4	3e-16	35078996
rs10790175	rs2622935	0.652122037777389	Polypeptide N-acetylgalactosaminyltransferase 1 levels	1e-30	34648354
rs10790175	rs4938353	0.631513731168776	Blood protein levels	2e-14	27532455
rs10790177	rs4938354	0.985680250441197	Proprotein convertase subtilisin/kexin type 7 levels	3e-295	36168886
rs10790177	rs1794116	0.908661902300735	Protein CASC4 levels	5e-13	34648354
rs10790177	rs1794116	0.908661902300735	Asialoglycoprotein receptor 1 levels	7e-18	34648354
rs10790177	rs171052	0.894276162327604	Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)	1e-38	35870639
rs10790177	rs2622935	0.696095281293536	Serum levels of protein CASC4	3e-16	35078996
rs10790177	rs2622935	0.696095281293536	Polypeptide N-acetylgalactosaminyltransferase 1 levels	1e-30	34648354
rs10790177	rs4938353	0.669862311453402	Blood protein levels	2e-14	27532455
rs10790177	rs1060211	0.623867089796535	Diastolic blood pressure	5e-09	35762941
rs10799694	rs6680628	0.713102627326381	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs10800107	rs7554904	0.946545200665594	Metabolite levels	4e-06	23823483
rs10800107	rs7554904	0.946545200665594	Metabolite levels	2e-06	23823483
rs10800107	rs1425754	0.917745636869306	Metabolite levels	1e-06	23823483
rs10800107	rs10918211	0.799238605652475	White blood cell count	1e-26	34925446
rs10800107	rs10918211	0.799238605652475	Neutrophil count	5e-34	34925446
rs10800110	rs10918211	0.926692060087105	White blood cell count	1e-26	34925446
rs10800110	rs10918211	0.926692060087105	Neutrophil count	5e-34	34925446
rs10800110	rs7554904	0.90683176193895	Metabolite levels	4e-06	23823483
rs10800110	rs7554904	0.90683176193895	Metabolite levels	2e-06	23823483
rs10800110	rs1425754	0.85915814428413	Metabolite levels	1e-06	23823483
rs10800111	rs10918211	0.945360214500732	White blood cell count	1e-26	34925446
rs10800111	rs10918211	0.945360214500732	Neutrophil count	5e-34	34925446
rs10800111	rs7554904	0.885378960115755	Metabolite levels	4e-06	23823483
rs10800111	rs7554904	0.885378960115755	Metabolite levels	2e-06	23823483
rs10800111	rs1425754	0.838448934146851	Metabolite levels	1e-06	23823483
rs10801680	rs12145712	0.921455579113295	Pulse pressure	1e-10	35762941
rs10801680	rs10922476	0.745248081385375	Corneal resistance factor	4e-17	33311554
rs10801680	rs12145922	0.741010535485214	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs10801680	rs12145922	0.741010535485214	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs10801680	rs3806340	0.741010535485214	Corneal resistance factor (MTAG)	3e-18	35446358
rs10801680	rs3806340	0.741010535485214	Height	1e-12	35831902
rs10801680	rs3806340	0.741010535485214	Height	7e-17	36224396
rs10801680	rs3806340	0.741010535485214	Height	3e-47	36224396
rs10801680	rs6699417	0.721996235063185	Height	5e-09	20881960
rs10801680	rs6699417	0.721996235063185	Height	2e-11	35831902
rs10801680	rs6699417	0.721996235063185	Height	1e-300	36224396
rs10801680	rs6699417	0.721996235063185	Height	1e-300	36224396
rs10801680	rs4233334	0.721059603695696	Body surface area	6e-09	36502284
rs10801680	rs786906	0.71389780682673	Systolic blood pressure	1e-06	27618447
rs10801680	rs786906	0.71389780682673	Intraocular pressure	5e-09	29617998
rs10801680	rs12021820	0.711939482066933	Mean corpuscular hemoglobin	2e-11	32888493
rs10801680	rs10801682	0.710636902988109	Mean corpuscular hemoglobin	1e-09	30595370
rs10801680	rs7551732	0.705186503909752	Height	6e-20	25282103
rs10801680	rs7551732	0.705186503909752	Gamma glutamyl transferase levels	5e-08	33339817
rs10801680	rs1002436	0.606694867444583	Red blood cell count	4e-22	32888493
rs10801680	rs1002436	0.606694867444583	Alanine aminotransferase levels	6e-11	33547301
rs10801680	rs1002436	0.606694867444583	Aspartate aminotransferase levels	1e-20	33547301
rs10801680	rs1002436	0.606694867444583	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs10801696	rs10801696	1	Imidazole lactate levels	3e-195	35050183
rs10801696	rs1206228892	0.999199829927895	Imidazole lactate levels	5e-186	35050183
rs10801696	rs2810876	0.994408967179355	Imidazole lactate levels	2e-122	35347128
rs10801696	rs2765527	0.853486534371323	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs10801696	rs7532151	0.717082459063155	Imidazole lactate levels	9e-12	33177712
rs10801696	rs12729558	0.690287614446339	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs10801696	rs10127863	0.669826545629635	Intraocular pressure	9e-10	29617998
rs10801696	rs9787133	0.658631139268485	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10801696	rs10801690	0.640635317687594	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs10801696	rs12143830	0.602594484350983	Central corneal thickness (MTAG)	4e-10	35446358
rs10801697	rs10922531	0.945618847874226	Serum metabolite levels	2e-69	33031748
rs10801697	rs12729558	0.908886914662666	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs10801697	rs7530513	0.861117051155524	Height	8e-11	35831902
rs10801697	rs7530513	0.861117051155524	Imidazole lactate levels	8e-166	36635386
rs10801697	rs12144640	0.861117051155524	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10801697	rs1409152	0.849211930082339	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs10801697	rs1409152	0.849211930082339	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs10801697	rs10801699	0.847025621675857	X-23639 levels	2e-10	36635386
rs10801697	rs7532151	0.844294007135275	Imidazole lactate levels	9e-12	33177712
rs10801697	rs10801690	0.818008915777123	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs10801697	rs12120164	0.811781280239785	Metabolite peak levels (QI2146)	1e-26	35995766
rs10801697	rs9787133	0.78852622105922	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10801697	rs2765527	0.740325542090107	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs10801697	rs2810876	0.634194707871901	Imidazole lactate levels	2e-122	35347128
rs10801697	rs10801696	0.632953044816836	Imidazole lactate levels	3e-195	35050183
rs10801697	rs1206228892	0.632446574733326	Imidazole lactate levels	5e-186	35050183
rs10801698	rs10922531	0.944833842157713	Serum metabolite levels	2e-69	33031748
rs10801698	rs12729558	0.909641974856823	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs10801698	rs7530513	0.860405171685901	Height	8e-11	35831902
rs10801698	rs7530513	0.860405171685901	Imidazole lactate levels	8e-166	36635386
rs10801698	rs12144640	0.860405171685901	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10801698	rs1409152	0.848508845968389	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs10801698	rs1409152	0.848508845968389	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs10801698	rs10801699	0.846324345965422	X-23639 levels	2e-10	36635386
rs10801698	rs7532151	0.844997709501403	Imidazole lactate levels	9e-12	33177712
rs10801698	rs10801690	0.81869730163795	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs10801698	rs12120164	0.811108642547787	Metabolite peak levels (QI2146)	1e-26	35995766
rs10801698	rs9787133	0.789195672142082	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10801698	rs2765527	0.739538397318966	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs10801698	rs2810876	0.634720060819191	Imidazole lactate levels	2e-122	35347128
rs10801698	rs10801696	0.633476735622828	Imidazole lactate levels	3e-195	35050183
rs10801698	rs1206228892	0.632969846497608	Imidazole lactate levels	5e-186	35050183
rs10801699	rs10801699	1	X-23639 levels	2e-10	36635386
rs10801699	rs1409152	0.994009539071866	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs10801699	rs1409152	0.994009539071866	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs10801699	rs12120164	0.95522120564294	Metabolite peak levels (QI2146)	1e-26	35995766
rs10801699	rs10922531	0.801222013045496	Serum metabolite levels	2e-69	33031748
rs10801699	rs12729558	0.775057124028699	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs10801699	rs7532151	0.714008664115822	Imidazole lactate levels	9e-12	33177712
rs10801699	rs7530513	0.711947700717531	Height	8e-11	35831902
rs10801699	rs7530513	0.711947700717531	Imidazole lactate levels	8e-166	36635386
rs10801699	rs12144640	0.711947700717531	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10801699	rs10801690	0.694702448932256	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs10801699	rs9787133	0.668623903739804	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10801699	rs2765527	0.626746332393541	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs10801699	rs10922532	0.607056222206734	Blood urea nitrogen levels	2e-08	31152163
rs10801699	rs10922532	0.607056222206734	Waist circumference adjusted for body mass index	2e-11	34021172
rs10801699	rs10922532	0.607056222206734	X-23639 levels	4e-11	35050183
rs10801907	rs12145712	0.847586692489315	Pulse pressure	1e-10	35762941
rs10801907	rs4233334	0.795416527271428	Body surface area	6e-09	36502284
rs10801907	rs12021820	0.787760321079102	Mean corpuscular hemoglobin	2e-11	32888493
rs10801907	rs786906	0.786998050262049	Systolic blood pressure	1e-06	27618447
rs10801907	rs786906	0.786998050262049	Intraocular pressure	5e-09	29617998
rs10801907	rs10801682	0.785279519116815	Mean corpuscular hemoglobin	1e-09	30595370
rs10801907	rs10922476	0.670016504941802	Corneal resistance factor	4e-17	33311554
rs10801907	rs12145922	0.668685666109922	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs10801907	rs12145922	0.668685666109922	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs10801907	rs3806340	0.668685666109922	Corneal resistance factor (MTAG)	3e-18	35446358
rs10801907	rs3806340	0.668685666109922	Height	1e-12	35831902
rs10801907	rs3806340	0.668685666109922	Height	7e-17	36224396
rs10801907	rs3806340	0.668685666109922	Height	3e-47	36224396
rs10801907	rs6699417	0.665438211470433	Height	5e-09	20881960
rs10801907	rs6699417	0.665438211470433	Height	2e-11	35831902
rs10801907	rs6699417	0.665438211470433	Height	1e-300	36224396
rs10801907	rs6699417	0.665438211470433	Height	1e-300	36224396
rs10801907	rs12143830	0.649867067706444	Central corneal thickness (MTAG)	4e-10	35446358
rs10801907	rs7551732	0.61824316424052	Height	6e-20	25282103
rs10801907	rs7551732	0.61824316424052	Gamma glutamyl transferase levels	5e-08	33339817
rs10803254	rs7545078	0.672637519960196	Smoking initiation	2e-09	36477530
rs10803254	rs6700087	0.640562481470079	Smoking initiation	6e-11	36477530
rs10803654	rs12620999	0.997954266035728	Systemic lupus erythematosus	3e-06	19838195
rs10803655	rs12620999	0.811753239944211	Systemic lupus erythematosus	3e-06	19838195
rs10807141	rs9366863	0.99679027670559	Adult body size	9e-33	32376654
rs10807141	rs9366863	0.99679027670559	Body mass index	2e-44	30595370
rs10807141	rs9469872	0.973655621338095	HDL cholesterol levels	3e-11	36333282
rs10807141	rs11755393	0.966664123350239	Body mass index	3e-26	29273807
rs10807141	rs11755393	0.966664123350239	Systemic lupus erythematosus	2e-12	33493351
rs10807141	rs11755393	0.966664123350239	Systemic lupus erythematosus	2e-06	33493351
rs10807141	rs11755393	0.966664123350239	Systemic lupus erythematosus	1e-07	33493351
rs10807141	rs11755393	0.966664123350239	Systemic lupus erythematosus	2e-08	19838195
rs10807141	rs11755393	0.966664123350239	Body mass index	4e-55	36581621
rs10807141	rs2814949	0.95945865759442	Essential hypertension (time to event)	9e-09	32589924
rs10807141	rs6941110	0.957074733003238	Sex hormone-binding globulin levels	5e-27	36653534
rs10807141	rs2744944	0.950011203272154	Hypothyroidism	3e-10	34594039
rs10807141	rs2744944	0.950011203272154	High density lipoprotein cholesterol levels	3e-86	34887591
rs10807141	rs2744944	0.950011203272154	Multi-trait sex score	7e-22	37277458
rs10807141	rs9462030	0.937769025902711	Red cell distribution width	5e-25	32888493
rs10807141	rs9469857	0.933149364952149	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs10807141	rs2764208	0.932413435736606	Systemic lupus erythematosus	7e-06	24871463
rs10807141	rs2263329	0.930542906374067	HDL cholesterol	6e-35	34594039
rs10807141	rs2263329	0.930542906374067	HDL cholesterol levels	8e-43	32203549
rs10807141	rs2263329	0.930542906374067	High density lipoprotein cholesterol levels	2e-52	34887591
rs10807141	rs9469899	0.921248611178217	Prostate cancer (advanced)	2e-06	29892016
rs10807141	rs9469899	0.921248611178217	Prostate cancer	5e-09	29892016
rs10807141	rs9469899	0.921248611178217	Prostate cancer	8e-11	33398198
rs10807141	rs9469899	0.921248611178217	Hand grip strength	3e-15	29691431
rs10807141	rs9469899	0.921248611178217	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs10807141	rs9469899	0.921248611178217	Graves' disease	4e-10	34594039
rs10807141	rs9469899	0.921248611178217	Coronary artery disease	1e-11	36474045
rs10807141	rs9469899	0.921248611178217	Predicted visceral adipose tissue	2e-20	31501611
rs10807141	rs9469899	0.921248611178217	Medication use (thyroid preparations)	2e-09	31015401
rs10807141	rs9469899	0.921248611178217	Medication use (thyroid preparations)	3e-10	34594039
rs10807141	rs111868030	0.906077651495445	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs10807141	rs9296128	0.88468539190401	Hip circumference adjusted for BMI	4e-13	34021172
rs10807141	rs9368830	0.88288793616956	HDL cholesterol	4e-21	30275531
rs10807141	rs9368828	0.851679048294784	Body mass index	1e-34	34594039
rs10807141	rs6912327	0.812848662289752	Fasting insulin	5e-06	33402679
rs10807141	rs6912327	0.812848662289752	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs10807141	rs2744973	0.796836784799695	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs10807141	rs2744973	0.796836784799695	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs10807141	rs2744973	0.796836784799695	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs10807141	rs2744973	0.796836784799695	Multi-trait sex score	6e-20	37277458
rs10807141	rs112283401	0.790257863293587	Red cell distribution width	4e-27	30595370
rs10807141	rs6940215	0.63406229264072	Insomnia	2e-10	35835914
rs10807141	rs6940215	0.63406229264072	Insomnia	1e-13	35835914
rs10807141	rs6940215	0.63406229264072	Hip circumference adjusted for BMI	8e-10	34021172
rs10807141	rs6940215	0.63406229264072	Multi-trait sex score	2e-23	37277458
rs10807141	rs6940215	0.63406229264072	Multi-trait sex score	4e-23	37277458
rs10807141	rs6457796	0.625137095146929	Insomnia	1e-08	30804565
rs10807141	rs6457796	0.625137095146929	Plateletcrit	9e-11	32888494
rs10807141	rs6457796	0.625137095146929	Systemic lupus erythematosus	3e-22	33272962
rs10807141	rs6457796	0.625137095146929	Body mass index	5e-13	30108127
rs10807141	rs6457796	0.625137095146929	Body mass index	1e-14	26426971
rs10807141	rs6457796	0.625137095146929	Educational attainment	5e-19	35361970
rs10807141	rs205262	0.609384697690614	Body mass index	2e-09	26961502
rs10807141	rs205262	0.609384697690614	Walking pace	4e-10	33128006
rs10807141	rs205262	0.609384697690614	Body mass index	8e-13	30108127
rs10807141	rs205262	0.609384697690614	Body mass index	2e-09	25673413
rs10807141	rs205262	0.609384697690614	Body mass index	2e-14	26426971
rs10807141	rs205262	0.609384697690614	BMI in non-smokers	3e-07	28443625
rs10807141	rs205262	0.609384697690614	BMI in non-smokers	6e-09	28443625
rs10807141	rs205262	0.609384697690614	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs10807141	rs205262	0.609384697690614	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs10807141	rs205262	0.609384697690614	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs10807141	rs205262	0.609384697690614	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs10807141	rs205262	0.609384697690614	Gastroesophageal reflux disease	1e-10	34187846
rs10807141	rs205262	0.609384697690614	Body mass index	3e-10	25673413
rs10807141	rs205262	0.609384697690614	Body mass index	2e-10	25673413
rs10807141	rs205262	0.609384697690614	ICD10 M54: Dorsalgia	2e-12	35110524
rs10807141	rs9689160	0.604523533516379	Lung function (forced vital capacity)	3e-14	36914875
rs10813815	rs10970976	0.698074474445964	Asthma	4e-06	22561531
rs10813815	rs10970975	0.647538023321284	Red blood cell count	9e-14	34594039
rs10813815	rs10970975	0.647538023321284	Red blood cell count	6e-21	30595370
rs10813815	rs12985	0.624255935653419	Hematocrit	1e-26	32888493
rs10813815	rs12985	0.624255935653419	Hemoglobin concentration	4e-23	32888493
rs10813815	rs12985	0.624255935653419	Hematocrit	4e-27	32888493
rs10813815	rs12985	0.624255935653419	Hemoglobin concentration	5e-23	32888493
rs10813815	rs12985	0.624255935653419	Hemoglobin	1e-15	34594039
rs10813815	rs12985	0.624255935653419	Hematocrit	2e-16	34594039
rs10813815	rs12985	0.624255935653419	Triglyceride levels	1e-08	34887591
rs10813816	rs12985	0.725990809697579	Hematocrit	1e-26	32888493
rs10813816	rs12985	0.725990809697579	Hemoglobin concentration	4e-23	32888493
rs10813816	rs12985	0.725990809697579	Hematocrit	4e-27	32888493
rs10813816	rs12985	0.725990809697579	Hemoglobin concentration	5e-23	32888493
rs10813816	rs12985	0.725990809697579	Hemoglobin	1e-15	34594039
rs10813816	rs12985	0.725990809697579	Hematocrit	2e-16	34594039
rs10813816	rs12985	0.725990809697579	Triglyceride levels	1e-08	34887591
rs10813816	rs10970975	0.604944632732512	Red blood cell count	9e-14	34594039
rs10813816	rs10970975	0.604944632732512	Red blood cell count	6e-21	30595370
rs10832917	rs4353250	0.982220524622188	Insulin-like growth factor 1 levels	2e-14	33462484
rs10832917	rs4353250	0.982220524622188	Amyloid A serum levels	2e-51	21124955
rs10832917	rs4150575	0.629292299076963	Imidazole lactate levels	1e-10	36635386
rs10836006	rs1467510	0.93459119954891	Platelet distribution width	1e-14	32888494
rs10836006	rs12276109	0.792252401155647	Severe COVID-19 infection	6e-08	36662838
rs10836009	rs1467510	0.937070585408734	Platelet distribution width	1e-14	32888494
rs10836009	rs12276109	0.794393692596915	Severe COVID-19 infection	6e-08	36662838
rs10849045	rs10849045	1	Height	2e-07	36224396
rs10850092	rs4767027	0.998785762519793	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10850092	rs2057778	0.99757238798652	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10850092	rs2057778	0.99757238798652	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10850092	rs2057778	0.99757238798652	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10850092	rs11066452	0.977221991111765	Blood protein levels	6e-08	30072576
rs10850092	rs1131476	0.971509070243431	Systemic lupus erythematosus	1e-09	33272962
rs10850092	rs2660	0.971509070243431	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10850092	rs2660	0.971509070243431	COVID-19 (critical illness vs population)	3e-15	37198478
rs10850092	rs1859336	0.938790929403504	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10850092	rs6489882	0.919768958194515	Chronic lymphocytic leukemia	5e-08	28165464
rs10850092	rs6489867	0.64222910396762	COVID-19 (critical illness vs population)	1e-09	33307546
rs10850092	rs1557866	0.602578612645332	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10850093	rs4767027	0.996356175144463	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10850093	rs2057778	0.995145751016778	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10850093	rs2057778	0.995145751016778	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10850093	rs2057778	0.995145751016778	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10850093	rs11066452	0.977226175636546	Blood protein levels	6e-08	30072576
rs10850093	rs1131476	0.96915037922071	Systemic lupus erythematosus	1e-09	33272962
rs10850093	rs2660	0.96915037922071	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10850093	rs2660	0.96915037922071	COVID-19 (critical illness vs population)	3e-15	37198478
rs10850093	rs1859336	0.938791729220282	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10850093	rs6489882	0.922072395810244	Chronic lymphocytic leukemia	5e-08	28165464
rs10850093	rs6489867	0.64240111973944	COVID-19 (critical illness vs population)	1e-09	33307546
rs10850093	rs1557866	0.601998215801261	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10850094	rs4767027	0.995143266837031	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10850094	rs2057778	0.99151037760122	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10850094	rs2057778	0.99151037760122	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10850094	rs2057778	0.99151037760122	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10850094	rs11066452	0.976040967737102	Blood protein levels	6e-08	30072576
rs10850094	rs1131476	0.965616796408349	Systemic lupus erythematosus	1e-09	33272962
rs10850094	rs2660	0.965616796408349	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10850094	rs2660	0.965616796408349	COVID-19 (critical illness vs population)	3e-15	37198478
rs10850094	rs1859336	0.94230135786891	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10850094	rs6489882	0.923239079434794	Chronic lymphocytic leukemia	5e-08	28165464
rs10850094	rs6489867	0.64178946475813	COVID-19 (critical illness vs population)	1e-09	33307546
rs10850094	rs1557866	0.606391161792539	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10850095	rs4767027	0.992717147463958	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10850095	rs2057778	0.989090672464441	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10850095	rs2057778	0.989090672464441	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10850095	rs2057778	0.989090672464441	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10850095	rs11066452	0.973643356287071	Blood protein levels	6e-08	30072576
rs10850095	rs1131476	0.963232839642405	Systemic lupus erythematosus	1e-09	33272962
rs10850095	rs2660	0.963232839642405	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10850095	rs2660	0.963232839642405	COVID-19 (critical illness vs population)	3e-15	37198478
rs10850095	rs1859336	0.939959346664211	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10850095	rs6489882	0.920926797573545	Chronic lymphocytic leukemia	5e-08	28165464
rs10850095	rs6489867	0.639870694956099	COVID-19 (critical illness vs population)	1e-09	33307546
rs10850095	rs1557866	0.604861724239839	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10850096	rs4767027	0.996356532839968	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10850096	rs2057778	0.992721558416588	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10850096	rs2057778	0.992721558416588	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10850096	rs2057778	0.992721558416588	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10850096	rs11066452	0.977233259469999	Blood protein levels	6e-08	30072576
rs10850096	rs1131476	0.966794064114406	Systemic lupus erythematosus	1e-09	33272962
rs10850096	rs2660	0.966794064114406	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10850096	rs2660	0.966794064114406	COVID-19 (critical illness vs population)	3e-15	37198478
rs10850096	rs1859336	0.94346602921748	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10850096	rs6489882	0.924384737888608	Chronic lymphocytic leukemia	5e-08	28165464
rs10850096	rs6489867	0.642575306093359	COVID-19 (critical illness vs population)	1e-09	33307546
rs10850096	rs1557866	0.605625703855193	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10850098	rs1859336	0.988177482319676	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10850098	rs11066452	0.970558177145172	Blood protein levels	6e-08	30072576
rs10850098	rs6489882	0.968361838534634	Chronic lymphocytic leukemia	5e-08	28165464
rs10850098	rs4767027	0.949549248492631	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10850098	rs2057778	0.946037927351934	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10850098	rs2057778	0.946037927351934	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10850098	rs2057778	0.946037927351934	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10850098	rs1131476	0.920800186540991	Systemic lupus erythematosus	1e-09	33272962
rs10850098	rs2660	0.920800186540991	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10850098	rs2660	0.920800186540991	COVID-19 (critical illness vs population)	3e-15	37198478
rs10850098	rs6489867	0.676103284678255	COVID-19 (critical illness vs population)	1e-09	33307546
rs10850098	rs1557866	0.625844491721027	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10850099	rs1859336	0.983407098684218	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10850099	rs6489882	0.963678317369446	Chronic lymphocytic leukemia	5e-08	28165464
rs10850099	rs11066452	0.960959623324381	Blood protein levels	6e-08	30072576
rs10850099	rs4767027	0.939874106232232	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10850099	rs2057778	0.936380203428974	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10850099	rs2057778	0.936380203428974	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10850099	rs2057778	0.936380203428974	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10850099	rs1131476	0.911413492661145	Systemic lupus erythematosus	1e-09	33272962
rs10850099	rs2660	0.911413492661145	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10850099	rs2660	0.911413492661145	COVID-19 (critical illness vs population)	3e-15	37198478
rs10850099	rs6489867	0.669695762456863	COVID-19 (critical illness vs population)	1e-09	33307546
rs10850099	rs1557866	0.623452299526821	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10850100	rs1859336	0.983407098684218	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10850100	rs6489882	0.963678317369446	Chronic lymphocytic leukemia	5e-08	28165464
rs10850100	rs11066452	0.960959623324381	Blood protein levels	6e-08	30072576
rs10850100	rs4767027	0.939874106232232	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10850100	rs2057778	0.936380203428974	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs10850100	rs2057778	0.936380203428974	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs10850100	rs2057778	0.936380203428974	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs10850100	rs1131476	0.911413492661145	Systemic lupus erythematosus	1e-09	33272962
rs10850100	rs2660	0.911413492661145	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs10850100	rs2660	0.911413492661145	COVID-19 (critical illness vs population)	3e-15	37198478
rs10850100	rs6489867	0.669695762456863	COVID-19 (critical illness vs population)	1e-09	33307546
rs10850100	rs1557866	0.623452299526821	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10850103	rs1557866	0.99699230140913	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs10850103	rs1293767	0.900357199170312	Adult asthma	2e-06	27611488
rs10850103	rs1293767	0.900357199170312	Adult asthma	9e-07	27611488
rs10850103	rs6489882	0.639727501972703	Chronic lymphocytic leukemia	5e-08	28165464
rs10850103	rs1859336	0.617793468862207	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs10850103	rs10744789	0.608190304246746	Vitamin D levels or COVID-19 (MTAG)	5e-12	37212302
rs10850103	rs4767027	0.601252101712516	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs10853882	rs4801635	0.922896238973047	Plasma anti-thyroglobulin levels	9e-07	29678681
rs10866016	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs10866016	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs10866016	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs10866016	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs10866016	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs10866016	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs10866016	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs10866016	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs10866016	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs10866016	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs10866016	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs10866016	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs10866016	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs10866016	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs10866016	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs10866016	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs10866016	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs10866016	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs10866016	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs10866016	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs10866016	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs10866016	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs10866016	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs10866016	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs10866016	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs10866016	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs10869497	rs11144225	0.856234831757741	Nicotinamide riboside kinase 1 levels	3e-133	34648354
rs10869499	rs11144225	0.861463344197805	Nicotinamide riboside kinase 1 levels	3e-133	34648354
rs10872644	rs10872649	0.968196788254147	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs10872644	rs10872649	0.968196788254147	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs10872644	rs10872649	0.968196788254147	Right hippocampal volume (body)	1e-10	37337106
rs10872644	rs7752089	0.926976243063387	Brain morphology (MOSTest)	2e-31	35164939
rs10872644	rs1934534	0.870533291990847	Pain (pleiotropy)	2e-08	37844115
rs10872644	rs1934534	0.870533291990847	Pain (pleiotropy)	2e-06	37844115
rs10872644	rs4380763	0.868240633682335	Subcortical volume (min-P)	1e-11	32665545
rs10872644	rs9322194	0.854657623276004	Brainstem volume	2e-11	31636452
rs10872644	rs11155671	0.853783446703842	Testicular germ cell tumor	2e-09	28604728
rs10872644	rs80147756	0.830665260650974	HippSubfield lh volume subiculum-head	3e-10	33875891
rs10872644	rs4421206	0.827482022400809	Brain morphology (min-P)	4e-11	32665545
rs10872644	rs9505982	0.810841693885976	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs10872644	rs9688452	0.805359522381	Brainstem global volume Whole-brainstem	1e-11	33875891
rs10872644	rs9688452	0.805359522381	aseg lh volume VentralDC	2e-10	33875891
rs10872644	rs9285521	0.737499235438454	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs10872644	rs12526675	0.731593781467718	Brain morphology (MOSTest)	7e-22	32665545
rs10872644	rs2342764	0.686416992921172	Cortical thickness	1e-08	34560273
rs10872644	rs56103941	0.653112464542202	Right presubiculum volume (head)	4e-08	37337106
rs10872644	rs12523793	0.616876684371875	Subcortical volume (MOSTest)	4e-24	32665545
rs10872644	rs12523793	0.616876684371875	C-reactive protein levels	3e-08	35459240
rs10872644	rs12523793	0.616876684371875	C-reactive protein levels (MTAG)	2e-08	36376304
rs10872644	rs11155662	0.613342022073821	Vertex-wise cortical thickness	2e-09	34910505
rs10872651	rs56103941	0.981403208509759	Right presubiculum volume (head)	4e-08	37337106
rs10872651	rs12523793	0.939536788717274	Subcortical volume (MOSTest)	4e-24	32665545
rs10872651	rs12523793	0.939536788717274	C-reactive protein levels	3e-08	35459240
rs10872651	rs12523793	0.939536788717274	C-reactive protein levels (MTAG)	2e-08	36376304
rs10872651	rs11155662	0.920446835268762	Vertex-wise cortical thickness	2e-09	34910505
rs10872651	rs12526675	0.884452974391547	Brain morphology (MOSTest)	7e-22	32665545
rs10872651	rs2342764	0.822987063929201	Cortical thickness	1e-08	34560273
rs10872651	rs58189451	0.750293665351029	Drinks per week	1e-09	36477530
rs10872651	rs9285521	0.739577193210202	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs10872651	rs7752089	0.663342091324222	Brain morphology (MOSTest)	2e-31	35164939
rs10872651	rs9322194	0.652606735630198	Brainstem volume	2e-11	31636452
rs10872651	rs10872649	0.638695612304226	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs10872651	rs10872649	0.638695612304226	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs10872651	rs10872649	0.638695612304226	Right hippocampal volume (body)	1e-10	37337106
rs10872651	rs11155675	0.636414102052177	Brain region volumes	3e-09	31676860
rs10872651	rs1125	0.629385763921244	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs10872651	rs1125	0.629385763921244	Vertical cup-disc ratio	8e-14	34077760
rs10872651	rs9371201	0.626302040656265	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs10872651	rs4421206	0.612954023390231	Brain morphology (min-P)	4e-11	32665545
rs10872653	rs10872653	1	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs10872653	rs55763431	0.991920973218723	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs10872653	rs9689694	0.990120077233172	Right hippocampal volume (head)	6e-11	37337106
rs10872653	rs9689694	0.990120077233172	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs10872653	rs9689694	0.990120077233172	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs10872653	rs9689694	0.990120077233172	Left hippocampal volume (head)	6e-12	37337106
rs10872653	rs2095375	0.987428985005238	Serum metabolite levels	1e-20	33031748
rs10872653	rs2095375	0.987428985005238	Serum metabolite levels	1e-20	33031748
rs10872653	rs9383843	0.986537706971453	Migraine	1e-09	35115687
rs10872653	rs10872645	0.984758360799649	Blood protein levels	2e-86	30072576
rs10872653	rs9688867	0.983927961297746	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs10872653	rs9688867	0.983927961297746	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs10872653	rs9688809	0.983927961297746	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs10872653	rs34337297	0.980289347047308	Serum levels of protein LRP11	3e-161	35078996
rs10872653	rs14314	0.968831388785044	Macular thickness	3e-19	30535121
rs10872653	rs14314	0.968831388785044	Vertex-wise sulcal depth	7e-17	34910505
rs10872653	rs14314	0.968831388785044	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs10872653	rs14314	0.968831388785044	Left hippocampal volume (body)	7e-15	37337106
rs10872653	rs14314	0.968831388785044	Left subiculum volume (body)	1e-14	37337106
rs10872653	rs9322193	0.9443369194958	Lung cancer	1e-07	27393504
rs10872653	rs4039600	0.900479845897492	Adenine levels	1e-11	35347128
rs10872653	rs1934534	0.63655279561687	Pain (pleiotropy)	2e-08	37844115
rs10872653	rs1934534	0.63655279561687	Pain (pleiotropy)	2e-06	37844115
rs10872653	rs4380763	0.636033908583699	Subcortical volume (min-P)	1e-11	32665545
rs10872653	rs11155671	0.625629893723964	Testicular germ cell tumor	2e-09	28604728
rs10872653	rs80147756	0.610835947800951	HippSubfield lh volume subiculum-head	3e-10	33875891
rs10872653	rs4421206	0.603296923188388	Brain morphology (min-P)	4e-11	32665545
rs10873172	rs10873172	1	Cutaneous melanoma or hair colour	6e-27	32341527
rs10873172	rs10873172	1	Nevus count or cutaneous melanoma	6e-13	32341527
rs10873172	rs10873172	1	Blond vs. brown/black hair color	6e-15	30531825
rs10873172	rs10873172	1	Cutaneous malignant melanoma	6e-08	32341527
rs10873172	rs10873172	1	Hair color	4e-17	30595370
rs10873172	rs2357176	0.83123966311423	Nevus count or cutaneous melanoma	4e-08	30429480
rs10873172	rs1255908	0.716404888772121	PR interval	8e-14	32439900
rs10873172	rs1255908	0.716404888772121	PR interval	6e-14	32439900
rs10873172	rs12878653	0.707507675271073	Youthful appearance (self-reported)	3e-14	32339537
rs10874424	rs10465746	0.790457166244093	Obesity-related traits	8e-06	23251661
rs10874424	rs11580836	0.757632685633379	Body mass index	2e-09	36581621
rs10875742	rs10875742	1	Lung function (FVC)	6e-09	30595370
rs10875742	rs4760685	0.621460329365255	Chondrocalcin levels	1e-159	34648354
rs10876448	rs10876448	1	Mean corpuscular hemoglobin	2e-16	32888493
rs10876448	rs10876448	1	Reticulocyte count	3e-18	32888494
rs10876448	rs10876448	1	Reticulocyte fraction of red cells	1e-10	32888494
rs10876448	rs2446066	0.999092856617345	Vertex-wise sulcal depth	1e-10	34910505
rs10876448	rs2446066	0.999092856617345	Vertex-wise cortical surface area	2e-13	34910505
rs10876448	rs2446066	0.999092856617345	Red blood cell count	1e-10	27863252
rs10876448	rs2446066	0.999092856617345	Cortical surface area	3e-08	34560273
rs10876448	rs2608301	0.999092856617345	Low density lipoprotein cholesterol levels	2e-12	34887591
rs10876448	rs2460882	0.997278539615478	Mean corpuscular volume	3e-15	29403010
rs10876448	rs2460882	0.997278539615478	Percentage gas trapping	6e-07	26030696
rs10876448	rs12582170	0.963989566807596	Mean corpuscular volume	1e-21	27863252
rs10876448	rs12582170	0.963989566807596	Mean corpuscular hemoglobin	7e-37	32888493
rs10876448	rs12582170	0.963989566807596	Mean reticulocyte volume	2e-33	32888494
rs10876448	rs12582170	0.963989566807596	Mean corpuscular volume	1e-67	32888493
rs10876448	rs12582170	0.963989566807596	Mean corpuscular hemoglobin	2e-21	32888494
rs10876448	rs12582170	0.963989566807596	Mean corpuscular volume	1e-26	34104963
rs10876448	rs111379945	0.767150692255209	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs10876448	rs111379945	0.767150692255209	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs10876448	rs111379945	0.767150692255209	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs10876448	rs79205721	0.616889188997008	Vertex-wise cortical thickness	2e-09	34910505
rs10891310	rs10891301	0.668944455530451	Pyruvate dehydrogenase protein X component, mitochondrial levels	1e-18	34648354
rs10891310	rs2276390	0.656369553327862	Waist-hip ratio	6e-28	30239722
rs10892079	rs2622935	0.831074739433141	Serum levels of protein CASC4	3e-16	35078996
rs10892079	rs2622935	0.831074739433141	Polypeptide N-acetylgalactosaminyltransferase 1 levels	1e-30	34648354
rs10892079	rs4938354	0.820239679146115	Proprotein convertase subtilisin/kexin type 7 levels	3e-295	36168886
rs10892079	rs1794116	0.749839119863153	Protein CASC4 levels	5e-13	34648354
rs10892079	rs1794116	0.749839119863153	Asialoglycoprotein receptor 1 levels	7e-18	34648354
rs10892079	rs1060211	0.747102016923524	Diastolic blood pressure	5e-09	35762941
rs10892079	rs171052	0.740878601337456	Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)	1e-38	35870639
rs10892079	rs4938344	0.732567120826774	Cerebrospinal fluid biomarker levels	7e-19	28031287
rs10892079	rs9326248	0.720322893366768	Proprotein convertase subtilisin/kexin type 7 levels	2e-105	28240269
rs10892079	rs1871757	0.702669976502519	Transgelin levels	2e-15	34648354
rs10892079	rs4938353	0.69232810075628	Blood protein levels	2e-14	27532455
rs10892079	rs7128382	0.656478962706269	Systolic blood pressure	4e-11	30578418
rs10892079	rs6589598	0.628192629345555	Blood protein levels	0	30072576
rs10892079	rs6589598	0.628192629345555	Blood protein levels	3e-13	30072576
rs10892079	rs6589598	0.628192629345555	Blood protein levels	2e-15	30072576
rs10892079	rs6589598	0.628192629345555	Blood protein levels	2e-10	30072576
rs10892079	rs6589598	0.628192629345555	Protein-tyrosine sulfotransferase 2 levels	6e-14	34648354
rs10892079	rs6589598	0.628192629345555	Beta-1,4-galactosyltransferase 7 levels	5e-13	34648354
rs10892085	rs4938354	0.81610296455661	Proprotein convertase subtilisin/kexin type 7 levels	3e-295	36168886
rs10892085	rs1794116	0.783933891889504	Protein CASC4 levels	5e-13	34648354
rs10892085	rs1794116	0.783933891889504	Asialoglycoprotein receptor 1 levels	7e-18	34648354
rs10892085	rs171052	0.772359676157167	Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)	1e-38	35870639
rs10902481	rs10902475	0.694326318344701	Menarche (age at onset)	5e-09	30595370
rs10916996	rs6680628	0.713102627326381	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs10918210	rs10918211	0.947800904805803	White blood cell count	1e-26	34925446
rs10918210	rs10918211	0.947800904805803	Neutrophil count	5e-34	34925446
rs10918210	rs7554904	0.886142576971243	Metabolite levels	4e-06	23823483
rs10918210	rs7554904	0.886142576971243	Metabolite levels	2e-06	23823483
rs10918210	rs1425754	0.839144851473342	Metabolite levels	1e-06	23823483
rs10918211	rs10918211	1	White blood cell count	1e-26	34925446
rs10918211	rs10918211	1	Neutrophil count	5e-34	34925446
rs10918211	rs7554904	0.838451560042083	Metabolite levels	4e-06	23823483
rs10918211	rs7554904	0.838451560042083	Metabolite levels	2e-06	23823483
rs10918211	rs1425754	0.795264045889391	Metabolite levels	1e-06	23823483
rs10918219	rs10733045	0.801970464354285	DNA methylation-estimated granulocyte proportions	5e-09	34187551
rs10918219	rs10918211	0.70377142530252	White blood cell count	1e-26	34925446
rs10918219	rs10918211	0.70377142530252	Neutrophil count	5e-34	34925446
rs10918221	rs10733045	0.837199941825479	DNA methylation-estimated granulocyte proportions	5e-09	34187551
rs10918221	rs10918211	0.665525821612628	White blood cell count	1e-26	34925446
rs10918221	rs10918211	0.665525821612628	Neutrophil count	5e-34	34925446
rs10918221	rs4147592	0.605821251090095	Height	9e-39	36224396
rs10918221	rs10737515	0.603868126268551	Height	4e-10	30595370
rs10922474	rs12145712	0.908027860012041	Pulse pressure	1e-10	35762941
rs10922474	rs10922476	0.755605896038251	Corneal resistance factor	4e-17	33311554
rs10922474	rs12145922	0.751335498059164	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs10922474	rs12145922	0.751335498059164	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs10922474	rs3806340	0.751335498059164	Corneal resistance factor (MTAG)	3e-18	35446358
rs10922474	rs3806340	0.751335498059164	Height	1e-12	35831902
rs10922474	rs3806340	0.751335498059164	Height	7e-17	36224396
rs10922474	rs3806340	0.751335498059164	Height	3e-47	36224396
rs10922474	rs4233334	0.733798701709493	Body surface area	6e-09	36502284
rs10922474	rs786906	0.726529565863115	Systolic blood pressure	1e-06	27618447
rs10922474	rs786906	0.726529565863115	Intraocular pressure	5e-09	29617998
rs10922474	rs12021820	0.724555846094558	Mean corpuscular hemoglobin	2e-11	32888493
rs10922474	rs10801682	0.723216463198949	Mean corpuscular hemoglobin	1e-09	30595370
rs10922474	rs6699417	0.71141819793794	Height	5e-09	20881960
rs10922474	rs6699417	0.71141819793794	Height	2e-11	35831902
rs10922474	rs6699417	0.71141819793794	Height	1e-300	36224396
rs10922474	rs6699417	0.71141819793794	Height	1e-300	36224396
rs10922474	rs7551732	0.694382847427553	Height	6e-20	25282103
rs10922474	rs7551732	0.694382847427553	Gamma glutamyl transferase levels	5e-08	33339817
rs10922474	rs1002436	0.61389569034205	Red blood cell count	4e-22	32888493
rs10922474	rs1002436	0.61389569034205	Alanine aminotransferase levels	6e-11	33547301
rs10922474	rs1002436	0.61389569034205	Aspartate aminotransferase levels	1e-20	33547301
rs10922474	rs1002436	0.61389569034205	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs10922476	rs10922476	1	Corneal resistance factor	4e-17	33311554
rs10922476	rs12145922	0.990171408212607	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs10922476	rs12145922	0.990171408212607	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs10922476	rs3806340	0.990171408212607	Corneal resistance factor (MTAG)	3e-18	35446358
rs10922476	rs3806340	0.990171408212607	Height	1e-12	35831902
rs10922476	rs3806340	0.990171408212607	Height	7e-17	36224396
rs10922476	rs3806340	0.990171408212607	Height	3e-47	36224396
rs10922476	rs1002436	0.788249252132468	Red blood cell count	4e-22	32888493
rs10922476	rs1002436	0.788249252132468	Alanine aminotransferase levels	6e-11	33547301
rs10922476	rs1002436	0.788249252132468	Aspartate aminotransferase levels	1e-20	33547301
rs10922476	rs1002436	0.788249252132468	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs10922476	rs12145712	0.766237743653392	Pulse pressure	1e-10	35762941
rs10922476	rs4233334	0.740415749228398	Body surface area	6e-09	36502284
rs10922476	rs786906	0.733040217412627	Systolic blood pressure	1e-06	27618447
rs10922476	rs786906	0.733040217412627	Intraocular pressure	5e-09	29617998
rs10922476	rs12021820	0.731060714021295	Mean corpuscular hemoglobin	2e-11	32888493
rs10922476	rs10801682	0.729673137181162	Mean corpuscular hemoglobin	1e-09	30595370
rs10922476	rs7551732	0.711069461810224	Height	6e-20	25282103
rs10922476	rs7551732	0.711069461810224	Gamma glutamyl transferase levels	5e-08	33339817
rs10922476	rs6699417	0.655832554238034	Height	5e-09	20881960
rs10922476	rs6699417	0.655832554238034	Height	2e-11	35831902
rs10922476	rs6699417	0.655832554238034	Height	1e-300	36224396
rs10922476	rs6699417	0.655832554238034	Height	1e-300	36224396
rs10922477	rs10922476	0.99671864054187	Corneal resistance factor	4e-17	33311554
rs10922477	rs12145922	0.993442001468783	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs10922477	rs12145922	0.993442001468783	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs10922477	rs3806340	0.993442001468783	Corneal resistance factor (MTAG)	3e-18	35446358
rs10922477	rs3806340	0.993442001468783	Height	1e-12	35831902
rs10922477	rs3806340	0.993442001468783	Height	7e-17	36224396
rs10922477	rs3806340	0.993442001468783	Height	3e-47	36224396
rs10922477	rs1002436	0.791047005797935	Red blood cell count	4e-22	32888493
rs10922477	rs1002436	0.791047005797935	Alanine aminotransferase levels	6e-11	33547301
rs10922477	rs1002436	0.791047005797935	Aspartate aminotransferase levels	1e-20	33547301
rs10922477	rs1002436	0.791047005797935	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs10922477	rs12145712	0.767655119601722	Pulse pressure	1e-10	35762941
rs10922477	rs4233334	0.743380959415756	Body surface area	6e-09	36502284
rs10922477	rs786906	0.735983786533467	Systolic blood pressure	1e-06	27618447
rs10922477	rs786906	0.735983786533467	Intraocular pressure	5e-09	29617998
rs10922477	rs12021820	0.734000572241907	Mean corpuscular hemoglobin	2e-11	32888493
rs10922477	rs10801682	0.73260632548694	Mean corpuscular hemoglobin	1e-09	30595370
rs10922477	rs7551732	0.712267750023906	Height	6e-20	25282103
rs10922477	rs7551732	0.712267750023906	Gamma glutamyl transferase levels	5e-08	33339817
rs10922477	rs6699417	0.657004207917171	Height	5e-09	20881960
rs10922477	rs6699417	0.657004207917171	Height	2e-11	35831902
rs10922477	rs6699417	0.657004207917171	Height	1e-300	36224396
rs10922477	rs6699417	0.657004207917171	Height	1e-300	36224396
rs10922529	rs12729558	0.942565481125474	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs10922529	rs10922531	0.910286829158396	Serum metabolite levels	2e-69	33031748
rs10922529	rs7532151	0.8756376316582	Imidazole lactate levels	9e-12	33177712
rs10922529	rs10801690	0.848662056499011	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs10922529	rs7530513	0.829076338130532	Height	8e-11	35831902
rs10922529	rs7530513	0.829076338130532	Imidazole lactate levels	8e-166	36635386
rs10922529	rs12144640	0.829076338130532	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10922529	rs9787133	0.818323612530072	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs10922529	rs1409152	0.817567084548514	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs10922529	rs1409152	0.817567084548514	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs10922529	rs10801699	0.815462169890363	X-23639 levels	2e-10	36635386
rs10922529	rs12120164	0.781506787010305	Metabolite peak levels (QI2146)	1e-26	35995766
rs10922529	rs2765527	0.768936367352191	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs10922529	rs2810876	0.65741796331764	Imidazole lactate levels	2e-122	35347128
rs10922529	rs10801696	0.656099872438216	Imidazole lactate levels	3e-195	35050183
rs10922529	rs1206228892	0.655574333067312	Imidazole lactate levels	5e-186	35050183
rs10927361	rs7545078	0.689327991302291	Smoking initiation	2e-09	36477530
rs10927361	rs6700087	0.627242247602383	Smoking initiation	6e-11	36477530
rs10927363	rs7545078	0.742799894570185	Smoking initiation	2e-09	36477530
rs10927363	rs6700087	0.67922686740304	Smoking initiation	6e-11	36477530
rs10927364	rs7545078	0.628661165760296	Smoking initiation	2e-09	36477530
rs10927365	rs7545078	0.745293298400549	Smoking initiation	2e-09	36477530
rs10927365	rs6700087	0.682975342249922	Smoking initiation	6e-11	36477530
rs10927367	rs7545078	0.791618544057469	Smoking initiation	2e-09	36477530
rs10927367	rs6700087	0.751810563619993	Smoking initiation	6e-11	36477530
rs10927368	rs7545078	0.786773988702123	Smoking initiation	2e-09	36477530
rs10927368	rs6700087	0.747064552962494	Smoking initiation	6e-11	36477530
rs10929214	rs12620999	0.827916897720439	Systemic lupus erythematosus	3e-06	19838195
rs10929215	rs12620999	0.998976363944945	Systemic lupus erythematosus	3e-06	19838195
rs10940512	rs9292122	0.94322628119853	Prostate cancer	5e-09	33398198
rs10940512	rs702689	0.759633493484575	Vertex-wise sulcal depth	2e-22	34910505
rs10940513	rs702689	0.811089152767705	Vertex-wise sulcal depth	2e-22	34910505
rs10940513	rs96844	0.736097876012626	Type 2 diabetes	5e-08	30297969
rs10940513	rs96844	0.736097876012626	Height	4e-33	36224396
rs10940513	rs10061757	0.71529549406087	Height	4e-30	30595370
rs10940513	rs9292122	0.657463128099306	Prostate cancer	5e-09	33398198
rs10940513	rs33320	0.622255862481108	Height	9e-14	36224396
rs10940513	rs2257505	0.615804718803918	Height	8e-192	36224396
rs10940518	rs10036895	0.98363458547254	Breast cancer	2e-12	34290314
rs10941110	rs7721230	0.654901464097858	Skin color	4e-10	36672889
rs10941112	rs7721230	0.643420346198562	Skin color	4e-10	36672889
rs10944128	rs2842611	0.840684642879111	High density lipoprotein cholesterol levels	5e-09	34887591
rs10944128	rs1173416	0.809888818493639	Height	2e-59	36224396
rs10944128	rs9450288	0.794202045222155	Height	2e-10	36224396
rs10944129	rs2842611	0.83471618244102	High density lipoprotein cholesterol levels	5e-09	34887591
rs10944129	rs1173416	0.802920432717297	Height	2e-59	36224396
rs10944129	rs9450288	0.789944559003688	Height	2e-10	36224396
rs10947521	rs9366863	0.995189572731047	Adult body size	9e-33	32376654
rs10947521	rs9366863	0.995189572731047	Body mass index	2e-44	30595370
rs10947521	rs9469872	0.965745175013975	HDL cholesterol levels	3e-11	36333282
rs10947521	rs11755393	0.95877156577772	Body mass index	3e-26	29273807
rs10947521	rs11755393	0.95877156577772	Systemic lupus erythematosus	2e-12	33493351
rs10947521	rs11755393	0.95877156577772	Systemic lupus erythematosus	2e-06	33493351
rs10947521	rs11755393	0.95877156577772	Systemic lupus erythematosus	1e-07	33493351
rs10947521	rs11755393	0.95877156577772	Systemic lupus erythematosus	2e-08	19838195
rs10947521	rs11755393	0.95877156577772	Body mass index	4e-55	36581621
rs10947521	rs2814949	0.957882853813307	Essential hypertension (time to event)	9e-09	32589924
rs10947521	rs6941110	0.949235764673811	Sex hormone-binding globulin levels	5e-27	36653534
rs10947521	rs2744944	0.948449570523015	Hypothyroidism	3e-10	34594039
rs10947521	rs2744944	0.948449570523015	High density lipoprotein cholesterol levels	3e-86	34887591
rs10947521	rs2744944	0.948449570523015	Multi-trait sex score	7e-22	37277458
rs10947521	rs9462030	0.930024661057241	Red cell distribution width	5e-25	32888493
rs10947521	rs2263329	0.929008282832072	HDL cholesterol	6e-35	34594039
rs10947521	rs2263329	0.929008282832072	HDL cholesterol levels	8e-43	32203549
rs10947521	rs2263329	0.929008282832072	High density lipoprotein cholesterol levels	2e-52	34887591
rs10947521	rs9469857	0.925425725911572	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs10947521	rs2764208	0.924693862967635	Systemic lupus erythematosus	7e-06	24871463
rs10947521	rs9469899	0.913562423330778	Prostate cancer (advanced)	2e-06	29892016
rs10947521	rs9469899	0.913562423330778	Prostate cancer	5e-09	29892016
rs10947521	rs9469899	0.913562423330778	Prostate cancer	8e-11	33398198
rs10947521	rs9469899	0.913562423330778	Hand grip strength	3e-15	29691431
rs10947521	rs9469899	0.913562423330778	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs10947521	rs9469899	0.913562423330778	Graves' disease	4e-10	34594039
rs10947521	rs9469899	0.913562423330778	Coronary artery disease	1e-11	36474045
rs10947521	rs9469899	0.913562423330778	Predicted visceral adipose tissue	2e-20	31501611
rs10947521	rs9469899	0.913562423330778	Medication use (thyroid preparations)	2e-09	31015401
rs10947521	rs9469899	0.913562423330778	Medication use (thyroid preparations)	3e-10	34594039
rs10947521	rs111868030	0.904620337099782	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs10947521	rs9368830	0.881323639547412	HDL cholesterol	4e-21	30275531
rs10947521	rs9296128	0.877186845523019	Hip circumference adjusted for BMI	4e-13	34021172
rs10947521	rs9368828	0.850225391109643	Body mass index	1e-34	34594039
rs10947521	rs6912327	0.805682877398315	Fasting insulin	5e-06	33402679
rs10947521	rs6912327	0.805682877398315	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs10947521	rs2744973	0.795551777273387	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs10947521	rs2744973	0.795551777273387	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs10947521	rs2744973	0.795551777273387	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs10947521	rs2744973	0.795551777273387	Multi-trait sex score	6e-20	37277458
rs10947521	rs112283401	0.78319381517489	Red cell distribution width	4e-27	30595370
rs10947521	rs6940215	0.632974993998808	Insomnia	2e-10	35835914
rs10947521	rs6940215	0.632974993998808	Insomnia	1e-13	35835914
rs10947521	rs6940215	0.632974993998808	Hip circumference adjusted for BMI	8e-10	34021172
rs10947521	rs6940215	0.632974993998808	Multi-trait sex score	2e-23	37277458
rs10947521	rs6940215	0.632974993998808	Multi-trait sex score	4e-23	37277458
rs10947521	rs6457796	0.624120442872488	Insomnia	1e-08	30804565
rs10947521	rs6457796	0.624120442872488	Plateletcrit	9e-11	32888494
rs10947521	rs6457796	0.624120442872488	Systemic lupus erythematosus	3e-22	33272962
rs10947521	rs6457796	0.624120442872488	Body mass index	5e-13	30108127
rs10947521	rs6457796	0.624120442872488	Body mass index	1e-14	26426971
rs10947521	rs6457796	0.624120442872488	Educational attainment	5e-19	35361970
rs10947521	rs205262	0.608401232147416	Body mass index	2e-09	26961502
rs10947521	rs205262	0.608401232147416	Walking pace	4e-10	33128006
rs10947521	rs205262	0.608401232147416	Body mass index	8e-13	30108127
rs10947521	rs205262	0.608401232147416	Body mass index	2e-09	25673413
rs10947521	rs205262	0.608401232147416	Body mass index	2e-14	26426971
rs10947521	rs205262	0.608401232147416	BMI in non-smokers	3e-07	28443625
rs10947521	rs205262	0.608401232147416	BMI in non-smokers	6e-09	28443625
rs10947521	rs205262	0.608401232147416	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs10947521	rs205262	0.608401232147416	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs10947521	rs205262	0.608401232147416	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs10947521	rs205262	0.608401232147416	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs10947521	rs205262	0.608401232147416	Gastroesophageal reflux disease	1e-10	34187846
rs10947521	rs205262	0.608401232147416	Body mass index	3e-10	25673413
rs10947521	rs205262	0.608401232147416	Body mass index	2e-10	25673413
rs10947521	rs205262	0.608401232147416	ICD10 M54: Dorsalgia	2e-12	35110524
rs10947521	rs9689160	0.603547887833499	Lung function (forced vital capacity)	3e-14	36914875
rs10947531	rs9462030	0.99035688450784	Red cell distribution width	5e-25	32888493
rs10947531	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs10947531	rs2764208	0.98316776027726	Systemic lupus erythematosus	7e-06	24871463
rs10947531	rs9469899	0.97372510997998	Prostate cancer (advanced)	2e-06	29892016
rs10947531	rs9469899	0.97372510997998	Prostate cancer	5e-09	29892016
rs10947531	rs9469899	0.97372510997998	Prostate cancer	8e-11	33398198
rs10947531	rs9469899	0.97372510997998	Hand grip strength	3e-15	29691431
rs10947531	rs9469899	0.97372510997998	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs10947531	rs9469899	0.97372510997998	Graves' disease	4e-10	34594039
rs10947531	rs9469899	0.97372510997998	Coronary artery disease	1e-11	36474045
rs10947531	rs9469899	0.97372510997998	Predicted visceral adipose tissue	2e-20	31501611
rs10947531	rs9469899	0.97372510997998	Medication use (thyroid preparations)	2e-09	31015401
rs10947531	rs9469899	0.97372510997998	Medication use (thyroid preparations)	3e-10	34594039
rs10947531	rs9469872	0.947843420042249	HDL cholesterol levels	3e-11	36333282
rs10947531	rs11755393	0.942863454109952	Body mass index	3e-26	29273807
rs10947531	rs11755393	0.942863454109952	Systemic lupus erythematosus	2e-12	33493351
rs10947531	rs11755393	0.942863454109952	Systemic lupus erythematosus	2e-06	33493351
rs10947531	rs11755393	0.942863454109952	Systemic lupus erythematosus	1e-07	33493351
rs10947531	rs11755393	0.942863454109952	Systemic lupus erythematosus	2e-08	19838195
rs10947531	rs11755393	0.942863454109952	Body mass index	4e-55	36581621
rs10947531	rs9366863	0.937643557564107	Adult body size	9e-33	32376654
rs10947531	rs9366863	0.937643557564107	Body mass index	2e-44	30595370
rs10947531	rs9296128	0.933390553846562	Hip circumference adjusted for BMI	4e-13	34021172
rs10947531	rs6941110	0.931367062468927	Sex hormone-binding globulin levels	5e-27	36653534
rs10947531	rs2814949	0.901583560438718	Essential hypertension (time to event)	9e-09	32589924
rs10947531	rs2744944	0.892271454786639	Hypothyroidism	3e-10	34594039
rs10947531	rs2744944	0.892271454786639	High density lipoprotein cholesterol levels	3e-86	34887591
rs10947531	rs2744944	0.892271454786639	Multi-trait sex score	7e-22	37277458
rs10947531	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs10947531	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs10947531	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs10947531	rs111868030	0.849441761297275	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs10947531	rs9368830	0.830084187792525	HDL cholesterol	4e-21	30275531
rs10947531	rs9368828	0.803658173339717	Body mass index	1e-34	34594039
rs10947531	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs10947531	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs10947531	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs10947531	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs10947531	rs6912327	0.790564668507463	Fasting insulin	5e-06	33402679
rs10947531	rs6912327	0.790564668507463	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs10947531	rs112283401	0.766845687865746	Red cell distribution width	4e-27	30595370
rs10947531	rs9689160	0.627575422825611	Lung function (forced vital capacity)	3e-14	36914875
rs10947532	rs9462030	0.962041376960364	Red cell distribution width	5e-25	32888493
rs10947532	rs9469857	0.954213293572495	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs10947532	rs2764208	0.953468659123264	Systemic lupus erythematosus	7e-06	24871463
rs10947532	rs9469899	0.945308979745132	Prostate cancer (advanced)	2e-06	29892016
rs10947532	rs9469899	0.945308979745132	Prostate cancer	5e-09	29892016
rs10947532	rs9469899	0.945308979745132	Prostate cancer	8e-11	33398198
rs10947532	rs9469899	0.945308979745132	Hand grip strength	3e-15	29691431
rs10947532	rs9469899	0.945308979745132	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs10947532	rs9469899	0.945308979745132	Graves' disease	4e-10	34594039
rs10947532	rs9469899	0.945308979745132	Coronary artery disease	1e-11	36474045
rs10947532	rs9469899	0.945308979745132	Predicted visceral adipose tissue	2e-20	31501611
rs10947532	rs9469899	0.945308979745132	Medication use (thyroid preparations)	2e-09	31015401
rs10947532	rs9469899	0.945308979745132	Medication use (thyroid preparations)	3e-10	34594039
rs10947532	rs9469872	0.918160297978079	HDL cholesterol levels	3e-11	36333282
rs10947532	rs11755393	0.914506748912101	Body mass index	3e-26	29273807
rs10947532	rs11755393	0.914506748912101	Systemic lupus erythematosus	2e-12	33493351
rs10947532	rs11755393	0.914506748912101	Systemic lupus erythematosus	2e-06	33493351
rs10947532	rs11755393	0.914506748912101	Systemic lupus erythematosus	1e-07	33493351
rs10947532	rs11755393	0.914506748912101	Systemic lupus erythematosus	2e-08	19838195
rs10947532	rs11755393	0.914506748912101	Body mass index	4e-55	36581621
rs10947532	rs9366863	0.908167155792052	Adult body size	9e-33	32376654
rs10947532	rs9366863	0.908167155792052	Body mass index	2e-44	30595370
rs10947532	rs9296128	0.90519267285778	Hip circumference adjusted for BMI	4e-13	34021172
rs10947532	rs6941110	0.903568887091945	Sex hormone-binding globulin levels	5e-27	36653534
rs10947532	rs2814949	0.872591452233302	Essential hypertension (time to event)	9e-09	32589924
rs10947532	rs2744944	0.863548022076558	Hypothyroidism	3e-10	34594039
rs10947532	rs2744944	0.863548022076558	High density lipoprotein cholesterol levels	3e-86	34887591
rs10947532	rs2744944	0.863548022076558	Multi-trait sex score	7e-22	37277458
rs10947532	rs2263329	0.846408383040484	HDL cholesterol	6e-35	34594039
rs10947532	rs2263329	0.846408383040484	HDL cholesterol levels	8e-43	32203549
rs10947532	rs2263329	0.846408383040484	High density lipoprotein cholesterol levels	2e-52	34887591
rs10947532	rs111868030	0.822655673149564	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs10947532	rs9368830	0.801326416549888	HDL cholesterol	4e-21	30275531
rs10947532	rs9368828	0.778286430150428	Body mass index	1e-34	34594039
rs10947532	rs2744973	0.775626888501588	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs10947532	rs2744973	0.775626888501588	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs10947532	rs2744973	0.775626888501588	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs10947532	rs2744973	0.775626888501588	Multi-trait sex score	6e-20	37277458
rs10947532	rs6912327	0.767167784755893	Fasting insulin	5e-06	33402679
rs10947532	rs6912327	0.767167784755893	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs10947532	rs112283401	0.742425501388951	Red cell distribution width	4e-27	30595370
rs10947532	rs9689160	0.608618841343267	Lung function (forced vital capacity)	3e-14	36914875
rs10949827	rs12539962	0.973042893776437	Colorectal cancer	3e-08	36539618
rs10949827	rs4355658	0.675230796371327	Height	3e-13	36224396
rs10949827	rs13232536	0.653303931622265	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10949827	rs7806956	0.653118844213511	Esophageal squamous cell carcinoma	3e-07	37673066
rs10949828	rs13232536	0.87912916903053	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10949828	rs4355658	0.825741865552951	Height	3e-13	36224396
rs10949828	rs12539962	0.728794359238129	Colorectal cancer	3e-08	36539618
rs10949828	rs4304220	0.649494822755635	Height	2e-14	36224396
rs10949828	rs7806956	0.620398900871971	Esophageal squamous cell carcinoma	3e-07	37673066
rs10949829	rs4304220	0.850474395093578	Height	2e-14	36224396
rs10949829	rs13232536	0.849711740913385	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs10949829	rs4355658	0.831385635619404	Height	3e-13	36224396
rs10949829	rs7806956	0.613690157903892	Esophageal squamous cell carcinoma	3e-07	37673066
rs10956879	rs6471393	0.603161967728713	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs10970975	rs10970975	1	Red blood cell count	9e-14	34594039
rs10970975	rs10970975	1	Red blood cell count	6e-21	30595370
rs10970975	rs10970976	0.935286484401219	Asthma	4e-06	22561531
rs10970976	rs10970976	1	Asthma	4e-06	22561531
rs10970976	rs10970975	0.935286484401219	Red blood cell count	9e-14	34594039
rs10970976	rs10970975	0.935286484401219	Red blood cell count	6e-21	30595370
rs11024634	rs4353250	0.983551999162654	Insulin-like growth factor 1 levels	2e-14	33462484
rs11024634	rs4353250	0.983551999162654	Amyloid A serum levels	2e-51	21124955
rs11024634	rs4150575	0.645518135952187	Imidazole lactate levels	1e-10	36635386
rs11032098	rs1467510	0.93459119954891	Platelet distribution width	1e-14	32888494
rs11032098	rs12276109	0.792252401155647	Severe COVID-19 infection	6e-08	36662838
rs11032100	rs1467510	0.93459119954891	Platelet distribution width	1e-14	32888494
rs11032100	rs12276109	0.792252401155647	Severe COVID-19 infection	6e-08	36662838
rs11032101	rs1467510	0.929187983988311	Platelet distribution width	1e-14	32888494
rs11032101	rs12276109	0.786617450755559	Severe COVID-19 infection	6e-08	36662838
rs11032135	rs1467510	0.679698897104035	Platelet distribution width	1e-14	32888494
rs11032135	rs12276109	0.611326246709603	Severe COVID-19 infection	6e-08	36662838
rs11052877	rs11052877	1	Multiple sclerosis	6e-13	24076602
rs11052877	rs11052877	1	Lymphocyte count	1e-290	32888493
rs11052877	rs11052877	1	Lymphocyte count	6e-271	32888493
rs11052877	rs11052877	1	White blood cell count	4e-43	32888493
rs11052877	rs11052877	1	White blood cell count	4e-39	32888493
rs11052877	rs11052877	1	White blood cell count	4e-19	32888494
rs11052877	rs11052877	1	Lymphocyte count	9e-17	34594039
rs11052877	rs11052877	1	Lymphocyte count	1e-84	34469753
rs11052877	rs11052877	1	Platelet-to-lymphocyte ratio	1e-69	34469753
rs11052877	rs11052877	1	Basophil count	1e-14	34469753
rs11052877	rs11052877	1	Lymphocyte count	3e-149	34594039
rs11052877	rs11052877	1	Lymphocyte count	3e-09	34925446
rs11052877	rs11052877	1	White blood cell count	1e-28	34594039
rs11052877	rs10844706	0.938466455849527	Lymphocyte percentage of white cells	4e-30	32888494
rs11052877	rs10844706	0.938466455849527	Lymphocyte count	1e-55	32888494
rs11052877	rs10844706	0.938466455849527	Neutrophil percentage of white cells	3e-23	32888494
rs11052877	rs10844706	0.938466455849527	Lymphocyte count	2e-75	27863252
rs11052877	rs10844706	0.938466455849527	Lymphocyte percentage of white cells	3e-42	27863252
rs11052877	rs10844706	0.938466455849527	Lymphocyte-to-monocyte ratio	6e-72	34469753
rs11052877	rs10844682	0.733149906881221	Eosinophil percentage of white cells	6e-13	32888494
rs11052877	rs10844682	0.733149906881221	Monocyte percentage of white cells	1e-27	32888494
rs11052877	rs10844682	0.733149906881221	Monocyte percentage of white cells	3e-12	27863252
rs11052877	rs10772108	0.732244901047017	White blood cell count	4e-15	27863252
rs11052877	rs10844639	0.616756271418344	Lymphocyte count	6e-11	29403010
rs11066451	rs11066452	0.994001162465346	Blood protein levels	6e-08	30072576
rs11066451	rs4767027	0.972509219387989	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs11066451	rs2057778	0.968937243077192	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs11066451	rs2057778	0.968937243077192	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs11066451	rs2057778	0.968937243077192	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs11066451	rs1859336	0.955166603094454	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs11066451	rs1131476	0.943361135586727	Systemic lupus erythematosus	1e-09	33272962
rs11066451	rs2660	0.943361135586727	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs11066451	rs2660	0.943361135586727	COVID-19 (critical illness vs population)	3e-15	37198478
rs11066451	rs6489882	0.935872588176718	Chronic lymphocytic leukemia	5e-08	28165464
rs11066451	rs6489867	0.653117345149645	COVID-19 (critical illness vs population)	1e-09	33307546
rs11066452	rs11066452	1	Blood protein levels	6e-08	30072576
rs11066452	rs4767027	0.978419663267803	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs11066452	rs2057778	0.974833152960539	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs11066452	rs2057778	0.974833152960539	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs11066452	rs2057778	0.974833152960539	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs11066452	rs1859336	0.961008387917111	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs11066452	rs1131476	0.949153887779849	Systemic lupus erythematosus	1e-09	33272962
rs11066452	rs2660	0.949153887779849	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs11066452	rs2660	0.949153887779849	COVID-19 (critical illness vs population)	3e-15	37198478
rs11066452	rs6489882	0.941636366144249	Chronic lymphocytic leukemia	5e-08	28165464
rs11066452	rs6489867	0.657751543418632	COVID-19 (critical illness vs population)	1e-09	33307546
rs11070314	rs4924522	0.832300960531559	Lung function (forced vital capacity)	5e-18	36914875
rs11070314	rs9796	0.719982236395295	Menopause (age at onset)	1e-10	26414677
rs11070315	rs9796	0.815068334376783	Menopause (age at onset)	1e-10	26414677
rs11070315	rs4924522	0.773542489196644	Lung function (forced vital capacity)	5e-18	36914875
rs11070315	rs8037837	0.604787949856803	Red blood cell count	6e-20	32888493
rs11070315	rs8037837	0.604787949856803	Red blood cell count	1e-10	30595370
rs11070317	rs9796	0.726692056819654	Menopause (age at onset)	1e-10	26414677
rs11070317	rs4924522	0.690703686125878	Lung function (forced vital capacity)	5e-18	36914875
rs11071642	rs8034216	0.961006953961627	C-reactive protein levels	2e-10	31900758
rs11071642	rs17271340	0.923747995469921	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs11071642	rs17271305	0.895048128095926	Two-hour glucose challenge	1e-07	20081857
rs11071642	rs35967150	0.889805401523528	C-reactive protein levels (MTAG)	1e-08	36376304
rs11071642	rs11634163	0.882486017291656	C-reactive protein	2e-08	34594039
rs11071642	rs11634163	0.882486017291656	Two-hour glucose	3e-14	34059833
rs11071642	rs189400382	0.879356525104275	C-reactive protein levels	1e-08	35459240
rs11071642	rs13379492	0.870730420926823	Lung function (FEV1/FVC)	6e-08	30595370
rs11071642	rs28373613	0.631165737835863	Height (standard GWA)	8e-12	37106081
rs11071649	rs2162062	0.911337689563192	Height	2e-13	35831902
rs11071649	rs1436958	0.871721939325378	IgG glycosylation	9e-06	23382691
rs11071649	rs933807	0.862814373090677	Fat-free mass	6e-06	30593698
rs11071649	rs933807	0.862814373090677	Fat-free mass	2e-07	30593698
rs11071649	rs933807	0.862814373090677	Fat-free mass	8e-11	30593698
rs11071649	rs7178540	0.756681043174467	Height	1e-31	36224396
rs11071649	rs11635977	0.739345714675568	Height	2e-25	36224396
rs11071649	rs72749770	0.72727084638283	Low density lipoprotein cholesterol levels	9e-10	32493714
rs11071649	rs72749770	0.72727084638283	Apolipoprotein B levels	2e-09	32203549
rs11071649	rs7162536	0.726027190803859	Height	4e-29	34594039
rs11071649	rs7178424	0.717232616213015	Height	6e-09	20881960
rs11071649	rs7178424	0.717232616213015	Height	6e-13	35831902
rs11071649	rs7178424	0.717232616213015	Height	3e-251	36224396
rs11071649	rs17271431	0.713178929389679	Height	2e-11	34594039
rs11071649	rs17205463	0.712524336560825	Serum levels of protein IGF1	8e-08	27329260
rs11071649	rs17205463	0.712524336560825	Appendicular lean mass	4e-43	33097823
rs11071649	rs17205463	0.712524336560825	Height	2e-35	30595370
rs11071649	rs731820	0.700529205951415	Height	2e-13	31562340
rs11071649	rs731820	0.700529205951415	Height	2e-12	35831902
rs11076176	rs11076176	1	Total lipid levels in small HDL	6e-14	35213538
rs11076176	rs11076176	1	Cholesteryl ester levels in small HDL	2e-22	35213538
rs11076176	rs11076176	1	Phospholipid levels in small HDL	4e-16	35213538
rs11076176	rs11076176	1	Concentration of small HDL particles	3e-17	35213538
rs11076176	rs11076176	1	Total free cholesterol levels	4e-08	35213538
rs11076176	rs11076176	1	High-density lipoprotein 3 cholesterol levels	2e-22	34592243
rs11076176	rs11076176	1	Triglyceride levels x long total sleep time interaction (2df test)	9e-11	31719535
rs11076176	rs11076176	1	Triglyceride levels in medium HDL	2e-11	32150548
rs11076176	rs11076176	1	Multi-trait sex score	4e-106	37277458
rs11076176	rs11076176	1	Multi-trait sex score	2e-99	37277458
rs11076176	rs11076176	1	Multi-trait sum score	5e-22	37277458
rs11076176	rs11076176	1	Multi-trait sum score	2e-22	37277458
rs11076176	rs11076176	1	Concentration of small HDL particles (UKB data field 23572)	3e-14	36764567
rs11076176	rs11076176	1	Cholesteryl esters in small HDL (UKB data field 23576)	9e-19	36764567
rs11076176	rs11076176	1	Total lipids in small HDL (UKB data field 23573)	3e-11	36764567
rs11086009	rs4808407	0.937559247617622	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs1108889	rs56103941	0.770553159584654	Right presubiculum volume (head)	4e-08	37337106
rs1108889	rs12523793	0.734193560968511	Subcortical volume (MOSTest)	4e-24	32665545
rs1108889	rs12523793	0.734193560968511	C-reactive protein levels	3e-08	35459240
rs1108889	rs12523793	0.734193560968511	C-reactive protein levels (MTAG)	2e-08	36376304
rs1108889	rs2342764	0.732296471400008	Cortical thickness	1e-08	34560273
rs1108889	rs11155662	0.726443353463955	Vertex-wise cortical thickness	2e-09	34910505
rs1108889	rs12526675	0.687056889920563	Brain morphology (MOSTest)	7e-22	32665545
rs1109480	rs1109480	1	Smoking initiation (ever regular vs never regular) (MTAG)	2e-14	30643251
rs1109480	rs1109480	1	Age of smoking initiation (MTAG)	6e-10	30643251
rs1109480	rs1109480	1	Smoking initiation (ever regular vs never regular)	2e-10	30643251
rs1109480	rs1109480	1	Smoking status (ever vs never smokers)	9e-10	30643258
rs1109480	rs1109480	1	Externalizing behaviour (multivariate analysis)	2e-13	34446935
rs1109480	rs1109480	1	Smoking status	5e-10	30595370
rs1109480	rs1168067	0.653244282713272	Lifetime smoking	6e-09	34855049
rs1109480	rs2859263	0.601664441807442	Smoking initiation	2e-29	36477530
rs1109480	rs2859263	0.601664441807442	Smoking initiation	3e-31	36477530
rs11100713	rs17007017	0.800035776861681	Conduct disorder	7e-06	20585324
rs11100713	rs34402449	0.763428080573936	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs11100713	rs1550057	0.692957261598851	Conduct disorder	4e-06	20585324
rs11100713	rs1550057	0.692957261598851	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs11101981	rs11101981	1	Glutathione S-transferase Mu 3 levels	2e-189	34648354
rs11123174	rs11889663	0.914455019243289	C-reactive protein levels (MTAG)	2e-12	36376304
rs11123174	rs17626434	0.790837911044677	C-reactive protein levels	8e-12	31900758
rs11123175	rs11889663	0.985553286931388	C-reactive protein levels (MTAG)	2e-12	36376304
rs11123175	rs17626434	0.857688907580668	C-reactive protein levels	8e-12	31900758
rs11125869	rs1177308	0.881034537981197	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11125869	rs1177308	0.881034537981197	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11125869	rs7558954	0.878864757263608	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11125869	rs11685226	0.854304231273364	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs11125869	rs11685226	0.854304231273364	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11125869	rs777587	0.740507518070254	Proteoglycan 3 levels	6e-29	34648354
rs11125869	rs777587	0.740507518070254	Pappalysin-1 levels	1e-25	34648354
rs11125869	rs12617371	0.704932691809332	Immature fraction of reticulocytes	8e-18	32888494
rs11125869	rs2463097	0.674310827255721	White blood cell count	3e-26	30595370
rs11125869	rs10199672	0.642197483309265	Height	6e-12	34594039
rs11125869	rs10199672	0.642197483309265	Height	2e-12	31562340
rs11125869	rs2593620	0.624050338995679	Serum levels of protein PRG3	5e-14	35078996
rs11125870	rs1177308	0.896609665461903	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11125870	rs1177308	0.896609665461903	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11125870	rs7558954	0.894441305793463	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11125870	rs11685226	0.869493445136184	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs11125870	rs11685226	0.869493445136184	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11125870	rs777587	0.729304642086665	Proteoglycan 3 levels	6e-29	34648354
rs11125870	rs777587	0.729304642086665	Pappalysin-1 levels	1e-25	34648354
rs11125870	rs12617371	0.693875807367962	Immature fraction of reticulocytes	8e-18	32888494
rs11125870	rs2463097	0.663739678817039	White blood cell count	3e-26	30595370
rs11125870	rs2593620	0.637076626988583	Serum levels of protein PRG3	5e-14	35078996
rs11125870	rs10199672	0.631449631518405	Height	6e-12	34594039
rs11125870	rs10199672	0.631449631518405	Height	2e-12	31562340
rs11125870	rs2421200	0.611873162791824	Neutrophil count	1e-26	32888493
rs11125870	rs2421200	0.611873162791824	Neutrophil count	1e-25	32888493
rs11126222	rs10173269	0.658654967114719	Intraocular pressure	5e-12	29617998
rs11126222	rs10173269	0.658654967114719	Lung function (FEV1/FVC)	5e-23	36914875
rs11126222	rs10173269	0.658654967114719	Chronic obstructive pulmonary disease liability (machine learning-based score)	7e-09	37069358
rs11126222	rs10173269	0.658654967114719	Lung function (FEV1/FVC)	8e-18	30595370
rs11126223	rs10173269	0.663606410205619	Intraocular pressure	5e-12	29617998
rs11126223	rs10173269	0.663606410205619	Lung function (FEV1/FVC)	5e-23	36914875
rs11126223	rs10173269	0.663606410205619	Chronic obstructive pulmonary disease liability (machine learning-based score)	7e-09	37069358
rs11126223	rs10173269	0.663606410205619	Lung function (FEV1/FVC)	8e-18	30595370
rs1112729	rs55763431	1	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs1112729	rs9689694	0.998201794182664	Right hippocampal volume (head)	6e-11	37337106
rs1112729	rs9689694	0.998201794182664	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs1112729	rs9689694	0.998201794182664	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs1112729	rs9689694	0.998201794182664	Left hippocampal volume (head)	6e-12	37337106
rs1112729	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs1112729	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs1112729	rs9383843	0.994608621917206	Migraine	1e-09	35115687
rs1112729	rs10872645	0.99281581932217	Blood protein levels	2e-86	30072576
rs1112729	rs9688867	0.991946733398874	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs1112729	rs9688867	0.991946733398874	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs1112729	rs9688809	0.991946733398874	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs1112729	rs10872653	0.991920973218723	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs1112729	rs34337297	0.988337309266227	Serum levels of protein LRP11	3e-161	35078996
rs1112729	rs14314	0.97680053310452	Macular thickness	3e-19	30535121
rs1112729	rs14314	0.97680053310452	Vertex-wise sulcal depth	7e-17	34910505
rs1112729	rs14314	0.97680053310452	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs1112729	rs14314	0.97680053310452	Left hippocampal volume (body)	7e-15	37337106
rs1112729	rs14314	0.97680053310452	Left subiculum volume (body)	1e-14	37337106
rs1112729	rs9322193	0.952199474125302	Lung cancer	1e-07	27393504
rs1112729	rs4039600	0.908526761368909	Adenine levels	1e-11	35347128
rs1112729	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-08	37844115
rs1112729	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-06	37844115
rs1112729	rs4380763	0.641447984668751	Subcortical volume (min-P)	1e-11	32665545
rs1112729	rs11155671	0.630994895975767	Testicular germ cell tumor	2e-09	28604728
rs1112729	rs80147756	0.616065401687589	HippSubfield lh volume subiculum-head	3e-10	33875891
rs1112729	rs4421206	0.60846358923055	Brain morphology (min-P)	4e-11	32665545
rs1112729	rs9505982	0.60194342559747	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs1112730	rs55763431	1	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs1112730	rs9689694	0.998201794182664	Right hippocampal volume (head)	6e-11	37337106
rs1112730	rs9689694	0.998201794182664	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs1112730	rs9689694	0.998201794182664	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs1112730	rs9689694	0.998201794182664	Left hippocampal volume (head)	6e-12	37337106
rs1112730	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs1112730	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs1112730	rs9383843	0.994608621917206	Migraine	1e-09	35115687
rs1112730	rs10872645	0.99281581932217	Blood protein levels	2e-86	30072576
rs1112730	rs9688867	0.991946733398874	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs1112730	rs9688867	0.991946733398874	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs1112730	rs9688809	0.991946733398874	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs1112730	rs10872653	0.991920973218723	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs1112730	rs34337297	0.988337309266227	Serum levels of protein LRP11	3e-161	35078996
rs1112730	rs14314	0.97680053310452	Macular thickness	3e-19	30535121
rs1112730	rs14314	0.97680053310452	Vertex-wise sulcal depth	7e-17	34910505
rs1112730	rs14314	0.97680053310452	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs1112730	rs14314	0.97680053310452	Left hippocampal volume (body)	7e-15	37337106
rs1112730	rs14314	0.97680053310452	Left subiculum volume (body)	1e-14	37337106
rs1112730	rs9322193	0.952199474125302	Lung cancer	1e-07	27393504
rs1112730	rs4039600	0.908526761368909	Adenine levels	1e-11	35347128
rs1112730	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-08	37844115
rs1112730	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-06	37844115
rs1112730	rs4380763	0.641447984668751	Subcortical volume (min-P)	1e-11	32665545
rs1112730	rs11155671	0.630994895975767	Testicular germ cell tumor	2e-09	28604728
rs1112730	rs80147756	0.616065401687589	HippSubfield lh volume subiculum-head	3e-10	33875891
rs1112730	rs4421206	0.60846358923055	Brain morphology (min-P)	4e-11	32665545
rs1112730	rs9505982	0.60194342559747	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs11127429	rs9309711	0.644671780054842	Neurofibrillary tangles	3e-06	25188341
rs11127430	rs9309711	0.644671780054842	Neurofibrillary tangles	3e-06	25188341
rs111298861	rs9611441	0.964342653585515	C-reactive protein levels	1e-08	30388399
rs111298861	rs138354	0.963531237303193	Apolipoprotein B levels	8e-09	32203549
rs111298861	rs103197	0.928495550274053	Bipolar disorder (MTAG)	7e-09	34159505
rs111298861	rs5758128	0.885944960988285	Low density lipoprotein cholesterol levels	6e-13	32154731
rs111298861	rs5758128	0.885944960988285	Total cholesterol levels	4e-08	34594039
rs11130631	rs7610312	0.997507911336935	Red blood cell count	5e-09	27863252
rs11130631	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs11130631	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs11130631	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11130631	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs11130631	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs11130631	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs11130631	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs11130631	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs11130631	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs11130631	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs11130631	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11130631	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs11130631	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs11130631	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs11130631	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs11130631	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs11130631	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs11130631	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs11130631	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs11130631	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs11130631	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11130631	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs11130631	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs11130631	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs11130631	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs11130632	rs7610312	0.997507911336935	Red blood cell count	5e-09	27863252
rs11130632	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs11130632	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs11130632	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11130632	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs11130632	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs11130632	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs11130632	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs11130632	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs11130632	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs11130632	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs11130632	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11130632	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs11130632	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs11130632	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs11130632	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs11130632	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs11130632	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs11130632	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs11130632	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs11130632	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs11130632	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11130632	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs11130632	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs11130632	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs11130632	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs11130637	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11130637	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs11130637	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs11130637	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs11130637	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs11130637	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs11130637	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs11130637	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs11130637	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs11130637	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs11130637	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs11130637	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11130637	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs11130637	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs11130637	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs11130637	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs11130637	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs11130637	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs11130637	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs11130637	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs11130637	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs11130637	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11130637	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs11130637	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs11130637	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs11130637	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs11130638	rs11130638	1	Hemoglobin concentration	2e-23	32888493
rs11130638	rs11705721	0.997542556420607	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11130638	rs34579268	0.992666190052037	Hematocrit	5e-30	32888493
rs11130638	rs34579268	0.992666190052037	Hematocrit	2e-27	32888493
rs11130638	rs34579268	0.992666190052037	Hemoglobin concentration	5e-26	32888493
rs11130638	rs7610312	0.974305051875382	Red blood cell count	5e-09	27863252
rs11130638	rs6775517	0.973073452515608	Hematocrit	1e-17	34594039
rs11130638	rs57700771	0.968215279985774	Red blood cell count	9e-21	30595370
rs11130638	rs55704295	0.90116903455247	Red blood cell count	8e-26	32888493
rs11130638	rs55704295	0.90116903455247	Red blood cell count	5e-23	32888493
rs11130638	rs55704295	0.90116903455247	Serum total protein level	2e-29	34594039
rs11130638	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11130638	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs11130638	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs11130638	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs11130638	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs11130638	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs11130638	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs11130638	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs11130638	rs55692656	0.81463026319101	vWF levels	3e-08	30586737
rs11130638	rs55692656	0.81463026319101	vWF levels	6e-09	30586737
rs11130638	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11130638	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs11130638	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs11130638	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs11130638	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs11130639	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11130639	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs11130639	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs11130639	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs11130639	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs11130639	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs11130639	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs11130639	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs11130639	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs11130639	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs11130639	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs11130639	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11130639	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs11130639	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs11130639	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs11130639	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs11130639	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs11130639	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs11130639	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs11130639	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs11130639	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs11130639	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11130639	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs11130639	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs11130639	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs11130639	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs11130642	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs11130642	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs11130642	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs11130642	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11130642	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs11130642	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs11130642	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs11130642	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs11130642	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs11130642	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs11130642	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs11130642	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11130642	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs11130642	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs11130642	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs11130642	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs11130642	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs11130642	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs11130642	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs11130642	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs11130642	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs11130642	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11130642	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs11130642	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs11130642	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs11130642	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs11130643	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs11130643	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs11130643	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs11130643	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11130643	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs11130643	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs11130643	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs11130643	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs11130643	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs11130643	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs11130643	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs11130643	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11130643	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs11130643	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs11130643	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs11130643	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs11130643	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs11130643	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs11130643	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs11130643	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs11130643	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs11130643	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11130643	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs11130643	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs11130643	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs11130643	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs11130646	rs34579268	0.955085413278545	Hematocrit	5e-30	32888493
rs11130646	rs34579268	0.955085413278545	Hematocrit	2e-27	32888493
rs11130646	rs34579268	0.955085413278545	Hemoglobin concentration	5e-26	32888493
rs11130646	rs11705721	0.947587040196354	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11130646	rs11130638	0.947587040196354	Hemoglobin concentration	2e-23	32888493
rs11130646	rs7610312	0.923991352356711	Red blood cell count	5e-09	27863252
rs11130646	rs6775517	0.922895543276151	Hematocrit	1e-17	34594039
rs11130646	rs57700771	0.917885780476742	Red blood cell count	9e-21	30595370
rs11130646	rs11719450	0.891936831655851	Hemoglobin concentration	2e-09	27863252
rs11130646	rs11719450	0.891936831655851	Hemoglobin levels	2e-16	32327693
rs11130646	rs11922478	0.880006506125174	Semaphorin-6B levels	4e-12	34648354
rs11130646	rs4681679	0.862661392959953	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11130646	rs55704295	0.852100360391609	Red blood cell count	8e-26	32888493
rs11130646	rs55704295	0.852100360391609	Red blood cell count	5e-23	32888493
rs11130646	rs55704295	0.852100360391609	Serum total protein level	2e-29	34594039
rs11130646	rs56384862	0.829436867787751	Body mass index	8e-12	29273807
rs11130646	rs56384862	0.829436867787751	Body mass index	3e-06	30108127
rs11130646	rs56384862	0.829436867787751	Hemoglobin levels	1e-16	32327693
rs11130646	rs56384862	0.829436867787751	Body mass index	3e-14	36581621
rs11130646	rs55692656	0.769088296275161	vWF levels	3e-08	30586737
rs11130646	rs55692656	0.769088296275161	vWF levels	6e-09	30586737
rs11130646	rs55954186	0.702591776617076	vWF levels	5e-09	30586737
rs11130646	rs55954186	0.702591776617076	vWF levels	9e-09	30586737
rs11130646	rs11708895	0.699967618092768	Red blood cell count	1e-20	32888494
rs11130646	rs6445969	0.678494433571196	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11130646	rs7431952	0.60913204295871	Hemoglobin levels	1e-12	32327693
rs11135483	rs1974871	0.915928168625137	Granulysin levels	5e-13	34648354
rs11135483	rs4869314	0.904031415730621	Arthritis (juvenile idiopathic)	3e-09	33106285
rs11135483	rs4869314	0.904031415730621	Neutrophil count	1e-10	34594039
rs11135483	rs4869314	0.904031415730621	White blood cell count	2e-07	30595370
rs11135483	rs2549782	0.849361253243921	Systolic blood pressure	6e-07	33230300
rs11135483	rs2549782	0.849361253243921	Diastolic blood pressure	1e-14	33230300
rs11135483	rs2549782	0.849361253243921	Diastolic blood pressure	3e-11	33230300
rs11135483	rs2549782	0.849361253243921	Systolic blood pressure	5e-09	33230300
rs11135483	rs2549797	0.849348240799059	Systolic blood pressure	7e-07	33230300
rs11135483	rs2549797	0.849348240799059	Diastolic blood pressure	1e-14	33230300
rs11135483	rs2549797	0.849348240799059	Diastolic blood pressure	3e-11	33230300
rs11135483	rs2549797	0.849348240799059	Systolic blood pressure	4e-09	33230300
rs11135483	rs1056893	0.847135286489959	Systolic blood pressure	1e-06	33230300
rs11135483	rs1056893	0.847135286489959	Diastolic blood pressure	7e-15	33230300
rs11135483	rs1056893	0.847135286489959	Diastolic blood pressure	2e-11	33230300
rs11135483	rs1056893	0.847135286489959	Systolic blood pressure	7e-09	33230300
rs11135483	rs4869313	0.828357185450209	Pediatric autoimmune diseases	9e-08	26301688
rs11135483	rs1559359	0.820636070816653	Diastolic blood pressure	7e-10	34594039
rs11135483	rs2910686	0.80253660120544	Neutrophil count	4e-14	32888493
rs11135483	rs2910686	0.80253660120544	Psoriasis	2e-08	23143594
rs11135483	rs2910686	0.80253660120544	Ankylosing spondylitis	5e-17	23749187
rs11135483	rs2910686	0.80253660120544	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs11135483	rs2927608	0.801202731069476	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs11135483	rs2927608	0.801202731069476	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs11135483	rs2927608	0.801202731069476	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs11135483	rs1019503	0.729569739835629	Systolic blood pressure	2e-06	33230300
rs11135483	rs1019503	0.729569739835629	Diastolic blood pressure	2e-14	33230300
rs11135483	rs1019503	0.729569739835629	Diastolic blood pressure	4e-11	33230300
rs11135483	rs1019503	0.729569739835629	Systolic blood pressure	1e-08	33230300
rs11135483	rs3096168	0.724039884485379	Aspartate aminotransferase levels	8e-12	33547301
rs11135483	rs1423357	0.704327617321427	General cognitive ability	9e-06	29844566
rs11135483	rs2432142	0.6904338387539	Neutrophil count	2e-14	32888493
rs11135483	rs2432142	0.6904338387539	White blood cell count	1e-11	32888493
rs11135483	rs38033	0.684931067922502	Blood protein levels	0	30072576
rs11135483	rs27293	0.674903607971109	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs11135483	rs27293	0.674903607971109	Diastolic blood pressure	3e-11	35762941
rs11135483	rs7705093	0.666169336546314	Birdshot chorioretinopathy	2e-09	24957906
rs11135484	rs1974871	0.914447793650926	Granulysin levels	5e-13	34648354
rs11135484	rs4869314	0.902449833011494	Arthritis (juvenile idiopathic)	3e-09	33106285
rs11135484	rs4869314	0.902449833011494	Neutrophil count	1e-10	34594039
rs11135484	rs4869314	0.902449833011494	White blood cell count	2e-07	30595370
rs11135484	rs2549782	0.847884202182743	Systolic blood pressure	6e-07	33230300
rs11135484	rs2549782	0.847884202182743	Diastolic blood pressure	1e-14	33230300
rs11135484	rs2549782	0.847884202182743	Diastolic blood pressure	3e-11	33230300
rs11135484	rs2549782	0.847884202182743	Systolic blood pressure	5e-09	33230300
rs11135484	rs2549797	0.847872277116823	Systolic blood pressure	7e-07	33230300
rs11135484	rs2549797	0.847872277116823	Diastolic blood pressure	1e-14	33230300
rs11135484	rs2549797	0.847872277116823	Diastolic blood pressure	3e-11	33230300
rs11135484	rs2549797	0.847872277116823	Systolic blood pressure	4e-09	33230300
rs11135484	rs1056893	0.845659826887978	Systolic blood pressure	1e-06	33230300
rs11135484	rs1056893	0.845659826887978	Diastolic blood pressure	7e-15	33230300
rs11135484	rs1056893	0.845659826887978	Diastolic blood pressure	2e-11	33230300
rs11135484	rs1056893	0.845659826887978	Systolic blood pressure	7e-09	33230300
rs11135484	rs4869313	0.827019362526065	Pediatric autoimmune diseases	9e-08	26301688
rs11135484	rs1559359	0.819244847777432	Diastolic blood pressure	7e-10	34594039
rs11135484	rs2910686	0.801180453359671	Neutrophil count	4e-14	32888493
rs11135484	rs2910686	0.801180453359671	Psoriasis	2e-08	23143594
rs11135484	rs2910686	0.801180453359671	Ankylosing spondylitis	5e-17	23749187
rs11135484	rs2910686	0.801180453359671	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs11135484	rs2927608	0.799849823507757	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs11135484	rs2927608	0.799849823507757	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs11135484	rs2927608	0.799849823507757	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs11135484	rs1019503	0.730829802753617	Systolic blood pressure	2e-06	33230300
rs11135484	rs1019503	0.730829802753617	Diastolic blood pressure	2e-14	33230300
rs11135484	rs1019503	0.730829802753617	Diastolic blood pressure	4e-11	33230300
rs11135484	rs1019503	0.730829802753617	Systolic blood pressure	1e-08	33230300
rs11135484	rs3096168	0.72530172163861	Aspartate aminotransferase levels	8e-12	33547301
rs11135484	rs1423357	0.703135171701633	General cognitive ability	9e-06	29844566
rs11135484	rs2432142	0.689253511231485	Neutrophil count	2e-14	32888493
rs11135484	rs2432142	0.689253511231485	White blood cell count	1e-11	32888493
rs11135484	rs38033	0.683744325754718	Blood protein levels	0	30072576
rs11135484	rs27293	0.673727778218266	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs11135484	rs27293	0.673727778218266	Diastolic blood pressure	3e-11	35762941
rs11135484	rs7705093	0.664989054688526	Birdshot chorioretinopathy	2e-09	24957906
rs11136092	rs746011	0.967250738900561	Triglycerides	2e-10	30275531
rs11136092	rs11781149	0.947308708988046	Refractive error	2e-17	32231278
rs11136092	rs1545837	0.818663655416126	Lung function (FVC)	1e-10	30595370
rs11136092	rs2280104	0.805197219735385	Parkinson's disease	3e-08	28892059
rs11136092	rs2280104	0.805197219735385	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs11136092	rs2280104	0.805197219735385	Serum total protein level	3e-12	34594039
rs11136092	rs4242434	0.78467024711497	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs11136092	rs13271626	0.761456230558046	Haemorrhoidal disease	3e-10	33888516
rs11136092	rs4872007	0.743032829521603	Superior temporal gyrus volume	8e-06	31530798
rs11136092	rs11778693	0.741865202673845	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs11136092	rs11778693	0.741865202673845	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs11136092	rs11780207	0.671065978529475	Estimated glomerular filtration rate	2e-13	33462484
rs11136092	rs11780207	0.671065978529475	Serum total protein level	2e-09	33462484
rs11136092	rs11780207	0.671065978529475	Creatinine levels	2e-13	33462484
rs11136092	rs34269854	0.650244196572772	Lung function (forced vital capacity)	3e-09	36914875
rs11136092	rs11782130	0.608746591173635	C-reactive protein levels	9e-09	35459240
rs11136093	rs11781149	0.91678099854978	Refractive error	2e-17	32231278
rs11136093	rs746011	0.891099972168767	Triglycerides	2e-10	30275531
rs11136093	rs1545837	0.852802245966921	Lung function (FVC)	1e-10	30595370
rs11136093	rs4242434	0.813079179079086	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs11136093	rs2280104	0.792069351230249	Parkinson's disease	3e-08	28892059
rs11136093	rs2280104	0.792069351230249	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs11136093	rs2280104	0.792069351230249	Serum total protein level	3e-12	34594039
rs11136093	rs4872007	0.734024313569562	Superior temporal gyrus volume	8e-06	31530798
rs11136093	rs11780207	0.704731669666344	Estimated glomerular filtration rate	2e-13	33462484
rs11136093	rs11780207	0.704731669666344	Serum total protein level	2e-09	33462484
rs11136093	rs11780207	0.704731669666344	Creatinine levels	2e-13	33462484
rs11136093	rs13271626	0.693198329020294	Haemorrhoidal disease	3e-10	33888516
rs11136093	rs11778693	0.670055993349282	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs11136093	rs11778693	0.670055993349282	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs11136093	rs34269854	0.631887554790334	Lung function (forced vital capacity)	3e-09	36914875
rs11136093	rs4592028	0.626263529625419	Non-albumin protein levels	3e-09	33462484
rs111379945	rs111379945	1	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs111379945	rs111379945	1	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs111379945	rs111379945	1	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs111379945	rs10876448	0.767150692255209	Mean corpuscular hemoglobin	2e-16	32888493
rs111379945	rs10876448	0.767150692255209	Reticulocyte count	3e-18	32888494
rs111379945	rs10876448	0.767150692255209	Reticulocyte fraction of red cells	1e-10	32888494
rs111379945	rs2446066	0.766400621245193	Vertex-wise sulcal depth	1e-10	34910505
rs111379945	rs2446066	0.766400621245193	Vertex-wise cortical surface area	2e-13	34910505
rs111379945	rs2446066	0.766400621245193	Red blood cell count	1e-10	27863252
rs111379945	rs2446066	0.766400621245193	Cortical surface area	3e-08	34560273
rs111379945	rs2608301	0.766400621245193	Low density lipoprotein cholesterol levels	2e-12	34887591
rs111379945	rs2460882	0.764700078020799	Mean corpuscular volume	3e-15	29403010
rs111379945	rs2460882	0.764700078020799	Percentage gas trapping	6e-07	26030696
rs111379945	rs12582170	0.738175359351501	Mean corpuscular volume	1e-21	27863252
rs111379945	rs12582170	0.738175359351501	Mean corpuscular hemoglobin	7e-37	32888493
rs111379945	rs12582170	0.738175359351501	Mean reticulocyte volume	2e-33	32888494
rs111379945	rs12582170	0.738175359351501	Mean corpuscular volume	1e-67	32888493
rs111379945	rs12582170	0.738175359351501	Mean corpuscular hemoglobin	2e-21	32888494
rs111379945	rs12582170	0.738175359351501	Mean corpuscular volume	1e-26	34104963
rs11150589	rs11150589	1	Ulcerative colitis	3e-10	26192919
rs11150589	rs11150589	1	Inflammatory bowel disease	9e-07	26192919
rs11150589	rs11150589	1	Ulcerative colitis	6e-10	23128233
rs11150589	rs11150589	1	Lymphocyte percentage of white cells	3e-34	32888494
rs11150589	rs11150589	1	Neutrophil percentage of white cells	3e-14	32888494
rs11150589	rs11150589	1	Ulcerative colitis	1e-06	28067908
rs11150589	rs11150589	1	Neutrophil percentage of white cells	1e-11	27863252
rs11150589	rs11150589	1	Neutrophil-to-lymphocyte ratio	3e-23	34469753
rs11150589	rs11150589	1	Lymphocyte count	1e-90	34594039
rs11150589	rs11150589	1	White blood cell count	1e-36	34594039
rs11150589	rs12598978	1	Lymphocyte count	7e-186	32888493
rs11150589	rs12598978	1	Lymphocyte count	2e-181	32888493
rs11150589	rs12598978	1	Lymphocyte count	5e-57	34469753
rs11150589	rs12598978	1	Platelet-to-lymphocyte ratio	3e-41	34469753
rs11150589	rs12598978	1	Lymphocyte-to-monocyte ratio	3e-10	34469753
rs11150589	rs12598978	1	Insulin receptor levels	4e-16	34648354
rs11150589	rs12716977	1	Lymphocyte count	4e-130	32888494
rs11150589	rs12716977	1	Neutrophil count	8e-20	32888494
rs11150589	rs12716977	1	White blood cell count	3e-67	32888494
rs11150589	rs12716977	1	Lymphocyte count	1e-59	27863252
rs11150589	rs12716977	1	Lymphocyte percentage of white cells	2e-17	27863252
rs11150589	rs12716977	1	Monocyte count	5e-21	34469753
rs11150589	rs12716977	1	Basophil count	2e-20	34469753
rs11150589	rs11574938	0.988456975288191	Neutrophil count	3e-24	32888493
rs11150589	rs11574938	0.988456975288191	White blood cell count	2e-93	32888493
rs11150589	rs11574938	0.988456975288191	Neutrophil count	2e-25	32888493
rs11150589	rs11574938	0.988456975288191	White blood cell count	8e-91	32888493
rs11150589	rs11574938	0.988456975288191	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	5e-14	26974007
rs11150589	rs11574938	0.988456975288191	White blood cell count	6e-27	27863252
rs11150589	rs11574938	0.988456975288191	White blood cell count	5e-63	30595370
rs11150589	rs7196129	0.890635864789256	Basophil count	7e-16	32888493
rs11150589	rs7196129	0.890635864789256	Basophil count	7e-17	32888494
rs11150589	rs7196129	0.890635864789256	Basophil count	2e-13	32888493
rs11150589	rs7196129	0.890635864789256	Monocyte count	1e-23	32888494
rs11150589	rs7196129	0.890635864789256	Monocyte count	2e-39	32888493
rs11150589	rs7196129	0.890635864789256	Monocyte count	5e-37	32888493
rs11150589	rs7196129	0.890635864789256	Monocyte count	2e-10	27863252
rs11150589	rs7196129	0.890635864789256	Monocyte count	3e-18	34594039
rs111543747	rs1177308	0.86013246849068	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs111543747	rs1177308	0.86013246849068	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs111543747	rs7558954	0.857918576585849	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs111543747	rs11685226	0.83725767508124	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs111543747	rs11685226	0.83725767508124	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs111543747	rs777587	0.697371882493676	Proteoglycan 3 levels	6e-29	34648354
rs111543747	rs777587	0.697371882493676	Pappalysin-1 levels	1e-25	34648354
rs111543747	rs12617371	0.66452565740711	Immature fraction of reticulocytes	8e-18	32888494
rs111543747	rs2463097	0.646240099296724	White blood cell count	3e-26	30595370
rs111543747	rs2593620	0.609108462676768	Serum levels of protein PRG3	5e-14	35078996
rs111543747	rs10199672	0.602852284455767	Height	6e-12	34594039
rs111543747	rs10199672	0.602852284455767	Height	2e-12	31562340
rs11155669	rs11155671	0.971814020427767	Testicular germ cell tumor	2e-09	28604728
rs11155669	rs4380763	0.958276062827803	Subcortical volume (min-P)	1e-11	32665545
rs11155669	rs1934534	0.957484726667962	Pain (pleiotropy)	2e-08	37844115
rs11155669	rs1934534	0.957484726667962	Pain (pleiotropy)	2e-06	37844115
rs11155669	rs9505982	0.95698773745613	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs11155669	rs4421206	0.915657303754281	Brain morphology (min-P)	4e-11	32665545
rs11155669	rs80147756	0.915368144261389	HippSubfield lh volume subiculum-head	3e-10	33875891
rs11155669	rs9688452	0.895940200896495	Brainstem global volume Whole-brainstem	1e-11	33875891
rs11155669	rs9688452	0.895940200896495	aseg lh volume VentralDC	2e-10	33875891
rs11155669	rs10872649	0.842920415828591	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs11155669	rs10872649	0.842920415828591	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs11155669	rs10872649	0.842920415828591	Right hippocampal volume (body)	1e-10	37337106
rs11155669	rs7752089	0.815495365193352	Brain morphology (MOSTest)	2e-31	35164939
rs11155669	rs9322194	0.814585443110178	Brainstem volume	2e-11	31636452
rs11155669	rs9285521	0.691505561563633	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs11155669	rs12526675	0.64191131022555	Brain morphology (MOSTest)	7e-22	32665545
rs11155669	rs9688809	0.623404030870067	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs11155669	rs34337297	0.620403987554827	Serum levels of protein LRP11	3e-161	35078996
rs11155669	rs10872645	0.619626621352508	Blood protein levels	2e-86	30072576
rs11155669	rs14314	0.618596384932292	Macular thickness	3e-19	30535121
rs11155669	rs14314	0.618596384932292	Vertex-wise sulcal depth	7e-17	34910505
rs11155669	rs14314	0.618596384932292	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs11155669	rs14314	0.618596384932292	Left hippocampal volume (body)	7e-15	37337106
rs11155669	rs14314	0.618596384932292	Left subiculum volume (body)	1e-14	37337106
rs11155669	rs55763431	0.618282535409484	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs11155669	rs9322193	0.617792898435188	Lung cancer	1e-07	27393504
rs11155669	rs9689694	0.617148172459009	Right hippocampal volume (head)	6e-11	37337106
rs11155669	rs9689694	0.617148172459009	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs11155669	rs9689694	0.617148172459009	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs11155669	rs9689694	0.617148172459009	Left hippocampal volume (head)	6e-12	37337106
rs11155669	rs9383843	0.615806374791431	Migraine	1e-09	35115687
rs11155669	rs2095375	0.615240116562053	Serum metabolite levels	1e-20	33031748
rs11155669	rs2095375	0.615240116562053	Serum metabolite levels	1e-20	33031748
rs11155669	rs10872653	0.612978468509956	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs11155669	rs9688867	0.612673837793602	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs11155669	rs9688867	0.612673837793602	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs11155669	rs2342764	0.602337531120273	Cortical thickness	1e-08	34560273
rs11155670	rs9285521	0.85979988281357	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs11155670	rs9322194	0.836369469785251	Brainstem volume	2e-11	31636452
rs11155670	rs9505982	0.784046977783547	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs11155670	rs10872649	0.783158038861716	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs11155670	rs10872649	0.783158038861716	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs11155670	rs10872649	0.783158038861716	Right hippocampal volume (body)	1e-10	37337106
rs11155670	rs4421206	0.77703630193155	Brain morphology (min-P)	4e-11	32665545
rs11155670	rs9688452	0.762619059596741	Brainstem global volume Whole-brainstem	1e-11	33875891
rs11155670	rs9688452	0.762619059596741	aseg lh volume VentralDC	2e-10	33875891
rs11155670	rs12526675	0.75732294418218	Brain morphology (MOSTest)	7e-22	32665545
rs11155670	rs7752089	0.753194805739892	Brain morphology (MOSTest)	2e-31	35164939
rs11155670	rs11155671	0.746871220346004	Testicular germ cell tumor	2e-09	28604728
rs11155670	rs1934534	0.737693293209688	Pain (pleiotropy)	2e-08	37844115
rs11155670	rs1934534	0.737693293209688	Pain (pleiotropy)	2e-06	37844115
rs11155670	rs4380763	0.736933569566004	Subcortical volume (min-P)	1e-11	32665545
rs11155670	rs11155662	0.7121561481904	Vertex-wise cortical thickness	2e-09	34910505
rs11155670	rs2342764	0.71132367153789	Cortical thickness	1e-08	34560273
rs11155670	rs56103941	0.705772724858545	Right presubiculum volume (head)	4e-08	37337106
rs11155670	rs80147756	0.699323358208151	HippSubfield lh volume subiculum-head	3e-10	33875891
rs11155670	rs12523793	0.694898982384518	Subcortical volume (MOSTest)	4e-24	32665545
rs11155670	rs12523793	0.694898982384518	C-reactive protein levels	3e-08	35459240
rs11155670	rs12523793	0.694898982384518	C-reactive protein levels (MTAG)	2e-08	36376304
rs11155671	rs11155671	1	Testicular germ cell tumor	2e-09	28604728
rs11155671	rs4380763	0.978201220405314	Subcortical volume (min-P)	1e-11	32665545
rs11155671	rs1934534	0.977399448789531	Pain (pleiotropy)	2e-08	37844115
rs11155671	rs1934534	0.977399448789531	Pain (pleiotropy)	2e-06	37844115
rs11155671	rs9505982	0.940522125561972	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs11155671	rs80147756	0.93491512546878	HippSubfield lh volume subiculum-head	3e-10	33875891
rs11155671	rs4421206	0.928990200758795	Brain morphology (min-P)	4e-11	32665545
rs11155671	rs9688452	0.909051087541644	Brainstem global volume Whole-brainstem	1e-11	33875891
rs11155671	rs9688452	0.909051087541644	aseg lh volume VentralDC	2e-10	33875891
rs11155671	rs10872649	0.858750505639521	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs11155671	rs10872649	0.858750505639521	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs11155671	rs10872649	0.858750505639521	Right hippocampal volume (body)	1e-10	37337106
rs11155671	rs7752089	0.820938388921372	Brain morphology (MOSTest)	2e-31	35164939
rs11155671	rs9322194	0.797078603265342	Brainstem volume	2e-11	31636452
rs11155671	rs9285521	0.678285605513331	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs11155671	rs12526675	0.647482769351255	Brain morphology (MOSTest)	7e-22	32665545
rs11155671	rs9688809	0.63617655797888	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs11155671	rs34337297	0.63313839283991	Serum levels of protein LRP11	3e-161	35078996
rs11155671	rs10872645	0.632353335416958	Blood protein levels	2e-86	30072576
rs11155671	rs14314	0.631318253052168	Macular thickness	3e-19	30535121
rs11155671	rs14314	0.631318253052168	Vertex-wise sulcal depth	7e-17	34910505
rs11155671	rs14314	0.631318253052168	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs11155671	rs14314	0.631318253052168	Left hippocampal volume (body)	7e-15	37337106
rs11155671	rs14314	0.631318253052168	Left subiculum volume (body)	1e-14	37337106
rs11155671	rs55763431	0.630994895975767	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs11155671	rs9689694	0.629847205930743	Right hippocampal volume (head)	6e-11	37337106
rs11155671	rs9689694	0.629847205930743	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs11155671	rs9689694	0.629847205930743	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs11155671	rs9689694	0.629847205930743	Left hippocampal volume (head)	6e-12	37337106
rs11155671	rs9383843	0.628491054167888	Migraine	1e-09	35115687
rs11155671	rs2095375	0.62791813730041	Serum metabolite levels	1e-20	33031748
rs11155671	rs2095375	0.62791813730041	Serum metabolite levels	1e-20	33031748
rs11155671	rs10872653	0.625629893723964	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs11155671	rs9688867	0.625331650978852	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs11155671	rs9688867	0.625331650978852	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs11155671	rs9322193	0.619729209898932	Lung cancer	1e-07	27393504
rs11155671	rs2342764	0.606619102055631	Cortical thickness	1e-08	34560273
rs11155683	rs55763431	0.999100898383198	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs11155683	rs9689694	0.997304309335619	Right hippocampal volume (head)	6e-11	37337106
rs11155683	rs9689694	0.997304309335619	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs11155683	rs9689694	0.997304309335619	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs11155683	rs9689694	0.997304309335619	Left hippocampal volume (head)	6e-12	37337106
rs11155683	rs2095375	0.994611041252096	Serum metabolite levels	1e-20	33031748
rs11155683	rs2095375	0.994611041252096	Serum metabolite levels	1e-20	33031748
rs11155683	rs9383843	0.993713293512006	Migraine	1e-09	35115687
rs11155683	rs10872645	0.991921031227827	Blood protein levels	2e-86	30072576
rs11155683	rs9688867	0.991050053070433	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs11155683	rs9688867	0.991050053070433	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs11155683	rs9688809	0.991050053070433	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs11155683	rs10872653	0.991028598695202	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs11155683	rs34337297	0.987445481699736	Serum levels of protein LRP11	3e-161	35078996
rs11155683	rs14314	0.975912726634237	Macular thickness	3e-19	30535121
rs11155683	rs14314	0.975912726634237	Vertex-wise sulcal depth	7e-17	34910505
rs11155683	rs14314	0.975912726634237	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs11155683	rs14314	0.975912726634237	Left hippocampal volume (body)	7e-15	37337106
rs11155683	rs14314	0.975912726634237	Left subiculum volume (body)	1e-14	37337106
rs11155683	rs9322193	0.951324487658223	Lung cancer	1e-07	27393504
rs11155683	rs4039600	0.907699535974971	Adenine levels	1e-11	35347128
rs11155683	rs1934534	0.641181263206031	Pain (pleiotropy)	2e-08	37844115
rs11155683	rs1934534	0.641181263206031	Pain (pleiotropy)	2e-06	37844115
rs11155683	rs4380763	0.640658612653105	Subcortical volume (min-P)	1e-11	32665545
rs11155683	rs11155671	0.630211864027202	Testicular germ cell tumor	2e-09	28604728
rs11155683	rs80147756	0.615284344343926	HippSubfield lh volume subiculum-head	3e-10	33875891
rs11155683	rs4421206	0.607684183816724	Brain morphology (min-P)	4e-11	32665545
rs11155683	rs9505982	0.601171815167425	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs11155689	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs11155689	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs11155689	rs9383843	0.999100085712971	Migraine	1e-09	35115687
rs11155689	rs55763431	0.995506640298119	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs11155689	rs9689694	0.993707895167345	Right hippocampal volume (head)	6e-11	37337106
rs11155689	rs9689694	0.993707895167345	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs11155689	rs9689694	0.993707895167345	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs11155689	rs9689694	0.993707895167345	Left hippocampal volume (head)	6e-12	37337106
rs11155689	rs10872645	0.988335410721321	Blood protein levels	2e-86	30072576
rs11155689	rs9688867	0.987484746280957	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs11155689	rs9688867	0.987484746280957	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs11155689	rs9688809	0.987484746280957	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs11155689	rs10872653	0.987428985005238	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs11155689	rs34337297	0.983863132808358	Serum levels of protein LRP11	3e-161	35078996
rs11155689	rs14314	0.981250032026204	Macular thickness	3e-19	30535121
rs11155689	rs14314	0.981250032026204	Vertex-wise sulcal depth	7e-17	34910505
rs11155689	rs14314	0.981250032026204	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs11155689	rs14314	0.981250032026204	Left hippocampal volume (body)	7e-15	37337106
rs11155689	rs14314	0.981250032026204	Left subiculum volume (body)	1e-14	37337106
rs11155689	rs9322193	0.947826521476432	Lung cancer	1e-07	27393504
rs11155689	rs4039600	0.904085337095829	Adenine levels	1e-11	35347128
rs11155689	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-08	37844115
rs11155689	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-06	37844115
rs11155689	rs4380763	0.638343493751961	Subcortical volume (min-P)	1e-11	32665545
rs11155689	rs11155671	0.62791813730041	Testicular germ cell tumor	2e-09	28604728
rs11155689	rs80147756	0.613057484647013	HippSubfield lh volume subiculum-head	3e-10	33875891
rs11155689	rs4421206	0.605487928690632	Brain morphology (min-P)	4e-11	32665545
rs11158523	rs1255908	0.687991907174363	PR interval	8e-14	32439900
rs11158523	rs1255908	0.687991907174363	PR interval	6e-14	32439900
rs11163861	rs11580836	0.994668916796541	Body mass index	2e-09	36581621
rs11163861	rs10465746	0.963412722076756	Obesity-related traits	8e-06	23251661
rs11163862	rs11580836	0.850333002145371	Body mass index	2e-09	36581621
rs11163862	rs10465746	0.820528275128006	Obesity-related traits	8e-06	23251661
rs11163867	rs10465746	0.828590471217286	Obesity-related traits	8e-06	23251661
rs11163867	rs11580836	0.791836958256623	Body mass index	2e-09	36581621
rs11163868	rs11580836	0.98669511644378	Body mass index	2e-09	36581621
rs11163868	rs10465746	0.964310172827516	Obesity-related traits	8e-06	23251661
rs11163872	rs11580836	0.834360198742529	Body mass index	2e-09	36581621
rs11163872	rs10465746	0.814265642570438	Obesity-related traits	8e-06	23251661
rs11163874	rs10465746	0.950416024380455	Obesity-related traits	8e-06	23251661
rs11163874	rs11580836	0.910472806566042	Body mass index	2e-09	36581621
rs11163875	rs11580836	0.944733196565228	Body mass index	2e-09	36581621
rs11163875	rs10465746	0.926861038035231	Obesity-related traits	8e-06	23251661
rs11163876	rs10465746	0.951353764350454	Obesity-related traits	8e-06	23251661
rs11163876	rs11580836	0.909522655298996	Body mass index	2e-09	36581621
rs11163878	rs11580836	0.912046517997753	Body mass index	2e-09	36581621
rs11163878	rs10465746	0.892645736932303	Obesity-related traits	8e-06	23251661
rs11163879	rs10465746	0.955632599796726	Obesity-related traits	8e-06	23251661
rs11163879	rs11580836	0.913824862642466	Body mass index	2e-09	36581621
rs11170557	rs10876448	0.883700845341315	Mean corpuscular hemoglobin	2e-16	32888493
rs11170557	rs10876448	0.883700845341315	Reticulocyte count	3e-18	32888494
rs11170557	rs10876448	0.883700845341315	Reticulocyte fraction of red cells	1e-10	32888494
rs11170557	rs2446066	0.882857396402273	Vertex-wise sulcal depth	1e-10	34910505
rs11170557	rs2446066	0.882857396402273	Vertex-wise cortical surface area	2e-13	34910505
rs11170557	rs2446066	0.882857396402273	Red blood cell count	1e-10	27863252
rs11170557	rs2446066	0.882857396402273	Cortical surface area	3e-08	34560273
rs11170557	rs2608301	0.882857396402273	Low density lipoprotein cholesterol levels	2e-12	34887591
rs11170557	rs2460882	0.881150514383946	Mean corpuscular volume	3e-15	29403010
rs11170557	rs2460882	0.881150514383946	Percentage gas trapping	6e-07	26030696
rs11170557	rs111379945	0.871904824764124	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs11170557	rs111379945	0.871904824764124	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs11170557	rs111379945	0.871904824764124	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs11170557	rs12582170	0.853335857985957	Mean corpuscular volume	1e-21	27863252
rs11170557	rs12582170	0.853335857985957	Mean corpuscular hemoglobin	7e-37	32888493
rs11170557	rs12582170	0.853335857985957	Mean reticulocyte volume	2e-33	32888494
rs11170557	rs12582170	0.853335857985957	Mean corpuscular volume	1e-67	32888493
rs11170557	rs12582170	0.853335857985957	Mean corpuscular hemoglobin	2e-21	32888494
rs11170557	rs12582170	0.853335857985957	Mean corpuscular volume	1e-26	34104963
rs11170775	rs920778	0.735899237916289	Haemorrhoidal disease	7e-10	33888516
rs11204750	rs8444	0.942373923231125	Cutaneous malignant melanoma	4e-14	32341527
rs11204750	rs2867296	0.938356899376626	Neurological blood protein biomarker levels	3e-12	31320639
rs11204750	rs4970988	0.810836286325049	Urate levels	1e-07	23263486
rs11204750	rs12405726	0.79098609882593	Bitter non-alcoholic beverage consumption	2e-10	31046077
rs11204750	rs72704658	0.784338281892679	Nevus count or cutaneous melanoma	2e-10	30429480
rs11204750	rs143887202	0.745373344656784	Cathepsin S levels	4e-62	34648354
rs11204750	rs10888393	0.730372744086081	Cathepsin S levels	1e-26	36168886
rs11204750	rs10305664	0.729552667176991	Tea consumption	7e-06	31046077
rs11204750	rs10888395	0.711565122411021	Monocyte chemoattractant protein-1 levels	6e-07	27989323
rs11204750	rs2230061	0.682013249693566	Fat body mass	4e-08	24064335
rs11204750	rs1336900	0.629194356723941	Cathepsin S levels	1e-19	28240269
rs11204750	rs10399947	0.620416641959969	Cutaneous squamous cell carcinoma	7e-09	32041948
rs11204750	rs11587444	0.62032559518243	Morning person	2e-08	30595370
rs11204915	rs2999545	0.971472020204134	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs11204915	rs7523082	0.934058901992562	Metabolite peak levels (QI9845)	2e-14	35995766
rs11204915	rs10888445	0.92548408393701	Beta-hydroxyisovalerate levels	5e-13	36635386
rs11204915	rs7541453	0.917465150388614	Serum metabolite levels	2e-16	33031748
rs11204915	rs7541453	0.917465150388614	Serum metabolite levels	2e-16	33031748
rs11204915	rs7541453	0.917465150388614	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs11204915	rs10788817	0.852084550575942	Serum metabolite levels	3e-13	24625756
rs11204915	rs10788817	0.852084550575942	Metabolite peak levels (QI2718)	5e-18	35995766
rs11204915	rs10788817	0.852084550575942	3-hydroxylaurate levels	2e-12	36635386
rs11204915	rs10788817	0.852084550575942	Tetradecadienoate (14:2) levels	8e-17	36635386
rs11204915	rs11204914	0.848132439778539	Carnitine C9 levels	1e-13	35995766
rs11204915	rs11204914	0.848132439778539	Metabolite peak levels (QI6204)	1e-32	35995766
rs11204915	rs11204914	0.848132439778539	Metabolite peak levels (QI6252)	2e-32	35995766
rs11204915	rs6685187	0.823087482186241	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs11204915	rs6698740	0.820850609177105	Beta-hydroxyisovalerate levels	1e-13	35347128
rs11204915	rs1060870	0.819391442305452	Serum metabolite levels	1e-11	33031748
rs11204915	rs1060870	0.819391442305452	Serum metabolite levels	1e-15	33031748
rs11204915	rs2338201	0.807934115676087	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs11204915	rs2338201	0.807934115676087	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs11204915	rs2338201	0.807934115676087	Dodecadienoate (12:2) levels	7e-15	36635386
rs11204915	rs2130525	0.727551602481641	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs11204915	rs2279501	0.699297850253501	Serum metabolite levels	3e-14	33031748
rs11204915	rs7542137	0.698021818962042	Beta-hydroxyisovalerate levels	3e-11	35050183
rs11204915	rs7542137	0.698021818962042	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs11204915	rs7542137	0.698021818962042	3-hydroxysebacate levels	2e-10	36635386
rs11204915	rs3007711	0.67778406623389	Electrodermal activity	9e-06	25387706
rs11204915	rs2999541	0.676803461609928	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs11204915	rs28415528	0.601473647634291	Serum metabolite concentrations in chronic kidney disease	4e-09	29545352
rs11204915	rs28415528	0.601473647634291	Acylcarnitine (13:0) levels	1e-28	35668104
rs11204915	rs28415528	0.601473647634291	Acylcarnitine (13:0) levels	9e-25	35668104
rs11204915	rs28415528	0.601473647634291	X-23680 levels	8e-52	35347128
rs11204915	rs28415528	0.601473647634291	X-18921 levels	1e-100	35347128
rs11204915	rs28415528	0.601473647634291	Cis-4-decenoate (10:1n6) (X-23293) levels	7e-84	35050183
rs11204915	rs28415528	0.601473647634291	X-18921 levels	2e-156	35050183
rs11204915	rs28415528	0.601473647634291	3-hydroxydecanoate levels	8e-35	35050183
rs11204915	rs28415528	0.601473647634291	3-hydroxyoctanoate levels	4e-17	35050183
rs11204915	rs28415528	0.601473647634291	Urine X-24798 levels in chronic kidney disease	9e-14	37277652
rs11204915	rs28415528	0.601473647634291	Urine 4-hydroxyphenylacetoylcarnitine levels in chronic kidney disease	4e-23	37277652
rs11204915	rs28415528	0.601473647634291	Plasma X-23680 levels in chronic kidney disease	1e-17	37277652
rs11204915	rs28415528	0.601473647634291	Urine X-23680 levels in chronic kidney disease	3e-13	37277652
rs11204915	rs28415528	0.601473647634291	X-21607 levels	2e-55	36635386
rs11204915	rs28415528	0.601473647634291	X-21353 levels	1e-42	36635386
rs11204915	rs28415528	0.601473647634291	X-18921 levels	2e-139	36635386
rs11204915	rs28415528	0.601473647634291	X-23680 levels	2e-77	36635386
rs11204915	rs28415528	0.601473647634291	Cis-4-decenoate (10:1n6) levels	4e-148	36635386
rs11204915	rs28415528	0.601473647634291	4-hydroxyphenylacetoylcarnitine levels	3e-34	36635386
rs11204915	rs28415528	0.601473647634291	X-18888 levels	6e-12	36635386
rs11204915	rs28415528	0.601473647634291	Indoleacetoylcarnitine levels	2e-20	36635386
rs11204915	rs28415528	0.601473647634291	3-hydroxyoctanoate levels	2e-13	36635386
rs11204915	rs28415528	0.601473647634291	3-hydroxydecanoate levels	3e-39	36635386
rs11213941	rs11213941	1	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs11213941	rs11213941	1	Eczema	8e-14	30595370
rs11213941	rs659529	0.823294515769256	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs11213941	rs659529	0.823294515769256	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs11213941	rs659529	0.823294515769256	Atopic dermatitis	5e-10	34116867
rs11213941	rs11213940	0.753810212039244	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI	2e-13	31669095
rs11213941	rs34634095	0.674031455058855	Fish- and plant-related diet	3e-09	32066663
rs11213941	rs663763	0.673605260936442	Layilin levels	3e-21	36168886
rs11213941	rs480293	0.642383252219129	Oily fish consumption	4e-11	32193382
rs11213941	rs539524	0.633717478506455	Asthma	1e-10	32296059
rs11213941	rs1613778	0.611238840223634	Total bilirubin levels	3e-08	34594039
rs11213948	rs480293	0.9956932477181	Oily fish consumption	4e-11	32193382
rs11213948	rs1613778	0.938070256834687	Total bilirubin levels	3e-08	34594039
rs11213948	rs34634095	0.932661605352807	Fish- and plant-related diet	3e-09	32066663
rs11213948	rs542831	0.912121377078516	Asthma	5e-13	31361310
rs11213948	rs1784776	0.909641398675365	Asthma	2e-09	32296059
rs11213948	rs1784775	0.909641398675365	Asthma	2e-09	30929738
rs11213948	rs1784775	0.909641398675365	Asthma (adult onset)	6e-09	30929738
rs11213948	rs1789358	0.907992721503636	Asthma	2e-08	34103634
rs11213948	rs539524	0.901656166367181	Asthma	1e-10	32296059
rs11213948	rs12791699	0.872819772977464	Pork consumption	9e-09	32066663
rs11213948	rs12791699	0.872819772977464	Oily fish consumption	9e-09	32066663
rs11213948	rs487985	0.872819772977464	Highest math class taken	1e-08	30038396
rs11213948	rs10891286	0.847124006719349	Noncognitive aspects of educational attainment	5e-10	33414549
rs11213948	rs4459340	0.843154706559344	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs11213948	rs505372	0.798027252150916	Breast cancer	3e-06	29059683
rs11213948	rs505372	0.798027252150916	Medication use (beta blocking agents)	2e-08	34594039
rs11213948	rs659529	0.797428492484743	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs11213948	rs659529	0.797428492484743	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs11213948	rs659529	0.797428492484743	Atopic dermatitis	5e-10	34116867
rs11213948	rs9734135	0.760360869890654	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs11213948	rs11213941	0.644151747384443	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs11213948	rs11213941	0.644151747384443	Eczema	8e-14	30595370
rs11213948	rs663763	0.64019728098108	Layilin levels	3e-21	36168886
rs112239142	rs6723298	0.681484830362498	Smoking initiation	2e-12	36477530
rs112239142	rs2194492	0.662668606198191	Educational attainment	9e-09	35361970
rs112239142	rs13020443	0.652872841840035	Type 2 diabetes	3e-11	32541925
rs112283401	rs112283401	1	Red cell distribution width	4e-27	30595370
rs112283401	rs9469872	0.796699333730006	HDL cholesterol levels	3e-11	36333282
rs112283401	rs11755393	0.796480925818498	Body mass index	3e-26	29273807
rs112283401	rs11755393	0.796480925818498	Systemic lupus erythematosus	2e-12	33493351
rs112283401	rs11755393	0.796480925818498	Systemic lupus erythematosus	2e-06	33493351
rs112283401	rs11755393	0.796480925818498	Systemic lupus erythematosus	1e-07	33493351
rs112283401	rs11755393	0.796480925818498	Systemic lupus erythematosus	2e-08	19838195
rs112283401	rs11755393	0.796480925818498	Body mass index	4e-55	36581621
rs112283401	rs9366863	0.787098450530365	Adult body size	9e-33	32376654
rs112283401	rs9366863	0.787098450530365	Body mass index	2e-44	30595370
rs112283401	rs6941110	0.785387713498646	Sex hormone-binding globulin levels	5e-27	36653534
rs112283401	rs9462030	0.766497776717205	Red cell distribution width	5e-25	32888493
rs112283401	rs9469857	0.759166077209552	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs112283401	rs2764208	0.755458408444623	Systemic lupus erythematosus	7e-06	24871463
rs112283401	rs2814949	0.754496559814612	Essential hypertension (time to event)	9e-09	32589924
rs112283401	rs9469899	0.752227310371297	Prostate cancer (advanced)	2e-06	29892016
rs112283401	rs9469899	0.752227310371297	Prostate cancer	5e-09	29892016
rs112283401	rs9469899	0.752227310371297	Prostate cancer	8e-11	33398198
rs112283401	rs9469899	0.752227310371297	Hand grip strength	3e-15	29691431
rs112283401	rs9469899	0.752227310371297	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs112283401	rs9469899	0.752227310371297	Graves' disease	4e-10	34594039
rs112283401	rs9469899	0.752227310371297	Coronary artery disease	1e-11	36474045
rs112283401	rs9469899	0.752227310371297	Predicted visceral adipose tissue	2e-20	31501611
rs112283401	rs9469899	0.752227310371297	Medication use (thyroid preparations)	2e-09	31015401
rs112283401	rs9469899	0.752227310371297	Medication use (thyroid preparations)	3e-10	34594039
rs112283401	rs2744944	0.745363325410403	Hypothyroidism	3e-10	34594039
rs112283401	rs2744944	0.745363325410403	High density lipoprotein cholesterol levels	3e-86	34887591
rs112283401	rs2744944	0.745363325410403	Multi-trait sex score	7e-22	37277458
rs112283401	rs2263329	0.728202401380231	HDL cholesterol	6e-35	34594039
rs112283401	rs2263329	0.728202401380231	HDL cholesterol levels	8e-43	32203549
rs112283401	rs2263329	0.728202401380231	High density lipoprotein cholesterol levels	2e-52	34887591
rs112283401	rs9368828	0.727087992420628	Body mass index	1e-34	34594039
rs112283401	rs111868030	0.713290994148087	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs112283401	rs9296128	0.710537247170967	Hip circumference adjusted for BMI	4e-13	34021172
rs112283401	rs9368830	0.692329079777226	HDL cholesterol	4e-21	30275531
rs112283401	rs2744973	0.664747177304558	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs112283401	rs2744973	0.664747177304558	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs112283401	rs2744973	0.664747177304558	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs112283401	rs2744973	0.664747177304558	Multi-trait sex score	6e-20	37277458
rs112283401	rs6912327	0.641574485988104	Fasting insulin	5e-06	33402679
rs112283401	rs6912327	0.641574485988104	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs112327514	rs9462030	0.994373913660559	Red cell distribution width	5e-25	32888493
rs112327514	rs9469857	0.984761860276752	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs112327514	rs2764208	0.983972294036617	Systemic lupus erythematosus	7e-06	24871463
rs112327514	rs9469899	0.977693690324335	Prostate cancer (advanced)	2e-06	29892016
rs112327514	rs9469899	0.977693690324335	Prostate cancer	5e-09	29892016
rs112327514	rs9469899	0.977693690324335	Prostate cancer	8e-11	33398198
rs112327514	rs9469899	0.977693690324335	Hand grip strength	3e-15	29691431
rs112327514	rs9469899	0.977693690324335	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs112327514	rs9469899	0.977693690324335	Graves' disease	4e-10	34594039
rs112327514	rs9469899	0.977693690324335	Coronary artery disease	1e-11	36474045
rs112327514	rs9469899	0.977693690324335	Predicted visceral adipose tissue	2e-20	31501611
rs112327514	rs9469899	0.977693690324335	Medication use (thyroid preparations)	2e-09	31015401
rs112327514	rs9469899	0.977693690324335	Medication use (thyroid preparations)	3e-10	34594039
rs112327514	rs9469872	0.948616480320373	HDL cholesterol levels	3e-11	36333282
rs112327514	rs11755393	0.946752658211181	Body mass index	3e-26	29273807
rs112327514	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-12	33493351
rs112327514	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-06	33493351
rs112327514	rs11755393	0.946752658211181	Systemic lupus erythematosus	1e-07	33493351
rs112327514	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-08	19838195
rs112327514	rs11755393	0.946752658211181	Body mass index	4e-55	36581621
rs112327514	rs9366863	0.938413835677258	Adult body size	9e-33	32376654
rs112327514	rs9366863	0.938413835677258	Body mass index	2e-44	30595370
rs112327514	rs6941110	0.935247375317915	Sex hormone-binding globulin levels	5e-27	36653534
rs112327514	rs9296128	0.934198692532671	Hip circumference adjusted for BMI	4e-13	34021172
rs112327514	rs2814949	0.902335914866459	Essential hypertension (time to event)	9e-09	32589924
rs112327514	rs2744944	0.893023538028903	Hypothyroidism	3e-10	34594039
rs112327514	rs2744944	0.893023538028903	High density lipoprotein cholesterol levels	3e-86	34887591
rs112327514	rs2744944	0.893023538028903	Multi-trait sex score	7e-22	37277458
rs112327514	rs2263329	0.873890090753199	HDL cholesterol	6e-35	34594039
rs112327514	rs2263329	0.873890090753199	HDL cholesterol levels	8e-43	32203549
rs112327514	rs2263329	0.873890090753199	High density lipoprotein cholesterol levels	2e-52	34887591
rs112327514	rs111868030	0.850215739645168	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs112327514	rs9368830	0.829314976366607	HDL cholesterol	4e-21	30275531
rs112327514	rs9368828	0.80294162376271	Body mass index	1e-34	34594039
rs112327514	rs2744973	0.799489696126742	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs112327514	rs2744973	0.799489696126742	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs112327514	rs2744973	0.799489696126742	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs112327514	rs2744973	0.799489696126742	Multi-trait sex score	6e-20	37277458
rs112327514	rs6912327	0.791347099634255	Fasting insulin	5e-06	33402679
rs112327514	rs6912327	0.791347099634255	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs112327514	rs112283401	0.770469283630436	Red cell distribution width	4e-27	30595370
rs112327514	rs9689160	0.627068448532794	Lung function (forced vital capacity)	3e-14	36914875
rs112417725	rs61586425	0.96260058751508	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs112417725	rs8075598	0.772342615293195	Non-albumin protein levels	3e-10	29403010
rs112417725	rs6565604	0.769097072343008	Non-melanoma skin cancer	3e-06	34290314
rs112417725	rs9894429	0.675418676256894	Eye color traits	9e-14	20463881
rs112417725	rs9894429	0.675418676256894	Body mass index	4e-08	36581621
rs1125340	rs9462030	0.995175518696793	Red cell distribution width	5e-25	32888493
rs1125340	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs1125340	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs1125340	rs9469899	0.978497589843936	Prostate cancer (advanced)	2e-06	29892016
rs1125340	rs9469899	0.978497589843936	Prostate cancer	5e-09	29892016
rs1125340	rs9469899	0.978497589843936	Prostate cancer	8e-11	33398198
rs1125340	rs9469899	0.978497589843936	Hand grip strength	3e-15	29691431
rs1125340	rs9469899	0.978497589843936	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs1125340	rs9469899	0.978497589843936	Graves' disease	4e-10	34594039
rs1125340	rs9469899	0.978497589843936	Coronary artery disease	1e-11	36474045
rs1125340	rs9469899	0.978497589843936	Predicted visceral adipose tissue	2e-20	31501611
rs1125340	rs9469899	0.978497589843936	Medication use (thyroid preparations)	2e-09	31015401
rs1125340	rs9469899	0.978497589843936	Medication use (thyroid preparations)	3e-10	34594039
rs1125340	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs1125340	rs11755393	0.947554267093235	Body mass index	3e-26	29273807
rs1125340	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-12	33493351
rs1125340	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-06	33493351
rs1125340	rs11755393	0.947554267093235	Systemic lupus erythematosus	1e-07	33493351
rs1125340	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-08	19838195
rs1125340	rs11755393	0.947554267093235	Body mass index	4e-55	36581621
rs1125340	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs1125340	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs1125340	rs6941110	0.936033811762549	Sex hormone-binding globulin levels	5e-27	36653534
rs1125340	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs1125340	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs1125340	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs1125340	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs1125340	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs1125340	rs2263329	0.874645285202942	HDL cholesterol	6e-35	34594039
rs1125340	rs2263329	0.874645285202942	HDL cholesterol levels	8e-43	32203549
rs1125340	rs2263329	0.874645285202942	High density lipoprotein cholesterol levels	2e-52	34887591
rs1125340	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs1125340	rs9368830	0.830084187792525	HDL cholesterol	4e-21	30275531
rs1125340	rs9368828	0.803658173339717	Body mass index	1e-34	34594039
rs1125340	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs1125340	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs1125340	rs2744973	0.800145420504899	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs1125340	rs2744973	0.800145420504899	Multi-trait sex score	6e-20	37277458
rs1125340	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs1125340	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs1125340	rs112283401	0.769696819914803	Red cell distribution width	4e-27	30595370
rs1125340	rs9689160	0.627575422825611	Lung function (forced vital capacity)	3e-14	36914875
rs1125341	rs9462030	0.995175518696793	Red cell distribution width	5e-25	32888493
rs1125341	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs1125341	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs1125341	rs9469899	0.978497589843936	Prostate cancer (advanced)	2e-06	29892016
rs1125341	rs9469899	0.978497589843936	Prostate cancer	5e-09	29892016
rs1125341	rs9469899	0.978497589843936	Prostate cancer	8e-11	33398198
rs1125341	rs9469899	0.978497589843936	Hand grip strength	3e-15	29691431
rs1125341	rs9469899	0.978497589843936	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs1125341	rs9469899	0.978497589843936	Graves' disease	4e-10	34594039
rs1125341	rs9469899	0.978497589843936	Coronary artery disease	1e-11	36474045
rs1125341	rs9469899	0.978497589843936	Predicted visceral adipose tissue	2e-20	31501611
rs1125341	rs9469899	0.978497589843936	Medication use (thyroid preparations)	2e-09	31015401
rs1125341	rs9469899	0.978497589843936	Medication use (thyroid preparations)	3e-10	34594039
rs1125341	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs1125341	rs11755393	0.947554267093235	Body mass index	3e-26	29273807
rs1125341	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-12	33493351
rs1125341	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-06	33493351
rs1125341	rs11755393	0.947554267093235	Systemic lupus erythematosus	1e-07	33493351
rs1125341	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-08	19838195
rs1125341	rs11755393	0.947554267093235	Body mass index	4e-55	36581621
rs1125341	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs1125341	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs1125341	rs6941110	0.936033811762549	Sex hormone-binding globulin levels	5e-27	36653534
rs1125341	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs1125341	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs1125341	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs1125341	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs1125341	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs1125341	rs2263329	0.874645285202942	HDL cholesterol	6e-35	34594039
rs1125341	rs2263329	0.874645285202942	HDL cholesterol levels	8e-43	32203549
rs1125341	rs2263329	0.874645285202942	High density lipoprotein cholesterol levels	2e-52	34887591
rs1125341	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs1125341	rs9368830	0.830084187792525	HDL cholesterol	4e-21	30275531
rs1125341	rs9368828	0.803658173339717	Body mass index	1e-34	34594039
rs1125341	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs1125341	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs1125341	rs2744973	0.800145420504899	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs1125341	rs2744973	0.800145420504899	Multi-trait sex score	6e-20	37277458
rs1125341	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs1125341	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs1125341	rs112283401	0.769696819914803	Red cell distribution width	4e-27	30595370
rs1125341	rs9689160	0.627575422825611	Lung function (forced vital capacity)	3e-14	36914875
rs112583316	rs777587	0.857260274902088	Proteoglycan 3 levels	6e-29	34648354
rs112583316	rs777587	0.857260274902088	Pappalysin-1 levels	1e-25	34648354
rs112583316	rs12617371	0.812168454256479	Immature fraction of reticulocytes	8e-18	32888494
rs112583316	rs2463097	0.779230480804493	White blood cell count	3e-26	30595370
rs112583316	rs11685226	0.768047763500022	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs112583316	rs11685226	0.768047763500022	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs112583316	rs1177308	0.758825164310594	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs112583316	rs1177308	0.758825164310594	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs112583316	rs2593620	0.758029749779205	Serum levels of protein PRG3	5e-14	35078996
rs112583316	rs7558954	0.756735047885906	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs112583316	rs10199672	0.745770195111677	Height	6e-12	34594039
rs112583316	rs10199672	0.745770195111677	Height	2e-12	31562340
rs112583316	rs2421200	0.727648645006624	Neutrophil count	1e-26	32888493
rs112583316	rs2421200	0.727648645006624	Neutrophil count	1e-25	32888493
rs112583316	rs10169482	0.674490126159512	C-reactive protein levels	4e-09	33462484
rs112583316	rs2950269	0.628942881001964	Eosinophil side fluorescence	3e-18	37596262
rs112583316	rs12616433	0.603873466107786	Eosinophil forward scatter	4e-13	37596262
rs112583316	rs12616433	0.603873466107786	Eosinophil side scatter	2e-18	37596262
rs112612275	rs8077038	0.990148293912724	Educational attainment (MTAG)	4e-10	30038396
rs112612275	rs8077038	0.990148293912724	Highest math class taken (MTAG)	5e-16	30038396
rs112612275	rs12949956	0.982488167642959	Self-reported math ability	3e-11	30038396
rs112612275	rs12949956	0.982488167642959	Self-reported math ability (MTAG)	3e-14	30038396
rs112612275	rs12949956	0.982488167642959	Highest math class taken	8e-12	30038396
rs112612275	rs7211615	0.967701434862142	Heel bone mineral density	1e-08	30595370
rs112612275	rs9894429	0.644158157676546	Eye color traits	9e-14	20463881
rs112612275	rs9894429	0.644158157676546	Body mass index	4e-08	36581621
rs1126551	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs1126551	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs1126551	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs1126551	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs1126551	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs1126551	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs1126551	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs1126551	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs1126551	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs1126551	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs1126551	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs1126551	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs1126551	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs1126551	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs1126551	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs1126551	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs1126551	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs1126551	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs1126551	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs1126551	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs1126551	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs1126551	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs1126551	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs1126551	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs1126551	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs1126551	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs1126722	rs7610312	0.982620671052266	Red blood cell count	5e-09	27863252
rs1126722	rs6775517	0.981409287399962	Hematocrit	1e-17	34594039
rs1126722	rs57700771	0.976427845788879	Red blood cell count	9e-21	30595370
rs1126722	rs34579268	0.969587498092384	Hematocrit	5e-30	32888493
rs1126722	rs34579268	0.969587498092384	Hematocrit	2e-27	32888493
rs1126722	rs34579268	0.969587498092384	Hemoglobin concentration	5e-26	32888493
rs1126722	rs11705721	0.962122285194624	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs1126722	rs11130638	0.962122285194624	Hemoglobin concentration	2e-23	32888493
rs1126722	rs55704295	0.907971862622776	Red blood cell count	8e-26	32888493
rs1126722	rs55704295	0.907971862622776	Red blood cell count	5e-23	32888493
rs1126722	rs55704295	0.907971862622776	Serum total protein level	2e-29	34594039
rs1126722	rs4681679	0.885211123744596	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs1126722	rs11719450	0.878193582130008	Hemoglobin concentration	2e-09	27863252
rs1126722	rs11719450	0.878193582130008	Hemoglobin levels	2e-16	32327693
rs1126722	rs11922478	0.866394468740846	Semaphorin-6B levels	4e-12	34648354
rs1126722	rs56384862	0.847367450034689	Body mass index	8e-12	29273807
rs1126722	rs56384862	0.847367450034689	Body mass index	3e-06	30108127
rs1126722	rs56384862	0.847367450034689	Hemoglobin levels	1e-16	32327693
rs1126722	rs56384862	0.847367450034689	Body mass index	3e-14	36581621
rs1126722	rs55692656	0.823945226436869	vWF levels	3e-08	30586737
rs1126722	rs55692656	0.823945226436869	vWF levels	6e-09	30586737
rs1126722	rs6445969	0.697013857550564	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs1126722	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs1126722	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs1126722	rs11708895	0.690655689592221	Red blood cell count	1e-20	32888494
rs1126722	rs7431952	0.625440092209776	Hemoglobin levels	1e-12	32327693
rs1126735	rs4681679	0.980169760294324	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs1126735	rs11719450	0.972246291427922	Hemoglobin concentration	2e-09	27863252
rs1126735	rs11719450	0.972246291427922	Hemoglobin levels	2e-16	32327693
rs1126735	rs56384862	0.938226041357988	Body mass index	8e-12	29273807
rs1126735	rs56384862	0.938226041357988	Body mass index	3e-06	30108127
rs1126735	rs56384862	0.938226041357988	Hemoglobin levels	1e-16	32327693
rs1126735	rs56384862	0.938226041357988	Body mass index	3e-14	36581621
rs1126735	rs7610312	0.886370771647821	Red blood cell count	5e-09	27863252
rs1126735	rs6775517	0.885469176917851	Hematocrit	1e-17	34594039
rs1126735	rs57700771	0.880017439750526	Red blood cell count	9e-21	30595370
rs1126735	rs34579268	0.875932489033185	Hematocrit	5e-30	32888493
rs1126735	rs34579268	0.875932489033185	Hematocrit	2e-27	32888493
rs1126735	rs34579268	0.875932489033185	Hemoglobin concentration	5e-26	32888493
rs1126735	rs11705721	0.868063090103448	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs1126735	rs11130638	0.868063090103448	Hemoglobin concentration	2e-23	32888493
rs1126735	rs55692656	0.829826000626818	vWF levels	3e-08	30586737
rs1126735	rs55692656	0.829826000626818	vWF levels	6e-09	30586737
rs1126735	rs11922478	0.807834642986997	Semaphorin-6B levels	4e-12	34648354
rs1126735	rs55704295	0.807537423203701	Red blood cell count	8e-26	32888493
rs1126735	rs55704295	0.807537423203701	Red blood cell count	5e-23	32888493
rs1126735	rs55704295	0.807537423203701	Serum total protein level	2e-29	34594039
rs1126735	rs6445969	0.771837823463599	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs1126735	rs55954186	0.767431595196939	vWF levels	5e-09	30586737
rs1126735	rs55954186	0.767431595196939	vWF levels	9e-09	30586737
rs1126735	rs11708895	0.764700342906702	Red blood cell count	1e-20	32888494
rs1126735	rs7431952	0.692944118445573	Hemoglobin levels	1e-12	32327693
rs1126735	rs9311676	0.639400425454062	Systemic lupus erythematosus	5e-06	27399966
rs1126735	rs9311676	0.639400425454062	Systemic lupus erythematosus	3e-14	26502338
rs1126735	rs9311676	0.639400425454062	Waist circumference adjusted for body mass index	3e-08	34021172
rs1126735	rs9822855	0.618089486567881	Educational attainment	9e-120	35361970
rs112695134	rs1177308	0.883512506862016	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs112695134	rs1177308	0.883512506862016	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs112695134	rs7558954	0.881345750976718	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs112695134	rs11685226	0.861412570177957	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs112695134	rs11685226	0.861412570177957	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs112695134	rs777587	0.720055259531164	Proteoglycan 3 levels	6e-29	34648354
rs112695134	rs777587	0.720055259531164	Pappalysin-1 levels	1e-25	34648354
rs112695134	rs12617371	0.683555824152615	Immature fraction of reticulocytes	8e-18	32888494
rs112695134	rs2463097	0.653524098283981	White blood cell count	3e-26	30595370
rs112695134	rs2593620	0.62745206073197	Serum levels of protein PRG3	5e-14	35078996
rs112695134	rs10199672	0.621737159245029	Height	6e-12	34594039
rs112695134	rs10199672	0.621737159245029	Height	2e-12	31562340
rs112695134	rs2421200	0.602556536463424	Neutrophil count	1e-26	32888493
rs112695134	rs2421200	0.602556536463424	Neutrophil count	1e-25	32888493
rs1127155	rs4304220	0.781312836786948	Height	2e-14	36224396
rs1127155	rs4355658	0.755102890371493	Height	3e-13	36224396
rs1127155	rs12539962	0.618512783048812	Colorectal cancer	3e-08	36539618
rs1127156	rs4304220	0.868060221372779	Height	2e-14	36224396
rs1127156	rs4355658	0.818485054235964	Height	3e-13	36224396
rs1127156	rs13232536	0.614657395717792	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs1127156	rs12539962	0.601759792635005	Colorectal cancer	3e-08	36539618
rs1131476	rs1131476	1	Systemic lupus erythematosus	1e-09	33272962
rs1131476	rs2660	1	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs1131476	rs2660	1	COVID-19 (critical illness vs population)	3e-15	37198478
rs1131476	rs2057778	0.971509070243431	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1131476	rs2057778	0.971509070243431	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1131476	rs2057778	0.971509070243431	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1131476	rs4767027	0.97032942751798	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1131476	rs11066452	0.949153887779849	Blood protein levels	6e-08	30072576
rs1131476	rs1859336	0.911479300471044	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1131476	rs6489882	0.895047912374631	Chronic lymphocytic leukemia	5e-08	28165464
rs1131476	rs6489867	0.621471512329174	COVID-19 (critical illness vs population)	1e-09	33307546
rs1131668	rs6517156	0.935063087403378	Free testosterone levels	5e-09	36653534
rs1131668	rs2834161	0.770203573602282	COVID-19 with respiratory failure requiring mechanical ventilation	6e-07	35848942
rs1131668	rs2300371	0.7344941943608	Major depressive disorder or severe COVID-19 (pleiotropy)	8e-09	37426090
rs1131668	rs9636867	0.718150930748273	COVID-19 (hospitalized covid vs population)	2e-46	37198478
rs1131668	rs9636867	0.718150930748273	COVID-19 (critical illness vs population)	5e-48	37198478
rs1131668	rs17860115	0.718086030945208	COVID-19 (critical illness vs population or mild symptoms)	1e-21	35255492
rs1131668	rs17860115	0.718086030945208	COVID-19 (critical illness vs population or mild symptoms)	2e-08	35255492
rs1131668	rs9976829	0.713781569691474	COVID-19	3e-06	33949668
rs1131668	rs9976829	0.713781569691474	COVID-19 (severe vs population)	8e-12	35264675
rs1131668	rs13050728	0.713781569691474	COVID-19 (critical illness vs population)	5e-12	33307546
rs1131668	rs13050728	0.713781569691474	COVID-19 (critical illness vs population)	1e-16	34237774
rs1131668	rs13050728	0.713781569691474	COVID-19 (hospitalized vs population)	3e-20	34237774
rs1131668	rs13050728	0.713781569691474	COVID-19 (hospitalized vs population)	5e-23	35922517
rs1131668	rs13050728	0.713781569691474	SARS-CoV-2 infection	3e-07	35922517
rs1131668	rs13050728	0.713781569691474	COVID-19 (critical illness vs population)	1e-18	35922517
rs1131668	rs13050728	0.713781569691474	COVID-19 with respiratory failure	2e-19	35848942
rs1131668	rs13050728	0.713781569691474	COVID-19 with respiratory failure requiring mechanical ventilation	2e-15	35848942
rs1131668	rs13050728	0.713781569691474	COVID-19 severity	4e-22	35368071
rs1131668	rs13050728	0.713781569691474	Critical COVID-19 or osteoarthritis (MTAG)	3e-16	37398645
rs1131668	rs13050728	0.713781569691474	COVID-19 hospitalization or osteoarthritis (MTAG)	2e-11	37398645
rs1131668	rs11088247	0.698473800477958	COVID-19 severity	9e-10	35368071
rs1131668	rs12482060	0.693320432452872	COVID-19	2e-12	35264675
rs1131668	rs62226152	0.614527641817077	COVID-19 critical illness or age-related macular degeneration (MTAG)	3e-08	36614910
rs1131668	rs62226152	0.614527641817077	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-12	36614910
rs1131668	rs62226152	0.614527641817077	COVID-19 infection or age-related macular degeneration (MTAG)	1e-06	36614910
rs11316	rs4304220	0.998388718845539	Height	2e-14	36224396
rs11316	rs13232536	0.727430665480951	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs11316	rs4355658	0.70394150402541	Height	3e-13	36224396
rs11316	rs13227841	0.612367270032016	Asthma	2e-09	32514122
rs113768535	rs6723298	0.676365869352655	Smoking initiation	2e-12	36477530
rs113768535	rs2194492	0.657609756084126	Educational attainment	9e-09	35361970
rs113768535	rs13020443	0.647823835336573	Type 2 diabetes	3e-11	32541925
rs113798548	rs55679149	0.607896058905632	Remission after SSRI treatment in MDD or openness	8e-07	29559929
rs1138888	rs1138888	1	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs1138888	rs1138888	1	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs1138888	rs4802157	0.977915568428117	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs1138888	rs12978398	0.636036892159996	Pregnancy-specific beta-1-glycoprotein 4 levels	0	34648354
rs1138888	rs7257250	0.611766230341	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	7e-117	29875488
rs113915083	rs8077038	0.953246884726767	Educational attainment (MTAG)	4e-10	30038396
rs113915083	rs8077038	0.953246884726767	Highest math class taken (MTAG)	5e-16	30038396
rs113915083	rs12949956	0.945306033009516	Self-reported math ability	3e-11	30038396
rs113915083	rs12949956	0.945306033009516	Self-reported math ability (MTAG)	3e-14	30038396
rs113915083	rs12949956	0.945306033009516	Highest math class taken	8e-12	30038396
rs113915083	rs7211615	0.931553921031339	Heel bone mineral density	1e-08	30595370
rs113915083	rs9894429	0.618878241524008	Eye color traits	9e-14	20463881
rs113915083	rs9894429	0.618878241524008	Body mass index	4e-08	36581621
rs113954805	rs1467510	0.770882124696308	Platelet distribution width	1e-14	32888494
rs113954805	rs12276109	0.65241294917418	Severe COVID-19 infection	6e-08	36662838
rs1140047	rs4353250	0.991117795148309	Insulin-like growth factor 1 levels	2e-14	33462484
rs1140047	rs4353250	0.991117795148309	Amyloid A serum levels	2e-51	21124955
rs1140047	rs4150575	0.634837127154608	Imidazole lactate levels	1e-10	36635386
rs1142981	rs6442487	0.684404572380576	Height	4e-58	36224396
rs1147611	rs1147611	1	Blood protein levels	3e-139	30072576
rs1147611	rs2282326	0.933431700280176	Serum levels of protein GSTO1	4e-265	35078996
rs1147611	rs2282326	0.933431700280176	Glutathione S-transferase omega-1 levels (GSTO1.12436.84.3)	0	29875488
rs11485298	rs28568334	0.800714331304701	Educational attainment	4e-13	35361970
rs11485298	rs28482086	0.711412164573406	Educational attainment (years of education)	5e-09	30038396
rs114976176	rs114976176	1	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs114976176	rs59937473	0.955384408437312	Protein quantitative trait loci	3e-67	32492067
rs114976176	rs59937473	0.955384408437312	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs114976176	rs17714252	0.945594059660049	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs114976176	rs17714252	0.945594059660049	Retinal vascular fractal dimension	2e-07	34743558
rs114976176	rs58461606	0.944642759894773	Blood protein levels	0	30072576
rs114976176	rs7566279	0.940749842069163	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs114976176	rs7595075	0.930065277359219	Waist circumference adjusted for body mass index	2e-09	34021172
rs114976176	rs7595075	0.930065277359219	HDL cholesterol	3e-11	34594039
rs114976176	rs7595075	0.930065277359219	HDL cholesterol levels	6e-13	32203549
rs114976176	rs79716074	0.926179283488751	Plateletcrit	1e-09	32888494
rs114976176	rs79716074	0.926179283488751	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs114976176	rs79716074	0.926179283488751	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs114976176	rs79716074	0.926179283488751	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs114976176	rs55753056	0.92372796052393	Height	2e-22	30595370
rs114976176	rs17713729	0.923208775761571	Body mass index	2e-09	31669095
rs114976176	rs17713729	0.923208775761571	Serum creatinine levels	4e-14	34594039
rs114976176	rs17713729	0.923208775761571	High density lipoprotein cholesterol levels	7e-17	34887591
rs114976176	rs17713396	0.916427833611337	Blood urea nitrogen levels	3e-21	34272381
rs114976176	rs17713396	0.916427833611337	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs114976176	rs17713396	0.916427833611337	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs114976176	rs7601944	0.915462856674283	Smoking initiation	4e-15	36477530
rs114976176	rs6710091	0.914487849562585	Waist circumference adjusted for body mass index	8e-11	31669095
rs114976176	rs6710091	0.914487849562585	HDL cholesterol	5e-08	30275531
rs114976176	rs6710091	0.914487849562585	High density lipoprotein cholesterol levels	3e-24	34887591
rs114976176	rs7605824	0.914447497372036	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs114976176	rs3791221	0.902161566356217	Blood urea nitrogen levels	2e-07	31152163
rs114976176	rs3791221	0.902161566356217	Estimated glomerular filtration rate	2e-10	31152163
rs114976176	rs3791221	0.902161566356217	Estimated glomerular filtration rate	1e-11	31152163
rs114976176	rs3791221	0.902161566356217	Blood urea nitrogen levels	7e-26	34594039
rs114976176	rs62114538	0.891083533403396	Triglyceride levels	6e-12	34887591
rs114976176	rs60843830	0.885077073623467	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs114976176	rs60843830	0.885077073623467	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs114976176	rs60843830	0.885077073623467	Adventurousness	7e-10	30643258
rs114976176	rs2290911	0.872638278313611	Height	5e-07	29782485
rs114976176	rs2290911	0.872638278313611	Large artery stroke	6e-06	28265093
rs114976176	rs2290911	0.872638278313611	Height	8e-112	36224396
rs114976176	rs2126129	0.864759951608062	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs114976176	rs11553746	0.833259144509657	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs114976176	rs11553746	0.833259144509657	High density lipoprotein cholesterol levels	2e-07	29083408
rs114976176	rs11553746	0.833259144509657	High density lipoprotein cholesterol levels	7e-15	29083408
rs114976176	rs11553746	0.833259144509657	Large artery stroke	4e-06	28265093
rs114976176	rs62114548	0.805289840211442	Retinal vascular fractal density	2e-09	34743558
rs114976176	rs17713879	0.804840468662087	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs114976176	rs17713879	0.804840468662087	Smoking initiation	1e-10	36477530
rs114976176	rs17713879	0.804840468662087	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs114976176	rs17713879	0.804840468662087	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs114976176	rs17713879	0.804840468662087	Triglyceride levels	3e-10	34887591
rs114976176	rs17713879	0.804840468662087	Aging (eyeAgeAcceleration)	6e-50	36975205
rs114976176	rs79154857	0.761395746076435	Pulse pressure	5e-08	34594039
rs114976176	rs62114506	0.705172419689713	Gamma glutamyl transpeptidase	3e-14	34594039
rs114976176	rs62114506	0.705172419689713	Apolipoprotein A1 levels	3e-10	32203549
rs114976176	rs62114506	0.705172419689713	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs114976176	rs62114506	0.705172419689713	HDL cholesterol levels	8e-10	36333282
rs11498	rs1177308	0.830755854956438	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11498	rs1177308	0.830755854956438	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11498	rs11685226	0.829415416798731	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs11498	rs11685226	0.829415416798731	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11498	rs7558954	0.828623685499601	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11498	rs777587	0.691146262714115	Proteoglycan 3 levels	6e-29	34648354
rs11498	rs777587	0.691146262714115	Pappalysin-1 levels	1e-25	34648354
rs11498	rs12617371	0.666450600950438	Immature fraction of reticulocytes	8e-18	32888494
rs11498	rs2463097	0.649738754033226	White blood cell count	3e-26	30595370
rs11498	rs10199672	0.604486435260385	Height	6e-12	34594039
rs11498	rs10199672	0.604486435260385	Height	2e-12	31562340
rs11498	rs2593620	0.602699042455541	Serum levels of protein PRG3	5e-14	35078996
rs11549490	rs6471393	0.610738625381275	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs11553746	rs11553746	1	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs11553746	rs11553746	1	High density lipoprotein cholesterol levels	2e-07	29083408
rs11553746	rs11553746	1	High density lipoprotein cholesterol levels	7e-15	29083408
rs11553746	rs11553746	1	Large artery stroke	4e-06	28265093
rs11553746	rs62114548	0.921171758259597	Retinal vascular fractal density	2e-09	34743558
rs11553746	rs2290911	0.918506756272095	Height	5e-07	29782485
rs11553746	rs2290911	0.918506756272095	Large artery stroke	6e-06	28265093
rs11553746	rs2290911	0.918506756272095	Height	8e-112	36224396
rs11553746	rs7595075	0.891178106801703	Waist circumference adjusted for body mass index	2e-09	34021172
rs11553746	rs7595075	0.891178106801703	HDL cholesterol	3e-11	34594039
rs11553746	rs7595075	0.891178106801703	HDL cholesterol levels	6e-13	32203549
rs11553746	rs79716074	0.889027013141091	Plateletcrit	1e-09	32888494
rs11553746	rs79716074	0.889027013141091	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs11553746	rs79716074	0.889027013141091	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs11553746	rs79716074	0.889027013141091	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs11553746	rs17713729	0.886448939377224	Body mass index	2e-09	31669095
rs11553746	rs17713729	0.886448939377224	Serum creatinine levels	4e-14	34594039
rs11553746	rs17713729	0.886448939377224	High density lipoprotein cholesterol levels	7e-17	34887591
rs11553746	rs58461606	0.883333507794152	Blood protein levels	0	30072576
rs11553746	rs7605824	0.87993608765608	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs11553746	rs7566279	0.879034497010994	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs11553746	rs17713396	0.877286154388629	Blood urea nitrogen levels	3e-21	34272381
rs11553746	rs17713396	0.877286154388629	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs11553746	rs17713396	0.877286154388629	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs11553746	rs6710091	0.875310498182565	Waist circumference adjusted for body mass index	8e-11	31669095
rs11553746	rs6710091	0.875310498182565	HDL cholesterol	5e-08	30275531
rs11553746	rs6710091	0.875310498182565	High density lipoprotein cholesterol levels	3e-24	34887591
rs11553746	rs3791221	0.841267908683928	Blood urea nitrogen levels	2e-07	31152163
rs11553746	rs3791221	0.841267908683928	Estimated glomerular filtration rate	2e-10	31152163
rs11553746	rs3791221	0.841267908683928	Estimated glomerular filtration rate	1e-11	31152163
rs11553746	rs3791221	0.841267908683928	Blood urea nitrogen levels	7e-26	34594039
rs11553746	rs17713879	0.84041642595357	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs11553746	rs17713879	0.84041642595357	Smoking initiation	1e-10	36477530
rs11553746	rs17713879	0.84041642595357	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs11553746	rs17713879	0.84041642595357	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs11553746	rs17713879	0.84041642595357	Triglyceride levels	3e-10	34887591
rs11553746	rs17713879	0.84041642595357	Aging (eyeAgeAcceleration)	6e-50	36975205
rs11553746	rs114976176	0.833259144509657	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs11553746	rs62114506	0.826254986349496	Gamma glutamyl transpeptidase	3e-14	34594039
rs11553746	rs62114506	0.826254986349496	Apolipoprotein A1 levels	3e-10	32203549
rs11553746	rs62114506	0.826254986349496	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs11553746	rs62114506	0.826254986349496	HDL cholesterol levels	8e-10	36333282
rs11553746	rs2126129	0.824876187836281	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs11553746	rs59937473	0.810494941361884	Protein quantitative trait loci	3e-67	32492067
rs11553746	rs59937473	0.810494941361884	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs11553746	rs17714252	0.808107216860173	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs11553746	rs17714252	0.808107216860173	Retinal vascular fractal dimension	2e-07	34743558
rs11553746	rs79154857	0.781817997412769	Pulse pressure	5e-08	34594039
rs11553746	rs55753056	0.780788630168538	Height	2e-22	30595370
rs11553746	rs7601944	0.773379461037296	Smoking initiation	4e-15	36477530
rs11553746	rs62114538	0.752976898733998	Triglyceride levels	6e-12	34887591
rs11553746	rs60843830	0.74633295688915	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs11553746	rs60843830	0.74633295688915	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs11553746	rs60843830	0.74633295688915	Adventurousness	7e-10	30643258
rs1156361	rs1859336	0.989350389660873	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1156361	rs6489882	0.97418202082575	Chronic lymphocytic leukemia	5e-08	28165464
rs1156361	rs11066452	0.967005697012195	Blood protein levels	6e-08	30072576
rs1156361	rs4767027	0.946001320824587	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1156361	rs2057778	0.944828547928737	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1156361	rs2057778	0.944828547928737	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1156361	rs2057778	0.944828547928737	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1156361	rs1131476	0.919624747131793	Systemic lupus erythematosus	1e-09	33272962
rs1156361	rs2660	0.919624747131793	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs1156361	rs2660	0.919624747131793	COVID-19 (critical illness vs population)	3e-15	37198478
rs1156361	rs6489867	0.673534903261012	COVID-19 (critical illness vs population)	1e-09	33307546
rs1156361	rs1557866	0.628717178866799	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs11574938	rs11574938	1	Neutrophil count	3e-24	32888493
rs11574938	rs11574938	1	White blood cell count	2e-93	32888493
rs11574938	rs11574938	1	Neutrophil count	2e-25	32888493
rs11574938	rs11574938	1	White blood cell count	8e-91	32888493
rs11574938	rs11574938	1	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	5e-14	26974007
rs11574938	rs11574938	1	White blood cell count	6e-27	27863252
rs11574938	rs11574938	1	White blood cell count	5e-63	30595370
rs11574938	rs11150589	0.988456975288191	Ulcerative colitis	3e-10	26192919
rs11574938	rs11150589	0.988456975288191	Inflammatory bowel disease	9e-07	26192919
rs11574938	rs11150589	0.988456975288191	Ulcerative colitis	6e-10	23128233
rs11574938	rs11150589	0.988456975288191	Lymphocyte percentage of white cells	3e-34	32888494
rs11574938	rs11150589	0.988456975288191	Neutrophil percentage of white cells	3e-14	32888494
rs11574938	rs11150589	0.988456975288191	Ulcerative colitis	1e-06	28067908
rs11574938	rs11150589	0.988456975288191	Neutrophil percentage of white cells	1e-11	27863252
rs11574938	rs11150589	0.988456975288191	Neutrophil-to-lymphocyte ratio	3e-23	34469753
rs11574938	rs11150589	0.988456975288191	Lymphocyte count	1e-90	34594039
rs11574938	rs11150589	0.988456975288191	White blood cell count	1e-36	34594039
rs11574938	rs12598978	0.988456975288191	Lymphocyte count	7e-186	32888493
rs11574938	rs12598978	0.988456975288191	Lymphocyte count	2e-181	32888493
rs11574938	rs12598978	0.988456975288191	Lymphocyte count	5e-57	34469753
rs11574938	rs12598978	0.988456975288191	Platelet-to-lymphocyte ratio	3e-41	34469753
rs11574938	rs12598978	0.988456975288191	Lymphocyte-to-monocyte ratio	3e-10	34469753
rs11574938	rs12598978	0.988456975288191	Insulin receptor levels	4e-16	34648354
rs11574938	rs12716977	0.988456975288191	Lymphocyte count	4e-130	32888494
rs11574938	rs12716977	0.988456975288191	Neutrophil count	8e-20	32888494
rs11574938	rs12716977	0.988456975288191	White blood cell count	3e-67	32888494
rs11574938	rs12716977	0.988456975288191	Lymphocyte count	1e-59	27863252
rs11574938	rs12716977	0.988456975288191	Lymphocyte percentage of white cells	2e-17	27863252
rs11574938	rs12716977	0.988456975288191	Monocyte count	5e-21	34469753
rs11574938	rs12716977	0.988456975288191	Basophil count	2e-20	34469753
rs11574938	rs7196129	0.87943966047578	Basophil count	7e-16	32888493
rs11574938	rs7196129	0.87943966047578	Basophil count	7e-17	32888494
rs11574938	rs7196129	0.87943966047578	Basophil count	2e-13	32888493
rs11574938	rs7196129	0.87943966047578	Monocyte count	1e-23	32888494
rs11574938	rs7196129	0.87943966047578	Monocyte count	2e-39	32888493
rs11574938	rs7196129	0.87943966047578	Monocyte count	5e-37	32888493
rs11574938	rs7196129	0.87943966047578	Monocyte count	2e-10	27863252
rs11574938	rs7196129	0.87943966047578	Monocyte count	3e-18	34594039
rs11576870	rs11580836	0.998221389128993	Body mass index	2e-09	36581621
rs11576870	rs10465746	0.958206121290169	Obesity-related traits	8e-06	23251661
rs11590498	rs7545078	0.691079773535879	Smoking initiation	2e-09	36477530
rs11590498	rs6700087	0.630222193226462	Smoking initiation	6e-11	36477530
rs116142917	rs116142917	1	Lymphocyte count	7e-18	32888494
rs116142917	rs2868708	0.918539067927247	Lymphocyte count	3e-11	34469753
rs116142917	rs2868708	0.918539067927247	White blood cell count	1e-09	30595370
rs116142917	rs6831339	0.915238572755671	High density lipoprotein cholesterol levels	9e-09	34887591
rs116142917	rs6823199	0.82334598792736	Pulse pressure	4e-14	30224653
rs116142917	rs13111599	0.81835614976554	HDL cholesterol levels	3e-09	32203549
rs116142917	rs13111599	0.81835614976554	Apolipoprotein A1 levels	4e-08	32203549
rs116142917	rs6535419	0.805588338139887	Pulse pressure	6e-10	30578418
rs116142917	rs4302451	0.683631520539143	Eosinophil counts	2e-09	30595370
rs116142917	rs11099563	0.674705835177984	High density lipoprotein cholesterol levels	3e-11	34887591
rs116142917	rs28528763	0.654985845134774	White blood cell count	7e-12	32888494
rs116142917	rs35895091	0.648517013693211	Cardiovascular disease	1e-07	30595370
rs11616765	rs4424789	0.946698947716022	Periostin levels	2e-19	34648354
rs11616765	rs9603222	0.82241024128289	Blood protein levels	2e-12	30072576
rs11616974	rs2224797	0.791032048920812	Red blood cell count	5e-08	30595370
rs11616974	rs2224797	0.791032048920812	Mean corpuscular hemoglobin	3e-09	30595370
rs11619265	rs7987940	0.69600525102269	AFP levels	6e-08	36329257
rs11619265	rs9535244	0.630199369656209	Lung function (FVC)	1e-08	30595370
rs11621904	rs8014112	1	Height	9e-54	36224396
rs11630918	rs11072513	0.909102873094436	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	6e-10	35589863
rs11630918	rs4480762	0.904649834223869	Monocyte percentage of white cells	2e-28	32888494
rs11630918	rs200520096	0.85259731798167	Diastolic blood pressure x depressive symptoms interaction (2df test)	3e-08	34734193
rs11630918	rs1127796	0.758130050907538	Red cell distribution width	4e-12	32888493
rs11630918	rs1127796	0.758130050907538	Red cell distribution width	2e-13	32888493
rs11630918	rs1127796	0.758130050907538	Insulin levels in overweight individuals	2e-08	34620218
rs11630918	rs1133322	0.757485506055142	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	4e-12	29912962
rs11630918	rs12899430	0.740704867919801	Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	1e-11	29912962
rs11630918	rs6495122	0.673756916325355	Coffee consumption	7e-09	21876539
rs11630918	rs6495122	0.673756916325355	Caffeine consumption	6e-07	21490707
rs11630918	rs6495122	0.673756916325355	Diastolic blood pressure	2e-10	19430479
rs11630918	rs6495122	0.673756916325355	Mean arterial pressure	2e-15	27618448
rs11630918	rs6495122	0.673756916325355	Diastolic blood pressure	4e-06	27841878
rs11630918	rs6495122	0.673756916325355	Diastolic blood pressure	5e-06	27841878
rs11630918	rs6495122	0.673756916325355	Systolic blood pressure	1e-16	27841878
rs11630918	rs6495122	0.673756916325355	Diastolic blood pressure	3e-29	27841878
rs11630918	rs6495122	0.673756916325355	Systolic blood pressure (cigarette smoking interaction)	4e-23	29455858
rs11630918	rs6495122	0.673756916325355	Diastolic blood pressure (cigarette smoking interaction)	5e-30	29455858
rs11630918	rs6495122	0.673756916325355	Total cholesterol levels	9e-13	34887591
rs11630918	rs6495122	0.673756916325355	Total cholesterol levels	7e-13	34594039
rs11630918	rs6495122	0.673756916325355	Non-HDL cholesterol levels	1e-08	34887591
rs11630918	rs6495122	0.673756916325355	Total cholesterol levels	3e-14	34887591
rs11630918	rs12917376	0.638471296936138	Red blood cell count	7e-31	32888493
rs11630918	rs12917376	0.638471296936138	Platelet distribution width	6e-24	32888494
rs11630918	rs12917376	0.638471296936138	Red blood cell count	3e-27	32888493
rs11630918	rs12917376	0.638471296936138	Plateletcrit	6e-14	32888494
rs11630918	rs12917376	0.638471296936138	Low density lipoprotein cholesterol levels	4e-08	32154731
rs11630918	rs12917376	0.638471296936138	Low density lipoprotein cholesterol levels	4e-15	34887591
rs11630918	rs12917376	0.638471296936138	Low density lipoprotein cholesterol levels	2e-14	34887591
rs11630918	rs12917376	0.638471296936138	Non-HDL cholesterol levels	9e-09	34887591
rs11630918	rs3812945	0.634189320953469	LDL cholesterol	8e-10	30275531
rs11630918	rs3812945	0.634189320953469	Height	5e-30	36224396
rs11632425	rs8034216	0.908417701301489	C-reactive protein levels	2e-10	31900758
rs11632425	rs17271340	0.869399005854994	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs11632425	rs13379492	0.84348919415816	Lung function (FEV1/FVC)	6e-08	30595370
rs11632425	rs17271305	0.841536406759153	Two-hour glucose challenge	1e-07	20081857
rs11632425	rs35967150	0.838308471675281	C-reactive protein levels (MTAG)	1e-08	36376304
rs11632425	rs11634163	0.826870486992228	C-reactive protein	2e-08	34594039
rs11632425	rs11634163	0.826870486992228	Two-hour glucose	3e-14	34059833
rs11632425	rs189400382	0.823753396392776	C-reactive protein levels	1e-08	35459240
rs11632425	rs28373613	0.666233434022637	Height (standard GWA)	8e-12	37106081
rs11633500	rs2162062	0.871014244843655	Height	2e-13	35831902
rs11633500	rs1436958	0.843264769068627	IgG glycosylation	9e-06	23382691
rs11633500	rs933807	0.829716690877441	Fat-free mass	6e-06	30593698
rs11633500	rs933807	0.829716690877441	Fat-free mass	2e-07	30593698
rs11633500	rs933807	0.829716690877441	Fat-free mass	8e-11	30593698
rs11633500	rs7178540	0.810439523485691	Height	1e-31	36224396
rs11633500	rs7162536	0.7754265605146	Height	4e-29	34594039
rs11633500	rs7178424	0.766822422414176	Height	6e-09	20881960
rs11633500	rs7178424	0.766822422414176	Height	6e-13	35831902
rs11633500	rs7178424	0.766822422414176	Height	3e-251	36224396
rs11633500	rs17271431	0.76265676464191	Height	2e-11	34594039
rs11633500	rs11635977	0.762180888909896	Height	2e-25	36224396
rs11633500	rs17205463	0.762021174822805	Serum levels of protein IGF1	8e-08	27329260
rs11633500	rs17205463	0.762021174822805	Appendicular lean mass	4e-43	33097823
rs11633500	rs17205463	0.762021174822805	Height	2e-35	30595370
rs11633500	rs731820	0.751881045092165	Height	2e-13	31562340
rs11633500	rs731820	0.751881045092165	Height	2e-12	35831902
rs11633500	rs72749770	0.72938144602109	Low density lipoprotein cholesterol levels	9e-10	32493714
rs11633500	rs72749770	0.72938144602109	Apolipoprotein B levels	2e-09	32203549
rs11635091	rs7173566	0.633557916481302	5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)	6e-16	29875488
rs11635091	rs57141546	0.625928224649875	5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)	7e-16	29875488
rs11635091	rs4994246	0.618446516475622	5-formyltetrahydrofolate cyclo-ligase levels	5.00000000228973e-315	34648354
rs11635569	rs28373613	0.96125142951036	Height (standard GWA)	8e-12	37106081
rs11635569	rs13379492	0.630523203624351	Lung function (FEV1/FVC)	6e-08	30595370
rs11635980	rs17271340	0.95037341915635	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs11635980	rs8034216	0.942962145124293	C-reactive protein levels	2e-10	31900758
rs11635980	rs35967150	0.9228133989497	C-reactive protein levels (MTAG)	1e-08	36376304
rs11635980	rs17271305	0.919594460176815	Two-hour glucose challenge	1e-07	20081857
rs11635980	rs11634163	0.911169739912061	C-reactive protein	2e-08	34594039
rs11635980	rs11634163	0.911169739912061	Two-hour glucose	3e-14	34059833
rs11635980	rs189400382	0.908005923693783	C-reactive protein levels	1e-08	35459240
rs11635980	rs13379492	0.813668509907942	Lung function (FEV1/FVC)	6e-08	30595370
rs11643057	rs2270365	0.79092487182595	NmrA-like family domain-containing protein 1 levels	4e-12	34648354
rs11643057	rs12598836	0.753318782235496	Migraine	2e-10	35115687
rs11643057	rs8046785	0.731124641940406	Waist-hip index	4e-08	34021172
rs11643057	rs8046785	0.731124641940406	Waist-to-hip ratio adjusted for BMI	3e-08	34021172
rs11643057	rs8046785	0.731124641940406	Hip circumference adjusted for BMI	4e-08	34021172
rs11643057	rs4424915	0.703145708004559	Hair color	5e-08	30595370
rs11643057	rs1641868	0.651630085697723	A body shape index	3e-10	34021172
rs11650082	rs12949545	0.805807523410727	Highest math class taken (MTAG)	3e-08	30038396
rs11651785	rs12949545	0.980924133530384	Highest math class taken (MTAG)	3e-08	30038396
rs11652908	rs732222	0.675054881338268	Galectin-9 levels	5e-41	34814699
rs11652908	rs4239242	0.621826964763662	Serum levels of protein LGALS9	5e-20	35078996
rs11652908	rs74321993	0.616623799099265	Galectin-9 levels	2e-35	34648354
rs11652908	rs62055780	0.611986573424371	Blood protein levels	8e-12	30072576
rs11652908	rs4794974	0.609200860103804	Galectin-9 levels	1e-75	36349687
rs11665675	rs1989455	0.678385517866328	Height	2e-31	36224396
rs11671293	rs28377509	0.994395192610248	Platelet count	2e-26	32888493
rs11671293	rs6509933	0.60753271227956	OTU99_54 (Holdemanella) abundance	6e-06	33462482
rs11677775	rs12617371	0.928506238336092	Immature fraction of reticulocytes	8e-18	32888494
rs11677775	rs777587	0.91684471215469	Proteoglycan 3 levels	6e-29	34648354
rs11677775	rs777587	0.91684471215469	Pappalysin-1 levels	1e-25	34648354
rs11677775	rs2463097	0.888375914630234	White blood cell count	3e-26	30595370
rs11677775	rs10199672	0.873782784771902	Height	6e-12	34594039
rs11677775	rs10199672	0.873782784771902	Height	2e-12	31562340
rs11677775	rs2593620	0.865716921434634	Serum levels of protein PRG3	5e-14	35078996
rs11677775	rs2421200	0.842100358752292	Neutrophil count	1e-26	32888493
rs11677775	rs2421200	0.842100358752292	Neutrophil count	1e-25	32888493
rs11677775	rs11685226	0.80794303643371	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs11677775	rs11685226	0.80794303643371	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11677775	rs1177308	0.799345906841595	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11677775	rs1177308	0.799345906841595	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11677775	rs7558954	0.795554448385242	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11677775	rs10169482	0.777924189709614	C-reactive protein levels	4e-09	33462484
rs11677775	rs2950269	0.725236351940131	Eosinophil side fluorescence	3e-18	37596262
rs11677775	rs12616433	0.717338092493261	Eosinophil forward scatter	4e-13	37596262
rs11677775	rs12616433	0.717338092493261	Eosinophil side scatter	2e-18	37596262
rs11680338	rs6705511	0.733204345256426	Self-reported math ability	4e-09	30038396
rs11680338	rs6705511	0.733204345256426	Self-reported math ability (MTAG)	3e-10	30038396
rs11680338	rs34276187	0.727022295007494	Highest math class taken (MTAG)	2e-08	30038396
rs11683025	rs11889663	0.986397924958345	C-reactive protein levels (MTAG)	2e-12	36376304
rs11683025	rs17626434	0.858446113735327	C-reactive protein levels	8e-12	31900758
rs11683487	rs6705511	0.684288886266676	Self-reported math ability	4e-09	30038396
rs11683487	rs6705511	0.684288886266676	Self-reported math ability (MTAG)	3e-10	30038396
rs11683487	rs34276187	0.678579850399691	Highest math class taken (MTAG)	2e-08	30038396
rs11685226	rs11685226	1	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs11685226	rs11685226	1	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11685226	rs7558954	0.970140608806709	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11685226	rs1177308	0.969264094290767	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11685226	rs1177308	0.969264094290767	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11685226	rs777587	0.822547485090148	Proteoglycan 3 levels	6e-29	34648354
rs11685226	rs777587	0.822547485090148	Pappalysin-1 levels	1e-25	34648354
rs11685226	rs12617371	0.781134249779905	Immature fraction of reticulocytes	8e-18	32888494
rs11685226	rs2463097	0.747800276006198	White blood cell count	3e-26	30595370
rs11685226	rs2593620	0.723161075291974	Serum levels of protein PRG3	5e-14	35078996
rs11685226	rs10199672	0.715789881586892	Height	6e-12	34594039
rs11685226	rs10199672	0.715789881586892	Height	2e-12	31562340
rs11685226	rs2421200	0.694573978940695	Neutrophil count	1e-26	32888493
rs11685226	rs2421200	0.694573978940695	Neutrophil count	1e-25	32888493
rs11685226	rs10169482	0.641198574459674	C-reactive protein levels	4e-09	33462484
rs11685226	rs12616433	0.619075999423864	Eosinophil forward scatter	4e-13	37596262
rs11685226	rs12616433	0.619075999423864	Eosinophil side scatter	2e-18	37596262
rs11686031	rs11686031	1	Human papilloma virus 16 positive oropharyngeal cancer	5e-06	34642315
rs11688322	rs1177308	0.856252791894577	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11688322	rs1177308	0.856252791894577	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11688322	rs7558954	0.855721429410156	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11688322	rs11685226	0.854577649889773	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs11688322	rs11685226	0.854577649889773	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11688322	rs777587	0.717364338972601	Proteoglycan 3 levels	6e-29	34648354
rs11688322	rs777587	0.717364338972601	Pappalysin-1 levels	1e-25	34648354
rs11688322	rs12617371	0.689138712682328	Immature fraction of reticulocytes	8e-18	32888494
rs11688322	rs2463097	0.659153566593935	White blood cell count	3e-26	30595370
rs11688322	rs10199672	0.636221500470274	Height	6e-12	34594039
rs11688322	rs10199672	0.636221500470274	Height	2e-12	31562340
rs11688322	rs2593620	0.63379334298312	Serum levels of protein PRG3	5e-14	35078996
rs11688322	rs2421200	0.609935543230443	Neutrophil count	1e-26	32888493
rs11688322	rs2421200	0.609935543230443	Neutrophil count	1e-25	32888493
rs11689249	rs12620999	0.816216906617039	Systemic lupus erythematosus	3e-06	19838195
rs11691055	rs6705511	0.735761353153999	Self-reported math ability	4e-09	30038396
rs11691055	rs6705511	0.735761353153999	Self-reported math ability (MTAG)	3e-10	30038396
rs11691055	rs34276187	0.729866516489957	Highest math class taken (MTAG)	2e-08	30038396
rs11691217	rs6705511	0.733204345256426	Self-reported math ability	4e-09	30038396
rs11691217	rs6705511	0.733204345256426	Self-reported math ability (MTAG)	3e-10	30038396
rs11691217	rs34276187	0.727022295007494	Highest math class taken (MTAG)	2e-08	30038396
rs1169470	rs770199	0.874504160302511	Hair color	3e-08	30595370
rs1169474	rs770199	0.874802284498468	Hair color	3e-08	30595370
rs11708336	rs11715071	0.98453857880939	Body mass index	3e-08	36581621
rs11712139	rs11705721	0.998771724238106	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11712139	rs11130638	0.996316683230996	Hemoglobin concentration	2e-23	32888493
rs11712139	rs34579268	0.989002539022943	Hematocrit	5e-30	32888493
rs11712139	rs34579268	0.989002539022943	Hematocrit	2e-27	32888493
rs11712139	rs34579268	0.989002539022943	Hemoglobin concentration	5e-26	32888493
rs11712139	rs7610312	0.975551083510437	Red blood cell count	5e-09	27863252
rs11712139	rs6775517	0.974315497774772	Hematocrit	1e-17	34594039
rs11712139	rs57700771	0.969463276187608	Red blood cell count	9e-21	30595370
rs11712139	rs55704295	0.902468134481723	Red blood cell count	8e-26	32888493
rs11712139	rs55704295	0.902468134481723	Red blood cell count	5e-23	32888493
rs11712139	rs55704295	0.902468134481723	Serum total protein level	2e-29	34594039
rs11712139	rs4681679	0.873028382868029	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11712139	rs11719450	0.847197913735465	Hemoglobin concentration	2e-09	27863252
rs11712139	rs11719450	0.847197913735465	Hemoglobin levels	2e-16	32327693
rs11712139	rs56384862	0.836055048829766	Body mass index	8e-12	29273807
rs11712139	rs56384862	0.836055048829766	Body mass index	3e-06	30108127
rs11712139	rs56384862	0.836055048829766	Hemoglobin levels	1e-16	32327693
rs11712139	rs56384862	0.836055048829766	Body mass index	3e-14	36581621
rs11712139	rs11922478	0.833354314963673	Semaphorin-6B levels	4e-12	34648354
rs11712139	rs55692656	0.815765007871067	vWF levels	3e-08	30586737
rs11712139	rs55692656	0.815765007871067	vWF levels	6e-09	30586737
rs11712139	rs6445969	0.68676266138349	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11712139	rs11708895	0.68288509618066	Red blood cell count	1e-20	32888494
rs11712139	rs55954186	0.678591091271848	vWF levels	5e-09	30586737
rs11712139	rs55954186	0.678591091271848	vWF levels	9e-09	30586737
rs11712139	rs7431952	0.616692623739664	Hemoglobin levels	1e-12	32327693
rs11712213	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11712213	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs11712213	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs11712213	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs11712213	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs11712213	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs11712213	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs11712213	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs11712213	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs11712213	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs11712213	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs11712213	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11712213	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs11712213	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs11712213	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs11712213	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs11712213	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs11712213	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs11712213	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs11712213	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs11712213	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs11712213	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11712213	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs11712213	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs11712213	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs11712213	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs11712486	rs17648188	0.758839007229293	Hepatocyte growth factor-like protein levels	4e-11	36168886
rs11713965	rs11715071	0.998965848200729	Body mass index	3e-08	36581621
rs11714120	rs11715071	1	Body mass index	3e-08	36581621
rs11714389	rs34579268	0.952652033364436	Hematocrit	5e-30	32888493
rs11714389	rs34579268	0.952652033364436	Hematocrit	2e-27	32888493
rs11714389	rs34579268	0.952652033364436	Hemoglobin concentration	5e-26	32888493
rs11714389	rs11705721	0.945172508064527	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11714389	rs11130638	0.945172508064527	Hemoglobin concentration	2e-23	32888493
rs11714389	rs7610312	0.921636130813003	Red blood cell count	5e-09	27863252
rs11714389	rs6775517	0.920540748201261	Hematocrit	1e-17	34594039
rs11714389	rs57700771	0.915544743043459	Red blood cell count	9e-21	30595370
rs11714389	rs11719450	0.889702516562743	Hemoglobin concentration	2e-09	27863252
rs11714389	rs11719450	0.889702516562743	Hemoglobin levels	2e-16	32327693
rs11714389	rs11922478	0.877803280857418	Semaphorin-6B levels	4e-12	34648354
rs11714389	rs4681679	0.860478903787736	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11714389	rs55704295	0.849926998094376	Red blood cell count	8e-26	32888493
rs11714389	rs55704295	0.849926998094376	Red blood cell count	5e-23	32888493
rs11714389	rs55704295	0.849926998094376	Serum total protein level	2e-29	34594039
rs11714389	rs56384862	0.827341238501781	Body mass index	8e-12	29273807
rs11714389	rs56384862	0.827341238501781	Body mass index	3e-06	30108127
rs11714389	rs56384862	0.827341238501781	Hemoglobin levels	1e-16	32327693
rs11714389	rs56384862	0.827341238501781	Body mass index	3e-14	36581621
rs11714389	rs55692656	0.771316989439116	vWF levels	3e-08	30586737
rs11714389	rs55692656	0.771316989439116	vWF levels	6e-09	30586737
rs11714389	rs55954186	0.700832735127738	vWF levels	5e-09	30586737
rs11714389	rs55954186	0.700832735127738	vWF levels	9e-09	30586737
rs11714389	rs11708895	0.698211637161504	Red blood cell count	1e-20	32888494
rs11714389	rs6445969	0.676776251074341	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11714389	rs7431952	0.607581297676037	Hemoglobin levels	1e-12	32327693
rs11714807	rs11705721	0.998771724238106	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11714807	rs11130638	0.996316683230996	Hemoglobin concentration	2e-23	32888493
rs11714807	rs34579268	0.989002539022943	Hematocrit	5e-30	32888493
rs11714807	rs34579268	0.989002539022943	Hematocrit	2e-27	32888493
rs11714807	rs34579268	0.989002539022943	Hemoglobin concentration	5e-26	32888493
rs11714807	rs7610312	0.975551083510437	Red blood cell count	5e-09	27863252
rs11714807	rs6775517	0.974315497774772	Hematocrit	1e-17	34594039
rs11714807	rs57700771	0.969463276187608	Red blood cell count	9e-21	30595370
rs11714807	rs55704295	0.902468134481723	Red blood cell count	8e-26	32888493
rs11714807	rs55704295	0.902468134481723	Red blood cell count	5e-23	32888493
rs11714807	rs55704295	0.902468134481723	Serum total protein level	2e-29	34594039
rs11714807	rs4681679	0.873028382868029	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11714807	rs11719450	0.847197913735465	Hemoglobin concentration	2e-09	27863252
rs11714807	rs11719450	0.847197913735465	Hemoglobin levels	2e-16	32327693
rs11714807	rs56384862	0.836055048829766	Body mass index	8e-12	29273807
rs11714807	rs56384862	0.836055048829766	Body mass index	3e-06	30108127
rs11714807	rs56384862	0.836055048829766	Hemoglobin levels	1e-16	32327693
rs11714807	rs56384862	0.836055048829766	Body mass index	3e-14	36581621
rs11714807	rs11922478	0.833354314963673	Semaphorin-6B levels	4e-12	34648354
rs11714807	rs55692656	0.815765007871067	vWF levels	3e-08	30586737
rs11714807	rs55692656	0.815765007871067	vWF levels	6e-09	30586737
rs11714807	rs6445969	0.68676266138349	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11714807	rs11708895	0.68288509618066	Red blood cell count	1e-20	32888494
rs11714807	rs55954186	0.678591091271848	vWF levels	5e-09	30586737
rs11714807	rs55954186	0.678591091271848	vWF levels	9e-09	30586737
rs11714807	rs7431952	0.616692623739664	Hemoglobin levels	1e-12	32327693
rs11715054	rs11715071	0.998965337354587	Body mass index	3e-08	36581621
rs11715071	rs11715071	1	Body mass index	3e-08	36581621
rs1171600	rs1171602	0.970783796709008	Platelet distribution width	7e-16	32888494
rs1171602	rs1171602	1	Platelet distribution width	7e-16	32888494
rs11718114	rs11715071	0.998965848200729	Body mass index	3e-08	36581621
rs11718352	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11718352	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs11718352	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs11718352	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs11718352	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs11718352	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs11718352	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs11718352	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs11718352	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs11718352	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs11718352	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs11718352	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11718352	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs11718352	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs11718352	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs11718352	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs11718352	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs11718352	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs11718352	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs11718352	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs11718352	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs11718352	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11718352	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs11718352	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs11718352	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs11718352	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs11719192	rs34579268	0.95871273299168	Hematocrit	5e-30	32888493
rs11719192	rs34579268	0.95871273299168	Hematocrit	2e-27	32888493
rs11719192	rs34579268	0.95871273299168	Hemoglobin concentration	5e-26	32888493
rs11719192	rs11705721	0.95121527300604	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11719192	rs11130638	0.95121527300604	Hemoglobin concentration	2e-23	32888493
rs11719192	rs7610312	0.927622361836393	Red blood cell count	5e-09	27863252
rs11719192	rs6775517	0.926518533697862	Hematocrit	1e-17	34594039
rs11719192	rs57700771	0.921513384962667	Red blood cell count	9e-21	30595370
rs11719192	rs11719450	0.888370053326894	Hemoglobin concentration	2e-09	27863252
rs11719192	rs11719450	0.888370053326894	Hemoglobin levels	2e-16	32327693
rs11719192	rs11922478	0.8764591016744	Semaphorin-6B levels	4e-12	34648354
rs11719192	rs4681679	0.863968107658352	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11719192	rs55704295	0.855743196024625	Red blood cell count	8e-26	32888493
rs11719192	rs55704295	0.855743196024625	Red blood cell count	5e-23	32888493
rs11719192	rs55704295	0.855743196024625	Serum total protein level	2e-29	34594039
rs11719192	rs56384862	0.830775211639981	Body mass index	8e-12	29273807
rs11719192	rs56384862	0.830775211639981	Body mass index	3e-06	30108127
rs11719192	rs56384862	0.830775211639981	Hemoglobin levels	1e-16	32327693
rs11719192	rs56384862	0.830775211639981	Body mass index	3e-14	36581621
rs11719192	rs55692656	0.772354360944702	vWF levels	3e-08	30586737
rs11719192	rs55692656	0.772354360944702	vWF levels	6e-09	30586737
rs11719192	rs55954186	0.70171137281945	vWF levels	5e-09	30586737
rs11719192	rs55954186	0.70171137281945	vWF levels	9e-09	30586737
rs11719192	rs11708895	0.6990887461095	Red blood cell count	1e-20	32888494
rs11719192	rs6445969	0.679935888185189	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11719192	rs7431952	0.610600607383583	Hemoglobin levels	1e-12	32327693
rs11721168	rs34579268	0.996332630637603	Hematocrit	5e-30	32888493
rs11721168	rs34579268	0.996332630637603	Hematocrit	2e-27	32888493
rs11721168	rs34579268	0.996332630637603	Hemoglobin concentration	5e-26	32888493
rs11721168	rs11705721	0.991452203371308	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11721168	rs11130638	0.989011479737702	Hemoglobin concentration	2e-23	32888493
rs11721168	rs7610312	0.968401735627337	Red blood cell count	5e-09	27863252
rs11721168	rs6775517	0.967167894712518	Hematocrit	1e-17	34594039
rs11721168	rs57700771	0.962354888765282	Red blood cell count	9e-21	30595370
rs11721168	rs55704295	0.89585437662129	Red blood cell count	8e-26	32888493
rs11721168	rs55704295	0.89585437662129	Red blood cell count	5e-23	32888493
rs11721168	rs55704295	0.89585437662129	Serum total protein level	2e-29	34594039
rs11721168	rs4681679	0.866623218452849	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11721168	rs11719450	0.855134687439518	Hemoglobin concentration	2e-09	27863252
rs11721168	rs11719450	0.855134687439518	Hemoglobin levels	2e-16	32327693
rs11721168	rs11922478	0.841350181507995	Semaphorin-6B levels	4e-12	34648354
rs11721168	rs56384862	0.829924447396528	Body mass index	8e-12	29273807
rs11721168	rs56384862	0.829924447396528	Body mass index	3e-06	30108127
rs11721168	rs56384862	0.829924447396528	Hemoglobin levels	1e-16	32327693
rs11721168	rs56384862	0.829924447396528	Body mass index	3e-14	36581621
rs11721168	rs55692656	0.809465095066586	vWF levels	3e-08	30586737
rs11721168	rs55692656	0.809465095066586	vWF levels	6e-09	30586737
rs11721168	rs6445969	0.681719408895529	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11721168	rs11708895	0.677880557515999	Red blood cell count	1e-20	32888494
rs11721168	rs55954186	0.673618021317974	vWF levels	5e-09	30586737
rs11721168	rs55954186	0.673618021317974	vWF levels	9e-09	30586737
rs11721168	rs7431952	0.612139699205181	Hemoglobin levels	1e-12	32327693
rs11730	rs6705511	0.694182009848296	Self-reported math ability	4e-09	30038396
rs11730	rs6705511	0.694182009848296	Self-reported math ability (MTAG)	3e-10	30038396
rs11730	rs34276187	0.68839980519794	Highest math class taken (MTAG)	2e-08	30038396
rs1173416	rs1173416	1	Height	2e-59	36224396
rs1173416	rs2842611	0.842223499580091	High density lipoprotein cholesterol levels	5e-09	34887591
rs1173416	rs9450288	0.808227943687902	Height	2e-10	36224396
rs1173418	rs1173416	0.949031830477023	Height	2e-59	36224396
rs1173418	rs2842611	0.883552533676973	High density lipoprotein cholesterol levels	5e-09	34887591
rs1173418	rs9450288	0.841771723007375	Height	2e-10	36224396
rs11749121	rs56373295	0.607601295116252	Plateletcrit	2e-15	32888494
rs11749347	rs6891834	0.711743353329593	Height	2e-31	36224396
rs11750025	rs1974871	0.914373252076738	Granulysin levels	5e-13	34648354
rs11750025	rs4869314	0.904031415730621	Arthritis (juvenile idiopathic)	3e-09	33106285
rs11750025	rs4869314	0.904031415730621	Neutrophil count	1e-10	34594039
rs11750025	rs4869314	0.904031415730621	White blood cell count	2e-07	30595370
rs11750025	rs2549782	0.847872277116823	Systolic blood pressure	6e-07	33230300
rs11750025	rs2549782	0.847872277116823	Diastolic blood pressure	1e-14	33230300
rs11750025	rs2549782	0.847872277116823	Diastolic blood pressure	3e-11	33230300
rs11750025	rs2549782	0.847872277116823	Systolic blood pressure	5e-09	33230300
rs11750025	rs2549797	0.847859148252041	Systolic blood pressure	7e-07	33230300
rs11750025	rs2549797	0.847859148252041	Diastolic blood pressure	1e-14	33230300
rs11750025	rs2549797	0.847859148252041	Diastolic blood pressure	3e-11	33230300
rs11750025	rs2549797	0.847859148252041	Systolic blood pressure	4e-09	33230300
rs11750025	rs1056893	0.845648327079026	Systolic blood pressure	1e-06	33230300
rs11750025	rs1056893	0.845648327079026	Diastolic blood pressure	7e-15	33230300
rs11750025	rs1056893	0.845648327079026	Diastolic blood pressure	2e-11	33230300
rs11750025	rs1056893	0.845648327079026	Systolic blood pressure	7e-09	33230300
rs11750025	rs4869313	0.826865311559686	Pediatric autoimmune diseases	9e-08	26301688
rs11750025	rs1559359	0.81916393600306	Diastolic blood pressure	7e-10	34594039
rs11750025	rs2910686	0.80107740721686	Neutrophil count	4e-14	32888493
rs11750025	rs2910686	0.80107740721686	Psoriasis	2e-08	23143594
rs11750025	rs2910686	0.80107740721686	Ankylosing spondylitis	5e-17	23749187
rs11750025	rs2910686	0.80107740721686	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs11750025	rs2927608	0.799744353671514	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs11750025	rs2927608	0.799744353671514	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs11750025	rs2927608	0.799744353671514	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs11750025	rs1019503	0.728197499974739	Systolic blood pressure	2e-06	33230300
rs11750025	rs1019503	0.728197499974739	Diastolic blood pressure	2e-14	33230300
rs11750025	rs1019503	0.728197499974739	Diastolic blood pressure	4e-11	33230300
rs11750025	rs1019503	0.728197499974739	Systolic blood pressure	1e-08	33230300
rs11750025	rs3096168	0.722672791507237	Aspartate aminotransferase levels	8e-12	33547301
rs11750025	rs1423357	0.702943686573764	General cognitive ability	9e-06	29844566
rs11750025	rs2432142	0.689063892401146	Neutrophil count	2e-14	32888493
rs11750025	rs2432142	0.689063892401146	White blood cell count	1e-11	32888493
rs11750025	rs38033	0.683569861451389	Blood protein levels	0	30072576
rs11750025	rs27293	0.673552042114302	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs11750025	rs27293	0.673552042114302	Diastolic blood pressure	3e-11	35762941
rs11750025	rs7705093	0.664829960196814	Birdshot chorioretinopathy	2e-09	24957906
rs11752251	rs2842611	0.666950769519387	High density lipoprotein cholesterol levels	5e-09	34887591
rs11752251	rs1173416	0.649274740077363	Height	2e-59	36224396
rs11752251	rs9450288	0.643316836332997	Height	2e-10	36224396
rs11752795	rs2842611	0.98478423620542	High density lipoprotein cholesterol levels	5e-09	34887591
rs11752795	rs1173416	0.830282131517997	Height	2e-59	36224396
rs11752795	rs9450288	0.808635462636857	Height	2e-10	36224396
rs11754574	rs9462030	0.994373913660559	Red cell distribution width	5e-25	32888493
rs11754574	rs9469857	0.984761860276752	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs11754574	rs2764208	0.983972294036617	Systemic lupus erythematosus	7e-06	24871463
rs11754574	rs9469899	0.977693690324335	Prostate cancer (advanced)	2e-06	29892016
rs11754574	rs9469899	0.977693690324335	Prostate cancer	5e-09	29892016
rs11754574	rs9469899	0.977693690324335	Prostate cancer	8e-11	33398198
rs11754574	rs9469899	0.977693690324335	Hand grip strength	3e-15	29691431
rs11754574	rs9469899	0.977693690324335	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs11754574	rs9469899	0.977693690324335	Graves' disease	4e-10	34594039
rs11754574	rs9469899	0.977693690324335	Coronary artery disease	1e-11	36474045
rs11754574	rs9469899	0.977693690324335	Predicted visceral adipose tissue	2e-20	31501611
rs11754574	rs9469899	0.977693690324335	Medication use (thyroid preparations)	2e-09	31015401
rs11754574	rs9469899	0.977693690324335	Medication use (thyroid preparations)	3e-10	34594039
rs11754574	rs9469872	0.948616480320373	HDL cholesterol levels	3e-11	36333282
rs11754574	rs11755393	0.946752658211181	Body mass index	3e-26	29273807
rs11754574	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-12	33493351
rs11754574	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-06	33493351
rs11754574	rs11755393	0.946752658211181	Systemic lupus erythematosus	1e-07	33493351
rs11754574	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-08	19838195
rs11754574	rs11755393	0.946752658211181	Body mass index	4e-55	36581621
rs11754574	rs9366863	0.938413835677258	Adult body size	9e-33	32376654
rs11754574	rs9366863	0.938413835677258	Body mass index	2e-44	30595370
rs11754574	rs6941110	0.935247375317915	Sex hormone-binding globulin levels	5e-27	36653534
rs11754574	rs9296128	0.934198692532671	Hip circumference adjusted for BMI	4e-13	34021172
rs11754574	rs2814949	0.902335914866459	Essential hypertension (time to event)	9e-09	32589924
rs11754574	rs2744944	0.893023538028903	Hypothyroidism	3e-10	34594039
rs11754574	rs2744944	0.893023538028903	High density lipoprotein cholesterol levels	3e-86	34887591
rs11754574	rs2744944	0.893023538028903	Multi-trait sex score	7e-22	37277458
rs11754574	rs2263329	0.873890090753199	HDL cholesterol	6e-35	34594039
rs11754574	rs2263329	0.873890090753199	HDL cholesterol levels	8e-43	32203549
rs11754574	rs2263329	0.873890090753199	High density lipoprotein cholesterol levels	2e-52	34887591
rs11754574	rs111868030	0.850215739645168	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs11754574	rs9368830	0.829314976366607	HDL cholesterol	4e-21	30275531
rs11754574	rs9368828	0.80294162376271	Body mass index	1e-34	34594039
rs11754574	rs2744973	0.799489696126742	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs11754574	rs2744973	0.799489696126742	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs11754574	rs2744973	0.799489696126742	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs11754574	rs2744973	0.799489696126742	Multi-trait sex score	6e-20	37277458
rs11754574	rs6912327	0.791347099634255	Fasting insulin	5e-06	33402679
rs11754574	rs6912327	0.791347099634255	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs11754574	rs112283401	0.770469283630436	Red cell distribution width	4e-27	30595370
rs11754574	rs9689160	0.627068448532794	Lung function (forced vital capacity)	3e-14	36914875
rs11755393	rs11755393	1	Body mass index	3e-26	29273807
rs11755393	rs11755393	1	Systemic lupus erythematosus	2e-12	33493351
rs11755393	rs11755393	1	Systemic lupus erythematosus	2e-06	33493351
rs11755393	rs11755393	1	Systemic lupus erythematosus	1e-07	33493351
rs11755393	rs11755393	1	Systemic lupus erythematosus	2e-08	19838195
rs11755393	rs11755393	1	Body mass index	4e-55	36581621
rs11755393	rs9469872	0.973790640397902	HDL cholesterol levels	3e-11	36333282
rs11755393	rs9366863	0.963539594764905	Adult body size	9e-33	32376654
rs11755393	rs9366863	0.963539594764905	Body mass index	2e-44	30595370
rs11755393	rs6941110	0.96042432428924	Sex hormone-binding globulin levels	5e-27	36653534
rs11755393	rs9462030	0.942982809247869	Red cell distribution width	5e-25	32888493
rs11755393	rs9469857	0.933717288059645	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs11755393	rs2764208	0.933006118158596	Systemic lupus erythematosus	7e-06	24871463
rs11755393	rs2814949	0.926776227817379	Essential hypertension (time to event)	9e-09	32589924
rs11755393	rs9469899	0.926155764655461	Prostate cancer (advanced)	2e-06	29892016
rs11755393	rs9469899	0.926155764655461	Prostate cancer	5e-09	29892016
rs11755393	rs9469899	0.926155764655461	Prostate cancer	8e-11	33398198
rs11755393	rs9469899	0.926155764655461	Hand grip strength	3e-15	29691431
rs11755393	rs9469899	0.926155764655461	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs11755393	rs9469899	0.926155764655461	Graves' disease	4e-10	34594039
rs11755393	rs9469899	0.926155764655461	Coronary artery disease	1e-11	36474045
rs11755393	rs9469899	0.926155764655461	Predicted visceral adipose tissue	2e-20	31501611
rs11755393	rs9469899	0.926155764655461	Medication use (thyroid preparations)	2e-09	31015401
rs11755393	rs9469899	0.926155764655461	Medication use (thyroid preparations)	3e-10	34594039
rs11755393	rs2744944	0.917569011329476	Hypothyroidism	3e-10	34594039
rs11755393	rs2744944	0.917569011329476	High density lipoprotein cholesterol levels	3e-86	34887591
rs11755393	rs2744944	0.917569011329476	Multi-trait sex score	7e-22	37277458
rs11755393	rs2263329	0.898569690885672	HDL cholesterol	6e-35	34594039
rs11755393	rs2263329	0.898569690885672	HDL cholesterol levels	8e-43	32203549
rs11755393	rs2263329	0.898569690885672	High density lipoprotein cholesterol levels	2e-52	34887591
rs11755393	rs9296128	0.88580748304751	Hip circumference adjusted for BMI	4e-13	34021172
rs11755393	rs111868030	0.875208207072485	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs11755393	rs9368830	0.850896311437697	HDL cholesterol	4e-21	30275531
rs11755393	rs9368828	0.822734322097911	Body mass index	1e-34	34594039
rs11755393	rs6912327	0.819151244554246	Fasting insulin	5e-06	33402679
rs11755393	rs6912327	0.819151244554246	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs11755393	rs112283401	0.796480925818498	Red cell distribution width	4e-27	30595370
rs11755393	rs2744973	0.768834665996764	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs11755393	rs2744973	0.768834665996764	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs11755393	rs2744973	0.768834665996764	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs11755393	rs2744973	0.768834665996764	Multi-trait sex score	6e-20	37277458
rs11755393	rs6940215	0.622666103131952	Insomnia	2e-10	35835914
rs11755393	rs6940215	0.622666103131952	Insomnia	1e-13	35835914
rs11755393	rs6940215	0.622666103131952	Hip circumference adjusted for BMI	8e-10	34021172
rs11755393	rs6940215	0.622666103131952	Multi-trait sex score	2e-23	37277458
rs11755393	rs6940215	0.622666103131952	Multi-trait sex score	4e-23	37277458
rs11755393	rs6457796	0.622569130911958	Insomnia	1e-08	30804565
rs11755393	rs6457796	0.622569130911958	Plateletcrit	9e-11	32888494
rs11755393	rs6457796	0.622569130911958	Systemic lupus erythematosus	3e-22	33272962
rs11755393	rs6457796	0.622569130911958	Body mass index	5e-13	30108127
rs11755393	rs6457796	0.622569130911958	Body mass index	1e-14	26426971
rs11755393	rs6457796	0.622569130911958	Educational attainment	5e-19	35361970
rs11755393	rs9469918	0.60659448079015	Hip circumference adjusted for BMI	8e-09	34021172
rs11755393	rs9469918	0.60659448079015	Hip circumference adjusted for BMI	2e-08	34021172
rs11755393	rs9469918	0.60659448079015	Multi-trait sex score	4e-08	37277458
rs11755420	rs9462030	0.991961796545434	Red cell distribution width	5e-25	32888493
rs11755420	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs11755420	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs11755420	rs9469899	0.975314640267064	Prostate cancer (advanced)	2e-06	29892016
rs11755420	rs9469899	0.975314640267064	Prostate cancer	5e-09	29892016
rs11755420	rs9469899	0.975314640267064	Prostate cancer	8e-11	33398198
rs11755420	rs9469899	0.975314640267064	Hand grip strength	3e-15	29691431
rs11755420	rs9469899	0.975314640267064	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs11755420	rs9469899	0.975314640267064	Graves' disease	4e-10	34594039
rs11755420	rs9469899	0.975314640267064	Coronary artery disease	1e-11	36474045
rs11755420	rs9469899	0.975314640267064	Predicted visceral adipose tissue	2e-20	31501611
rs11755420	rs9469899	0.975314640267064	Medication use (thyroid preparations)	2e-09	31015401
rs11755420	rs9469899	0.975314640267064	Medication use (thyroid preparations)	3e-10	34594039
rs11755420	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs11755420	rs11755393	0.944425765145638	Body mass index	3e-26	29273807
rs11755420	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-12	33493351
rs11755420	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-06	33493351
rs11755420	rs11755393	0.944425765145638	Systemic lupus erythematosus	1e-07	33493351
rs11755420	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-08	19838195
rs11755420	rs11755393	0.944425765145638	Body mass index	4e-55	36581621
rs11755420	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs11755420	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs11755420	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs11755420	rs6941110	0.932921349732261	Sex hormone-binding globulin levels	5e-27	36653534
rs11755420	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs11755420	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs11755420	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs11755420	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs11755420	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs11755420	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs11755420	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs11755420	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs11755420	rs9368830	0.831547762090701	HDL cholesterol	4e-21	30275531
rs11755420	rs9368828	0.805103390346437	Body mass index	1e-34	34594039
rs11755420	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs11755420	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs11755420	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs11755420	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs11755420	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs11755420	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs11755420	rs112283401	0.766845687865746	Red cell distribution width	4e-27	30595370
rs11755420	rs9689160	0.628913951683802	Lung function (forced vital capacity)	3e-14	36914875
rs11757370	rs9462030	0.991961796545434	Red cell distribution width	5e-25	32888493
rs11757370	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs11757370	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs11757370	rs9469899	0.975314640267064	Prostate cancer (advanced)	2e-06	29892016
rs11757370	rs9469899	0.975314640267064	Prostate cancer	5e-09	29892016
rs11757370	rs9469899	0.975314640267064	Prostate cancer	8e-11	33398198
rs11757370	rs9469899	0.975314640267064	Hand grip strength	3e-15	29691431
rs11757370	rs9469899	0.975314640267064	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs11757370	rs9469899	0.975314640267064	Graves' disease	4e-10	34594039
rs11757370	rs9469899	0.975314640267064	Coronary artery disease	1e-11	36474045
rs11757370	rs9469899	0.975314640267064	Predicted visceral adipose tissue	2e-20	31501611
rs11757370	rs9469899	0.975314640267064	Medication use (thyroid preparations)	2e-09	31015401
rs11757370	rs9469899	0.975314640267064	Medication use (thyroid preparations)	3e-10	34594039
rs11757370	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs11757370	rs11755393	0.944425765145638	Body mass index	3e-26	29273807
rs11757370	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-12	33493351
rs11757370	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-06	33493351
rs11757370	rs11755393	0.944425765145638	Systemic lupus erythematosus	1e-07	33493351
rs11757370	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-08	19838195
rs11757370	rs11755393	0.944425765145638	Body mass index	4e-55	36581621
rs11757370	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs11757370	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs11757370	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs11757370	rs6941110	0.932921349732261	Sex hormone-binding globulin levels	5e-27	36653534
rs11757370	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs11757370	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs11757370	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs11757370	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs11757370	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs11757370	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs11757370	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs11757370	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs11757370	rs9368830	0.831547762090701	HDL cholesterol	4e-21	30275531
rs11757370	rs9368828	0.805103390346437	Body mass index	1e-34	34594039
rs11757370	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs11757370	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs11757370	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs11757370	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs11757370	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs11757370	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs11757370	rs112283401	0.766845687865746	Red cell distribution width	4e-27	30595370
rs11757370	rs9689160	0.628913951683802	Lung function (forced vital capacity)	3e-14	36914875
rs11759151	rs9469872	0.990405711342429	HDL cholesterol levels	3e-11	36333282
rs11759151	rs11755393	0.983248753744816	Body mass index	3e-26	29273807
rs11759151	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-12	33493351
rs11759151	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-06	33493351
rs11759151	rs11755393	0.983248753744816	Systemic lupus erythematosus	1e-07	33493351
rs11759151	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-08	19838195
rs11759151	rs11755393	0.983248753744816	Body mass index	4e-55	36581621
rs11759151	rs9366863	0.980050279338797	Adult body size	9e-33	32376654
rs11759151	rs9366863	0.980050279338797	Body mass index	2e-44	30595370
rs11759151	rs6941110	0.972130533054557	Sex hormone-binding globulin levels	5e-27	36653534
rs11759151	rs9462030	0.954406403718491	Red cell distribution width	5e-25	32888493
rs11759151	rs9469857	0.949763837643909	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs11759151	rs2764208	0.949033981000713	Systemic lupus erythematosus	7e-06	24871463
rs11759151	rs2814949	0.943009894530421	Essential hypertension (time to event)	9e-09	32589924
rs11759151	rs9469899	0.937611946179886	Prostate cancer (advanced)	2e-06	29892016
rs11759151	rs9469899	0.937611946179886	Prostate cancer	5e-09	29892016
rs11759151	rs9469899	0.937611946179886	Prostate cancer	8e-11	33398198
rs11759151	rs9469899	0.937611946179886	Hand grip strength	3e-15	29691431
rs11759151	rs9469899	0.937611946179886	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs11759151	rs9469899	0.937611946179886	Graves' disease	4e-10	34594039
rs11759151	rs9469899	0.937611946179886	Coronary artery disease	1e-11	36474045
rs11759151	rs9469899	0.937611946179886	Predicted visceral adipose tissue	2e-20	31501611
rs11759151	rs9469899	0.937611946179886	Medication use (thyroid preparations)	2e-09	31015401
rs11759151	rs9469899	0.937611946179886	Medication use (thyroid preparations)	3e-10	34594039
rs11759151	rs2744944	0.933676458189598	Hypothyroidism	3e-10	34594039
rs11759151	rs2744944	0.933676458189598	High density lipoprotein cholesterol levels	3e-86	34887591
rs11759151	rs2744944	0.933676458189598	Multi-trait sex score	7e-22	37277458
rs11759151	rs2263329	0.914432373659788	HDL cholesterol	6e-35	34594039
rs11759151	rs2263329	0.914432373659788	HDL cholesterol levels	8e-43	32203549
rs11759151	rs2263329	0.914432373659788	High density lipoprotein cholesterol levels	2e-52	34887591
rs11759151	rs9296128	0.901155780048215	Hip circumference adjusted for BMI	4e-13	34021172
rs11759151	rs111868030	0.890460424513595	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs11759151	rs9368830	0.866839594529055	HDL cholesterol	4e-21	30275531
rs11759151	rs9368828	0.8378148480019	Body mass index	1e-34	34594039
rs11759151	rs6912327	0.829083022514325	Fasting insulin	5e-06	33402679
rs11759151	rs6912327	0.829083022514325	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs11759151	rs112283401	0.806269190971807	Red cell distribution width	4e-27	30595370
rs11759151	rs2744973	0.782572341748002	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs11759151	rs2744973	0.782572341748002	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs11759151	rs2744973	0.782572341748002	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs11759151	rs2744973	0.782572341748002	Multi-trait sex score	6e-20	37277458
rs11759151	rs6940215	0.634643562406843	Insomnia	2e-10	35835914
rs11759151	rs6940215	0.634643562406843	Insomnia	1e-13	35835914
rs11759151	rs6940215	0.634643562406843	Hip circumference adjusted for BMI	8e-10	34021172
rs11759151	rs6940215	0.634643562406843	Multi-trait sex score	2e-23	37277458
rs11759151	rs6940215	0.634643562406843	Multi-trait sex score	4e-23	37277458
rs11759151	rs6457796	0.626169994896438	Insomnia	1e-08	30804565
rs11759151	rs6457796	0.626169994896438	Plateletcrit	9e-11	32888494
rs11759151	rs6457796	0.626169994896438	Systemic lupus erythematosus	3e-22	33272962
rs11759151	rs6457796	0.626169994896438	Body mass index	5e-13	30108127
rs11759151	rs6457796	0.626169994896438	Body mass index	1e-14	26426971
rs11759151	rs6457796	0.626169994896438	Educational attainment	5e-19	35361970
rs11759151	rs9689160	0.605720875679005	Lung function (forced vital capacity)	3e-14	36914875
rs11759151	rs9469918	0.600168366795112	Hip circumference adjusted for BMI	8e-09	34021172
rs11759151	rs9469918	0.600168366795112	Hip circumference adjusted for BMI	2e-08	34021172
rs11759151	rs9469918	0.600168366795112	Multi-trait sex score	4e-08	37277458
rs11759548	rs12210271	0.926915970791343	ACE-inhibitor discontinuation	1e-19	35751511
rs11762644	rs13232536	0.851198713786371	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs11762644	rs4304220	0.850474395093578	Height	2e-14	36224396
rs11762644	rs4355658	0.831385635619404	Height	3e-13	36224396
rs11762644	rs7806956	0.613690157903892	Esophageal squamous cell carcinoma	3e-07	37673066
rs11763367	rs4304220	0.848847959892597	Height	2e-14	36224396
rs11763367	rs4355658	0.80168709653085	Height	3e-13	36224396
rs11763367	rs13232536	0.610020381295221	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs11763578	rs4304220	0.873755253658995	Height	2e-14	36224396
rs11763578	rs13232536	0.727544476006927	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs11763578	rs13227841	0.682920028824347	Asthma	2e-09	32514122
rs11763578	rs4355658	0.641789450989951	Height	3e-13	36224396
rs11764412	rs4304220	0.756999981499685	Height	2e-14	36224396
rs11764412	rs4355658	0.74683264552256	Height	3e-13	36224396
rs11764412	rs13232536	0.621421219030077	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs11764412	rs12539962	0.601514064788002	Colorectal cancer	3e-08	36539618
rs11770024	rs4304220	0.745440819090402	Height	2e-14	36224396
rs11770024	rs4355658	0.734422853469026	Height	3e-13	36224396
rs11770024	rs13232536	0.612309757326713	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs1177273	rs1177308	0.815580173934659	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177273	rs1177308	0.815580173934659	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177273	rs7558954	0.813507394582256	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177273	rs11685226	0.812551427290811	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177273	rs11685226	0.812551427290811	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177273	rs777587	0.678232942284426	Proteoglycan 3 levels	6e-29	34648354
rs1177273	rs777587	0.678232942284426	Pappalysin-1 levels	1e-25	34648354
rs1177273	rs12617371	0.65499434391219	Immature fraction of reticulocytes	8e-18	32888494
rs1177273	rs2463097	0.638755688746965	White blood cell count	3e-26	30595370
rs1177273	rs10199672	0.602386301734834	Height	6e-12	34594039
rs1177273	rs10199672	0.602386301734834	Height	2e-12	31562340
rs1177273	rs2593620	0.600308325232856	Serum levels of protein PRG3	5e-14	35078996
rs1177276	rs1177308	0.861636651311266	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177276	rs1177308	0.861636651311266	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177276	rs7558954	0.861093245677744	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177276	rs11685226	0.859998037307387	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177276	rs11685226	0.859998037307387	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177276	rs777587	0.720652448899268	Proteoglycan 3 levels	6e-29	34648354
rs1177276	rs777587	0.720652448899268	Pappalysin-1 levels	1e-25	34648354
rs1177276	rs12617371	0.695180301908347	Immature fraction of reticulocytes	8e-18	32888494
rs1177276	rs2463097	0.664989662835277	White blood cell count	3e-26	30595370
rs1177276	rs10199672	0.632715121301726	Height	6e-12	34594039
rs1177276	rs10199672	0.632715121301726	Height	2e-12	31562340
rs1177276	rs2593620	0.630345116210082	Serum levels of protein PRG3	5e-14	35078996
rs1177276	rs2421200	0.606593624309247	Neutrophil count	1e-26	32888493
rs1177276	rs2421200	0.606593624309247	Neutrophil count	1e-25	32888493
rs1177277	rs1177308	0.861636651311266	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177277	rs1177308	0.861636651311266	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177277	rs7558954	0.861093245677744	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177277	rs11685226	0.859998037307387	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177277	rs11685226	0.859998037307387	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177277	rs777587	0.720652448899268	Proteoglycan 3 levels	6e-29	34648354
rs1177277	rs777587	0.720652448899268	Pappalysin-1 levels	1e-25	34648354
rs1177277	rs12617371	0.695180301908347	Immature fraction of reticulocytes	8e-18	32888494
rs1177277	rs2463097	0.664989662835277	White blood cell count	3e-26	30595370
rs1177277	rs10199672	0.632715121301726	Height	6e-12	34594039
rs1177277	rs10199672	0.632715121301726	Height	2e-12	31562340
rs1177277	rs2593620	0.630345116210082	Serum levels of protein PRG3	5e-14	35078996
rs1177277	rs2421200	0.606593624309247	Neutrophil count	1e-26	32888493
rs1177277	rs2421200	0.606593624309247	Neutrophil count	1e-25	32888493
rs1177278	rs1177308	0.862401237294725	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177278	rs1177308	0.862401237294725	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177278	rs7558954	0.860285498851644	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177278	rs11685226	0.859197110550585	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177278	rs11685226	0.859197110550585	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177278	rs777587	0.719891351501641	Proteoglycan 3 levels	6e-29	34648354
rs1177278	rs777587	0.719891351501641	Pappalysin-1 levels	1e-25	34648354
rs1177278	rs12617371	0.694437729131295	Immature fraction of reticulocytes	8e-18	32888494
rs1177278	rs2463097	0.664254554475957	White blood cell count	3e-26	30595370
rs1177278	rs10199672	0.632016166675415	Height	6e-12	34594039
rs1177278	rs10199672	0.632016166675415	Height	2e-12	31562340
rs1177278	rs2593620	0.629657747807404	Serum levels of protein PRG3	5e-14	35078996
rs1177278	rs2421200	0.605927450294745	Neutrophil count	1e-26	32888493
rs1177278	rs2421200	0.605927450294745	Neutrophil count	1e-25	32888493
rs1177285	rs7558954	0.814200488231343	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177285	rs1177308	0.813151532953832	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177285	rs1177308	0.813151532953832	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177285	rs11685226	0.812900711771546	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177285	rs11685226	0.812900711771546	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177285	rs777587	0.681559402977797	Proteoglycan 3 levels	6e-29	34648354
rs1177285	rs777587	0.681559402977797	Pappalysin-1 levels	1e-25	34648354
rs1177285	rs12617371	0.658042855249066	Immature fraction of reticulocytes	8e-18	32888494
rs1177285	rs2463097	0.630294957368747	White blood cell count	3e-26	30595370
rs1177302	rs1177308	0.987521514961239	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177302	rs1177308	0.987521514961239	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177302	rs7558954	0.983358833036882	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177302	rs11685226	0.960359660121747	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177302	rs11685226	0.960359660121747	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177302	rs777587	0.803547170541459	Proteoglycan 3 levels	6e-29	34648354
rs1177302	rs777587	0.803547170541459	Pappalysin-1 levels	1e-25	34648354
rs1177302	rs12617371	0.762813022366709	Immature fraction of reticulocytes	8e-18	32888494
rs1177302	rs2463097	0.729551617110523	White blood cell count	3e-26	30595370
rs1177302	rs2593620	0.706147622876813	Serum levels of protein PRG3	5e-14	35078996
rs1177302	rs10199672	0.698534311621854	Height	6e-12	34594039
rs1177302	rs10199672	0.698534311621854	Height	2e-12	31562340
rs1177302	rs2421200	0.678178136182542	Neutrophil count	1e-26	32888493
rs1177302	rs2421200	0.678178136182542	Neutrophil count	1e-25	32888493
rs1177302	rs10169482	0.625783702288125	C-reactive protein levels	4e-09	33462484
rs1177302	rs12616433	0.604922503962538	Eosinophil forward scatter	4e-13	37596262
rs1177302	rs12616433	0.604922503962538	Eosinophil side scatter	2e-18	37596262
rs1177303	rs1177308	0.891705102673263	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177303	rs1177308	0.891705102673263	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177303	rs7558954	0.887944080881565	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177303	rs11685226	0.867848749782715	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177303	rs11685226	0.867848749782715	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177303	rs777587	0.724815766173406	Proteoglycan 3 levels	6e-29	34648354
rs1177303	rs777587	0.724815766173406	Pappalysin-1 levels	1e-25	34648354
rs1177303	rs12617371	0.685358093045474	Immature fraction of reticulocytes	8e-18	32888494
rs1177303	rs2463097	0.655390695767454	White blood cell count	3e-26	30595370
rs1177303	rs2593620	0.62897113557262	Serum levels of protein PRG3	5e-14	35078996
rs1177303	rs10199672	0.623358849860561	Height	6e-12	34594039
rs1177303	rs10199672	0.623358849860561	Height	2e-12	31562340
rs1177303	rs2421200	0.603953308773796	Neutrophil count	1e-26	32888493
rs1177303	rs2421200	0.603953308773796	Neutrophil count	1e-25	32888493
rs1177305	rs1177308	0.998326213499392	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177305	rs1177308	0.998326213499392	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177305	rs7558954	0.994156600829902	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177305	rs11685226	0.969246149509315	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177305	rs11685226	0.969246149509315	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177305	rs777587	0.812189430419427	Proteoglycan 3 levels	6e-29	34648354
rs1177305	rs777587	0.812189430419427	Pappalysin-1 levels	1e-25	34648354
rs1177305	rs12617371	0.772599643694912	Immature fraction of reticulocytes	8e-18	32888494
rs1177305	rs2463097	0.739273254666168	White blood cell count	3e-26	30595370
rs1177305	rs2593620	0.715283101710241	Serum levels of protein PRG3	5e-14	35078996
rs1177305	rs10199672	0.707772254995259	Height	6e-12	34594039
rs1177305	rs10199672	0.707772254995259	Height	2e-12	31562340
rs1177305	rs2421200	0.687004352259211	Neutrophil count	1e-26	32888493
rs1177305	rs2421200	0.687004352259211	Neutrophil count	1e-25	32888493
rs1177305	rs10169482	0.635312979298281	C-reactive protein levels	4e-09	33462484
rs1177305	rs12616433	0.612655235852763	Eosinophil forward scatter	4e-13	37596262
rs1177305	rs12616433	0.612655235852763	Eosinophil side scatter	2e-18	37596262
rs1177306	rs1177308	0.903324126337175	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177306	rs1177308	0.903324126337175	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177306	rs7558954	0.899551299709064	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177306	rs11685226	0.877613624974971	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177306	rs11685226	0.877613624974971	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177306	rs777587	0.734150739193158	Proteoglycan 3 levels	6e-29	34648354
rs1177306	rs777587	0.734150739193158	Pappalysin-1 levels	1e-25	34648354
rs1177306	rs12617371	0.695741407808437	Immature fraction of reticulocytes	8e-18	32888494
rs1177306	rs2463097	0.66566902999737	White blood cell count	3e-26	30595370
rs1177306	rs2593620	0.6386529591253	Serum levels of protein PRG3	5e-14	35078996
rs1177306	rs10199672	0.633129562767133	Height	6e-12	34594039
rs1177306	rs10199672	0.633129562767133	Height	2e-12	31562340
rs1177306	rs2421200	0.613324517907032	Neutrophil count	1e-26	32888493
rs1177306	rs2421200	0.613324517907032	Neutrophil count	1e-25	32888493
rs1177307	rs1177308	1	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177307	rs1177308	1	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177307	rs7558954	0.994153455910475	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177307	rs11685226	0.969264094290767	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177307	rs11685226	0.969264094290767	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177307	rs777587	0.81212280613882	Proteoglycan 3 levels	6e-29	34648354
rs1177307	rs777587	0.81212280613882	Pappalysin-1 levels	1e-25	34648354
rs1177307	rs12617371	0.772547045108143	Immature fraction of reticulocytes	8e-18	32888494
rs1177307	rs2463097	0.739198141897958	White blood cell count	3e-26	30595370
rs1177307	rs2593620	0.715274872510782	Serum levels of protein PRG3	5e-14	35078996
rs1177307	rs10199672	0.707740154719448	Height	6e-12	34594039
rs1177307	rs10199672	0.707740154719448	Height	2e-12	31562340
rs1177307	rs2421200	0.687015563520449	Neutrophil count	1e-26	32888493
rs1177307	rs2421200	0.687015563520449	Neutrophil count	1e-25	32888493
rs1177307	rs10169482	0.635165585310781	C-reactive protein levels	4e-09	33462484
rs1177307	rs12616433	0.612762474257459	Eosinophil forward scatter	4e-13	37596262
rs1177307	rs12616433	0.612762474257459	Eosinophil side scatter	2e-18	37596262
rs1177308	rs1177308	1	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177308	rs1177308	1	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177308	rs7558954	0.994153455910475	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177308	rs11685226	0.969264094290767	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177308	rs11685226	0.969264094290767	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177308	rs777587	0.81212280613882	Proteoglycan 3 levels	6e-29	34648354
rs1177308	rs777587	0.81212280613882	Pappalysin-1 levels	1e-25	34648354
rs1177308	rs12617371	0.772547045108143	Immature fraction of reticulocytes	8e-18	32888494
rs1177308	rs2463097	0.739198141897958	White blood cell count	3e-26	30595370
rs1177308	rs2593620	0.715274872510782	Serum levels of protein PRG3	5e-14	35078996
rs1177308	rs10199672	0.707740154719448	Height	6e-12	34594039
rs1177308	rs10199672	0.707740154719448	Height	2e-12	31562340
rs1177308	rs2421200	0.687015563520449	Neutrophil count	1e-26	32888493
rs1177308	rs2421200	0.687015563520449	Neutrophil count	1e-25	32888493
rs1177308	rs10169482	0.635165585310781	C-reactive protein levels	4e-09	33462484
rs1177308	rs12616433	0.612762474257459	Eosinophil forward scatter	4e-13	37596262
rs1177308	rs12616433	0.612762474257459	Eosinophil side scatter	2e-18	37596262
rs1177309	rs7558954	0.99665601112115	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177309	rs1177308	0.99248491660712	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177309	rs1177308	0.99248491660712	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1177309	rs11685226	0.970140608806709	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1177309	rs11685226	0.970140608806709	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1177309	rs777587	0.809726902910783	Proteoglycan 3 levels	6e-29	34648354
rs1177309	rs777587	0.809726902910783	Pappalysin-1 levels	1e-25	34648354
rs1177309	rs12617371	0.768787854000435	Immature fraction of reticulocytes	8e-18	32888494
rs1177309	rs2463097	0.735472666198727	White blood cell count	3e-26	30595370
rs1177309	rs2593620	0.711749987602683	Serum levels of protein PRG3	5e-14	35078996
rs1177309	rs10199672	0.70418487708206	Height	6e-12	34594039
rs1177309	rs10199672	0.70418487708206	Height	2e-12	31562340
rs1177309	rs2421200	0.684979630038931	Neutrophil count	1e-26	32888493
rs1177309	rs2421200	0.684979630038931	Neutrophil count	1e-25	32888493
rs1177309	rs10169482	0.634148754577131	C-reactive protein levels	4e-09	33462484
rs1177309	rs12616433	0.609734723770261	Eosinophil forward scatter	4e-13	37596262
rs1177309	rs12616433	0.609734723770261	Eosinophil side scatter	2e-18	37596262
rs1177610	rs770199	0.892749529592475	Hair color	3e-08	30595370
rs1177611	rs770199	0.891774495389377	Hair color	3e-08	30595370
rs11776549	rs4242434	0.932990590843518	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs11776549	rs11781149	0.862952051617437	Refractive error	2e-17	32231278
rs11776549	rs746011	0.817343063487315	Triglycerides	2e-10	30275531
rs11776549	rs1545837	0.790119555164369	Lung function (FVC)	1e-10	30595370
rs11776549	rs2280104	0.751973672826221	Parkinson's disease	3e-08	28892059
rs11776549	rs2280104	0.751973672826221	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs11776549	rs2280104	0.751973672826221	Serum total protein level	3e-12	34594039
rs11776549	rs4872007	0.713109538118105	Superior temporal gyrus volume	8e-06	31530798
rs11776549	rs11780207	0.678238364597818	Estimated glomerular filtration rate	2e-13	33462484
rs11776549	rs11780207	0.678238364597818	Serum total protein level	2e-09	33462484
rs11776549	rs11780207	0.678238364597818	Creatinine levels	2e-13	33462484
rs11776549	rs13271626	0.617201727483143	Haemorrhoidal disease	3e-10	33888516
rs1177697	rs1171602	0.964868518387977	Platelet distribution width	7e-16	32888494
rs11778782	rs4413755	0.882960774632752	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs11781149	rs11781149	1	Refractive error	2e-17	32231278
rs11781149	rs746011	0.929979255754999	Triglycerides	2e-10	30275531
rs11781149	rs1545837	0.862875745565629	Lung function (FVC)	1e-10	30595370
rs11781149	rs4242434	0.825988242743545	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs11781149	rs2280104	0.770109872756348	Parkinson's disease	3e-08	28892059
rs11781149	rs2280104	0.770109872756348	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs11781149	rs2280104	0.770109872756348	Serum total protein level	3e-12	34594039
rs11781149	rs4872007	0.725411289855309	Superior temporal gyrus volume	8e-06	31530798
rs11781149	rs13271626	0.722886333968177	Haemorrhoidal disease	3e-10	33888516
rs11781149	rs11778693	0.700411059629331	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs11781149	rs11778693	0.700411059629331	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs11781149	rs11780207	0.674933228568773	Estimated glomerular filtration rate	2e-13	33462484
rs11781149	rs11780207	0.674933228568773	Serum total protein level	2e-09	33462484
rs11781149	rs11780207	0.674933228568773	Creatinine levels	2e-13	33462484
rs11781149	rs34269854	0.673134018586233	Lung function (forced vital capacity)	3e-09	36914875
rs11781149	rs11782130	0.633032008319811	C-reactive protein levels	9e-09	35459240
rs11781149	rs4592028	0.62386955507058	Non-albumin protein levels	3e-09	33462484
rs11801791	rs11578888	0.991247294681936	Longevity	3e-06	31484785
rs11801791	rs7172	0.988847844949577	Protein quantitative trait loci (liver)	1e-12	32778093
rs11801791	rs4971040	0.937247818752573	Depression (broad)	2e-07	29662059
rs11804610	rs7545078	0.792956848910646	Smoking initiation	2e-09	36477530
rs11804610	rs6700087	0.75452065695527	Smoking initiation	6e-11	36477530
rs11807807	rs11580836	0.931027988593435	Body mass index	2e-09	36581621
rs11807807	rs10465746	0.911844899584594	Obesity-related traits	8e-06	23251661
rs1184912	rs770199	0.884993793411369	Hair color	3e-08	30595370
rs1185652	rs770199	0.893869901863626	Hair color	3e-08	30595370
rs11869450	rs2285583	0.952099299696155	AFP levels	2e-08	36329257
rs11869450	rs9897542	0.759938431707936	Total bilirubin levels	8e-11	34594039
rs11869450	rs178785	0.759246700235725	Lung function (FVC)	5e-09	30595370
rs11869450	rs4792716	0.713928189636166	Body mass index	2e-11	31669095
rs11869450	rs4792716	0.713928189636166	Adult body size	5e-09	32376654
rs11869450	rs1075901	0.711916290655206	Body mass index	4e-13	30239722
rs11869450	rs1075901	0.711916290655206	Body mass index	4e-13	30239722
rs11869450	rs1075901	0.711916290655206	Body mass index (MTAG)	7e-13	36376304
rs11869450	rs1075901	0.711916290655206	Body mass index	4e-14	36581621
rs11869450	rs1075901	0.711916290655206	Body mass index	4e-12	30595370
rs11869450	rs9916868	0.679304015700995	Weight	3e-09	34594039
rs11869450	rs178835	0.638958042347014	C-reactive protein levels	2e-13	31900758
rs11886950	rs777587	0.896529274939775	Proteoglycan 3 levels	6e-29	34648354
rs11886950	rs777587	0.896529274939775	Pappalysin-1 levels	1e-25	34648354
rs11886950	rs11685226	0.889195133507036	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs11886950	rs11685226	0.889195133507036	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11886950	rs7558954	0.868256810084875	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11886950	rs1177308	0.866064640293866	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11886950	rs1177308	0.866064640293866	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11886950	rs12617371	0.852638605508787	Immature fraction of reticulocytes	8e-18	32888494
rs11886950	rs2463097	0.815870398102655	White blood cell count	3e-26	30595370
rs11886950	rs2593620	0.798158417662417	Serum levels of protein PRG3	5e-14	35078996
rs11886950	rs10199672	0.785570566863931	Height	6e-12	34594039
rs11886950	rs10199672	0.785570566863931	Height	2e-12	31562340
rs11886950	rs2421200	0.768135523915884	Neutrophil count	1e-26	32888493
rs11886950	rs2421200	0.768135523915884	Neutrophil count	1e-25	32888493
rs11886950	rs10169482	0.702370450094956	C-reactive protein levels	4e-09	33462484
rs11886950	rs2950269	0.667329997269988	Eosinophil side fluorescence	3e-18	37596262
rs11886950	rs12616433	0.647029374654405	Eosinophil forward scatter	4e-13	37596262
rs11886950	rs12616433	0.647029374654405	Eosinophil side scatter	2e-18	37596262
rs11897994	rs11685226	0.898326779990635	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs11897994	rs11685226	0.898326779990635	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11897994	rs777587	0.893469287254554	Proteoglycan 3 levels	6e-29	34648354
rs11897994	rs777587	0.893469287254554	Pappalysin-1 levels	1e-25	34648354
rs11897994	rs7558954	0.877298443223808	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11897994	rs1177308	0.875088370432825	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11897994	rs1177308	0.875088370432825	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11897994	rs12617371	0.849618070828296	Immature fraction of reticulocytes	8e-18	32888494
rs11897994	rs2463097	0.813001768515945	White blood cell count	3e-26	30595370
rs11897994	rs2593620	0.792165507939773	Serum levels of protein PRG3	5e-14	35078996
rs11897994	rs10199672	0.782620353939498	Height	6e-12	34594039
rs11897994	rs10199672	0.782620353939498	Height	2e-12	31562340
rs11897994	rs2421200	0.763630750102805	Neutrophil count	1e-26	32888493
rs11897994	rs2421200	0.763630750102805	Neutrophil count	1e-25	32888493
rs11897994	rs10169482	0.698623132914034	C-reactive protein levels	4e-09	33462484
rs11897994	rs2950269	0.661671683350845	Eosinophil side fluorescence	3e-18	37596262
rs11897994	rs12616433	0.651963782263542	Eosinophil forward scatter	4e-13	37596262
rs11897994	rs12616433	0.651963782263542	Eosinophil side scatter	2e-18	37596262
rs11903270	rs777587	0.899637402646507	Proteoglycan 3 levels	6e-29	34648354
rs11903270	rs777587	0.899637402646507	Pappalysin-1 levels	1e-25	34648354
rs11903270	rs11685226	0.892333182904119	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs11903270	rs11685226	0.892333182904119	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11903270	rs7558954	0.871350957848674	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs11903270	rs1177308	0.869156262935102	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11903270	rs1177308	0.869156262935102	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs11903270	rs12617371	0.855671471514709	Immature fraction of reticulocytes	8e-18	32888494
rs11903270	rs2463097	0.818828296992793	White blood cell count	3e-26	30595370
rs11903270	rs2593620	0.798158417662417	Serum levels of protein PRG3	5e-14	35078996
rs11903270	rs10199672	0.788484066306582	Height	6e-12	34594039
rs11903270	rs10199672	0.788484066306582	Height	2e-12	31562340
rs11903270	rs2421200	0.768135523915884	Neutrophil count	1e-26	32888493
rs11903270	rs2421200	0.768135523915884	Neutrophil count	1e-25	32888493
rs11903270	rs10169482	0.703732298427863	C-reactive protein levels	4e-09	33462484
rs11903270	rs2950269	0.667329997269988	Eosinophil side fluorescence	3e-18	37596262
rs11903270	rs12616433	0.648375974104039	Eosinophil forward scatter	4e-13	37596262
rs11903270	rs12616433	0.648375974104039	Eosinophil side scatter	2e-18	37596262
rs11915190	rs34579268	0.997553208031117	Hematocrit	5e-30	32888493
rs11915190	rs34579268	0.997553208031117	Hematocrit	2e-27	32888493
rs11915190	rs34579268	0.997553208031117	Hemoglobin concentration	5e-26	32888493
rs11915190	rs11705721	0.992666190052037	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11915190	rs11130638	0.99022309179521	Hemoglobin concentration	2e-23	32888493
rs11915190	rs7610312	0.969587498092384	Red blood cell count	5e-09	27863252
rs11915190	rs6775517	0.968353367786582	Hematocrit	1e-17	34594039
rs11915190	rs57700771	0.963533857690389	Red blood cell count	9e-21	30595370
rs11915190	rs55704295	0.896951308250866	Red blood cell count	8e-26	32888493
rs11915190	rs55704295	0.896951308250866	Red blood cell count	5e-23	32888493
rs11915190	rs55704295	0.896951308250866	Serum total protein level	2e-29	34594039
rs11915190	rs4681679	0.867685553599419	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11915190	rs11719450	0.856182356625152	Hemoglobin concentration	2e-09	27863252
rs11915190	rs11719450	0.856182356625152	Hemoglobin levels	2e-16	32327693
rs11915190	rs11922478	0.84238097045896	Semaphorin-6B levels	4e-12	34648354
rs11915190	rs56384862	0.830941244618146	Body mass index	8e-12	29273807
rs11915190	rs56384862	0.830941244618146	Body mass index	3e-06	30108127
rs11915190	rs56384862	0.830941244618146	Hemoglobin levels	1e-16	32327693
rs11915190	rs56384862	0.830941244618146	Body mass index	3e-14	36581621
rs11915190	rs55692656	0.810509969156353	vWF levels	3e-08	30586737
rs11915190	rs55692656	0.810509969156353	vWF levels	6e-09	30586737
rs11915190	rs6445969	0.682555862731748	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11915190	rs11708895	0.678710590436549	Red blood cell count	1e-20	32888494
rs11915190	rs55954186	0.674442834963047	vWF levels	5e-09	30586737
rs11915190	rs55954186	0.674442834963047	vWF levels	9e-09	30586737
rs11915190	rs7431952	0.61289482913478	Hemoglobin levels	1e-12	32327693
rs11918453	rs34579268	0.952652033364436	Hematocrit	5e-30	32888493
rs11918453	rs34579268	0.952652033364436	Hematocrit	2e-27	32888493
rs11918453	rs34579268	0.952652033364436	Hemoglobin concentration	5e-26	32888493
rs11918453	rs11705721	0.945172508064527	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11918453	rs11130638	0.945172508064527	Hemoglobin concentration	2e-23	32888493
rs11918453	rs7610312	0.921636130813003	Red blood cell count	5e-09	27863252
rs11918453	rs6775517	0.920540748201261	Hematocrit	1e-17	34594039
rs11918453	rs57700771	0.915544743043459	Red blood cell count	9e-21	30595370
rs11918453	rs11719450	0.889702516562743	Hemoglobin concentration	2e-09	27863252
rs11918453	rs11719450	0.889702516562743	Hemoglobin levels	2e-16	32327693
rs11918453	rs11922478	0.877803280857418	Semaphorin-6B levels	4e-12	34648354
rs11918453	rs4681679	0.860478903787736	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11918453	rs55704295	0.849926998094376	Red blood cell count	8e-26	32888493
rs11918453	rs55704295	0.849926998094376	Red blood cell count	5e-23	32888493
rs11918453	rs55704295	0.849926998094376	Serum total protein level	2e-29	34594039
rs11918453	rs56384862	0.827341238501781	Body mass index	8e-12	29273807
rs11918453	rs56384862	0.827341238501781	Body mass index	3e-06	30108127
rs11918453	rs56384862	0.827341238501781	Hemoglobin levels	1e-16	32327693
rs11918453	rs56384862	0.827341238501781	Body mass index	3e-14	36581621
rs11918453	rs55692656	0.767020496758316	vWF levels	3e-08	30586737
rs11918453	rs55692656	0.767020496758316	vWF levels	6e-09	30586737
rs11918453	rs55954186	0.700832735127738	vWF levels	5e-09	30586737
rs11918453	rs55954186	0.700832735127738	vWF levels	9e-09	30586737
rs11918453	rs11708895	0.698211637161504	Red blood cell count	1e-20	32888494
rs11918453	rs6445969	0.676776251074341	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11918453	rs7431952	0.607581297676037	Hemoglobin levels	1e-12	32327693
rs11919206	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs11919206	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs11919206	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs11919206	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11919206	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs11919206	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs11919206	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs11919206	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs11919206	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs11919206	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs11919206	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs11919206	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11919206	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs11919206	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs11919206	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs11919206	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs11919206	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs11919206	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs11919206	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs11919206	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs11919206	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs11919206	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11919206	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs11919206	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs11919206	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs11919206	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs11921259	rs4681679	0.992032487623277	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11921259	rs11719450	0.962967506584444	Hemoglobin concentration	2e-09	27863252
rs11921259	rs11719450	0.962967506584444	Hemoglobin levels	2e-16	32327693
rs11921259	rs56384862	0.949862825433659	Body mass index	8e-12	29273807
rs11921259	rs56384862	0.949862825433659	Body mass index	3e-06	30108127
rs11921259	rs56384862	0.949862825433659	Hemoglobin levels	1e-16	32327693
rs11921259	rs56384862	0.949862825433659	Body mass index	3e-14	36581621
rs11921259	rs7610312	0.897370995288432	Red blood cell count	5e-09	27863252
rs11921259	rs6775517	0.896457241860952	Hematocrit	1e-17	34594039
rs11921259	rs57700771	0.890975717320469	Red blood cell count	9e-21	30595370
rs11921259	rs11705721	0.878892995470518	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11921259	rs11130638	0.878892995470518	Hemoglobin concentration	2e-23	32888493
rs11921259	rs34579268	0.872447361277141	Hematocrit	5e-30	32888493
rs11921259	rs34579268	0.872447361277141	Hematocrit	2e-27	32888493
rs11921259	rs34579268	0.872447361277141	Hemoglobin concentration	5e-26	32888493
rs11921259	rs55692656	0.840308459402013	vWF levels	3e-08	30586737
rs11921259	rs55692656	0.840308459402013	vWF levels	6e-09	30586737
rs11921259	rs55704295	0.818055969257026	Red blood cell count	8e-26	32888493
rs11921259	rs55704295	0.818055969257026	Red blood cell count	5e-23	32888493
rs11921259	rs55704295	0.818055969257026	Serum total protein level	2e-29	34594039
rs11921259	rs11922478	0.796707967840934	Semaphorin-6B levels	4e-12	34648354
rs11921259	rs6445969	0.780007676917409	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11921259	rs11708895	0.775388393175908	Red blood cell count	1e-20	32888494
rs11921259	rs55954186	0.770499092026061	vWF levels	5e-09	30586737
rs11921259	rs55954186	0.770499092026061	vWF levels	9e-09	30586737
rs11921259	rs7431952	0.700686666573679	Hemoglobin levels	1e-12	32327693
rs11921259	rs9311676	0.640346899280251	Systemic lupus erythematosus	5e-06	27399966
rs11921259	rs9311676	0.640346899280251	Systemic lupus erythematosus	3e-14	26502338
rs11921259	rs9311676	0.640346899280251	Waist circumference adjusted for body mass index	3e-08	34021172
rs11921259	rs9822855	0.625496938444291	Educational attainment	9e-120	35361970
rs11922478	rs11922478	1	Semaphorin-6B levels	4e-12	34648354
rs11922478	rs7610312	0.851920186570224	Red blood cell count	5e-09	27863252
rs11922478	rs6775517	0.851125477778299	Hematocrit	1e-17	34594039
rs11922478	rs57700771	0.845520138131371	Red blood cell count	9e-21	30595370
rs11922478	rs55704295	0.843623773520645	Red blood cell count	8e-26	32888493
rs11922478	rs55704295	0.843623773520645	Red blood cell count	5e-23	32888493
rs11922478	rs55704295	0.843623773520645	Serum total protein level	2e-29	34594039
rs11922478	rs34579268	0.84238097045896	Hematocrit	5e-30	32888493
rs11922478	rs34579268	0.84238097045896	Hematocrit	2e-27	32888493
rs11922478	rs34579268	0.84238097045896	Hemoglobin concentration	5e-26	32888493
rs11922478	rs11705721	0.834383311646294	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11922478	rs11130638	0.834383311646294	Hemoglobin concentration	2e-23	32888493
rs11922478	rs11719450	0.819840798839373	Hemoglobin concentration	2e-09	27863252
rs11922478	rs11719450	0.819840798839373	Hemoglobin levels	2e-16	32327693
rs11922478	rs4681679	0.791915538711332	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11922478	rs56384862	0.757643173691223	Body mass index	8e-12	29273807
rs11922478	rs56384862	0.757643173691223	Body mass index	3e-06	30108127
rs11922478	rs56384862	0.757643173691223	Hemoglobin levels	1e-16	32327693
rs11922478	rs56384862	0.757643173691223	Body mass index	3e-14	36581621
rs11922478	rs55692656	0.704794751535169	vWF levels	3e-08	30586737
rs11922478	rs55692656	0.704794751535169	vWF levels	6e-09	30586737
rs11922478	rs55954186	0.618699908209666	vWF levels	5e-09	30586737
rs11922478	rs55954186	0.618699908209666	vWF levels	9e-09	30586737
rs11922478	rs11708895	0.616615047346515	Red blood cell count	1e-20	32888494
rs11922478	rs6445969	0.610374344885176	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11924677	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs11924677	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs11924677	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs11924677	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11924677	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs11924677	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs11924677	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs11924677	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs11924677	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs11924677	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs11924677	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs11924677	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11924677	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs11924677	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs11924677	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs11924677	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs11924677	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs11924677	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs11924677	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs11924677	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs11924677	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs11924677	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11924677	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs11924677	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs11924677	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs11924677	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs11925862	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs11925862	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs11925862	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs11925862	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs11925862	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs11925862	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs11925862	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs11925862	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs11925862	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs11925862	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs11925862	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs11925862	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs11925862	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs11925862	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs11925862	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs11925862	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs11925862	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs11925862	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs11925862	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs11925862	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs11925862	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs11925862	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs11925862	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs11925862	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs11925862	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs11925862	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs11935989	rs2868708	0.961225104403855	Lymphocyte count	3e-11	34469753
rs11935989	rs2868708	0.961225104403855	White blood cell count	1e-09	30595370
rs11935989	rs6831339	0.957953480623664	High density lipoprotein cholesterol levels	9e-09	34887591
rs11935989	rs6535419	0.909313562636612	Pulse pressure	6e-10	30578418
rs11935989	rs116142917	0.882591861484152	Lymphocyte count	7e-18	32888494
rs11935989	rs6823199	0.86709086512645	Pulse pressure	4e-14	30224653
rs11935989	rs13111599	0.854826910586776	HDL cholesterol levels	3e-09	32203549
rs11935989	rs13111599	0.854826910586776	Apolipoprotein A1 levels	4e-08	32203549
rs11935989	rs4302451	0.77205460216148	Eosinophil counts	2e-09	30595370
rs11935989	rs35895091	0.729966472853422	Cardiovascular disease	1e-07	30595370
rs11935989	rs11099563	0.712215358183033	High density lipoprotein cholesterol levels	3e-11	34887591
rs11935989	rs28528763	0.693245930435801	White blood cell count	7e-12	32888494
rs11935989	rs7662402	0.606956066858491	Brain morphology (MOSTest)	3e-08	35164939
rs11937821	rs2868708	0.955572780324377	Lymphocyte count	3e-11	34469753
rs11937821	rs2868708	0.955572780324377	White blood cell count	1e-09	30595370
rs11937821	rs6831339	0.952320272588391	High density lipoprotein cholesterol levels	9e-09	34887591
rs11937821	rs6535419	0.898806225173611	Pulse pressure	6e-10	30578418
rs11937821	rs116142917	0.877554180919723	Lymphocyte count	7e-18	32888494
rs11937821	rs13111599	0.862884615710652	HDL cholesterol levels	3e-09	32203549
rs11937821	rs13111599	0.862884615710652	Apolipoprotein A1 levels	4e-08	32203549
rs11937821	rs6823199	0.856880322967361	Pulse pressure	4e-14	30224653
rs11937821	rs4302451	0.781700291904463	Eosinophil counts	2e-09	30595370
rs11937821	rs35895091	0.729940686715988	Cardiovascular disease	1e-07	30595370
rs11937821	rs11099563	0.707062675222745	High density lipoprotein cholesterol levels	3e-11	34887591
rs11937821	rs28528763	0.684073385507691	White blood cell count	7e-12	32888494
rs11937821	rs7662402	0.60378011265033	Brain morphology (MOSTest)	3e-08	35164939
rs11957122	rs4700008	0.967008839020811	1,2-dipalmitoyl-GPE (16:0/16:0) levels in elite athletes	4e-06	31882771
rs11960484	rs10061757	0.975647287137183	Height	4e-30	30595370
rs11960484	rs832540	0.783279250017207	Coronary artery disease	2e-08	29212778
rs11960484	rs33321	0.727775605312695	Height	1e-19	34594039
rs11965761	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs11965761	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs11965761	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs11965761	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs11965761	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs11965761	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs11965761	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs11965761	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs11965761	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs11965761	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs11965761	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs11965761	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs11965761	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs11965761	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs11965761	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs11965761	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs11965761	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs11965761	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs11965761	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs11965761	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs11965761	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs11965761	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs11965761	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs11965761	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs11965761	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs11965761	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs11965761	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs11965761	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs11965761	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs11965761	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs11965761	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs11965761	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs11965761	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs11965761	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs11965761	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs11965761	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs11965761	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs11965761	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs11965761	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs11965761	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs11965761	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs11965761	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs11981405	rs12539962	0.961144356497784	Colorectal cancer	3e-08	36539618
rs11981405	rs7806956	0.680470616502446	Esophageal squamous cell carcinoma	3e-07	37673066
rs11981405	rs4355658	0.659238380500531	Height	3e-13	36224396
rs11981405	rs13232536	0.635007761762099	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs1198864	rs1198872	0.745230494777498	Cardiac Troponin-T levels	2e-06	23247143
rs11990610	rs4841280	0.766765012308416	Multi-trait sum score	2e-08	37277458
rs11990610	rs17151145	0.697861613933635	Body mass index (MTAG)	3e-13	36376304
rs11990610	rs57105322	0.67471183063053	White blood cell count	6e-08	30595370
rs11990610	rs58764043	0.663983388905935	Self-reported math ability (MTAG)	4e-10	30038396
rs11991937	rs1036385	0.827066255699269	Height	6e-11	36224396
rs11991937	rs2016749	0.775585330373215	Calcium levels	2e-08	34594039
rs1201873	rs9366863	0.940849055113523	Adult body size	9e-33	32376654
rs1201873	rs9366863	0.940849055113523	Body mass index	2e-44	30595370
rs1201873	rs2263329	0.940655641443067	HDL cholesterol	6e-35	34594039
rs1201873	rs2263329	0.940655641443067	HDL cholesterol levels	8e-43	32203549
rs1201873	rs2263329	0.940655641443067	High density lipoprotein cholesterol levels	2e-52	34887591
rs1201873	rs2814949	0.932513806135282	Essential hypertension (time to event)	9e-09	32589924
rs1201873	rs2744944	0.919933389519172	Hypothyroidism	3e-10	34594039
rs1201873	rs2744944	0.919933389519172	High density lipoprotein cholesterol levels	3e-86	34887591
rs1201873	rs2744944	0.919933389519172	Multi-trait sex score	7e-22	37277458
rs1201873	rs9469872	0.913766945564516	HDL cholesterol levels	3e-11	36333282
rs1201873	rs11755393	0.905903294464934	Body mass index	3e-26	29273807
rs1201873	rs11755393	0.905903294464934	Systemic lupus erythematosus	2e-12	33493351
rs1201873	rs11755393	0.905903294464934	Systemic lupus erythematosus	2e-06	33493351
rs1201873	rs11755393	0.905903294464934	Systemic lupus erythematosus	1e-07	33493351
rs1201873	rs11755393	0.905903294464934	Systemic lupus erythematosus	2e-08	19838195
rs1201873	rs11755393	0.905903294464934	Body mass index	4e-55	36581621
rs1201873	rs6941110	0.897561462707972	Sex hormone-binding globulin levels	5e-27	36653534
rs1201873	rs9462030	0.878177537323604	Red cell distribution width	5e-25	32888493
rs1201873	rs111868030	0.877780898759579	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs1201873	rs9469857	0.876648766996811	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs1201873	rs2764208	0.874374184116208	Systemic lupus erythematosus	7e-06	24871463
rs1201873	rs9469899	0.862720549125437	Prostate cancer (advanced)	2e-06	29892016
rs1201873	rs9469899	0.862720549125437	Prostate cancer	5e-09	29892016
rs1201873	rs9469899	0.862720549125437	Prostate cancer	8e-11	33398198
rs1201873	rs9469899	0.862720549125437	Hand grip strength	3e-15	29691431
rs1201873	rs9469899	0.862720549125437	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs1201873	rs9469899	0.862720549125437	Graves' disease	4e-10	34594039
rs1201873	rs9469899	0.862720549125437	Coronary artery disease	1e-11	36474045
rs1201873	rs9469899	0.862720549125437	Predicted visceral adipose tissue	2e-20	31501611
rs1201873	rs9469899	0.862720549125437	Medication use (thyroid preparations)	2e-09	31015401
rs1201873	rs9469899	0.862720549125437	Medication use (thyroid preparations)	3e-10	34594039
rs1201873	rs9368830	0.852497463124632	HDL cholesterol	4e-21	30275531
rs1201873	rs9296128	0.827010074329824	Hip circumference adjusted for BMI	4e-13	34021172
rs1201873	rs9368828	0.822517582058365	Body mass index	1e-34	34594039
rs1201873	rs2744973	0.80102199856715	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs1201873	rs2744973	0.80102199856715	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs1201873	rs2744973	0.80102199856715	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs1201873	rs2744973	0.80102199856715	Multi-trait sex score	6e-20	37277458
rs1201873	rs6912327	0.755772660829954	Fasting insulin	5e-06	33402679
rs1201873	rs6912327	0.755772660829954	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs1201873	rs112283401	0.73119125337537	Red cell distribution width	4e-27	30595370
rs1201873	rs205262	0.608754045740785	Body mass index	2e-09	26961502
rs1201873	rs205262	0.608754045740785	Walking pace	4e-10	33128006
rs1201873	rs205262	0.608754045740785	Body mass index	8e-13	30108127
rs1201873	rs205262	0.608754045740785	Body mass index	2e-09	25673413
rs1201873	rs205262	0.608754045740785	Body mass index	2e-14	26426971
rs1201873	rs205262	0.608754045740785	BMI in non-smokers	3e-07	28443625
rs1201873	rs205262	0.608754045740785	BMI in non-smokers	6e-09	28443625
rs1201873	rs205262	0.608754045740785	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs1201873	rs205262	0.608754045740785	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs1201873	rs205262	0.608754045740785	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs1201873	rs205262	0.608754045740785	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs1201873	rs205262	0.608754045740785	Gastroesophageal reflux disease	1e-10	34187846
rs1201873	rs205262	0.608754045740785	Body mass index	3e-10	25673413
rs1201873	rs205262	0.608754045740785	Body mass index	2e-10	25673413
rs1201873	rs205262	0.608754045740785	ICD10 M54: Dorsalgia	2e-12	35110524
rs1201874	rs9366863	0.949360342873222	Adult body size	9e-33	32376654
rs1201874	rs9366863	0.949360342873222	Body mass index	2e-44	30595370
rs1201874	rs2263329	0.949209735707694	HDL cholesterol	6e-35	34594039
rs1201874	rs2263329	0.949209735707694	HDL cholesterol levels	8e-43	32203549
rs1201874	rs2263329	0.949209735707694	High density lipoprotein cholesterol levels	2e-52	34887591
rs1201874	rs2814949	0.940950189411525	Essential hypertension (time to event)	9e-09	32589924
rs1201874	rs2744944	0.928347622456149	Hypothyroidism	3e-10	34594039
rs1201874	rs2744944	0.928347622456149	High density lipoprotein cholesterol levels	3e-86	34887591
rs1201874	rs2744944	0.928347622456149	Multi-trait sex score	7e-22	37277458
rs1201874	rs9469872	0.922155086764924	HDL cholesterol levels	3e-11	36333282
rs1201874	rs11755393	0.914176501756008	Body mass index	3e-26	29273807
rs1201874	rs11755393	0.914176501756008	Systemic lupus erythematosus	2e-12	33493351
rs1201874	rs11755393	0.914176501756008	Systemic lupus erythematosus	2e-06	33493351
rs1201874	rs11755393	0.914176501756008	Systemic lupus erythematosus	1e-07	33493351
rs1201874	rs11755393	0.914176501756008	Systemic lupus erythematosus	2e-08	19838195
rs1201874	rs11755393	0.914176501756008	Body mass index	4e-55	36581621
rs1201874	rs6941110	0.905901773123825	Sex hormone-binding globulin levels	5e-27	36653534
rs1201874	rs9462030	0.886552535024622	Red cell distribution width	5e-25	32888493
rs1201874	rs111868030	0.886376500956913	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs1201874	rs9469857	0.885029293594478	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs1201874	rs2764208	0.882753849848433	Systemic lupus erythematosus	7e-06	24871463
rs1201874	rs9469899	0.870927391582473	Prostate cancer (advanced)	2e-06	29892016
rs1201874	rs9469899	0.870927391582473	Prostate cancer	5e-09	29892016
rs1201874	rs9469899	0.870927391582473	Prostate cancer	8e-11	33398198
rs1201874	rs9469899	0.870927391582473	Hand grip strength	3e-15	29691431
rs1201874	rs9469899	0.870927391582473	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs1201874	rs9469899	0.870927391582473	Graves' disease	4e-10	34594039
rs1201874	rs9469899	0.870927391582473	Coronary artery disease	1e-11	36474045
rs1201874	rs9469899	0.870927391582473	Predicted visceral adipose tissue	2e-20	31501611
rs1201874	rs9469899	0.870927391582473	Medication use (thyroid preparations)	2e-09	31015401
rs1201874	rs9469899	0.870927391582473	Medication use (thyroid preparations)	3e-10	34594039
rs1201874	rs9368830	0.860305359738956	HDL cholesterol	4e-21	30275531
rs1201874	rs9296128	0.835371010384834	Hip circumference adjusted for BMI	4e-13	34021172
rs1201874	rs9368828	0.830609486480426	Body mass index	1e-34	34594039
rs1201874	rs2744973	0.809738572623874	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs1201874	rs2744973	0.809738572623874	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs1201874	rs2744973	0.809738572623874	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs1201874	rs2744973	0.809738572623874	Multi-trait sex score	6e-20	37277458
rs1201874	rs6912327	0.764095496158548	Fasting insulin	5e-06	33402679
rs1201874	rs6912327	0.764095496158548	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs1201874	rs112283401	0.739383192747273	Red cell distribution width	4e-27	30595370
rs1201874	rs205262	0.620085579724632	Body mass index	2e-09	26961502
rs1201874	rs205262	0.620085579724632	Walking pace	4e-10	33128006
rs1201874	rs205262	0.620085579724632	Body mass index	8e-13	30108127
rs1201874	rs205262	0.620085579724632	Body mass index	2e-09	25673413
rs1201874	rs205262	0.620085579724632	Body mass index	2e-14	26426971
rs1201874	rs205262	0.620085579724632	BMI in non-smokers	3e-07	28443625
rs1201874	rs205262	0.620085579724632	BMI in non-smokers	6e-09	28443625
rs1201874	rs205262	0.620085579724632	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs1201874	rs205262	0.620085579724632	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs1201874	rs205262	0.620085579724632	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs1201874	rs205262	0.620085579724632	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs1201874	rs205262	0.620085579724632	Gastroesophageal reflux disease	1e-10	34187846
rs1201874	rs205262	0.620085579724632	Body mass index	3e-10	25673413
rs1201874	rs205262	0.620085579724632	Body mass index	2e-10	25673413
rs1201874	rs205262	0.620085579724632	ICD10 M54: Dorsalgia	2e-12	35110524
rs12043239	rs10918211	0.876820718652555	White blood cell count	1e-26	34925446
rs12043239	rs10918211	0.876820718652555	Neutrophil count	5e-34	34925446
rs12043239	rs7554904	0.873812888206862	Metabolite levels	4e-06	23823483
rs12043239	rs7554904	0.873812888206862	Metabolite levels	2e-06	23823483
rs12043239	rs1425754	0.84353084151329	Metabolite levels	1e-06	23823483
rs12065833	rs10801699	0.996573983662775	X-23639 levels	2e-10	36635386
rs12065833	rs1409152	0.994014183389214	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs12065833	rs1409152	0.994014183389214	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs12065833	rs12120164	0.955136023613527	Metabolite peak levels (QI2146)	1e-26	35995766
rs12065833	rs10922531	0.801318132830972	Serum metabolite levels	2e-69	33031748
rs12065833	rs12729558	0.775338978686462	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs12065833	rs7532151	0.714348481365239	Imidazole lactate levels	9e-12	33177712
rs12065833	rs7530513	0.711850172852285	Height	8e-11	35831902
rs12065833	rs7530513	0.711850172852285	Imidazole lactate levels	8e-166	36635386
rs12065833	rs12144640	0.711850172852285	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12065833	rs10801690	0.695050320972548	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs12065833	rs9787133	0.668983186537334	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12065833	rs2765527	0.627215914849086	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs12065833	rs10922532	0.606228915824923	Blood urea nitrogen levels	2e-08	31152163
rs12065833	rs10922532	0.606228915824923	Waist circumference adjusted for body mass index	2e-11	34021172
rs12065833	rs10922532	0.606228915824923	X-23639 levels	4e-11	35050183
rs12067594	rs6698740	0.992734882721908	Beta-hydroxyisovalerate levels	1e-13	35347128
rs12067594	rs1060870	0.991121068613225	Serum metabolite levels	1e-11	33031748
rs12067594	rs1060870	0.991121068613225	Serum metabolite levels	1e-15	33031748
rs12067594	rs6685187	0.98709475357957	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs12067594	rs11204914	0.976725770556228	Carnitine C9 levels	1e-13	35995766
rs12067594	rs11204914	0.976725770556228	Metabolite peak levels (QI6204)	1e-32	35995766
rs12067594	rs11204914	0.976725770556228	Metabolite peak levels (QI6252)	2e-32	35995766
rs12067594	rs2338201	0.972662694168605	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs12067594	rs2338201	0.972662694168605	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs12067594	rs2338201	0.972662694168605	Dodecadienoate (12:2) levels	7e-15	36635386
rs12067594	rs10788817	0.963899835909592	Serum metabolite levels	3e-13	24625756
rs12067594	rs10788817	0.963899835909592	Metabolite peak levels (QI2718)	5e-18	35995766
rs12067594	rs10788817	0.963899835909592	3-hydroxylaurate levels	2e-12	36635386
rs12067594	rs10788817	0.963899835909592	Tetradecadienoate (14:2) levels	8e-17	36635386
rs12067594	rs7542137	0.846745780757752	Beta-hydroxyisovalerate levels	3e-11	35050183
rs12067594	rs7542137	0.846745780757752	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs12067594	rs7542137	0.846745780757752	3-hydroxysebacate levels	2e-10	36635386
rs12067594	rs7523082	0.824499763143435	Metabolite peak levels (QI9845)	2e-14	35995766
rs12067594	rs2130525	0.821967519356685	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs12067594	rs10888445	0.818843321549607	Beta-hydroxyisovalerate levels	5e-13	36635386
rs12067594	rs7541453	0.812958424774429	Serum metabolite levels	2e-16	33031748
rs12067594	rs7541453	0.812958424774429	Serum metabolite levels	2e-16	33031748
rs12067594	rs7541453	0.812958424774429	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs12067594	rs2999545	0.803901755215247	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs12067594	rs2279501	0.788734629919723	Serum metabolite levels	3e-14	33031748
rs12067594	rs3007711	0.766313328559464	Electrodermal activity	9e-06	25387706
rs12067594	rs2999541	0.765390328917933	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs12067594	rs1038747	0.66732209577073	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs12068025	rs3850718	0.644752878224109	Height	7e-54	36224396
rs12068025	rs12736461	0.604999052569871	Height	4e-11	30595370
rs12070578	rs10465746	0.760532175997044	Obesity-related traits	8e-06	23251661
rs12070578	rs11580836	0.739440518538032	Body mass index	2e-09	36581621
rs12089784	rs835341	0.820067908021785	Ascending aorta distensibility (MTAG)	8e-09	35922433
rs12089784	rs946155	0.633579150163226	Glutathione peroxidase 7 levels (GPX7.8345.27.3)	2e-61	29875488
rs12116923	rs2279501	0.963298359307862	Serum metabolite levels	3e-14	33031748
rs12116923	rs1038747	0.837787727032424	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs12116923	rs10788817	0.795452202758938	Serum metabolite levels	3e-13	24625756
rs12116923	rs10788817	0.795452202758938	Metabolite peak levels (QI2718)	5e-18	35995766
rs12116923	rs10788817	0.795452202758938	3-hydroxylaurate levels	2e-12	36635386
rs12116923	rs10788817	0.795452202758938	Tetradecadienoate (14:2) levels	8e-17	36635386
rs12116923	rs11204914	0.789162039776022	Carnitine C9 levels	1e-13	35995766
rs12116923	rs11204914	0.789162039776022	Metabolite peak levels (QI6204)	1e-32	35995766
rs12116923	rs11204914	0.789162039776022	Metabolite peak levels (QI6252)	2e-32	35995766
rs12116923	rs2130525	0.774207118181802	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs12116923	rs6698740	0.765424642286002	Beta-hydroxyisovalerate levels	1e-13	35347128
rs12116923	rs6685187	0.764659920111466	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs12116923	rs1060870	0.763995497832226	Serum metabolite levels	1e-11	33031748
rs12116923	rs1060870	0.763995497832226	Serum metabolite levels	1e-15	33031748
rs12116923	rs2338201	0.752576196400736	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs12116923	rs2338201	0.752576196400736	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs12116923	rs2338201	0.752576196400736	Dodecadienoate (12:2) levels	7e-15	36635386
rs12116923	rs7542137	0.710763458600531	Beta-hydroxyisovalerate levels	3e-11	35050183
rs12116923	rs7542137	0.710763458600531	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs12116923	rs7542137	0.710763458600531	3-hydroxysebacate levels	2e-10	36635386
rs12116923	rs2999545	0.7035811385606	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs12116923	rs3007711	0.698726786072389	Electrodermal activity	9e-06	25387706
rs12116923	rs2999541	0.695197903865155	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs12116923	rs9943251	0.664223663138546	Serum metabolite levels	1e-30	33031748
rs12116923	rs9943251	0.664223663138546	X-23680 levels	2e-45	35050183
rs12116923	rs9943251	0.664223663138546	Urine glucuronide of C8H14O2 (1)* levels in chronic kidney disease	2e-14	37277652
rs12116923	rs9943251	0.664223663138546	Plasma X-18921 levels in chronic kidney disease	3e-66	37277652
rs12116923	rs9943251	0.664223663138546	Urine indoleacetylglutamine levels in chronic kidney disease	2e-28	37277652
rs12116923	rs9943251	0.664223663138546	Metabolite peak levels (QI9912)	7e-15	35995766
rs12116923	rs9943251	0.664223663138546	Eicosanoid tetranor 12(R) HETE b levels	7e-15	37524825
rs12116923	rs16833668	0.663611163322608	Nonaylcarnitine levels	3e-21	33414548
rs12116923	rs16833668	0.663611163322608	Dodecadienoate (12:2) levels	5e-23	35347128
rs12116923	rs16833668	0.663611163322608	X-21353 levels	9e-67	35347128
rs12116923	rs16833669	0.655621929097727	Plasma X-21353 levels in chronic kidney disease	3e-28	37277652
rs12116923	rs61817724	0.655010423707499	X-23641 levels	6e-13	35347128
rs12116923	rs61817724	0.655010423707499	X-18888 levels	5e-18	35347128
rs12116923	rs61817724	0.655010423707499	3-hydroxyhexanoate levels	2e-13	35347128
rs12116923	rs61817724	0.655010423707499	3-hydroxyoctanoate levels	1e-44	35347128
rs12116923	rs7523082	0.642259713428649	Metabolite peak levels (QI9845)	2e-14	35995766
rs12116923	rs10888445	0.635569452995551	Beta-hydroxyisovalerate levels	5e-13	36635386
rs12116923	rs7541453	0.632938666761502	Serum metabolite levels	2e-16	33031748
rs12116923	rs7541453	0.632938666761502	Serum metabolite levels	2e-16	33031748
rs12116923	rs7541453	0.632938666761502	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs12116923	rs16833670	0.625562293821735	X-13431 levels	5e-49	36635386
rs12116923	rs2337685	0.624954130784581	X-13431 levels	2e-34	35347128
rs12116923	rs6675930	0.624954130784581	Cis-4-decenoate (10:1n6) levels	3e-166	35347128
rs12116923	rs6675930	0.624954130784581	3-hydroxydecanoate levels	3e-70	35347128
rs12116923	rs6675930	0.624954130784581	3-hydroxylaurate levels	2e-24	35347128
rs12116923	rs80320664	0.624051052530574	X-23680 levels	3e-45	35050183
rs12116923	rs6682605	0.623590418875528	Tetradecadienoate (14:2) levels	2e-25	35347128
rs12116923	rs6682605	0.623590418875528	X-21607 levels	4e-20	35347128
rs12116923	rs6693388	0.623590418875528	Plasma beta-hydroxyisovalerate levels in chronic kidney disease	1e-13	37277652
rs12116923	rs6693388	0.623590418875528	Plasma 3-hydroxydecanoate levels in chronic kidney disease	6e-24	37277652
rs12116923	rs6693388	0.623590418875528	Plasma 3-hydroxylaurate levels in chronic kidney disease	9e-13	37277652
rs12116923	rs6693388	0.623590418875528	Linoleate 18:2n6-to-X-12442--5,8-tetradecadienoate ratio	4e-38	24816252
rs12116923	rs6693388	0.623590418875528	Undecenoylcarnitine (C11:1) levels	6e-25	36635386
rs12116923	rs6693396	0.622835451347655	X-13431 levels	2e-47	35050183
rs12116923	rs10675058	0.61244221028433	Undecenoylcarnitine (C11:1) levels	8e-15	35347128
rs12120160	rs11580836	0.994668916796541	Body mass index	2e-09	36581621
rs12120160	rs10465746	0.961675621009925	Obesity-related traits	8e-06	23251661
rs12120164	rs12120164	1	Metabolite peak levels (QI2146)	1e-26	35995766
rs12120164	rs10801699	0.95522120564294	X-23639 levels	2e-10	36635386
rs12120164	rs1409152	0.952762826720193	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs12120164	rs1409152	0.952762826720193	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs12120164	rs10922531	0.843557360470077	Serum metabolite levels	2e-69	33031748
rs12120164	rs12729558	0.742751767255872	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs12120164	rs7532151	0.68394890339059	Imidazole lactate levels	9e-12	33177712
rs12120164	rs7530513	0.675937989963433	Height	8e-11	35831902
rs12120164	rs7530513	0.675937989963433	Imidazole lactate levels	8e-166	36635386
rs12120164	rs12144640	0.675937989963433	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12120164	rs10801690	0.666591110365428	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs12120164	rs9787133	0.641286483061881	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12120164	rs10922532	0.636803395790923	Blood urea nitrogen levels	2e-08	31152163
rs12120164	rs10922532	0.636803395790923	Waist circumference adjusted for body mass index	2e-11	34021172
rs12120164	rs10922532	0.636803395790923	X-23639 levels	4e-11	35050183
rs12120164	rs2765527	0.600497599721733	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs12120863	rs17433780	0.657120914269404	Carotid intima media thickness	2e-06	26343869
rs12122780	rs61798917	0.804016189266633	Height	2e-10	30595370
rs12125301	rs61798917	0.809468001366775	Height	2e-10	30595370
rs12127266	rs11580836	0.992895055335095	Body mass index	2e-09	36581621
rs12127266	rs10465746	0.961675621009925	Obesity-related traits	8e-06	23251661
rs12130865	rs12729558	0.963973041787066	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs12130865	rs7532151	0.954682145886265	Imidazole lactate levels	9e-12	33177712
rs12130865	rs9787133	0.89051105179029	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12130865	rs10801690	0.861730172745915	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs12130865	rs10922531	0.828902817963706	Serum metabolite levels	2e-69	33031748
rs12130865	rs7530513	0.760541770558103	Height	8e-11	35831902
rs12130865	rs7530513	0.760541770558103	Imidazole lactate levels	8e-166	36635386
rs12130865	rs12144640	0.760541770558103	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12130865	rs1409152	0.74985998988194	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs12130865	rs1409152	0.74985998988194	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs12130865	rs10801699	0.747924548014567	X-23639 levels	2e-10	36635386
rs12130865	rs2765527	0.71862249592223	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs12130865	rs12120164	0.716654635457915	Metabolite peak levels (QI2146)	1e-26	35995766
rs12130865	rs1206228892	0.691732757786189	Imidazole lactate levels	5e-186	35050183
rs12130865	rs2810876	0.691090270070181	Imidazole lactate levels	2e-122	35347128
rs12130865	rs10801696	0.690954847916304	Imidazole lactate levels	3e-195	35050183
rs12131212	rs10918211	0.987822844943387	White blood cell count	1e-26	34925446
rs12131212	rs10918211	0.987822844943387	Neutrophil count	5e-34	34925446
rs12131212	rs7554904	0.846547211694724	Metabolite levels	4e-06	23823483
rs12131212	rs7554904	0.846547211694724	Metabolite levels	2e-06	23823483
rs12131212	rs1425754	0.803028757078277	Metabolite levels	1e-06	23823483
rs12133778	rs11580836	0.92688903339604	Body mass index	2e-09	36581621
rs12133778	rs10465746	0.90279935040244	Obesity-related traits	8e-06	23251661
rs12133778	rs1536166	0.608046410648283	Body mass index	2e-08	30595370
rs12139281	rs7545078	0.744045679676547	Smoking initiation	2e-09	36477530
rs12139281	rs6700087	0.68043764181155	Smoking initiation	6e-11	36477530
rs12140068	rs11580836	0.98846589040294	Body mass index	2e-09	36581621
rs12140068	rs10465746	0.967771896673522	Obesity-related traits	8e-06	23251661
rs12140288	rs12140288	1	Waist circumference adjusted for body mass index	2e-08	34021172
rs12140288	rs12140288	1	Waist circumference adjusted for body mass index	3e-08	34021172
rs12142	rs17495047	0.992163625461416	Adolescent idiopathic scoliosis	3e-07	30019117
rs12144640	rs7530513	1	Height	8e-11	35831902
rs12144640	rs7530513	1	Imidazole lactate levels	8e-166	36635386
rs12144640	rs12144640	1	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12144640	rs10922531	0.80923994601834	Serum metabolite levels	2e-69	33031748
rs12144640	rs12729558	0.788060337808832	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs12144640	rs7532151	0.726171261347773	Imidazole lactate levels	9e-12	33177712
rs12144640	rs1409152	0.714191806031104	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs12144640	rs1409152	0.714191806031104	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs12144640	rs10801699	0.711947700717531	X-23639 levels	2e-10	36635386
rs12144640	rs10801690	0.703851231584988	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs12144640	rs9787133	0.67752087578048	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12144640	rs12120164	0.675937989963433	Metabolite peak levels (QI2146)	1e-26	35995766
rs12144640	rs2765527	0.637506947699747	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs12145712	rs12145712	1	Pulse pressure	1e-10	35762941
rs12145712	rs10922476	0.766237743653392	Corneal resistance factor	4e-17	33311554
rs12145712	rs12145922	0.76480247995091	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs12145712	rs12145922	0.76480247995091	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs12145712	rs3806340	0.76480247995091	Corneal resistance factor (MTAG)	3e-18	35446358
rs12145712	rs3806340	0.76480247995091	Height	1e-12	35831902
rs12145712	rs3806340	0.76480247995091	Height	7e-17	36224396
rs12145712	rs3806340	0.76480247995091	Height	3e-47	36224396
rs12145712	rs7551732	0.728793202809659	Height	6e-20	25282103
rs12145712	rs7551732	0.728793202809659	Gamma glutamyl transferase levels	5e-08	33339817
rs12145712	rs6699417	0.714462987439151	Height	5e-09	20881960
rs12145712	rs6699417	0.714462987439151	Height	2e-11	35831902
rs12145712	rs6699417	0.714462987439151	Height	1e-300	36224396
rs12145712	rs6699417	0.714462987439151	Height	1e-300	36224396
rs12145712	rs4233334	0.680444700576795	Body surface area	6e-09	36502284
rs12145712	rs786906	0.676083108061571	Systolic blood pressure	1e-06	27618447
rs12145712	rs786906	0.676083108061571	Intraocular pressure	5e-09	29617998
rs12145712	rs12021820	0.675510093131221	Mean corpuscular hemoglobin	2e-11	32888493
rs12145712	rs10801682	0.672875335223555	Mean corpuscular hemoglobin	1e-09	30595370
rs12145712	rs1002436	0.62996754176992	Red blood cell count	4e-22	32888493
rs12145712	rs1002436	0.62996754176992	Alanine aminotransferase levels	6e-11	33547301
rs12145712	rs1002436	0.62996754176992	Aspartate aminotransferase levels	1e-20	33547301
rs12145712	rs1002436	0.62996754176992	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs12145922	rs12145922	1	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs12145922	rs12145922	1	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs12145922	rs3806340	1	Corneal resistance factor (MTAG)	3e-18	35446358
rs12145922	rs3806340	1	Height	1e-12	35831902
rs12145922	rs3806340	1	Height	7e-17	36224396
rs12145922	rs3806340	1	Height	3e-47	36224396
rs12145922	rs10922476	0.990171408212607	Corneal resistance factor	4e-17	33311554
rs12145922	rs1002436	0.792740081790145	Red blood cell count	4e-22	32888493
rs12145922	rs1002436	0.792740081790145	Alanine aminotransferase levels	6e-11	33547301
rs12145922	rs1002436	0.792740081790145	Aspartate aminotransferase levels	1e-20	33547301
rs12145922	rs1002436	0.792740081790145	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs12145922	rs12145712	0.76480247995091	Pulse pressure	1e-10	35762941
rs12145922	rs4233334	0.744604202574526	Body surface area	6e-09	36502284
rs12145922	rs786906	0.739993372007039	Systolic blood pressure	1e-06	27618447
rs12145922	rs786906	0.739993372007039	Intraocular pressure	5e-09	29617998
rs12145922	rs12021820	0.738004432371056	Mean corpuscular hemoglobin	2e-11	32888493
rs12145922	rs10801682	0.73522060033223	Mean corpuscular hemoglobin	1e-09	30595370
rs12145922	rs7551732	0.706784401987764	Height	6e-20	25282103
rs12145922	rs7551732	0.706784401987764	Gamma glutamyl transferase levels	5e-08	33339817
rs12145922	rs6699417	0.654470567529921	Height	5e-09	20881960
rs12145922	rs6699417	0.654470567529921	Height	2e-11	35831902
rs12145922	rs6699417	0.654470567529921	Height	1e-300	36224396
rs12145922	rs6699417	0.654470567529921	Height	1e-300	36224396
rs12146038	rs10465746	0.957425805897381	Obesity-related traits	8e-06	23251661
rs12146038	rs11580836	0.918882622322386	Body mass index	2e-09	36581621
rs12147217	rs1255908	0.709188966258663	PR interval	8e-14	32439900
rs12147217	rs1255908	0.709188966258663	PR interval	6e-14	32439900
rs1214752	rs1214752	1	Coronary artery disease	1e-06	29212778
rs1214752	rs9394952	0.641844837233931	Age-related hearing impairment	3e-11	34108613
rs1214752	rs4714680	0.610451507401411	Height	2e-09	34594039
rs1214752	rs4714680	0.610451507401411	Hip circumference adjusted for BMI	4e-08	34021172
rs12150317	rs12949545	0.833245064250135	Highest math class taken (MTAG)	3e-08	30038396
rs12152336	rs7610312	0.997507911336935	Red blood cell count	5e-09	27863252
rs12152336	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs12152336	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs12152336	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs12152336	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs12152336	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs12152336	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs12152336	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs12152336	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs12152336	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs12152336	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs12152336	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs12152336	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs12152336	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs12152336	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs12152336	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs12152336	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs12152336	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs12152336	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs12152336	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs12152336	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs12152336	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs12152336	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs12152336	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs12152336	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs12152336	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs12152337	rs7610312	0.996262025068184	Red blood cell count	5e-09	27863252
rs12152337	rs6775517	0.995028828030816	Hematocrit	1e-17	34594039
rs12152337	rs57700771	0.990036982637881	Red blood cell count	9e-21	30595370
rs12152337	rs11705721	0.975533272989242	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs12152337	rs11130638	0.973088134374053	Hemoglobin concentration	2e-23	32888493
rs12152337	rs34579268	0.965948032289439	Hematocrit	5e-30	32888493
rs12152337	rs34579268	0.965948032289439	Hematocrit	2e-27	32888493
rs12152337	rs34579268	0.965948032289439	Hemoglobin concentration	5e-26	32888493
rs12152337	rs55704295	0.92132923533695	Red blood cell count	8e-26	32888493
rs12152337	rs55704295	0.92132923533695	Red blood cell count	5e-23	32888493
rs12152337	rs55704295	0.92132923533695	Serum total protein level	2e-29	34594039
rs12152337	rs4681679	0.891178409312595	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs12152337	rs11719450	0.864779036123091	Hemoglobin concentration	2e-09	27863252
rs12152337	rs11719450	0.864779036123091	Hemoglobin levels	2e-16	32327693
rs12152337	rs56384862	0.853252345707702	Body mass index	8e-12	29273807
rs12152337	rs56384862	0.853252345707702	Body mass index	3e-06	30108127
rs12152337	rs56384862	0.853252345707702	Hemoglobin levels	1e-16	32327693
rs12152337	rs56384862	0.853252345707702	Body mass index	3e-14	36581621
rs12152337	rs11922478	0.850585315479344	Semaphorin-6B levels	4e-12	34648354
rs12152337	rs55692656	0.833938044592497	vWF levels	3e-08	30586737
rs12152337	rs55692656	0.833938044592497	vWF levels	6e-09	30586737
rs12152337	rs6445969	0.700217521146712	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs12152337	rs11708895	0.696188630969468	Red blood cell count	1e-20	32888494
rs12152337	rs55954186	0.691785955296345	vWF levels	5e-09	30586737
rs12152337	rs55954186	0.691785955296345	vWF levels	9e-09	30586737
rs12152337	rs7431952	0.628500341709349	Hemoglobin levels	1e-12	32327693
rs1216566	rs2549794	0.985817574002442	Crohn's disease	1e-10	21102463
rs1216566	rs2549794	0.985817574002442	Systolic blood pressure	1e-07	33230300
rs1216566	rs2549794	0.985817574002442	Diastolic blood pressure	1e-15	33230300
rs1216566	rs2549794	0.985817574002442	Diastolic blood pressure	2e-12	33230300
rs1216566	rs2549794	0.985817574002442	Systolic blood pressure	4e-10	33230300
rs1216566	rs1363907	0.984063398686924	Crohn's disease	4e-16	26192919
rs1216566	rs1363907	0.984063398686924	Ulcerative colitis	4e-06	26192919
rs1216566	rs1363907	0.984063398686924	Inflammatory bowel disease	5e-15	26192919
rs1216566	rs1363907	0.984063398686924	Inflammatory bowel disease	6e-13	23128233
rs1216566	rs1363907	0.984063398686924	Inflammatory bowel disease	1e-10	28067908
rs1216566	rs1363907	0.984063398686924	Crohn's disease	1e-14	28067908
rs1216566	rs2617439	0.956648864763054	Neutrophil count	8e-11	32888494
rs1216566	rs716848	0.953230785839892	Neutrophil percentage of white cells	2e-09	32888494
rs1216566	rs38029	0.944618169028889	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1216566	rs2548532	0.884056058078882	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1216566	rs27660	0.79044592981686	Coronary artery disease	3e-08	35915156
rs1216566	rs1423357	0.779122425297551	General cognitive ability	9e-06	29844566
rs1216566	rs2432142	0.764087371724239	Neutrophil count	2e-14	32888493
rs1216566	rs2432142	0.764087371724239	White blood cell count	1e-11	32888493
rs1216566	rs38033	0.762292638028374	Blood protein levels	0	30072576
rs1216566	rs27293	0.753679178609643	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1216566	rs27293	0.753679178609643	Diastolic blood pressure	3e-11	35762941
rs1216566	rs7705093	0.74421427737538	Birdshot chorioretinopathy	2e-09	24957906
rs1216566	rs4869313	0.713453886718405	Pediatric autoimmune diseases	9e-08	26301688
rs1216566	rs2927608	0.710692929216121	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1216566	rs2927608	0.710692929216121	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1216566	rs2927608	0.710692929216121	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1216566	rs2910686	0.708359086902875	Neutrophil count	4e-14	32888493
rs1216566	rs2910686	0.708359086902875	Psoriasis	2e-08	23143594
rs1216566	rs2910686	0.708359086902875	Ankylosing spondylitis	5e-17	23749187
rs1216566	rs2910686	0.708359086902875	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1216566	rs1559359	0.645871548042299	Diastolic blood pressure	7e-10	34594039
rs1216566	rs1974871	0.640964414989154	Granulysin levels	5e-13	34648354
rs1216566	rs2549797	0.628888417970098	Systolic blood pressure	7e-07	33230300
rs1216566	rs2549797	0.628888417970098	Diastolic blood pressure	1e-14	33230300
rs1216566	rs2549797	0.628888417970098	Diastolic blood pressure	3e-11	33230300
rs1216566	rs2549797	0.628888417970098	Systolic blood pressure	4e-09	33230300
rs1216566	rs2549782	0.627871770928677	Systolic blood pressure	6e-07	33230300
rs1216566	rs2549782	0.627871770928677	Diastolic blood pressure	1e-14	33230300
rs1216566	rs2549782	0.627871770928677	Diastolic blood pressure	3e-11	33230300
rs1216566	rs2549782	0.627871770928677	Systolic blood pressure	5e-09	33230300
rs1216566	rs1056893	0.627364128502738	Systolic blood pressure	1e-06	33230300
rs1216566	rs1056893	0.627364128502738	Diastolic blood pressure	7e-15	33230300
rs1216566	rs1056893	0.627364128502738	Diastolic blood pressure	2e-11	33230300
rs1216566	rs1056893	0.627364128502738	Systolic blood pressure	7e-09	33230300
rs1216567	rs2549794	0.985817574002442	Crohn's disease	1e-10	21102463
rs1216567	rs2549794	0.985817574002442	Systolic blood pressure	1e-07	33230300
rs1216567	rs2549794	0.985817574002442	Diastolic blood pressure	1e-15	33230300
rs1216567	rs2549794	0.985817574002442	Diastolic blood pressure	2e-12	33230300
rs1216567	rs2549794	0.985817574002442	Systolic blood pressure	4e-10	33230300
rs1216567	rs1363907	0.984063398686924	Crohn's disease	4e-16	26192919
rs1216567	rs1363907	0.984063398686924	Ulcerative colitis	4e-06	26192919
rs1216567	rs1363907	0.984063398686924	Inflammatory bowel disease	5e-15	26192919
rs1216567	rs1363907	0.984063398686924	Inflammatory bowel disease	6e-13	23128233
rs1216567	rs1363907	0.984063398686924	Inflammatory bowel disease	1e-10	28067908
rs1216567	rs1363907	0.984063398686924	Crohn's disease	1e-14	28067908
rs1216567	rs2617439	0.956648864763054	Neutrophil count	8e-11	32888494
rs1216567	rs716848	0.953230785839892	Neutrophil percentage of white cells	2e-09	32888494
rs1216567	rs38029	0.944618169028889	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1216567	rs2548532	0.884056058078882	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1216567	rs27660	0.79044592981686	Coronary artery disease	3e-08	35915156
rs1216567	rs1423357	0.779122425297551	General cognitive ability	9e-06	29844566
rs1216567	rs2432142	0.764087371724239	Neutrophil count	2e-14	32888493
rs1216567	rs2432142	0.764087371724239	White blood cell count	1e-11	32888493
rs1216567	rs38033	0.762292638028374	Blood protein levels	0	30072576
rs1216567	rs27293	0.753679178609643	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1216567	rs27293	0.753679178609643	Diastolic blood pressure	3e-11	35762941
rs1216567	rs7705093	0.74421427737538	Birdshot chorioretinopathy	2e-09	24957906
rs1216567	rs4869313	0.713453886718405	Pediatric autoimmune diseases	9e-08	26301688
rs1216567	rs2927608	0.710692929216121	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1216567	rs2927608	0.710692929216121	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1216567	rs2927608	0.710692929216121	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1216567	rs2910686	0.708359086902875	Neutrophil count	4e-14	32888493
rs1216567	rs2910686	0.708359086902875	Psoriasis	2e-08	23143594
rs1216567	rs2910686	0.708359086902875	Ankylosing spondylitis	5e-17	23749187
rs1216567	rs2910686	0.708359086902875	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1216567	rs1559359	0.645871548042299	Diastolic blood pressure	7e-10	34594039
rs1216567	rs1974871	0.640964414989154	Granulysin levels	5e-13	34648354
rs1216567	rs2549797	0.628888417970098	Systolic blood pressure	7e-07	33230300
rs1216567	rs2549797	0.628888417970098	Diastolic blood pressure	1e-14	33230300
rs1216567	rs2549797	0.628888417970098	Diastolic blood pressure	3e-11	33230300
rs1216567	rs2549797	0.628888417970098	Systolic blood pressure	4e-09	33230300
rs1216567	rs2549782	0.627871770928677	Systolic blood pressure	6e-07	33230300
rs1216567	rs2549782	0.627871770928677	Diastolic blood pressure	1e-14	33230300
rs1216567	rs2549782	0.627871770928677	Diastolic blood pressure	3e-11	33230300
rs1216567	rs2549782	0.627871770928677	Systolic blood pressure	5e-09	33230300
rs1216567	rs1056893	0.627364128502738	Systolic blood pressure	1e-06	33230300
rs1216567	rs1056893	0.627364128502738	Diastolic blood pressure	7e-15	33230300
rs1216567	rs1056893	0.627364128502738	Diastolic blood pressure	2e-11	33230300
rs1216567	rs1056893	0.627364128502738	Systolic blood pressure	7e-09	33230300
rs1216571	rs2549794	0.985817574002442	Crohn's disease	1e-10	21102463
rs1216571	rs2549794	0.985817574002442	Systolic blood pressure	1e-07	33230300
rs1216571	rs2549794	0.985817574002442	Diastolic blood pressure	1e-15	33230300
rs1216571	rs2549794	0.985817574002442	Diastolic blood pressure	2e-12	33230300
rs1216571	rs2549794	0.985817574002442	Systolic blood pressure	4e-10	33230300
rs1216571	rs1363907	0.984063398686924	Crohn's disease	4e-16	26192919
rs1216571	rs1363907	0.984063398686924	Ulcerative colitis	4e-06	26192919
rs1216571	rs1363907	0.984063398686924	Inflammatory bowel disease	5e-15	26192919
rs1216571	rs1363907	0.984063398686924	Inflammatory bowel disease	6e-13	23128233
rs1216571	rs1363907	0.984063398686924	Inflammatory bowel disease	1e-10	28067908
rs1216571	rs1363907	0.984063398686924	Crohn's disease	1e-14	28067908
rs1216571	rs2617439	0.956648864763054	Neutrophil count	8e-11	32888494
rs1216571	rs716848	0.953230785839892	Neutrophil percentage of white cells	2e-09	32888494
rs1216571	rs38029	0.944618169028889	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1216571	rs2548532	0.884056058078882	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1216571	rs27660	0.79044592981686	Coronary artery disease	3e-08	35915156
rs1216571	rs1423357	0.779122425297551	General cognitive ability	9e-06	29844566
rs1216571	rs2432142	0.764087371724239	Neutrophil count	2e-14	32888493
rs1216571	rs2432142	0.764087371724239	White blood cell count	1e-11	32888493
rs1216571	rs38033	0.762292638028374	Blood protein levels	0	30072576
rs1216571	rs27293	0.753679178609643	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1216571	rs27293	0.753679178609643	Diastolic blood pressure	3e-11	35762941
rs1216571	rs7705093	0.74421427737538	Birdshot chorioretinopathy	2e-09	24957906
rs1216571	rs4869313	0.713453886718405	Pediatric autoimmune diseases	9e-08	26301688
rs1216571	rs2927608	0.710692929216121	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1216571	rs2927608	0.710692929216121	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1216571	rs2927608	0.710692929216121	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1216571	rs2910686	0.708359086902875	Neutrophil count	4e-14	32888493
rs1216571	rs2910686	0.708359086902875	Psoriasis	2e-08	23143594
rs1216571	rs2910686	0.708359086902875	Ankylosing spondylitis	5e-17	23749187
rs1216571	rs2910686	0.708359086902875	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1216571	rs1559359	0.645871548042299	Diastolic blood pressure	7e-10	34594039
rs1216571	rs1974871	0.640964414989154	Granulysin levels	5e-13	34648354
rs1216571	rs2549797	0.628888417970098	Systolic blood pressure	7e-07	33230300
rs1216571	rs2549797	0.628888417970098	Diastolic blood pressure	1e-14	33230300
rs1216571	rs2549797	0.628888417970098	Diastolic blood pressure	3e-11	33230300
rs1216571	rs2549797	0.628888417970098	Systolic blood pressure	4e-09	33230300
rs1216571	rs2549782	0.627871770928677	Systolic blood pressure	6e-07	33230300
rs1216571	rs2549782	0.627871770928677	Diastolic blood pressure	1e-14	33230300
rs1216571	rs2549782	0.627871770928677	Diastolic blood pressure	3e-11	33230300
rs1216571	rs2549782	0.627871770928677	Systolic blood pressure	5e-09	33230300
rs1216571	rs1056893	0.627364128502738	Systolic blood pressure	1e-06	33230300
rs1216571	rs1056893	0.627364128502738	Diastolic blood pressure	7e-15	33230300
rs1216571	rs1056893	0.627364128502738	Diastolic blood pressure	2e-11	33230300
rs1216571	rs1056893	0.627364128502738	Systolic blood pressure	7e-09	33230300
rs12174716	rs9505982	0.973508666178487	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs12174716	rs11155671	0.949041222730362	Testicular germ cell tumor	2e-09	28604728
rs12174716	rs4380763	0.935737969996025	Subcortical volume (min-P)	1e-11	32665545
rs12174716	rs1934534	0.934965110040512	Pain (pleiotropy)	2e-08	37844115
rs12174716	rs1934534	0.934965110040512	Pain (pleiotropy)	2e-06	37844115
rs12174716	rs80147756	0.896087982969853	HippSubfield lh volume subiculum-head	3e-10	33875891
rs12174716	rs4421206	0.894697440809314	Brain morphology (min-P)	4e-11	32665545
rs12174716	rs9688452	0.87548217712304	Brainstem global volume Whole-brainstem	1e-11	33875891
rs12174716	rs9688452	0.87548217712304	aseg lh volume VentralDC	2e-10	33875891
rs12174716	rs9322194	0.829641770646195	Brainstem volume	2e-11	31636452
rs12174716	rs10872649	0.822653545360237	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs12174716	rs10872649	0.822653545360237	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs12174716	rs10872649	0.822653545360237	Right hippocampal volume (body)	1e-10	37337106
rs12174716	rs7752089	0.793626174539809	Brain morphology (MOSTest)	2e-31	35164939
rs12174716	rs9285521	0.705895954660876	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs12174716	rs12526675	0.621440741374097	Brain morphology (MOSTest)	7e-22	32665545
rs12174716	rs9688809	0.608739390911716	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs12174716	rs34337297	0.60583660335374	Serum levels of protein LRP11	3e-161	35078996
rs12174716	rs10872645	0.605063705788907	Blood protein levels	2e-86	30072576
rs12174716	rs14314	0.603989431900568	Macular thickness	3e-19	30535121
rs12174716	rs14314	0.603989431900568	Vertex-wise sulcal depth	7e-17	34910505
rs12174716	rs14314	0.603989431900568	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs12174716	rs14314	0.603989431900568	Left hippocampal volume (body)	7e-15	37337106
rs12174716	rs14314	0.603989431900568	Left subiculum volume (body)	1e-14	37337106
rs12174716	rs55763431	0.603737325452575	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs12174716	rs9322193	0.603150456017381	Lung cancer	1e-07	27393504
rs12174716	rs9689694	0.60262941514447	Right hippocampal volume (head)	6e-11	37337106
rs12174716	rs9689694	0.60262941514447	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs12174716	rs9689694	0.60262941514447	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs12174716	rs9689694	0.60262941514447	Left hippocampal volume (head)	6e-12	37337106
rs12174716	rs9383843	0.601305308447833	Migraine	1e-09	35115687
rs12174716	rs2095375	0.600752259343354	Serum metabolite levels	1e-20	33031748
rs12174716	rs2095375	0.600752259343354	Serum metabolite levels	1e-20	33031748
rs12176034	rs56103941	0.960694458739035	Right presubiculum volume (head)	4e-08	37337106
rs12176034	rs12523793	0.929579652334047	Subcortical volume (MOSTest)	4e-24	32665545
rs12176034	rs12523793	0.929579652334047	C-reactive protein levels	3e-08	35459240
rs12176034	rs12523793	0.929579652334047	C-reactive protein levels (MTAG)	2e-08	36376304
rs12176034	rs11155662	0.910723926455738	Vertex-wise cortical thickness	2e-09	34910505
rs12176034	rs12526675	0.865783414175787	Brain morphology (MOSTest)	7e-22	32665545
rs12176034	rs2342764	0.804338926714567	Cortical thickness	1e-08	34560273
rs12176034	rs58189451	0.741781469648161	Drinks per week	1e-09	36477530
rs12176034	rs9285521	0.732910747668455	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs12176034	rs7752089	0.649260973836226	Brain morphology (MOSTest)	2e-31	35164939
rs12176034	rs9322194	0.647088217532619	Brainstem volume	2e-11	31636452
rs12176034	rs10872649	0.62527172981678	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs12176034	rs10872649	0.62527172981678	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs12176034	rs10872649	0.62527172981678	Right hippocampal volume (body)	1e-10	37337106
rs12176034	rs11155675	0.624033276571437	Brain region volumes	3e-09	31676860
rs12176034	rs1125	0.618431110321524	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs12176034	rs1125	0.618431110321524	Vertical cup-disc ratio	8e-14	34077760
rs12176034	rs9371201	0.613996917112888	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs12177835	rs9462030	0.995175518696793	Red cell distribution width	5e-25	32888493
rs12177835	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs12177835	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs12177835	rs9469899	0.978497589843936	Prostate cancer (advanced)	2e-06	29892016
rs12177835	rs9469899	0.978497589843936	Prostate cancer	5e-09	29892016
rs12177835	rs9469899	0.978497589843936	Prostate cancer	8e-11	33398198
rs12177835	rs9469899	0.978497589843936	Hand grip strength	3e-15	29691431
rs12177835	rs9469899	0.978497589843936	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs12177835	rs9469899	0.978497589843936	Graves' disease	4e-10	34594039
rs12177835	rs9469899	0.978497589843936	Coronary artery disease	1e-11	36474045
rs12177835	rs9469899	0.978497589843936	Predicted visceral adipose tissue	2e-20	31501611
rs12177835	rs9469899	0.978497589843936	Medication use (thyroid preparations)	2e-09	31015401
rs12177835	rs9469899	0.978497589843936	Medication use (thyroid preparations)	3e-10	34594039
rs12177835	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs12177835	rs11755393	0.947554267093235	Body mass index	3e-26	29273807
rs12177835	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-12	33493351
rs12177835	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-06	33493351
rs12177835	rs11755393	0.947554267093235	Systemic lupus erythematosus	1e-07	33493351
rs12177835	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-08	19838195
rs12177835	rs11755393	0.947554267093235	Body mass index	4e-55	36581621
rs12177835	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs12177835	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs12177835	rs6941110	0.936033811762549	Sex hormone-binding globulin levels	5e-27	36653534
rs12177835	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs12177835	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs12177835	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs12177835	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs12177835	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs12177835	rs2263329	0.874645285202942	HDL cholesterol	6e-35	34594039
rs12177835	rs2263329	0.874645285202942	HDL cholesterol levels	8e-43	32203549
rs12177835	rs2263329	0.874645285202942	High density lipoprotein cholesterol levels	2e-52	34887591
rs12177835	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs12177835	rs9368830	0.830084187792525	HDL cholesterol	4e-21	30275531
rs12177835	rs9368828	0.803658173339717	Body mass index	1e-34	34594039
rs12177835	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs12177835	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs12177835	rs2744973	0.800145420504899	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs12177835	rs2744973	0.800145420504899	Multi-trait sex score	6e-20	37277458
rs12177835	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs12177835	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs12177835	rs112283401	0.769696819914803	Red cell distribution width	4e-27	30595370
rs12177835	rs9689160	0.627575422825611	Lung function (forced vital capacity)	3e-14	36914875
rs12184292	rs11580836	0.988469156161941	Body mass index	2e-09	36581621
rs12184292	rs10465746	0.969495485519888	Obesity-related traits	8e-06	23251661
rs12189125	rs1974871	0.990233097273986	Granulysin levels	5e-13	34648354
rs12189125	rs4869313	0.895416332372459	Pediatric autoimmune diseases	9e-08	26301688
rs12189125	rs4869314	0.835444042909515	Arthritis (juvenile idiopathic)	3e-09	33106285
rs12189125	rs4869314	0.835444042909515	Neutrophil count	1e-10	34594039
rs12189125	rs4869314	0.835444042909515	White blood cell count	2e-07	30595370
rs12189125	rs2549782	0.786965459272757	Systolic blood pressure	6e-07	33230300
rs12189125	rs2549782	0.786965459272757	Diastolic blood pressure	1e-14	33230300
rs12189125	rs2549782	0.786965459272757	Diastolic blood pressure	3e-11	33230300
rs12189125	rs2549782	0.786965459272757	Systolic blood pressure	5e-09	33230300
rs12189125	rs2549797	0.786890480087216	Systolic blood pressure	7e-07	33230300
rs12189125	rs2549797	0.786890480087216	Diastolic blood pressure	1e-14	33230300
rs12189125	rs2549797	0.786890480087216	Diastolic blood pressure	3e-11	33230300
rs12189125	rs2549797	0.786890480087216	Systolic blood pressure	4e-09	33230300
rs12189125	rs1056893	0.784843215082667	Systolic blood pressure	1e-06	33230300
rs12189125	rs1056893	0.784843215082667	Diastolic blood pressure	7e-15	33230300
rs12189125	rs1056893	0.784843215082667	Diastolic blood pressure	2e-11	33230300
rs12189125	rs1056893	0.784843215082667	Systolic blood pressure	7e-09	33230300
rs12189125	rs1559359	0.755669919684015	Diastolic blood pressure	7e-10	34594039
rs12189125	rs2927608	0.739869747532583	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs12189125	rs2927608	0.739869747532583	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs12189125	rs2927608	0.739869747532583	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs12189125	rs2910686	0.737062648257549	Neutrophil count	4e-14	32888493
rs12189125	rs2910686	0.737062648257549	Psoriasis	2e-08	23143594
rs12189125	rs2910686	0.737062648257549	Ankylosing spondylitis	5e-17	23749187
rs12189125	rs2910686	0.737062648257549	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs12189125	rs1019503	0.673957524180627	Systolic blood pressure	2e-06	33230300
rs12189125	rs1019503	0.673957524180627	Diastolic blood pressure	2e-14	33230300
rs12189125	rs1019503	0.673957524180627	Diastolic blood pressure	4e-11	33230300
rs12189125	rs1019503	0.673957524180627	Systolic blood pressure	1e-08	33230300
rs12189125	rs3096168	0.66832890402965	Aspartate aminotransferase levels	8e-12	33547301
rs12189125	rs2549794	0.646409978455324	Crohn's disease	1e-10	21102463
rs12189125	rs2549794	0.646409978455324	Systolic blood pressure	1e-07	33230300
rs12189125	rs2549794	0.646409978455324	Diastolic blood pressure	1e-15	33230300
rs12189125	rs2549794	0.646409978455324	Diastolic blood pressure	2e-12	33230300
rs12189125	rs2549794	0.646409978455324	Systolic blood pressure	4e-10	33230300
rs12189125	rs716848	0.643267021315707	Neutrophil percentage of white cells	2e-09	32888494
rs12189125	rs1363907	0.6421379192888	Crohn's disease	4e-16	26192919
rs12189125	rs1363907	0.6421379192888	Ulcerative colitis	4e-06	26192919
rs12189125	rs1363907	0.6421379192888	Inflammatory bowel disease	5e-15	26192919
rs12189125	rs1363907	0.6421379192888	Inflammatory bowel disease	6e-13	23128233
rs12189125	rs1363907	0.6421379192888	Inflammatory bowel disease	1e-10	28067908
rs12189125	rs1363907	0.6421379192888	Crohn's disease	1e-14	28067908
rs12189125	rs1423357	0.639166556012	General cognitive ability	9e-06	29844566
rs12189125	rs2432142	0.625932588393455	Neutrophil count	2e-14	32888493
rs12189125	rs2432142	0.625932588393455	White blood cell count	1e-11	32888493
rs12189125	rs38033	0.621496703134634	Blood protein levels	0	30072576
rs12189125	rs27293	0.611804329053508	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs12189125	rs27293	0.611804329053508	Diastolic blood pressure	3e-11	35762941
rs12189125	rs2617439	0.609592684718481	Neutrophil count	8e-11	32888494
rs12189125	rs7705093	0.604347751793237	Birdshot chorioretinopathy	2e-09	24957906
rs12191637	rs2842611	0.600486785761411	High density lipoprotein cholesterol levels	5e-09	34887591
rs12193777	rs2842611	0.925852818327252	High density lipoprotein cholesterol levels	5e-09	34887591
rs12193777	rs1173416	0.909320527165816	Height	2e-59	36224396
rs12193777	rs9450288	0.881195187740879	Height	2e-10	36224396
rs12201281	rs9366863	0.996789482122815	Adult body size	9e-33	32376654
rs12201281	rs9366863	0.996789482122815	Body mass index	2e-44	30595370
rs12201281	rs9469872	0.967321616804907	HDL cholesterol levels	3e-11	36333282
rs12201281	rs2814949	0.965789213116863	Essential hypertension (time to event)	9e-09	32589924
rs12201281	rs11755393	0.96042432428924	Body mass index	3e-26	29273807
rs12201281	rs11755393	0.96042432428924	Systemic lupus erythematosus	2e-12	33493351
rs12201281	rs11755393	0.96042432428924	Systemic lupus erythematosus	2e-06	33493351
rs12201281	rs11755393	0.96042432428924	Systemic lupus erythematosus	1e-07	33493351
rs12201281	rs11755393	0.96042432428924	Systemic lupus erythematosus	2e-08	19838195
rs12201281	rs11755393	0.96042432428924	Body mass index	4e-55	36581621
rs12201281	rs2744944	0.956284829294483	Hypothyroidism	3e-10	34594039
rs12201281	rs2744944	0.956284829294483	High density lipoprotein cholesterol levels	3e-86	34887591
rs12201281	rs2744944	0.956284829294483	Multi-trait sex score	7e-22	37277458
rs12201281	rs6941110	0.950771893021151	Sex hormone-binding globulin levels	5e-27	36653534
rs12201281	rs2263329	0.936708028958723	HDL cholesterol	6e-35	34594039
rs12201281	rs2263329	0.936708028958723	HDL cholesterol levels	8e-43	32203549
rs12201281	rs2263329	0.936708028958723	High density lipoprotein cholesterol levels	2e-52	34887591
rs12201281	rs9462030	0.931419479830988	Red cell distribution width	5e-25	32888493
rs12201281	rs9469857	0.926803412921535	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs12201281	rs2764208	0.926061584984758	Systemic lupus erythematosus	7e-06	24871463
rs12201281	rs9469899	0.915040259384048	Prostate cancer (advanced)	2e-06	29892016
rs12201281	rs9469899	0.915040259384048	Prostate cancer	5e-09	29892016
rs12201281	rs9469899	0.915040259384048	Prostate cancer	8e-11	33398198
rs12201281	rs9469899	0.915040259384048	Hand grip strength	3e-15	29691431
rs12201281	rs9469899	0.915040259384048	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs12201281	rs9469899	0.915040259384048	Graves' disease	4e-10	34594039
rs12201281	rs9469899	0.915040259384048	Coronary artery disease	1e-11	36474045
rs12201281	rs9469899	0.915040259384048	Predicted visceral adipose tissue	2e-20	31501611
rs12201281	rs9469899	0.915040259384048	Medication use (thyroid preparations)	2e-09	31015401
rs12201281	rs9469899	0.915040259384048	Medication use (thyroid preparations)	3e-10	34594039
rs12201281	rs111868030	0.91193218776079	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs12201281	rs9368830	0.887660633514307	HDL cholesterol	4e-21	30275531
rs12201281	rs9296128	0.878313187390349	Hip circumference adjusted for BMI	4e-13	34021172
rs12201281	rs9368828	0.857518935783425	Body mass index	1e-34	34594039
rs12201281	rs6912327	0.80645255635335	Fasting insulin	5e-06	33402679
rs12201281	rs6912327	0.80645255635335	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs12201281	rs2744973	0.801999104898128	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs12201281	rs2744973	0.801999104898128	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs12201281	rs2744973	0.801999104898128	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs12201281	rs2744973	0.801999104898128	Multi-trait sex score	6e-20	37277458
rs12201281	rs112283401	0.783948645861745	Red cell distribution width	4e-27	30595370
rs12201281	rs6940215	0.634489426722422	Insomnia	2e-10	35835914
rs12201281	rs6940215	0.634489426722422	Insomnia	1e-13	35835914
rs12201281	rs6940215	0.634489426722422	Hip circumference adjusted for BMI	8e-10	34021172
rs12201281	rs6940215	0.634489426722422	Multi-trait sex score	2e-23	37277458
rs12201281	rs6940215	0.634489426722422	Multi-trait sex score	4e-23	37277458
rs12201281	rs6457796	0.625243499218886	Insomnia	1e-08	30804565
rs12201281	rs6457796	0.625243499218886	Plateletcrit	9e-11	32888494
rs12201281	rs6457796	0.625243499218886	Systemic lupus erythematosus	3e-22	33272962
rs12201281	rs6457796	0.625243499218886	Body mass index	5e-13	30108127
rs12201281	rs6457796	0.625243499218886	Body mass index	1e-14	26426971
rs12201281	rs6457796	0.625243499218886	Educational attainment	5e-19	35361970
rs12201281	rs205262	0.613335619305583	Body mass index	2e-09	26961502
rs12201281	rs205262	0.613335619305583	Walking pace	4e-10	33128006
rs12201281	rs205262	0.613335619305583	Body mass index	8e-13	30108127
rs12201281	rs205262	0.613335619305583	Body mass index	2e-09	25673413
rs12201281	rs205262	0.613335619305583	Body mass index	2e-14	26426971
rs12201281	rs205262	0.613335619305583	BMI in non-smokers	3e-07	28443625
rs12201281	rs205262	0.613335619305583	BMI in non-smokers	6e-09	28443625
rs12201281	rs205262	0.613335619305583	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs12201281	rs205262	0.613335619305583	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs12201281	rs205262	0.613335619305583	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs12201281	rs205262	0.613335619305583	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs12201281	rs205262	0.613335619305583	Gastroesophageal reflux disease	1e-10	34187846
rs12201281	rs205262	0.613335619305583	Body mass index	3e-10	25673413
rs12201281	rs205262	0.613335619305583	Body mass index	2e-10	25673413
rs12201281	rs205262	0.613335619305583	ICD10 M54: Dorsalgia	2e-12	35110524
rs12201281	rs9689160	0.604502119718961	Lung function (forced vital capacity)	3e-14	36914875
rs12203963	rs2842611	0.923440358542311	High density lipoprotein cholesterol levels	5e-09	34887591
rs12203963	rs1173416	0.907016127412856	Height	2e-59	36224396
rs12203963	rs9450288	0.881914095288778	Height	2e-10	36224396
rs12205092	rs56103941	0.98221398955644	Right presubiculum volume (head)	4e-08	37337106
rs12205092	rs12523793	0.941844916981034	Subcortical volume (MOSTest)	4e-24	32665545
rs12205092	rs12523793	0.941844916981034	C-reactive protein levels	3e-08	35459240
rs12205092	rs12523793	0.941844916981034	C-reactive protein levels (MTAG)	2e-08	36376304
rs12205092	rs11155662	0.924309612979751	Vertex-wise cortical thickness	2e-09	34910505
rs12205092	rs12526675	0.886843888482327	Brain morphology (MOSTest)	7e-22	32665545
rs12205092	rs2342764	0.823757696334349	Cortical thickness	1e-08	34560273
rs12205092	rs58189451	0.752529732957725	Drinks per week	1e-09	36477530
rs12205092	rs9285521	0.741841255366786	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs12205092	rs7752089	0.664334710051987	Brain morphology (MOSTest)	2e-31	35164939
rs12205092	rs9322194	0.65482005424553	Brainstem volume	2e-11	31636452
rs12205092	rs10872649	0.641016148632241	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs12205092	rs10872649	0.641016148632241	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs12205092	rs10872649	0.641016148632241	Right hippocampal volume (body)	1e-10	37337106
rs12205092	rs11155675	0.637972818030396	Brain region volumes	3e-09	31676860
rs12205092	rs1125	0.632298220154184	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs12205092	rs1125	0.632298220154184	Vertical cup-disc ratio	8e-14	34077760
rs12205092	rs9371201	0.629205668462273	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs12205092	rs4421206	0.613980424572745	Brain morphology (min-P)	4e-11	32665545
rs12206573	rs2842611	0.925852818327252	High density lipoprotein cholesterol levels	5e-09	34887591
rs12206573	rs1173416	0.910874437025469	Height	2e-59	36224396
rs12206573	rs9450288	0.882719052997207	Height	2e-10	36224396
rs12213779	rs55763431	0.999100898383198	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs12213779	rs9689694	0.997304309335619	Right hippocampal volume (head)	6e-11	37337106
rs12213779	rs9689694	0.997304309335619	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs12213779	rs9689694	0.997304309335619	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs12213779	rs9689694	0.997304309335619	Left hippocampal volume (head)	6e-12	37337106
rs12213779	rs2095375	0.994611041252096	Serum metabolite levels	1e-20	33031748
rs12213779	rs2095375	0.994611041252096	Serum metabolite levels	1e-20	33031748
rs12213779	rs9383843	0.993713293512006	Migraine	1e-09	35115687
rs12213779	rs10872645	0.991921031227827	Blood protein levels	2e-86	30072576
rs12213779	rs9688867	0.991050053070433	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs12213779	rs9688867	0.991050053070433	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs12213779	rs9688809	0.991050053070433	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs12213779	rs10872653	0.991028598695202	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs12213779	rs34337297	0.987445481699736	Serum levels of protein LRP11	3e-161	35078996
rs12213779	rs14314	0.975912726634237	Macular thickness	3e-19	30535121
rs12213779	rs14314	0.975912726634237	Vertex-wise sulcal depth	7e-17	34910505
rs12213779	rs14314	0.975912726634237	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs12213779	rs14314	0.975912726634237	Left hippocampal volume (body)	7e-15	37337106
rs12213779	rs14314	0.975912726634237	Left subiculum volume (body)	1e-14	37337106
rs12213779	rs9322193	0.951324487658223	Lung cancer	1e-07	27393504
rs12213779	rs4039600	0.907699535974971	Adenine levels	1e-11	35347128
rs12213779	rs1934534	0.641181263206031	Pain (pleiotropy)	2e-08	37844115
rs12213779	rs1934534	0.641181263206031	Pain (pleiotropy)	2e-06	37844115
rs12213779	rs4380763	0.640658612653105	Subcortical volume (min-P)	1e-11	32665545
rs12213779	rs11155671	0.630211864027202	Testicular germ cell tumor	2e-09	28604728
rs12213779	rs80147756	0.615284344343926	HippSubfield lh volume subiculum-head	3e-10	33875891
rs12213779	rs4421206	0.607684183816724	Brain morphology (min-P)	4e-11	32665545
rs12213779	rs9505982	0.601171815167425	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs12234128	rs9505982	0.963314429434118	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs12234128	rs11155671	0.962248666178789	Testicular germ cell tumor	2e-09	28604728
rs12234128	rs1934534	0.949574241198072	Pain (pleiotropy)	2e-08	37844115
rs12234128	rs1934534	0.949574241198072	Pain (pleiotropy)	2e-06	37844115
rs12234128	rs4380763	0.948780128879162	Subcortical volume (min-P)	1e-11	32665545
rs12234128	rs80147756	0.907625881947008	HippSubfield lh volume subiculum-head	3e-10	33875891
rs12234128	rs4421206	0.901750629996866	Brain morphology (min-P)	4e-11	32665545
rs12234128	rs9688452	0.882187015117132	Brainstem global volume Whole-brainstem	1e-11	33875891
rs12234128	rs9688452	0.882187015117132	aseg lh volume VentralDC	2e-10	33875891
rs12234128	rs10872649	0.836961223512305	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs12234128	rs10872649	0.836961223512305	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs12234128	rs10872649	0.836961223512305	Right hippocampal volume (body)	1e-10	37337106
rs12234128	rs9322194	0.817369688420409	Brainstem volume	2e-11	31636452
rs12234128	rs7752089	0.80381370706851	Brain morphology (MOSTest)	2e-31	35164939
rs12234128	rs9285521	0.696700170827016	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs12234128	rs12526675	0.63009657715211	Brain morphology (MOSTest)	7e-22	32665545
rs12234128	rs9688809	0.622380263325635	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs12234128	rs34337297	0.619387009880427	Serum levels of protein LRP11	3e-161	35078996
rs12234128	rs10872645	0.618609955516243	Blood protein levels	2e-86	30072576
rs12234128	rs14314	0.617576643978536	Macular thickness	3e-19	30535121
rs12234128	rs14314	0.617576643978536	Vertex-wise sulcal depth	7e-17	34910505
rs12234128	rs14314	0.617576643978536	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs12234128	rs14314	0.617576643978536	Left hippocampal volume (body)	7e-15	37337106
rs12234128	rs14314	0.617576643978536	Left subiculum volume (body)	1e-14	37337106
rs12234128	rs55763431	0.617267105499172	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs12234128	rs9322193	0.616770679099916	Lung cancer	1e-07	27393504
rs12234128	rs9689694	0.616134589257647	Right hippocampal volume (head)	6e-11	37337106
rs12234128	rs9689694	0.616134589257647	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs12234128	rs9689694	0.616134589257647	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs12234128	rs9689694	0.616134589257647	Left hippocampal volume (head)	6e-12	37337106
rs12234128	rs9383843	0.614794026484087	Migraine	1e-09	35115687
rs12234128	rs2095375	0.614228690408634	Serum metabolite levels	1e-20	33031748
rs12234128	rs2095375	0.614228690408634	Serum metabolite levels	1e-20	33031748
rs12234128	rs10872653	0.61197072546167	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs12234128	rs9688867	0.611659974217722	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs12234128	rs9688867	0.611659974217722	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs12271282	rs1467510	0.932053637305133	Platelet distribution width	1e-14	32888494
rs12271282	rs12276109	0.79023232077841	Severe COVID-19 infection	6e-08	36662838
rs12278243	rs1467510	0.931208899103857	Platelet distribution width	1e-14	32888494
rs12278243	rs12276109	0.789559845626418	Severe COVID-19 infection	6e-08	36662838
rs12283951	rs1467510	0.863241656370862	Platelet distribution width	1e-14	32888494
rs12283951	rs12276109	0.768271882653643	Severe COVID-19 infection	6e-08	36662838
rs12286683	rs4353250	0.983532917584102	Insulin-like growth factor 1 levels	2e-14	33462484
rs12286683	rs4353250	0.983532917584102	Amyloid A serum levels	2e-51	21124955
rs12286683	rs4150575	0.645692869213749	Imidazole lactate levels	1e-10	36635386
rs12293544	rs4353250	0.979785521404991	Insulin-like growth factor 1 levels	2e-14	33462484
rs12293544	rs4353250	0.979785521404991	Amyloid A serum levels	2e-51	21124955
rs12293544	rs4150575	0.648156260215757	Imidazole lactate levels	1e-10	36635386
rs1230365	rs1230361	0.812416432158972	Diastolic blood pressure night-to-day ratio in hypertension	9e-06	29973135
rs12312094	rs920778	0.609780602623111	Haemorrhoidal disease	7e-10	33888516
rs12316258	rs7955859	0.975166564765564	Waist-hip index	7e-09	34021172
rs12316258	rs7955859	0.975166564765564	Waist-to-hip ratio adjusted for BMI	4e-09	34021172
rs12316258	rs59864950	0.742952192235758	COVID-19 (covid vs negative)	5e-06	35224516
rs12322160	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs12322160	rs6489882	0.970680553445448	Chronic lymphocytic leukemia	5e-08	28165464
rs12322160	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs12322160	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs12322160	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs12322160	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs12322160	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs12322160	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs12322160	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs12322160	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs12322160	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs12322160	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs12324180	rs9806545	0.734279249211588	Brain morphology (MOSTest)	3e-08	35164939
rs12324180	rs11071719	0.724580353639918	Vertex-wise sulcal depth	1e-20	34910505
rs12324180	rs11071719	0.724580353639918	Vertex-wise cortical surface area	9e-14	34910505
rs12324180	rs4775609	0.708530929906395	Systolic blood pressure	6e-11	35762941
rs12324180	rs62013179	0.703462220511187	Cortical surface area	7e-17	34560273
rs12324180	rs55962736	0.664848591667264	Pulse pressure	2e-13	35762941
rs12325802	rs7211615	0.656186492763318	Heel bone mineral density	1e-08	30595370
rs12325802	rs61586425	0.65088889025074	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs12325802	rs8077038	0.633352696675265	Educational attainment (MTAG)	4e-10	30038396
rs12325802	rs8077038	0.633352696675265	Highest math class taken (MTAG)	5e-16	30038396
rs12325802	rs12949956	0.626207566304659	Self-reported math ability	3e-11	30038396
rs12325802	rs12949956	0.626207566304659	Self-reported math ability (MTAG)	3e-14	30038396
rs12325802	rs12949956	0.626207566304659	Highest math class taken	8e-12	30038396
rs12366001	rs11213941	0.999054460148876	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs12366001	rs11213941	0.999054460148876	Eczema	8e-14	30595370
rs12366001	rs659529	0.82407371030261	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs12366001	rs659529	0.82407371030261	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs12366001	rs659529	0.82407371030261	Atopic dermatitis	5e-10	34116867
rs12366001	rs11213940	0.754847030374601	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI	2e-13	31669095
rs12366001	rs34634095	0.674709355507909	Fish- and plant-related diet	3e-09	32066663
rs12366001	rs663763	0.674243749061517	Layilin levels	3e-21	36168886
rs12366001	rs480293	0.641616241717093	Oily fish consumption	4e-11	32193382
rs12366001	rs539524	0.634368099401032	Asthma	1e-10	32296059
rs12366001	rs1613778	0.610507866930932	Total bilirubin levels	3e-08	34594039
rs12403396	rs7545078	0.686655343885701	Smoking initiation	2e-09	36477530
rs12403396	rs6700087	0.625967196547238	Smoking initiation	6e-11	36477530
rs12403432	rs7545078	0.74155593904977	Smoking initiation	2e-09	36477530
rs12403432	rs6700087	0.678017879505704	Smoking initiation	6e-11	36477530
rs12407641	rs11580836	0.992010046891823	Body mass index	2e-09	36581621
rs12407641	rs10465746	0.966012389346654	Obesity-related traits	8e-06	23251661
rs12409596	rs7545078	0.739359734294317	Smoking initiation	2e-09	36477530
rs12409596	rs6700087	0.679997941316848	Smoking initiation	6e-11	36477530
rs12409974	rs7545078	0.74342255817342	Smoking initiation	2e-09	36477530
rs12409974	rs6700087	0.679832031048992	Smoking initiation	6e-11	36477530
rs12410617	rs11580836	0.990238810183229	Body mass index	2e-09	36581621
rs12410617	rs10465746	0.967753153920005	Obesity-related traits	8e-06	23251661
rs1241980	rs479581	0.612841021974585	Hematocrit	9e-16	34594039
rs12439356	rs731820	0.952300675957397	Height	2e-13	31562340
rs12439356	rs731820	0.952300675957397	Height	2e-12	35831902
rs12439356	rs7178424	0.924482634044653	Height	6e-09	20881960
rs12439356	rs7178424	0.924482634044653	Height	6e-13	35831902
rs12439356	rs7178424	0.924482634044653	Height	3e-251	36224396
rs12439356	rs17271431	0.922198705079543	Height	2e-11	34594039
rs12439356	rs7162536	0.919007688758167	Height	4e-29	34594039
rs12439356	rs17205463	0.901657756132425	Serum levels of protein IGF1	8e-08	27329260
rs12439356	rs17205463	0.901657756132425	Appendicular lean mass	4e-43	33097823
rs12439356	rs17205463	0.901657756132425	Height	2e-35	30595370
rs12439356	rs7178540	0.884209560145605	Height	1e-31	36224396
rs12439356	rs11635977	0.883601483884536	Height	2e-25	36224396
rs12439356	rs72749770	0.843382197412827	Low density lipoprotein cholesterol levels	9e-10	32493714
rs12439356	rs72749770	0.843382197412827	Apolipoprotein B levels	2e-09	32203549
rs12439356	rs12901247	0.643489487579759	Insular cortex volume	4e-06	31530798
rs12439356	rs2162062	0.606483589557415	Height	2e-13	35831902
rs12442212	rs7178424	0.994118056508994	Height	6e-09	20881960
rs12442212	rs7178424	0.994118056508994	Height	6e-13	35831902
rs12442212	rs7178424	0.994118056508994	Height	3e-251	36224396
rs12442212	rs17271431	0.991601127769811	Height	2e-11	34594039
rs12442212	rs17205463	0.969921972185429	Serum levels of protein IGF1	8e-08	27329260
rs12442212	rs17205463	0.969921972185429	Appendicular lean mass	4e-43	33097823
rs12442212	rs17205463	0.969921972185429	Height	2e-35	30595370
rs12442212	rs7178540	0.953179845239014	Height	1e-31	36224396
rs12442212	rs731820	0.880815846465882	Height	2e-13	31562340
rs12442212	rs731820	0.880815846465882	Height	2e-12	35831902
rs12442212	rs7162536	0.847343753836363	Height	4e-29	34594039
rs12442212	rs11635977	0.814423479527259	Height	2e-25	36224396
rs12442212	rs72749770	0.777950428901199	Low density lipoprotein cholesterol levels	9e-10	32493714
rs12442212	rs72749770	0.777950428901199	Apolipoprotein B levels	2e-09	32203549
rs12442212	rs2162062	0.658080861312668	Height	2e-13	35831902
rs12442212	rs1436958	0.636512655089035	IgG glycosylation	9e-06	23382691
rs12442212	rs933807	0.623487393955135	Fat-free mass	6e-06	30593698
rs12442212	rs933807	0.623487393955135	Fat-free mass	2e-07	30593698
rs12442212	rs933807	0.623487393955135	Fat-free mass	8e-11	30593698
rs12459933	rs4808407	0.911855321391349	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs12467046	rs6705511	0.733204345256426	Self-reported math ability	4e-09	30038396
rs12467046	rs6705511	0.733204345256426	Self-reported math ability (MTAG)	3e-10	30038396
rs12467046	rs34276187	0.727022295007494	Highest math class taken (MTAG)	2e-08	30038396
rs12471191	rs6705511	0.733204345256426	Self-reported math ability	4e-09	30038396
rs12471191	rs6705511	0.733204345256426	Self-reported math ability (MTAG)	3e-10	30038396
rs12471191	rs34276187	0.727022295007494	Highest math class taken (MTAG)	2e-08	30038396
rs12474078	rs3732055	0.933245035743741	Citrulline levels	1e-10	36635386
rs12474078	rs3732055	0.933245035743741	Gamma-glutamylcitrulline levels	1e-10	36635386
rs12474078	rs3856349	0.872694275816227	LanC-like protein 1 levels	5e-22	34648354
rs1248800037	rs10891301	0.853875591552532	Pyruvate dehydrogenase protein X component, mitochondrial levels	1e-18	34648354
rs1248800037	rs2276390	0.835428707373753	Waist-hip ratio	6e-28	30239722
rs1248800037	rs11214088	0.703025823821042	Gamma glutamyl transpeptidase	4e-11	34594039
rs12495490	rs7610312	0.997507911336935	Red blood cell count	5e-09	27863252
rs12495490	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs12495490	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs12495490	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs12495490	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs12495490	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs12495490	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs12495490	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs12495490	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs12495490	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs12495490	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs12495490	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs12495490	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs12495490	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs12495490	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs12495490	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs12495490	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs12495490	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs12495490	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs12495490	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs12495490	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs12495490	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs12495490	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs12495490	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs12495490	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs12495490	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs12496906	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs12496906	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs12496906	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs12496906	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs12496906	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs12496906	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs12496906	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs12496906	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs12496906	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs12496906	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs12496906	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs12496906	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs12496906	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs12496906	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs12496906	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs12496906	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs12496906	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs12496906	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs12496906	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs12496906	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs12496906	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs12496906	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs12496906	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs12496906	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs12496906	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs12496906	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs12516666	rs1974871	0.916669349652752	Granulysin levels	5e-13	34648354
rs12516666	rs4869314	0.904823271627218	Arthritis (juvenile idiopathic)	3e-09	33106285
rs12516666	rs4869314	0.904823271627218	Neutrophil count	1e-10	34594039
rs12516666	rs4869314	0.904823271627218	White blood cell count	2e-07	30595370
rs12516666	rs2549782	0.85010077253848	Systolic blood pressure	6e-07	33230300
rs12516666	rs2549782	0.85010077253848	Diastolic blood pressure	1e-14	33230300
rs12516666	rs2549782	0.85010077253848	Diastolic blood pressure	3e-11	33230300
rs12516666	rs2549782	0.85010077253848	Systolic blood pressure	5e-09	33230300
rs12516666	rs2549797	0.85008721562494	Systolic blood pressure	7e-07	33230300
rs12516666	rs2549797	0.85008721562494	Diastolic blood pressure	1e-14	33230300
rs12516666	rs2549797	0.85008721562494	Diastolic blood pressure	3e-11	33230300
rs12516666	rs2549797	0.85008721562494	Systolic blood pressure	4e-09	33230300
rs12516666	rs1056893	0.847874009087815	Systolic blood pressure	1e-06	33230300
rs12516666	rs1056893	0.847874009087815	Diastolic blood pressure	7e-15	33230300
rs12516666	rs1056893	0.847874009087815	Diastolic blood pressure	2e-11	33230300
rs12516666	rs1056893	0.847874009087815	Systolic blood pressure	7e-09	33230300
rs12516666	rs4869313	0.829026994780015	Pediatric autoimmune diseases	9e-08	26301688
rs12516666	rs1559359	0.821332617036965	Diastolic blood pressure	7e-10	34594039
rs12516666	rs2910686	0.803215586138696	Neutrophil count	4e-14	32888493
rs12516666	rs2910686	0.803215586138696	Psoriasis	2e-08	23143594
rs12516666	rs2910686	0.803215586138696	Ankylosing spondylitis	5e-17	23749187
rs12516666	rs2910686	0.803215586138696	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs12516666	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs12516666	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs12516666	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs12516666	rs1019503	0.728940392110976	Systolic blood pressure	2e-06	33230300
rs12516666	rs1019503	0.728940392110976	Diastolic blood pressure	2e-14	33230300
rs12516666	rs1019503	0.728940392110976	Diastolic blood pressure	4e-11	33230300
rs12516666	rs1019503	0.728940392110976	Systolic blood pressure	1e-08	33230300
rs12516666	rs3096168	0.723409651088165	Aspartate aminotransferase levels	8e-12	33547301
rs12516666	rs1423357	0.704924641235886	General cognitive ability	9e-06	29844566
rs12516666	rs2432142	0.691024795840694	Neutrophil count	2e-14	32888493
rs12516666	rs2432142	0.691024795840694	White blood cell count	1e-11	32888493
rs12516666	rs38033	0.685525237258851	Blood protein levels	0	30072576
rs12516666	rs27293	0.67549231404753	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs12516666	rs27293	0.67549231404753	Diastolic blood pressure	3e-11	35762941
rs12516666	rs7705093	0.666760272686482	Birdshot chorioretinopathy	2e-09	24957906
rs12525871	rs10872653	0.97864683583914	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs12525871	rs55763431	0.977729804762848	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs12525871	rs9689694	0.975960996466	Right hippocampal volume (head)	6e-11	37337106
rs12525871	rs9689694	0.975960996466	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs12525871	rs9689694	0.975960996466	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs12525871	rs9689694	0.975960996466	Left hippocampal volume (head)	6e-12	37337106
rs12525871	rs2095375	0.973304630426183	Serum metabolite levels	1e-20	33031748
rs12525871	rs2095375	0.973304630426183	Serum metabolite levels	1e-20	33031748
rs12525871	rs9383843	0.972416026227929	Migraine	1e-09	35115687
rs12525871	rs10872645	0.970642018335885	Blood protein levels	2e-86	30072576
rs12525871	rs9688867	0.969760734527868	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs12525871	rs9688867	0.969760734527868	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs12525871	rs9688809	0.969760734527868	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs12525871	rs34337297	0.966226351001168	Serum levels of protein LRP11	3e-161	35078996
rs12525871	rs14314	0.954816126433104	Macular thickness	3e-19	30535121
rs12525871	rs14314	0.954816126433104	Vertex-wise sulcal depth	7e-17	34910505
rs12525871	rs14314	0.954816126433104	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs12525871	rs14314	0.954816126433104	Left hippocampal volume (body)	7e-15	37337106
rs12525871	rs14314	0.954816126433104	Left subiculum volume (body)	1e-14	37337106
rs12525871	rs9322193	0.930528119144898	Lung cancer	1e-07	27393504
rs12525871	rs4039600	0.887658220560601	Adenine levels	1e-11	35347128
rs12525871	rs1934534	0.623476240421047	Pain (pleiotropy)	2e-08	37844115
rs12525871	rs1934534	0.623476240421047	Pain (pleiotropy)	2e-06	37844115
rs12525871	rs4380763	0.622958943056137	Subcortical volume (min-P)	1e-11	32665545
rs12525871	rs11155671	0.613994227157526	Testicular germ cell tumor	2e-09	28604728
rs12537291	rs13232536	0.794424056050063	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs12537291	rs12539962	0.752144723507567	Colorectal cancer	3e-08	36539618
rs12537291	rs4355658	0.738842084932984	Height	3e-13	36224396
rs12539962	rs12539962	1	Colorectal cancer	3e-08	36539618
rs12539962	rs4355658	0.678489443385138	Height	3e-13	36224396
rs12539962	rs13232536	0.656745693438625	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs12539962	rs7806956	0.654229211874087	Esophageal squamous cell carcinoma	3e-07	37673066
rs1255856	rs2357176	0.960591409556343	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255856	rs10873172	0.858685824101653	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255856	rs10873172	0.858685824101653	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255856	rs10873172	0.858685824101653	Blond vs. brown/black hair color	6e-15	30531825
rs1255856	rs10873172	0.858685824101653	Cutaneous malignant melanoma	6e-08	32341527
rs1255856	rs10873172	0.858685824101653	Hair color	4e-17	30595370
rs1255856	rs1255908	0.806740163913992	PR interval	8e-14	32439900
rs1255856	rs1255908	0.806740163913992	PR interval	6e-14	32439900
rs1255856	rs12878653	0.743375379494804	Youthful appearance (self-reported)	3e-14	32339537
rs1255857	rs2357176	0.908462887292577	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255857	rs1255908	0.835542512778939	PR interval	8e-14	32439900
rs1255857	rs1255908	0.835542512778939	PR interval	6e-14	32439900
rs1255857	rs10873172	0.810909389822445	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255857	rs10873172	0.810909389822445	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255857	rs10873172	0.810909389822445	Blond vs. brown/black hair color	6e-15	30531825
rs1255857	rs10873172	0.810909389822445	Cutaneous malignant melanoma	6e-08	32341527
rs1255857	rs10873172	0.810909389822445	Hair color	4e-17	30595370
rs1255857	rs12878653	0.786585013583182	Youthful appearance (self-reported)	3e-14	32339537
rs1255867	rs2357176	0.993661032790869	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255867	rs10873172	0.835293310092193	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255867	rs10873172	0.835293310092193	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255867	rs10873172	0.835293310092193	Blond vs. brown/black hair color	6e-15	30531825
rs1255867	rs10873172	0.835293310092193	Cutaneous malignant melanoma	6e-08	32341527
rs1255867	rs10873172	0.835293310092193	Hair color	4e-17	30595370
rs1255867	rs1255908	0.777455365399171	PR interval	8e-14	32439900
rs1255867	rs1255908	0.777455365399171	PR interval	6e-14	32439900
rs1255867	rs12878653	0.71373169170279	Youthful appearance (self-reported)	3e-14	32339537
rs1255869	rs2357176	0.972128780017926	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255869	rs10873172	0.814575420669607	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255869	rs10873172	0.814575420669607	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255869	rs10873172	0.814575420669607	Blond vs. brown/black hair color	6e-15	30531825
rs1255869	rs10873172	0.814575420669607	Cutaneous malignant melanoma	6e-08	32341527
rs1255869	rs10873172	0.814575420669607	Hair color	4e-17	30595370
rs1255869	rs1255908	0.755627227054588	PR interval	8e-14	32439900
rs1255869	rs1255908	0.755627227054588	PR interval	6e-14	32439900
rs1255869	rs12878653	0.690393008007603	Youthful appearance (self-reported)	3e-14	32339537
rs1255872	rs2357176	0.990949728029379	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255872	rs10873172	0.832762111324712	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255872	rs10873172	0.832762111324712	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255872	rs10873172	0.832762111324712	Blond vs. brown/black hair color	6e-15	30531825
rs1255872	rs10873172	0.832762111324712	Cutaneous malignant melanoma	6e-08	32341527
rs1255872	rs10873172	0.832762111324712	Hair color	4e-17	30595370
rs1255872	rs1255908	0.779833059441103	PR interval	8e-14	32439900
rs1255872	rs1255908	0.779833059441103	PR interval	6e-14	32439900
rs1255872	rs12878653	0.711139860396304	Youthful appearance (self-reported)	3e-14	32339537
rs1255873	rs2357176	0.954368579717461	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255873	rs10873172	0.857786032847973	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255873	rs10873172	0.857786032847973	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255873	rs10873172	0.857786032847973	Blond vs. brown/black hair color	6e-15	30531825
rs1255873	rs10873172	0.857786032847973	Cutaneous malignant melanoma	6e-08	32341527
rs1255873	rs10873172	0.857786032847973	Hair color	4e-17	30595370
rs1255873	rs1255908	0.810739894553684	PR interval	8e-14	32439900
rs1255873	rs1255908	0.810739894553684	PR interval	6e-14	32439900
rs1255873	rs12878653	0.738780501263147	Youthful appearance (self-reported)	3e-14	32339537
rs1255874	rs2357176	0.990949728029379	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255874	rs10873172	0.832762111324712	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255874	rs10873172	0.832762111324712	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255874	rs10873172	0.832762111324712	Blond vs. brown/black hair color	6e-15	30531825
rs1255874	rs10873172	0.832762111324712	Cutaneous malignant melanoma	6e-08	32341527
rs1255874	rs10873172	0.832762111324712	Hair color	4e-17	30595370
rs1255874	rs1255908	0.779833059441103	PR interval	8e-14	32439900
rs1255874	rs1255908	0.779833059441103	PR interval	6e-14	32439900
rs1255874	rs12878653	0.711139860396304	Youthful appearance (self-reported)	3e-14	32339537
rs1255875	rs2357176	0.989143955311981	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255875	rs10873172	0.831099390494104	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255875	rs10873172	0.831099390494104	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255875	rs10873172	0.831099390494104	Blond vs. brown/black hair color	6e-15	30531825
rs1255875	rs10873172	0.831099390494104	Cutaneous malignant melanoma	6e-08	32341527
rs1255875	rs10873172	0.831099390494104	Hair color	4e-17	30595370
rs1255875	rs1255908	0.778188807400615	PR interval	8e-14	32439900
rs1255875	rs1255908	0.778188807400615	PR interval	6e-14	32439900
rs1255875	rs12878653	0.711139860396304	Youthful appearance (self-reported)	3e-14	32339537
rs1255876	rs2357176	0.954368579717461	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255876	rs10873172	0.857786032847973	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255876	rs10873172	0.857786032847973	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255876	rs10873172	0.857786032847973	Blond vs. brown/black hair color	6e-15	30531825
rs1255876	rs10873172	0.857786032847973	Cutaneous malignant melanoma	6e-08	32341527
rs1255876	rs10873172	0.857786032847973	Hair color	4e-17	30595370
rs1255876	rs1255908	0.810739894553684	PR interval	8e-14	32439900
rs1255876	rs1255908	0.810739894553684	PR interval	6e-14	32439900
rs1255876	rs12878653	0.738780501263147	Youthful appearance (self-reported)	3e-14	32339537
rs1255877	rs2357176	0.95784686565651	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255877	rs10873172	0.801238474367755	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255877	rs10873172	0.801238474367755	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255877	rs10873172	0.801238474367755	Blond vs. brown/black hair color	6e-15	30531825
rs1255877	rs10873172	0.801238474367755	Cutaneous malignant melanoma	6e-08	32341527
rs1255877	rs10873172	0.801238474367755	Hair color	4e-17	30595370
rs1255877	rs1255908	0.798030514998719	PR interval	8e-14	32439900
rs1255877	rs1255908	0.798030514998719	PR interval	6e-14	32439900
rs1255877	rs12878653	0.691111826782628	Youthful appearance (self-reported)	3e-14	32339537
rs1255878	rs2357176	0.913373737420679	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255878	rs1255908	0.839813319032668	PR interval	8e-14	32439900
rs1255878	rs1255908	0.839813319032668	PR interval	6e-14	32439900
rs1255878	rs10873172	0.758629087607535	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255878	rs10873172	0.758629087607535	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255878	rs10873172	0.758629087607535	Blond vs. brown/black hair color	6e-15	30531825
rs1255878	rs10873172	0.758629087607535	Cutaneous malignant melanoma	6e-08	32341527
rs1255878	rs10873172	0.758629087607535	Hair color	4e-17	30595370
rs1255878	rs12878653	0.638711162912417	Youthful appearance (self-reported)	3e-14	32339537
rs1255879	rs2357176	0.911577628686487	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255879	rs1255908	0.841651336995571	PR interval	8e-14	32439900
rs1255879	rs1255908	0.841651336995571	PR interval	6e-14	32439900
rs1255879	rs10873172	0.757057622069765	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255879	rs10873172	0.757057622069765	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255879	rs10873172	0.757057622069765	Blond vs. brown/black hair color	6e-15	30531825
rs1255879	rs10873172	0.757057622069765	Cutaneous malignant melanoma	6e-08	32341527
rs1255879	rs10873172	0.757057622069765	Hair color	4e-17	30595370
rs1255879	rs12878653	0.637427660548415	Youthful appearance (self-reported)	3e-14	32339537
rs1255880	rs2357176	0.910645445115708	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255880	rs1255908	0.840948101994	PR interval	8e-14	32439900
rs1255880	rs1255908	0.840948101994	PR interval	6e-14	32439900
rs1255880	rs10873172	0.756312954723617	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255880	rs10873172	0.756312954723617	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255880	rs10873172	0.756312954723617	Blond vs. brown/black hair color	6e-15	30531825
rs1255880	rs10873172	0.756312954723617	Cutaneous malignant melanoma	6e-08	32341527
rs1255880	rs10873172	0.756312954723617	Hair color	4e-17	30595370
rs1255880	rs12878653	0.637064072080933	Youthful appearance (self-reported)	3e-14	32339537
rs1255881	rs2357176	0.912436978274554	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255881	rs1255908	0.842571161527625	PR interval	8e-14	32439900
rs1255881	rs1255908	0.842571161527625	PR interval	6e-14	32439900
rs1255881	rs10873172	0.757880578063114	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255881	rs10873172	0.757880578063114	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255881	rs10873172	0.757880578063114	Blond vs. brown/black hair color	6e-15	30531825
rs1255881	rs10873172	0.757880578063114	Cutaneous malignant melanoma	6e-08	32341527
rs1255881	rs10873172	0.757880578063114	Hair color	4e-17	30595370
rs1255881	rs12878653	0.638344737353839	Youthful appearance (self-reported)	3e-14	32339537
rs1255882	rs2357176	0.909860423299621	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255882	rs1255908	0.845013587407688	PR interval	8e-14	32439900
rs1255882	rs1255908	0.845013587407688	PR interval	6e-14	32439900
rs1255882	rs10873172	0.75541316748348	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255882	rs10873172	0.75541316748348	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255882	rs10873172	0.75541316748348	Blond vs. brown/black hair color	6e-15	30531825
rs1255882	rs10873172	0.75541316748348	Cutaneous malignant melanoma	6e-08	32341527
rs1255882	rs10873172	0.75541316748348	Hair color	4e-17	30595370
rs1255882	rs12878653	0.640271928580955	Youthful appearance (self-reported)	3e-14	32339537
rs1255883	rs2357176	0.877607502773347	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255883	rs1255908	0.876788024227719	PR interval	8e-14	32439900
rs1255883	rs1255908	0.876788024227719	PR interval	6e-14	32439900
rs1255883	rs10873172	0.782678799034399	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255883	rs10873172	0.782678799034399	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255883	rs10873172	0.782678799034399	Blond vs. brown/black hair color	6e-15	30531825
rs1255883	rs10873172	0.782678799034399	Cutaneous malignant melanoma	6e-08	32341527
rs1255883	rs10873172	0.782678799034399	Hair color	4e-17	30595370
rs1255883	rs12878653	0.665344526378	Youthful appearance (self-reported)	3e-14	32339537
rs1255885	rs2357176	0.877664794097568	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255885	rs1255908	0.876722370569826	PR interval	8e-14	32439900
rs1255885	rs1255908	0.876722370569826	PR interval	6e-14	32439900
rs1255885	rs10873172	0.782677488749128	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255885	rs10873172	0.782677488749128	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255885	rs10873172	0.782677488749128	Blond vs. brown/black hair color	6e-15	30531825
rs1255885	rs10873172	0.782677488749128	Cutaneous malignant melanoma	6e-08	32341527
rs1255885	rs10873172	0.782677488749128	Hair color	4e-17	30595370
rs1255885	rs12878653	0.665094771203681	Youthful appearance (self-reported)	3e-14	32339537
rs1255887	rs2357176	0.876825971678304	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255887	rs1255908	0.875799547446987	PR interval	8e-14	32439900
rs1255887	rs1255908	0.875799547446987	PR interval	6e-14	32439900
rs1255887	rs10873172	0.781853959708448	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255887	rs10873172	0.781853959708448	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255887	rs10873172	0.781853959708448	Blond vs. brown/black hair color	6e-15	30531825
rs1255887	rs10873172	0.781853959708448	Cutaneous malignant melanoma	6e-08	32341527
rs1255887	rs10873172	0.781853959708448	Hair color	4e-17	30595370
rs1255887	rs12878653	0.665772270183048	Youthful appearance (self-reported)	3e-14	32339537
rs1255890	rs2357176	0.908069012655792	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255890	rs1255908	0.846855442291877	PR interval	8e-14	32439900
rs1255890	rs1255908	0.846855442291877	PR interval	6e-14	32439900
rs1255890	rs10873172	0.753846171677752	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255890	rs10873172	0.753846171677752	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255890	rs10873172	0.753846171677752	Blond vs. brown/black hair color	6e-15	30531825
rs1255890	rs10873172	0.753846171677752	Cutaneous malignant melanoma	6e-08	32341527
rs1255890	rs10873172	0.753846171677752	Hair color	4e-17	30595370
rs1255890	rs12878653	0.634316077374605	Youthful appearance (self-reported)	3e-14	32339537
rs1255891	rs2357176	0.907175035044622	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255891	rs1255908	0.846040063079883	PR interval	8e-14	32439900
rs1255891	rs1255908	0.846040063079883	PR interval	6e-14	32439900
rs1255891	rs10873172	0.754667946581567	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255891	rs10873172	0.754667946581567	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255891	rs10873172	0.754667946581567	Blond vs. brown/black hair color	6e-15	30531825
rs1255891	rs10873172	0.754667946581567	Cutaneous malignant melanoma	6e-08	32341527
rs1255891	rs10873172	0.754667946581567	Hair color	4e-17	30595370
rs1255891	rs12878653	0.633677678405813	Youthful appearance (self-reported)	3e-14	32339537
rs1255892	rs1255908	0.881213131369704	PR interval	8e-14	32439900
rs1255892	rs1255908	0.881213131369704	PR interval	6e-14	32439900
rs1255892	rs2357176	0.873301629695374	Nevus count or cutaneous melanoma	4e-08	30429480
rs1255892	rs10873172	0.778566837861597	Cutaneous melanoma or hair colour	6e-27	32341527
rs1255892	rs10873172	0.778566837861597	Nevus count or cutaneous melanoma	6e-13	32341527
rs1255892	rs10873172	0.778566837861597	Blond vs. brown/black hair color	6e-15	30531825
rs1255892	rs10873172	0.778566837861597	Cutaneous malignant melanoma	6e-08	32341527
rs1255892	rs10873172	0.778566837861597	Hair color	4e-17	30595370
rs1255892	rs12878653	0.661217601984619	Youthful appearance (self-reported)	3e-14	32339537
rs12562586	rs2999541	0.998312664655077	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs12562586	rs3007711	0.994096517836459	Electrodermal activity	9e-06	25387706
rs12562586	rs2130525	0.893816172918683	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs12562586	rs7542137	0.843034613031191	Beta-hydroxyisovalerate levels	3e-11	35050183
rs12562586	rs7542137	0.843034613031191	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs12562586	rs7542137	0.843034613031191	3-hydroxysebacate levels	2e-10	36635386
rs12562586	rs10788817	0.786696054518924	Serum metabolite levels	3e-13	24625756
rs12562586	rs10788817	0.786696054518924	Metabolite peak levels (QI2718)	5e-18	35995766
rs12562586	rs10788817	0.786696054518924	3-hydroxylaurate levels	2e-12	36635386
rs12562586	rs10788817	0.786696054518924	Tetradecadienoate (14:2) levels	8e-17	36635386
rs12562586	rs11204914	0.782846584450259	Carnitine C9 levels	1e-13	35995766
rs12562586	rs11204914	0.782846584450259	Metabolite peak levels (QI6204)	1e-32	35995766
rs12562586	rs11204914	0.782846584450259	Metabolite peak levels (QI6252)	2e-32	35995766
rs12562586	rs6685187	0.758794526214143	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs12562586	rs6698740	0.756727760616333	Beta-hydroxyisovalerate levels	1e-13	35347128
rs12562586	rs1060870	0.755288997259183	Serum metabolite levels	1e-11	33031748
rs12562586	rs1060870	0.755288997259183	Serum metabolite levels	1e-15	33031748
rs12562586	rs2338201	0.745782563759008	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs12562586	rs2338201	0.745782563759008	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs12562586	rs2338201	0.745782563759008	Dodecadienoate (12:2) levels	7e-15	36635386
rs12562586	rs2279501	0.728735189992634	Serum metabolite levels	3e-14	33031748
rs12562586	rs56000812	0.683236956187348	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs12562586	rs56078223	0.681103088647864	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs12562586	rs56078223	0.681103088647864	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs12562586	rs10494270	0.671670700984085	Nonaylcarnitine levels	5e-13	26068415
rs12562586	rs9943221	0.664946338794324	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs12562586	rs2999545	0.66422960107209	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs12562586	rs7523082	0.629451206404021	Metabolite peak levels (QI9845)	2e-14	35995766
rs12562586	rs10888445	0.626296352087981	Beta-hydroxyisovalerate levels	5e-13	36635386
rs12562586	rs7541453	0.623622103321364	Serum metabolite levels	2e-16	33031748
rs12562586	rs7541453	0.623622103321364	Serum metabolite levels	2e-16	33031748
rs12562586	rs7541453	0.623622103321364	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs12562586	rs1038747	0.620188414124879	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs12562586	rs6684312	0.610404814818086	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs12565696	rs6680628	0.674505987699408	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs12566538	rs6680628	0.677959625650796	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs12582170	rs12582170	1	Mean corpuscular volume	1e-21	27863252
rs12582170	rs12582170	1	Mean corpuscular hemoglobin	7e-37	32888493
rs12582170	rs12582170	1	Mean reticulocyte volume	2e-33	32888494
rs12582170	rs12582170	1	Mean corpuscular volume	1e-67	32888493
rs12582170	rs12582170	1	Mean corpuscular hemoglobin	2e-21	32888494
rs12582170	rs12582170	1	Mean corpuscular volume	1e-26	34104963
rs12582170	rs2446066	0.964891010380584	Vertex-wise sulcal depth	1e-10	34910505
rs12582170	rs2446066	0.964891010380584	Vertex-wise cortical surface area	2e-13	34910505
rs12582170	rs2446066	0.964891010380584	Red blood cell count	1e-10	27863252
rs12582170	rs2446066	0.964891010380584	Cortical surface area	3e-08	34560273
rs12582170	rs2608301	0.964891010380584	Low density lipoprotein cholesterol levels	2e-12	34887591
rs12582170	rs10876448	0.963989566807596	Mean corpuscular hemoglobin	2e-16	32888493
rs12582170	rs10876448	0.963989566807596	Reticulocyte count	3e-18	32888494
rs12582170	rs10876448	0.963989566807596	Reticulocyte fraction of red cells	1e-10	32888494
rs12582170	rs2460882	0.96308865857094	Mean corpuscular volume	3e-15	29403010
rs12582170	rs2460882	0.96308865857094	Percentage gas trapping	6e-07	26030696
rs12582170	rs111379945	0.738175359351501	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs12582170	rs111379945	0.738175359351501	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs12582170	rs111379945	0.738175359351501	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs12592402	rs1436958	0.932325374235504	IgG glycosylation	9e-06	23382691
rs12592402	rs2162062	0.833357152746129	Height	2e-13	35831902
rs12592402	rs933807	0.78736392346245	Fat-free mass	6e-06	30593698
rs12592402	rs933807	0.78736392346245	Fat-free mass	2e-07	30593698
rs12592402	rs933807	0.78736392346245	Fat-free mass	8e-11	30593698
rs12592402	rs7178540	0.697096418688117	Height	1e-31	36224396
rs12592402	rs11635977	0.680211342852721	Height	2e-25	36224396
rs12592402	rs72749770	0.669889920836908	Low density lipoprotein cholesterol levels	9e-10	32493714
rs12592402	rs72749770	0.669889920836908	Apolipoprotein B levels	2e-09	32203549
rs12592402	rs7162536	0.668853949134581	Height	4e-29	34594039
rs12592402	rs7178424	0.659677542885107	Height	6e-09	20881960
rs12592402	rs7178424	0.659677542885107	Height	6e-13	35831902
rs12592402	rs7178424	0.659677542885107	Height	3e-251	36224396
rs12592402	rs17271431	0.657222022117297	Height	2e-11	34594039
rs12592402	rs17205463	0.656639154043756	Serum levels of protein IGF1	8e-08	27329260
rs12592402	rs17205463	0.656639154043756	Appendicular lean mass	4e-43	33097823
rs12592402	rs17205463	0.656639154043756	Height	2e-35	30595370
rs12592402	rs731820	0.644282492310623	Height	2e-13	31562340
rs12592402	rs731820	0.644282492310623	Height	2e-12	35831902
rs12592402	rs12901247	0.603683598530754	Insular cortex volume	4e-06	31530798
rs12594658	rs2162062	0.921539392814035	Height	2e-13	35831902
rs12594658	rs1436958	0.87813884381534	IgG glycosylation	9e-06	23382691
rs12594658	rs933807	0.872484407375994	Fat-free mass	6e-06	30593698
rs12594658	rs933807	0.872484407375994	Fat-free mass	2e-07	30593698
rs12594658	rs933807	0.872484407375994	Fat-free mass	8e-11	30593698
rs12594658	rs7178540	0.763247121879877	Height	1e-31	36224396
rs12594658	rs11635977	0.745984778520896	Height	2e-25	36224396
rs12594658	rs72749770	0.733928666494136	Low density lipoprotein cholesterol levels	9e-10	32493714
rs12594658	rs72749770	0.733928666494136	Apolipoprotein B levels	2e-09	32203549
rs12594658	rs7162536	0.732600857929024	Height	4e-29	34594039
rs12594658	rs7178424	0.723418086916744	Height	6e-09	20881960
rs12594658	rs7178424	0.723418086916744	Height	6e-13	35831902
rs12594658	rs7178424	0.723418086916744	Height	3e-251	36224396
rs12594658	rs17271431	0.719324729737004	Height	2e-11	34594039
rs12594658	rs17205463	0.718641196596949	Serum levels of protein IGF1	8e-08	27329260
rs12594658	rs17205463	0.718641196596949	Appendicular lean mass	4e-43	33097823
rs12594658	rs17205463	0.718641196596949	Height	2e-35	30595370
rs12594658	rs731820	0.707055527646313	Height	2e-13	31562340
rs12594658	rs731820	0.707055527646313	Height	2e-12	35831902
rs12594946	rs1436958	0.93314913519458	IgG glycosylation	9e-06	23382691
rs12594946	rs2162062	0.838901525332486	Height	2e-13	35831902
rs12594946	rs933807	0.792767811188395	Fat-free mass	6e-06	30593698
rs12594946	rs933807	0.792767811188395	Fat-free mass	2e-07	30593698
rs12594946	rs933807	0.792767811188395	Fat-free mass	8e-11	30593698
rs12594946	rs7178540	0.702115415768213	Height	1e-31	36224396
rs12594946	rs11635977	0.685161294573687	Height	2e-25	36224396
rs12594946	rs72749770	0.674798879460231	Low density lipoprotein cholesterol levels	9e-10	32493714
rs12594946	rs72749770	0.674798879460231	Apolipoprotein B levels	2e-09	32203549
rs12594946	rs7162536	0.673760652657706	Height	4e-29	34594039
rs12594946	rs7178424	0.664562403654746	Height	6e-09	20881960
rs12594946	rs7178424	0.664562403654746	Height	6e-13	35831902
rs12594946	rs7178424	0.664562403654746	Height	3e-251	36224396
rs12594946	rs17271431	0.66209834056373	Height	2e-11	34594039
rs12594946	rs17205463	0.661514642999334	Serum levels of protein IGF1	8e-08	27329260
rs12594946	rs17205463	0.661514642999334	Appendicular lean mass	4e-43	33097823
rs12594946	rs17205463	0.661514642999334	Height	2e-35	30595370
rs12594946	rs731820	0.649093107487945	Height	2e-13	31562340
rs12594946	rs731820	0.649093107487945	Height	2e-12	35831902
rs12594946	rs12901247	0.604421550827768	Insular cortex volume	4e-06	31530798
rs12598978	rs11150589	1	Ulcerative colitis	3e-10	26192919
rs12598978	rs11150589	1	Inflammatory bowel disease	9e-07	26192919
rs12598978	rs11150589	1	Ulcerative colitis	6e-10	23128233
rs12598978	rs11150589	1	Lymphocyte percentage of white cells	3e-34	32888494
rs12598978	rs11150589	1	Neutrophil percentage of white cells	3e-14	32888494
rs12598978	rs11150589	1	Ulcerative colitis	1e-06	28067908
rs12598978	rs11150589	1	Neutrophil percentage of white cells	1e-11	27863252
rs12598978	rs11150589	1	Neutrophil-to-lymphocyte ratio	3e-23	34469753
rs12598978	rs11150589	1	Lymphocyte count	1e-90	34594039
rs12598978	rs11150589	1	White blood cell count	1e-36	34594039
rs12598978	rs12598978	1	Lymphocyte count	7e-186	32888493
rs12598978	rs12598978	1	Lymphocyte count	2e-181	32888493
rs12598978	rs12598978	1	Lymphocyte count	5e-57	34469753
rs12598978	rs12598978	1	Platelet-to-lymphocyte ratio	3e-41	34469753
rs12598978	rs12598978	1	Lymphocyte-to-monocyte ratio	3e-10	34469753
rs12598978	rs12598978	1	Insulin receptor levels	4e-16	34648354
rs12598978	rs12716977	1	Lymphocyte count	4e-130	32888494
rs12598978	rs12716977	1	Neutrophil count	8e-20	32888494
rs12598978	rs12716977	1	White blood cell count	3e-67	32888494
rs12598978	rs12716977	1	Lymphocyte count	1e-59	27863252
rs12598978	rs12716977	1	Lymphocyte percentage of white cells	2e-17	27863252
rs12598978	rs12716977	1	Monocyte count	5e-21	34469753
rs12598978	rs12716977	1	Basophil count	2e-20	34469753
rs12598978	rs11574938	0.988456975288191	Neutrophil count	3e-24	32888493
rs12598978	rs11574938	0.988456975288191	White blood cell count	2e-93	32888493
rs12598978	rs11574938	0.988456975288191	Neutrophil count	2e-25	32888493
rs12598978	rs11574938	0.988456975288191	White blood cell count	8e-91	32888493
rs12598978	rs11574938	0.988456975288191	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	5e-14	26974007
rs12598978	rs11574938	0.988456975288191	White blood cell count	6e-27	27863252
rs12598978	rs11574938	0.988456975288191	White blood cell count	5e-63	30595370
rs12598978	rs7196129	0.890635864789256	Basophil count	7e-16	32888493
rs12598978	rs7196129	0.890635864789256	Basophil count	7e-17	32888494
rs12598978	rs7196129	0.890635864789256	Basophil count	2e-13	32888493
rs12598978	rs7196129	0.890635864789256	Monocyte count	1e-23	32888494
rs12598978	rs7196129	0.890635864789256	Monocyte count	2e-39	32888493
rs12598978	rs7196129	0.890635864789256	Monocyte count	5e-37	32888493
rs12598978	rs7196129	0.890635864789256	Monocyte count	2e-10	27863252
rs12598978	rs7196129	0.890635864789256	Monocyte count	3e-18	34594039
rs12599206	rs2076435	0.940103568165303	Inguinal hernia	2e-08	35022708
rs12599206	rs2076435	0.940103568165303	Inguinal hernia	2e-09	35022708
rs12599206	rs2076438	0.822264601251058	Coronary artery disease	3e-08	33020668
rs12599206	rs2235642	0.818875314817891	Coronary artery disease	8e-06	29212778
rs12599207	rs2076435	0.952250584017623	Inguinal hernia	2e-08	35022708
rs12599207	rs2076435	0.952250584017623	Inguinal hernia	2e-09	35022708
rs12599207	rs2076438	0.833146893676533	Coronary artery disease	3e-08	33020668
rs12599207	rs2235642	0.829713410041099	Coronary artery disease	8e-06	29212778
rs12603317	rs7211615	0.655176638023522	Heel bone mineral density	1e-08	30595370
rs12603317	rs61586425	0.650271977908236	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs12603317	rs8077038	0.632343349654723	Educational attainment (MTAG)	4e-10	30038396
rs12603317	rs8077038	0.632343349654723	Highest math class taken (MTAG)	5e-16	30038396
rs12603317	rs12949956	0.625191548011202	Self-reported math ability	3e-11	30038396
rs12603317	rs12949956	0.625191548011202	Self-reported math ability (MTAG)	3e-14	30038396
rs12603317	rs12949956	0.625191548011202	Highest math class taken	8e-12	30038396
rs12616041	rs1177308	0.894285899526549	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs12616041	rs1177308	0.894285899526549	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs12616041	rs7558954	0.892125725527935	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs12616041	rs11685226	0.867173192769676	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs12616041	rs11685226	0.867173192769676	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs12616041	rs777587	0.727322728974395	Proteoglycan 3 levels	6e-29	34648354
rs12616041	rs777587	0.727322728974395	Pappalysin-1 levels	1e-25	34648354
rs12616041	rs12617371	0.691922187591647	Immature fraction of reticulocytes	8e-18	32888494
rs12616041	rs2463097	0.661867695011062	White blood cell count	3e-26	30595370
rs12616041	rs2593620	0.635132482883067	Serum levels of protein PRG3	5e-14	35078996
rs12616041	rs10199672	0.629554458001626	Height	6e-12	34594039
rs12616041	rs10199672	0.629554458001626	Height	2e-12	31562340
rs12616041	rs2421200	0.609935543230443	Neutrophil count	1e-26	32888493
rs12616041	rs2421200	0.609935543230443	Neutrophil count	1e-25	32888493
rs12618926	rs3732055	0.933245035743741	Citrulline levels	1e-10	36635386
rs12618926	rs3732055	0.933245035743741	Gamma-glutamylcitrulline levels	1e-10	36635386
rs12618926	rs3856349	0.874196727045148	LanC-like protein 1 levels	5e-22	34648354
rs12620999	rs12620999	1	Systemic lupus erythematosus	3e-06	19838195
rs12643434	rs6831339	0.883185564495681	High density lipoprotein cholesterol levels	9e-09	34887591
rs12643434	rs2868708	0.880032466389234	Lymphocyte count	3e-11	34469753
rs12643434	rs2868708	0.880032466389234	White blood cell count	1e-09	30595370
rs12643434	rs6823199	0.841224773088237	Pulse pressure	4e-14	30224653
rs12643434	rs13111599	0.817870530448834	HDL cholesterol levels	3e-09	32203549
rs12643434	rs13111599	0.817870530448834	Apolipoprotein A1 levels	4e-08	32203549
rs12643434	rs6535419	0.807039641923425	Pulse pressure	6e-10	30578418
rs12643434	rs116142917	0.806478538549228	Lymphocyte count	7e-18	32888494
rs12643434	rs28528763	0.773216158579947	White blood cell count	7e-12	32888494
rs12643434	rs4302451	0.691946899869764	Eosinophil counts	2e-09	30595370
rs12643434	rs35895091	0.677430861749696	Cardiovascular disease	1e-07	30595370
rs12643434	rs11099563	0.6617143972045	High density lipoprotein cholesterol levels	3e-11	34887591
rs12649778	rs17007017	0.77150260511902	Conduct disorder	7e-06	20585324
rs12649778	rs34402449	0.726482315131617	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs12649778	rs1550057	0.696059081842344	Conduct disorder	4e-06	20585324
rs12649778	rs1550057	0.696059081842344	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs12651942	rs10061757	0.982702420296288	Height	4e-30	30595370
rs12651942	rs832540	0.758460942838338	Coronary artery disease	2e-08	29212778
rs12651942	rs33321	0.711165407148901	Height	1e-19	34594039
rs12652692	rs12652692	1	Platelet count	2e-34	32888494
rs12652692	rs56373295	0.935110605430932	Plateletcrit	2e-15	32888494
rs12653791	rs12652692	0.912120171023855	Platelet count	2e-34	32888494
rs12653791	rs56373295	0.862860378916459	Plateletcrit	2e-15	32888494
rs12654015	rs1974871	0.914227723857722	Granulysin levels	5e-13	34648354
rs12654015	rs4869314	0.902604804767149	Arthritis (juvenile idiopathic)	3e-09	33106285
rs12654015	rs4869314	0.902604804767149	Neutrophil count	1e-10	34594039
rs12654015	rs4869314	0.902604804767149	White blood cell count	2e-07	30595370
rs12654015	rs2549782	0.847851745094422	Systolic blood pressure	6e-07	33230300
rs12654015	rs2549782	0.847851745094422	Diastolic blood pressure	1e-14	33230300
rs12654015	rs2549782	0.847851745094422	Diastolic blood pressure	3e-11	33230300
rs12654015	rs2549782	0.847851745094422	Systolic blood pressure	5e-09	33230300
rs12654015	rs2549797	0.847836208003916	Systolic blood pressure	7e-07	33230300
rs12654015	rs2549797	0.847836208003916	Diastolic blood pressure	1e-14	33230300
rs12654015	rs2549797	0.847836208003916	Diastolic blood pressure	3e-11	33230300
rs12654015	rs2549797	0.847836208003916	Systolic blood pressure	4e-09	33230300
rs12654015	rs1056893	0.845628637057037	Systolic blood pressure	1e-06	33230300
rs12654015	rs1056893	0.845628637057037	Diastolic blood pressure	7e-15	33230300
rs12654015	rs1056893	0.845628637057037	Diastolic blood pressure	2e-11	33230300
rs12654015	rs1056893	0.845628637057037	Systolic blood pressure	7e-09	33230300
rs12654015	rs4869313	0.826560413822121	Pediatric autoimmune diseases	9e-08	26301688
rs12654015	rs1559359	0.819005293654359	Diastolic blood pressure	7e-10	34594039
rs12654015	rs2910686	0.800874421538218	Neutrophil count	4e-14	32888493
rs12654015	rs2910686	0.800874421538218	Psoriasis	2e-08	23143594
rs12654015	rs2910686	0.800874421538218	Ankylosing spondylitis	5e-17	23749187
rs12654015	rs2910686	0.800874421538218	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs12654015	rs2927608	0.799536515092862	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs12654015	rs2927608	0.799536515092862	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs12654015	rs2927608	0.799536515092862	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs12654015	rs1019503	0.72705507797645	Systolic blood pressure	2e-06	33230300
rs12654015	rs1019503	0.72705507797645	Diastolic blood pressure	2e-14	33230300
rs12654015	rs1019503	0.72705507797645	Diastolic blood pressure	4e-11	33230300
rs12654015	rs1019503	0.72705507797645	Systolic blood pressure	1e-08	33230300
rs12654015	rs3096168	0.721521685708896	Aspartate aminotransferase levels	8e-12	33547301
rs12654015	rs1423357	0.705332405981614	General cognitive ability	9e-06	29844566
rs12654015	rs2432142	0.691428316781013	Neutrophil count	2e-14	32888493
rs12654015	rs2432142	0.691428316781013	White blood cell count	1e-11	32888493
rs12654015	rs38033	0.685947139579313	Blood protein levels	0	30072576
rs12654015	rs27293	0.675907444362893	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs12654015	rs27293	0.675907444362893	Diastolic blood pressure	3e-11	35762941
rs12654015	rs7705093	0.667194282564593	Birdshot chorioretinopathy	2e-09	24957906
rs12655858	rs1974871	0.914227723857722	Granulysin levels	5e-13	34648354
rs12655858	rs4869314	0.902604804767149	Arthritis (juvenile idiopathic)	3e-09	33106285
rs12655858	rs4869314	0.902604804767149	Neutrophil count	1e-10	34594039
rs12655858	rs4869314	0.902604804767149	White blood cell count	2e-07	30595370
rs12655858	rs2549782	0.847851745094422	Systolic blood pressure	6e-07	33230300
rs12655858	rs2549782	0.847851745094422	Diastolic blood pressure	1e-14	33230300
rs12655858	rs2549782	0.847851745094422	Diastolic blood pressure	3e-11	33230300
rs12655858	rs2549782	0.847851745094422	Systolic blood pressure	5e-09	33230300
rs12655858	rs2549797	0.847836208003916	Systolic blood pressure	7e-07	33230300
rs12655858	rs2549797	0.847836208003916	Diastolic blood pressure	1e-14	33230300
rs12655858	rs2549797	0.847836208003916	Diastolic blood pressure	3e-11	33230300
rs12655858	rs2549797	0.847836208003916	Systolic blood pressure	4e-09	33230300
rs12655858	rs1056893	0.845628637057037	Systolic blood pressure	1e-06	33230300
rs12655858	rs1056893	0.845628637057037	Diastolic blood pressure	7e-15	33230300
rs12655858	rs1056893	0.845628637057037	Diastolic blood pressure	2e-11	33230300
rs12655858	rs1056893	0.845628637057037	Systolic blood pressure	7e-09	33230300
rs12655858	rs4869313	0.826560413822121	Pediatric autoimmune diseases	9e-08	26301688
rs12655858	rs1559359	0.819005293654359	Diastolic blood pressure	7e-10	34594039
rs12655858	rs2910686	0.800874421538218	Neutrophil count	4e-14	32888493
rs12655858	rs2910686	0.800874421538218	Psoriasis	2e-08	23143594
rs12655858	rs2910686	0.800874421538218	Ankylosing spondylitis	5e-17	23749187
rs12655858	rs2910686	0.800874421538218	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs12655858	rs2927608	0.799536515092862	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs12655858	rs2927608	0.799536515092862	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs12655858	rs2927608	0.799536515092862	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs12655858	rs1019503	0.72705507797645	Systolic blood pressure	2e-06	33230300
rs12655858	rs1019503	0.72705507797645	Diastolic blood pressure	2e-14	33230300
rs12655858	rs1019503	0.72705507797645	Diastolic blood pressure	4e-11	33230300
rs12655858	rs1019503	0.72705507797645	Systolic blood pressure	1e-08	33230300
rs12655858	rs3096168	0.721521685708896	Aspartate aminotransferase levels	8e-12	33547301
rs12655858	rs1423357	0.705332405981614	General cognitive ability	9e-06	29844566
rs12655858	rs2432142	0.691428316781013	Neutrophil count	2e-14	32888493
rs12655858	rs2432142	0.691428316781013	White blood cell count	1e-11	32888493
rs12655858	rs38033	0.685947139579313	Blood protein levels	0	30072576
rs12655858	rs27293	0.675907444362893	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs12655858	rs27293	0.675907444362893	Diastolic blood pressure	3e-11	35762941
rs12655858	rs7705093	0.667194282564593	Birdshot chorioretinopathy	2e-09	24957906
rs12662162	rs9505982	0.983952696389212	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs12662162	rs11155671	0.933005235861518	Testicular germ cell tumor	2e-09	28604728
rs12662162	rs4380763	0.919878519417271	Subcortical volume (min-P)	1e-11	32665545
rs12662162	rs1934534	0.919120086098325	Pain (pleiotropy)	2e-08	37844115
rs12662162	rs1934534	0.919120086098325	Pain (pleiotropy)	2e-06	37844115
rs12662162	rs4421206	0.900101951216177	Brain morphology (min-P)	4e-11	32665545
rs12662162	rs9688452	0.881093589142322	Brainstem global volume Whole-brainstem	1e-11	33875891
rs12662162	rs9688452	0.881093589142322	aseg lh volume VentralDC	2e-10	33875891
rs12662162	rs80147756	0.87725607670911	HippSubfield lh volume subiculum-head	3e-10	33875891
rs12662162	rs9322194	0.848182802933598	Brainstem volume	2e-11	31636452
rs12662162	rs10872649	0.802908408587306	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs12662162	rs10872649	0.802908408587306	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs12662162	rs10872649	0.802908408587306	Right hippocampal volume (body)	1e-10	37337106
rs12662162	rs7752089	0.775229879052575	Brain morphology (MOSTest)	2e-31	35164939
rs12662162	rs9285521	0.72089724274936	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs12662162	rs12526675	0.636126017163355	Brain morphology (MOSTest)	7e-22	32665545
rs12662162	rs11155662	0.600788806192248	Vertex-wise cortical thickness	2e-09	34910505
rs12662174	rs9505982	0.982339842035043	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs12662174	rs11155671	0.931397469364064	Testicular germ cell tumor	2e-09	28604728
rs12662174	rs4380763	0.918276075437315	Subcortical volume (min-P)	1e-11	32665545
rs12662174	rs1934534	0.917517530366942	Pain (pleiotropy)	2e-08	37844115
rs12662174	rs1934534	0.917517530366942	Pain (pleiotropy)	2e-06	37844115
rs12662174	rs4421206	0.898560234056058	Brain morphology (min-P)	4e-11	32665545
rs12662174	rs9688452	0.879545656921996	Brainstem global volume Whole-brainstem	1e-11	33875891
rs12662174	rs9688452	0.879545656921996	aseg lh volume VentralDC	2e-10	33875891
rs12662174	rs80147756	0.875720057578007	HippSubfield lh volume subiculum-head	3e-10	33875891
rs12662174	rs9322194	0.846805369589448	Brainstem volume	2e-11	31636452
rs12662174	rs10872649	0.801465738914683	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs12662174	rs10872649	0.801465738914683	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs12662174	rs10872649	0.801465738914683	Right hippocampal volume (body)	1e-10	37337106
rs12662174	rs7752089	0.773852327518932	Brain morphology (MOSTest)	2e-31	35164939
rs12662174	rs9285521	0.719687115323018	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs12662174	rs12526675	0.635043982181693	Brain morphology (MOSTest)	7e-22	32665545
rs12668451	rs13232536	0.870943720088861	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs12668451	rs4355658	0.814421124175241	Height	3e-13	36224396
rs12668451	rs12539962	0.73494005038325	Colorectal cancer	3e-08	36539618
rs12668451	rs4304220	0.642404203693689	Height	2e-14	36224396
rs12668451	rs7806956	0.626506086972405	Esophageal squamous cell carcinoma	3e-07	37673066
rs1266870	rs2357176	0.962306702357759	Nevus count or cutaneous melanoma	4e-08	30429480
rs1266870	rs10873172	0.805371336521388	Cutaneous melanoma or hair colour	6e-27	32341527
rs1266870	rs10873172	0.805371336521388	Nevus count or cutaneous melanoma	6e-13	32341527
rs1266870	rs10873172	0.805371336521388	Blond vs. brown/black hair color	6e-15	30531825
rs1266870	rs10873172	0.805371336521388	Cutaneous malignant melanoma	6e-08	32341527
rs1266870	rs10873172	0.805371336521388	Hair color	4e-17	30595370
rs1266870	rs1255908	0.7972706047085	PR interval	8e-14	32439900
rs1266870	rs1255908	0.7972706047085	PR interval	6e-14	32439900
rs1266870	rs12878653	0.690455254207231	Youthful appearance (self-reported)	3e-14	32339537
rs1268068	rs1268068	1	Stool frequency	3e-08	34957435
rs1268068	rs1269175	0.7066871387952	Body mass index	8e-10	30239722
rs1268068	rs13328298	0.646632550740279	Endometrial endometrioid carcinoma	1e-11	27135401
rs1268068	rs13328298	0.646632550740279	Endometrial cancer	4e-10	27135401
rs1268068	rs2797160	0.639446158361981	Endometrial cancer	4e-13	27008869
rs1268068	rs2747716	0.63050956285959	Endometrial cancer (endometrioid histology)	4e-10	30093612
rs1268068	rs2747716	0.63050956285959	Endometrial cancer	3e-10	30093612
rs1268068	rs1268083	0.613926974566605	Migraine	5e-09	27322543
rs12701856	rs10256972	0.715014791084338	Endometriosis	3e-06	27506219
rs12701856	rs10256972	0.715014791084338	Longevity	1e-06	20834067
rs12701856	rs10951594	0.673651664156865	Mean corpuscular volume	7e-15	32888493
rs12701856	rs10951594	0.673651664156865	Resistance to COVID-19 infection (Exposed negative vs positive)	2e-17	36662838
rs1270526	rs2357176	0.960534381646214	Nevus count or cutaneous melanoma	4e-08	30429480
rs1270526	rs10873172	0.803672509449456	Cutaneous melanoma or hair colour	6e-27	32341527
rs1270526	rs10873172	0.803672509449456	Nevus count or cutaneous melanoma	6e-13	32341527
rs1270526	rs10873172	0.803672509449456	Blond vs. brown/black hair color	6e-15	30531825
rs1270526	rs10873172	0.803672509449456	Cutaneous malignant melanoma	6e-08	32341527
rs1270526	rs10873172	0.803672509449456	Hair color	4e-17	30595370
rs1270526	rs1255908	0.795447687841425	PR interval	8e-14	32439900
rs1270526	rs1255908	0.795447687841425	PR interval	6e-14	32439900
rs1270526	rs12878653	0.6885539514605	Youthful appearance (self-reported)	3e-14	32339537
rs12707240	rs12707240	1	Eosinophil percentage of white cells	6e-12	32888494
rs12713435	rs2593620	0.89327860845629	Serum levels of protein PRG3	5e-14	35078996
rs12713435	rs777587	0.885942146584992	Proteoglycan 3 levels	6e-29	34648354
rs12713435	rs777587	0.885942146584992	Pappalysin-1 levels	1e-25	34648354
rs12713435	rs2421200	0.872192024547238	Neutrophil count	1e-26	32888493
rs12713435	rs2421200	0.872192024547238	Neutrophil count	1e-25	32888493
rs12713435	rs12617371	0.863408597397771	Immature fraction of reticulocytes	8e-18	32888494
rs12713435	rs2463097	0.829693777003406	White blood cell count	3e-26	30595370
rs12713435	rs10199672	0.820843800062849	Height	6e-12	34594039
rs12713435	rs10199672	0.820843800062849	Height	2e-12	31562340
rs12713435	rs11685226	0.771228894803246	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs12713435	rs11685226	0.771228894803246	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs12713435	rs1177308	0.763015119217511	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs12713435	rs1177308	0.763015119217511	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs12713435	rs7558954	0.759356462125836	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs12713435	rs2950269	0.754249386239384	Eosinophil side fluorescence	3e-18	37596262
rs12713435	rs12616433	0.742776467447632	Eosinophil forward scatter	4e-13	37596262
rs12713435	rs12616433	0.742776467447632	Eosinophil side scatter	2e-18	37596262
rs12713435	rs10169482	0.727277337342806	C-reactive protein levels	4e-09	33462484
rs12713435	rs10206089	0.613060955817708	White blood cell count	7e-11	27863252
rs12713435	rs10206089	0.613060955817708	Myeloid white cell count	1e-09	27863252
rs12713435	rs10206089	0.613060955817708	Sum neutrophil eosinophil counts	2e-09	27863252
rs12713435	rs10206089	0.613060955817708	Granulocyte count	3e-09	27863252
rs12716977	rs11150589	1	Ulcerative colitis	3e-10	26192919
rs12716977	rs11150589	1	Inflammatory bowel disease	9e-07	26192919
rs12716977	rs11150589	1	Ulcerative colitis	6e-10	23128233
rs12716977	rs11150589	1	Lymphocyte percentage of white cells	3e-34	32888494
rs12716977	rs11150589	1	Neutrophil percentage of white cells	3e-14	32888494
rs12716977	rs11150589	1	Ulcerative colitis	1e-06	28067908
rs12716977	rs11150589	1	Neutrophil percentage of white cells	1e-11	27863252
rs12716977	rs11150589	1	Neutrophil-to-lymphocyte ratio	3e-23	34469753
rs12716977	rs11150589	1	Lymphocyte count	1e-90	34594039
rs12716977	rs11150589	1	White blood cell count	1e-36	34594039
rs12716977	rs12598978	1	Lymphocyte count	7e-186	32888493
rs12716977	rs12598978	1	Lymphocyte count	2e-181	32888493
rs12716977	rs12598978	1	Lymphocyte count	5e-57	34469753
rs12716977	rs12598978	1	Platelet-to-lymphocyte ratio	3e-41	34469753
rs12716977	rs12598978	1	Lymphocyte-to-monocyte ratio	3e-10	34469753
rs12716977	rs12598978	1	Insulin receptor levels	4e-16	34648354
rs12716977	rs12716977	1	Lymphocyte count	4e-130	32888494
rs12716977	rs12716977	1	Neutrophil count	8e-20	32888494
rs12716977	rs12716977	1	White blood cell count	3e-67	32888494
rs12716977	rs12716977	1	Lymphocyte count	1e-59	27863252
rs12716977	rs12716977	1	Lymphocyte percentage of white cells	2e-17	27863252
rs12716977	rs12716977	1	Monocyte count	5e-21	34469753
rs12716977	rs12716977	1	Basophil count	2e-20	34469753
rs12716977	rs11574938	0.988456975288191	Neutrophil count	3e-24	32888493
rs12716977	rs11574938	0.988456975288191	White blood cell count	2e-93	32888493
rs12716977	rs11574938	0.988456975288191	Neutrophil count	2e-25	32888493
rs12716977	rs11574938	0.988456975288191	White blood cell count	8e-91	32888493
rs12716977	rs11574938	0.988456975288191	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	5e-14	26974007
rs12716977	rs11574938	0.988456975288191	White blood cell count	6e-27	27863252
rs12716977	rs11574938	0.988456975288191	White blood cell count	5e-63	30595370
rs12716977	rs7196129	0.890635864789256	Basophil count	7e-16	32888493
rs12716977	rs7196129	0.890635864789256	Basophil count	7e-17	32888494
rs12716977	rs7196129	0.890635864789256	Basophil count	2e-13	32888493
rs12716977	rs7196129	0.890635864789256	Monocyte count	1e-23	32888494
rs12716977	rs7196129	0.890635864789256	Monocyte count	2e-39	32888493
rs12716977	rs7196129	0.890635864789256	Monocyte count	5e-37	32888493
rs12716977	rs7196129	0.890635864789256	Monocyte count	2e-10	27863252
rs12716977	rs7196129	0.890635864789256	Monocyte count	3e-18	34594039
rs12721505	rs73045343	0.652448773075449	Serum total protein level	1e-12	34594039
rs12721505	rs6759004	0.635523213745608	Triptolide cytotoxicity	3e-07	26121980
rs1272714	rs2357176	0.968539026627085	Nevus count or cutaneous melanoma	4e-08	30429480
rs1272714	rs10873172	0.811274996102666	Cutaneous melanoma or hair colour	6e-27	32341527
rs1272714	rs10873172	0.811274996102666	Nevus count or cutaneous melanoma	6e-13	32341527
rs1272714	rs10873172	0.811274996102666	Blond vs. brown/black hair color	6e-15	30531825
rs1272714	rs10873172	0.811274996102666	Cutaneous malignant melanoma	6e-08	32341527
rs1272714	rs10873172	0.811274996102666	Hair color	4e-17	30595370
rs1272714	rs1255908	0.791819971300033	PR interval	8e-14	32439900
rs1272714	rs1255908	0.791819971300033	PR interval	6e-14	32439900
rs1272714	rs12878653	0.687184623825913	Youthful appearance (self-reported)	3e-14	32339537
rs12729558	rs12729558	1	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs12729558	rs7532151	0.921581966954593	Imidazole lactate levels	9e-12	33177712
rs12729558	rs9787133	0.862031361334792	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12729558	rs10801690	0.861690746176742	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs12729558	rs10922531	0.858931202615633	Serum metabolite levels	2e-69	33031748
rs12729558	rs7530513	0.788060337808832	Height	8e-11	35831902
rs12729558	rs7530513	0.788060337808832	Imidazole lactate levels	8e-166	36635386
rs12729558	rs12144640	0.788060337808832	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12729558	rs1409152	0.777057844811651	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs12729558	rs1409152	0.777057844811651	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs12729558	rs10801699	0.775057124028699	X-23639 levels	2e-10	36635386
rs12729558	rs12120164	0.742751767255872	Metabolite peak levels (QI2146)	1e-26	35995766
rs12729558	rs2765527	0.715913614040997	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs12729558	rs1206228892	0.69107719716239	Imidazole lactate levels	5e-186	35050183
rs12729558	rs2810876	0.690371265841145	Imidazole lactate levels	2e-122	35347128
rs12729558	rs10801696	0.690287614446339	Imidazole lactate levels	3e-195	35050183
rs12729969	rs10801699	0.998285907305798	X-23639 levels	2e-10	36635386
rs12729969	rs1409152	0.995721709784585	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs12729969	rs1409152	0.995721709784585	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs12729969	rs12120164	0.956864561637726	Metabolite peak levels (QI2146)	1e-26	35995766
rs12729969	rs10922531	0.802785043694205	Serum metabolite levels	2e-69	33031748
rs12729969	rs12729558	0.776670862872413	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs12729969	rs7532151	0.715586286954016	Imidazole lactate levels	9e-12	33177712
rs12729969	rs7530513	0.713344248406322	Height	8e-11	35831902
rs12729969	rs7530513	0.713344248406322	Imidazole lactate levels	8e-166	36635386
rs12729969	rs12144640	0.713344248406322	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12729969	rs10801690	0.696263854539572	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs12729969	rs9787133	0.670163354584784	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12729969	rs2765527	0.628293351920004	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs12729969	rs10922532	0.608104119915621	Blood urea nitrogen levels	2e-08	31152163
rs12729969	rs10922532	0.608104119915621	Waist circumference adjusted for body mass index	2e-11	34021172
rs12729969	rs10922532	0.608104119915621	X-23639 levels	4e-11	35050183
rs12730621	rs10465746	0.803912588287651	Obesity-related traits	8e-06	23251661
rs12730621	rs11580836	0.7711168122813	Body mass index	2e-09	36581621
rs1273192	rs2357176	0.915992836174498	Nevus count or cutaneous melanoma	4e-08	30429480
rs1273192	rs1255908	0.837272845922539	PR interval	8e-14	32439900
rs1273192	rs1255908	0.837272845922539	PR interval	6e-14	32439900
rs1273192	rs10873172	0.761063359774639	Cutaneous melanoma or hair colour	6e-27	32341527
rs1273192	rs10873172	0.761063359774639	Nevus count or cutaneous melanoma	6e-13	32341527
rs1273192	rs10873172	0.761063359774639	Blond vs. brown/black hair color	6e-15	30531825
rs1273192	rs10873172	0.761063359774639	Cutaneous malignant melanoma	6e-08	32341527
rs1273192	rs10873172	0.761063359774639	Hair color	4e-17	30595370
rs1273192	rs12878653	0.641190312991281	Youthful appearance (self-reported)	3e-14	32339537
rs12738214	rs11580836	0.938026773351314	Body mass index	2e-09	36581621
rs12738214	rs10465746	0.908529796753717	Obesity-related traits	8e-06	23251661
rs12738214	rs1536166	0.60151928904454	Body mass index	2e-08	30595370
rs12745189	rs3754450	0.72391494320556	Seasonality and depression	3e-06	30217971
rs12748268	rs11580836	0.986713287754637	Body mass index	2e-09	36581621
rs12748268	rs10465746	0.964242352693142	Obesity-related traits	8e-06	23251661
rs12749350	rs10465746	0.80448071280468	Obesity-related traits	8e-06	23251661
rs12749350	rs11580836	0.771630458427919	Body mass index	2e-09	36581621
rs12749373	rs1409152	0.98465233724682	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs12749373	rs1409152	0.98465233724682	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs12749373	rs10801699	0.982076282317442	X-23639 levels	2e-10	36635386
rs12749373	rs12120164	0.940672162932198	Metabolite peak levels (QI2146)	1e-26	35995766
rs12749373	rs10922531	0.788709262235759	Serum metabolite levels	2e-69	33031748
rs12749373	rs12729558	0.767897994153274	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs12749373	rs7532151	0.707394346387859	Imidazole lactate levels	9e-12	33177712
rs12749373	rs7530513	0.703711513156493	Height	8e-11	35831902
rs12749373	rs7530513	0.703711513156493	Imidazole lactate levels	8e-166	36635386
rs12749373	rs12144640	0.703711513156493	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12749373	rs10801690	0.688225269871635	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs12749373	rs9787133	0.662335411351691	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs12749373	rs2765527	0.621076067186842	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs12758441	rs11580836	0.994668916796541	Body mass index	2e-09	36581621
rs12758441	rs10465746	0.963412722076756	Obesity-related traits	8e-06	23251661
rs12759527	rs11580836	0.948216309267624	Body mass index	2e-09	36581621
rs12759527	rs10465746	0.928576700944167	Obesity-related traits	8e-06	23251661
rs12781	rs5756090	0.96243167823062	Severe COVID-19 infection	4e-08	36662838
rs12781	rs2227169	0.877715750637276	Severe COVID-19 infection	4e-13	36662838
rs12781	rs1053982	0.858888709596489	Severe COVID-19 infection	9e-06	36662838
rs12781	rs6000172	0.858846307776117	Severe COVID-19 infection	1e-07	36662838
rs12781	rs4821461	0.848018128039085	Severe COVID-19 infection	4e-06	36662838
rs12875311	rs12875311	1	Height	2e-19	36224396
rs12875311	rs9603612	0.987936042321529	Systemic lupus erythematosus or rheumatoid arthritis	3e-13	27193031
rs12875311	rs7320598	0.982842172019873	Height	5e-16	31562340
rs12875311	rs7320598	0.982842172019873	Rheumatoid arthritis	2e-14	35470158
rs12875311	rs9603608	0.965072725951656	Respiratory diseases	8e-08	30595370
rs12875311	rs9943	0.960344049980344	Asthma	4e-09	31959851
rs12875311	rs34394770	0.94827750094683	Psoriasis	5e-08	25903422
rs12875311	rs34394770	0.94827750094683	Psoriasis	3e-08	25903422
rs12875311	rs34394770	0.94827750094683	Height	3e-11	34594039
rs12875311	rs34394770	0.94827750094683	Eosinophil counts	9e-24	34469753
rs12875311	rs9603605	0.944392585705994	Menarche (age at onset)	5e-14	30595370
rs12875311	rs8002731	0.886660664919701	Asthma (adult onset)	4e-10	31669095
rs12875311	rs8002731	0.886660664919701	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	4e-10	35470158
rs12875311	rs9603616	0.868382266012238	Rheumatoid arthritis	2e-12	30423114
rs12875311	rs9603616	0.868382266012238	Rheumatoid arthritis	8e-11	30423114
rs12875311	rs9603616	0.868382266012238	Rheumatoid arthritis	2e-12	24390342
rs12875311	rs9603616	0.868382266012238	Rheumatoid arthritis	3e-11	24390342
rs12875311	rs9603616	0.868382266012238	Asthma	4e-08	34594039
rs12875311	rs11618582	0.868382266012238	Age of onset of adult onset asthma	9e-09	36778051
rs12875311	rs12872801	0.818789266162783	Systemic lupus erythematosus (MTAG)	4e-08	36750564
rs12875311	rs12872801	0.818789266162783	Eosinophil counts	5e-40	30595370
rs12875311	rs7993214	0.802543444877616	Psoriasis	2e-06	18369459
rs12875311	rs7993214	0.802543444877616	Multiple sclerosis	2e-06	24076602
rs12875311	rs7993214	0.802543444877616	Rheumatoid arthritis (ACPA-positive)	5e-06	23143596
rs12875311	rs7993214	0.802543444877616	COVID-19 hospitalization or rheumatoid arthritis (MTAG)	5e-11	36762574
rs12875311	rs34270626	0.630970781355052	Asthma	6e-10	32296059
rs12875311	rs9532434	0.622387163473177	Eosinophil counts	5e-38	32888493
rs12875311	rs9532434	0.622387163473177	Eosinophil counts	5e-32	32888494
rs12875311	rs9532434	0.622387163473177	Eosinophil counts	8e-36	32888493
rs12875311	rs9532434	0.622387163473177	Eosinophil percentage of white cells	7e-34	32888494
rs12875311	rs9532434	0.622387163473177	Eosinophil percentage of white cells	2e-12	27863252
rs12875311	rs9532434	0.622387163473177	Rheumatoid arthritis	2e-19	33310728
rs12875311	rs9532434	0.622387163473177	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	5e-08	23603761
rs12875311	rs9532434	0.622387163473177	Eosinophil counts	1e-11	27863252
rs12875311	rs9532434	0.622387163473177	Sum eosinophil basophil counts	1e-10	27863252
rs12875311	rs9532434	0.622387163473177	Neutrophil percentage of granulocytes	2e-09	27863252
rs12875311	rs9532434	0.622387163473177	Eosinophil percentage of granulocytes	2e-10	27863252
rs12875311	rs9532434	0.622387163473177	Rheumatoid arthritis	9e-22	36333501
rs12875311	rs9532434	0.622387163473177	Rheumatoid arthritis	5e-15	36333501
rs12875311	rs9532434	0.622387163473177	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	7e-15	36333501
rs12875311	rs9532434	0.622387163473177	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	6e-18	36333501
rs12875311	rs9532434	0.622387163473177	Rheumatoid arthritis	2e-07	36333501
rs12875311	rs9532430	0.622354605324409	Eosinophil counts	9e-16	35935937
rs12875311	rs9603618	0.610820562278929	Rheumatoid arthritis (ACPA-positive)	5e-09	24532676
rs12881652	rs10873172	0.860928873497883	Cutaneous melanoma or hair colour	6e-27	32341527
rs12881652	rs10873172	0.860928873497883	Nevus count or cutaneous melanoma	6e-13	32341527
rs12881652	rs10873172	0.860928873497883	Blond vs. brown/black hair color	6e-15	30531825
rs12881652	rs10873172	0.860928873497883	Cutaneous malignant melanoma	6e-08	32341527
rs12881652	rs10873172	0.860928873497883	Hair color	4e-17	30595370
rs12881652	rs2357176	0.754501031875824	Nevus count or cutaneous melanoma	4e-08	30429480
rs12881652	rs1255908	0.650806236282582	PR interval	8e-14	32439900
rs12881652	rs1255908	0.650806236282582	PR interval	6e-14	32439900
rs12881652	rs12878653	0.630672633673131	Youthful appearance (self-reported)	3e-14	32339537
rs12900999	rs13379492	0.937210873114155	Lung function (FEV1/FVC)	6e-08	30595370
rs12900999	rs8034216	0.895586004780656	C-reactive protein levels	2e-10	31900758
rs12900999	rs17271340	0.857838496120168	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs12900999	rs17271305	0.834191589044437	Two-hour glucose challenge	1e-07	20081857
rs12900999	rs35967150	0.829152224383031	C-reactive protein levels (MTAG)	1e-08	36376304
rs12900999	rs11634163	0.820124121721475	C-reactive protein	2e-08	34594039
rs12900999	rs11634163	0.820124121721475	Two-hour glucose	3e-14	34059833
rs12900999	rs189400382	0.817123125990321	C-reactive protein levels	1e-08	35459240
rs12900999	rs28373613	0.676483820373735	Height (standard GWA)	8e-12	37106081
rs12906423	rs28373613	0.9216113749505	Height (standard GWA)	8e-12	37106081
rs12906423	rs13379492	0.648973413203213	Lung function (FEV1/FVC)	6e-08	30595370
rs12906423	rs8034216	0.630677692020183	C-reactive protein levels	2e-10	31900758
rs12906423	rs17271340	0.601978768375303	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs12908081	rs28373613	0.906996084481878	Height (standard GWA)	8e-12	37106081
rs12908081	rs13379492	0.651375135461268	Lung function (FEV1/FVC)	6e-08	30595370
rs12908081	rs8034216	0.617142788510597	C-reactive protein levels	2e-10	31900758
rs12909947	rs12901247	0.827527124912409	Insular cortex volume	4e-06	31530798
rs12909947	rs72749770	0.718467168410777	Low density lipoprotein cholesterol levels	9e-10	32493714
rs12909947	rs72749770	0.718467168410777	Apolipoprotein B levels	2e-09	32203549
rs12909947	rs2042608	0.71792737593411	Glycemic traits (multi-trait analysis)	3e-09	29743933
rs12909947	rs11635977	0.717585569658674	Height	2e-25	36224396
rs12909947	rs7162536	0.700186749661228	Height	4e-29	34594039
rs12909947	rs731820	0.668589006490936	Height	2e-13	31562340
rs12909947	rs731820	0.668589006490936	Height	2e-12	35831902
rs12909947	rs2162062	0.639316562085098	Height	2e-13	35831902
rs12909947	rs7178540	0.610143630049432	Height	1e-31	36224396
rs12909947	rs933807	0.604540699548472	Fat-free mass	6e-06	30593698
rs12909947	rs933807	0.604540699548472	Fat-free mass	2e-07	30593698
rs12909947	rs933807	0.604540699548472	Fat-free mass	8e-11	30593698
rs12911564	rs28373613	0.883529567593557	Height (standard GWA)	8e-12	37106081
rs12911564	rs13379492	0.624215360376113	Lung function (FEV1/FVC)	6e-08	30595370
rs12911564	rs8034216	0.606324209588899	C-reactive protein levels	2e-10	31900758
rs12912208	rs72749770	0.811938391073324	Low density lipoprotein cholesterol levels	9e-10	32493714
rs12912208	rs72749770	0.811938391073324	Apolipoprotein B levels	2e-09	32203549
rs12912208	rs12901247	0.807664136796968	Insular cortex volume	4e-06	31530798
rs12912208	rs11635977	0.800753877317456	Height	2e-25	36224396
rs12912208	rs7162536	0.767967906275979	Height	4e-29	34594039
rs12912208	rs731820	0.737665300409464	Height	2e-13	31562340
rs12912208	rs731820	0.737665300409464	Height	2e-12	35831902
rs12912208	rs7178540	0.677463082953085	Height	1e-31	36224396
rs12912208	rs2042608	0.672582734642304	Glycemic traits (multi-trait analysis)	3e-09	29743933
rs12912208	rs7178424	0.651674590585907	Height	6e-09	20881960
rs12912208	rs7178424	0.651674590585907	Height	6e-13	35831902
rs12912208	rs7178424	0.651674590585907	Height	3e-251	36224396
rs12912208	rs17271431	0.64995826201924	Height	2e-11	34594039
rs12912208	rs17205463	0.647756680014848	Serum levels of protein IGF1	8e-08	27329260
rs12912208	rs17205463	0.647756680014848	Appendicular lean mass	4e-43	33097823
rs12912208	rs17205463	0.647756680014848	Height	2e-35	30595370
rs12912208	rs1436958	0.639045823906228	IgG glycosylation	9e-06	23382691
rs12915295	rs28373613	0.911529995784578	Height (standard GWA)	8e-12	37106081
rs12915295	rs13379492	0.651527269442024	Lung function (FEV1/FVC)	6e-08	30595370
rs12915295	rs8034216	0.637980381983838	C-reactive protein levels	2e-10	31900758
rs12915295	rs17271340	0.610645134732988	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs12915825	rs28373613	0.894616667546242	Height (standard GWA)	8e-12	37106081
rs12915825	rs13379492	0.632030987205953	Lung function (FEV1/FVC)	6e-08	30595370
rs12916268	rs28373613	0.877697872381648	Height (standard GWA)	8e-12	37106081
rs12916268	rs13379492	0.618857176090958	Lung function (FEV1/FVC)	6e-08	30595370
rs12948839	rs7211615	0.645922858735024	Heel bone mineral density	1e-08	30595370
rs12948839	rs61586425	0.645788991440076	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs12948839	rs8077038	0.623344708009716	Educational attainment (MTAG)	4e-10	30038396
rs12948839	rs8077038	0.623344708009716	Highest math class taken (MTAG)	5e-16	30038396
rs12948839	rs12949956	0.616295896685777	Self-reported math ability	3e-11	30038396
rs12948839	rs12949956	0.616295896685777	Self-reported math ability (MTAG)	3e-14	30038396
rs12948839	rs12949956	0.616295896685777	Highest math class taken	8e-12	30038396
rs12949956	rs12949956	1	Self-reported math ability	3e-11	30038396
rs12949956	rs12949956	1	Self-reported math ability (MTAG)	3e-14	30038396
rs12949956	rs12949956	1	Highest math class taken	8e-12	30038396
rs12949956	rs8077038	0.972723762315257	Educational attainment (MTAG)	4e-10	30038396
rs12949956	rs8077038	0.972723762315257	Highest math class taken (MTAG)	5e-16	30038396
rs12949956	rs7211615	0.950659681538421	Heel bone mineral density	1e-08	30595370
rs12949956	rs9894429	0.632633762391902	Eye color traits	9e-14	20463881
rs12949956	rs9894429	0.632633762391902	Body mass index	4e-08	36581621
rs12950315	rs1055636	0.848803700588956	Severe COVID-19 infection	1e-08	36662838
rs12974543	rs1138888	0.787605924524312	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs12974543	rs1138888	0.787605924524312	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs12974543	rs4802157	0.767239493503077	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs12974543	rs2355433	0.666461987372299	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs12974543	rs2355433	0.666461987372299	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs12974543	rs2355433	0.666461987372299	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs12987765	rs6705511	0.694973056512879	Self-reported math ability	4e-09	30038396
rs12987765	rs6705511	0.694973056512879	Self-reported math ability (MTAG)	3e-10	30038396
rs12987765	rs34276187	0.689176520742724	Highest math class taken (MTAG)	2e-08	30038396
rs12994589	rs8207	0.805329563692721	Monocyte count	1e-10	32888493
rs12994589	rs8207	0.805329563692721	Height	2e-18	36224396
rs12994589	rs6738934	0.652414794746147	Vaginal microbiome MetaCyc pathway (PWY-5741|ethylmalonyl-CoA pathway)	3e-07	34282934
rs12996459	rs6705511	0.751628261629561	Self-reported math ability	4e-09	30038396
rs12996459	rs6705511	0.751628261629561	Self-reported math ability (MTAG)	3e-10	30038396
rs12996459	rs34276187	0.745805117068144	Highest math class taken (MTAG)	2e-08	30038396
rs12998170	rs6723298	0.676365869352655	Smoking initiation	2e-12	36477530
rs12998170	rs2194492	0.657609756084126	Educational attainment	9e-09	35361970
rs12998170	rs13020443	0.647823835336573	Type 2 diabetes	3e-11	32541925
rs12999245	rs11685226	0.886864696594781	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs12999245	rs11685226	0.886864696594781	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs12999245	rs1177308	0.882291634551555	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs12999245	rs1177308	0.882291634551555	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs12999245	rs7558954	0.880188700027473	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs12999245	rs777587	0.744666767344111	Proteoglycan 3 levels	6e-29	34648354
rs12999245	rs777587	0.744666767344111	Pappalysin-1 levels	1e-25	34648354
rs12999245	rs12617371	0.703032774661678	Immature fraction of reticulocytes	8e-18	32888494
rs12999245	rs2463097	0.672989865329007	White blood cell count	3e-26	30595370
rs12999245	rs2593620	0.645245173580117	Serum levels of protein PRG3	5e-14	35078996
rs12999245	rs10199672	0.63989423901339	Height	6e-12	34594039
rs12999245	rs10199672	0.63989423901339	Height	2e-12	31562340
rs12999245	rs2421200	0.619611086607861	Neutrophil count	1e-26	32888493
rs12999245	rs2421200	0.619611086607861	Neutrophil count	1e-25	32888493
rs13002460	rs8207	0.804416785369721	Monocyte count	1e-10	32888493
rs13002460	rs8207	0.804416785369721	Height	2e-18	36224396
rs13002460	rs6738934	0.651636023733943	Vaginal microbiome MetaCyc pathway (PWY-5741|ethylmalonyl-CoA pathway)	3e-07	34282934
rs13004590	rs6705511	0.695764578631741	Self-reported math ability	4e-09	30038396
rs13004590	rs6705511	0.695764578631741	Self-reported math ability (MTAG)	3e-10	30038396
rs13004590	rs34276187	0.689953701698619	Highest math class taken (MTAG)	2e-08	30038396
rs13005377	rs12620999	0.995914670808034	Systemic lupus erythematosus	3e-06	19838195
rs13007071	rs12620999	0.997952236837549	Systemic lupus erythematosus	3e-06	19838195
rs13020962	rs6705511	0.715708291898553	Self-reported math ability	4e-09	30038396
rs13020962	rs6705511	0.715708291898553	Self-reported math ability (MTAG)	3e-10	30038396
rs13020962	rs34276187	0.709535605507491	Highest math class taken (MTAG)	2e-08	30038396
rs13022812	rs11889663	0.875745378561054	C-reactive protein levels (MTAG)	2e-12	36376304
rs13022812	rs17626434	0.749533560920555	C-reactive protein levels	8e-12	31900758
rs13025888	rs6705511	0.752653094598621	Self-reported math ability	4e-09	30038396
rs13025888	rs6705511	0.752653094598621	Self-reported math ability (MTAG)	3e-10	30038396
rs13025888	rs34276187	0.746482702095445	Highest math class taken (MTAG)	2e-08	30038396
rs13027560	rs13027560	1	Lung function (FEV1/FVC)	1e-18	30595370
rs13027560	rs12615659	0.824983237260413	Microalbuminuria	1e-06	26631737
rs13027560	rs2084448	0.769159750830144	Lung function (FEV1/FVC)	5e-14	30804560
rs13062193	rs11715071	1	Body mass index	3e-08	36581621
rs13066191	rs11715071	0.998965848200729	Body mass index	3e-08	36581621
rs13066534	rs11715071	0.996902277562366	Body mass index	3e-08	36581621
rs13073692	rs17648188	0.768942291623803	Hepatocyte growth factor-like protein levels	4e-11	36168886
rs13092252	rs11715071	0.998965848200729	Body mass index	3e-08	36581621
rs13092582	rs11715071	0.998965848200729	Body mass index	3e-08	36581621
rs13099025	rs11715071	0.998965848200729	Body mass index	3e-08	36581621
rs13109003	rs7655841	0.872328259396427	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs13109003	rs337277	0.846219077963461	Metabolite peak levels (QI10992)	3e-52	35995766
rs13109003	rs337277	0.846219077963461	Metabolite peak levels (QI4667)	7e-18	35995766
rs13109003	rs337277	0.846219077963461	Metabolite peak levels (QI4708)	1e-21	35995766
rs13109003	rs337277	0.846219077963461	Metabolite peak levels (QI5169)	7e-57	35995766
rs13109003	rs10010659	0.600558317792905	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs13115831	rs17495047	0.968028756937255	Adolescent idiopathic scoliosis	3e-07	30019117
rs13121507	rs17495047	0.964114885392063	Adolescent idiopathic scoliosis	3e-07	30019117
rs13130762	rs337277	0.918643000840208	Metabolite peak levels (QI10992)	3e-52	35995766
rs13130762	rs337277	0.918643000840208	Metabolite peak levels (QI4667)	7e-18	35995766
rs13130762	rs337277	0.918643000840208	Metabolite peak levels (QI4708)	1e-21	35995766
rs13130762	rs337277	0.918643000840208	Metabolite peak levels (QI5169)	7e-57	35995766
rs13130762	rs7655841	0.741749611154469	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs13138726	rs10222974	0.732564665500022	Height	3e-07	36224396
rs13170029	rs1423357	0.994959466688381	General cognitive ability	9e-06	29844566
rs13170029	rs2432142	0.983242252425129	Neutrophil count	2e-14	32888493
rs13170029	rs2432142	0.983242252425129	White blood cell count	1e-11	32888493
rs13170029	rs38033	0.978393831694969	Blood protein levels	0	30072576
rs13170029	rs27293	0.95935531279904	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs13170029	rs27293	0.95935531279904	Diastolic blood pressure	3e-11	35762941
rs13170029	rs7705093	0.950806331697708	Birdshot chorioretinopathy	2e-09	24957906
rs13170029	rs2910686	0.870289088151113	Neutrophil count	4e-14	32888493
rs13170029	rs2910686	0.870289088151113	Psoriasis	2e-08	23143594
rs13170029	rs2910686	0.870289088151113	Ankylosing spondylitis	5e-17	23749187
rs13170029	rs2910686	0.870289088151113	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs13170029	rs2927608	0.866968221414478	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs13170029	rs2927608	0.866968221414478	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs13170029	rs2927608	0.866968221414478	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs13170029	rs2617439	0.782225989402018	Neutrophil count	8e-11	32888494
rs13170029	rs2549797	0.774982290440628	Systolic blood pressure	7e-07	33230300
rs13170029	rs2549797	0.774982290440628	Diastolic blood pressure	1e-14	33230300
rs13170029	rs2549797	0.774982290440628	Diastolic blood pressure	3e-11	33230300
rs13170029	rs2549797	0.774982290440628	Systolic blood pressure	4e-09	33230300
rs13170029	rs2549782	0.773723338353128	Systolic blood pressure	6e-07	33230300
rs13170029	rs2549782	0.773723338353128	Diastolic blood pressure	1e-14	33230300
rs13170029	rs2549782	0.773723338353128	Diastolic blood pressure	3e-11	33230300
rs13170029	rs2549782	0.773723338353128	Systolic blood pressure	5e-09	33230300
rs13170029	rs1056893	0.773094705747213	Systolic blood pressure	1e-06	33230300
rs13170029	rs1056893	0.773094705747213	Diastolic blood pressure	7e-15	33230300
rs13170029	rs1056893	0.773094705747213	Diastolic blood pressure	2e-11	33230300
rs13170029	rs1056893	0.773094705747213	Systolic blood pressure	7e-09	33230300
rs13170029	rs2549794	0.768132591060609	Crohn's disease	1e-10	21102463
rs13170029	rs2549794	0.768132591060609	Systolic blood pressure	1e-07	33230300
rs13170029	rs2549794	0.768132591060609	Diastolic blood pressure	1e-15	33230300
rs13170029	rs2549794	0.768132591060609	Diastolic blood pressure	2e-12	33230300
rs13170029	rs2549794	0.768132591060609	Systolic blood pressure	4e-10	33230300
rs13170029	rs38029	0.765907449266346	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs13170029	rs1363907	0.763493052704713	Crohn's disease	4e-16	26192919
rs13170029	rs1363907	0.763493052704713	Ulcerative colitis	4e-06	26192919
rs13170029	rs1363907	0.763493052704713	Inflammatory bowel disease	5e-15	26192919
rs13170029	rs1363907	0.763493052704713	Inflammatory bowel disease	6e-13	23128233
rs13170029	rs1363907	0.763493052704713	Inflammatory bowel disease	1e-10	28067908
rs13170029	rs1363907	0.763493052704713	Crohn's disease	1e-14	28067908
rs13170029	rs716848	0.735113320991913	Neutrophil percentage of white cells	2e-09	32888494
rs13170029	rs4869313	0.723544973408983	Pediatric autoimmune diseases	9e-08	26301688
rs13170029	rs1559359	0.717386499605123	Diastolic blood pressure	7e-10	34594039
rs13170029	rs2548532	0.690211356663169	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs13170029	rs4869314	0.670449535461436	Arthritis (juvenile idiopathic)	3e-09	33106285
rs13170029	rs4869314	0.670449535461436	Neutrophil count	1e-10	34594039
rs13170029	rs4869314	0.670449535461436	White blood cell count	2e-07	30595370
rs13170029	rs1974871	0.643807907416153	Granulysin levels	5e-13	34648354
rs13170029	rs1019503	0.639795049352606	Systolic blood pressure	2e-06	33230300
rs13170029	rs1019503	0.639795049352606	Diastolic blood pressure	2e-14	33230300
rs13170029	rs1019503	0.639795049352606	Diastolic blood pressure	4e-11	33230300
rs13170029	rs1019503	0.639795049352606	Systolic blood pressure	1e-08	33230300
rs13170029	rs27660	0.636352191499118	Coronary artery disease	3e-08	35915156
rs13170029	rs3096168	0.632358713296919	Aspartate aminotransferase levels	8e-12	33547301
rs13170697	rs2431501	0.98907877381423	Lung function (FEV1/FVC)	7e-13	36914875
rs13176880	rs301901	0.971187650797326	Height	4e-16	25282103
rs13176880	rs301901	0.971187650797326	Height	2e-06	35831902
rs13176880	rs158796	0.943152098810518	Height	5e-243	36224396
rs13176880	rs292172	0.930506684093548	Appendicular lean mass	8e-13	31761296
rs13176880	rs300046	0.91555147195293	Meat-related diet	5e-08	32066663
rs13176880	rs300053	0.893528518175331	Height	3e-11	34594039
rs13176880	rs300053	0.893528518175331	Height	3e-36	34594039
rs13176880	rs300053	0.893528518175331	Height	2e-14	31562340
rs13176880	rs158791	0.887844187333427	Height	2e-31	36224396
rs13176880	rs158622	0.883727103930527	Height	4e-15	36224396
rs13176880	rs292168	0.839212901778301	Red cell distribution width	3e-10	30595370
rs13188599	rs10061757	0.821996038206739	Height	4e-30	30595370
rs13188599	rs702689	0.705249465942221	Vertex-wise sulcal depth	2e-22	34910505
rs13188599	rs96844	0.676888957670521	Type 2 diabetes	5e-08	30297969
rs13188599	rs96844	0.676888957670521	Height	4e-33	36224396
rs13188599	rs9292122	0.645239658278966	Prostate cancer	5e-09	33398198
rs13188599	rs832540	0.634603146056539	Coronary artery disease	2e-08	29212778
rs13189819	rs1974871	0.915928168625137	Granulysin levels	5e-13	34648354
rs13189819	rs4869314	0.904031415730621	Arthritis (juvenile idiopathic)	3e-09	33106285
rs13189819	rs4869314	0.904031415730621	Neutrophil count	1e-10	34594039
rs13189819	rs4869314	0.904031415730621	White blood cell count	2e-07	30595370
rs13189819	rs2549782	0.849361253243921	Systolic blood pressure	6e-07	33230300
rs13189819	rs2549782	0.849361253243921	Diastolic blood pressure	1e-14	33230300
rs13189819	rs2549782	0.849361253243921	Diastolic blood pressure	3e-11	33230300
rs13189819	rs2549782	0.849361253243921	Systolic blood pressure	5e-09	33230300
rs13189819	rs2549797	0.849348240799059	Systolic blood pressure	7e-07	33230300
rs13189819	rs2549797	0.849348240799059	Diastolic blood pressure	1e-14	33230300
rs13189819	rs2549797	0.849348240799059	Diastolic blood pressure	3e-11	33230300
rs13189819	rs2549797	0.849348240799059	Systolic blood pressure	4e-09	33230300
rs13189819	rs1056893	0.847135286489959	Systolic blood pressure	1e-06	33230300
rs13189819	rs1056893	0.847135286489959	Diastolic blood pressure	7e-15	33230300
rs13189819	rs1056893	0.847135286489959	Diastolic blood pressure	2e-11	33230300
rs13189819	rs1056893	0.847135286489959	Systolic blood pressure	7e-09	33230300
rs13189819	rs4869313	0.828357185450209	Pediatric autoimmune diseases	9e-08	26301688
rs13189819	rs1559359	0.820636070816653	Diastolic blood pressure	7e-10	34594039
rs13189819	rs2910686	0.80253660120544	Neutrophil count	4e-14	32888493
rs13189819	rs2910686	0.80253660120544	Psoriasis	2e-08	23143594
rs13189819	rs2910686	0.80253660120544	Ankylosing spondylitis	5e-17	23749187
rs13189819	rs2910686	0.80253660120544	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs13189819	rs2927608	0.801202731069476	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs13189819	rs2927608	0.801202731069476	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs13189819	rs2927608	0.801202731069476	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs13189819	rs1019503	0.729569739835629	Systolic blood pressure	2e-06	33230300
rs13189819	rs1019503	0.729569739835629	Diastolic blood pressure	2e-14	33230300
rs13189819	rs1019503	0.729569739835629	Diastolic blood pressure	4e-11	33230300
rs13189819	rs1019503	0.729569739835629	Systolic blood pressure	1e-08	33230300
rs13189819	rs3096168	0.724039884485379	Aspartate aminotransferase levels	8e-12	33547301
rs13189819	rs1423357	0.704327617321427	General cognitive ability	9e-06	29844566
rs13189819	rs2432142	0.6904338387539	Neutrophil count	2e-14	32888493
rs13189819	rs2432142	0.6904338387539	White blood cell count	1e-11	32888493
rs13189819	rs38033	0.684931067922502	Blood protein levels	0	30072576
rs13189819	rs27293	0.674903607971109	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs13189819	rs27293	0.674903607971109	Diastolic blood pressure	3e-11	35762941
rs13189819	rs7705093	0.666169336546314	Birdshot chorioretinopathy	2e-09	24957906
rs13189973	rs13189973	1	Lymphocyte count	2e-16	32888493
rs13189973	rs2548499	0.637346251228666	Lymphocyte count	9e-14	32888494
rs13191846	rs9394952	0.931701368476418	Age-related hearing impairment	3e-11	34108613
rs13191846	rs4714680	0.91034780189018	Height	2e-09	34594039
rs13191846	rs4714680	0.91034780189018	Hip circumference adjusted for BMI	4e-08	34021172
rs13191846	rs9369409	0.756704919007962	Waist-hip index	5e-09	34021172
rs13191846	rs9369409	0.756704919007962	Medication use (calcium channel blockers)	3e-10	31015401
rs13191846	rs9369409	0.756704919007962	Waist-to-hip ratio adjusted for BMI	1e-09	34021172
rs13191846	rs9369409	0.756704919007962	Medication use (calcium channel blockers)	4e-17	34594039
rs13191846	rs9369409	0.756704919007962	Waist-hip ratio	8e-15	30595370
rs13191846	rs4714678	0.752702925225345	Systolic blood pressure	1e-17	30487518
rs13191846	rs4714678	0.752702925225345	Mean arterial pressure	9e-16	30487518
rs13191846	rs4714678	0.752702925225345	Urea levels	3e-10	33462484
rs13191846	rs4714678	0.752702925225345	Blood urea nitrogen levels	8e-11	34594039
rs13191846	rs6912283	0.735653955122725	Bioavailable testosterone levels	1e-12	32042192
rs13191846	rs6912283	0.735653955122725	Serum alkaline phosphatase levels	2e-10	33547301
rs13191846	rs6912283	0.735653955122725	Heel bone mineral density	6e-09	30598549
rs13191846	rs6912283	0.735653955122725	Hip index	7e-11	34021172
rs13191846	rs9394951	0.735184441471724	Mean corpuscular volume	1e-16	32888494
rs13191846	rs9394951	0.735184441471724	Mean reticulocyte volume	4e-14	32888494
rs13191846	rs9394951	0.735184441471724	Mean spheric corpuscular volume	1e-17	32888494
rs13191846	rs9394951	0.735184441471724	Medication use (diuretics)	6e-11	31015401
rs13191846	rs9394951	0.735184441471724	Medication use (agents acting on the renin-angiotensin system)	2e-09	31015401
rs13191846	rs9394951	0.735184441471724	Medication use (agents acting on the renin-angiotensin system)	2e-14	34594039
rs13191846	rs9394951	0.735184441471724	Medication use (diuretics)	2e-14	34594039
rs13191846	rs6919440	0.733426828807574	Diastolic blood pressure	1e-11	30487518
rs13191846	rs6919440	0.733426828807574	Systolic blood pressure	5e-09	27618452
rs13191846	rs6919440	0.733426828807574	Mean corpuscular hemoglobin	9e-11	32888493
rs13191846	rs6919440	0.733426828807574	Mean corpuscular volume	1e-14	32888493
rs13191846	rs6919440	0.733426828807574	Platelet count	5e-22	32888493
rs13191846	rs6919440	0.733426828807574	Platelet count	2e-23	32888493
rs13191846	rs6919440	0.733426828807574	Mean corpuscular volume	4e-14	32888493
rs13191846	rs6919440	0.733426828807574	Plateletcrit	3e-09	27863252
rs13191846	rs6919440	0.733426828807574	Hip circumference adjusted for BMI	4e-16	34021172
rs13191846	rs6919440	0.733426828807574	Mean arterial pressure	1e-14	34594039
rs13191846	rs6919440	0.733426828807574	Superior parietal thickness (unadjusted for global measures)	4e-09	36893272
rs13191846	rs2611336	0.73151439096983	Hearing problems	2e-08	37165447
rs13191846	rs4714677	0.730273919700613	Heel bone mineral density	3e-10	30595370
rs13191846	rs2396004	0.730090862517013	Mean corpuscular hemoglobin	1e-12	32888494
rs13191846	rs2396004	0.730090862517013	Chronotype	3e-09	30696823
rs13191846	rs2396004	0.730090862517013	Carnitine levels	4e-11	33414548
rs13191846	rs2396004	0.730090862517013	Total testosterone levels	4e-08	34321204
rs13191846	rs9394948	0.730025158891544	Serum uric acid levels	1e-11	29403010
rs13191846	rs9394948	0.730025158891544	Serum uric acid levels	2e-13	30993211
rs13191846	rs10948071	0.724106013496987	Systolic blood pressure	4e-10	30487518
rs13191846	rs10948071	0.724106013496987	Mean arterial pressure	4e-09	30487518
rs13191846	rs10948071	0.724106013496987	Diastolic blood pressure	1e-06	30487518
rs13191846	rs10948071	0.724106013496987	Pulse pressure	4e-06	30487518
rs13191846	rs10948071	0.724106013496987	Hypertension	1e-06	30487518
rs13191846	rs10948071	0.724106013496987	Age-related hearing impairment (MTAG)	1e-18	32986727
rs13191846	rs10948071	0.724106013496987	Pulse pressure	3e-06	27841878
rs13191846	rs10948071	0.724106013496987	Systolic blood pressure	1e-09	27841878
rs13191846	rs10948071	0.724106013496987	Diastolic blood pressure (cigarette smoking interaction)	1e-10	29455858
rs13191846	rs10948071	0.724106013496987	Systolic blood pressure (cigarette smoking interaction)	8e-21	29455858
rs13191846	rs2254303	0.716810661962106	Pulse pressure	6e-11	30487518
rs13191846	rs2254303	0.716810661962106	Height	3e-18	34594039
rs13191846	rs2254303	0.716810661962106	Height	4e-08	31562340
rs13191846	rs2254303	0.716810661962106	Hearing problems	1e-23	37165447
rs13191846	rs1574430	0.682072345525347	Urate levels	3e-14	31578528
rs13191846	rs56401710	0.682072345525347	Urate levels	4e-10	31578528
rs13191846	rs56401710	0.682072345525347	Urate levels	5e-14	31578528
rs13191846	rs56401710	0.682072345525347	Urate levels	5e-30	31578528
rs13191846	rs2242416	0.669656541825034	Age-related hearing impairment	1e-17	34108613
rs13191846	rs2242416	0.669656541825034	Body mass index	3e-08	36581621
rs13191846	rs2242416	0.669656541825034	Hearing problems	1e-17	37165447
rs13191846	rs1214752	0.667462798631033	Coronary artery disease	1e-06	29212778
rs13191846	rs62415384	0.627096873388766	Total testosterone levels	3e-08	32042192
rs13191846	rs62415384	0.627096873388766	Tyrosine levels	2e-11	35213538
rs13191846	rs10948077	0.613855358038775	Gamma-glutamylglutamate levels	1e-10	36635386
rs13198620	rs9469857	0.996776778921405	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs13198620	rs2764208	0.995972777577403	Systemic lupus erythematosus	7e-06	24871463
rs13198620	rs9462030	0.982341944636037	Red cell distribution width	5e-25	32888493
rs13198620	rs9469899	0.965886102309356	Prostate cancer (advanced)	2e-06	29892016
rs13198620	rs9469899	0.965886102309356	Prostate cancer	5e-09	29892016
rs13198620	rs9469899	0.965886102309356	Prostate cancer	8e-11	33398198
rs13198620	rs9469899	0.965886102309356	Hand grip strength	3e-15	29691431
rs13198620	rs9469899	0.965886102309356	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs13198620	rs9469899	0.965886102309356	Graves' disease	4e-10	34594039
rs13198620	rs9469899	0.965886102309356	Coronary artery disease	1e-11	36474045
rs13198620	rs9469899	0.965886102309356	Predicted visceral adipose tissue	2e-20	31501611
rs13198620	rs9469899	0.965886102309356	Medication use (thyroid preparations)	2e-09	31015401
rs13198620	rs9469899	0.965886102309356	Medication use (thyroid preparations)	3e-10	34594039
rs13198620	rs9469872	0.96054887345204	HDL cholesterol levels	3e-11	36333282
rs13198620	rs9296128	0.945681992424858	Hip circumference adjusted for BMI	4e-13	34021172
rs13198620	rs11755393	0.935272594959748	Body mass index	3e-26	29273807
rs13198620	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-12	33493351
rs13198620	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-06	33493351
rs13198620	rs11755393	0.935272594959748	Systemic lupus erythematosus	1e-07	33493351
rs13198620	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-08	19838195
rs13198620	rs11755393	0.935272594959748	Body mass index	4e-55	36581621
rs13198620	rs9366863	0.931525188678084	Adult body size	9e-33	32376654
rs13198620	rs9366863	0.931525188678084	Body mass index	2e-44	30595370
rs13198620	rs6941110	0.923705176714688	Sex hormone-binding globulin levels	5e-27	36653534
rs13198620	rs2744944	0.904579222323617	Hypothyroidism	3e-10	34594039
rs13198620	rs2744944	0.904579222323617	High density lipoprotein cholesterol levels	3e-86	34887591
rs13198620	rs2744944	0.904579222323617	Multi-trait sex score	7e-22	37277458
rs13198620	rs2814949	0.89561287838885	Essential hypertension (time to event)	9e-09	32589924
rs13198620	rs2263329	0.882234019129751	HDL cholesterol	6e-35	34594039
rs13198620	rs2263329	0.882234019129751	HDL cholesterol levels	8e-43	32203549
rs13198620	rs2263329	0.882234019129751	High density lipoprotein cholesterol levels	2e-52	34887591
rs13198620	rs111868030	0.861138045850585	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs13198620	rs9368830	0.823175715403171	HDL cholesterol	4e-21	30275531
rs13198620	rs9368828	0.813764410103364	Body mass index	1e-34	34594039
rs13198620	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs13198620	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs13198620	rs2744973	0.792134506553775	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs13198620	rs2744973	0.792134506553775	Multi-trait sex score	6e-20	37277458
rs13198620	rs6912327	0.779895917756941	Fasting insulin	5e-06	33402679
rs13198620	rs6912327	0.779895917756941	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs13198620	rs112283401	0.757749108732694	Red cell distribution width	4e-27	30595370
rs13198620	rs9689160	0.620633913312638	Lung function (forced vital capacity)	3e-14	36914875
rs13198620	rs9462027	0.600261280766747	Systemic lupus erythematosus	1e-10	27399966
rs13198620	rs9462027	0.600261280766747	Systemic lupus erythematosus	8e-09	26502338
rs13198620	rs9462027	0.600261280766747	Systemic lupus erythematosus	2e-08	28714469
rs13198620	rs9462027	0.600261280766747	Alzheimer's disease or gastroesophageal reflux disease	2e-06	35851147
rs13206387	rs9366863	0.980876487817697	Adult body size	9e-33	32376654
rs13206387	rs9366863	0.980876487817697	Body mass index	2e-44	30595370
rs13206387	rs9469872	0.970545616445791	HDL cholesterol levels	3e-11	36333282
rs13206387	rs11755393	0.963434247038835	Body mass index	3e-26	29273807
rs13206387	rs11755393	0.963434247038835	Systemic lupus erythematosus	2e-12	33493351
rs13206387	rs11755393	0.963434247038835	Systemic lupus erythematosus	2e-06	33493351
rs13206387	rs11755393	0.963434247038835	Systemic lupus erythematosus	1e-07	33493351
rs13206387	rs11755393	0.963434247038835	Systemic lupus erythematosus	2e-08	19838195
rs13206387	rs11755393	0.963434247038835	Body mass index	4e-55	36581621
rs13206387	rs6941110	0.952464755041263	Sex hormone-binding globulin levels	5e-27	36653534
rs13206387	rs2814949	0.943804827904036	Essential hypertension (time to event)	9e-09	32589924
rs13206387	rs9462030	0.934958733006129	Red cell distribution width	5e-25	32888493
rs13206387	rs2744944	0.934484584652378	Hypothyroidism	3e-10	34594039
rs13206387	rs2744944	0.934484584652378	High density lipoprotein cholesterol levels	3e-86	34887591
rs13206387	rs2744944	0.934484584652378	Multi-trait sex score	7e-22	37277458
rs13206387	rs9469857	0.93036769704585	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs13206387	rs2764208	0.929647863750363	Systemic lupus erythematosus	7e-06	24871463
rs13206387	rs9469899	0.918310613876687	Prostate cancer (advanced)	2e-06	29892016
rs13206387	rs9469899	0.918310613876687	Prostate cancer	5e-09	29892016
rs13206387	rs9469899	0.918310613876687	Prostate cancer	8e-11	33398198
rs13206387	rs9469899	0.918310613876687	Hand grip strength	3e-15	29691431
rs13206387	rs9469899	0.918310613876687	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs13206387	rs9469899	0.918310613876687	Graves' disease	4e-10	34594039
rs13206387	rs9469899	0.918310613876687	Coronary artery disease	1e-11	36474045
rs13206387	rs9469899	0.918310613876687	Predicted visceral adipose tissue	2e-20	31501611
rs13206387	rs9469899	0.918310613876687	Medication use (thyroid preparations)	2e-09	31015401
rs13206387	rs9469899	0.918310613876687	Medication use (thyroid preparations)	3e-10	34594039
rs13206387	rs2263329	0.915261511992809	HDL cholesterol	6e-35	34594039
rs13206387	rs2263329	0.915261511992809	HDL cholesterol levels	8e-43	32203549
rs13206387	rs2263329	0.915261511992809	High density lipoprotein cholesterol levels	2e-52	34887591
rs13206387	rs111868030	0.891438643598796	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs13206387	rs9296128	0.882318275505166	Hip circumference adjusted for BMI	4e-13	34021172
rs13206387	rs9368830	0.870449097748271	HDL cholesterol	4e-21	30275531
rs13206387	rs9368828	0.838646183794381	Body mass index	1e-34	34594039
rs13206387	rs6912327	0.811070987562377	Fasting insulin	5e-06	33402679
rs13206387	rs6912327	0.811070987562377	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs13206387	rs112283401	0.788510948310497	Red cell distribution width	4e-27	30595370
rs13206387	rs2744973	0.783731045944234	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs13206387	rs2744973	0.783731045944234	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs13206387	rs2744973	0.783731045944234	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs13206387	rs2744973	0.783731045944234	Multi-trait sex score	6e-20	37277458
rs13206387	rs6940215	0.626718230822247	Insomnia	2e-10	35835914
rs13206387	rs6940215	0.626718230822247	Insomnia	1e-13	35835914
rs13206387	rs6940215	0.626718230822247	Hip circumference adjusted for BMI	8e-10	34021172
rs13206387	rs6940215	0.626718230822247	Multi-trait sex score	2e-23	37277458
rs13206387	rs6940215	0.626718230822247	Multi-trait sex score	4e-23	37277458
rs13206387	rs6457796	0.618367657626186	Insomnia	1e-08	30804565
rs13206387	rs6457796	0.618367657626186	Plateletcrit	9e-11	32888494
rs13206387	rs6457796	0.618367657626186	Systemic lupus erythematosus	3e-22	33272962
rs13206387	rs6457796	0.618367657626186	Body mass index	5e-13	30108127
rs13206387	rs6457796	0.618367657626186	Body mass index	1e-14	26426971
rs13206387	rs6457796	0.618367657626186	Educational attainment	5e-19	35361970
rs13215181	rs9462030	0.968849843494592	Red cell distribution width	5e-25	32888493
rs13215181	rs9469857	0.967232759041887	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs13215181	rs2764208	0.96642048112717	Systemic lupus erythematosus	7e-06	24871463
rs13215181	rs9469899	0.95269015589677	Prostate cancer (advanced)	2e-06	29892016
rs13215181	rs9469899	0.95269015589677	Prostate cancer	5e-09	29892016
rs13215181	rs9469899	0.95269015589677	Prostate cancer	8e-11	33398198
rs13215181	rs9469899	0.95269015589677	Hand grip strength	3e-15	29691431
rs13215181	rs9469899	0.95269015589677	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs13215181	rs9469899	0.95269015589677	Graves' disease	4e-10	34594039
rs13215181	rs9469899	0.95269015589677	Coronary artery disease	1e-11	36474045
rs13215181	rs9469899	0.95269015589677	Predicted visceral adipose tissue	2e-20	31501611
rs13215181	rs9469899	0.95269015589677	Medication use (thyroid preparations)	2e-09	31015401
rs13215181	rs9469899	0.95269015589677	Medication use (thyroid preparations)	3e-10	34594039
rs13215181	rs9469872	0.931842753889732	HDL cholesterol levels	3e-11	36333282
rs13215181	rs11755393	0.922494374212867	Body mass index	3e-26	29273807
rs13215181	rs11755393	0.922494374212867	Systemic lupus erythematosus	2e-12	33493351
rs13215181	rs11755393	0.922494374212867	Systemic lupus erythematosus	2e-06	33493351
rs13215181	rs11755393	0.922494374212867	Systemic lupus erythematosus	1e-07	33493351
rs13215181	rs11755393	0.922494374212867	Systemic lupus erythematosus	2e-08	19838195
rs13215181	rs11755393	0.922494374212867	Body mass index	4e-55	36581621
rs13215181	rs9366863	0.918600827318741	Adult body size	9e-33	32376654
rs13215181	rs9366863	0.918600827318741	Body mass index	2e-44	30595370
rs13215181	rs9296128	0.916435953668343	Hip circumference adjusted for BMI	4e-13	34021172
rs13215181	rs6941110	0.910807433661116	Sex hormone-binding globulin levels	5e-27	36653534
rs13215181	rs2814949	0.882989134703046	Essential hypertension (time to event)	9e-09	32589924
rs13215181	rs2744944	0.876691448599524	Hypothyroidism	3e-10	34594039
rs13215181	rs2744944	0.876691448599524	High density lipoprotein cholesterol levels	3e-86	34887591
rs13215181	rs2744944	0.876691448599524	Multi-trait sex score	7e-22	37277458
rs13215181	rs2263329	0.85905584877157	HDL cholesterol	6e-35	34594039
rs13215181	rs2263329	0.85905584877157	HDL cholesterol levels	8e-43	32203549
rs13215181	rs2263329	0.85905584877157	High density lipoprotein cholesterol levels	2e-52	34887591
rs13215181	rs111868030	0.839106048711697	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs13215181	rs9368830	0.812994967740486	HDL cholesterol	4e-21	30275531
rs13215181	rs9368828	0.791362604818163	Body mass index	1e-34	34594039
rs13215181	rs2744973	0.780095407352511	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs13215181	rs2744973	0.780095407352511	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs13215181	rs2744973	0.780095407352511	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs13215181	rs2744973	0.780095407352511	Multi-trait sex score	6e-20	37277458
rs13215181	rs6912327	0.775382833049593	Fasting insulin	5e-06	33402679
rs13215181	rs6912327	0.775382833049593	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs13215181	rs112283401	0.74483616869716	Red cell distribution width	4e-27	30595370
rs13215181	rs9689160	0.611993488184945	Lung function (forced vital capacity)	3e-14	36914875
rs13219589	rs9469872	0.98720241099489	HDL cholesterol levels	3e-11	36333282
rs13219589	rs11755393	0.984850809056202	Body mass index	3e-26	29273807
rs13219589	rs11755393	0.984850809056202	Systemic lupus erythematosus	2e-12	33493351
rs13219589	rs11755393	0.984850809056202	Systemic lupus erythematosus	2e-06	33493351
rs13219589	rs11755393	0.984850809056202	Systemic lupus erythematosus	1e-07	33493351
rs13219589	rs11755393	0.984850809056202	Systemic lupus erythematosus	2e-08	19838195
rs13219589	rs11755393	0.984850809056202	Body mass index	4e-55	36581621
rs13219589	rs9366863	0.976860982963086	Adult body size	9e-33	32376654
rs13219589	rs9366863	0.976860982963086	Body mass index	2e-44	30595370
rs13219589	rs6941110	0.973702783416799	Sex hormone-binding globulin levels	5e-27	36653534
rs13219589	rs9462030	0.955940696217343	Red cell distribution width	5e-25	32888493
rs13219589	rs9469857	0.946587798313119	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs13219589	rs2764208	0.945856861873276	Systemic lupus erythematosus	7e-06	24871463
rs13219589	rs2814949	0.939888741028689	Essential hypertension (time to event)	9e-09	32589924
rs13219589	rs9469899	0.939150617656352	Prostate cancer (advanced)	2e-06	29892016
rs13219589	rs9469899	0.939150617656352	Prostate cancer	5e-09	29892016
rs13219589	rs9469899	0.939150617656352	Prostate cancer	8e-11	33398198
rs13219589	rs9469899	0.939150617656352	Hand grip strength	3e-15	29691431
rs13219589	rs9469899	0.939150617656352	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs13219589	rs9469899	0.939150617656352	Graves' disease	4e-10	34594039
rs13219589	rs9469899	0.939150617656352	Coronary artery disease	1e-11	36474045
rs13219589	rs9469899	0.939150617656352	Predicted visceral adipose tissue	2e-20	31501611
rs13219589	rs9469899	0.939150617656352	Medication use (thyroid preparations)	2e-09	31015401
rs13219589	rs9469899	0.939150617656352	Medication use (thyroid preparations)	3e-10	34594039
rs13219589	rs2744944	0.930563121541505	Hypothyroidism	3e-10	34594039
rs13219589	rs2744944	0.930563121541505	High density lipoprotein cholesterol levels	3e-86	34887591
rs13219589	rs2744944	0.930563121541505	Multi-trait sex score	7e-22	37277458
rs13219589	rs2263329	0.911338067082369	HDL cholesterol	6e-35	34594039
rs13219589	rs2263329	0.911338067082369	HDL cholesterol levels	8e-43	32203549
rs13219589	rs2263329	0.911338067082369	High density lipoprotein cholesterol levels	2e-52	34887591
rs13219589	rs9296128	0.898008968022849	Hip circumference adjusted for BMI	4e-13	34021172
rs13219589	rs111868030	0.887331747144213	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs13219589	rs9368830	0.863908938269681	HDL cholesterol	4e-21	30275531
rs13219589	rs9368828	0.83483633935768	Body mass index	1e-34	34594039
rs13219589	rs6912327	0.830416950508655	Fasting insulin	5e-06	33402679
rs13219589	rs6912327	0.830416950508655	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs13219589	rs112283401	0.809043683139579	Red cell distribution width	4e-27	30595370
rs13219589	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs13219589	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs13219589	rs2744973	0.779518782641824	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs13219589	rs2744973	0.779518782641824	Multi-trait sex score	6e-20	37277458
rs13219589	rs6940215	0.631797836113969	Insomnia	2e-10	35835914
rs13219589	rs6940215	0.631797836113969	Insomnia	1e-13	35835914
rs13219589	rs6940215	0.631797836113969	Hip circumference adjusted for BMI	8e-10	34021172
rs13219589	rs6940215	0.631797836113969	Multi-trait sex score	2e-23	37277458
rs13219589	rs6940215	0.631797836113969	Multi-trait sex score	4e-23	37277458
rs13219589	rs6457796	0.627184527171391	Insomnia	1e-08	30804565
rs13219589	rs6457796	0.627184527171391	Plateletcrit	9e-11	32888494
rs13219589	rs6457796	0.627184527171391	Systemic lupus erythematosus	3e-22	33272962
rs13219589	rs6457796	0.627184527171391	Body mass index	5e-13	30108127
rs13219589	rs6457796	0.627184527171391	Body mass index	1e-14	26426971
rs13219589	rs6457796	0.627184527171391	Educational attainment	5e-19	35361970
rs13219589	rs9469918	0.602909256276846	Hip circumference adjusted for BMI	8e-09	34021172
rs13219589	rs9469918	0.602909256276846	Hip circumference adjusted for BMI	2e-08	34021172
rs13219589	rs9469918	0.602909256276846	Multi-trait sex score	4e-08	37277458
rs13219589	rs9689160	0.602761401207754	Lung function (forced vital capacity)	3e-14	36914875
rs13220394	rs9469872	0.952596328378425	HDL cholesterol levels	3e-11	36333282
rs13220394	rs11755393	0.933593302600081	Body mass index	3e-26	29273807
rs13220394	rs11755393	0.933593302600081	Systemic lupus erythematosus	2e-12	33493351
rs13220394	rs11755393	0.933593302600081	Systemic lupus erythematosus	2e-06	33493351
rs13220394	rs11755393	0.933593302600081	Systemic lupus erythematosus	1e-07	33493351
rs13220394	rs11755393	0.933593302600081	Systemic lupus erythematosus	2e-08	19838195
rs13220394	rs11755393	0.933593302600081	Body mass index	4e-55	36581621
rs13220394	rs9366863	0.923705412932581	Adult body size	9e-33	32376654
rs13220394	rs9366863	0.923705412932581	Body mass index	2e-44	30595370
rs13220394	rs6941110	0.920555254316961	Sex hormone-binding globulin levels	5e-27	36653534
rs13220394	rs9469857	0.911741867456404	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs13220394	rs2764208	0.910968992657564	Systemic lupus erythematosus	7e-06	24871463
rs13220394	rs9462030	0.902536461723707	Red cell distribution width	5e-25	32888493
rs13220394	rs2744944	0.896874905122449	Hypothyroidism	3e-10	34594039
rs13220394	rs2744944	0.896874905122449	High density lipoprotein cholesterol levels	3e-86	34887591
rs13220394	rs2744944	0.896874905122449	Multi-trait sex score	7e-22	37277458
rs13220394	rs2814949	0.887932934453092	Essential hypertension (time to event)	9e-09	32589924
rs13220394	rs9469899	0.886799380682447	Prostate cancer (advanced)	2e-06	29892016
rs13220394	rs9469899	0.886799380682447	Prostate cancer	5e-09	29892016
rs13220394	rs9469899	0.886799380682447	Prostate cancer	8e-11	33398198
rs13220394	rs9469899	0.886799380682447	Hand grip strength	3e-15	29691431
rs13220394	rs9469899	0.886799380682447	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs13220394	rs9469899	0.886799380682447	Graves' disease	4e-10	34594039
rs13220394	rs9469899	0.886799380682447	Coronary artery disease	1e-11	36474045
rs13220394	rs9469899	0.886799380682447	Predicted visceral adipose tissue	2e-20	31501611
rs13220394	rs9469899	0.886799380682447	Medication use (thyroid preparations)	2e-09	31015401
rs13220394	rs9469899	0.886799380682447	Medication use (thyroid preparations)	3e-10	34594039
rs13220394	rs2263329	0.876164477820696	HDL cholesterol	6e-35	34594039
rs13220394	rs2263329	0.876164477820696	HDL cholesterol levels	8e-43	32203549
rs13220394	rs2263329	0.876164477820696	High density lipoprotein cholesterol levels	2e-52	34887591
rs13220394	rs9368828	0.869967982380226	Body mass index	1e-34	34594039
rs13220394	rs9296128	0.865804699247957	Hip circumference adjusted for BMI	4e-13	34021172
rs13220394	rs111868030	0.861295893034638	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs13220394	rs112283401	0.826118576866932	Red cell distribution width	4e-27	30595370
rs13220394	rs9368830	0.815670356956042	HDL cholesterol	4e-21	30275531
rs13220394	rs2744973	0.794021705117346	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs13220394	rs2744973	0.794021705117346	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs13220394	rs2744973	0.794021705117346	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs13220394	rs2744973	0.794021705117346	Multi-trait sex score	6e-20	37277458
rs13220394	rs6912327	0.777368334796605	Fasting insulin	5e-06	33402679
rs13220394	rs6912327	0.777368334796605	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs13221434	rs4304220	0.719561069160284	Height	2e-14	36224396
rs13221434	rs4355658	0.693643849207162	Height	3e-13	36224396
rs13221434	rs12539962	0.612738249775875	Colorectal cancer	3e-08	36539618
rs13223112	rs4304220	0.995975238332255	Height	2e-14	36224396
rs13223112	rs13232536	0.723967449167848	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs13223112	rs4355658	0.704420503565492	Height	3e-13	36224396
rs13223112	rs13227841	0.609114581634749	Asthma	2e-09	32514122
rs13223593	rs4304220	0.860241724096027	Height	2e-14	36224396
rs13223593	rs4355658	0.811207986396841	Height	3e-13	36224396
rs13223593	rs13232536	0.608175784424151	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs13226443	rs12701798	0.752627620182907	Medication use (calcium channel blockers)	1e-08	34594039
rs13226443	rs7811577	0.72395618458433	Medication use (calcium channel blockers)	2e-09	34594039
rs13226443	rs2960826	0.631484559558889	Mean corpuscular hemoglobin	4e-08	34594039
rs13226443	rs2960826	0.631484559558889	Mean corpuscular volume	4e-12	34594039
rs13226443	rs1104888	0.614603921769757	Mean corpuscular volume	2e-17	32888493
rs13226443	rs1104888	0.614603921769757	Mean corpuscular hemoglobin	4e-12	30595370
rs13227249	rs7811577	0.83062560654891	Medication use (calcium channel blockers)	2e-09	34594039
rs13227249	rs12701798	0.755718444625089	Medication use (calcium channel blockers)	1e-08	34594039
rs13227249	rs2960826	0.729235551759396	Mean corpuscular hemoglobin	4e-08	34594039
rs13227249	rs2960826	0.729235551759396	Mean corpuscular volume	4e-12	34594039
rs13227249	rs1104888	0.70464847331379	Mean corpuscular volume	2e-17	32888493
rs13227249	rs1104888	0.70464847331379	Mean corpuscular hemoglobin	4e-12	30595370
rs13228435	rs4304220	0.865833524039324	Height	2e-14	36224396
rs13228435	rs4355658	0.817717373306373	Height	3e-13	36224396
rs13228435	rs13232536	0.612767594848163	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs13229452	rs13233747	0.620779083306143	Mean platelet volume	1e-26	32888493
rs13229452	rs13233747	0.620779083306143	Mean platelet volume	3e-18	32888494
rs13229452	rs13233747	0.620779083306143	Mean platelet volume	1e-28	32888493
rs13229452	rs13233747	0.620779083306143	Platelet distribution width	7e-10	32888494
rs13232536	rs13232536	1	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs13232536	rs4355658	0.748907207177926	Height	3e-13	36224396
rs13232536	rs4304220	0.726056351724776	Height	2e-14	36224396
rs13232536	rs7806956	0.695367825998457	Esophageal squamous cell carcinoma	3e-07	37673066
rs13232536	rs12539962	0.656745693438625	Colorectal cancer	3e-08	36539618
rs13234080	rs4304220	0.865923752729569	Height	2e-14	36224396
rs13234080	rs4355658	0.817671094799672	Height	3e-13	36224396
rs13234080	rs13232536	0.612811176092629	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs13234534	rs13232536	0.851198713786371	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs13234534	rs4304220	0.850474395093578	Height	2e-14	36224396
rs13234534	rs4355658	0.831385635619404	Height	3e-13	36224396
rs13234534	rs7806956	0.613690157903892	Esophageal squamous cell carcinoma	3e-07	37673066
rs1323692	rs2224797	0.908359222111316	Red blood cell count	5e-08	30595370
rs1323692	rs2224797	0.908359222111316	Mean corpuscular hemoglobin	3e-09	30595370
rs13241921	rs4304220	0.866635419320974	Height	2e-14	36224396
rs13241921	rs4355658	0.816950225861042	Height	3e-13	36224396
rs13241921	rs13232536	0.613426149347321	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs13241921	rs12539962	0.600428418698391	Colorectal cancer	3e-08	36539618
rs13242043	rs4304220	0.997583637260812	Height	2e-14	36224396
rs13242043	rs13232536	0.725359533245334	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs13242043	rs4355658	0.701821903057068	Height	3e-13	36224396
rs13242043	rs13227841	0.614235608990304	Asthma	2e-09	32514122
rs1324484	rs10465746	0.961755738444977	Obesity-related traits	8e-06	23251661
rs1324484	rs11580836	0.919744840769345	Body mass index	2e-09	36581621
rs13246460	rs4304220	0.867347575367006	Height	2e-14	36224396
rs13246460	rs4355658	0.817717373306373	Height	3e-13	36224396
rs13246460	rs13232536	0.614041555744898	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs13246460	rs12539962	0.601093864378622	Colorectal cancer	3e-08	36539618
rs13247441	rs4304220	0.858283106803682	Height	2e-14	36224396
rs13247441	rs4355658	0.808813715369481	Height	3e-13	36224396
rs13247441	rs13232536	0.607684980513735	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs1325922	rs1409152	0.997430506024653	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs1325922	rs1409152	0.997430506024653	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs1325922	rs10801699	0.994862964476203	X-23639 levels	2e-10	36635386
rs1325922	rs12120164	0.953581400936058	Metabolite peak levels (QI2146)	1e-26	35995766
rs1325922	rs10922531	0.799662381916488	Serum metabolite levels	2e-69	33031748
rs1325922	rs12729558	0.777864407241764	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs1325922	rs7532151	0.716656510122277	Imidazole lactate levels	9e-12	33177712
rs1325922	rs7530513	0.714890027445513	Height	8e-11	35831902
rs1325922	rs7530513	0.714890027445513	Imidazole lactate levels	8e-166	36635386
rs1325922	rs12144640	0.714890027445513	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1325922	rs10801690	0.697305706819518	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs1325922	rs9787133	0.671166038362537	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1325922	rs2765527	0.629137893624164	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs1325922	rs10922532	0.606010589023952	Blood urea nitrogen levels	2e-08	31152163
rs1325922	rs10922532	0.606010589023952	Waist circumference adjusted for body mass index	2e-11	34021172
rs1325922	rs10922532	0.606010589023952	X-23639 levels	4e-11	35050183
rs1325923	rs12729558	0.946629856232447	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs1325923	rs10922531	0.907727213068194	Serum metabolite levels	2e-69	33031748
rs1325923	rs7532151	0.873540641403732	Imidazole lactate levels	9e-12	33177712
rs1325923	rs10801690	0.8466190337152	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs1325923	rs7530513	0.832490474096479	Height	8e-11	35831902
rs1325923	rs7530513	0.832490474096479	Imidazole lactate levels	8e-166	36635386
rs1325923	rs12144640	0.832490474096479	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1325923	rs1409152	0.82093903832024	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs1325923	rs1409152	0.82093903832024	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs1325923	rs10801699	0.818825450655192	X-23639 levels	2e-10	36635386
rs1325923	rs9787133	0.816349472582233	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1325923	rs12120164	0.784732721190749	Metabolite peak levels (QI2146)	1e-26	35995766
rs1325923	rs2765527	0.765782873842068	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs1325923	rs2810876	0.656028937379871	Imidazole lactate levels	2e-122	35347128
rs1325923	rs10801696	0.654718193699616	Imidazole lactate levels	3e-195	35050183
rs1325923	rs1206228892	0.654194307795355	Imidazole lactate levels	5e-186	35050183
rs1325924	rs10922531	0.947191168164576	Serum metabolite levels	2e-69	33031748
rs1325924	rs12729558	0.90737832172115	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs1325924	rs7530513	0.859421707654639	Height	8e-11	35831902
rs1325924	rs7530513	0.859421707654639	Imidazole lactate levels	8e-166	36635386
rs1325924	rs12144640	0.859421707654639	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1325924	rs10801699	0.848430235674283	X-23639 levels	2e-10	36635386
rs1325924	rs1409152	0.847516535864849	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs1325924	rs1409152	0.847516535864849	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs1325924	rs7532151	0.842888025988318	Imidazole lactate levels	9e-12	33177712
rs1325924	rs10801690	0.816633536855326	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs1325924	rs12120164	0.813128533974344	Metabolite peak levels (QI2146)	1e-26	35995766
rs1325924	rs9787133	0.787188673695872	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1325924	rs2765527	0.739101724503623	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs1325924	rs2810876	0.633145064728671	Imidazole lactate levels	2e-122	35347128
rs1325924	rs10801696	0.631906722592861	Imidazole lactate levels	3e-195	35050183
rs1325924	rs1206228892	0.63140108974508	Imidazole lactate levels	5e-186	35050183
rs13264187	rs746011	0.837013091453544	Triglycerides	2e-10	30275531
rs13264187	rs2280104	0.829012837642489	Parkinson's disease	3e-08	28892059
rs13264187	rs2280104	0.829012837642489	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs13264187	rs2280104	0.829012837642489	Serum total protein level	3e-12	34594039
rs13264187	rs11781149	0.803419047199513	Refractive error	2e-17	32231278
rs13264187	rs4872007	0.802757578025308	Superior temporal gyrus volume	8e-06	31530798
rs13264187	rs4242434	0.800490337301921	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs13264187	rs1545837	0.739070329975971	Lung function (FVC)	1e-10	30595370
rs13264187	rs11778693	0.65365378208214	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs13264187	rs11778693	0.65365378208214	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs13264187	rs13271626	0.639781604814601	Haemorrhoidal disease	3e-10	33888516
rs13264187	rs11780207	0.605822815029994	Estimated glomerular filtration rate	2e-13	33462484
rs13264187	rs11780207	0.605822815029994	Serum total protein level	2e-09	33462484
rs13264187	rs11780207	0.605822815029994	Creatinine levels	2e-13	33462484
rs1327090	rs28482086	0.818334812330457	Educational attainment (years of education)	5e-09	30038396
rs1327090	rs3931020	0.753497006090543	Resistin levels	6e-12	22843503
rs1327090	rs28568334	0.735491400642037	Educational attainment	4e-13	35361970
rs13271626	rs13271626	1	Haemorrhoidal disease	3e-10	33888516
rs13271626	rs11778693	0.963935853919279	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs13271626	rs11778693	0.963935853919279	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs13271626	rs34269854	0.844567010757286	Lung function (forced vital capacity)	3e-09	36914875
rs13271626	rs746011	0.741948621114249	Triglycerides	2e-10	30275531
rs13271626	rs11781149	0.722886333968177	Refractive error	2e-17	32231278
rs13271626	rs11780207	0.641173538635232	Estimated glomerular filtration rate	2e-13	33462484
rs13271626	rs11780207	0.641173538635232	Serum total protein level	2e-09	33462484
rs13271626	rs11780207	0.641173538635232	Creatinine levels	2e-13	33462484
rs13271626	rs751680	0.628343906574752	Insomnia	7e-09	35835914
rs13271626	rs11782130	0.621871245507561	C-reactive protein levels	9e-09	35459240
rs13271626	rs4592028	0.621423858958808	Non-albumin protein levels	3e-09	33462484
rs13271626	rs1545837	0.613163970922197	Lung function (FVC)	1e-10	30595370
rs13271626	rs2280104	0.604171012518999	Parkinson's disease	3e-08	28892059
rs13271626	rs2280104	0.604171012518999	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs13271626	rs2280104	0.604171012518999	Serum total protein level	3e-12	34594039
rs1328281	rs770199	0.852929506165033	Hair color	3e-08	30595370
rs1332618	rs1332618	1	Platelet count	4e-15	32888494
rs1332618	rs2795857	0.760280036360552	Height	2e-123	36224396
rs1332618	rs2462017	0.7425678731196	Lymphocyte count	3e-12	32888493
rs1332618	rs2488010	0.734464324343075	Monocyte count	9e-16	32888493
rs1332618	rs2462021	0.733786307561801	Suicide risk	8e-06	21041247
rs1332618	rs2795863	0.719184975615456	Height	3e-20	36224396
rs1332618	rs503598	0.702289714818999	White blood cell count	2e-08	30595370
rs1332618	rs2689216	0.692666705680307	Platelet count	2e-22	32888493
rs1332618	rs2689216	0.692666705680307	Platelet count	1e-21	32888493
rs1332618	rs1571956	0.672018672733402	Neutrophil count	1e-11	32888493
rs1332618	rs2482820	0.667112353643111	Monocyte count	9e-13	32888494
rs1332618	rs2482819	0.664539490552783	Neutrophil count	4e-10	32888493
rs13358339	rs1423357	0.995801127438382	General cognitive ability	9e-06	29844566
rs13358339	rs2432142	0.975750292532493	Neutrophil count	2e-14	32888493
rs13358339	rs2432142	0.975750292532493	White blood cell count	1e-11	32888493
rs13358339	rs38033	0.970929692253116	Blood protein levels	0	30072576
rs13358339	rs27293	0.965117130562221	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs13358339	rs27293	0.965117130562221	Diastolic blood pressure	3e-11	35762941
rs13358339	rs7705093	0.959797728294831	Birdshot chorioretinopathy	2e-09	24957906
rs13358339	rs2910686	0.866380322399965	Neutrophil count	4e-14	32888493
rs13358339	rs2910686	0.866380322399965	Psoriasis	2e-08	23143594
rs13358339	rs2910686	0.866380322399965	Ankylosing spondylitis	5e-17	23749187
rs13358339	rs2910686	0.866380322399965	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs13358339	rs2927608	0.86306745754575	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs13358339	rs2927608	0.86306745754575	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs13358339	rs2927608	0.86306745754575	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs13358339	rs2617439	0.775436627241083	Neutrophil count	8e-11	32888494
rs13358339	rs2549797	0.771288863694505	Systolic blood pressure	7e-07	33230300
rs13358339	rs2549797	0.771288863694505	Diastolic blood pressure	1e-14	33230300
rs13358339	rs2549797	0.771288863694505	Diastolic blood pressure	3e-11	33230300
rs13358339	rs2549797	0.771288863694505	Systolic blood pressure	4e-09	33230300
rs13358339	rs2549782	0.77003276060378	Systolic blood pressure	6e-07	33230300
rs13358339	rs2549782	0.77003276060378	Diastolic blood pressure	1e-14	33230300
rs13358339	rs2549782	0.77003276060378	Diastolic blood pressure	3e-11	33230300
rs13358339	rs2549782	0.77003276060378	Systolic blood pressure	5e-09	33230300
rs13358339	rs1056893	0.769405550601151	Systolic blood pressure	1e-06	33230300
rs13358339	rs1056893	0.769405550601151	Diastolic blood pressure	7e-15	33230300
rs13358339	rs1056893	0.769405550601151	Diastolic blood pressure	2e-11	33230300
rs13358339	rs1056893	0.769405550601151	Systolic blood pressure	7e-09	33230300
rs13358339	rs2549794	0.765956938317049	Crohn's disease	1e-10	21102463
rs13358339	rs2549794	0.765956938317049	Systolic blood pressure	1e-07	33230300
rs13358339	rs2549794	0.765956938317049	Diastolic blood pressure	1e-15	33230300
rs13358339	rs2549794	0.765956938317049	Diastolic blood pressure	2e-12	33230300
rs13358339	rs2549794	0.765956938317049	Systolic blood pressure	4e-10	33230300
rs13358339	rs38029	0.763735174653609	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs13358339	rs1363907	0.761324393115545	Crohn's disease	4e-16	26192919
rs13358339	rs1363907	0.761324393115545	Ulcerative colitis	4e-06	26192919
rs13358339	rs1363907	0.761324393115545	Inflammatory bowel disease	5e-15	26192919
rs13358339	rs1363907	0.761324393115545	Inflammatory bowel disease	6e-13	23128233
rs13358339	rs1363907	0.761324393115545	Inflammatory bowel disease	1e-10	28067908
rs13358339	rs1363907	0.761324393115545	Crohn's disease	1e-14	28067908
rs13358339	rs716848	0.732987213159576	Neutrophil percentage of white cells	2e-09	32888494
rs13358339	rs4869313	0.719996718449287	Pediatric autoimmune diseases	9e-08	26301688
rs13358339	rs1559359	0.713849570373492	Diastolic blood pressure	7e-10	34594039
rs13358339	rs2548532	0.688155001664067	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs13358339	rs4869314	0.667009380743377	Arthritis (juvenile idiopathic)	3e-09	33106285
rs13358339	rs4869314	0.667009380743377	Neutrophil count	1e-10	34594039
rs13358339	rs4869314	0.667009380743377	White blood cell count	2e-07	30595370
rs13358339	rs1974871	0.640463949152955	Granulysin levels	5e-13	34648354
rs13358339	rs1019503	0.636405903285001	Systolic blood pressure	2e-06	33230300
rs13358339	rs1019503	0.636405903285001	Diastolic blood pressure	2e-14	33230300
rs13358339	rs1019503	0.636405903285001	Diastolic blood pressure	4e-11	33230300
rs13358339	rs1019503	0.636405903285001	Systolic blood pressure	1e-08	33230300
rs13358339	rs27660	0.634374937042969	Coronary artery disease	3e-08	35915156
rs13358339	rs3096168	0.628992744462035	Aspartate aminotransferase levels	8e-12	33547301
rs1337444	rs10733045	0.865591821795096	DNA methylation-estimated granulocyte proportions	5e-09	34187551
rs1337444	rs10918211	0.65759373706894	White blood cell count	1e-26	34925446
rs1337444	rs10918211	0.65759373706894	Neutrophil count	5e-34	34925446
rs1337444	rs4147592	0.629991237398046	Height	9e-39	36224396
rs1337444	rs10737515	0.628002658902332	Height	4e-10	30595370
rs1337448	rs10733045	0.795438412322117	DNA methylation-estimated granulocyte proportions	5e-09	34187551
rs1337448	rs10918211	0.718385795016745	White blood cell count	1e-26	34925446
rs1337448	rs10918211	0.718385795016745	Neutrophil count	5e-34	34925446
rs13379492	rs13379492	1	Lung function (FEV1/FVC)	6e-08	30595370
rs13379492	rs8034216	0.850101438622757	C-reactive protein levels	2e-10	31900758
rs13379492	rs17271340	0.808805248370757	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs13379492	rs17271305	0.784239054555528	Two-hour glucose challenge	1e-07	20081857
rs13379492	rs35967150	0.779192624957618	C-reactive protein levels (MTAG)	1e-08	36376304
rs13379492	rs11634163	0.770238817738126	C-reactive protein	2e-08	34594039
rs13379492	rs11634163	0.770238817738126	Two-hour glucose	3e-14	34059833
rs13379492	rs189400382	0.767263070696297	C-reactive protein levels	1e-08	35459240
rs13379492	rs28373613	0.648123356541928	Height (standard GWA)	8e-12	37106081
rs13379947	rs28373613	0.893369722880466	Height (standard GWA)	8e-12	37106081
rs13379947	rs13379492	0.698151377557726	Lung function (FEV1/FVC)	6e-08	30595370
rs13383546	rs8207	0.800158531056724	Monocyte count	1e-10	32888493
rs13383546	rs8207	0.800158531056724	Height	2e-18	36224396
rs13383546	rs6738934	0.647811184614644	Vaginal microbiome MetaCyc pathway (PWY-5741|ethylmalonyl-CoA pathway)	3e-07	34282934
rs13387186	rs73045343	0.641795471126356	Serum total protein level	1e-12	34594039
rs13387186	rs6759004	0.625108190032328	Triptolide cytotoxicity	3e-07	26121980
rs13406807	rs58588820	0.992022848499615	Total cholesterol levels	1e-09	34887591
rs13406807	rs58588820	0.992022848499615	Total cholesterol levels	8e-11	34887591
rs13406807	rs6547629	0.889811603163411	Height	3e-09	36224396
rs13406807	rs10206961	0.628079325819032	Parental longevity (father's age at death)	2e-06	31484785
rs13412131	rs6723298	0.68170060563315	Smoking initiation	2e-12	36477530
rs13412131	rs2194492	0.662869006834723	Educational attainment	9e-09	35361970
rs13412131	rs13020443	0.65304230788433	Type 2 diabetes	3e-11	32541925
rs13429910	rs10173269	0.640012794112761	Intraocular pressure	5e-12	29617998
rs13429910	rs10173269	0.640012794112761	Lung function (FEV1/FVC)	5e-23	36914875
rs13429910	rs10173269	0.640012794112761	Chronic obstructive pulmonary disease liability (machine learning-based score)	7e-09	37069358
rs13429910	rs10173269	0.640012794112761	Lung function (FEV1/FVC)	8e-18	30595370
rs13435203	rs6831339	0.997503647785946	High density lipoprotein cholesterol levels	9e-09	34887591
rs13435203	rs2868708	0.994177551829006	Lymphocyte count	3e-11	34469753
rs13435203	rs2868708	0.994177551829006	White blood cell count	1e-09	30595370
rs13435203	rs116142917	0.912947411826701	Lymphocyte count	7e-18	32888494
rs13435203	rs6823199	0.896528748092421	Pulse pressure	4e-14	30224653
rs13435203	rs13111599	0.890194292641774	HDL cholesterol levels	3e-09	32203549
rs13435203	rs13111599	0.890194292641774	Apolipoprotein A1 levels	4e-08	32203549
rs13435203	rs6535419	0.873380159198881	Pulse pressure	6e-10	30578418
rs13435203	rs4302451	0.746002807610814	Eosinophil counts	2e-09	30595370
rs13435203	rs11099563	0.743542707135665	High density lipoprotein cholesterol levels	3e-11	34887591
rs13435203	rs28528763	0.719458178077788	White blood cell count	7e-12	32888494
rs13435203	rs35895091	0.704878527094716	Cardiovascular disease	1e-07	30595370
rs13435203	rs7662402	0.622328838661515	Brain morphology (MOSTest)	3e-08	35164939
rs1346035	rs12901247	0.852673641537566	Insular cortex volume	4e-06	31530798
rs1346035	rs72749770	0.735354824853301	Low density lipoprotein cholesterol levels	9e-10	32493714
rs1346035	rs72749770	0.735354824853301	Apolipoprotein B levels	2e-09	32203549
rs1346035	rs11635977	0.695151970366684	Height	2e-25	36224396
rs1346035	rs2042608	0.686172604426788	Glycemic traits (multi-trait analysis)	3e-09	29743933
rs1346035	rs7162536	0.6767336635053	Height	4e-29	34594039
rs1346035	rs731820	0.646292413814581	Height	2e-13	31562340
rs1346035	rs731820	0.646292413814581	Height	2e-12	35831902
rs1346035	rs2162062	0.625034754006358	Height	2e-13	35831902
rs1359331	rs10465746	0.75346272712971	Obesity-related traits	8e-06	23251661
rs1359331	rs11580836	0.731171997823178	Body mass index	2e-09	36581621
rs1363907	rs1363907	1	Crohn's disease	4e-16	26192919
rs1363907	rs1363907	1	Ulcerative colitis	4e-06	26192919
rs1363907	rs1363907	1	Inflammatory bowel disease	5e-15	26192919
rs1363907	rs1363907	1	Inflammatory bowel disease	6e-13	23128233
rs1363907	rs1363907	1	Inflammatory bowel disease	1e-10	28067908
rs1363907	rs1363907	1	Crohn's disease	1e-14	28067908
rs1363907	rs2549794	0.994668192117369	Crohn's disease	1e-10	21102463
rs1363907	rs2549794	0.994668192117369	Systolic blood pressure	1e-07	33230300
rs1363907	rs2549794	0.994668192117369	Diastolic blood pressure	1e-15	33230300
rs1363907	rs2549794	0.994668192117369	Diastolic blood pressure	2e-12	33230300
rs1363907	rs2549794	0.994668192117369	Systolic blood pressure	4e-10	33230300
rs1363907	rs2617439	0.941188032600576	Neutrophil count	8e-11	32888494
rs1363907	rs716848	0.937565262665602	Neutrophil percentage of white cells	2e-09	32888494
rs1363907	rs38029	0.929204620400647	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1363907	rs2548532	0.893549053800425	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1363907	rs27660	0.777538629741749	Coronary artery disease	3e-08	35915156
rs1363907	rs1423357	0.764618581415287	General cognitive ability	9e-06	29844566
rs1363907	rs2432142	0.749751329254888	Neutrophil count	2e-14	32888493
rs1363907	rs2432142	0.749751329254888	White blood cell count	1e-11	32888493
rs1363907	rs38033	0.747879341021451	Blood protein levels	0	30072576
rs1363907	rs27293	0.739378792587365	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1363907	rs27293	0.739378792587365	Diastolic blood pressure	3e-11	35762941
rs1363907	rs7705093	0.729916732034797	Birdshot chorioretinopathy	2e-09	24957906
rs1363907	rs2927608	0.722372274451754	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1363907	rs2927608	0.722372274451754	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1363907	rs2927608	0.722372274451754	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1363907	rs2910686	0.720002086599683	Neutrophil count	4e-14	32888493
rs1363907	rs2910686	0.720002086599683	Psoriasis	2e-08	23143594
rs1363907	rs2910686	0.720002086599683	Ankylosing spondylitis	5e-17	23749187
rs1363907	rs2910686	0.720002086599683	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1363907	rs4869313	0.719764569481716	Pediatric autoimmune diseases	9e-08	26301688
rs1363907	rs1559359	0.651421821858804	Diastolic blood pressure	7e-10	34594039
rs1363907	rs1974871	0.646485295817104	Granulysin levels	5e-13	34648354
rs1363907	rs2549797	0.633881150231873	Systolic blood pressure	7e-07	33230300
rs1363907	rs2549797	0.633881150231873	Diastolic blood pressure	1e-14	33230300
rs1363907	rs2549797	0.633881150231873	Diastolic blood pressure	3e-11	33230300
rs1363907	rs2549797	0.633881150231873	Systolic blood pressure	4e-09	33230300
rs1363907	rs2549782	0.632853515974189	Systolic blood pressure	6e-07	33230300
rs1363907	rs2549782	0.632853515974189	Diastolic blood pressure	1e-14	33230300
rs1363907	rs2549782	0.632853515974189	Diastolic blood pressure	3e-11	33230300
rs1363907	rs2549782	0.632853515974189	Systolic blood pressure	5e-09	33230300
rs1363907	rs1056893	0.632340387305134	Systolic blood pressure	1e-06	33230300
rs1363907	rs1056893	0.632340387305134	Diastolic blood pressure	7e-15	33230300
rs1363907	rs1056893	0.632340387305134	Diastolic blood pressure	2e-11	33230300
rs1363907	rs1056893	0.632340387305134	Systolic blood pressure	7e-09	33230300
rs1363908	rs1363907	0.998221389128993	Crohn's disease	4e-16	26192919
rs1363908	rs1363907	0.998221389128993	Ulcerative colitis	4e-06	26192919
rs1363908	rs1363907	0.998221389128993	Inflammatory bowel disease	5e-15	26192919
rs1363908	rs1363907	0.998221389128993	Inflammatory bowel disease	6e-13	23128233
rs1363908	rs1363907	0.998221389128993	Inflammatory bowel disease	1e-10	28067908
rs1363908	rs1363907	0.998221389128993	Crohn's disease	1e-14	28067908
rs1363908	rs2549794	0.996444141380409	Crohn's disease	1e-10	21102463
rs1363908	rs2549794	0.996444141380409	Systolic blood pressure	1e-07	33230300
rs1363908	rs2549794	0.996444141380409	Diastolic blood pressure	1e-15	33230300
rs1363908	rs2549794	0.996444141380409	Diastolic blood pressure	2e-12	33230300
rs1363908	rs2549794	0.996444141380409	Systolic blood pressure	4e-10	33230300
rs1363908	rs2617439	0.942920861913098	Neutrophil count	8e-11	32888494
rs1363908	rs716848	0.939279999795698	Neutrophil percentage of white cells	2e-09	32888494
rs1363908	rs38029	0.930921404819159	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1363908	rs2548532	0.895263592533118	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1363908	rs27660	0.779176880005977	Coronary artery disease	3e-08	35915156
rs1363908	rs1423357	0.766132945310865	General cognitive ability	9e-06	29844566
rs1363908	rs2432142	0.751250620991241	Neutrophil count	2e-14	32888493
rs1363908	rs2432142	0.751250620991241	White blood cell count	1e-11	32888493
rs1363908	rs38033	0.749373171913046	Blood protein levels	0	30072576
rs1363908	rs27293	0.740864515722166	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1363908	rs27293	0.740864515722166	Diastolic blood pressure	3e-11	35762941
rs1363908	rs7705093	0.731389169083199	Birdshot chorioretinopathy	2e-09	24957906
rs1363908	rs4869313	0.721225019799505	Pediatric autoimmune diseases	9e-08	26301688
rs1363908	rs2927608	0.720919457353305	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1363908	rs2927608	0.720919457353305	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1363908	rs2927608	0.720919457353305	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1363908	rs2910686	0.718552051013529	Neutrophil count	4e-14	32888493
rs1363908	rs2910686	0.718552051013529	Psoriasis	2e-08	23143594
rs1363908	rs2910686	0.718552051013529	Ankylosing spondylitis	5e-17	23749187
rs1363908	rs2910686	0.718552051013529	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1363908	rs1559359	0.652799285648767	Diastolic blood pressure	7e-10	34594039
rs1363908	rs1974871	0.647857196949029	Granulysin levels	5e-13	34648354
rs1363908	rs2549797	0.635232154952041	Systolic blood pressure	7e-07	33230300
rs1363908	rs2549797	0.635232154952041	Diastolic blood pressure	1e-14	33230300
rs1363908	rs2549797	0.635232154952041	Diastolic blood pressure	3e-11	33230300
rs1363908	rs2549797	0.635232154952041	Systolic blood pressure	4e-09	33230300
rs1363908	rs2549782	0.6342033097284	Systolic blood pressure	6e-07	33230300
rs1363908	rs2549782	0.6342033097284	Diastolic blood pressure	1e-14	33230300
rs1363908	rs2549782	0.6342033097284	Diastolic blood pressure	3e-11	33230300
rs1363908	rs2549782	0.6342033097284	Systolic blood pressure	5e-09	33230300
rs1363908	rs1056893	0.633689576385674	Systolic blood pressure	1e-06	33230300
rs1363908	rs1056893	0.633689576385674	Diastolic blood pressure	7e-15	33230300
rs1363908	rs1056893	0.633689576385674	Diastolic blood pressure	2e-11	33230300
rs1363908	rs1056893	0.633689576385674	Systolic blood pressure	7e-09	33230300
rs1363955	rs13189973	0.975177593256642	Lymphocyte count	2e-16	32888493
rs1363955	rs2548499	0.629839489552357	Lymphocyte count	9e-14	32888494
rs1363956	rs13189973	0.975177593256642	Lymphocyte count	2e-16	32888493
rs1363956	rs2548499	0.629839489552357	Lymphocyte count	9e-14	32888494
rs1363974	rs1423357	0.995801127438382	General cognitive ability	9e-06	29844566
rs1363974	rs2432142	0.980743379484291	Neutrophil count	2e-14	32888493
rs1363974	rs2432142	0.980743379484291	White blood cell count	1e-11	32888493
rs1363974	rs38033	0.977557586134674	Blood protein levels	0	30072576
rs1363974	rs27293	0.956886541215479	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1363974	rs27293	0.956886541215479	Diastolic blood pressure	3e-11	35762941
rs1363974	rs7705093	0.953245313556209	Birdshot chorioretinopathy	2e-09	24957906
rs1363974	rs2910686	0.866380322399965	Neutrophil count	4e-14	32888493
rs1363974	rs2910686	0.866380322399965	Psoriasis	2e-08	23143594
rs1363974	rs2910686	0.866380322399965	Ankylosing spondylitis	5e-17	23749187
rs1363974	rs2910686	0.866380322399965	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1363974	rs2927608	0.86306745754575	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1363974	rs2927608	0.86306745754575	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1363974	rs2927608	0.86306745754575	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1363974	rs2617439	0.780029318995875	Neutrophil count	8e-11	32888494
rs1363974	rs2549797	0.771288863694505	Systolic blood pressure	7e-07	33230300
rs1363974	rs2549797	0.771288863694505	Diastolic blood pressure	1e-14	33230300
rs1363974	rs2549797	0.771288863694505	Diastolic blood pressure	3e-11	33230300
rs1363974	rs2549797	0.771288863694505	Systolic blood pressure	4e-09	33230300
rs1363974	rs2549782	0.77003276060378	Systolic blood pressure	6e-07	33230300
rs1363974	rs2549782	0.77003276060378	Diastolic blood pressure	1e-14	33230300
rs1363974	rs2549782	0.77003276060378	Diastolic blood pressure	3e-11	33230300
rs1363974	rs2549782	0.77003276060378	Systolic blood pressure	5e-09	33230300
rs1363974	rs1056893	0.769405550601151	Systolic blood pressure	1e-06	33230300
rs1363974	rs1056893	0.769405550601151	Diastolic blood pressure	7e-15	33230300
rs1363974	rs1056893	0.769405550601151	Diastolic blood pressure	2e-11	33230300
rs1363974	rs1056893	0.769405550601151	Systolic blood pressure	7e-09	33230300
rs1363974	rs2549794	0.765956938317049	Crohn's disease	1e-10	21102463
rs1363974	rs2549794	0.765956938317049	Systolic blood pressure	1e-07	33230300
rs1363974	rs2549794	0.765956938317049	Diastolic blood pressure	1e-15	33230300
rs1363974	rs2549794	0.765956938317049	Diastolic blood pressure	2e-12	33230300
rs1363974	rs2549794	0.765956938317049	Systolic blood pressure	4e-10	33230300
rs1363974	rs38029	0.763735174653609	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1363974	rs1363907	0.761324393115545	Crohn's disease	4e-16	26192919
rs1363974	rs1363907	0.761324393115545	Ulcerative colitis	4e-06	26192919
rs1363974	rs1363907	0.761324393115545	Inflammatory bowel disease	5e-15	26192919
rs1363974	rs1363907	0.761324393115545	Inflammatory bowel disease	6e-13	23128233
rs1363974	rs1363907	0.761324393115545	Inflammatory bowel disease	1e-10	28067908
rs1363974	rs1363907	0.761324393115545	Crohn's disease	1e-14	28067908
rs1363974	rs716848	0.732987213159576	Neutrophil percentage of white cells	2e-09	32888494
rs1363974	rs4869313	0.719996718449287	Pediatric autoimmune diseases	9e-08	26301688
rs1363974	rs1559359	0.713849570373492	Diastolic blood pressure	7e-10	34594039
rs1363974	rs2548532	0.688155001664067	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1363974	rs4869314	0.667009380743377	Arthritis (juvenile idiopathic)	3e-09	33106285
rs1363974	rs4869314	0.667009380743377	Neutrophil count	1e-10	34594039
rs1363974	rs4869314	0.667009380743377	White blood cell count	2e-07	30595370
rs1363974	rs1974871	0.640463949152955	Granulysin levels	5e-13	34648354
rs1363974	rs1019503	0.636405903285001	Systolic blood pressure	2e-06	33230300
rs1363974	rs1019503	0.636405903285001	Diastolic blood pressure	2e-14	33230300
rs1363974	rs1019503	0.636405903285001	Diastolic blood pressure	4e-11	33230300
rs1363974	rs1019503	0.636405903285001	Systolic blood pressure	1e-08	33230300
rs1363974	rs27660	0.634374937042969	Coronary artery disease	3e-08	35915156
rs1363974	rs3096168	0.628992744462035	Aspartate aminotransferase levels	8e-12	33547301
rs1363975	rs2549797	0.998384968528502	Systolic blood pressure	7e-07	33230300
rs1363975	rs2549797	0.998384968528502	Diastolic blood pressure	1e-14	33230300
rs1363975	rs2549797	0.998384968528502	Diastolic blood pressure	3e-11	33230300
rs1363975	rs2549797	0.998384968528502	Systolic blood pressure	4e-09	33230300
rs1363975	rs2549782	0.996770215293769	Systolic blood pressure	6e-07	33230300
rs1363975	rs2549782	0.996770215293769	Diastolic blood pressure	1e-14	33230300
rs1363975	rs2549782	0.996770215293769	Diastolic blood pressure	3e-11	33230300
rs1363975	rs2549782	0.996770215293769	Systolic blood pressure	5e-09	33230300
rs1363975	rs1056893	0.995963920468337	Systolic blood pressure	1e-06	33230300
rs1363975	rs1056893	0.995963920468337	Diastolic blood pressure	7e-15	33230300
rs1363975	rs1056893	0.995963920468337	Diastolic blood pressure	2e-11	33230300
rs1363975	rs1056893	0.995963920468337	Systolic blood pressure	7e-09	33230300
rs1363975	rs2910686	0.883405801408269	Neutrophil count	4e-14	32888493
rs1363975	rs2910686	0.883405801408269	Psoriasis	2e-08	23143594
rs1363975	rs2910686	0.883405801408269	Ankylosing spondylitis	5e-17	23749187
rs1363975	rs2910686	0.883405801408269	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1363975	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1363975	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1363975	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1363975	rs1019503	0.821407790924749	Systolic blood pressure	2e-06	33230300
rs1363975	rs1019503	0.821407790924749	Diastolic blood pressure	2e-14	33230300
rs1363975	rs1019503	0.821407790924749	Diastolic blood pressure	4e-11	33230300
rs1363975	rs1019503	0.821407790924749	Systolic blood pressure	1e-08	33230300
rs1363975	rs3096168	0.811202377454582	Aspartate aminotransferase levels	8e-12	33547301
rs1363975	rs4869314	0.802832426522136	Arthritis (juvenile idiopathic)	3e-09	33106285
rs1363975	rs4869314	0.802832426522136	Neutrophil count	1e-10	34594039
rs1363975	rs4869314	0.802832426522136	White blood cell count	2e-07	30595370
rs1363975	rs1974871	0.781356033193366	Granulysin levels	5e-13	34648354
rs1363975	rs1423357	0.774002093298599	General cognitive ability	9e-06	29844566
rs1363975	rs2432142	0.759420640776436	Neutrophil count	2e-14	32888493
rs1363975	rs2432142	0.759420640776436	White blood cell count	1e-11	32888493
rs1363975	rs38033	0.753465786339274	Blood protein levels	0	30072576
rs1363975	rs27293	0.741550282856657	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1363975	rs27293	0.741550282856657	Diastolic blood pressure	3e-11	35762941
rs1363975	rs4869313	0.737148159764535	Pediatric autoimmune diseases	9e-08	26301688
rs1363975	rs7705093	0.733610904822643	Birdshot chorioretinopathy	2e-09	24957906
rs1363975	rs1559359	0.722243312523596	Diastolic blood pressure	7e-10	34594039
rs1363975	rs2549794	0.637126282330081	Crohn's disease	1e-10	21102463
rs1363975	rs2549794	0.637126282330081	Systolic blood pressure	1e-07	33230300
rs1363975	rs2549794	0.637126282330081	Diastolic blood pressure	1e-15	33230300
rs1363975	rs2549794	0.637126282330081	Diastolic blood pressure	2e-12	33230300
rs1363975	rs2549794	0.637126282330081	Systolic blood pressure	4e-10	33230300
rs1363975	rs1363907	0.6355545414163	Crohn's disease	4e-16	26192919
rs1363975	rs1363907	0.6355545414163	Ulcerative colitis	4e-06	26192919
rs1363975	rs1363907	0.6355545414163	Inflammatory bowel disease	5e-15	26192919
rs1363975	rs1363907	0.6355545414163	Inflammatory bowel disease	6e-13	23128233
rs1363975	rs1363907	0.6355545414163	Inflammatory bowel disease	1e-10	28067908
rs1363975	rs1363907	0.6355545414163	Crohn's disease	1e-14	28067908
rs1363975	rs716848	0.632963888908437	Neutrophil percentage of white cells	2e-09	32888494
rs1363975	rs2617439	0.605271865790052	Neutrophil count	8e-11	32888494
rs1363976	rs2548532	0.947123638194255	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1363976	rs27660	0.902377527320858	Coronary artery disease	3e-08	35915156
rs1363976	rs2549794	0.850541468015022	Crohn's disease	1e-10	21102463
rs1363976	rs2549794	0.850541468015022	Systolic blood pressure	1e-07	33230300
rs1363976	rs2549794	0.850541468015022	Diastolic blood pressure	1e-15	33230300
rs1363976	rs2549794	0.850541468015022	Diastolic blood pressure	2e-12	33230300
rs1363976	rs2549794	0.850541468015022	Systolic blood pressure	4e-10	33230300
rs1363976	rs1363907	0.849019764212085	Crohn's disease	4e-16	26192919
rs1363976	rs1363907	0.849019764212085	Ulcerative colitis	4e-06	26192919
rs1363976	rs1363907	0.849019764212085	Inflammatory bowel disease	5e-15	26192919
rs1363976	rs1363907	0.849019764212085	Inflammatory bowel disease	6e-13	23128233
rs1363976	rs1363907	0.849019764212085	Inflammatory bowel disease	1e-10	28067908
rs1363976	rs1363907	0.849019764212085	Crohn's disease	1e-14	28067908
rs1363976	rs2617439	0.801507503893088	Neutrophil count	8e-11	32888494
rs1363976	rs716848	0.796277282820126	Neutrophil percentage of white cells	2e-09	32888494
rs1363976	rs38029	0.793345054219416	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1363976	rs1423357	0.651894220498529	General cognitive ability	9e-06	29844566
rs1363976	rs2432142	0.637935515563779	Neutrophil count	2e-14	32888493
rs1363976	rs2432142	0.637935515563779	White blood cell count	1e-11	32888493
rs1363976	rs38033	0.637681627262109	Blood protein levels	0	30072576
rs1363976	rs27293	0.630864630907304	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1363976	rs27293	0.630864630907304	Diastolic blood pressure	3e-11	35762941
rs1363976	rs4869313	0.627220820934038	Pediatric autoimmune diseases	9e-08	26301688
rs1363976	rs7705093	0.6221512504851	Birdshot chorioretinopathy	2e-09	24957906
rs1363976	rs2927608	0.611878456886854	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1363976	rs2927608	0.611878456886854	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1363976	rs2927608	0.611878456886854	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1363976	rs2910686	0.609853923225629	Neutrophil count	4e-14	32888493
rs1363976	rs2910686	0.609853923225629	Psoriasis	2e-08	23143594
rs1363976	rs2910686	0.609853923225629	Ankylosing spondylitis	5e-17	23749187
rs1363976	rs2910686	0.609853923225629	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1363977	rs2549797	0.997577023040581	Systolic blood pressure	7e-07	33230300
rs1363977	rs2549797	0.997577023040581	Diastolic blood pressure	1e-14	33230300
rs1363977	rs2549797	0.997577023040581	Diastolic blood pressure	3e-11	33230300
rs1363977	rs2549797	0.997577023040581	Systolic blood pressure	4e-09	33230300
rs1363977	rs2549782	0.995963575506415	Systolic blood pressure	6e-07	33230300
rs1363977	rs2549782	0.995963575506415	Diastolic blood pressure	1e-14	33230300
rs1363977	rs2549782	0.995963575506415	Diastolic blood pressure	3e-11	33230300
rs1363977	rs2549782	0.995963575506415	Systolic blood pressure	5e-09	33230300
rs1363977	rs1056893	0.995157932656523	Systolic blood pressure	1e-06	33230300
rs1363977	rs1056893	0.995157932656523	Diastolic blood pressure	7e-15	33230300
rs1363977	rs1056893	0.995157932656523	Diastolic blood pressure	2e-11	33230300
rs1363977	rs1056893	0.995157932656523	Systolic blood pressure	7e-09	33230300
rs1363977	rs2910686	0.88258957135714	Neutrophil count	4e-14	32888493
rs1363977	rs2910686	0.88258957135714	Psoriasis	2e-08	23143594
rs1363977	rs2910686	0.88258957135714	Ankylosing spondylitis	5e-17	23749187
rs1363977	rs2910686	0.88258957135714	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1363977	rs2927608	0.879684914197427	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1363977	rs2927608	0.879684914197427	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1363977	rs2927608	0.879684914197427	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1363977	rs1019503	0.820743601045281	Systolic blood pressure	2e-06	33230300
rs1363977	rs1019503	0.820743601045281	Diastolic blood pressure	2e-14	33230300
rs1363977	rs1019503	0.820743601045281	Diastolic blood pressure	4e-11	33230300
rs1363977	rs1019503	0.820743601045281	Systolic blood pressure	1e-08	33230300
rs1363977	rs3096168	0.81053867648862	Aspartate aminotransferase levels	8e-12	33547301
rs1363977	rs4869314	0.802130383293629	Arthritis (juvenile idiopathic)	3e-09	33106285
rs1363977	rs4869314	0.802130383293629	Neutrophil count	1e-10	34594039
rs1363977	rs4869314	0.802130383293629	White blood cell count	2e-07	30595370
rs1363977	rs1974871	0.780597796896251	Granulysin levels	5e-13	34648354
rs1363977	rs1423357	0.773179138366056	General cognitive ability	9e-06	29844566
rs1363977	rs2432142	0.758605595922521	Neutrophil count	2e-14	32888493
rs1363977	rs2432142	0.758605595922521	White blood cell count	1e-11	32888493
rs1363977	rs38033	0.752663203522515	Blood protein levels	0	30072576
rs1363977	rs27293	0.74075248323268	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1363977	rs27293	0.74075248323268	Diastolic blood pressure	3e-11	35762941
rs1363977	rs4869313	0.736367817866212	Pediatric autoimmune diseases	9e-08	26301688
rs1363977	rs7705093	0.732827367969837	Birdshot chorioretinopathy	2e-09	24957906
rs1363977	rs1559359	0.721510548876381	Diastolic blood pressure	7e-10	34594039
rs1363977	rs2549794	0.636287481477341	Crohn's disease	1e-10	21102463
rs1363977	rs2549794	0.636287481477341	Systolic blood pressure	1e-07	33230300
rs1363977	rs2549794	0.636287481477341	Diastolic blood pressure	1e-15	33230300
rs1363977	rs2549794	0.636287481477341	Diastolic blood pressure	2e-12	33230300
rs1363977	rs2549794	0.636287481477341	Systolic blood pressure	4e-10	33230300
rs1363977	rs1363907	0.634717502378441	Crohn's disease	4e-16	26192919
rs1363977	rs1363907	0.634717502378441	Ulcerative colitis	4e-06	26192919
rs1363977	rs1363907	0.634717502378441	Inflammatory bowel disease	5e-15	26192919
rs1363977	rs1363907	0.634717502378441	Inflammatory bowel disease	6e-13	23128233
rs1363977	rs1363907	0.634717502378441	Inflammatory bowel disease	1e-10	28067908
rs1363977	rs1363907	0.634717502378441	Crohn's disease	1e-14	28067908
rs1363977	rs716848	0.632143277588337	Neutrophil percentage of white cells	2e-09	32888494
rs1363977	rs2617439	0.604444763156173	Neutrophil count	8e-11	32888494
rs1374491	rs7655841	0.872232928834665	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1374491	rs337277	0.846198176999294	Metabolite peak levels (QI10992)	3e-52	35995766
rs1374491	rs337277	0.846198176999294	Metabolite peak levels (QI4667)	7e-18	35995766
rs1374491	rs337277	0.846198176999294	Metabolite peak levels (QI4708)	1e-21	35995766
rs1374491	rs337277	0.846198176999294	Metabolite peak levels (QI5169)	7e-57	35995766
rs1374491	rs10010659	0.600325503716927	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs1378601	rs8071834	0.969714026481791	Platelet count	3e-11	34594039
rs1378601	rs712273	0.966390310295338	Red blood cell count	5e-17	32888493
rs1378601	rs8069321	0.849010814195877	Serum albumin levels	2e-09	34594039
rs1378601	rs865923	0.717933028343236	Red blood cell count	2e-14	32888493
rs1378601	rs865923	0.717933028343236	Red blood cell count	1e-10	32888494
rs1378601	rs865923	0.717933028343236	Red blood cell count	1e-11	34594039
rs1378601	rs865923	0.717933028343236	Height	3e-25	30595370
rs1378601	rs865923	0.717933028343236	Red blood cell count	1e-10	30595370
rs1378601	rs854779	0.670174331748311	Height	4e-79	36224396
rs1378601	rs854772	0.620078001765217	Mean corpuscular hemoglobin	3e-12	32888494
rs1378601	rs854776	0.601051299878551	Mean corpuscular hemoglobin	2e-15	32888493
rs1378601	rs854776	0.601051299878551	Mean corpuscular volume	1e-11	32888493
rs1378601	rs854776	0.601051299878551	Mean corpuscular volume	5e-12	32888493
rs1378602	rs8071834	0.991960135707819	Platelet count	3e-11	34594039
rs1378602	rs712273	0.941455224738158	Red blood cell count	5e-17	32888493
rs1378602	rs8069321	0.871531645534308	Serum albumin levels	2e-09	34594039
rs1378602	rs865923	0.697435905265577	Red blood cell count	2e-14	32888493
rs1378602	rs865923	0.697435905265577	Red blood cell count	1e-10	32888494
rs1378602	rs865923	0.697435905265577	Red blood cell count	1e-11	34594039
rs1378602	rs865923	0.697435905265577	Height	3e-25	30595370
rs1378602	rs865923	0.697435905265577	Red blood cell count	1e-10	30595370
rs1378602	rs854779	0.647143296216095	Height	4e-79	36224396
rs1378602	rs854772	0.602106317275784	Mean corpuscular hemoglobin	3e-12	32888494
rs137931729	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs137931729	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs137931729	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs137931729	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs137931729	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs137931729	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs137931729	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs137931729	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs137931729	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs137931729	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs137931729	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs137931729	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs137931729	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs137931729	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs137931729	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs137931729	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs137931729	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs137931729	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs137931729	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs137931729	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs137931729	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs137931729	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs137931729	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs137931729	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs137931729	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs137931729	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs137931729	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs137931729	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs137931729	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs137931729	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs137931729	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs137931729	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs137931729	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs137931729	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs137931729	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs137931729	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs137931729	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs137931729	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs137931729	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs137931729	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs137931729	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs137931729	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs1387833	rs2999541	0.882289408218581	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs1387833	rs3007711	0.878398431808309	Electrodermal activity	9e-06	25387706
rs1387833	rs10788817	0.83722046375582	Serum metabolite levels	3e-13	24625756
rs1387833	rs10788817	0.83722046375582	Metabolite peak levels (QI2718)	5e-18	35995766
rs1387833	rs10788817	0.83722046375582	3-hydroxylaurate levels	2e-12	36635386
rs1387833	rs10788817	0.83722046375582	Tetradecadienoate (14:2) levels	8e-17	36635386
rs1387833	rs11204914	0.832041822884117	Carnitine C9 levels	1e-13	35995766
rs1387833	rs11204914	0.832041822884117	Metabolite peak levels (QI6204)	1e-32	35995766
rs1387833	rs11204914	0.832041822884117	Metabolite peak levels (QI6252)	2e-32	35995766
rs1387833	rs2130525	0.81784980286917	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs1387833	rs2279501	0.813576096380675	Serum metabolite levels	3e-14	33031748
rs1387833	rs6685187	0.807023422166438	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs1387833	rs6698740	0.804881109285963	Beta-hydroxyisovalerate levels	1e-13	35347128
rs1387833	rs1060870	0.803407720082969	Serum metabolite levels	1e-11	33031748
rs1387833	rs1060870	0.803407720082969	Serum metabolite levels	1e-15	33031748
rs1387833	rs2338201	0.793338432697401	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs1387833	rs2338201	0.793338432697401	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs1387833	rs2338201	0.793338432697401	Dodecadienoate (12:2) levels	7e-15	36635386
rs1387833	rs7542137	0.743611620199148	Beta-hydroxyisovalerate levels	3e-11	35050183
rs1387833	rs7542137	0.743611620199148	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs1387833	rs7542137	0.743611620199148	3-hydroxysebacate levels	2e-10	36635386
rs1387833	rs2999545	0.739735803833544	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs1387833	rs1038747	0.694624322189456	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs1387833	rs10494270	0.679139791183295	Nonaylcarnitine levels	5e-13	26068415
rs1387833	rs9943221	0.672349239694292	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs1387833	rs7523082	0.66950054145855	Metabolite peak levels (QI9845)	2e-14	35995766
rs1387833	rs10888445	0.666462883651273	Beta-hydroxyisovalerate levels	5e-13	36635386
rs1387833	rs7541453	0.663020096391278	Serum metabolite levels	2e-16	33031748
rs1387833	rs7541453	0.663020096391278	Serum metabolite levels	2e-16	33031748
rs1387833	rs7541453	0.663020096391278	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs1387833	rs56000812	0.625805701640895	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs1387833	rs56078223	0.623790887287829	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs1387833	rs56078223	0.623790887287829	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs1396080	rs6821305	0.64684108924508	Weight	1e-11	34594039
rs1396080	rs6821305	0.64684108924508	Appendicular lean mass	3e-26	33097823
rs1396080	rs6821305	0.64684108924508	Body surface area	5e-15	36502284
rs1396080	rs6821305	0.64684108924508	Hip circumference adjusted for BMI	3e-12	34021172
rs1396080	rs6821305	0.64684108924508	Multi-trait sex score	5e-09	37277458
rs1396080	rs769246	0.60443638040711	Red cell distribution width	8e-08	30595370
rs140288	rs140288	1	Triglyceride levels	4e-11	32203549
rs140288	rs140287	0.778024291344496	Liver enzyme levels (gamma-glutamyl transferase)	4e-99	33972514
rs140288	rs5760147	0.749467619101191	Neutrophil count	5e-09	32888494
rs140288	rs5760147	0.749467619101191	Glutathione S-transferase theta-1 levels	0	34648354
rs140288	rs9608229	0.737406194294079	Triglyceride levels in non-type 2 diabetes	1e-10	36269708
rs140288	rs2739330	0.654229068159216	Liver enzyme levels (gamma-glutamyl transferase)	2e-09	22001757
rs140288	rs1985951	0.649464910403609	Neutrophil count	1e-10	32888493
rs140288	rs2739344	0.62581316921906	Total testosterone levels	6e-09	36653534
rs1409148	rs10922531	0.944833842157713	Serum metabolite levels	2e-69	33031748
rs1409148	rs12729558	0.90807641108719	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs1409148	rs7530513	0.860405171685901	Height	8e-11	35831902
rs1409148	rs7530513	0.860405171685901	Imidazole lactate levels	8e-166	36635386
rs1409148	rs12144640	0.860405171685901	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1409148	rs1409152	0.848508845968389	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs1409148	rs1409152	0.848508845968389	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs1409148	rs10801699	0.846324345965422	X-23639 levels	2e-10	36635386
rs1409148	rs7532151	0.844997709501403	Imidazole lactate levels	9e-12	33177712
rs1409148	rs10801690	0.81869730163795	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs1409148	rs12120164	0.811108642547787	Metabolite peak levels (QI2146)	1e-26	35995766
rs1409148	rs9787133	0.789195672142082	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1409148	rs2765527	0.740938070433258	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs1409148	rs2810876	0.634720060819191	Imidazole lactate levels	2e-122	35347128
rs1409148	rs10801696	0.633476735622828	Imidazole lactate levels	3e-195	35050183
rs1409148	rs1206228892	0.632969846497608	Imidazole lactate levels	5e-186	35050183
rs1409151	rs10922531	0.945618847874226	Serum metabolite levels	2e-69	33031748
rs1409151	rs12729558	0.908886914662666	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs1409151	rs7530513	0.861117051155524	Height	8e-11	35831902
rs1409151	rs7530513	0.861117051155524	Imidazole lactate levels	8e-166	36635386
rs1409151	rs12144640	0.861117051155524	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1409151	rs1409152	0.849211930082339	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs1409151	rs1409152	0.849211930082339	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs1409151	rs10801699	0.847025621675857	X-23639 levels	2e-10	36635386
rs1409151	rs7532151	0.844294007135275	Imidazole lactate levels	9e-12	33177712
rs1409151	rs10801690	0.818008915777123	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs1409151	rs12120164	0.811781280239785	Metabolite peak levels (QI2146)	1e-26	35995766
rs1409151	rs9787133	0.78852622105922	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1409151	rs2765527	0.740325542090107	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs1409151	rs2810876	0.634194707871901	Imidazole lactate levels	2e-122	35347128
rs1409151	rs10801696	0.632953044816836	Imidazole lactate levels	3e-195	35050183
rs1409151	rs1206228892	0.632446574733326	Imidazole lactate levels	5e-186	35050183
rs1409152	rs1409152	1	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs1409152	rs1409152	1	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs1409152	rs10801699	0.994009539071866	X-23639 levels	2e-10	36635386
rs1409152	rs12120164	0.952762826720193	Metabolite peak levels (QI2146)	1e-26	35995766
rs1409152	rs10922531	0.798883837743098	Serum metabolite levels	2e-69	33031748
rs1409152	rs12729558	0.777057844811651	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs1409152	rs7532151	0.715867956991574	Imidazole lactate levels	9e-12	33177712
rs1409152	rs7530513	0.714191806031104	Height	8e-11	35831902
rs1409152	rs7530513	0.714191806031104	Imidazole lactate levels	8e-166	36635386
rs1409152	rs12144640	0.714191806031104	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1409152	rs10801690	0.696525242176338	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs1409152	rs9787133	0.670396524285348	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1409152	rs2765527	0.628364598968609	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs1409152	rs10922532	0.605488619337216	Blood urea nitrogen levels	2e-08	31152163
rs1409152	rs10922532	0.605488619337216	Waist circumference adjusted for body mass index	2e-11	34021172
rs1409152	rs10922532	0.605488619337216	X-23639 levels	4e-11	35050183
rs1410789	rs115320831	0.962293465720003	Excessive daytime sleepiness	4e-07	27992416
rs1413655	rs14314	0.894208964780474	Macular thickness	3e-19	30535121
rs1413655	rs14314	0.894208964780474	Vertex-wise sulcal depth	7e-17	34910505
rs1413655	rs14314	0.894208964780474	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs1413655	rs14314	0.894208964780474	Left hippocampal volume (body)	7e-15	37337106
rs1413655	rs14314	0.894208964780474	Left subiculum volume (body)	1e-14	37337106
rs1413655	rs2095375	0.880420838349017	Serum metabolite levels	1e-20	33031748
rs1413655	rs2095375	0.880420838349017	Serum metabolite levels	1e-20	33031748
rs1413655	rs9383843	0.879561516481981	Migraine	1e-09	35115687
rs1413655	rs55763431	0.876189329292502	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs1413655	rs9689694	0.874589921004102	Right hippocampal volume (head)	6e-11	37337106
rs1413655	rs9689694	0.874589921004102	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs1413655	rs9689694	0.874589921004102	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs1413655	rs9689694	0.874589921004102	Left hippocampal volume (head)	6e-12	37337106
rs1413655	rs10872645	0.872880731466766	Blood protein levels	2e-86	30072576
rs1413655	rs10872653	0.868948226900715	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs1413655	rs9688867	0.868529688870124	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs1413655	rs9688867	0.868529688870124	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs1413655	rs9688809	0.868529688870124	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs1413655	rs34337297	0.865485418076589	Serum levels of protein LRP11	3e-161	35078996
rs1413655	rs9322193	0.833347618105978	Lung cancer	1e-07	27393504
rs1413655	rs4039600	0.795372911105125	Adenine levels	1e-11	35347128
rs1423357	rs1423357	1	General cognitive ability	9e-06	29844566
rs1423357	rs2432142	0.979899984928291	Neutrophil count	2e-14	32888493
rs1423357	rs2432142	0.979899984928291	White blood cell count	1e-11	32888493
rs1423357	rs38033	0.975102202497434	Blood protein levels	0	30072576
rs1423357	rs27293	0.961018107387047	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1423357	rs27293	0.961018107387047	Diastolic blood pressure	3e-11	35762941
rs1423357	rs7705093	0.955767659948791	Birdshot chorioretinopathy	2e-09	24957906
rs1423357	rs2910686	0.87043618777691	Neutrophil count	4e-14	32888493
rs1423357	rs2910686	0.87043618777691	Psoriasis	2e-08	23143594
rs1423357	rs2910686	0.87043618777691	Ankylosing spondylitis	5e-17	23749187
rs1423357	rs2910686	0.87043618777691	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1423357	rs2927608	0.867108692926631	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1423357	rs2927608	0.867108692926631	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1423357	rs2927608	0.867108692926631	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1423357	rs2617439	0.77874134092308	Neutrophil count	8e-11	32888494
rs1423357	rs2549797	0.775259401195032	Systolic blood pressure	7e-07	33230300
rs1423357	rs2549797	0.775259401195032	Diastolic blood pressure	1e-14	33230300
rs1423357	rs2549797	0.775259401195032	Diastolic blood pressure	3e-11	33230300
rs1423357	rs2549797	0.775259401195032	Systolic blood pressure	4e-09	33230300
rs1423357	rs2549782	0.774002093298599	Systolic blood pressure	6e-07	33230300
rs1423357	rs2549782	0.774002093298599	Diastolic blood pressure	1e-14	33230300
rs1423357	rs2549782	0.774002093298599	Diastolic blood pressure	3e-11	33230300
rs1423357	rs2549782	0.774002093298599	Systolic blood pressure	5e-09	33230300
rs1423357	rs1056893	0.773374281680326	Systolic blood pressure	1e-06	33230300
rs1423357	rs1056893	0.773374281680326	Diastolic blood pressure	7e-15	33230300
rs1423357	rs1056893	0.773374281680326	Diastolic blood pressure	2e-11	33230300
rs1423357	rs1056893	0.773374281680326	Systolic blood pressure	7e-09	33230300
rs1423357	rs2549794	0.769261023230232	Crohn's disease	1e-10	21102463
rs1423357	rs2549794	0.769261023230232	Systolic blood pressure	1e-07	33230300
rs1423357	rs2549794	0.769261023230232	Diastolic blood pressure	1e-15	33230300
rs1423357	rs2549794	0.769261023230232	Diastolic blood pressure	2e-12	33230300
rs1423357	rs2549794	0.769261023230232	Systolic blood pressure	4e-10	33230300
rs1423357	rs38029	0.767032269737887	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1423357	rs1363907	0.764618581415287	Crohn's disease	4e-16	26192919
rs1423357	rs1363907	0.764618581415287	Ulcerative colitis	4e-06	26192919
rs1423357	rs1363907	0.764618581415287	Inflammatory bowel disease	5e-15	26192919
rs1423357	rs1363907	0.764618581415287	Inflammatory bowel disease	6e-13	23128233
rs1423357	rs1363907	0.764618581415287	Inflammatory bowel disease	1e-10	28067908
rs1423357	rs1363907	0.764618581415287	Crohn's disease	1e-14	28067908
rs1423357	rs716848	0.736249142777582	Neutrophil percentage of white cells	2e-09	32888494
rs1423357	rs4869313	0.723527572951896	Pediatric autoimmune diseases	9e-08	26301688
rs1423357	rs1559359	0.717506455015528	Diastolic blood pressure	7e-10	34594039
rs1423357	rs2548532	0.691123671665965	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1423357	rs4869314	0.670773393286175	Arthritis (juvenile idiopathic)	3e-09	33106285
rs1423357	rs4869314	0.670773393286175	Neutrophil count	1e-10	34594039
rs1423357	rs4869314	0.670773393286175	White blood cell count	2e-07	30595370
rs1423357	rs1974871	0.643898786501875	Granulysin levels	5e-13	34648354
rs1423357	rs1019503	0.640256626312341	Systolic blood pressure	2e-06	33230300
rs1423357	rs1019503	0.640256626312341	Diastolic blood pressure	2e-14	33230300
rs1423357	rs1019503	0.640256626312341	Diastolic blood pressure	4e-11	33230300
rs1423357	rs1019503	0.640256626312341	Systolic blood pressure	1e-08	33230300
rs1423357	rs27660	0.637068656440241	Coronary artery disease	3e-08	35915156
rs1423357	rs3096168	0.63280331979523	Aspartate aminotransferase levels	8e-12	33547301
rs1423566	rs1423357	0.990782165983573	General cognitive ability	9e-06	29844566
rs1423566	rs2432142	0.97909240113781	Neutrophil count	2e-14	32888493
rs1423566	rs2432142	0.97909240113781	White blood cell count	1e-11	32888493
rs1423566	rs38033	0.974221194924239	Blood protein levels	0	30072576
rs1423566	rs27293	0.963456842940968	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1423566	rs27293	0.963456842940968	Diastolic blood pressure	3e-11	35762941
rs1423566	rs7705093	0.956470262714641	Birdshot chorioretinopathy	2e-09	24957906
rs1423566	rs2910686	0.866241295324916	Neutrophil count	4e-14	32888493
rs1423566	rs2910686	0.866241295324916	Psoriasis	2e-08	23143594
rs1423566	rs2910686	0.866241295324916	Ankylosing spondylitis	5e-17	23749187
rs1423566	rs2910686	0.866241295324916	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1423566	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1423566	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1423566	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1423566	rs2617439	0.778918998998163	Neutrophil count	8e-11	32888494
rs1423566	rs2549797	0.771019548090089	Systolic blood pressure	7e-07	33230300
rs1423566	rs2549797	0.771019548090089	Diastolic blood pressure	1e-14	33230300
rs1423566	rs2549797	0.771019548090089	Diastolic blood pressure	3e-11	33230300
rs1423566	rs2549797	0.771019548090089	Systolic blood pressure	4e-09	33230300
rs1423566	rs2549782	0.769761797387831	Systolic blood pressure	6e-07	33230300
rs1423566	rs2549782	0.769761797387831	Diastolic blood pressure	1e-14	33230300
rs1423566	rs2549782	0.769761797387831	Diastolic blood pressure	3e-11	33230300
rs1423566	rs2549782	0.769761797387831	Systolic blood pressure	5e-09	33230300
rs1423566	rs1056893	0.769133764694912	Systolic blood pressure	1e-06	33230300
rs1423566	rs1056893	0.769133764694912	Diastolic blood pressure	7e-15	33230300
rs1423566	rs1056893	0.769133764694912	Diastolic blood pressure	2e-11	33230300
rs1423566	rs1056893	0.769133764694912	Systolic blood pressure	7e-09	33230300
rs1423566	rs2549794	0.76483812290131	Crohn's disease	1e-10	21102463
rs1423566	rs2549794	0.76483812290131	Systolic blood pressure	1e-07	33230300
rs1423566	rs2549794	0.76483812290131	Diastolic blood pressure	1e-15	33230300
rs1423566	rs2549794	0.76483812290131	Diastolic blood pressure	2e-12	33230300
rs1423566	rs2549794	0.76483812290131	Systolic blood pressure	4e-10	33230300
rs1423566	rs38029	0.762619945032584	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1423566	rs1363907	0.760208444462172	Crohn's disease	4e-16	26192919
rs1423566	rs1363907	0.760208444462172	Ulcerative colitis	4e-06	26192919
rs1423566	rs1363907	0.760208444462172	Inflammatory bowel disease	5e-15	26192919
rs1423566	rs1363907	0.760208444462172	Inflammatory bowel disease	6e-13	23128233
rs1423566	rs1363907	0.760208444462172	Inflammatory bowel disease	1e-10	28067908
rs1423566	rs1363907	0.760208444462172	Crohn's disease	1e-14	28067908
rs1423566	rs716848	0.731860855278461	Neutrophil percentage of white cells	2e-09	32888494
rs1423566	rs4869313	0.720020495635562	Pediatric autoimmune diseases	9e-08	26301688
rs1423566	rs1559359	0.713736407994285	Diastolic blood pressure	7e-10	34594039
rs1423566	rs2548532	0.687251061417594	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1423566	rs4869314	0.666692723251499	Arthritis (juvenile idiopathic)	3e-09	33106285
rs1423566	rs4869314	0.666692723251499	Neutrophil count	1e-10	34594039
rs1423566	rs4869314	0.666692723251499	White blood cell count	2e-07	30595370
rs1423566	rs1974871	0.640379183170097	Granulysin levels	5e-13	34648354
rs1423566	rs1019503	0.6359518868097	Systolic blood pressure	2e-06	33230300
rs1423566	rs1019503	0.6359518868097	Diastolic blood pressure	2e-14	33230300
rs1423566	rs1019503	0.6359518868097	Diastolic blood pressure	4e-11	33230300
rs1423566	rs1019503	0.6359518868097	Systolic blood pressure	1e-08	33230300
rs1423566	rs27660	0.633665826402108	Coronary artery disease	3e-08	35915156
rs1423566	rs3096168	0.628555573509049	Aspartate aminotransferase levels	8e-12	33547301
rs14314	rs14314	1	Macular thickness	3e-19	30535121
rs14314	rs14314	1	Vertex-wise sulcal depth	7e-17	34910505
rs14314	rs14314	1	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs14314	rs14314	1	Left hippocampal volume (body)	7e-15	37337106
rs14314	rs14314	1	Left subiculum volume (body)	1e-14	37337106
rs14314	rs2095375	0.981250032026204	Serum metabolite levels	1e-20	33031748
rs14314	rs2095375	0.981250032026204	Serum metabolite levels	1e-20	33031748
rs14314	rs9383843	0.980357942371438	Migraine	1e-09	35115687
rs14314	rs55763431	0.97680053310452	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs14314	rs9689694	0.975027002056927	Right hippocampal volume (head)	6e-11	37337106
rs14314	rs9689694	0.975027002056927	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs14314	rs9689694	0.975027002056927	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs14314	rs9689694	0.975027002056927	Left hippocampal volume (head)	6e-12	37337106
rs14314	rs10872645	0.969710900369798	Blood protein levels	2e-86	30072576
rs14314	rs9688867	0.968848438982756	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs14314	rs9688867	0.968848438982756	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs14314	rs9688809	0.968848438982756	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs14314	rs10872653	0.968831388785044	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs14314	rs34337297	0.965291980407256	Serum levels of protein LRP11	3e-161	35078996
rs14314	rs9322193	0.929624389777146	Lung cancer	1e-07	27393504
rs14314	rs4039600	0.886575759034076	Adenine levels	1e-11	35347128
rs14314	rs1934534	0.642303286702625	Pain (pleiotropy)	2e-08	37844115
rs14314	rs1934534	0.642303286702625	Pain (pleiotropy)	2e-06	37844115
rs14314	rs4380763	0.64177827340696	Subcortical volume (min-P)	1e-11	32665545
rs14314	rs11155671	0.631318253052168	Testicular germ cell tumor	2e-09	28604728
rs14314	rs80147756	0.616296053418261	HippSubfield lh volume subiculum-head	3e-10	33875891
rs14314	rs4421206	0.60865479010598	Brain morphology (min-P)	4e-11	32665545
rs14314	rs9505982	0.602173265238806	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs1435134	rs17007017	0.985992650545312	Conduct disorder	7e-06	20585324
rs1435134	rs34402449	0.644980791738943	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs1436958	rs1436958	1	IgG glycosylation	9e-06	23382691
rs1436958	rs2162062	0.807159330282455	Height	2e-13	35831902
rs1436958	rs933807	0.760832135352714	Fat-free mass	6e-06	30593698
rs1436958	rs933807	0.760832135352714	Fat-free mass	2e-07	30593698
rs1436958	rs933807	0.760832135352714	Fat-free mass	8e-11	30593698
rs1436958	rs7178540	0.679038874861345	Height	1e-31	36224396
rs1436958	rs11635977	0.662940393048143	Height	2e-25	36224396
rs1436958	rs7162536	0.648986459341251	Height	4e-29	34594039
rs1436958	rs72749770	0.648915610360449	Low density lipoprotein cholesterol levels	9e-10	32493714
rs1436958	rs72749770	0.648915610360449	Apolipoprotein B levels	2e-09	32203549
rs1436958	rs7178424	0.638658365351086	Height	6e-09	20881960
rs1436958	rs7178424	0.638658365351086	Height	6e-13	35831902
rs1436958	rs7178424	0.638658365351086	Height	3e-251	36224396
rs1436958	rs17271431	0.636170813812933	Height	2e-11	34594039
rs1436958	rs17205463	0.635497459039717	Serum levels of protein IGF1	8e-08	27329260
rs1436958	rs17205463	0.635497459039717	Appendicular lean mass	4e-43	33097823
rs1436958	rs17205463	0.635497459039717	Height	2e-35	30595370
rs1436958	rs731820	0.627761325523757	Height	2e-13	31562340
rs1436958	rs731820	0.627761325523757	Height	2e-12	35831902
rs1445557	rs7321596	0.991654242234341	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs1445557	rs8002861	0.959407011004526	Leprosy	7e-06	25642632
rs1445998	rs10036895	0.886164620338354	Breast cancer	2e-12	34290314
rs144769121	rs28373613	0.857393797271283	Height (standard GWA)	8e-12	37106081
rs144769121	rs13379492	0.6291317816403	Lung function (FEV1/FVC)	6e-08	30595370
rs1466008	rs33321	0.841157784296556	Height	1e-19	34594039
rs1466008	rs832540	0.786393571425975	Coronary artery disease	2e-08	29212778
rs1466008	rs10061757	0.682142265566853	Height	4e-30	30595370
rs1466008	rs33320	0.645391280897683	Height	9e-14	36224396
rs1466008	rs2257505	0.643616516373991	Height	8e-192	36224396
rs1467508	rs1467510	0.937918709630256	Platelet distribution width	1e-14	32888494
rs1467508	rs12276109	0.793601338209993	Severe COVID-19 infection	6e-08	36662838
rs1467509	rs1467510	0.881991046985557	Platelet distribution width	1e-14	32888494
rs1467509	rs12276109	0.712571832142507	Severe COVID-19 infection	6e-08	36662838
rs1467510	rs1467510	1	Platelet distribution width	1e-14	32888494
rs1467510	rs12276109	0.743560041395489	Severe COVID-19 infection	6e-08	36662838
rs1467712	rs10970975	0.988699430519462	Red blood cell count	9e-14	34594039
rs1467712	rs10970975	0.988699430519462	Red blood cell count	6e-21	30595370
rs1467712	rs10970976	0.939373749696379	Asthma	4e-06	22561531
rs1467713	rs10970975	0.991306729419373	Red blood cell count	9e-14	34594039
rs1467713	rs10970975	0.991306729419373	Red blood cell count	6e-21	30595370
rs1467713	rs10970976	0.941837174227913	Asthma	4e-06	22561531
rs1471539	rs1471539	1	Mean reticulocyte volume	1e-10	32888494
rs1471539	rs1471539	1	Mean spheric corpuscular volume	8e-13	32888494
rs1471539	rs2501968	0.997601571483327	Ischemic stroke	1e-08	34594039
rs1471539	rs9369898	0.828972268052289	Homocysteine levels	2e-10	23824729
rs1474984	rs1467510	0.794440395495822	Platelet distribution width	1e-14	32888494
rs1474984	rs12276109	0.704937335973005	Severe COVID-19 infection	6e-08	36662838
rs1475263	rs11580836	0.995556007882718	Body mass index	2e-09	36581621
rs1475263	rs10465746	0.962552773381678	Obesity-related traits	8e-06	23251661
rs1475933	rs3213282	0.605560161046271	Low density lipoprotein cholesterol levels	3e-11	32154731
rs1477364	rs27660	0.970283054695428	Coronary artery disease	3e-08	35915156
rs1477364	rs2548532	0.882199960972769	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1477364	rs2549794	0.800596953917101	Crohn's disease	1e-10	21102463
rs1477364	rs2549794	0.800596953917101	Systolic blood pressure	1e-07	33230300
rs1477364	rs2549794	0.800596953917101	Diastolic blood pressure	1e-15	33230300
rs1477364	rs2549794	0.800596953917101	Diastolic blood pressure	2e-12	33230300
rs1477364	rs2549794	0.800596953917101	Systolic blood pressure	4e-10	33230300
rs1477364	rs2617439	0.799068068581831	Neutrophil count	8e-11	32888494
rs1477364	rs1363907	0.795861984855665	Crohn's disease	4e-16	26192919
rs1477364	rs1363907	0.795861984855665	Ulcerative colitis	4e-06	26192919
rs1477364	rs1363907	0.795861984855665	Inflammatory bowel disease	5e-15	26192919
rs1477364	rs1363907	0.795861984855665	Inflammatory bowel disease	6e-13	23128233
rs1477364	rs1363907	0.795861984855665	Inflammatory bowel disease	1e-10	28067908
rs1477364	rs1363907	0.795861984855665	Crohn's disease	1e-14	28067908
rs1477364	rs38029	0.789738330910868	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1477364	rs716848	0.771085111377198	Neutrophil percentage of white cells	2e-09	32888494
rs1477364	rs1423357	0.654131402832371	General cognitive ability	9e-06	29844566
rs1477364	rs38033	0.640354960888782	Blood protein levels	0	30072576
rs1477364	rs2432142	0.639989740143303	Neutrophil count	2e-14	32888493
rs1477364	rs2432142	0.639989740143303	White blood cell count	1e-11	32888493
rs1477364	rs27293	0.631920653445076	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1477364	rs27293	0.631920653445076	Diastolic blood pressure	3e-11	35762941
rs1477364	rs7705093	0.625172678224955	Birdshot chorioretinopathy	2e-09	24957906
rs1490189	rs3007711	0.87914904840537	Electrodermal activity	9e-06	25387706
rs1490189	rs2999541	0.875181016499645	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs1490189	rs10788817	0.833513617231333	Serum metabolite levels	3e-13	24625756
rs1490189	rs10788817	0.833513617231333	Metabolite peak levels (QI2718)	5e-18	35995766
rs1490189	rs10788817	0.833513617231333	3-hydroxylaurate levels	2e-12	36635386
rs1490189	rs10788817	0.833513617231333	Tetradecadienoate (14:2) levels	8e-17	36635386
rs1490189	rs11204914	0.828341130200784	Carnitine C9 levels	1e-13	35995766
rs1490189	rs11204914	0.828341130200784	Metabolite peak levels (QI6204)	1e-32	35995766
rs1490189	rs11204914	0.828341130200784	Metabolite peak levels (QI6252)	2e-32	35995766
rs1490189	rs2279501	0.815826769865871	Serum metabolite levels	3e-14	33031748
rs1490189	rs2130525	0.81108221698646	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs1490189	rs6685187	0.804857567964656	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs1490189	rs6698740	0.802718359645937	Beta-hydroxyisovalerate levels	1e-13	35347128
rs1490189	rs1060870	0.801246829023367	Serum metabolite levels	1e-11	33031748
rs1490189	rs1060870	0.801246829023367	Serum metabolite levels	1e-15	33031748
rs1490189	rs2338201	0.792656864942989	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs1490189	rs2338201	0.792656864942989	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs1490189	rs2338201	0.792656864942989	Dodecadienoate (12:2) levels	7e-15	36635386
rs1490189	rs7542137	0.74144442379484	Beta-hydroxyisovalerate levels	3e-11	35050183
rs1490189	rs7542137	0.74144442379484	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs1490189	rs7542137	0.74144442379484	3-hydroxysebacate levels	2e-10	36635386
rs1490189	rs2999545	0.740522806174299	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs1490189	rs1038747	0.696714802339706	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs1490189	rs9943221	0.674357566377497	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs1490189	rs7523082	0.674273690037225	Metabolite peak levels (QI9845)	2e-14	35995766
rs1490189	rs10494270	0.673907659400778	Nonaylcarnitine levels	5e-13	26068415
rs1490189	rs10888445	0.668550646056468	Beta-hydroxyisovalerate levels	5e-13	36635386
rs1490189	rs7541453	0.665110153370499	Serum metabolite levels	2e-16	33031748
rs1490189	rs7541453	0.665110153370499	Serum metabolite levels	2e-16	33031748
rs1490189	rs7541453	0.665110153370499	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs1490189	rs56000812	0.620701921010798	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs1490189	rs56078223	0.618693900674223	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs1490189	rs56078223	0.618693900674223	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs149359	rs149359	1	Skin color	4e-10	36672889
rs149359	rs149359	1	Skin phototype score	4e-09	36672889
rs149666881	rs1467510	0.754750658555155	Platelet distribution width	1e-14	32888494
rs149666881	rs12276109	0.640990146210231	Severe COVID-19 infection	6e-08	36662838
rs150380	rs158796	0.988201796179025	Height	5e-243	36224396
rs150380	rs292172	0.966508934210246	Appendicular lean mass	8e-13	31761296
rs150380	rs301901	0.953291329047178	Height	4e-16	25282103
rs150380	rs301901	0.953291329047178	Height	2e-06	35831902
rs150380	rs158622	0.927576888469992	Height	4e-15	36224396
rs150380	rs158791	0.919999356072478	Height	2e-31	36224396
rs150380	rs292168	0.878938958961482	Red cell distribution width	3e-10	30595370
rs150380	rs300053	0.877337767842958	Height	3e-11	34594039
rs150380	rs300053	0.877337767842958	Height	3e-36	34594039
rs150380	rs300053	0.877337767842958	Height	2e-14	31562340
rs150380	rs300046	0.867427786445185	Meat-related diet	5e-08	32066663
rs150621	rs150621	1	Appendicular lean mass	5e-12	31761296
rs150621	rs2098713	0.744835824984924	Telomere length	3e-06	24795349
rs150621	rs757720522	0.627820041266215	Appendicular lean mass	3e-11	31761296
rs151944	rs158796	0.833365899903549	Height	5e-243	36224396
rs151944	rs292172	0.81114344955078	Appendicular lean mass	8e-13	31761296
rs151944	rs158622	0.803995085325656	Height	4e-15	36224396
rs151944	rs301901	0.800232972971809	Height	4e-16	25282103
rs151944	rs301901	0.800232972971809	Height	2e-06	35831902
rs151944	rs300053	0.767453835705396	Height	3e-11	34594039
rs151944	rs300053	0.767453835705396	Height	3e-36	34594039
rs151944	rs300053	0.767453835705396	Height	2e-14	31562340
rs151944	rs158791	0.765913339068286	Height	2e-31	36224396
rs151944	rs292168	0.739720721070585	Red cell distribution width	3e-10	30595370
rs151944	rs300046	0.728700859746966	Meat-related diet	5e-08	32066663
rs1529089	rs1529089	1	Height	4e-36	36224396
rs1533586	rs6705511	0.763768945217387	Self-reported math ability	4e-09	30038396
rs1533586	rs6705511	0.763768945217387	Self-reported math ability (MTAG)	3e-10	30038396
rs1533586	rs34276187	0.756053105682094	Highest math class taken (MTAG)	2e-08	30038396
rs1533586	rs289848	0.603088492204535	Externalizing behaviour (multivariate analysis)	2e-10	34446935
rs1536165	rs11580836	0.798741754172999	Body mass index	2e-09	36581621
rs1536165	rs10465746	0.783152557629007	Obesity-related traits	8e-06	23251661
rs1536259	rs1409152	0.998287057187516	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs1536259	rs1409152	0.998287057187516	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs1536259	rs10801699	0.995717312503191	X-23639 levels	2e-10	36635386
rs1536259	rs12120164	0.954400860098366	Metabolite peak levels (QI2146)	1e-26	35995766
rs1536259	rs10922531	0.800441773227527	Serum metabolite levels	2e-69	33031748
rs1536259	rs12729558	0.778671854275356	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs1536259	rs7532151	0.717445937039881	Imidazole lactate levels	9e-12	33177712
rs1536259	rs7530513	0.715589008844664	Height	8e-11	35831902
rs1536259	rs7530513	0.715589008844664	Imidazole lactate levels	8e-166	36635386
rs1536259	rs12144640	0.715589008844664	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1536259	rs10801690	0.698087039277431	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs1536259	rs9787133	0.671936412578359	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs1536259	rs2765527	0.629912067975694	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs1536259	rs10922532	0.606533123008602	Blood urea nitrogen levels	2e-08	31152163
rs1536259	rs10922532	0.606533123008602	Waist circumference adjusted for body mass index	2e-11	34021172
rs1536259	rs10922532	0.606533123008602	X-23639 levels	4e-11	35050183
rs1543513	rs7987940	0.725924882694936	AFP levels	6e-08	36329257
rs1543513	rs9535244	0.654648735475475	Lung function (FVC)	1e-08	30595370
rs1543558	rs9469872	0.997591666762885	HDL cholesterol levels	3e-11	36333282
rs1543558	rs11755393	0.976194552233128	Body mass index	3e-26	29273807
rs1543558	rs11755393	0.976194552233128	Systemic lupus erythematosus	2e-12	33493351
rs1543558	rs11755393	0.976194552233128	Systemic lupus erythematosus	2e-06	33493351
rs1543558	rs11755393	0.976194552233128	Systemic lupus erythematosus	1e-07	33493351
rs1543558	rs11755393	0.976194552233128	Systemic lupus erythematosus	2e-08	19838195
rs1543558	rs11755393	0.976194552233128	Body mass index	4e-55	36581621
rs1543558	rs9366863	0.968105638270769	Adult body size	9e-33	32376654
rs1543558	rs9366863	0.968105638270769	Body mass index	2e-44	30595370
rs1543558	rs6941110	0.964942818945902	Sex hormone-binding globulin levels	5e-27	36653534
rs1543558	rs9469857	0.956557773971852	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs1543558	rs2764208	0.955811525389837	Systemic lupus erythematosus	7e-06	24871463
rs1543558	rs9462030	0.947082851030347	Red cell distribution width	5e-25	32888493
rs1543558	rs2744944	0.940628895325189	Hypothyroidism	3e-10	34594039
rs1543558	rs2744944	0.940628895325189	High density lipoprotein cholesterol levels	3e-86	34887591
rs1543558	rs2744944	0.940628895325189	Multi-trait sex score	7e-22	37277458
rs1543558	rs2814949	0.931342848816908	Essential hypertension (time to event)	9e-09	32589924
rs1543558	rs9469899	0.930508601942989	Prostate cancer (advanced)	2e-06	29892016
rs1543558	rs9469899	0.930508601942989	Prostate cancer	5e-09	29892016
rs1543558	rs9469899	0.930508601942989	Prostate cancer	8e-11	33398198
rs1543558	rs9469899	0.930508601942989	Hand grip strength	3e-15	29691431
rs1543558	rs9469899	0.930508601942989	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs1543558	rs9469899	0.930508601942989	Graves' disease	4e-10	34594039
rs1543558	rs9469899	0.930508601942989	Coronary artery disease	1e-11	36474045
rs1543558	rs9469899	0.930508601942989	Predicted visceral adipose tissue	2e-20	31501611
rs1543558	rs9469899	0.930508601942989	Medication use (thyroid preparations)	2e-09	31015401
rs1543558	rs9469899	0.930508601942989	Medication use (thyroid preparations)	3e-10	34594039
rs1543558	rs2263329	0.918144140309451	HDL cholesterol	6e-35	34594039
rs1543558	rs2263329	0.918144140309451	HDL cholesterol levels	8e-43	32203549
rs1543558	rs2263329	0.918144140309451	High density lipoprotein cholesterol levels	2e-52	34887591
rs1543558	rs9296128	0.907460691616326	Hip circumference adjusted for BMI	4e-13	34021172
rs1543558	rs111868030	0.89672309495691	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs1543558	rs9368830	0.856091466475765	HDL cholesterol	4e-21	30275531
rs1543558	rs9368828	0.84421126632391	Body mass index	1e-34	34594039
rs1543558	rs6912327	0.82138163299191	Fasting insulin	5e-06	33402679
rs1543558	rs6912327	0.82138163299191	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs1543558	rs112283401	0.798669580159486	Red cell distribution width	4e-27	30595370
rs1543558	rs2744973	0.770527006968501	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs1543558	rs2744973	0.770527006968501	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs1543558	rs2744973	0.770527006968501	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs1543558	rs2744973	0.770527006968501	Multi-trait sex score	6e-20	37277458
rs1543558	rs6940215	0.623177661304694	Insomnia	2e-10	35835914
rs1543558	rs6940215	0.623177661304694	Insomnia	1e-13	35835914
rs1543558	rs6940215	0.623177661304694	Hip circumference adjusted for BMI	8e-10	34021172
rs1543558	rs6940215	0.623177661304694	Multi-trait sex score	2e-23	37277458
rs1543558	rs6940215	0.623177661304694	Multi-trait sex score	4e-23	37277458
rs1543558	rs6457796	0.617929950788679	Insomnia	1e-08	30804565
rs1543558	rs6457796	0.617929950788679	Plateletcrit	9e-11	32888494
rs1543558	rs6457796	0.617929950788679	Systemic lupus erythematosus	3e-22	33272962
rs1543558	rs6457796	0.617929950788679	Body mass index	5e-13	30108127
rs1543558	rs6457796	0.617929950788679	Body mass index	1e-14	26426971
rs1543558	rs6457796	0.617929950788679	Educational attainment	5e-19	35361970
rs1543558	rs205262	0.600865068481551	Body mass index	2e-09	26961502
rs1543558	rs205262	0.600865068481551	Walking pace	4e-10	33128006
rs1543558	rs205262	0.600865068481551	Body mass index	8e-13	30108127
rs1543558	rs205262	0.600865068481551	Body mass index	2e-09	25673413
rs1543558	rs205262	0.600865068481551	Body mass index	2e-14	26426971
rs1543558	rs205262	0.600865068481551	BMI in non-smokers	3e-07	28443625
rs1543558	rs205262	0.600865068481551	BMI in non-smokers	6e-09	28443625
rs1543558	rs205262	0.600865068481551	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs1543558	rs205262	0.600865068481551	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs1543558	rs205262	0.600865068481551	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs1543558	rs205262	0.600865068481551	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs1543558	rs205262	0.600865068481551	Gastroesophageal reflux disease	1e-10	34187846
rs1543558	rs205262	0.600865068481551	Body mass index	3e-10	25673413
rs1543558	rs205262	0.600865068481551	Body mass index	2e-10	25673413
rs1543558	rs205262	0.600865068481551	ICD10 M54: Dorsalgia	2e-12	35110524
rs1543559	rs9469857	0.995167393533915	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs1543559	rs2764208	0.994361845411173	Systemic lupus erythematosus	7e-06	24871463
rs1543559	rs9462030	0.985543379140446	Red cell distribution width	5e-25	32888493
rs1543559	rs9469899	0.969076740318365	Prostate cancer (advanced)	2e-06	29892016
rs1543559	rs9469899	0.969076740318365	Prostate cancer	5e-09	29892016
rs1543559	rs9469899	0.969076740318365	Prostate cancer	8e-11	33398198
rs1543559	rs9469899	0.969076740318365	Hand grip strength	3e-15	29691431
rs1543559	rs9469899	0.969076740318365	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs1543559	rs9469899	0.969076740318365	Graves' disease	4e-10	34594039
rs1543559	rs9469899	0.969076740318365	Coronary artery disease	1e-11	36474045
rs1543559	rs9469899	0.969076740318365	Predicted visceral adipose tissue	2e-20	31501611
rs1543559	rs9469899	0.969076740318365	Medication use (thyroid preparations)	2e-09	31015401
rs1543559	rs9469899	0.969076740318365	Medication use (thyroid preparations)	3e-10	34594039
rs1543559	rs9469872	0.959000722139928	HDL cholesterol levels	3e-11	36333282
rs1543559	rs9296128	0.944063332182943	Hip circumference adjusted for BMI	4e-13	34021172
rs1543559	rs11755393	0.938431335917675	Body mass index	3e-26	29273807
rs1543559	rs11755393	0.938431335917675	Systemic lupus erythematosus	2e-12	33493351
rs1543559	rs11755393	0.938431335917675	Systemic lupus erythematosus	2e-06	33493351
rs1543559	rs11755393	0.938431335917675	Systemic lupus erythematosus	1e-07	33493351
rs1543559	rs11755393	0.938431335917675	Systemic lupus erythematosus	2e-08	19838195
rs1543559	rs11755393	0.938431335917675	Body mass index	4e-55	36581621
rs1543559	rs9366863	0.929996365231511	Adult body size	9e-33	32376654
rs1543559	rs9366863	0.929996365231511	Body mass index	2e-44	30595370
rs1543559	rs6941110	0.926825325061688	Sex hormone-binding globulin levels	5e-27	36653534
rs1543559	rs2744944	0.903072592823728	Hypothyroidism	3e-10	34594039
rs1543559	rs2744944	0.903072592823728	High density lipoprotein cholesterol levels	3e-86	34887591
rs1543559	rs2744944	0.903072592823728	Multi-trait sex score	7e-22	37277458
rs1543559	rs2814949	0.894119611284443	Essential hypertension (time to event)	9e-09	32589924
rs1543559	rs2263329	0.880733248600002	HDL cholesterol	6e-35	34594039
rs1543559	rs2263329	0.880733248600002	HDL cholesterol levels	8e-43	32203549
rs1543559	rs2263329	0.880733248600002	High density lipoprotein cholesterol levels	2e-52	34887591
rs1543559	rs111868030	0.859587059047363	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs1543559	rs9368830	0.821800065466397	HDL cholesterol	4e-21	30275531
rs1543559	rs9368828	0.812306440295693	Body mass index	1e-34	34594039
rs1543559	rs2744973	0.790539519166468	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs1543559	rs2744973	0.790539519166468	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs1543559	rs2744973	0.790539519166468	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs1543559	rs2744973	0.790539519166468	Multi-trait sex score	6e-20	37277458
rs1543559	rs6912327	0.782659944169834	Fasting insulin	5e-06	33402679
rs1543559	rs6912327	0.782659944169834	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs1543559	rs112283401	0.760472324840381	Red cell distribution width	4e-27	30595370
rs1543559	rs9689160	0.617657633986917	Lung function (forced vital capacity)	3e-14	36914875
rs1543559	rs9462027	0.60123030536493	Systemic lupus erythematosus	1e-10	27399966
rs1543559	rs9462027	0.60123030536493	Systemic lupus erythematosus	8e-09	26502338
rs1543559	rs9462027	0.60123030536493	Systemic lupus erythematosus	2e-08	28714469
rs1543559	rs9462027	0.60123030536493	Alzheimer's disease or gastroesophageal reflux disease	2e-06	35851147
rs1544777	rs2617439	0.97597632109584	Neutrophil count	8e-11	32888494
rs1544777	rs2549794	0.961177730147346	Crohn's disease	1e-10	21102463
rs1544777	rs2549794	0.961177730147346	Systolic blood pressure	1e-07	33230300
rs1544777	rs2549794	0.961177730147346	Diastolic blood pressure	1e-15	33230300
rs1544777	rs2549794	0.961177730147346	Diastolic blood pressure	2e-12	33230300
rs1544777	rs2549794	0.961177730147346	Systolic blood pressure	4e-10	33230300
rs1544777	rs38029	0.960290476030872	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1544777	rs1363907	0.955961893072307	Crohn's disease	4e-16	26192919
rs1544777	rs1363907	0.955961893072307	Ulcerative colitis	4e-06	26192919
rs1544777	rs1363907	0.955961893072307	Inflammatory bowel disease	5e-15	26192919
rs1544777	rs1363907	0.955961893072307	Inflammatory bowel disease	6e-13	23128233
rs1544777	rs1363907	0.955961893072307	Inflammatory bowel disease	1e-10	28067908
rs1544777	rs1363907	0.955961893072307	Crohn's disease	1e-14	28067908
rs1544777	rs716848	0.925759800001742	Neutrophil percentage of white cells	2e-09	32888494
rs1544777	rs2548532	0.863440763302988	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1544777	rs27660	0.794956192680947	Coronary artery disease	3e-08	35915156
rs1544777	rs1423357	0.793194479976656	General cognitive ability	9e-06	29844566
rs1544777	rs38033	0.783849217553313	Blood protein levels	0	30072576
rs1544777	rs2432142	0.782614330577445	Neutrophil count	2e-14	32888493
rs1544777	rs2432142	0.782614330577445	White blood cell count	1e-11	32888493
rs1544777	rs27293	0.765989355881724	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1544777	rs27293	0.765989355881724	Diastolic blood pressure	3e-11	35762941
rs1544777	rs7705093	0.759455557697934	Birdshot chorioretinopathy	2e-09	24957906
rs1544777	rs4869313	0.697763192072908	Pediatric autoimmune diseases	9e-08	26301688
rs1544777	rs2927608	0.696652145864368	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1544777	rs2927608	0.696652145864368	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1544777	rs2927608	0.696652145864368	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1544777	rs2910686	0.694348733287004	Neutrophil count	4e-14	32888493
rs1544777	rs2910686	0.694348733287004	Psoriasis	2e-08	23143594
rs1544777	rs2910686	0.694348733287004	Ankylosing spondylitis	5e-17	23749187
rs1544777	rs2910686	0.694348733287004	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1544777	rs1559359	0.635257207141491	Diastolic blood pressure	7e-10	34594039
rs1544777	rs1974871	0.626327746257714	Granulysin levels	5e-13	34648354
rs1544777	rs2549797	0.618586993960692	Systolic blood pressure	7e-07	33230300
rs1544777	rs2549797	0.618586993960692	Diastolic blood pressure	1e-14	33230300
rs1544777	rs2549797	0.618586993960692	Diastolic blood pressure	3e-11	33230300
rs1544777	rs2549797	0.618586993960692	Systolic blood pressure	4e-09	33230300
rs1544777	rs2549782	0.617581201372622	Systolic blood pressure	6e-07	33230300
rs1544777	rs2549782	0.617581201372622	Diastolic blood pressure	1e-14	33230300
rs1544777	rs2549782	0.617581201372622	Diastolic blood pressure	3e-11	33230300
rs1544777	rs2549782	0.617581201372622	Systolic blood pressure	5e-09	33230300
rs1544777	rs1056893	0.617078978915086	Systolic blood pressure	1e-06	33230300
rs1544777	rs1056893	0.617078978915086	Diastolic blood pressure	7e-15	33230300
rs1544777	rs1056893	0.617078978915086	Diastolic blood pressure	2e-11	33230300
rs1544777	rs1056893	0.617078978915086	Systolic blood pressure	7e-09	33230300
rs1547022	rs1467510	0.690684421295881	Platelet distribution width	1e-14	32888494
rs1547022	rs12276109	0.621364951617028	Severe COVID-19 infection	6e-08	36662838
rs155055	rs155060	0.729817524642767	Body mass index	3e-10	36581621
rs1556138	rs10970975	0.817139209954068	Red blood cell count	9e-14	34594039
rs1556138	rs10970975	0.817139209954068	Red blood cell count	6e-21	30595370
rs1556138	rs10970976	0.787606070942434	Asthma	4e-06	22561531
rs1557866	rs1557866	1	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs1557866	rs1293767	0.897639450963228	Adult asthma	2e-06	27611488
rs1557866	rs1293767	0.897639450963228	Adult asthma	9e-07	27611488
rs1557866	rs6489882	0.64174960194697	Chronic lymphocytic leukemia	5e-08	28165464
rs1557866	rs1859336	0.61982849623932	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1557866	rs10744789	0.610025075807648	Vitamin D levels or COVID-19 (MTAG)	5e-12	37212302
rs1557866	rs4767027	0.6033381828865	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1557866	rs2057778	0.600481748899161	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1557866	rs2057778	0.600481748899161	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1557866	rs2057778	0.600481748899161	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1558183	rs1079558	0.874248219981672	White matter microstructure (fractional anisotropy)	3e-08	31666681
rs1558183	rs1079558	0.874248219981672	Age of smoking initiation	3e-10	36477530
rs1558183	rs9745545	0.681880571618026	Neuroblastoma or malignant cutaneous melanoma	1e-12	31605138
rs1559354	rs1974871	0.91585488420033	Granulysin levels	5e-13	34648354
rs1559354	rs4869314	0.904083249088078	Arthritis (juvenile idiopathic)	3e-09	33106285
rs1559354	rs4869314	0.904083249088078	Neutrophil count	1e-10	34594039
rs1559354	rs4869314	0.904083249088078	White blood cell count	2e-07	30595370
rs1559354	rs2549782	0.849350553468495	Systolic blood pressure	6e-07	33230300
rs1559354	rs2549782	0.849350553468495	Diastolic blood pressure	1e-14	33230300
rs1559354	rs2549782	0.849350553468495	Diastolic blood pressure	3e-11	33230300
rs1559354	rs2549782	0.849350553468495	Systolic blood pressure	5e-09	33230300
rs1559354	rs2549797	0.849336335969296	Systolic blood pressure	7e-07	33230300
rs1559354	rs2549797	0.849336335969296	Diastolic blood pressure	1e-14	33230300
rs1559354	rs2549797	0.849336335969296	Diastolic blood pressure	3e-11	33230300
rs1559354	rs2549797	0.849336335969296	Systolic blood pressure	4e-09	33230300
rs1559354	rs1056893	0.847125009318234	Systolic blood pressure	1e-06	33230300
rs1559354	rs1056893	0.847125009318234	Diastolic blood pressure	7e-15	33230300
rs1559354	rs1056893	0.847125009318234	Diastolic blood pressure	2e-11	33230300
rs1559354	rs1056893	0.847125009318234	Systolic blood pressure	7e-09	33230300
rs1559354	rs4869313	0.828204193776253	Pediatric autoimmune diseases	9e-08	26301688
rs1559354	rs1559359	0.820556275106077	Diastolic blood pressure	7e-10	34594039
rs1559354	rs2910686	0.802434624025319	Neutrophil count	4e-14	32888493
rs1559354	rs2910686	0.802434624025319	Psoriasis	2e-08	23143594
rs1559354	rs2910686	0.802434624025319	Ankylosing spondylitis	5e-17	23749187
rs1559354	rs2910686	0.802434624025319	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1559354	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1559354	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1559354	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1559354	rs1019503	0.728311499553418	Systolic blood pressure	2e-06	33230300
rs1559354	rs1019503	0.728311499553418	Diastolic blood pressure	2e-14	33230300
rs1559354	rs1019503	0.728311499553418	Diastolic blood pressure	4e-11	33230300
rs1559354	rs1019503	0.728311499553418	Systolic blood pressure	1e-08	33230300
rs1559354	rs3096168	0.722779873820606	Aspartate aminotransferase levels	8e-12	33547301
rs1559354	rs1423357	0.704136975909934	General cognitive ability	9e-06	29844566
rs1559354	rs2432142	0.690245044619686	Neutrophil count	2e-14	32888493
rs1559354	rs2432142	0.690245044619686	White blood cell count	1e-11	32888493
rs1559354	rs38033	0.684757433951945	Blood protein levels	0	30072576
rs1559354	rs27293	0.67472868610218	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1559354	rs27293	0.67472868610218	Diastolic blood pressure	3e-11	35762941
rs1559354	rs7705093	0.66601105887613	Birdshot chorioretinopathy	2e-09	24957906
rs1559359	rs1559359	1	Diastolic blood pressure	7e-10	34594039
rs1559359	rs4869313	0.854751919383938	Pediatric autoimmune diseases	9e-08	26301688
rs1559359	rs2910686	0.822080246447415	Neutrophil count	4e-14	32888493
rs1559359	rs2910686	0.822080246447415	Psoriasis	2e-08	23143594
rs1559359	rs2910686	0.822080246447415	Ankylosing spondylitis	5e-17	23749187
rs1559359	rs2910686	0.822080246447415	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1559359	rs2927608	0.820594705404337	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1559359	rs2927608	0.820594705404337	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1559359	rs2927608	0.820594705404337	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1559359	rs1974871	0.762663472344161	Granulysin levels	5e-13	34648354
rs1559359	rs4869314	0.739734471225072	Arthritis (juvenile idiopathic)	3e-09	33106285
rs1559359	rs4869314	0.739734471225072	Neutrophil count	1e-10	34594039
rs1559359	rs4869314	0.739734471225072	White blood cell count	2e-07	30595370
rs1559359	rs2549797	0.723541538378184	Systolic blood pressure	7e-07	33230300
rs1559359	rs2549797	0.723541538378184	Diastolic blood pressure	1e-14	33230300
rs1559359	rs2549797	0.723541538378184	Diastolic blood pressure	3e-11	33230300
rs1559359	rs2549797	0.723541538378184	Systolic blood pressure	4e-09	33230300
rs1559359	rs2549782	0.722243312523596	Systolic blood pressure	6e-07	33230300
rs1559359	rs2549782	0.722243312523596	Diastolic blood pressure	1e-14	33230300
rs1559359	rs2549782	0.722243312523596	Diastolic blood pressure	3e-11	33230300
rs1559359	rs2549782	0.722243312523596	Systolic blood pressure	5e-09	33230300
rs1559359	rs1056893	0.721595073700671	Systolic blood pressure	1e-06	33230300
rs1559359	rs1056893	0.721595073700671	Diastolic blood pressure	7e-15	33230300
rs1559359	rs1056893	0.721595073700671	Diastolic blood pressure	2e-11	33230300
rs1559359	rs1056893	0.721595073700671	Systolic blood pressure	7e-09	33230300
rs1559359	rs1423357	0.717506455015528	General cognitive ability	9e-06	29844566
rs1559359	rs2432142	0.703462362731093	Neutrophil count	2e-14	32888493
rs1559359	rs2432142	0.703462362731093	White blood cell count	1e-11	32888493
rs1559359	rs38033	0.698653917116328	Blood protein levels	0	30072576
rs1559359	rs7705093	0.688557140232811	Birdshot chorioretinopathy	2e-09	24957906
rs1559359	rs27293	0.688378940896262	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1559359	rs27293	0.688378940896262	Diastolic blood pressure	3e-11	35762941
rs1559359	rs2549794	0.655723501015219	Crohn's disease	1e-10	21102463
rs1559359	rs2549794	0.655723501015219	Systolic blood pressure	1e-07	33230300
rs1559359	rs2549794	0.655723501015219	Diastolic blood pressure	1e-15	33230300
rs1559359	rs2549794	0.655723501015219	Diastolic blood pressure	2e-12	33230300
rs1559359	rs2549794	0.655723501015219	Systolic blood pressure	4e-10	33230300
rs1559359	rs1363907	0.651421821858804	Crohn's disease	4e-16	26192919
rs1559359	rs1363907	0.651421821858804	Ulcerative colitis	4e-06	26192919
rs1559359	rs1363907	0.651421821858804	Inflammatory bowel disease	5e-15	26192919
rs1559359	rs1363907	0.651421821858804	Inflammatory bowel disease	6e-13	23128233
rs1559359	rs1363907	0.651421821858804	Inflammatory bowel disease	1e-10	28067908
rs1559359	rs1363907	0.651421821858804	Crohn's disease	1e-14	28067908
rs1559359	rs2617439	0.622613267458013	Neutrophil count	8e-11	32888494
rs1559359	rs38029	0.611661944560565	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1559359	rs716848	0.605543950624869	Neutrophil percentage of white cells	2e-09	32888494
rs1565497	rs10922476	0.995079646664606	Corneal resistance factor	4e-17	33311554
rs1565497	rs12145922	0.995079646664606	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs1565497	rs12145922	0.995079646664606	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs1565497	rs3806340	0.995079646664606	Corneal resistance factor (MTAG)	3e-18	35446358
rs1565497	rs3806340	0.995079646664606	Height	1e-12	35831902
rs1565497	rs3806340	0.995079646664606	Height	7e-17	36224396
rs1565497	rs3806340	0.995079646664606	Height	3e-47	36224396
rs1565497	rs1002436	0.792545384220523	Red blood cell count	4e-22	32888493
rs1565497	rs1002436	0.792545384220523	Alanine aminotransferase levels	6e-11	33547301
rs1565497	rs1002436	0.792545384220523	Aspartate aminotransferase levels	1e-20	33547301
rs1565497	rs1002436	0.792545384220523	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs1565497	rs12145712	0.766218334792046	Pulse pressure	1e-10	35762941
rs1565497	rs4233334	0.744778775400741	Body surface area	6e-09	36502284
rs1565497	rs786906	0.735983786533467	Systolic blood pressure	1e-06	27618447
rs1565497	rs786906	0.735983786533467	Intraocular pressure	5e-09	29617998
rs1565497	rs12021820	0.734000572241907	Mean corpuscular hemoglobin	2e-11	32888493
rs1565497	rs10801682	0.73260632548694	Mean corpuscular hemoglobin	1e-09	30595370
rs1565497	rs7551732	0.710836560107885	Height	6e-20	25282103
rs1565497	rs7551732	0.710836560107885	Gamma glutamyl transferase levels	5e-08	33339817
rs1565497	rs6699417	0.655640820784056	Height	5e-09	20881960
rs1565497	rs6699417	0.655640820784056	Height	2e-11	35831902
rs1565497	rs6699417	0.655640820784056	Height	1e-300	36224396
rs1565497	rs6699417	0.655640820784056	Height	1e-300	36224396
rs1565498	rs10922476	0.995079646664606	Corneal resistance factor	4e-17	33311554
rs1565498	rs12145922	0.995079646664606	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs1565498	rs12145922	0.995079646664606	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs1565498	rs3806340	0.995079646664606	Corneal resistance factor (MTAG)	3e-18	35446358
rs1565498	rs3806340	0.995079646664606	Height	1e-12	35831902
rs1565498	rs3806340	0.995079646664606	Height	7e-17	36224396
rs1565498	rs3806340	0.995079646664606	Height	3e-47	36224396
rs1565498	rs1002436	0.792545384220523	Red blood cell count	4e-22	32888493
rs1565498	rs1002436	0.792545384220523	Alanine aminotransferase levels	6e-11	33547301
rs1565498	rs1002436	0.792545384220523	Aspartate aminotransferase levels	1e-20	33547301
rs1565498	rs1002436	0.792545384220523	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs1565498	rs12145712	0.766218334792046	Pulse pressure	1e-10	35762941
rs1565498	rs4233334	0.744778775400741	Body surface area	6e-09	36502284
rs1565498	rs786906	0.735983786533467	Systolic blood pressure	1e-06	27618447
rs1565498	rs786906	0.735983786533467	Intraocular pressure	5e-09	29617998
rs1565498	rs12021820	0.734000572241907	Mean corpuscular hemoglobin	2e-11	32888493
rs1565498	rs10801682	0.73260632548694	Mean corpuscular hemoglobin	1e-09	30595370
rs1565498	rs7551732	0.710836560107885	Height	6e-20	25282103
rs1565498	rs7551732	0.710836560107885	Gamma glutamyl transferase levels	5e-08	33339817
rs1565498	rs6699417	0.655640820784056	Height	5e-09	20881960
rs1565498	rs6699417	0.655640820784056	Height	2e-11	35831902
rs1565498	rs6699417	0.655640820784056	Height	1e-300	36224396
rs1565498	rs6699417	0.655640820784056	Height	1e-300	36224396
rs1570284	rs11144225	0.859812519133059	Nicotinamide riboside kinase 1 levels	3e-133	34648354
rs1570690	rs11580836	0.951705831060347	Body mass index	2e-09	36581621
rs1570690	rs10465746	0.930293950271114	Obesity-related traits	8e-06	23251661
rs1570691	rs11580836	0.846559157288458	Body mass index	2e-09	36581621
rs1570691	rs10465746	0.824654291712291	Obesity-related traits	8e-06	23251661
rs1571956	rs1571956	1	Neutrophil count	1e-11	32888493
rs1571956	rs2482820	0.984059709108457	Monocyte count	9e-13	32888494
rs1571956	rs2482819	0.980728850240957	Neutrophil count	4e-10	32888493
rs1571956	rs2689216	0.95096450383159	Platelet count	2e-22	32888493
rs1571956	rs2689216	0.95096450383159	Platelet count	1e-21	32888493
rs1571956	rs2795863	0.918320241565425	Height	3e-20	36224396
rs1571956	rs2488010	0.869175537786209	Monocyte count	9e-16	32888493
rs1571956	rs2462021	0.868407679849885	Suicide risk	8e-06	21041247
rs1571956	rs2462017	0.85023785171218	Lymphocyte count	3e-12	32888493
rs1571956	rs503598	0.808321465095278	White blood cell count	2e-08	30595370
rs1571956	rs2795857	0.694889903177436	Height	2e-123	36224396
rs1571956	rs1332618	0.672018672733402	Platelet count	4e-15	32888494
rs1571956	rs2091084	0.650573086325918	White blood cell count	6e-19	32888493
rs1571956	rs2091084	0.650573086325918	Lymphocyte count	3e-10	32888494
rs1571956	rs2091084	0.650573086325918	White blood cell count	4e-13	32888494
rs1571956	rs2462015	0.6030804340141	White blood cell count	5e-17	32888493
rs1574108	rs10256972	0.715759674186961	Endometriosis	3e-06	27506219
rs1574108	rs10256972	0.715759674186961	Longevity	1e-06	20834067
rs1574108	rs10951594	0.6730845428247	Mean corpuscular volume	7e-15	32888493
rs1574108	rs10951594	0.6730845428247	Resistance to COVID-19 infection (Exposed negative vs positive)	2e-17	36662838
rs1578557	rs770199	0.889053956235553	Hair color	3e-08	30595370
rs1578558	rs770199	0.886211894290065	Hair color	3e-08	30595370
rs158623	rs158796	0.97824691413735	Height	5e-243	36224396
rs158623	rs292172	0.95000844681783	Appendicular lean mass	8e-13	31761296
rs158623	rs158622	0.946843653046654	Height	4e-15	36224396
rs158623	rs301901	0.935452362235291	Height	4e-16	25282103
rs158623	rs301901	0.935452362235291	Height	2e-06	35831902
rs158623	rs300053	0.895637013400766	Height	3e-11	34594039
rs158623	rs300053	0.895637013400766	Height	3e-36	34594039
rs158623	rs300053	0.895637013400766	Height	2e-14	31562340
rs158623	rs158791	0.894546256807503	Height	2e-31	36224396
rs158623	rs292168	0.865217822178562	Red cell distribution width	3e-10	30595370
rs158623	rs300046	0.852385928888223	Meat-related diet	5e-08	32066663
rs158791	rs158791	1	Height	2e-31	36224396
rs158791	rs292168	0.924833496273835	Red cell distribution width	3e-10	30595370
rs158791	rs300046	0.923428793308635	Meat-related diet	5e-08	32066663
rs158791	rs158796	0.911435719559204	Height	5e-243	36224396
rs158791	rs292172	0.910654105266378	Appendicular lean mass	8e-13	31761296
rs158791	rs301901	0.90411108417463	Height	4e-16	25282103
rs158791	rs301901	0.90411108417463	Height	2e-06	35831902
rs158791	rs158622	0.854022207355334	Height	4e-15	36224396
rs158791	rs300053	0.821836487847451	Height	3e-11	34594039
rs158791	rs300053	0.821836487847451	Height	3e-36	34594039
rs158791	rs300053	0.821836487847451	Height	2e-14	31562340
rs158796	rs158796	1	Height	5e-243	36224396
rs158796	rs292172	0.968209072821377	Appendicular lean mass	8e-13	31761296
rs158796	rs301901	0.953083202107179	Height	4e-16	25282103
rs158796	rs301901	0.953083202107179	Height	2e-06	35831902
rs158796	rs158622	0.927823036119609	Height	4e-15	36224396
rs158796	rs158791	0.911435719559204	Height	2e-31	36224396
rs158796	rs292168	0.880057488069896	Red cell distribution width	3e-10	30595370
rs158796	rs300053	0.87685065265463	Height	3e-11	34594039
rs158796	rs300053	0.87685065265463	Height	3e-36	34594039
rs158796	rs300053	0.87685065265463	Height	2e-14	31562340
rs158796	rs300046	0.868318659654523	Meat-related diet	5e-08	32066663
rs158803	rs158791	0.94987211019682	Height	2e-31	36224396
rs158803	rs292168	0.938784522913763	Red cell distribution width	3e-10	30595370
rs158803	rs158796	0.914362214284923	Height	5e-243	36224396
rs158803	rs292172	0.900768734705151	Appendicular lean mass	8e-13	31761296
rs158803	rs300046	0.900270884648856	Meat-related diet	5e-08	32066663
rs158803	rs301901	0.883957386874809	Height	4e-16	25282103
rs158803	rs301901	0.883957386874809	Height	2e-06	35831902
rs158803	rs158622	0.855863419565501	Height	4e-15	36224396
rs158803	rs300053	0.806491509003587	Height	3e-11	34594039
rs158803	rs300053	0.806491509003587	Height	3e-36	34594039
rs158803	rs300053	0.806491509003587	Height	2e-14	31562340
rs159751	rs158796	0.949197141910363	Height	5e-243	36224396
rs159751	rs301901	0.939585938472768	Height	4e-16	25282103
rs159751	rs301901	0.939585938472768	Height	2e-06	35831902
rs159751	rs292172	0.931192029549771	Appendicular lean mass	8e-13	31761296
rs159751	rs158622	0.926529454767772	Height	4e-15	36224396
rs159751	rs158791	0.908335969614177	Height	2e-31	36224396
rs159751	rs300053	0.90783399642305	Height	3e-11	34594039
rs159751	rs300053	0.90783399642305	Height	3e-36	34594039
rs159751	rs300053	0.90783399642305	Height	2e-14	31562340
rs159751	rs300046	0.853245257203075	Meat-related diet	5e-08	32066663
rs159751	rs292168	0.847110518967789	Red cell distribution width	3e-10	30595370
rs159753	rs158796	0.978064421104278	Height	5e-243	36224396
rs159753	rs301901	0.967992101347294	Height	4e-16	25282103
rs159753	rs301901	0.967992101347294	Height	2e-06	35831902
rs159753	rs292172	0.956632250061559	Appendicular lean mass	8e-13	31761296
rs159753	rs158791	0.925941407472719	Height	2e-31	36224396
rs159753	rs158622	0.918307383318219	Height	4e-15	36224396
rs159753	rs300053	0.891036896749027	Height	3e-11	34594039
rs159753	rs300053	0.891036896749027	Height	3e-36	34594039
rs159753	rs300053	0.891036896749027	Height	2e-14	31562340
rs159753	rs300046	0.87914152011285	Meat-related diet	5e-08	32066663
rs159753	rs292168	0.868553892925781	Red cell distribution width	3e-10	30595370
rs159882	rs149359	0.893289110042922	Skin color	4e-10	36672889
rs159882	rs149359	0.893289110042922	Skin phototype score	4e-09	36672889
rs1602251	rs10788817	0.887152488307341	Serum metabolite levels	3e-13	24625756
rs1602251	rs10788817	0.887152488307341	Metabolite peak levels (QI2718)	5e-18	35995766
rs1602251	rs10788817	0.887152488307341	3-hydroxylaurate levels	2e-12	36635386
rs1602251	rs10788817	0.887152488307341	Tetradecadienoate (14:2) levels	8e-17	36635386
rs1602251	rs11204914	0.882063435666427	Carnitine C9 levels	1e-13	35995766
rs1602251	rs11204914	0.882063435666427	Metabolite peak levels (QI6204)	1e-32	35995766
rs1602251	rs11204914	0.882063435666427	Metabolite peak levels (QI6252)	2e-32	35995766
rs1602251	rs6685187	0.85610023726755	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs1602251	rs6698740	0.853883001397781	Beta-hydroxyisovalerate levels	1e-13	35347128
rs1602251	rs1060870	0.85237262443814	Serum metabolite levels	1e-11	33031748
rs1602251	rs1060870	0.85237262443814	Serum metabolite levels	1e-15	33031748
rs1602251	rs2999541	0.849980868523861	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs1602251	rs3007711	0.846229205742287	Electrodermal activity	9e-06	25387706
rs1602251	rs2338201	0.841776693684887	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs1602251	rs2338201	0.841776693684887	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs1602251	rs2338201	0.841776693684887	Dodecadienoate (12:2) levels	7e-15	36635386
rs1602251	rs2130525	0.784187811659796	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs1602251	rs2999545	0.784011407787411	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs1602251	rs2279501	0.76453695650941	Serum metabolite levels	3e-14	33031748
rs1602251	rs7523082	0.710968748996342	Metabolite peak levels (QI9845)	2e-14	35995766
rs1602251	rs7542137	0.710486250887858	Beta-hydroxyisovalerate levels	3e-11	35050183
rs1602251	rs7542137	0.710486250887858	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs1602251	rs7542137	0.710486250887858	3-hydroxysebacate levels	2e-10	36635386
rs1602251	rs10888445	0.708009308420614	Beta-hydroxyisovalerate levels	5e-13	36635386
rs1602251	rs7541453	0.703909948322554	Serum metabolite levels	2e-16	33031748
rs1602251	rs7541453	0.703909948322554	Serum metabolite levels	2e-16	33031748
rs1602251	rs7541453	0.703909948322554	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs1602251	rs1038747	0.649441651807721	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs1602251	rs10494270	0.642850688408298	Nonaylcarnitine levels	5e-13	26068415
rs1602251	rs9943221	0.636240228601284	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs1602251	rs56000812	0.601541519240516	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs1611989	rs1613778	1	Total bilirubin levels	3e-08	34594039
rs1611989	rs480293	0.935626834667536	Oily fish consumption	4e-11	32193382
rs1611989	rs34634095	0.910919530370342	Fish- and plant-related diet	3e-09	32066663
rs1611989	rs542831	0.855065397973158	Asthma	5e-13	31361310
rs1611989	rs1784776	0.852577939792858	Asthma	2e-09	32296059
rs1611989	rs1784775	0.852577939792858	Asthma	2e-09	30929738
rs1611989	rs1784775	0.852577939792858	Asthma (adult onset)	6e-09	30929738
rs1611989	rs1789358	0.851068015632425	Asthma	2e-08	34103634
rs1611989	rs539524	0.848778527435129	Asthma	1e-10	32296059
rs1611989	rs12791699	0.816470622573358	Pork consumption	9e-09	32066663
rs1611989	rs12791699	0.816470622573358	Oily fish consumption	9e-09	32066663
rs1611989	rs487985	0.816470622573358	Highest math class taken	1e-08	30038396
rs1611989	rs10891286	0.803235505342935	Noncognitive aspects of educational attainment	5e-10	33414549
rs1611989	rs4459340	0.799235235999553	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs1611989	rs659529	0.766416744414889	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs1611989	rs659529	0.766416744414889	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs1611989	rs659529	0.766416744414889	Atopic dermatitis	5e-10	34116867
rs1611989	rs505372	0.741485181382245	Breast cancer	3e-06	29059683
rs1611989	rs505372	0.741485181382245	Medication use (beta blocking agents)	2e-08	34594039
rs1611989	rs9734135	0.717281787131826	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs1611989	rs663763	0.612843736118845	Layilin levels	3e-21	36168886
rs1611989	rs11213941	0.611238840223634	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs1611989	rs11213941	0.611238840223634	Eczema	8e-14	30595370
rs1612013	rs1613778	0.995641508028598	Total bilirubin levels	3e-08	34594039
rs1612013	rs480293	0.939795705608453	Oily fish consumption	4e-11	32193382
rs1612013	rs34634095	0.906743581377472	Fish- and plant-related diet	3e-09	32066663
rs1612013	rs542831	0.857515088862161	Asthma	5e-13	31361310
rs1612013	rs1784776	0.855029059161452	Asthma	2e-09	32296059
rs1612013	rs1784775	0.855029059161452	Asthma	2e-09	30929738
rs1612013	rs1784775	0.855029059161452	Asthma (adult onset)	6e-09	30929738
rs1612013	rs1789358	0.853512156754139	Asthma	2e-08	34103634
rs1612013	rs539524	0.851090370924141	Asthma	1e-10	32296059
rs1612013	rs12791699	0.818897522730267	Pork consumption	9e-09	32066663
rs1612013	rs12791699	0.818897522730267	Oily fish consumption	9e-09	32066663
rs1612013	rs487985	0.818897522730267	Highest math class taken	1e-08	30038396
rs1612013	rs10891286	0.80569039530531	Noncognitive aspects of educational attainment	5e-10	33414549
rs1612013	rs4459340	0.801692276095933	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs1612013	rs659529	0.768853852762703	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs1612013	rs659529	0.768853852762703	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs1612013	rs659529	0.768853852762703	Atopic dermatitis	5e-10	34116867
rs1612013	rs505372	0.743953256048904	Breast cancer	3e-06	29059683
rs1612013	rs505372	0.743953256048904	Medication use (beta blocking agents)	2e-08	34594039
rs1612013	rs9734135	0.719786539926058	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs1612013	rs663763	0.614823059823583	Layilin levels	3e-21	36168886
rs1612013	rs11213941	0.613747222873401	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs1612013	rs11213941	0.613747222873401	Eczema	8e-14	30595370
rs1613778	rs1613778	1	Total bilirubin levels	3e-08	34594039
rs1613778	rs480293	0.935626834667536	Oily fish consumption	4e-11	32193382
rs1613778	rs34634095	0.910919530370342	Fish- and plant-related diet	3e-09	32066663
rs1613778	rs542831	0.855065397973158	Asthma	5e-13	31361310
rs1613778	rs1784776	0.852577939792858	Asthma	2e-09	32296059
rs1613778	rs1784775	0.852577939792858	Asthma	2e-09	30929738
rs1613778	rs1784775	0.852577939792858	Asthma (adult onset)	6e-09	30929738
rs1613778	rs1789358	0.851068015632425	Asthma	2e-08	34103634
rs1613778	rs539524	0.848778527435129	Asthma	1e-10	32296059
rs1613778	rs12791699	0.816470622573358	Pork consumption	9e-09	32066663
rs1613778	rs12791699	0.816470622573358	Oily fish consumption	9e-09	32066663
rs1613778	rs487985	0.816470622573358	Highest math class taken	1e-08	30038396
rs1613778	rs10891286	0.803235505342935	Noncognitive aspects of educational attainment	5e-10	33414549
rs1613778	rs4459340	0.799235235999553	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs1613778	rs659529	0.766416744414889	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs1613778	rs659529	0.766416744414889	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs1613778	rs659529	0.766416744414889	Atopic dermatitis	5e-10	34116867
rs1613778	rs505372	0.741485181382245	Breast cancer	3e-06	29059683
rs1613778	rs505372	0.741485181382245	Medication use (beta blocking agents)	2e-08	34594039
rs1613778	rs9734135	0.717281787131826	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs1613778	rs663763	0.612843736118845	Layilin levels	3e-21	36168886
rs1613778	rs11213941	0.611238840223634	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs1613778	rs11213941	0.611238840223634	Eczema	8e-14	30595370
rs1615070	rs11685226	0.970916612096567	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1615070	rs11685226	0.970916612096567	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1615070	rs7558954	0.969272510658424	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1615070	rs1177308	0.963491898400568	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1615070	rs1177308	0.963491898400568	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1615070	rs777587	0.810632025902868	Proteoglycan 3 levels	6e-29	34648354
rs1615070	rs777587	0.810632025902868	Pappalysin-1 levels	1e-25	34648354
rs1615070	rs12617371	0.76818674698558	Immature fraction of reticulocytes	8e-18	32888494
rs1615070	rs2463097	0.734945910142622	White blood cell count	3e-26	30595370
rs1615070	rs2593620	0.711063531583193	Serum levels of protein PRG3	5e-14	35078996
rs1615070	rs10199672	0.703563795953125	Height	6e-12	34594039
rs1615070	rs10199672	0.703563795953125	Height	2e-12	31562340
rs1615070	rs2421200	0.682880622029249	Neutrophil count	1e-26	32888493
rs1615070	rs2421200	0.682880622029249	Neutrophil count	1e-25	32888493
rs1615070	rs10169482	0.632555507814284	C-reactive protein levels	4e-09	33462484
rs1615070	rs12616433	0.608803284923184	Eosinophil forward scatter	4e-13	37596262
rs1615070	rs12616433	0.608803284923184	Eosinophil side scatter	2e-18	37596262
rs1619652	rs480293	0.99225697965895	Oily fish consumption	4e-11	32193382
rs1619652	rs1613778	0.934611508845756	Total bilirubin levels	3e-08	34594039
rs1619652	rs34634095	0.929366334960265	Fish- and plant-related diet	3e-09	32066663
rs1619652	rs542831	0.913698996544353	Asthma	5e-13	31361310
rs1619652	rs1784776	0.911212003515555	Asthma	2e-09	32296059
rs1619652	rs1784775	0.911212003515555	Asthma	2e-09	30929738
rs1619652	rs1784775	0.911212003515555	Asthma (adult onset)	6e-09	30929738
rs1619652	rs1789358	0.909566054826951	Asthma	2e-08	34103634
rs1619652	rs539524	0.903343068014232	Asthma	1e-10	32296059
rs1619652	rs12791699	0.874327782371777	Pork consumption	9e-09	32066663
rs1619652	rs12791699	0.874327782371777	Oily fish consumption	9e-09	32066663
rs1619652	rs487985	0.874327782371777	Highest math class taken	1e-08	30038396
rs1619652	rs10891286	0.851773045021498	Noncognitive aspects of educational attainment	5e-10	33414549
rs1619652	rs4459340	0.847787126942338	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs1619652	rs505372	0.79932158988023	Breast cancer	3e-06	29059683
rs1619652	rs505372	0.79932158988023	Medication use (beta blocking agents)	2e-08	34594039
rs1619652	rs659529	0.795655993833724	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs1619652	rs659529	0.795655993833724	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs1619652	rs659529	0.795655993833724	Atopic dermatitis	5e-10	34116867
rs1619652	rs9734135	0.764644888597933	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs1619652	rs11213941	0.642164905176561	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs1619652	rs11213941	0.642164905176561	Eczema	8e-14	30595370
rs1619652	rs663763	0.638848672607051	Layilin levels	3e-21	36168886
rs166170	rs10061757	0.927259013515129	Height	4e-30	30595370
rs166170	rs33321	0.77967818063589	Height	1e-19	34594039
rs166170	rs832540	0.754911322232783	Coronary artery disease	2e-08	29212778
rs166170	rs702689	0.628898967929742	Vertex-wise sulcal depth	2e-22	34910505
rs166170	rs96844	0.600070235524345	Type 2 diabetes	5e-08	30297969
rs166170	rs96844	0.600070235524345	Height	4e-33	36224396
rs1665258	rs1177308	0.902428703117223	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665258	rs1177308	0.902428703117223	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665258	rs7558954	0.900260887006433	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665258	rs11685226	0.875168329373703	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1665258	rs11685226	0.875168329373703	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665258	rs777587	0.733264746729499	Proteoglycan 3 levels	6e-29	34648354
rs1665258	rs777587	0.733264746729499	Pappalysin-1 levels	1e-25	34648354
rs1665258	rs12617371	0.693502912580375	Immature fraction of reticulocytes	8e-18	32888494
rs1665258	rs2463097	0.663453079578804	White blood cell count	3e-26	30595370
rs1665258	rs2593620	0.636565658960749	Serum levels of protein PRG3	5e-14	35078996
rs1665258	rs10199672	0.631023054010593	Height	6e-12	34594039
rs1665258	rs10199672	0.631023054010593	Height	2e-12	31562340
rs1665258	rs2421200	0.611304164342667	Neutrophil count	1e-26	32888493
rs1665258	rs2421200	0.611304164342667	Neutrophil count	1e-25	32888493
rs1665262	rs1177308	0.895170196261031	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665262	rs1177308	0.895170196261031	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665262	rs7558954	0.893012900599568	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665262	rs11685226	0.871183354202846	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1665262	rs11685226	0.871183354202846	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665262	rs777587	0.729629094007786	Proteoglycan 3 levels	6e-29	34648354
rs1665262	rs777587	0.729629094007786	Pappalysin-1 levels	1e-25	34648354
rs1665262	rs12617371	0.692758392508348	Immature fraction of reticulocytes	8e-18	32888494
rs1665262	rs2463097	0.662716068441559	White blood cell count	3e-26	30595370
rs1665262	rs2593620	0.63587143053943	Serum levels of protein PRG3	5e-14	35078996
rs1665262	rs10199672	0.630322442312136	Height	6e-12	34594039
rs1665262	rs10199672	0.630322442312136	Height	2e-12	31562340
rs1665262	rs2421200	0.610632204365707	Neutrophil count	1e-26	32888493
rs1665262	rs2421200	0.610632204365707	Neutrophil count	1e-25	32888493
rs1665263	rs1177308	0.894340796249947	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665263	rs1177308	0.894340796249947	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665263	rs7558954	0.892183423847849	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665263	rs11685226	0.868789984347657	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1665263	rs11685226	0.868789984347657	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665263	rs777587	0.728859461096563	Proteoglycan 3 levels	6e-29	34648354
rs1665263	rs777587	0.728859461096563	Pappalysin-1 levels	1e-25	34648354
rs1665263	rs12617371	0.692014692743524	Immature fraction of reticulocytes	8e-18	32888494
rs1665263	rs2463097	0.663339447727045	White blood cell count	3e-26	30595370
rs1665263	rs2593620	0.636518868819651	Serum levels of protein PRG3	5e-14	35078996
rs1665263	rs10199672	0.630953574903168	Height	6e-12	34594039
rs1665263	rs10199672	0.630953574903168	Height	2e-12	31562340
rs1665263	rs2421200	0.611277488881856	Neutrophil count	1e-26	32888493
rs1665263	rs2421200	0.611277488881856	Neutrophil count	1e-25	32888493
rs1665271	rs1177308	0.896609665461903	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665271	rs1177308	0.896609665461903	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665271	rs7558954	0.894441305793463	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665271	rs11685226	0.869493445136184	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1665271	rs11685226	0.869493445136184	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665271	rs777587	0.729304642086665	Proteoglycan 3 levels	6e-29	34648354
rs1665271	rs777587	0.729304642086665	Pappalysin-1 levels	1e-25	34648354
rs1665271	rs12617371	0.693875807367962	Immature fraction of reticulocytes	8e-18	32888494
rs1665271	rs2463097	0.663739678817039	White blood cell count	3e-26	30595370
rs1665271	rs2593620	0.637076626988583	Serum levels of protein PRG3	5e-14	35078996
rs1665271	rs10199672	0.631449631518405	Height	6e-12	34594039
rs1665271	rs10199672	0.631449631518405	Height	2e-12	31562340
rs1665271	rs2421200	0.611873162791824	Neutrophil count	1e-26	32888493
rs1665271	rs2421200	0.611873162791824	Neutrophil count	1e-25	32888493
rs1665273	rs1177308	0.89583458498073	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665273	rs1177308	0.89583458498073	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1665273	rs7558954	0.893668955608421	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665273	rs11685226	0.868719536109931	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1665273	rs11685226	0.868719536109931	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1665273	rs777587	0.728643583992974	Proteoglycan 3 levels	6e-29	34648354
rs1665273	rs777587	0.728643583992974	Pappalysin-1 levels	1e-25	34648354
rs1665273	rs12617371	0.693224184897175	Immature fraction of reticulocytes	8e-18	32888494
rs1665273	rs2463097	0.663115285628288	White blood cell count	3e-26	30595370
rs1665273	rs2593620	0.636428159104115	Serum levels of protein PRG3	5e-14	35078996
rs1665273	rs10199672	0.630817499236321	Height	6e-12	34594039
rs1665273	rs10199672	0.630817499236321	Height	2e-12	31562340
rs1665273	rs2421200	0.611226867200355	Neutrophil count	1e-26	32888493
rs1665273	rs2421200	0.611226867200355	Neutrophil count	1e-25	32888493
rs1674974	rs10010659	0.988887402484263	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs1686511	rs4807	0.975580676288281	Height	3e-23	36224396
rs16875540	rs6453397	0.953664239571691	Platelet distribution width	9e-50	32888494
rs16875558	rs56373295	0.750849436424442	Plateletcrit	2e-15	32888494
rs16875558	rs12652692	0.738477840212467	Platelet count	2e-34	32888494
rs16916186	rs6471393	0.612261336952198	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs1699379	rs7655841	0.861736369008099	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699379	rs337277	0.861400548091152	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699379	rs337277	0.861400548091152	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699379	rs337277	0.861400548091152	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699379	rs337277	0.861400548091152	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699379	rs10010659	0.605349449027767	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs1699380	rs337277	0.962663336213969	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699380	rs337277	0.962663336213969	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699380	rs337277	0.962663336213969	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699380	rs337277	0.962663336213969	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699380	rs7655841	0.741137199106036	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699384	rs337277	0.865615068399894	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699384	rs337277	0.865615068399894	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699384	rs337277	0.865615068399894	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699384	rs337277	0.865615068399894	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699384	rs7655841	0.829218447686795	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699385	rs7655841	0.860062671529313	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699385	rs337277	0.8596781148772	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699385	rs337277	0.8596781148772	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699385	rs337277	0.8596781148772	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699385	rs337277	0.8596781148772	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699385	rs10010659	0.604067022865556	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs1699387	rs337277	1	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699387	rs337277	1	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699387	rs337277	1	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699387	rs337277	1	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699387	rs7655841	0.744284009433704	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699388	rs7655841	0.866278520678964	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699388	rs337277	0.8658142170077	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699388	rs337277	0.8658142170077	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699388	rs337277	0.8658142170077	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699388	rs337277	0.8658142170077	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699388	rs10010659	0.609294495593555	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs1699389	rs7655841	0.861736369008099	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699389	rs337277	0.861400548091152	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699389	rs337277	0.861400548091152	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699389	rs337277	0.861400548091152	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699389	rs337277	0.861400548091152	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699389	rs10010659	0.605349449027767	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs1699391	rs7655841	0.861736369008099	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699391	rs337277	0.861400548091152	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699391	rs337277	0.861400548091152	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699391	rs337277	0.861400548091152	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699391	rs337277	0.861400548091152	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699391	rs10010659	0.605349449027767	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs1699392	rs337277	0.914840703008739	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699392	rs337277	0.914840703008739	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699392	rs337277	0.914840703008739	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699392	rs337277	0.914840703008739	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699392	rs7655841	0.737872433479271	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699393	rs337277	0.886080063082448	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699393	rs337277	0.886080063082448	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699393	rs337277	0.886080063082448	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699393	rs337277	0.886080063082448	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699393	rs7655841	0.818354339620477	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1699394	rs337277	0.924899307700967	Metabolite peak levels (QI10992)	3e-52	35995766
rs1699394	rs337277	0.924899307700967	Metabolite peak levels (QI4667)	7e-18	35995766
rs1699394	rs337277	0.924899307700967	Metabolite peak levels (QI4708)	1e-21	35995766
rs1699394	rs337277	0.924899307700967	Metabolite peak levels (QI5169)	7e-57	35995766
rs1699394	rs7655841	0.804426478127461	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1709419	rs337277	0.981244623459218	Metabolite peak levels (QI10992)	3e-52	35995766
rs1709419	rs337277	0.981244623459218	Metabolite peak levels (QI4667)	7e-18	35995766
rs1709419	rs337277	0.981244623459218	Metabolite peak levels (QI4708)	1e-21	35995766
rs1709419	rs337277	0.981244623459218	Metabolite peak levels (QI5169)	7e-57	35995766
rs1709419	rs7655841	0.756210507317289	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1710548	rs400625	0.630547026773898	Posterior-cingulate cortex volume	5e-06	31530798
rs17105613	rs920778	0.647582396617801	Haemorrhoidal disease	7e-10	33888516
rs17205407	rs7162536	0.998348172884859	Height	4e-29	34594039
rs17205407	rs731820	0.961851617196376	Height	2e-13	31562340
rs17205407	rs731820	0.961851617196376	Height	2e-12	35831902
rs17205407	rs11635977	0.958273745691603	Height	2e-25	36224396
rs17205407	rs72749770	0.916135990784348	Low density lipoprotein cholesterol levels	9e-10	32493714
rs17205407	rs72749770	0.916135990784348	Apolipoprotein B levels	2e-09	32203549
rs17205407	rs7178540	0.884514873771189	Height	1e-31	36224396
rs17205407	rs7178424	0.84800226032745	Height	6e-09	20881960
rs17205407	rs7178424	0.84800226032745	Height	6e-13	35831902
rs17205407	rs7178424	0.84800226032745	Height	3e-251	36224396
rs17205407	rs17271431	0.847336151292672	Height	2e-11	34594039
rs17205407	rs17205463	0.844442465394157	Serum levels of protein IGF1	8e-08	27329260
rs17205407	rs17205463	0.844442465394157	Appendicular lean mass	4e-43	33097823
rs17205407	rs17205463	0.844442465394157	Height	2e-35	30595370
rs17205407	rs12901247	0.697915957186433	Insular cortex volume	4e-06	31530798
rs17205407	rs2162062	0.666915802598844	Height	2e-13	35831902
rs17205407	rs1436958	0.650142918666179	IgG glycosylation	9e-06	23382691
rs17205407	rs933807	0.634219779201142	Fat-free mass	6e-06	30593698
rs17205407	rs933807	0.634219779201142	Fat-free mass	2e-07	30593698
rs17205407	rs933807	0.634219779201142	Fat-free mass	8e-11	30593698
rs17255424	rs7321631	0.801347127896291	Varicose veins	3e-08	34594039
rs17255424	rs7321631	0.801347127896291	Varicose veins	1e-08	36653477
rs17255466	rs9547937	0.987465522879599	Serum levels of protein POSTN	6e-18	35078996
rs17255466	rs9603222	0.675798095714415	Blood protein levels	2e-12	30072576
rs17271193	rs13379492	0.934090663291971	Lung function (FEV1/FVC)	6e-08	30595370
rs17271193	rs8034216	0.888449231237703	C-reactive protein levels	2e-10	31900758
rs17271193	rs17271340	0.85286507054685	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs17271193	rs17271305	0.825254367246148	Two-hour glucose challenge	1e-07	20081857
rs17271193	rs35967150	0.820236999263476	C-reactive protein levels (MTAG)	1e-08	36376304
rs17271193	rs11634163	0.813240863283864	C-reactive protein	2e-08	34594039
rs17271193	rs11634163	0.813240863283864	Two-hour glucose	3e-14	34059833
rs17271193	rs189400382	0.810251754957399	C-reactive protein levels	1e-08	35459240
rs17271193	rs28373613	0.678917608733418	Height (standard GWA)	8e-12	37106081
rs17271431	rs17271431	1	Height	2e-11	34594039
rs17271431	rs7178424	0.990765364770238	Height	6e-09	20881960
rs17271431	rs7178424	0.990765364770238	Height	6e-13	35831902
rs17271431	rs7178424	0.990765364770238	Height	3e-251	36224396
rs17271431	rs17205463	0.978215659803776	Serum levels of protein IGF1	8e-08	27329260
rs17271431	rs17205463	0.978215659803776	Appendicular lean mass	4e-43	33097823
rs17271431	rs17205463	0.978215659803776	Height	2e-35	30595370
rs17271431	rs7178540	0.949958310409171	Height	1e-31	36224396
rs17271431	rs731820	0.879398540973023	Height	2e-13	31562340
rs17271431	rs731820	0.879398540973023	Height	2e-12	35831902
rs17271431	rs7162536	0.845892960134514	Height	4e-29	34594039
rs17271431	rs11635977	0.812981988451024	Height	2e-25	36224396
rs17271431	rs72749770	0.77656621133819	Low density lipoprotein cholesterol levels	9e-10	32493714
rs17271431	rs72749770	0.77656621133819	Apolipoprotein B levels	2e-09	32203549
rs17271431	rs2162062	0.657819043591804	Height	2e-13	35831902
rs17271431	rs1436958	0.636170813812933	IgG glycosylation	9e-06	23382691
rs17271431	rs933807	0.623150103884288	Fat-free mass	6e-06	30593698
rs17271431	rs933807	0.623150103884288	Fat-free mass	2e-07	30593698
rs17271431	rs933807	0.623150103884288	Fat-free mass	8e-11	30593698
rs17271438	rs731820	0.924958436710336	Height	2e-13	31562340
rs17271438	rs731820	0.924958436710336	Height	2e-12	35831902
rs17271438	rs17271431	0.904081241617168	Height	2e-11	34594039
rs17271438	rs17205463	0.898005289786883	Serum levels of protein IGF1	8e-08	27329260
rs17271438	rs17205463	0.898005289786883	Appendicular lean mass	4e-43	33097823
rs17271438	rs17205463	0.898005289786883	Height	2e-35	30595370
rs17271438	rs7178424	0.896812701748726	Height	6e-09	20881960
rs17271438	rs7178424	0.896812701748726	Height	6e-13	35831902
rs17271438	rs7178424	0.896812701748726	Height	3e-251	36224396
rs17271438	rs7162536	0.892412932882609	Height	4e-29	34594039
rs17271438	rs11635977	0.871445631310367	Height	2e-25	36224396
rs17271438	rs7178540	0.856983719118021	Height	1e-31	36224396
rs17271438	rs72749770	0.81791280756907	Low density lipoprotein cholesterol levels	9e-10	32493714
rs17271438	rs72749770	0.81791280756907	Apolipoprotein B levels	2e-09	32203549
rs17271438	rs12901247	0.625814935296079	Insular cortex volume	4e-06	31530798
rs1729656	rs1177308	0.824679952163777	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1729656	rs1177308	0.824679952163777	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1729656	rs11685226	0.821714408736567	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1729656	rs11685226	0.821714408736567	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1729656	rs7558954	0.82104962206297	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1729656	rs777587	0.686117370920643	Proteoglycan 3 levels	6e-29	34648354
rs1729656	rs777587	0.686117370920643	Pappalysin-1 levels	1e-25	34648354
rs1729656	rs12617371	0.664154624195433	Immature fraction of reticulocytes	8e-18	32888494
rs1729656	rs2463097	0.647651375033584	White blood cell count	3e-26	30595370
rs1729656	rs10199672	0.611265288749751	Height	6e-12	34594039
rs1729656	rs10199672	0.611265288749751	Height	2e-12	31562340
rs1729656	rs2593620	0.609319985116159	Serum levels of protein PRG3	5e-14	35078996
rs1729671	rs1177308	0.902428703117223	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1729671	rs1177308	0.902428703117223	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1729671	rs7558954	0.900260887006433	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1729671	rs11685226	0.875168329373703	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1729671	rs11685226	0.875168329373703	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1729671	rs777587	0.733264746729499	Proteoglycan 3 levels	6e-29	34648354
rs1729671	rs777587	0.733264746729499	Pappalysin-1 levels	1e-25	34648354
rs1729671	rs12617371	0.693502912580375	Immature fraction of reticulocytes	8e-18	32888494
rs1729671	rs2463097	0.663453079578804	White blood cell count	3e-26	30595370
rs1729671	rs2593620	0.636565658960749	Serum levels of protein PRG3	5e-14	35078996
rs1729671	rs10199672	0.631023054010593	Height	6e-12	34594039
rs1729671	rs10199672	0.631023054010593	Height	2e-12	31562340
rs1729671	rs2421200	0.611304164342667	Neutrophil count	1e-26	32888493
rs1729671	rs2421200	0.611304164342667	Neutrophil count	1e-25	32888493
rs1729673	rs1177308	0.899986428927572	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1729673	rs1177308	0.899986428927572	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1729673	rs7558954	0.899426816836384	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1729673	rs11685226	0.872768455167345	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1729673	rs11685226	0.872768455167345	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1729673	rs777587	0.732492437034431	Proteoglycan 3 levels	6e-29	34648354
rs1729673	rs777587	0.732492437034431	Pappalysin-1 levels	1e-25	34648354
rs1729673	rs12617371	0.69555009390756	Immature fraction of reticulocytes	8e-18	32888494
rs1729673	rs2463097	0.665438424119014	White blood cell count	3e-26	30595370
rs1729673	rs2593620	0.63855640617862	Serum levels of protein PRG3	5e-14	35078996
rs1729673	rs10199672	0.63298755821807	Height	6e-12	34594039
rs1729673	rs10199672	0.63298755821807	Height	2e-12	31562340
rs1729673	rs2421200	0.613268367193869	Neutrophil count	1e-26	32888493
rs1729673	rs2421200	0.613268367193869	Neutrophil count	1e-25	32888493
rs1729674	rs7558954	0.99665601112115	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1729674	rs1177308	0.990817778678033	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1729674	rs1177308	0.990817778678033	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs1729674	rs11685226	0.968489488119513	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs1729674	rs11685226	0.968489488119513	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs1729674	rs777587	0.806752441117639	Proteoglycan 3 levels	6e-29	34648354
rs1729674	rs777587	0.806752441117639	Pappalysin-1 levels	1e-25	34648354
rs1729674	rs12617371	0.768787854000435	Immature fraction of reticulocytes	8e-18	32888494
rs1729674	rs2463097	0.735472666198727	White blood cell count	3e-26	30595370
rs1729674	rs2593620	0.711749987602683	Serum levels of protein PRG3	5e-14	35078996
rs1729674	rs10199672	0.70418487708206	Height	6e-12	34594039
rs1729674	rs10199672	0.70418487708206	Height	2e-12	31562340
rs1729674	rs2421200	0.68360259034643	Neutrophil count	1e-26	32888493
rs1729674	rs2421200	0.68360259034643	Neutrophil count	1e-25	32888493
rs1729674	rs10169482	0.634148754577131	C-reactive protein levels	4e-09	33462484
rs1729674	rs12616433	0.609734723770261	Eosinophil forward scatter	4e-13	37596262
rs1729674	rs12616433	0.609734723770261	Eosinophil side scatter	2e-18	37596262
rs17334303	rs13027560	0.998042386669302	Lung function (FEV1/FVC)	1e-18	30595370
rs17334303	rs12615659	0.826602444507383	Microalbuminuria	1e-06	26631737
rs17334303	rs2084448	0.76896102707848	Lung function (FEV1/FVC)	5e-14	30804560
rs1734343	rs4807	0.632578646874405	Height	3e-23	36224396
rs1734409	rs1734409	1	Type 2 diabetes or peripheral artery disease (MTAG)	2e-08	36042491
rs1734433	rs4807	0.979525916832865	Height	3e-23	36224396
rs1734435	rs4807	0.976592252120443	Height	3e-23	36224396
rs1734436	rs4807	0.992121017996921	Height	3e-23	36224396
rs17350440	rs34402449	0.768216552018244	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs17350440	rs1550057	0.738318927280564	Conduct disorder	4e-06	20585324
rs17350440	rs1550057	0.738318927280564	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs17350440	rs17007017	0.697515023518826	Conduct disorder	7e-06	20585324
rs1737	rs1737	1	Arginine levels	3e-24	35995766
rs1737	rs1739	0.994295207135261	Metabolite peak levels (QI7389)	3e-91	35995766
rs1737	rs942810	0.807918529385487	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs1737	rs942810	0.807918529385487	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs1737	rs942810	0.807918529385487	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs1737	rs942810	0.807918529385487	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs1737	rs942810	0.807918529385487	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs1737	rs942810	0.807918529385487	N6-methyllysine levels (advanced age)	2e-11	37118062
rs1737	rs6584194	0.694178673461821	Metabolite peak levels (QI9680)	2e-135	35995766
rs1737	rs6584194	0.694178673461821	Metabolite peak levels (QI8984)	5e-11	35995766
rs1737	rs6584194	0.694178673461821	X-24736 levels	3e-13	36635386
rs1737	rs4488133	0.630822370850487	Serum metabolite levels	2e-281	23093944
rs1737	rs4488133	0.630822370850487	Serum metabolite levels	1e-27	23093944
rs1737	rs4488133	0.630822370850487	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs1737	rs4488133	0.630822370850487	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs1737	rs4488133	0.630822370850487	Urine X-12112 levels in chronic kidney disease	0	37277652
rs1737	rs4488133	0.630822370850487	X-12093 levels	1e-48	24816252
rs1737	rs4488133	0.630822370850487	X-12092 levels	0	24816252
rs1737	rs11598867	0.63015378370456	Urinary metabolites	1e-307	26352407
rs1737	rs7072216	0.629562263553594	Metabolite levels	8e-15	21931564
rs1737	rs7072216	0.629562263553594	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs1737	rs6584202	0.625890778006308	Obesity-related traits	4e-07	23251661
rs1737	rs10883083	0.621776150568137	N2-acetyl,N6-methyllysine levels	0	35347128
rs1737	rs10883083	0.621776150568137	X-12112 levels	0	35347128
rs1737	rs10883083	0.621776150568137	Arginine levels	1e-16	35347128
rs1737	rs10883083	0.621776150568137	Metabolite peak levels (QI8972)	2e-124	35995766
rs1737	rs10883083	0.621776150568137	Metabolite peak levels (QI5171)	8e-96	35995766
rs1737	rs2147896	0.621776150568137	Urinary metabolites (H-NMR features)	3e-164	24586186
rs1737	rs2147896	0.621776150568137	Urinary metabolites (H-NMR features)	8e-30	24586186
rs1737	rs2147896	0.621776150568137	Urinary metabolites (H-NMR features)	2e-55	24586186
rs1737	rs2147896	0.621776150568137	Urinary metabolites (H-NMR features)	6e-19	24586186
rs1737	rs2147896	0.621776150568137	Urinary metabolites (H-NMR features)	4e-34	24586186
rs1737	rs2147896	0.621776150568137	Trimethylamine levels	4e-144	33283231
rs1737	rs2147896	0.621776150568137	Serum metabolite levels	1e-15	33031748
rs1737	rs2147896	0.621776150568137	Serum metabolite levels	4e-226	33031748
rs1737	rs2147896	0.621776150568137	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs1737	rs2147896	0.621776150568137	Urinary metabolite levels in chronic kidney disease	0	31959995
rs1737	rs2147896	0.621776150568137	Urinary metabolite levels in chronic kidney disease	0	31959995
rs1737	rs2147896	0.621776150568137	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs1737	rs2147896	0.621776150568137	N6-methyllysine levels	3e-198	33437055
rs1737	rs2147896	0.621776150568137	N6-methyllysine levels	0	35347128
rs1737	rs2147896	0.621776150568137	N-methylpipecolate levels	0	35050183
rs1737	rs2147896	0.621776150568137	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs1737	rs2147896	0.621776150568137	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs1737	rs2147896	0.621776150568137	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs1737	rs2147896	0.621776150568137	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1737	rs2147896	0.621776150568137	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs1737	rs2147896	0.621776150568137	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1737	rs2147896	0.621776150568137	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1737	rs2147896	0.621776150568137	X-12092 levels	4e-191	27073872
rs1737	rs2147896	0.621776150568137	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs1737	rs2147896	0.621776150568137	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs1737	rs2147896	0.621776150568137	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs1737	rs2147896	0.621776150568137	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs1737	rs2147896	0.621776150568137	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs1737	rs2147896	0.621776150568137	N6-methyllysine levels (advanced age)	5e-25	37118062
rs1737	rs2147896	0.621776150568137	X-12112 levels	0	36635386
rs1737	rs2147896	0.621776150568137	N6-methyllysine levels	0	36635386
rs1737	rs2147896	0.621776150568137	N6,N6-dimethyllysine levels	0	36635386
rs1737	rs2147896	0.621776150568137	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs1737	rs2147896	0.621776150568137	N2-acetyl,N6-methyllysine levels	0	36635386
rs1737	rs10786415	0.621776150568137	N6,N6-dimethyllysine levels	0	35347128
rs1737	rs10786415	0.621776150568137	N-methylpipecolate levels	0	35347128
rs1737	rs10786415	0.621776150568137	X-25810 levels	4e-11	36635386
rs1737	rs942814	0.621776150568137	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs1737	rs4539242	0.621118010520074	Urinary metabolites (H-NMR features)	2e-20	24586186
rs1737	rs4539242	0.621118010520074	X-24809 levels	4e-67	33177712
rs1737	rs4539242	0.621118010520074	X-24983 levels	8e-59	33177712
rs1737	rs4539242	0.621118010520074	X-12112 levels	4e-63	33177712
rs1737	rs4539242	0.621118010520074	N-methylpipecolate levels	3e-12	33177712
rs1737	rs4539242	0.621118010520074	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs1737	rs4539242	0.621118010520074	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs1737	rs4539242	0.621118010520074	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs1737	rs4539242	0.621118010520074	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs1737	rs4539242	0.621118010520074	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs1737	rs4539242	0.621118010520074	N6-methyllysine levels (advanced age)	5e-25	37118062
rs1737	rs4539242	0.621118010520074	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs1737	rs7905265	0.61855760508477	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs1737	rs7905265	0.61855760508477	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs1737	rs7905265	0.61855760508477	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs1737	rs7905265	0.61855760508477	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1737	rs7905265	0.61855760508477	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs1737	rs7905265	0.61855760508477	N6,N6-dimethyllysine levels	2e-132	35995766
rs1737	rs7905265	0.61855760508477	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs1737	rs10786414	0.611531473653635	ADMA levels	5e-18	35995766
rs17380837	rs17380837	1	Atrial fibrillation	5e-12	30061737
rs17380837	rs17380837	1	Hypertrophic cardiomyopathy (sarcomere negative)	4e-07	33495597
rs17380837	rs17380837	1	Atrial fibrillation (MTAG)	6e-11	35872910
rs17380837	rs113819537	0.909413896140244	Atrial fibrillation	2e-09	29892015
rs17380837	rs113819537	0.909413896140244	Atrial fibrillation	7e-09	29892015
rs17380837	rs113819537	0.909413896140244	Atrial fibrillation/atrial flutter	6e-10	34594039
rs17380837	rs113819537	0.909413896140244	Heart failure (multivariate analysis)	5e-08	36376295
rs17380837	rs113819537	0.909413896140244	Atrial fibrillation	3e-16	36653681
rs1739	rs1739	1	Metabolite peak levels (QI7389)	3e-91	35995766
rs1739	rs1737	0.994295207135261	Arginine levels	3e-24	35995766
rs1739	rs942810	0.808660459174245	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs1739	rs942810	0.808660459174245	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs1739	rs942810	0.808660459174245	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs1739	rs942810	0.808660459174245	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs1739	rs942810	0.808660459174245	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs1739	rs942810	0.808660459174245	N6-methyllysine levels (advanced age)	2e-11	37118062
rs1739	rs6584194	0.694891528620875	Metabolite peak levels (QI9680)	2e-135	35995766
rs1739	rs6584194	0.694891528620875	Metabolite peak levels (QI8984)	5e-11	35995766
rs1739	rs6584194	0.694891528620875	X-24736 levels	3e-13	36635386
rs1739	rs4488133	0.631529425313549	Serum metabolite levels	2e-281	23093944
rs1739	rs4488133	0.631529425313549	Serum metabolite levels	1e-27	23093944
rs1739	rs4488133	0.631529425313549	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs1739	rs4488133	0.631529425313549	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs1739	rs4488133	0.631529425313549	Urine X-12112 levels in chronic kidney disease	0	37277652
rs1739	rs4488133	0.631529425313549	X-12093 levels	1e-48	24816252
rs1739	rs4488133	0.631529425313549	X-12092 levels	0	24816252
rs1739	rs11598867	0.630839792962201	Urinary metabolites	1e-307	26352407
rs1739	rs7072216	0.630270635841883	Metabolite levels	8e-15	21931564
rs1739	rs7072216	0.630270635841883	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs1739	rs6584202	0.626406607263975	Obesity-related traits	4e-07	23251661
rs1739	rs10883083	0.622481884535144	N2-acetyl,N6-methyllysine levels	0	35347128
rs1739	rs10883083	0.622481884535144	X-12112 levels	0	35347128
rs1739	rs10883083	0.622481884535144	Arginine levels	1e-16	35347128
rs1739	rs10883083	0.622481884535144	Metabolite peak levels (QI8972)	2e-124	35995766
rs1739	rs10883083	0.622481884535144	Metabolite peak levels (QI5171)	8e-96	35995766
rs1739	rs2147896	0.622481884535144	Urinary metabolites (H-NMR features)	3e-164	24586186
rs1739	rs2147896	0.622481884535144	Urinary metabolites (H-NMR features)	8e-30	24586186
rs1739	rs2147896	0.622481884535144	Urinary metabolites (H-NMR features)	2e-55	24586186
rs1739	rs2147896	0.622481884535144	Urinary metabolites (H-NMR features)	6e-19	24586186
rs1739	rs2147896	0.622481884535144	Urinary metabolites (H-NMR features)	4e-34	24586186
rs1739	rs2147896	0.622481884535144	Trimethylamine levels	4e-144	33283231
rs1739	rs2147896	0.622481884535144	Serum metabolite levels	1e-15	33031748
rs1739	rs2147896	0.622481884535144	Serum metabolite levels	4e-226	33031748
rs1739	rs2147896	0.622481884535144	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs1739	rs2147896	0.622481884535144	Urinary metabolite levels in chronic kidney disease	0	31959995
rs1739	rs2147896	0.622481884535144	Urinary metabolite levels in chronic kidney disease	0	31959995
rs1739	rs2147896	0.622481884535144	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs1739	rs2147896	0.622481884535144	N6-methyllysine levels	3e-198	33437055
rs1739	rs2147896	0.622481884535144	N6-methyllysine levels	0	35347128
rs1739	rs2147896	0.622481884535144	N-methylpipecolate levels	0	35050183
rs1739	rs2147896	0.622481884535144	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs1739	rs2147896	0.622481884535144	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs1739	rs2147896	0.622481884535144	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs1739	rs2147896	0.622481884535144	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1739	rs2147896	0.622481884535144	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs1739	rs2147896	0.622481884535144	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1739	rs2147896	0.622481884535144	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1739	rs2147896	0.622481884535144	X-12092 levels	4e-191	27073872
rs1739	rs2147896	0.622481884535144	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs1739	rs2147896	0.622481884535144	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs1739	rs2147896	0.622481884535144	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs1739	rs2147896	0.622481884535144	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs1739	rs2147896	0.622481884535144	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs1739	rs2147896	0.622481884535144	N6-methyllysine levels (advanced age)	5e-25	37118062
rs1739	rs2147896	0.622481884535144	X-12112 levels	0	36635386
rs1739	rs2147896	0.622481884535144	N6-methyllysine levels	0	36635386
rs1739	rs2147896	0.622481884535144	N6,N6-dimethyllysine levels	0	36635386
rs1739	rs2147896	0.622481884535144	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs1739	rs2147896	0.622481884535144	N2-acetyl,N6-methyllysine levels	0	36635386
rs1739	rs10786415	0.622481884535144	N6,N6-dimethyllysine levels	0	35347128
rs1739	rs10786415	0.622481884535144	N-methylpipecolate levels	0	35347128
rs1739	rs10786415	0.622481884535144	X-25810 levels	4e-11	36635386
rs1739	rs942814	0.622481884535144	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs1739	rs4539242	0.621823085913778	Urinary metabolites (H-NMR features)	2e-20	24586186
rs1739	rs4539242	0.621823085913778	X-24809 levels	4e-67	33177712
rs1739	rs4539242	0.621823085913778	X-24983 levels	8e-59	33177712
rs1739	rs4539242	0.621823085913778	X-12112 levels	4e-63	33177712
rs1739	rs4539242	0.621823085913778	N-methylpipecolate levels	3e-12	33177712
rs1739	rs4539242	0.621823085913778	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs1739	rs4539242	0.621823085913778	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs1739	rs4539242	0.621823085913778	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs1739	rs4539242	0.621823085913778	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs1739	rs4539242	0.621823085913778	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs1739	rs4539242	0.621823085913778	N6-methyllysine levels (advanced age)	5e-25	37118062
rs1739	rs4539242	0.621823085913778	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs1739	rs7905265	0.619262671779416	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs1739	rs7905265	0.619262671779416	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs1739	rs7905265	0.619262671779416	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs1739	rs7905265	0.619262671779416	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs1739	rs7905265	0.619262671779416	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs1739	rs7905265	0.619262671779416	N6,N6-dimethyllysine levels	2e-132	35995766
rs1739	rs7905265	0.619262671779416	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs1739	rs10786414	0.612235846770023	ADMA levels	5e-18	35995766
rs1739	rs942813	0.600943634173753	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs17466784	rs13420542	0.887817676788468	1-myristoyl-2-palmitoyl-GPC (14:0/16:0) levels in elite athletes	6e-06	31882771
rs17472737	rs10922531	0.944049604554211	Serum metabolite levels	2e-69	33031748
rs17472737	rs12729558	0.90726670249369	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs17472737	rs7530513	0.859693988771533	Height	8e-11	35831902
rs17472737	rs7530513	0.859693988771533	Imidazole lactate levels	8e-166	36635386
rs17472737	rs12144640	0.859693988771533	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs17472737	rs1409152	0.847806449804315	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs17472737	rs1409152	0.847806449804315	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs17472737	rs10801699	0.84562375643539	X-23639 levels	2e-10	36635386
rs17472737	rs7532151	0.842697180592124	Imidazole lactate levels	9e-12	33177712
rs17472737	rs10801690	0.816430955916262	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs17472737	rs12120164	0.810436663015471	Metabolite peak levels (QI2146)	1e-26	35995766
rs17472737	rs9787133	0.78696712990737	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs17472737	rs2765527	0.741551012367457	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs17472737	rs2810876	0.635245768495325	Imidazole lactate levels	2e-122	35347128
rs17472737	rs10801696	0.634000780035037	Imidazole lactate levels	3e-195	35050183
rs17472737	rs1206228892	0.633493471585162	Imidazole lactate levels	5e-186	35050183
rs17472779	rs10922531	0.945618847874226	Serum metabolite levels	2e-69	33031748
rs17472779	rs12729558	0.908886914662666	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs17472779	rs7530513	0.861117051155524	Height	8e-11	35831902
rs17472779	rs7530513	0.861117051155524	Imidazole lactate levels	8e-166	36635386
rs17472779	rs12144640	0.861117051155524	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs17472779	rs1409152	0.849211930082339	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs17472779	rs1409152	0.849211930082339	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs17472779	rs10801699	0.847025621675857	X-23639 levels	2e-10	36635386
rs17472779	rs7532151	0.844294007135275	Imidazole lactate levels	9e-12	33177712
rs17472779	rs10801690	0.818008915777123	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs17472779	rs12120164	0.811781280239785	Metabolite peak levels (QI2146)	1e-26	35995766
rs17472779	rs9787133	0.78852622105922	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs17472779	rs2765527	0.740325542090107	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs17472779	rs2810876	0.634194707871901	Imidazole lactate levels	2e-122	35347128
rs17472779	rs10801696	0.632953044816836	Imidazole lactate levels	3e-195	35050183
rs17472779	rs1206228892	0.632446574733326	Imidazole lactate levels	5e-186	35050183
rs17475760	rs11580836	0.98758023543925	Body mass index	2e-09	36581621
rs17475760	rs10465746	0.965170136551455	Obesity-related traits	8e-06	23251661
rs17495047	rs17495047	1	Adolescent idiopathic scoliosis	3e-07	30019117
rs1752777	rs770199	0.899480842202492	Hair color	3e-08	30595370
rs17534614	rs11580836	0.949978225529331	Body mass index	2e-09	36581621
rs17534614	rs10465746	0.932052643334536	Obesity-related traits	8e-06	23251661
rs17540852	rs777587	0.934051970045092	Proteoglycan 3 levels	6e-29	34648354
rs17540852	rs777587	0.934051970045092	Pappalysin-1 levels	1e-25	34648354
rs17540852	rs12617371	0.928443278801358	Immature fraction of reticulocytes	8e-18	32888494
rs17540852	rs2463097	0.889506165976098	White blood cell count	3e-26	30595370
rs17540852	rs2593620	0.869284087322392	Serum levels of protein PRG3	5e-14	35078996
rs17540852	rs10199672	0.858654759787837	Height	6e-12	34594039
rs17540852	rs10199672	0.858654759787837	Height	2e-12	31562340
rs17540852	rs2421200	0.83529505496414	Neutrophil count	1e-26	32888493
rs17540852	rs2421200	0.83529505496414	Neutrophil count	1e-25	32888493
rs17540852	rs11685226	0.818413044816087	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs17540852	rs11685226	0.818413044816087	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs17540852	rs1177308	0.809605129977434	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs17540852	rs1177308	0.809605129977434	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs17540852	rs7558954	0.807238916645312	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs17540852	rs10169482	0.770660679546185	C-reactive protein levels	4e-09	33462484
rs17540852	rs2950269	0.732036670370086	Eosinophil side fluorescence	3e-18	37596262
rs17540852	rs12616433	0.710919516547541	Eosinophil forward scatter	4e-13	37596262
rs17540852	rs12616433	0.710919516547541	Eosinophil side scatter	2e-18	37596262
rs1756012	rs337277	0.923993479975432	Metabolite peak levels (QI10992)	3e-52	35995766
rs1756012	rs337277	0.923993479975432	Metabolite peak levels (QI4667)	7e-18	35995766
rs1756012	rs337277	0.923993479975432	Metabolite peak levels (QI4708)	1e-21	35995766
rs1756012	rs337277	0.923993479975432	Metabolite peak levels (QI5169)	7e-57	35995766
rs1756012	rs7655841	0.803627559882624	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1757924	rs337277	0.867650138318586	Metabolite peak levels (QI10992)	3e-52	35995766
rs1757924	rs337277	0.867650138318586	Metabolite peak levels (QI4667)	7e-18	35995766
rs1757924	rs337277	0.867650138318586	Metabolite peak levels (QI4708)	1e-21	35995766
rs1757924	rs337277	0.867650138318586	Metabolite peak levels (QI5169)	7e-57	35995766
rs1757924	rs7655841	0.700532143164279	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1757925	rs337277	0.918643000840208	Metabolite peak levels (QI10992)	3e-52	35995766
rs1757925	rs337277	0.918643000840208	Metabolite peak levels (QI4667)	7e-18	35995766
rs1757925	rs337277	0.918643000840208	Metabolite peak levels (QI4708)	1e-21	35995766
rs1757925	rs337277	0.918643000840208	Metabolite peak levels (QI5169)	7e-57	35995766
rs1757925	rs7655841	0.741749611154469	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1757927	rs337277	0.919498117161105	Metabolite peak levels (QI10992)	3e-52	35995766
rs1757927	rs337277	0.919498117161105	Metabolite peak levels (QI4667)	7e-18	35995766
rs1757927	rs337277	0.919498117161105	Metabolite peak levels (QI4708)	1e-21	35995766
rs1757927	rs337277	0.919498117161105	Metabolite peak levels (QI5169)	7e-57	35995766
rs1757927	rs7655841	0.742467227443807	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1757928	rs337277	0.919498117161105	Metabolite peak levels (QI10992)	3e-52	35995766
rs1757928	rs337277	0.919498117161105	Metabolite peak levels (QI4667)	7e-18	35995766
rs1757928	rs337277	0.919498117161105	Metabolite peak levels (QI4708)	1e-21	35995766
rs1757928	rs337277	0.919498117161105	Metabolite peak levels (QI5169)	7e-57	35995766
rs1757928	rs7655841	0.742467227443807	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1757930	rs337277	0.905811587320768	Metabolite peak levels (QI10992)	3e-52	35995766
rs1757930	rs337277	0.905811587320768	Metabolite peak levels (QI4667)	7e-18	35995766
rs1757930	rs337277	0.905811587320768	Metabolite peak levels (QI4708)	1e-21	35995766
rs1757930	rs337277	0.905811587320768	Metabolite peak levels (QI5169)	7e-57	35995766
rs1757930	rs7655841	0.812579008723062	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1757935	rs337277	0.919498117161105	Metabolite peak levels (QI10992)	3e-52	35995766
rs1757935	rs337277	0.919498117161105	Metabolite peak levels (QI4667)	7e-18	35995766
rs1757935	rs337277	0.919498117161105	Metabolite peak levels (QI4708)	1e-21	35995766
rs1757935	rs337277	0.919498117161105	Metabolite peak levels (QI5169)	7e-57	35995766
rs1757935	rs7655841	0.742467227443807	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs17640469	rs6743685	0.699740285939359	Height	1e-35	30595370
rs17640469	rs4637087	0.671621642900719	Waist circumference adjusted for body mass index	3e-10	31669095
rs17640469	rs12104955	0.662216133469651	Carpal tunnel syndrome	4e-08	30833571
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for body mass index	7e-07	25673412
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for body mass index	4e-06	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for body mass index	5e-08	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for body mass index	5e-06	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for body mass index	8e-08	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for BMI in non-smokers	1e-06	28443625
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	2e-07	28443625
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	2e-07	28443625
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	2e-06	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	2e-06	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	1e-08	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	3e-08	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for BMI in active individuals	2e-07	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for BMI in active individuals	1e-06	28448500
rs17640469	rs6715793	0.659326773206119	Waist circumference adjusted for body mass index	1e-08	25673412
rs17640469	rs6715793	0.659326773206119	Height	4e-37	36224396
rs17640469	rs6715793	0.659326773206119	Height	3e-16	36224396
rs17640469	rs6715793	0.659326773206119	Height	1e-300	36224396
rs17672976	rs10872653	0.996398963379575	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs17672976	rs55763431	0.995508517308269	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs17672976	rs9689694	0.993707610711994	Right hippocampal volume (head)	6e-11	37337106
rs17672976	rs9689694	0.993707610711994	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs17672976	rs9689694	0.993707610711994	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs17672976	rs9689694	0.993707610711994	Left hippocampal volume (head)	6e-12	37337106
rs17672976	rs2095375	0.991013810602254	Serum metabolite levels	1e-20	33031748
rs17672976	rs2095375	0.991013810602254	Serum metabolite levels	1e-20	33031748
rs17672976	rs9383843	0.990119838616633	Migraine	1e-09	35115687
rs17672976	rs10872645	0.988335114239339	Blood protein levels	2e-86	30072576
rs17672976	rs9688867	0.987491421814693	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs17672976	rs9688867	0.987491421814693	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs17672976	rs9688809	0.987491421814693	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs17672976	rs34337297	0.983860681246269	Serum levels of protein LRP11	3e-161	35078996
rs17672976	rs14314	0.97237068229241	Macular thickness	3e-19	30535121
rs17672976	rs14314	0.97237068229241	Vertex-wise sulcal depth	7e-17	34910505
rs17672976	rs14314	0.97237068229241	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs17672976	rs14314	0.97237068229241	Left hippocampal volume (body)	7e-15	37337106
rs17672976	rs14314	0.97237068229241	Left subiculum volume (body)	1e-14	37337106
rs17672976	rs9322193	0.947828234863957	Lung cancer	1e-07	27393504
rs17672976	rs4039600	0.904010090256514	Adenine levels	1e-11	35347128
rs17672976	rs1934534	0.639075075721001	Pain (pleiotropy)	2e-08	37844115
rs17672976	rs1934534	0.639075075721001	Pain (pleiotropy)	2e-06	37844115
rs17672976	rs4380763	0.638554621082928	Subcortical volume (min-P)	1e-11	32665545
rs17672976	rs11155671	0.628128244412566	Testicular germ cell tumor	2e-09	28604728
rs17672976	rs80147756	0.613282304302921	HippSubfield lh volume subiculum-head	3e-10	33875891
rs17672976	rs4421206	0.605718731517047	Brain morphology (min-P)	4e-11	32665545
rs17673294	rs2095375	0.9691336819337	Serum metabolite levels	1e-20	33031748
rs17673294	rs2095375	0.9691336819337	Serum metabolite levels	1e-20	33031748
rs17673294	rs9383843	0.968243089633977	Migraine	1e-09	35115687
rs17673294	rs55763431	0.964705351614839	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs17673294	rs9689694	0.962962171528204	Right hippocampal volume (head)	6e-11	37337106
rs17673294	rs9689694	0.962962171528204	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs17673294	rs9689694	0.962962171528204	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs17673294	rs9689694	0.962962171528204	Left hippocampal volume (head)	6e-12	37337106
rs17673294	rs10872645	0.957682341832426	Blood protein levels	2e-86	30072576
rs17673294	rs10872653	0.956858885444185	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs17673294	rs9688867	0.956766616955364	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs17673294	rs9688867	0.956766616955364	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs17673294	rs9688809	0.956766616955364	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs17673294	rs34337297	0.953311798077316	Serum levels of protein LRP11	3e-161	35078996
rs17673294	rs14314	0.950652117002334	Macular thickness	3e-19	30535121
rs17673294	rs14314	0.950652117002334	Vertex-wise sulcal depth	7e-17	34910505
rs17673294	rs14314	0.950652117002334	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs17673294	rs14314	0.950652117002334	Left hippocampal volume (body)	7e-15	37337106
rs17673294	rs14314	0.950652117002334	Left subiculum volume (body)	1e-14	37337106
rs17673294	rs9322193	0.91785386669778	Lung cancer	1e-07	27393504
rs17673294	rs4039600	0.87575411971709	Adenine levels	1e-11	35347128
rs17673294	rs1934534	0.611847858517652	Pain (pleiotropy)	2e-08	37844115
rs17673294	rs1934534	0.611847858517652	Pain (pleiotropy)	2e-06	37844115
rs17673294	rs4380763	0.611332598046357	Subcortical volume (min-P)	1e-11	32665545
rs17673294	rs11155671	0.601126014342396	Testicular germ cell tumor	2e-09	28604728
rs17713396	rs17713396	1	Blood urea nitrogen levels	3e-21	34272381
rs17713396	rs17713396	1	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs17713396	rs17713396	1	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs17713396	rs6710091	0.995896703776475	Waist circumference adjusted for body mass index	8e-11	31669095
rs17713396	rs6710091	0.995896703776475	HDL cholesterol	5e-08	30275531
rs17713396	rs6710091	0.995896703776475	High density lipoprotein cholesterol levels	3e-24	34887591
rs17713396	rs7595075	0.979567877244492	Waist circumference adjusted for body mass index	2e-09	34021172
rs17713396	rs7595075	0.979567877244492	HDL cholesterol	3e-11	34594039
rs17713396	rs7595075	0.979567877244492	HDL cholesterol levels	6e-13	32203549
rs17713396	rs17713729	0.976540483628502	Body mass index	2e-09	31669095
rs17713396	rs17713729	0.976540483628502	Serum creatinine levels	4e-14	34594039
rs17713396	rs17713729	0.976540483628502	High density lipoprotein cholesterol levels	7e-17	34887591
rs17713396	rs79716074	0.975496010353594	Plateletcrit	1e-09	32888494
rs17713396	rs79716074	0.975496010353594	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs17713396	rs79716074	0.975496010353594	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs17713396	rs79716074	0.975496010353594	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs17713396	rs58461606	0.968561170294304	Blood protein levels	0	30072576
rs17713396	rs7605824	0.96144932476189	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs17713396	rs7566279	0.960458363925077	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs17713396	rs3791221	0.957171548039843	Blood urea nitrogen levels	2e-07	31152163
rs17713396	rs3791221	0.957171548039843	Estimated glomerular filtration rate	2e-10	31152163
rs17713396	rs3791221	0.957171548039843	Estimated glomerular filtration rate	1e-11	31152163
rs17713396	rs3791221	0.957171548039843	Blood urea nitrogen levels	7e-26	34594039
rs17713396	rs2290911	0.951296204883857	Height	5e-07	29782485
rs17713396	rs2290911	0.951296204883857	Large artery stroke	6e-06	28265093
rs17713396	rs2290911	0.951296204883857	Height	8e-112	36224396
rs17713396	rs2126129	0.943150490337401	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs17713396	rs114976176	0.916427833611337	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs17713396	rs59937473	0.888295510243272	Protein quantitative trait loci	3e-67	32492067
rs17713396	rs59937473	0.888295510243272	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs17713396	rs17714252	0.880460924179714	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs17713396	rs17714252	0.880460924179714	Retinal vascular fractal dimension	2e-07	34743558
rs17713396	rs7601944	0.878274871142706	Smoking initiation	4e-15	36477530
rs17713396	rs11553746	0.877286154388629	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs17713396	rs11553746	0.877286154388629	High density lipoprotein cholesterol levels	2e-07	29083408
rs17713396	rs11553746	0.877286154388629	High density lipoprotein cholesterol levels	7e-15	29083408
rs17713396	rs11553746	0.877286154388629	Large artery stroke	4e-06	28265093
rs17713396	rs55753056	0.869460830875673	Height	2e-22	30595370
rs17713396	rs62114548	0.848653788157476	Retinal vascular fractal density	2e-09	34743558
rs17713396	rs62114538	0.827750218333053	Triglyceride levels	6e-12	34887591
rs17713396	rs17713879	0.825767190729948	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs17713396	rs17713879	0.825767190729948	Smoking initiation	1e-10	36477530
rs17713396	rs17713879	0.825767190729948	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs17713396	rs17713879	0.825767190729948	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs17713396	rs17713879	0.825767190729948	Triglyceride levels	3e-10	34887591
rs17713396	rs17713879	0.825767190729948	Aging (eyeAgeAcceleration)	6e-50	36975205
rs17713396	rs60843830	0.81925344884844	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs17713396	rs60843830	0.81925344884844	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs17713396	rs60843830	0.81925344884844	Adventurousness	7e-10	30643258
rs17713396	rs79154857	0.792627466532873	Pulse pressure	5e-08	34594039
rs17713396	rs62114506	0.770899000063918	Gamma glutamyl transpeptidase	3e-14	34594039
rs17713396	rs62114506	0.770899000063918	Apolipoprotein A1 levels	3e-10	32203549
rs17713396	rs62114506	0.770899000063918	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs17713396	rs62114506	0.770899000063918	HDL cholesterol levels	8e-10	36333282
rs17713568	rs3791221	0.977962568980164	Blood urea nitrogen levels	2e-07	31152163
rs17713568	rs3791221	0.977962568980164	Estimated glomerular filtration rate	2e-10	31152163
rs17713568	rs3791221	0.977962568980164	Estimated glomerular filtration rate	1e-11	31152163
rs17713568	rs3791221	0.977962568980164	Blood urea nitrogen levels	7e-26	34594039
rs17713568	rs17713396	0.962665531020174	Blood urea nitrogen levels	3e-21	34272381
rs17713568	rs17713396	0.962665531020174	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs17713568	rs17713396	0.962665531020174	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs17713568	rs6710091	0.962665531020174	Waist circumference adjusted for body mass index	8e-11	31669095
rs17713568	rs6710091	0.962665531020174	HDL cholesterol	5e-08	30275531
rs17713568	rs6710091	0.962665531020174	High density lipoprotein cholesterol levels	3e-24	34887591
rs17713568	rs7595075	0.958659731980021	Waist circumference adjusted for body mass index	2e-09	34021172
rs17713568	rs7595075	0.958659731980021	HDL cholesterol	3e-11	34594039
rs17713568	rs7595075	0.958659731980021	HDL cholesterol levels	6e-13	32203549
rs17713568	rs17713729	0.955662705664306	Body mass index	2e-09	31669095
rs17713568	rs17713729	0.955662705664306	Serum creatinine levels	4e-14	34594039
rs17713568	rs17713729	0.955662705664306	High density lipoprotein cholesterol levels	7e-17	34887591
rs17713568	rs79716074	0.95466309073953	Plateletcrit	1e-09	32888494
rs17713568	rs79716074	0.95466309073953	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs17713568	rs79716074	0.95466309073953	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs17713568	rs79716074	0.95466309073953	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs17713568	rs58461606	0.947751931285785	Blood protein levels	0	30072576
rs17713568	rs7605824	0.942759685958639	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs17713568	rs7566279	0.939799387552818	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs17713568	rs2290911	0.921138516301682	Height	5e-07	29782485
rs17713568	rs2290911	0.921138516301682	Large artery stroke	6e-06	28265093
rs17713568	rs2290911	0.921138516301682	Height	8e-112	36224396
rs17713568	rs2126129	0.909168928076003	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs17713568	rs55753056	0.903612047040595	Height	2e-22	30595370
rs17713568	rs7601944	0.897352866628361	Smoking initiation	4e-15	36477530
rs17713568	rs114976176	0.896211460633637	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs17713568	rs59937473	0.868291710467658	Protein quantitative trait loci	3e-67	32492067
rs17713568	rs59937473	0.868291710467658	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs17713568	rs17714252	0.862462635828254	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs17713568	rs17714252	0.862462635828254	Retinal vascular fractal dimension	2e-07	34743558
rs17713568	rs17713879	0.858787394144276	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs17713568	rs17713879	0.858787394144276	Smoking initiation	1e-10	36477530
rs17713568	rs17713879	0.858787394144276	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs17713568	rs17713879	0.858787394144276	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs17713568	rs17713879	0.858787394144276	Triglyceride levels	3e-10	34887591
rs17713568	rs17713879	0.858787394144276	Aging (eyeAgeAcceleration)	6e-50	36975205
rs17713568	rs11553746	0.858563456639048	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs17713568	rs11553746	0.858563456639048	High density lipoprotein cholesterol levels	2e-07	29083408
rs17713568	rs11553746	0.858563456639048	High density lipoprotein cholesterol levels	7e-15	29083408
rs17713568	rs11553746	0.858563456639048	Large artery stroke	4e-06	28265093
rs17713568	rs62114548	0.830227296257233	Retinal vascular fractal density	2e-09	34743558
rs17713568	rs62114538	0.808426452212637	Triglyceride levels	6e-12	34887591
rs17713568	rs60843830	0.802496627356788	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs17713568	rs60843830	0.802496627356788	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs17713568	rs60843830	0.802496627356788	Adventurousness	7e-10	30643258
rs17713568	rs79154857	0.775397518677203	Pulse pressure	5e-08	34594039
rs17713568	rs62114506	0.743171272030052	Gamma glutamyl transpeptidase	3e-14	34594039
rs17713568	rs62114506	0.743171272030052	Apolipoprotein A1 levels	3e-10	32203549
rs17713568	rs62114506	0.743171272030052	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs17713568	rs62114506	0.743171272030052	HDL cholesterol levels	8e-10	36333282
rs17713729	rs17713729	1	Body mass index	2e-09	31669095
rs17713729	rs17713729	1	Serum creatinine levels	4e-14	34594039
rs17713729	rs17713729	1	High density lipoprotein cholesterol levels	7e-17	34887591
rs17713729	rs7595075	0.986707082428316	Waist circumference adjusted for body mass index	2e-09	34021172
rs17713729	rs7595075	0.986707082428316	HDL cholesterol	3e-11	34594039
rs17713729	rs7595075	0.986707082428316	HDL cholesterol levels	6e-13	32203549
rs17713729	rs79716074	0.982629929266046	Plateletcrit	1e-09	32888494
rs17713729	rs79716074	0.982629929266046	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs17713729	rs79716074	0.982629929266046	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs17713729	rs79716074	0.982629929266046	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs17713729	rs17713396	0.976540483628502	Blood urea nitrogen levels	3e-21	34272381
rs17713729	rs17713396	0.976540483628502	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs17713729	rs17713396	0.976540483628502	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs17713729	rs6710091	0.976540483628502	Waist circumference adjusted for body mass index	8e-11	31669095
rs17713729	rs6710091	0.976540483628502	HDL cholesterol	5e-08	30275531
rs17713729	rs6710091	0.976540483628502	High density lipoprotein cholesterol levels	3e-24	34887591
rs17713729	rs58461606	0.97562591867227	Blood protein levels	0	30072576
rs17713729	rs7605824	0.968509419380304	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs17713729	rs7566279	0.967512314372094	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs17713729	rs3791221	0.936376354499974	Blood urea nitrogen levels	2e-07	31152163
rs17713729	rs3791221	0.936376354499974	Estimated glomerular filtration rate	2e-10	31152163
rs17713729	rs3791221	0.936376354499974	Estimated glomerular filtration rate	1e-11	31152163
rs17713729	rs3791221	0.936376354499974	Blood urea nitrogen levels	7e-26	34594039
rs17713729	rs2290911	0.932272934045243	Height	5e-07	29782485
rs17713729	rs2290911	0.932272934045243	Large artery stroke	6e-06	28265093
rs17713729	rs2290911	0.932272934045243	Height	8e-112	36224396
rs17713729	rs114976176	0.923208775761571	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs17713729	rs2126129	0.922310481058114	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs17713729	rs59937473	0.894865535033273	Protein quantitative trait loci	3e-67	32492067
rs17713729	rs59937473	0.894865535033273	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs17713729	rs17714252	0.887018840932175	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs17713729	rs17714252	0.887018840932175	Retinal vascular fractal dimension	2e-07	34743558
rs17713729	rs11553746	0.886448939377224	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs17713729	rs11553746	0.886448939377224	High density lipoprotein cholesterol levels	2e-07	29083408
rs17713729	rs11553746	0.886448939377224	High density lipoprotein cholesterol levels	7e-15	29083408
rs17713729	rs11553746	0.886448939377224	Large artery stroke	4e-06	28265093
rs17713729	rs55753056	0.86658998465199	Height	2e-22	30595370
rs17713729	rs62114548	0.865340097228133	Retinal vascular fractal density	2e-09	34743558
rs17713729	rs7601944	0.85866323562213	Smoking initiation	4e-15	36477530
rs17713729	rs62114538	0.841239949634886	Triglyceride levels	6e-12	34887591
rs17713729	rs17713879	0.832305996355653	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs17713729	rs17713879	0.832305996355653	Smoking initiation	1e-10	36477530
rs17713729	rs17713879	0.832305996355653	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs17713729	rs17713879	0.832305996355653	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs17713729	rs17713879	0.832305996355653	Triglyceride levels	3e-10	34887591
rs17713729	rs17713879	0.832305996355653	Aging (eyeAgeAcceleration)	6e-50	36975205
rs17713729	rs60843830	0.825774063080855	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs17713729	rs60843830	0.825774063080855	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs17713729	rs60843830	0.825774063080855	Adventurousness	7e-10	30643258
rs17713729	rs79154857	0.799614336875836	Pulse pressure	5e-08	34594039
rs17713729	rs62114506	0.753243615000402	Gamma glutamyl transpeptidase	3e-14	34594039
rs17713729	rs62114506	0.753243615000402	Apolipoprotein A1 levels	3e-10	32203549
rs17713729	rs62114506	0.753243615000402	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs17713729	rs62114506	0.753243615000402	HDL cholesterol levels	8e-10	36333282
rs17713879	rs17713879	1	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs17713879	rs17713879	1	Smoking initiation	1e-10	36477530
rs17713879	rs17713879	1	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs17713879	rs17713879	1	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs17713879	rs17713879	1	Triglyceride levels	3e-10	34887591
rs17713879	rs17713879	1	Aging (eyeAgeAcceleration)	6e-50	36975205
rs17713879	rs3791221	0.864922747744083	Blood urea nitrogen levels	2e-07	31152163
rs17713879	rs3791221	0.864922747744083	Estimated glomerular filtration rate	2e-10	31152163
rs17713879	rs3791221	0.864922747744083	Estimated glomerular filtration rate	1e-11	31152163
rs17713879	rs3791221	0.864922747744083	Blood urea nitrogen levels	7e-26	34594039
rs17713879	rs58461606	0.852999424245067	Blood protein levels	0	30072576
rs17713879	rs7566279	0.845444305706713	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs17713879	rs62114538	0.841143060821282	Triglyceride levels	6e-12	34887591
rs17713879	rs11553746	0.84041642595357	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs17713879	rs11553746	0.84041642595357	High density lipoprotein cholesterol levels	2e-07	29083408
rs17713879	rs11553746	0.84041642595357	High density lipoprotein cholesterol levels	7e-15	29083408
rs17713879	rs11553746	0.84041642595357	Large artery stroke	4e-06	28265093
rs17713879	rs7595075	0.838753425257464	Waist circumference adjusted for body mass index	2e-09	34021172
rs17713879	rs7595075	0.838753425257464	HDL cholesterol	3e-11	34594039
rs17713879	rs7595075	0.838753425257464	HDL cholesterol levels	6e-13	32203549
rs17713879	rs79716074	0.834997269468915	Plateletcrit	1e-09	32888494
rs17713879	rs79716074	0.834997269468915	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs17713879	rs79716074	0.834997269468915	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs17713879	rs79716074	0.834997269468915	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs17713879	rs17713729	0.832305996355653	Body mass index	2e-09	31669095
rs17713879	rs17713729	0.832305996355653	Serum creatinine levels	4e-14	34594039
rs17713879	rs17713729	0.832305996355653	High density lipoprotein cholesterol levels	7e-17	34887591
rs17713879	rs17713396	0.825767190729948	Blood urea nitrogen levels	3e-21	34272381
rs17713879	rs17713396	0.825767190729948	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs17713879	rs17713396	0.825767190729948	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs17713879	rs7605824	0.824099596520275	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs17713879	rs6710091	0.823920285174706	Waist circumference adjusted for body mass index	8e-11	31669095
rs17713879	rs6710091	0.823920285174706	HDL cholesterol	5e-08	30275531
rs17713879	rs6710091	0.823920285174706	High density lipoprotein cholesterol levels	3e-24	34887591
rs17713879	rs62114548	0.812367459814487	Retinal vascular fractal density	2e-09	34743558
rs17713879	rs114976176	0.804840468662087	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs17713879	rs55753056	0.800050393660176	Height	2e-22	30595370
rs17713879	rs7601944	0.792486307475073	Smoking initiation	4e-15	36477530
rs17713879	rs2290911	0.786537934298288	Height	5e-07	29782485
rs17713879	rs2290911	0.786537934298288	Large artery stroke	6e-06	28265093
rs17713879	rs2290911	0.786537934298288	Height	8e-112	36224396
rs17713879	rs2126129	0.779683215637523	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs17713879	rs59937473	0.778955495302141	Protein quantitative trait loci	3e-67	32492067
rs17713879	rs59937473	0.778955495302141	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs17713879	rs17714252	0.776928681209853	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs17713879	rs17714252	0.776928681209853	Retinal vascular fractal dimension	2e-07	34743558
rs17713879	rs60843830	0.719856545572522	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs17713879	rs60843830	0.719856545572522	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs17713879	rs60843830	0.719856545572522	Adventurousness	7e-10	30643258
rs17713879	rs62114506	0.718219522185062	Gamma glutamyl transpeptidase	3e-14	34594039
rs17713879	rs62114506	0.718219522185062	Apolipoprotein A1 levels	3e-10	32203549
rs17713879	rs62114506	0.718219522185062	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs17713879	rs62114506	0.718219522185062	HDL cholesterol levels	8e-10	36333282
rs17713879	rs79154857	0.688790051543909	Pulse pressure	5e-08	34594039
rs17714252	rs17714252	1	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs17714252	rs17714252	1	Retinal vascular fractal dimension	2e-07	34743558
rs17714252	rs59937473	0.990201275425039	Protein quantitative trait loci	3e-67	32492067
rs17714252	rs59937473	0.990201275425039	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs17714252	rs55753056	0.955711592226136	Height	2e-22	30595370
rs17714252	rs7601944	0.947251988705884	Smoking initiation	4e-15	36477530
rs17714252	rs114976176	0.945594059660049	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs17714252	rs60843830	0.939942830890094	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs17714252	rs60843830	0.939942830890094	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs17714252	rs60843830	0.939942830890094	Adventurousness	7e-10	30643258
rs17714252	rs62114538	0.921933407185393	Triglyceride levels	6e-12	34887591
rs17714252	rs58461606	0.909652749158712	Blood protein levels	0	30072576
rs17714252	rs7566279	0.907819230326481	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs17714252	rs7595075	0.89371215063775	Waist circumference adjusted for body mass index	2e-09	34021172
rs17714252	rs7595075	0.89371215063775	HDL cholesterol	3e-11	34594039
rs17714252	rs7595075	0.89371215063775	HDL cholesterol levels	6e-13	32203549
rs17714252	rs79716074	0.891854730099189	Plateletcrit	1e-09	32888494
rs17714252	rs79716074	0.891854730099189	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs17714252	rs79716074	0.891854730099189	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs17714252	rs79716074	0.891854730099189	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs17714252	rs17713729	0.887018840932175	Body mass index	2e-09	31669095
rs17714252	rs17713729	0.887018840932175	Serum creatinine levels	4e-14	34594039
rs17714252	rs17713729	0.887018840932175	High density lipoprotein cholesterol levels	7e-17	34887591
rs17714252	rs17713396	0.880460924179714	Blood urea nitrogen levels	3e-21	34272381
rs17714252	rs17713396	0.880460924179714	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs17714252	rs17713396	0.880460924179714	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs17714252	rs7605824	0.880336088844923	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs17714252	rs6710091	0.878575971359278	Waist circumference adjusted for body mass index	8e-11	31669095
rs17714252	rs6710091	0.878575971359278	HDL cholesterol	5e-08	30275531
rs17714252	rs6710091	0.878575971359278	High density lipoprotein cholesterol levels	3e-24	34887591
rs17714252	rs3791221	0.868036569908977	Blood urea nitrogen levels	2e-07	31152163
rs17714252	rs3791221	0.868036569908977	Estimated glomerular filtration rate	2e-10	31152163
rs17714252	rs3791221	0.868036569908977	Estimated glomerular filtration rate	1e-11	31152163
rs17714252	rs3791221	0.868036569908977	Blood urea nitrogen levels	7e-26	34594039
rs17714252	rs2290911	0.838358734315244	Height	5e-07	29782485
rs17714252	rs2290911	0.838358734315244	Large artery stroke	6e-06	28265093
rs17714252	rs2290911	0.838358734315244	Height	8e-112	36224396
rs17714252	rs2126129	0.830465564235985	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs17714252	rs11553746	0.808107216860173	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs17714252	rs11553746	0.808107216860173	High density lipoprotein cholesterol levels	2e-07	29083408
rs17714252	rs11553746	0.808107216860173	High density lipoprotein cholesterol levels	7e-15	29083408
rs17714252	rs11553746	0.808107216860173	Large artery stroke	4e-06	28265093
rs17714252	rs62114548	0.778658572641777	Retinal vascular fractal density	2e-09	34743558
rs17714252	rs17713879	0.776928681209853	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs17714252	rs17713879	0.776928681209853	Smoking initiation	1e-10	36477530
rs17714252	rs17713879	0.776928681209853	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs17714252	rs17713879	0.776928681209853	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs17714252	rs17713879	0.776928681209853	Triglyceride levels	3e-10	34887591
rs17714252	rs17713879	0.776928681209853	Aging (eyeAgeAcceleration)	6e-50	36975205
rs17714252	rs79154857	0.74009675089568	Pulse pressure	5e-08	34594039
rs17714252	rs62114506	0.679171887814835	Gamma glutamyl transpeptidase	3e-14	34594039
rs17714252	rs62114506	0.679171887814835	Apolipoprotein A1 levels	3e-10	32203549
rs17714252	rs62114506	0.679171887814835	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs17714252	rs62114506	0.679171887814835	HDL cholesterol levels	8e-10	36333282
rs17720428	rs11170776	0.755599369871327	Waist-to-hip ratio adjusted for BMI	2e-09	31669095
rs17798290	rs6705511	0.640828364516054	Self-reported math ability	4e-09	30038396
rs17798290	rs6705511	0.640828364516054	Self-reported math ability (MTAG)	3e-10	30038396
rs17798290	rs34276187	0.639197726504155	Highest math class taken (MTAG)	2e-08	30038396
rs1784778	rs480293	0.991399259567543	Oily fish consumption	4e-11	32193382
rs1784778	rs1613778	0.933748181820138	Total bilirubin levels	3e-08	34594039
rs1784778	rs34634095	0.928543809557403	Fish- and plant-related diet	3e-09	32066663
rs1784778	rs542831	0.914508891353446	Asthma	5e-13	31361310
rs1784778	rs1784776	0.912019728935529	Asthma	2e-09	32296059
rs1784778	rs1784775	0.912019728935529	Asthma	2e-09	30929738
rs1784778	rs1784775	0.912019728935529	Asthma (adult onset)	6e-09	30929738
rs1784778	rs1789358	0.910373885061398	Asthma	2e-08	34103634
rs1784778	rs539524	0.904173303504737	Asthma	1e-10	32296059
rs1784778	rs12791699	0.875111903728065	Pork consumption	9e-09	32066663
rs1784778	rs12791699	0.875111903728065	Oily fish consumption	9e-09	32066663
rs1784778	rs487985	0.875111903728065	Highest math class taken	1e-08	30038396
rs1784778	rs10891286	0.852536411224807	Noncognitive aspects of educational attainment	5e-10	33414549
rs1784778	rs4459340	0.848547002740268	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs1784778	rs505372	0.800039508631975	Breast cancer	3e-06	29059683
rs1784778	rs505372	0.800039508631975	Medication use (beta blocking agents)	2e-08	34594039
rs1784778	rs659529	0.794824156357958	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs1784778	rs659529	0.794824156357958	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs1784778	rs659529	0.794824156357958	Atopic dermatitis	5e-10	34116867
rs1784778	rs9734135	0.765331474493096	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs1784778	rs11213941	0.641306913815754	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs1784778	rs11213941	0.641306913815754	Eczema	8e-14	30595370
rs1784778	rs663763	0.63817213092125	Layilin levels	3e-21	36168886
rs1784786	rs539524	0.996607723601558	Asthma	1e-10	32296059
rs1784786	rs1789358	0.914530177468623	Asthma	2e-08	34103634
rs1784786	rs1784776	0.911353278697041	Asthma	2e-09	32296059
rs1784786	rs1784775	0.911353278697041	Asthma	2e-09	30929738
rs1784786	rs1784775	0.911353278697041	Asthma (adult onset)	6e-09	30929738
rs1784786	rs542831	0.910454804301439	Asthma	5e-13	31361310
rs1784786	rs34634095	0.907892482688033	Fish- and plant-related diet	3e-09	32066663
rs1784786	rs480293	0.904122623798514	Oily fish consumption	4e-11	32193382
rs1784786	rs12791699	0.902657429268881	Pork consumption	9e-09	32066663
rs1784786	rs12791699	0.902657429268881	Oily fish consumption	9e-09	32066663
rs1784786	rs487985	0.902657429268881	Highest math class taken	1e-08	30038396
rs1784786	rs10891286	0.877694290209001	Noncognitive aspects of educational attainment	5e-10	33414549
rs1784786	rs4459340	0.873838028444544	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs1784786	rs1613778	0.850479009348611	Total bilirubin levels	3e-08	34594039
rs1784786	rs505372	0.828468059527453	Breast cancer	3e-06	29059683
rs1784786	rs505372	0.828468059527453	Medication use (beta blocking agents)	2e-08	34594039
rs1784786	rs9734135	0.791892754971114	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs1784786	rs659529	0.781459759264572	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs1784786	rs659529	0.781459759264572	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs1784786	rs659529	0.781459759264572	Atopic dermatitis	5e-10	34116867
rs1784786	rs11213941	0.6340192227399	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs1784786	rs11213941	0.6340192227399	Eczema	8e-14	30595370
rs1784786	rs663763	0.623889043878716	Layilin levels	3e-21	36168886
rs1789351	rs1613778	1	Total bilirubin levels	3e-08	34594039
rs1789351	rs480293	0.935626834667536	Oily fish consumption	4e-11	32193382
rs1789351	rs34634095	0.910919530370342	Fish- and plant-related diet	3e-09	32066663
rs1789351	rs542831	0.855065397973158	Asthma	5e-13	31361310
rs1789351	rs1784776	0.852577939792858	Asthma	2e-09	32296059
rs1789351	rs1784775	0.852577939792858	Asthma	2e-09	30929738
rs1789351	rs1784775	0.852577939792858	Asthma (adult onset)	6e-09	30929738
rs1789351	rs1789358	0.851068015632425	Asthma	2e-08	34103634
rs1789351	rs539524	0.848778527435129	Asthma	1e-10	32296059
rs1789351	rs12791699	0.816470622573358	Pork consumption	9e-09	32066663
rs1789351	rs12791699	0.816470622573358	Oily fish consumption	9e-09	32066663
rs1789351	rs487985	0.816470622573358	Highest math class taken	1e-08	30038396
rs1789351	rs10891286	0.803235505342935	Noncognitive aspects of educational attainment	5e-10	33414549
rs1789351	rs4459340	0.799235235999553	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs1789351	rs659529	0.766416744414889	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs1789351	rs659529	0.766416744414889	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs1789351	rs659529	0.766416744414889	Atopic dermatitis	5e-10	34116867
rs1789351	rs505372	0.741485181382245	Breast cancer	3e-06	29059683
rs1789351	rs505372	0.741485181382245	Medication use (beta blocking agents)	2e-08	34594039
rs1789351	rs9734135	0.717281787131826	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs1789351	rs663763	0.612843736118845	Layilin levels	3e-21	36168886
rs1789351	rs11213941	0.611238840223634	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs1789351	rs11213941	0.611238840223634	Eczema	8e-14	30595370
rs1789361	rs539524	0.996607723601558	Asthma	1e-10	32296059
rs1789361	rs1789358	0.914530177468623	Asthma	2e-08	34103634
rs1789361	rs1784776	0.911353278697041	Asthma	2e-09	32296059
rs1789361	rs1784775	0.911353278697041	Asthma	2e-09	30929738
rs1789361	rs1784775	0.911353278697041	Asthma (adult onset)	6e-09	30929738
rs1789361	rs542831	0.910454804301439	Asthma	5e-13	31361310
rs1789361	rs34634095	0.907892482688033	Fish- and plant-related diet	3e-09	32066663
rs1789361	rs480293	0.904122623798514	Oily fish consumption	4e-11	32193382
rs1789361	rs12791699	0.902657429268881	Pork consumption	9e-09	32066663
rs1789361	rs12791699	0.902657429268881	Oily fish consumption	9e-09	32066663
rs1789361	rs487985	0.902657429268881	Highest math class taken	1e-08	30038396
rs1789361	rs10891286	0.877694290209001	Noncognitive aspects of educational attainment	5e-10	33414549
rs1789361	rs4459340	0.873838028444544	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs1789361	rs1613778	0.850479009348611	Total bilirubin levels	3e-08	34594039
rs1789361	rs505372	0.828468059527453	Breast cancer	3e-06	29059683
rs1789361	rs505372	0.828468059527453	Medication use (beta blocking agents)	2e-08	34594039
rs1789361	rs9734135	0.791892754971114	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs1789361	rs659529	0.781459759264572	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs1789361	rs659529	0.781459759264572	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs1789361	rs659529	0.781459759264572	Atopic dermatitis	5e-10	34116867
rs1789361	rs11213941	0.6340192227399	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs1789361	rs11213941	0.6340192227399	Eczema	8e-14	30595370
rs1789361	rs663763	0.623889043878716	Layilin levels	3e-21	36168886
rs18059	rs27293	0.760584950357084	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs18059	rs27293	0.760584950357084	Diastolic blood pressure	3e-11	35762941
rs18059	rs38033	0.751074826532661	Blood protein levels	0	30072576
rs18059	rs1423357	0.737675536368185	General cognitive ability	9e-06	29844566
rs18059	rs2432142	0.729057220721887	Neutrophil count	2e-14	32888493
rs18059	rs2432142	0.729057220721887	White blood cell count	1e-11	32888493
rs18059	rs7705093	0.703136915144684	Birdshot chorioretinopathy	2e-09	24957906
rs18059	rs2910686	0.621635310546695	Neutrophil count	4e-14	32888493
rs18059	rs2910686	0.621635310546695	Psoriasis	2e-08	23143594
rs18059	rs2910686	0.621635310546695	Ankylosing spondylitis	5e-17	23749187
rs18059	rs2910686	0.621635310546695	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs18059	rs2927608	0.619198799597492	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs18059	rs2927608	0.619198799597492	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs18059	rs2927608	0.619198799597492	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs18059	rs38029	0.606647277591973	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1809452	rs746011	0.853735952008648	Triglycerides	2e-10	30275531
rs1809452	rs4242434	0.842132246939975	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs1809452	rs11781149	0.820379816341913	Refractive error	2e-17	32231278
rs1809452	rs2280104	0.779684041690904	Parkinson's disease	3e-08	28892059
rs1809452	rs2280104	0.779684041690904	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs1809452	rs2280104	0.779684041690904	Serum total protein level	3e-12	34594039
rs1809452	rs1545837	0.759754527752967	Lung function (FVC)	1e-10	30595370
rs1809452	rs4872007	0.721530528711142	Superior temporal gyrus volume	8e-06	31530798
rs1809452	rs13271626	0.658820138107192	Haemorrhoidal disease	3e-10	33888516
rs1809452	rs11778693	0.635608264056566	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs1809452	rs11778693	0.635608264056566	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs1809452	rs11780207	0.624481038983008	Estimated glomerular filtration rate	2e-13	33462484
rs1809452	rs11780207	0.624481038983008	Serum total protein level	2e-09	33462484
rs1809452	rs11780207	0.624481038983008	Creatinine levels	2e-13	33462484
rs1811464	rs7321596	0.99249065457011	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs1811464	rs8002861	0.958569707666156	Leprosy	7e-06	25642632
rs181391	rs181392	0.976800807686009	Smoking initiation	2e-09	36477530
rs181392	rs181392	1	Smoking initiation	2e-09	36477530
rs181393	rs181392	0.973943152581479	Smoking initiation	2e-09	36477530
rs1814736	rs6680628	0.798874134371729	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs1815697	rs770199	0.873795284086732	Hair color	3e-08	30595370
rs1819595	rs7321596	0.796615377633285	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs1819595	rs8002861	0.76904056886824	Leprosy	7e-06	25642632
rs1820148	rs1363907	0.998221389128993	Crohn's disease	4e-16	26192919
rs1820148	rs1363907	0.998221389128993	Ulcerative colitis	4e-06	26192919
rs1820148	rs1363907	0.998221389128993	Inflammatory bowel disease	5e-15	26192919
rs1820148	rs1363907	0.998221389128993	Inflammatory bowel disease	6e-13	23128233
rs1820148	rs1363907	0.998221389128993	Inflammatory bowel disease	1e-10	28067908
rs1820148	rs1363907	0.998221389128993	Crohn's disease	1e-14	28067908
rs1820148	rs2549794	0.996444141380409	Crohn's disease	1e-10	21102463
rs1820148	rs2549794	0.996444141380409	Systolic blood pressure	1e-07	33230300
rs1820148	rs2549794	0.996444141380409	Diastolic blood pressure	1e-15	33230300
rs1820148	rs2549794	0.996444141380409	Diastolic blood pressure	2e-12	33230300
rs1820148	rs2549794	0.996444141380409	Systolic blood pressure	4e-10	33230300
rs1820148	rs2617439	0.942920861913098	Neutrophil count	8e-11	32888494
rs1820148	rs716848	0.939279999795698	Neutrophil percentage of white cells	2e-09	32888494
rs1820148	rs38029	0.930921404819159	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1820148	rs2548532	0.895263592533118	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs1820148	rs27660	0.779176880005977	Coronary artery disease	3e-08	35915156
rs1820148	rs1423357	0.766132945310865	General cognitive ability	9e-06	29844566
rs1820148	rs2432142	0.751250620991241	Neutrophil count	2e-14	32888493
rs1820148	rs2432142	0.751250620991241	White blood cell count	1e-11	32888493
rs1820148	rs38033	0.749373171913046	Blood protein levels	0	30072576
rs1820148	rs27293	0.740864515722166	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1820148	rs27293	0.740864515722166	Diastolic blood pressure	3e-11	35762941
rs1820148	rs7705093	0.731389169083199	Birdshot chorioretinopathy	2e-09	24957906
rs1820148	rs4869313	0.721225019799505	Pediatric autoimmune diseases	9e-08	26301688
rs1820148	rs2927608	0.720919457353305	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1820148	rs2927608	0.720919457353305	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1820148	rs2927608	0.720919457353305	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1820148	rs2910686	0.718552051013529	Neutrophil count	4e-14	32888493
rs1820148	rs2910686	0.718552051013529	Psoriasis	2e-08	23143594
rs1820148	rs2910686	0.718552051013529	Ankylosing spondylitis	5e-17	23749187
rs1820148	rs2910686	0.718552051013529	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1820148	rs1559359	0.652799285648767	Diastolic blood pressure	7e-10	34594039
rs1820148	rs1974871	0.647857196949029	Granulysin levels	5e-13	34648354
rs1820148	rs2549797	0.635232154952041	Systolic blood pressure	7e-07	33230300
rs1820148	rs2549797	0.635232154952041	Diastolic blood pressure	1e-14	33230300
rs1820148	rs2549797	0.635232154952041	Diastolic blood pressure	3e-11	33230300
rs1820148	rs2549797	0.635232154952041	Systolic blood pressure	4e-09	33230300
rs1820148	rs2549782	0.6342033097284	Systolic blood pressure	6e-07	33230300
rs1820148	rs2549782	0.6342033097284	Diastolic blood pressure	1e-14	33230300
rs1820148	rs2549782	0.6342033097284	Diastolic blood pressure	3e-11	33230300
rs1820148	rs2549782	0.6342033097284	Systolic blood pressure	5e-09	33230300
rs1820148	rs1056893	0.633689576385674	Systolic blood pressure	1e-06	33230300
rs1820148	rs1056893	0.633689576385674	Diastolic blood pressure	7e-15	33230300
rs1820148	rs1056893	0.633689576385674	Diastolic blood pressure	2e-11	33230300
rs1820148	rs1056893	0.633689576385674	Systolic blood pressure	7e-09	33230300
rs1822438	rs1822438	1	Hip circumference adjusted for BMI	4e-12	34021172
rs1822438	rs1443512	0.96502895685598	Waist-hip ratio	6e-17	20935629
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for body mass index	1e-14	25673412
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for body mass index	7e-13	25673412
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for body mass index	8e-16	25673412
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for body mass index	1e-13	25673412
rs1822438	rs1443512	0.96502895685598	Waist-hip ratio	2e-13	25673412
rs1822438	rs1443512	0.96502895685598	Waist-hip ratio	3e-11	25673412
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	5e-12	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	1e-13	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	1e-13	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	5e-12	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for body mass index	5e-13	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for body mass index	1e-13	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for body mass index	4e-13	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for body mass index	3e-13	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI	4e-13	26426971
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (age <50)	6e-06	26426971
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (age >50)	1e-08	26426971
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	7e-13	26426971
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI in non-smokers	3e-07	28443625
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI in non-smokers	5e-07	28443625
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	5e-07	28443625
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	5e-07	28443625
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	1e-10	28443625
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	2e-11	28443625
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI in active individuals	6e-14	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI in active individuals	3e-12	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI in active individuals	6e-14	28448500
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI in active individuals	3e-12	28448500
rs1822438	rs1443512	0.96502895685598	Waist-hip ratio	5e-08	30575882
rs1822438	rs1443512	0.96502895685598	Waist-to-hip ratio adjusted for BMI	3e-51	30575882
rs1822438	rs4759309	0.964986686408734	Gluteofemoral adipose tissue volumes (adjusted for BMI and height)	4e-08	35773277
rs1822438	rs894739	0.92804231739358	Hip index	6e-13	34021172
rs1822438	rs894739	0.92804231739358	Gluteofemoral adipose tissue volumes (adjusted for BMI and height)	6e-10	35773277
rs1822438	rs894739	0.92804231739358	Waist-hip ratio	6e-45	30595370
rs1822438	rs2366149	0.799471121947194	A body shape index	5e-24	34021172
rs1822438	rs2366149	0.799471121947194	Waist-hip index	1e-37	34021172
rs1822438	rs2366149	0.799471121947194	Waist-to-hip ratio adjusted for BMI	7e-38	34021172
rs1822438	rs2366149	0.799471121947194	Waist circumference adjusted for body mass index	1e-20	34021172
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for body mass index	4e-12	25673412
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for body mass index	3e-13	25673412
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for body mass index	3e-13	25673412
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for body mass index	2e-13	25673412
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	2e-14	26426971
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for BMI	3e-14	26426971
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for BMI in non-smokers	3e-08	28443625
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for BMI in non-smokers	9e-11	28443625
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	4e-09	28443625
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	2e-10	28443625
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	7e-11	28443625
rs1822438	rs10783615	0.69983590366066	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	7e-13	28443625
rs1822438	rs10747688	0.617532252763364	Waist-hip index	5e-10	34021172
rs1822438	rs10747688	0.617532252763364	Hip index	2e-13	34021172
rs1822438	rs10747688	0.617532252763364	Waist-hip index	2e-31	34021172
rs1822438	rs10747688	0.617532252763364	Waist-to-hip ratio adjusted for BMI	2e-10	34021172
rs1822438	rs10747688	0.617532252763364	Waist-to-hip ratio adjusted for BMI	7e-32	34021172
rs1822969	rs7321596	0.797407545782453	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs1822969	rs8002861	0.769835254798585	Leprosy	7e-06	25642632
rs1838169	rs920778	0.665141124194203	Haemorrhoidal disease	7e-10	33888516
rs184182	rs158796	0.943620039741797	Height	5e-243	36224396
rs184182	rs301901	0.935783202303258	Height	4e-16	25282103
rs184182	rs301901	0.935783202303258	Height	2e-06	35831902
rs184182	rs292172	0.925609909142216	Appendicular lean mass	8e-13	31761296
rs184182	rs158622	0.920764339496666	Height	4e-15	36224396
rs184182	rs300053	0.904290486300423	Height	3e-11	34594039
rs184182	rs300053	0.904290486300423	Height	3e-36	34594039
rs184182	rs300053	0.904290486300423	Height	2e-14	31562340
rs184182	rs158791	0.903129165591841	Height	2e-31	36224396
rs184182	rs300046	0.850037164427213	Meat-related diet	5e-08	32066663
rs184182	rs292168	0.842185617525768	Red cell distribution width	3e-10	30595370
rs185219	rs10061757	0.928067301413549	Height	4e-30	30595370
rs185219	rs33321	0.780392420336078	Height	1e-19	34594039
rs185219	rs832540	0.755599493975386	Coronary artery disease	2e-08	29212778
rs185219	rs702689	0.628356577522988	Vertex-wise sulcal depth	2e-22	34910505
rs185219	rs96844	0.600797365168364	Type 2 diabetes	5e-08	30297969
rs185219	rs96844	0.600797365168364	Height	4e-33	36224396
rs1854773	rs7655841	0.875287949700953	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1854773	rs337277	0.854157226775754	Metabolite peak levels (QI10992)	3e-52	35995766
rs1854773	rs337277	0.854157226775754	Metabolite peak levels (QI4667)	7e-18	35995766
rs1854773	rs337277	0.854157226775754	Metabolite peak levels (QI4708)	1e-21	35995766
rs1854773	rs337277	0.854157226775754	Metabolite peak levels (QI5169)	7e-57	35995766
rs1854773	rs10010659	0.601908053233516	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs1854774	rs337277	0.807132870596833	Metabolite peak levels (QI10992)	3e-52	35995766
rs1854774	rs337277	0.807132870596833	Metabolite peak levels (QI4667)	7e-18	35995766
rs1854774	rs337277	0.807132870596833	Metabolite peak levels (QI4708)	1e-21	35995766
rs1854774	rs337277	0.807132870596833	Metabolite peak levels (QI5169)	7e-57	35995766
rs1854774	rs7655841	0.774140648456335	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1859329	rs1859336	0.984602444847398	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1859329	rs6489882	0.976513189032161	Chronic lymphocytic leukemia	5e-08	28165464
rs1859329	rs11066452	0.962206627655933	Blood protein levels	6e-08	30072576
rs1859329	rs4767027	0.941164087791983	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1859329	rs2057778	0.939997217495369	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1859329	rs2057778	0.939997217495369	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1859329	rs2057778	0.939997217495369	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1859329	rs1131476	0.914929001603984	Systemic lupus erythematosus	1e-09	33272962
rs1859329	rs2660	0.914929001603984	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs1859329	rs2660	0.914929001603984	COVID-19 (critical illness vs population)	3e-15	37198478
rs1859329	rs6489867	0.670331323347399	COVID-19 (critical illness vs population)	1e-09	33307546
rs1859329	rs1557866	0.631765732233281	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs1859332	rs1859336	0.990514851892827	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1859332	rs6489882	0.970674614503094	Chronic lymphocytic leukemia	5e-08	28165464
rs1859332	rs11066452	0.968105401489477	Blood protein levels	6e-08	30072576
rs1859332	rs4767027	0.947043874980002	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1859332	rs2057778	0.943536106753098	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1859332	rs2057778	0.943536106753098	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1859332	rs2057778	0.943536106753098	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1859332	rs1131476	0.918383512421039	Systemic lupus erythematosus	1e-09	33272962
rs1859332	rs2660	0.918383512421039	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs1859332	rs2660	0.918383512421039	COVID-19 (critical illness vs population)	3e-15	37198478
rs1859332	rs6489867	0.674663242951612	COVID-19 (critical illness vs population)	1e-09	33307546
rs1859332	rs1557866	0.626760860801046	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs1859333	rs1859336	0.991702769125355	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1859333	rs6489882	0.971843155449831	Chronic lymphocytic leukemia	5e-08	28165464
rs1859333	rs11066452	0.969306185590769	Blood protein levels	6e-08	30072576
rs1859333	rs4767027	0.948254276476331	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1859333	rs2057778	0.944744331811606	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1859333	rs2057778	0.944744331811606	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1859333	rs2057778	0.944744331811606	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1859333	rs1131476	0.919557832711146	Systemic lupus erythematosus	1e-09	33272962
rs1859333	rs2660	0.919557832711146	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs1859333	rs2660	0.919557832711146	COVID-19 (critical illness vs population)	3e-15	37198478
rs1859333	rs6489867	0.675464836232867	COVID-19 (critical illness vs population)	1e-09	33307546
rs1859333	rs1557866	0.628118528869361	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs1860643	rs9897542	0.885420417421782	Total bilirubin levels	8e-11	34594039
rs1860643	rs2285583	0.738436035319409	AFP levels	2e-08	36329257
rs1860644	rs9897542	0.88313251161946	Total bilirubin levels	8e-11	34594039
rs1860644	rs2285583	0.736411970426907	AFP levels	2e-08	36329257
rs1860645	rs9897542	0.882354173097602	Total bilirubin levels	8e-11	34594039
rs1860645	rs2285583	0.735784577610723	AFP levels	2e-08	36329257
rs1861695	rs4764133	0.614818974917216	Osteoarthritis of the hand	2e-15	28855172
rs1861695	rs4764133	0.614818974917216	Low hand grip strength (60 years and older) (EWGSOP)	4e-09	33510174
rs1861695	rs4764133	0.614818974917216	Hand osteoarthritis severity (hand Klsum)	3e-12	33055079
rs1861695	rs4764133	0.614818974917216	Finger osteoarthritis severity (hand Klsum)	5e-14	33055079
rs1867731	rs10061757	0.7708086690169	Height	4e-30	30595370
rs1867731	rs702689	0.695490392441594	Vertex-wise sulcal depth	2e-22	34910505
rs1867731	rs33321	0.642877950311621	Height	1e-19	34594039
rs1867731	rs832540	0.621817645199773	Coronary artery disease	2e-08	29212778
rs1871925	rs11580836	0.939569271120748	Body mass index	2e-09	36581621
rs1871925	rs10465746	0.920126743362839	Obesity-related traits	8e-06	23251661
rs1880953	rs12539962	0.957954162589591	Colorectal cancer	3e-08	36539618
rs1880953	rs7806956	0.682967333704774	Esophageal squamous cell carcinoma	3e-07	37673066
rs1880953	rs4355658	0.657971282573405	Height	3e-13	36224396
rs1880953	rs13232536	0.633671606419837	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs1881125	rs7811577	0.75652476581225	Medication use (calcium channel blockers)	2e-09	34594039
rs1881125	rs12701798	0.726478502701584	Medication use (calcium channel blockers)	1e-08	34594039
rs1881125	rs2960826	0.647048609720227	Mean corpuscular hemoglobin	4e-08	34594039
rs1881125	rs2960826	0.647048609720227	Mean corpuscular volume	4e-12	34594039
rs1881125	rs1104888	0.633153355459244	Mean corpuscular volume	2e-17	32888493
rs1881125	rs1104888	0.633153355459244	Mean corpuscular hemoglobin	4e-12	30595370
rs188488	rs158796	0.951604969563969	Height	5e-243	36224396
rs188488	rs301901	0.940285098223362	Height	4e-16	25282103
rs188488	rs301901	0.940285098223362	Height	2e-06	35831902
rs188488	rs292172	0.935235910859437	Appendicular lean mass	8e-13	31761296
rs188488	rs158622	0.929026066656355	Height	4e-15	36224396
rs188488	rs158791	0.90570361830832	Height	2e-31	36224396
rs188488	rs300053	0.901930560248194	Height	3e-11	34594039
rs188488	rs300053	0.901930560248194	Height	3e-36	34594039
rs188488	rs300053	0.901930560248194	Height	2e-14	31562340
rs188488	rs300046	0.855297515745574	Meat-related diet	5e-08	32066663
rs188488	rs292168	0.850800164921993	Red cell distribution width	3e-10	30595370
rs188541	rs301901	0.972196190609795	Height	4e-16	25282103
rs188541	rs301901	0.972196190609795	Height	2e-06	35831902
rs188541	rs158796	0.939012367720038	Height	5e-243	36224396
rs188541	rs300053	0.919577461107472	Height	3e-11	34594039
rs188541	rs300053	0.919577461107472	Height	3e-36	34594039
rs188541	rs300053	0.919577461107472	Height	2e-14	31562340
rs188541	rs292172	0.918100092210995	Appendicular lean mass	8e-13	31761296
rs188541	rs158622	0.915864984736825	Height	4e-15	36224396
rs188541	rs158791	0.88449876241222	Height	2e-31	36224396
rs188541	rs300046	0.881620832272698	Meat-related diet	5e-08	32066663
rs188541	rs292168	0.834625621999603	Red cell distribution width	3e-10	30595370
rs188580753	rs12539962	0.84212032674595	Colorectal cancer	3e-08	36539618
rs188580753	rs13232536	0.728876028784142	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs188580753	rs4355658	0.679652382592148	Height	3e-13	36224396
rs188580753	rs7806956	0.640604128621463	Esophageal squamous cell carcinoma	3e-07	37673066
rs1886574	rs9462030	0.991955420745471	Red cell distribution width	5e-25	32888493
rs1886574	rs9469857	0.982346496461085	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs1886574	rs2764208	0.981552640300428	Systemic lupus erythematosus	7e-06	24871463
rs1886574	rs9469899	0.975348127909009	Prostate cancer (advanced)	2e-06	29892016
rs1886574	rs9469899	0.975348127909009	Prostate cancer	5e-09	29892016
rs1886574	rs9469899	0.975348127909009	Prostate cancer	8e-11	33398198
rs1886574	rs9469899	0.975348127909009	Hand grip strength	3e-15	29691431
rs1886574	rs9469899	0.975348127909009	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs1886574	rs9469899	0.975348127909009	Graves' disease	4e-10	34594039
rs1886574	rs9469899	0.975348127909009	Coronary artery disease	1e-11	36474045
rs1886574	rs9469899	0.975348127909009	Predicted visceral adipose tissue	2e-20	31501611
rs1886574	rs9469899	0.975348127909009	Medication use (thyroid preparations)	2e-09	31015401
rs1886574	rs9469899	0.975348127909009	Medication use (thyroid preparations)	3e-10	34594039
rs1886574	rs9469872	0.946322137010833	HDL cholesterol levels	3e-11	36333282
rs1886574	rs11755393	0.94450440153765	Body mass index	3e-26	29273807
rs1886574	rs11755393	0.94450440153765	Systemic lupus erythematosus	2e-12	33493351
rs1886574	rs11755393	0.94450440153765	Systemic lupus erythematosus	2e-06	33493351
rs1886574	rs11755393	0.94450440153765	Systemic lupus erythematosus	1e-07	33493351
rs1886574	rs11755393	0.94450440153765	Systemic lupus erythematosus	2e-08	19838195
rs1886574	rs11755393	0.94450440153765	Body mass index	4e-55	36581621
rs1886574	rs9366863	0.936125067281398	Adult body size	9e-33	32376654
rs1886574	rs9366863	0.936125067281398	Body mass index	2e-44	30595370
rs1886574	rs6941110	0.932955342017087	Sex hormone-binding globulin levels	5e-27	36653534
rs1886574	rs9296128	0.931724402564694	Hip circumference adjusted for BMI	4e-13	34021172
rs1886574	rs2814949	0.900105782065479	Essential hypertension (time to event)	9e-09	32589924
rs1886574	rs2744944	0.890787288517945	Hypothyroidism	3e-10	34594039
rs1886574	rs2744944	0.890787288517945	High density lipoprotein cholesterol levels	3e-86	34887591
rs1886574	rs2744944	0.890787288517945	Multi-trait sex score	7e-22	37277458
rs1886574	rs2263329	0.871647490663517	HDL cholesterol	6e-35	34594039
rs1886574	rs2263329	0.871647490663517	HDL cholesterol levels	8e-43	32203549
rs1886574	rs2263329	0.871647490663517	High density lipoprotein cholesterol levels	2e-52	34887591
rs1886574	rs111868030	0.847840099237953	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs1886574	rs9368830	0.827314736643418	HDL cholesterol	4e-21	30275531
rs1886574	rs9368828	0.800751653096818	Body mass index	1e-34	34594039
rs1886574	rs2744973	0.796933839166572	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs1886574	rs2744973	0.796933839166572	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs1886574	rs2744973	0.796933839166572	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs1886574	rs2744973	0.796933839166572	Multi-trait sex score	6e-20	37277458
rs1886574	rs6912327	0.788885010038493	Fasting insulin	5e-06	33402679
rs1886574	rs6912327	0.788885010038493	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs1886574	rs112283401	0.766612759553585	Red cell distribution width	4e-27	30595370
rs1886574	rs9689160	0.624258477199827	Lung function (forced vital capacity)	3e-14	36914875
rs1888997	rs11087521	0.884795238919768	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs1888997	rs59934506	0.864972401170809	Body fat percentage	4e-16	33980691
rs1888997	rs59934506	0.864972401170809	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs1888997	rs59934506	0.864972401170809	Alanine aminotransferase levels	2e-10	33980691
rs1888997	rs2424698	0.860153812871685	wg lh intensity-contrast middletemporal	3e-13	33875891
rs1888997	rs2424698	0.860153812871685	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs1888997	rs2424698	0.860153812871685	wg rh intensity-contrast middletemporal	7e-13	33875891
rs1888997	rs2424698	0.860153812871685	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs1888997	rs2424698	0.860153812871685	C-reactive protein	5e-11	34594039
rs1888997	rs7267979	0.860131691227903	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs1888997	rs7020	0.852318539622667	wg rh intensity-contrast fusiform	1e-10	33875891
rs1888997	rs7020	0.852318539622667	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs1888997	rs7020	0.852318539622667	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs1888997	rs7020	0.852318539622667	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs1888997	rs2151144	0.847804255438228	wg lh intensity-contrast fusiform	5e-12	33875891
rs1888997	rs2151144	0.847804255438228	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs1888997	rs2151144	0.847804255438228	wg rh intensity-contrast insula	6e-18	33875891
rs1888997	rs2151144	0.847804255438228	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs1888997	rs2151144	0.847804255438228	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs1888997	rs2151144	0.847804255438228	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs1888997	rs6083838	0.84441030628224	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs1888997	rs6083838	0.84441030628224	wg lh intensity-contrast insula	6e-13	33875891
rs1888997	rs7274104	0.832009340544273	Cortical thickness	4e-08	34560273
rs1888997	rs6115101	0.815322315503541	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs1888997	rs6115101	0.815322315503541	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs1888997	rs6115101	0.815322315503541	wg rh intensity-contrast supramarginal	3e-11	33875891
rs1888997	rs6115118	0.815322315503541	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs1888997	rs6138553	0.814572937592695	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs1888997	rs6115099	0.809736857421595	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs1888997	rs6115200	0.807003368495287	Height	9e-09	36224396
rs1888997	rs6115204	0.805564575763374	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs1888997	rs6138556	0.80341107039639	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs1888997	rs6083799	0.790865027510139	Serum alkaline phosphatase levels	1e-71	33547301
rs1888997	rs2261795	0.772002144546854	Non-HDL cholesterol levels	1e-09	34887591
rs1888997	rs84816	0.764453971276313	aseg rh intensity Caudate	7e-09	33875891
rs1888997	rs84816	0.764453971276313	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs1888997	rs4815412	0.764232266297646	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs1888997	rs12428	0.758966656048457	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs1888997	rs2500406	0.753591199236113	Brain region volumes	2e-08	31676860
rs1888997	rs2500406	0.753591199236113	Height	1e-33	36224396
rs1888997	rs2856	0.75137204064328	Blood protein levels	6e-07	27532455
rs1888997	rs6132824	0.742840703148197	Multi-trait sum score	5e-08	37277458
rs1888997	rs11699953	0.742154445492788	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs1888997	rs8184820	0.740082873609034	Brain morphology (MOSTest)	4e-13	35164939
rs1888997	rs9927	0.719190258956152	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs1888997	rs3746337	0.696647016469058	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs1888997	rs3746337	0.696647016469058	wg lh intensity-contrast frontalpole	1e-09	33875891
rs1888997	rs3746337	0.696647016469058	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs1888997	rs3746337	0.696647016469058	Total cholesterol levels	3e-09	34887591
rs1888997	rs2500430	0.69147459245562	Serum alkaline phosphatase levels	7e-10	31666285
rs1888997	rs6050464	0.679833121399532	Brain region volumes	5e-09	31676860
rs1888997	rs6050464	0.679833121399532	Apolipoprotein B levels	6e-14	32203549
rs1888997	rs1888995	0.677702329906384	Weight	2e-11	34594039
rs1888997	rs2260997	0.666279160768586	Subcortical volume (MOSTest)	4e-09	32665545
rs1888997	rs2260997	0.666279160768586	Platelet distribution width	5e-17	32888494
rs1889473	rs14314	0.810345998690158	Macular thickness	3e-19	30535121
rs1889473	rs14314	0.810345998690158	Vertex-wise sulcal depth	7e-17	34910505
rs1889473	rs14314	0.810345998690158	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs1889473	rs14314	0.810345998690158	Left hippocampal volume (body)	7e-15	37337106
rs1889473	rs14314	0.810345998690158	Left subiculum volume (body)	1e-14	37337106
rs1889473	rs2095375	0.797724019197196	Serum metabolite levels	1e-20	33031748
rs1889473	rs2095375	0.797724019197196	Serum metabolite levels	1e-20	33031748
rs1889473	rs9383843	0.796890416810158	Migraine	1e-09	35115687
rs1889473	rs55763431	0.793669282407219	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs1889473	rs9689694	0.792217830062972	Right hippocampal volume (head)	6e-11	37337106
rs1889473	rs9689694	0.792217830062972	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs1889473	rs9689694	0.792217830062972	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs1889473	rs9689694	0.792217830062972	Left hippocampal volume (head)	6e-12	37337106
rs1889473	rs10872645	0.792113851073251	Blood protein levels	2e-86	30072576
rs1889473	rs10872653	0.787044698300527	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs1889473	rs9688867	0.786239463830698	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs1889473	rs9688867	0.786239463830698	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs1889473	rs9688809	0.786239463830698	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs1889473	rs34337297	0.783636510320692	Serum levels of protein LRP11	3e-161	35078996
rs1889473	rs9322193	0.757513130442914	Lung cancer	1e-07	27393504
rs1889473	rs4039600	0.723849704444396	Adenine levels	1e-11	35347128
rs1891867	rs2795857	0.893381975976389	Height	2e-123	36224396
rs1891867	rs2462017	0.857113238068198	Lymphocyte count	3e-12	32888493
rs1891867	rs2488010	0.848040994609278	Monocyte count	9e-16	32888493
rs1891867	rs2462021	0.847287252565143	Suicide risk	8e-06	21041247
rs1891867	rs1332618	0.832509852864309	Platelet count	4e-15	32888494
rs1891867	rs2795863	0.824564195181695	Height	3e-20	36224396
rs1891867	rs503598	0.812150391132248	White blood cell count	2e-08	30595370
rs1891867	rs2689216	0.786983316669442	Platelet count	2e-22	32888493
rs1891867	rs2689216	0.786983316669442	Platelet count	1e-21	32888493
rs1891867	rs1571956	0.772672492794871	Neutrophil count	1e-11	32888493
rs1891867	rs2482820	0.763043234906076	Monocyte count	9e-13	32888494
rs1891867	rs2482819	0.760199689934919	Neutrophil count	4e-10	32888493
rs189235	rs337277	0.962663336213969	Metabolite peak levels (QI10992)	3e-52	35995766
rs189235	rs337277	0.962663336213969	Metabolite peak levels (QI4667)	7e-18	35995766
rs189235	rs337277	0.962663336213969	Metabolite peak levels (QI4708)	1e-21	35995766
rs189235	rs337277	0.962663336213969	Metabolite peak levels (QI5169)	7e-57	35995766
rs189235	rs7655841	0.741137199106036	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs1906276	rs7545078	0.790950162521672	Smoking initiation	2e-09	36477530
rs1906276	rs6700087	0.751150659737387	Smoking initiation	6e-11	36477530
rs1907040	rs10788817	0.885472940480271	Serum metabolite levels	3e-13	24625756
rs1907040	rs10788817	0.885472940480271	Metabolite peak levels (QI2718)	5e-18	35995766
rs1907040	rs10788817	0.885472940480271	3-hydroxylaurate levels	2e-12	36635386
rs1907040	rs10788817	0.885472940480271	Tetradecadienoate (14:2) levels	8e-17	36635386
rs1907040	rs11204914	0.880401869937543	Carnitine C9 levels	1e-13	35995766
rs1907040	rs11204914	0.880401869937543	Metabolite peak levels (QI6204)	1e-32	35995766
rs1907040	rs11204914	0.880401869937543	Metabolite peak levels (QI6252)	2e-32	35995766
rs1907040	rs6685187	0.854453512570875	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs1907040	rs2999541	0.853279262873829	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs1907040	rs6698740	0.852237902811265	Beta-hydroxyisovalerate levels	1e-13	35347128
rs1907040	rs1060870	0.850729419304286	Serum metabolite levels	1e-11	33031748
rs1907040	rs1060870	0.850729419304286	Serum metabolite levels	1e-15	33031748
rs1907040	rs3007711	0.849526208020124	Electrodermal activity	9e-06	25387706
rs1907040	rs2338201	0.840131942080051	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs1907040	rs2338201	0.840131942080051	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs1907040	rs2338201	0.840131942080051	Dodecadienoate (12:2) levels	7e-15	36635386
rs1907040	rs2130525	0.787242947947995	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs1907040	rs2999545	0.780844453141222	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs1907040	rs2279501	0.761707141090725	Serum metabolite levels	3e-14	33031748
rs1907040	rs7523082	0.709280153026355	Metabolite peak levels (QI9845)	2e-14	35995766
rs1907040	rs7542137	0.709228146175676	Beta-hydroxyisovalerate levels	3e-11	35050183
rs1907040	rs7542137	0.709228146175676	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs1907040	rs7542137	0.709228146175676	3-hydroxysebacate levels	2e-10	36635386
rs1907040	rs10888445	0.706334743151687	Beta-hydroxyisovalerate levels	5e-13	36635386
rs1907040	rs7541453	0.70220605843253	Serum metabolite levels	2e-16	33031748
rs1907040	rs7541453	0.70220605843253	Serum metabolite levels	2e-16	33031748
rs1907040	rs7541453	0.70220605843253	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs1907040	rs1038747	0.646747787169445	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs1907040	rs10494270	0.640730195076581	Nonaylcarnitine levels	5e-13	26068415
rs1907040	rs9943221	0.634130153523502	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs1907040	rs56000812	0.605056360344401	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs1907040	rs56078223	0.603100378600595	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs1907040	rs56078223	0.603100378600595	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs192249	rs33321	0.733011853437001	Height	1e-19	34594039
rs192249	rs832540	0.711614005169086	Coronary artery disease	2e-08	29212778
rs1934534	rs1934534	1	Pain (pleiotropy)	2e-08	37844115
rs1934534	rs1934534	1	Pain (pleiotropy)	2e-06	37844115
rs1934534	rs4380763	0.995942064195752	Subcortical volume (min-P)	1e-11	32665545
rs1934534	rs11155671	0.977399448789531	Testicular germ cell tumor	2e-09	28604728
rs1934534	rs80147756	0.953906937178241	HippSubfield lh volume subiculum-head	3e-10	33875891
rs1934534	rs4421206	0.944799029335397	Brain morphology (min-P)	4e-11	32665545
rs1934534	rs9505982	0.926534338165198	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs1934534	rs9688452	0.919951258485909	Brainstem global volume Whole-brainstem	1e-11	33875891
rs1934534	rs9688452	0.919951258485909	aseg lh volume VentralDC	2e-10	33875891
rs1934534	rs10872649	0.875498313802008	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs1934534	rs10872649	0.875498313802008	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs1934534	rs10872649	0.875498313802008	Right hippocampal volume (body)	1e-10	37337106
rs1934534	rs7752089	0.833003017682259	Brain morphology (MOSTest)	2e-31	35164939
rs1934534	rs9322194	0.784692650667056	Brainstem volume	2e-11	31636452
rs1934534	rs9285521	0.669721397775164	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs1934534	rs12526675	0.65494266857045	Brain morphology (MOSTest)	7e-22	32665545
rs1934534	rs9688809	0.647204991781655	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs1934534	rs10872645	0.644713780776187	Blood protein levels	2e-86	30072576
rs1934534	rs34337297	0.644133119384334	Serum levels of protein LRP11	3e-161	35078996
rs1934534	rs14314	0.642303286702625	Macular thickness	3e-19	30535121
rs1934534	rs14314	0.642303286702625	Vertex-wise sulcal depth	7e-17	34910505
rs1934534	rs14314	0.642303286702625	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs1934534	rs14314	0.642303286702625	Left hippocampal volume (body)	7e-15	37337106
rs1934534	rs14314	0.642303286702625	Left subiculum volume (body)	1e-14	37337106
rs1934534	rs55763431	0.641970793150743	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs1934534	rs9689694	0.640811466409662	Right hippocampal volume (head)	6e-11	37337106
rs1934534	rs9689694	0.640811466409662	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs1934534	rs9689694	0.640811466409662	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs1934534	rs9689694	0.640811466409662	Left hippocampal volume (head)	6e-12	37337106
rs1934534	rs9383843	0.639442991035185	Migraine	1e-09	35115687
rs1934534	rs2095375	0.63886426029342	Serum metabolite levels	1e-20	33031748
rs1934534	rs2095375	0.63886426029342	Serum metabolite levels	1e-20	33031748
rs1934534	rs10872653	0.63655279561687	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs1934534	rs9688867	0.634900224488811	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs1934534	rs9688867	0.634900224488811	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs1934534	rs9322193	0.615805006800916	Lung cancer	1e-07	27393504
rs1934534	rs2342764	0.61397612156062	Cortical thickness	1e-08	34560273
rs1935220	rs770199	0.878239512167608	Hair color	3e-08	30595370
rs1935221	rs770199	0.899480842202492	Hair color	3e-08	30595370
rs194059	rs832540	0.990175404720453	Coronary artery disease	2e-08	29212778
rs194059	rs33321	0.928665139023399	Height	1e-19	34594039
rs194059	rs10061757	0.768798199753131	Height	4e-30	30595370
rs1951832	rs2224797	0.909104756222664	Red blood cell count	5e-08	30595370
rs1951832	rs2224797	0.909104756222664	Mean corpuscular hemoglobin	3e-09	30595370
rs1952065	rs10465746	0.805326040910925	Obesity-related traits	8e-06	23251661
rs1952065	rs11580836	0.772477680190211	Body mass index	2e-09	36581621
rs1952066	rs10465746	0.804758285155484	Obesity-related traits	8e-06	23251661
rs1952066	rs11580836	0.770437457253271	Body mass index	2e-09	36581621
rs1952151	rs1952151	1	Height	3e-148	36224396
rs1952151	rs4982404	0.853101885323067	Height	1e-24	34594039
rs1952151	rs7140850	0.808570529059378	Body surface area	2e-08	36502284
rs1952151	rs8019890	0.713126804820201	Appendicular lean mass	2e-38	33097823
rs1952151	rs8019890	0.713126804820201	Height (weighted GWA)	2e-07	37106081
rs1952151	rs8019890	0.713126804820201	Height (standard GWA)	6e-15	37106081
rs1952151	rs8019890	0.713126804820201	Height	2e-39	30595370
rs1966266	rs5756090	0.961516282973786	Severe COVID-19 infection	4e-08	36662838
rs1966266	rs2227169	0.876920510920786	Severe COVID-19 infection	4e-13	36662838
rs1966266	rs1053982	0.858110520057224	Severe COVID-19 infection	9e-06	36662838
rs1966266	rs6000172	0.858046117641523	Severe COVID-19 infection	1e-07	36662838
rs1966266	rs4821461	0.847213872881496	Severe COVID-19 infection	4e-06	36662838
rs1966267	rs5756090	0.961516282973786	Severe COVID-19 infection	4e-08	36662838
rs1966267	rs2227169	0.876920510920786	Severe COVID-19 infection	4e-13	36662838
rs1966267	rs1053982	0.858110520057224	Severe COVID-19 infection	9e-06	36662838
rs1966267	rs6000172	0.858046117641523	Severe COVID-19 infection	1e-07	36662838
rs1966267	rs4821461	0.847213872881496	Severe COVID-19 infection	4e-06	36662838
rs1969111	rs28482086	0.825741735448284	Educational attainment (years of education)	5e-09	30038396
rs1969111	rs3931020	0.759935780816368	Resistin levels	6e-12	22843503
rs1969111	rs28568334	0.742170059913173	Educational attainment	4e-13	35361970
rs1969111	rs277402	0.603494772016433	Heel bone mineral density	2e-09	30048462
rs1970477	rs8002180	0.963132024892058	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs1970477	rs9590228	0.91746449707134	Height	7e-22	36224396
rs1970477	rs9524869	0.809387309794571	Serum metabolite levels	6e-32	33031748
rs1970477	rs9524869	0.809387309794571	N-acetylcarnosine levels	1e-42	35347128
rs1970477	rs9524869	0.809387309794571	N-acetylcarnosine levels	9e-47	35050183
rs1970477	rs9524869	0.809387309794571	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs1970477	rs9524869	0.809387309794571	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs1970477	rs9524869	0.809387309794571	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs1970477	rs9524869	0.809387309794571	N-acetylcarnosine levels	2e-60	36635386
rs1971230	rs10876448	0.914759336598525	Mean corpuscular hemoglobin	2e-16	32888493
rs1971230	rs10876448	0.914759336598525	Reticulocyte count	3e-18	32888494
rs1971230	rs10876448	0.914759336598525	Reticulocyte fraction of red cells	1e-10	32888494
rs1971230	rs2446066	0.913904795977004	Vertex-wise sulcal depth	1e-10	34910505
rs1971230	rs2446066	0.913904795977004	Vertex-wise cortical surface area	2e-13	34910505
rs1971230	rs2446066	0.913904795977004	Red blood cell count	1e-10	27863252
rs1971230	rs2446066	0.913904795977004	Cortical surface area	3e-08	34560273
rs1971230	rs2608301	0.913904795977004	Low density lipoprotein cholesterol levels	2e-12	34887591
rs1971230	rs2460882	0.912143450848978	Mean corpuscular volume	3e-15	29403010
rs1971230	rs2460882	0.912143450848978	Percentage gas trapping	6e-07	26030696
rs1971230	rs12582170	0.883642908569201	Mean corpuscular volume	1e-21	27863252
rs1971230	rs12582170	0.883642908569201	Mean corpuscular hemoglobin	7e-37	32888493
rs1971230	rs12582170	0.883642908569201	Mean reticulocyte volume	2e-33	32888494
rs1971230	rs12582170	0.883642908569201	Mean corpuscular volume	1e-67	32888493
rs1971230	rs12582170	0.883642908569201	Mean corpuscular hemoglobin	2e-21	32888494
rs1971230	rs12582170	0.883642908569201	Mean corpuscular volume	1e-26	34104963
rs1971230	rs111379945	0.84426449539601	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs1971230	rs111379945	0.84426449539601	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs1971230	rs111379945	0.84426449539601	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs1971328	rs6680628	0.713102627326381	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs1974871	rs1974871	1	Granulysin levels	5e-13	34648354
rs1974871	rs4869313	0.901290820613549	Pediatric autoimmune diseases	9e-08	26301688
rs1974871	rs4869314	0.829930968819113	Arthritis (juvenile idiopathic)	3e-09	33106285
rs1974871	rs4869314	0.829930968819113	Neutrophil count	1e-10	34594039
rs1974871	rs4869314	0.829930968819113	White blood cell count	2e-07	30595370
rs1974871	rs2549782	0.782793333712093	Systolic blood pressure	6e-07	33230300
rs1974871	rs2549782	0.782793333712093	Diastolic blood pressure	1e-14	33230300
rs1974871	rs2549782	0.782793333712093	Diastolic blood pressure	3e-11	33230300
rs1974871	rs2549782	0.782793333712093	Systolic blood pressure	5e-09	33230300
rs1974871	rs2549797	0.782713498592836	Systolic blood pressure	7e-07	33230300
rs1974871	rs2549797	0.782713498592836	Diastolic blood pressure	1e-14	33230300
rs1974871	rs2549797	0.782713498592836	Diastolic blood pressure	3e-11	33230300
rs1974871	rs2549797	0.782713498592836	Systolic blood pressure	4e-09	33230300
rs1974871	rs1056893	0.780678212009348	Systolic blood pressure	1e-06	33230300
rs1974871	rs1056893	0.780678212009348	Diastolic blood pressure	7e-15	33230300
rs1974871	rs1056893	0.780678212009348	Diastolic blood pressure	2e-11	33230300
rs1974871	rs1056893	0.780678212009348	Systolic blood pressure	7e-09	33230300
rs1974871	rs1559359	0.762663472344161	Diastolic blood pressure	7e-10	34594039
rs1974871	rs2927608	0.745292343886263	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs1974871	rs2927608	0.745292343886263	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs1974871	rs2927608	0.745292343886263	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs1974871	rs2910686	0.742481353718913	Neutrophil count	4e-14	32888493
rs1974871	rs2910686	0.742481353718913	Psoriasis	2e-08	23143594
rs1974871	rs2910686	0.742481353718913	Ankylosing spondylitis	5e-17	23749187
rs1974871	rs2910686	0.742481353718913	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs1974871	rs1019503	0.669261235917001	Systolic blood pressure	2e-06	33230300
rs1974871	rs1019503	0.669261235917001	Diastolic blood pressure	2e-14	33230300
rs1974871	rs1019503	0.669261235917001	Diastolic blood pressure	4e-11	33230300
rs1974871	rs1019503	0.669261235917001	Systolic blood pressure	1e-08	33230300
rs1974871	rs3096168	0.663626203145482	Aspartate aminotransferase levels	8e-12	33547301
rs1974871	rs2549794	0.650770503938115	Crohn's disease	1e-10	21102463
rs1974871	rs2549794	0.650770503938115	Systolic blood pressure	1e-07	33230300
rs1974871	rs2549794	0.650770503938115	Diastolic blood pressure	1e-15	33230300
rs1974871	rs2549794	0.650770503938115	Diastolic blood pressure	2e-12	33230300
rs1974871	rs2549794	0.650770503938115	Systolic blood pressure	4e-10	33230300
rs1974871	rs1363907	0.646485295817104	Crohn's disease	4e-16	26192919
rs1974871	rs1363907	0.646485295817104	Ulcerative colitis	4e-06	26192919
rs1974871	rs1363907	0.646485295817104	Inflammatory bowel disease	5e-15	26192919
rs1974871	rs1363907	0.646485295817104	Inflammatory bowel disease	6e-13	23128233
rs1974871	rs1363907	0.646485295817104	Inflammatory bowel disease	1e-10	28067908
rs1974871	rs1363907	0.646485295817104	Crohn's disease	1e-14	28067908
rs1974871	rs1423357	0.643898786501875	General cognitive ability	9e-06	29844566
rs1974871	rs716848	0.643592798349629	Neutrophil percentage of white cells	2e-09	32888494
rs1974871	rs2432142	0.630612732808046	Neutrophil count	2e-14	32888493
rs1974871	rs2432142	0.630612732808046	White blood cell count	1e-11	32888493
rs1974871	rs38033	0.626202780286607	Blood protein levels	0	30072576
rs1974871	rs27293	0.616463840026967	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs1974871	rs27293	0.616463840026967	Diastolic blood pressure	3e-11	35762941
rs1974871	rs2617439	0.613775962364259	Neutrophil count	8e-11	32888494
rs1974871	rs7705093	0.609024649303833	Birdshot chorioretinopathy	2e-09	24957906
rs1974871	rs38029	0.601584850958235	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs1977582	rs2795857	0.984382819755337	Height	2e-123	36224396
rs1977582	rs2462017	0.781518335932116	Lymphocyte count	3e-12	32888493
rs1977582	rs2488010	0.772610636158843	Monocyte count	9e-16	32888493
rs1977582	rs2462021	0.771874483232084	Suicide risk	8e-06	21041247
rs1977582	rs1332618	0.770038700567823	Platelet count	4e-15	32888494
rs1977582	rs2795863	0.752254800501425	Height	3e-20	36224396
rs1977582	rs503598	0.737466553700183	White blood cell count	2e-08	30595370
rs1977582	rs2689216	0.717831928259146	Platelet count	2e-22	32888493
rs1977582	rs2689216	0.717831928259146	Platelet count	1e-21	32888493
rs1977582	rs1571956	0.704437876616986	Neutrophil count	1e-11	32888493
rs1977582	rs2482820	0.695345211211993	Monocyte count	9e-13	32888494
rs1977582	rs2482819	0.692566623548962	Neutrophil count	4e-10	32888493
rs1977582	rs2091084	0.650309323216134	White blood cell count	6e-19	32888493
rs1977582	rs2091084	0.650309323216134	Lymphocyte count	3e-10	32888494
rs1977582	rs2091084	0.650309323216134	White blood cell count	4e-13	32888494
rs1977582	rs2462015	0.604917735615068	White blood cell count	5e-17	32888493
rs1977583	rs2795857	0.968812518934399	Height	2e-123	36224396
rs1977583	rs2462017	0.7698825973047	Lymphocyte count	3e-12	32888493
rs1977583	rs2488010	0.760989607046712	Monocyte count	9e-16	32888493
rs1977583	rs2462021	0.760255441310901	Suicide risk	8e-06	21041247
rs1977583	rs1332618	0.757351369099186	Platelet count	4e-15	32888494
rs1977583	rs2795863	0.740900750518589	Height	3e-20	36224396
rs1977583	rs503598	0.725922869121072	White blood cell count	2e-08	30595370
rs1977583	rs2689216	0.706737975428137	Platelet count	2e-22	32888493
rs1977583	rs2689216	0.706737975428137	Platelet count	1e-21	32888493
rs1977583	rs1571956	0.69349897201956	Neutrophil count	1e-11	32888493
rs1977583	rs2482820	0.685877146667382	Monocyte count	9e-13	32888494
rs1977583	rs2482819	0.683103510473842	Neutrophil count	4e-10	32888493
rs1977583	rs2091084	0.639225528887715	White blood cell count	6e-19	32888493
rs1977583	rs2091084	0.639225528887715	Lymphocyte count	3e-10	32888494
rs1977583	rs2091084	0.639225528887715	White blood cell count	4e-13	32888494
rs1980851	rs28482086	0.821513563152442	Educational attainment (years of education)	5e-09	30038396
rs1980851	rs3931020	0.755530438558387	Resistin levels	6e-12	22843503
rs1980851	rs28568334	0.738033157653115	Educational attainment	4e-13	35361970
rs1981554	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1981554	rs6489882	0.973012290739672	Chronic lymphocytic leukemia	5e-08	28165464
rs1981554	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs1981554	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1981554	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1981554	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1981554	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1981554	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs1981554	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs1981554	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs1981554	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs1981554	rs1557866	0.629477186112456	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs1981555	rs1859336	0.974270923210188	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1981555	rs6489882	0.959234593556817	Chronic lymphocytic leukemia	5e-08	28165464
rs1981555	rs11066452	0.952258866983591	Blood protein levels	6e-08	30072576
rs1981555	rs4767027	0.931559191577056	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1981555	rs2057778	0.930396692917226	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1981555	rs2057778	0.930396692917226	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1981555	rs2057778	0.930396692917226	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1981555	rs1131476	0.905406190042129	Systemic lupus erythematosus	1e-09	33272962
rs1981555	rs2660	0.905406190042129	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs1981555	rs2660	0.905406190042129	COVID-19 (critical illness vs population)	3e-15	37198478
rs1981555	rs6489867	0.683991702880807	COVID-19 (critical illness vs population)	1e-09	33307546
rs1981555	rs1557866	0.618964349262652	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs1981556	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1981556	rs6489882	0.973012290739672	Chronic lymphocytic leukemia	5e-08	28165464
rs1981556	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs1981556	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1981556	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1981556	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1981556	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1981556	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs1981556	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs1981556	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs1981556	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs1981556	rs1557866	0.629477186112456	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs1981557	rs1859336	0.974230491613237	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs1981557	rs6489882	0.956896490958683	Chronic lymphocytic leukemia	5e-08	28165464
rs1981557	rs11066452	0.952180771291252	Blood protein levels	6e-08	30072576
rs1981557	rs4767027	0.931448746971396	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs1981557	rs2057778	0.927982279001952	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs1981557	rs2057778	0.927982279001952	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs1981557	rs2057778	0.927982279001952	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs1981557	rs1131476	0.903059605334448	Systemic lupus erythematosus	1e-09	33272962
rs1981557	rs2660	0.903059605334448	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs1981557	rs2660	0.903059605334448	COVID-19 (critical illness vs population)	3e-15	37198478
rs1981557	rs6489867	0.684149456125262	COVID-19 (critical illness vs population)	1e-09	33307546
rs1981557	rs1557866	0.620449571091017	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs1981916	rs28373613	0.907304514675214	Height (standard GWA)	8e-12	37106081
rs1981916	rs13379492	0.651408365814433	Lung function (FEV1/FVC)	6e-08	30595370
rs1981916	rs8034216	0.617196249952419	C-reactive protein levels	2e-10	31900758
rs1981917	rs28373613	0.918891180684044	Height (standard GWA)	8e-12	37106081
rs1981917	rs13379492	0.649182314950624	Lung function (FEV1/FVC)	6e-08	30595370
rs1981917	rs8034216	0.611891824184966	C-reactive protein levels	2e-10	31900758
rs1984111	rs14314	0.810849395515045	Macular thickness	3e-19	30535121
rs1984111	rs14314	0.810849395515045	Vertex-wise sulcal depth	7e-17	34910505
rs1984111	rs14314	0.810849395515045	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs1984111	rs14314	0.810849395515045	Left hippocampal volume (body)	7e-15	37337106
rs1984111	rs14314	0.810849395515045	Left subiculum volume (body)	1e-14	37337106
rs1984111	rs2095375	0.798207474343759	Serum metabolite levels	1e-20	33031748
rs1984111	rs2095375	0.798207474343759	Serum metabolite levels	1e-20	33031748
rs1984111	rs9383843	0.797374300127021	Migraine	1e-09	35115687
rs1984111	rs55763431	0.794153068637892	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs1984111	rs9689694	0.792698863339901	Right hippocampal volume (head)	6e-11	37337106
rs1984111	rs9689694	0.792698863339901	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs1984111	rs9689694	0.792698863339901	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs1984111	rs9689694	0.792698863339901	Left hippocampal volume (head)	6e-12	37337106
rs1984111	rs10872645	0.792596686743492	Blood protein levels	2e-86	30072576
rs1984111	rs10872653	0.787517921757417	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs1984111	rs9688867	0.786727060767537	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs1984111	rs9688867	0.786727060767537	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs1984111	rs9688809	0.786727060767537	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs1984111	rs34337297	0.784113237570199	Serum levels of protein LRP11	3e-161	35078996
rs1984111	rs9322193	0.757991194185638	Lung cancer	1e-07	27393504
rs1984111	rs4039600	0.724233187724527	Adenine levels	1e-11	35347128
rs1986965	rs10222974	0.711039885567002	Height	3e-07	36224396
rs1989670	rs4304220	0.867347575367006	Height	2e-14	36224396
rs1989670	rs4355658	0.817717373306373	Height	3e-13	36224396
rs1989670	rs13232536	0.614041555744898	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs1989670	rs12539962	0.601093864378622	Colorectal cancer	3e-08	36539618
rs1998702	rs9469872	0.998394044555158	HDL cholesterol levels	3e-11	36333282
rs1998702	rs11755393	0.972191494663217	Body mass index	3e-26	29273807
rs1998702	rs11755393	0.972191494663217	Systemic lupus erythematosus	2e-12	33493351
rs1998702	rs11755393	0.972191494663217	Systemic lupus erythematosus	2e-06	33493351
rs1998702	rs11755393	0.972191494663217	Systemic lupus erythematosus	1e-07	33493351
rs1998702	rs11755393	0.972191494663217	Systemic lupus erythematosus	2e-08	19838195
rs1998702	rs11755393	0.972191494663217	Body mass index	4e-55	36581621
rs1998702	rs9366863	0.968905389782434	Adult body size	9e-33	32376654
rs1998702	rs9366863	0.968905389782434	Body mass index	2e-44	30595370
rs1998702	rs6941110	0.961014536054212	Sex hormone-binding globulin levels	5e-27	36653534
rs1998702	rs9469857	0.959006274758683	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs1998702	rs2764208	0.956688621501686	Systemic lupus erythematosus	7e-06	24871463
rs1998702	rs9462030	0.943249855180756	Red cell distribution width	5e-25	32888493
rs1998702	rs2744944	0.941416618774382	Hypothyroidism	3e-10	34594039
rs1998702	rs2744944	0.941416618774382	High density lipoprotein cholesterol levels	3e-86	34887591
rs1998702	rs2744944	0.941416618774382	Multi-trait sex score	7e-22	37277458
rs1998702	rs2814949	0.932112280228606	Essential hypertension (time to event)	9e-09	32589924
rs1998702	rs9469899	0.926664914053113	Prostate cancer (advanced)	2e-06	29892016
rs1998702	rs9469899	0.926664914053113	Prostate cancer	5e-09	29892016
rs1998702	rs9469899	0.926664914053113	Prostate cancer	8e-11	33398198
rs1998702	rs9469899	0.926664914053113	Hand grip strength	3e-15	29691431
rs1998702	rs9469899	0.926664914053113	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs1998702	rs9469899	0.926664914053113	Graves' disease	4e-10	34594039
rs1998702	rs9469899	0.926664914053113	Coronary artery disease	1e-11	36474045
rs1998702	rs9469899	0.926664914053113	Predicted visceral adipose tissue	2e-20	31501611
rs1998702	rs9469899	0.926664914053113	Medication use (thyroid preparations)	2e-09	31015401
rs1998702	rs9469899	0.926664914053113	Medication use (thyroid preparations)	3e-10	34594039
rs1998702	rs2263329	0.920494784878998	HDL cholesterol	6e-35	34594039
rs1998702	rs2263329	0.920494784878998	HDL cholesterol levels	8e-43	32203549
rs1998702	rs2263329	0.920494784878998	High density lipoprotein cholesterol levels	2e-52	34887591
rs1998702	rs9296128	0.90842424848005	Hip circumference adjusted for BMI	4e-13	34021172
rs1998702	rs111868030	0.89768257356005	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs1998702	rs9368830	0.856690094205737	HDL cholesterol	4e-21	30275531
rs1998702	rs9368828	0.845024785173927	Body mass index	1e-34	34594039
rs1998702	rs6912327	0.818052127940994	Fasting insulin	5e-06	33402679
rs1998702	rs6912327	0.818052127940994	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs1998702	rs112283401	0.795388673802119	Red cell distribution width	4e-27	30595370
rs1998702	rs2744973	0.773092821146705	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs1998702	rs2744973	0.773092821146705	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs1998702	rs2744973	0.773092821146705	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs1998702	rs2744973	0.773092821146705	Multi-trait sex score	6e-20	37277458
rs1998702	rs6940215	0.624379848759855	Insomnia	2e-10	35835914
rs1998702	rs6940215	0.624379848759855	Insomnia	1e-13	35835914
rs1998702	rs6940215	0.624379848759855	Hip circumference adjusted for BMI	8e-10	34021172
rs1998702	rs6940215	0.624379848759855	Multi-trait sex score	2e-23	37277458
rs1998702	rs6940215	0.624379848759855	Multi-trait sex score	4e-23	37277458
rs1998702	rs6457796	0.615403088028926	Insomnia	1e-08	30804565
rs1998702	rs6457796	0.615403088028926	Plateletcrit	9e-11	32888494
rs1998702	rs6457796	0.615403088028926	Systemic lupus erythematosus	3e-22	33272962
rs1998702	rs6457796	0.615403088028926	Body mass index	5e-13	30108127
rs1998702	rs6457796	0.615403088028926	Body mass index	1e-14	26426971
rs1998702	rs6457796	0.615403088028926	Educational attainment	5e-19	35361970
rs1998702	rs205262	0.602339102119846	Body mass index	2e-09	26961502
rs1998702	rs205262	0.602339102119846	Walking pace	4e-10	33128006
rs1998702	rs205262	0.602339102119846	Body mass index	8e-13	30108127
rs1998702	rs205262	0.602339102119846	Body mass index	2e-09	25673413
rs1998702	rs205262	0.602339102119846	Body mass index	2e-14	26426971
rs1998702	rs205262	0.602339102119846	BMI in non-smokers	3e-07	28443625
rs1998702	rs205262	0.602339102119846	BMI in non-smokers	6e-09	28443625
rs1998702	rs205262	0.602339102119846	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs1998702	rs205262	0.602339102119846	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs1998702	rs205262	0.602339102119846	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs1998702	rs205262	0.602339102119846	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs1998702	rs205262	0.602339102119846	Gastroesophageal reflux disease	1e-10	34187846
rs1998702	rs205262	0.602339102119846	Body mass index	3e-10	25673413
rs1998702	rs205262	0.602339102119846	Body mass index	2e-10	25673413
rs1998702	rs205262	0.602339102119846	ICD10 M54: Dorsalgia	2e-12	35110524
rs2002471	rs11170776	0.745088770431201	Waist-to-hip ratio adjusted for BMI	2e-09	31669095
rs2002472	rs920778	0.860848626942262	Haemorrhoidal disease	7e-10	33888516
rs2005918	rs2695294	0.752964885215832	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs2005918	rs2695295	0.752329978072923	Serum levels of protein NAAA	1e-68	35078996
rs2005918	rs2695295	0.752329978072923	Serum levels of protein SMPDL3A	8e-86	35078996
rs2005918	rs2559856	0.75094154237597	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs2005918	rs3809260	0.74394070216065	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs2005918	rs2559851	0.69453945414693	Cathepsin F levels	2e-96	34648354
rs2005918	rs2559851	0.69453945414693	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs2005918	rs2559850	0.646311124555218	Serum levels of protein CTSH	1e-19	35078996
rs2005918	rs2559850	0.646311124555218	Vitamin C levels	6e-20	33203707
rs2005918	rs2559850	0.646311124555218	Cathepsin L2 levels	1e-24	34648354
rs2005918	rs2559850	0.646311124555218	Islet amyloid polypeptide levels	1e-49	34648354
rs2005918	rs2559850	0.646311124555218	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs2007468	rs5756090	0.901345444326118	Severe COVID-19 infection	4e-08	36662838
rs2007468	rs6000172	0.777980636515662	Severe COVID-19 infection	1e-07	36662838
rs2007468	rs4821461	0.766410228140057	Severe COVID-19 infection	4e-06	36662838
rs2007468	rs2227169	0.764090674803511	Severe COVID-19 infection	4e-13	36662838
rs2007468	rs1053982	0.747687595671405	Severe COVID-19 infection	9e-06	36662838
rs2007706	rs5756090	0.820377595753737	Severe COVID-19 infection	4e-08	36662838
rs2007706	rs4821461	0.720756846484065	Severe COVID-19 infection	4e-06	36662838
rs2007706	rs6000172	0.709104342150684	Severe COVID-19 infection	1e-07	36662838
rs2007706	rs2227169	0.698027609968242	Severe COVID-19 infection	4e-13	36662838
rs2007706	rs1053982	0.681469649201469	Severe COVID-19 infection	9e-06	36662838
rs2008908	rs2622935	0.778140363975911	Serum levels of protein CASC4	3e-16	35078996
rs2008908	rs2622935	0.778140363975911	Polypeptide N-acetylgalactosaminyltransferase 1 levels	1e-30	34648354
rs2008908	rs4938354	0.773339905914093	Proprotein convertase subtilisin/kexin type 7 levels	3e-295	36168886
rs2008908	rs1871757	0.751847650373474	Transgelin levels	2e-15	34648354
rs2008908	rs1794116	0.751372664227344	Protein CASC4 levels	5e-13	34648354
rs2008908	rs1794116	0.751372664227344	Asialoglycoprotein receptor 1 levels	7e-18	34648354
rs2008908	rs4938344	0.719146436962915	Cerebrospinal fluid biomarker levels	7e-19	28031287
rs2008908	rs9326248	0.715013705825641	Proprotein convertase subtilisin/kexin type 7 levels	2e-105	28240269
rs2008908	rs7128382	0.701320914365516	Systolic blood pressure	4e-11	30578418
rs2008908	rs171052	0.695677948304991	Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)	1e-38	35870639
rs2008908	rs1060211	0.690582054451905	Diastolic blood pressure	5e-09	35762941
rs2008908	rs6589598	0.67267874918577	Blood protein levels	0	30072576
rs2008908	rs6589598	0.67267874918577	Blood protein levels	3e-13	30072576
rs2008908	rs6589598	0.67267874918577	Blood protein levels	2e-15	30072576
rs2008908	rs6589598	0.67267874918577	Blood protein levels	2e-10	30072576
rs2008908	rs6589598	0.67267874918577	Protein-tyrosine sulfotransferase 2 levels	6e-14	34648354
rs2008908	rs6589598	0.67267874918577	Beta-1,4-galactosyltransferase 7 levels	5e-13	34648354
rs2008908	rs4938353	0.641021763684537	Blood protein levels	2e-14	27532455
rs2009527	rs2041387	0.860726554601025	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2009527	rs2532497	0.840572733816278	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2009527	rs2532497	0.840572733816278	Tapasin-related protein levels	0	34648354
rs2016831	rs1557866	1	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs2016831	rs1293767	0.897639450963228	Adult asthma	2e-06	27611488
rs2016831	rs1293767	0.897639450963228	Adult asthma	9e-07	27611488
rs2016831	rs6489882	0.64174960194697	Chronic lymphocytic leukemia	5e-08	28165464
rs2016831	rs1859336	0.61982849623932	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs2016831	rs10744789	0.610025075807648	Vitamin D levels or COVID-19 (MTAG)	5e-12	37212302
rs2016831	rs4767027	0.6033381828865	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs2016831	rs2057778	0.600481748899161	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs2016831	rs2057778	0.600481748899161	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs2016831	rs2057778	0.600481748899161	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs2022062	rs3213282	0.608150927292831	Low density lipoprotein cholesterol levels	3e-11	32154731
rs2024094	rs1138888	0.715980054675994	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs2024094	rs1138888	0.715980054675994	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs2024094	rs4802157	0.69917062609198	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs2024095	rs1138888	0.794412369323271	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs2024095	rs1138888	0.794412369323271	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs2024095	rs4802157	0.773978393577186	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs2024095	rs2355433	0.669016349429688	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs2024095	rs2355433	0.669016349429688	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs2024095	rs2355433	0.669016349429688	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs2024591	rs10465746	0.750354422756532	Obesity-related traits	8e-06	23251661
rs2024591	rs11580836	0.728157937318082	Body mass index	2e-09	36581621
rs2027445	rs8002180	0.963132024892058	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs2027445	rs9590228	0.91746449707134	Height	7e-22	36224396
rs2027445	rs9524869	0.809387309794571	Serum metabolite levels	6e-32	33031748
rs2027445	rs9524869	0.809387309794571	N-acetylcarnosine levels	1e-42	35347128
rs2027445	rs9524869	0.809387309794571	N-acetylcarnosine levels	9e-47	35050183
rs2027445	rs9524869	0.809387309794571	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs2027445	rs9524869	0.809387309794571	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs2027445	rs9524869	0.809387309794571	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs2027445	rs9524869	0.809387309794571	N-acetylcarnosine levels	2e-60	36635386
rs2038638	rs7987940	0.71831144171676	AFP levels	6e-08	36329257
rs2038638	rs9535244	0.652177505353611	Lung function (FVC)	1e-08	30595370
rs2038839	rs9469872	0.95829158969358	HDL cholesterol levels	3e-11	36333282
rs2038839	rs11755393	0.950969143237736	Body mass index	3e-26	29273807
rs2038839	rs11755393	0.950969143237736	Systemic lupus erythematosus	2e-12	33493351
rs2038839	rs11755393	0.950969143237736	Systemic lupus erythematosus	2e-06	33493351
rs2038839	rs11755393	0.950969143237736	Systemic lupus erythematosus	1e-07	33493351
rs2038839	rs11755393	0.950969143237736	Systemic lupus erythematosus	2e-08	19838195
rs2038839	rs11755393	0.950969143237736	Body mass index	4e-55	36581621
rs2038839	rs9366863	0.948147387122498	Adult body size	9e-33	32376654
rs2038839	rs9366863	0.948147387122498	Body mass index	2e-44	30595370
rs2038839	rs6941110	0.94040753568696	Sex hormone-binding globulin levels	5e-27	36653534
rs2038839	rs9462030	0.923398114598207	Red cell distribution width	5e-25	32888493
rs2038839	rs9469857	0.918877131708682	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2038839	rs2764208	0.91819072300959	Systemic lupus erythematosus	7e-06	24871463
rs2038839	rs2814949	0.911618968201906	Essential hypertension (time to event)	9e-09	32589924
rs2038839	rs9469899	0.906555958302049	Prostate cancer (advanced)	2e-06	29892016
rs2038839	rs9469899	0.906555958302049	Prostate cancer	5e-09	29892016
rs2038839	rs9469899	0.906555958302049	Prostate cancer	8e-11	33398198
rs2038839	rs9469899	0.906555958302049	Hand grip strength	3e-15	29691431
rs2038839	rs9469899	0.906555958302049	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2038839	rs9469899	0.906555958302049	Graves' disease	4e-10	34594039
rs2038839	rs9469899	0.906555958302049	Coronary artery disease	1e-11	36474045
rs2038839	rs9469899	0.906555958302049	Predicted visceral adipose tissue	2e-20	31501611
rs2038839	rs9469899	0.906555958302049	Medication use (thyroid preparations)	2e-09	31015401
rs2038839	rs9469899	0.906555958302049	Medication use (thyroid preparations)	3e-10	34594039
rs2038839	rs2744944	0.902555271466449	Hypothyroidism	3e-10	34594039
rs2038839	rs2744944	0.902555271466449	High density lipoprotein cholesterol levels	3e-86	34887591
rs2038839	rs2744944	0.902555271466449	Multi-trait sex score	7e-22	37277458
rs2038839	rs2263329	0.885338790769141	HDL cholesterol	6e-35	34594039
rs2038839	rs2263329	0.885338790769141	HDL cholesterol levels	8e-43	32203549
rs2038839	rs2263329	0.885338790769141	High density lipoprotein cholesterol levels	2e-52	34887591
rs2038839	rs9296128	0.871783256281563	Hip circumference adjusted for BMI	4e-13	34021172
rs2038839	rs111868030	0.861274087826917	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2038839	rs9368830	0.837264120713978	HDL cholesterol	4e-21	30275531
rs2038839	rs9368828	0.811669951769348	Body mass index	1e-34	34594039
rs2038839	rs6912327	0.804812818361656	Fasting insulin	5e-06	33402679
rs2038839	rs6912327	0.804812818361656	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2038839	rs112283401	0.779482818735648	Red cell distribution width	4e-27	30595370
rs2038839	rs2744973	0.758068707726603	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2038839	rs2744973	0.758068707726603	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2038839	rs2744973	0.758068707726603	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2038839	rs2744973	0.758068707726603	Multi-trait sex score	6e-20	37277458
rs2038839	rs6940215	0.613617191861681	Insomnia	2e-10	35835914
rs2038839	rs6940215	0.613617191861681	Insomnia	1e-13	35835914
rs2038839	rs6940215	0.613617191861681	Hip circumference adjusted for BMI	8e-10	34021172
rs2038839	rs6940215	0.613617191861681	Multi-trait sex score	2e-23	37277458
rs2038839	rs6940215	0.613617191861681	Multi-trait sex score	4e-23	37277458
rs2038839	rs6457796	0.606408583395711	Insomnia	1e-08	30804565
rs2038839	rs6457796	0.606408583395711	Plateletcrit	9e-11	32888494
rs2038839	rs6457796	0.606408583395711	Systemic lupus erythematosus	3e-22	33272962
rs2038839	rs6457796	0.606408583395711	Body mass index	5e-13	30108127
rs2038839	rs6457796	0.606408583395711	Body mass index	1e-14	26426971
rs2038839	rs6457796	0.606408583395711	Educational attainment	5e-19	35361970
rs2038840	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2038840	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs2038840	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs2038840	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs2038840	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs2038840	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs2038840	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs2038840	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2038840	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs2038840	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs2038840	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs2038840	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs2038840	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs2038840	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs2038840	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs2038840	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs2038840	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs2038840	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs2038840	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs2038840	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs2038840	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs2038840	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs2038840	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs2038840	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs2038840	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs2038840	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs2038840	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs2038840	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs2038840	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs2038840	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs2038840	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs2038840	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2038840	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs2038840	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs2038840	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2038840	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2038840	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2038840	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs2038840	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs2038840	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2038840	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs2038840	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs2038841	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2038841	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs2038841	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs2038841	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs2038841	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs2038841	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs2038841	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs2038841	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2038841	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs2038841	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs2038841	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs2038841	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs2038841	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs2038841	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs2038841	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs2038841	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs2038841	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs2038841	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs2038841	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs2038841	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs2038841	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs2038841	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs2038841	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs2038841	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs2038841	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs2038841	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs2038841	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs2038841	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs2038841	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs2038841	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs2038841	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs2038841	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2038841	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs2038841	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs2038841	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2038841	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2038841	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2038841	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs2038841	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs2038841	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2038841	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs2038841	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs2040349	rs58588820	0.811937091968275	Total cholesterol levels	1e-09	34887591
rs2040349	rs58588820	0.811937091968275	Total cholesterol levels	8e-11	34887591
rs2040349	rs6547629	0.728284817582546	Height	3e-09	36224396
rs2041384	rs2532497	0.861417841978632	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2041384	rs2532497	0.861417841978632	Tapasin-related protein levels	0	34648354
rs2041384	rs2041387	0.847505100399152	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2041385	rs2532497	0.858004988336399	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2041385	rs2532497	0.858004988336399	Tapasin-related protein levels	0	34648354
rs2041385	rs2041387	0.844539090695664	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2041387	rs2041387	1	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2041387	rs2532497	0.729767808706032	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2041387	rs2532497	0.729767808706032	Tapasin-related protein levels	0	34648354
rs2041388	rs2532497	0.99753328962634	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2041388	rs2532497	0.99753328962634	Tapasin-related protein levels	0	34648354
rs2041388	rs2041387	0.73184125940997	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2047653	rs6680628	0.681660888026549	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs2047654	rs6680628	0.68264972829523	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs205258	rs2263329	0.966546098869616	HDL cholesterol	6e-35	34594039
rs205258	rs2263329	0.966546098869616	HDL cholesterol levels	8e-43	32203549
rs205258	rs2263329	0.966546098869616	High density lipoprotein cholesterol levels	2e-52	34887591
rs205258	rs9366863	0.952499575085844	Adult body size	9e-33	32376654
rs205258	rs9366863	0.952499575085844	Body mass index	2e-44	30595370
rs205258	rs2744944	0.945483947567097	Hypothyroidism	3e-10	34594039
rs205258	rs2744944	0.945483947567097	High density lipoprotein cholesterol levels	3e-86	34887591
rs205258	rs2744944	0.945483947567097	Multi-trait sex score	7e-22	37277458
rs205258	rs2814949	0.944074280347672	Essential hypertension (time to event)	9e-09	32589924
rs205258	rs9469872	0.93923442416383	HDL cholesterol levels	3e-11	36333282
rs205258	rs11755393	0.917254422113034	Body mass index	3e-26	29273807
rs205258	rs11755393	0.917254422113034	Systemic lupus erythematosus	2e-12	33493351
rs205258	rs11755393	0.917254422113034	Systemic lupus erythematosus	2e-06	33493351
rs205258	rs11755393	0.917254422113034	Systemic lupus erythematosus	1e-07	33493351
rs205258	rs11755393	0.917254422113034	Systemic lupus erythematosus	2e-08	19838195
rs205258	rs11755393	0.917254422113034	Body mass index	4e-55	36581621
rs205258	rs6941110	0.908968756321491	Sex hormone-binding globulin levels	5e-27	36653534
rs205258	rs111868030	0.903201853896945	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs205258	rs9469857	0.900261598602014	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs205258	rs2764208	0.897968427893056	Systemic lupus erythematosus	7e-06	24871463
rs205258	rs9462030	0.88807098876791	Red cell distribution width	5e-25	32888493
rs205258	rs9469899	0.872430657137805	Prostate cancer (advanced)	2e-06	29892016
rs205258	rs9469899	0.872430657137805	Prostate cancer	5e-09	29892016
rs205258	rs9469899	0.872430657137805	Prostate cancer	8e-11	33398198
rs205258	rs9469899	0.872430657137805	Hand grip strength	3e-15	29691431
rs205258	rs9469899	0.872430657137805	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs205258	rs9469899	0.872430657137805	Graves' disease	4e-10	34594039
rs205258	rs9469899	0.872430657137805	Coronary artery disease	1e-11	36474045
rs205258	rs9469899	0.872430657137805	Predicted visceral adipose tissue	2e-20	31501611
rs205258	rs9469899	0.872430657137805	Medication use (thyroid preparations)	2e-09	31015401
rs205258	rs9469899	0.872430657137805	Medication use (thyroid preparations)	3e-10	34594039
rs205258	rs9368830	0.866272741358458	HDL cholesterol	4e-21	30275531
rs205258	rs9296128	0.850215739645168	Hip circumference adjusted for BMI	4e-13	34021172
rs205258	rs9368828	0.846841926205149	Body mass index	1e-34	34594039
rs205258	rs2744973	0.809738572623874	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs205258	rs2744973	0.809738572623874	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs205258	rs2744973	0.809738572623874	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs205258	rs2744973	0.809738572623874	Multi-trait sex score	6e-20	37277458
rs205258	rs6912327	0.768366636489921	Fasting insulin	5e-06	33402679
rs205258	rs6912327	0.768366636489921	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs205258	rs112283401	0.742182750845035	Red cell distribution width	4e-27	30595370
rs205258	rs205262	0.630756089992058	Body mass index	2e-09	26961502
rs205258	rs205262	0.630756089992058	Walking pace	4e-10	33128006
rs205258	rs205262	0.630756089992058	Body mass index	8e-13	30108127
rs205258	rs205262	0.630756089992058	Body mass index	2e-09	25673413
rs205258	rs205262	0.630756089992058	Body mass index	2e-14	26426971
rs205258	rs205262	0.630756089992058	BMI in non-smokers	3e-07	28443625
rs205258	rs205262	0.630756089992058	BMI in non-smokers	6e-09	28443625
rs205258	rs205262	0.630756089992058	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs205258	rs205262	0.630756089992058	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs205258	rs205262	0.630756089992058	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs205258	rs205262	0.630756089992058	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs205258	rs205262	0.630756089992058	Gastroesophageal reflux disease	1e-10	34187846
rs205258	rs205262	0.630756089992058	Body mass index	3e-10	25673413
rs205258	rs205262	0.630756089992058	Body mass index	2e-10	25673413
rs205258	rs205262	0.630756089992058	ICD10 M54: Dorsalgia	2e-12	35110524
rs205259	rs9366863	0.961067882286274	Adult body size	9e-33	32376654
rs205259	rs9366863	0.961067882286274	Body mass index	2e-44	30595370
rs205259	rs2263329	0.959393255367374	HDL cholesterol	6e-35	34594039
rs205259	rs2263329	0.959393255367374	HDL cholesterol levels	8e-43	32203549
rs205259	rs2263329	0.959393255367374	High density lipoprotein cholesterol levels	2e-52	34887591
rs205259	rs2814949	0.952559572280474	Essential hypertension (time to event)	9e-09	32589924
rs205259	rs2744944	0.938363067323545	Hypothyroidism	3e-10	34594039
rs205259	rs2744944	0.938363067323545	High density lipoprotein cholesterol levels	3e-86	34887591
rs205259	rs2744944	0.938363067323545	Multi-trait sex score	7e-22	37277458
rs205259	rs9469872	0.932139619748421	HDL cholesterol levels	3e-11	36333282
rs205259	rs11755393	0.92556712909128	Body mass index	3e-26	29273807
rs205259	rs11755393	0.92556712909128	Systemic lupus erythematosus	2e-12	33493351
rs205259	rs11755393	0.92556712909128	Systemic lupus erythematosus	2e-06	33493351
rs205259	rs11755393	0.92556712909128	Systemic lupus erythematosus	1e-07	33493351
rs205259	rs11755393	0.92556712909128	Systemic lupus erythematosus	2e-08	19838195
rs205259	rs11755393	0.92556712909128	Body mass index	4e-55	36581621
rs205259	rs6941110	0.917371207902841	Sex hormone-binding globulin levels	5e-27	36653534
rs205259	rs111868030	0.896623011036922	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs205259	rs9462030	0.896527796226074	Red cell distribution width	5e-25	32888493
rs205259	rs9469857	0.893487643346647	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs205259	rs2764208	0.891213349707232	Systemic lupus erythematosus	7e-06	24871463
rs205259	rs9469899	0.880698901798549	Prostate cancer (advanced)	2e-06	29892016
rs205259	rs9469899	0.880698901798549	Prostate cancer	5e-09	29892016
rs205259	rs9469899	0.880698901798549	Prostate cancer	8e-11	33398198
rs205259	rs9469899	0.880698901798549	Hand grip strength	3e-15	29691431
rs205259	rs9469899	0.880698901798549	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs205259	rs9469899	0.880698901798549	Graves' disease	4e-10	34594039
rs205259	rs9469899	0.880698901798549	Coronary artery disease	1e-11	36474045
rs205259	rs9469899	0.880698901798549	Predicted visceral adipose tissue	2e-20	31501611
rs205259	rs9469899	0.880698901798549	Medication use (thyroid preparations)	2e-09	31015401
rs205259	rs9469899	0.880698901798549	Medication use (thyroid preparations)	3e-10	34594039
rs205259	rs9368830	0.871085205846903	HDL cholesterol	4e-21	30275531
rs205259	rs9296128	0.843853705838665	Hip circumference adjusted for BMI	4e-13	34021172
rs205259	rs9368828	0.840247758644241	Body mass index	1e-34	34594039
rs205259	rs2744973	0.818672084776135	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs205259	rs2744973	0.818672084776135	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs205259	rs2744973	0.818672084776135	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs205259	rs2744973	0.818672084776135	Multi-trait sex score	6e-20	37277458
rs205259	rs6912327	0.77546281090312	Fasting insulin	5e-06	33402679
rs205259	rs6912327	0.77546281090312	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs205259	rs112283401	0.750571744130531	Red cell distribution width	4e-27	30595370
rs205259	rs205262	0.626504478942582	Body mass index	2e-09	26961502
rs205259	rs205262	0.626504478942582	Walking pace	4e-10	33128006
rs205259	rs205262	0.626504478942582	Body mass index	8e-13	30108127
rs205259	rs205262	0.626504478942582	Body mass index	2e-09	25673413
rs205259	rs205262	0.626504478942582	Body mass index	2e-14	26426971
rs205259	rs205262	0.626504478942582	BMI in non-smokers	3e-07	28443625
rs205259	rs205262	0.626504478942582	BMI in non-smokers	6e-09	28443625
rs205259	rs205262	0.626504478942582	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs205259	rs205262	0.626504478942582	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs205259	rs205262	0.626504478942582	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs205259	rs205262	0.626504478942582	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs205259	rs205262	0.626504478942582	Gastroesophageal reflux disease	1e-10	34187846
rs205259	rs205262	0.626504478942582	Body mass index	3e-10	25673413
rs205259	rs205262	0.626504478942582	Body mass index	2e-10	25673413
rs205259	rs205262	0.626504478942582	ICD10 M54: Dorsalgia	2e-12	35110524
rs205259	rs6940215	0.605657184250838	Insomnia	2e-10	35835914
rs205259	rs6940215	0.605657184250838	Insomnia	1e-13	35835914
rs205259	rs6940215	0.605657184250838	Hip circumference adjusted for BMI	8e-10	34021172
rs205259	rs6940215	0.605657184250838	Multi-trait sex score	2e-23	37277458
rs205259	rs6940215	0.605657184250838	Multi-trait sex score	4e-23	37277458
rs2059817	rs324126	0.600338428279215	Colonoscopy-negative controls vs population controls	6e-06	29228715
rs2060573	rs2060573	1	Chronic obstructive pulmonary disease liability (machine learning-based score)	4e-30	37069358
rs2061163	rs4353250	0.996190566057837	Insulin-like growth factor 1 levels	2e-14	33462484
rs2061163	rs4353250	0.996190566057837	Amyloid A serum levels	2e-51	21124955
rs2061163	rs4150575	0.633036784330263	Imidazole lactate levels	1e-10	36635386
rs2061164	rs4353250	0.993644417462038	Insulin-like growth factor 1 levels	2e-14	33462484
rs2061164	rs4353250	0.993644417462038	Amyloid A serum levels	2e-51	21124955
rs2061164	rs4150575	0.636808897587536	Imidazole lactate levels	1e-10	36635386
rs2064521	rs11155671	0.975806902752313	Testicular germ cell tumor	2e-09	28604728
rs2064521	rs4380763	0.962233695928481	Subcortical volume (min-P)	1e-11	32665545
rs2064521	rs1934534	0.961439846419339	Pain (pleiotropy)	2e-08	37844115
rs2064521	rs1934534	0.961439846419339	Pain (pleiotropy)	2e-06	37844115
rs2064521	rs9505982	0.960984470323939	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs2064521	rs80147756	0.919265542636776	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2064521	rs4421206	0.91491817608183	Brain morphology (min-P)	4e-11	32665545
rs2064521	rs9688452	0.895176300816421	Brainstem global volume Whole-brainstem	1e-11	33875891
rs2064521	rs9688452	0.895176300816421	aseg lh volume VentralDC	2e-10	33875891
rs2064521	rs10872649	0.846688334478121	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs2064521	rs10872649	0.846688334478121	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs2064521	rs10872649	0.846688334478121	Right hippocampal volume (body)	1e-10	37337106
rs2064521	rs9322194	0.815502230885224	Brainstem volume	2e-11	31636452
rs2064521	rs7752089	0.813419829880675	Brain morphology (MOSTest)	2e-31	35164939
rs2064521	rs9285521	0.69377665275824	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs2064521	rs12526675	0.641605306519562	Brain morphology (MOSTest)	7e-22	32665545
rs2064521	rs9688809	0.62764400998608	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2064521	rs34337297	0.624631289012377	Serum levels of protein LRP11	3e-161	35078996
rs2064521	rs10872645	0.623851361592884	Blood protein levels	2e-86	30072576
rs2064521	rs14314	0.622819500612405	Macular thickness	3e-19	30535121
rs2064521	rs14314	0.622819500612405	Vertex-wise sulcal depth	7e-17	34910505
rs2064521	rs14314	0.622819500612405	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2064521	rs14314	0.622819500612405	Left hippocampal volume (body)	7e-15	37337106
rs2064521	rs14314	0.622819500612405	Left subiculum volume (body)	1e-14	37337106
rs2064521	rs55763431	0.622502497965433	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2064521	rs9322193	0.622014837885711	Lung cancer	1e-07	27393504
rs2064521	rs9689694	0.621363701232172	Right hippocampal volume (head)	6e-11	37337106
rs2064521	rs9689694	0.621363701232172	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2064521	rs9689694	0.621363701232172	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2064521	rs9689694	0.621363701232172	Left hippocampal volume (head)	6e-12	37337106
rs2064521	rs9383843	0.620017125674574	Migraine	1e-09	35115687
rs2064521	rs2095375	0.619448652179028	Serum metabolite levels	1e-20	33031748
rs2064521	rs2095375	0.619448652179028	Serum metabolite levels	1e-20	33031748
rs2064521	rs10872653	0.617178156003887	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2064521	rs9688867	0.616875633366164	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2064521	rs9688867	0.616875633366164	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2064521	rs2342764	0.600828918817829	Cortical thickness	1e-08	34560273
rs2065663	rs56103941	0.975806084358663	Right presubiculum volume (head)	4e-08	37337106
rs2065663	rs12523793	0.948031213165015	Subcortical volume (MOSTest)	4e-24	32665545
rs2065663	rs12523793	0.948031213165015	C-reactive protein levels	3e-08	35459240
rs2065663	rs12523793	0.948031213165015	C-reactive protein levels (MTAG)	2e-08	36376304
rs2065663	rs11155662	0.930469838747782	Vertex-wise cortical thickness	2e-09	34910505
rs2065663	rs12526675	0.881062264125746	Brain morphology (MOSTest)	7e-22	32665545
rs2065663	rs2342764	0.817986490492341	Cortical thickness	1e-08	34560273
rs2065663	rs58189451	0.758523419215507	Drinks per week	1e-09	36477530
rs2065663	rs9285521	0.747910134625474	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs2065663	rs9322194	0.660753671709409	Brainstem volume	2e-11	31636452
rs2065663	rs7752089	0.65997628901527	Brain morphology (MOSTest)	2e-31	35164939
rs2065663	rs11155675	0.642150522665708	Brain region volumes	3e-09	31676860
rs2065663	rs10872649	0.636857369000678	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs2065663	rs10872649	0.636857369000678	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs2065663	rs10872649	0.636857369000678	Right hippocampal volume (body)	1e-10	37337106
rs2065663	rs1125	0.636458122717305	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs2065663	rs1125	0.636458122717305	Vertical cup-disc ratio	8e-14	34077760
rs2065663	rs9371201	0.631984539634412	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs2065663	rs4421206	0.609959732385212	Brain morphology (min-P)	4e-11	32665545
rs2070180	rs3772130	0.985645676912715	Cognitive performance	6e-06	19734545
rs2070180	rs3772128	0.985645676912715	Mean spheric corpuscular volume	4e-09	32888494
rs2070180	rs33988592	0.977776664818839	Mean corpuscular hemoglobin	9e-11	32888493
rs2070180	rs33988592	0.977776664818839	Mean corpuscular volume	4e-12	32888493
rs2070180	rs6791046	0.973104700975406	Mean reticulocyte volume	4e-12	32888494
rs2070180	rs1573819	0.934010578675428	Mean corpuscular volume	3e-10	32888493
rs2070180	rs13433692	0.669246362950967	Corneal resistance factor (MTAG)	5e-08	35446358
rs2071566	rs7359095	0.617590919877227	Height (standard GWA)	5e-10	37106081
rs2073483	rs11101981	0.70137821620328	Glutathione S-transferase Mu 3 levels	2e-189	34648354
rs2074219	rs409942	0.897582298791576	Total cholesterol levels	8e-06	35884923
rs2074219	rs739669	0.76214246612729	BMI at birth	5e-17	35315439
rs2074219	rs222837	0.710069462390037	Metabolite levels	7e-06	23823483
rs2074219	rs2654189	0.668910339548453	Eosinophil counts	4e-11	32888494
rs2074219	rs2654189	0.668910339548453	Eosinophil percentage of white cells	6e-12	32888494
rs2074219	rs2654189	0.668910339548453	Eosinophil counts	1e-09	30595370
rs2074219	rs5415	0.659046719357841	Birth weight	5e-06	23202124
rs2074219	rs5415	0.659046719357841	LDL cholesterol levels	1e-06	35884923
rs2074219	rs13331	0.633796437386258	Heel bone mineral density	4e-08	30595370
rs2076435	rs2076435	1	Inguinal hernia	2e-08	35022708
rs2076435	rs2076435	1	Inguinal hernia	2e-09	35022708
rs2076435	rs2076438	0.871766354423689	Coronary artery disease	3e-08	33020668
rs2076435	rs2235642	0.869675116792042	Coronary artery disease	8e-06	29212778
rs2076616	rs2076616	1	Rheumatoid arthritis	1e-13	36333501
rs2076616	rs761426	0.657729573617913	Rheumatoid arthritis	1e-06	30423114
rs2076616	rs761426	0.657729573617913	Rheumatoid arthritis	2e-10	30423114
rs2076616	rs2076614	0.648240361702142	Waist circumference adjusted for body mass index	7e-09	34021172
rs2076616	rs7523863	0.645252469510404	Hip circumference adjusted for BMI	3e-09	34021172
rs2077848	rs7987940	0.728057602754619	AFP levels	6e-08	36329257
rs2077848	rs9535244	0.65656595422785	Lung function (FVC)	1e-08	30595370
rs2079866	rs2532497	1	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2079866	rs2532497	1	Tapasin-related protein levels	0	34648354
rs2079866	rs2041387	0.729767808706032	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2081191	rs2891698	0.661319920234706	Hiatus hernia	4e-10	36584111
rs2081191	rs2891698	0.661319920234706	Hernia	1e-09	36584111
rs2081191	rs2891698	0.661319920234706	ICD10 K44: Diaphragmatic hernia	3e-13	36076102
rs2094833	rs2357176	0.955250336771477	Nevus count or cutaneous melanoma	4e-08	30429480
rs2094833	rs10873172	0.860353315806518	Cutaneous melanoma or hair colour	6e-27	32341527
rs2094833	rs10873172	0.860353315806518	Nevus count or cutaneous melanoma	6e-13	32341527
rs2094833	rs10873172	0.860353315806518	Blond vs. brown/black hair color	6e-15	30531825
rs2094833	rs10873172	0.860353315806518	Cutaneous malignant melanoma	6e-08	32341527
rs2094833	rs10873172	0.860353315806518	Hair color	4e-17	30595370
rs2094833	rs1255908	0.801551649119497	PR interval	8e-14	32439900
rs2094833	rs1255908	0.801551649119497	PR interval	6e-14	32439900
rs2094833	rs12878653	0.744763354448504	Youthful appearance (self-reported)	3e-14	32339537
rs2095375	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs2095375	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs2095375	rs9383843	0.999100085712971	Migraine	1e-09	35115687
rs2095375	rs55763431	0.995506640298119	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2095375	rs9689694	0.993707895167345	Right hippocampal volume (head)	6e-11	37337106
rs2095375	rs9689694	0.993707895167345	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2095375	rs9689694	0.993707895167345	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2095375	rs9689694	0.993707895167345	Left hippocampal volume (head)	6e-12	37337106
rs2095375	rs10872645	0.988335410721321	Blood protein levels	2e-86	30072576
rs2095375	rs9688867	0.987484746280957	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2095375	rs9688867	0.987484746280957	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2095375	rs9688809	0.987484746280957	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2095375	rs10872653	0.987428985005238	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2095375	rs34337297	0.983863132808358	Serum levels of protein LRP11	3e-161	35078996
rs2095375	rs14314	0.981250032026204	Macular thickness	3e-19	30535121
rs2095375	rs14314	0.981250032026204	Vertex-wise sulcal depth	7e-17	34910505
rs2095375	rs14314	0.981250032026204	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2095375	rs14314	0.981250032026204	Left hippocampal volume (body)	7e-15	37337106
rs2095375	rs14314	0.981250032026204	Left subiculum volume (body)	1e-14	37337106
rs2095375	rs9322193	0.947826521476432	Lung cancer	1e-07	27393504
rs2095375	rs4039600	0.904085337095829	Adenine levels	1e-11	35347128
rs2095375	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-08	37844115
rs2095375	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-06	37844115
rs2095375	rs4380763	0.638343493751961	Subcortical volume (min-P)	1e-11	32665545
rs2095375	rs11155671	0.62791813730041	Testicular germ cell tumor	2e-09	28604728
rs2095375	rs80147756	0.613057484647013	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2095375	rs4421206	0.605487928690632	Brain morphology (min-P)	4e-11	32665545
rs2097466	rs6000172	0.923846450980591	Severe COVID-19 infection	1e-07	36662838
rs2097466	rs4821461	0.909793269832403	Severe COVID-19 infection	4e-06	36662838
rs2097466	rs2227169	0.908725536796226	Severe COVID-19 infection	4e-13	36662838
rs2097466	rs1053982	0.885825244783056	Severe COVID-19 infection	9e-06	36662838
rs2097466	rs5756090	0.790916834861975	Severe COVID-19 infection	4e-08	36662838
rs2097467	rs5756090	0.936387928587835	Severe COVID-19 infection	4e-08	36662838
rs2097467	rs6000172	0.869965499056907	Severe COVID-19 infection	1e-07	36662838
rs2097467	rs4821461	0.860648824857712	Severe COVID-19 infection	4e-06	36662838
rs2097467	rs2227169	0.854218987277396	Severe COVID-19 infection	4e-13	36662838
rs2097467	rs1053982	0.8341753615744	Severe COVID-19 infection	9e-06	36662838
rs2103646	rs2263329	0.961791862221056	HDL cholesterol	6e-35	34594039
rs2103646	rs2263329	0.961791862221056	HDL cholesterol levels	8e-43	32203549
rs2103646	rs2263329	0.961791862221056	High density lipoprotein cholesterol levels	2e-52	34887591
rs2103646	rs9366863	0.947774370577962	Adult body size	9e-33	32376654
rs2103646	rs9366863	0.947774370577962	Body mass index	2e-44	30595370
rs2103646	rs2744944	0.940775261240349	Hypothyroidism	3e-10	34594039
rs2103646	rs2744944	0.940775261240349	High density lipoprotein cholesterol levels	3e-86	34887591
rs2103646	rs2744944	0.940775261240349	Multi-trait sex score	7e-22	37277458
rs2103646	rs2814949	0.939364337272363	Essential hypertension (time to event)	9e-09	32589924
rs2103646	rs9469872	0.934541801745851	HDL cholesterol levels	3e-11	36333282
rs2103646	rs11755393	0.912605565858241	Body mass index	3e-26	29273807
rs2103646	rs11755393	0.912605565858241	Systemic lupus erythematosus	2e-12	33493351
rs2103646	rs11755393	0.912605565858241	Systemic lupus erythematosus	2e-06	33493351
rs2103646	rs11755393	0.912605565858241	Systemic lupus erythematosus	1e-07	33493351
rs2103646	rs11755393	0.912605565858241	Systemic lupus erythematosus	2e-08	19838195
rs2103646	rs11755393	0.912605565858241	Body mass index	4e-55	36581621
rs2103646	rs6941110	0.904357960464292	Sex hormone-binding globulin levels	5e-27	36653534
rs2103646	rs111868030	0.898653528810315	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2103646	rs9469857	0.895693083702917	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2103646	rs2764208	0.893407220371806	Systemic lupus erythematosus	7e-06	24871463
rs2103646	rs9462030	0.883532693181269	Red cell distribution width	5e-25	32888493
rs2103646	rs9469899	0.867918999676628	Prostate cancer (advanced)	2e-06	29892016
rs2103646	rs9469899	0.867918999676628	Prostate cancer	5e-09	29892016
rs2103646	rs9469899	0.867918999676628	Prostate cancer	8e-11	33398198
rs2103646	rs9469899	0.867918999676628	Hand grip strength	3e-15	29691431
rs2103646	rs9469899	0.867918999676628	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2103646	rs9469899	0.867918999676628	Graves' disease	4e-10	34594039
rs2103646	rs9469899	0.867918999676628	Coronary artery disease	1e-11	36474045
rs2103646	rs9469899	0.867918999676628	Predicted visceral adipose tissue	2e-20	31501611
rs2103646	rs9469899	0.867918999676628	Medication use (thyroid preparations)	2e-09	31015401
rs2103646	rs9469899	0.867918999676628	Medication use (thyroid preparations)	3e-10	34594039
rs2103646	rs9368830	0.858738233717419	HDL cholesterol	4e-21	30275531
rs2103646	rs9296128	0.845806834938024	Hip circumference adjusted for BMI	4e-13	34021172
rs2103646	rs9368828	0.842408602530965	Body mass index	1e-34	34594039
rs2103646	rs2744973	0.808419727239955	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2103646	rs2744973	0.808419727239955	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2103646	rs2744973	0.808419727239955	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2103646	rs2744973	0.808419727239955	Multi-trait sex score	6e-20	37277458
rs2103646	rs6912327	0.76279343316362	Fasting insulin	5e-06	33402679
rs2103646	rs6912327	0.76279343316362	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2103646	rs112283401	0.738103684449493	Red cell distribution width	4e-27	30595370
rs2103646	rs205262	0.629736555487492	Body mass index	2e-09	26961502
rs2103646	rs205262	0.629736555487492	Walking pace	4e-10	33128006
rs2103646	rs205262	0.629736555487492	Body mass index	8e-13	30108127
rs2103646	rs205262	0.629736555487492	Body mass index	2e-09	25673413
rs2103646	rs205262	0.629736555487492	Body mass index	2e-14	26426971
rs2103646	rs205262	0.629736555487492	BMI in non-smokers	3e-07	28443625
rs2103646	rs205262	0.629736555487492	BMI in non-smokers	6e-09	28443625
rs2103646	rs205262	0.629736555487492	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2103646	rs205262	0.629736555487492	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2103646	rs205262	0.629736555487492	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2103646	rs205262	0.629736555487492	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2103646	rs205262	0.629736555487492	Gastroesophageal reflux disease	1e-10	34187846
rs2103646	rs205262	0.629736555487492	Body mass index	3e-10	25673413
rs2103646	rs205262	0.629736555487492	Body mass index	2e-10	25673413
rs2103646	rs205262	0.629736555487492	ICD10 M54: Dorsalgia	2e-12	35110524
rs2105063	rs2105063	1	Waist-to-hip ratio adjusted for BMI	6e-10	34021172
rs2105063	rs2105063	1	Waist-hip index	6e-10	34021172
rs2105312	rs770199	0.895435216818556	Hair color	3e-08	30595370
rs2105313	rs770199	0.895435216818556	Hair color	3e-08	30595370
rs2105314	rs770199	0.89446431721285	Hair color	3e-08	30595370
rs2106842	rs222857	0.607904151272537	Birth weight	1e-24	31043758
rs2106842	rs222857	0.607904151272537	Diastolic blood pressure	2e-15	35762941
rs2106842	rs222857	0.607904151272537	Lung function (forced vital capacity)	7e-13	36914875
rs2107564	rs1138888	0.779165707660171	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs2107564	rs1138888	0.779165707660171	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs2107564	rs4802157	0.758940116656422	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs2107564	rs2355433	0.65875119340858	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs2107564	rs2355433	0.65875119340858	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs2107564	rs2355433	0.65875119340858	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs2108624	rs4808407	0.936757773982323	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs2111595	rs10804157	0.82460005027261	Uterine leiomyomata	4e-09	36726022
rs2113508	rs6705511	0.68423580404257	Self-reported math ability	4e-09	30038396
rs2113508	rs6705511	0.68423580404257	Self-reported math ability (MTAG)	3e-10	30038396
rs2113508	rs34276187	0.678542798972211	Highest math class taken (MTAG)	2e-08	30038396
rs2118177	rs58588820	0.812639441468101	Total cholesterol levels	1e-09	34887591
rs2118177	rs58588820	0.812639441468101	Total cholesterol levels	8e-11	34887591
rs2118177	rs6547629	0.727621464322639	Height	3e-09	36224396
rs2121030	rs7321596	0.785737738355528	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs2121030	rs8002861	0.758701595480718	Leprosy	7e-06	25642632
rs2126129	rs2126129	1	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs2126129	rs17713396	0.943150490337401	Blood urea nitrogen levels	3e-21	34272381
rs2126129	rs17713396	0.943150490337401	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs2126129	rs17713396	0.943150490337401	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs2126129	rs6710091	0.941147228787264	Waist circumference adjusted for body mass index	8e-11	31669095
rs2126129	rs6710091	0.941147228787264	HDL cholesterol	5e-08	30275531
rs2126129	rs6710091	0.941147228787264	High density lipoprotein cholesterol levels	3e-24	34887591
rs2126129	rs7595075	0.925197806906726	Waist circumference adjusted for body mass index	2e-09	34021172
rs2126129	rs7595075	0.925197806906726	HDL cholesterol	3e-11	34594039
rs2126129	rs7595075	0.925197806906726	HDL cholesterol levels	6e-13	32203549
rs2126129	rs17713729	0.922310481058114	Body mass index	2e-09	31669095
rs2126129	rs17713729	0.922310481058114	Serum creatinine levels	4e-14	34594039
rs2126129	rs17713729	0.922310481058114	High density lipoprotein cholesterol levels	7e-17	34887591
rs2126129	rs79716074	0.921174984721494	Plateletcrit	1e-09	32888494
rs2126129	rs79716074	0.921174984721494	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs2126129	rs79716074	0.921174984721494	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs2126129	rs79716074	0.921174984721494	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs2126129	rs58461606	0.914746362768209	Blood protein levels	0	30072576
rs2126129	rs7605824	0.907688137920993	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs2126129	rs7566279	0.90674324951163	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs2126129	rs3791221	0.904245032832917	Blood urea nitrogen levels	2e-07	31152163
rs2126129	rs3791221	0.904245032832917	Estimated glomerular filtration rate	2e-10	31152163
rs2126129	rs3791221	0.904245032832917	Estimated glomerular filtration rate	1e-11	31152163
rs2126129	rs3791221	0.904245032832917	Blood urea nitrogen levels	7e-26	34594039
rs2126129	rs2290911	0.898540154575427	Height	5e-07	29782485
rs2126129	rs2290911	0.898540154575427	Large artery stroke	6e-06	28265093
rs2126129	rs2290911	0.898540154575427	Height	8e-112	36224396
rs2126129	rs114976176	0.864759951608062	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs2126129	rs59937473	0.838191166194178	Protein quantitative trait loci	3e-67	32492067
rs2126129	rs59937473	0.838191166194178	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs2126129	rs17714252	0.830465564235985	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs2126129	rs17714252	0.830465564235985	Retinal vascular fractal dimension	2e-07	34743558
rs2126129	rs7601944	0.828967438912067	Smoking initiation	4e-15	36477530
rs2126129	rs11553746	0.824876187836281	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs2126129	rs11553746	0.824876187836281	High density lipoprotein cholesterol levels	2e-07	29083408
rs2126129	rs11553746	0.824876187836281	High density lipoprotein cholesterol levels	7e-15	29083408
rs2126129	rs11553746	0.824876187836281	Large artery stroke	4e-06	28265093
rs2126129	rs55753056	0.820268776968265	Height	2e-22	30595370
rs2126129	rs62114548	0.797666527561014	Retinal vascular fractal density	2e-09	34743558
rs2126129	rs62114538	0.780206397620172	Triglyceride levels	6e-12	34887591
rs2126129	rs17713879	0.779683215637523	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs2126129	rs17713879	0.779683215637523	Smoking initiation	1e-10	36477530
rs2126129	rs17713879	0.779683215637523	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs2126129	rs17713879	0.779683215637523	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs2126129	rs17713879	0.779683215637523	Triglyceride levels	3e-10	34887591
rs2126129	rs17713879	0.779683215637523	Aging (eyeAgeAcceleration)	6e-50	36975205
rs2126129	rs60843830	0.771507409919261	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs2126129	rs60843830	0.771507409919261	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs2126129	rs60843830	0.771507409919261	Adventurousness	7e-10	30643258
rs2126129	rs79154857	0.760287308882308	Pulse pressure	5e-08	34594039
rs2126129	rs62114506	0.718263033693867	Gamma glutamyl transpeptidase	3e-14	34594039
rs2126129	rs62114506	0.718263033693867	Apolipoprotein A1 levels	3e-10	32203549
rs2126129	rs62114506	0.718263033693867	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs2126129	rs62114506	0.718263033693867	HDL cholesterol levels	8e-10	36333282
rs2130392	rs2130392	1	Kawasaki disease	3e-08	22446962
rs2130525	rs2130525	1	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2130525	rs7542137	0.90987704931336	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2130525	rs7542137	0.90987704931336	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2130525	rs7542137	0.90987704931336	3-hydroxysebacate levels	2e-10	36635386
rs2130525	rs2999541	0.892194099916733	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2130525	rs3007711	0.88829997623759	Electrodermal activity	9e-06	25387706
rs2130525	rs10788817	0.847202579169262	Serum metabolite levels	3e-13	24625756
rs2130525	rs10788817	0.847202579169262	Metabolite peak levels (QI2718)	5e-18	35995766
rs2130525	rs10788817	0.847202579169262	3-hydroxylaurate levels	2e-12	36635386
rs2130525	rs10788817	0.847202579169262	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2130525	rs11204914	0.842040229564155	Carnitine C9 levels	1e-13	35995766
rs2130525	rs11204914	0.842040229564155	Metabolite peak levels (QI6204)	1e-32	35995766
rs2130525	rs11204914	0.842040229564155	Metabolite peak levels (QI6252)	2e-32	35995766
rs2130525	rs6685187	0.816833639055597	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2130525	rs6698740	0.814676365339384	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2130525	rs1060870	0.813195501359851	Serum metabolite levels	1e-11	33031748
rs2130525	rs1060870	0.813195501359851	Serum metabolite levels	1e-15	33031748
rs2130525	rs2279501	0.807535128834029	Serum metabolite levels	3e-14	33031748
rs2130525	rs2338201	0.803022108363714	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2130525	rs2338201	0.803022108363714	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2130525	rs2338201	0.803022108363714	Dodecadienoate (12:2) levels	7e-15	36635386
rs2130525	rs2999545	0.747190745162041	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2130525	rs1038747	0.690131784743589	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2130525	rs7523082	0.677808298256372	Metabolite peak levels (QI9845)	2e-14	35995766
rs2130525	rs10888445	0.674784984545718	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2130525	rs7541453	0.671214619450745	Serum metabolite levels	2e-16	33031748
rs2130525	rs7541453	0.671214619450745	Serum metabolite levels	2e-16	33031748
rs2130525	rs7541453	0.671214619450745	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2130525	rs56000812	0.632211232564652	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2130525	rs56078223	0.631607507923256	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2130525	rs56078223	0.631607507923256	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs2130525	rs10494270	0.624220801934398	Nonaylcarnitine levels	5e-13	26068415
rs2130525	rs9943221	0.61911861276673	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2130525	rs9943251	0.603565249501131	Serum metabolite levels	1e-30	33031748
rs2130525	rs9943251	0.603565249501131	X-23680 levels	2e-45	35050183
rs2130525	rs9943251	0.603565249501131	Urine glucuronide of C8H14O2 (1)* levels in chronic kidney disease	2e-14	37277652
rs2130525	rs9943251	0.603565249501131	Plasma X-18921 levels in chronic kidney disease	3e-66	37277652
rs2130525	rs9943251	0.603565249501131	Urine indoleacetylglutamine levels in chronic kidney disease	2e-28	37277652
rs2130525	rs9943251	0.603565249501131	Metabolite peak levels (QI9912)	7e-15	35995766
rs2130525	rs9943251	0.603565249501131	Eicosanoid tetranor 12(R) HETE b levels	7e-15	37524825
rs2130525	rs16833668	0.6029527513343	Nonaylcarnitine levels	3e-21	33414548
rs2130525	rs16833668	0.6029527513343	Dodecadienoate (12:2) levels	5e-23	35347128
rs2130525	rs16833668	0.6029527513343	X-21353 levels	9e-67	35347128
rs213583	rs149359	0.96000901174177	Skin color	4e-10	36672889
rs213583	rs149359	0.96000901174177	Skin phototype score	4e-09	36672889
rs2140427	rs2795857	0.894905854382788	Height	2e-123	36224396
rs2140427	rs2462017	0.855573688245598	Lymphocyte count	3e-12	32888493
rs2140427	rs2488010	0.84650429261771	Monocyte count	9e-16	32888493
rs2140427	rs2462021	0.845750873759662	Suicide risk	8e-06	21041247
rs2140427	rs1332618	0.834128755288934	Platelet count	4e-15	32888494
rs2140427	rs2795863	0.823062429772992	Height	3e-20	36224396
rs2140427	rs503598	0.810627020145998	White blood cell count	2e-08	30595370
rs2140427	rs2689216	0.785517564792392	Platelet count	2e-22	32888493
rs2140427	rs2689216	0.785517564792392	Platelet count	1e-21	32888493
rs2140427	rs1571956	0.771226282270333	Neutrophil count	1e-11	32888493
rs2140427	rs2482820	0.761608413040607	Monocyte count	9e-13	32888494
rs2140427	rs2482819	0.758766183451568	Neutrophil count	4e-10	32888493
rs2151912	rs14314	0.963584179091548	Macular thickness	3e-19	30535121
rs2151912	rs14314	0.963584179091548	Vertex-wise sulcal depth	7e-17	34910505
rs2151912	rs14314	0.963584179091548	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2151912	rs14314	0.963584179091548	Left hippocampal volume (body)	7e-15	37337106
rs2151912	rs14314	0.963584179091548	Left subiculum volume (body)	1e-14	37337106
rs2151912	rs2095375	0.951899976312487	Serum metabolite levels	1e-20	33031748
rs2151912	rs2095375	0.951899976312487	Serum metabolite levels	1e-20	33031748
rs2151912	rs9383843	0.951033866819073	Migraine	1e-09	35115687
rs2151912	rs55763431	0.947546865708462	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2151912	rs9689694	0.945758659872013	Right hippocampal volume (head)	6e-11	37337106
rs2151912	rs9689694	0.945758659872013	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2151912	rs9689694	0.945758659872013	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2151912	rs9689694	0.945758659872013	Left hippocampal volume (head)	6e-12	37337106
rs2151912	rs10872645	0.944035950084425	Blood protein levels	2e-86	30072576
rs2151912	rs9688867	0.939826545028269	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2151912	rs9688867	0.939826545028269	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2151912	rs9688809	0.939826545028269	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2151912	rs10872653	0.939545190065492	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2151912	rs34337297	0.936142696483463	Serum levels of protein LRP11	3e-161	35078996
rs2151912	rs9322193	0.902874528204152	Lung cancer	1e-07	27393504
rs2151912	rs4039600	0.901727330421126	Adenine levels	1e-11	35347128
rs2151912	rs1934534	0.623077988555732	Pain (pleiotropy)	2e-08	37844115
rs2151912	rs1934534	0.623077988555732	Pain (pleiotropy)	2e-06	37844115
rs2151912	rs4380763	0.622568144699535	Subcortical volume (min-P)	1e-11	32665545
rs2151912	rs11155671	0.612285268775539	Testicular germ cell tumor	2e-09	28604728
rs2151913	rs2095375	0.982204903462668	Serum metabolite levels	1e-20	33031748
rs2151913	rs2095375	0.982204903462668	Serum metabolite levels	1e-20	33031748
rs2151913	rs9383843	0.98131036348005	Migraine	1e-09	35115687
rs2151913	rs55763431	0.97774903424985	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2151913	rs9689694	0.975982323562444	Right hippocampal volume (head)	6e-11	37337106
rs2151913	rs9689694	0.975982323562444	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2151913	rs9689694	0.975982323562444	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2151913	rs9689694	0.975982323562444	Left hippocampal volume (head)	6e-12	37337106
rs2151913	rs10872645	0.970663255525272	Blood protein levels	2e-86	30072576
rs2151913	rs10872653	0.969804664262822	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2151913	rs9688867	0.969775080059322	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2151913	rs9688867	0.969775080059322	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2151913	rs9688809	0.969775080059322	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2151913	rs34337297	0.966249628756295	Serum levels of protein LRP11	3e-161	35078996
rs2151913	rs14314	0.963609669323676	Macular thickness	3e-19	30535121
rs2151913	rs14314	0.963609669323676	Vertex-wise sulcal depth	7e-17	34910505
rs2151913	rs14314	0.963609669323676	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2151913	rs14314	0.963609669323676	Left hippocampal volume (body)	7e-15	37337106
rs2151913	rs14314	0.963609669323676	Left subiculum volume (body)	1e-14	37337106
rs2151913	rs9322193	0.930546606287193	Lung cancer	1e-07	27393504
rs2151913	rs4039600	0.887751767814643	Adenine levels	1e-11	35347128
rs2151913	rs1934534	0.623283347410232	Pain (pleiotropy)	2e-08	37844115
rs2151913	rs1934534	0.623283347410232	Pain (pleiotropy)	2e-06	37844115
rs2151913	rs4380763	0.622765735182671	Subcortical volume (min-P)	1e-11	32665545
rs2151913	rs11155671	0.613801239833795	Testicular germ cell tumor	2e-09	28604728
rs2157992	rs34351630	0.832791083491329	Lung function (FVC)	3e-10	30804560
rs2157992	rs34351630	0.832791083491329	FEV1	7e-09	30804560
rs2157992	rs1972503	0.770166159804656	Dorsomedial frontal area (unadjusted for global measures)	2e-09	36893272
rs2157992	rs178803	0.755032614974562	Red meat related metabolomic signature	3e-10	36974753
rs2157992	rs12937088	0.7331888225874	Sex hormone-binding globulin levels adjusted for BMI	9e-17	32042192
rs2157992	rs12937088	0.7331888225874	Sex hormone-binding globulin levels	9e-08	32042192
rs2157992	rs11078333	0.72003980747471	Free thyroxine concentration	2e-12	30367059
rs2157992	rs178796	0.715970953062611	Cortical surface area	1e-06	36893272
rs2157992	rs178795	0.714519617130445	C-reactive protein	3e-09	34594039
rs2157992	rs143493691	0.690043566279228	Dorsolateral prefrontal area (unadjusted for global measures)	2e-08	36893272
rs2157992	rs9903464	0.686389250150679	Vertex-wise cortical surface area	6e-09	34910505
rs2157992	rs9903464	0.686389250150679	Brain morphology (MOSTest)	1e-09	35164939
rs2161548	rs1423357	0.997476188032824	General cognitive ability	9e-06	29844566
rs2161548	rs2432142	0.98073473442063	Neutrophil count	2e-14	32888493
rs2161548	rs2432142	0.98073473442063	White blood cell count	1e-11	32888493
rs2161548	rs38033	0.977584041187968	Blood protein levels	0	30072576
rs2161548	rs27293	0.963485007233434	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2161548	rs27293	0.963485007233434	Diastolic blood pressure	3e-11	35762941
rs2161548	rs7705093	0.953297891964223	Birdshot chorioretinopathy	2e-09	24957906
rs2161548	rs2910686	0.87117488940083	Neutrophil count	4e-14	32888493
rs2161548	rs2910686	0.87117488940083	Psoriasis	2e-08	23143594
rs2161548	rs2910686	0.87117488940083	Ankylosing spondylitis	5e-17	23749187
rs2161548	rs2910686	0.87117488940083	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2161548	rs2927608	0.867847781437238	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2161548	rs2927608	0.867847781437238	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2161548	rs2927608	0.867847781437238	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2161548	rs2617439	0.779611606776172	Neutrophil count	8e-11	32888494
rs2161548	rs2549797	0.775916085839203	Systolic blood pressure	7e-07	33230300
rs2161548	rs2549797	0.775916085839203	Diastolic blood pressure	1e-14	33230300
rs2161548	rs2549797	0.775916085839203	Diastolic blood pressure	3e-11	33230300
rs2161548	rs2549797	0.775916085839203	Systolic blood pressure	4e-09	33230300
rs2161548	rs2549782	0.774657715655368	Systolic blood pressure	6e-07	33230300
rs2161548	rs2549782	0.774657715655368	Diastolic blood pressure	1e-14	33230300
rs2161548	rs2549782	0.774657715655368	Diastolic blood pressure	3e-11	33230300
rs2161548	rs2549782	0.774657715655368	Systolic blood pressure	5e-09	33230300
rs2161548	rs1056893	0.774029373605063	Systolic blood pressure	1e-06	33230300
rs2161548	rs1056893	0.774029373605063	Diastolic blood pressure	7e-15	33230300
rs2161548	rs1056893	0.774029373605063	Diastolic blood pressure	2e-11	33230300
rs2161548	rs1056893	0.774029373605063	Systolic blood pressure	7e-09	33230300
rs2161548	rs2549794	0.770117429035187	Crohn's disease	1e-10	21102463
rs2161548	rs2549794	0.770117429035187	Systolic blood pressure	1e-07	33230300
rs2161548	rs2549794	0.770117429035187	Diastolic blood pressure	1e-15	33230300
rs2161548	rs2549794	0.770117429035187	Diastolic blood pressure	2e-12	33230300
rs2161548	rs2549794	0.770117429035187	Systolic blood pressure	4e-10	33230300
rs2161548	rs38029	0.769406192581153	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2161548	rs1363907	0.765471950795662	Crohn's disease	4e-16	26192919
rs2161548	rs1363907	0.765471950795662	Ulcerative colitis	4e-06	26192919
rs2161548	rs1363907	0.765471950795662	Inflammatory bowel disease	5e-15	26192919
rs2161548	rs1363907	0.765471950795662	Inflammatory bowel disease	6e-13	23128233
rs2161548	rs1363907	0.765471950795662	Inflammatory bowel disease	1e-10	28067908
rs2161548	rs1363907	0.765471950795662	Crohn's disease	1e-14	28067908
rs2161548	rs716848	0.737072861206968	Neutrophil percentage of white cells	2e-09	32888494
rs2161548	rs4869313	0.724243498029293	Pediatric autoimmune diseases	9e-08	26301688
rs2161548	rs1559359	0.718178949052076	Diastolic blood pressure	7e-10	34594039
rs2161548	rs2548532	0.691994863480986	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2161548	rs4869314	0.671365438278877	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2161548	rs4869314	0.671365438278877	Neutrophil count	1e-10	34594039
rs2161548	rs4869314	0.671365438278877	White blood cell count	2e-07	30595370
rs2161548	rs1974871	0.644541410636336	Granulysin levels	5e-13	34648354
rs2161548	rs1019503	0.642110968498842	Systolic blood pressure	2e-06	33230300
rs2161548	rs1019503	0.642110968498842	Diastolic blood pressure	2e-14	33230300
rs2161548	rs1019503	0.642110968498842	Diastolic blood pressure	4e-11	33230300
rs2161548	rs1019503	0.642110968498842	Systolic blood pressure	1e-08	33230300
rs2161548	rs27660	0.637970660764074	Coronary artery disease	3e-08	35915156
rs2161548	rs3096168	0.634650517893711	Aspartate aminotransferase levels	8e-12	33547301
rs216385	rs150621	0.911807059090407	Appendicular lean mass	5e-12	31761296
rs216385	rs2098713	0.76979560233776	Telomere length	3e-06	24795349
rs216385	rs757720522	0.647971706994232	Appendicular lean mass	3e-11	31761296
rs216387	rs150621	0.940284309554606	Appendicular lean mass	5e-12	31761296
rs216387	rs2098713	0.794254651124185	Telomere length	3e-06	24795349
rs216387	rs757720522	0.670105753103737	Appendicular lean mass	3e-11	31761296
rs216389	rs150621	0.954040754427296	Appendicular lean mass	5e-12	31761296
rs216389	rs2098713	0.776076246123876	Telomere length	3e-06	24795349
rs216389	rs757720522	0.653992750298045	Appendicular lean mass	3e-11	31761296
rs216393	rs150621	0.923345467944923	Appendicular lean mass	5e-12	31761296
rs216393	rs2098713	0.753197542399505	Telomere length	3e-06	24795349
rs216393	rs757720522	0.634825726813187	Appendicular lean mass	3e-11	31761296
rs216396	rs150621	0.896848971970598	Appendicular lean mass	5e-12	31761296
rs216396	rs2098713	0.831950937414744	Telomere length	3e-06	24795349
rs216396	rs757720522	0.707048765590379	Appendicular lean mass	3e-11	31761296
rs2167564	rs777587	0.830961641932123	Proteoglycan 3 levels	6e-29	34648354
rs2167564	rs777587	0.830961641932123	Pappalysin-1 levels	1e-25	34648354
rs2167564	rs11685226	0.800141481865303	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs2167564	rs11685226	0.800141481865303	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2167564	rs1177308	0.790813186079759	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2167564	rs1177308	0.790813186079759	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2167564	rs7558954	0.790193518824891	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2167564	rs12617371	0.787845814866385	Immature fraction of reticulocytes	8e-18	32888494
rs2167564	rs2463097	0.755821095025644	White blood cell count	3e-26	30595370
rs2167564	rs2593620	0.731002090765839	Serum levels of protein PRG3	5e-14	35078996
rs2167564	rs10199672	0.723603580170685	Height	6e-12	34594039
rs2167564	rs10199672	0.723603580170685	Height	2e-12	31562340
rs2167564	rs2421200	0.702243692250736	Neutrophil count	1e-26	32888493
rs2167564	rs2421200	0.702243692250736	Neutrophil count	1e-25	32888493
rs2167564	rs10169482	0.651339911738107	C-reactive protein levels	4e-09	33462484
rs2167564	rs2950269	0.604761379522005	Eosinophil side fluorescence	3e-18	37596262
rs2184292	rs2357176	0.957898713658532	Nevus count or cutaneous melanoma	4e-08	30429480
rs2184292	rs10873172	0.859553036370424	Cutaneous melanoma or hair colour	6e-27	32341527
rs2184292	rs10873172	0.859553036370424	Nevus count or cutaneous melanoma	6e-13	32341527
rs2184292	rs10873172	0.859553036370424	Blond vs. brown/black hair color	6e-15	30531825
rs2184292	rs10873172	0.859553036370424	Cutaneous malignant melanoma	6e-08	32341527
rs2184292	rs10873172	0.859553036370424	Hair color	4e-17	30595370
rs2184292	rs1255908	0.804289804574104	PR interval	8e-14	32439900
rs2184292	rs1255908	0.804289804574104	PR interval	6e-14	32439900
rs2184292	rs12878653	0.742682694155078	Youthful appearance (self-reported)	3e-14	32339537
rs2184369	rs10872653	0.996398963379575	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2184369	rs55763431	0.995508517308269	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2184369	rs9689694	0.993707610711994	Right hippocampal volume (head)	6e-11	37337106
rs2184369	rs9689694	0.993707610711994	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2184369	rs9689694	0.993707610711994	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2184369	rs9689694	0.993707610711994	Left hippocampal volume (head)	6e-12	37337106
rs2184369	rs2095375	0.991013810602254	Serum metabolite levels	1e-20	33031748
rs2184369	rs2095375	0.991013810602254	Serum metabolite levels	1e-20	33031748
rs2184369	rs9383843	0.990119838616633	Migraine	1e-09	35115687
rs2184369	rs10872645	0.988335114239339	Blood protein levels	2e-86	30072576
rs2184369	rs9688867	0.987491421814693	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2184369	rs9688867	0.987491421814693	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2184369	rs9688809	0.987491421814693	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2184369	rs34337297	0.983860681246269	Serum levels of protein LRP11	3e-161	35078996
rs2184369	rs14314	0.97237068229241	Macular thickness	3e-19	30535121
rs2184369	rs14314	0.97237068229241	Vertex-wise sulcal depth	7e-17	34910505
rs2184369	rs14314	0.97237068229241	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2184369	rs14314	0.97237068229241	Left hippocampal volume (body)	7e-15	37337106
rs2184369	rs14314	0.97237068229241	Left subiculum volume (body)	1e-14	37337106
rs2184369	rs9322193	0.947828234863957	Lung cancer	1e-07	27393504
rs2184369	rs4039600	0.904010090256514	Adenine levels	1e-11	35347128
rs2184369	rs1934534	0.639075075721001	Pain (pleiotropy)	2e-08	37844115
rs2184369	rs1934534	0.639075075721001	Pain (pleiotropy)	2e-06	37844115
rs2184369	rs4380763	0.638554621082928	Subcortical volume (min-P)	1e-11	32665545
rs2184369	rs11155671	0.628128244412566	Testicular germ cell tumor	2e-09	28604728
rs2184369	rs80147756	0.613282304302921	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2184369	rs4421206	0.605718731517047	Brain morphology (min-P)	4e-11	32665545
rs2184370	rs7752089	0.954235754317712	Brain morphology (MOSTest)	2e-31	35164939
rs2184370	rs10872649	0.894611317553067	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs2184370	rs10872649	0.894611317553067	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs2184370	rs10872649	0.894611317553067	Right hippocampal volume (body)	1e-10	37337106
rs2184370	rs9322194	0.803986330885399	Brainstem volume	2e-11	31636452
rs2184370	rs1934534	0.79853373824741	Pain (pleiotropy)	2e-08	37844115
rs2184370	rs1934534	0.79853373824741	Pain (pleiotropy)	2e-06	37844115
rs2184370	rs4380763	0.797764348732261	Subcortical volume (min-P)	1e-11	32665545
rs2184370	rs11155671	0.788097793756578	Testicular germ cell tumor	2e-09	28604728
rs2184370	rs80147756	0.760987267094721	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2184370	rs9505982	0.754454900749523	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs2184370	rs4421206	0.753424833476502	Brain morphology (min-P)	4e-11	32665545
rs2184370	rs12526675	0.732406494190816	Brain morphology (MOSTest)	7e-22	32665545
rs2184370	rs9688452	0.731531077612289	Brainstem global volume Whole-brainstem	1e-11	33875891
rs2184370	rs9688452	0.731531077612289	aseg lh volume VentralDC	2e-10	33875891
rs2184370	rs2342764	0.718306781454237	Cortical thickness	1e-08	34560273
rs2184370	rs9285521	0.680196424382764	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs2184370	rs56103941	0.66069029111658	Right presubiculum volume (head)	4e-08	37337106
rs2184370	rs12523793	0.620509974732735	Subcortical volume (MOSTest)	4e-24	32665545
rs2184370	rs12523793	0.620509974732735	C-reactive protein levels	3e-08	35459240
rs2184370	rs12523793	0.620509974732735	C-reactive protein levels (MTAG)	2e-08	36376304
rs2184370	rs11155662	0.616037320509997	Vertex-wise cortical thickness	2e-09	34910505
rs2185631	rs9394952	0.621388275894716	Age-related hearing impairment	3e-11	34108613
rs2190838	rs1138888	0.82154275827214	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs2190838	rs1138888	0.82154275827214	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs2190838	rs4802157	0.800717818816067	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs2190838	rs2355433	0.678061087258336	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs2190838	rs2355433	0.678061087258336	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs2190838	rs2355433	0.678061087258336	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs2212520	rs480293	0.994833371534336	Oily fish consumption	4e-11	32193382
rs2212520	rs1613778	0.938886520003136	Total bilirubin levels	3e-08	34594039
rs2212520	rs34634095	0.933497111311918	Fish- and plant-related diet	3e-09	32066663
rs2212520	rs542831	0.91127465049659	Asthma	5e-13	31361310
rs2212520	rs1784776	0.908794151340335	Asthma	2e-09	32296059
rs2212520	rs1784775	0.908794151340335	Asthma	2e-09	30929738
rs2212520	rs1784775	0.908794151340335	Asthma (adult onset)	6e-09	30929738
rs2212520	rs1789358	0.907147889112705	Asthma	2e-08	34103634
rs2212520	rs539524	0.90248369080161	Asthma	1e-10	32296059
rs2212520	rs12791699	0.871980588279954	Pork consumption	9e-09	32066663
rs2212520	rs12791699	0.871980588279954	Oily fish consumption	9e-09	32066663
rs2212520	rs487985	0.871980588279954	Highest math class taken	1e-08	30038396
rs2212520	rs10891286	0.846279768729948	Noncognitive aspects of educational attainment	5e-10	33414549
rs2212520	rs4459340	0.842309692992369	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs2212520	rs659529	0.799715821096168	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs2212520	rs659529	0.799715821096168	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs2212520	rs659529	0.799715821096168	Atopic dermatitis	5e-10	34116867
rs2212520	rs505372	0.797172567314368	Breast cancer	3e-06	29059683
rs2212520	rs505372	0.797172567314368	Medication use (beta blocking agents)	2e-08	34594039
rs2212520	rs9734135	0.759499044860584	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs2212520	rs11213941	0.646194608398419	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs2212520	rs11213941	0.646194608398419	Eczema	8e-14	30595370
rs2212520	rs663763	0.642243736930832	Layilin levels	3e-21	36168886
rs2216292	rs2430691	0.607561271202903	Height	4e-44	36224396
rs2216720	rs2548499	0.922248179859067	Lymphocyte count	9e-14	32888494
rs2216720	rs2648731	0.732726543803166	Type 2 diabetes	7e-12	34594039
rs2216720	rs2648731	0.732726543803166	Type 2 diabetes	3e-19	34594039
rs2216720	rs2648731	0.732726543803166	Lymphocyte count	2e-11	34594039
rs2216720	rs2648731	0.732726543803166	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs2216720	rs2648731	0.732726543803166	Medication use (drugs used in diabetes)	3e-09	34594039
rs2216720	rs13189973	0.616945869501183	Lymphocyte count	2e-16	32888493
rs2218880	rs6705511	0.753417830179467	Self-reported math ability	4e-09	30038396
rs2218880	rs6705511	0.753417830179467	Self-reported math ability (MTAG)	3e-10	30038396
rs2218880	rs34276187	0.747265886435918	Highest math class taken (MTAG)	2e-08	30038396
rs2224797	rs2224797	1	Red blood cell count	5e-08	30595370
rs2224797	rs2224797	1	Mean corpuscular hemoglobin	3e-09	30595370
rs2224990	rs11580836	0.884840689913709	Body mass index	2e-09	36581621
rs2224990	rs10465746	0.868621536263875	Obesity-related traits	8e-06	23251661
rs2224990	rs1536166	0.631897242392879	Body mass index	2e-08	30595370
rs2224990	rs28726372	0.606047174959013	Body mass index	4e-08	31669095
rs2224990	rs28726372	0.606047174959013	Adult body size	9e-10	32376654
rs2227169	rs2227169	1	Severe COVID-19 infection	4e-13	36662838
rs2227169	rs6000172	0.976696266163879	Severe COVID-19 infection	1e-07	36662838
rs2227169	rs1053982	0.975137801378867	Severe COVID-19 infection	9e-06	36662838
rs2227169	rs4821461	0.963067367873366	Severe COVID-19 infection	4e-06	36662838
rs2227169	rs5756090	0.84791440864453	Severe COVID-19 infection	4e-08	36662838
rs222837	rs222837	1	Metabolite levels	7e-06	23823483
rs222837	rs739669	0.765585949281714	BMI at birth	5e-17	35315439
rs222837	rs409942	0.638136108786975	Total cholesterol levels	8e-06	35884923
rs222837	rs13331	0.635330120980625	Heel bone mineral density	4e-08	30595370
rs222843	rs409942	0.8984085785552	Total cholesterol levels	8e-06	35884923
rs222843	rs739669	0.772533799191549	BMI at birth	5e-17	35315439
rs222843	rs222837	0.719079838869942	Metabolite levels	7e-06	23823483
rs222843	rs2654189	0.67596226132272	Eosinophil counts	4e-11	32888494
rs222843	rs2654189	0.67596226132272	Eosinophil percentage of white cells	6e-12	32888494
rs222843	rs2654189	0.67596226132272	Eosinophil counts	1e-09	30595370
rs222843	rs5415	0.666143556352766	Birth weight	5e-06	23202124
rs222843	rs5415	0.666143556352766	LDL cholesterol levels	1e-06	35884923
rs222843	rs13331	0.642976344191283	Heel bone mineral density	4e-08	30595370
rs222850	rs409942	0.851444771182454	Total cholesterol levels	8e-06	35884923
rs222850	rs739669	0.765468249648756	BMI at birth	5e-17	35315439
rs222850	rs222837	0.714718525162767	Metabolite levels	7e-06	23823483
rs222850	rs2654189	0.659012068844941	Eosinophil counts	4e-11	32888494
rs222850	rs2654189	0.659012068844941	Eosinophil percentage of white cells	6e-12	32888494
rs222850	rs2654189	0.659012068844941	Eosinophil counts	1e-09	30595370
rs222850	rs5415	0.649317715193497	Birth weight	5e-06	23202124
rs222850	rs5415	0.649317715193497	LDL cholesterol levels	1e-06	35884923
rs222850	rs13331	0.638345469535796	Heel bone mineral density	4e-08	30595370
rs2232748	rs58588820	0.954881311130964	Total cholesterol levels	1e-09	34887591
rs2232748	rs58588820	0.954881311130964	Total cholesterol levels	8e-11	34887591
rs2232748	rs6547629	0.861600688020183	Height	3e-09	36224396
rs2232748	rs10206961	0.649709834076939	Parental longevity (father's age at death)	2e-06	31484785
rs223323	rs223332	0.971048363860165	Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))	3e-08	33686288
rs223323	rs4699032	0.95047676689832	Estimated glomerular filtration rate (creatinine)	7e-40	35710981
rs223323	rs223449	0.950128024385506	Atrial fibrillation	3e-10	36653681
rs223323	rs223376	0.936855667789461	Serum creatinine levels	1e-29	34594039
rs223323	rs11722779	0.935476633362359	Schizophrenia	3e-08	28991256
rs223323	rs11722779	0.935476633362359	Schizophrenia	4e-08	30285260
rs223323	rs4645215	0.934651245621019	Migraine or type 1 diabetes	6e-09	36808568
rs223323	rs223480	0.933790195827528	Creatinine levels	4e-08	36329257
rs223323	rs10006327	0.930872538750732	Atrial fibrillation	4e-08	30061737
rs223323	rs10017313	0.928290141178652	Triglyceride levels	8e-09	34887591
rs223323	rs10017313	0.928290141178652	Triglyceride levels	2e-12	34887591
rs223323	rs7676765	0.883391904486754	Schizophrenia	3e-10	31740837
rs223323	rs7681002	0.882636797171211	Cardiovascular disease	2e-13	30595370
rs223323	rs223337	0.870313484186193	Migraine or glucose levels	5e-09	36808568
rs223323	rs223346	0.852738367614792	Schizophrenia vs ADHD (ordinary least squares (OLS))	8e-10	33686288
rs223323	rs223497	0.84280994247897	Headache or glucose levels	2e-08	36808568
rs223323	rs13130741	0.837278168672313	Medication use (agents acting on the renin-angiotensin system)	7e-09	31015401
rs223323	rs223308	0.82828852017416	Estimated glomerular filtration rate	3e-21	31152163
rs223323	rs223351	0.822145064106793	Hemoglobin A1c levels	4e-13	34594039
rs223323	rs7694724	0.814528640484877	Schizophrenia	2e-08	35396580
rs223323	rs223454	0.808545558801857	Alanine aminotransferase levels	6e-09	33547301
rs223323	rs223423	0.807887293519171	Type 2 diabetes	2e-09	35551307
rs223323	rs223423	0.807887293519171	Type 2 diabetes	4e-08	35551307
rs223323	rs3974481	0.786324937127261	Liver enzyme levels (alkaline phosphatase)	2e-15	33972514
rs223323	rs223482	0.785896423941777	Glutamate levels in elite athletes	5e-06	31882771
rs223323	rs223482	0.785896423941777	Gamma-glutamylglutamine levels in elite athletes	5e-06	31882771
rs223323	rs223482	0.785896423941777	Migraine or fasting glucose levels	6e-11	36808568
rs223323	rs223482	0.785896423941777	Headache or fasting glucose levels	4e-10	36808568
rs223323	rs223486	0.785253938600019	Fasting glucose	4e-08	33402679
rs223323	rs3960788	0.775712569111399	Atrial fibrillation	2e-12	29892015
rs223323	rs3960788	0.775712569111399	Atrial fibrillation	4e-11	29892015
rs223323	rs3960788	0.775712569111399	Atrial fibrillation (MTAG)	4e-08	35872910
rs223323	rs6533052	0.772438221408494	Multiple sclerosis	7e-16	31604244
rs223323	rs7659468	0.768278146838314	Type 2 diabetes	1e-14	32541925
rs223323	rs7695096	0.743544414741811	Type 2 diabetes	1e-16	32541925
rs223323	rs223498	0.723896860788472	Sarcoidosis	1e-09	26051272
rs223323	rs7688014	0.693856027535404	Estimated glomerular filtration rate	2e-12	31451708
rs223323	rs7688014	0.693856027535404	Schizophrenia	3e-06	26198764
rs223323	rs9884397	0.650847650688163	Cholesteryl esters to total lipids ratio in medium VLDL	2e-08	35213538
rs223323	rs9884397	0.650847650688163	Cholesterol to total lipids ratio in medium VLDL	2e-08	35213538
rs223323	rs9884397	0.650847650688163	Triglycerides to total lipids ratio in medium VLDL	4e-08	35213538
rs223323	rs223490	0.623913472571351	Alanine aminotransferase levels	1e-08	34594039
rs223323	rs223490	0.623913472571351	AFP levels	3e-12	36329257
rs223324	rs4699032	1	Estimated glomerular filtration rate (creatinine)	7e-40	35710981
rs223324	rs223376	0.985974733917791	Serum creatinine levels	1e-29	34594039
rs223324	rs11722779	0.975328110171829	Schizophrenia	3e-08	28991256
rs223324	rs11722779	0.975328110171829	Schizophrenia	4e-08	30285260
rs223324	rs4645215	0.974513658193992	Migraine or type 1 diabetes	6e-09	36808568
rs223324	rs10017313	0.967955263221156	Triglyceride levels	8e-09	34887591
rs223324	rs10017313	0.967955263221156	Triglyceride levels	2e-12	34887591
rs223324	rs223332	0.967299559971356	Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))	3e-08	33686288
rs223324	rs223449	0.946041433181059	Atrial fibrillation	3e-10	36653681
rs223324	rs223480	0.929981156498244	Creatinine levels	4e-08	36329257
rs223324	rs7676765	0.922023902434941	Schizophrenia	3e-10	31740837
rs223324	rs7681002	0.921233200163455	Cardiovascular disease	2e-13	30595370
rs223324	rs223337	0.915708667614325	Migraine or glucose levels	5e-09	36808568
rs223324	rs223346	0.897217260449876	Schizophrenia vs ADHD (ordinary least squares (OLS))	8e-10	33686288
rs223324	rs10006327	0.886903807152493	Atrial fibrillation	4e-08	30061737
rs223324	rs223308	0.871445309365219	Estimated glomerular filtration rate	3e-21	31152163
rs223324	rs223351	0.865217858514172	Hemoglobin A1c levels	4e-13	34594039
rs223324	rs223454	0.851001221900901	Alanine aminotransferase levels	6e-09	33547301
rs223324	rs223423	0.850308509960376	Type 2 diabetes	2e-09	35551307
rs223324	rs223423	0.850308509960376	Type 2 diabetes	4e-08	35551307
rs223324	rs223482	0.827489805889521	Glutamate levels in elite athletes	5e-06	31882771
rs223324	rs223482	0.827489805889521	Gamma-glutamylglutamine levels in elite athletes	5e-06	31882771
rs223324	rs223482	0.827489805889521	Migraine or fasting glucose levels	6e-11	36808568
rs223324	rs223482	0.827489805889521	Headache or fasting glucose levels	4e-10	36808568
rs223324	rs223486	0.826813552775535	Fasting glucose	4e-08	33402679
rs223324	rs3974481	0.81943372010798	Liver enzyme levels (alkaline phosphatase)	2e-15	33972514
rs223324	rs6533052	0.805527276592125	Multiple sclerosis	7e-16	31604244
rs223324	rs7659468	0.801440037586664	Type 2 diabetes	1e-14	32541925
rs223324	rs223497	0.800431146381074	Headache or glucose levels	2e-08	36808568
rs223324	rs13130741	0.794436821887969	Medication use (agents acting on the renin-angiotensin system)	7e-09	31015401
rs223324	rs3960788	0.785697812326678	Atrial fibrillation	2e-12	29892015
rs223324	rs3960788	0.785697812326678	Atrial fibrillation	4e-11	29892015
rs223324	rs3960788	0.785697812326678	Atrial fibrillation (MTAG)	4e-08	35872910
rs223324	rs7694724	0.772742608900222	Schizophrenia	2e-08	35396580
rs223324	rs7695096	0.755492290968891	Type 2 diabetes	1e-16	32541925
rs223324	rs223498	0.686089960371609	Sarcoidosis	1e-09	26051272
rs223324	rs9884397	0.677613747622098	Cholesteryl esters to total lipids ratio in medium VLDL	2e-08	35213538
rs223324	rs9884397	0.677613747622098	Cholesterol to total lipids ratio in medium VLDL	2e-08	35213538
rs223324	rs9884397	0.677613747622098	Triglycerides to total lipids ratio in medium VLDL	4e-08	35213538
rs223324	rs7688014	0.658677966182412	Estimated glomerular filtration rate	2e-12	31451708
rs223324	rs7688014	0.658677966182412	Schizophrenia	3e-06	26198764
rs223326	rs223332	0.994182905957367	Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))	3e-08	33686288
rs223326	rs4699032	0.97295935604513	Estimated glomerular filtration rate (creatinine)	7e-40	35710981
rs223326	rs223449	0.972788920160727	Atrial fibrillation	3e-10	36653681
rs223326	rs223376	0.959154767221446	Serum creatinine levels	1e-29	34594039
rs223326	rs11722779	0.958044222170426	Schizophrenia	3e-08	28991256
rs223326	rs11722779	0.958044222170426	Schizophrenia	4e-08	30285260
rs223326	rs4645215	0.957222295135632	Migraine or type 1 diabetes	6e-09	36808568
rs223326	rs223480	0.95638705485583	Creatinine levels	4e-08	36329257
rs223326	rs10017313	0.950755110440363	Triglyceride levels	8e-09	34887591
rs223326	rs10017313	0.950755110440363	Triglyceride levels	2e-12	34887591
rs223326	rs10006327	0.912084390748181	Atrial fibrillation	4e-08	30061737
rs223326	rs7676765	0.905276308195467	Schizophrenia	3e-10	31740837
rs223326	rs7681002	0.904502839221354	Cardiovascular disease	2e-13	30595370
rs223326	rs223337	0.890922018535802	Migraine or glucose levels	5e-09	36808568
rs223326	rs223346	0.87293092377336	Schizophrenia vs ADHD (ordinary least squares (OLS))	8e-10	33686288
rs223326	rs223308	0.847880867028533	Estimated glomerular filtration rate	3e-21	31152163
rs223326	rs223351	0.841699275054486	Hemoglobin A1c levels	4e-13	34594039
rs223326	rs223454	0.827819600349079	Alanine aminotransferase levels	6e-09	33547301
rs223326	rs223423	0.827145696951274	Type 2 diabetes	2e-09	35551307
rs223326	rs223423	0.827145696951274	Type 2 diabetes	4e-08	35551307
rs223326	rs223497	0.824669778107093	Headache or glucose levels	2e-08	36808568
rs223326	rs13130741	0.818911192627981	Medication use (agents acting on the renin-angiotensin system)	7e-09	31015401
rs223326	rs3974481	0.805406581564634	Liver enzyme levels (alkaline phosphatase)	2e-15	33972514
rs223326	rs223482	0.804778983689323	Glutamate levels in elite athletes	5e-06	31882771
rs223326	rs223482	0.804778983689323	Gamma-glutamylglutamine levels in elite athletes	5e-06	31882771
rs223326	rs223482	0.804778983689323	Migraine or fasting glucose levels	6e-11	36808568
rs223326	rs223482	0.804778983689323	Headache or fasting glucose levels	4e-10	36808568
rs223326	rs223486	0.804121168435321	Fasting glucose	4e-08	33402679
rs223326	rs7694724	0.796634603966458	Schizophrenia	2e-08	35396580
rs223326	rs3960788	0.791985393791231	Atrial fibrillation	2e-12	29892015
rs223326	rs3960788	0.791985393791231	Atrial fibrillation	4e-11	29892015
rs223326	rs3960788	0.791985393791231	Atrial fibrillation (MTAG)	4e-08	35872910
rs223326	rs6533052	0.791478287944812	Multiple sclerosis	7e-16	31604244
rs223326	rs7659468	0.787342417213967	Type 2 diabetes	1e-14	32541925
rs223326	rs7695096	0.762007570011971	Type 2 diabetes	1e-16	32541925
rs223326	rs223498	0.707777344005307	Sarcoidosis	1e-09	26051272
rs223326	rs7688014	0.678206340117971	Estimated glomerular filtration rate	2e-12	31451708
rs223326	rs7688014	0.678206340117971	Schizophrenia	3e-06	26198764
rs223326	rs9884397	0.666659431464582	Cholesteryl esters to total lipids ratio in medium VLDL	2e-08	35213538
rs223326	rs9884397	0.666659431464582	Cholesterol to total lipids ratio in medium VLDL	2e-08	35213538
rs223326	rs9884397	0.666659431464582	Triglycerides to total lipids ratio in medium VLDL	4e-08	35213538
rs223326	rs223490	0.607116964852226	Alanine aminotransferase levels	1e-08	34594039
rs223326	rs223490	0.607116964852226	AFP levels	3e-12	36329257
rs223327	rs223332	0.993349258216287	Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))	3e-08	33686288
rs223327	rs4699032	0.972149201501028	Estimated glomerular filtration rate (creatinine)	7e-40	35710981
rs223327	rs223449	0.971972340077543	Atrial fibrillation	3e-10	36653681
rs223327	rs223376	0.95835122451356	Serum creatinine levels	1e-29	34594039
rs223327	rs11722779	0.95723100296986	Schizophrenia	3e-08	28991256
rs223327	rs11722779	0.95723100296986	Schizophrenia	4e-08	30285260
rs223327	rs4645215	0.956408951043808	Migraine or type 1 diabetes	6e-09	36808568
rs223327	rs223480	0.955572780324377	Creatinine levels	4e-08	36329257
rs223327	rs10017313	0.94994558852669	Triglyceride levels	8e-09	34887591
rs223327	rs10017313	0.94994558852669	Triglyceride levels	2e-12	34887591
rs223327	rs10006327	0.911262572322264	Atrial fibrillation	4e-08	30061737
rs223327	rs7676765	0.904487699943794	Schizophrenia	3e-10	31740837
rs223327	rs7681002	0.903714892628955	Cardiovascular disease	2e-13	30595370
rs223327	rs223337	0.890179395088542	Migraine or glucose levels	5e-09	36808568
rs223327	rs223346	0.872203289997432	Schizophrenia vs ADHD (ordinary least squares (OLS))	8e-10	33686288
rs223327	rs223308	0.847174861651214	Estimated glomerular filtration rate	3e-21	31152163
rs223327	rs223351	0.840994643779251	Hemoglobin A1c levels	4e-13	34594039
rs223327	rs223454	0.827125064798053	Alanine aminotransferase levels	6e-09	33547301
rs223327	rs223423	0.826451724915884	Type 2 diabetes	2e-09	35551307
rs223327	rs223423	0.826451724915884	Type 2 diabetes	4e-08	35551307
rs223327	rs223497	0.823906004483444	Headache or glucose levels	2e-08	36808568
rs223327	rs13130741	0.818164739550664	Medication use (agents acting on the renin-angiotensin system)	7e-09	31015401
rs223327	rs3974481	0.804718976773822	Liver enzyme levels (alkaline phosphatase)	2e-15	33972514
rs223327	rs223482	0.804098554409394	Glutamate levels in elite athletes	5e-06	31882771
rs223327	rs223482	0.804098554409394	Gamma-glutamylglutamine levels in elite athletes	5e-06	31882771
rs223327	rs223482	0.804098554409394	Migraine or fasting glucose levels	6e-11	36808568
rs223327	rs223482	0.804098554409394	Headache or fasting glucose levels	4e-10	36808568
rs223327	rs223486	0.80344129156507	Fasting glucose	4e-08	33402679
rs223327	rs7694724	0.795888186399654	Schizophrenia	2e-08	35396580
rs223327	rs3960788	0.791294439295423	Atrial fibrillation	2e-12	29892015
rs223327	rs3960788	0.791294439295423	Atrial fibrillation	4e-11	29892015
rs223327	rs3960788	0.791294439295423	Atrial fibrillation (MTAG)	4e-08	35872910
rs223327	rs6533052	0.790792177508703	Multiple sclerosis	7e-16	31604244
rs223327	rs7659468	0.78665543236836	Type 2 diabetes	1e-14	32541925
rs223327	rs7695096	0.76134224623191	Type 2 diabetes	1e-16	32541925
rs223327	rs223498	0.70703877043703	Sarcoidosis	1e-09	26051272
rs223327	rs7688014	0.677394846626312	Estimated glomerular filtration rate	2e-12	31451708
rs223327	rs7688014	0.677394846626312	Schizophrenia	3e-06	26198764
rs223327	rs9884397	0.66608965564034	Cholesteryl esters to total lipids ratio in medium VLDL	2e-08	35213538
rs223327	rs9884397	0.66608965564034	Cholesterol to total lipids ratio in medium VLDL	2e-08	35213538
rs223327	rs9884397	0.66608965564034	Triglycerides to total lipids ratio in medium VLDL	4e-08	35213538
rs223327	rs223490	0.606573266699894	Alanine aminotransferase levels	1e-08	34594039
rs223327	rs223490	0.606573266699894	AFP levels	3e-12	36329257
rs223329	rs4699032	1	Estimated glomerular filtration rate (creatinine)	7e-40	35710981
rs223329	rs223376	0.985974733917791	Serum creatinine levels	1e-29	34594039
rs223329	rs11722779	0.975328110171829	Schizophrenia	3e-08	28991256
rs223329	rs11722779	0.975328110171829	Schizophrenia	4e-08	30285260
rs223329	rs4645215	0.974513658193992	Migraine or type 1 diabetes	6e-09	36808568
rs223329	rs10017313	0.967955263221156	Triglyceride levels	8e-09	34887591
rs223329	rs10017313	0.967955263221156	Triglyceride levels	2e-12	34887591
rs223329	rs223332	0.967299559971356	Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))	3e-08	33686288
rs223329	rs223449	0.946041433181059	Atrial fibrillation	3e-10	36653681
rs223329	rs223480	0.929981156498244	Creatinine levels	4e-08	36329257
rs223329	rs7676765	0.922023902434941	Schizophrenia	3e-10	31740837
rs223329	rs7681002	0.921233200163455	Cardiovascular disease	2e-13	30595370
rs223329	rs223337	0.915708667614325	Migraine or glucose levels	5e-09	36808568
rs223329	rs223346	0.897217260449876	Schizophrenia vs ADHD (ordinary least squares (OLS))	8e-10	33686288
rs223329	rs10006327	0.886903807152493	Atrial fibrillation	4e-08	30061737
rs223329	rs223308	0.871445309365219	Estimated glomerular filtration rate	3e-21	31152163
rs223329	rs223351	0.865217858514172	Hemoglobin A1c levels	4e-13	34594039
rs223329	rs223454	0.851001221900901	Alanine aminotransferase levels	6e-09	33547301
rs223329	rs223423	0.850308509960376	Type 2 diabetes	2e-09	35551307
rs223329	rs223423	0.850308509960376	Type 2 diabetes	4e-08	35551307
rs223329	rs223482	0.827489805889521	Glutamate levels in elite athletes	5e-06	31882771
rs223329	rs223482	0.827489805889521	Gamma-glutamylglutamine levels in elite athletes	5e-06	31882771
rs223329	rs223482	0.827489805889521	Migraine or fasting glucose levels	6e-11	36808568
rs223329	rs223482	0.827489805889521	Headache or fasting glucose levels	4e-10	36808568
rs223329	rs223486	0.826813552775535	Fasting glucose	4e-08	33402679
rs223329	rs3974481	0.81943372010798	Liver enzyme levels (alkaline phosphatase)	2e-15	33972514
rs223329	rs6533052	0.805527276592125	Multiple sclerosis	7e-16	31604244
rs223329	rs7659468	0.801440037586664	Type 2 diabetes	1e-14	32541925
rs223329	rs223497	0.800431146381074	Headache or glucose levels	2e-08	36808568
rs223329	rs13130741	0.794436821887969	Medication use (agents acting on the renin-angiotensin system)	7e-09	31015401
rs223329	rs3960788	0.785697812326678	Atrial fibrillation	2e-12	29892015
rs223329	rs3960788	0.785697812326678	Atrial fibrillation	4e-11	29892015
rs223329	rs3960788	0.785697812326678	Atrial fibrillation (MTAG)	4e-08	35872910
rs223329	rs7694724	0.772742608900222	Schizophrenia	2e-08	35396580
rs223329	rs7695096	0.755492290968891	Type 2 diabetes	1e-16	32541925
rs223329	rs223498	0.686089960371609	Sarcoidosis	1e-09	26051272
rs223329	rs9884397	0.677613747622098	Cholesteryl esters to total lipids ratio in medium VLDL	2e-08	35213538
rs223329	rs9884397	0.677613747622098	Cholesterol to total lipids ratio in medium VLDL	2e-08	35213538
rs223329	rs9884397	0.677613747622098	Triglycerides to total lipids ratio in medium VLDL	4e-08	35213538
rs223329	rs7688014	0.658677966182412	Estimated glomerular filtration rate	2e-12	31451708
rs223329	rs7688014	0.658677966182412	Schizophrenia	3e-06	26198764
rs223330	rs4699032	1	Estimated glomerular filtration rate (creatinine)	7e-40	35710981
rs223330	rs223376	0.985974733917791	Serum creatinine levels	1e-29	34594039
rs223330	rs11722779	0.975328110171829	Schizophrenia	3e-08	28991256
rs223330	rs11722779	0.975328110171829	Schizophrenia	4e-08	30285260
rs223330	rs4645215	0.974513658193992	Migraine or type 1 diabetes	6e-09	36808568
rs223330	rs10017313	0.967955263221156	Triglyceride levels	8e-09	34887591
rs223330	rs10017313	0.967955263221156	Triglyceride levels	2e-12	34887591
rs223330	rs223332	0.967299559971356	Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))	3e-08	33686288
rs223330	rs223449	0.946041433181059	Atrial fibrillation	3e-10	36653681
rs223330	rs223480	0.929981156498244	Creatinine levels	4e-08	36329257
rs223330	rs7676765	0.922023902434941	Schizophrenia	3e-10	31740837
rs223330	rs7681002	0.921233200163455	Cardiovascular disease	2e-13	30595370
rs223330	rs223337	0.915708667614325	Migraine or glucose levels	5e-09	36808568
rs223330	rs223346	0.897217260449876	Schizophrenia vs ADHD (ordinary least squares (OLS))	8e-10	33686288
rs223330	rs10006327	0.886903807152493	Atrial fibrillation	4e-08	30061737
rs223330	rs223308	0.871445309365219	Estimated glomerular filtration rate	3e-21	31152163
rs223330	rs223351	0.865217858514172	Hemoglobin A1c levels	4e-13	34594039
rs223330	rs223454	0.851001221900901	Alanine aminotransferase levels	6e-09	33547301
rs223330	rs223423	0.850308509960376	Type 2 diabetes	2e-09	35551307
rs223330	rs223423	0.850308509960376	Type 2 diabetes	4e-08	35551307
rs223330	rs223482	0.827489805889521	Glutamate levels in elite athletes	5e-06	31882771
rs223330	rs223482	0.827489805889521	Gamma-glutamylglutamine levels in elite athletes	5e-06	31882771
rs223330	rs223482	0.827489805889521	Migraine or fasting glucose levels	6e-11	36808568
rs223330	rs223482	0.827489805889521	Headache or fasting glucose levels	4e-10	36808568
rs223330	rs223486	0.826813552775535	Fasting glucose	4e-08	33402679
rs223330	rs3974481	0.81943372010798	Liver enzyme levels (alkaline phosphatase)	2e-15	33972514
rs223330	rs6533052	0.805527276592125	Multiple sclerosis	7e-16	31604244
rs223330	rs7659468	0.801440037586664	Type 2 diabetes	1e-14	32541925
rs223330	rs223497	0.800431146381074	Headache or glucose levels	2e-08	36808568
rs223330	rs13130741	0.794436821887969	Medication use (agents acting on the renin-angiotensin system)	7e-09	31015401
rs223330	rs3960788	0.785697812326678	Atrial fibrillation	2e-12	29892015
rs223330	rs3960788	0.785697812326678	Atrial fibrillation	4e-11	29892015
rs223330	rs3960788	0.785697812326678	Atrial fibrillation (MTAG)	4e-08	35872910
rs223330	rs7694724	0.772742608900222	Schizophrenia	2e-08	35396580
rs223330	rs7695096	0.755492290968891	Type 2 diabetes	1e-16	32541925
rs223330	rs223498	0.686089960371609	Sarcoidosis	1e-09	26051272
rs223330	rs9884397	0.677613747622098	Cholesteryl esters to total lipids ratio in medium VLDL	2e-08	35213538
rs223330	rs9884397	0.677613747622098	Cholesterol to total lipids ratio in medium VLDL	2e-08	35213538
rs223330	rs9884397	0.677613747622098	Triglycerides to total lipids ratio in medium VLDL	4e-08	35213538
rs223330	rs7688014	0.658677966182412	Estimated glomerular filtration rate	2e-12	31451708
rs223330	rs7688014	0.658677966182412	Schizophrenia	3e-06	26198764
rs223358	rs223332	0.955499977347904	Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))	3e-08	33686288
rs223358	rs223449	0.951025914128107	Atrial fibrillation	3e-10	36653681
rs223358	rs223376	0.937786809742308	Serum creatinine levels	1e-29	34594039
rs223358	rs223480	0.93465185497373	Creatinine levels	4e-08	36329257
rs223358	rs4699032	0.933614947075025	Estimated glomerular filtration rate (creatinine)	7e-40	35710981
rs223358	rs10006327	0.931600356168455	Atrial fibrillation	4e-08	30061737
rs223358	rs11722779	0.918666436005622	Schizophrenia	3e-08	28991256
rs223358	rs11722779	0.918666436005622	Schizophrenia	4e-08	30285260
rs223358	rs4645215	0.917844286055986	Migraine or type 1 diabetes	6e-09	36808568
rs223358	rs10017313	0.911551502001661	Triglyceride levels	8e-09	34887591
rs223358	rs10017313	0.911551502001661	Triglyceride levels	2e-12	34887591
rs223358	rs7676765	0.867083611005551	Schizophrenia	3e-10	31740837
rs223358	rs7681002	0.866338571213843	Cardiovascular disease	2e-13	30595370
rs223358	rs223497	0.860533018482846	Headache or glucose levels	2e-08	36808568
rs223358	rs223337	0.856011395864213	Migraine or glucose levels	5e-09	36808568
rs223358	rs223346	0.838645901825461	Schizophrenia vs ADHD (ordinary least squares (OLS))	8e-10	33686288
rs223358	rs13130741	0.838140529169816	Medication use (agents acting on the renin-angiotensin system)	7e-09	31015401
rs223358	rs223351	0.820297014633279	Hemoglobin A1c levels	4e-13	34594039
rs223358	rs7694724	0.815316284152673	Schizophrenia	2e-08	35396580
rs223358	rs223308	0.813006576980774	Estimated glomerular filtration rate	3e-21	31152163
rs223358	rs223454	0.809702315765482	Alanine aminotransferase levels	6e-09	33547301
rs223358	rs223423	0.809045231502166	Type 2 diabetes	2e-09	35551307
rs223358	rs223423	0.809045231502166	Type 2 diabetes	4e-08	35551307
rs223358	rs223482	0.787061410231166	Glutamate levels in elite athletes	5e-06	31882771
rs223358	rs223482	0.787061410231166	Gamma-glutamylglutamine levels in elite athletes	5e-06	31882771
rs223358	rs223482	0.787061410231166	Migraine or fasting glucose levels	6e-11	36808568
rs223358	rs223482	0.787061410231166	Headache or fasting glucose levels	4e-10	36808568
rs223358	rs223486	0.786420078409915	Fasting glucose	4e-08	33402679
rs223358	rs3974481	0.771444626073499	Liver enzyme levels (alkaline phosphatase)	2e-15	33972514
rs223358	rs3960788	0.760860068469481	Atrial fibrillation	2e-12	29892015
rs223358	rs3960788	0.760860068469481	Atrial fibrillation	4e-11	29892015
rs223358	rs3960788	0.760860068469481	Atrial fibrillation (MTAG)	4e-08	35872910
rs223358	rs6533052	0.75765432347515	Multiple sclerosis	7e-16	31604244
rs223358	rs7659468	0.753512289282737	Type 2 diabetes	1e-14	32541925
rs223358	rs223498	0.741659152506424	Sarcoidosis	1e-09	26051272
rs223358	rs7695096	0.729108832428808	Type 2 diabetes	1e-16	32541925
rs223358	rs7688014	0.69676011309569	Estimated glomerular filtration rate	2e-12	31451708
rs223358	rs7688014	0.69676011309569	Schizophrenia	3e-06	26198764
rs223358	rs223490	0.639591094743145	Alanine aminotransferase levels	1e-08	34594039
rs223358	rs223490	0.639591094743145	AFP levels	3e-12	36329257
rs223358	rs9884397	0.637755808292648	Cholesteryl esters to total lipids ratio in medium VLDL	2e-08	35213538
rs223358	rs9884397	0.637755808292648	Cholesterol to total lipids ratio in medium VLDL	2e-08	35213538
rs223358	rs9884397	0.637755808292648	Triglycerides to total lipids ratio in medium VLDL	4e-08	35213538
rs223426	rs223376	0.982736195490998	Serum creatinine levels	1e-29	34594039
rs223426	rs4699032	0.973754356721592	Estimated glomerular filtration rate (creatinine)	7e-40	35710981
rs223426	rs223449	0.972227729226397	Atrial fibrillation	3e-10	36653681
rs223426	rs223480	0.954413128575504	Creatinine levels	4e-08	36329257
rs223426	rs11722779	0.951138659096158	Schizophrenia	3e-08	28991256
rs223426	rs11722779	0.951138659096158	Schizophrenia	4e-08	30285260
rs223426	rs4645215	0.950339540991068	Migraine or type 1 diabetes	6e-09	36808568
rs223426	rs10017313	0.943855829384514	Triglyceride levels	8e-09	34887591
rs223426	rs10017313	0.943855829384514	Triglyceride levels	2e-12	34887591
rs223426	rs223332	0.943301749958883	Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))	3e-08	33686288
rs223426	rs7676765	0.898516774011865	Schizophrenia	3e-10	31740837
rs223426	rs7681002	0.897733294837601	Cardiovascular disease	2e-13	30595370
rs223426	rs223337	0.891839431498399	Migraine or glucose levels	5e-09	36808568
rs223426	rs223454	0.87454096149341	Alanine aminotransferase levels	6e-09	33547301
rs223426	rs223423	0.87383297911437	Type 2 diabetes	2e-09	35551307
rs223426	rs223423	0.87383297911437	Type 2 diabetes	4e-08	35551307
rs223426	rs223346	0.873509319720864	Schizophrenia vs ADHD (ordinary least squares (OLS))	8e-10	33686288
rs223426	rs10006327	0.864192227315419	Atrial fibrillation	4e-08	30061737
rs223426	rs223351	0.853888147361626	Hemoglobin A1c levels	4e-13	34594039
rs223426	rs223482	0.849104817128941	Glutamate levels in elite athletes	5e-06	31882771
rs223426	rs223482	0.849104817128941	Gamma-glutamylglutamine levels in elite athletes	5e-06	31882771
rs223426	rs223482	0.849104817128941	Migraine or fasting glucose levels	6e-11	36808568
rs223426	rs223482	0.849104817128941	Headache or fasting glucose levels	4e-10	36808568
rs223426	rs223486	0.848414265211942	Fasting glucose	4e-08	33402679
rs223426	rs223308	0.846445895211296	Estimated glomerular filtration rate	3e-21	31152163
rs223426	rs223497	0.823223359763012	Headache or glucose levels	2e-08	36808568
rs223426	rs3974481	0.796676168930185	Liver enzyme levels (alkaline phosphatase)	2e-15	33972514
rs223426	rs6533052	0.783026185925267	Multiple sclerosis	7e-16	31604244
rs223426	rs7659468	0.779031460853771	Type 2 diabetes	1e-14	32541925
rs223426	rs13130741	0.772685616585674	Medication use (agents acting on the renin-angiotensin system)	7e-09	31015401
rs223426	rs3960788	0.763562207319476	Atrial fibrillation	2e-12	29892015
rs223426	rs3960788	0.763562207319476	Atrial fibrillation	4e-11	29892015
rs223426	rs3960788	0.763562207319476	Atrial fibrillation (MTAG)	4e-08	35872910
rs223426	rs7694724	0.751406940694663	Schizophrenia	2e-08	35396580
rs223426	rs7695096	0.733640795121775	Type 2 diabetes	1e-16	32541925
rs223426	rs223498	0.707787870965497	Sarcoidosis	1e-09	26051272
rs223426	rs9884397	0.656134303605478	Cholesteryl esters to total lipids ratio in medium VLDL	2e-08	35213538
rs223426	rs9884397	0.656134303605478	Cholesterol to total lipids ratio in medium VLDL	2e-08	35213538
rs223426	rs9884397	0.656134303605478	Triglycerides to total lipids ratio in medium VLDL	4e-08	35213538
rs223426	rs7688014	0.645542159866696	Estimated glomerular filtration rate	2e-12	31451708
rs223426	rs7688014	0.645542159866696	Schizophrenia	3e-06	26198764
rs223426	rs223490	0.600839060761368	Alanine aminotransferase levels	1e-08	34594039
rs223426	rs223490	0.600839060761368	AFP levels	3e-12	36329257
rs2235568	rs2263329	0.960204154429727	HDL cholesterol	6e-35	34594039
rs2235568	rs2263329	0.960204154429727	HDL cholesterol levels	8e-43	32203549
rs2235568	rs2263329	0.960204154429727	High density lipoprotein cholesterol levels	2e-52	34887591
rs2235568	rs9366863	0.946191184869444	Adult body size	9e-33	32376654
rs2235568	rs9366863	0.946191184869444	Body mass index	2e-44	30595370
rs2235568	rs2744944	0.939196705849828	Hypothyroidism	3e-10	34594039
rs2235568	rs2744944	0.939196705849828	High density lipoprotein cholesterol levels	3e-86	34887591
rs2235568	rs2744944	0.939196705849828	Multi-trait sex score	7e-22	37277458
rs2235568	rs2814949	0.937781272440345	Essential hypertension (time to event)	9e-09	32589924
rs2235568	rs9469872	0.932968939170937	HDL cholesterol levels	3e-11	36333282
rs2235568	rs11755393	0.91103739377738	Body mass index	3e-26	29273807
rs2235568	rs11755393	0.91103739377738	Systemic lupus erythematosus	2e-12	33493351
rs2235568	rs11755393	0.91103739377738	Systemic lupus erythematosus	2e-06	33493351
rs2235568	rs11755393	0.91103739377738	Systemic lupus erythematosus	1e-07	33493351
rs2235568	rs11755393	0.91103739377738	Systemic lupus erythematosus	2e-08	19838195
rs2235568	rs11755393	0.91103739377738	Body mass index	4e-55	36581621
rs2235568	rs6941110	0.902816862638613	Sex hormone-binding globulin levels	5e-27	36653534
rs2235568	rs111868030	0.897178719874563	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2235568	rs9469857	0.894184083961367	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2235568	rs2764208	0.891901978433689	Systemic lupus erythematosus	7e-06	24871463
rs2235568	rs9462030	0.882032647840032	Red cell distribution width	5e-25	32888493
rs2235568	rs9469899	0.866415228793728	Prostate cancer (advanced)	2e-06	29892016
rs2235568	rs9469899	0.866415228793728	Prostate cancer	5e-09	29892016
rs2235568	rs9469899	0.866415228793728	Prostate cancer	8e-11	33398198
rs2235568	rs9469899	0.866415228793728	Hand grip strength	3e-15	29691431
rs2235568	rs9469899	0.866415228793728	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2235568	rs9469899	0.866415228793728	Graves' disease	4e-10	34594039
rs2235568	rs9469899	0.866415228793728	Coronary artery disease	1e-11	36474045
rs2235568	rs9469899	0.866415228793728	Predicted visceral adipose tissue	2e-20	31501611
rs2235568	rs9469899	0.866415228793728	Medication use (thyroid preparations)	2e-09	31015401
rs2235568	rs9469899	0.866415228793728	Medication use (thyroid preparations)	3e-10	34594039
rs2235568	rs9368830	0.857173878728201	HDL cholesterol	4e-21	30275531
rs2235568	rs9296128	0.844379847743564	Hip circumference adjusted for BMI	4e-13	34021172
rs2235568	rs9368828	0.840940904456712	Body mass index	1e-34	34594039
rs2235568	rs2744973	0.807103197791255	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2235568	rs2744973	0.807103197791255	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2235568	rs2744973	0.807103197791255	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2235568	rs2744973	0.807103197791255	Multi-trait sex score	6e-20	37277458
rs2235568	rs6912327	0.761493659871611	Fasting insulin	5e-06	33402679
rs2235568	rs6912327	0.761493659871611	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2235568	rs112283401	0.73682642824086	Red cell distribution width	4e-27	30595370
rs2235568	rs205262	0.630056664822242	Body mass index	2e-09	26961502
rs2235568	rs205262	0.630056664822242	Walking pace	4e-10	33128006
rs2235568	rs205262	0.630056664822242	Body mass index	8e-13	30108127
rs2235568	rs205262	0.630056664822242	Body mass index	2e-09	25673413
rs2235568	rs205262	0.630056664822242	Body mass index	2e-14	26426971
rs2235568	rs205262	0.630056664822242	BMI in non-smokers	3e-07	28443625
rs2235568	rs205262	0.630056664822242	BMI in non-smokers	6e-09	28443625
rs2235568	rs205262	0.630056664822242	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2235568	rs205262	0.630056664822242	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2235568	rs205262	0.630056664822242	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2235568	rs205262	0.630056664822242	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2235568	rs205262	0.630056664822242	Gastroesophageal reflux disease	1e-10	34187846
rs2235568	rs205262	0.630056664822242	Body mass index	3e-10	25673413
rs2235568	rs205262	0.630056664822242	Body mass index	2e-10	25673413
rs2235568	rs205262	0.630056664822242	ICD10 M54: Dorsalgia	2e-12	35110524
rs2235569	rs2263329	0.960204154429727	HDL cholesterol	6e-35	34594039
rs2235569	rs2263329	0.960204154429727	HDL cholesterol levels	8e-43	32203549
rs2235569	rs2263329	0.960204154429727	High density lipoprotein cholesterol levels	2e-52	34887591
rs2235569	rs9366863	0.946191184869444	Adult body size	9e-33	32376654
rs2235569	rs9366863	0.946191184869444	Body mass index	2e-44	30595370
rs2235569	rs2744944	0.939196705849828	Hypothyroidism	3e-10	34594039
rs2235569	rs2744944	0.939196705849828	High density lipoprotein cholesterol levels	3e-86	34887591
rs2235569	rs2744944	0.939196705849828	Multi-trait sex score	7e-22	37277458
rs2235569	rs2814949	0.937781272440345	Essential hypertension (time to event)	9e-09	32589924
rs2235569	rs9469872	0.932968939170937	HDL cholesterol levels	3e-11	36333282
rs2235569	rs11755393	0.91103739377738	Body mass index	3e-26	29273807
rs2235569	rs11755393	0.91103739377738	Systemic lupus erythematosus	2e-12	33493351
rs2235569	rs11755393	0.91103739377738	Systemic lupus erythematosus	2e-06	33493351
rs2235569	rs11755393	0.91103739377738	Systemic lupus erythematosus	1e-07	33493351
rs2235569	rs11755393	0.91103739377738	Systemic lupus erythematosus	2e-08	19838195
rs2235569	rs11755393	0.91103739377738	Body mass index	4e-55	36581621
rs2235569	rs6941110	0.902816862638613	Sex hormone-binding globulin levels	5e-27	36653534
rs2235569	rs111868030	0.897178719874563	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2235569	rs9469857	0.894184083961367	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2235569	rs2764208	0.891901978433689	Systemic lupus erythematosus	7e-06	24871463
rs2235569	rs9462030	0.882032647840032	Red cell distribution width	5e-25	32888493
rs2235569	rs9469899	0.866415228793728	Prostate cancer (advanced)	2e-06	29892016
rs2235569	rs9469899	0.866415228793728	Prostate cancer	5e-09	29892016
rs2235569	rs9469899	0.866415228793728	Prostate cancer	8e-11	33398198
rs2235569	rs9469899	0.866415228793728	Hand grip strength	3e-15	29691431
rs2235569	rs9469899	0.866415228793728	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2235569	rs9469899	0.866415228793728	Graves' disease	4e-10	34594039
rs2235569	rs9469899	0.866415228793728	Coronary artery disease	1e-11	36474045
rs2235569	rs9469899	0.866415228793728	Predicted visceral adipose tissue	2e-20	31501611
rs2235569	rs9469899	0.866415228793728	Medication use (thyroid preparations)	2e-09	31015401
rs2235569	rs9469899	0.866415228793728	Medication use (thyroid preparations)	3e-10	34594039
rs2235569	rs9368830	0.857173878728201	HDL cholesterol	4e-21	30275531
rs2235569	rs9296128	0.844379847743564	Hip circumference adjusted for BMI	4e-13	34021172
rs2235569	rs9368828	0.840940904456712	Body mass index	1e-34	34594039
rs2235569	rs2744973	0.807103197791255	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2235569	rs2744973	0.807103197791255	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2235569	rs2744973	0.807103197791255	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2235569	rs2744973	0.807103197791255	Multi-trait sex score	6e-20	37277458
rs2235569	rs6912327	0.761493659871611	Fasting insulin	5e-06	33402679
rs2235569	rs6912327	0.761493659871611	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2235569	rs112283401	0.73682642824086	Red cell distribution width	4e-27	30595370
rs2235569	rs205262	0.630056664822242	Body mass index	2e-09	26961502
rs2235569	rs205262	0.630056664822242	Walking pace	4e-10	33128006
rs2235569	rs205262	0.630056664822242	Body mass index	8e-13	30108127
rs2235569	rs205262	0.630056664822242	Body mass index	2e-09	25673413
rs2235569	rs205262	0.630056664822242	Body mass index	2e-14	26426971
rs2235569	rs205262	0.630056664822242	BMI in non-smokers	3e-07	28443625
rs2235569	rs205262	0.630056664822242	BMI in non-smokers	6e-09	28443625
rs2235569	rs205262	0.630056664822242	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2235569	rs205262	0.630056664822242	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2235569	rs205262	0.630056664822242	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2235569	rs205262	0.630056664822242	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2235569	rs205262	0.630056664822242	Gastroesophageal reflux disease	1e-10	34187846
rs2235569	rs205262	0.630056664822242	Body mass index	3e-10	25673413
rs2235569	rs205262	0.630056664822242	Body mass index	2e-10	25673413
rs2235569	rs205262	0.630056664822242	ICD10 M54: Dorsalgia	2e-12	35110524
rs2239829	rs5756090	0.961516282973786	Severe COVID-19 infection	4e-08	36662838
rs2239829	rs2227169	0.876920510920786	Severe COVID-19 infection	4e-13	36662838
rs2239829	rs1053982	0.858110520057224	Severe COVID-19 infection	9e-06	36662838
rs2239829	rs6000172	0.858046117641523	Severe COVID-19 infection	1e-07	36662838
rs2239829	rs4821461	0.847213872881496	Severe COVID-19 infection	4e-06	36662838
rs2243750	rs2041387	0.862617534231383	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2243750	rs2532497	0.836824149216161	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2243750	rs2532497	0.836824149216161	Tapasin-related protein levels	0	34648354
rs2243977	rs2041387	0.864681329807641	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2243977	rs2532497	0.836545877906788	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2243977	rs2532497	0.836545877906788	Tapasin-related protein levels	0	34648354
rs2244083	rs2041387	0.859695624895137	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2244083	rs2532497	0.839633176484045	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2244083	rs2532497	0.839633176484045	Tapasin-related protein levels	0	34648354
rs2251172	rs2695294	0.894791714191205	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs2251172	rs2695295	0.894091942241177	Serum levels of protein NAAA	1e-68	35078996
rs2251172	rs2695295	0.894091942241177	Serum levels of protein SMPDL3A	8e-86	35078996
rs2251172	rs2559856	0.892577945434679	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs2251172	rs3809260	0.883446110733181	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs2251172	rs2559851	0.82382122514458	Cathepsin F levels	2e-96	34648354
rs2251172	rs2559851	0.82382122514458	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs2251172	rs2559850	0.709918940893804	Serum levels of protein CTSH	1e-19	35078996
rs2251172	rs2559850	0.709918940893804	Vitamin C levels	6e-20	33203707
rs2251172	rs2559850	0.709918940893804	Cathepsin L2 levels	1e-24	34648354
rs2251172	rs2559850	0.709918940893804	Islet amyloid polypeptide levels	1e-49	34648354
rs2251172	rs2559850	0.709918940893804	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs2251187	rs2695294	0.892543125869097	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs2251187	rs2695295	0.89184498834732	Serum levels of protein NAAA	1e-68	35078996
rs2251187	rs2695295	0.89184498834732	Serum levels of protein SMPDL3A	8e-86	35078996
rs2251187	rs2559856	0.890332914923366	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs2251187	rs3809260	0.881211726390464	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs2251187	rs2559851	0.821654498318671	Cathepsin F levels	2e-96	34648354
rs2251187	rs2559851	0.821654498318671	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs2251187	rs2559850	0.707875059255036	Serum levels of protein CTSH	1e-19	35078996
rs2251187	rs2559850	0.707875059255036	Vitamin C levels	6e-20	33203707
rs2251187	rs2559850	0.707875059255036	Cathepsin L2 levels	1e-24	34648354
rs2251187	rs2559850	0.707875059255036	Islet amyloid polypeptide levels	1e-49	34648354
rs2251187	rs2559850	0.707875059255036	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs2254556	rs2596517	0.983711350914687	Hip circumference adjusted for BMI	7e-14	34021172
rs2254556	rs2596484	0.977542198992523	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs2254556	rs2523644	0.902256556638081	Myocardial infarction	5e-07	30226566
rs2255546	rs2549797	0.998384968528502	Systolic blood pressure	7e-07	33230300
rs2255546	rs2549797	0.998384968528502	Diastolic blood pressure	1e-14	33230300
rs2255546	rs2549797	0.998384968528502	Diastolic blood pressure	3e-11	33230300
rs2255546	rs2549797	0.998384968528502	Systolic blood pressure	4e-09	33230300
rs2255546	rs2549782	0.996770215293769	Systolic blood pressure	6e-07	33230300
rs2255546	rs2549782	0.996770215293769	Diastolic blood pressure	1e-14	33230300
rs2255546	rs2549782	0.996770215293769	Diastolic blood pressure	3e-11	33230300
rs2255546	rs2549782	0.996770215293769	Systolic blood pressure	5e-09	33230300
rs2255546	rs1056893	0.995963920468337	Systolic blood pressure	1e-06	33230300
rs2255546	rs1056893	0.995963920468337	Diastolic blood pressure	7e-15	33230300
rs2255546	rs1056893	0.995963920468337	Diastolic blood pressure	2e-11	33230300
rs2255546	rs1056893	0.995963920468337	Systolic blood pressure	7e-09	33230300
rs2255546	rs2910686	0.883405801408269	Neutrophil count	4e-14	32888493
rs2255546	rs2910686	0.883405801408269	Psoriasis	2e-08	23143594
rs2255546	rs2910686	0.883405801408269	Ankylosing spondylitis	5e-17	23749187
rs2255546	rs2910686	0.883405801408269	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2255546	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2255546	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2255546	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2255546	rs1019503	0.821407790924749	Systolic blood pressure	2e-06	33230300
rs2255546	rs1019503	0.821407790924749	Diastolic blood pressure	2e-14	33230300
rs2255546	rs1019503	0.821407790924749	Diastolic blood pressure	4e-11	33230300
rs2255546	rs1019503	0.821407790924749	Systolic blood pressure	1e-08	33230300
rs2255546	rs3096168	0.811202377454582	Aspartate aminotransferase levels	8e-12	33547301
rs2255546	rs4869314	0.802832426522136	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2255546	rs4869314	0.802832426522136	Neutrophil count	1e-10	34594039
rs2255546	rs4869314	0.802832426522136	White blood cell count	2e-07	30595370
rs2255546	rs1974871	0.781356033193366	Granulysin levels	5e-13	34648354
rs2255546	rs1423357	0.774002093298599	General cognitive ability	9e-06	29844566
rs2255546	rs2432142	0.759420640776436	Neutrophil count	2e-14	32888493
rs2255546	rs2432142	0.759420640776436	White blood cell count	1e-11	32888493
rs2255546	rs38033	0.753465786339274	Blood protein levels	0	30072576
rs2255546	rs27293	0.741550282856657	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2255546	rs27293	0.741550282856657	Diastolic blood pressure	3e-11	35762941
rs2255546	rs4869313	0.737148159764535	Pediatric autoimmune diseases	9e-08	26301688
rs2255546	rs7705093	0.733610904822643	Birdshot chorioretinopathy	2e-09	24957906
rs2255546	rs1559359	0.722243312523596	Diastolic blood pressure	7e-10	34594039
rs2255546	rs2549794	0.637126282330081	Crohn's disease	1e-10	21102463
rs2255546	rs2549794	0.637126282330081	Systolic blood pressure	1e-07	33230300
rs2255546	rs2549794	0.637126282330081	Diastolic blood pressure	1e-15	33230300
rs2255546	rs2549794	0.637126282330081	Diastolic blood pressure	2e-12	33230300
rs2255546	rs2549794	0.637126282330081	Systolic blood pressure	4e-10	33230300
rs2255546	rs1363907	0.6355545414163	Crohn's disease	4e-16	26192919
rs2255546	rs1363907	0.6355545414163	Ulcerative colitis	4e-06	26192919
rs2255546	rs1363907	0.6355545414163	Inflammatory bowel disease	5e-15	26192919
rs2255546	rs1363907	0.6355545414163	Inflammatory bowel disease	6e-13	23128233
rs2255546	rs1363907	0.6355545414163	Inflammatory bowel disease	1e-10	28067908
rs2255546	rs1363907	0.6355545414163	Crohn's disease	1e-14	28067908
rs2255546	rs716848	0.632963888908437	Neutrophil percentage of white cells	2e-09	32888494
rs2255546	rs2617439	0.605271865790052	Neutrophil count	8e-11	32888494
rs2255633	rs2549797	0.998384968528502	Systolic blood pressure	7e-07	33230300
rs2255633	rs2549797	0.998384968528502	Diastolic blood pressure	1e-14	33230300
rs2255633	rs2549797	0.998384968528502	Diastolic blood pressure	3e-11	33230300
rs2255633	rs2549797	0.998384968528502	Systolic blood pressure	4e-09	33230300
rs2255633	rs2549782	0.996770215293769	Systolic blood pressure	6e-07	33230300
rs2255633	rs2549782	0.996770215293769	Diastolic blood pressure	1e-14	33230300
rs2255633	rs2549782	0.996770215293769	Diastolic blood pressure	3e-11	33230300
rs2255633	rs2549782	0.996770215293769	Systolic blood pressure	5e-09	33230300
rs2255633	rs1056893	0.995963920468337	Systolic blood pressure	1e-06	33230300
rs2255633	rs1056893	0.995963920468337	Diastolic blood pressure	7e-15	33230300
rs2255633	rs1056893	0.995963920468337	Diastolic blood pressure	2e-11	33230300
rs2255633	rs1056893	0.995963920468337	Systolic blood pressure	7e-09	33230300
rs2255633	rs2910686	0.883405801408269	Neutrophil count	4e-14	32888493
rs2255633	rs2910686	0.883405801408269	Psoriasis	2e-08	23143594
rs2255633	rs2910686	0.883405801408269	Ankylosing spondylitis	5e-17	23749187
rs2255633	rs2910686	0.883405801408269	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2255633	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2255633	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2255633	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2255633	rs1019503	0.821407790924749	Systolic blood pressure	2e-06	33230300
rs2255633	rs1019503	0.821407790924749	Diastolic blood pressure	2e-14	33230300
rs2255633	rs1019503	0.821407790924749	Diastolic blood pressure	4e-11	33230300
rs2255633	rs1019503	0.821407790924749	Systolic blood pressure	1e-08	33230300
rs2255633	rs3096168	0.811202377454582	Aspartate aminotransferase levels	8e-12	33547301
rs2255633	rs4869314	0.802832426522136	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2255633	rs4869314	0.802832426522136	Neutrophil count	1e-10	34594039
rs2255633	rs4869314	0.802832426522136	White blood cell count	2e-07	30595370
rs2255633	rs1974871	0.781356033193366	Granulysin levels	5e-13	34648354
rs2255633	rs1423357	0.774002093298599	General cognitive ability	9e-06	29844566
rs2255633	rs2432142	0.759420640776436	Neutrophil count	2e-14	32888493
rs2255633	rs2432142	0.759420640776436	White blood cell count	1e-11	32888493
rs2255633	rs38033	0.753465786339274	Blood protein levels	0	30072576
rs2255633	rs27293	0.741550282856657	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2255633	rs27293	0.741550282856657	Diastolic blood pressure	3e-11	35762941
rs2255633	rs4869313	0.737148159764535	Pediatric autoimmune diseases	9e-08	26301688
rs2255633	rs7705093	0.733610904822643	Birdshot chorioretinopathy	2e-09	24957906
rs2255633	rs1559359	0.722243312523596	Diastolic blood pressure	7e-10	34594039
rs2255633	rs2549794	0.637126282330081	Crohn's disease	1e-10	21102463
rs2255633	rs2549794	0.637126282330081	Systolic blood pressure	1e-07	33230300
rs2255633	rs2549794	0.637126282330081	Diastolic blood pressure	1e-15	33230300
rs2255633	rs2549794	0.637126282330081	Diastolic blood pressure	2e-12	33230300
rs2255633	rs2549794	0.637126282330081	Systolic blood pressure	4e-10	33230300
rs2255633	rs1363907	0.6355545414163	Crohn's disease	4e-16	26192919
rs2255633	rs1363907	0.6355545414163	Ulcerative colitis	4e-06	26192919
rs2255633	rs1363907	0.6355545414163	Inflammatory bowel disease	5e-15	26192919
rs2255633	rs1363907	0.6355545414163	Inflammatory bowel disease	6e-13	23128233
rs2255633	rs1363907	0.6355545414163	Inflammatory bowel disease	1e-10	28067908
rs2255633	rs1363907	0.6355545414163	Crohn's disease	1e-14	28067908
rs2255633	rs716848	0.632963888908437	Neutrophil percentage of white cells	2e-09	32888494
rs2255633	rs2617439	0.605271865790052	Neutrophil count	8e-11	32888494
rs2255634	rs2549797	0.995159884587842	Systolic blood pressure	7e-07	33230300
rs2255634	rs2549797	0.995159884587842	Diastolic blood pressure	1e-14	33230300
rs2255634	rs2549797	0.995159884587842	Diastolic blood pressure	3e-11	33230300
rs2255634	rs2549797	0.995159884587842	Systolic blood pressure	4e-09	33230300
rs2255634	rs2549782	0.993546854747311	Systolic blood pressure	6e-07	33230300
rs2255634	rs2549782	0.993546854747311	Diastolic blood pressure	1e-14	33230300
rs2255634	rs2549782	0.993546854747311	Diastolic blood pressure	3e-11	33230300
rs2255634	rs2549782	0.993546854747311	Systolic blood pressure	5e-09	33230300
rs2255634	rs1056893	0.99274142046977	Systolic blood pressure	1e-06	33230300
rs2255634	rs1056893	0.99274142046977	Diastolic blood pressure	7e-15	33230300
rs2255634	rs1056893	0.99274142046977	Diastolic blood pressure	2e-11	33230300
rs2255634	rs1056893	0.99274142046977	Systolic blood pressure	7e-09	33230300
rs2255634	rs2910686	0.88350791430001	Neutrophil count	4e-14	32888493
rs2255634	rs2910686	0.88350791430001	Psoriasis	2e-08	23143594
rs2255634	rs2910686	0.88350791430001	Ankylosing spondylitis	5e-17	23749187
rs2255634	rs2910686	0.88350791430001	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2255634	rs2927608	0.880606094553239	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2255634	rs2927608	0.880606094553239	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2255634	rs2927608	0.880606094553239	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2255634	rs1019503	0.818370431066554	Systolic blood pressure	2e-06	33230300
rs2255634	rs1019503	0.818370431066554	Diastolic blood pressure	2e-14	33230300
rs2255634	rs1019503	0.818370431066554	Diastolic blood pressure	4e-11	33230300
rs2255634	rs1019503	0.818370431066554	Systolic blood pressure	1e-08	33230300
rs2255634	rs3096168	0.80819103854523	Aspartate aminotransferase levels	8e-12	33547301
rs2255634	rs4869314	0.79991037352157	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2255634	rs4869314	0.79991037352157	Neutrophil count	1e-10	34594039
rs2255634	rs4869314	0.79991037352157	White blood cell count	2e-07	30595370
rs2255634	rs1974871	0.778566386113163	Granulysin levels	5e-13	34648354
rs2255634	rs1423357	0.771297654609218	General cognitive ability	9e-06	29844566
rs2255634	rs2432142	0.756742391186598	Neutrophil count	2e-14	32888493
rs2255634	rs2432142	0.756742391186598	White blood cell count	1e-11	32888493
rs2255634	rs38033	0.750789840732441	Blood protein levels	0	30072576
rs2255634	rs27293	0.738897621851693	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2255634	rs27293	0.738897621851693	Diastolic blood pressure	3e-11	35762941
rs2255634	rs4869313	0.734488965325321	Pediatric autoimmune diseases	9e-08	26301688
rs2255634	rs7705093	0.7309632884413	Birdshot chorioretinopathy	2e-09	24957906
rs2255634	rs1559359	0.719567868762347	Diastolic blood pressure	7e-10	34594039
rs2255634	rs1363907	0.635877784691844	Crohn's disease	4e-16	26192919
rs2255634	rs1363907	0.635877784691844	Ulcerative colitis	4e-06	26192919
rs2255634	rs1363907	0.635877784691844	Inflammatory bowel disease	5e-15	26192919
rs2255634	rs1363907	0.635877784691844	Inflammatory bowel disease	6e-13	23128233
rs2255634	rs1363907	0.635877784691844	Inflammatory bowel disease	1e-10	28067908
rs2255634	rs1363907	0.635877784691844	Crohn's disease	1e-14	28067908
rs2255634	rs2549794	0.634745401024378	Crohn's disease	1e-10	21102463
rs2255634	rs2549794	0.634745401024378	Systolic blood pressure	1e-07	33230300
rs2255634	rs2549794	0.634745401024378	Diastolic blood pressure	1e-15	33230300
rs2255634	rs2549794	0.634745401024378	Diastolic blood pressure	2e-12	33230300
rs2255634	rs2549794	0.634745401024378	Systolic blood pressure	4e-10	33230300
rs2255634	rs716848	0.630582218904218	Neutrophil percentage of white cells	2e-09	32888494
rs2255634	rs2617439	0.602958345103803	Neutrophil count	8e-11	32888494
rs2255637	rs2549797	0.995159884587842	Systolic blood pressure	7e-07	33230300
rs2255637	rs2549797	0.995159884587842	Diastolic blood pressure	1e-14	33230300
rs2255637	rs2549797	0.995159884587842	Diastolic blood pressure	3e-11	33230300
rs2255637	rs2549797	0.995159884587842	Systolic blood pressure	4e-09	33230300
rs2255637	rs2549782	0.993546854747311	Systolic blood pressure	6e-07	33230300
rs2255637	rs2549782	0.993546854747311	Diastolic blood pressure	1e-14	33230300
rs2255637	rs2549782	0.993546854747311	Diastolic blood pressure	3e-11	33230300
rs2255637	rs2549782	0.993546854747311	Systolic blood pressure	5e-09	33230300
rs2255637	rs1056893	0.99274142046977	Systolic blood pressure	1e-06	33230300
rs2255637	rs1056893	0.99274142046977	Diastolic blood pressure	7e-15	33230300
rs2255637	rs1056893	0.99274142046977	Diastolic blood pressure	2e-11	33230300
rs2255637	rs1056893	0.99274142046977	Systolic blood pressure	7e-09	33230300
rs2255637	rs2910686	0.88350791430001	Neutrophil count	4e-14	32888493
rs2255637	rs2910686	0.88350791430001	Psoriasis	2e-08	23143594
rs2255637	rs2910686	0.88350791430001	Ankylosing spondylitis	5e-17	23749187
rs2255637	rs2910686	0.88350791430001	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2255637	rs2927608	0.880606094553239	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2255637	rs2927608	0.880606094553239	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2255637	rs2927608	0.880606094553239	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2255637	rs1019503	0.818370431066554	Systolic blood pressure	2e-06	33230300
rs2255637	rs1019503	0.818370431066554	Diastolic blood pressure	2e-14	33230300
rs2255637	rs1019503	0.818370431066554	Diastolic blood pressure	4e-11	33230300
rs2255637	rs1019503	0.818370431066554	Systolic blood pressure	1e-08	33230300
rs2255637	rs3096168	0.80819103854523	Aspartate aminotransferase levels	8e-12	33547301
rs2255637	rs4869314	0.79991037352157	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2255637	rs4869314	0.79991037352157	Neutrophil count	1e-10	34594039
rs2255637	rs4869314	0.79991037352157	White blood cell count	2e-07	30595370
rs2255637	rs1974871	0.778566386113163	Granulysin levels	5e-13	34648354
rs2255637	rs1423357	0.771297654609218	General cognitive ability	9e-06	29844566
rs2255637	rs2432142	0.756742391186598	Neutrophil count	2e-14	32888493
rs2255637	rs2432142	0.756742391186598	White blood cell count	1e-11	32888493
rs2255637	rs38033	0.750789840732441	Blood protein levels	0	30072576
rs2255637	rs27293	0.738897621851693	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2255637	rs27293	0.738897621851693	Diastolic blood pressure	3e-11	35762941
rs2255637	rs4869313	0.734488965325321	Pediatric autoimmune diseases	9e-08	26301688
rs2255637	rs7705093	0.7309632884413	Birdshot chorioretinopathy	2e-09	24957906
rs2255637	rs1559359	0.719567868762347	Diastolic blood pressure	7e-10	34594039
rs2255637	rs1363907	0.635877784691844	Crohn's disease	4e-16	26192919
rs2255637	rs1363907	0.635877784691844	Ulcerative colitis	4e-06	26192919
rs2255637	rs1363907	0.635877784691844	Inflammatory bowel disease	5e-15	26192919
rs2255637	rs1363907	0.635877784691844	Inflammatory bowel disease	6e-13	23128233
rs2255637	rs1363907	0.635877784691844	Inflammatory bowel disease	1e-10	28067908
rs2255637	rs1363907	0.635877784691844	Crohn's disease	1e-14	28067908
rs2255637	rs2549794	0.634745401024378	Crohn's disease	1e-10	21102463
rs2255637	rs2549794	0.634745401024378	Systolic blood pressure	1e-07	33230300
rs2255637	rs2549794	0.634745401024378	Diastolic blood pressure	1e-15	33230300
rs2255637	rs2549794	0.634745401024378	Diastolic blood pressure	2e-12	33230300
rs2255637	rs2549794	0.634745401024378	Systolic blood pressure	4e-10	33230300
rs2255637	rs716848	0.630582218904218	Neutrophil percentage of white cells	2e-09	32888494
rs2255637	rs2617439	0.602958345103803	Neutrophil count	8e-11	32888494
rs2257649	rs2257649	1	Total Phosphatidylglycerol levels	3e-10	35668104
rs2257649	rs4815400	0.991053965646892	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs2257649	rs6037062	0.681393236327394	Lung function (forced vital capacity)	3e-13	36914875
rs2257649	rs6037062	0.681393236327394	Lung function (FVC)	5e-12	30595370
rs2257649	rs2500430	0.653130610660174	Serum alkaline phosphatase levels	7e-10	31666285
rs2257649	rs2273473	0.627195671497041	Vertex-wise cortical thickness	1e-12	34910505
rs2257649	rs6050463	0.602312415582052	Low density lipoprotein cholesterol levels	6e-09	32154731
rs2257649	rs6050463	0.602312415582052	LDL cholesterol levels	2e-09	32203549
rs2257649	rs6115094	0.602312415582052	Brain morphology (MOSTest)	1e-08	32665545
rs2257649	rs6115094	0.602312415582052	Non-HDL cholesterol levels	3e-09	34887591
rs2259961	rs2257649	0.995524022096962	Total Phosphatidylglycerol levels	3e-10	35668104
rs2259961	rs4815400	0.995523741287323	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs2259961	rs6037062	0.679123205701901	Lung function (forced vital capacity)	3e-13	36914875
rs2259961	rs6037062	0.679123205701901	Lung function (FVC)	5e-12	30595370
rs2259961	rs2500430	0.656293035819639	Serum alkaline phosphatase levels	7e-10	31666285
rs2259961	rs2273473	0.625087370302606	Vertex-wise cortical thickness	1e-12	34910505
rs2259961	rs6050463	0.600258595941668	Low density lipoprotein cholesterol levels	6e-09	32154731
rs2259961	rs6050463	0.600258595941668	LDL cholesterol levels	2e-09	32203549
rs2259961	rs6115094	0.600258595941668	Brain morphology (MOSTest)	1e-08	32665545
rs2259961	rs6115094	0.600258595941668	Non-HDL cholesterol levels	3e-09	34887591
rs2259961	rs2856	0.600132503321642	Blood protein levels	6e-07	27532455
rs2262245	rs9366863	0.928444004203868	Adult body size	9e-33	32376654
rs2262245	rs9366863	0.928444004203868	Body mass index	2e-44	30595370
rs2262245	rs2263329	0.928228783932259	HDL cholesterol	6e-35	34594039
rs2262245	rs2263329	0.928228783932259	HDL cholesterol levels	8e-43	32203549
rs2262245	rs2263329	0.928228783932259	High density lipoprotein cholesterol levels	2e-52	34887591
rs2262245	rs2814949	0.920183673679836	Essential hypertension (time to event)	9e-09	32589924
rs2262245	rs2744944	0.90766909584149	Hypothyroidism	3e-10	34594039
rs2262245	rs2744944	0.90766909584149	High density lipoprotein cholesterol levels	3e-86	34887591
rs2262245	rs2744944	0.90766909584149	Multi-trait sex score	7e-22	37277458
rs2262245	rs9469872	0.901543018057212	HDL cholesterol levels	3e-11	36333282
rs2262245	rs11755393	0.893773351194749	Body mass index	3e-26	29273807
rs2262245	rs11755393	0.893773351194749	Systemic lupus erythematosus	2e-12	33493351
rs2262245	rs11755393	0.893773351194749	Systemic lupus erythematosus	2e-06	33493351
rs2262245	rs11755393	0.893773351194749	Systemic lupus erythematosus	1e-07	33493351
rs2262245	rs11755393	0.893773351194749	Systemic lupus erythematosus	2e-08	19838195
rs2262245	rs11755393	0.893773351194749	Body mass index	4e-55	36581621
rs2262245	rs6941110	0.885433139228275	Sex hormone-binding globulin levels	5e-27	36653534
rs2262245	rs111868030	0.86861027800245	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2262245	rs9462030	0.866114988165	Red cell distribution width	5e-25	32888493
rs2262245	rs9469857	0.863090642072652	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2262245	rs2764208	0.860828185761095	Systemic lupus erythematosus	7e-06	24871463
rs2262245	rs9469899	0.849330749125023	Prostate cancer (advanced)	2e-06	29892016
rs2262245	rs9469899	0.849330749125023	Prostate cancer	5e-09	29892016
rs2262245	rs9469899	0.849330749125023	Prostate cancer	8e-11	33398198
rs2262245	rs9469899	0.849330749125023	Hand grip strength	3e-15	29691431
rs2262245	rs9469899	0.849330749125023	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2262245	rs9469899	0.849330749125023	Graves' disease	4e-10	34594039
rs2262245	rs9469899	0.849330749125023	Coronary artery disease	1e-11	36474045
rs2262245	rs9469899	0.849330749125023	Predicted visceral adipose tissue	2e-20	31501611
rs2262245	rs9469899	0.849330749125023	Medication use (thyroid preparations)	2e-09	31015401
rs2262245	rs9469899	0.849330749125023	Medication use (thyroid preparations)	3e-10	34594039
rs2262245	rs9368830	0.84084067815957	HDL cholesterol	4e-21	30275531
rs2262245	rs9296128	0.813717616643814	Hip circumference adjusted for BMI	4e-13	34021172
rs2262245	rs9368828	0.810854107847934	Body mass index	1e-34	34594039
rs2262245	rs2744973	0.787638213506716	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2262245	rs2744973	0.787638213506716	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2262245	rs2744973	0.787638213506716	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2262245	rs2744973	0.787638213506716	Multi-trait sex score	6e-20	37277458
rs2262245	rs6912327	0.744273162211682	Fasting insulin	5e-06	33402679
rs2262245	rs6912327	0.744273162211682	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2262245	rs112283401	0.719879161126552	Red cell distribution width	4e-27	30595370
rs2262664	rs4465929	0.861922983561748	Type 2 diabetes	5e-11	32541925
rs2262664	rs4685260	0.8559431110599	Body mass index	4e-09	30595370
rs2262664	rs2470538	0.843888382041583	Body mass index	3e-08	36581621
rs2262664	rs2470548	0.7995266209215	Mean platelet volume	4e-12	32888494
rs2262664	rs2255248	0.789047468875548	Body mass index (MTAG)	8e-10	36376304
rs2262664	rs2455793	0.639332635792285	Body mass index	1e-09	30239722
rs2262664	rs2455793	0.639332635792285	Body mass index	2e-09	31669095
rs2262664	rs924753	0.621379534351245	Type 2 diabetes	1e-11	32541925
rs2263204	rs11087521	0.887902614668885	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2263204	rs59934506	0.86934359497789	Body fat percentage	4e-16	33980691
rs2263204	rs59934506	0.86934359497789	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2263204	rs59934506	0.86934359497789	Alanine aminotransferase levels	2e-10	33980691
rs2263204	rs2424698	0.855779588438699	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2263204	rs2424698	0.855779588438699	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2263204	rs2424698	0.855779588438699	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2263204	rs2424698	0.855779588438699	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2263204	rs2424698	0.855779588438699	C-reactive protein	5e-11	34594039
rs2263204	rs7267979	0.855582755890214	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2263204	rs2151144	0.853597257308151	wg lh intensity-contrast fusiform	5e-12	33875891
rs2263204	rs2151144	0.853597257308151	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2263204	rs2151144	0.853597257308151	wg rh intensity-contrast insula	6e-18	33875891
rs2263204	rs2151144	0.853597257308151	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2263204	rs2151144	0.853597257308151	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2263204	rs2151144	0.853597257308151	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2263204	rs6083838	0.850189316543984	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2263204	rs6083838	0.850189316543984	wg lh intensity-contrast insula	6e-13	33875891
rs2263204	rs7020	0.849269663220769	wg rh intensity-contrast fusiform	1e-10	33875891
rs2263204	rs7020	0.849269663220769	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2263204	rs7020	0.849269663220769	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2263204	rs7020	0.849269663220769	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2263204	rs7274104	0.829024778485518	Cortical thickness	4e-08	34560273
rs2263204	rs6115101	0.811046630463783	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2263204	rs6115101	0.811046630463783	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2263204	rs6115101	0.811046630463783	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2263204	rs6115118	0.811046630463783	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2263204	rs6138553	0.810298816872542	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2263204	rs6115200	0.808468922020439	Height	9e-09	36224396
rs2263204	rs6115204	0.805590109532413	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2263204	rs6115099	0.805479467566256	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2263204	rs6138556	0.799160280828504	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2263204	rs6083799	0.786434467516414	Serum alkaline phosphatase levels	1e-71	33547301
rs2263204	rs2261795	0.769011624542181	Non-HDL cholesterol levels	1e-09	34887591
rs2263204	rs84816	0.768504782598772	aseg rh intensity Caudate	7e-09	33875891
rs2263204	rs84816	0.768504782598772	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2263204	rs4815412	0.766865942361776	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2263204	rs12428	0.764395063570626	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2263204	rs2500406	0.759444331424572	Brain region volumes	2e-08	31676860
rs2263204	rs2500406	0.759444331424572	Height	1e-33	36224396
rs2263204	rs2856	0.75676747740544	Blood protein levels	6e-07	27532455
rs2263204	rs6132824	0.738716661986784	Multi-trait sum score	5e-08	37277458
rs2263204	rs11699953	0.738031861495046	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2263204	rs8184820	0.735966603125621	Brain morphology (MOSTest)	4e-13	35164939
rs2263204	rs9927	0.716251070385913	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2263204	rs3746337	0.692655969666814	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2263204	rs3746337	0.692655969666814	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2263204	rs3746337	0.692655969666814	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2263204	rs3746337	0.692655969666814	Total cholesterol levels	3e-09	34887591
rs2263204	rs2500430	0.688557488585385	Serum alkaline phosphatase levels	7e-10	31666285
rs2263204	rs1888995	0.682032019735885	Weight	2e-11	34594039
rs2263204	rs6050464	0.677046093029646	Brain region volumes	5e-09	31676860
rs2263204	rs6050464	0.677046093029646	Apolipoprotein B levels	6e-14	32203549
rs2263204	rs2260997	0.66229930826586	Subcortical volume (MOSTest)	4e-09	32665545
rs2263204	rs2260997	0.66229930826586	Platelet distribution width	5e-17	32888494
rs2263310	rs2596517	0.868967719366329	Hip circumference adjusted for BMI	7e-14	34021172
rs2263310	rs2596484	0.863516171923899	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs2263310	rs2523644	0.794871683565765	Myocardial infarction	5e-07	30226566
rs2269595	rs5756090	0.931053382065138	Severe COVID-19 infection	4e-08	36662838
rs2269595	rs6000172	0.865043958953949	Severe COVID-19 infection	1e-07	36662838
rs2269595	rs4821461	0.855728926538219	Severe COVID-19 infection	4e-06	36662838
rs2269595	rs2227169	0.849368037213976	Severe COVID-19 infection	4e-13	36662838
rs2269595	rs1053982	0.829407665973997	Severe COVID-19 infection	9e-06	36662838
rs2269596	rs6000172	0.887805398067411	Severe COVID-19 infection	1e-07	36662838
rs2269596	rs4821461	0.873560355303707	Severe COVID-19 infection	4e-06	36662838
rs2269596	rs2227169	0.87339545278735	Severe COVID-19 infection	4e-13	36662838
rs2269596	rs1053982	0.851332833116228	Severe COVID-19 infection	9e-06	36662838
rs2269596	rs5756090	0.776905783470603	Severe COVID-19 infection	4e-08	36662838
rs2270756	rs2548499	0.929235707278985	Lymphocyte count	9e-14	32888494
rs2270756	rs2648731	0.761726887596384	Type 2 diabetes	7e-12	34594039
rs2270756	rs2648731	0.761726887596384	Type 2 diabetes	3e-19	34594039
rs2270756	rs2648731	0.761726887596384	Lymphocyte count	2e-11	34594039
rs2270756	rs2648731	0.761726887596384	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs2270756	rs2648731	0.761726887596384	Medication use (drugs used in diabetes)	3e-09	34594039
rs2270756	rs13189973	0.610964920004537	Lymphocyte count	2e-16	32888493
rs2271594	rs2271594	1	Weight	1e-08	34594039
rs2271811	rs34276187	0.667388837692313	Highest math class taken (MTAG)	2e-08	30038396
rs2271811	rs6705511	0.649005523342619	Self-reported math ability	4e-09	30038396
rs2271811	rs6705511	0.649005523342619	Self-reported math ability (MTAG)	3e-10	30038396
rs2272718	rs746011	0.992562106264115	Triglycerides	2e-10	30275531
rs2272718	rs11781149	0.926906937124637	Refractive error	2e-17	32231278
rs2272718	rs1545837	0.801898601323317	Lung function (FVC)	1e-10	30595370
rs2272718	rs2280104	0.799556332000438	Parkinson's disease	3e-08	28892059
rs2272718	rs2280104	0.799556332000438	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs2272718	rs2280104	0.799556332000438	Serum total protein level	3e-12	34594039
rs2272718	rs4242434	0.778884283033861	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs2272718	rs13271626	0.738972966365274	Haemorrhoidal disease	3e-10	33888516
rs2272718	rs4872007	0.737630350013088	Superior temporal gyrus volume	8e-06	31530798
rs2272718	rs11778693	0.718142436332242	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs2272718	rs11778693	0.718142436332242	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs2272718	rs11780207	0.657888122081841	Estimated glomerular filtration rate	2e-13	33462484
rs2272718	rs11780207	0.657888122081841	Serum total protein level	2e-09	33462484
rs2272718	rs11780207	0.657888122081841	Creatinine levels	2e-13	33462484
rs2272718	rs34269854	0.623995076703916	Lung function (forced vital capacity)	3e-09	36914875
rs2272718	rs11782130	0.61194503311378	C-reactive protein levels	9e-09	35459240
rs2272718	rs4592028	0.601348096927488	Non-albumin protein levels	3e-09	33462484
rs2273768	rs11144225	0.751476174879125	Nicotinamide riboside kinase 1 levels	3e-133	34648354
rs2275046	rs14314	0.986593048281786	Macular thickness	3e-19	30535121
rs2275046	rs14314	0.986593048281786	Vertex-wise sulcal depth	7e-17	34910505
rs2275046	rs14314	0.986593048281786	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2275046	rs14314	0.986593048281786	Left hippocampal volume (body)	7e-15	37337106
rs2275046	rs14314	0.986593048281786	Left subiculum volume (body)	1e-14	37337106
rs2275046	rs2095375	0.971491379396487	Serum metabolite levels	1e-20	33031748
rs2275046	rs2095375	0.971491379396487	Serum metabolite levels	1e-20	33031748
rs2275046	rs9383843	0.970604940864448	Migraine	1e-09	35115687
rs2275046	rs55763431	0.96706794355099	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2275046	rs9689694	0.965301404519326	Right hippocampal volume (head)	6e-11	37337106
rs2275046	rs9689694	0.965301404519326	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2275046	rs9689694	0.965301404519326	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2275046	rs9689694	0.965301404519326	Left hippocampal volume (head)	6e-12	37337106
rs2275046	rs10872645	0.963538157897097	Blood protein levels	2e-86	30072576
rs2275046	rs9688867	0.95916626365629	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2275046	rs9688867	0.95916626365629	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2275046	rs9688809	0.95916626365629	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2275046	rs10872653	0.959132380135107	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2275046	rs34337297	0.955617670229547	Serum levels of protein LRP11	3e-161	35078996
rs2275046	rs9322193	0.921874859966224	Lung cancer	1e-07	27393504
rs2275046	rs4039600	0.878948715727455	Adenine levels	1e-11	35347128
rs2275046	rs1934534	0.638785575160329	Pain (pleiotropy)	2e-08	37844115
rs2275046	rs1934534	0.638785575160329	Pain (pleiotropy)	2e-06	37844115
rs2275046	rs4380763	0.638261980206262	Subcortical volume (min-P)	1e-11	32665545
rs2275046	rs11155671	0.627831607327848	Testicular germ cell tumor	2e-09	28604728
rs2275046	rs80147756	0.61284893991081	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2275046	rs4421206	0.605228001045799	Brain morphology (min-P)	4e-11	32665545
rs2275046	rs9505982	0.600085373384314	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs2278018	rs1974871	0.916669349652752	Granulysin levels	5e-13	34648354
rs2278018	rs4869314	0.904823271627218	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2278018	rs4869314	0.904823271627218	Neutrophil count	1e-10	34594039
rs2278018	rs4869314	0.904823271627218	White blood cell count	2e-07	30595370
rs2278018	rs2549782	0.85010077253848	Systolic blood pressure	6e-07	33230300
rs2278018	rs2549782	0.85010077253848	Diastolic blood pressure	1e-14	33230300
rs2278018	rs2549782	0.85010077253848	Diastolic blood pressure	3e-11	33230300
rs2278018	rs2549782	0.85010077253848	Systolic blood pressure	5e-09	33230300
rs2278018	rs2549797	0.85008721562494	Systolic blood pressure	7e-07	33230300
rs2278018	rs2549797	0.85008721562494	Diastolic blood pressure	1e-14	33230300
rs2278018	rs2549797	0.85008721562494	Diastolic blood pressure	3e-11	33230300
rs2278018	rs2549797	0.85008721562494	Systolic blood pressure	4e-09	33230300
rs2278018	rs1056893	0.847874009087815	Systolic blood pressure	1e-06	33230300
rs2278018	rs1056893	0.847874009087815	Diastolic blood pressure	7e-15	33230300
rs2278018	rs1056893	0.847874009087815	Diastolic blood pressure	2e-11	33230300
rs2278018	rs1056893	0.847874009087815	Systolic blood pressure	7e-09	33230300
rs2278018	rs4869313	0.829026994780015	Pediatric autoimmune diseases	9e-08	26301688
rs2278018	rs1559359	0.821332617036965	Diastolic blood pressure	7e-10	34594039
rs2278018	rs2910686	0.803215586138696	Neutrophil count	4e-14	32888493
rs2278018	rs2910686	0.803215586138696	Psoriasis	2e-08	23143594
rs2278018	rs2910686	0.803215586138696	Ankylosing spondylitis	5e-17	23749187
rs2278018	rs2910686	0.803215586138696	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2278018	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2278018	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2278018	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2278018	rs1019503	0.728940392110976	Systolic blood pressure	2e-06	33230300
rs2278018	rs1019503	0.728940392110976	Diastolic blood pressure	2e-14	33230300
rs2278018	rs1019503	0.728940392110976	Diastolic blood pressure	4e-11	33230300
rs2278018	rs1019503	0.728940392110976	Systolic blood pressure	1e-08	33230300
rs2278018	rs3096168	0.723409651088165	Aspartate aminotransferase levels	8e-12	33547301
rs2278018	rs1423357	0.704924641235886	General cognitive ability	9e-06	29844566
rs2278018	rs2432142	0.691024795840694	Neutrophil count	2e-14	32888493
rs2278018	rs2432142	0.691024795840694	White blood cell count	1e-11	32888493
rs2278018	rs38033	0.685525237258851	Blood protein levels	0	30072576
rs2278018	rs27293	0.67549231404753	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2278018	rs27293	0.67549231404753	Diastolic blood pressure	3e-11	35762941
rs2278018	rs7705093	0.666760272686482	Birdshot chorioretinopathy	2e-09	24957906
rs2278019	rs1974871	0.91585488420033	Granulysin levels	5e-13	34648354
rs2278019	rs4869314	0.904083249088078	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2278019	rs4869314	0.904083249088078	Neutrophil count	1e-10	34594039
rs2278019	rs4869314	0.904083249088078	White blood cell count	2e-07	30595370
rs2278019	rs2549782	0.849350553468495	Systolic blood pressure	6e-07	33230300
rs2278019	rs2549782	0.849350553468495	Diastolic blood pressure	1e-14	33230300
rs2278019	rs2549782	0.849350553468495	Diastolic blood pressure	3e-11	33230300
rs2278019	rs2549782	0.849350553468495	Systolic blood pressure	5e-09	33230300
rs2278019	rs2549797	0.849336335969296	Systolic blood pressure	7e-07	33230300
rs2278019	rs2549797	0.849336335969296	Diastolic blood pressure	1e-14	33230300
rs2278019	rs2549797	0.849336335969296	Diastolic blood pressure	3e-11	33230300
rs2278019	rs2549797	0.849336335969296	Systolic blood pressure	4e-09	33230300
rs2278019	rs1056893	0.847125009318234	Systolic blood pressure	1e-06	33230300
rs2278019	rs1056893	0.847125009318234	Diastolic blood pressure	7e-15	33230300
rs2278019	rs1056893	0.847125009318234	Diastolic blood pressure	2e-11	33230300
rs2278019	rs1056893	0.847125009318234	Systolic blood pressure	7e-09	33230300
rs2278019	rs4869313	0.828204193776253	Pediatric autoimmune diseases	9e-08	26301688
rs2278019	rs1559359	0.820556275106077	Diastolic blood pressure	7e-10	34594039
rs2278019	rs2910686	0.802434624025319	Neutrophil count	4e-14	32888493
rs2278019	rs2910686	0.802434624025319	Psoriasis	2e-08	23143594
rs2278019	rs2910686	0.802434624025319	Ankylosing spondylitis	5e-17	23749187
rs2278019	rs2910686	0.802434624025319	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2278019	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2278019	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2278019	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2278019	rs1019503	0.728311499553418	Systolic blood pressure	2e-06	33230300
rs2278019	rs1019503	0.728311499553418	Diastolic blood pressure	2e-14	33230300
rs2278019	rs1019503	0.728311499553418	Diastolic blood pressure	4e-11	33230300
rs2278019	rs1019503	0.728311499553418	Systolic blood pressure	1e-08	33230300
rs2278019	rs3096168	0.722779873820606	Aspartate aminotransferase levels	8e-12	33547301
rs2278019	rs1423357	0.704136975909934	General cognitive ability	9e-06	29844566
rs2278019	rs2432142	0.690245044619686	Neutrophil count	2e-14	32888493
rs2278019	rs2432142	0.690245044619686	White blood cell count	1e-11	32888493
rs2278019	rs38033	0.684757433951945	Blood protein levels	0	30072576
rs2278019	rs27293	0.67472868610218	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2278019	rs27293	0.67472868610218	Diastolic blood pressure	3e-11	35762941
rs2278019	rs7705093	0.66601105887613	Birdshot chorioretinopathy	2e-09	24957906
rs2279501	rs2279501	1	Serum metabolite levels	3e-14	33031748
rs2279501	rs1038747	0.860915660405781	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2279501	rs10788817	0.813601831058084	Serum metabolite levels	3e-13	24625756
rs2279501	rs10788817	0.813601831058084	Metabolite peak levels (QI2718)	5e-18	35995766
rs2279501	rs10788817	0.813601831058084	3-hydroxylaurate levels	2e-12	36635386
rs2279501	rs10788817	0.813601831058084	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2279501	rs2130525	0.807535128834029	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2279501	rs11204914	0.807273361532505	Carnitine C9 levels	1e-13	35995766
rs2279501	rs11204914	0.807273361532505	Metabolite peak levels (QI6204)	1e-32	35995766
rs2279501	rs11204914	0.807273361532505	Metabolite peak levels (QI6252)	2e-32	35995766
rs2279501	rs6685187	0.782457412061492	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2279501	rs6698740	0.781782711963395	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2279501	rs1060870	0.780339085259768	Serum metabolite levels	1e-11	33031748
rs2279501	rs1060870	0.780339085259768	Serum metabolite levels	1e-15	33031748
rs2279501	rs2338201	0.770199055210022	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2279501	rs2338201	0.770199055210022	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2279501	rs2338201	0.770199055210022	Dodecadienoate (12:2) levels	7e-15	36635386
rs2279501	rs7542137	0.739899153246818	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2279501	rs7542137	0.739899153246818	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2279501	rs7542137	0.739899153246818	3-hydroxysebacate levels	2e-10	36635386
rs2279501	rs3007711	0.730893661908317	Electrodermal activity	9e-06	25387706
rs2279501	rs2999541	0.727270447289022	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2279501	rs2999545	0.710666456076079	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2279501	rs9943251	0.666052827033192	Serum metabolite levels	1e-30	33031748
rs2279501	rs9943251	0.666052827033192	X-23680 levels	2e-45	35050183
rs2279501	rs9943251	0.666052827033192	Urine glucuronide of C8H14O2 (1)* levels in chronic kidney disease	2e-14	37277652
rs2279501	rs9943251	0.666052827033192	Plasma X-18921 levels in chronic kidney disease	3e-66	37277652
rs2279501	rs9943251	0.666052827033192	Urine indoleacetylglutamine levels in chronic kidney disease	2e-28	37277652
rs2279501	rs9943251	0.666052827033192	Metabolite peak levels (QI9912)	7e-15	35995766
rs2279501	rs9943251	0.666052827033192	Eicosanoid tetranor 12(R) HETE b levels	7e-15	37524825
rs2279501	rs16833668	0.665442180107134	Nonaylcarnitine levels	3e-21	33414548
rs2279501	rs16833668	0.665442180107134	Dodecadienoate (12:2) levels	5e-23	35347128
rs2279501	rs16833668	0.665442180107134	X-21353 levels	9e-67	35347128
rs2279501	rs16833669	0.65180718824807	Plasma X-21353 levels in chronic kidney disease	3e-28	37277652
rs2279501	rs61817724	0.651199211522454	X-23641 levels	6e-13	35347128
rs2279501	rs61817724	0.651199211522454	X-18888 levels	5e-18	35347128
rs2279501	rs61817724	0.651199211522454	3-hydroxyhexanoate levels	2e-13	35347128
rs2279501	rs61817724	0.651199211522454	3-hydroxyoctanoate levels	1e-44	35347128
rs2279501	rs7523082	0.647639429453019	Metabolite peak levels (QI9845)	2e-14	35995766
rs2279501	rs10888445	0.646149453883077	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2279501	rs7541453	0.643433569896226	Serum metabolite levels	2e-16	33031748
rs2279501	rs7541453	0.643433569896226	Serum metabolite levels	2e-16	33031748
rs2279501	rs7541453	0.643433569896226	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2279501	rs16833670	0.621798471928506	X-13431 levels	5e-49	36635386
rs2279501	rs2337685	0.621193860170164	X-13431 levels	2e-34	35347128
rs2279501	rs6675930	0.621193860170164	Cis-4-decenoate (10:1n6) levels	3e-166	35347128
rs2279501	rs6675930	0.621193860170164	3-hydroxydecanoate levels	3e-70	35347128
rs2279501	rs6675930	0.621193860170164	3-hydroxylaurate levels	2e-24	35347128
rs2279501	rs80320664	0.620289697991517	X-23680 levels	3e-45	35050183
rs2279501	rs6682605	0.619834932712366	Tetradecadienoate (14:2) levels	2e-25	35347128
rs2279501	rs6682605	0.619834932712366	X-21607 levels	4e-20	35347128
rs2279501	rs6693388	0.619834932712366	Plasma beta-hydroxyisovalerate levels in chronic kidney disease	1e-13	37277652
rs2279501	rs6693388	0.619834932712366	Plasma 3-hydroxydecanoate levels in chronic kidney disease	6e-24	37277652
rs2279501	rs6693388	0.619834932712366	Plasma 3-hydroxylaurate levels in chronic kidney disease	9e-13	37277652
rs2279501	rs6693388	0.619834932712366	Linoleate 18:2n6-to-X-12442--5,8-tetradecadienoate ratio	4e-38	24816252
rs2279501	rs6693388	0.619834932712366	Undecenoylcarnitine (C11:1) levels	6e-25	36635386
rs2279501	rs6693396	0.619081199827542	X-13431 levels	2e-47	35050183
rs2279501	rs10675058	0.605839742054768	Undecenoylcarnitine (C11:1) levels	8e-15	35347128
rs2279502	rs2279501	0.983668741326763	Serum metabolite levels	3e-14	33031748
rs2279502	rs1038747	0.851410153409346	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2279502	rs10788817	0.816188272407076	Serum metabolite levels	3e-13	24625756
rs2279502	rs10788817	0.816188272407076	Metabolite peak levels (QI2718)	5e-18	35995766
rs2279502	rs10788817	0.816188272407076	3-hydroxylaurate levels	2e-12	36635386
rs2279502	rs10788817	0.816188272407076	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2279502	rs11204914	0.809905849502495	Carnitine C9 levels	1e-13	35995766
rs2279502	rs11204914	0.809905849502495	Metabolite peak levels (QI6204)	1e-32	35995766
rs2279502	rs11204914	0.809905849502495	Metabolite peak levels (QI6252)	2e-32	35995766
rs2279502	rs2130525	0.797725112991496	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2279502	rs6685187	0.78645015157305	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2279502	rs6698740	0.78432386358742	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2279502	rs1060870	0.782879481789274	Serum metabolite levels	1e-11	33031748
rs2279502	rs1060870	0.782879481789274	Serum metabolite levels	1e-15	33031748
rs2279502	rs2338201	0.774105949005765	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2279502	rs2338201	0.774105949005765	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2279502	rs2338201	0.774105949005765	Dodecadienoate (12:2) levels	7e-15	36635386
rs2279502	rs7542137	0.729174831750865	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2279502	rs7542137	0.729174831750865	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2279502	rs7542137	0.729174831750865	3-hydroxysebacate levels	2e-10	36635386
rs2279502	rs2999545	0.723459844411426	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2279502	rs3007711	0.72199300548497	Electrodermal activity	9e-06	25387706
rs2279502	rs2999541	0.718384502755272	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2279502	rs7523082	0.658348884944078	Metabolite peak levels (QI9845)	2e-14	35995766
rs2279502	rs9943251	0.657349401789936	Serum metabolite levels	1e-30	33031748
rs2279502	rs9943251	0.657349401789936	X-23680 levels	2e-45	35050183
rs2279502	rs9943251	0.657349401789936	Urine glucuronide of C8H14O2 (1)* levels in chronic kidney disease	2e-14	37277652
rs2279502	rs9943251	0.657349401789936	Plasma X-18921 levels in chronic kidney disease	3e-66	37277652
rs2279502	rs9943251	0.657349401789936	Urine indoleacetylglutamine levels in chronic kidney disease	2e-28	37277652
rs2279502	rs9943251	0.657349401789936	Metabolite peak levels (QI9912)	7e-15	35995766
rs2279502	rs9943251	0.657349401789936	Eicosanoid tetranor 12(R) HETE b levels	7e-15	37524825
rs2279502	rs16833668	0.656746734290818	Nonaylcarnitine levels	3e-21	33414548
rs2279502	rs16833668	0.656746734290818	Dodecadienoate (12:2) levels	5e-23	35347128
rs2279502	rs16833668	0.656746734290818	X-21353 levels	9e-67	35347128
rs2279502	rs10888445	0.652951685591643	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2279502	rs7541453	0.650083390438664	Serum metabolite levels	2e-16	33031748
rs2279502	rs7541453	0.650083390438664	Serum metabolite levels	2e-16	33031748
rs2279502	rs7541453	0.650083390438664	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2279502	rs16833669	0.643183650353871	Plasma X-21353 levels in chronic kidney disease	3e-28	37277652
rs2279502	rs61817724	0.642583650474965	X-23641 levels	6e-13	35347128
rs2279502	rs61817724	0.642583650474965	X-18888 levels	5e-18	35347128
rs2279502	rs61817724	0.642583650474965	3-hydroxyhexanoate levels	2e-13	35347128
rs2279502	rs61817724	0.642583650474965	3-hydroxyoctanoate levels	1e-44	35347128
rs2279502	rs16833670	0.613290120163419	X-13431 levels	5e-49	36635386
rs2279502	rs2337685	0.612693536397481	X-13431 levels	2e-34	35347128
rs2279502	rs6675930	0.612693536397481	Cis-4-decenoate (10:1n6) levels	3e-166	35347128
rs2279502	rs6675930	0.612693536397481	3-hydroxydecanoate levels	3e-70	35347128
rs2279502	rs6675930	0.612693536397481	3-hydroxylaurate levels	2e-24	35347128
rs2279502	rs6682605	0.612693536397481	Tetradecadienoate (14:2) levels	2e-25	35347128
rs2279502	rs6682605	0.612693536397481	X-21607 levels	4e-20	35347128
rs2279502	rs6693388	0.612693536397481	Plasma beta-hydroxyisovalerate levels in chronic kidney disease	1e-13	37277652
rs2279502	rs6693388	0.612693536397481	Plasma 3-hydroxydecanoate levels in chronic kidney disease	6e-24	37277652
rs2279502	rs6693388	0.612693536397481	Plasma 3-hydroxylaurate levels in chronic kidney disease	9e-13	37277652
rs2279502	rs6693388	0.612693536397481	Linoleate 18:2n6-to-X-12442--5,8-tetradecadienoate ratio	4e-38	24816252
rs2279502	rs6693388	0.612693536397481	Undecenoylcarnitine (C11:1) levels	6e-25	36635386
rs2279502	rs6693396	0.611941562647234	X-13431 levels	2e-47	35050183
rs2279502	rs80320664	0.611786930560551	X-23680 levels	3e-45	35050183
rs2279502	rs10675058	0.600768488749326	Undecenoylcarnitine (C11:1) levels	8e-15	35347128
rs2281235	rs2076435	0.961395039427459	Inguinal hernia	2e-08	35022708
rs2281235	rs2076435	0.961395039427459	Inguinal hernia	2e-09	35022708
rs2281235	rs2076438	0.842614683780776	Coronary artery disease	3e-08	33020668
rs2281235	rs2235642	0.839136514014366	Coronary artery disease	8e-06	29212778
rs2281236	rs2076435	0.950660525527307	Inguinal hernia	2e-08	35022708
rs2281236	rs2076435	0.950660525527307	Inguinal hernia	2e-09	35022708
rs2281236	rs2076438	0.833055067055795	Coronary artery disease	3e-08	33020668
rs2281236	rs2235642	0.829618857625594	Coronary artery disease	8e-06	29212778
rs2285583	rs2285583	1	AFP levels	2e-08	36329257
rs2285583	rs178785	0.790653432937955	Lung function (FVC)	5e-09	30595370
rs2285583	rs9897542	0.725944899192314	Total bilirubin levels	8e-11	34594039
rs2285583	rs1075901	0.722229931556422	Body mass index	4e-13	30239722
rs2285583	rs1075901	0.722229931556422	Body mass index	4e-13	30239722
rs2285583	rs1075901	0.722229931556422	Body mass index (MTAG)	7e-13	36376304
rs2285583	rs1075901	0.722229931556422	Body mass index	4e-14	36581621
rs2285583	rs1075901	0.722229931556422	Body mass index	4e-12	30595370
rs2285583	rs4792716	0.720176671739602	Body mass index	2e-11	31669095
rs2285583	rs4792716	0.720176671739602	Adult body size	5e-09	32376654
rs2285583	rs178835	0.665501719107267	C-reactive protein levels	2e-13	31900758
rs2285583	rs9916868	0.655935166982774	Weight	3e-09	34594039
rs2285932	rs1557866	1	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs2285932	rs1293767	0.897639450963228	Adult asthma	2e-06	27611488
rs2285932	rs1293767	0.897639450963228	Adult asthma	9e-07	27611488
rs2285932	rs6489882	0.64174960194697	Chronic lymphocytic leukemia	5e-08	28165464
rs2285932	rs1859336	0.61982849623932	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs2285932	rs10744789	0.610025075807648	Vitamin D levels or COVID-19 (MTAG)	5e-12	37212302
rs2285932	rs4767027	0.6033381828865	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs2285932	rs2057778	0.600481748899161	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs2285932	rs2057778	0.600481748899161	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs2285932	rs2057778	0.600481748899161	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs2286795	rs2285583	0.925809910196269	AFP levels	2e-08	36329257
rs2286795	rs178785	0.740704562690965	Lung function (FVC)	5e-09	30595370
rs2286795	rs9897542	0.736069491927959	Total bilirubin levels	8e-11	34594039
rs2286795	rs4792716	0.696324815681713	Body mass index	2e-11	31669095
rs2286795	rs4792716	0.696324815681713	Adult body size	5e-09	32376654
rs2286795	rs1075901	0.694369737056878	Body mass index	4e-13	30239722
rs2286795	rs1075901	0.694369737056878	Body mass index	4e-13	30239722
rs2286795	rs1075901	0.694369737056878	Body mass index (MTAG)	7e-13	36376304
rs2286795	rs1075901	0.694369737056878	Body mass index	4e-14	36581621
rs2286795	rs1075901	0.694369737056878	Body mass index	4e-12	30595370
rs2286795	rs9916868	0.662296017542719	Weight	3e-09	34594039
rs2286795	rs178835	0.623800868658273	C-reactive protein levels	2e-13	31900758
rs2290911	rs2290911	1	Height	5e-07	29782485
rs2290911	rs2290911	1	Large artery stroke	6e-06	28265093
rs2290911	rs2290911	1	Height	8e-112	36224396
rs2290911	rs17713396	0.951296204883857	Blood urea nitrogen levels	3e-21	34272381
rs2290911	rs17713396	0.951296204883857	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs2290911	rs17713396	0.951296204883857	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs2290911	rs6710091	0.94927208968099	Waist circumference adjusted for body mass index	8e-11	31669095
rs2290911	rs6710091	0.94927208968099	HDL cholesterol	5e-08	30275531
rs2290911	rs6710091	0.94927208968099	High density lipoprotein cholesterol levels	3e-24	34887591
rs2290911	rs7595075	0.933156773039156	Waist circumference adjusted for body mass index	2e-09	34021172
rs2290911	rs7595075	0.933156773039156	HDL cholesterol	3e-11	34594039
rs2290911	rs7595075	0.933156773039156	HDL cholesterol levels	6e-13	32203549
rs2290911	rs17713729	0.932272934045243	Body mass index	2e-09	31669095
rs2290911	rs17713729	0.932272934045243	Serum creatinine levels	4e-14	34594039
rs2290911	rs17713729	0.932272934045243	High density lipoprotein cholesterol levels	7e-17	34887591
rs2290911	rs79716074	0.929071345012972	Plateletcrit	1e-09	32888494
rs2290911	rs79716074	0.929071345012972	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs2290911	rs79716074	0.929071345012972	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs2290911	rs79716074	0.929071345012972	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs2290911	rs58461606	0.92273092997089	Blood protein levels	0	30072576
rs2290911	rs11553746	0.918506756272095	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs2290911	rs11553746	0.918506756272095	High density lipoprotein cholesterol levels	2e-07	29083408
rs2290911	rs11553746	0.918506756272095	High density lipoprotein cholesterol levels	7e-15	29083408
rs2290911	rs11553746	0.918506756272095	Large artery stroke	4e-06	28265093
rs2290911	rs3791221	0.916336839042153	Blood urea nitrogen levels	2e-07	31152163
rs2290911	rs3791221	0.916336839042153	Estimated glomerular filtration rate	2e-10	31152163
rs2290911	rs3791221	0.916336839042153	Estimated glomerular filtration rate	1e-11	31152163
rs2290911	rs3791221	0.916336839042153	Blood urea nitrogen levels	7e-26	34594039
rs2290911	rs7605824	0.91554762949124	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs2290911	rs7566279	0.914603158458187	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs2290911	rs2126129	0.898540154575427	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs2290911	rs114976176	0.872638278313611	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs2290911	rs62114548	0.857569457141098	Retinal vascular fractal density	2e-09	34743558
rs2290911	rs59937473	0.846205863771949	Protein quantitative trait loci	3e-67	32492067
rs2290911	rs59937473	0.846205863771949	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs2290911	rs7601944	0.840848833822044	Smoking initiation	4e-15	36477530
rs2290911	rs17714252	0.838358734315244	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs2290911	rs17714252	0.838358734315244	Retinal vascular fractal dimension	2e-07	34743558
rs2290911	rs55753056	0.831992441150366	Height	2e-22	30595370
rs2290911	rs79154857	0.813004624259726	Pulse pressure	5e-08	34594039
rs2290911	rs62114506	0.807022715452728	Gamma glutamyl transpeptidase	3e-14	34594039
rs2290911	rs62114506	0.807022715452728	Apolipoprotein A1 levels	3e-10	32203549
rs2290911	rs62114506	0.807022715452728	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs2290911	rs62114506	0.807022715452728	HDL cholesterol levels	8e-10	36333282
rs2290911	rs62114538	0.788120941998057	Triglyceride levels	6e-12	34887591
rs2290911	rs17713879	0.786537934298288	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs2290911	rs17713879	0.786537934298288	Smoking initiation	1e-10	36477530
rs2290911	rs17713879	0.786537934298288	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs2290911	rs17713879	0.786537934298288	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs2290911	rs17713879	0.786537934298288	Triglyceride levels	3e-10	34887591
rs2290911	rs17713879	0.786537934298288	Aging (eyeAgeAcceleration)	6e-50	36975205
rs2290911	rs60843830	0.776453984015556	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs2290911	rs60843830	0.776453984015556	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs2290911	rs60843830	0.776453984015556	Adventurousness	7e-10	30643258
rs2291232	rs13271626	0.992454186344178	Haemorrhoidal disease	3e-10	33888516
rs2291232	rs11778693	0.971297920798049	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs2291232	rs11778693	0.971297920798049	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs2291232	rs34269854	0.849462125804243	Lung function (forced vital capacity)	3e-09	36914875
rs2291232	rs746011	0.739124230882888	Triglycerides	2e-10	30275531
rs2291232	rs11781149	0.721759372166859	Refractive error	2e-17	32231278
rs2291232	rs11780207	0.638428307298168	Estimated glomerular filtration rate	2e-13	33462484
rs2291232	rs11780207	0.638428307298168	Serum total protein level	2e-09	33462484
rs2291232	rs11780207	0.638428307298168	Creatinine levels	2e-13	33462484
rs2291232	rs751680	0.627948637247543	Insomnia	7e-09	35835914
rs2291232	rs11782130	0.624798837584499	C-reactive protein levels	9e-09	35459240
rs2291232	rs4592028	0.62156858404381	Non-albumin protein levels	3e-09	33462484
rs2291232	rs1545837	0.610589028891761	Lung function (FVC)	1e-10	30595370
rs2291232	rs2280104	0.600126503974634	Parkinson's disease	3e-08	28892059
rs2291232	rs2280104	0.600126503974634	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs2291232	rs2280104	0.600126503974634	Serum total protein level	3e-12	34594039
rs2291426	rs7545078	0.773750190412147	Smoking initiation	2e-09	36477530
rs2291426	rs6700087	0.706202421255781	Smoking initiation	6e-11	36477530
rs2293484	rs12539962	0.949935440273914	Colorectal cancer	3e-08	36539618
rs2293484	rs7806956	0.680295581414566	Esophageal squamous cell carcinoma	3e-07	37673066
rs2293484	rs4355658	0.652647546729027	Height	3e-13	36224396
rs2293484	rs13232536	0.63237852881306	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs2296360	rs9462030	0.988782358320132	Red cell distribution width	5e-25	32888493
rs2296360	rs9469857	0.979208008419995	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2296360	rs2764208	0.978426972269226	Systemic lupus erythematosus	7e-06	24871463
rs2296360	rs9469899	0.972086133473201	Prostate cancer (advanced)	2e-06	29892016
rs2296360	rs9469899	0.972086133473201	Prostate cancer	5e-09	29892016
rs2296360	rs9469899	0.972086133473201	Prostate cancer	8e-11	33398198
rs2296360	rs9469899	0.972086133473201	Hand grip strength	3e-15	29691431
rs2296360	rs9469899	0.972086133473201	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2296360	rs9469899	0.972086133473201	Graves' disease	4e-10	34594039
rs2296360	rs9469899	0.972086133473201	Coronary artery disease	1e-11	36474045
rs2296360	rs9469899	0.972086133473201	Predicted visceral adipose tissue	2e-20	31501611
rs2296360	rs9469899	0.972086133473201	Medication use (thyroid preparations)	2e-09	31015401
rs2296360	rs9469899	0.972086133473201	Medication use (thyroid preparations)	3e-10	34594039
rs2296360	rs9469872	0.943074025040154	HDL cholesterol levels	3e-11	36333282
rs2296360	rs11755393	0.942721544114407	Body mass index	3e-26	29273807
rs2296360	rs11755393	0.942721544114407	Systemic lupus erythematosus	2e-12	33493351
rs2296360	rs11755393	0.942721544114407	Systemic lupus erythematosus	2e-06	33493351
rs2296360	rs11755393	0.942721544114407	Systemic lupus erythematosus	1e-07	33493351
rs2296360	rs11755393	0.942721544114407	Systemic lupus erythematosus	2e-08	19838195
rs2296360	rs11755393	0.942721544114407	Body mass index	4e-55	36581621
rs2296360	rs9366863	0.932909943286639	Adult body size	9e-33	32376654
rs2296360	rs9366863	0.932909943286639	Body mass index	2e-44	30595370
rs2296360	rs6941110	0.92976164349929	Sex hormone-binding globulin levels	5e-27	36653534
rs2296360	rs9296128	0.928933537287342	Hip circumference adjusted for BMI	4e-13	34021172
rs2296360	rs2814949	0.896922285403527	Essential hypertension (time to event)	9e-09	32589924
rs2296360	rs2744944	0.887660046458666	Hypothyroidism	3e-10	34594039
rs2296360	rs2744944	0.887660046458666	High density lipoprotein cholesterol levels	3e-86	34887591
rs2296360	rs2744944	0.887660046458666	Multi-trait sex score	7e-22	37277458
rs2296360	rs2263329	0.868622311241962	HDL cholesterol	6e-35	34594039
rs2296360	rs2263329	0.868622311241962	HDL cholesterol levels	8e-43	32203549
rs2296360	rs2263329	0.868622311241962	High density lipoprotein cholesterol levels	2e-52	34887591
rs2296360	rs111868030	0.845213930199717	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2296360	rs9368830	0.823949551778332	HDL cholesterol	4e-21	30275531
rs2296360	rs9368828	0.797943451974278	Body mass index	1e-34	34594039
rs2296360	rs2744973	0.794915726131875	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2296360	rs2744973	0.794915726131875	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2296360	rs2744973	0.794915726131875	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2296360	rs2744973	0.794915726131875	Multi-trait sex score	6e-20	37277458
rs2296360	rs6912327	0.786712423583275	Fasting insulin	5e-06	33402679
rs2296360	rs6912327	0.786712423583275	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2296360	rs112283401	0.764477494086479	Red cell distribution width	4e-27	30595370
rs2296360	rs9689160	0.623532075072339	Lung function (forced vital capacity)	3e-14	36914875
rs2298570	rs7524908	0.657063326893438	Height	5e-27	30595370
rs2298570	rs3828081	0.654634098692303	Cognitive function (immediate memory)	8e-08	35386118
rs2302415	rs2285583	0.950492549911853	AFP levels	2e-08	36329257
rs2302415	rs9897542	0.761196127256224	Total bilirubin levels	8e-11	34594039
rs2302415	rs178785	0.760558010202397	Lung function (FVC)	5e-09	30595370
rs2302415	rs4792716	0.712382063871526	Body mass index	2e-11	31669095
rs2302415	rs4792716	0.712382063871526	Adult body size	5e-09	32376654
rs2302415	rs1075901	0.710365638759571	Body mass index	4e-13	30239722
rs2302415	rs1075901	0.710365638759571	Body mass index	4e-13	30239722
rs2302415	rs1075901	0.710365638759571	Body mass index (MTAG)	7e-13	36376304
rs2302415	rs1075901	0.710365638759571	Body mass index	4e-14	36581621
rs2302415	rs1075901	0.710365638759571	Body mass index	4e-12	30595370
rs2302415	rs9916868	0.677760266537238	Weight	3e-09	34594039
rs2302415	rs178835	0.637447470190634	C-reactive protein levels	2e-13	31900758
rs2303208	rs1974871	0.915187650253955	Granulysin levels	5e-13	34648354
rs2303208	rs4869314	0.903240269841892	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2303208	rs4869314	0.903240269841892	Neutrophil count	1e-10	34594039
rs2303208	rs4869314	0.903240269841892	White blood cell count	2e-07	30595370
rs2303208	rs2549782	0.848622396754244	Systolic blood pressure	6e-07	33230300
rs2303208	rs2549782	0.848622396754244	Diastolic blood pressure	1e-14	33230300
rs2303208	rs2549782	0.848622396754244	Diastolic blood pressure	3e-11	33230300
rs2303208	rs2549782	0.848622396754244	Systolic blood pressure	5e-09	33230300
rs2303208	rs2549797	0.848609928258369	Systolic blood pressure	7e-07	33230300
rs2303208	rs2549797	0.848609928258369	Diastolic blood pressure	1e-14	33230300
rs2303208	rs2549797	0.848609928258369	Diastolic blood pressure	3e-11	33230300
rs2303208	rs2549797	0.848609928258369	Systolic blood pressure	4e-09	33230300
rs2303208	rs1056893	0.846397226051936	Systolic blood pressure	1e-06	33230300
rs2303208	rs1056893	0.846397226051936	Diastolic blood pressure	7e-15	33230300
rs2303208	rs1056893	0.846397226051936	Diastolic blood pressure	2e-11	33230300
rs2303208	rs1056893	0.846397226051936	Systolic blood pressure	7e-09	33230300
rs2303208	rs4869313	0.827687974966473	Pediatric autoimmune diseases	9e-08	26301688
rs2303208	rs1559359	0.819940148008461	Diastolic blood pressure	7e-10	34594039
rs2303208	rs2910686	0.801858223883726	Neutrophil count	4e-14	32888493
rs2303208	rs2910686	0.801858223883726	Psoriasis	2e-08	23143594
rs2303208	rs2910686	0.801858223883726	Ankylosing spondylitis	5e-17	23749187
rs2303208	rs2910686	0.801858223883726	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2303208	rs2927608	0.80052597462367	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2303208	rs2927608	0.80052597462367	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2303208	rs2927608	0.80052597462367	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2303208	rs1019503	0.728826769949896	Systolic blood pressure	2e-06	33230300
rs2303208	rs1019503	0.728826769949896	Diastolic blood pressure	2e-14	33230300
rs2303208	rs1019503	0.728826769949896	Diastolic blood pressure	4e-11	33230300
rs2303208	rs1019503	0.728826769949896	Systolic blood pressure	1e-08	33230300
rs2303208	rs3096168	0.723302944773894	Aspartate aminotransferase levels	8e-12	33547301
rs2303208	rs1423357	0.703731127715226	General cognitive ability	9e-06	29844566
rs2303208	rs2432142	0.689843410786977	Neutrophil count	2e-14	32888493
rs2303208	rs2432142	0.689843410786977	White blood cell count	1e-11	32888493
rs2303208	rs38033	0.684337430991923	Blood protein levels	0	30072576
rs2303208	rs27293	0.674315429596653	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2303208	rs27293	0.674315429596653	Diastolic blood pressure	3e-11	35762941
rs2303208	rs7705093	0.665578930783243	Birdshot chorioretinopathy	2e-09	24957906
rs2305876	rs2868708	0.923365050158184	Lymphocyte count	3e-11	34469753
rs2305876	rs2868708	0.923365050158184	White blood cell count	1e-09	30595370
rs2305876	rs6831339	0.920168043119913	High density lipoprotein cholesterol levels	9e-09	34887591
rs2305876	rs6535419	0.879988193518798	Pulse pressure	6e-10	30578418
rs2305876	rs13111599	0.852031180502105	HDL cholesterol levels	3e-09	32203549
rs2305876	rs13111599	0.852031180502105	Apolipoprotein A1 levels	4e-08	32203549
rs2305876	rs116142917	0.846645417295296	Lymphocyte count	7e-18	32888494
rs2305876	rs6823199	0.844588489224876	Pulse pressure	4e-14	30224653
rs2305876	rs4302451	0.800982593424625	Eosinophil counts	2e-09	30595370
rs2305876	rs35895091	0.715661584153353	Cardiovascular disease	1e-07	30595370
rs2305876	rs11099563	0.690469902795925	High density lipoprotein cholesterol levels	3e-11	34887591
rs2305876	rs28528763	0.675795256531338	White blood cell count	7e-12	32888494
rs2306060	rs7601944	0.948346365532696	Smoking initiation	4e-15	36477530
rs2306060	rs55753056	0.939602700743612	Height	2e-22	30595370
rs2306060	rs114976176	0.926836298274795	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs2306060	rs3791221	0.926810123825671	Blood urea nitrogen levels	2e-07	31152163
rs2306060	rs3791221	0.926810123825671	Estimated glomerular filtration rate	2e-10	31152163
rs2306060	rs3791221	0.926810123825671	Estimated glomerular filtration rate	1e-11	31152163
rs2306060	rs3791221	0.926810123825671	Blood urea nitrogen levels	7e-26	34594039
rs2306060	rs17713396	0.912759274041664	Blood urea nitrogen levels	3e-21	34272381
rs2306060	rs17713396	0.912759274041664	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs2306060	rs17713396	0.912759274041664	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs2306060	rs6710091	0.910833003105097	Waist circumference adjusted for body mass index	8e-11	31669095
rs2306060	rs6710091	0.910833003105097	HDL cholesterol	5e-08	30275531
rs2306060	rs6710091	0.910833003105097	High density lipoprotein cholesterol levels	3e-24	34887591
rs2306060	rs59937473	0.904844114727543	Protein quantitative trait loci	3e-67	32492067
rs2306060	rs59937473	0.904844114727543	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs2306060	rs7595075	0.897406079032762	Waist circumference adjusted for body mass index	2e-09	34021172
rs2306060	rs7595075	0.897406079032762	HDL cholesterol	3e-11	34594039
rs2306060	rs7595075	0.897406079032762	HDL cholesterol levels	6e-13	32203549
rs2306060	rs17714252	0.897234386070784	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs2306060	rs17714252	0.897234386070784	Retinal vascular fractal dimension	2e-07	34743558
rs2306060	rs79716074	0.893614722241438	Plateletcrit	1e-09	32888494
rs2306060	rs79716074	0.893614722241438	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs2306060	rs79716074	0.893614722241438	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs2306060	rs79716074	0.893614722241438	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs2306060	rs17713729	0.892599307569948	Body mass index	2e-09	31669095
rs2306060	rs17713729	0.892599307569948	Serum creatinine levels	4e-14	34594039
rs2306060	rs17713729	0.892599307569948	High density lipoprotein cholesterol levels	7e-17	34887591
rs2306060	rs58461606	0.886820895419122	Blood protein levels	0	30072576
rs2306060	rs2290911	0.883087805703531	Height	5e-07	29782485
rs2306060	rs2290911	0.883087805703531	Large artery stroke	6e-06	28265093
rs2306060	rs2290911	0.883087805703531	Height	8e-112	36224396
rs2306060	rs7566279	0.88305770118129	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs2306060	rs7605824	0.882118184890298	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs2306060	rs2126129	0.861654150298799	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs2306060	rs62114538	0.842589662387226	Triglyceride levels	6e-12	34887591
rs2306060	rs60843830	0.838613989201412	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs2306060	rs60843830	0.838613989201412	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs2306060	rs60843830	0.838613989201412	Adventurousness	7e-10	30643258
rs2306060	rs11553746	0.812439482979362	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs2306060	rs11553746	0.812439482979362	High density lipoprotein cholesterol levels	2e-07	29083408
rs2306060	rs11553746	0.812439482979362	High density lipoprotein cholesterol levels	7e-15	29083408
rs2306060	rs11553746	0.812439482979362	Large artery stroke	4e-06	28265093
rs2306060	rs17713879	0.80155287027142	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs2306060	rs17713879	0.80155287027142	Smoking initiation	1e-10	36477530
rs2306060	rs17713879	0.80155287027142	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs2306060	rs17713879	0.80155287027142	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs2306060	rs17713879	0.80155287027142	Triglyceride levels	3e-10	34887591
rs2306060	rs17713879	0.80155287027142	Aging (eyeAgeAcceleration)	6e-50	36975205
rs2306060	rs62114548	0.775732902771558	Retinal vascular fractal density	2e-09	34743558
rs2306060	rs79154857	0.738401783092066	Pulse pressure	5e-08	34594039
rs2306060	rs62114506	0.712433967131082	Gamma glutamyl transpeptidase	3e-14	34594039
rs2306060	rs62114506	0.712433967131082	Apolipoprotein A1 levels	3e-10	32203549
rs2306060	rs62114506	0.712433967131082	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs2306060	rs62114506	0.712433967131082	HDL cholesterol levels	8e-10	36333282
rs2316509	rs6680628	0.718145129572011	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs2338201	rs2338201	1	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2338201	rs2338201	1	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2338201	rs2338201	1	Dodecadienoate (12:2) levels	7e-15	36635386
rs2338201	rs6685187	0.982289677881086	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2338201	rs6698740	0.978276106019325	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2338201	rs1060870	0.976674389399637	Serum metabolite levels	1e-11	33031748
rs2338201	rs1060870	0.976674389399637	Serum metabolite levels	1e-15	33031748
rs2338201	rs11204914	0.954460250974028	Carnitine C9 levels	1e-13	35995766
rs2338201	rs11204914	0.954460250974028	Metabolite peak levels (QI6204)	1e-32	35995766
rs2338201	rs11204914	0.954460250974028	Metabolite peak levels (QI6252)	2e-32	35995766
rs2338201	rs10788817	0.941782447809442	Serum metabolite levels	3e-13	24625756
rs2338201	rs10788817	0.941782447809442	Metabolite peak levels (QI2718)	5e-18	35995766
rs2338201	rs10788817	0.941782447809442	3-hydroxylaurate levels	2e-12	36635386
rs2338201	rs10788817	0.941782447809442	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2338201	rs7523082	0.844875824418582	Metabolite peak levels (QI9845)	2e-14	35995766
rs2338201	rs10888445	0.831807599397699	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2338201	rs7541453	0.824371863113005	Serum metabolite levels	2e-16	33031748
rs2338201	rs7541453	0.824371863113005	Serum metabolite levels	2e-16	33031748
rs2338201	rs7541453	0.824371863113005	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2338201	rs7542137	0.821551651154406	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2338201	rs7542137	0.821551651154406	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2338201	rs7542137	0.821551651154406	3-hydroxysebacate levels	2e-10	36635386
rs2338201	rs2130525	0.803022108363714	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2338201	rs2999545	0.785099171462165	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2338201	rs2279501	0.770199055210022	Serum metabolite levels	3e-14	33031748
rs2338201	rs3007711	0.749422690073395	Electrodermal activity	9e-06	25387706
rs2338201	rs2999541	0.747081739629544	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2338201	rs1038747	0.651602269969447	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2338209	rs2999541	0.974888279748459	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2338209	rs3007711	0.970679698011362	Electrodermal activity	9e-06	25387706
rs2338209	rs2130525	0.907138317129113	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2338209	rs7542137	0.826576322835661	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2338209	rs7542137	0.826576322835661	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2338209	rs7542137	0.826576322835661	3-hydroxysebacate levels	2e-10	36635386
rs2338209	rs10788817	0.773680510533734	Serum metabolite levels	3e-13	24625756
rs2338209	rs10788817	0.773680510533734	Metabolite peak levels (QI2718)	5e-18	35995766
rs2338209	rs10788817	0.773680510533734	3-hydroxylaurate levels	2e-12	36635386
rs2338209	rs10788817	0.773680510533734	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2338209	rs11204914	0.769775684878135	Carnitine C9 levels	1e-13	35995766
rs2338209	rs11204914	0.769775684878135	Metabolite peak levels (QI6204)	1e-32	35995766
rs2338209	rs11204914	0.769775684878135	Metabolite peak levels (QI6252)	2e-32	35995766
rs2338209	rs2279501	0.748000723880403	Serum metabolite levels	3e-14	33031748
rs2338209	rs6685187	0.745985135507609	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2338209	rs6698740	0.7439386158195	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2338209	rs1060870	0.7425086321327	Serum metabolite levels	1e-11	33031748
rs2338209	rs1060870	0.7425086321327	Serum metabolite levels	1e-15	33031748
rs2338209	rs2338201	0.733158998735501	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2338209	rs2338201	0.733158998735501	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2338209	rs2338201	0.733158998735501	Dodecadienoate (12:2) levels	7e-15	36635386
rs2338209	rs56000812	0.688275229677798	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2338209	rs10494270	0.687343330762768	Nonaylcarnitine levels	5e-13	26068415
rs2338209	rs56078223	0.686121533573598	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2338209	rs56078223	0.686121533573598	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs2338209	rs2999545	0.684139848688769	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2338209	rs9943221	0.680538969876549	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2338209	rs1038747	0.638419148333419	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2338209	rs6684312	0.620453616021252	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs2338209	rs7523082	0.618928992045673	Metabolite peak levels (QI9845)	2e-14	35995766
rs2338209	rs10888445	0.615735608979455	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2338209	rs7541453	0.613287172513155	Serum metabolite levels	2e-16	33031748
rs2338209	rs7541453	0.613287172513155	Serum metabolite levels	2e-16	33031748
rs2338209	rs7541453	0.613287172513155	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2342857	rs2095375	0.996402482833012	Serum metabolite levels	1e-20	33031748
rs2342857	rs2095375	0.996402482833012	Serum metabolite levels	1e-20	33031748
rs2342857	rs9383843	0.99550580600308	Migraine	1e-09	35115687
rs2342857	rs55763431	0.991920973218723	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2342857	rs9689694	0.990120077233172	Right hippocampal volume (head)	6e-11	37337106
rs2342857	rs9689694	0.990120077233172	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2342857	rs9689694	0.990120077233172	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2342857	rs9689694	0.990120077233172	Left hippocampal volume (head)	6e-12	37337106
rs2342857	rs10872645	0.984758360799649	Blood protein levels	2e-86	30072576
rs2342857	rs9688867	0.983927961297746	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2342857	rs9688867	0.983927961297746	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2342857	rs9688809	0.983927961297746	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2342857	rs10872653	0.98383797587251	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2342857	rs34337297	0.980289347047308	Serum levels of protein LRP11	3e-161	35078996
rs2342857	rs14314	0.977702858437736	Macular thickness	3e-19	30535121
rs2342857	rs14314	0.977702858437736	Vertex-wise sulcal depth	7e-17	34910505
rs2342857	rs14314	0.977702858437736	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2342857	rs14314	0.977702858437736	Left hippocampal volume (body)	7e-15	37337106
rs2342857	rs14314	0.977702858437736	Left subiculum volume (body)	1e-14	37337106
rs2342857	rs9322193	0.9443369194958	Lung cancer	1e-07	27393504
rs2342857	rs4039600	0.900479845897492	Adenine levels	1e-11	35347128
rs2342857	rs1934534	0.63655279561687	Pain (pleiotropy)	2e-08	37844115
rs2342857	rs1934534	0.63655279561687	Pain (pleiotropy)	2e-06	37844115
rs2342857	rs4380763	0.636033908583699	Subcortical volume (min-P)	1e-11	32665545
rs2342857	rs11155671	0.625629893723964	Testicular germ cell tumor	2e-09	28604728
rs2342857	rs80147756	0.610835947800951	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2342857	rs4421206	0.603296923188388	Brain morphology (min-P)	4e-11	32665545
rs2342858	rs2095375	0.99370703743102	Serum metabolite levels	1e-20	33031748
rs2342858	rs2095375	0.99370703743102	Serum metabolite levels	1e-20	33031748
rs2342858	rs9383843	0.992812249173311	Migraine	1e-09	35115687
rs2342858	rs55763431	0.991025895185066	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2342858	rs9689694	0.989224462300629	Right hippocampal volume (head)	6e-11	37337106
rs2342858	rs9689694	0.989224462300629	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2342858	rs9689694	0.989224462300629	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2342858	rs9689694	0.989224462300629	Left hippocampal volume (head)	6e-12	37337106
rs2342858	rs10872645	0.983865433873434	Blood protein levels	2e-86	30072576
rs2342858	rs9688867	0.983040093004793	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2342858	rs9688867	0.983040093004793	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2342858	rs9688809	0.983040093004793	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2342858	rs10872653	0.982941564437895	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2342858	rs34337297	0.979397234999922	Serum levels of protein LRP11	3e-161	35078996
rs2342858	rs14314	0.975040396201557	Macular thickness	3e-19	30535121
rs2342858	rs14314	0.975040396201557	Vertex-wise sulcal depth	7e-17	34910505
rs2342858	rs14314	0.975040396201557	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2342858	rs14314	0.975040396201557	Left hippocampal volume (body)	7e-15	37337106
rs2342858	rs14314	0.975040396201557	Left subiculum volume (body)	1e-14	37337106
rs2342858	rs9322193	0.945211760584523	Lung cancer	1e-07	27393504
rs2342858	rs4039600	0.901306613765509	Adenine levels	1e-11	35347128
rs2342858	rs1934534	0.637341796886556	Pain (pleiotropy)	2e-08	37844115
rs2342858	rs1934534	0.637341796886556	Pain (pleiotropy)	2e-06	37844115
rs2342858	rs4380763	0.636822751180142	Subcortical volume (min-P)	1e-11	32665545
rs2342858	rs11155671	0.626412363775734	Testicular germ cell tumor	2e-09	28604728
rs2342858	rs80147756	0.611616436077105	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2342858	rs4421206	0.604075752225663	Brain morphology (min-P)	4e-11	32665545
rs2342860	rs10872653	0.996398963379575	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2342860	rs55763431	0.995508517308269	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2342860	rs9689694	0.993707610711994	Right hippocampal volume (head)	6e-11	37337106
rs2342860	rs9689694	0.993707610711994	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2342860	rs9689694	0.993707610711994	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2342860	rs9689694	0.993707610711994	Left hippocampal volume (head)	6e-12	37337106
rs2342860	rs2095375	0.991013810602254	Serum metabolite levels	1e-20	33031748
rs2342860	rs2095375	0.991013810602254	Serum metabolite levels	1e-20	33031748
rs2342860	rs9383843	0.990119838616633	Migraine	1e-09	35115687
rs2342860	rs10872645	0.988335114239339	Blood protein levels	2e-86	30072576
rs2342860	rs9688867	0.987491421814693	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2342860	rs9688867	0.987491421814693	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2342860	rs9688809	0.987491421814693	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2342860	rs34337297	0.983860681246269	Serum levels of protein LRP11	3e-161	35078996
rs2342860	rs14314	0.97237068229241	Macular thickness	3e-19	30535121
rs2342860	rs14314	0.97237068229241	Vertex-wise sulcal depth	7e-17	34910505
rs2342860	rs14314	0.97237068229241	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2342860	rs14314	0.97237068229241	Left hippocampal volume (body)	7e-15	37337106
rs2342860	rs14314	0.97237068229241	Left subiculum volume (body)	1e-14	37337106
rs2342860	rs9322193	0.947828234863957	Lung cancer	1e-07	27393504
rs2342860	rs4039600	0.904010090256514	Adenine levels	1e-11	35347128
rs2342860	rs1934534	0.639075075721001	Pain (pleiotropy)	2e-08	37844115
rs2342860	rs1934534	0.639075075721001	Pain (pleiotropy)	2e-06	37844115
rs2342860	rs4380763	0.638554621082928	Subcortical volume (min-P)	1e-11	32665545
rs2342860	rs11155671	0.628128244412566	Testicular germ cell tumor	2e-09	28604728
rs2342860	rs80147756	0.613282304302921	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2342860	rs4421206	0.605718731517047	Brain morphology (min-P)	4e-11	32665545
rs2342861	rs10872653	0.995498226786074	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2342861	rs55763431	0.994611831582603	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2342861	rs9689694	0.992810385806177	Right hippocampal volume (head)	6e-11	37337106
rs2342861	rs9689694	0.992810385806177	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2342861	rs9689694	0.992810385806177	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2342861	rs9689694	0.992810385806177	Left hippocampal volume (head)	6e-12	37337106
rs2342861	rs2095375	0.990116855987002	Serum metabolite levels	1e-20	33031748
rs2342861	rs2095375	0.990116855987002	Serum metabolite levels	1e-20	33031748
rs2342861	rs9383843	0.989223691829243	Migraine	1e-09	35115687
rs2342861	rs10872645	0.987440580198331	Blood protein levels	2e-86	30072576
rs2342861	rs9688867	0.986601957338234	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2342861	rs9688867	0.986601957338234	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2342861	rs9688809	0.986601957338234	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2342861	rs34337297	0.982966961213692	Serum levels of protein LRP11	3e-161	35078996
rs2342861	rs14314	0.971486300951365	Macular thickness	3e-19	30535121
rs2342861	rs14314	0.971486300951365	Vertex-wise sulcal depth	7e-17	34910505
rs2342861	rs14314	0.971486300951365	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2342861	rs14314	0.971486300951365	Left hippocampal volume (body)	7e-15	37337106
rs2342861	rs14314	0.971486300951365	Left subiculum volume (body)	1e-14	37337106
rs2342861	rs9322193	0.94695555526718	Lung cancer	1e-07	27393504
rs2342861	rs4039600	0.903108388538094	Adenine levels	1e-11	35347128
rs2342861	rs1934534	0.638496970761271	Pain (pleiotropy)	2e-08	37844115
rs2342861	rs1934534	0.638496970761271	Pain (pleiotropy)	2e-06	37844115
rs2342861	rs4380763	0.637976986047805	Subcortical volume (min-P)	1e-11	32665545
rs2342861	rs11155671	0.627555942289287	Testicular germ cell tumor	2e-09	28604728
rs2342861	rs80147756	0.612726682973468	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2342861	rs4421206	0.605170744396575	Brain morphology (min-P)	4e-11	32665545
rs2351010	rs1423357	0.990790918085228	General cognitive ability	9e-06	29844566
rs2351010	rs2432142	0.975776387282486	Neutrophil count	2e-14	32888493
rs2351010	rs2432142	0.975776387282486	White blood cell count	1e-11	32888493
rs2351010	rs38033	0.972558135425505	Blood protein levels	0	30072576
rs2351010	rs27293	0.960161439492884	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2351010	rs27293	0.960161439492884	Diastolic blood pressure	3e-11	35762941
rs2351010	rs7705093	0.958085902147036	Birdshot chorioretinopathy	2e-09	24957906
rs2351010	rs2910686	0.86308375708675	Neutrophil count	4e-14	32888493
rs2351010	rs2910686	0.86308375708675	Psoriasis	2e-08	23143594
rs2351010	rs2910686	0.86308375708675	Ankylosing spondylitis	5e-17	23749187
rs2351010	rs2910686	0.86308375708675	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2351010	rs2927608	0.85978581673532	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2351010	rs2927608	0.85978581673532	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2351010	rs2927608	0.85978581673532	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2351010	rs2617439	0.776071796295408	Neutrophil count	8e-11	32888494
rs2351010	rs2549797	0.767995212869218	Systolic blood pressure	7e-07	33230300
rs2351010	rs2549797	0.767995212869218	Diastolic blood pressure	1e-14	33230300
rs2351010	rs2549797	0.767995212869218	Diastolic blood pressure	3e-11	33230300
rs2351010	rs2549797	0.767995212869218	Systolic blood pressure	4e-09	33230300
rs2351010	rs2549782	0.766739247773326	Systolic blood pressure	6e-07	33230300
rs2351010	rs2549782	0.766739247773326	Diastolic blood pressure	1e-14	33230300
rs2351010	rs2549782	0.766739247773326	Diastolic blood pressure	3e-11	33230300
rs2351010	rs2549782	0.766739247773326	Systolic blood pressure	5e-09	33230300
rs2351010	rs1056893	0.76611210670884	Systolic blood pressure	1e-06	33230300
rs2351010	rs1056893	0.76611210670884	Diastolic blood pressure	7e-15	33230300
rs2351010	rs1056893	0.76611210670884	Diastolic blood pressure	2e-11	33230300
rs2351010	rs1056893	0.76611210670884	Systolic blood pressure	7e-09	33230300
rs2351010	rs2549794	0.762014418737972	Crohn's disease	1e-10	21102463
rs2351010	rs2549794	0.762014418737972	Systolic blood pressure	1e-07	33230300
rs2351010	rs2549794	0.762014418737972	Diastolic blood pressure	1e-15	33230300
rs2351010	rs2549794	0.762014418737972	Diastolic blood pressure	2e-12	33230300
rs2351010	rs2549794	0.762014418737972	Systolic blood pressure	4e-10	33230300
rs2351010	rs38029	0.759800995851057	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2351010	rs1363907	0.757393683787106	Crohn's disease	4e-16	26192919
rs2351010	rs1363907	0.757393683787106	Ulcerative colitis	4e-06	26192919
rs2351010	rs1363907	0.757393683787106	Inflammatory bowel disease	5e-15	26192919
rs2351010	rs1363907	0.757393683787106	Inflammatory bowel disease	6e-13	23128233
rs2351010	rs1363907	0.757393683787106	Inflammatory bowel disease	1e-10	28067908
rs2351010	rs1363907	0.757393683787106	Crohn's disease	1e-14	28067908
rs2351010	rs716848	0.729095015891513	Neutrophil percentage of white cells	2e-09	32888494
rs2351010	rs4869313	0.71719912287302	Pediatric autoimmune diseases	9e-08	26301688
rs2351010	rs1559359	0.710883390615778	Diastolic blood pressure	7e-10	34594039
rs2351010	rs2548532	0.684612707857486	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2351010	rs4869314	0.663856590047384	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2351010	rs4869314	0.663856590047384	Neutrophil count	1e-10	34594039
rs2351010	rs4869314	0.663856590047384	White blood cell count	2e-07	30595370
rs2351010	rs1974871	0.63768866012564	Granulysin levels	5e-13	34648354
rs2351010	rs1019503	0.633115805986541	Systolic blood pressure	2e-06	33230300
rs2351010	rs1019503	0.633115805986541	Diastolic blood pressure	2e-14	33230300
rs2351010	rs1019503	0.633115805986541	Diastolic blood pressure	4e-11	33230300
rs2351010	rs1019503	0.633115805986541	Systolic blood pressure	1e-08	33230300
rs2351010	rs27660	0.631160717896164	Coronary artery disease	3e-08	35915156
rs2351010	rs3096168	0.625742995294097	Aspartate aminotransferase levels	8e-12	33547301
rs2351011	rs1363907	0.997332496219044	Crohn's disease	4e-16	26192919
rs2351011	rs1363907	0.997332496219044	Ulcerative colitis	4e-06	26192919
rs2351011	rs1363907	0.997332496219044	Inflammatory bowel disease	5e-15	26192919
rs2351011	rs1363907	0.997332496219044	Inflammatory bowel disease	6e-13	23128233
rs2351011	rs1363907	0.997332496219044	Inflammatory bowel disease	1e-10	28067908
rs2351011	rs1363907	0.997332496219044	Crohn's disease	1e-14	28067908
rs2351011	rs2549794	0.992005512926076	Crohn's disease	1e-10	21102463
rs2351011	rs2549794	0.992005512926076	Systolic blood pressure	1e-07	33230300
rs2351011	rs2549794	0.992005512926076	Diastolic blood pressure	1e-15	33230300
rs2351011	rs2549794	0.992005512926076	Diastolic blood pressure	2e-12	33230300
rs2351011	rs2549794	0.992005512926076	Systolic blood pressure	4e-10	33230300
rs2351011	rs2617439	0.938574515181278	Neutrophil count	8e-11	32888494
rs2351011	rs716848	0.935001632468156	Neutrophil percentage of white cells	2e-09	32888494
rs2351011	rs38029	0.926621232799994	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2351011	rs2548532	0.890919389837854	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2351011	rs27660	0.77496251394521	Coronary artery disease	3e-08	35915156
rs2351011	rs1423357	0.762395936122117	General cognitive ability	9e-06	29844566
rs2351011	rs2432142	0.747549370672213	Neutrophil count	2e-14	32888493
rs2351011	rs2432142	0.747549370672213	White blood cell count	1e-11	32888493
rs2351011	rs38033	0.745693387600544	Blood protein levels	0	30072576
rs2351011	rs27293	0.737202570771803	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2351011	rs27293	0.737202570771803	Diastolic blood pressure	3e-11	35762941
rs2351011	rs7705093	0.727767687205442	Birdshot chorioretinopathy	2e-09	24957906
rs2351011	rs2927608	0.720277396715991	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2351011	rs2927608	0.720277396715991	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2351011	rs2927608	0.720277396715991	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2351011	rs2910686	0.71791209765445	Neutrophil count	4e-14	32888493
rs2351011	rs2910686	0.71791209765445	Psoriasis	2e-08	23143594
rs2351011	rs2910686	0.71791209765445	Ankylosing spondylitis	5e-17	23749187
rs2351011	rs2910686	0.71791209765445	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2351011	rs4869313	0.717635917434642	Pediatric autoimmune diseases	9e-08	26301688
rs2351011	rs1559359	0.649439402138841	Diastolic blood pressure	7e-10	34594039
rs2351011	rs1974871	0.644511330869306	Granulysin levels	5e-13	34648354
rs2351011	rs2549797	0.631965033269392	Systolic blood pressure	7e-07	33230300
rs2351011	rs2549797	0.631965033269392	Diastolic blood pressure	1e-14	33230300
rs2351011	rs2549797	0.631965033269392	Diastolic blood pressure	3e-11	33230300
rs2351011	rs2549797	0.631965033269392	Systolic blood pressure	4e-09	33230300
rs2351011	rs2549782	0.630939526215582	Systolic blood pressure	6e-07	33230300
rs2351011	rs2549782	0.630939526215582	Diastolic blood pressure	1e-14	33230300
rs2351011	rs2549782	0.630939526215582	Diastolic blood pressure	3e-11	33230300
rs2351011	rs2549782	0.630939526215582	Systolic blood pressure	5e-09	33230300
rs2351011	rs1056893	0.630427459725895	Systolic blood pressure	1e-06	33230300
rs2351011	rs1056893	0.630427459725895	Diastolic blood pressure	7e-15	33230300
rs2351011	rs1056893	0.630427459725895	Diastolic blood pressure	2e-11	33230300
rs2351011	rs1056893	0.630427459725895	Systolic blood pressure	7e-09	33230300
rs2355433	rs2355433	1	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs2355433	rs2355433	1	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs2355433	rs2355433	1	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs2357175	rs2357176	0.96238191343181	Nevus count or cutaneous melanoma	4e-08	30429480
rs2357175	rs10873172	0.855289873710719	Cutaneous melanoma or hair colour	6e-27	32341527
rs2357175	rs10873172	0.855289873710719	Nevus count or cutaneous melanoma	6e-13	32341527
rs2357175	rs10873172	0.855289873710719	Blond vs. brown/black hair color	6e-15	30531825
rs2357175	rs10873172	0.855289873710719	Cutaneous malignant melanoma	6e-08	32341527
rs2357175	rs10873172	0.855289873710719	Hair color	4e-17	30595370
rs2357175	rs1255908	0.803376531487733	PR interval	8e-14	32439900
rs2357175	rs1255908	0.803376531487733	PR interval	6e-14	32439900
rs2357175	rs12878653	0.741706199426997	Youthful appearance (self-reported)	3e-14	32339537
rs2357176	rs2357176	1	Nevus count or cutaneous melanoma	4e-08	30429480
rs2357176	rs10873172	0.83123966311423	Cutaneous melanoma or hair colour	6e-27	32341527
rs2357176	rs10873172	0.83123966311423	Nevus count or cutaneous melanoma	6e-13	32341527
rs2357176	rs10873172	0.83123966311423	Blond vs. brown/black hair color	6e-15	30531825
rs2357176	rs10873172	0.83123966311423	Cutaneous malignant melanoma	6e-08	32341527
rs2357176	rs10873172	0.83123966311423	Hair color	4e-17	30595370
rs2357176	rs1255908	0.773622014493381	PR interval	8e-14	32439900
rs2357176	rs1255908	0.773622014493381	PR interval	6e-14	32439900
rs2357176	rs12878653	0.71338400456279	Youthful appearance (self-reported)	3e-14	32339537
rs2363279	rs10256972	0.632895759338724	Endometriosis	3e-06	27506219
rs2363279	rs10256972	0.632895759338724	Longevity	1e-06	20834067
rs2364837	rs10876448	0.884579560889605	Mean corpuscular hemoglobin	2e-16	32888493
rs2364837	rs10876448	0.884579560889605	Reticulocyte count	3e-18	32888494
rs2364837	rs10876448	0.884579560889605	Reticulocyte fraction of red cells	1e-10	32888494
rs2364837	rs2446066	0.883735300298317	Vertex-wise sulcal depth	1e-10	34910505
rs2364837	rs2446066	0.883735300298317	Vertex-wise cortical surface area	2e-13	34910505
rs2364837	rs2446066	0.883735300298317	Red blood cell count	1e-10	27863252
rs2364837	rs2446066	0.883735300298317	Cortical surface area	3e-08	34560273
rs2364837	rs2608301	0.883735300298317	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2364837	rs2460882	0.882028860537853	Mean corpuscular volume	3e-15	29403010
rs2364837	rs2460882	0.882028860537853	Percentage gas trapping	6e-07	26030696
rs2364837	rs111379945	0.872802481155866	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2364837	rs111379945	0.872802481155866	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2364837	rs111379945	0.872802481155866	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2364837	rs12582170	0.854207938700647	Mean corpuscular volume	1e-21	27863252
rs2364837	rs12582170	0.854207938700647	Mean corpuscular hemoglobin	7e-37	32888493
rs2364837	rs12582170	0.854207938700647	Mean reticulocyte volume	2e-33	32888494
rs2364837	rs12582170	0.854207938700647	Mean corpuscular volume	1e-67	32888493
rs2364837	rs12582170	0.854207938700647	Mean corpuscular hemoglobin	2e-21	32888494
rs2364837	rs12582170	0.854207938700647	Mean corpuscular volume	1e-26	34104963
rs2366150	rs920778	0.811303304940348	Haemorrhoidal disease	7e-10	33888516
rs2366152	rs920778	0.608460391072794	Haemorrhoidal disease	7e-10	33888516
rs2366274	rs150621	0.90207369257851	Appendicular lean mass	5e-12	31761296
rs2366274	rs2098713	0.766257997296105	Telomere length	3e-06	24795349
rs2366274	rs757720522	0.644533376993735	Appendicular lean mass	3e-11	31761296
rs2384074	rs1557866	0.842217466806426	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs2384074	rs1293767	0.755307727168274	Adult asthma	2e-06	27611488
rs2384074	rs1293767	0.755307727168274	Adult asthma	9e-07	27611488
rs2384074	rs6489882	0.669602235524783	Chronic lymphocytic leukemia	5e-08	28165464
rs2384074	rs1859336	0.648973257412746	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs2384074	rs4767027	0.632759018499755	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs2384074	rs2057778	0.62989058741415	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs2384074	rs2057778	0.62989058741415	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs2384074	rs2057778	0.62989058741415	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs2384074	rs11066452	0.625619615625358	Blood protein levels	6e-08	30072576
rs2384074	rs1131476	0.612945252977642	Systemic lupus erythematosus	1e-09	33272962
rs2384074	rs2660	0.612945252977642	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs2384074	rs2660	0.612945252977642	COVID-19 (critical illness vs population)	3e-15	37198478
rs2389232	rs9590228	0.996661991195421	Height	7e-22	36224396
rs2389232	rs8002180	0.945800175888648	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs2389232	rs9524869	0.735250456473247	Serum metabolite levels	6e-32	33031748
rs2389232	rs9524869	0.735250456473247	N-acetylcarnosine levels	1e-42	35347128
rs2389232	rs9524869	0.735250456473247	N-acetylcarnosine levels	9e-47	35050183
rs2389232	rs9524869	0.735250456473247	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs2389232	rs9524869	0.735250456473247	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs2389232	rs9524869	0.735250456473247	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs2389232	rs9524869	0.735250456473247	N-acetylcarnosine levels	2e-60	36635386
rs2389617	rs10465746	0.803912588287651	Obesity-related traits	8e-06	23251661
rs2389617	rs11580836	0.7711168122813	Body mass index	2e-09	36581621
rs2389647	rs11580836	0.881001868130685	Body mass index	2e-09	36581621
rs2389647	rs10465746	0.861641825545985	Obesity-related traits	8e-06	23251661
rs2389647	rs1536166	0.626029233621755	Body mass index	2e-08	30595370
rs2389647	rs28726372	0.601583459201669	Body mass index	4e-08	31669095
rs2389647	rs28726372	0.601583459201669	Adult body size	9e-10	32376654
rs2390675	rs12729558	0.946629856232447	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs2390675	rs10922531	0.907727213068194	Serum metabolite levels	2e-69	33031748
rs2390675	rs7532151	0.873540641403732	Imidazole lactate levels	9e-12	33177712
rs2390675	rs10801690	0.8466190337152	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs2390675	rs7530513	0.832490474096479	Height	8e-11	35831902
rs2390675	rs7530513	0.832490474096479	Imidazole lactate levels	8e-166	36635386
rs2390675	rs12144640	0.832490474096479	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs2390675	rs1409152	0.82093903832024	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs2390675	rs1409152	0.82093903832024	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs2390675	rs10801699	0.818825450655192	X-23639 levels	2e-10	36635386
rs2390675	rs9787133	0.816349472582233	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs2390675	rs12120164	0.784732721190749	Metabolite peak levels (QI2146)	1e-26	35995766
rs2390675	rs2765527	0.765782873842068	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs2390675	rs2810876	0.656028937379871	Imidazole lactate levels	2e-122	35347128
rs2390675	rs10801696	0.654718193699616	Imidazole lactate levels	3e-195	35050183
rs2390675	rs1206228892	0.654194307795355	Imidazole lactate levels	5e-186	35050183
rs2394997	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs2394997	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs2394997	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs2394997	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs2394997	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs2394997	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs2394997	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs2394997	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs2394997	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs2394997	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs2394997	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs2394997	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs2394997	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs2394997	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs2394997	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs2394997	rs13437082	0.631513452560533	Height	5e-08	19343178
rs2394997	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs2395002	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs2395002	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs2395002	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs2395002	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs2395002	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs2395002	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs2395002	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs2395002	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs2395002	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs2395002	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs2395002	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs2395002	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs2395002	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs2395002	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs2395002	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs2395002	rs13437082	0.631513452560533	Height	5e-08	19343178
rs2395002	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs2395604	rs9462030	0.99357301333205	Red cell distribution width	5e-25	32888493
rs2395604	rs9469857	0.987167370196909	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2395604	rs2764208	0.986378118060005	Systemic lupus erythematosus	7e-06	24871463
rs2395604	rs9469899	0.976890497656135	Prostate cancer (advanced)	2e-06	29892016
rs2395604	rs9469899	0.976890497656135	Prostate cancer	5e-09	29892016
rs2395604	rs9469899	0.976890497656135	Prostate cancer	8e-11	33398198
rs2395604	rs9469899	0.976890497656135	Hand grip strength	3e-15	29691431
rs2395604	rs9469899	0.976890497656135	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2395604	rs9469899	0.976890497656135	Graves' disease	4e-10	34594039
rs2395604	rs9469899	0.976890497656135	Coronary artery disease	1e-11	36474045
rs2395604	rs9469899	0.976890497656135	Predicted visceral adipose tissue	2e-20	31501611
rs2395604	rs9469899	0.976890497656135	Medication use (thyroid preparations)	2e-09	31015401
rs2395604	rs9469899	0.976890497656135	Medication use (thyroid preparations)	3e-10	34594039
rs2395604	rs9469872	0.950958897261736	HDL cholesterol levels	3e-11	36333282
rs2395604	rs11755393	0.945951754817663	Body mass index	3e-26	29273807
rs2395604	rs11755393	0.945951754817663	Systemic lupus erythematosus	2e-12	33493351
rs2395604	rs11755393	0.945951754817663	Systemic lupus erythematosus	2e-06	33493351
rs2395604	rs11755393	0.945951754817663	Systemic lupus erythematosus	1e-07	33493351
rs2395604	rs11755393	0.945951754817663	Systemic lupus erythematosus	2e-08	19838195
rs2395604	rs11755393	0.945951754817663	Body mass index	4e-55	36581621
rs2395604	rs9366863	0.940745161360336	Adult body size	9e-33	32376654
rs2395604	rs9366863	0.940745161360336	Body mass index	2e-44	30595370
rs2395604	rs9296128	0.936571612931796	Hip circumference adjusted for BMI	4e-13	34021172
rs2395604	rs6941110	0.934461630809766	Sex hormone-binding globulin levels	5e-27	36653534
rs2395604	rs2814949	0.904618439960805	Essential hypertension (time to event)	9e-09	32589924
rs2395604	rs2744944	0.895298340251238	Hypothyroidism	3e-10	34594039
rs2395604	rs2744944	0.895298340251238	High density lipoprotein cholesterol levels	3e-86	34887591
rs2395604	rs2744944	0.895298340251238	Multi-trait sex score	7e-22	37277458
rs2395604	rs2263329	0.876147482727081	HDL cholesterol	6e-35	34594039
rs2395604	rs2263329	0.876147482727081	HDL cholesterol levels	8e-43	32203549
rs2395604	rs2263329	0.876147482727081	High density lipoprotein cholesterol levels	2e-52	34887591
rs2395604	rs111868030	0.852482577090651	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2395604	rs9368830	0.831471957770903	HDL cholesterol	4e-21	30275531
rs2395604	rs9368828	0.805114650245497	Body mass index	1e-34	34594039
rs2395604	rs2744973	0.80175483440061	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2395604	rs2744973	0.80175483440061	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2395604	rs2744973	0.80175483440061	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2395604	rs2744973	0.80175483440061	Multi-trait sex score	6e-20	37277458
rs2395604	rs6912327	0.790683255534353	Fasting insulin	5e-06	33402679
rs2395604	rs6912327	0.790683255534353	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2395604	rs112283401	0.768388542503119	Red cell distribution width	4e-27	30595370
rs2395604	rs9689160	0.629238044690856	Lung function (forced vital capacity)	3e-14	36914875
rs2395606	rs9462030	0.960493851248035	Red cell distribution width	5e-25	32888493
rs2395606	rs9469857	0.955820571398928	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2395606	rs2764208	0.955077443167702	Systemic lupus erythematosus	7e-06	24871463
rs2395606	rs9469899	0.943757051129522	Prostate cancer (advanced)	2e-06	29892016
rs2395606	rs9469899	0.943757051129522	Prostate cancer	5e-09	29892016
rs2395606	rs9469899	0.943757051129522	Prostate cancer	8e-11	33398198
rs2395606	rs9469899	0.943757051129522	Hand grip strength	3e-15	29691431
rs2395606	rs9469899	0.943757051129522	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2395606	rs9469899	0.943757051129522	Graves' disease	4e-10	34594039
rs2395606	rs9469899	0.943757051129522	Coronary artery disease	1e-11	36474045
rs2395606	rs9469899	0.943757051129522	Predicted visceral adipose tissue	2e-20	31501611
rs2395606	rs9469899	0.943757051129522	Medication use (thyroid preparations)	2e-09	31015401
rs2395606	rs9469899	0.943757051129522	Medication use (thyroid preparations)	3e-10	34594039
rs2395606	rs9469872	0.919705408600411	HDL cholesterol levels	3e-11	36333282
rs2395606	rs11755393	0.912959329103966	Body mass index	3e-26	29273807
rs2395606	rs11755393	0.912959329103966	Systemic lupus erythematosus	2e-12	33493351
rs2395606	rs11755393	0.912959329103966	Systemic lupus erythematosus	2e-06	33493351
rs2395606	rs11755393	0.912959329103966	Systemic lupus erythematosus	1e-07	33493351
rs2395606	rs11755393	0.912959329103966	Systemic lupus erythematosus	2e-08	19838195
rs2395606	rs11755393	0.912959329103966	Body mass index	4e-55	36581621
rs2395606	rs9366863	0.909706440053818	Adult body size	9e-33	32376654
rs2395606	rs9366863	0.909706440053818	Body mass index	2e-44	30595370
rs2395606	rs9296128	0.906807253775028	Hip circumference adjusted for BMI	4e-13	34021172
rs2395606	rs6941110	0.902050761306116	Sex hormone-binding globulin levels	5e-27	36653534
rs2395606	rs2814949	0.874094028345412	Essential hypertension (time to event)	9e-09	32589924
rs2395606	rs2744944	0.865049797050743	Hypothyroidism	3e-10	34594039
rs2395606	rs2744944	0.865049797050743	High density lipoprotein cholesterol levels	3e-86	34887591
rs2395606	rs2744944	0.865049797050743	Multi-trait sex score	7e-22	37277458
rs2395606	rs2263329	0.847907154309901	HDL cholesterol	6e-35	34594039
rs2395606	rs2263329	0.847907154309901	HDL cholesterol levels	8e-43	32203549
rs2395606	rs2263329	0.847907154309901	High density lipoprotein cholesterol levels	2e-52	34887591
rs2395606	rs111868030	0.824199863959664	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2395606	rs9368830	0.802710028560223	HDL cholesterol	4e-21	30275531
rs2395606	rs9368828	0.779738924904885	Body mass index	1e-34	34594039
rs2395606	rs2744973	0.7772303286918	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2395606	rs2744973	0.7772303286918	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2395606	rs2744973	0.7772303286918	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2395606	rs2744973	0.7772303286918	Multi-trait sex score	6e-20	37277458
rs2395606	rs6912327	0.765882849676738	Fasting insulin	5e-06	33402679
rs2395606	rs6912327	0.765882849676738	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2395606	rs112283401	0.741162488482932	Red cell distribution width	4e-27	30595370
rs2395606	rs9689160	0.610270460512345	Lung function (forced vital capacity)	3e-14	36914875
rs2396027	rs9394952	0.909865779778962	Age-related hearing impairment	3e-11	34108613
rs2396027	rs4714680	0.890461969820828	Height	2e-09	34594039
rs2396027	rs4714680	0.890461969820828	Hip circumference adjusted for BMI	4e-08	34021172
rs2396027	rs9369409	0.733751033386911	Waist-hip index	5e-09	34021172
rs2396027	rs9369409	0.733751033386911	Medication use (calcium channel blockers)	3e-10	31015401
rs2396027	rs9369409	0.733751033386911	Waist-to-hip ratio adjusted for BMI	1e-09	34021172
rs2396027	rs9369409	0.733751033386911	Medication use (calcium channel blockers)	4e-17	34594039
rs2396027	rs9369409	0.733751033386911	Waist-hip ratio	8e-15	30595370
rs2396027	rs4714678	0.732633819794788	Systolic blood pressure	1e-17	30487518
rs2396027	rs4714678	0.732633819794788	Mean arterial pressure	9e-16	30487518
rs2396027	rs4714678	0.732633819794788	Urea levels	3e-10	33462484
rs2396027	rs4714678	0.732633819794788	Blood urea nitrogen levels	8e-11	34594039
rs2396027	rs6912283	0.718948916334597	Bioavailable testosterone levels	1e-12	32042192
rs2396027	rs6912283	0.718948916334597	Serum alkaline phosphatase levels	2e-10	33547301
rs2396027	rs6912283	0.718948916334597	Heel bone mineral density	6e-09	30598549
rs2396027	rs6912283	0.718948916334597	Hip index	7e-11	34021172
rs2396027	rs6919440	0.716762622216922	Diastolic blood pressure	1e-11	30487518
rs2396027	rs6919440	0.716762622216922	Systolic blood pressure	5e-09	27618452
rs2396027	rs6919440	0.716762622216922	Mean corpuscular hemoglobin	9e-11	32888493
rs2396027	rs6919440	0.716762622216922	Mean corpuscular volume	1e-14	32888493
rs2396027	rs6919440	0.716762622216922	Platelet count	5e-22	32888493
rs2396027	rs6919440	0.716762622216922	Platelet count	2e-23	32888493
rs2396027	rs6919440	0.716762622216922	Mean corpuscular volume	4e-14	32888493
rs2396027	rs6919440	0.716762622216922	Plateletcrit	3e-09	27863252
rs2396027	rs6919440	0.716762622216922	Hip circumference adjusted for BMI	4e-16	34021172
rs2396027	rs6919440	0.716762622216922	Mean arterial pressure	1e-14	34594039
rs2396027	rs6919440	0.716762622216922	Superior parietal thickness (unadjusted for global measures)	4e-09	36893272
rs2396027	rs2396004	0.713450905177459	Mean corpuscular hemoglobin	1e-12	32888494
rs2396027	rs2396004	0.713450905177459	Chronotype	3e-09	30696823
rs2396027	rs2396004	0.713450905177459	Carnitine levels	4e-11	33414548
rs2396027	rs2396004	0.713450905177459	Total testosterone levels	4e-08	34321204
rs2396027	rs9394951	0.712897198323996	Mean corpuscular volume	1e-16	32888494
rs2396027	rs9394951	0.712897198323996	Mean reticulocyte volume	4e-14	32888494
rs2396027	rs9394951	0.712897198323996	Mean spheric corpuscular volume	1e-17	32888494
rs2396027	rs9394951	0.712897198323996	Medication use (diuretics)	6e-11	31015401
rs2396027	rs9394951	0.712897198323996	Medication use (agents acting on the renin-angiotensin system)	2e-09	31015401
rs2396027	rs9394951	0.712897198323996	Medication use (agents acting on the renin-angiotensin system)	2e-14	34594039
rs2396027	rs9394951	0.712897198323996	Medication use (diuretics)	2e-14	34594039
rs2396027	rs2611336	0.70883945458658	Hearing problems	2e-08	37165447
rs2396027	rs4714677	0.707606525905477	Heel bone mineral density	3e-10	30595370
rs2396027	rs9394948	0.707322893659545	Serum uric acid levels	1e-11	29403010
rs2396027	rs9394948	0.707322893659545	Serum uric acid levels	2e-13	30993211
rs2396027	rs10948071	0.701476163673584	Systolic blood pressure	4e-10	30487518
rs2396027	rs10948071	0.701476163673584	Mean arterial pressure	4e-09	30487518
rs2396027	rs10948071	0.701476163673584	Diastolic blood pressure	1e-06	30487518
rs2396027	rs10948071	0.701476163673584	Pulse pressure	4e-06	30487518
rs2396027	rs10948071	0.701476163673584	Hypertension	1e-06	30487518
rs2396027	rs10948071	0.701476163673584	Age-related hearing impairment (MTAG)	1e-18	32986727
rs2396027	rs10948071	0.701476163673584	Pulse pressure	3e-06	27841878
rs2396027	rs10948071	0.701476163673584	Systolic blood pressure	1e-09	27841878
rs2396027	rs10948071	0.701476163673584	Diastolic blood pressure (cigarette smoking interaction)	1e-10	29455858
rs2396027	rs10948071	0.701476163673584	Systolic blood pressure (cigarette smoking interaction)	8e-21	29455858
rs2396027	rs2254303	0.694280002696476	Pulse pressure	6e-11	30487518
rs2396027	rs2254303	0.694280002696476	Height	3e-18	34594039
rs2396027	rs2254303	0.694280002696476	Height	4e-08	31562340
rs2396027	rs2254303	0.694280002696476	Hearing problems	1e-23	37165447
rs2396027	rs1214752	0.688876956452195	Coronary artery disease	1e-06	29212778
rs2396027	rs1574430	0.660680365431081	Urate levels	3e-14	31578528
rs2396027	rs56401710	0.660680365431081	Urate levels	4e-10	31578528
rs2396027	rs56401710	0.660680365431081	Urate levels	5e-14	31578528
rs2396027	rs56401710	0.660680365431081	Urate levels	5e-30	31578528
rs2396027	rs2242416	0.648635648949334	Age-related hearing impairment	1e-17	34108613
rs2396027	rs2242416	0.648635648949334	Body mass index	3e-08	36581621
rs2396027	rs2242416	0.648635648949334	Hearing problems	1e-17	37165447
rs2396027	rs10948077	0.632179028989301	Gamma-glutamylglutamate levels	1e-10	36635386
rs2396027	rs62415384	0.607380549851878	Total testosterone levels	3e-08	32042192
rs2396027	rs62415384	0.607380549851878	Tyrosine levels	2e-11	35213538
rs2408597	rs702689	0.770578720957721	Vertex-wise sulcal depth	2e-22	34910505
rs2408597	rs10061757	0.753450488883083	Height	4e-30	30595370
rs2408597	rs96844	0.743308088578319	Type 2 diabetes	5e-08	30297969
rs2408597	rs96844	0.743308088578319	Height	4e-33	36224396
rs2408597	rs9292122	0.704487363627969	Prostate cancer	5e-09	33398198
rs2408597	rs33320	0.624483919570891	Height	9e-14	36224396
rs2408597	rs2257505	0.621117535351016	Height	8e-192	36224396
rs2413386	rs5756090	0.960690435254106	Severe COVID-19 infection	4e-08	36662838
rs2413386	rs2227169	0.875984476726737	Severe COVID-19 infection	4e-13	36662838
rs2413386	rs1053982	0.857169102038953	Severe COVID-19 infection	9e-06	36662838
rs2413386	rs6000172	0.8571512771768	Severe COVID-19 infection	1e-07	36662838
rs2413386	rs4821461	0.846345232869351	Severe COVID-19 infection	4e-06	36662838
rs2413387	rs6000172	0.988692860954464	Severe COVID-19 infection	1e-07	36662838
rs2413387	rs4821461	0.974896697681696	Severe COVID-19 infection	4e-06	36662838
rs2413387	rs2227169	0.972361601983557	Severe COVID-19 infection	4e-13	36662838
rs2413387	rs1053982	0.948015322343849	Severe COVID-19 infection	9e-06	36662838
rs2413387	rs5756090	0.822246501003084	Severe COVID-19 infection	4e-08	36662838
rs2414753	rs8034216	0.950104104161067	C-reactive protein levels	2e-10	31900758
rs2414753	rs17271340	0.908627687996666	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs2414753	rs17271305	0.885785532764092	Two-hour glucose challenge	1e-07	20081857
rs2414753	rs13379492	0.884551311915656	Lung function (FEV1/FVC)	6e-08	30595370
rs2414753	rs35967150	0.878419856686678	C-reactive protein levels (MTAG)	1e-08	36376304
rs2414753	rs11634163	0.866916854072922	C-reactive protein	2e-08	34594039
rs2414753	rs11634163	0.866916854072922	Two-hour glucose	3e-14	34059833
rs2414753	rs189400382	0.86378709816929	C-reactive protein levels	1e-08	35459240
rs2414753	rs28373613	0.646600663030577	Height (standard GWA)	8e-12	37106081
rs2414755	rs28373613	0.894305804875352	Height (standard GWA)	8e-12	37106081
rs2414755	rs13379492	0.632336569189591	Lung function (FEV1/FVC)	6e-08	30595370
rs2419132	rs1467510	0.904512897797224	Platelet distribution width	1e-14	32888494
rs2419132	rs12276109	0.768140423425929	Severe COVID-19 infection	6e-08	36662838
rs2420811	rs7558954	0.857242663117599	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2420811	rs11685226	0.855710676745261	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs2420811	rs11685226	0.855710676745261	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2420811	rs1177308	0.852972086293982	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2420811	rs1177308	0.852972086293982	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2420811	rs777587	0.720197432435515	Proteoglycan 3 levels	6e-29	34648354
rs2420811	rs777587	0.720197432435515	Pappalysin-1 levels	1e-25	34648354
rs2420811	rs2593620	0.70855820558318	Serum levels of protein PRG3	5e-14	35078996
rs2420811	rs12617371	0.684650426645811	Immature fraction of reticulocytes	8e-18	32888494
rs2420811	rs2421200	0.684373012940373	Neutrophil count	1e-26	32888493
rs2420811	rs2421200	0.684373012940373	Neutrophil count	1e-25	32888493
rs2420811	rs2463097	0.651228226487312	White blood cell count	3e-26	30595370
rs2420811	rs10199672	0.634139585046732	Height	6e-12	34594039
rs2420811	rs10199672	0.634139585046732	Height	2e-12	31562340
rs2420811	rs12616433	0.60617149293173	Eosinophil forward scatter	4e-13	37596262
rs2420811	rs12616433	0.60617149293173	Eosinophil side scatter	2e-18	37596262
rs2424703	rs2257649	0.996420706420706	Total Phosphatidylglycerol levels	3e-10	35668104
rs2424703	rs4815400	0.991059238263072	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs2424703	rs6037062	0.679799359059529	Lung function (forced vital capacity)	3e-13	36914875
rs2424703	rs6037062	0.679799359059529	Lung function (FVC)	5e-12	30595370
rs2424703	rs2500430	0.654120656597488	Serum alkaline phosphatase levels	7e-10	31666285
rs2424703	rs2273473	0.625768822433543	Vertex-wise cortical thickness	1e-12	34910505
rs2424703	rs6050463	0.600930729864808	Low density lipoprotein cholesterol levels	6e-09	32154731
rs2424703	rs6050463	0.600930729864808	LDL cholesterol levels	2e-09	32203549
rs2424703	rs6115094	0.600930729864808	Brain morphology (MOSTest)	1e-08	32665545
rs2424703	rs6115094	0.600930729864808	Non-HDL cholesterol levels	3e-09	34887591
rs2424703	rs2856	0.600676759317941	Blood protein levels	6e-07	27532455
rs2424710	rs11087521	0.884080195069864	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2424710	rs59934506	0.864178898061418	Body fat percentage	4e-16	33980691
rs2424710	rs59934506	0.864178898061418	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2424710	rs59934506	0.864178898061418	Alanine aminotransferase levels	2e-10	33980691
rs2424710	rs7267979	0.860822477072828	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2424710	rs2424698	0.85945572904836	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2424710	rs2424698	0.85945572904836	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2424710	rs2424698	0.85945572904836	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2424710	rs2424698	0.85945572904836	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2424710	rs2424698	0.85945572904836	C-reactive protein	5e-11	34594039
rs2424710	rs7020	0.853008621751875	wg rh intensity-contrast fusiform	1e-10	33875891
rs2424710	rs7020	0.853008621751875	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2424710	rs7020	0.853008621751875	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2424710	rs7020	0.853008621751875	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2424710	rs2151144	0.848485154639452	wg lh intensity-contrast fusiform	5e-12	33875891
rs2424710	rs2151144	0.848485154639452	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2424710	rs2151144	0.848485154639452	wg rh intensity-contrast insula	6e-18	33875891
rs2424710	rs2151144	0.848485154639452	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2424710	rs2151144	0.848485154639452	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2424710	rs2151144	0.848485154639452	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2424710	rs6083838	0.845088483525078	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2424710	rs6083838	0.845088483525078	wg lh intensity-contrast insula	6e-13	33875891
rs2424710	rs7274104	0.83124531092901	Cortical thickness	4e-08	34560273
rs2424710	rs6115118	0.81608151573944	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2424710	rs6115101	0.814631563072867	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2424710	rs6115101	0.814631563072867	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2424710	rs6115101	0.814631563072867	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2424710	rs6138553	0.813882249857733	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2424710	rs6115099	0.809050695413357	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2424710	rs6115200	0.806296442442829	Height	9e-09	36224396
rs2424710	rs6115204	0.804858305948032	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2424710	rs6138556	0.802721353655491	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2424710	rs6083799	0.791499068003161	Serum alkaline phosphatase levels	1e-71	33547301
rs2424710	rs2261795	0.77262107019595	Non-HDL cholesterol levels	1e-09	34887591
rs2424710	rs84816	0.76507389151655	aseg rh intensity Caudate	7e-09	33875891
rs2424710	rs84816	0.76507389151655	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2424710	rs4815412	0.764846140475378	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2424710	rs12428	0.759577477645092	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2424710	rs2500406	0.754395545654725	Brain region volumes	2e-08	31676860
rs2424710	rs2500406	0.754395545654725	Height	1e-33	36224396
rs2424710	rs2856	0.751975600872912	Blood protein levels	6e-07	27532455
rs2424710	rs6132824	0.742155987344917	Multi-trait sum score	5e-08	37277458
rs2424710	rs11699953	0.741469794947371	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2424710	rs8184820	0.740777092299614	Brain morphology (MOSTest)	4e-13	35164939
rs2424710	rs9927	0.719768009275116	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2424710	rs3746337	0.695985257170965	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2424710	rs3746337	0.695985257170965	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2424710	rs3746337	0.695985257170965	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2424710	rs3746337	0.695985257170965	Total cholesterol levels	3e-09	34887591
rs2424710	rs2500430	0.692028991307427	Serum alkaline phosphatase levels	7e-10	31666285
rs2424710	rs6050464	0.680421901381303	Brain region volumes	5e-09	31676860
rs2424710	rs6050464	0.680421901381303	Apolipoprotein B levels	6e-14	32203549
rs2424710	rs1888995	0.678510700961587	Weight	2e-11	34594039
rs2424710	rs2260997	0.666898057309535	Subcortical volume (MOSTest)	4e-09	32665545
rs2424710	rs2260997	0.666898057309535	Platelet distribution width	5e-17	32888494
rs2424711	rs11087521	0.884795238919768	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2424711	rs59934506	0.863484800915169	Body fat percentage	4e-16	33980691
rs2424711	rs59934506	0.863484800915169	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2424711	rs59934506	0.863484800915169	Alanine aminotransferase levels	2e-10	33980691
rs2424711	rs2424698	0.860153812871685	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2424711	rs2424698	0.860153812871685	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2424711	rs2424698	0.860153812871685	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2424711	rs2424698	0.860153812871685	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2424711	rs2424698	0.860153812871685	C-reactive protein	5e-11	34594039
rs2424711	rs7267979	0.860131691227903	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2424711	rs7020	0.852318539622667	wg rh intensity-contrast fusiform	1e-10	33875891
rs2424711	rs7020	0.852318539622667	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2424711	rs7020	0.852318539622667	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2424711	rs7020	0.852318539622667	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2424711	rs2151144	0.847804255438228	wg lh intensity-contrast fusiform	5e-12	33875891
rs2424711	rs2151144	0.847804255438228	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2424711	rs2151144	0.847804255438228	wg rh intensity-contrast insula	6e-18	33875891
rs2424711	rs2151144	0.847804255438228	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2424711	rs2151144	0.847804255438228	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2424711	rs2151144	0.847804255438228	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2424711	rs6083838	0.84441030628224	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2424711	rs6083838	0.84441030628224	wg lh intensity-contrast insula	6e-13	33875891
rs2424711	rs7274104	0.83055080164442	Cortical thickness	4e-08	34560273
rs2424711	rs6115118	0.81677290837666	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2424711	rs6115101	0.815322315503541	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2424711	rs6115101	0.815322315503541	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2424711	rs6115101	0.815322315503541	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2424711	rs6138553	0.814572937592695	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2424711	rs6115099	0.809736857421595	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2424711	rs6115200	0.807003368495287	Height	9e-09	36224396
rs2424711	rs6115204	0.805564575763374	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2424711	rs6138556	0.80341107039639	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2424711	rs6083799	0.790865027510139	Serum alkaline phosphatase levels	1e-71	33547301
rs2424711	rs2261795	0.772002144546854	Non-HDL cholesterol levels	1e-09	34887591
rs2424711	rs84816	0.764453971276313	aseg rh intensity Caudate	7e-09	33875891
rs2424711	rs84816	0.764453971276313	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2424711	rs4815412	0.764232266297646	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2424711	rs12428	0.758966656048457	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2424711	rs2500406	0.753591199236113	Brain region volumes	2e-08	31676860
rs2424711	rs2500406	0.753591199236113	Height	1e-33	36224396
rs2424711	rs2856	0.75137204064328	Blood protein levels	6e-07	27532455
rs2424711	rs6132824	0.742840703148197	Multi-trait sum score	5e-08	37277458
rs2424711	rs11699953	0.742154445492788	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2424711	rs8184820	0.741461147277612	Brain morphology (MOSTest)	4e-13	35164939
rs2424711	rs9927	0.719190258956152	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2424711	rs3746337	0.696647016469058	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2424711	rs3746337	0.696647016469058	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2424711	rs3746337	0.696647016469058	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2424711	rs3746337	0.696647016469058	Total cholesterol levels	3e-09	34887591
rs2424711	rs2500430	0.69147459245562	Serum alkaline phosphatase levels	7e-10	31666285
rs2424711	rs6050464	0.679833121399532	Brain region volumes	5e-09	31676860
rs2424711	rs6050464	0.679833121399532	Apolipoprotein B levels	6e-14	32203549
rs2424711	rs1888995	0.679056227253602	Weight	2e-11	34594039
rs2424711	rs2260997	0.667585724775813	Subcortical volume (MOSTest)	4e-09	32665545
rs2424711	rs2260997	0.667585724775813	Platelet distribution width	5e-17	32888494
rs2431501	rs2431501	1	Lung function (FEV1/FVC)	7e-13	36914875
rs2431502	rs2431501	0.992753195719811	Lung function (FEV1/FVC)	7e-13	36914875
rs2432141	rs2432142	0.997476666363832	Neutrophil count	2e-14	32888493
rs2432141	rs2432142	0.997476666363832	White blood cell count	1e-11	32888493
rs2432141	rs1423357	0.97739908913745	General cognitive ability	9e-06	29844566
rs2432141	rs38033	0.961050134378478	Blood protein levels	0	30072576
rs2432141	rs27293	0.942168919392206	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2432141	rs27293	0.942168919392206	Diastolic blood pressure	3e-11	35762941
rs2432141	rs7705093	0.933767423678113	Birdshot chorioretinopathy	2e-09	24957906
rs2432141	rs2910686	0.852647493567612	Neutrophil count	4e-14	32888493
rs2432141	rs2910686	0.852647493567612	Psoriasis	2e-08	23143594
rs2432141	rs2910686	0.852647493567612	Ankylosing spondylitis	5e-17	23749187
rs2432141	rs2910686	0.852647493567612	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2432141	rs2927608	0.849350977086346	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2432141	rs2927608	0.849350977086346	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2432141	rs2927608	0.849350977086346	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2432141	rs2617439	0.799672259555542	Neutrophil count	8e-11	32888494
rs2432141	rs2549797	0.758576410372656	Systolic blood pressure	7e-07	33230300
rs2432141	rs2549797	0.758576410372656	Diastolic blood pressure	1e-14	33230300
rs2432141	rs2549797	0.758576410372656	Diastolic blood pressure	3e-11	33230300
rs2432141	rs2549797	0.758576410372656	Systolic blood pressure	4e-09	33230300
rs2432141	rs2549782	0.757333665540957	Systolic blood pressure	6e-07	33230300
rs2432141	rs2549782	0.757333665540957	Diastolic blood pressure	1e-14	33230300
rs2432141	rs2549782	0.757333665540957	Diastolic blood pressure	3e-11	33230300
rs2432141	rs2549782	0.757333665540957	Systolic blood pressure	5e-09	33230300
rs2432141	rs1056893	0.756713125768901	Systolic blood pressure	1e-06	33230300
rs2432141	rs1056893	0.756713125768901	Diastolic blood pressure	7e-15	33230300
rs2432141	rs1056893	0.756713125768901	Diastolic blood pressure	2e-11	33230300
rs2432141	rs1056893	0.756713125768901	Systolic blood pressure	7e-09	33230300
rs2432141	rs2549794	0.751993309116957	Crohn's disease	1e-10	21102463
rs2432141	rs2549794	0.751993309116957	Systolic blood pressure	1e-07	33230300
rs2432141	rs2549794	0.751993309116957	Diastolic blood pressure	1e-15	33230300
rs2432141	rs2549794	0.751993309116957	Diastolic blood pressure	2e-12	33230300
rs2432141	rs2549794	0.751993309116957	Systolic blood pressure	4e-10	33230300
rs2432141	rs38029	0.749787815401197	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2432141	rs1363907	0.747408011609617	Crohn's disease	4e-16	26192919
rs2432141	rs1363907	0.747408011609617	Ulcerative colitis	4e-06	26192919
rs2432141	rs1363907	0.747408011609617	Inflammatory bowel disease	5e-15	26192919
rs2432141	rs1363907	0.747408011609617	Inflammatory bowel disease	6e-13	23128233
rs2432141	rs1363907	0.747408011609617	Inflammatory bowel disease	1e-10	28067908
rs2432141	rs1363907	0.747408011609617	Crohn's disease	1e-14	28067908
rs2432141	rs716848	0.719441268632936	Neutrophil percentage of white cells	2e-09	32888494
rs2432141	rs4869313	0.707253132510366	Pediatric autoimmune diseases	9e-08	26301688
rs2432141	rs1559359	0.701404959176838	Diastolic blood pressure	7e-10	34594039
rs2432141	rs2548532	0.67450367193518	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2432141	rs4869314	0.655297187348025	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2432141	rs4869314	0.655297187348025	Neutrophil count	1e-10	34594039
rs2432141	rs4869314	0.655297187348025	White blood cell count	2e-07	30595370
rs2432141	rs1974871	0.628659706099596	Granulysin levels	5e-13	34648354
rs2432141	rs1019503	0.625137116492661	Systolic blood pressure	2e-06	33230300
rs2432141	rs1019503	0.625137116492661	Diastolic blood pressure	2e-14	33230300
rs2432141	rs1019503	0.625137116492661	Diastolic blood pressure	4e-11	33230300
rs2432141	rs1019503	0.625137116492661	Systolic blood pressure	1e-08	33230300
rs2432141	rs27660	0.620776004445316	Coronary artery disease	3e-08	35915156
rs2432141	rs3096168	0.617775413394157	Aspartate aminotransferase levels	8e-12	33547301
rs2432142	rs2432142	1	Neutrophil count	2e-14	32888493
rs2432142	rs2432142	1	White blood cell count	1e-11	32888493
rs2432142	rs1423357	0.979899984928291	General cognitive ability	9e-06	29844566
rs2432142	rs38033	0.963515474841602	Blood protein levels	0	30072576
rs2432142	rs27293	0.944613407644149	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2432142	rs27293	0.944613407644149	Diastolic blood pressure	3e-11	35762941
rs2432142	rs7705093	0.936185758727266	Birdshot chorioretinopathy	2e-09	24957906
rs2432142	rs2910686	0.854917381046533	Neutrophil count	4e-14	32888493
rs2432142	rs2910686	0.854917381046533	Psoriasis	2e-08	23143594
rs2432142	rs2910686	0.854917381046533	Ankylosing spondylitis	5e-17	23749187
rs2432142	rs2910686	0.854917381046533	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2432142	rs2927608	0.851618675994664	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2432142	rs2927608	0.851618675994664	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2432142	rs2927608	0.851618675994664	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2432142	rs2617439	0.797448083451027	Neutrophil count	8e-11	32888494
rs2432142	rs2549797	0.760665744729764	Systolic blood pressure	7e-07	33230300
rs2432142	rs2549797	0.760665744729764	Diastolic blood pressure	1e-14	33230300
rs2432142	rs2549797	0.760665744729764	Diastolic blood pressure	3e-11	33230300
rs2432142	rs2549797	0.760665744729764	Systolic blood pressure	4e-09	33230300
rs2432142	rs2549782	0.759420640776436	Systolic blood pressure	6e-07	33230300
rs2432142	rs2549782	0.759420640776436	Diastolic blood pressure	1e-14	33230300
rs2432142	rs2549782	0.759420640776436	Diastolic blood pressure	3e-11	33230300
rs2432142	rs2549782	0.759420640776436	Systolic blood pressure	5e-09	33230300
rs2432142	rs1056893	0.758798923015246	Systolic blood pressure	1e-06	33230300
rs2432142	rs1056893	0.758798923015246	Diastolic blood pressure	7e-15	33230300
rs2432142	rs1056893	0.758798923015246	Diastolic blood pressure	2e-11	33230300
rs2432142	rs1056893	0.758798923015246	Systolic blood pressure	7e-09	33230300
rs2432142	rs2549794	0.7543446728158	Crohn's disease	1e-10	21102463
rs2432142	rs2549794	0.7543446728158	Systolic blood pressure	1e-07	33230300
rs2432142	rs2549794	0.7543446728158	Diastolic blood pressure	1e-15	33230300
rs2432142	rs2549794	0.7543446728158	Diastolic blood pressure	2e-12	33230300
rs2432142	rs2549794	0.7543446728158	Systolic blood pressure	4e-10	33230300
rs2432142	rs38029	0.752136595520502	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2432142	rs1363907	0.749751329254888	Crohn's disease	4e-16	26192919
rs2432142	rs1363907	0.749751329254888	Ulcerative colitis	4e-06	26192919
rs2432142	rs1363907	0.749751329254888	Inflammatory bowel disease	5e-15	26192919
rs2432142	rs1363907	0.749751329254888	Inflammatory bowel disease	6e-13	23128233
rs2432142	rs1363907	0.749751329254888	Inflammatory bowel disease	1e-10	28067908
rs2432142	rs1363907	0.749751329254888	Crohn's disease	1e-14	28067908
rs2432142	rs716848	0.721719134405304	Neutrophil percentage of white cells	2e-09	32888494
rs2432142	rs4869313	0.709371416020062	Pediatric autoimmune diseases	9e-08	26301688
rs2432142	rs1559359	0.703462362731093	Diastolic blood pressure	7e-10	34594039
rs2432142	rs2548532	0.676815890480715	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2432142	rs4869314	0.6572160588966	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2432142	rs4869314	0.6572160588966	Neutrophil count	1e-10	34594039
rs2432142	rs4869314	0.6572160588966	White blood cell count	2e-07	30595370
rs2432142	rs1974871	0.630612732808046	Granulysin levels	5e-13	34648354
rs2432142	rs1019503	0.62697092556985	Systolic blood pressure	2e-06	33230300
rs2432142	rs1019503	0.62697092556985	Diastolic blood pressure	2e-14	33230300
rs2432142	rs1019503	0.62697092556985	Diastolic blood pressure	4e-11	33230300
rs2432142	rs1019503	0.62697092556985	Systolic blood pressure	1e-08	33230300
rs2432142	rs27660	0.62309288082855	Coronary artery disease	3e-08	35915156
rs2432142	rs3096168	0.61960202810081	Aspartate aminotransferase levels	8e-12	33547301
rs2441467	rs1177308	0.824679952163777	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2441467	rs1177308	0.824679952163777	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2441467	rs11685226	0.823246451905371	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs2441467	rs11685226	0.823246451905371	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2441467	rs7558954	0.822577704795702	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2441467	rs777587	0.687498352728923	Proteoglycan 3 levels	6e-29	34648354
rs2441467	rs777587	0.687498352728923	Pappalysin-1 levels	1e-25	34648354
rs2441467	rs12617371	0.665514099738506	Immature fraction of reticulocytes	8e-18	32888494
rs2441467	rs2463097	0.648989831289249	White blood cell count	3e-26	30595370
rs2441467	rs10199672	0.612570546953382	Height	6e-12	34594039
rs2441467	rs10199672	0.612570546953382	Height	2e-12	31562340
rs2441467	rs2593620	0.610627139676008	Serum levels of protein PRG3	5e-14	35078996
rs2445388	rs2430691	0.606232331410259	Height	4e-44	36224396
rs2446066	rs2446066	1	Vertex-wise sulcal depth	1e-10	34910505
rs2446066	rs2446066	1	Vertex-wise cortical surface area	2e-13	34910505
rs2446066	rs2446066	1	Red blood cell count	1e-10	27863252
rs2446066	rs2446066	1	Cortical surface area	3e-08	34560273
rs2446066	rs2608301	1	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2446066	rs10876448	0.999092856617345	Mean corpuscular hemoglobin	2e-16	32888493
rs2446066	rs10876448	0.999092856617345	Reticulocyte count	3e-18	32888494
rs2446066	rs10876448	0.999092856617345	Reticulocyte fraction of red cells	1e-10	32888494
rs2446066	rs2460882	0.998186251598715	Mean corpuscular volume	3e-15	29403010
rs2446066	rs2460882	0.998186251598715	Percentage gas trapping	6e-07	26030696
rs2446066	rs12582170	0.964891010380584	Mean corpuscular volume	1e-21	27863252
rs2446066	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	7e-37	32888493
rs2446066	rs12582170	0.964891010380584	Mean reticulocyte volume	2e-33	32888494
rs2446066	rs12582170	0.964891010380584	Mean corpuscular volume	1e-67	32888493
rs2446066	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	2e-21	32888494
rs2446066	rs12582170	0.964891010380584	Mean corpuscular volume	1e-26	34104963
rs2446066	rs111379945	0.766400621245193	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2446066	rs111379945	0.766400621245193	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2446066	rs111379945	0.766400621245193	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2446066	rs79205721	0.617589919422487	Vertex-wise cortical thickness	2e-09	34910505
rs2448704	rs9369898	0.93087952582293	Homocysteine levels	2e-10	23824729
rs2448704	rs2501968	0.835887431032606	Ischemic stroke	1e-08	34594039
rs2448704	rs1471539	0.833877534225974	Mean reticulocyte volume	1e-10	32888494
rs2448704	rs1471539	0.833877534225974	Mean spheric corpuscular volume	8e-13	32888494
rs2460882	rs2460882	1	Mean corpuscular volume	3e-15	29403010
rs2460882	rs2460882	1	Percentage gas trapping	6e-07	26030696
rs2460882	rs2446066	0.998186251598715	Vertex-wise sulcal depth	1e-10	34910505
rs2460882	rs2446066	0.998186251598715	Vertex-wise cortical surface area	2e-13	34910505
rs2460882	rs2446066	0.998186251598715	Red blood cell count	1e-10	27863252
rs2460882	rs2446066	0.998186251598715	Cortical surface area	3e-08	34560273
rs2460882	rs2608301	0.998186251598715	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2460882	rs10876448	0.997278539615478	Mean corpuscular hemoglobin	2e-16	32888493
rs2460882	rs10876448	0.997278539615478	Reticulocyte count	3e-18	32888494
rs2460882	rs10876448	0.997278539615478	Reticulocyte fraction of red cells	1e-10	32888494
rs2460882	rs12582170	0.96308865857094	Mean corpuscular volume	1e-21	27863252
rs2460882	rs12582170	0.96308865857094	Mean corpuscular hemoglobin	7e-37	32888493
rs2460882	rs12582170	0.96308865857094	Mean reticulocyte volume	2e-33	32888494
rs2460882	rs12582170	0.96308865857094	Mean corpuscular volume	1e-67	32888493
rs2460882	rs12582170	0.96308865857094	Mean corpuscular hemoglobin	2e-21	32888494
rs2460882	rs12582170	0.96308865857094	Mean corpuscular volume	1e-26	34104963
rs2460882	rs111379945	0.764700078020799	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2460882	rs111379945	0.764700078020799	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2460882	rs111379945	0.764700078020799	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2460882	rs79205721	0.616188890445325	Vertex-wise cortical thickness	2e-09	34910505
rs2462022	rs1332618	0.960238681997078	Platelet count	4e-15	32888494
rs2462022	rs2795857	0.733767188242164	Height	2e-123	36224396
rs2462022	rs2462017	0.718568682721658	Lymphocyte count	3e-12	32888493
rs2462022	rs2488010	0.709242630415958	Monocyte count	9e-16	32888493
rs2462022	rs2462021	0.708581630557895	Suicide risk	8e-06	21041247
rs2462022	rs2795863	0.695512771506805	Height	3e-20	36224396
rs2462022	rs503598	0.676511925101617	White blood cell count	2e-08	30595370
rs2462022	rs2689216	0.666698748702912	Platelet count	2e-22	32888493
rs2462022	rs2689216	0.666698748702912	Platelet count	1e-21	32888493
rs2462022	rs1571956	0.65184707115818	Neutrophil count	1e-11	32888493
rs2462022	rs2482820	0.647002575189455	Monocyte count	9e-13	32888494
rs2462022	rs2482819	0.644487673341413	Neutrophil count	4e-10	32888493
rs2470523	rs4465929	0.861922983561748	Type 2 diabetes	5e-11	32541925
rs2470523	rs4685260	0.8559431110599	Body mass index	4e-09	30595370
rs2470523	rs2470538	0.843888382041583	Body mass index	3e-08	36581621
rs2470523	rs2470548	0.7995266209215	Mean platelet volume	4e-12	32888494
rs2470523	rs2255248	0.789047468875548	Body mass index (MTAG)	8e-10	36376304
rs2470523	rs2455793	0.639332635792285	Body mass index	1e-09	30239722
rs2470523	rs2455793	0.639332635792285	Body mass index	2e-09	31669095
rs2470523	rs924753	0.621379534351245	Type 2 diabetes	1e-11	32541925
rs2474765	rs2257649	0.900902440878927	Total Phosphatidylglycerol levels	3e-10	35668104
rs2474765	rs4815400	0.895831743942353	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs2474765	rs6037062	0.750598140078469	Lung function (forced vital capacity)	3e-13	36914875
rs2474765	rs6037062	0.750598140078469	Lung function (FVC)	5e-12	30595370
rs2474765	rs2273473	0.705167637378615	Vertex-wise cortical thickness	1e-12	34910505
rs2474765	rs6050463	0.673175572024427	Low density lipoprotein cholesterol levels	6e-09	32154731
rs2474765	rs6050463	0.673175572024427	LDL cholesterol levels	2e-09	32203549
rs2474765	rs6115094	0.673175572024427	Brain morphology (MOSTest)	1e-08	32665545
rs2474765	rs6115094	0.673175572024427	Non-HDL cholesterol levels	3e-09	34887591
rs2474765	rs8115257	0.639600340633974	Total cholesterol levels	2e-09	34887591
rs2474765	rs8115257	0.639600340633974	Low density lipoprotein cholesterol levels	1e-10	34887591
rs2474765	rs2500430	0.603319763316346	Serum alkaline phosphatase levels	7e-10	31666285
rs2474767	rs2257649	0.905861612846574	Total Phosphatidylglycerol levels	3e-10	35668104
rs2474767	rs4815400	0.900775669552584	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs2474767	rs6037062	0.75538209209769	Lung function (forced vital capacity)	3e-13	36914875
rs2474767	rs6037062	0.75538209209769	Lung function (FVC)	5e-12	30595370
rs2474767	rs2273473	0.700880483113216	Vertex-wise cortical thickness	1e-12	34910505
rs2474767	rs6050463	0.671811994662003	Low density lipoprotein cholesterol levels	6e-09	32154731
rs2474767	rs6050463	0.671811994662003	LDL cholesterol levels	2e-09	32203549
rs2474767	rs6115094	0.671811994662003	Brain morphology (MOSTest)	1e-08	32665545
rs2474767	rs6115094	0.671811994662003	Non-HDL cholesterol levels	3e-09	34887591
rs2474767	rs8115257	0.635583511210574	Total cholesterol levels	2e-09	34887591
rs2474767	rs8115257	0.635583511210574	Low density lipoprotein cholesterol levels	1e-10	34887591
rs2474767	rs2500430	0.60778467612083	Serum alkaline phosphatase levels	7e-10	31666285
rs2474780	rs2257649	0.994631863216235	Total Phosphatidylglycerol levels	3e-10	35668104
rs2474780	rs4815400	0.994631045543332	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs2474780	rs6037062	0.678368362087773	Lung function (forced vital capacity)	3e-13	36914875
rs2474780	rs6037062	0.678368362087773	Lung function (FVC)	5e-12	30595370
rs2474780	rs2500430	0.656887131641887	Serum alkaline phosphatase levels	7e-10	31666285
rs2474780	rs2273473	0.624386308398252	Vertex-wise cortical thickness	1e-12	34910505
rs2474780	rs2856	0.600676759317941	Blood protein levels	6e-07	27532455
rs2477507	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2477507	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2477507	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2477507	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2477507	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2477507	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2477507	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2477507	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2477507	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2477507	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2477507	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2477507	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2477507	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2477507	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2477507	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2477507	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2477507	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2477507	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2477507	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2477507	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2477507	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2477507	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2477507	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2477507	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2477507	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2477507	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2477507	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2477507	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2477507	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2477507	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2477507	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2477507	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2477507	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2477507	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2477507	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2477507	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2477507	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2477507	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2477507	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2477507	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2477507	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2477507	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2477507	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2477507	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2477507	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2477507	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2477507	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2477507	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2477507	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2477507	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2477507	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2477507	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2477507	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2477507	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2477507	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2477507	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2477507	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2477507	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2477507	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2477507	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2477507	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2477507	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2477507	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2477507	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2477507	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2477507	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2477507	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2477507	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2477508	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2477508	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2477508	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2477508	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2477508	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2477508	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2477508	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2477508	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2477508	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2477508	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2477508	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2477508	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2477508	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2477508	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2477508	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2477508	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2477508	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2477508	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2477508	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2477508	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2477508	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2477508	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2477508	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2477508	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2477508	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2477508	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2477508	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2477508	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2477508	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2477508	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2477508	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2477508	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2477508	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2477508	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2477508	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2477508	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2477508	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2477508	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2477508	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2477508	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2477508	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2477508	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2477508	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2477508	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2477508	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2477508	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2477508	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2477508	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2477508	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2477508	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2477508	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2477508	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2477508	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2477508	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2477508	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2477508	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2477508	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2477508	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2477508	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2477508	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2477508	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2477508	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2477508	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2477508	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2477508	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2477508	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2477508	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2477508	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2482820	rs2482820	1	Monocyte count	9e-13	32888494
rs2482820	rs2482819	0.99663726061012	Neutrophil count	4e-10	32888493
rs2482820	rs1571956	0.984059709108457	Neutrophil count	1e-11	32888493
rs2482820	rs2689216	0.946862476557127	Platelet count	2e-22	32888493
rs2482820	rs2689216	0.946862476557127	Platelet count	1e-21	32888493
rs2482820	rs2795863	0.907842395799845	Height	3e-20	36224396
rs2482820	rs2488010	0.857442536736053	Monocyte count	9e-16	32888493
rs2482820	rs2462021	0.856681219429101	Suicide risk	8e-06	21041247
rs2482820	rs2462017	0.838612220552192	Lymphocyte count	3e-12	32888493
rs2482820	rs503598	0.801563499529973	White blood cell count	2e-08	30595370
rs2482820	rs2795857	0.685877146667382	Height	2e-123	36224396
rs2482820	rs1332618	0.667112353643111	Platelet count	4e-15	32888494
rs2482820	rs2091084	0.642076839966318	White blood cell count	6e-19	32888493
rs2482820	rs2091084	0.642076839966318	Lymphocyte count	3e-10	32888494
rs2482820	rs2091084	0.642076839966318	White blood cell count	4e-13	32888494
rs2482825	rs2795857	0.971333784168011	Height	2e-123	36224396
rs2482825	rs2462017	0.785543545646549	Lymphocyte count	3e-12	32888493
rs2482825	rs1332618	0.776812607600062	Platelet count	4e-15	32888494
rs2482825	rs2488010	0.776643247857687	Monocyte count	9e-16	32888493
rs2482825	rs2462021	0.775907262206602	Suicide risk	8e-06	21041247
rs2482825	rs2795863	0.756170002551575	Height	3e-20	36224396
rs2482825	rs503598	0.741517363768211	White blood cell count	2e-08	30595370
rs2482825	rs2689216	0.723081332565485	Platelet count	2e-22	32888493
rs2482825	rs2689216	0.723081332565485	Platelet count	1e-21	32888493
rs2482825	rs1571956	0.702580291867264	Neutrophil count	1e-11	32888493
rs2482825	rs2482820	0.694883538358503	Monocyte count	9e-13	32888494
rs2482825	rs2482819	0.692115357501564	Neutrophil count	4e-10	32888493
rs2482825	rs2091084	0.653655398068487	White blood cell count	6e-19	32888493
rs2482825	rs2091084	0.653655398068487	Lymphocyte count	3e-10	32888494
rs2482825	rs2091084	0.653655398068487	White blood cell count	4e-13	32888494
rs2482825	rs2462015	0.608344991941852	White blood cell count	5e-17	32888493
rs2482828	rs1332618	0.870474721384774	Platelet count	4e-15	32888494
rs2482828	rs2795857	0.796113931086365	Height	2e-123	36224396
rs2482828	rs2462017	0.643297779682176	Lymphocyte count	3e-12	32888493
rs2482828	rs2488010	0.635542003118947	Monocyte count	9e-16	32888493
rs2482828	rs2462021	0.634896872810033	Suicide risk	8e-06	21041247
rs2482828	rs2795863	0.629825702021832	Height	3e-20	36224396
rs2482828	rs503598	0.611350273675902	White blood cell count	2e-08	30595370
rs2482828	rs2689216	0.603724291579577	Platelet count	2e-22	32888493
rs2482828	rs2689216	0.603724291579577	Platelet count	1e-21	32888493
rs2482911	rs11087521	0.887902614668885	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2482911	rs59934506	0.86934359497789	Body fat percentage	4e-16	33980691
rs2482911	rs59934506	0.86934359497789	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2482911	rs59934506	0.86934359497789	Alanine aminotransferase levels	2e-10	33980691
rs2482911	rs2424698	0.855779588438699	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2482911	rs2424698	0.855779588438699	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2482911	rs2424698	0.855779588438699	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2482911	rs2424698	0.855779588438699	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2482911	rs2424698	0.855779588438699	C-reactive protein	5e-11	34594039
rs2482911	rs7267979	0.855582755890214	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2482911	rs2151144	0.853597257308151	wg lh intensity-contrast fusiform	5e-12	33875891
rs2482911	rs2151144	0.853597257308151	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2482911	rs2151144	0.853597257308151	wg rh intensity-contrast insula	6e-18	33875891
rs2482911	rs2151144	0.853597257308151	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2482911	rs2151144	0.853597257308151	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2482911	rs2151144	0.853597257308151	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2482911	rs6083838	0.850189316543984	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2482911	rs6083838	0.850189316543984	wg lh intensity-contrast insula	6e-13	33875891
rs2482911	rs7020	0.849269663220769	wg rh intensity-contrast fusiform	1e-10	33875891
rs2482911	rs7020	0.849269663220769	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2482911	rs7020	0.849269663220769	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2482911	rs7020	0.849269663220769	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2482911	rs7274104	0.829024778485518	Cortical thickness	4e-08	34560273
rs2482911	rs6115101	0.811046630463783	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2482911	rs6115101	0.811046630463783	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2482911	rs6115101	0.811046630463783	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2482911	rs6115118	0.811046630463783	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2482911	rs6138553	0.810298816872542	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2482911	rs6115200	0.808468922020439	Height	9e-09	36224396
rs2482911	rs6115204	0.805590109532413	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2482911	rs6115099	0.805479467566256	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2482911	rs6138556	0.799160280828504	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2482911	rs6083799	0.786434467516414	Serum alkaline phosphatase levels	1e-71	33547301
rs2482911	rs2261795	0.769011624542181	Non-HDL cholesterol levels	1e-09	34887591
rs2482911	rs84816	0.768504782598772	aseg rh intensity Caudate	7e-09	33875891
rs2482911	rs84816	0.768504782598772	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2482911	rs4815412	0.766865942361776	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2482911	rs12428	0.764395063570626	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2482911	rs2500406	0.759444331424572	Brain region volumes	2e-08	31676860
rs2482911	rs2500406	0.759444331424572	Height	1e-33	36224396
rs2482911	rs2856	0.75676747740544	Blood protein levels	6e-07	27532455
rs2482911	rs6132824	0.738716661986784	Multi-trait sum score	5e-08	37277458
rs2482911	rs11699953	0.738031861495046	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2482911	rs8184820	0.735966603125621	Brain morphology (MOSTest)	4e-13	35164939
rs2482911	rs9927	0.716251070385913	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2482911	rs3746337	0.692655969666814	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2482911	rs3746337	0.692655969666814	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2482911	rs3746337	0.692655969666814	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2482911	rs3746337	0.692655969666814	Total cholesterol levels	3e-09	34887591
rs2482911	rs2500430	0.688557488585385	Serum alkaline phosphatase levels	7e-10	31666285
rs2482911	rs1888995	0.682032019735885	Weight	2e-11	34594039
rs2482911	rs6050464	0.677046093029646	Brain region volumes	5e-09	31676860
rs2482911	rs6050464	0.677046093029646	Apolipoprotein B levels	6e-14	32203549
rs2482911	rs2260997	0.66229930826586	Subcortical volume (MOSTest)	4e-09	32665545
rs2482911	rs2260997	0.66229930826586	Platelet distribution width	5e-17	32888494
rs2482918	rs11087521	0.887186854687084	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2482918	rs59934506	0.867058001222087	Body fat percentage	4e-16	33980691
rs2482918	rs59934506	0.867058001222087	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2482918	rs59934506	0.867058001222087	Alanine aminotransferase levels	2e-10	33980691
rs2482918	rs7267979	0.854792190033957	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2482918	rs2151144	0.854280898125979	wg lh intensity-contrast fusiform	5e-12	33875891
rs2482918	rs2151144	0.854280898125979	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2482918	rs2151144	0.854280898125979	wg rh intensity-contrast insula	6e-18	33875891
rs2482918	rs2151144	0.854280898125979	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2482918	rs2151144	0.854280898125979	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2482918	rs2151144	0.854280898125979	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2482918	rs2424698	0.853597184243981	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2482918	rs2424698	0.853597184243981	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2482918	rs2424698	0.853597184243981	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2482918	rs2424698	0.853597184243981	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2482918	rs2424698	0.853597184243981	C-reactive protein	5e-11	34594039
rs2482918	rs6083838	0.849394336130677	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2482918	rs6083838	0.849394336130677	wg lh intensity-contrast insula	6e-13	33875891
rs2482918	rs7020	0.848484549707691	wg rh intensity-contrast fusiform	1e-10	33875891
rs2482918	rs7020	0.848484549707691	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2482918	rs7020	0.848484549707691	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2482918	rs7020	0.848484549707691	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2482918	rs7274104	0.82680755918585	Cortical thickness	4e-08	34560273
rs2482918	rs6115101	0.808913505604549	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2482918	rs6115101	0.808913505604549	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2482918	rs6115101	0.808913505604549	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2482918	rs6115118	0.808913505604549	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2482918	rs6138553	0.808166474569636	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2482918	rs6115200	0.807761870927316	Height	9e-09	36224396
rs2482918	rs6115204	0.804884369023411	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2482918	rs6115099	0.80335548000142	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2482918	rs6138556	0.797039610257547	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2482918	rs6083799	0.785645176995553	Serum alkaline phosphatase levels	1e-71	33547301
rs2482918	rs84816	0.769126741341161	aseg rh intensity Caudate	7e-09	33875891
rs2482918	rs84816	0.769126741341161	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2482918	rs2261795	0.768222295806942	Non-HDL cholesterol levels	1e-09	34887591
rs2482918	rs4815412	0.766075298961379	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2482918	rs12428	0.765008436797432	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2482918	rs2500406	0.758835500047089	Brain region volumes	2e-08	31676860
rs2482918	rs2500406	0.758835500047089	Height	1e-33	36224396
rs2482918	rs2856	0.757373567845316	Blood protein levels	6e-07	27532455
rs2482918	rs6132824	0.73665940989546	Multi-trait sum score	5e-08	37277458
rs2482918	rs11699953	0.735975338560959	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2482918	rs8184820	0.733913234641979	Brain morphology (MOSTest)	4e-13	35164939
rs2482918	rs9927	0.71546515568146	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2482918	rs3746337	0.690665183648401	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2482918	rs3746337	0.690665183648401	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2482918	rs3746337	0.690665183648401	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2482918	rs3746337	0.690665183648401	Total cholesterol levels	3e-09	34887591
rs2482918	rs2500430	0.687771175491283	Serum alkaline phosphatase levels	7e-10	31666285
rs2482918	rs1888995	0.680129455838542	Weight	2e-11	34594039
rs2482918	rs6050464	0.676314470807181	Brain region volumes	5e-09	31676860
rs2482918	rs6050464	0.676314470807181	Apolipoprotein B levels	6e-14	32203549
rs2482918	rs2260997	0.661614912034225	Subcortical volume (MOSTest)	4e-09	32665545
rs2482918	rs2260997	0.661614912034225	Platelet distribution width	5e-17	32888494
rs2482937	rs11087521	0.884959385990416	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2482937	rs59934506	0.867754266275786	Body fat percentage	4e-16	33980691
rs2482937	rs59934506	0.867754266275786	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2482937	rs59934506	0.867754266275786	Alanine aminotransferase levels	2e-10	33980691
rs2482937	rs2424698	0.855876270187637	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2482937	rs2424698	0.855876270187637	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2482937	rs2424698	0.855876270187637	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2482937	rs2424698	0.855876270187637	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2482937	rs2424698	0.855876270187637	C-reactive protein	5e-11	34594039
rs2482937	rs7267979	0.855481709878106	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2482937	rs2151144	0.852007727721538	wg lh intensity-contrast fusiform	5e-12	33875891
rs2482937	rs2151144	0.852007727721538	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2482937	rs2151144	0.852007727721538	wg rh intensity-contrast insula	6e-18	33875891
rs2482937	rs2151144	0.852007727721538	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2482937	rs2151144	0.852007727721538	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2482937	rs2151144	0.852007727721538	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2482937	rs7020	0.849173926484684	wg rh intensity-contrast fusiform	1e-10	33875891
rs2482937	rs7020	0.849173926484684	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2482937	rs7020	0.849173926484684	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2482937	rs7020	0.849173926484684	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2482937	rs6083838	0.848600027319046	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2482937	rs6083838	0.848600027319046	wg lh intensity-contrast insula	6e-13	33875891
rs2482937	rs7274104	0.828957084991951	Cortical thickness	4e-08	34560273
rs2482937	rs6115118	0.812562772140482	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2482937	rs6115101	0.811116026134744	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2482937	rs6115101	0.811116026134744	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2482937	rs6115101	0.811116026134744	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2482937	rs6138553	0.810367624745255	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2482937	rs6115200	0.805616674560336	Height	9e-09	36224396
rs2482937	rs6115099	0.80555346169725	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2482937	rs6115204	0.804179220176433	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2482937	rs6138556	0.799220340485042	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2482937	rs6083799	0.786277937415754	Serum alkaline phosphatase levels	1e-71	33547301
rs2482937	rs2261795	0.770248599330193	Non-HDL cholesterol levels	1e-09	34887591
rs2482937	rs4815412	0.769504947563561	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2482937	rs84816	0.766936501581836	aseg rh intensity Caudate	7e-09	33875891
rs2482937	rs84816	0.766936501581836	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2482937	rs12428	0.764217813797733	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2482937	rs2500406	0.758227177089067	Brain region volumes	2e-08	31676860
rs2482937	rs2500406	0.758227177089067	Height	1e-33	36224396
rs2482937	rs2856	0.756581809208987	Blood protein levels	6e-07	27532455
rs2482937	rs6132824	0.73872838807191	Multi-trait sum score	5e-08	37277458
rs2482937	rs11699953	0.738043055269525	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2482937	rs8184820	0.737352754598978	Brain morphology (MOSTest)	4e-13	35164939
rs2482937	rs9927	0.718770429993143	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2482937	rs3746337	0.69266997140959	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2482937	rs3746337	0.69266997140959	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2482937	rs3746337	0.69266997140959	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2482937	rs3746337	0.69266997140959	Total cholesterol levels	3e-09	34887591
rs2482937	rs2500430	0.689665317635211	Serum alkaline phosphatase levels	7e-10	31666285
rs2482937	rs1888995	0.680939841071844	Weight	2e-11	34594039
rs2482937	rs6050464	0.678222615523304	Brain region volumes	5e-09	31676860
rs2482937	rs6050464	0.678222615523304	Apolipoprotein B levels	6e-14	32203549
rs2482937	rs2260997	0.663534826330257	Subcortical volume (MOSTest)	4e-09	32665545
rs2482937	rs2260997	0.663534826330257	Platelet distribution width	5e-17	32888494
rs2487757	rs770199	0.879717140817735	Hair color	3e-08	30595370
rs2487758	rs770199	0.879717140817735	Hair color	3e-08	30595370
rs2488003	rs1332618	0.985539188252627	Platelet count	4e-15	32888494
rs2488003	rs2795857	0.755492436575832	Height	2e-123	36224396
rs2488003	rs2462017	0.741797852198726	Lymphocyte count	3e-12	32888493
rs2488003	rs2488010	0.733736842501387	Monocyte count	9e-16	32888493
rs2488003	rs2462021	0.733061768361694	Suicide risk	8e-06	21041247
rs2488003	rs2795863	0.716946257585062	Height	3e-20	36224396
rs2488003	rs503598	0.70030258404478	White blood cell count	2e-08	30595370
rs2488003	rs2689216	0.68766212407517	Platelet count	2e-22	32888493
rs2488003	rs2689216	0.68766212407517	Platelet count	1e-21	32888493
rs2488003	rs1571956	0.671206660915608	Neutrophil count	1e-11	32888493
rs2488003	rs2482820	0.662141502766272	Monocyte count	9e-13	32888494
rs2488003	rs2482819	0.659589782215445	Neutrophil count	4e-10	32888493
rs2488004	rs2795857	0.963977070885766	Height	2e-123	36224396
rs2488004	rs2462017	0.765995461949472	Lymphocyte count	3e-12	32888493
rs2488004	rs2488010	0.757094715598015	Monocyte count	9e-16	32888493
rs2488004	rs2462021	0.756360344328132	Suicide risk	8e-06	21041247
rs2488004	rs1332618	0.753682081428107	Platelet count	4e-15	32888494
rs2488004	rs2795863	0.735687395828107	Height	3e-20	36224396
rs2488004	rs503598	0.722008258311392	White blood cell count	2e-08	30595370
rs2488004	rs2689216	0.701642908970773	Platelet count	2e-22	32888493
rs2488004	rs2689216	0.701642908970773	Platelet count	1e-21	32888493
rs2488004	rs1571956	0.688478553304822	Neutrophil count	1e-11	32888493
rs2488004	rs2482820	0.679516591063943	Monocyte count	9e-13	32888494
rs2488004	rs2482819	0.676748996853757	Neutrophil count	4e-10	32888493
rs2488004	rs2091084	0.633406556534076	White blood cell count	6e-19	32888493
rs2488004	rs2091084	0.633406556534076	Lymphocyte count	3e-10	32888494
rs2488004	rs2091084	0.633406556534076	White blood cell count	4e-13	32888494
rs2492860	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2492860	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2492860	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2492860	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2492860	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2492860	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2492860	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2492860	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2492860	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2492860	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2492860	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2492860	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2492860	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2492860	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2492860	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2492860	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2492860	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2492860	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2492860	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2492860	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2492860	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2492860	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2492860	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2492860	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2492860	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2492860	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2492860	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2492860	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2492860	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2492860	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2492860	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2492860	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2492860	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2492860	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2492860	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2492860	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2492860	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2492860	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2492860	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2492860	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2492860	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2492860	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2492860	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2492860	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2492860	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2492860	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2492860	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2492860	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2492860	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2492860	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2492860	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2492860	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2492860	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2492860	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2492860	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2492860	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2492860	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2492860	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2492860	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2492860	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2492860	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2492860	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2492860	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2492860	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2492860	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2492860	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2492860	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2492860	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2492861	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2492861	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2492861	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2492861	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2492861	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2492861	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2492861	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2492861	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2492861	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2492861	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2492861	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2492861	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2492861	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2492861	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2492861	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2492861	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2492861	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2492861	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2492861	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2492861	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2492861	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2492861	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2492861	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2492861	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2492861	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2492861	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2492861	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2492861	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2492861	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2492861	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2492861	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2492861	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2492861	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2492861	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2492861	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2492861	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2492861	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2492861	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2492861	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2492861	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2492861	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2492861	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2492861	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2492861	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2492861	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2492861	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2492861	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2492861	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2492861	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2492861	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2492861	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2492861	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2492861	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2492861	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2492861	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2492861	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2492861	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2492861	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2492861	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2492861	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2492861	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2492861	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2492861	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2492861	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2492861	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2492861	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2492861	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2492861	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2500400	rs11087521	0.842473644875337	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2500400	rs6083799	0.825814808845161	Serum alkaline phosphatase levels	1e-71	33547301
rs2500400	rs59934506	0.820534082558018	Body fat percentage	4e-16	33980691
rs2500400	rs59934506	0.820534082558018	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2500400	rs59934506	0.820534082558018	Alanine aminotransferase levels	2e-10	33980691
rs2500400	rs2424698	0.820322256412216	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2500400	rs2424698	0.820322256412216	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2500400	rs2424698	0.820322256412216	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2500400	rs2424698	0.820322256412216	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2500400	rs2424698	0.820322256412216	C-reactive protein	5e-11	34594039
rs2500400	rs2261795	0.807466481397793	Non-HDL cholesterol levels	1e-09	34887591
rs2500400	rs7267979	0.807047207545951	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2500400	rs4815412	0.805135549545064	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2500400	rs2151144	0.80335065993865	wg lh intensity-contrast fusiform	5e-12	33875891
rs2500400	rs2151144	0.80335065993865	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2500400	rs2151144	0.80335065993865	wg rh intensity-contrast insula	6e-18	33875891
rs2500400	rs2151144	0.80335065993865	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2500400	rs2151144	0.80335065993865	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2500400	rs2151144	0.80335065993865	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2500400	rs12428	0.801102119351426	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2500400	rs7020	0.801068938982472	wg rh intensity-contrast fusiform	1e-10	33875891
rs2500400	rs7020	0.801068938982472	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2500400	rs7020	0.801068938982472	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2500400	rs7020	0.801068938982472	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2500400	rs6083838	0.799953757253362	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2500400	rs6083838	0.799953757253362	wg lh intensity-contrast insula	6e-13	33875891
rs2500400	rs2856	0.793017292901349	Blood protein levels	6e-07	27532455
rs2500400	rs7274104	0.790744405351875	Cortical thickness	4e-08	34560273
rs2500400	rs6115101	0.775829168321108	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2500400	rs6115101	0.775829168321108	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2500400	rs6115101	0.775829168321108	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2500400	rs6115118	0.775829168321108	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2500400	rs6138553	0.775081749822106	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2500400	rs6115099	0.770520988826377	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2500400	rs6138556	0.763949600891772	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2500400	rs6115200	0.763653822781397	Height	9e-09	36224396
rs2500400	rs6115204	0.762255379261042	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2500400	rs9927	0.752093462596759	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2500400	rs2500430	0.722916144338845	Serum alkaline phosphatase levels	7e-10	31666285
rs2500400	rs2500406	0.720676715795368	Brain region volumes	2e-08	31676860
rs2500400	rs2500406	0.720676715795368	Height	1e-33	36224396
rs2500400	rs84816	0.719006766226054	aseg rh intensity Caudate	7e-09	33875891
rs2500400	rs84816	0.719006766226054	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2500400	rs6132824	0.704868497588115	Multi-trait sum score	5e-08	37277458
rs2500400	rs11699953	0.704183795891948	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2500400	rs8184820	0.702184361112583	Brain morphology (MOSTest)	4e-13	35164939
rs2500400	rs2260997	0.688828776795652	Subcortical volume (MOSTest)	4e-09	32665545
rs2500400	rs2260997	0.688828776795652	Platelet distribution width	5e-17	32888494
rs2500400	rs3746337	0.65995911851831	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2500400	rs3746337	0.65995911851831	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2500400	rs3746337	0.65995911851831	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2500400	rs3746337	0.65995911851831	Total cholesterol levels	3e-09	34887591
rs2500400	rs1888995	0.647160918758311	Weight	2e-11	34594039
rs2500400	rs6050464	0.63983805765889	Brain region volumes	5e-09	31676860
rs2500400	rs6050464	0.63983805765889	Apolipoprotein B levels	6e-14	32203549
rs2500401	rs11087521	0.885591829866678	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2500401	rs59934506	0.868647252501822	Body fat percentage	4e-16	33980691
rs2500401	rs59934506	0.868647252501822	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2500401	rs59934506	0.868647252501822	Alanine aminotransferase levels	2e-10	33980691
rs2500401	rs2424698	0.854987814616746	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2500401	rs2424698	0.854987814616746	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2500401	rs2424698	0.854987814616746	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2500401	rs2424698	0.854987814616746	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2500401	rs2424698	0.854987814616746	C-reactive protein	5e-11	34594039
rs2500401	rs7267979	0.854893720965013	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2500401	rs2151144	0.851436530214229	wg lh intensity-contrast fusiform	5e-12	33875891
rs2500401	rs2151144	0.851436530214229	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2500401	rs2151144	0.851436530214229	wg rh intensity-contrast insula	6e-18	33875891
rs2500401	rs2151144	0.851436530214229	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2500401	rs2151144	0.851436530214229	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2500401	rs2151144	0.851436530214229	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2500401	rs7020	0.848580769090853	wg rh intensity-contrast fusiform	1e-10	33875891
rs2500401	rs7020	0.848580769090853	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2500401	rs7020	0.848580769090853	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2500401	rs7020	0.848580769090853	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2500401	rs6083838	0.848034164021757	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2500401	rs6083838	0.848034164021757	wg lh intensity-contrast insula	6e-13	33875891
rs2500401	rs7274104	0.828330904873642	Cortical thickness	4e-08	34560273
rs2500401	rs6115101	0.810289440449206	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2500401	rs6115101	0.810289440449206	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2500401	rs6115101	0.810289440449206	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2500401	rs6115118	0.810289440449206	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2500401	rs6138553	0.809542278959964	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2500401	rs6115200	0.806296442442829	Height	9e-09	36224396
rs2500401	rs6115204	0.804858305948032	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2500401	rs6115099	0.804722256817177	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2500401	rs6138556	0.798413456453686	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2500401	rs6083799	0.785802128407074	Serum alkaline phosphatase levels	1e-71	33547301
rs2500401	rs2261795	0.768393846970778	Non-HDL cholesterol levels	1e-09	34887591
rs2500401	rs84816	0.766477952042645	aseg rh intensity Caudate	7e-09	33875891
rs2500401	rs84816	0.766477952042645	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2500401	rs4815412	0.766251059308048	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2500401	rs12428	0.762379309474734	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2500401	rs2500406	0.758637158492025	Brain region volumes	2e-08	31676860
rs2500401	rs2500406	0.758637158492025	Height	1e-33	36224396
rs2500401	rs2856	0.754765142962429	Blood protein levels	6e-07	27532455
rs2500401	rs6132824	0.738023148677841	Multi-trait sum score	5e-08	37277458
rs2500401	rs11699953	0.737338945536581	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2500401	rs8184820	0.735274333681176	Brain morphology (MOSTest)	4e-13	35164939
rs2500401	rs9927	0.715674451785121	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2500401	rs3746337	0.691983071985257	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2500401	rs3746337	0.691983071985257	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2500401	rs3746337	0.691983071985257	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2500401	rs3746337	0.691983071985257	Total cholesterol levels	3e-09	34887591
rs2500401	rs2500430	0.688004209775029	Serum alkaline phosphatase levels	7e-10	31666285
rs2500401	rs1888995	0.681221411968106	Weight	2e-11	34594039
rs2500401	rs6050464	0.676458509229755	Brain region volumes	5e-09	31676860
rs2500401	rs6050464	0.676458509229755	Apolipoprotein B levels	6e-14	32203549
rs2500401	rs2260997	0.661682266789619	Subcortical volume (MOSTest)	4e-09	32665545
rs2500401	rs2260997	0.661682266789619	Platelet distribution width	5e-17	32888494
rs2500430	rs2500430	1	Serum alkaline phosphatase levels	7e-10	31666285
rs2500430	rs6083799	0.87444823434992	Serum alkaline phosphatase levels	1e-71	33547301
rs2500430	rs2261795	0.85339825204479	Non-HDL cholesterol levels	1e-09	34887591
rs2500430	rs4815412	0.842602270532946	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2500430	rs12428	0.836493455488282	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2500430	rs2856	0.826203879844803	Blood protein levels	6e-07	27532455
rs2500430	rs7267979	0.801325812678665	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2500430	rs7020	0.796216265667506	wg rh intensity-contrast fusiform	1e-10	33875891
rs2500430	rs7020	0.796216265667506	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2500430	rs7020	0.796216265667506	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2500430	rs7020	0.796216265667506	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2500430	rs2151144	0.788387953205733	wg lh intensity-contrast fusiform	5e-12	33875891
rs2500430	rs2151144	0.788387953205733	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2500430	rs2151144	0.788387953205733	wg rh intensity-contrast insula	6e-18	33875891
rs2500430	rs2151144	0.788387953205733	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2500430	rs2151144	0.788387953205733	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2500430	rs2151144	0.788387953205733	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2500430	rs9927	0.786622688931334	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2500430	rs6083838	0.782999551593381	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2500430	rs6083838	0.782999551593381	wg lh intensity-contrast insula	6e-13	33875891
rs2500430	rs2260997	0.751250557147232	Subcortical volume (MOSTest)	4e-09	32665545
rs2500430	rs2260997	0.751250557147232	Platelet distribution width	5e-17	32888494
rs2500430	rs84816	0.691447119314122	aseg rh intensity Caudate	7e-09	33875891
rs2500430	rs84816	0.691447119314122	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2500430	rs4815400	0.654316174554683	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs2500430	rs2257649	0.653130610660174	Total Phosphatidylglycerol levels	3e-10	35668104
rs2500430	rs11087521	0.611610773628701	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2500430	rs6050464	0.60540416815876	Brain region volumes	5e-09	31676860
rs2500430	rs6050464	0.60540416815876	Apolipoprotein B levels	6e-14	32203549
rs2500430	rs2424698	0.604766601327107	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2500430	rs2424698	0.604766601327107	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2500430	rs2424698	0.604766601327107	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2500430	rs2424698	0.604766601327107	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2500430	rs2424698	0.604766601327107	C-reactive protein	5e-11	34594039
rs2500432	rs11087521	0.883284257491973	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2500432	rs59934506	0.863484800915169	Body fat percentage	4e-16	33980691
rs2500432	rs59934506	0.863484800915169	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2500432	rs59934506	0.863484800915169	Alanine aminotransferase levels	2e-10	33980691
rs2500432	rs7267979	0.861616512017724	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2500432	rs2424698	0.858662582245871	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2500432	rs2424698	0.858662582245871	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2500432	rs2424698	0.858662582245871	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2500432	rs2424698	0.858662582245871	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2500432	rs2424698	0.858662582245871	C-reactive protein	5e-11	34594039
rs2500432	rs7020	0.852318539622667	wg rh intensity-contrast fusiform	1e-10	33875891
rs2500432	rs7020	0.852318539622667	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2500432	rs7020	0.852318539622667	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2500432	rs7020	0.852318539622667	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2500432	rs2151144	0.847804255438228	wg lh intensity-contrast fusiform	5e-12	33875891
rs2500432	rs2151144	0.847804255438228	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2500432	rs2151144	0.847804255438228	wg rh intensity-contrast insula	6e-18	33875891
rs2500432	rs2151144	0.847804255438228	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2500432	rs2151144	0.847804255438228	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2500432	rs2151144	0.847804255438228	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2500432	rs6083838	0.84441030628224	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2500432	rs6083838	0.84441030628224	wg lh intensity-contrast insula	6e-13	33875891
rs2500432	rs7274104	0.83055080164442	Cortical thickness	4e-08	34560273
rs2500432	rs6115118	0.815322315503541	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2500432	rs6115101	0.813873011905745	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2500432	rs6115101	0.813873011905745	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2500432	rs6115101	0.813873011905745	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2500432	rs6138553	0.813124351136283	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2500432	rs6115099	0.808292116317157	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2500432	rs6115200	0.805564575763374	Height	9e-09	36224396
rs2500432	rs6115204	0.80412706677578	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2500432	rs6138556	0.801973173590496	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2500432	rs6083799	0.790865027510139	Serum alkaline phosphatase levels	1e-71	33547301
rs2500432	rs2261795	0.772002144546854	Non-HDL cholesterol levels	1e-09	34887591
rs2500432	rs4815412	0.765636646529068	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2500432	rs84816	0.764453971276313	aseg rh intensity Caudate	7e-09	33875891
rs2500432	rs84816	0.764453971276313	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2500432	rs12428	0.7603663893095	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2500432	rs2500406	0.755003021271188	Brain region volumes	2e-08	31676860
rs2500432	rs2500406	0.755003021271188	Height	1e-33	36224396
rs2500432	rs2856	0.75137204064328	Blood protein levels	6e-07	27532455
rs2500432	rs6132824	0.741461147277612	Multi-trait sum score	5e-08	37277458
rs2500432	rs11699953	0.740775552544526	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2500432	rs8184820	0.740082873609034	Brain morphology (MOSTest)	4e-13	35164939
rs2500432	rs9927	0.719190258956152	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2500432	rs3746337	0.696647016469058	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2500432	rs3746337	0.696647016469058	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2500432	rs3746337	0.696647016469058	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2500432	rs3746337	0.696647016469058	Total cholesterol levels	3e-09	34887591
rs2500432	rs2500430	0.69147459245562	Serum alkaline phosphatase levels	7e-10	31666285
rs2500432	rs6050464	0.679833121399532	Brain region volumes	5e-09	31676860
rs2500432	rs6050464	0.679833121399532	Apolipoprotein B levels	6e-14	32203549
rs2500432	rs1888995	0.679056227253602	Weight	2e-11	34594039
rs2500432	rs2260997	0.667585724775813	Subcortical volume (MOSTest)	4e-09	32665545
rs2500432	rs2260997	0.667585724775813	Platelet distribution width	5e-17	32888494
rs2500436	rs11087521	0.888701088665383	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2500436	rs59934506	0.868548595846372	Body fat percentage	4e-16	33980691
rs2500436	rs59934506	0.868548595846372	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2500436	rs59934506	0.868548595846372	Alanine aminotransferase levels	2e-10	33980691
rs2500436	rs2424698	0.855083932903559	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2500436	rs2424698	0.855083932903559	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2500436	rs2424698	0.855083932903559	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2500436	rs2424698	0.855083932903559	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2500436	rs2424698	0.855083932903559	C-reactive protein	5e-11	34594039
rs2500436	rs7267979	0.854792190033957	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2500436	rs2151144	0.854280898125979	wg lh intensity-contrast fusiform	5e-12	33875891
rs2500436	rs2151144	0.854280898125979	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2500436	rs2151144	0.854280898125979	wg rh intensity-contrast insula	6e-18	33875891
rs2500436	rs2151144	0.854280898125979	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2500436	rs2151144	0.854280898125979	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2500436	rs2151144	0.854280898125979	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2500436	rs6083838	0.849394336130677	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2500436	rs6083838	0.849394336130677	wg lh intensity-contrast insula	6e-13	33875891
rs2500436	rs7020	0.848484549707691	wg rh intensity-contrast fusiform	1e-10	33875891
rs2500436	rs7020	0.848484549707691	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2500436	rs7020	0.848484549707691	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2500436	rs7020	0.848484549707691	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2500436	rs7274104	0.828262731860052	Cortical thickness	4e-08	34560273
rs2500436	rs6115101	0.810358311969165	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2500436	rs6115101	0.810358311969165	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2500436	rs6115101	0.810358311969165	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2500436	rs6115118	0.810358311969165	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2500436	rs6138553	0.809610563400273	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2500436	rs6115200	0.809202547291579	Height	9e-09	36224396
rs2500436	rs6115204	0.806322478171259	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2500436	rs6115099	0.804795728057543	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2500436	rs6138556	0.798473003381694	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2500436	rs6083799	0.785645176995553	Serum alkaline phosphatase levels	1e-71	33547301
rs2500436	rs84816	0.769126741341161	aseg rh intensity Caudate	7e-09	33875891
rs2500436	rs84816	0.769126741341161	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2500436	rs2261795	0.768222295806942	Non-HDL cholesterol levels	1e-09	34887591
rs2500436	rs4815412	0.766075298961379	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2500436	rs12428	0.765008436797432	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2500436	rs2500406	0.758835500047089	Brain region volumes	2e-08	31676860
rs2500436	rs2500406	0.758835500047089	Height	1e-33	36224396
rs2500436	rs2856	0.757373567845316	Blood protein levels	6e-07	27532455
rs2500436	rs6132824	0.738034420621288	Multi-trait sum score	5e-08	37277458
rs2500436	rs11699953	0.737349685827585	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2500436	rs8184820	0.73528568123569	Brain morphology (MOSTest)	4e-13	35164939
rs2500436	rs9927	0.71546515568146	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2500436	rs3746337	0.691996647116792	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2500436	rs3746337	0.691996647116792	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2500436	rs3746337	0.691996647116792	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2500436	rs3746337	0.691996647116792	Total cholesterol levels	3e-09	34887591
rs2500436	rs2500430	0.687771175491283	Serum alkaline phosphatase levels	7e-10	31666285
rs2500436	rs1888995	0.681485702296275	Weight	2e-11	34594039
rs2500436	rs6050464	0.676314470807181	Brain region volumes	5e-09	31676860
rs2500436	rs6050464	0.676314470807181	Apolipoprotein B levels	6e-14	32203549
rs2500436	rs2260997	0.661614912034225	Subcortical volume (MOSTest)	4e-09	32665545
rs2500436	rs2260997	0.661614912034225	Platelet distribution width	5e-17	32888494
rs2500446	rs11087521	0.883448370635091	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs2500446	rs59934506	0.866264379550669	Body fat percentage	4e-16	33980691
rs2500446	rs59934506	0.866264379550669	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs2500446	rs59934506	0.866264379550669	Alanine aminotransferase levels	2e-10	33980691
rs2500446	rs2424698	0.855876270187637	wg lh intensity-contrast middletemporal	3e-13	33875891
rs2500446	rs2424698	0.855876270187637	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs2500446	rs2424698	0.855876270187637	wg rh intensity-contrast middletemporal	7e-13	33875891
rs2500446	rs2424698	0.855876270187637	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs2500446	rs2424698	0.855876270187637	C-reactive protein	5e-11	34594039
rs2500446	rs7267979	0.855481709878106	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs2500446	rs2151144	0.850530981627263	wg lh intensity-contrast fusiform	5e-12	33875891
rs2500446	rs2151144	0.850530981627263	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs2500446	rs2151144	0.850530981627263	wg rh intensity-contrast insula	6e-18	33875891
rs2500446	rs2151144	0.850530981627263	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs2500446	rs2151144	0.850530981627263	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs2500446	rs2151144	0.850530981627263	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs2500446	rs7020	0.849173926484684	wg rh intensity-contrast fusiform	1e-10	33875891
rs2500446	rs7020	0.849173926484684	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs2500446	rs7020	0.849173926484684	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs2500446	rs7020	0.849173926484684	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs2500446	rs6083838	0.847126132127779	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs2500446	rs6083838	0.847126132127779	wg lh intensity-contrast insula	6e-13	33875891
rs2500446	rs7274104	0.828957084991951	Cortical thickness	4e-08	34560273
rs2500446	rs6115118	0.812562772140482	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs2500446	rs6115101	0.811116026134744	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs2500446	rs6115101	0.811116026134744	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs2500446	rs6115101	0.811116026134744	wg rh intensity-contrast supramarginal	3e-11	33875891
rs2500446	rs6138553	0.810367624745255	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs2500446	rs6115099	0.80555346169725	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs2500446	rs6115200	0.804179220176433	Height	9e-09	36224396
rs2500446	rs6115204	0.802743049356195	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs2500446	rs6138556	0.799220340485042	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs2500446	rs6083799	0.786277937415754	Serum alkaline phosphatase levels	1e-71	33547301
rs2500446	rs2261795	0.770248599330193	Non-HDL cholesterol levels	1e-09	34887591
rs2500446	rs4815412	0.768097121454821	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs2500446	rs84816	0.765532094680832	aseg rh intensity Caudate	7e-09	33875891
rs2500446	rs84816	0.765532094680832	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs2500446	rs12428	0.762814637099551	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs2500446	rs2500406	0.756812441850547	Brain region volumes	2e-08	31676860
rs2500446	rs2500406	0.756812441850547	Height	1e-33	36224396
rs2500446	rs2856	0.755184786861092	Blood protein levels	6e-07	27532455
rs2500446	rs6132824	0.73872838807191	Multi-trait sum score	5e-08	37277458
rs2500446	rs11699953	0.738043055269525	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs2500446	rs8184820	0.737352754598978	Brain morphology (MOSTest)	4e-13	35164939
rs2500446	rs9927	0.718770429993143	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs2500446	rs3746337	0.69266997140959	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs2500446	rs3746337	0.69266997140959	wg lh intensity-contrast frontalpole	1e-09	33875891
rs2500446	rs3746337	0.69266997140959	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs2500446	rs3746337	0.69266997140959	Total cholesterol levels	3e-09	34887591
rs2500446	rs2500430	0.689665317635211	Serum alkaline phosphatase levels	7e-10	31666285
rs2500446	rs1888995	0.679584161672314	Weight	2e-11	34594039
rs2500446	rs6050464	0.678222615523304	Brain region volumes	5e-09	31676860
rs2500446	rs6050464	0.678222615523304	Apolipoprotein B levels	6e-14	32203549
rs2500446	rs2260997	0.663534826330257	Subcortical volume (MOSTest)	4e-09	32665545
rs2500446	rs2260997	0.663534826330257	Platelet distribution width	5e-17	32888494
rs2501965	rs1471539	0.997600451129997	Mean reticulocyte volume	1e-10	32888494
rs2501965	rs1471539	0.997600451129997	Mean spheric corpuscular volume	8e-13	32888494
rs2501965	rs2501968	0.995205781502464	Ischemic stroke	1e-08	34594039
rs2501965	rs9369898	0.831214257492971	Homocysteine levels	2e-10	23824729
rs2501968	rs2501968	1	Ischemic stroke	1e-08	34594039
rs2501968	rs1471539	0.997601571483327	Mean reticulocyte volume	1e-10	32888494
rs2501968	rs1471539	0.997601571483327	Mean spheric corpuscular volume	8e-13	32888494
rs2501968	rs9369898	0.831034440052992	Homocysteine levels	2e-10	23824729
rs250414	rs7721230	0.738047524287788	Skin color	4e-10	36672889
rs2505108	rs1332618	0.927235503361361	Platelet count	4e-15	32888494
rs2505108	rs2795857	0.738804669872894	Height	2e-123	36224396
rs2505108	rs2462017	0.718784992567769	Lymphocyte count	3e-12	32888493
rs2505108	rs2488010	0.71079341449039	Monocyte count	9e-16	32888493
rs2505108	rs2462021	0.710125177971031	Suicide risk	8e-06	21041247
rs2505108	rs2795863	0.697242134476183	Height	3e-20	36224396
rs2505108	rs503598	0.680461607124948	White blood cell count	2e-08	30595370
rs2505108	rs2689216	0.669763042347029	Platelet count	2e-22	32888493
rs2505108	rs2689216	0.669763042347029	Platelet count	1e-21	32888493
rs2505108	rs1571956	0.652241881917954	Neutrophil count	1e-11	32888493
rs2505108	rs2482820	0.648782059902474	Monocyte count	9e-13	32888494
rs2505108	rs2482819	0.646238689104912	Neutrophil count	4e-10	32888493
rs2505111	rs2462017	0.884802959785003	Lymphocyte count	3e-12	32888493
rs2505111	rs2795857	0.878074667134202	Height	2e-123	36224396
rs2505111	rs2488010	0.875492260002128	Monocyte count	9e-16	32888493
rs2505111	rs2462021	0.874720003274177	Suicide risk	8e-06	21041247
rs2505111	rs2795863	0.853360112988923	Height	3e-20	36224396
rs2505111	rs503598	0.838690103382694	White blood cell count	2e-08	30595370
rs2505111	rs1332618	0.818419151501141	Platelet count	4e-15	32888494
rs2505111	rs2689216	0.815085755756384	Platelet count	2e-22	32888493
rs2505111	rs2689216	0.815085755756384	Platelet count	1e-21	32888493
rs2505111	rs1571956	0.800593131534501	Neutrophil count	1e-11	32888493
rs2505111	rs2482820	0.790812344684628	Monocyte count	9e-13	32888494
rs2505111	rs2482819	0.78789222794043	Neutrophil count	4e-10	32888493
rs2505111	rs2091084	0.609810567984939	White blood cell count	6e-19	32888493
rs2505111	rs2091084	0.609810567984939	Lymphocyte count	3e-10	32888494
rs2505111	rs2091084	0.609810567984939	White blood cell count	4e-13	32888494
rs2507988	rs2596517	0.961803002899657	Hip circumference adjusted for BMI	7e-14	34021172
rs2507988	rs2596484	0.955770865302314	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs2507988	rs2523644	0.881752940760993	Myocardial infarction	5e-07	30226566
rs251339	rs2549794	0.877284030352632	Crohn's disease	1e-10	21102463
rs251339	rs2549794	0.877284030352632	Systolic blood pressure	1e-07	33230300
rs251339	rs2549794	0.877284030352632	Diastolic blood pressure	1e-15	33230300
rs251339	rs2549794	0.877284030352632	Diastolic blood pressure	2e-12	33230300
rs251339	rs2549794	0.877284030352632	Systolic blood pressure	4e-10	33230300
rs251339	rs716848	0.876081973098903	Neutrophil percentage of white cells	2e-09	32888494
rs251339	rs1363907	0.872310289958182	Crohn's disease	4e-16	26192919
rs251339	rs1363907	0.872310289958182	Ulcerative colitis	4e-06	26192919
rs251339	rs1363907	0.872310289958182	Inflammatory bowel disease	5e-15	26192919
rs251339	rs1363907	0.872310289958182	Inflammatory bowel disease	6e-13	23128233
rs251339	rs1363907	0.872310289958182	Inflammatory bowel disease	1e-10	28067908
rs251339	rs1363907	0.872310289958182	Crohn's disease	1e-14	28067908
rs251339	rs2617439	0.828776799714942	Neutrophil count	8e-11	32888494
rs251339	rs38029	0.817026477440176	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs251339	rs2548532	0.788307899716357	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs251339	rs2549782	0.726248581173856	Systolic blood pressure	6e-07	33230300
rs251339	rs2549782	0.726248581173856	Diastolic blood pressure	1e-14	33230300
rs251339	rs2549782	0.726248581173856	Diastolic blood pressure	3e-11	33230300
rs251339	rs2549782	0.726248581173856	Systolic blood pressure	5e-09	33230300
rs251339	rs2549797	0.724586823875399	Systolic blood pressure	7e-07	33230300
rs251339	rs2549797	0.724586823875399	Diastolic blood pressure	1e-14	33230300
rs251339	rs2549797	0.724586823875399	Diastolic blood pressure	3e-11	33230300
rs251339	rs2549797	0.724586823875399	Systolic blood pressure	4e-09	33230300
rs251339	rs1056893	0.722829197095183	Systolic blood pressure	1e-06	33230300
rs251339	rs1056893	0.722829197095183	Diastolic blood pressure	7e-15	33230300
rs251339	rs1056893	0.722829197095183	Diastolic blood pressure	2e-11	33230300
rs251339	rs1056893	0.722829197095183	Systolic blood pressure	7e-09	33230300
rs251339	rs27660	0.685677245389053	Coronary artery disease	3e-08	35915156
rs251339	rs1974871	0.672600242877769	Granulysin levels	5e-13	34648354
rs251339	rs1423357	0.658111570630694	General cognitive ability	9e-06	29844566
rs251339	rs2432142	0.644511852615395	Neutrophil count	2e-14	32888493
rs251339	rs2432142	0.644511852615395	White blood cell count	1e-11	32888493
rs251339	rs38033	0.641945028163577	Blood protein levels	0	30072576
rs251339	rs27293	0.634316071321372	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs251339	rs27293	0.634316071321372	Diastolic blood pressure	3e-11	35762941
rs251339	rs7705093	0.6247608740738	Birdshot chorioretinopathy	2e-09	24957906
rs251339	rs4869313	0.615084788398675	Pediatric autoimmune diseases	9e-08	26301688
rs251339	rs2927608	0.606920853896431	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs251339	rs2927608	0.606920853896431	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs251339	rs2927608	0.606920853896431	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs251339	rs2910686	0.604657752318867	Neutrophil count	4e-14	32888493
rs251339	rs2910686	0.604657752318867	Psoriasis	2e-08	23143594
rs251339	rs2910686	0.604657752318867	Ankylosing spondylitis	5e-17	23749187
rs251339	rs2910686	0.604657752318867	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs251340	rs2549794	0.999110315224948	Crohn's disease	1e-10	21102463
rs251340	rs2549794	0.999110315224948	Systolic blood pressure	1e-07	33230300
rs251340	rs2549794	0.999110315224948	Diastolic blood pressure	1e-15	33230300
rs251340	rs2549794	0.999110315224948	Diastolic blood pressure	2e-12	33230300
rs251340	rs2549794	0.999110315224948	Systolic blood pressure	4e-10	33230300
rs251340	rs1363907	0.993781103132944	Crohn's disease	4e-16	26192919
rs251340	rs1363907	0.993781103132944	Ulcerative colitis	4e-06	26192919
rs251340	rs1363907	0.993781103132944	Inflammatory bowel disease	5e-15	26192919
rs251340	rs1363907	0.993781103132944	Inflammatory bowel disease	6e-13	23128233
rs251340	rs1363907	0.993781103132944	Inflammatory bowel disease	1e-10	28067908
rs251340	rs1363907	0.993781103132944	Crohn's disease	1e-14	28067908
rs251340	rs2617439	0.945506755714289	Neutrophil count	8e-11	32888494
rs251340	rs716848	0.938428471012939	Neutrophil percentage of white cells	2e-09	32888494
rs251340	rs38029	0.933489306890891	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs251340	rs2548532	0.897778287225109	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs251340	rs27660	0.781515933672439	Coronary artery disease	3e-08	35915156
rs251340	rs1423357	0.768454437089007	General cognitive ability	9e-06	29844566
rs251340	rs2432142	0.753547568514724	Neutrophil count	2e-14	32888493
rs251340	rs2432142	0.753547568514724	White blood cell count	1e-11	32888493
rs251340	rs38033	0.751669770051801	Blood protein levels	0	30072576
rs251340	rs27293	0.743146509055169	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs251340	rs27293	0.743146509055169	Diastolic blood pressure	3e-11	35762941
rs251340	rs7705093	0.733658503692707	Birdshot chorioretinopathy	2e-09	24957906
rs251340	rs4869313	0.723478791353516	Pediatric autoimmune diseases	9e-08	26301688
rs251340	rs2927608	0.717377031537283	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs251340	rs2927608	0.717377031537283	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs251340	rs2927608	0.717377031537283	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs251340	rs2910686	0.715017291424976	Neutrophil count	4e-14	32888493
rs251340	rs2910686	0.715017291424976	Psoriasis	2e-08	23143594
rs251340	rs2910686	0.715017291424976	Ankylosing spondylitis	5e-17	23749187
rs251340	rs2910686	0.715017291424976	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs251340	rs1559359	0.654950385191935	Diastolic blood pressure	7e-10	34594039
rs251340	rs1974871	0.650000061828718	Granulysin levels	5e-13	34648354
rs251340	rs2549782	0.637693628642632	Systolic blood pressure	6e-07	33230300
rs251340	rs2549782	0.637693628642632	Diastolic blood pressure	1e-14	33230300
rs251340	rs2549782	0.637693628642632	Diastolic blood pressure	3e-11	33230300
rs251340	rs2549782	0.637693628642632	Systolic blood pressure	5e-09	33230300
rs251340	rs2549797	0.637370281415612	Systolic blood pressure	7e-07	33230300
rs251340	rs2549797	0.637370281415612	Diastolic blood pressure	1e-14	33230300
rs251340	rs2549797	0.637370281415612	Diastolic blood pressure	3e-11	33230300
rs251340	rs2549797	0.637370281415612	Systolic blood pressure	4e-09	33230300
rs251340	rs1056893	0.635825446775611	Systolic blood pressure	1e-06	33230300
rs251340	rs1056893	0.635825446775611	Diastolic blood pressure	7e-15	33230300
rs251340	rs1056893	0.635825446775611	Diastolic blood pressure	2e-11	33230300
rs251340	rs1056893	0.635825446775611	Systolic blood pressure	7e-09	33230300
rs251341	rs2549794	1	Crohn's disease	1e-10	21102463
rs251341	rs2549794	1	Systolic blood pressure	1e-07	33230300
rs251341	rs2549794	1	Diastolic blood pressure	1e-15	33230300
rs251341	rs2549794	1	Diastolic blood pressure	2e-12	33230300
rs251341	rs2549794	1	Systolic blood pressure	4e-10	33230300
rs251341	rs1363907	0.994668192117369	Crohn's disease	4e-16	26192919
rs251341	rs1363907	0.994668192117369	Ulcerative colitis	4e-06	26192919
rs251341	rs1363907	0.994668192117369	Inflammatory bowel disease	5e-15	26192919
rs251341	rs1363907	0.994668192117369	Inflammatory bowel disease	6e-13	23128233
rs251341	rs1363907	0.994668192117369	Inflammatory bowel disease	1e-10	28067908
rs251341	rs1363907	0.994668192117369	Crohn's disease	1e-14	28067908
rs251341	rs2617439	0.946359227117998	Neutrophil count	8e-11	32888494
rs251341	rs716848	0.939292694140925	Neutrophil percentage of white cells	2e-09	32888494
rs251341	rs38029	0.934339838530374	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs251341	rs2548532	0.898577738157948	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs251341	rs27660	0.782215834508668	Coronary artery disease	3e-08	35915156
rs251341	rs1423357	0.769261023230232	General cognitive ability	9e-06	29844566
rs251341	rs2432142	0.7543446728158	Neutrophil count	2e-14	32888493
rs251341	rs2432142	0.7543446728158	White blood cell count	1e-11	32888493
rs251341	rs38033	0.752472000190678	Blood protein levels	0	30072576
rs251341	rs27293	0.743942234032582	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs251341	rs27293	0.743942234032582	Diastolic blood pressure	3e-11	35762941
rs251341	rs7705093	0.734454866219682	Birdshot chorioretinopathy	2e-09	24957906
rs251341	rs4869313	0.724271578137786	Pediatric autoimmune diseases	9e-08	26301688
rs251341	rs2927608	0.718185251163119	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs251341	rs2927608	0.718185251163119	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs251341	rs2927608	0.718185251163119	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs251341	rs2910686	0.715824837135211	Neutrophil count	4e-14	32888493
rs251341	rs2910686	0.715824837135211	Psoriasis	2e-08	23143594
rs251341	rs2910686	0.715824837135211	Ankylosing spondylitis	5e-17	23749187
rs251341	rs2910686	0.715824837135211	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs251341	rs1559359	0.655723501015219	Diastolic blood pressure	7e-10	34594039
rs251341	rs1974871	0.650770503938115	Granulysin levels	5e-13	34648354
rs251341	rs2549797	0.638156925849082	Systolic blood pressure	7e-07	33230300
rs251341	rs2549797	0.638156925849082	Diastolic blood pressure	1e-14	33230300
rs251341	rs2549797	0.638156925849082	Diastolic blood pressure	3e-11	33230300
rs251341	rs2549797	0.638156925849082	Systolic blood pressure	4e-09	33230300
rs251341	rs2549782	0.637126282330081	Systolic blood pressure	6e-07	33230300
rs251341	rs2549782	0.637126282330081	Diastolic blood pressure	1e-14	33230300
rs251341	rs2549782	0.637126282330081	Diastolic blood pressure	3e-11	33230300
rs251341	rs2549782	0.637126282330081	Systolic blood pressure	5e-09	33230300
rs251341	rs1056893	0.636611651041898	Systolic blood pressure	1e-06	33230300
rs251341	rs1056893	0.636611651041898	Diastolic blood pressure	7e-15	33230300
rs251341	rs1056893	0.636611651041898	Diastolic blood pressure	2e-11	33230300
rs251341	rs1056893	0.636611651041898	Systolic blood pressure	7e-09	33230300
rs251343	rs1363907	0.997332496219044	Crohn's disease	4e-16	26192919
rs251343	rs1363907	0.997332496219044	Ulcerative colitis	4e-06	26192919
rs251343	rs1363907	0.997332496219044	Inflammatory bowel disease	5e-15	26192919
rs251343	rs1363907	0.997332496219044	Inflammatory bowel disease	6e-13	23128233
rs251343	rs1363907	0.997332496219044	Inflammatory bowel disease	1e-10	28067908
rs251343	rs1363907	0.997332496219044	Crohn's disease	1e-14	28067908
rs251343	rs2549794	0.997331737918692	Crohn's disease	1e-10	21102463
rs251343	rs2549794	0.997331737918692	Systolic blood pressure	1e-07	33230300
rs251343	rs2549794	0.997331737918692	Diastolic blood pressure	1e-15	33230300
rs251343	rs2549794	0.997331737918692	Diastolic blood pressure	2e-12	33230300
rs251343	rs2549794	0.997331737918692	Systolic blood pressure	4e-10	33230300
rs251343	rs2617439	0.943771304356488	Neutrophil count	8e-11	32888494
rs251343	rs716848	0.940144240899896	Neutrophil percentage of white cells	2e-09	32888494
rs251343	rs38029	0.931769910958928	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs251343	rs2548532	0.896061097153848	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs251343	rs27660	0.779874991921538	Coronary artery disease	3e-08	35915156
rs251343	rs1423357	0.766937563980367	General cognitive ability	9e-06	29844566
rs251343	rs2432142	0.75204577203976	Neutrophil count	2e-14	32888493
rs251343	rs2432142	0.75204577203976	White blood cell count	1e-11	32888493
rs251343	rs38033	0.750173438177283	Blood protein levels	0	30072576
rs251343	rs27293	0.741658287013036	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs251343	rs27293	0.741658287013036	Diastolic blood pressure	3e-11	35762941
rs251343	rs7705093	0.73218357345822	Birdshot chorioretinopathy	2e-09	24957906
rs251343	rs4869313	0.722015851981284	Pediatric autoimmune diseases	9e-08	26301688
rs251343	rs2927608	0.720277396715991	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs251343	rs2927608	0.720277396715991	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs251343	rs2927608	0.720277396715991	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs251343	rs2910686	0.71791209765445	Neutrophil count	4e-14	32888493
rs251343	rs2910686	0.71791209765445	Psoriasis	2e-08	23143594
rs251343	rs2910686	0.71791209765445	Ankylosing spondylitis	5e-17	23749187
rs251343	rs2910686	0.71791209765445	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs251343	rs1559359	0.653570456578247	Diastolic blood pressure	7e-10	34594039
rs251343	rs1974871	0.648625697307447	Granulysin levels	5e-13	34648354
rs251343	rs2549797	0.636016811494757	Systolic blood pressure	7e-07	33230300
rs251343	rs2549797	0.636016811494757	Diastolic blood pressure	1e-14	33230300
rs251343	rs2549797	0.636016811494757	Diastolic blood pressure	3e-11	33230300
rs251343	rs2549797	0.636016811494757	Systolic blood pressure	4e-09	33230300
rs251343	rs2549782	0.634987672644476	Systolic blood pressure	6e-07	33230300
rs251343	rs2549782	0.634987672644476	Diastolic blood pressure	1e-14	33230300
rs251343	rs2549782	0.634987672644476	Diastolic blood pressure	3e-11	33230300
rs251343	rs2549782	0.634987672644476	Systolic blood pressure	5e-09	33230300
rs251343	rs1056893	0.634473792683738	Systolic blood pressure	1e-06	33230300
rs251343	rs1056893	0.634473792683738	Diastolic blood pressure	7e-15	33230300
rs251343	rs1056893	0.634473792683738	Diastolic blood pressure	2e-11	33230300
rs251343	rs1056893	0.634473792683738	Systolic blood pressure	7e-09	33230300
rs2521989	rs409942	0.898489946195419	Total cholesterol levels	8e-06	35884923
rs2521989	rs739669	0.763011433072893	BMI at birth	5e-17	35315439
rs2521989	rs222837	0.710810739618933	Metabolite levels	7e-06	23823483
rs2521989	rs2654189	0.669901461668727	Eosinophil counts	4e-11	32888494
rs2521989	rs2654189	0.669901461668727	Eosinophil percentage of white cells	6e-12	32888494
rs2521989	rs2654189	0.669901461668727	Eosinophil counts	1e-09	30595370
rs2521989	rs5415	0.660008240922024	Birth weight	5e-06	23202124
rs2521989	rs5415	0.660008240922024	LDL cholesterol levels	1e-06	35884923
rs2521989	rs13331	0.634610355915839	Heel bone mineral density	4e-08	30595370
rs2521991	rs409942	0.72631921341597	Total cholesterol levels	8e-06	35884923
rs2521991	rs1475373485	0.644052258828111	Total cholesterol levels	7e-06	35884923
rs2523518	rs2596517	0.965721627483783	Hip circumference adjusted for BMI	7e-14	34021172
rs2523518	rs2596484	0.959664982892769	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs2523518	rs2523644	0.885420299413844	Myocardial infarction	5e-07	30226566
rs2523644	rs2523644	1	Myocardial infarction	5e-07	30226566
rs2523644	rs2596517	0.894693026421851	Hip circumference adjusted for BMI	7e-14	34021172
rs2523644	rs2596484	0.885402558903371	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs252888	rs832540	0.906894586013376	Coronary artery disease	2e-08	29212778
rs252888	rs33321	0.874337211809985	Height	1e-19	34594039
rs252888	rs10061757	0.71163923196408	Height	4e-30	30595370
rs252890	rs33321	0.911440148381543	Height	1e-19	34594039
rs252890	rs832540	0.857280842917323	Coronary artery disease	2e-08	29212778
rs252890	rs10061757	0.718059285816168	Height	4e-30	30595370
rs252890	rs96844	0.645679344152858	Type 2 diabetes	5e-08	30297969
rs252890	rs96844	0.645679344152858	Height	4e-33	36224396
rs252894	rs832540	0.899166769742762	Coronary artery disease	2e-08	29212778
rs252894	rs33321	0.866846718962365	Height	1e-19	34594039
rs252894	rs10061757	0.706394480845258	Height	4e-30	30595370
rs252901	rs702689	0.767197294704348	Vertex-wise sulcal depth	2e-22	34910505
rs252901	rs10061757	0.755504496652027	Height	4e-30	30595370
rs252901	rs33321	0.633265735823956	Height	1e-19	34594039
rs252901	rs832540	0.613915035229029	Coronary artery disease	2e-08	29212778
rs252903	rs10061757	0.81991585171797	Height	4e-30	30595370
rs252903	rs702689	0.708643904988636	Vertex-wise sulcal depth	2e-22	34910505
rs252903	rs832540	0.652935554923539	Coronary artery disease	2e-08	29212778
rs252903	rs33321	0.643186778243825	Height	1e-19	34594039
rs252905	rs10061757	0.9521513167413	Height	4e-30	30595370
rs252905	rs832540	0.764470693922437	Coronary artery disease	2e-08	29212778
rs252905	rs33321	0.755786249029135	Height	1e-19	34594039
rs252905	rs702689	0.609812156810786	Vertex-wise sulcal depth	2e-22	34910505
rs252906	rs10061757	0.952072397640322	Height	4e-30	30595370
rs252906	rs832540	0.767273509443376	Coronary artery disease	2e-08	29212778
rs252906	rs33321	0.758616128018847	Height	1e-19	34594039
rs252906	rs702689	0.611582527903224	Vertex-wise sulcal depth	2e-22	34910505
rs252907	rs10061757	0.941754213869479	Height	4e-30	30595370
rs252907	rs832540	0.757465999559989	Coronary artery disease	2e-08	29212778
rs252907	rs33321	0.749061232399354	Height	1e-19	34594039
rs252907	rs702689	0.603429826774087	Vertex-wise sulcal depth	2e-22	34910505
rs252908	rs10061757	0.950413042030457	Height	4e-30	30595370
rs252908	rs832540	0.762785880791143	Coronary artery disease	2e-08	29212778
rs252908	rs33321	0.754154813804079	Height	1e-19	34594039
rs252908	rs702689	0.608745111772441	Vertex-wise sulcal depth	2e-22	34910505
rs252913	rs33321	0.886224117373008	Height	1e-19	34594039
rs252913	rs832540	0.857573649514957	Coronary artery disease	2e-08	29212778
rs252913	rs10061757	0.776394283415324	Height	4e-30	30595370
rs252913	rs96844	0.643166367299129	Type 2 diabetes	5e-08	30297969
rs252913	rs96844	0.643166367299129	Height	4e-33	36224396
rs252914	rs33321	0.89301747370795	Height	1e-19	34594039
rs252914	rs832540	0.864391213161067	Coronary artery disease	2e-08	29212778
rs252914	rs10061757	0.697690653148961	Height	4e-30	30595370
rs252917	rs10061757	0.950413042030457	Height	4e-30	30595370
rs252917	rs832540	0.765870547075633	Coronary artery disease	2e-08	29212778
rs252917	rs33321	0.757199617232602	Height	1e-19	34594039
rs252917	rs702689	0.608745111772441	Vertex-wise sulcal depth	2e-22	34910505
rs252920	rs10061757	0.867138424273165	Height	4e-30	30595370
rs252920	rs33321	0.808330920039547	Height	1e-19	34594039
rs252920	rs832540	0.781774207700059	Coronary artery disease	2e-08	29212778
rs252923	rs33321	0.804178905926725	Height	1e-19	34594039
rs252923	rs832540	0.753179868937212	Coronary artery disease	2e-08	29212778
rs252923	rs10061757	0.671378645037949	Height	4e-30	30595370
rs252923	rs33320	0.651297651500556	Height	9e-14	36224396
rs252923	rs2257505	0.648982655907393	Height	8e-192	36224396
rs2532497	rs2532497	1	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2532497	rs2532497	1	Tapasin-related protein levels	0	34648354
rs2532497	rs2041387	0.729767808706032	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2534709	rs2041387	0.86056079885672	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs2534709	rs2532497	0.834959460463328	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2534709	rs2532497	0.834959460463328	Tapasin-related protein levels	0	34648354
rs2534713	rs2532497	0.90676531995132	Tapasin-related protein levels (TAPBPL.6364.7.3)	0	29875488
rs2534713	rs2532497	0.90676531995132	Tapasin-related protein levels	0	34648354
rs2534713	rs2041387	0.773484652660242	Tapasin-related protein level in Chronic kidney disease with hypertension and no diabetes (6364_7)	1e-109	35870639
rs25479	rs3213282	0.606333698127571	Low density lipoprotein cholesterol levels	3e-11	32154731
rs2548224	rs1423357	0.990764297446341	General cognitive ability	9e-06	29844566
rs2548224	rs2432142	0.979072275436562	Neutrophil count	2e-14	32888493
rs2548224	rs2432142	0.979072275436562	White blood cell count	1e-11	32888493
rs2548224	rs38033	0.974252707616318	Blood protein levels	0	30072576
rs2548224	rs27293	0.95525079565903	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2548224	rs27293	0.95525079565903	Diastolic blood pressure	3e-11	35762941
rs2548224	rs7705093	0.946739633629446	Birdshot chorioretinopathy	2e-09	24957906
rs2548224	rs2910686	0.874207699789134	Neutrophil count	4e-14	32888493
rs2548224	rs2910686	0.874207699789134	Psoriasis	2e-08	23143594
rs2548224	rs2910686	0.874207699789134	Ankylosing spondylitis	5e-17	23749187
rs2548224	rs2910686	0.874207699789134	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2548224	rs2927608	0.870878826096267	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2548224	rs2927608	0.870878826096267	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2548224	rs2927608	0.870878826096267	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2548224	rs2617439	0.781353930476308	Neutrophil count	8e-11	32888494
rs2548224	rs2549797	0.775777328273559	Systolic blood pressure	7e-07	33230300
rs2548224	rs2549797	0.775777328273559	Diastolic blood pressure	1e-14	33230300
rs2548224	rs2549797	0.775777328273559	Diastolic blood pressure	3e-11	33230300
rs2548224	rs2549797	0.775777328273559	Systolic blood pressure	4e-09	33230300
rs2548224	rs2549782	0.774518135685328	Systolic blood pressure	6e-07	33230300
rs2548224	rs2549782	0.774518135685328	Diastolic blood pressure	1e-14	33230300
rs2548224	rs2549782	0.774518135685328	Diastolic blood pressure	3e-11	33230300
rs2548224	rs2549782	0.774518135685328	Systolic blood pressure	5e-09	33230300
rs2548224	rs1056893	0.773889382986713	Systolic blood pressure	1e-06	33230300
rs2548224	rs1056893	0.773889382986713	Diastolic blood pressure	7e-15	33230300
rs2548224	rs1056893	0.773889382986713	Diastolic blood pressure	2e-11	33230300
rs2548224	rs1056893	0.773889382986713	Systolic blood pressure	7e-09	33230300
rs2548224	rs2549794	0.770312012734179	Crohn's disease	1e-10	21102463
rs2548224	rs2549794	0.770312012734179	Systolic blood pressure	1e-07	33230300
rs2548224	rs2549794	0.770312012734179	Diastolic blood pressure	1e-15	33230300
rs2548224	rs2549794	0.770312012734179	Diastolic blood pressure	2e-12	33230300
rs2548224	rs2549794	0.770312012734179	Systolic blood pressure	4e-10	33230300
rs2548224	rs1363907	0.768696912111947	Crohn's disease	4e-16	26192919
rs2548224	rs1363907	0.768696912111947	Ulcerative colitis	4e-06	26192919
rs2548224	rs1363907	0.768696912111947	Inflammatory bowel disease	5e-15	26192919
rs2548224	rs1363907	0.768696912111947	Inflammatory bowel disease	6e-13	23128233
rs2548224	rs1363907	0.768696912111947	Inflammatory bowel disease	1e-10	28067908
rs2548224	rs1363907	0.768696912111947	Crohn's disease	1e-14	28067908
rs2548224	rs38029	0.765051973838028	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2548224	rs716848	0.740202301245923	Neutrophil percentage of white cells	2e-09	32888494
rs2548224	rs4869313	0.724252067878847	Pediatric autoimmune diseases	9e-08	26301688
rs2548224	rs1559359	0.715310028473695	Diastolic blood pressure	7e-10	34594039
rs2548224	rs2548532	0.692271412801508	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2548224	rs4869314	0.668512577839861	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2548224	rs4869314	0.668512577839861	Neutrophil count	1e-10	34594039
rs2548224	rs4869314	0.668512577839861	White blood cell count	2e-07	30595370
rs2548224	rs1974871	0.644495821728752	Granulysin levels	5e-13	34648354
rs2548224	rs1019503	0.640566184767512	Systolic blood pressure	2e-06	33230300
rs2548224	rs1019503	0.640566184767512	Diastolic blood pressure	2e-14	33230300
rs2548224	rs1019503	0.640566184767512	Diastolic blood pressure	4e-11	33230300
rs2548224	rs1019503	0.640566184767512	Systolic blood pressure	1e-08	33230300
rs2548224	rs27660	0.635450759408812	Coronary artery disease	3e-08	35915156
rs2548224	rs3096168	0.630514491687691	Aspartate aminotransferase levels	8e-12	33547301
rs2548225	rs1423357	0.990782165983573	General cognitive ability	9e-06	29844566
rs2548225	rs2432142	0.97909240113781	Neutrophil count	2e-14	32888493
rs2548225	rs2432142	0.97909240113781	White blood cell count	1e-11	32888493
rs2548225	rs38033	0.974221194924239	Blood protein levels	0	30072576
rs2548225	rs27293	0.963456842940968	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2548225	rs27293	0.963456842940968	Diastolic blood pressure	3e-11	35762941
rs2548225	rs7705093	0.956470262714641	Birdshot chorioretinopathy	2e-09	24957906
rs2548225	rs2910686	0.866241295324916	Neutrophil count	4e-14	32888493
rs2548225	rs2910686	0.866241295324916	Psoriasis	2e-08	23143594
rs2548225	rs2910686	0.866241295324916	Ankylosing spondylitis	5e-17	23749187
rs2548225	rs2910686	0.866241295324916	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2548225	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2548225	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2548225	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2548225	rs2617439	0.778918998998163	Neutrophil count	8e-11	32888494
rs2548225	rs2549797	0.771019548090089	Systolic blood pressure	7e-07	33230300
rs2548225	rs2549797	0.771019548090089	Diastolic blood pressure	1e-14	33230300
rs2548225	rs2549797	0.771019548090089	Diastolic blood pressure	3e-11	33230300
rs2548225	rs2549797	0.771019548090089	Systolic blood pressure	4e-09	33230300
rs2548225	rs2549782	0.769761797387831	Systolic blood pressure	6e-07	33230300
rs2548225	rs2549782	0.769761797387831	Diastolic blood pressure	1e-14	33230300
rs2548225	rs2549782	0.769761797387831	Diastolic blood pressure	3e-11	33230300
rs2548225	rs2549782	0.769761797387831	Systolic blood pressure	5e-09	33230300
rs2548225	rs1056893	0.769133764694912	Systolic blood pressure	1e-06	33230300
rs2548225	rs1056893	0.769133764694912	Diastolic blood pressure	7e-15	33230300
rs2548225	rs1056893	0.769133764694912	Diastolic blood pressure	2e-11	33230300
rs2548225	rs1056893	0.769133764694912	Systolic blood pressure	7e-09	33230300
rs2548225	rs2549794	0.76483812290131	Crohn's disease	1e-10	21102463
rs2548225	rs2549794	0.76483812290131	Systolic blood pressure	1e-07	33230300
rs2548225	rs2549794	0.76483812290131	Diastolic blood pressure	1e-15	33230300
rs2548225	rs2549794	0.76483812290131	Diastolic blood pressure	2e-12	33230300
rs2548225	rs2549794	0.76483812290131	Systolic blood pressure	4e-10	33230300
rs2548225	rs38029	0.762619945032584	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2548225	rs1363907	0.760208444462172	Crohn's disease	4e-16	26192919
rs2548225	rs1363907	0.760208444462172	Ulcerative colitis	4e-06	26192919
rs2548225	rs1363907	0.760208444462172	Inflammatory bowel disease	5e-15	26192919
rs2548225	rs1363907	0.760208444462172	Inflammatory bowel disease	6e-13	23128233
rs2548225	rs1363907	0.760208444462172	Inflammatory bowel disease	1e-10	28067908
rs2548225	rs1363907	0.760208444462172	Crohn's disease	1e-14	28067908
rs2548225	rs716848	0.731860855278461	Neutrophil percentage of white cells	2e-09	32888494
rs2548225	rs4869313	0.720020495635562	Pediatric autoimmune diseases	9e-08	26301688
rs2548225	rs1559359	0.713736407994285	Diastolic blood pressure	7e-10	34594039
rs2548225	rs2548532	0.687251061417594	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2548225	rs4869314	0.666692723251499	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2548225	rs4869314	0.666692723251499	Neutrophil count	1e-10	34594039
rs2548225	rs4869314	0.666692723251499	White blood cell count	2e-07	30595370
rs2548225	rs1974871	0.640379183170097	Granulysin levels	5e-13	34648354
rs2548225	rs1019503	0.6359518868097	Systolic blood pressure	2e-06	33230300
rs2548225	rs1019503	0.6359518868097	Diastolic blood pressure	2e-14	33230300
rs2548225	rs1019503	0.6359518868097	Diastolic blood pressure	4e-11	33230300
rs2548225	rs1019503	0.6359518868097	Systolic blood pressure	1e-08	33230300
rs2548225	rs27660	0.633665826402108	Coronary artery disease	3e-08	35915156
rs2548225	rs3096168	0.628555573509049	Aspartate aminotransferase levels	8e-12	33547301
rs2548226	rs2617439	0.998210856910547	Neutrophil count	8e-11	32888494
rs2548226	rs2549794	0.948096798438145	Crohn's disease	1e-10	21102463
rs2548226	rs2549794	0.948096798438145	Systolic blood pressure	1e-07	33230300
rs2548226	rs2549794	0.948096798438145	Diastolic blood pressure	1e-15	33230300
rs2548226	rs2549794	0.948096798438145	Diastolic blood pressure	2e-12	33230300
rs2548226	rs2549794	0.948096798438145	Systolic blood pressure	4e-10	33230300
rs2548226	rs38029	0.943740819971597	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2548226	rs1363907	0.942920334439977	Crohn's disease	4e-16	26192919
rs2548226	rs1363907	0.942920334439977	Ulcerative colitis	4e-06	26192919
rs2548226	rs1363907	0.942920334439977	Inflammatory bowel disease	5e-15	26192919
rs2548226	rs1363907	0.942920334439977	Inflammatory bowel disease	6e-13	23128233
rs2548226	rs1363907	0.942920334439977	Inflammatory bowel disease	1e-10	28067908
rs2548226	rs1363907	0.942920334439977	Crohn's disease	1e-14	28067908
rs2548226	rs716848	0.913003411426017	Neutrophil percentage of white cells	2e-09	32888494
rs2548226	rs2548532	0.850757684946283	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2548226	rs2432142	0.798879235401297	Neutrophil count	2e-14	32888493
rs2548226	rs2432142	0.798879235401297	White blood cell count	1e-11	32888493
rs2548226	rs27660	0.780789643356663	Coronary artery disease	3e-08	35915156
rs2548226	rs1423357	0.780162661826111	General cognitive ability	9e-06	29844566
rs2548226	rs38033	0.767897747392721	Blood protein levels	0	30072576
rs2548226	rs27293	0.75321753897492	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2548226	rs27293	0.75321753897492	Diastolic blood pressure	3e-11	35762941
rs2548226	rs7705093	0.745286638736589	Birdshot chorioretinopathy	2e-09	24957906
rs2548226	rs4869313	0.685624295076391	Pediatric autoimmune diseases	9e-08	26301688
rs2548226	rs2927608	0.684619402383746	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2548226	rs2927608	0.684619402383746	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2548226	rs2927608	0.684619402383746	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2548226	rs2910686	0.682340096409303	Neutrophil count	4e-14	32888493
rs2548226	rs2910686	0.682340096409303	Psoriasis	2e-08	23143594
rs2548226	rs2910686	0.682340096409303	Ankylosing spondylitis	5e-17	23749187
rs2548226	rs2910686	0.682340096409303	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2548226	rs1559359	0.623801555367491	Diastolic blood pressure	7e-10	34594039
rs2548226	rs1974871	0.614955857496202	Granulysin levels	5e-13	34648354
rs2548226	rs2549797	0.607375639690469	Systolic blood pressure	7e-07	33230300
rs2548226	rs2549797	0.607375639690469	Diastolic blood pressure	1e-14	33230300
rs2548226	rs2549797	0.607375639690469	Diastolic blood pressure	3e-11	33230300
rs2548226	rs2549797	0.607375639690469	Systolic blood pressure	4e-09	33230300
rs2548226	rs2549782	0.606380363369213	Systolic blood pressure	6e-07	33230300
rs2548226	rs2549782	0.606380363369213	Diastolic blood pressure	1e-14	33230300
rs2548226	rs2549782	0.606380363369213	Diastolic blood pressure	3e-11	33230300
rs2548226	rs2549782	0.606380363369213	Systolic blood pressure	5e-09	33230300
rs2548226	rs1056893	0.605883392049607	Systolic blood pressure	1e-06	33230300
rs2548226	rs1056893	0.605883392049607	Diastolic blood pressure	7e-15	33230300
rs2548226	rs1056893	0.605883392049607	Diastolic blood pressure	2e-11	33230300
rs2548226	rs1056893	0.605883392049607	Systolic blood pressure	7e-09	33230300
rs2548494	rs2548499	0.938950530931861	Lymphocyte count	9e-14	32888494
rs2548494	rs2648731	0.74819084524149	Type 2 diabetes	7e-12	34594039
rs2548494	rs2648731	0.74819084524149	Type 2 diabetes	3e-19	34594039
rs2548494	rs2648731	0.74819084524149	Lymphocyte count	2e-11	34594039
rs2548494	rs2648731	0.74819084524149	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs2548494	rs2648731	0.74819084524149	Medication use (drugs used in diabetes)	3e-09	34594039
rs2548494	rs13189973	0.627933014586021	Lymphocyte count	2e-16	32888493
rs2548496	rs2548496	1	Lymphocyte count	3e-16	32888493
rs2548497	rs2548499	0.938950530931861	Lymphocyte count	9e-14	32888494
rs2548497	rs2648731	0.74819084524149	Type 2 diabetes	7e-12	34594039
rs2548497	rs2648731	0.74819084524149	Type 2 diabetes	3e-19	34594039
rs2548497	rs2648731	0.74819084524149	Lymphocyte count	2e-11	34594039
rs2548497	rs2648731	0.74819084524149	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs2548497	rs2648731	0.74819084524149	Medication use (drugs used in diabetes)	3e-09	34594039
rs2548497	rs13189973	0.627933014586021	Lymphocyte count	2e-16	32888493
rs2548499	rs2548499	1	Lymphocyte count	9e-14	32888494
rs2548499	rs2648731	0.798430935497835	Type 2 diabetes	7e-12	34594039
rs2548499	rs2648731	0.798430935497835	Type 2 diabetes	3e-19	34594039
rs2548499	rs2648731	0.798430935497835	Lymphocyte count	2e-11	34594039
rs2548499	rs2648731	0.798430935497835	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs2548499	rs2648731	0.798430935497835	Medication use (drugs used in diabetes)	3e-09	34594039
rs2548499	rs13189973	0.637346251228666	Lymphocyte count	2e-16	32888493
rs2548516	rs1423357	0.990782165983573	General cognitive ability	9e-06	29844566
rs2548516	rs2432142	0.97909240113781	Neutrophil count	2e-14	32888493
rs2548516	rs2432142	0.97909240113781	White blood cell count	1e-11	32888493
rs2548516	rs38033	0.974221194924239	Blood protein levels	0	30072576
rs2548516	rs27293	0.963456842940968	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2548516	rs27293	0.963456842940968	Diastolic blood pressure	3e-11	35762941
rs2548516	rs7705093	0.956470262714641	Birdshot chorioretinopathy	2e-09	24957906
rs2548516	rs2910686	0.866241295324916	Neutrophil count	4e-14	32888493
rs2548516	rs2910686	0.866241295324916	Psoriasis	2e-08	23143594
rs2548516	rs2910686	0.866241295324916	Ankylosing spondylitis	5e-17	23749187
rs2548516	rs2910686	0.866241295324916	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2548516	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2548516	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2548516	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2548516	rs2617439	0.778918998998163	Neutrophil count	8e-11	32888494
rs2548516	rs2549797	0.771019548090089	Systolic blood pressure	7e-07	33230300
rs2548516	rs2549797	0.771019548090089	Diastolic blood pressure	1e-14	33230300
rs2548516	rs2549797	0.771019548090089	Diastolic blood pressure	3e-11	33230300
rs2548516	rs2549797	0.771019548090089	Systolic blood pressure	4e-09	33230300
rs2548516	rs2549782	0.769761797387831	Systolic blood pressure	6e-07	33230300
rs2548516	rs2549782	0.769761797387831	Diastolic blood pressure	1e-14	33230300
rs2548516	rs2549782	0.769761797387831	Diastolic blood pressure	3e-11	33230300
rs2548516	rs2549782	0.769761797387831	Systolic blood pressure	5e-09	33230300
rs2548516	rs1056893	0.769133764694912	Systolic blood pressure	1e-06	33230300
rs2548516	rs1056893	0.769133764694912	Diastolic blood pressure	7e-15	33230300
rs2548516	rs1056893	0.769133764694912	Diastolic blood pressure	2e-11	33230300
rs2548516	rs1056893	0.769133764694912	Systolic blood pressure	7e-09	33230300
rs2548516	rs2549794	0.76483812290131	Crohn's disease	1e-10	21102463
rs2548516	rs2549794	0.76483812290131	Systolic blood pressure	1e-07	33230300
rs2548516	rs2549794	0.76483812290131	Diastolic blood pressure	1e-15	33230300
rs2548516	rs2549794	0.76483812290131	Diastolic blood pressure	2e-12	33230300
rs2548516	rs2549794	0.76483812290131	Systolic blood pressure	4e-10	33230300
rs2548516	rs38029	0.762619945032584	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2548516	rs1363907	0.760208444462172	Crohn's disease	4e-16	26192919
rs2548516	rs1363907	0.760208444462172	Ulcerative colitis	4e-06	26192919
rs2548516	rs1363907	0.760208444462172	Inflammatory bowel disease	5e-15	26192919
rs2548516	rs1363907	0.760208444462172	Inflammatory bowel disease	6e-13	23128233
rs2548516	rs1363907	0.760208444462172	Inflammatory bowel disease	1e-10	28067908
rs2548516	rs1363907	0.760208444462172	Crohn's disease	1e-14	28067908
rs2548516	rs716848	0.731860855278461	Neutrophil percentage of white cells	2e-09	32888494
rs2548516	rs4869313	0.720020495635562	Pediatric autoimmune diseases	9e-08	26301688
rs2548516	rs1559359	0.713736407994285	Diastolic blood pressure	7e-10	34594039
rs2548516	rs2548532	0.687251061417594	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2548516	rs4869314	0.666692723251499	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2548516	rs4869314	0.666692723251499	Neutrophil count	1e-10	34594039
rs2548516	rs4869314	0.666692723251499	White blood cell count	2e-07	30595370
rs2548516	rs1974871	0.640379183170097	Granulysin levels	5e-13	34648354
rs2548516	rs1019503	0.6359518868097	Systolic blood pressure	2e-06	33230300
rs2548516	rs1019503	0.6359518868097	Diastolic blood pressure	2e-14	33230300
rs2548516	rs1019503	0.6359518868097	Diastolic blood pressure	4e-11	33230300
rs2548516	rs1019503	0.6359518868097	Systolic blood pressure	1e-08	33230300
rs2548516	rs27660	0.633665826402108	Coronary artery disease	3e-08	35915156
rs2548516	rs3096168	0.628555573509049	Aspartate aminotransferase levels	8e-12	33547301
rs2548520	rs2549797	0.995157518131503	Systolic blood pressure	7e-07	33230300
rs2548520	rs2549797	0.995157518131503	Diastolic blood pressure	1e-14	33230300
rs2548520	rs2549797	0.995157518131503	Diastolic blood pressure	3e-11	33230300
rs2548520	rs2549797	0.995157518131503	Systolic blood pressure	4e-09	33230300
rs2548520	rs2549782	0.993545654782087	Systolic blood pressure	6e-07	33230300
rs2548520	rs2549782	0.993545654782087	Diastolic blood pressure	1e-14	33230300
rs2548520	rs2549782	0.993545654782087	Diastolic blood pressure	3e-11	33230300
rs2548520	rs2549782	0.993545654782087	Systolic blood pressure	5e-09	33230300
rs2548520	rs1056893	0.992740802966323	Systolic blood pressure	1e-06	33230300
rs2548520	rs1056893	0.992740802966323	Diastolic blood pressure	7e-15	33230300
rs2548520	rs1056893	0.992740802966323	Diastolic blood pressure	2e-11	33230300
rs2548520	rs1056893	0.992740802966323	Systolic blood pressure	7e-09	33230300
rs2548520	rs2910686	0.883405801408269	Neutrophil count	4e-14	32888493
rs2548520	rs2910686	0.883405801408269	Psoriasis	2e-08	23143594
rs2548520	rs2910686	0.883405801408269	Ankylosing spondylitis	5e-17	23749187
rs2548520	rs2910686	0.883405801408269	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2548520	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2548520	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2548520	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2548520	rs1019503	0.818497155248466	Systolic blood pressure	2e-06	33230300
rs2548520	rs1019503	0.818497155248466	Diastolic blood pressure	2e-14	33230300
rs2548520	rs1019503	0.818497155248466	Diastolic blood pressure	4e-11	33230300
rs2548520	rs1019503	0.818497155248466	Systolic blood pressure	1e-08	33230300
rs2548520	rs3096168	0.808309756130604	Aspartate aminotransferase levels	8e-12	33547301
rs2548520	rs4869314	0.801389713361272	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2548520	rs4869314	0.801389713361272	Neutrophil count	1e-10	34594039
rs2548520	rs4869314	0.801389713361272	White blood cell count	2e-07	30595370
rs2548520	rs1974871	0.778485394373192	Granulysin levels	5e-13	34648354
rs2548520	rs1423357	0.771102100728405	General cognitive ability	9e-06	29844566
rs2548520	rs2432142	0.756548664661565	Neutrophil count	2e-14	32888493
rs2548520	rs2432142	0.756548664661565	White blood cell count	1e-11	32888493
rs2548520	rs38033	0.750611949419352	Blood protein levels	0	30072576
rs2548520	rs27293	0.738718358168888	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2548520	rs27293	0.738718358168888	Diastolic blood pressure	3e-11	35762941
rs2548520	rs4869313	0.734335131264831	Pediatric autoimmune diseases	9e-08	26301688
rs2548520	rs7705093	0.730801347218657	Birdshot chorioretinopathy	2e-09	24957906
rs2548520	rs1559359	0.71948282322732	Diastolic blood pressure	7e-10	34594039
rs2548520	rs1363907	0.6355545414163	Crohn's disease	4e-16	26192919
rs2548520	rs1363907	0.6355545414163	Ulcerative colitis	4e-06	26192919
rs2548520	rs1363907	0.6355545414163	Inflammatory bowel disease	5e-15	26192919
rs2548520	rs1363907	0.6355545414163	Inflammatory bowel disease	6e-13	23128233
rs2548520	rs1363907	0.6355545414163	Inflammatory bowel disease	1e-10	28067908
rs2548520	rs1363907	0.6355545414163	Crohn's disease	1e-14	28067908
rs2548520	rs2549794	0.634421147015539	Crohn's disease	1e-10	21102463
rs2548520	rs2549794	0.634421147015539	Systolic blood pressure	1e-07	33230300
rs2548520	rs2549794	0.634421147015539	Diastolic blood pressure	1e-15	33230300
rs2548520	rs2549794	0.634421147015539	Diastolic blood pressure	2e-12	33230300
rs2548520	rs2549794	0.634421147015539	Systolic blood pressure	4e-10	33230300
rs2548520	rs716848	0.630282453225041	Neutrophil percentage of white cells	2e-09	32888494
rs2548520	rs2617439	0.602627277019224	Neutrophil count	8e-11	32888494
rs2548521	rs2549797	0.995157518131503	Systolic blood pressure	7e-07	33230300
rs2548521	rs2549797	0.995157518131503	Diastolic blood pressure	1e-14	33230300
rs2548521	rs2549797	0.995157518131503	Diastolic blood pressure	3e-11	33230300
rs2548521	rs2549797	0.995157518131503	Systolic blood pressure	4e-09	33230300
rs2548521	rs2549782	0.993545654782087	Systolic blood pressure	6e-07	33230300
rs2548521	rs2549782	0.993545654782087	Diastolic blood pressure	1e-14	33230300
rs2548521	rs2549782	0.993545654782087	Diastolic blood pressure	3e-11	33230300
rs2548521	rs2549782	0.993545654782087	Systolic blood pressure	5e-09	33230300
rs2548521	rs1056893	0.992740802966323	Systolic blood pressure	1e-06	33230300
rs2548521	rs1056893	0.992740802966323	Diastolic blood pressure	7e-15	33230300
rs2548521	rs1056893	0.992740802966323	Diastolic blood pressure	2e-11	33230300
rs2548521	rs1056893	0.992740802966323	Systolic blood pressure	7e-09	33230300
rs2548521	rs2910686	0.883405801408269	Neutrophil count	4e-14	32888493
rs2548521	rs2910686	0.883405801408269	Psoriasis	2e-08	23143594
rs2548521	rs2910686	0.883405801408269	Ankylosing spondylitis	5e-17	23749187
rs2548521	rs2910686	0.883405801408269	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2548521	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2548521	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2548521	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2548521	rs1019503	0.818497155248466	Systolic blood pressure	2e-06	33230300
rs2548521	rs1019503	0.818497155248466	Diastolic blood pressure	2e-14	33230300
rs2548521	rs1019503	0.818497155248466	Diastolic blood pressure	4e-11	33230300
rs2548521	rs1019503	0.818497155248466	Systolic blood pressure	1e-08	33230300
rs2548521	rs3096168	0.808309756130604	Aspartate aminotransferase levels	8e-12	33547301
rs2548521	rs4869314	0.801389713361272	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2548521	rs4869314	0.801389713361272	Neutrophil count	1e-10	34594039
rs2548521	rs4869314	0.801389713361272	White blood cell count	2e-07	30595370
rs2548521	rs1974871	0.778485394373192	Granulysin levels	5e-13	34648354
rs2548521	rs1423357	0.771102100728405	General cognitive ability	9e-06	29844566
rs2548521	rs2432142	0.756548664661565	Neutrophil count	2e-14	32888493
rs2548521	rs2432142	0.756548664661565	White blood cell count	1e-11	32888493
rs2548521	rs38033	0.750611949419352	Blood protein levels	0	30072576
rs2548521	rs27293	0.738718358168888	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2548521	rs27293	0.738718358168888	Diastolic blood pressure	3e-11	35762941
rs2548521	rs4869313	0.734335131264831	Pediatric autoimmune diseases	9e-08	26301688
rs2548521	rs7705093	0.730801347218657	Birdshot chorioretinopathy	2e-09	24957906
rs2548521	rs1559359	0.71948282322732	Diastolic blood pressure	7e-10	34594039
rs2548521	rs1363907	0.6355545414163	Crohn's disease	4e-16	26192919
rs2548521	rs1363907	0.6355545414163	Ulcerative colitis	4e-06	26192919
rs2548521	rs1363907	0.6355545414163	Inflammatory bowel disease	5e-15	26192919
rs2548521	rs1363907	0.6355545414163	Inflammatory bowel disease	6e-13	23128233
rs2548521	rs1363907	0.6355545414163	Inflammatory bowel disease	1e-10	28067908
rs2548521	rs1363907	0.6355545414163	Crohn's disease	1e-14	28067908
rs2548521	rs2549794	0.634421147015539	Crohn's disease	1e-10	21102463
rs2548521	rs2549794	0.634421147015539	Systolic blood pressure	1e-07	33230300
rs2548521	rs2549794	0.634421147015539	Diastolic blood pressure	1e-15	33230300
rs2548521	rs2549794	0.634421147015539	Diastolic blood pressure	2e-12	33230300
rs2548521	rs2549794	0.634421147015539	Systolic blood pressure	4e-10	33230300
rs2548521	rs716848	0.630282453225041	Neutrophil percentage of white cells	2e-09	32888494
rs2548521	rs2617439	0.602627277019224	Neutrophil count	8e-11	32888494
rs2548530	rs2549794	1	Crohn's disease	1e-10	21102463
rs2548530	rs2549794	1	Systolic blood pressure	1e-07	33230300
rs2548530	rs2549794	1	Diastolic blood pressure	1e-15	33230300
rs2548530	rs2549794	1	Diastolic blood pressure	2e-12	33230300
rs2548530	rs2549794	1	Systolic blood pressure	4e-10	33230300
rs2548530	rs1363907	0.994668192117369	Crohn's disease	4e-16	26192919
rs2548530	rs1363907	0.994668192117369	Ulcerative colitis	4e-06	26192919
rs2548530	rs1363907	0.994668192117369	Inflammatory bowel disease	5e-15	26192919
rs2548530	rs1363907	0.994668192117369	Inflammatory bowel disease	6e-13	23128233
rs2548530	rs1363907	0.994668192117369	Inflammatory bowel disease	1e-10	28067908
rs2548530	rs1363907	0.994668192117369	Crohn's disease	1e-14	28067908
rs2548530	rs2617439	0.946359227117998	Neutrophil count	8e-11	32888494
rs2548530	rs716848	0.939292694140925	Neutrophil percentage of white cells	2e-09	32888494
rs2548530	rs38029	0.934339838530374	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2548530	rs2548532	0.898577738157948	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2548530	rs27660	0.782215834508668	Coronary artery disease	3e-08	35915156
rs2548530	rs1423357	0.769261023230232	General cognitive ability	9e-06	29844566
rs2548530	rs2432142	0.7543446728158	Neutrophil count	2e-14	32888493
rs2548530	rs2432142	0.7543446728158	White blood cell count	1e-11	32888493
rs2548530	rs38033	0.752472000190678	Blood protein levels	0	30072576
rs2548530	rs27293	0.743942234032582	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2548530	rs27293	0.743942234032582	Diastolic blood pressure	3e-11	35762941
rs2548530	rs7705093	0.734454866219682	Birdshot chorioretinopathy	2e-09	24957906
rs2548530	rs4869313	0.724271578137786	Pediatric autoimmune diseases	9e-08	26301688
rs2548530	rs2927608	0.718185251163119	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2548530	rs2927608	0.718185251163119	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2548530	rs2927608	0.718185251163119	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2548530	rs2910686	0.715824837135211	Neutrophil count	4e-14	32888493
rs2548530	rs2910686	0.715824837135211	Psoriasis	2e-08	23143594
rs2548530	rs2910686	0.715824837135211	Ankylosing spondylitis	5e-17	23749187
rs2548530	rs2910686	0.715824837135211	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2548530	rs1559359	0.655723501015219	Diastolic blood pressure	7e-10	34594039
rs2548530	rs1974871	0.650770503938115	Granulysin levels	5e-13	34648354
rs2548530	rs2549797	0.638156925849082	Systolic blood pressure	7e-07	33230300
rs2548530	rs2549797	0.638156925849082	Diastolic blood pressure	1e-14	33230300
rs2548530	rs2549797	0.638156925849082	Diastolic blood pressure	3e-11	33230300
rs2548530	rs2549797	0.638156925849082	Systolic blood pressure	4e-09	33230300
rs2548530	rs2549782	0.637126282330081	Systolic blood pressure	6e-07	33230300
rs2548530	rs2549782	0.637126282330081	Diastolic blood pressure	1e-14	33230300
rs2548530	rs2549782	0.637126282330081	Diastolic blood pressure	3e-11	33230300
rs2548530	rs2549782	0.637126282330081	Systolic blood pressure	5e-09	33230300
rs2548530	rs1056893	0.636611651041898	Systolic blood pressure	1e-06	33230300
rs2548530	rs1056893	0.636611651041898	Diastolic blood pressure	7e-15	33230300
rs2548530	rs1056893	0.636611651041898	Diastolic blood pressure	2e-11	33230300
rs2548530	rs1056893	0.636611651041898	Systolic blood pressure	7e-09	33230300
rs2548532	rs2548532	1	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2548532	rs2549794	0.898577738157948	Crohn's disease	1e-10	21102463
rs2548532	rs2549794	0.898577738157948	Systolic blood pressure	1e-07	33230300
rs2548532	rs2549794	0.898577738157948	Diastolic blood pressure	1e-15	33230300
rs2548532	rs2549794	0.898577738157948	Diastolic blood pressure	2e-12	33230300
rs2548532	rs2549794	0.898577738157948	Systolic blood pressure	4e-10	33230300
rs2548532	rs1363907	0.893549053800425	Crohn's disease	4e-16	26192919
rs2548532	rs1363907	0.893549053800425	Ulcerative colitis	4e-06	26192919
rs2548532	rs1363907	0.893549053800425	Inflammatory bowel disease	5e-15	26192919
rs2548532	rs1363907	0.893549053800425	Inflammatory bowel disease	6e-13	23128233
rs2548532	rs1363907	0.893549053800425	Inflammatory bowel disease	1e-10	28067908
rs2548532	rs1363907	0.893549053800425	Crohn's disease	1e-14	28067908
rs2548532	rs27660	0.869243989465338	Coronary artery disease	3e-08	35915156
rs2548532	rs2617439	0.848964670937389	Neutrophil count	8e-11	32888494
rs2548532	rs716848	0.842305340971938	Neutrophil percentage of white cells	2e-09	32888494
rs2548532	rs38029	0.838522777765782	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2548532	rs1423357	0.691123671665965	General cognitive ability	9e-06	29844566
rs2548532	rs2432142	0.676815890480715	Neutrophil count	2e-14	32888493
rs2548532	rs2432142	0.676815890480715	White blood cell count	1e-11	32888493
rs2548532	rs38033	0.676139290890649	Blood protein levels	0	30072576
rs2548532	rs27293	0.667776737803057	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2548532	rs27293	0.667776737803057	Diastolic blood pressure	3e-11	35762941
rs2548532	rs4869313	0.66196408542932	Pediatric autoimmune diseases	9e-08	26301688
rs2548532	rs7705093	0.65985087037463	Birdshot chorioretinopathy	2e-09	24957906
rs2548532	rs2927608	0.645151203149521	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2548532	rs2927608	0.645151203149521	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2548532	rs2927608	0.645151203149521	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2548532	rs2910686	0.643030559643807	Neutrophil count	4e-14	32888493
rs2548532	rs2910686	0.643030559643807	Psoriasis	2e-08	23143594
rs2548532	rs2910686	0.643030559643807	Ankylosing spondylitis	5e-17	23749187
rs2548532	rs2910686	0.643030559643807	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2549783	rs2549794	0.969470546334514	Crohn's disease	1e-10	21102463
rs2549783	rs2549794	0.969470546334514	Systolic blood pressure	1e-07	33230300
rs2549783	rs2549794	0.969470546334514	Diastolic blood pressure	1e-15	33230300
rs2549783	rs2549794	0.969470546334514	Diastolic blood pressure	2e-12	33230300
rs2549783	rs2549794	0.969470546334514	Systolic blood pressure	4e-10	33230300
rs2549783	rs1363907	0.964227814144098	Crohn's disease	4e-16	26192919
rs2549783	rs1363907	0.964227814144098	Ulcerative colitis	4e-06	26192919
rs2549783	rs1363907	0.964227814144098	Inflammatory bowel disease	5e-15	26192919
rs2549783	rs1363907	0.964227814144098	Inflammatory bowel disease	6e-13	23128233
rs2549783	rs1363907	0.964227814144098	Inflammatory bowel disease	1e-10	28067908
rs2549783	rs1363907	0.964227814144098	Crohn's disease	1e-14	28067908
rs2549783	rs2617439	0.917106781409651	Neutrophil count	8e-11	32888494
rs2549783	rs716848	0.909637210653351	Neutrophil percentage of white cells	2e-09	32888494
rs2549783	rs38029	0.905154038408795	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2549783	rs2548532	0.871144650736018	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2549783	rs27660	0.758198805729827	Coronary artery disease	3e-08	35915156
rs2549783	rs1423357	0.741588818667216	General cognitive ability	9e-06	29844566
rs2549783	rs2432142	0.726998317842702	Neutrophil count	2e-14	32888493
rs2549783	rs2432142	0.726998317842702	White blood cell count	1e-11	32888493
rs2549783	rs38033	0.724950457193685	Blood protein levels	0	30072576
rs2549783	rs27293	0.716644108941684	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2549783	rs27293	0.716644108941684	Diastolic blood pressure	3e-11	35762941
rs2549783	rs7705093	0.707135965081102	Birdshot chorioretinopathy	2e-09	24957906
rs2549783	rs4869313	0.698506849935739	Pediatric autoimmune diseases	9e-08	26301688
rs2549783	rs2927608	0.690463038620212	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2549783	rs2927608	0.690463038620212	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2549783	rs2927608	0.690463038620212	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2549783	rs2910686	0.688125988638802	Neutrophil count	4e-14	32888493
rs2549783	rs2910686	0.688125988638802	Psoriasis	2e-08	23143594
rs2549783	rs2910686	0.688125988638802	Ankylosing spondylitis	5e-17	23749187
rs2549783	rs2910686	0.688125988638802	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2549783	rs1559359	0.633257470754664	Diastolic blood pressure	7e-10	34594039
rs2549783	rs1974871	0.625691548322374	Granulysin levels	5e-13	34648354
rs2549783	rs2549782	0.611484387262566	Systolic blood pressure	6e-07	33230300
rs2549783	rs2549782	0.611484387262566	Diastolic blood pressure	1e-14	33230300
rs2549783	rs2549782	0.611484387262566	Diastolic blood pressure	3e-11	33230300
rs2549783	rs2549782	0.611484387262566	Systolic blood pressure	5e-09	33230300
rs2549783	rs2549797	0.611185448559703	Systolic blood pressure	7e-07	33230300
rs2549783	rs2549797	0.611185448559703	Diastolic blood pressure	1e-14	33230300
rs2549783	rs2549797	0.611185448559703	Diastolic blood pressure	3e-11	33230300
rs2549783	rs2549797	0.611185448559703	Systolic blood pressure	4e-09	33230300
rs2549783	rs1056893	0.609655521934816	Systolic blood pressure	1e-06	33230300
rs2549783	rs1056893	0.609655521934816	Diastolic blood pressure	7e-15	33230300
rs2549783	rs1056893	0.609655521934816	Diastolic blood pressure	2e-11	33230300
rs2549783	rs1056893	0.609655521934816	Systolic blood pressure	7e-09	33230300
rs2549794	rs2549794	1	Crohn's disease	1e-10	21102463
rs2549794	rs2549794	1	Systolic blood pressure	1e-07	33230300
rs2549794	rs2549794	1	Diastolic blood pressure	1e-15	33230300
rs2549794	rs2549794	1	Diastolic blood pressure	2e-12	33230300
rs2549794	rs2549794	1	Systolic blood pressure	4e-10	33230300
rs2549794	rs1363907	0.994668192117369	Crohn's disease	4e-16	26192919
rs2549794	rs1363907	0.994668192117369	Ulcerative colitis	4e-06	26192919
rs2549794	rs1363907	0.994668192117369	Inflammatory bowel disease	5e-15	26192919
rs2549794	rs1363907	0.994668192117369	Inflammatory bowel disease	6e-13	23128233
rs2549794	rs1363907	0.994668192117369	Inflammatory bowel disease	1e-10	28067908
rs2549794	rs1363907	0.994668192117369	Crohn's disease	1e-14	28067908
rs2549794	rs2617439	0.946359227117998	Neutrophil count	8e-11	32888494
rs2549794	rs716848	0.939292694140925	Neutrophil percentage of white cells	2e-09	32888494
rs2549794	rs38029	0.934339838530374	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2549794	rs2548532	0.898577738157948	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2549794	rs27660	0.782215834508668	Coronary artery disease	3e-08	35915156
rs2549794	rs1423357	0.769261023230232	General cognitive ability	9e-06	29844566
rs2549794	rs2432142	0.7543446728158	Neutrophil count	2e-14	32888493
rs2549794	rs2432142	0.7543446728158	White blood cell count	1e-11	32888493
rs2549794	rs38033	0.752472000190678	Blood protein levels	0	30072576
rs2549794	rs27293	0.743942234032582	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2549794	rs27293	0.743942234032582	Diastolic blood pressure	3e-11	35762941
rs2549794	rs7705093	0.734454866219682	Birdshot chorioretinopathy	2e-09	24957906
rs2549794	rs4869313	0.724271578137786	Pediatric autoimmune diseases	9e-08	26301688
rs2549794	rs2927608	0.718185251163119	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2549794	rs2927608	0.718185251163119	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2549794	rs2927608	0.718185251163119	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2549794	rs2910686	0.715824837135211	Neutrophil count	4e-14	32888493
rs2549794	rs2910686	0.715824837135211	Psoriasis	2e-08	23143594
rs2549794	rs2910686	0.715824837135211	Ankylosing spondylitis	5e-17	23749187
rs2549794	rs2910686	0.715824837135211	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2549794	rs1559359	0.655723501015219	Diastolic blood pressure	7e-10	34594039
rs2549794	rs1974871	0.650770503938115	Granulysin levels	5e-13	34648354
rs2549794	rs2549797	0.638156925849082	Systolic blood pressure	7e-07	33230300
rs2549794	rs2549797	0.638156925849082	Diastolic blood pressure	1e-14	33230300
rs2549794	rs2549797	0.638156925849082	Diastolic blood pressure	3e-11	33230300
rs2549794	rs2549797	0.638156925849082	Systolic blood pressure	4e-09	33230300
rs2549794	rs2549782	0.637126282330081	Systolic blood pressure	6e-07	33230300
rs2549794	rs2549782	0.637126282330081	Diastolic blood pressure	1e-14	33230300
rs2549794	rs2549782	0.637126282330081	Diastolic blood pressure	3e-11	33230300
rs2549794	rs2549782	0.637126282330081	Systolic blood pressure	5e-09	33230300
rs2549794	rs1056893	0.636611651041898	Systolic blood pressure	1e-06	33230300
rs2549794	rs1056893	0.636611651041898	Diastolic blood pressure	7e-15	33230300
rs2549794	rs1056893	0.636611651041898	Diastolic blood pressure	2e-11	33230300
rs2549794	rs1056893	0.636611651041898	Systolic blood pressure	7e-09	33230300
rs2549801	rs2549797	0.995157518131503	Systolic blood pressure	7e-07	33230300
rs2549801	rs2549797	0.995157518131503	Diastolic blood pressure	1e-14	33230300
rs2549801	rs2549797	0.995157518131503	Diastolic blood pressure	3e-11	33230300
rs2549801	rs2549797	0.995157518131503	Systolic blood pressure	4e-09	33230300
rs2549801	rs2549782	0.993545654782087	Systolic blood pressure	6e-07	33230300
rs2549801	rs2549782	0.993545654782087	Diastolic blood pressure	1e-14	33230300
rs2549801	rs2549782	0.993545654782087	Diastolic blood pressure	3e-11	33230300
rs2549801	rs2549782	0.993545654782087	Systolic blood pressure	5e-09	33230300
rs2549801	rs1056893	0.992740802966323	Systolic blood pressure	1e-06	33230300
rs2549801	rs1056893	0.992740802966323	Diastolic blood pressure	7e-15	33230300
rs2549801	rs1056893	0.992740802966323	Diastolic blood pressure	2e-11	33230300
rs2549801	rs1056893	0.992740802966323	Systolic blood pressure	7e-09	33230300
rs2549801	rs2910686	0.883405801408269	Neutrophil count	4e-14	32888493
rs2549801	rs2910686	0.883405801408269	Psoriasis	2e-08	23143594
rs2549801	rs2910686	0.883405801408269	Ankylosing spondylitis	5e-17	23749187
rs2549801	rs2910686	0.883405801408269	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2549801	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2549801	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2549801	rs2927608	0.880501389520753	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2549801	rs1019503	0.818497155248466	Systolic blood pressure	2e-06	33230300
rs2549801	rs1019503	0.818497155248466	Diastolic blood pressure	2e-14	33230300
rs2549801	rs1019503	0.818497155248466	Diastolic blood pressure	4e-11	33230300
rs2549801	rs1019503	0.818497155248466	Systolic blood pressure	1e-08	33230300
rs2549801	rs3096168	0.808309756130604	Aspartate aminotransferase levels	8e-12	33547301
rs2549801	rs4869314	0.801389713361272	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2549801	rs4869314	0.801389713361272	Neutrophil count	1e-10	34594039
rs2549801	rs4869314	0.801389713361272	White blood cell count	2e-07	30595370
rs2549801	rs1974871	0.778485394373192	Granulysin levels	5e-13	34648354
rs2549801	rs1423357	0.771102100728405	General cognitive ability	9e-06	29844566
rs2549801	rs2432142	0.756548664661565	Neutrophil count	2e-14	32888493
rs2549801	rs2432142	0.756548664661565	White blood cell count	1e-11	32888493
rs2549801	rs38033	0.750611949419352	Blood protein levels	0	30072576
rs2549801	rs27293	0.738718358168888	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2549801	rs27293	0.738718358168888	Diastolic blood pressure	3e-11	35762941
rs2549801	rs4869313	0.734335131264831	Pediatric autoimmune diseases	9e-08	26301688
rs2549801	rs7705093	0.730801347218657	Birdshot chorioretinopathy	2e-09	24957906
rs2549801	rs1559359	0.71948282322732	Diastolic blood pressure	7e-10	34594039
rs2549801	rs1363907	0.6355545414163	Crohn's disease	4e-16	26192919
rs2549801	rs1363907	0.6355545414163	Ulcerative colitis	4e-06	26192919
rs2549801	rs1363907	0.6355545414163	Inflammatory bowel disease	5e-15	26192919
rs2549801	rs1363907	0.6355545414163	Inflammatory bowel disease	6e-13	23128233
rs2549801	rs1363907	0.6355545414163	Inflammatory bowel disease	1e-10	28067908
rs2549801	rs1363907	0.6355545414163	Crohn's disease	1e-14	28067908
rs2549801	rs2549794	0.634421147015539	Crohn's disease	1e-10	21102463
rs2549801	rs2549794	0.634421147015539	Systolic blood pressure	1e-07	33230300
rs2549801	rs2549794	0.634421147015539	Diastolic blood pressure	1e-15	33230300
rs2549801	rs2549794	0.634421147015539	Diastolic blood pressure	2e-12	33230300
rs2549801	rs2549794	0.634421147015539	Systolic blood pressure	4e-10	33230300
rs2549801	rs716848	0.630282453225041	Neutrophil percentage of white cells	2e-09	32888494
rs2549801	rs2617439	0.602627277019224	Neutrophil count	8e-11	32888494
rs2559854	rs2559856	0.997595552859166	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs2559854	rs3809260	0.989605933477964	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs2559854	rs2695294	0.972921753601566	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs2559854	rs2695295	0.968966032400551	Serum levels of protein NAAA	1e-68	35078996
rs2559854	rs2695295	0.968966032400551	Serum levels of protein SMPDL3A	8e-86	35078996
rs2559854	rs2559851	0.922558194389456	Cathepsin F levels	2e-96	34648354
rs2559854	rs2559851	0.922558194389456	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs2559854	rs2559850	0.801486364951597	Serum levels of protein CTSH	1e-19	35078996
rs2559854	rs2559850	0.801486364951597	Vitamin C levels	6e-20	33203707
rs2559854	rs2559850	0.801486364951597	Cathepsin L2 levels	1e-24	34648354
rs2559854	rs2559850	0.801486364951597	Islet amyloid polypeptide levels	1e-49	34648354
rs2559854	rs2559850	0.801486364951597	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs2559855	rs2559856	1	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs2559855	rs3809260	0.99040265073975	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs2559855	rs2695294	0.975295772885657	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs2559855	rs2695295	0.971336442489687	Serum levels of protein NAAA	1e-68	35078996
rs2559855	rs2695295	0.971336442489687	Serum levels of protein SMPDL3A	8e-86	35078996
rs2559855	rs2559851	0.923316091679184	Cathepsin F levels	2e-96	34648354
rs2559855	rs2559851	0.923316091679184	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs2559855	rs2559850	0.802156889107722	Serum levels of protein CTSH	1e-19	35078996
rs2559855	rs2559850	0.802156889107722	Vitamin C levels	6e-20	33203707
rs2559855	rs2559850	0.802156889107722	Cathepsin L2 levels	1e-24	34648354
rs2559855	rs2559850	0.802156889107722	Islet amyloid polypeptide levels	1e-49	34648354
rs2559855	rs2559850	0.802156889107722	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs2592493	rs1177308	0.894513535979611	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2592493	rs1177308	0.894513535979611	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2592493	rs7558954	0.892364557978774	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2592493	rs11685226	0.875249680474593	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs2592493	rs11685226	0.875249680474593	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2592493	rs777587	0.729191737478032	Proteoglycan 3 levels	6e-29	34648354
rs2592493	rs777587	0.729191737478032	Pappalysin-1 levels	1e-25	34648354
rs2592493	rs12617371	0.689511878593251	Immature fraction of reticulocytes	8e-18	32888494
rs2592493	rs2463097	0.659605124546287	White blood cell count	3e-26	30595370
rs2592493	rs2593620	0.632640508865796	Serum levels of protein PRG3	5e-14	35078996
rs2592493	rs10199672	0.62717286887612	Height	6e-12	34594039
rs2592493	rs10199672	0.62717286887612	Height	2e-12	31562340
rs2592493	rs2421200	0.607412089732271	Neutrophil count	1e-26	32888493
rs2592493	rs2421200	0.607412089732271	Neutrophil count	1e-25	32888493
rs2592494	rs1177308	0.804400283647113	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2592494	rs1177308	0.804400283647113	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2592494	rs11685226	0.802498914943771	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs2592494	rs11685226	0.802498914943771	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2592494	rs7558954	0.802431762053089	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2592494	rs777587	0.671448991570258	Proteoglycan 3 levels	6e-29	34648354
rs2592494	rs777587	0.671448991570258	Pappalysin-1 levels	1e-25	34648354
rs2592494	rs2593620	0.661732651418485	Serum levels of protein PRG3	5e-14	35078996
rs2592494	rs12617371	0.63991858975938	Immature fraction of reticulocytes	8e-18	32888494
rs2592494	rs2421200	0.637108741700139	Neutrophil count	1e-26	32888493
rs2592494	rs2421200	0.637108741700139	Neutrophil count	1e-25	32888493
rs2592494	rs2463097	0.624666127304875	White blood cell count	3e-26	30595370
rs2592496	rs1177308	0.832296903145054	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2592496	rs1177308	0.832296903145054	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2592496	rs7558954	0.830164853563105	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2592496	rs11685226	0.829408059409393	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs2592496	rs11685226	0.829408059409393	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2592496	rs777587	0.691215095655956	Proteoglycan 3 levels	6e-29	34648354
rs2592496	rs777587	0.691215095655956	Pappalysin-1 levels	1e-25	34648354
rs2592496	rs12617371	0.666508271098175	Immature fraction of reticulocytes	8e-18	32888494
rs2592496	rs2463097	0.64982025188512	White blood cell count	3e-26	30595370
rs2592496	rs10199672	0.604522843133944	Height	6e-12	34594039
rs2592496	rs10199672	0.604522843133944	Height	2e-12	31562340
rs2592496	rs2593620	0.602711595442969	Serum levels of protein PRG3	5e-14	35078996
rs2593623	rs2593620	0.920241472877001	Serum levels of protein PRG3	5e-14	35078996
rs2593623	rs2421200	0.896745524979461	Neutrophil count	1e-26	32888493
rs2593623	rs2421200	0.896745524979461	Neutrophil count	1e-25	32888493
rs2593623	rs12617371	0.89072298154467	Immature fraction of reticulocytes	8e-18	32888494
rs2593623	rs777587	0.87022352495108	Proteoglycan 3 levels	6e-29	34648354
rs2593623	rs777587	0.87022352495108	Pappalysin-1 levels	1e-25	34648354
rs2593623	rs2463097	0.843498027720322	White blood cell count	3e-26	30595370
rs2593623	rs10199672	0.839501507755851	Height	6e-12	34594039
rs2593623	rs10199672	0.839501507755851	Height	2e-12	31562340
rs2593623	rs2950269	0.775999836037225	Eosinophil side fluorescence	3e-18	37596262
rs2593623	rs12616433	0.76543835516195	Eosinophil forward scatter	4e-13	37596262
rs2593623	rs12616433	0.76543835516195	Eosinophil side scatter	2e-18	37596262
rs2593623	rs11685226	0.752782665166172	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs2593623	rs11685226	0.752782665166172	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2593623	rs1177308	0.744991965596877	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2593623	rs1177308	0.744991965596877	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2593623	rs7558954	0.741454632290643	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2593623	rs10169482	0.73282987359436	C-reactive protein levels	4e-09	33462484
rs2593623	rs10206089	0.634832859317914	White blood cell count	7e-11	27863252
rs2593623	rs10206089	0.634832859317914	Myeloid white cell count	1e-09	27863252
rs2593623	rs10206089	0.634832859317914	Sum neutrophil eosinophil counts	2e-09	27863252
rs2593623	rs10206089	0.634832859317914	Granulocyte count	3e-09	27863252
rs2596434	rs2596517	0.965721627483783	Hip circumference adjusted for BMI	7e-14	34021172
rs2596434	rs2596484	0.959664982892769	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs2596434	rs2523644	0.885420299413844	Myocardial infarction	5e-07	30226566
rs2596438	rs2596517	0.963689808764498	Hip circumference adjusted for BMI	7e-14	34021172
rs2596438	rs2596484	0.957623877384422	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs2596438	rs2523644	0.883563537066467	Myocardial infarction	5e-07	30226566
rs2600662	rs12617371	0.918616720183756	Immature fraction of reticulocytes	8e-18	32888494
rs2600662	rs777587	0.879125806506619	Proteoglycan 3 levels	6e-29	34648354
rs2600662	rs777587	0.879125806506619	Pappalysin-1 levels	1e-25	34648354
rs2600662	rs2463097	0.871495825052658	White blood cell count	3e-26	30595370
rs2600662	rs10199672	0.857820692010195	Height	6e-12	34594039
rs2600662	rs10199672	0.857820692010195	Height	2e-12	31562340
rs2600662	rs2593620	0.849307823391625	Serum levels of protein PRG3	5e-14	35078996
rs2600662	rs2421200	0.830092259767262	Neutrophil count	1e-26	32888493
rs2600662	rs2421200	0.830092259767262	Neutrophil count	1e-25	32888493
rs2600662	rs11685226	0.772996938785341	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs2600662	rs11685226	0.772996938785341	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2600662	rs1177308	0.767729473290065	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2600662	rs1177308	0.767729473290065	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2600662	rs7558954	0.764068487172	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2600662	rs10169482	0.745331866181237	C-reactive protein levels	4e-09	33462484
rs2600662	rs2950269	0.710653680929982	Eosinophil side fluorescence	3e-18	37596262
rs2600662	rs12616433	0.695936736721668	Eosinophil forward scatter	4e-13	37596262
rs2600662	rs12616433	0.695936736721668	Eosinophil side scatter	2e-18	37596262
rs2600664	rs12617371	0.921772594628579	Immature fraction of reticulocytes	8e-18	32888494
rs2600664	rs777587	0.894607938435605	Proteoglycan 3 levels	6e-29	34648354
rs2600664	rs777587	0.894607938435605	Pappalysin-1 levels	1e-25	34648354
rs2600664	rs2463097	0.876094898807456	White blood cell count	3e-26	30595370
rs2600664	rs10199672	0.862400879697498	Height	6e-12	34594039
rs2600664	rs10199672	0.862400879697498	Height	2e-12	31562340
rs2600664	rs2593620	0.852354022264047	Serum levels of protein PRG3	5e-14	35078996
rs2600664	rs2421200	0.830092259767262	Neutrophil count	1e-26	32888493
rs2600664	rs2421200	0.830092259767262	Neutrophil count	1e-25	32888493
rs2600664	rs11685226	0.778869329264939	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs2600664	rs11685226	0.778869329264939	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2600664	rs1177308	0.77357168398915	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2600664	rs1177308	0.77357168398915	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs2600664	rs7558954	0.769894174088863	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs2600664	rs10169482	0.760875211417464	C-reactive protein levels	4e-09	33462484
rs2600664	rs2950269	0.714855859640145	Eosinophil side fluorescence	3e-18	37596262
rs2600664	rs12616433	0.707176664470246	Eosinophil forward scatter	4e-13	37596262
rs2600664	rs12616433	0.707176664470246	Eosinophil side scatter	2e-18	37596262
rs2608301	rs2446066	1	Vertex-wise sulcal depth	1e-10	34910505
rs2608301	rs2446066	1	Vertex-wise cortical surface area	2e-13	34910505
rs2608301	rs2446066	1	Red blood cell count	1e-10	27863252
rs2608301	rs2446066	1	Cortical surface area	3e-08	34560273
rs2608301	rs2608301	1	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2608301	rs10876448	0.999092856617345	Mean corpuscular hemoglobin	2e-16	32888493
rs2608301	rs10876448	0.999092856617345	Reticulocyte count	3e-18	32888494
rs2608301	rs10876448	0.999092856617345	Reticulocyte fraction of red cells	1e-10	32888494
rs2608301	rs2460882	0.998186251598715	Mean corpuscular volume	3e-15	29403010
rs2608301	rs2460882	0.998186251598715	Percentage gas trapping	6e-07	26030696
rs2608301	rs12582170	0.964891010380584	Mean corpuscular volume	1e-21	27863252
rs2608301	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	7e-37	32888493
rs2608301	rs12582170	0.964891010380584	Mean reticulocyte volume	2e-33	32888494
rs2608301	rs12582170	0.964891010380584	Mean corpuscular volume	1e-67	32888493
rs2608301	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	2e-21	32888494
rs2608301	rs12582170	0.964891010380584	Mean corpuscular volume	1e-26	34104963
rs2608301	rs111379945	0.766400621245193	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2608301	rs111379945	0.766400621245193	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2608301	rs111379945	0.766400621245193	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2608301	rs79205721	0.617589919422487	Vertex-wise cortical thickness	2e-09	34910505
rs2608302	rs2446066	1	Vertex-wise sulcal depth	1e-10	34910505
rs2608302	rs2446066	1	Vertex-wise cortical surface area	2e-13	34910505
rs2608302	rs2446066	1	Red blood cell count	1e-10	27863252
rs2608302	rs2446066	1	Cortical surface area	3e-08	34560273
rs2608302	rs2608301	1	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2608302	rs10876448	0.999092856617345	Mean corpuscular hemoglobin	2e-16	32888493
rs2608302	rs10876448	0.999092856617345	Reticulocyte count	3e-18	32888494
rs2608302	rs10876448	0.999092856617345	Reticulocyte fraction of red cells	1e-10	32888494
rs2608302	rs2460882	0.998186251598715	Mean corpuscular volume	3e-15	29403010
rs2608302	rs2460882	0.998186251598715	Percentage gas trapping	6e-07	26030696
rs2608302	rs12582170	0.964891010380584	Mean corpuscular volume	1e-21	27863252
rs2608302	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	7e-37	32888493
rs2608302	rs12582170	0.964891010380584	Mean reticulocyte volume	2e-33	32888494
rs2608302	rs12582170	0.964891010380584	Mean corpuscular volume	1e-67	32888493
rs2608302	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	2e-21	32888494
rs2608302	rs12582170	0.964891010380584	Mean corpuscular volume	1e-26	34104963
rs2608302	rs111379945	0.766400621245193	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2608302	rs111379945	0.766400621245193	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2608302	rs111379945	0.766400621245193	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2608302	rs79205721	0.617589919422487	Vertex-wise cortical thickness	2e-09	34910505
rs2617435	rs1423357	0.990782165983573	General cognitive ability	9e-06	29844566
rs2617435	rs2432142	0.97909240113781	Neutrophil count	2e-14	32888493
rs2617435	rs2432142	0.97909240113781	White blood cell count	1e-11	32888493
rs2617435	rs38033	0.974221194924239	Blood protein levels	0	30072576
rs2617435	rs27293	0.963456842940968	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2617435	rs27293	0.963456842940968	Diastolic blood pressure	3e-11	35762941
rs2617435	rs7705093	0.956470262714641	Birdshot chorioretinopathy	2e-09	24957906
rs2617435	rs2910686	0.866241295324916	Neutrophil count	4e-14	32888493
rs2617435	rs2910686	0.866241295324916	Psoriasis	2e-08	23143594
rs2617435	rs2910686	0.866241295324916	Ankylosing spondylitis	5e-17	23749187
rs2617435	rs2910686	0.866241295324916	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2617435	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2617435	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2617435	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2617435	rs2617439	0.778918998998163	Neutrophil count	8e-11	32888494
rs2617435	rs2549797	0.771019548090089	Systolic blood pressure	7e-07	33230300
rs2617435	rs2549797	0.771019548090089	Diastolic blood pressure	1e-14	33230300
rs2617435	rs2549797	0.771019548090089	Diastolic blood pressure	3e-11	33230300
rs2617435	rs2549797	0.771019548090089	Systolic blood pressure	4e-09	33230300
rs2617435	rs2549782	0.769761797387831	Systolic blood pressure	6e-07	33230300
rs2617435	rs2549782	0.769761797387831	Diastolic blood pressure	1e-14	33230300
rs2617435	rs2549782	0.769761797387831	Diastolic blood pressure	3e-11	33230300
rs2617435	rs2549782	0.769761797387831	Systolic blood pressure	5e-09	33230300
rs2617435	rs1056893	0.769133764694912	Systolic blood pressure	1e-06	33230300
rs2617435	rs1056893	0.769133764694912	Diastolic blood pressure	7e-15	33230300
rs2617435	rs1056893	0.769133764694912	Diastolic blood pressure	2e-11	33230300
rs2617435	rs1056893	0.769133764694912	Systolic blood pressure	7e-09	33230300
rs2617435	rs2549794	0.76483812290131	Crohn's disease	1e-10	21102463
rs2617435	rs2549794	0.76483812290131	Systolic blood pressure	1e-07	33230300
rs2617435	rs2549794	0.76483812290131	Diastolic blood pressure	1e-15	33230300
rs2617435	rs2549794	0.76483812290131	Diastolic blood pressure	2e-12	33230300
rs2617435	rs2549794	0.76483812290131	Systolic blood pressure	4e-10	33230300
rs2617435	rs38029	0.762619945032584	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2617435	rs1363907	0.760208444462172	Crohn's disease	4e-16	26192919
rs2617435	rs1363907	0.760208444462172	Ulcerative colitis	4e-06	26192919
rs2617435	rs1363907	0.760208444462172	Inflammatory bowel disease	5e-15	26192919
rs2617435	rs1363907	0.760208444462172	Inflammatory bowel disease	6e-13	23128233
rs2617435	rs1363907	0.760208444462172	Inflammatory bowel disease	1e-10	28067908
rs2617435	rs1363907	0.760208444462172	Crohn's disease	1e-14	28067908
rs2617435	rs716848	0.731860855278461	Neutrophil percentage of white cells	2e-09	32888494
rs2617435	rs4869313	0.720020495635562	Pediatric autoimmune diseases	9e-08	26301688
rs2617435	rs1559359	0.713736407994285	Diastolic blood pressure	7e-10	34594039
rs2617435	rs2548532	0.687251061417594	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2617435	rs4869314	0.666692723251499	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2617435	rs4869314	0.666692723251499	Neutrophil count	1e-10	34594039
rs2617435	rs4869314	0.666692723251499	White blood cell count	2e-07	30595370
rs2617435	rs1974871	0.640379183170097	Granulysin levels	5e-13	34648354
rs2617435	rs1019503	0.6359518868097	Systolic blood pressure	2e-06	33230300
rs2617435	rs1019503	0.6359518868097	Diastolic blood pressure	2e-14	33230300
rs2617435	rs1019503	0.6359518868097	Diastolic blood pressure	4e-11	33230300
rs2617435	rs1019503	0.6359518868097	Systolic blood pressure	1e-08	33230300
rs2617435	rs27660	0.633665826402108	Coronary artery disease	3e-08	35915156
rs2617435	rs3096168	0.628555573509049	Aspartate aminotransferase levels	8e-12	33547301
rs2617447	rs2549794	0.984935663305698	Crohn's disease	1e-10	21102463
rs2617447	rs2549794	0.984935663305698	Systolic blood pressure	1e-07	33230300
rs2617447	rs2549794	0.984935663305698	Diastolic blood pressure	1e-15	33230300
rs2617447	rs2549794	0.984935663305698	Diastolic blood pressure	2e-12	33230300
rs2617447	rs2549794	0.984935663305698	Systolic blood pressure	4e-10	33230300
rs2617447	rs1363907	0.983183056637549	Crohn's disease	4e-16	26192919
rs2617447	rs1363907	0.983183056637549	Ulcerative colitis	4e-06	26192919
rs2617447	rs1363907	0.983183056637549	Inflammatory bowel disease	5e-15	26192919
rs2617447	rs1363907	0.983183056637549	Inflammatory bowel disease	6e-13	23128233
rs2617447	rs1363907	0.983183056637549	Inflammatory bowel disease	1e-10	28067908
rs2617447	rs1363907	0.983183056637549	Crohn's disease	1e-14	28067908
rs2617447	rs2617439	0.95751551160828	Neutrophil count	8e-11	32888494
rs2617447	rs716848	0.952379041589512	Neutrophil percentage of white cells	2e-09	32888494
rs2617447	rs38029	0.945482845020358	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2617447	rs2548532	0.88314571795964	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2617447	rs27660	0.791157342969516	Coronary artery disease	3e-08	35915156
rs2617447	rs1423357	0.779942532048287	General cognitive ability	9e-06	29844566
rs2617447	rs2432142	0.764897843673224	Neutrophil count	2e-14	32888493
rs2617447	rs2432142	0.764897843673224	White blood cell count	1e-11	32888493
rs2617447	rs38033	0.763108341986867	Blood protein levels	0	30072576
rs2617447	rs27293	0.754488269166998	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2617447	rs27293	0.754488269166998	Diastolic blood pressure	3e-11	35762941
rs2617447	rs7705093	0.745024043293086	Birdshot chorioretinopathy	2e-09	24957906
rs2617447	rs4869313	0.712788785804826	Pediatric autoimmune diseases	9e-08	26301688
rs2617447	rs2927608	0.710057044995001	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2617447	rs2927608	0.710057044995001	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2617447	rs2927608	0.710057044995001	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2617447	rs2910686	0.707725289688674	Neutrophil count	4e-14	32888493
rs2617447	rs2910686	0.707725289688674	Psoriasis	2e-08	23143594
rs2617447	rs2910686	0.707725289688674	Ankylosing spondylitis	5e-17	23749187
rs2617447	rs2910686	0.707725289688674	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2617447	rs1559359	0.645269213916488	Diastolic blood pressure	7e-10	34594039
rs2617447	rs1974871	0.640364946855364	Granulysin levels	5e-13	34648354
rs2617447	rs2549797	0.628325686328835	Systolic blood pressure	7e-07	33230300
rs2617447	rs2549797	0.628325686328835	Diastolic blood pressure	1e-14	33230300
rs2617447	rs2549797	0.628325686328835	Diastolic blood pressure	3e-11	33230300
rs2617447	rs2549797	0.628325686328835	Systolic blood pressure	4e-09	33230300
rs2617447	rs2549782	0.627309948410338	Systolic blood pressure	6e-07	33230300
rs2617447	rs2549782	0.627309948410338	Diastolic blood pressure	1e-14	33230300
rs2617447	rs2549782	0.627309948410338	Diastolic blood pressure	3e-11	33230300
rs2617447	rs2549782	0.627309948410338	Systolic blood pressure	5e-09	33230300
rs2617447	rs1056893	0.626802759936802	Systolic blood pressure	1e-06	33230300
rs2617447	rs1056893	0.626802759936802	Diastolic blood pressure	7e-15	33230300
rs2617447	rs1056893	0.626802759936802	Diastolic blood pressure	2e-11	33230300
rs2617447	rs1056893	0.626802759936802	Systolic blood pressure	7e-09	33230300
rs2624	rs61798917	0.743123497460904	Height	2e-10	30595370
rs2648726	rs2548499	0.933016489701105	Lymphocyte count	9e-14	32888494
rs2648726	rs2648731	0.746570020164513	Type 2 diabetes	7e-12	34594039
rs2648726	rs2648731	0.746570020164513	Type 2 diabetes	3e-19	34594039
rs2648726	rs2648731	0.746570020164513	Lymphocyte count	2e-11	34594039
rs2648726	rs2648731	0.746570020164513	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs2648726	rs2648731	0.746570020164513	Medication use (drugs used in diabetes)	3e-09	34594039
rs2648726	rs13189973	0.629035495612512	Lymphocyte count	2e-16	32888493
rs2648727	rs2548499	0.934002948251594	Lymphocyte count	9e-14	32888494
rs2648727	rs2648731	0.743900721786353	Type 2 diabetes	7e-12	34594039
rs2648727	rs2648731	0.743900721786353	Type 2 diabetes	3e-19	34594039
rs2648727	rs2648731	0.743900721786353	Lymphocyte count	2e-11	34594039
rs2648727	rs2648731	0.743900721786353	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs2648727	rs2648731	0.743900721786353	Medication use (drugs used in diabetes)	3e-09	34594039
rs2648727	rs13189973	0.629882443057438	Lymphocyte count	2e-16	32888493
rs2648729	rs2548499	0.938950530931861	Lymphocyte count	9e-14	32888494
rs2648729	rs2648731	0.74819084524149	Type 2 diabetes	7e-12	34594039
rs2648729	rs2648731	0.74819084524149	Type 2 diabetes	3e-19	34594039
rs2648729	rs2648731	0.74819084524149	Lymphocyte count	2e-11	34594039
rs2648729	rs2648731	0.74819084524149	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs2648729	rs2648731	0.74819084524149	Medication use (drugs used in diabetes)	3e-09	34594039
rs2648729	rs13189973	0.627933014586021	Lymphocyte count	2e-16	32888493
rs2648730	rs2548499	0.938950530931861	Lymphocyte count	9e-14	32888494
rs2648730	rs2648731	0.74819084524149	Type 2 diabetes	7e-12	34594039
rs2648730	rs2648731	0.74819084524149	Type 2 diabetes	3e-19	34594039
rs2648730	rs2648731	0.74819084524149	Lymphocyte count	2e-11	34594039
rs2648730	rs2648731	0.74819084524149	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs2648730	rs2648731	0.74819084524149	Medication use (drugs used in diabetes)	3e-09	34594039
rs2648730	rs13189973	0.627933014586021	Lymphocyte count	2e-16	32888493
rs2654183	rs409942	0.898489946195419	Total cholesterol levels	8e-06	35884923
rs2654183	rs739669	0.763011433072893	BMI at birth	5e-17	35315439
rs2654183	rs222837	0.710810739618933	Metabolite levels	7e-06	23823483
rs2654183	rs2654189	0.669901461668727	Eosinophil counts	4e-11	32888494
rs2654183	rs2654189	0.669901461668727	Eosinophil percentage of white cells	6e-12	32888494
rs2654183	rs2654189	0.669901461668727	Eosinophil counts	1e-09	30595370
rs2654183	rs5415	0.660008240922024	Birth weight	5e-06	23202124
rs2654183	rs5415	0.660008240922024	LDL cholesterol levels	1e-06	35884923
rs2654183	rs13331	0.634610355915839	Heel bone mineral density	4e-08	30595370
rs2654186	rs409942	0.895768559097892	Total cholesterol levels	8e-06	35884923
rs2654186	rs739669	0.762066787998186	BMI at birth	5e-17	35315439
rs2654186	rs222837	0.710135164847054	Metabolite levels	7e-06	23823483
rs2654186	rs2654189	0.668585136313901	Eosinophil counts	4e-11	32888494
rs2654186	rs2654189	0.668585136313901	Eosinophil percentage of white cells	6e-12	32888494
rs2654186	rs2654189	0.668585136313901	Eosinophil counts	1e-09	30595370
rs2654186	rs5415	0.658752356698234	Birth weight	5e-06	23202124
rs2654186	rs5415	0.658752356698234	LDL cholesterol levels	1e-06	35884923
rs2654186	rs13331	0.63368326944239	Heel bone mineral density	4e-08	30595370
rs2654188	rs409942	0.902061842292175	Total cholesterol levels	8e-06	35884923
rs2654188	rs5415	0.769550354295139	Birth weight	5e-06	23202124
rs2654188	rs5415	0.769550354295139	LDL cholesterol levels	1e-06	35884923
rs2654188	rs2654189	0.76882230682547	Eosinophil counts	4e-11	32888494
rs2654188	rs2654189	0.76882230682547	Eosinophil percentage of white cells	6e-12	32888494
rs2654188	rs2654189	0.76882230682547	Eosinophil counts	1e-09	30595370
rs2654188	rs739669	0.669465127564074	BMI at birth	5e-17	35315439
rs2654188	rs222837	0.622488690054337	Metabolite levels	7e-06	23823483
rs2654190	rs409942	0.910173782401342	Total cholesterol levels	8e-06	35884923
rs2654190	rs2654189	0.779653631305497	Eosinophil counts	4e-11	32888494
rs2654190	rs2654189	0.779653631305497	Eosinophil percentage of white cells	6e-12	32888494
rs2654190	rs2654189	0.779653631305497	Eosinophil counts	1e-09	30595370
rs2654190	rs5415	0.777004336024348	Birth weight	5e-06	23202124
rs2654190	rs5415	0.777004336024348	LDL cholesterol levels	1e-06	35884923
rs2654190	rs739669	0.674099092174398	BMI at birth	5e-17	35315439
rs2654190	rs222837	0.626428620170737	Metabolite levels	7e-06	23823483
rs2655310	rs337277	0.901088247728839	Metabolite peak levels (QI10992)	3e-52	35995766
rs2655310	rs337277	0.901088247728839	Metabolite peak levels (QI4667)	7e-18	35995766
rs2655310	rs337277	0.901088247728839	Metabolite peak levels (QI4708)	1e-21	35995766
rs2655310	rs337277	0.901088247728839	Metabolite peak levels (QI5169)	7e-57	35995766
rs2655310	rs7655841	0.752418605235943	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs2660	rs1131476	1	Systemic lupus erythematosus	1e-09	33272962
rs2660	rs2660	1	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs2660	rs2660	1	COVID-19 (critical illness vs population)	3e-15	37198478
rs2660	rs2057778	0.971509070243431	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs2660	rs2057778	0.971509070243431	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs2660	rs2057778	0.971509070243431	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs2660	rs4767027	0.97032942751798	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs2660	rs11066452	0.949153887779849	Blood protein levels	6e-08	30072576
rs2660	rs1859336	0.911479300471044	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs2660	rs6489882	0.895047912374631	Chronic lymphocytic leukemia	5e-08	28165464
rs2660	rs6489867	0.621471512329174	COVID-19 (critical illness vs population)	1e-09	33307546
rs2662024	rs33321	0.753259640601648	Height	1e-19	34594039
rs2662024	rs832540	0.709703966856608	Coronary artery disease	2e-08	29212778
rs2662024	rs10061757	0.604571301400752	Height	4e-30	30595370
rs2662038	rs33321	0.894814282884655	Height	1e-19	34594039
rs2662038	rs832540	0.871612785466849	Coronary artery disease	2e-08	29212778
rs2662038	rs10061757	0.732803519766025	Height	4e-30	30595370
rs2662038	rs96844	0.636293069849735	Type 2 diabetes	5e-08	30297969
rs2662038	rs96844	0.636293069849735	Height	4e-33	36224396
rs2662040	rs33321	0.97280263336004	Height	1e-19	34594039
rs2662040	rs832540	0.913625443824302	Coronary artery disease	2e-08	29212778
rs2662040	rs10061757	0.7096155042299	Height	4e-30	30595370
rs2662040	rs96844	0.60650820322085	Type 2 diabetes	5e-08	30297969
rs2662040	rs96844	0.60650820322085	Height	4e-33	36224396
rs2682561	rs3213282	0.609438842828878	Low density lipoprotein cholesterol levels	3e-11	32154731
rs2683452	rs8207	0.799251037717141	Monocyte count	1e-10	32888493
rs2683452	rs8207	0.799251037717141	Height	2e-18	36224396
rs2683452	rs6738934	0.650858602744178	Vaginal microbiome MetaCyc pathway (PWY-5741|ethylmalonyl-CoA pathway)	3e-07	34282934
rs2683522	rs2446066	0.995467577711887	Vertex-wise sulcal depth	1e-10	34910505
rs2683522	rs2446066	0.995467577711887	Vertex-wise cortical surface area	2e-13	34910505
rs2683522	rs2446066	0.995467577711887	Red blood cell count	1e-10	27863252
rs2683522	rs2446066	0.995467577711887	Cortical surface area	3e-08	34560273
rs2683522	rs2608301	0.995467577711887	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2683522	rs10876448	0.994561230037976	Mean corpuscular hemoglobin	2e-16	32888493
rs2683522	rs10876448	0.994561230037976	Reticulocyte count	3e-18	32888494
rs2683522	rs10876448	0.994561230037976	Reticulocyte fraction of red cells	1e-10	32888494
rs2683522	rs2460882	0.993655420261393	Mean corpuscular volume	3e-15	29403010
rs2683522	rs2460882	0.993655420261393	Percentage gas trapping	6e-07	26030696
rs2683522	rs12582170	0.963989566807596	Mean corpuscular volume	1e-21	27863252
rs2683522	rs12582170	0.963989566807596	Mean corpuscular hemoglobin	7e-37	32888493
rs2683522	rs12582170	0.963989566807596	Mean reticulocyte volume	2e-33	32888494
rs2683522	rs12582170	0.963989566807596	Mean corpuscular volume	1e-67	32888493
rs2683522	rs12582170	0.963989566807596	Mean corpuscular hemoglobin	2e-21	32888494
rs2683522	rs12582170	0.963989566807596	Mean corpuscular volume	1e-26	34104963
rs2683522	rs111379945	0.767150692255209	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2683522	rs111379945	0.767150692255209	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2683522	rs111379945	0.767150692255209	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2683522	rs79205721	0.616889188997008	Vertex-wise cortical thickness	2e-09	34910505
rs2683524	rs10876448	0.939127032336435	Mean corpuscular hemoglobin	2e-16	32888493
rs2683524	rs10876448	0.939127032336435	Reticulocyte count	3e-18	32888494
rs2683524	rs10876448	0.939127032336435	Reticulocyte fraction of red cells	1e-10	32888494
rs2683524	rs2446066	0.938265667278351	Vertex-wise sulcal depth	1e-10	34910505
rs2683524	rs2446066	0.938265667278351	Vertex-wise cortical surface area	2e-13	34910505
rs2683524	rs2446066	0.938265667278351	Red blood cell count	1e-10	27863252
rs2683524	rs2446066	0.938265667278351	Cortical surface area	3e-08	34560273
rs2683524	rs2608301	0.938265667278351	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2683524	rs2460882	0.936453908938224	Mean corpuscular volume	3e-15	29403010
rs2683524	rs2460882	0.936453908938224	Percentage gas trapping	6e-07	26030696
rs2683524	rs12582170	0.907363699332623	Mean corpuscular volume	1e-21	27863252
rs2683524	rs12582170	0.907363699332623	Mean corpuscular hemoglobin	7e-37	32888493
rs2683524	rs12582170	0.907363699332623	Mean reticulocyte volume	2e-33	32888494
rs2683524	rs12582170	0.907363699332623	Mean corpuscular volume	1e-67	32888493
rs2683524	rs12582170	0.907363699332623	Mean corpuscular hemoglobin	2e-21	32888494
rs2683524	rs12582170	0.907363699332623	Mean corpuscular volume	1e-26	34104963
rs2683524	rs111379945	0.781866711143979	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2683524	rs111379945	0.781866711143979	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2683524	rs111379945	0.781866711143979	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2683525	rs10876448	0.943557119051306	Mean corpuscular hemoglobin	2e-16	32888493
rs2683525	rs10876448	0.943557119051306	Reticulocyte count	3e-18	32888494
rs2683525	rs10876448	0.943557119051306	Reticulocyte fraction of red cells	1e-10	32888494
rs2683525	rs2446066	0.94269328912809	Vertex-wise sulcal depth	1e-10	34910505
rs2683525	rs2446066	0.94269328912809	Vertex-wise cortical surface area	2e-13	34910505
rs2683525	rs2446066	0.94269328912809	Red blood cell count	1e-10	27863252
rs2683525	rs2446066	0.94269328912809	Cortical surface area	3e-08	34560273
rs2683525	rs2608301	0.94269328912809	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2683525	rs2460882	0.94087754656316	Mean corpuscular volume	3e-15	29403010
rs2683525	rs2460882	0.94087754656316	Percentage gas trapping	6e-07	26030696
rs2683525	rs12582170	0.911715454747235	Mean corpuscular volume	1e-21	27863252
rs2683525	rs12582170	0.911715454747235	Mean corpuscular hemoglobin	7e-37	32888493
rs2683525	rs12582170	0.911715454747235	Mean reticulocyte volume	2e-33	32888494
rs2683525	rs12582170	0.911715454747235	Mean corpuscular volume	1e-67	32888493
rs2683525	rs12582170	0.911715454747235	Mean corpuscular hemoglobin	2e-21	32888494
rs2683525	rs12582170	0.911715454747235	Mean corpuscular volume	1e-26	34104963
rs2683525	rs111379945	0.784268551758523	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2683525	rs111379945	0.784268551758523	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2683525	rs111379945	0.784268551758523	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2683764	rs7817052	0.60255190259619	Metabolite levels	4e-06	23823483
rs2694847	rs2446066	1	Vertex-wise sulcal depth	1e-10	34910505
rs2694847	rs2446066	1	Vertex-wise cortical surface area	2e-13	34910505
rs2694847	rs2446066	1	Red blood cell count	1e-10	27863252
rs2694847	rs2446066	1	Cortical surface area	3e-08	34560273
rs2694847	rs2608301	1	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2694847	rs10876448	0.999092856617345	Mean corpuscular hemoglobin	2e-16	32888493
rs2694847	rs10876448	0.999092856617345	Reticulocyte count	3e-18	32888494
rs2694847	rs10876448	0.999092856617345	Reticulocyte fraction of red cells	1e-10	32888494
rs2694847	rs2460882	0.998186251598715	Mean corpuscular volume	3e-15	29403010
rs2694847	rs2460882	0.998186251598715	Percentage gas trapping	6e-07	26030696
rs2694847	rs12582170	0.964891010380584	Mean corpuscular volume	1e-21	27863252
rs2694847	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	7e-37	32888493
rs2694847	rs12582170	0.964891010380584	Mean reticulocyte volume	2e-33	32888494
rs2694847	rs12582170	0.964891010380584	Mean corpuscular volume	1e-67	32888493
rs2694847	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	2e-21	32888494
rs2694847	rs12582170	0.964891010380584	Mean corpuscular volume	1e-26	34104963
rs2694847	rs111379945	0.766400621245193	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2694847	rs111379945	0.766400621245193	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2694847	rs111379945	0.766400621245193	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2694847	rs79205721	0.617589919422487	Vertex-wise cortical thickness	2e-09	34910505
rs2695297	rs2695294	0.894791714191205	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs2695297	rs2695295	0.894091942241177	Serum levels of protein NAAA	1e-68	35078996
rs2695297	rs2695295	0.894091942241177	Serum levels of protein SMPDL3A	8e-86	35078996
rs2695297	rs2559856	0.892577945434679	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs2695297	rs3809260	0.883446110733181	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs2695297	rs2559851	0.82382122514458	Cathepsin F levels	2e-96	34648354
rs2695297	rs2559851	0.82382122514458	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs2695297	rs2559850	0.709918940893804	Serum levels of protein CTSH	1e-19	35078996
rs2695297	rs2559850	0.709918940893804	Vitamin C levels	6e-20	33203707
rs2695297	rs2559850	0.709918940893804	Cathepsin L2 levels	1e-24	34648354
rs2695297	rs2559850	0.709918940893804	Islet amyloid polypeptide levels	1e-49	34648354
rs2695297	rs2559850	0.709918940893804	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs27289	rs27293	0.992479542659572	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27289	rs27293	0.992479542659572	Diastolic blood pressure	3e-11	35762941
rs27289	rs38033	0.980003023155052	Blood protein levels	0	30072576
rs27289	rs1423357	0.961906211271806	General cognitive ability	9e-06	29844566
rs27289	rs2432142	0.945497657271182	Neutrophil count	2e-14	32888493
rs27289	rs2432142	0.945497657271182	White blood cell count	1e-11	32888493
rs27289	rs7705093	0.926311712189767	Birdshot chorioretinopathy	2e-09	24957906
rs27289	rs2910686	0.8372806209969	Neutrophil count	4e-14	32888493
rs27289	rs2910686	0.8372806209969	Psoriasis	2e-08	23143594
rs27289	rs2910686	0.8372806209969	Ankylosing spondylitis	5e-17	23749187
rs27289	rs2910686	0.8372806209969	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27289	rs2927608	0.834054860113684	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27289	rs2927608	0.834054860113684	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27289	rs2927608	0.834054860113684	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27289	rs38029	0.789891769793353	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27289	rs2617439	0.750137668236412	Neutrophil count	8e-11	32888494
rs27289	rs2549797	0.743209094808833	Systolic blood pressure	7e-07	33230300
rs27289	rs2549797	0.743209094808833	Diastolic blood pressure	1e-14	33230300
rs27289	rs2549797	0.743209094808833	Diastolic blood pressure	3e-11	33230300
rs27289	rs2549797	0.743209094808833	Systolic blood pressure	4e-09	33230300
rs27289	rs2549794	0.742231799369305	Crohn's disease	1e-10	21102463
rs27289	rs2549794	0.742231799369305	Systolic blood pressure	1e-07	33230300
rs27289	rs2549794	0.742231799369305	Diastolic blood pressure	1e-15	33230300
rs27289	rs2549794	0.742231799369305	Diastolic blood pressure	2e-12	33230300
rs27289	rs2549794	0.742231799369305	Systolic blood pressure	4e-10	33230300
rs27289	rs2549782	0.741966838554094	Systolic blood pressure	6e-07	33230300
rs27289	rs2549782	0.741966838554094	Diastolic blood pressure	1e-14	33230300
rs27289	rs2549782	0.741966838554094	Diastolic blood pressure	3e-11	33230300
rs27289	rs2549782	0.741966838554094	Systolic blood pressure	5e-09	33230300
rs27289	rs1056893	0.741346543111277	Systolic blood pressure	1e-06	33230300
rs27289	rs1056893	0.741346543111277	Diastolic blood pressure	7e-15	33230300
rs27289	rs1056893	0.741346543111277	Diastolic blood pressure	2e-11	33230300
rs27289	rs1056893	0.741346543111277	Systolic blood pressure	7e-09	33230300
rs27289	rs1363907	0.737672994857246	Crohn's disease	4e-16	26192919
rs27289	rs1363907	0.737672994857246	Ulcerative colitis	4e-06	26192919
rs27289	rs1363907	0.737672994857246	Inflammatory bowel disease	5e-15	26192919
rs27289	rs1363907	0.737672994857246	Inflammatory bowel disease	6e-13	23128233
rs27289	rs1363907	0.737672994857246	Inflammatory bowel disease	1e-10	28067908
rs27289	rs1363907	0.737672994857246	Crohn's disease	1e-14	28067908
rs27289	rs716848	0.709675111832997	Neutrophil percentage of white cells	2e-09	32888494
rs27289	rs4869313	0.694244600524715	Pediatric autoimmune diseases	9e-08	26301688
rs27289	rs1559359	0.687590674928226	Diastolic blood pressure	7e-10	34594039
rs27289	rs2548532	0.666340449396082	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27289	rs4869314	0.641900853963576	Arthritis (juvenile idiopathic)	3e-09	33106285
rs27289	rs4869314	0.641900853963576	Neutrophil count	1e-10	34594039
rs27289	rs4869314	0.641900853963576	White blood cell count	2e-07	30595370
rs27289	rs27660	0.626803383724346	Coronary artery disease	3e-08	35915156
rs27289	rs1974871	0.615744172895661	Granulysin levels	5e-13	34648354
rs27289	rs1019503	0.611050828467404	Systolic blood pressure	2e-06	33230300
rs27289	rs1019503	0.611050828467404	Diastolic blood pressure	2e-14	33230300
rs27289	rs1019503	0.611050828467404	Diastolic blood pressure	4e-11	33230300
rs27289	rs1019503	0.611050828467404	Systolic blood pressure	1e-08	33230300
rs27289	rs3096168	0.603872650393772	Aspartate aminotransferase levels	8e-12	33547301
rs27290	rs27293	0.992491996061856	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27290	rs27293	0.992491996061856	Diastolic blood pressure	3e-11	35762941
rs27290	rs38033	0.980015664107233	Blood protein levels	0	30072576
rs27290	rs1423357	0.961963815385734	General cognitive ability	9e-06	29844566
rs27290	rs2432142	0.945557843246377	Neutrophil count	2e-14	32888493
rs27290	rs2432142	0.945557843246377	White blood cell count	1e-11	32888493
rs27290	rs7705093	0.92630789602504	Birdshot chorioretinopathy	2e-09	24957906
rs27290	rs2910686	0.837184469268335	Neutrophil count	4e-14	32888493
rs27290	rs2910686	0.837184469268335	Psoriasis	2e-08	23143594
rs27290	rs2910686	0.837184469268335	Ankylosing spondylitis	5e-17	23749187
rs27290	rs2910686	0.837184469268335	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27290	rs2927608	0.833965019201711	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27290	rs2927608	0.833965019201711	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27290	rs2927608	0.833965019201711	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27290	rs38029	0.791847437498657	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27290	rs2617439	0.750587930466179	Neutrophil count	8e-11	32888494
rs27290	rs2549797	0.742981843416837	Systolic blood pressure	7e-07	33230300
rs27290	rs2549797	0.742981843416837	Diastolic blood pressure	1e-14	33230300
rs27290	rs2549797	0.742981843416837	Diastolic blood pressure	3e-11	33230300
rs27290	rs2549797	0.742981843416837	Systolic blood pressure	4e-09	33230300
rs27290	rs2549794	0.74265455965444	Crohn's disease	1e-10	21102463
rs27290	rs2549794	0.74265455965444	Systolic blood pressure	1e-07	33230300
rs27290	rs2549794	0.74265455965444	Diastolic blood pressure	1e-15	33230300
rs27290	rs2549794	0.74265455965444	Diastolic blood pressure	2e-12	33230300
rs27290	rs2549794	0.74265455965444	Systolic blood pressure	4e-10	33230300
rs27290	rs2549782	0.741737930265409	Systolic blood pressure	6e-07	33230300
rs27290	rs2549782	0.741737930265409	Diastolic blood pressure	1e-14	33230300
rs27290	rs2549782	0.741737930265409	Diastolic blood pressure	3e-11	33230300
rs27290	rs2549782	0.741737930265409	Systolic blood pressure	5e-09	33230300
rs27290	rs1056893	0.741116807528394	Systolic blood pressure	1e-06	33230300
rs27290	rs1056893	0.741116807528394	Diastolic blood pressure	7e-15	33230300
rs27290	rs1056893	0.741116807528394	Diastolic blood pressure	2e-11	33230300
rs27290	rs1056893	0.741116807528394	Systolic blood pressure	7e-09	33230300
rs27290	rs1363907	0.738093438687372	Crohn's disease	4e-16	26192919
rs27290	rs1363907	0.738093438687372	Ulcerative colitis	4e-06	26192919
rs27290	rs1363907	0.738093438687372	Inflammatory bowel disease	5e-15	26192919
rs27290	rs1363907	0.738093438687372	Inflammatory bowel disease	6e-13	23128233
rs27290	rs1363907	0.738093438687372	Inflammatory bowel disease	1e-10	28067908
rs27290	rs1363907	0.738093438687372	Crohn's disease	1e-14	28067908
rs27290	rs716848	0.710048613499209	Neutrophil percentage of white cells	2e-09	32888494
rs27290	rs4869313	0.694301836004007	Pediatric autoimmune diseases	9e-08	26301688
rs27290	rs1559359	0.68751375450861	Diastolic blood pressure	7e-10	34594039
rs27290	rs2548532	0.666919442991058	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27290	rs4869314	0.64162277027279	Arthritis (juvenile idiopathic)	3e-09	33106285
rs27290	rs4869314	0.64162277027279	Neutrophil count	1e-10	34594039
rs27290	rs4869314	0.64162277027279	White blood cell count	2e-07	30595370
rs27290	rs27660	0.627550663838268	Coronary artery disease	3e-08	35915156
rs27290	rs1974871	0.615692037719165	Granulysin levels	5e-13	34648354
rs27290	rs1019503	0.613196345262987	Systolic blood pressure	2e-06	33230300
rs27290	rs1019503	0.613196345262987	Diastolic blood pressure	2e-14	33230300
rs27290	rs1019503	0.613196345262987	Diastolic blood pressure	4e-11	33230300
rs27290	rs1019503	0.613196345262987	Systolic blood pressure	1e-08	33230300
rs27290	rs3096168	0.606019408612002	Aspartate aminotransferase levels	8e-12	33547301
rs27293	rs27293	1	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27293	rs27293	1	Diastolic blood pressure	3e-11	35762941
rs27293	rs38033	0.979165719976911	Blood protein levels	0	30072576
rs27293	rs1423357	0.961018107387047	General cognitive ability	9e-06	29844566
rs27293	rs2432142	0.944613407644149	Neutrophil count	2e-14	32888493
rs27293	rs2432142	0.944613407644149	White blood cell count	1e-11	32888493
rs27293	rs7705093	0.925519435880764	Birdshot chorioretinopathy	2e-09	24957906
rs27293	rs2910686	0.836648451311368	Neutrophil count	4e-14	32888493
rs27293	rs2910686	0.836648451311368	Psoriasis	2e-08	23143594
rs27293	rs2910686	0.836648451311368	Ankylosing spondylitis	5e-17	23749187
rs27293	rs2910686	0.836648451311368	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27293	rs2927608	0.834931995905953	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27293	rs2927608	0.834931995905953	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27293	rs2927608	0.834931995905953	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27293	rs38029	0.791676647817495	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27293	rs2617439	0.751832431074164	Neutrophil count	8e-11	32888494
rs27293	rs2549794	0.743942234032582	Crohn's disease	1e-10	21102463
rs27293	rs2549794	0.743942234032582	Systolic blood pressure	1e-07	33230300
rs27293	rs2549794	0.743942234032582	Diastolic blood pressure	1e-15	33230300
rs27293	rs2549794	0.743942234032582	Diastolic blood pressure	2e-12	33230300
rs27293	rs2549794	0.743942234032582	Systolic blood pressure	4e-10	33230300
rs27293	rs2549797	0.742789822337033	Systolic blood pressure	7e-07	33230300
rs27293	rs2549797	0.742789822337033	Diastolic blood pressure	1e-14	33230300
rs27293	rs2549797	0.742789822337033	Diastolic blood pressure	3e-11	33230300
rs27293	rs2549797	0.742789822337033	Systolic blood pressure	4e-09	33230300
rs27293	rs2549782	0.741550282856657	Systolic blood pressure	6e-07	33230300
rs27293	rs2549782	0.741550282856657	Diastolic blood pressure	1e-14	33230300
rs27293	rs2549782	0.741550282856657	Diastolic blood pressure	3e-11	33230300
rs27293	rs2549782	0.741550282856657	Systolic blood pressure	5e-09	33230300
rs27293	rs1056893	0.740931343938947	Systolic blood pressure	1e-06	33230300
rs27293	rs1056893	0.740931343938947	Diastolic blood pressure	7e-15	33230300
rs27293	rs1056893	0.740931343938947	Diastolic blood pressure	2e-11	33230300
rs27293	rs1056893	0.740931343938947	Systolic blood pressure	7e-09	33230300
rs27293	rs1363907	0.739378792587365	Crohn's disease	4e-16	26192919
rs27293	rs1363907	0.739378792587365	Ulcerative colitis	4e-06	26192919
rs27293	rs1363907	0.739378792587365	Inflammatory bowel disease	5e-15	26192919
rs27293	rs1363907	0.739378792587365	Inflammatory bowel disease	6e-13	23128233
rs27293	rs1363907	0.739378792587365	Inflammatory bowel disease	1e-10	28067908
rs27293	rs1363907	0.739378792587365	Crohn's disease	1e-14	28067908
rs27293	rs716848	0.711385408039983	Neutrophil percentage of white cells	2e-09	32888494
rs27293	rs4869313	0.694874301684017	Pediatric autoimmune diseases	9e-08	26301688
rs27293	rs1559359	0.688378940896262	Diastolic blood pressure	7e-10	34594039
rs27293	rs2548532	0.667776737803057	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27293	rs4869314	0.644227415419062	Arthritis (juvenile idiopathic)	3e-09	33106285
rs27293	rs4869314	0.644227415419062	Neutrophil count	1e-10	34594039
rs27293	rs4869314	0.644227415419062	White blood cell count	2e-07	30595370
rs27293	rs27660	0.628014566308903	Coronary artery disease	3e-08	35915156
rs27293	rs1974871	0.616463840026967	Granulysin levels	5e-13	34648354
rs27293	rs1019503	0.61093273709134	Systolic blood pressure	2e-06	33230300
rs27293	rs1019503	0.61093273709134	Diastolic blood pressure	2e-14	33230300
rs27293	rs1019503	0.61093273709134	Diastolic blood pressure	4e-11	33230300
rs27293	rs1019503	0.61093273709134	Systolic blood pressure	1e-08	33230300
rs27293	rs3096168	0.603738030855582	Aspartate aminotransferase levels	8e-12	33547301
rs27295	rs27293	0.996654627178214	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27295	rs27293	0.996654627178214	Diastolic blood pressure	3e-11	35762941
rs27295	rs38033	0.982489604412486	Blood protein levels	0	30072576
rs27295	rs1423357	0.964364838259147	General cognitive ability	9e-06	29844566
rs27295	rs2432142	0.947933994951388	Neutrophil count	2e-14	32888493
rs27295	rs2432142	0.947933994951388	White blood cell count	1e-11	32888493
rs27295	rs7705093	0.928727771263053	Birdshot chorioretinopathy	2e-09	24957906
rs27295	rs2910686	0.839583724238078	Neutrophil count	4e-14	32888493
rs27295	rs2910686	0.839583724238078	Psoriasis	2e-08	23143594
rs27295	rs2910686	0.839583724238078	Ankylosing spondylitis	5e-17	23749187
rs27295	rs2910686	0.839583724238078	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27295	rs2927608	0.837870696008422	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27295	rs2927608	0.837870696008422	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27295	rs2927608	0.837870696008422	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27295	rs38029	0.793629200695305	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27295	rs2617439	0.753780595156768	Neutrophil count	8e-11	32888494
rs27295	rs2549794	0.745850445253859	Crohn's disease	1e-10	21102463
rs27295	rs2549794	0.745850445253859	Systolic blood pressure	1e-07	33230300
rs27295	rs2549794	0.745850445253859	Diastolic blood pressure	1e-15	33230300
rs27295	rs2549794	0.745850445253859	Diastolic blood pressure	2e-12	33230300
rs27295	rs2549794	0.745850445253859	Systolic blood pressure	4e-10	33230300
rs27295	rs2549797	0.745395962961471	Systolic blood pressure	7e-07	33230300
rs27295	rs2549797	0.745395962961471	Diastolic blood pressure	1e-14	33230300
rs27295	rs2549797	0.745395962961471	Diastolic blood pressure	3e-11	33230300
rs27295	rs2549797	0.745395962961471	Systolic blood pressure	4e-09	33230300
rs27295	rs2549782	0.744152158923118	Systolic blood pressure	6e-07	33230300
rs27295	rs2549782	0.744152158923118	Diastolic blood pressure	1e-14	33230300
rs27295	rs2549782	0.744152158923118	Diastolic blood pressure	3e-11	33230300
rs27295	rs2549782	0.744152158923118	Systolic blood pressure	5e-09	33230300
rs27295	rs1056893	0.743531090583136	Systolic blood pressure	1e-06	33230300
rs27295	rs1056893	0.743531090583136	Diastolic blood pressure	7e-15	33230300
rs27295	rs1056893	0.743531090583136	Diastolic blood pressure	2e-11	33230300
rs27295	rs1056893	0.743531090583136	Systolic blood pressure	7e-09	33230300
rs27295	rs1363907	0.741279719893692	Crohn's disease	4e-16	26192919
rs27295	rs1363907	0.741279719893692	Ulcerative colitis	4e-06	26192919
rs27295	rs1363907	0.741279719893692	Inflammatory bowel disease	5e-15	26192919
rs27295	rs1363907	0.741279719893692	Inflammatory bowel disease	6e-13	23128233
rs27295	rs1363907	0.741279719893692	Inflammatory bowel disease	1e-10	28067908
rs27295	rs1363907	0.741279719893692	Crohn's disease	1e-14	28067908
rs27295	rs716848	0.713203499138104	Neutrophil percentage of white cells	2e-09	32888494
rs27295	rs4869313	0.697712363903514	Pediatric autoimmune diseases	9e-08	26301688
rs27295	rs1559359	0.691045527291068	Diastolic blood pressure	7e-10	34594039
rs27295	rs2548532	0.669790121131411	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27295	rs4869314	0.645259957724748	Arthritis (juvenile idiopathic)	3e-09	33106285
rs27295	rs4869314	0.645259957724748	Neutrophil count	1e-10	34594039
rs27295	rs4869314	0.645259957724748	White blood cell count	2e-07	30595370
rs27295	rs27660	0.630187400731565	Coronary artery disease	3e-08	35915156
rs27295	rs1974871	0.619007771731807	Granulysin levels	5e-13	34648354
rs27295	rs1019503	0.613074755379955	Systolic blood pressure	2e-06	33230300
rs27295	rs1019503	0.613074755379955	Diastolic blood pressure	2e-14	33230300
rs27295	rs1019503	0.613074755379955	Diastolic blood pressure	4e-11	33230300
rs27295	rs1019503	0.613074755379955	Systolic blood pressure	1e-08	33230300
rs27295	rs3096168	0.605881315530673	Aspartate aminotransferase levels	8e-12	33547301
rs27298	rs27293	0.970937599728484	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27298	rs27293	0.970937599728484	Diastolic blood pressure	3e-11	35762941
rs27298	rs38033	0.956956073204728	Blood protein levels	0	30072576
rs27298	rs1423357	0.93865598508922	General cognitive ability	9e-06	29844566
rs27298	rs2432142	0.9224260844176	Neutrophil count	2e-14	32888493
rs27298	rs2432142	0.9224260844176	White blood cell count	1e-11	32888493
rs27298	rs7705093	0.904081997230925	Birdshot chorioretinopathy	2e-09	24957906
rs27298	rs2910686	0.817035678211321	Neutrophil count	4e-14	32888493
rs27298	rs2910686	0.817035678211321	Psoriasis	2e-08	23143594
rs27298	rs2910686	0.817035678211321	Ankylosing spondylitis	5e-17	23749187
rs27298	rs2910686	0.817035678211321	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27298	rs2927608	0.815296361365141	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27298	rs2927608	0.815296361365141	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27298	rs2927608	0.815296361365141	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27298	rs38029	0.766838380844224	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27298	rs2617439	0.727294658144671	Neutrophil count	8e-11	32888494
rs27298	rs2549797	0.725376231096698	Systolic blood pressure	7e-07	33230300
rs27298	rs2549797	0.725376231096698	Diastolic blood pressure	1e-14	33230300
rs27298	rs2549797	0.725376231096698	Diastolic blood pressure	3e-11	33230300
rs27298	rs2549797	0.725376231096698	Systolic blood pressure	4e-09	33230300
rs27298	rs2549782	0.724165186673507	Systolic blood pressure	6e-07	33230300
rs27298	rs2549782	0.724165186673507	Diastolic blood pressure	1e-14	33230300
rs27298	rs2549782	0.724165186673507	Diastolic blood pressure	3e-11	33230300
rs27298	rs2549782	0.724165186673507	Systolic blood pressure	5e-09	33230300
rs27298	rs1056893	0.723560476196382	Systolic blood pressure	1e-06	33230300
rs27298	rs1056893	0.723560476196382	Diastolic blood pressure	7e-15	33230300
rs27298	rs1056893	0.723560476196382	Diastolic blood pressure	2e-11	33230300
rs27298	rs1056893	0.723560476196382	Systolic blood pressure	7e-09	33230300
rs27298	rs2549794	0.71976627119101	Crohn's disease	1e-10	21102463
rs27298	rs2549794	0.71976627119101	Systolic blood pressure	1e-07	33230300
rs27298	rs2549794	0.71976627119101	Diastolic blood pressure	1e-15	33230300
rs27298	rs2549794	0.71976627119101	Diastolic blood pressure	2e-12	33230300
rs27298	rs2549794	0.71976627119101	Systolic blood pressure	4e-10	33230300
rs27298	rs1363907	0.715290086657488	Crohn's disease	4e-16	26192919
rs27298	rs1363907	0.715290086657488	Ulcerative colitis	4e-06	26192919
rs27298	rs1363907	0.715290086657488	Inflammatory bowel disease	5e-15	26192919
rs27298	rs1363907	0.715290086657488	Inflammatory bowel disease	6e-13	23128233
rs27298	rs1363907	0.715290086657488	Inflammatory bowel disease	1e-10	28067908
rs27298	rs1363907	0.715290086657488	Crohn's disease	1e-14	28067908
rs27298	rs716848	0.688126402578009	Neutrophil percentage of white cells	2e-09	32888494
rs27298	rs4869313	0.675915634924625	Pediatric autoimmune diseases	9e-08	26301688
rs27298	rs1559359	0.670563643851604	Diastolic blood pressure	7e-10	34594039
rs27298	rs2548532	0.643313291383092	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27298	rs4869314	0.627219418386371	Arthritis (juvenile idiopathic)	3e-09	33106285
rs27298	rs4869314	0.627219418386371	Neutrophil count	1e-10	34594039
rs27298	rs4869314	0.627219418386371	White blood cell count	2e-07	30595370
rs27298	rs27660	0.602577835079694	Coronary artery disease	3e-08	35915156
rs27300	rs27293	0.927097489153193	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27300	rs27293	0.927097489153193	Diastolic blood pressure	3e-11	35762941
rs27300	rs38033	0.913460148923291	Blood protein levels	0	30072576
rs27300	rs1423357	0.896061638429484	General cognitive ability	9e-06	29844566
rs27300	rs2432142	0.880255074459058	Neutrophil count	2e-14	32888493
rs27300	rs2432142	0.880255074459058	White blood cell count	1e-11	32888493
rs27300	rs7705093	0.861707311140155	Birdshot chorioretinopathy	2e-09	24957906
rs27300	rs2910686	0.775873998284901	Neutrophil count	4e-14	32888493
rs27300	rs2910686	0.775873998284901	Psoriasis	2e-08	23143594
rs27300	rs2910686	0.775873998284901	Ankylosing spondylitis	5e-17	23749187
rs27300	rs2910686	0.775873998284901	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27300	rs2927608	0.774241253157636	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27300	rs2927608	0.774241253157636	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27300	rs2927608	0.774241253157636	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27300	rs2549797	0.733550080492919	Systolic blood pressure	7e-07	33230300
rs27300	rs2549797	0.733550080492919	Diastolic blood pressure	1e-14	33230300
rs27300	rs2549797	0.733550080492919	Diastolic blood pressure	3e-11	33230300
rs27300	rs2549797	0.733550080492919	Systolic blood pressure	4e-09	33230300
rs27300	rs2549782	0.732306530465857	Systolic blood pressure	6e-07	33230300
rs27300	rs2549782	0.732306530465857	Diastolic blood pressure	1e-14	33230300
rs27300	rs2549782	0.732306530465857	Diastolic blood pressure	3e-11	33230300
rs27300	rs2549782	0.732306530465857	Systolic blood pressure	5e-09	33230300
rs27300	rs716848	0.732163622630304	Neutrophil percentage of white cells	2e-09	32888494
rs27300	rs38029	0.732077030628758	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27300	rs1056893	0.731685589445727	Systolic blood pressure	1e-06	33230300
rs27300	rs1056893	0.731685589445727	Diastolic blood pressure	7e-15	33230300
rs27300	rs1056893	0.731685589445727	Diastolic blood pressure	2e-11	33230300
rs27300	rs1056893	0.731685589445727	Systolic blood pressure	7e-09	33230300
rs27300	rs2617439	0.693871753532689	Neutrophil count	8e-11	32888494
rs27300	rs2549794	0.686309932034732	Crohn's disease	1e-10	21102463
rs27300	rs2549794	0.686309932034732	Systolic blood pressure	1e-07	33230300
rs27300	rs2549794	0.686309932034732	Diastolic blood pressure	1e-15	33230300
rs27300	rs2549794	0.686309932034732	Diastolic blood pressure	2e-12	33230300
rs27300	rs2549794	0.686309932034732	Systolic blood pressure	4e-10	33230300
rs27300	rs1363907	0.681937170712147	Crohn's disease	4e-16	26192919
rs27300	rs1363907	0.681937170712147	Ulcerative colitis	4e-06	26192919
rs27300	rs1363907	0.681937170712147	Inflammatory bowel disease	5e-15	26192919
rs27300	rs1363907	0.681937170712147	Inflammatory bowel disease	6e-13	23128233
rs27300	rs1363907	0.681937170712147	Inflammatory bowel disease	1e-10	28067908
rs27300	rs1363907	0.681937170712147	Crohn's disease	1e-14	28067908
rs27300	rs4869313	0.640180073858551	Pediatric autoimmune diseases	9e-08	26301688
rs27300	rs4869314	0.633887176244119	Arthritis (juvenile idiopathic)	3e-09	33106285
rs27300	rs4869314	0.633887176244119	Neutrophil count	1e-10	34594039
rs27300	rs4869314	0.633887176244119	White blood cell count	2e-07	30595370
rs27300	rs1559359	0.633541393723406	Diastolic blood pressure	7e-10	34594039
rs27300	rs1019503	0.625501753239548	Systolic blood pressure	2e-06	33230300
rs27300	rs1019503	0.625501753239548	Diastolic blood pressure	2e-14	33230300
rs27300	rs1019503	0.625501753239548	Diastolic blood pressure	4e-11	33230300
rs27300	rs1019503	0.625501753239548	Systolic blood pressure	1e-08	33230300
rs27300	rs3096168	0.618315746077604	Aspartate aminotransferase levels	8e-12	33547301
rs27300	rs2548532	0.613347874182768	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27300	rs1974871	0.605180762874061	Granulysin levels	5e-13	34648354
rs27302	rs27293	0.747566550409428	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27302	rs27293	0.747566550409428	Diastolic blood pressure	3e-11	35762941
rs27302	rs38033	0.744015198631645	Blood protein levels	0	30072576
rs27302	rs1423357	0.727616020417027	General cognitive ability	9e-06	29844566
rs27302	rs38029	0.71417400626295	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27302	rs2432142	0.713389641984674	Neutrophil count	2e-14	32888493
rs27302	rs2432142	0.713389641984674	White blood cell count	1e-11	32888493
rs27302	rs7705093	0.692264521588206	Birdshot chorioretinopathy	2e-09	24957906
rs27302	rs2617439	0.676114590328661	Neutrophil count	8e-11	32888494
rs27302	rs2549794	0.668872739833158	Crohn's disease	1e-10	21102463
rs27302	rs2549794	0.668872739833158	Systolic blood pressure	1e-07	33230300
rs27302	rs2549794	0.668872739833158	Diastolic blood pressure	1e-15	33230300
rs27302	rs2549794	0.668872739833158	Diastolic blood pressure	2e-12	33230300
rs27302	rs2549794	0.668872739833158	Systolic blood pressure	4e-10	33230300
rs27302	rs1363907	0.664567363081479	Crohn's disease	4e-16	26192919
rs27302	rs1363907	0.664567363081479	Ulcerative colitis	4e-06	26192919
rs27302	rs1363907	0.664567363081479	Inflammatory bowel disease	5e-15	26192919
rs27302	rs1363907	0.664567363081479	Inflammatory bowel disease	6e-13	23128233
rs27302	rs1363907	0.664567363081479	Inflammatory bowel disease	1e-10	28067908
rs27302	rs1363907	0.664567363081479	Crohn's disease	1e-14	28067908
rs27302	rs716848	0.638441012497354	Neutrophil percentage of white cells	2e-09	32888494
rs27302	rs2927608	0.628852939681804	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27302	rs2927608	0.628852939681804	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27302	rs2927608	0.628852939681804	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27302	rs2910686	0.626451224744291	Neutrophil count	4e-14	32888493
rs27302	rs2910686	0.626451224744291	Psoriasis	2e-08	23143594
rs27302	rs2910686	0.626451224744291	Ankylosing spondylitis	5e-17	23749187
rs27302	rs2910686	0.626451224744291	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27302	rs4869313	0.61577317106272	Pediatric autoimmune diseases	9e-08	26301688
rs27306	rs38029	0.984927628374829	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27306	rs2617439	0.955095290607366	Neutrophil count	8e-11	32888494
rs27306	rs2549794	0.945584731938339	Crohn's disease	1e-10	21102463
rs27306	rs2549794	0.945584731938339	Systolic blood pressure	1e-07	33230300
rs27306	rs2549794	0.945584731938339	Diastolic blood pressure	1e-15	33230300
rs27306	rs2549794	0.945584731938339	Diastolic blood pressure	2e-12	33230300
rs27306	rs2549794	0.945584731938339	Systolic blood pressure	4e-10	33230300
rs27306	rs1363907	0.940415369973729	Crohn's disease	4e-16	26192919
rs27306	rs1363907	0.940415369973729	Ulcerative colitis	4e-06	26192919
rs27306	rs1363907	0.940415369973729	Inflammatory bowel disease	5e-15	26192919
rs27306	rs1363907	0.940415369973729	Inflammatory bowel disease	6e-13	23128233
rs27306	rs1363907	0.940415369973729	Inflammatory bowel disease	1e-10	28067908
rs27306	rs1363907	0.940415369973729	Crohn's disease	1e-14	28067908
rs27306	rs716848	0.91034253040502	Neutrophil percentage of white cells	2e-09	32888494
rs27306	rs2548532	0.849547862301898	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27306	rs38033	0.79796270086319	Blood protein levels	0	30072576
rs27306	rs27293	0.786129628750925	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27306	rs27293	0.786129628750925	Diastolic blood pressure	3e-11	35762941
rs27306	rs27660	0.782458552702348	Coronary artery disease	3e-08	35915156
rs27306	rs1423357	0.778301789950036	General cognitive ability	9e-06	29844566
rs27306	rs2432142	0.76329886790047	Neutrophil count	2e-14	32888493
rs27306	rs2432142	0.76329886790047	White blood cell count	1e-11	32888493
rs27306	rs7705093	0.743222076991417	Birdshot chorioretinopathy	2e-09	24957906
rs27306	rs4869313	0.683734368166859	Pediatric autoimmune diseases	9e-08	26301688
rs27306	rs2927608	0.682246185049993	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27306	rs2927608	0.682246185049993	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27306	rs2927608	0.682246185049993	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27306	rs2910686	0.679953578405308	Neutrophil count	4e-14	32888493
rs27306	rs2910686	0.679953578405308	Psoriasis	2e-08	23143594
rs27306	rs2910686	0.679953578405308	Ankylosing spondylitis	5e-17	23749187
rs27306	rs2910686	0.679953578405308	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27306	rs1559359	0.621485687953242	Diastolic blood pressure	7e-10	34594039
rs27306	rs1974871	0.612660352486129	Granulysin levels	5e-13	34648354
rs27306	rs2549797	0.604522906107151	Systolic blood pressure	7e-07	33230300
rs27306	rs2549797	0.604522906107151	Diastolic blood pressure	1e-14	33230300
rs27306	rs2549797	0.604522906107151	Diastolic blood pressure	3e-11	33230300
rs27306	rs2549797	0.604522906107151	Systolic blood pressure	4e-09	33230300
rs27306	rs2549782	0.603521850604923	Systolic blood pressure	6e-07	33230300
rs27306	rs2549782	0.603521850604923	Diastolic blood pressure	1e-14	33230300
rs27306	rs2549782	0.603521850604923	Diastolic blood pressure	3e-11	33230300
rs27306	rs2549782	0.603521850604923	Systolic blood pressure	5e-09	33230300
rs27306	rs1056893	0.603021993693021	Systolic blood pressure	1e-06	33230300
rs27306	rs1056893	0.603021993693021	Diastolic blood pressure	7e-15	33230300
rs27306	rs1056893	0.603021993693021	Diastolic blood pressure	2e-11	33230300
rs27306	rs1056893	0.603021993693021	Systolic blood pressure	7e-09	33230300
rs27307	rs27660	0.939132511775431	Coronary artery disease	3e-08	35915156
rs27307	rs2548532	0.922397847409735	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27307	rs2549794	0.830348441519259	Crohn's disease	1e-10	21102463
rs27307	rs2549794	0.830348441519259	Systolic blood pressure	1e-07	33230300
rs27307	rs2549794	0.830348441519259	Diastolic blood pressure	1e-15	33230300
rs27307	rs2549794	0.830348441519259	Diastolic blood pressure	2e-12	33230300
rs27307	rs2549794	0.830348441519259	Systolic blood pressure	4e-10	33230300
rs27307	rs2617439	0.829198580428525	Neutrophil count	8e-11	32888494
rs27307	rs1363907	0.825524371347387	Crohn's disease	4e-16	26192919
rs27307	rs1363907	0.825524371347387	Ulcerative colitis	4e-06	26192919
rs27307	rs1363907	0.825524371347387	Inflammatory bowel disease	5e-15	26192919
rs27307	rs1363907	0.825524371347387	Inflammatory bowel disease	6e-13	23128233
rs27307	rs1363907	0.825524371347387	Inflammatory bowel disease	1e-10	28067908
rs27307	rs1363907	0.825524371347387	Crohn's disease	1e-14	28067908
rs27307	rs38029	0.819389065652342	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27307	rs716848	0.799783417795382	Neutrophil percentage of white cells	2e-09	32888494
rs27307	rs1423357	0.67840718336149	General cognitive ability	9e-06	29844566
rs27307	rs38033	0.66408208534231	Blood protein levels	0	30072576
rs27307	rs2432142	0.664081121927556	Neutrophil count	2e-14	32888493
rs27307	rs2432142	0.664081121927556	White blood cell count	1e-11	32888493
rs27307	rs27293	0.654153006891191	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27307	rs27293	0.654153006891191	Diastolic blood pressure	3e-11	35762941
rs27307	rs7705093	0.648374412597179	Birdshot chorioretinopathy	2e-09	24957906
rs27307	rs4869313	0.615483222668294	Pediatric autoimmune diseases	9e-08	26301688
rs2735182	rs4938354	0.973025626032864	Proprotein convertase subtilisin/kexin type 7 levels	3e-295	36168886
rs2735182	rs1794116	0.896513677680155	Protein CASC4 levels	5e-13	34648354
rs2735182	rs1794116	0.896513677680155	Asialoglycoprotein receptor 1 levels	7e-18	34648354
rs2735182	rs171052	0.885198906116052	Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)	1e-38	35870639
rs2735182	rs2622935	0.704433598933986	Serum levels of protein CASC4	3e-16	35078996
rs2735182	rs2622935	0.704433598933986	Polypeptide N-acetylgalactosaminyltransferase 1 levels	1e-30	34648354
rs2735182	rs4938353	0.655594476973495	Blood protein levels	2e-14	27532455
rs2735182	rs1060211	0.611333850569567	Diastolic blood pressure	5e-09	35762941
rs2735182	rs4938344	0.604414083703702	Cerebrospinal fluid biomarker levels	7e-19	28031287
rs2737844	rs7359095	0.619241195066214	Height (standard GWA)	5e-10	37106081
rs2738926	rs4699032	0.997516013472599	Estimated glomerular filtration rate (creatinine)	7e-40	35710981
rs2738926	rs223376	0.983509805550695	Serum creatinine levels	1e-29	34594039
rs2738926	rs11722779	0.972862353336987	Schizophrenia	3e-08	28991256
rs2738926	rs11722779	0.972862353336987	Schizophrenia	4e-08	30285260
rs2738926	rs4645215	0.972048327328877	Migraine or type 1 diabetes	6e-09	36808568
rs2738926	rs10017313	0.96549988867758	Triglyceride levels	8e-09	34887591
rs2738926	rs10017313	0.96549988867758	Triglyceride levels	2e-12	34887591
rs2738926	rs223332	0.964832474336204	Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS))	3e-08	33686288
rs2738926	rs223449	0.943612858347494	Atrial fibrillation	3e-10	36653681
rs2738926	rs223480	0.9275678239795	Creatinine levels	4e-08	36329257
rs2738926	rs7676765	0.919630755947585	Schizophrenia	3e-10	31740837
rs2738926	rs7681002	0.918841535912183	Cardiovascular disease	2e-13	30595370
rs2738926	rs223337	0.913376488398973	Migraine or glucose levels	5e-09	36808568
rs2738926	rs223346	0.894918620372634	Schizophrenia vs ADHD (ordinary least squares (OLS))	8e-10	33686288
rs2738926	rs10006327	0.884513378005414	Atrial fibrillation	4e-08	30061737
rs2738926	rs223308	0.869194330432246	Estimated glomerular filtration rate	3e-21	31152163
rs2738926	rs223351	0.862973613044055	Hemoglobin A1c levels	4e-13	34594039
rs2738926	rs223454	0.848781041384356	Alanine aminotransferase levels	6e-09	33547301
rs2738926	rs223423	0.848089591224986	Type 2 diabetes	2e-09	35551307
rs2738926	rs223423	0.848089591224986	Type 2 diabetes	4e-08	35551307
rs2738926	rs223482	0.825306347770077	Glutamate levels in elite athletes	5e-06	31882771
rs2738926	rs223482	0.825306347770077	Gamma-glutamylglutamine levels in elite athletes	5e-06	31882771
rs2738926	rs223482	0.825306347770077	Migraine or fasting glucose levels	6e-11	36808568
rs2738926	rs223482	0.825306347770077	Headache or fasting glucose levels	4e-10	36808568
rs2738926	rs223486	0.824631332691399	Fasting glucose	4e-08	33402679
rs2738926	rs3974481	0.817251882747903	Liver enzyme levels (alkaline phosphatase)	2e-15	33972514
rs2738926	rs6533052	0.803358927123308	Multiple sclerosis	7e-16	31604244
rs2738926	rs7659468	0.799274038399174	Type 2 diabetes	1e-14	32541925
rs2738926	rs223497	0.798186501717367	Headache or glucose levels	2e-08	36808568
rs2738926	rs13130741	0.792219661300762	Medication use (agents acting on the renin-angiotensin system)	7e-09	31015401
rs2738926	rs3960788	0.783549147577225	Atrial fibrillation	2e-12	29892015
rs2738926	rs3960788	0.783549147577225	Atrial fibrillation	4e-11	29892015
rs2738926	rs3960788	0.783549147577225	Atrial fibrillation (MTAG)	4e-08	35872910
rs2738926	rs7694724	0.770543564534458	Schizophrenia	2e-08	35396580
rs2738926	rs7695096	0.753400931679518	Type 2 diabetes	1e-16	32541925
rs2738926	rs223498	0.683974940316779	Sarcoidosis	1e-09	26051272
rs2738926	rs9884397	0.675695293486698	Cholesteryl esters to total lipids ratio in medium VLDL	2e-08	35213538
rs2738926	rs9884397	0.675695293486698	Cholesterol to total lipids ratio in medium VLDL	2e-08	35213538
rs2738926	rs9884397	0.675695293486698	Triglycerides to total lipids ratio in medium VLDL	4e-08	35213538
rs2738926	rs7688014	0.657871273161585	Estimated glomerular filtration rate	2e-12	31451708
rs2738926	rs7688014	0.657871273161585	Schizophrenia	3e-06	26198764
rs27436	rs38033	0.991643789467721	Blood protein levels	0	30072576
rs27436	rs27293	0.985814650931702	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27436	rs27293	0.985814650931702	Diastolic blood pressure	3e-11	35762941
rs27436	rs1423357	0.973469292310871	General cognitive ability	9e-06	29844566
rs27436	rs2432142	0.956959805435376	Neutrophil count	2e-14	32888493
rs27436	rs2432142	0.956959805435376	White blood cell count	1e-11	32888493
rs27436	rs7705093	0.939223077917273	Birdshot chorioretinopathy	2e-09	24957906
rs27436	rs2910686	0.849466156142592	Neutrophil count	4e-14	32888493
rs27436	rs2910686	0.849466156142592	Psoriasis	2e-08	23143594
rs27436	rs2910686	0.849466156142592	Ankylosing spondylitis	5e-17	23749187
rs27436	rs2910686	0.849466156142592	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27436	rs2927608	0.846220310156589	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27436	rs2927608	0.846220310156589	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27436	rs2927608	0.846220310156589	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27436	rs38029	0.785293989619522	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27436	rs2617439	0.760674751265485	Neutrophil count	8e-11	32888494
rs27436	rs2549797	0.754599485789527	Systolic blood pressure	7e-07	33230300
rs27436	rs2549797	0.754599485789527	Diastolic blood pressure	1e-14	33230300
rs27436	rs2549797	0.754599485789527	Diastolic blood pressure	3e-11	33230300
rs27436	rs2549797	0.754599485789527	Systolic blood pressure	4e-09	33230300
rs27436	rs2549782	0.75334676124352	Systolic blood pressure	6e-07	33230300
rs27436	rs2549782	0.75334676124352	Diastolic blood pressure	1e-14	33230300
rs27436	rs2549782	0.75334676124352	Diastolic blood pressure	3e-11	33230300
rs27436	rs2549782	0.75334676124352	Systolic blood pressure	5e-09	33230300
rs27436	rs1056893	0.752721238511504	Systolic blood pressure	1e-06	33230300
rs27436	rs1056893	0.752721238511504	Diastolic blood pressure	7e-15	33230300
rs27436	rs1056893	0.752721238511504	Diastolic blood pressure	2e-11	33230300
rs27436	rs1056893	0.752721238511504	Systolic blood pressure	7e-09	33230300
rs27436	rs2549794	0.751184195955194	Crohn's disease	1e-10	21102463
rs27436	rs2549794	0.751184195955194	Systolic blood pressure	1e-07	33230300
rs27436	rs2549794	0.751184195955194	Diastolic blood pressure	1e-15	33230300
rs27436	rs2549794	0.751184195955194	Diastolic blood pressure	2e-12	33230300
rs27436	rs2549794	0.751184195955194	Systolic blood pressure	4e-10	33230300
rs27436	rs1363907	0.746595392802667	Crohn's disease	4e-16	26192919
rs27436	rs1363907	0.746595392802667	Ulcerative colitis	4e-06	26192919
rs27436	rs1363907	0.746595392802667	Inflammatory bowel disease	5e-15	26192919
rs27436	rs1363907	0.746595392802667	Inflammatory bowel disease	6e-13	23128233
rs27436	rs1363907	0.746595392802667	Inflammatory bowel disease	1e-10	28067908
rs27436	rs1363907	0.746595392802667	Crohn's disease	1e-14	28067908
rs27436	rs716848	0.718381181886781	Neutrophil percentage of white cells	2e-09	32888494
rs27436	rs4869313	0.705415060889047	Pediatric autoimmune diseases	9e-08	26301688
rs27436	rs1559359	0.698611685264676	Diastolic blood pressure	7e-10	34594039
rs27436	rs2548532	0.674982114509816	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27436	rs4869314	0.651129842973466	Arthritis (juvenile idiopathic)	3e-09	33106285
rs27436	rs4869314	0.651129842973466	Neutrophil count	1e-10	34594039
rs27436	rs4869314	0.651129842973466	White blood cell count	2e-07	30595370
rs27436	rs1974871	0.626173293623154	Granulysin levels	5e-13	34648354
rs27436	rs27660	0.622532155812667	Coronary artery disease	3e-08	35915156
rs27436	rs1019503	0.621324200062013	Systolic blood pressure	2e-06	33230300
rs27436	rs1019503	0.621324200062013	Diastolic blood pressure	2e-14	33230300
rs27436	rs1019503	0.621324200062013	Diastolic blood pressure	4e-11	33230300
rs27436	rs1019503	0.621324200062013	Systolic blood pressure	1e-08	33230300
rs27436	rs3096168	0.614086249231629	Aspartate aminotransferase levels	8e-12	33547301
rs2744941	rs9366863	0.983228134384127	Adult body size	9e-33	32376654
rs2744941	rs9366863	0.983228134384127	Body mass index	2e-44	30595370
rs2744941	rs2814949	0.972995932690023	Essential hypertension (time to event)	9e-09	32589924
rs2744941	rs2744944	0.958682693317866	Hypothyroidism	3e-10	34594039
rs2744941	rs2744944	0.958682693317866	High density lipoprotein cholesterol levels	3e-86	34887591
rs2744941	rs2744944	0.958682693317866	Multi-trait sex score	7e-22	37277458
rs2744941	rs9469872	0.953964114214784	HDL cholesterol levels	3e-11	36333282
rs2744941	rs11755393	0.947232214842642	Body mass index	3e-26	29273807
rs2744941	rs11755393	0.947232214842642	Systemic lupus erythematosus	2e-12	33493351
rs2744941	rs11755393	0.947232214842642	Systemic lupus erythematosus	2e-06	33493351
rs2744941	rs11755393	0.947232214842642	Systemic lupus erythematosus	1e-07	33493351
rs2744941	rs11755393	0.947232214842642	Systemic lupus erythematosus	2e-08	19838195
rs2744941	rs11755393	0.947232214842642	Body mass index	4e-55	36581621
rs2744941	rs2263329	0.945252907987163	HDL cholesterol	6e-35	34594039
rs2744941	rs2263329	0.945252907987163	HDL cholesterol levels	8e-43	32203549
rs2744941	rs2263329	0.945252907987163	High density lipoprotein cholesterol levels	2e-52	34887591
rs2744941	rs6941110	0.937491228938895	Sex hormone-binding globulin levels	5e-27	36653534
rs2744941	rs111868030	0.923084834440171	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2744941	rs9462030	0.91809180995442	Red cell distribution width	5e-25	32888493
rs2744941	rs9469857	0.913488835341185	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2744941	rs2764208	0.912738410671179	Systemic lupus erythematosus	7e-06	24871463
rs2744941	rs9469899	0.90197102225022	Prostate cancer (advanced)	2e-06	29892016
rs2744941	rs9469899	0.90197102225022	Prostate cancer	5e-09	29892016
rs2744941	rs9469899	0.90197102225022	Prostate cancer	8e-11	33398198
rs2744941	rs9469899	0.90197102225022	Hand grip strength	3e-15	29691431
rs2744941	rs9469899	0.90197102225022	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2744941	rs9469899	0.90197102225022	Graves' disease	4e-10	34594039
rs2744941	rs9469899	0.90197102225022	Coronary artery disease	1e-11	36474045
rs2744941	rs9469899	0.90197102225022	Predicted visceral adipose tissue	2e-20	31501611
rs2744941	rs9469899	0.90197102225022	Medication use (thyroid preparations)	2e-09	31015401
rs2744941	rs9469899	0.90197102225022	Medication use (thyroid preparations)	3e-10	34594039
rs2744941	rs9368830	0.890371062164164	HDL cholesterol	4e-21	30275531
rs2744941	rs9296128	0.865030624263867	Hip circumference adjusted for BMI	4e-13	34021172
rs2744941	rs9368828	0.85961482916034	Body mass index	1e-34	34594039
rs2744941	rs2744973	0.810464702622645	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2744941	rs2744973	0.810464702622645	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2744941	rs2744973	0.810464702622645	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2744941	rs2744973	0.810464702622645	Multi-trait sex score	6e-20	37277458
rs2744941	rs6912327	0.794691599783474	Fasting insulin	5e-06	33402679
rs2744941	rs6912327	0.794691599783474	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2744941	rs112283401	0.773777638503337	Red cell distribution width	4e-27	30595370
rs2744941	rs6940215	0.624589596761753	Insomnia	2e-10	35835914
rs2744941	rs6940215	0.624589596761753	Insomnia	1e-13	35835914
rs2744941	rs6940215	0.624589596761753	Hip circumference adjusted for BMI	8e-10	34021172
rs2744941	rs6940215	0.624589596761753	Multi-trait sex score	2e-23	37277458
rs2744941	rs6940215	0.624589596761753	Multi-trait sex score	4e-23	37277458
rs2744941	rs205262	0.617163619251596	Body mass index	2e-09	26961502
rs2744941	rs205262	0.617163619251596	Walking pace	4e-10	33128006
rs2744941	rs205262	0.617163619251596	Body mass index	8e-13	30108127
rs2744941	rs205262	0.617163619251596	Body mass index	2e-09	25673413
rs2744941	rs205262	0.617163619251596	Body mass index	2e-14	26426971
rs2744941	rs205262	0.617163619251596	BMI in non-smokers	3e-07	28443625
rs2744941	rs205262	0.617163619251596	BMI in non-smokers	6e-09	28443625
rs2744941	rs205262	0.617163619251596	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2744941	rs205262	0.617163619251596	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2744941	rs205262	0.617163619251596	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2744941	rs205262	0.617163619251596	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2744941	rs205262	0.617163619251596	Gastroesophageal reflux disease	1e-10	34187846
rs2744941	rs205262	0.617163619251596	Body mass index	3e-10	25673413
rs2744941	rs205262	0.617163619251596	Body mass index	2e-10	25673413
rs2744941	rs205262	0.617163619251596	ICD10 M54: Dorsalgia	2e-12	35110524
rs2744941	rs6457796	0.614727908960888	Insomnia	1e-08	30804565
rs2744941	rs6457796	0.614727908960888	Plateletcrit	9e-11	32888494
rs2744941	rs6457796	0.614727908960888	Systemic lupus erythematosus	3e-22	33272962
rs2744941	rs6457796	0.614727908960888	Body mass index	5e-13	30108127
rs2744941	rs6457796	0.614727908960888	Body mass index	1e-14	26426971
rs2744941	rs6457796	0.614727908960888	Educational attainment	5e-19	35361970
rs2744944	rs2744944	1	Hypothyroidism	3e-10	34594039
rs2744944	rs2744944	1	High density lipoprotein cholesterol levels	3e-86	34887591
rs2744944	rs2744944	1	Multi-trait sex score	7e-22	37277458
rs2744944	rs2814949	0.984011889441681	Essential hypertension (time to event)	9e-09	32589924
rs2744944	rs2263329	0.968931645686677	HDL cholesterol	6e-35	34594039
rs2744944	rs2263329	0.968931645686677	HDL cholesterol levels	8e-43	32203549
rs2744944	rs2263329	0.968931645686677	High density lipoprotein cholesterol levels	2e-52	34887591
rs2744944	rs9366863	0.953142583205874	Adult body size	9e-33	32376654
rs2744944	rs9366863	0.953142583205874	Body mass index	2e-44	30595370
rs2744944	rs9469872	0.942972684970972	HDL cholesterol levels	3e-11	36333282
rs2744944	rs11755393	0.917569011329476	Body mass index	3e-26	29273807
rs2744944	rs11755393	0.917569011329476	Systemic lupus erythematosus	2e-12	33493351
rs2744944	rs11755393	0.917569011329476	Systemic lupus erythematosus	2e-06	33493351
rs2744944	rs11755393	0.917569011329476	Systemic lupus erythematosus	1e-07	33493351
rs2744944	rs11755393	0.917569011329476	Systemic lupus erythematosus	2e-08	19838195
rs2744944	rs11755393	0.917569011329476	Body mass index	4e-55	36581621
rs2744944	rs9469899	0.911237394489752	Prostate cancer (advanced)	2e-06	29892016
rs2744944	rs9469899	0.911237394489752	Prostate cancer	5e-09	29892016
rs2744944	rs9469899	0.911237394489752	Prostate cancer	8e-11	33398198
rs2744944	rs9469899	0.911237394489752	Hand grip strength	3e-15	29691431
rs2744944	rs9469899	0.911237394489752	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2744944	rs9469899	0.911237394489752	Graves' disease	4e-10	34594039
rs2744944	rs9469899	0.911237394489752	Coronary artery disease	1e-11	36474045
rs2744944	rs9469899	0.911237394489752	Predicted visceral adipose tissue	2e-20	31501611
rs2744944	rs9469899	0.911237394489752	Medication use (thyroid preparations)	2e-09	31015401
rs2744944	rs9469899	0.911237394489752	Medication use (thyroid preparations)	3e-10	34594039
rs2744944	rs6941110	0.90816881545315	Sex hormone-binding globulin levels	5e-27	36653534
rs2744944	rs111868030	0.903734239324019	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2744944	rs9469857	0.903048490448695	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2744944	rs2764208	0.902320101561385	Systemic lupus erythematosus	7e-06	24871463
rs2744944	rs9462030	0.889288001154867	Red cell distribution width	5e-25	32888493
rs2744944	rs9368830	0.864183867687893	HDL cholesterol	4e-21	30275531
rs2744944	rs9296128	0.855275357080456	Hip circumference adjusted for BMI	4e-13	34021172
rs2744944	rs9368828	0.852406821228048	Body mass index	1e-34	34594039
rs2744944	rs2744973	0.781547647785811	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2744944	rs2744973	0.781547647785811	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2744944	rs2744973	0.781547647785811	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2744944	rs2744973	0.781547647785811	Multi-trait sex score	6e-20	37277458
rs2744944	rs6912327	0.768728534076815	Fasting insulin	5e-06	33402679
rs2744944	rs6912327	0.768728534076815	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2744944	rs112283401	0.745363325410403	Red cell distribution width	4e-27	30595370
rs2744944	rs205262	0.605937198471262	Body mass index	2e-09	26961502
rs2744944	rs205262	0.605937198471262	Walking pace	4e-10	33128006
rs2744944	rs205262	0.605937198471262	Body mass index	8e-13	30108127
rs2744944	rs205262	0.605937198471262	Body mass index	2e-09	25673413
rs2744944	rs205262	0.605937198471262	Body mass index	2e-14	26426971
rs2744944	rs205262	0.605937198471262	BMI in non-smokers	3e-07	28443625
rs2744944	rs205262	0.605937198471262	BMI in non-smokers	6e-09	28443625
rs2744944	rs205262	0.605937198471262	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2744944	rs205262	0.605937198471262	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2744944	rs205262	0.605937198471262	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2744944	rs205262	0.605937198471262	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2744944	rs205262	0.605937198471262	Gastroesophageal reflux disease	1e-10	34187846
rs2744944	rs205262	0.605937198471262	Body mass index	3e-10	25673413
rs2744944	rs205262	0.605937198471262	Body mass index	2e-10	25673413
rs2744944	rs205262	0.605937198471262	ICD10 M54: Dorsalgia	2e-12	35110524
rs2744944	rs6940215	0.60096683808882	Insomnia	2e-10	35835914
rs2744944	rs6940215	0.60096683808882	Insomnia	1e-13	35835914
rs2744944	rs6940215	0.60096683808882	Hip circumference adjusted for BMI	8e-10	34021172
rs2744944	rs6940215	0.60096683808882	Multi-trait sex score	2e-23	37277458
rs2744944	rs6940215	0.60096683808882	Multi-trait sex score	4e-23	37277458
rs2744957	rs9366863	0.984806524393287	Adult body size	9e-33	32376654
rs2744957	rs9366863	0.984806524393287	Body mass index	2e-44	30595370
rs2744957	rs2814949	0.972963809017027	Essential hypertension (time to event)	9e-09	32589924
rs2744957	rs2744944	0.95866536227475	Hypothyroidism	3e-10	34594039
rs2744957	rs2744944	0.95866536227475	High density lipoprotein cholesterol levels	3e-86	34887591
rs2744957	rs2744944	0.95866536227475	Multi-trait sex score	7e-22	37277458
rs2744957	rs9469872	0.955518798358637	HDL cholesterol levels	3e-11	36333282
rs2744957	rs11755393	0.948747158161882	Body mass index	3e-26	29273807
rs2744957	rs11755393	0.948747158161882	Systemic lupus erythematosus	2e-12	33493351
rs2744957	rs11755393	0.948747158161882	Systemic lupus erythematosus	2e-06	33493351
rs2744957	rs11755393	0.948747158161882	Systemic lupus erythematosus	1e-07	33493351
rs2744957	rs11755393	0.948747158161882	Systemic lupus erythematosus	2e-08	19838195
rs2744957	rs11755393	0.948747158161882	Body mass index	4e-55	36581621
rs2744957	rs2263329	0.946823888162705	HDL cholesterol	6e-35	34594039
rs2744957	rs2263329	0.946823888162705	HDL cholesterol levels	8e-43	32203549
rs2744957	rs2263329	0.946823888162705	High density lipoprotein cholesterol levels	2e-52	34887591
rs2744957	rs6941110	0.939043740786307	Sex hormone-binding globulin levels	5e-27	36653534
rs2744957	rs9462030	0.91968132517809	Red cell distribution width	5e-25	32888493
rs2744957	rs111868030	0.918567286436883	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2744957	rs9469857	0.916621859863398	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2744957	rs2764208	0.914333113625513	Systemic lupus erythematosus	7e-06	24871463
rs2744957	rs9469899	0.903506231545201	Prostate cancer (advanced)	2e-06	29892016
rs2744957	rs9469899	0.903506231545201	Prostate cancer	5e-09	29892016
rs2744957	rs9469899	0.903506231545201	Prostate cancer	8e-11	33398198
rs2744957	rs9469899	0.903506231545201	Hand grip strength	3e-15	29691431
rs2744957	rs9469899	0.903506231545201	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2744957	rs9469899	0.903506231545201	Graves' disease	4e-10	34594039
rs2744957	rs9469899	0.903506231545201	Coronary artery disease	1e-11	36474045
rs2744957	rs9469899	0.903506231545201	Predicted visceral adipose tissue	2e-20	31501611
rs2744957	rs9469899	0.903506231545201	Medication use (thyroid preparations)	2e-09	31015401
rs2744957	rs9469899	0.903506231545201	Medication use (thyroid preparations)	3e-10	34594039
rs2744957	rs9368830	0.890229724802766	HDL cholesterol	4e-21	30275531
rs2744957	rs9296128	0.866671428999764	Hip circumference adjusted for BMI	4e-13	34021172
rs2744957	rs9368828	0.859653315597537	Body mass index	1e-34	34594039
rs2744957	rs2744973	0.81078414442599	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2744957	rs2744973	0.81078414442599	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2744957	rs2744973	0.81078414442599	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2744957	rs2744973	0.81078414442599	Multi-trait sex score	6e-20	37277458
rs2744957	rs6912327	0.797850852230892	Fasting insulin	5e-06	33402679
rs2744957	rs6912327	0.797850852230892	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2744957	rs112283401	0.772605420628028	Red cell distribution width	4e-27	30595370
rs2744957	rs6940215	0.626320440962521	Insomnia	2e-10	35835914
rs2744957	rs6940215	0.626320440962521	Insomnia	1e-13	35835914
rs2744957	rs6940215	0.626320440962521	Hip circumference adjusted for BMI	8e-10	34021172
rs2744957	rs6940215	0.626320440962521	Multi-trait sex score	2e-23	37277458
rs2744957	rs6940215	0.626320440962521	Multi-trait sex score	4e-23	37277458
rs2744957	rs205262	0.619138634862477	Body mass index	2e-09	26961502
rs2744957	rs205262	0.619138634862477	Walking pace	4e-10	33128006
rs2744957	rs205262	0.619138634862477	Body mass index	8e-13	30108127
rs2744957	rs205262	0.619138634862477	Body mass index	2e-09	25673413
rs2744957	rs205262	0.619138634862477	Body mass index	2e-14	26426971
rs2744957	rs205262	0.619138634862477	BMI in non-smokers	3e-07	28443625
rs2744957	rs205262	0.619138634862477	BMI in non-smokers	6e-09	28443625
rs2744957	rs205262	0.619138634862477	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2744957	rs205262	0.619138634862477	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2744957	rs205262	0.619138634862477	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2744957	rs205262	0.619138634862477	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2744957	rs205262	0.619138634862477	Gastroesophageal reflux disease	1e-10	34187846
rs2744957	rs205262	0.619138634862477	Body mass index	3e-10	25673413
rs2744957	rs205262	0.619138634862477	Body mass index	2e-10	25673413
rs2744957	rs205262	0.619138634862477	ICD10 M54: Dorsalgia	2e-12	35110524
rs2744957	rs6457796	0.616635544055677	Insomnia	1e-08	30804565
rs2744957	rs6457796	0.616635544055677	Plateletcrit	9e-11	32888494
rs2744957	rs6457796	0.616635544055677	Systemic lupus erythematosus	3e-22	33272962
rs2744957	rs6457796	0.616635544055677	Body mass index	5e-13	30108127
rs2744957	rs6457796	0.616635544055677	Body mass index	1e-14	26426971
rs2744957	rs6457796	0.616635544055677	Educational attainment	5e-19	35361970
rs2744959	rs9366863	0.978470420738923	Adult body size	9e-33	32376654
rs2744959	rs9366863	0.978470420738923	Body mass index	2e-44	30595370
rs2744959	rs2814949	0.966698299727765	Essential hypertension (time to event)	9e-09	32589924
rs2744959	rs2744944	0.952415215063055	Hypothyroidism	3e-10	34594039
rs2744959	rs2744944	0.952415215063055	High density lipoprotein cholesterol levels	3e-86	34887591
rs2744959	rs2744944	0.952415215063055	Multi-trait sex score	7e-22	37277458
rs2744959	rs9469872	0.949278087194063	HDL cholesterol levels	3e-11	36333282
rs2744959	rs11755393	0.94259928638478	Body mass index	3e-26	29273807
rs2744959	rs11755393	0.94259928638478	Systemic lupus erythematosus	2e-12	33493351
rs2744959	rs11755393	0.94259928638478	Systemic lupus erythematosus	2e-06	33493351
rs2744959	rs11755393	0.94259928638478	Systemic lupus erythematosus	1e-07	33493351
rs2744959	rs11755393	0.94259928638478	Systemic lupus erythematosus	2e-08	19838195
rs2744959	rs11755393	0.94259928638478	Body mass index	4e-55	36581621
rs2744959	rs2263329	0.940563300835791	HDL cholesterol	6e-35	34594039
rs2744959	rs2263329	0.940563300835791	HDL cholesterol levels	8e-43	32203549
rs2744959	rs2263329	0.940563300835791	High density lipoprotein cholesterol levels	2e-52	34887591
rs2744959	rs6941110	0.932833899228951	Sex hormone-binding globulin levels	5e-27	36653534
rs2744959	rs9462030	0.913425771661126	Red cell distribution width	5e-25	32888493
rs2744959	rs111868030	0.912119079503382	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2744959	rs9469857	0.910365055096442	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2744959	rs2764208	0.908075374516138	Systemic lupus erythematosus	7e-06	24871463
rs2744959	rs9469899	0.897389864770553	Prostate cancer (advanced)	2e-06	29892016
rs2744959	rs9469899	0.897389864770553	Prostate cancer	5e-09	29892016
rs2744959	rs9469899	0.897389864770553	Prostate cancer	8e-11	33398198
rs2744959	rs9469899	0.897389864770553	Hand grip strength	3e-15	29691431
rs2744959	rs9469899	0.897389864770553	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2744959	rs9469899	0.897389864770553	Graves' disease	4e-10	34594039
rs2744959	rs9469899	0.897389864770553	Coronary artery disease	1e-11	36474045
rs2744959	rs9469899	0.897389864770553	Predicted visceral adipose tissue	2e-20	31501611
rs2744959	rs9469899	0.897389864770553	Medication use (thyroid preparations)	2e-09	31015401
rs2744959	rs9469899	0.897389864770553	Medication use (thyroid preparations)	3e-10	34594039
rs2744959	rs9368830	0.884469837038946	HDL cholesterol	4e-21	30275531
rs2744959	rs9296128	0.860394583285545	Hip circumference adjusted for BMI	4e-13	34021172
rs2744959	rs9368828	0.853618643985039	Body mass index	1e-34	34594039
rs2744959	rs2744973	0.817507945182075	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2744959	rs2744973	0.817507945182075	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2744959	rs2744973	0.817507945182075	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2744959	rs2744973	0.817507945182075	Multi-trait sex score	6e-20	37277458
rs2744959	rs6912327	0.790096268490065	Fasting insulin	5e-06	33402679
rs2744959	rs6912327	0.790096268490065	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2744959	rs112283401	0.766393235694892	Red cell distribution width	4e-27	30595370
rs2744959	rs6940215	0.630690006813807	Insomnia	2e-10	35835914
rs2744959	rs6940215	0.630690006813807	Insomnia	1e-13	35835914
rs2744959	rs6940215	0.630690006813807	Hip circumference adjusted for BMI	8e-10	34021172
rs2744959	rs6940215	0.630690006813807	Multi-trait sex score	2e-23	37277458
rs2744959	rs6940215	0.630690006813807	Multi-trait sex score	4e-23	37277458
rs2744959	rs205262	0.624484412966908	Body mass index	2e-09	26961502
rs2744959	rs205262	0.624484412966908	Walking pace	4e-10	33128006
rs2744959	rs205262	0.624484412966908	Body mass index	8e-13	30108127
rs2744959	rs205262	0.624484412966908	Body mass index	2e-09	25673413
rs2744959	rs205262	0.624484412966908	Body mass index	2e-14	26426971
rs2744959	rs205262	0.624484412966908	BMI in non-smokers	3e-07	28443625
rs2744959	rs205262	0.624484412966908	BMI in non-smokers	6e-09	28443625
rs2744959	rs205262	0.624484412966908	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2744959	rs205262	0.624484412966908	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2744959	rs205262	0.624484412966908	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2744959	rs205262	0.624484412966908	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2744959	rs205262	0.624484412966908	Gastroesophageal reflux disease	1e-10	34187846
rs2744959	rs205262	0.624484412966908	Body mass index	3e-10	25673413
rs2744959	rs205262	0.624484412966908	Body mass index	2e-10	25673413
rs2744959	rs205262	0.624484412966908	ICD10 M54: Dorsalgia	2e-12	35110524
rs2744959	rs6457796	0.622039852546887	Insomnia	1e-08	30804565
rs2744959	rs6457796	0.622039852546887	Plateletcrit	9e-11	32888494
rs2744959	rs6457796	0.622039852546887	Systemic lupus erythematosus	3e-22	33272962
rs2744959	rs6457796	0.622039852546887	Body mass index	5e-13	30108127
rs2744959	rs6457796	0.622039852546887	Body mass index	1e-14	26426971
rs2744959	rs6457796	0.622039852546887	Educational attainment	5e-19	35361970
rs2744961	rs2744944	0.993581208732441	Hypothyroidism	3e-10	34594039
rs2744961	rs2744944	0.993581208732441	High density lipoprotein cholesterol levels	3e-86	34887591
rs2744961	rs2744944	0.993581208732441	Multi-trait sex score	7e-22	37277458
rs2744961	rs2814949	0.990404577281153	Essential hypertension (time to event)	9e-09	32589924
rs2744961	rs2263329	0.9752624137761	HDL cholesterol	6e-35	34594039
rs2744961	rs2263329	0.9752624137761	HDL cholesterol levels	8e-43	32203549
rs2744961	rs2263329	0.9752624137761	High density lipoprotein cholesterol levels	2e-52	34887591
rs2744961	rs9366863	0.953138482352155	Adult body size	9e-33	32376654
rs2744961	rs9366863	0.953138482352155	Body mass index	2e-44	30595370
rs2744961	rs9469872	0.942969865958337	HDL cholesterol levels	3e-11	36333282
rs2744961	rs11755393	0.917581369325057	Body mass index	3e-26	29273807
rs2744961	rs11755393	0.917581369325057	Systemic lupus erythematosus	2e-12	33493351
rs2744961	rs11755393	0.917581369325057	Systemic lupus erythematosus	2e-06	33493351
rs2744961	rs11755393	0.917581369325057	Systemic lupus erythematosus	1e-07	33493351
rs2744961	rs11755393	0.917581369325057	Systemic lupus erythematosus	2e-08	19838195
rs2744961	rs11755393	0.917581369325057	Body mass index	4e-55	36581621
rs2744961	rs9469899	0.912760383202155	Prostate cancer (advanced)	2e-06	29892016
rs2744961	rs9469899	0.912760383202155	Prostate cancer	5e-09	29892016
rs2744961	rs9469899	0.912760383202155	Prostate cancer	8e-11	33398198
rs2744961	rs9469899	0.912760383202155	Hand grip strength	3e-15	29691431
rs2744961	rs9469899	0.912760383202155	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2744961	rs9469899	0.912760383202155	Graves' disease	4e-10	34594039
rs2744961	rs9469899	0.912760383202155	Coronary artery disease	1e-11	36474045
rs2744961	rs9469899	0.912760383202155	Predicted visceral adipose tissue	2e-20	31501611
rs2744961	rs9469899	0.912760383202155	Medication use (thyroid preparations)	2e-09	31015401
rs2744961	rs9469899	0.912760383202155	Medication use (thyroid preparations)	3e-10	34594039
rs2744961	rs111868030	0.908268352587188	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2744961	rs6941110	0.908159624140454	Sex hormone-binding globulin levels	5e-27	36653534
rs2744961	rs9469857	0.903012542434731	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2744961	rs2764208	0.902282272814699	Systemic lupus erythematosus	7e-06	24871463
rs2744961	rs9462030	0.889253935921324	Red cell distribution width	5e-25	32888493
rs2744961	rs9368830	0.864242227033779	HDL cholesterol	4e-21	30275531
rs2744961	rs9296128	0.85519708100431	Hip circumference adjusted for BMI	4e-13	34021172
rs2744961	rs9368828	0.852377818685793	Body mass index	1e-34	34594039
rs2744961	rs2744973	0.782822089936888	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2744961	rs2744973	0.782822089936888	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2744961	rs2744973	0.782822089936888	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2744961	rs2744973	0.782822089936888	Multi-trait sex score	6e-20	37277458
rs2744961	rs6912327	0.768591246645647	Fasting insulin	5e-06	33402679
rs2744961	rs6912327	0.768591246645647	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2744961	rs112283401	0.745227294119856	Red cell distribution width	4e-27	30595370
rs2744961	rs205262	0.609547235639794	Body mass index	2e-09	26961502
rs2744961	rs205262	0.609547235639794	Walking pace	4e-10	33128006
rs2744961	rs205262	0.609547235639794	Body mass index	8e-13	30108127
rs2744961	rs205262	0.609547235639794	Body mass index	2e-09	25673413
rs2744961	rs205262	0.609547235639794	Body mass index	2e-14	26426971
rs2744961	rs205262	0.609547235639794	BMI in non-smokers	3e-07	28443625
rs2744961	rs205262	0.609547235639794	BMI in non-smokers	6e-09	28443625
rs2744961	rs205262	0.609547235639794	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2744961	rs205262	0.609547235639794	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2744961	rs205262	0.609547235639794	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2744961	rs205262	0.609547235639794	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2744961	rs205262	0.609547235639794	Gastroesophageal reflux disease	1e-10	34187846
rs2744961	rs205262	0.609547235639794	Body mass index	3e-10	25673413
rs2744961	rs205262	0.609547235639794	Body mass index	2e-10	25673413
rs2744961	rs205262	0.609547235639794	ICD10 M54: Dorsalgia	2e-12	35110524
rs2744961	rs6940215	0.60074890793797	Insomnia	2e-10	35835914
rs2744961	rs6940215	0.60074890793797	Insomnia	1e-13	35835914
rs2744961	rs6940215	0.60074890793797	Hip circumference adjusted for BMI	8e-10	34021172
rs2744961	rs6940215	0.60074890793797	Multi-trait sex score	2e-23	37277458
rs2744961	rs6940215	0.60074890793797	Multi-trait sex score	4e-23	37277458
rs2744973	rs2744973	1	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2744973	rs2744973	1	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2744973	rs2744973	1	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2744973	rs2744973	1	Multi-trait sex score	6e-20	37277458
rs2744973	rs2263329	0.799727328392119	HDL cholesterol	6e-35	34594039
rs2744973	rs2263329	0.799727328392119	HDL cholesterol levels	8e-43	32203549
rs2744973	rs2263329	0.799727328392119	High density lipoprotein cholesterol levels	2e-52	34887591
rs2744973	rs9366863	0.799413475271135	Adult body size	9e-33	32376654
rs2744973	rs9366863	0.799413475271135	Body mass index	2e-44	30595370
rs2744973	rs9296128	0.798863079135444	Hip circumference adjusted for BMI	4e-13	34021172
rs2744973	rs9462030	0.796788371990572	Red cell distribution width	5e-25	32888493
rs2744973	rs2814949	0.792521762756774	Essential hypertension (time to event)	9e-09	32589924
rs2744973	rs9469857	0.792134506553775	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2744973	rs2764208	0.789742920777674	Systemic lupus erythematosus	7e-06	24871463
rs2744973	rs9469899	0.782641028345457	Prostate cancer (advanced)	2e-06	29892016
rs2744973	rs9469899	0.782641028345457	Prostate cancer	5e-09	29892016
rs2744973	rs9469899	0.782641028345457	Prostate cancer	8e-11	33398198
rs2744973	rs9469899	0.782641028345457	Hand grip strength	3e-15	29691431
rs2744973	rs9469899	0.782641028345457	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2744973	rs9469899	0.782641028345457	Graves' disease	4e-10	34594039
rs2744973	rs9469899	0.782641028345457	Coronary artery disease	1e-11	36474045
rs2744973	rs9469899	0.782641028345457	Predicted visceral adipose tissue	2e-20	31501611
rs2744973	rs9469899	0.782641028345457	Medication use (thyroid preparations)	2e-09	31015401
rs2744973	rs9469899	0.782641028345457	Medication use (thyroid preparations)	3e-10	34594039
rs2744973	rs2744944	0.781547647785811	Hypothyroidism	3e-10	34594039
rs2744973	rs2744944	0.781547647785811	High density lipoprotein cholesterol levels	3e-86	34887591
rs2744973	rs2744944	0.781547647785811	Multi-trait sex score	7e-22	37277458
rs2744973	rs6941110	0.774496169239364	Sex hormone-binding globulin levels	5e-27	36653534
rs2744973	rs9469872	0.772924967221123	HDL cholesterol levels	3e-11	36333282
rs2744973	rs11755393	0.768834665996764	Body mass index	3e-26	29273807
rs2744973	rs11755393	0.768834665996764	Systemic lupus erythematosus	2e-12	33493351
rs2744973	rs11755393	0.768834665996764	Systemic lupus erythematosus	2e-06	33493351
rs2744973	rs11755393	0.768834665996764	Systemic lupus erythematosus	1e-07	33493351
rs2744973	rs11755393	0.768834665996764	Systemic lupus erythematosus	2e-08	19838195
rs2744973	rs11755393	0.768834665996764	Body mass index	4e-55	36581621
rs2744973	rs9368828	0.758022775303766	Body mass index	1e-34	34594039
rs2744973	rs111868030	0.742793863489813	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2744973	rs9368830	0.724349713506961	HDL cholesterol	4e-21	30275531
rs2744973	rs112283401	0.664747177304558	Red cell distribution width	4e-27	30595370
rs2744973	rs6912327	0.614010739935541	Fasting insulin	5e-06	33402679
rs2744973	rs6912327	0.614010739935541	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2745181	rs2235642	0.721905835789746	Coronary artery disease	8e-06	29212778
rs2745181	rs2076438	0.718787116990012	Coronary artery disease	3e-08	33020668
rs2745181	rs2076435	0.646709733089739	Inguinal hernia	2e-08	35022708
rs2745181	rs2076435	0.646709733089739	Inguinal hernia	2e-09	35022708
rs2758848	rs2842611	0.926607506429491	High density lipoprotein cholesterol levels	5e-09	34887591
rs2758848	rs1173416	0.910104850825755	Height	2e-59	36224396
rs2758848	rs9450288	0.881942375130488	Height	2e-10	36224396
rs2758849	rs2842611	0.908281013478959	High density lipoprotein cholesterol levels	5e-09	34887591
rs2758849	rs1173416	0.892598734430262	Height	2e-59	36224396
rs2758849	rs9450288	0.877887799286674	Height	2e-10	36224396
rs2762	rs1423357	0.991615908837201	General cognitive ability	9e-06	29844566
rs2762	rs2432142	0.974931078526453	Neutrophil count	2e-14	32888493
rs2762	rs2432142	0.974931078526453	White blood cell count	1e-11	32888493
rs2762	rs38033	0.970088748897551	Blood protein levels	0	30072576
rs2762	rs27293	0.964283225551669	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2762	rs27293	0.964283225551669	Diastolic blood pressure	3e-11	35762941
rs2762	rs7705093	0.957300846145765	Birdshot chorioretinopathy	2e-09	24957906
rs2762	rs2910686	0.870147037464582	Neutrophil count	4e-14	32888493
rs2762	rs2910686	0.870147037464582	Psoriasis	2e-08	23143594
rs2762	rs2910686	0.870147037464582	Ankylosing spondylitis	5e-17	23749187
rs2762	rs2910686	0.870147037464582	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2762	rs2927608	0.86683277401578	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2762	rs2927608	0.86683277401578	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2762	rs2927608	0.86683277401578	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2762	rs2617439	0.774988963685081	Neutrophil count	8e-11	32888494
rs2762	rs2549797	0.774709823886111	Systolic blood pressure	7e-07	33230300
rs2762	rs2549797	0.774709823886111	Diastolic blood pressure	1e-14	33230300
rs2762	rs2549797	0.774709823886111	Diastolic blood pressure	3e-11	33230300
rs2762	rs2549797	0.774709823886111	Systolic blood pressure	4e-09	33230300
rs2762	rs2549782	0.773449222386896	Systolic blood pressure	6e-07	33230300
rs2762	rs2549782	0.773449222386896	Diastolic blood pressure	1e-14	33230300
rs2762	rs2549782	0.773449222386896	Diastolic blood pressure	3e-11	33230300
rs2762	rs2549782	0.773449222386896	Systolic blood pressure	5e-09	33230300
rs2762	rs1056893	0.772819766188629	Systolic blood pressure	1e-06	33230300
rs2762	rs1056893	0.772819766188629	Diastolic blood pressure	7e-15	33230300
rs2762	rs1056893	0.772819766188629	Diastolic blood pressure	2e-11	33230300
rs2762	rs1056893	0.772819766188629	Systolic blood pressure	7e-09	33230300
rs2762	rs2549794	0.768526198086246	Crohn's disease	1e-10	21102463
rs2762	rs2549794	0.768526198086246	Systolic blood pressure	1e-07	33230300
rs2762	rs2549794	0.768526198086246	Diastolic blood pressure	1e-15	33230300
rs2762	rs2549794	0.768526198086246	Diastolic blood pressure	2e-12	33230300
rs2762	rs2549794	0.768526198086246	Systolic blood pressure	4e-10	33230300
rs2762	rs1363907	0.763884518501011	Crohn's disease	4e-16	26192919
rs2762	rs1363907	0.763884518501011	Ulcerative colitis	4e-06	26192919
rs2762	rs1363907	0.763884518501011	Inflammatory bowel disease	5e-15	26192919
rs2762	rs1363907	0.763884518501011	Inflammatory bowel disease	6e-13	23128233
rs2762	rs1363907	0.763884518501011	Inflammatory bowel disease	1e-10	28067908
rs2762	rs1363907	0.763884518501011	Crohn's disease	1e-14	28067908
rs2762	rs38029	0.763276094099834	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2762	rs716848	0.735458248676331	Neutrophil percentage of white cells	2e-09	32888494
rs2762	rs4869313	0.723566456430885	Pediatric autoimmune diseases	9e-08	26301688
rs2762	rs1559359	0.717270704882365	Diastolic blood pressure	7e-10	34594039
rs2762	rs2548532	0.687841903248699	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2762	rs4869314	0.670129793904788	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2762	rs4869314	0.670129793904788	Neutrophil count	1e-10	34594039
rs2762	rs4869314	0.670129793904788	White blood cell count	2e-07	30595370
rs2762	rs1974871	0.643720747096145	Granulysin levels	5e-13	34648354
rs2762	rs1019503	0.639337606737278	Systolic blood pressure	2e-06	33230300
rs2762	rs1019503	0.639337606737278	Diastolic blood pressure	2e-14	33230300
rs2762	rs1019503	0.639337606737278	Diastolic blood pressure	4e-11	33230300
rs2762	rs1019503	0.639337606737278	Systolic blood pressure	1e-08	33230300
rs2762	rs27660	0.634201995040614	Coronary artery disease	3e-08	35915156
rs2762	rs3096168	0.631918176119629	Aspartate aminotransferase levels	8e-12	33547301
rs2764197	rs9469872	0.983999783529718	HDL cholesterol levels	3e-11	36333282
rs2764197	rs9366863	0.983208533186831	Adult body size	9e-33	32376654
rs2764197	rs9366863	0.983208533186831	Body mass index	2e-44	30595370
rs2764197	rs11755393	0.976921304317267	Body mass index	3e-26	29273807
rs2764197	rs11755393	0.976921304317267	Systemic lupus erythematosus	2e-12	33493351
rs2764197	rs11755393	0.976921304317267	Systemic lupus erythematosus	2e-06	33493351
rs2764197	rs11755393	0.976921304317267	Systemic lupus erythematosus	1e-07	33493351
rs2764197	rs11755393	0.976921304317267	Systemic lupus erythematosus	2e-08	19838195
rs2764197	rs11755393	0.976921304317267	Body mass index	4e-55	36581621
rs2764197	rs6941110	0.965766213294032	Sex hormone-binding globulin levels	5e-27	36653534
rs2764197	rs9462030	0.948015132413651	Red cell distribution width	5e-25	32888493
rs2764197	rs2814949	0.946124809533959	Essential hypertension (time to event)	9e-09	32589924
rs2764197	rs9469857	0.943378827679558	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2764197	rs2764208	0.942644899233424	Systemic lupus erythematosus	7e-06	24871463
rs2764197	rs2744944	0.936756488777885	Hypothyroidism	3e-10	34594039
rs2764197	rs2744944	0.936756488777885	High density lipoprotein cholesterol levels	3e-86	34887591
rs2764197	rs2744944	0.936756488777885	Multi-trait sex score	7e-22	37277458
rs2764197	rs9469899	0.93134346168744	Prostate cancer (advanced)	2e-06	29892016
rs2764197	rs9469899	0.93134346168744	Prostate cancer	5e-09	29892016
rs2764197	rs9469899	0.93134346168744	Prostate cancer	8e-11	33398198
rs2764197	rs9469899	0.93134346168744	Hand grip strength	3e-15	29691431
rs2764197	rs9469899	0.93134346168744	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2764197	rs9469899	0.93134346168744	Graves' disease	4e-10	34594039
rs2764197	rs9469899	0.93134346168744	Coronary artery disease	1e-11	36474045
rs2764197	rs9469899	0.93134346168744	Predicted visceral adipose tissue	2e-20	31501611
rs2764197	rs9469899	0.93134346168744	Medication use (thyroid preparations)	2e-09	31015401
rs2764197	rs9469899	0.93134346168744	Medication use (thyroid preparations)	3e-10	34594039
rs2764197	rs2263329	0.91744728003782	HDL cholesterol	6e-35	34594039
rs2764197	rs2263329	0.91744728003782	HDL cholesterol levels	8e-43	32203549
rs2764197	rs2263329	0.91744728003782	High density lipoprotein cholesterol levels	2e-52	34887591
rs2764197	rs9296128	0.894786239424834	Hip circumference adjusted for BMI	4e-13	34021172
rs2764197	rs111868030	0.893259582014213	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2764197	rs9368830	0.869986811869483	HDL cholesterol	4e-21	30275531
rs2764197	rs9368828	0.840657499688631	Body mass index	1e-34	34594039
rs2764197	rs6912327	0.822747803601124	Fasting insulin	5e-06	33402679
rs2764197	rs6912327	0.822747803601124	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2764197	rs112283401	0.800020153934568	Red cell distribution width	4e-27	30595370
rs2764197	rs2744973	0.784940730696001	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2764197	rs2744973	0.784940730696001	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2764197	rs2744973	0.784940730696001	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2764197	rs2744973	0.784940730696001	Multi-trait sex score	6e-20	37277458
rs2764197	rs6940215	0.63658979755868	Insomnia	2e-10	35835914
rs2764197	rs6940215	0.63658979755868	Insomnia	1e-13	35835914
rs2764197	rs6940215	0.63658979755868	Hip circumference adjusted for BMI	8e-10	34021172
rs2764197	rs6940215	0.63658979755868	Multi-trait sex score	2e-23	37277458
rs2764197	rs6940215	0.63658979755868	Multi-trait sex score	4e-23	37277458
rs2764197	rs6457796	0.627892023130373	Insomnia	1e-08	30804565
rs2764197	rs6457796	0.627892023130373	Plateletcrit	9e-11	32888494
rs2764197	rs6457796	0.627892023130373	Systemic lupus erythematosus	3e-22	33272962
rs2764197	rs6457796	0.627892023130373	Body mass index	5e-13	30108127
rs2764197	rs6457796	0.627892023130373	Body mass index	1e-14	26426971
rs2764197	rs6457796	0.627892023130373	Educational attainment	5e-19	35361970
rs2764197	rs9689160	0.607332402799307	Lung function (forced vital capacity)	3e-14	36914875
rs2764198	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2764198	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2764198	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2764198	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2764198	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2764198	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2764198	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2764198	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2764198	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2764198	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2764198	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2764198	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2764198	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2764198	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2764198	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2764198	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2764198	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2764198	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2764198	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2764198	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2764198	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2764198	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2764198	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2764198	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2764198	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2764198	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2764198	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2764198	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2764198	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2764198	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2764198	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2764198	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2764198	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2764198	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2764198	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2764198	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2764198	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2764198	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2764198	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2764198	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2764198	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2764198	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2764198	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2764198	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2764198	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2764198	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2764198	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2764198	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2764198	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2764198	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2764198	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2764198	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2764198	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2764198	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2764198	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2764198	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2764198	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2764198	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2764198	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2764198	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2764198	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2764198	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2764198	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2764198	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2764198	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2764198	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2764198	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2764198	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2764201	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2764201	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2764201	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2764201	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2764201	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2764201	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2764201	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2764201	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2764201	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2764201	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2764201	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2764201	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2764201	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2764201	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2764201	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2764201	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2764201	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2764201	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2764201	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2764201	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2764201	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2764201	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2764201	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2764201	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2764201	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2764201	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2764201	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2764201	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2764201	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2764201	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2764201	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2764201	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2764201	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2764201	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2764201	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2764201	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2764201	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2764201	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2764201	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2764201	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2764201	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2764201	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2764201	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2764201	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2764201	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2764201	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2764201	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2764201	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2764201	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2764201	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2764201	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2764201	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2764201	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2764201	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2764201	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2764201	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2764201	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2764201	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2764201	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2764201	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2764201	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2764201	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2764201	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2764201	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2764201	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2764201	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2764201	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2764201	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2764210	rs9469872	0.984794807652595	HDL cholesterol levels	3e-11	36333282
rs2764210	rs9366863	0.984002326716811	Adult body size	9e-33	32376654
rs2764210	rs9366863	0.984002326716811	Body mass index	2e-44	30595370
rs2764210	rs11755393	0.977721258211558	Body mass index	3e-26	29273807
rs2764210	rs11755393	0.977721258211558	Systemic lupus erythematosus	2e-12	33493351
rs2764210	rs11755393	0.977721258211558	Systemic lupus erythematosus	2e-06	33493351
rs2764210	rs11755393	0.977721258211558	Systemic lupus erythematosus	1e-07	33493351
rs2764210	rs11755393	0.977721258211558	Systemic lupus erythematosus	2e-08	19838195
rs2764210	rs11755393	0.977721258211558	Body mass index	4e-55	36581621
rs2764210	rs6941110	0.966551249921627	Sex hormone-binding globulin levels	5e-27	36653534
rs2764210	rs9462030	0.948781164374768	Red cell distribution width	5e-25	32888493
rs2764210	rs2814949	0.946906183640127	Essential hypertension (time to event)	9e-09	32589924
rs2764210	rs9469857	0.944141706095809	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2764210	rs2764208	0.943406604496225	Systemic lupus erythematosus	7e-06	24871463
rs2764210	rs2744944	0.937530814641698	Hypothyroidism	3e-10	34594039
rs2764210	rs2744944	0.937530814641698	High density lipoprotein cholesterol levels	3e-86	34887591
rs2764210	rs2744944	0.937530814641698	Multi-trait sex score	7e-22	37277458
rs2764210	rs9469899	0.932111650669377	Prostate cancer (advanced)	2e-06	29892016
rs2764210	rs9469899	0.932111650669377	Prostate cancer	5e-09	29892016
rs2764210	rs9469899	0.932111650669377	Prostate cancer	8e-11	33398198
rs2764210	rs9469899	0.932111650669377	Hand grip strength	3e-15	29691431
rs2764210	rs9469899	0.932111650669377	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2764210	rs9469899	0.932111650669377	Graves' disease	4e-10	34594039
rs2764210	rs9469899	0.932111650669377	Coronary artery disease	1e-11	36474045
rs2764210	rs9469899	0.932111650669377	Predicted visceral adipose tissue	2e-20	31501611
rs2764210	rs9469899	0.932111650669377	Medication use (thyroid preparations)	2e-09	31015401
rs2764210	rs9469899	0.932111650669377	Medication use (thyroid preparations)	3e-10	34594039
rs2764210	rs2263329	0.918208169762507	HDL cholesterol	6e-35	34594039
rs2764210	rs2263329	0.918208169762507	HDL cholesterol levels	8e-43	32203549
rs2764210	rs2263329	0.918208169762507	High density lipoprotein cholesterol levels	2e-52	34887591
rs2764210	rs9296128	0.895509385822609	Hip circumference adjusted for BMI	4e-13	34021172
rs2764210	rs111868030	0.89398206616372	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2764210	rs9368830	0.870762324463012	HDL cholesterol	4e-21	30275531
rs2764210	rs9368828	0.841378748692334	Body mass index	1e-34	34594039
rs2764210	rs6912327	0.823413457747397	Fasting insulin	5e-06	33402679
rs2764210	rs6912327	0.823413457747397	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2764210	rs112283401	0.800676132715852	Red cell distribution width	4e-27	30595370
rs2764210	rs2744973	0.785577524321816	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2764210	rs2744973	0.785577524321816	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2764210	rs2744973	0.785577524321816	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2764210	rs2744973	0.785577524321816	Multi-trait sex score	6e-20	37277458
rs2764210	rs6940215	0.637134204040477	Insomnia	2e-10	35835914
rs2764210	rs6940215	0.637134204040477	Insomnia	1e-13	35835914
rs2764210	rs6940215	0.637134204040477	Hip circumference adjusted for BMI	8e-10	34021172
rs2764210	rs6940215	0.637134204040477	Multi-trait sex score	2e-23	37277458
rs2764210	rs6940215	0.637134204040477	Multi-trait sex score	4e-23	37277458
rs2764210	rs6457796	0.628401121989321	Insomnia	1e-08	30804565
rs2764210	rs6457796	0.628401121989321	Plateletcrit	9e-11	32888494
rs2764210	rs6457796	0.628401121989321	Systemic lupus erythematosus	3e-22	33272962
rs2764210	rs6457796	0.628401121989321	Body mass index	5e-13	30108127
rs2764210	rs6457796	0.628401121989321	Body mass index	1e-14	26426971
rs2764210	rs6457796	0.628401121989321	Educational attainment	5e-19	35361970
rs2764210	rs9689160	0.607821022836942	Lung function (forced vital capacity)	3e-14	36914875
rs2764211	rs9469872	0.984799546079627	HDL cholesterol levels	3e-11	36333282
rs2764211	rs9366863	0.98400903200142	Adult body size	9e-33	32376654
rs2764211	rs9366863	0.98400903200142	Body mass index	2e-44	30595370
rs2764211	rs11755393	0.977709176840438	Body mass index	3e-26	29273807
rs2764211	rs11755393	0.977709176840438	Systemic lupus erythematosus	2e-12	33493351
rs2764211	rs11755393	0.977709176840438	Systemic lupus erythematosus	2e-06	33493351
rs2764211	rs11755393	0.977709176840438	Systemic lupus erythematosus	1e-07	33493351
rs2764211	rs11755393	0.977709176840438	Systemic lupus erythematosus	2e-08	19838195
rs2764211	rs11755393	0.977709176840438	Body mass index	4e-55	36581621
rs2764211	rs6941110	0.966561462109644	Sex hormone-binding globulin levels	5e-27	36653534
rs2764211	rs9462030	0.948816922632669	Red cell distribution width	5e-25	32888493
rs2764211	rs2814949	0.946906764688008	Essential hypertension (time to event)	9e-09	32589924
rs2764211	rs9469857	0.945745034446727	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2764211	rs2764208	0.943446991459199	Systemic lupus erythematosus	7e-06	24871463
rs2764211	rs2744944	0.937538194892291	Hypothyroidism	3e-10	34594039
rs2764211	rs2744944	0.937538194892291	High density lipoprotein cholesterol levels	3e-86	34887591
rs2764211	rs2744944	0.937538194892291	Multi-trait sex score	7e-22	37277458
rs2764211	rs9469899	0.932127438950297	Prostate cancer (advanced)	2e-06	29892016
rs2764211	rs9469899	0.932127438950297	Prostate cancer	5e-09	29892016
rs2764211	rs9469899	0.932127438950297	Prostate cancer	8e-11	33398198
rs2764211	rs9469899	0.932127438950297	Hand grip strength	3e-15	29691431
rs2764211	rs9469899	0.932127438950297	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2764211	rs9469899	0.932127438950297	Graves' disease	4e-10	34594039
rs2764211	rs9469899	0.932127438950297	Coronary artery disease	1e-11	36474045
rs2764211	rs9469899	0.932127438950297	Predicted visceral adipose tissue	2e-20	31501611
rs2764211	rs9469899	0.932127438950297	Medication use (thyroid preparations)	2e-09	31015401
rs2764211	rs9469899	0.932127438950297	Medication use (thyroid preparations)	3e-10	34594039
rs2764211	rs2263329	0.919768519181724	HDL cholesterol	6e-35	34594039
rs2764211	rs2263329	0.919768519181724	HDL cholesterol levels	8e-43	32203549
rs2764211	rs2263329	0.919768519181724	High density lipoprotein cholesterol levels	2e-52	34887591
rs2764211	rs9296128	0.895591015572484	Hip circumference adjusted for BMI	4e-13	34021172
rs2764211	rs111868030	0.89406371643797	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2764211	rs9368830	0.870707292201903	HDL cholesterol	4e-21	30275531
rs2764211	rs9368828	0.841412032180957	Body mass index	1e-34	34594039
rs2764211	rs6912327	0.823555828958404	Fasting insulin	5e-06	33402679
rs2764211	rs6912327	0.823555828958404	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2764211	rs112283401	0.800817261746326	Red cell distribution width	4e-27	30595370
rs2764211	rs2744973	0.787193814717962	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2764211	rs2744973	0.787193814717962	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2764211	rs2744973	0.787193814717962	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2764211	rs2744973	0.787193814717962	Multi-trait sex score	6e-20	37277458
rs2764211	rs6940215	0.637359204884221	Insomnia	2e-10	35835914
rs2764211	rs6940215	0.637359204884221	Insomnia	1e-13	35835914
rs2764211	rs6940215	0.637359204884221	Hip circumference adjusted for BMI	8e-10	34021172
rs2764211	rs6940215	0.637359204884221	Multi-trait sex score	2e-23	37277458
rs2764211	rs6940215	0.637359204884221	Multi-trait sex score	4e-23	37277458
rs2764211	rs6457796	0.628709605415222	Insomnia	1e-08	30804565
rs2764211	rs6457796	0.628709605415222	Plateletcrit	9e-11	32888494
rs2764211	rs6457796	0.628709605415222	Systemic lupus erythematosus	3e-22	33272962
rs2764211	rs6457796	0.628709605415222	Body mass index	5e-13	30108127
rs2764211	rs6457796	0.628709605415222	Body mass index	1e-14	26426971
rs2764211	rs6457796	0.628709605415222	Educational attainment	5e-19	35361970
rs2764211	rs9689160	0.608158397949106	Lung function (forced vital capacity)	3e-14	36914875
rs2765527	rs2765527	1	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs2765527	rs10801696	0.853486534371323	Imidazole lactate levels	3e-195	35050183
rs2765527	rs1206228892	0.85280298334678	Imidazole lactate levels	5e-186	35050183
rs2765527	rs2810876	0.849520665602014	Imidazole lactate levels	2e-122	35347128
rs2765527	rs7532151	0.747643784302327	Imidazole lactate levels	9e-12	33177712
rs2765527	rs12729558	0.715913614040997	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs2765527	rs10922531	0.699039265897705	Serum metabolite levels	2e-69	33031748
rs2765527	rs10801690	0.697091926274849	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs2765527	rs9787133	0.688960799081126	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs2765527	rs7530513	0.637506947699747	Height	8e-11	35831902
rs2765527	rs7530513	0.637506947699747	Imidazole lactate levels	8e-166	36635386
rs2765527	rs12144640	0.637506947699747	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs2765527	rs1409152	0.628364598968609	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs2765527	rs1409152	0.628364598968609	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs2765527	rs10801699	0.626746332393541	X-23639 levels	2e-10	36635386
rs2765527	rs12120164	0.600497599721733	Metabolite peak levels (QI2146)	1e-26	35995766
rs27659	rs38033	0.990807910704528	Blood protein levels	0	30072576
rs27659	rs27293	0.983306969254823	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27659	rs27293	0.983306969254823	Diastolic blood pressure	3e-11	35762941
rs27659	rs1423357	0.972559460460139	General cognitive ability	9e-06	29844566
rs27659	rs2432142	0.956052350084805	Neutrophil count	2e-14	32888493
rs27659	rs2432142	0.956052350084805	White blood cell count	1e-11	32888493
rs27659	rs7705093	0.930358696585925	Birdshot chorioretinopathy	2e-09	24957906
rs27659	rs2910686	0.848890191739983	Neutrophil count	4e-14	32888493
rs27659	rs2910686	0.848890191739983	Psoriasis	2e-08	23143594
rs27659	rs2910686	0.848890191739983	Ankylosing spondylitis	5e-17	23749187
rs27659	rs2910686	0.848890191739983	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27659	rs2927608	0.845634414703482	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27659	rs2927608	0.845634414703482	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27659	rs2927608	0.845634414703482	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27659	rs38029	0.788399212050842	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27659	rs2617439	0.759142511456607	Neutrophil count	8e-11	32888494
rs27659	rs2549797	0.754302941088151	Systolic blood pressure	7e-07	33230300
rs27659	rs2549797	0.754302941088151	Diastolic blood pressure	1e-14	33230300
rs27659	rs2549797	0.754302941088151	Diastolic blood pressure	3e-11	33230300
rs27659	rs2549797	0.754302941088151	Systolic blood pressure	4e-09	33230300
rs27659	rs2549782	0.753053774968733	Systolic blood pressure	6e-07	33230300
rs27659	rs2549782	0.753053774968733	Diastolic blood pressure	1e-14	33230300
rs27659	rs2549782	0.753053774968733	Diastolic blood pressure	3e-11	33230300
rs27659	rs2549782	0.753053774968733	Systolic blood pressure	5e-09	33230300
rs27659	rs1056893	0.752430029016342	Systolic blood pressure	1e-06	33230300
rs27659	rs1056893	0.752430029016342	Diastolic blood pressure	7e-15	33230300
rs27659	rs1056893	0.752430029016342	Diastolic blood pressure	2e-11	33230300
rs27659	rs1056893	0.752430029016342	Systolic blood pressure	7e-09	33230300
rs27659	rs2549794	0.751203782061934	Crohn's disease	1e-10	21102463
rs27659	rs2549794	0.751203782061934	Systolic blood pressure	1e-07	33230300
rs27659	rs2549794	0.751203782061934	Diastolic blood pressure	1e-15	33230300
rs27659	rs2549794	0.751203782061934	Diastolic blood pressure	2e-12	33230300
rs27659	rs2549794	0.751203782061934	Systolic blood pressure	4e-10	33230300
rs27659	rs1363907	0.746616464762215	Crohn's disease	4e-16	26192919
rs27659	rs1363907	0.746616464762215	Ulcerative colitis	4e-06	26192919
rs27659	rs1363907	0.746616464762215	Inflammatory bowel disease	5e-15	26192919
rs27659	rs1363907	0.746616464762215	Inflammatory bowel disease	6e-13	23128233
rs27659	rs1363907	0.746616464762215	Inflammatory bowel disease	1e-10	28067908
rs27659	rs1363907	0.746616464762215	Crohn's disease	1e-14	28067908
rs27659	rs716848	0.718466328605746	Neutrophil percentage of white cells	2e-09	32888494
rs27659	rs4869313	0.706032045756534	Pediatric autoimmune diseases	9e-08	26301688
rs27659	rs1559359	0.699456095748635	Diastolic blood pressure	7e-10	34594039
rs27659	rs2548532	0.674699015038249	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27659	rs4869314	0.653623423879415	Arthritis (juvenile idiopathic)	3e-09	33106285
rs27659	rs4869314	0.653623423879415	Neutrophil count	1e-10	34594039
rs27659	rs4869314	0.653623423879415	White blood cell count	2e-07	30595370
rs27659	rs1974871	0.626935590891868	Granulysin levels	5e-13	34648354
rs27659	rs27660	0.624791287374572	Coronary artery disease	3e-08	35915156
rs27659	rs1019503	0.621423546207303	Systolic blood pressure	2e-06	33230300
rs27659	rs1019503	0.621423546207303	Diastolic blood pressure	2e-14	33230300
rs27659	rs1019503	0.621423546207303	Diastolic blood pressure	4e-11	33230300
rs27659	rs1019503	0.621423546207303	Systolic blood pressure	1e-08	33230300
rs27659	rs3096168	0.614160693741127	Aspartate aminotransferase levels	8e-12	33547301
rs27660	rs27660	1	Coronary artery disease	3e-08	35915156
rs27660	rs2548532	0.869243989465338	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27660	rs38029	0.787855551507297	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27660	rs2549794	0.782215834508668	Crohn's disease	1e-10	21102463
rs27660	rs2549794	0.782215834508668	Systolic blood pressure	1e-07	33230300
rs27660	rs2549794	0.782215834508668	Diastolic blood pressure	1e-15	33230300
rs27660	rs2549794	0.782215834508668	Diastolic blood pressure	2e-12	33230300
rs27660	rs2549794	0.782215834508668	Systolic blood pressure	4e-10	33230300
rs27660	rs2617439	0.778913894992846	Neutrophil count	8e-11	32888494
rs27660	rs1363907	0.777538629741749	Crohn's disease	4e-16	26192919
rs27660	rs1363907	0.777538629741749	Ulcerative colitis	4e-06	26192919
rs27660	rs1363907	0.777538629741749	Inflammatory bowel disease	5e-15	26192919
rs27660	rs1363907	0.777538629741749	Inflammatory bowel disease	6e-13	23128233
rs27660	rs1363907	0.777538629741749	Inflammatory bowel disease	1e-10	28067908
rs27660	rs1363907	0.777538629741749	Crohn's disease	1e-14	28067908
rs27660	rs716848	0.753242552710886	Neutrophil percentage of white cells	2e-09	32888494
rs27660	rs1423357	0.637068656440241	General cognitive ability	9e-06	29844566
rs27660	rs27293	0.628014566308903	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27660	rs27293	0.628014566308903	Diastolic blood pressure	3e-11	35762941
rs27660	rs38033	0.62358225770101	Blood protein levels	0	30072576
rs27660	rs2432142	0.62309288082855	Neutrophil count	2e-14	32888493
rs27660	rs2432142	0.62309288082855	White blood cell count	1e-11	32888493
rs27660	rs7705093	0.608692122142801	Birdshot chorioretinopathy	2e-09	24957906
rs27711	rs38029	0.995556324124674	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27711	rs2617439	0.944655284922285	Neutrophil count	8e-11	32888494
rs27711	rs2549794	0.936950511420786	Crohn's disease	1e-10	21102463
rs27711	rs2549794	0.936950511420786	Systolic blood pressure	1e-07	33230300
rs27711	rs2549794	0.936950511420786	Diastolic blood pressure	1e-15	33230300
rs27711	rs2549794	0.936950511420786	Diastolic blood pressure	2e-12	33230300
rs27711	rs2549794	0.936950511420786	Systolic blood pressure	4e-10	33230300
rs27711	rs1363907	0.931807280192372	Crohn's disease	4e-16	26192919
rs27711	rs1363907	0.931807280192372	Ulcerative colitis	4e-06	26192919
rs27711	rs1363907	0.931807280192372	Inflammatory bowel disease	5e-15	26192919
rs27711	rs1363907	0.931807280192372	Inflammatory bowel disease	6e-13	23128233
rs27711	rs1363907	0.931807280192372	Inflammatory bowel disease	1e-10	28067908
rs27711	rs1363907	0.931807280192372	Crohn's disease	1e-14	28067908
rs27711	rs716848	0.901917674703006	Neutrophil percentage of white cells	2e-09	32888494
rs27711	rs2548532	0.841213454265118	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27711	rs27293	0.793804296322736	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27711	rs27293	0.793804296322736	Diastolic blood pressure	3e-11	35762941
rs27711	rs27660	0.790692905422786	Coronary artery disease	3e-08	35915156
rs27711	rs38033	0.788735911623121	Blood protein levels	0	30072576
rs27711	rs1423357	0.769166167558234	General cognitive ability	9e-06	29844566
rs27711	rs2432142	0.754253697215481	Neutrophil count	2e-14	32888493
rs27711	rs2432142	0.754253697215481	White blood cell count	1e-11	32888493
rs27711	rs7705093	0.734338494140087	Birdshot chorioretinopathy	2e-09	24957906
rs27711	rs4869313	0.673811691314223	Pediatric autoimmune diseases	9e-08	26301688
rs27711	rs2927608	0.673796902702505	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27711	rs2927608	0.673796902702505	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27711	rs2927608	0.673796902702505	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27711	rs2910686	0.671520839343101	Neutrophil count	4e-14	32888493
rs27711	rs2910686	0.671520839343101	Psoriasis	2e-08	23143594
rs27711	rs2910686	0.671520839343101	Ankylosing spondylitis	5e-17	23749187
rs27711	rs2910686	0.671520839343101	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27711	rs1559359	0.613443492681698	Diastolic blood pressure	7e-10	34594039
rs27711	rs1974871	0.603352228403674	Granulysin levels	5e-13	34648354
rs27712	rs27660	0.99323083130479	Coronary artery disease	3e-08	35915156
rs27712	rs2548532	0.873629686707677	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27712	rs38029	0.791927013871262	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27712	rs2549794	0.786272907630146	Crohn's disease	1e-10	21102463
rs27712	rs2549794	0.786272907630146	Systolic blood pressure	1e-07	33230300
rs27712	rs2549794	0.786272907630146	Diastolic blood pressure	1e-15	33230300
rs27712	rs2549794	0.786272907630146	Diastolic blood pressure	2e-12	33230300
rs27712	rs2549794	0.786272907630146	Systolic blood pressure	4e-10	33230300
rs27712	rs2617439	0.782983298419705	Neutrophil count	8e-11	32888494
rs27712	rs1363907	0.781582622137277	Crohn's disease	4e-16	26192919
rs27712	rs1363907	0.781582622137277	Ulcerative colitis	4e-06	26192919
rs27712	rs1363907	0.781582622137277	Inflammatory bowel disease	5e-15	26192919
rs27712	rs1363907	0.781582622137277	Inflammatory bowel disease	6e-13	23128233
rs27712	rs1363907	0.781582622137277	Inflammatory bowel disease	1e-10	28067908
rs27712	rs1363907	0.781582622137277	Crohn's disease	1e-14	28067908
rs27712	rs716848	0.757193186457823	Neutrophil percentage of white cells	2e-09	32888494
rs27712	rs1423357	0.640581688829215	General cognitive ability	9e-06	29844566
rs27712	rs27293	0.631488581726806	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27712	rs27293	0.631488581726806	Diastolic blood pressure	3e-11	35762941
rs27712	rs38033	0.627043047649538	Blood protein levels	0	30072576
rs27712	rs2432142	0.626568764264589	Neutrophil count	2e-14	32888493
rs27712	rs2432142	0.626568764264589	White blood cell count	1e-11	32888493
rs27712	rs7705093	0.612098758327361	Birdshot chorioretinopathy	2e-09	24957906
rs2775002	rs2357176	0.962242660433225	Nevus count or cutaneous melanoma	4e-08	30429480
rs2775002	rs10873172	0.807372672851604	Cutaneous melanoma or hair colour	6e-27	32341527
rs2775002	rs10873172	0.807372672851604	Nevus count or cutaneous melanoma	6e-13	32341527
rs2775002	rs10873172	0.807372672851604	Blond vs. brown/black hair color	6e-15	30531825
rs2775002	rs10873172	0.807372672851604	Cutaneous malignant melanoma	6e-08	32341527
rs2775002	rs10873172	0.807372672851604	Hair color	4e-17	30595370
rs2775002	rs1255908	0.748918855878347	PR interval	8e-14	32439900
rs2775002	rs1255908	0.748918855878347	PR interval	6e-14	32439900
rs2775002	rs12878653	0.682639717148828	Youthful appearance (self-reported)	3e-14	32339537
rs2779207	rs9897542	0.830212768477734	Total bilirubin levels	8e-11	34594039
rs2779207	rs2285583	0.687413274719038	AFP levels	2e-08	36329257
rs2779210	rs9897542	0.850909204168716	Total bilirubin levels	8e-11	34594039
rs2779210	rs2285583	0.708586403953906	AFP levels	2e-08	36329257
rs2792201	rs2357176	0.954391154054323	Nevus count or cutaneous melanoma	4e-08	30429480
rs2792201	rs10873172	0.857754373040282	Cutaneous melanoma or hair colour	6e-27	32341527
rs2792201	rs10873172	0.857754373040282	Nevus count or cutaneous melanoma	6e-13	32341527
rs2792201	rs10873172	0.857754373040282	Blond vs. brown/black hair color	6e-15	30531825
rs2792201	rs10873172	0.857754373040282	Cutaneous malignant melanoma	6e-08	32341527
rs2792201	rs10873172	0.857754373040282	Hair color	4e-17	30595370
rs2792201	rs1255908	0.808910257552654	PR interval	8e-14	32439900
rs2792201	rs1255908	0.808910257552654	PR interval	6e-14	32439900
rs2792201	rs12878653	0.738498265925869	Youthful appearance (self-reported)	3e-14	32339537
rs2794624	rs770199	0.896558237283904	Hair color	3e-08	30595370
rs2794625	rs770199	0.895285160644843	Hair color	3e-08	30595370
rs2794626	rs770199	0.899480842202492	Hair color	3e-08	30595370
rs2794627	rs770199	0.895285160644843	Hair color	3e-08	30595370
rs2794629	rs770199	0.893869901863626	Hair color	3e-08	30595370
rs2794633	rs770199	0.827309699186711	Hair color	3e-08	30595370
rs2795857	rs2795857	1	Height	2e-123	36224396
rs2795857	rs2462017	0.771348230839967	Lymphocyte count	3e-12	32888493
rs2795857	rs2488010	0.762444832183931	Monocyte count	9e-16	32888493
rs2795857	rs2462021	0.761709829479613	Suicide risk	8e-06	21041247
rs2795857	rs1332618	0.760280036360552	Platelet count	4e-15	32888494
rs2795857	rs2795863	0.742339098394327	Height	3e-20	36224396
rs2795857	rs503598	0.728753628744457	White blood cell count	2e-08	30595370
rs2795857	rs2689216	0.708141182337137	Platelet count	2e-22	32888493
rs2795857	rs2689216	0.708141182337137	Platelet count	1e-21	32888493
rs2795857	rs1571956	0.694889903177436	Neutrophil count	1e-11	32888493
rs2795857	rs2482820	0.685877146667382	Monocyte count	9e-13	32888494
rs2795857	rs2482819	0.683103510473842	Neutrophil count	4e-10	32888493
rs2795857	rs2091084	0.639225528887715	White blood cell count	6e-19	32888493
rs2795857	rs2091084	0.639225528887715	Lymphocyte count	3e-10	32888494
rs2795857	rs2091084	0.639225528887715	White blood cell count	4e-13	32888494
rs2795857	rs2462015	0.612804860948043	White blood cell count	5e-17	32888493
rs2795858	rs2795857	0.902304252461838	Height	2e-123	36224396
rs2795858	rs2462017	0.860960357674108	Lymphocyte count	3e-12	32888493
rs2795858	rs2488010	0.851888440529002	Monocyte count	9e-16	32888493
rs2795858	rs2462021	0.851134396194881	Suicide risk	8e-06	21041247
rs2795858	rs1332618	0.840824869051616	Platelet count	4e-15	32888494
rs2795858	rs2795863	0.829845097503921	Height	3e-20	36224396
rs2795858	rs503598	0.815991250217567	White blood cell count	2e-08	30595370
rs2795858	rs2689216	0.792137617355319	Platelet count	2e-22	32888493
rs2795858	rs2689216	0.792137617355319	Platelet count	1e-21	32888493
rs2795858	rs1571956	0.777758086223443	Neutrophil count	1e-11	32888493
rs2795858	rs2482820	0.768088789632932	Monocyte count	9e-13	32888494
rs2795858	rs2482819	0.76524062506949	Neutrophil count	4e-10	32888493
rs2795859	rs2462017	0.884049415378733	Lymphocyte count	3e-12	32888493
rs2795859	rs2795857	0.875667060220882	Height	2e-123	36224396
rs2795859	rs2488010	0.874732457430123	Monocyte count	9e-16	32888493
rs2795859	rs2462021	0.87395983707523	Suicide risk	8e-06	21041247
rs2795859	rs2795863	0.852632531032578	Height	3e-20	36224396
rs2795859	rs503598	0.837909295338638	White blood cell count	2e-08	30595370
rs2795859	rs1332618	0.816240555976548	Platelet count	4e-15	32888494
rs2795859	rs2689216	0.814374742147228	Platelet count	2e-22	32888493
rs2795859	rs2689216	0.814374742147228	Platelet count	1e-21	32888493
rs2795859	rs1571956	0.799898702934722	Neutrophil count	1e-11	32888493
rs2795859	rs2482820	0.790125804925822	Monocyte count	9e-13	32888494
rs2795859	rs2482819	0.787204294149527	Neutrophil count	4e-10	32888493
rs2795859	rs2091084	0.608923699121353	White blood cell count	6e-19	32888493
rs2795859	rs2091084	0.608923699121353	Lymphocyte count	3e-10	32888494
rs2795859	rs2091084	0.608923699121353	White blood cell count	4e-13	32888494
rs2798906	rs2462017	0.88563307989352	Lymphocyte count	3e-12	32888493
rs2798906	rs2488010	0.876305679622757	Monocyte count	9e-16	32888493
rs2798906	rs2795857	0.875667060220882	Height	2e-123	36224396
rs2798906	rs2462021	0.875532218509407	Suicide risk	8e-06	21041247
rs2798906	rs2795863	0.852632531032578	Height	3e-20	36224396
rs2798906	rs503598	0.839441885021602	White blood cell count	2e-08	30595370
rs2798906	rs1332618	0.816240555976548	Platelet count	4e-15	32888494
rs2798906	rs2689216	0.814374742147228	Platelet count	2e-22	32888493
rs2798906	rs2689216	0.814374742147228	Platelet count	1e-21	32888493
rs2798906	rs1571956	0.799898702934722	Neutrophil count	1e-11	32888493
rs2798906	rs2482820	0.790125804925822	Monocyte count	9e-13	32888494
rs2798906	rs2482819	0.787204294149527	Neutrophil count	4e-10	32888493
rs2798906	rs2091084	0.610205549866064	White blood cell count	6e-19	32888493
rs2798906	rs2091084	0.610205549866064	Lymphocyte count	3e-10	32888494
rs2798906	rs2091084	0.610205549866064	White blood cell count	4e-13	32888494
rs2798907	rs2795857	0.978605546883583	Height	2e-123	36224396
rs2798907	rs2462017	0.778319499730384	Lymphocyte count	3e-12	32888493
rs2798907	rs2488010	0.769395174290196	Monocyte count	9e-16	32888493
rs2798907	rs2462021	0.768658151439314	Suicide risk	8e-06	21041247
rs2798907	rs1332618	0.76560518981586	Platelet count	4e-15	32888494
rs2798907	rs2795863	0.747707719269384	Height	3e-20	36224396
rs2798907	rs503598	0.734197982711862	White blood cell count	2e-08	30595370
rs2798907	rs2689216	0.713386060014896	Platelet count	2e-22	32888493
rs2798907	rs2689216	0.713386060014896	Platelet count	1e-21	32888493
rs2798907	rs1571956	0.70006464662603	Neutrophil count	1e-11	32888493
rs2798907	rs2482820	0.691010915745393	Monocyte count	9e-13	32888494
rs2798907	rs2482819	0.688232417262501	Neutrophil count	4e-10	32888493
rs2798907	rs2091084	0.64627745989995	White blood cell count	6e-19	32888493
rs2798907	rs2091084	0.64627745989995	Lymphocyte count	3e-10	32888494
rs2798907	rs2091084	0.64627745989995	White blood cell count	4e-13	32888494
rs2798907	rs2462015	0.600810718883119	White blood cell count	5e-17	32888493
rs2798920	rs2462017	0.898403913203442	Lymphocyte count	3e-12	32888493
rs2798920	rs2488010	0.888977415861997	Monocyte count	9e-16	32888493
rs2798920	rs2462021	0.888196165538063	Suicide risk	8e-06	21041247
rs2798920	rs2795863	0.866753158332052	Height	3e-20	36224396
rs2798920	rs2795857	0.864697279186471	Height	2e-123	36224396
rs2798920	rs503598	0.851732554041222	White blood cell count	2e-08	30595370
rs2798920	rs2689216	0.828159327574441	Platelet count	2e-22	32888493
rs2798920	rs2689216	0.828159327574441	Platelet count	1e-21	32888493
rs2798920	rs1571956	0.813584185051672	Neutrophil count	1e-11	32888493
rs2798920	rs1332618	0.805723326004506	Platelet count	4e-15	32888494
rs2798920	rs2482820	0.803734034053284	Monocyte count	9e-13	32888494
rs2798920	rs2482819	0.800778319658928	Neutrophil count	4e-10	32888493
rs2798920	rs2091084	0.618885211012401	White blood cell count	6e-19	32888493
rs2798920	rs2091084	0.618885211012401	Lymphocyte count	3e-10	32888494
rs2798920	rs2091084	0.618885211012401	White blood cell count	4e-13	32888494
rs27993	rs38029	0.993775794396667	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27993	rs2617439	0.942856334484957	Neutrophil count	8e-11	32888494
rs27993	rs2549794	0.935192123274563	Crohn's disease	1e-10	21102463
rs27993	rs2549794	0.935192123274563	Systolic blood pressure	1e-07	33230300
rs27993	rs2549794	0.935192123274563	Diastolic blood pressure	1e-15	33230300
rs27993	rs2549794	0.935192123274563	Diastolic blood pressure	2e-12	33230300
rs27993	rs2549794	0.935192123274563	Systolic blood pressure	4e-10	33230300
rs27993	rs1363907	0.930054347723183	Crohn's disease	4e-16	26192919
rs27993	rs1363907	0.930054347723183	Ulcerative colitis	4e-06	26192919
rs27993	rs1363907	0.930054347723183	Inflammatory bowel disease	5e-15	26192919
rs27993	rs1363907	0.930054347723183	Inflammatory bowel disease	6e-13	23128233
rs27993	rs1363907	0.930054347723183	Inflammatory bowel disease	1e-10	28067908
rs27993	rs1363907	0.930054347723183	Crohn's disease	1e-14	28067908
rs27993	rs716848	0.90024170859561	Neutrophil percentage of white cells	2e-09	32888494
rs27993	rs2548532	0.839287990473901	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27993	rs27293	0.797127376735795	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27993	rs27293	0.797127376735795	Diastolic blood pressure	3e-11	35762941
rs27993	rs27660	0.788560015147266	Coronary artery disease	3e-08	35915156
rs27993	rs38033	0.787442977525731	Blood protein levels	0	30072576
rs27993	rs1423357	0.767838745343453	General cognitive ability	9e-06	29844566
rs27993	rs2432142	0.752933576461061	Neutrophil count	2e-14	32888493
rs27993	rs2432142	0.752933576461061	White blood cell count	1e-11	32888493
rs27993	rs7705093	0.733095998251812	Birdshot chorioretinopathy	2e-09	24957906
rs27993	rs2927608	0.672692733190517	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27993	rs2927608	0.672692733190517	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27993	rs2927608	0.672692733190517	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27993	rs4869313	0.672605929788301	Pediatric autoimmune diseases	9e-08	26301688
rs27993	rs2910686	0.67042222786985	Neutrophil count	4e-14	32888493
rs27993	rs2910686	0.67042222786985	Psoriasis	2e-08	23143594
rs27993	rs2910686	0.67042222786985	Ankylosing spondylitis	5e-17	23749187
rs27993	rs2910686	0.67042222786985	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27993	rs1559359	0.612403718786456	Diastolic blood pressure	7e-10	34594039
rs27993	rs1974871	0.602319978012618	Granulysin levels	5e-13	34648354
rs27997	rs2617439	0.966307105688029	Neutrophil count	8e-11	32888494
rs27997	rs38029	0.95767028097766	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27997	rs2549794	0.956808510933231	Crohn's disease	1e-10	21102463
rs27997	rs2549794	0.956808510933231	Systolic blood pressure	1e-07	33230300
rs27997	rs2549794	0.956808510933231	Diastolic blood pressure	1e-15	33230300
rs27997	rs2549794	0.956808510933231	Diastolic blood pressure	2e-12	33230300
rs27997	rs2549794	0.956808510933231	Systolic blood pressure	4e-10	33230300
rs27997	rs1363907	0.951605712984683	Crohn's disease	4e-16	26192919
rs27997	rs1363907	0.951605712984683	Ulcerative colitis	4e-06	26192919
rs27997	rs1363907	0.951605712984683	Inflammatory bowel disease	5e-15	26192919
rs27997	rs1363907	0.951605712984683	Inflammatory bowel disease	6e-13	23128233
rs27997	rs1363907	0.951605712984683	Inflammatory bowel disease	1e-10	28067908
rs27997	rs1363907	0.951605712984683	Crohn's disease	1e-14	28067908
rs27997	rs716848	0.921445450433931	Neutrophil percentage of white cells	2e-09	32888494
rs27997	rs2548532	0.859515437347234	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27997	rs1423357	0.79368246690628	General cognitive ability	9e-06	29844566
rs27997	rs27660	0.791389964866266	Coronary artery disease	3e-08	35915156
rs27997	rs2432142	0.778505690639077	Neutrophil count	2e-14	32888493
rs27997	rs2432142	0.778505690639077	White blood cell count	1e-11	32888493
rs27997	rs38033	0.778176805469998	Blood protein levels	0	30072576
rs27997	rs27293	0.76796291631148	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27997	rs27293	0.76796291631148	Diastolic blood pressure	3e-11	35762941
rs27997	rs7705093	0.759868417794204	Birdshot chorioretinopathy	2e-09	24957906
rs27997	rs2927608	0.696947568874493	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27997	rs2927608	0.696947568874493	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27997	rs2927608	0.696947568874493	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27997	rs4869313	0.696741091425775	Pediatric autoimmune diseases	9e-08	26301688
rs27997	rs2910686	0.694639283593856	Neutrophil count	4e-14	32888493
rs27997	rs2910686	0.694639283593856	Psoriasis	2e-08	23143594
rs27997	rs2910686	0.694639283593856	Ankylosing spondylitis	5e-17	23749187
rs27997	rs2910686	0.694639283593856	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27997	rs1559359	0.634163311411141	Diastolic blood pressure	7e-10	34594039
rs27997	rs1974871	0.625242691727933	Granulysin levels	5e-13	34648354
rs27997	rs2549797	0.618710015525708	Systolic blood pressure	7e-07	33230300
rs27997	rs2549797	0.618710015525708	Diastolic blood pressure	1e-14	33230300
rs27997	rs2549797	0.618710015525708	Diastolic blood pressure	3e-11	33230300
rs27997	rs2549797	0.618710015525708	Systolic blood pressure	4e-09	33230300
rs27997	rs2549782	0.61770209969325	Systolic blood pressure	6e-07	33230300
rs27997	rs2549782	0.61770209969325	Diastolic blood pressure	1e-14	33230300
rs27997	rs2549782	0.61770209969325	Diastolic blood pressure	3e-11	33230300
rs27997	rs2549782	0.61770209969325	Systolic blood pressure	5e-09	33230300
rs27997	rs1056893	0.61719881704499	Systolic blood pressure	1e-06	33230300
rs27997	rs1056893	0.61719881704499	Diastolic blood pressure	7e-15	33230300
rs27997	rs1056893	0.61719881704499	Diastolic blood pressure	2e-11	33230300
rs27997	rs1056893	0.61719881704499	Systolic blood pressure	7e-09	33230300
rs27998	rs27293	0.968476391175053	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs27998	rs27293	0.968476391175053	Diastolic blood pressure	3e-11	35762941
rs27998	rs38033	0.954512427864098	Blood protein levels	0	30072576
rs27998	rs1423357	0.936195583170607	General cognitive ability	9e-06	29844566
rs27998	rs2432142	0.919984927247319	Neutrophil count	2e-14	32888493
rs27998	rs2432142	0.919984927247319	White blood cell count	1e-11	32888493
rs27998	rs7705093	0.90172332913501	Birdshot chorioretinopathy	2e-09	24957906
rs27998	rs2910686	0.814877783053177	Neutrophil count	4e-14	32888493
rs27998	rs2910686	0.814877783053177	Psoriasis	2e-08	23143594
rs27998	rs2910686	0.814877783053177	Ankylosing spondylitis	5e-17	23749187
rs27998	rs2910686	0.814877783053177	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs27998	rs2927608	0.813135955042719	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs27998	rs2927608	0.813135955042719	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs27998	rs2927608	0.813135955042719	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs27998	rs38029	0.764275839253814	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs27998	rs2617439	0.72624173515018	Neutrophil count	8e-11	32888494
rs27998	rs2549797	0.723460300967381	Systolic blood pressure	7e-07	33230300
rs27998	rs2549797	0.723460300967381	Diastolic blood pressure	1e-14	33230300
rs27998	rs2549797	0.723460300967381	Diastolic blood pressure	3e-11	33230300
rs27998	rs2549797	0.723460300967381	Systolic blood pressure	4e-09	33230300
rs27998	rs2549782	0.722252391748386	Systolic blood pressure	6e-07	33230300
rs27998	rs2549782	0.722252391748386	Diastolic blood pressure	1e-14	33230300
rs27998	rs2549782	0.722252391748386	Diastolic blood pressure	3e-11	33230300
rs27998	rs2549782	0.722252391748386	Systolic blood pressure	5e-09	33230300
rs27998	rs1056893	0.721649246773187	Systolic blood pressure	1e-06	33230300
rs27998	rs1056893	0.721649246773187	Diastolic blood pressure	7e-15	33230300
rs27998	rs1056893	0.721649246773187	Diastolic blood pressure	2e-11	33230300
rs27998	rs1056893	0.721649246773187	Systolic blood pressure	7e-09	33230300
rs27998	rs2549794	0.718739579991915	Crohn's disease	1e-10	21102463
rs27998	rs2549794	0.718739579991915	Systolic blood pressure	1e-07	33230300
rs27998	rs2549794	0.718739579991915	Diastolic blood pressure	1e-15	33230300
rs27998	rs2549794	0.718739579991915	Diastolic blood pressure	2e-12	33230300
rs27998	rs2549794	0.718739579991915	Systolic blood pressure	4e-10	33230300
rs27998	rs1363907	0.714267474277047	Crohn's disease	4e-16	26192919
rs27998	rs1363907	0.714267474277047	Ulcerative colitis	4e-06	26192919
rs27998	rs1363907	0.714267474277047	Inflammatory bowel disease	5e-15	26192919
rs27998	rs1363907	0.714267474277047	Inflammatory bowel disease	6e-13	23128233
rs27998	rs1363907	0.714267474277047	Inflammatory bowel disease	1e-10	28067908
rs27998	rs1363907	0.714267474277047	Crohn's disease	1e-14	28067908
rs27998	rs716848	0.687155550364273	Neutrophil percentage of white cells	2e-09	32888494
rs27998	rs4869313	0.675205496940598	Pediatric autoimmune diseases	9e-08	26301688
rs27998	rs1559359	0.668603754127907	Diastolic blood pressure	7e-10	34594039
rs27998	rs2548532	0.642196130572244	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs27998	rs4869314	0.625492967456267	Arthritis (juvenile idiopathic)	3e-09	33106285
rs27998	rs4869314	0.625492967456267	Neutrophil count	1e-10	34594039
rs27998	rs4869314	0.625492967456267	White blood cell count	2e-07	30595370
rs27998	rs27660	0.601341915159219	Coronary artery disease	3e-08	35915156
rs280599	rs7655841	0.862090040795504	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs280599	rs337277	0.85624694990872	Metabolite peak levels (QI10992)	3e-52	35995766
rs280599	rs337277	0.85624694990872	Metabolite peak levels (QI4667)	7e-18	35995766
rs280599	rs337277	0.85624694990872	Metabolite peak levels (QI4708)	1e-21	35995766
rs280599	rs337277	0.85624694990872	Metabolite peak levels (QI5169)	7e-57	35995766
rs280599	rs10010659	0.60608265841687	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs280604	rs7655841	0.877200279815981	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs280604	rs337277	0.844848849104627	Metabolite peak levels (QI10992)	3e-52	35995766
rs280604	rs337277	0.844848849104627	Metabolite peak levels (QI4667)	7e-18	35995766
rs280604	rs337277	0.844848849104627	Metabolite peak levels (QI4708)	1e-21	35995766
rs280604	rs337277	0.844848849104627	Metabolite peak levels (QI5169)	7e-57	35995766
rs280604	rs10010659	0.600383311317196	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs2810876	rs2810876	1	Imidazole lactate levels	2e-122	35347128
rs2810876	rs10801696	0.994408967179355	Imidazole lactate levels	3e-195	35050183
rs2810876	rs1206228892	0.993612605165659	Imidazole lactate levels	5e-186	35050183
rs2810876	rs2765527	0.849520665602014	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs2810876	rs7532151	0.717278931449167	Imidazole lactate levels	9e-12	33177712
rs2810876	rs12729558	0.690371265841145	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs2810876	rs10127863	0.666547704406196	Intraocular pressure	9e-10	29617998
rs2810876	rs9787133	0.658883502812038	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs2810876	rs10801690	0.642138792748619	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs2810876	rs12143830	0.600626599932101	Central corneal thickness (MTAG)	4e-10	35446358
rs2814942	rs9366863	0.984814504463715	Adult body size	9e-33	32376654
rs2814942	rs9366863	0.984814504463715	Body mass index	2e-44	30595370
rs2814942	rs2814949	0.9729792398285	Essential hypertension (time to event)	9e-09	32589924
rs2814942	rs2744944	0.958673406573797	Hypothyroidism	3e-10	34594039
rs2814942	rs2744944	0.958673406573797	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814942	rs2744944	0.958673406573797	Multi-trait sex score	7e-22	37277458
rs2814942	rs9469872	0.955526620248468	HDL cholesterol levels	3e-11	36333282
rs2814942	rs11755393	0.948771478671485	Body mass index	3e-26	29273807
rs2814942	rs11755393	0.948771478671485	Systemic lupus erythematosus	2e-12	33493351
rs2814942	rs11755393	0.948771478671485	Systemic lupus erythematosus	2e-06	33493351
rs2814942	rs11755393	0.948771478671485	Systemic lupus erythematosus	1e-07	33493351
rs2814942	rs11755393	0.948771478671485	Systemic lupus erythematosus	2e-08	19838195
rs2814942	rs11755393	0.948771478671485	Body mass index	4e-55	36581621
rs2814942	rs2263329	0.945255275631571	HDL cholesterol	6e-35	34594039
rs2814942	rs2263329	0.945255275631571	HDL cholesterol levels	8e-43	32203549
rs2814942	rs2263329	0.945255275631571	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814942	rs6941110	0.939046018275209	Sex hormone-binding globulin levels	5e-27	36653534
rs2814942	rs111868030	0.923151210662201	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814942	rs9462030	0.91965806317376	Red cell distribution width	5e-25	32888493
rs2814942	rs9469857	0.915054189516501	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814942	rs2764208	0.914305216119331	Systemic lupus erythematosus	7e-06	24871463
rs2814942	rs9469899	0.903502434510482	Prostate cancer (advanced)	2e-06	29892016
rs2814942	rs9469899	0.903502434510482	Prostate cancer	5e-09	29892016
rs2814942	rs9469899	0.903502434510482	Prostate cancer	8e-11	33398198
rs2814942	rs9469899	0.903502434510482	Hand grip strength	3e-15	29691431
rs2814942	rs9469899	0.903502434510482	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814942	rs9469899	0.903502434510482	Graves' disease	4e-10	34594039
rs2814942	rs9469899	0.903502434510482	Coronary artery disease	1e-11	36474045
rs2814942	rs9469899	0.903502434510482	Predicted visceral adipose tissue	2e-20	31501611
rs2814942	rs9469899	0.903502434510482	Medication use (thyroid preparations)	2e-09	31015401
rs2814942	rs9469899	0.903502434510482	Medication use (thyroid preparations)	3e-10	34594039
rs2814942	rs9368830	0.89029981099603	HDL cholesterol	4e-21	30275531
rs2814942	rs9296128	0.866602262977582	Hip circumference adjusted for BMI	4e-13	34021172
rs2814942	rs9368828	0.85963351705055	Body mass index	1e-34	34594039
rs2814942	rs2744973	0.809156060484373	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814942	rs2744973	0.809156060484373	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814942	rs2744973	0.809156060484373	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814942	rs2744973	0.809156060484373	Multi-trait sex score	6e-20	37277458
rs2814942	rs6912327	0.796270032729252	Fasting insulin	5e-06	33402679
rs2814942	rs6912327	0.796270032729252	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814942	rs112283401	0.773905551713598	Red cell distribution width	4e-27	30595370
rs2814942	rs6940215	0.626105898704257	Insomnia	2e-10	35835914
rs2814942	rs6940215	0.626105898704257	Insomnia	1e-13	35835914
rs2814942	rs6940215	0.626105898704257	Hip circumference adjusted for BMI	8e-10	34021172
rs2814942	rs6940215	0.626105898704257	Multi-trait sex score	2e-23	37277458
rs2814942	rs6940215	0.626105898704257	Multi-trait sex score	4e-23	37277458
rs2814942	rs205262	0.617488039963177	Body mass index	2e-09	26961502
rs2814942	rs205262	0.617488039963177	Walking pace	4e-10	33128006
rs2814942	rs205262	0.617488039963177	Body mass index	8e-13	30108127
rs2814942	rs205262	0.617488039963177	Body mass index	2e-09	25673413
rs2814942	rs205262	0.617488039963177	Body mass index	2e-14	26426971
rs2814942	rs205262	0.617488039963177	BMI in non-smokers	3e-07	28443625
rs2814942	rs205262	0.617488039963177	BMI in non-smokers	6e-09	28443625
rs2814942	rs205262	0.617488039963177	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814942	rs205262	0.617488039963177	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814942	rs205262	0.617488039963177	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814942	rs205262	0.617488039963177	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814942	rs205262	0.617488039963177	Gastroesophageal reflux disease	1e-10	34187846
rs2814942	rs205262	0.617488039963177	Body mass index	3e-10	25673413
rs2814942	rs205262	0.617488039963177	Body mass index	2e-10	25673413
rs2814942	rs205262	0.617488039963177	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814942	rs6457796	0.616338273907787	Insomnia	1e-08	30804565
rs2814942	rs6457796	0.616338273907787	Plateletcrit	9e-11	32888494
rs2814942	rs6457796	0.616338273907787	Systemic lupus erythematosus	3e-22	33272962
rs2814942	rs6457796	0.616338273907787	Body mass index	5e-13	30108127
rs2814942	rs6457796	0.616338273907787	Body mass index	1e-14	26426971
rs2814942	rs6457796	0.616338273907787	Educational attainment	5e-19	35361970
rs2814945	rs9366863	0.983218992691612	Adult body size	9e-33	32376654
rs2814945	rs9366863	0.983218992691612	Body mass index	2e-44	30595370
rs2814945	rs2814949	0.9729792398285	Essential hypertension (time to event)	9e-09	32589924
rs2814945	rs2744944	0.958673406573797	Hypothyroidism	3e-10	34594039
rs2814945	rs2744944	0.958673406573797	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814945	rs2744944	0.958673406573797	Multi-trait sex score	7e-22	37277458
rs2814945	rs9469872	0.953955166983163	HDL cholesterol levels	3e-11	36333282
rs2814945	rs11755393	0.947206788413461	Body mass index	3e-26	29273807
rs2814945	rs11755393	0.947206788413461	Systemic lupus erythematosus	2e-12	33493351
rs2814945	rs11755393	0.947206788413461	Systemic lupus erythematosus	2e-06	33493351
rs2814945	rs11755393	0.947206788413461	Systemic lupus erythematosus	1e-07	33493351
rs2814945	rs11755393	0.947206788413461	Systemic lupus erythematosus	2e-08	19838195
rs2814945	rs11755393	0.947206788413461	Body mass index	4e-55	36581621
rs2814945	rs2263329	0.945255275631571	HDL cholesterol	6e-35	34594039
rs2814945	rs2263329	0.945255275631571	HDL cholesterol levels	8e-43	32203549
rs2814945	rs2263329	0.945255275631571	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814945	rs6941110	0.937487842776375	Sex hormone-binding globulin levels	5e-27	36653534
rs2814945	rs111868030	0.923151210662201	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814945	rs9462030	0.918113969143612	Red cell distribution width	5e-25	32888493
rs2814945	rs9469857	0.913513730784641	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814945	rs2764208	0.912765208538878	Systemic lupus erythematosus	7e-06	24871463
rs2814945	rs9469899	0.901973750340159	Prostate cancer (advanced)	2e-06	29892016
rs2814945	rs9469899	0.901973750340159	Prostate cancer	5e-09	29892016
rs2814945	rs9469899	0.901973750340159	Prostate cancer	8e-11	33398198
rs2814945	rs9469899	0.901973750340159	Hand grip strength	3e-15	29691431
rs2814945	rs9469899	0.901973750340159	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814945	rs9469899	0.901973750340159	Graves' disease	4e-10	34594039
rs2814945	rs9469899	0.901973750340159	Coronary artery disease	1e-11	36474045
rs2814945	rs9469899	0.901973750340159	Predicted visceral adipose tissue	2e-20	31501611
rs2814945	rs9469899	0.901973750340159	Medication use (thyroid preparations)	2e-09	31015401
rs2814945	rs9469899	0.901973750340159	Medication use (thyroid preparations)	3e-10	34594039
rs2814945	rs9368830	0.89029981099603	HDL cholesterol	4e-21	30275531
rs2814945	rs9296128	0.865098716623313	Hip circumference adjusted for BMI	4e-13	34021172
rs2814945	rs9368828	0.85963351705055	Body mass index	1e-34	34594039
rs2814945	rs2744973	0.809156060484373	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814945	rs2744973	0.809156060484373	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814945	rs2744973	0.809156060484373	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814945	rs2744973	0.809156060484373	Multi-trait sex score	6e-20	37277458
rs2814945	rs6912327	0.794820409985594	Fasting insulin	5e-06	33402679
rs2814945	rs6912327	0.794820409985594	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814945	rs112283401	0.772476535940695	Red cell distribution width	4e-27	30595370
rs2814945	rs6940215	0.624803185375279	Insomnia	2e-10	35835914
rs2814945	rs6940215	0.624803185375279	Insomnia	1e-13	35835914
rs2814945	rs6940215	0.624803185375279	Hip circumference adjusted for BMI	8e-10	34021172
rs2814945	rs6940215	0.624803185375279	Multi-trait sex score	2e-23	37277458
rs2814945	rs6940215	0.624803185375279	Multi-trait sex score	4e-23	37277458
rs2814945	rs205262	0.617488039963177	Body mass index	2e-09	26961502
rs2814945	rs205262	0.617488039963177	Walking pace	4e-10	33128006
rs2814945	rs205262	0.617488039963177	Body mass index	8e-13	30108127
rs2814945	rs205262	0.617488039963177	Body mass index	2e-09	25673413
rs2814945	rs205262	0.617488039963177	Body mass index	2e-14	26426971
rs2814945	rs205262	0.617488039963177	BMI in non-smokers	3e-07	28443625
rs2814945	rs205262	0.617488039963177	BMI in non-smokers	6e-09	28443625
rs2814945	rs205262	0.617488039963177	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814945	rs205262	0.617488039963177	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814945	rs205262	0.617488039963177	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814945	rs205262	0.617488039963177	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814945	rs205262	0.617488039963177	Gastroesophageal reflux disease	1e-10	34187846
rs2814945	rs205262	0.617488039963177	Body mass index	3e-10	25673413
rs2814945	rs205262	0.617488039963177	Body mass index	2e-10	25673413
rs2814945	rs205262	0.617488039963177	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814945	rs6457796	0.61502412129891	Insomnia	1e-08	30804565
rs2814945	rs6457796	0.61502412129891	Plateletcrit	9e-11	32888494
rs2814945	rs6457796	0.61502412129891	Systemic lupus erythematosus	3e-22	33272962
rs2814945	rs6457796	0.61502412129891	Body mass index	5e-13	30108127
rs2814945	rs6457796	0.61502412129891	Body mass index	1e-14	26426971
rs2814945	rs6457796	0.61502412129891	Educational attainment	5e-19	35361970
rs2814946	rs9366863	0.978483026700019	Adult body size	9e-33	32376654
rs2814946	rs9366863	0.978483026700019	Body mass index	2e-44	30595370
rs2814946	rs2814949	0.968300166118378	Essential hypertension (time to event)	9e-09	32589924
rs2814946	rs2744944	0.95399837901851	Hypothyroidism	3e-10	34594039
rs2814946	rs2744944	0.95399837901851	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814946	rs2744944	0.95399837901851	Multi-trait sex score	7e-22	37277458
rs2814946	rs9469872	0.949290390132596	HDL cholesterol levels	3e-11	36333282
rs2814946	rs11755393	0.942628010680132	Body mass index	3e-26	29273807
rs2814946	rs11755393	0.942628010680132	Systemic lupus erythematosus	2e-12	33493351
rs2814946	rs11755393	0.942628010680132	Systemic lupus erythematosus	2e-06	33493351
rs2814946	rs11755393	0.942628010680132	Systemic lupus erythematosus	1e-07	33493351
rs2814946	rs11755393	0.942628010680132	Systemic lupus erythematosus	2e-08	19838195
rs2814946	rs11755393	0.942628010680132	Body mass index	4e-55	36581621
rs2814946	rs2263329	0.940564279534001	HDL cholesterol	6e-35	34594039
rs2814946	rs2263329	0.940564279534001	HDL cholesterol levels	8e-43	32203549
rs2814946	rs2263329	0.940564279534001	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814946	rs6941110	0.932840591134223	Sex hormone-binding globulin levels	5e-27	36653534
rs2814946	rs111868030	0.926000866423641	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814946	rs9462030	0.9134069002722	Red cell distribution width	5e-25	32888493
rs2814946	rs9469857	0.908806618860231	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814946	rs2764208	0.908051854870722	Systemic lupus erythematosus	7e-06	24871463
rs2814946	rs9469899	0.897390323459539	Prostate cancer (advanced)	2e-06	29892016
rs2814946	rs9469899	0.897390323459539	Prostate cancer	5e-09	29892016
rs2814946	rs9469899	0.897390323459539	Prostate cancer	8e-11	33398198
rs2814946	rs9469899	0.897390323459539	Hand grip strength	3e-15	29691431
rs2814946	rs9469899	0.897390323459539	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814946	rs9469899	0.897390323459539	Graves' disease	4e-10	34594039
rs2814946	rs9469899	0.897390323459539	Coronary artery disease	1e-11	36474045
rs2814946	rs9469899	0.897390323459539	Predicted visceral adipose tissue	2e-20	31501611
rs2814946	rs9469899	0.897390323459539	Medication use (thyroid preparations)	2e-09	31015401
rs2814946	rs9469899	0.897390323459539	Medication use (thyroid preparations)	3e-10	34594039
rs2814946	rs9368830	0.886053958469669	HDL cholesterol	4e-21	30275531
rs2814946	rs9368828	0.862554465742403	Body mass index	1e-34	34594039
rs2814946	rs9296128	0.860329690802612	Hip circumference adjusted for BMI	4e-13	34021172
rs2814946	rs2744973	0.81146236820308	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814946	rs2744973	0.81146236820308	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814946	rs2744973	0.81146236820308	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814946	rs2744973	0.81146236820308	Multi-trait sex score	6e-20	37277458
rs2814946	rs6912327	0.789970569078635	Fasting insulin	5e-06	33402679
rs2814946	rs6912327	0.789970569078635	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814946	rs112283401	0.774830130266773	Red cell distribution width	4e-27	30595370
rs2814946	rs6940215	0.618758569507026	Insomnia	2e-10	35835914
rs2814946	rs6940215	0.618758569507026	Insomnia	1e-13	35835914
rs2814946	rs6940215	0.618758569507026	Hip circumference adjusted for BMI	8e-10	34021172
rs2814946	rs6940215	0.618758569507026	Multi-trait sex score	2e-23	37277458
rs2814946	rs6940215	0.618758569507026	Multi-trait sex score	4e-23	37277458
rs2814946	rs205262	0.610913421349574	Body mass index	2e-09	26961502
rs2814946	rs205262	0.610913421349574	Walking pace	4e-10	33128006
rs2814946	rs205262	0.610913421349574	Body mass index	8e-13	30108127
rs2814946	rs205262	0.610913421349574	Body mass index	2e-09	25673413
rs2814946	rs205262	0.610913421349574	Body mass index	2e-14	26426971
rs2814946	rs205262	0.610913421349574	BMI in non-smokers	3e-07	28443625
rs2814946	rs205262	0.610913421349574	BMI in non-smokers	6e-09	28443625
rs2814946	rs205262	0.610913421349574	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814946	rs205262	0.610913421349574	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814946	rs205262	0.610913421349574	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814946	rs205262	0.610913421349574	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814946	rs205262	0.610913421349574	Gastroesophageal reflux disease	1e-10	34187846
rs2814946	rs205262	0.610913421349574	Body mass index	3e-10	25673413
rs2814946	rs205262	0.610913421349574	Body mass index	2e-10	25673413
rs2814946	rs205262	0.610913421349574	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814946	rs6457796	0.608605264314622	Insomnia	1e-08	30804565
rs2814946	rs6457796	0.608605264314622	Plateletcrit	9e-11	32888494
rs2814946	rs6457796	0.608605264314622	Systemic lupus erythematosus	3e-22	33272962
rs2814946	rs6457796	0.608605264314622	Body mass index	5e-13	30108127
rs2814946	rs6457796	0.608605264314622	Body mass index	1e-14	26426971
rs2814946	rs6457796	0.608605264314622	Educational attainment	5e-19	35361970
rs2814947	rs9366863	0.975331238949664	Adult body size	9e-33	32376654
rs2814947	rs9366863	0.975331238949664	Body mass index	2e-44	30595370
rs2814947	rs2744944	0.972978784303048	Hypothyroidism	3e-10	34594039
rs2814947	rs2744944	0.972978784303048	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814947	rs2744944	0.972978784303048	Multi-trait sex score	7e-22	37277458
rs2814947	rs2814949	0.968344149556503	Essential hypertension (time to event)	9e-09	32589924
rs2814947	rs9469872	0.965059729049785	HDL cholesterol levels	3e-11	36333282
rs2814947	rs2263329	0.953101260251209	HDL cholesterol	6e-35	34594039
rs2814947	rs2263329	0.953101260251209	HDL cholesterol levels	8e-43	32203549
rs2814947	rs2263329	0.953101260251209	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814947	rs11755393	0.93956981411269	Body mass index	3e-26	29273807
rs2814947	rs11755393	0.93956981411269	Systemic lupus erythematosus	2e-12	33493351
rs2814947	rs11755393	0.93956981411269	Systemic lupus erythematosus	2e-06	33493351
rs2814947	rs11755393	0.93956981411269	Systemic lupus erythematosus	1e-07	33493351
rs2814947	rs11755393	0.93956981411269	Systemic lupus erythematosus	2e-08	19838195
rs2814947	rs11755393	0.93956981411269	Body mass index	4e-55	36581621
rs2814947	rs6941110	0.929751557373045	Sex hormone-binding globulin levels	5e-27	36653534
rs2814947	rs111868030	0.928992532361963	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814947	rs9469857	0.924196232118519	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814947	rs2764208	0.923433056612878	Systemic lupus erythematosus	7e-06	24871463
rs2814947	rs9462030	0.910295118043684	Red cell distribution width	5e-25	32888493
rs2814947	rs9469899	0.894347756296907	Prostate cancer (advanced)	2e-06	29892016
rs2814947	rs9469899	0.894347756296907	Prostate cancer	5e-09	29892016
rs2814947	rs9469899	0.894347756296907	Prostate cancer	8e-11	33398198
rs2814947	rs9469899	0.894347756296907	Hand grip strength	3e-15	29691431
rs2814947	rs9469899	0.894347756296907	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814947	rs9469899	0.894347756296907	Graves' disease	4e-10	34594039
rs2814947	rs9469899	0.894347756296907	Coronary artery disease	1e-11	36474045
rs2814947	rs9469899	0.894347756296907	Predicted visceral adipose tissue	2e-20	31501611
rs2814947	rs9469899	0.894347756296907	Medication use (thyroid preparations)	2e-09	31015401
rs2814947	rs9469899	0.894347756296907	Medication use (thyroid preparations)	3e-10	34594039
rs2814947	rs9368830	0.886205938470374	HDL cholesterol	4e-21	30275531
rs2814947	rs9296128	0.875261100275771	Hip circumference adjusted for BMI	4e-13	34021172
rs2814947	rs9368828	0.873031250341015	Body mass index	1e-34	34594039
rs2814947	rs2744973	0.800898756937281	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814947	rs2744973	0.800898756937281	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814947	rs2744973	0.800898756937281	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814947	rs2744973	0.800898756937281	Multi-trait sex score	6e-20	37277458
rs2814947	rs6912327	0.786835054455347	Fasting insulin	5e-06	33402679
rs2814947	rs6912327	0.786835054455347	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814947	rs112283401	0.763178385784414	Red cell distribution width	4e-27	30595370
rs2814947	rs205262	0.623516687260475	Body mass index	2e-09	26961502
rs2814947	rs205262	0.623516687260475	Walking pace	4e-10	33128006
rs2814947	rs205262	0.623516687260475	Body mass index	8e-13	30108127
rs2814947	rs205262	0.623516687260475	Body mass index	2e-09	25673413
rs2814947	rs205262	0.623516687260475	Body mass index	2e-14	26426971
rs2814947	rs205262	0.623516687260475	BMI in non-smokers	3e-07	28443625
rs2814947	rs205262	0.623516687260475	BMI in non-smokers	6e-09	28443625
rs2814947	rs205262	0.623516687260475	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814947	rs205262	0.623516687260475	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814947	rs205262	0.623516687260475	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814947	rs205262	0.623516687260475	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814947	rs205262	0.623516687260475	Gastroesophageal reflux disease	1e-10	34187846
rs2814947	rs205262	0.623516687260475	Body mass index	3e-10	25673413
rs2814947	rs205262	0.623516687260475	Body mass index	2e-10	25673413
rs2814947	rs205262	0.623516687260475	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814947	rs6940215	0.615750837834173	Insomnia	2e-10	35835914
rs2814947	rs6940215	0.615750837834173	Insomnia	1e-13	35835914
rs2814947	rs6940215	0.615750837834173	Hip circumference adjusted for BMI	8e-10	34021172
rs2814947	rs6940215	0.615750837834173	Multi-trait sex score	2e-23	37277458
rs2814947	rs6940215	0.615750837834173	Multi-trait sex score	4e-23	37277458
rs2814947	rs6457796	0.605411864961523	Insomnia	1e-08	30804565
rs2814947	rs6457796	0.605411864961523	Plateletcrit	9e-11	32888494
rs2814947	rs6457796	0.605411864961523	Systemic lupus erythematosus	3e-22	33272962
rs2814947	rs6457796	0.605411864961523	Body mass index	5e-13	30108127
rs2814947	rs6457796	0.605411864961523	Body mass index	1e-14	26426971
rs2814947	rs6457796	0.605411864961523	Educational attainment	5e-19	35361970
rs2814949	rs2814949	1	Essential hypertension (time to event)	9e-09	32589924
rs2814949	rs2744944	0.984011889441681	Hypothyroidism	3e-10	34594039
rs2814949	rs2744944	0.984011889441681	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814949	rs2744944	0.984011889441681	Multi-trait sex score	7e-22	37277458
rs2814949	rs2263329	0.969010750947406	HDL cholesterol	6e-35	34594039
rs2814949	rs2263329	0.969010750947406	HDL cholesterol levels	8e-43	32203549
rs2814949	rs2263329	0.969010750947406	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814949	rs9366863	0.962618453076092	Adult body size	9e-33	32376654
rs2814949	rs9366863	0.962618453076092	Body mass index	2e-44	30595370
rs2814949	rs9469872	0.933665854372005	HDL cholesterol levels	3e-11	36333282
rs2814949	rs11755393	0.926776227817379	Body mass index	3e-26	29273807
rs2814949	rs11755393	0.926776227817379	Systemic lupus erythematosus	2e-12	33493351
rs2814949	rs11755393	0.926776227817379	Systemic lupus erythematosus	2e-06	33493351
rs2814949	rs11755393	0.926776227817379	Systemic lupus erythematosus	1e-07	33493351
rs2814949	rs11755393	0.926776227817379	Systemic lupus erythematosus	2e-08	19838195
rs2814949	rs11755393	0.926776227817379	Body mass index	4e-55	36581621
rs2814949	rs9469899	0.922092435107363	Prostate cancer (advanced)	2e-06	29892016
rs2814949	rs9469899	0.922092435107363	Prostate cancer	5e-09	29892016
rs2814949	rs9469899	0.922092435107363	Prostate cancer	8e-11	33398198
rs2814949	rs9469899	0.922092435107363	Hand grip strength	3e-15	29691431
rs2814949	rs9469899	0.922092435107363	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814949	rs9469899	0.922092435107363	Graves' disease	4e-10	34594039
rs2814949	rs9469899	0.922092435107363	Coronary artery disease	1e-11	36474045
rs2814949	rs9469899	0.922092435107363	Predicted visceral adipose tissue	2e-20	31501611
rs2814949	rs9469899	0.922092435107363	Medication use (thyroid preparations)	2e-09	31015401
rs2814949	rs9469899	0.922092435107363	Medication use (thyroid preparations)	3e-10	34594039
rs2814949	rs6941110	0.917445774624504	Sex hormone-binding globulin levels	5e-27	36653534
rs2814949	rs111868030	0.899539497996124	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814949	rs9462030	0.898605958999402	Red cell distribution width	5e-25	32888493
rs2814949	rs9469857	0.894090207042686	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814949	rs2764208	0.893373793948083	Systemic lupus erythematosus	7e-06	24871463
rs2814949	rs9368830	0.872871957183779	HDL cholesterol	4e-21	30275531
rs2814949	rs9296128	0.846746338785186	Hip circumference adjusted for BMI	4e-13	34021172
rs2814949	rs9368828	0.84367902657356	Body mass index	1e-34	34594039
rs2814949	rs2744973	0.792521762756774	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814949	rs2744973	0.792521762756774	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814949	rs2744973	0.792521762756774	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814949	rs2744973	0.792521762756774	Multi-trait sex score	6e-20	37277458
rs2814949	rs6912327	0.777999862269606	Fasting insulin	5e-06	33402679
rs2814949	rs6912327	0.777999862269606	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814949	rs112283401	0.754496559814612	Red cell distribution width	4e-27	30595370
rs2814949	rs6940215	0.609754791546299	Insomnia	2e-10	35835914
rs2814949	rs6940215	0.609754791546299	Insomnia	1e-13	35835914
rs2814949	rs6940215	0.609754791546299	Hip circumference adjusted for BMI	8e-10	34021172
rs2814949	rs6940215	0.609754791546299	Multi-trait sex score	2e-23	37277458
rs2814949	rs6940215	0.609754791546299	Multi-trait sex score	4e-23	37277458
rs2814949	rs205262	0.603663418715409	Body mass index	2e-09	26961502
rs2814949	rs205262	0.603663418715409	Walking pace	4e-10	33128006
rs2814949	rs205262	0.603663418715409	Body mass index	8e-13	30108127
rs2814949	rs205262	0.603663418715409	Body mass index	2e-09	25673413
rs2814949	rs205262	0.603663418715409	Body mass index	2e-14	26426971
rs2814949	rs205262	0.603663418715409	BMI in non-smokers	3e-07	28443625
rs2814949	rs205262	0.603663418715409	BMI in non-smokers	6e-09	28443625
rs2814949	rs205262	0.603663418715409	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814949	rs205262	0.603663418715409	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814949	rs205262	0.603663418715409	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814949	rs205262	0.603663418715409	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814949	rs205262	0.603663418715409	Gastroesophageal reflux disease	1e-10	34187846
rs2814949	rs205262	0.603663418715409	Body mass index	3e-10	25673413
rs2814949	rs205262	0.603663418715409	Body mass index	2e-10	25673413
rs2814949	rs205262	0.603663418715409	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814949	rs6457796	0.60096021541377	Insomnia	1e-08	30804565
rs2814949	rs6457796	0.60096021541377	Plateletcrit	9e-11	32888494
rs2814949	rs6457796	0.60096021541377	Systemic lupus erythematosus	3e-22	33272962
rs2814949	rs6457796	0.60096021541377	Body mass index	5e-13	30108127
rs2814949	rs6457796	0.60096021541377	Body mass index	1e-14	26426971
rs2814949	rs6457796	0.60096021541377	Educational attainment	5e-19	35361970
rs2814951	rs9366863	0.993591630972162	Adult body size	9e-33	32376654
rs2814951	rs9366863	0.993591630972162	Body mass index	2e-44	30595370
rs2814951	rs9469872	0.97683676368625	HDL cholesterol levels	3e-11	36333282
rs2814951	rs11755393	0.969797951374802	Body mass index	3e-26	29273807
rs2814951	rs11755393	0.969797951374802	Systemic lupus erythematosus	2e-12	33493351
rs2814951	rs11755393	0.969797951374802	Systemic lupus erythematosus	2e-06	33493351
rs2814951	rs11755393	0.969797951374802	Systemic lupus erythematosus	1e-07	33493351
rs2814951	rs11755393	0.969797951374802	Systemic lupus erythematosus	2e-08	19838195
rs2814951	rs11755393	0.969797951374802	Body mass index	4e-55	36581621
rs2814951	rs6941110	0.960240227417688	Sex hormone-binding globulin levels	5e-27	36653534
rs2814951	rs2814949	0.956309769921058	Essential hypertension (time to event)	9e-09	32589924
rs2814951	rs2744944	0.94689063325274	Hypothyroidism	3e-10	34594039
rs2814951	rs2744944	0.94689063325274	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814951	rs2744944	0.94689063325274	Multi-trait sex score	7e-22	37277458
rs2814951	rs9462030	0.940957995158195	Red cell distribution width	5e-25	32888493
rs2814951	rs9469857	0.936336532989343	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814951	rs2764208	0.935603567916502	Systemic lupus erythematosus	7e-06	24871463
rs2814951	rs2263329	0.92747630835043	HDL cholesterol	6e-35	34594039
rs2814951	rs2263329	0.92747630835043	HDL cholesterol levels	8e-43	32203549
rs2814951	rs2263329	0.92747630835043	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814951	rs9469899	0.924366663889921	Prostate cancer (advanced)	2e-06	29892016
rs2814951	rs9469899	0.924366663889921	Prostate cancer	5e-09	29892016
rs2814951	rs9469899	0.924366663889921	Prostate cancer	8e-11	33398198
rs2814951	rs9469899	0.924366663889921	Hand grip strength	3e-15	29691431
rs2814951	rs9469899	0.924366663889921	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814951	rs9469899	0.924366663889921	Graves' disease	4e-10	34594039
rs2814951	rs9469899	0.924366663889921	Coronary artery disease	1e-11	36474045
rs2814951	rs9469899	0.924366663889921	Predicted visceral adipose tissue	2e-20	31501611
rs2814951	rs9469899	0.924366663889921	Medication use (thyroid preparations)	2e-09	31015401
rs2814951	rs9469899	0.924366663889921	Medication use (thyroid preparations)	3e-10	34594039
rs2814951	rs111868030	0.90316553748594	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814951	rs9296128	0.887885823107421	Hip circumference adjusted for BMI	4e-13	34021172
rs2814951	rs9368830	0.879762054498808	HDL cholesterol	4e-21	30275531
rs2814951	rs9368828	0.850257229573997	Body mass index	1e-34	34594039
rs2814951	rs6912327	0.816061319853837	Fasting insulin	5e-06	33402679
rs2814951	rs6912327	0.816061319853837	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814951	rs2744973	0.794268987207227	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814951	rs2744973	0.794268987207227	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814951	rs2744973	0.794268987207227	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814951	rs2744973	0.794268987207227	Multi-trait sex score	6e-20	37277458
rs2814951	rs112283401	0.793426925760962	Red cell distribution width	4e-27	30595370
rs2814951	rs6940215	0.631889575399368	Insomnia	2e-10	35835914
rs2814951	rs6940215	0.631889575399368	Insomnia	1e-13	35835914
rs2814951	rs6940215	0.631889575399368	Hip circumference adjusted for BMI	8e-10	34021172
rs2814951	rs6940215	0.631889575399368	Multi-trait sex score	2e-23	37277458
rs2814951	rs6940215	0.631889575399368	Multi-trait sex score	4e-23	37277458
rs2814951	rs6457796	0.623105545089912	Insomnia	1e-08	30804565
rs2814951	rs6457796	0.623105545089912	Plateletcrit	9e-11	32888494
rs2814951	rs6457796	0.623105545089912	Systemic lupus erythematosus	3e-22	33272962
rs2814951	rs6457796	0.623105545089912	Body mass index	5e-13	30108127
rs2814951	rs6457796	0.623105545089912	Body mass index	1e-14	26426971
rs2814951	rs6457796	0.623105545089912	Educational attainment	5e-19	35361970
rs2814951	rs205262	0.607419463717061	Body mass index	2e-09	26961502
rs2814951	rs205262	0.607419463717061	Walking pace	4e-10	33128006
rs2814951	rs205262	0.607419463717061	Body mass index	8e-13	30108127
rs2814951	rs205262	0.607419463717061	Body mass index	2e-09	25673413
rs2814951	rs205262	0.607419463717061	Body mass index	2e-14	26426971
rs2814951	rs205262	0.607419463717061	BMI in non-smokers	3e-07	28443625
rs2814951	rs205262	0.607419463717061	BMI in non-smokers	6e-09	28443625
rs2814951	rs205262	0.607419463717061	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814951	rs205262	0.607419463717061	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814951	rs205262	0.607419463717061	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814951	rs205262	0.607419463717061	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814951	rs205262	0.607419463717061	Gastroesophageal reflux disease	1e-10	34187846
rs2814951	rs205262	0.607419463717061	Body mass index	3e-10	25673413
rs2814951	rs205262	0.607419463717061	Body mass index	2e-10	25673413
rs2814951	rs205262	0.607419463717061	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814951	rs9689160	0.602573925769358	Lung function (forced vital capacity)	3e-14	36914875
rs2814952	rs9366863	0.989587718565155	Adult body size	9e-33	32376654
rs2814952	rs9366863	0.989587718565155	Body mass index	2e-44	30595370
rs2814952	rs9469872	0.979218733969363	HDL cholesterol levels	3e-11	36333282
rs2814952	rs11755393	0.972177889789447	Body mass index	3e-26	29273807
rs2814952	rs11755393	0.972177889789447	Systemic lupus erythematosus	2e-12	33493351
rs2814952	rs11755393	0.972177889789447	Systemic lupus erythematosus	2e-06	33493351
rs2814952	rs11755393	0.972177889789447	Systemic lupus erythematosus	1e-07	33493351
rs2814952	rs11755393	0.972177889789447	Systemic lupus erythematosus	2e-08	19838195
rs2814952	rs11755393	0.972177889789447	Body mass index	4e-55	36581621
rs2814952	rs6941110	0.961023185241809	Sex hormone-binding globulin levels	5e-27	36653534
rs2814952	rs2814949	0.952386294239383	Essential hypertension (time to event)	9e-09	32589924
rs2814952	rs9462030	0.943284011663667	Red cell distribution width	5e-25	32888493
rs2814952	rs2744944	0.942981975667547	Hypothyroidism	3e-10	34594039
rs2814952	rs2744944	0.942981975667547	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814952	rs2744944	0.942981975667547	Multi-trait sex score	7e-22	37277458
rs2814952	rs9469857	0.938655797493256	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814952	rs2764208	0.937921233003004	Systemic lupus erythematosus	7e-06	24871463
rs2814952	rs9469899	0.926679184125143	Prostate cancer (advanced)	2e-06	29892016
rs2814952	rs9469899	0.926679184125143	Prostate cancer	5e-09	29892016
rs2814952	rs9469899	0.926679184125143	Prostate cancer	8e-11	33398198
rs2814952	rs9469899	0.926679184125143	Hand grip strength	3e-15	29691431
rs2814952	rs9469899	0.926679184125143	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814952	rs9469899	0.926679184125143	Graves' disease	4e-10	34594039
rs2814952	rs9469899	0.926679184125143	Coronary artery disease	1e-11	36474045
rs2814952	rs9469899	0.926679184125143	Predicted visceral adipose tissue	2e-20	31501611
rs2814952	rs9469899	0.926679184125143	Medication use (thyroid preparations)	2e-09	31015401
rs2814952	rs9469899	0.926679184125143	Medication use (thyroid preparations)	3e-10	34594039
rs2814952	rs2263329	0.92360002283291	HDL cholesterol	6e-35	34594039
rs2814952	rs2263329	0.92360002283291	HDL cholesterol levels	8e-43	32203549
rs2814952	rs2263329	0.92360002283291	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814952	rs111868030	0.900824925680026	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814952	rs9296128	0.890129048347383	Hip circumference adjusted for BMI	4e-13	34021172
rs2814952	rs9368830	0.876034725143822	HDL cholesterol	4e-21	30275531
rs2814952	rs9368828	0.846536068286112	Body mass index	1e-34	34594039
rs2814952	rs6912327	0.819662527731012	Fasting insulin	5e-06	33402679
rs2814952	rs6912327	0.819662527731012	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814952	rs112283401	0.795528119862659	Red cell distribution width	4e-27	30595370
rs2814952	rs2744973	0.790556509160279	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814952	rs2744973	0.790556509160279	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814952	rs2744973	0.790556509160279	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814952	rs2744973	0.790556509160279	Multi-trait sex score	6e-20	37277458
rs2814952	rs6940215	0.632432049997532	Insomnia	2e-10	35835914
rs2814952	rs6940215	0.632432049997532	Insomnia	1e-13	35835914
rs2814952	rs6940215	0.632432049997532	Hip circumference adjusted for BMI	8e-10	34021172
rs2814952	rs6940215	0.632432049997532	Multi-trait sex score	2e-23	37277458
rs2814952	rs6940215	0.632432049997532	Multi-trait sex score	4e-23	37277458
rs2814952	rs6457796	0.623612774953658	Insomnia	1e-08	30804565
rs2814952	rs6457796	0.623612774953658	Plateletcrit	9e-11	32888494
rs2814952	rs6457796	0.623612774953658	Systemic lupus erythematosus	3e-22	33272962
rs2814952	rs6457796	0.623612774953658	Body mass index	5e-13	30108127
rs2814952	rs6457796	0.623612774953658	Body mass index	1e-14	26426971
rs2814952	rs6457796	0.623612774953658	Educational attainment	5e-19	35361970
rs2814952	rs205262	0.603977109035946	Body mass index	2e-09	26961502
rs2814952	rs205262	0.603977109035946	Walking pace	4e-10	33128006
rs2814952	rs205262	0.603977109035946	Body mass index	8e-13	30108127
rs2814952	rs205262	0.603977109035946	Body mass index	2e-09	25673413
rs2814952	rs205262	0.603977109035946	Body mass index	2e-14	26426971
rs2814952	rs205262	0.603977109035946	BMI in non-smokers	3e-07	28443625
rs2814952	rs205262	0.603977109035946	BMI in non-smokers	6e-09	28443625
rs2814952	rs205262	0.603977109035946	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814952	rs205262	0.603977109035946	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814952	rs205262	0.603977109035946	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814952	rs205262	0.603977109035946	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814952	rs205262	0.603977109035946	Gastroesophageal reflux disease	1e-10	34187846
rs2814952	rs205262	0.603977109035946	Body mass index	3e-10	25673413
rs2814952	rs205262	0.603977109035946	Body mass index	2e-10	25673413
rs2814952	rs205262	0.603977109035946	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814952	rs9689160	0.603060696621572	Lung function (forced vital capacity)	3e-14	36914875
rs2814953	rs9366863	0.987200122491554	Adult body size	9e-33	32376654
rs2814953	rs9366863	0.987200122491554	Body mass index	2e-44	30595370
rs2814953	rs9469872	0.978430888303458	HDL cholesterol levels	3e-11	36333282
rs2814953	rs11755393	0.971368365659604	Body mass index	3e-26	29273807
rs2814953	rs11755393	0.971368365659604	Systemic lupus erythematosus	2e-12	33493351
rs2814953	rs11755393	0.971368365659604	Systemic lupus erythematosus	2e-06	33493351
rs2814953	rs11755393	0.971368365659604	Systemic lupus erythematosus	1e-07	33493351
rs2814953	rs11755393	0.971368365659604	Systemic lupus erythematosus	2e-08	19838195
rs2814953	rs11755393	0.971368365659604	Body mass index	4e-55	36581621
rs2814953	rs6941110	0.960250778308962	Sex hormone-binding globulin levels	5e-27	36653534
rs2814953	rs2814949	0.950035946957681	Essential hypertension (time to event)	9e-09	32589924
rs2814953	rs9462030	0.942556047304354	Red cell distribution width	5e-25	32888493
rs2814953	rs2744944	0.940652797023369	Hypothyroidism	3e-10	34594039
rs2814953	rs2744944	0.940652797023369	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814953	rs2744944	0.940652797023369	Multi-trait sex score	7e-22	37277458
rs2814953	rs9469857	0.937933683465677	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814953	rs2764208	0.937202204176534	Systemic lupus erythematosus	7e-06	24871463
rs2814953	rs9469899	0.925929177503137	Prostate cancer (advanced)	2e-06	29892016
rs2814953	rs9469899	0.925929177503137	Prostate cancer	5e-09	29892016
rs2814953	rs9469899	0.925929177503137	Prostate cancer	8e-11	33398198
rs2814953	rs9469899	0.925929177503137	Hand grip strength	3e-15	29691431
rs2814953	rs9469899	0.925929177503137	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814953	rs9469899	0.925929177503137	Graves' disease	4e-10	34594039
rs2814953	rs9469899	0.925929177503137	Coronary artery disease	1e-11	36474045
rs2814953	rs9469899	0.925929177503137	Predicted visceral adipose tissue	2e-20	31501611
rs2814953	rs9469899	0.925929177503137	Medication use (thyroid preparations)	2e-09	31015401
rs2814953	rs9469899	0.925929177503137	Medication use (thyroid preparations)	3e-10	34594039
rs2814953	rs2263329	0.9213111944511	HDL cholesterol	6e-35	34594039
rs2814953	rs2263329	0.9213111944511	HDL cholesterol levels	8e-43	32203549
rs2814953	rs2263329	0.9213111944511	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814953	rs111868030	0.897119618110962	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814953	rs9296128	0.889489639458207	Hip circumference adjusted for BMI	4e-13	34021172
rs2814953	rs9368830	0.873701789610262	HDL cholesterol	4e-21	30275531
rs2814953	rs9368828	0.844366231934135	Body mass index	1e-34	34594039
rs2814953	rs6912327	0.817671318320859	Fasting insulin	5e-06	33402679
rs2814953	rs6912327	0.817671318320859	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814953	rs112283401	0.795015088706889	Red cell distribution width	4e-27	30595370
rs2814953	rs2744973	0.788640471152899	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814953	rs2744973	0.788640471152899	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814953	rs2744973	0.788640471152899	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814953	rs2744973	0.788640471152899	Multi-trait sex score	6e-20	37277458
rs2814953	rs6940215	0.632113957497335	Insomnia	2e-10	35835914
rs2814953	rs6940215	0.632113957497335	Insomnia	1e-13	35835914
rs2814953	rs6940215	0.632113957497335	Hip circumference adjusted for BMI	8e-10	34021172
rs2814953	rs6940215	0.632113957497335	Multi-trait sex score	2e-23	37277458
rs2814953	rs6940215	0.632113957497335	Multi-trait sex score	4e-23	37277458
rs2814953	rs6457796	0.62341303827353	Insomnia	1e-08	30804565
rs2814953	rs6457796	0.62341303827353	Plateletcrit	9e-11	32888494
rs2814953	rs6457796	0.62341303827353	Systemic lupus erythematosus	3e-22	33272962
rs2814953	rs6457796	0.62341303827353	Body mass index	5e-13	30108127
rs2814953	rs6457796	0.62341303827353	Body mass index	1e-14	26426971
rs2814953	rs6457796	0.62341303827353	Educational attainment	5e-19	35361970
rs2814953	rs9689160	0.602910150998464	Lung function (forced vital capacity)	3e-14	36914875
rs2814953	rs205262	0.602511477638259	Body mass index	2e-09	26961502
rs2814953	rs205262	0.602511477638259	Walking pace	4e-10	33128006
rs2814953	rs205262	0.602511477638259	Body mass index	8e-13	30108127
rs2814953	rs205262	0.602511477638259	Body mass index	2e-09	25673413
rs2814953	rs205262	0.602511477638259	Body mass index	2e-14	26426971
rs2814953	rs205262	0.602511477638259	BMI in non-smokers	3e-07	28443625
rs2814953	rs205262	0.602511477638259	BMI in non-smokers	6e-09	28443625
rs2814953	rs205262	0.602511477638259	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814953	rs205262	0.602511477638259	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814953	rs205262	0.602511477638259	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814953	rs205262	0.602511477638259	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814953	rs205262	0.602511477638259	Gastroesophageal reflux disease	1e-10	34187846
rs2814953	rs205262	0.602511477638259	Body mass index	3e-10	25673413
rs2814953	rs205262	0.602511477638259	Body mass index	2e-10	25673413
rs2814953	rs205262	0.602511477638259	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814955	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2814955	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2814955	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2814955	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2814955	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2814955	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2814955	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2814955	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2814955	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2814955	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2814955	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2814955	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2814955	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814955	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2814955	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2814955	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814955	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2814955	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2814955	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2814955	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2814955	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2814955	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814955	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2814955	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2814955	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2814955	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2814955	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2814955	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2814955	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2814955	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814955	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2814955	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814955	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2814955	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2814955	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2814955	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814955	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2814955	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814955	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814955	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814955	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2814955	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2814955	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2814955	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2814955	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2814955	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2814955	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2814955	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2814955	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2814955	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2814955	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2814955	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2814955	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2814955	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2814955	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2814955	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2814955	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2814955	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2814955	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2814955	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2814955	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814955	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814955	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814955	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814955	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2814955	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2814955	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2814955	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814956	rs9469872	0.984794807652595	HDL cholesterol levels	3e-11	36333282
rs2814956	rs9366863	0.984002326716811	Adult body size	9e-33	32376654
rs2814956	rs9366863	0.984002326716811	Body mass index	2e-44	30595370
rs2814956	rs11755393	0.977721258211558	Body mass index	3e-26	29273807
rs2814956	rs11755393	0.977721258211558	Systemic lupus erythematosus	2e-12	33493351
rs2814956	rs11755393	0.977721258211558	Systemic lupus erythematosus	2e-06	33493351
rs2814956	rs11755393	0.977721258211558	Systemic lupus erythematosus	1e-07	33493351
rs2814956	rs11755393	0.977721258211558	Systemic lupus erythematosus	2e-08	19838195
rs2814956	rs11755393	0.977721258211558	Body mass index	4e-55	36581621
rs2814956	rs6941110	0.966551249921627	Sex hormone-binding globulin levels	5e-27	36653534
rs2814956	rs9462030	0.948781164374768	Red cell distribution width	5e-25	32888493
rs2814956	rs2814949	0.946906183640127	Essential hypertension (time to event)	9e-09	32589924
rs2814956	rs9469857	0.944141706095809	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814956	rs2764208	0.943406604496225	Systemic lupus erythematosus	7e-06	24871463
rs2814956	rs2744944	0.937530814641698	Hypothyroidism	3e-10	34594039
rs2814956	rs2744944	0.937530814641698	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814956	rs2744944	0.937530814641698	Multi-trait sex score	7e-22	37277458
rs2814956	rs9469899	0.932111650669377	Prostate cancer (advanced)	2e-06	29892016
rs2814956	rs9469899	0.932111650669377	Prostate cancer	5e-09	29892016
rs2814956	rs9469899	0.932111650669377	Prostate cancer	8e-11	33398198
rs2814956	rs9469899	0.932111650669377	Hand grip strength	3e-15	29691431
rs2814956	rs9469899	0.932111650669377	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814956	rs9469899	0.932111650669377	Graves' disease	4e-10	34594039
rs2814956	rs9469899	0.932111650669377	Coronary artery disease	1e-11	36474045
rs2814956	rs9469899	0.932111650669377	Predicted visceral adipose tissue	2e-20	31501611
rs2814956	rs9469899	0.932111650669377	Medication use (thyroid preparations)	2e-09	31015401
rs2814956	rs9469899	0.932111650669377	Medication use (thyroid preparations)	3e-10	34594039
rs2814956	rs2263329	0.918208169762507	HDL cholesterol	6e-35	34594039
rs2814956	rs2263329	0.918208169762507	HDL cholesterol levels	8e-43	32203549
rs2814956	rs2263329	0.918208169762507	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814956	rs9296128	0.895509385822609	Hip circumference adjusted for BMI	4e-13	34021172
rs2814956	rs111868030	0.89398206616372	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814956	rs9368830	0.870762324463012	HDL cholesterol	4e-21	30275531
rs2814956	rs9368828	0.841378748692334	Body mass index	1e-34	34594039
rs2814956	rs6912327	0.823413457747397	Fasting insulin	5e-06	33402679
rs2814956	rs6912327	0.823413457747397	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814956	rs112283401	0.800676132715852	Red cell distribution width	4e-27	30595370
rs2814956	rs2744973	0.785577524321816	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814956	rs2744973	0.785577524321816	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814956	rs2744973	0.785577524321816	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814956	rs2744973	0.785577524321816	Multi-trait sex score	6e-20	37277458
rs2814956	rs6940215	0.637134204040477	Insomnia	2e-10	35835914
rs2814956	rs6940215	0.637134204040477	Insomnia	1e-13	35835914
rs2814956	rs6940215	0.637134204040477	Hip circumference adjusted for BMI	8e-10	34021172
rs2814956	rs6940215	0.637134204040477	Multi-trait sex score	2e-23	37277458
rs2814956	rs6940215	0.637134204040477	Multi-trait sex score	4e-23	37277458
rs2814956	rs6457796	0.628401121989321	Insomnia	1e-08	30804565
rs2814956	rs6457796	0.628401121989321	Plateletcrit	9e-11	32888494
rs2814956	rs6457796	0.628401121989321	Systemic lupus erythematosus	3e-22	33272962
rs2814956	rs6457796	0.628401121989321	Body mass index	5e-13	30108127
rs2814956	rs6457796	0.628401121989321	Body mass index	1e-14	26426971
rs2814956	rs6457796	0.628401121989321	Educational attainment	5e-19	35361970
rs2814956	rs9689160	0.607821022836942	Lung function (forced vital capacity)	3e-14	36914875
rs2814957	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2814957	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2814957	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2814957	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2814957	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2814957	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2814957	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2814957	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2814957	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2814957	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2814957	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2814957	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2814957	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814957	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2814957	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2814957	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814957	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2814957	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2814957	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2814957	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2814957	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2814957	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814957	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2814957	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2814957	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2814957	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2814957	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2814957	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2814957	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2814957	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814957	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2814957	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814957	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2814957	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2814957	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2814957	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814957	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2814957	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814957	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814957	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814957	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2814957	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2814957	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2814957	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2814957	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2814957	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2814957	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2814957	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2814957	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2814957	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2814957	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2814957	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2814957	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2814957	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2814957	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2814957	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2814957	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2814957	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2814957	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2814957	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2814957	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814957	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814957	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814957	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814957	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2814957	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2814957	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2814957	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814958	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2814958	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2814958	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2814958	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2814958	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2814958	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2814958	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2814958	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2814958	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2814958	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2814958	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2814958	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2814958	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814958	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2814958	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2814958	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814958	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2814958	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2814958	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2814958	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2814958	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2814958	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814958	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2814958	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2814958	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2814958	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2814958	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2814958	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2814958	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2814958	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814958	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2814958	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814958	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2814958	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2814958	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2814958	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814958	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2814958	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814958	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814958	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814958	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2814958	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2814958	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2814958	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2814958	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2814958	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2814958	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2814958	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2814958	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2814958	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2814958	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2814958	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2814958	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2814958	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2814958	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2814958	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2814958	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2814958	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2814958	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2814958	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2814958	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814958	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814958	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814958	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814958	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2814958	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2814958	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2814958	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814959	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2814959	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2814959	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2814959	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2814959	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2814959	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2814959	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2814959	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2814959	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2814959	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2814959	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2814959	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2814959	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814959	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2814959	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2814959	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814959	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2814959	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2814959	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2814959	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2814959	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2814959	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814959	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2814959	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2814959	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2814959	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2814959	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2814959	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2814959	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2814959	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814959	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2814959	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814959	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2814959	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2814959	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2814959	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814959	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2814959	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814959	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814959	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814959	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2814959	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2814959	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2814959	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2814959	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2814959	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2814959	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2814959	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2814959	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2814959	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2814959	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2814959	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2814959	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2814959	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2814959	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2814959	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2814959	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2814959	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2814959	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2814959	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2814959	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814959	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814959	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814959	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814959	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2814959	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2814959	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2814959	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814961	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs2814961	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs2814961	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs2814961	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs2814961	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs2814961	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs2814961	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs2814961	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs2814961	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs2814961	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs2814961	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs2814961	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs2814961	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814961	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs2814961	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs2814961	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814961	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs2814961	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs2814961	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs2814961	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs2814961	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs2814961	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814961	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs2814961	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs2814961	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs2814961	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs2814961	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs2814961	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs2814961	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs2814961	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814961	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs2814961	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814961	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs2814961	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs2814961	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs2814961	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814961	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs2814961	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814961	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814961	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814961	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs2814961	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs2814961	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs2814961	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs2814961	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs2814961	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs2814961	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs2814961	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs2814961	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs2814961	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs2814961	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs2814961	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs2814961	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs2814961	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs2814961	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs2814961	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs2814961	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs2814961	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs2814961	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs2814961	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs2814961	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814961	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814961	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814961	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814961	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs2814961	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs2814961	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs2814961	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814963	rs9469872	0.98400520187851	HDL cholesterol levels	3e-11	36333282
rs2814963	rs9366863	0.983215916960949	Adult body size	9e-33	32376654
rs2814963	rs9366863	0.983215916960949	Body mass index	2e-44	30595370
rs2814963	rs11755393	0.976909905933693	Body mass index	3e-26	29273807
rs2814963	rs11755393	0.976909905933693	Systemic lupus erythematosus	2e-12	33493351
rs2814963	rs11755393	0.976909905933693	Systemic lupus erythematosus	2e-06	33493351
rs2814963	rs11755393	0.976909905933693	Systemic lupus erythematosus	1e-07	33493351
rs2814963	rs11755393	0.976909905933693	Systemic lupus erythematosus	2e-08	19838195
rs2814963	rs11755393	0.976909905933693	Body mass index	4e-55	36581621
rs2814963	rs6941110	0.965777090653584	Sex hormone-binding globulin levels	5e-27	36653534
rs2814963	rs9462030	0.948051532236176	Red cell distribution width	5e-25	32888493
rs2814963	rs2814949	0.946126047048091	Essential hypertension (time to event)	9e-09	32589924
rs2814963	rs9469857	0.943417931619464	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814963	rs2764208	0.942685922036761	Systemic lupus erythematosus	7e-06	24871463
rs2814963	rs2744944	0.936764516027397	Hypothyroidism	3e-10	34594039
rs2814963	rs2744944	0.936764516027397	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814963	rs2744944	0.936764516027397	Multi-trait sex score	7e-22	37277458
rs2814963	rs9469899	0.931359889409606	Prostate cancer (advanced)	2e-06	29892016
rs2814963	rs9469899	0.931359889409606	Prostate cancer	5e-09	29892016
rs2814963	rs9469899	0.931359889409606	Prostate cancer	8e-11	33398198
rs2814963	rs9469899	0.931359889409606	Hand grip strength	3e-15	29691431
rs2814963	rs9469899	0.931359889409606	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814963	rs9469899	0.931359889409606	Graves' disease	4e-10	34594039
rs2814963	rs9469899	0.931359889409606	Coronary artery disease	1e-11	36474045
rs2814963	rs9469899	0.931359889409606	Predicted visceral adipose tissue	2e-20	31501611
rs2814963	rs9469899	0.931359889409606	Medication use (thyroid preparations)	2e-09	31015401
rs2814963	rs9469899	0.931359889409606	Medication use (thyroid preparations)	3e-10	34594039
rs2814963	rs2263329	0.91746687542176	HDL cholesterol	6e-35	34594039
rs2814963	rs2263329	0.91746687542176	HDL cholesterol levels	8e-43	32203549
rs2814963	rs2263329	0.91746687542176	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814963	rs9296128	0.8948684540018	Hip circumference adjusted for BMI	4e-13	34021172
rs2814963	rs111868030	0.893341816056237	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814963	rs9368830	0.869932412951952	HDL cholesterol	4e-21	30275531
rs2814963	rs9368828	0.84069135305439	Body mass index	1e-34	34594039
rs2814963	rs6912327	0.822890683405759	Fasting insulin	5e-06	33402679
rs2814963	rs6912327	0.822890683405759	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814963	rs112283401	0.800161776090551	Red cell distribution width	4e-27	30595370
rs2814963	rs2744973	0.785112162643234	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814963	rs2744973	0.785112162643234	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814963	rs2744973	0.785112162643234	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814963	rs2744973	0.785112162643234	Multi-trait sex score	6e-20	37277458
rs2814963	rs6940215	0.636815138725138	Insomnia	2e-10	35835914
rs2814963	rs6940215	0.636815138725138	Insomnia	1e-13	35835914
rs2814963	rs6940215	0.636815138725138	Hip circumference adjusted for BMI	8e-10	34021172
rs2814963	rs6940215	0.636815138725138	Multi-trait sex score	2e-23	37277458
rs2814963	rs6940215	0.636815138725138	Multi-trait sex score	4e-23	37277458
rs2814963	rs6457796	0.628200807936117	Insomnia	1e-08	30804565
rs2814963	rs6457796	0.628200807936117	Plateletcrit	9e-11	32888494
rs2814963	rs6457796	0.628200807936117	Systemic lupus erythematosus	3e-22	33272962
rs2814963	rs6457796	0.628200807936117	Body mass index	5e-13	30108127
rs2814963	rs6457796	0.628200807936117	Body mass index	1e-14	26426971
rs2814963	rs6457796	0.628200807936117	Educational attainment	5e-19	35361970
rs2814963	rs9689160	0.607670053332304	Lung function (forced vital capacity)	3e-14	36914875
rs2814972	rs2263329	0.968142248883583	HDL cholesterol	6e-35	34594039
rs2814972	rs2263329	0.968142248883583	HDL cholesterol levels	8e-43	32203549
rs2814972	rs2263329	0.968142248883583	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814972	rs9366863	0.954091197681385	Adult body size	9e-33	32376654
rs2814972	rs9366863	0.954091197681385	Body mass index	2e-44	30595370
rs2814972	rs2744944	0.947070925322409	Hypothyroidism	3e-10	34594039
rs2814972	rs2744944	0.947070925322409	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814972	rs2744944	0.947070925322409	Multi-trait sex score	7e-22	37277458
rs2814972	rs2814949	0.945665792851966	Essential hypertension (time to event)	9e-09	32589924
rs2814972	rs9469872	0.940815688160672	HDL cholesterol levels	3e-11	36333282
rs2814972	rs11755393	0.918831003302386	Body mass index	3e-26	29273807
rs2814972	rs11755393	0.918831003302386	Systemic lupus erythematosus	2e-12	33493351
rs2814972	rs11755393	0.918831003302386	Systemic lupus erythematosus	2e-06	33493351
rs2814972	rs11755393	0.918831003302386	Systemic lupus erythematosus	1e-07	33493351
rs2814972	rs11755393	0.918831003302386	Systemic lupus erythematosus	2e-08	19838195
rs2814972	rs11755393	0.918831003302386	Body mass index	4e-55	36581621
rs2814972	rs6941110	0.910518133090373	Sex hormone-binding globulin levels	5e-27	36653534
rs2814972	rs111868030	0.9046846082064	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814972	rs9469857	0.901778722268982	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814972	rs2764208	0.899481777427654	Systemic lupus erythematosus	7e-06	24871463
rs2814972	rs9462030	0.889579128589563	Red cell distribution width	5e-25	32888493
rs2814972	rs9469899	0.873942566095992	Prostate cancer (advanced)	2e-06	29892016
rs2814972	rs9469899	0.873942566095992	Prostate cancer	5e-09	29892016
rs2814972	rs9469899	0.873942566095992	Prostate cancer	8e-11	33398198
rs2814972	rs9469899	0.873942566095992	Hand grip strength	3e-15	29691431
rs2814972	rs9469899	0.873942566095992	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814972	rs9469899	0.873942566095992	Graves' disease	4e-10	34594039
rs2814972	rs9469899	0.873942566095992	Coronary artery disease	1e-11	36474045
rs2814972	rs9469899	0.873942566095992	Predicted visceral adipose tissue	2e-20	31501611
rs2814972	rs9469899	0.873942566095992	Medication use (thyroid preparations)	2e-09	31015401
rs2814972	rs9469899	0.873942566095992	Medication use (thyroid preparations)	3e-10	34594039
rs2814972	rs9368830	0.864859314377829	HDL cholesterol	4e-21	30275531
rs2814972	rs9296128	0.851650494377412	Hip circumference adjusted for BMI	4e-13	34021172
rs2814972	rs9368828	0.848317611511305	Body mass index	1e-34	34594039
rs2814972	rs2744973	0.811059740058729	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814972	rs2744973	0.811059740058729	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814972	rs2744973	0.811059740058729	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814972	rs2744973	0.811059740058729	Multi-trait sex score	6e-20	37277458
rs2814972	rs6912327	0.768248596179196	Fasting insulin	5e-06	33402679
rs2814972	rs6912327	0.768248596179196	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814972	rs112283401	0.743467148115697	Red cell distribution width	4e-27	30595370
rs2814972	rs205262	0.631777419463945	Body mass index	2e-09	26961502
rs2814972	rs205262	0.631777419463945	Walking pace	4e-10	33128006
rs2814972	rs205262	0.631777419463945	Body mass index	8e-13	30108127
rs2814972	rs205262	0.631777419463945	Body mass index	2e-09	25673413
rs2814972	rs205262	0.631777419463945	Body mass index	2e-14	26426971
rs2814972	rs205262	0.631777419463945	BMI in non-smokers	3e-07	28443625
rs2814972	rs205262	0.631777419463945	BMI in non-smokers	6e-09	28443625
rs2814972	rs205262	0.631777419463945	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814972	rs205262	0.631777419463945	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814972	rs205262	0.631777419463945	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814972	rs205262	0.631777419463945	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814972	rs205262	0.631777419463945	Gastroesophageal reflux disease	1e-10	34187846
rs2814972	rs205262	0.631777419463945	Body mass index	3e-10	25673413
rs2814972	rs205262	0.631777419463945	Body mass index	2e-10	25673413
rs2814972	rs205262	0.631777419463945	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814974	rs2263329	0.964148246449013	HDL cholesterol	6e-35	34594039
rs2814974	rs2263329	0.964148246449013	HDL cholesterol levels	8e-43	32203549
rs2814974	rs2263329	0.964148246449013	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814974	rs9366863	0.950100746089997	Adult body size	9e-33	32376654
rs2814974	rs9366863	0.950100746089997	Body mass index	2e-44	30595370
rs2814974	rs2744944	0.943090755258153	Hypothyroidism	3e-10	34594039
rs2814974	rs2744944	0.943090755258153	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814974	rs2744944	0.943090755258153	Multi-trait sex score	7e-22	37277458
rs2814974	rs2814949	0.94166814579124	Essential hypertension (time to event)	9e-09	32589924
rs2814974	rs9469872	0.936850294922191	HDL cholesterol levels	3e-11	36333282
rs2814974	rs11755393	0.914862414842146	Body mass index	3e-26	29273807
rs2814974	rs11755393	0.914862414842146	Systemic lupus erythematosus	2e-12	33493351
rs2814974	rs11755393	0.914862414842146	Systemic lupus erythematosus	2e-06	33493351
rs2814974	rs11755393	0.914862414842146	Systemic lupus erythematosus	1e-07	33493351
rs2814974	rs11755393	0.914862414842146	Systemic lupus erythematosus	2e-08	19838195
rs2814974	rs11755393	0.914862414842146	Body mass index	4e-55	36581621
rs2814974	rs6941110	0.906639120693703	Sex hormone-binding globulin levels	5e-27	36653534
rs2814974	rs111868030	0.901040350512242	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814974	rs9469857	0.898007333725791	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814974	rs2764208	0.895721802195624	Systemic lupus erythematosus	7e-06	24871463
rs2814974	rs9462030	0.885828492303205	Red cell distribution width	5e-25	32888493
rs2814974	rs9469899	0.870163558562911	Prostate cancer (advanced)	2e-06	29892016
rs2814974	rs9469899	0.870163558562911	Prostate cancer	5e-09	29892016
rs2814974	rs9469899	0.870163558562911	Prostate cancer	8e-11	33398198
rs2814974	rs9469899	0.870163558562911	Hand grip strength	3e-15	29691431
rs2814974	rs9469899	0.870163558562911	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814974	rs9469899	0.870163558562911	Graves' disease	4e-10	34594039
rs2814974	rs9469899	0.870163558562911	Coronary artery disease	1e-11	36474045
rs2814974	rs9469899	0.870163558562911	Predicted visceral adipose tissue	2e-20	31501611
rs2814974	rs9469899	0.870163558562911	Medication use (thyroid preparations)	2e-09	31015401
rs2814974	rs9469899	0.870163558562911	Medication use (thyroid preparations)	3e-10	34594039
rs2814974	rs9368830	0.860855355056694	HDL cholesterol	4e-21	30275531
rs2814974	rs9296128	0.848128133677357	Hip circumference adjusted for BMI	4e-13	34021172
rs2814974	rs9368828	0.844644047677037	Body mass index	1e-34	34594039
rs2814974	rs2744973	0.807911996528182	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814974	rs2744973	0.807911996528182	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814974	rs2744973	0.807911996528182	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814974	rs2744973	0.807911996528182	Multi-trait sex score	6e-20	37277458
rs2814974	rs6912327	0.76510590965005	Fasting insulin	5e-06	33402679
rs2814974	rs6912327	0.76510590965005	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814974	rs112283401	0.740380125656862	Red cell distribution width	4e-27	30595370
rs2814974	rs205262	0.629547873697217	Body mass index	2e-09	26961502
rs2814974	rs205262	0.629547873697217	Walking pace	4e-10	33128006
rs2814974	rs205262	0.629547873697217	Body mass index	8e-13	30108127
rs2814974	rs205262	0.629547873697217	Body mass index	2e-09	25673413
rs2814974	rs205262	0.629547873697217	Body mass index	2e-14	26426971
rs2814974	rs205262	0.629547873697217	BMI in non-smokers	3e-07	28443625
rs2814974	rs205262	0.629547873697217	BMI in non-smokers	6e-09	28443625
rs2814974	rs205262	0.629547873697217	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814974	rs205262	0.629547873697217	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814974	rs205262	0.629547873697217	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814974	rs205262	0.629547873697217	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814974	rs205262	0.629547873697217	Gastroesophageal reflux disease	1e-10	34187846
rs2814974	rs205262	0.629547873697217	Body mass index	3e-10	25673413
rs2814974	rs205262	0.629547873697217	Body mass index	2e-10	25673413
rs2814974	rs205262	0.629547873697217	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814975	rs9366863	0.947741470807198	Adult body size	9e-33	32376654
rs2814975	rs9366863	0.947741470807198	Body mass index	2e-44	30595370
rs2814975	rs2263329	0.946050186366829	HDL cholesterol	6e-35	34594039
rs2814975	rs2263329	0.946050186366829	HDL cholesterol levels	8e-43	32203549
rs2814975	rs2263329	0.946050186366829	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814975	rs2814949	0.939316510564335	Essential hypertension (time to event)	9e-09	32589924
rs2814975	rs2744944	0.925197468741304	Hypothyroidism	3e-10	34594039
rs2814975	rs2744944	0.925197468741304	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814975	rs2744944	0.925197468741304	Multi-trait sex score	7e-22	37277458
rs2814975	rs9469872	0.919016812737474	HDL cholesterol levels	3e-11	36333282
rs2814975	rs11755393	0.912541304855222	Body mass index	3e-26	29273807
rs2814975	rs11755393	0.912541304855222	Systemic lupus erythematosus	2e-12	33493351
rs2814975	rs11755393	0.912541304855222	Systemic lupus erythematosus	2e-06	33493351
rs2814975	rs11755393	0.912541304855222	Systemic lupus erythematosus	1e-07	33493351
rs2814975	rs11755393	0.912541304855222	Systemic lupus erythematosus	2e-08	19838195
rs2814975	rs11755393	0.912541304855222	Body mass index	4e-55	36581621
rs2814975	rs6941110	0.904336958032895	Sex hormone-binding globulin levels	5e-27	36653534
rs2814975	rs9462030	0.885078024887899	Red cell distribution width	5e-25	32888493
rs2814975	rs111868030	0.883507961674068	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814975	rs9469857	0.882048985133374	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814975	rs2764208	0.879783008391574	Systemic lupus erythematosus	7e-06	24871463
rs2814975	rs9469899	0.869411216183638	Prostate cancer (advanced)	2e-06	29892016
rs2814975	rs9469899	0.869411216183638	Prostate cancer	5e-09	29892016
rs2814975	rs9469899	0.869411216183638	Prostate cancer	8e-11	33398198
rs2814975	rs9469899	0.869411216183638	Hand grip strength	3e-15	29691431
rs2814975	rs9469899	0.869411216183638	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814975	rs9469899	0.869411216183638	Graves' disease	4e-10	34594039
rs2814975	rs9469899	0.869411216183638	Coronary artery disease	1e-11	36474045
rs2814975	rs9469899	0.869411216183638	Predicted visceral adipose tissue	2e-20	31501611
rs2814975	rs9469899	0.869411216183638	Medication use (thyroid preparations)	2e-09	31015401
rs2814975	rs9469899	0.869411216183638	Medication use (thyroid preparations)	3e-10	34594039
rs2814975	rs9368830	0.858584615771962	HDL cholesterol	4e-21	30275531
rs2814975	rs9296128	0.832597241140512	Hip circumference adjusted for BMI	4e-13	34021172
rs2814975	rs9368828	0.827709063471306	Body mass index	1e-34	34594039
rs2814975	rs2744973	0.821983232320428	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814975	rs2744973	0.821983232320428	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814975	rs2744973	0.821983232320428	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814975	rs2744973	0.821983232320428	Multi-trait sex score	6e-20	37277458
rs2814975	rs6912327	0.763034389829548	Fasting insulin	5e-06	33402679
rs2814975	rs6912327	0.763034389829548	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814975	rs112283401	0.738343109693035	Red cell distribution width	4e-27	30595370
rs2814975	rs205262	0.626367597785102	Body mass index	2e-09	26961502
rs2814975	rs205262	0.626367597785102	Walking pace	4e-10	33128006
rs2814975	rs205262	0.626367597785102	Body mass index	8e-13	30108127
rs2814975	rs205262	0.626367597785102	Body mass index	2e-09	25673413
rs2814975	rs205262	0.626367597785102	Body mass index	2e-14	26426971
rs2814975	rs205262	0.626367597785102	BMI in non-smokers	3e-07	28443625
rs2814975	rs205262	0.626367597785102	BMI in non-smokers	6e-09	28443625
rs2814975	rs205262	0.626367597785102	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814975	rs205262	0.626367597785102	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814975	rs205262	0.626367597785102	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814975	rs205262	0.626367597785102	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814975	rs205262	0.626367597785102	Gastroesophageal reflux disease	1e-10	34187846
rs2814975	rs205262	0.626367597785102	Body mass index	3e-10	25673413
rs2814975	rs205262	0.626367597785102	Body mass index	2e-10	25673413
rs2814975	rs205262	0.626367597785102	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814975	rs6940215	0.604498524670869	Insomnia	2e-10	35835914
rs2814975	rs6940215	0.604498524670869	Insomnia	1e-13	35835914
rs2814975	rs6940215	0.604498524670869	Hip circumference adjusted for BMI	8e-10	34021172
rs2814975	rs6940215	0.604498524670869	Multi-trait sex score	2e-23	37277458
rs2814975	rs6940215	0.604498524670869	Multi-trait sex score	4e-23	37277458
rs2814987	rs9366863	0.982404579707977	Adult body size	9e-33	32376654
rs2814987	rs9366863	0.982404579707977	Body mass index	2e-44	30595370
rs2814987	rs2814949	0.970566036840398	Essential hypertension (time to event)	9e-09	32589924
rs2814987	rs2744944	0.956295460949434	Hypothyroidism	3e-10	34594039
rs2814987	rs2744944	0.956295460949434	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814987	rs2744944	0.956295460949434	Multi-trait sex score	7e-22	37277458
rs2814987	rs9469872	0.953153101467116	HDL cholesterol levels	3e-11	36333282
rs2814987	rs11755393	0.94636689468847	Body mass index	3e-26	29273807
rs2814987	rs11755393	0.94636689468847	Systemic lupus erythematosus	2e-12	33493351
rs2814987	rs11755393	0.94636689468847	Systemic lupus erythematosus	2e-06	33493351
rs2814987	rs11755393	0.94636689468847	Systemic lupus erythematosus	1e-07	33493351
rs2814987	rs11755393	0.94636689468847	Systemic lupus erythematosus	2e-08	19838195
rs2814987	rs11755393	0.94636689468847	Body mass index	4e-55	36581621
rs2814987	rs2263329	0.946048821363012	HDL cholesterol	6e-35	34594039
rs2814987	rs2263329	0.946048821363012	HDL cholesterol levels	8e-43	32203549
rs2814987	rs2263329	0.946048821363012	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814987	rs6941110	0.936706215658224	Sex hormone-binding globulin levels	5e-27	36653534
rs2814987	rs9462030	0.917403096301705	Red cell distribution width	5e-25	32888493
rs2814987	rs111868030	0.916349817220739	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814987	rs9469857	0.91435109825279	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814987	rs2764208	0.912067938187105	Systemic lupus erythematosus	7e-06	24871463
rs2814987	rs9469899	0.901221941275194	Prostate cancer (advanced)	2e-06	29892016
rs2814987	rs9469899	0.901221941275194	Prostate cancer	5e-09	29892016
rs2814987	rs9469899	0.901221941275194	Prostate cancer	8e-11	33398198
rs2814987	rs9469899	0.901221941275194	Hand grip strength	3e-15	29691431
rs2814987	rs9469899	0.901221941275194	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814987	rs9469899	0.901221941275194	Graves' disease	4e-10	34594039
rs2814987	rs9469899	0.901221941275194	Coronary artery disease	1e-11	36474045
rs2814987	rs9469899	0.901221941275194	Predicted visceral adipose tissue	2e-20	31501611
rs2814987	rs9469899	0.901221941275194	Medication use (thyroid preparations)	2e-09	31015401
rs2814987	rs9469899	0.901221941275194	Medication use (thyroid preparations)	3e-10	34594039
rs2814987	rs9368830	0.890883684933573	HDL cholesterol	4e-21	30275531
rs2814987	rs9296128	0.864522583635304	Hip circumference adjusted for BMI	4e-13	34021172
rs2814987	rs9368828	0.857447548569454	Body mass index	1e-34	34594039
rs2814987	rs2744973	0.810292318655358	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814987	rs2744973	0.810292318655358	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814987	rs2744973	0.810292318655358	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814987	rs2744973	0.810292318655358	Multi-trait sex score	6e-20	37277458
rs2814987	rs6912327	0.795871583738474	Fasting insulin	5e-06	33402679
rs2814987	rs6912327	0.795871583738474	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814987	rs112283401	0.770659467344499	Red cell distribution width	4e-27	30595370
rs2814987	rs6940215	0.624689711941887	Insomnia	2e-10	35835914
rs2814987	rs6940215	0.624689711941887	Insomnia	1e-13	35835914
rs2814987	rs6940215	0.624689711941887	Hip circumference adjusted for BMI	8e-10	34021172
rs2814987	rs6940215	0.624689711941887	Multi-trait sex score	2e-23	37277458
rs2814987	rs6940215	0.624689711941887	Multi-trait sex score	4e-23	37277458
rs2814987	rs205262	0.618965461120526	Body mass index	2e-09	26961502
rs2814987	rs205262	0.618965461120526	Walking pace	4e-10	33128006
rs2814987	rs205262	0.618965461120526	Body mass index	8e-13	30108127
rs2814987	rs205262	0.618965461120526	Body mass index	2e-09	25673413
rs2814987	rs205262	0.618965461120526	Body mass index	2e-14	26426971
rs2814987	rs205262	0.618965461120526	BMI in non-smokers	3e-07	28443625
rs2814987	rs205262	0.618965461120526	BMI in non-smokers	6e-09	28443625
rs2814987	rs205262	0.618965461120526	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814987	rs205262	0.618965461120526	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814987	rs205262	0.618965461120526	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814987	rs205262	0.618965461120526	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814987	rs205262	0.618965461120526	Gastroesophageal reflux disease	1e-10	34187846
rs2814987	rs205262	0.618965461120526	Body mass index	3e-10	25673413
rs2814987	rs205262	0.618965461120526	Body mass index	2e-10	25673413
rs2814987	rs205262	0.618965461120526	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814987	rs6457796	0.61511143806218	Insomnia	1e-08	30804565
rs2814987	rs6457796	0.61511143806218	Plateletcrit	9e-11	32888494
rs2814987	rs6457796	0.61511143806218	Systemic lupus erythematosus	3e-22	33272962
rs2814987	rs6457796	0.61511143806218	Body mass index	5e-13	30108127
rs2814987	rs6457796	0.61511143806218	Body mass index	1e-14	26426971
rs2814987	rs6457796	0.61511143806218	Educational attainment	5e-19	35361970
rs2814988	rs9366863	0.976879734852022	Adult body size	9e-33	32376654
rs2814988	rs9366863	0.976879734852022	Body mass index	2e-44	30595370
rs2814988	rs2814949	0.965117830501518	Essential hypertension (time to event)	9e-09	32589924
rs2814988	rs2744944	0.950846004232846	Hypothyroidism	3e-10	34594039
rs2814988	rs2744944	0.950846004232846	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814988	rs2744944	0.950846004232846	Multi-trait sex score	7e-22	37277458
rs2814988	rs9469872	0.947711463946706	HDL cholesterol levels	3e-11	36333282
rs2814988	rs11755393	0.941039378736786	Body mass index	3e-26	29273807
rs2814988	rs11755393	0.941039378736786	Systemic lupus erythematosus	2e-12	33493351
rs2814988	rs11755393	0.941039378736786	Systemic lupus erythematosus	2e-06	33493351
rs2814988	rs11755393	0.941039378736786	Systemic lupus erythematosus	1e-07	33493351
rs2814988	rs11755393	0.941039378736786	Systemic lupus erythematosus	2e-08	19838195
rs2814988	rs11755393	0.941039378736786	Body mass index	4e-55	36581621
rs2814988	rs2263329	0.940563300835791	HDL cholesterol	6e-35	34594039
rs2814988	rs2263329	0.940563300835791	HDL cholesterol levels	8e-43	32203549
rs2814988	rs2263329	0.940563300835791	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814988	rs6941110	0.931280572393219	Sex hormone-binding globulin levels	5e-27	36653534
rs2814988	rs9462030	0.91188660760653	Red cell distribution width	5e-25	32888493
rs2814988	rs111868030	0.910576222067838	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814988	rs9469857	0.908828237476785	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814988	rs2764208	0.906540312473146	Systemic lupus erythematosus	7e-06	24871463
rs2814988	rs9469899	0.895866052696123	Prostate cancer (advanced)	2e-06	29892016
rs2814988	rs9469899	0.895866052696123	Prostate cancer	5e-09	29892016
rs2814988	rs9469899	0.895866052696123	Prostate cancer	8e-11	33398198
rs2814988	rs9469899	0.895866052696123	Hand grip strength	3e-15	29691431
rs2814988	rs9469899	0.895866052696123	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814988	rs9469899	0.895866052696123	Graves' disease	4e-10	34594039
rs2814988	rs9469899	0.895866052696123	Coronary artery disease	1e-11	36474045
rs2814988	rs9469899	0.895866052696123	Predicted visceral adipose tissue	2e-20	31501611
rs2814988	rs9469899	0.895866052696123	Medication use (thyroid preparations)	2e-09	31015401
rs2814988	rs9469899	0.895866052696123	Medication use (thyroid preparations)	3e-10	34594039
rs2814988	rs9368830	0.882961249824888	HDL cholesterol	4e-21	30275531
rs2814988	rs9296128	0.858896129279738	Hip circumference adjusted for BMI	4e-13	34021172
rs2814988	rs9368828	0.852131350304396	Body mass index	1e-34	34594039
rs2814988	rs2744973	0.818983639147584	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814988	rs2744973	0.818983639147584	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814988	rs2744973	0.818983639147584	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814988	rs2744973	0.818983639147584	Multi-trait sex score	6e-20	37277458
rs2814988	rs6912327	0.788651985188543	Fasting insulin	5e-06	33402679
rs2814988	rs6912327	0.788651985188543	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814988	rs112283401	0.764970886475229	Red cell distribution width	4e-27	30595370
rs2814988	rs6940215	0.629382264730682	Insomnia	2e-10	35835914
rs2814988	rs6940215	0.629382264730682	Insomnia	1e-13	35835914
rs2814988	rs6940215	0.629382264730682	Hip circumference adjusted for BMI	8e-10	34021172
rs2814988	rs6940215	0.629382264730682	Multi-trait sex score	2e-23	37277458
rs2814988	rs6940215	0.629382264730682	Multi-trait sex score	4e-23	37277458
rs2814988	rs205262	0.624484412966908	Body mass index	2e-09	26961502
rs2814988	rs205262	0.624484412966908	Walking pace	4e-10	33128006
rs2814988	rs205262	0.624484412966908	Body mass index	8e-13	30108127
rs2814988	rs205262	0.624484412966908	Body mass index	2e-09	25673413
rs2814988	rs205262	0.624484412966908	Body mass index	2e-14	26426971
rs2814988	rs205262	0.624484412966908	BMI in non-smokers	3e-07	28443625
rs2814988	rs205262	0.624484412966908	BMI in non-smokers	6e-09	28443625
rs2814988	rs205262	0.624484412966908	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814988	rs205262	0.624484412966908	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814988	rs205262	0.624484412966908	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814988	rs205262	0.624484412966908	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814988	rs205262	0.624484412966908	Gastroesophageal reflux disease	1e-10	34187846
rs2814988	rs205262	0.624484412966908	Body mass index	3e-10	25673413
rs2814988	rs205262	0.624484412966908	Body mass index	2e-10	25673413
rs2814988	rs205262	0.624484412966908	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814988	rs6457796	0.622039852546887	Insomnia	1e-08	30804565
rs2814988	rs6457796	0.622039852546887	Plateletcrit	9e-11	32888494
rs2814988	rs6457796	0.622039852546887	Systemic lupus erythematosus	3e-22	33272962
rs2814988	rs6457796	0.622039852546887	Body mass index	5e-13	30108127
rs2814988	rs6457796	0.622039852546887	Body mass index	1e-14	26426971
rs2814988	rs6457796	0.622039852546887	Educational attainment	5e-19	35361970
rs2814991	rs9366863	0.984806524393287	Adult body size	9e-33	32376654
rs2814991	rs9366863	0.984806524393287	Body mass index	2e-44	30595370
rs2814991	rs2814949	0.972963809017027	Essential hypertension (time to event)	9e-09	32589924
rs2814991	rs2744944	0.95866536227475	Hypothyroidism	3e-10	34594039
rs2814991	rs2744944	0.95866536227475	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814991	rs2744944	0.95866536227475	Multi-trait sex score	7e-22	37277458
rs2814991	rs9469872	0.955518798358637	HDL cholesterol levels	3e-11	36333282
rs2814991	rs11755393	0.948747158161882	Body mass index	3e-26	29273807
rs2814991	rs11755393	0.948747158161882	Systemic lupus erythematosus	2e-12	33493351
rs2814991	rs11755393	0.948747158161882	Systemic lupus erythematosus	2e-06	33493351
rs2814991	rs11755393	0.948747158161882	Systemic lupus erythematosus	1e-07	33493351
rs2814991	rs11755393	0.948747158161882	Systemic lupus erythematosus	2e-08	19838195
rs2814991	rs11755393	0.948747158161882	Body mass index	4e-55	36581621
rs2814991	rs2263329	0.946823888162705	HDL cholesterol	6e-35	34594039
rs2814991	rs2263329	0.946823888162705	HDL cholesterol levels	8e-43	32203549
rs2814991	rs2263329	0.946823888162705	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814991	rs6941110	0.939043740786307	Sex hormone-binding globulin levels	5e-27	36653534
rs2814991	rs9462030	0.91968132517809	Red cell distribution width	5e-25	32888493
rs2814991	rs111868030	0.918567286436883	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814991	rs9469857	0.916621859863398	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814991	rs2764208	0.914333113625513	Systemic lupus erythematosus	7e-06	24871463
rs2814991	rs9469899	0.903506231545201	Prostate cancer (advanced)	2e-06	29892016
rs2814991	rs9469899	0.903506231545201	Prostate cancer	5e-09	29892016
rs2814991	rs9469899	0.903506231545201	Prostate cancer	8e-11	33398198
rs2814991	rs9469899	0.903506231545201	Hand grip strength	3e-15	29691431
rs2814991	rs9469899	0.903506231545201	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814991	rs9469899	0.903506231545201	Graves' disease	4e-10	34594039
rs2814991	rs9469899	0.903506231545201	Coronary artery disease	1e-11	36474045
rs2814991	rs9469899	0.903506231545201	Predicted visceral adipose tissue	2e-20	31501611
rs2814991	rs9469899	0.903506231545201	Medication use (thyroid preparations)	2e-09	31015401
rs2814991	rs9469899	0.903506231545201	Medication use (thyroid preparations)	3e-10	34594039
rs2814991	rs9368830	0.890229724802766	HDL cholesterol	4e-21	30275531
rs2814991	rs9296128	0.866671428999764	Hip circumference adjusted for BMI	4e-13	34021172
rs2814991	rs9368828	0.859653315597537	Body mass index	1e-34	34594039
rs2814991	rs2744973	0.81078414442599	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814991	rs2744973	0.81078414442599	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814991	rs2744973	0.81078414442599	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814991	rs2744973	0.81078414442599	Multi-trait sex score	6e-20	37277458
rs2814991	rs6912327	0.79639988709278	Fasting insulin	5e-06	33402679
rs2814991	rs6912327	0.79639988709278	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814991	rs112283401	0.772605420628028	Red cell distribution width	4e-27	30595370
rs2814991	rs6940215	0.626320440962521	Insomnia	2e-10	35835914
rs2814991	rs6940215	0.626320440962521	Insomnia	1e-13	35835914
rs2814991	rs6940215	0.626320440962521	Hip circumference adjusted for BMI	8e-10	34021172
rs2814991	rs6940215	0.626320440962521	Multi-trait sex score	2e-23	37277458
rs2814991	rs6940215	0.626320440962521	Multi-trait sex score	4e-23	37277458
rs2814991	rs205262	0.619138634862477	Body mass index	2e-09	26961502
rs2814991	rs205262	0.619138634862477	Walking pace	4e-10	33128006
rs2814991	rs205262	0.619138634862477	Body mass index	8e-13	30108127
rs2814991	rs205262	0.619138634862477	Body mass index	2e-09	25673413
rs2814991	rs205262	0.619138634862477	Body mass index	2e-14	26426971
rs2814991	rs205262	0.619138634862477	BMI in non-smokers	3e-07	28443625
rs2814991	rs205262	0.619138634862477	BMI in non-smokers	6e-09	28443625
rs2814991	rs205262	0.619138634862477	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814991	rs205262	0.619138634862477	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814991	rs205262	0.619138634862477	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814991	rs205262	0.619138634862477	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814991	rs205262	0.619138634862477	Gastroesophageal reflux disease	1e-10	34187846
rs2814991	rs205262	0.619138634862477	Body mass index	3e-10	25673413
rs2814991	rs205262	0.619138634862477	Body mass index	2e-10	25673413
rs2814991	rs205262	0.619138634862477	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814991	rs6457796	0.616635544055677	Insomnia	1e-08	30804565
rs2814991	rs6457796	0.616635544055677	Plateletcrit	9e-11	32888494
rs2814991	rs6457796	0.616635544055677	Systemic lupus erythematosus	3e-22	33272962
rs2814991	rs6457796	0.616635544055677	Body mass index	5e-13	30108127
rs2814991	rs6457796	0.616635544055677	Body mass index	1e-14	26426971
rs2814991	rs6457796	0.616635544055677	Educational attainment	5e-19	35361970
rs2814992	rs9366863	0.969035918550022	Adult body size	9e-33	32376654
rs2814992	rs9366863	0.969035918550022	Body mass index	2e-44	30595370
rs2814992	rs2744944	0.961955934447774	Hypothyroidism	3e-10	34594039
rs2814992	rs2744944	0.961955934447774	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814992	rs2744944	0.961955934447774	Multi-trait sex score	7e-22	37277458
rs2814992	rs9469872	0.958801781786325	HDL cholesterol levels	3e-11	36333282
rs2814992	rs2814949	0.95736891324654	Essential hypertension (time to event)	9e-09	32589924
rs2814992	rs2263329	0.946844197665125	HDL cholesterol	6e-35	34594039
rs2814992	rs2263329	0.946844197665125	HDL cholesterol levels	8e-43	32203549
rs2814992	rs2263329	0.946844197665125	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814992	rs11755393	0.933445066076108	Body mass index	3e-26	29273807
rs2814992	rs11755393	0.933445066076108	Systemic lupus erythematosus	2e-12	33493351
rs2814992	rs11755393	0.933445066076108	Systemic lupus erythematosus	2e-06	33493351
rs2814992	rs11755393	0.933445066076108	Systemic lupus erythematosus	1e-07	33493351
rs2814992	rs11755393	0.933445066076108	Systemic lupus erythematosus	2e-08	19838195
rs2814992	rs11755393	0.933445066076108	Body mass index	4e-55	36581621
rs2814992	rs6941110	0.923587436094138	Sex hormone-binding globulin levels	5e-27	36653534
rs2814992	rs111868030	0.92104429146927	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814992	rs9469857	0.919505081789945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814992	rs2764208	0.91719282547403	Systemic lupus erythematosus	7e-06	24871463
rs2814992	rs9462030	0.904111338062519	Red cell distribution width	5e-25	32888493
rs2814992	rs9469899	0.888282658538992	Prostate cancer (advanced)	2e-06	29892016
rs2814992	rs9469899	0.888282658538992	Prostate cancer	5e-09	29892016
rs2814992	rs9469899	0.888282658538992	Prostate cancer	8e-11	33398198
rs2814992	rs9469899	0.888282658538992	Hand grip strength	3e-15	29691431
rs2814992	rs9469899	0.888282658538992	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814992	rs9469899	0.888282658538992	Graves' disease	4e-10	34594039
rs2814992	rs9469899	0.888282658538992	Coronary artery disease	1e-11	36474045
rs2814992	rs9469899	0.888282658538992	Predicted visceral adipose tissue	2e-20	31501611
rs2814992	rs9469899	0.888282658538992	Medication use (thyroid preparations)	2e-09	31015401
rs2814992	rs9469899	0.888282658538992	Medication use (thyroid preparations)	3e-10	34594039
rs2814992	rs9368830	0.875893326439264	HDL cholesterol	4e-21	30275531
rs2814992	rs9296128	0.869041902814524	Hip circumference adjusted for BMI	4e-13	34021172
rs2814992	rs9368828	0.86249534851383	Body mass index	1e-34	34594039
rs2814992	rs2744973	0.807761173405096	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814992	rs2744973	0.807761173405096	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814992	rs2744973	0.807761173405096	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814992	rs2744973	0.807761173405096	Multi-trait sex score	6e-20	37277458
rs2814992	rs6912327	0.780711831746376	Fasting insulin	5e-06	33402679
rs2814992	rs6912327	0.780711831746376	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814992	rs112283401	0.757145180684282	Red cell distribution width	4e-27	30595370
rs2814992	rs205262	0.630565902845013	Body mass index	2e-09	26961502
rs2814992	rs205262	0.630565902845013	Walking pace	4e-10	33128006
rs2814992	rs205262	0.630565902845013	Body mass index	8e-13	30108127
rs2814992	rs205262	0.630565902845013	Body mass index	2e-09	25673413
rs2814992	rs205262	0.630565902845013	Body mass index	2e-14	26426971
rs2814992	rs205262	0.630565902845013	BMI in non-smokers	3e-07	28443625
rs2814992	rs205262	0.630565902845013	BMI in non-smokers	6e-09	28443625
rs2814992	rs205262	0.630565902845013	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814992	rs205262	0.630565902845013	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814992	rs205262	0.630565902845013	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814992	rs205262	0.630565902845013	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814992	rs205262	0.630565902845013	Gastroesophageal reflux disease	1e-10	34187846
rs2814992	rs205262	0.630565902845013	Body mass index	3e-10	25673413
rs2814992	rs205262	0.630565902845013	Body mass index	2e-10	25673413
rs2814992	rs205262	0.630565902845013	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814992	rs6940215	0.62161004277195	Insomnia	2e-10	35835914
rs2814992	rs6940215	0.62161004277195	Insomnia	1e-13	35835914
rs2814992	rs6940215	0.62161004277195	Hip circumference adjusted for BMI	8e-10	34021172
rs2814992	rs6940215	0.62161004277195	Multi-trait sex score	2e-23	37277458
rs2814992	rs6940215	0.62161004277195	Multi-trait sex score	4e-23	37277458
rs2814992	rs6457796	0.612387928569592	Insomnia	1e-08	30804565
rs2814992	rs6457796	0.612387928569592	Plateletcrit	9e-11	32888494
rs2814992	rs6457796	0.612387928569592	Systemic lupus erythematosus	3e-22	33272962
rs2814992	rs6457796	0.612387928569592	Body mass index	5e-13	30108127
rs2814992	rs6457796	0.612387928569592	Body mass index	1e-14	26426971
rs2814992	rs6457796	0.612387928569592	Educational attainment	5e-19	35361970
rs2814995	rs9366863	0.972127567610469	Adult body size	9e-33	32376654
rs2814995	rs9366863	0.972127567610469	Body mass index	2e-44	30595370
rs2814995	rs2744944	0.965028975381518	Hypothyroidism	3e-10	34594039
rs2814995	rs2744944	0.965028975381518	High density lipoprotein cholesterol levels	3e-86	34887591
rs2814995	rs2744944	0.965028975381518	Multi-trait sex score	7e-22	37277458
rs2814995	rs9469872	0.961870906568866	HDL cholesterol levels	3e-11	36333282
rs2814995	rs2814949	0.960403658096162	Essential hypertension (time to event)	9e-09	32589924
rs2814995	rs2263329	0.949953680481548	HDL cholesterol	6e-35	34594039
rs2814995	rs2263329	0.949953680481548	HDL cholesterol levels	8e-43	32203549
rs2814995	rs2263329	0.949953680481548	High density lipoprotein cholesterol levels	2e-52	34887591
rs2814995	rs11755393	0.936395605654189	Body mass index	3e-26	29273807
rs2814995	rs11755393	0.936395605654189	Systemic lupus erythematosus	2e-12	33493351
rs2814995	rs11755393	0.936395605654189	Systemic lupus erythematosus	2e-06	33493351
rs2814995	rs11755393	0.936395605654189	Systemic lupus erythematosus	1e-07	33493351
rs2814995	rs11755393	0.936395605654189	Systemic lupus erythematosus	2e-08	19838195
rs2814995	rs11755393	0.936395605654189	Body mass index	4e-55	36581621
rs2814995	rs6941110	0.926634599237133	Sex hormone-binding globulin levels	5e-27	36653534
rs2814995	rs111868030	0.924446200340538	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs2814995	rs9469857	0.922685514077634	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs2814995	rs2764208	0.920379796100903	Systemic lupus erythematosus	7e-06	24871463
rs2814995	rs9462030	0.907257670468256	Red cell distribution width	5e-25	32888493
rs2814995	rs9469899	0.891302422504988	Prostate cancer (advanced)	2e-06	29892016
rs2814995	rs9469899	0.891302422504988	Prostate cancer	5e-09	29892016
rs2814995	rs9469899	0.891302422504988	Prostate cancer	8e-11	33398198
rs2814995	rs9469899	0.891302422504988	Hand grip strength	3e-15	29691431
rs2814995	rs9469899	0.891302422504988	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs2814995	rs9469899	0.891302422504988	Graves' disease	4e-10	34594039
rs2814995	rs9469899	0.891302422504988	Coronary artery disease	1e-11	36474045
rs2814995	rs9469899	0.891302422504988	Predicted visceral adipose tissue	2e-20	31501611
rs2814995	rs9469899	0.891302422504988	Medication use (thyroid preparations)	2e-09	31015401
rs2814995	rs9469899	0.891302422504988	Medication use (thyroid preparations)	3e-10	34594039
rs2814995	rs9368830	0.881527694396853	HDL cholesterol	4e-21	30275531
rs2814995	rs9296128	0.872364721003049	Hip circumference adjusted for BMI	4e-13	34021172
rs2814995	rs9368828	0.865548686232432	Body mass index	1e-34	34594039
rs2814995	rs2744973	0.799747627569941	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs2814995	rs2744973	0.799747627569941	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs2814995	rs2744973	0.799747627569941	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs2814995	rs2744973	0.799747627569941	Multi-trait sex score	6e-20	37277458
rs2814995	rs6912327	0.785641728926237	Fasting insulin	5e-06	33402679
rs2814995	rs6912327	0.785641728926237	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs2814995	rs112283401	0.760586994972442	Red cell distribution width	4e-27	30595370
rs2814995	rs205262	0.622829838952538	Body mass index	2e-09	26961502
rs2814995	rs205262	0.622829838952538	Walking pace	4e-10	33128006
rs2814995	rs205262	0.622829838952538	Body mass index	8e-13	30108127
rs2814995	rs205262	0.622829838952538	Body mass index	2e-09	25673413
rs2814995	rs205262	0.622829838952538	Body mass index	2e-14	26426971
rs2814995	rs205262	0.622829838952538	BMI in non-smokers	3e-07	28443625
rs2814995	rs205262	0.622829838952538	BMI in non-smokers	6e-09	28443625
rs2814995	rs205262	0.622829838952538	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs2814995	rs205262	0.622829838952538	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs2814995	rs205262	0.622829838952538	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs2814995	rs205262	0.622829838952538	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs2814995	rs205262	0.622829838952538	Gastroesophageal reflux disease	1e-10	34187846
rs2814995	rs205262	0.622829838952538	Body mass index	3e-10	25673413
rs2814995	rs205262	0.622829838952538	Body mass index	2e-10	25673413
rs2814995	rs205262	0.622829838952538	ICD10 M54: Dorsalgia	2e-12	35110524
rs2814995	rs6940215	0.614876453380101	Insomnia	2e-10	35835914
rs2814995	rs6940215	0.614876453380101	Insomnia	1e-13	35835914
rs2814995	rs6940215	0.614876453380101	Hip circumference adjusted for BMI	8e-10	34021172
rs2814995	rs6940215	0.614876453380101	Multi-trait sex score	2e-23	37277458
rs2814995	rs6940215	0.614876453380101	Multi-trait sex score	4e-23	37277458
rs2814995	rs6457796	0.605994199664358	Insomnia	1e-08	30804565
rs2814995	rs6457796	0.605994199664358	Plateletcrit	9e-11	32888494
rs2814995	rs6457796	0.605994199664358	Systemic lupus erythematosus	3e-22	33272962
rs2814995	rs6457796	0.605994199664358	Body mass index	5e-13	30108127
rs2814995	rs6457796	0.605994199664358	Body mass index	1e-14	26426971
rs2814995	rs6457796	0.605994199664358	Educational attainment	5e-19	35361970
rs2834349	rs2834349	1	Vaginal microbiome MetaCyc pathway (PWY-7315|dTDP-N-acetylthomosamine biosynthesis)	5e-07	34282934
rs28377509	rs28377509	1	Platelet count	2e-26	32888493
rs28377509	rs6509933	0.611031656199104	OTU99_54 (Holdemanella) abundance	6e-06	33462482
rs28383221	rs28383221	1	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28383221	rs28383224	0.986450944397525	Neuromyelitis optica	6e-12	29769526
rs28383221	rs28383224	0.986450944397525	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28383221	rs28383224	0.986450944397525	Waist-hip index	1e-19	34021172
rs28383221	rs28383224	0.986450944397525	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28383221	rs28383224	0.986450944397525	Waist circumference adjusted for body mass index	9e-10	34021172
rs28383221	rs28383233	0.981690933482194	Free cholesterol levels in very large HDL	4e-14	35213538
rs28383221	rs28383223	0.979332933050465	Alanine aminotransferase levels	7e-38	33547301
rs28383221	rs685244	0.969104268860845	Complement C4 levels	2e-12	36168886
rs28383221	rs3129755	0.875134558434715	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28383221	rs3129755	0.875134558434715	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28383221	rs3129755	0.875134558434715	Triglyceride levels in very large VLDL	3e-21	35213538
rs28383221	rs3129755	0.875134558434715	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28383221	rs3129755	0.875134558434715	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28383221	rs3129755	0.875134558434715	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28383221	rs3129755	0.875134558434715	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28383221	rs3129755	0.875134558434715	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28383221	rs3129755	0.875134558434715	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28383221	rs3129755	0.875134558434715	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28383221	rs3129755	0.875134558434715	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28383221	rs3129755	0.875134558434715	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28383221	rs3129755	0.875134558434715	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28383221	rs3129755	0.875134558434715	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28383221	rs3129755	0.875134558434715	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28383221	rs3129755	0.875134558434715	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28383221	rs3129755	0.875134558434715	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28383221	rs3129755	0.875134558434715	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28383221	rs3129755	0.875134558434715	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28383221	rs3129755	0.875134558434715	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28383221	rs3129755	0.875134558434715	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28383221	rs3129755	0.875134558434715	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28383221	rs3129755	0.875134558434715	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28383221	rs3129755	0.875134558434715	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28383221	rs3129755	0.875134558434715	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28383221	rs28383241	0.823643496242715	Alanine aminotransferase levels	9e-40	34594039
rs28383221	rs686250	0.703537144743865	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28383221	rs502803	0.686492418266065	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28383221	rs28752509	0.681915004066242	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28383221	rs28752509	0.681915004066242	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28383221	rs28752510	0.681915004066242	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28383221	rs28752510	0.681915004066242	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28383221	rs28752510	0.681915004066242	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28383221	rs28752510	0.681915004066242	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28383221	rs28752510	0.681915004066242	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28383221	rs28752510	0.681915004066242	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28383221	rs28752510	0.681915004066242	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28383221	rs28752510	0.681915004066242	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28383221	rs28752510	0.681915004066242	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28383221	rs28752510	0.681915004066242	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28383221	rs28752510	0.681915004066242	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28383221	rs28752510	0.681915004066242	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28383221	rs28752510	0.681915004066242	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28383221	rs28752510	0.681915004066242	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28383221	rs28752510	0.681915004066242	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28383221	rs28752510	0.681915004066242	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28383221	rs28752510	0.681915004066242	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28383221	rs28752510	0.681915004066242	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28383221	rs28752510	0.681915004066242	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28383221	rs28752510	0.681915004066242	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28383221	rs28752510	0.681915004066242	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28383221	rs28752510	0.681915004066242	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28383221	rs13191975	0.681915004066242	A body shape index	4e-12	34021172
rs28383221	rs5021727	0.680348350913673	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs28383221	rs5021727	0.680348350913673	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs28383221	rs5021727	0.680348350913673	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs28383221	rs5021727	0.680348350913673	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs28383221	rs5021727	0.680348350913673	Metabolic syndrome	2e-08	31589552
rs28383221	rs9271215	0.617001624792955	Gynecologic disease (multivariate analysis)	2e-08	31488892
rs28383224	rs28383224	1	Neuromyelitis optica	6e-12	29769526
rs28383224	rs28383224	1	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28383224	rs28383224	1	Waist-hip index	1e-19	34021172
rs28383224	rs28383224	1	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28383224	rs28383224	1	Waist circumference adjusted for body mass index	9e-10	34021172
rs28383224	rs28383233	0.990426367256839	Free cholesterol levels in very large HDL	4e-14	35213538
rs28383224	rs28383221	0.986450944397525	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28383224	rs28383223	0.984877348297598	Alanine aminotransferase levels	7e-38	33547301
rs28383224	rs685244	0.977777291254527	Complement C4 levels	2e-12	36168886
rs28383224	rs3129755	0.880339719962196	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28383224	rs3129755	0.880339719962196	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28383224	rs3129755	0.880339719962196	Triglyceride levels in very large VLDL	3e-21	35213538
rs28383224	rs3129755	0.880339719962196	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28383224	rs3129755	0.880339719962196	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28383224	rs3129755	0.880339719962196	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28383224	rs3129755	0.880339719962196	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28383224	rs3129755	0.880339719962196	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28383224	rs3129755	0.880339719962196	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28383224	rs3129755	0.880339719962196	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28383224	rs3129755	0.880339719962196	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28383224	rs3129755	0.880339719962196	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28383224	rs3129755	0.880339719962196	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28383224	rs3129755	0.880339719962196	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28383224	rs3129755	0.880339719962196	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28383224	rs3129755	0.880339719962196	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28383224	rs3129755	0.880339719962196	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28383224	rs3129755	0.880339719962196	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28383224	rs3129755	0.880339719962196	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28383224	rs3129755	0.880339719962196	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28383224	rs3129755	0.880339719962196	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28383224	rs3129755	0.880339719962196	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28383224	rs3129755	0.880339719962196	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28383224	rs3129755	0.880339719962196	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28383224	rs3129755	0.880339719962196	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28383224	rs28383241	0.828675574816387	Alanine aminotransferase levels	9e-40	34594039
rs28383224	rs686250	0.709801159004665	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28383224	rs502803	0.687048264514627	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28383224	rs28752509	0.683804583293427	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28383224	rs28752509	0.683804583293427	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28383224	rs28752510	0.683804583293427	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28383224	rs28752510	0.683804583293427	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28383224	rs28752510	0.683804583293427	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28383224	rs28752510	0.683804583293427	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28383224	rs28752510	0.683804583293427	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28383224	rs28752510	0.683804583293427	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28383224	rs28752510	0.683804583293427	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28383224	rs28752510	0.683804583293427	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28383224	rs28752510	0.683804583293427	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28383224	rs28752510	0.683804583293427	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28383224	rs28752510	0.683804583293427	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28383224	rs28752510	0.683804583293427	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28383224	rs28752510	0.683804583293427	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28383224	rs28752510	0.683804583293427	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28383224	rs28752510	0.683804583293427	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28383224	rs28752510	0.683804583293427	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28383224	rs28752510	0.683804583293427	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28383224	rs28752510	0.683804583293427	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28383224	rs28752510	0.683804583293427	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28383224	rs28752510	0.683804583293427	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28383224	rs28752510	0.683804583293427	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28383224	rs28752510	0.683804583293427	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28383224	rs13191975	0.683804583293427	A body shape index	4e-12	34021172
rs28383224	rs5021727	0.679571415029623	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs28383224	rs5021727	0.679571415029623	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs28383224	rs5021727	0.679571415029623	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs28383224	rs5021727	0.679571415029623	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs28383224	rs5021727	0.679571415029623	Metabolic syndrome	2e-08	31589552
rs28383224	rs9271215	0.620088628559981	Gynecologic disease (multivariate analysis)	2e-08	31488892
rs28383230	rs28383224	0.992815700820935	Neuromyelitis optica	6e-12	29769526
rs28383230	rs28383224	0.992815700820935	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28383230	rs28383224	0.992815700820935	Waist-hip index	1e-19	34021172
rs28383230	rs28383224	0.992815700820935	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28383230	rs28383224	0.992815700820935	Waist circumference adjusted for body mass index	9e-10	34021172
rs28383230	rs28383233	0.992815700820935	Free cholesterol levels in very large HDL	4e-14	35213538
rs28383230	rs28383221	0.984070159501048	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28383230	rs28383223	0.982495575323437	Alanine aminotransferase levels	7e-38	33547301
rs28383230	rs685244	0.978563450325181	Complement C4 levels	2e-12	36168886
rs28383230	rs3129755	0.87955097582268	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28383230	rs3129755	0.87955097582268	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28383230	rs3129755	0.87955097582268	Triglyceride levels in very large VLDL	3e-21	35213538
rs28383230	rs3129755	0.87955097582268	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28383230	rs3129755	0.87955097582268	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28383230	rs3129755	0.87955097582268	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28383230	rs3129755	0.87955097582268	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28383230	rs3129755	0.87955097582268	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28383230	rs3129755	0.87955097582268	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28383230	rs3129755	0.87955097582268	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28383230	rs3129755	0.87955097582268	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28383230	rs3129755	0.87955097582268	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28383230	rs3129755	0.87955097582268	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28383230	rs3129755	0.87955097582268	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28383230	rs3129755	0.87955097582268	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28383230	rs3129755	0.87955097582268	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28383230	rs3129755	0.87955097582268	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28383230	rs3129755	0.87955097582268	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28383230	rs3129755	0.87955097582268	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28383230	rs3129755	0.87955097582268	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28383230	rs3129755	0.87955097582268	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28383230	rs3129755	0.87955097582268	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28383230	rs3129755	0.87955097582268	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28383230	rs3129755	0.87955097582268	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28383230	rs3129755	0.87955097582268	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28383230	rs28383241	0.83226131589686	Alanine aminotransferase levels	9e-40	34594039
rs28383230	rs686250	0.71059699961516	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28383230	rs502803	0.686265161794761	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28383230	rs28752509	0.683023056954773	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28383230	rs28752509	0.683023056954773	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28383230	rs28752510	0.683023056954773	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28383230	rs28752510	0.683023056954773	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28383230	rs28752510	0.683023056954773	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28383230	rs28752510	0.683023056954773	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28383230	rs28752510	0.683023056954773	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28383230	rs28752510	0.683023056954773	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28383230	rs28752510	0.683023056954773	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28383230	rs28752510	0.683023056954773	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28383230	rs28752510	0.683023056954773	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28383230	rs28752510	0.683023056954773	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28383230	rs28752510	0.683023056954773	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28383230	rs28752510	0.683023056954773	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28383230	rs28752510	0.683023056954773	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28383230	rs28752510	0.683023056954773	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28383230	rs28752510	0.683023056954773	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28383230	rs28752510	0.683023056954773	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28383230	rs28752510	0.683023056954773	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28383230	rs28752510	0.683023056954773	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28383230	rs28752510	0.683023056954773	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28383230	rs28752510	0.683023056954773	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28383230	rs28752510	0.683023056954773	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28383230	rs28752510	0.683023056954773	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28383230	rs13191975	0.683023056954773	A body shape index	4e-12	34021172
rs28383230	rs5021727	0.678795158307076	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs28383230	rs5021727	0.678795158307076	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs28383230	rs5021727	0.678795158307076	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs28383230	rs5021727	0.678795158307076	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs28383230	rs5021727	0.678795158307076	Metabolic syndrome	2e-08	31589552
rs28383230	rs9271215	0.618127405934058	Gynecologic disease (multivariate analysis)	2e-08	31488892
rs28383233	rs28383233	1	Free cholesterol levels in very large HDL	4e-14	35213538
rs28383233	rs28383224	0.990426367256839	Neuromyelitis optica	6e-12	29769526
rs28383233	rs28383224	0.990426367256839	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28383233	rs28383224	0.990426367256839	Waist-hip index	1e-19	34021172
rs28383233	rs28383224	0.990426367256839	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28383233	rs28383224	0.990426367256839	Waist circumference adjusted for body mass index	9e-10	34021172
rs28383233	rs28383221	0.981690933482194	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28383233	rs28383223	0.980121663662968	Alanine aminotransferase levels	7e-38	33547301
rs28383233	rs685244	0.977777291254527	Complement C4 levels	2e-12	36168886
rs28383233	rs3129755	0.877341263125979	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28383233	rs3129755	0.877341263125979	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28383233	rs3129755	0.877341263125979	Triglyceride levels in very large VLDL	3e-21	35213538
rs28383233	rs3129755	0.877341263125979	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28383233	rs3129755	0.877341263125979	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28383233	rs3129755	0.877341263125979	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28383233	rs3129755	0.877341263125979	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28383233	rs3129755	0.877341263125979	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28383233	rs3129755	0.877341263125979	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28383233	rs3129755	0.877341263125979	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28383233	rs3129755	0.877341263125979	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28383233	rs3129755	0.877341263125979	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28383233	rs3129755	0.877341263125979	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28383233	rs3129755	0.877341263125979	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28383233	rs3129755	0.877341263125979	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28383233	rs3129755	0.877341263125979	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28383233	rs3129755	0.877341263125979	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28383233	rs3129755	0.877341263125979	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28383233	rs3129755	0.877341263125979	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28383233	rs3129755	0.877341263125979	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28383233	rs3129755	0.877341263125979	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28383233	rs3129755	0.877341263125979	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28383233	rs3129755	0.877341263125979	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28383233	rs3129755	0.877341263125979	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28383233	rs3129755	0.877341263125979	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28383233	rs28383241	0.830134251082346	Alanine aminotransferase levels	9e-40	34594039
rs28383233	rs686250	0.709801159004665	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28383233	rs502803	0.685709410449289	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28383233	rs28752509	0.682468815413249	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28383233	rs28752509	0.682468815413249	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28383233	rs28752510	0.682468815413249	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28383233	rs28752510	0.682468815413249	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28383233	rs28752510	0.682468815413249	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28383233	rs28752510	0.682468815413249	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28383233	rs28752510	0.682468815413249	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28383233	rs28752510	0.682468815413249	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28383233	rs28752510	0.682468815413249	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28383233	rs28752510	0.682468815413249	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28383233	rs28752510	0.682468815413249	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28383233	rs28752510	0.682468815413249	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28383233	rs28752510	0.682468815413249	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28383233	rs28752510	0.682468815413249	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28383233	rs28752510	0.682468815413249	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28383233	rs28752510	0.682468815413249	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28383233	rs28752510	0.682468815413249	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28383233	rs28752510	0.682468815413249	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28383233	rs28752510	0.682468815413249	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28383233	rs28752510	0.682468815413249	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28383233	rs28752510	0.682468815413249	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28383233	rs28752510	0.682468815413249	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28383233	rs28752510	0.682468815413249	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28383233	rs28752510	0.682468815413249	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28383233	rs13191975	0.682468815413249	A body shape index	4e-12	34021172
rs28383233	rs5021727	0.678240495933316	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs28383233	rs5021727	0.678240495933316	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs28383233	rs5021727	0.678240495933316	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs28383233	rs5021727	0.678240495933316	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs28383233	rs5021727	0.678240495933316	Metabolic syndrome	2e-08	31589552
rs28383233	rs9271215	0.617564294922136	Gynecologic disease (multivariate analysis)	2e-08	31488892
rs28383233	rs34077986	0.603442444352668	A body shape index	5e-11	34021172
rs28383236	rs28383233	0.975520921404973	Free cholesterol levels in very large HDL	4e-14	35213538
rs28383236	rs28383224	0.966068159895462	Neuromyelitis optica	6e-12	29769526
rs28383236	rs28383224	0.966068159895462	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28383236	rs28383224	0.966068159895462	Waist-hip index	1e-19	34021172
rs28383236	rs28383224	0.966068159895462	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28383236	rs28383224	0.966068159895462	Waist circumference adjusted for body mass index	9e-10	34021172
rs28383236	rs28383221	0.959018174212273	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28383236	rs28383223	0.957373123979323	Alanine aminotransferase levels	7e-38	33547301
rs28383236	rs685244	0.956553526470812	Complement C4 levels	2e-12	36168886
rs28383236	rs3129755	0.853232459063442	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28383236	rs3129755	0.853232459063442	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28383236	rs3129755	0.853232459063442	Triglyceride levels in very large VLDL	3e-21	35213538
rs28383236	rs3129755	0.853232459063442	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28383236	rs3129755	0.853232459063442	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28383236	rs3129755	0.853232459063442	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28383236	rs3129755	0.853232459063442	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28383236	rs3129755	0.853232459063442	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28383236	rs3129755	0.853232459063442	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28383236	rs3129755	0.853232459063442	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28383236	rs3129755	0.853232459063442	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28383236	rs3129755	0.853232459063442	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28383236	rs3129755	0.853232459063442	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28383236	rs3129755	0.853232459063442	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28383236	rs3129755	0.853232459063442	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28383236	rs3129755	0.853232459063442	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28383236	rs3129755	0.853232459063442	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28383236	rs3129755	0.853232459063442	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28383236	rs3129755	0.853232459063442	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28383236	rs3129755	0.853232459063442	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28383236	rs3129755	0.853232459063442	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28383236	rs3129755	0.853232459063442	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28383236	rs3129755	0.853232459063442	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28383236	rs3129755	0.853232459063442	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28383236	rs3129755	0.853232459063442	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28383236	rs28383241	0.813067646756019	Alanine aminotransferase levels	9e-40	34594039
rs28383236	rs686250	0.692197890936151	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28383236	rs502803	0.663086536873089	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28383236	rs28752509	0.659891377836942	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28383236	rs28752509	0.659891377836942	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28383236	rs28752510	0.659891377836942	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28383236	rs28752510	0.659891377836942	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28383236	rs28752510	0.659891377836942	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28383236	rs28752510	0.659891377836942	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28383236	rs28752510	0.659891377836942	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28383236	rs28752510	0.659891377836942	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28383236	rs28752510	0.659891377836942	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28383236	rs28752510	0.659891377836942	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28383236	rs28752510	0.659891377836942	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28383236	rs28752510	0.659891377836942	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28383236	rs28752510	0.659891377836942	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28383236	rs28752510	0.659891377836942	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28383236	rs28752510	0.659891377836942	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28383236	rs28752510	0.659891377836942	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28383236	rs28752510	0.659891377836942	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28383236	rs28752510	0.659891377836942	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28383236	rs28752510	0.659891377836942	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28383236	rs28752510	0.659891377836942	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28383236	rs28752510	0.659891377836942	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28383236	rs28752510	0.659891377836942	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28383236	rs28752510	0.659891377836942	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28383236	rs28752510	0.659891377836942	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28383236	rs13191975	0.659891377836942	A body shape index	4e-12	34021172
rs28383236	rs5021727	0.65581939115255	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs28383236	rs5021727	0.65581939115255	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs28383236	rs5021727	0.65581939115255	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs28383236	rs5021727	0.65581939115255	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs28383236	rs5021727	0.65581939115255	Metabolic syndrome	2e-08	31589552
rs28383236	rs34077986	0.618584831049623	A body shape index	5e-11	34021172
rs28383236	rs9271215	0.602424174828279	Gynecologic disease (multivariate analysis)	2e-08	31488892
rs28383242	rs28383241	0.982501932013463	Alanine aminotransferase levels	9e-40	34594039
rs28383242	rs28383233	0.815554354980574	Free cholesterol levels in very large HDL	4e-14	35213538
rs28383242	rs28383224	0.814107724873888	Neuromyelitis optica	6e-12	29769526
rs28383242	rs28383224	0.814107724873888	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28383242	rs28383224	0.814107724873888	Waist-hip index	1e-19	34021172
rs28383242	rs28383224	0.814107724873888	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28383242	rs28383224	0.814107724873888	Waist circumference adjusted for body mass index	9e-10	34021172
rs28383242	rs28383221	0.809123450039817	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28383242	rs28383223	0.807006939143161	Alanine aminotransferase levels	7e-38	33547301
rs28383242	rs685244	0.802956087100234	Complement C4 levels	2e-12	36168886
rs28383242	rs3129755	0.756221736160275	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28383242	rs3129755	0.756221736160275	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28383242	rs3129755	0.756221736160275	Triglyceride levels in very large VLDL	3e-21	35213538
rs28383242	rs3129755	0.756221736160275	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28383242	rs3129755	0.756221736160275	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28383242	rs3129755	0.756221736160275	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28383242	rs3129755	0.756221736160275	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28383242	rs3129755	0.756221736160275	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28383242	rs3129755	0.756221736160275	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28383242	rs3129755	0.756221736160275	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28383242	rs3129755	0.756221736160275	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28383242	rs3129755	0.756221736160275	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28383242	rs3129755	0.756221736160275	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28383242	rs3129755	0.756221736160275	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28383242	rs3129755	0.756221736160275	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28383242	rs3129755	0.756221736160275	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28383242	rs3129755	0.756221736160275	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28383242	rs3129755	0.756221736160275	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28383242	rs3129755	0.756221736160275	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28383242	rs3129755	0.756221736160275	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28383242	rs3129755	0.756221736160275	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28383242	rs3129755	0.756221736160275	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28383242	rs3129755	0.756221736160275	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28383242	rs3129755	0.756221736160275	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28383242	rs3129755	0.756221736160275	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28383242	rs28752509	0.60459576221266	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28383242	rs28752509	0.60459576221266	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28383242	rs28752510	0.60459576221266	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28383242	rs28752510	0.60459576221266	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28383242	rs28752510	0.60459576221266	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28383242	rs28752510	0.60459576221266	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28383242	rs28752510	0.60459576221266	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28383242	rs28752510	0.60459576221266	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28383242	rs28752510	0.60459576221266	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28383242	rs28752510	0.60459576221266	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28383242	rs28752510	0.60459576221266	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28383242	rs28752510	0.60459576221266	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28383242	rs28752510	0.60459576221266	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28383242	rs28752510	0.60459576221266	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28383242	rs28752510	0.60459576221266	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28383242	rs28752510	0.60459576221266	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28383242	rs28752510	0.60459576221266	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28383242	rs28752510	0.60459576221266	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28383242	rs28752510	0.60459576221266	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28383242	rs28752510	0.60459576221266	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28383242	rs28752510	0.60459576221266	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28383242	rs28752510	0.60459576221266	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28383242	rs28752510	0.60459576221266	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28383242	rs28752510	0.60459576221266	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28383242	rs502803	0.603937853670109	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28383242	rs13191975	0.603337304377752	A body shape index	4e-12	34021172
rs28383314	rs28383314	1	Eosinophil counts	6e-199	32888493
rs28383314	rs28383314	1	Eosinophil counts	2e-194	32888493
rs28383314	rs28383314	1	Eosinophil percentage of white cells	7e-27	27863252
rs28383314	rs28383314	1	Intraocular pressure	3e-09	29785010
rs28383314	rs28383314	1	Nasal polyps	5e-08	30643255
rs28383314	rs28383314	1	A body shape index	1e-20	34021172
rs28383314	rs28383314	1	Triglyceride levels in medium HDL	2e-21	35213538
rs28383314	rs28383314	1	Triglycerides to total lipids ratio in large HDL	7e-12	35213538
rs28383314	rs28383314	1	Phospholipids to total lipids ratio in medium LDL	1e-11	35213538
rs28383314	rs28383314	1	Triglyceride levels in large HDL	4e-08	35213538
rs28383314	rs28383314	1	Total lipid levels in small HDL	5e-22	35213538
rs28383314	rs28383314	1	Phospholipids to total lipids ratio in small LDL	9e-13	35213538
rs28383314	rs28383314	1	Total fatty acid levels	4e-25	35213538
rs28383314	rs28383314	1	Total triglycerides levels	8e-24	35213538
rs28383314	rs28383314	1	Phospholipid levels in small HDL	8e-22	35213538
rs28383314	rs28383314	1	Free cholesterol to total lipids ratio in small LDL	6e-17	35213538
rs28383314	rs28383314	1	Saturated fatty acid levels	4e-20	35213538
rs28383314	rs28383314	1	Triglyceride levels in small VLDL	2e-27	35213538
rs28383314	rs28383314	1	Triglyceride levels in small HDL	4e-24	35213538
rs28383314	rs28383314	1	Triglyceride levels in VLDL	9e-23	35213538
rs28383314	rs28383314	1	Triglyceride levels in very large HDL	6e-13	35213538
rs28383314	rs28383314	1	Triglycerides to total lipids ratio in very large HDL	8e-21	35213538
rs28383314	rs28383314	1	Triglyceride levels in very small VLDL	2e-25	35213538
rs28383314	rs28383314	1	Eosinophil counts	1e-60	27863252
rs28383314	rs28383314	1	Sum eosinophil basophil counts	9e-64	27863252
rs28383314	rs28383314	1	Eosinophil counts	9e-101	34594039
rs28383314	rs28383314	1	Triglyceride levels	4e-49	32154731
rs28383314	rs28383314	1	Triglyceride levels	4e-76	32203549
rs28383314	rs28383314	1	Eosinophil counts	6e-103	34469753
rs28383314	rs28383314	1	Waist-to-hip ratio adjusted for BMI	2e-12	34021172
rs28383314	rs28383314	1	Waist-hip index	4e-11	34021172
rs28383314	rs28383314	1	Triglyceride levels in HDL	8e-21	35213538
rs28383314	rs28383314	1	Hip circumference adjusted for BMI	5e-19	34021172
rs28383314	rs28383314	1	Triglycerides	4e-59	34594039
rs28383314	rs28383314	1	Eosinophil counts	1e-49	35935937
rs28383314	rs28383314	1	Primary sclerosing cholangitis (MTAG)	2e-75	36828809
rs28383314	rs28383314	1	Total triglycerides levels (UKB data field 23407)	2e-20	36764567
rs28383314	rs28383314	1	Triglycerides in very small VLDL (UKB data field 23522)	7e-20	36764567
rs28383314	rs28383314	1	Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)	6e-17	36764567
rs28383314	rs28383314	1	Triglycerides in medium HDL (UKB data field 23571)	7e-16	36764567
rs28383314	rs28383314	1	Monounsaturated fatty acids levels (UKB data field 23447)	4e-18	36764567
rs28383314	rs28383314	1	Saturated fatty acids levels (UKB data field 23448)	4e-15	36764567
rs28383314	rs28383314	1	Triglycerides in small LDL (UKB data field 23550)	4e-19	36764567
rs28383314	rs28383314	1	Phospholipids to total lipids in medium LDL percentage (UKB data field 23619)	8e-11	36764567
rs28383314	rs28383314	1	Triglycerides in HDL (UKB data field 23410)	9e-16	36764567
rs28383314	rs28383314	1	Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)	1e-16	36764567
rs28383314	rs28383314	1	Total fatty acids levels (UKB data field 23442)	9e-17	36764567
rs28383314	rs28383314	1	Triglycerides in small HDL (UKB data field 23578)	1e-20	36764567
rs28383314	rs686250	0.811458139973306	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28383314	rs9271573	0.661107709221404	Sjögren's syndrome	3e-42	28076899
rs28383314	rs9271573	0.661107709221404	Sjögren's syndrome	3e-34	28076899
rs28383314	rs9271573	0.661107709221404	Triglyceride levels in large LDL	6e-20	35213538
rs28383314	rs9271573	0.661107709221404	Triglyceride levels in LDL	1e-21	35213538
rs28383314	rs9271573	0.661107709221404	Triglyceride levels in medium LDL	6e-23	35213538
rs28383314	rs9271573	0.661107709221404	Triglyceride levels in small LDL	9e-24	35213538
rs28383314	rs9271573	0.661107709221404	Monounsaturated fatty acid levels	4e-25	35213538
rs28383314	rs9271573	0.661107709221404	Ratio of polyunsaturated fatty acids to monounsaturated fatty acids	1e-12	35213538
rs28383314	rs9271573	0.661107709221404	Membranous nephropathy	3e-154	32231244
rs28383314	rs9271573	0.661107709221404	Membranous nephropathy	2e-60	32231244
rs28383314	rs9271573	0.661107709221404	Membranous nephropathy	4e-102	32231244
rs28383314	rs9271573	0.661107709221404	High-density lipoprotein levels (MTAG)	4e-12	37669986
rs28383314	rs9271573	0.661107709221404	Triglyceride levels (MTAG)	5e-08	37669986
rs28383314	rs9271573	0.661107709221404	Triglycerides in medium LDL (UKB data field 23543)	7e-18	36764567
rs28383314	rs9271573	0.661107709221404	Triglycerides in LDL (UKB data field 23409)	5e-17	36764567
rs28383314	rs9271573	0.661107709221404	Triglycerides in large LDL (UKB data field 23536)	1e-15	36764567
rs28383314	rs9271593	0.655185798675452	Hip circumference adjusted for BMI	4e-12	34021172
rs28383314	rs3129770	0.653514623217446	Sjögren's syndrome	1e-96	24097067
rs28383314	rs3129770	0.653514623217446	Ribonuclease T2 levels	4e-28	34648354
rs28398813	rs9469857	0.996776778921405	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs28398813	rs2764208	0.995972777577403	Systemic lupus erythematosus	7e-06	24871463
rs28398813	rs9462030	0.982341944636037	Red cell distribution width	5e-25	32888493
rs28398813	rs9469899	0.965886102309356	Prostate cancer (advanced)	2e-06	29892016
rs28398813	rs9469899	0.965886102309356	Prostate cancer	5e-09	29892016
rs28398813	rs9469899	0.965886102309356	Prostate cancer	8e-11	33398198
rs28398813	rs9469899	0.965886102309356	Hand grip strength	3e-15	29691431
rs28398813	rs9469899	0.965886102309356	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs28398813	rs9469899	0.965886102309356	Graves' disease	4e-10	34594039
rs28398813	rs9469899	0.965886102309356	Coronary artery disease	1e-11	36474045
rs28398813	rs9469899	0.965886102309356	Predicted visceral adipose tissue	2e-20	31501611
rs28398813	rs9469899	0.965886102309356	Medication use (thyroid preparations)	2e-09	31015401
rs28398813	rs9469899	0.965886102309356	Medication use (thyroid preparations)	3e-10	34594039
rs28398813	rs9469872	0.96054887345204	HDL cholesterol levels	3e-11	36333282
rs28398813	rs9296128	0.945681992424858	Hip circumference adjusted for BMI	4e-13	34021172
rs28398813	rs11755393	0.935272594959748	Body mass index	3e-26	29273807
rs28398813	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-12	33493351
rs28398813	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-06	33493351
rs28398813	rs11755393	0.935272594959748	Systemic lupus erythematosus	1e-07	33493351
rs28398813	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-08	19838195
rs28398813	rs11755393	0.935272594959748	Body mass index	4e-55	36581621
rs28398813	rs9366863	0.931525188678084	Adult body size	9e-33	32376654
rs28398813	rs9366863	0.931525188678084	Body mass index	2e-44	30595370
rs28398813	rs6941110	0.923705176714688	Sex hormone-binding globulin levels	5e-27	36653534
rs28398813	rs2744944	0.904579222323617	Hypothyroidism	3e-10	34594039
rs28398813	rs2744944	0.904579222323617	High density lipoprotein cholesterol levels	3e-86	34887591
rs28398813	rs2744944	0.904579222323617	Multi-trait sex score	7e-22	37277458
rs28398813	rs2814949	0.89561287838885	Essential hypertension (time to event)	9e-09	32589924
rs28398813	rs2263329	0.882234019129751	HDL cholesterol	6e-35	34594039
rs28398813	rs2263329	0.882234019129751	HDL cholesterol levels	8e-43	32203549
rs28398813	rs2263329	0.882234019129751	High density lipoprotein cholesterol levels	2e-52	34887591
rs28398813	rs111868030	0.861138045850585	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs28398813	rs9368830	0.823175715403171	HDL cholesterol	4e-21	30275531
rs28398813	rs9368828	0.813764410103364	Body mass index	1e-34	34594039
rs28398813	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs28398813	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs28398813	rs2744973	0.792134506553775	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs28398813	rs2744973	0.792134506553775	Multi-trait sex score	6e-20	37277458
rs28398813	rs6912327	0.779895917756941	Fasting insulin	5e-06	33402679
rs28398813	rs6912327	0.779895917756941	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs28398813	rs112283401	0.757749108732694	Red cell distribution width	4e-27	30595370
rs28398813	rs9689160	0.620633913312638	Lung function (forced vital capacity)	3e-14	36914875
rs28398813	rs9462027	0.600261280766747	Systemic lupus erythematosus	1e-10	27399966
rs28398813	rs9462027	0.600261280766747	Systemic lupus erythematosus	8e-09	26502338
rs28398813	rs9462027	0.600261280766747	Systemic lupus erythematosus	2e-08	28714469
rs28398813	rs9462027	0.600261280766747	Alzheimer's disease or gastroesophageal reflux disease	2e-06	35851147
rs28411984	rs13379492	0.904843345134877	Lung function (FEV1/FVC)	6e-08	30595370
rs28411984	rs8034216	0.860265940586927	C-reactive protein levels	2e-10	31900758
rs28411984	rs17271340	0.819778676147229	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs28411984	rs17271305	0.797211618061923	Two-hour glucose challenge	1e-07	20081857
rs28411984	rs35967150	0.7923581980418	C-reactive protein levels (MTAG)	1e-08	36376304
rs28411984	rs11634163	0.783644068499346	C-reactive protein	2e-08	34594039
rs28411984	rs11634163	0.783644068499346	Two-hour glucose	3e-14	34059833
rs28411984	rs189400382	0.780747536407479	C-reactive protein levels	1e-08	35459240
rs28411984	rs28373613	0.65298910417594	Height (standard GWA)	8e-12	37106081
rs28414777	rs13232536	0.794424056050063	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs28414777	rs12539962	0.752144723507567	Colorectal cancer	3e-08	36539618
rs28414777	rs4355658	0.738842084932984	Height	3e-13	36224396
rs28416443	rs6723298	0.676119774841744	Smoking initiation	2e-12	36477530
rs28416443	rs2194492	0.657305532011391	Educational attainment	9e-09	35361970
rs28416443	rs13020443	0.647375460304393	Type 2 diabetes	3e-11	32541925
rs2842600	rs2842611	0.978420510842203	High density lipoprotein cholesterol levels	5e-09	34887591
rs2842600	rs1173416	0.828972992042111	Height	2e-59	36224396
rs2842600	rs9450288	0.801471737861465	Height	2e-10	36224396
rs2842605	rs2842611	0.920988692360663	High density lipoprotein cholesterol levels	5e-09	34887591
rs2842605	rs1173416	0.909389527499461	Height	2e-59	36224396
rs2842605	rs9450288	0.87652571828692	Height	2e-10	36224396
rs2842610	rs2842611	0.925753600292981	High density lipoprotein cholesterol levels	5e-09	34887591
rs2842610	rs1173416	0.907800356557104	Height	2e-59	36224396
rs2842610	rs9450288	0.881138819652381	Height	2e-10	36224396
rs2842611	rs2842611	1	High density lipoprotein cholesterol levels	5e-09	34887591
rs2842611	rs1173416	0.842223499580091	Height	2e-59	36224396
rs2842611	rs9450288	0.81781875828014	Height	2e-10	36224396
rs2842615	rs2842611	0.925098660948292	High density lipoprotein cholesterol levels	5e-09	34887591
rs2842615	rs1173416	0.90853675612433	Height	2e-59	36224396
rs2842615	rs9450288	0.881971830473139	Height	2e-10	36224396
rs2842617	rs2475792	0.773740305513454	Neutrophil count	1e-08	34594039
rs2842617	rs4593336	0.756296349024888	Body mass index	2e-08	36581621
rs2842617	rs2475787	0.732831715660344	Neutrophil count	1e-11	32888493
rs2842617	rs10806334	0.676904394136095	White blood cell count	4e-12	32888493
rs2842617	rs10806334	0.676904394136095	Neutrophil count	9e-12	32888493
rs2842617	rs10806334	0.676904394136095	White blood cell count	3e-13	32888493
rs28445286	rs11580836	0.941288522184552	Body mass index	2e-09	36581621
rs28445286	rs10465746	0.923510160283991	Obesity-related traits	8e-06	23251661
rs28513564	rs8034216	0.924349353624621	C-reactive protein levels	2e-10	31900758
rs28513564	rs17271340	0.882964090964545	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs28513564	rs17271305	0.855129979903529	Two-hour glucose challenge	1e-07	20081857
rs28513564	rs35967150	0.851896518915718	C-reactive protein levels (MTAG)	1e-08	36376304
rs28513564	rs13379492	0.840507456857819	Lung function (FEV1/FVC)	6e-08	30595370
rs28513564	rs11634163	0.840393766494328	C-reactive protein	2e-08	34594039
rs28513564	rs11634163	0.840393766494328	Two-hour glucose	3e-14	34059833
rs28513564	rs189400382	0.83725993829822	C-reactive protein levels	1e-08	35459240
rs28513564	rs28373613	0.660147918781539	Height (standard GWA)	8e-12	37106081
rs28531938	rs2868708	0.900130597958264	Lymphocyte count	3e-11	34469753
rs28531938	rs2868708	0.900130597958264	White blood cell count	1e-09	30595370
rs28531938	rs6831339	0.896909375892415	High density lipoprotein cholesterol levels	9e-09	34887591
rs28531938	rs6535419	0.845783644568149	Pulse pressure	6e-10	30578418
rs28531938	rs116142917	0.823247924475397	Lymphocyte count	7e-18	32888494
rs28531938	rs13111599	0.818844832642191	HDL cholesterol levels	3e-09	32203549
rs28531938	rs13111599	0.818844832642191	Apolipoprotein A1 levels	4e-08	32203549
rs28531938	rs6823199	0.810801961587948	Pulse pressure	4e-14	30224653
rs28531938	rs4302451	0.747138562339231	Eosinophil counts	2e-09	30595370
rs28531938	rs11099563	0.741928545346119	High density lipoprotein cholesterol levels	3e-11	34887591
rs28531938	rs28528763	0.722756547647288	White blood cell count	7e-12	32888494
rs28531938	rs35895091	0.697355839510802	Cardiovascular disease	1e-07	30595370
rs28531938	rs7662402	0.637635761692803	Brain morphology (MOSTest)	3e-08	35164939
rs28538500	rs4924522	0.832868148990848	Lung function (forced vital capacity)	5e-18	36914875
rs28538500	rs9796	0.752179601687292	Menopause (age at onset)	1e-10	26414677
rs28567085	rs11580836	0.940411358196851	Body mass index	2e-09	36581621
rs28567085	rs10465746	0.920923662930719	Obesity-related traits	8e-06	23251661
rs2859491	rs1363907	0.996444361394507	Crohn's disease	4e-16	26192919
rs2859491	rs1363907	0.996444361394507	Ulcerative colitis	4e-06	26192919
rs2859491	rs1363907	0.996444361394507	Inflammatory bowel disease	5e-15	26192919
rs2859491	rs1363907	0.996444361394507	Inflammatory bowel disease	6e-13	23128233
rs2859491	rs1363907	0.996444361394507	Inflammatory bowel disease	1e-10	28067908
rs2859491	rs1363907	0.996444361394507	Crohn's disease	1e-14	28067908
rs2859491	rs2549794	0.994668192117369	Crohn's disease	1e-10	21102463
rs2859491	rs2549794	0.994668192117369	Systolic blood pressure	1e-07	33230300
rs2859491	rs2549794	0.994668192117369	Diastolic blood pressure	1e-15	33230300
rs2859491	rs2549794	0.994668192117369	Diastolic blood pressure	2e-12	33230300
rs2859491	rs2549794	0.994668192117369	Systolic blood pressure	4e-10	33230300
rs2859491	rs2617439	0.941188032600576	Neutrophil count	8e-11	32888494
rs2859491	rs716848	0.934140488298518	Neutrophil percentage of white cells	2e-09	32888494
rs2859491	rs38029	0.929204620400647	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2859491	rs2548532	0.893549053800425	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2859491	rs27660	0.777538629741749	Coronary artery disease	3e-08	35915156
rs2859491	rs1423357	0.764618581415287	General cognitive ability	9e-06	29844566
rs2859491	rs2432142	0.749751329254888	Neutrophil count	2e-14	32888493
rs2859491	rs2432142	0.749751329254888	White blood cell count	1e-11	32888493
rs2859491	rs38033	0.747879341021451	Blood protein levels	0	30072576
rs2859491	rs27293	0.739378792587365	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2859491	rs27293	0.739378792587365	Diastolic blood pressure	3e-11	35762941
rs2859491	rs7705093	0.729916732034797	Birdshot chorioretinopathy	2e-09	24957906
rs2859491	rs4869313	0.719764569481716	Pediatric autoimmune diseases	9e-08	26301688
rs2859491	rs2927608	0.719468102660556	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2859491	rs2927608	0.719468102660556	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2859491	rs2927608	0.719468102660556	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2859491	rs2910686	0.717103477036417	Neutrophil count	4e-14	32888493
rs2859491	rs2910686	0.717103477036417	Psoriasis	2e-08	23143594
rs2859491	rs2910686	0.717103477036417	Ankylosing spondylitis	5e-17	23749187
rs2859491	rs2910686	0.717103477036417	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2859491	rs1559359	0.651421821858804	Diastolic blood pressure	7e-10	34594039
rs2859491	rs1974871	0.646485295817104	Granulysin levels	5e-13	34648354
rs2859491	rs2549797	0.633881150231873	Systolic blood pressure	7e-07	33230300
rs2859491	rs2549797	0.633881150231873	Diastolic blood pressure	1e-14	33230300
rs2859491	rs2549797	0.633881150231873	Diastolic blood pressure	3e-11	33230300
rs2859491	rs2549797	0.633881150231873	Systolic blood pressure	4e-09	33230300
rs2859491	rs2549782	0.632853515974189	Systolic blood pressure	6e-07	33230300
rs2859491	rs2549782	0.632853515974189	Diastolic blood pressure	1e-14	33230300
rs2859491	rs2549782	0.632853515974189	Diastolic blood pressure	3e-11	33230300
rs2859491	rs2549782	0.632853515974189	Systolic blood pressure	5e-09	33230300
rs2859491	rs1056893	0.632340387305134	Systolic blood pressure	1e-06	33230300
rs2859491	rs1056893	0.632340387305134	Diastolic blood pressure	7e-15	33230300
rs2859491	rs1056893	0.632340387305134	Diastolic blood pressure	2e-11	33230300
rs2859491	rs1056893	0.632340387305134	Systolic blood pressure	7e-09	33230300
rs28609180	rs835341	0.739320940288228	Ascending aorta distensibility (MTAG)	8e-09	35922433
rs28609180	rs946155	0.669174428487918	Glutathione peroxidase 7 levels (GPX7.8345.27.3)	2e-61	29875488
rs28633936	rs12729558	0.940136194504634	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs28633936	rs10922531	0.908036565021028	Serum metabolite levels	2e-69	33031748
rs28633936	rs7532151	0.873241260091959	Imidazole lactate levels	9e-12	33177712
rs28633936	rs10801690	0.846292891189904	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs28633936	rs7530513	0.827035693878862	Height	8e-11	35831902
rs28633936	rs7530513	0.827035693878862	Imidazole lactate levels	8e-166	36635386
rs28633936	rs12144640	0.827035693878862	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs28633936	rs9787133	0.815981585592354	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs28633936	rs1409152	0.815551652789864	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs28633936	rs1409152	0.815551652789864	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs28633936	rs10801699	0.813451922026514	X-23639 levels	2e-10	36635386
rs28633936	rs12120164	0.779578631820917	Metabolite peak levels (QI2146)	1e-26	35995766
rs28633936	rs2765527	0.765150595961786	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs28633936	rs2810876	0.655100707556212	Imidazole lactate levels	2e-122	35347128
rs28633936	rs10801696	0.653781112363765	Imidazole lactate levels	3e-195	35050183
rs28633936	rs1206228892	0.653255789052006	Imidazole lactate levels	5e-186	35050183
rs28655592	rs6831339	1	High density lipoprotein cholesterol levels	9e-09	34887591
rs28655592	rs2868708	0.996670557915363	Lymphocyte count	3e-11	34469753
rs28655592	rs2868708	0.996670557915363	White blood cell count	1e-09	30595370
rs28655592	rs116142917	0.915238572755671	Lymphocyte count	7e-18	32888494
rs28655592	rs6823199	0.895826456408638	Pulse pressure	4e-14	30224653
rs28655592	rs13111599	0.889525024994145	HDL cholesterol levels	3e-09	32203549
rs28655592	rs13111599	0.889525024994145	Apolipoprotein A1 levels	4e-08	32203549
rs28655592	rs6535419	0.874229728768598	Pulse pressure	6e-10	30578418
rs28655592	rs11099563	0.745403496805278	High density lipoprotein cholesterol levels	3e-11	34887591
rs28655592	rs4302451	0.743813141137588	Eosinophil counts	2e-09	30595370
rs28655592	rs28528763	0.718855802699315	White blood cell count	7e-12	32888494
rs28655592	rs35895091	0.704383113526372	Cardiovascular disease	1e-07	30595370
rs28655592	rs7662402	0.62120795462088	Brain morphology (MOSTest)	3e-08	35164939
rs28660208	rs7211615	0.656186492763318	Heel bone mineral density	1e-08	30595370
rs28660208	rs61586425	0.65088889025074	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs28660208	rs8077038	0.633352696675265	Educational attainment (MTAG)	4e-10	30038396
rs28660208	rs8077038	0.633352696675265	Highest math class taken (MTAG)	5e-16	30038396
rs28660208	rs12949956	0.626207566304659	Self-reported math ability	3e-11	30038396
rs28660208	rs12949956	0.626207566304659	Self-reported math ability (MTAG)	3e-14	30038396
rs28660208	rs12949956	0.626207566304659	Highest math class taken	8e-12	30038396
rs28675115	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs28675115	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs28675115	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs28675115	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs28675115	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs28675115	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs28675115	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs28675115	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs28675115	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs28675115	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs28675115	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs28675115	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs28675115	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs28675115	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs28675115	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs28675115	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs28675115	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs28675115	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs28675115	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs28675115	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs28675115	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs28675115	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs28675115	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs28675115	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs28675115	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs28675115	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs28675115	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs28675115	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs28675115	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs28675115	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs28675115	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs28675115	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs28675115	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs28675115	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs28675115	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs28675115	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs28675115	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs28675115	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs28675115	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs28675115	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs28675115	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs28675115	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs2868708	rs2868708	1	Lymphocyte count	3e-11	34469753
rs2868708	rs2868708	1	White blood cell count	1e-09	30595370
rs2868708	rs6831339	0.996670557915363	High density lipoprotein cholesterol levels	9e-09	34887591
rs2868708	rs116142917	0.918539067927247	Lymphocyte count	7e-18	32888494
rs2868708	rs6823199	0.897337821704765	Pulse pressure	4e-14	30224653
rs2868708	rs13111599	0.891008615084399	HDL cholesterol levels	3e-09	32203549
rs2868708	rs13111599	0.891008615084399	Apolipoprotein A1 levels	4e-08	32203549
rs2868708	rs6535419	0.877270437329696	Pulse pressure	6e-10	30578418
rs2868708	rs4302451	0.746708567449369	Eosinophil counts	2e-09	30595370
rs2868708	rs11099563	0.742666974535489	High density lipoprotein cholesterol levels	3e-11	34887591
rs2868708	rs28528763	0.720187719316555	White blood cell count	7e-12	32888494
rs2868708	rs35895091	0.70700538420665	Cardiovascular disease	1e-07	30595370
rs2868708	rs7662402	0.618740097592053	Brain morphology (MOSTest)	3e-08	35164939
rs28752514	rs28383224	0.978628044338302	Neuromyelitis optica	6e-12	29769526
rs28752514	rs28383224	0.978628044338302	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28752514	rs28383224	0.978628044338302	Waist-hip index	1e-19	34021172
rs28752514	rs28383224	0.978628044338302	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28752514	rs28383224	0.978628044338302	Waist circumference adjusted for body mass index	9e-10	34021172
rs28752514	rs28383223	0.973043770405714	Alanine aminotransferase levels	7e-38	33547301
rs28752514	rs28383233	0.97073464203536	Free cholesterol levels in very large HDL	4e-14	35213538
rs28752514	rs28383221	0.966807555069372	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28752514	rs685244	0.95809346969303	Complement C4 levels	2e-12	36168886
rs28752514	rs3129755	0.86527111692498	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28752514	rs3129755	0.86527111692498	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28752514	rs3129755	0.86527111692498	Triglyceride levels in very large VLDL	3e-21	35213538
rs28752514	rs3129755	0.86527111692498	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28752514	rs3129755	0.86527111692498	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28752514	rs3129755	0.86527111692498	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28752514	rs3129755	0.86527111692498	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28752514	rs3129755	0.86527111692498	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28752514	rs3129755	0.86527111692498	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28752514	rs3129755	0.86527111692498	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28752514	rs3129755	0.86527111692498	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28752514	rs3129755	0.86527111692498	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28752514	rs3129755	0.86527111692498	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28752514	rs3129755	0.86527111692498	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28752514	rs3129755	0.86527111692498	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28752514	rs3129755	0.86527111692498	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28752514	rs3129755	0.86527111692498	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28752514	rs3129755	0.86527111692498	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28752514	rs3129755	0.86527111692498	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28752514	rs3129755	0.86527111692498	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28752514	rs3129755	0.86527111692498	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28752514	rs3129755	0.86527111692498	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28752514	rs3129755	0.86527111692498	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28752514	rs3129755	0.86527111692498	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28752514	rs3129755	0.86527111692498	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28752514	rs28383241	0.819186098191807	Alanine aminotransferase levels	9e-40	34594039
rs28752514	rs686250	0.696927406588357	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28752514	rs502803	0.668994858444034	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28752514	rs28752509	0.667106300586535	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28752514	rs28752509	0.667106300586535	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28752514	rs28752510	0.667106300586535	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28752514	rs28752510	0.667106300586535	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28752514	rs28752510	0.667106300586535	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28752514	rs28752510	0.667106300586535	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28752514	rs28752510	0.667106300586535	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28752514	rs28752510	0.667106300586535	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28752514	rs28752510	0.667106300586535	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28752514	rs28752510	0.667106300586535	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28752514	rs28752510	0.667106300586535	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28752514	rs28752510	0.667106300586535	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28752514	rs28752510	0.667106300586535	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28752514	rs28752510	0.667106300586535	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28752514	rs28752510	0.667106300586535	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28752514	rs28752510	0.667106300586535	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28752514	rs28752510	0.667106300586535	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28752514	rs28752510	0.667106300586535	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28752514	rs28752510	0.667106300586535	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28752514	rs28752510	0.667106300586535	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28752514	rs28752510	0.667106300586535	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28752514	rs28752510	0.667106300586535	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28752514	rs28752510	0.667106300586535	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28752514	rs28752510	0.667106300586535	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28752514	rs13191975	0.665787269552611	A body shape index	4e-12	34021172
rs28752514	rs5021727	0.661679664943678	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs28752514	rs5021727	0.661679664943678	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs28752514	rs5021727	0.661679664943678	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs28752514	rs5021727	0.661679664943678	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs28752514	rs5021727	0.661679664943678	Metabolic syndrome	2e-08	31589552
rs28752514	rs9271215	0.607782953664952	Gynecologic disease (multivariate analysis)	2e-08	31488892
rs28752515	rs28383224	0.964666854884246	Neuromyelitis optica	6e-12	29769526
rs28752515	rs28383224	0.964666854884246	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28752515	rs28383224	0.964666854884246	Waist-hip index	1e-19	34021172
rs28752515	rs28383224	0.964666854884246	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28752515	rs28383224	0.964666854884246	Waist circumference adjusted for body mass index	9e-10	34021172
rs28752515	rs28383233	0.95683102211543	Free cholesterol levels in very large HDL	4e-14	35213538
rs28752515	rs28383223	0.955939599321619	Alanine aminotransferase levels	7e-38	33547301
rs28752515	rs28383221	0.952938737285235	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28752515	rs685244	0.942632764925252	Complement C4 levels	2e-12	36168886
rs28752515	rs3129755	0.851371381691059	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28752515	rs3129755	0.851371381691059	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28752515	rs3129755	0.851371381691059	Triglyceride levels in very large VLDL	3e-21	35213538
rs28752515	rs3129755	0.851371381691059	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28752515	rs3129755	0.851371381691059	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28752515	rs3129755	0.851371381691059	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28752515	rs3129755	0.851371381691059	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28752515	rs3129755	0.851371381691059	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28752515	rs3129755	0.851371381691059	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28752515	rs3129755	0.851371381691059	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28752515	rs3129755	0.851371381691059	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28752515	rs3129755	0.851371381691059	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28752515	rs3129755	0.851371381691059	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28752515	rs3129755	0.851371381691059	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28752515	rs3129755	0.851371381691059	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28752515	rs3129755	0.851371381691059	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28752515	rs3129755	0.851371381691059	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28752515	rs3129755	0.851371381691059	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28752515	rs3129755	0.851371381691059	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28752515	rs3129755	0.851371381691059	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28752515	rs3129755	0.851371381691059	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28752515	rs3129755	0.851371381691059	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28752515	rs3129755	0.851371381691059	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28752515	rs3129755	0.851371381691059	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28752515	rs3129755	0.851371381691059	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28752515	rs28383241	0.812330938251109	Alanine aminotransferase levels	9e-40	34594039
rs28752515	rs686250	0.685738606524374	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28752515	rs502803	0.655086959942605	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28752515	rs28752509	0.653212345978212	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28752515	rs28752509	0.653212345978212	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28752515	rs28752510	0.653212345978212	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28752515	rs28752510	0.653212345978212	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28752515	rs28752510	0.653212345978212	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28752515	rs28752510	0.653212345978212	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28752515	rs28752510	0.653212345978212	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28752515	rs28752510	0.653212345978212	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28752515	rs28752510	0.653212345978212	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28752515	rs28752510	0.653212345978212	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28752515	rs28752510	0.653212345978212	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28752515	rs28752510	0.653212345978212	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28752515	rs28752510	0.653212345978212	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28752515	rs28752510	0.653212345978212	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28752515	rs28752510	0.653212345978212	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28752515	rs28752510	0.653212345978212	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28752515	rs28752510	0.653212345978212	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28752515	rs28752510	0.653212345978212	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28752515	rs28752510	0.653212345978212	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28752515	rs28752510	0.653212345978212	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28752515	rs28752510	0.653212345978212	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28752515	rs28752510	0.653212345978212	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28752515	rs28752510	0.653212345978212	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28752515	rs28752510	0.653212345978212	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28752515	rs13191975	0.651907288195185	A body shape index	4e-12	34021172
rs28752515	rs5021727	0.647897230432137	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs28752515	rs5021727	0.647897230432137	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs28752515	rs5021727	0.647897230432137	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs28752515	rs5021727	0.647897230432137	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs28752515	rs5021727	0.647897230432137	Metabolic syndrome	2e-08	31589552
rs28752516	rs3129755	0.93323744502627	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28752516	rs3129755	0.93323744502627	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28752516	rs3129755	0.93323744502627	Triglyceride levels in very large VLDL	3e-21	35213538
rs28752516	rs3129755	0.93323744502627	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28752516	rs3129755	0.93323744502627	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28752516	rs3129755	0.93323744502627	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28752516	rs3129755	0.93323744502627	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28752516	rs3129755	0.93323744502627	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28752516	rs3129755	0.93323744502627	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28752516	rs3129755	0.93323744502627	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28752516	rs3129755	0.93323744502627	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28752516	rs3129755	0.93323744502627	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28752516	rs3129755	0.93323744502627	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28752516	rs3129755	0.93323744502627	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28752516	rs3129755	0.93323744502627	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28752516	rs3129755	0.93323744502627	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28752516	rs3129755	0.93323744502627	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28752516	rs3129755	0.93323744502627	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28752516	rs3129755	0.93323744502627	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28752516	rs3129755	0.93323744502627	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28752516	rs3129755	0.93323744502627	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28752516	rs3129755	0.93323744502627	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28752516	rs3129755	0.93323744502627	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28752516	rs3129755	0.93323744502627	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28752516	rs3129755	0.93323744502627	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28752516	rs28383224	0.884890276365053	Neuromyelitis optica	6e-12	29769526
rs28752516	rs28383224	0.884890276365053	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28752516	rs28383224	0.884890276365053	Waist-hip index	1e-19	34021172
rs28752516	rs28383224	0.884890276365053	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28752516	rs28383224	0.884890276365053	Waist circumference adjusted for body mass index	9e-10	34021172
rs28752516	rs28383223	0.877743599679156	Alanine aminotransferase levels	7e-38	33547301
rs28752516	rs28383233	0.877382756610046	Free cholesterol levels in very large HDL	4e-14	35213538
rs28752516	rs28383221	0.873685400939959	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28752516	rs685244	0.863282841780639	Complement C4 levels	2e-12	36168886
rs28752516	rs28383241	0.776987996156806	Alanine aminotransferase levels	9e-40	34594039
rs28752516	rs502803	0.718797016988586	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28752516	rs13191975	0.712707393479136	A body shape index	4e-12	34021172
rs28752516	rs5021727	0.711466390310881	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs28752516	rs5021727	0.711466390310881	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs28752516	rs5021727	0.711466390310881	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs28752516	rs5021727	0.711466390310881	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs28752516	rs5021727	0.711466390310881	Metabolic syndrome	2e-08	31589552
rs28752516	rs28752509	0.709981027884508	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28752516	rs28752509	0.709981027884508	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28752516	rs28752510	0.709981027884508	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28752516	rs28752510	0.709981027884508	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28752516	rs28752510	0.709981027884508	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28752516	rs28752510	0.709981027884508	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28752516	rs28752510	0.709981027884508	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28752516	rs28752510	0.709981027884508	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28752516	rs28752510	0.709981027884508	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28752516	rs28752510	0.709981027884508	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28752516	rs28752510	0.709981027884508	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28752516	rs28752510	0.709981027884508	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28752516	rs28752510	0.709981027884508	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28752516	rs28752510	0.709981027884508	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28752516	rs28752510	0.709981027884508	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28752516	rs28752510	0.709981027884508	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28752516	rs28752510	0.709981027884508	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28752516	rs28752510	0.709981027884508	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28752516	rs28752510	0.709981027884508	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28752516	rs28752510	0.709981027884508	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28752516	rs28752510	0.709981027884508	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28752516	rs28752510	0.709981027884508	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28752516	rs28752510	0.709981027884508	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28752516	rs28752510	0.709981027884508	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28752516	rs686250	0.628313401746601	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28752527	rs28383224	0.988835238679774	Neuromyelitis optica	6e-12	29769526
rs28752527	rs28383224	0.988835238679774	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs28752527	rs28383224	0.988835238679774	Waist-hip index	1e-19	34021172
rs28752527	rs28383224	0.988835238679774	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs28752527	rs28383224	0.988835238679774	Waist circumference adjusted for body mass index	9e-10	34021172
rs28752527	rs28383233	0.988835238679774	Free cholesterol levels in very large HDL	4e-14	35213538
rs28752527	rs28383221	0.980106821454377	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs28752527	rs685244	0.979359238854954	Complement C4 levels	2e-12	36168886
rs28752527	rs28383223	0.978538993164836	Alanine aminotransferase levels	7e-38	33547301
rs28752527	rs3129755	0.874347921410212	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs28752527	rs3129755	0.874347921410212	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs28752527	rs3129755	0.874347921410212	Triglyceride levels in very large VLDL	3e-21	35213538
rs28752527	rs3129755	0.874347921410212	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs28752527	rs3129755	0.874347921410212	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs28752527	rs3129755	0.874347921410212	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs28752527	rs3129755	0.874347921410212	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs28752527	rs3129755	0.874347921410212	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs28752527	rs3129755	0.874347921410212	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs28752527	rs3129755	0.874347921410212	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs28752527	rs3129755	0.874347921410212	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs28752527	rs3129755	0.874347921410212	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs28752527	rs3129755	0.874347921410212	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs28752527	rs3129755	0.874347921410212	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs28752527	rs3129755	0.874347921410212	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs28752527	rs3129755	0.874347921410212	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs28752527	rs3129755	0.874347921410212	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs28752527	rs3129755	0.874347921410212	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs28752527	rs3129755	0.874347921410212	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs28752527	rs3129755	0.874347921410212	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs28752527	rs3129755	0.874347921410212	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs28752527	rs3129755	0.874347921410212	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs28752527	rs3129755	0.874347921410212	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs28752527	rs3129755	0.874347921410212	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs28752527	rs3129755	0.874347921410212	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs28752527	rs28383241	0.828675574816387	Alanine aminotransferase levels	9e-40	34594039
rs28752527	rs686250	0.712545016601559	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs28752527	rs502803	0.683035619682909	Basal cell carcinoma (MTAG)	2e-95	36496446
rs28752527	rs28752509	0.679801197484253	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs28752527	rs28752509	0.679801197484253	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs28752527	rs28752510	0.679801197484253	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs28752527	rs28752510	0.679801197484253	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs28752527	rs28752510	0.679801197484253	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs28752527	rs28752510	0.679801197484253	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs28752527	rs28752510	0.679801197484253	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs28752527	rs28752510	0.679801197484253	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs28752527	rs28752510	0.679801197484253	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs28752527	rs28752510	0.679801197484253	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs28752527	rs28752510	0.679801197484253	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs28752527	rs28752510	0.679801197484253	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs28752527	rs28752510	0.679801197484253	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs28752527	rs28752510	0.679801197484253	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs28752527	rs28752510	0.679801197484253	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs28752527	rs28752510	0.679801197484253	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs28752527	rs28752510	0.679801197484253	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs28752527	rs28752510	0.679801197484253	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs28752527	rs28752510	0.679801197484253	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs28752527	rs28752510	0.679801197484253	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs28752527	rs28752510	0.679801197484253	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs28752527	rs28752510	0.679801197484253	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs28752527	rs28752510	0.679801197484253	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs28752527	rs28752510	0.679801197484253	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs28752527	rs13191975	0.679801197484253	A body shape index	4e-12	34021172
rs28752527	rs5021727	0.675582571418403	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs28752527	rs5021727	0.675582571418403	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs28752527	rs5021727	0.675582571418403	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs28752527	rs5021727	0.675582571418403	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs28752527	rs5021727	0.675582571418403	Metabolic syndrome	2e-08	31589552
rs28752527	rs9271215	0.616304058854604	Gynecologic disease (multivariate analysis)	2e-08	31488892
rs2880435	rs14314	0.98039997512537	Macular thickness	3e-19	30535121
rs2880435	rs14314	0.98039997512537	Vertex-wise sulcal depth	7e-17	34910505
rs2880435	rs14314	0.98039997512537	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs2880435	rs14314	0.98039997512537	Left hippocampal volume (body)	7e-15	37337106
rs2880435	rs14314	0.98039997512537	Left subiculum volume (body)	1e-14	37337106
rs2880435	rs2095375	0.974225324729676	Serum metabolite levels	1e-20	33031748
rs2880435	rs2095375	0.974225324729676	Serum metabolite levels	1e-20	33031748
rs2880435	rs9383843	0.973335361828827	Migraine	1e-09	35115687
rs2880435	rs55763431	0.96979066672448	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs2880435	rs9689694	0.968029822119269	Right hippocampal volume (head)	6e-11	37337106
rs2880435	rs9689694	0.968029822119269	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs2880435	rs9689694	0.968029822119269	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs2880435	rs9689694	0.968029822119269	Left hippocampal volume (head)	6e-12	37337106
rs2880435	rs10872645	0.966259547533452	Blood protein levels	2e-86	30072576
rs2880435	rs10872653	0.961874305151698	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs2880435	rs9688867	0.961857545418188	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs2880435	rs9688867	0.961857545418188	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs2880435	rs9688809	0.961857545418188	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs2880435	rs34337297	0.958339173052065	Serum levels of protein LRP11	3e-161	35078996
rs2880435	rs9322193	0.922803658393954	Lung cancer	1e-07	27393504
rs2880435	rs4039600	0.880129807168563	Adenine levels	1e-11	35347128
rs2880435	rs1934534	0.633325019745606	Pain (pleiotropy)	2e-08	37844115
rs2880435	rs1934534	0.633325019745606	Pain (pleiotropy)	2e-06	37844115
rs2880435	rs4380763	0.632802523740271	Subcortical volume (min-P)	1e-11	32665545
rs2880435	rs11155671	0.622416005374288	Testicular germ cell tumor	2e-09	28604728
rs2880435	rs80147756	0.608774095661436	HippSubfield lh volume subiculum-head	3e-10	33875891
rs2880435	rs4421206	0.602474258355294	Brain morphology (min-P)	4e-11	32665545
rs2880436	rs2342764	0.763956347992358	Cortical thickness	1e-08	34560273
rs2880436	rs56103941	0.720251564360755	Right presubiculum volume (head)	4e-08	37337106
rs2880436	rs12526675	0.717916539967706	Brain morphology (MOSTest)	7e-22	32665545
rs2880436	rs12523793	0.683723099163022	Subcortical volume (MOSTest)	4e-24	32665545
rs2880436	rs12523793	0.683723099163022	C-reactive protein levels	3e-08	35459240
rs2880436	rs12523793	0.683723099163022	C-reactive protein levels (MTAG)	2e-08	36376304
rs2880436	rs11155662	0.675980782189302	Vertex-wise cortical thickness	2e-09	34910505
rs2880436	rs9322225	0.600445456989699	Low-density lipoprotein receptor-related protein 11 levels	0	34648354
rs2880488	rs6705511	0.666349249876025	Self-reported math ability	4e-09	30038396
rs2880488	rs6705511	0.666349249876025	Self-reported math ability (MTAG)	3e-10	30038396
rs2880488	rs34276187	0.661844703861133	Highest math class taken (MTAG)	2e-08	30038396
rs2883678	rs1138888	0.822599432292578	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs2883678	rs1138888	0.822599432292578	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs2883678	rs4802157	0.801782346754245	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs2883678	rs2355433	0.678848487521298	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs2883678	rs2355433	0.678848487521298	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs2883678	rs2355433	0.678848487521298	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs28837073	rs2162062	0.925646462423096	Height	2e-13	35831902
rs28837073	rs1436958	0.872439135094438	IgG glycosylation	9e-06	23382691
rs28837073	rs933807	0.870077904956995	Fat-free mass	6e-06	30593698
rs28837073	rs933807	0.870077904956995	Fat-free mass	2e-07	30593698
rs28837073	rs933807	0.870077904956995	Fat-free mass	8e-11	30593698
rs28837073	rs7178540	0.757761729751113	Height	1e-31	36224396
rs28837073	rs11635977	0.740512278804514	Height	2e-25	36224396
rs28837073	rs72749770	0.728476023196131	Low density lipoprotein cholesterol levels	9e-10	32493714
rs28837073	rs72749770	0.728476023196131	Apolipoprotein B levels	2e-09	32203549
rs28837073	rs7162536	0.727181087311902	Height	4e-29	34594039
rs28837073	rs7178424	0.718153283404938	Height	6e-09	20881960
rs28837073	rs7178424	0.718153283404938	Height	6e-13	35831902
rs28837073	rs7178424	0.718153283404938	Height	3e-251	36224396
rs28837073	rs17271431	0.714082843474882	Height	2e-11	34594039
rs28837073	rs17205463	0.713410612058301	Serum levels of protein IGF1	8e-08	27329260
rs28837073	rs17205463	0.713410612058301	Appendicular lean mass	4e-43	33097823
rs28837073	rs17205463	0.713410612058301	Height	2e-35	30595370
rs28837073	rs731820	0.701709354253985	Height	2e-13	31562340
rs28837073	rs731820	0.701709354253985	Height	2e-12	35831902
rs2884111	rs2357176	0.997281888669287	Nevus count or cutaneous melanoma	4e-08	30429480
rs2884111	rs10873172	0.831964999977028	Cutaneous melanoma or hair colour	6e-27	32341527
rs2884111	rs10873172	0.831964999977028	Nevus count or cutaneous melanoma	6e-13	32341527
rs2884111	rs10873172	0.831964999977028	Blond vs. brown/black hair color	6e-15	30531825
rs2884111	rs10873172	0.831964999977028	Cutaneous malignant melanoma	6e-08	32341527
rs2884111	rs10873172	0.831964999977028	Hair color	4e-17	30595370
rs2884111	rs1255908	0.774174131445432	PR interval	8e-14	32439900
rs2884111	rs1255908	0.774174131445432	PR interval	6e-14	32439900
rs2884111	rs12878653	0.715358817893223	Youthful appearance (self-reported)	3e-14	32339537
rs289032	rs10214160	0.843935667721367	Diastolic blood pressure	1e-10	35762941
rs289032	rs433750	0.837973240404751	Essential hypertension (time to event)	3e-08	32589924
rs289032	rs34314	0.666861555738157	Diastolic blood pressure	1e-08	30487518
rs289032	rs158359	0.648186834196748	Diastolic blood pressure	1e-09	34594039
rs289032	rs1020992	0.618333550484723	Mean arterial pressure	4e-08	30487518
rs289033	rs10214160	0.842319841968407	Diastolic blood pressure	1e-10	35762941
rs289033	rs433750	0.839739864433236	Essential hypertension (time to event)	3e-08	32589924
rs289033	rs34314	0.664871449814814	Diastolic blood pressure	1e-08	30487518
rs289033	rs158359	0.649478545309643	Diastolic blood pressure	1e-09	34594039
rs289033	rs1020992	0.61970217438718	Mean arterial pressure	4e-08	30487518
rs289034	rs10214160	0.839581340473667	Diastolic blood pressure	1e-10	35762941
rs289034	rs433750	0.838715981283703	Essential hypertension (time to event)	3e-08	32589924
rs289034	rs34314	0.664887509697959	Diastolic blood pressure	1e-08	30487518
rs289034	rs158359	0.64625570930427	Diastolic blood pressure	1e-09	34594039
rs289034	rs1020992	0.616287489949862	Mean arterial pressure	4e-08	30487518
rs2893083	rs12729558	0.946629856232447	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs2893083	rs10922531	0.907727213068194	Serum metabolite levels	2e-69	33031748
rs2893083	rs7532151	0.873540641403732	Imidazole lactate levels	9e-12	33177712
rs2893083	rs10801690	0.8466190337152	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs2893083	rs7530513	0.832490474096479	Height	8e-11	35831902
rs2893083	rs7530513	0.832490474096479	Imidazole lactate levels	8e-166	36635386
rs2893083	rs12144640	0.832490474096479	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs2893083	rs1409152	0.82093903832024	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs2893083	rs1409152	0.82093903832024	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs2893083	rs10801699	0.818825450655192	X-23639 levels	2e-10	36635386
rs2893083	rs9787133	0.816349472582233	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs2893083	rs12120164	0.784732721190749	Metabolite peak levels (QI2146)	1e-26	35995766
rs2893083	rs2765527	0.765782873842068	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs2893083	rs2810876	0.656028937379871	Imidazole lactate levels	2e-122	35347128
rs2893083	rs10801696	0.654718193699616	Imidazole lactate levels	3e-195	35050183
rs2893083	rs1206228892	0.654194307795355	Imidazole lactate levels	5e-186	35050183
rs2898566	rs4729660	0.83835260776909	Blood protein levels	1e-06	30072576
rs2898566	rs2227631	0.675450154562307	Plasminogen activator inhibitor type 1 levels (PAI-1)	3e-24	22990020
rs2898566	rs2227631	0.675450154562307	Ischemic stroke or plasminogen activator inhibitor 1 levels (pleiotropy)	2e-14	35285134
rs2898566	rs2227631	0.675450154562307	Fibrinogen levels or plasminogen activator inhibitor 1 levels (pleiotropy)	2e-14	35285134
rs2898566	rs2227631	0.675450154562307	Venous thromboembolism or plasminogen activator inhibitor 1 levels (pleiotropy)	5e-14	35285134
rs2898566	rs2227631	0.675450154562307	Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy)	1e-13	35285134
rs2898566	rs2227631	0.675450154562307	Plasminogen activator inhibitor 1 levels	6e-15	34648354
rs289924	rs6705511	0.689059518281127	Self-reported math ability	4e-09	30038396
rs289924	rs6705511	0.689059518281127	Self-reported math ability (MTAG)	3e-10	30038396
rs289924	rs34276187	0.681061775888539	Highest math class taken (MTAG)	2e-08	30038396
rs2899677	rs1436958	0.98775460243063	IgG glycosylation	9e-06	23382691
rs2899677	rs2162062	0.811879264425288	Height	2e-13	35831902
rs2899677	rs933807	0.765602644745847	Fat-free mass	6e-06	30593698
rs2899677	rs933807	0.765602644745847	Fat-free mass	2e-07	30593698
rs2899677	rs933807	0.765602644745847	Fat-free mass	8e-11	30593698
rs2899677	rs7178540	0.676022917074713	Height	1e-31	36224396
rs2899677	rs11635977	0.659890351914031	Height	2e-25	36224396
rs2899677	rs72749770	0.649970670160335	Low density lipoprotein cholesterol levels	9e-10	32493714
rs2899677	rs72749770	0.649970670160335	Apolipoprotein B levels	2e-09	32203549
rs2899677	rs7162536	0.648712396753466	Height	4e-29	34594039
rs2899677	rs7178424	0.638575753104979	Height	6e-09	20881960
rs2899677	rs7178424	0.638575753104979	Height	6e-13	35831902
rs2899677	rs7178424	0.638575753104979	Height	3e-251	36224396
rs2899677	rs17271431	0.636098977548149	Height	2e-11	34594039
rs2899677	rs17205463	0.635440058009702	Serum levels of protein IGF1	8e-08	27329260
rs2899677	rs17205463	0.635440058009702	Appendicular lean mass	4e-43	33097823
rs2899677	rs17205463	0.635440058009702	Height	2e-35	30595370
rs2899677	rs731820	0.62476200161087	Height	2e-13	31562340
rs2899677	rs731820	0.62476200161087	Height	2e-12	35831902
rs2900823	rs1467510	0.930813780140554	Platelet distribution width	1e-14	32888494
rs2900823	rs12276109	0.788077610447065	Severe COVID-19 infection	6e-08	36662838
rs2910686	rs2910686	1	Neutrophil count	4e-14	32888493
rs2910686	rs2910686	1	Psoriasis	2e-08	23143594
rs2910686	rs2910686	1	Ankylosing spondylitis	5e-17	23749187
rs2910686	rs2910686	1	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2910686	rs2927608	0.99671888313561	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2910686	rs2927608	0.99671888313561	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2910686	rs2927608	0.99671888313561	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2910686	rs2549797	0.881773936609154	Systolic blood pressure	7e-07	33230300
rs2910686	rs2549797	0.881773936609154	Diastolic blood pressure	1e-14	33230300
rs2910686	rs2549797	0.881773936609154	Diastolic blood pressure	3e-11	33230300
rs2910686	rs2549797	0.881773936609154	Systolic blood pressure	4e-09	33230300
rs2910686	rs2549782	0.880345428468229	Systolic blood pressure	6e-07	33230300
rs2910686	rs2549782	0.880345428468229	Diastolic blood pressure	1e-14	33230300
rs2910686	rs2549782	0.880345428468229	Diastolic blood pressure	3e-11	33230300
rs2910686	rs2549782	0.880345428468229	Systolic blood pressure	5e-09	33230300
rs2910686	rs1056893	0.879632131419435	Systolic blood pressure	1e-06	33230300
rs2910686	rs1056893	0.879632131419435	Diastolic blood pressure	7e-15	33230300
rs2910686	rs1056893	0.879632131419435	Diastolic blood pressure	2e-11	33230300
rs2910686	rs1056893	0.879632131419435	Systolic blood pressure	7e-09	33230300
rs2910686	rs1423357	0.87043618777691	General cognitive ability	9e-06	29844566
rs2910686	rs2432142	0.854917381046533	Neutrophil count	2e-14	32888493
rs2910686	rs2432142	0.854917381046533	White blood cell count	1e-11	32888493
rs2910686	rs38033	0.849518575818066	Blood protein levels	0	30072576
rs2910686	rs27293	0.836648451311368	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2910686	rs27293	0.836648451311368	Diastolic blood pressure	3e-11	35762941
rs2910686	rs4869313	0.833536813521386	Pediatric autoimmune diseases	9e-08	26301688
rs2910686	rs7705093	0.829221731307697	Birdshot chorioretinopathy	2e-09	24957906
rs2910686	rs1559359	0.822080246447415	Diastolic blood pressure	7e-10	34594039
rs2910686	rs4869314	0.762591226401811	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2910686	rs4869314	0.762591226401811	Neutrophil count	1e-10	34594039
rs2910686	rs4869314	0.762591226401811	White blood cell count	2e-07	30595370
rs2910686	rs1974871	0.742481353718913	Granulysin levels	5e-13	34648354
rs2910686	rs1019503	0.728063149440856	Systolic blood pressure	2e-06	33230300
rs2910686	rs1019503	0.728063149440856	Diastolic blood pressure	2e-14	33230300
rs2910686	rs1019503	0.728063149440856	Diastolic blood pressure	4e-11	33230300
rs2910686	rs1019503	0.728063149440856	Systolic blood pressure	1e-08	33230300
rs2910686	rs1363907	0.720002086599683	Crohn's disease	4e-16	26192919
rs2910686	rs1363907	0.720002086599683	Ulcerative colitis	4e-06	26192919
rs2910686	rs1363907	0.720002086599683	Inflammatory bowel disease	5e-15	26192919
rs2910686	rs1363907	0.720002086599683	Inflammatory bowel disease	6e-13	23128233
rs2910686	rs1363907	0.720002086599683	Inflammatory bowel disease	1e-10	28067908
rs2910686	rs1363907	0.720002086599683	Crohn's disease	1e-14	28067908
rs2910686	rs2549794	0.715824837135211	Crohn's disease	1e-10	21102463
rs2910686	rs2549794	0.715824837135211	Systolic blood pressure	1e-07	33230300
rs2910686	rs2549794	0.715824837135211	Diastolic blood pressure	1e-15	33230300
rs2910686	rs2549794	0.715824837135211	Diastolic blood pressure	2e-12	33230300
rs2910686	rs2549794	0.715824837135211	Systolic blood pressure	4e-10	33230300
rs2910686	rs3096168	0.715183549824199	Aspartate aminotransferase levels	8e-12	33547301
rs2910686	rs2617439	0.681090691678914	Neutrophil count	8e-11	32888494
rs2910686	rs38029	0.669646319346924	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2910686	rs716848	0.666094310613863	Neutrophil percentage of white cells	2e-09	32888494
rs2910686	rs2548532	0.643030559643807	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2910687	rs2617439	0.97773138071496	Neutrophil count	8e-11	32888494
rs2910687	rs2549794	0.968203588800627	Crohn's disease	1e-10	21102463
rs2910687	rs2549794	0.968203588800627	Systolic blood pressure	1e-07	33230300
rs2910687	rs2549794	0.968203588800627	Diastolic blood pressure	1e-15	33230300
rs2910687	rs2549794	0.968203588800627	Diastolic blood pressure	2e-12	33230300
rs2910687	rs2549794	0.968203588800627	Systolic blood pressure	4e-10	33230300
rs2910687	rs38029	0.963801374842541	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2910687	rs1363907	0.962966751346425	Crohn's disease	4e-16	26192919
rs2910687	rs1363907	0.962966751346425	Ulcerative colitis	4e-06	26192919
rs2910687	rs1363907	0.962966751346425	Inflammatory bowel disease	5e-15	26192919
rs2910687	rs1363907	0.962966751346425	Inflammatory bowel disease	6e-13	23128233
rs2910687	rs1363907	0.962966751346425	Inflammatory bowel disease	1e-10	28067908
rs2910687	rs1363907	0.962966751346425	Crohn's disease	1e-14	28067908
rs2910687	rs716848	0.932657440642715	Neutrophil percentage of white cells	2e-09	32888494
rs2910687	rs2548532	0.869988245243669	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2910687	rs27660	0.799489704795009	Coronary artery disease	3e-08	35915156
rs2910687	rs1423357	0.798076645093431	General cognitive ability	9e-06	29844566
rs2910687	rs2432142	0.78284285007026	Neutrophil count	2e-14	32888493
rs2910687	rs2432142	0.78284285007026	White blood cell count	1e-11	32888493
rs2910687	rs38033	0.781046889117401	Blood protein levels	0	30072576
rs2910687	rs27293	0.770792696444794	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2910687	rs27293	0.770792696444794	Diastolic blood pressure	3e-11	35762941
rs2910687	rs7705093	0.762749275685636	Birdshot chorioretinopathy	2e-09	24957906
rs2910687	rs4869313	0.702344561213704	Pediatric autoimmune diseases	9e-08	26301688
rs2910687	rs2927608	0.701298427289399	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2910687	rs2927608	0.701298427289399	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2910687	rs2927608	0.701298427289399	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2910687	rs2910686	0.698989525386034	Neutrophil count	4e-14	32888493
rs2910687	rs2910686	0.698989525386034	Psoriasis	2e-08	23143594
rs2910687	rs2910686	0.698989525386034	Ankylosing spondylitis	5e-17	23749187
rs2910687	rs2910686	0.698989525386034	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2910687	rs1559359	0.639693267520071	Diastolic blood pressure	7e-10	34594039
rs2910687	rs1974871	0.630730772207583	Granulysin levels	5e-13	34648354
rs2910687	rs2549797	0.623051958540966	Systolic blood pressure	7e-07	33230300
rs2910687	rs2549797	0.623051958540966	Diastolic blood pressure	1e-14	33230300
rs2910687	rs2549797	0.623051958540966	Diastolic blood pressure	3e-11	33230300
rs2910687	rs2549797	0.623051958540966	Systolic blood pressure	4e-09	33230300
rs2910687	rs2549782	0.622043771888994	Systolic blood pressure	6e-07	33230300
rs2910687	rs2549782	0.622043771888994	Diastolic blood pressure	1e-14	33230300
rs2910687	rs2549782	0.622043771888994	Diastolic blood pressure	3e-11	33230300
rs2910687	rs2549782	0.622043771888994	Systolic blood pressure	5e-09	33230300
rs2910687	rs1056893	0.62154035399066	Systolic blood pressure	1e-06	33230300
rs2910687	rs1056893	0.62154035399066	Diastolic blood pressure	7e-15	33230300
rs2910687	rs1056893	0.62154035399066	Diastolic blood pressure	2e-11	33230300
rs2910687	rs1056893	0.62154035399066	Systolic blood pressure	7e-09	33230300
rs2910688	rs2549797	0.993545752342503	Systolic blood pressure	7e-07	33230300
rs2910688	rs2549797	0.993545752342503	Diastolic blood pressure	1e-14	33230300
rs2910688	rs2549797	0.993545752342503	Diastolic blood pressure	3e-11	33230300
rs2910688	rs2549797	0.993545752342503	Systolic blood pressure	4e-09	33230300
rs2910688	rs2549782	0.9919353335992	Systolic blood pressure	6e-07	33230300
rs2910688	rs2549782	0.9919353335992	Diastolic blood pressure	1e-14	33230300
rs2910688	rs2549782	0.9919353335992	Diastolic blood pressure	3e-11	33230300
rs2910688	rs2549782	0.9919353335992	Systolic blood pressure	5e-09	33230300
rs2910688	rs1056893	0.991131203120991	Systolic blood pressure	1e-06	33230300
rs2910688	rs1056893	0.991131203120991	Diastolic blood pressure	7e-15	33230300
rs2910688	rs1056893	0.991131203120991	Diastolic blood pressure	2e-11	33230300
rs2910688	rs1056893	0.991131203120991	Systolic blood pressure	7e-09	33230300
rs2910688	rs2910686	0.884937979207073	Neutrophil count	4e-14	32888493
rs2910688	rs2910686	0.884937979207073	Psoriasis	2e-08	23143594
rs2910688	rs2910686	0.884937979207073	Ankylosing spondylitis	5e-17	23749187
rs2910688	rs2910686	0.884937979207073	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2910688	rs2927608	0.882031464632627	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2910688	rs2927608	0.882031464632627	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2910688	rs2927608	0.882031464632627	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2910688	rs1019503	0.819951827332205	Systolic blood pressure	2e-06	33230300
rs2910688	rs1019503	0.819951827332205	Diastolic blood pressure	2e-14	33230300
rs2910688	rs1019503	0.819951827332205	Diastolic blood pressure	4e-11	33230300
rs2910688	rs1019503	0.819951827332205	Systolic blood pressure	1e-08	33230300
rs2910688	rs3096168	0.806865382918933	Aspartate aminotransferase levels	8e-12	33547301
rs2910688	rs4869314	0.798508179433808	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2910688	rs4869314	0.798508179433808	Neutrophil count	1e-10	34594039
rs2910688	rs4869314	0.798508179433808	White blood cell count	2e-07	30595370
rs2910688	rs1974871	0.777052056071746	Granulysin levels	5e-13	34648354
rs2910688	rs1423357	0.76965414555913	General cognitive ability	9e-06	29844566
rs2910688	rs2432142	0.755114716945787	Neutrophil count	2e-14	32888493
rs2910688	rs2432142	0.755114716945787	White blood cell count	1e-11	32888493
rs2910688	rs38033	0.749187061537408	Blood protein levels	0	30072576
rs2910688	rs27293	0.737304427501355	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2910688	rs27293	0.737304427501355	Diastolic blood pressure	3e-11	35762941
rs2910688	rs4869313	0.732930633637412	Pediatric autoimmune diseases	9e-08	26301688
rs2910688	rs7705093	0.729398589779121	Birdshot chorioretinopathy	2e-09	24957906
rs2910688	rs1559359	0.718104560658497	Diastolic blood pressure	7e-10	34594039
rs2910688	rs1363907	0.636907211037889	Crohn's disease	4e-16	26192919
rs2910688	rs1363907	0.636907211037889	Ulcerative colitis	4e-06	26192919
rs2910688	rs1363907	0.636907211037889	Inflammatory bowel disease	5e-15	26192919
rs2910688	rs1363907	0.636907211037889	Inflammatory bowel disease	6e-13	23128233
rs2910688	rs1363907	0.636907211037889	Inflammatory bowel disease	1e-10	28067908
rs2910688	rs1363907	0.636907211037889	Crohn's disease	1e-14	28067908
rs2910688	rs2549794	0.633070737486187	Crohn's disease	1e-10	21102463
rs2910688	rs2549794	0.633070737486187	Systolic blood pressure	1e-07	33230300
rs2910688	rs2549794	0.633070737486187	Diastolic blood pressure	1e-15	33230300
rs2910688	rs2549794	0.633070737486187	Diastolic blood pressure	2e-12	33230300
rs2910688	rs2549794	0.633070737486187	Systolic blood pressure	4e-10	33230300
rs2910688	rs716848	0.631622459595708	Neutrophil percentage of white cells	2e-09	32888494
rs2910688	rs2617439	0.60130715392172	Neutrophil count	8e-11	32888494
rs2910788	rs1423357	0.993285967825322	General cognitive ability	9e-06	29844566
rs2910788	rs2432142	0.976585000930904	Neutrophil count	2e-14	32888493
rs2910788	rs2432142	0.976585000930904	White blood cell count	1e-11	32888493
rs2910788	rs38033	0.971751761686874	Blood protein levels	0	30072576
rs2910788	rs27293	0.965938541743268	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2910788	rs27293	0.965938541743268	Diastolic blood pressure	3e-11	35762941
rs2910788	rs7705093	0.95896457761629	Birdshot chorioretinopathy	2e-09	24957906
rs2910788	rs2910686	0.868667461483031	Neutrophil count	4e-14	32888493
rs2910788	rs2910686	0.868667461483031	Psoriasis	2e-08	23143594
rs2910788	rs2910686	0.868667461483031	Ankylosing spondylitis	5e-17	23749187
rs2910788	rs2910686	0.868667461483031	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2910788	rs2927608	0.865352436770287	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2910788	rs2927608	0.865352436770287	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2910788	rs2927608	0.865352436770287	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2910788	rs2617439	0.776306321714294	Neutrophil count	8e-11	32888494
rs2910788	rs2549797	0.773394707940612	Systolic blood pressure	7e-07	33230300
rs2910788	rs2549797	0.773394707940612	Diastolic blood pressure	1e-14	33230300
rs2910788	rs2549797	0.773394707940612	Diastolic blood pressure	3e-11	33230300
rs2910788	rs2549797	0.773394707940612	Systolic blood pressure	4e-09	33230300
rs2910788	rs2549782	0.772136236630038	Systolic blood pressure	6e-07	33230300
rs2910788	rs2549782	0.772136236630038	Diastolic blood pressure	1e-14	33230300
rs2910788	rs2549782	0.772136236630038	Diastolic blood pressure	3e-11	33230300
rs2910788	rs2549782	0.772136236630038	Systolic blood pressure	5e-09	33230300
rs2910788	rs1056893	0.771507844098997	Systolic blood pressure	1e-06	33230300
rs2910788	rs1056893	0.771507844098997	Diastolic blood pressure	7e-15	33230300
rs2910788	rs1056893	0.771507844098997	Diastolic blood pressure	2e-11	33230300
rs2910788	rs1056893	0.771507844098997	Systolic blood pressure	7e-09	33230300
rs2910788	rs2549794	0.766812769771518	Crohn's disease	1e-10	21102463
rs2910788	rs2549794	0.766812769771518	Systolic blood pressure	1e-07	33230300
rs2910788	rs2549794	0.766812769771518	Diastolic blood pressure	1e-15	33230300
rs2910788	rs2549794	0.766812769771518	Diastolic blood pressure	2e-12	33230300
rs2910788	rs2549794	0.766812769771518	Systolic blood pressure	4e-10	33230300
rs2910788	rs38029	0.76459041781779	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2910788	rs1363907	0.762177181350136	Crohn's disease	4e-16	26192919
rs2910788	rs1363907	0.762177181350136	Ulcerative colitis	4e-06	26192919
rs2910788	rs1363907	0.762177181350136	Inflammatory bowel disease	5e-15	26192919
rs2910788	rs1363907	0.762177181350136	Inflammatory bowel disease	6e-13	23128233
rs2910788	rs1363907	0.762177181350136	Inflammatory bowel disease	1e-10	28067908
rs2910788	rs1363907	0.762177181350136	Crohn's disease	1e-14	28067908
rs2910788	rs716848	0.733810324689119	Neutrophil percentage of white cells	2e-09	32888494
rs2910788	rs4869313	0.722132986758308	Pediatric autoimmune diseases	9e-08	26301688
rs2910788	rs1559359	0.715924175309518	Diastolic blood pressure	7e-10	34594039
rs2910788	rs2548532	0.689025410859739	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2910788	rs4869314	0.668944411273792	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2910788	rs4869314	0.668944411273792	Neutrophil count	1e-10	34594039
rs2910788	rs4869314	0.668944411273792	White blood cell count	2e-07	30595370
rs2910788	rs1974871	0.642434251553665	Granulysin levels	5e-13	34648354
rs2910788	rs1019503	0.638255285167473	Systolic blood pressure	2e-06	33230300
rs2910788	rs1019503	0.638255285167473	Diastolic blood pressure	2e-14	33230300
rs2910788	rs1019503	0.638255285167473	Diastolic blood pressure	4e-11	33230300
rs2910788	rs1019503	0.638255285167473	Systolic blood pressure	1e-08	33230300
rs2910788	rs27660	0.635275987184695	Coronary artery disease	3e-08	35915156
rs2910788	rs3096168	0.63083498337377	Aspartate aminotransferase levels	8e-12	33547301
rs2910789	rs1423357	0.990782165983573	General cognitive ability	9e-06	29844566
rs2910789	rs2432142	0.97909240113781	Neutrophil count	2e-14	32888493
rs2910789	rs2432142	0.97909240113781	White blood cell count	1e-11	32888493
rs2910789	rs38033	0.974221194924239	Blood protein levels	0	30072576
rs2910789	rs27293	0.963456842940968	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2910789	rs27293	0.963456842940968	Diastolic blood pressure	3e-11	35762941
rs2910789	rs7705093	0.956470262714641	Birdshot chorioretinopathy	2e-09	24957906
rs2910789	rs2910686	0.866241295324916	Neutrophil count	4e-14	32888493
rs2910789	rs2910686	0.866241295324916	Psoriasis	2e-08	23143594
rs2910789	rs2910686	0.866241295324916	Ankylosing spondylitis	5e-17	23749187
rs2910789	rs2910686	0.866241295324916	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2910789	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2910789	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2910789	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2910789	rs2617439	0.778918998998163	Neutrophil count	8e-11	32888494
rs2910789	rs2549797	0.771019548090089	Systolic blood pressure	7e-07	33230300
rs2910789	rs2549797	0.771019548090089	Diastolic blood pressure	1e-14	33230300
rs2910789	rs2549797	0.771019548090089	Diastolic blood pressure	3e-11	33230300
rs2910789	rs2549797	0.771019548090089	Systolic blood pressure	4e-09	33230300
rs2910789	rs2549782	0.769761797387831	Systolic blood pressure	6e-07	33230300
rs2910789	rs2549782	0.769761797387831	Diastolic blood pressure	1e-14	33230300
rs2910789	rs2549782	0.769761797387831	Diastolic blood pressure	3e-11	33230300
rs2910789	rs2549782	0.769761797387831	Systolic blood pressure	5e-09	33230300
rs2910789	rs1056893	0.769133764694912	Systolic blood pressure	1e-06	33230300
rs2910789	rs1056893	0.769133764694912	Diastolic blood pressure	7e-15	33230300
rs2910789	rs1056893	0.769133764694912	Diastolic blood pressure	2e-11	33230300
rs2910789	rs1056893	0.769133764694912	Systolic blood pressure	7e-09	33230300
rs2910789	rs2549794	0.76483812290131	Crohn's disease	1e-10	21102463
rs2910789	rs2549794	0.76483812290131	Systolic blood pressure	1e-07	33230300
rs2910789	rs2549794	0.76483812290131	Diastolic blood pressure	1e-15	33230300
rs2910789	rs2549794	0.76483812290131	Diastolic blood pressure	2e-12	33230300
rs2910789	rs2549794	0.76483812290131	Systolic blood pressure	4e-10	33230300
rs2910789	rs38029	0.762619945032584	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2910789	rs1363907	0.760208444462172	Crohn's disease	4e-16	26192919
rs2910789	rs1363907	0.760208444462172	Ulcerative colitis	4e-06	26192919
rs2910789	rs1363907	0.760208444462172	Inflammatory bowel disease	5e-15	26192919
rs2910789	rs1363907	0.760208444462172	Inflammatory bowel disease	6e-13	23128233
rs2910789	rs1363907	0.760208444462172	Inflammatory bowel disease	1e-10	28067908
rs2910789	rs1363907	0.760208444462172	Crohn's disease	1e-14	28067908
rs2910789	rs716848	0.731860855278461	Neutrophil percentage of white cells	2e-09	32888494
rs2910789	rs4869313	0.720020495635562	Pediatric autoimmune diseases	9e-08	26301688
rs2910789	rs1559359	0.713736407994285	Diastolic blood pressure	7e-10	34594039
rs2910789	rs2548532	0.687251061417594	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2910789	rs4869314	0.666692723251499	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2910789	rs4869314	0.666692723251499	Neutrophil count	1e-10	34594039
rs2910789	rs4869314	0.666692723251499	White blood cell count	2e-07	30595370
rs2910789	rs1974871	0.640379183170097	Granulysin levels	5e-13	34648354
rs2910789	rs1019503	0.6359518868097	Systolic blood pressure	2e-06	33230300
rs2910789	rs1019503	0.6359518868097	Diastolic blood pressure	2e-14	33230300
rs2910789	rs1019503	0.6359518868097	Diastolic blood pressure	4e-11	33230300
rs2910789	rs1019503	0.6359518868097	Systolic blood pressure	1e-08	33230300
rs2910789	rs27660	0.633665826402108	Coronary artery disease	3e-08	35915156
rs2910789	rs3096168	0.628555573509049	Aspartate aminotransferase levels	8e-12	33547301
rs2910792	rs1423357	0.990782165983573	General cognitive ability	9e-06	29844566
rs2910792	rs2432142	0.97909240113781	Neutrophil count	2e-14	32888493
rs2910792	rs2432142	0.97909240113781	White blood cell count	1e-11	32888493
rs2910792	rs38033	0.974221194924239	Blood protein levels	0	30072576
rs2910792	rs27293	0.963456842940968	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2910792	rs27293	0.963456842940968	Diastolic blood pressure	3e-11	35762941
rs2910792	rs7705093	0.956470262714641	Birdshot chorioretinopathy	2e-09	24957906
rs2910792	rs2910686	0.866241295324916	Neutrophil count	4e-14	32888493
rs2910792	rs2910686	0.866241295324916	Psoriasis	2e-08	23143594
rs2910792	rs2910686	0.866241295324916	Ankylosing spondylitis	5e-17	23749187
rs2910792	rs2910686	0.866241295324916	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2910792	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2910792	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2910792	rs2927608	0.862935011158896	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2910792	rs2617439	0.778918998998163	Neutrophil count	8e-11	32888494
rs2910792	rs2549797	0.771019548090089	Systolic blood pressure	7e-07	33230300
rs2910792	rs2549797	0.771019548090089	Diastolic blood pressure	1e-14	33230300
rs2910792	rs2549797	0.771019548090089	Diastolic blood pressure	3e-11	33230300
rs2910792	rs2549797	0.771019548090089	Systolic blood pressure	4e-09	33230300
rs2910792	rs2549782	0.769761797387831	Systolic blood pressure	6e-07	33230300
rs2910792	rs2549782	0.769761797387831	Diastolic blood pressure	1e-14	33230300
rs2910792	rs2549782	0.769761797387831	Diastolic blood pressure	3e-11	33230300
rs2910792	rs2549782	0.769761797387831	Systolic blood pressure	5e-09	33230300
rs2910792	rs1056893	0.769133764694912	Systolic blood pressure	1e-06	33230300
rs2910792	rs1056893	0.769133764694912	Diastolic blood pressure	7e-15	33230300
rs2910792	rs1056893	0.769133764694912	Diastolic blood pressure	2e-11	33230300
rs2910792	rs1056893	0.769133764694912	Systolic blood pressure	7e-09	33230300
rs2910792	rs2549794	0.76483812290131	Crohn's disease	1e-10	21102463
rs2910792	rs2549794	0.76483812290131	Systolic blood pressure	1e-07	33230300
rs2910792	rs2549794	0.76483812290131	Diastolic blood pressure	1e-15	33230300
rs2910792	rs2549794	0.76483812290131	Diastolic blood pressure	2e-12	33230300
rs2910792	rs2549794	0.76483812290131	Systolic blood pressure	4e-10	33230300
rs2910792	rs38029	0.762619945032584	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2910792	rs1363907	0.760208444462172	Crohn's disease	4e-16	26192919
rs2910792	rs1363907	0.760208444462172	Ulcerative colitis	4e-06	26192919
rs2910792	rs1363907	0.760208444462172	Inflammatory bowel disease	5e-15	26192919
rs2910792	rs1363907	0.760208444462172	Inflammatory bowel disease	6e-13	23128233
rs2910792	rs1363907	0.760208444462172	Inflammatory bowel disease	1e-10	28067908
rs2910792	rs1363907	0.760208444462172	Crohn's disease	1e-14	28067908
rs2910792	rs716848	0.731860855278461	Neutrophil percentage of white cells	2e-09	32888494
rs2910792	rs4869313	0.720020495635562	Pediatric autoimmune diseases	9e-08	26301688
rs2910792	rs1559359	0.713736407994285	Diastolic blood pressure	7e-10	34594039
rs2910792	rs2548532	0.687251061417594	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2910792	rs4869314	0.666692723251499	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2910792	rs4869314	0.666692723251499	Neutrophil count	1e-10	34594039
rs2910792	rs4869314	0.666692723251499	White blood cell count	2e-07	30595370
rs2910792	rs1974871	0.640379183170097	Granulysin levels	5e-13	34648354
rs2910792	rs1019503	0.6359518868097	Systolic blood pressure	2e-06	33230300
rs2910792	rs1019503	0.6359518868097	Diastolic blood pressure	2e-14	33230300
rs2910792	rs1019503	0.6359518868097	Diastolic blood pressure	4e-11	33230300
rs2910792	rs1019503	0.6359518868097	Systolic blood pressure	1e-08	33230300
rs2910792	rs27660	0.633665826402108	Coronary artery disease	3e-08	35915156
rs2910792	rs3096168	0.628555573509049	Aspartate aminotransferase levels	8e-12	33547301
rs2910793	rs2549794	0.999110315224948	Crohn's disease	1e-10	21102463
rs2910793	rs2549794	0.999110315224948	Systolic blood pressure	1e-07	33230300
rs2910793	rs2549794	0.999110315224948	Diastolic blood pressure	1e-15	33230300
rs2910793	rs2549794	0.999110315224948	Diastolic blood pressure	2e-12	33230300
rs2910793	rs2549794	0.999110315224948	Systolic blood pressure	4e-10	33230300
rs2910793	rs1363907	0.993781103132944	Crohn's disease	4e-16	26192919
rs2910793	rs1363907	0.993781103132944	Ulcerative colitis	4e-06	26192919
rs2910793	rs1363907	0.993781103132944	Inflammatory bowel disease	5e-15	26192919
rs2910793	rs1363907	0.993781103132944	Inflammatory bowel disease	6e-13	23128233
rs2910793	rs1363907	0.993781103132944	Inflammatory bowel disease	1e-10	28067908
rs2910793	rs1363907	0.993781103132944	Crohn's disease	1e-14	28067908
rs2910793	rs2617439	0.945506755714289	Neutrophil count	8e-11	32888494
rs2910793	rs716848	0.938428471012939	Neutrophil percentage of white cells	2e-09	32888494
rs2910793	rs38029	0.933489306890891	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2910793	rs2548532	0.897778287225109	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2910793	rs27660	0.781515933672439	Coronary artery disease	3e-08	35915156
rs2910793	rs1423357	0.768454437089007	General cognitive ability	9e-06	29844566
rs2910793	rs2432142	0.753547568514724	Neutrophil count	2e-14	32888493
rs2910793	rs2432142	0.753547568514724	White blood cell count	1e-11	32888493
rs2910793	rs38033	0.751669770051801	Blood protein levels	0	30072576
rs2910793	rs27293	0.743146509055169	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2910793	rs27293	0.743146509055169	Diastolic blood pressure	3e-11	35762941
rs2910793	rs7705093	0.733658503692707	Birdshot chorioretinopathy	2e-09	24957906
rs2910793	rs4869313	0.724943211320757	Pediatric autoimmune diseases	9e-08	26301688
rs2910793	rs2927608	0.718826482715931	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2910793	rs2927608	0.718826482715931	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2910793	rs2927608	0.718826482715931	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2910793	rs2910686	0.716463963527449	Neutrophil count	4e-14	32888493
rs2910793	rs2910686	0.716463963527449	Psoriasis	2e-08	23143594
rs2910793	rs2910686	0.716463963527449	Ankylosing spondylitis	5e-17	23749187
rs2910793	rs2910686	0.716463963527449	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2910793	rs1559359	0.656331769039233	Diastolic blood pressure	7e-10	34594039
rs2910793	rs1974871	0.651375880870933	Granulysin levels	5e-13	34648354
rs2910793	rs2549797	0.638725189926001	Systolic blood pressure	7e-07	33230300
rs2910793	rs2549797	0.638725189926001	Diastolic blood pressure	1e-14	33230300
rs2910793	rs2549797	0.638725189926001	Diastolic blood pressure	3e-11	33230300
rs2910793	rs2549797	0.638725189926001	Systolic blood pressure	4e-09	33230300
rs2910793	rs2549782	0.637693628642632	Systolic blood pressure	6e-07	33230300
rs2910793	rs2549782	0.637693628642632	Diastolic blood pressure	1e-14	33230300
rs2910793	rs2549782	0.637693628642632	Diastolic blood pressure	3e-11	33230300
rs2910793	rs2549782	0.637693628642632	Systolic blood pressure	5e-09	33230300
rs2910793	rs1056893	0.637178539087113	Systolic blood pressure	1e-06	33230300
rs2910793	rs1056893	0.637178539087113	Diastolic blood pressure	7e-15	33230300
rs2910793	rs1056893	0.637178539087113	Diastolic blood pressure	2e-11	33230300
rs2910793	rs1056893	0.637178539087113	Systolic blood pressure	7e-09	33230300
rs2914940	rs6471393	0.61090695705497	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs2918284	rs4291002	0.837106866953001	Waist-to-hip ratio adjusted for BMI	2e-10	31669095
rs2918284	rs10463416	0.833821046396873	Waist-to-hip ratio adjusted for BMI	9e-14	30239722
rs2918284	rs6884531	0.821324160913858	Waist-hip ratio	9e-10	30595370
rs292168	rs292168	1	Red cell distribution width	3e-10	30595370
rs292168	rs158791	0.924833496273835	Height	2e-31	36224396
rs292168	rs292172	0.908513905979373	Appendicular lean mass	8e-13	31761296
rs292168	rs158796	0.880057488069896	Height	5e-243	36224396
rs292168	rs300046	0.872859656132456	Meat-related diet	5e-08	32066663
rs292168	rs301901	0.850319150327774	Height	4e-16	25282103
rs292168	rs301901	0.850319150327774	Height	2e-06	35831902
rs292168	rs158622	0.825728644002943	Height	4e-15	36224396
rs292168	rs300053	0.771511251529813	Height	3e-11	34594039
rs292168	rs300053	0.771511251529813	Height	3e-36	34594039
rs292168	rs300053	0.771511251529813	Height	2e-14	31562340
rs292172	rs292172	1	Appendicular lean mass	8e-13	31761296
rs292172	rs158796	0.968209072821377	Height	5e-243	36224396
rs292172	rs301901	0.938688162818642	Height	4e-16	25282103
rs292172	rs301901	0.938688162818642	Height	2e-06	35831902
rs292172	rs158791	0.910654105266378	Height	2e-31	36224396
rs292172	rs292168	0.908513905979373	Red cell distribution width	3e-10	30595370
rs292172	rs158622	0.90648629506408	Height	4e-15	36224396
rs292172	rs300046	0.866584128702158	Meat-related diet	5e-08	32066663
rs292172	rs300053	0.857204403083675	Height	3e-11	34594039
rs292172	rs300053	0.857204403083675	Height	3e-36	34594039
rs292172	rs300053	0.857204403083675	Height	2e-14	31562340
rs292178	rs292172	0.989067093899641	Appendicular lean mass	8e-13	31761296
rs292178	rs158796	0.975618059676875	Height	5e-243	36224396
rs292178	rs301901	0.944207256399989	Height	4e-16	25282103
rs292178	rs301901	0.944207256399989	Height	2e-06	35831902
rs292178	rs158622	0.912249332250958	Height	4e-15	36224396
rs292178	rs158791	0.911056376075368	Height	2e-31	36224396
rs292178	rs292168	0.900738726918401	Red cell distribution width	3e-10	30595370
rs292178	rs300046	0.866688589886872	Meat-related diet	5e-08	32066663
rs292178	rs300053	0.862242981216081	Height	3e-11	34594039
rs292178	rs300053	0.862242981216081	Height	3e-36	34594039
rs292178	rs300053	0.862242981216081	Height	2e-14	31562340
rs292183	rs158791	0.971891678000383	Height	2e-31	36224396
rs292183	rs292168	0.940454803540527	Red cell distribution width	3e-10	30595370
rs292183	rs300046	0.916758558386444	Meat-related diet	5e-08	32066663
rs292183	rs158796	0.901386005038726	Height	5e-243	36224396
rs292183	rs292172	0.897643115749852	Appendicular lean mass	8e-13	31761296
rs292183	rs301901	0.89372106113575	Height	4e-16	25282103
rs292183	rs301901	0.89372106113575	Height	2e-06	35831902
rs292183	rs158622	0.845062787570477	Height	4e-15	36224396
rs292183	rs300053	0.815768378692212	Height	3e-11	34594039
rs292183	rs300053	0.815768378692212	Height	3e-36	34594039
rs292183	rs300053	0.815768378692212	Height	2e-14	31562340
rs292184	rs158791	0.98803725438033	Height	2e-31	36224396
rs292184	rs292168	0.933306964697589	Red cell distribution width	3e-10	30595370
rs292184	rs158796	0.921103489395177	Height	5e-243	36224396
rs292184	rs292172	0.920195773611173	Appendicular lean mass	8e-13	31761296
rs292184	rs300046	0.917191595427499	Meat-related diet	5e-08	32066663
rs292184	rs301901	0.897620035000707	Height	4e-16	25282103
rs292184	rs301901	0.897620035000707	Height	2e-06	35831902
rs292184	rs158622	0.863034806646882	Height	4e-15	36224396
rs292184	rs300053	0.815915214752493	Height	3e-11	34594039
rs292184	rs300053	0.815915214752493	Height	3e-36	34594039
rs292184	rs300053	0.815915214752493	Height	2e-14	31562340
rs2927608	rs2927608	1	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2927608	rs2927608	1	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2927608	rs2927608	1	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2927608	rs2910686	0.99671888313561	Neutrophil count	4e-14	32888493
rs2927608	rs2910686	0.99671888313561	Psoriasis	2e-08	23143594
rs2927608	rs2910686	0.99671888313561	Ankylosing spondylitis	5e-17	23749187
rs2927608	rs2910686	0.99671888313561	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2927608	rs2549797	0.878869034680268	Systolic blood pressure	7e-07	33230300
rs2927608	rs2549797	0.878869034680268	Diastolic blood pressure	1e-14	33230300
rs2927608	rs2549797	0.878869034680268	Diastolic blood pressure	3e-11	33230300
rs2927608	rs2549797	0.878869034680268	Systolic blood pressure	4e-09	33230300
rs2927608	rs2549782	0.877445224125343	Systolic blood pressure	6e-07	33230300
rs2927608	rs2549782	0.877445224125343	Diastolic blood pressure	1e-14	33230300
rs2927608	rs2549782	0.877445224125343	Diastolic blood pressure	3e-11	33230300
rs2927608	rs2549782	0.877445224125343	Systolic blood pressure	5e-09	33230300
rs2927608	rs1056893	0.876734272722441	Systolic blood pressure	1e-06	33230300
rs2927608	rs1056893	0.876734272722441	Diastolic blood pressure	7e-15	33230300
rs2927608	rs1056893	0.876734272722441	Diastolic blood pressure	2e-11	33230300
rs2927608	rs1056893	0.876734272722441	Systolic blood pressure	7e-09	33230300
rs2927608	rs1423357	0.867108692926631	General cognitive ability	9e-06	29844566
rs2927608	rs2432142	0.851618675994664	Neutrophil count	2e-14	32888493
rs2927608	rs2432142	0.851618675994664	White blood cell count	1e-11	32888493
rs2927608	rs38033	0.846269539892368	Blood protein levels	0	30072576
rs2927608	rs4869313	0.836413515926563	Pediatric autoimmune diseases	9e-08	26301688
rs2927608	rs27293	0.834931995905953	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2927608	rs27293	0.834931995905953	Diastolic blood pressure	3e-11	35762941
rs2927608	rs7705093	0.826045876956366	Birdshot chorioretinopathy	2e-09	24957906
rs2927608	rs1559359	0.820594705404337	Diastolic blood pressure	7e-10	34594039
rs2927608	rs4869314	0.761394813116994	Arthritis (juvenile idiopathic)	3e-09	33106285
rs2927608	rs4869314	0.761394813116994	Neutrophil count	1e-10	34594039
rs2927608	rs4869314	0.761394813116994	White blood cell count	2e-07	30595370
rs2927608	rs1974871	0.745292343886263	Granulysin levels	5e-13	34648354
rs2927608	rs1019503	0.725671646678876	Systolic blood pressure	2e-06	33230300
rs2927608	rs1019503	0.725671646678876	Diastolic blood pressure	2e-14	33230300
rs2927608	rs1019503	0.725671646678876	Diastolic blood pressure	4e-11	33230300
rs2927608	rs1019503	0.725671646678876	Systolic blood pressure	1e-08	33230300
rs2927608	rs1363907	0.722372274451754	Crohn's disease	4e-16	26192919
rs2927608	rs1363907	0.722372274451754	Ulcerative colitis	4e-06	26192919
rs2927608	rs1363907	0.722372274451754	Inflammatory bowel disease	5e-15	26192919
rs2927608	rs1363907	0.722372274451754	Inflammatory bowel disease	6e-13	23128233
rs2927608	rs1363907	0.722372274451754	Inflammatory bowel disease	1e-10	28067908
rs2927608	rs1363907	0.722372274451754	Crohn's disease	1e-14	28067908
rs2927608	rs2549794	0.718185251163119	Crohn's disease	1e-10	21102463
rs2927608	rs2549794	0.718185251163119	Systolic blood pressure	1e-07	33230300
rs2927608	rs2549794	0.718185251163119	Diastolic blood pressure	1e-15	33230300
rs2927608	rs2549794	0.718185251163119	Diastolic blood pressure	2e-12	33230300
rs2927608	rs2549794	0.718185251163119	Systolic blood pressure	4e-10	33230300
rs2927608	rs3096168	0.712797662526419	Aspartate aminotransferase levels	8e-12	33547301
rs2927608	rs2617439	0.683365864112624	Neutrophil count	8e-11	32888494
rs2927608	rs38029	0.671916148421366	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2927608	rs716848	0.668391970217703	Neutrophil percentage of white cells	2e-09	32888494
rs2927608	rs2548532	0.645151203149521	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2927609	rs1363907	1	Crohn's disease	4e-16	26192919
rs2927609	rs1363907	1	Ulcerative colitis	4e-06	26192919
rs2927609	rs1363907	1	Inflammatory bowel disease	5e-15	26192919
rs2927609	rs1363907	1	Inflammatory bowel disease	6e-13	23128233
rs2927609	rs1363907	1	Inflammatory bowel disease	1e-10	28067908
rs2927609	rs1363907	1	Crohn's disease	1e-14	28067908
rs2927609	rs2549794	0.994668192117369	Crohn's disease	1e-10	21102463
rs2927609	rs2549794	0.994668192117369	Systolic blood pressure	1e-07	33230300
rs2927609	rs2549794	0.994668192117369	Diastolic blood pressure	1e-15	33230300
rs2927609	rs2549794	0.994668192117369	Diastolic blood pressure	2e-12	33230300
rs2927609	rs2549794	0.994668192117369	Systolic blood pressure	4e-10	33230300
rs2927609	rs2617439	0.941188032600576	Neutrophil count	8e-11	32888494
rs2927609	rs716848	0.937565262665602	Neutrophil percentage of white cells	2e-09	32888494
rs2927609	rs38029	0.929204620400647	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs2927609	rs2548532	0.893549053800425	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs2927609	rs27660	0.777538629741749	Coronary artery disease	3e-08	35915156
rs2927609	rs1423357	0.764618581415287	General cognitive ability	9e-06	29844566
rs2927609	rs2432142	0.749751329254888	Neutrophil count	2e-14	32888493
rs2927609	rs2432142	0.749751329254888	White blood cell count	1e-11	32888493
rs2927609	rs38033	0.747879341021451	Blood protein levels	0	30072576
rs2927609	rs27293	0.739378792587365	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs2927609	rs27293	0.739378792587365	Diastolic blood pressure	3e-11	35762941
rs2927609	rs7705093	0.729916732034797	Birdshot chorioretinopathy	2e-09	24957906
rs2927609	rs2927608	0.722372274451754	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs2927609	rs2927608	0.722372274451754	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs2927609	rs2927608	0.722372274451754	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs2927609	rs2910686	0.720002086599683	Neutrophil count	4e-14	32888493
rs2927609	rs2910686	0.720002086599683	Psoriasis	2e-08	23143594
rs2927609	rs2910686	0.720002086599683	Ankylosing spondylitis	5e-17	23749187
rs2927609	rs2910686	0.720002086599683	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs2927609	rs4869313	0.719764569481716	Pediatric autoimmune diseases	9e-08	26301688
rs2927609	rs1559359	0.651421821858804	Diastolic blood pressure	7e-10	34594039
rs2927609	rs1974871	0.646485295817104	Granulysin levels	5e-13	34648354
rs2927609	rs2549797	0.633881150231873	Systolic blood pressure	7e-07	33230300
rs2927609	rs2549797	0.633881150231873	Diastolic blood pressure	1e-14	33230300
rs2927609	rs2549797	0.633881150231873	Diastolic blood pressure	3e-11	33230300
rs2927609	rs2549797	0.633881150231873	Systolic blood pressure	4e-09	33230300
rs2927609	rs2549782	0.632853515974189	Systolic blood pressure	6e-07	33230300
rs2927609	rs2549782	0.632853515974189	Diastolic blood pressure	1e-14	33230300
rs2927609	rs2549782	0.632853515974189	Diastolic blood pressure	3e-11	33230300
rs2927609	rs2549782	0.632853515974189	Systolic blood pressure	5e-09	33230300
rs2927609	rs1056893	0.632340387305134	Systolic blood pressure	1e-06	33230300
rs2927609	rs1056893	0.632340387305134	Diastolic blood pressure	7e-15	33230300
rs2927609	rs1056893	0.632340387305134	Diastolic blood pressure	2e-11	33230300
rs2927609	rs1056893	0.632340387305134	Systolic blood pressure	7e-09	33230300
rs2932565	rs2999541	0.976535955754025	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2932565	rs3007711	0.972330252523801	Electrodermal activity	9e-06	25387706
rs2932565	rs2130525	0.908623901357237	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2932565	rs7542137	0.823450888350622	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2932565	rs7542137	0.823450888350622	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2932565	rs7542137	0.823450888350622	3-hydroxysebacate levels	2e-10	36635386
rs2932565	rs10788817	0.76903310687488	Serum metabolite levels	3e-13	24625756
rs2932565	rs10788817	0.76903310687488	Metabolite peak levels (QI2718)	5e-18	35995766
rs2932565	rs10788817	0.76903310687488	3-hydroxylaurate levels	2e-12	36635386
rs2932565	rs10788817	0.76903310687488	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2932565	rs11204914	0.765151224544855	Carnitine C9 levels	1e-13	35995766
rs2932565	rs11204914	0.765151224544855	Metabolite peak levels (QI6204)	1e-32	35995766
rs2932565	rs11204914	0.765151224544855	Metabolite peak levels (QI6252)	2e-32	35995766
rs2932565	rs2279501	0.743554141061325	Serum metabolite levels	3e-14	33031748
rs2932565	rs6685187	0.741428234610822	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2932565	rs6698740	0.739387863660669	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2932565	rs1060870	0.737962844738878	Serum metabolite levels	1e-11	33031748
rs2932565	rs1060870	0.737962844738878	Serum metabolite levels	1e-15	33031748
rs2932565	rs2338201	0.728633466619752	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2932565	rs2338201	0.728633466619752	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2932565	rs2338201	0.728633466619752	Dodecadienoate (12:2) levels	7e-15	36635386
rs2932565	rs56000812	0.693400342248857	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2932565	rs56078223	0.691241807524175	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2932565	rs56078223	0.691241807524175	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs2932565	rs10494270	0.684948783703693	Nonaylcarnitine levels	5e-13	26068415
rs2932565	rs2999545	0.678292622375964	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2932565	rs9943221	0.678156535729168	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2932565	rs1038747	0.634246195930803	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2932565	rs6684312	0.621138311606577	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs2932565	rs7523082	0.614630042379937	Metabolite peak levels (QI9845)	2e-14	35995766
rs2932565	rs10888445	0.611457864839916	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2932565	rs7541453	0.608986584288474	Serum metabolite levels	2e-16	33031748
rs2932565	rs7541453	0.608986584288474	Serum metabolite levels	2e-16	33031748
rs2932565	rs7541453	0.608986584288474	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2932577	rs2999541	0.867349712810051	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2932577	rs3007711	0.86345337879139	Electrodermal activity	9e-06	25387706
rs2932577	rs10788817	0.814629286935822	Serum metabolite levels	3e-13	24625756
rs2932577	rs10788817	0.814629286935822	Metabolite peak levels (QI2718)	5e-18	35995766
rs2932577	rs10788817	0.814629286935822	3-hydroxylaurate levels	2e-12	36635386
rs2932577	rs10788817	0.814629286935822	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2932577	rs11204914	0.809419621142707	Carnitine C9 levels	1e-13	35995766
rs2932577	rs11204914	0.809419621142707	Metabolite peak levels (QI6204)	1e-32	35995766
rs2932577	rs11204914	0.809419621142707	Metabolite peak levels (QI6252)	2e-32	35995766
rs2932577	rs2130525	0.804153282478018	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2932577	rs2279501	0.79307706108559	Serum metabolite levels	3e-14	33031748
rs2932577	rs6685187	0.784824295295737	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2932577	rs6698740	0.782715747993336	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2932577	rs1060870	0.78125954568159	Serum metabolite levels	1e-11	33031748
rs2932577	rs1060870	0.78125954568159	Serum metabolite levels	1e-15	33031748
rs2932577	rs2338201	0.77142145127226	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2932577	rs2338201	0.77142145127226	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2932577	rs2338201	0.77142145127226	Dodecadienoate (12:2) levels	7e-15	36635386
rs2932577	rs7542137	0.730384632421455	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2932577	rs7542137	0.730384632421455	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2932577	rs7542137	0.730384632421455	3-hydroxysebacate levels	2e-10	36635386
rs2932577	rs2999545	0.726575038997959	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2932577	rs1038747	0.67650791357927	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2932577	rs10494270	0.663489561386983	Nonaylcarnitine levels	5e-13	26068415
rs2932577	rs7523082	0.657246910259553	Metabolite peak levels (QI9845)	2e-14	35995766
rs2932577	rs9943221	0.656794924654707	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2932577	rs10888445	0.650202747643893	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2932577	rs7541453	0.647027812407422	Serum metabolite levels	2e-16	33031748
rs2932577	rs7541453	0.647027812407422	Serum metabolite levels	2e-16	33031748
rs2932577	rs7541453	0.647027812407422	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2932577	rs56000812	0.608612220324219	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2932577	rs56078223	0.606609820262847	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2932577	rs56078223	0.606609820262847	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs2932579	rs3007711	0.876899448819256	Electrodermal activity	9e-06	25387706
rs2932579	rs2999541	0.872935208701168	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2932579	rs10788817	0.832619135042783	Serum metabolite levels	3e-13	24625756
rs2932579	rs10788817	0.832619135042783	Metabolite peak levels (QI2718)	5e-18	35995766
rs2932579	rs10788817	0.832619135042783	3-hydroxylaurate levels	2e-12	36635386
rs2932579	rs10788817	0.832619135042783	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2932579	rs11204914	0.827459446923081	Carnitine C9 levels	1e-13	35995766
rs2932579	rs11204914	0.827459446923081	Metabolite peak levels (QI6204)	1e-32	35995766
rs2932579	rs11204914	0.827459446923081	Metabolite peak levels (QI6252)	2e-32	35995766
rs2932579	rs2279501	0.819542467833586	Serum metabolite levels	3e-14	33031748
rs2932579	rs2130525	0.808870756419475	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2932579	rs6685187	0.803981418164743	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2932579	rs6698740	0.801843052175099	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2932579	rs1060870	0.800372692976088	Serum metabolite levels	1e-11	33031748
rs2932579	rs1060870	0.800372692976088	Serum metabolite levels	1e-15	33031748
rs2932579	rs2338201	0.791778481781343	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2932579	rs2338201	0.791778481781343	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2932579	rs2338201	0.791778481781343	Dodecadienoate (12:2) levels	7e-15	36635386
rs2932579	rs7542137	0.740778949903606	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2932579	rs7542137	0.740778949903606	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2932579	rs7542137	0.740778949903606	3-hydroxysebacate levels	2e-10	36635386
rs2932579	rs2999545	0.736761248055531	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2932579	rs1038747	0.700043356690877	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2932579	rs9943221	0.674112753203728	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2932579	rs7523082	0.673333347510061	Metabolite peak levels (QI9845)	2e-14	35995766
rs2932579	rs10494270	0.672220713029692	Nonaylcarnitine levels	5e-13	26068415
rs2932579	rs10888445	0.667622851549981	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2932579	rs7541453	0.664159553327326	Serum metabolite levels	2e-16	33031748
rs2932579	rs7541453	0.664159553327326	Serum metabolite levels	2e-16	33031748
rs2932579	rs7541453	0.664159553327326	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2932579	rs56000812	0.619133884634759	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2932579	rs56078223	0.617129504719467	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2932579	rs56078223	0.617129504719467	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs2947336	rs2446066	1	Vertex-wise sulcal depth	1e-10	34910505
rs2947336	rs2446066	1	Vertex-wise cortical surface area	2e-13	34910505
rs2947336	rs2446066	1	Red blood cell count	1e-10	27863252
rs2947336	rs2446066	1	Cortical surface area	3e-08	34560273
rs2947336	rs2608301	1	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2947336	rs10876448	0.999092856617345	Mean corpuscular hemoglobin	2e-16	32888493
rs2947336	rs10876448	0.999092856617345	Reticulocyte count	3e-18	32888494
rs2947336	rs10876448	0.999092856617345	Reticulocyte fraction of red cells	1e-10	32888494
rs2947336	rs2460882	0.998186251598715	Mean corpuscular volume	3e-15	29403010
rs2947336	rs2460882	0.998186251598715	Percentage gas trapping	6e-07	26030696
rs2947336	rs12582170	0.964891010380584	Mean corpuscular volume	1e-21	27863252
rs2947336	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	7e-37	32888493
rs2947336	rs12582170	0.964891010380584	Mean reticulocyte volume	2e-33	32888494
rs2947336	rs12582170	0.964891010380584	Mean corpuscular volume	1e-67	32888493
rs2947336	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	2e-21	32888494
rs2947336	rs12582170	0.964891010380584	Mean corpuscular volume	1e-26	34104963
rs2947336	rs111379945	0.766400621245193	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2947336	rs111379945	0.766400621245193	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2947336	rs111379945	0.766400621245193	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2947336	rs79205721	0.617589919422487	Vertex-wise cortical thickness	2e-09	34910505
rs2947337	rs2446066	1	Vertex-wise sulcal depth	1e-10	34910505
rs2947337	rs2446066	1	Vertex-wise cortical surface area	2e-13	34910505
rs2947337	rs2446066	1	Red blood cell count	1e-10	27863252
rs2947337	rs2446066	1	Cortical surface area	3e-08	34560273
rs2947337	rs2608301	1	Low density lipoprotein cholesterol levels	2e-12	34887591
rs2947337	rs10876448	0.999092856617345	Mean corpuscular hemoglobin	2e-16	32888493
rs2947337	rs10876448	0.999092856617345	Reticulocyte count	3e-18	32888494
rs2947337	rs10876448	0.999092856617345	Reticulocyte fraction of red cells	1e-10	32888494
rs2947337	rs2460882	0.998186251598715	Mean corpuscular volume	3e-15	29403010
rs2947337	rs2460882	0.998186251598715	Percentage gas trapping	6e-07	26030696
rs2947337	rs12582170	0.964891010380584	Mean corpuscular volume	1e-21	27863252
rs2947337	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	7e-37	32888493
rs2947337	rs12582170	0.964891010380584	Mean reticulocyte volume	2e-33	32888494
rs2947337	rs12582170	0.964891010380584	Mean corpuscular volume	1e-67	32888493
rs2947337	rs12582170	0.964891010380584	Mean corpuscular hemoglobin	2e-21	32888494
rs2947337	rs12582170	0.964891010380584	Mean corpuscular volume	1e-26	34104963
rs2947337	rs111379945	0.766400621245193	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs2947337	rs111379945	0.766400621245193	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs2947337	rs111379945	0.766400621245193	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs2947337	rs79205721	0.617589919422487	Vertex-wise cortical thickness	2e-09	34910505
rs296962	rs158796	0.972236759840121	Height	5e-243	36224396
rs296962	rs292172	0.960708151351011	Appendicular lean mass	8e-13	31761296
rs296962	rs301901	0.949053021298031	Height	4e-16	25282103
rs296962	rs301901	0.949053021298031	Height	2e-06	35831902
rs296962	rs158791	0.915742335350517	Height	2e-31	36224396
rs296962	rs158622	0.912354206349881	Height	4e-15	36224396
rs296962	rs292168	0.87632907032111	Red cell distribution width	3e-10	30595370
rs296962	rs300053	0.873131308099897	Height	3e-11	34594039
rs296962	rs300053	0.873131308099897	Height	3e-36	34594039
rs296962	rs300053	0.873131308099897	Height	2e-14	31562340
rs296962	rs300046	0.867926782394536	Meat-related diet	5e-08	32066663
rs2969884	rs4807	0.633118672583715	Height	3e-23	36224396
rs2972572	rs3965185	0.937591379324481	High-density lipoprotein levels (MTAG)	4e-11	36376304
rs2972574	rs3965185	0.987014732448789	High-density lipoprotein levels (MTAG)	4e-11	36376304
rs2976372	rs6471393	0.721314626995926	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs2983489	rs2257649	0.899159116821395	Total Phosphatidylglycerol levels	3e-10	35668104
rs2983489	rs4815400	0.894093911255583	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs2983489	rs6037062	0.749189472407338	Lung function (forced vital capacity)	3e-13	36914875
rs2983489	rs6037062	0.749189472407338	Lung function (FVC)	5e-12	30595370
rs2983489	rs2273473	0.706664386324125	Vertex-wise cortical thickness	1e-12	34910505
rs2983489	rs6050463	0.674628074016151	Low density lipoprotein cholesterol levels	6e-09	32154731
rs2983489	rs6050463	0.674628074016151	LDL cholesterol levels	2e-09	32203549
rs2983489	rs6115094	0.674628074016151	Brain morphology (MOSTest)	1e-08	32665545
rs2983489	rs6115094	0.674628074016151	Non-HDL cholesterol levels	3e-09	34887591
rs2983489	rs8115257	0.641032265585082	Total cholesterol levels	2e-09	34887591
rs2983489	rs8115257	0.641032265585082	Low density lipoprotein cholesterol levels	1e-10	34887591
rs2983489	rs2500430	0.602158448289509	Serum alkaline phosphatase levels	7e-10	31666285
rs2987045	rs770199	0.864745183920419	Hair color	3e-08	30595370
rs2994421	rs2357176	0.960504507710522	Nevus count or cutaneous melanoma	4e-08	30429480
rs2994421	rs10873172	0.803785411248515	Cutaneous melanoma or hair colour	6e-27	32341527
rs2994421	rs10873172	0.803785411248515	Nevus count or cutaneous melanoma	6e-13	32341527
rs2994421	rs10873172	0.803785411248515	Blond vs. brown/black hair color	6e-15	30531825
rs2994421	rs10873172	0.803785411248515	Cutaneous malignant melanoma	6e-08	32341527
rs2994421	rs10873172	0.803785411248515	Hair color	4e-17	30595370
rs2994421	rs1255908	0.795753621142345	PR interval	8e-14	32439900
rs2994421	rs1255908	0.795753621142345	PR interval	6e-14	32439900
rs2994421	rs12878653	0.689144560118904	Youthful appearance (self-reported)	3e-14	32339537
rs2995025	rs770199	0.891774495389377	Hair color	3e-08	30595370
rs299591	rs149359	0.915180556909546	Skin color	4e-10	36672889
rs299591	rs149359	0.915180556909546	Skin phototype score	4e-09	36672889
rs299592	rs149359	0.965497885970948	Skin color	4e-10	36672889
rs299592	rs149359	0.965497885970948	Skin phototype score	4e-09	36672889
rs299594	rs149359	0.951868395644622	Skin color	4e-10	36672889
rs299594	rs149359	0.951868395644622	Skin phototype score	4e-09	36672889
rs299596	rs149359	0.948129052035311	Skin color	4e-10	36672889
rs299596	rs149359	0.948129052035311	Skin phototype score	4e-09	36672889
rs299597	rs149359	0.941871374869572	Skin color	4e-10	36672889
rs299597	rs149359	0.941871374869572	Skin phototype score	4e-09	36672889
rs299606	rs149359	0.789351255117976	Skin color	4e-10	36672889
rs299606	rs149359	0.789351255117976	Skin phototype score	4e-09	36672889
rs299611	rs149359	0.796384572691485	Skin color	4e-10	36672889
rs299611	rs149359	0.796384572691485	Skin phototype score	4e-09	36672889
rs2999506	rs3007711	0.88051601174669	Electrodermal activity	9e-06	25387706
rs2999506	rs2999541	0.876548392445917	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2999506	rs10788817	0.82781510869046	Serum metabolite levels	3e-13	24625756
rs2999506	rs10788817	0.82781510869046	Metabolite peak levels (QI2718)	5e-18	35995766
rs2999506	rs10788817	0.82781510869046	3-hydroxylaurate levels	2e-12	36635386
rs2999506	rs10788817	0.82781510869046	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2999506	rs11204914	0.822636606992428	Carnitine C9 levels	1e-13	35995766
rs2999506	rs11204914	0.822636606992428	Metabolite peak levels (QI6204)	1e-32	35995766
rs2999506	rs11204914	0.822636606992428	Metabolite peak levels (QI6252)	2e-32	35995766
rs2999506	rs2130525	0.812521342720924	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2999506	rs2279501	0.809912896983131	Serum metabolite levels	3e-14	33031748
rs2999506	rs6685187	0.799254081463107	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2999506	rs6698740	0.797123327337086	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2999506	rs1060870	0.795656194078802	Serum metabolite levels	1e-11	33031748
rs2999506	rs1060870	0.795656194078802	Serum metabolite levels	1e-15	33031748
rs2999506	rs2338201	0.7871186157675	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2999506	rs2338201	0.7871186157675	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2999506	rs2338201	0.7871186157675	Dodecadienoate (12:2) levels	7e-15	36635386
rs2999506	rs7542137	0.744219734118729	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2999506	rs7542137	0.744219734118729	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2999506	rs7542137	0.744219734118729	3-hydroxysebacate levels	2e-10	36635386
rs2999506	rs2999545	0.735414511445417	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2999506	rs1038747	0.691449424106437	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2999506	rs9943221	0.67630215402954	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2999506	rs10494270	0.675846824271737	Nonaylcarnitine levels	5e-13	26068415
rs2999506	rs7523082	0.669465745695152	Metabolite peak levels (QI9845)	2e-14	35995766
rs2999506	rs10888445	0.663745254149784	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2999506	rs7541453	0.660370110960911	Serum metabolite levels	2e-16	33031748
rs2999506	rs7541453	0.660370110960911	Serum metabolite levels	2e-16	33031748
rs2999506	rs7541453	0.660370110960911	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2999506	rs56000812	0.622444401047783	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2999506	rs56078223	0.620431074141669	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2999506	rs56078223	0.620431074141669	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs2999541	rs2999541	1	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2999541	rs3007711	0.995783742126405	Electrodermal activity	9e-06	25387706
rs2999541	rs2130525	0.892194099916733	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2999541	rs7542137	0.84454600981745	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2999541	rs7542137	0.84454600981745	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2999541	rs7542137	0.84454600981745	3-hydroxysebacate levels	2e-10	36635386
rs2999541	rs10788817	0.78803489023865	Serum metabolite levels	3e-13	24625756
rs2999541	rs10788817	0.78803489023865	Metabolite peak levels (QI2718)	5e-18	35995766
rs2999541	rs10788817	0.78803489023865	3-hydroxylaurate levels	2e-12	36635386
rs2999541	rs10788817	0.78803489023865	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2999541	rs11204914	0.784189575914813	Carnitine C9 levels	1e-13	35995766
rs2999541	rs11204914	0.784189575914813	Metabolite peak levels (QI6204)	1e-32	35995766
rs2999541	rs11204914	0.784189575914813	Metabolite peak levels (QI6252)	2e-32	35995766
rs2999541	rs6685187	0.760111553400485	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2999541	rs6698740	0.75804274474034	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2999541	rs1060870	0.756603012838021	Serum metabolite levels	1e-11	33031748
rs2999541	rs1060870	0.756603012838021	Serum metabolite levels	1e-15	33031748
rs2999541	rs2338201	0.747081739629544	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2999541	rs2338201	0.747081739629544	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2999541	rs2338201	0.747081739629544	Dodecadienoate (12:2) levels	7e-15	36635386
rs2999541	rs2279501	0.727270447289022	Serum metabolite levels	3e-14	33031748
rs2999541	rs56000812	0.682084106322215	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2999541	rs56078223	0.679952879480075	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2999541	rs56078223	0.679952879480075	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs2999541	rs10494270	0.670503454851672	Nonaylcarnitine levels	5e-13	26068415
rs2999541	rs9943221	0.663785006203325	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2999541	rs2999545	0.662705733796985	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2999541	rs7523082	0.630553122298745	Metabolite peak levels (QI9845)	2e-14	35995766
rs2999541	rs10888445	0.627400974162425	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2999541	rs7541453	0.624707223046545	Serum metabolite levels	2e-16	33031748
rs2999541	rs7541453	0.624707223046545	Serum metabolite levels	2e-16	33031748
rs2999541	rs7541453	0.624707223046545	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2999541	rs1038747	0.618799228812066	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2999541	rs6684312	0.612169241811288	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs2999542	rs2999541	0.979040317617248	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2999542	rs3007711	0.974831441421246	Electrodermal activity	9e-06	25387706
rs2999542	rs2130525	0.910997822021044	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2999542	rs7542137	0.82571984637431	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2999542	rs7542137	0.82571984637431	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2999542	rs7542137	0.82571984637431	3-hydroxysebacate levels	2e-10	36635386
rs2999542	rs10788817	0.771147880366233	Serum metabolite levels	3e-13	24625756
rs2999542	rs10788817	0.771147880366233	Metabolite peak levels (QI2718)	5e-18	35995766
rs2999542	rs10788817	0.771147880366233	3-hydroxylaurate levels	2e-12	36635386
rs2999542	rs10788817	0.771147880366233	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2999542	rs11204914	0.76726509132762	Carnitine C9 levels	1e-13	35995766
rs2999542	rs11204914	0.76726509132762	Metabolite peak levels (QI6204)	1e-32	35995766
rs2999542	rs11204914	0.76726509132762	Metabolite peak levels (QI6252)	2e-32	35995766
rs2999542	rs2279501	0.744246198458145	Serum metabolite levels	3e-14	33031748
rs2999542	rs6685187	0.743505544931023	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2999542	rs6698740	0.741462130548351	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2999542	rs1060870	0.740035258256122	Serum metabolite levels	1e-11	33031748
rs2999542	rs1060870	0.740035258256122	Serum metabolite levels	1e-15	33031748
rs2999542	rs2338201	0.730688662276779	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2999542	rs2338201	0.730688662276779	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2999542	rs2338201	0.730688662276779	Dodecadienoate (12:2) levels	7e-15	36635386
rs2999542	rs56000812	0.692812215890143	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2999542	rs56078223	0.690655029564491	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2999542	rs56078223	0.690655029564491	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs2999542	rs10494270	0.68435172031691	Nonaylcarnitine levels	5e-13	26068415
rs2999542	rs2999545	0.680231365755319	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2999542	rs9943221	0.677562492799832	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2999542	rs1038747	0.634856394129328	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2999542	rs6684312	0.620596276596885	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs2999542	rs7523082	0.616464897103658	Metabolite peak levels (QI9845)	2e-14	35995766
rs2999542	rs10888445	0.613290872919964	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2999542	rs7541453	0.610806867273193	Serum metabolite levels	2e-16	33031748
rs2999542	rs7541453	0.610806867273193	Serum metabolite levels	2e-16	33031748
rs2999542	rs7541453	0.610806867273193	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2999544	rs2999541	0.975717618239451	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2999544	rs3007711	0.971508977660991	Electrodermal activity	9e-06	25387706
rs2999544	rs2130525	0.907909224349424	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2999544	rs7542137	0.827320655777374	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2999544	rs7542137	0.827320655777374	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2999544	rs7542137	0.827320655777374	3-hydroxysebacate levels	2e-10	36635386
rs2999544	rs10788817	0.774340359842214	Serum metabolite levels	3e-13	24625756
rs2999544	rs10788817	0.774340359842214	Metabolite peak levels (QI2718)	5e-18	35995766
rs2999544	rs10788817	0.774340359842214	3-hydroxylaurate levels	2e-12	36635386
rs2999544	rs10788817	0.774340359842214	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2999544	rs11204914	0.77043758646945	Carnitine C9 levels	1e-13	35995766
rs2999544	rs11204914	0.77043758646945	Metabolite peak levels (QI6204)	1e-32	35995766
rs2999544	rs11204914	0.77043758646945	Metabolite peak levels (QI6252)	2e-32	35995766
rs2999544	rs2279501	0.748693600120386	Serum metabolite levels	3e-14	33031748
rs2999544	rs6685187	0.746634254754226	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2999544	rs6698740	0.744586729286297	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2999544	rs1060870	0.743156269049105	Serum metabolite levels	1e-11	33031748
rs2999544	rs1060870	0.743156269049105	Serum metabolite levels	1e-15	33031748
rs2999544	rs2338201	0.733799326911839	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2999544	rs2338201	0.733799326911839	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2999544	rs2338201	0.733799326911839	Dodecadienoate (12:2) levels	7e-15	36635386
rs2999544	rs56000812	0.689181308818345	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2999544	rs56078223	0.687026914040693	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2999544	rs56078223	0.687026914040693	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs2999544	rs10494270	0.686743747983125	Nonaylcarnitine levels	5e-13	26068415
rs2999544	rs2999545	0.684720610794415	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2999544	rs9943221	0.679942419997079	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2999544	rs1038747	0.639030255365813	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2999544	rs6684312	0.621338518459561	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs2999544	rs7523082	0.619472161700511	Metabolite peak levels (QI9845)	2e-14	35995766
rs2999544	rs10888445	0.616280113659672	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2999544	rs7541453	0.613822067077198	Serum metabolite levels	2e-16	33031748
rs2999544	rs7541453	0.613822067077198	Serum metabolite levels	2e-16	33031748
rs2999544	rs7541453	0.613822067077198	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2999546	rs2999541	0.880033812822133	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs2999546	rs3007711	0.876151080180833	Electrodermal activity	9e-06	25387706
rs2999546	rs10788817	0.834822039638316	Serum metabolite levels	3e-13	24625756
rs2999546	rs10788817	0.834822039638316	Metabolite peak levels (QI2718)	5e-18	35995766
rs2999546	rs10788817	0.834822039638316	3-hydroxylaurate levels	2e-12	36635386
rs2999546	rs10788817	0.834822039638316	Tetradecadienoate (14:2) levels	8e-17	36635386
rs2999546	rs11204914	0.82966011045014	Carnitine C9 levels	1e-13	35995766
rs2999546	rs11204914	0.82966011045014	Metabolite peak levels (QI6204)	1e-32	35995766
rs2999546	rs11204914	0.82966011045014	Metabolite peak levels (QI6252)	2e-32	35995766
rs2999546	rs2130525	0.815628465050612	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs2999546	rs2279501	0.811313202522241	Serum metabolite levels	3e-14	33031748
rs2999546	rs6685187	0.804672212449202	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs2999546	rs6698740	0.80253277151383	Beta-hydroxyisovalerate levels	1e-13	35347128
rs2999546	rs1060870	0.801061902131042	Serum metabolite levels	1e-11	33031748
rs2999546	rs1060870	0.801061902131042	Serum metabolite levels	1e-15	33031748
rs2999546	rs2338201	0.790999688189991	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs2999546	rs2338201	0.790999688189991	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs2999546	rs2338201	0.790999688189991	Dodecadienoate (12:2) levels	7e-15	36635386
rs2999546	rs2999545	0.744410174127244	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs2999546	rs7542137	0.741512389762499	Beta-hydroxyisovalerate levels	3e-11	35050183
rs2999546	rs7542137	0.741512389762499	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs2999546	rs7542137	0.741512389762499	3-hydroxysebacate levels	2e-10	36635386
rs2999546	rs1038747	0.69247012768737	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs2999546	rs10494270	0.677445838203252	Nonaylcarnitine levels	5e-13	26068415
rs2999546	rs7523082	0.673913415337622	Metabolite peak levels (QI9845)	2e-14	35995766
rs2999546	rs9943221	0.670663591486949	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs2999546	rs10888445	0.666869957559935	Beta-hydroxyisovalerate levels	5e-13	36635386
rs2999546	rs7541453	0.663400401482348	Serum metabolite levels	2e-16	33031748
rs2999546	rs7541453	0.663400401482348	Serum metabolite levels	2e-16	33031748
rs2999546	rs7541453	0.663400401482348	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs2999546	rs56000812	0.624230727961349	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs2999546	rs56078223	0.622219556034329	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs2999546	rs56078223	0.622219556034329	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs300046	rs300046	1	Meat-related diet	5e-08	32066663
rs300046	rs158791	0.923428793308635	Height	2e-31	36224396
rs300046	rs301901	0.900826056967152	Height	4e-16	25282103
rs300046	rs301901	0.900826056967152	Height	2e-06	35831902
rs300046	rs292168	0.872859656132456	Red cell distribution width	3e-10	30595370
rs300046	rs158796	0.868318659654523	Height	5e-243	36224396
rs300046	rs292172	0.866584128702158	Appendicular lean mass	8e-13	31761296
rs300046	rs300053	0.817002083472368	Height	3e-11	34594039
rs300046	rs300053	0.817002083472368	Height	3e-36	34594039
rs300046	rs300053	0.817002083472368	Height	2e-14	31562340
rs300046	rs158622	0.814051748128397	Height	4e-15	36224396
rs300051	rs301901	0.959428039985514	Height	4e-16	25282103
rs300051	rs301901	0.959428039985514	Height	2e-06	35831902
rs300051	rs158796	0.931660191869278	Height	5e-243	36224396
rs300051	rs292172	0.920804885956169	Appendicular lean mass	8e-13	31761296
rs300051	rs300046	0.900386330119123	Meat-related diet	5e-08	32066663
rs300051	rs158791	0.879606458125408	Height	2e-31	36224396
rs300051	rs300053	0.87876716212232	Height	3e-11	34594039
rs300051	rs300053	0.87876716212232	Height	3e-36	34594039
rs300051	rs300053	0.87876716212232	Height	2e-14	31562340
rs300051	rs158622	0.872876085853002	Height	4e-15	36224396
rs300051	rs292168	0.831116056174391	Red cell distribution width	3e-10	30595370
rs300053	rs300053	1	Height	3e-11	34594039
rs300053	rs300053	1	Height	3e-36	34594039
rs300053	rs300053	1	Height	2e-14	31562340
rs300053	rs301901	0.89358348041667	Height	4e-16	25282103
rs300053	rs301901	0.89358348041667	Height	2e-06	35831902
rs300053	rs158796	0.87685065265463	Height	5e-243	36224396
rs300053	rs292172	0.857204403083675	Appendicular lean mass	8e-13	31761296
rs300053	rs158622	0.856854844357668	Height	4e-15	36224396
rs300053	rs158791	0.821836487847451	Height	2e-31	36224396
rs300053	rs300046	0.817002083472368	Meat-related diet	5e-08	32066663
rs300053	rs292168	0.771511251529813	Red cell distribution width	3e-10	30595370
rs300055	rs301901	0.959867783205488	Height	4e-16	25282103
rs300055	rs301901	0.959867783205488	Height	2e-06	35831902
rs300055	rs158796	0.941571883075287	Height	5e-243	36224396
rs300055	rs300053	0.929148878429754	Height	3e-11	34594039
rs300055	rs300053	0.929148878429754	Height	3e-36	34594039
rs300055	rs300053	0.929148878429754	Height	2e-14	31562340
rs300055	rs292172	0.92053326323857	Appendicular lean mass	8e-13	31761296
rs300055	rs158622	0.919575731303842	Height	4e-15	36224396
rs300055	rs158791	0.887415418128401	Height	2e-31	36224396
rs300055	rs300046	0.873605153438598	Meat-related diet	5e-08	32066663
rs300055	rs292168	0.836039600575627	Red cell distribution width	3e-10	30595370
rs300058	rs158796	0.948881579783097	Height	5e-243	36224396
rs300058	rs301901	0.929757402809119	Height	4e-16	25282103
rs300058	rs301901	0.929757402809119	Height	2e-06	35831902
rs300058	rs292172	0.927459104136857	Appendicular lean mass	8e-13	31761296
rs300058	rs158622	0.925483085660037	Height	4e-15	36224396
rs300058	rs300053	0.89220234182102	Height	3e-11	34594039
rs300058	rs300053	0.89220234182102	Height	3e-36	34594039
rs300058	rs300053	0.89220234182102	Height	2e-14	31562340
rs300058	rs158791	0.889394720268664	Height	2e-31	36224396
rs300058	rs292168	0.846194262790117	Red cell distribution width	3e-10	30595370
rs300058	rs300046	0.840169449318042	Meat-related diet	5e-08	32066663
rs300061	rs158796	0.963455463381713	Height	5e-243	36224396
rs300061	rs292172	0.945195772629273	Appendicular lean mass	8e-13	31761296
rs300061	rs158622	0.940144123398354	Height	4e-15	36224396
rs300061	rs301901	0.935842919449758	Height	4e-16	25282103
rs300061	rs301901	0.935842919449758	Height	2e-06	35831902
rs300061	rs300053	0.904388379598404	Height	3e-11	34594039
rs300061	rs300053	0.904388379598404	Height	3e-36	34594039
rs300061	rs300053	0.904388379598404	Height	2e-14	31562340
rs300061	rs158791	0.893541915819034	Height	2e-31	36224396
rs300061	rs292168	0.861163121505893	Red cell distribution width	3e-10	30595370
rs300061	rs300046	0.853343210301876	Meat-related diet	5e-08	32066663
rs300063	rs158796	0.981519675921397	Height	5e-243	36224396
rs300063	rs292172	0.963191449433213	Appendicular lean mass	8e-13	31761296
rs300063	rs301901	0.951755918596313	Height	4e-16	25282103
rs300063	rs301901	0.951755918596313	Height	2e-06	35831902
rs300063	rs158622	0.921013951076515	Height	4e-15	36224396
rs300063	rs158791	0.908798552659883	Height	2e-31	36224396
rs300063	rs300053	0.882403696167962	Height	3e-11	34594039
rs300063	rs300053	0.882403696167962	Height	3e-36	34594039
rs300063	rs300053	0.882403696167962	Height	2e-14	31562340
rs300063	rs292168	0.87599887786468	Red cell distribution width	3e-10	30595370
rs300063	rs300046	0.867800376414356	Meat-related diet	5e-08	32066663
rs300064	rs158796	0.979013762338526	Height	5e-243	36224396
rs300064	rs292172	0.959053686763963	Appendicular lean mass	8e-13	31761296
rs300064	rs301901	0.950949379578569	Height	4e-16	25282103
rs300064	rs301901	0.950949379578569	Height	2e-06	35831902
rs300064	rs158622	0.918582645672875	Height	4e-15	36224396
rs300064	rs158791	0.91779756005065	Height	2e-31	36224396
rs300064	rs300053	0.881645949970014	Height	3e-11	34594039
rs300064	rs300053	0.881645949970014	Height	3e-36	34594039
rs300064	rs300053	0.881645949970014	Height	2e-14	31562340
rs300064	rs292168	0.872052546612156	Red cell distribution width	3e-10	30595370
rs300064	rs300046	0.867063282269116	Meat-related diet	5e-08	32066663
rs3002698	rs11087521	0.885510881159929	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs3002698	rs59934506	0.86576657423415	Body fat percentage	4e-16	33980691
rs3002698	rs59934506	0.86576657423415	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs3002698	rs59934506	0.86576657423415	Alanine aminotransferase levels	2e-10	33980691
rs3002698	rs7267979	0.860925685367584	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs3002698	rs2424698	0.860852480920275	wg lh intensity-contrast middletemporal	3e-13	33875891
rs3002698	rs2424698	0.860852480920275	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs3002698	rs2424698	0.860852480920275	wg rh intensity-contrast middletemporal	7e-13	33875891
rs3002698	rs2424698	0.860852480920275	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs3002698	rs2424698	0.860852480920275	C-reactive protein	5e-11	34594039
rs3002698	rs7020	0.853106353797714	wg rh intensity-contrast fusiform	1e-10	33875891
rs3002698	rs7020	0.853106353797714	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs3002698	rs7020	0.853106353797714	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs3002698	rs7020	0.853106353797714	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs3002698	rs2151144	0.848597793685039	wg lh intensity-contrast fusiform	5e-12	33875891
rs3002698	rs2151144	0.848597793685039	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs3002698	rs2151144	0.848597793685039	wg rh intensity-contrast insula	6e-18	33875891
rs3002698	rs2151144	0.848597793685039	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs3002698	rs2151144	0.848597793685039	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs3002698	rs2151144	0.848597793685039	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs3002698	rs6083838	0.845203718951427	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs3002698	rs6083838	0.845203718951427	wg lh intensity-contrast insula	6e-13	33875891
rs3002698	rs7274104	0.832774015313452	Cortical thickness	4e-08	34560273
rs3002698	rs6115101	0.816013646867733	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs3002698	rs6115101	0.816013646867733	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs3002698	rs6115101	0.816013646867733	wg rh intensity-contrast supramarginal	3e-11	33875891
rs3002698	rs6115118	0.816013646867733	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs3002698	rs6138553	0.81526420423319	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs3002698	rs6115099	0.810423594522509	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs3002698	rs6115200	0.80627143895536	Height	9e-09	36224396
rs3002698	rs6115204	0.804833273269577	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs3002698	rs6138556	0.804101365667406	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs3002698	rs6083799	0.791657829863605	Serum alkaline phosphatase levels	1e-71	33547301
rs3002698	rs2261795	0.772794263574283	Non-HDL cholesterol levels	1e-09	34887591
rs3002698	rs84816	0.763834525019251	aseg rh intensity Caudate	7e-09	33875891
rs3002698	rs84816	0.763834525019251	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs3002698	rs4815412	0.763618861444708	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs3002698	rs12428	0.759755497214167	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs3002698	rs2500406	0.754198589202499	Brain region volumes	2e-08	31676860
rs3002698	rs2500406	0.754198589202499	Height	1e-33	36224396
rs3002698	rs2856	0.752161998792123	Blood protein levels	6e-07	27532455
rs3002698	rs6132824	0.743525997420545	Multi-trait sum score	5e-08	37277458
rs3002698	rs11699953	0.7428396745168	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs3002698	rs8184820	0.740766845299658	Brain morphology (MOSTest)	4e-13	35164939
rs3002698	rs9927	0.719979015807918	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs3002698	rs3746337	0.69730933734768	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs3002698	rs3746337	0.69730933734768	wg lh intensity-contrast frontalpole	1e-09	33875891
rs3002698	rs3746337	0.69730933734768	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs3002698	rs3746337	0.69730933734768	Total cholesterol levels	3e-09	34887591
rs3002698	rs2500430	0.692263791533519	Serum alkaline phosphatase levels	7e-10	31666285
rs3002698	rs6050464	0.680567398847555	Brain region volumes	5e-09	31676860
rs3002698	rs6050464	0.680567398847555	Apolipoprotein B levels	6e-14	32203549
rs3002698	rs1888995	0.67824774389966	Weight	2e-11	34594039
rs3002698	rs2260997	0.666966724155298	Subcortical volume (MOSTest)	4e-09	32665545
rs3002698	rs2260997	0.666966724155298	Platelet distribution width	5e-17	32888494
rs3007670	rs2999541	1	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs3007670	rs3007711	0.995783742126405	Electrodermal activity	9e-06	25387706
rs3007670	rs2130525	0.892194099916733	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs3007670	rs7542137	0.84454600981745	Beta-hydroxyisovalerate levels	3e-11	35050183
rs3007670	rs7542137	0.84454600981745	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs3007670	rs7542137	0.84454600981745	3-hydroxysebacate levels	2e-10	36635386
rs3007670	rs10788817	0.78803489023865	Serum metabolite levels	3e-13	24625756
rs3007670	rs10788817	0.78803489023865	Metabolite peak levels (QI2718)	5e-18	35995766
rs3007670	rs10788817	0.78803489023865	3-hydroxylaurate levels	2e-12	36635386
rs3007670	rs10788817	0.78803489023865	Tetradecadienoate (14:2) levels	8e-17	36635386
rs3007670	rs11204914	0.784189575914813	Carnitine C9 levels	1e-13	35995766
rs3007670	rs11204914	0.784189575914813	Metabolite peak levels (QI6204)	1e-32	35995766
rs3007670	rs11204914	0.784189575914813	Metabolite peak levels (QI6252)	2e-32	35995766
rs3007670	rs6685187	0.760111553400485	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs3007670	rs6698740	0.75804274474034	Beta-hydroxyisovalerate levels	1e-13	35347128
rs3007670	rs1060870	0.756603012838021	Serum metabolite levels	1e-11	33031748
rs3007670	rs1060870	0.756603012838021	Serum metabolite levels	1e-15	33031748
rs3007670	rs2338201	0.747081739629544	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs3007670	rs2338201	0.747081739629544	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs3007670	rs2338201	0.747081739629544	Dodecadienoate (12:2) levels	7e-15	36635386
rs3007670	rs2279501	0.727270447289022	Serum metabolite levels	3e-14	33031748
rs3007670	rs56000812	0.682084106322215	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs3007670	rs56078223	0.679952879480075	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs3007670	rs56078223	0.679952879480075	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs3007670	rs10494270	0.670503454851672	Nonaylcarnitine levels	5e-13	26068415
rs3007670	rs9943221	0.663785006203325	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs3007670	rs2999545	0.662705733796985	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs3007670	rs7523082	0.630553122298745	Metabolite peak levels (QI9845)	2e-14	35995766
rs3007670	rs10888445	0.627400974162425	Beta-hydroxyisovalerate levels	5e-13	36635386
rs3007670	rs7541453	0.624707223046545	Serum metabolite levels	2e-16	33031748
rs3007670	rs7541453	0.624707223046545	Serum metabolite levels	2e-16	33031748
rs3007670	rs7541453	0.624707223046545	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs3007670	rs1038747	0.618799228812066	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs3007670	rs6684312	0.612169241811288	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs3007685	rs2999541	1	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs3007685	rs3007711	0.995783742126405	Electrodermal activity	9e-06	25387706
rs3007685	rs2130525	0.892194099916733	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs3007685	rs7542137	0.84454600981745	Beta-hydroxyisovalerate levels	3e-11	35050183
rs3007685	rs7542137	0.84454600981745	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs3007685	rs7542137	0.84454600981745	3-hydroxysebacate levels	2e-10	36635386
rs3007685	rs10788817	0.78803489023865	Serum metabolite levels	3e-13	24625756
rs3007685	rs10788817	0.78803489023865	Metabolite peak levels (QI2718)	5e-18	35995766
rs3007685	rs10788817	0.78803489023865	3-hydroxylaurate levels	2e-12	36635386
rs3007685	rs10788817	0.78803489023865	Tetradecadienoate (14:2) levels	8e-17	36635386
rs3007685	rs11204914	0.784189575914813	Carnitine C9 levels	1e-13	35995766
rs3007685	rs11204914	0.784189575914813	Metabolite peak levels (QI6204)	1e-32	35995766
rs3007685	rs11204914	0.784189575914813	Metabolite peak levels (QI6252)	2e-32	35995766
rs3007685	rs6685187	0.760111553400485	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs3007685	rs6698740	0.75804274474034	Beta-hydroxyisovalerate levels	1e-13	35347128
rs3007685	rs1060870	0.756603012838021	Serum metabolite levels	1e-11	33031748
rs3007685	rs1060870	0.756603012838021	Serum metabolite levels	1e-15	33031748
rs3007685	rs2338201	0.747081739629544	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs3007685	rs2338201	0.747081739629544	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs3007685	rs2338201	0.747081739629544	Dodecadienoate (12:2) levels	7e-15	36635386
rs3007685	rs2279501	0.727270447289022	Serum metabolite levels	3e-14	33031748
rs3007685	rs56000812	0.682084106322215	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs3007685	rs56078223	0.679952879480075	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs3007685	rs56078223	0.679952879480075	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs3007685	rs10494270	0.670503454851672	Nonaylcarnitine levels	5e-13	26068415
rs3007685	rs9943221	0.663785006203325	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs3007685	rs2999545	0.662705733796985	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs3007685	rs7523082	0.630553122298745	Metabolite peak levels (QI9845)	2e-14	35995766
rs3007685	rs10888445	0.627400974162425	Beta-hydroxyisovalerate levels	5e-13	36635386
rs3007685	rs7541453	0.624707223046545	Serum metabolite levels	2e-16	33031748
rs3007685	rs7541453	0.624707223046545	Serum metabolite levels	2e-16	33031748
rs3007685	rs7541453	0.624707223046545	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs3007685	rs1038747	0.618799228812066	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs3007685	rs6684312	0.612169241811288	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs3007711	rs3007711	1	Electrodermal activity	9e-06	25387706
rs3007711	rs2999541	0.995783742126405	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs3007711	rs2130525	0.88829997623759	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs3007711	rs7542137	0.845358437878175	Beta-hydroxyisovalerate levels	3e-11	35050183
rs3007711	rs7542137	0.845358437878175	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs3007711	rs7542137	0.845358437878175	3-hydroxysebacate levels	2e-10	36635386
rs3007711	rs10788817	0.787495595905526	Serum metabolite levels	3e-13	24625756
rs3007711	rs10788817	0.787495595905526	Metabolite peak levels (QI2718)	5e-18	35995766
rs3007711	rs10788817	0.787495595905526	3-hydroxylaurate levels	2e-12	36635386
rs3007711	rs10788817	0.787495595905526	Tetradecadienoate (14:2) levels	8e-17	36635386
rs3007711	rs11204914	0.783641184082685	Carnitine C9 levels	1e-13	35995766
rs3007711	rs11204914	0.783641184082685	Metabolite peak levels (QI6204)	1e-32	35995766
rs3007711	rs11204914	0.783641184082685	Metabolite peak levels (QI6252)	2e-32	35995766
rs3007711	rs6685187	0.76102138875327	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs3007711	rs6698740	0.758951575290857	Beta-hydroxyisovalerate levels	1e-13	35347128
rs3007711	rs1060870	0.757510557106821	Serum metabolite levels	1e-11	33031748
rs3007711	rs1060870	0.757510557106821	Serum metabolite levels	1e-15	33031748
rs3007711	rs2338201	0.749422690073395	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs3007711	rs2338201	0.749422690073395	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs3007711	rs2338201	0.749422690073395	Dodecadienoate (12:2) levels	7e-15	36635386
rs3007711	rs2279501	0.730893661908317	Serum metabolite levels	3e-14	33031748
rs3007711	rs56000812	0.677889411167584	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs3007711	rs56078223	0.675762364270363	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs3007711	rs56078223	0.675762364270363	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs3007711	rs9943221	0.666975525820922	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs3007711	rs10494270	0.666448281707045	Nonaylcarnitine levels	5e-13	26068415
rs3007711	rs2999545	0.659635299672285	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs3007711	rs7523082	0.631511048621715	Metabolite peak levels (QI9845)	2e-14	35995766
rs3007711	rs10888445	0.629652673007083	Beta-hydroxyisovalerate levels	5e-13	36635386
rs3007711	rs7541453	0.626978273975582	Serum metabolite levels	2e-16	33031748
rs3007711	rs7541453	0.626978273975582	Serum metabolite levels	2e-16	33031748
rs3007711	rs7541453	0.626978273975582	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs3007711	rs1038747	0.622188864120507	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs3007711	rs6684312	0.615183657050702	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs301859	rs301901	0.977284575554222	Height	4e-16	25282103
rs301859	rs301901	0.977284575554222	Height	2e-06	35831902
rs301859	rs158796	0.937386639383958	Height	5e-243	36224396
rs301859	rs292172	0.916472069610979	Appendicular lean mass	8e-13	31761296
rs301859	rs300053	0.91643260941394	Height	3e-11	34594039
rs301859	rs300053	0.91643260941394	Height	3e-36	34594039
rs301859	rs300053	0.91643260941394	Height	2e-14	31562340
rs301859	rs158622	0.914163875205171	Height	4e-15	36224396
rs301859	rs158791	0.883020586932242	Height	2e-31	36224396
rs301859	rs300046	0.880224247066874	Meat-related diet	5e-08	32066663
rs301859	rs292168	0.831663744815804	Red cell distribution width	3e-10	30595370
rs301874	rs2098713	0.844947763509309	Telomere length	3e-06	24795349
rs301874	rs150621	0.805257685062309	Appendicular lean mass	5e-12	31761296
rs301874	rs757720522	0.736020316756615	Appendicular lean mass	3e-11	31761296
rs301874	rs300046	0.621344825114955	Meat-related diet	5e-08	32066663
rs301874	rs158791	0.619356297514167	Height	2e-31	36224396
rs301874	rs292168	0.607899939554565	Red cell distribution width	3e-10	30595370
rs301917	rs158796	0.962575550379678	Height	5e-243	36224396
rs301917	rs301901	0.943148342754006	Height	4e-16	25282103
rs301917	rs301901	0.943148342754006	Height	2e-06	35831902
rs301917	rs292172	0.942708327660646	Appendicular lean mass	8e-13	31761296
rs301917	rs158622	0.936117975536411	Height	4e-15	36224396
rs301917	rs300053	0.901812344431095	Height	3e-11	34594039
rs301917	rs300053	0.901812344431095	Height	3e-36	34594039
rs301917	rs300053	0.901812344431095	Height	2e-14	31562340
rs301917	rs158791	0.890995452246809	Height	2e-31	36224396
rs301917	rs292168	0.857058588668227	Red cell distribution width	3e-10	30595370
rs301917	rs300046	0.852341215691471	Meat-related diet	5e-08	32066663
rs30252	rs30252	1	Atrial fibrillation	4e-14	29892015
rs3087978	rs1173416	0.944251765580398	Height	2e-59	36224396
rs3087978	rs2842611	0.892722247273103	High density lipoprotein cholesterol levels	5e-09	34887591
rs3087978	rs9450288	0.849219815506103	Height	2e-10	36224396
rs3099460	rs10061757	0.924611039859452	Height	4e-30	30595370
rs3099460	rs33321	0.778621539088208	Height	1e-19	34594039
rs3099460	rs832540	0.753764994651373	Coronary artery disease	2e-08	29212778
rs3099460	rs702689	0.62619041859614	Vertex-wise sulcal depth	2e-22	34910505
rs3099554	rs6738934	0.702445486697774	Vaginal microbiome MetaCyc pathway (PWY-5741|ethylmalonyl-CoA pathway)	3e-07	34282934
rs3099554	rs8207	0.642884494618111	Monocyte count	1e-10	32888493
rs3099554	rs8207	0.642884494618111	Height	2e-18	36224396
rs3104057	rs158796	0.973884522829429	Height	5e-243	36224396
rs3104057	rs292172	0.955757831129878	Appendicular lean mass	8e-13	31761296
rs3104057	rs301901	0.943985107148632	Height	4e-16	25282103
rs3104057	rs301901	0.943985107148632	Height	2e-06	35831902
rs3104057	rs158622	0.914078635479686	Height	4e-15	36224396
rs3104057	rs158791	0.905768931894601	Height	2e-31	36224396
rs3104057	rs292168	0.882504907935512	Red cell distribution width	3e-10	30595370
rs3104057	rs300053	0.874488459339053	Height	3e-11	34594039
rs3104057	rs300053	0.874488459339053	Height	3e-36	34594039
rs3104057	rs300053	0.874488459339053	Height	2e-14	31562340
rs3104057	rs300046	0.8579801970189	Meat-related diet	5e-08	32066663
rs3105369	rs337277	0.919498117161105	Metabolite peak levels (QI10992)	3e-52	35995766
rs3105369	rs337277	0.919498117161105	Metabolite peak levels (QI4667)	7e-18	35995766
rs3105369	rs337277	0.919498117161105	Metabolite peak levels (QI4708)	1e-21	35995766
rs3105369	rs337277	0.919498117161105	Metabolite peak levels (QI5169)	7e-57	35995766
rs3105369	rs7655841	0.742467227443807	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs3113489	rs337277	0.864776991955795	Metabolite peak levels (QI10992)	3e-52	35995766
rs3113489	rs337277	0.864776991955795	Metabolite peak levels (QI4667)	7e-18	35995766
rs3113489	rs337277	0.864776991955795	Metabolite peak levels (QI4708)	1e-21	35995766
rs3113489	rs337277	0.864776991955795	Metabolite peak levels (QI5169)	7e-57	35995766
rs3113489	rs7655841	0.829917533104912	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs3118737	rs770199	0.651003712179551	Hair color	3e-08	30595370
rs3128980	rs1063631	0.743476573677726	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs3128980	rs1063631	0.743476573677726	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs3128980	rs6928810	0.74128290547935	Platelet distribution width	1e-14	32888494
rs3128980	rs3869132	0.737979917780161	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs3128980	rs3869132	0.737979917780161	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs3128980	rs9266825	0.721506780741275	Autism spectrum disorder	6e-06	35215271
rs3128980	rs199530775	0.6188188548506	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs3128980	rs55957433	0.6188188548506	Hip circumference adjusted for BMI	3e-08	34021172
rs3129755	rs3129755	1	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs3129755	rs3129755	1	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs3129755	rs3129755	1	Triglyceride levels in very large VLDL	3e-21	35213538
rs3129755	rs3129755	1	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs3129755	rs3129755	1	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs3129755	rs3129755	1	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs3129755	rs3129755	1	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs3129755	rs3129755	1	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs3129755	rs3129755	1	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs3129755	rs3129755	1	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs3129755	rs3129755	1	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs3129755	rs3129755	1	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs3129755	rs3129755	1	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs3129755	rs3129755	1	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs3129755	rs3129755	1	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs3129755	rs3129755	1	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs3129755	rs3129755	1	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs3129755	rs3129755	1	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs3129755	rs3129755	1	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs3129755	rs3129755	1	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs3129755	rs3129755	1	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs3129755	rs3129755	1	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs3129755	rs3129755	1	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs3129755	rs3129755	1	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs3129755	rs3129755	1	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs3129755	rs28383224	0.880339719962196	Neuromyelitis optica	6e-12	29769526
rs3129755	rs28383224	0.880339719962196	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs3129755	rs28383224	0.880339719962196	Waist-hip index	1e-19	34021172
rs3129755	rs28383224	0.880339719962196	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs3129755	rs28383224	0.880339719962196	Waist circumference adjusted for body mass index	9e-10	34021172
rs3129755	rs28383233	0.877341263125979	Free cholesterol levels in very large HDL	4e-14	35213538
rs3129755	rs28383221	0.875134558434715	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs3129755	rs28383223	0.871770775737067	Alanine aminotransferase levels	7e-38	33547301
rs3129755	rs685244	0.86333485231187	Complement C4 levels	2e-12	36168886
rs3129755	rs28383241	0.765508240302123	Alanine aminotransferase levels	9e-40	34594039
rs3129755	rs502803	0.72382082655676	Basal cell carcinoma (MTAG)	2e-95	36496446
rs3129755	rs13191975	0.717716731792511	A body shape index	4e-12	34021172
rs3129755	rs5021727	0.716422121937072	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs3129755	rs5021727	0.716422121937072	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs3129755	rs5021727	0.716422121937072	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs3129755	rs5021727	0.716422121937072	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs3129755	rs5021727	0.716422121937072	Metabolic syndrome	2e-08	31589552
rs3129755	rs28752509	0.714981377350873	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs3129755	rs28752509	0.714981377350873	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs3129755	rs28752510	0.714981377350873	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs3129755	rs28752510	0.714981377350873	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs3129755	rs28752510	0.714981377350873	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs3129755	rs28752510	0.714981377350873	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs3129755	rs28752510	0.714981377350873	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs3129755	rs28752510	0.714981377350873	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs3129755	rs28752510	0.714981377350873	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs3129755	rs28752510	0.714981377350873	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs3129755	rs28752510	0.714981377350873	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs3129755	rs28752510	0.714981377350873	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs3129755	rs28752510	0.714981377350873	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs3129755	rs28752510	0.714981377350873	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs3129755	rs28752510	0.714981377350873	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs3129755	rs28752510	0.714981377350873	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs3129755	rs28752510	0.714981377350873	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs3129755	rs28752510	0.714981377350873	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs3129755	rs28752510	0.714981377350873	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs3129755	rs28752510	0.714981377350873	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs3129755	rs28752510	0.714981377350873	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs3129755	rs28752510	0.714981377350873	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs3129755	rs28752510	0.714981377350873	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs3129755	rs28752510	0.714981377350873	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs3129755	rs686250	0.629002351072293	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs3129756	rs3129754	0.995689126609818	Waist-hip index	2e-12	34021172
rs3129756	rs3129754	0.995689126609818	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs3129756	rs4959106	0.868666212742816	Interleukin-6 levels	7e-13	33067605
rs3129756	rs34077986	0.852465853871301	A body shape index	5e-11	34021172
rs3129756	rs34656207	0.700498950351513	Aspartate aminotransferase levels	1e-111	33547301
rs3129756	rs34656207	0.700498950351513	Aspartate aminotransferase levels	1e-126	34594039
rs3129756	rs4959105	0.630347958975588	Lymphocyte count	3e-16	29403010
rs3129756	rs33915496	0.627494542830905	Lymphocyte count	1e-16	32888493
rs3129762	rs3129762	1	Butyrophilin-like protein 9 levels	1e-51	34648354
rs3129762	rs3129757	0.993750354722081	Cathepsin L1 levels	9e-17	33067605
rs3129762	rs9271366	0.984398019214591	Ulcerative colitis	7e-06	26278503
rs3129762	rs9271366	0.984398019214591	Multiple sclerosis	7e-184	19525955
rs3129762	rs9271366	0.984398019214591	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs3129762	rs9271366	0.984398019214591	Ulcerative colitis	1e-18	23511034
rs3129762	rs9271366	0.984398019214591	Immunoglobulin A	3e-33	20694011
rs3129762	rs9271366	0.984398019214591	Multiple sclerosis	4e-17	20598377
rs3129762	rs9271366	0.984398019214591	Crohn's disease	5e-12	23850713
rs3129762	rs9271366	0.984398019214591	Systemic lupus erythematosus	1e-07	19838195
rs3129762	rs3135005	0.91747763364198	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs3129762	rs1966002	0.833087637855502	Systemic lupus erythematosus	8e-31	33272962
rs3129762	rs9271055	0.827702117502632	Height	5e-09	36224396
rs3129762	rs9270986	0.825390355827359	Myasthenia gravis	6e-08	25643325
rs3129762	rs9270984	0.824274864002717	Systemic lupus erythematosus	5e-24	23273568
rs3129762	rs9271082	0.814332279810966	IgA nephropathy	8e-09	34076728
rs3129762	rs4329147	0.783845838847991	Childhood ear infection	1e-11	28928442
rs3129762	rs4329147	0.783845838847991	Childhood ear infection	1e-11	27182965
rs3129762	rs4367411	0.75269186673833	Total omega-3 fatty acid levels	7e-09	35692035
rs3129762	rs9271025	0.730395047496906	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs3129762	rs9271421	0.667250365785725	GDH/6PGL endoplasmic bifunctional protein levels (H6PD.7161.25.3)	5e-29	29875488
rs3129762	rs9268851	0.624512010820168	Serum levels of protein H6PD	1e-96	35078996
rs3129762	rs9268851	0.624512010820168	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs3129762	rs9271363	0.608492461568664	Colorectal cancer	9e-20	36539618
rs3135005	rs3135005	1	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs3135005	rs9271366	0.929249816269998	Ulcerative colitis	7e-06	26278503
rs3135005	rs9271366	0.929249816269998	Multiple sclerosis	7e-184	19525955
rs3135005	rs9271366	0.929249816269998	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs3135005	rs9271366	0.929249816269998	Ulcerative colitis	1e-18	23511034
rs3135005	rs9271366	0.929249816269998	Immunoglobulin A	3e-33	20694011
rs3135005	rs9271366	0.929249816269998	Multiple sclerosis	4e-17	20598377
rs3135005	rs9271366	0.929249816269998	Crohn's disease	5e-12	23850713
rs3135005	rs9271366	0.929249816269998	Systemic lupus erythematosus	1e-07	19838195
rs3135005	rs3129757	0.920405948223329	Cathepsin L1 levels	9e-17	33067605
rs3135005	rs3129762	0.91747763364198	Butyrophilin-like protein 9 levels	1e-51	34648354
rs3135005	rs9271055	0.775847110683158	Height	5e-09	36224396
rs3135005	rs9270986	0.773627457163994	Myasthenia gravis	6e-08	25643325
rs3135005	rs9270984	0.772678776615759	Systemic lupus erythematosus	5e-24	23273568
rs3135005	rs1966002	0.768244447809621	Systemic lupus erythematosus	8e-31	33272962
rs3135005	rs9271082	0.760582064342899	IgA nephropathy	8e-09	34076728
rs3135005	rs4329147	0.729384871174091	Childhood ear infection	1e-11	28928442
rs3135005	rs4329147	0.729384871174091	Childhood ear infection	1e-11	27182965
rs3135005	rs4367411	0.718316283062517	Total omega-3 fatty acid levels	7e-09	35692035
rs3135005	rs9271025	0.707843144340417	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs3135005	rs9271421	0.624447211675126	GDH/6PGL endoplasmic bifunctional protein levels (H6PD.7161.25.3)	5e-29	29875488
rs318513	rs10010659	0.965785540179359	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs318517	rs10010659	0.966788933965318	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs318543	rs10010659	0.992933936506113	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs318552	rs10010659	0.991914665665751	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs3195676	rs7721230	0.752830934298015	Skin color	4e-10	36672889
rs3213245	rs3213282	0.607486747611722	Low density lipoprotein cholesterol levels	3e-11	32154731
rs3213255	rs3213282	0.618424968308371	Low density lipoprotein cholesterol levels	3e-11	32154731
rs3213263	rs3213282	0.615843131369158	Low density lipoprotein cholesterol levels	3e-11	32154731
rs3213276	rs3213282	0.732869986086581	Low density lipoprotein cholesterol levels	3e-11	32154731
rs3213329	rs3213282	0.601588377659801	Low density lipoprotein cholesterol levels	3e-11	32154731
rs324126	rs324126	1	Colonoscopy-negative controls vs population controls	6e-06	29228715
rs3309	rs9292122	0.984887708989562	Prostate cancer	5e-09	33398198
rs3309	rs702689	0.707615068103069	Vertex-wise sulcal depth	2e-22	34910505
rs331498	rs33321	0.933512669985549	Height	1e-19	34594039
rs331498	rs832540	0.880908029304773	Coronary artery disease	2e-08	29212778
rs331498	rs10061757	0.682510600469254	Height	4e-30	30595370
rs331498	rs96844	0.613273024040691	Type 2 diabetes	5e-08	30297969
rs331498	rs96844	0.613273024040691	Height	4e-33	36224396
rs331499	rs33321	0.972871779532279	Height	1e-19	34594039
rs331499	rs832540	0.912209671020834	Coronary artery disease	2e-08	29212778
rs331499	rs10061757	0.705391423138971	Height	4e-30	30595370
rs331499	rs96844	0.601756449544451	Type 2 diabetes	5e-08	30297969
rs331499	rs96844	0.601756449544451	Height	4e-33	36224396
rs33318	rs33321	0.980684560824404	Height	1e-19	34594039
rs33318	rs832540	0.917988105855156	Coronary artery disease	2e-08	29212778
rs33318	rs10061757	0.710430965544587	Height	4e-30	30595370
rs33318	rs96844	0.608168349866359	Type 2 diabetes	5e-08	30297969
rs33318	rs96844	0.608168349866359	Height	4e-33	36224396
rs33319	rs33321	0.924141131009501	Height	1e-19	34594039
rs33319	rs832540	0.863199645330202	Coronary artery disease	2e-08	29212778
rs33319	rs10061757	0.720405373628469	Height	4e-30	30595370
rs33319	rs96844	0.651453220855357	Type 2 diabetes	5e-08	30297969
rs33319	rs96844	0.651453220855357	Height	4e-33	36224396
rs33323	rs10061757	0.965292829932318	Height	4e-30	30595370
rs33323	rs832540	0.793975838076231	Coronary artery disease	2e-08	29212778
rs33323	rs33321	0.738070389662613	Height	1e-19	34594039
rs33328	rs10061757	0.92720241879833	Height	4e-30	30595370
rs33328	rs33321	0.779563351803182	Height	1e-19	34594039
rs33328	rs832540	0.754757919881851	Coronary artery disease	2e-08	29212778
rs33328	rs702689	0.627814527706756	Vertex-wise sulcal depth	2e-22	34910505
rs33328	rs96844	0.600232273940177	Type 2 diabetes	5e-08	30297969
rs33328	rs96844	0.600232273940177	Height	4e-33	36224396
rs337100	rs337100	1	Pulse pressure	5e-09	28739976
rs337100	rs337100	1	Pulse pressure	3e-08	28739976
rs337263	rs337277	0.948932140802198	Metabolite peak levels (QI10992)	3e-52	35995766
rs337263	rs337277	0.948932140802198	Metabolite peak levels (QI4667)	7e-18	35995766
rs337263	rs337277	0.948932140802198	Metabolite peak levels (QI4708)	1e-21	35995766
rs337263	rs337277	0.948932140802198	Metabolite peak levels (QI5169)	7e-57	35995766
rs337263	rs7655841	0.78185733191267	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs337266	rs337277	0.926445192922731	Metabolite peak levels (QI10992)	3e-52	35995766
rs337266	rs337277	0.926445192922731	Metabolite peak levels (QI4667)	7e-18	35995766
rs337266	rs337277	0.926445192922731	Metabolite peak levels (QI4708)	1e-21	35995766
rs337266	rs337277	0.926445192922731	Metabolite peak levels (QI5169)	7e-57	35995766
rs337266	rs7655841	0.743041788754351	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs337267	rs337277	0.927326175024698	Metabolite peak levels (QI10992)	3e-52	35995766
rs337267	rs337277	0.927326175024698	Metabolite peak levels (QI4667)	7e-18	35995766
rs337267	rs337277	0.927326175024698	Metabolite peak levels (QI4708)	1e-21	35995766
rs337267	rs337277	0.927326175024698	Metabolite peak levels (QI5169)	7e-57	35995766
rs337267	rs7655841	0.743777218959869	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs337270	rs337277	0.868307060851615	Metabolite peak levels (QI10992)	3e-52	35995766
rs337270	rs337277	0.868307060851615	Metabolite peak levels (QI4667)	7e-18	35995766
rs337270	rs337277	0.868307060851615	Metabolite peak levels (QI4708)	1e-21	35995766
rs337270	rs337277	0.868307060851615	Metabolite peak levels (QI5169)	7e-57	35995766
rs337270	rs7655841	0.677503987896072	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs337274	rs337277	0.921342810425913	Metabolite peak levels (QI10992)	3e-52	35995766
rs337274	rs337277	0.921342810425913	Metabolite peak levels (QI4667)	7e-18	35995766
rs337274	rs337277	0.921342810425913	Metabolite peak levels (QI4708)	1e-21	35995766
rs337274	rs337277	0.921342810425913	Metabolite peak levels (QI5169)	7e-57	35995766
rs337274	rs7655841	0.766238361434792	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs337275	rs337277	0.924985554607382	Metabolite peak levels (QI10992)	3e-52	35995766
rs337275	rs337277	0.924985554607382	Metabolite peak levels (QI4667)	7e-18	35995766
rs337275	rs337277	0.924985554607382	Metabolite peak levels (QI4708)	1e-21	35995766
rs337275	rs337277	0.924985554607382	Metabolite peak levels (QI5169)	7e-57	35995766
rs337275	rs7655841	0.769764196390445	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs337277	rs337277	1	Metabolite peak levels (QI10992)	3e-52	35995766
rs337277	rs337277	1	Metabolite peak levels (QI4667)	7e-18	35995766
rs337277	rs337277	1	Metabolite peak levels (QI4708)	1e-21	35995766
rs337277	rs337277	1	Metabolite peak levels (QI5169)	7e-57	35995766
rs337277	rs7655841	0.744284009433704	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs337278	rs337277	0.930115551699897	Metabolite peak levels (QI10992)	3e-52	35995766
rs337278	rs337277	0.930115551699897	Metabolite peak levels (QI4667)	7e-18	35995766
rs337278	rs337277	0.930115551699897	Metabolite peak levels (QI4708)	1e-21	35995766
rs337278	rs337277	0.930115551699897	Metabolite peak levels (QI5169)	7e-57	35995766
rs337278	rs7655841	0.737155638473396	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs34027561	rs13271626	0.987754605088469	Haemorrhoidal disease	3e-10	33888516
rs34027561	rs11778693	0.964820826472312	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs34027561	rs11778693	0.964820826472312	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs34027561	rs34269854	0.845196699627752	Lung function (forced vital capacity)	3e-09	36914875
rs34027561	rs746011	0.736695014651101	Triglycerides	2e-10	30275531
rs34027561	rs11781149	0.719371535578708	Refractive error	2e-17	32231278
rs34027561	rs11780207	0.637744268503106	Estimated glomerular filtration rate	2e-13	33462484
rs34027561	rs11780207	0.637744268503106	Serum total protein level	2e-09	33462484
rs34027561	rs11780207	0.637744268503106	Creatinine levels	2e-13	33462484
rs34027561	rs751680	0.627149432248274	Insomnia	7e-09	35835914
rs34027561	rs11782130	0.621176987474976	C-reactive protein levels	9e-09	35459240
rs34027561	rs4592028	0.616469671677289	Non-albumin protein levels	3e-09	33462484
rs34027561	rs1545837	0.60842458424448	Lung function (FVC)	1e-10	30595370
rs34042490	rs6501801	0.843654813702659	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-07	31719535
rs34042490	rs6501801	0.843654813702659	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-10	31719535
rs34042490	rs6501801	0.843654813702659	HDL cholesterol levels x long total sleep time interaction (1df test)	7e-06	31719535
rs34042490	rs8065231	0.814393326796072	HDL cholesterol levels x long total sleep time interaction (2df test)	5e-10	31719535
rs34042490	rs8065231	0.814393326796072	HDL cholesterol levels x long total sleep time interaction (1df test)	6e-07	31719535
rs34076535	rs11580836	0.830254000613156	Body mass index	2e-09	36581621
rs34076535	rs10465746	0.80110867308228	Obesity-related traits	8e-06	23251661
rs34086582	rs34579268	0.991443244201913	Hematocrit	5e-30	32888493
rs34086582	rs34579268	0.991443244201913	Hematocrit	2e-27	32888493
rs34086582	rs34579268	0.991443244201913	Hemoglobin concentration	5e-26	32888493
rs34086582	rs11705721	0.984086793695795	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs34086582	rs11130638	0.984086793695795	Hemoglobin concentration	2e-23	32888493
rs34086582	rs7610312	0.960936879326119	Red blood cell count	5e-09	27863252
rs34086582	rs6775517	0.959726850026845	Hematocrit	1e-17	34594039
rs34086582	rs57700771	0.954878604795084	Red blood cell count	9e-21	30595370
rs34086582	rs55704295	0.888076804607177	Red blood cell count	8e-26	32888493
rs34086582	rs55704295	0.888076804607177	Red blood cell count	5e-23	32888493
rs34086582	rs55704295	0.888076804607177	Serum total protein level	2e-29	34594039
rs34086582	rs4681679	0.863497436932052	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs34086582	rs11719450	0.856687043626059	Hemoglobin concentration	2e-09	27863252
rs34086582	rs11719450	0.856687043626059	Hemoglobin levels	2e-16	32327693
rs34086582	rs11922478	0.84518832890047	Semaphorin-6B levels	4e-12	34648354
rs34086582	rs56384862	0.826591297052904	Body mass index	8e-12	29273807
rs34086582	rs56384862	0.826591297052904	Body mass index	3e-06	30108127
rs34086582	rs56384862	0.826591297052904	Hemoglobin levels	1e-16	32327693
rs34086582	rs56384862	0.826591297052904	Body mass index	3e-14	36581621
rs34086582	rs55692656	0.802670874026944	vWF levels	3e-08	30586737
rs34086582	rs55692656	0.802670874026944	vWF levels	6e-09	30586737
rs34086582	rs6445969	0.682186570638521	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs34086582	rs55954186	0.676297255094716	vWF levels	5e-09	30586737
rs34086582	rs55954186	0.676297255094716	vWF levels	9e-09	30586737
rs34086582	rs11708895	0.673724290377287	Red blood cell count	1e-20	32888494
rs34086582	rs7431952	0.612229717178956	Hemoglobin levels	1e-12	32327693
rs34086988	rs3772130	0.916066060671385	Cognitive performance	6e-06	19734545
rs34086988	rs3772128	0.916066060671385	Mean spheric corpuscular volume	4e-09	32888494
rs34086988	rs33988592	0.908491481240339	Mean corpuscular hemoglobin	9e-11	32888493
rs34086988	rs33988592	0.908491481240339	Mean corpuscular volume	4e-12	32888493
rs34086988	rs6791046	0.904052897317498	Mean reticulocyte volume	4e-12	32888494
rs34086988	rs1573819	0.866945072179545	Mean corpuscular volume	3e-10	32888493
rs34086988	rs13433692	0.62559032874296	Corneal resistance factor (MTAG)	5e-08	35446358
rs34092307	rs6723298	0.68079875165929	Smoking initiation	2e-12	36477530
rs34092307	rs2194492	0.660639002491709	Educational attainment	9e-09	35361970
rs34092307	rs13020443	0.650770860274251	Type 2 diabetes	3e-11	32541925
rs34107631	rs2431501	0.996365076708427	Lung function (FEV1/FVC)	7e-13	36914875
rs34136174	rs4959106	0.979107668796708	Interleukin-6 levels	7e-13	33067605
rs34136174	rs34077986	0.969998716697366	A body shape index	5e-11	34021172
rs34136174	rs3129754	0.865921764973324	Waist-hip index	2e-12	34021172
rs34136174	rs3129754	0.865921764973324	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs34136174	rs34656207	0.802535689290397	Aspartate aminotransferase levels	1e-111	33547301
rs34136174	rs34656207	0.802535689290397	Aspartate aminotransferase levels	1e-126	34594039
rs34136174	rs33915496	0.74736567181296	Lymphocyte count	1e-16	32888493
rs34136174	rs4959105	0.734093736505725	Lymphocyte count	3e-16	29403010
rs34136174	rs33932178	0.64869403726512	Lymphocyte count	3e-22	34594039
rs34136174	rs685244	0.607628759878155	Complement C4 levels	2e-12	36168886
rs34136174	rs3104414	0.607245031892203	HLA DR+ T cell%T cell	9e-09	32929287
rs34136174	rs3104414	0.607245031892203	Chronic sinus infection	2e-06	28928442
rs34136174	rs3104414	0.607245031892203	Hip circumference adjusted for BMI	9e-13	34021172
rs34136174	rs28383224	0.602429831962672	Neuromyelitis optica	6e-12	29769526
rs34136174	rs28383224	0.602429831962672	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs34136174	rs28383224	0.602429831962672	Waist-hip index	1e-19	34021172
rs34136174	rs28383224	0.602429831962672	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs34136174	rs28383224	0.602429831962672	Waist circumference adjusted for body mass index	9e-10	34021172
rs34138933	rs1436958	0.97829966453148	IgG glycosylation	9e-06	23382691
rs34138933	rs2162062	0.803373858242654	Height	2e-13	35831902
rs34138933	rs933807	0.757662715047819	Fat-free mass	6e-06	30593698
rs34138933	rs933807	0.757662715047819	Fat-free mass	2e-07	30593698
rs34138933	rs933807	0.757662715047819	Fat-free mass	8e-11	30593698
rs34138933	rs7178540	0.674872100792219	Height	1e-31	36224396
rs34138933	rs11635977	0.65855054797013	Height	2e-25	36224396
rs34138933	rs72749770	0.648538806568653	Low density lipoprotein cholesterol levels	9e-10	32493714
rs34138933	rs72749770	0.648538806568653	Apolipoprotein B levels	2e-09	32203549
rs34138933	rs7162536	0.647384598883998	Height	4e-29	34594039
rs34138933	rs7178424	0.637723440917106	Height	6e-09	20881960
rs34138933	rs7178424	0.637723440917106	Height	6e-13	35831902
rs34138933	rs7178424	0.637723440917106	Height	3e-251	36224396
rs34138933	rs17271431	0.635274368939389	Height	2e-11	34594039
rs34138933	rs17205463	0.634651203346316	Serum levels of protein IGF1	8e-08	27329260
rs34138933	rs17205463	0.634651203346316	Appendicular lean mass	4e-43	33097823
rs34138933	rs17205463	0.634651203346316	Height	2e-35	30595370
rs34138933	rs731820	0.623361574781812	Height	2e-13	31562340
rs34138933	rs731820	0.623361574781812	Height	2e-12	35831902
rs34141614	rs9462030	0.960493851248035	Red cell distribution width	5e-25	32888493
rs34141614	rs9469857	0.955820571398928	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs34141614	rs2764208	0.955077443167702	Systemic lupus erythematosus	7e-06	24871463
rs34141614	rs9469899	0.943757051129522	Prostate cancer (advanced)	2e-06	29892016
rs34141614	rs9469899	0.943757051129522	Prostate cancer	5e-09	29892016
rs34141614	rs9469899	0.943757051129522	Prostate cancer	8e-11	33398198
rs34141614	rs9469899	0.943757051129522	Hand grip strength	3e-15	29691431
rs34141614	rs9469899	0.943757051129522	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs34141614	rs9469899	0.943757051129522	Graves' disease	4e-10	34594039
rs34141614	rs9469899	0.943757051129522	Coronary artery disease	1e-11	36474045
rs34141614	rs9469899	0.943757051129522	Predicted visceral adipose tissue	2e-20	31501611
rs34141614	rs9469899	0.943757051129522	Medication use (thyroid preparations)	2e-09	31015401
rs34141614	rs9469899	0.943757051129522	Medication use (thyroid preparations)	3e-10	34594039
rs34141614	rs9469872	0.919705408600411	HDL cholesterol levels	3e-11	36333282
rs34141614	rs11755393	0.912959329103966	Body mass index	3e-26	29273807
rs34141614	rs11755393	0.912959329103966	Systemic lupus erythematosus	2e-12	33493351
rs34141614	rs11755393	0.912959329103966	Systemic lupus erythematosus	2e-06	33493351
rs34141614	rs11755393	0.912959329103966	Systemic lupus erythematosus	1e-07	33493351
rs34141614	rs11755393	0.912959329103966	Systemic lupus erythematosus	2e-08	19838195
rs34141614	rs11755393	0.912959329103966	Body mass index	4e-55	36581621
rs34141614	rs9366863	0.909706440053818	Adult body size	9e-33	32376654
rs34141614	rs9366863	0.909706440053818	Body mass index	2e-44	30595370
rs34141614	rs9296128	0.906807253775028	Hip circumference adjusted for BMI	4e-13	34021172
rs34141614	rs6941110	0.902050761306116	Sex hormone-binding globulin levels	5e-27	36653534
rs34141614	rs2814949	0.874094028345412	Essential hypertension (time to event)	9e-09	32589924
rs34141614	rs2744944	0.865049797050743	Hypothyroidism	3e-10	34594039
rs34141614	rs2744944	0.865049797050743	High density lipoprotein cholesterol levels	3e-86	34887591
rs34141614	rs2744944	0.865049797050743	Multi-trait sex score	7e-22	37277458
rs34141614	rs2263329	0.847907154309901	HDL cholesterol	6e-35	34594039
rs34141614	rs2263329	0.847907154309901	HDL cholesterol levels	8e-43	32203549
rs34141614	rs2263329	0.847907154309901	High density lipoprotein cholesterol levels	2e-52	34887591
rs34141614	rs111868030	0.824199863959664	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs34141614	rs9368830	0.802710028560223	HDL cholesterol	4e-21	30275531
rs34141614	rs9368828	0.779738924904885	Body mass index	1e-34	34594039
rs34141614	rs2744973	0.7772303286918	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs34141614	rs2744973	0.7772303286918	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs34141614	rs2744973	0.7772303286918	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs34141614	rs2744973	0.7772303286918	Multi-trait sex score	6e-20	37277458
rs34141614	rs6912327	0.765882849676738	Fasting insulin	5e-06	33402679
rs34141614	rs6912327	0.765882849676738	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs34141614	rs112283401	0.741162488482932	Red cell distribution width	4e-27	30595370
rs34141614	rs9689160	0.610270460512345	Lung function (forced vital capacity)	3e-14	36914875
rs34155960	rs10465746	0.803912588287651	Obesity-related traits	8e-06	23251661
rs34155960	rs11580836	0.7711168122813	Body mass index	2e-09	36581621
rs34157004	rs4421206	0.990353728072038	Brain morphology (min-P)	4e-11	32665545
rs34157004	rs9688452	0.961056532983615	Brainstem global volume Whole-brainstem	1e-11	33875891
rs34157004	rs9688452	0.961056532983615	aseg lh volume VentralDC	2e-10	33875891
rs34157004	rs4380763	0.939524340679462	Subcortical volume (min-P)	1e-11	32665545
rs34157004	rs1934534	0.935625349310075	Pain (pleiotropy)	2e-08	37844115
rs34157004	rs1934534	0.935625349310075	Pain (pleiotropy)	2e-06	37844115
rs34157004	rs11155671	0.919878743644679	Testicular germ cell tumor	2e-09	28604728
rs34157004	rs80147756	0.894807178683323	HippSubfield lh volume subiculum-head	3e-10	33875891
rs34157004	rs9505982	0.894021808352304	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs34157004	rs10872649	0.816691644119174	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs34157004	rs10872649	0.816691644119174	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs34157004	rs10872649	0.816691644119174	Right hippocampal volume (body)	1e-10	37337106
rs34157004	rs7752089	0.780102965989661	Brain morphology (MOSTest)	2e-31	35164939
rs34157004	rs9322194	0.752421419021496	Brainstem volume	2e-11	31636452
rs34157004	rs9285521	0.694172519821489	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs34157004	rs12526675	0.682026872744677	Brain morphology (MOSTest)	7e-22	32665545
rs34157004	rs2342764	0.639113993442423	Cortical thickness	1e-08	34560273
rs34157004	rs9688809	0.608479278222665	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs34157004	rs56103941	0.607582007347074	Right presubiculum volume (head)	4e-08	37337106
rs34157004	rs34337297	0.606989170808779	Serum levels of protein LRP11	3e-161	35078996
rs34157004	rs10872645	0.604882201121145	Blood protein levels	2e-86	30072576
rs34157004	rs14314	0.603728210201737	Macular thickness	3e-19	30535121
rs34157004	rs14314	0.603728210201737	Vertex-wise sulcal depth	7e-17	34910505
rs34157004	rs14314	0.603728210201737	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs34157004	rs14314	0.603728210201737	Left hippocampal volume (body)	7e-15	37337106
rs34157004	rs14314	0.603728210201737	Left subiculum volume (body)	1e-14	37337106
rs34157004	rs55763431	0.60355769361549	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs34157004	rs9689694	0.602467608001322	Right hippocampal volume (head)	6e-11	37337106
rs34157004	rs9689694	0.602467608001322	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs34157004	rs9689694	0.602467608001322	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs34157004	rs9689694	0.602467608001322	Left hippocampal volume (head)	6e-12	37337106
rs34157004	rs9383843	0.601145350097432	Migraine	1e-09	35115687
rs34157004	rs2095375	0.600601195004103	Serum metabolite levels	1e-20	33031748
rs34157004	rs2095375	0.600601195004103	Serum metabolite levels	1e-20	33031748
rs34199419	rs9469857	0.957109293899814	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs34199419	rs2764208	0.956277291464066	Systemic lupus erythematosus	7e-06	24871463
rs34199419	rs9462030	0.942998599830495	Red cell distribution width	5e-25	32888493
rs34199419	rs9469899	0.927308444286701	Prostate cancer (advanced)	2e-06	29892016
rs34199419	rs9469899	0.927308444286701	Prostate cancer	5e-09	29892016
rs34199419	rs9469899	0.927308444286701	Prostate cancer	8e-11	33398198
rs34199419	rs9469899	0.927308444286701	Hand grip strength	3e-15	29691431
rs34199419	rs9469899	0.927308444286701	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs34199419	rs9469899	0.927308444286701	Graves' disease	4e-10	34594039
rs34199419	rs9469899	0.927308444286701	Coronary artery disease	1e-11	36474045
rs34199419	rs9469899	0.927308444286701	Predicted visceral adipose tissue	2e-20	31501611
rs34199419	rs9469899	0.927308444286701	Medication use (thyroid preparations)	2e-09	31015401
rs34199419	rs9469899	0.927308444286701	Medication use (thyroid preparations)	3e-10	34594039
rs34199419	rs9469872	0.922248064937922	HDL cholesterol levels	3e-11	36333282
rs34199419	rs9296128	0.906023350936138	Hip circumference adjusted for BMI	4e-13	34021172
rs34199419	rs11755393	0.8978033023071	Body mass index	3e-26	29273807
rs34199419	rs11755393	0.8978033023071	Systemic lupus erythematosus	2e-12	33493351
rs34199419	rs11755393	0.8978033023071	Systemic lupus erythematosus	2e-06	33493351
rs34199419	rs11755393	0.8978033023071	Systemic lupus erythematosus	1e-07	33493351
rs34199419	rs11755393	0.8978033023071	Systemic lupus erythematosus	2e-08	19838195
rs34199419	rs11755393	0.8978033023071	Body mass index	4e-55	36581621
rs34199419	rs9366863	0.89372572479501	Adult body size	9e-33	32376654
rs34199419	rs9366863	0.89372572479501	Body mass index	2e-44	30595370
rs34199419	rs6941110	0.885999935866179	Sex hormone-binding globulin levels	5e-27	36653534
rs34199419	rs2744944	0.867331871141334	Hypothyroidism	3e-10	34594039
rs34199419	rs2744944	0.867331871141334	High density lipoprotein cholesterol levels	3e-86	34887591
rs34199419	rs2744944	0.867331871141334	Multi-trait sex score	7e-22	37277458
rs34199419	rs2814949	0.858668968011045	Essential hypertension (time to event)	9e-09	32589924
rs34199419	rs2263329	0.845195093136769	HDL cholesterol	6e-35	34594039
rs34199419	rs2263329	0.845195093136769	HDL cholesterol levels	8e-43	32203549
rs34199419	rs2263329	0.845195093136769	High density lipoprotein cholesterol levels	2e-52	34887591
rs34199419	rs111868030	0.829068721082314	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs34199419	rs9368830	0.788877024371249	HDL cholesterol	4e-21	30275531
rs34199419	rs9368828	0.779293531905636	Body mass index	1e-34	34594039
rs34199419	rs6912327	0.755006832644724	Fasting insulin	5e-06	33402679
rs34199419	rs6912327	0.755006832644724	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs34199419	rs2744973	0.75498691197498	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs34199419	rs2744973	0.75498691197498	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs34199419	rs2744973	0.75498691197498	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs34199419	rs2744973	0.75498691197498	Multi-trait sex score	6e-20	37277458
rs34199419	rs112283401	0.722073866147307	Red cell distribution width	4e-27	30595370
rs34263671	rs13253048	0.679770206671734	Epigenetic age acceleration in alcohol use disorder	9e-07	31466081
rs34296237	rs11705721	0.998770830929096	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs34296237	rs11130638	0.996314005503276	Hemoglobin concentration	2e-23	32888493
rs34296237	rs34579268	0.989003551763989	Hematocrit	5e-30	32888493
rs34296237	rs34579268	0.989003551763989	Hematocrit	2e-27	32888493
rs34296237	rs34579268	0.989003551763989	Hemoglobin concentration	5e-26	32888493
rs34296237	rs7610312	0.975504725467132	Red blood cell count	5e-09	27863252
rs34296237	rs6775517	0.974272835397253	Hematocrit	1e-17	34594039
rs34296237	rs57700771	0.969408070647425	Red blood cell count	9e-21	30595370
rs34296237	rs55704295	0.90227869171292	Red blood cell count	8e-26	32888493
rs34296237	rs55704295	0.90227869171292	Red blood cell count	5e-23	32888493
rs34296237	rs55704295	0.90227869171292	Serum total protein level	2e-29	34594039
rs34296237	rs4681679	0.872787844981565	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs34296237	rs11719450	0.84692336240339	Hemoglobin concentration	2e-09	27863252
rs34296237	rs11719450	0.84692336240339	Hemoglobin levels	2e-16	32327693
rs34296237	rs56384862	0.835738959615301	Body mass index	8e-12	29273807
rs34296237	rs56384862	0.835738959615301	Body mass index	3e-06	30108127
rs34296237	rs56384862	0.835738959615301	Hemoglobin levels	1e-16	32327693
rs34296237	rs56384862	0.835738959615301	Body mass index	3e-14	36581621
rs34296237	rs11922478	0.833052903941345	Semaphorin-6B levels	4e-12	34648354
rs34296237	rs55692656	0.815687299542974	vWF levels	3e-08	30586737
rs34296237	rs55692656	0.815687299542974	vWF levels	6e-09	30586737
rs34296237	rs6445969	0.686162467694239	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs34296237	rs11708895	0.682265847229808	Red blood cell count	1e-20	32888494
rs34296237	rs55954186	0.677963439546121	vWF levels	5e-09	30586737
rs34296237	rs55954186	0.677963439546121	vWF levels	9e-09	30586737
rs34296237	rs7431952	0.615984281190998	Hemoglobin levels	1e-12	32327693
rs3432	rs61586425	0.646406665714274	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs3432	rs7211615	0.645339279270203	Heel bone mineral density	1e-08	30595370
rs3432	rs8077038	0.622779150743897	Educational attainment (MTAG)	4e-10	30038396
rs3432	rs8077038	0.622779150743897	Highest math class taken (MTAG)	5e-16	30038396
rs3432	rs12949956	0.615738100455642	Self-reported math ability	3e-11	30038396
rs3432	rs12949956	0.615738100455642	Self-reported math ability (MTAG)	3e-14	30038396
rs3432	rs12949956	0.615738100455642	Highest math class taken	8e-12	30038396
rs34341095	rs4959106	0.941261740350776	Interleukin-6 levels	7e-13	33067605
rs34341095	rs34077986	0.93731908685825	A body shape index	5e-11	34021172
rs34341095	rs3129754	0.833613582205763	Waist-hip index	2e-12	34021172
rs34341095	rs3129754	0.833613582205763	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs34341095	rs34656207	0.770915586713138	Aspartate aminotransferase levels	1e-111	33547301
rs34341095	rs34656207	0.770915586713138	Aspartate aminotransferase levels	1e-126	34594039
rs34341095	rs33915496	0.714781487305347	Lymphocyte count	1e-16	32888493
rs34341095	rs4959105	0.701666881713684	Lymphocyte count	3e-16	29403010
rs34341095	rs33932178	0.624910827696022	Lymphocyte count	3e-22	34594039
rs34341844	rs4959106	0.970783852925083	Interleukin-6 levels	7e-13	33067605
rs34341844	rs34077986	0.961744339124614	A body shape index	5e-11	34021172
rs34341844	rs3129754	0.857114491421388	Waist-hip index	2e-12	34021172
rs34341844	rs3129754	0.857114491421388	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs34341844	rs34656207	0.794908434989164	Aspartate aminotransferase levels	1e-111	33547301
rs34341844	rs34656207	0.794908434989164	Aspartate aminotransferase levels	1e-126	34594039
rs34341844	rs33915496	0.737816765169308	Lymphocyte count	1e-16	32888493
rs34341844	rs4959105	0.72607743264045	Lymphocyte count	3e-16	29403010
rs34341844	rs33932178	0.640090097869146	Lymphocyte count	3e-22	34594039
rs34343190	rs10465746	0.719938045409676	Obesity-related traits	8e-06	23251661
rs34343190	rs11580836	0.699947974848953	Body mass index	2e-09	36581621
rs34343863	rs3774577	0.609184951934473	Free androgen index	1e-10	36653534
rs34385951	rs6723298	0.680581352924382	Smoking initiation	2e-12	36477530
rs34385951	rs2194492	0.660437398912968	Educational attainment	9e-09	35361970
rs34385951	rs13020443	0.650600188391662	Type 2 diabetes	3e-11	32541925
rs34394770	rs34394770	1	Psoriasis	5e-08	25903422
rs34394770	rs34394770	1	Psoriasis	3e-08	25903422
rs34394770	rs34394770	1	Height	3e-11	34594039
rs34394770	rs34394770	1	Eosinophil counts	9e-24	34469753
rs34394770	rs9603605	0.981993618784535	Menarche (age at onset)	5e-14	30595370
rs34394770	rs9943	0.960330028231038	Asthma	4e-09	31959851
rs34394770	rs9603612	0.960142692761279	Systemic lupus erythematosus or rheumatoid arthritis	3e-13	27193031
rs34394770	rs12875311	0.94827750094683	Height	2e-19	36224396
rs34394770	rs7320598	0.943351220057018	Height	5e-16	31562340
rs34394770	rs7320598	0.943351220057018	Rheumatoid arthritis	2e-14	35470158
rs34394770	rs9603608	0.927967961541499	Respiratory diseases	8e-08	30595370
rs34394770	rs8002731	0.842058569279041	Asthma (adult onset)	4e-10	31669095
rs34394770	rs8002731	0.842058569279041	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	4e-10	35470158
rs34394770	rs9603616	0.824286580101165	Rheumatoid arthritis	2e-12	30423114
rs34394770	rs9603616	0.824286580101165	Rheumatoid arthritis	8e-11	30423114
rs34394770	rs9603616	0.824286580101165	Rheumatoid arthritis	2e-12	24390342
rs34394770	rs9603616	0.824286580101165	Rheumatoid arthritis	3e-11	24390342
rs34394770	rs9603616	0.824286580101165	Asthma	4e-08	34594039
rs34394770	rs11618582	0.824286580101165	Age of onset of adult onset asthma	9e-09	36778051
rs34394770	rs12872801	0.772151214174854	Systemic lupus erythematosus (MTAG)	4e-08	36750564
rs34394770	rs12872801	0.772151214174854	Eosinophil counts	5e-40	30595370
rs34394770	rs7993214	0.760747673610832	Psoriasis	2e-06	18369459
rs34394770	rs7993214	0.760747673610832	Multiple sclerosis	2e-06	24076602
rs34394770	rs7993214	0.760747673610832	Rheumatoid arthritis (ACPA-positive)	5e-06	23143596
rs34394770	rs7993214	0.760747673610832	COVID-19 hospitalization or rheumatoid arthritis (MTAG)	5e-11	36762574
rs34394770	rs34270626	0.601879103850795	Asthma	6e-10	32296059
rs34433746	rs6723298	0.675563807185136	Smoking initiation	2e-12	36477530
rs34433746	rs2194492	0.65675129437051	Educational attainment	9e-09	35361970
rs34433746	rs13020443	0.646810928455321	Type 2 diabetes	3e-11	32541925
rs34452578	rs6705511	0.651163048523666	Self-reported math ability	4e-09	30038396
rs34452578	rs6705511	0.651163048523666	Self-reported math ability (MTAG)	3e-10	30038396
rs34452578	rs34276187	0.645581368308825	Highest math class taken (MTAG)	2e-08	30038396
rs34493158	rs9469872	0.990405711342429	HDL cholesterol levels	3e-11	36333282
rs34493158	rs11755393	0.983248753744816	Body mass index	3e-26	29273807
rs34493158	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-12	33493351
rs34493158	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-06	33493351
rs34493158	rs11755393	0.983248753744816	Systemic lupus erythematosus	1e-07	33493351
rs34493158	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-08	19838195
rs34493158	rs11755393	0.983248753744816	Body mass index	4e-55	36581621
rs34493158	rs9366863	0.980050279338797	Adult body size	9e-33	32376654
rs34493158	rs9366863	0.980050279338797	Body mass index	2e-44	30595370
rs34493158	rs6941110	0.972130533054557	Sex hormone-binding globulin levels	5e-27	36653534
rs34493158	rs9462030	0.954406403718491	Red cell distribution width	5e-25	32888493
rs34493158	rs9469857	0.949763837643909	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs34493158	rs2764208	0.949033981000713	Systemic lupus erythematosus	7e-06	24871463
rs34493158	rs2814949	0.943009894530421	Essential hypertension (time to event)	9e-09	32589924
rs34493158	rs9469899	0.937611946179886	Prostate cancer (advanced)	2e-06	29892016
rs34493158	rs9469899	0.937611946179886	Prostate cancer	5e-09	29892016
rs34493158	rs9469899	0.937611946179886	Prostate cancer	8e-11	33398198
rs34493158	rs9469899	0.937611946179886	Hand grip strength	3e-15	29691431
rs34493158	rs9469899	0.937611946179886	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs34493158	rs9469899	0.937611946179886	Graves' disease	4e-10	34594039
rs34493158	rs9469899	0.937611946179886	Coronary artery disease	1e-11	36474045
rs34493158	rs9469899	0.937611946179886	Predicted visceral adipose tissue	2e-20	31501611
rs34493158	rs9469899	0.937611946179886	Medication use (thyroid preparations)	2e-09	31015401
rs34493158	rs9469899	0.937611946179886	Medication use (thyroid preparations)	3e-10	34594039
rs34493158	rs2744944	0.933676458189598	Hypothyroidism	3e-10	34594039
rs34493158	rs2744944	0.933676458189598	High density lipoprotein cholesterol levels	3e-86	34887591
rs34493158	rs2744944	0.933676458189598	Multi-trait sex score	7e-22	37277458
rs34493158	rs2263329	0.914432373659788	HDL cholesterol	6e-35	34594039
rs34493158	rs2263329	0.914432373659788	HDL cholesterol levels	8e-43	32203549
rs34493158	rs2263329	0.914432373659788	High density lipoprotein cholesterol levels	2e-52	34887591
rs34493158	rs9296128	0.901155780048215	Hip circumference adjusted for BMI	4e-13	34021172
rs34493158	rs111868030	0.890460424513595	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs34493158	rs9368830	0.866839594529055	HDL cholesterol	4e-21	30275531
rs34493158	rs9368828	0.8378148480019	Body mass index	1e-34	34594039
rs34493158	rs6912327	0.829083022514325	Fasting insulin	5e-06	33402679
rs34493158	rs6912327	0.829083022514325	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs34493158	rs112283401	0.806269190971807	Red cell distribution width	4e-27	30595370
rs34493158	rs2744973	0.782572341748002	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs34493158	rs2744973	0.782572341748002	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs34493158	rs2744973	0.782572341748002	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs34493158	rs2744973	0.782572341748002	Multi-trait sex score	6e-20	37277458
rs34493158	rs6940215	0.634643562406843	Insomnia	2e-10	35835914
rs34493158	rs6940215	0.634643562406843	Insomnia	1e-13	35835914
rs34493158	rs6940215	0.634643562406843	Hip circumference adjusted for BMI	8e-10	34021172
rs34493158	rs6940215	0.634643562406843	Multi-trait sex score	2e-23	37277458
rs34493158	rs6940215	0.634643562406843	Multi-trait sex score	4e-23	37277458
rs34493158	rs6457796	0.626169994896438	Insomnia	1e-08	30804565
rs34493158	rs6457796	0.626169994896438	Plateletcrit	9e-11	32888494
rs34493158	rs6457796	0.626169994896438	Systemic lupus erythematosus	3e-22	33272962
rs34493158	rs6457796	0.626169994896438	Body mass index	5e-13	30108127
rs34493158	rs6457796	0.626169994896438	Body mass index	1e-14	26426971
rs34493158	rs6457796	0.626169994896438	Educational attainment	5e-19	35361970
rs34493158	rs9689160	0.605720875679005	Lung function (forced vital capacity)	3e-14	36914875
rs34493158	rs9469918	0.600168366795112	Hip circumference adjusted for BMI	8e-09	34021172
rs34493158	rs9469918	0.600168366795112	Hip circumference adjusted for BMI	2e-08	34021172
rs34493158	rs9469918	0.600168366795112	Multi-trait sex score	4e-08	37277458
rs34548459	rs6723298	0.675563807185136	Smoking initiation	2e-12	36477530
rs34548459	rs2194492	0.65675129437051	Educational attainment	9e-09	35361970
rs34548459	rs13020443	0.646810928455321	Type 2 diabetes	3e-11	32541925
rs34579268	rs34579268	1	Hematocrit	5e-30	32888493
rs34579268	rs34579268	1	Hematocrit	2e-27	32888493
rs34579268	rs34579268	1	Hemoglobin concentration	5e-26	32888493
rs34579268	rs11130638	0.992666190052037	Hemoglobin concentration	2e-23	32888493
rs34579268	rs11705721	0.99022309179521	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs34579268	rs7610312	0.967156024230531	Red blood cell count	5e-09	27863252
rs34579268	rs6775517	0.965926157286347	Hematocrit	1e-17	34594039
rs34579268	rs57700771	0.961107268724456	Red blood cell count	9e-21	30595370
rs34579268	rs55704295	0.894556427781491	Red blood cell count	8e-26	32888493
rs34579268	rs55704295	0.894556427781491	Red blood cell count	5e-23	32888493
rs34579268	rs55704295	0.894556427781491	Serum total protein level	2e-29	34594039
rs34579268	rs4681679	0.867685553599419	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs34579268	rs11719450	0.856182356625152	Hemoglobin concentration	2e-09	27863252
rs34579268	rs11719450	0.856182356625152	Hemoglobin levels	2e-16	32327693
rs34579268	rs11922478	0.84238097045896	Semaphorin-6B levels	4e-12	34648354
rs34579268	rs56384862	0.830941244618146	Body mass index	8e-12	29273807
rs34579268	rs56384862	0.830941244618146	Body mass index	3e-06	30108127
rs34579268	rs56384862	0.830941244618146	Hemoglobin levels	1e-16	32327693
rs34579268	rs56384862	0.830941244618146	Body mass index	3e-14	36581621
rs34579268	rs55692656	0.808331269402373	vWF levels	3e-08	30586737
rs34579268	rs55692656	0.808331269402373	vWF levels	6e-09	30586737
rs34579268	rs6445969	0.682555862731748	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs34579268	rs11708895	0.678710590436549	Red blood cell count	1e-20	32888494
rs34579268	rs55954186	0.674442834963047	vWF levels	5e-09	30586737
rs34579268	rs55954186	0.674442834963047	vWF levels	9e-09	30586737
rs34579268	rs7431952	0.61289482913478	Hemoglobin levels	1e-12	32327693
rs34584100	rs1255908	0.686746173109325	PR interval	8e-14	32439900
rs34584100	rs1255908	0.686746173109325	PR interval	6e-14	32439900
rs34599306	rs4959106	0.965820360303444	Interleukin-6 levels	7e-13	33067605
rs34599306	rs34077986	0.955168277224106	A body shape index	5e-11	34021172
rs34599306	rs3129754	0.853744024525871	Waist-hip index	2e-12	34021172
rs34599306	rs3129754	0.853744024525871	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs34599306	rs34656207	0.789939886486566	Aspartate aminotransferase levels	1e-111	33547301
rs34599306	rs34656207	0.789939886486566	Aspartate aminotransferase levels	1e-126	34594039
rs34599306	rs33915496	0.734317895839641	Lymphocyte count	1e-16	32888493
rs34599306	rs4959105	0.725580311259052	Lymphocyte count	3e-16	29403010
rs34599306	rs33932178	0.637953103734154	Lymphocyte count	3e-22	34594039
rs34634095	rs34634095	1	Fish- and plant-related diet	3e-09	32066663
rs34634095	rs480293	0.930160584151136	Oily fish consumption	4e-11	32193382
rs34634095	rs1613778	0.910919530370342	Total bilirubin levels	3e-08	34594039
rs34634095	rs539524	0.906223898169096	Asthma	1e-10	32296059
rs34634095	rs542831	0.854699136278835	Asthma	5e-13	31361310
rs34634095	rs1784776	0.852324505813531	Asthma	2e-09	32296059
rs34634095	rs1784775	0.852324505813531	Asthma	2e-09	30929738
rs34634095	rs1784775	0.852324505813531	Asthma (adult onset)	6e-09	30929738
rs34634095	rs1789358	0.850713629390301	Asthma	2e-08	34103634
rs34634095	rs659529	0.827790458676816	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs34634095	rs659529	0.827790458676816	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs34634095	rs659529	0.827790458676816	Atopic dermatitis	5e-10	34116867
rs34634095	rs12791699	0.816895532795906	Pork consumption	9e-09	32066663
rs34634095	rs12791699	0.816895532795906	Oily fish consumption	9e-09	32066663
rs34634095	rs487985	0.816895532795906	Highest math class taken	1e-08	30038396
rs34634095	rs10891286	0.792302753509142	Noncognitive aspects of educational attainment	5e-10	33414549
rs34634095	rs4459340	0.788503942921229	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs34634095	rs505372	0.748351281534454	Breast cancer	3e-06	29059683
rs34634095	rs505372	0.748351281534454	Medication use (beta blocking agents)	2e-08	34594039
rs34634095	rs9734135	0.712255708024774	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs34634095	rs11213941	0.674031455058855	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs34634095	rs11213941	0.674031455058855	Eczema	8e-14	30595370
rs34634095	rs663763	0.662130272067261	Layilin levels	3e-21	36168886
rs34639984	rs6723298	0.680581352924382	Smoking initiation	2e-12	36477530
rs34639984	rs2194492	0.660437398912968	Educational attainment	9e-09	35361970
rs34639984	rs13020443	0.650600188391662	Type 2 diabetes	3e-11	32541925
rs34657362	rs11889663	0.87208665834665	C-reactive protein levels (MTAG)	2e-12	36376304
rs34657362	rs17626434	0.786518950195943	C-reactive protein levels	8e-12	31900758
rs34657938	rs9462030	0.987191069058618	Red cell distribution width	5e-25	32888493
rs34657938	rs9469857	0.97762744914066	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs34657938	rs2764208	0.976848840539534	Systemic lupus erythematosus	7e-06	24871463
rs34657938	rs9469899	0.970490291516216	Prostate cancer (advanced)	2e-06	29892016
rs34657938	rs9469899	0.970490291516216	Prostate cancer	5e-09	29892016
rs34657938	rs9469899	0.970490291516216	Prostate cancer	8e-11	33398198
rs34657938	rs9469899	0.970490291516216	Hand grip strength	3e-15	29691431
rs34657938	rs9469899	0.970490291516216	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs34657938	rs9469899	0.970490291516216	Graves' disease	4e-10	34594039
rs34657938	rs9469899	0.970490291516216	Coronary artery disease	1e-11	36474045
rs34657938	rs9469899	0.970490291516216	Predicted visceral adipose tissue	2e-20	31501611
rs34657938	rs9469899	0.970490291516216	Medication use (thyroid preparations)	2e-09	31015401
rs34657938	rs9469899	0.970490291516216	Medication use (thyroid preparations)	3e-10	34594039
rs34657938	rs9469872	0.941496713295079	HDL cholesterol levels	3e-11	36333282
rs34657938	rs11755393	0.941128830333753	Body mass index	3e-26	29273807
rs34657938	rs11755393	0.941128830333753	Systemic lupus erythematosus	2e-12	33493351
rs34657938	rs11755393	0.941128830333753	Systemic lupus erythematosus	2e-06	33493351
rs34657938	rs11755393	0.941128830333753	Systemic lupus erythematosus	1e-07	33493351
rs34657938	rs11755393	0.941128830333753	Systemic lupus erythematosus	2e-08	19838195
rs34657938	rs11755393	0.941128830333753	Body mass index	4e-55	36581621
rs34657938	rs9366863	0.931343606928913	Adult body size	9e-33	32376654
rs34657938	rs9366863	0.931343606928913	Body mass index	2e-44	30595370
rs34657938	rs6941110	0.928200475422759	Sex hormone-binding globulin levels	5e-27	36653534
rs34657938	rs9296128	0.927435137573395	Hip circumference adjusted for BMI	4e-13	34021172
rs34657938	rs2814949	0.895381643538885	Essential hypertension (time to event)	9e-09	32589924
rs34657938	rs2744944	0.886133673514892	Hypothyroidism	3e-10	34594039
rs34657938	rs2744944	0.886133673514892	High density lipoprotein cholesterol levels	3e-86	34887591
rs34657938	rs2744944	0.886133673514892	Multi-trait sex score	7e-22	37277458
rs34657938	rs2263329	0.867123177937652	HDL cholesterol	6e-35	34594039
rs34657938	rs2263329	0.867123177937652	HDL cholesterol levels	8e-43	32203549
rs34657938	rs2263329	0.867123177937652	High density lipoprotein cholesterol levels	2e-52	34887591
rs34657938	rs111868030	0.843790480825785	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs34657938	rs9368830	0.82242267164523	HDL cholesterol	4e-21	30275531
rs34657938	rs9368828	0.796521059435536	Body mass index	1e-34	34594039
rs34657938	rs2744973	0.793614030105693	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs34657938	rs2744973	0.793614030105693	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs34657938	rs2744973	0.793614030105693	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs34657938	rs2744973	0.793614030105693	Multi-trait sex score	6e-20	37277458
rs34657938	rs6912327	0.785393454630338	Fasting insulin	5e-06	33402679
rs34657938	rs6912327	0.785393454630338	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs34657938	rs112283401	0.763178385784414	Red cell distribution width	4e-27	30595370
rs34657938	rs9689160	0.622525665820703	Lung function (forced vital capacity)	3e-14	36914875
rs34667636	rs3772130	0.974722597422271	Cognitive performance	6e-06	19734545
rs34667636	rs3772128	0.974722597422271	Mean spheric corpuscular volume	4e-09	32888494
rs34667636	rs33988592	0.966899804852791	Mean corpuscular hemoglobin	9e-11	32888493
rs34667636	rs33988592	0.966899804852791	Mean corpuscular volume	4e-12	32888493
rs34667636	rs6791046	0.962264476351149	Mean reticulocyte volume	4e-12	32888494
rs34667636	rs1573819	0.923482131834752	Mean corpuscular volume	3e-10	32888493
rs34667636	rs13433692	0.660978431975389	Corneal resistance factor (MTAG)	5e-08	35446358
rs34850435	rs4959106	0.993291244452767	Interleukin-6 levels	7e-13	33067605
rs34850435	rs34077986	0.964215638228578	A body shape index	5e-11	34021172
rs34850435	rs3129754	0.866657207640338	Waist-hip index	2e-12	34021172
rs34850435	rs3129754	0.866657207640338	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs34850435	rs34656207	0.806310872180888	Aspartate aminotransferase levels	1e-111	33547301
rs34850435	rs34656207	0.806310872180888	Aspartate aminotransferase levels	1e-126	34594039
rs34850435	rs33915496	0.743461429204864	Lymphocyte count	1e-16	32888493
rs34850435	rs4959105	0.736217307113455	Lymphocyte count	3e-16	29403010
rs34850435	rs33932178	0.646344930765896	Lymphocyte count	3e-22	34594039
rs34850435	rs3104414	0.61059661749914	HLA DR+ T cell%T cell	9e-09	32929287
rs34850435	rs3104414	0.61059661749914	Chronic sinus infection	2e-06	28928442
rs34850435	rs3104414	0.61059661749914	Hip circumference adjusted for BMI	9e-13	34021172
rs34850435	rs685244	0.600748712360264	Complement C4 levels	2e-12	36168886
rs34946565	rs4304220	0.797592205954496	Height	2e-14	36224396
rs34946565	rs4355658	0.746341922389387	Height	3e-13	36224396
rs34946565	rs13232536	0.611725023930161	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs34965045	rs13379492	0.922588089003546	Lung function (FEV1/FVC)	6e-08	30595370
rs34965045	rs8034216	0.910095131767267	C-reactive protein levels	2e-10	31900758
rs34965045	rs17271340	0.874376330529392	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs34965045	rs17271305	0.849303424154512	Two-hour glucose challenge	1e-07	20081857
rs34965045	rs35967150	0.842289866714338	C-reactive protein levels (MTAG)	1e-08	36376304
rs34965045	rs11634163	0.833295377026056	C-reactive protein	2e-08	34594039
rs34965045	rs11634163	0.833295377026056	Two-hour glucose	3e-14	34059833
rs34965045	rs189400382	0.830305362904274	C-reactive protein levels	1e-08	35459240
rs34965045	rs28373613	0.6762583409957	Height (standard GWA)	8e-12	37106081
rs34985232	rs4959106	0.977432928954299	Interleukin-6 levels	7e-13	33067605
rs34985232	rs34077986	0.974963637586946	A body shape index	5e-11	34021172
rs34985232	rs3129754	0.865692601600609	Waist-hip index	2e-12	34021172
rs34985232	rs3129754	0.865692601600609	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs34985232	rs34656207	0.802165626217252	Aspartate aminotransferase levels	1e-111	33547301
rs34985232	rs34656207	0.802165626217252	Aspartate aminotransferase levels	1e-126	34594039
rs34985232	rs33915496	0.751404255635058	Lymphocyte count	1e-16	32888493
rs34985232	rs4959105	0.732081588812899	Lymphocyte count	3e-16	29403010
rs34985232	rs33932178	0.649431014155486	Lymphocyte count	3e-22	34594039
rs34985232	rs685244	0.606861318816184	Complement C4 levels	2e-12	36168886
rs34985232	rs3104414	0.605056123568338	HLA DR+ T cell%T cell	9e-09	32929287
rs34985232	rs3104414	0.605056123568338	Chronic sinus infection	2e-06	28928442
rs34985232	rs3104414	0.605056123568338	Hip circumference adjusted for BMI	9e-13	34021172
rs34985895	rs8444	0.942373923231125	Cutaneous malignant melanoma	4e-14	32341527
rs34985895	rs2867296	0.938356899376626	Neurological blood protein biomarker levels	3e-12	31320639
rs34985895	rs4970988	0.810836286325049	Urate levels	1e-07	23263486
rs34985895	rs12405726	0.79098609882593	Bitter non-alcoholic beverage consumption	2e-10	31046077
rs34985895	rs72704658	0.784338281892679	Nevus count or cutaneous melanoma	2e-10	30429480
rs34985895	rs143887202	0.745373344656784	Cathepsin S levels	4e-62	34648354
rs34985895	rs10888393	0.730372744086081	Cathepsin S levels	1e-26	36168886
rs34985895	rs10305664	0.729552667176991	Tea consumption	7e-06	31046077
rs34985895	rs10888395	0.711565122411021	Monocyte chemoattractant protein-1 levels	6e-07	27989323
rs34985895	rs2230061	0.682013249693566	Fat body mass	4e-08	24064335
rs34985895	rs1336900	0.629194356723941	Cathepsin S levels	1e-19	28240269
rs34985895	rs10399947	0.620416641959969	Cutaneous squamous cell carcinoma	7e-09	32041948
rs34985895	rs11587444	0.62032559518243	Morning person	2e-08	30595370
rs35015708	rs11685226	0.984124250399825	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs35015708	rs11685226	0.984124250399825	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs35015708	rs7558954	0.967630421827319	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs35015708	rs1177308	0.965122570734161	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs35015708	rs1177308	0.965122570734161	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs35015708	rs777587	0.813961432524438	Proteoglycan 3 levels	6e-29	34648354
rs35015708	rs777587	0.813961432524438	Pappalysin-1 levels	1e-25	34648354
rs35015708	rs12617371	0.772821106403179	Immature fraction of reticulocytes	8e-18	32888494
rs35015708	rs2463097	0.739584408260814	White blood cell count	3e-26	30595370
rs35015708	rs2593620	0.715326101781588	Serum levels of protein PRG3	5e-14	35078996
rs35015708	rs10199672	0.707910727835378	Height	6e-12	34594039
rs35015708	rs10199672	0.707910727835378	Height	2e-12	31562340
rs35015708	rs2421200	0.686969122475201	Neutrophil count	1e-26	32888493
rs35015708	rs2421200	0.686969122475201	Neutrophil count	1e-25	32888493
rs35015708	rs10169482	0.634604532355674	C-reactive protein levels	4e-09	33462484
rs35015708	rs12616433	0.612234594856826	Eosinophil forward scatter	4e-13	37596262
rs35015708	rs12616433	0.612234594856826	Eosinophil side scatter	2e-18	37596262
rs35023423	rs12729558	0.944155321057687	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs35023423	rs10922531	0.910286829158396	Serum metabolite levels	2e-69	33031748
rs35023423	rs7532151	0.877163531542317	Imidazole lactate levels	9e-12	33177712
rs35023423	rs10801690	0.850163083649712	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs35023423	rs7530513	0.829076338130532	Height	8e-11	35831902
rs35023423	rs7530513	0.829076338130532	Imidazole lactate levels	8e-166	36635386
rs35023423	rs12144640	0.829076338130532	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs35023423	rs9787133	0.819796061905817	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs35023423	rs1409152	0.817567084548514	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs35023423	rs1409152	0.817567084548514	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs35023423	rs10801699	0.815462169890363	X-23639 levels	2e-10	36635386
rs35023423	rs12120164	0.781506787010305	Metabolite peak levels (QI2146)	1e-26	35995766
rs35023423	rs2765527	0.767515094669359	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs35023423	rs2810876	0.65741796331764	Imidazole lactate levels	2e-122	35347128
rs35023423	rs1206228892	0.656888279643592	Imidazole lactate levels	5e-186	35050183
rs35023423	rs10801696	0.656099872438216	Imidazole lactate levels	3e-195	35050183
rs35029150	rs4959106	0.976599702958723	Interleukin-6 levels	7e-13	33067605
rs35029150	rs34077986	0.967511992880507	A body shape index	5e-11	34021172
rs35029150	rs3129754	0.863258123549554	Waist-hip index	2e-12	34021172
rs35029150	rs3129754	0.863258123549554	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs35029150	rs34656207	0.799757060219433	Aspartate aminotransferase levels	1e-111	33547301
rs35029150	rs34656207	0.799757060219433	Aspartate aminotransferase levels	1e-126	34594039
rs35029150	rs33915496	0.742955532836333	Lymphocyte count	1e-16	32888493
rs35029150	rs4959105	0.731204851571043	Lymphocyte count	3e-16	29403010
rs35029150	rs33932178	0.647080680996649	Lymphocyte count	3e-22	34594039
rs35029150	rs3104414	0.602744025839029	HLA DR+ T cell%T cell	9e-09	32929287
rs35029150	rs3104414	0.602744025839029	Chronic sinus infection	2e-06	28928442
rs35029150	rs3104414	0.602744025839029	Hip circumference adjusted for BMI	9e-13	34021172
rs35029150	rs685244	0.601254547099526	Complement C4 levels	2e-12	36168886
rs35123892	rs2162062	0.92157598335519	Height	2e-13	35831902
rs35123892	rs1436958	0.878117153975983	IgG glycosylation	9e-06	23382691
rs35123892	rs933807	0.872464870247345	Fat-free mass	6e-06	30593698
rs35123892	rs933807	0.872464870247345	Fat-free mass	2e-07	30593698
rs35123892	rs933807	0.872464870247345	Fat-free mass	8e-11	30593698
rs35123892	rs7178540	0.763350635319521	Height	1e-31	36224396
rs35123892	rs11635977	0.746116258934267	Height	2e-25	36224396
rs35123892	rs72749770	0.73407333129171	Low density lipoprotein cholesterol levels	9e-10	32493714
rs35123892	rs72749770	0.73407333129171	Apolipoprotein B levels	2e-09	32203549
rs35123892	rs7162536	0.732730574406378	Height	4e-29	34594039
rs35123892	rs7178424	0.723480056192026	Height	6e-09	20881960
rs35123892	rs7178424	0.723480056192026	Height	6e-13	35831902
rs35123892	rs7178424	0.723480056192026	Height	3e-251	36224396
rs35123892	rs17271431	0.719382342114727	Height	2e-11	34594039
rs35123892	rs17205463	0.718693667560741	Serum levels of protein IGF1	8e-08	27329260
rs35123892	rs17205463	0.718693667560741	Appendicular lean mass	4e-43	33097823
rs35123892	rs17205463	0.718693667560741	Height	2e-35	30595370
rs35123892	rs731820	0.707196809446927	Height	2e-13	31562340
rs35123892	rs731820	0.707196809446927	Height	2e-12	35831902
rs35128369	rs4959106	0.97826196526503	Interleukin-6 levels	7e-13	33067605
rs35128369	rs34077986	0.969165430419469	A body shape index	5e-11	34021172
rs35128369	rs3129754	0.864843046541661	Waist-hip index	2e-12	34021172
rs35128369	rs3129754	0.864843046541661	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs35128369	rs34656207	0.801301173728843	Aspartate aminotransferase levels	1e-111	33547301
rs35128369	rs34656207	0.801301173728843	Aspartate aminotransferase levels	1e-126	34594039
rs35128369	rs33915496	0.74446530276963	Lymphocyte count	1e-16	32888493
rs35128369	rs4959105	0.732703603069595	Lymphocyte count	3e-16	29403010
rs35128369	rs33932178	0.647080680996649	Lymphocyte count	3e-22	34594039
rs35128369	rs3104414	0.604156433449567	HLA DR+ T cell%T cell	9e-09	32929287
rs35128369	rs3104414	0.604156433449567	Chronic sinus infection	2e-06	28928442
rs35128369	rs3104414	0.604156433449567	Hip circumference adjusted for BMI	9e-13	34021172
rs35128369	rs685244	0.602526582529317	Complement C4 levels	2e-12	36168886
rs35224808	rs2357176	0.931276806477134	Nevus count or cutaneous melanoma	4e-08	30429480
rs35224808	rs10873172	0.836576848478435	Cutaneous melanoma or hair colour	6e-27	32341527
rs35224808	rs10873172	0.836576848478435	Nevus count or cutaneous melanoma	6e-13	32341527
rs35224808	rs10873172	0.836576848478435	Blond vs. brown/black hair color	6e-15	30531825
rs35224808	rs10873172	0.836576848478435	Cutaneous malignant melanoma	6e-08	32341527
rs35224808	rs10873172	0.836576848478435	Hair color	4e-17	30595370
rs35224808	rs1255908	0.781359633682023	PR interval	8e-14	32439900
rs35224808	rs1255908	0.781359633682023	PR interval	6e-14	32439900
rs35224808	rs12878653	0.724972137875854	Youthful appearance (self-reported)	3e-14	32339537
rs35341794	rs11685226	0.984124250399825	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs35341794	rs11685226	0.984124250399825	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs35341794	rs7558954	0.967630421827319	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs35341794	rs1177308	0.965122570734161	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs35341794	rs1177308	0.965122570734161	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs35341794	rs777587	0.813961432524438	Proteoglycan 3 levels	6e-29	34648354
rs35341794	rs777587	0.813961432524438	Pappalysin-1 levels	1e-25	34648354
rs35341794	rs12617371	0.772821106403179	Immature fraction of reticulocytes	8e-18	32888494
rs35341794	rs2463097	0.739584408260814	White blood cell count	3e-26	30595370
rs35341794	rs2593620	0.715326101781588	Serum levels of protein PRG3	5e-14	35078996
rs35341794	rs10199672	0.707910727835378	Height	6e-12	34594039
rs35341794	rs10199672	0.707910727835378	Height	2e-12	31562340
rs35341794	rs2421200	0.686969122475201	Neutrophil count	1e-26	32888493
rs35341794	rs2421200	0.686969122475201	Neutrophil count	1e-25	32888493
rs35341794	rs10169482	0.634604532355674	C-reactive protein levels	4e-09	33462484
rs35341794	rs12616433	0.612234594856826	Eosinophil forward scatter	4e-13	37596262
rs35341794	rs12616433	0.612234594856826	Eosinophil side scatter	2e-18	37596262
rs35361329	rs1255908	0.68968850876342	PR interval	8e-14	32439900
rs35361329	rs1255908	0.68968850876342	PR interval	6e-14	32439900
rs35371567	rs6723298	0.68079875165929	Smoking initiation	2e-12	36477530
rs35371567	rs2194492	0.660639002491709	Educational attainment	9e-09	35361970
rs35371567	rs13020443	0.650770860274251	Type 2 diabetes	3e-11	32541925
rs35414	rs35414	1	Skin color	2e-21	36672889
rs35414	rs35414	1	Ease of skin tanning	5e-10	36672889
rs35414	rs35414	1	Skin phototype score	4e-19	36672889
rs35414	rs35414	1	Skin color (Fitzpatrick scale)	3e-14	36672889
rs35440570	rs10891301	0.688624447517048	Pyruvate dehydrogenase protein X component, mitochondrial levels	1e-18	34648354
rs35440570	rs2276390	0.635413336530196	Waist-hip ratio	6e-28	30239722
rs35446814	rs61586425	0.647327350124544	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs35446814	rs7211615	0.643913963972059	Heel bone mineral density	1e-08	30595370
rs35446814	rs8077038	0.621337300075886	Educational attainment (MTAG)	4e-10	30038396
rs35446814	rs8077038	0.621337300075886	Highest math class taken (MTAG)	5e-16	30038396
rs35446814	rs12949956	0.614275417556863	Self-reported math ability	3e-11	30038396
rs35446814	rs12949956	0.614275417556863	Self-reported math ability (MTAG)	3e-14	30038396
rs35446814	rs12949956	0.614275417556863	Highest math class taken	8e-12	30038396
rs3547	rs3213282	0.604266978859962	Low density lipoprotein cholesterol levels	3e-11	32154731
rs35484705	rs3129754	1	Waist-hip index	2e-12	34021172
rs35484705	rs3129754	1	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs35484705	rs4959106	0.864843046541661	Interleukin-6 levels	7e-13	33067605
rs35484705	rs34077986	0.848683106675117	A body shape index	5e-11	34021172
rs35484705	rs34656207	0.699451656000218	Aspartate aminotransferase levels	1e-111	33547301
rs35484705	rs34656207	0.699451656000218	Aspartate aminotransferase levels	1e-126	34594039
rs35484705	rs4959105	0.626331416268315	Lymphocyte count	3e-16	29403010
rs35484705	rs33915496	0.623494077777862	Lymphocyte count	1e-16	32888493
rs35489159	rs8207	0.802286245630596	Monocyte count	1e-10	32888493
rs35489159	rs8207	0.802286245630596	Height	2e-18	36224396
rs35489159	rs6738934	0.649722196900312	Vaginal microbiome MetaCyc pathway (PWY-5741|ethylmalonyl-CoA pathway)	3e-07	34282934
rs35507645	rs11685226	0.996645455617622	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs35507645	rs11685226	0.996645455617622	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs35507645	rs7558954	0.973426320015638	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs35507645	rs1177308	0.972557044082667	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs35507645	rs1177308	0.972557044082667	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs35507645	rs777587	0.825399518395242	Proteoglycan 3 levels	6e-29	34648354
rs35507645	rs777587	0.825399518395242	Pappalysin-1 levels	1e-25	34648354
rs35507645	rs12617371	0.783941279592438	Immature fraction of reticulocytes	8e-18	32888494
rs35507645	rs2463097	0.750490750677167	White blood cell count	3e-26	30595370
rs35507645	rs2593620	0.725959097651564	Serum levels of protein PRG3	5e-14	35078996
rs35507645	rs10199672	0.718516806391121	Height	6e-12	34594039
rs35507645	rs10199672	0.718516806391121	Height	2e-12	31562340
rs35507645	rs2421200	0.697360693061303	Neutrophil count	1e-26	32888493
rs35507645	rs2421200	0.697360693061303	Neutrophil count	1e-25	32888493
rs35507645	rs10169482	0.643516256096985	C-reactive protein levels	4e-09	33462484
rs35507645	rs12616433	0.621939876978205	Eosinophil forward scatter	4e-13	37596262
rs35507645	rs12616433	0.621939876978205	Eosinophil side scatter	2e-18	37596262
rs35516531	rs17648188	0.752180227724824	Hepatocyte growth factor-like protein levels	4e-11	36168886
rs35534739	rs4959106	0.96995602797784	Interleukin-6 levels	7e-13	33067605
rs35534739	rs34077986	0.960922477060726	A body shape index	5e-11	34021172
rs35534739	rs3129754	0.85627103884484	Waist-hip index	2e-12	34021172
rs35534739	rs3129754	0.85627103884484	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs35534739	rs34656207	0.794049625989952	Aspartate aminotransferase levels	1e-111	33547301
rs35534739	rs34656207	0.794049625989952	Aspartate aminotransferase levels	1e-126	34594039
rs35534739	rs33915496	0.736941127688496	Lymphocyte count	1e-16	32888493
rs35534739	rs4959105	0.725205832194966	Lymphocyte count	3e-16	29403010
rs35534739	rs33932178	0.640636175658327	Lymphocyte count	3e-22	34594039
rs35542934	rs4959106	0.979925641030161	Interleukin-6 levels	7e-13	33067605
rs35542934	rs34077986	0.972476540362984	A body shape index	5e-11	34021172
rs35542934	rs3129754	0.868017253349413	Waist-hip index	2e-12	34021172
rs35542934	rs3129754	0.868017253349413	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs35542934	rs34656207	0.805942449423953	Aspartate aminotransferase levels	1e-111	33547301
rs35542934	rs34656207	0.805942449423953	Aspartate aminotransferase levels	1e-126	34594039
rs35542934	rs33915496	0.753556103929237	Lymphocyte count	1e-16	32888493
rs35542934	rs4959105	0.734203888992404	Lymphocyte count	3e-16	29403010
rs35542934	rs33932178	0.648528818031482	Lymphocyte count	3e-22	34594039
rs35542934	rs3104414	0.608403573731753	HLA DR+ T cell%T cell	9e-09	32929287
rs35542934	rs3104414	0.608403573731753	Chronic sinus infection	2e-06	28928442
rs35542934	rs3104414	0.608403573731753	Hip circumference adjusted for BMI	9e-13	34021172
rs35542934	rs685244	0.605074685869257	Complement C4 levels	2e-12	36168886
rs35558014	rs4355658	0.961590039764107	Height	3e-13	36224396
rs35558014	rs13232536	0.777208748869383	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs35558014	rs12539962	0.702303534789542	Colorectal cancer	3e-08	36539618
rs35558014	rs4304220	0.687372889344627	Height	2e-14	36224396
rs35558953	rs3129754	1	Waist-hip index	2e-12	34021172
rs35558953	rs3129754	1	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs35558953	rs4959106	0.864843046541661	Interleukin-6 levels	7e-13	33067605
rs35558953	rs34077986	0.848683106675117	A body shape index	5e-11	34021172
rs35558953	rs34656207	0.699451656000218	Aspartate aminotransferase levels	1e-111	33547301
rs35558953	rs34656207	0.699451656000218	Aspartate aminotransferase levels	1e-126	34594039
rs35558953	rs4959105	0.626331416268315	Lymphocyte count	3e-16	29403010
rs35558953	rs33915496	0.623494077777862	Lymphocyte count	1e-16	32888493
rs35656642	rs4959106	0.886552634352139	Interleukin-6 levels	7e-13	33067605
rs35656642	rs3129754	0.886245958403748	Waist-hip index	2e-12	34021172
rs35656642	rs3129754	0.886245958403748	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs35656642	rs34077986	0.882895726332307	A body shape index	5e-11	34021172
rs35656642	rs34656207	0.714101051803081	Aspartate aminotransferase levels	1e-111	33547301
rs35656642	rs34656207	0.714101051803081	Aspartate aminotransferase levels	1e-126	34594039
rs35656642	rs33915496	0.656893257858321	Lymphocyte count	1e-16	32888493
rs35656642	rs4959105	0.646956386262868	Lymphocyte count	3e-16	29403010
rs35659175	rs6705511	0.684343114315122	Self-reported math ability	4e-09	30038396
rs35659175	rs6705511	0.684343114315122	Self-reported math ability (MTAG)	3e-10	30038396
rs35659175	rs34276187	0.678618047875414	Highest math class taken (MTAG)	2e-08	30038396
rs35716097	rs35716097	1	Phosphorus levels	2e-23	29403010
rs35716097	rs35716097	1	Glomerular filtration rate	4e-09	27588450
rs35716097	rs35716097	1	Glomerular filtration rate	6e-07	27588450
rs35716097	rs35716097	1	Glomerular filtration rate	2e-17	27588450
rs35716097	rs10051765	0.750630869528198	Vitamin C levels	4e-09	33203707
rs35716097	rs10051765	0.750630869528198	Kidney stones	8e-15	31729369
rs35716097	rs56235845	0.680297384870867	Hematocrit	9e-11	27863252
rs35716097	rs56235845	0.680297384870867	Hemoglobin concentration	1e-09	27863252
rs35716097	rs56235845	0.680297384870867	Kidney stones	3e-21	31729369
rs35716097	rs56235845	0.680297384870867	Hemoglobin levels	7e-16	32327693
rs35716097	rs6556313	0.676300760235852	Eosinophil counts	2e-20	32888493
rs35716097	rs6556313	0.676300760235852	Eosinophil counts	1e-16	32888494
rs35716097	rs6556313	0.676300760235852	Eosinophil percentage of white cells	1e-11	32888494
rs35716097	rs6556313	0.676300760235852	Calcium levels	1e-12	33887147
rs35716097	rs6556313	0.676300760235852	Eosinophil counts	1e-21	30595370
rs35716097	rs4976689	0.66962328561604	Eosinophil counts	4e-18	34594039
rs35716097	rs4976646	0.664930596201883	Multiple sclerosis	4e-18	24076602
rs35716097	rs4976646	0.664930596201883	Blood urea nitrogen levels	1e-19	31152163
rs35716097	rs4976646	0.664930596201883	Chronic kidney disease	2e-10	31152163
rs35716097	rs4976646	0.664930596201883	Crohn's disease	3e-08	26192919
rs35716097	rs4976646	0.664930596201883	Ulcerative colitis	3e-09	26192919
rs35716097	rs4976646	0.664930596201883	Inflammatory bowel disease	3e-12	26192919
rs35716097	rs4976646	0.664930596201883	Tumor necrosis factor receptor 2 levels	4e-10	33067605
rs35716097	rs4976646	0.664930596201883	Inflammatory bowel disease	4e-09	28067908
rs35716097	rs4976646	0.664930596201883	Ulcerative colitis	4e-08	28067908
rs35716097	rs67111717	0.654984202577041	Multiple sclerosis	3e-21	31604244
rs35735333	rs2257649	0.984858340057688	Total Phosphatidylglycerol levels	3e-10	35668104
rs35735333	rs4815400	0.984854842143623	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs35735333	rs6037062	0.677386413356236	Lung function (forced vital capacity)	3e-13	36914875
rs35735333	rs6037062	0.677386413356236	Lung function (FVC)	5e-12	30595370
rs35735333	rs2500430	0.654135733381844	Serum alkaline phosphatase levels	7e-10	31666285
rs35735333	rs2273473	0.62225549344026	Vertex-wise cortical thickness	1e-12	34910505
rs35735333	rs2856	0.607139188744657	Blood protein levels	6e-07	27532455
rs35735333	rs4815412	0.603465434349461	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs35735333	rs12428	0.60277612837475	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs35763894	rs4421206	0.990353728072038	Brain morphology (min-P)	4e-11	32665545
rs35763894	rs9688452	0.961056532983615	Brainstem global volume Whole-brainstem	1e-11	33875891
rs35763894	rs9688452	0.961056532983615	aseg lh volume VentralDC	2e-10	33875891
rs35763894	rs4380763	0.939524340679462	Subcortical volume (min-P)	1e-11	32665545
rs35763894	rs1934534	0.935625349310075	Pain (pleiotropy)	2e-08	37844115
rs35763894	rs1934534	0.935625349310075	Pain (pleiotropy)	2e-06	37844115
rs35763894	rs11155671	0.919878743644679	Testicular germ cell tumor	2e-09	28604728
rs35763894	rs80147756	0.894807178683323	HippSubfield lh volume subiculum-head	3e-10	33875891
rs35763894	rs9505982	0.894021808352304	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs35763894	rs10872649	0.816691644119174	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs35763894	rs10872649	0.816691644119174	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs35763894	rs10872649	0.816691644119174	Right hippocampal volume (body)	1e-10	37337106
rs35763894	rs7752089	0.780102965989661	Brain morphology (MOSTest)	2e-31	35164939
rs35763894	rs9322194	0.752421419021496	Brainstem volume	2e-11	31636452
rs35763894	rs9285521	0.694172519821489	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs35763894	rs12526675	0.682026872744677	Brain morphology (MOSTest)	7e-22	32665545
rs35763894	rs2342764	0.639113993442423	Cortical thickness	1e-08	34560273
rs35763894	rs9688809	0.608479278222665	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs35763894	rs56103941	0.607582007347074	Right presubiculum volume (head)	4e-08	37337106
rs35763894	rs34337297	0.606989170808779	Serum levels of protein LRP11	3e-161	35078996
rs35763894	rs10872645	0.604882201121145	Blood protein levels	2e-86	30072576
rs35763894	rs14314	0.603728210201737	Macular thickness	3e-19	30535121
rs35763894	rs14314	0.603728210201737	Vertex-wise sulcal depth	7e-17	34910505
rs35763894	rs14314	0.603728210201737	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs35763894	rs14314	0.603728210201737	Left hippocampal volume (body)	7e-15	37337106
rs35763894	rs14314	0.603728210201737	Left subiculum volume (body)	1e-14	37337106
rs35763894	rs55763431	0.60355769361549	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs35763894	rs9689694	0.602467608001322	Right hippocampal volume (head)	6e-11	37337106
rs35763894	rs9689694	0.602467608001322	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs35763894	rs9689694	0.602467608001322	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs35763894	rs9689694	0.602467608001322	Left hippocampal volume (head)	6e-12	37337106
rs35763894	rs9383843	0.601145350097432	Migraine	1e-09	35115687
rs35763894	rs2095375	0.600601195004103	Serum metabolite levels	1e-20	33031748
rs35763894	rs2095375	0.600601195004103	Serum metabolite levels	1e-20	33031748
rs35830138	rs4421206	0.988765167080548	Brain morphology (min-P)	4e-11	32665545
rs35830138	rs9688452	0.961117607261601	Brainstem global volume Whole-brainstem	1e-11	33875891
rs35830138	rs9688452	0.961117607261601	aseg lh volume VentralDC	2e-10	33875891
rs35830138	rs4380763	0.938062641188875	Subcortical volume (min-P)	1e-11	32665545
rs35830138	rs1934534	0.935734002238831	Pain (pleiotropy)	2e-08	37844115
rs35830138	rs1934534	0.935734002238831	Pain (pleiotropy)	2e-06	37844115
rs35830138	rs11155671	0.91842722470675	Testicular germ cell tumor	2e-09	28604728
rs35830138	rs80147756	0.893332879172098	HippSubfield lh volume subiculum-head	3e-10	33875891
rs35830138	rs9505982	0.892540111002248	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs35830138	rs10872649	0.816694345309627	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs35830138	rs10872649	0.816694345309627	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs35830138	rs10872649	0.816694345309627	Right hippocampal volume (body)	1e-10	37337106
rs35830138	rs7752089	0.780032431545459	Brain morphology (MOSTest)	2e-31	35164939
rs35830138	rs9322194	0.752252668754943	Brainstem volume	2e-11	31636452
rs35830138	rs9285521	0.695221151417369	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs35830138	rs12526675	0.682937503098603	Brain morphology (MOSTest)	7e-22	32665545
rs35830138	rs2342764	0.639935690364978	Cortical thickness	1e-08	34560273
rs35830138	rs56103941	0.608329399921911	Right presubiculum volume (head)	4e-08	37337106
rs35830138	rs9688809	0.606513199642091	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs35830138	rs34337297	0.605033676855484	Serum levels of protein LRP11	3e-161	35078996
rs35830138	rs10872645	0.604253255514016	Blood protein levels	2e-86	30072576
rs35830138	rs14314	0.601769780557275	Macular thickness	3e-19	30535121
rs35830138	rs14314	0.601769780557275	Vertex-wise sulcal depth	7e-17	34910505
rs35830138	rs14314	0.601769780557275	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs35830138	rs14314	0.601769780557275	Left hippocampal volume (body)	7e-15	37337106
rs35830138	rs14314	0.601769780557275	Left subiculum volume (body)	1e-14	37337106
rs35830138	rs55763431	0.601607486242739	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs35830138	rs9689694	0.600520915954922	Right hippocampal volume (head)	6e-11	37337106
rs35830138	rs9689694	0.600520915954922	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs35830138	rs9689694	0.600520915954922	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs35830138	rs9689694	0.600520915954922	Left hippocampal volume (head)	6e-12	37337106
rs35839188	rs9469857	0.989543793406407	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs35839188	rs2764208	0.988738867945909	Systemic lupus erythematosus	7e-06	24871463
rs35839188	rs9462030	0.975164897452128	Red cell distribution width	5e-25	32888493
rs35839188	rs9469899	0.958807359162744	Prostate cancer (advanced)	2e-06	29892016
rs35839188	rs9469899	0.958807359162744	Prostate cancer	5e-09	29892016
rs35839188	rs9469899	0.958807359162744	Prostate cancer	8e-11	33398198
rs35839188	rs9469899	0.958807359162744	Hand grip strength	3e-15	29691431
rs35839188	rs9469899	0.958807359162744	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs35839188	rs9469899	0.958807359162744	Graves' disease	4e-10	34594039
rs35839188	rs9469899	0.958807359162744	Coronary artery disease	1e-11	36474045
rs35839188	rs9469899	0.958807359162744	Predicted visceral adipose tissue	2e-20	31501611
rs35839188	rs9469899	0.958807359162744	Medication use (thyroid preparations)	2e-09	31015401
rs35839188	rs9469899	0.958807359162744	Medication use (thyroid preparations)	3e-10	34594039
rs35839188	rs9469872	0.953504363503026	HDL cholesterol levels	3e-11	36333282
rs35839188	rs9296128	0.938546850923152	Hip circumference adjusted for BMI	4e-13	34021172
rs35839188	rs11755393	0.92834919670856	Body mass index	3e-26	29273807
rs35839188	rs11755393	0.92834919670856	Systemic lupus erythematosus	2e-12	33493351
rs35839188	rs11755393	0.92834919670856	Systemic lupus erythematosus	2e-06	33493351
rs35839188	rs11755393	0.92834919670856	Systemic lupus erythematosus	1e-07	33493351
rs35839188	rs11755393	0.92834919670856	Systemic lupus erythematosus	2e-08	19838195
rs35839188	rs11755393	0.92834919670856	Body mass index	4e-55	36581621
rs35839188	rs9366863	0.924581327301309	Adult body size	9e-33	32376654
rs35839188	rs9366863	0.924581327301309	Body mass index	2e-44	30595370
rs35839188	rs6941110	0.916785081778096	Sex hormone-binding globulin levels	5e-27	36653534
rs35839188	rs2744944	0.897737000774542	Hypothyroidism	3e-10	34594039
rs35839188	rs2744944	0.897737000774542	High density lipoprotein cholesterol levels	3e-86	34887591
rs35839188	rs2744944	0.897737000774542	Multi-trait sex score	7e-22	37277458
rs35839188	rs2814949	0.888814851061705	Essential hypertension (time to event)	9e-09	32589924
rs35839188	rs2263329	0.875455287067743	HDL cholesterol	6e-35	34594039
rs35839188	rs2263329	0.875455287067743	HDL cholesterol levels	8e-43	32203549
rs35839188	rs2263329	0.875455287067743	High density lipoprotein cholesterol levels	2e-52	34887591
rs35839188	rs111868030	0.857313746672353	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs35839188	rs9368830	0.816751628660009	HDL cholesterol	4e-21	30275531
rs35839188	rs9368828	0.807226942277605	Body mass index	1e-34	34594039
rs35839188	rs2744973	0.785394988011163	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs35839188	rs2744973	0.785394988011163	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs35839188	rs2744973	0.785394988011163	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs35839188	rs2744973	0.785394988011163	Multi-trait sex score	6e-20	37277458
rs35839188	rs6912327	0.774706225623161	Fasting insulin	5e-06	33402679
rs35839188	rs6912327	0.774706225623161	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs35839188	rs112283401	0.751221377971103	Red cell distribution width	4e-27	30595370
rs35839188	rs9689160	0.615509351753417	Lung function (forced vital capacity)	3e-14	36914875
rs35928237	rs4959106	0.971611301117028	Interleukin-6 levels	7e-13	33067605
rs35928237	rs34077986	0.962562690578776	A body shape index	5e-11	34021172
rs35928237	rs3129754	0.858066854704911	Waist-hip index	2e-12	34021172
rs35928237	rs3129754	0.858066854704911	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs35928237	rs34656207	0.794406657091319	Aspartate aminotransferase levels	1e-111	33547301
rs35928237	rs34656207	0.794406657091319	Aspartate aminotransferase levels	1e-126	34594039
rs35928237	rs33915496	0.738940541954101	Lymphocyte count	1e-16	32888493
rs35928237	rs4959105	0.727200150833153	Lymphocyte count	3e-16	29403010
rs35928237	rs33932178	0.642778742331005	Lymphocyte count	3e-22	34594039
rs35946036	rs10465746	0.953013627745295	Obesity-related traits	8e-06	23251661
rs35946036	rs11580836	0.911309344642201	Body mass index	2e-09	36581621
rs35952885	rs4242434	0.896024757221124	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs35952885	rs11781149	0.869747559692909	Refractive error	2e-17	32231278
rs35952885	rs746011	0.826795353172651	Triglycerides	2e-10	30275531
rs35952885	rs1545837	0.803376005518158	Lung function (FVC)	1e-10	30595370
rs35952885	rs2280104	0.789281716665331	Parkinson's disease	3e-08	28892059
rs35952885	rs2280104	0.789281716665331	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs35952885	rs2280104	0.789281716665331	Serum total protein level	3e-12	34594039
rs35952885	rs4872007	0.736912791798104	Superior temporal gyrus volume	8e-06	31530798
rs35952885	rs11780207	0.686516136589916	Estimated glomerular filtration rate	2e-13	33462484
rs35952885	rs11780207	0.686516136589916	Serum total protein level	2e-09	33462484
rs35952885	rs11780207	0.686516136589916	Creatinine levels	2e-13	33462484
rs35952885	rs11778693	0.636977057700019	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs35952885	rs11778693	0.636977057700019	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs35952885	rs13271626	0.626532900495263	Haemorrhoidal disease	3e-10	33888516
rs35952885	rs4592028	0.615481115290779	Non-albumin protein levels	3e-09	33462484
rs35969331	rs11580836	0.94559565373907	Body mass index	2e-09	36581621
rs35969331	rs10465746	0.92598541714472	Obesity-related traits	8e-06	23251661
rs35980977	rs7987940	0.708544895397811	AFP levels	6e-08	36329257
rs35980977	rs9535244	0.641234294326217	Lung function (FVC)	1e-08	30595370
rs36124427	rs4959106	0.979107668796708	Interleukin-6 levels	7e-13	33067605
rs36124427	rs34077986	0.969998716697366	A body shape index	5e-11	34021172
rs36124427	rs3129754	0.865921764973324	Waist-hip index	2e-12	34021172
rs36124427	rs3129754	0.865921764973324	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs36124427	rs34656207	0.802535689290397	Aspartate aminotransferase levels	1e-111	33547301
rs36124427	rs34656207	0.802535689290397	Aspartate aminotransferase levels	1e-126	34594039
rs36124427	rs33915496	0.74736567181296	Lymphocyte count	1e-16	32888493
rs36124427	rs4959105	0.734093736505725	Lymphocyte count	3e-16	29403010
rs36124427	rs33932178	0.64869403726512	Lymphocyte count	3e-22	34594039
rs36124427	rs685244	0.607628759878155	Complement C4 levels	2e-12	36168886
rs36124427	rs3104414	0.607245031892203	HLA DR+ T cell%T cell	9e-09	32929287
rs36124427	rs3104414	0.607245031892203	Chronic sinus infection	2e-06	28928442
rs36124427	rs3104414	0.607245031892203	Hip circumference adjusted for BMI	9e-13	34021172
rs36124427	rs28383224	0.602429831962672	Neuromyelitis optica	6e-12	29769526
rs36124427	rs28383224	0.602429831962672	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs36124427	rs28383224	0.602429831962672	Waist-hip index	1e-19	34021172
rs36124427	rs28383224	0.602429831962672	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs36124427	rs28383224	0.602429831962672	Waist circumference adjusted for body mass index	9e-10	34021172
rs36133747	rs4304220	0.702794987857296	Height	2e-14	36224396
rs36133747	rs4355658	0.664484692466921	Height	3e-13	36224396
rs36216559	rs17713729	0.991818658634909	Body mass index	2e-09	31669095
rs36216559	rs17713729	0.991818658634909	Serum creatinine levels	4e-14	34594039
rs36216559	rs17713729	0.991818658634909	High density lipoprotein cholesterol levels	7e-17	34887591
rs36216559	rs7595075	0.990797071098203	Waist circumference adjusted for body mass index	2e-09	34021172
rs36216559	rs7595075	0.990797071098203	HDL cholesterol	3e-11	34594039
rs36216559	rs7595075	0.990797071098203	HDL cholesterol levels	6e-13	32203549
rs36216559	rs79716074	0.986717499214558	Plateletcrit	1e-09	32888494
rs36216559	rs79716074	0.986717499214558	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs36216559	rs79716074	0.986717499214558	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs36216559	rs79716074	0.986717499214558	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs36216559	rs58461606	0.979672100447326	Blood protein levels	0	30072576
rs36216559	rs17713396	0.976555857951644	Blood urea nitrogen levels	3e-21	34272381
rs36216559	rs17713396	0.976555857951644	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs36216559	rs17713396	0.976555857951644	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs36216559	rs6710091	0.974529814457314	Waist circumference adjusted for body mass index	8e-11	31669095
rs36216559	rs6710091	0.974529814457314	HDL cholesterol	5e-08	30275531
rs36216559	rs6710091	0.974529814457314	High density lipoprotein cholesterol levels	3e-24	34887591
rs36216559	rs7605824	0.972554222824762	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs36216559	rs7566279	0.971553521059119	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs36216559	rs3791221	0.936369344914432	Blood urea nitrogen levels	2e-07	31152163
rs36216559	rs3791221	0.936369344914432	Estimated glomerular filtration rate	2e-10	31152163
rs36216559	rs3791221	0.936369344914432	Estimated glomerular filtration rate	1e-11	31152163
rs36216559	rs3791221	0.936369344914432	Blood urea nitrogen levels	7e-26	34594039
rs36216559	rs2290911	0.930353045362874	Height	5e-07	29782485
rs36216559	rs2290911	0.930353045362874	Large artery stroke	6e-06	28265093
rs36216559	rs2290911	0.930353045362874	Height	8e-112	36224396
rs36216559	rs114976176	0.927090166479508	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs36216559	rs2126129	0.922371514157378	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs36216559	rs59937473	0.898622146205177	Protein quantitative trait loci	3e-67	32492067
rs36216559	rs59937473	0.898622146205177	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs36216559	rs17714252	0.890769677144866	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs36216559	rs17714252	0.890769677144866	Retinal vascular fractal dimension	2e-07	34743558
rs36216559	rs11553746	0.888600241039624	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs36216559	rs11553746	0.888600241039624	High density lipoprotein cholesterol levels	2e-07	29083408
rs36216559	rs11553746	0.888600241039624	High density lipoprotein cholesterol levels	7e-15	29083408
rs36216559	rs11553746	0.888600241039624	Large artery stroke	4e-06	28265093
rs36216559	rs55753056	0.868398974395842	Height	2e-22	30595370
rs36216559	rs62114548	0.867429773501538	Retinal vascular fractal density	2e-09	34743558
rs36216559	rs7601944	0.860461362507345	Smoking initiation	4e-15	36477530
rs36216559	rs62114538	0.844811374945392	Triglyceride levels	6e-12	34887591
rs36216559	rs17713879	0.836057270323431	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs36216559	rs17713879	0.836057270323431	Smoking initiation	1e-10	36477530
rs36216559	rs17713879	0.836057270323431	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs36216559	rs17713879	0.836057270323431	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs36216559	rs17713879	0.836057270323431	Triglyceride levels	3e-10	34887591
rs36216559	rs17713879	0.836057270323431	Aging (eyeAgeAcceleration)	6e-50	36975205
rs36216559	rs60843830	0.829515525710009	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs36216559	rs60843830	0.829515525710009	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs36216559	rs60843830	0.829515525710009	Adventurousness	7e-10	30643258
rs36216559	rs79154857	0.801745597013049	Pulse pressure	5e-08	34594039
rs36216559	rs62114506	0.751688820613942	Gamma glutamyl transpeptidase	3e-14	34594039
rs36216559	rs62114506	0.751688820613942	Apolipoprotein A1 levels	3e-10	32203549
rs36216559	rs62114506	0.751688820613942	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs36216559	rs62114506	0.751688820613942	HDL cholesterol levels	8e-10	36333282
rs3729838	rs28377509	0.991196552066348	Platelet count	2e-26	32888493
rs3729838	rs6509933	0.606733702181964	OTU99_54 (Holdemanella) abundance	6e-06	33462482
rs3734268	rs2764208	1	Systemic lupus erythematosus	7e-06	24871463
rs3734268	rs9469857	0.994363579966998	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs3734268	rs9462030	0.979948846273265	Red cell distribution width	5e-25	32888493
rs3734268	rs9469899	0.96354553338453	Prostate cancer (advanced)	2e-06	29892016
rs3734268	rs9469899	0.96354553338453	Prostate cancer	5e-09	29892016
rs3734268	rs9469899	0.96354553338453	Prostate cancer	8e-11	33398198
rs3734268	rs9469899	0.96354553338453	Hand grip strength	3e-15	29691431
rs3734268	rs9469899	0.96354553338453	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs3734268	rs9469899	0.96354553338453	Graves' disease	4e-10	34594039
rs3734268	rs9469899	0.96354553338453	Coronary artery disease	1e-11	36474045
rs3734268	rs9469899	0.96354553338453	Predicted visceral adipose tissue	2e-20	31501611
rs3734268	rs9469899	0.96354553338453	Medication use (thyroid preparations)	2e-09	31015401
rs3734268	rs9469899	0.96354553338453	Medication use (thyroid preparations)	3e-10	34594039
rs3734268	rs9469872	0.958227492160117	HDL cholesterol levels	3e-11	36333282
rs3734268	rs9296128	0.94325488802781	Hip circumference adjusted for BMI	4e-13	34021172
rs3734268	rs11755393	0.933006118158596	Body mass index	3e-26	29273807
rs3734268	rs11755393	0.933006118158596	Systemic lupus erythematosus	2e-12	33493351
rs3734268	rs11755393	0.933006118158596	Systemic lupus erythematosus	2e-06	33493351
rs3734268	rs11755393	0.933006118158596	Systemic lupus erythematosus	1e-07	33493351
rs3734268	rs11755393	0.933006118158596	Systemic lupus erythematosus	2e-08	19838195
rs3734268	rs11755393	0.933006118158596	Body mass index	4e-55	36581621
rs3734268	rs9366863	0.929232788778709	Adult body size	9e-33	32376654
rs3734268	rs9366863	0.929232788778709	Body mass index	2e-44	30595370
rs3734268	rs6941110	0.921417496348263	Sex hormone-binding globulin levels	5e-27	36653534
rs3734268	rs2744944	0.902320101561385	Hypothyroidism	3e-10	34594039
rs3734268	rs2744944	0.902320101561385	High density lipoprotein cholesterol levels	3e-86	34887591
rs3734268	rs2744944	0.902320101561385	Multi-trait sex score	7e-22	37277458
rs3734268	rs2814949	0.893373793948083	Essential hypertension (time to event)	9e-09	32589924
rs3734268	rs2263329	0.879983684454224	HDL cholesterol	6e-35	34594039
rs3734268	rs2263329	0.879983684454224	HDL cholesterol levels	8e-43	32203549
rs3734268	rs2263329	0.879983684454224	High density lipoprotein cholesterol levels	2e-52	34887591
rs3734268	rs111868030	0.85881241867559	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs3734268	rs9368830	0.821112992491793	HDL cholesterol	4e-21	30275531
rs3734268	rs9368828	0.811578256757851	Body mass index	1e-34	34594039
rs3734268	rs2744973	0.789742920777674	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs3734268	rs2744973	0.789742920777674	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs3734268	rs2744973	0.789742920777674	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs3734268	rs2744973	0.789742920777674	Multi-trait sex score	6e-20	37277458
rs3734268	rs6912327	0.777573531539846	Fasting insulin	5e-06	33402679
rs3734268	rs6912327	0.777573531539846	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs3734268	rs112283401	0.755458408444623	Red cell distribution width	4e-27	30595370
rs3734268	rs9689160	0.61683561435316	Lung function (forced vital capacity)	3e-14	36914875
rs3734295	rs9322194	0.987248654292438	Brainstem volume	2e-11	31636452
rs3734295	rs10872649	0.839506761931102	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs3734295	rs10872649	0.839506761931102	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs3734295	rs10872649	0.839506761931102	Right hippocampal volume (body)	1e-10	37337106
rs3734295	rs9505982	0.834279480336565	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs3734295	rs9285521	0.818230726251764	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs3734295	rs7752089	0.806028343035228	Brain morphology (MOSTest)	2e-31	35164939
rs3734295	rs11155671	0.792768811600334	Testicular germ cell tumor	2e-09	28604728
rs3734295	rs4380763	0.7810627761982	Subcortical volume (min-P)	1e-11	32665545
rs3734295	rs1934534	0.780414758168024	Pain (pleiotropy)	2e-08	37844115
rs3734295	rs1934534	0.780414758168024	Pain (pleiotropy)	2e-06	37844115
rs3734295	rs4421206	0.752860774160076	Brain morphology (min-P)	4e-11	32665545
rs3734295	rs80147756	0.73981741954983	HippSubfield lh volume subiculum-head	3e-10	33875891
rs3734295	rs9688452	0.737013030310921	Brainstem global volume Whole-brainstem	1e-11	33875891
rs3734295	rs9688452	0.737013030310921	aseg lh volume VentralDC	2e-10	33875891
rs3734295	rs11155662	0.707103306756705	Vertex-wise cortical thickness	2e-09	34910505
rs3734295	rs12526675	0.697586418588635	Brain morphology (MOSTest)	7e-22	32665545
rs3734295	rs2342764	0.649913208617183	Cortical thickness	1e-08	34560273
rs3734295	rs56103941	0.647467131167589	Right presubiculum volume (head)	4e-08	37337106
rs3734295	rs12523793	0.639901529970119	Subcortical volume (MOSTest)	4e-24	32665545
rs3734295	rs12523793	0.639901529970119	C-reactive protein levels	3e-08	35459240
rs3734295	rs12523793	0.639901529970119	C-reactive protein levels (MTAG)	2e-08	36376304
rs3736147	rs11781149	0.935098799211319	Refractive error	2e-17	32231278
rs3736147	rs746011	0.872867894388259	Triglycerides	2e-10	30275531
rs3736147	rs1545837	0.807124799858581	Lung function (FVC)	1e-10	30595370
rs3736147	rs4242434	0.773677661973415	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs3736147	rs2280104	0.720962911302867	Parkinson's disease	3e-08	28892059
rs3736147	rs2280104	0.720962911302867	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs3736147	rs2280104	0.720962911302867	Serum total protein level	3e-12	34594039
rs3736147	rs34269854	0.713816757081661	Lung function (forced vital capacity)	3e-09	36914875
rs3736147	rs4872007	0.676376047059844	Superior temporal gyrus volume	8e-06	31530798
rs3736147	rs13271626	0.674992215454489	Haemorrhoidal disease	3e-10	33888516
rs3736147	rs11782130	0.668777202735702	C-reactive protein levels	9e-09	35459240
rs3736147	rs11778693	0.649964145518607	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs3736147	rs11778693	0.649964145518607	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs3736147	rs11780207	0.626813790885283	Estimated glomerular filtration rate	2e-13	33462484
rs3736147	rs11780207	0.626813790885283	Serum total protein level	2e-09	33462484
rs3736147	rs11780207	0.626813790885283	Creatinine levels	2e-13	33462484
rs3746224	rs1989455	0.621312503153094	Height	2e-31	36224396
rs3748581	rs7524908	0.684399350349812	Height	5e-27	30595370
rs3748581	rs3828081	0.678702547110537	Cognitive function (immediate memory)	8e-08	35386118
rs3749935	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs3749935	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs3749935	rs6928810	0.890092667905038	Platelet distribution width	1e-14	32888494
rs3749935	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs3749935	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs3749935	rs9266825	0.864263096403477	Autism spectrum disorder	6e-06	35215271
rs3749935	rs199530775	0.740076610728635	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs3749935	rs55957433	0.740076610728635	Hip circumference adjusted for BMI	3e-08	34021172
rs3749935	rs6934175	0.67384422555715	Psoriatic arthritis	5e-28	30552173
rs3749935	rs17200242	0.664511943065584	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs3749935	rs7751505	0.657706582280067	Pubertal anthropometrics	4e-06	23449627
rs3749935	rs35026345	0.65640936672589	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs3749935	rs72848707	0.653592630236073	HDL cholesterol levels	7e-06	35884923
rs3749935	rs13437088	0.631438004864122	Psoriasis	3e-40	23143594
rs3749935	rs13437082	0.630743556638567	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs3749935	rs13437082	0.630743556638567	Height	5e-08	19343178
rs3749935	rs72657657	0.623149040879308	Hip circumference adjusted for BMI	4e-13	34021172
rs3749937	rs1063631	0.889109434897423	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs3749937	rs1063631	0.889109434897423	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs3749937	rs6928810	0.885969117703678	Platelet distribution width	1e-14	32888494
rs3749937	rs3869132	0.885108377318858	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs3749937	rs3869132	0.885108377318858	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs3749937	rs9266825	0.859897196501783	Autism spectrum disorder	6e-06	35215271
rs3749937	rs199530775	0.735525552085305	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs3749937	rs55957433	0.735525552085305	Hip circumference adjusted for BMI	3e-08	34021172
rs3749937	rs6934175	0.669348129020705	Psoriatic arthritis	5e-28	30552173
rs3749937	rs17200242	0.660084112880524	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs3749937	rs72848707	0.65793352094278	HDL cholesterol levels	7e-06	35884923
rs3749937	rs7751505	0.653690040235052	Pubertal anthropometrics	4e-06	23449627
rs3749937	rs35026345	0.652379003219626	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs3749937	rs13437088	0.627596755542824	Psoriasis	3e-40	23143594
rs3749937	rs13437082	0.626902033611209	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs3749937	rs13437082	0.626902033611209	Height	5e-08	19343178
rs3749937	rs72657657	0.619320582973504	Hip circumference adjusted for BMI	4e-13	34021172
rs3749939	rs1063631	0.890773622443227	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs3749939	rs1063631	0.890773622443227	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs3749939	rs6928810	0.887616959898339	Platelet distribution width	1e-14	32888494
rs3749939	rs3869132	0.886761758257403	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs3749939	rs3869132	0.886761758257403	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs3749939	rs9266825	0.86164186149912	Autism spectrum disorder	6e-06	35215271
rs3749939	rs199530775	0.737344084055403	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs3749939	rs55957433	0.737344084055403	Hip circumference adjusted for BMI	3e-08	34021172
rs3749939	rs6934175	0.671144620017627	Psoriatic arthritis	5e-28	30552173
rs3749939	rs17200242	0.661853328334436	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs3749939	rs72848707	0.656785019642125	HDL cholesterol levels	7e-06	35884923
rs3749939	rs7751505	0.655294993033348	Pubertal anthropometrics	4e-06	23449627
rs3749939	rs35026345	0.653989474731011	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs3749939	rs13437088	0.629131666658441	Psoriasis	3e-40	23143594
rs3749939	rs13437082	0.628437053255131	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs3749939	rs13437082	0.628437053255131	Height	5e-08	19343178
rs3749939	rs72657657	0.620850375656362	Hip circumference adjusted for BMI	4e-13	34021172
rs3753754	rs835341	0.87116998663612	Ascending aorta distensibility (MTAG)	8e-09	35922433
rs3753754	rs946155	0.811137262229013	Glutathione peroxidase 7 levels (GPX7.8345.27.3)	2e-61	29875488
rs3754450	rs3754450	1	Seasonality and depression	3e-06	30217971
rs3759375	rs1859336	0.988162497871829	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs3759375	rs6489882	0.973012290739672	Chronic lymphocytic leukemia	5e-08	28165464
rs3759375	rs11066452	0.965805012189525	Blood protein levels	6e-08	30072576
rs3759375	rs4767027	0.944791083807623	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs3759375	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs3759375	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs3759375	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs3759375	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs3759375	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs3759375	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs3759375	rs6489867	0.672733397366654	COVID-19 (critical illness vs population)	1e-09	33307546
rs3759375	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs3759376	rs1859336	0.988162497871829	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs3759376	rs6489882	0.973012290739672	Chronic lymphocytic leukemia	5e-08	28165464
rs3759376	rs11066452	0.965805012189525	Blood protein levels	6e-08	30072576
rs3759376	rs4767027	0.944791083807623	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs3759376	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs3759376	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs3759376	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs3759376	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs3759376	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs3759376	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs3759376	rs6489867	0.672733397366654	COVID-19 (critical illness vs population)	1e-09	33307546
rs3759376	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs3759956	rs2060573	0.987769946633897	Chronic obstructive pulmonary disease liability (machine learning-based score)	4e-30	37069358
rs3760297	rs9897542	0.925329901612298	Total bilirubin levels	8e-11	34594039
rs3760297	rs2285583	0.767598838089262	AFP levels	2e-08	36329257
rs3763162	rs14314	0.963787254093108	Macular thickness	3e-19	30535121
rs3763162	rs14314	0.963787254093108	Vertex-wise sulcal depth	7e-17	34910505
rs3763162	rs14314	0.963787254093108	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs3763162	rs14314	0.963787254093108	Left hippocampal volume (body)	7e-15	37337106
rs3763162	rs14314	0.963787254093108	Left subiculum volume (body)	1e-14	37337106
rs3763162	rs2095375	0.950723186757169	Serum metabolite levels	1e-20	33031748
rs3763162	rs2095375	0.950723186757169	Serum metabolite levels	1e-20	33031748
rs3763162	rs9383843	0.949843597134059	Migraine	1e-09	35115687
rs3763162	rs55763431	0.946344893760322	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs3763162	rs9689694	0.94461391312984	Right hippocampal volume (head)	6e-11	37337106
rs3763162	rs9689694	0.94461391312984	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs3763162	rs9689694	0.94461391312984	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs3763162	rs9689694	0.94461391312984	Left hippocampal volume (head)	6e-12	37337106
rs3763162	rs10872645	0.939390153522825	Blood protein levels	2e-86	30072576
rs3763162	rs10872653	0.938558163595904	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs3763162	rs9688867	0.938504319402211	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs3763162	rs9688867	0.938504319402211	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs3763162	rs9688809	0.938504319402211	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs3763162	rs34337297	0.935059870377418	Serum levels of protein LRP11	3e-161	35078996
rs3763162	rs9322193	0.899994262294925	Lung cancer	1e-07	27393504
rs3763162	rs4039600	0.858124565601181	Adenine levels	1e-11	35347128
rs3763162	rs1934534	0.615090135740504	Pain (pleiotropy)	2e-08	37844115
rs3763162	rs1934534	0.615090135740504	Pain (pleiotropy)	2e-06	37844115
rs3763162	rs4380763	0.614573140573611	Subcortical volume (min-P)	1e-11	32665545
rs3763162	rs11155671	0.604337815041001	Testicular germ cell tumor	2e-09	28604728
rs3764084	rs9535255	0.601419345079029	Low density lipoprotein cholesterol levels	4e-09	34887591
rs3764089	rs7987940	0.710339093251735	AFP levels	6e-08	36329257
rs3764089	rs9535244	0.644584143314829	Lung function (FVC)	1e-08	30595370
rs3765051	rs12617371	0.942824989388884	Immature fraction of reticulocytes	8e-18	32888494
rs3765051	rs777587	0.899682907801029	Proteoglycan 3 levels	6e-29	34648354
rs3765051	rs777587	0.899682907801029	Pappalysin-1 levels	1e-25	34648354
rs3765051	rs2463097	0.893090828856991	White blood cell count	3e-26	30595370
rs3765051	rs10199672	0.879933457061012	Height	6e-12	34594039
rs3765051	rs10199672	0.879933457061012	Height	2e-12	31562340
rs3765051	rs2593620	0.870262220735682	Serum levels of protein PRG3	5e-14	35078996
rs3765051	rs2421200	0.851116876032176	Neutrophil count	1e-26	32888493
rs3765051	rs2421200	0.851116876032176	Neutrophil count	1e-25	32888493
rs3765051	rs11685226	0.794333957549772	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs3765051	rs11685226	0.794333957549772	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs3765051	rs1177308	0.788800210214684	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs3765051	rs1177308	0.788800210214684	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs3765051	rs7558954	0.78504357355068	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs3765051	rs10169482	0.763912766804848	C-reactive protein levels	4e-09	33462484
rs3765051	rs2950269	0.730723062435922	Eosinophil side fluorescence	3e-18	37596262
rs3765051	rs12616433	0.717035683829346	Eosinophil forward scatter	4e-13	37596262
rs3765051	rs12616433	0.717035683829346	Eosinophil side scatter	2e-18	37596262
rs3770690	rs3732055	0.934044938908913	Citrulline levels	1e-10	36635386
rs3770690	rs3732055	0.934044938908913	Gamma-glutamylcitrulline levels	1e-10	36635386
rs3770690	rs3856349	0.873451643991566	LanC-like protein 1 levels	5e-22	34648354
rs3770691	rs3732055	0.932445830927723	Citrulline levels	1e-10	36635386
rs3770691	rs3732055	0.932445830927723	Gamma-glutamylcitrulline levels	1e-10	36635386
rs3770691	rs3856349	0.874942360778853	LanC-like protein 1 levels	5e-22	34648354
rs3775594	rs34402449	0.800343938863247	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs3775594	rs17007017	0.797105855115467	Conduct disorder	7e-06	20585324
rs3775594	rs1550057	0.727915659804829	Conduct disorder	4e-06	20585324
rs3775594	rs1550057	0.727915659804829	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs3787082	rs2257649	0.819547093738534	Total Phosphatidylglycerol levels	3e-10	35668104
rs3787082	rs4815400	0.814732576727235	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs3787082	rs2273473	0.782118290397892	Vertex-wise cortical thickness	1e-12	34910505
rs3787082	rs6050463	0.75084834789603	Low density lipoprotein cholesterol levels	6e-09	32154731
rs3787082	rs6050463	0.75084834789603	LDL cholesterol levels	2e-09	32203549
rs3787082	rs6115094	0.75084834789603	Brain morphology (MOSTest)	1e-08	32665545
rs3787082	rs6115094	0.75084834789603	Non-HDL cholesterol levels	3e-09	34887591
rs3787082	rs8115257	0.713336507061507	Total cholesterol levels	2e-09	34887591
rs3787082	rs8115257	0.713336507061507	Low density lipoprotein cholesterol levels	1e-10	34887591
rs3787082	rs6037062	0.682832311877683	Lung function (forced vital capacity)	3e-13	36914875
rs3787082	rs6037062	0.682832311877683	Lung function (FVC)	5e-12	30595370
rs3788032	rs400625	0.658172817321416	Posterior-cingulate cortex volume	5e-06	31530798
rs3791220	rs3791221	0.998993026011148	Blood urea nitrogen levels	2e-07	31152163
rs3791220	rs3791221	0.998993026011148	Estimated glomerular filtration rate	2e-10	31152163
rs3791220	rs3791221	0.998993026011148	Estimated glomerular filtration rate	1e-11	31152163
rs3791220	rs3791221	0.998993026011148	Blood urea nitrogen levels	7e-26	34594039
rs3791220	rs17713396	0.958136913392674	Blood urea nitrogen levels	3e-21	34272381
rs3791220	rs17713396	0.958136913392674	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs3791220	rs17713396	0.958136913392674	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs3791220	rs6710091	0.956146488196147	Waist circumference adjusted for body mass index	8e-11	31669095
rs3791220	rs6710091	0.956146488196147	HDL cholesterol	5e-08	30275531
rs3791220	rs6710091	0.956146488196147	High density lipoprotein cholesterol levels	3e-24	34887591
rs3791220	rs58461606	0.955069953803792	Blood protein levels	0	30072576
rs3791220	rs7566279	0.947166689313797	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs3791220	rs7595075	0.940297592084877	Waist circumference adjusted for body mass index	2e-09	34021172
rs3791220	rs7595075	0.940297592084877	HDL cholesterol	3e-11	34594039
rs3791220	rs7595075	0.940297592084877	HDL cholesterol levels	6e-13	32203549
rs3791220	rs17713729	0.937327239233321	Body mass index	2e-09	31669095
rs3791220	rs17713729	0.937327239233321	Serum creatinine levels	4e-14	34594039
rs3791220	rs17713729	0.937327239233321	High density lipoprotein cholesterol levels	7e-17	34887591
rs3791220	rs79716074	0.936367017446538	Plateletcrit	1e-09	32888494
rs3791220	rs79716074	0.936367017446538	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs3791220	rs79716074	0.936367017446538	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs3791220	rs79716074	0.936367017446538	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs3791220	rs7605824	0.924579841948998	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs3791220	rs2290911	0.917260496503133	Height	5e-07	29782485
rs3791220	rs2290911	0.917260496503133	Large artery stroke	6e-06	28265093
rs3791220	rs2290911	0.917260496503133	Height	8e-112	36224396
rs3791220	rs7601944	0.916695788194964	Smoking initiation	4e-15	36477530
rs3791220	rs55753056	0.907906746869019	Height	2e-22	30595370
rs3791220	rs2126129	0.905166118042141	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs3791220	rs114976176	0.903100817078975	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs3791220	rs59937473	0.874745341809504	Protein quantitative trait loci	3e-67	32492067
rs3791220	rs59937473	0.874745341809504	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs3791220	rs17714252	0.868960477543208	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs3791220	rs17714252	0.868960477543208	Retinal vascular fractal dimension	2e-07	34743558
rs3791220	rs17713879	0.865830618057044	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs3791220	rs17713879	0.865830618057044	Smoking initiation	1e-10	36477530
rs3791220	rs17713879	0.865830618057044	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs3791220	rs17713879	0.865830618057044	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs3791220	rs17713879	0.865830618057044	Triglyceride levels	3e-10	34887591
rs3791220	rs17713879	0.865830618057044	Aging (eyeAgeAcceleration)	6e-50	36975205
rs3791220	rs11553746	0.842120639936047	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs3791220	rs11553746	0.842120639936047	High density lipoprotein cholesterol levels	2e-07	29083408
rs3791220	rs11553746	0.842120639936047	High density lipoprotein cholesterol levels	7e-15	29083408
rs3791220	rs11553746	0.842120639936047	Large artery stroke	4e-06	28265093
rs3791220	rs62114538	0.814353730627742	Triglyceride levels	6e-12	34887591
rs3791220	rs62114548	0.814044698788328	Retinal vascular fractal density	2e-09	34743558
rs3791220	rs60843830	0.80956037461147	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs3791220	rs60843830	0.80956037461147	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs3791220	rs60843830	0.80956037461147	Adventurousness	7e-10	30643258
rs3791220	rs79154857	0.760265764168684	Pulse pressure	5e-08	34594039
rs3791220	rs62114506	0.740081652175385	Gamma glutamyl transpeptidase	3e-14	34594039
rs3791220	rs62114506	0.740081652175385	Apolipoprotein A1 levels	3e-10	32203549
rs3791220	rs62114506	0.740081652175385	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs3791220	rs62114506	0.740081652175385	HDL cholesterol levels	8e-10	36333282
rs3791221	rs3791221	1	Blood urea nitrogen levels	2e-07	31152163
rs3791221	rs3791221	1	Estimated glomerular filtration rate	2e-10	31152163
rs3791221	rs3791221	1	Estimated glomerular filtration rate	1e-11	31152163
rs3791221	rs3791221	1	Blood urea nitrogen levels	7e-26	34594039
rs3791221	rs17713396	0.957171548039843	Blood urea nitrogen levels	3e-21	34272381
rs3791221	rs17713396	0.957171548039843	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs3791221	rs17713396	0.957171548039843	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs3791221	rs6710091	0.95518258188227	Waist circumference adjusted for body mass index	8e-11	31669095
rs3791221	rs6710091	0.95518258188227	HDL cholesterol	5e-08	30275531
rs3791221	rs6710091	0.95518258188227	High density lipoprotein cholesterol levels	3e-24	34887591
rs3791221	rs58461606	0.954103328735304	Blood protein levels	0	30072576
rs3791221	rs7566279	0.946206954090112	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs3791221	rs7595075	0.939345323947796	Waist circumference adjusted for body mass index	2e-09	34021172
rs3791221	rs7595075	0.939345323947796	HDL cholesterol	3e-11	34594039
rs3791221	rs7595075	0.939345323947796	HDL cholesterol levels	6e-13	32203549
rs3791221	rs79716074	0.937387421388553	Plateletcrit	1e-09	32888494
rs3791221	rs79716074	0.937387421388553	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs3791221	rs79716074	0.937387421388553	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs3791221	rs79716074	0.937387421388553	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs3791221	rs17713729	0.936376354499974	Body mass index	2e-09	31669095
rs3791221	rs17713729	0.936376354499974	Serum creatinine levels	4e-14	34594039
rs3791221	rs17713729	0.936376354499974	High density lipoprotein cholesterol levels	7e-17	34887591
rs3791221	rs7605824	0.923637028346039	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs3791221	rs2290911	0.916336839042153	Height	5e-07	29782485
rs3791221	rs2290911	0.916336839042153	Large artery stroke	6e-06	28265093
rs3791221	rs2290911	0.916336839042153	Height	8e-112	36224396
rs3791221	rs7601944	0.915726987055323	Smoking initiation	4e-15	36477530
rs3791221	rs55753056	0.906945934259793	Height	2e-22	30595370
rs3791221	rs2126129	0.904245032832917	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs3791221	rs114976176	0.902161566356217	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs3791221	rs59937473	0.87381599865357	Protein quantitative trait loci	3e-67	32492067
rs3791221	rs59937473	0.87381599865357	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs3791221	rs17714252	0.868036569908977	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs3791221	rs17714252	0.868036569908977	Retinal vascular fractal dimension	2e-07	34743558
rs3791221	rs17713879	0.864922747744083	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs3791221	rs17713879	0.864922747744083	Smoking initiation	1e-10	36477530
rs3791221	rs17713879	0.864922747744083	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs3791221	rs17713879	0.864922747744083	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs3791221	rs17713879	0.864922747744083	Triglyceride levels	3e-10	34887591
rs3791221	rs17713879	0.864922747744083	Aging (eyeAgeAcceleration)	6e-50	36975205
rs3791221	rs11553746	0.841267908683928	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs3791221	rs11553746	0.841267908683928	High density lipoprotein cholesterol levels	2e-07	29083408
rs3791221	rs11553746	0.841267908683928	High density lipoprotein cholesterol levels	7e-15	29083408
rs3791221	rs11553746	0.841267908683928	Large artery stroke	4e-06	28265093
rs3791221	rs62114538	0.813455829508995	Triglyceride levels	6e-12	34887591
rs3791221	rs62114548	0.81320546481105	Retinal vascular fractal density	2e-09	34743558
rs3791221	rs60843830	0.808695425971242	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs3791221	rs60843830	0.808695425971242	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs3791221	rs60843830	0.808695425971242	Adventurousness	7e-10	30643258
rs3791221	rs79154857	0.759481027426754	Pulse pressure	5e-08	34594039
rs3791221	rs62114506	0.739334359767701	Gamma glutamyl transpeptidase	3e-14	34594039
rs3791221	rs62114506	0.739334359767701	Apolipoprotein A1 levels	3e-10	32203549
rs3791221	rs62114506	0.739334359767701	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs3791221	rs62114506	0.739334359767701	HDL cholesterol levels	8e-10	36333282
rs3791223	rs2290911	0.980292321893901	Height	5e-07	29782485
rs3791223	rs2290911	0.980292321893901	Large artery stroke	6e-06	28265093
rs3791223	rs2290911	0.980292321893901	Height	8e-112	36224396
rs3791223	rs17713396	0.954220033956048	Blood urea nitrogen levels	3e-21	34272381
rs3791223	rs17713396	0.954220033956048	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs3791223	rs17713396	0.954220033956048	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs3791223	rs6710091	0.95220051055013	Waist circumference adjusted for body mass index	8e-11	31669095
rs3791223	rs6710091	0.95220051055013	HDL cholesterol	5e-08	30275531
rs3791223	rs6710091	0.95220051055013	High density lipoprotein cholesterol levels	3e-24	34887591
rs3791223	rs7595075	0.936121339433331	Waist circumference adjusted for body mass index	2e-09	34021172
rs3791223	rs7595075	0.936121339433331	HDL cholesterol	3e-11	34594039
rs3791223	rs7595075	0.936121339433331	HDL cholesterol levels	6e-13	32203549
rs3791223	rs17713729	0.93521420539142	Body mass index	2e-09	31669095
rs3791223	rs17713729	0.93521420539142	Serum creatinine levels	4e-14	34594039
rs3791223	rs17713729	0.93521420539142	High density lipoprotein cholesterol levels	7e-17	34887591
rs3791223	rs79716074	0.93206179912922	Plateletcrit	1e-09	32888494
rs3791223	rs79716074	0.93206179912922	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs3791223	rs79716074	0.93206179912922	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs3791223	rs79716074	0.93206179912922	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs3791223	rs58461606	0.925610032974755	Blood protein levels	0	30072576
rs3791223	rs7605824	0.918484224620925	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs3791223	rs2126129	0.917607029442765	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs3791223	rs7566279	0.917533542144876	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs3791223	rs3791221	0.915077568733102	Blood urea nitrogen levels	2e-07	31152163
rs3791223	rs3791221	0.915077568733102	Estimated glomerular filtration rate	2e-10	31152163
rs3791223	rs3791221	0.915077568733102	Estimated glomerular filtration rate	1e-11	31152163
rs3791223	rs3791221	0.915077568733102	Blood urea nitrogen levels	7e-26	34594039
rs3791223	rs11553746	0.904139586761514	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs3791223	rs11553746	0.904139586761514	High density lipoprotein cholesterol levels	2e-07	29083408
rs3791223	rs11553746	0.904139586761514	High density lipoprotein cholesterol levels	7e-15	29083408
rs3791223	rs11553746	0.904139586761514	Large artery stroke	4e-06	28265093
rs3791223	rs114976176	0.875292711696716	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs3791223	rs62114548	0.861327544246361	Retinal vascular fractal density	2e-09	34743558
rs3791223	rs59937473	0.84858648513679	Protein quantitative trait loci	3e-67	32492067
rs3791223	rs59937473	0.84858648513679	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs3791223	rs17714252	0.840787813546249	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs3791223	rs17714252	0.840787813546249	Retinal vascular fractal dimension	2e-07	34743558
rs3791223	rs7601944	0.839341173416298	Smoking initiation	4e-15	36477530
rs3791223	rs55753056	0.830558731200457	Height	2e-22	30595370
rs3791223	rs79154857	0.817340059643378	Pulse pressure	5e-08	34594039
rs3791223	rs62114506	0.794432034111551	Gamma glutamyl transpeptidase	3e-14	34594039
rs3791223	rs62114506	0.794432034111551	Apolipoprotein A1 levels	3e-10	32203549
rs3791223	rs62114506	0.794432034111551	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs3791223	rs62114506	0.794432034111551	HDL cholesterol levels	8e-10	36333282
rs3791223	rs62114538	0.790219869078776	Triglyceride levels	6e-12	34887591
rs3791223	rs17713879	0.7858389078765	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs3791223	rs17713879	0.7858389078765	Smoking initiation	1e-10	36477530
rs3791223	rs17713879	0.7858389078765	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs3791223	rs17713879	0.7858389078765	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs3791223	rs17713879	0.7858389078765	Triglyceride levels	3e-10	34887591
rs3791223	rs17713879	0.7858389078765	Aging (eyeAgeAcceleration)	6e-50	36975205
rs3791223	rs60843830	0.779417306652124	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs3791223	rs60843830	0.779417306652124	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs3791223	rs60843830	0.779417306652124	Adventurousness	7e-10	30643258
rs3791224	rs7601944	0.952964528594588	Smoking initiation	4e-15	36477530
rs3791224	rs55753056	0.944275561503634	Height	2e-22	30595370
rs3791224	rs3791221	0.916926511805395	Blood urea nitrogen levels	2e-07	31152163
rs3791224	rs3791221	0.916926511805395	Estimated glomerular filtration rate	2e-10	31152163
rs3791224	rs3791221	0.916926511805395	Estimated glomerular filtration rate	1e-11	31152163
rs3791224	rs3791221	0.916926511805395	Blood urea nitrogen levels	7e-26	34594039
rs3791224	rs114976176	0.916872000194752	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs3791224	rs59937473	0.90976572100523	Protein quantitative trait loci	3e-67	32492067
rs3791224	rs59937473	0.90976572100523	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs3791224	rs17713396	0.90323790887383	Blood urea nitrogen levels	3e-21	34272381
rs3791224	rs17713396	0.90323790887383	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs3791224	rs17713396	0.90323790887383	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs3791224	rs17714252	0.902198280784985	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs3791224	rs17714252	0.902198280784985	Retinal vascular fractal dimension	2e-07	34743558
rs3791224	rs6710091	0.901328717461258	Waist circumference adjusted for body mass index	8e-11	31669095
rs3791224	rs6710091	0.901328717461258	HDL cholesterol	5e-08	30275531
rs3791224	rs6710091	0.901328717461258	High density lipoprotein cholesterol levels	3e-24	34887591
rs3791224	rs7595075	0.888020934288238	Waist circumference adjusted for body mass index	2e-09	34021172
rs3791224	rs7595075	0.888020934288238	HDL cholesterol	3e-11	34594039
rs3791224	rs7595075	0.888020934288238	HDL cholesterol levels	6e-13	32203549
rs3791224	rs79716074	0.884274720962963	Plateletcrit	1e-09	32888494
rs3791224	rs79716074	0.884274720962963	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs3791224	rs79716074	0.884274720962963	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs3791224	rs79716074	0.884274720962963	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs3791224	rs17713729	0.883239668609788	Body mass index	2e-09	31669095
rs3791224	rs17713729	0.883239668609788	Serum creatinine levels	4e-14	34594039
rs3791224	rs17713729	0.883239668609788	High density lipoprotein cholesterol levels	7e-17	34887591
rs3791224	rs58461606	0.877455694168591	Blood protein levels	0	30072576
rs3791224	rs7566279	0.873748826951017	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs3791224	rs7605824	0.872823372822092	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs3791224	rs2126129	0.869568679375457	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs3791224	rs2290911	0.866499972969712	Height	5e-07	29782485
rs3791224	rs2290911	0.866499972969712	Large artery stroke	6e-06	28265093
rs3791224	rs2290911	0.866499972969712	Height	8e-112	36224396
rs3791224	rs62114538	0.847071987962891	Triglyceride levels	6e-12	34887591
rs3791224	rs60843830	0.844093851969937	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs3791224	rs60843830	0.844093851969937	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs3791224	rs60843830	0.844093851969937	Adventurousness	7e-10	30643258
rs3791224	rs11553746	0.797005226759779	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs3791224	rs11553746	0.797005226759779	High density lipoprotein cholesterol levels	2e-07	29083408
rs3791224	rs11553746	0.797005226759779	High density lipoprotein cholesterol levels	7e-15	29083408
rs3791224	rs11553746	0.797005226759779	Large artery stroke	4e-06	28265093
rs3791224	rs17713879	0.792796663700927	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs3791224	rs17713879	0.792796663700927	Smoking initiation	1e-10	36477530
rs3791224	rs17713879	0.792796663700927	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs3791224	rs17713879	0.792796663700927	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs3791224	rs17713879	0.792796663700927	Triglyceride levels	3e-10	34887591
rs3791224	rs17713879	0.792796663700927	Aging (eyeAgeAcceleration)	6e-50	36975205
rs3791224	rs62114548	0.769643705785025	Retinal vascular fractal density	2e-09	34743558
rs3791224	rs79154857	0.724055947015001	Pulse pressure	5e-08	34594039
rs3791224	rs62114506	0.698750962563719	Gamma glutamyl transpeptidase	3e-14	34594039
rs3791224	rs62114506	0.698750962563719	Apolipoprotein A1 levels	3e-10	32203549
rs3791224	rs62114506	0.698750962563719	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs3791224	rs62114506	0.698750962563719	HDL cholesterol levels	8e-10	36333282
rs3797796	rs1423357	0.995794502119052	General cognitive ability	9e-06	29844566
rs3797796	rs2432142	0.979065779469532	Neutrophil count	2e-14	32888493
rs3797796	rs2432142	0.979065779469532	White blood cell count	1e-11	32888493
rs3797796	rs38033	0.975939289856528	Blood protein levels	0	30072576
rs3797796	rs27293	0.961846980771358	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs3797796	rs27293	0.961846980771358	Diastolic blood pressure	3e-11	35762941
rs3797796	rs7705093	0.951690628584951	Birdshot chorioretinopathy	2e-09	24957906
rs3797796	rs2910686	0.869697967566678	Neutrophil count	4e-14	32888493
rs3797796	rs2910686	0.869697967566678	Psoriasis	2e-08	23143594
rs3797796	rs2910686	0.869697967566678	Ankylosing spondylitis	5e-17	23749187
rs3797796	rs2910686	0.869697967566678	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs3797796	rs2927608	0.866370086108369	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs3797796	rs2927608	0.866370086108369	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs3797796	rs2927608	0.866370086108369	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs3797796	rs2617439	0.777871671683522	Neutrophil count	8e-11	32888494
rs3797796	rs2549797	0.7746031445069	Systolic blood pressure	7e-07	33230300
rs3797796	rs2549797	0.7746031445069	Diastolic blood pressure	1e-14	33230300
rs3797796	rs2549797	0.7746031445069	Diastolic blood pressure	3e-11	33230300
rs3797796	rs2549797	0.7746031445069	Systolic blood pressure	4e-09	33230300
rs3797796	rs2549782	0.773346898205598	Systolic blood pressure	6e-07	33230300
rs3797796	rs2549782	0.773346898205598	Diastolic blood pressure	1e-14	33230300
rs3797796	rs2549782	0.773346898205598	Diastolic blood pressure	3e-11	33230300
rs3797796	rs2549782	0.773346898205598	Systolic blood pressure	5e-09	33230300
rs3797796	rs1056893	0.772719616673685	Systolic blood pressure	1e-06	33230300
rs3797796	rs1056893	0.772719616673685	Diastolic blood pressure	7e-15	33230300
rs3797796	rs1056893	0.772719616673685	Diastolic blood pressure	2e-11	33230300
rs3797796	rs1056893	0.772719616673685	Systolic blood pressure	7e-09	33230300
rs3797796	rs2549794	0.768405203756576	Crohn's disease	1e-10	21102463
rs3797796	rs2549794	0.768405203756576	Systolic blood pressure	1e-07	33230300
rs3797796	rs2549794	0.768405203756576	Diastolic blood pressure	1e-15	33230300
rs3797796	rs2549794	0.768405203756576	Diastolic blood pressure	2e-12	33230300
rs3797796	rs2549794	0.768405203756576	Systolic blood pressure	4e-10	33230300
rs3797796	rs38029	0.767693731813758	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs3797796	rs1363907	0.763765796797254	Crohn's disease	4e-16	26192919
rs3797796	rs1363907	0.763765796797254	Ulcerative colitis	4e-06	26192919
rs3797796	rs1363907	0.763765796797254	Inflammatory bowel disease	5e-15	26192919
rs3797796	rs1363907	0.763765796797254	Inflammatory bowel disease	6e-13	23128233
rs3797796	rs1363907	0.763765796797254	Inflammatory bowel disease	1e-10	28067908
rs3797796	rs1363907	0.763765796797254	Crohn's disease	1e-14	28067908
rs3797796	rs716848	0.735425989277956	Neutrophil percentage of white cells	2e-09	32888494
rs3797796	rs4869313	0.722812122265753	Pediatric autoimmune diseases	9e-08	26301688
rs3797796	rs1559359	0.716834402466422	Diastolic blood pressure	7e-10	34594039
rs3797796	rs2548532	0.690253107988685	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs3797796	rs4869314	0.670181734663472	Arthritis (juvenile idiopathic)	3e-09	33106285
rs3797796	rs4869314	0.670181734663472	Neutrophil count	1e-10	34594039
rs3797796	rs4869314	0.670181734663472	White blood cell count	2e-07	30595370
rs3797796	rs1974871	0.643256588958591	Granulysin levels	5e-13	34648354
rs3797796	rs1019503	0.641029284114502	Systolic blood pressure	2e-06	33230300
rs3797796	rs1019503	0.641029284114502	Diastolic blood pressure	2e-14	33230300
rs3797796	rs1019503	0.641029284114502	Diastolic blood pressure	4e-11	33230300
rs3797796	rs1019503	0.641029284114502	Systolic blood pressure	1e-08	33230300
rs3797796	rs27660	0.636167344622296	Coronary artery disease	3e-08	35915156
rs3797796	rs3096168	0.633567922730865	Aspartate aminotransferase levels	8e-12	33547301
rs3798352	rs9469857	0.972879756872117	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs3798352	rs2764208	0.972052789407752	Systemic lupus erythematosus	7e-06	24871463
rs3798352	rs9462030	0.958643979307624	Red cell distribution width	5e-25	32888493
rs3798352	rs9469899	0.942708309267351	Prostate cancer (advanced)	2e-06	29892016
rs3798352	rs9469899	0.942708309267351	Prostate cancer	5e-09	29892016
rs3798352	rs9469899	0.942708309267351	Prostate cancer	8e-11	33398198
rs3798352	rs9469899	0.942708309267351	Hand grip strength	3e-15	29691431
rs3798352	rs9469899	0.942708309267351	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs3798352	rs9469899	0.942708309267351	Graves' disease	4e-10	34594039
rs3798352	rs9469899	0.942708309267351	Coronary artery disease	1e-11	36474045
rs3798352	rs9469899	0.942708309267351	Predicted visceral adipose tissue	2e-20	31501611
rs3798352	rs9469899	0.942708309267351	Medication use (thyroid preparations)	2e-09	31015401
rs3798352	rs9469899	0.942708309267351	Medication use (thyroid preparations)	3e-10	34594039
rs3798352	rs9469872	0.937561087560877	HDL cholesterol levels	3e-11	36333282
rs3798352	rs9296128	0.923203349437426	Hip circumference adjusted for BMI	4e-13	34021172
rs3798352	rs11755393	0.912828508989521	Body mass index	3e-26	29273807
rs3798352	rs11755393	0.912828508989521	Systemic lupus erythematosus	2e-12	33493351
rs3798352	rs11755393	0.912828508989521	Systemic lupus erythematosus	2e-06	33493351
rs3798352	rs11755393	0.912828508989521	Systemic lupus erythematosus	1e-07	33493351
rs3798352	rs11755393	0.912828508989521	Systemic lupus erythematosus	2e-08	19838195
rs3798352	rs11755393	0.912828508989521	Body mass index	4e-55	36581621
rs3798352	rs9366863	0.908824436035794	Adult body size	9e-33	32376654
rs3798352	rs9366863	0.908824436035794	Body mass index	2e-44	30595370
rs3798352	rs6941110	0.901051193752665	Sex hormone-binding globulin levels	5e-27	36653534
rs3798352	rs2744944	0.883722955112804	Hypothyroidism	3e-10	34594039
rs3798352	rs2744944	0.883722955112804	High density lipoprotein cholesterol levels	3e-86	34887591
rs3798352	rs2744944	0.883722955112804	Multi-trait sex score	7e-22	37277458
rs3798352	rs2814949	0.874947039995409	Essential hypertension (time to event)	9e-09	32589924
rs3798352	rs2263329	0.865943665500709	HDL cholesterol	6e-35	34594039
rs3798352	rs2263329	0.865943665500709	HDL cholesterol levels	8e-43	32203549
rs3798352	rs2263329	0.865943665500709	High density lipoprotein cholesterol levels	2e-52	34887591
rs3798352	rs111868030	0.847030198558201	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs3798352	rs9368830	0.804191085338246	HDL cholesterol	4e-21	30275531
rs3798352	rs9368828	0.800759354657762	Body mass index	1e-34	34594039
rs3798352	rs2744973	0.777081399983836	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs3798352	rs2744973	0.777081399983836	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs3798352	rs2744973	0.777081399983836	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs3798352	rs2744973	0.777081399983836	Multi-trait sex score	6e-20	37277458
rs3798352	rs6912327	0.756903739587217	Fasting insulin	5e-06	33402679
rs3798352	rs6912327	0.756903739587217	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs3798352	rs112283401	0.742071411747699	Red cell distribution width	4e-27	30595370
rs3802790	rs1467510	0.932838354829749	Platelet distribution width	1e-14	32888494
rs3802790	rs12276109	0.791024434209696	Severe COVID-19 infection	6e-08	36662838
rs3802968	rs4353250	0.987314807273758	Insulin-like growth factor 1 levels	2e-14	33462484
rs3802968	rs4353250	0.987314807273758	Amyloid A serum levels	2e-51	21124955
rs3802968	rs4150575	0.644872554099736	Imidazole lactate levels	1e-10	36635386
rs38029	rs38029	1	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38029	rs2617439	0.942004951079713	Neutrophil count	8e-11	32888494
rs38029	rs2549794	0.934339838530374	Crohn's disease	1e-10	21102463
rs38029	rs2549794	0.934339838530374	Systolic blood pressure	1e-07	33230300
rs38029	rs2549794	0.934339838530374	Diastolic blood pressure	1e-15	33230300
rs38029	rs2549794	0.934339838530374	Diastolic blood pressure	2e-12	33230300
rs38029	rs2549794	0.934339838530374	Systolic blood pressure	4e-10	33230300
rs38029	rs1363907	0.929204620400647	Crohn's disease	4e-16	26192919
rs38029	rs1363907	0.929204620400647	Ulcerative colitis	4e-06	26192919
rs38029	rs1363907	0.929204620400647	Inflammatory bowel disease	5e-15	26192919
rs38029	rs1363907	0.929204620400647	Inflammatory bowel disease	6e-13	23128233
rs38029	rs1363907	0.929204620400647	Inflammatory bowel disease	1e-10	28067908
rs38029	rs1363907	0.929204620400647	Crohn's disease	1e-14	28067908
rs38029	rs716848	0.899400188769012	Neutrophil percentage of white cells	2e-09	32888494
rs38029	rs2548532	0.838522777765782	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38029	rs27293	0.791676647817495	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38029	rs27293	0.791676647817495	Diastolic blood pressure	3e-11	35762941
rs38029	rs27660	0.787855551507297	Coronary artery disease	3e-08	35915156
rs38029	rs38033	0.786616422324486	Blood protein levels	0	30072576
rs38029	rs1423357	0.767032269737887	General cognitive ability	9e-06	29844566
rs38029	rs2432142	0.752136595520502	Neutrophil count	2e-14	32888493
rs38029	rs2432142	0.752136595520502	White blood cell count	1e-11	32888493
rs38029	rs7705093	0.732299758749041	Birdshot chorioretinopathy	2e-09	24957906
rs38029	rs2927608	0.671916148421366	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38029	rs2927608	0.671916148421366	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38029	rs2927608	0.671916148421366	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38029	rs4869313	0.671848415102067	Pediatric autoimmune diseases	9e-08	26301688
rs38029	rs2910686	0.669646319346924	Neutrophil count	4e-14	32888493
rs38029	rs2910686	0.669646319346924	Psoriasis	2e-08	23143594
rs38029	rs2910686	0.669646319346924	Ankylosing spondylitis	5e-17	23749187
rs38029	rs2910686	0.669646319346924	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38029	rs1559359	0.611661944560565	Diastolic blood pressure	7e-10	34594039
rs38029	rs1974871	0.601584850958235	Granulysin levels	5e-13	34648354
rs38031	rs38029	0.972610126400927	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38031	rs2617439	0.961835492485983	Neutrophil count	8e-11	32888494
rs38031	rs2549794	0.954205582441686	Crohn's disease	1e-10	21102463
rs38031	rs2549794	0.954205582441686	Systolic blood pressure	1e-07	33230300
rs38031	rs2549794	0.954205582441686	Diastolic blood pressure	1e-15	33230300
rs38031	rs2549794	0.954205582441686	Diastolic blood pressure	2e-12	33230300
rs38031	rs2549794	0.954205582441686	Systolic blood pressure	4e-10	33230300
rs38031	rs1363907	0.949010781335253	Crohn's disease	4e-16	26192919
rs38031	rs1363907	0.949010781335253	Ulcerative colitis	4e-06	26192919
rs38031	rs1363907	0.949010781335253	Inflammatory bowel disease	5e-15	26192919
rs38031	rs1363907	0.949010781335253	Inflammatory bowel disease	6e-13	23128233
rs38031	rs1363907	0.949010781335253	Inflammatory bowel disease	1e-10	28067908
rs38031	rs1363907	0.949010781335253	Crohn's disease	1e-14	28067908
rs38031	rs716848	0.919035086225543	Neutrophil percentage of white cells	2e-09	32888494
rs38031	rs2548532	0.857927096919284	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38031	rs27660	0.805719338320115	Coronary artery disease	3e-08	35915156
rs38031	rs1423357	0.785944273645366	General cognitive ability	9e-06	29844566
rs38031	rs27293	0.780209858355554	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38031	rs27293	0.780209858355554	Diastolic blood pressure	3e-11	35762941
rs38031	rs2432142	0.770823265915683	Neutrophil count	2e-14	32888493
rs38031	rs2432142	0.770823265915683	White blood cell count	1e-11	32888493
rs38031	rs38033	0.770623568059592	Blood protein levels	0	30072576
rs38031	rs7705093	0.750995436146084	Birdshot chorioretinopathy	2e-09	24957906
rs38031	rs4869313	0.691063138782496	Pediatric autoimmune diseases	9e-08	26301688
rs38031	rs2927608	0.690188567956884	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38031	rs2927608	0.690188567956884	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38031	rs2927608	0.690188567956884	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38031	rs2910686	0.687904473914829	Neutrophil count	4e-14	32888493
rs38031	rs2910686	0.687904473914829	Psoriasis	2e-08	23143594
rs38031	rs2910686	0.687904473914829	Ankylosing spondylitis	5e-17	23749187
rs38031	rs2910686	0.687904473914829	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38031	rs1559359	0.630481402701682	Diastolic blood pressure	7e-10	34594039
rs38031	rs1974871	0.620236141544169	Granulysin levels	5e-13	34648354
rs38031	rs2549797	0.612791163441269	Systolic blood pressure	7e-07	33230300
rs38031	rs2549797	0.612791163441269	Diastolic blood pressure	1e-14	33230300
rs38031	rs2549797	0.612791163441269	Diastolic blood pressure	3e-11	33230300
rs38031	rs2549797	0.612791163441269	Systolic blood pressure	4e-09	33230300
rs38031	rs2549782	0.611793793479769	Systolic blood pressure	6e-07	33230300
rs38031	rs2549782	0.611793793479769	Diastolic blood pressure	1e-14	33230300
rs38031	rs2549782	0.611793793479769	Diastolic blood pressure	3e-11	33230300
rs38031	rs2549782	0.611793793479769	Systolic blood pressure	5e-09	33230300
rs38031	rs1056893	0.611295776697133	Systolic blood pressure	1e-06	33230300
rs38031	rs1056893	0.611295776697133	Diastolic blood pressure	7e-15	33230300
rs38031	rs1056893	0.611295776697133	Diastolic blood pressure	2e-11	33230300
rs38031	rs1056893	0.611295776697133	Systolic blood pressure	7e-09	33230300
rs38032	rs38029	0.981415726018293	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38032	rs2617439	0.95690390226389	Neutrophil count	8e-11	32888494
rs38032	rs2549794	0.942164709437285	Crohn's disease	1e-10	21102463
rs38032	rs2549794	0.942164709437285	Systolic blood pressure	1e-07	33230300
rs38032	rs2549794	0.942164709437285	Diastolic blood pressure	1e-15	33230300
rs38032	rs2549794	0.942164709437285	Diastolic blood pressure	2e-12	33230300
rs38032	rs2549794	0.942164709437285	Systolic blood pressure	4e-10	33230300
rs38032	rs1363907	0.937005549220463	Crohn's disease	4e-16	26192919
rs38032	rs1363907	0.937005549220463	Ulcerative colitis	4e-06	26192919
rs38032	rs1363907	0.937005549220463	Inflammatory bowel disease	5e-15	26192919
rs38032	rs1363907	0.937005549220463	Inflammatory bowel disease	6e-13	23128233
rs38032	rs1363907	0.937005549220463	Inflammatory bowel disease	1e-10	28067908
rs38032	rs1363907	0.937005549220463	Crohn's disease	1e-14	28067908
rs38032	rs716848	0.90696547346693	Neutrophil percentage of white cells	2e-09	32888494
rs38032	rs2548532	0.846475023371506	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38032	rs38033	0.800805938677345	Blood protein levels	0	30072576
rs38032	rs27293	0.78284263293318	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38032	rs27293	0.78284263293318	Diastolic blood pressure	3e-11	35762941
rs38032	rs27660	0.779666560986283	Coronary artery disease	3e-08	35915156
rs38032	rs1423357	0.775060522279616	General cognitive ability	9e-06	29844566
rs38032	rs2432142	0.764626196644802	Neutrophil count	2e-14	32888493
rs38032	rs2432142	0.764626196644802	White blood cell count	1e-11	32888493
rs38032	rs7705093	0.741503386508204	Birdshot chorioretinopathy	2e-09	24957906
rs38032	rs4869313	0.680684504779218	Pediatric autoimmune diseases	9e-08	26301688
rs38032	rs2927608	0.679124118731132	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38032	rs2927608	0.679124118731132	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38032	rs2927608	0.679124118731132	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38032	rs2910686	0.676834207294897	Neutrophil count	4e-14	32888493
rs38032	rs2910686	0.676834207294897	Psoriasis	2e-08	23143594
rs38032	rs2910686	0.676834207294897	Ankylosing spondylitis	5e-17	23749187
rs38032	rs2910686	0.676834207294897	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38032	rs1559359	0.618502531863296	Diastolic blood pressure	7e-10	34594039
rs38032	rs1974871	0.609699745110166	Granulysin levels	5e-13	34648354
rs38032	rs2549797	0.601487637283235	Systolic blood pressure	7e-07	33230300
rs38032	rs2549797	0.601487637283235	Diastolic blood pressure	1e-14	33230300
rs38032	rs2549797	0.601487637283235	Diastolic blood pressure	3e-11	33230300
rs38032	rs2549797	0.601487637283235	Systolic blood pressure	4e-09	33230300
rs38032	rs2549782	0.600487766806199	Systolic blood pressure	6e-07	33230300
rs38032	rs2549782	0.600487766806199	Diastolic blood pressure	1e-14	33230300
rs38032	rs2549782	0.600487766806199	Diastolic blood pressure	3e-11	33230300
rs38032	rs2549782	0.600487766806199	Systolic blood pressure	5e-09	33230300
rs38033	rs38033	1	Blood protein levels	0	30072576
rs38033	rs27293	0.979165719976911	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38033	rs27293	0.979165719976911	Diastolic blood pressure	3e-11	35762941
rs38033	rs1423357	0.975102202497434	General cognitive ability	9e-06	29844566
rs38033	rs2432142	0.963515474841602	Neutrophil count	2e-14	32888493
rs38033	rs2432142	0.963515474841602	White blood cell count	1e-11	32888493
rs38033	rs7705093	0.932761253508765	Birdshot chorioretinopathy	2e-09	24957906
rs38033	rs2910686	0.849518575818066	Neutrophil count	4e-14	32888493
rs38033	rs2910686	0.849518575818066	Psoriasis	2e-08	23143594
rs38033	rs2910686	0.849518575818066	Ankylosing spondylitis	5e-17	23749187
rs38033	rs2910686	0.849518575818066	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38033	rs2927608	0.846269539892368	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38033	rs2927608	0.846269539892368	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38033	rs2927608	0.846269539892368	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38033	rs38029	0.786616422324486	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38033	rs2617439	0.766505845789161	Neutrophil count	8e-11	32888494
rs38033	rs2549797	0.754717679295166	Systolic blood pressure	7e-07	33230300
rs38033	rs2549797	0.754717679295166	Diastolic blood pressure	1e-14	33230300
rs38033	rs2549797	0.754717679295166	Diastolic blood pressure	3e-11	33230300
rs38033	rs2549797	0.754717679295166	Systolic blood pressure	4e-09	33230300
rs38033	rs2549782	0.753465786339274	Systolic blood pressure	6e-07	33230300
rs38033	rs2549782	0.753465786339274	Diastolic blood pressure	1e-14	33230300
rs38033	rs2549782	0.753465786339274	Diastolic blood pressure	3e-11	33230300
rs38033	rs2549782	0.753465786339274	Systolic blood pressure	5e-09	33230300
rs38033	rs1056893	0.752840678828088	Systolic blood pressure	1e-06	33230300
rs38033	rs1056893	0.752840678828088	Diastolic blood pressure	7e-15	33230300
rs38033	rs1056893	0.752840678828088	Diastolic blood pressure	2e-11	33230300
rs38033	rs1056893	0.752840678828088	Systolic blood pressure	7e-09	33230300
rs38033	rs2549794	0.752472000190678	Crohn's disease	1e-10	21102463
rs38033	rs2549794	0.752472000190678	Systolic blood pressure	1e-07	33230300
rs38033	rs2549794	0.752472000190678	Diastolic blood pressure	1e-15	33230300
rs38033	rs2549794	0.752472000190678	Diastolic blood pressure	2e-12	33230300
rs38033	rs2549794	0.752472000190678	Systolic blood pressure	4e-10	33230300
rs38033	rs1363907	0.747879341021451	Crohn's disease	4e-16	26192919
rs38033	rs1363907	0.747879341021451	Ulcerative colitis	4e-06	26192919
rs38033	rs1363907	0.747879341021451	Inflammatory bowel disease	5e-15	26192919
rs38033	rs1363907	0.747879341021451	Inflammatory bowel disease	6e-13	23128233
rs38033	rs1363907	0.747879341021451	Inflammatory bowel disease	1e-10	28067908
rs38033	rs1363907	0.747879341021451	Crohn's disease	1e-14	28067908
rs38033	rs716848	0.719652538718898	Neutrophil percentage of white cells	2e-09	32888494
rs38033	rs4869313	0.705389682429572	Pediatric autoimmune diseases	9e-08	26301688
rs38033	rs1559359	0.698653917116328	Diastolic blood pressure	7e-10	34594039
rs38033	rs2548532	0.676139290890649	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38033	rs4869314	0.65127299971695	Arthritis (juvenile idiopathic)	3e-09	33106285
rs38033	rs4869314	0.65127299971695	Neutrophil count	1e-10	34594039
rs38033	rs4869314	0.65127299971695	White blood cell count	2e-07	30595370
rs38033	rs1974871	0.626202780286607	Granulysin levels	5e-13	34648354
rs38033	rs27660	0.62358225770101	Coronary artery disease	3e-08	35915156
rs38033	rs1019503	0.621535749459884	Systolic blood pressure	2e-06	33230300
rs38033	rs1019503	0.621535749459884	Diastolic blood pressure	2e-14	33230300
rs38033	rs1019503	0.621535749459884	Diastolic blood pressure	4e-11	33230300
rs38033	rs1019503	0.621535749459884	Systolic blood pressure	1e-08	33230300
rs38033	rs3096168	0.614289631620916	Aspartate aminotransferase levels	8e-12	33547301
rs38034	rs38033	0.994989724564962	Blood protein levels	0	30072576
rs38034	rs27293	0.982506567056273	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38034	rs27293	0.982506567056273	Diastolic blood pressure	3e-11	35762941
rs38034	rs1423357	0.970213408512719	General cognitive ability	9e-06	29844566
rs38034	rs2432142	0.958658807324785	Neutrophil count	2e-14	32888493
rs38034	rs2432142	0.958658807324785	White blood cell count	1e-11	32888493
rs38034	rs7705093	0.937596394048455	Birdshot chorioretinopathy	2e-09	24957906
rs38034	rs2910686	0.846311581742608	Neutrophil count	4e-14	32888493
rs38034	rs2910686	0.846311581742608	Psoriasis	2e-08	23143594
rs38034	rs2910686	0.846311581742608	Ankylosing spondylitis	5e-17	23749187
rs38034	rs2910686	0.846311581742608	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38034	rs2927608	0.843077101946612	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38034	rs2927608	0.843077101946612	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38034	rs2927608	0.843077101946612	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38034	rs38029	0.782657171537135	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38034	rs2617439	0.762635598898535	Neutrophil count	8e-11	32888494
rs38034	rs2549797	0.751512164653752	Systolic blood pressure	7e-07	33230300
rs38034	rs2549797	0.751512164653752	Diastolic blood pressure	1e-14	33230300
rs38034	rs2549797	0.751512164653752	Diastolic blood pressure	3e-11	33230300
rs38034	rs2549797	0.751512164653752	Systolic blood pressure	4e-09	33230300
rs38034	rs2549782	0.750260394009511	Systolic blood pressure	6e-07	33230300
rs38034	rs2549782	0.750260394009511	Diastolic blood pressure	1e-14	33230300
rs38034	rs2549782	0.750260394009511	Diastolic blood pressure	3e-11	33230300
rs38034	rs2549782	0.750260394009511	Systolic blood pressure	5e-09	33230300
rs38034	rs1056893	0.749635347663181	Systolic blood pressure	1e-06	33230300
rs38034	rs1056893	0.749635347663181	Diastolic blood pressure	7e-15	33230300
rs38034	rs1056893	0.749635347663181	Diastolic blood pressure	2e-11	33230300
rs38034	rs1056893	0.749635347663181	Systolic blood pressure	7e-09	33230300
rs38034	rs2549794	0.748616425648974	Crohn's disease	1e-10	21102463
rs38034	rs2549794	0.748616425648974	Systolic blood pressure	1e-07	33230300
rs38034	rs2549794	0.748616425648974	Diastolic blood pressure	1e-15	33230300
rs38034	rs2549794	0.748616425648974	Diastolic blood pressure	2e-12	33230300
rs38034	rs2549794	0.748616425648974	Systolic blood pressure	4e-10	33230300
rs38034	rs1363907	0.744035311544064	Crohn's disease	4e-16	26192919
rs38034	rs1363907	0.744035311544064	Ulcerative colitis	4e-06	26192919
rs38034	rs1363907	0.744035311544064	Inflammatory bowel disease	5e-15	26192919
rs38034	rs1363907	0.744035311544064	Inflammatory bowel disease	6e-13	23128233
rs38034	rs1363907	0.744035311544064	Inflammatory bowel disease	1e-10	28067908
rs38034	rs1363907	0.744035311544064	Crohn's disease	1e-14	28067908
rs38034	rs716848	0.715846214053946	Neutrophil percentage of white cells	2e-09	32888494
rs38034	rs4869313	0.702668675353397	Pediatric autoimmune diseases	9e-08	26301688
rs38034	rs1559359	0.695767885359163	Diastolic blood pressure	7e-10	34594039
rs38034	rs2548532	0.672674804853279	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38034	rs4869314	0.648204408061219	Arthritis (juvenile idiopathic)	3e-09	33106285
rs38034	rs4869314	0.648204408061219	Neutrophil count	1e-10	34594039
rs38034	rs4869314	0.648204408061219	White blood cell count	2e-07	30595370
rs38034	rs1974871	0.623502544318979	Granulysin levels	5e-13	34648354
rs38034	rs27660	0.62043834221155	Coronary artery disease	3e-08	35915156
rs38034	rs1019503	0.61832946427296	Systolic blood pressure	2e-06	33230300
rs38034	rs1019503	0.61832946427296	Diastolic blood pressure	2e-14	33230300
rs38034	rs1019503	0.61832946427296	Diastolic blood pressure	4e-11	33230300
rs38034	rs1019503	0.61832946427296	Systolic blood pressure	1e-08	33230300
rs38034	rs3096168	0.611122709570184	Aspartate aminotransferase levels	8e-12	33547301
rs38038	rs38033	0.989142060708394	Blood protein levels	0	30072576
rs38038	rs27293	0.983318052230236	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38038	rs27293	0.983318052230236	Diastolic blood pressure	3e-11	35762941
rs38038	rs1423357	0.970972860343165	General cognitive ability	9e-06	29844566
rs38038	rs2432142	0.954484333267526	Neutrophil count	2e-14	32888493
rs38038	rs2432142	0.954484333267526	White blood cell count	1e-11	32888493
rs38038	rs7705093	0.936798107876101	Birdshot chorioretinopathy	2e-09	24957906
rs38038	rs2910686	0.847200480713343	Neutrophil count	4e-14	32888493
rs38038	rs2910686	0.847200480713343	Psoriasis	2e-08	23143594
rs38038	rs2910686	0.847200480713343	Ankylosing spondylitis	5e-17	23749187
rs38038	rs2910686	0.847200480713343	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38038	rs2927608	0.843956805211583	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38038	rs2927608	0.843956805211583	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38038	rs2927608	0.843956805211583	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38038	rs38029	0.782895577423294	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38038	rs2617439	0.758298808152916	Neutrophil count	8e-11	32888494
rs38038	rs2549797	0.752515871795783	Systolic blood pressure	7e-07	33230300
rs38038	rs2549797	0.752515871795783	Diastolic blood pressure	1e-14	33230300
rs38038	rs2549797	0.752515871795783	Diastolic blood pressure	3e-11	33230300
rs38038	rs2549797	0.752515871795783	Systolic blood pressure	4e-09	33230300
rs38038	rs2549782	0.751265526668877	Systolic blood pressure	6e-07	33230300
rs38038	rs2549782	0.751265526668877	Diastolic blood pressure	1e-14	33230300
rs38038	rs2549782	0.751265526668877	Diastolic blood pressure	3e-11	33230300
rs38038	rs2549782	0.751265526668877	Systolic blood pressure	5e-09	33230300
rs38038	rs1056893	0.750641192070129	Systolic blood pressure	1e-06	33230300
rs38038	rs1056893	0.750641192070129	Diastolic blood pressure	7e-15	33230300
rs38038	rs1056893	0.750641192070129	Diastolic blood pressure	2e-11	33230300
rs38038	rs1056893	0.750641192070129	Systolic blood pressure	7e-09	33230300
rs38038	rs2549794	0.748836125957468	Crohn's disease	1e-10	21102463
rs38038	rs2549794	0.748836125957468	Systolic blood pressure	1e-07	33230300
rs38038	rs2549794	0.748836125957468	Diastolic blood pressure	1e-15	33230300
rs38038	rs2549794	0.748836125957468	Diastolic blood pressure	2e-12	33230300
rs38038	rs2549794	0.748836125957468	Systolic blood pressure	4e-10	33230300
rs38038	rs1363907	0.744255399872989	Crohn's disease	4e-16	26192919
rs38038	rs1363907	0.744255399872989	Ulcerative colitis	4e-06	26192919
rs38038	rs1363907	0.744255399872989	Inflammatory bowel disease	5e-15	26192919
rs38038	rs1363907	0.744255399872989	Inflammatory bowel disease	6e-13	23128233
rs38038	rs1363907	0.744255399872989	Inflammatory bowel disease	1e-10	28067908
rs38038	rs1363907	0.744255399872989	Crohn's disease	1e-14	28067908
rs38038	rs716848	0.716107068711295	Neutrophil percentage of white cells	2e-09	32888494
rs38038	rs4869313	0.703300827950347	Pediatric autoimmune diseases	9e-08	26301688
rs38038	rs1559359	0.696559345985151	Diastolic blood pressure	7e-10	34594039
rs38038	rs2548532	0.672672171159672	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38038	rs4869314	0.649217826460495	Arthritis (juvenile idiopathic)	3e-09	33106285
rs38038	rs4869314	0.649217826460495	Neutrophil count	1e-10	34594039
rs38038	rs4869314	0.649217826460495	White blood cell count	2e-07	30595370
rs38038	rs1974871	0.624225595833682	Granulysin levels	5e-13	34648354
rs38038	rs27660	0.620216115005863	Coronary artery disease	3e-08	35915156
rs38038	rs1019503	0.61949673361307	Systolic blood pressure	2e-06	33230300
rs38038	rs1019503	0.61949673361307	Diastolic blood pressure	2e-14	33230300
rs38038	rs1019503	0.61949673361307	Diastolic blood pressure	4e-11	33230300
rs38038	rs1019503	0.61949673361307	Systolic blood pressure	1e-08	33230300
rs38038	rs3096168	0.612265914388455	Aspartate aminotransferase levels	8e-12	33547301
rs38039	rs2548532	0.925163067622138	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38039	rs2617439	0.909096335747362	Neutrophil count	8e-11	32888494
rs38039	rs2549794	0.904045219220634	Crohn's disease	1e-10	21102463
rs38039	rs2549794	0.904045219220634	Systolic blood pressure	1e-07	33230300
rs38039	rs2549794	0.904045219220634	Diastolic blood pressure	1e-15	33230300
rs38039	rs2549794	0.904045219220634	Diastolic blood pressure	2e-12	33230300
rs38039	rs2549794	0.904045219220634	Systolic blood pressure	4e-10	33230300
rs38039	rs38029	0.899703812867189	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38039	rs1363907	0.899001159207591	Crohn's disease	4e-16	26192919
rs38039	rs1363907	0.899001159207591	Ulcerative colitis	4e-06	26192919
rs38039	rs1363907	0.899001159207591	Inflammatory bowel disease	5e-15	26192919
rs38039	rs1363907	0.899001159207591	Inflammatory bowel disease	6e-13	23128233
rs38039	rs1363907	0.899001159207591	Inflammatory bowel disease	1e-10	28067908
rs38039	rs1363907	0.899001159207591	Crohn's disease	1e-14	28067908
rs38039	rs716848	0.870772821183593	Neutrophil percentage of white cells	2e-09	32888494
rs38039	rs27660	0.854251596839954	Coronary artery disease	3e-08	35915156
rs38039	rs1423357	0.742534870759455	General cognitive ability	9e-06	29844566
rs38039	rs38033	0.72822713206176	Blood protein levels	0	30072576
rs38039	rs2432142	0.727730068150335	Neutrophil count	2e-14	32888493
rs38039	rs2432142	0.727730068150335	White blood cell count	1e-11	32888493
rs38039	rs27293	0.718125458226711	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38039	rs27293	0.718125458226711	Diastolic blood pressure	3e-11	35762941
rs38039	rs7705093	0.709613021862801	Birdshot chorioretinopathy	2e-09	24957906
rs38039	rs4869313	0.662423801643952	Pediatric autoimmune diseases	9e-08	26301688
rs38039	rs2927608	0.654964652080885	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38039	rs2927608	0.654964652080885	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38039	rs2927608	0.654964652080885	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38039	rs2910686	0.652807951509009	Neutrophil count	4e-14	32888493
rs38039	rs2910686	0.652807951509009	Psoriasis	2e-08	23143594
rs38039	rs2910686	0.652807951509009	Ankylosing spondylitis	5e-17	23749187
rs38039	rs2910686	0.652807951509009	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38039	rs1559359	0.602449700796835	Diastolic blood pressure	7e-10	34594039
rs38040	rs38033	0.9026802216806	Blood protein levels	0	30072576
rs38040	rs27293	0.897256277256488	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38040	rs27293	0.897256277256488	Diastolic blood pressure	3e-11	35762941
rs38040	rs1423357	0.886308298276392	General cognitive ability	9e-06	29844566
rs38040	rs2432142	0.870641175360072	Neutrophil count	2e-14	32888493
rs38040	rs2432142	0.870641175360072	White blood cell count	1e-11	32888493
rs38040	rs7705093	0.852395473486359	Birdshot chorioretinopathy	2e-09	24957906
rs38040	rs2549797	0.830082350531309	Systolic blood pressure	7e-07	33230300
rs38040	rs2549797	0.830082350531309	Diastolic blood pressure	1e-14	33230300
rs38040	rs2549797	0.830082350531309	Diastolic blood pressure	3e-11	33230300
rs38040	rs2549797	0.830082350531309	Systolic blood pressure	4e-09	33230300
rs38040	rs2549782	0.828705304399036	Systolic blood pressure	6e-07	33230300
rs38040	rs2549782	0.828705304399036	Diastolic blood pressure	1e-14	33230300
rs38040	rs2549782	0.828705304399036	Diastolic blood pressure	3e-11	33230300
rs38040	rs2549782	0.828705304399036	Systolic blood pressure	5e-09	33230300
rs38040	rs1056893	0.828017704174431	Systolic blood pressure	1e-06	33230300
rs38040	rs1056893	0.828017704174431	Diastolic blood pressure	7e-15	33230300
rs38040	rs1056893	0.828017704174431	Diastolic blood pressure	2e-11	33230300
rs38040	rs1056893	0.828017704174431	Systolic blood pressure	7e-09	33230300
rs38040	rs2910686	0.766477965788535	Neutrophil count	4e-14	32888493
rs38040	rs2910686	0.766477965788535	Psoriasis	2e-08	23143594
rs38040	rs2910686	0.766477965788535	Ankylosing spondylitis	5e-17	23749187
rs38040	rs2910686	0.766477965788535	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38040	rs2927608	0.763534032873776	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38040	rs2927608	0.763534032873776	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38040	rs2927608	0.763534032873776	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38040	rs38029	0.714705606516131	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38040	rs2617439	0.691921587783105	Neutrophil count	8e-11	32888494
rs38040	rs2549794	0.683859457992242	Crohn's disease	1e-10	21102463
rs38040	rs2549794	0.683859457992242	Systolic blood pressure	1e-07	33230300
rs38040	rs2549794	0.683859457992242	Diastolic blood pressure	1e-15	33230300
rs38040	rs2549794	0.683859457992242	Diastolic blood pressure	2e-12	33230300
rs38040	rs2549794	0.683859457992242	Systolic blood pressure	4e-10	33230300
rs38040	rs1019503	0.683272502693899	Systolic blood pressure	2e-06	33230300
rs38040	rs1019503	0.683272502693899	Diastolic blood pressure	2e-14	33230300
rs38040	rs1019503	0.683272502693899	Diastolic blood pressure	4e-11	33230300
rs38040	rs1019503	0.683272502693899	Systolic blood pressure	1e-08	33230300
rs38040	rs1363907	0.679471787057498	Crohn's disease	4e-16	26192919
rs38040	rs1363907	0.679471787057498	Ulcerative colitis	4e-06	26192919
rs38040	rs1363907	0.679471787057498	Inflammatory bowel disease	5e-15	26192919
rs38040	rs1363907	0.679471787057498	Inflammatory bowel disease	6e-13	23128233
rs38040	rs1363907	0.679471787057498	Inflammatory bowel disease	1e-10	28067908
rs38040	rs1363907	0.679471787057498	Crohn's disease	1e-14	28067908
rs38040	rs3096168	0.676083417219416	Aspartate aminotransferase levels	8e-12	33547301
rs38040	rs4869314	0.662322221359308	Arthritis (juvenile idiopathic)	3e-09	33106285
rs38040	rs4869314	0.662322221359308	Neutrophil count	1e-10	34594039
rs38040	rs4869314	0.662322221359308	White blood cell count	2e-07	30595370
rs38040	rs716848	0.651897423674968	Neutrophil percentage of white cells	2e-09	32888494
rs38040	rs1974871	0.638306590185692	Granulysin levels	5e-13	34648354
rs38040	rs4869313	0.633249891130463	Pediatric autoimmune diseases	9e-08	26301688
rs38040	rs1559359	0.62384741095134	Diastolic blood pressure	7e-10	34594039
rs38040	rs2548532	0.614581167345842	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38043	rs38033	0.962858052038628	Blood protein levels	0	30072576
rs38043	rs27293	0.950459059226539	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38043	rs27293	0.950459059226539	Diastolic blood pressure	3e-11	35762941
rs38043	rs1423357	0.944345293225865	General cognitive ability	9e-06	29844566
rs38043	rs2432142	0.92805169393888	Neutrophil count	2e-14	32888493
rs38043	rs2432142	0.92805169393888	White blood cell count	1e-11	32888493
rs38043	rs7705093	0.901873156874122	Birdshot chorioretinopathy	2e-09	24957906
rs38043	rs2927608	0.828629324112313	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38043	rs2927608	0.828629324112313	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38043	rs2927608	0.828629324112313	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38043	rs2910686	0.825852423810826	Neutrophil count	4e-14	32888493
rs38043	rs2910686	0.825852423810826	Psoriasis	2e-08	23143594
rs38043	rs2910686	0.825852423810826	Ankylosing spondylitis	5e-17	23749187
rs38043	rs2910686	0.825852423810826	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38043	rs38029	0.817099156363144	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38043	rs2617439	0.790106052460227	Neutrophil count	8e-11	32888494
rs38043	rs2549794	0.780623593503493	Crohn's disease	1e-10	21102463
rs38043	rs2549794	0.780623593503493	Systolic blood pressure	1e-07	33230300
rs38043	rs2549794	0.780623593503493	Diastolic blood pressure	1e-15	33230300
rs38043	rs2549794	0.780623593503493	Diastolic blood pressure	2e-12	33230300
rs38043	rs2549794	0.780623593503493	Systolic blood pressure	4e-10	33230300
rs38043	rs1363907	0.775947125489722	Crohn's disease	4e-16	26192919
rs38043	rs1363907	0.775947125489722	Ulcerative colitis	4e-06	26192919
rs38043	rs1363907	0.775947125489722	Inflammatory bowel disease	5e-15	26192919
rs38043	rs1363907	0.775947125489722	Inflammatory bowel disease	6e-13	23128233
rs38043	rs1363907	0.775947125489722	Inflammatory bowel disease	1e-10	28067908
rs38043	rs1363907	0.775947125489722	Crohn's disease	1e-14	28067908
rs38043	rs716848	0.747466865873645	Neutrophil percentage of white cells	2e-09	32888494
rs38043	rs4869313	0.735671231609046	Pediatric autoimmune diseases	9e-08	26301688
rs38043	rs2549797	0.734125481687146	Systolic blood pressure	7e-07	33230300
rs38043	rs2549797	0.734125481687146	Diastolic blood pressure	1e-14	33230300
rs38043	rs2549797	0.734125481687146	Diastolic blood pressure	3e-11	33230300
rs38043	rs2549797	0.734125481687146	Systolic blood pressure	4e-09	33230300
rs38043	rs2549782	0.732913289463192	Systolic blood pressure	6e-07	33230300
rs38043	rs2549782	0.732913289463192	Diastolic blood pressure	1e-14	33230300
rs38043	rs2549782	0.732913289463192	Diastolic blood pressure	3e-11	33230300
rs38043	rs2549782	0.732913289463192	Systolic blood pressure	5e-09	33230300
rs38043	rs1056893	0.732308005630156	Systolic blood pressure	1e-06	33230300
rs38043	rs1056893	0.732308005630156	Diastolic blood pressure	7e-15	33230300
rs38043	rs1056893	0.732308005630156	Diastolic blood pressure	2e-11	33230300
rs38043	rs1056893	0.732308005630156	Systolic blood pressure	7e-09	33230300
rs38043	rs2548532	0.701332768244188	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38043	rs1559359	0.682597257204518	Diastolic blood pressure	7e-10	34594039
rs38043	rs1974871	0.655714117948145	Granulysin levels	5e-13	34648354
rs38043	rs27660	0.647787634722482	Coronary artery disease	3e-08	35915156
rs38043	rs4869314	0.634263105257351	Arthritis (juvenile idiopathic)	3e-09	33106285
rs38043	rs4869314	0.634263105257351	Neutrophil count	1e-10	34594039
rs38043	rs4869314	0.634263105257351	White blood cell count	2e-07	30595370
rs38043	rs1019503	0.602728271992885	Systolic blood pressure	2e-06	33230300
rs38043	rs1019503	0.602728271992885	Diastolic blood pressure	2e-14	33230300
rs38043	rs1019503	0.602728271992885	Diastolic blood pressure	4e-11	33230300
rs38043	rs1019503	0.602728271992885	Systolic blood pressure	1e-08	33230300
rs38044	rs38033	0.9966540251289	Blood protein levels	0	30072576
rs38044	rs27293	0.982477030779728	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs38044	rs27293	0.982477030779728	Diastolic blood pressure	3e-11	35762941
rs38044	rs1423357	0.978378010090661	General cognitive ability	9e-06	29844566
rs38044	rs2432142	0.961821091213594	Neutrophil count	2e-14	32888493
rs38044	rs2432142	0.961821091213594	White blood cell count	1e-11	32888493
rs38044	rs7705093	0.934390752694905	Birdshot chorioretinopathy	2e-09	24957906
rs38044	rs2910686	0.852689138431834	Neutrophil count	4e-14	32888493
rs38044	rs2910686	0.852689138431834	Psoriasis	2e-08	23143594
rs38044	rs2910686	0.852689138431834	Ankylosing spondylitis	5e-17	23749187
rs38044	rs2910686	0.852689138431834	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs38044	rs2927608	0.849428671773648	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs38044	rs2927608	0.849428671773648	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs38044	rs2927608	0.849428671773648	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs38044	rs38029	0.789269376077663	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs38044	rs2617439	0.764546790178909	Neutrophil count	8e-11	32888494
rs38044	rs2549797	0.757820758995601	Systolic blood pressure	7e-07	33230300
rs38044	rs2549797	0.757820758995601	Diastolic blood pressure	1e-14	33230300
rs38044	rs2549797	0.757820758995601	Diastolic blood pressure	3e-11	33230300
rs38044	rs2549797	0.757820758995601	Systolic blood pressure	4e-09	33230300
rs38044	rs2549782	0.75656790970355	Systolic blood pressure	6e-07	33230300
rs38044	rs2549782	0.75656790970355	Diastolic blood pressure	1e-14	33230300
rs38044	rs2549782	0.75656790970355	Diastolic blood pressure	3e-11	33230300
rs38044	rs2549782	0.75656790970355	Systolic blood pressure	5e-09	33230300
rs38044	rs1056893	0.75594232460157	Systolic blood pressure	1e-06	33230300
rs38044	rs1056893	0.75594232460157	Diastolic blood pressure	7e-15	33230300
rs38044	rs1056893	0.75594232460157	Diastolic blood pressure	2e-11	33230300
rs38044	rs1056893	0.75594232460157	Systolic blood pressure	7e-09	33230300
rs38044	rs2549794	0.755055486770887	Crohn's disease	1e-10	21102463
rs38044	rs2549794	0.755055486770887	Systolic blood pressure	1e-07	33230300
rs38044	rs2549794	0.755055486770887	Diastolic blood pressure	1e-15	33230300
rs38044	rs2549794	0.755055486770887	Diastolic blood pressure	2e-12	33230300
rs38044	rs2549794	0.755055486770887	Systolic blood pressure	4e-10	33230300
rs38044	rs1363907	0.750455092463746	Crohn's disease	4e-16	26192919
rs38044	rs1363907	0.750455092463746	Ulcerative colitis	4e-06	26192919
rs38044	rs1363907	0.750455092463746	Inflammatory bowel disease	5e-15	26192919
rs38044	rs1363907	0.750455092463746	Inflammatory bowel disease	6e-13	23128233
rs38044	rs1363907	0.750455092463746	Inflammatory bowel disease	1e-10	28067908
rs38044	rs1363907	0.750455092463746	Crohn's disease	1e-14	28067908
rs38044	rs716848	0.722203037662821	Neutrophil percentage of white cells	2e-09	32888494
rs38044	rs4869313	0.708149787642141	Pediatric autoimmune diseases	9e-08	26301688
rs38044	rs1559359	0.701512071353586	Diastolic blood pressure	7e-10	34594039
rs38044	rs2548532	0.67846072265019	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs38044	rs4869314	0.654213523595411	Arthritis (juvenile idiopathic)	3e-09	33106285
rs38044	rs4869314	0.654213523595411	Neutrophil count	1e-10	34594039
rs38044	rs4869314	0.654213523595411	White blood cell count	2e-07	30595370
rs38044	rs1974871	0.62888699810349	Granulysin levels	5e-13	34648354
rs38044	rs27660	0.625688884222627	Coronary artery disease	3e-08	35915156
rs38044	rs1019503	0.624546248331702	Systolic blood pressure	2e-06	33230300
rs38044	rs1019503	0.624546248331702	Diastolic blood pressure	2e-14	33230300
rs38044	rs1019503	0.624546248331702	Diastolic blood pressure	4e-11	33230300
rs38044	rs1019503	0.624546248331702	Systolic blood pressure	1e-08	33230300
rs38044	rs3096168	0.617268756705755	Aspartate aminotransferase levels	8e-12	33547301
rs3805749	rs56103941	0.978988351566096	Right presubiculum volume (head)	4e-08	37337106
rs3805749	rs12523793	0.937188614781173	Subcortical volume (MOSTest)	4e-24	32665545
rs3805749	rs12523793	0.937188614781173	C-reactive protein levels	3e-08	35459240
rs3805749	rs12523793	0.937188614781173	C-reactive protein levels (MTAG)	2e-08	36376304
rs3805749	rs11155662	0.918120525095268	Vertex-wise cortical thickness	2e-09	34910505
rs3805749	rs12526675	0.882138370907159	Brain morphology (MOSTest)	7e-22	32665545
rs3805749	rs2342764	0.820772011729059	Cortical thickness	1e-08	34560273
rs3805749	rs58189451	0.748153114377316	Drinks per week	1e-09	36477530
rs3805749	rs9285521	0.737438573782964	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs3805749	rs7752089	0.661259735145389	Brain morphology (MOSTest)	2e-31	35164939
rs3805749	rs9322194	0.650569225853273	Brainstem volume	2e-11	31636452
rs3805749	rs10872649	0.636631712689146	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs3805749	rs10872649	0.636631712689146	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs3805749	rs10872649	0.636631712689146	Right hippocampal volume (body)	1e-10	37337106
rs3805749	rs11155675	0.634529211227153	Brain region volumes	3e-09	31676860
rs3805749	rs1125	0.627511702224986	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs3805749	rs1125	0.627511702224986	Vertical cup-disc ratio	8e-14	34077760
rs3805749	rs9371201	0.624432723747226	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs3805749	rs4421206	0.610922691037612	Brain morphology (min-P)	4e-11	32665545
rs3806340	rs12145922	1	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs3806340	rs12145922	1	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs3806340	rs3806340	1	Corneal resistance factor (MTAG)	3e-18	35446358
rs3806340	rs3806340	1	Height	1e-12	35831902
rs3806340	rs3806340	1	Height	7e-17	36224396
rs3806340	rs3806340	1	Height	3e-47	36224396
rs3806340	rs10922476	0.990171408212607	Corneal resistance factor	4e-17	33311554
rs3806340	rs1002436	0.792740081790145	Red blood cell count	4e-22	32888493
rs3806340	rs1002436	0.792740081790145	Alanine aminotransferase levels	6e-11	33547301
rs3806340	rs1002436	0.792740081790145	Aspartate aminotransferase levels	1e-20	33547301
rs3806340	rs1002436	0.792740081790145	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs3806340	rs12145712	0.76480247995091	Pulse pressure	1e-10	35762941
rs3806340	rs4233334	0.744604202574526	Body surface area	6e-09	36502284
rs3806340	rs786906	0.739993372007039	Systolic blood pressure	1e-06	27618447
rs3806340	rs786906	0.739993372007039	Intraocular pressure	5e-09	29617998
rs3806340	rs12021820	0.738004432371056	Mean corpuscular hemoglobin	2e-11	32888493
rs3806340	rs10801682	0.73522060033223	Mean corpuscular hemoglobin	1e-09	30595370
rs3806340	rs7551732	0.706784401987764	Height	6e-20	25282103
rs3806340	rs7551732	0.706784401987764	Gamma glutamyl transferase levels	5e-08	33339817
rs3806340	rs6699417	0.654470567529921	Height	5e-09	20881960
rs3806340	rs6699417	0.654470567529921	Height	2e-11	35831902
rs3806340	rs6699417	0.654470567529921	Height	1e-300	36224396
rs3806340	rs6699417	0.654470567529921	Height	1e-300	36224396
rs3809138	rs17380837	0.981159390667531	Atrial fibrillation	5e-12	30061737
rs3809138	rs17380837	0.981159390667531	Hypertrophic cardiomyopathy (sarcomere negative)	4e-07	33495597
rs3809138	rs17380837	0.981159390667531	Atrial fibrillation (MTAG)	6e-11	35872910
rs3809138	rs113819537	0.927023969103427	Atrial fibrillation	2e-09	29892015
rs3809138	rs113819537	0.927023969103427	Atrial fibrillation	7e-09	29892015
rs3809138	rs113819537	0.927023969103427	Atrial fibrillation/atrial flutter	6e-10	34594039
rs3809138	rs113819537	0.927023969103427	Heart failure (multivariate analysis)	5e-08	36376295
rs3809138	rs113819537	0.927023969103427	Atrial fibrillation	3e-16	36653681
rs3809260	rs3809260	1	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs3809260	rs2559856	0.99040265073975	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs3809260	rs2695294	0.965817240204022	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs3809260	rs2695295	0.961880695870984	Serum levels of protein NAAA	1e-68	35078996
rs3809260	rs2695295	0.961880695870984	Serum levels of protein SMPDL3A	8e-86	35078996
rs3809260	rs2559851	0.929440453029941	Cathepsin F levels	2e-96	34648354
rs3809260	rs2559851	0.929440453029941	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs3809260	rs2559850	0.807719159537286	Serum levels of protein CTSH	1e-19	35078996
rs3809260	rs2559850	0.807719159537286	Vitamin C levels	6e-20	33203707
rs3809260	rs2559850	0.807719159537286	Cathepsin L2 levels	1e-24	34648354
rs3809260	rs2559850	0.807719159537286	Islet amyloid polypeptide levels	1e-49	34648354
rs3809260	rs2559850	0.807719159537286	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs3815178	rs1859336	0.985788525925027	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs3815178	rs6489882	0.977682959846833	Chronic lymphocytic leukemia	5e-08	28165464
rs3815178	rs11066452	0.963405477973367	Blood protein levels	6e-08	30072576
rs3815178	rs4767027	0.942372467751562	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs3815178	rs2057778	0.94120412293466	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs3815178	rs2057778	0.94120412293466	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs3815178	rs2057778	0.94120412293466	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs3815178	rs1131476	0.916102037064252	Systemic lupus erythematosus	1e-09	33272962
rs3815178	rs2660	0.916102037064252	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs3815178	rs2660	0.916102037064252	COVID-19 (critical illness vs population)	3e-15	37198478
rs3815178	rs6489867	0.671131607720329	COVID-19 (critical illness vs population)	1e-09	33307546
rs3815178	rs1557866	0.631001458816178	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs3815852	rs10182296	0.659621906135228	Estimated glomerular filtration rate (creatinine)	8e-20	34272381
rs3815852	rs10182296	0.659621906135228	Mean corpuscular hemoglobin	2e-13	30595370
rs3815852	rs10432479	0.658117086305049	Estimated glomerular filtration rate	9e-13	31152163
rs3815852	rs10432479	0.658117086305049	Estimated glomerular filtration rate (creatinine)	2e-11	34272381
rs3818228	rs1467510	0.936285702887573	Platelet distribution width	1e-14	32888494
rs3818228	rs12276109	0.793601338209993	Severe COVID-19 infection	6e-08	36662838
rs3820242	rs10922531	0.945618847874226	Serum metabolite levels	2e-69	33031748
rs3820242	rs12729558	0.908886914662666	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs3820242	rs7530513	0.861117051155524	Height	8e-11	35831902
rs3820242	rs7530513	0.861117051155524	Imidazole lactate levels	8e-166	36635386
rs3820242	rs12144640	0.861117051155524	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs3820242	rs1409152	0.849211930082339	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs3820242	rs1409152	0.849211930082339	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs3820242	rs10801699	0.847025621675857	X-23639 levels	2e-10	36635386
rs3820242	rs7532151	0.844294007135275	Imidazole lactate levels	9e-12	33177712
rs3820242	rs10801690	0.818008915777123	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs3820242	rs12120164	0.811781280239785	Metabolite peak levels (QI2146)	1e-26	35995766
rs3820242	rs9787133	0.78852622105922	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs3820242	rs2765527	0.740325542090107	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs3820242	rs2810876	0.634194707871901	Imidazole lactate levels	2e-122	35347128
rs3820242	rs10801696	0.632953044816836	Imidazole lactate levels	3e-195	35050183
rs3820242	rs1206228892	0.632446574733326	Imidazole lactate levels	5e-186	35050183
rs3822464	rs7721230	0.983056439569847	Skin color	4e-10	36672889
rs3825025	rs4353250	0.987314807273758	Insulin-like growth factor 1 levels	2e-14	33462484
rs3825025	rs4353250	0.987314807273758	Amyloid A serum levels	2e-51	21124955
rs3825025	rs4150575	0.644872554099736	Imidazole lactate levels	1e-10	36635386
rs3826	rs1552244	0.92194389823782	Alzheimer's disease	2e-06	24755620
rs3826	rs76041173	0.686782227820232	Cysteine-rich with EGF-like domain protein 1 levels (CRELD1.7628.40.3)	8e-149	29875488
rs3828165	rs11553746	0.961545846344924	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs3828165	rs11553746	0.961545846344924	High density lipoprotein cholesterol levels	2e-07	29083408
rs3828165	rs11553746	0.961545846344924	High density lipoprotein cholesterol levels	7e-15	29083408
rs3828165	rs11553746	0.961545846344924	Large artery stroke	4e-06	28265093
rs3828165	rs2290911	0.934769063231647	Height	5e-07	29782485
rs3828165	rs2290911	0.934769063231647	Large artery stroke	6e-06	28265093
rs3828165	rs2290911	0.934769063231647	Height	8e-112	36224396
rs3828165	rs62114548	0.89880641776937	Retinal vascular fractal density	2e-09	34743558
rs3828165	rs17713396	0.892844786927087	Blood urea nitrogen levels	3e-21	34272381
rs3828165	rs17713396	0.892844786927087	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs3828165	rs17713396	0.892844786927087	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs3828165	rs6710091	0.890859348788983	Waist circumference adjusted for body mass index	8e-11	31669095
rs3828165	rs6710091	0.890859348788983	HDL cholesterol	5e-08	30275531
rs3828165	rs6710091	0.890859348788983	High density lipoprotein cholesterol levels	3e-24	34887591
rs3828165	rs7595075	0.875055403274063	Waist circumference adjusted for body mass index	2e-09	34021172
rs3828165	rs7595075	0.875055403274063	HDL cholesterol	3e-11	34594039
rs3828165	rs7595075	0.875055403274063	HDL cholesterol levels	6e-13	32203549
rs3828165	rs17713729	0.874301872100766	Body mass index	2e-09	31669095
rs3828165	rs17713729	0.874301872100766	Serum creatinine levels	4e-14	34594039
rs3828165	rs17713729	0.874301872100766	High density lipoprotein cholesterol levels	7e-17	34887591
rs3828165	rs79716074	0.870974468989138	Plateletcrit	1e-09	32888494
rs3828165	rs79716074	0.870974468989138	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs3828165	rs79716074	0.870974468989138	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs3828165	rs79716074	0.870974468989138	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs3828165	rs58461606	0.865319109480892	Blood protein levels	0	30072576
rs3828165	rs7605824	0.858091487584029	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs3828165	rs7566279	0.857202744946013	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs3828165	rs3791221	0.856211670674404	Blood urea nitrogen levels	2e-07	31152163
rs3828165	rs3791221	0.856211670674404	Estimated glomerular filtration rate	2e-10	31152163
rs3828165	rs3791221	0.856211670674404	Estimated glomerular filtration rate	1e-11	31152163
rs3828165	rs3791221	0.856211670674404	Blood urea nitrogen levels	7e-26	34594039
rs3828165	rs2126129	0.855946351428516	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs3828165	rs62114506	0.844330009607344	Gamma glutamyl transpeptidase	3e-14	34594039
rs3828165	rs62114506	0.844330009607344	Apolipoprotein A1 levels	3e-10	32203549
rs3828165	rs62114506	0.844330009607344	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs3828165	rs62114506	0.844330009607344	HDL cholesterol levels	8e-10	36333282
rs3828165	rs17713879	0.822929230452977	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs3828165	rs17713879	0.822929230452977	Smoking initiation	1e-10	36477530
rs3828165	rs17713879	0.822929230452977	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs3828165	rs17713879	0.822929230452977	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs3828165	rs17713879	0.822929230452977	Triglyceride levels	3e-10	34887591
rs3828165	rs17713879	0.822929230452977	Aging (eyeAgeAcceleration)	6e-50	36975205
rs3828165	rs114976176	0.817714040268498	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs3828165	rs59937473	0.793279159962458	Protein quantitative trait loci	3e-67	32492067
rs3828165	rs59937473	0.793279159962458	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs3828165	rs17714252	0.789108446941022	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs3828165	rs17714252	0.789108446941022	Retinal vascular fractal dimension	2e-07	34743558
rs3828165	rs7601944	0.785330596778078	Smoking initiation	4e-15	36477530
rs3828165	rs55753056	0.776504778759732	Height	2e-22	30595370
rs3828165	rs79154857	0.763717078039813	Pulse pressure	5e-08	34594039
rs3828165	rs62114538	0.73818402123758	Triglyceride levels	6e-12	34887591
rs3828165	rs60843830	0.726654981875691	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs3828165	rs60843830	0.726654981875691	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs3828165	rs60843830	0.726654981875691	Adventurousness	7e-10	30643258
rs3830020	rs942810	0.896077609847251	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs3830020	rs942810	0.896077609847251	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs3830020	rs942810	0.896077609847251	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs3830020	rs942810	0.896077609847251	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs3830020	rs942810	0.896077609847251	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs3830020	rs942810	0.896077609847251	N6-methyllysine levels (advanced age)	2e-11	37118062
rs3830020	rs1739	0.881127689330923	Metabolite peak levels (QI7389)	3e-91	35995766
rs3830020	rs1737	0.880322488581763	Arginine levels	3e-24	35995766
rs3830020	rs6584194	0.772727887304467	Metabolite peak levels (QI9680)	2e-135	35995766
rs3830020	rs6584194	0.772727887304467	Metabolite peak levels (QI8984)	5e-11	35995766
rs3830020	rs6584194	0.772727887304467	X-24736 levels	3e-13	36635386
rs3830020	rs4488133	0.694270474239652	Serum metabolite levels	2e-281	23093944
rs3830020	rs4488133	0.694270474239652	Serum metabolite levels	1e-27	23093944
rs3830020	rs4488133	0.694270474239652	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs3830020	rs4488133	0.694270474239652	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs3830020	rs4488133	0.694270474239652	Urine X-12112 levels in chronic kidney disease	0	37277652
rs3830020	rs4488133	0.694270474239652	X-12093 levels	1e-48	24816252
rs3830020	rs4488133	0.694270474239652	X-12092 levels	0	24816252
rs3830020	rs10883083	0.694163229364823	N2-acetyl,N6-methyllysine levels	0	35347128
rs3830020	rs10883083	0.694163229364823	X-12112 levels	0	35347128
rs3830020	rs10883083	0.694163229364823	Arginine levels	1e-16	35347128
rs3830020	rs10883083	0.694163229364823	Metabolite peak levels (QI8972)	2e-124	35995766
rs3830020	rs10883083	0.694163229364823	Metabolite peak levels (QI5171)	8e-96	35995766
rs3830020	rs2147896	0.694163229364823	Urinary metabolites (H-NMR features)	3e-164	24586186
rs3830020	rs2147896	0.694163229364823	Urinary metabolites (H-NMR features)	8e-30	24586186
rs3830020	rs2147896	0.694163229364823	Urinary metabolites (H-NMR features)	2e-55	24586186
rs3830020	rs2147896	0.694163229364823	Urinary metabolites (H-NMR features)	6e-19	24586186
rs3830020	rs2147896	0.694163229364823	Urinary metabolites (H-NMR features)	4e-34	24586186
rs3830020	rs2147896	0.694163229364823	Trimethylamine levels	4e-144	33283231
rs3830020	rs2147896	0.694163229364823	Serum metabolite levels	1e-15	33031748
rs3830020	rs2147896	0.694163229364823	Serum metabolite levels	4e-226	33031748
rs3830020	rs2147896	0.694163229364823	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs3830020	rs2147896	0.694163229364823	Urinary metabolite levels in chronic kidney disease	0	31959995
rs3830020	rs2147896	0.694163229364823	Urinary metabolite levels in chronic kidney disease	0	31959995
rs3830020	rs2147896	0.694163229364823	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs3830020	rs2147896	0.694163229364823	N6-methyllysine levels	3e-198	33437055
rs3830020	rs2147896	0.694163229364823	N6-methyllysine levels	0	35347128
rs3830020	rs2147896	0.694163229364823	N-methylpipecolate levels	0	35050183
rs3830020	rs2147896	0.694163229364823	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs3830020	rs2147896	0.694163229364823	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs3830020	rs2147896	0.694163229364823	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs3830020	rs2147896	0.694163229364823	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs3830020	rs2147896	0.694163229364823	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs3830020	rs2147896	0.694163229364823	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs3830020	rs2147896	0.694163229364823	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs3830020	rs2147896	0.694163229364823	X-12092 levels	4e-191	27073872
rs3830020	rs2147896	0.694163229364823	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs3830020	rs2147896	0.694163229364823	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs3830020	rs2147896	0.694163229364823	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs3830020	rs2147896	0.694163229364823	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs3830020	rs2147896	0.694163229364823	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs3830020	rs2147896	0.694163229364823	N6-methyllysine levels (advanced age)	5e-25	37118062
rs3830020	rs2147896	0.694163229364823	X-12112 levels	0	36635386
rs3830020	rs2147896	0.694163229364823	N6-methyllysine levels	0	36635386
rs3830020	rs2147896	0.694163229364823	N6,N6-dimethyllysine levels	0	36635386
rs3830020	rs2147896	0.694163229364823	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs3830020	rs2147896	0.694163229364823	N2-acetyl,N6-methyllysine levels	0	36635386
rs3830020	rs10786415	0.694163229364823	N6,N6-dimethyllysine levels	0	35347128
rs3830020	rs10786415	0.694163229364823	N-methylpipecolate levels	0	35347128
rs3830020	rs10786415	0.694163229364823	X-25810 levels	4e-11	36635386
rs3830020	rs942814	0.694163229364823	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs3830020	rs4539242	0.693482487940448	Urinary metabolites (H-NMR features)	2e-20	24586186
rs3830020	rs4539242	0.693482487940448	X-24809 levels	4e-67	33177712
rs3830020	rs4539242	0.693482487940448	X-24983 levels	8e-59	33177712
rs3830020	rs4539242	0.693482487940448	X-12112 levels	4e-63	33177712
rs3830020	rs4539242	0.693482487940448	N-methylpipecolate levels	3e-12	33177712
rs3830020	rs4539242	0.693482487940448	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs3830020	rs4539242	0.693482487940448	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs3830020	rs4539242	0.693482487940448	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs3830020	rs4539242	0.693482487940448	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs3830020	rs4539242	0.693482487940448	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs3830020	rs4539242	0.693482487940448	N6-methyllysine levels (advanced age)	5e-25	37118062
rs3830020	rs4539242	0.693482487940448	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs3830020	rs7072216	0.692823135717399	Metabolite levels	8e-15	21931564
rs3830020	rs7072216	0.692823135717399	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs3830020	rs10786414	0.683049892419788	ADMA levels	5e-18	35995766
rs3830020	rs7905265	0.68107300686181	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs3830020	rs7905265	0.68107300686181	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs3830020	rs7905265	0.68107300686181	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs3830020	rs7905265	0.68107300686181	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs3830020	rs7905265	0.68107300686181	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs3830020	rs7905265	0.68107300686181	N6,N6-dimethyllysine levels	2e-132	35995766
rs3830020	rs7905265	0.68107300686181	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs3830020	rs11598867	0.670342481370078	Urinary metabolites	1e-307	26352407
rs3830020	rs942813	0.665408389890266	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs3830020	rs7096654	0.615850674058447	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs3830020	rs7096654	0.615850674058447	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs3830020	rs7096654	0.615850674058447	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs3830020	rs7096654	0.615850674058447	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs3849749	rs2549794	0.999110315224948	Crohn's disease	1e-10	21102463
rs3849749	rs2549794	0.999110315224948	Systolic blood pressure	1e-07	33230300
rs3849749	rs2549794	0.999110315224948	Diastolic blood pressure	1e-15	33230300
rs3849749	rs2549794	0.999110315224948	Diastolic blood pressure	2e-12	33230300
rs3849749	rs2549794	0.999110315224948	Systolic blood pressure	4e-10	33230300
rs3849749	rs1363907	0.993781103132944	Crohn's disease	4e-16	26192919
rs3849749	rs1363907	0.993781103132944	Ulcerative colitis	4e-06	26192919
rs3849749	rs1363907	0.993781103132944	Inflammatory bowel disease	5e-15	26192919
rs3849749	rs1363907	0.993781103132944	Inflammatory bowel disease	6e-13	23128233
rs3849749	rs1363907	0.993781103132944	Inflammatory bowel disease	1e-10	28067908
rs3849749	rs1363907	0.993781103132944	Crohn's disease	1e-14	28067908
rs3849749	rs2617439	0.945506755714289	Neutrophil count	8e-11	32888494
rs3849749	rs716848	0.938428471012939	Neutrophil percentage of white cells	2e-09	32888494
rs3849749	rs38029	0.933489306890891	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs3849749	rs2548532	0.897778287225109	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs3849749	rs27660	0.781515933672439	Coronary artery disease	3e-08	35915156
rs3849749	rs1423357	0.768454437089007	General cognitive ability	9e-06	29844566
rs3849749	rs2432142	0.753547568514724	Neutrophil count	2e-14	32888493
rs3849749	rs2432142	0.753547568514724	White blood cell count	1e-11	32888493
rs3849749	rs38033	0.751669770051801	Blood protein levels	0	30072576
rs3849749	rs27293	0.743146509055169	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs3849749	rs27293	0.743146509055169	Diastolic blood pressure	3e-11	35762941
rs3849749	rs7705093	0.733658503692707	Birdshot chorioretinopathy	2e-09	24957906
rs3849749	rs4869313	0.723478791353516	Pediatric autoimmune diseases	9e-08	26301688
rs3849749	rs2927608	0.717377031537283	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs3849749	rs2927608	0.717377031537283	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs3849749	rs2927608	0.717377031537283	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs3849749	rs2910686	0.715017291424976	Neutrophil count	4e-14	32888493
rs3849749	rs2910686	0.715017291424976	Psoriasis	2e-08	23143594
rs3849749	rs2910686	0.715017291424976	Ankylosing spondylitis	5e-17	23749187
rs3849749	rs2910686	0.715017291424976	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs3849749	rs1559359	0.654950385191935	Diastolic blood pressure	7e-10	34594039
rs3849749	rs1974871	0.650000061828718	Granulysin levels	5e-13	34648354
rs3849749	rs2549782	0.637693628642632	Systolic blood pressure	6e-07	33230300
rs3849749	rs2549782	0.637693628642632	Diastolic blood pressure	1e-14	33230300
rs3849749	rs2549782	0.637693628642632	Diastolic blood pressure	3e-11	33230300
rs3849749	rs2549782	0.637693628642632	Systolic blood pressure	5e-09	33230300
rs3849749	rs2549797	0.637370281415612	Systolic blood pressure	7e-07	33230300
rs3849749	rs2549797	0.637370281415612	Diastolic blood pressure	1e-14	33230300
rs3849749	rs2549797	0.637370281415612	Diastolic blood pressure	3e-11	33230300
rs3849749	rs2549797	0.637370281415612	Systolic blood pressure	4e-09	33230300
rs3849749	rs1056893	0.635825446775611	Systolic blood pressure	1e-06	33230300
rs3849749	rs1056893	0.635825446775611	Diastolic blood pressure	7e-15	33230300
rs3849749	rs1056893	0.635825446775611	Diastolic blood pressure	2e-11	33230300
rs3849749	rs1056893	0.635825446775611	Systolic blood pressure	7e-09	33230300
rs3856340	rs3732055	0.933245035743741	Citrulline levels	1e-10	36635386
rs3856340	rs3732055	0.933245035743741	Gamma-glutamylcitrulline levels	1e-10	36635386
rs3856340	rs3856349	0.874196727045148	LanC-like protein 1 levels	5e-22	34648354
rs3859475	rs1138888	0.988998534822846	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs3859475	rs1138888	0.988998534822846	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs3859475	rs4802157	0.967151348333064	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs3859475	rs12978398	0.639732978546213	Pregnancy-specific beta-1-glycoprotein 4 levels	0	34648354
rs3859475	rs7257250	0.614888660464132	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	7e-117	29875488
rs3869132	rs3869132	1	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs3869132	rs3869132	1	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs3869132	rs6928810	0.990577573109513	Platelet distribution width	1e-14	32888494
rs3869132	rs9266825	0.865291623635069	Autism spectrum disorder	6e-06	35215271
rs3869132	rs1063631	0.789443198138892	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs3869132	rs1063631	0.789443198138892	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs3869132	rs72848707	0.656485079187968	HDL cholesterol levels	7e-06	35884923
rs3869132	rs199530775	0.644918473229168	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs3869132	rs55957433	0.644918473229168	Hip circumference adjusted for BMI	3e-08	34021172
rs387930	rs4363385	0.623925518265633	Inflammatory skin disease	2e-15	25574825
rs388098	rs301901	0.968092176554695	Height	4e-16	25282103
rs388098	rs301901	0.968092176554695	Height	2e-06	35831902
rs388098	rs158796	0.936583022376569	Height	5e-243	36224396
rs388098	rs300053	0.922279003508987	Height	3e-11	34594039
rs388098	rs300053	0.922279003508987	Height	3e-36	34594039
rs388098	rs300053	0.922279003508987	Height	2e-14	31562340
rs388098	rs292172	0.915661098493611	Appendicular lean mass	8e-13	31761296
rs388098	rs158622	0.914903884844205	Height	4e-15	36224396
rs388098	rs158791	0.8823179827015	Height	2e-31	36224396
rs388098	rs300046	0.879585240034016	Meat-related diet	5e-08	32066663
rs388098	rs292168	0.831009309574937	Red cell distribution width	3e-10	30595370
rs3889717	rs7558954	0.992484740135727	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs3889717	rs1177308	0.988322646715919	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs3889717	rs1177308	0.988322646715919	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs3889717	rs11685226	0.96602688560698	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs3889717	rs11685226	0.96602688560698	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs3889717	rs777587	0.805978901929145	Proteoglycan 3 levels	6e-29	34648354
rs3889717	rs777587	0.805978901929145	Pappalysin-1 levels	1e-25	34648354
rs3889717	rs12617371	0.766588549030528	Immature fraction of reticulocytes	8e-18	32888494
rs3889717	rs2463097	0.733316149128271	White blood cell count	3e-26	30595370
rs3889717	rs2593620	0.709646926392767	Serum levels of protein PRG3	5e-14	35078996
rs3889717	rs10199672	0.702087470366391	Height	6e-12	34594039
rs3889717	rs10199672	0.702087470366391	Height	2e-12	31562340
rs3889717	rs2421200	0.681547250388976	Neutrophil count	1e-26	32888493
rs3889717	rs2421200	0.681547250388976	Neutrophil count	1e-25	32888493
rs3889717	rs10169482	0.632121373985499	C-reactive protein levels	4e-09	33462484
rs3889717	rs12616433	0.607814507737204	Eosinophil forward scatter	4e-13	37596262
rs3889717	rs12616433	0.607814507737204	Eosinophil side scatter	2e-18	37596262
rs389376	rs337277	0.941605861046584	Metabolite peak levels (QI10992)	3e-52	35995766
rs389376	rs337277	0.941605861046584	Metabolite peak levels (QI4667)	7e-18	35995766
rs389376	rs337277	0.941605861046584	Metabolite peak levels (QI4708)	1e-21	35995766
rs389376	rs337277	0.941605861046584	Metabolite peak levels (QI5169)	7e-57	35995766
rs389376	rs7655841	0.779790816463348	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs390260	rs337277	0.962663336213969	Metabolite peak levels (QI10992)	3e-52	35995766
rs390260	rs337277	0.962663336213969	Metabolite peak levels (QI4667)	7e-18	35995766
rs390260	rs337277	0.962663336213969	Metabolite peak levels (QI4708)	1e-21	35995766
rs390260	rs337277	0.962663336213969	Metabolite peak levels (QI5169)	7e-57	35995766
rs390260	rs7655841	0.741137199106036	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs3908118	rs6705511	0.762250710700349	Self-reported math ability	4e-09	30038396
rs3908118	rs6705511	0.762250710700349	Self-reported math ability (MTAG)	3e-10	30038396
rs3908118	rs34276187	0.754424203021543	Highest math class taken (MTAG)	2e-08	30038396
rs3909451	rs1423357	0.992457556806882	General cognitive ability	9e-06	29844566
rs3909451	rs2432142	0.97244588462353	Neutrophil count	2e-14	32888493
rs3909451	rs2432142	0.97244588462353	White blood cell count	1e-11	32888493
rs3909451	rs38033	0.967607116255855	Blood protein levels	0	30072576
rs3909451	rs27293	0.961809942209821	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs3909451	rs27293	0.961809942209821	Diastolic blood pressure	3e-11	35762941
rs3909451	rs7705093	0.958108411735894	Birdshot chorioretinopathy	2e-09	24957906
rs3909451	rs2910686	0.864695305030182	Neutrophil count	4e-14	32888493
rs3909451	rs2910686	0.864695305030182	Psoriasis	2e-08	23143594
rs3909451	rs2910686	0.864695305030182	Ankylosing spondylitis	5e-17	23749187
rs3909451	rs2910686	0.864695305030182	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs3909451	rs2927608	0.861391555109564	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs3909451	rs2927608	0.861391555109564	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs3909451	rs2927608	0.861391555109564	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs3909451	rs2617439	0.772805077681738	Neutrophil count	8e-11	32888494
rs3909451	rs2549797	0.771019548090089	Systolic blood pressure	7e-07	33230300
rs3909451	rs2549797	0.771019548090089	Diastolic blood pressure	1e-14	33230300
rs3909451	rs2549797	0.771019548090089	Diastolic blood pressure	3e-11	33230300
rs3909451	rs2549797	0.771019548090089	Systolic blood pressure	4e-09	33230300
rs3909451	rs2549782	0.769761797387831	Systolic blood pressure	6e-07	33230300
rs3909451	rs2549782	0.769761797387831	Diastolic blood pressure	1e-14	33230300
rs3909451	rs2549782	0.769761797387831	Diastolic blood pressure	3e-11	33230300
rs3909451	rs2549782	0.769761797387831	Systolic blood pressure	5e-09	33230300
rs3909451	rs1056893	0.769133764694912	Systolic blood pressure	1e-06	33230300
rs3909451	rs1056893	0.769133764694912	Diastolic blood pressure	7e-15	33230300
rs3909451	rs1056893	0.769133764694912	Diastolic blood pressure	2e-11	33230300
rs3909451	rs1056893	0.769133764694912	Systolic blood pressure	7e-09	33230300
rs3909451	rs2549794	0.763325891462089	Crohn's disease	1e-10	21102463
rs3909451	rs2549794	0.763325891462089	Systolic blood pressure	1e-07	33230300
rs3909451	rs2549794	0.763325891462089	Diastolic blood pressure	1e-15	33230300
rs3909451	rs2549794	0.763325891462089	Diastolic blood pressure	2e-12	33230300
rs3909451	rs2549794	0.763325891462089	Systolic blood pressure	4e-10	33230300
rs3909451	rs38029	0.761109693989044	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs3909451	rs1363907	0.758701227685606	Crohn's disease	4e-16	26192919
rs3909451	rs1363907	0.758701227685606	Ulcerative colitis	4e-06	26192919
rs3909451	rs1363907	0.758701227685606	Inflammatory bowel disease	5e-15	26192919
rs3909451	rs1363907	0.758701227685606	Inflammatory bowel disease	6e-13	23128233
rs3909451	rs1363907	0.758701227685606	Inflammatory bowel disease	1e-10	28067908
rs3909451	rs1363907	0.758701227685606	Crohn's disease	1e-14	28067908
rs3909451	rs716848	0.731860855278461	Neutrophil percentage of white cells	2e-09	32888494
rs3909451	rs4869313	0.718602155373228	Pediatric autoimmune diseases	9e-08	26301688
rs3909451	rs1559359	0.71233641438174	Diastolic blood pressure	7e-10	34594039
rs3909451	rs2548532	0.68579104612647	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs3909451	rs4869314	0.666692723251499	Arthritis (juvenile idiopathic)	3e-09	33106285
rs3909451	rs4869314	0.666692723251499	Neutrophil count	1e-10	34594039
rs3909451	rs4869314	0.666692723251499	White blood cell count	2e-07	30595370
rs3909451	rs1974871	0.640379183170097	Granulysin levels	5e-13	34648354
rs3909451	rs1019503	0.6359518868097	Systolic blood pressure	2e-06	33230300
rs3909451	rs1019503	0.6359518868097	Diastolic blood pressure	2e-14	33230300
rs3909451	rs1019503	0.6359518868097	Diastolic blood pressure	4e-11	33230300
rs3909451	rs1019503	0.6359518868097	Systolic blood pressure	1e-08	33230300
rs3909451	rs27660	0.632229923090847	Coronary artery disease	3e-08	35915156
rs3909451	rs3096168	0.628555573509049	Aspartate aminotransferase levels	8e-12	33547301
rs391396	rs337277	0.962701619808313	Metabolite peak levels (QI10992)	3e-52	35995766
rs391396	rs337277	0.962701619808313	Metabolite peak levels (QI4667)	7e-18	35995766
rs391396	rs337277	0.962701619808313	Metabolite peak levels (QI4708)	1e-21	35995766
rs391396	rs337277	0.962701619808313	Metabolite peak levels (QI5169)	7e-57	35995766
rs391396	rs7655841	0.771689579788529	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs3923279	rs4304220	0.885883977494939	Height	2e-14	36224396
rs3923279	rs4355658	0.796405094984908	Height	3e-13	36224396
rs3923279	rs13232536	0.630127209674534	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs3936151	rs12210271	0.866796054796786	ACE-inhibitor discontinuation	1e-19	35751511
rs3937434	rs1557866	1	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs3937434	rs1293767	0.897639450963228	Adult asthma	2e-06	27611488
rs3937434	rs1293767	0.897639450963228	Adult asthma	9e-07	27611488
rs3937434	rs6489882	0.64174960194697	Chronic lymphocytic leukemia	5e-08	28165464
rs3937434	rs1859336	0.61982849623932	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs3937434	rs10744789	0.610025075807648	Vitamin D levels or COVID-19 (MTAG)	5e-12	37212302
rs3937434	rs4767027	0.6033381828865	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs3937434	rs2057778	0.600481748899161	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs3937434	rs2057778	0.600481748899161	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs3937434	rs2057778	0.600481748899161	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs3940815	rs2868708	0.949909243135387	Lymphocyte count	3e-11	34469753
rs3940815	rs2868708	0.949909243135387	White blood cell count	1e-09	30595370
rs3940815	rs6831339	0.946668262269866	High density lipoprotein cholesterol levels	9e-09	34887591
rs3940815	rs6535419	0.891705080195728	Pulse pressure	6e-10	30578418
rs3940815	rs116142917	0.872192838196552	Lymphocyte count	7e-18	32888494
rs3940815	rs13111599	0.863560569662666	HDL cholesterol levels	3e-09	32203549
rs3940815	rs13111599	0.863560569662666	Apolipoprotein A1 levels	4e-08	32203549
rs3940815	rs6823199	0.856058653317188	Pulse pressure	4e-14	30224653
rs3940815	rs4302451	0.788360913843005	Eosinophil counts	2e-09	30595370
rs3940815	rs35895091	0.736048099472026	Cardiovascular disease	1e-07	30595370
rs3940815	rs11099563	0.703816366308186	High density lipoprotein cholesterol levels	3e-11	34887591
rs3940815	rs28528763	0.681960359412479	White blood cell count	7e-12	32888494
rs3940815	rs7662402	0.603537680622422	Brain morphology (MOSTest)	3e-08	35164939
rs395864	rs337277	0.929605574081129	Metabolite peak levels (QI10992)	3e-52	35995766
rs395864	rs337277	0.929605574081129	Metabolite peak levels (QI4667)	7e-18	35995766
rs395864	rs337277	0.929605574081129	Metabolite peak levels (QI4708)	1e-21	35995766
rs395864	rs337277	0.929605574081129	Metabolite peak levels (QI5169)	7e-57	35995766
rs395864	rs7655841	0.768732183308365	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs39602	rs27293	0.948699088338168	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs39602	rs27293	0.948699088338168	Diastolic blood pressure	3e-11	35762941
rs39602	rs38033	0.936514250721669	Blood protein levels	0	30072576
rs39602	rs1423357	0.919280269430492	General cognitive ability	9e-06	29844566
rs39602	rs2432142	0.903284573461683	Neutrophil count	2e-14	32888493
rs39602	rs2432142	0.903284573461683	White blood cell count	1e-11	32888493
rs39602	rs7705093	0.885490875364118	Birdshot chorioretinopathy	2e-09	24957906
rs39602	rs2910686	0.797593932163197	Neutrophil count	4e-14	32888493
rs39602	rs2910686	0.797593932163197	Psoriasis	2e-08	23143594
rs39602	rs2910686	0.797593932163197	Ankylosing spondylitis	5e-17	23749187
rs39602	rs2910686	0.797593932163197	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs39602	rs2927608	0.794511922431733	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs39602	rs2927608	0.794511922431733	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs39602	rs2927608	0.794511922431733	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs39602	rs38029	0.754814478796992	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs39602	rs716848	0.75438697987608	Neutrophil percentage of white cells	2e-09	32888494
rs39602	rs2549797	0.753332231617698	Systolic blood pressure	7e-07	33230300
rs39602	rs2549797	0.753332231617698	Diastolic blood pressure	1e-14	33230300
rs39602	rs2549797	0.753332231617698	Diastolic blood pressure	3e-11	33230300
rs39602	rs2549797	0.753332231617698	Systolic blood pressure	4e-09	33230300
rs39602	rs2549782	0.752056092501688	Systolic blood pressure	6e-07	33230300
rs39602	rs2549782	0.752056092501688	Diastolic blood pressure	1e-14	33230300
rs39602	rs2549782	0.752056092501688	Diastolic blood pressure	3e-11	33230300
rs39602	rs2549782	0.752056092501688	Systolic blood pressure	5e-09	33230300
rs39602	rs1056893	0.751418878765488	Systolic blood pressure	1e-06	33230300
rs39602	rs1056893	0.751418878765488	Diastolic blood pressure	7e-15	33230300
rs39602	rs1056893	0.751418878765488	Diastolic blood pressure	2e-11	33230300
rs39602	rs1056893	0.751418878765488	Systolic blood pressure	7e-09	33230300
rs39602	rs2617439	0.71635758556176	Neutrophil count	8e-11	32888494
rs39602	rs2549794	0.708431804337817	Crohn's disease	1e-10	21102463
rs39602	rs2549794	0.708431804337817	Systolic blood pressure	1e-07	33230300
rs39602	rs2549794	0.708431804337817	Diastolic blood pressure	1e-15	33230300
rs39602	rs2549794	0.708431804337817	Diastolic blood pressure	2e-12	33230300
rs39602	rs2549794	0.708431804337817	Systolic blood pressure	4e-10	33230300
rs39602	rs1363907	0.703975432147077	Crohn's disease	4e-16	26192919
rs39602	rs1363907	0.703975432147077	Ulcerative colitis	4e-06	26192919
rs39602	rs1363907	0.703975432147077	Inflammatory bowel disease	5e-15	26192919
rs39602	rs1363907	0.703975432147077	Inflammatory bowel disease	6e-13	23128233
rs39602	rs1363907	0.703975432147077	Inflammatory bowel disease	1e-10	28067908
rs39602	rs1363907	0.703975432147077	Crohn's disease	1e-14	28067908
rs39602	rs4869313	0.659726506817882	Pediatric autoimmune diseases	9e-08	26301688
rs39602	rs1559359	0.651850648318679	Diastolic blood pressure	7e-10	34594039
rs39602	rs4869314	0.650377504898789	Arthritis (juvenile idiopathic)	3e-09	33106285
rs39602	rs4869314	0.650377504898789	Neutrophil count	1e-10	34594039
rs39602	rs4869314	0.650377504898789	White blood cell count	2e-07	30595370
rs39602	rs1019503	0.641998914766391	Systolic blood pressure	2e-06	33230300
rs39602	rs1019503	0.641998914766391	Diastolic blood pressure	2e-14	33230300
rs39602	rs1019503	0.641998914766391	Diastolic blood pressure	4e-11	33230300
rs39602	rs1019503	0.641998914766391	Systolic blood pressure	1e-08	33230300
rs39602	rs2548532	0.635888461544991	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs39602	rs3096168	0.634822990061964	Aspartate aminotransferase levels	8e-12	33547301
rs39602	rs1974871	0.62311267452123	Granulysin levels	5e-13	34648354
rs39642	rs33321	0.834588787457091	Height	1e-19	34594039
rs39642	rs832540	0.780151336292055	Coronary artery disease	2e-08	29212778
rs39642	rs10061757	0.677688913582763	Height	4e-30	30595370
rs39642	rs33320	0.637409696506409	Height	9e-14	36224396
rs39642	rs2257505	0.635587538434684	Height	8e-192	36224396
rs3965185	rs3965185	1	High-density lipoprotein levels (MTAG)	4e-11	36376304
rs3997903	rs2523644	0.923714986391472	Myocardial infarction	5e-07	30226566
rs3997903	rs2596517	0.826271895067485	Hip circumference adjusted for BMI	7e-14	34021172
rs3997903	rs2596484	0.817656834691324	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs3997937	rs1063631	0.890773622443227	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs3997937	rs1063631	0.890773622443227	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs3997937	rs6928810	0.887616959898339	Platelet distribution width	1e-14	32888494
rs3997937	rs3869132	0.886761758257403	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs3997937	rs3869132	0.886761758257403	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs3997937	rs9266825	0.86164186149912	Autism spectrum disorder	6e-06	35215271
rs3997937	rs199530775	0.743529839324808	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs3997937	rs55957433	0.743529839324808	Hip circumference adjusted for BMI	3e-08	34021172
rs3997937	rs6934175	0.67710109001668	Psoriatic arthritis	5e-28	30552173
rs3997937	rs17200242	0.667748939401918	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs3997937	rs7751505	0.655294993033348	Pubertal anthropometrics	4e-06	23449627
rs3997937	rs35026345	0.653989474731011	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs3997937	rs72848707	0.650888217218811	HDL cholesterol levels	7e-06	35884923
rs3997937	rs13437088	0.629131666658441	Psoriasis	3e-40	23143594
rs3997937	rs13437082	0.628437053255131	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs3997937	rs13437082	0.628437053255131	Height	5e-08	19343178
rs3997937	rs72657657	0.620850375656362	Hip circumference adjusted for BMI	4e-13	34021172
rs3997982	rs2523644	0.98684133447689	Myocardial infarction	5e-07	30226566
rs3997982	rs2596517	0.882890827857817	Hip circumference adjusted for BMI	7e-14	34021172
rs3997982	rs2596484	0.873716863088897	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs400893	rs400625	0.650035699632948	Posterior-cingulate cortex volume	5e-06	31530798
rs401074	rs400625	0.643818914226357	Posterior-cingulate cortex volume	5e-06	31530798
rs402514	rs409942	0.903845410423348	Total cholesterol levels	8e-06	35884923
rs402514	rs739669	0.769385494339149	BMI at birth	5e-17	35315439
rs402514	rs222837	0.715738940696434	Metabolite levels	7e-06	23823483
rs402514	rs2654189	0.673587709162732	Eosinophil counts	4e-11	32888494
rs402514	rs2654189	0.673587709162732	Eosinophil percentage of white cells	6e-12	32888494
rs402514	rs2654189	0.673587709162732	Eosinophil counts	1e-09	30595370
rs402514	rs5415	0.663732941027	Birth weight	5e-06	23202124
rs402514	rs5415	0.663732941027	LDL cholesterol levels	1e-06	35884923
rs402514	rs13331	0.640241851508974	Heel bone mineral density	4e-08	30595370
rs4028470	rs1138888	0.808709550607823	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs4028470	rs1138888	0.808709550607823	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs4028470	rs4802157	0.788028052514213	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs4028470	rs2355433	0.687204555740626	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs4028470	rs2355433	0.687204555740626	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs4028470	rs2355433	0.687204555740626	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs4039600	rs4039600	1	Adenine levels	1e-11	35347128
rs4039600	rs9322193	0.919677723448607	Lung cancer	1e-07	27393504
rs4039600	rs34337297	0.918042980241449	Serum levels of protein LRP11	3e-161	35078996
rs4039600	rs10872645	0.908526761368909	Blood protein levels	2e-86	30072576
rs4039600	rs55763431	0.908526761368909	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4039600	rs9689694	0.90671845849643	Right hippocampal volume (head)	6e-11	37337106
rs4039600	rs9689694	0.90671845849643	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4039600	rs9689694	0.90671845849643	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4039600	rs9689694	0.90671845849643	Left hippocampal volume (head)	6e-12	37337106
rs4039600	rs2095375	0.904085337095829	Serum metabolite levels	1e-20	33031748
rs4039600	rs2095375	0.904085337095829	Serum metabolite levels	1e-20	33031748
rs4039600	rs9383843	0.90325933276309	Migraine	1e-09	35115687
rs4039600	rs9688867	0.901117293295773	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4039600	rs9688867	0.901117293295773	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4039600	rs9688809	0.901117293295773	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4039600	rs10872653	0.900479845897492	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4039600	rs14314	0.886575759034076	Macular thickness	3e-19	30535121
rs4039600	rs14314	0.886575759034076	Vertex-wise sulcal depth	7e-17	34910505
rs4039600	rs14314	0.886575759034076	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4039600	rs14314	0.886575759034076	Left hippocampal volume (body)	7e-15	37337106
rs4039600	rs14314	0.886575759034076	Left subiculum volume (body)	1e-14	37337106
rs409942	rs409942	1	Total cholesterol levels	8e-06	35884923
rs409942	rs2654189	0.722715635905094	Eosinophil counts	4e-11	32888494
rs409942	rs2654189	0.722715635905094	Eosinophil percentage of white cells	6e-12	32888494
rs409942	rs2654189	0.722715635905094	Eosinophil counts	1e-09	30595370
rs409942	rs5415	0.711602476385462	Birth weight	5e-06	23202124
rs409942	rs5415	0.711602476385462	LDL cholesterol levels	1e-06	35884923
rs409942	rs739669	0.696085637050349	BMI at birth	5e-17	35315439
rs409942	rs222837	0.638136108786975	Metabolite levels	7e-06	23823483
rs4101376	rs7321596	0.99249065457011	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs4101376	rs8002861	0.958569707666156	Leprosy	7e-06	25642632
rs4112225	rs6680628	0.707034390060903	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs412212	rs400625	0.646157129571669	Posterior-cingulate cortex volume	5e-06	31530798
rs412392	rs2263329	0.957108538627218	HDL cholesterol	6e-35	34594039
rs412392	rs2263329	0.957108538627218	HDL cholesterol levels	8e-43	32203549
rs412392	rs2263329	0.957108538627218	High density lipoprotein cholesterol levels	2e-52	34887591
rs412392	rs9366863	0.94315852082807	Adult body size	9e-33	32376654
rs412392	rs9366863	0.94315852082807	Body mass index	2e-44	30595370
rs412392	rs2744944	0.936182376669992	Hypothyroidism	3e-10	34594039
rs412392	rs2744944	0.936182376669992	High density lipoprotein cholesterol levels	3e-86	34887591
rs412392	rs2744944	0.936182376669992	Multi-trait sex score	7e-22	37277458
rs412392	rs2814949	0.934800875982652	Essential hypertension (time to event)	9e-09	32589924
rs412392	rs9469872	0.929962329905989	HDL cholesterol levels	3e-11	36333282
rs412392	rs11755393	0.908143768388437	Body mass index	3e-26	29273807
rs412392	rs11755393	0.908143768388437	Systemic lupus erythematosus	2e-12	33493351
rs412392	rs11755393	0.908143768388437	Systemic lupus erythematosus	2e-06	33493351
rs412392	rs11755393	0.908143768388437	Systemic lupus erythematosus	1e-07	33493351
rs412392	rs11755393	0.908143768388437	Systemic lupus erythematosus	2e-08	19838195
rs412392	rs11755393	0.908143768388437	Body mass index	4e-55	36581621
rs412392	rs6941110	0.899826072066233	Sex hormone-binding globulin levels	5e-27	36653534
rs412392	rs111868030	0.893842838320505	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs412392	rs9469857	0.892591080883743	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs412392	rs2764208	0.890300784133336	Systemic lupus erythematosus	7e-06	24871463
rs412392	rs9462030	0.880458462215726	Red cell distribution width	5e-25	32888493
rs412392	rs9469899	0.864950597772919	Prostate cancer (advanced)	2e-06	29892016
rs412392	rs9469899	0.864950597772919	Prostate cancer	5e-09	29892016
rs412392	rs9469899	0.864950597772919	Prostate cancer	8e-11	33398198
rs412392	rs9469899	0.864950597772919	Hand grip strength	3e-15	29691431
rs412392	rs9469899	0.864950597772919	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs412392	rs9469899	0.864950597772919	Graves' disease	4e-10	34594039
rs412392	rs9469899	0.864950597772919	Coronary artery disease	1e-11	36474045
rs412392	rs9469899	0.864950597772919	Predicted visceral adipose tissue	2e-20	31501611
rs412392	rs9469899	0.864950597772919	Medication use (thyroid preparations)	2e-09	31015401
rs412392	rs9469899	0.864950597772919	Medication use (thyroid preparations)	3e-10	34594039
rs412392	rs9368830	0.854599270927261	HDL cholesterol	4e-21	30275531
rs412392	rs9296128	0.842608489887549	Hip circumference adjusted for BMI	4e-13	34021172
rs412392	rs9368828	0.837946166000622	Body mass index	1e-34	34594039
rs412392	rs2744973	0.803432717179286	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs412392	rs2744973	0.803432717179286	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs412392	rs2744973	0.803432717179286	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs412392	rs2744973	0.803432717179286	Multi-trait sex score	6e-20	37277458
rs412392	rs6912327	0.758068066235717	Fasting insulin	5e-06	33402679
rs412392	rs6912327	0.758068066235717	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs412392	rs112283401	0.7334508428626	Red cell distribution width	4e-27	30595370
rs412392	rs205262	0.623126543168229	Body mass index	2e-09	26961502
rs412392	rs205262	0.623126543168229	Walking pace	4e-10	33128006
rs412392	rs205262	0.623126543168229	Body mass index	8e-13	30108127
rs412392	rs205262	0.623126543168229	Body mass index	2e-09	25673413
rs412392	rs205262	0.623126543168229	Body mass index	2e-14	26426971
rs412392	rs205262	0.623126543168229	BMI in non-smokers	3e-07	28443625
rs412392	rs205262	0.623126543168229	BMI in non-smokers	6e-09	28443625
rs412392	rs205262	0.623126543168229	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs412392	rs205262	0.623126543168229	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs412392	rs205262	0.623126543168229	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs412392	rs205262	0.623126543168229	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs412392	rs205262	0.623126543168229	Gastroesophageal reflux disease	1e-10	34187846
rs412392	rs205262	0.623126543168229	Body mass index	3e-10	25673413
rs412392	rs205262	0.623126543168229	Body mass index	2e-10	25673413
rs412392	rs205262	0.623126543168229	ICD10 M54: Dorsalgia	2e-12	35110524
rs4133294	rs10222974	0.742303035704235	Height	3e-07	36224396
rs4133294	rs4859699	0.632317667026929	Androstenediol (3alpha, 17alpha) monosulfate (2) levels in elite athletes	3e-06	31882771
rs414206	rs409942	0.89491602474043	Total cholesterol levels	8e-06	35884923
rs414206	rs739669	0.759770129720532	BMI at birth	5e-17	35315439
rs414206	rs222837	0.707656070914157	Metabolite levels	7e-06	23823483
rs414206	rs2654189	0.666919133767247	Eosinophil counts	4e-11	32888494
rs414206	rs2654189	0.666919133767247	Eosinophil percentage of white cells	6e-12	32888494
rs414206	rs2654189	0.666919133767247	Eosinophil counts	1e-09	30595370
rs414206	rs5415	0.657051753179669	Birth weight	5e-06	23202124
rs414206	rs5415	0.657051753179669	LDL cholesterol levels	1e-06	35884923
rs414206	rs13331	0.631700781809686	Heel bone mineral density	4e-08	30595370
rs4143843	rs2162062	0.871075589263846	Height	2e-13	35831902
rs4143843	rs1436958	0.844732289564599	IgG glycosylation	9e-06	23382691
rs4143843	rs933807	0.82956921541132	Fat-free mass	6e-06	30593698
rs4143843	rs933807	0.82956921541132	Fat-free mass	2e-07	30593698
rs4143843	rs933807	0.82956921541132	Fat-free mass	8e-11	30593698
rs4143843	rs7178540	0.80626783741112	Height	1e-31	36224396
rs4143843	rs7162536	0.771480801651388	Height	4e-29	34594039
rs4143843	rs11635977	0.76419723515547	Height	2e-25	36224396
rs4143843	rs7178424	0.762584699353333	Height	6e-09	20881960
rs4143843	rs7178424	0.762584699353333	Height	6e-13	35831902
rs4143843	rs7178424	0.762584699353333	Height	3e-251	36224396
rs4143843	rs17271431	0.758411408390333	Height	2e-11	34594039
rs4143843	rs17205463	0.757753227967567	Serum levels of protein IGF1	8e-08	27329260
rs4143843	rs17205463	0.757753227967567	Appendicular lean mass	4e-43	33097823
rs4143843	rs17205463	0.757753227967567	Height	2e-35	30595370
rs4143843	rs731820	0.748067133538821	Height	2e-13	31562340
rs4143843	rs731820	0.748067133538821	Height	2e-12	35831902
rs4143843	rs72749770	0.729930315842701	Low density lipoprotein cholesterol levels	9e-10	32493714
rs4143843	rs72749770	0.729930315842701	Apolipoprotein B levels	2e-09	32203549
rs4145871	rs28568334	0.800714331304701	Educational attainment	4e-13	35361970
rs4145871	rs28482086	0.711412164573406	Educational attainment (years of education)	5e-09	30038396
rs4146565	rs9292122	0.842845138577539	Prostate cancer	5e-09	33398198
rs4146565	rs702689	0.720981003360899	Vertex-wise sulcal depth	2e-22	34910505
rs4150526	rs4353250	0.983551999162654	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150526	rs4353250	0.983551999162654	Amyloid A serum levels	2e-51	21124955
rs4150526	rs4150575	0.647334721968027	Imidazole lactate levels	1e-10	36635386
rs4150561	rs4353250	0.982262760023821	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150561	rs4353250	0.982262760023821	Amyloid A serum levels	2e-51	21124955
rs4150561	rs4150575	0.644872554099736	Imidazole lactate levels	1e-10	36635386
rs4150564	rs4353250	0.982262760023821	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150564	rs4353250	0.982262760023821	Amyloid A serum levels	2e-51	21124955
rs4150564	rs4150575	0.644872554099736	Imidazole lactate levels	1e-10	36635386
rs4150566	rs4150575	0.99698423010608	Imidazole lactate levels	1e-10	36635386
rs4150566	rs4150579	0.763769295957049	Survival in pancreatic cancer	9e-06	28470677
rs4150566	rs4150579	0.763769295957049	Serum amyloid A-1 protein levels	5e-33	28240269
rs4150566	rs9783347	0.762102545538044	Pancreatic cancer	9e-06	23180869
rs4150566	rs4353250	0.633025158061488	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150566	rs4353250	0.633025158061488	Amyloid A serum levels	2e-51	21124955
rs4150575	rs4150575	1	Imidazole lactate levels	1e-10	36635386
rs4150575	rs9783347	0.762872120639379	Pancreatic cancer	9e-06	23180869
rs4150575	rs4150579	0.761206729878907	Survival in pancreatic cancer	9e-06	28470677
rs4150575	rs4150579	0.761206729878907	Serum amyloid A-1 protein levels	5e-33	28240269
rs4150575	rs4353250	0.635991214392597	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150575	rs4353250	0.635991214392597	Amyloid A serum levels	2e-51	21124955
rs4150588	rs4150575	1	Imidazole lactate levels	1e-10	36635386
rs4150588	rs9783347	0.762872120639379	Pancreatic cancer	9e-06	23180869
rs4150588	rs4150579	0.761206729878907	Survival in pancreatic cancer	9e-06	28470677
rs4150588	rs4150579	0.761206729878907	Serum amyloid A-1 protein levels	5e-33	28240269
rs4150588	rs4353250	0.635991214392597	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150588	rs4353250	0.635991214392597	Amyloid A serum levels	2e-51	21124955
rs4150610	rs4353250	0.982302844046854	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150610	rs4353250	0.982302844046854	Amyloid A serum levels	2e-51	21124955
rs4150610	rs4150575	0.648156260215757	Imidazole lactate levels	1e-10	36635386
rs4150622	rs4353250	0.957843863418035	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150622	rs4353250	0.957843863418035	Amyloid A serum levels	2e-51	21124955
rs4150622	rs4150575	0.664673178994094	Imidazole lactate levels	1e-10	36635386
rs4150641	rs4150575	1	Imidazole lactate levels	1e-10	36635386
rs4150641	rs9783347	0.762872120639379	Pancreatic cancer	9e-06	23180869
rs4150641	rs4150579	0.761206729878907	Survival in pancreatic cancer	9e-06	28470677
rs4150641	rs4150579	0.761206729878907	Serum amyloid A-1 protein levels	5e-33	28240269
rs4150641	rs4353250	0.635991214392597	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150641	rs4353250	0.635991214392597	Amyloid A serum levels	2e-51	21124955
rs4150653	rs4353250	0.880479202562846	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150653	rs4353250	0.880479202562846	Amyloid A serum levels	2e-51	21124955
rs4150655	rs4150575	1	Imidazole lactate levels	1e-10	36635386
rs4150655	rs9783347	0.762872120639379	Pancreatic cancer	9e-06	23180869
rs4150655	rs4150579	0.761206729878907	Survival in pancreatic cancer	9e-06	28470677
rs4150655	rs4150579	0.761206729878907	Serum amyloid A-1 protein levels	5e-33	28240269
rs4150655	rs4353250	0.635991214392597	Insulin-like growth factor 1 levels	2e-14	33462484
rs4150655	rs4353250	0.635991214392597	Amyloid A serum levels	2e-51	21124955
rs41519045	rs2596517	0.96966864798039	Hip circumference adjusted for BMI	7e-14	34021172
rs41519045	rs2596484	0.963587318809188	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs41519045	rs2523644	0.889114237357636	Myocardial infarction	5e-07	30226566
rs416100	rs409942	0.700576859958723	Total cholesterol levels	8e-06	35884923
rs416100	rs5415	0.605208969073066	Birth weight	5e-06	23202124
rs416100	rs5415	0.605208969073066	LDL cholesterol levels	1e-06	35884923
rs416100	rs2654189	0.605072722824236	Eosinophil counts	4e-11	32888494
rs416100	rs2654189	0.605072722824236	Eosinophil percentage of white cells	6e-12	32888494
rs416100	rs2654189	0.605072722824236	Eosinophil counts	1e-09	30595370
rs41751	rs41748	0.647632339223394	Resting heart rate	7e-06	29769521
rs41751	rs41748	0.647632339223394	Resting heart rate	7e-09	27798624
rs41751	rs964449	0.622710817620413	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41751	rs11562010	0.618229430298785	Platelet count	9e-13	27863252
rs41752	rs41748	0.646844240116752	Resting heart rate	7e-06	29769521
rs41752	rs41748	0.646844240116752	Resting heart rate	7e-09	27798624
rs41752	rs964449	0.623337371589163	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41752	rs11562010	0.618855942859015	Platelet count	9e-13	27863252
rs41753	rs41748	0.645594071252046	Resting heart rate	7e-06	29769521
rs41753	rs41748	0.645594071252046	Resting heart rate	7e-09	27798624
rs41753	rs964449	0.622084955942937	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41753	rs11562010	0.617603610594874	Platelet count	9e-13	27863252
rs41756	rs41748	0.633853284582217	Resting heart rate	7e-06	29769521
rs41756	rs41748	0.633853284582217	Resting heart rate	7e-09	27798624
rs41756	rs964449	0.621219627796654	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41756	rs11562010	0.616680890414819	Platelet count	9e-13	27863252
rs41757	rs41748	0.633242075496098	Resting heart rate	7e-06	29769521
rs41757	rs41748	0.633242075496098	Resting heart rate	7e-09	27798624
rs41757	rs964449	0.620600704634751	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41757	rs11562010	0.61606201663177	Platelet count	9e-13	27863252
rs41759	rs41748	0.634026610358589	Resting heart rate	7e-06	29769521
rs41759	rs41748	0.634026610358589	Resting heart rate	7e-09	27798624
rs41759	rs964449	0.621349564717932	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41759	rs11562010	0.616803615767888	Platelet count	9e-13	27863252
rs41760	rs41748	0.633242075496098	Resting heart rate	7e-06	29769521
rs41760	rs41748	0.633242075496098	Resting heart rate	7e-09	27798624
rs41760	rs964449	0.620600704634751	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41760	rs11562010	0.61606201663177	Platelet count	9e-13	27863252
rs41761	rs41748	0.631674632442818	Resting heart rate	7e-06	29769521
rs41761	rs41748	0.631674632442818	Resting heart rate	7e-09	27798624
rs41761	rs964449	0.619104518813862	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41761	rs11562010	0.614580336241564	Platelet count	9e-13	27863252
rs41763	rs41748	0.630979694100066	Resting heart rate	7e-06	29769521
rs41763	rs41748	0.630979694100066	Resting heart rate	7e-09	27798624
rs41763	rs964449	0.622362126617037	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41763	rs11562010	0.617794462670702	Platelet count	9e-13	27863252
rs41764	rs41748	0.631847703960798	Resting heart rate	7e-06	29769521
rs41764	rs41748	0.631847703960798	Resting heart rate	7e-09	27798624
rs41764	rs964449	0.626081509542131	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41764	rs11562010	0.62151354949896	Platelet count	9e-13	27863252
rs41766	rs41748	0.630454869290787	Resting heart rate	7e-06	29769521
rs41766	rs41748	0.630454869290787	Resting heart rate	7e-09	27798624
rs41766	rs964449	0.624709049366952	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41766	rs11562010	0.620148414953366	Platelet count	9e-13	27863252
rs41767	rs41748	0.629845983327485	Resting heart rate	7e-06	29769521
rs41767	rs41748	0.629845983327485	Resting heart rate	7e-09	27798624
rs41767	rs964449	0.624088296483493	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41767	rs11562010	0.61952771056654	Platelet count	9e-13	27863252
rs41768	rs41748	0.63002054793855	Resting heart rate	7e-06	29769521
rs41768	rs41748	0.63002054793855	Resting heart rate	7e-09	27798624
rs41768	rs964449	0.626963201676561	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41768	rs11562010	0.622380717966608	Platelet count	9e-13	27863252
rs41769	rs41748	0.63123798915114	Resting heart rate	7e-06	29769521
rs41769	rs41748	0.63123798915114	Resting heart rate	7e-09	27798624
rs41769	rs964449	0.625459920807155	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41769	rs11562010	0.620892008788922	Platelet count	9e-13	27863252
rs41772	rs964449	0.633109038787057	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs41772	rs41748	0.631552187318953	Resting heart rate	7e-06	29769521
rs41772	rs41748	0.631552187318953	Resting heart rate	7e-09	27798624
rs41772	rs11562010	0.628569466178257	Platelet count	9e-13	27863252
rs418550	rs4363385	0.644468127105402	Inflammatory skin disease	2e-15	25574825
rs422309	rs1508798	0.852790023609131	Coronary artery disease	5e-13	29212778
rs422309	rs1508798	0.852790023609131	Coronary artery disease	6e-08	33020668
rs4228	rs34579268	0.990222686924722	Hematocrit	5e-30	32888493
rs4228	rs34579268	0.990222686924722	Hematocrit	2e-27	32888493
rs4228	rs34579268	0.990222686924722	Hemoglobin concentration	5e-26	32888493
rs4228	rs11705721	0.982875271305247	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs4228	rs11130638	0.982875271305247	Hemoglobin concentration	2e-23	32888493
rs4228	rs7610312	0.959753788710397	Red blood cell count	5e-09	27863252
rs4228	rs6775517	0.958544035847111	Hematocrit	1e-17	34594039
rs4228	rs57700771	0.953702350068657	Red blood cell count	9e-21	30595370
rs4228	rs55704295	0.886983197883615	Red blood cell count	8e-26	32888493
rs4228	rs55704295	0.886983197883615	Red blood cell count	5e-23	32888493
rs4228	rs55704295	0.886983197883615	Serum total protein level	2e-29	34594039
rs4228	rs4681679	0.862434017679772	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs4228	rs11719450	0.855633769323382	Hemoglobin concentration	2e-09	27863252
rs4228	rs11719450	0.855633769323382	Hemoglobin levels	2e-16	32327693
rs4228	rs11922478	0.844149766494221	Semaphorin-6B levels	4e-12	34648354
rs4228	rs56384862	0.825573793131696	Body mass index	8e-12	29273807
rs4228	rs56384862	0.825573793131696	Body mass index	3e-06	30108127
rs4228	rs56384862	0.825573793131696	Hemoglobin levels	1e-16	32327693
rs4228	rs56384862	0.825573793131696	Body mass index	3e-14	36581621
rs4228	rs55692656	0.801628991874269	vWF levels	3e-08	30586737
rs4228	rs55692656	0.801628991874269	vWF levels	6e-09	30586737
rs4228	rs6445969	0.679066325911899	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs4228	rs55954186	0.67546660356926	vWF levels	5e-09	30586737
rs4228	rs55954186	0.67546660356926	vWF levels	9e-09	30586737
rs4228	rs11708895	0.672895081755273	Red blood cell count	1e-20	32888494
rs4228	rs7431952	0.609248382260008	Hemoglobin levels	1e-12	32327693
rs4233335	rs2765527	0.947043963708608	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs4233335	rs10801696	0.898256798110086	Imidazole lactate levels	3e-195	35050183
rs4233335	rs1206228892	0.8975367754448	Imidazole lactate levels	5e-186	35050183
rs4233335	rs2810876	0.892774524687146	Imidazole lactate levels	2e-122	35347128
rs4233335	rs7532151	0.796939151066626	Imidazole lactate levels	9e-12	33177712
rs4233335	rs12729558	0.765963874206796	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs4233335	rs9787133	0.735425141345209	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs4233335	rs10801690	0.71418848996018	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs4233335	rs10922531	0.662906162314136	Serum metabolite levels	2e-69	33031748
rs4233335	rs7530513	0.604739647539651	Height	8e-11	35831902
rs4233335	rs7530513	0.604739647539651	Imidazole lactate levels	8e-166	36635386
rs4233335	rs12144640	0.604739647539651	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs4233336	rs55679149	0.647760483311527	Remission after SSRI treatment in MDD or openness	8e-07	29559929
rs4233336	rs12089335	0.636148287185584	Guanylate-binding protein 1 levels	4e-26	34648354
rs4238033	rs1859336	0.982232090187523	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4238033	rs6489882	0.98120356743201	Chronic lymphocytic leukemia	5e-08	28165464
rs4238033	rs11066452	0.959810758296141	Blood protein levels	6e-08	30072576
rs4238033	rs4767027	0.938749181712357	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4238033	rs2057778	0.937585258200669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4238033	rs2057778	0.937585258200669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4238033	rs2057778	0.937585258200669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4238033	rs1131476	0.912584729848029	Systemic lupus erythematosus	1e-09	33272962
rs4238033	rs2660	0.912584729848029	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4238033	rs2660	0.912584729848029	COVID-19 (critical illness vs population)	3e-15	37198478
rs4238033	rs6489867	0.668731973951964	COVID-19 (critical illness vs population)	1e-09	33307546
rs4238033	rs1557866	0.633298573207346	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs42383	rs41748	0.634026610358589	Resting heart rate	7e-06	29769521
rs42383	rs41748	0.634026610358589	Resting heart rate	7e-09	27798624
rs42383	rs964449	0.621349564717932	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs42383	rs11562010	0.616803615767888	Platelet count	9e-13	27863252
rs4242279	rs7752089	0.992795235695475	Brain morphology (MOSTest)	2e-31	35164939
rs4242279	rs10872649	0.926545782353895	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4242279	rs10872649	0.926545782353895	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4242279	rs10872649	0.926545782353895	Right hippocampal volume (body)	1e-10	37337106
rs4242279	rs1934534	0.827693800649818	Pain (pleiotropy)	2e-08	37844115
rs4242279	rs1934534	0.827693800649818	Pain (pleiotropy)	2e-06	37844115
rs4242279	rs4380763	0.826919229920767	Subcortical volume (min-P)	1e-11	32665545
rs4242279	rs11155671	0.815676136213192	Testicular germ cell tumor	2e-09	28604728
rs4242279	rs9322194	0.809695445759063	Brainstem volume	2e-11	31636452
rs4242279	rs80147756	0.789873130971202	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4242279	rs4421206	0.782329889547284	Brain morphology (min-P)	4e-11	32665545
rs4242279	rs9505982	0.781852849059669	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4242279	rs9688452	0.759714354289614	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4242279	rs9688452	0.759714354289614	aseg lh volume VentralDC	2e-10	33875891
rs4242279	rs12526675	0.73488438137294	Brain morphology (MOSTest)	7e-22	32665545
rs4242279	rs2342764	0.711888959839321	Cortical thickness	1e-08	34560273
rs4242279	rs9285521	0.686606104444649	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4242279	rs56103941	0.664237169998896	Right presubiculum volume (head)	4e-08	37337106
rs4242279	rs12523793	0.624558320039411	Subcortical volume (MOSTest)	4e-24	32665545
rs4242279	rs12523793	0.624558320039411	C-reactive protein levels	3e-08	35459240
rs4242279	rs12523793	0.624558320039411	C-reactive protein levels (MTAG)	2e-08	36376304
rs4242279	rs11155662	0.619894430574822	Vertex-wise cortical thickness	2e-09	34910505
rs4249196	rs10876448	0.902538230027752	Mean corpuscular hemoglobin	2e-16	32888493
rs4249196	rs10876448	0.902538230027752	Reticulocyte count	3e-18	32888494
rs4249196	rs10876448	0.902538230027752	Reticulocyte fraction of red cells	1e-10	32888494
rs4249196	rs2446066	0.901693373611473	Vertex-wise sulcal depth	1e-10	34910505
rs4249196	rs2446066	0.901693373611473	Vertex-wise cortical surface area	2e-13	34910505
rs4249196	rs2446066	0.901693373611473	Red blood cell count	1e-10	27863252
rs4249196	rs2446066	0.901693373611473	Cortical surface area	3e-08	34560273
rs4249196	rs2608301	0.901693373611473	Low density lipoprotein cholesterol levels	2e-12	34887591
rs4249196	rs2460882	0.899931578621178	Mean corpuscular volume	3e-15	29403010
rs4249196	rs2460882	0.899931578621178	Percentage gas trapping	6e-07	26030696
rs4249196	rs12582170	0.871553713728492	Mean corpuscular volume	1e-21	27863252
rs4249196	rs12582170	0.871553713728492	Mean corpuscular hemoglobin	7e-37	32888493
rs4249196	rs12582170	0.871553713728492	Mean reticulocyte volume	2e-33	32888494
rs4249196	rs12582170	0.871553713728492	Mean corpuscular volume	1e-67	32888493
rs4249196	rs12582170	0.871553713728492	Mean corpuscular hemoglobin	2e-21	32888494
rs4249196	rs12582170	0.871553713728492	Mean corpuscular volume	1e-26	34104963
rs4249196	rs111379945	0.837239404381689	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs4249196	rs111379945	0.837239404381689	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs4249196	rs111379945	0.837239404381689	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs425463	rs836788	0.885748664420422	Glomerular filtration rate (creatinine)	1e-07	26831199
rs4255023	rs4304220	0.997583637260812	Height	2e-14	36224396
rs4255023	rs13232536	0.725359533245334	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4255023	rs4355658	0.703188864930741	Height	3e-13	36224396
rs4255023	rs13227841	0.610439369280967	Asthma	2e-09	32514122
rs4258241	rs11580836	0.893174698676356	Body mass index	2e-09	36581621
rs4258241	rs10465746	0.875066647555843	Obesity-related traits	8e-06	23251661
rs4258241	rs1536166	0.625640075353168	Body mass index	2e-08	30595370
rs4259246	rs9469872	0.96494929526803	HDL cholesterol levels	3e-11	36333282
rs4259246	rs11755393	0.964336676300205	Body mass index	3e-26	29273807
rs4259246	rs11755393	0.964336676300205	Systemic lupus erythematosus	2e-12	33493351
rs4259246	rs11755393	0.964336676300205	Systemic lupus erythematosus	2e-06	33493351
rs4259246	rs11755393	0.964336676300205	Systemic lupus erythematosus	1e-07	33493351
rs4259246	rs11755393	0.964336676300205	Systemic lupus erythematosus	2e-08	19838195
rs4259246	rs11755393	0.964336676300205	Body mass index	4e-55	36581621
rs4259246	rs9366863	0.954705825631092	Adult body size	9e-33	32376654
rs4259246	rs9366863	0.954705825631092	Body mass index	2e-44	30595370
rs4259246	rs6941110	0.951561961032268	Sex hormone-binding globulin levels	5e-27	36653534
rs4259246	rs9462030	0.933796138065356	Red cell distribution width	5e-25	32888493
rs4259246	rs9469857	0.924527796605831	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs4259246	rs2764208	0.923789487797446	Systemic lupus erythematosus	7e-06	24871463
rs4259246	rs2814949	0.918208809208379	Essential hypertension (time to event)	9e-09	32589924
rs4259246	rs9469899	0.917364069250459	Prostate cancer (advanced)	2e-06	29892016
rs4259246	rs9469899	0.917364069250459	Prostate cancer	5e-09	29892016
rs4259246	rs9469899	0.917364069250459	Prostate cancer	8e-11	33398198
rs4259246	rs9469899	0.917364069250459	Hand grip strength	3e-15	29691431
rs4259246	rs9469899	0.917364069250459	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs4259246	rs9469899	0.917364069250459	Graves' disease	4e-10	34594039
rs4259246	rs9469899	0.917364069250459	Coronary artery disease	1e-11	36474045
rs4259246	rs9469899	0.917364069250459	Predicted visceral adipose tissue	2e-20	31501611
rs4259246	rs9469899	0.917364069250459	Medication use (thyroid preparations)	2e-09	31015401
rs4259246	rs9469899	0.917364069250459	Medication use (thyroid preparations)	3e-10	34594039
rs4259246	rs2744944	0.908938316281529	Hypothyroidism	3e-10	34594039
rs4259246	rs2744944	0.908938316281529	High density lipoprotein cholesterol levels	3e-86	34887591
rs4259246	rs2744944	0.908938316281529	Multi-trait sex score	7e-22	37277458
rs4259246	rs2263329	0.889847100179858	HDL cholesterol	6e-35	34594039
rs4259246	rs2263329	0.889847100179858	HDL cholesterol levels	8e-43	32203549
rs4259246	rs2263329	0.889847100179858	High density lipoprotein cholesterol levels	2e-52	34887591
rs4259246	rs9296128	0.876157076585895	Hip circumference adjusted for BMI	4e-13	34021172
rs4259246	rs111868030	0.86560653556635	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs4259246	rs9368830	0.843554480190535	HDL cholesterol	4e-21	30275531
rs4259246	rs9368828	0.814155265662348	Body mass index	1e-34	34594039
rs4259246	rs6912327	0.808846546975657	Fasting insulin	5e-06	33402679
rs4259246	rs6912327	0.808846546975657	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs4259246	rs112283401	0.786310100224095	Red cell distribution width	4e-27	30595370
rs4259246	rs2744973	0.75832873760468	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs4259246	rs2744973	0.75832873760468	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs4259246	rs2744973	0.75832873760468	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs4259246	rs2744973	0.75832873760468	Multi-trait sex score	6e-20	37277458
rs4259246	rs6940215	0.612069922002256	Insomnia	2e-10	35835914
rs4259246	rs6940215	0.612069922002256	Insomnia	1e-13	35835914
rs4259246	rs6940215	0.612069922002256	Hip circumference adjusted for BMI	8e-10	34021172
rs4259246	rs6940215	0.612069922002256	Multi-trait sex score	2e-23	37277458
rs4259246	rs6940215	0.612069922002256	Multi-trait sex score	4e-23	37277458
rs4259246	rs6457796	0.606644932840775	Insomnia	1e-08	30804565
rs4259246	rs6457796	0.606644932840775	Plateletcrit	9e-11	32888494
rs4259246	rs6457796	0.606644932840775	Systemic lupus erythematosus	3e-22	33272962
rs4259246	rs6457796	0.606644932840775	Body mass index	5e-13	30108127
rs4259246	rs6457796	0.606644932840775	Body mass index	1e-14	26426971
rs4259246	rs6457796	0.606644932840775	Educational attainment	5e-19	35361970
rs4262056	rs1550057	0.694288596023987	Conduct disorder	4e-06	20585324
rs4262056	rs1550057	0.694288596023987	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs4262056	rs34402449	0.643359058530367	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs426521	rs337277	0.953367929236883	Metabolite peak levels (QI10992)	3e-52	35995766
rs426521	rs337277	0.953367929236883	Metabolite peak levels (QI4667)	7e-18	35995766
rs426521	rs337277	0.953367929236883	Metabolite peak levels (QI4708)	1e-21	35995766
rs426521	rs337277	0.953367929236883	Metabolite peak levels (QI5169)	7e-57	35995766
rs426521	rs7655841	0.732061778017865	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs427784	rs409942	0.613730523738168	Total cholesterol levels	8e-06	35884923
rs4282407	rs9462030	0.968019848542112	Red cell distribution width	5e-25	32888493
rs4282407	rs9469857	0.958501234616649	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs4282407	rs2764208	0.957700511085635	Systemic lupus erythematosus	7e-06	24871463
rs4282407	rs9469899	0.951779880438575	Prostate cancer (advanced)	2e-06	29892016
rs4282407	rs9469899	0.951779880438575	Prostate cancer	5e-09	29892016
rs4282407	rs9469899	0.951779880438575	Prostate cancer	8e-11	33398198
rs4282407	rs9469899	0.951779880438575	Hand grip strength	3e-15	29691431
rs4282407	rs9469899	0.951779880438575	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs4282407	rs9469899	0.951779880438575	Graves' disease	4e-10	34594039
rs4282407	rs9469899	0.951779880438575	Coronary artery disease	1e-11	36474045
rs4282407	rs9469899	0.951779880438575	Predicted visceral adipose tissue	2e-20	31501611
rs4282407	rs9469899	0.951779880438575	Medication use (thyroid preparations)	2e-09	31015401
rs4282407	rs9469899	0.951779880438575	Medication use (thyroid preparations)	3e-10	34594039
rs4282407	rs9469872	0.923160066840422	HDL cholesterol levels	3e-11	36333282
rs4282407	rs11755393	0.921498752753058	Body mass index	3e-26	29273807
rs4282407	rs11755393	0.921498752753058	Systemic lupus erythematosus	2e-12	33493351
rs4282407	rs11755393	0.921498752753058	Systemic lupus erythematosus	2e-06	33493351
rs4282407	rs11755393	0.921498752753058	Systemic lupus erythematosus	1e-07	33493351
rs4282407	rs11755393	0.921498752753058	Systemic lupus erythematosus	2e-08	19838195
rs4282407	rs11755393	0.921498752753058	Body mass index	4e-55	36581621
rs4282407	rs9366863	0.913068321805107	Adult body size	9e-33	32376654
rs4282407	rs9366863	0.913068321805107	Body mass index	2e-44	30595370
rs4282407	rs6941110	0.90991602601297	Sex hormone-binding globulin levels	5e-27	36653534
rs4282407	rs9296128	0.908118239229141	Hip circumference adjusted for BMI	4e-13	34021172
rs4282407	rs2814949	0.877544569874343	Essential hypertension (time to event)	9e-09	32589924
rs4282407	rs2744944	0.871294271862742	Hypothyroidism	3e-10	34594039
rs4282407	rs2744944	0.871294271862742	High density lipoprotein cholesterol levels	3e-86	34887591
rs4282407	rs2744944	0.871294271862742	Multi-trait sex score	7e-22	37277458
rs4282407	rs2263329	0.849301471948449	HDL cholesterol	6e-35	34594039
rs4282407	rs2263329	0.849301471948449	HDL cholesterol levels	8e-43	32203549
rs4282407	rs2263329	0.849301471948449	High density lipoprotein cholesterol levels	2e-52	34887591
rs4282407	rs111868030	0.825284679677159	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs4282407	rs9368830	0.807545968586024	HDL cholesterol	4e-21	30275531
rs4282407	rs2744973	0.790118684419551	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs4282407	rs2744973	0.790118684419551	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs4282407	rs2744973	0.790118684419551	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs4282407	rs2744973	0.790118684419551	Multi-trait sex score	6e-20	37277458
rs4282407	rs9368828	0.779216951593775	Body mass index	1e-34	34594039
rs4282407	rs6912327	0.76799823508253	Fasting insulin	5e-06	33402679
rs4282407	rs6912327	0.76799823508253	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs4282407	rs112283401	0.757306747024724	Red cell distribution width	4e-27	30595370
rs4282407	rs9689160	0.606139503145162	Lung function (forced vital capacity)	3e-14	36914875
rs4283171	rs28373613	0.896159776765658	Height (standard GWA)	8e-12	37106081
rs4283171	rs13379492	0.63436022382373	Lung function (FEV1/FVC)	6e-08	30595370
rs4286826	rs4304220	0.867347575367006	Height	2e-14	36224396
rs4286826	rs4355658	0.817717373306373	Height	3e-13	36224396
rs4286826	rs13232536	0.614041555744898	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4286826	rs12539962	0.601093864378622	Colorectal cancer	3e-08	36539618
rs4288177	rs2842611	0.636424696015144	High density lipoprotein cholesterol levels	5e-09	34887591
rs4288177	rs1173416	0.626159690737542	Height	2e-59	36224396
rs4293973	rs2475792	0.845652139284938	Neutrophil count	1e-08	34594039
rs4293973	rs2475787	0.826911651393239	Neutrophil count	1e-11	32888493
rs4293973	rs4593336	0.750314052923665	Body mass index	2e-08	36581621
rs4293973	rs10806334	0.72874846010947	White blood cell count	4e-12	32888493
rs4293973	rs10806334	0.72874846010947	Neutrophil count	9e-12	32888493
rs4293973	rs10806334	0.72874846010947	White blood cell count	3e-13	32888493
rs4294674	rs4424789	0.989745989270462	Periostin levels	2e-19	34648354
rs4294674	rs9603222	0.812850341962488	Blood protein levels	2e-12	30072576
rs4295766	rs4295766	1	Red blood cell count	7e-09	34594039
rs4295766	rs10819461	0.769285081299555	Hemoglobin	8e-11	32888494
rs4295766	rs10819461	0.769285081299555	Hemoglobin concentration	1e-13	32888493
rs4295766	rs10819461	0.769285081299555	Hemoglobin concentration	2e-13	32888493
rs4295766	rs1977447	0.727971029763561	Plasma succinylcarnitine (C4-DC) levels in chronic kidney disease	8e-16	37277652
rs4295766	rs3118625	0.722624811746504	2-methylmalonylcarnitine (C4-DC) levels	5e-37	35347128
rs4295766	rs3118625	0.722624811746504	Succinylcarnitine (c4-dc) levels	2e-23	35347128
rs4295766	rs3118625	0.722624811746504	succinylcarnitine measurement (elderly offspring)	1e-13	37118062
rs4295766	rs3118625	0.722624811746504	succinylcarnitine measurement (advanced age)	6e-07	37118062
rs4295766	rs2254230	0.702174141878298	succinylcarnitine measurement (elderly offspring)	5e-14	37118062
rs4295766	rs2254230	0.702174141878298	succinylcarnitine measurement (advanced age)	3e-07	37118062
rs4296866	rs2842611	0.745821147239061	High density lipoprotein cholesterol levels	5e-09	34887591
rs4296866	rs1173416	0.603830027116689	Height	2e-59	36224396
rs4301345	rs4304220	0.834640271016584	Height	2e-14	36224396
rs4301345	rs4355658	0.786993141336451	Height	3e-13	36224396
rs4302451	rs4302451	1	Eosinophil counts	2e-09	30595370
rs4302451	rs6535419	0.762580229547809	Pulse pressure	6e-10	30578418
rs4302451	rs13111599	0.756622726673469	HDL cholesterol levels	3e-09	32203549
rs4302451	rs13111599	0.756622726673469	Apolipoprotein A1 levels	4e-08	32203549
rs4302451	rs2868708	0.746708567449369	Lymphocyte count	3e-11	34469753
rs4302451	rs2868708	0.746708567449369	White blood cell count	1e-09	30595370
rs4302451	rs6831339	0.743813141137588	High density lipoprotein cholesterol levels	9e-09	34887591
rs4302451	rs6823199	0.735303570658353	Pulse pressure	4e-14	30224653
rs4302451	rs116142917	0.683631520539143	Lymphocyte count	7e-18	32888494
rs4302451	rs35895091	0.647057500570835	Cardiovascular disease	1e-07	30595370
rs4302451	rs28528763	0.63375060552078	White blood cell count	7e-12	32888494
rs4304218	rs4304220	0.998388718845539	Height	2e-14	36224396
rs4304218	rs13232536	0.726056351724776	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4304218	rs4355658	0.702573861618576	Height	3e-13	36224396
rs4304218	rs13227841	0.613633321895856	Asthma	2e-09	32514122
rs4304220	rs4304220	1	Height	2e-14	36224396
rs4304220	rs13232536	0.726056351724776	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4304220	rs4355658	0.70394150402541	Height	3e-13	36224396
rs4304220	rs13227841	0.612367270032016	Asthma	2e-09	32514122
rs430827	rs38033	0.954487259458483	Blood protein levels	0	30072576
rs430827	rs27293	0.948763213491656	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs430827	rs27293	0.948763213491656	Diastolic blood pressure	3e-11	35762941
rs430827	rs1423357	0.936596973436343	General cognitive ability	9e-06	29844566
rs430827	rs2432142	0.92041367501069	Neutrophil count	2e-14	32888493
rs430827	rs2432142	0.92041367501069	White blood cell count	1e-11	32888493
rs430827	rs7705093	0.903140481710148	Birdshot chorioretinopathy	2e-09	24957906
rs430827	rs2910686	0.816850894455964	Neutrophil count	4e-14	32888493
rs430827	rs2910686	0.816850894455964	Psoriasis	2e-08	23143594
rs430827	rs2910686	0.816850894455964	Ankylosing spondylitis	5e-17	23749187
rs430827	rs2910686	0.816850894455964	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs430827	rs2927608	0.81366380606647	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs430827	rs2927608	0.81366380606647	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs430827	rs2927608	0.81366380606647	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs430827	rs38029	0.751555607761147	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs430827	rs2617439	0.727405306535228	Neutrophil count	8e-11	32888494
rs430827	rs2549797	0.724020642675219	Systolic blood pressure	7e-07	33230300
rs430827	rs2549797	0.724020642675219	Diastolic blood pressure	1e-14	33230300
rs430827	rs2549797	0.724020642675219	Diastolic blood pressure	3e-11	33230300
rs430827	rs2549797	0.724020642675219	Systolic blood pressure	4e-09	33230300
rs430827	rs2549782	0.722794788693438	Systolic blood pressure	6e-07	33230300
rs430827	rs2549782	0.722794788693438	Diastolic blood pressure	1e-14	33230300
rs430827	rs2549782	0.722794788693438	Diastolic blood pressure	3e-11	33230300
rs430827	rs2549782	0.722794788693438	Systolic blood pressure	5e-09	33230300
rs430827	rs1056893	0.722182683783247	Systolic blood pressure	1e-06	33230300
rs430827	rs1056893	0.722182683783247	Diastolic blood pressure	7e-15	33230300
rs430827	rs1056893	0.722182683783247	Diastolic blood pressure	2e-11	33230300
rs430827	rs1056893	0.722182683783247	Systolic blood pressure	7e-09	33230300
rs430827	rs2549794	0.719671021834109	Crohn's disease	1e-10	21102463
rs430827	rs2549794	0.719671021834109	Systolic blood pressure	1e-07	33230300
rs430827	rs2549794	0.719671021834109	Diastolic blood pressure	1e-15	33230300
rs430827	rs2549794	0.719671021834109	Diastolic blood pressure	2e-12	33230300
rs430827	rs2549794	0.719671021834109	Systolic blood pressure	4e-10	33230300
rs430827	rs1363907	0.715187830071534	Crohn's disease	4e-16	26192919
rs430827	rs1363907	0.715187830071534	Ulcerative colitis	4e-06	26192919
rs430827	rs1363907	0.715187830071534	Inflammatory bowel disease	5e-15	26192919
rs430827	rs1363907	0.715187830071534	Inflammatory bowel disease	6e-13	23128233
rs430827	rs1363907	0.715187830071534	Inflammatory bowel disease	1e-10	28067908
rs430827	rs1363907	0.715187830071534	Crohn's disease	1e-14	28067908
rs430827	rs716848	0.687711350555572	Neutrophil percentage of white cells	2e-09	32888494
rs430827	rs4869313	0.675643551828617	Pediatric autoimmune diseases	9e-08	26301688
rs430827	rs1559359	0.670492964722062	Diastolic blood pressure	7e-10	34594039
rs430827	rs2548532	0.644706364608214	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs430827	rs4869314	0.625382443630279	Arthritis (juvenile idiopathic)	3e-09	33106285
rs430827	rs4869314	0.625382443630279	Neutrophil count	1e-10	34594039
rs430827	rs4869314	0.625382443630279	White blood cell count	2e-07	30595370
rs4310765	rs1255908	0.690311029997725	PR interval	8e-14	32439900
rs4310765	rs1255908	0.690311029997725	PR interval	6e-14	32439900
rs4311854	rs6680628	0.799623200362637	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs4314544	rs4304220	0.865923752729569	Height	2e-14	36224396
rs4314544	rs4355658	0.816183611358124	Height	3e-13	36224396
rs4314544	rs13232536	0.612811176092629	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs43183	rs33321	0.84274621846216	Height	1e-19	34594039
rs43183	rs832540	0.787940734801972	Coronary artery disease	2e-08	29212778
rs43183	rs10061757	0.683564409627621	Height	4e-30	30595370
rs43183	rs33320	0.645391280897683	Height	9e-14	36224396
rs43183	rs2257505	0.643616516373991	Height	8e-192	36224396
rs4327742	rs4304220	0.914175340349584	Height	2e-14	36224396
rs4327742	rs13232536	0.714640672847638	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4327742	rs13227841	0.677156140639388	Asthma	2e-09	32514122
rs4327742	rs4355658	0.639023090261658	Height	3e-13	36224396
rs4329147	rs4329147	1	Childhood ear infection	1e-11	28928442
rs4329147	rs4329147	1	Childhood ear infection	1e-11	27182965
rs4329147	rs9270986	0.929036183433597	Myasthenia gravis	6e-08	25643325
rs4329147	rs9271055	0.923626201345709	Height	5e-09	36224396
rs4329147	rs9270984	0.920842191552064	Systemic lupus erythematosus	5e-24	23273568
rs4329147	rs1966002	0.918285814266541	Systemic lupus erythematosus	8e-31	33272962
rs4329147	rs9271082	0.903961104411883	IgA nephropathy	8e-09	34076728
rs4329147	rs4367411	0.863508144303131	Total omega-3 fatty acid levels	7e-09	35692035
rs4329147	rs9271025	0.823404641000422	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs4329147	rs9271366	0.789097537251532	Ulcerative colitis	7e-06	26278503
rs4329147	rs9271366	0.789097537251532	Multiple sclerosis	7e-184	19525955
rs4329147	rs9271366	0.789097537251532	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs4329147	rs9271366	0.789097537251532	Ulcerative colitis	1e-18	23511034
rs4329147	rs9271366	0.789097537251532	Immunoglobulin A	3e-33	20694011
rs4329147	rs9271366	0.789097537251532	Multiple sclerosis	4e-17	20598377
rs4329147	rs9271366	0.789097537251532	Crohn's disease	5e-12	23850713
rs4329147	rs9271366	0.789097537251532	Systemic lupus erythematosus	1e-07	19838195
rs4329147	rs3129757	0.789072698840297	Cathepsin L1 levels	9e-17	33067605
rs4329147	rs3129762	0.783845838847991	Butyrophilin-like protein 9 levels	1e-51	34648354
rs4329147	rs3135005	0.729384871174091	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs4329147	rs9271147	0.673628966516459	Albumin levels	2e-15	36329257
rs4329147	rs9270539	0.628775105942701	Systemic lupus erythematosus	4e-36	34076728
rs4329147	rs745475218	0.614544303430073	Allergen component sensitization (Hevea brasiliensis 8)	3e-08	37780799
rs4329147	rs9271100	0.613770082719941	Systemic lupus erythematosus	1e-12	19838193
rs4329147	rs9271100	0.613770082719941	Ulcerative colitis	2e-94	26192919
rs4329147	rs9271100	0.613770082719941	Leprosy	8e-95	25642632
rs4329147	rs9271170	0.611433232556102	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs4329147	rs9271192	0.610039431853943	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs4329147	rs9271192	0.610039431853943	Alzheimer's disease	5e-07	31473137
rs4329147	rs9271192	0.610039431853943	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs4329147	rs9271192	0.610039431853943	Alzheimer's disease (late onset)	3e-12	24162737
rs4329147	rs9271192	0.610039431853943	Alzheimer's disease (late onset)	5e-07	30617256
rs4329147	rs9271060	0.606467255921726	Crohn's disease	1e-22	26891255
rs4329147	rs9270970	0.605659630066846	Systemic lupus erythematosus	4e-26	32771030
rs4329147	rs9271536	0.603457102353212	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs4329147	rs9271536	0.603457102353212	SSC-A on CD4+ T cell	9e-14	32929287
rs4329147	rs9271536	0.603457102353212	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs4329147	rs9271536	0.603457102353212	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs4329147	rs9271536	0.603457102353212	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs4329147	rs9271536	0.603457102353212	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs4329147	rs9271429	0.601556066109227	Systemic lupus erythematosus	2e-11	34076728
rs4333464	rs4304220	0.865923752729569	Height	2e-14	36224396
rs4333464	rs4355658	0.816183611358124	Height	3e-13	36224396
rs4333464	rs13232536	0.612811176092629	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4334152	rs7999758	0.996404398207632	Height	6e-17	30595370
rs4334152	rs6563739	0.995507991824923	Menarche (age at onset)	2e-11	25231870
rs4334152	rs4598779	0.919101183993816	Height	7e-77	36224396
rs4338088	rs4413755	0.780186810298536	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs4339119	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs4339119	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs4339119	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs4339119	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs4339119	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs4339119	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs4339119	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs4339119	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs4339119	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs4339119	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs4339119	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs4339119	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs4339119	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs4339119	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs4339119	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs4339119	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs4339119	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs4339119	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs4339119	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs4339119	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs4339119	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs4339119	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs4339119	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs4339119	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs4339119	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs4339119	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs4340343	rs11863150	0.787975208280614	Height	2e-11	36224396
rs4340343	rs6565180	0.739430805137803	Tonsillectomy	5e-07	28928442
rs4340343	rs7404371	0.638379247847514	Common executive function	2e-08	36150907
rs4341060	rs4304220	0.796142307175126	Height	2e-14	36224396
rs4341060	rs4355658	0.744922943039292	Height	3e-13	36224396
rs4341060	rs13232536	0.61045519185812	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4348284	rs2842611	0.995969897807807	High density lipoprotein cholesterol levels	5e-09	34887591
rs4348284	rs1173416	0.840029172779929	Height	2e-59	36224396
rs4348284	rs9450288	0.815643277636195	Height	2e-10	36224396
rs4353250	rs4353250	1	Insulin-like growth factor 1 levels	2e-14	33462484
rs4353250	rs4353250	1	Amyloid A serum levels	2e-51	21124955
rs4353250	rs4150575	0.635991214392597	Imidazole lactate levels	1e-10	36635386
rs4354168	rs1934534	0.995943802333407	Pain (pleiotropy)	2e-08	37844115
rs4354168	rs1934534	0.995943802333407	Pain (pleiotropy)	2e-06	37844115
rs4354168	rs4380763	0.995132686451715	Subcortical volume (min-P)	1e-11	32665545
rs4354168	rs11155671	0.97659396614931	Testicular germ cell tumor	2e-09	28604728
rs4354168	rs80147756	0.951496023466008	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4354168	rs4421206	0.943958752189012	Brain morphology (min-P)	4e-11	32665545
rs4354168	rs9505982	0.925715085985985	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4354168	rs9688452	0.919154111492971	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4354168	rs9688452	0.919154111492971	aseg lh volume VentralDC	2e-10	33875891
rs4354168	rs10872649	0.873158559317697	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4354168	rs10872649	0.873158559317697	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4354168	rs10872649	0.873158559317697	Right hippocampal volume (body)	1e-10	37337106
rs4354168	rs7752089	0.830670694342513	Brain morphology (MOSTest)	2e-31	35164939
rs4354168	rs9322194	0.788072847625652	Brainstem volume	2e-11	31636452
rs4354168	rs9285521	0.672760498787248	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4354168	rs12526675	0.657859857503892	Brain morphology (MOSTest)	7e-22	32665545
rs4354168	rs9688809	0.645625250136627	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4354168	rs10872645	0.64314301757417	Blood protein levels	2e-86	30072576
rs4354168	rs34337297	0.642563770015394	Serum levels of protein LRP11	3e-161	35078996
rs4354168	rs14314	0.640729689186696	Macular thickness	3e-19	30535121
rs4354168	rs14314	0.640729689186696	Vertex-wise sulcal depth	7e-17	34910505
rs4354168	rs14314	0.640729689186696	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4354168	rs14314	0.640729689186696	Left hippocampal volume (body)	7e-15	37337106
rs4354168	rs14314	0.640729689186696	Left subiculum volume (body)	1e-14	37337106
rs4354168	rs55763431	0.640403803996752	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4354168	rs9689694	0.639247301814976	Right hippocampal volume (head)	6e-11	37337106
rs4354168	rs9689694	0.639247301814976	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4354168	rs9689694	0.639247301814976	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4354168	rs9689694	0.639247301814976	Left hippocampal volume (head)	6e-12	37337106
rs4354168	rs9383843	0.637880711649535	Migraine	1e-09	35115687
rs4354168	rs2095375	0.637303391355156	Serum metabolite levels	1e-20	33031748
rs4354168	rs2095375	0.637303391355156	Serum metabolite levels	1e-20	33031748
rs4354168	rs10872653	0.634997560039998	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4354168	rs9688867	0.633337489473293	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4354168	rs9688867	0.633337489473293	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4354168	rs2342764	0.616763325468598	Cortical thickness	1e-08	34560273
rs4354168	rs9322193	0.614263491923918	Lung cancer	1e-07	27393504
rs4355413	rs10222974	0.72280437695314	Height	3e-07	36224396
rs4355658	rs4355658	1	Height	3e-13	36224396
rs4355658	rs13232536	0.748907207177926	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4355658	rs4304220	0.70394150402541	Height	2e-14	36224396
rs4355658	rs12539962	0.678489443385138	Colorectal cancer	3e-08	36539618
rs4358485	rs9292122	0.87097449095133	Prostate cancer	5e-09	33398198
rs4358485	rs702689	0.700571981347732	Vertex-wise sulcal depth	2e-22	34910505
rs4358800	rs4872007	0.935890479042534	Superior temporal gyrus volume	8e-06	31530798
rs4358800	rs746011	0.765984806726814	Triglycerides	2e-10	30275531
rs4358800	rs11781149	0.745822983654966	Refractive error	2e-17	32231278
rs4358800	rs2280104	0.745189989530267	Parkinson's disease	3e-08	28892059
rs4358800	rs2280104	0.745189989530267	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs4358800	rs2280104	0.745189989530267	Serum total protein level	3e-12	34594039
rs4358800	rs4242434	0.709004585296711	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs4358800	rs1545837	0.68477278581502	Lung function (FVC)	1e-10	30595370
rs4360063	rs1423357	0.994959466688381	General cognitive ability	9e-06	29844566
rs4360063	rs2432142	0.981574195517426	Neutrophil count	2e-14	32888493
rs4360063	rs2432142	0.981574195517426	White blood cell count	1e-11	32888493
rs4360063	rs38033	0.978393831694969	Blood protein levels	0	30072576
rs4360063	rs27293	0.957711152076847	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs4360063	rs27293	0.957711152076847	Diastolic blood pressure	3e-11	35762941
rs4360063	rs7705093	0.952440391942808	Birdshot chorioretinopathy	2e-09	24957906
rs4360063	rs2910686	0.867189817239639	Neutrophil count	4e-14	32888493
rs4360063	rs2910686	0.867189817239639	Psoriasis	2e-08	23143594
rs4360063	rs2910686	0.867189817239639	Ankylosing spondylitis	5e-17	23749187
rs4360063	rs2910686	0.867189817239639	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs4360063	rs2927608	0.863874032408933	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs4360063	rs2927608	0.863874032408933	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs4360063	rs2927608	0.863874032408933	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs4360063	rs2617439	0.780691283683259	Neutrophil count	8e-11	32888494
rs4360063	rs2549797	0.772081308973134	Systolic blood pressure	7e-07	33230300
rs4360063	rs2549797	0.772081308973134	Diastolic blood pressure	1e-14	33230300
rs4360063	rs2549797	0.772081308973134	Diastolic blood pressure	3e-11	33230300
rs4360063	rs2549797	0.772081308973134	Systolic blood pressure	4e-09	33230300
rs4360063	rs2549782	0.770824965070256	Systolic blood pressure	6e-07	33230300
rs4360063	rs2549782	0.770824965070256	Diastolic blood pressure	1e-14	33230300
rs4360063	rs2549782	0.770824965070256	Diastolic blood pressure	3e-11	33230300
rs4360063	rs2549782	0.770824965070256	Systolic blood pressure	5e-09	33230300
rs4360063	rs1056893	0.770197634817831	Systolic blood pressure	1e-06	33230300
rs4360063	rs1056893	0.770197634817831	Diastolic blood pressure	7e-15	33230300
rs4360063	rs1056893	0.770197634817831	Diastolic blood pressure	2e-11	33230300
rs4360063	rs1056893	0.770197634817831	Systolic blood pressure	7e-09	33230300
rs4360063	rs2549794	0.766616393906736	Crohn's disease	1e-10	21102463
rs4360063	rs2549794	0.766616393906736	Systolic blood pressure	1e-07	33230300
rs4360063	rs2549794	0.766616393906736	Diastolic blood pressure	1e-15	33230300
rs4360063	rs2549794	0.766616393906736	Diastolic blood pressure	2e-12	33230300
rs4360063	rs2549794	0.766616393906736	Systolic blood pressure	4e-10	33230300
rs4360063	rs38029	0.764393235137417	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs4360063	rs1363907	0.761981873378018	Crohn's disease	4e-16	26192919
rs4360063	rs1363907	0.761981873378018	Ulcerative colitis	4e-06	26192919
rs4360063	rs1363907	0.761981873378018	Inflammatory bowel disease	5e-15	26192919
rs4360063	rs1363907	0.761981873378018	Inflammatory bowel disease	6e-13	23128233
rs4360063	rs1363907	0.761981873378018	Inflammatory bowel disease	1e-10	28067908
rs4360063	rs1363907	0.761981873378018	Crohn's disease	1e-14	28067908
rs4360063	rs716848	0.73363825375351	Neutrophil percentage of white cells	2e-09	32888494
rs4360063	rs4869313	0.720701421312081	Pediatric autoimmune diseases	9e-08	26301688
rs4360063	rs1559359	0.714579417578003	Diastolic blood pressure	7e-10	34594039
rs4360063	rs2548532	0.688747512472099	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs4360063	rs4869314	0.667760578780539	Arthritis (juvenile idiopathic)	3e-09	33106285
rs4360063	rs4869314	0.667760578780539	Neutrophil count	1e-10	34594039
rs4360063	rs4869314	0.667760578780539	White blood cell count	2e-07	30595370
rs4360063	rs1974871	0.641149468221397	Granulysin levels	5e-13	34648354
rs4360063	rs1019503	0.63717437660129	Systolic blood pressure	2e-06	33230300
rs4360063	rs1019503	0.63717437660129	Diastolic blood pressure	2e-14	33230300
rs4360063	rs1019503	0.63717437660129	Diastolic blood pressure	4e-11	33230300
rs4360063	rs1019503	0.63717437660129	Systolic blood pressure	1e-08	33230300
rs4360063	rs27660	0.634912571232083	Coronary artery disease	3e-08	35915156
rs4360063	rs3096168	0.629753205081647	Aspartate aminotransferase levels	8e-12	33547301
rs4360814	rs9590228	0.995828693373021	Height	7e-22	36224396
rs4360814	rs8002180	0.941780130302216	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs4360814	rs9524869	0.731587616275879	Serum metabolite levels	6e-32	33031748
rs4360814	rs9524869	0.731587616275879	N-acetylcarnosine levels	1e-42	35347128
rs4360814	rs9524869	0.731587616275879	N-acetylcarnosine levels	9e-47	35050183
rs4360814	rs9524869	0.731587616275879	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs4360814	rs9524869	0.731587616275879	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs4360814	rs9524869	0.731587616275879	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs4360814	rs9524869	0.731587616275879	N-acetylcarnosine levels	2e-60	36635386
rs4367411	rs4367411	1	Total omega-3 fatty acid levels	7e-09	35692035
rs4367411	rs9270984	0.896654740917682	Systemic lupus erythematosus	5e-24	23273568
rs4367411	rs9271055	0.894058393071526	Height	5e-09	36224396
rs4367411	rs9270986	0.894056437872953	Myasthenia gravis	6e-08	25643325
rs4367411	rs1966002	0.886349000069599	Systemic lupus erythematosus	8e-31	33272962
rs4367411	rs9271082	0.882551546784798	IgA nephropathy	8e-09	34076728
rs4367411	rs4329147	0.863508144303131	Childhood ear infection	1e-11	28928442
rs4367411	rs4329147	0.863508144303131	Childhood ear infection	1e-11	27182965
rs4367411	rs9271025	0.83285222145967	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs4367411	rs9271366	0.760296454799756	Ulcerative colitis	7e-06	26278503
rs4367411	rs9271366	0.760296454799756	Multiple sclerosis	7e-184	19525955
rs4367411	rs9271366	0.760296454799756	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs4367411	rs9271366	0.760296454799756	Ulcerative colitis	1e-18	23511034
rs4367411	rs9271366	0.760296454799756	Immunoglobulin A	3e-33	20694011
rs4367411	rs9271366	0.760296454799756	Multiple sclerosis	4e-17	20598377
rs4367411	rs9271366	0.760296454799756	Crohn's disease	5e-12	23850713
rs4367411	rs9271366	0.760296454799756	Systemic lupus erythematosus	1e-07	19838195
rs4367411	rs3129757	0.757705642201261	Cathepsin L1 levels	9e-17	33067605
rs4367411	rs3129762	0.75269186673833	Butyrophilin-like protein 9 levels	1e-51	34648354
rs4367411	rs3135005	0.718316283062517	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs4367411	rs9271147	0.659210917510946	Albumin levels	2e-15	36329257
rs4377286	rs12620999	0.906235792128452	Systemic lupus erythematosus	3e-06	19838195
rs4380763	rs4380763	1	Subcortical volume (min-P)	1e-11	32665545
rs4380763	rs1934534	0.995942064195752	Pain (pleiotropy)	2e-08	37844115
rs4380763	rs1934534	0.995942064195752	Pain (pleiotropy)	2e-06	37844115
rs4380763	rs11155671	0.978201220405314	Testicular germ cell tumor	2e-09	28604728
rs4380763	rs80147756	0.953102562204467	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4380763	rs4421206	0.948721367236895	Brain morphology (min-P)	4e-11	32665545
rs4380763	rs9505982	0.927300997774675	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4380763	rs9688452	0.919166718077943	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4380763	rs9688452	0.919166718077943	aseg lh volume VentralDC	2e-10	33875891
rs4380763	rs10872649	0.87471767800093	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4380763	rs10872649	0.87471767800093	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4380763	rs10872649	0.87471767800093	Right hippocampal volume (body)	1e-10	37337106
rs4380763	rs7752089	0.832224857758033	Brain morphology (MOSTest)	2e-31	35164939
rs4380763	rs9322194	0.785342218375748	Brainstem volume	2e-11	31636452
rs4380763	rs9285521	0.670293565444463	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4380763	rs12526675	0.655477989553322	Brain morphology (MOSTest)	7e-22	32665545
rs4380763	rs9688809	0.646677928573052	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4380763	rs34337297	0.64498216887593	Serum levels of protein LRP11	3e-161	35078996
rs4380763	rs10872645	0.642818118026562	Blood protein levels	2e-86	30072576
rs4380763	rs14314	0.64177827340696	Macular thickness	3e-19	30535121
rs4380763	rs14314	0.64177827340696	Vertex-wise sulcal depth	7e-17	34910505
rs4380763	rs14314	0.64177827340696	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4380763	rs14314	0.64177827340696	Left hippocampal volume (body)	7e-15	37337106
rs4380763	rs14314	0.64177827340696	Left subiculum volume (body)	1e-14	37337106
rs4380763	rs55763431	0.641447984668751	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4380763	rs9689694	0.640289600310425	Right hippocampal volume (head)	6e-11	37337106
rs4380763	rs9689694	0.640289600310425	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4380763	rs9689694	0.640289600310425	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4380763	rs9689694	0.640289600310425	Left hippocampal volume (head)	6e-12	37337106
rs4380763	rs9383843	0.638921753913664	Migraine	1e-09	35115687
rs4380763	rs2095375	0.638343493751961	Serum metabolite levels	1e-20	33031748
rs4380763	rs2095375	0.638343493751961	Serum metabolite levels	1e-20	33031748
rs4380763	rs10872653	0.636033908583699	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4380763	rs9688867	0.634378835328062	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4380763	rs9688867	0.634378835328062	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4380763	rs9322193	0.615290697365256	Lung cancer	1e-07	27393504
rs4380763	rs2342764	0.614480969266673	Cortical thickness	1e-08	34560273
rs4385671	rs6680628	0.79612670233665	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs4394010	rs7655841	0.91457566169595	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs4394010	rs337277	0.814664007000361	Metabolite peak levels (QI10992)	3e-52	35995766
rs4394010	rs337277	0.814664007000361	Metabolite peak levels (QI4667)	7e-18	35995766
rs4394010	rs337277	0.814664007000361	Metabolite peak levels (QI4708)	1e-21	35995766
rs4394010	rs337277	0.814664007000361	Metabolite peak levels (QI5169)	7e-57	35995766
rs4394010	rs10010659	0.627157210313849	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs4399910	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs4399910	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs4399910	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs4399910	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs4399910	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs4399910	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs4399910	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs4399910	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs4399910	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs4399910	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs4399910	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs4399910	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs4399910	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs4399910	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs4399910	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs4399910	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs4399910	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs4399910	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs4399910	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs4399910	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs4399910	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs4399910	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs4399910	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs4399910	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs4399910	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs4399910	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs4408676	rs12620999	0.907052659167795	Systemic lupus erythematosus	3e-06	19838195
rs4413756	rs4413755	0.922156641231741	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs4424789	rs4424789	1	Periostin levels	2e-19	34648354
rs4424789	rs9603222	0.81783398008739	Blood protein levels	2e-12	30072576
rs4431401	rs2842611	0.897730641058714	High density lipoprotein cholesterol levels	5e-09	34887591
rs4431401	rs1173416	0.871037000491495	Height	2e-59	36224396
rs4431401	rs9450288	0.84936635413784	Height	2e-10	36224396
rs4434603	rs4413755	0.879197211874076	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs4440516	rs13232536	0.876649519798329	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4440516	rs4355658	0.840768482804115	Height	3e-13	36224396
rs4440516	rs4304220	0.818030830841612	Height	2e-14	36224396
rs4440516	rs7806956	0.6322206095791	Esophageal squamous cell carcinoma	3e-07	37673066
rs444309	rs38033	0.954487259458483	Blood protein levels	0	30072576
rs444309	rs27293	0.948763213491656	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs444309	rs27293	0.948763213491656	Diastolic blood pressure	3e-11	35762941
rs444309	rs1423357	0.936596973436343	General cognitive ability	9e-06	29844566
rs444309	rs2432142	0.92041367501069	Neutrophil count	2e-14	32888493
rs444309	rs2432142	0.92041367501069	White blood cell count	1e-11	32888493
rs444309	rs7705093	0.903140481710148	Birdshot chorioretinopathy	2e-09	24957906
rs444309	rs2910686	0.816850894455964	Neutrophil count	4e-14	32888493
rs444309	rs2910686	0.816850894455964	Psoriasis	2e-08	23143594
rs444309	rs2910686	0.816850894455964	Ankylosing spondylitis	5e-17	23749187
rs444309	rs2910686	0.816850894455964	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs444309	rs2927608	0.81366380606647	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs444309	rs2927608	0.81366380606647	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs444309	rs2927608	0.81366380606647	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs444309	rs38029	0.751555607761147	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs444309	rs2617439	0.727405306535228	Neutrophil count	8e-11	32888494
rs444309	rs2549797	0.724020642675219	Systolic blood pressure	7e-07	33230300
rs444309	rs2549797	0.724020642675219	Diastolic blood pressure	1e-14	33230300
rs444309	rs2549797	0.724020642675219	Diastolic blood pressure	3e-11	33230300
rs444309	rs2549797	0.724020642675219	Systolic blood pressure	4e-09	33230300
rs444309	rs2549782	0.722794788693438	Systolic blood pressure	6e-07	33230300
rs444309	rs2549782	0.722794788693438	Diastolic blood pressure	1e-14	33230300
rs444309	rs2549782	0.722794788693438	Diastolic blood pressure	3e-11	33230300
rs444309	rs2549782	0.722794788693438	Systolic blood pressure	5e-09	33230300
rs444309	rs1056893	0.722182683783247	Systolic blood pressure	1e-06	33230300
rs444309	rs1056893	0.722182683783247	Diastolic blood pressure	7e-15	33230300
rs444309	rs1056893	0.722182683783247	Diastolic blood pressure	2e-11	33230300
rs444309	rs1056893	0.722182683783247	Systolic blood pressure	7e-09	33230300
rs444309	rs2549794	0.719671021834109	Crohn's disease	1e-10	21102463
rs444309	rs2549794	0.719671021834109	Systolic blood pressure	1e-07	33230300
rs444309	rs2549794	0.719671021834109	Diastolic blood pressure	1e-15	33230300
rs444309	rs2549794	0.719671021834109	Diastolic blood pressure	2e-12	33230300
rs444309	rs2549794	0.719671021834109	Systolic blood pressure	4e-10	33230300
rs444309	rs1363907	0.715187830071534	Crohn's disease	4e-16	26192919
rs444309	rs1363907	0.715187830071534	Ulcerative colitis	4e-06	26192919
rs444309	rs1363907	0.715187830071534	Inflammatory bowel disease	5e-15	26192919
rs444309	rs1363907	0.715187830071534	Inflammatory bowel disease	6e-13	23128233
rs444309	rs1363907	0.715187830071534	Inflammatory bowel disease	1e-10	28067908
rs444309	rs1363907	0.715187830071534	Crohn's disease	1e-14	28067908
rs444309	rs716848	0.687711350555572	Neutrophil percentage of white cells	2e-09	32888494
rs444309	rs4869313	0.675643551828617	Pediatric autoimmune diseases	9e-08	26301688
rs444309	rs1559359	0.670492964722062	Diastolic blood pressure	7e-10	34594039
rs444309	rs2548532	0.644706364608214	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs444309	rs4869314	0.625382443630279	Arthritis (juvenile idiopathic)	3e-09	33106285
rs444309	rs4869314	0.625382443630279	Neutrophil count	1e-10	34594039
rs444309	rs4869314	0.625382443630279	White blood cell count	2e-07	30595370
rs4448355	rs9299199	0.973356270713027	Height	9e-24	36224396
rs4448355	rs9299199	0.973356270713027	Height	1e-06	36224396
rs4448355	rs7858562	0.616501120999104	Height	4e-07	31562340
rs4448355	rs10441737	0.606241180362255	Menarche (age at onset)	4e-15	23599027
rs445294	rs337277	0.979380786677887	Metabolite peak levels (QI10992)	3e-52	35995766
rs445294	rs337277	0.979380786677887	Metabolite peak levels (QI4667)	7e-18	35995766
rs445294	rs337277	0.979380786677887	Metabolite peak levels (QI4708)	1e-21	35995766
rs445294	rs337277	0.979380786677887	Metabolite peak levels (QI5169)	7e-57	35995766
rs445294	rs7655841	0.754384841661933	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs4455682	rs1934534	0.997564059997432	Pain (pleiotropy)	2e-08	37844115
rs4455682	rs1934534	0.997564059997432	Pain (pleiotropy)	2e-06	37844115
rs4455682	rs4380763	0.996753348768678	Subcortical volume (min-P)	1e-11	32665545
rs4455682	rs11155671	0.978204174624377	Testicular germ cell tumor	2e-09	28604728
rs4455682	rs80147756	0.953128545173021	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4455682	rs4421206	0.945604939088439	Brain morphology (min-P)	4e-11	32665545
rs4455682	rs9505982	0.927328365366758	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4455682	rs9688452	0.920736519418401	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4455682	rs9688452	0.920736519418401	aseg lh volume VentralDC	2e-10	33875891
rs4455682	rs10872649	0.874765724489718	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4455682	rs10872649	0.874765724489718	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4455682	rs10872649	0.874765724489718	Right hippocampal volume (body)	1e-10	37337106
rs4455682	rs7752089	0.832308216900515	Brain morphology (MOSTest)	2e-31	35164939
rs4455682	rs9322194	0.785471589376143	Brainstem volume	2e-11	31636452
rs4455682	rs9285521	0.670469036762165	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4455682	rs12526675	0.655715949137713	Brain morphology (MOSTest)	7e-22	32665545
rs4455682	rs9688809	0.64773253853613	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4455682	rs10872645	0.645238329221999	Blood protein levels	2e-86	30072576
rs4455682	rs34337297	0.644657195687723	Serum levels of protein LRP11	3e-161	35078996
rs4455682	rs14314	0.642828781670817	Macular thickness	3e-19	30535121
rs4455682	rs14314	0.642828781670817	Vertex-wise sulcal depth	7e-17	34910505
rs4455682	rs14314	0.642828781670817	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4455682	rs14314	0.642828781670817	Left hippocampal volume (body)	7e-15	37337106
rs4455682	rs14314	0.642828781670817	Left subiculum volume (body)	1e-14	37337106
rs4455682	rs55763431	0.642494081275194	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4455682	rs9689694	0.641333811286787	Right hippocampal volume (head)	6e-11	37337106
rs4455682	rs9689694	0.641333811286787	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4455682	rs9689694	0.641333811286787	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4455682	rs9689694	0.641333811286787	Left hippocampal volume (head)	6e-12	37337106
rs4455682	rs9383843	0.639964706358834	Migraine	1e-09	35115687
rs4455682	rs2095375	0.639385504605282	Serum metabolite levels	1e-20	33031748
rs4455682	rs2095375	0.639385504605282	Serum metabolite levels	1e-20	33031748
rs4455682	rs10872653	0.637072158696129	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4455682	rs9688867	0.635422092014558	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4455682	rs9688867	0.635422092014558	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4455682	rs9322193	0.616319788244154	Lung cancer	1e-07	27393504
rs4455682	rs2342764	0.614741395813369	Cortical thickness	1e-08	34560273
rs4458741	rs4304220	0.867438084559385	Height	2e-14	36224396
rs4458741	rs4355658	0.817671094799672	Height	3e-13	36224396
rs4458741	rs13232536	0.612811176092629	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4460244	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs4460244	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs4460244	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs4460244	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs4460244	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs4460244	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs4460244	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs4460244	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs4460244	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs4460244	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs4460244	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs4460244	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs4460244	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs4460244	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs4460244	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs4460244	rs13437082	0.631513452560533	Height	5e-08	19343178
rs4460244	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs4460245	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs4460245	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs4460245	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs4460245	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs4460245	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs4460245	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs4460245	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs4460245	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs4460245	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs4460245	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs4460245	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs4460245	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs4460245	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs4460245	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs4460245	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs4460245	rs13437082	0.631513452560533	Height	5e-08	19343178
rs4460245	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs4464937	rs6471393	0.607696582165483	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs4466058	rs7655841	0.879969768057429	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs4466058	rs337277	0.842829820857088	Metabolite peak levels (QI10992)	3e-52	35995766
rs4466058	rs337277	0.842829820857088	Metabolite peak levels (QI4667)	7e-18	35995766
rs4466058	rs337277	0.842829820857088	Metabolite peak levels (QI4708)	1e-21	35995766
rs4466058	rs337277	0.842829820857088	Metabolite peak levels (QI5169)	7e-57	35995766
rs4466058	rs10010659	0.603026222772903	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs4473910	rs4304220	0.867347575367006	Height	2e-14	36224396
rs4473910	rs4355658	0.817717373306373	Height	3e-13	36224396
rs4473910	rs13232536	0.614041555744898	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4473910	rs12539962	0.601093864378622	Colorectal cancer	3e-08	36539618
rs4478449	rs9270984	0.881956000437201	Systemic lupus erythematosus	5e-24	23273568
rs4478449	rs9271055	0.874303119746396	Height	5e-09	36224396
rs4478449	rs9270986	0.874287305406891	Myasthenia gravis	6e-08	25643325
rs4478449	rs9271082	0.867977198904617	IgA nephropathy	8e-09	34076728
rs4478449	rs1966002	0.866739174347133	Systemic lupus erythematosus	8e-31	33272962
rs4478449	rs4367411	0.863988756513225	Total omega-3 fatty acid levels	7e-09	35692035
rs4478449	rs4329147	0.846767068095666	Childhood ear infection	1e-11	28928442
rs4478449	rs4329147	0.846767068095666	Childhood ear infection	1e-11	27182965
rs4478449	rs9271025	0.811303086155576	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs4478449	rs9271366	0.743856711616552	Ulcerative colitis	7e-06	26278503
rs4478449	rs9271366	0.743856711616552	Multiple sclerosis	7e-184	19525955
rs4478449	rs9271366	0.743856711616552	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs4478449	rs9271366	0.743856711616552	Ulcerative colitis	1e-18	23511034
rs4478449	rs9271366	0.743856711616552	Immunoglobulin A	3e-33	20694011
rs4478449	rs9271366	0.743856711616552	Multiple sclerosis	4e-17	20598377
rs4478449	rs9271366	0.743856711616552	Crohn's disease	5e-12	23850713
rs4478449	rs9271366	0.743856711616552	Systemic lupus erythematosus	1e-07	19838195
rs4478449	rs3129757	0.741300437856395	Cathepsin L1 levels	9e-17	33067605
rs4478449	rs3129762	0.736380124441599	Butyrophilin-like protein 9 levels	1e-51	34648354
rs4478449	rs3135005	0.695338578628459	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs4478449	rs9271147	0.635586712344567	Albumin levels	2e-15	36329257
rs4484569	rs4304220	0.867347575367006	Height	2e-14	36224396
rs4484569	rs4355658	0.817717373306373	Height	3e-13	36224396
rs4484569	rs13232536	0.614041555744898	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4484569	rs12539962	0.601093864378622	Colorectal cancer	3e-08	36539618
rs4485233	rs4598779	0.963657866221082	Height	7e-77	36224396
rs4485233	rs6563739	0.952851430863215	Menarche (age at onset)	2e-11	25231870
rs4485233	rs7999758	0.951992629839857	Height	6e-17	30595370
rs4488133	rs4488133	1	Serum metabolite levels	2e-281	23093944
rs4488133	rs4488133	1	Serum metabolite levels	1e-27	23093944
rs4488133	rs4488133	1	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs4488133	rs4488133	1	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs4488133	rs4488133	1	Urine X-12112 levels in chronic kidney disease	0	37277652
rs4488133	rs4488133	1	X-12093 levels	1e-48	24816252
rs4488133	rs4488133	1	X-12092 levels	0	24816252
rs4488133	rs7072216	0.995026291800485	Metabolite levels	8e-15	21931564
rs4488133	rs7072216	0.995026291800485	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs4488133	rs10883083	0.981812255561224	N2-acetyl,N6-methyllysine levels	0	35347128
rs4488133	rs10883083	0.981812255561224	X-12112 levels	0	35347128
rs4488133	rs10883083	0.981812255561224	Arginine levels	1e-16	35347128
rs4488133	rs10883083	0.981812255561224	Metabolite peak levels (QI8972)	2e-124	35995766
rs4488133	rs10883083	0.981812255561224	Metabolite peak levels (QI5171)	8e-96	35995766
rs4488133	rs2147896	0.981812255561224	Urinary metabolites (H-NMR features)	3e-164	24586186
rs4488133	rs2147896	0.981812255561224	Urinary metabolites (H-NMR features)	8e-30	24586186
rs4488133	rs2147896	0.981812255561224	Urinary metabolites (H-NMR features)	2e-55	24586186
rs4488133	rs2147896	0.981812255561224	Urinary metabolites (H-NMR features)	6e-19	24586186
rs4488133	rs2147896	0.981812255561224	Urinary metabolites (H-NMR features)	4e-34	24586186
rs4488133	rs2147896	0.981812255561224	Trimethylamine levels	4e-144	33283231
rs4488133	rs2147896	0.981812255561224	Serum metabolite levels	1e-15	33031748
rs4488133	rs2147896	0.981812255561224	Serum metabolite levels	4e-226	33031748
rs4488133	rs2147896	0.981812255561224	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs4488133	rs2147896	0.981812255561224	Urinary metabolite levels in chronic kidney disease	0	31959995
rs4488133	rs2147896	0.981812255561224	Urinary metabolite levels in chronic kidney disease	0	31959995
rs4488133	rs2147896	0.981812255561224	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs4488133	rs2147896	0.981812255561224	N6-methyllysine levels	3e-198	33437055
rs4488133	rs2147896	0.981812255561224	N6-methyllysine levels	0	35347128
rs4488133	rs2147896	0.981812255561224	N-methylpipecolate levels	0	35050183
rs4488133	rs2147896	0.981812255561224	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs4488133	rs2147896	0.981812255561224	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs4488133	rs2147896	0.981812255561224	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs4488133	rs2147896	0.981812255561224	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs4488133	rs2147896	0.981812255561224	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs4488133	rs2147896	0.981812255561224	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs4488133	rs2147896	0.981812255561224	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs4488133	rs2147896	0.981812255561224	X-12092 levels	4e-191	27073872
rs4488133	rs2147896	0.981812255561224	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs4488133	rs2147896	0.981812255561224	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs4488133	rs2147896	0.981812255561224	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs4488133	rs2147896	0.981812255561224	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs4488133	rs2147896	0.981812255561224	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs4488133	rs2147896	0.981812255561224	N6-methyllysine levels (advanced age)	5e-25	37118062
rs4488133	rs2147896	0.981812255561224	X-12112 levels	0	36635386
rs4488133	rs2147896	0.981812255561224	N6-methyllysine levels	0	36635386
rs4488133	rs2147896	0.981812255561224	N6,N6-dimethyllysine levels	0	36635386
rs4488133	rs2147896	0.981812255561224	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs4488133	rs2147896	0.981812255561224	N2-acetyl,N6-methyllysine levels	0	36635386
rs4488133	rs10786415	0.981812255561224	N6,N6-dimethyllysine levels	0	35347128
rs4488133	rs10786415	0.981812255561224	N-methylpipecolate levels	0	35347128
rs4488133	rs10786415	0.981812255561224	X-25810 levels	4e-11	36635386
rs4488133	rs942814	0.981812255561224	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs4488133	rs4539242	0.980987040331281	Urinary metabolites (H-NMR features)	2e-20	24586186
rs4488133	rs4539242	0.980987040331281	X-24809 levels	4e-67	33177712
rs4488133	rs4539242	0.980987040331281	X-24983 levels	8e-59	33177712
rs4488133	rs4539242	0.980987040331281	X-12112 levels	4e-63	33177712
rs4488133	rs4539242	0.980987040331281	N-methylpipecolate levels	3e-12	33177712
rs4488133	rs4539242	0.980987040331281	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs4488133	rs4539242	0.980987040331281	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs4488133	rs4539242	0.980987040331281	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs4488133	rs4539242	0.980987040331281	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs4488133	rs4539242	0.980987040331281	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs4488133	rs4539242	0.980987040331281	N6-methyllysine levels (advanced age)	5e-25	37118062
rs4488133	rs4539242	0.980987040331281	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs4488133	rs7905265	0.977704345853385	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs4488133	rs7905265	0.977704345853385	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs4488133	rs7905265	0.977704345853385	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs4488133	rs7905265	0.977704345853385	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs4488133	rs7905265	0.977704345853385	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs4488133	rs7905265	0.977704345853385	N6,N6-dimethyllysine levels	2e-132	35995766
rs4488133	rs7905265	0.977704345853385	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs4488133	rs10786414	0.962170440812522	ADMA levels	5e-18	35995766
rs4488133	rs11598867	0.918950945396474	Urinary metabolites	1e-307	26352407
rs4488133	rs942813	0.90536747748887	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs4488133	rs6584194	0.897193204111208	Metabolite peak levels (QI9680)	2e-135	35995766
rs4488133	rs6584194	0.897193204111208	Metabolite peak levels (QI8984)	5e-11	35995766
rs4488133	rs6584194	0.897193204111208	X-24736 levels	3e-13	36635386
rs4488133	rs7096654	0.893462271820487	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs4488133	rs7096654	0.893462271820487	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs4488133	rs7096654	0.893462271820487	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs4488133	rs7096654	0.893462271820487	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs4488133	rs942810	0.783300785879443	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs4488133	rs942810	0.783300785879443	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs4488133	rs942810	0.783300785879443	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs4488133	rs942810	0.783300785879443	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs4488133	rs942810	0.783300785879443	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs4488133	rs942810	0.783300785879443	N6-methyllysine levels (advanced age)	2e-11	37118062
rs4488133	rs4345897	0.710520327249915	Urinary metabolites (H-NMR features)	2e-19	24586186
rs4488133	rs4345897	0.710520327249915	Urinary metabolites (H-NMR features)	4e-12	24586186
rs4488133	rs4345897	0.710520327249915	Metabolite levels	2e-91	23281178
rs4488133	rs4345897	0.710520327249915	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	4e-25	37118062
rs4488133	rs4345897	0.710520327249915	N6,N6-dimethyllysine levels (elderly offspring)	4e-17	37118062
rs4488133	rs4345897	0.710520327249915	N6-methyllysine levels (elderly offspring)	1e-41	37118062
rs4488133	rs4345897	0.710520327249915	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs4488133	rs4345897	0.710520327249915	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs4488133	rs4345897	0.710520327249915	N6-methyllysine levels (advanced age)	6e-22	37118062
rs4488133	rs2182169	0.68225136283351	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-23	37118062
rs4488133	rs2182169	0.68225136283351	N6,N6-dimethyllysine levels (elderly offspring)	3e-16	37118062
rs4488133	rs2182169	0.68225136283351	N6-methyllysine levels (elderly offspring)	7e-40	37118062
rs4488133	rs2182169	0.68225136283351	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs4488133	rs2182169	0.68225136283351	N6,N6-dimethyllysine levels (advanced age)	4e-09	37118062
rs4488133	rs2182169	0.68225136283351	N6-methyllysine levels (advanced age)	1e-21	37118062
rs4488133	rs6584192	0.678696405960941	Metabolite levels	4e-33	23823483
rs4488133	rs6584192	0.678696405960941	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs4488133	rs6584192	0.678696405960941	N6,N6-dimethyllysine levels (elderly offspring)	2e-16	37118062
rs4488133	rs6584192	0.678696405960941	N6-methyllysine levels (elderly offspring)	3e-41	37118062
rs4488133	rs6584192	0.678696405960941	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs4488133	rs6584192	0.678696405960941	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs4488133	rs6584192	0.678696405960941	N6-methyllysine levels (advanced age)	6e-22	37118062
rs4488133	rs2147895	0.670440977457393	Hydroxyhexadecanoylcarnitine levels	9e-19	35888728
rs4488133	rs2147895	0.670440977457393	Plasma arginine levels in chronic kidney disease	7e-13	37277652
rs4488133	rs2147895	0.670440977457393	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-24	37118062
rs4488133	rs2147895	0.670440977457393	N6,N6-dimethyllysine levels (elderly offspring)	7e-17	37118062
rs4488133	rs2147895	0.670440977457393	N6-methyllysine levels (elderly offspring)	2e-39	37118062
rs4488133	rs2147895	0.670440977457393	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs4488133	rs2147895	0.670440977457393	N6,N6-dimethyllysine levels (advanced age)	2e-09	37118062
rs4488133	rs2147895	0.670440977457393	N6-methyllysine levels (advanced age)	4e-21	37118062
rs4488133	rs2182168	0.665007197747936	Urine X-22162 levels in chronic kidney disease	3e-13	37277652
rs4488133	rs2182168	0.665007197747936	Arginine levels	1e-17	36635386
rs4488133	rs1739	0.631529425313549	Metabolite peak levels (QI7389)	3e-91	35995766
rs4488133	rs1737	0.630822370850487	Arginine levels	3e-24	35995766
rs4488133	rs11189591	0.621418976165147	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs4488133	rs11189591	0.621418976165147	N6,N6-dimethyllysine levels (elderly offspring)	1e-16	37118062
rs4488133	rs11189591	0.621418976165147	N6-methyllysine levels (elderly offspring)	1e-40	37118062
rs4488133	rs11189591	0.621418976165147	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs4488133	rs11189591	0.621418976165147	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs4488133	rs11189591	0.621418976165147	N6-methyllysine levels (advanced age)	6e-22	37118062
rs4492929	rs6563739	0.996405751913892	Menarche (age at onset)	2e-11	25231870
rs4492929	rs7999758	0.99550772836075	Height	6e-17	30595370
rs4492929	rs4598779	0.916478598381179	Height	7e-77	36224396
rs4497901	rs7601944	0.996123450868338	Smoking initiation	4e-15	36477530
rs4497901	rs55753056	0.989352616486158	Height	2e-22	30595370
rs4497901	rs59937473	0.952946135662487	Protein quantitative trait loci	3e-67	32492067
rs4497901	rs59937473	0.952946135662487	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs4497901	rs17714252	0.945351625054956	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs4497901	rs17714252	0.945351625054956	Retinal vascular fractal dimension	2e-07	34743558
rs4497901	rs3791221	0.913836120861782	Blood urea nitrogen levels	2e-07	31152163
rs4497901	rs3791221	0.913836120861782	Estimated glomerular filtration rate	2e-10	31152163
rs4497901	rs3791221	0.913836120861782	Estimated glomerular filtration rate	1e-11	31152163
rs4497901	rs3791221	0.913836120861782	Blood urea nitrogen levels	7e-26	34594039
rs4497901	rs114976176	0.913578254931848	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs4497901	rs62114538	0.887830014480364	Triglyceride levels	6e-12	34887591
rs4497901	rs60843830	0.887569187659672	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs4497901	rs60843830	0.887569187659672	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs4497901	rs60843830	0.887569187659672	Adventurousness	7e-10	30643258
rs4497901	rs6710091	0.880146584605624	Waist circumference adjusted for body mass index	8e-11	31669095
rs4497901	rs6710091	0.880146584605624	HDL cholesterol	5e-08	30275531
rs4497901	rs6710091	0.880146584605624	High density lipoprotein cholesterol levels	3e-24	34887591
rs4497901	rs17713396	0.876405149985028	Blood urea nitrogen levels	3e-21	34272381
rs4497901	rs17713396	0.876405149985028	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs4497901	rs17713396	0.876405149985028	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs4497901	rs58461606	0.875103744434084	Blood protein levels	0	30072576
rs4497901	rs7566279	0.871485403636813	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs4497901	rs7595075	0.861519103712229	Waist circumference adjusted for body mass index	2e-09	34021172
rs4497901	rs7595075	0.861519103712229	HDL cholesterol	3e-11	34594039
rs4497901	rs7595075	0.861519103712229	HDL cholesterol levels	6e-13	32203549
rs4497901	rs17713729	0.85866323562213	Body mass index	2e-09	31669095
rs4497901	rs17713729	0.85866323562213	Serum creatinine levels	4e-14	34594039
rs4497901	rs17713729	0.85866323562213	High density lipoprotein cholesterol levels	7e-17	34887591
rs4497901	rs79716074	0.857871987565526	Plateletcrit	1e-09	32888494
rs4497901	rs79716074	0.857871987565526	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs4497901	rs79716074	0.857871987565526	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs4497901	rs79716074	0.857871987565526	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs4497901	rs7605824	0.846583721180345	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs4497901	rs2290911	0.838999257094006	Height	5e-07	29782485
rs4497901	rs2290911	0.838999257094006	Large artery stroke	6e-06	28265093
rs4497901	rs2290911	0.838999257094006	Height	8e-112	36224396
rs4497901	rs2126129	0.827142067353748	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs4497901	rs17713879	0.790727746088909	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs4497901	rs17713879	0.790727746088909	Smoking initiation	1e-10	36477530
rs4497901	rs17713879	0.790727746088909	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs4497901	rs17713879	0.790727746088909	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs4497901	rs17713879	0.790727746088909	Triglyceride levels	3e-10	34887591
rs4497901	rs17713879	0.790727746088909	Aging (eyeAgeAcceleration)	6e-50	36975205
rs4497901	rs11553746	0.771576558274419	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs4497901	rs11553746	0.771576558274419	High density lipoprotein cholesterol levels	2e-07	29083408
rs4497901	rs11553746	0.771576558274419	High density lipoprotein cholesterol levels	7e-15	29083408
rs4497901	rs11553746	0.771576558274419	Large artery stroke	4e-06	28265093
rs4497901	rs62114548	0.744618023914473	Retinal vascular fractal density	2e-09	34743558
rs4497901	rs79154857	0.702265260593528	Pulse pressure	5e-08	34594039
rs4497901	rs62114506	0.678260199832923	Gamma glutamyl transpeptidase	3e-14	34594039
rs4497901	rs62114506	0.678260199832923	Apolipoprotein A1 levels	3e-10	32203549
rs4497901	rs62114506	0.678260199832923	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs4497901	rs62114506	0.678260199832923	HDL cholesterol levels	8e-10	36333282
rs4507641	rs12539962	0.83456465342746	Colorectal cancer	3e-08	36539618
rs4507641	rs13232536	0.731740288656466	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4507641	rs4355658	0.683690330843529	Height	3e-13	36224396
rs4507641	rs7806956	0.63560169503662	Esophageal squamous cell carcinoma	3e-07	37673066
rs4511324	rs11170776	0.635253768131154	Waist-to-hip ratio adjusted for BMI	2e-09	31669095
rs4511324	rs12422555	0.621151471910579	Height	6e-28	36224396
rs4513788	rs9366863	0.992788119165587	Adult body size	9e-33	32376654
rs4513788	rs9366863	0.992788119165587	Body mass index	2e-44	30595370
rs4513788	rs9469872	0.976040590729399	HDL cholesterol levels	3e-11	36333282
rs4513788	rs11755393	0.969013620276777	Body mass index	3e-26	29273807
rs4513788	rs11755393	0.969013620276777	Systemic lupus erythematosus	2e-12	33493351
rs4513788	rs11755393	0.969013620276777	Systemic lupus erythematosus	2e-06	33493351
rs4513788	rs11755393	0.969013620276777	Systemic lupus erythematosus	1e-07	33493351
rs4513788	rs11755393	0.969013620276777	Systemic lupus erythematosus	2e-08	19838195
rs4513788	rs11755393	0.969013620276777	Body mass index	4e-55	36581621
rs4513788	rs6941110	0.959447970565844	Sex hormone-binding globulin levels	5e-27	36653534
rs4513788	rs2814949	0.955524788928273	Essential hypertension (time to event)	9e-09	32589924
rs4513788	rs2744944	0.946105877349639	Hypothyroidism	3e-10	34594039
rs4513788	rs2744944	0.946105877349639	High density lipoprotein cholesterol levels	3e-86	34887591
rs4513788	rs2744944	0.946105877349639	Multi-trait sex score	7e-22	37277458
rs4513788	rs9462030	0.940159861957892	Red cell distribution width	5e-25	32888493
rs4513788	rs9469857	0.935538850358178	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs4513788	rs2764208	0.934805143322481	Systemic lupus erythematosus	7e-06	24871463
rs4513788	rs2263329	0.926693358002709	HDL cholesterol	6e-35	34594039
rs4513788	rs2263329	0.926693358002709	HDL cholesterol levels	8e-43	32203549
rs4513788	rs2263329	0.926693358002709	High density lipoprotein cholesterol levels	2e-52	34887591
rs4513788	rs9469899	0.923586279868781	Prostate cancer (advanced)	2e-06	29892016
rs4513788	rs9469899	0.923586279868781	Prostate cancer	5e-09	29892016
rs4513788	rs9469899	0.923586279868781	Prostate cancer	8e-11	33398198
rs4513788	rs9469899	0.923586279868781	Hand grip strength	3e-15	29691431
rs4513788	rs9469899	0.923586279868781	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs4513788	rs9469899	0.923586279868781	Graves' disease	4e-10	34594039
rs4513788	rs9469899	0.923586279868781	Coronary artery disease	1e-11	36474045
rs4513788	rs9469899	0.923586279868781	Predicted visceral adipose tissue	2e-20	31501611
rs4513788	rs9469899	0.923586279868781	Medication use (thyroid preparations)	2e-09	31015401
rs4513788	rs9469899	0.923586279868781	Medication use (thyroid preparations)	3e-10	34594039
rs4513788	rs111868030	0.902358122698311	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs4513788	rs9296128	0.887084816115133	Hip circumference adjusted for BMI	4e-13	34021172
rs4513788	rs9368830	0.879038628719932	HDL cholesterol	4e-21	30275531
rs4513788	rs9368828	0.849499505229908	Body mass index	1e-34	34594039
rs4513788	rs6912327	0.81525723903876	Fasting insulin	5e-06	33402679
rs4513788	rs6912327	0.81525723903876	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs4513788	rs2744973	0.793457578360454	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs4513788	rs2744973	0.793457578360454	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs4513788	rs2744973	0.793457578360454	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs4513788	rs2744973	0.793457578360454	Multi-trait sex score	6e-20	37277458
rs4513788	rs112283401	0.79263375319919	Red cell distribution width	4e-27	30595370
rs4513788	rs6940215	0.631123679114648	Insomnia	2e-10	35835914
rs4513788	rs6940215	0.631123679114648	Insomnia	1e-13	35835914
rs4513788	rs6940215	0.631123679114648	Hip circumference adjusted for BMI	8e-10	34021172
rs4513788	rs6940215	0.631123679114648	Multi-trait sex score	2e-23	37277458
rs4513788	rs6940215	0.631123679114648	Multi-trait sex score	4e-23	37277458
rs4513788	rs6457796	0.623612774953658	Insomnia	1e-08	30804565
rs4513788	rs6457796	0.623612774953658	Plateletcrit	9e-11	32888494
rs4513788	rs6457796	0.623612774953658	Systemic lupus erythematosus	3e-22	33272962
rs4513788	rs6457796	0.623612774953658	Body mass index	5e-13	30108127
rs4513788	rs6457796	0.623612774953658	Body mass index	1e-14	26426971
rs4513788	rs6457796	0.623612774953658	Educational attainment	5e-19	35361970
rs4513788	rs205262	0.607910136067804	Body mass index	2e-09	26961502
rs4513788	rs205262	0.607910136067804	Walking pace	4e-10	33128006
rs4513788	rs205262	0.607910136067804	Body mass index	8e-13	30108127
rs4513788	rs205262	0.607910136067804	Body mass index	2e-09	25673413
rs4513788	rs205262	0.607910136067804	Body mass index	2e-14	26426971
rs4513788	rs205262	0.607910136067804	BMI in non-smokers	3e-07	28443625
rs4513788	rs205262	0.607910136067804	BMI in non-smokers	6e-09	28443625
rs4513788	rs205262	0.607910136067804	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs4513788	rs205262	0.607910136067804	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs4513788	rs205262	0.607910136067804	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs4513788	rs205262	0.607910136067804	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs4513788	rs205262	0.607910136067804	Gastroesophageal reflux disease	1e-10	34187846
rs4513788	rs205262	0.607910136067804	Body mass index	3e-10	25673413
rs4513788	rs205262	0.607910136067804	Body mass index	2e-10	25673413
rs4513788	rs205262	0.607910136067804	ICD10 M54: Dorsalgia	2e-12	35110524
rs4513788	rs9689160	0.603060696621572	Lung function (forced vital capacity)	3e-14	36914875
rs4515756	rs6680628	0.791404388179781	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs4530889	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs4530889	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs4530889	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs4530889	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs4530889	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs4530889	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs4530889	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs4530889	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs4530889	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs4530889	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs4530889	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs4530889	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs4530889	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs4530889	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs4530889	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs4530889	rs13437082	0.631513452560533	Height	5e-08	19343178
rs4530889	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs4535041	rs7424551	0.60089829183745	Intake of total sugars	7e-08	31005972
rs4543144	rs10222974	0.73889619157718	Height	3e-07	36224396
rs4543144	rs4859699	0.621807411594247	Androstenediol (3alpha, 17alpha) monosulfate (2) levels in elite athletes	3e-06	31882771
rs4552	rs2095375	0.999099813848841	Serum metabolite levels	1e-20	33031748
rs4552	rs2095375	0.999099813848841	Serum metabolite levels	1e-20	33031748
rs4552	rs9383843	0.99820070965219	Migraine	1e-09	35115687
rs4552	rs55763431	0.994609419325741	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4552	rs9689694	0.992810135991821	Right hippocampal volume (head)	6e-11	37337106
rs4552	rs9689694	0.992810135991821	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4552	rs9689694	0.992810135991821	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4552	rs9689694	0.992810135991821	Left hippocampal volume (head)	6e-12	37337106
rs4552	rs10872645	0.987440345949903	Blood protein levels	2e-86	30072576
rs4552	rs9688867	0.986594752310371	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4552	rs9688867	0.986594752310371	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4552	rs9688809	0.986594752310371	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4552	rs10872653	0.986530427250756	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4552	rs34337297	0.982968884774808	Serum levels of protein LRP11	3e-161	35078996
rs4552	rs14314	0.980362443046792	Macular thickness	3e-19	30535121
rs4552	rs14314	0.980362443046792	Vertex-wise sulcal depth	7e-17	34910505
rs4552	rs14314	0.980362443046792	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4552	rs14314	0.980362443046792	Left hippocampal volume (body)	7e-15	37337106
rs4552	rs14314	0.980362443046792	Left subiculum volume (body)	1e-14	37337106
rs4552	rs9322193	0.94695333800893	Lung cancer	1e-07	27393504
rs4552	rs4039600	0.903183149152297	Adenine levels	1e-11	35347128
rs4552	rs1934534	0.638285875690943	Pain (pleiotropy)	2e-08	37844115
rs4552	rs1934534	0.638285875690943	Pain (pleiotropy)	2e-06	37844115
rs4552	rs4380763	0.637765579448099	Subcortical volume (min-P)	1e-11	32665545
rs4552	rs11155671	0.627345563129369	Testicular germ cell tumor	2e-09	28604728
rs4552	rs80147756	0.612501602164309	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4552	rs4421206	0.604939685898671	Brain morphology (min-P)	4e-11	32665545
rs4558538	rs12620999	0.82616292483684	Systemic lupus erythematosus	3e-06	19838195
rs4562	rs409942	0.899313428147647	Total cholesterol levels	8e-06	35884923
rs4562	rs739669	0.763373828686417	BMI at birth	5e-17	35315439
rs4562	rs222837	0.70738492563226	Metabolite levels	7e-06	23823483
rs4562	rs2654189	0.680299154971126	Eosinophil counts	4e-11	32888494
rs4562	rs2654189	0.680299154971126	Eosinophil percentage of white cells	6e-12	32888494
rs4562	rs2654189	0.680299154971126	Eosinophil counts	1e-09	30595370
rs4562	rs5415	0.670393892519377	Birth weight	5e-06	23202124
rs4562	rs5415	0.670393892519377	LDL cholesterol levels	1e-06	35884923
rs4562	rs13331	0.634650888476869	Heel bone mineral density	4e-08	30595370
rs4574828	rs4413755	0.926233740239007	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs4574829	rs4413755	0.919428729436656	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs4575672	rs12620999	0.877238134432194	Systemic lupus erythematosus	3e-06	19838195
rs4591705	rs10061757	0.994769750434766	Height	4e-30	30595370
rs4591705	rs832540	0.769935596962698	Coronary artery disease	2e-08	29212778
rs4591705	rs33321	0.723841163675122	Height	1e-19	34594039
rs4599092	rs2593620	0.905802469041397	Serum levels of protein PRG3	5e-14	35078996
rs4599092	rs2421200	0.884223621724274	Neutrophil count	1e-26	32888493
rs4599092	rs2421200	0.884223621724274	Neutrophil count	1e-25	32888493
rs4599092	rs777587	0.875848580737512	Proteoglycan 3 levels	6e-29	34648354
rs4599092	rs777587	0.875848580737512	Pappalysin-1 levels	1e-25	34648354
rs4599092	rs12617371	0.868563900648353	Immature fraction of reticulocytes	8e-18	32888494
rs4599092	rs2463097	0.832229106910091	White blood cell count	3e-26	30595370
rs4599092	rs10199672	0.827110642439564	Height	6e-12	34594039
rs4599092	rs10199672	0.827110642439564	Height	2e-12	31562340
rs4599092	rs2950269	0.766182061402435	Eosinophil side fluorescence	3e-18	37596262
rs4599092	rs12616433	0.753381614655384	Eosinophil forward scatter	4e-13	37596262
rs4599092	rs12616433	0.753381614655384	Eosinophil side scatter	2e-18	37596262
rs4599092	rs11685226	0.750630648079235	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs4599092	rs11685226	0.750630648079235	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs4599092	rs1177308	0.742754207058145	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs4599092	rs1177308	0.742754207058145	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs4599092	rs7558954	0.740632986259021	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs4599092	rs10169482	0.739690131929902	C-reactive protein levels	4e-09	33462484
rs4599092	rs10206089	0.619728367935692	White blood cell count	7e-11	27863252
rs4599092	rs10206089	0.619728367935692	Myeloid white cell count	1e-09	27863252
rs4599092	rs10206089	0.619728367935692	Sum neutrophil eosinophil counts	2e-09	27863252
rs4599092	rs10206089	0.619728367935692	Granulocyte count	3e-09	27863252
rs4601124	rs9462030	0.959689486104409	Red cell distribution width	5e-25	32888493
rs4601124	rs9469857	0.955016633838152	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs4601124	rs2764208	0.954272752192096	Systemic lupus erythematosus	7e-06	24871463
rs4601124	rs9469899	0.94297050673558	Prostate cancer (advanced)	2e-06	29892016
rs4601124	rs9469899	0.94297050673558	Prostate cancer	5e-09	29892016
rs4601124	rs9469899	0.94297050673558	Prostate cancer	8e-11	33398198
rs4601124	rs9469899	0.94297050673558	Hand grip strength	3e-15	29691431
rs4601124	rs9469899	0.94297050673558	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs4601124	rs9469899	0.94297050673558	Graves' disease	4e-10	34594039
rs4601124	rs9469899	0.94297050673558	Coronary artery disease	1e-11	36474045
rs4601124	rs9469899	0.94297050673558	Predicted visceral adipose tissue	2e-20	31501611
rs4601124	rs9469899	0.94297050673558	Medication use (thyroid preparations)	2e-09	31015401
rs4601124	rs9469899	0.94297050673558	Medication use (thyroid preparations)	3e-10	34594039
rs4601124	rs9469872	0.91893256620608	HDL cholesterol levels	3e-11	36333282
rs4601124	rs11755393	0.912198026025879	Body mass index	3e-26	29273807
rs4601124	rs11755393	0.912198026025879	Systemic lupus erythematosus	2e-12	33493351
rs4601124	rs11755393	0.912198026025879	Systemic lupus erythematosus	2e-06	33493351
rs4601124	rs11755393	0.912198026025879	Systemic lupus erythematosus	1e-07	33493351
rs4601124	rs11755393	0.912198026025879	Systemic lupus erythematosus	2e-08	19838195
rs4601124	rs11755393	0.912198026025879	Body mass index	4e-55	36581621
rs4601124	rs9366863	0.908936511814713	Adult body size	9e-33	32376654
rs4601124	rs9366863	0.908936511814713	Body mass index	2e-44	30595370
rs4601124	rs9296128	0.905999661926689	Hip circumference adjusted for BMI	4e-13	34021172
rs4601124	rs6941110	0.901282524174805	Sex hormone-binding globulin levels	5e-27	36653534
rs4601124	rs2814949	0.873342460717246	Essential hypertension (time to event)	9e-09	32589924
rs4601124	rs2744944	0.864298629923149	Hypothyroidism	3e-10	34594039
rs4601124	rs2744944	0.864298629923149	High density lipoprotein cholesterol levels	3e-86	34887591
rs4601124	rs2744944	0.864298629923149	Multi-trait sex score	7e-22	37277458
rs4601124	rs2263329	0.847157489121814	HDL cholesterol	6e-35	34594039
rs4601124	rs2263329	0.847157489121814	HDL cholesterol levels	8e-43	32203549
rs4601124	rs2263329	0.847157489121814	High density lipoprotein cholesterol levels	2e-52	34887591
rs4601124	rs111868030	0.823427478263458	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs4601124	rs9368830	0.802017965065297	HDL cholesterol	4e-21	30275531
rs4601124	rs9368828	0.779012404729994	Body mass index	1e-34	34594039
rs4601124	rs2744973	0.77642830083588	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs4601124	rs2744973	0.77642830083588	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs4601124	rs2744973	0.77642830083588	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs4601124	rs2744973	0.77642830083588	Multi-trait sex score	6e-20	37277458
rs4601124	rs6912327	0.765103536426861	Fasting insulin	5e-06	33402679
rs4601124	rs6912327	0.765103536426861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs4601124	rs112283401	0.740395442404934	Red cell distribution width	4e-27	30595370
rs4601124	rs9689160	0.610761619382448	Lung function (forced vital capacity)	3e-14	36914875
rs4602885	rs4872007	0.776203713567779	Superior temporal gyrus volume	8e-06	31530798
rs4602885	rs4242434	0.65688854855891	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs4602885	rs746011	0.647800772665628	Triglycerides	2e-10	30275531
rs4602885	rs11781149	0.629732837170123	Refractive error	2e-17	32231278
rs4602885	rs2280104	0.626066855839882	Parkinson's disease	3e-08	28892059
rs4602885	rs2280104	0.626066855839882	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs4602885	rs2280104	0.626066855839882	Serum total protein level	3e-12	34594039
rs4613979	rs4413755	0.924666222512384	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs4619126	rs1467510	0.846478427352828	Platelet distribution width	1e-14	32888494
rs4619126	rs12276109	0.782574307142494	Severe COVID-19 infection	6e-08	36662838
rs4624858	rs9462030	0.987180487381562	Red cell distribution width	5e-25	32888493
rs4624858	rs9469857	0.977613670572122	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs4624858	rs2764208	0.976833084679152	Systemic lupus erythematosus	7e-06	24871463
rs4624858	rs9469899	0.970499698755999	Prostate cancer (advanced)	2e-06	29892016
rs4624858	rs9469899	0.970499698755999	Prostate cancer	5e-09	29892016
rs4624858	rs9469899	0.970499698755999	Prostate cancer	8e-11	33398198
rs4624858	rs9469899	0.970499698755999	Hand grip strength	3e-15	29691431
rs4624858	rs9469899	0.970499698755999	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs4624858	rs9469899	0.970499698755999	Graves' disease	4e-10	34594039
rs4624858	rs9469899	0.970499698755999	Coronary artery disease	1e-11	36474045
rs4624858	rs9469899	0.970499698755999	Predicted visceral adipose tissue	2e-20	31501611
rs4624858	rs9469899	0.970499698755999	Medication use (thyroid preparations)	2e-09	31015401
rs4624858	rs9469899	0.970499698755999	Medication use (thyroid preparations)	3e-10	34594039
rs4624858	rs9469872	0.941512093802008	HDL cholesterol levels	3e-11	36333282
rs4624858	rs11755393	0.94116109780304	Body mass index	3e-26	29273807
rs4624858	rs11755393	0.94116109780304	Systemic lupus erythematosus	2e-12	33493351
rs4624858	rs11755393	0.94116109780304	Systemic lupus erythematosus	2e-06	33493351
rs4624858	rs11755393	0.94116109780304	Systemic lupus erythematosus	1e-07	33493351
rs4624858	rs11755393	0.94116109780304	Systemic lupus erythematosus	2e-08	19838195
rs4624858	rs11755393	0.94116109780304	Body mass index	4e-55	36581621
rs4624858	rs9366863	0.931356312048286	Adult body size	9e-33	32376654
rs4624858	rs9366863	0.931356312048286	Body mass index	2e-44	30595370
rs4624858	rs6941110	0.928210442884273	Sex hormone-binding globulin levels	5e-27	36653534
rs4624858	rs9296128	0.9273760812786	Hip circumference adjusted for BMI	4e-13	34021172
rs4624858	rs2814949	0.895399520141368	Essential hypertension (time to event)	9e-09	32589924
rs4624858	rs2744944	0.88614471784862	Hypothyroidism	3e-10	34594039
rs4624858	rs2744944	0.88614471784862	High density lipoprotein cholesterol levels	3e-86	34887591
rs4624858	rs2744944	0.88614471784862	Multi-trait sex score	7e-22	37277458
rs4624858	rs2263329	0.867122515006952	HDL cholesterol	6e-35	34594039
rs4624858	rs2263329	0.867122515006952	HDL cholesterol levels	8e-43	32203549
rs4624858	rs2263329	0.867122515006952	High density lipoprotein cholesterol levels	2e-52	34887591
rs4624858	rs111868030	0.843728343575908	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs4624858	rs9368830	0.82249310607252	HDL cholesterol	4e-21	30275531
rs4624858	rs9368828	0.796505096883086	Body mass index	1e-34	34594039
rs4624858	rs2744973	0.793461479540782	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs4624858	rs2744973	0.793461479540782	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs4624858	rs2744973	0.793461479540782	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs4624858	rs2744973	0.793461479540782	Multi-trait sex score	6e-20	37277458
rs4624858	rs6912327	0.785270833699742	Fasting insulin	5e-06	33402679
rs4624858	rs6912327	0.785270833699742	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs4624858	rs112283401	0.763056526177386	Red cell distribution width	4e-27	30595370
rs4624858	rs9689160	0.622199676272216	Lung function (forced vital capacity)	3e-14	36914875
rs4629091	rs4808407	0.935956809866182	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs4632942	rs13232536	0.800508612066287	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4632942	rs12539962	0.745784440407828	Colorectal cancer	3e-08	36539618
rs4632942	rs4355658	0.745364249267765	Height	3e-13	36224396
rs4640862	rs2842611	0.925852818327252	High density lipoprotein cholesterol levels	5e-09	34887591
rs4640862	rs1173416	0.909320527165816	Height	2e-59	36224396
rs4640862	rs9450288	0.882719052997207	Height	2e-10	36224396
rs4640941	rs4304220	1	Height	2e-14	36224396
rs4640941	rs13232536	0.726056351724776	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4640941	rs4355658	0.70394150402541	Height	3e-13	36224396
rs4640941	rs13227841	0.612367270032016	Asthma	2e-09	32514122
rs4641970	rs9309711	0.723426346978449	Neurofibrillary tangles	3e-06	25188341
rs4654747	rs6680628	0.799623200362637	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs4654752	rs6680628	0.71383239065603	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs4654753	rs6680628	0.713102627326381	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs4654937	rs6680628	0.899896240463203	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs4654938	rs6680628	0.797126058709413	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs4654939	rs6680628	0.718145129572011	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs4656070	rs10801699	0.998285907305798	X-23639 levels	2e-10	36635386
rs4656070	rs1409152	0.995721709784585	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs4656070	rs1409152	0.995721709784585	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs4656070	rs12120164	0.956864561637726	Metabolite peak levels (QI2146)	1e-26	35995766
rs4656070	rs10922531	0.802785043694205	Serum metabolite levels	2e-69	33031748
rs4656070	rs12729558	0.776670862872413	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs4656070	rs7532151	0.715586286954016	Imidazole lactate levels	9e-12	33177712
rs4656070	rs7530513	0.713344248406322	Height	8e-11	35831902
rs4656070	rs7530513	0.713344248406322	Imidazole lactate levels	8e-166	36635386
rs4656070	rs12144640	0.713344248406322	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs4656070	rs10801690	0.696263854539572	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs4656070	rs9787133	0.670163354584784	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs4656070	rs2765527	0.628293351920004	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs4656070	rs10922532	0.608104119915621	Blood urea nitrogen levels	2e-08	31152163
rs4656070	rs10922532	0.608104119915621	Waist circumference adjusted for body mass index	2e-11	34021172
rs4656070	rs10922532	0.608104119915621	X-23639 levels	4e-11	35050183
rs4656071	rs10801699	0.998285907305798	X-23639 levels	2e-10	36635386
rs4656071	rs1409152	0.995721709784585	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs4656071	rs1409152	0.995721709784585	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs4656071	rs12120164	0.956864561637726	Metabolite peak levels (QI2146)	1e-26	35995766
rs4656071	rs10922531	0.802785043694205	Serum metabolite levels	2e-69	33031748
rs4656071	rs12729558	0.776670862872413	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs4656071	rs7532151	0.715586286954016	Imidazole lactate levels	9e-12	33177712
rs4656071	rs7530513	0.713344248406322	Height	8e-11	35831902
rs4656071	rs7530513	0.713344248406322	Imidazole lactate levels	8e-166	36635386
rs4656071	rs12144640	0.713344248406322	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs4656071	rs10801690	0.696263854539572	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs4656071	rs9787133	0.670163354584784	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs4656071	rs2765527	0.628293351920004	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs4656071	rs10922532	0.608104119915621	Blood urea nitrogen levels	2e-08	31152163
rs4656071	rs10922532	0.608104119915621	Waist circumference adjusted for body mass index	2e-11	34021172
rs4656071	rs10922532	0.608104119915621	X-23639 levels	4e-11	35050183
rs4656094	rs55679149	0.77907528098502	Remission after SSRI treatment in MDD or openness	8e-07	29559929
rs4656094	rs12089335	0.746942447016729	Guanylate-binding protein 1 levels	4e-26	34648354
rs4658434	rs7545078	0.629070583999774	Smoking initiation	2e-09	36477530
rs4658684	rs7545078	0.745293298400549	Smoking initiation	2e-09	36477530
rs4658684	rs6700087	0.682975342249922	Smoking initiation	6e-11	36477530
rs4658685	rs7545078	0.792117972560148	Smoking initiation	2e-09	36477530
rs4658685	rs6700087	0.753728483959021	Smoking initiation	6e-11	36477530
rs4663240	rs12620999	0.998976363944945	Systemic lupus erythematosus	3e-06	19838195
rs4663701	rs12620999	0.841378276769042	Systemic lupus erythematosus	3e-06	19838195
rs4664285	rs6705511	0.85437728322816	Self-reported math ability	4e-09	30038396
rs4664285	rs6705511	0.85437728322816	Self-reported math ability (MTAG)	3e-10	30038396
rs4664285	rs34276187	0.846904748931516	Highest math class taken (MTAG)	2e-08	30038396
rs4664336	rs6705511	0.601940533581279	Self-reported math ability	4e-09	30038396
rs4664336	rs6705511	0.601940533581279	Self-reported math ability (MTAG)	3e-10	30038396
rs4665073	rs6705511	0.852721467813967	Self-reported math ability	4e-09	30038396
rs4665073	rs6705511	0.852721467813967	Self-reported math ability (MTAG)	3e-10	30038396
rs4665073	rs34276187	0.845245676309372	Highest math class taken (MTAG)	2e-08	30038396
rs4665076	rs6705511	0.83709965485947	Self-reported math ability	4e-09	30038396
rs4665076	rs6705511	0.83709965485947	Self-reported math ability (MTAG)	3e-10	30038396
rs4665076	rs34276187	0.829628024490052	Highest math class taken (MTAG)	2e-08	30038396
rs4665114	rs6705511	0.750270821587799	Self-reported math ability	4e-09	30038396
rs4665114	rs6705511	0.750270821587799	Self-reported math ability (MTAG)	3e-10	30038396
rs4665114	rs34276187	0.744111572266498	Highest math class taken (MTAG)	2e-08	30038396
rs4665137	rs6705511	0.694973056512879	Self-reported math ability	4e-09	30038396
rs4665137	rs6705511	0.694973056512879	Self-reported math ability (MTAG)	3e-10	30038396
rs4665137	rs34276187	0.689176520742724	Highest math class taken (MTAG)	2e-08	30038396
rs4665167	rs6723298	0.681140785769026	Smoking initiation	2e-12	36477530
rs4665167	rs2194492	0.662310927153408	Educational attainment	9e-09	35361970
rs4665167	rs13020443	0.652473855583577	Type 2 diabetes	3e-11	32541925
rs4665169	rs6723298	0.676457572674373	Smoking initiation	2e-12	36477530
rs4665169	rs2194492	0.657657055780904	Educational attainment	9e-09	35361970
rs4665169	rs13020443	0.647768214650479	Type 2 diabetes	3e-11	32541925
rs4665170	rs6723298	0.677232860837647	Smoking initiation	2e-12	36477530
rs4665170	rs2194492	0.658415154942084	Educational attainment	9e-09	35361970
rs4665170	rs13020443	0.648505695086041	Type 2 diabetes	3e-11	32541925
rs4671873	rs13391405	0.632865340958707	Cis-4-decenoylcarnitine (C10:1) levels in elite athletes	8e-06	31882771
rs4672427	rs777587	0.832562412815338	Proteoglycan 3 levels	6e-29	34648354
rs4672427	rs777587	0.832562412815338	Pappalysin-1 levels	1e-25	34648354
rs4672427	rs2593620	0.831484662357187	Serum levels of protein PRG3	5e-14	35078996
rs4672427	rs12617371	0.810261705769636	Immature fraction of reticulocytes	8e-18	32888494
rs4672427	rs2421200	0.798184496491884	Neutrophil count	1e-26	32888493
rs4672427	rs2421200	0.798184496491884	Neutrophil count	1e-25	32888493
rs4672427	rs2463097	0.774594111891964	White blood cell count	3e-26	30595370
rs4672427	rs10199672	0.751005682920282	Height	6e-12	34594039
rs4672427	rs10199672	0.751005682920282	Height	2e-12	31562340
rs4672427	rs11685226	0.712186725081158	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs4672427	rs11685226	0.712186725081158	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs4672427	rs1177308	0.704859953348564	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs4672427	rs1177308	0.704859953348564	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs4672427	rs7558954	0.702883254190749	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs4672427	rs2950269	0.696011282506881	Eosinophil side fluorescence	3e-18	37596262
rs4672427	rs10169482	0.67468785573463	C-reactive protein levels	4e-09	33462484
rs4672427	rs12616433	0.667214465708306	Eosinophil forward scatter	4e-13	37596262
rs4672427	rs12616433	0.667214465708306	Eosinophil side scatter	2e-18	37596262
rs4673963	rs7424551	0.631441588328447	Intake of total sugars	7e-08	31005972
rs4673964	rs7424551	0.633881065011631	Intake of total sugars	7e-08	31005972
rs4681679	rs4681679	1	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs4681679	rs11719450	0.957725185621849	Hemoglobin concentration	2e-09	27863252
rs4681679	rs11719450	0.957725185621849	Hemoglobin levels	2e-16	32327693
rs4681679	rs56384862	0.944606337888957	Body mass index	8e-12	29273807
rs4681679	rs56384862	0.944606337888957	Body mass index	3e-06	30108127
rs4681679	rs56384862	0.944606337888957	Hemoglobin levels	1e-16	32327693
rs4681679	rs56384862	0.944606337888957	Body mass index	3e-14	36581621
rs4681679	rs6775517	0.896457241860952	Hematocrit	1e-17	34594039
rs4681679	rs7610312	0.892497092737587	Red blood cell count	5e-09	27863252
rs4681679	rs57700771	0.888543089245025	Red blood cell count	9e-21	30595370
rs4681679	rs11705721	0.874103222104975	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs4681679	rs11130638	0.874103222104975	Hemoglobin concentration	2e-23	32888493
rs4681679	rs34579268	0.867685553599419	Hematocrit	5e-30	32888493
rs4681679	rs34579268	0.867685553599419	Hematocrit	2e-27	32888493
rs4681679	rs34579268	0.867685553599419	Hemoglobin concentration	5e-26	32888493
rs4681679	rs55692656	0.835686093312707	vWF levels	3e-08	30586737
rs4681679	rs55692656	0.835686093312707	vWF levels	6e-09	30586737
rs4681679	rs55704295	0.813290777634158	Red blood cell count	8e-26	32888493
rs4681679	rs55704295	0.813290777634158	Red blood cell count	5e-23	32888493
rs4681679	rs55704295	0.813290777634158	Serum total protein level	2e-29	34594039
rs4681679	rs11922478	0.791915538711332	Semaphorin-6B levels	4e-12	34648354
rs4681679	rs6445969	0.782551616550955	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs4681679	rs11708895	0.772842245677948	Red blood cell count	1e-20	32888494
rs4681679	rs55954186	0.767955367376573	vWF levels	5e-09	30586737
rs4681679	rs55954186	0.767955367376573	vWF levels	9e-09	30586737
rs4681679	rs7431952	0.703168681734759	Hemoglobin levels	1e-12	32327693
rs4681679	rs9311676	0.636380580568103	Systemic lupus erythematosus	5e-06	27399966
rs4681679	rs9311676	0.636380580568103	Systemic lupus erythematosus	3e-14	26502338
rs4681679	rs9311676	0.636380580568103	Waist circumference adjusted for body mass index	3e-08	34021172
rs4681679	rs9822855	0.627969837799089	Educational attainment	9e-120	35361970
rs4681682	rs4681679	0.992068226560984	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs4681682	rs11719450	0.952692897314339	Hemoglobin concentration	2e-09	27863252
rs4681682	rs11719450	0.952692897314339	Hemoglobin levels	2e-16	32327693
rs4681682	rs56384862	0.939708016901768	Body mass index	8e-12	29273807
rs4681682	rs56384862	0.939708016901768	Body mass index	3e-06	30108127
rs4681682	rs56384862	0.939708016901768	Hemoglobin levels	1e-16	32327693
rs4681682	rs56384862	0.939708016901768	Body mass index	3e-14	36581621
rs4681682	rs6775517	0.891466342725766	Hematocrit	1e-17	34594039
rs4681682	rs7610312	0.887535288599035	Red blood cell count	5e-09	27863252
rs4681682	rs57700771	0.883610330464417	Red blood cell count	9e-21	30595370
rs4681682	rs11705721	0.869187866949396	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs4681682	rs11130638	0.869187866949396	Hemoglobin concentration	2e-23	32888493
rs4681682	rs34579268	0.862788476133389	Hematocrit	5e-30	32888493
rs4681682	rs34579268	0.862788476133389	Hematocrit	2e-27	32888493
rs4681682	rs34579268	0.862788476133389	Hemoglobin concentration	5e-26	32888493
rs4681682	rs55692656	0.830880156318343	vWF levels	3e-08	30586737
rs4681682	rs55692656	0.830880156318343	vWF levels	6e-09	30586737
rs4681682	rs55704295	0.808909879538636	Red blood cell count	8e-26	32888493
rs4681682	rs55704295	0.808909879538636	Red blood cell count	5e-23	32888493
rs4681682	rs55704295	0.808909879538636	Serum total protein level	2e-29	34594039
rs4681682	rs11922478	0.787768402167796	Semaphorin-6B levels	4e-12	34648354
rs4681682	rs6445969	0.776333448425951	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs4681682	rs11708895	0.766704811117492	Red blood cell count	1e-20	32888494
rs4681682	rs55954186	0.761856701526075	vWF levels	5e-09	30586737
rs4681682	rs55954186	0.761856701526075	vWF levels	9e-09	30586737
rs4681682	rs7431952	0.707462250077366	Hemoglobin levels	1e-12	32327693
rs4681682	rs9311676	0.632540857485396	Systemic lupus erythematosus	5e-06	27399966
rs4681682	rs9311676	0.632540857485396	Systemic lupus erythematosus	3e-14	26502338
rs4681682	rs9311676	0.632540857485396	Waist circumference adjusted for body mass index	3e-08	34021172
rs4681682	rs9822855	0.622985311108345	Educational attainment	9e-120	35361970
rs4681846	rs4681679	0.997340621684775	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs4681846	rs11719450	0.957725185621849	Hemoglobin concentration	2e-09	27863252
rs4681846	rs11719450	0.957725185621849	Hemoglobin levels	2e-16	32327693
rs4681846	rs56384862	0.944606337888957	Body mass index	8e-12	29273807
rs4681846	rs56384862	0.944606337888957	Body mass index	3e-06	30108127
rs4681846	rs56384862	0.944606337888957	Hemoglobin levels	1e-16	32327693
rs4681846	rs56384862	0.944606337888957	Body mass index	3e-14	36581621
rs4681846	rs6775517	0.896457241860952	Hematocrit	1e-17	34594039
rs4681846	rs7610312	0.892497092737587	Red blood cell count	5e-09	27863252
rs4681846	rs57700771	0.888543089245025	Red blood cell count	9e-21	30595370
rs4681846	rs11705721	0.874103222104975	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs4681846	rs11130638	0.874103222104975	Hemoglobin concentration	2e-23	32888493
rs4681846	rs34579268	0.867685553599419	Hematocrit	5e-30	32888493
rs4681846	rs34579268	0.867685553599419	Hematocrit	2e-27	32888493
rs4681846	rs34579268	0.867685553599419	Hemoglobin concentration	5e-26	32888493
rs4681846	rs55692656	0.835686093312707	vWF levels	3e-08	30586737
rs4681846	rs55692656	0.835686093312707	vWF levels	6e-09	30586737
rs4681846	rs55704295	0.813290777634158	Red blood cell count	8e-26	32888493
rs4681846	rs55704295	0.813290777634158	Red blood cell count	5e-23	32888493
rs4681846	rs55704295	0.813290777634158	Serum total protein level	2e-29	34594039
rs4681846	rs11922478	0.794309946096118	Semaphorin-6B levels	4e-12	34648354
rs4681846	rs6445969	0.780007676917409	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs4681846	rs11708895	0.770300285457583	Red blood cell count	1e-20	32888494
rs4681846	rs55954186	0.765415848597123	vWF levels	5e-09	30586737
rs4681846	rs55954186	0.765415848597123	vWF levels	9e-09	30586737
rs4681846	rs7431952	0.700686666573679	Hemoglobin levels	1e-12	32327693
rs4681846	rs9311676	0.636380580568103	Systemic lupus erythematosus	5e-06	27399966
rs4681846	rs9311676	0.636380580568103	Systemic lupus erythematosus	3e-14	26502338
rs4681846	rs9311676	0.636380580568103	Waist circumference adjusted for body mass index	3e-08	34021172
rs4681846	rs9822855	0.627969837799089	Educational attainment	9e-120	35361970
rs4681847	rs4681679	0.99867086876754	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs4681847	rs11719450	0.959062364989163	Hemoglobin concentration	2e-09	27863252
rs4681847	rs11719450	0.959062364989163	Hemoglobin levels	2e-16	32327693
rs4681847	rs56384862	0.945971833827975	Body mass index	8e-12	29273807
rs4681847	rs56384862	0.945971833827975	Body mass index	3e-06	30108127
rs4681847	rs56384862	0.945971833827975	Hemoglobin levels	1e-16	32327693
rs4681847	rs56384862	0.945971833827975	Body mass index	3e-14	36581621
rs4681847	rs6775517	0.897650336959633	Hematocrit	1e-17	34594039
rs4681847	rs7610312	0.893692846376017	Red blood cell count	5e-09	27863252
rs4681847	rs57700771	0.889741492252773	Red blood cell count	9e-21	30595370
rs4681847	rs11705721	0.875271761031879	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs4681847	rs11130638	0.875271761031879	Hemoglobin concentration	2e-23	32888493
rs4681847	rs34579268	0.868845520909068	Hematocrit	5e-30	32888493
rs4681847	rs34579268	0.868845520909068	Hematocrit	2e-27	32888493
rs4681847	rs34579268	0.868845520909068	Hemoglobin concentration	5e-26	32888493
rs4681847	rs55692656	0.836803321248679	vWF levels	3e-08	30586737
rs4681847	rs55692656	0.836803321248679	vWF levels	6e-09	30586737
rs4681847	rs55704295	0.814538559368595	Red blood cell count	8e-26	32888493
rs4681847	rs55704295	0.814538559368595	Red blood cell count	5e-23	32888493
rs4681847	rs55704295	0.814538559368595	Serum total protein level	2e-29	34594039
rs4681847	rs11922478	0.793213773736734	Semaphorin-6B levels	4e-12	34648354
rs4681847	rs6445969	0.781509635010321	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs4681847	rs11708895	0.771813792704081	Red blood cell count	1e-20	32888494
rs4681847	rs55954186	0.766933410894765	vWF levels	5e-09	30586737
rs4681847	rs55954186	0.766933410894765	vWF levels	9e-09	30586737
rs4681847	rs7431952	0.702228003591455	Hemoglobin levels	1e-12	32327693
rs4681847	rs9311676	0.637386682769212	Systemic lupus erythematosus	5e-06	27399966
rs4681847	rs9311676	0.637386682769212	Systemic lupus erythematosus	3e-14	26502338
rs4681847	rs9311676	0.637386682769212	Waist circumference adjusted for body mass index	3e-08	34021172
rs4681847	rs9822855	0.627134578173932	Educational attainment	9e-120	35361970
rs4683066	rs11715071	0.983504453070437	Body mass index	3e-08	36581621
rs4683067	rs11715071	0.997931186235437	Body mass index	3e-08	36581621
rs4707211	rs2842611	0.925852818327252	High density lipoprotein cholesterol levels	5e-09	34887591
rs4707211	rs1173416	0.909320527165816	Height	2e-59	36224396
rs4707211	rs9450288	0.884244234738033	Height	2e-10	36224396
rs4707212	rs2842611	0.925852818327252	High density lipoprotein cholesterol levels	5e-09	34887591
rs4707212	rs1173416	0.909320527165816	Height	2e-59	36224396
rs4707212	rs9450288	0.884244234738033	Height	2e-10	36224396
rs4714684	rs9394952	0.835115461130758	Age-related hearing impairment	3e-11	34108613
rs4714684	rs4714680	0.789485482097705	Height	2e-09	34594039
rs4714684	rs4714680	0.789485482097705	Hip circumference adjusted for BMI	4e-08	34021172
rs4714684	rs1214752	0.765288829309904	Coronary artery disease	1e-06	29212778
rs4717106	rs12539962	0.950417046109961	Colorectal cancer	3e-08	36539618
rs4717106	rs4355658	0.65728846513634	Height	3e-13	36224396
rs4717106	rs7806956	0.637819550060867	Esophageal squamous cell carcinoma	3e-07	37673066
rs4717106	rs13232536	0.636828005658685	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4717109	rs4304220	0.866545648270098	Height	2e-14	36224396
rs4717109	rs4355658	0.818485054235964	Height	3e-13	36224396
rs4717109	rs13232536	0.613382880258207	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4717110	rs4304220	0.797794532955096	Height	2e-14	36224396
rs4717110	rs4355658	0.747573742745905	Height	3e-13	36224396
rs4717110	rs13232536	0.611831684997624	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4717111	rs4304220	0.797794532955096	Height	2e-14	36224396
rs4717111	rs4355658	0.747573742745905	Height	3e-13	36224396
rs4717111	rs13232536	0.611831684997624	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4717112	rs4304220	0.790919605466814	Height	2e-14	36224396
rs4717112	rs4355658	0.74013259946311	Height	3e-13	36224396
rs4717112	rs13232536	0.605940146366174	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4717819	rs4304220	0.901026547425921	Height	2e-14	36224396
rs4717819	rs13232536	0.782042475664639	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4717819	rs4355658	0.766861801001888	Height	3e-13	36224396
rs4717821	rs4304220	0.998388718845539	Height	2e-14	36224396
rs4717821	rs13232536	0.726056351724776	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4717821	rs4355658	0.70394150402541	Height	3e-13	36224396
rs4717821	rs13227841	0.611102525580065	Asthma	2e-09	32514122
rs4717822	rs4304220	0.899978713316012	Height	2e-14	36224396
rs4717822	rs4355658	0.787355680361081	Height	3e-13	36224396
rs4717822	rs13232536	0.640920014269693	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4717823	rs4304220	0.962051544064083	Height	2e-14	36224396
rs4717823	rs13232536	0.754438643929562	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs4717823	rs4355658	0.67470310951247	Height	3e-13	36224396
rs4717823	rs13227841	0.640792937263983	Asthma	2e-09	32514122
rs4717826	rs4304220	0.699381202126198	Height	2e-14	36224396
rs4717826	rs4355658	0.68600795259526	Height	3e-13	36224396
rs4717826	rs13227841	0.606225064325859	Asthma	2e-09	32514122
rs4717826	rs12539962	0.605530265917889	Colorectal cancer	3e-08	36539618
rs472465	rs480293	0.995695207629268	Oily fish consumption	4e-11	32193382
rs472465	rs1613778	0.936339793844063	Total bilirubin levels	3e-08	34594039
rs472465	rs34634095	0.931012935427624	Fish- and plant-related diet	3e-09	32066663
rs472465	rs542831	0.912081877582302	Asthma	5e-13	31361310
rs472465	rs1784776	0.909599216180407	Asthma	2e-09	32296059
rs472465	rs1784775	0.909599216180407	Asthma	2e-09	30929738
rs472465	rs1784775	0.909599216180407	Asthma (adult onset)	6e-09	30929738
rs472465	rs1789358	0.907953058315268	Asthma	2e-08	34103634
rs472465	rs539524	0.901685338144075	Asthma	1e-10	32296059
rs472465	rs12791699	0.872762126067607	Pork consumption	9e-09	32066663
rs472465	rs12791699	0.872762126067607	Oily fish consumption	9e-09	32066663
rs472465	rs487985	0.872762126067607	Highest math class taken	1e-08	30038396
rs472465	rs10891286	0.850248830512744	Noncognitive aspects of educational attainment	5e-10	33414549
rs472465	rs4459340	0.84626988173925	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs472465	rs505372	0.797888120521458	Breast cancer	3e-06	29059683
rs472465	rs505372	0.797888120521458	Medication use (beta blocking agents)	2e-08	34594039
rs472465	rs659529	0.795762329959368	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs472465	rs659529	0.795762329959368	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs472465	rs659529	0.795762329959368	Atopic dermatitis	5e-10	34116867
rs472465	rs9734135	0.763273981578337	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs472465	rs11213941	0.64243308401841	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs472465	rs11213941	0.64243308401841	Eczema	8e-14	30595370
rs472465	rs663763	0.638842257704005	Layilin levels	3e-21	36168886
rs474667	rs337277	0.981244623459218	Metabolite peak levels (QI10992)	3e-52	35995766
rs474667	rs337277	0.981244623459218	Metabolite peak levels (QI4667)	7e-18	35995766
rs474667	rs337277	0.981244623459218	Metabolite peak levels (QI4708)	1e-21	35995766
rs474667	rs337277	0.981244623459218	Metabolite peak levels (QI5169)	7e-57	35995766
rs474667	rs7655841	0.756210507317289	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs474794	rs337277	0.980312438729664	Metabolite peak levels (QI10992)	3e-52	35995766
rs474794	rs337277	0.980312438729664	Metabolite peak levels (QI4667)	7e-18	35995766
rs474794	rs337277	0.980312438729664	Metabolite peak levels (QI4708)	1e-21	35995766
rs474794	rs337277	0.980312438729664	Metabolite peak levels (QI5169)	7e-57	35995766
rs474794	rs7655841	0.755297400918809	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs4759059	rs920778	0.841408293559309	Haemorrhoidal disease	7e-10	33888516
rs4766663	rs1859336	0.984602444847398	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766663	rs6489882	0.967176766167267	Chronic lymphocytic leukemia	5e-08	28165464
rs4766663	rs11066452	0.964554497750017	Blood protein levels	6e-08	30072576
rs4766663	rs4767027	0.943497645385293	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766663	rs2057778	0.939997217495369	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766663	rs2057778	0.939997217495369	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766663	rs2057778	0.939997217495369	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766663	rs1131476	0.914929001603984	Systemic lupus erythematosus	1e-09	33272962
rs4766663	rs2660	0.914929001603984	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766663	rs2660	0.914929001603984	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766663	rs6489867	0.670331323347399	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766663	rs1557866	0.625404181990618	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766664	rs1859336	0.984591989539696	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766664	rs6489882	0.967172553197103	Chronic lymphocytic leukemia	5e-08	28165464
rs4766664	rs11066452	0.964506716173637	Blood protein levels	6e-08	30072576
rs4766664	rs4767027	0.943416381863401	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766664	rs2057778	0.939915137495168	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766664	rs2057778	0.939915137495168	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766664	rs2057778	0.939915137495168	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766664	rs1131476	0.914864152576805	Systemic lupus erythematosus	1e-09	33272962
rs4766664	rs2660	0.914864152576805	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766664	rs2660	0.914864152576805	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766664	rs6489867	0.670495279014415	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766664	rs1557866	0.624807585318302	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766665	rs1859336	0.984584311711367	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766665	rs6489882	0.967171076802868	Chronic lymphocytic leukemia	5e-08	28165464
rs4766665	rs11066452	0.962110643836697	Blood protein levels	6e-08	30072576
rs4766665	rs4767027	0.941001141327276	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766665	rs2057778	0.937504241664939	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766665	rs2057778	0.937504241664939	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766665	rs2057778	0.937504241664939	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766665	rs1131476	0.912520909071841	Systemic lupus erythematosus	1e-09	33272962
rs4766665	rs2660	0.912520909071841	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766665	rs2660	0.912520909071841	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766665	rs6489867	0.670661380047481	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766665	rs1557866	0.622098002207682	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766666	rs1859336	0.982296787841801	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766666	rs6489882	0.962563686249733	Chronic lymphocytic leukemia	5e-08	28165464
rs4766666	rs11066452	0.96003001411187	Blood protein levels	6e-08	30072576
rs4766666	rs4767027	0.939101336437832	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766666	rs2057778	0.935613588357654	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766666	rs2057778	0.935613588357654	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766666	rs2057778	0.935613588357654	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766666	rs1131476	0.910594147567952	Systemic lupus erythematosus	1e-09	33272962
rs4766666	rs2660	0.910594147567952	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766666	rs2660	0.910594147567952	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766666	rs6489867	0.668094548028701	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766666	rs1557866	0.620875773885386	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766667	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766667	rs6489882	0.970680553445448	Chronic lymphocytic leukemia	5e-08	28165464
rs4766667	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs4766667	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766667	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766667	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766667	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766667	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs4766667	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766667	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766667	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766667	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766668	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766668	rs6489882	0.970680553445448	Chronic lymphocytic leukemia	5e-08	28165464
rs4766668	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs4766668	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766668	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766668	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766668	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766668	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs4766668	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766668	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766668	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766668	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766669	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766669	rs6489882	0.970680553445448	Chronic lymphocytic leukemia	5e-08	28165464
rs4766669	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs4766669	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766669	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766669	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766669	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766669	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs4766669	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766669	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766669	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766669	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766670	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766670	rs6489882	0.970680553445448	Chronic lymphocytic leukemia	5e-08	28165464
rs4766670	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs4766670	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766670	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766670	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766670	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766670	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs4766670	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766670	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766670	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766670	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766671	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766671	rs6489882	0.973012290739672	Chronic lymphocytic leukemia	5e-08	28165464
rs4766671	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs4766671	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766671	rs2057778	0.945953175289466	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766671	rs2057778	0.945953175289466	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766671	rs2057778	0.945953175289466	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766671	rs1131476	0.920732753917687	Systemic lupus erythematosus	1e-09	33272962
rs4766671	rs2660	0.920732753917687	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766671	rs2660	0.920732753917687	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766671	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766671	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766672	rs1859336	0.948457134159983	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766672	rs6489882	0.931390533333558	Chronic lymphocytic leukemia	5e-08	28165464
rs4766672	rs11066452	0.92701450207403	Blood protein levels	6e-08	30072576
rs4766672	rs4767027	0.906836430010846	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766672	rs2057778	0.9056915201348	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766672	rs2057778	0.9056915201348	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766672	rs2057778	0.9056915201348	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766672	rs1131476	0.881066211130712	Systemic lupus erythematosus	1e-09	33272962
rs4766672	rs2660	0.881066211130712	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766672	rs2660	0.881066211130712	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766672	rs6489867	0.704445594009011	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766672	rs1557866	0.6002224165896	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766673	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766673	rs6489882	0.973012290739672	Chronic lymphocytic leukemia	5e-08	28165464
rs4766673	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs4766673	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766673	rs2057778	0.945953175289466	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766673	rs2057778	0.945953175289466	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766673	rs2057778	0.945953175289466	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766673	rs1131476	0.920732753917687	Systemic lupus erythematosus	1e-09	33272962
rs4766673	rs2660	0.920732753917687	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766673	rs2660	0.920732753917687	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766673	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766673	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4766674	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4766674	rs6489882	0.973012290739672	Chronic lymphocytic leukemia	5e-08	28165464
rs4766674	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs4766674	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4766674	rs2057778	0.945953175289466	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4766674	rs2057778	0.945953175289466	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4766674	rs2057778	0.945953175289466	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4766674	rs1131476	0.920732753917687	Systemic lupus erythematosus	1e-09	33272962
rs4766674	rs2660	0.920732753917687	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4766674	rs2660	0.920732753917687	COVID-19 (critical illness vs population)	3e-15	37198478
rs4766674	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs4766674	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767024	rs4767027	0.993930611589695	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767024	rs2057778	0.990299806494544	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767024	rs2057778	0.990299806494544	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767024	rs2057778	0.990299806494544	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767024	rs11066452	0.972458233212723	Blood protein levels	6e-08	30072576
rs4767024	rs1131476	0.964440121336424	Systemic lupus erythematosus	1e-09	33272962
rs4767024	rs2660	0.964440121336424	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767024	rs2660	0.964440121336424	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767024	rs1859336	0.938801682824916	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767024	rs6489882	0.919792293281528	Chronic lymphocytic leukemia	5e-08	28165464
rs4767024	rs6489867	0.639258743875753	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767024	rs1557866	0.602943114916342	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767025	rs4767027	0.996356532839968	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767025	rs2057778	0.992721558416588	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767025	rs2057778	0.992721558416588	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767025	rs2057778	0.992721558416588	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767025	rs11066452	0.974841003712127	Blood protein levels	6e-08	30072576
rs4767025	rs1131476	0.966794064114406	Systemic lupus erythematosus	1e-09	33272962
rs4767025	rs2660	0.966794064114406	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767025	rs2660	0.966794064114406	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767025	rs1859336	0.936464296257148	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767025	rs6489882	0.917484604324638	Chronic lymphocytic leukemia	5e-08	28165464
rs4767025	rs6489867	0.640829140436559	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767025	rs1557866	0.601419053212683	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767026	rs1131476	0.978754454324944	Systemic lupus erythematosus	1e-09	33272962
rs4767026	rs2660	0.978754454324944	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767026	rs2660	0.978754454324944	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767026	rs4767027	0.956577738184546	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767026	rs2057778	0.953050935975866	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767026	rs2057778	0.953050935975866	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767026	rs2057778	0.953050935975866	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767026	rs11066452	0.935589823737867	Blood protein levels	6e-08	30072576
rs4767026	rs1859336	0.898280862417729	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767026	rs6489882	0.879773090823229	Chronic lymphocytic leukemia	5e-08	28165464
rs4767026	rs6489867	0.634345801711772	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767027	rs4767027	1	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767027	rs2057778	0.996358763724451	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767027	rs2057778	0.996358763724451	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767027	rs2057778	0.996358763724451	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767027	rs11066452	0.978419663267803	Blood protein levels	6e-08	30072576
rs4767027	rs1131476	0.97032942751798	Systemic lupus erythematosus	1e-09	33272962
rs4767027	rs2660	0.97032942751798	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767027	rs2660	0.97032942751798	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767027	rs1859336	0.939956325931902	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767027	rs6489882	0.920919567161265	Chronic lymphocytic leukemia	5e-08	28165464
rs4767027	rs6489867	0.643187703666908	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767027	rs1557866	0.6033381828865	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767028	rs1131476	0.996419680741754	Systemic lupus erythematosus	1e-09	33272962
rs4767028	rs2660	0.996419680741754	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767028	rs2660	0.996419680741754	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767028	rs4767027	0.973815999695679	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767028	rs2057778	0.970243768031476	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767028	rs2057778	0.970243768031476	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767028	rs2057778	0.970243768031476	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767028	rs11066452	0.95259289093647	Blood protein levels	6e-08	30072576
rs4767028	rs1859336	0.914825609519285	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767028	rs6489882	0.896107791606747	Chronic lymphocytic leukemia	5e-08	28165464
rs4767028	rs6489867	0.624227918102694	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767029	rs4767027	0.998785762519793	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767029	rs2057778	0.99757238798652	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767029	rs2057778	0.99757238798652	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767029	rs2057778	0.99757238798652	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767029	rs11066452	0.977221991111765	Blood protein levels	6e-08	30072576
rs4767029	rs1131476	0.971509070243431	Systemic lupus erythematosus	1e-09	33272962
rs4767029	rs2660	0.971509070243431	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767029	rs2660	0.971509070243431	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767029	rs1859336	0.938790929403504	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767029	rs6489882	0.919768958194515	Chronic lymphocytic leukemia	5e-08	28165464
rs4767029	rs6489867	0.64222910396762	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767029	rs1557866	0.602578612645332	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767030	rs1131476	0.996419292611805	Systemic lupus erythematosus	1e-09	33272962
rs4767030	rs2660	0.996419292611805	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767030	rs2660	0.996419292611805	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767030	rs4767027	0.97148942956078	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767030	rs2057778	0.970295454320532	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767030	rs2057778	0.970295454320532	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767030	rs2057778	0.970295454320532	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767030	rs11066452	0.950298063296239	Blood protein levels	6e-08	30072576
rs4767030	rs1859336	0.912592635879852	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767030	rs6489882	0.893903163566506	Chronic lymphocytic leukemia	5e-08	28165464
rs4767030	rs6489867	0.624093212821069	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767031	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767031	rs6489882	0.970680553445448	Chronic lymphocytic leukemia	5e-08	28165464
rs4767031	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs4767031	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767031	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767031	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767031	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767031	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs4767031	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767031	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767031	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767031	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767032	rs1859336	0.983407098684218	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767032	rs6489882	0.966006385100681	Chronic lymphocytic leukemia	5e-08	28165464
rs4767032	rs11066452	0.960959623324381	Blood protein levels	6e-08	30072576
rs4767032	rs4767027	0.939874106232232	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767032	rs2057778	0.936380203428974	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767032	rs2057778	0.936380203428974	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767032	rs2057778	0.936380203428974	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767032	rs1131476	0.911413492661145	Systemic lupus erythematosus	1e-09	33272962
rs4767032	rs2660	0.911413492661145	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767032	rs2660	0.911413492661145	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767032	rs6489867	0.669695762456863	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767032	rs1557866	0.621340081983519	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767033	rs1859336	0.976337750097342	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767033	rs6489882	0.956710966363023	Chronic lymphocytic leukemia	5e-08	28165464
rs4767033	rs11066452	0.953930568976932	Blood protein levels	6e-08	30072576
rs4767033	rs4767027	0.932888437434199	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767033	rs2057778	0.929410028564715	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767033	rs2057778	0.929410028564715	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767033	rs2057778	0.929410028564715	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767033	rs1131476	0.904594346943201	Systemic lupus erythematosus	1e-09	33272962
rs4767033	rs2660	0.904594346943201	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767033	rs2660	0.904594346943201	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767033	rs6489867	0.664414169790497	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767033	rs1557866	0.612927052856802	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767034	rs1859336	0.983407098684218	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767034	rs6489882	0.963678317369446	Chronic lymphocytic leukemia	5e-08	28165464
rs4767034	rs11066452	0.960959623324381	Blood protein levels	6e-08	30072576
rs4767034	rs4767027	0.939874106232232	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767034	rs2057778	0.936380203428974	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767034	rs2057778	0.936380203428974	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767034	rs2057778	0.936380203428974	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767034	rs1131476	0.911413492661145	Systemic lupus erythematosus	1e-09	33272962
rs4767034	rs2660	0.911413492661145	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767034	rs2660	0.911413492661145	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767034	rs6489867	0.669695762456863	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767034	rs1557866	0.623452299526821	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767036	rs1859336	0.976567321212551	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767036	rs6489882	0.956896490958683	Chronic lymphocytic leukemia	5e-08	28165464
rs4767036	rs11066452	0.954504608964788	Blood protein levels	6e-08	30072576
rs4767036	rs4767027	0.933758531733291	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767036	rs2057778	0.930286944564661	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767036	rs2057778	0.930286944564661	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767036	rs2057778	0.930286944564661	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767036	rs1131476	0.905314138061879	Systemic lupus erythematosus	1e-09	33272962
rs4767036	rs2660	0.905314138061879	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767036	rs2660	0.905314138061879	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767036	rs6489867	0.685922756228423	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767036	rs1557866	0.618355200502854	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767037	rs1859336	0.974230491613237	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767037	rs6489882	0.956896490958683	Chronic lymphocytic leukemia	5e-08	28165464
rs4767037	rs11066452	0.952180771291252	Blood protein levels	6e-08	30072576
rs4767037	rs4767027	0.931448746971396	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767037	rs2057778	0.927982279001952	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767037	rs2057778	0.927982279001952	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767037	rs2057778	0.927982279001952	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767037	rs1131476	0.903059605334448	Systemic lupus erythematosus	1e-09	33272962
rs4767037	rs2660	0.903059605334448	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767037	rs2660	0.903059605334448	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767037	rs6489867	0.684149456125262	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767037	rs1557866	0.620449571091017	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767040	rs1859336	0.974270923210188	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767040	rs6489882	0.959234593556817	Chronic lymphocytic leukemia	5e-08	28165464
rs4767040	rs11066452	0.952258866983591	Blood protein levels	6e-08	30072576
rs4767040	rs4767027	0.931559191577056	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767040	rs2057778	0.930396692917226	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767040	rs2057778	0.930396692917226	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767040	rs2057778	0.930396692917226	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767040	rs1131476	0.905406190042129	Systemic lupus erythematosus	1e-09	33272962
rs4767040	rs2660	0.905406190042129	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767040	rs2660	0.905406190042129	COVID-19 (critical illness vs population)	3e-15	37198478
rs4767040	rs6489867	0.683991702880807	COVID-19 (critical illness vs population)	1e-09	33307546
rs4767040	rs1557866	0.618964349262652	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4767041	rs1859336	0.746740146023313	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4767041	rs6489882	0.745125805537863	Chronic lymphocytic leukemia	5e-08	28165464
rs4767041	rs11066452	0.729558509457063	Blood protein levels	6e-08	30072576
rs4767041	rs4767027	0.713295231427556	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4767041	rs2057778	0.712291996249232	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4767041	rs2057778	0.712291996249232	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4767041	rs2057778	0.712291996249232	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4767041	rs1131476	0.690627990592484	Systemic lupus erythematosus	1e-09	33272962
rs4767041	rs2660	0.690627990592484	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4767041	rs2660	0.690627990592484	COVID-19 (critical illness vs population)	3e-15	37198478
rs4774427	rs8034216	0.910585328348282	C-reactive protein levels	2e-10	31900758
rs4774427	rs17271340	0.872369752559582	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs4774427	rs13379492	0.848982544733624	Lung function (FEV1/FVC)	6e-08	30595370
rs4774427	rs17271305	0.846292440834998	Two-hour glucose challenge	1e-07	20081857
rs4774427	rs35967150	0.839161070881828	C-reactive protein levels (MTAG)	1e-08	36376304
rs4774427	rs11634163	0.832051721914753	C-reactive protein	2e-08	34594039
rs4774427	rs11634163	0.832051721914753	Two-hour glucose	3e-14	34059833
rs4774427	rs189400382	0.829014705348778	C-reactive protein levels	1e-08	35459240
rs4774427	rs28373613	0.614708419034796	Height (standard GWA)	8e-12	37106081
rs4775453	rs28373613	0.907841181087514	Height (standard GWA)	8e-12	37106081
rs4775453	rs13379492	0.637832033606998	Lung function (FEV1/FVC)	6e-08	30595370
rs4775453	rs8034216	0.604090113996106	C-reactive protein levels	2e-10	31900758
rs4775455	rs1436958	0.953927875221167	IgG glycosylation	9e-06	23382691
rs4775455	rs2162062	0.847062489674896	Height	2e-13	35831902
rs4775455	rs933807	0.801220039708492	Fat-free mass	6e-06	30593698
rs4775455	rs933807	0.801220039708492	Fat-free mass	2e-07	30593698
rs4775455	rs933807	0.801220039708492	Fat-free mass	8e-11	30593698
rs4775455	rs7178540	0.711659332033333	Height	1e-31	36224396
rs4775455	rs11635977	0.694292286442106	Height	2e-25	36224396
rs4775455	rs72749770	0.680920164640355	Low density lipoprotein cholesterol levels	9e-10	32493714
rs4775455	rs72749770	0.680920164640355	Apolipoprotein B levels	2e-09	32203549
rs4775455	rs7162536	0.680016075621181	Height	4e-29	34594039
rs4775455	rs7178424	0.671412026339113	Height	6e-09	20881960
rs4775455	rs7178424	0.671412026339113	Height	6e-13	35831902
rs4775455	rs7178424	0.671412026339113	Height	3e-251	36224396
rs4775455	rs17271431	0.668970558150838	Height	2e-11	34594039
rs4775455	rs17205463	0.668432931853242	Serum levels of protein IGF1	8e-08	27329260
rs4775455	rs17205463	0.668432931853242	Appendicular lean mass	4e-43	33097823
rs4775455	rs17205463	0.668432931853242	Height	2e-35	30595370
rs4775455	rs731820	0.657829174980935	Height	2e-13	31562340
rs4775455	rs731820	0.657829174980935	Height	2e-12	35831902
rs4775455	rs12901247	0.614651030787923	Insular cortex volume	4e-06	31530798
rs4791658	rs9897542	0.697215300862777	Total bilirubin levels	8e-11	34594039
rs4792713	rs9897542	0.922132825927048	Total bilirubin levels	8e-11	34594039
rs4792713	rs2285583	0.763793013270704	AFP levels	2e-08	36329257
rs4796395	rs12949545	0.829155017117967	Highest math class taken (MTAG)	3e-08	30038396
rs4796396	rs12949545	0.829155017117967	Highest math class taken (MTAG)	3e-08	30038396
rs479667	rs539524	0.996607723601558	Asthma	1e-10	32296059
rs479667	rs1789358	0.914530177468623	Asthma	2e-08	34103634
rs479667	rs1784776	0.911353278697041	Asthma	2e-09	32296059
rs479667	rs1784775	0.911353278697041	Asthma	2e-09	30929738
rs479667	rs1784775	0.911353278697041	Asthma (adult onset)	6e-09	30929738
rs479667	rs542831	0.910454804301439	Asthma	5e-13	31361310
rs479667	rs34634095	0.907892482688033	Fish- and plant-related diet	3e-09	32066663
rs479667	rs480293	0.904122623798514	Oily fish consumption	4e-11	32193382
rs479667	rs12791699	0.902657429268881	Pork consumption	9e-09	32066663
rs479667	rs12791699	0.902657429268881	Oily fish consumption	9e-09	32066663
rs479667	rs487985	0.902657429268881	Highest math class taken	1e-08	30038396
rs479667	rs10891286	0.877694290209001	Noncognitive aspects of educational attainment	5e-10	33414549
rs479667	rs4459340	0.873838028444544	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs479667	rs1613778	0.850479009348611	Total bilirubin levels	3e-08	34594039
rs479667	rs505372	0.828468059527453	Breast cancer	3e-06	29059683
rs479667	rs505372	0.828468059527453	Medication use (beta blocking agents)	2e-08	34594039
rs479667	rs9734135	0.791892754971114	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs479667	rs659529	0.781459759264572	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs479667	rs659529	0.781459759264572	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs479667	rs659529	0.781459759264572	Atopic dermatitis	5e-10	34116867
rs479667	rs11213941	0.6340192227399	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs479667	rs11213941	0.6340192227399	Eczema	8e-14	30595370
rs479667	rs663763	0.623889043878716	Layilin levels	3e-21	36168886
rs4801634	rs4801635	0.965196145731453	Plasma anti-thyroglobulin levels	9e-07	29678681
rs4801635	rs4801635	1	Plasma anti-thyroglobulin levels	9e-07	29678681
rs4802156	rs1138888	0.798612135299409	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs4802156	rs1138888	0.798612135299409	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs4802156	rs4802157	0.778207169161439	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs4802156	rs2355433	0.672166495429124	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs4802156	rs2355433	0.672166495429124	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs4802156	rs2355433	0.672166495429124	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs480293	rs480293	1	Oily fish consumption	4e-11	32193382
rs480293	rs1613778	0.935626834667536	Total bilirubin levels	3e-08	34594039
rs480293	rs34634095	0.930160584151136	Fish- and plant-related diet	3e-09	32066663
rs480293	rs542831	0.911356680250351	Asthma	5e-13	31361310
rs480293	rs1784776	0.908881534561693	Asthma	2e-09	32296059
rs480293	rs1784775	0.908881534561693	Asthma	2e-09	30929738
rs480293	rs1784775	0.908881534561693	Asthma (adult onset)	6e-09	30929738
rs480293	rs1789358	0.907230232679165	Asthma	2e-08	34103634
rs480293	rs539524	0.900802615816764	Asthma	1e-10	32296059
rs480293	rs12791699	0.872098755500751	Pork consumption	9e-09	32066663
rs480293	rs12791699	0.872098755500751	Oily fish consumption	9e-09	32066663
rs480293	rs487985	0.872098755500751	Highest math class taken	1e-08	30038396
rs480293	rs10891286	0.846452917612898	Noncognitive aspects of educational attainment	5e-10	33414549
rs480293	rs4459340	0.842491325284755	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs480293	rs505372	0.797453330357739	Breast cancer	3e-06	29059683
rs480293	rs505372	0.797453330357739	Medication use (beta blocking agents)	2e-08	34594039
rs480293	rs659529	0.795254592081873	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs480293	rs659529	0.795254592081873	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs480293	rs659529	0.795254592081873	Atopic dermatitis	5e-10	34116867
rs480293	rs9734135	0.759859867299018	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs480293	rs11213941	0.642383252219129	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs480293	rs11213941	0.642383252219129	Eczema	8e-14	30595370
rs480293	rs663763	0.63815093929711	Layilin levels	3e-21	36168886
rs4807999	rs4808407	0.923162405587471	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs4808000	rs4808407	0.923162405587471	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs4808001	rs4808407	0.925590422437114	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs4808002	rs4808407	0.932598345216716	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs4808003	rs4808407	0.932598345216716	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs4808004	rs4808407	0.934315397065072	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs4808147	rs10419226	0.612411632955796	Esophageal adenocarcinoma	8e-07	24121790
rs4808147	rs10419226	0.612411632955796	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	4e-10	24121790
rs4808147	rs10419226	0.612411632955796	Barrett's esophagus	6e-08	24121790
rs4815413	rs2257649	0.983963333301816	Total Phosphatidylglycerol levels	3e-10	35668104
rs4815413	rs4815400	0.982185364912335	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs4815413	rs6037062	0.6767099014667	Lung function (forced vital capacity)	3e-13	36914875
rs4815413	rs6037062	0.6767099014667	Lung function (FVC)	5e-12	30595370
rs4815413	rs2500430	0.650784265405464	Serum alkaline phosphatase levels	7e-10	31666285
rs4815413	rs2273473	0.621574395309	Vertex-wise cortical thickness	1e-12	34910505
rs4815413	rs2856	0.605269782706696	Blood protein levels	6e-07	27532455
rs4815413	rs4815412	0.601608251673476	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs4815413	rs12428	0.600918569709305	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs4815429	rs4815400	0.934809370265597	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs4815429	rs2257649	0.933107741646847	Total Phosphatidylglycerol levels	3e-10	35668104
rs4815429	rs6037062	0.638369707869192	Lung function (forced vital capacity)	3e-13	36914875
rs4815429	rs6037062	0.638369707869192	Lung function (FVC)	5e-12	30595370
rs4815429	rs2500430	0.604840091550531	Serum alkaline phosphatase levels	7e-10	31666285
rs4821461	rs4821461	1	Severe COVID-19 infection	4e-06	36662838
rs4821461	rs6000172	0.979128833961024	Severe COVID-19 infection	1e-07	36662838
rs4821461	rs2227169	0.963067367873366	Severe COVID-19 infection	4e-13	36662838
rs4821461	rs1053982	0.939017742744797	Severe COVID-19 infection	9e-06	36662838
rs4821461	rs5756090	0.817839569758009	Severe COVID-19 infection	4e-08	36662838
rs4845409	rs2999541	0.966664047381536	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs4845409	rs3007711	0.962449988301092	Electrodermal activity	9e-06	25387706
rs4845409	rs7542137	0.876550287079655	Beta-hydroxyisovalerate levels	3e-11	35050183
rs4845409	rs7542137	0.876550287079655	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs4845409	rs7542137	0.876550287079655	3-hydroxysebacate levels	2e-10	36635386
rs4845409	rs2130525	0.861705201075358	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs4845409	rs10788817	0.761584103786005	Serum metabolite levels	3e-13	24625756
rs4845409	rs10788817	0.761584103786005	Metabolite peak levels (QI2718)	5e-18	35995766
rs4845409	rs10788817	0.761584103786005	3-hydroxylaurate levels	2e-12	36635386
rs4845409	rs10788817	0.761584103786005	Tetradecadienoate (14:2) levels	8e-17	36635386
rs4845409	rs11204914	0.75910446606586	Carnitine C9 levels	1e-13	35995766
rs4845409	rs11204914	0.75910446606586	Metabolite peak levels (QI6204)	1e-32	35995766
rs4845409	rs11204914	0.75910446606586	Metabolite peak levels (QI6252)	2e-32	35995766
rs4845409	rs6685187	0.735515767593769	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs4845409	rs6698740	0.733485299586114	Beta-hydroxyisovalerate levels	1e-13	35347128
rs4845409	rs1060870	0.732063337031581	Serum metabolite levels	1e-11	33031748
rs4845409	rs1060870	0.732063337031581	Serum metabolite levels	1e-15	33031748
rs4845409	rs2338201	0.72282539882897	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs4845409	rs2338201	0.72282539882897	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs4845409	rs2338201	0.72282539882897	Dodecadienoate (12:2) levels	7e-15	36635386
rs4845409	rs56000812	0.705606159833729	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs4845409	rs56078223	0.703421053925111	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs4845409	rs56078223	0.703421053925111	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs4845409	rs2279501	0.701425228450549	Serum metabolite levels	3e-14	33031748
rs4845409	rs2999545	0.639871823544348	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs4845409	rs10494270	0.637644082718857	Nonaylcarnitine levels	5e-13	26068415
rs4845409	rs6684312	0.633880269948957	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs4845409	rs9943221	0.631119862827757	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs4845409	rs7523082	0.610071542690938	Metabolite peak levels (QI9845)	2e-14	35995766
rs4845409	rs10888445	0.606862803229128	Beta-hydroxyisovalerate levels	5e-13	36635386
rs4845409	rs7541453	0.60455120793122	Serum metabolite levels	2e-16	33031748
rs4845409	rs7541453	0.60455120793122	Serum metabolite levels	2e-16	33031748
rs4845409	rs7541453	0.60455120793122	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs4845713	rs2999541	0.961670121039672	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs4845713	rs3007711	0.957465510983551	Electrodermal activity	9e-06	25387706
rs4845713	rs7542137	0.871832008759726	Beta-hydroxyisovalerate levels	3e-11	35050183
rs4845713	rs7542137	0.871832008759726	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs4845713	rs7542137	0.871832008759726	3-hydroxysebacate levels	2e-10	36635386
rs4845713	rs2130525	0.857027482619903	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs4845713	rs10788817	0.757240105056416	Serum metabolite levels	3e-13	24625756
rs4845713	rs10788817	0.757240105056416	Metabolite peak levels (QI2718)	5e-18	35995766
rs4845713	rs10788817	0.757240105056416	3-hydroxylaurate levels	2e-12	36635386
rs4845713	rs10788817	0.757240105056416	Tetradecadienoate (14:2) levels	8e-17	36635386
rs4845713	rs11204914	0.754765385449135	Carnitine C9 levels	1e-13	35995766
rs4845713	rs11204914	0.754765385449135	Metabolite peak levels (QI6204)	1e-32	35995766
rs4845713	rs11204914	0.754765385449135	Metabolite peak levels (QI6252)	2e-32	35995766
rs4845713	rs6685187	0.7312479096803	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs4845713	rs6698740	0.729223550941716	Beta-hydroxyisovalerate levels	1e-13	35347128
rs4845713	rs1060870	0.727805727406384	Serum metabolite levels	1e-11	33031748
rs4845713	rs1060870	0.727805727406384	Serum metabolite levels	1e-15	33031748
rs4845713	rs2338201	0.718597366834794	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs4845713	rs2338201	0.718597366834794	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs4845713	rs2338201	0.718597366834794	Dodecadienoate (12:2) levels	7e-15	36635386
rs4845713	rs56000812	0.701072686113499	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs4845713	rs56078223	0.698893748021506	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs4845713	rs56078223	0.698893748021506	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs4845713	rs2279501	0.697225928184058	Serum metabolite levels	3e-14	33031748
rs4845713	rs2999545	0.635913624159491	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs4845713	rs10494270	0.633384374309433	Nonaylcarnitine levels	5e-13	26068415
rs4845713	rs6684312	0.629552391602374	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs4845713	rs9943221	0.626884266603191	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs4845713	rs7523082	0.606210801360053	Metabolite peak levels (QI9845)	2e-14	35995766
rs4845713	rs10888445	0.603011755014086	Beta-hydroxyisovalerate levels	5e-13	36635386
rs4845713	rs7541453	0.600709060451787	Serum metabolite levels	2e-16	33031748
rs4845713	rs7541453	0.600709060451787	Serum metabolite levels	2e-16	33031748
rs4845713	rs7541453	0.600709060451787	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs4845930	rs7524908	0.724791706270285	Height	5e-27	30595370
rs4845930	rs3828081	0.714589395129558	Cognitive function (immediate memory)	8e-08	35386118
rs4846199	rs7524908	0.728149090391326	Height	5e-27	30595370
rs4846199	rs3828081	0.715301510404402	Cognitive function (immediate memory)	8e-08	35386118
rs484834	rs480293	0.996553664195234	Oily fish consumption	4e-11	32193382
rs484834	rs1613778	0.938936306353125	Total bilirubin levels	3e-08	34594039
rs484834	rs34634095	0.933486717580242	Fish- and plant-related diet	3e-09	32066663
rs484834	rs542831	0.912968637658945	Asthma	5e-13	31361310
rs484834	rs1784776	0.910489180520672	Asthma	2e-09	32296059
rs484834	rs1784775	0.910489180520672	Asthma	2e-09	30929738
rs484834	rs1784775	0.910489180520672	Asthma (adult onset)	6e-09	30929738
rs484834	rs1789358	0.908838086823443	Asthma	2e-08	34103634
rs484834	rs539524	0.902454993829896	Asthma	1e-10	32296059
rs484834	rs12791699	0.873659489232336	Pork consumption	9e-09	32066663
rs484834	rs12791699	0.873659489232336	Oily fish consumption	9e-09	32066663
rs484834	rs487985	0.873659489232336	Highest math class taken	1e-08	30038396
rs484834	rs10891286	0.84796878278266	Noncognitive aspects of educational attainment	5e-10	33414549
rs484834	rs4459340	0.84400025929961	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs484834	rs505372	0.798882491357711	Breast cancer	3e-06	29059683
rs484834	rs505372	0.798882491357711	Medication use (beta blocking agents)	2e-08	34594039
rs484834	rs659529	0.796703063134625	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs484834	rs659529	0.796703063134625	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs484834	rs659529	0.796703063134625	Atopic dermatitis	5e-10	34116867
rs484834	rs9734135	0.76122326434691	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs484834	rs11213941	0.643561601330614	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs484834	rs11213941	0.643561601330614	Eczema	8e-14	30595370
rs484834	rs663763	0.639514405368792	Layilin levels	3e-21	36168886
rs486038	rs480293	0.994833371534336	Oily fish consumption	4e-11	32193382
rs486038	rs1613778	0.937204752835295	Total bilirubin levels	3e-08	34594039
rs486038	rs34634095	0.931837011464509	Fish- and plant-related diet	3e-09	32066663
rs486038	rs542831	0.91127465049659	Asthma	5e-13	31361310
rs486038	rs1784776	0.908794151340335	Asthma	2e-09	32296059
rs486038	rs1784775	0.908794151340335	Asthma	2e-09	30929738
rs486038	rs1784775	0.908794151340335	Asthma (adult onset)	6e-09	30929738
rs486038	rs1789358	0.907147889112705	Asthma	2e-08	34103634
rs486038	rs539524	0.900857840756424	Asthma	1e-10	32296059
rs486038	rs12791699	0.871980588279954	Pork consumption	9e-09	32066663
rs486038	rs12791699	0.871980588279954	Oily fish consumption	9e-09	32066663
rs486038	rs487985	0.871980588279954	Highest math class taken	1e-08	30038396
rs486038	rs10891286	0.849487979442717	Noncognitive aspects of educational attainment	5e-10	33414549
rs486038	rs4459340	0.845512509582147	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs486038	rs505372	0.797172567314368	Breast cancer	3e-06	29059683
rs486038	rs505372	0.797172567314368	Medication use (beta blocking agents)	2e-08	34594039
rs486038	rs659529	0.795037091738613	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs486038	rs659529	0.795037091738613	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs486038	rs659529	0.795037091738613	Atopic dermatitis	5e-10	34116867
rs486038	rs9734135	0.762589657967328	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs486038	rs11213941	0.641843310697947	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs486038	rs11213941	0.641843310697947	Eczema	8e-14	30595370
rs486038	rs663763	0.638159628418063	Layilin levels	3e-21	36168886
rs4862406	rs2130392	0.983085858320946	Kawasaki disease	3e-08	22446962
rs4865745	rs2548499	0.935980357166003	Lymphocyte count	9e-14	32888494
rs4865745	rs2648731	0.745586353939907	Type 2 diabetes	7e-12	34594039
rs4865745	rs2648731	0.745586353939907	Type 2 diabetes	3e-19	34594039
rs4865745	rs2648731	0.745586353939907	Lymphocyte count	2e-11	34594039
rs4865745	rs2648731	0.745586353939907	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs4865745	rs2648731	0.745586353939907	Medication use (drugs used in diabetes)	3e-09	34594039
rs4865745	rs13189973	0.630080488637796	Lymphocyte count	2e-16	32888493
rs4869311	rs1974871	0.916669349652752	Granulysin levels	5e-13	34648354
rs4869311	rs4869314	0.904823271627218	Arthritis (juvenile idiopathic)	3e-09	33106285
rs4869311	rs4869314	0.904823271627218	Neutrophil count	1e-10	34594039
rs4869311	rs4869314	0.904823271627218	White blood cell count	2e-07	30595370
rs4869311	rs2549782	0.85010077253848	Systolic blood pressure	6e-07	33230300
rs4869311	rs2549782	0.85010077253848	Diastolic blood pressure	1e-14	33230300
rs4869311	rs2549782	0.85010077253848	Diastolic blood pressure	3e-11	33230300
rs4869311	rs2549782	0.85010077253848	Systolic blood pressure	5e-09	33230300
rs4869311	rs2549797	0.85008721562494	Systolic blood pressure	7e-07	33230300
rs4869311	rs2549797	0.85008721562494	Diastolic blood pressure	1e-14	33230300
rs4869311	rs2549797	0.85008721562494	Diastolic blood pressure	3e-11	33230300
rs4869311	rs2549797	0.85008721562494	Systolic blood pressure	4e-09	33230300
rs4869311	rs1056893	0.847874009087815	Systolic blood pressure	1e-06	33230300
rs4869311	rs1056893	0.847874009087815	Diastolic blood pressure	7e-15	33230300
rs4869311	rs1056893	0.847874009087815	Diastolic blood pressure	2e-11	33230300
rs4869311	rs1056893	0.847874009087815	Systolic blood pressure	7e-09	33230300
rs4869311	rs4869313	0.829026994780015	Pediatric autoimmune diseases	9e-08	26301688
rs4869311	rs1559359	0.821332617036965	Diastolic blood pressure	7e-10	34594039
rs4869311	rs2910686	0.803215586138696	Neutrophil count	4e-14	32888493
rs4869311	rs2910686	0.803215586138696	Psoriasis	2e-08	23143594
rs4869311	rs2910686	0.803215586138696	Ankylosing spondylitis	5e-17	23749187
rs4869311	rs2910686	0.803215586138696	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs4869311	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs4869311	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs4869311	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs4869311	rs1019503	0.728940392110976	Systolic blood pressure	2e-06	33230300
rs4869311	rs1019503	0.728940392110976	Diastolic blood pressure	2e-14	33230300
rs4869311	rs1019503	0.728940392110976	Diastolic blood pressure	4e-11	33230300
rs4869311	rs1019503	0.728940392110976	Systolic blood pressure	1e-08	33230300
rs4869311	rs3096168	0.723409651088165	Aspartate aminotransferase levels	8e-12	33547301
rs4869311	rs1423357	0.704924641235886	General cognitive ability	9e-06	29844566
rs4869311	rs2432142	0.691024795840694	Neutrophil count	2e-14	32888493
rs4869311	rs2432142	0.691024795840694	White blood cell count	1e-11	32888493
rs4869311	rs38033	0.685525237258851	Blood protein levels	0	30072576
rs4869311	rs27293	0.67549231404753	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs4869311	rs27293	0.67549231404753	Diastolic blood pressure	3e-11	35762941
rs4869311	rs7705093	0.666760272686482	Birdshot chorioretinopathy	2e-09	24957906
rs4869312	rs1974871	0.917411194226669	Granulysin levels	5e-13	34648354
rs4869312	rs4869314	0.904083249088078	Arthritis (juvenile idiopathic)	3e-09	33106285
rs4869312	rs4869314	0.904083249088078	Neutrophil count	1e-10	34594039
rs4869312	rs4869314	0.904083249088078	White blood cell count	2e-07	30595370
rs4869312	rs2549782	0.849350553468495	Systolic blood pressure	6e-07	33230300
rs4869312	rs2549782	0.849350553468495	Diastolic blood pressure	1e-14	33230300
rs4869312	rs2549782	0.849350553468495	Diastolic blood pressure	3e-11	33230300
rs4869312	rs2549782	0.849350553468495	Systolic blood pressure	5e-09	33230300
rs4869312	rs2549797	0.849336335969296	Systolic blood pressure	7e-07	33230300
rs4869312	rs2549797	0.849336335969296	Diastolic blood pressure	1e-14	33230300
rs4869312	rs2549797	0.849336335969296	Diastolic blood pressure	3e-11	33230300
rs4869312	rs2549797	0.849336335969296	Systolic blood pressure	4e-09	33230300
rs4869312	rs1056893	0.847125009318234	Systolic blood pressure	1e-06	33230300
rs4869312	rs1056893	0.847125009318234	Diastolic blood pressure	7e-15	33230300
rs4869312	rs1056893	0.847125009318234	Diastolic blood pressure	2e-11	33230300
rs4869312	rs1056893	0.847125009318234	Systolic blood pressure	7e-09	33230300
rs4869312	rs4869313	0.829697403760072	Pediatric autoimmune diseases	9e-08	26301688
rs4869312	rs1559359	0.820556275106077	Diastolic blood pressure	7e-10	34594039
rs4869312	rs2910686	0.802434624025319	Neutrophil count	4e-14	32888493
rs4869312	rs2910686	0.802434624025319	Psoriasis	2e-08	23143594
rs4869312	rs2910686	0.802434624025319	Ankylosing spondylitis	5e-17	23749187
rs4869312	rs2910686	0.802434624025319	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs4869312	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs4869312	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs4869312	rs2927608	0.801098325977439	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs4869312	rs1019503	0.728311499553418	Systolic blood pressure	2e-06	33230300
rs4869312	rs1019503	0.728311499553418	Diastolic blood pressure	2e-14	33230300
rs4869312	rs1019503	0.728311499553418	Diastolic blood pressure	4e-11	33230300
rs4869312	rs1019503	0.728311499553418	Systolic blood pressure	1e-08	33230300
rs4869312	rs3096168	0.722779873820606	Aspartate aminotransferase levels	8e-12	33547301
rs4869312	rs1423357	0.704136975909934	General cognitive ability	9e-06	29844566
rs4869312	rs2432142	0.690245044619686	Neutrophil count	2e-14	32888493
rs4869312	rs2432142	0.690245044619686	White blood cell count	1e-11	32888493
rs4869312	rs38033	0.684757433951945	Blood protein levels	0	30072576
rs4869312	rs27293	0.67472868610218	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs4869312	rs27293	0.67472868610218	Diastolic blood pressure	3e-11	35762941
rs4869312	rs7705093	0.66601105887613	Birdshot chorioretinopathy	2e-09	24957906
rs4869313	rs4869313	1	Pediatric autoimmune diseases	9e-08	26301688
rs4869313	rs1974871	0.901290820613549	Granulysin levels	5e-13	34648354
rs4869313	rs1559359	0.854751919383938	Diastolic blood pressure	7e-10	34594039
rs4869313	rs2927608	0.836413515926563	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs4869313	rs2927608	0.836413515926563	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs4869313	rs2927608	0.836413515926563	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs4869313	rs2910686	0.833536813521386	Neutrophil count	4e-14	32888493
rs4869313	rs2910686	0.833536813521386	Psoriasis	2e-08	23143594
rs4869313	rs2910686	0.833536813521386	Ankylosing spondylitis	5e-17	23749187
rs4869313	rs2910686	0.833536813521386	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs4869313	rs4869314	0.751068795663226	Arthritis (juvenile idiopathic)	3e-09	33106285
rs4869313	rs4869314	0.751068795663226	Neutrophil count	1e-10	34594039
rs4869313	rs4869314	0.751068795663226	White blood cell count	2e-07	30595370
rs4869313	rs2549797	0.738403729649621	Systolic blood pressure	7e-07	33230300
rs4869313	rs2549797	0.738403729649621	Diastolic blood pressure	1e-14	33230300
rs4869313	rs2549797	0.738403729649621	Diastolic blood pressure	3e-11	33230300
rs4869313	rs2549797	0.738403729649621	Systolic blood pressure	4e-09	33230300
rs4869313	rs2549782	0.737148159764535	Systolic blood pressure	6e-07	33230300
rs4869313	rs2549782	0.737148159764535	Diastolic blood pressure	1e-14	33230300
rs4869313	rs2549782	0.737148159764535	Diastolic blood pressure	3e-11	33230300
rs4869313	rs2549782	0.737148159764535	Systolic blood pressure	5e-09	33230300
rs4869313	rs1056893	0.736521216991853	Systolic blood pressure	1e-06	33230300
rs4869313	rs1056893	0.736521216991853	Diastolic blood pressure	7e-15	33230300
rs4869313	rs1056893	0.736521216991853	Diastolic blood pressure	2e-11	33230300
rs4869313	rs1056893	0.736521216991853	Systolic blood pressure	7e-09	33230300
rs4869313	rs2549794	0.724271578137786	Crohn's disease	1e-10	21102463
rs4869313	rs2549794	0.724271578137786	Systolic blood pressure	1e-07	33230300
rs4869313	rs2549794	0.724271578137786	Diastolic blood pressure	1e-15	33230300
rs4869313	rs2549794	0.724271578137786	Diastolic blood pressure	2e-12	33230300
rs4869313	rs2549794	0.724271578137786	Systolic blood pressure	4e-10	33230300
rs4869313	rs1423357	0.723527572951896	General cognitive ability	9e-06	29844566
rs4869313	rs1363907	0.719764569481716	Crohn's disease	4e-16	26192919
rs4869313	rs1363907	0.719764569481716	Ulcerative colitis	4e-06	26192919
rs4869313	rs1363907	0.719764569481716	Inflammatory bowel disease	5e-15	26192919
rs4869313	rs1363907	0.719764569481716	Inflammatory bowel disease	6e-13	23128233
rs4869313	rs1363907	0.719764569481716	Inflammatory bowel disease	1e-10	28067908
rs4869313	rs1363907	0.719764569481716	Crohn's disease	1e-14	28067908
rs4869313	rs2432142	0.709371416020062	Neutrophil count	2e-14	32888493
rs4869313	rs2432142	0.709371416020062	White blood cell count	1e-11	32888493
rs4869313	rs38033	0.705389682429572	Blood protein levels	0	30072576
rs4869313	rs27293	0.694874301684017	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs4869313	rs27293	0.694874301684017	Diastolic blood pressure	3e-11	35762941
rs4869313	rs7705093	0.687721817084065	Birdshot chorioretinopathy	2e-09	24957906
rs4869313	rs2617439	0.684314458247576	Neutrophil count	8e-11	32888494
rs4869313	rs716848	0.672069843350811	Neutrophil percentage of white cells	2e-09	32888494
rs4869313	rs38029	0.671848415102067	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs4869313	rs2548532	0.66196408542932	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs4869313	rs1019503	0.604742379022325	Systolic blood pressure	2e-06	33230300
rs4869313	rs1019503	0.604742379022325	Diastolic blood pressure	2e-14	33230300
rs4869313	rs1019503	0.604742379022325	Diastolic blood pressure	4e-11	33230300
rs4869313	rs1019503	0.604742379022325	Systolic blood pressure	1e-08	33230300
rs4869730	rs2095375	0.982204903462668	Serum metabolite levels	1e-20	33031748
rs4869730	rs2095375	0.982204903462668	Serum metabolite levels	1e-20	33031748
rs4869730	rs9383843	0.98131036348005	Migraine	1e-09	35115687
rs4869730	rs55763431	0.97774903424985	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4869730	rs9689694	0.975982323562444	Right hippocampal volume (head)	6e-11	37337106
rs4869730	rs9689694	0.975982323562444	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4869730	rs9689694	0.975982323562444	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4869730	rs9689694	0.975982323562444	Left hippocampal volume (head)	6e-12	37337106
rs4869730	rs10872645	0.970663255525272	Blood protein levels	2e-86	30072576
rs4869730	rs10872653	0.969804664262822	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4869730	rs9688867	0.969775080059322	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4869730	rs9688867	0.969775080059322	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4869730	rs9688809	0.969775080059322	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4869730	rs34337297	0.966249628756295	Serum levels of protein LRP11	3e-161	35078996
rs4869730	rs14314	0.963609669323676	Macular thickness	3e-19	30535121
rs4869730	rs14314	0.963609669323676	Vertex-wise sulcal depth	7e-17	34910505
rs4869730	rs14314	0.963609669323676	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4869730	rs14314	0.963609669323676	Left hippocampal volume (body)	7e-15	37337106
rs4869730	rs14314	0.963609669323676	Left subiculum volume (body)	1e-14	37337106
rs4869730	rs9322193	0.930546606287193	Lung cancer	1e-07	27393504
rs4869730	rs4039600	0.887751767814643	Adenine levels	1e-11	35347128
rs4869730	rs1934534	0.623283347410232	Pain (pleiotropy)	2e-08	37844115
rs4869730	rs1934534	0.623283347410232	Pain (pleiotropy)	2e-06	37844115
rs4869730	rs4380763	0.622765735182671	Subcortical volume (min-P)	1e-11	32665545
rs4869730	rs11155671	0.613801239833795	Testicular germ cell tumor	2e-09	28604728
rs4869731	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs4869731	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs4869731	rs9383843	0.999100085712971	Migraine	1e-09	35115687
rs4869731	rs55763431	0.995506640298119	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4869731	rs9689694	0.993707895167345	Right hippocampal volume (head)	6e-11	37337106
rs4869731	rs9689694	0.993707895167345	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4869731	rs9689694	0.993707895167345	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4869731	rs9689694	0.993707895167345	Left hippocampal volume (head)	6e-12	37337106
rs4869731	rs10872645	0.988335410721321	Blood protein levels	2e-86	30072576
rs4869731	rs9688867	0.987484746280957	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4869731	rs9688867	0.987484746280957	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4869731	rs9688809	0.987484746280957	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4869731	rs10872653	0.987428985005238	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4869731	rs34337297	0.983863132808358	Serum levels of protein LRP11	3e-161	35078996
rs4869731	rs14314	0.981250032026204	Macular thickness	3e-19	30535121
rs4869731	rs14314	0.981250032026204	Vertex-wise sulcal depth	7e-17	34910505
rs4869731	rs14314	0.981250032026204	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4869731	rs14314	0.981250032026204	Left hippocampal volume (body)	7e-15	37337106
rs4869731	rs14314	0.981250032026204	Left subiculum volume (body)	1e-14	37337106
rs4869731	rs9322193	0.947826521476432	Lung cancer	1e-07	27393504
rs4869731	rs4039600	0.904085337095829	Adenine levels	1e-11	35347128
rs4869731	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-08	37844115
rs4869731	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-06	37844115
rs4869731	rs4380763	0.638343493751961	Subcortical volume (min-P)	1e-11	32665545
rs4869731	rs11155671	0.62791813730041	Testicular germ cell tumor	2e-09	28604728
rs4869731	rs80147756	0.613057484647013	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4869731	rs4421206	0.605487928690632	Brain morphology (min-P)	4e-11	32665545
rs4869812	rs4380763	0.991913034263146	Subcortical volume (min-P)	1e-11	32665545
rs4869812	rs1934534	0.987876482922309	Pain (pleiotropy)	2e-08	37844115
rs4869812	rs1934534	0.987876482922309	Pain (pleiotropy)	2e-06	37844115
rs4869812	rs11155671	0.97019428049392	Testicular germ cell tumor	2e-09	28604728
rs4869812	rs80147756	0.946675054470943	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4869812	rs4421206	0.940687618409135	Brain morphology (min-P)	4e-11	32665545
rs4869812	rs9505982	0.919400413917053	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4869812	rs9688452	0.91136072607878	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4869812	rs9688452	0.91136072607878	aseg lh volume VentralDC	2e-10	33875891
rs4869812	rs10872649	0.866950646550467	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4869812	rs10872649	0.866950646550467	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4869812	rs10872649	0.866950646550467	Right hippocampal volume (body)	1e-10	37337106
rs4869812	rs7752089	0.824482649800147	Brain morphology (MOSTest)	2e-31	35164939
rs4869812	rs9322194	0.777592053257706	Brainstem volume	2e-11	31636452
rs4869812	rs9285521	0.662855497222093	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4869812	rs12526675	0.647785547018124	Brain morphology (MOSTest)	7e-22	32665545
rs4869812	rs9688809	0.641433745917234	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4869812	rs34337297	0.639766220175349	Serum levels of protein LRP11	3e-161	35078996
rs4869812	rs10872645	0.637610005588875	Blood protein levels	2e-86	30072576
rs4869812	rs14314	0.636554487412254	Macular thickness	3e-19	30535121
rs4869812	rs14314	0.636554487412254	Vertex-wise sulcal depth	7e-17	34910505
rs4869812	rs14314	0.636554487412254	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4869812	rs14314	0.636554487412254	Left hippocampal volume (body)	7e-15	37337106
rs4869812	rs14314	0.636554487412254	Left subiculum volume (body)	1e-14	37337106
rs4869812	rs55763431	0.636246135766542	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4869812	rs9689694	0.635097127944719	Right hippocampal volume (head)	6e-11	37337106
rs4869812	rs9689694	0.635097127944719	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4869812	rs9689694	0.635097127944719	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4869812	rs9689694	0.635097127944719	Left hippocampal volume (head)	6e-12	37337106
rs4869812	rs9383843	0.633735539831966	Migraine	1e-09	35115687
rs4869812	rs2095375	0.633161961856057	Serum metabolite levels	1e-20	33031748
rs4869812	rs2095375	0.633161961856057	Serum metabolite levels	1e-20	33031748
rs4869812	rs10872653	0.630871077452483	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4869812	rs9688867	0.629191109768388	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4869812	rs9688867	0.629191109768388	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4869812	rs9322193	0.610173421344654	Lung cancer	1e-07	27393504
rs4869812	rs2342764	0.606868813346658	Cortical thickness	1e-08	34560273
rs4870019	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs4870019	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs4870019	rs9383843	0.999100085712971	Migraine	1e-09	35115687
rs4870019	rs55763431	0.995506640298119	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4870019	rs9689694	0.993707895167345	Right hippocampal volume (head)	6e-11	37337106
rs4870019	rs9689694	0.993707895167345	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4870019	rs9689694	0.993707895167345	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4870019	rs9689694	0.993707895167345	Left hippocampal volume (head)	6e-12	37337106
rs4870019	rs10872645	0.988335410721321	Blood protein levels	2e-86	30072576
rs4870019	rs9688867	0.987484746280957	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4870019	rs9688867	0.987484746280957	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4870019	rs9688809	0.987484746280957	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4870019	rs10872653	0.987428985005238	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4870019	rs34337297	0.983863132808358	Serum levels of protein LRP11	3e-161	35078996
rs4870019	rs14314	0.981250032026204	Macular thickness	3e-19	30535121
rs4870019	rs14314	0.981250032026204	Vertex-wise sulcal depth	7e-17	34910505
rs4870019	rs14314	0.981250032026204	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4870019	rs14314	0.981250032026204	Left hippocampal volume (body)	7e-15	37337106
rs4870019	rs14314	0.981250032026204	Left subiculum volume (body)	1e-14	37337106
rs4870019	rs9322193	0.947826521476432	Lung cancer	1e-07	27393504
rs4870019	rs4039600	0.904085337095829	Adenine levels	1e-11	35347128
rs4870019	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-08	37844115
rs4870019	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-06	37844115
rs4870019	rs4380763	0.638343493751961	Subcortical volume (min-P)	1e-11	32665545
rs4870019	rs11155671	0.62791813730041	Testicular germ cell tumor	2e-09	28604728
rs4870019	rs80147756	0.613057484647013	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4870019	rs4421206	0.605487928690632	Brain morphology (min-P)	4e-11	32665545
rs4870020	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs4870020	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs4870020	rs9383843	0.999100085712971	Migraine	1e-09	35115687
rs4870020	rs55763431	0.995506640298119	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4870020	rs9689694	0.993707895167345	Right hippocampal volume (head)	6e-11	37337106
rs4870020	rs9689694	0.993707895167345	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4870020	rs9689694	0.993707895167345	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4870020	rs9689694	0.993707895167345	Left hippocampal volume (head)	6e-12	37337106
rs4870020	rs10872645	0.988335410721321	Blood protein levels	2e-86	30072576
rs4870020	rs9688867	0.987484746280957	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4870020	rs9688867	0.987484746280957	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4870020	rs9688809	0.987484746280957	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4870020	rs10872653	0.987428985005238	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4870020	rs34337297	0.983863132808358	Serum levels of protein LRP11	3e-161	35078996
rs4870020	rs14314	0.981250032026204	Macular thickness	3e-19	30535121
rs4870020	rs14314	0.981250032026204	Vertex-wise sulcal depth	7e-17	34910505
rs4870020	rs14314	0.981250032026204	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4870020	rs14314	0.981250032026204	Left hippocampal volume (body)	7e-15	37337106
rs4870020	rs14314	0.981250032026204	Left subiculum volume (body)	1e-14	37337106
rs4870020	rs9322193	0.947826521476432	Lung cancer	1e-07	27393504
rs4870020	rs4039600	0.904085337095829	Adenine levels	1e-11	35347128
rs4870020	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-08	37844115
rs4870020	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-06	37844115
rs4870020	rs4380763	0.638343493751961	Subcortical volume (min-P)	1e-11	32665545
rs4870020	rs11155671	0.62791813730041	Testicular germ cell tumor	2e-09	28604728
rs4870020	rs80147756	0.613057484647013	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4870020	rs4421206	0.605487928690632	Brain morphology (min-P)	4e-11	32665545
rs4870048	rs14314	0.816319595559153	Macular thickness	3e-19	30535121
rs4870048	rs14314	0.816319595559153	Vertex-wise sulcal depth	7e-17	34910505
rs4870048	rs14314	0.816319595559153	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4870048	rs14314	0.816319595559153	Left hippocampal volume (body)	7e-15	37337106
rs4870048	rs14314	0.816319595559153	Left subiculum volume (body)	1e-14	37337106
rs4870048	rs2095375	0.803379716224837	Serum metabolite levels	1e-20	33031748
rs4870048	rs2095375	0.803379716224837	Serum metabolite levels	1e-20	33031748
rs4870048	rs9383843	0.802554598665239	Migraine	1e-09	35115687
rs4870048	rs55763431	0.799336671911981	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4870048	rs9689694	0.797840911997779	Right hippocampal volume (head)	6e-11	37337106
rs4870048	rs9689694	0.797840911997779	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4870048	rs9689694	0.797840911997779	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4870048	rs9689694	0.797840911997779	Left hippocampal volume (head)	6e-12	37337106
rs4870048	rs10872645	0.79776753084052	Blood protein levels	2e-86	30072576
rs4870048	rs10872653	0.79254368740563	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4870048	rs9688867	0.791982415264241	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4870048	rs9688867	0.791982415264241	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4870048	rs9688809	0.791982415264241	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4870048	rs34337297	0.789199846311825	Serum levels of protein LRP11	3e-161	35078996
rs4870048	rs9322193	0.75855627511656	Lung cancer	1e-07	27393504
rs4870048	rs4039600	0.723397260640484	Adenine levels	1e-11	35347128
rs4870049	rs7752089	0.892344066091824	Brain morphology (MOSTest)	2e-31	35164939
rs4870049	rs10872649	0.83672438622553	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4870049	rs10872649	0.83672438622553	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4870049	rs10872649	0.83672438622553	Right hippocampal volume (body)	1e-10	37337106
rs4870049	rs12526675	0.825547858719885	Brain morphology (MOSTest)	7e-22	32665545
rs4870049	rs2342764	0.798769524700028	Cortical thickness	1e-08	34560273
rs4870049	rs9322194	0.761534472908724	Brainstem volume	2e-11	31636452
rs4870049	rs4380763	0.74720128789391	Subcortical volume (min-P)	1e-11	32665545
rs4870049	rs1934534	0.746577882588948	Pain (pleiotropy)	2e-08	37844115
rs4870049	rs1934534	0.746577882588948	Pain (pleiotropy)	2e-06	37844115
rs4870049	rs56103941	0.743456813354417	Right presubiculum volume (head)	4e-08	37337106
rs4870049	rs11155671	0.739061543323703	Testicular germ cell tumor	2e-09	28604728
rs4870049	rs80147756	0.709115248313981	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4870049	rs4421206	0.702714251257134	Brain morphology (min-P)	4e-11	32665545
rs4870049	rs9505982	0.701293193787511	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4870049	rs12523793	0.699321634951723	Subcortical volume (MOSTest)	4e-24	32665545
rs4870049	rs12523793	0.699321634951723	C-reactive protein levels	3e-08	35459240
rs4870049	rs12523793	0.699321634951723	C-reactive protein levels (MTAG)	2e-08	36376304
rs4870049	rs11155662	0.694980487417547	Vertex-wise cortical thickness	2e-09	34910505
rs4870049	rs9688452	0.682373806262992	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4870049	rs9688452	0.682373806262992	aseg lh volume VentralDC	2e-10	33875891
rs4870049	rs9285521	0.661179958230776	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4870050	rs7752089	0.999198224369687	Brain morphology (MOSTest)	2e-31	35164939
rs4870050	rs10872649	0.932791015474055	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4870050	rs10872649	0.932791015474055	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4870050	rs10872649	0.932791015474055	Right hippocampal volume (body)	1e-10	37337106
rs4870050	rs1934534	0.833686415710927	Pain (pleiotropy)	2e-08	37844115
rs4870050	rs1934534	0.833686415710927	Pain (pleiotropy)	2e-06	37844115
rs4870050	rs4380763	0.832908178147418	Subcortical volume (min-P)	1e-11	32665545
rs4870050	rs11155671	0.821618598010922	Testicular germ cell tumor	2e-09	28604728
rs4870050	rs9322194	0.812534488067159	Brainstem volume	2e-11	31636452
rs4870050	rs80147756	0.795688044942673	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4870050	rs4421206	0.788102600190659	Brain morphology (min-P)	4e-11	32665545
rs4870050	rs9505982	0.784777104256723	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4870050	rs9688452	0.765429618796933	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4870050	rs9688452	0.765429618796933	aseg lh volume VentralDC	2e-10	33875891
rs4870050	rs12526675	0.738840144596447	Brain morphology (MOSTest)	7e-22	32665545
rs4870050	rs2342764	0.715756822911084	Cortical thickness	1e-08	34560273
rs4870050	rs9285521	0.689158734282494	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4870050	rs56103941	0.665318265022127	Right presubiculum volume (head)	4e-08	37337106
rs4870050	rs12523793	0.625578597400833	Subcortical volume (MOSTest)	4e-24	32665545
rs4870050	rs12523793	0.625578597400833	C-reactive protein levels	3e-08	35459240
rs4870050	rs12523793	0.625578597400833	C-reactive protein levels (MTAG)	2e-08	36376304
rs4870050	rs11155662	0.620919097804464	Vertex-wise cortical thickness	2e-09	34910505
rs4870052	rs2342764	0.993548492059152	Cortical thickness	1e-08	34560273
rs4870052	rs12526675	0.92410245145391	Brain morphology (MOSTest)	7e-22	32665545
rs4870052	rs56103941	0.82949206607693	Right presubiculum volume (head)	4e-08	37337106
rs4870052	rs12523793	0.776064931951585	Subcortical volume (MOSTest)	4e-24	32665545
rs4870052	rs12523793	0.776064931951585	C-reactive protein levels	3e-08	35459240
rs4870052	rs12523793	0.776064931951585	C-reactive protein levels (MTAG)	2e-08	36376304
rs4870052	rs11155662	0.764278991495911	Vertex-wise cortical thickness	2e-09	34910505
rs4870052	rs7752089	0.715174119276395	Brain morphology (MOSTest)	2e-31	35164939
rs4870052	rs9285521	0.671433699704532	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4870052	rs10872649	0.667299674742447	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4870052	rs10872649	0.667299674742447	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4870052	rs10872649	0.667299674742447	Right hippocampal volume (body)	1e-10	37337106
rs4870052	rs9322194	0.652648819138249	Brainstem volume	2e-11	31636452
rs4870052	rs4421206	0.644427166464767	Brain morphology (min-P)	4e-11	32665545
rs4870052	rs9688452	0.625701072416472	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4870052	rs9688452	0.625701072416472	aseg lh volume VentralDC	2e-10	33875891
rs4870052	rs4380763	0.612209236313443	Subcortical volume (min-P)	1e-11	32665545
rs4870052	rs1934534	0.610438998664972	Pain (pleiotropy)	2e-08	37844115
rs4870052	rs1934534	0.610438998664972	Pain (pleiotropy)	2e-06	37844115
rs4870052	rs58189451	0.606387219924285	Drinks per week	1e-09	36477530
rs4870052	rs11155671	0.604358631580626	Testicular germ cell tumor	2e-09	28604728
rs4870267	rs4380763	0.991913034263146	Subcortical volume (min-P)	1e-11	32665545
rs4870267	rs1934534	0.987876482922309	Pain (pleiotropy)	2e-08	37844115
rs4870267	rs1934534	0.987876482922309	Pain (pleiotropy)	2e-06	37844115
rs4870267	rs11155671	0.97019428049392	Testicular germ cell tumor	2e-09	28604728
rs4870267	rs80147756	0.946675054470943	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4870267	rs4421206	0.940687618409135	Brain morphology (min-P)	4e-11	32665545
rs4870267	rs9505982	0.919400413917053	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4870267	rs9688452	0.91136072607878	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4870267	rs9688452	0.91136072607878	aseg lh volume VentralDC	2e-10	33875891
rs4870267	rs10872649	0.866950646550467	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4870267	rs10872649	0.866950646550467	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4870267	rs10872649	0.866950646550467	Right hippocampal volume (body)	1e-10	37337106
rs4870267	rs7752089	0.824482649800147	Brain morphology (MOSTest)	2e-31	35164939
rs4870267	rs9322194	0.777592053257706	Brainstem volume	2e-11	31636452
rs4870267	rs9285521	0.662855497222093	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4870267	rs12526675	0.647785547018124	Brain morphology (MOSTest)	7e-22	32665545
rs4870267	rs9688809	0.641433745917234	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4870267	rs34337297	0.639766220175349	Serum levels of protein LRP11	3e-161	35078996
rs4870267	rs10872645	0.637610005588875	Blood protein levels	2e-86	30072576
rs4870267	rs14314	0.636554487412254	Macular thickness	3e-19	30535121
rs4870267	rs14314	0.636554487412254	Vertex-wise sulcal depth	7e-17	34910505
rs4870267	rs14314	0.636554487412254	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4870267	rs14314	0.636554487412254	Left hippocampal volume (body)	7e-15	37337106
rs4870267	rs14314	0.636554487412254	Left subiculum volume (body)	1e-14	37337106
rs4870267	rs55763431	0.636246135766542	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4870267	rs9689694	0.635097127944719	Right hippocampal volume (head)	6e-11	37337106
rs4870267	rs9689694	0.635097127944719	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4870267	rs9689694	0.635097127944719	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4870267	rs9689694	0.635097127944719	Left hippocampal volume (head)	6e-12	37337106
rs4870267	rs9383843	0.633735539831966	Migraine	1e-09	35115687
rs4870267	rs2095375	0.633161961856057	Serum metabolite levels	1e-20	33031748
rs4870267	rs2095375	0.633161961856057	Serum metabolite levels	1e-20	33031748
rs4870267	rs10872653	0.630871077452483	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4870267	rs9688867	0.629191109768388	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4870267	rs9688867	0.629191109768388	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4870267	rs9322193	0.610173421344654	Lung cancer	1e-07	27393504
rs4870267	rs2342764	0.606868813346658	Cortical thickness	1e-08	34560273
rs4870493	rs4421206	0.989554446092648	Brain morphology (min-P)	4e-11	32665545
rs4870493	rs9688452	0.96344982252849	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4870493	rs9688452	0.96344982252849	aseg lh volume VentralDC	2e-10	33875891
rs4870493	rs4380763	0.938766064908054	Subcortical volume (min-P)	1e-11	32665545
rs4870493	rs1934534	0.938002959981884	Pain (pleiotropy)	2e-08	37844115
rs4870493	rs1934534	0.938002959981884	Pain (pleiotropy)	2e-06	37844115
rs4870493	rs11155671	0.920679692075842	Testicular germ cell tumor	2e-09	28604728
rs4870493	rs9505982	0.894796193702679	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4870493	rs80147756	0.894056086340278	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4870493	rs10872649	0.817420566085706	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4870493	rs10872649	0.817420566085706	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4870493	rs10872649	0.817420566085706	Right hippocampal volume (body)	1e-10	37337106
rs4870493	rs7752089	0.780795594790506	Brain morphology (MOSTest)	2e-31	35164939
rs4870493	rs9322194	0.767079362952712	Brainstem volume	2e-11	31636452
rs4870493	rs9285521	0.710929331587468	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4870493	rs12526675	0.698647960800575	Brain morphology (MOSTest)	7e-22	32665545
rs4870493	rs2342764	0.655230821887098	Cortical thickness	1e-08	34560273
rs4870493	rs56103941	0.623329971537558	Right presubiculum volume (head)	4e-08	37337106
rs4870493	rs9688809	0.607987105537316	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4870493	rs10872645	0.605718784814751	Blood protein levels	2e-86	30072576
rs4870493	rs34337297	0.605173222549255	Serum levels of protein LRP11	3e-161	35078996
rs4870493	rs14314	0.603237952279521	Macular thickness	3e-19	30535121
rs4870493	rs14314	0.603237952279521	Vertex-wise sulcal depth	7e-17	34910505
rs4870493	rs14314	0.603237952279521	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4870493	rs14314	0.603237952279521	Left hippocampal volume (body)	7e-15	37337106
rs4870493	rs14314	0.603237952279521	Left subiculum volume (body)	1e-14	37337106
rs4870493	rs55763431	0.603069494003749	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4870493	rs9689694	0.601980288388791	Right hippocampal volume (head)	6e-11	37337106
rs4870493	rs9689694	0.601980288388791	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4870493	rs9689694	0.601980288388791	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4870493	rs9689694	0.601980288388791	Left hippocampal volume (head)	6e-12	37337106
rs4870493	rs9383843	0.600658617922277	Migraine	1e-09	35115687
rs4870493	rs2095375	0.600114902257735	Serum metabolite levels	1e-20	33031748
rs4870493	rs2095375	0.600114902257735	Serum metabolite levels	1e-20	33031748
rs4870509	rs56103941	0.980608623965723	Right presubiculum volume (head)	4e-08	37337106
rs4870509	rs12523793	0.941802609304703	Subcortical volume (MOSTest)	4e-24	32665545
rs4870509	rs12523793	0.941802609304703	C-reactive protein levels	3e-08	35459240
rs4870509	rs12523793	0.941802609304703	C-reactive protein levels (MTAG)	2e-08	36376304
rs4870509	rs11155662	0.932130899536141	Vertex-wise cortical thickness	2e-09	34910505
rs4870509	rs12526675	0.889966530222144	Brain morphology (MOSTest)	7e-22	32665545
rs4870509	rs2342764	0.823782603121429	Cortical thickness	1e-08	34560273
rs4870509	rs58189451	0.756830256368449	Drinks per week	1e-09	36477530
rs4870509	rs9285521	0.750323900841056	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4870509	rs7752089	0.660614130505353	Brain morphology (MOSTest)	2e-31	35164939
rs4870509	rs9322194	0.657606455912403	Brainstem volume	2e-11	31636452
rs4870509	rs11155675	0.63764429380765	Brain region volumes	3e-09	31676860
rs4870509	rs1125	0.637434753648379	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs4870509	rs1125	0.637434753648379	Vertical cup-disc ratio	8e-14	34077760
rs4870509	rs10872649	0.634804510272673	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4870509	rs10872649	0.634804510272673	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4870509	rs10872649	0.634804510272673	Right hippocampal volume (body)	1e-10	37337106
rs4870509	rs9371201	0.62616061156023	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs4870509	rs4421206	0.621888710351773	Brain morphology (min-P)	4e-11	32665545
rs4870509	rs9688452	0.60521366929721	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4870509	rs9688452	0.60521366929721	aseg lh volume VentralDC	2e-10	33875891
rs4870529	rs1934534	0.995941640474453	Pain (pleiotropy)	2e-08	37844115
rs4870529	rs1934534	0.995941640474453	Pain (pleiotropy)	2e-06	37844115
rs4870529	rs4380763	0.995131673493715	Subcortical volume (min-P)	1e-11	32665545
rs4870529	rs11155671	0.976598244626535	Testicular germ cell tumor	2e-09	28604728
rs4870529	rs80147756	0.954712050573477	HippSubfield lh volume subiculum-head	3e-10	33875891
rs4870529	rs4421206	0.944030220065534	Brain morphology (min-P)	4e-11	32665545
rs4870529	rs9505982	0.925768221231163	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs4870529	rs9688452	0.917625878058272	Brainstem global volume Whole-brainstem	1e-11	33875891
rs4870529	rs9688452	0.917625878058272	aseg lh volume VentralDC	2e-10	33875891
rs4870529	rs10872649	0.874765724489718	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs4870529	rs10872649	0.874765724489718	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs4870529	rs10872649	0.874765724489718	Right hippocampal volume (body)	1e-10	37337106
rs4870529	rs7752089	0.832308216900515	Brain morphology (MOSTest)	2e-31	35164939
rs4870529	rs9322194	0.784043542755041	Brainstem volume	2e-11	31636452
rs4870529	rs9285521	0.667831533956461	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs4870529	rs12526675	0.65440772644864	Brain morphology (MOSTest)	7e-22	32665545
rs4870529	rs9688809	0.646358878660492	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs4870529	rs34337297	0.643284752918591	Serum levels of protein LRP11	3e-161	35078996
rs4870529	rs10872645	0.642494081275194	Blood protein levels	2e-86	30072576
rs4870529	rs14314	0.641460536993591	Macular thickness	3e-19	30535121
rs4870529	rs14314	0.641460536993591	Vertex-wise sulcal depth	7e-17	34910505
rs4870529	rs14314	0.641460536993591	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs4870529	rs14314	0.641460536993591	Left hippocampal volume (body)	7e-15	37337106
rs4870529	rs14314	0.641460536993591	Left subiculum volume (body)	1e-14	37337106
rs4870529	rs55763431	0.641124150373489	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs4870529	rs9689694	0.639964706358834	Right hippocampal volume (head)	6e-11	37337106
rs4870529	rs9689694	0.639964706358834	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs4870529	rs9689694	0.639964706358834	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs4870529	rs9689694	0.639964706358834	Left hippocampal volume (head)	6e-12	37337106
rs4870529	rs9383843	0.638597064359943	Migraine	1e-09	35115687
rs4870529	rs2095375	0.638018275670017	Serum metabolite levels	1e-20	33031748
rs4870529	rs2095375	0.638018275670017	Serum metabolite levels	1e-20	33031748
rs4870529	rs10872653	0.635706579594753	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs4870529	rs9688867	0.634061555228714	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs4870529	rs9688867	0.634061555228714	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs4870529	rs9322193	0.614981644438093	Lung cancer	1e-07	27393504
rs4870529	rs2342764	0.612203179248937	Cortical thickness	1e-08	34560273
rs4870891	rs4413755	0.712310244806012	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs4872007	rs4872007	1	Superior temporal gyrus volume	8e-06	31530798
rs4872007	rs2280104	0.757798849882453	Parkinson's disease	3e-08	28892059
rs4872007	rs2280104	0.757798849882453	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs4872007	rs2280104	0.757798849882453	Serum total protein level	3e-12	34594039
rs4872007	rs746011	0.743777494010229	Triglycerides	2e-10	30275531
rs4872007	rs11781149	0.725411289855309	Refractive error	2e-17	32231278
rs4872007	rs4242434	0.700300035710973	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs4872007	rs1545837	0.663361490051887	Lung function (FVC)	1e-10	30595370
rs487233	rs337277	0.942546318078807	Metabolite peak levels (QI10992)	3e-52	35995766
rs487233	rs337277	0.942546318078807	Metabolite peak levels (QI4667)	7e-18	35995766
rs487233	rs337277	0.942546318078807	Metabolite peak levels (QI4708)	1e-21	35995766
rs487233	rs337277	0.942546318078807	Metabolite peak levels (QI5169)	7e-57	35995766
rs487233	rs7655841	0.778875366377684	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs4872527	rs4242434	0.932306875770295	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs4872527	rs11781149	0.874813425635047	Refractive error	2e-17	32231278
rs4872527	rs746011	0.828166236241444	Triglycerides	2e-10	30275531
rs4872527	rs1545837	0.8082378610832	Lung function (FVC)	1e-10	30595370
rs4872527	rs2280104	0.767562051734397	Parkinson's disease	3e-08	28892059
rs4872527	rs2280104	0.767562051734397	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs4872527	rs2280104	0.767562051734397	Serum total protein level	3e-12	34594039
rs4872527	rs4872007	0.72817078412705	Superior temporal gyrus volume	8e-06	31530798
rs4872527	rs11780207	0.634064962834728	Estimated glomerular filtration rate	2e-13	33462484
rs4872527	rs11780207	0.634064962834728	Serum total protein level	2e-09	33462484
rs4872527	rs11780207	0.634064962834728	Creatinine levels	2e-13	33462484
rs4872527	rs13271626	0.632445058897543	Haemorrhoidal disease	3e-10	33888516
rs4872527	rs11778693	0.611039264107887	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs4872527	rs11778693	0.611039264107887	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs4872527	rs4592028	0.603609944538687	Non-albumin protein levels	3e-09	33462484
rs4872531	rs2280104	0.957659983731206	Parkinson's disease	3e-08	28892059
rs4872531	rs2280104	0.957659983731206	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs4872531	rs2280104	0.957659983731206	Serum total protein level	3e-12	34594039
rs4872531	rs1545837	0.866226144889132	Lung function (FVC)	1e-10	30595370
rs4872531	rs746011	0.78527960327227	Triglycerides	2e-10	30275531
rs4872531	rs4872007	0.751596424279767	Superior temporal gyrus volume	8e-06	31530798
rs4872531	rs11781149	0.749846658321731	Refractive error	2e-17	32231278
rs4872531	rs11780207	0.714151782442634	Estimated glomerular filtration rate	2e-13	33462484
rs4872531	rs11780207	0.714151782442634	Serum total protein level	2e-09	33462484
rs4872531	rs11780207	0.714151782442634	Creatinine levels	2e-13	33462484
rs4872531	rs4242434	0.71213012902793	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs487501	rs337277	0.939817261398369	Metabolite peak levels (QI10992)	3e-52	35995766
rs487501	rs337277	0.939817261398369	Metabolite peak levels (QI4667)	7e-18	35995766
rs487501	rs337277	0.939817261398369	Metabolite peak levels (QI4708)	1e-21	35995766
rs487501	rs337277	0.939817261398369	Metabolite peak levels (QI5169)	7e-57	35995766
rs487501	rs7655841	0.777847110659492	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs488219	rs581045	0.995683639607497	Height	4e-12	36224396
rs488219	rs581045	0.995683639607497	Height	3e-131	36224396
rs488219	rs2510897	0.987076869447253	Height	4e-09	25429064
rs488219	rs570806	0.969187550782521	Resistance to COVID-19 infection (Exposed negative vs positive)	1e-06	36662838
rs488219	rs12796102	0.953951245639686	Estimated glomerular filtration rate (creatinine)	2e-09	35710981
rs488219	rs568688	0.849252795863003	Height	2e-11	30595370
rs488219	rs494459	0.693070238000193	Height	2e-08	20881960
rs488219	rs576283	0.692379156015048	Height (standard GWA)	9e-13	37106081
rs488219	rs607472	0.639307804291479	Fat-free mass	4e-08	30593698
rs488219	rs607472	0.639307804291479	Fat-free mass	9e-06	30593698
rs488219	rs607472	0.639307804291479	Fat-free mass	1e-12	30593698
rs488219	rs607472	0.639307804291479	Body surface area	5e-12	36502284
rs488219	rs492144	0.634423966148612	Height	3e-20	34594039
rs490492	rs480293	0.9956932477181	Oily fish consumption	4e-11	32193382
rs490492	rs1613778	0.938070256834687	Total bilirubin levels	3e-08	34594039
rs490492	rs34634095	0.932661605352807	Fish- and plant-related diet	3e-09	32066663
rs490492	rs542831	0.912121377078516	Asthma	5e-13	31361310
rs490492	rs1784776	0.909641398675365	Asthma	2e-09	32296059
rs490492	rs1784775	0.909641398675365	Asthma	2e-09	30929738
rs490492	rs1784775	0.909641398675365	Asthma (adult onset)	6e-09	30929738
rs490492	rs1789358	0.907992721503636	Asthma	2e-08	34103634
rs490492	rs539524	0.901656166367181	Asthma	1e-10	32296059
rs490492	rs12791699	0.872819772977464	Pork consumption	9e-09	32066663
rs490492	rs12791699	0.872819772977464	Oily fish consumption	9e-09	32066663
rs490492	rs487985	0.872819772977464	Highest math class taken	1e-08	30038396
rs490492	rs10891286	0.847124006719349	Noncognitive aspects of educational attainment	5e-10	33414549
rs490492	rs4459340	0.843154706559344	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs490492	rs505372	0.798027252150916	Breast cancer	3e-06	29059683
rs490492	rs505372	0.798027252150916	Medication use (beta blocking agents)	2e-08	34594039
rs490492	rs659529	0.795869809104914	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs490492	rs659529	0.795869809104914	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs490492	rs659529	0.795869809104914	Atopic dermatitis	5e-10	34116867
rs490492	rs9734135	0.760360869890654	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs490492	rs11213941	0.642702150104698	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs490492	rs11213941	0.642702150104698	Eczema	8e-14	30595370
rs490492	rs663763	0.638836797920623	Layilin levels	3e-21	36168886
rs4907185	rs10465746	0.748879308942418	Obesity-related traits	8e-06	23251661
rs4907185	rs11580836	0.728157937318082	Body mass index	2e-09	36581621
rs4907186	rs10465746	0.762653527337397	Obesity-related traits	8e-06	23251661
rs4907186	rs11580836	0.741529941455566	Body mass index	2e-09	36581621
rs4907188	rs10465746	0.761572750348507	Obesity-related traits	8e-06	23251661
rs4907188	rs11580836	0.738945314410555	Body mass index	2e-09	36581621
rs4907189	rs11580836	0.989355879663348	Body mass index	2e-09	36581621
rs4907189	rs10465746	0.96687390989799	Obesity-related traits	8e-06	23251661
rs4907191	rs10465746	0.954775797257431	Obesity-related traits	8e-06	23251661
rs4907191	rs11580836	0.912963377575661	Body mass index	2e-09	36581621
rs4924520	rs4924522	0.839321885132624	Lung function (forced vital capacity)	5e-18	36914875
rs4924520	rs9796	0.713463380907499	Menopause (age at onset)	1e-10	26414677
rs4924521	rs4924522	0.855786737219582	Lung function (forced vital capacity)	5e-18	36914875
rs4924521	rs9796	0.731751147916775	Menopause (age at onset)	1e-10	26414677
rs4924526	rs4924522	0.858916471858647	Lung function (forced vital capacity)	5e-18	36914875
rs4924526	rs9796	0.736590016582719	Menopause (age at onset)	1e-10	26414677
rs4924839	rs8071834	0.997585827078475	Platelet count	3e-11	34594039
rs4924839	rs712273	0.946899841499793	Red blood cell count	5e-17	32888493
rs4924839	rs8069321	0.873645773129055	Serum albumin levels	2e-09	34594039
rs4924839	rs865923	0.702034228951846	Red blood cell count	2e-14	32888493
rs4924839	rs865923	0.702034228951846	Red blood cell count	1e-10	32888494
rs4924839	rs865923	0.702034228951846	Red blood cell count	1e-11	34594039
rs4924839	rs865923	0.702034228951846	Height	3e-25	30595370
rs4924839	rs865923	0.702034228951846	Red blood cell count	1e-10	30595370
rs4924839	rs854779	0.651627515575346	Height	4e-79	36224396
rs4924839	rs854772	0.606294315589577	Mean corpuscular hemoglobin	3e-12	32888494
rs493445	rs337277	0.91568640578077	Metabolite peak levels (QI10992)	3e-52	35995766
rs493445	rs337277	0.91568640578077	Metabolite peak levels (QI4667)	7e-18	35995766
rs493445	rs337277	0.91568640578077	Metabolite peak levels (QI4708)	1e-21	35995766
rs493445	rs337277	0.91568640578077	Metabolite peak levels (QI5169)	7e-57	35995766
rs493445	rs7655841	0.734998697794339	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs4938354	rs4938354	1	Proprotein convertase subtilisin/kexin type 7 levels	3e-295	36168886
rs4938354	rs1794116	0.902554087076189	Protein CASC4 levels	5e-13	34648354
rs4938354	rs1794116	0.902554087076189	Asialoglycoprotein receptor 1 levels	7e-18	34648354
rs4938354	rs171052	0.892908243606645	Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)	1e-38	35870639
rs4938354	rs2622935	0.689378724571795	Serum levels of protein CASC4	3e-16	35078996
rs4938354	rs2622935	0.689378724571795	Polypeptide N-acetylgalactosaminyltransferase 1 levels	1e-30	34648354
rs4938354	rs4938353	0.663059545597262	Blood protein levels	2e-14	27532455
rs4938354	rs1060211	0.617038793653797	Diastolic blood pressure	5e-09	35762941
rs4938792	rs663763	0.641889943709189	Layilin levels	3e-21	36168886
rs4938792	rs11213941	0.62781934906446	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs4938792	rs11213941	0.62781934906446	Eczema	8e-14	30595370
rs4941643	rs7987940	0.668576963052235	AFP levels	6e-08	36329257
rs4941643	rs9535244	0.648703462662684	Lung function (FVC)	1e-08	30595370
rs4941940	rs7999758	0.996404398207632	Height	6e-17	30595370
rs4941940	rs6563739	0.995507991824923	Menarche (age at onset)	2e-11	25231870
rs4941940	rs4598779	0.919101183993816	Height	7e-77	36224396
rs4943688	rs7999758	0.999100627979417	Height	6e-17	30595370
rs4943688	rs6563739	0.998202334989452	Menarche (age at onset)	2e-11	25231870
rs4943688	rs4598779	0.919928791409094	Height	7e-77	36224396
rs4943689	rs7999758	0.999100627979417	Height	6e-17	30595370
rs4943689	rs6563739	0.998202334989452	Menarche (age at onset)	2e-11	25231870
rs4943689	rs4598779	0.919928791409094	Height	7e-77	36224396
rs4947319	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs4947319	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs4947319	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs4947319	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs4947319	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs4947319	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs4947319	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs4947319	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs4947319	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs4947319	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs4947319	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs4947319	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs4947319	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs4947319	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs4947319	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs4947319	rs13437082	0.631513452560533	Height	5e-08	19343178
rs4947319	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs4959017	rs2523644	0.977437151862699	Myocardial infarction	5e-07	30226566
rs4959017	rs2596517	0.873529133682939	Hip circumference adjusted for BMI	7e-14	34021172
rs4959017	rs2596484	0.864370116665436	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs4959066	rs2523644	0.977437151862699	Myocardial infarction	5e-07	30226566
rs4959066	rs2596517	0.873529133682939	Hip circumference adjusted for BMI	7e-14	34021172
rs4959066	rs2596484	0.864370116665436	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs4959103	rs4959106	0.981587995635034	Interleukin-6 levels	7e-13	33067605
rs4959103	rs34077986	0.954332370095835	A body shape index	5e-11	34021172
rs4959103	rs3129754	0.874271983256323	Waist-hip index	2e-12	34021172
rs4959103	rs3129754	0.874271983256323	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs4959103	rs34656207	0.794950289703001	Aspartate aminotransferase levels	1e-111	33547301
rs4959103	rs34656207	0.794950289703001	Aspartate aminotransferase levels	1e-126	34594039
rs4959103	rs4959105	0.752072965050118	Lymphocyte count	3e-16	29403010
rs4959103	rs33915496	0.732178423565352	Lymphocyte count	1e-16	32888493
rs4959103	rs33932178	0.640950630404188	Lymphocyte count	3e-22	34594039
rs4959103	rs3104414	0.600948628285659	HLA DR+ T cell%T cell	9e-09	32929287
rs4959103	rs3104414	0.600948628285659	Chronic sinus infection	2e-06	28928442
rs4959103	rs3104414	0.600948628285659	Hip circumference adjusted for BMI	9e-13	34021172
rs4959104	rs4959106	0.980754194492335	Interleukin-6 levels	7e-13	33067605
rs4959104	rs34077986	0.953510633304631	A body shape index	5e-11	34021172
rs4959104	rs3129754	0.873419717989956	Waist-hip index	2e-12	34021172
rs4959104	rs3129754	0.873419717989956	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs4959104	rs34656207	0.794089662835264	Aspartate aminotransferase levels	1e-111	33547301
rs4959104	rs34656207	0.794089662835264	Aspartate aminotransferase levels	1e-126	34594039
rs4959104	rs4959105	0.752706270822562	Lymphocyte count	3e-16	29403010
rs4959104	rs33915496	0.731304013919228	Lymphocyte count	1e-16	32888493
rs4959104	rs33932178	0.640053983815966	Lymphocyte count	3e-22	34594039
rs4959104	rs3104414	0.600051999963655	HLA DR+ T cell%T cell	9e-09	32929287
rs4959104	rs3104414	0.600051999963655	Chronic sinus infection	2e-06	28928442
rs4959104	rs3104414	0.600051999963655	Hip circumference adjusted for BMI	9e-13	34021172
rs4959106	rs4959106	1	Interleukin-6 levels	7e-13	33067605
rs4959106	rs34077986	0.959265979513649	A body shape index	5e-11	34021172
rs4959106	rs3129754	0.864843046541661	Waist-hip index	2e-12	34021172
rs4959106	rs3129754	0.864843046541661	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs4959106	rs34656207	0.804393868331103	Aspartate aminotransferase levels	1e-111	33547301
rs4959106	rs34656207	0.804393868331103	Aspartate aminotransferase levels	1e-126	34594039
rs4959106	rs4959105	0.740220376926212	Lymphocyte count	3e-16	29403010
rs4959106	rs33915496	0.736931777655446	Lymphocyte count	1e-16	32888493
rs4959106	rs33932178	0.641304319073365	Lymphocyte count	3e-22	34594039
rs4959106	rs3104414	0.609822592976005	HLA DR+ T cell%T cell	9e-09	32929287
rs4959106	rs3104414	0.609822592976005	Chronic sinus infection	2e-06	28928442
rs4959106	rs3104414	0.609822592976005	Hip circumference adjusted for BMI	9e-13	34021172
rs4974527	rs10698992	0.641571503514557	von Willebrand factor A domain-containing protein 2 levels	9e-13	34648354
rs4975193	rs7655841	0.86246096901551	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs4975193	rs337277	0.862233053018962	Metabolite peak levels (QI10992)	3e-52	35995766
rs4975193	rs337277	0.862233053018962	Metabolite peak levels (QI4667)	7e-18	35995766
rs4975193	rs337277	0.862233053018962	Metabolite peak levels (QI4708)	1e-21	35995766
rs4975193	rs337277	0.862233053018962	Metabolite peak levels (QI5169)	7e-57	35995766
rs4975193	rs10010659	0.605750076577525	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs4979003	rs9299199	0.973356270713027	Height	9e-24	36224396
rs4979003	rs9299199	0.973356270713027	Height	1e-06	36224396
rs4979003	rs7858562	0.616501120999104	Height	4e-07	31562340
rs4979003	rs10441737	0.606241180362255	Menarche (age at onset)	4e-15	23599027
rs4982404	rs4982404	1	Height	1e-24	34594039
rs4982404	rs1952151	0.853101885323067	Height	3e-148	36224396
rs4982404	rs8019890	0.831545699419164	Appendicular lean mass	2e-38	33097823
rs4982404	rs8019890	0.831545699419164	Height (weighted GWA)	2e-07	37106081
rs4982404	rs8019890	0.831545699419164	Height (standard GWA)	6e-15	37106081
rs4982404	rs8019890	0.831545699419164	Height	2e-39	30595370
rs4982404	rs7140850	0.688060603580931	Body surface area	2e-08	36502284
rs4988618	rs1859336	0.98933757770146	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs4988618	rs6489882	0.969512030435073	Chronic lymphocytic leukemia	5e-08	28165464
rs4988618	rs11066452	0.966954133895254	Blood protein levels	6e-08	30072576
rs4988618	rs4767027	0.945916428648305	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs4988618	rs2057778	0.942411646180287	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs4988618	rs2057778	0.942411646180287	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs4988618	rs2057778	0.942411646180287	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs4988618	rs1131476	0.917275672841003	Systemic lupus erythematosus	1e-09	33272962
rs4988618	rs2660	0.917275672841003	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs4988618	rs2660	0.917275672841003	COVID-19 (critical illness vs population)	3e-15	37198478
rs4988618	rs6489867	0.673697409914444	COVID-19 (critical illness vs population)	1e-09	33307546
rs4988618	rs1557866	0.628118528869361	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs4994790	rs4304220	0.799870014024335	Height	2e-14	36224396
rs4994790	rs4355658	0.749800178581838	Height	3e-13	36224396
rs4994790	rs13232536	0.613685085192701	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs500163	rs480293	0.994833371534336	Oily fish consumption	4e-11	32193382
rs500163	rs1613778	0.938886520003136	Total bilirubin levels	3e-08	34594039
rs500163	rs34634095	0.933497111311918	Fish- and plant-related diet	3e-09	32066663
rs500163	rs542831	0.91127465049659	Asthma	5e-13	31361310
rs500163	rs1784776	0.908794151340335	Asthma	2e-09	32296059
rs500163	rs1784775	0.908794151340335	Asthma	2e-09	30929738
rs500163	rs1784775	0.908794151340335	Asthma (adult onset)	6e-09	30929738
rs500163	rs1789358	0.907147889112705	Asthma	2e-08	34103634
rs500163	rs539524	0.900857840756424	Asthma	1e-10	32296059
rs500163	rs12791699	0.871980588279954	Pork consumption	9e-09	32066663
rs500163	rs12791699	0.871980588279954	Oily fish consumption	9e-09	32066663
rs500163	rs487985	0.871980588279954	Highest math class taken	1e-08	30038396
rs500163	rs10891286	0.846279768729948	Noncognitive aspects of educational attainment	5e-10	33414549
rs500163	rs4459340	0.842309692992369	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs500163	rs659529	0.798154719464466	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs500163	rs659529	0.798154719464466	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs500163	rs659529	0.798154719464466	Atopic dermatitis	5e-10	34116867
rs500163	rs505372	0.797172567314368	Breast cancer	3e-06	29059683
rs500163	rs505372	0.797172567314368	Medication use (beta blocking agents)	2e-08	34594039
rs500163	rs9734135	0.759499044860584	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs500163	rs11213941	0.644742542525151	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs500163	rs11213941	0.644742542525151	Eczema	8e-14	30595370
rs500163	rs663763	0.640880919967368	Layilin levels	3e-21	36168886
rs503598	rs503598	1	White blood cell count	2e-08	30595370
rs503598	rs2462017	0.937321841403594	Lymphocyte count	3e-12	32888493
rs503598	rs2488010	0.929039719601961	Monocyte count	9e-16	32888493
rs503598	rs2462021	0.928222643248812	Suicide risk	8e-06	21041247
rs503598	rs2795863	0.873629779899777	Height	3e-20	36224396
rs503598	rs2689216	0.837909295338638	Platelet count	2e-22	32888493
rs503598	rs2689216	0.837909295338638	Platelet count	1e-21	32888493
rs503598	rs1571956	0.808321465095278	Neutrophil count	1e-11	32888493
rs503598	rs2482820	0.801563499529973	Monocyte count	9e-13	32888494
rs503598	rs2482819	0.798558190207114	Neutrophil count	4e-10	32888493
rs503598	rs2795857	0.728753628744457	Height	2e-123	36224396
rs503598	rs1332618	0.702289714818999	Platelet count	4e-15	32888494
rs503598	rs2091084	0.641247576926244	White blood cell count	6e-19	32888493
rs503598	rs2091084	0.641247576926244	Lymphocyte count	3e-10	32888494
rs503598	rs2091084	0.641247576926244	White blood cell count	4e-13	32888494
rs504968	rs337277	0.856350857635595	Metabolite peak levels (QI10992)	3e-52	35995766
rs504968	rs337277	0.856350857635595	Metabolite peak levels (QI4667)	7e-18	35995766
rs504968	rs337277	0.856350857635595	Metabolite peak levels (QI4708)	1e-21	35995766
rs504968	rs337277	0.856350857635595	Metabolite peak levels (QI5169)	7e-57	35995766
rs504968	rs7655841	0.667351872403951	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs510388	rs480293	0.967491206288932	Oily fish consumption	4e-11	32193382
rs510388	rs1613778	0.957203714510926	Total bilirubin levels	3e-08	34594039
rs510388	rs34634095	0.938606867131046	Fish- and plant-related diet	3e-09	32066663
rs510388	rs542831	0.88473000602507	Asthma	5e-13	31361310
rs510388	rs1784776	0.882257333167627	Asthma	2e-09	32296059
rs510388	rs1784775	0.882257333167627	Asthma	2e-09	30929738
rs510388	rs1784775	0.882257333167627	Asthma (adult onset)	6e-09	30929738
rs510388	rs1789358	0.880665241431254	Asthma	2e-08	34103634
rs510388	rs539524	0.876838816693159	Asthma	1e-10	32296059
rs510388	rs12791699	0.845842388276754	Pork consumption	9e-09	32066663
rs510388	rs12791699	0.845842388276754	Oily fish consumption	9e-09	32066663
rs510388	rs487985	0.845842388276754	Highest math class taken	1e-08	30038396
rs510388	rs10891286	0.832923355809397	Noncognitive aspects of educational attainment	5e-10	33414549
rs510388	rs4459340	0.828945286306848	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs510388	rs659529	0.797433259424732	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs510388	rs659529	0.797433259424732	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs510388	rs659529	0.797433259424732	Atopic dermatitis	5e-10	34116867
rs510388	rs505372	0.779035722210011	Breast cancer	3e-06	29059683
rs510388	rs505372	0.779035722210011	Medication use (beta blocking agents)	2e-08	34594039
rs510388	rs9734135	0.753641767649938	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs510388	rs11213941	0.642881298059931	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs510388	rs11213941	0.642881298059931	Eczema	8e-14	30595370
rs510388	rs663763	0.638220143468869	Layilin levels	3e-21	36168886
rs512669	rs34634095	0.964405977573446	Fish- and plant-related diet	3e-09	32066663
rs512669	rs480293	0.962014491357949	Oily fish consumption	4e-11	32193382
rs512669	rs539524	0.937293795028257	Asthma	1e-10	32296059
rs512669	rs1613778	0.904578087324743	Total bilirubin levels	3e-08	34594039
rs512669	rs542831	0.887096121457063	Asthma	5e-13	31361310
rs512669	rs1784776	0.884696804318216	Asthma	2e-09	32296059
rs512669	rs1784775	0.884696804318216	Asthma	2e-09	30929738
rs512669	rs1784775	0.884696804318216	Asthma (adult onset)	6e-09	30929738
rs512669	rs1789358	0.883032271822842	Asthma	2e-08	34103634
rs512669	rs12791699	0.848684175292388	Pork consumption	9e-09	32066663
rs512669	rs12791699	0.848684175292388	Oily fish consumption	9e-09	32066663
rs512669	rs487985	0.848684175292388	Highest math class taken	1e-08	30038396
rs512669	rs659529	0.831334598855103	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs512669	rs659529	0.831334598855103	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs512669	rs659529	0.831334598855103	Atopic dermatitis	5e-10	34116867
rs512669	rs10891286	0.823826044172714	Noncognitive aspects of educational attainment	5e-10	33414549
rs512669	rs4459340	0.819986115637551	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs512669	rs505372	0.776351398845555	Breast cancer	3e-06	29059683
rs512669	rs505372	0.776351398845555	Medication use (beta blocking agents)	2e-08	34594039
rs512669	rs9734135	0.739911499471952	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs512669	rs11213941	0.677850016248756	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs512669	rs11213941	0.677850016248756	Eczema	8e-14	30595370
rs512669	rs663763	0.667678291744508	Layilin levels	3e-21	36168886
rs517659	rs337277	0.946019846562147	Metabolite peak levels (QI10992)	3e-52	35995766
rs517659	rs337277	0.946019846562147	Metabolite peak levels (QI4667)	7e-18	35995766
rs517659	rs337277	0.946019846562147	Metabolite peak levels (QI4708)	1e-21	35995766
rs517659	rs337277	0.946019846562147	Metabolite peak levels (QI5169)	7e-57	35995766
rs517659	rs7655841	0.758009242055424	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs517982	rs34634095	0.964405977573446	Fish- and plant-related diet	3e-09	32066663
rs517982	rs480293	0.96033111112789	Oily fish consumption	4e-11	32193382
rs517982	rs539524	0.935644923086709	Asthma	1e-10	32296059
rs517982	rs1613778	0.904578087324743	Total bilirubin levels	3e-08	34594039
rs517982	rs542831	0.885473629948596	Asthma	5e-13	31361310
rs517982	rs1784776	0.883075910056846	Asthma	2e-09	32296059
rs517982	rs1784775	0.883075910056846	Asthma	2e-09	30929738
rs517982	rs1784775	0.883075910056846	Asthma (adult onset)	6e-09	30929738
rs517982	rs1789358	0.881413701562794	Asthma	2e-08	34103634
rs517982	rs12791699	0.847094449769889	Pork consumption	9e-09	32066663
rs517982	rs12791699	0.847094449769889	Oily fish consumption	9e-09	32066663
rs517982	rs487985	0.847094449769889	Highest math class taken	1e-08	30038396
rs517982	rs659529	0.831334598855103	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs517982	rs659529	0.831334598855103	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs517982	rs659529	0.831334598855103	Atopic dermatitis	5e-10	34116867
rs517982	rs10891286	0.822253297129876	Noncognitive aspects of educational attainment	5e-10	33414549
rs517982	rs4459340	0.818415995918391	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs517982	rs505372	0.774810759030799	Breast cancer	3e-06	29059683
rs517982	rs505372	0.774810759030799	Medication use (beta blocking agents)	2e-08	34594039
rs517982	rs9734135	0.738395982284111	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs517982	rs11213941	0.677850016248756	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs517982	rs11213941	0.677850016248756	Eczema	8e-14	30595370
rs517982	rs663763	0.667678291744508	Layilin levels	3e-21	36168886
rs525212	rs3753693	0.876187395746038	Type 2 diabetes	1e-10	32541925
rs525212	rs10915188	0.777935205030428	Type 2 diabetes	4e-10	32541925
rs529529	rs480293	0.990536156872326	Oily fish consumption	4e-11	32193382
rs529529	rs1613778	0.941387885245501	Total bilirubin levels	3e-08	34594039
rs529529	rs34634095	0.935996052827673	Fish- and plant-related diet	3e-09	32066663
rs529529	rs542831	0.907126117130986	Asthma	5e-13	31361310
rs529529	rs1784776	0.904648385073117	Asthma	2e-09	32296059
rs529529	rs1784775	0.904648385073117	Asthma	2e-09	30929738
rs529529	rs1784775	0.904648385073117	Asthma (adult onset)	6e-09	30929738
rs529529	rs1789358	0.903009149774792	Asthma	2e-08	34103634
rs529529	rs539524	0.896813771808056	Asthma	1e-10	32296059
rs529529	rs12791699	0.867906067569564	Pork consumption	9e-09	32066663
rs529529	rs12791699	0.867906067569564	Oily fish consumption	9e-09	32066663
rs529529	rs487985	0.867906067569564	Highest math class taken	1e-08	30038396
rs529529	rs10891286	0.842235148973096	Noncognitive aspects of educational attainment	5e-10	33414549
rs529529	rs4459340	0.838269707903174	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs529529	rs659529	0.795762329959368	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs529529	rs659529	0.795762329959368	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs529529	rs659529	0.795762329959368	Atopic dermatitis	5e-10	34116867
rs529529	rs505372	0.79318370463901	Breast cancer	3e-06	29059683
rs529529	rs505372	0.79318370463901	Medication use (beta blocking agents)	2e-08	34594039
rs529529	rs9734135	0.755554839806103	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs529529	rs11213941	0.64243308401841	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs529529	rs11213941	0.64243308401841	Eczema	8e-14	30595370
rs529529	rs663763	0.638842257704005	Layilin levels	3e-21	36168886
rs539524	rs539524	1	Asthma	1e-10	32296059
rs539524	rs1789358	0.911160235324055	Asthma	2e-08	34103634
rs539524	rs1784776	0.907984088843516	Asthma	2e-09	32296059
rs539524	rs1784775	0.907984088843516	Asthma	2e-09	30929738
rs539524	rs1784775	0.907984088843516	Asthma (adult onset)	6e-09	30929738
rs539524	rs542831	0.907090436720021	Asthma	5e-13	31361310
rs539524	rs34634095	0.906223898169096	Fish- and plant-related diet	3e-09	32066663
rs539524	rs480293	0.900802615816764	Oily fish consumption	4e-11	32193382
rs539524	rs12791699	0.8992902991663	Pork consumption	9e-09	32066663
rs539524	rs12791699	0.8992902991663	Oily fish consumption	9e-09	32066663
rs539524	rs487985	0.8992902991663	Highest math class taken	1e-08	30038396
rs539524	rs10891286	0.874333077857686	Noncognitive aspects of educational attainment	5e-10	33414549
rs539524	rs4459340	0.870477730923643	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs539524	rs1613778	0.848778527435129	Total bilirubin levels	3e-08	34594039
rs539524	rs505372	0.825118539829958	Breast cancer	3e-06	29059683
rs539524	rs505372	0.825118539829958	Medication use (beta blocking agents)	2e-08	34594039
rs539524	rs9734135	0.78855194559327	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs539524	rs659529	0.779777545989707	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs539524	rs659529	0.779777545989707	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs539524	rs659529	0.779777545989707	Atopic dermatitis	5e-10	34116867
rs539524	rs11213941	0.633717478506455	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs539524	rs11213941	0.633717478506455	Eczema	8e-14	30595370
rs539524	rs663763	0.622524544715422	Layilin levels	3e-21	36168886
rs542424	rs539524	0.998302431972607	Asthma	1e-10	32296059
rs542424	rs1789358	0.912800472105222	Asthma	2e-08	34103634
rs542424	rs1784776	0.909622273378951	Asthma	2e-09	32296059
rs542424	rs1784775	0.909622273378951	Asthma	2e-09	30929738
rs542424	rs1784775	0.909622273378951	Asthma (adult onset)	6e-09	30929738
rs542424	rs542831	0.908727209201342	Asthma	5e-13	31361310
rs542424	rs34634095	0.906223898169096	Fish- and plant-related diet	3e-09	32066663
rs542424	rs480293	0.902427653782485	Oily fish consumption	4e-11	32193382
rs542424	rs12791699	0.900922866001535	Pork consumption	9e-09	32066663
rs542424	rs12791699	0.900922866001535	Oily fish consumption	9e-09	32066663
rs542424	rs487985	0.900922866001535	Highest math class taken	1e-08	30038396
rs542424	rs10891286	0.875949515728759	Noncognitive aspects of educational attainment	5e-10	33414549
rs542424	rs4459340	0.87209167690963	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs542424	rs1613778	0.848778527435129	Total bilirubin levels	3e-08	34594039
rs542424	rs505372	0.826703161298702	Breast cancer	3e-06	29059683
rs542424	rs505372	0.826703161298702	Medication use (beta blocking agents)	2e-08	34594039
rs542424	rs9734135	0.790112916776348	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs542424	rs659529	0.779777545989707	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs542424	rs659529	0.779777545989707	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs542424	rs659529	0.779777545989707	Atopic dermatitis	5e-10	34116867
rs542424	rs11213941	0.633717478506455	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs542424	rs11213941	0.633717478506455	Eczema	8e-14	30595370
rs542424	rs663763	0.622524544715422	Layilin levels	3e-21	36168886
rs5435	rs409942	0.710840897561152	Total cholesterol levels	8e-06	35884923
rs5435	rs5415	0.651679896254113	Birth weight	5e-06	23202124
rs5435	rs5415	0.651679896254113	LDL cholesterol levels	1e-06	35884923
rs5435	rs2654189	0.61813385216581	Eosinophil counts	4e-11	32888494
rs5435	rs2654189	0.61813385216581	Eosinophil percentage of white cells	6e-12	32888494
rs5435	rs2654189	0.61813385216581	Eosinophil counts	1e-09	30595370
rs546956	rs337277	0.91568640578077	Metabolite peak levels (QI10992)	3e-52	35995766
rs546956	rs337277	0.91568640578077	Metabolite peak levels (QI4667)	7e-18	35995766
rs546956	rs337277	0.91568640578077	Metabolite peak levels (QI4708)	1e-21	35995766
rs546956	rs337277	0.91568640578077	Metabolite peak levels (QI5169)	7e-57	35995766
rs546956	rs7655841	0.734998697794339	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs549143	rs480293	0.9956932477181	Oily fish consumption	4e-11	32193382
rs549143	rs1613778	0.938070256834687	Total bilirubin levels	3e-08	34594039
rs549143	rs34634095	0.932661605352807	Fish- and plant-related diet	3e-09	32066663
rs549143	rs542831	0.912121377078516	Asthma	5e-13	31361310
rs549143	rs1784776	0.909641398675365	Asthma	2e-09	32296059
rs549143	rs1784775	0.909641398675365	Asthma	2e-09	30929738
rs549143	rs1784775	0.909641398675365	Asthma (adult onset)	6e-09	30929738
rs549143	rs1789358	0.907992721503636	Asthma	2e-08	34103634
rs549143	rs539524	0.901656166367181	Asthma	1e-10	32296059
rs549143	rs12791699	0.872819772977464	Pork consumption	9e-09	32066663
rs549143	rs12791699	0.872819772977464	Oily fish consumption	9e-09	32066663
rs549143	rs487985	0.872819772977464	Highest math class taken	1e-08	30038396
rs549143	rs10891286	0.847124006719349	Noncognitive aspects of educational attainment	5e-10	33414549
rs549143	rs4459340	0.843154706559344	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs549143	rs505372	0.798027252150916	Breast cancer	3e-06	29059683
rs549143	rs505372	0.798027252150916	Medication use (beta blocking agents)	2e-08	34594039
rs549143	rs659529	0.797428492484743	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs549143	rs659529	0.797428492484743	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs549143	rs659529	0.797428492484743	Atopic dermatitis	5e-10	34116867
rs549143	rs9734135	0.760360869890654	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs549143	rs11213941	0.644151747384443	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs549143	rs11213941	0.644151747384443	Eczema	8e-14	30595370
rs549143	rs663763	0.64019728098108	Layilin levels	3e-21	36168886
rs553632	rs480293	0.9956932477181	Oily fish consumption	4e-11	32193382
rs553632	rs1613778	0.938070256834687	Total bilirubin levels	3e-08	34594039
rs553632	rs34634095	0.932661605352807	Fish- and plant-related diet	3e-09	32066663
rs553632	rs542831	0.912121377078516	Asthma	5e-13	31361310
rs553632	rs1784776	0.909641398675365	Asthma	2e-09	32296059
rs553632	rs1784775	0.909641398675365	Asthma	2e-09	30929738
rs553632	rs1784775	0.909641398675365	Asthma (adult onset)	6e-09	30929738
rs553632	rs1789358	0.907992721503636	Asthma	2e-08	34103634
rs553632	rs539524	0.901656166367181	Asthma	1e-10	32296059
rs553632	rs12791699	0.872819772977464	Pork consumption	9e-09	32066663
rs553632	rs12791699	0.872819772977464	Oily fish consumption	9e-09	32066663
rs553632	rs487985	0.872819772977464	Highest math class taken	1e-08	30038396
rs553632	rs10891286	0.847124006719349	Noncognitive aspects of educational attainment	5e-10	33414549
rs553632	rs4459340	0.843154706559344	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs553632	rs505372	0.798027252150916	Breast cancer	3e-06	29059683
rs553632	rs505372	0.798027252150916	Medication use (beta blocking agents)	2e-08	34594039
rs553632	rs659529	0.797428492484743	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs553632	rs659529	0.797428492484743	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs553632	rs659529	0.797428492484743	Atopic dermatitis	5e-10	34116867
rs553632	rs9734135	0.760360869890654	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs553632	rs11213941	0.644151747384443	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs553632	rs11213941	0.644151747384443	Eczema	8e-14	30595370
rs553632	rs663763	0.64019728098108	Layilin levels	3e-21	36168886
rs55646457	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs55646457	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs55646457	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs55646457	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs55646457	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs55646457	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs55646457	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs55646457	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs55646457	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs55646457	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs55646457	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs55646457	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs55646457	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs55646457	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs55646457	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs55646457	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs55646457	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs55646457	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs55646457	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs55646457	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs55646457	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs55646457	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs55646457	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs55646457	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs55646457	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs55646457	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs55661467	rs11099563	0.656042027587067	High density lipoprotein cholesterol levels	3e-11	34887591
rs55661467	rs4302451	0.626902943001734	Eosinophil counts	2e-09	30595370
rs55661467	rs2868708	0.613561824482394	Lymphocyte count	3e-11	34469753
rs55661467	rs2868708	0.613561824482394	White blood cell count	1e-09	30595370
rs55661467	rs6831339	0.610609004619758	High density lipoprotein cholesterol levels	9e-09	34887591
rs55661467	rs6535419	0.602984902925462	Pulse pressure	6e-10	30578418
rs55667381	rs56309584	0.676177492318959	Initial pursuit acceleration	9e-06	29064472
rs55693838	rs11580836	0.829387834914169	Body mass index	2e-09	36581621
rs55693838	rs10465746	0.800270956487337	Obesity-related traits	8e-06	23251661
rs55708077	rs6705511	0.840478301549175	Self-reported math ability	4e-09	30038396
rs55708077	rs6705511	0.840478301549175	Self-reported math ability (MTAG)	3e-10	30038396
rs55708077	rs34276187	0.832961076554142	Highest math class taken (MTAG)	2e-08	30038396
rs55715051	rs1063631	0.89243993556192	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs55715051	rs1063631	0.89243993556192	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs55715051	rs6928810	0.889266905277565	Platelet distribution width	1e-14	32888494
rs55715051	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs55715051	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs55715051	rs9266825	0.863388785752485	Autism spectrum disorder	6e-06	35215271
rs55715051	rs199530775	0.739165137320618	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs55715051	rs55957433	0.739165137320618	Hip circumference adjusted for BMI	3e-08	34021172
rs55715051	rs6934175	0.672943707181796	Psoriatic arthritis	5e-28	30552173
rs55715051	rs17200242	0.66362509863508	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs55715051	rs7751505	0.656902163915952	Pubertal anthropometrics	4e-06	23449627
rs55715051	rs35026345	0.655602177487711	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs55715051	rs72848707	0.652690496234301	HDL cholesterol levels	7e-06	35884923
rs55715051	rs13437088	0.630668695341699	Psoriasis	3e-40	23143594
rs55715051	rs13437082	0.629974191739058	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs55715051	rs13437082	0.629974191739058	Height	5e-08	19343178
rs55715051	rs72657657	0.622382288399658	Hip circumference adjusted for BMI	4e-13	34021172
rs55727087	rs11705721	0.998770830929096	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs55727087	rs11130638	0.996314005503276	Hemoglobin concentration	2e-23	32888493
rs55727087	rs34579268	0.989003551763989	Hematocrit	5e-30	32888493
rs55727087	rs34579268	0.989003551763989	Hematocrit	2e-27	32888493
rs55727087	rs34579268	0.989003551763989	Hemoglobin concentration	5e-26	32888493
rs55727087	rs7610312	0.975504725467132	Red blood cell count	5e-09	27863252
rs55727087	rs6775517	0.974272835397253	Hematocrit	1e-17	34594039
rs55727087	rs57700771	0.969408070647425	Red blood cell count	9e-21	30595370
rs55727087	rs55704295	0.90227869171292	Red blood cell count	8e-26	32888493
rs55727087	rs55704295	0.90227869171292	Red blood cell count	5e-23	32888493
rs55727087	rs55704295	0.90227869171292	Serum total protein level	2e-29	34594039
rs55727087	rs4681679	0.875180166806482	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs55727087	rs11719450	0.849292030877445	Hemoglobin concentration	2e-09	27863252
rs55727087	rs11719450	0.849292030877445	Hemoglobin levels	2e-16	32327693
rs55727087	rs56384862	0.838114594660657	Body mass index	8e-12	29273807
rs55727087	rs56384862	0.838114594660657	Body mass index	3e-06	30108127
rs55727087	rs56384862	0.838114594660657	Hemoglobin levels	1e-16	32327693
rs55727087	rs56384862	0.838114594660657	Body mass index	3e-14	36581621
rs55727087	rs11922478	0.835414324003647	Semaphorin-6B levels	4e-12	34648354
rs55727087	rs55692656	0.81788144732913	vWF levels	3e-08	30586737
rs55727087	rs55692656	0.81788144732913	vWF levels	6e-09	30586737
rs55727087	rs6445969	0.688456917623591	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs55727087	rs11708895	0.684566346682108	Red blood cell count	1e-20	32888494
rs55727087	rs55954186	0.680261770012473	vWF levels	5e-09	30586737
rs55727087	rs55954186	0.680261770012473	vWF levels	9e-09	30586737
rs55727087	rs7431952	0.618222156868521	Hemoglobin levels	1e-12	32327693
rs55742348	rs17713396	0.959440465855479	Blood urea nitrogen levels	3e-21	34272381
rs55742348	rs17713396	0.959440465855479	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs55742348	rs17713396	0.959440465855479	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs55742348	rs6710091	0.9574337078063	Waist circumference adjusted for body mass index	8e-11	31669095
rs55742348	rs6710091	0.9574337078063	HDL cholesterol	5e-08	30275531
rs55742348	rs6710091	0.9574337078063	High density lipoprotein cholesterol levels	3e-24	34887591
rs55742348	rs7595075	0.941455274273236	Waist circumference adjusted for body mass index	2e-09	34021172
rs55742348	rs7595075	0.941455274273236	HDL cholesterol	3e-11	34594039
rs55742348	rs7595075	0.941455274273236	HDL cholesterol levels	6e-13	32203549
rs55742348	rs2126129	0.93935975583207	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs55742348	rs17713729	0.938508195374087	Body mass index	2e-09	31669095
rs55742348	rs17713729	0.938508195374087	Serum creatinine levels	4e-14	34594039
rs55742348	rs17713729	0.938508195374087	High density lipoprotein cholesterol levels	7e-17	34887591
rs55742348	rs79716074	0.937461046111397	Plateletcrit	1e-09	32888494
rs55742348	rs79716074	0.937461046111397	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs55742348	rs79716074	0.937461046111397	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs55742348	rs79716074	0.937461046111397	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs55742348	rs58461606	0.930750490151404	Blood protein levels	0	30072576
rs55742348	rs7605824	0.923768033896487	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs55742348	rs7566279	0.922803466972081	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs55742348	rs3791221	0.919739007017786	Blood urea nitrogen levels	2e-07	31152163
rs55742348	rs3791221	0.919739007017786	Estimated glomerular filtration rate	2e-10	31152163
rs55742348	rs3791221	0.919739007017786	Estimated glomerular filtration rate	1e-11	31152163
rs55742348	rs3791221	0.919739007017786	Blood urea nitrogen levels	7e-26	34594039
rs55742348	rs2290911	0.91554762949124	Height	5e-07	29782485
rs55742348	rs2290911	0.91554762949124	Large artery stroke	6e-06	28265093
rs55742348	rs2290911	0.91554762949124	Height	8e-112	36224396
rs55742348	rs114976176	0.881845227678042	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs55742348	rs59937473	0.85446498155497	Protein quantitative trait loci	3e-67	32492067
rs55742348	rs59937473	0.85446498155497	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs55742348	rs17714252	0.846782394247122	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs55742348	rs17714252	0.846782394247122	Retinal vascular fractal dimension	2e-07	34743558
rs55742348	rs7601944	0.844751588468502	Smoking initiation	4e-15	36477530
rs55742348	rs11553746	0.844728453350653	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs55742348	rs11553746	0.844728453350653	High density lipoprotein cholesterol levels	2e-07	29083408
rs55742348	rs11553746	0.844728453350653	High density lipoprotein cholesterol levels	7e-15	29083408
rs55742348	rs11553746	0.844728453350653	Large artery stroke	4e-06	28265093
rs55742348	rs55753056	0.83610857906504	Height	2e-22	30595370
rs55742348	rs62114548	0.818717005082599	Retinal vascular fractal density	2e-09	34743558
rs55742348	rs62114538	0.795397203770112	Triglyceride levels	6e-12	34887591
rs55742348	rs17713879	0.793074337398592	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs55742348	rs17713879	0.793074337398592	Smoking initiation	1e-10	36477530
rs55742348	rs17713879	0.793074337398592	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs55742348	rs17713879	0.793074337398592	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs55742348	rs17713879	0.793074337398592	Triglyceride levels	3e-10	34887591
rs55742348	rs17713879	0.793074337398592	Aging (eyeAgeAcceleration)	6e-50	36975205
rs55742348	rs60843830	0.786699556472452	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs55742348	rs60843830	0.786699556472452	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs55742348	rs60843830	0.786699556472452	Adventurousness	7e-10	30643258
rs55742348	rs79154857	0.76170520272145	Pulse pressure	5e-08	34594039
rs55742348	rs62114506	0.739929309804203	Gamma glutamyl transpeptidase	3e-14	34594039
rs55742348	rs62114506	0.739929309804203	Apolipoprotein A1 levels	3e-10	32203549
rs55742348	rs62114506	0.739929309804203	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs55742348	rs62114506	0.739929309804203	HDL cholesterol levels	8e-10	36333282
rs55753056	rs55753056	1	Height	2e-22	30595370
rs55753056	rs7601944	0.989352616486158	Smoking initiation	4e-15	36477530
rs55753056	rs59937473	0.963355803594055	Protein quantitative trait loci	3e-67	32492067
rs55753056	rs59937473	0.963355803594055	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs55753056	rs17714252	0.955711592226136	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs55753056	rs17714252	0.955711592226136	Retinal vascular fractal dimension	2e-07	34743558
rs55753056	rs114976176	0.92372796052393	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs55753056	rs3791221	0.906945934259793	Blood urea nitrogen levels	2e-07	31152163
rs55753056	rs3791221	0.906945934259793	Estimated glomerular filtration rate	2e-10	31152163
rs55753056	rs3791221	0.906945934259793	Estimated glomerular filtration rate	1e-11	31152163
rs55753056	rs3791221	0.906945934259793	Blood urea nitrogen levels	7e-26	34594039
rs55753056	rs62114538	0.897823032194472	Triglyceride levels	6e-12	34887591
rs55753056	rs60843830	0.897547033870195	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs55753056	rs60843830	0.897547033870195	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs55753056	rs60843830	0.897547033870195	Adventurousness	7e-10	30643258
rs55753056	rs58461606	0.884999536468298	Blood protein levels	0	30072576
rs55753056	rs7566279	0.881357311834518	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs55753056	rs7595075	0.871325038642404	Waist circumference adjusted for body mass index	2e-09	34021172
rs55753056	rs7595075	0.871325038642404	HDL cholesterol	3e-11	34594039
rs55753056	rs7595075	0.871325038642404	HDL cholesterol levels	6e-13	32203549
rs55753056	rs17713396	0.869460830875673	Blood urea nitrogen levels	3e-21	34272381
rs55753056	rs17713396	0.869460830875673	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs55753056	rs17713396	0.869460830875673	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs55753056	rs6710091	0.869460830875673	Waist circumference adjusted for body mass index	8e-11	31669095
rs55753056	rs6710091	0.869460830875673	HDL cholesterol	5e-08	30275531
rs55753056	rs6710091	0.869460830875673	High density lipoprotein cholesterol levels	3e-24	34887591
rs55753056	rs79716074	0.86765363520271	Plateletcrit	1e-09	32888494
rs55753056	rs79716074	0.86765363520271	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs55753056	rs79716074	0.86765363520271	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs55753056	rs79716074	0.86765363520271	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs55753056	rs17713729	0.86658998465199	Body mass index	2e-09	31669095
rs55753056	rs17713729	0.86658998465199	Serum creatinine levels	4e-14	34594039
rs55753056	rs17713729	0.86658998465199	High density lipoprotein cholesterol levels	7e-17	34887591
rs55753056	rs7605824	0.85628861847886	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs55753056	rs2290911	0.831992441150366	Height	5e-07	29782485
rs55753056	rs2290911	0.831992441150366	Large artery stroke	6e-06	28265093
rs55753056	rs2290911	0.831992441150366	Height	8e-112	36224396
rs55753056	rs2126129	0.820268776968265	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs55753056	rs17713879	0.800050393660176	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs55753056	rs17713879	0.800050393660176	Smoking initiation	1e-10	36477530
rs55753056	rs17713879	0.800050393660176	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs55753056	rs17713879	0.800050393660176	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs55753056	rs17713879	0.800050393660176	Triglyceride levels	3e-10	34887591
rs55753056	rs17713879	0.800050393660176	Aging (eyeAgeAcceleration)	6e-50	36975205
rs55753056	rs11553746	0.780788630168538	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs55753056	rs11553746	0.780788630168538	High density lipoprotein cholesterol levels	2e-07	29083408
rs55753056	rs11553746	0.780788630168538	High density lipoprotein cholesterol levels	7e-15	29083408
rs55753056	rs11553746	0.780788630168538	Large artery stroke	4e-06	28265093
rs55753056	rs62114548	0.75363271021339	Retinal vascular fractal density	2e-09	34743558
rs55753056	rs79154857	0.709250413773156	Pulse pressure	5e-08	34594039
rs55753056	rs62114506	0.671051850876355	Gamma glutamyl transpeptidase	3e-14	34594039
rs55753056	rs62114506	0.671051850876355	Apolipoprotein A1 levels	3e-10	32203549
rs55753056	rs62114506	0.671051850876355	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs55753056	rs62114506	0.671051850876355	HDL cholesterol levels	8e-10	36333282
rs55761375	rs6700087	0.916464749625554	Smoking initiation	6e-11	36477530
rs55761375	rs7545078	0.886679434449295	Smoking initiation	2e-09	36477530
rs55770741	rs2549794	0.894471687209794	Crohn's disease	1e-10	21102463
rs55770741	rs2549794	0.894471687209794	Systolic blood pressure	1e-07	33230300
rs55770741	rs2549794	0.894471687209794	Diastolic blood pressure	1e-15	33230300
rs55770741	rs2549794	0.894471687209794	Diastolic blood pressure	2e-12	33230300
rs55770741	rs2549794	0.894471687209794	Systolic blood pressure	4e-10	33230300
rs55770741	rs1363907	0.889458262670899	Crohn's disease	4e-16	26192919
rs55770741	rs1363907	0.889458262670899	Ulcerative colitis	4e-06	26192919
rs55770741	rs1363907	0.889458262670899	Inflammatory bowel disease	5e-15	26192919
rs55770741	rs1363907	0.889458262670899	Inflammatory bowel disease	6e-13	23128233
rs55770741	rs1363907	0.889458262670899	Inflammatory bowel disease	1e-10	28067908
rs55770741	rs1363907	0.889458262670899	Crohn's disease	1e-14	28067908
rs55770741	rs2617439	0.843594755046524	Neutrophil count	8e-11	32888494
rs55770741	rs716848	0.837604234835051	Neutrophil percentage of white cells	2e-09	32888494
rs55770741	rs38029	0.832490793181676	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs55770741	rs2548532	0.813604292990687	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs55770741	rs4869313	0.772862773933824	Pediatric autoimmune diseases	9e-08	26301688
rs55770741	rs27660	0.709485320757506	Coronary artery disease	3e-08	35915156
rs55770741	rs1559359	0.699955639686877	Diastolic blood pressure	7e-10	34594039
rs55770741	rs1974871	0.697666880678283	Granulysin levels	5e-13	34648354
rs55770741	rs1423357	0.680588401348513	General cognitive ability	9e-06	29844566
rs55770741	rs2432142	0.666589513495053	Neutrophil count	2e-14	32888493
rs55770741	rs2432142	0.666589513495053	White blood cell count	1e-11	32888493
rs55770741	rs38033	0.664972372543772	Blood protein levels	0	30072576
rs55770741	rs27293	0.655550885179432	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs55770741	rs27293	0.655550885179432	Diastolic blood pressure	3e-11	35762941
rs55770741	rs7705093	0.649576170120599	Birdshot chorioretinopathy	2e-09	24957906
rs55770741	rs2927608	0.640123808063898	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs55770741	rs2927608	0.640123808063898	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs55770741	rs2927608	0.640123808063898	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs55770741	rs2910686	0.637909470415816	Neutrophil count	4e-14	32888493
rs55770741	rs2910686	0.637909470415816	Psoriasis	2e-08	23143594
rs55770741	rs2910686	0.637909470415816	Ankylosing spondylitis	5e-17	23749187
rs55770741	rs2910686	0.637909470415816	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs55775354	rs6705511	0.730995029189951	Self-reported math ability	4e-09	30038396
rs55775354	rs6705511	0.730995029189951	Self-reported math ability (MTAG)	3e-10	30038396
rs55775354	rs34276187	0.725154729250659	Highest math class taken (MTAG)	2e-08	30038396
rs55783924	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs55783924	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs55783924	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs55783924	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs55783924	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs55783924	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs55783924	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs55783924	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs55783924	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs55783924	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs55783924	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs55783924	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs55783924	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs55783924	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs55783924	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs55783924	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs55783924	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs55783924	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs55783924	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs55783924	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs55783924	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs55783924	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs55783924	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs55783924	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs55783924	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs55783924	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs55818134	rs2868708	0.961225104403855	Lymphocyte count	3e-11	34469753
rs55818134	rs2868708	0.961225104403855	White blood cell count	1e-09	30595370
rs55818134	rs6831339	0.957953480623664	High density lipoprotein cholesterol levels	9e-09	34887591
rs55818134	rs6535419	0.909313562636612	Pulse pressure	6e-10	30578418
rs55818134	rs116142917	0.882591861484152	Lymphocyte count	7e-18	32888494
rs55818134	rs6823199	0.86709086512645	Pulse pressure	4e-14	30224653
rs55818134	rs13111599	0.854826910586776	HDL cholesterol levels	3e-09	32203549
rs55818134	rs13111599	0.854826910586776	Apolipoprotein A1 levels	4e-08	32203549
rs55818134	rs4302451	0.77205460216148	Eosinophil counts	2e-09	30595370
rs55818134	rs35895091	0.729966472853422	Cardiovascular disease	1e-07	30595370
rs55818134	rs11099563	0.712215358183033	High density lipoprotein cholesterol levels	3e-11	34887591
rs55818134	rs28528763	0.693245930435801	White blood cell count	7e-12	32888494
rs55818134	rs7662402	0.606956066858491	Brain morphology (MOSTest)	3e-08	35164939
rs55845662	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs55845662	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs55845662	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs55845662	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs55845662	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs55845662	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs55845662	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs55845662	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs55845662	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs55845662	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs55845662	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs55845662	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs55845662	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs55845662	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs55845662	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs55845662	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs55845662	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs55845662	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs55845662	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs55845662	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs55845662	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs55845662	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs55845662	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs55845662	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs55845662	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs55845662	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs55849538	rs11155662	0.915531978811802	Vertex-wise cortical thickness	2e-09	34910505
rs55849538	rs56103941	0.906177171035783	Right presubiculum volume (head)	4e-08	37337106
rs55849538	rs12523793	0.892811448639482	Subcortical volume (MOSTest)	4e-24	32665545
rs55849538	rs12523793	0.892811448639482	C-reactive protein levels	3e-08	35459240
rs55849538	rs12523793	0.892811448639482	C-reactive protein levels (MTAG)	2e-08	36376304
rs55849538	rs12526675	0.813211786179234	Brain morphology (MOSTest)	7e-22	32665545
rs55849538	rs9285521	0.801662639451362	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs55849538	rs2342764	0.758101573512481	Cortical thickness	1e-08	34560273
rs55849538	rs58189451	0.737179419692631	Drinks per week	1e-09	36477530
rs55849538	rs9322194	0.702663439788932	Brainstem volume	2e-11	31636452
rs55849538	rs9505982	0.644281327370576	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs55849538	rs10872649	0.636334235516138	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs55849538	rs10872649	0.636334235516138	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs55849538	rs10872649	0.636334235516138	Right hippocampal volume (body)	1e-10	37337106
rs55849538	rs4421206	0.633213840593487	Brain morphology (min-P)	4e-11	32665545
rs55849538	rs9688452	0.622373179880181	Brainstem global volume Whole-brainstem	1e-11	33875891
rs55849538	rs9688452	0.622373179880181	aseg lh volume VentralDC	2e-10	33875891
rs55849538	rs11155671	0.611259657944973	Testicular germ cell tumor	2e-09	28604728
rs55849538	rs7752089	0.610426553138956	Brain morphology (MOSTest)	2e-31	35164939
rs55849538	rs1934534	0.602216109043906	Pain (pleiotropy)	2e-08	37844115
rs55849538	rs1934534	0.602216109043906	Pain (pleiotropy)	2e-06	37844115
rs55849538	rs4380763	0.601455064431731	Subcortical volume (min-P)	1e-11	32665545
rs55908966	rs11685226	0.973447068933337	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs55908966	rs11685226	0.973447068933337	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs55908966	rs7558954	0.963524149763044	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs55908966	rs1177308	0.959408419136574	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs55908966	rs1177308	0.959408419136574	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs55908966	rs777587	0.805267262697909	Proteoglycan 3 levels	6e-29	34648354
rs55908966	rs777587	0.805267262697909	Pappalysin-1 levels	1e-25	34648354
rs55908966	rs12617371	0.765888001030679	Immature fraction of reticulocytes	8e-18	32888494
rs55908966	rs2463097	0.732644905460495	White blood cell count	3e-26	30595370
rs55908966	rs2593620	0.708949230322617	Serum levels of protein PRG3	5e-14	35078996
rs55908966	rs10199672	0.701407514946282	Height	6e-12	34594039
rs55908966	rs10199672	0.701407514946282	Height	2e-12	31562340
rs55908966	rs2421200	0.68085266761077	Neutrophil count	1e-26	32888493
rs55908966	rs2421200	0.68085266761077	Neutrophil count	1e-25	32888493
rs55908966	rs10169482	0.630240532759762	C-reactive protein levels	4e-09	33462484
rs55908966	rs12616433	0.607101551560494	Eosinophil forward scatter	4e-13	37596262
rs55908966	rs12616433	0.607101551560494	Eosinophil side scatter	2e-18	37596262
rs55917554	rs61586425	0.642858911824647	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs55917554	rs7211615	0.637323459124936	Heel bone mineral density	1e-08	30595370
rs55917554	rs8077038	0.614769823522377	Educational attainment (MTAG)	4e-10	30038396
rs55917554	rs8077038	0.614769823522377	Highest math class taken (MTAG)	5e-16	30038396
rs55917554	rs12949956	0.607676906917568	Self-reported math ability	3e-11	30038396
rs55917554	rs12949956	0.607676906917568	Self-reported math ability (MTAG)	3e-14	30038396
rs55917554	rs12949956	0.607676906917568	Highest math class taken	8e-12	30038396
rs55936343	rs7545078	0.781554068582191	Smoking initiation	2e-09	36477530
rs55936343	rs6700087	0.741892557760703	Smoking initiation	6e-11	36477530
rs55936726	rs2290911	0.966833169783453	Height	5e-07	29782485
rs55936726	rs2290911	0.966833169783453	Large artery stroke	6e-06	28265093
rs55936726	rs2290911	0.966833169783453	Height	8e-112	36224396
rs55936726	rs17713729	0.958364722238427	Body mass index	2e-09	31669095
rs55936726	rs17713729	0.958364722238427	Serum creatinine levels	4e-14	34594039
rs55936726	rs17713729	0.958364722238427	High density lipoprotein cholesterol levels	7e-17	34887591
rs55936726	rs7595075	0.955245206646468	Waist circumference adjusted for body mass index	2e-09	34021172
rs55936726	rs7595075	0.955245206646468	HDL cholesterol	3e-11	34594039
rs55936726	rs7595075	0.955245206646468	HDL cholesterol levels	6e-13	32203549
rs55936726	rs79716074	0.951147448416258	Plateletcrit	1e-09	32888494
rs55936726	rs79716074	0.951147448416258	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs55936726	rs79716074	0.951147448416258	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs55936726	rs79716074	0.951147448416258	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs55936726	rs58461606	0.944579338056716	Blood protein levels	0	30072576
rs55936726	rs17713396	0.941135255092332	Blood urea nitrogen levels	3e-21	34272381
rs55936726	rs17713396	0.941135255092332	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs55936726	rs17713396	0.941135255092332	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs55936726	rs6710091	0.939128118017011	Waist circumference adjusted for body mass index	8e-11	31669095
rs55936726	rs6710091	0.939128118017011	HDL cholesterol	5e-08	30275531
rs55936726	rs6710091	0.939128118017011	High density lipoprotein cholesterol levels	3e-24	34887591
rs55936726	rs7605824	0.937390298359234	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs55936726	rs7566279	0.936426145032911	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs55936726	rs11553746	0.923265991287466	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs55936726	rs11553746	0.923265991287466	High density lipoprotein cholesterol levels	2e-07	29083408
rs55936726	rs11553746	0.923265991287466	High density lipoprotein cholesterol levels	7e-15	29083408
rs55936726	rs11553746	0.923265991287466	Large artery stroke	4e-06	28265093
rs55936726	rs3791221	0.902419771097844	Blood urea nitrogen levels	2e-07	31152163
rs55936726	rs3791221	0.902419771097844	Estimated glomerular filtration rate	2e-10	31152163
rs55936726	rs3791221	0.902419771097844	Estimated glomerular filtration rate	1e-11	31152163
rs55936726	rs3791221	0.902419771097844	Blood urea nitrogen levels	7e-26	34594039
rs55936726	rs114976176	0.893586714505586	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs55936726	rs2126129	0.88889656331738	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs55936726	rs62114548	0.887799279080257	Retinal vascular fractal density	2e-09	34743558
rs55936726	rs59937473	0.866469682756511	Protein quantitative trait loci	3e-67	32492067
rs55936726	rs59937473	0.866469682756511	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs55936726	rs17714252	0.858592745342497	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs55936726	rs17714252	0.858592745342497	Retinal vascular fractal dimension	2e-07	34743558
rs55936726	rs55753056	0.837089827528743	Height	2e-22	30595370
rs55936726	rs79154857	0.833615375452449	Pulse pressure	5e-08	34594039
rs55936726	rs7601944	0.82934090028144	Smoking initiation	4e-15	36477530
rs55936726	rs62114538	0.814511837075066	Triglyceride levels	6e-12	34887591
rs55936726	rs17713879	0.803144758196702	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs55936726	rs17713879	0.803144758196702	Smoking initiation	1e-10	36477530
rs55936726	rs17713879	0.803144758196702	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs55936726	rs17713879	0.803144758196702	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs55936726	rs17713879	0.803144758196702	Triglyceride levels	3e-10	34887591
rs55936726	rs17713879	0.803144758196702	Aging (eyeAgeAcceleration)	6e-50	36975205
rs55936726	rs60843830	0.796650387262595	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs55936726	rs60843830	0.796650387262595	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs55936726	rs60843830	0.796650387262595	Adventurousness	7e-10	30643258
rs55936726	rs62114506	0.78123173586915	Gamma glutamyl transpeptidase	3e-14	34594039
rs55936726	rs62114506	0.78123173586915	Apolipoprotein A1 levels	3e-10	32203549
rs55936726	rs62114506	0.78123173586915	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs55936726	rs62114506	0.78123173586915	HDL cholesterol levels	8e-10	36333282
rs55946380	rs2290911	0.970902508465161	Height	5e-07	29782485
rs55946380	rs2290911	0.970902508465161	Large artery stroke	6e-06	28265093
rs55946380	rs2290911	0.970902508465161	Height	8e-112	36224396
rs55946380	rs7595075	0.959326867605807	Waist circumference adjusted for body mass index	2e-09	34021172
rs55946380	rs7595075	0.959326867605807	HDL cholesterol	3e-11	34594039
rs55946380	rs7595075	0.959326867605807	HDL cholesterol levels	6e-13	32203549
rs55946380	rs79716074	0.957241278240882	Plateletcrit	1e-09	32888494
rs55946380	rs79716074	0.957241278240882	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs55946380	rs79716074	0.957241278240882	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs55946380	rs79716074	0.957241278240882	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs55946380	rs17713729	0.954350998784094	Body mass index	2e-09	31669095
rs55946380	rs17713729	0.954350998784094	Serum creatinine levels	4e-14	34594039
rs55946380	rs17713729	0.954350998784094	High density lipoprotein cholesterol levels	7e-17	34887591
rs55946380	rs58461606	0.95065466148833	Blood protein levels	0	30072576
rs55946380	rs17713396	0.94517242462086	Blood urea nitrogen levels	3e-21	34272381
rs55946380	rs17713396	0.94517242462086	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs55946380	rs17713396	0.94517242462086	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs55946380	rs7605824	0.943432131697817	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs55946380	rs6710091	0.9431589489937	Waist circumference adjusted for body mass index	8e-11	31669095
rs55946380	rs6710091	0.9431589489937	HDL cholesterol	5e-08	30275531
rs55946380	rs6710091	0.9431589489937	High density lipoprotein cholesterol levels	3e-24	34887591
rs55946380	rs7566279	0.942464509057737	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs55946380	rs11553746	0.929184427930137	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs55946380	rs11553746	0.929184427930137	High density lipoprotein cholesterol levels	2e-07	29083408
rs55946380	rs11553746	0.929184427930137	High density lipoprotein cholesterol levels	7e-15	29083408
rs55946380	rs11553746	0.929184427930137	Large artery stroke	4e-06	28265093
rs55946380	rs3791221	0.906378206166575	Blood urea nitrogen levels	2e-07	31152163
rs55946380	rs3791221	0.906378206166575	Estimated glomerular filtration rate	2e-10	31152163
rs55946380	rs3791221	0.906378206166575	Estimated glomerular filtration rate	1e-11	31152163
rs55946380	rs3791221	0.906378206166575	Blood urea nitrogen levels	7e-26	34594039
rs55946380	rs114976176	0.897531764185784	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs55946380	rs2126129	0.892746686698733	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs55946380	rs62114548	0.885612025763811	Retinal vascular fractal density	2e-09	34743558
rs55946380	rs59937473	0.872264877670575	Protein quantitative trait loci	3e-67	32492067
rs55946380	rs59937473	0.872264877670575	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs55946380	rs17714252	0.864350992816099	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs55946380	rs17714252	0.864350992816099	Retinal vascular fractal dimension	2e-07	34743558
rs55946380	rs55753056	0.840922345114414	Height	2e-22	30595370
rs55946380	rs79154857	0.839136600391591	Pulse pressure	5e-08	34594039
rs55946380	rs7601944	0.833152982805302	Smoking initiation	4e-15	36477530
rs55946380	rs62114538	0.811077476351982	Triglyceride levels	6e-12	34887591
rs55946380	rs17713879	0.806782545633346	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs55946380	rs17713879	0.806782545633346	Smoking initiation	1e-10	36477530
rs55946380	rs17713879	0.806782545633346	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs55946380	rs17713879	0.806782545633346	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs55946380	rs17713879	0.806782545633346	Triglyceride levels	3e-10	34887591
rs55946380	rs17713879	0.806782545633346	Aging (eyeAgeAcceleration)	6e-50	36975205
rs55946380	rs60843830	0.802102818371645	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs55946380	rs60843830	0.802102818371645	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs55946380	rs60843830	0.802102818371645	Adventurousness	7e-10	30643258
rs55946380	rs62114506	0.784527233565134	Gamma glutamyl transpeptidase	3e-14	34594039
rs55946380	rs62114506	0.784527233565134	Apolipoprotein A1 levels	3e-10	32203549
rs55946380	rs62114506	0.784527233565134	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs55946380	rs62114506	0.784527233565134	HDL cholesterol levels	8e-10	36333282
rs55957433	rs199530775	1	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs55957433	rs55957433	1	Hip circumference adjusted for BMI	3e-08	34021172
rs55957433	rs6934175	0.646763575953364	Psoriatic arthritis	5e-28	30552173
rs55957433	rs6928810	0.646590769339288	Platelet distribution width	1e-14	32888494
rs55957433	rs3869132	0.644918473229168	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs55957433	rs3869132	0.644918473229168	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs55957433	rs1063631	0.641546285492807	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs55957433	rs1063631	0.641546285492807	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs55957433	rs17200242	0.639190406194931	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs55957433	rs9266825	0.60082564188442	Autism spectrum disorder	6e-06	35215271
rs55961601	rs1063631	0.893319633462769	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs55961601	rs1063631	0.893319633462769	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs55961601	rs6928810	0.891745775528609	Platelet distribution width	1e-14	32888494
rs55961601	rs3869132	0.890904456181924	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs55961601	rs3869132	0.890904456181924	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs55961601	rs9266825	0.864393099012024	Autism spectrum disorder	6e-06	35215271
rs55961601	rs199530775	0.74035514200756	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs55961601	rs55957433	0.74035514200756	Hip circumference adjusted for BMI	3e-08	34021172
rs55961601	rs6934175	0.67415805304045	Psoriatic arthritis	5e-28	30552173
rs55961601	rs17200242	0.664813628388513	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs55961601	rs7751505	0.657893319519128	Pubertal anthropometrics	4e-06	23449627
rs55961601	rs35026345	0.656601329684581	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs55961601	rs72848707	0.653924568061247	HDL cholesterol levels	7e-06	35884923
rs55961601	rs13437088	0.631593833437287	Psoriasis	3e-40	23143594
rs55961601	rs13437082	0.630900064794185	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs55961601	rs13437082	0.630900064794185	Height	5e-08	19343178
rs55961601	rs72657657	0.623308096601472	Hip circumference adjusted for BMI	4e-13	34021172
rs55987902	rs6471393	0.610399554723808	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs55994092	rs7545078	0.631370562224004	Smoking initiation	2e-09	36477530
rs56026131	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs56026131	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs56026131	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs56026131	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs56026131	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs56026131	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs56026131	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs56026131	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs56026131	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs56026131	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs56026131	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs56026131	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs56026131	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs56026131	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs56026131	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs56026131	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs56026131	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs56026131	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs56026131	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs56026131	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs56026131	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs56026131	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs56026131	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs56026131	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs56026131	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs56026131	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs56028017	rs7610312	0.993772118570341	Red blood cell count	5e-09	27863252
rs56028017	rs6775517	0.992546964841009	Hematocrit	1e-17	34594039
rs56028017	rs57700771	0.987542783484534	Red blood cell count	9e-21	30595370
rs56028017	rs11705721	0.973100036833204	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs56028017	rs11130638	0.970656122022856	Hemoglobin concentration	2e-23	32888493
rs56028017	rs34579268	0.963533857690389	Hematocrit	5e-30	32888493
rs56028017	rs34579268	0.963533857690389	Hematocrit	2e-27	32888493
rs56028017	rs34579268	0.963533857690389	Hemoglobin concentration	5e-26	32888493
rs56028017	rs55704295	0.921180060807874	Red blood cell count	8e-26	32888493
rs56028017	rs55704295	0.921180060807874	Red blood cell count	5e-23	32888493
rs56028017	rs55704295	0.921180060807874	Serum total protein level	2e-29	34594039
rs56028017	rs4681679	0.893411670835406	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs56028017	rs11719450	0.866952265555465	Hemoglobin concentration	2e-09	27863252
rs56028017	rs11719450	0.866952265555465	Hemoglobin levels	2e-16	32327693
rs56028017	rs56384862	0.855389529761866	Body mass index	8e-12	29273807
rs56028017	rs56384862	0.855389529761866	Body mass index	3e-06	30108127
rs56028017	rs56384862	0.855389529761866	Hemoglobin levels	1e-16	32327693
rs56028017	rs56384862	0.855389529761866	Body mass index	3e-14	36581621
rs56028017	rs11922478	0.852723020020629	Semaphorin-6B levels	4e-12	34648354
rs56028017	rs55692656	0.831666464111107	vWF levels	3e-08	30586737
rs56028017	rs55692656	0.831666464111107	vWF levels	6e-09	30586737
rs56028017	rs6445969	0.704313066438816	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs56028017	rs11708895	0.697931790872419	Red blood cell count	1e-20	32888494
rs56028017	rs55954186	0.693518104072523	vWF levels	5e-09	30586737
rs56028017	rs55954186	0.693518104072523	vWF levels	9e-09	30586737
rs56028017	rs7431952	0.632366544137611	Hemoglobin levels	1e-12	32327693
rs56033718	rs11719450	0.993302955401488	Hemoglobin concentration	2e-09	27863252
rs56033718	rs11719450	0.993302955401488	Hemoglobin levels	2e-16	32327693
rs56033718	rs4681679	0.96167656668267	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs56033718	rs56384862	0.924511317018826	Body mass index	8e-12	29273807
rs56033718	rs56384862	0.924511317018826	Body mass index	3e-06	30108127
rs56033718	rs56384862	0.924511317018826	Hemoglobin levels	1e-16	32327693
rs56033718	rs56384862	0.924511317018826	Body mass index	3e-14	36581621
rs56033718	rs7610312	0.869662463577559	Red blood cell count	5e-09	27863252
rs56033718	rs6775517	0.868810732780455	Hematocrit	1e-17	34594039
rs56033718	rs57700771	0.863291580447445	Red blood cell count	9e-21	30595370
rs56033718	rs34579268	0.859645344976412	Hematocrit	5e-30	32888493
rs56033718	rs34579268	0.859645344976412	Hematocrit	2e-27	32888493
rs56033718	rs34579268	0.859645344976412	Hemoglobin concentration	5e-26	32888493
rs56033718	rs11705721	0.851721807264584	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs56033718	rs11130638	0.851721807264584	Hemoglobin concentration	2e-23	32888493
rs56033718	rs11922478	0.826214955844422	Semaphorin-6B levels	4e-12	34648354
rs56033718	rs55692656	0.814181449527451	vWF levels	3e-08	30586737
rs56033718	rs55692656	0.814181449527451	vWF levels	6e-09	30586737
rs56033718	rs55704295	0.792630213170154	Red blood cell count	8e-26	32888493
rs56033718	rs55704295	0.792630213170154	Red blood cell count	5e-23	32888493
rs56033718	rs55704295	0.792630213170154	Serum total protein level	2e-29	34594039
rs56033718	rs55954186	0.782395747167591	vWF levels	5e-09	30586737
rs56033718	rs55954186	0.782395747167591	vWF levels	9e-09	30586737
rs56033718	rs11708895	0.779632745964208	Red blood cell count	1e-20	32888494
rs56033718	rs6445969	0.756444983131143	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs56033718	rs7431952	0.679486570831977	Hemoglobin levels	1e-12	32327693
rs56033718	rs9311676	0.653266228240809	Systemic lupus erythematosus	5e-06	27399966
rs56033718	rs9311676	0.653266228240809	Systemic lupus erythematosus	3e-14	26502338
rs56033718	rs9311676	0.653266228240809	Waist circumference adjusted for body mass index	3e-08	34021172
rs56033718	rs9822855	0.630579878922429	Educational attainment	9e-120	35361970
rs56080538	rs9611441	0.962932569791409	C-reactive protein levels	1e-08	30388399
rs56080538	rs138354	0.962095370021271	Apolipoprotein B levels	8e-09	32203549
rs56080538	rs103197	0.927476734734841	Bipolar disorder (MTAG)	7e-09	34159505
rs56080538	rs5758128	0.885621817709744	Low density lipoprotein cholesterol levels	6e-13	32154731
rs56080538	rs5758128	0.885621817709744	Total cholesterol levels	4e-08	34594039
rs56113711	rs7610312	0.997507911336935	Red blood cell count	5e-09	27863252
rs56113711	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs56113711	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs56113711	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs56113711	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs56113711	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs56113711	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs56113711	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs56113711	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs56113711	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs56113711	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs56113711	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs56113711	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs56113711	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs56113711	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs56113711	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs56113711	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs56113711	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs56113711	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs56113711	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs56113711	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs56113711	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs56113711	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs56113711	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs56113711	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs56113711	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs56165145	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs56165145	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs56165145	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs56165145	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs56165145	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs56165145	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs56165145	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs56165145	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs56165145	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs56165145	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs56165145	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs56165145	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs56165145	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs56165145	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs56165145	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs56165145	rs13437082	0.631513452560533	Height	5e-08	19343178
rs56165145	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs56167178	rs10804157	0.723075397074969	Uterine leiomyomata	4e-09	36726022
rs56167434	rs2290911	0.96157225213799	Height	5e-07	29782485
rs56167434	rs2290911	0.96157225213799	Large artery stroke	6e-06	28265093
rs56167434	rs2290911	0.96157225213799	Height	8e-112	36224396
rs56167434	rs79716074	0.954239910619468	Plateletcrit	1e-09	32888494
rs56167434	rs79716074	0.954239910619468	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs56167434	rs79716074	0.954239910619468	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs56167434	rs79716074	0.954239910619468	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs56167434	rs7595075	0.950254293600088	Waist circumference adjusted for body mass index	2e-09	34021172
rs56167434	rs7595075	0.950254293600088	HDL cholesterol	3e-11	34594039
rs56167434	rs7595075	0.950254293600088	HDL cholesterol levels	6e-13	32203549
rs56167434	rs7566279	0.94754799050806	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs56167434	rs17713729	0.945310071515485	Body mass index	2e-09	31669095
rs56167434	rs17713729	0.945310071515485	Serum creatinine levels	4e-14	34594039
rs56167434	rs17713729	0.945310071515485	High density lipoprotein cholesterol levels	7e-17	34887591
rs56167434	rs7605824	0.944488777134368	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs56167434	rs58461606	0.941673953134411	Blood protein levels	0	30072576
rs56167434	rs17713396	0.936149315170628	Blood urea nitrogen levels	3e-21	34272381
rs56167434	rs17713396	0.936149315170628	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs56167434	rs17713396	0.936149315170628	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs56167434	rs6710091	0.934142927797438	Waist circumference adjusted for body mass index	8e-11	31669095
rs56167434	rs6710091	0.934142927797438	HDL cholesterol	5e-08	30275531
rs56167434	rs6710091	0.934142927797438	High density lipoprotein cholesterol levels	3e-24	34887591
rs56167434	rs11553746	0.923785302008342	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs56167434	rs11553746	0.923785302008342	High density lipoprotein cholesterol levels	2e-07	29083408
rs56167434	rs11553746	0.923785302008342	High density lipoprotein cholesterol levels	7e-15	29083408
rs56167434	rs11553746	0.923785302008342	Large artery stroke	4e-06	28265093
rs56167434	rs3791221	0.897680906852853	Blood urea nitrogen levels	2e-07	31152163
rs56167434	rs3791221	0.897680906852853	Estimated glomerular filtration rate	2e-10	31152163
rs56167434	rs3791221	0.897680906852853	Estimated glomerular filtration rate	1e-11	31152163
rs56167434	rs3791221	0.897680906852853	Blood urea nitrogen levels	7e-26	34594039
rs56167434	rs114976176	0.892794254134286	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs56167434	rs62114548	0.884377723979998	Retinal vascular fractal density	2e-09	34743558
rs56167434	rs2126129	0.883818926788969	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs56167434	rs59937473	0.867711849514207	Protein quantitative trait loci	3e-67	32492067
rs56167434	rs59937473	0.867711849514207	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs56167434	rs17714252	0.863565120153871	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs56167434	rs17714252	0.863565120153871	Retinal vascular fractal dimension	2e-07	34743558
rs56167434	rs79154857	0.837704567496049	Pulse pressure	5e-08	34594039
rs56167434	rs55753056	0.836489914463296	Height	2e-22	30595370
rs56167434	rs7601944	0.828747096009355	Smoking initiation	4e-15	36477530
rs56167434	rs60843830	0.808508123476356	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs56167434	rs60843830	0.808508123476356	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs56167434	rs60843830	0.808508123476356	Adventurousness	7e-10	30643258
rs56167434	rs62114538	0.806794904581565	Triglyceride levels	6e-12	34887591
rs56167434	rs17713879	0.798459852911842	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs56167434	rs17713879	0.798459852911842	Smoking initiation	1e-10	36477530
rs56167434	rs17713879	0.798459852911842	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs56167434	rs17713879	0.798459852911842	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs56167434	rs17713879	0.798459852911842	Triglyceride levels	3e-10	34887591
rs56167434	rs17713879	0.798459852911842	Aging (eyeAgeAcceleration)	6e-50	36975205
rs56167434	rs62114506	0.774974301523729	Gamma glutamyl transpeptidase	3e-14	34594039
rs56167434	rs62114506	0.774974301523729	Apolipoprotein A1 levels	3e-10	32203549
rs56167434	rs62114506	0.774974301523729	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs56167434	rs62114506	0.774974301523729	HDL cholesterol levels	8e-10	36333282
rs56190366	rs11715071	0.886644719615789	Body mass index	3e-08	36581621
rs56235845	rs56235845	1	Hematocrit	9e-11	27863252
rs56235845	rs56235845	1	Hemoglobin concentration	1e-09	27863252
rs56235845	rs56235845	1	Kidney stones	3e-21	31729369
rs56235845	rs56235845	1	Hemoglobin levels	7e-16	32327693
rs56235845	rs10051765	0.911407698620145	Vitamin C levels	4e-09	33203707
rs56235845	rs10051765	0.911407698620145	Kidney stones	8e-15	31729369
rs56235845	rs6556313	0.774257989697013	Eosinophil counts	2e-20	32888493
rs56235845	rs6556313	0.774257989697013	Eosinophil counts	1e-16	32888494
rs56235845	rs6556313	0.774257989697013	Eosinophil percentage of white cells	1e-11	32888494
rs56235845	rs6556313	0.774257989697013	Calcium levels	1e-12	33887147
rs56235845	rs6556313	0.774257989697013	Eosinophil counts	1e-21	30595370
rs56235845	rs4976689	0.763087616448197	Eosinophil counts	4e-18	34594039
rs56235845	rs4976646	0.757648297343978	Multiple sclerosis	4e-18	24076602
rs56235845	rs4976646	0.757648297343978	Blood urea nitrogen levels	1e-19	31152163
rs56235845	rs4976646	0.757648297343978	Chronic kidney disease	2e-10	31152163
rs56235845	rs4976646	0.757648297343978	Crohn's disease	3e-08	26192919
rs56235845	rs4976646	0.757648297343978	Ulcerative colitis	3e-09	26192919
rs56235845	rs4976646	0.757648297343978	Inflammatory bowel disease	3e-12	26192919
rs56235845	rs4976646	0.757648297343978	Tumor necrosis factor receptor 2 levels	4e-10	33067605
rs56235845	rs4976646	0.757648297343978	Inflammatory bowel disease	4e-09	28067908
rs56235845	rs4976646	0.757648297343978	Ulcerative colitis	4e-08	28067908
rs56235845	rs67111717	0.748687034966832	Multiple sclerosis	3e-21	31604244
rs56235845	rs35716097	0.680297384870867	Phosphorus levels	2e-23	29403010
rs56235845	rs35716097	0.680297384870867	Glomerular filtration rate	4e-09	27588450
rs56235845	rs35716097	0.680297384870867	Glomerular filtration rate	6e-07	27588450
rs56235845	rs35716097	0.680297384870867	Glomerular filtration rate	2e-17	27588450
rs56235845	rs11135015	0.63517164592504	Eosinophil counts	4e-21	32888493
rs56246654	rs1063631	0.888457181809669	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs56246654	rs1063631	0.888457181809669	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs56246654	rs6928810	0.885283037138904	Platelet distribution width	1e-14	32888494
rs56246654	rs3869132	0.884439629258944	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs56246654	rs3869132	0.884439629258944	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs56246654	rs9266825	0.859541247353603	Autism spectrum disorder	6e-06	35215271
rs56246654	rs199530775	0.737267358063975	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs56246654	rs55957433	0.737267358063975	Hip circumference adjusted for BMI	3e-08	34021172
rs56246654	rs6934175	0.669700426503033	Psoriatic arthritis	5e-28	30552173
rs56246654	rs17200242	0.660401647231583	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs56246654	rs7751505	0.653631250320394	Pubertal anthropometrics	4e-06	23449627
rs56246654	rs35026345	0.65233830515138	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs56246654	rs72848707	0.649511563938302	HDL cholesterol levels	7e-06	35884923
rs56246654	rs13437088	0.627449777636642	Psoriasis	3e-40	23143594
rs56246654	rs13437082	0.626757715145923	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs56246654	rs13437082	0.626757715145923	Height	5e-08	19343178
rs56246654	rs72657657	0.619189069117407	Hip circumference adjusted for BMI	4e-13	34021172
rs56259749	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs56259749	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs56259749	rs6928810	0.890092667905038	Platelet distribution width	1e-14	32888494
rs56259749	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs56259749	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs56259749	rs9266825	0.864263096403477	Autism spectrum disorder	6e-06	35215271
rs56259749	rs199530775	0.740076610728635	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs56259749	rs55957433	0.740076610728635	Hip circumference adjusted for BMI	3e-08	34021172
rs56259749	rs6934175	0.67384422555715	Psoriatic arthritis	5e-28	30552173
rs56259749	rs17200242	0.664511943065584	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs56259749	rs7751505	0.657706582280067	Pubertal anthropometrics	4e-06	23449627
rs56259749	rs35026345	0.65640936672589	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs56259749	rs72848707	0.653592630236073	HDL cholesterol levels	7e-06	35884923
rs56259749	rs13437088	0.631438004864122	Psoriasis	3e-40	23143594
rs56259749	rs13437082	0.630743556638567	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs56259749	rs13437082	0.630743556638567	Height	5e-08	19343178
rs56259749	rs72657657	0.623149040879308	Hip circumference adjusted for BMI	4e-13	34021172
rs56281646	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs56281646	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs56281646	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs56281646	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs56281646	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs56281646	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs56281646	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs56281646	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs56281646	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs56281646	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs56281646	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs56281646	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs56281646	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs56281646	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs56281646	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs56281646	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs56281646	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs56281646	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs56281646	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs56281646	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs56281646	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs56281646	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs56281646	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs56281646	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs56281646	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs56281646	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs56289115	rs2076435	0.994416745826611	Inguinal hernia	2e-08	35022708
rs56289115	rs2076435	0.994416745826611	Inguinal hernia	2e-09	35022708
rs56289115	rs2076438	0.869363383241982	Coronary artery disease	3e-08	33020668
rs56289115	rs2235642	0.867267208860499	Coronary artery disease	8e-06	29212778
rs56321614	rs59937473	0.981426760814957	Protein quantitative trait loci	3e-67	32492067
rs56321614	rs59937473	0.981426760814957	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs56321614	rs17714252	0.971644240845101	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs56321614	rs17714252	0.971644240845101	Retinal vascular fractal dimension	2e-07	34743558
rs56321614	rs55753056	0.945270807283288	Height	2e-22	30595370
rs56321614	rs114976176	0.938529539358843	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs56321614	rs7601944	0.93687378437624	Smoking initiation	4e-15	36477530
rs56321614	rs62114538	0.913705450912567	Triglyceride levels	6e-12	34887591
rs56321614	rs60843830	0.911712775768613	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs56321614	rs60843830	0.911712775768613	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs56321614	rs60843830	0.911712775768613	Adventurousness	7e-10	30643258
rs56321614	rs58461606	0.898542518691154	Blood protein levels	0	30072576
rs56321614	rs7566279	0.894781954467255	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs56321614	rs7595075	0.882561174572398	Waist circumference adjusted for body mass index	2e-09	34021172
rs56321614	rs7595075	0.882561174572398	HDL cholesterol	3e-11	34594039
rs56321614	rs7595075	0.882561174572398	HDL cholesterol levels	6e-13	32203549
rs56321614	rs79716074	0.880695301253119	Plateletcrit	1e-09	32888494
rs56321614	rs79716074	0.880695301253119	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs56321614	rs79716074	0.880695301253119	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs56321614	rs79716074	0.880695301253119	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs56321614	rs17713729	0.875917607514801	Body mass index	2e-09	31669095
rs56321614	rs17713729	0.875917607514801	Serum creatinine levels	4e-14	34594039
rs56321614	rs17713729	0.875917607514801	High density lipoprotein cholesterol levels	7e-17	34887591
rs56321614	rs17713396	0.869362188752154	Blood urea nitrogen levels	3e-21	34272381
rs56321614	rs17713396	0.869362188752154	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs56321614	rs17713396	0.869362188752154	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs56321614	rs7605824	0.8693000249558	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs56321614	rs6710091	0.867484737107151	Waist circumference adjusted for body mass index	8e-11	31669095
rs56321614	rs6710091	0.867484737107151	HDL cholesterol	5e-08	30275531
rs56321614	rs6710091	0.867484737107151	High density lipoprotein cholesterol levels	3e-24	34887591
rs56321614	rs3791221	0.855452473240376	Blood urea nitrogen levels	2e-07	31152163
rs56321614	rs3791221	0.855452473240376	Estimated glomerular filtration rate	2e-10	31152163
rs56321614	rs3791221	0.855452473240376	Estimated glomerular filtration rate	1e-11	31152163
rs56321614	rs3791221	0.855452473240376	Blood urea nitrogen levels	7e-26	34594039
rs56321614	rs2290911	0.827089352876278	Height	5e-07	29782485
rs56321614	rs2290911	0.827089352876278	Large artery stroke	6e-06	28265093
rs56321614	rs2290911	0.827089352876278	Height	8e-112	36224396
rs56321614	rs2126129	0.819418859129874	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs56321614	rs11553746	0.790947735560002	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs56321614	rs11553746	0.790947735560002	High density lipoprotein cholesterol levels	2e-07	29083408
rs56321614	rs11553746	0.790947735560002	High density lipoprotein cholesterol levels	7e-15	29083408
rs56321614	rs11553746	0.790947735560002	Large artery stroke	4e-06	28265093
rs56321614	rs62114548	0.763817724984577	Retinal vascular fractal density	2e-09	34743558
rs56321614	rs17713879	0.761340302383042	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs56321614	rs17713879	0.761340302383042	Smoking initiation	1e-10	36477530
rs56321614	rs17713879	0.761340302383042	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs56321614	rs17713879	0.761340302383042	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs56321614	rs17713879	0.761340302383042	Triglyceride levels	3e-10	34887591
rs56321614	rs17713879	0.761340302383042	Aging (eyeAgeAcceleration)	6e-50	36975205
rs56321614	rs79154857	0.71615075961672	Pulse pressure	5e-08	34594039
rs56321614	rs62114506	0.663704093489864	Gamma glutamyl transpeptidase	3e-14	34594039
rs56321614	rs62114506	0.663704093489864	Apolipoprotein A1 levels	3e-10	32203549
rs56321614	rs62114506	0.663704093489864	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs56321614	rs62114506	0.663704093489864	HDL cholesterol levels	8e-10	36333282
rs56335655	rs6700087	0.916464749625554	Smoking initiation	6e-11	36477530
rs56335655	rs7545078	0.886679434449295	Smoking initiation	2e-09	36477530
rs56355906	rs41748	0.648097166393016	Resting heart rate	7e-06	29769521
rs56355906	rs41748	0.648097166393016	Resting heart rate	7e-09	27798624
rs56355906	rs964449	0.623217954471339	P-cresol sulfate levels in elite athletes	2e-06	31882771
rs56355906	rs11562010	0.618743698328835	Platelet count	9e-13	27863252
rs56373295	rs56373295	1	Plateletcrit	2e-15	32888494
rs56373295	rs12652692	0.935110605430932	Platelet count	2e-34	32888494
rs56376752	rs34276187	0.666030313564836	Highest math class taken (MTAG)	2e-08	30038396
rs56376752	rs6705511	0.649133661441198	Self-reported math ability	4e-09	30038396
rs56376752	rs6705511	0.649133661441198	Self-reported math ability (MTAG)	3e-10	30038396
rs56398717	rs11705721	0.997542556420607	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs56398717	rs11130638	0.995088136071539	Hemoglobin concentration	2e-23	32888493
rs56398717	rs34579268	0.987783003656705	Hematocrit	5e-30	32888493
rs56398717	rs34579268	0.987783003656705	Hematocrit	2e-27	32888493
rs56398717	rs34579268	0.987783003656705	Hemoglobin concentration	5e-26	32888493
rs56398717	rs7610312	0.974305051875382	Red blood cell count	5e-09	27863252
rs56398717	rs6775517	0.973073452515608	Hematocrit	1e-17	34594039
rs56398717	rs57700771	0.968215279985774	Red blood cell count	9e-21	30595370
rs56398717	rs55704295	0.90116903455247	Red blood cell count	8e-26	32888493
rs56398717	rs55704295	0.90116903455247	Red blood cell count	5e-23	32888493
rs56398717	rs55704295	0.90116903455247	Serum total protein level	2e-29	34594039
rs56398717	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs56398717	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs56398717	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs56398717	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs56398717	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs56398717	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs56398717	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs56398717	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs56398717	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs56398717	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs56398717	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs56398717	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs56398717	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs56398717	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs56398717	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs566647	rs480293	0.993974035135191	Oily fish consumption	4e-11	32193382
rs566647	rs1613778	0.936339793844063	Total bilirubin levels	3e-08	34594039
rs566647	rs34634095	0.931012935427624	Fish- and plant-related diet	3e-09	32066663
rs566647	rs542831	0.910428457413584	Asthma	5e-13	31361310
rs566647	rs1784776	0.907947438015822	Asthma	2e-09	32296059
rs566647	rs1784775	0.907947438015822	Asthma	2e-09	30929738
rs566647	rs1784775	0.907947438015822	Asthma (adult onset)	6e-09	30929738
rs566647	rs1789358	0.906303589152272	Asthma	2e-08	34103634
rs566647	rs539524	0.900060016525453	Asthma	1e-10	32296059
rs566647	rs12791699	0.871141934646305	Pork consumption	9e-09	32066663
rs566647	rs12791699	0.871141934646305	Oily fish consumption	9e-09	32066663
rs566647	rs487985	0.871141934646305	Highest math class taken	1e-08	30038396
rs566647	rs10891286	0.845436068320325	Noncognitive aspects of educational attainment	5e-10	33414549
rs566647	rs4459340	0.841465218104524	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs566647	rs505372	0.796318436354616	Breast cancer	3e-06	29059683
rs566647	rs505372	0.796318436354616	Medication use (beta blocking agents)	2e-08	34594039
rs566647	rs659529	0.794204910552515	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs566647	rs659529	0.794204910552515	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs566647	rs659529	0.794204910552515	Atopic dermatitis	5e-10	34116867
rs566647	rs9734135	0.758637788766477	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs566647	rs11213941	0.64243308401841	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs566647	rs11213941	0.64243308401841	Eczema	8e-14	30595370
rs566647	rs663763	0.637482896469245	Layilin levels	3e-21	36168886
rs56683119	rs7554904	0.867527014115821	Metabolite levels	4e-06	23823483
rs56683119	rs7554904	0.867527014115821	Metabolite levels	2e-06	23823483
rs56683119	rs1425754	0.841083787553984	Metabolite levels	1e-06	23823483
rs56683119	rs10918211	0.738708718838966	White blood cell count	1e-26	34925446
rs56683119	rs10918211	0.738708718838966	Neutrophil count	5e-34	34925446
rs568038	rs659529	0.99646883202341	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs568038	rs659529	0.99646883202341	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs568038	rs659529	0.99646883202341	Atopic dermatitis	5e-10	34116867
rs568038	rs34634095	0.824673038093306	Fish- and plant-related diet	3e-09	32066663
rs568038	rs11213941	0.823090713525606	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs568038	rs11213941	0.823090713525606	Eczema	8e-14	30595370
rs568038	rs663763	0.818511430189642	Layilin levels	3e-21	36168886
rs568038	rs480293	0.792156699386847	Oily fish consumption	4e-11	32193382
rs568038	rs539524	0.776775263925897	Asthma	1e-10	32296059
rs568038	rs1613778	0.763313837587661	Total bilirubin levels	3e-08	34594039
rs568038	rs542831	0.725717267039664	Asthma	5e-13	31361310
rs568038	rs1784776	0.723321346532215	Asthma	2e-09	32296059
rs568038	rs1784775	0.723321346532215	Asthma	2e-09	30929738
rs568038	rs1784775	0.723321346532215	Asthma (adult onset)	6e-09	30929738
rs568038	rs1789358	0.722042637309181	Asthma	2e-08	34103634
rs568038	rs12791699	0.689567647351348	Pork consumption	9e-09	32066663
rs568038	rs12791699	0.689567647351348	Oily fish consumption	9e-09	32066663
rs568038	rs487985	0.689567647351348	Highest math class taken	1e-08	30038396
rs568038	rs10891286	0.673475212017599	Noncognitive aspects of educational attainment	5e-10	33414549
rs568038	rs4459340	0.669635760886704	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs568038	rs11213940	0.621612846322505	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI	2e-13	31669095
rs568038	rs505372	0.617500046771317	Breast cancer	3e-06	29059683
rs568038	rs505372	0.617500046771317	Medication use (beta blocking agents)	2e-08	34594039
rs568506	rs480293	0.996553664195234	Oily fish consumption	4e-11	32193382
rs568506	rs1613778	0.938936306353125	Total bilirubin levels	3e-08	34594039
rs568506	rs34634095	0.933486717580242	Fish- and plant-related diet	3e-09	32066663
rs568506	rs542831	0.912968637658945	Asthma	5e-13	31361310
rs568506	rs1784776	0.910489180520672	Asthma	2e-09	32296059
rs568506	rs1784775	0.910489180520672	Asthma	2e-09	30929738
rs568506	rs1784775	0.910489180520672	Asthma (adult onset)	6e-09	30929738
rs568506	rs1789358	0.908838086823443	Asthma	2e-08	34103634
rs568506	rs539524	0.902454993829896	Asthma	1e-10	32296059
rs568506	rs12791699	0.873659489232336	Pork consumption	9e-09	32066663
rs568506	rs12791699	0.873659489232336	Oily fish consumption	9e-09	32066663
rs568506	rs487985	0.873659489232336	Highest math class taken	1e-08	30038396
rs568506	rs10891286	0.84796878278266	Noncognitive aspects of educational attainment	5e-10	33414549
rs568506	rs4459340	0.84400025929961	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs568506	rs505372	0.798882491357711	Breast cancer	3e-06	29059683
rs568506	rs505372	0.798882491357711	Medication use (beta blocking agents)	2e-08	34594039
rs568506	rs659529	0.796703063134625	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs568506	rs659529	0.796703063134625	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs568506	rs659529	0.796703063134625	Atopic dermatitis	5e-10	34116867
rs568506	rs9734135	0.76122326434691	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs568506	rs11213941	0.643561601330614	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs568506	rs11213941	0.643561601330614	Eczema	8e-14	30595370
rs568506	rs663763	0.639514405368792	Layilin levels	3e-21	36168886
rs56863085	rs73045343	0.611198372100856	Serum total protein level	1e-12	34594039
rs57012784	rs9505982	0.964904267873357	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs57012784	rs11155671	0.962248666178789	Testicular germ cell tumor	2e-09	28604728
rs57012784	rs1934534	0.949574241198072	Pain (pleiotropy)	2e-08	37844115
rs57012784	rs1934534	0.949574241198072	Pain (pleiotropy)	2e-06	37844115
rs57012784	rs4380763	0.948780128879162	Subcortical volume (min-P)	1e-11	32665545
rs57012784	rs80147756	0.907625881947008	HippSubfield lh volume subiculum-head	3e-10	33875891
rs57012784	rs4421206	0.901750629996866	Brain morphology (min-P)	4e-11	32665545
rs57012784	rs9688452	0.882187015117132	Brainstem global volume Whole-brainstem	1e-11	33875891
rs57012784	rs9688452	0.882187015117132	aseg lh volume VentralDC	2e-10	33875891
rs57012784	rs10872649	0.835483149713342	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs57012784	rs10872649	0.835483149713342	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs57012784	rs10872649	0.835483149713342	Right hippocampal volume (body)	1e-10	37337106
rs57012784	rs9322194	0.817369688420409	Brainstem volume	2e-11	31636452
rs57012784	rs7752089	0.80381370706851	Brain morphology (MOSTest)	2e-31	35164939
rs57012784	rs9285521	0.696700170827016	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs57012784	rs12526675	0.63009657715211	Brain morphology (MOSTest)	7e-22	32665545
rs57012784	rs9688809	0.622380263325635	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs57012784	rs34337297	0.619387009880427	Serum levels of protein LRP11	3e-161	35078996
rs57012784	rs10872645	0.618609955516243	Blood protein levels	2e-86	30072576
rs57012784	rs14314	0.617576643978536	Macular thickness	3e-19	30535121
rs57012784	rs14314	0.617576643978536	Vertex-wise sulcal depth	7e-17	34910505
rs57012784	rs14314	0.617576643978536	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs57012784	rs14314	0.617576643978536	Left hippocampal volume (body)	7e-15	37337106
rs57012784	rs14314	0.617576643978536	Left subiculum volume (body)	1e-14	37337106
rs57012784	rs55763431	0.617267105499172	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs57012784	rs9322193	0.616770679099916	Lung cancer	1e-07	27393504
rs57012784	rs9689694	0.616134589257647	Right hippocampal volume (head)	6e-11	37337106
rs57012784	rs9689694	0.616134589257647	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs57012784	rs9689694	0.616134589257647	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs57012784	rs9689694	0.616134589257647	Left hippocampal volume (head)	6e-12	37337106
rs57012784	rs9383843	0.614794026484087	Migraine	1e-09	35115687
rs57012784	rs2095375	0.614228690408634	Serum metabolite levels	1e-20	33031748
rs57012784	rs2095375	0.614228690408634	Serum metabolite levels	1e-20	33031748
rs57012784	rs10872653	0.61197072546167	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs57012784	rs9688867	0.611659974217722	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs57012784	rs9688867	0.611659974217722	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs57282335	rs4807	0.966736033981077	Height	3e-23	36224396
rs57484342	rs1859336	0.984602444847398	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs57484342	rs6489882	0.967176766167267	Chronic lymphocytic leukemia	5e-08	28165464
rs57484342	rs11066452	0.962206627655933	Blood protein levels	6e-08	30072576
rs57484342	rs4767027	0.941164087791983	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs57484342	rs2057778	0.93766882265791	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs57484342	rs2057778	0.93766882265791	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs57484342	rs2057778	0.93766882265791	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs57484342	rs1131476	0.912651049917873	Systemic lupus erythematosus	1e-09	33272962
rs57484342	rs2660	0.912651049917873	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs57484342	rs2660	0.912651049917873	COVID-19 (critical illness vs population)	3e-15	37198478
rs57484342	rs6489867	0.670331323347399	COVID-19 (critical illness vs population)	1e-09	33307546
rs57484342	rs1557866	0.623290818802835	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs5750234	rs5756090	0.956209208707202	Severe COVID-19 infection	4e-08	36662838
rs5750234	rs2227169	0.871873395124338	Severe COVID-19 infection	4e-13	36662838
rs5750234	rs1053982	0.853120822788198	Severe COVID-19 infection	9e-06	36662838
rs5750234	rs6000172	0.85306167680198	Severe COVID-19 infection	1e-07	36662838
rs5750234	rs4821461	0.842265630727793	Severe COVID-19 infection	4e-06	36662838
rs5750236	rs5756090	0.963303887478651	Severe COVID-19 infection	4e-08	36662838
rs5750236	rs2227169	0.878582970723232	Severe COVID-19 infection	4e-13	36662838
rs5750236	rs1053982	0.859750087489695	Severe COVID-19 infection	9e-06	36662838
rs5750236	rs6000172	0.859695373122526	Severe COVID-19 infection	1e-07	36662838
rs5750236	rs4821461	0.848856105383115	Severe COVID-19 infection	4e-06	36662838
rs5750238	rs6000172	0.997378244350416	Severe COVID-19 infection	1e-07	36662838
rs5750238	rs4821461	0.978253294613129	Severe COVID-19 infection	4e-06	36662838
rs5750238	rs2227169	0.975840515241513	Severe COVID-19 infection	4e-13	36662838
rs5750238	rs1053982	0.956596308659475	Severe COVID-19 infection	9e-06	36662838
rs5750238	rs5756090	0.827941422469236	Severe COVID-19 infection	4e-08	36662838
rs57542652	rs17713396	0.888384744874639	Blood urea nitrogen levels	3e-21	34272381
rs57542652	rs17713396	0.888384744874639	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs57542652	rs17713396	0.888384744874639	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs57542652	rs6710091	0.888384744874639	Waist circumference adjusted for body mass index	8e-11	31669095
rs57542652	rs6710091	0.888384744874639	HDL cholesterol	5e-08	30275531
rs57542652	rs6710091	0.888384744874639	High density lipoprotein cholesterol levels	3e-24	34887591
rs57542652	rs7595075	0.870537130235759	Waist circumference adjusted for body mass index	2e-09	34021172
rs57542652	rs7595075	0.870537130235759	HDL cholesterol	3e-11	34594039
rs57542652	rs7595075	0.870537130235759	HDL cholesterol levels	6e-13	32203549
rs57542652	rs17713729	0.867846950186353	Body mass index	2e-09	31669095
rs57542652	rs17713729	0.867846950186353	Serum creatinine levels	4e-14	34594039
rs57542652	rs17713729	0.867846950186353	High density lipoprotein cholesterol levels	7e-17	34887591
rs57542652	rs79716074	0.866419429228567	Plateletcrit	1e-09	32888494
rs57542652	rs79716074	0.866419429228567	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs57542652	rs79716074	0.866419429228567	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs57542652	rs79716074	0.866419429228567	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs57542652	rs58461606	0.860921738628858	Blood protein levels	0	30072576
rs57542652	rs7605824	0.855563609398925	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs57542652	rs2126129	0.855056827970948	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs57542652	rs7566279	0.854682178697914	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs57542652	rs3791221	0.852105406454378	Blood urea nitrogen levels	2e-07	31152163
rs57542652	rs3791221	0.852105406454378	Estimated glomerular filtration rate	2e-10	31152163
rs57542652	rs3791221	0.852105406454378	Estimated glomerular filtration rate	1e-11	31152163
rs57542652	rs3791221	0.852105406454378	Blood urea nitrogen levels	7e-26	34594039
rs57542652	rs2290911	0.839444122540065	Height	5e-07	29782485
rs57542652	rs2290911	0.839444122540065	Large artery stroke	6e-06	28265093
rs57542652	rs2290911	0.839444122540065	Height	8e-112	36224396
rs57542652	rs114976176	0.813634089198324	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs57542652	rs59937473	0.789586644000525	Protein quantitative trait loci	3e-67	32492067
rs57542652	rs59937473	0.789586644000525	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs57542652	rs7601944	0.781908799017152	Smoking initiation	4e-15	36477530
rs57542652	rs17714252	0.78169599893274	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs57542652	rs17714252	0.78169599893274	Retinal vascular fractal dimension	2e-07	34743558
rs57542652	rs55753056	0.773000375156757	Height	2e-22	30595370
rs57542652	rs62114548	0.765877257259298	Retinal vascular fractal density	2e-09	34743558
rs57542652	rs11553746	0.764773194420998	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs57542652	rs11553746	0.764773194420998	High density lipoprotein cholesterol levels	2e-07	29083408
rs57542652	rs11553746	0.764773194420998	High density lipoprotein cholesterol levels	7e-15	29083408
rs57542652	rs11553746	0.764773194420998	Large artery stroke	4e-06	28265093
rs57542652	rs79154857	0.76111050794768	Pulse pressure	5e-08	34594039
rs57542652	rs62114538	0.734889665924747	Triglyceride levels	6e-12	34887591
rs57542652	rs17713879	0.728520209575149	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs57542652	rs17713879	0.728520209575149	Smoking initiation	1e-10	36477530
rs57542652	rs17713879	0.728520209575149	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs57542652	rs17713879	0.728520209575149	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs57542652	rs17713879	0.728520209575149	Triglyceride levels	3e-10	34887591
rs57542652	rs17713879	0.728520209575149	Aging (eyeAgeAcceleration)	6e-50	36975205
rs57542652	rs60843830	0.720371465769704	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs57542652	rs60843830	0.720371465769704	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs57542652	rs60843830	0.720371465769704	Adventurousness	7e-10	30643258
rs57542652	rs62114506	0.652187635420161	Gamma glutamyl transpeptidase	3e-14	34594039
rs57542652	rs62114506	0.652187635420161	Apolipoprotein A1 levels	3e-10	32203549
rs57542652	rs62114506	0.652187635420161	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs57542652	rs62114506	0.652187635420161	HDL cholesterol levels	8e-10	36333282
rs5756090	rs5756090	1	Severe COVID-19 infection	4e-08	36662838
rs5756090	rs2227169	0.84791440864453	Severe COVID-19 infection	4e-13	36662838
rs5756090	rs1053982	0.829738922000518	Severe COVID-19 infection	9e-06	36662838
rs5756090	rs6000172	0.828835575055883	Severe COVID-19 infection	1e-07	36662838
rs5756090	rs4821461	0.817839569758009	Severe COVID-19 infection	4e-06	36662838
rs5756091	rs1053982	0.995686059578223	Severe COVID-19 infection	9e-06	36662838
rs5756091	rs2227169	0.972513859682112	Severe COVID-19 infection	4e-13	36662838
rs5756091	rs6000172	0.954773827340952	Severe COVID-19 infection	1e-07	36662838
rs5756091	rs4821461	0.936337373016099	Severe COVID-19 infection	4e-06	36662838
rs5756091	rs5756090	0.833333874687368	Severe COVID-19 infection	4e-08	36662838
rs5756094	rs1053982	0.996547767151515	Severe COVID-19 infection	9e-06	36662838
rs5756094	rs2227169	0.973380078796745	Severe COVID-19 infection	4e-13	36662838
rs5756094	rs6000172	0.955645195006925	Severe COVID-19 infection	1e-07	36662838
rs5756094	rs4821461	0.937210143882016	Severe COVID-19 infection	4e-06	36662838
rs5756094	rs5756090	0.827745092960711	Severe COVID-19 infection	4e-08	36662838
rs5756096	rs6000172	0.998251877706482	Severe COVID-19 infection	1e-07	36662838
rs5756096	rs4821461	0.979128833961024	Severe COVID-19 infection	4e-06	36662838
rs5756096	rs2227169	0.976696266163879	Severe COVID-19 infection	4e-13	36662838
rs5756096	rs1053982	0.957434234185563	Severe COVID-19 infection	9e-06	36662838
rs5756096	rs5756090	0.828835575055883	Severe COVID-19 infection	4e-08	36662838
rs5756097	rs6000172	0.999125826500833	Severe COVID-19 infection	1e-07	36662838
rs5756097	rs4821461	0.979987654780127	Severe COVID-19 infection	4e-06	36662838
rs5756097	rs2227169	0.977564128707638	Severe COVID-19 infection	4e-13	36662838
rs5756097	rs1053982	0.958297688006713	Severe COVID-19 infection	9e-06	36662838
rs5756097	rs5756090	0.829571838056263	Severe COVID-19 infection	4e-08	36662838
rs57594397	rs11781149	0.992711213890407	Refractive error	2e-17	32231278
rs57594397	rs746011	0.925021274652788	Triglycerides	2e-10	30275531
rs57594397	rs1545837	0.858114291136682	Lung function (FVC)	1e-10	30595370
rs57594397	rs4242434	0.821393507406706	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs57594397	rs2280104	0.765691712437898	Parkinson's disease	3e-08	28892059
rs57594397	rs2280104	0.765691712437898	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs57594397	rs2280104	0.765691712437898	Serum total protein level	3e-12	34594039
rs57594397	rs4872007	0.721150088809437	Superior temporal gyrus volume	8e-06	31530798
rs57594397	rs13271626	0.71857436606502	Haemorrhoidal disease	3e-10	33888516
rs57594397	rs11778693	0.696169139335769	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs57594397	rs11778693	0.696169139335769	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs57594397	rs11780207	0.670820153478684	Estimated glomerular filtration rate	2e-13	33462484
rs57594397	rs11780207	0.670820153478684	Serum total protein level	2e-09	33462484
rs57594397	rs11780207	0.670820153478684	Creatinine levels	2e-13	33462484
rs57594397	rs34269854	0.668929578463057	Lung function (forced vital capacity)	3e-09	36914875
rs57594397	rs11782130	0.63052444641941	C-reactive protein levels	9e-09	35459240
rs57594397	rs4592028	0.619905401481601	Non-albumin protein levels	3e-09	33462484
rs576492	rs337277	0.943334594273955	Metabolite peak levels (QI10992)	3e-52	35995766
rs576492	rs337277	0.943334594273955	Metabolite peak levels (QI4667)	7e-18	35995766
rs576492	rs337277	0.943334594273955	Metabolite peak levels (QI4708)	1e-21	35995766
rs576492	rs337277	0.943334594273955	Metabolite peak levels (QI5169)	7e-57	35995766
rs576492	rs7655841	0.756853284037077	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs57940840	rs12210271	0.785628515429768	ACE-inhibitor discontinuation	1e-19	35751511
rs583032	rs34634095	0.954591947575605	Fish- and plant-related diet	3e-09	32066663
rs583032	rs480293	0.922586601544235	Oily fish consumption	4e-11	32193382
rs583032	rs539524	0.898203574171054	Asthma	1e-10	32296059
rs583032	rs1613778	0.895769334645724	Total bilirubin levels	3e-08	34594039
rs583032	rs659529	0.87121440016493	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs583032	rs659529	0.87121440016493	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs583032	rs659529	0.87121440016493	Atopic dermatitis	5e-10	34116867
rs583032	rs542831	0.847928118997052	Asthma	5e-13	31361310
rs583032	rs1784776	0.845595961942713	Asthma	2e-09	32296059
rs583032	rs1784775	0.845595961942713	Asthma	2e-09	30929738
rs583032	rs1784775	0.845595961942713	Asthma (adult onset)	6e-09	30929738
rs583032	rs1789358	0.843961738929015	Asthma	2e-08	34103634
rs583032	rs12791699	0.810506819471971	Pork consumption	9e-09	32066663
rs583032	rs12791699	0.810506819471971	Oily fish consumption	9e-09	32066663
rs583032	rs487985	0.810506819471971	Highest math class taken	1e-08	30038396
rs583032	rs10891286	0.787887090461434	Noncognitive aspects of educational attainment	5e-10	33414549
rs583032	rs4459340	0.784153357690679	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs583032	rs505372	0.74022884359595	Breast cancer	3e-06	29059683
rs583032	rs505372	0.74022884359595	Medication use (beta blocking agents)	2e-08	34594039
rs583032	rs11213941	0.717078837307391	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs583032	rs11213941	0.717078837307391	Eczema	8e-14	30595370
rs583032	rs9734135	0.706301754490834	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs583032	rs663763	0.695726956560248	Layilin levels	3e-21	36168886
rs58398000	rs61586425	0.962580269904148	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs58398000	rs8075598	0.772126594121031	Non-albumin protein levels	3e-10	29403010
rs58398000	rs6565604	0.768883645152339	Non-melanoma skin cancer	3e-06	34290314
rs58398000	rs9894429	0.675108372702816	Eye color traits	9e-14	20463881
rs58398000	rs9894429	0.675108372702816	Body mass index	4e-08	36581621
rs58461606	rs58461606	1	Blood protein levels	0	30072576
rs58461606	rs7566279	0.991849088519422	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs58461606	rs7595075	0.982716994940685	Waist circumference adjusted for body mass index	2e-09	34021172
rs58461606	rs7595075	0.982716994940685	HDL cholesterol	3e-11	34594039
rs58461606	rs7595075	0.982716994940685	HDL cholesterol levels	6e-13	32203549
rs58461606	rs79716074	0.980693700282243	Plateletcrit	1e-09	32888494
rs58461606	rs79716074	0.980693700282243	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs58461606	rs79716074	0.980693700282243	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs58461606	rs79716074	0.980693700282243	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs58461606	rs17713729	0.97562591867227	Body mass index	2e-09	31669095
rs58461606	rs17713729	0.97562591867227	Serum creatinine levels	4e-14	34594039
rs58461606	rs17713729	0.97562591867227	High density lipoprotein cholesterol levels	7e-17	34887591
rs58461606	rs17713396	0.968561170294304	Blood urea nitrogen levels	3e-21	34272381
rs58461606	rs17713396	0.968561170294304	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs58461606	rs17713396	0.968561170294304	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs58461606	rs7605824	0.966574034714791	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs58461606	rs6710091	0.966547293042135	Waist circumference adjusted for body mass index	8e-11	31669095
rs58461606	rs6710091	0.966547293042135	HDL cholesterol	5e-08	30275531
rs58461606	rs6710091	0.966547293042135	High density lipoprotein cholesterol levels	3e-24	34887591
rs58461606	rs3791221	0.954103328735304	Blood urea nitrogen levels	2e-07	31152163
rs58461606	rs3791221	0.954103328735304	Estimated glomerular filtration rate	2e-10	31152163
rs58461606	rs3791221	0.954103328735304	Estimated glomerular filtration rate	1e-11	31152163
rs58461606	rs3791221	0.954103328735304	Blood urea nitrogen levels	7e-26	34594039
rs58461606	rs114976176	0.944642759894773	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs58461606	rs2290911	0.92273092997089	Height	5e-07	29782485
rs58461606	rs2290911	0.92273092997089	Large artery stroke	6e-06	28265093
rs58461606	rs2290911	0.92273092997089	Height	8e-112	36224396
rs58461606	rs59937473	0.917541261834209	Protein quantitative trait loci	3e-67	32492067
rs58461606	rs59937473	0.917541261834209	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs58461606	rs2126129	0.914746362768209	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs58461606	rs17714252	0.909652749158712	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs58461606	rs17714252	0.909652749158712	Retinal vascular fractal dimension	2e-07	34743558
rs58461606	rs55753056	0.884999536468298	Height	2e-22	30595370
rs58461606	rs11553746	0.883333507794152	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs58461606	rs11553746	0.883333507794152	High density lipoprotein cholesterol levels	2e-07	29083408
rs58461606	rs11553746	0.883333507794152	High density lipoprotein cholesterol levels	7e-15	29083408
rs58461606	rs11553746	0.883333507794152	Large artery stroke	4e-06	28265093
rs58461606	rs7601944	0.876966260079639	Smoking initiation	4e-15	36477530
rs58461606	rs62114548	0.85445574075844	Retinal vascular fractal density	2e-09	34743558
rs58461606	rs62114538	0.853664455271958	Triglyceride levels	6e-12	34887591
rs58461606	rs17713879	0.852999424245067	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs58461606	rs17713879	0.852999424245067	Smoking initiation	1e-10	36477530
rs58461606	rs17713879	0.852999424245067	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs58461606	rs17713879	0.852999424245067	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs58461606	rs17713879	0.852999424245067	Triglyceride levels	3e-10	34887591
rs58461606	rs17713879	0.852999424245067	Aging (eyeAgeAcceleration)	6e-50	36975205
rs58461606	rs60843830	0.848278323232766	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs58461606	rs60843830	0.848278323232766	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs58461606	rs60843830	0.848278323232766	Adventurousness	7e-10	30643258
rs58461606	rs79154857	0.796979980850777	Pulse pressure	5e-08	34594039
rs58461606	rs62114506	0.745516159996788	Gamma glutamyl transpeptidase	3e-14	34594039
rs58461606	rs62114506	0.745516159996788	Apolipoprotein A1 levels	3e-10	32203549
rs58461606	rs62114506	0.745516159996788	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs58461606	rs62114506	0.745516159996788	HDL cholesterol levels	8e-10	36333282
rs58588820	rs58588820	1	Total cholesterol levels	1e-09	34887591
rs58588820	rs58588820	1	Total cholesterol levels	8e-11	34887591
rs58588820	rs6547629	0.896966843565354	Height	3e-09	36224396
rs58588820	rs10206961	0.633843470658045	Parental longevity (father's age at death)	2e-06	31484785
rs58671447	rs9462030	0.992772816782388	Red cell distribution width	5e-25	32888493
rs58671447	rs9469857	0.987972909528024	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs58671447	rs2764208	0.987184426748861	Systemic lupus erythematosus	7e-06	24871463
rs58671447	rs9469899	0.976088010907773	Prostate cancer (advanced)	2e-06	29892016
rs58671447	rs9469899	0.976088010907773	Prostate cancer	5e-09	29892016
rs58671447	rs9469899	0.976088010907773	Prostate cancer	8e-11	33398198
rs58671447	rs9469899	0.976088010907773	Hand grip strength	3e-15	29691431
rs58671447	rs9469899	0.976088010907773	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs58671447	rs9469899	0.976088010907773	Graves' disease	4e-10	34594039
rs58671447	rs9469899	0.976088010907773	Coronary artery disease	1e-11	36474045
rs58671447	rs9469899	0.976088010907773	Predicted visceral adipose tissue	2e-20	31501611
rs58671447	rs9469899	0.976088010907773	Medication use (thyroid preparations)	2e-09	31015401
rs58671447	rs9469899	0.976088010907773	Medication use (thyroid preparations)	3e-10	34594039
rs58671447	rs9469872	0.9517336722848	HDL cholesterol levels	3e-11	36333282
rs58671447	rs11755393	0.945151555983629	Body mass index	3e-26	29273807
rs58671447	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-12	33493351
rs58671447	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-06	33493351
rs58671447	rs11755393	0.945151555983629	Systemic lupus erythematosus	1e-07	33493351
rs58671447	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-08	19838195
rs58671447	rs11755393	0.945151555983629	Body mass index	4e-55	36581621
rs58671447	rs9366863	0.941517151790621	Adult body size	9e-33	32376654
rs58671447	rs9366863	0.941517151790621	Body mass index	2e-44	30595370
rs58671447	rs9296128	0.937381558456179	Hip circumference adjusted for BMI	4e-13	34021172
rs58671447	rs6941110	0.933676577326679	Sex hormone-binding globulin levels	5e-27	36653534
rs58671447	rs2814949	0.905372479297637	Essential hypertension (time to event)	9e-09	32589924
rs58671447	rs2744944	0.896052112029689	Hypothyroidism	3e-10	34594039
rs58671447	rs2744944	0.896052112029689	High density lipoprotein cholesterol levels	3e-86	34887591
rs58671447	rs2744944	0.896052112029689	Multi-trait sex score	7e-22	37277458
rs58671447	rs2263329	0.876899408662782	HDL cholesterol	6e-35	34594039
rs58671447	rs2263329	0.876899408662782	HDL cholesterol levels	8e-43	32203549
rs58671447	rs2263329	0.876899408662782	High density lipoprotein cholesterol levels	2e-52	34887591
rs58671447	rs111868030	0.8532583235175	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs58671447	rs9368830	0.832166605810923	HDL cholesterol	4e-21	30275531
rs58671447	rs9368828	0.805843694938069	Body mass index	1e-34	34594039
rs58671447	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs58671447	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs58671447	rs2744973	0.802560449404375	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs58671447	rs2744973	0.802560449404375	Multi-trait sex score	6e-20	37277458
rs58671447	rs6912327	0.790019995220374	Fasting insulin	5e-06	33402679
rs58671447	rs6912327	0.790019995220374	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs58671447	rs112283401	0.767735267176354	Red cell distribution width	4e-27	30595370
rs58671447	rs9689160	0.630070395157481	Lung function (forced vital capacity)	3e-14	36914875
rs58689608	rs7655841	0.861736369008099	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs58689608	rs337277	0.861400548091152	Metabolite peak levels (QI10992)	3e-52	35995766
rs58689608	rs337277	0.861400548091152	Metabolite peak levels (QI4667)	7e-18	35995766
rs58689608	rs337277	0.861400548091152	Metabolite peak levels (QI4708)	1e-21	35995766
rs58689608	rs337277	0.861400548091152	Metabolite peak levels (QI5169)	7e-57	35995766
rs58689608	rs10010659	0.605349449027767	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs58743434	rs12440803	0.610216875736258	Height	1e-107	36224396
rs58743434	rs12440803	0.610216875736258	Height	3e-22	30595370
rs58747679	rs17380837	0.984283715867965	Atrial fibrillation	5e-12	30061737
rs58747679	rs17380837	0.984283715867965	Hypertrophic cardiomyopathy (sarcomere negative)	4e-07	33495597
rs58747679	rs17380837	0.984283715867965	Atrial fibrillation (MTAG)	6e-11	35872910
rs58747679	rs113819537	0.918465571702412	Atrial fibrillation	2e-09	29892015
rs58747679	rs113819537	0.918465571702412	Atrial fibrillation	7e-09	29892015
rs58747679	rs113819537	0.918465571702412	Atrial fibrillation/atrial flutter	6e-10	34594039
rs58747679	rs113819537	0.918465571702412	Heart failure (multivariate analysis)	5e-08	36376295
rs58747679	rs113819537	0.918465571702412	Atrial fibrillation	3e-16	36653681
rs58843872	rs9462030	0.992772816782388	Red cell distribution width	5e-25	32888493
rs58843872	rs9469857	0.987972909528024	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs58843872	rs2764208	0.987184426748861	Systemic lupus erythematosus	7e-06	24871463
rs58843872	rs9469899	0.976088010907773	Prostate cancer (advanced)	2e-06	29892016
rs58843872	rs9469899	0.976088010907773	Prostate cancer	5e-09	29892016
rs58843872	rs9469899	0.976088010907773	Prostate cancer	8e-11	33398198
rs58843872	rs9469899	0.976088010907773	Hand grip strength	3e-15	29691431
rs58843872	rs9469899	0.976088010907773	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs58843872	rs9469899	0.976088010907773	Graves' disease	4e-10	34594039
rs58843872	rs9469899	0.976088010907773	Coronary artery disease	1e-11	36474045
rs58843872	rs9469899	0.976088010907773	Predicted visceral adipose tissue	2e-20	31501611
rs58843872	rs9469899	0.976088010907773	Medication use (thyroid preparations)	2e-09	31015401
rs58843872	rs9469899	0.976088010907773	Medication use (thyroid preparations)	3e-10	34594039
rs58843872	rs9469872	0.9517336722848	HDL cholesterol levels	3e-11	36333282
rs58843872	rs11755393	0.945151555983629	Body mass index	3e-26	29273807
rs58843872	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-12	33493351
rs58843872	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-06	33493351
rs58843872	rs11755393	0.945151555983629	Systemic lupus erythematosus	1e-07	33493351
rs58843872	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-08	19838195
rs58843872	rs11755393	0.945151555983629	Body mass index	4e-55	36581621
rs58843872	rs9366863	0.941517151790621	Adult body size	9e-33	32376654
rs58843872	rs9366863	0.941517151790621	Body mass index	2e-44	30595370
rs58843872	rs9296128	0.937381558456179	Hip circumference adjusted for BMI	4e-13	34021172
rs58843872	rs6941110	0.933676577326679	Sex hormone-binding globulin levels	5e-27	36653534
rs58843872	rs2814949	0.905372479297637	Essential hypertension (time to event)	9e-09	32589924
rs58843872	rs2744944	0.896052112029689	Hypothyroidism	3e-10	34594039
rs58843872	rs2744944	0.896052112029689	High density lipoprotein cholesterol levels	3e-86	34887591
rs58843872	rs2744944	0.896052112029689	Multi-trait sex score	7e-22	37277458
rs58843872	rs2263329	0.876899408662782	HDL cholesterol	6e-35	34594039
rs58843872	rs2263329	0.876899408662782	HDL cholesterol levels	8e-43	32203549
rs58843872	rs2263329	0.876899408662782	High density lipoprotein cholesterol levels	2e-52	34887591
rs58843872	rs111868030	0.8532583235175	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs58843872	rs9368830	0.832166605810923	HDL cholesterol	4e-21	30275531
rs58843872	rs9368828	0.805843694938069	Body mass index	1e-34	34594039
rs58843872	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs58843872	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs58843872	rs2744973	0.802560449404375	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs58843872	rs2744973	0.802560449404375	Multi-trait sex score	6e-20	37277458
rs58843872	rs6912327	0.790019995220374	Fasting insulin	5e-06	33402679
rs58843872	rs6912327	0.790019995220374	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs58843872	rs112283401	0.767735267176354	Red cell distribution width	4e-27	30595370
rs58843872	rs9689160	0.630070395157481	Lung function (forced vital capacity)	3e-14	36914875
rs59076819	rs201610020	0.876435413594333	Platelet side fluorescence distribution width	6e-11	37596262
rs59076819	rs6935045	0.855179572467943	Annual healthcare cost	5e-13	37704630
rs59076819	rs2394996	0.853983554930942	Natural cytotoxicity triggering receptor 3 levels	2e-34	36168886
rs59076819	rs61447909	0.629491995326167	Keratinocyte cancer (MTAG)	4e-13	31174203
rs59076819	rs61447909	0.629491995326167	Squamous cell carcinoma	2e-06	31174203
rs59151988	rs10891301	0.649865806136386	Pyruvate dehydrogenase protein X component, mitochondrial levels	1e-18	34648354
rs59151988	rs2276390	0.637991728256706	Waist-hip ratio	6e-28	30239722
rs59151988	rs603646	0.61187637091199	High density lipoprotein cholesterol levels	3e-08	34887591
rs59162539	rs9368830	0.965309232461449	HDL cholesterol	4e-21	30275531
rs59162539	rs9469872	0.891053865060549	HDL cholesterol levels	3e-11	36333282
rs59162539	rs9366863	0.885887566429174	Adult body size	9e-33	32376654
rs59162539	rs9366863	0.885887566429174	Body mass index	2e-44	30595370
rs59162539	rs11755393	0.883280230888615	Body mass index	3e-26	29273807
rs59162539	rs11755393	0.883280230888615	Systemic lupus erythematosus	2e-12	33493351
rs59162539	rs11755393	0.883280230888615	Systemic lupus erythematosus	2e-06	33493351
rs59162539	rs11755393	0.883280230888615	Systemic lupus erythematosus	1e-07	33493351
rs59162539	rs11755393	0.883280230888615	Systemic lupus erythematosus	2e-08	19838195
rs59162539	rs11755393	0.883280230888615	Body mass index	4e-55	36581621
rs59162539	rs6941110	0.874021443703248	Sex hormone-binding globulin levels	5e-27	36653534
rs59162539	rs9462030	0.858665802440903	Red cell distribution width	5e-25	32888493
rs59162539	rs9469857	0.854415871973512	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs59162539	rs2764208	0.853832310496549	Systemic lupus erythematosus	7e-06	24871463
rs59162539	rs2814949	0.850298141450624	Essential hypertension (time to event)	9e-09	32589924
rs59162539	rs2744944	0.841819776051258	Hypothyroidism	3e-10	34594039
rs59162539	rs2744944	0.841819776051258	High density lipoprotein cholesterol levels	3e-86	34887591
rs59162539	rs2744944	0.841819776051258	Multi-trait sex score	7e-22	37277458
rs59162539	rs9469899	0.841599247057586	Prostate cancer (advanced)	2e-06	29892016
rs59162539	rs9469899	0.841599247057586	Prostate cancer	5e-09	29892016
rs59162539	rs9469899	0.841599247057586	Prostate cancer	8e-11	33398198
rs59162539	rs9469899	0.841599247057586	Hand grip strength	3e-15	29691431
rs59162539	rs9469899	0.841599247057586	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs59162539	rs9469899	0.841599247057586	Graves' disease	4e-10	34594039
rs59162539	rs9469899	0.841599247057586	Coronary artery disease	1e-11	36474045
rs59162539	rs9469899	0.841599247057586	Predicted visceral adipose tissue	2e-20	31501611
rs59162539	rs9469899	0.841599247057586	Medication use (thyroid preparations)	2e-09	31015401
rs59162539	rs9469899	0.841599247057586	Medication use (thyroid preparations)	3e-10	34594039
rs59162539	rs2263329	0.824201651081721	HDL cholesterol	6e-35	34594039
rs59162539	rs2263329	0.824201651081721	HDL cholesterol levels	8e-43	32203549
rs59162539	rs2263329	0.824201651081721	High density lipoprotein cholesterol levels	2e-52	34887591
rs59162539	rs9296128	0.81075697730502	Hip circumference adjusted for BMI	4e-13	34021172
rs59162539	rs111868030	0.804966799883344	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs59162539	rs9368828	0.753718076311346	Body mass index	1e-34	34594039
rs59162539	rs6912327	0.747244914942509	Fasting insulin	5e-06	33402679
rs59162539	rs6912327	0.747244914942509	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs59162539	rs112283401	0.724234616434767	Red cell distribution width	4e-27	30595370
rs59162539	rs2744973	0.707493957138136	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs59162539	rs2744973	0.707493957138136	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs59162539	rs2744973	0.707493957138136	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs59162539	rs2744973	0.707493957138136	Multi-trait sex score	6e-20	37277458
rs59162539	rs3800458	0.633407092412803	Insomnia	7e-11	35835914
rs59162539	rs3800458	0.633407092412803	Insomnia	2e-12	35835914
rs59247111	rs6723298	0.68437583224024	Smoking initiation	2e-12	36477530
rs59247111	rs2194492	0.661552230382898	Educational attainment	9e-09	35361970
rs59247111	rs13020443	0.65435019698681	Type 2 diabetes	3e-11	32541925
rs59643048	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs59643048	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs59643048	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs59643048	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs59643048	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs59643048	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs59643048	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs59643048	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs59643048	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs59643048	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs59643048	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs59643048	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs59643048	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs59643048	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs59643048	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs59643048	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs59643048	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs59643048	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs59643048	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs59643048	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs59643048	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs59643048	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs59643048	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs59643048	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs59643048	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs59643048	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs59743803	rs73045343	0.652448773075449	Serum total protein level	1e-12	34594039
rs59743803	rs6759004	0.635523213745608	Triptolide cytotoxicity	3e-07	26121980
rs59937473	rs59937473	1	Protein quantitative trait loci	3e-67	32492067
rs59937473	rs59937473	1	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs59937473	rs17714252	0.990201275425039	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs59937473	rs17714252	0.990201275425039	Retinal vascular fractal dimension	2e-07	34743558
rs59937473	rs55753056	0.963355803594055	Height	2e-22	30595370
rs59937473	rs114976176	0.955384408437312	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs59937473	rs7601944	0.954852492431937	Smoking initiation	4e-15	36477530
rs59937473	rs62114538	0.931225477105573	Triglyceride levels	6e-12	34887591
rs59937473	rs60843830	0.930482341833977	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs59937473	rs60843830	0.930482341833977	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs59937473	rs60843830	0.930482341833977	Adventurousness	7e-10	30643258
rs59937473	rs58461606	0.917541261834209	Blood protein levels	0	30072576
rs59937473	rs7566279	0.913799948303693	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs59937473	rs7595075	0.901593998029507	Waist circumference adjusted for body mass index	2e-09	34021172
rs59937473	rs7595075	0.901593998029507	HDL cholesterol	3e-11	34594039
rs59937473	rs7595075	0.901593998029507	HDL cholesterol levels	6e-13	32203549
rs59937473	rs79716074	0.899737590508745	Plateletcrit	1e-09	32888494
rs59937473	rs79716074	0.899737590508745	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs59937473	rs79716074	0.899737590508745	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs59937473	rs79716074	0.899737590508745	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs59937473	rs17713729	0.894865535033273	Body mass index	2e-09	31669095
rs59937473	rs17713729	0.894865535033273	Serum creatinine levels	4e-14	34594039
rs59937473	rs17713729	0.894865535033273	High density lipoprotein cholesterol levels	7e-17	34887591
rs59937473	rs17713396	0.888295510243272	Blood urea nitrogen levels	3e-21	34272381
rs59937473	rs17713396	0.888295510243272	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs59937473	rs17713396	0.888295510243272	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs59937473	rs6710091	0.886403792087758	Waist circumference adjusted for body mass index	8e-11	31669095
rs59937473	rs6710091	0.886403792087758	HDL cholesterol	5e-08	30275531
rs59937473	rs6710091	0.886403792087758	High density lipoprotein cholesterol levels	3e-24	34887591
rs59937473	rs7605824	0.886252251596762	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs59937473	rs3791221	0.87381599865357	Blood urea nitrogen levels	2e-07	31152163
rs59937473	rs3791221	0.87381599865357	Estimated glomerular filtration rate	2e-10	31152163
rs59937473	rs3791221	0.87381599865357	Estimated glomerular filtration rate	1e-11	31152163
rs59937473	rs3791221	0.87381599865357	Blood urea nitrogen levels	7e-26	34594039
rs59937473	rs2290911	0.846205863771949	Height	5e-07	29782485
rs59937473	rs2290911	0.846205863771949	Large artery stroke	6e-06	28265093
rs59937473	rs2290911	0.846205863771949	Height	8e-112	36224396
rs59937473	rs2126129	0.838191166194178	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs59937473	rs11553746	0.810494941361884	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs59937473	rs11553746	0.810494941361884	High density lipoprotein cholesterol levels	2e-07	29083408
rs59937473	rs11553746	0.810494941361884	High density lipoprotein cholesterol levels	7e-15	29083408
rs59937473	rs11553746	0.810494941361884	Large artery stroke	4e-06	28265093
rs59937473	rs62114548	0.782766585110263	Retinal vascular fractal density	2e-09	34743558
rs59937473	rs17713879	0.778955495302141	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs59937473	rs17713879	0.778955495302141	Smoking initiation	1e-10	36477530
rs59937473	rs17713879	0.778955495302141	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs59937473	rs17713879	0.778955495302141	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs59937473	rs17713879	0.778955495302141	Triglyceride levels	3e-10	34887591
rs59937473	rs17713879	0.778955495302141	Aging (eyeAgeAcceleration)	6e-50	36975205
rs59937473	rs79154857	0.735355672866385	Pulse pressure	5e-08	34594039
rs59937473	rs62114506	0.683543483855114	Gamma glutamyl transpeptidase	3e-14	34594039
rs59937473	rs62114506	0.683543483855114	Apolipoprotein A1 levels	3e-10	32203549
rs59937473	rs62114506	0.683543483855114	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs59937473	rs62114506	0.683543483855114	HDL cholesterol levels	8e-10	36333282
rs59951439	rs12652692	0.904683490138911	Platelet count	2e-34	32888494
rs59951439	rs56373295	0.855712910831506	Plateletcrit	2e-15	32888494
rs5995239	rs5756090	0.962388465211945	Severe COVID-19 infection	4e-08	36662838
rs5995239	rs2227169	0.877787709118665	Severe COVID-19 infection	4e-13	36662838
rs5995239	rs1053982	0.858971872731513	Severe COVID-19 infection	9e-06	36662838
rs5995239	rs6000172	0.85889514709431	Severe COVID-19 infection	1e-07	36662838
rs5995239	rs4821461	0.848051805706428	Severe COVID-19 infection	4e-06	36662838
rs5995240	rs5756090	0.965093152154479	Severe COVID-19 infection	4e-08	36662838
rs5995240	rs2227169	0.878582970723232	Severe COVID-19 infection	4e-13	36662838
rs5995240	rs1053982	0.859750087489695	Severe COVID-19 infection	9e-06	36662838
rs5995240	rs6000172	0.858046117641523	Severe COVID-19 infection	1e-07	36662838
rs5995240	rs4821461	0.847213872881496	Severe COVID-19 infection	4e-06	36662838
rs5995242	rs6000172	0.986106275719658	Severe COVID-19 infection	1e-07	36662838
rs5995242	rs4821461	0.972346176441619	Severe COVID-19 infection	4e-06	36662838
rs5995242	rs2227169	0.969784270316886	Severe COVID-19 infection	4e-13	36662838
rs5995242	rs1053982	0.945459834509493	Severe COVID-19 infection	9e-06	36662838
rs5995242	rs5756090	0.820064951225381	Severe COVID-19 infection	4e-08	36662838
rs6000176	rs5756090	0.935484160283505	Severe COVID-19 infection	4e-08	36662838
rs6000176	rs6000172	0.869164891703989	Severe COVID-19 infection	1e-07	36662838
rs6000176	rs4821461	0.859843524847952	Severe COVID-19 infection	4e-06	36662838
rs6000176	rs2227169	0.853433814410096	Severe COVID-19 infection	4e-13	36662838
rs6000176	rs1053982	0.833407542673306	Severe COVID-19 infection	9e-06	36662838
rs60149603	rs2290911	0.969771573203041	Height	5e-07	29782485
rs60149603	rs2290911	0.969771573203041	Large artery stroke	6e-06	28265093
rs60149603	rs2290911	0.969771573203041	Height	8e-112	36224396
rs60149603	rs7595075	0.940216647480773	Waist circumference adjusted for body mass index	2e-09	34021172
rs60149603	rs7595075	0.940216647480773	HDL cholesterol	3e-11	34594039
rs60149603	rs7595075	0.940216647480773	HDL cholesterol levels	6e-13	32203549
rs60149603	rs79716074	0.938125498546331	Plateletcrit	1e-09	32888494
rs60149603	rs79716074	0.938125498546331	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs60149603	rs79716074	0.938125498546331	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs60149603	rs79716074	0.938125498546331	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs60149603	rs17713729	0.935307628938793	Body mass index	2e-09	31669095
rs60149603	rs17713729	0.935307628938793	Serum creatinine levels	4e-14	34594039
rs60149603	rs17713729	0.935307628938793	High density lipoprotein cholesterol levels	7e-17	34887591
rs60149603	rs11553746	0.933760452954363	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs60149603	rs11553746	0.933760452954363	High density lipoprotein cholesterol levels	2e-07	29083408
rs60149603	rs11553746	0.933760452954363	High density lipoprotein cholesterol levels	7e-15	29083408
rs60149603	rs11553746	0.933760452954363	Large artery stroke	4e-06	28265093
rs60149603	rs58461606	0.931739923212688	Blood protein levels	0	30072576
rs60149603	rs7566279	0.929556362898296	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs60149603	rs7605824	0.926514336128631	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs60149603	rs17713396	0.926165120466018	Blood urea nitrogen levels	3e-21	34272381
rs60149603	rs17713396	0.926165120466018	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs60149603	rs17713396	0.926165120466018	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs60149603	rs6710091	0.924166395543331	Waist circumference adjusted for body mass index	8e-11	31669095
rs60149603	rs6710091	0.924166395543331	HDL cholesterol	5e-08	30275531
rs60149603	rs6710091	0.924166395543331	High density lipoprotein cholesterol levels	3e-24	34887591
rs60149603	rs3791221	0.888062158270771	Blood urea nitrogen levels	2e-07	31152163
rs60149603	rs3791221	0.888062158270771	Estimated glomerular filtration rate	2e-10	31152163
rs60149603	rs3791221	0.888062158270771	Estimated glomerular filtration rate	1e-11	31152163
rs60149603	rs3791221	0.888062158270771	Blood urea nitrogen levels	7e-26	34594039
rs60149603	rs114976176	0.88326569935259	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs60149603	rs2126129	0.873931562890144	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs60149603	rs62114548	0.870215179258587	Retinal vascular fractal density	2e-09	34743558
rs60149603	rs17714252	0.865660288642945	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs60149603	rs17714252	0.865660288642945	Retinal vascular fractal dimension	2e-07	34743558
rs60149603	rs59937473	0.858494881349662	Protein quantitative trait loci	3e-67	32492067
rs60149603	rs59937473	0.858494881349662	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs60149603	rs79154857	0.837180014927702	Pulse pressure	5e-08	34594039
rs60149603	rs55753056	0.827504310762722	Height	2e-22	30595370
rs60149603	rs7601944	0.81981413098203	Smoking initiation	4e-15	36477530
rs60149603	rs60843830	0.802932010238937	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs60149603	rs60843830	0.802932010238937	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs60149603	rs60843830	0.802932010238937	Adventurousness	7e-10	30643258
rs60149603	rs62114538	0.798079875428888	Triglyceride levels	6e-12	34887591
rs60149603	rs17713879	0.792907214165806	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs60149603	rs17713879	0.792907214165806	Smoking initiation	1e-10	36477530
rs60149603	rs17713879	0.792907214165806	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs60149603	rs17713879	0.792907214165806	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs60149603	rs17713879	0.792907214165806	Triglyceride levels	3e-10	34887591
rs60149603	rs17713879	0.792907214165806	Aging (eyeAgeAcceleration)	6e-50	36975205
rs60149603	rs62114506	0.785815270939056	Gamma glutamyl transpeptidase	3e-14	34594039
rs60149603	rs62114506	0.785815270939056	Apolipoprotein A1 levels	3e-10	32203549
rs60149603	rs62114506	0.785815270939056	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs60149603	rs62114506	0.785815270939056	HDL cholesterol levels	8e-10	36333282
rs60224040	rs12210271	0.919898884308981	ACE-inhibitor discontinuation	1e-19	35751511
rs6037158	rs2257649	0.95411291553241	Total Phosphatidylglycerol levels	3e-10	35668104
rs6037158	rs4815400	0.954111474455189	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs6037158	rs6037062	0.657955351282419	Lung function (forced vital capacity)	3e-13	36914875
rs6037158	rs6037062	0.657955351282419	Lung function (FVC)	5e-12	30595370
rs6037158	rs2500430	0.625350572432084	Serum alkaline phosphatase levels	7e-10	31666285
rs6037158	rs2273473	0.603757621849557	Vertex-wise cortical thickness	1e-12	34910505
rs60484953	rs11553746	0.964781361742929	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs60484953	rs11553746	0.964781361742929	High density lipoprotein cholesterol levels	2e-07	29083408
rs60484953	rs11553746	0.964781361742929	High density lipoprotein cholesterol levels	7e-15	29083408
rs60484953	rs11553746	0.964781361742929	Large artery stroke	4e-06	28265093
rs60484953	rs2290911	0.935773533500823	Height	5e-07	29782485
rs60484953	rs2290911	0.935773533500823	Large artery stroke	6e-06	28265093
rs60484953	rs2290911	0.935773533500823	Height	8e-112	36224396
rs60484953	rs62114548	0.901913152956275	Retinal vascular fractal density	2e-09	34743558
rs60484953	rs17713396	0.8937810089181	Blood urea nitrogen levels	3e-21	34272381
rs60484953	rs17713396	0.8937810089181	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs60484953	rs17713396	0.8937810089181	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs60484953	rs6710091	0.891796151603943	Waist circumference adjusted for body mass index	8e-11	31669095
rs60484953	rs6710091	0.891796151603943	HDL cholesterol	5e-08	30275531
rs60484953	rs6710091	0.891796151603943	High density lipoprotein cholesterol levels	3e-24	34887591
rs60484953	rs7595075	0.877963929014092	Waist circumference adjusted for body mass index	2e-09	34021172
rs60484953	rs7595075	0.877963929014092	HDL cholesterol	3e-11	34594039
rs60484953	rs7595075	0.877963929014092	HDL cholesterol levels	6e-13	32203549
rs60484953	rs17713729	0.877203085840824	Body mass index	2e-09	31669095
rs60484953	rs17713729	0.877203085840824	Serum creatinine levels	4e-14	34594039
rs60484953	rs17713729	0.877203085840824	High density lipoprotein cholesterol levels	7e-17	34887591
rs60484953	rs79716074	0.873884000099576	Plateletcrit	1e-09	32888494
rs60484953	rs79716074	0.873884000099576	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs60484953	rs79716074	0.873884000099576	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs60484953	rs79716074	0.873884000099576	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs60484953	rs58461606	0.868190725717816	Blood protein levels	0	30072576
rs60484953	rs7605824	0.860967925334973	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs60484953	rs7566279	0.860076232540255	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs60484953	rs3791221	0.857088262450504	Blood urea nitrogen levels	2e-07	31152163
rs60484953	rs3791221	0.857088262450504	Estimated glomerular filtration rate	2e-10	31152163
rs60484953	rs3791221	0.857088262450504	Estimated glomerular filtration rate	1e-11	31152163
rs60484953	rs3791221	0.857088262450504	Blood urea nitrogen levels	7e-26	34594039
rs60484953	rs2126129	0.856927824177126	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs60484953	rs62114506	0.845718351523896	Gamma glutamyl transpeptidase	3e-14	34594039
rs60484953	rs62114506	0.845718351523896	Apolipoprotein A1 levels	3e-10	32203549
rs60484953	rs62114506	0.845718351523896	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs60484953	rs62114506	0.845718351523896	HDL cholesterol levels	8e-10	36333282
rs60484953	rs17713879	0.82570289898163	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs60484953	rs17713879	0.82570289898163	Smoking initiation	1e-10	36477530
rs60484953	rs17713879	0.82570289898163	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs60484953	rs17713879	0.82570289898163	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs60484953	rs17713879	0.82570289898163	Triglyceride levels	3e-10	34887591
rs60484953	rs17713879	0.82570289898163	Aging (eyeAgeAcceleration)	6e-50	36975205
rs60484953	rs114976176	0.820456445781872	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs60484953	rs59937473	0.795913409361883	Protein quantitative trait loci	3e-67	32492067
rs60484953	rs59937473	0.795913409361883	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs60484953	rs17714252	0.791746897367058	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs60484953	rs17714252	0.791746897367058	Retinal vascular fractal dimension	2e-07	34743558
rs60484953	rs7601944	0.786091825145007	Smoking initiation	4e-15	36477530
rs60484953	rs55753056	0.779079334096554	Height	2e-22	30595370
rs60484953	rs79154857	0.766824486772013	Pulse pressure	5e-08	34594039
rs60484953	rs62114538	0.740662425362422	Triglyceride levels	6e-12	34887591
rs60484953	rs60843830	0.729339802519298	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs60484953	rs60843830	0.729339802519298	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs60484953	rs60843830	0.729339802519298	Adventurousness	7e-10	30643258
rs6050498	rs2257649	0.814617289689196	Total Phosphatidylglycerol levels	3e-10	35668104
rs6050498	rs4815400	0.809819135483639	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs6050498	rs2273473	0.786445237414116	Vertex-wise cortical thickness	1e-12	34910505
rs6050498	rs6050463	0.753585729897808	Low density lipoprotein cholesterol levels	6e-09	32154731
rs6050498	rs6050463	0.753585729897808	LDL cholesterol levels	2e-09	32203549
rs6050498	rs6115094	0.753585729897808	Brain morphology (MOSTest)	1e-08	32665545
rs6050498	rs6115094	0.753585729897808	Non-HDL cholesterol levels	3e-09	34887591
rs6050498	rs8115257	0.718898533525726	Total cholesterol levels	2e-09	34887591
rs6050498	rs8115257	0.718898533525726	Low density lipoprotein cholesterol levels	1e-10	34887591
rs6050498	rs6037062	0.679546058881604	Lung function (forced vital capacity)	3e-13	36914875
rs6050498	rs6037062	0.679546058881604	Lung function (FVC)	5e-12	30595370
rs6050611	rs11087521	0.88647169243249	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs6050611	rs59934506	0.866264379550669	Body fat percentage	4e-16	33980691
rs6050611	rs59934506	0.866264379550669	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs6050611	rs59934506	0.866264379550669	Alanine aminotransferase levels	2e-10	33980691
rs6050611	rs7267979	0.855481709878106	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs6050611	rs2151144	0.853485754714405	wg lh intensity-contrast fusiform	5e-12	33875891
rs6050611	rs2151144	0.853485754714405	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs6050611	rs2151144	0.853485754714405	wg rh intensity-contrast insula	6e-18	33875891
rs6050611	rs2151144	0.853485754714405	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs6050611	rs2151144	0.853485754714405	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs6050611	rs2151144	0.853485754714405	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs6050611	rs2424698	0.852902740129756	wg lh intensity-contrast middletemporal	3e-13	33875891
rs6050611	rs2424698	0.852902740129756	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs6050611	rs2424698	0.852902740129756	wg rh intensity-contrast middletemporal	7e-13	33875891
rs6050611	rs2424698	0.852902740129756	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs6050611	rs2424698	0.852902740129756	C-reactive protein	5e-11	34594039
rs6050611	rs6083838	0.848600027319046	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs6050611	rs6083838	0.848600027319046	wg lh intensity-contrast insula	6e-13	33875891
rs6050611	rs7020	0.847700098380419	wg rh intensity-contrast fusiform	1e-10	33875891
rs6050611	rs7020	0.847700098380419	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs6050611	rs7020	0.847700098380419	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs6050611	rs7020	0.847700098380419	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs6050611	rs7274104	0.826046849326006	Cortical thickness	4e-08	34560273
rs6050611	rs6115118	0.809670569222897	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs6050611	rs6115101	0.808226401404942	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs6050611	rs6115101	0.808226401404942	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs6050611	rs6115101	0.808226401404942	wg rh intensity-contrast supramarginal	3e-11	33875891
rs6050611	rs6138553	0.807479435556448	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs6050611	rs6115200	0.807055412507903	Height	9e-09	36224396
rs6050611	rs6115204	0.804179220176433	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs6050611	rs6115099	0.802672949081385	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs6050611	rs6138556	0.796353549796699	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs6050611	rs6083799	0.784856561874901	Serum alkaline phosphatase levels	1e-71	33547301
rs6050611	rs84816	0.768342195529871	aseg rh intensity Caudate	7e-09	33875891
rs6050611	rs84816	0.768342195529871	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs6050611	rs2261795	0.767433645911728	Non-HDL cholesterol levels	1e-09	34887591
rs6050611	rs4815412	0.766690584349789	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs6050611	rs12428	0.765622279862923	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs6050611	rs2500406	0.759643233399462	Brain region volumes	2e-08	31676860
rs6050611	rs2500406	0.759643233399462	Height	1e-33	36224396
rs6050611	rs2856	0.756581809208987	Blood protein levels	6e-07	27532455
rs6050611	rs6132824	0.735978403147615	Multi-trait sum score	5e-08	37277458
rs6050611	rs11699953	0.735294397731921	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs6050611	rs8184820	0.734605333717821	Brain morphology (MOSTest)	4e-13	35164939
rs6050611	rs9927	0.714679928905928	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs6050611	rs3746337	0.691337883120946	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs6050611	rs3746337	0.691337883120946	wg lh intensity-contrast frontalpole	1e-09	33875891
rs6050611	rs3746337	0.691337883120946	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs6050611	rs3746337	0.691337883120946	Total cholesterol levels	3e-09	34887591
rs6050611	rs2500430	0.686985559281146	Serum alkaline phosphatase levels	7e-10	31666285
rs6050611	rs1888995	0.682296871323756	Weight	2e-11	34594039
rs6050611	rs6050464	0.675583486184828	Brain region volumes	5e-09	31676860
rs6050611	rs6050464	0.675583486184828	Apolipoprotein B levels	6e-14	32203549
rs6050611	rs2260997	0.662232326014647	Subcortical volume (MOSTest)	4e-09	32665545
rs6050611	rs2260997	0.662232326014647	Platelet distribution width	5e-17	32888494
rs60588038	rs4924522	0.82222557706398	Lung function (forced vital capacity)	5e-18	36914875
rs60588038	rs9796	0.731085012740177	Menopause (age at onset)	1e-10	26414677
rs6076343	rs2257649	0.983057565029946	Total Phosphatidylglycerol levels	3e-10	35668104
rs6076343	rs4815400	0.981282285781015	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs6076343	rs6037062	0.671834396212338	Lung function (forced vital capacity)	3e-13	36914875
rs6076343	rs6037062	0.671834396212338	Lung function (FVC)	5e-12	30595370
rs6076343	rs2500430	0.654520230485166	Serum alkaline phosphatase levels	7e-10	31666285
rs6076343	rs2273473	0.618158636650604	Vertex-wise cortical thickness	1e-12	34910505
rs6076343	rs2856	0.606273993618475	Blood protein levels	6e-07	27532455
rs6076343	rs12428	0.601930383626058	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs6081731	rs6081731	1	Metabolite levels	6e-06	23823483
rs6083845	rs2257649	0.979519450890709	Total Phosphatidylglycerol levels	3e-10	35668104
rs6083845	rs4815400	0.979519124959931	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs6083845	rs6037062	0.66891895569137	Lung function (forced vital capacity)	3e-13	36914875
rs6083845	rs6037062	0.66891895569137	Lung function (FVC)	5e-12	30595370
rs6083845	rs2500430	0.651568336862709	Serum alkaline phosphatase levels	7e-10	31666285
rs6083845	rs2273473	0.616769982404179	Vertex-wise cortical thickness	1e-12	34910505
rs6083845	rs2856	0.60472315377365	Blood protein levels	6e-07	27532455
rs6083845	rs12428	0.600378194638378	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs6083856	rs11087521	0.887985289961312	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs6083856	rs59934506	0.867754266275786	Body fat percentage	4e-16	33980691
rs6083856	rs59934506	0.867754266275786	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs6083856	rs59934506	0.867754266275786	Alanine aminotransferase levels	2e-10	33980691
rs6083856	rs7267979	0.855481709878106	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs6083856	rs2151144	0.854965062605865	wg lh intensity-contrast fusiform	5e-12	33875891
rs6083856	rs2151144	0.854965062605865	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs6083856	rs2151144	0.854965062605865	wg rh intensity-contrast insula	6e-18	33875891
rs6083856	rs2151144	0.854965062605865	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs6083856	rs2151144	0.854965062605865	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs6083856	rs2151144	0.854965062605865	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs6083856	rs2424698	0.854388858360043	wg lh intensity-contrast middletemporal	3e-13	33875891
rs6083856	rs2424698	0.854388858360043	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs6083856	rs2424698	0.854388858360043	wg rh intensity-contrast middletemporal	7e-13	33875891
rs6083856	rs2424698	0.854388858360043	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs6083856	rs2424698	0.854388858360043	C-reactive protein	5e-11	34594039
rs6083856	rs6083838	0.850075203594191	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs6083856	rs6083838	0.850075203594191	wg lh intensity-contrast insula	6e-13	33875891
rs6083856	rs7020	0.849173926484684	wg rh intensity-contrast fusiform	1e-10	33875891
rs6083856	rs7020	0.849173926484684	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs6083856	rs7020	0.849173926484684	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs6083856	rs7020	0.849173926484684	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs6083856	rs7274104	0.827501327471815	Cortical thickness	4e-08	34560273
rs6083856	rs6115101	0.809670569222897	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs6083856	rs6115101	0.809670569222897	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs6083856	rs6115101	0.809670569222897	wg rh intensity-contrast supramarginal	3e-11	33875891
rs6083856	rs6115118	0.809670569222897	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs6083856	rs6138553	0.808922885648998	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs6083856	rs6115200	0.808495434019134	Height	9e-09	36224396
rs6083856	rs6115204	0.805616674560336	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs6083856	rs6115099	0.804112560473937	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs6083856	rs6138556	0.797786301289813	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs6083856	rs6083799	0.786277937415754	Serum alkaline phosphatase levels	1e-71	33547301
rs6083856	rs84816	0.769749176524937	aseg rh intensity Caudate	7e-09	33875891
rs6083856	rs84816	0.769749176524937	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs6083856	rs2261795	0.76884047847216	Non-HDL cholesterol levels	1e-09	34887591
rs6083856	rs4815412	0.766690584349789	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs6083856	rs12428	0.765622279862923	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs6083856	rs2500406	0.759643233399462	Brain region volumes	2e-08	31676860
rs6083856	rs2500406	0.759643233399462	Height	1e-33	36224396
rs6083856	rs2856	0.757980122544434	Blood protein levels	6e-07	27532455
rs6083856	rs6132824	0.737352754598978	Multi-trait sum score	5e-08	37277458
rs6083856	rs11699953	0.736668085513417	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs6083856	rs8184820	0.734605333717821	Brain morphology (MOSTest)	4e-13	35164939
rs6083856	rs9927	0.716042132301883	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs6083856	rs3746337	0.691337883120946	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs6083856	rs3746337	0.691337883120946	wg lh intensity-contrast frontalpole	1e-09	33875891
rs6083856	rs3746337	0.691337883120946	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs6083856	rs3746337	0.691337883120946	Total cholesterol levels	3e-09	34887591
rs6083856	rs2500430	0.688324786412718	Serum alkaline phosphatase levels	7e-10	31666285
rs6083856	rs1888995	0.680939841071844	Weight	2e-11	34594039
rs6083856	rs6050464	0.676902407758807	Brain region volumes	5e-09	31676860
rs6083856	rs6050464	0.676902407758807	Apolipoprotein B levels	6e-14	32203549
rs6083856	rs2260997	0.662232326014647	Subcortical volume (MOSTest)	4e-09	32665545
rs6083856	rs2260997	0.662232326014647	Platelet distribution width	5e-17	32888494
rs60843830	rs60843830	1	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs60843830	rs60843830	1	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs60843830	rs60843830	1	Adventurousness	7e-10	30643258
rs60843830	rs17714252	0.939942830890094	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs60843830	rs17714252	0.939942830890094	Retinal vascular fractal dimension	2e-07	34743558
rs60843830	rs59937473	0.930482341833977	Protein quantitative trait loci	3e-67	32492067
rs60843830	rs59937473	0.930482341833977	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs60843830	rs55753056	0.897547033870195	Height	2e-22	30595370
rs60843830	rs7601944	0.889432694718884	Smoking initiation	4e-15	36477530
rs60843830	rs114976176	0.885077073623467	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs60843830	rs62114538	0.865668272348357	Triglyceride levels	6e-12	34887591
rs60843830	rs7566279	0.853813660972891	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs60843830	rs58461606	0.848278323232766	Blood protein levels	0	30072576
rs60843830	rs79716074	0.835870753273051	Plateletcrit	1e-09	32888494
rs60843830	rs79716074	0.835870753273051	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs60843830	rs79716074	0.835870753273051	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs60843830	rs79716074	0.835870753273051	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs60843830	rs7595075	0.832191535528432	Waist circumference adjusted for body mass index	2e-09	34021172
rs60843830	rs7595075	0.832191535528432	HDL cholesterol	3e-11	34594039
rs60843830	rs7595075	0.832191535528432	HDL cholesterol levels	6e-13	32203549
rs60843830	rs7605824	0.826812330358767	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs60843830	rs17713729	0.825774063080855	Body mass index	2e-09	31669095
rs60843830	rs17713729	0.825774063080855	Serum creatinine levels	4e-14	34594039
rs60843830	rs17713729	0.825774063080855	High density lipoprotein cholesterol levels	7e-17	34887591
rs60843830	rs17713396	0.81925344884844	Blood urea nitrogen levels	3e-21	34272381
rs60843830	rs17713396	0.81925344884844	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs60843830	rs17713396	0.81925344884844	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs60843830	rs6710091	0.817413425343089	Waist circumference adjusted for body mass index	8e-11	31669095
rs60843830	rs6710091	0.817413425343089	HDL cholesterol	5e-08	30275531
rs60843830	rs6710091	0.817413425343089	High density lipoprotein cholesterol levels	3e-24	34887591
rs60843830	rs3791221	0.808695425971242	Blood urea nitrogen levels	2e-07	31152163
rs60843830	rs3791221	0.808695425971242	Estimated glomerular filtration rate	2e-10	31152163
rs60843830	rs3791221	0.808695425971242	Estimated glomerular filtration rate	1e-11	31152163
rs60843830	rs3791221	0.808695425971242	Blood urea nitrogen levels	7e-26	34594039
rs60843830	rs2290911	0.776453984015556	Height	5e-07	29782485
rs60843830	rs2290911	0.776453984015556	Large artery stroke	6e-06	28265093
rs60843830	rs2290911	0.776453984015556	Height	8e-112	36224396
rs60843830	rs2126129	0.771507409919261	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs60843830	rs11553746	0.74633295688915	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs60843830	rs11553746	0.74633295688915	High density lipoprotein cholesterol levels	2e-07	29083408
rs60843830	rs11553746	0.74633295688915	High density lipoprotein cholesterol levels	7e-15	29083408
rs60843830	rs11553746	0.74633295688915	Large artery stroke	4e-06	28265093
rs60843830	rs62114548	0.724153234499926	Retinal vascular fractal density	2e-09	34743558
rs60843830	rs17713879	0.719856545572522	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs60843830	rs17713879	0.719856545572522	Smoking initiation	1e-10	36477530
rs60843830	rs17713879	0.719856545572522	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs60843830	rs17713879	0.719856545572522	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs60843830	rs17713879	0.719856545572522	Triglyceride levels	3e-10	34887591
rs60843830	rs17713879	0.719856545572522	Aging (eyeAgeAcceleration)	6e-50	36975205
rs60843830	rs79154857	0.698301408581121	Pulse pressure	5e-08	34594039
rs60843830	rs62114506	0.616185395029572	Gamma glutamyl transpeptidase	3e-14	34594039
rs60843830	rs62114506	0.616185395029572	Apolipoprotein A1 levels	3e-10	32203549
rs60843830	rs62114506	0.616185395029572	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs60843830	rs62114506	0.616185395029572	HDL cholesterol levels	8e-10	36333282
rs60909079	rs2868708	0.949909243135387	Lymphocyte count	3e-11	34469753
rs60909079	rs2868708	0.949909243135387	White blood cell count	1e-09	30595370
rs60909079	rs6831339	0.946668262269866	High density lipoprotein cholesterol levels	9e-09	34887591
rs60909079	rs6535419	0.891705080195728	Pulse pressure	6e-10	30578418
rs60909079	rs116142917	0.872192838196552	Lymphocyte count	7e-18	32888494
rs60909079	rs13111599	0.863560569662666	HDL cholesterol levels	3e-09	32203549
rs60909079	rs13111599	0.863560569662666	Apolipoprotein A1 levels	4e-08	32203549
rs60909079	rs6823199	0.856058653317188	Pulse pressure	4e-14	30224653
rs60909079	rs4302451	0.788360913843005	Eosinophil counts	2e-09	30595370
rs60909079	rs35895091	0.736048099472026	Cardiovascular disease	1e-07	30595370
rs60909079	rs11099563	0.703816366308186	High density lipoprotein cholesterol levels	3e-11	34887591
rs60909079	rs28528763	0.681960359412479	White blood cell count	7e-12	32888494
rs60909079	rs7662402	0.603537680622422	Brain morphology (MOSTest)	3e-08	35164939
rs60935857	rs324126	0.611945787263584	Colonoscopy-negative controls vs population controls	6e-06	29228715
rs60956116	rs6723298	0.68170060563315	Smoking initiation	2e-12	36477530
rs60956116	rs2194492	0.662869006834723	Educational attainment	9e-09	35361970
rs60956116	rs13020443	0.65304230788433	Type 2 diabetes	3e-11	32541925
rs60997156	rs11685226	0.996645455617622	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs60997156	rs11685226	0.996645455617622	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs60997156	rs7558954	0.973426320015638	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs60997156	rs1177308	0.972557044082667	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs60997156	rs1177308	0.972557044082667	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs60997156	rs777587	0.825399518395242	Proteoglycan 3 levels	6e-29	34648354
rs60997156	rs777587	0.825399518395242	Pappalysin-1 levels	1e-25	34648354
rs60997156	rs12617371	0.783941279592438	Immature fraction of reticulocytes	8e-18	32888494
rs60997156	rs2463097	0.750490750677167	White blood cell count	3e-26	30595370
rs60997156	rs2593620	0.725959097651564	Serum levels of protein PRG3	5e-14	35078996
rs60997156	rs10199672	0.718516806391121	Height	6e-12	34594039
rs60997156	rs10199672	0.718516806391121	Height	2e-12	31562340
rs60997156	rs2421200	0.697360693061303	Neutrophil count	1e-26	32888493
rs60997156	rs2421200	0.697360693061303	Neutrophil count	1e-25	32888493
rs60997156	rs10169482	0.643516256096985	C-reactive protein levels	4e-09	33462484
rs60997156	rs12616433	0.621939876978205	Eosinophil forward scatter	4e-13	37596262
rs60997156	rs12616433	0.621939876978205	Eosinophil side scatter	2e-18	37596262
rs6107045	rs11087521	0.896459462057486	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs6107045	rs59934506	0.854987803284461	Body fat percentage	4e-16	33980691
rs6107045	rs59934506	0.854987803284461	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs6107045	rs59934506	0.854987803284461	Alanine aminotransferase levels	2e-10	33980691
rs6107045	rs2424698	0.841944665809683	wg lh intensity-contrast middletemporal	3e-13	33875891
rs6107045	rs2424698	0.841944665809683	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs6107045	rs2424698	0.841944665809683	wg rh intensity-contrast middletemporal	7e-13	33875891
rs6107045	rs2424698	0.841944665809683	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs6107045	rs2424698	0.841944665809683	C-reactive protein	5e-11	34594039
rs6107045	rs7267979	0.841331374215673	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs6107045	rs2151144	0.840800032399968	wg lh intensity-contrast fusiform	5e-12	33875891
rs6107045	rs2151144	0.840800032399968	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs6107045	rs2151144	0.840800032399968	wg rh intensity-contrast insula	6e-18	33875891
rs6107045	rs2151144	0.840800032399968	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs6107045	rs2151144	0.840800032399968	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs6107045	rs2151144	0.840800032399968	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs6107045	rs6083838	0.83594575976706	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs6107045	rs6083838	0.83594575976706	wg lh intensity-contrast insula	6e-13	33875891
rs6107045	rs7020	0.835084578439574	wg rh intensity-contrast fusiform	1e-10	33875891
rs6107045	rs7020	0.835084578439574	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs6107045	rs7020	0.835084578439574	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs6107045	rs7020	0.835084578439574	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs6107045	rs6115200	0.816480001886329	Height	9e-09	36224396
rs6107045	rs7274104	0.815081040422575	Cortical thickness	4e-08	34560273
rs6107045	rs6115204	0.813587197295397	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs6107045	rs6115101	0.797542070009571	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs6107045	rs6115101	0.797542070009571	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs6107045	rs6115101	0.797542070009571	wg rh intensity-contrast supramarginal	3e-11	33875891
rs6107045	rs6115118	0.797542070009571	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs6107045	rs6138553	0.79679960747039	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs6107045	rs6115099	0.792029634829213	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs6107045	rs6138556	0.785740871655325	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs6107045	rs84816	0.775852921676448	aseg rh intensity Caudate	7e-09	33875891
rs6107045	rs84816	0.775852921676448	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs6107045	rs6083799	0.772596615716661	Serum alkaline phosphatase levels	1e-71	33547301
rs6107045	rs2261795	0.762266435045508	Non-HDL cholesterol levels	1e-09	34887591
rs6107045	rs12428	0.760449097502472	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs6107045	rs4815412	0.760117383365236	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs6107045	rs2856	0.751422404573232	Blood protein levels	6e-07	27532455
rs6107045	rs2500406	0.746542261194513	Brain region volumes	2e-08	31676860
rs6107045	rs2500406	0.746542261194513	Height	1e-33	36224396
rs6107045	rs6132824	0.725731485409853	Multi-trait sum score	5e-08	37277458
rs6107045	rs11699953	0.725051662645298	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs6107045	rs8184820	0.723005960697032	Brain morphology (MOSTest)	4e-13	35164939
rs6107045	rs9927	0.702845435056282	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs6107045	rs3746337	0.682733569890003	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs6107045	rs3746337	0.682733569890003	wg lh intensity-contrast frontalpole	1e-09	33875891
rs6107045	rs3746337	0.682733569890003	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs6107045	rs3746337	0.682733569890003	Total cholesterol levels	3e-09	34887591
rs6107045	rs2500430	0.675311341165766	Serum alkaline phosphatase levels	7e-10	31666285
rs6107045	rs1888995	0.66985548657065	Weight	2e-11	34594039
rs6107045	rs6050464	0.66683005771116	Brain region volumes	5e-09	31676860
rs6107045	rs6050464	0.66683005771116	Apolipoprotein B levels	6e-14	32203549
rs6107045	rs2260997	0.649825077162699	Subcortical volume (MOSTest)	4e-09	32665545
rs6107045	rs2260997	0.649825077162699	Platelet distribution width	5e-17	32888494
rs6107046	rs11087521	0.8985338260765	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs6107046	rs59934506	0.857449016616761	Body fat percentage	4e-16	33980691
rs6107046	rs59934506	0.857449016616761	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs6107046	rs59934506	0.857449016616761	Alanine aminotransferase levels	2e-10	33980691
rs6107046	rs2424698	0.843916774821942	wg lh intensity-contrast middletemporal	3e-13	33875891
rs6107046	rs2424698	0.843916774821942	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs6107046	rs2424698	0.843916774821942	wg rh intensity-contrast middletemporal	7e-13	33875891
rs6107046	rs2424698	0.843916774821942	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs6107046	rs2424698	0.843916774821942	C-reactive protein	5e-11	34594039
rs6107046	rs7267979	0.843782143856426	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs6107046	rs2151144	0.843276932432646	wg lh intensity-contrast fusiform	5e-12	33875891
rs6107046	rs2151144	0.843276932432646	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs6107046	rs2151144	0.843276932432646	wg rh intensity-contrast insula	6e-18	33875891
rs6107046	rs2151144	0.843276932432646	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs6107046	rs2151144	0.843276932432646	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs6107046	rs2151144	0.843276932432646	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs6107046	rs6083838	0.838422575489035	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs6107046	rs6083838	0.838422575489035	wg lh intensity-contrast insula	6e-13	33875891
rs6107046	rs7020	0.837513807889922	wg rh intensity-contrast fusiform	1e-10	33875891
rs6107046	rs7020	0.837513807889922	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs6107046	rs7020	0.837513807889922	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs6107046	rs7020	0.837513807889922	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs6107046	rs6115200	0.818585200803202	Height	9e-09	36224396
rs6107046	rs7274104	0.817413661732809	Cortical thickness	4e-08	34560273
rs6107046	rs6115204	0.815688417170877	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs6107046	rs6115101	0.799519164266151	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs6107046	rs6115101	0.799519164266151	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs6107046	rs6115101	0.799519164266151	wg rh intensity-contrast supramarginal	3e-11	33875891
rs6107046	rs6115118	0.799519164266151	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs6107046	rs6138553	0.798777086891715	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs6107046	rs6115099	0.793988503547796	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs6107046	rs6138556	0.787724056934625	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs6107046	rs84816	0.778382064508512	aseg rh intensity Caudate	7e-09	33875891
rs6107046	rs84816	0.778382064508512	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs6107046	rs6083799	0.775097942068757	Serum alkaline phosphatase levels	1e-71	33547301
rs6107046	rs2261795	0.764794374997949	Non-HDL cholesterol levels	1e-09	34887591
rs6107046	rs12428	0.762991675181007	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs6107046	rs4815412	0.76265343610742	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs6107046	rs2856	0.753974283438803	Blood protein levels	6e-07	27532455
rs6107046	rs2500406	0.748153962710728	Brain region volumes	2e-08	31676860
rs6107046	rs2500406	0.748153962710728	Height	1e-33	36224396
rs6107046	rs6132824	0.727747197205206	Multi-trait sum score	5e-08	37277458
rs6107046	rs11699953	0.727067701388432	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs6107046	rs8184820	0.725017652119426	Brain morphology (MOSTest)	4e-13	35164939
rs6107046	rs9927	0.705387790428897	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs6107046	rs3746337	0.684682475339293	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs6107046	rs3746337	0.684682475339293	wg lh intensity-contrast frontalpole	1e-09	33875891
rs6107046	rs3746337	0.684682475339293	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs6107046	rs3746337	0.684682475339293	Total cholesterol levels	3e-09	34887591
rs6107046	rs2500430	0.677878003485436	Serum alkaline phosphatase levels	7e-10	31666285
rs6107046	rs1888995	0.671215334325775	Weight	2e-11	34594039
rs6107046	rs6050464	0.669150741740633	Brain region volumes	5e-09	31676860
rs6107046	rs6050464	0.669150741740633	Apolipoprotein B levels	6e-14	32203549
rs6107046	rs2260997	0.651924485898746	Subcortical volume (MOSTest)	4e-09	32665545
rs6107046	rs2260997	0.651924485898746	Platelet distribution width	5e-17	32888494
rs6111959	rs6045400	0.782631730186981	Menarche (age at onset)	5e-11	30595370
rs6111959	rs6045385	0.772187557988781	Body mass index	2e-08	34594039
rs6115107	rs2257649	0.813799258660109	Total Phosphatidylglycerol levels	3e-10	35668104
rs6115107	rs4815400	0.8090038202459	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs6115107	rs2273473	0.787167877806644	Vertex-wise cortical thickness	1e-12	34910505
rs6115107	rs6050463	0.751226647345651	Low density lipoprotein cholesterol levels	6e-09	32154731
rs6115107	rs6050463	0.751226647345651	LDL cholesterol levels	2e-09	32203549
rs6115107	rs6115094	0.751226647345651	Brain morphology (MOSTest)	1e-08	32665545
rs6115107	rs6115094	0.751226647345651	Non-HDL cholesterol levels	3e-09	34887591
rs6115107	rs8115257	0.716595117071143	Total cholesterol levels	2e-09	34887591
rs6115107	rs8115257	0.716595117071143	Low density lipoprotein cholesterol levels	1e-10	34887591
rs6115107	rs6037062	0.677311680765218	Lung function (forced vital capacity)	3e-13	36914875
rs6115107	rs6037062	0.677311680765218	Lung function (FVC)	5e-12	30595370
rs6115140	rs11087521	0.884795238919768	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs6115140	rs59934506	0.863484800915169	Body fat percentage	4e-16	33980691
rs6115140	rs59934506	0.863484800915169	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs6115140	rs59934506	0.863484800915169	Alanine aminotransferase levels	2e-10	33980691
rs6115140	rs2424698	0.860153812871685	wg lh intensity-contrast middletemporal	3e-13	33875891
rs6115140	rs2424698	0.860153812871685	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs6115140	rs2424698	0.860153812871685	wg rh intensity-contrast middletemporal	7e-13	33875891
rs6115140	rs2424698	0.860153812871685	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs6115140	rs2424698	0.860153812871685	C-reactive protein	5e-11	34594039
rs6115140	rs7267979	0.860131691227903	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs6115140	rs7020	0.852318539622667	wg rh intensity-contrast fusiform	1e-10	33875891
rs6115140	rs7020	0.852318539622667	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs6115140	rs7020	0.852318539622667	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs6115140	rs7020	0.852318539622667	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs6115140	rs2151144	0.847804255438228	wg lh intensity-contrast fusiform	5e-12	33875891
rs6115140	rs2151144	0.847804255438228	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs6115140	rs2151144	0.847804255438228	wg rh intensity-contrast insula	6e-18	33875891
rs6115140	rs2151144	0.847804255438228	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs6115140	rs2151144	0.847804255438228	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs6115140	rs2151144	0.847804255438228	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs6115140	rs6083838	0.84441030628224	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs6115140	rs6083838	0.84441030628224	wg lh intensity-contrast insula	6e-13	33875891
rs6115140	rs7274104	0.83055080164442	Cortical thickness	4e-08	34560273
rs6115140	rs6115118	0.81677290837666	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs6115140	rs6115101	0.815322315503541	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs6115140	rs6115101	0.815322315503541	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs6115140	rs6115101	0.815322315503541	wg rh intensity-contrast supramarginal	3e-11	33875891
rs6115140	rs6138553	0.814572937592695	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs6115140	rs6115099	0.809736857421595	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs6115140	rs6115200	0.807003368495287	Height	9e-09	36224396
rs6115140	rs6115204	0.805564575763374	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs6115140	rs6138556	0.80341107039639	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs6115140	rs6083799	0.790865027510139	Serum alkaline phosphatase levels	1e-71	33547301
rs6115140	rs2261795	0.772002144546854	Non-HDL cholesterol levels	1e-09	34887591
rs6115140	rs84816	0.764453971276313	aseg rh intensity Caudate	7e-09	33875891
rs6115140	rs84816	0.764453971276313	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs6115140	rs4815412	0.764232266297646	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs6115140	rs12428	0.758966656048457	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs6115140	rs2500406	0.753591199236113	Brain region volumes	2e-08	31676860
rs6115140	rs2500406	0.753591199236113	Height	1e-33	36224396
rs6115140	rs2856	0.75137204064328	Blood protein levels	6e-07	27532455
rs6115140	rs6132824	0.742840703148197	Multi-trait sum score	5e-08	37277458
rs6115140	rs11699953	0.742154445492788	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs6115140	rs8184820	0.741461147277612	Brain morphology (MOSTest)	4e-13	35164939
rs6115140	rs9927	0.719190258956152	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs6115140	rs3746337	0.696647016469058	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs6115140	rs3746337	0.696647016469058	wg lh intensity-contrast frontalpole	1e-09	33875891
rs6115140	rs3746337	0.696647016469058	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs6115140	rs3746337	0.696647016469058	Total cholesterol levels	3e-09	34887591
rs6115140	rs2500430	0.69147459245562	Serum alkaline phosphatase levels	7e-10	31666285
rs6115140	rs6050464	0.679833121399532	Brain region volumes	5e-09	31676860
rs6115140	rs6050464	0.679833121399532	Apolipoprotein B levels	6e-14	32203549
rs6115140	rs1888995	0.679056227253602	Weight	2e-11	34594039
rs6115140	rs2260997	0.667585724775813	Subcortical volume (MOSTest)	4e-09	32665545
rs6115140	rs2260997	0.667585724775813	Platelet distribution width	5e-17	32888494
rs6115188	rs4815400	0.977747349224299	Phosphatidylglycerol (36:1) levels	2e-18	35668104
rs6115188	rs2257649	0.977747150729364	Total Phosphatidylglycerol levels	3e-10	35668104
rs6115188	rs6037062	0.673183346148731	Lung function (forced vital capacity)	3e-13	36914875
rs6115188	rs6037062	0.673183346148731	Lung function (FVC)	5e-12	30595370
rs6115188	rs2500430	0.647440690031942	Serum alkaline phosphatase levels	7e-10	31666285
rs6115188	rs2273473	0.619517614102268	Vertex-wise cortical thickness	1e-12	34910505
rs6115188	rs2856	0.608692402231672	Blood protein levels	6e-07	27532455
rs6115188	rs12428	0.60433069400263	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs6115191	rs11087521	0.899336878196953	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs6115191	rs59934506	0.858141317061456	Body fat percentage	4e-16	33980691
rs6115191	rs59934506	0.858141317061456	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs6115191	rs59934506	0.858141317061456	Alanine aminotransferase levels	2e-10	33980691
rs6115191	rs2424698	0.844703858772662	wg lh intensity-contrast middletemporal	3e-13	33875891
rs6115191	rs2424698	0.844703858772662	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs6115191	rs2424698	0.844703858772662	wg rh intensity-contrast middletemporal	7e-13	33875891
rs6115191	rs2424698	0.844703858772662	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs6115191	rs2424698	0.844703858772662	C-reactive protein	5e-11	34594039
rs6115191	rs7267979	0.844467141455169	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs6115191	rs2151144	0.843956609016145	wg lh intensity-contrast fusiform	5e-12	33875891
rs6115191	rs2151144	0.843956609016145	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs6115191	rs2151144	0.843956609016145	wg rh intensity-contrast insula	6e-18	33875891
rs6115191	rs2151144	0.843956609016145	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs6115191	rs2151144	0.843956609016145	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs6115191	rs2151144	0.843956609016145	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs6115191	rs6083838	0.839098964898396	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs6115191	rs6083838	0.839098964898396	wg lh intensity-contrast insula	6e-13	33875891
rs6115191	rs7020	0.838198647530844	wg rh intensity-contrast fusiform	1e-10	33875891
rs6115191	rs7020	0.838198647530844	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs6115191	rs7020	0.838198647530844	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs6115191	rs7020	0.838198647530844	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs6115191	rs6115200	0.819323222871235	Height	9e-09	36224396
rs6115191	rs7274104	0.81810339093386	Cortical thickness	4e-08	34560273
rs6115191	rs6115204	0.81642518323601	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs6115191	rs6115101	0.800271739328012	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs6115191	rs6115101	0.800271739328012	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs6115191	rs6115101	0.800271739328012	wg rh intensity-contrast supramarginal	3e-11	33875891
rs6115191	rs6115118	0.800271739328012	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs6115191	rs6138553	0.799529011603038	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs6115191	rs6115099	0.794741079050647	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs6115191	rs6138556	0.788466294195468	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs6115191	rs84816	0.779007832989888	aseg rh intensity Caudate	7e-09	33875891
rs6115191	rs84816	0.779007832989888	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs6115191	rs6083799	0.775726386502259	Serum alkaline phosphatase levels	1e-71	33547301
rs6115191	rs2261795	0.765411002152783	Non-HDL cholesterol levels	1e-09	34887591
rs6115191	rs12428	0.763604509775759	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs6115191	rs4815412	0.763267171568695	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs6115191	rs2856	0.754579303429853	Blood protein levels	6e-07	27532455
rs6115191	rs2500406	0.748955951342163	Brain region volumes	2e-08	31676860
rs6115191	rs2500406	0.748955951342163	Height	1e-33	36224396
rs6115191	rs6132824	0.728436268927722	Multi-trait sum score	5e-08	37277458
rs6115191	rs11699953	0.727756177362278	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs6115191	rs8184820	0.725705478466945	Brain morphology (MOSTest)	4e-13	35164939
rs6115191	rs9927	0.705960648203409	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs6115191	rs3746337	0.685352151387029	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs6115191	rs3746337	0.685352151387029	wg lh intensity-contrast frontalpole	1e-09	33875891
rs6115191	rs3746337	0.685352151387029	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs6115191	rs3746337	0.685352151387029	Total cholesterol levels	3e-09	34887591
rs6115191	rs2500430	0.67842758244085	Serum alkaline phosphatase levels	7e-10	31666285
rs6115191	rs1888995	0.672020345976615	Weight	2e-11	34594039
rs6115191	rs6050464	0.669735476927517	Brain region volumes	5e-09	31676860
rs6115191	rs6050464	0.669735476927517	Apolipoprotein B levels	6e-14	32203549
rs6115191	rs2260997	0.652537331972488	Subcortical volume (MOSTest)	4e-09	32665545
rs6115191	rs2260997	0.652537331972488	Platelet distribution width	5e-17	32888494
rs61266553	rs1859336	0.984602444847398	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs61266553	rs6489882	0.967176766167267	Chronic lymphocytic leukemia	5e-08	28165464
rs61266553	rs11066452	0.962206627655933	Blood protein levels	6e-08	30072576
rs61266553	rs4767027	0.941164087791983	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs61266553	rs2057778	0.93766882265791	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs61266553	rs2057778	0.93766882265791	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs61266553	rs2057778	0.93766882265791	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs61266553	rs1131476	0.912651049917873	Systemic lupus erythematosus	1e-09	33272962
rs61266553	rs2660	0.912651049917873	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs61266553	rs2660	0.912651049917873	COVID-19 (critical illness vs population)	3e-15	37198478
rs61266553	rs6489867	0.670331323347399	COVID-19 (critical illness vs population)	1e-09	33307546
rs61266553	rs1557866	0.623290818802835	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs61277166	rs1063631	0.895688415955326	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs61277166	rs1063631	0.895688415955326	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs61277166	rs6928810	0.889266905277565	Platelet distribution width	1e-14	32888494
rs61277166	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs61277166	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs61277166	rs9266825	0.866630127730656	Autism spectrum disorder	6e-06	35215271
rs61277166	rs199530775	0.739165137320618	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs61277166	rs55957433	0.739165137320618	Hip circumference adjusted for BMI	3e-08	34021172
rs61277166	rs6934175	0.675921974207854	Psoriatic arthritis	5e-28	30552173
rs61277166	rs17200242	0.666572918568088	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs61277166	rs7751505	0.659750033979713	Pubertal anthropometrics	4e-06	23449627
rs61277166	rs35026345	0.658450681246847	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs61277166	rs72848707	0.655638991280889	HDL cholesterol levels	7e-06	35884923
rs61277166	rs13437088	0.633437864038569	Psoriasis	3e-40	23143594
rs61277166	rs13437082	0.632742221721105	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs61277166	rs13437082	0.632742221721105	Height	5e-08	19343178
rs61277166	rs72657657	0.62513475842961	Hip circumference adjusted for BMI	4e-13	34021172
rs61289882	rs73045343	0.650142714381821	Serum total protein level	1e-12	34594039
rs61289882	rs6759004	0.633268733665631	Triptolide cytotoxicity	3e-07	26121980
rs61478890	rs1859336	0.976337750097342	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs61478890	rs6489882	0.956710966363023	Chronic lymphocytic leukemia	5e-08	28165464
rs61478890	rs11066452	0.953930568976932	Blood protein levels	6e-08	30072576
rs61478890	rs4767027	0.932888437434199	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs61478890	rs2057778	0.929410028564715	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs61478890	rs2057778	0.929410028564715	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs61478890	rs2057778	0.929410028564715	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs61478890	rs1131476	0.904594346943201	Systemic lupus erythematosus	1e-09	33272962
rs61478890	rs2660	0.904594346943201	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs61478890	rs2660	0.904594346943201	COVID-19 (critical illness vs population)	3e-15	37198478
rs61478890	rs6489867	0.664414169790497	COVID-19 (critical illness vs population)	1e-09	33307546
rs61478890	rs1557866	0.612927052856802	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs61798917	rs61798917	1	Height	2e-10	30595370
rs61896951	rs539524	0.947184837578903	Asthma	1e-10	32296059
rs61896951	rs1789358	0.864618318300769	Asthma	2e-08	34103634
rs61896951	rs1784776	0.861486623650556	Asthma	2e-09	32296059
rs61896951	rs1784775	0.861486623650556	Asthma	2e-09	30929738
rs61896951	rs1784775	0.861486623650556	Asthma (adult onset)	6e-09	30929738
rs61896951	rs542831	0.860641528585029	Asthma	5e-13	31361310
rs61896951	rs34634095	0.858749589599944	Fish- and plant-related diet	3e-09	32066663
rs61896951	rs480293	0.85477522164369	Oily fish consumption	4e-11	32193382
rs61896951	rs12791699	0.852914559616038	Pork consumption	9e-09	32066663
rs61896951	rs12791699	0.852914559616038	Oily fish consumption	9e-09	32066663
rs61896951	rs487985	0.852914559616038	Highest math class taken	1e-08	30038396
rs61896951	rs10891286	0.828307212332051	Noncognitive aspects of educational attainment	5e-10	33414549
rs61896951	rs4459340	0.824505973562374	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs61896951	rs1613778	0.802091238314374	Total bilirubin levels	3e-08	34594039
rs61896951	rs505372	0.78905918122603	Breast cancer	3e-06	29059683
rs61896951	rs505372	0.78905918122603	Medication use (beta blocking agents)	2e-08	34594039
rs61896951	rs9734135	0.758977969349035	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs61896951	rs659529	0.736098396207138	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs61896951	rs659529	0.736098396207138	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs61896951	rs659529	0.736098396207138	Atopic dermatitis	5e-10	34116867
rs61984073	rs2357176	0.955250336771477	Nevus count or cutaneous melanoma	4e-08	30429480
rs61984073	rs10873172	0.860353315806518	Cutaneous melanoma or hair colour	6e-27	32341527
rs61984073	rs10873172	0.860353315806518	Nevus count or cutaneous melanoma	6e-13	32341527
rs61984073	rs10873172	0.860353315806518	Blond vs. brown/black hair color	6e-15	30531825
rs61984073	rs10873172	0.860353315806518	Cutaneous malignant melanoma	6e-08	32341527
rs61984073	rs10873172	0.860353315806518	Hair color	4e-17	30595370
rs61984073	rs1255908	0.801551649119497	PR interval	8e-14	32439900
rs61984073	rs1255908	0.801551649119497	PR interval	6e-14	32439900
rs61984073	rs12878653	0.744763354448504	Youthful appearance (self-reported)	3e-14	32339537
rs62008532	rs17271340	0.955782027253219	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs62008532	rs8034216	0.950467060877961	C-reactive protein levels	2e-10	31900758
rs62008532	rs35967150	0.930440587563267	C-reactive protein levels (MTAG)	1e-08	36376304
rs62008532	rs17271305	0.925070242409641	Two-hour glucose challenge	1e-07	20081857
rs62008532	rs11634163	0.920896009750129	C-reactive protein	2e-08	34594039
rs62008532	rs11634163	0.920896009750129	Two-hour glucose	3e-14	34059833
rs62008532	rs189400382	0.917722726650077	C-reactive protein levels	1e-08	35459240
rs62008532	rs13379492	0.822759104501023	Lung function (FEV1/FVC)	6e-08	30595370
rs62059170	rs409942	0.613730523738168	Total cholesterol levels	8e-06	35884923
rs62075720	rs61586425	0.64903925567182	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs62075720	rs7211615	0.645175235314912	Heel bone mineral density	1e-08	30595370
rs62075720	rs8077038	0.622437849071212	Educational attainment (MTAG)	4e-10	30038396
rs62075720	rs8077038	0.622437849071212	Highest math class taken (MTAG)	5e-16	30038396
rs62075720	rs12949956	0.615279355095687	Self-reported math ability	3e-11	30038396
rs62075720	rs12949956	0.615279355095687	Self-reported math ability (MTAG)	3e-14	30038396
rs62075720	rs12949956	0.615279355095687	Highest math class taken	8e-12	30038396
rs62091793	rs6501801	0.837909390558202	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-07	31719535
rs62091793	rs6501801	0.837909390558202	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-10	31719535
rs62091793	rs6501801	0.837909390558202	HDL cholesterol levels x long total sleep time interaction (1df test)	7e-06	31719535
rs62091793	rs8065231	0.807454137880338	HDL cholesterol levels x long total sleep time interaction (2df test)	5e-10	31719535
rs62091793	rs8065231	0.807454137880338	HDL cholesterol levels x long total sleep time interaction (1df test)	6e-07	31719535
rs62114494	rs2126129	0.959910506738195	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs62114494	rs2290911	0.930801514060696	Height	5e-07	29782485
rs62114494	rs2290911	0.930801514060696	Large artery stroke	6e-06	28265093
rs62114494	rs2290911	0.930801514060696	Height	8e-112	36224396
rs62114494	rs17713396	0.906282054908425	Blood urea nitrogen levels	3e-21	34272381
rs62114494	rs17713396	0.906282054908425	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs62114494	rs17713396	0.906282054908425	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs62114494	rs6710091	0.904302871019766	Waist circumference adjusted for body mass index	8e-11	31669095
rs62114494	rs6710091	0.904302871019766	HDL cholesterol	5e-08	30275531
rs62114494	rs6710091	0.904302871019766	High density lipoprotein cholesterol levels	3e-24	34887591
rs62114494	rs7595075	0.888547285305012	Waist circumference adjusted for body mass index	2e-09	34021172
rs62114494	rs7595075	0.888547285305012	HDL cholesterol	3e-11	34594039
rs62114494	rs7595075	0.888547285305012	HDL cholesterol levels	6e-13	32203549
rs62114494	rs17713729	0.887725752844897	Body mass index	2e-09	31669095
rs62114494	rs17713729	0.887725752844897	Serum creatinine levels	4e-14	34594039
rs62114494	rs17713729	0.887725752844897	High density lipoprotein cholesterol levels	7e-17	34887591
rs62114494	rs79716074	0.884525264244675	Plateletcrit	1e-09	32888494
rs62114494	rs79716074	0.884525264244675	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs62114494	rs79716074	0.884525264244675	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs62114494	rs79716074	0.884525264244675	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs62114494	rs58461606	0.878537945934403	Blood protein levels	0	30072576
rs62114494	rs7605824	0.873386380812872	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs62114494	rs7566279	0.870537988709432	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs62114494	rs3791221	0.868822737615069	Blood urea nitrogen levels	2e-07	31152163
rs62114494	rs3791221	0.868822737615069	Estimated glomerular filtration rate	2e-10	31152163
rs62114494	rs3791221	0.868822737615069	Estimated glomerular filtration rate	1e-11	31152163
rs62114494	rs3791221	0.868822737615069	Blood urea nitrogen levels	7e-26	34594039
rs62114494	rs11553746	0.854757940609663	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs62114494	rs11553746	0.854757940609663	High density lipoprotein cholesterol levels	2e-07	29083408
rs62114494	rs11553746	0.854757940609663	High density lipoprotein cholesterol levels	7e-15	29083408
rs62114494	rs11553746	0.854757940609663	Large artery stroke	4e-06	28265093
rs62114494	rs114976176	0.832012015062966	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs62114494	rs62114548	0.81360867439674	Retinal vascular fractal density	2e-09	34743558
rs62114494	rs59937473	0.804853945264801	Protein quantitative trait loci	3e-67	32492067
rs62114494	rs59937473	0.804853945264801	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs62114494	rs17714252	0.797140397211549	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs62114494	rs17714252	0.797140397211549	Retinal vascular fractal dimension	2e-07	34743558
rs62114494	rs7601944	0.796343372655907	Smoking initiation	4e-15	36477530
rs62114494	rs79154857	0.788260486825197	Pulse pressure	5e-08	34594039
rs62114494	rs55753056	0.787649464965185	Height	2e-22	30595370
rs62114494	rs62114538	0.748779100303977	Triglyceride levels	6e-12	34887591
rs62114494	rs17713879	0.745911595047498	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs62114494	rs17713879	0.745911595047498	Smoking initiation	1e-10	36477530
rs62114494	rs17713879	0.745911595047498	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs62114494	rs17713879	0.745911595047498	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs62114494	rs17713879	0.745911595047498	Triglyceride levels	3e-10	34887591
rs62114494	rs17713879	0.745911595047498	Aging (eyeAgeAcceleration)	6e-50	36975205
rs62114494	rs62114506	0.74446934961184	Gamma glutamyl transpeptidase	3e-14	34594039
rs62114494	rs62114506	0.74446934961184	Apolipoprotein A1 levels	3e-10	32203549
rs62114494	rs62114506	0.74446934961184	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs62114494	rs62114506	0.74446934961184	HDL cholesterol levels	8e-10	36333282
rs62114494	rs60843830	0.737831055192239	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs62114494	rs60843830	0.737831055192239	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs62114494	rs60843830	0.737831055192239	Adventurousness	7e-10	30643258
rs62114497	rs11553746	0.919475878586806	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs62114497	rs11553746	0.919475878586806	High density lipoprotein cholesterol levels	2e-07	29083408
rs62114497	rs11553746	0.919475878586806	High density lipoprotein cholesterol levels	7e-15	29083408
rs62114497	rs11553746	0.919475878586806	Large artery stroke	4e-06	28265093
rs62114497	rs2290911	0.894112177689187	Height	5e-07	29782485
rs62114497	rs2290911	0.894112177689187	Large artery stroke	6e-06	28265093
rs62114497	rs2290911	0.894112177689187	Height	8e-112	36224396
rs62114497	rs2126129	0.891554254158471	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs62114497	rs62114548	0.868432888270414	Retinal vascular fractal density	2e-09	34743558
rs62114497	rs17713396	0.863372152706578	Blood urea nitrogen levels	3e-21	34272381
rs62114497	rs17713396	0.863372152706578	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs62114497	rs17713396	0.863372152706578	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs62114497	rs6710091	0.861416565836132	Waist circumference adjusted for body mass index	8e-11	31669095
rs62114497	rs6710091	0.861416565836132	HDL cholesterol	5e-08	30275531
rs62114497	rs6710091	0.861416565836132	High density lipoprotein cholesterol levels	3e-24	34887591
rs62114497	rs7595075	0.845851692570751	Waist circumference adjusted for body mass index	2e-09	34021172
rs62114497	rs7595075	0.845851692570751	HDL cholesterol	3e-11	34594039
rs62114497	rs7595075	0.845851692570751	HDL cholesterol levels	6e-13	32203549
rs62114497	rs17713729	0.845139580889595	Body mass index	2e-09	31669095
rs62114497	rs17713729	0.845139580889595	Serum creatinine levels	4e-14	34594039
rs62114497	rs17713729	0.845139580889595	High density lipoprotein cholesterol levels	7e-17	34887591
rs62114497	rs79716074	0.841812921333816	Plateletcrit	1e-09	32888494
rs62114497	rs79716074	0.841812921333816	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs62114497	rs79716074	0.841812921333816	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs62114497	rs79716074	0.841812921333816	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs62114497	rs58461606	0.83639227537977	Blood protein levels	0	30072576
rs62114497	rs7605824	0.82922620091567	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs62114497	rs7566279	0.828360895366818	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs62114497	rs3791221	0.827691640849235	Blood urea nitrogen levels	2e-07	31152163
rs62114497	rs3791221	0.827691640849235	Estimated glomerular filtration rate	2e-10	31152163
rs62114497	rs3791221	0.827691640849235	Estimated glomerular filtration rate	1e-11	31152163
rs62114497	rs3791221	0.827691640849235	Blood urea nitrogen levels	7e-26	34594039
rs62114497	rs62114506	0.80285749791943	Gamma glutamyl transpeptidase	3e-14	34594039
rs62114497	rs62114506	0.80285749791943	Apolipoprotein A1 levels	3e-10	32203549
rs62114497	rs62114506	0.80285749791943	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs62114497	rs62114506	0.80285749791943	HDL cholesterol levels	8e-10	36333282
rs62114497	rs17713879	0.794929631343671	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs62114497	rs17713879	0.794929631343671	Smoking initiation	1e-10	36477530
rs62114497	rs17713879	0.794929631343671	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs62114497	rs17713879	0.794929631343671	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs62114497	rs17713879	0.794929631343671	Triglyceride levels	3e-10	34887591
rs62114497	rs17713879	0.794929631343671	Aging (eyeAgeAcceleration)	6e-50	36975205
rs62114497	rs114976176	0.789913668668812	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs62114497	rs59937473	0.766240991729819	Protein quantitative trait loci	3e-67	32492067
rs62114497	rs59937473	0.766240991729819	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs62114497	rs17714252	0.762101808269494	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs62114497	rs17714252	0.762101808269494	Retinal vascular fractal dimension	2e-07	34743558
rs62114497	rs7601944	0.758654046218441	Smoking initiation	4e-15	36477530
rs62114497	rs55753056	0.749925518645347	Height	2e-22	30595370
rs62114497	rs79154857	0.738641283085958	Pulse pressure	5e-08	34594039
rs62114497	rs62114538	0.712481998352653	Triglyceride levels	6e-12	34887591
rs62114497	rs60843830	0.700199413968036	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs62114497	rs60843830	0.700199413968036	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs62114497	rs60843830	0.700199413968036	Adventurousness	7e-10	30643258
rs62114501	rs11553746	0.977351148880735	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs62114501	rs11553746	0.977351148880735	High density lipoprotein cholesterol levels	2e-07	29083408
rs62114501	rs11553746	0.977351148880735	High density lipoprotein cholesterol levels	7e-15	29083408
rs62114501	rs11553746	0.977351148880735	Large artery stroke	4e-06	28265093
rs62114501	rs2290911	0.935987823389652	Height	5e-07	29782485
rs62114501	rs2290911	0.935987823389652	Large artery stroke	6e-06	28265093
rs62114501	rs2290911	0.935987823389652	Height	8e-112	36224396
rs62114501	rs62114548	0.899604136587972	Retinal vascular fractal density	2e-09	34743558
rs62114501	rs17713396	0.894196811683899	Blood urea nitrogen levels	3e-21	34272381
rs62114501	rs17713396	0.894196811683899	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs62114501	rs17713396	0.894196811683899	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs62114501	rs6710091	0.892201639284981	Waist circumference adjusted for body mass index	8e-11	31669095
rs62114501	rs6710091	0.892201639284981	HDL cholesterol	5e-08	30275531
rs62114501	rs6710091	0.892201639284981	High density lipoprotein cholesterol levels	3e-24	34887591
rs62114501	rs7595075	0.876320480555687	Waist circumference adjusted for body mass index	2e-09	34021172
rs62114501	rs7595075	0.876320480555687	HDL cholesterol	3e-11	34594039
rs62114501	rs7595075	0.876320480555687	HDL cholesterol levels	6e-13	32203549
rs62114501	rs17713729	0.875585360756103	Body mass index	2e-09	31669095
rs62114501	rs17713729	0.875585360756103	Serum creatinine levels	4e-14	34594039
rs62114501	rs17713729	0.875585360756103	High density lipoprotein cholesterol levels	7e-17	34887591
rs62114501	rs79716074	0.872204969361569	Plateletcrit	1e-09	32888494
rs62114501	rs79716074	0.872204969361569	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs62114501	rs79716074	0.872204969361569	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs62114501	rs79716074	0.872204969361569	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs62114501	rs58461606	0.866631723370344	Blood protein levels	0	30072576
rs62114501	rs7605824	0.861286791492028	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs62114501	rs7566279	0.86039949930906	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs62114501	rs3791221	0.857680123466818	Blood urea nitrogen levels	2e-07	31152163
rs62114501	rs3791221	0.857680123466818	Estimated glomerular filtration rate	2e-10	31152163
rs62114501	rs3791221	0.857680123466818	Estimated glomerular filtration rate	1e-11	31152163
rs62114501	rs3791221	0.857680123466818	Blood urea nitrogen levels	7e-26	34594039
rs62114501	rs62114506	0.843632280398713	Gamma glutamyl transpeptidase	3e-14	34594039
rs62114501	rs62114506	0.843632280398713	Apolipoprotein A1 levels	3e-10	32203549
rs62114501	rs62114506	0.843632280398713	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs62114501	rs62114506	0.843632280398713	HDL cholesterol levels	8e-10	36333282
rs62114501	rs2126129	0.841332741732692	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs62114501	rs17713879	0.824239129209038	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs62114501	rs17713879	0.824239129209038	Smoking initiation	1e-10	36477530
rs62114501	rs17713879	0.824239129209038	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs62114501	rs17713879	0.824239129209038	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs62114501	rs17713879	0.824239129209038	Triglyceride levels	3e-10	34887591
rs62114501	rs17713879	0.824239129209038	Aging (eyeAgeAcceleration)	6e-50	36975205
rs62114501	rs114976176	0.819087841532458	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs62114501	rs59937473	0.794825229179581	Protein quantitative trait loci	3e-67	32492067
rs62114501	rs59937473	0.794825229179581	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs62114501	rs17714252	0.792444975942018	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs62114501	rs17714252	0.792444975942018	Retinal vascular fractal dimension	2e-07	34743558
rs62114501	rs7601944	0.787024269768822	Smoking initiation	4e-15	36477530
rs62114501	rs55753056	0.778120349360423	Height	2e-22	30595370
rs62114501	rs79154857	0.767303887798979	Pulse pressure	5e-08	34594039
rs62114501	rs62114538	0.739819106766143	Triglyceride levels	6e-12	34887591
rs62114501	rs60843830	0.729276893947973	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs62114501	rs60843830	0.729276893947973	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs62114501	rs60843830	0.729276893947973	Adventurousness	7e-10	30643258
rs62114505	rs2290911	0.995805869623455	Height	5e-07	29782485
rs62114505	rs2290911	0.995805869623455	Large artery stroke	6e-06	28265093
rs62114505	rs2290911	0.995805869623455	Height	8e-112	36224396
rs62114505	rs17713396	0.951296204883857	Blood urea nitrogen levels	3e-21	34272381
rs62114505	rs17713396	0.951296204883857	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs62114505	rs17713396	0.951296204883857	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs62114505	rs6710091	0.951296204883857	Waist circumference adjusted for body mass index	8e-11	31669095
rs62114505	rs6710091	0.951296204883857	HDL cholesterol	5e-08	30275531
rs62114505	rs6710091	0.951296204883857	High density lipoprotein cholesterol levels	3e-24	34887591
rs62114505	rs7595075	0.933156773039156	Waist circumference adjusted for body mass index	2e-09	34021172
rs62114505	rs7595075	0.933156773039156	HDL cholesterol	3e-11	34594039
rs62114505	rs7595075	0.933156773039156	HDL cholesterol levels	6e-13	32203549
rs62114505	rs17713729	0.932272934045243	Body mass index	2e-09	31669095
rs62114505	rs17713729	0.932272934045243	Serum creatinine levels	4e-14	34594039
rs62114505	rs17713729	0.932272934045243	High density lipoprotein cholesterol levels	7e-17	34887591
rs62114505	rs79716074	0.929071345012972	Plateletcrit	1e-09	32888494
rs62114505	rs79716074	0.929071345012972	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs62114505	rs79716074	0.929071345012972	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs62114505	rs79716074	0.929071345012972	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs62114505	rs58461606	0.92273092997089	Blood protein levels	0	30072576
rs62114505	rs11553746	0.918506756272095	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs62114505	rs11553746	0.918506756272095	High density lipoprotein cholesterol levels	2e-07	29083408
rs62114505	rs11553746	0.918506756272095	High density lipoprotein cholesterol levels	7e-15	29083408
rs62114505	rs11553746	0.918506756272095	Large artery stroke	4e-06	28265093
rs62114505	rs7605824	0.917531659818363	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs62114505	rs7566279	0.914603158458187	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs62114505	rs3791221	0.912403978093752	Blood urea nitrogen levels	2e-07	31152163
rs62114505	rs3791221	0.912403978093752	Estimated glomerular filtration rate	2e-10	31152163
rs62114505	rs3791221	0.912403978093752	Estimated glomerular filtration rate	1e-11	31152163
rs62114505	rs3791221	0.912403978093752	Blood urea nitrogen levels	7e-26	34594039
rs62114505	rs2126129	0.898540154575427	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs62114505	rs114976176	0.87455427097516	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs62114505	rs62114548	0.857569457141098	Retinal vascular fractal density	2e-09	34743558
rs62114505	rs59937473	0.846205863771949	Protein quantitative trait loci	3e-67	32492067
rs62114505	rs59937473	0.846205863771949	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs62114505	rs17714252	0.838358734315244	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs62114505	rs17714252	0.838358734315244	Retinal vascular fractal dimension	2e-07	34743558
rs62114505	rs7601944	0.837151716821007	Smoking initiation	4e-15	36477530
rs62114505	rs55753056	0.830150756260034	Height	2e-22	30595370
rs62114505	rs79154857	0.813004624259726	Pulse pressure	5e-08	34594039
rs62114505	rs62114506	0.809014094840204	Gamma glutamyl transpeptidase	3e-14	34594039
rs62114505	rs62114506	0.809014094840204	Apolipoprotein A1 levels	3e-10	32203549
rs62114505	rs62114506	0.809014094840204	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs62114505	rs62114506	0.809014094840204	HDL cholesterol levels	8e-10	36333282
rs62114505	rs62114538	0.788120941998057	Triglyceride levels	6e-12	34887591
rs62114505	rs17713879	0.782895392617153	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs62114505	rs17713879	0.782895392617153	Smoking initiation	1e-10	36477530
rs62114505	rs17713879	0.782895392617153	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs62114505	rs17713879	0.782895392617153	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs62114505	rs17713879	0.782895392617153	Triglyceride levels	3e-10	34887591
rs62114505	rs17713879	0.782895392617153	Aging (eyeAgeAcceleration)	6e-50	36975205
rs62114505	rs60843830	0.776453984015556	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs62114505	rs60843830	0.776453984015556	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs62114505	rs60843830	0.776453984015556	Adventurousness	7e-10	30643258
rs62114506	rs62114506	1	Gamma glutamyl transpeptidase	3e-14	34594039
rs62114506	rs62114506	1	Apolipoprotein A1 levels	3e-10	32203549
rs62114506	rs62114506	1	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs62114506	rs62114506	1	HDL cholesterol levels	8e-10	36333282
rs62114506	rs11553746	0.826254986349496	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs62114506	rs11553746	0.826254986349496	High density lipoprotein cholesterol levels	2e-07	29083408
rs62114506	rs11553746	0.826254986349496	High density lipoprotein cholesterol levels	7e-15	29083408
rs62114506	rs11553746	0.826254986349496	Large artery stroke	4e-06	28265093
rs62114506	rs2290911	0.807022715452728	Height	5e-07	29782485
rs62114506	rs2290911	0.807022715452728	Large artery stroke	6e-06	28265093
rs62114506	rs2290911	0.807022715452728	Height	8e-112	36224396
rs62114506	rs17713396	0.770899000063918	Blood urea nitrogen levels	3e-21	34272381
rs62114506	rs17713396	0.770899000063918	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs62114506	rs17713396	0.770899000063918	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs62114506	rs6710091	0.770899000063918	Waist circumference adjusted for body mass index	8e-11	31669095
rs62114506	rs6710091	0.770899000063918	HDL cholesterol	5e-08	30275531
rs62114506	rs6710091	0.770899000063918	High density lipoprotein cholesterol levels	3e-24	34887591
rs62114506	rs62114548	0.76889130207956	Retinal vascular fractal density	2e-09	34743558
rs62114506	rs7595075	0.753681119053721	Waist circumference adjusted for body mass index	2e-09	34021172
rs62114506	rs7595075	0.753681119053721	HDL cholesterol	3e-11	34594039
rs62114506	rs7595075	0.753681119053721	HDL cholesterol levels	6e-13	32203549
rs62114506	rs17713729	0.753243615000402	Body mass index	2e-09	31669095
rs62114506	rs17713729	0.753243615000402	Serum creatinine levels	4e-14	34594039
rs62114506	rs17713729	0.753243615000402	High density lipoprotein cholesterol levels	7e-17	34887591
rs62114506	rs79716074	0.749540036699701	Plateletcrit	1e-09	32888494
rs62114506	rs79716074	0.749540036699701	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs62114506	rs79716074	0.749540036699701	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs62114506	rs79716074	0.749540036699701	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs62114506	rs58461606	0.745516159996788	Blood protein levels	0	30072576
rs62114506	rs3791221	0.739334359767701	Blood urea nitrogen levels	2e-07	31152163
rs62114506	rs3791221	0.739334359767701	Estimated glomerular filtration rate	2e-10	31152163
rs62114506	rs3791221	0.739334359767701	Estimated glomerular filtration rate	1e-11	31152163
rs62114506	rs3791221	0.739334359767701	Blood urea nitrogen levels	7e-26	34594039
rs62114506	rs7605824	0.738049269459168	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs62114506	rs7566279	0.73728566231881	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs62114506	rs2126129	0.718263033693867	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs62114506	rs17713879	0.718219522185062	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs62114506	rs17713879	0.718219522185062	Smoking initiation	1e-10	36477530
rs62114506	rs17713879	0.718219522185062	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs62114506	rs17713879	0.718219522185062	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs62114506	rs17713879	0.718219522185062	Triglyceride levels	3e-10	34887591
rs62114506	rs17713879	0.718219522185062	Aging (eyeAgeAcceleration)	6e-50	36975205
rs62114506	rs114976176	0.705172419689713	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs62114506	rs59937473	0.683543483855114	Protein quantitative trait loci	3e-67	32492067
rs62114506	rs59937473	0.683543483855114	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs62114506	rs17714252	0.679171887814835	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs62114506	rs17714252	0.679171887814835	Retinal vascular fractal dimension	2e-07	34743558
rs62114506	rs7601944	0.678260199832923	Smoking initiation	4e-15	36477530
rs62114506	rs55753056	0.671051850876355	Height	2e-22	30595370
rs62114506	rs79154857	0.649824233130282	Pulse pressure	5e-08	34594039
rs62114506	rs62114538	0.645187261671091	Triglyceride levels	6e-12	34887591
rs62114506	rs60843830	0.616185395029572	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs62114506	rs60843830	0.616185395029572	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs62114506	rs60843830	0.616185395029572	Adventurousness	7e-10	30643258
rs62114538	rs62114538	1	Triglyceride levels	6e-12	34887591
rs62114538	rs59937473	0.931225477105573	Protein quantitative trait loci	3e-67	32492067
rs62114538	rs59937473	0.931225477105573	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs62114538	rs17714252	0.921933407185393	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs62114538	rs17714252	0.921933407185393	Retinal vascular fractal dimension	2e-07	34743558
rs62114538	rs55753056	0.897823032194472	Height	2e-22	30595370
rs62114538	rs114976176	0.891083533403396	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs62114538	rs7601944	0.889648139949407	Smoking initiation	4e-15	36477530
rs62114538	rs60843830	0.865668272348357	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs62114538	rs60843830	0.865668272348357	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs62114538	rs60843830	0.865668272348357	Adventurousness	7e-10	30643258
rs62114538	rs58461606	0.853664455271958	Blood protein levels	0	30072576
rs62114538	rs7566279	0.850145369755988	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs62114538	rs17713729	0.841239949634886	Body mass index	2e-09	31669095
rs62114538	rs17713729	0.841239949634886	Serum creatinine levels	4e-14	34594039
rs62114538	rs17713729	0.841239949634886	High density lipoprotein cholesterol levels	7e-17	34887591
rs62114538	rs17713879	0.841143060821282	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs62114538	rs17713879	0.841143060821282	Smoking initiation	1e-10	36477530
rs62114538	rs17713879	0.841143060821282	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs62114538	rs17713879	0.841143060821282	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs62114538	rs17713879	0.841143060821282	Triglyceride levels	3e-10	34887591
rs62114538	rs17713879	0.841143060821282	Aging (eyeAgeAcceleration)	6e-50	36975205
rs62114538	rs7595075	0.840435350239468	Waist circumference adjusted for body mass index	2e-09	34021172
rs62114538	rs7595075	0.840435350239468	HDL cholesterol	3e-11	34594039
rs62114538	rs7595075	0.840435350239468	HDL cholesterol levels	6e-13	32203549
rs62114538	rs79716074	0.836871211657686	Plateletcrit	1e-09	32888494
rs62114538	rs79716074	0.836871211657686	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs62114538	rs79716074	0.836871211657686	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs62114538	rs79716074	0.836871211657686	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs62114538	rs17713396	0.827750218333053	Blood urea nitrogen levels	3e-21	34272381
rs62114538	rs17713396	0.827750218333053	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs62114538	rs17713396	0.827750218333053	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs62114538	rs6710091	0.825945931001907	Waist circumference adjusted for body mass index	8e-11	31669095
rs62114538	rs6710091	0.825945931001907	HDL cholesterol	5e-08	30275531
rs62114538	rs6710091	0.825945931001907	High density lipoprotein cholesterol levels	3e-24	34887591
rs62114538	rs7605824	0.823908017511588	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs62114538	rs3791221	0.813455829508995	Blood urea nitrogen levels	2e-07	31152163
rs62114538	rs3791221	0.813455829508995	Estimated glomerular filtration rate	2e-10	31152163
rs62114538	rs3791221	0.813455829508995	Estimated glomerular filtration rate	1e-11	31152163
rs62114538	rs3791221	0.813455829508995	Blood urea nitrogen levels	7e-26	34594039
rs62114538	rs2290911	0.788120941998057	Height	5e-07	29782485
rs62114538	rs2290911	0.788120941998057	Large artery stroke	6e-06	28265093
rs62114538	rs2290911	0.788120941998057	Height	8e-112	36224396
rs62114538	rs2126129	0.780206397620172	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs62114538	rs11553746	0.752976898733998	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs62114538	rs11553746	0.752976898733998	High density lipoprotein cholesterol levels	2e-07	29083408
rs62114538	rs11553746	0.752976898733998	High density lipoprotein cholesterol levels	7e-15	29083408
rs62114538	rs11553746	0.752976898733998	Large artery stroke	4e-06	28265093
rs62114538	rs62114548	0.733191210922654	Retinal vascular fractal density	2e-09	34743558
rs62114538	rs79154857	0.691980121156076	Pulse pressure	5e-08	34594039
rs62114538	rs62114506	0.645187261671091	Gamma glutamyl transpeptidase	3e-14	34594039
rs62114538	rs62114506	0.645187261671091	Apolipoprotein A1 levels	3e-10	32203549
rs62114538	rs62114506	0.645187261671091	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs62114538	rs62114506	0.645187261671091	HDL cholesterol levels	8e-10	36333282
rs62114544	rs2290911	0.969882806040876	Height	5e-07	29782485
rs62114544	rs2290911	0.969882806040876	Large artery stroke	6e-06	28265093
rs62114544	rs2290911	0.969882806040876	Height	8e-112	36224396
rs62114544	rs7595075	0.958304077129677	Waist circumference adjusted for body mass index	2e-09	34021172
rs62114544	rs7595075	0.958304077129677	HDL cholesterol	3e-11	34594039
rs62114544	rs7595075	0.958304077129677	HDL cholesterol levels	6e-13	32203549
rs62114544	rs79716074	0.956220678776163	Plateletcrit	1e-09	32888494
rs62114544	rs79716074	0.956220678776163	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs62114544	rs79716074	0.956220678776163	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs62114544	rs79716074	0.956220678776163	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs62114544	rs17713729	0.953331300076239	Body mass index	2e-09	31669095
rs62114544	rs17713729	0.953331300076239	Serum creatinine levels	4e-14	34594039
rs62114544	rs17713729	0.953331300076239	High density lipoprotein cholesterol levels	7e-17	34887591
rs62114544	rs58461606	0.949635133496508	Blood protein levels	0	30072576
rs62114544	rs17713396	0.944160782754183	Blood urea nitrogen levels	3e-21	34272381
rs62114544	rs17713396	0.944160782754183	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs62114544	rs17713396	0.944160782754183	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs62114544	rs7605824	0.942419677538781	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs62114544	rs6710091	0.942148895431834	Waist circumference adjusted for body mass index	8e-11	31669095
rs62114544	rs6710091	0.942148895431834	HDL cholesterol	5e-08	30275531
rs62114544	rs6710091	0.942148895431834	High density lipoprotein cholesterol levels	3e-24	34887591
rs62114544	rs7566279	0.941452546460631	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs62114544	rs11553746	0.928213849880046	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs62114544	rs11553746	0.928213849880046	High density lipoprotein cholesterol levels	2e-07	29083408
rs62114544	rs11553746	0.928213849880046	High density lipoprotein cholesterol levels	7e-15	29083408
rs62114544	rs11553746	0.928213849880046	Large artery stroke	4e-06	28265093
rs62114544	rs3791221	0.905386292507204	Blood urea nitrogen levels	2e-07	31152163
rs62114544	rs3791221	0.905386292507204	Estimated glomerular filtration rate	2e-10	31152163
rs62114544	rs3791221	0.905386292507204	Estimated glomerular filtration rate	1e-11	31152163
rs62114544	rs3791221	0.905386292507204	Blood urea nitrogen levels	7e-26	34594039
rs62114544	rs114976176	0.896543204170851	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs62114544	rs2126129	0.8917819147971	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs62114544	rs62114548	0.884667725937179	Retinal vascular fractal density	2e-09	34743558
rs62114544	rs59937473	0.871285097762097	Protein quantitative trait loci	3e-67	32492067
rs62114544	rs59937473	0.871285097762097	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs62114544	rs17714252	0.863378720069326	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs62114544	rs17714252	0.863378720069326	Retinal vascular fractal dimension	2e-07	34743558
rs62114544	rs55753056	0.839961979774189	Height	2e-22	30595370
rs62114544	rs79154857	0.838244220111899	Pulse pressure	5e-08	34594039
rs62114544	rs7601944	0.832197737613402	Smoking initiation	4e-15	36477530
rs62114544	rs62114538	0.810132872340946	Triglyceride levels	6e-12	34887591
rs62114544	rs17713879	0.805870977725149	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs62114544	rs17713879	0.805870977725149	Smoking initiation	1e-10	36477530
rs62114544	rs17713879	0.805870977725149	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs62114544	rs17713879	0.805870977725149	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs62114544	rs17713879	0.805870977725149	Triglyceride levels	3e-10	34887591
rs62114544	rs17713879	0.805870977725149	Aging (eyeAgeAcceleration)	6e-50	36975205
rs62114544	rs60843830	0.801195335019932	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs62114544	rs60843830	0.801195335019932	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs62114544	rs60843830	0.801195335019932	Adventurousness	7e-10	30643258
rs62114544	rs62114506	0.783701441629483	Gamma glutamyl transpeptidase	3e-14	34594039
rs62114544	rs62114506	0.783701441629483	Apolipoprotein A1 levels	3e-10	32203549
rs62114544	rs62114506	0.783701441629483	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs62114544	rs62114506	0.783701441629483	HDL cholesterol levels	8e-10	36333282
rs62114548	rs62114548	1	Retinal vascular fractal density	2e-09	34743558
rs62114548	rs11553746	0.921171758259597	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs62114548	rs11553746	0.921171758259597	High density lipoprotein cholesterol levels	2e-07	29083408
rs62114548	rs11553746	0.921171758259597	High density lipoprotein cholesterol levels	7e-15	29083408
rs62114548	rs11553746	0.921171758259597	Large artery stroke	4e-06	28265093
rs62114548	rs79716074	0.867915061701594	Plateletcrit	1e-09	32888494
rs62114548	rs79716074	0.867915061701594	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs62114548	rs79716074	0.867915061701594	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs62114548	rs79716074	0.867915061701594	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs62114548	rs17713729	0.865340097228133	Body mass index	2e-09	31669095
rs62114548	rs17713729	0.865340097228133	Serum creatinine levels	4e-14	34594039
rs62114548	rs17713729	0.865340097228133	High density lipoprotein cholesterol levels	7e-17	34887591
rs62114548	rs7595075	0.862209946089467	Waist circumference adjusted for body mass index	2e-09	34021172
rs62114548	rs7595075	0.862209946089467	HDL cholesterol	3e-11	34594039
rs62114548	rs7595075	0.862209946089467	HDL cholesterol levels	6e-13	32203549
rs62114548	rs2290911	0.857569457141098	Height	5e-07	29782485
rs62114548	rs2290911	0.857569457141098	Large artery stroke	6e-06	28265093
rs62114548	rs2290911	0.857569457141098	Height	8e-112	36224396
rs62114548	rs7605824	0.856972777986691	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs62114548	rs58461606	0.85445574075844	Blood protein levels	0	30072576
rs62114548	rs7566279	0.854148958731259	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs62114548	rs17713396	0.848653788157476	Blood urea nitrogen levels	3e-21	34272381
rs62114548	rs17713396	0.848653788157476	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs62114548	rs17713396	0.848653788157476	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs62114548	rs6710091	0.846725962732625	Waist circumference adjusted for body mass index	8e-11	31669095
rs62114548	rs6710091	0.846725962732625	HDL cholesterol	5e-08	30275531
rs62114548	rs6710091	0.846725962732625	High density lipoprotein cholesterol levels	3e-24	34887591
rs62114548	rs3791221	0.81320546481105	Blood urea nitrogen levels	2e-07	31152163
rs62114548	rs3791221	0.81320546481105	Estimated glomerular filtration rate	2e-10	31152163
rs62114548	rs3791221	0.81320546481105	Estimated glomerular filtration rate	1e-11	31152163
rs62114548	rs3791221	0.81320546481105	Blood urea nitrogen levels	7e-26	34594039
rs62114548	rs17713879	0.812367459814487	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs62114548	rs17713879	0.812367459814487	Smoking initiation	1e-10	36477530
rs62114548	rs17713879	0.812367459814487	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs62114548	rs17713879	0.812367459814487	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs62114548	rs17713879	0.812367459814487	Triglyceride levels	3e-10	34887591
rs62114548	rs17713879	0.812367459814487	Aging (eyeAgeAcceleration)	6e-50	36975205
rs62114548	rs114976176	0.805289840211442	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs62114548	rs2126129	0.797666527561014	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs62114548	rs59937473	0.782766585110263	Protein quantitative trait loci	3e-67	32492067
rs62114548	rs59937473	0.782766585110263	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs62114548	rs17714252	0.778658572641777	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs62114548	rs17714252	0.778658572641777	Retinal vascular fractal dimension	2e-07	34743558
rs62114548	rs62114506	0.76889130207956	Gamma glutamyl transpeptidase	3e-14	34594039
rs62114548	rs62114506	0.76889130207956	Apolipoprotein A1 levels	3e-10	32203549
rs62114548	rs62114506	0.76889130207956	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs62114548	rs62114506	0.76889130207956	HDL cholesterol levels	8e-10	36333282
rs62114548	rs79154857	0.767854308708141	Pulse pressure	5e-08	34594039
rs62114548	rs55753056	0.75363271021339	Height	2e-22	30595370
rs62114548	rs7601944	0.746375202502089	Smoking initiation	4e-15	36477530
rs62114548	rs62114538	0.733191210922654	Triglyceride levels	6e-12	34887591
rs62114548	rs60843830	0.724153234499926	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs62114548	rs60843830	0.724153234499926	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs62114548	rs60843830	0.724153234499926	Adventurousness	7e-10	30643258
rs62166774	rs58588820	0.991228469800775	Total cholesterol levels	1e-09	34887591
rs62166774	rs58588820	0.991228469800775	Total cholesterol levels	8e-11	34887591
rs62166774	rs6547629	0.889099071809316	Height	3e-09	36224396
rs62166774	rs10206961	0.627505344214983	Parental longevity (father's age at death)	2e-06	31484785
rs62203668	rs3732055	0.933904550200725	Citrulline levels	1e-10	36635386
rs62203668	rs3732055	0.933904550200725	Gamma-glutamylcitrulline levels	1e-10	36635386
rs62203668	rs3856349	0.876425006738301	LanC-like protein 1 levels	5e-22	34648354
rs62258080	rs4681679	0.992032487623277	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62258080	rs11719450	0.962967506584444	Hemoglobin concentration	2e-09	27863252
rs62258080	rs11719450	0.962967506584444	Hemoglobin levels	2e-16	32327693
rs62258080	rs56384862	0.949862825433659	Body mass index	8e-12	29273807
rs62258080	rs56384862	0.949862825433659	Body mass index	3e-06	30108127
rs62258080	rs56384862	0.949862825433659	Hemoglobin levels	1e-16	32327693
rs62258080	rs56384862	0.949862825433659	Body mass index	3e-14	36581621
rs62258080	rs7610312	0.897370995288432	Red blood cell count	5e-09	27863252
rs62258080	rs6775517	0.896457241860952	Hematocrit	1e-17	34594039
rs62258080	rs57700771	0.890975717320469	Red blood cell count	9e-21	30595370
rs62258080	rs11705721	0.878892995470518	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62258080	rs11130638	0.878892995470518	Hemoglobin concentration	2e-23	32888493
rs62258080	rs34579268	0.872447361277141	Hematocrit	5e-30	32888493
rs62258080	rs34579268	0.872447361277141	Hematocrit	2e-27	32888493
rs62258080	rs34579268	0.872447361277141	Hemoglobin concentration	5e-26	32888493
rs62258080	rs55692656	0.840308459402013	vWF levels	3e-08	30586737
rs62258080	rs55692656	0.840308459402013	vWF levels	6e-09	30586737
rs62258080	rs55704295	0.818055969257026	Red blood cell count	8e-26	32888493
rs62258080	rs55704295	0.818055969257026	Red blood cell count	5e-23	32888493
rs62258080	rs55704295	0.818055969257026	Serum total protein level	2e-29	34594039
rs62258080	rs11922478	0.796707967840934	Semaphorin-6B levels	4e-12	34648354
rs62258080	rs6445969	0.780007676917409	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62258080	rs11708895	0.775388393175908	Red blood cell count	1e-20	32888494
rs62258080	rs55954186	0.770499092026061	vWF levels	5e-09	30586737
rs62258080	rs55954186	0.770499092026061	vWF levels	9e-09	30586737
rs62258080	rs7431952	0.700686666573679	Hemoglobin levels	1e-12	32327693
rs62258080	rs9311676	0.640346899280251	Systemic lupus erythematosus	5e-06	27399966
rs62258080	rs9311676	0.640346899280251	Systemic lupus erythematosus	3e-14	26502338
rs62258080	rs9311676	0.640346899280251	Waist circumference adjusted for body mass index	3e-08	34021172
rs62258080	rs9822855	0.625496938444291	Educational attainment	9e-120	35361970
rs62258081	rs7610312	0.996264814125615	Red blood cell count	5e-09	27863252
rs62258081	rs6775517	0.99502789361999	Hematocrit	1e-17	34594039
rs62258081	rs57700771	0.990049051798856	Red blood cell count	9e-21	30595370
rs62258081	rs11705721	0.975522577534433	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62258081	rs11130638	0.973079277493584	Hemoglobin concentration	2e-23	32888493
rs62258081	rs34579268	0.965935587224752	Hematocrit	5e-30	32888493
rs62258081	rs34579268	0.965935587224752	Hematocrit	2e-27	32888493
rs62258081	rs34579268	0.965935587224752	Hemoglobin concentration	5e-26	32888493
rs62258081	rs55704295	0.921481065753948	Red blood cell count	8e-26	32888493
rs62258081	rs55704295	0.921481065753948	Red blood cell count	5e-23	32888493
rs62258081	rs55704295	0.921481065753948	Serum total protein level	2e-29	34594039
rs62258081	rs4681679	0.891383594383988	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62258081	rs11719450	0.865019998187266	Hemoglobin concentration	2e-09	27863252
rs62258081	rs11719450	0.865019998187266	Hemoglobin levels	2e-16	32327693
rs62258081	rs56384862	0.853536143954891	Body mass index	8e-12	29273807
rs62258081	rs56384862	0.853536143954891	Body mass index	3e-06	30108127
rs62258081	rs56384862	0.853536143954891	Hemoglobin levels	1e-16	32327693
rs62258081	rs56384862	0.853536143954891	Body mass index	3e-14	36581621
rs62258081	rs11922478	0.85085425597871	Semaphorin-6B levels	4e-12	34648354
rs62258081	rs55692656	0.83397936386423	vWF levels	3e-08	30586737
rs62258081	rs55692656	0.83397936386423	vWF levels	6e-09	30586737
rs62258081	rs6445969	0.700797270192413	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62258081	rs11708895	0.696787955644329	Red blood cell count	1e-20	32888494
rs62258081	rs55954186	0.69239402414515	vWF levels	5e-09	30586737
rs62258081	rs55954186	0.69239402414515	vWF levels	9e-09	30586737
rs62258081	rs7431952	0.629193276057565	Hemoglobin levels	1e-12	32327693
rs62258093	rs7610312	0.996262025068184	Red blood cell count	5e-09	27863252
rs62258093	rs6775517	0.995028828030816	Hematocrit	1e-17	34594039
rs62258093	rs57700771	0.990036982637881	Red blood cell count	9e-21	30595370
rs62258093	rs11705721	0.975533272989242	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62258093	rs11130638	0.973088134374053	Hemoglobin concentration	2e-23	32888493
rs62258093	rs34579268	0.965948032289439	Hematocrit	5e-30	32888493
rs62258093	rs34579268	0.965948032289439	Hematocrit	2e-27	32888493
rs62258093	rs34579268	0.965948032289439	Hemoglobin concentration	5e-26	32888493
rs62258093	rs55704295	0.92132923533695	Red blood cell count	8e-26	32888493
rs62258093	rs55704295	0.92132923533695	Red blood cell count	5e-23	32888493
rs62258093	rs55704295	0.92132923533695	Serum total protein level	2e-29	34594039
rs62258093	rs4681679	0.893612813644655	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62258093	rs11719450	0.867189384980001	Hemoglobin concentration	2e-09	27863252
rs62258093	rs11719450	0.867189384980001	Hemoglobin levels	2e-16	32327693
rs62258093	rs56384862	0.855669632900471	Body mass index	8e-12	29273807
rs62258093	rs56384862	0.855669632900471	Body mass index	3e-06	30108127
rs62258093	rs56384862	0.855669632900471	Hemoglobin levels	1e-16	32327693
rs62258093	rs56384862	0.855669632900471	Body mass index	3e-14	36581621
rs62258093	rs11922478	0.852988244781249	Semaphorin-6B levels	4e-12	34648354
rs62258093	rs55692656	0.833938044592497	vWF levels	3e-08	30586737
rs62258093	rs55692656	0.833938044592497	vWF levels	6e-09	30586737
rs62258093	rs6445969	0.702551659529173	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62258093	rs11708895	0.698528835382625	Red blood cell count	1e-20	32888494
rs62258093	rs55954186	0.694123932201465	vWF levels	5e-09	30586737
rs62258093	rs55954186	0.694123932201465	vWF levels	9e-09	30586737
rs62258093	rs7431952	0.63077674310126	Hemoglobin levels	1e-12	32327693
rs62258094	rs7610312	0.996262025068184	Red blood cell count	5e-09	27863252
rs62258094	rs6775517	0.995028828030816	Hematocrit	1e-17	34594039
rs62258094	rs57700771	0.990036982637881	Red blood cell count	9e-21	30595370
rs62258094	rs11705721	0.975533272989242	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62258094	rs11130638	0.973088134374053	Hemoglobin concentration	2e-23	32888493
rs62258094	rs34579268	0.965948032289439	Hematocrit	5e-30	32888493
rs62258094	rs34579268	0.965948032289439	Hematocrit	2e-27	32888493
rs62258094	rs34579268	0.965948032289439	Hemoglobin concentration	5e-26	32888493
rs62258094	rs55704295	0.92132923533695	Red blood cell count	8e-26	32888493
rs62258094	rs55704295	0.92132923533695	Red blood cell count	5e-23	32888493
rs62258094	rs55704295	0.92132923533695	Serum total protein level	2e-29	34594039
rs62258094	rs4681679	0.893612813644655	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62258094	rs11719450	0.867189384980001	Hemoglobin concentration	2e-09	27863252
rs62258094	rs11719450	0.867189384980001	Hemoglobin levels	2e-16	32327693
rs62258094	rs56384862	0.855669632900471	Body mass index	8e-12	29273807
rs62258094	rs56384862	0.855669632900471	Body mass index	3e-06	30108127
rs62258094	rs56384862	0.855669632900471	Hemoglobin levels	1e-16	32327693
rs62258094	rs56384862	0.855669632900471	Body mass index	3e-14	36581621
rs62258094	rs11922478	0.852988244781249	Semaphorin-6B levels	4e-12	34648354
rs62258094	rs55692656	0.833938044592497	vWF levels	3e-08	30586737
rs62258094	rs55692656	0.833938044592497	vWF levels	6e-09	30586737
rs62258094	rs6445969	0.702551659529173	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62258094	rs11708895	0.698528835382625	Red blood cell count	1e-20	32888494
rs62258094	rs55954186	0.694123932201465	vWF levels	5e-09	30586737
rs62258094	rs55954186	0.694123932201465	vWF levels	9e-09	30586737
rs62258094	rs7431952	0.63077674310126	Hemoglobin levels	1e-12	32327693
rs62258120	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62258120	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs62258120	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs62258120	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs62258120	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs62258120	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs62258120	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs62258120	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs62258120	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs62258120	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs62258120	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs62258120	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62258120	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs62258120	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs62258120	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs62258120	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs62258120	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs62258120	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs62258120	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs62258120	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs62258120	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs62258120	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62258120	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs62258120	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs62258120	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs62258120	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs62258135	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62258135	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs62258135	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs62258135	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs62258135	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs62258135	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs62258135	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs62258135	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs62258135	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs62258135	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs62258135	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs62258135	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62258135	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs62258135	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs62258135	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs62258135	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs62258135	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs62258135	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs62258135	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs62258135	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs62258135	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs62258135	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62258135	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs62258135	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs62258135	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs62258135	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs62258139	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62258139	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs62258139	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs62258139	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs62258139	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs62258139	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs62258139	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs62258139	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs62258139	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs62258139	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs62258139	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs62258139	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62258139	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs62258139	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs62258139	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs62258139	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs62258139	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs62258139	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs62258139	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs62258139	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs62258139	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs62258139	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62258139	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs62258139	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs62258139	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs62258139	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs62258140	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62258140	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs62258140	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs62258140	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs62258140	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs62258140	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs62258140	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs62258140	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs62258140	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs62258140	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs62258140	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs62258140	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62258140	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs62258140	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs62258140	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs62258140	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs62258140	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs62258140	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs62258140	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs62258140	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs62258140	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs62258140	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62258140	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs62258140	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs62258140	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs62258140	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs62259772	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs62259772	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs62259772	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs62259772	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62259772	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs62259772	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs62259772	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs62259772	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs62259772	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs62259772	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs62259772	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs62259772	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62259772	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs62259772	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs62259772	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs62259772	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs62259772	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs62259772	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs62259772	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs62259772	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs62259772	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs62259772	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62259772	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs62259772	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs62259772	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs62259772	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs62259778	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs62259778	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs62259778	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs62259778	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62259778	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs62259778	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs62259778	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs62259778	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs62259778	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs62259778	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs62259778	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs62259778	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62259778	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs62259778	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs62259778	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs62259778	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs62259778	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs62259778	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs62259778	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs62259778	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs62259778	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs62259778	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62259778	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs62259778	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs62259778	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs62259778	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs62259779	rs34579268	0.992664009445447	Hematocrit	5e-30	32888493
rs62259779	rs34579268	0.992664009445447	Hematocrit	2e-27	32888493
rs62259779	rs34579268	0.992664009445447	Hemoglobin concentration	5e-26	32888493
rs62259779	rs11705721	0.985312820227107	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62259779	rs11130638	0.985312820227107	Hemoglobin concentration	2e-23	32888493
rs62259779	rs7610312	0.962179454919699	Red blood cell count	5e-09	27863252
rs62259779	rs6775517	0.960965462381968	Hematocrit	1e-17	34594039
rs62259779	rs57700771	0.956123080965294	Red blood cell count	9e-21	30595370
rs62259779	rs55704295	0.889371381241971	Red blood cell count	8e-26	32888493
rs62259779	rs55704295	0.889371381241971	Red blood cell count	5e-23	32888493
rs62259779	rs55704295	0.889371381241971	Serum total protein level	2e-29	34594039
rs62259779	rs4681679	0.864809523382781	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62259779	rs11719450	0.858011982237588	Hemoglobin concentration	2e-09	27863252
rs62259779	rs11719450	0.858011982237588	Hemoglobin levels	2e-16	32327693
rs62259779	rs11922478	0.84652425886163	Semaphorin-6B levels	4e-12	34648354
rs62259779	rs56384862	0.827932371601615	Body mass index	8e-12	29273807
rs62259779	rs56384862	0.827932371601615	Body mass index	3e-06	30108127
rs62259779	rs56384862	0.827932371601615	Hemoglobin levels	1e-16	32327693
rs62259779	rs56384862	0.827932371601615	Body mass index	3e-14	36581621
rs62259779	rs55692656	0.803801790045693	vWF levels	3e-08	30586737
rs62259779	rs55692656	0.803801790045693	vWF levels	6e-09	30586737
rs62259779	rs6445969	0.681346400856519	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62259779	rs55954186	0.677758199184846	vWF levels	5e-09	30586737
rs62259779	rs55954186	0.677758199184846	vWF levels	9e-09	30586737
rs62259779	rs11708895	0.675177249473708	Red blood cell count	1e-20	32888494
rs62259779	rs7431952	0.611471571851035	Hemoglobin levels	1e-12	32327693
rs62259780	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs62259780	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs62259780	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs62259780	rs11705721	0.982861382781062	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62259780	rs11130638	0.982861382781062	Hemoglobin concentration	2e-23	32888493
rs62259780	rs7610312	0.959694929493922	Red blood cell count	5e-09	27863252
rs62259780	rs6775517	0.958488861290179	Hematocrit	1e-17	34594039
rs62259780	rs57700771	0.953634756001868	Red blood cell count	9e-21	30595370
rs62259780	rs55704295	0.886782901092956	Red blood cell count	8e-26	32888493
rs62259780	rs55704295	0.886782901092956	Red blood cell count	5e-23	32888493
rs62259780	rs55704295	0.886782901092956	Serum total protein level	2e-29	34594039
rs62259780	rs4681679	0.862186045589471	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62259780	rs11719450	0.860125250234298	Hemoglobin concentration	2e-09	27863252
rs62259780	rs11719450	0.860125250234298	Hemoglobin levels	2e-16	32327693
rs62259780	rs11922478	0.848608065358954	Semaphorin-6B levels	4e-12	34648354
rs62259780	rs56384862	0.829973993879152	Body mass index	8e-12	29273807
rs62259780	rs56384862	0.829973993879152	Body mass index	3e-06	30108127
rs62259780	rs56384862	0.829973993879152	Hemoglobin levels	1e-16	32327693
rs62259780	rs56384862	0.829973993879152	Body mass index	3e-14	36581621
rs62259780	rs55692656	0.801540538736439	vWF levels	3e-08	30586737
rs62259780	rs55692656	0.801540538736439	vWF levels	6e-09	30586737
rs62259780	rs6445969	0.683028384594427	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62259780	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs62259780	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs62259780	rs11708895	0.676841762322323	Red blood cell count	1e-20	32888494
rs62259780	rs7431952	0.61298934619404	Hemoglobin levels	1e-12	32327693
rs62259782	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs62259782	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs62259782	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs62259782	rs11705721	0.982861382781062	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62259782	rs11130638	0.982861382781062	Hemoglobin concentration	2e-23	32888493
rs62259782	rs7610312	0.959694929493922	Red blood cell count	5e-09	27863252
rs62259782	rs6775517	0.958488861290179	Hematocrit	1e-17	34594039
rs62259782	rs57700771	0.953634756001868	Red blood cell count	9e-21	30595370
rs62259782	rs55704295	0.886782901092956	Red blood cell count	8e-26	32888493
rs62259782	rs55704295	0.886782901092956	Red blood cell count	5e-23	32888493
rs62259782	rs55704295	0.886782901092956	Serum total protein level	2e-29	34594039
rs62259782	rs4681679	0.862186045589471	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62259782	rs11719450	0.860125250234298	Hemoglobin concentration	2e-09	27863252
rs62259782	rs11719450	0.860125250234298	Hemoglobin levels	2e-16	32327693
rs62259782	rs11922478	0.848608065358954	Semaphorin-6B levels	4e-12	34648354
rs62259782	rs56384862	0.829973993879152	Body mass index	8e-12	29273807
rs62259782	rs56384862	0.829973993879152	Body mass index	3e-06	30108127
rs62259782	rs56384862	0.829973993879152	Hemoglobin levels	1e-16	32327693
rs62259782	rs56384862	0.829973993879152	Body mass index	3e-14	36581621
rs62259782	rs55692656	0.801540538736439	vWF levels	3e-08	30586737
rs62259782	rs55692656	0.801540538736439	vWF levels	6e-09	30586737
rs62259782	rs6445969	0.683028384594427	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62259782	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs62259782	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs62259782	rs11708895	0.676841762322323	Red blood cell count	1e-20	32888494
rs62259782	rs7431952	0.61298934619404	Hemoglobin levels	1e-12	32327693
rs62259783	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs62259783	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs62259783	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs62259783	rs11705721	0.982861382781062	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs62259783	rs11130638	0.982861382781062	Hemoglobin concentration	2e-23	32888493
rs62259783	rs7610312	0.959694929493922	Red blood cell count	5e-09	27863252
rs62259783	rs6775517	0.958488861290179	Hematocrit	1e-17	34594039
rs62259783	rs57700771	0.953634756001868	Red blood cell count	9e-21	30595370
rs62259783	rs55704295	0.886782901092956	Red blood cell count	8e-26	32888493
rs62259783	rs55704295	0.886782901092956	Red blood cell count	5e-23	32888493
rs62259783	rs55704295	0.886782901092956	Serum total protein level	2e-29	34594039
rs62259783	rs4681679	0.862186045589471	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs62259783	rs11719450	0.860125250234298	Hemoglobin concentration	2e-09	27863252
rs62259783	rs11719450	0.860125250234298	Hemoglobin levels	2e-16	32327693
rs62259783	rs11922478	0.848608065358954	Semaphorin-6B levels	4e-12	34648354
rs62259783	rs56384862	0.829973993879152	Body mass index	8e-12	29273807
rs62259783	rs56384862	0.829973993879152	Body mass index	3e-06	30108127
rs62259783	rs56384862	0.829973993879152	Hemoglobin levels	1e-16	32327693
rs62259783	rs56384862	0.829973993879152	Body mass index	3e-14	36581621
rs62259783	rs55692656	0.801540538736439	vWF levels	3e-08	30586737
rs62259783	rs55692656	0.801540538736439	vWF levels	6e-09	30586737
rs62259783	rs6445969	0.683028384594427	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs62259783	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs62259783	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs62259783	rs11708895	0.676841762322323	Red blood cell count	1e-20	32888494
rs62259783	rs7431952	0.61298934619404	Hemoglobin levels	1e-12	32327693
rs62297175	rs17495047	0.803146953432948	Adolescent idiopathic scoliosis	3e-07	30019117
rs62327586	rs34402449	0.879044838059324	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs62327586	rs1550057	0.846489199862589	Conduct disorder	4e-06	20585324
rs62327586	rs1550057	0.846489199862589	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs62327586	rs17007017	0.671804996598121	Conduct disorder	7e-06	20585324
rs62439784	rs9285521	0.905591254361863	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs62439784	rs9322194	0.900369302005662	Brainstem volume	2e-11	31636452
rs62439784	rs11155662	0.781392606825477	Vertex-wise cortical thickness	2e-09	34910505
rs62439784	rs12526675	0.767151135455438	Brain morphology (MOSTest)	7e-22	32665545
rs62439784	rs10872649	0.762117855517597	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs62439784	rs10872649	0.762117855517597	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs62439784	rs10872649	0.762117855517597	Right hippocampal volume (body)	1e-10	37337106
rs62439784	rs9505982	0.758544287434646	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs62439784	rs4421206	0.745800450102666	Brain morphology (min-P)	4e-11	32665545
rs62439784	rs7752089	0.733509459997103	Brain morphology (MOSTest)	2e-31	35164939
rs62439784	rs9688452	0.731082261199548	Brainstem global volume Whole-brainstem	1e-11	33875891
rs62439784	rs9688452	0.731082261199548	aseg lh volume VentralDC	2e-10	33875891
rs62439784	rs11155671	0.720430931874119	Testicular germ cell tumor	2e-09	28604728
rs62439784	rs2342764	0.719090685130357	Cortical thickness	1e-08	34560273
rs62439784	rs56103941	0.7146436589953	Right presubiculum volume (head)	4e-08	37337106
rs62439784	rs4380763	0.710843840948086	Subcortical volume (min-P)	1e-11	32665545
rs62439784	rs1934534	0.710255969402307	Pain (pleiotropy)	2e-08	37844115
rs62439784	rs1934534	0.710255969402307	Pain (pleiotropy)	2e-06	37844115
rs62439784	rs12523793	0.701970628714402	Subcortical volume (MOSTest)	4e-24	32665545
rs62439784	rs12523793	0.701970628714402	C-reactive protein levels	3e-08	35459240
rs62439784	rs12523793	0.701970628714402	C-reactive protein levels (MTAG)	2e-08	36376304
rs62439784	rs80147756	0.670125564309706	HippSubfield lh volume subiculum-head	3e-10	33875891
rs62439808	rs9505982	0.973518135288985	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs62439808	rs11155671	0.944254783738748	Testicular germ cell tumor	2e-09	28604728
rs62439808	rs1934534	0.93176442397615	Pain (pleiotropy)	2e-08	37844115
rs62439808	rs1934534	0.93176442397615	Pain (pleiotropy)	2e-06	37844115
rs62439808	rs4380763	0.930972277781742	Subcortical volume (min-P)	1e-11	32665545
rs62439808	rs80147756	0.889959151698796	HippSubfield lh volume subiculum-head	3e-10	33875891
rs62439808	rs4421206	0.884034032144502	Brain morphology (min-P)	4e-11	32665545
rs62439808	rs9688452	0.864878800887101	Brainstem global volume Whole-brainstem	1e-11	33875891
rs62439808	rs9688452	0.864878800887101	aseg lh volume VentralDC	2e-10	33875891
rs62439808	rs9322194	0.825478095854919	Brainstem volume	2e-11	31636452
rs62439808	rs10872649	0.818300750094212	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs62439808	rs10872649	0.818300750094212	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs62439808	rs10872649	0.818300750094212	Right hippocampal volume (body)	1e-10	37337106
rs62439808	rs7752089	0.786573685878791	Brain morphology (MOSTest)	2e-31	35164939
rs62439808	rs9285521	0.702172069678416	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs62439808	rs12526675	0.612988400642286	Brain morphology (MOSTest)	7e-22	32665545
rs62439808	rs9688809	0.610739350533803	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs62439808	rs34337297	0.607823299729702	Serum levels of protein LRP11	3e-161	35078996
rs62439808	rs10872645	0.607049792499931	Blood protein levels	2e-86	30072576
rs62439808	rs14314	0.605981522998092	Macular thickness	3e-19	30535121
rs62439808	rs14314	0.605981522998092	Vertex-wise sulcal depth	7e-17	34910505
rs62439808	rs14314	0.605981522998092	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs62439808	rs14314	0.605981522998092	Left hippocampal volume (body)	7e-15	37337106
rs62439808	rs14314	0.605981522998092	Left subiculum volume (body)	1e-14	37337106
rs62439808	rs55763431	0.605720997223681	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs62439808	rs9322193	0.605147385674623	Lung cancer	1e-07	27393504
rs62439808	rs9689694	0.604609479306989	Right hippocampal volume (head)	6e-11	37337106
rs62439808	rs9689694	0.604609479306989	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs62439808	rs9689694	0.604609479306989	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs62439808	rs9689694	0.604609479306989	Left hippocampal volume (head)	6e-12	37337106
rs62439808	rs9383843	0.603282959647635	Migraine	1e-09	35115687
rs62439808	rs2095375	0.602728109084006	Serum metabolite levels	1e-20	33031748
rs62439808	rs2095375	0.602728109084006	Serum metabolite levels	1e-20	33031748
rs62439808	rs10872653	0.600512023525579	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs62439808	rs9688867	0.600131691445231	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs62439808	rs9688867	0.600131691445231	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs62439836	rs4380763	0.991913034263146	Subcortical volume (min-P)	1e-11	32665545
rs62439836	rs1934534	0.987876482922309	Pain (pleiotropy)	2e-08	37844115
rs62439836	rs1934534	0.987876482922309	Pain (pleiotropy)	2e-06	37844115
rs62439836	rs11155671	0.97019428049392	Testicular germ cell tumor	2e-09	28604728
rs62439836	rs80147756	0.946675054470943	HippSubfield lh volume subiculum-head	3e-10	33875891
rs62439836	rs4421206	0.940687618409135	Brain morphology (min-P)	4e-11	32665545
rs62439836	rs9505982	0.919400413917053	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs62439836	rs9688452	0.91136072607878	Brainstem global volume Whole-brainstem	1e-11	33875891
rs62439836	rs9688452	0.91136072607878	aseg lh volume VentralDC	2e-10	33875891
rs62439836	rs10872649	0.866950646550467	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs62439836	rs10872649	0.866950646550467	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs62439836	rs10872649	0.866950646550467	Right hippocampal volume (body)	1e-10	37337106
rs62439836	rs7752089	0.824482649800147	Brain morphology (MOSTest)	2e-31	35164939
rs62439836	rs9322194	0.777592053257706	Brainstem volume	2e-11	31636452
rs62439836	rs9285521	0.662855497222093	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs62439836	rs12526675	0.647785547018124	Brain morphology (MOSTest)	7e-22	32665545
rs62439836	rs9688809	0.641433745917234	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs62439836	rs34337297	0.639766220175349	Serum levels of protein LRP11	3e-161	35078996
rs62439836	rs10872645	0.637610005588875	Blood protein levels	2e-86	30072576
rs62439836	rs14314	0.636554487412254	Macular thickness	3e-19	30535121
rs62439836	rs14314	0.636554487412254	Vertex-wise sulcal depth	7e-17	34910505
rs62439836	rs14314	0.636554487412254	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs62439836	rs14314	0.636554487412254	Left hippocampal volume (body)	7e-15	37337106
rs62439836	rs14314	0.636554487412254	Left subiculum volume (body)	1e-14	37337106
rs62439836	rs55763431	0.636246135766542	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs62439836	rs9689694	0.635097127944719	Right hippocampal volume (head)	6e-11	37337106
rs62439836	rs9689694	0.635097127944719	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs62439836	rs9689694	0.635097127944719	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs62439836	rs9689694	0.635097127944719	Left hippocampal volume (head)	6e-12	37337106
rs62439836	rs9383843	0.633735539831966	Migraine	1e-09	35115687
rs62439836	rs2095375	0.633161961856057	Serum metabolite levels	1e-20	33031748
rs62439836	rs2095375	0.633161961856057	Serum metabolite levels	1e-20	33031748
rs62439836	rs10872653	0.630871077452483	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs62439836	rs9688867	0.629191109768388	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs62439836	rs9688867	0.629191109768388	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs62439836	rs9322193	0.610173421344654	Lung cancer	1e-07	27393504
rs62439836	rs2342764	0.606868813346658	Cortical thickness	1e-08	34560273
rs62439837	rs56103941	0.957541905820398	Right presubiculum volume (head)	4e-08	37337106
rs62439837	rs12523793	0.918524628242681	Subcortical volume (MOSTest)	4e-24	32665545
rs62439837	rs12523793	0.918524628242681	C-reactive protein levels	3e-08	35459240
rs62439837	rs12523793	0.918524628242681	C-reactive protein levels (MTAG)	2e-08	36376304
rs62439837	rs11155662	0.906017878706449	Vertex-wise cortical thickness	2e-09	34910505
rs62439837	rs12526675	0.867460494458036	Brain morphology (MOSTest)	7e-22	32665545
rs62439837	rs2342764	0.804409678321245	Cortical thickness	1e-08	34560273
rs62439837	rs58189451	0.736427877167817	Drinks per week	1e-09	36477530
rs62439837	rs9285521	0.731794404180233	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs62439837	rs7752089	0.645816645381276	Brain morphology (MOSTest)	2e-31	35164939
rs62439837	rs9322194	0.642263773804229	Brainstem volume	2e-11	31636452
rs62439837	rs10872649	0.621949031715791	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs62439837	rs10872649	0.621949031715791	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs62439837	rs10872649	0.621949031715791	Right hippocampal volume (body)	1e-10	37337106
rs62439837	rs1125	0.613759954626133	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs62439837	rs1125	0.613759954626133	Vertical cup-disc ratio	8e-14	34077760
rs62439837	rs11155675	0.611256561347998	Brain region volumes	3e-09	31676860
rs62439837	rs4421206	0.610605638893474	Brain morphology (min-P)	4e-11	32665545
rs62439840	rs56103941	0.969409673967039	Right presubiculum volume (head)	4e-08	37337106
rs62439840	rs12523793	0.949549564149185	Subcortical volume (MOSTest)	4e-24	32665545
rs62439840	rs12523793	0.949549564149185	C-reactive protein levels	3e-08	35459240
rs62439840	rs12523793	0.949549564149185	C-reactive protein levels (MTAG)	2e-08	36376304
rs62439840	rs11155662	0.936721943835299	Vertex-wise cortical thickness	2e-09	34910505
rs62439840	rs12526675	0.878183641062621	Brain morphology (MOSTest)	7e-22	32665545
rs62439840	rs2342764	0.815113096478698	Cortical thickness	1e-08	34560273
rs62439840	rs58189451	0.762947447890392	Drinks per week	1e-09	36477530
rs62439840	rs9285521	0.755163339614222	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs62439840	rs9322194	0.663737741470418	Brainstem volume	2e-11	31636452
rs62439840	rs7752089	0.653879277022489	Brain morphology (MOSTest)	2e-31	35164939
rs62439840	rs1125	0.642668143000072	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs62439840	rs1125	0.642668143000072	Vertical cup-disc ratio	8e-14	34077760
rs62439840	rs11155675	0.640126124694937	Brain region volumes	3e-09	31676860
rs62439840	rs10872649	0.62963521630817	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs62439840	rs10872649	0.62963521630817	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs62439840	rs10872649	0.62963521630817	Right hippocampal volume (body)	1e-10	37337106
rs62439840	rs9371201	0.627251458142934	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs62439840	rs4421206	0.61811634420998	Brain morphology (min-P)	4e-11	32665545
rs62439840	rs9505982	0.601271057784171	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs62439840	rs9688452	0.600296327613293	Brainstem global volume Whole-brainstem	1e-11	33875891
rs62439840	rs9688452	0.600296327613293	aseg lh volume VentralDC	2e-10	33875891
rs62441279	rs1934534	0.99513218081432	Pain (pleiotropy)	2e-08	37844115
rs62441279	rs1934534	0.99513218081432	Pain (pleiotropy)	2e-06	37844115
rs62441279	rs4380763	0.994321724879116	Subcortical volume (min-P)	1e-11	32665545
rs62441279	rs11155671	0.975792209078407	Testicular germ cell tumor	2e-09	28604728
rs62441279	rs80147756	0.957050571929598	HippSubfield lh volume subiculum-head	3e-10	33875891
rs62441279	rs4421206	0.943189427160819	Brain morphology (min-P)	4e-11	32665545
rs62441279	rs9505982	0.924948468856781	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs62441279	rs9688452	0.916829152564444	Brainstem global volume Whole-brainstem	1e-11	33875891
rs62441279	rs9688452	0.916829152564444	aseg lh volume VentralDC	2e-10	33875891
rs62441279	rs10872649	0.875450750946709	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs62441279	rs10872649	0.875450750946709	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs62441279	rs10872649	0.875450750946709	Right hippocampal volume (body)	1e-10	37337106
rs62441279	rs7752089	0.832920105230639	Brain morphology (MOSTest)	2e-31	35164939
rs62441279	rs9322194	0.783136952165317	Brainstem volume	2e-11	31636452
rs62441279	rs9285521	0.668228267068473	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs62441279	rs12526675	0.656013689799862	Brain morphology (MOSTest)	7e-22	32665545
rs62441279	rs9688809	0.647524572610375	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs62441279	rs10872645	0.643666125612405	Blood protein levels	2e-86	30072576
rs62441279	rs34337297	0.643086407207707	Serum levels of protein LRP11	3e-161	35078996
rs62441279	rs14314	0.642621551111441	Macular thickness	3e-19	30535121
rs62441279	rs14314	0.642621551111441	Vertex-wise sulcal depth	7e-17	34910505
rs62441279	rs14314	0.642621551111441	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs62441279	rs14314	0.642621551111441	Left hippocampal volume (body)	7e-15	37337106
rs62441279	rs14314	0.642621551111441	Left subiculum volume (body)	1e-14	37337106
rs62441279	rs55763431	0.64229515959616	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs62441279	rs9689694	0.641136892796269	Right hippocampal volume (head)	6e-11	37337106
rs62441279	rs9689694	0.641136892796269	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs62441279	rs9689694	0.641136892796269	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs62441279	rs9689694	0.641136892796269	Left hippocampal volume (head)	6e-12	37337106
rs62441279	rs9383843	0.639768212331115	Migraine	1e-09	35115687
rs62441279	rs2095375	0.639190010261945	Serum metabolite levels	1e-20	33031748
rs62441279	rs2095375	0.639190010261945	Serum metabolite levels	1e-20	33031748
rs62441279	rs10872653	0.636880657079625	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs62441279	rs9688867	0.635218029257464	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs62441279	rs9688867	0.635218029257464	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs62441279	rs9322193	0.614776859288689	Lung cancer	1e-07	27393504
rs62441279	rs2342764	0.613716355801567	Cortical thickness	1e-08	34560273
rs62441303	rs55763431	1	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs62441303	rs9689694	0.998201794182664	Right hippocampal volume (head)	6e-11	37337106
rs62441303	rs9689694	0.998201794182664	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs62441303	rs9689694	0.998201794182664	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs62441303	rs9689694	0.998201794182664	Left hippocampal volume (head)	6e-12	37337106
rs62441303	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs62441303	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs62441303	rs9383843	0.994608621917206	Migraine	1e-09	35115687
rs62441303	rs10872645	0.99281581932217	Blood protein levels	2e-86	30072576
rs62441303	rs9688867	0.991946733398874	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs62441303	rs9688867	0.991946733398874	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs62441303	rs9688809	0.991946733398874	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs62441303	rs10872653	0.991920973218723	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs62441303	rs34337297	0.988337309266227	Serum levels of protein LRP11	3e-161	35078996
rs62441303	rs14314	0.97680053310452	Macular thickness	3e-19	30535121
rs62441303	rs14314	0.97680053310452	Vertex-wise sulcal depth	7e-17	34910505
rs62441303	rs14314	0.97680053310452	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs62441303	rs14314	0.97680053310452	Left hippocampal volume (body)	7e-15	37337106
rs62441303	rs14314	0.97680053310452	Left subiculum volume (body)	1e-14	37337106
rs62441303	rs9322193	0.952199474125302	Lung cancer	1e-07	27393504
rs62441303	rs4039600	0.908526761368909	Adenine levels	1e-11	35347128
rs62441303	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-08	37844115
rs62441303	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-06	37844115
rs62441303	rs4380763	0.641447984668751	Subcortical volume (min-P)	1e-11	32665545
rs62441303	rs11155671	0.630994895975767	Testicular germ cell tumor	2e-09	28604728
rs62441303	rs80147756	0.616065401687589	HippSubfield lh volume subiculum-head	3e-10	33875891
rs62441303	rs4421206	0.60846358923055	Brain morphology (min-P)	4e-11	32665545
rs62441303	rs9505982	0.60194342559747	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs631490	rs480293	0.972584297062843	Oily fish consumption	4e-11	32193382
rs631490	rs1613778	0.962424471328265	Total bilirubin levels	3e-08	34594039
rs631490	rs34634095	0.943554083346546	Fish- and plant-related diet	3e-09	32066663
rs631490	rs542831	0.889742863064239	Asthma	5e-13	31361310
rs631490	rs1784776	0.887273170650018	Asthma	2e-09	32296059
rs631490	rs1784775	0.887273170650018	Asthma	2e-09	30929738
rs631490	rs1784775	0.887273170650018	Asthma (adult onset)	6e-09	30929738
rs631490	rs1789358	0.88566678447604	Asthma	2e-08	34103634
rs631490	rs539524	0.881569065137818	Asthma	1e-10	32296059
rs631490	rs12791699	0.850809317760182	Pork consumption	9e-09	32066663
rs631490	rs12791699	0.850809317760182	Oily fish consumption	9e-09	32066663
rs631490	rs487985	0.850809317760182	Highest math class taken	1e-08	30038396
rs631490	rs10891286	0.837948225322446	Noncognitive aspects of educational attainment	5e-10	33414549
rs631490	rs4459340	0.833974712457891	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs631490	rs659529	0.802426652589045	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs631490	rs659529	0.802426652589045	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs631490	rs659529	0.802426652589045	Atopic dermatitis	5e-10	34116867
rs631490	rs505372	0.776338780764251	Breast cancer	3e-06	29059683
rs631490	rs505372	0.776338780764251	Medication use (beta blocking agents)	2e-08	34594039
rs631490	rs9734135	0.75108747937169	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs631490	rs11213941	0.648035252413006	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs631490	rs11213941	0.648035252413006	Eczema	8e-14	30595370
rs631490	rs663763	0.642276534691163	Layilin levels	3e-21	36168886
rs641071	rs1147611	0.998387987255143	Blood protein levels	3e-139	30072576
rs641071	rs2282326	0.933431700280176	Serum levels of protein GSTO1	4e-265	35078996
rs641071	rs2282326	0.933431700280176	Glutathione S-transferase omega-1 levels (GSTO1.12436.84.3)	0	29875488
rs6416868	rs2285583	0.952908460568148	AFP levels	2e-08	36329257
rs6416868	rs178785	0.761537218717428	Lung function (FVC)	5e-09	30595370
rs6416868	rs9897542	0.760885377668172	Total bilirubin levels	8e-11	34594039
rs6416868	rs4792716	0.716253162162274	Body mass index	2e-11	31669095
rs6416868	rs4792716	0.716253162162274	Adult body size	5e-09	32376654
rs6416868	rs1075901	0.714248077068673	Body mass index	4e-13	30239722
rs6416868	rs1075901	0.714248077068673	Body mass index	4e-13	30239722
rs6416868	rs1075901	0.714248077068673	Body mass index (MTAG)	7e-13	36376304
rs6416868	rs1075901	0.714248077068673	Body mass index	4e-14	36581621
rs6416868	rs1075901	0.714248077068673	Body mass index	4e-12	30595370
rs6416868	rs9916868	0.680286463102921	Weight	3e-09	34594039
rs6416868	rs178835	0.639930608571176	C-reactive protein levels	2e-13	31900758
rs6420132	rs14314	0.989263077880703	Macular thickness	3e-19	30535121
rs6420132	rs14314	0.989263077880703	Vertex-wise sulcal depth	7e-17	34910505
rs6420132	rs14314	0.989263077880703	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs6420132	rs14314	0.989263077880703	Left hippocampal volume (body)	7e-15	37337106
rs6420132	rs14314	0.989263077880703	Left subiculum volume (body)	1e-14	37337106
rs6420132	rs2095375	0.974123845052554	Serum metabolite levels	1e-20	33031748
rs6420132	rs2095375	0.974123845052554	Serum metabolite levels	1e-20	33031748
rs6420132	rs9383843	0.973236607102427	Migraine	1e-09	35115687
rs6420132	rs55763431	0.969694828358027	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs6420132	rs9689694	0.967923515975539	Right hippocampal volume (head)	6e-11	37337106
rs6420132	rs9689694	0.967923515975539	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs6420132	rs9689694	0.967923515975539	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs6420132	rs9689694	0.967923515975539	Left hippocampal volume (head)	6e-12	37337106
rs6420132	rs10872645	0.966158676176427	Blood protein levels	2e-86	30072576
rs6420132	rs9688867	0.961786016840635	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs6420132	rs9688867	0.961786016840635	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs6420132	rs9688809	0.961786016840635	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs6420132	rs10872653	0.961739405932324	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs6420132	rs34337297	0.958223091091892	Serum levels of protein LRP11	3e-161	35078996
rs6420132	rs9322193	0.924433763061646	Lung cancer	1e-07	27393504
rs6420132	rs4039600	0.881366542382	Adenine levels	1e-11	35347128
rs6420132	rs1934534	0.639773536213299	Pain (pleiotropy)	2e-08	37844115
rs6420132	rs1934534	0.639773536213299	Pain (pleiotropy)	2e-06	37844115
rs6420132	rs4380763	0.639250099708334	Subcortical volume (min-P)	1e-11	32665545
rs6420132	rs11155671	0.628812525863419	Testicular germ cell tumor	2e-09	28604728
rs6420132	rs80147756	0.613842663838334	HippSubfield lh volume subiculum-head	3e-10	33875891
rs6420132	rs4421206	0.606226103231638	Brain morphology (min-P)	4e-11	32665545
rs6420132	rs9505982	0.601068449270398	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs6428487	rs12729558	0.943376796758529	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs6428487	rs10922531	0.911038354854598	Serum metabolite levels	2e-69	33031748
rs6428487	rs7532151	0.876437960571985	Imidazole lactate levels	9e-12	33177712
rs6428487	rs10801690	0.849453302201437	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs6428487	rs7530513	0.829757856598866	Height	8e-11	35831902
rs6428487	rs7530513	0.829757856598866	Imidazole lactate levels	8e-166	36635386
rs6428487	rs12144640	0.829757856598866	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs6428487	rs9787133	0.819105799095949	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs6428487	rs1409152	0.818240182746187	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs6428487	rs1409152	0.818240182746187	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs6428487	rs10801699	0.816133536811239	X-23639 levels	2e-10	36635386
rs6428487	rs12120164	0.782150737261046	Metabolite peak levels (QI2146)	1e-26	35995766
rs6428487	rs2765527	0.76830480438336	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs6428487	rs2810876	0.65819194532928	Imidazole lactate levels	2e-122	35347128
rs6428487	rs10801696	0.656874358149138	Imidazole lactate levels	3e-195	35050183
rs6428487	rs1206228892	0.656348746946613	Imidazole lactate levels	5e-186	35050183
rs6428502	rs55679149	0.77907528098502	Remission after SSRI treatment in MDD or openness	8e-07	29559929
rs6428502	rs12089335	0.746942447016729	Guanylate-binding protein 1 levels	4e-26	34648354
rs6442487	rs6442487	1	Height	4e-58	36224396
rs6445973	rs4681679	0.99867086876754	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs6445973	rs11719450	0.959062364989163	Hemoglobin concentration	2e-09	27863252
rs6445973	rs11719450	0.959062364989163	Hemoglobin levels	2e-16	32327693
rs6445973	rs56384862	0.945971833827975	Body mass index	8e-12	29273807
rs6445973	rs56384862	0.945971833827975	Body mass index	3e-06	30108127
rs6445973	rs56384862	0.945971833827975	Hemoglobin levels	1e-16	32327693
rs6445973	rs56384862	0.945971833827975	Body mass index	3e-14	36581621
rs6445973	rs6775517	0.897650336959633	Hematocrit	1e-17	34594039
rs6445973	rs7610312	0.893692846376017	Red blood cell count	5e-09	27863252
rs6445973	rs57700771	0.889741492252773	Red blood cell count	9e-21	30595370
rs6445973	rs11705721	0.875271761031879	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs6445973	rs11130638	0.875271761031879	Hemoglobin concentration	2e-23	32888493
rs6445973	rs34579268	0.868845520909068	Hematocrit	5e-30	32888493
rs6445973	rs34579268	0.868845520909068	Hematocrit	2e-27	32888493
rs6445973	rs34579268	0.868845520909068	Hemoglobin concentration	5e-26	32888493
rs6445973	rs55692656	0.836803321248679	vWF levels	3e-08	30586737
rs6445973	rs55692656	0.836803321248679	vWF levels	6e-09	30586737
rs6445973	rs55704295	0.814538559368595	Red blood cell count	8e-26	32888493
rs6445973	rs55704295	0.814538559368595	Red blood cell count	5e-23	32888493
rs6445973	rs55704295	0.814538559368595	Serum total protein level	2e-29	34594039
rs6445973	rs11922478	0.793213773736734	Semaphorin-6B levels	4e-12	34648354
rs6445973	rs6445969	0.781509635010321	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs6445973	rs11708895	0.771813792704081	Red blood cell count	1e-20	32888494
rs6445973	rs55954186	0.766933410894765	vWF levels	5e-09	30586737
rs6445973	rs55954186	0.766933410894765	vWF levels	9e-09	30586737
rs6445973	rs7431952	0.702228003591455	Hemoglobin levels	1e-12	32327693
rs6445973	rs9311676	0.637386682769212	Systemic lupus erythematosus	5e-06	27399966
rs6445973	rs9311676	0.637386682769212	Systemic lupus erythematosus	3e-14	26502338
rs6445973	rs9311676	0.637386682769212	Waist circumference adjusted for body mass index	3e-08	34021172
rs6445973	rs9822855	0.627134578173932	Educational attainment	9e-120	35361970
rs6450403	rs1862618	0.655000835602051	Initial pursuit acceleration	2e-07	29064472
rs6450403	rs2432195	0.654100490478332	C-reactive protein levels	5e-10	31900758
rs6450403	rs10461617	0.63023772545428	Type 2 diabetes	4e-06	23209189
rs6450406	rs9292122	0.936357163188553	Prostate cancer	5e-09	33398198
rs6450406	rs702689	0.756416848738348	Vertex-wise sulcal depth	2e-22	34910505
rs6450411	rs10036895	0.914058832413621	Breast cancer	2e-12	34290314
rs6453397	rs6453397	1	Platelet distribution width	9e-50	32888494
rs6454472	rs9450288	0.891417950483462	Height	2e-10	36224396
rs6454472	rs2842611	0.839485301301437	High density lipoprotein cholesterol levels	5e-09	34887591
rs6454472	rs1173416	0.8241201288472	Height	2e-59	36224396
rs6454481	rs2475792	0.845652139284938	Neutrophil count	1e-08	34594039
rs6454481	rs2475787	0.826911651393239	Neutrophil count	1e-11	32888493
rs6454481	rs4593336	0.750314052923665	Body mass index	2e-08	36581621
rs6454481	rs10806334	0.72874846010947	White blood cell count	4e-12	32888493
rs6454481	rs10806334	0.72874846010947	Neutrophil count	9e-12	32888493
rs6454481	rs10806334	0.72874846010947	White blood cell count	3e-13	32888493
rs6454483	rs2475787	0.849457984860075	Neutrophil count	1e-11	32888493
rs6454483	rs2475792	0.78786734688808	Neutrophil count	1e-08	34594039
rs6454483	rs10806334	0.724393487373122	White blood cell count	4e-12	32888493
rs6454483	rs10806334	0.724393487373122	Neutrophil count	9e-12	32888493
rs6454483	rs10806334	0.724393487373122	White blood cell count	3e-13	32888493
rs6454483	rs4593336	0.699859422863424	Body mass index	2e-08	36581621
rs6454492	rs1173416	0.629924099730479	Height	2e-59	36224396
rs6457789	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6457789	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs6457789	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs6457789	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs6457789	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs6457789	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs6457789	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs6457789	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6457789	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs6457789	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs6457789	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs6457789	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs6457789	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs6457789	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs6457789	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs6457789	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs6457789	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs6457789	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs6457789	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs6457789	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs6457789	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs6457789	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs6457789	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs6457789	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs6457789	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs6457789	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs6457789	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs6457789	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs6457789	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs6457789	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs6457789	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs6457789	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6457789	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs6457789	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs6457789	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6457789	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6457789	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6457789	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs6457789	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs6457789	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6457789	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs6457789	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs6457791	rs9469872	0.987195898074882	HDL cholesterol levels	3e-11	36333282
rs6457791	rs11755393	0.980086655728515	Body mass index	3e-26	29273807
rs6457791	rs11755393	0.980086655728515	Systemic lupus erythematosus	2e-12	33493351
rs6457791	rs11755393	0.980086655728515	Systemic lupus erythematosus	2e-06	33493351
rs6457791	rs11755393	0.980086655728515	Systemic lupus erythematosus	1e-07	33493351
rs6457791	rs11755393	0.980086655728515	Systemic lupus erythematosus	2e-08	19838195
rs6457791	rs11755393	0.980086655728515	Body mass index	4e-55	36581621
rs6457791	rs9366863	0.976851990214078	Adult body size	9e-33	32376654
rs6457791	rs9366863	0.976851990214078	Body mass index	2e-44	30595370
rs6457791	rs6941110	0.968938808024004	Sex hormone-binding globulin levels	5e-27	36653534
rs6457791	rs9462030	0.951188384851995	Red cell distribution width	5e-25	32888493
rs6457791	rs9469857	0.946547595770691	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6457791	rs2764208	0.945814738290137	Systemic lupus erythematosus	7e-06	24871463
rs6457791	rs2814949	0.939885928983196	Essential hypertension (time to event)	9e-09	32589924
rs6457791	rs9469899	0.934465404522903	Prostate cancer (advanced)	2e-06	29892016
rs6457791	rs9469899	0.934465404522903	Prostate cancer	5e-09	29892016
rs6457791	rs9469899	0.934465404522903	Prostate cancer	8e-11	33398198
rs6457791	rs9469899	0.934465404522903	Hand grip strength	3e-15	29691431
rs6457791	rs9469899	0.934465404522903	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6457791	rs9469899	0.934465404522903	Graves' disease	4e-10	34594039
rs6457791	rs9469899	0.934465404522903	Coronary artery disease	1e-11	36474045
rs6457791	rs9469899	0.934465404522903	Predicted visceral adipose tissue	2e-20	31501611
rs6457791	rs9469899	0.934465404522903	Medication use (thyroid preparations)	2e-09	31015401
rs6457791	rs9469899	0.934465404522903	Medication use (thyroid preparations)	3e-10	34594039
rs6457791	rs2744944	0.930553556835631	Hypothyroidism	3e-10	34594039
rs6457791	rs2744944	0.930553556835631	High density lipoprotein cholesterol levels	3e-86	34887591
rs6457791	rs2744944	0.930553556835631	Multi-trait sex score	7e-22	37277458
rs6457791	rs2263329	0.912852532223848	HDL cholesterol	6e-35	34594039
rs6457791	rs2263329	0.912852532223848	HDL cholesterol levels	8e-43	32203549
rs6457791	rs2263329	0.912852532223848	High density lipoprotein cholesterol levels	2e-52	34887591
rs6457791	rs9296128	0.897925639875797	Hip circumference adjusted for BMI	4e-13	34021172
rs6457791	rs111868030	0.887248297550219	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6457791	rs9368830	0.865452433613345	HDL cholesterol	4e-21	30275531
rs6457791	rs9368828	0.8362717860663	Body mass index	1e-34	34594039
rs6457791	rs6912327	0.828793738389432	Fasting insulin	5e-06	33402679
rs6457791	rs6912327	0.828793738389432	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6457791	rs112283401	0.803069498591469	Red cell distribution width	4e-27	30595370
rs6457791	rs2744973	0.780786027729415	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6457791	rs2744973	0.780786027729415	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6457791	rs2744973	0.780786027729415	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6457791	rs2744973	0.780786027729415	Multi-trait sex score	6e-20	37277458
rs6457791	rs6940215	0.632880969302522	Insomnia	2e-10	35835914
rs6457791	rs6940215	0.632880969302522	Insomnia	1e-13	35835914
rs6457791	rs6940215	0.632880969302522	Hip circumference adjusted for BMI	8e-10	34021172
rs6457791	rs6940215	0.632880969302522	Multi-trait sex score	2e-23	37277458
rs6457791	rs6940215	0.632880969302522	Multi-trait sex score	4e-23	37277458
rs6457791	rs6457796	0.624228009392291	Insomnia	1e-08	30804565
rs6457791	rs6457796	0.624228009392291	Plateletcrit	9e-11	32888494
rs6457791	rs6457796	0.624228009392291	Systemic lupus erythematosus	3e-22	33272962
rs6457791	rs6457796	0.624228009392291	Body mass index	5e-13	30108127
rs6457791	rs6457796	0.624228009392291	Body mass index	1e-14	26426971
rs6457791	rs6457796	0.624228009392291	Educational attainment	5e-19	35361970
rs6457791	rs9689160	0.603733435094497	Lung function (forced vital capacity)	3e-14	36914875
rs6457795	rs9469872	0.98720241099489	HDL cholesterol levels	3e-11	36333282
rs6457795	rs11755393	0.986444884059495	Body mass index	3e-26	29273807
rs6457795	rs11755393	0.986444884059495	Systemic lupus erythematosus	2e-12	33493351
rs6457795	rs11755393	0.986444884059495	Systemic lupus erythematosus	2e-06	33493351
rs6457795	rs11755393	0.986444884059495	Systemic lupus erythematosus	1e-07	33493351
rs6457795	rs11755393	0.986444884059495	Systemic lupus erythematosus	2e-08	19838195
rs6457795	rs11755393	0.986444884059495	Body mass index	4e-55	36581621
rs6457795	rs9366863	0.976860982963086	Adult body size	9e-33	32376654
rs6457795	rs9366863	0.976860982963086	Body mass index	2e-44	30595370
rs6457795	rs6941110	0.973702783416799	Sex hormone-binding globulin levels	5e-27	36653534
rs6457795	rs9462030	0.955940696217343	Red cell distribution width	5e-25	32888493
rs6457795	rs9469857	0.946587798313119	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6457795	rs2764208	0.945856861873276	Systemic lupus erythematosus	7e-06	24871463
rs6457795	rs2814949	0.939888741028689	Essential hypertension (time to event)	9e-09	32589924
rs6457795	rs9469899	0.939150617656352	Prostate cancer (advanced)	2e-06	29892016
rs6457795	rs9469899	0.939150617656352	Prostate cancer	5e-09	29892016
rs6457795	rs9469899	0.939150617656352	Prostate cancer	8e-11	33398198
rs6457795	rs9469899	0.939150617656352	Hand grip strength	3e-15	29691431
rs6457795	rs9469899	0.939150617656352	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6457795	rs9469899	0.939150617656352	Graves' disease	4e-10	34594039
rs6457795	rs9469899	0.939150617656352	Coronary artery disease	1e-11	36474045
rs6457795	rs9469899	0.939150617656352	Predicted visceral adipose tissue	2e-20	31501611
rs6457795	rs9469899	0.939150617656352	Medication use (thyroid preparations)	2e-09	31015401
rs6457795	rs9469899	0.939150617656352	Medication use (thyroid preparations)	3e-10	34594039
rs6457795	rs2744944	0.930563121541505	Hypothyroidism	3e-10	34594039
rs6457795	rs2744944	0.930563121541505	High density lipoprotein cholesterol levels	3e-86	34887591
rs6457795	rs2744944	0.930563121541505	Multi-trait sex score	7e-22	37277458
rs6457795	rs2263329	0.911338067082369	HDL cholesterol	6e-35	34594039
rs6457795	rs2263329	0.911338067082369	HDL cholesterol levels	8e-43	32203549
rs6457795	rs2263329	0.911338067082369	High density lipoprotein cholesterol levels	2e-52	34887591
rs6457795	rs9296128	0.898008968022849	Hip circumference adjusted for BMI	4e-13	34021172
rs6457795	rs111868030	0.887331747144213	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6457795	rs9368830	0.863908938269681	HDL cholesterol	4e-21	30275531
rs6457795	rs9368828	0.83483633935768	Body mass index	1e-34	34594039
rs6457795	rs6912327	0.830416950508655	Fasting insulin	5e-06	33402679
rs6457795	rs6912327	0.830416950508655	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6457795	rs112283401	0.807583844795641	Red cell distribution width	4e-27	30595370
rs6457795	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6457795	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6457795	rs2744973	0.779518782641824	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6457795	rs2744973	0.779518782641824	Multi-trait sex score	6e-20	37277458
rs6457795	rs6940215	0.631797836113969	Insomnia	2e-10	35835914
rs6457795	rs6940215	0.631797836113969	Insomnia	1e-13	35835914
rs6457795	rs6940215	0.631797836113969	Hip circumference adjusted for BMI	8e-10	34021172
rs6457795	rs6940215	0.631797836113969	Multi-trait sex score	2e-23	37277458
rs6457795	rs6940215	0.631797836113969	Multi-trait sex score	4e-23	37277458
rs6457795	rs6457796	0.627184527171391	Insomnia	1e-08	30804565
rs6457795	rs6457796	0.627184527171391	Plateletcrit	9e-11	32888494
rs6457795	rs6457796	0.627184527171391	Systemic lupus erythematosus	3e-22	33272962
rs6457795	rs6457796	0.627184527171391	Body mass index	5e-13	30108127
rs6457795	rs6457796	0.627184527171391	Body mass index	1e-14	26426971
rs6457795	rs6457796	0.627184527171391	Educational attainment	5e-19	35361970
rs6457795	rs9689160	0.602761401207754	Lung function (forced vital capacity)	3e-14	36914875
rs6457795	rs9469918	0.601654933170762	Hip circumference adjusted for BMI	8e-09	34021172
rs6457795	rs9469918	0.601654933170762	Hip circumference adjusted for BMI	2e-08	34021172
rs6457795	rs9469918	0.601654933170762	Multi-trait sex score	4e-08	37277458
rs6460055	rs12539962	0.871529611535201	Colorectal cancer	3e-08	36539618
rs6460055	rs13232536	0.700115142193057	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6460055	rs7806956	0.663398979043393	Esophageal squamous cell carcinoma	3e-07	37673066
rs6460055	rs4355658	0.65384206371159	Height	3e-13	36224396
rs6460056	rs12539962	0.842137501386361	Colorectal cancer	3e-08	36539618
rs6460056	rs13232536	0.730190823767413	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6460056	rs4355658	0.681059622254188	Height	3e-13	36224396
rs6460056	rs7806956	0.641720621513774	Esophageal squamous cell carcinoma	3e-07	37673066
rs6460061	rs4401719	0.603550490194344	Sib-shared facial trait 541; Facial segment 21; 3D morphology of the nose sides	5e-08	33983923
rs6484618	rs1467510	0.930813780140554	Platelet distribution width	1e-14	32888494
rs6484618	rs12276109	0.788077610447065	Severe COVID-19 infection	6e-08	36662838
rs6484619	rs1467510	0.935501617606302	Platelet distribution width	1e-14	32888494
rs6484619	rs12276109	0.792809798884211	Severe COVID-19 infection	6e-08	36662838
rs6484623	rs1467510	0.936285702887573	Platelet distribution width	1e-14	32888494
rs6484623	rs12276109	0.793601338209993	Severe COVID-19 infection	6e-08	36662838
rs6484640	rs1467510	0.863241656370862	Platelet distribution width	1e-14	32888494
rs6484640	rs12276109	0.768271882653643	Severe COVID-19 infection	6e-08	36662838
rs6484641	rs1467510	0.863241656370862	Platelet distribution width	1e-14	32888494
rs6484641	rs12276109	0.768271882653643	Severe COVID-19 infection	6e-08	36662838
rs6486419	rs4353250	0.982281233666377	Insulin-like growth factor 1 levels	2e-14	33462484
rs6486419	rs4353250	0.982281233666377	Amyloid A serum levels	2e-51	21124955
rs6486419	rs4150575	0.646513591735319	Imidazole lactate levels	1e-10	36635386
rs6488727	rs2430691	0.640088708036964	Height	4e-44	36224396
rs6489864	rs4767027	0.996356532839968	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489864	rs2057778	0.992721558416588	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489864	rs2057778	0.992721558416588	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489864	rs2057778	0.992721558416588	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489864	rs11066452	0.977233259469999	Blood protein levels	6e-08	30072576
rs6489864	rs1131476	0.966794064114406	Systemic lupus erythematosus	1e-09	33272962
rs6489864	rs2660	0.966794064114406	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489864	rs2660	0.966794064114406	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489864	rs1859336	0.94346602921748	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489864	rs6489882	0.924384737888608	Chronic lymphocytic leukemia	5e-08	28165464
rs6489864	rs6489867	0.642575306093359	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489864	rs1557866	0.605625703855193	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489865	rs4767027	0.996356532839968	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489865	rs2057778	0.992721558416588	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489865	rs2057778	0.992721558416588	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489865	rs2057778	0.992721558416588	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489865	rs11066452	0.977233259469999	Blood protein levels	6e-08	30072576
rs6489865	rs1131476	0.966794064114406	Systemic lupus erythematosus	1e-09	33272962
rs6489865	rs2660	0.966794064114406	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489865	rs2660	0.966794064114406	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489865	rs1859336	0.94346602921748	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489865	rs6489882	0.924384737888608	Chronic lymphocytic leukemia	5e-08	28165464
rs6489865	rs6489867	0.642575306093359	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489865	rs1557866	0.605625703855193	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489866	rs1859336	0.989350389660873	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489866	rs11066452	0.971709590063016	Blood protein levels	6e-08	30072576
rs6489866	rs6489882	0.969520116487699	Chronic lymphocytic leukemia	5e-08	28165464
rs6489866	rs4767027	0.950676937922514	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489866	rs2057778	0.947162637647294	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489866	rs2057778	0.947162637647294	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489866	rs2057778	0.947162637647294	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489866	rs1131476	0.921908276488657	Systemic lupus erythematosus	1e-09	33272962
rs6489866	rs2660	0.921908276488657	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489866	rs2660	0.921908276488657	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489866	rs6489867	0.677069245979427	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489866	rs1557866	0.62660109236697	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489868	rs1859336	0.989350389660873	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489868	rs11066452	0.971709590063016	Blood protein levels	6e-08	30072576
rs6489868	rs6489882	0.969520116487699	Chronic lymphocytic leukemia	5e-08	28165464
rs6489868	rs4767027	0.950676937922514	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489868	rs2057778	0.947162637647294	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489868	rs2057778	0.947162637647294	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489868	rs2057778	0.947162637647294	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489868	rs1131476	0.921908276488657	Systemic lupus erythematosus	1e-09	33272962
rs6489868	rs2660	0.921908276488657	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489868	rs2660	0.921908276488657	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489868	rs6489867	0.677069245979427	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489868	rs1557866	0.62660109236697	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489869	rs1859336	0.985802334441578	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489869	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs6489869	rs6489882	0.966025470616194	Chronic lymphocytic leukemia	5e-08	28165464
rs6489869	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489869	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489869	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489869	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489869	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs6489869	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489869	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489869	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489869	rs1557866	0.623133646578058	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489870	rs1859336	0.988177482319676	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489870	rs11066452	0.970558177145172	Blood protein levels	6e-08	30072576
rs6489870	rs6489882	0.968361838534634	Chronic lymphocytic leukemia	5e-08	28165464
rs6489870	rs4767027	0.949549248492631	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489870	rs2057778	0.946037927351934	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489870	rs2057778	0.946037927351934	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489870	rs2057778	0.946037927351934	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489870	rs1131476	0.920800186540991	Systemic lupus erythematosus	1e-09	33272962
rs6489870	rs2660	0.920800186540991	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489870	rs2660	0.920800186540991	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489870	rs6489867	0.676103284678255	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489870	rs1557866	0.625844491721027	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489874	rs1859336	0.991702769125355	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489874	rs6489882	0.971843155449831	Chronic lymphocytic leukemia	5e-08	28165464
rs6489874	rs11066452	0.969306185590769	Blood protein levels	6e-08	30072576
rs6489874	rs4767027	0.948254276476331	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489874	rs2057778	0.944744331811606	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489874	rs2057778	0.944744331811606	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489874	rs2057778	0.944744331811606	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489874	rs1131476	0.919557832711146	Systemic lupus erythematosus	1e-09	33272962
rs6489874	rs2660	0.919557832711146	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489874	rs2660	0.919557832711146	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489874	rs6489867	0.675464836232867	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489874	rs1557866	0.628118528869361	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489875	rs1859336	0.991702769125355	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489875	rs6489882	0.971843155449831	Chronic lymphocytic leukemia	5e-08	28165464
rs6489875	rs11066452	0.969306185590769	Blood protein levels	6e-08	30072576
rs6489875	rs4767027	0.948254276476331	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489875	rs2057778	0.944744331811606	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489875	rs2057778	0.944744331811606	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489875	rs2057778	0.944744331811606	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489875	rs1131476	0.919557832711146	Systemic lupus erythematosus	1e-09	33272962
rs6489875	rs2660	0.919557832711146	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489875	rs2660	0.919557832711146	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489875	rs6489867	0.675464836232867	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489875	rs1557866	0.628118528869361	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489876	rs1859336	0.991702769125355	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489876	rs6489882	0.971843155449831	Chronic lymphocytic leukemia	5e-08	28165464
rs6489876	rs11066452	0.969306185590769	Blood protein levels	6e-08	30072576
rs6489876	rs4767027	0.948254276476331	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489876	rs2057778	0.944744331811606	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489876	rs2057778	0.944744331811606	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489876	rs2057778	0.944744331811606	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489876	rs1131476	0.919557832711146	Systemic lupus erythematosus	1e-09	33272962
rs6489876	rs2660	0.919557832711146	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489876	rs2660	0.919557832711146	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489876	rs6489867	0.675464836232867	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489876	rs1557866	0.628118528869361	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489877	rs1859336	0.989350389660873	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489877	rs6489882	0.969520116487699	Chronic lymphocytic leukemia	5e-08	28165464
rs6489877	rs11066452	0.967005697012195	Blood protein levels	6e-08	30072576
rs6489877	rs4767027	0.946001320824587	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489877	rs2057778	0.942497337703979	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489877	rs2057778	0.942497337703979	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489877	rs2057778	0.942497337703979	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489877	rs1131476	0.917344049387646	Systemic lupus erythematosus	1e-09	33272962
rs6489877	rs2660	0.917344049387646	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489877	rs2660	0.917344049387646	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489877	rs6489867	0.673534903261012	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489877	rs1557866	0.62660109236697	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489878	rs1859336	0.991702769125355	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489878	rs6489882	0.971843155449831	Chronic lymphocytic leukemia	5e-08	28165464
rs6489878	rs11066452	0.969306185590769	Blood protein levels	6e-08	30072576
rs6489878	rs4767027	0.948254276476331	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489878	rs2057778	0.944744331811606	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489878	rs2057778	0.944744331811606	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489878	rs2057778	0.944744331811606	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489878	rs1131476	0.919557832711146	Systemic lupus erythematosus	1e-09	33272962
rs6489878	rs2660	0.919557832711146	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489878	rs2660	0.919557832711146	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489878	rs6489867	0.675464836232867	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489878	rs1557866	0.628118528869361	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489879	rs1859336	0.982232090187523	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489879	rs6489882	0.98120356743201	Chronic lymphocytic leukemia	5e-08	28165464
rs6489879	rs11066452	0.959810758296141	Blood protein levels	6e-08	30072576
rs6489879	rs4767027	0.938749181712357	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489879	rs2057778	0.937585258200669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489879	rs2057778	0.937585258200669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489879	rs2057778	0.937585258200669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489879	rs1131476	0.912584729848029	Systemic lupus erythematosus	1e-09	33272962
rs6489879	rs2660	0.912584729848029	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489879	rs2660	0.912584729848029	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489879	rs6489867	0.668731973951964	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489879	rs1557866	0.633298573207346	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489880	rs6489882	0.983551893536507	Chronic lymphocytic leukemia	5e-08	28165464
rs6489880	rs1859336	0.979875022368182	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489880	rs11066452	0.957467076735588	Blood protein levels	6e-08	30072576
rs6489880	rs4767027	0.936419921609197	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489880	rs2057778	0.935258270165009	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489880	rs2057778	0.935258270165009	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489880	rs2057778	0.935258270165009	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489880	rs1131476	0.910308150301377	Systemic lupus erythematosus	1e-09	33272962
rs6489880	rs2660	0.910308150301377	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489880	rs2660	0.910308150301377	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489880	rs6489867	0.666970990561271	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489880	rs1557866	0.635430274324674	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6489881	rs6489882	0.746253711055108	Chronic lymphocytic leukemia	5e-08	28165464
rs6489881	rs1859336	0.744054842402969	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489881	rs11066452	0.726901457263323	Blood protein levels	6e-08	30072576
rs6489881	rs4767027	0.710665979601736	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489881	rs2057778	0.709665273180621	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489881	rs2057778	0.709665273180621	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489881	rs2057778	0.709665273180621	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489881	rs1131476	0.688056695747539	Systemic lupus erythematosus	1e-09	33272962
rs6489881	rs2660	0.688056695747539	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489881	rs2660	0.688056695747539	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489882	rs6489882	1	Chronic lymphocytic leukemia	5e-08	28165464
rs6489882	rs1859336	0.963683539049667	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs6489882	rs11066452	0.941636366144249	Blood protein levels	6e-08	30072576
rs6489882	rs4767027	0.920919567161265	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs6489882	rs2057778	0.919768958194515	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs6489882	rs2057778	0.919768958194515	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs6489882	rs2057778	0.919768958194515	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs6489882	rs1131476	0.895047912374631	Systemic lupus erythematosus	1e-09	33272962
rs6489882	rs2660	0.895047912374631	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs6489882	rs2660	0.895047912374631	COVID-19 (critical illness vs population)	3e-15	37198478
rs6489882	rs6489867	0.653693013427547	COVID-19 (critical illness vs population)	1e-09	33307546
rs6489882	rs1557866	0.64174960194697	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs6495455	rs7173566	0.748668339542301	5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)	6e-16	29875488
rs6495455	rs57141546	0.740568767013048	5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)	7e-16	29875488
rs6495455	rs4994246	0.710383590410198	5-formyltetrahydrofolate cyclo-ligase levels	5.00000000228973e-315	34648354
rs6495456	rs7173566	0.748668339542301	5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)	6e-16	29875488
rs6495456	rs57141546	0.740568767013048	5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)	7e-16	29875488
rs6495456	rs4994246	0.710383590410198	5-formyltetrahydrofolate cyclo-ligase levels	5.00000000228973e-315	34648354
rs650461	rs603646	0.983179048290332	High density lipoprotein cholesterol levels	3e-08	34887591
rs650461	rs498547	0.859978344187023	General risk tolerance (MTAG)	4e-09	30643258
rs6517156	rs6517156	1	Free testosterone levels	5e-09	36653534
rs6517156	rs2834161	0.778776213975732	COVID-19 with respiratory failure requiring mechanical ventilation	6e-07	35848942
rs6517156	rs2300371	0.744090948271394	Major depressive disorder or severe COVID-19 (pleiotropy)	8e-09	37426090
rs6517156	rs9636867	0.727582403111822	COVID-19 (hospitalized covid vs population)	2e-46	37198478
rs6517156	rs9636867	0.727582403111822	COVID-19 (critical illness vs population)	5e-48	37198478
rs6517156	rs17860115	0.727485903848253	COVID-19 (critical illness vs population or mild symptoms)	1e-21	35255492
rs6517156	rs17860115	0.727485903848253	COVID-19 (critical illness vs population or mild symptoms)	2e-08	35255492
rs6517156	rs9976829	0.723101731444468	COVID-19	3e-06	33949668
rs6517156	rs9976829	0.723101731444468	COVID-19 (severe vs population)	8e-12	35264675
rs6517156	rs13050728	0.723101731444468	COVID-19 (critical illness vs population)	5e-12	33307546
rs6517156	rs13050728	0.723101731444468	COVID-19 (critical illness vs population)	1e-16	34237774
rs6517156	rs13050728	0.723101731444468	COVID-19 (hospitalized vs population)	3e-20	34237774
rs6517156	rs13050728	0.723101731444468	COVID-19 (hospitalized vs population)	5e-23	35922517
rs6517156	rs13050728	0.723101731444468	SARS-CoV-2 infection	3e-07	35922517
rs6517156	rs13050728	0.723101731444468	COVID-19 (critical illness vs population)	1e-18	35922517
rs6517156	rs13050728	0.723101731444468	COVID-19 with respiratory failure	2e-19	35848942
rs6517156	rs13050728	0.723101731444468	COVID-19 with respiratory failure requiring mechanical ventilation	2e-15	35848942
rs6517156	rs13050728	0.723101731444468	COVID-19 severity	4e-22	35368071
rs6517156	rs13050728	0.723101731444468	Critical COVID-19 or osteoarthritis (MTAG)	3e-16	37398645
rs6517156	rs13050728	0.723101731444468	COVID-19 hospitalization or osteoarthritis (MTAG)	2e-11	37398645
rs6517156	rs11088247	0.708322277534044	COVID-19 severity	9e-10	35368071
rs6517156	rs12482060	0.703005699981092	COVID-19	2e-12	35264675
rs6517156	rs62226152	0.622268866216114	COVID-19 critical illness or age-related macular degeneration (MTAG)	3e-08	36614910
rs6517156	rs62226152	0.622268866216114	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-12	36614910
rs6517156	rs62226152	0.622268866216114	COVID-19 infection or age-related macular degeneration (MTAG)	1e-06	36614910
rs6531582	rs35619511	0.997597642926141	Severe COVID-19 infection	2e-06	36662838
rs6531583	rs35619511	0.997597642926141	Severe COVID-19 infection	2e-06	36662838
rs6531584	rs35619511	0.997597642926141	Severe COVID-19 infection	2e-06	36662838
rs6534707	rs7655841	0.872232928834665	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs6534707	rs337277	0.846198176999294	Metabolite peak levels (QI10992)	3e-52	35995766
rs6534707	rs337277	0.846198176999294	Metabolite peak levels (QI4667)	7e-18	35995766
rs6534707	rs337277	0.846198176999294	Metabolite peak levels (QI4708)	1e-21	35995766
rs6534707	rs337277	0.846198176999294	Metabolite peak levels (QI5169)	7e-57	35995766
rs6534707	rs10010659	0.600325503716927	Water consumption (glasses per day) (UKB data field 1528)	1e-08	32193382
rs6535407	rs11099563	0.681733958292981	High density lipoprotein cholesterol levels	3e-11	34887591
rs6535407	rs4302451	0.656331255136503	Eosinophil counts	2e-09	30595370
rs6535407	rs2868708	0.617523742210538	Lymphocyte count	3e-11	34469753
rs6535407	rs2868708	0.617523742210538	White blood cell count	1e-09	30595370
rs6535407	rs6831339	0.614523802937831	High density lipoprotein cholesterol levels	9e-09	34887591
rs6535412	rs2868708	0.89794164355118	Lymphocyte count	3e-11	34469753
rs6535412	rs2868708	0.89794164355118	White blood cell count	1e-09	30595370
rs6535412	rs6831339	0.894705586156706	High density lipoprotein cholesterol levels	9e-09	34887591
rs6535412	rs6535419	0.845786568406914	Pulse pressure	6e-10	30578418
rs6535412	rs116142917	0.818863070449529	Lymphocyte count	7e-18	32888494
rs6535412	rs6823199	0.807726875758925	Pulse pressure	4e-14	30224653
rs6535412	rs13111599	0.804013639231058	HDL cholesterol levels	3e-09	32203549
rs6535412	rs13111599	0.804013639231058	Apolipoprotein A1 levels	4e-08	32203549
rs6535412	rs11099563	0.754098577620523	High density lipoprotein cholesterol levels	3e-11	34887591
rs6535412	rs4302451	0.746473343316698	Eosinophil counts	2e-09	30595370
rs6535412	rs28528763	0.721540869121671	White blood cell count	7e-12	32888494
rs6535412	rs35895091	0.695392443407951	Cardiovascular disease	1e-07	30595370
rs6535412	rs7662402	0.647107920693399	Brain morphology (MOSTest)	3e-08	35164939
rs6537035	rs1550057	0.877810996470718	Conduct disorder	4e-06	20585324
rs6537035	rs1550057	0.877810996470718	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs6537035	rs34402449	0.877522216856752	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs6541094	rs3828081	0.668158289225068	Cognitive function (immediate memory)	8e-08	35386118
rs6541094	rs7524908	0.666195893443664	Height	5e-27	30595370
rs6543699	rs12104955	0.944984670918699	Carpal tunnel syndrome	4e-08	30833571
rs6543699	rs2061027	0.854456258961368	Osteoarthritis	3e-13	30664745
rs6543699	rs4671010	0.852002557923965	Body mass index or osteoarthritis (pleiotropy)	4e-12	36889626
rs6543699	rs4671010	0.852002557923965	Body mass index or knee osteoarthritis (pleiotropy)	9e-12	36889626
rs6543699	rs2367623	0.846166687576941	Height	3e-11	35831902
rs6543699	rs17567417	0.845143694325223	Knee osteoarthritis	2e-12	30664745
rs6543699	rs17567417	0.845143694325223	Height	4e-07	28552196
rs6543699	rs17567417	0.845143694325223	Height	4e-30	36224396
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for body mass index	7e-07	25673412
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for body mass index	4e-06	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for body mass index	5e-08	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for body mass index	5e-06	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for body mass index	8e-08	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for BMI in non-smokers	1e-06	28443625
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	2e-07	28443625
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	2e-07	28443625
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	2e-06	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	2e-06	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	1e-08	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	3e-08	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for BMI in active individuals	2e-07	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for BMI in active individuals	1e-06	28448500
rs6543699	rs6715793	0.819325151785146	Waist circumference adjusted for body mass index	1e-08	25673412
rs6543699	rs6715793	0.819325151785146	Height	4e-37	36224396
rs6543699	rs6715793	0.819325151785146	Height	3e-16	36224396
rs6543699	rs6715793	0.819325151785146	Height	1e-300	36224396
rs6543699	rs7581446	0.784869243039319	Osteoarthritis of the hip or knee	5e-11	34450027
rs6543699	rs6743685	0.779763625777466	Height	1e-35	30595370
rs6543699	rs4637087	0.759939431796088	Waist circumference adjusted for body mass index	3e-10	31669095
rs6543699	rs6712473	0.684872716133159	Carpal tunnel syndrome	2e-12	35332129
rs6543699	rs6712473	0.684872716133159	Height	2e-260	36224396
rs6545850	rs2593620	0.890921650710604	Serum levels of protein PRG3	5e-14	35078996
rs6545850	rs777587	0.886757590484039	Proteoglycan 3 levels	6e-29	34648354
rs6545850	rs777587	0.886757590484039	Pappalysin-1 levels	1e-25	34648354
rs6545850	rs2421200	0.869830216600234	Neutrophil count	1e-26	32888493
rs6545850	rs2421200	0.869830216600234	Neutrophil count	1e-25	32888493
rs6545850	rs12617371	0.86420063902977	Immature fraction of reticulocytes	8e-18	32888494
rs6545850	rs2463097	0.830507263541784	White blood cell count	3e-26	30595370
rs6545850	rs10199672	0.821596350326081	Height	6e-12	34594039
rs6545850	rs10199672	0.821596350326081	Height	2e-12	31562340
rs6545850	rs11685226	0.773279625570374	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs6545850	rs11685226	0.773279625570374	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs6545850	rs1177308	0.7665219969493	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs6545850	rs1177308	0.7665219969493	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs6545850	rs7558954	0.764309604124051	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs6545850	rs2950269	0.75342841136857	Eosinophil side fluorescence	3e-18	37596262
rs6545850	rs12616433	0.740402773316078	Eosinophil forward scatter	4e-13	37596262
rs6545850	rs12616433	0.740402773316078	Eosinophil side scatter	2e-18	37596262
rs6545850	rs10169482	0.736521543177026	C-reactive protein levels	4e-09	33462484
rs6545850	rs10206089	0.610567875920088	White blood cell count	7e-11	27863252
rs6545850	rs10206089	0.610567875920088	Myeloid white cell count	1e-09	27863252
rs6545850	rs10206089	0.610567875920088	Sum neutrophil eosinophil counts	2e-09	27863252
rs6545850	rs10206089	0.610567875920088	Granulocyte count	3e-09	27863252
rs6545855	rs12617371	0.929250769348935	Immature fraction of reticulocytes	8e-18	32888494
rs6545855	rs777587	0.906607627214993	Proteoglycan 3 levels	6e-29	34648354
rs6545855	rs777587	0.906607627214993	Pappalysin-1 levels	1e-25	34648354
rs6545855	rs2463097	0.881290174793407	White blood cell count	3e-26	30595370
rs6545855	rs10199672	0.868443999416935	Height	6e-12	34594039
rs6545855	rs10199672	0.868443999416935	Height	2e-12	31562340
rs6545855	rs2593620	0.858989231911212	Serum levels of protein PRG3	5e-14	35078996
rs6545855	rs2421200	0.84157845079385	Neutrophil count	1e-26	32888493
rs6545855	rs2421200	0.84157845079385	Neutrophil count	1e-25	32888493
rs6545855	rs11685226	0.797270332178804	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs6545855	rs11685226	0.797270332178804	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs6545855	rs1177308	0.791650932983051	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs6545855	rs1177308	0.791650932983051	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs6545855	rs7558954	0.787869863098459	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs6545855	rs10169482	0.780946190350919	C-reactive protein levels	4e-09	33462484
rs6545855	rs2950269	0.724913923078081	Eosinophil side fluorescence	3e-18	37596262
rs6545855	rs12616433	0.717323922012467	Eosinophil forward scatter	4e-13	37596262
rs6545855	rs12616433	0.717323922012467	Eosinophil side scatter	2e-18	37596262
rs6547629	rs6547629	1	Height	3e-09	36224396
rs6547629	rs58588820	0.896966843565354	Total cholesterol levels	1e-09	34887591
rs6547629	rs58588820	0.896966843565354	Total cholesterol levels	8e-11	34887591
rs6547629	rs10206961	0.706083973381646	Parental longevity (father's age at death)	2e-06	31484785
rs6556942	rs2549794	0.896979471157847	Crohn's disease	1e-10	21102463
rs6556942	rs2549794	0.896979471157847	Systolic blood pressure	1e-07	33230300
rs6556942	rs2549794	0.896979471157847	Diastolic blood pressure	1e-15	33230300
rs6556942	rs2549794	0.896979471157847	Diastolic blood pressure	2e-12	33230300
rs6556942	rs2549794	0.896979471157847	Systolic blood pressure	4e-10	33230300
rs6556942	rs1363907	0.89195833851095	Crohn's disease	4e-16	26192919
rs6556942	rs1363907	0.89195833851095	Ulcerative colitis	4e-06	26192919
rs6556942	rs1363907	0.89195833851095	Inflammatory bowel disease	5e-15	26192919
rs6556942	rs1363907	0.89195833851095	Inflammatory bowel disease	6e-13	23128233
rs6556942	rs1363907	0.89195833851095	Inflammatory bowel disease	1e-10	28067908
rs6556942	rs1363907	0.89195833851095	Crohn's disease	1e-14	28067908
rs6556942	rs2617439	0.846022945376557	Neutrophil count	8e-11	32888494
rs6556942	rs716848	0.840024079505069	Neutrophil percentage of white cells	2e-09	32888494
rs6556942	rs38029	0.834901595086987	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs6556942	rs2548532	0.815986338753563	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs6556942	rs4869313	0.775199424474529	Pediatric autoimmune diseases	9e-08	26301688
rs6556942	rs27660	0.710139570737041	Coronary artery disease	3e-08	35915156
rs6556942	rs1559359	0.7021862858307	Diastolic blood pressure	7e-10	34594039
rs6556942	rs1974871	0.699894198880473	Granulysin levels	5e-13	34648354
rs6556942	rs1423357	0.682761270649145	General cognitive ability	9e-06	29844566
rs6556942	rs2432142	0.668738166615963	Neutrophil count	2e-14	32888493
rs6556942	rs2432142	0.668738166615963	White blood cell count	1e-11	32888493
rs6556942	rs38033	0.667120815687261	Blood protein levels	0	30072576
rs6556942	rs27293	0.657682430615737	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs6556942	rs27293	0.657682430615737	Diastolic blood pressure	3e-11	35762941
rs6556942	rs7705093	0.651700267952	Birdshot chorioretinopathy	2e-09	24957906
rs6556942	rs2927608	0.642242937912838	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs6556942	rs2927608	0.642242937912838	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs6556942	rs2927608	0.642242937912838	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs6556942	rs2910686	0.64002518729084	Neutrophil count	4e-14	32888493
rs6556942	rs2910686	0.64002518729084	Psoriasis	2e-08	23143594
rs6556942	rs2910686	0.64002518729084	Ankylosing spondylitis	5e-17	23749187
rs6556942	rs2910686	0.64002518729084	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs6561526	rs7987940	0.668576963052235	AFP levels	6e-08	36329257
rs6561526	rs9535244	0.648703462662684	Lung function (FVC)	1e-08	30595370
rs6563555	rs4424789	0.94449645329191	Periostin levels	2e-19	34648354
rs6563555	rs9603222	0.820264576881806	Blood protein levels	2e-12	30072576
rs6563737	rs7999758	0.997302693536412	Height	6e-17	30595370
rs6563737	rs6563739	0.996405479333726	Menarche (age at onset)	2e-11	25231870
rs6563737	rs4598779	0.919928791409094	Height	7e-77	36224396
rs6563740	rs7999758	0.967398985326975	Height	6e-17	30595370
rs6563740	rs6563739	0.966510229658837	Menarche (age at onset)	2e-11	25231870
rs6563740	rs4598779	0.95005620543236	Height	7e-77	36224396
rs6565610	rs8077038	0.992334358967039	Educational attainment (MTAG)	4e-10	30038396
rs6565610	rs8077038	0.992334358967039	Highest math class taken (MTAG)	5e-16	30038396
rs6565610	rs12949956	0.978091509668946	Self-reported math ability	3e-11	30038396
rs6565610	rs12949956	0.978091509668946	Self-reported math ability (MTAG)	3e-14	30038396
rs6565610	rs12949956	0.978091509668946	Highest math class taken	8e-12	30038396
rs6565610	rs7211615	0.972013314296527	Heel bone mineral density	1e-08	30595370
rs6565610	rs9894429	0.647554549101907	Eye color traits	9e-14	20463881
rs6565610	rs9894429	0.647554549101907	Body mass index	4e-08	36581621
rs6565611	rs8077038	0.995618001510414	Educational attainment (MTAG)	4e-10	30038396
rs6565611	rs8077038	0.995618001510414	Highest math class taken (MTAG)	5e-16	30038396
rs6565611	rs12949956	0.972723762315257	Self-reported math ability	3e-11	30038396
rs6565611	rs12949956	0.972723762315257	Self-reported math ability (MTAG)	3e-14	30038396
rs6565611	rs12949956	0.972723762315257	Highest math class taken	8e-12	30038396
rs6565611	rs7211615	0.966617149084095	Heel bone mineral density	1e-08	30595370
rs6565611	rs9894429	0.649509835252423	Eye color traits	9e-14	20463881
rs6565611	rs9894429	0.649509835252423	Body mass index	4e-08	36581621
rs6565614	rs7211615	0.656186492763318	Heel bone mineral density	1e-08	30595370
rs6565614	rs61586425	0.65088889025074	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs6565614	rs8077038	0.633352696675265	Educational attainment (MTAG)	4e-10	30038396
rs6565614	rs8077038	0.633352696675265	Highest math class taken (MTAG)	5e-16	30038396
rs6565614	rs12949956	0.626207566304659	Self-reported math ability	3e-11	30038396
rs6565614	rs12949956	0.626207566304659	Self-reported math ability (MTAG)	3e-14	30038396
rs6565614	rs12949956	0.626207566304659	Highest math class taken	8e-12	30038396
rs6565615	rs7211615	0.656186492763318	Heel bone mineral density	1e-08	30595370
rs6565615	rs61586425	0.65088889025074	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs6565615	rs8077038	0.633352696675265	Educational attainment (MTAG)	4e-10	30038396
rs6565615	rs8077038	0.633352696675265	Highest math class taken (MTAG)	5e-16	30038396
rs6565615	rs12949956	0.626207566304659	Self-reported math ability	3e-11	30038396
rs6565615	rs12949956	0.626207566304659	Self-reported math ability (MTAG)	3e-14	30038396
rs6565615	rs12949956	0.626207566304659	Highest math class taken	8e-12	30038396
rs6565616	rs61586425	0.911453939083227	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs6565616	rs8075598	0.731365484410794	Non-albumin protein levels	3e-10	29403010
rs6565616	rs6565604	0.728194586145082	Non-melanoma skin cancer	3e-06	34290314
rs6565616	rs9894429	0.639339336414491	Eye color traits	9e-14	20463881
rs6565616	rs9894429	0.639339336414491	Body mass index	4e-08	36581621
rs6576956	rs11580836	0.994668192117369	Body mass index	2e-09	36581621
rs6576956	rs10465746	0.961693345241521	Obesity-related traits	8e-06	23251661
rs6584194	rs6584194	1	Metabolite peak levels (QI9680)	2e-135	35995766
rs6584194	rs6584194	1	Metabolite peak levels (QI8984)	5e-11	35995766
rs6584194	rs6584194	1	X-24736 levels	3e-13	36635386
rs6584194	rs4488133	0.897193204111208	Serum metabolite levels	2e-281	23093944
rs6584194	rs4488133	0.897193204111208	Serum metabolite levels	1e-27	23093944
rs6584194	rs4488133	0.897193204111208	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs6584194	rs4488133	0.897193204111208	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs6584194	rs4488133	0.897193204111208	Urine X-12112 levels in chronic kidney disease	0	37277652
rs6584194	rs4488133	0.897193204111208	X-12093 levels	1e-48	24816252
rs6584194	rs4488133	0.897193204111208	X-12092 levels	0	24816252
rs6584194	rs10883083	0.894241137013551	N2-acetyl,N6-methyllysine levels	0	35347128
rs6584194	rs10883083	0.894241137013551	X-12112 levels	0	35347128
rs6584194	rs10883083	0.894241137013551	Arginine levels	1e-16	35347128
rs6584194	rs10883083	0.894241137013551	Metabolite peak levels (QI8972)	2e-124	35995766
rs6584194	rs10883083	0.894241137013551	Metabolite peak levels (QI5171)	8e-96	35995766
rs6584194	rs2147896	0.894241137013551	Urinary metabolites (H-NMR features)	3e-164	24586186
rs6584194	rs2147896	0.894241137013551	Urinary metabolites (H-NMR features)	8e-30	24586186
rs6584194	rs2147896	0.894241137013551	Urinary metabolites (H-NMR features)	2e-55	24586186
rs6584194	rs2147896	0.894241137013551	Urinary metabolites (H-NMR features)	6e-19	24586186
rs6584194	rs2147896	0.894241137013551	Urinary metabolites (H-NMR features)	4e-34	24586186
rs6584194	rs2147896	0.894241137013551	Trimethylamine levels	4e-144	33283231
rs6584194	rs2147896	0.894241137013551	Serum metabolite levels	1e-15	33031748
rs6584194	rs2147896	0.894241137013551	Serum metabolite levels	4e-226	33031748
rs6584194	rs2147896	0.894241137013551	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs6584194	rs2147896	0.894241137013551	Urinary metabolite levels in chronic kidney disease	0	31959995
rs6584194	rs2147896	0.894241137013551	Urinary metabolite levels in chronic kidney disease	0	31959995
rs6584194	rs2147896	0.894241137013551	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs6584194	rs2147896	0.894241137013551	N6-methyllysine levels	3e-198	33437055
rs6584194	rs2147896	0.894241137013551	N6-methyllysine levels	0	35347128
rs6584194	rs2147896	0.894241137013551	N-methylpipecolate levels	0	35050183
rs6584194	rs2147896	0.894241137013551	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs6584194	rs2147896	0.894241137013551	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs6584194	rs2147896	0.894241137013551	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs6584194	rs2147896	0.894241137013551	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs6584194	rs2147896	0.894241137013551	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs6584194	rs2147896	0.894241137013551	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs6584194	rs2147896	0.894241137013551	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs6584194	rs2147896	0.894241137013551	X-12092 levels	4e-191	27073872
rs6584194	rs2147896	0.894241137013551	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs6584194	rs2147896	0.894241137013551	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs6584194	rs2147896	0.894241137013551	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs6584194	rs2147896	0.894241137013551	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs6584194	rs2147896	0.894241137013551	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs6584194	rs2147896	0.894241137013551	N6-methyllysine levels (advanced age)	5e-25	37118062
rs6584194	rs2147896	0.894241137013551	X-12112 levels	0	36635386
rs6584194	rs2147896	0.894241137013551	N6-methyllysine levels	0	36635386
rs6584194	rs2147896	0.894241137013551	N6,N6-dimethyllysine levels	0	36635386
rs6584194	rs2147896	0.894241137013551	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs6584194	rs2147896	0.894241137013551	N2-acetyl,N6-methyllysine levels	0	36635386
rs6584194	rs10786415	0.894241137013551	N6,N6-dimethyllysine levels	0	35347128
rs6584194	rs10786415	0.894241137013551	N-methylpipecolate levels	0	35347128
rs6584194	rs10786415	0.894241137013551	X-25810 levels	4e-11	36635386
rs6584194	rs942814	0.894241137013551	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs6584194	rs4539242	0.893440763151156	Urinary metabolites (H-NMR features)	2e-20	24586186
rs6584194	rs4539242	0.893440763151156	X-24809 levels	4e-67	33177712
rs6584194	rs4539242	0.893440763151156	X-24983 levels	8e-59	33177712
rs6584194	rs4539242	0.893440763151156	X-12112 levels	4e-63	33177712
rs6584194	rs4539242	0.893440763151156	N-methylpipecolate levels	3e-12	33177712
rs6584194	rs4539242	0.893440763151156	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs6584194	rs4539242	0.893440763151156	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs6584194	rs4539242	0.893440763151156	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs6584194	rs4539242	0.893440763151156	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs6584194	rs4539242	0.893440763151156	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs6584194	rs4539242	0.893440763151156	N6-methyllysine levels (advanced age)	5e-25	37118062
rs6584194	rs4539242	0.893440763151156	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs6584194	rs7072216	0.892605280141193	Metabolite levels	8e-15	21931564
rs6584194	rs7072216	0.892605280141193	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs6584194	rs7905265	0.879504157190734	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs6584194	rs7905265	0.879504157190734	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs6584194	rs7905265	0.879504157190734	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs6584194	rs7905265	0.879504157190734	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs6584194	rs7905265	0.879504157190734	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs6584194	rs7905265	0.879504157190734	N6,N6-dimethyllysine levels	2e-132	35995766
rs6584194	rs7905265	0.879504157190734	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs6584194	rs10786414	0.875807525056515	ADMA levels	5e-18	35995766
rs6584194	rs942810	0.872336718709741	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs6584194	rs942810	0.872336718709741	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs6584194	rs942810	0.872336718709741	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs6584194	rs942810	0.872336718709741	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs6584194	rs942810	0.872336718709741	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs6584194	rs942810	0.872336718709741	N6-methyllysine levels (advanced age)	2e-11	37118062
rs6584194	rs11598867	0.834850915170501	Urinary metabolites	1e-307	26352407
rs6584194	rs942813	0.821779625946569	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs6584194	rs7096654	0.803881557106065	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs6584194	rs7096654	0.803881557106065	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs6584194	rs7096654	0.803881557106065	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs6584194	rs7096654	0.803881557106065	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs6584194	rs1739	0.694891528620875	Metabolite peak levels (QI7389)	3e-91	35995766
rs6584194	rs1737	0.694178673461821	Arginine levels	3e-24	35995766
rs6584194	rs4345897	0.63124672683097	Urinary metabolites (H-NMR features)	2e-19	24586186
rs6584194	rs4345897	0.63124672683097	Urinary metabolites (H-NMR features)	4e-12	24586186
rs6584194	rs4345897	0.63124672683097	Metabolite levels	2e-91	23281178
rs6584194	rs4345897	0.63124672683097	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	4e-25	37118062
rs6584194	rs4345897	0.63124672683097	N6,N6-dimethyllysine levels (elderly offspring)	4e-17	37118062
rs6584194	rs4345897	0.63124672683097	N6-methyllysine levels (elderly offspring)	1e-41	37118062
rs6584194	rs4345897	0.63124672683097	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs6584194	rs4345897	0.63124672683097	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs6584194	rs4345897	0.63124672683097	N6-methyllysine levels (advanced age)	6e-22	37118062
rs6584194	rs2182169	0.603863987495016	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-23	37118062
rs6584194	rs2182169	0.603863987495016	N6,N6-dimethyllysine levels (elderly offspring)	3e-16	37118062
rs6584194	rs2182169	0.603863987495016	N6-methyllysine levels (elderly offspring)	7e-40	37118062
rs6584194	rs2182169	0.603863987495016	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs6584194	rs2182169	0.603863987495016	N6,N6-dimethyllysine levels (advanced age)	4e-09	37118062
rs6584194	rs2182169	0.603863987495016	N6-methyllysine levels (advanced age)	1e-21	37118062
rs6584194	rs6584192	0.600465388400047	Metabolite levels	4e-33	23823483
rs6584194	rs6584192	0.600465388400047	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs6584194	rs6584192	0.600465388400047	N6,N6-dimethyllysine levels (elderly offspring)	2e-16	37118062
rs6584194	rs6584192	0.600465388400047	N6-methyllysine levels (elderly offspring)	3e-41	37118062
rs6584194	rs6584192	0.600465388400047	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs6584194	rs6584192	0.600465388400047	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs6584194	rs6584192	0.600465388400047	N6-methyllysine levels (advanced age)	6e-22	37118062
rs6584197	rs6584202	0.997589167127939	Obesity-related traits	4e-07	23251661
rs6584197	rs45523432	0.8384771349587	Resting-state network 9 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs6584197	rs3830025	0.835677573063616	Resting-state network 3 amplitude (blood oxygenation level dependent) (Attention)	2e-08	36462729
rs6584197	rs3830025	0.835677573063616	Resting-state network 20 amplitude (blood oxygenation level dependent) (Precuneal default mode network)	1e-08	36462729
rs6584197	rs7901577	0.685519744006167	Serum metabolite levels	3e-89	33031748
rs6584197	rs942810	0.639573032709964	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs6584197	rs942810	0.639573032709964	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs6584197	rs942810	0.639573032709964	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs6584197	rs942810	0.639573032709964	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs6584197	rs942810	0.639573032709964	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs6584197	rs942810	0.639573032709964	N6-methyllysine levels (advanced age)	2e-11	37118062
rs6584197	rs1739	0.625632812595297	Metabolite peak levels (QI7389)	3e-91	35995766
rs6584197	rs1737	0.62511701938186	Arginine levels	3e-24	35995766
rs6584202	rs6584202	1	Obesity-related traits	4e-07	23251661
rs6584202	rs45523432	0.83766299172376	Resting-state network 9 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs6584202	rs3830025	0.836366299228085	Resting-state network 3 amplitude (blood oxygenation level dependent) (Attention)	2e-08	36462729
rs6584202	rs3830025	0.836366299228085	Resting-state network 20 amplitude (blood oxygenation level dependent) (Precuneal default mode network)	1e-08	36462729
rs6584202	rs7901577	0.684704442291769	Serum metabolite levels	3e-89	33031748
rs6584202	rs942810	0.639058365010731	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs6584202	rs942810	0.639058365010731	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs6584202	rs942810	0.639058365010731	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs6584202	rs942810	0.639058365010731	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs6584202	rs942810	0.639058365010731	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs6584202	rs942810	0.639058365010731	N6-methyllysine levels (advanced age)	2e-11	37118062
rs6584202	rs1739	0.626406607263975	Metabolite peak levels (QI7389)	3e-91	35995766
rs6584202	rs1737	0.625890778006308	Arginine levels	3e-24	35995766
rs6584592	rs2282326	0.643092183885265	Serum levels of protein GSTO1	4e-265	35078996
rs6584592	rs2282326	0.643092183885265	Glutathione S-transferase omega-1 levels (GSTO1.12436.84.3)	0	29875488
rs6584592	rs1147611	0.604787744909974	Blood protein levels	3e-139	30072576
rs6589260	rs10891301	0.667035101496847	Pyruvate dehydrogenase protein X component, mitochondrial levels	1e-18	34648354
rs6589260	rs2276390	0.654123296266504	Waist-hip ratio	6e-28	30239722
rs659529	rs659529	1	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs659529	rs659529	1	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs659529	rs659529	1	Atopic dermatitis	5e-10	34116867
rs659529	rs34634095	0.827790458676816	Fish- and plant-related diet	3e-09	32066663
rs659529	rs11213941	0.823294515769256	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs659529	rs11213941	0.823294515769256	Eczema	8e-14	30595370
rs659529	rs663763	0.815289747527746	Layilin levels	3e-21	36168886
rs659529	rs480293	0.795254592081873	Oily fish consumption	4e-11	32193382
rs659529	rs539524	0.779777545989707	Asthma	1e-10	32296059
rs659529	rs1613778	0.766416744414889	Total bilirubin levels	3e-08	34594039
rs659529	rs542831	0.725742971234315	Asthma	5e-13	31361310
rs659529	rs1784776	0.723349606315163	Asthma	2e-09	32296059
rs659529	rs1784775	0.723349606315163	Asthma	2e-09	30929738
rs659529	rs1784775	0.723349606315163	Asthma (adult onset)	6e-09	30929738
rs659529	rs1789358	0.722068633841631	Asthma	2e-08	34103634
rs659529	rs12791699	0.689611339424657	Pork consumption	9e-09	32066663
rs659529	rs12791699	0.689611339424657	Oily fish consumption	9e-09	32066663
rs659529	rs487985	0.689611339424657	Highest math class taken	1e-08	30038396
rs659529	rs10891286	0.673542985612133	Noncognitive aspects of educational attainment	5e-10	33414549
rs659529	rs4459340	0.669707562927714	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs659529	rs11213940	0.622049593031705	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI	2e-13	31669095
rs659529	rs505372	0.617620031380447	Breast cancer	3e-06	29059683
rs659529	rs505372	0.617620031380447	Medication use (beta blocking agents)	2e-08	34594039
rs66483059	rs12210271	0.873694416824418	ACE-inhibitor discontinuation	1e-19	35751511
rs66506671	rs9469872	0.95829158969358	HDL cholesterol levels	3e-11	36333282
rs66506671	rs11755393	0.950969143237736	Body mass index	3e-26	29273807
rs66506671	rs11755393	0.950969143237736	Systemic lupus erythematosus	2e-12	33493351
rs66506671	rs11755393	0.950969143237736	Systemic lupus erythematosus	2e-06	33493351
rs66506671	rs11755393	0.950969143237736	Systemic lupus erythematosus	1e-07	33493351
rs66506671	rs11755393	0.950969143237736	Systemic lupus erythematosus	2e-08	19838195
rs66506671	rs11755393	0.950969143237736	Body mass index	4e-55	36581621
rs66506671	rs9366863	0.948147387122498	Adult body size	9e-33	32376654
rs66506671	rs9366863	0.948147387122498	Body mass index	2e-44	30595370
rs66506671	rs6941110	0.94040753568696	Sex hormone-binding globulin levels	5e-27	36653534
rs66506671	rs9462030	0.923398114598207	Red cell distribution width	5e-25	32888493
rs66506671	rs9469857	0.918877131708682	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs66506671	rs2764208	0.91819072300959	Systemic lupus erythematosus	7e-06	24871463
rs66506671	rs2814949	0.911618968201906	Essential hypertension (time to event)	9e-09	32589924
rs66506671	rs9469899	0.906555958302049	Prostate cancer (advanced)	2e-06	29892016
rs66506671	rs9469899	0.906555958302049	Prostate cancer	5e-09	29892016
rs66506671	rs9469899	0.906555958302049	Prostate cancer	8e-11	33398198
rs66506671	rs9469899	0.906555958302049	Hand grip strength	3e-15	29691431
rs66506671	rs9469899	0.906555958302049	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs66506671	rs9469899	0.906555958302049	Graves' disease	4e-10	34594039
rs66506671	rs9469899	0.906555958302049	Coronary artery disease	1e-11	36474045
rs66506671	rs9469899	0.906555958302049	Predicted visceral adipose tissue	2e-20	31501611
rs66506671	rs9469899	0.906555958302049	Medication use (thyroid preparations)	2e-09	31015401
rs66506671	rs9469899	0.906555958302049	Medication use (thyroid preparations)	3e-10	34594039
rs66506671	rs2744944	0.902555271466449	Hypothyroidism	3e-10	34594039
rs66506671	rs2744944	0.902555271466449	High density lipoprotein cholesterol levels	3e-86	34887591
rs66506671	rs2744944	0.902555271466449	Multi-trait sex score	7e-22	37277458
rs66506671	rs2263329	0.885338790769141	HDL cholesterol	6e-35	34594039
rs66506671	rs2263329	0.885338790769141	HDL cholesterol levels	8e-43	32203549
rs66506671	rs2263329	0.885338790769141	High density lipoprotein cholesterol levels	2e-52	34887591
rs66506671	rs9296128	0.871783256281563	Hip circumference adjusted for BMI	4e-13	34021172
rs66506671	rs111868030	0.861274087826917	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs66506671	rs9368830	0.837264120713978	HDL cholesterol	4e-21	30275531
rs66506671	rs9368828	0.811669951769348	Body mass index	1e-34	34594039
rs66506671	rs6912327	0.804812818361656	Fasting insulin	5e-06	33402679
rs66506671	rs6912327	0.804812818361656	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs66506671	rs112283401	0.779482818735648	Red cell distribution width	4e-27	30595370
rs66506671	rs2744973	0.758068707726603	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs66506671	rs2744973	0.758068707726603	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs66506671	rs2744973	0.758068707726603	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs66506671	rs2744973	0.758068707726603	Multi-trait sex score	6e-20	37277458
rs66506671	rs6940215	0.613617191861681	Insomnia	2e-10	35835914
rs66506671	rs6940215	0.613617191861681	Insomnia	1e-13	35835914
rs66506671	rs6940215	0.613617191861681	Hip circumference adjusted for BMI	8e-10	34021172
rs66506671	rs6940215	0.613617191861681	Multi-trait sex score	2e-23	37277458
rs66506671	rs6940215	0.613617191861681	Multi-trait sex score	4e-23	37277458
rs66506671	rs6457796	0.606408583395711	Insomnia	1e-08	30804565
rs66506671	rs6457796	0.606408583395711	Plateletcrit	9e-11	32888494
rs66506671	rs6457796	0.606408583395711	Systemic lupus erythematosus	3e-22	33272962
rs66506671	rs6457796	0.606408583395711	Body mass index	5e-13	30108127
rs66506671	rs6457796	0.606408583395711	Body mass index	1e-14	26426971
rs66506671	rs6457796	0.606408583395711	Educational attainment	5e-19	35361970
rs66516768	rs12526675	0.836986322925772	Brain morphology (MOSTest)	7e-22	32665545
rs66516768	rs4421206	0.806653662656176	Brain morphology (min-P)	4e-11	32665545
rs66516768	rs10872649	0.806648412675362	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs66516768	rs10872649	0.806648412675362	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs66516768	rs10872649	0.806648412675362	Right hippocampal volume (body)	1e-10	37337106
rs66516768	rs9285521	0.801255544292482	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs66516768	rs2342764	0.785079751216163	Cortical thickness	1e-08	34560273
rs66516768	rs9688452	0.783834649345811	Brainstem global volume Whole-brainstem	1e-11	33875891
rs66516768	rs9688452	0.783834649345811	aseg lh volume VentralDC	2e-10	33875891
rs66516768	rs9322194	0.77604110919919	Brainstem volume	2e-11	31636452
rs66516768	rs7752089	0.769684623391655	Brain morphology (MOSTest)	2e-31	35164939
rs66516768	rs4380763	0.765289565721816	Subcortical volume (min-P)	1e-11	32665545
rs66516768	rs1934534	0.763259538368946	Pain (pleiotropy)	2e-08	37844115
rs66516768	rs1934534	0.763259538368946	Pain (pleiotropy)	2e-06	37844115
rs66516768	rs11155671	0.748600771314322	Testicular germ cell tumor	2e-09	28604728
rs66516768	rs56103941	0.746323071452136	Right presubiculum volume (head)	4e-08	37337106
rs66516768	rs9505982	0.726531476990084	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs66516768	rs80147756	0.72220892390839	HippSubfield lh volume subiculum-head	3e-10	33875891
rs66516768	rs12523793	0.709722159616102	Subcortical volume (MOSTest)	4e-24	32665545
rs66516768	rs12523793	0.709722159616102	C-reactive protein levels	3e-08	35459240
rs66516768	rs12523793	0.709722159616102	C-reactive protein levels (MTAG)	2e-08	36376304
rs66516768	rs11155662	0.69601519792387	Vertex-wise cortical thickness	2e-09	34910505
rs6656535	rs8444	0.942373923231125	Cutaneous malignant melanoma	4e-14	32341527
rs6656535	rs2867296	0.938356899376626	Neurological blood protein biomarker levels	3e-12	31320639
rs6656535	rs4970988	0.810836286325049	Urate levels	1e-07	23263486
rs6656535	rs12405726	0.79098609882593	Bitter non-alcoholic beverage consumption	2e-10	31046077
rs6656535	rs72704658	0.784338281892679	Nevus count or cutaneous melanoma	2e-10	30429480
rs6656535	rs143887202	0.745373344656784	Cathepsin S levels	4e-62	34648354
rs6656535	rs10888393	0.730372744086081	Cathepsin S levels	1e-26	36168886
rs6656535	rs10305664	0.729552667176991	Tea consumption	7e-06	31046077
rs6656535	rs10888395	0.711565122411021	Monocyte chemoattractant protein-1 levels	6e-07	27989323
rs6656535	rs2230061	0.682013249693566	Fat body mass	4e-08	24064335
rs6656535	rs1336900	0.629194356723941	Cathepsin S levels	1e-19	28240269
rs6656535	rs10399947	0.620416641959969	Cutaneous squamous cell carcinoma	7e-09	32041948
rs6656535	rs11587444	0.62032559518243	Morning person	2e-08	30595370
rs66588921	rs6705511	0.765421736813133	Self-reported math ability	4e-09	30038396
rs66588921	rs6705511	0.765421736813133	Self-reported math ability (MTAG)	3e-10	30038396
rs66588921	rs34276187	0.759214027254628	Highest math class taken (MTAG)	2e-08	30038396
rs6660003	rs6680628	0.71624439796792	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs6660531	rs7545078	0.633000667055078	Smoking initiation	2e-09	36477530
rs6663465	rs12729558	0.946629856232447	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs6663465	rs10922531	0.907727213068194	Serum metabolite levels	2e-69	33031748
rs6663465	rs7532151	0.873540641403732	Imidazole lactate levels	9e-12	33177712
rs6663465	rs10801690	0.8466190337152	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs6663465	rs7530513	0.832490474096479	Height	8e-11	35831902
rs6663465	rs7530513	0.832490474096479	Imidazole lactate levels	8e-166	36635386
rs6663465	rs12144640	0.832490474096479	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs6663465	rs1409152	0.82093903832024	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs6663465	rs1409152	0.82093903832024	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs6663465	rs10801699	0.818825450655192	X-23639 levels	2e-10	36635386
rs6663465	rs9787133	0.816349472582233	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs6663465	rs12120164	0.784732721190749	Metabolite peak levels (QI2146)	1e-26	35995766
rs6663465	rs2765527	0.765782873842068	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs6663465	rs2810876	0.656028937379871	Imidazole lactate levels	2e-122	35347128
rs6663465	rs10801696	0.654718193699616	Imidazole lactate levels	3e-195	35050183
rs6663465	rs1206228892	0.654194307795355	Imidazole lactate levels	5e-186	35050183
rs6663949	rs10465746	0.666485425118218	Obesity-related traits	8e-06	23251661
rs6663949	rs11580836	0.637440009002819	Body mass index	2e-09	36581621
rs6666448	rs12142240	0.702139394424618	Menopause (age at onset)	7e-09	26414677
rs6666448	rs112869704	0.694415287559841	Age at menopause	4e-13	30595370
rs6666997	rs6680628	0.798126034296977	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs66676918	rs1063631	0.882554092010145	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs66676918	rs1063631	0.882554092010145	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs66676918	rs6928810	0.879457998363124	Platelet distribution width	1e-14	32888494
rs66676918	rs3869132	0.878585231250779	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs66676918	rs3869132	0.878585231250779	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs66676918	rs9266825	0.853189602739	Autism spectrum disorder	6e-06	35215271
rs66676918	rs199530775	0.730358320230927	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs66676918	rs55957433	0.730358320230927	Hip circumference adjusted for BMI	3e-08	34021172
rs66676918	rs6934175	0.662804519571424	Psoriatic arthritis	5e-28	30552173
rs66676918	rs17200242	0.653625177219074	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs66676918	rs7751505	0.649070855182524	Pubertal anthropometrics	4e-06	23449627
rs66676918	rs35026345	0.647748548132933	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs66676918	rs72848707	0.642569083727913	HDL cholesterol levels	7e-06	35884923
rs66676918	rs13437088	0.623156484525899	Psoriasis	3e-40	23143594
rs66676918	rs13437082	0.62246212500795	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs66676918	rs13437082	0.62246212500795	Height	5e-08	19343178
rs66676918	rs72657657	0.614898941732872	Hip circumference adjusted for BMI	4e-13	34021172
rs6670658	rs10465746	0.944403490488107	Obesity-related traits	8e-06	23251661
rs6670658	rs11580836	0.904501633982238	Body mass index	2e-09	36581621
rs6673179	rs12729558	0.945815419579361	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs6673179	rs10922531	0.906975848741528	Serum metabolite levels	2e-69	33031748
rs6673179	rs7532151	0.872740435563474	Imidazole lactate levels	9e-12	33177712
rs6673179	rs10801690	0.845827942826344	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs6673179	rs7530513	0.831806336294474	Height	8e-11	35831902
rs6673179	rs7530513	0.831806336294474	Imidazole lactate levels	8e-166	36635386
rs6673179	rs12144640	0.831806336294474	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs6673179	rs1409152	0.820263353148538	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs6673179	rs1409152	0.820263353148538	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs6673179	rs10801699	0.819671156738678	X-23639 levels	2e-10	36635386
rs6673179	rs9787133	0.815567474922997	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs6673179	rs12120164	0.784086295989202	Metabolite peak levels (QI2146)	1e-26	35995766
rs6673179	rs2765527	0.764993383358067	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs6673179	rs2810876	0.655255278422818	Imidazole lactate levels	2e-122	35347128
rs6673179	rs10801696	0.653944031555424	Imidazole lactate levels	3e-195	35050183
rs6673179	rs1206228892	0.653420217974946	Imidazole lactate levels	5e-186	35050183
rs6674949	rs7524908	0.682476253680368	Height	5e-27	30595370
rs6674949	rs3828081	0.675363674736874	Cognitive function (immediate memory)	8e-08	35386118
rs6675223	rs6680628	0.793657613865689	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs66793022	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs66793022	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs66793022	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs66793022	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs66793022	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs66793022	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs66793022	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs66793022	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs66793022	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs66793022	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs66793022	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs66793022	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs66793022	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs66793022	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs66793022	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs66793022	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs66793022	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs66793022	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs66793022	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs66793022	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs66793022	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs66793022	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs66793022	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs66793022	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs66793022	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs66793022	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs6680125	rs6680628	0.67599583311681	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs6681742	rs8444	0.942373923231125	Cutaneous malignant melanoma	4e-14	32341527
rs6681742	rs2867296	0.938356899376626	Neurological blood protein biomarker levels	3e-12	31320639
rs6681742	rs4970988	0.810836286325049	Urate levels	1e-07	23263486
rs6681742	rs12405726	0.79098609882593	Bitter non-alcoholic beverage consumption	2e-10	31046077
rs6681742	rs72704658	0.784338281892679	Nevus count or cutaneous melanoma	2e-10	30429480
rs6681742	rs143887202	0.745373344656784	Cathepsin S levels	4e-62	34648354
rs6681742	rs10888393	0.730372744086081	Cathepsin S levels	1e-26	36168886
rs6681742	rs10305664	0.729552667176991	Tea consumption	7e-06	31046077
rs6681742	rs10888395	0.711565122411021	Monocyte chemoattractant protein-1 levels	6e-07	27989323
rs6681742	rs2230061	0.682013249693566	Fat body mass	4e-08	24064335
rs6681742	rs1336900	0.629194356723941	Cathepsin S levels	1e-19	28240269
rs6681742	rs10399947	0.620416641959969	Cutaneous squamous cell carcinoma	7e-09	32041948
rs6681742	rs11587444	0.62032559518243	Morning person	2e-08	30595370
rs6682686	rs10801696	0.999199857041977	Imidazole lactate levels	3e-195	35050183
rs6682686	rs1206228892	0.998400327220321	Imidazole lactate levels	5e-186	35050183
rs6682686	rs2810876	0.99520593990034	Imidazole lactate levels	2e-122	35347128
rs6682686	rs2765527	0.85417060959166	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs6682686	rs7532151	0.716304095131995	Imidazole lactate levels	9e-12	33177712
rs6682686	rs12729558	0.689498730821059	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs6682686	rs10127863	0.670479365323203	Intraocular pressure	9e-10	29617998
rs6682686	rs9787133	0.657899431914794	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs6682686	rs10801690	0.641192899339957	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs6682686	rs12143830	0.6031936338493	Central corneal thickness (MTAG)	4e-10	35446358
rs6682868	rs7524908	0.683247221360777	Height	5e-27	30595370
rs6682868	rs3828081	0.675976133813091	Cognitive function (immediate memory)	8e-08	35386118
rs6685187	rs6685187	1	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs6685187	rs6698740	0.994334227445493	Beta-hydroxyisovalerate levels	1e-13	35347128
rs6685187	rs1060870	0.992718344958297	Serum metabolite levels	1e-11	33031748
rs6685187	rs1060870	0.992718344958297	Serum metabolite levels	1e-15	33031748
rs6685187	rs2338201	0.982289677881086	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs6685187	rs2338201	0.982289677881086	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs6685187	rs2338201	0.982289677881086	Dodecadienoate (12:2) levels	7e-15	36635386
rs6685187	rs11204914	0.968649369332175	Carnitine C9 levels	1e-13	35995766
rs6685187	rs11204914	0.968649369332175	Metabolite peak levels (QI6204)	1e-32	35995766
rs6685187	rs11204914	0.968649369332175	Metabolite peak levels (QI6252)	2e-32	35995766
rs6685187	rs10788817	0.955906829676114	Serum metabolite levels	3e-13	24625756
rs6685187	rs10788817	0.955906829676114	Metabolite peak levels (QI2718)	5e-18	35995766
rs6685187	rs10788817	0.955906829676114	3-hydroxylaurate levels	2e-12	36635386
rs6685187	rs10788817	0.955906829676114	Tetradecadienoate (14:2) levels	8e-17	36635386
rs6685187	rs7542137	0.834030341322238	Beta-hydroxyisovalerate levels	3e-11	35050183
rs6685187	rs7542137	0.834030341322238	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs6685187	rs7542137	0.834030341322238	3-hydroxysebacate levels	2e-10	36635386
rs6685187	rs7523082	0.833839804194436	Metabolite peak levels (QI9845)	2e-14	35995766
rs6685187	rs10888445	0.817894740998637	Beta-hydroxyisovalerate levels	5e-13	36635386
rs6685187	rs2130525	0.816833639055597	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs6685187	rs7541453	0.812106804709942	Serum metabolite levels	2e-16	33031748
rs6685187	rs7541453	0.812106804709942	Serum metabolite levels	2e-16	33031748
rs6685187	rs7541453	0.812106804709942	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs6685187	rs2999545	0.799925355198851	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs6685187	rs2279501	0.782457412061492	Serum metabolite levels	3e-14	33031748
rs6685187	rs3007711	0.76102138875327	Electrodermal activity	9e-06	25387706
rs6685187	rs2999541	0.760111553400485	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs6685187	rs1038747	0.661879967270732	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs6685344	rs10465746	0.954859935816171	Obesity-related traits	8e-06	23251661
rs6685344	rs11580836	0.916299094924863	Body mass index	2e-09	36581621
rs6687372	rs11580836	0.944733196565228	Body mass index	2e-09	36581621
rs6687372	rs10465746	0.925146961544304	Obesity-related traits	8e-06	23251661
rs6689242	rs7545078	0.675444466574543	Smoking initiation	2e-09	36477530
rs6689242	rs6700087	0.614158440549037	Smoking initiation	6e-11	36477530
rs6692233	rs11580836	0.845260527692738	Body mass index	2e-09	36581621
rs6692233	rs10465746	0.818443632788659	Obesity-related traits	8e-06	23251661
rs6692233	rs1536166	0.614476698129096	Body mass index	2e-08	30595370
rs6695687	rs7545078	0.629026829703607	Smoking initiation	2e-09	36477530
rs6698740	rs6698740	1	Beta-hydroxyisovalerate levels	1e-13	35347128
rs6698740	rs1060870	0.99837959677725	Serum metabolite levels	1e-11	33031748
rs6698740	rs1060870	0.99837959677725	Serum metabolite levels	1e-15	33031748
rs6698740	rs6685187	0.994334227445493	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs6698740	rs2338201	0.978276106019325	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs6698740	rs2338201	0.978276106019325	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs6698740	rs2338201	0.978276106019325	Dodecadienoate (12:2) levels	7e-15	36635386
rs6698740	rs11204914	0.969454413510555	Carnitine C9 levels	1e-13	35995766
rs6698740	rs11204914	0.969454413510555	Metabolite peak levels (QI6204)	1e-32	35995766
rs6698740	rs11204914	0.969454413510555	Metabolite peak levels (QI6252)	2e-32	35995766
rs6698740	rs10788817	0.956703560944964	Serum metabolite levels	3e-13	24625756
rs6698740	rs10788817	0.956703560944964	Metabolite peak levels (QI2718)	5e-18	35995766
rs6698740	rs10788817	0.956703560944964	3-hydroxylaurate levels	2e-12	36635386
rs6698740	rs10788817	0.956703560944964	Tetradecadienoate (14:2) levels	8e-17	36635386
rs6698740	rs7542137	0.839352566311773	Beta-hydroxyisovalerate levels	3e-11	35050183
rs6698740	rs7542137	0.839352566311773	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs6698740	rs7542137	0.839352566311773	3-hydroxysebacate levels	2e-10	36635386
rs6698740	rs7523082	0.831579559692658	Metabolite peak levels (QI9845)	2e-14	35995766
rs6698740	rs2130525	0.814676365339384	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs6698740	rs10888445	0.812752660257769	Beta-hydroxyisovalerate levels	5e-13	36635386
rs6698740	rs7541453	0.806975754916076	Serum metabolite levels	2e-16	33031748
rs6698740	rs7541453	0.806975754916076	Serum metabolite levels	2e-16	33031748
rs6698740	rs7541453	0.806975754916076	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs6698740	rs2999545	0.797727648929538	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs6698740	rs2279501	0.781782711963395	Serum metabolite levels	3e-14	33031748
rs6698740	rs3007711	0.758951575290857	Electrodermal activity	9e-06	25387706
rs6698740	rs2999541	0.75804274474034	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs6698740	rs1038747	0.661235473039532	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs6703382	rs11580836	0.944718411083462	Body mass index	2e-09	36581621
rs6703382	rs10465746	0.926824374678406	Obesity-related traits	8e-06	23251661
rs6709534	rs2290911	0.970069381377158	Height	5e-07	29782485
rs6709534	rs2290911	0.970069381377158	Large artery stroke	6e-06	28265093
rs6709534	rs2290911	0.970069381377158	Height	8e-112	36224396
rs6709534	rs17713396	0.944145301864024	Blood urea nitrogen levels	3e-21	34272381
rs6709534	rs17713396	0.944145301864024	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs6709534	rs17713396	0.944145301864024	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs6709534	rs6710091	0.942139487329495	Waist circumference adjusted for body mass index	8e-11	31669095
rs6709534	rs6710091	0.942139487329495	HDL cholesterol	5e-08	30275531
rs6709534	rs6710091	0.942139487329495	High density lipoprotein cholesterol levels	3e-24	34887591
rs6709534	rs7595075	0.926169756145242	Waist circumference adjusted for body mass index	2e-09	34021172
rs6709534	rs7595075	0.926169756145242	HDL cholesterol	3e-11	34594039
rs6709534	rs7595075	0.926169756145242	HDL cholesterol levels	6e-13	32203549
rs6709534	rs2126129	0.925679914127328	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs6709534	rs17713729	0.925266831655516	Body mass index	2e-09	31669095
rs6709534	rs17713729	0.925266831655516	Serum creatinine levels	4e-14	34594039
rs6709534	rs17713729	0.925266831655516	High density lipoprotein cholesterol levels	7e-17	34887591
rs6709534	rs79716074	0.922139239466947	Plateletcrit	1e-09	32888494
rs6709534	rs79716074	0.922139239466947	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs6709534	rs79716074	0.922139239466947	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs6709534	rs79716074	0.922139239466947	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs6709534	rs58461606	0.915721640336996	Blood protein levels	0	30072576
rs6709534	rs7605824	0.908648028838563	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs6709534	rs7566279	0.907703206339229	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs6709534	rs3791221	0.905242065211951	Blood urea nitrogen levels	2e-07	31152163
rs6709534	rs3791221	0.905242065211951	Estimated glomerular filtration rate	2e-10	31152163
rs6709534	rs3791221	0.905242065211951	Estimated glomerular filtration rate	1e-11	31152163
rs6709534	rs3791221	0.905242065211951	Blood urea nitrogen levels	7e-26	34594039
rs6709534	rs11553746	0.894466301018157	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs6709534	rs11553746	0.894466301018157	High density lipoprotein cholesterol levels	2e-07	29083408
rs6709534	rs11553746	0.894466301018157	High density lipoprotein cholesterol levels	7e-15	29083408
rs6709534	rs11553746	0.894466301018157	Large artery stroke	4e-06	28265093
rs6709534	rs114976176	0.865722816567458	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs6709534	rs62114548	0.851935694815727	Retinal vascular fractal density	2e-09	34743558
rs6709534	rs59937473	0.839171309224406	Protein quantitative trait loci	3e-67	32492067
rs6709534	rs59937473	0.839171309224406	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs6709534	rs17714252	0.831430772442407	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs6709534	rs17714252	0.831430772442407	Retinal vascular fractal dimension	2e-07	34743558
rs6709534	rs7601944	0.829968711898577	Smoking initiation	4e-15	36477530
rs6709534	rs55753056	0.821252602431428	Height	2e-22	30595370
rs6709534	rs79154857	0.808283120820675	Pulse pressure	5e-08	34594039
rs6709534	rs62114506	0.785565962751939	Gamma glutamyl transpeptidase	3e-14	34594039
rs6709534	rs62114506	0.785565962751939	Apolipoprotein A1 levels	3e-10	32203549
rs6709534	rs62114506	0.785565962751939	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs6709534	rs62114506	0.785565962751939	HDL cholesterol levels	8e-10	36333282
rs6709534	rs62114538	0.781174979131468	Triglyceride levels	6e-12	34887591
rs6709534	rs17713879	0.776911202938935	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs6709534	rs17713879	0.776911202938935	Smoking initiation	1e-10	36477530
rs6709534	rs17713879	0.776911202938935	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs6709534	rs17713879	0.776911202938935	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs6709534	rs17713879	0.776911202938935	Triglyceride levels	3e-10	34887591
rs6709534	rs17713879	0.776911202938935	Aging (eyeAgeAcceleration)	6e-50	36975205
rs6709534	rs60843830	0.770536480313786	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs6709534	rs60843830	0.770536480313786	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs6709534	rs60843830	0.770536480313786	Adventurousness	7e-10	30643258
rs6710091	rs6710091	1	Waist circumference adjusted for body mass index	8e-11	31669095
rs6710091	rs6710091	1	HDL cholesterol	5e-08	30275531
rs6710091	rs6710091	1	High density lipoprotein cholesterol levels	3e-24	34887591
rs6710091	rs17713396	0.995896703776475	Blood urea nitrogen levels	3e-21	34272381
rs6710091	rs17713396	0.995896703776475	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs6710091	rs17713396	0.995896703776475	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs6710091	rs7595075	0.977536264243732	Waist circumference adjusted for body mass index	2e-09	34021172
rs6710091	rs7595075	0.977536264243732	HDL cholesterol	3e-11	34594039
rs6710091	rs7595075	0.977536264243732	HDL cholesterol levels	6e-13	32203549
rs6710091	rs17713729	0.976540483628502	Body mass index	2e-09	31669095
rs6710091	rs17713729	0.976540483628502	Serum creatinine levels	4e-14	34594039
rs6710091	rs17713729	0.976540483628502	High density lipoprotein cholesterol levels	7e-17	34887591
rs6710091	rs79716074	0.973467644777114	Plateletcrit	1e-09	32888494
rs6710091	rs79716074	0.973467644777114	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs6710091	rs79716074	0.973467644777114	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs6710091	rs79716074	0.973467644777114	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs6710091	rs58461606	0.966547293042135	Blood protein levels	0	30072576
rs6710091	rs7605824	0.959440465855479	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs6710091	rs7566279	0.958451020898533	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs6710091	rs3791221	0.95518258188227	Blood urea nitrogen levels	2e-07	31152163
rs6710091	rs3791221	0.95518258188227	Estimated glomerular filtration rate	2e-10	31152163
rs6710091	rs3791221	0.95518258188227	Estimated glomerular filtration rate	1e-11	31152163
rs6710091	rs3791221	0.95518258188227	Blood urea nitrogen levels	7e-26	34594039
rs6710091	rs2290911	0.94927208968099	Height	5e-07	29782485
rs6710091	rs2290911	0.94927208968099	Large artery stroke	6e-06	28265093
rs6710091	rs2290911	0.94927208968099	Height	8e-112	36224396
rs6710091	rs2126129	0.941147228787264	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs6710091	rs114976176	0.914487849562585	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs6710091	rs59937473	0.886403792087758	Protein quantitative trait loci	3e-67	32492067
rs6710091	rs59937473	0.886403792087758	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs6710091	rs17714252	0.878575971359278	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs6710091	rs17714252	0.878575971359278	Retinal vascular fractal dimension	2e-07	34743558
rs6710091	rs7601944	0.876405149985028	Smoking initiation	4e-15	36477530
rs6710091	rs11553746	0.875310498182565	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs6710091	rs11553746	0.875310498182565	High density lipoprotein cholesterol levels	2e-07	29083408
rs6710091	rs11553746	0.875310498182565	High density lipoprotein cholesterol levels	7e-15	29083408
rs6710091	rs11553746	0.875310498182565	Large artery stroke	4e-06	28265093
rs6710091	rs55753056	0.869460830875673	Height	2e-22	30595370
rs6710091	rs62114548	0.846725962732625	Retinal vascular fractal density	2e-09	34743558
rs6710091	rs62114538	0.825945931001907	Triglyceride levels	6e-12	34887591
rs6710091	rs17713879	0.823920285174706	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs6710091	rs17713879	0.823920285174706	Smoking initiation	1e-10	36477530
rs6710091	rs17713879	0.823920285174706	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs6710091	rs17713879	0.823920285174706	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs6710091	rs17713879	0.823920285174706	Triglyceride levels	3e-10	34887591
rs6710091	rs17713879	0.823920285174706	Aging (eyeAgeAcceleration)	6e-50	36975205
rs6710091	rs60843830	0.817413425343089	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs6710091	rs60843830	0.817413425343089	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs6710091	rs60843830	0.817413425343089	Adventurousness	7e-10	30643258
rs6710091	rs79154857	0.792627466532873	Pulse pressure	5e-08	34594039
rs6710091	rs62114506	0.770899000063918	Gamma glutamyl transpeptidase	3e-14	34594039
rs6710091	rs62114506	0.770899000063918	Apolipoprotein A1 levels	3e-10	32203549
rs6710091	rs62114506	0.770899000063918	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs6710091	rs62114506	0.770899000063918	HDL cholesterol levels	8e-10	36333282
rs67111717	rs67111717	1	Multiple sclerosis	3e-21	31604244
rs67111717	rs4976646	0.972132013023064	Multiple sclerosis	4e-18	24076602
rs67111717	rs4976646	0.972132013023064	Blood urea nitrogen levels	1e-19	31152163
rs67111717	rs4976646	0.972132013023064	Chronic kidney disease	2e-10	31152163
rs67111717	rs4976646	0.972132013023064	Crohn's disease	3e-08	26192919
rs67111717	rs4976646	0.972132013023064	Ulcerative colitis	3e-09	26192919
rs67111717	rs4976646	0.972132013023064	Inflammatory bowel disease	3e-12	26192919
rs67111717	rs4976646	0.972132013023064	Tumor necrosis factor receptor 2 levels	4e-10	33067605
rs67111717	rs4976646	0.972132013023064	Inflammatory bowel disease	4e-09	28067908
rs67111717	rs4976646	0.972132013023064	Ulcerative colitis	4e-08	28067908
rs67111717	rs4976689	0.968920266947255	Eosinophil counts	4e-18	34594039
rs67111717	rs6556313	0.963200619681623	Eosinophil counts	2e-20	32888493
rs67111717	rs6556313	0.963200619681623	Eosinophil counts	1e-16	32888494
rs67111717	rs6556313	0.963200619681623	Eosinophil percentage of white cells	1e-11	32888494
rs67111717	rs6556313	0.963200619681623	Calcium levels	1e-12	33887147
rs67111717	rs6556313	0.963200619681623	Eosinophil counts	1e-21	30595370
rs67111717	rs10051765	0.813735556691507	Vitamin C levels	4e-09	33203707
rs67111717	rs10051765	0.813735556691507	Kidney stones	8e-15	31729369
rs67111717	rs56235845	0.748687034966832	Hematocrit	9e-11	27863252
rs67111717	rs56235845	0.748687034966832	Hemoglobin concentration	1e-09	27863252
rs67111717	rs56235845	0.748687034966832	Kidney stones	3e-21	31729369
rs67111717	rs56235845	0.748687034966832	Hemoglobin levels	7e-16	32327693
rs67111717	rs11135015	0.747304718473038	Eosinophil counts	4e-21	32888493
rs67111717	rs4976647	0.717454954276516	Calcium levels	7e-18	34594039
rs67111717	rs12654812	0.655224905984877	Renal function-related traits (sCR)	5e-07	22797727
rs67111717	rs12654812	0.655224905984877	Renal function-related traits (eGRFcrea)	2e-07	22797727
rs67111717	rs12654812	0.655224905984877	Kidney stones	6e-11	26272126
rs67111717	rs12654812	0.655224905984877	Inflammatory bowel disease	2e-08	23128233
rs67111717	rs12654812	0.655224905984877	Serum phosphate levels	2e-86	33462484
rs67111717	rs12654812	0.655224905984877	Urea levels	4e-26	33462484
rs67111717	rs12654812	0.655224905984877	Urate levels	2e-11	33462484
rs67111717	rs12654812	0.655224905984877	Cystatin C levels	7e-72	33462484
rs67111717	rs12654812	0.655224905984877	Creatinine levels	7e-40	33462484
rs67111717	rs12654812	0.655224905984877	Estimated glomerular filtration rate	3e-38	33462484
rs67111717	rs12654812	0.655224905984877	Calcium levels	5e-13	33462484
rs67111717	rs35716097	0.654984202577041	Phosphorus levels	2e-23	29403010
rs67111717	rs35716097	0.654984202577041	Glomerular filtration rate	4e-09	27588450
rs67111717	rs35716097	0.654984202577041	Glomerular filtration rate	6e-07	27588450
rs67111717	rs35716097	0.654984202577041	Glomerular filtration rate	2e-17	27588450
rs6715189	rs12618864	0.689404700831039	Interleukin-19 levels	6e-13	36168886
rs67303849	rs6705511	0.752653094598621	Self-reported math ability	4e-09	30038396
rs67303849	rs6705511	0.752653094598621	Self-reported math ability (MTAG)	3e-10	30038396
rs67303849	rs34276187	0.746482702095445	Highest math class taken (MTAG)	2e-08	30038396
rs6733550	rs58588820	0.974548237791576	Total cholesterol levels	1e-09	34887591
rs6733550	rs58588820	0.974548237791576	Total cholesterol levels	8e-11	34887591
rs6733550	rs6547629	0.88315432654742	Height	3e-09	36224396
rs6733550	rs10206961	0.638602994082487	Parental longevity (father's age at death)	2e-06	31484785
rs6739323	rs6743685	0.711067680154239	Height	1e-35	30595370
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for body mass index	7e-07	25673412
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for body mass index	4e-06	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for body mass index	5e-08	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for body mass index	5e-06	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for body mass index	8e-08	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for BMI in non-smokers	1e-06	28443625
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	2e-07	28443625
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	2e-07	28443625
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	2e-06	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	2e-06	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	1e-08	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	3e-08	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for BMI in active individuals	2e-07	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for BMI in active individuals	1e-06	28448500
rs6739323	rs6715793	0.659296544661019	Waist circumference adjusted for body mass index	1e-08	25673412
rs6739323	rs6715793	0.659296544661019	Height	4e-37	36224396
rs6739323	rs6715793	0.659296544661019	Height	3e-16	36224396
rs6739323	rs6715793	0.659296544661019	Height	1e-300	36224396
rs6739323	rs4637087	0.652387420433237	Waist circumference adjusted for body mass index	3e-10	31669095
rs6739323	rs12104955	0.637126548586675	Carpal tunnel syndrome	4e-08	30833571
rs6739517	rs6705511	0.732532988626945	Self-reported math ability	4e-09	30038396
rs6739517	rs6705511	0.732532988626945	Self-reported math ability (MTAG)	3e-10	30038396
rs6739517	rs34276187	0.726316296613324	Highest math class taken (MTAG)	2e-08	30038396
rs674230	rs659529	0.996470203948668	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs674230	rs659529	0.996470203948668	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs674230	rs659529	0.996470203948668	Atopic dermatitis	5e-10	34116867
rs674230	rs34634095	0.829466299207561	Fish- and plant-related diet	3e-09	32066663
rs674230	rs11213941	0.819572046237076	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs674230	rs11213941	0.819572046237076	Eczema	8e-14	30595370
rs674230	rs663763	0.8124011663467	Layilin levels	3e-21	36168886
rs674230	rs480293	0.792170548190293	Oily fish consumption	4e-11	32193382
rs674230	rs539524	0.776830694608213	Asthma	1e-10	32296059
rs674230	rs1613778	0.767899133944575	Total bilirubin levels	3e-08	34594039
rs674230	rs542831	0.722708789457406	Asthma	5e-13	31361310
rs674230	rs1784776	0.720314147100366	Asthma	2e-09	32296059
rs674230	rs1784775	0.720314147100366	Asthma	2e-09	30929738
rs674230	rs1784775	0.720314147100366	Asthma (adult onset)	6e-09	30929738
rs674230	rs1789358	0.719041799644811	Asthma	2e-08	34103634
rs674230	rs12791699	0.686611433754424	Pork consumption	9e-09	32066663
rs674230	rs12791699	0.686611433754424	Oily fish consumption	9e-09	32066663
rs674230	rs487985	0.686611433754424	Highest math class taken	1e-08	30038396
rs674230	rs10891286	0.670517249770137	Noncognitive aspects of educational attainment	5e-10	33414549
rs674230	rs4459340	0.666680116749377	Medication use (agents acting on the renin-angiotensin system)	2e-12	31015401
rs674230	rs11213940	0.618108488839477	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI	2e-13	31669095
rs674230	rs505372	0.614587590375725	Breast cancer	3e-06	29059683
rs674230	rs505372	0.614587590375725	Medication use (beta blocking agents)	2e-08	34594039
rs6746869	rs8207	0.778005006244301	Monocyte count	1e-10	32888493
rs6746869	rs8207	0.778005006244301	Height	2e-18	36224396
rs6746869	rs6738934	0.630325495596745	Vaginal microbiome MetaCyc pathway (PWY-5741|ethylmalonyl-CoA pathway)	3e-07	34282934
rs6759076	rs6759076	1	Juvenile osteochondritis dissecans	6e-06	26422391
rs6761095	rs6547740	0.737517759660007	Resistance to COVID-19 infection (Exposed negative vs positive)	3e-08	36662838
rs6761095	rs6547741	0.73674806257879	Oral cavity cancer	4e-08	27749845
rs6761095	rs1528402	0.73674806257879	Resistance to COVID-19 infection (Exposed negative vs positive)	6e-06	36662838
rs6761095	rs2178197	0.709952828276601	Alcohol consumption (drinks per week)	2e-09	30643251
rs6761095	rs4666006	0.686211486901706	Resistance to COVID-19 infection (Exposed negative vs positive)	4e-08	36662838
rs6761095	rs1919126	0.657068531387969	Mean arterial pressure	9e-06	27618448
rs67675428	rs1550057	0.939053353429998	Conduct disorder	4e-06	20585324
rs67675428	rs1550057	0.939053353429998	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs67675428	rs34402449	0.938919532119883	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs67675428	rs17007017	0.608827996980029	Conduct disorder	7e-06	20585324
rs6773232	rs6442487	0.658012635844587	Height	4e-58	36224396
rs67744575	rs2868708	0.906686356328718	Lymphocyte count	3e-11	34469753
rs67744575	rs2868708	0.906686356328718	White blood cell count	1e-09	30595370
rs67744575	rs6831339	0.903437022404678	High density lipoprotein cholesterol levels	9e-09	34887591
rs67744575	rs6535419	0.858788350897931	Pulse pressure	6e-10	30578418
rs67744575	rs116142917	0.827331986266373	Lymphocyte count	7e-18	32888494
rs67744575	rs6823199	0.817432533078708	Pulse pressure	4e-14	30224653
rs67744575	rs13111599	0.806200623306028	HDL cholesterol levels	3e-09	32203549
rs67744575	rs13111599	0.806200623306028	Apolipoprotein A1 levels	4e-08	32203549
rs67744575	rs11099563	0.751938261762805	High density lipoprotein cholesterol levels	3e-11	34887591
rs67744575	rs28528763	0.732075631938953	White blood cell count	7e-12	32888494
rs67744575	rs4302451	0.731369238141348	Eosinophil counts	2e-09	30595370
rs67744575	rs35895091	0.690514670314218	Cardiovascular disease	1e-07	30595370
rs67744575	rs7662402	0.64229189110434	Brain morphology (MOSTest)	3e-08	35164939
rs6775710	rs4681679	0.992068226560984	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs6775710	rs11719450	0.952692897314339	Hemoglobin concentration	2e-09	27863252
rs6775710	rs11719450	0.952692897314339	Hemoglobin levels	2e-16	32327693
rs6775710	rs56384862	0.939708016901768	Body mass index	8e-12	29273807
rs6775710	rs56384862	0.939708016901768	Body mass index	3e-06	30108127
rs6775710	rs56384862	0.939708016901768	Hemoglobin levels	1e-16	32327693
rs6775710	rs56384862	0.939708016901768	Body mass index	3e-14	36581621
rs6775710	rs6775517	0.891466342725766	Hematocrit	1e-17	34594039
rs6775710	rs7610312	0.887535288599035	Red blood cell count	5e-09	27863252
rs6775710	rs57700771	0.883610330464417	Red blood cell count	9e-21	30595370
rs6775710	rs11705721	0.869187866949396	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs6775710	rs11130638	0.869187866949396	Hemoglobin concentration	2e-23	32888493
rs6775710	rs34579268	0.862788476133389	Hematocrit	5e-30	32888493
rs6775710	rs34579268	0.862788476133389	Hematocrit	2e-27	32888493
rs6775710	rs34579268	0.862788476133389	Hemoglobin concentration	5e-26	32888493
rs6775710	rs55692656	0.833177318393976	vWF levels	3e-08	30586737
rs6775710	rs55692656	0.833177318393976	vWF levels	6e-09	30586737
rs6775710	rs55704295	0.808909879538636	Red blood cell count	8e-26	32888493
rs6775710	rs55704295	0.808909879538636	Red blood cell count	5e-23	32888493
rs6775710	rs55704295	0.808909879538636	Serum total protein level	2e-29	34594039
rs6775710	rs11922478	0.787768402167796	Semaphorin-6B levels	4e-12	34648354
rs6775710	rs6445969	0.776333448425951	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs6775710	rs11708895	0.766704811117492	Red blood cell count	1e-20	32888494
rs6775710	rs55954186	0.761856701526075	vWF levels	5e-09	30586737
rs6775710	rs55954186	0.761856701526075	vWF levels	9e-09	30586737
rs6775710	rs7431952	0.697555055925862	Hemoglobin levels	1e-12	32327693
rs6775710	rs9311676	0.632540857485396	Systemic lupus erythematosus	5e-06	27399966
rs6775710	rs9311676	0.632540857485396	Systemic lupus erythematosus	3e-14	26502338
rs6775710	rs9311676	0.632540857485396	Waist circumference adjusted for body mass index	3e-08	34021172
rs6775710	rs9822855	0.622985311108345	Educational attainment	9e-120	35361970
rs67904096	rs7610312	0.997507911336935	Red blood cell count	5e-09	27863252
rs67904096	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs67904096	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs67904096	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs67904096	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs67904096	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs67904096	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs67904096	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs67904096	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs67904096	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs67904096	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs67904096	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs67904096	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs67904096	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs67904096	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs67904096	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs67904096	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs67904096	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs67904096	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs67904096	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs67904096	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs67904096	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs67904096	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs67904096	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs67904096	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs67904096	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs6791192	rs6442487	0.681131262113136	Height	4e-58	36224396
rs6799077	rs11705721	1	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs6799077	rs11130638	0.997542556420607	Hemoglobin concentration	2e-23	32888493
rs6799077	rs34579268	0.99022309179521	Hematocrit	5e-30	32888493
rs6799077	rs34579268	0.99022309179521	Hematocrit	2e-27	32888493
rs6799077	rs34579268	0.99022309179521	Hemoglobin concentration	5e-26	32888493
rs6799077	rs7610312	0.976750802846984	Red blood cell count	5e-09	27863252
rs6799077	rs6775517	0.975514924318744	Hematocrit	1e-17	34594039
rs6799077	rs57700771	0.970656122022856	Red blood cell count	9e-21	30595370
rs6799077	rs55704295	0.903577977410358	Red blood cell count	8e-26	32888493
rs6799077	rs55704295	0.903577977410358	Red blood cell count	5e-23	32888493
rs6799077	rs55704295	0.903577977410358	Serum total protein level	2e-29	34594039
rs6799077	rs4681679	0.874103222104975	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs6799077	rs11719450	0.848243947782203	Hemoglobin concentration	2e-09	27863252
rs6799077	rs11719450	0.848243947782203	Hemoglobin levels	2e-16	32327693
rs6799077	rs56384862	0.837083814139513	Body mass index	8e-12	29273807
rs6799077	rs56384862	0.837083814139513	Body mass index	3e-06	30108127
rs6799077	rs56384862	0.837083814139513	Hemoglobin levels	1e-16	32327693
rs6799077	rs56384862	0.837083814139513	Body mass index	3e-14	36581621
rs6799077	rs11922478	0.834383311646294	Semaphorin-6B levels	4e-12	34648354
rs6799077	rs55692656	0.816822191269083	vWF levels	3e-08	30586737
rs6799077	rs55692656	0.816822191269083	vWF levels	6e-09	30586737
rs6799077	rs6445969	0.68760896060997	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs6799077	rs11708895	0.683724898901785	Red blood cell count	1e-20	32888494
rs6799077	rs55954186	0.679425613284655	vWF levels	5e-09	30586737
rs6799077	rs55954186	0.679425613284655	vWF levels	9e-09	30586737
rs6799077	rs7431952	0.61745664198744	Hemoglobin levels	1e-12	32327693
rs68021431	rs7610312	0.945711077983445	Red blood cell count	5e-09	27863252
rs68021431	rs6775517	0.944641176427222	Hematocrit	1e-17	34594039
rs68021431	rs4681679	0.943898429673138	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs68021431	rs57700771	0.939398946204585	Red blood cell count	9e-21	30595370
rs68021431	rs11705721	0.926132864375579	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs68021431	rs11130638	0.92371257439953	Hemoglobin concentration	2e-23	32888493
rs68021431	rs34579268	0.916934620565904	Hematocrit	5e-30	32888493
rs68021431	rs34579268	0.916934620565904	Hematocrit	2e-27	32888493
rs68021431	rs34579268	0.916934620565904	Hemoglobin concentration	5e-26	32888493
rs68021431	rs11719450	0.91616869496881	Hemoglobin concentration	2e-09	27863252
rs68021431	rs11719450	0.91616869496881	Hemoglobin levels	2e-16	32327693
rs68021431	rs56384862	0.90388718773813	Body mass index	8e-12	29273807
rs68021431	rs56384862	0.90388718773813	Body mass index	3e-06	30108127
rs68021431	rs56384862	0.90388718773813	Hemoglobin levels	1e-16	32327693
rs68021431	rs56384862	0.90388718773813	Body mass index	3e-14	36581621
rs68021431	rs55692656	0.885474437133709	vWF levels	3e-08	30586737
rs68021431	rs55692656	0.885474437133709	vWF levels	6e-09	30586737
rs68021431	rs55704295	0.868526683558318	Red blood cell count	8e-26	32888493
rs68021431	rs55704295	0.868526683558318	Red blood cell count	5e-23	32888493
rs68021431	rs55704295	0.868526683558318	Serum total protein level	2e-29	34594039
rs68021431	rs11922478	0.798825144782023	Semaphorin-6B levels	4e-12	34648354
rs68021431	rs6445969	0.742563814680342	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs68021431	rs11708895	0.738257894954163	Red blood cell count	1e-20	32888494
rs68021431	rs55954186	0.733615703987289	vWF levels	5e-09	30586737
rs68021431	rs55954186	0.733615703987289	vWF levels	9e-09	30586737
rs68021431	rs7431952	0.667068587205614	Hemoglobin levels	1e-12	32327693
rs68021431	rs9311676	0.606626968096133	Systemic lupus erythematosus	5e-06	27399966
rs68021431	rs9311676	0.606626968096133	Systemic lupus erythematosus	3e-14	26502338
rs68021431	rs9311676	0.606626968096133	Waist circumference adjusted for body mass index	3e-08	34021172
rs68041688	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs68041688	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs68041688	rs6928810	0.890092667905038	Platelet distribution width	1e-14	32888494
rs68041688	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs68041688	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs68041688	rs9266825	0.864263096403477	Autism spectrum disorder	6e-06	35215271
rs68041688	rs199530775	0.741622971640871	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs68041688	rs55957433	0.741622971640871	Hip circumference adjusted for BMI	3e-08	34021172
rs68041688	rs6934175	0.67384422555715	Psoriatic arthritis	5e-28	30552173
rs68041688	rs17200242	0.664511943065584	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs68041688	rs7751505	0.657706582280067	Pubertal anthropometrics	4e-06	23449627
rs68041688	rs35026345	0.65640936672589	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs68041688	rs72848707	0.653592630236073	HDL cholesterol levels	7e-06	35884923
rs68041688	rs13437088	0.631438004864122	Psoriasis	3e-40	23143594
rs68041688	rs13437082	0.630743556638567	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs68041688	rs13437082	0.630743556638567	Height	5e-08	19343178
rs68041688	rs72657657	0.623149040879308	Hip circumference adjusted for BMI	4e-13	34021172
rs68044560	rs73045343	0.652448773075449	Serum total protein level	1e-12	34594039
rs68044560	rs6759004	0.635523213745608	Triptolide cytotoxicity	3e-07	26121980
rs68094537	rs1063631	0.861195465342961	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs68094537	rs1063631	0.861195465342961	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs68094537	rs6928810	0.859904309659747	Platelet distribution width	1e-14	32888494
rs68094537	rs3869132	0.85736525767403	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs68094537	rs3869132	0.85736525767403	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs68094537	rs9266825	0.830803564793576	Autism spectrum disorder	6e-06	35215271
rs68094537	rs199530775	0.71768640543529	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs68094537	rs55957433	0.71768640543529	Hip circumference adjusted for BMI	3e-08	34021172
rs68094537	rs6934175	0.664785809025046	Psoriatic arthritis	5e-28	30552173
rs68094537	rs7751505	0.656725819024193	Pubertal anthropometrics	4e-06	23449627
rs68094537	rs17200242	0.655701594163338	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs68094537	rs35026345	0.655337024270907	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs68094537	rs13437088	0.629546601794571	Psoriasis	3e-40	23143594
rs68094537	rs13437082	0.628839781231278	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs68094537	rs13437082	0.628839781231278	Height	5e-08	19343178
rs68094537	rs72657657	0.621194880693134	Hip circumference adjusted for BMI	4e-13	34021172
rs68094537	rs72848707	0.619525562521246	HDL cholesterol levels	7e-06	35884923
rs6812286	rs1550057	0.609111475530131	Conduct disorder	4e-06	20585324
rs6812286	rs1550057	0.609111475530131	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs6812361	rs7655841	0.675396720170554	Chronic obstructive pulmonary disease (moderate to severe)	7e-07	24621683
rs6821305	rs6821305	1	Weight	1e-11	34594039
rs6821305	rs6821305	1	Appendicular lean mass	3e-26	33097823
rs6821305	rs6821305	1	Body surface area	5e-15	36502284
rs6821305	rs6821305	1	Hip circumference adjusted for BMI	3e-12	34021172
rs6821305	rs6821305	1	Multi-trait sex score	5e-09	37277458
rs6830422	rs2868708	0.943370626433219	Lymphocyte count	3e-11	34469753
rs6830422	rs2868708	0.943370626433219	White blood cell count	1e-09	30595370
rs6830422	rs6831339	0.940132223205479	High density lipoprotein cholesterol levels	9e-09	34887591
rs6830422	rs6535419	0.887228275241334	Pulse pressure	6e-10	30578418
rs6830422	rs116142917	0.86556120141627	Lymphocyte count	7e-18	32888494
rs6830422	rs13111599	0.856160727617373	HDL cholesterol levels	3e-09	32203549
rs6830422	rs13111599	0.856160727617373	Apolipoprotein A1 levels	4e-08	32203549
rs6830422	rs6823199	0.848591372306061	Pulse pressure	4e-14	30224653
rs6830422	rs4302451	0.78974495669212	Eosinophil counts	2e-09	30595370
rs6830422	rs35895091	0.728170387751094	Cardiovascular disease	1e-07	30595370
rs6830422	rs11099563	0.705685749019987	High density lipoprotein cholesterol levels	3e-11	34887591
rs6830422	rs28528763	0.675390034661931	White blood cell count	7e-12	32888494
rs6830422	rs7662402	0.605095168796919	Brain morphology (MOSTest)	3e-08	35164939
rs6831339	rs6831339	1	High density lipoprotein cholesterol levels	9e-09	34887591
rs6831339	rs2868708	0.996670557915363	Lymphocyte count	3e-11	34469753
rs6831339	rs2868708	0.996670557915363	White blood cell count	1e-09	30595370
rs6831339	rs116142917	0.915238572755671	Lymphocyte count	7e-18	32888494
rs6831339	rs6823199	0.895826456408638	Pulse pressure	4e-14	30224653
rs6831339	rs13111599	0.889525024994145	HDL cholesterol levels	3e-09	32203549
rs6831339	rs13111599	0.889525024994145	Apolipoprotein A1 levels	4e-08	32203549
rs6831339	rs6535419	0.874229728768598	Pulse pressure	6e-10	30578418
rs6831339	rs11099563	0.745403496805278	High density lipoprotein cholesterol levels	3e-11	34887591
rs6831339	rs4302451	0.743813141137588	Eosinophil counts	2e-09	30595370
rs6831339	rs28528763	0.718855802699315	White blood cell count	7e-12	32888494
rs6831339	rs35895091	0.704383113526372	Cardiovascular disease	1e-07	30595370
rs6831339	rs7662402	0.62120795462088	Brain morphology (MOSTest)	3e-08	35164939
rs685244	rs685244	1	Complement C4 levels	2e-12	36168886
rs685244	rs28383224	0.977777291254527	Neuromyelitis optica	6e-12	29769526
rs685244	rs28383224	0.977777291254527	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs685244	rs28383224	0.977777291254527	Waist-hip index	1e-19	34021172
rs685244	rs28383224	0.977777291254527	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs685244	rs28383224	0.977777291254527	Waist circumference adjusted for body mass index	9e-10	34021172
rs685244	rs28383233	0.977777291254527	Free cholesterol levels in very large HDL	4e-14	35213538
rs685244	rs28383221	0.969104268860845	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs685244	rs28383223	0.967496429982453	Alanine aminotransferase levels	7e-38	33547301
rs685244	rs3129755	0.86333485231187	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs685244	rs3129755	0.86333485231187	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs685244	rs3129755	0.86333485231187	Triglyceride levels in very large VLDL	3e-21	35213538
rs685244	rs3129755	0.86333485231187	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs685244	rs3129755	0.86333485231187	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs685244	rs3129755	0.86333485231187	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs685244	rs3129755	0.86333485231187	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs685244	rs3129755	0.86333485231187	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs685244	rs3129755	0.86333485231187	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs685244	rs3129755	0.86333485231187	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs685244	rs3129755	0.86333485231187	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs685244	rs3129755	0.86333485231187	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs685244	rs3129755	0.86333485231187	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs685244	rs3129755	0.86333485231187	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs685244	rs3129755	0.86333485231187	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs685244	rs3129755	0.86333485231187	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs685244	rs3129755	0.86333485231187	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs685244	rs3129755	0.86333485231187	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs685244	rs3129755	0.86333485231187	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs685244	rs3129755	0.86333485231187	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs685244	rs3129755	0.86333485231187	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs685244	rs3129755	0.86333485231187	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs685244	rs3129755	0.86333485231187	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs685244	rs3129755	0.86333485231187	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs685244	rs3129755	0.86333485231187	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs685244	rs28383241	0.817529907715656	Alanine aminotransferase levels	9e-40	34594039
rs685244	rs686250	0.703385575310001	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs685244	rs502803	0.670624825623682	Basal cell carcinoma (MTAG)	2e-95	36496446
rs685244	rs28752509	0.667415549123707	Free cholesterol to total lipids ratio in small VLDL	1e-17	35213538
rs685244	rs28752509	0.667415549123707	Phospholipids to total lipids ratio in small VLDL	3e-18	35213538
rs685244	rs28752510	0.667415549123707	Triglycerides to total lipids ratio in large LDL	3e-13	35213538
rs685244	rs28752510	0.667415549123707	Triglycerides to total lipids ratio in medium LDL	3e-13	35213538
rs685244	rs28752510	0.667415549123707	Cholesteryl esters to total lipids ratio in large HDL	3e-14	35213538
rs685244	rs28752510	0.667415549123707	Cholesteryl esters to total lipids ratio in medium HDL	2e-09	35213538
rs685244	rs28752510	0.667415549123707	Triglycerides to total lipids ratio in IDL	4e-17	35213538
rs685244	rs28752510	0.667415549123707	Cholesterol to total lipids ratio in large HDL	2e-15	35213538
rs685244	rs28752510	0.667415549123707	Cholesterol to total lipids ratio in small HDL	2e-11	35213538
rs685244	rs28752510	0.667415549123707	Triglycerides to total lipids ratio in small HDL	5e-09	35213538
rs685244	rs28752510	0.667415549123707	Triglycerides to total lipids ratio in small LDL	2e-17	35213538
rs685244	rs28752510	0.667415549123707	Cholesterol to total lipids ratio in very small VLDL	2e-20	35213538
rs685244	rs28752510	0.667415549123707	Cholesteryl esters to total lipids ratio in very small VLDL	1e-19	35213538
rs685244	rs28752510	0.667415549123707	Free cholesterol to total lipids ratio in very small VLDL	4e-14	35213538
rs685244	rs28752510	0.667415549123707	Triglycerides to total lipids ratio in very small VLDL	5e-23	35213538
rs685244	rs28752510	0.667415549123707	Free cholesterol to total lipids ratio in IDL	5e-10	35213538
rs685244	rs28752510	0.667415549123707	Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602)	2e-12	36764567
rs685244	rs28752510	0.667415549123707	Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)	2e-17	36764567
rs685244	rs28752510	0.667415549123707	Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)	5e-13	36764567
rs685244	rs28752510	0.667415549123707	Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)	3e-15	36764567
rs685244	rs28752510	0.667415549123707	Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)	9e-16	36764567
rs685244	rs28752510	0.667415549123707	Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)	1e-14	36764567
rs685244	rs28752510	0.667415549123707	Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)	1e-14	36764567
rs685244	rs28752510	0.667415549123707	Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)	2e-14	36764567
rs685244	rs13191975	0.667415549123707	A body shape index	4e-12	34021172
rs685244	rs5021727	0.663280516622684	Cholesterol levels in chylomicrons and extremely large VLDL	1e-08	35213538
rs685244	rs5021727	0.663280516622684	Nonalcoholic fatty liver disease (imputed)	3e-09	35047847
rs685244	rs5021727	0.663280516622684	Cholesteryl ester levels in chylomicrons and extremely large VLDL	4e-08	35213538
rs685244	rs5021727	0.663280516622684	Free cholesterol levels in chylomicrons and extremely large VLDL	2e-09	35213538
rs685244	rs5021727	0.663280516622684	Metabolic syndrome	2e-08	31589552
rs685244	rs34077986	0.6073750733685	A body shape index	5e-11	34021172
rs685244	rs9271215	0.605225180521777	Gynecologic disease (multivariate analysis)	2e-08	31488892
rs6858248	rs6831339	0.946975696719041	High density lipoprotein cholesterol levels	9e-09	34887591
rs6858248	rs2868708	0.943769737052355	Lymphocyte count	3e-11	34469753
rs6858248	rs2868708	0.943769737052355	White blood cell count	1e-09	30595370
rs6858248	rs116142917	0.861533343286452	Lymphocyte count	7e-18	32888494
rs6858248	rs6823199	0.847777071011521	Pulse pressure	4e-14	30224653
rs6858248	rs13111599	0.842358580292852	HDL cholesterol levels	3e-09	32203549
rs6858248	rs13111599	0.842358580292852	Apolipoprotein A1 levels	4e-08	32203549
rs6858248	rs6535419	0.826741206339042	Pulse pressure	6e-10	30578418
rs6858248	rs11099563	0.78714110550868	High density lipoprotein cholesterol levels	3e-11	34887591
rs6858248	rs28528763	0.759233377816943	White blood cell count	7e-12	32888494
rs6858248	rs4302451	0.707250713438173	Eosinophil counts	2e-09	30595370
rs6858248	rs35895091	0.66744503522439	Cardiovascular disease	1e-07	30595370
rs6858248	rs7662402	0.657900654440709	Brain morphology (MOSTest)	3e-08	35164939
rs6859168	rs2549794	0.995553793460866	Crohn's disease	1e-10	21102463
rs6859168	rs2549794	0.995553793460866	Systolic blood pressure	1e-07	33230300
rs6859168	rs2549794	0.995553793460866	Diastolic blood pressure	1e-15	33230300
rs6859168	rs2549794	0.995553793460866	Diastolic blood pressure	2e-12	33230300
rs6859168	rs2549794	0.995553793460866	Systolic blood pressure	4e-10	33230300
rs6859168	rs1363907	0.990235217827176	Crohn's disease	4e-16	26192919
rs6859168	rs1363907	0.990235217827176	Ulcerative colitis	4e-06	26192919
rs6859168	rs1363907	0.990235217827176	Inflammatory bowel disease	5e-15	26192919
rs6859168	rs1363907	0.990235217827176	Inflammatory bowel disease	6e-13	23128233
rs6859168	rs1363907	0.990235217827176	Inflammatory bowel disease	1e-10	28067908
rs6859168	rs1363907	0.990235217827176	Crohn's disease	1e-14	28067908
rs6859168	rs2617439	0.941973931297228	Neutrophil count	8e-11	32888494
rs6859168	rs716848	0.935027507122484	Neutrophil percentage of white cells	2e-09	32888494
rs6859168	rs38029	0.930012898385396	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs6859168	rs2548532	0.894106676049037	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs6859168	rs27660	0.779391191503446	Coronary artery disease	3e-08	35915156
rs6859168	rs1423357	0.765611824567946	General cognitive ability	9e-06	29844566
rs6859168	rs2432142	0.75072733248979	Neutrophil count	2e-14	32888493
rs6859168	rs2432142	0.75072733248979	White blood cell count	1e-11	32888493
rs6859168	rs38033	0.748891841533781	Blood protein levels	0	30072576
rs6859168	rs27293	0.740375006383978	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs6859168	rs27293	0.740375006383978	Diastolic blood pressure	3e-11	35762941
rs6859168	rs7705093	0.730942659254367	Birdshot chorioretinopathy	2e-09	24957906
rs6859168	rs4869313	0.720796579670353	Pediatric autoimmune diseases	9e-08	26301688
rs6859168	rs2927608	0.714816193944706	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs6859168	rs2927608	0.714816193944706	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs6859168	rs2927608	0.714816193944706	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs6859168	rs2910686	0.712464863469631	Neutrophil count	4e-14	32888493
rs6859168	rs2910686	0.712464863469631	Psoriasis	2e-08	23143594
rs6859168	rs2910686	0.712464863469631	Ankylosing spondylitis	5e-17	23749187
rs6859168	rs2910686	0.712464863469631	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs6859168	rs1559359	0.652521298241796	Diastolic blood pressure	7e-10	34594039
rs6859168	rs1974871	0.647582529183503	Granulysin levels	5e-13	34648354
rs6859168	rs2549782	0.635426302102967	Systolic blood pressure	6e-07	33230300
rs6859168	rs2549782	0.635426302102967	Diastolic blood pressure	1e-14	33230300
rs6859168	rs2549782	0.635426302102967	Diastolic blood pressure	3e-11	33230300
rs6859168	rs2549782	0.635426302102967	Systolic blood pressure	5e-09	33230300
rs6859168	rs2549797	0.635100927677166	Systolic blood pressure	7e-07	33230300
rs6859168	rs2549797	0.635100927677166	Diastolic blood pressure	1e-14	33230300
rs6859168	rs2549797	0.635100927677166	Diastolic blood pressure	3e-11	33230300
rs6859168	rs2549797	0.635100927677166	Systolic blood pressure	4e-09	33230300
rs6859168	rs1056893	0.633561589973591	Systolic blood pressure	1e-06	33230300
rs6859168	rs1056893	0.633561589973591	Diastolic blood pressure	7e-15	33230300
rs6859168	rs1056893	0.633561589973591	Diastolic blood pressure	2e-11	33230300
rs6859168	rs1056893	0.633561589973591	Systolic blood pressure	7e-09	33230300
rs6860727	rs2098713	0.952797720896289	Telomere length	3e-06	24795349
rs6860727	rs757720522	0.813899338354479	Appendicular lean mass	3e-11	31761296
rs6860727	rs150621	0.776765980048523	Appendicular lean mass	5e-12	31761296
rs6862118	rs9292122	0.927505691659097	Prostate cancer	5e-09	33398198
rs6862118	rs702689	0.758915595939914	Vertex-wise sulcal depth	2e-22	34910505
rs686250	rs686250	1	Chronic elevation of alanine aminotransferase (cALT) levels	3e-09	35654975
rs686250	rs28383314	0.811458139973306	Eosinophil counts	6e-199	32888493
rs686250	rs28383314	0.811458139973306	Eosinophil counts	2e-194	32888493
rs686250	rs28383314	0.811458139973306	Eosinophil percentage of white cells	7e-27	27863252
rs686250	rs28383314	0.811458139973306	Intraocular pressure	3e-09	29785010
rs686250	rs28383314	0.811458139973306	Nasal polyps	5e-08	30643255
rs686250	rs28383314	0.811458139973306	A body shape index	1e-20	34021172
rs686250	rs28383314	0.811458139973306	Triglyceride levels in medium HDL	2e-21	35213538
rs686250	rs28383314	0.811458139973306	Triglycerides to total lipids ratio in large HDL	7e-12	35213538
rs686250	rs28383314	0.811458139973306	Phospholipids to total lipids ratio in medium LDL	1e-11	35213538
rs686250	rs28383314	0.811458139973306	Triglyceride levels in large HDL	4e-08	35213538
rs686250	rs28383314	0.811458139973306	Total lipid levels in small HDL	5e-22	35213538
rs686250	rs28383314	0.811458139973306	Phospholipids to total lipids ratio in small LDL	9e-13	35213538
rs686250	rs28383314	0.811458139973306	Total fatty acid levels	4e-25	35213538
rs686250	rs28383314	0.811458139973306	Total triglycerides levels	8e-24	35213538
rs686250	rs28383314	0.811458139973306	Phospholipid levels in small HDL	8e-22	35213538
rs686250	rs28383314	0.811458139973306	Free cholesterol to total lipids ratio in small LDL	6e-17	35213538
rs686250	rs28383314	0.811458139973306	Saturated fatty acid levels	4e-20	35213538
rs686250	rs28383314	0.811458139973306	Triglyceride levels in small VLDL	2e-27	35213538
rs686250	rs28383314	0.811458139973306	Triglyceride levels in small HDL	4e-24	35213538
rs686250	rs28383314	0.811458139973306	Triglyceride levels in VLDL	9e-23	35213538
rs686250	rs28383314	0.811458139973306	Triglyceride levels in very large HDL	6e-13	35213538
rs686250	rs28383314	0.811458139973306	Triglycerides to total lipids ratio in very large HDL	8e-21	35213538
rs686250	rs28383314	0.811458139973306	Triglyceride levels in very small VLDL	2e-25	35213538
rs686250	rs28383314	0.811458139973306	Eosinophil counts	1e-60	27863252
rs686250	rs28383314	0.811458139973306	Sum eosinophil basophil counts	9e-64	27863252
rs686250	rs28383314	0.811458139973306	Eosinophil counts	9e-101	34594039
rs686250	rs28383314	0.811458139973306	Triglyceride levels	4e-49	32154731
rs686250	rs28383314	0.811458139973306	Triglyceride levels	4e-76	32203549
rs686250	rs28383314	0.811458139973306	Eosinophil counts	6e-103	34469753
rs686250	rs28383314	0.811458139973306	Waist-to-hip ratio adjusted for BMI	2e-12	34021172
rs686250	rs28383314	0.811458139973306	Waist-hip index	4e-11	34021172
rs686250	rs28383314	0.811458139973306	Triglyceride levels in HDL	8e-21	35213538
rs686250	rs28383314	0.811458139973306	Hip circumference adjusted for BMI	5e-19	34021172
rs686250	rs28383314	0.811458139973306	Triglycerides	4e-59	34594039
rs686250	rs28383314	0.811458139973306	Eosinophil counts	1e-49	35935937
rs686250	rs28383314	0.811458139973306	Primary sclerosing cholangitis (MTAG)	2e-75	36828809
rs686250	rs28383314	0.811458139973306	Total triglycerides levels (UKB data field 23407)	2e-20	36764567
rs686250	rs28383314	0.811458139973306	Triglycerides in very small VLDL (UKB data field 23522)	7e-20	36764567
rs686250	rs28383314	0.811458139973306	Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)	6e-17	36764567
rs686250	rs28383314	0.811458139973306	Triglycerides in medium HDL (UKB data field 23571)	7e-16	36764567
rs686250	rs28383314	0.811458139973306	Monounsaturated fatty acids levels (UKB data field 23447)	4e-18	36764567
rs686250	rs28383314	0.811458139973306	Saturated fatty acids levels (UKB data field 23448)	4e-15	36764567
rs686250	rs28383314	0.811458139973306	Triglycerides in small LDL (UKB data field 23550)	4e-19	36764567
rs686250	rs28383314	0.811458139973306	Phospholipids to total lipids in medium LDL percentage (UKB data field 23619)	8e-11	36764567
rs686250	rs28383314	0.811458139973306	Triglycerides in HDL (UKB data field 23410)	9e-16	36764567
rs686250	rs28383314	0.811458139973306	Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)	1e-16	36764567
rs686250	rs28383314	0.811458139973306	Total fatty acids levels (UKB data field 23442)	9e-17	36764567
rs686250	rs28383314	0.811458139973306	Triglycerides in small HDL (UKB data field 23578)	1e-20	36764567
rs686250	rs28383224	0.709801159004665	Neuromyelitis optica	6e-12	29769526
rs686250	rs28383224	0.709801159004665	Neuromyelitis optica (AQP4-IgG-positive)	8e-11	29769526
rs686250	rs28383224	0.709801159004665	Waist-hip index	1e-19	34021172
rs686250	rs28383224	0.709801159004665	Waist-to-hip ratio adjusted for BMI	4e-20	34021172
rs686250	rs28383224	0.709801159004665	Waist circumference adjusted for body mass index	9e-10	34021172
rs686250	rs28383233	0.709801159004665	Free cholesterol levels in very large HDL	4e-14	35213538
rs686250	rs28383221	0.703537144743865	Proteasome subunit alpha type-5 levels	4e-17	34648354
rs686250	rs685244	0.703385575310001	Complement C4 levels	2e-12	36168886
rs686250	rs28383223	0.703279608885565	Alanine aminotransferase levels	7e-38	33547301
rs686250	rs3129755	0.629002351072293	Free cholesterol to total lipids ratio in large LDL	2e-23	35213538
rs686250	rs3129755	0.629002351072293	Free cholesterol to total lipids ratio in medium LDL	1e-20	35213538
rs686250	rs3129755	0.629002351072293	Triglyceride levels in very large VLDL	3e-21	35213538
rs686250	rs3129755	0.629002351072293	Triglycerides in VLDL (UKB data field 23408)	2e-20	36764567
rs686250	rs3129755	0.629002351072293	Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)	2e-11	36764567
rs686250	rs3129755	0.629002351072293	Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)	5e-19	36764567
rs686250	rs3129755	0.629002351072293	Triglycerides in chylomicrons and extremely large VLDL (UKB data field 23487)	3e-15	36764567
rs686250	rs3129755	0.629002351072293	Average diameter for VLDL particles (UKB data field 23431)	7e-17	36764567
rs686250	rs3129755	0.629002351072293	Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458)	2e-12	36764567
rs686250	rs3129755	0.629002351072293	Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)	4e-20	36764567
rs686250	rs3129755	0.629002351072293	Triglycerides to phosphoglycerides ratio (UKB data field 23435)	2e-17	36764567
rs686250	rs3129755	0.629002351072293	Triglycerides in large VLDL (UKB data field 23501)	1e-18	36764567
rs686250	rs3129755	0.629002351072293	Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)	2e-16	36764567
rs686250	rs3129755	0.629002351072293	Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)	2e-16	36764567
rs686250	rs3129755	0.629002351072293	Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)	4e-16	36764567
rs686250	rs3129755	0.629002351072293	Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)	1e-14	36764567
rs686250	rs3129755	0.629002351072293	Triglycerides in very large VLDL (UKB data field 23494)	5e-20	36764567
rs686250	rs3129755	0.629002351072293	Triglycerides in small VLDL (UKB data field 23515)	1e-21	36764567
rs686250	rs3129755	0.629002351072293	Triglycerides to total lipids in large HDL percentage (UKB data field 23638)	1e-12	36764567
rs686250	rs3129755	0.629002351072293	Triglycerides to total lipids in small HDL percentage (UKB data field 23648)	2e-15	36764567
rs686250	rs3129755	0.629002351072293	Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)	3e-14	36764567
rs686250	rs3129755	0.629002351072293	Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)	7e-14	36764567
rs686250	rs3129755	0.629002351072293	Triglycerides to total lipids in small LDL percentage (UKB data field 23628)	3e-13	36764567
rs686250	rs3129755	0.629002351072293	Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)	6e-15	36764567
rs686250	rs3129755	0.629002351072293	Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)	5e-18	36764567
rs6868302	rs1974871	0.992670060004415	Granulysin levels	5e-13	34648354
rs6868302	rs4869313	0.897709249727032	Pediatric autoimmune diseases	9e-08	26301688
rs6868302	rs4869314	0.836233288582707	Arthritis (juvenile idiopathic)	3e-09	33106285
rs6868302	rs4869314	0.836233288582707	Neutrophil count	1e-10	34594039
rs6868302	rs4869314	0.836233288582707	White blood cell count	2e-07	30595370
rs6868302	rs2549782	0.789146272625007	Systolic blood pressure	6e-07	33230300
rs6868302	rs2549782	0.789146272625007	Diastolic blood pressure	1e-14	33230300
rs6868302	rs2549782	0.789146272625007	Diastolic blood pressure	3e-11	33230300
rs6868302	rs2549782	0.789146272625007	Systolic blood pressure	5e-09	33230300
rs6868302	rs2549797	0.78907078790371	Systolic blood pressure	7e-07	33230300
rs6868302	rs2549797	0.78907078790371	Diastolic blood pressure	1e-14	33230300
rs6868302	rs2549797	0.78907078790371	Diastolic blood pressure	3e-11	33230300
rs6868302	rs2549797	0.78907078790371	Systolic blood pressure	4e-09	33230300
rs6868302	rs1056893	0.78702116018211	Systolic blood pressure	1e-06	33230300
rs6868302	rs1056893	0.78702116018211	Diastolic blood pressure	7e-15	33230300
rs6868302	rs1056893	0.78702116018211	Diastolic blood pressure	2e-11	33230300
rs6868302	rs1056893	0.78702116018211	Systolic blood pressure	7e-09	33230300
rs6868302	rs1559359	0.757785267046349	Diastolic blood pressure	7e-10	34594039
rs6868302	rs2927608	0.741955885670711	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs6868302	rs2927608	0.741955885670711	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs6868302	rs2927608	0.741955885670711	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs6868302	rs2910686	0.739145242130013	Neutrophil count	4e-14	32888493
rs6868302	rs2910686	0.739145242130013	Psoriasis	2e-08	23143594
rs6868302	rs2910686	0.739145242130013	Ankylosing spondylitis	5e-17	23749187
rs6868302	rs2910686	0.739145242130013	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs6868302	rs1019503	0.674695375625805	Systolic blood pressure	2e-06	33230300
rs6868302	rs1019503	0.674695375625805	Diastolic blood pressure	2e-14	33230300
rs6868302	rs1019503	0.674695375625805	Diastolic blood pressure	4e-11	33230300
rs6868302	rs1019503	0.674695375625805	Systolic blood pressure	1e-08	33230300
rs6868302	rs3096168	0.669060461559361	Aspartate aminotransferase levels	8e-12	33547301
rs6868302	rs2549794	0.648325466456607	Crohn's disease	1e-10	21102463
rs6868302	rs2549794	0.648325466456607	Systolic blood pressure	1e-07	33230300
rs6868302	rs2549794	0.648325466456607	Diastolic blood pressure	1e-15	33230300
rs6868302	rs2549794	0.648325466456607	Diastolic blood pressure	2e-12	33230300
rs6868302	rs2549794	0.648325466456607	Systolic blood pressure	4e-10	33230300
rs6868302	rs716848	0.645178435044537	Neutrophil percentage of white cells	2e-09	32888494
rs6868302	rs1363907	0.644046842280994	Crohn's disease	4e-16	26192919
rs6868302	rs1363907	0.644046842280994	Ulcerative colitis	4e-06	26192919
rs6868302	rs1363907	0.644046842280994	Inflammatory bowel disease	5e-15	26192919
rs6868302	rs1363907	0.644046842280994	Inflammatory bowel disease	6e-13	23128233
rs6868302	rs1363907	0.644046842280994	Inflammatory bowel disease	1e-10	28067908
rs6868302	rs1363907	0.644046842280994	Crohn's disease	1e-14	28067908
rs6868302	rs1423357	0.641083165579552	General cognitive ability	9e-06	29844566
rs6868302	rs2432142	0.627828660562641	Neutrophil count	2e-14	32888493
rs6868302	rs2432142	0.627828660562641	White blood cell count	1e-11	32888493
rs6868302	rs38033	0.623388216946902	Blood protein levels	0	30072576
rs6868302	rs27293	0.613680181757404	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs6868302	rs27293	0.613680181757404	Diastolic blood pressure	3e-11	35762941
rs6868302	rs2617439	0.611450527075941	Neutrophil count	8e-11	32888494
rs6868302	rs7705093	0.60621458876885	Birdshot chorioretinopathy	2e-09	24957906
rs6869819	rs2548499	0.935980357166003	Lymphocyte count	9e-14	32888494
rs6869819	rs2648731	0.745586353939907	Type 2 diabetes	7e-12	34594039
rs6869819	rs2648731	0.745586353939907	Type 2 diabetes	3e-19	34594039
rs6869819	rs2648731	0.745586353939907	Lymphocyte count	2e-11	34594039
rs6869819	rs2648731	0.745586353939907	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs6869819	rs2648731	0.745586353939907	Medication use (drugs used in diabetes)	3e-09	34594039
rs6869819	rs13189973	0.630080488637796	Lymphocyte count	2e-16	32888493
rs6870175	rs9292122	0.842845138577539	Prostate cancer	5e-09	33398198
rs6870175	rs702689	0.720981003360899	Vertex-wise sulcal depth	2e-22	34910505
rs6871162	rs1423357	0.992444862168494	General cognitive ability	9e-06	29844566
rs6871162	rs2432142	0.975750292532493	Neutrophil count	2e-14	32888493
rs6871162	rs2432142	0.975750292532493	White blood cell count	1e-11	32888493
rs6871162	rs38033	0.970929692253116	Blood protein levels	0	30072576
rs6871162	rs27293	0.965117130562221	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs6871162	rs27293	0.965117130562221	Diastolic blood pressure	3e-11	35762941
rs6871162	rs7705093	0.958157520586775	Birdshot chorioretinopathy	2e-09	24957906
rs6871162	rs2910686	0.867928398130532	Neutrophil count	4e-14	32888493
rs6871162	rs2910686	0.867928398130532	Psoriasis	2e-08	23143594
rs6871162	rs2910686	0.867928398130532	Ankylosing spondylitis	5e-17	23749187
rs6871162	rs2910686	0.867928398130532	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs6871162	rs2927608	0.86461299321567	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs6871162	rs2927608	0.86461299321567	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs6871162	rs2927608	0.86461299321567	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs6871162	rs2617439	0.775436627241083	Neutrophil count	8e-11	32888494
rs6871162	rs2549797	0.772737794044806	Systolic blood pressure	7e-07	33230300
rs6871162	rs2549797	0.772737794044806	Diastolic blood pressure	1e-14	33230300
rs6871162	rs2549797	0.772737794044806	Diastolic blood pressure	3e-11	33230300
rs6871162	rs2549797	0.772737794044806	Systolic blood pressure	4e-09	33230300
rs6871162	rs2549782	0.771480386785357	Systolic blood pressure	6e-07	33230300
rs6871162	rs2549782	0.771480386785357	Diastolic blood pressure	1e-14	33230300
rs6871162	rs2549782	0.771480386785357	Diastolic blood pressure	3e-11	33230300
rs6871162	rs2549782	0.771480386785357	Systolic blood pressure	5e-09	33230300
rs6871162	rs1056893	0.770852525567031	Systolic blood pressure	1e-06	33230300
rs6871162	rs1056893	0.770852525567031	Diastolic blood pressure	7e-15	33230300
rs6871162	rs1056893	0.770852525567031	Diastolic blood pressure	2e-11	33230300
rs6871162	rs1056893	0.770852525567031	Systolic blood pressure	7e-09	33230300
rs6871162	rs2549794	0.765956938317049	Crohn's disease	1e-10	21102463
rs6871162	rs2549794	0.765956938317049	Systolic blood pressure	1e-07	33230300
rs6871162	rs2549794	0.765956938317049	Diastolic blood pressure	1e-15	33230300
rs6871162	rs2549794	0.765956938317049	Diastolic blood pressure	2e-12	33230300
rs6871162	rs2549794	0.765956938317049	Systolic blood pressure	4e-10	33230300
rs6871162	rs38029	0.763735174653609	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs6871162	rs1363907	0.761324393115545	Crohn's disease	4e-16	26192919
rs6871162	rs1363907	0.761324393115545	Ulcerative colitis	4e-06	26192919
rs6871162	rs1363907	0.761324393115545	Inflammatory bowel disease	5e-15	26192919
rs6871162	rs1363907	0.761324393115545	Inflammatory bowel disease	6e-13	23128233
rs6871162	rs1363907	0.761324393115545	Inflammatory bowel disease	1e-10	28067908
rs6871162	rs1363907	0.761324393115545	Crohn's disease	1e-14	28067908
rs6871162	rs716848	0.732987213159576	Neutrophil percentage of white cells	2e-09	32888494
rs6871162	rs4869313	0.72141696623369	Pediatric autoimmune diseases	9e-08	26301688
rs6871162	rs1559359	0.715251575177822	Diastolic blood pressure	7e-10	34594039
rs6871162	rs2548532	0.688155001664067	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs6871162	rs4869314	0.668352301449219	Arthritis (juvenile idiopathic)	3e-09	33106285
rs6871162	rs4869314	0.668352301449219	Neutrophil count	1e-10	34594039
rs6871162	rs4869314	0.668352301449219	White blood cell count	2e-07	30595370
rs6871162	rs1974871	0.641791646064563	Granulysin levels	5e-13	34648354
rs6871162	rs1019503	0.637714654431911	Systolic blood pressure	2e-06	33230300
rs6871162	rs1019503	0.637714654431911	Diastolic blood pressure	2e-14	33230300
rs6871162	rs1019503	0.637714654431911	Diastolic blood pressure	4e-11	33230300
rs6871162	rs1019503	0.637714654431911	Systolic blood pressure	1e-08	33230300
rs6871162	rs27660	0.634374937042969	Coronary artery disease	3e-08	35915156
rs6871162	rs3096168	0.630293917594092	Aspartate aminotransferase levels	8e-12	33547301
rs6873866	rs2549794	0.995562000082271	Crohn's disease	1e-10	21102463
rs6873866	rs2549794	0.995562000082271	Systolic blood pressure	1e-07	33230300
rs6873866	rs2549794	0.995562000082271	Diastolic blood pressure	1e-15	33230300
rs6873866	rs2549794	0.995562000082271	Diastolic blood pressure	2e-12	33230300
rs6873866	rs2549794	0.995562000082271	Systolic blood pressure	4e-10	33230300
rs6873866	rs1363907	0.993786200402931	Crohn's disease	4e-16	26192919
rs6873866	rs1363907	0.993786200402931	Ulcerative colitis	4e-06	26192919
rs6873866	rs1363907	0.993786200402931	Inflammatory bowel disease	5e-15	26192919
rs6873866	rs1363907	0.993786200402931	Inflammatory bowel disease	6e-13	23128233
rs6873866	rs1363907	0.993786200402931	Inflammatory bowel disease	1e-10	28067908
rs6873866	rs1363907	0.993786200402931	Crohn's disease	1e-14	28067908
rs6873866	rs2617439	0.942106858631589	Neutrophil count	8e-11	32888494
rs6873866	rs716848	0.934981708476961	Neutrophil percentage of white cells	2e-09	32888494
rs6873866	rs38029	0.93009714754026	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs6873866	rs2548532	0.89458985022993	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs6873866	rs27660	0.778724530789838	Coronary artery disease	3e-08	35915156
rs6873866	rs1423357	0.765237639910985	General cognitive ability	9e-06	29844566
rs6873866	rs2432142	0.750368595756532	Neutrophil count	2e-14	32888493
rs6873866	rs2432142	0.750368595756532	White blood cell count	1e-11	32888493
rs6873866	rs38033	0.748470365940372	Blood protein levels	0	30072576
rs6873866	rs27293	0.739973052657568	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs6873866	rs27293	0.739973052657568	Diastolic blood pressure	3e-11	35762941
rs6873866	rs7705093	0.730482523231789	Birdshot chorioretinopathy	2e-09	24957906
rs6873866	rs4869313	0.720317084956774	Pediatric autoimmune diseases	9e-08	26301688
rs6873866	rs2927608	0.71704602826148	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs6873866	rs2927608	0.71704602826148	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs6873866	rs2927608	0.71704602826148	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs6873866	rs2910686	0.714683420631671	Neutrophil count	4e-14	32888493
rs6873866	rs2910686	0.714683420631671	Psoriasis	2e-08	23143594
rs6873866	rs2910686	0.714683420631671	Ankylosing spondylitis	5e-17	23749187
rs6873866	rs2910686	0.714683420631671	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs6873866	rs1559359	0.651867254619139	Diastolic blood pressure	7e-10	34594039
rs6873866	rs1974871	0.646927601951451	Granulysin levels	5e-13	34648354
rs6873866	rs2549797	0.634233295843595	Systolic blood pressure	7e-07	33230300
rs6873866	rs2549797	0.634233295843595	Diastolic blood pressure	1e-14	33230300
rs6873866	rs2549797	0.634233295843595	Diastolic blood pressure	3e-11	33230300
rs6873866	rs2549797	0.634233295843595	Systolic blood pressure	4e-09	33230300
rs6873866	rs2549782	0.633204119516348	Systolic blood pressure	6e-07	33230300
rs6873866	rs2549782	0.633204119516348	Diastolic blood pressure	1e-14	33230300
rs6873866	rs2549782	0.633204119516348	Diastolic blood pressure	3e-11	33230300
rs6873866	rs2549782	0.633204119516348	Systolic blood pressure	5e-09	33230300
rs6873866	rs1056893	0.632690220848134	Systolic blood pressure	1e-06	33230300
rs6873866	rs1056893	0.632690220848134	Diastolic blood pressure	7e-15	33230300
rs6873866	rs1056893	0.632690220848134	Diastolic blood pressure	2e-11	33230300
rs6873866	rs1056893	0.632690220848134	Systolic blood pressure	7e-09	33230300
rs6875748	rs158796	0.960952038365131	Height	5e-243	36224396
rs6875748	rs292172	0.939458148256145	Appendicular lean mass	8e-13	31761296
rs6875748	rs158622	0.93609652658271	Height	4e-15	36224396
rs6875748	rs301901	0.93335491659444	Height	4e-16	25282103
rs6875748	rs301901	0.93335491659444	Height	2e-06	35831902
rs6875748	rs300053	0.901909942677962	Height	3e-11	34594039
rs6875748	rs300053	0.901909942677962	Height	3e-36	34594039
rs6875748	rs300053	0.901909942677962	Height	2e-14	31562340
rs6875748	rs158791	0.899135123296457	Height	2e-31	36224396
rs6875748	rs292168	0.855585034546147	Red cell distribution width	3e-10	30595370
rs6875748	rs300046	0.8493168343156	Meat-related diet	5e-08	32066663
rs6875926	rs7721230	0.74035235895623	Skin color	4e-10	36672889
rs688354	rs659529	0.805495476851493	Asthma or allergic disease (pleiotropy)	6e-11	29785011
rs688354	rs659529	0.805495476851493	Allergic disease (asthma, hay fever or eczema)	1e-10	29785011
rs688354	rs659529	0.805495476851493	Atopic dermatitis	5e-10	34116867
rs688354	rs1613778	0.733728937903282	Total bilirubin levels	3e-08	34594039
rs688354	rs480293	0.69768786665397	Oily fish consumption	4e-11	32193382
rs688354	rs11213940	0.692580502473183	Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI	2e-13	31669095
rs688354	rs34634095	0.668855024668207	Fish- and plant-related diet	3e-09	32066663
rs688354	rs663763	0.659020360310741	Layilin levels	3e-21	36168886
rs688354	rs505372	0.642282524611661	Breast cancer	3e-06	29059683
rs688354	rs505372	0.642282524611661	Medication use (beta blocking agents)	2e-08	34594039
rs688354	rs542831	0.628978572313979	Asthma	5e-13	31361310
rs688354	rs539524	0.628810650507153	Asthma	1e-10	32296059
rs688354	rs1784776	0.626404924454783	Asthma	2e-09	32296059
rs688354	rs1784775	0.626404924454783	Asthma	2e-09	30929738
rs688354	rs1784775	0.626404924454783	Asthma (adult onset)	6e-09	30929738
rs688354	rs1789358	0.625509680975918	Asthma	2e-08	34103634
rs688354	rs9734135	0.625210905500535	Medication use (agents acting on the renin-angiotensin system)	8e-14	34594039
rs688354	rs11213941	0.623418943316933	Allergic disease (asthma, hay fever or eczema)	3e-18	31361310
rs688354	rs11213941	0.623418943316933	Eczema	8e-14	30595370
rs6886108	rs150621	0.905867975475522	Appendicular lean mass	5e-12	31761296
rs6886108	rs2098713	0.769774692169011	Telomere length	3e-06	24795349
rs6886108	rs757720522	0.64778266050053	Appendicular lean mass	3e-11	31761296
rs6887500	rs1423357	0.992444862168494	General cognitive ability	9e-06	29844566
rs6887500	rs2432142	0.975750292532493	Neutrophil count	2e-14	32888493
rs6887500	rs2432142	0.975750292532493	White blood cell count	1e-11	32888493
rs6887500	rs38033	0.970929692253116	Blood protein levels	0	30072576
rs6887500	rs27293	0.965117130562221	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs6887500	rs27293	0.965117130562221	Diastolic blood pressure	3e-11	35762941
rs6887500	rs7705093	0.958157520586775	Birdshot chorioretinopathy	2e-09	24957906
rs6887500	rs2910686	0.867928398130532	Neutrophil count	4e-14	32888493
rs6887500	rs2910686	0.867928398130532	Psoriasis	2e-08	23143594
rs6887500	rs2910686	0.867928398130532	Ankylosing spondylitis	5e-17	23749187
rs6887500	rs2910686	0.867928398130532	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs6887500	rs2927608	0.86461299321567	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs6887500	rs2927608	0.86461299321567	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs6887500	rs2927608	0.86461299321567	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs6887500	rs2617439	0.776966017772775	Neutrophil count	8e-11	32888494
rs6887500	rs2549797	0.772737794044806	Systolic blood pressure	7e-07	33230300
rs6887500	rs2549797	0.772737794044806	Diastolic blood pressure	1e-14	33230300
rs6887500	rs2549797	0.772737794044806	Diastolic blood pressure	3e-11	33230300
rs6887500	rs2549797	0.772737794044806	Systolic blood pressure	4e-09	33230300
rs6887500	rs2549782	0.771480386785357	Systolic blood pressure	6e-07	33230300
rs6887500	rs2549782	0.771480386785357	Diastolic blood pressure	1e-14	33230300
rs6887500	rs2549782	0.771480386785357	Diastolic blood pressure	3e-11	33230300
rs6887500	rs2549782	0.771480386785357	Systolic blood pressure	5e-09	33230300
rs6887500	rs1056893	0.770852525567031	Systolic blood pressure	1e-06	33230300
rs6887500	rs1056893	0.770852525567031	Diastolic blood pressure	7e-15	33230300
rs6887500	rs1056893	0.770852525567031	Diastolic blood pressure	2e-11	33230300
rs6887500	rs1056893	0.770852525567031	Systolic blood pressure	7e-09	33230300
rs6887500	rs2549794	0.767472340714024	Crohn's disease	1e-10	21102463
rs6887500	rs2549794	0.767472340714024	Systolic blood pressure	1e-07	33230300
rs6887500	rs2549794	0.767472340714024	Diastolic blood pressure	1e-15	33230300
rs6887500	rs2549794	0.767472340714024	Diastolic blood pressure	2e-12	33230300
rs6887500	rs2549794	0.767472340714024	Systolic blood pressure	4e-10	33230300
rs6887500	rs38029	0.76524859455322	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs6887500	rs1363907	0.762834778322094	Crohn's disease	4e-16	26192919
rs6887500	rs1363907	0.762834778322094	Ulcerative colitis	4e-06	26192919
rs6887500	rs1363907	0.762834778322094	Inflammatory bowel disease	5e-15	26192919
rs6887500	rs1363907	0.762834778322094	Inflammatory bowel disease	6e-13	23128233
rs6887500	rs1363907	0.762834778322094	Inflammatory bowel disease	1e-10	28067908
rs6887500	rs1363907	0.762834778322094	Crohn's disease	1e-14	28067908
rs6887500	rs716848	0.734461487148458	Neutrophil percentage of white cells	2e-09	32888494
rs6887500	rs4869313	0.72283861341112	Pediatric autoimmune diseases	9e-08	26301688
rs6887500	rs1559359	0.715251575177822	Diastolic blood pressure	7e-10	34594039
rs6887500	rs2548532	0.689618078516892	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs6887500	rs4869314	0.668352301449219	Arthritis (juvenile idiopathic)	3e-09	33106285
rs6887500	rs4869314	0.668352301449219	Neutrophil count	1e-10	34594039
rs6887500	rs4869314	0.668352301449219	White blood cell count	2e-07	30595370
rs6887500	rs1974871	0.643120717725143	Granulysin levels	5e-13	34648354
rs6887500	rs1019503	0.637714654431911	Systolic blood pressure	2e-06	33230300
rs6887500	rs1019503	0.637714654431911	Diastolic blood pressure	2e-14	33230300
rs6887500	rs1019503	0.637714654431911	Diastolic blood pressure	4e-11	33230300
rs6887500	rs1019503	0.637714654431911	Systolic blood pressure	1e-08	33230300
rs6887500	rs27660	0.635813812393668	Coronary artery disease	3e-08	35915156
rs6887500	rs3096168	0.630293917594092	Aspartate aminotransferase levels	8e-12	33547301
rs6888317	rs9292122	0.851730068345913	Prostate cancer	5e-09	33398198
rs6888317	rs702689	0.728793565554181	Vertex-wise sulcal depth	2e-22	34910505
rs6893754	rs702689	0.772002316021091	Vertex-wise sulcal depth	2e-22	34910505
rs6893754	rs10061757	0.750512345521776	Height	4e-30	30595370
rs6893754	rs96844	0.744710790302108	Type 2 diabetes	5e-08	30297969
rs6893754	rs96844	0.744710790302108	Height	4e-33	36224396
rs6893754	rs9292122	0.701771813538703	Prostate cancer	5e-09	33398198
rs6893754	rs33320	0.625764916876503	Height	9e-14	36224396
rs6893754	rs2257505	0.622394591166073	Height	8e-192	36224396
rs6895442	rs10036895	0.959312292879001	Breast cancer	2e-12	34290314
rs6899661	rs14314	0.991065618494945	Macular thickness	3e-19	30535121
rs6899661	rs14314	0.991065618494945	Vertex-wise sulcal depth	7e-17	34910505
rs6899661	rs14314	0.991065618494945	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs6899661	rs14314	0.991065618494945	Left hippocampal volume (body)	7e-15	37337106
rs6899661	rs14314	0.991065618494945	Left subiculum volume (body)	1e-14	37337106
rs6899661	rs2095375	0.975975236937588	Serum metabolite levels	1e-20	33031748
rs6899661	rs2095375	0.975975236937588	Serum metabolite levels	1e-20	33031748
rs6899661	rs9383843	0.975084744237025	Migraine	1e-09	35115687
rs6899661	rs55763431	0.971536881896403	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs6899661	rs9689694	0.969772876994275	Right hippocampal volume (head)	6e-11	37337106
rs6899661	rs9689694	0.969772876994275	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs6899661	rs9689694	0.969772876994275	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs6899661	rs9689694	0.969772876994275	Left hippocampal volume (head)	6e-12	37337106
rs6899661	rs10872645	0.968001546532056	Blood protein levels	2e-86	30072576
rs6899661	rs10872653	0.963607371693358	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs6899661	rs9688867	0.963599034110188	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs6899661	rs9688867	0.963599034110188	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs6899661	rs9688809	0.963599034110188	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs6899661	rs34337297	0.960071174237363	Serum levels of protein LRP11	3e-161	35078996
rs6899661	rs9322193	0.924502756859666	Lung cancer	1e-07	27393504
rs6899661	rs4039600	0.881735545965163	Adenine levels	1e-11	35347128
rs6899661	rs1934534	0.638964541012813	Pain (pleiotropy)	2e-08	37844115
rs6899661	rs1934534	0.638964541012813	Pain (pleiotropy)	2e-06	37844115
rs6899661	rs4380763	0.638439838683101	Subcortical volume (min-P)	1e-11	32665545
rs6899661	rs11155671	0.628005812951324	Testicular germ cell tumor	2e-09	28604728
rs6899661	rs80147756	0.614309916751365	HippSubfield lh volume subiculum-head	3e-10	33875891
rs6899661	rs4421206	0.605336011370241	Brain morphology (min-P)	4e-11	32665545
rs6899938	rs9462030	0.992772816782388	Red cell distribution width	5e-25	32888493
rs6899938	rs9469857	0.987972909528024	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6899938	rs2764208	0.987184426748861	Systemic lupus erythematosus	7e-06	24871463
rs6899938	rs9469899	0.976088010907773	Prostate cancer (advanced)	2e-06	29892016
rs6899938	rs9469899	0.976088010907773	Prostate cancer	5e-09	29892016
rs6899938	rs9469899	0.976088010907773	Prostate cancer	8e-11	33398198
rs6899938	rs9469899	0.976088010907773	Hand grip strength	3e-15	29691431
rs6899938	rs9469899	0.976088010907773	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6899938	rs9469899	0.976088010907773	Graves' disease	4e-10	34594039
rs6899938	rs9469899	0.976088010907773	Coronary artery disease	1e-11	36474045
rs6899938	rs9469899	0.976088010907773	Predicted visceral adipose tissue	2e-20	31501611
rs6899938	rs9469899	0.976088010907773	Medication use (thyroid preparations)	2e-09	31015401
rs6899938	rs9469899	0.976088010907773	Medication use (thyroid preparations)	3e-10	34594039
rs6899938	rs9469872	0.9517336722848	HDL cholesterol levels	3e-11	36333282
rs6899938	rs11755393	0.945151555983629	Body mass index	3e-26	29273807
rs6899938	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-12	33493351
rs6899938	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-06	33493351
rs6899938	rs11755393	0.945151555983629	Systemic lupus erythematosus	1e-07	33493351
rs6899938	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-08	19838195
rs6899938	rs11755393	0.945151555983629	Body mass index	4e-55	36581621
rs6899938	rs9366863	0.941517151790621	Adult body size	9e-33	32376654
rs6899938	rs9366863	0.941517151790621	Body mass index	2e-44	30595370
rs6899938	rs9296128	0.937381558456179	Hip circumference adjusted for BMI	4e-13	34021172
rs6899938	rs6941110	0.933676577326679	Sex hormone-binding globulin levels	5e-27	36653534
rs6899938	rs2814949	0.905372479297637	Essential hypertension (time to event)	9e-09	32589924
rs6899938	rs2744944	0.896052112029689	Hypothyroidism	3e-10	34594039
rs6899938	rs2744944	0.896052112029689	High density lipoprotein cholesterol levels	3e-86	34887591
rs6899938	rs2744944	0.896052112029689	Multi-trait sex score	7e-22	37277458
rs6899938	rs2263329	0.876899408662782	HDL cholesterol	6e-35	34594039
rs6899938	rs2263329	0.876899408662782	HDL cholesterol levels	8e-43	32203549
rs6899938	rs2263329	0.876899408662782	High density lipoprotein cholesterol levels	2e-52	34887591
rs6899938	rs111868030	0.8532583235175	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6899938	rs9368830	0.832166605810923	HDL cholesterol	4e-21	30275531
rs6899938	rs9368828	0.805843694938069	Body mass index	1e-34	34594039
rs6899938	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6899938	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6899938	rs2744973	0.802560449404375	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6899938	rs2744973	0.802560449404375	Multi-trait sex score	6e-20	37277458
rs6899938	rs6912327	0.790019995220374	Fasting insulin	5e-06	33402679
rs6899938	rs6912327	0.790019995220374	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6899938	rs112283401	0.767735267176354	Red cell distribution width	4e-27	30595370
rs6899938	rs9689160	0.630070395157481	Lung function (forced vital capacity)	3e-14	36914875
rs6900188	rs9462030	0.992772816782388	Red cell distribution width	5e-25	32888493
rs6900188	rs9469857	0.987972909528024	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6900188	rs2764208	0.987184426748861	Systemic lupus erythematosus	7e-06	24871463
rs6900188	rs9469899	0.976088010907773	Prostate cancer (advanced)	2e-06	29892016
rs6900188	rs9469899	0.976088010907773	Prostate cancer	5e-09	29892016
rs6900188	rs9469899	0.976088010907773	Prostate cancer	8e-11	33398198
rs6900188	rs9469899	0.976088010907773	Hand grip strength	3e-15	29691431
rs6900188	rs9469899	0.976088010907773	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6900188	rs9469899	0.976088010907773	Graves' disease	4e-10	34594039
rs6900188	rs9469899	0.976088010907773	Coronary artery disease	1e-11	36474045
rs6900188	rs9469899	0.976088010907773	Predicted visceral adipose tissue	2e-20	31501611
rs6900188	rs9469899	0.976088010907773	Medication use (thyroid preparations)	2e-09	31015401
rs6900188	rs9469899	0.976088010907773	Medication use (thyroid preparations)	3e-10	34594039
rs6900188	rs9469872	0.9517336722848	HDL cholesterol levels	3e-11	36333282
rs6900188	rs11755393	0.945151555983629	Body mass index	3e-26	29273807
rs6900188	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-12	33493351
rs6900188	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-06	33493351
rs6900188	rs11755393	0.945151555983629	Systemic lupus erythematosus	1e-07	33493351
rs6900188	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-08	19838195
rs6900188	rs11755393	0.945151555983629	Body mass index	4e-55	36581621
rs6900188	rs9366863	0.941517151790621	Adult body size	9e-33	32376654
rs6900188	rs9366863	0.941517151790621	Body mass index	2e-44	30595370
rs6900188	rs9296128	0.937381558456179	Hip circumference adjusted for BMI	4e-13	34021172
rs6900188	rs6941110	0.933676577326679	Sex hormone-binding globulin levels	5e-27	36653534
rs6900188	rs2814949	0.905372479297637	Essential hypertension (time to event)	9e-09	32589924
rs6900188	rs2744944	0.896052112029689	Hypothyroidism	3e-10	34594039
rs6900188	rs2744944	0.896052112029689	High density lipoprotein cholesterol levels	3e-86	34887591
rs6900188	rs2744944	0.896052112029689	Multi-trait sex score	7e-22	37277458
rs6900188	rs2263329	0.876899408662782	HDL cholesterol	6e-35	34594039
rs6900188	rs2263329	0.876899408662782	HDL cholesterol levels	8e-43	32203549
rs6900188	rs2263329	0.876899408662782	High density lipoprotein cholesterol levels	2e-52	34887591
rs6900188	rs111868030	0.8532583235175	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6900188	rs9368830	0.832166605810923	HDL cholesterol	4e-21	30275531
rs6900188	rs9368828	0.805843694938069	Body mass index	1e-34	34594039
rs6900188	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6900188	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6900188	rs2744973	0.802560449404375	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6900188	rs2744973	0.802560449404375	Multi-trait sex score	6e-20	37277458
rs6900188	rs6912327	0.790019995220374	Fasting insulin	5e-06	33402679
rs6900188	rs6912327	0.790019995220374	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6900188	rs112283401	0.767735267176354	Red cell distribution width	4e-27	30595370
rs6900188	rs9689160	0.630070395157481	Lung function (forced vital capacity)	3e-14	36914875
rs6900428	rs1173416	0.61746244885984	Height	2e-59	36224396
rs6900847	rs9469872	0.989602360375081	HDL cholesterol levels	3e-11	36333282
rs6900847	rs11755393	0.982457344981919	Body mass index	3e-26	29273807
rs6900847	rs11755393	0.982457344981919	Systemic lupus erythematosus	2e-12	33493351
rs6900847	rs11755393	0.982457344981919	Systemic lupus erythematosus	2e-06	33493351
rs6900847	rs11755393	0.982457344981919	Systemic lupus erythematosus	1e-07	33493351
rs6900847	rs11755393	0.982457344981919	Systemic lupus erythematosus	2e-08	19838195
rs6900847	rs11755393	0.982457344981919	Body mass index	4e-55	36581621
rs6900847	rs9366863	0.979249812537902	Adult body size	9e-33	32376654
rs6900847	rs9366863	0.979249812537902	Body mass index	2e-44	30595370
rs6900847	rs6941110	0.972916319966086	Sex hormone-binding globulin levels	5e-27	36653534
rs6900847	rs9462030	0.953600997897508	Red cell distribution width	5e-25	32888493
rs6900847	rs9469857	0.948958876349948	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6900847	rs2764208	0.948228268565716	Systemic lupus erythematosus	7e-06	24871463
rs6900847	rs2814949	0.942228029060502	Essential hypertension (time to event)	9e-09	32589924
rs6900847	rs9469899	0.936824429889162	Prostate cancer (advanced)	2e-06	29892016
rs6900847	rs9469899	0.936824429889162	Prostate cancer	5e-09	29892016
rs6900847	rs9469899	0.936824429889162	Prostate cancer	8e-11	33398198
rs6900847	rs9469899	0.936824429889162	Hand grip strength	3e-15	29691431
rs6900847	rs9469899	0.936824429889162	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6900847	rs9469899	0.936824429889162	Graves' disease	4e-10	34594039
rs6900847	rs9469899	0.936824429889162	Coronary artery disease	1e-11	36474045
rs6900847	rs9469899	0.936824429889162	Predicted visceral adipose tissue	2e-20	31501611
rs6900847	rs9469899	0.936824429889162	Medication use (thyroid preparations)	2e-09	31015401
rs6900847	rs9469899	0.936824429889162	Medication use (thyroid preparations)	3e-10	34594039
rs6900847	rs2744944	0.932894858729782	Hypothyroidism	3e-10	34594039
rs6900847	rs2744944	0.932894858729782	High density lipoprotein cholesterol levels	3e-86	34887591
rs6900847	rs2744944	0.932894858729782	Multi-trait sex score	7e-22	37277458
rs6900847	rs2263329	0.913652658082569	HDL cholesterol	6e-35	34594039
rs6900847	rs2263329	0.913652658082569	HDL cholesterol levels	8e-43	32203549
rs6900847	rs2263329	0.913652658082569	High density lipoprotein cholesterol levels	2e-52	34887591
rs6900847	rs9296128	0.900347335694377	Hip circumference adjusted for BMI	4e-13	34021172
rs6900847	rs111868030	0.889656487827352	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6900847	rs9368830	0.866119309902887	HDL cholesterol	4e-21	30275531
rs6900847	rs9368828	0.837060583626047	Body mass index	1e-34	34594039
rs6900847	rs6912327	0.829749699521727	Fasting insulin	5e-06	33402679
rs6900847	rs6912327	0.829749699521727	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6900847	rs112283401	0.805468351114375	Red cell distribution width	4e-27	30595370
rs6900847	rs2744973	0.781764983128108	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6900847	rs2744973	0.781764983128108	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6900847	rs2744973	0.781764983128108	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6900847	rs2744973	0.781764983128108	Multi-trait sex score	6e-20	37277458
rs6900847	rs6940215	0.633874805397152	Insomnia	2e-10	35835914
rs6900847	rs6940215	0.633874805397152	Insomnia	1e-13	35835914
rs6900847	rs6940215	0.633874805397152	Hip circumference adjusted for BMI	8e-10	34021172
rs6900847	rs6940215	0.633874805397152	Multi-trait sex score	2e-23	37277458
rs6900847	rs6940215	0.633874805397152	Multi-trait sex score	4e-23	37277458
rs6900847	rs6457796	0.625353100915273	Insomnia	1e-08	30804565
rs6900847	rs6457796	0.625353100915273	Plateletcrit	9e-11	32888494
rs6900847	rs6457796	0.625353100915273	Systemic lupus erythematosus	3e-22	33272962
rs6900847	rs6457796	0.625353100915273	Body mass index	5e-13	30108127
rs6900847	rs6457796	0.625353100915273	Body mass index	1e-14	26426971
rs6900847	rs6457796	0.625353100915273	Educational attainment	5e-19	35361970
rs6900847	rs9689160	0.604895610101661	Lung function (forced vital capacity)	3e-14	36914875
rs6903998	rs14314	0.810849395515045	Macular thickness	3e-19	30535121
rs6903998	rs14314	0.810849395515045	Vertex-wise sulcal depth	7e-17	34910505
rs6903998	rs14314	0.810849395515045	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs6903998	rs14314	0.810849395515045	Left hippocampal volume (body)	7e-15	37337106
rs6903998	rs14314	0.810849395515045	Left subiculum volume (body)	1e-14	37337106
rs6903998	rs2095375	0.798207474343759	Serum metabolite levels	1e-20	33031748
rs6903998	rs2095375	0.798207474343759	Serum metabolite levels	1e-20	33031748
rs6903998	rs9383843	0.797374300127021	Migraine	1e-09	35115687
rs6903998	rs55763431	0.794153068637892	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs6903998	rs9689694	0.792698863339901	Right hippocampal volume (head)	6e-11	37337106
rs6903998	rs9689694	0.792698863339901	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs6903998	rs9689694	0.792698863339901	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs6903998	rs9689694	0.792698863339901	Left hippocampal volume (head)	6e-12	37337106
rs6903998	rs10872645	0.792596686743492	Blood protein levels	2e-86	30072576
rs6903998	rs10872653	0.787517921757417	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs6903998	rs9688867	0.786727060767537	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs6903998	rs9688867	0.786727060767537	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs6903998	rs9688809	0.786727060767537	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs6903998	rs34337297	0.784113237570199	Serum levels of protein LRP11	3e-161	35078996
rs6903998	rs9322193	0.757991194185638	Lung cancer	1e-07	27393504
rs6903998	rs4039600	0.724233187724527	Adenine levels	1e-11	35347128
rs6905393	rs9462030	0.960493851248035	Red cell distribution width	5e-25	32888493
rs6905393	rs9469857	0.955820571398928	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6905393	rs2764208	0.955077443167702	Systemic lupus erythematosus	7e-06	24871463
rs6905393	rs9469899	0.943757051129522	Prostate cancer (advanced)	2e-06	29892016
rs6905393	rs9469899	0.943757051129522	Prostate cancer	5e-09	29892016
rs6905393	rs9469899	0.943757051129522	Prostate cancer	8e-11	33398198
rs6905393	rs9469899	0.943757051129522	Hand grip strength	3e-15	29691431
rs6905393	rs9469899	0.943757051129522	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6905393	rs9469899	0.943757051129522	Graves' disease	4e-10	34594039
rs6905393	rs9469899	0.943757051129522	Coronary artery disease	1e-11	36474045
rs6905393	rs9469899	0.943757051129522	Predicted visceral adipose tissue	2e-20	31501611
rs6905393	rs9469899	0.943757051129522	Medication use (thyroid preparations)	2e-09	31015401
rs6905393	rs9469899	0.943757051129522	Medication use (thyroid preparations)	3e-10	34594039
rs6905393	rs9469872	0.919705408600411	HDL cholesterol levels	3e-11	36333282
rs6905393	rs11755393	0.912959329103966	Body mass index	3e-26	29273807
rs6905393	rs11755393	0.912959329103966	Systemic lupus erythematosus	2e-12	33493351
rs6905393	rs11755393	0.912959329103966	Systemic lupus erythematosus	2e-06	33493351
rs6905393	rs11755393	0.912959329103966	Systemic lupus erythematosus	1e-07	33493351
rs6905393	rs11755393	0.912959329103966	Systemic lupus erythematosus	2e-08	19838195
rs6905393	rs11755393	0.912959329103966	Body mass index	4e-55	36581621
rs6905393	rs9366863	0.909706440053818	Adult body size	9e-33	32376654
rs6905393	rs9366863	0.909706440053818	Body mass index	2e-44	30595370
rs6905393	rs9296128	0.906807253775028	Hip circumference adjusted for BMI	4e-13	34021172
rs6905393	rs6941110	0.902050761306116	Sex hormone-binding globulin levels	5e-27	36653534
rs6905393	rs2814949	0.874094028345412	Essential hypertension (time to event)	9e-09	32589924
rs6905393	rs2744944	0.865049797050743	Hypothyroidism	3e-10	34594039
rs6905393	rs2744944	0.865049797050743	High density lipoprotein cholesterol levels	3e-86	34887591
rs6905393	rs2744944	0.865049797050743	Multi-trait sex score	7e-22	37277458
rs6905393	rs2263329	0.847907154309901	HDL cholesterol	6e-35	34594039
rs6905393	rs2263329	0.847907154309901	HDL cholesterol levels	8e-43	32203549
rs6905393	rs2263329	0.847907154309901	High density lipoprotein cholesterol levels	2e-52	34887591
rs6905393	rs111868030	0.824199863959664	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6905393	rs9368830	0.802710028560223	HDL cholesterol	4e-21	30275531
rs6905393	rs9368828	0.779738924904885	Body mass index	1e-34	34594039
rs6905393	rs2744973	0.7772303286918	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6905393	rs2744973	0.7772303286918	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6905393	rs2744973	0.7772303286918	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6905393	rs2744973	0.7772303286918	Multi-trait sex score	6e-20	37277458
rs6905393	rs6912327	0.765882849676738	Fasting insulin	5e-06	33402679
rs6905393	rs6912327	0.765882849676738	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6905393	rs112283401	0.741162488482932	Red cell distribution width	4e-27	30595370
rs6905393	rs9689160	0.610270460512345	Lung function (forced vital capacity)	3e-14	36914875
rs6906129	rs9469872	0.981656215472806	HDL cholesterol levels	3e-11	36333282
rs6906129	rs11755393	0.980844876191681	Body mass index	3e-26	29273807
rs6906129	rs11755393	0.980844876191681	Systemic lupus erythematosus	2e-12	33493351
rs6906129	rs11755393	0.980844876191681	Systemic lupus erythematosus	2e-06	33493351
rs6906129	rs11755393	0.980844876191681	Systemic lupus erythematosus	1e-07	33493351
rs6906129	rs11755393	0.980844876191681	Systemic lupus erythematosus	2e-08	19838195
rs6906129	rs11755393	0.980844876191681	Body mass index	4e-55	36581621
rs6906129	rs9366863	0.971352163102019	Adult body size	9e-33	32376654
rs6906129	rs9366863	0.971352163102019	Body mass index	2e-44	30595370
rs6906129	rs6941110	0.968211716097332	Sex hormone-binding globulin levels	5e-27	36653534
rs6906129	rs9462030	0.950582196127467	Red cell distribution width	5e-25	32888493
rs6906129	rs9469857	0.941265431184422	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6906129	rs2764208	0.940542668883984	Systemic lupus erythematosus	7e-06	24871463
rs6906129	rs2814949	0.934466288936762	Essential hypertension (time to event)	9e-09	32589924
rs6906129	rs9469899	0.933776826324812	Prostate cancer (advanced)	2e-06	29892016
rs6906129	rs9469899	0.933776826324812	Prostate cancer	5e-09	29892016
rs6906129	rs9469899	0.933776826324812	Prostate cancer	8e-11	33398198
rs6906129	rs9469899	0.933776826324812	Hand grip strength	3e-15	29691431
rs6906129	rs9469899	0.933776826324812	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6906129	rs9469899	0.933776826324812	Graves' disease	4e-10	34594039
rs6906129	rs9469899	0.933776826324812	Coronary artery disease	1e-11	36474045
rs6906129	rs9469899	0.933776826324812	Predicted visceral adipose tissue	2e-20	31501611
rs6906129	rs9469899	0.933776826324812	Medication use (thyroid preparations)	2e-09	31015401
rs6906129	rs9469899	0.933776826324812	Medication use (thyroid preparations)	3e-10	34594039
rs6906129	rs2744944	0.925189632379508	Hypothyroidism	3e-10	34594039
rs6906129	rs2744944	0.925189632379508	High density lipoprotein cholesterol levels	3e-86	34887591
rs6906129	rs2744944	0.925189632379508	Multi-trait sex score	7e-22	37277458
rs6906129	rs2263329	0.90605792406099	HDL cholesterol	6e-35	34594039
rs6906129	rs2263329	0.90605792406099	HDL cholesterol levels	8e-43	32203549
rs6906129	rs2263329	0.90605792406099	High density lipoprotein cholesterol levels	2e-52	34887591
rs6906129	rs9296128	0.892963264256922	Hip circumference adjusted for BMI	4e-13	34021172
rs6906129	rs111868030	0.882318275505166	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6906129	rs9368830	0.85852768007331	HDL cholesterol	4e-21	30275531
rs6906129	rs9368828	0.829831722996626	Body mass index	1e-34	34594039
rs6906129	rs6912327	0.825758221304195	Fasting insulin	5e-06	33402679
rs6906129	rs6912327	0.825758221304195	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6906129	rs112283401	0.802992431348129	Red cell distribution width	4e-27	30595370
rs6906129	rs2744973	0.77510055809948	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6906129	rs2744973	0.77510055809948	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6906129	rs2744973	0.77510055809948	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6906129	rs2744973	0.77510055809948	Multi-trait sex score	6e-20	37277458
rs6906129	rs6940215	0.628021541353883	Insomnia	2e-10	35835914
rs6906129	rs6940215	0.628021541353883	Insomnia	1e-13	35835914
rs6906129	rs6940215	0.628021541353883	Hip circumference adjusted for BMI	8e-10	34021172
rs6906129	rs6940215	0.628021541353883	Multi-trait sex score	2e-23	37277458
rs6906129	rs6940215	0.628021541353883	Multi-trait sex score	4e-23	37277458
rs6906129	rs6457796	0.623641284304566	Insomnia	1e-08	30804565
rs6906129	rs6457796	0.623641284304566	Plateletcrit	9e-11	32888494
rs6906129	rs6457796	0.623641284304566	Systemic lupus erythematosus	3e-22	33272962
rs6906129	rs6457796	0.623641284304566	Body mass index	5e-13	30108127
rs6906129	rs6457796	0.623641284304566	Body mass index	1e-14	26426971
rs6906129	rs6457796	0.623641284304566	Educational attainment	5e-19	35361970
rs6906129	rs9469918	0.605232112941401	Hip circumference adjusted for BMI	8e-09	34021172
rs6906129	rs9469918	0.605232112941401	Hip circumference adjusted for BMI	2e-08	34021172
rs6906129	rs9469918	0.605232112941401	Multi-trait sex score	4e-08	37277458
rs6906606	rs9469857	0.963362777802231	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6906606	rs2764208	0.962536767034974	Systemic lupus erythematosus	7e-06	24871463
rs6906606	rs9462030	0.949199807117378	Red cell distribution width	5e-25	32888493
rs6906606	rs9469899	0.93337339051711	Prostate cancer (advanced)	2e-06	29892016
rs6906606	rs9469899	0.93337339051711	Prostate cancer	5e-09	29892016
rs6906606	rs9469899	0.93337339051711	Prostate cancer	8e-11	33398198
rs6906606	rs9469899	0.93337339051711	Hand grip strength	3e-15	29691431
rs6906606	rs9469899	0.93337339051711	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6906606	rs9469899	0.93337339051711	Graves' disease	4e-10	34594039
rs6906606	rs9469899	0.93337339051711	Coronary artery disease	1e-11	36474045
rs6906606	rs9469899	0.93337339051711	Predicted visceral adipose tissue	2e-20	31501611
rs6906606	rs9469899	0.93337339051711	Medication use (thyroid preparations)	2e-09	31015401
rs6906606	rs9469899	0.93337339051711	Medication use (thyroid preparations)	3e-10	34594039
rs6906606	rs9469872	0.928263247892104	HDL cholesterol levels	3e-11	36333282
rs6906606	rs9296128	0.912311665096052	Hip circumference adjusted for BMI	4e-13	34021172
rs6906606	rs11755393	0.903675929921703	Body mass index	3e-26	29273807
rs6906606	rs11755393	0.903675929921703	Systemic lupus erythematosus	2e-12	33493351
rs6906606	rs11755393	0.903675929921703	Systemic lupus erythematosus	2e-06	33493351
rs6906606	rs11755393	0.903675929921703	Systemic lupus erythematosus	1e-07	33493351
rs6906606	rs11755393	0.903675929921703	Systemic lupus erythematosus	2e-08	19838195
rs6906606	rs11755393	0.903675929921703	Body mass index	4e-55	36581621
rs6906606	rs9366863	0.899665380853152	Adult body size	9e-33	32376654
rs6906606	rs9366863	0.899665380853152	Body mass index	2e-44	30595370
rs6906606	rs6941110	0.891927222439394	Sex hormone-binding globulin levels	5e-27	36653534
rs6906606	rs2744944	0.873184864403438	Hypothyroidism	3e-10	34594039
rs6906606	rs2744944	0.873184864403438	High density lipoprotein cholesterol levels	3e-86	34887591
rs6906606	rs2744944	0.873184864403438	Multi-trait sex score	7e-22	37277458
rs6906606	rs2814949	0.864469936286806	Essential hypertension (time to event)	9e-09	32589924
rs6906606	rs2263329	0.851024808111532	HDL cholesterol	6e-35	34594039
rs6906606	rs2263329	0.851024808111532	HDL cholesterol levels	8e-43	32203549
rs6906606	rs2263329	0.851024808111532	High density lipoprotein cholesterol levels	2e-52	34887591
rs6906606	rs111868030	0.833631847422824	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6906606	rs9368830	0.7942202115894	HDL cholesterol	4e-21	30275531
rs6906606	rs9368828	0.784959877461908	Body mass index	1e-34	34594039
rs6906606	rs6912327	0.761063920846359	Fasting insulin	5e-06	33402679
rs6906606	rs6912327	0.761063920846359	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6906606	rs2744973	0.75975556820604	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6906606	rs2744973	0.75975556820604	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6906606	rs2744973	0.75975556820604	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6906606	rs2744973	0.75975556820604	Multi-trait sex score	6e-20	37277458
rs6906606	rs112283401	0.728006656797612	Red cell distribution width	4e-27	30595370
rs6906759	rs9469872	1	HDL cholesterol levels	3e-11	36333282
rs6906759	rs11755393	0.973790640397902	Body mass index	3e-26	29273807
rs6906759	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-12	33493351
rs6906759	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-06	33493351
rs6906759	rs11755393	0.973790640397902	Systemic lupus erythematosus	1e-07	33493351
rs6906759	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-08	19838195
rs6906759	rs11755393	0.973790640397902	Body mass index	4e-55	36581621
rs6906759	rs9366863	0.970483919695282	Adult body size	9e-33	32376654
rs6906759	rs9366863	0.970483919695282	Body mass index	2e-44	30595370
rs6906759	rs6941110	0.96258381097747	Sex hormone-binding globulin levels	5e-27	36653534
rs6906759	rs9469857	0.958971476515971	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6906759	rs2764208	0.958227492160117	Systemic lupus erythematosus	7e-06	24871463
rs6906759	rs9462030	0.944781064859332	Red cell distribution width	5e-25	32888493
rs6906759	rs2744944	0.942972684970972	Hypothyroidism	3e-10	34594039
rs6906759	rs2744944	0.942972684970972	High density lipoprotein cholesterol levels	3e-86	34887591
rs6906759	rs2744944	0.942972684970972	Multi-trait sex score	7e-22	37277458
rs6906759	rs2814949	0.933665854372005	Essential hypertension (time to event)	9e-09	32589924
rs6906759	rs9469899	0.92820039426473	Prostate cancer (advanced)	2e-06	29892016
rs6906759	rs9469899	0.92820039426473	Prostate cancer	5e-09	29892016
rs6906759	rs9469899	0.92820039426473	Prostate cancer	8e-11	33398198
rs6906759	rs9469899	0.92820039426473	Hand grip strength	3e-15	29691431
rs6906759	rs9469899	0.92820039426473	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6906759	rs9469899	0.92820039426473	Graves' disease	4e-10	34594039
rs6906759	rs9469899	0.92820039426473	Coronary artery disease	1e-11	36474045
rs6906759	rs9469899	0.92820039426473	Predicted visceral adipose tissue	2e-20	31501611
rs6906759	rs9469899	0.92820039426473	Medication use (thyroid preparations)	2e-09	31015401
rs6906759	rs9469899	0.92820039426473	Medication use (thyroid preparations)	3e-10	34594039
rs6906759	rs2263329	0.920478897573699	HDL cholesterol	6e-35	34594039
rs6906759	rs2263329	0.920478897573699	HDL cholesterol levels	8e-43	32203549
rs6906759	rs2263329	0.920478897573699	High density lipoprotein cholesterol levels	2e-52	34887591
rs6906759	rs9296128	0.909885484027307	Hip circumference adjusted for BMI	4e-13	34021172
rs6906759	rs111868030	0.899134497274885	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6906759	rs9368830	0.858231507139136	HDL cholesterol	4e-21	30275531
rs6906759	rs9368828	0.846474268217447	Body mass index	1e-34	34594039
rs6906759	rs6912327	0.819382202499493	Fasting insulin	5e-06	33402679
rs6906759	rs6912327	0.819382202499493	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6906759	rs112283401	0.796699333730006	Red cell distribution width	4e-27	30595370
rs6906759	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6906759	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6906759	rs2744973	0.772924967221123	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6906759	rs2744973	0.772924967221123	Multi-trait sex score	6e-20	37277458
rs6906759	rs6940215	0.625459662116117	Insomnia	2e-10	35835914
rs6906759	rs6940215	0.625459662116117	Insomnia	1e-13	35835914
rs6906759	rs6940215	0.625459662116117	Hip circumference adjusted for BMI	8e-10	34021172
rs6906759	rs6940215	0.625459662116117	Multi-trait sex score	2e-23	37277458
rs6906759	rs6940215	0.625459662116117	Multi-trait sex score	4e-23	37277458
rs6906759	rs6457796	0.61641252194767	Insomnia	1e-08	30804565
rs6906759	rs6457796	0.61641252194767	Plateletcrit	9e-11	32888494
rs6906759	rs6457796	0.61641252194767	Systemic lupus erythematosus	3e-22	33272962
rs6906759	rs6457796	0.61641252194767	Body mass index	5e-13	30108127
rs6906759	rs6457796	0.61641252194767	Body mass index	1e-14	26426971
rs6906759	rs6457796	0.61641252194767	Educational attainment	5e-19	35361970
rs6906759	rs205262	0.603317711536489	Body mass index	2e-09	26961502
rs6906759	rs205262	0.603317711536489	Walking pace	4e-10	33128006
rs6906759	rs205262	0.603317711536489	Body mass index	8e-13	30108127
rs6906759	rs205262	0.603317711536489	Body mass index	2e-09	25673413
rs6906759	rs205262	0.603317711536489	Body mass index	2e-14	26426971
rs6906759	rs205262	0.603317711536489	BMI in non-smokers	3e-07	28443625
rs6906759	rs205262	0.603317711536489	BMI in non-smokers	6e-09	28443625
rs6906759	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs6906759	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs6906759	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs6906759	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs6906759	rs205262	0.603317711536489	Gastroesophageal reflux disease	1e-10	34187846
rs6906759	rs205262	0.603317711536489	Body mass index	3e-10	25673413
rs6906759	rs205262	0.603317711536489	Body mass index	2e-10	25673413
rs6906759	rs205262	0.603317711536489	ICD10 M54: Dorsalgia	2e-12	35110524
rs6907244	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6907244	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs6907244	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs6907244	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs6907244	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs6907244	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs6907244	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs6907244	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6907244	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs6907244	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs6907244	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs6907244	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs6907244	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs6907244	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs6907244	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs6907244	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs6907244	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs6907244	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs6907244	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs6907244	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs6907244	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs6907244	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs6907244	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs6907244	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs6907244	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs6907244	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs6907244	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs6907244	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs6907244	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs6907244	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs6907244	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs6907244	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6907244	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs6907244	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs6907244	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6907244	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6907244	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6907244	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs6907244	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs6907244	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6907244	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs6907244	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs6911878	rs1063631	0.89243993556192	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs6911878	rs1063631	0.89243993556192	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs6911878	rs6928810	0.889266905277565	Platelet distribution width	1e-14	32888494
rs6911878	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs6911878	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs6911878	rs9266825	0.863388785752485	Autism spectrum disorder	6e-06	35215271
rs6911878	rs199530775	0.740710716560911	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs6911878	rs55957433	0.740710716560911	Hip circumference adjusted for BMI	3e-08	34021172
rs6911878	rs6934175	0.672943707181796	Psoriatic arthritis	5e-28	30552173
rs6911878	rs17200242	0.66362509863508	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs6911878	rs7751505	0.656902163915952	Pubertal anthropometrics	4e-06	23449627
rs6911878	rs72848707	0.655638991280889	HDL cholesterol levels	7e-06	35884923
rs6911878	rs35026345	0.655602177487711	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs6911878	rs13437088	0.630668695341699	Psoriasis	3e-40	23143594
rs6911878	rs13437082	0.629974191739058	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs6911878	rs13437082	0.629974191739058	Height	5e-08	19343178
rs6911878	rs72657657	0.622382288399658	Hip circumference adjusted for BMI	4e-13	34021172
rs6912659	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs6912659	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs6912659	rs6928810	0.890092667905038	Platelet distribution width	1e-14	32888494
rs6912659	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs6912659	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs6912659	rs9266825	0.864263096403477	Autism spectrum disorder	6e-06	35215271
rs6912659	rs199530775	0.741622971640871	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs6912659	rs55957433	0.741622971640871	Hip circumference adjusted for BMI	3e-08	34021172
rs6912659	rs6934175	0.67384422555715	Psoriatic arthritis	5e-28	30552173
rs6912659	rs17200242	0.664511943065584	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs6912659	rs7751505	0.657706582280067	Pubertal anthropometrics	4e-06	23449627
rs6912659	rs35026345	0.65640936672589	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs6912659	rs72848707	0.655066901958558	HDL cholesterol levels	7e-06	35884923
rs6912659	rs13437088	0.631438004864122	Psoriasis	3e-40	23143594
rs6912659	rs13437082	0.630743556638567	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs6912659	rs13437082	0.630743556638567	Height	5e-08	19343178
rs6912659	rs72657657	0.623149040879308	Hip circumference adjusted for BMI	4e-13	34021172
rs6913486	rs56103941	0.970216353369485	Right presubiculum volume (head)	4e-08	37337106
rs6913486	rs12523793	0.950328206743057	Subcortical volume (MOSTest)	4e-24	32665545
rs6913486	rs12523793	0.950328206743057	C-reactive protein levels	3e-08	35459240
rs6913486	rs12523793	0.950328206743057	C-reactive protein levels (MTAG)	2e-08	36376304
rs6913486	rs11155662	0.940661217054184	Vertex-wise cortical thickness	2e-09	34910505
rs6913486	rs12526675	0.880499523035903	Brain morphology (MOSTest)	7e-22	32665545
rs6913486	rs2342764	0.814396013955628	Cortical thickness	1e-08	34560273
rs6913486	rs58189451	0.766529412356163	Drinks per week	1e-09	36477530
rs6913486	rs9285521	0.755930434600277	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs6913486	rs9322194	0.663170655318471	Brainstem volume	2e-11	31636452
rs6913486	rs7752089	0.653339124736549	Brain morphology (MOSTest)	2e-31	35164939
rs6913486	rs11155675	0.643400247196662	Brain region volumes	3e-09	31676860
rs6913486	rs1125	0.643194148346727	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs6913486	rs1125	0.643194148346727	Vertical cup-disc ratio	8e-14	34077760
rs6913486	rs9371201	0.630492028666783	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs6913486	rs10872649	0.627836134984091	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs6913486	rs10872649	0.627836134984091	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs6913486	rs10872649	0.627836134984091	Right hippocampal volume (body)	1e-10	37337106
rs6913486	rs4421206	0.61506655329087	Brain morphology (min-P)	4e-11	32665545
rs6913486	rs9505982	0.600776354237239	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs6914319	rs2095375	0.99819989996776	Serum metabolite levels	1e-20	33031748
rs6914319	rs2095375	0.99819989996776	Serum metabolite levels	1e-20	33031748
rs6914319	rs9383843	0.997301067714085	Migraine	1e-09	35115687
rs6914319	rs55763431	0.995506640298119	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs6914319	rs9689694	0.993707895167345	Right hippocampal volume (head)	6e-11	37337106
rs6914319	rs9689694	0.993707895167345	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs6914319	rs9689694	0.993707895167345	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs6914319	rs9689694	0.993707895167345	Left hippocampal volume (head)	6e-12	37337106
rs6914319	rs10872645	0.988335410721321	Blood protein levels	2e-86	30072576
rs6914319	rs9688867	0.987484746280957	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs6914319	rs9688867	0.987484746280957	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs6914319	rs9688809	0.987484746280957	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs6914319	rs10872653	0.987428985005238	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs6914319	rs34337297	0.983863132808358	Serum levels of protein LRP11	3e-161	35078996
rs6914319	rs14314	0.979470359097395	Macular thickness	3e-19	30535121
rs6914319	rs14314	0.979470359097395	Vertex-wise sulcal depth	7e-17	34910505
rs6914319	rs14314	0.979470359097395	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs6914319	rs14314	0.979470359097395	Left hippocampal volume (body)	7e-15	37337106
rs6914319	rs14314	0.979470359097395	Left subiculum volume (body)	1e-14	37337106
rs6914319	rs9322193	0.947826521476432	Lung cancer	1e-07	27393504
rs6914319	rs4039600	0.904085337095829	Adenine levels	1e-11	35347128
rs6914319	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-08	37844115
rs6914319	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-06	37844115
rs6914319	rs4380763	0.638343493751961	Subcortical volume (min-P)	1e-11	32665545
rs6914319	rs11155671	0.62791813730041	Testicular germ cell tumor	2e-09	28604728
rs6914319	rs80147756	0.613057484647013	HippSubfield lh volume subiculum-head	3e-10	33875891
rs6914319	rs4421206	0.605487928690632	Brain morphology (min-P)	4e-11	32665545
rs6915220	rs1063631	0.89243993556192	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs6915220	rs1063631	0.89243993556192	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs6915220	rs6928810	0.889266905277565	Platelet distribution width	1e-14	32888494
rs6915220	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs6915220	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs6915220	rs9266825	0.863388785752485	Autism spectrum disorder	6e-06	35215271
rs6915220	rs199530775	0.739165137320618	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs6915220	rs55957433	0.739165137320618	Hip circumference adjusted for BMI	3e-08	34021172
rs6915220	rs6934175	0.672943707181796	Psoriatic arthritis	5e-28	30552173
rs6915220	rs17200242	0.66362509863508	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs6915220	rs7751505	0.658325328967215	Pubertal anthropometrics	4e-06	23449627
rs6915220	rs35026345	0.657025657520171	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs6915220	rs72848707	0.652690496234301	HDL cholesterol levels	7e-06	35884923
rs6915220	rs13437088	0.630668695341699	Psoriasis	3e-40	23143594
rs6915220	rs13437082	0.629974191739058	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs6915220	rs13437082	0.629974191739058	Height	5e-08	19343178
rs6915220	rs72657657	0.622382288399658	Hip circumference adjusted for BMI	4e-13	34021172
rs6919654	rs9469872	0.952596328378425	HDL cholesterol levels	3e-11	36333282
rs6919654	rs11755393	0.933593302600081	Body mass index	3e-26	29273807
rs6919654	rs11755393	0.933593302600081	Systemic lupus erythematosus	2e-12	33493351
rs6919654	rs11755393	0.933593302600081	Systemic lupus erythematosus	2e-06	33493351
rs6919654	rs11755393	0.933593302600081	Systemic lupus erythematosus	1e-07	33493351
rs6919654	rs11755393	0.933593302600081	Systemic lupus erythematosus	2e-08	19838195
rs6919654	rs11755393	0.933593302600081	Body mass index	4e-55	36581621
rs6919654	rs9366863	0.923705412932581	Adult body size	9e-33	32376654
rs6919654	rs9366863	0.923705412932581	Body mass index	2e-44	30595370
rs6919654	rs6941110	0.920555254316961	Sex hormone-binding globulin levels	5e-27	36653534
rs6919654	rs9469857	0.911741867456404	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6919654	rs2764208	0.910968992657564	Systemic lupus erythematosus	7e-06	24871463
rs6919654	rs9462030	0.902536461723707	Red cell distribution width	5e-25	32888493
rs6919654	rs2744944	0.896874905122449	Hypothyroidism	3e-10	34594039
rs6919654	rs2744944	0.896874905122449	High density lipoprotein cholesterol levels	3e-86	34887591
rs6919654	rs2744944	0.896874905122449	Multi-trait sex score	7e-22	37277458
rs6919654	rs2814949	0.887932934453092	Essential hypertension (time to event)	9e-09	32589924
rs6919654	rs9469899	0.886799380682447	Prostate cancer (advanced)	2e-06	29892016
rs6919654	rs9469899	0.886799380682447	Prostate cancer	5e-09	29892016
rs6919654	rs9469899	0.886799380682447	Prostate cancer	8e-11	33398198
rs6919654	rs9469899	0.886799380682447	Hand grip strength	3e-15	29691431
rs6919654	rs9469899	0.886799380682447	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6919654	rs9469899	0.886799380682447	Graves' disease	4e-10	34594039
rs6919654	rs9469899	0.886799380682447	Coronary artery disease	1e-11	36474045
rs6919654	rs9469899	0.886799380682447	Predicted visceral adipose tissue	2e-20	31501611
rs6919654	rs9469899	0.886799380682447	Medication use (thyroid preparations)	2e-09	31015401
rs6919654	rs9469899	0.886799380682447	Medication use (thyroid preparations)	3e-10	34594039
rs6919654	rs2263329	0.876164477820696	HDL cholesterol	6e-35	34594039
rs6919654	rs2263329	0.876164477820696	HDL cholesterol levels	8e-43	32203549
rs6919654	rs2263329	0.876164477820696	High density lipoprotein cholesterol levels	2e-52	34887591
rs6919654	rs9368828	0.869967982380226	Body mass index	1e-34	34594039
rs6919654	rs9296128	0.865804699247957	Hip circumference adjusted for BMI	4e-13	34021172
rs6919654	rs111868030	0.861295893034638	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6919654	rs112283401	0.826118576866932	Red cell distribution width	4e-27	30595370
rs6919654	rs9368830	0.815670356956042	HDL cholesterol	4e-21	30275531
rs6919654	rs2744973	0.794021705117346	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6919654	rs2744973	0.794021705117346	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6919654	rs2744973	0.794021705117346	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6919654	rs2744973	0.794021705117346	Multi-trait sex score	6e-20	37277458
rs6919654	rs6912327	0.777368334796605	Fasting insulin	5e-06	33402679
rs6919654	rs6912327	0.777368334796605	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6924898	rs9469872	0.98720241099489	HDL cholesterol levels	3e-11	36333282
rs6924898	rs11755393	0.986444884059495	Body mass index	3e-26	29273807
rs6924898	rs11755393	0.986444884059495	Systemic lupus erythematosus	2e-12	33493351
rs6924898	rs11755393	0.986444884059495	Systemic lupus erythematosus	2e-06	33493351
rs6924898	rs11755393	0.986444884059495	Systemic lupus erythematosus	1e-07	33493351
rs6924898	rs11755393	0.986444884059495	Systemic lupus erythematosus	2e-08	19838195
rs6924898	rs11755393	0.986444884059495	Body mass index	4e-55	36581621
rs6924898	rs9366863	0.976860982963086	Adult body size	9e-33	32376654
rs6924898	rs9366863	0.976860982963086	Body mass index	2e-44	30595370
rs6924898	rs6941110	0.973702783416799	Sex hormone-binding globulin levels	5e-27	36653534
rs6924898	rs9462030	0.955940696217343	Red cell distribution width	5e-25	32888493
rs6924898	rs9469857	0.946587798313119	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6924898	rs2764208	0.945856861873276	Systemic lupus erythematosus	7e-06	24871463
rs6924898	rs2814949	0.939888741028689	Essential hypertension (time to event)	9e-09	32589924
rs6924898	rs9469899	0.939150617656352	Prostate cancer (advanced)	2e-06	29892016
rs6924898	rs9469899	0.939150617656352	Prostate cancer	5e-09	29892016
rs6924898	rs9469899	0.939150617656352	Prostate cancer	8e-11	33398198
rs6924898	rs9469899	0.939150617656352	Hand grip strength	3e-15	29691431
rs6924898	rs9469899	0.939150617656352	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6924898	rs9469899	0.939150617656352	Graves' disease	4e-10	34594039
rs6924898	rs9469899	0.939150617656352	Coronary artery disease	1e-11	36474045
rs6924898	rs9469899	0.939150617656352	Predicted visceral adipose tissue	2e-20	31501611
rs6924898	rs9469899	0.939150617656352	Medication use (thyroid preparations)	2e-09	31015401
rs6924898	rs9469899	0.939150617656352	Medication use (thyroid preparations)	3e-10	34594039
rs6924898	rs2744944	0.930563121541505	Hypothyroidism	3e-10	34594039
rs6924898	rs2744944	0.930563121541505	High density lipoprotein cholesterol levels	3e-86	34887591
rs6924898	rs2744944	0.930563121541505	Multi-trait sex score	7e-22	37277458
rs6924898	rs2263329	0.911338067082369	HDL cholesterol	6e-35	34594039
rs6924898	rs2263329	0.911338067082369	HDL cholesterol levels	8e-43	32203549
rs6924898	rs2263329	0.911338067082369	High density lipoprotein cholesterol levels	2e-52	34887591
rs6924898	rs9296128	0.898008968022849	Hip circumference adjusted for BMI	4e-13	34021172
rs6924898	rs111868030	0.887331747144213	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6924898	rs9368830	0.863908938269681	HDL cholesterol	4e-21	30275531
rs6924898	rs9368828	0.83483633935768	Body mass index	1e-34	34594039
rs6924898	rs6912327	0.830416950508655	Fasting insulin	5e-06	33402679
rs6924898	rs6912327	0.830416950508655	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6924898	rs112283401	0.807583844795641	Red cell distribution width	4e-27	30595370
rs6924898	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6924898	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6924898	rs2744973	0.779518782641824	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6924898	rs2744973	0.779518782641824	Multi-trait sex score	6e-20	37277458
rs6924898	rs6940215	0.631797836113969	Insomnia	2e-10	35835914
rs6924898	rs6940215	0.631797836113969	Insomnia	1e-13	35835914
rs6924898	rs6940215	0.631797836113969	Hip circumference adjusted for BMI	8e-10	34021172
rs6924898	rs6940215	0.631797836113969	Multi-trait sex score	2e-23	37277458
rs6924898	rs6940215	0.631797836113969	Multi-trait sex score	4e-23	37277458
rs6924898	rs6457796	0.627184527171391	Insomnia	1e-08	30804565
rs6924898	rs6457796	0.627184527171391	Plateletcrit	9e-11	32888494
rs6924898	rs6457796	0.627184527171391	Systemic lupus erythematosus	3e-22	33272962
rs6924898	rs6457796	0.627184527171391	Body mass index	5e-13	30108127
rs6924898	rs6457796	0.627184527171391	Body mass index	1e-14	26426971
rs6924898	rs6457796	0.627184527171391	Educational attainment	5e-19	35361970
rs6924898	rs9689160	0.602761401207754	Lung function (forced vital capacity)	3e-14	36914875
rs6924898	rs9469918	0.601654933170762	Hip circumference adjusted for BMI	8e-09	34021172
rs6924898	rs9469918	0.601654933170762	Hip circumference adjusted for BMI	2e-08	34021172
rs6924898	rs9469918	0.601654933170762	Multi-trait sex score	4e-08	37277458
rs6925623	rs9462030	0.987986365028275	Red cell distribution width	5e-25	32888493
rs6925623	rs9469857	0.978417382468831	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6925623	rs2764208	0.977637560625387	Systemic lupus erythematosus	7e-06	24871463
rs6925623	rs9469899	0.971287862772447	Prostate cancer (advanced)	2e-06	29892016
rs6925623	rs9469899	0.971287862772447	Prostate cancer	5e-09	29892016
rs6925623	rs9469899	0.971287862772447	Prostate cancer	8e-11	33398198
rs6925623	rs9469899	0.971287862772447	Hand grip strength	3e-15	29691431
rs6925623	rs9469899	0.971287862772447	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6925623	rs9469899	0.971287862772447	Graves' disease	4e-10	34594039
rs6925623	rs9469899	0.971287862772447	Coronary artery disease	1e-11	36474045
rs6925623	rs9469899	0.971287862772447	Predicted visceral adipose tissue	2e-20	31501611
rs6925623	rs9469899	0.971287862772447	Medication use (thyroid preparations)	2e-09	31015401
rs6925623	rs9469899	0.971287862772447	Medication use (thyroid preparations)	3e-10	34594039
rs6925623	rs9469872	0.942285023333223	HDL cholesterol levels	3e-11	36333282
rs6925623	rs11755393	0.941924837871495	Body mass index	3e-26	29273807
rs6925623	rs11755393	0.941924837871495	Systemic lupus erythematosus	2e-12	33493351
rs6925623	rs11755393	0.941924837871495	Systemic lupus erythematosus	2e-06	33493351
rs6925623	rs11755393	0.941924837871495	Systemic lupus erythematosus	1e-07	33493351
rs6925623	rs11755393	0.941924837871495	Systemic lupus erythematosus	2e-08	19838195
rs6925623	rs11755393	0.941924837871495	Body mass index	4e-55	36581621
rs6925623	rs9366863	0.932126431630567	Adult body size	9e-33	32376654
rs6925623	rs9366863	0.932126431630567	Body mass index	2e-44	30595370
rs6925623	rs6941110	0.928980717116146	Sex hormone-binding globulin levels	5e-27	36653534
rs6925623	rs9296128	0.928184009121138	Hip circumference adjusted for BMI	4e-13	34021172
rs6925623	rs2814949	0.896151626247455	Essential hypertension (time to event)	9e-09	32589924
rs6925623	rs2744944	0.886896524873778	Hypothyroidism	3e-10	34594039
rs6925623	rs2744944	0.886896524873778	High density lipoprotein cholesterol levels	3e-86	34887591
rs6925623	rs2744944	0.886896524873778	Multi-trait sex score	7e-22	37277458
rs6925623	rs2263329	0.867872415381575	HDL cholesterol	6e-35	34594039
rs6925623	rs2263329	0.867872415381575	HDL cholesterol levels	8e-43	32203549
rs6925623	rs2263329	0.867872415381575	High density lipoprotein cholesterol levels	2e-52	34887591
rs6925623	rs111868030	0.844501893330201	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6925623	rs9368830	0.823185774094917	HDL cholesterol	4e-21	30275531
rs6925623	rs9368828	0.797231942549761	Body mass index	1e-34	34594039
rs6925623	rs2744973	0.79426459286975	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6925623	rs2744973	0.79426459286975	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6925623	rs2744973	0.79426459286975	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6925623	rs2744973	0.79426459286975	Multi-trait sex score	6e-20	37277458
rs6925623	rs6912327	0.786052649890042	Fasting insulin	5e-06	33402679
rs6925623	rs6912327	0.786052649890042	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6925623	rs112283401	0.763827654904998	Red cell distribution width	4e-27	30595370
rs6925623	rs9689160	0.623028649935304	Lung function (forced vital capacity)	3e-14	36914875
rs6925764	rs9469872	0.972206356910474	HDL cholesterol levels	3e-11	36333282
rs6925764	rs11755393	0.969739574296871	Body mass index	3e-26	29273807
rs6925764	rs11755393	0.969739574296871	Systemic lupus erythematosus	2e-12	33493351
rs6925764	rs11755393	0.969739574296871	Systemic lupus erythematosus	2e-06	33493351
rs6925764	rs11755393	0.969739574296871	Systemic lupus erythematosus	1e-07	33493351
rs6925764	rs11755393	0.969739574296871	Systemic lupus erythematosus	2e-08	19838195
rs6925764	rs11755393	0.969739574296871	Body mass index	4e-55	36581621
rs6925764	rs9366863	0.965116949301785	Adult body size	9e-33	32376654
rs6925764	rs9366863	0.965116949301785	Body mass index	2e-44	30595370
rs6925764	rs6941110	0.958850613697009	Sex hormone-binding globulin levels	5e-27	36653534
rs6925764	rs9462030	0.941421341369959	Red cell distribution width	5e-25	32888493
rs6925764	rs9469857	0.932163275430845	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6925764	rs2764208	0.931452516435087	Systemic lupus erythematosus	7e-06	24871463
rs6925764	rs2814949	0.928322608405777	Essential hypertension (time to event)	9e-09	32589924
rs6925764	rs9469899	0.924610098384204	Prostate cancer (advanced)	2e-06	29892016
rs6925764	rs9469899	0.924610098384204	Prostate cancer	5e-09	29892016
rs6925764	rs9469899	0.924610098384204	Prostate cancer	8e-11	33398198
rs6925764	rs9469899	0.924610098384204	Hand grip strength	3e-15	29691431
rs6925764	rs9469899	0.924610098384204	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6925764	rs9469899	0.924610098384204	Graves' disease	4e-10	34594039
rs6925764	rs9469899	0.924610098384204	Coronary artery disease	1e-11	36474045
rs6925764	rs9469899	0.924610098384204	Predicted visceral adipose tissue	2e-20	31501611
rs6925764	rs9469899	0.924610098384204	Medication use (thyroid preparations)	2e-09	31015401
rs6925764	rs9469899	0.924610098384204	Medication use (thyroid preparations)	3e-10	34594039
rs6925764	rs2744944	0.920648581832824	Hypothyroidism	3e-10	34594039
rs6925764	rs2744944	0.920648581832824	High density lipoprotein cholesterol levels	3e-86	34887591
rs6925764	rs2744944	0.920648581832824	Multi-trait sex score	7e-22	37277458
rs6925764	rs2263329	0.900093645933285	HDL cholesterol	6e-35	34594039
rs6925764	rs2263329	0.900093645933285	HDL cholesterol levels	8e-43	32203549
rs6925764	rs2263329	0.900093645933285	High density lipoprotein cholesterol levels	2e-52	34887591
rs6925764	rs9296128	0.884289394890882	Hip circumference adjusted for BMI	4e-13	34021172
rs6925764	rs111868030	0.87671848348015	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6925764	rs9368830	0.856818687302604	HDL cholesterol	4e-21	30275531
rs6925764	rs9368828	0.827115712029515	Body mass index	1e-34	34594039
rs6925764	rs6912327	0.817682899913463	Fasting insulin	5e-06	33402679
rs6925764	rs6912327	0.817682899913463	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6925764	rs112283401	0.795033147852321	Red cell distribution width	4e-27	30595370
rs6925764	rs2744973	0.77169379560867	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6925764	rs2744973	0.77169379560867	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6925764	rs2744973	0.77169379560867	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6925764	rs2744973	0.77169379560867	Multi-trait sex score	6e-20	37277458
rs6925764	rs6940215	0.621368713707672	Insomnia	2e-10	35835914
rs6925764	rs6940215	0.621368713707672	Insomnia	1e-13	35835914
rs6925764	rs6940215	0.621368713707672	Hip circumference adjusted for BMI	8e-10	34021172
rs6925764	rs6940215	0.621368713707672	Multi-trait sex score	2e-23	37277458
rs6925764	rs6940215	0.621368713707672	Multi-trait sex score	4e-23	37277458
rs6925764	rs6457796	0.617301465106178	Insomnia	1e-08	30804565
rs6925764	rs6457796	0.617301465106178	Plateletcrit	9e-11	32888494
rs6925764	rs6457796	0.617301465106178	Systemic lupus erythematosus	3e-22	33272962
rs6925764	rs6457796	0.617301465106178	Body mass index	5e-13	30108127
rs6925764	rs6457796	0.617301465106178	Body mass index	1e-14	26426971
rs6925764	rs6457796	0.617301465106178	Educational attainment	5e-19	35361970
rs6927475	rs2842611	0.915017111727264	High density lipoprotein cholesterol levels	5e-09	34887591
rs6927475	rs1173416	0.898464941982551	Height	2e-59	36224396
rs6927475	rs9450288	0.876660853631503	Height	2e-10	36224396
rs6927870	rs6928810	0.930741565003011	Platelet distribution width	1e-14	32888494
rs6927870	rs3869132	0.929794327334553	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs6927870	rs3869132	0.929794327334553	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs6927870	rs9266825	0.892875807980593	Autism spectrum disorder	6e-06	35215271
rs6927870	rs1063631	0.816028955932932	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs6927870	rs1063631	0.816028955932932	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs6927870	rs72848707	0.674803004814335	HDL cholesterol levels	7e-06	35884923
rs6927870	rs199530775	0.663288819491156	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs6927870	rs55957433	0.663288819491156	Hip circumference adjusted for BMI	3e-08	34021172
rs6928810	rs6928810	1	Platelet distribution width	1e-14	32888494
rs6928810	rs3869132	0.990577573109513	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs6928810	rs3869132	0.990577573109513	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs6928810	rs9266825	0.866513584285416	Autism spectrum disorder	6e-06	35215271
rs6928810	rs1063631	0.790394568989778	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs6928810	rs1063631	0.790394568989778	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs6928810	rs72848707	0.653918896553083	HDL cholesterol levels	7e-06	35884923
rs6928810	rs199530775	0.646590769339288	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs6928810	rs55957433	0.646590769339288	Hip circumference adjusted for BMI	3e-08	34021172
rs6929470	rs9469857	0.957109293899814	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6929470	rs2764208	0.956277291464066	Systemic lupus erythematosus	7e-06	24871463
rs6929470	rs9462030	0.942998599830495	Red cell distribution width	5e-25	32888493
rs6929470	rs9469899	0.927308444286701	Prostate cancer (advanced)	2e-06	29892016
rs6929470	rs9469899	0.927308444286701	Prostate cancer	5e-09	29892016
rs6929470	rs9469899	0.927308444286701	Prostate cancer	8e-11	33398198
rs6929470	rs9469899	0.927308444286701	Hand grip strength	3e-15	29691431
rs6929470	rs9469899	0.927308444286701	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6929470	rs9469899	0.927308444286701	Graves' disease	4e-10	34594039
rs6929470	rs9469899	0.927308444286701	Coronary artery disease	1e-11	36474045
rs6929470	rs9469899	0.927308444286701	Predicted visceral adipose tissue	2e-20	31501611
rs6929470	rs9469899	0.927308444286701	Medication use (thyroid preparations)	2e-09	31015401
rs6929470	rs9469899	0.927308444286701	Medication use (thyroid preparations)	3e-10	34594039
rs6929470	rs9469872	0.922248064937922	HDL cholesterol levels	3e-11	36333282
rs6929470	rs9296128	0.906023350936138	Hip circumference adjusted for BMI	4e-13	34021172
rs6929470	rs11755393	0.8978033023071	Body mass index	3e-26	29273807
rs6929470	rs11755393	0.8978033023071	Systemic lupus erythematosus	2e-12	33493351
rs6929470	rs11755393	0.8978033023071	Systemic lupus erythematosus	2e-06	33493351
rs6929470	rs11755393	0.8978033023071	Systemic lupus erythematosus	1e-07	33493351
rs6929470	rs11755393	0.8978033023071	Systemic lupus erythematosus	2e-08	19838195
rs6929470	rs11755393	0.8978033023071	Body mass index	4e-55	36581621
rs6929470	rs9366863	0.89372572479501	Adult body size	9e-33	32376654
rs6929470	rs9366863	0.89372572479501	Body mass index	2e-44	30595370
rs6929470	rs6941110	0.885999935866179	Sex hormone-binding globulin levels	5e-27	36653534
rs6929470	rs2744944	0.867331871141334	Hypothyroidism	3e-10	34594039
rs6929470	rs2744944	0.867331871141334	High density lipoprotein cholesterol levels	3e-86	34887591
rs6929470	rs2744944	0.867331871141334	Multi-trait sex score	7e-22	37277458
rs6929470	rs2814949	0.858668968011045	Essential hypertension (time to event)	9e-09	32589924
rs6929470	rs2263329	0.845195093136769	HDL cholesterol	6e-35	34594039
rs6929470	rs2263329	0.845195093136769	HDL cholesterol levels	8e-43	32203549
rs6929470	rs2263329	0.845195093136769	High density lipoprotein cholesterol levels	2e-52	34887591
rs6929470	rs111868030	0.829068721082314	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6929470	rs9368830	0.788877024371249	HDL cholesterol	4e-21	30275531
rs6929470	rs9368828	0.779293531905636	Body mass index	1e-34	34594039
rs6929470	rs6912327	0.755006832644724	Fasting insulin	5e-06	33402679
rs6929470	rs6912327	0.755006832644724	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6929470	rs2744973	0.75498691197498	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6929470	rs2744973	0.75498691197498	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6929470	rs2744973	0.75498691197498	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6929470	rs2744973	0.75498691197498	Multi-trait sex score	6e-20	37277458
rs6929470	rs112283401	0.722073866147307	Red cell distribution width	4e-27	30595370
rs6929567	rs9366863	0.99679027670559	Adult body size	9e-33	32376654
rs6929567	rs9366863	0.99679027670559	Body mass index	2e-44	30595370
rs6929567	rs9469872	0.973655621338095	HDL cholesterol levels	3e-11	36333282
rs6929567	rs11755393	0.966664123350239	Body mass index	3e-26	29273807
rs6929567	rs11755393	0.966664123350239	Systemic lupus erythematosus	2e-12	33493351
rs6929567	rs11755393	0.966664123350239	Systemic lupus erythematosus	2e-06	33493351
rs6929567	rs11755393	0.966664123350239	Systemic lupus erythematosus	1e-07	33493351
rs6929567	rs11755393	0.966664123350239	Systemic lupus erythematosus	2e-08	19838195
rs6929567	rs11755393	0.966664123350239	Body mass index	4e-55	36581621
rs6929567	rs2814949	0.95945865759442	Essential hypertension (time to event)	9e-09	32589924
rs6929567	rs6941110	0.957074733003238	Sex hormone-binding globulin levels	5e-27	36653534
rs6929567	rs2744944	0.950011203272154	Hypothyroidism	3e-10	34594039
rs6929567	rs2744944	0.950011203272154	High density lipoprotein cholesterol levels	3e-86	34887591
rs6929567	rs2744944	0.950011203272154	Multi-trait sex score	7e-22	37277458
rs6929567	rs9462030	0.937769025902711	Red cell distribution width	5e-25	32888493
rs6929567	rs9469857	0.933149364952149	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6929567	rs2764208	0.932413435736606	Systemic lupus erythematosus	7e-06	24871463
rs6929567	rs2263329	0.930542906374067	HDL cholesterol	6e-35	34594039
rs6929567	rs2263329	0.930542906374067	HDL cholesterol levels	8e-43	32203549
rs6929567	rs2263329	0.930542906374067	High density lipoprotein cholesterol levels	2e-52	34887591
rs6929567	rs9469899	0.921248611178217	Prostate cancer (advanced)	2e-06	29892016
rs6929567	rs9469899	0.921248611178217	Prostate cancer	5e-09	29892016
rs6929567	rs9469899	0.921248611178217	Prostate cancer	8e-11	33398198
rs6929567	rs9469899	0.921248611178217	Hand grip strength	3e-15	29691431
rs6929567	rs9469899	0.921248611178217	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6929567	rs9469899	0.921248611178217	Graves' disease	4e-10	34594039
rs6929567	rs9469899	0.921248611178217	Coronary artery disease	1e-11	36474045
rs6929567	rs9469899	0.921248611178217	Predicted visceral adipose tissue	2e-20	31501611
rs6929567	rs9469899	0.921248611178217	Medication use (thyroid preparations)	2e-09	31015401
rs6929567	rs9469899	0.921248611178217	Medication use (thyroid preparations)	3e-10	34594039
rs6929567	rs111868030	0.906077651495445	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6929567	rs9296128	0.88468539190401	Hip circumference adjusted for BMI	4e-13	34021172
rs6929567	rs9368830	0.88288793616956	HDL cholesterol	4e-21	30275531
rs6929567	rs9368828	0.851679048294784	Body mass index	1e-34	34594039
rs6929567	rs6912327	0.812848662289752	Fasting insulin	5e-06	33402679
rs6929567	rs6912327	0.812848662289752	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6929567	rs2744973	0.796836784799695	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6929567	rs2744973	0.796836784799695	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6929567	rs2744973	0.796836784799695	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6929567	rs2744973	0.796836784799695	Multi-trait sex score	6e-20	37277458
rs6929567	rs112283401	0.790257863293587	Red cell distribution width	4e-27	30595370
rs6929567	rs6940215	0.63406229264072	Insomnia	2e-10	35835914
rs6929567	rs6940215	0.63406229264072	Insomnia	1e-13	35835914
rs6929567	rs6940215	0.63406229264072	Hip circumference adjusted for BMI	8e-10	34021172
rs6929567	rs6940215	0.63406229264072	Multi-trait sex score	2e-23	37277458
rs6929567	rs6940215	0.63406229264072	Multi-trait sex score	4e-23	37277458
rs6929567	rs6457796	0.625137095146929	Insomnia	1e-08	30804565
rs6929567	rs6457796	0.625137095146929	Plateletcrit	9e-11	32888494
rs6929567	rs6457796	0.625137095146929	Systemic lupus erythematosus	3e-22	33272962
rs6929567	rs6457796	0.625137095146929	Body mass index	5e-13	30108127
rs6929567	rs6457796	0.625137095146929	Body mass index	1e-14	26426971
rs6929567	rs6457796	0.625137095146929	Educational attainment	5e-19	35361970
rs6929567	rs205262	0.609384697690614	Body mass index	2e-09	26961502
rs6929567	rs205262	0.609384697690614	Walking pace	4e-10	33128006
rs6929567	rs205262	0.609384697690614	Body mass index	8e-13	30108127
rs6929567	rs205262	0.609384697690614	Body mass index	2e-09	25673413
rs6929567	rs205262	0.609384697690614	Body mass index	2e-14	26426971
rs6929567	rs205262	0.609384697690614	BMI in non-smokers	3e-07	28443625
rs6929567	rs205262	0.609384697690614	BMI in non-smokers	6e-09	28443625
rs6929567	rs205262	0.609384697690614	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs6929567	rs205262	0.609384697690614	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs6929567	rs205262	0.609384697690614	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs6929567	rs205262	0.609384697690614	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs6929567	rs205262	0.609384697690614	Gastroesophageal reflux disease	1e-10	34187846
rs6929567	rs205262	0.609384697690614	Body mass index	3e-10	25673413
rs6929567	rs205262	0.609384697690614	Body mass index	2e-10	25673413
rs6929567	rs205262	0.609384697690614	ICD10 M54: Dorsalgia	2e-12	35110524
rs6929567	rs9689160	0.604523533516379	Lung function (forced vital capacity)	3e-14	36914875
rs6930036	rs9462030	0.991973323084328	Red cell distribution width	5e-25	32888493
rs6930036	rs9469857	0.987176694560192	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6930036	rs2764208	0.986389433458688	Systemic lupus erythematosus	7e-06	24871463
rs6930036	rs9469899	0.975286229149324	Prostate cancer (advanced)	2e-06	29892016
rs6930036	rs9469899	0.975286229149324	Prostate cancer	5e-09	29892016
rs6930036	rs9469899	0.975286229149324	Prostate cancer	8e-11	33398198
rs6930036	rs9469899	0.975286229149324	Hand grip strength	3e-15	29691431
rs6930036	rs9469899	0.975286229149324	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6930036	rs9469899	0.975286229149324	Graves' disease	4e-10	34594039
rs6930036	rs9469899	0.975286229149324	Coronary artery disease	1e-11	36474045
rs6930036	rs9469899	0.975286229149324	Predicted visceral adipose tissue	2e-20	31501611
rs6930036	rs9469899	0.975286229149324	Medication use (thyroid preparations)	2e-09	31015401
rs6930036	rs9469899	0.975286229149324	Medication use (thyroid preparations)	3e-10	34594039
rs6930036	rs9469872	0.9509390607211	HDL cholesterol levels	3e-11	36333282
rs6930036	rs11755393	0.944352060781661	Body mass index	3e-26	29273807
rs6930036	rs11755393	0.944352060781661	Systemic lupus erythematosus	2e-12	33493351
rs6930036	rs11755393	0.944352060781661	Systemic lupus erythematosus	2e-06	33493351
rs6930036	rs11755393	0.944352060781661	Systemic lupus erythematosus	1e-07	33493351
rs6930036	rs11755393	0.944352060781661	Systemic lupus erythematosus	2e-08	19838195
rs6930036	rs11755393	0.944352060781661	Body mass index	4e-55	36581621
rs6930036	rs9366863	0.940728057758258	Adult body size	9e-33	32376654
rs6930036	rs9366863	0.940728057758258	Body mass index	2e-44	30595370
rs6930036	rs9296128	0.936626672105552	Hip circumference adjusted for BMI	4e-13	34021172
rs6930036	rs6941110	0.932892213958832	Sex hormone-binding globulin levels	5e-27	36653534
rs6930036	rs2814949	0.904596288583152	Essential hypertension (time to event)	9e-09	32589924
rs6930036	rs2744944	0.89528309843648	Hypothyroidism	3e-10	34594039
rs6930036	rs2744944	0.89528309843648	High density lipoprotein cholesterol levels	3e-86	34887591
rs6930036	rs2744944	0.89528309843648	Multi-trait sex score	7e-22	37277458
rs6930036	rs2263329	0.876144094738658	HDL cholesterol	6e-35	34594039
rs6930036	rs2263329	0.876144094738658	HDL cholesterol levels	8e-43	32203549
rs6930036	rs2263329	0.876144094738658	High density lipoprotein cholesterol levels	2e-52	34887591
rs6930036	rs111868030	0.852541106101868	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6930036	rs9368830	0.831397247480196	HDL cholesterol	4e-21	30275531
rs6930036	rs9368828	0.806573277904584	Body mass index	1e-34	34594039
rs6930036	rs2744973	0.801904500036379	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6930036	rs2744973	0.801904500036379	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6930036	rs2744973	0.801904500036379	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6930036	rs2744973	0.801904500036379	Multi-trait sex score	6e-20	37277458
rs6930036	rs6912327	0.789357317923654	Fasting insulin	5e-06	33402679
rs6930036	rs6912327	0.789357317923654	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6930036	rs112283401	0.767082566425639	Red cell distribution width	4e-27	30595370
rs6930036	rs9689160	0.629562990742547	Lung function (forced vital capacity)	3e-14	36914875
rs6931044	rs3129754	0.95141198868925	Waist-hip index	2e-12	34021172
rs6931044	rs3129754	0.95141198868925	Waist-to-hip ratio adjusted for BMI	8e-13	34021172
rs6931044	rs4959106	0.892469765622689	Interleukin-6 levels	7e-13	33067605
rs6931044	rs34077986	0.869670330395338	A body shape index	5e-11	34021172
rs6931044	rs34656207	0.703815125225277	Aspartate aminotransferase levels	1e-111	33547301
rs6931044	rs34656207	0.703815125225277	Aspartate aminotransferase levels	1e-126	34594039
rs6931044	rs4959105	0.656573697942246	Lymphocyte count	3e-16	29403010
rs6931044	rs33915496	0.642221416542645	Lymphocyte count	1e-16	32888493
rs6934631	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs6934631	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs6934631	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs6934631	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs6934631	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs6934631	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs6934631	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs6934631	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs6934631	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs6934631	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs6934631	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs6934631	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs6934631	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs6934631	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs6934631	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs6934631	rs13437082	0.631513452560533	Height	5e-08	19343178
rs6934631	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs6934662	rs9469872	0.969727896556969	HDL cholesterol levels	3e-11	36333282
rs6934662	rs11755393	0.959760466571718	Body mass index	3e-26	29273807
rs6934662	rs11755393	0.959760466571718	Systemic lupus erythematosus	2e-12	33493351
rs6934662	rs11755393	0.959760466571718	Systemic lupus erythematosus	2e-06	33493351
rs6934662	rs11755393	0.959760466571718	Systemic lupus erythematosus	1e-07	33493351
rs6934662	rs11755393	0.959760466571718	Systemic lupus erythematosus	2e-08	19838195
rs6934662	rs11755393	0.959760466571718	Body mass index	4e-55	36581621
rs6934662	rs9366863	0.956293198602647	Adult body size	9e-33	32376654
rs6934662	rs9366863	0.956293198602647	Body mass index	2e-44	30595370
rs6934662	rs6941110	0.948422241647839	Sex hormone-binding globulin levels	5e-27	36653534
rs6934662	rs9462030	0.930503047081931	Red cell distribution width	5e-25	32888493
rs6934662	rs9469857	0.928976716595016	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6934662	rs2764208	0.928223696470366	Systemic lupus erythematosus	7e-06	24871463
rs6934662	rs2814949	0.919804985077444	Essential hypertension (time to event)	9e-09	32589924
rs6934662	rs9469899	0.914239464845368	Prostate cancer (advanced)	2e-06	29892016
rs6934662	rs9469899	0.914239464845368	Prostate cancer	5e-09	29892016
rs6934662	rs9469899	0.914239464845368	Prostate cancer	8e-11	33398198
rs6934662	rs9469899	0.914239464845368	Hand grip strength	3e-15	29691431
rs6934662	rs9469899	0.914239464845368	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6934662	rs9469899	0.914239464845368	Graves' disease	4e-10	34594039
rs6934662	rs9469899	0.914239464845368	Coronary artery disease	1e-11	36474045
rs6934662	rs9469899	0.914239464845368	Predicted visceral adipose tissue	2e-20	31501611
rs6934662	rs9469899	0.914239464845368	Medication use (thyroid preparations)	2e-09	31015401
rs6934662	rs9469899	0.914239464845368	Medication use (thyroid preparations)	3e-10	34594039
rs6934662	rs2744944	0.913551318067054	Hypothyroidism	3e-10	34594039
rs6934662	rs2744944	0.913551318067054	High density lipoprotein cholesterol levels	3e-86	34887591
rs6934662	rs2744944	0.913551318067054	Multi-trait sex score	7e-22	37277458
rs6934662	rs2263329	0.895854936573227	HDL cholesterol	6e-35	34594039
rs6934662	rs2263329	0.895854936573227	HDL cholesterol levels	8e-43	32203549
rs6934662	rs2263329	0.895854936573227	High density lipoprotein cholesterol levels	2e-52	34887591
rs6934662	rs9296128	0.880192925494522	Hip circumference adjusted for BMI	4e-13	34021172
rs6934662	rs111868030	0.875650955589838	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6934662	rs9368830	0.846938273866638	HDL cholesterol	4e-21	30275531
rs6934662	rs9368828	0.822716824833568	Body mass index	1e-34	34594039
rs6934662	rs6912327	0.81376852287035	Fasting insulin	5e-06	33402679
rs6934662	rs6912327	0.81376852287035	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6934662	rs112283401	0.782507378059216	Red cell distribution width	4e-27	30595370
rs6934662	rs2744973	0.760040906055463	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6934662	rs2744973	0.760040906055463	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6934662	rs2744973	0.760040906055463	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6934662	rs2744973	0.760040906055463	Multi-trait sex score	6e-20	37277458
rs6934662	rs6940215	0.618309968680268	Insomnia	2e-10	35835914
rs6934662	rs6940215	0.618309968680268	Insomnia	1e-13	35835914
rs6934662	rs6940215	0.618309968680268	Hip circumference adjusted for BMI	8e-10	34021172
rs6934662	rs6940215	0.618309968680268	Multi-trait sex score	2e-23	37277458
rs6934662	rs6940215	0.618309968680268	Multi-trait sex score	4e-23	37277458
rs6934662	rs6457796	0.608474395898416	Insomnia	1e-08	30804565
rs6934662	rs6457796	0.608474395898416	Plateletcrit	9e-11	32888494
rs6934662	rs6457796	0.608474395898416	Systemic lupus erythematosus	3e-22	33272962
rs6934662	rs6457796	0.608474395898416	Body mass index	5e-13	30108127
rs6934662	rs6457796	0.608474395898416	Body mass index	1e-14	26426971
rs6934662	rs6457796	0.608474395898416	Educational attainment	5e-19	35361970
rs6936395	rs14314	0.995524022096962	Macular thickness	3e-19	30535121
rs6936395	rs14314	0.995524022096962	Vertex-wise sulcal depth	7e-17	34910505
rs6936395	rs14314	0.995524022096962	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs6936395	rs14314	0.995524022096962	Left hippocampal volume (body)	7e-15	37337106
rs6936395	rs14314	0.995524022096962	Left subiculum volume (body)	1e-14	37337106
rs6936395	rs2095375	0.980386022444601	Serum metabolite levels	1e-20	33031748
rs6936395	rs2095375	0.980386022444601	Serum metabolite levels	1e-20	33031748
rs6936395	rs9383843	0.979493654706539	Migraine	1e-09	35115687
rs6936395	rs55763431	0.975937262857595	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs6936395	rs9689694	0.974167427671015	Right hippocampal volume (head)	6e-11	37337106
rs6936395	rs9689694	0.974167427671015	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs6936395	rs9689694	0.974167427671015	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs6936395	rs9689694	0.974167427671015	Left hippocampal volume (head)	6e-12	37337106
rs6936395	rs10872645	0.972392359535804	Blood protein levels	2e-86	30072576
rs6936395	rs9688867	0.967982687699475	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs6936395	rs9688867	0.967982687699475	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs6936395	rs9688809	0.967982687699475	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs6936395	rs10872653	0.967982595568586	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs6936395	rs34337297	0.964439955228822	Serum levels of protein LRP11	3e-161	35078996
rs6936395	rs9322193	0.928784253595695	Lung cancer	1e-07	27393504
rs6936395	rs4039600	0.88585786503681	Adenine levels	1e-11	35347128
rs6936395	rs1934534	0.642681498817581	Pain (pleiotropy)	2e-08	37844115
rs6936395	rs1934534	0.642681498817581	Pain (pleiotropy)	2e-06	37844115
rs6936395	rs4380763	0.642155694802365	Subcortical volume (min-P)	1e-11	32665545
rs6936395	rs11155671	0.63169118104307	Testicular germ cell tumor	2e-09	28604728
rs6936395	rs80147756	0.617975092312284	HippSubfield lh volume subiculum-head	3e-10	33875891
rs6936395	rs4421206	0.608982330202127	Brain morphology (min-P)	4e-11	32665545
rs6936395	rs9505982	0.602511034394113	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs6937784	rs9366863	0.98402102695107	Adult body size	9e-33	32376654
rs6937784	rs9366863	0.98402102695107	Body mass index	2e-44	30595370
rs6937784	rs2814949	0.973780580512323	Essential hypertension (time to event)	9e-09	32589924
rs6937784	rs2744944	0.959465427719031	Hypothyroidism	3e-10	34594039
rs6937784	rs2744944	0.959465427719031	High density lipoprotein cholesterol levels	3e-86	34887591
rs6937784	rs2744944	0.959465427719031	Multi-trait sex score	7e-22	37277458
rs6937784	rs9469872	0.954745079114618	HDL cholesterol levels	3e-11	36333282
rs6937784	rs11755393	0.948001562957214	Body mass index	3e-26	29273807
rs6937784	rs11755393	0.948001562957214	Systemic lupus erythematosus	2e-12	33493351
rs6937784	rs11755393	0.948001562957214	Systemic lupus erythematosus	2e-06	33493351
rs6937784	rs11755393	0.948001562957214	Systemic lupus erythematosus	1e-07	33493351
rs6937784	rs11755393	0.948001562957214	Systemic lupus erythematosus	2e-08	19838195
rs6937784	rs11755393	0.948001562957214	Body mass index	4e-55	36581621
rs6937784	rs2263329	0.946036363989924	HDL cholesterol	6e-35	34594039
rs6937784	rs2263329	0.946036363989924	HDL cholesterol levels	8e-43	32203549
rs6937784	rs2263329	0.946036363989924	High density lipoprotein cholesterol levels	2e-52	34887591
rs6937784	rs6941110	0.93826833682322	Sex hormone-binding globulin levels	5e-27	36653534
rs6937784	rs111868030	0.923894299534295	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6937784	rs9462030	0.918874647279762	Red cell distribution width	5e-25	32888493
rs6937784	rs9469857	0.914271223226873	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6937784	rs2764208	0.913521523890551	Systemic lupus erythematosus	7e-06	24871463
rs6937784	rs9469899	0.902736445612218	Prostate cancer (advanced)	2e-06	29892016
rs6937784	rs9469899	0.902736445612218	Prostate cancer	5e-09	29892016
rs6937784	rs9469899	0.902736445612218	Prostate cancer	8e-11	33398198
rs6937784	rs9469899	0.902736445612218	Hand grip strength	3e-15	29691431
rs6937784	rs9469899	0.902736445612218	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6937784	rs9469899	0.902736445612218	Graves' disease	4e-10	34594039
rs6937784	rs9469899	0.902736445612218	Coronary artery disease	1e-11	36474045
rs6937784	rs9469899	0.902736445612218	Predicted visceral adipose tissue	2e-20	31501611
rs6937784	rs9469899	0.902736445612218	Medication use (thyroid preparations)	2e-09	31015401
rs6937784	rs9469899	0.902736445612218	Medication use (thyroid preparations)	3e-10	34594039
rs6937784	rs9368830	0.891092436649803	HDL cholesterol	4e-21	30275531
rs6937784	rs9296128	0.86581615157002	Hip circumference adjusted for BMI	4e-13	34021172
rs6937784	rs9368828	0.860370652837463	Body mass index	1e-34	34594039
rs6937784	rs2744973	0.809810096319745	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6937784	rs2744973	0.809810096319745	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6937784	rs2744973	0.809810096319745	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6937784	rs2744973	0.809810096319745	Multi-trait sex score	6e-20	37277458
rs6937784	rs6912327	0.795480518257751	Fasting insulin	5e-06	33402679
rs6937784	rs6912327	0.795480518257751	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6937784	rs112283401	0.773126803372041	Red cell distribution width	4e-27	30595370
rs6937784	rs6940215	0.625347442190556	Insomnia	2e-10	35835914
rs6937784	rs6940215	0.625347442190556	Insomnia	1e-13	35835914
rs6937784	rs6940215	0.625347442190556	Hip circumference adjusted for BMI	8e-10	34021172
rs6937784	rs6940215	0.625347442190556	Multi-trait sex score	2e-23	37277458
rs6937784	rs6940215	0.625347442190556	Multi-trait sex score	4e-23	37277458
rs6937784	rs205262	0.617988018193744	Body mass index	2e-09	26961502
rs6937784	rs205262	0.617988018193744	Walking pace	4e-10	33128006
rs6937784	rs205262	0.617988018193744	Body mass index	8e-13	30108127
rs6937784	rs205262	0.617988018193744	Body mass index	2e-09	25673413
rs6937784	rs205262	0.617988018193744	Body mass index	2e-14	26426971
rs6937784	rs205262	0.617988018193744	BMI in non-smokers	3e-07	28443625
rs6937784	rs205262	0.617988018193744	BMI in non-smokers	6e-09	28443625
rs6937784	rs205262	0.617988018193744	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs6937784	rs205262	0.617988018193744	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs6937784	rs205262	0.617988018193744	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs6937784	rs205262	0.617988018193744	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs6937784	rs205262	0.617988018193744	Gastroesophageal reflux disease	1e-10	34187846
rs6937784	rs205262	0.617988018193744	Body mass index	3e-10	25673413
rs6937784	rs205262	0.617988018193744	Body mass index	2e-10	25673413
rs6937784	rs205262	0.617988018193744	ICD10 M54: Dorsalgia	2e-12	35110524
rs6937784	rs6457796	0.615532755533823	Insomnia	1e-08	30804565
rs6937784	rs6457796	0.615532755533823	Plateletcrit	9e-11	32888494
rs6937784	rs6457796	0.615532755533823	Systemic lupus erythematosus	3e-22	33272962
rs6937784	rs6457796	0.615532755533823	Body mass index	5e-13	30108127
rs6937784	rs6457796	0.615532755533823	Body mass index	1e-14	26426971
rs6937784	rs6457796	0.615532755533823	Educational attainment	5e-19	35361970
rs6939600	rs11755393	1	Body mass index	3e-26	29273807
rs6939600	rs11755393	1	Systemic lupus erythematosus	2e-12	33493351
rs6939600	rs11755393	1	Systemic lupus erythematosus	2e-06	33493351
rs6939600	rs11755393	1	Systemic lupus erythematosus	1e-07	33493351
rs6939600	rs11755393	1	Systemic lupus erythematosus	2e-08	19838195
rs6939600	rs11755393	1	Body mass index	4e-55	36581621
rs6939600	rs9469872	0.973790640397902	HDL cholesterol levels	3e-11	36333282
rs6939600	rs9366863	0.963539594764905	Adult body size	9e-33	32376654
rs6939600	rs9366863	0.963539594764905	Body mass index	2e-44	30595370
rs6939600	rs6941110	0.96042432428924	Sex hormone-binding globulin levels	5e-27	36653534
rs6939600	rs9462030	0.942982809247869	Red cell distribution width	5e-25	32888493
rs6939600	rs9469857	0.933717288059645	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6939600	rs2764208	0.933006118158596	Systemic lupus erythematosus	7e-06	24871463
rs6939600	rs2814949	0.926776227817379	Essential hypertension (time to event)	9e-09	32589924
rs6939600	rs9469899	0.926155764655461	Prostate cancer (advanced)	2e-06	29892016
rs6939600	rs9469899	0.926155764655461	Prostate cancer	5e-09	29892016
rs6939600	rs9469899	0.926155764655461	Prostate cancer	8e-11	33398198
rs6939600	rs9469899	0.926155764655461	Hand grip strength	3e-15	29691431
rs6939600	rs9469899	0.926155764655461	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6939600	rs9469899	0.926155764655461	Graves' disease	4e-10	34594039
rs6939600	rs9469899	0.926155764655461	Coronary artery disease	1e-11	36474045
rs6939600	rs9469899	0.926155764655461	Predicted visceral adipose tissue	2e-20	31501611
rs6939600	rs9469899	0.926155764655461	Medication use (thyroid preparations)	2e-09	31015401
rs6939600	rs9469899	0.926155764655461	Medication use (thyroid preparations)	3e-10	34594039
rs6939600	rs2744944	0.917569011329476	Hypothyroidism	3e-10	34594039
rs6939600	rs2744944	0.917569011329476	High density lipoprotein cholesterol levels	3e-86	34887591
rs6939600	rs2744944	0.917569011329476	Multi-trait sex score	7e-22	37277458
rs6939600	rs2263329	0.898569690885672	HDL cholesterol	6e-35	34594039
rs6939600	rs2263329	0.898569690885672	HDL cholesterol levels	8e-43	32203549
rs6939600	rs2263329	0.898569690885672	High density lipoprotein cholesterol levels	2e-52	34887591
rs6939600	rs9296128	0.88580748304751	Hip circumference adjusted for BMI	4e-13	34021172
rs6939600	rs111868030	0.875208207072485	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6939600	rs9368830	0.850896311437697	HDL cholesterol	4e-21	30275531
rs6939600	rs9368828	0.822734322097911	Body mass index	1e-34	34594039
rs6939600	rs6912327	0.819151244554246	Fasting insulin	5e-06	33402679
rs6939600	rs6912327	0.819151244554246	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6939600	rs112283401	0.796480925818498	Red cell distribution width	4e-27	30595370
rs6939600	rs2744973	0.768834665996764	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6939600	rs2744973	0.768834665996764	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6939600	rs2744973	0.768834665996764	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6939600	rs2744973	0.768834665996764	Multi-trait sex score	6e-20	37277458
rs6939600	rs6940215	0.622666103131952	Insomnia	2e-10	35835914
rs6939600	rs6940215	0.622666103131952	Insomnia	1e-13	35835914
rs6939600	rs6940215	0.622666103131952	Hip circumference adjusted for BMI	8e-10	34021172
rs6939600	rs6940215	0.622666103131952	Multi-trait sex score	2e-23	37277458
rs6939600	rs6940215	0.622666103131952	Multi-trait sex score	4e-23	37277458
rs6939600	rs6457796	0.622569130911958	Insomnia	1e-08	30804565
rs6939600	rs6457796	0.622569130911958	Plateletcrit	9e-11	32888494
rs6939600	rs6457796	0.622569130911958	Systemic lupus erythematosus	3e-22	33272962
rs6939600	rs6457796	0.622569130911958	Body mass index	5e-13	30108127
rs6939600	rs6457796	0.622569130911958	Body mass index	1e-14	26426971
rs6939600	rs6457796	0.622569130911958	Educational attainment	5e-19	35361970
rs6939600	rs9469918	0.60659448079015	Hip circumference adjusted for BMI	8e-09	34021172
rs6939600	rs9469918	0.60659448079015	Hip circumference adjusted for BMI	2e-08	34021172
rs6939600	rs9469918	0.60659448079015	Multi-trait sex score	4e-08	37277458
rs6940258	rs6940878	0.692249551399838	Red blood cell count	4e-74	32888494
rs6940258	rs4580893	0.686671209483283	Plateletcrit	4e-27	27863252
rs6940258	rs7750574	0.684453666165015	Red blood cell forward scatter	2e-15	37596262
rs6940258	rs7750574	0.684453666165015	Red blood cell haemoglobin equivalent	4e-16	37596262
rs6940258	rs35367489	0.676842147210334	Red blood cell count	3e-20	29403010
rs6940258	rs12664956	0.651339673991603	Mean corpuscular volume	2e-28	29403010
rs6940258	rs12664956	0.651339673991603	Red blood cell traits (multivariate analysis)	1e-06	32171239
rs6940258	rs12664956	0.651339673991603	Mean corpuscular volume	4e-08	32171239
rs6940258	rs12664956	0.651339673991603	Mean corpuscular hemoglobin	1e-30	29403010
rs6940258	rs12664956	0.651339673991603	Mean corpuscular hemoglobin	2e-06	32171239
rs6940258	rs12664956	0.651339673991603	Platelet count	1e-21	32888494
rs6940258	rs6904897	0.631529088141273	Mean corpuscular volume	4e-55	27863252
rs6940258	rs6904897	0.631529088141273	Mean spheric corpuscular volume	1e-55	32888494
rs6940258	rs6904897	0.631529088141273	Mean corpuscular hemoglobin	2e-67	27863252
rs6940395	rs9469857	0.993560351631218	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6940395	rs2764208	0.992753258994264	Systemic lupus erythematosus	7e-06	24871463
rs6940395	rs9462030	0.979152308417478	Red cell distribution width	5e-25	32888493
rs6940395	rs9469899	0.962766479808125	Prostate cancer (advanced)	2e-06	29892016
rs6940395	rs9469899	0.962766479808125	Prostate cancer	5e-09	29892016
rs6940395	rs9469899	0.962766479808125	Prostate cancer	8e-11	33398198
rs6940395	rs9469899	0.962766479808125	Hand grip strength	3e-15	29691431
rs6940395	rs9469899	0.962766479808125	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6940395	rs9469899	0.962766479808125	Graves' disease	4e-10	34594039
rs6940395	rs9469899	0.962766479808125	Coronary artery disease	1e-11	36474045
rs6940395	rs9469899	0.962766479808125	Predicted visceral adipose tissue	2e-20	31501611
rs6940395	rs9469899	0.962766479808125	Medication use (thyroid preparations)	2e-09	31015401
rs6940395	rs9469899	0.962766479808125	Medication use (thyroid preparations)	3e-10	34594039
rs6940395	rs9469872	0.957454825143524	HDL cholesterol levels	3e-11	36333282
rs6940395	rs9296128	0.942447033658596	Hip circumference adjusted for BMI	4e-13	34021172
rs6940395	rs11755393	0.932251725994051	Body mass index	3e-26	29273807
rs6940395	rs11755393	0.932251725994051	Systemic lupus erythematosus	2e-12	33493351
rs6940395	rs11755393	0.932251725994051	Systemic lupus erythematosus	2e-06	33493351
rs6940395	rs11755393	0.932251725994051	Systemic lupus erythematosus	1e-07	33493351
rs6940395	rs11755393	0.932251725994051	Systemic lupus erythematosus	2e-08	19838195
rs6940395	rs11755393	0.932251725994051	Body mass index	4e-55	36581621
rs6940395	rs9366863	0.92846976836223	Adult body size	9e-33	32376654
rs6940395	rs9366863	0.92846976836223	Body mass index	2e-44	30595370
rs6940395	rs6941110	0.920656046985625	Sex hormone-binding globulin levels	5e-27	36653534
rs6940395	rs2744944	0.901568158491952	Hypothyroidism	3e-10	34594039
rs6940395	rs2744944	0.901568158491952	High density lipoprotein cholesterol levels	3e-86	34887591
rs6940395	rs2744944	0.901568158491952	Multi-trait sex score	7e-22	37277458
rs6940395	rs2814949	0.892628519963885	Essential hypertension (time to event)	9e-09	32589924
rs6940395	rs2263329	0.879234666925632	HDL cholesterol	6e-35	34594039
rs6940395	rs2263329	0.879234666925632	HDL cholesterol levels	8e-43	32203549
rs6940395	rs2263329	0.879234666925632	High density lipoprotein cholesterol levels	2e-52	34887591
rs6940395	rs111868030	0.858038346169142	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6940395	rs9368830	0.820426420117022	HDL cholesterol	4e-21	30275531
rs6940395	rs9368828	0.810850606691918	Body mass index	1e-34	34594039
rs6940395	rs2744973	0.788946918418038	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6940395	rs2744973	0.788946918418038	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6940395	rs2744973	0.788946918418038	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6940395	rs2744973	0.788946918418038	Multi-trait sex score	6e-20	37277458
rs6940395	rs6912327	0.776800557429317	Fasting insulin	5e-06	33402679
rs6940395	rs6912327	0.776800557429317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6940395	rs112283401	0.754695984616199	Red cell distribution width	4e-27	30595370
rs6940395	rs9689160	0.616014278324462	Lung function (forced vital capacity)	3e-14	36914875
rs6941110	rs6941110	1	Sex hormone-binding globulin levels	5e-27	36653534
rs6941110	rs9469872	0.96258381097747	HDL cholesterol levels	3e-11	36333282
rs6941110	rs11755393	0.96042432428924	Body mass index	3e-26	29273807
rs6941110	rs11755393	0.96042432428924	Systemic lupus erythematosus	2e-12	33493351
rs6941110	rs11755393	0.96042432428924	Systemic lupus erythematosus	2e-06	33493351
rs6941110	rs11755393	0.96042432428924	Systemic lupus erythematosus	1e-07	33493351
rs6941110	rs11755393	0.96042432428924	Systemic lupus erythematosus	2e-08	19838195
rs6941110	rs11755393	0.96042432428924	Body mass index	4e-55	36581621
rs6941110	rs9366863	0.953918635452588	Adult body size	9e-33	32376654
rs6941110	rs9366863	0.953918635452588	Body mass index	2e-44	30595370
rs6941110	rs9462030	0.932974160870551	Red cell distribution width	5e-25	32888493
rs6941110	rs9469857	0.922158003834804	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6941110	rs2764208	0.921417496348263	Systemic lupus erythematosus	7e-06	24871463
rs6941110	rs2814949	0.917445774624504	Essential hypertension (time to event)	9e-09	32589924
rs6941110	rs9469899	0.915040259384048	Prostate cancer (advanced)	2e-06	29892016
rs6941110	rs9469899	0.915040259384048	Prostate cancer	5e-09	29892016
rs6941110	rs9469899	0.915040259384048	Prostate cancer	8e-11	33398198
rs6941110	rs9469899	0.915040259384048	Hand grip strength	3e-15	29691431
rs6941110	rs9469899	0.915040259384048	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6941110	rs9469899	0.915040259384048	Graves' disease	4e-10	34594039
rs6941110	rs9469899	0.915040259384048	Coronary artery disease	1e-11	36474045
rs6941110	rs9469899	0.915040259384048	Predicted visceral adipose tissue	2e-20	31501611
rs6941110	rs9469899	0.915040259384048	Medication use (thyroid preparations)	2e-09	31015401
rs6941110	rs9469899	0.915040259384048	Medication use (thyroid preparations)	3e-10	34594039
rs6941110	rs2744944	0.90816881545315	Hypothyroidism	3e-10	34594039
rs6941110	rs2744944	0.90816881545315	High density lipoprotein cholesterol levels	3e-86	34887591
rs6941110	rs2744944	0.90816881545315	Multi-trait sex score	7e-22	37277458
rs6941110	rs2263329	0.889067980590598	HDL cholesterol	6e-35	34594039
rs6941110	rs2263329	0.889067980590598	HDL cholesterol levels	8e-43	32203549
rs6941110	rs2263329	0.889067980590598	High density lipoprotein cholesterol levels	2e-52	34887591
rs6941110	rs9296128	0.873777697661248	Hip circumference adjusted for BMI	4e-13	34021172
rs6941110	rs111868030	0.864741940179916	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6941110	rs9368830	0.842906356464362	HDL cholesterol	4e-21	30275531
rs6941110	rs9368828	0.813386833065711	Body mass index	1e-34	34594039
rs6941110	rs6912327	0.809373204619975	Fasting insulin	5e-06	33402679
rs6941110	rs6912327	0.809373204619975	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6941110	rs112283401	0.785387713498646	Red cell distribution width	4e-27	30595370
rs6941110	rs2744973	0.774496169239364	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6941110	rs2744973	0.774496169239364	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6941110	rs2744973	0.774496169239364	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6941110	rs2744973	0.774496169239364	Multi-trait sex score	6e-20	37277458
rs6941110	rs6940215	0.609813362160337	Insomnia	2e-10	35835914
rs6941110	rs6940215	0.609813362160337	Insomnia	1e-13	35835914
rs6941110	rs6940215	0.609813362160337	Hip circumference adjusted for BMI	8e-10	34021172
rs6941110	rs6940215	0.609813362160337	Multi-trait sex score	2e-23	37277458
rs6941110	rs6940215	0.609813362160337	Multi-trait sex score	4e-23	37277458
rs6941110	rs6457796	0.60424137486488	Insomnia	1e-08	30804565
rs6941110	rs6457796	0.60424137486488	Plateletcrit	9e-11	32888494
rs6941110	rs6457796	0.60424137486488	Systemic lupus erythematosus	3e-22	33272962
rs6941110	rs6457796	0.60424137486488	Body mass index	5e-13	30108127
rs6941110	rs6457796	0.60424137486488	Body mass index	1e-14	26426971
rs6941110	rs6457796	0.60424137486488	Educational attainment	5e-19	35361970
rs6942040	rs9462030	0.991961796545434	Red cell distribution width	5e-25	32888493
rs6942040	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs6942040	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs6942040	rs9469899	0.975314640267064	Prostate cancer (advanced)	2e-06	29892016
rs6942040	rs9469899	0.975314640267064	Prostate cancer	5e-09	29892016
rs6942040	rs9469899	0.975314640267064	Prostate cancer	8e-11	33398198
rs6942040	rs9469899	0.975314640267064	Hand grip strength	3e-15	29691431
rs6942040	rs9469899	0.975314640267064	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs6942040	rs9469899	0.975314640267064	Graves' disease	4e-10	34594039
rs6942040	rs9469899	0.975314640267064	Coronary artery disease	1e-11	36474045
rs6942040	rs9469899	0.975314640267064	Predicted visceral adipose tissue	2e-20	31501611
rs6942040	rs9469899	0.975314640267064	Medication use (thyroid preparations)	2e-09	31015401
rs6942040	rs9469899	0.975314640267064	Medication use (thyroid preparations)	3e-10	34594039
rs6942040	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs6942040	rs11755393	0.944425765145638	Body mass index	3e-26	29273807
rs6942040	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-12	33493351
rs6942040	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-06	33493351
rs6942040	rs11755393	0.944425765145638	Systemic lupus erythematosus	1e-07	33493351
rs6942040	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-08	19838195
rs6942040	rs11755393	0.944425765145638	Body mass index	4e-55	36581621
rs6942040	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs6942040	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs6942040	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs6942040	rs6941110	0.932921349732261	Sex hormone-binding globulin levels	5e-27	36653534
rs6942040	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs6942040	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs6942040	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs6942040	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs6942040	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs6942040	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs6942040	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs6942040	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs6942040	rs9368830	0.831547762090701	HDL cholesterol	4e-21	30275531
rs6942040	rs9368828	0.805103390346437	Body mass index	1e-34	34594039
rs6942040	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs6942040	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs6942040	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs6942040	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs6942040	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs6942040	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs6942040	rs112283401	0.766845687865746	Red cell distribution width	4e-27	30595370
rs6942040	rs9689160	0.628913951683802	Lung function (forced vital capacity)	3e-14	36914875
rs6944710	rs4304220	0.889800576578576	Height	2e-14	36224396
rs6944710	rs13232536	0.731230959959043	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6944710	rs13227841	0.670876655955872	Asthma	2e-09	32514122
rs6944710	rs4355658	0.655480961367518	Height	3e-13	36224396
rs6946037	rs4304220	0.995975238332255	Height	2e-14	36224396
rs6946037	rs13232536	0.723967449167848	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6946037	rs4355658	0.704420503565492	Height	3e-13	36224396
rs6946037	rs13227841	0.609114581634749	Asthma	2e-09	32514122
rs6947264	rs12539962	0.841356727485851	Colorectal cancer	3e-08	36539618
rs6947264	rs13232536	0.728219305844191	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6947264	rs4355658	0.678949503846382	Height	3e-13	36224396
rs6947264	rs7806956	0.640046453264303	Esophageal squamous cell carcinoma	3e-07	37673066
rs6949053	rs4304220	0.706809900531021	Height	2e-14	36224396
rs6949053	rs4355658	0.69430812766348	Height	3e-13	36224396
rs6949053	rs12539962	0.613348477534029	Colorectal cancer	3e-08	36539618
rs6952976	rs13232536	0.788610104808548	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6952976	rs12539962	0.75644536989492	Colorectal cancer	3e-08	36539618
rs6952976	rs4355658	0.73458637207914	Height	3e-13	36224396
rs6958663	rs12539962	0.873098954518342	Colorectal cancer	3e-08	36539618
rs6958663	rs13232536	0.698702434329049	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6958663	rs7806956	0.661910188807342	Esophageal squamous cell carcinoma	3e-07	37673066
rs6958663	rs4355658	0.652579817767507	Height	3e-13	36224396
rs6965004	rs12539962	0.90439652455763	Colorectal cancer	3e-08	36539618
rs6965004	rs4355658	0.696381343168822	Height	3e-13	36224396
rs6965004	rs13232536	0.677933746063815	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6968360	rs4304220	0.782622617182685	Height	2e-14	36224396
rs6968360	rs4355658	0.755091490760339	Height	3e-13	36224396
rs6968360	rs12539962	0.618515770289098	Colorectal cancer	3e-08	36539618
rs6974182	rs4304220	0.868862949321539	Height	2e-14	36224396
rs6974182	rs4355658	0.819206054822882	Height	3e-13	36224396
rs6974182	rs13232536	0.614041555744898	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6974182	rs12539962	0.601093864378622	Colorectal cancer	3e-08	36539618
rs6974378	rs4304220	0.868862949321539	Height	2e-14	36224396
rs6974378	rs4355658	0.819206054822882	Height	3e-13	36224396
rs6974378	rs13232536	0.614041555744898	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs6974378	rs12539962	0.601093864378622	Colorectal cancer	3e-08	36539618
rs6998116	rs4413755	0.887251578585686	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs6998145	rs4413755	0.920921770445803	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs7005423	rs1036385	0.745653141100853	Height	6e-11	36224396
rs7005423	rs2016749	0.697754216762033	Calcium levels	2e-08	34594039
rs7005613	rs1036385	0.754107833542235	Height	6e-11	36224396
rs7005613	rs2016749	0.706069408692796	Calcium levels	2e-08	34594039
rs7005927	rs1036385	0.743929630866044	Height	6e-11	36224396
rs7005927	rs2016749	0.696903589967595	Calcium levels	2e-08	34594039
rs7006887	rs6471393	0.607190942697309	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs7012804	rs1036385	0.735842612740993	Height	6e-11	36224396
rs7012804	rs2016749	0.689804478528168	Calcium levels	2e-08	34594039
rs7013131	rs1036385	0.870546980170988	Height	6e-11	36224396
rs7013131	rs2016749	0.816714609985307	Calcium levels	2e-08	34594039
rs7015444	rs4413755	0.923915974182185	13-HODE + 9-HODE levels in elite athletes	3e-06	31882771
rs7019	rs11087521	0.880028549771129	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs7019	rs59934506	0.862300988384814	Body fat percentage	4e-16	33980691
rs7019	rs59934506	0.862300988384814	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs7019	rs59934506	0.862300988384814	Alanine aminotransferase levels	2e-10	33980691
rs7019	rs7267979	0.855998045641917	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs7019	rs2424698	0.855403816575781	wg lh intensity-contrast middletemporal	3e-13	33875891
rs7019	rs2424698	0.855403816575781	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs7019	rs2424698	0.855403816575781	wg rh intensity-contrast middletemporal	7e-13	33875891
rs7019	rs2424698	0.855403816575781	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs7019	rs2424698	0.855403816575781	C-reactive protein	5e-11	34594039
rs7019	rs7020	0.84966362523667	wg rh intensity-contrast fusiform	1e-10	33875891
rs7019	rs7020	0.84966362523667	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs7019	rs7020	0.84966362523667	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs7019	rs7020	0.84966362523667	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs7019	rs2151144	0.845200869720665	wg lh intensity-contrast fusiform	5e-12	33875891
rs7019	rs2151144	0.845200869720665	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs7019	rs2151144	0.845200869720665	wg rh intensity-contrast insula	6e-18	33875891
rs7019	rs2151144	0.845200869720665	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs7019	rs2151144	0.845200869720665	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs7019	rs2151144	0.845200869720665	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs7019	rs6083838	0.841820368669407	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs7019	rs6083838	0.841820368669407	wg lh intensity-contrast insula	6e-13	33875891
rs7019	rs7274104	0.829306260620363	Cortical thickness	4e-08	34560273
rs7019	rs6115101	0.810779424839599	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs7019	rs6115101	0.810779424839599	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs7019	rs6115101	0.810779424839599	wg rh intensity-contrast supramarginal	3e-11	33875891
rs7019	rs6115118	0.810779424839599	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs7019	rs6138553	0.810033952818878	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs7019	rs6115099	0.805193797575931	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs7019	rs6115200	0.801185201188123	Height	9e-09	36224396
rs7019	rs6115204	0.799751448550851	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs7019	rs6138556	0.798930266721602	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs7019	rs6083799	0.787070944686718	Serum alkaline phosphatase levels	1e-71	33547301
rs7019	rs2261795	0.769706387820632	Non-HDL cholesterol levels	1e-09	34887591
rs7019	rs84816	0.760744384494989	aseg rh intensity Caudate	7e-09	33875891
rs7019	rs84816	0.760744384494989	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs7019	rs4815412	0.760558858250387	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs7019	rs12428	0.756708029070522	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs7019	rs2500406	0.75018603505339	Brain region volumes	2e-08	31676860
rs7019	rs2500406	0.75018603505339	Height	1e-33	36224396
rs7019	rs2856	0.749150743702865	Blood protein levels	6e-07	27532455
rs7019	rs6132824	0.738679221693055	Multi-trait sum score	5e-08	37277458
rs7019	rs11699953	0.737996541980031	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs7019	rs8184820	0.735928831782856	Brain morphology (MOSTest)	4e-13	35164939
rs7019	rs9927	0.717096467875244	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs7019	rs3746337	0.692608834928937	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs7019	rs3746337	0.692608834928937	wg lh intensity-contrast frontalpole	1e-09	33875891
rs7019	rs3746337	0.692608834928937	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs7019	rs3746337	0.692608834928937	Total cholesterol levels	3e-09	34887591
rs7019	rs2500430	0.689497693649821	Serum alkaline phosphatase levels	7e-10	31666285
rs7019	rs6050464	0.677629775366033	Brain region volumes	5e-09	31676860
rs7019	rs6050464	0.677629775366033	Apolipoprotein B levels	6e-14	32203549
rs7019	rs1888995	0.674215357950289	Weight	2e-11	34594039
rs7019	rs2260997	0.662575813365962	Subcortical volume (MOSTest)	4e-09	32665545
rs7019	rs2260997	0.662575813365962	Platelet distribution width	5e-17	32888494
rs702679	rs33321	0.838143680054652	Height	1e-19	34594039
rs702679	rs832540	0.785046544604546	Coronary artery disease	2e-08	29212778
rs702679	rs10061757	0.682287067980772	Height	4e-30	30595370
rs702679	rs33320	0.642538032126043	Height	9e-14	36224396
rs702679	rs2257505	0.642068059481625	Height	8e-192	36224396
rs702680	rs33321	0.971045851441941	Height	1e-19	34594039
rs702680	rs832540	0.915261232828465	Coronary artery disease	2e-08	29212778
rs702680	rs10061757	0.711048233718897	Height	4e-30	30595370
rs702680	rs96844	0.605403129244626	Type 2 diabetes	5e-08	30297969
rs702680	rs96844	0.605403129244626	Height	4e-33	36224396
rs702691	rs10061757	0.9521513167413	Height	4e-30	30595370
rs702691	rs832540	0.764470693922437	Coronary artery disease	2e-08	29212778
rs702691	rs33321	0.755786249029135	Height	1e-19	34594039
rs702691	rs702689	0.609812156810786	Vertex-wise sulcal depth	2e-22	34910505
rs7028328	rs770199	0.880403261723429	Hair color	3e-08	30595370
rs703842	rs703842	1	Multiple sclerosis	5e-11	19525955
rs703842	rs703842	1	Height	1e-08	36224396
rs703842	rs1021469	0.676870573901933	Self-reported math ability (MTAG)	1e-08	30038396
rs703842	rs10877022	0.609668934540246	Insomnia	8e-14	35835914
rs7072004	rs72815789	0.797763969641303	COVID-19 (covid vs negative)	1e-05	35224516
rs7072004	rs7085238	0.673578816626726	Depression (age of onset)	9e-07	35330412
rs7072216	rs7072216	1	Metabolite levels	8e-15	21931564
rs7072216	rs7072216	1	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs7072216	rs4488133	0.995026291800485	Serum metabolite levels	2e-281	23093944
rs7072216	rs4488133	0.995026291800485	Serum metabolite levels	1e-27	23093944
rs7072216	rs4488133	0.995026291800485	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs7072216	rs4488133	0.995026291800485	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs7072216	rs4488133	0.995026291800485	Urine X-12112 levels in chronic kidney disease	0	37277652
rs7072216	rs4488133	0.995026291800485	X-12093 levels	1e-48	24816252
rs7072216	rs4488133	0.995026291800485	X-12092 levels	0	24816252
rs7072216	rs10883083	0.986739800087918	N2-acetyl,N6-methyllysine levels	0	35347128
rs7072216	rs10883083	0.986739800087918	X-12112 levels	0	35347128
rs7072216	rs10883083	0.986739800087918	Arginine levels	1e-16	35347128
rs7072216	rs10883083	0.986739800087918	Metabolite peak levels (QI8972)	2e-124	35995766
rs7072216	rs10883083	0.986739800087918	Metabolite peak levels (QI5171)	8e-96	35995766
rs7072216	rs2147896	0.986739800087918	Urinary metabolites (H-NMR features)	3e-164	24586186
rs7072216	rs2147896	0.986739800087918	Urinary metabolites (H-NMR features)	8e-30	24586186
rs7072216	rs2147896	0.986739800087918	Urinary metabolites (H-NMR features)	2e-55	24586186
rs7072216	rs2147896	0.986739800087918	Urinary metabolites (H-NMR features)	6e-19	24586186
rs7072216	rs2147896	0.986739800087918	Urinary metabolites (H-NMR features)	4e-34	24586186
rs7072216	rs2147896	0.986739800087918	Trimethylamine levels	4e-144	33283231
rs7072216	rs2147896	0.986739800087918	Serum metabolite levels	1e-15	33031748
rs7072216	rs2147896	0.986739800087918	Serum metabolite levels	4e-226	33031748
rs7072216	rs2147896	0.986739800087918	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs7072216	rs2147896	0.986739800087918	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7072216	rs2147896	0.986739800087918	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7072216	rs2147896	0.986739800087918	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs7072216	rs2147896	0.986739800087918	N6-methyllysine levels	3e-198	33437055
rs7072216	rs2147896	0.986739800087918	N6-methyllysine levels	0	35347128
rs7072216	rs2147896	0.986739800087918	N-methylpipecolate levels	0	35050183
rs7072216	rs2147896	0.986739800087918	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs7072216	rs2147896	0.986739800087918	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs7072216	rs2147896	0.986739800087918	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7072216	rs2147896	0.986739800087918	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7072216	rs2147896	0.986739800087918	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs7072216	rs2147896	0.986739800087918	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7072216	rs2147896	0.986739800087918	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7072216	rs2147896	0.986739800087918	X-12092 levels	4e-191	27073872
rs7072216	rs2147896	0.986739800087918	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7072216	rs2147896	0.986739800087918	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7072216	rs2147896	0.986739800087918	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7072216	rs2147896	0.986739800087918	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7072216	rs2147896	0.986739800087918	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7072216	rs2147896	0.986739800087918	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7072216	rs2147896	0.986739800087918	X-12112 levels	0	36635386
rs7072216	rs2147896	0.986739800087918	N6-methyllysine levels	0	36635386
rs7072216	rs2147896	0.986739800087918	N6,N6-dimethyllysine levels	0	36635386
rs7072216	rs2147896	0.986739800087918	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs7072216	rs2147896	0.986739800087918	N2-acetyl,N6-methyllysine levels	0	36635386
rs7072216	rs10786415	0.986739800087918	N6,N6-dimethyllysine levels	0	35347128
rs7072216	rs10786415	0.986739800087918	N-methylpipecolate levels	0	35347128
rs7072216	rs10786415	0.986739800087918	X-25810 levels	4e-11	36635386
rs7072216	rs942814	0.986739800087918	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs7072216	rs4539242	0.98591376291277	Urinary metabolites (H-NMR features)	2e-20	24586186
rs7072216	rs4539242	0.98591376291277	X-24809 levels	4e-67	33177712
rs7072216	rs4539242	0.98591376291277	X-24983 levels	8e-59	33177712
rs7072216	rs4539242	0.98591376291277	X-12112 levels	4e-63	33177712
rs7072216	rs4539242	0.98591376291277	N-methylpipecolate levels	3e-12	33177712
rs7072216	rs4539242	0.98591376291277	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7072216	rs4539242	0.98591376291277	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7072216	rs4539242	0.98591376291277	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7072216	rs4539242	0.98591376291277	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7072216	rs4539242	0.98591376291277	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7072216	rs4539242	0.98591376291277	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7072216	rs4539242	0.98591376291277	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs7072216	rs7905265	0.982614628506826	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs7072216	rs7905265	0.982614628506826	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs7072216	rs7905265	0.982614628506826	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7072216	rs7905265	0.982614628506826	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7072216	rs7905265	0.982614628506826	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs7072216	rs7905265	0.982614628506826	N6,N6-dimethyllysine levels	2e-132	35995766
rs7072216	rs7905265	0.982614628506826	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs7072216	rs10786414	0.967019331933946	ADMA levels	5e-18	35995766
rs7072216	rs11598867	0.923809047685922	Urinary metabolites	1e-307	26352407
rs7072216	rs942813	0.90991228612558	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs7072216	rs7096654	0.898036324381816	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs7072216	rs7096654	0.898036324381816	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs7072216	rs7096654	0.898036324381816	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs7072216	rs7096654	0.898036324381816	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs7072216	rs6584194	0.892605280141193	Metabolite peak levels (QI9680)	2e-135	35995766
rs7072216	rs6584194	0.892605280141193	Metabolite peak levels (QI8984)	5e-11	35995766
rs7072216	rs6584194	0.892605280141193	X-24736 levels	3e-13	36635386
rs7072216	rs942810	0.779080228106588	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs7072216	rs942810	0.779080228106588	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs7072216	rs942810	0.779080228106588	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs7072216	rs942810	0.779080228106588	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7072216	rs942810	0.779080228106588	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7072216	rs942810	0.779080228106588	N6-methyllysine levels (advanced age)	2e-11	37118062
rs7072216	rs4345897	0.715175878290893	Urinary metabolites (H-NMR features)	2e-19	24586186
rs7072216	rs4345897	0.715175878290893	Urinary metabolites (H-NMR features)	4e-12	24586186
rs7072216	rs4345897	0.715175878290893	Metabolite levels	2e-91	23281178
rs7072216	rs4345897	0.715175878290893	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	4e-25	37118062
rs7072216	rs4345897	0.715175878290893	N6,N6-dimethyllysine levels (elderly offspring)	4e-17	37118062
rs7072216	rs4345897	0.715175878290893	N6-methyllysine levels (elderly offspring)	1e-41	37118062
rs7072216	rs4345897	0.715175878290893	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs7072216	rs4345897	0.715175878290893	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs7072216	rs4345897	0.715175878290893	N6-methyllysine levels (advanced age)	6e-22	37118062
rs7072216	rs2182169	0.686878278349611	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-23	37118062
rs7072216	rs2182169	0.686878278349611	N6,N6-dimethyllysine levels (elderly offspring)	3e-16	37118062
rs7072216	rs2182169	0.686878278349611	N6-methyllysine levels (elderly offspring)	7e-40	37118062
rs7072216	rs2182169	0.686878278349611	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7072216	rs2182169	0.686878278349611	N6,N6-dimethyllysine levels (advanced age)	4e-09	37118062
rs7072216	rs2182169	0.686878278349611	N6-methyllysine levels (advanced age)	1e-21	37118062
rs7072216	rs6584192	0.68331585678712	Metabolite levels	4e-33	23823483
rs7072216	rs6584192	0.68331585678712	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs7072216	rs6584192	0.68331585678712	N6,N6-dimethyllysine levels (elderly offspring)	2e-16	37118062
rs7072216	rs6584192	0.68331585678712	N6-methyllysine levels (elderly offspring)	3e-41	37118062
rs7072216	rs6584192	0.68331585678712	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs7072216	rs6584192	0.68331585678712	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs7072216	rs6584192	0.68331585678712	N6-methyllysine levels (advanced age)	6e-22	37118062
rs7072216	rs2147895	0.674998466820006	Hydroxyhexadecanoylcarnitine levels	9e-19	35888728
rs7072216	rs2147895	0.674998466820006	Plasma arginine levels in chronic kidney disease	7e-13	37277652
rs7072216	rs2147895	0.674998466820006	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-24	37118062
rs7072216	rs2147895	0.674998466820006	N6,N6-dimethyllysine levels (elderly offspring)	7e-17	37118062
rs7072216	rs2147895	0.674998466820006	N6-methyllysine levels (elderly offspring)	2e-39	37118062
rs7072216	rs2147895	0.674998466820006	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs7072216	rs2147895	0.674998466820006	N6,N6-dimethyllysine levels (advanced age)	2e-09	37118062
rs7072216	rs2147895	0.674998466820006	N6-methyllysine levels (advanced age)	4e-21	37118062
rs7072216	rs2182168	0.669620508354983	Urine X-22162 levels in chronic kidney disease	3e-13	37277652
rs7072216	rs2182168	0.669620508354983	Arginine levels	1e-17	36635386
rs7072216	rs1739	0.630270635841883	Metabolite peak levels (QI7389)	3e-91	35995766
rs7072216	rs1737	0.629562263553594	Arginine levels	3e-24	35995766
rs7072216	rs11189591	0.625983975526178	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs7072216	rs11189591	0.625983975526178	N6,N6-dimethyllysine levels (elderly offspring)	1e-16	37118062
rs7072216	rs11189591	0.625983975526178	N6-methyllysine levels (elderly offspring)	1e-40	37118062
rs7072216	rs11189591	0.625983975526178	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs7072216	rs11189591	0.625983975526178	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs7072216	rs11189591	0.625983975526178	N6-methyllysine levels (advanced age)	6e-22	37118062
rs708990	rs6081731	0.995856319746818	Metabolite levels	6e-06	23823483
rs7099030	rs2282326	0.655749169849446	Serum levels of protein GSTO1	4e-265	35078996
rs7099030	rs2282326	0.655749169849446	Glutathione S-transferase omega-1 levels (GSTO1.12436.84.3)	0	29875488
rs7099030	rs1147611	0.617951382866467	Blood protein levels	3e-139	30072576
rs7107152	rs4938354	0.958134651621166	Proprotein convertase subtilisin/kexin type 7 levels	3e-295	36168886
rs7107152	rs1794116	0.927844908913912	Protein CASC4 levels	5e-13	34648354
rs7107152	rs1794116	0.927844908913912	Asialoglycoprotein receptor 1 levels	7e-18	34648354
rs7107152	rs171052	0.906119648767627	Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)	1e-38	35870639
rs7107152	rs2622935	0.67069808857934	Serum levels of protein CASC4	3e-16	35078996
rs7107152	rs2622935	0.67069808857934	Polypeptide N-acetylgalactosaminyltransferase 1 levels	1e-30	34648354
rs7107152	rs4938353	0.643074204208129	Blood protein levels	2e-14	27532455
rs7107152	rs4938344	0.601387151372862	Cerebrospinal fluid biomarker levels	7e-19	28031287
rs7117401	rs1467510	0.936285702887573	Platelet distribution width	1e-14	32888494
rs7117401	rs12276109	0.795068875298425	Severe COVID-19 infection	6e-08	36662838
rs7129995	rs4353250	0.987314807273758	Insulin-like growth factor 1 levels	2e-14	33462484
rs7129995	rs4353250	0.987314807273758	Amyloid A serum levels	2e-51	21124955
rs7129995	rs4150575	0.632219674554612	Imidazole lactate levels	1e-10	36635386
rs7131509	rs7131509	1	Estimated glomerular filtration rate (creatinine)	1e-17	35710981
rs7131509	rs7131509	1	Estimated glomerular filtration rate	3e-10	31015462
rs7131509	rs7131509	1	Estimated glomerular filtration rate (creatinine)	2e-14	34272381
rs7131509	rs7131509	1	Blood urea nitrogen levels	2e-06	34272381
rs7131509	rs3892895	0.891009754220787	Estimated glomerular filtration rate	1e-13	31152163
rs7131509	rs3018691	0.66806046190981	White blood cell count	2e-08	34594039
rs7131998	rs6489882	0.885803209534024	Chronic lymphocytic leukemia	5e-08	28165464
rs7131998	rs1859336	0.851283070462791	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7131998	rs4767027	0.840553008305932	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7131998	rs2057778	0.839479981211228	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7131998	rs2057778	0.839479981211228	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7131998	rs2057778	0.839479981211228	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7131998	rs11066452	0.830043158615354	Blood protein levels	6e-08	30072576
rs7131998	rs1131476	0.81647232244208	Systemic lupus erythematosus	1e-09	33272962
rs7131998	rs2660	0.81647232244208	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7131998	rs2660	0.81647232244208	COVID-19 (critical illness vs population)	3e-15	37198478
rs7131998	rs1557866	0.637179521865453	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs7131998	rs2269899	0.63309862816551	COVID-19 with respiratory failure requiring mechanical ventilation	8e-14	35848942
rs7132404	rs1859336	0.991702769125355	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7132404	rs6489882	0.971843155449831	Chronic lymphocytic leukemia	5e-08	28165464
rs7132404	rs11066452	0.969306185590769	Blood protein levels	6e-08	30072576
rs7132404	rs4767027	0.948254276476331	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7132404	rs2057778	0.944744331811606	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7132404	rs2057778	0.944744331811606	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7132404	rs2057778	0.944744331811606	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7132404	rs1131476	0.919557832711146	Systemic lupus erythematosus	1e-09	33272962
rs7132404	rs2660	0.919557832711146	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7132404	rs2660	0.919557832711146	COVID-19 (critical illness vs population)	3e-15	37198478
rs7132404	rs6489867	0.675464836232867	COVID-19 (critical illness vs population)	1e-09	33307546
rs7132404	rs1557866	0.628118528869361	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs7135577	rs1131476	0.9940358241333	Systemic lupus erythematosus	1e-09	33272962
rs7135577	rs2660	0.9940358241333	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7135577	rs2660	0.9940358241333	COVID-19 (critical illness vs population)	3e-15	37198478
rs7135577	rs4767027	0.971387465652543	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7135577	rs2057778	0.967819517695829	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7135577	rs2057778	0.967819517695829	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7135577	rs2057778	0.967819517695829	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7135577	rs11066452	0.950207858646928	Blood protein levels	6e-08	30072576
rs7135577	rs1859336	0.917067026634898	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7135577	rs6489882	0.898320757002546	Chronic lymphocytic leukemia	5e-08	28165464
rs7135577	rs6489867	0.622657236695098	COVID-19 (critical illness vs population)	1e-09	33307546
rs7140850	rs7140850	1	Body surface area	2e-08	36502284
rs7140850	rs1952151	0.808570529059378	Height	3e-148	36224396
rs7140850	rs4982404	0.688060603580931	Height	1e-24	34594039
rs71415129	rs6723298	0.680581352924382	Smoking initiation	2e-12	36477530
rs71415129	rs2194492	0.661753233468959	Educational attainment	9e-09	35361970
rs71415129	rs13020443	0.651905797152911	Type 2 diabetes	3e-11	32541925
rs71440841	rs3809260	0.949198608405343	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs71440841	rs2559856	0.943039474597247	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs71440841	rs2695294	0.92210112337931	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs71440841	rs2695295	0.918312353513258	Serum levels of protein NAAA	1e-68	35078996
rs71440841	rs2695295	0.918312353513258	Serum levels of protein SMPDL3A	8e-86	35078996
rs71440841	rs2559851	0.887393690785924	Cathepsin F levels	2e-96	34648354
rs71440841	rs2559851	0.887393690785924	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs71440841	rs2559850	0.766448340121601	Serum levels of protein CTSH	1e-19	35078996
rs71440841	rs2559850	0.766448340121601	Vitamin C levels	6e-20	33203707
rs71440841	rs2559850	0.766448340121601	Cathepsin L2 levels	1e-24	34648354
rs71440841	rs2559850	0.766448340121601	Islet amyloid polypeptide levels	1e-49	34648354
rs71440841	rs2559850	0.766448340121601	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs71513892	rs11781149	0.900150895488065	Refractive error	2e-17	32231278
rs71513892	rs746011	0.877579049821455	Triglycerides	2e-10	30275531
rs71513892	rs1545837	0.776972997084841	Lung function (FVC)	1e-10	30595370
rs71513892	rs4242434	0.75288119562941	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs71513892	rs2280104	0.701076553805605	Parkinson's disease	3e-08	28892059
rs71513892	rs2280104	0.701076553805605	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs71513892	rs2280104	0.701076553805605	Serum total protein level	3e-12	34594039
rs71513892	rs34269854	0.698733133743915	Lung function (forced vital capacity)	3e-09	36914875
rs71513892	rs11782130	0.694900911973086	C-reactive protein levels	9e-09	35459240
rs71513892	rs13271626	0.663828359424243	Haemorrhoidal disease	3e-10	33888516
rs71513892	rs4872007	0.657229979485818	Superior temporal gyrus volume	8e-06	31530798
rs71513892	rs11778693	0.648360350248638	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs71513892	rs11778693	0.648360350248638	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs71513892	rs11780207	0.620894009540727	Estimated glomerular filtration rate	2e-13	33462484
rs71513892	rs11780207	0.620894009540727	Serum total protein level	2e-09	33462484
rs71513892	rs11780207	0.620894009540727	Creatinine levels	2e-13	33462484
rs71513892	rs4592028	0.610977154763671	Non-albumin protein levels	3e-09	33462484
rs7153680	rs1255908	0.663866926725814	PR interval	8e-14	32439900
rs7153680	rs1255908	0.663866926725814	PR interval	6e-14	32439900
rs715378	rs17007017	0.776393863671443	Conduct disorder	7e-06	20585324
rs715378	rs34402449	0.746970236923109	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs715378	rs1550057	0.677566800860726	Conduct disorder	4e-06	20585324
rs715378	rs1550057	0.677566800860726	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs7156570	rs2357176	0.997281888669287	Nevus count or cutaneous melanoma	4e-08	30429480
rs7156570	rs10873172	0.831964999977028	Cutaneous melanoma or hair colour	6e-27	32341527
rs7156570	rs10873172	0.831964999977028	Nevus count or cutaneous melanoma	6e-13	32341527
rs7156570	rs10873172	0.831964999977028	Blond vs. brown/black hair color	6e-15	30531825
rs7156570	rs10873172	0.831964999977028	Cutaneous malignant melanoma	6e-08	32341527
rs7156570	rs10873172	0.831964999977028	Hair color	4e-17	30595370
rs7156570	rs1255908	0.774174131445432	PR interval	8e-14	32439900
rs7156570	rs1255908	0.774174131445432	PR interval	6e-14	32439900
rs7156570	rs12878653	0.715358817893223	Youthful appearance (self-reported)	3e-14	32339537
rs7160245	rs4271522	0.816711169866184	Gamma glutamyl transpeptidase	5e-14	34594039
rs7160245	rs3861491	0.751356484126876	Gamma glutamyl transferase levels	7e-14	33462484
rs7160245	rs3861491	0.751356484126876	Liver enzyme levels (gamma-glutamyl transferase)	2e-10	35810165
rs7160245	rs3861491	0.751356484126876	Liver enzyme levels (gamma-glutamyl transferase)	1e-26	33972514
rs71654350	rs2617439	0.979517218262394	Neutrophil count	8e-11	32888494
rs71654350	rs2549794	0.964681029274688	Crohn's disease	1e-10	21102463
rs71654350	rs2549794	0.964681029274688	Systolic blood pressure	1e-07	33230300
rs71654350	rs2549794	0.964681029274688	Diastolic blood pressure	1e-15	33230300
rs71654350	rs2549794	0.964681029274688	Diastolic blood pressure	2e-12	33230300
rs71654350	rs2549794	0.964681029274688	Systolic blood pressure	4e-10	33230300
rs71654350	rs38029	0.960290476030872	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs71654350	rs1363907	0.959454688036833	Crohn's disease	4e-16	26192919
rs71654350	rs1363907	0.959454688036833	Ulcerative colitis	4e-06	26192919
rs71654350	rs1363907	0.959454688036833	Inflammatory bowel disease	5e-15	26192919
rs71654350	rs1363907	0.959454688036833	Inflammatory bowel disease	6e-13	23128233
rs71654350	rs1363907	0.959454688036833	Inflammatory bowel disease	1e-10	28067908
rs71654350	rs1363907	0.959454688036833	Crohn's disease	1e-14	28067908
rs71654350	rs716848	0.929179046765341	Neutrophil percentage of white cells	2e-09	32888494
rs71654350	rs2548532	0.866822994866086	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs71654350	rs27660	0.796617467434287	Coronary artery disease	3e-08	35915156
rs71654350	rs1423357	0.794741325129083	General cognitive ability	9e-06	29844566
rs71654350	rs2432142	0.784150538163829	Neutrophil count	2e-14	32888493
rs71654350	rs2432142	0.784150538163829	White blood cell count	1e-11	32888493
rs71654350	rs38033	0.782316982800041	Blood protein levels	0	30072576
rs71654350	rs27293	0.76750593485263	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs71654350	rs27293	0.76750593485263	Diastolic blood pressure	3e-11	35762941
rs71654350	rs7705093	0.759455557697934	Birdshot chorioretinopathy	2e-09	24957906
rs71654350	rs4869313	0.700648925748606	Pediatric autoimmune diseases	9e-08	26301688
rs71654350	rs2927608	0.699518206540172	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs71654350	rs2927608	0.699518206540172	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs71654350	rs2927608	0.699518206540172	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs71654350	rs2910686	0.697209276458643	Neutrophil count	4e-14	32888493
rs71654350	rs2910686	0.697209276458643	Psoriasis	2e-08	23143594
rs71654350	rs2910686	0.697209276458643	Ankylosing spondylitis	5e-17	23749187
rs71654350	rs2910686	0.697209276458643	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs71654350	rs1559359	0.637987081919886	Diastolic blood pressure	7e-10	34594039
rs71654350	rs1974871	0.629037723069859	Granulysin levels	5e-13	34648354
rs71654350	rs2549797	0.621265384692044	Systolic blood pressure	7e-07	33230300
rs71654350	rs2549797	0.621265384692044	Diastolic blood pressure	1e-14	33230300
rs71654350	rs2549797	0.621265384692044	Diastolic blood pressure	3e-11	33230300
rs71654350	rs2549797	0.621265384692044	Systolic blood pressure	4e-09	33230300
rs71654350	rs2549782	0.620257186015875	Systolic blood pressure	6e-07	33230300
rs71654350	rs2549782	0.620257186015875	Diastolic blood pressure	1e-14	33230300
rs71654350	rs2549782	0.620257186015875	Diastolic blood pressure	3e-11	33230300
rs71654350	rs2549782	0.620257186015875	Systolic blood pressure	5e-09	33230300
rs71654350	rs1056893	0.619753762119439	Systolic blood pressure	1e-06	33230300
rs71654350	rs1056893	0.619753762119439	Diastolic blood pressure	7e-15	33230300
rs71654350	rs1056893	0.619753762119439	Diastolic blood pressure	2e-11	33230300
rs71654350	rs1056893	0.619753762119439	Systolic blood pressure	7e-09	33230300
rs7166891	rs28373613	0.881005779122451	Height (standard GWA)	8e-12	37106081
rs7168214	rs12440803	0.638707664882013	Height	1e-107	36224396
rs7168214	rs12440803	0.638707664882013	Height	3e-22	30595370
rs7168214	rs34783982	0.630428955006594	Squamous cell lung carcinoma	9e-06	28604730
rs716848	rs716848	1	Neutrophil percentage of white cells	2e-09	32888494
rs716848	rs2549794	0.939292694140925	Crohn's disease	1e-10	21102463
rs716848	rs2549794	0.939292694140925	Systolic blood pressure	1e-07	33230300
rs716848	rs2549794	0.939292694140925	Diastolic blood pressure	1e-15	33230300
rs716848	rs2549794	0.939292694140925	Diastolic blood pressure	2e-12	33230300
rs716848	rs2549794	0.939292694140925	Systolic blood pressure	4e-10	33230300
rs716848	rs1363907	0.937565262665602	Crohn's disease	4e-16	26192919
rs716848	rs1363907	0.937565262665602	Ulcerative colitis	4e-06	26192919
rs716848	rs1363907	0.937565262665602	Inflammatory bowel disease	5e-15	26192919
rs716848	rs1363907	0.937565262665602	Inflammatory bowel disease	6e-13	23128233
rs716848	rs1363907	0.937565262665602	Inflammatory bowel disease	1e-10	28067908
rs716848	rs1363907	0.937565262665602	Crohn's disease	1e-14	28067908
rs716848	rs2617439	0.911327607052255	Neutrophil count	8e-11	32888494
rs716848	rs38029	0.899400188769012	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs716848	rs2548532	0.842305340971938	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs716848	rs27660	0.753242552710886	Coronary artery disease	3e-08	35915156
rs716848	rs1423357	0.736249142777582	General cognitive ability	9e-06	29844566
rs716848	rs2432142	0.721719134405304	Neutrophil count	2e-14	32888493
rs716848	rs2432142	0.721719134405304	White blood cell count	1e-11	32888493
rs716848	rs38033	0.719652538718898	Blood protein levels	0	30072576
rs716848	rs27293	0.711385408039983	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs716848	rs27293	0.711385408039983	Diastolic blood pressure	3e-11	35762941
rs716848	rs7705093	0.701887917740982	Birdshot chorioretinopathy	2e-09	24957906
rs716848	rs4869313	0.672069843350811	Pediatric autoimmune diseases	9e-08	26301688
rs716848	rs2927608	0.668391970217703	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs716848	rs2927608	0.668391970217703	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs716848	rs2927608	0.668391970217703	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs716848	rs2910686	0.666094310613863	Neutrophil count	4e-14	32888493
rs716848	rs2910686	0.666094310613863	Psoriasis	2e-08	23143594
rs716848	rs2910686	0.666094310613863	Ankylosing spondylitis	5e-17	23749187
rs716848	rs2910686	0.666094310613863	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs716848	rs1974871	0.643592798349629	Granulysin levels	5e-13	34648354
rs716848	rs2549797	0.634007211751283	Systolic blood pressure	7e-07	33230300
rs716848	rs2549797	0.634007211751283	Diastolic blood pressure	1e-14	33230300
rs716848	rs2549797	0.634007211751283	Diastolic blood pressure	3e-11	33230300
rs716848	rs2549797	0.634007211751283	Systolic blood pressure	4e-09	33230300
rs716848	rs2549782	0.632963888908437	Systolic blood pressure	6e-07	33230300
rs716848	rs2549782	0.632963888908437	Diastolic blood pressure	1e-14	33230300
rs716848	rs2549782	0.632963888908437	Diastolic blood pressure	3e-11	33230300
rs716848	rs2549782	0.632963888908437	Systolic blood pressure	5e-09	33230300
rs716848	rs1056893	0.632442926564083	Systolic blood pressure	1e-06	33230300
rs716848	rs1056893	0.632442926564083	Diastolic blood pressure	7e-15	33230300
rs716848	rs1056893	0.632442926564083	Diastolic blood pressure	2e-11	33230300
rs716848	rs1056893	0.632442926564083	Systolic blood pressure	7e-09	33230300
rs716848	rs1559359	0.605543950624869	Diastolic blood pressure	7e-10	34594039
rs7169669	rs4924522	0.83233139765662	Lung function (forced vital capacity)	5e-18	36914875
rs7169669	rs9796	0.752736680364951	Menopause (age at onset)	1e-10	26414677
rs7169845	rs12440803	0.617574621387938	Height	1e-107	36224396
rs7169845	rs12440803	0.617574621387938	Height	3e-22	30595370
rs7169845	rs34783982	0.609444784570188	Squamous cell lung carcinoma	9e-06	28604730
rs7170293	rs28373613	0.895625870374699	Height (standard GWA)	8e-12	37106081
rs7172145	rs28373613	0.884367194682365	Height (standard GWA)	8e-12	37106081
rs7172967	rs13379492	0.901835196311801	Lung function (FEV1/FVC)	6e-08	30595370
rs7172967	rs8034216	0.85933993309215	C-reactive protein levels	2e-10	31900758
rs7172967	rs17271340	0.818886414918839	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs7172967	rs17271305	0.796347401372874	Two-hour glucose challenge	1e-07	20081857
rs7172967	rs35967150	0.79149863319047	C-reactive protein levels (MTAG)	1e-08	36376304
rs7172967	rs11634163	0.782792257251446	C-reactive protein	2e-08	34594039
rs7172967	rs11634163	0.782792257251446	Two-hour glucose	3e-14	34059833
rs7172967	rs189400382	0.779898304324416	C-reactive protein levels	1e-08	35459240
rs7172967	rs28373613	0.652155820120484	Height (standard GWA)	8e-12	37106081
rs7174555	rs4924522	0.817458092906543	Lung function (forced vital capacity)	5e-18	36914875
rs7174555	rs9796	0.73100874736493	Menopause (age at onset)	1e-10	26414677
rs7177276	rs7178424	0.994118056508994	Height	6e-09	20881960
rs7177276	rs7178424	0.994118056508994	Height	6e-13	35831902
rs7177276	rs7178424	0.994118056508994	Height	3e-251	36224396
rs7177276	rs17271431	0.993278633844987	Height	2e-11	34594039
rs7177276	rs17205463	0.974907288490575	Serum levels of protein IGF1	8e-08	27329260
rs7177276	rs17205463	0.974907288490575	Appendicular lean mass	4e-43	33097823
rs7177276	rs17205463	0.974907288490575	Height	2e-35	30595370
rs7177276	rs7178540	0.956455464883168	Height	1e-31	36224396
rs7177276	rs731820	0.885506633608997	Height	2e-13	31562340
rs7177276	rs731820	0.885506633608997	Height	2e-12	35831902
rs7177276	rs7162536	0.848879887513462	Height	4e-29	34594039
rs7177276	rs11635977	0.815930061559089	Height	2e-25	36224396
rs7177276	rs72749770	0.779419763419589	Low density lipoprotein cholesterol levels	9e-10	32493714
rs7177276	rs72749770	0.779419763419589	Apolipoprotein B levels	2e-09	32203549
rs7177276	rs2162062	0.662239289079905	Height	2e-13	35831902
rs7177276	rs1436958	0.64063551912493	IgG glycosylation	9e-06	23382691
rs7177276	rs933807	0.627565235307829	Fat-free mass	6e-06	30593698
rs7177276	rs933807	0.627565235307829	Fat-free mass	2e-07	30593698
rs7177276	rs933807	0.627565235307829	Fat-free mass	8e-11	30593698
rs7177711	rs731820	0.99179385801632	Height	2e-13	31562340
rs7177711	rs731820	0.99179385801632	Height	2e-12	35831902
rs7177711	rs7162536	0.958602008076261	Height	4e-29	34594039
rs7177711	rs7178540	0.92433925516239	Height	1e-31	36224396
rs7177711	rs11635977	0.922657305671816	Height	2e-25	36224396
rs7177711	rs7178424	0.887820629161757	Height	6e-09	20881960
rs7177711	rs7178424	0.887820629161757	Height	6e-13	35831902
rs7177711	rs7178424	0.887820629161757	Height	3e-251	36224396
rs7177711	rs17271431	0.885653045962445	Height	2e-11	34594039
rs7177711	rs72749770	0.881160093489209	Low density lipoprotein cholesterol levels	9e-10	32493714
rs7177711	rs72749770	0.881160093489209	Apolipoprotein B levels	2e-09	32203549
rs7177711	rs17205463	0.865696200135525	Serum levels of protein IGF1	8e-08	27329260
rs7177711	rs17205463	0.865696200135525	Appendicular lean mass	4e-43	33097823
rs7177711	rs17205463	0.865696200135525	Height	2e-35	30595370
rs7177711	rs12901247	0.669079865270413	Insular cortex volume	4e-06	31530798
rs7177711	rs2162062	0.641009332057711	Height	2e-13	35831902
rs7177711	rs1436958	0.625070461817124	IgG glycosylation	9e-06	23382691
rs7177711	rs933807	0.609465690422243	Fat-free mass	6e-06	30593698
rs7177711	rs933807	0.609465690422243	Fat-free mass	2e-07	30593698
rs7177711	rs933807	0.609465690422243	Fat-free mass	8e-11	30593698
rs7178424	rs7178424	1	Height	6e-09	20881960
rs7178424	rs7178424	1	Height	6e-13	35831902
rs7178424	rs7178424	1	Height	3e-251	36224396
rs7178424	rs17271431	0.990765364770238	Height	2e-11	34594039
rs7178424	rs17205463	0.969099592984123	Serum levels of protein IGF1	8e-08	27329260
rs7178424	rs17205463	0.969099592984123	Appendicular lean mass	4e-43	33097823
rs7178424	rs17205463	0.969099592984123	Height	2e-35	30595370
rs7178424	rs7178540	0.95726323696271	Height	1e-31	36224396
rs7178424	rs731820	0.880000087379366	Height	2e-13	31562340
rs7178424	rs731820	0.880000087379366	Height	2e-12	35831902
rs7178424	rs7162536	0.846555899374869	Height	4e-29	34594039
rs7178424	rs11635977	0.813655435551072	Height	2e-25	36224396
rs7178424	rs72749770	0.777195968130821	Low density lipoprotein cholesterol levels	9e-10	32493714
rs7178424	rs72749770	0.777195968130821	Apolipoprotein B levels	2e-09	32203549
rs7178424	rs2162062	0.661611168071998	Height	2e-13	35831902
rs7178424	rs1436958	0.638658365351086	IgG glycosylation	9e-06	23382691
rs7178424	rs933807	0.626969430124871	Fat-free mass	6e-06	30593698
rs7178424	rs933807	0.626969430124871	Fat-free mass	2e-07	30593698
rs7178424	rs933807	0.626969430124871	Fat-free mass	8e-11	30593698
rs7178540	rs7178540	1	Height	1e-31	36224396
rs7178540	rs7178424	0.95726323696271	Height	6e-09	20881960
rs7178540	rs7178424	0.95726323696271	Height	6e-13	35831902
rs7178540	rs7178424	0.95726323696271	Height	3e-251	36224396
rs7178540	rs17271431	0.949958310409171	Height	2e-11	34594039
rs7178540	rs17205463	0.932164981215475	Serum levels of protein IGF1	8e-08	27329260
rs7178540	rs17205463	0.932164981215475	Appendicular lean mass	4e-43	33097823
rs7178540	rs17205463	0.932164981215475	Height	2e-35	30595370
rs7178540	rs731820	0.919566857773495	Height	2e-13	31562340
rs7178540	rs731820	0.919566857773495	Height	2e-12	35831902
rs7178540	rs7162536	0.883008475897579	Height	4e-29	34594039
rs7178540	rs11635977	0.849624750318449	Height	2e-25	36224396
rs7178540	rs72749770	0.81202322069555	Low density lipoprotein cholesterol levels	9e-10	32493714
rs7178540	rs72749770	0.81202322069555	Apolipoprotein B levels	2e-09	32203549
rs7178540	rs2162062	0.69854350870088	Height	2e-13	35831902
rs7178540	rs1436958	0.679038874861345	IgG glycosylation	9e-06	23382691
rs7178540	rs933807	0.66414729752091	Fat-free mass	6e-06	30593698
rs7178540	rs933807	0.66414729752091	Fat-free mass	2e-07	30593698
rs7178540	rs933807	0.66414729752091	Fat-free mass	8e-11	30593698
rs7178540	rs12901247	0.612806030468198	Insular cortex volume	4e-06	31530798
rs7178945	rs7178540	0.996666025563626	Height	1e-31	36224396
rs7178945	rs7178424	0.954026504679291	Height	6e-09	20881960
rs7178945	rs7178424	0.954026504679291	Height	6e-13	35831902
rs7178945	rs7178424	0.954026504679291	Height	3e-251	36224396
rs7178945	rs17271431	0.953273159007795	Height	2e-11	34594039
rs7178945	rs17205463	0.935459675226063	Serum levels of protein IGF1	8e-08	27329260
rs7178945	rs17205463	0.935459675226063	Appendicular lean mass	4e-43	33097823
rs7178945	rs17205463	0.935459675226063	Height	2e-35	30595370
rs7178945	rs731820	0.92269792911	Height	2e-13	31562340
rs7178945	rs731820	0.92269792911	Height	2e-12	35831902
rs7178945	rs7162536	0.886113367315251	Height	4e-29	34594039
rs7178945	rs11635977	0.852680452472277	Height	2e-25	36224396
rs7178945	rs72749770	0.814992669509122	Low density lipoprotein cholesterol levels	9e-10	32493714
rs7178945	rs72749770	0.814992669509122	Apolipoprotein B levels	2e-09	32203549
rs7178945	rs2162062	0.697275444578898	Height	2e-13	35831902
rs7178945	rs1436958	0.679230222500826	IgG glycosylation	9e-06	23382691
rs7178945	rs933807	0.662942106046321	Fat-free mass	6e-06	30593698
rs7178945	rs933807	0.662942106046321	Fat-free mass	2e-07	30593698
rs7178945	rs933807	0.662942106046321	Fat-free mass	8e-11	30593698
rs7178945	rs12901247	0.614008082826369	Insular cortex volume	4e-06	31530798
rs7179506	rs8034216	0.945805133566861	C-reactive protein levels	2e-10	31900758
rs7179506	rs17271340	0.908582973666462	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs7179506	rs13379492	0.88656467826609	Lung function (FEV1/FVC)	6e-08	30595370
rs7179506	rs17271305	0.881493744750081	Two-hour glucose challenge	1e-07	20081857
rs7179506	rs35967150	0.878309996768766	C-reactive protein levels (MTAG)	1e-08	36376304
rs7179506	rs11634163	0.866797560722267	C-reactive protein	2e-08	34594039
rs7179506	rs11634163	0.866797560722267	Two-hour glucose	3e-14	34059833
rs7179506	rs189400382	0.863665037702432	C-reactive protein levels	1e-08	35459240
rs7179506	rs28373613	0.638553120136612	Height (standard GWA)	8e-12	37106081
rs719125	rs73045343	0.620177966243383	Serum total protein level	1e-12	34594039
rs719125	rs6759004	0.605484055726073	Triptolide cytotoxicity	3e-07	26121980
rs720746	rs13271626	0.993393512599535	Haemorrhoidal disease	3e-10	33888516
rs720746	rs11778693	0.964834842068144	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs720746	rs11778693	0.964834842068144	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs720746	rs34269854	0.840226120115029	Lung function (forced vital capacity)	3e-09	36914875
rs720746	rs746011	0.739828933873814	Triglycerides	2e-10	30275531
rs720746	rs11781149	0.722462539808183	Refractive error	2e-17	32231278
rs720746	rs11780207	0.639113251920841	Estimated glomerular filtration rate	2e-13	33462484
rs720746	rs11780207	0.639113251920841	Serum total protein level	2e-09	33462484
rs720746	rs11780207	0.639113251920841	Creatinine levels	2e-13	33462484
rs720746	rs751680	0.627345397344634	Insomnia	7e-09	35835914
rs720746	rs11782130	0.621163702683346	C-reactive protein levels	9e-09	35459240
rs720746	rs4592028	0.620796791791957	Non-albumin protein levels	3e-09	33462484
rs720746	rs1545837	0.6127583950648	Lung function (FVC)	1e-10	30595370
rs720746	rs2280104	0.602280824314264	Parkinson's disease	3e-08	28892059
rs720746	rs2280104	0.602280824314264	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs720746	rs2280104	0.602280824314264	Serum total protein level	3e-12	34594039
rs7210043	rs61586425	0.654440899491765	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7210043	rs7211615	0.649858179206154	Heel bone mineral density	1e-08	30595370
rs7210043	rs8077038	0.627188941789712	Educational attainment (MTAG)	4e-10	30038396
rs7210043	rs8077038	0.627188941789712	Highest math class taken (MTAG)	5e-16	30038396
rs7210043	rs12949956	0.620107777254216	Self-reported math ability	3e-11	30038396
rs7210043	rs12949956	0.620107777254216	Self-reported math ability (MTAG)	3e-14	30038396
rs7210043	rs12949956	0.620107777254216	Highest math class taken	8e-12	30038396
rs7210193	rs61586425	0.649952823898651	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7210193	rs7211615	0.64751295344895	Heel bone mineral density	1e-08	30595370
rs7210193	rs8077038	0.624916056089808	Educational attainment (MTAG)	4e-10	30038396
rs7210193	rs8077038	0.624916056089808	Highest math class taken (MTAG)	5e-16	30038396
rs7210193	rs12949956	0.619438179942815	Self-reported math ability	3e-11	30038396
rs7210193	rs12949956	0.619438179942815	Self-reported math ability (MTAG)	3e-14	30038396
rs7210193	rs12949956	0.619438179942815	Highest math class taken	8e-12	30038396
rs721457	rs7987940	0.728823279181782	AFP levels	6e-08	36329257
rs721457	rs9535244	0.657179783503073	Lung function (FVC)	1e-08	30595370
rs7215539	rs61586425	0.642858911824647	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7215539	rs7211615	0.637323459124936	Heel bone mineral density	1e-08	30595370
rs7215539	rs8077038	0.614769823522377	Educational attainment (MTAG)	4e-10	30038396
rs7215539	rs8077038	0.614769823522377	Highest math class taken (MTAG)	5e-16	30038396
rs7215539	rs12949956	0.607676906917568	Self-reported math ability	3e-11	30038396
rs7215539	rs12949956	0.607676906917568	Self-reported math ability (MTAG)	3e-14	30038396
rs7215539	rs12949956	0.607676906917568	Highest math class taken	8e-12	30038396
rs7219915	rs8077038	0.994525865978978	Educational attainment (MTAG)	4e-10	30038396
rs7219915	rs8077038	0.994525865978978	Highest math class taken (MTAG)	5e-16	30038396
rs7219915	rs12949956	0.971655580599903	Self-reported math ability	3e-11	30038396
rs7219915	rs12949956	0.971655580599903	Self-reported math ability (MTAG)	3e-14	30038396
rs7219915	rs12949956	0.971655580599903	Highest math class taken	8e-12	30038396
rs7219915	rs7211615	0.963402539830892	Heel bone mineral density	1e-08	30595370
rs7219915	rs9894429	0.648614796488217	Eye color traits	9e-14	20463881
rs7219915	rs9894429	0.648614796488217	Body mass index	4e-08	36581621
rs7220155	rs7211615	0.656781280509996	Heel bone mineral density	1e-08	30595370
rs7220155	rs61586425	0.650271977908236	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7220155	rs8077038	0.633929159500213	Educational attainment (MTAG)	4e-10	30038396
rs7220155	rs8077038	0.633929159500213	Highest math class taken (MTAG)	5e-16	30038396
rs7220155	rs12949956	0.626776139901104	Self-reported math ability	3e-11	30038396
rs7220155	rs12949956	0.626776139901104	Self-reported math ability (MTAG)	3e-14	30038396
rs7220155	rs12949956	0.626776139901104	Highest math class taken	8e-12	30038396
rs722259	rs10918211	0.941532430462926	White blood cell count	1e-26	34925446
rs722259	rs10918211	0.941532430462926	Neutrophil count	5e-34	34925446
rs722259	rs7554904	0.880062931586833	Metabolite levels	4e-06	23823483
rs722259	rs7554904	0.880062931586833	Metabolite levels	2e-06	23823483
rs722259	rs1425754	0.833212107526448	Metabolite levels	1e-06	23823483
rs7247859	rs1138888	0.82059165300624	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs7247859	rs1138888	0.82059165300624	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs7247859	rs4802157	0.799789531676801	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs7247859	rs2355433	0.680539367348051	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs7247859	rs2355433	0.680539367348051	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs7247859	rs2355433	0.680539367348051	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs7248142	rs1138888	0.8015066534532	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs7248142	rs1138888	0.8015066534532	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs7248142	rs4802157	0.781064569452684	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs7248142	rs2355433	0.674729976082877	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs7248142	rs2355433	0.674729976082877	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs7248142	rs2355433	0.674729976082877	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs7255035	rs1989455	0.659875119660817	Height	2e-31	36224396
rs7259345	rs4808407	0.919945528074459	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs7270835	rs11087521	0.899336878196953	wg lh intensity-contrast inferiorparietal	2e-11	33875891
rs7270835	rs59934506	0.858141317061456	Body fat percentage	4e-16	33980691
rs7270835	rs59934506	0.858141317061456	Metabolic biomarkers (multivariate analysis)	1e-13	33980691
rs7270835	rs59934506	0.858141317061456	Alanine aminotransferase levels	2e-10	33980691
rs7270835	rs2424698	0.844703858772662	wg lh intensity-contrast middletemporal	3e-13	33875891
rs7270835	rs2424698	0.844703858772662	wg lh intensity-contrast parsopercularis	1e-11	33875891
rs7270835	rs2424698	0.844703858772662	wg rh intensity-contrast middletemporal	7e-13	33875891
rs7270835	rs2424698	0.844703858772662	wg rh intensity-contrast parahippocampal	1e-09	33875891
rs7270835	rs2424698	0.844703858772662	C-reactive protein	5e-11	34594039
rs7270835	rs7267979	0.844467141455169	Liver enzyme levels (alkaline phosphatase)	7e-10	22001757
rs7270835	rs2151144	0.843956609016145	wg lh intensity-contrast fusiform	5e-12	33875891
rs7270835	rs2151144	0.843956609016145	wg lh intensity-contrast inferiortemporal	2e-13	33875891
rs7270835	rs2151144	0.843956609016145	wg rh intensity-contrast insula	6e-18	33875891
rs7270835	rs2151144	0.843956609016145	wg lh intensity-contrast posteriorcingulate	7e-11	33875891
rs7270835	rs2151144	0.843956609016145	wg rh intensity-contrast inferiorparietal	8e-12	33875891
rs7270835	rs2151144	0.843956609016145	wg rh intensity-contrast inferiortemporal	9e-14	33875891
rs7270835	rs6083838	0.839098964898396	wg lh intensity-contrast rostralanteriorcingulate	6e-16	33875891
rs7270835	rs6083838	0.839098964898396	wg lh intensity-contrast insula	6e-13	33875891
rs7270835	rs7020	0.838198647530844	wg rh intensity-contrast fusiform	1e-10	33875891
rs7270835	rs7020	0.838198647530844	wg rh intensity-contrast parstriangularis	6e-11	33875891
rs7270835	rs7020	0.838198647530844	wg rh intensity-contrast rostralmiddlefrontal	9e-17	33875891
rs7270835	rs7020	0.838198647530844	wg rh intensity-contrast superiortemporal	5e-10	33875891
rs7270835	rs6115200	0.819323222871235	Height	9e-09	36224396
rs7270835	rs7274104	0.81810339093386	Cortical thickness	4e-08	34560273
rs7270835	rs6115204	0.81642518323601	wg lh intensity-contrast parsorbitalis	1e-10	33875891
rs7270835	rs6115101	0.800271739328012	wg lh intensity-contrast lateralorbitofrontal	6e-19	33875891
rs7270835	rs6115101	0.800271739328012	wg lh intensity-contrast rostralmiddlefrontal	4e-17	33875891
rs7270835	rs6115101	0.800271739328012	wg rh intensity-contrast supramarginal	3e-11	33875891
rs7270835	rs6115118	0.800271739328012	wg rh intensity-contrast parsorbitalis	9e-11	33875891
rs7270835	rs6138553	0.799529011603038	wg rh intensity-contrast lateralorbitofrontal	4e-15	33875891
rs7270835	rs6115099	0.794741079050647	wg lh intensity-contrast medialorbitofrontal	2e-15	33875891
rs7270835	rs6138556	0.788466294195468	wg rh intensity-contrast rostralanteriorcingulate	1e-12	33875891
rs7270835	rs84816	0.779007832989888	aseg rh intensity Caudate	7e-09	33875891
rs7270835	rs84816	0.779007832989888	wg rh intensity-contrast isthmuscingulate	4e-10	33875891
rs7270835	rs6083799	0.775726386502259	Serum alkaline phosphatase levels	1e-71	33547301
rs7270835	rs2261795	0.765411002152783	Non-HDL cholesterol levels	1e-09	34887591
rs7270835	rs12428	0.763604509775759	wg rh intensity-contrast posteriorcingulate	4e-12	33875891
rs7270835	rs4815412	0.763267171568695	Phosphatidylglycerol (36:2) levels	2e-10	35668104
rs7270835	rs2856	0.754579303429853	Blood protein levels	6e-07	27532455
rs7270835	rs2500406	0.748955951342163	Brain region volumes	2e-08	31676860
rs7270835	rs2500406	0.748955951342163	Height	1e-33	36224396
rs7270835	rs6132824	0.728436268927722	Multi-trait sum score	5e-08	37277458
rs7270835	rs11699953	0.727756177362278	wg rh intensity-contrast superiorfrontal	3e-10	33875891
rs7270835	rs8184820	0.725705478466945	Brain morphology (MOSTest)	4e-13	35164939
rs7270835	rs9927	0.705960648203409	Ventromedial occipital thickness (unadjusted for global measures)	4e-08	36893272
rs7270835	rs3746337	0.685352151387029	wg lh intensity-contrast superiorfrontal	6e-10	33875891
rs7270835	rs3746337	0.685352151387029	wg lh intensity-contrast frontalpole	1e-09	33875891
rs7270835	rs3746337	0.685352151387029	IDP T1 FAST ROIs R ventral striatum	2e-09	33875891
rs7270835	rs3746337	0.685352151387029	Total cholesterol levels	3e-09	34887591
rs7270835	rs2500430	0.67842758244085	Serum alkaline phosphatase levels	7e-10	31666285
rs7270835	rs1888995	0.672020345976615	Weight	2e-11	34594039
rs7270835	rs6050464	0.669735476927517	Brain region volumes	5e-09	31676860
rs7270835	rs6050464	0.669735476927517	Apolipoprotein B levels	6e-14	32203549
rs7270835	rs2260997	0.652537331972488	Subcortical volume (MOSTest)	4e-09	32665545
rs7270835	rs2260997	0.652537331972488	Platelet distribution width	5e-17	32888494
rs72735675	rs4924522	0.833186256604774	Lung function (forced vital capacity)	5e-18	36914875
rs72735675	rs9796	0.759853135764183	Menopause (age at onset)	1e-10	26414677
rs72775415	rs7545078	0.744669259583899	Smoking initiation	2e-09	36477530
rs72775415	rs6700087	0.681043700180431	Smoking initiation	6e-11	36477530
rs72857167	rs61586425	0.652123819020388	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs72857167	rs7211615	0.64701009681856	Heel bone mineral density	1e-08	30595370
rs72857167	rs8077038	0.624307153469696	Educational attainment (MTAG)	4e-10	30038396
rs72857167	rs8077038	0.624307153469696	Highest math class taken (MTAG)	5e-16	30038396
rs72857167	rs12949956	0.617184021142845	Self-reported math ability	3e-11	30038396
rs72857167	rs12949956	0.617184021142845	Self-reported math ability (MTAG)	3e-14	30038396
rs72857167	rs12949956	0.617184021142845	Highest math class taken	8e-12	30038396
rs72884963	rs777587	0.906792706103706	Proteoglycan 3 levels	6e-29	34648354
rs72884963	rs777587	0.906792706103706	Pappalysin-1 levels	1e-25	34648354
rs72884963	rs11685226	0.905008646502879	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs72884963	rs11685226	0.905008646502879	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs72884963	rs7558954	0.879266298509036	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs72884963	rs1177308	0.875483592071576	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs72884963	rs1177308	0.875483592071576	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs72884963	rs12617371	0.861041045855594	Immature fraction of reticulocytes	8e-18	32888494
rs72884963	rs2463097	0.82425933413954	White blood cell count	3e-26	30595370
rs72884963	rs2593620	0.803050099303426	Serum levels of protein PRG3	5e-14	35078996
rs72884963	rs10199672	0.793519200263665	Height	6e-12	34594039
rs72884963	rs10199672	0.793519200263665	Height	2e-12	31562340
rs72884963	rs2421200	0.772800140238337	Neutrophil count	1e-26	32888493
rs72884963	rs2421200	0.772800140238337	Neutrophil count	1e-25	32888493
rs72884963	rs10169482	0.710738611646655	C-reactive protein levels	4e-09	33462484
rs72884963	rs2950269	0.671437135061874	Eosinophil side fluorescence	3e-18	37596262
rs72884963	rs12616433	0.650611982108338	Eosinophil forward scatter	4e-13	37596262
rs72884963	rs12616433	0.650611982108338	Eosinophil side scatter	2e-18	37596262
rs7298184	rs1859336	0.991702769125355	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7298184	rs6489882	0.971843155449831	Chronic lymphocytic leukemia	5e-08	28165464
rs7298184	rs11066452	0.969306185590769	Blood protein levels	6e-08	30072576
rs7298184	rs4767027	0.948254276476331	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7298184	rs2057778	0.944744331811606	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7298184	rs2057778	0.944744331811606	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7298184	rs2057778	0.944744331811606	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7298184	rs1131476	0.919557832711146	Systemic lupus erythematosus	1e-09	33272962
rs7298184	rs2660	0.919557832711146	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7298184	rs2660	0.919557832711146	COVID-19 (critical illness vs population)	3e-15	37198478
rs7298184	rs6489867	0.675464836232867	COVID-19 (critical illness vs population)	1e-09	33307546
rs7298184	rs1557866	0.628118528869361	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs7299132	rs1859336	0.983416966421152	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7299132	rs6489882	0.980027835952642	Chronic lymphocytic leukemia	5e-08	28165464
rs7299132	rs11066452	0.961008387917111	Blood protein levels	6e-08	30072576
rs7299132	rs4767027	0.939956325931902	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7299132	rs2057778	0.938790929403504	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7299132	rs2057778	0.938790929403504	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7299132	rs2057778	0.938790929403504	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7299132	rs1131476	0.913756566013858	Systemic lupus erythematosus	1e-09	33272962
rs7299132	rs2660	0.913756566013858	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7299132	rs2660	0.913756566013858	COVID-19 (critical illness vs population)	3e-15	37198478
rs7299132	rs6489867	0.669531445527841	COVID-19 (critical illness vs population)	1e-09	33307546
rs7299132	rs1557866	0.632531435691387	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs7309185	rs7306771	0.811525200691509	Blood protein levels	5e-06	30072576
rs7311182	rs1859336	0.97749859802022	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7311182	rs6489882	0.976527955307671	Chronic lymphocytic leukemia	5e-08	28165464
rs7311182	rs11066452	0.955026331792544	Blood protein levels	6e-08	30072576
rs7311182	rs4767027	0.933926772078152	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7311182	rs2057778	0.932768733129495	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7311182	rs2057778	0.932768733129495	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7311182	rs2057778	0.932768733129495	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7311182	rs1131476	0.907903370528063	Systemic lupus erythematosus	1e-09	33272962
rs7311182	rs2660	0.907903370528063	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7311182	rs2660	0.907903370528063	COVID-19 (critical illness vs population)	3e-15	37198478
rs7311182	rs6489867	0.665538143902397	COVID-19 (critical illness vs population)	1e-09	33307546
rs7311182	rs1557866	0.636381544715255	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs7317112	rs9590228	0.973483230584597	Height	7e-22	36224396
rs7317112	rs8002180	0.928477810039364	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs7317112	rs9524869	0.751758775437733	Serum metabolite levels	6e-32	33031748
rs7317112	rs9524869	0.751758775437733	N-acetylcarnosine levels	1e-42	35347128
rs7317112	rs9524869	0.751758775437733	N-acetylcarnosine levels	9e-47	35050183
rs7317112	rs9524869	0.751758775437733	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs7317112	rs9524869	0.751758775437733	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs7317112	rs9524869	0.751758775437733	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs7317112	rs9524869	0.751758775437733	N-acetylcarnosine levels	2e-60	36635386
rs7317772	rs7987940	0.719222977127829	AFP levels	6e-08	36329257
rs7317772	rs9535244	0.647249419005438	Lung function (FVC)	1e-08	30595370
rs73207312	rs73207312	1	General cognitive ability	1e-07	29844566
rs73207312	rs3864117	0.920739743880607	Eosinophil counts	3e-09	34594039
rs73207312	rs17164088	0.886914279678427	Smoking initiation	1e-09	36477530
rs73207312	rs1828803	0.833224577873945	Eosinophil counts	1e-10	32888493
rs73207312	rs1828803	0.833224577873945	Eosinophil percentage of white cells	3e-10	32888494
rs73207312	rs1828803	0.833224577873945	Eosinophil counts	5e-12	30595370
rs73207312	rs3733215	0.700818025811377	Systolic blood pressure	1e-14	30578418
rs73207312	rs4690028	0.684660225857068	Pulse pressure	1e-12	30578418
rs7320988	rs7321596	0.794346296384118	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs7320988	rs8002861	0.766789568446449	Leprosy	7e-06	25642632
rs7321631	rs7321631	1	Varicose veins	3e-08	34594039
rs7321631	rs7321631	1	Varicose veins	1e-08	36653477
rs732217	rs3965185	0.937591379324481	High-density lipoprotein levels (MTAG)	4e-11	36376304
rs7322318	rs8002180	0.997521731675182	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs7322318	rs9590228	0.946599939415632	Height	7e-22	36224396
rs7322318	rs9524869	0.783070843993527	Serum metabolite levels	6e-32	33031748
rs7322318	rs9524869	0.783070843993527	N-acetylcarnosine levels	1e-42	35347128
rs7322318	rs9524869	0.783070843993527	N-acetylcarnosine levels	9e-47	35050183
rs7322318	rs9524869	0.783070843993527	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs7322318	rs9524869	0.783070843993527	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs7322318	rs9524869	0.783070843993527	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs7322318	rs9524869	0.783070843993527	N-acetylcarnosine levels	2e-60	36635386
rs7324611	rs9603222	0.878569012241203	Blood protein levels	2e-12	30072576
rs7324611	rs4424789	0.877336712375117	Periostin levels	2e-19	34648354
rs7324611	rs9547937	0.62305969764026	Serum levels of protein POSTN	6e-18	35078996
rs7325354	rs7999758	0.962245379114381	Height	6e-17	30595370
rs7325354	rs6563739	0.96135817394433	Menarche (age at onset)	2e-11	25231870
rs7325354	rs4598779	0.944817424088586	Height	7e-77	36224396
rs7325813	rs8002180	0.962321361877987	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs7325813	rs9590228	0.916741971231161	Height	7e-22	36224396
rs7325813	rs9524869	0.811842986268085	Serum metabolite levels	6e-32	33031748
rs7325813	rs9524869	0.811842986268085	N-acetylcarnosine levels	1e-42	35347128
rs7325813	rs9524869	0.811842986268085	N-acetylcarnosine levels	9e-47	35050183
rs7325813	rs9524869	0.811842986268085	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs7325813	rs9524869	0.811842986268085	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs7325813	rs9524869	0.811842986268085	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs7325813	rs9524869	0.811842986268085	N-acetylcarnosine levels	2e-60	36635386
rs7326345	rs7987940	0.667840864630735	AFP levels	6e-08	36329257
rs7326345	rs9535244	0.648089769371747	Lung function (FVC)	1e-08	30595370
rs7329947	rs9547937	0.880042214781888	Serum levels of protein POSTN	6e-18	35078996
rs7330016	rs7999758	0.997302693536412	Height	6e-17	30595370
rs7330016	rs6563739	0.996405479333726	Menarche (age at onset)	2e-11	25231870
rs7330016	rs4598779	0.919928791409094	Height	7e-77	36224396
rs7330515	rs7999758	0.997302693536412	Height	6e-17	30595370
rs7330515	rs6563739	0.996405479333726	Menarche (age at onset)	2e-11	25231870
rs7330515	rs4598779	0.919928791409094	Height	7e-77	36224396
rs7331874	rs7321631	0.993419850511506	Varicose veins	3e-08	34594039
rs7331874	rs7321631	0.993419850511506	Varicose veins	1e-08	36653477
rs7333313	rs7321631	0.997527514590759	Varicose veins	3e-08	34594039
rs7333313	rs7321631	0.997527514590759	Varicose veins	1e-08	36653477
rs7334812	rs7321596	0.785065441959594	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs7334812	rs8002861	0.758051801751182	Leprosy	7e-06	25642632
rs73371226	rs7211615	0.625785045789442	Heel bone mineral density	1e-08	30595370
rs73371226	rs61586425	0.621317756498101	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs73371226	rs8077038	0.603858366558941	Educational attainment (MTAG)	4e-10	30038396
rs73371226	rs8077038	0.603858366558941	Highest math class taken (MTAG)	5e-16	30038396
rs73402255	rs199530775	0.613144001010619	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs73402255	rs55957433	0.613144001010619	Hip circumference adjusted for BMI	3e-08	34021172
rs73404265	rs3869132	0.838946475328366	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs73404265	rs3869132	0.838946475328366	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs73404265	rs6928810	0.833914499553637	Platelet distribution width	1e-14	32888494
rs73404265	rs199530775	0.732885043072399	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs73404265	rs55957433	0.732885043072399	Hip circumference adjusted for BMI	3e-08	34021172
rs73404265	rs6934175	0.706145688735985	Psoriatic arthritis	5e-28	30552173
rs73404265	rs9266825	0.704096612105333	Autism spectrum disorder	6e-06	35215271
rs73404265	rs17200242	0.692850719641313	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs73404265	rs9469003	0.65965067650598	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	2e-09	21801394
rs73404265	rs4346874	0.659486653030908	Height	2e-125	36224396
rs73404265	rs1063631	0.642973808243753	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs73404265	rs1063631	0.642973808243753	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs7341253	rs9469857	0.996776778921405	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7341253	rs2764208	0.995972777577403	Systemic lupus erythematosus	7e-06	24871463
rs7341253	rs9462030	0.982341944636037	Red cell distribution width	5e-25	32888493
rs7341253	rs9469899	0.965886102309356	Prostate cancer (advanced)	2e-06	29892016
rs7341253	rs9469899	0.965886102309356	Prostate cancer	5e-09	29892016
rs7341253	rs9469899	0.965886102309356	Prostate cancer	8e-11	33398198
rs7341253	rs9469899	0.965886102309356	Hand grip strength	3e-15	29691431
rs7341253	rs9469899	0.965886102309356	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7341253	rs9469899	0.965886102309356	Graves' disease	4e-10	34594039
rs7341253	rs9469899	0.965886102309356	Coronary artery disease	1e-11	36474045
rs7341253	rs9469899	0.965886102309356	Predicted visceral adipose tissue	2e-20	31501611
rs7341253	rs9469899	0.965886102309356	Medication use (thyroid preparations)	2e-09	31015401
rs7341253	rs9469899	0.965886102309356	Medication use (thyroid preparations)	3e-10	34594039
rs7341253	rs9469872	0.96054887345204	HDL cholesterol levels	3e-11	36333282
rs7341253	rs9296128	0.945681992424858	Hip circumference adjusted for BMI	4e-13	34021172
rs7341253	rs11755393	0.935272594959748	Body mass index	3e-26	29273807
rs7341253	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-12	33493351
rs7341253	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-06	33493351
rs7341253	rs11755393	0.935272594959748	Systemic lupus erythematosus	1e-07	33493351
rs7341253	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-08	19838195
rs7341253	rs11755393	0.935272594959748	Body mass index	4e-55	36581621
rs7341253	rs9366863	0.931525188678084	Adult body size	9e-33	32376654
rs7341253	rs9366863	0.931525188678084	Body mass index	2e-44	30595370
rs7341253	rs6941110	0.923705176714688	Sex hormone-binding globulin levels	5e-27	36653534
rs7341253	rs2744944	0.904579222323617	Hypothyroidism	3e-10	34594039
rs7341253	rs2744944	0.904579222323617	High density lipoprotein cholesterol levels	3e-86	34887591
rs7341253	rs2744944	0.904579222323617	Multi-trait sex score	7e-22	37277458
rs7341253	rs2814949	0.89561287838885	Essential hypertension (time to event)	9e-09	32589924
rs7341253	rs2263329	0.882234019129751	HDL cholesterol	6e-35	34594039
rs7341253	rs2263329	0.882234019129751	HDL cholesterol levels	8e-43	32203549
rs7341253	rs2263329	0.882234019129751	High density lipoprotein cholesterol levels	2e-52	34887591
rs7341253	rs111868030	0.861138045850585	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7341253	rs9368830	0.823175715403171	HDL cholesterol	4e-21	30275531
rs7341253	rs9368828	0.813764410103364	Body mass index	1e-34	34594039
rs7341253	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7341253	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7341253	rs2744973	0.792134506553775	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7341253	rs2744973	0.792134506553775	Multi-trait sex score	6e-20	37277458
rs7341253	rs6912327	0.779895917756941	Fasting insulin	5e-06	33402679
rs7341253	rs6912327	0.779895917756941	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7341253	rs112283401	0.757749108732694	Red cell distribution width	4e-27	30595370
rs7341253	rs9689160	0.620633913312638	Lung function (forced vital capacity)	3e-14	36914875
rs7341253	rs9462027	0.600261280766747	Systemic lupus erythematosus	1e-10	27399966
rs7341253	rs9462027	0.600261280766747	Systemic lupus erythematosus	8e-09	26502338
rs7341253	rs9462027	0.600261280766747	Systemic lupus erythematosus	2e-08	28714469
rs7341253	rs9462027	0.600261280766747	Alzheimer's disease or gastroesophageal reflux disease	2e-06	35851147
rs7341267	rs9469872	0.999196626279725	HDL cholesterol levels	3e-11	36333282
rs7341267	rs11755393	0.973006267673655	Body mass index	3e-26	29273807
rs7341267	rs11755393	0.973006267673655	Systemic lupus erythematosus	2e-12	33493351
rs7341267	rs11755393	0.973006267673655	Systemic lupus erythematosus	2e-06	33493351
rs7341267	rs11755393	0.973006267673655	Systemic lupus erythematosus	1e-07	33493351
rs7341267	rs11755393	0.973006267673655	Systemic lupus erythematosus	2e-08	19838195
rs7341267	rs11755393	0.973006267673655	Body mass index	4e-55	36581621
rs7341267	rs9366863	0.96969057058587	Adult body size	9e-33	32376654
rs7341267	rs9366863	0.96969057058587	Body mass index	2e-44	30595370
rs7341267	rs6941110	0.961792090949207	Sex hormone-binding globulin levels	5e-27	36653534
rs7341267	rs9469857	0.95816631106693	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7341267	rs2764208	0.957421571358085	Systemic lupus erythematosus	7e-06	24871463
rs7341267	rs9462030	0.943982829177098	Red cell distribution width	5e-25	32888493
rs7341267	rs2744944	0.942190841439973	Hypothyroidism	3e-10	34594039
rs7341267	rs2744944	0.942190841439973	High density lipoprotein cholesterol levels	3e-86	34887591
rs7341267	rs2744944	0.942190841439973	Multi-trait sex score	7e-22	37277458
rs7341267	rs2814949	0.932890943997085	Essential hypertension (time to event)	9e-09	32589924
rs7341267	rs9469899	0.927419887147737	Prostate cancer (advanced)	2e-06	29892016
rs7341267	rs9469899	0.927419887147737	Prostate cancer	5e-09	29892016
rs7341267	rs9469899	0.927419887147737	Prostate cancer	8e-11	33398198
rs7341267	rs9469899	0.927419887147737	Hand grip strength	3e-15	29691431
rs7341267	rs9469899	0.927419887147737	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7341267	rs9469899	0.927419887147737	Graves' disease	4e-10	34594039
rs7341267	rs9469899	0.927419887147737	Coronary artery disease	1e-11	36474045
rs7341267	rs9469899	0.927419887147737	Predicted visceral adipose tissue	2e-20	31501611
rs7341267	rs9469899	0.927419887147737	Medication use (thyroid preparations)	2e-09	31015401
rs7341267	rs9469899	0.927419887147737	Medication use (thyroid preparations)	3e-10	34594039
rs7341267	rs2263329	0.91970006654252	HDL cholesterol	6e-35	34594039
rs7341267	rs2263329	0.91970006654252	HDL cholesterol levels	8e-43	32203549
rs7341267	rs2263329	0.91970006654252	High density lipoprotein cholesterol levels	2e-52	34887591
rs7341267	rs9296128	0.909076616501735	Hip circumference adjusted for BMI	4e-13	34021172
rs7341267	rs111868030	0.898330096015476	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7341267	rs9368830	0.857517630321916	HDL cholesterol	4e-21	30275531
rs7341267	rs9368828	0.845719370925057	Body mass index	1e-34	34594039
rs7341267	rs6912327	0.818577786160058	Fasting insulin	5e-06	33402679
rs7341267	rs6912327	0.818577786160058	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7341267	rs112283401	0.795905789640068	Red cell distribution width	4e-27	30595370
rs7341267	rs2744973	0.772125032959257	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7341267	rs2744973	0.772125032959257	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7341267	rs2744973	0.772125032959257	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7341267	rs2744973	0.772125032959257	Multi-trait sex score	6e-20	37277458
rs7341267	rs6940215	0.626000271071788	Insomnia	2e-10	35835914
rs7341267	rs6940215	0.626000271071788	Insomnia	1e-13	35835914
rs7341267	rs6940215	0.626000271071788	Hip circumference adjusted for BMI	8e-10	34021172
rs7341267	rs6940215	0.626000271071788	Multi-trait sex score	2e-23	37277458
rs7341267	rs6940215	0.626000271071788	Multi-trait sex score	4e-23	37277458
rs7341267	rs6457796	0.616917893932585	Insomnia	1e-08	30804565
rs7341267	rs6457796	0.616917893932585	Plateletcrit	9e-11	32888494
rs7341267	rs6457796	0.616917893932585	Systemic lupus erythematosus	3e-22	33272962
rs7341267	rs6457796	0.616917893932585	Body mass index	5e-13	30108127
rs7341267	rs6457796	0.616917893932585	Body mass index	1e-14	26426971
rs7341267	rs6457796	0.616917893932585	Educational attainment	5e-19	35361970
rs7341267	rs205262	0.603807651185129	Body mass index	2e-09	26961502
rs7341267	rs205262	0.603807651185129	Walking pace	4e-10	33128006
rs7341267	rs205262	0.603807651185129	Body mass index	8e-13	30108127
rs7341267	rs205262	0.603807651185129	Body mass index	2e-09	25673413
rs7341267	rs205262	0.603807651185129	Body mass index	2e-14	26426971
rs7341267	rs205262	0.603807651185129	BMI in non-smokers	3e-07	28443625
rs7341267	rs205262	0.603807651185129	BMI in non-smokers	6e-09	28443625
rs7341267	rs205262	0.603807651185129	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs7341267	rs205262	0.603807651185129	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs7341267	rs205262	0.603807651185129	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs7341267	rs205262	0.603807651185129	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs7341267	rs205262	0.603807651185129	Gastroesophageal reflux disease	1e-10	34187846
rs7341267	rs205262	0.603807651185129	Body mass index	3e-10	25673413
rs7341267	rs205262	0.603807651185129	Body mass index	2e-10	25673413
rs7341267	rs205262	0.603807651185129	ICD10 M54: Dorsalgia	2e-12	35110524
rs7341329	rs9469872	1	HDL cholesterol levels	3e-11	36333282
rs7341329	rs11755393	0.973790640397902	Body mass index	3e-26	29273807
rs7341329	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-12	33493351
rs7341329	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-06	33493351
rs7341329	rs11755393	0.973790640397902	Systemic lupus erythematosus	1e-07	33493351
rs7341329	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-08	19838195
rs7341329	rs11755393	0.973790640397902	Body mass index	4e-55	36581621
rs7341329	rs9366863	0.970483919695282	Adult body size	9e-33	32376654
rs7341329	rs9366863	0.970483919695282	Body mass index	2e-44	30595370
rs7341329	rs6941110	0.96258381097747	Sex hormone-binding globulin levels	5e-27	36653534
rs7341329	rs9469857	0.958971476515971	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7341329	rs2764208	0.958227492160117	Systemic lupus erythematosus	7e-06	24871463
rs7341329	rs9462030	0.944781064859332	Red cell distribution width	5e-25	32888493
rs7341329	rs2744944	0.942972684970972	Hypothyroidism	3e-10	34594039
rs7341329	rs2744944	0.942972684970972	High density lipoprotein cholesterol levels	3e-86	34887591
rs7341329	rs2744944	0.942972684970972	Multi-trait sex score	7e-22	37277458
rs7341329	rs2814949	0.933665854372005	Essential hypertension (time to event)	9e-09	32589924
rs7341329	rs9469899	0.92820039426473	Prostate cancer (advanced)	2e-06	29892016
rs7341329	rs9469899	0.92820039426473	Prostate cancer	5e-09	29892016
rs7341329	rs9469899	0.92820039426473	Prostate cancer	8e-11	33398198
rs7341329	rs9469899	0.92820039426473	Hand grip strength	3e-15	29691431
rs7341329	rs9469899	0.92820039426473	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7341329	rs9469899	0.92820039426473	Graves' disease	4e-10	34594039
rs7341329	rs9469899	0.92820039426473	Coronary artery disease	1e-11	36474045
rs7341329	rs9469899	0.92820039426473	Predicted visceral adipose tissue	2e-20	31501611
rs7341329	rs9469899	0.92820039426473	Medication use (thyroid preparations)	2e-09	31015401
rs7341329	rs9469899	0.92820039426473	Medication use (thyroid preparations)	3e-10	34594039
rs7341329	rs2263329	0.920478897573699	HDL cholesterol	6e-35	34594039
rs7341329	rs2263329	0.920478897573699	HDL cholesterol levels	8e-43	32203549
rs7341329	rs2263329	0.920478897573699	High density lipoprotein cholesterol levels	2e-52	34887591
rs7341329	rs9296128	0.909885484027307	Hip circumference adjusted for BMI	4e-13	34021172
rs7341329	rs111868030	0.899134497274885	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7341329	rs9368830	0.858231507139136	HDL cholesterol	4e-21	30275531
rs7341329	rs9368828	0.846474268217447	Body mass index	1e-34	34594039
rs7341329	rs6912327	0.819382202499493	Fasting insulin	5e-06	33402679
rs7341329	rs6912327	0.819382202499493	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7341329	rs112283401	0.796699333730006	Red cell distribution width	4e-27	30595370
rs7341329	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7341329	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7341329	rs2744973	0.772924967221123	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7341329	rs2744973	0.772924967221123	Multi-trait sex score	6e-20	37277458
rs7341329	rs6940215	0.625459662116117	Insomnia	2e-10	35835914
rs7341329	rs6940215	0.625459662116117	Insomnia	1e-13	35835914
rs7341329	rs6940215	0.625459662116117	Hip circumference adjusted for BMI	8e-10	34021172
rs7341329	rs6940215	0.625459662116117	Multi-trait sex score	2e-23	37277458
rs7341329	rs6940215	0.625459662116117	Multi-trait sex score	4e-23	37277458
rs7341329	rs6457796	0.61641252194767	Insomnia	1e-08	30804565
rs7341329	rs6457796	0.61641252194767	Plateletcrit	9e-11	32888494
rs7341329	rs6457796	0.61641252194767	Systemic lupus erythematosus	3e-22	33272962
rs7341329	rs6457796	0.61641252194767	Body mass index	5e-13	30108127
rs7341329	rs6457796	0.61641252194767	Body mass index	1e-14	26426971
rs7341329	rs6457796	0.61641252194767	Educational attainment	5e-19	35361970
rs7341329	rs205262	0.603317711536489	Body mass index	2e-09	26961502
rs7341329	rs205262	0.603317711536489	Walking pace	4e-10	33128006
rs7341329	rs205262	0.603317711536489	Body mass index	8e-13	30108127
rs7341329	rs205262	0.603317711536489	Body mass index	2e-09	25673413
rs7341329	rs205262	0.603317711536489	Body mass index	2e-14	26426971
rs7341329	rs205262	0.603317711536489	BMI in non-smokers	3e-07	28443625
rs7341329	rs205262	0.603317711536489	BMI in non-smokers	6e-09	28443625
rs7341329	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs7341329	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs7341329	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs7341329	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs7341329	rs205262	0.603317711536489	Gastroesophageal reflux disease	1e-10	34187846
rs7341329	rs205262	0.603317711536489	Body mass index	3e-10	25673413
rs7341329	rs205262	0.603317711536489	Body mass index	2e-10	25673413
rs7341329	rs205262	0.603317711536489	ICD10 M54: Dorsalgia	2e-12	35110524
rs735822	rs2224797	0.847082583116436	Red blood cell count	5e-08	30595370
rs735822	rs2224797	0.847082583116436	Mean corpuscular hemoglobin	3e-09	30595370
rs7381555	rs9505982	0.991135094764066	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs7381555	rs11155671	0.939827976843549	Testicular germ cell tumor	2e-09	28604728
rs7381555	rs4380763	0.926625357288334	Subcortical volume (min-P)	1e-11	32665545
rs7381555	rs1934534	0.925860683326993	Pain (pleiotropy)	2e-08	37844115
rs7381555	rs1934534	0.925860683326993	Pain (pleiotropy)	2e-06	37844115
rs7381555	rs4421206	0.906968993890852	Brain morphology (min-P)	4e-11	32665545
rs7381555	rs9688452	0.887783563823529	Brainstem global volume Whole-brainstem	1e-11	33875891
rs7381555	rs9688452	0.887783563823529	aseg lh volume VentralDC	2e-10	33875891
rs7381555	rs80147756	0.883969692795904	HippSubfield lh volume subiculum-head	3e-10	33875891
rs7381555	rs9322194	0.84063157945411	Brainstem volume	2e-11	31636452
rs7381555	rs10872649	0.809449646019844	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs7381555	rs10872649	0.809449646019844	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs7381555	rs10872649	0.809449646019844	Right hippocampal volume (body)	1e-10	37337106
rs7381555	rs7752089	0.781848960320936	Brain morphology (MOSTest)	2e-31	35164939
rs7381555	rs9285521	0.714263225227831	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs7381555	rs12526675	0.630194226198213	Brain morphology (MOSTest)	7e-22	32665545
rs7381555	rs9688809	0.600475548247581	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs739636	rs7211222	1	Coronary artery disease or von Willebrand factor levels (pleiotropy)	8e-11	35285134
rs739636	rs8072215	0.978537343035439	Albumin levels	1e-08	34321204
rs739636	rs1869365	0.966344958089203	vWF and FVIII levels	5e-08	30586737
rs739636	rs12941469	0.895791214569761	Monocyte count	4e-22	32888493
rs739636	rs11869069	0.887436729148128	Coronary artery disease or fibrinogen levels (pleiotropy)	4e-12	35285134
rs739636	rs9903204	0.887436729148128	Albumin levels	4e-11	34321204
rs739636	rs7224737	0.887436729148128	Fibrinogen levels	6e-09	26561523
rs739636	rs7224737	0.887436729148128	Fibrinogen levels	2e-09	28107422
rs739636	rs7224737	0.887436729148128	Fibrinogen levels	5e-09	28107422
rs739636	rs12603330	0.887436729148128	Albumin levels	1e-13	34321204
rs739636	rs2285657	0.873794973312703	Mean reticulocyte volume	6e-16	32888494
rs739636	rs730086	0.857807879066483	Inflammatory bowel disease	2e-06	26278503
rs739636	rs730086	0.857807879066483	Height	2e-74	36224396
rs739636	rs8071235	0.842537671209857	Monocyte count	2e-23	32888493
rs739636	rs2074164	0.841964493710224	Coronary artery disease	7e-09	29212778
rs739636	rs2074164	0.841964493710224	Coronary artery disease	3e-12	33020668
rs739636	rs2074164	0.841964493710224	Coronary artery disease	1e-09	36474045
rs739636	rs2074158	0.792882791210293	Coronary artery disease	2e-10	29212778
rs739636	rs2074158	0.792882791210293	High density lipoprotein cholesterol levels	8e-07	29083408
rs739636	rs2074158	0.792882791210293	High density lipoprotein cholesterol levels	4e-06	29083408
rs739636	rs1122326	0.7656054923875	Hematocrit	3e-10	32888493
rs739636	rs1122326	0.7656054923875	Monocyte count	9e-14	32888494
rs739636	rs1122326	0.7656054923875	Serum albumin levels	4e-31	34594039
rs739636	rs35370188	0.693241860634229	Mean spheric corpuscular volume	2e-10	32888494
rs739636	rs12325861	0.65199184780262	Medication use (thyroid preparations)	2e-14	31015401
rs739636	rs12325861	0.65199184780262	Hypothyroidism	2e-13	36093044
rs739636	rs12325861	0.65199184780262	Hypothyroidism	2e-12	30595370
rs739636	rs11079035	0.651370686926242	White blood cell count	6e-09	32888494
rs739636	rs11079035	0.651370686926242	Vitiligo	7e-10	27723757
rs739636	rs11079035	0.651370686926242	Monocyte count	3e-13	34594039
rs739636	rs11079035	0.651370686926242	White blood cell count	3e-11	30595370
rs739636	rs9902341	0.650129426382274	Hypothyroidism	5e-10	34594039
rs739636	rs9902341	0.650129426382274	Mean corpuscular volume	2e-16	34594039
rs739636	rs61653336	0.641943670603091	Albumin levels	1e-11	35213538
rs739636	rs61653336	0.641943670603091	Albumin levels (UKB data field 23479)	8e-10	36764567
rs739636	rs13380830	0.633702791510507	Medication use (thyroid preparations)	2e-15	34594039
rs739636	rs13380830	0.633702791510507	Autoimmune traits	5e-09	30595370
rs739636	rs12952244	0.617356313291253	Coronary artery disease	2e-10	36474045
rs7405629	rs61586425	0.653821481271265	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7405629	rs7211615	0.650446259108904	Heel bone mineral density	1e-08	30595370
rs7405629	rs8077038	0.627758881994403	Educational attainment (MTAG)	4e-10	30038396
rs7405629	rs8077038	0.627758881994403	Highest math class taken (MTAG)	5e-16	30038396
rs7405629	rs12949956	0.620669906899048	Self-reported math ability	3e-11	30038396
rs7405629	rs12949956	0.620669906899048	Self-reported math ability (MTAG)	3e-14	30038396
rs7405629	rs12949956	0.620669906899048	Highest math class taken	8e-12	30038396
rs7405827	rs61586425	0.653821481271265	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7405827	rs7211615	0.650446259108904	Heel bone mineral density	1e-08	30595370
rs7405827	rs8077038	0.627758881994403	Educational attainment (MTAG)	4e-10	30038396
rs7405827	rs8077038	0.627758881994403	Highest math class taken (MTAG)	5e-16	30038396
rs7405827	rs12949956	0.620669906899048	Self-reported math ability	3e-11	30038396
rs7405827	rs12949956	0.620669906899048	Self-reported math ability (MTAG)	3e-14	30038396
rs7405827	rs12949956	0.620669906899048	Highest math class taken	8e-12	30038396
rs7405845	rs7211615	0.656186492763318	Heel bone mineral density	1e-08	30595370
rs7405845	rs61586425	0.65088889025074	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7405845	rs8077038	0.633352696675265	Educational attainment (MTAG)	4e-10	30038396
rs7405845	rs8077038	0.633352696675265	Highest math class taken (MTAG)	5e-16	30038396
rs7405845	rs12949956	0.626207566304659	Self-reported math ability	3e-11	30038396
rs7405845	rs12949956	0.626207566304659	Self-reported math ability (MTAG)	3e-14	30038396
rs7405845	rs12949956	0.626207566304659	Highest math class taken	8e-12	30038396
rs7406040	rs8077038	0.996711960307176	Educational attainment (MTAG)	4e-10	30038396
rs7406040	rs8077038	0.996711960307176	Highest math class taken (MTAG)	5e-16	30038396
rs7406040	rs12949956	0.973793727308279	Self-reported math ability	3e-11	30038396
rs7406040	rs12949956	0.973793727308279	Self-reported math ability (MTAG)	3e-14	30038396
rs7406040	rs12949956	0.973793727308279	Highest math class taken	8e-12	30038396
rs7406040	rs7211615	0.967692778455764	Heel bone mineral density	1e-08	30595370
rs7406040	rs9894429	0.650406394175317	Eye color traits	9e-14	20463881
rs7406040	rs9894429	0.650406394175317	Body mass index	4e-08	36581621
rs7406045	rs6501801	0.848529949168202	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-07	31719535
rs7406045	rs6501801	0.848529949168202	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-10	31719535
rs7406045	rs6501801	0.848529949168202	HDL cholesterol levels x long total sleep time interaction (1df test)	7e-06	31719535
rs7406045	rs8065231	0.820698439438322	HDL cholesterol levels x long total sleep time interaction (2df test)	5e-10	31719535
rs7406045	rs8065231	0.820698439438322	HDL cholesterol levels x long total sleep time interaction (1df test)	6e-07	31719535
rs7406089	rs7211615	0.656186492763318	Heel bone mineral density	1e-08	30595370
rs7406089	rs61586425	0.65088889025074	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7406089	rs8077038	0.633352696675265	Educational attainment (MTAG)	4e-10	30038396
rs7406089	rs8077038	0.633352696675265	Highest math class taken (MTAG)	5e-16	30038396
rs7406089	rs12949956	0.626207566304659	Self-reported math ability	3e-11	30038396
rs7406089	rs12949956	0.626207566304659	Self-reported math ability (MTAG)	3e-14	30038396
rs7406089	rs12949956	0.626207566304659	Highest math class taken	8e-12	30038396
rs7406173	rs6501801	0.84343004615765	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-07	31719535
rs7406173	rs6501801	0.84343004615765	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-10	31719535
rs7406173	rs6501801	0.84343004615765	HDL cholesterol levels x long total sleep time interaction (1df test)	7e-06	31719535
rs7406173	rs8065231	0.814225118422771	HDL cholesterol levels x long total sleep time interaction (2df test)	5e-10	31719535
rs7406173	rs8065231	0.814225118422771	HDL cholesterol levels x long total sleep time interaction (1df test)	6e-07	31719535
rs7406219	rs61586425	0.949646063799734	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7406219	rs8075598	0.76259126733174	Non-albumin protein levels	3e-10	29403010
rs7406219	rs6565604	0.759379199999364	Non-melanoma skin cancer	3e-06	34290314
rs7406219	rs9894429	0.667101709009081	Eye color traits	9e-14	20463881
rs7406219	rs9894429	0.667101709009081	Body mass index	4e-08	36581621
rs7406360	rs8077038	0.991260353508657	Educational attainment (MTAG)	4e-10	30038396
rs7406360	rs8077038	0.991260353508657	Highest math class taken (MTAG)	5e-16	30038396
rs7406360	rs12949956	0.968461690649105	Self-reported math ability	3e-11	30038396
rs7406360	rs12949956	0.968461690649105	Self-reported math ability (MTAG)	3e-14	30038396
rs7406360	rs12949956	0.968461690649105	Highest math class taken	8e-12	30038396
rs7406360	rs7211615	0.960197130573302	Heel bone mineral density	1e-08	30595370
rs7406360	rs9894429	0.644336557411989	Eye color traits	9e-14	20463881
rs7406360	rs9894429	0.644336557411989	Body mass index	4e-08	36581621
rs7406450	rs7211615	0.613100620956705	Heel bone mineral density	1e-08	30595370
rs7406450	rs61586425	0.60461942631266	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7406465	rs7211615	0.656186492763318	Heel bone mineral density	1e-08	30595370
rs7406465	rs61586425	0.65088889025074	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7406465	rs8077038	0.633352696675265	Educational attainment (MTAG)	4e-10	30038396
rs7406465	rs8077038	0.633352696675265	Highest math class taken (MTAG)	5e-16	30038396
rs7406465	rs12949956	0.626207566304659	Self-reported math ability	3e-11	30038396
rs7406465	rs12949956	0.626207566304659	Self-reported math ability (MTAG)	3e-14	30038396
rs7406465	rs12949956	0.626207566304659	Highest math class taken	8e-12	30038396
rs7406636	rs61586425	0.654598102084878	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs7406636	rs7211615	0.651035050973492	Heel bone mineral density	1e-08	30595370
rs7406636	rs8077038	0.628329512207982	Educational attainment (MTAG)	4e-10	30038396
rs7406636	rs8077038	0.628329512207982	Highest math class taken (MTAG)	5e-16	30038396
rs7406636	rs12949956	0.621232717091092	Self-reported math ability	3e-11	30038396
rs7406636	rs12949956	0.621232717091092	Self-reported math ability (MTAG)	3e-14	30038396
rs7406636	rs12949956	0.621232717091092	Highest math class taken	8e-12	30038396
rs7406705	rs7211615	0.754685696230538	Heel bone mineral density	1e-08	30595370
rs7406705	rs8077038	0.728783095846533	Educational attainment (MTAG)	4e-10	30038396
rs7406705	rs8077038	0.728783095846533	Highest math class taken (MTAG)	5e-16	30038396
rs7406705	rs12949956	0.720309590143528	Self-reported math ability	3e-11	30038396
rs7406705	rs12949956	0.720309590143528	Self-reported math ability (MTAG)	3e-14	30038396
rs7406705	rs12949956	0.720309590143528	Highest math class taken	8e-12	30038396
rs7406977	rs6501801	0.826318192471152	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-07	31719535
rs7406977	rs6501801	0.826318192471152	HDL cholesterol levels x long total sleep time interaction (2df test)	3e-10	31719535
rs7406977	rs6501801	0.826318192471152	HDL cholesterol levels x long total sleep time interaction (1df test)	7e-06	31719535
rs7406977	rs8065231	0.800174866354943	HDL cholesterol levels x long total sleep time interaction (2df test)	5e-10	31719535
rs7406977	rs8065231	0.800174866354943	HDL cholesterol levels x long total sleep time interaction (1df test)	6e-07	31719535
rs74393176	rs1423357	0.943848057310346	General cognitive ability	9e-06	29844566
rs74393176	rs2432142	0.932466722540965	Neutrophil count	2e-14	32888493
rs74393176	rs2432142	0.932466722540965	White blood cell count	1e-11	32888493
rs74393176	rs38033	0.927339657456468	Blood protein levels	0	30072576
rs74393176	rs27293	0.918537143303872	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs74393176	rs27293	0.918537143303872	Diastolic blood pressure	3e-11	35762941
rs74393176	rs7705093	0.909714616891044	Birdshot chorioretinopathy	2e-09	24957906
rs74393176	rs2910686	0.820768840603674	Neutrophil count	4e-14	32888493
rs74393176	rs2910686	0.820768840603674	Psoriasis	2e-08	23143594
rs74393176	rs2910686	0.820768840603674	Ankylosing spondylitis	5e-17	23749187
rs74393176	rs2910686	0.820768840603674	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs74393176	rs2927608	0.817626402652823	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs74393176	rs2927608	0.817626402652823	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs74393176	rs2927608	0.817626402652823	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs74393176	rs2617439	0.74176330025453	Neutrophil count	8e-11	32888494
rs74393176	rs2549797	0.733526214283533	Systolic blood pressure	7e-07	33230300
rs74393176	rs2549797	0.733526214283533	Diastolic blood pressure	1e-14	33230300
rs74393176	rs2549797	0.733526214283533	Diastolic blood pressure	3e-11	33230300
rs74393176	rs2549797	0.733526214283533	Systolic blood pressure	4e-09	33230300
rs74393176	rs2549782	0.732275685376665	Systolic blood pressure	6e-07	33230300
rs74393176	rs2549782	0.732275685376665	Diastolic blood pressure	1e-14	33230300
rs74393176	rs2549782	0.732275685376665	Diastolic blood pressure	3e-11	33230300
rs74393176	rs2549782	0.732275685376665	Systolic blood pressure	5e-09	33230300
rs74393176	rs1056893	0.731651259816313	Systolic blood pressure	1e-06	33230300
rs74393176	rs1056893	0.731651259816313	Diastolic blood pressure	7e-15	33230300
rs74393176	rs1056893	0.731651259816313	Diastolic blood pressure	2e-11	33230300
rs74393176	rs1056893	0.731651259816313	Systolic blood pressure	7e-09	33230300
rs74393176	rs2549794	0.727823331754749	Crohn's disease	1e-10	21102463
rs74393176	rs2549794	0.727823331754749	Systolic blood pressure	1e-07	33230300
rs74393176	rs2549794	0.727823331754749	Diastolic blood pressure	1e-15	33230300
rs74393176	rs2549794	0.727823331754749	Diastolic blood pressure	2e-12	33230300
rs74393176	rs2549794	0.727823331754749	Systolic blood pressure	4e-10	33230300
rs74393176	rs38029	0.727150602078152	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs74393176	rs1363907	0.723304505948879	Crohn's disease	4e-16	26192919
rs74393176	rs1363907	0.723304505948879	Ulcerative colitis	4e-06	26192919
rs74393176	rs1363907	0.723304505948879	Inflammatory bowel disease	5e-15	26192919
rs74393176	rs1363907	0.723304505948879	Inflammatory bowel disease	6e-13	23128233
rs74393176	rs1363907	0.723304505948879	Inflammatory bowel disease	1e-10	28067908
rs74393176	rs1363907	0.723304505948879	Crohn's disease	1e-14	28067908
rs74393176	rs716848	0.695319139519153	Neutrophil percentage of white cells	2e-09	32888494
rs74393176	rs4869313	0.680433198033871	Pediatric autoimmune diseases	9e-08	26301688
rs74393176	rs1559359	0.674100173261631	Diastolic blood pressure	7e-10	34594039
rs74393176	rs2548532	0.653990849336159	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs74393176	rs4869314	0.636210817222642	Arthritis (juvenile idiopathic)	3e-09	33106285
rs74393176	rs4869314	0.636210817222642	Neutrophil count	1e-10	34594039
rs74393176	rs4869314	0.636210817222642	White blood cell count	2e-07	30595370
rs74393176	rs1974871	0.608299590531172	Granulysin levels	5e-13	34648354
rs74393176	rs27660	0.604878905501477	Coronary artery disease	3e-08	35915156
rs74393176	rs1019503	0.600406069272557	Systolic blood pressure	2e-06	33230300
rs74393176	rs1019503	0.600406069272557	Diastolic blood pressure	2e-14	33230300
rs74393176	rs1019503	0.600406069272557	Diastolic blood pressure	4e-11	33230300
rs74393176	rs1019503	0.600406069272557	Systolic blood pressure	1e-08	33230300
rs7450246	rs12526675	0.844203410257868	Brain morphology (MOSTest)	7e-22	32665545
rs7450246	rs9285521	0.815101761189003	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs7450246	rs10872649	0.813865595122697	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs7450246	rs10872649	0.813865595122697	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs7450246	rs10872649	0.813865595122697	Right hippocampal volume (body)	1e-10	37337106
rs7450246	rs4421206	0.810879154425539	Brain morphology (min-P)	4e-11	32665545
rs7450246	rs2342764	0.790868705466641	Cortical thickness	1e-08	34560273
rs7450246	rs9688452	0.789337300993229	Brainstem global volume Whole-brainstem	1e-11	33875891
rs7450246	rs9688452	0.789337300993229	aseg lh volume VentralDC	2e-10	33875891
rs7450246	rs9322194	0.787849088377538	Brainstem volume	2e-11	31636452
rs7450246	rs7752089	0.775523836409445	Brain morphology (MOSTest)	2e-31	35164939
rs7450246	rs1934534	0.770004042012715	Pain (pleiotropy)	2e-08	37844115
rs7450246	rs1934534	0.770004042012715	Pain (pleiotropy)	2e-06	37844115
rs7450246	rs4380763	0.769216613353408	Subcortical volume (min-P)	1e-11	32665545
rs7450246	rs56103941	0.760580135905388	Right presubiculum volume (head)	4e-08	37337106
rs7450246	rs11155671	0.753903070691235	Testicular germ cell tumor	2e-09	28604728
rs7450246	rs9505982	0.738777032952429	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs7450246	rs80147756	0.727527958007173	HippSubfield lh volume subiculum-head	3e-10	33875891
rs7450246	rs12523793	0.723884171661406	Subcortical volume (MOSTest)	4e-24	32665545
rs7450246	rs12523793	0.723884171661406	C-reactive protein levels	3e-08	35459240
rs7450246	rs12523793	0.723884171661406	C-reactive protein levels (MTAG)	2e-08	36376304
rs7450246	rs11155662	0.709971053120589	Vertex-wise cortical thickness	2e-09	34910505
rs7451769	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs7451769	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs7451769	rs6928810	0.890092667905038	Platelet distribution width	1e-14	32888494
rs7451769	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs7451769	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs7451769	rs9266825	0.864263096403477	Autism spectrum disorder	6e-06	35215271
rs7451769	rs199530775	0.740076610728635	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs7451769	rs55957433	0.740076610728635	Hip circumference adjusted for BMI	3e-08	34021172
rs7451769	rs6934175	0.67384422555715	Psoriatic arthritis	5e-28	30552173
rs7451769	rs17200242	0.664511943065584	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs7451769	rs7751505	0.657706582280067	Pubertal anthropometrics	4e-06	23449627
rs7451769	rs35026345	0.65640936672589	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs7451769	rs72848707	0.655066901958558	HDL cholesterol levels	7e-06	35884923
rs7451769	rs13437088	0.631438004864122	Psoriasis	3e-40	23143594
rs7451769	rs13437082	0.630743556638567	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs7451769	rs13437082	0.630743556638567	Height	5e-08	19343178
rs7451769	rs72657657	0.623149040879308	Hip circumference adjusted for BMI	4e-13	34021172
rs746011	rs746011	1	Triglycerides	2e-10	30275531
rs746011	rs11781149	0.929979255754999	Refractive error	2e-17	32231278
rs746011	rs2280104	0.806035118361677	Parkinson's disease	3e-08	28892059
rs746011	rs2280104	0.806035118361677	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs746011	rs2280104	0.806035118361677	Serum total protein level	3e-12	34594039
rs746011	rs1545837	0.804729795897555	Lung function (FVC)	1e-10	30595370
rs746011	rs4242434	0.785088711002652	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	8e-06	26242244
rs746011	rs4872007	0.743777494010229	Superior temporal gyrus volume	8e-06	31530798
rs746011	rs13271626	0.741948621114249	Haemorrhoidal disease	3e-10	33888516
rs746011	rs11778693	0.721118860193631	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs746011	rs11778693	0.721118860193631	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs746011	rs11780207	0.658796228292632	Estimated glomerular filtration rate	2e-13	33462484
rs746011	rs11780207	0.658796228292632	Serum total protein level	2e-09	33462484
rs746011	rs11780207	0.658796228292632	Creatinine levels	2e-13	33462484
rs746011	rs34269854	0.626910806995952	Lung function (forced vital capacity)	3e-09	36914875
rs746011	rs11782130	0.614781159698133	C-reactive protein levels	9e-09	35459240
rs746011	rs4592028	0.60395135821022	Non-albumin protein levels	3e-09	33462484
rs7502384	rs12949545	0.696865996839169	Highest math class taken (MTAG)	3e-08	30038396
rs7502613	rs12949545	0.854644945241631	Highest math class taken (MTAG)	3e-08	30038396
rs7502836	rs12949545	0.858043917854494	Highest math class taken (MTAG)	3e-08	30038396
rs75074497	rs55679149	0.621959373390864	Remission after SSRI treatment in MDD or openness	8e-07	29559929
rs75074497	rs12089335	0.604488372080428	Guanylate-binding protein 1 levels	4e-26	34648354
rs7518750	rs12145922	0.99344313105702	Liver enzyme levels (gamma-glutamyl transferase)	4e-11	22001757
rs7518750	rs12145922	0.99344313105702	Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels in elite athletes	1e-05	31882771
rs7518750	rs3806340	0.99344313105702	Corneal resistance factor (MTAG)	3e-18	35446358
rs7518750	rs3806340	0.99344313105702	Height	1e-12	35831902
rs7518750	rs3806340	0.99344313105702	Height	7e-17	36224396
rs7518750	rs3806340	0.99344313105702	Height	3e-47	36224396
rs7518750	rs10922476	0.988537620773445	Corneal resistance factor	4e-17	33311554
rs7518750	rs1002436	0.798359501402653	Red blood cell count	4e-22	32888493
rs7518750	rs1002436	0.798359501402653	Alanine aminotransferase levels	6e-11	33547301
rs7518750	rs1002436	0.798359501402653	Aspartate aminotransferase levels	1e-20	33547301
rs7518750	rs1002436	0.798359501402653	Liver enzyme levels (gamma-glutamyl transferase)	1e-52	33972514
rs7518750	rs12145712	0.760465567108899	Pulse pressure	1e-10	35762941
rs7518750	rs4233334	0.743556250621148	Body surface area	6e-09	36502284
rs7518750	rs786906	0.734761080543451	Systolic blood pressure	1e-06	27618447
rs7518750	rs786906	0.734761080543451	Intraocular pressure	5e-09	29617998
rs7518750	rs12021820	0.732779814378689	Mean corpuscular hemoglobin	2e-11	32888493
rs7518750	rs10801682	0.731382566645662	Mean corpuscular hemoglobin	1e-09	30595370
rs7518750	rs7551732	0.712035743061253	Height	6e-20	25282103
rs7518750	rs7551732	0.712035743061253	Gamma glutamyl transferase levels	5e-08	33339817
rs7518750	rs6699417	0.655449948005638	Height	5e-09	20881960
rs7518750	rs6699417	0.655449948005638	Height	2e-11	35831902
rs7518750	rs6699417	0.655449948005638	Height	1e-300	36224396
rs7518750	rs6699417	0.655449948005638	Height	1e-300	36224396
rs7524684	rs7545078	0.680754962690847	Smoking initiation	2e-09	36477530
rs7524684	rs6700087	0.649680133136631	Smoking initiation	6e-11	36477530
rs7525293	rs7545078	0.743148848190339	Smoking initiation	2e-09	36477530
rs7525293	rs6700087	0.679609663857361	Smoking initiation	6e-11	36477530
rs7526419	rs12729558	0.942598805700112	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs7526419	rs10922531	0.911790601098972	Serum metabolite levels	2e-69	33031748
rs7526419	rs7532151	0.875712886583013	Imidazole lactate levels	9e-12	33177712
rs7526419	rs10801690	0.848744006982775	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs7526419	rs7530513	0.828913163655181	Height	8e-11	35831902
rs7526419	rs7530513	0.828913163655181	Imidazole lactate levels	8e-166	36635386
rs7526419	rs12144640	0.828913163655181	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs7526419	rs9787133	0.818416009243821	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs7526419	rs1409152	0.817395692601685	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs7526419	rs1409152	0.817395692601685	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs7526419	rs10801699	0.8168055474211	X-23639 levels	2e-10	36635386
rs7526419	rs12120164	0.78279530491526	Metabolite peak levels (QI2146)	1e-26	35995766
rs7526419	rs2765527	0.767673673991905	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs7526419	rs2810876	0.658966710855796	Imidazole lactate levels	2e-122	35347128
rs7526419	rs10801696	0.656334763227395	Imidazole lactate levels	3e-195	35050183
rs7526419	rs1206228892	0.655809583792579	Imidazole lactate levels	5e-186	35050183
rs7527656	rs6680628	0.713102627326381	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs7528009	rs7545078	0.712315550112054	Smoking initiation	2e-09	36477530
rs7528009	rs6700087	0.653516405663156	Smoking initiation	6e-11	36477530
rs7529293	rs11580836	0.847438129767045	Body mass index	2e-09	36581621
rs7529293	rs10465746	0.817662594967223	Obesity-related traits	8e-06	23251661
rs7530513	rs7530513	1	Height	8e-11	35831902
rs7530513	rs7530513	1	Imidazole lactate levels	8e-166	36635386
rs7530513	rs12144640	1	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs7530513	rs10922531	0.80923994601834	Serum metabolite levels	2e-69	33031748
rs7530513	rs12729558	0.788060337808832	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs7530513	rs7532151	0.726171261347773	Imidazole lactate levels	9e-12	33177712
rs7530513	rs1409152	0.714191806031104	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs7530513	rs1409152	0.714191806031104	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs7530513	rs10801699	0.711947700717531	X-23639 levels	2e-10	36635386
rs7530513	rs10801690	0.703851231584988	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs7530513	rs9787133	0.67752087578048	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs7530513	rs12120164	0.675937989963433	Metabolite peak levels (QI2146)	1e-26	35995766
rs7530513	rs2765527	0.637506947699747	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs7531537	rs11580836	0.983160077397768	Body mass index	2e-09	36581621
rs7531537	rs10465746	0.960854207681536	Obesity-related traits	8e-06	23251661
rs7532151	rs7532151	1	Imidazole lactate levels	9e-12	33177712
rs7532151	rs9787133	0.933701286784286	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs7532151	rs12729558	0.921581966954593	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs7532151	rs10801690	0.900104291620233	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs7532151	rs10922531	0.797482389683964	Serum metabolite levels	2e-69	33031748
rs7532151	rs2765527	0.747643784302327	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs7532151	rs7530513	0.726171261347773	Height	8e-11	35831902
rs7532151	rs7530513	0.726171261347773	Imidazole lactate levels	8e-166	36635386
rs7532151	rs12144640	0.726171261347773	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs7532151	rs1206228892	0.717861501941744	Imidazole lactate levels	5e-186	35050183
rs7532151	rs2810876	0.717278931449167	Imidazole lactate levels	2e-122	35347128
rs7532151	rs10801696	0.717082459063155	Imidazole lactate levels	3e-195	35050183
rs7532151	rs1409152	0.715867956991574	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs7532151	rs1409152	0.715867956991574	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs7532151	rs10801699	0.714008664115822	X-23639 levels	2e-10	36635386
rs7532151	rs12120164	0.68394890339059	Metabolite peak levels (QI2146)	1e-26	35995766
rs7541867	rs61798917	0.808556027800037	Height	2e-10	30595370
rs7542137	rs7542137	1	Beta-hydroxyisovalerate levels	3e-11	35050183
rs7542137	rs7542137	1	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs7542137	rs7542137	1	3-hydroxysebacate levels	2e-10	36635386
rs7542137	rs2130525	0.90987704931336	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs7542137	rs3007711	0.845358437878175	Electrodermal activity	9e-06	25387706
rs7542137	rs2999541	0.84454600981745	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs7542137	rs6698740	0.839352566311773	Beta-hydroxyisovalerate levels	1e-13	35347128
rs7542137	rs1060870	0.837849309538796	Serum metabolite levels	1e-11	33031748
rs7542137	rs1060870	0.837849309538796	Serum metabolite levels	1e-15	33031748
rs7542137	rs6685187	0.834030341322238	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs7542137	rs11204914	0.823343894432035	Carnitine C9 levels	1e-13	35995766
rs7542137	rs11204914	0.823343894432035	Metabolite peak levels (QI6204)	1e-32	35995766
rs7542137	rs11204914	0.823343894432035	Metabolite peak levels (QI6252)	2e-32	35995766
rs7542137	rs2338201	0.821551651154406	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs7542137	rs2338201	0.821551651154406	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs7542137	rs2338201	0.821551651154406	Dodecadienoate (12:2) levels	7e-15	36635386
rs7542137	rs10788817	0.813583129770671	Serum metabolite levels	3e-13	24625756
rs7542137	rs10788817	0.813583129770671	Metabolite peak levels (QI2718)	5e-18	35995766
rs7542137	rs10788817	0.813583129770671	3-hydroxylaurate levels	2e-12	36635386
rs7542137	rs10788817	0.813583129770671	Tetradecadienoate (14:2) levels	8e-17	36635386
rs7542137	rs2279501	0.739899153246818	Serum metabolite levels	3e-14	33031748
rs7542137	rs7523082	0.696144137457916	Metabolite peak levels (QI9845)	2e-14	35995766
rs7542137	rs10888445	0.690366787085998	Beta-hydroxyisovalerate levels	5e-13	36635386
rs7542137	rs7541453	0.686757734368865	Serum metabolite levels	2e-16	33031748
rs7542137	rs7541453	0.686757734368865	Serum metabolite levels	2e-16	33031748
rs7542137	rs7541453	0.686757734368865	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs7542137	rs2999545	0.676361886072484	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs7542137	rs1038747	0.630807802989718	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs7542137	rs56000812	0.618652412989666	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs7542137	rs56078223	0.618052260424713	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs7542137	rs56078223	0.618052260424713	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs7542137	rs6684312	0.605014230086382	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs7543817	rs10733045	0.858872631386418	DNA methylation-estimated granulocyte proportions	5e-09	34187551
rs7543817	rs10918211	0.652021358137219	White blood cell count	1e-26	34925446
rs7543817	rs10918211	0.652021358137219	Neutrophil count	5e-34	34925446
rs7543817	rs4147592	0.625609045619655	Height	9e-39	36224396
rs7543817	rs10737515	0.623636356318608	Height	4e-10	30595370
rs7545635	rs6680628	0.717194471751764	Liver enzyme levels (alkaline phosphatase)	1e-300	33972514
rs7546933	rs11578888	0.984917902090178	Longevity	3e-06	31484785
rs7546933	rs7172	0.984101491289467	Protein quantitative trait loci (liver)	1e-12	32778093
rs7546933	rs4971040	0.93267350322469	Depression (broad)	2e-07	29662059
rs7555459	rs28482086	0.791429368739552	Educational attainment (years of education)	5e-09	30038396
rs7555459	rs3931020	0.730101555287898	Resistin levels	6e-12	22843503
rs7555459	rs28568334	0.710492790989435	Educational attainment	4e-13	35361970
rs7558169	rs6705511	0.640556414798617	Self-reported math ability	4e-09	30038396
rs7558169	rs6705511	0.640556414798617	Self-reported math ability (MTAG)	3e-10	30038396
rs7558169	rs34276187	0.635122861257446	Highest math class taken (MTAG)	2e-08	30038396
rs7558954	rs7558954	1	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs7558954	rs1177308	0.994153455910475	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs7558954	rs1177308	0.994153455910475	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs7558954	rs11685226	0.970140608806709	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs7558954	rs11685226	0.970140608806709	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs7558954	rs777587	0.809726902910783	Proteoglycan 3 levels	6e-29	34648354
rs7558954	rs777587	0.809726902910783	Pappalysin-1 levels	1e-25	34648354
rs7558954	rs12617371	0.768787854000435	Immature fraction of reticulocytes	8e-18	32888494
rs7558954	rs2463097	0.735472666198727	White blood cell count	3e-26	30595370
rs7558954	rs2593620	0.711749987602683	Serum levels of protein PRG3	5e-14	35078996
rs7558954	rs10199672	0.70418487708206	Height	6e-12	34594039
rs7558954	rs10199672	0.70418487708206	Height	2e-12	31562340
rs7558954	rs2421200	0.68360259034643	Neutrophil count	1e-26	32888493
rs7558954	rs2421200	0.68360259034643	Neutrophil count	1e-25	32888493
rs7558954	rs10169482	0.634148754577131	C-reactive protein levels	4e-09	33462484
rs7558954	rs12616433	0.609734723770261	Eosinophil forward scatter	4e-13	37596262
rs7558954	rs12616433	0.609734723770261	Eosinophil side scatter	2e-18	37596262
rs7559296	rs6705511	0.752653094598621	Self-reported math ability	4e-09	30038396
rs7559296	rs6705511	0.752653094598621	Self-reported math ability (MTAG)	3e-10	30038396
rs7559296	rs34276187	0.746482702095445	Highest math class taken (MTAG)	2e-08	30038396
rs75610088	rs1423357	0.968271092207506	General cognitive ability	9e-06	29844566
rs75610088	rs2432142	0.950119250438954	Neutrophil count	2e-14	32888493
rs75610088	rs2432142	0.950119250438954	White blood cell count	1e-11	32888493
rs75610088	rs38033	0.94727252338084	Blood protein levels	0	30072576
rs75610088	rs27293	0.931711405776148	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs75610088	rs27293	0.931711405776148	Diastolic blood pressure	3e-11	35762941
rs75610088	rs7705093	0.926802000825745	Birdshot chorioretinopathy	2e-09	24957906
rs75610088	rs2910686	0.843474377867338	Neutrophil count	4e-14	32888493
rs75610088	rs2910686	0.843474377867338	Psoriasis	2e-08	23143594
rs75610088	rs2910686	0.843474377867338	Ankylosing spondylitis	5e-17	23749187
rs75610088	rs2910686	0.843474377867338	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs75610088	rs2927608	0.840159929350918	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs75610088	rs2927608	0.840159929350918	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs75610088	rs2927608	0.840159929350918	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs75610088	rs2617439	0.753887252701473	Neutrophil count	8e-11	32888494
rs75610088	rs2549797	0.750713296949314	Systolic blood pressure	7e-07	33230300
rs75610088	rs2549797	0.750713296949314	Diastolic blood pressure	1e-14	33230300
rs75610088	rs2549797	0.750713296949314	Diastolic blood pressure	3e-11	33230300
rs75610088	rs2549797	0.750713296949314	Systolic blood pressure	4e-09	33230300
rs75610088	rs2549782	0.7494874399106	Systolic blood pressure	6e-07	33230300
rs75610088	rs2549782	0.7494874399106	Diastolic blood pressure	1e-14	33230300
rs75610088	rs2549782	0.7494874399106	Diastolic blood pressure	3e-11	33230300
rs75610088	rs2549782	0.7494874399106	Systolic blood pressure	5e-09	33230300
rs75610088	rs1056893	0.748875332689443	Systolic blood pressure	1e-06	33230300
rs75610088	rs1056893	0.748875332689443	Diastolic blood pressure	7e-15	33230300
rs75610088	rs1056893	0.748875332689443	Diastolic blood pressure	2e-11	33230300
rs75610088	rs1056893	0.748875332689443	Systolic blood pressure	7e-09	33230300
rs75610088	rs2549794	0.744750806917582	Crohn's disease	1e-10	21102463
rs75610088	rs2549794	0.744750806917582	Systolic blood pressure	1e-07	33230300
rs75610088	rs2549794	0.744750806917582	Diastolic blood pressure	1e-15	33230300
rs75610088	rs2549794	0.744750806917582	Diastolic blood pressure	2e-12	33230300
rs75610088	rs2549794	0.744750806917582	Systolic blood pressure	4e-10	33230300
rs75610088	rs38029	0.74254377030594	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs75610088	rs1363907	0.740193837024227	Crohn's disease	4e-16	26192919
rs75610088	rs1363907	0.740193837024227	Ulcerative colitis	4e-06	26192919
rs75610088	rs1363907	0.740193837024227	Inflammatory bowel disease	5e-15	26192919
rs75610088	rs1363907	0.740193837024227	Inflammatory bowel disease	6e-13	23128233
rs75610088	rs1363907	0.740193837024227	Inflammatory bowel disease	1e-10	28067908
rs75610088	rs1363907	0.740193837024227	Crohn's disease	1e-14	28067908
rs75610088	rs716848	0.712592157636376	Neutrophil percentage of white cells	2e-09	32888494
rs75610088	rs4869313	0.698054113614181	Pediatric autoimmune diseases	9e-08	26301688
rs75610088	rs1559359	0.693031972354865	Diastolic blood pressure	7e-10	34594039
rs75610088	rs2548532	0.666598104237405	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs75610088	rs4869314	0.648357392261245	Arthritis (juvenile idiopathic)	3e-09	33106285
rs75610088	rs4869314	0.648357392261245	Neutrophil count	1e-10	34594039
rs75610088	rs4869314	0.648357392261245	White blood cell count	2e-07	30595370
rs75610088	rs1974871	0.620615642633405	Granulysin levels	5e-13	34648354
rs75610088	rs1019503	0.619128622863885	Systolic blood pressure	2e-06	33230300
rs75610088	rs1019503	0.619128622863885	Diastolic blood pressure	2e-14	33230300
rs75610088	rs1019503	0.619128622863885	Diastolic blood pressure	4e-11	33230300
rs75610088	rs1019503	0.619128622863885	Systolic blood pressure	1e-08	33230300
rs75610088	rs27660	0.612073017227345	Coronary artery disease	3e-08	35915156
rs75610088	rs3096168	0.611727889844778	Aspartate aminotransferase levels	8e-12	33547301
rs7566279	rs7566279	1	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs7566279	rs58461606	0.991849088519422	Blood protein levels	0	30072576
rs7566279	rs79716074	0.978619048827281	Plateletcrit	1e-09	32888494
rs7566279	rs79716074	0.978619048827281	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs7566279	rs79716074	0.978619048827281	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs7566279	rs79716074	0.978619048827281	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs7566279	rs7595075	0.97456856098759	Waist circumference adjusted for body mass index	2e-09	34021172
rs7566279	rs7595075	0.97456856098759	HDL cholesterol	3e-11	34594039
rs7566279	rs7595075	0.97456856098759	HDL cholesterol levels	6e-13	32203549
rs7566279	rs7605824	0.968548171681207	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs7566279	rs17713729	0.967512314372094	Body mass index	2e-09	31669095
rs7566279	rs17713729	0.967512314372094	Serum creatinine levels	4e-14	34594039
rs7566279	rs17713729	0.967512314372094	High density lipoprotein cholesterol levels	7e-17	34887591
rs7566279	rs17713396	0.960458363925077	Blood urea nitrogen levels	3e-21	34272381
rs7566279	rs17713396	0.960458363925077	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs7566279	rs17713396	0.960458363925077	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs7566279	rs6710091	0.958451020898533	Waist circumference adjusted for body mass index	8e-11	31669095
rs7566279	rs6710091	0.958451020898533	HDL cholesterol	5e-08	30275531
rs7566279	rs6710091	0.958451020898533	High density lipoprotein cholesterol levels	3e-24	34887591
rs7566279	rs3791221	0.946206954090112	Blood urea nitrogen levels	2e-07	31152163
rs7566279	rs3791221	0.946206954090112	Estimated glomerular filtration rate	2e-10	31152163
rs7566279	rs3791221	0.946206954090112	Estimated glomerular filtration rate	1e-11	31152163
rs7566279	rs3791221	0.946206954090112	Blood urea nitrogen levels	7e-26	34594039
rs7566279	rs114976176	0.940749842069163	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs7566279	rs2290911	0.914603158458187	Height	5e-07	29782485
rs7566279	rs2290911	0.914603158458187	Large artery stroke	6e-06	28265093
rs7566279	rs2290911	0.914603158458187	Height	8e-112	36224396
rs7566279	rs59937473	0.913799948303693	Protein quantitative trait loci	3e-67	32492067
rs7566279	rs59937473	0.913799948303693	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs7566279	rs17714252	0.907819230326481	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs7566279	rs17714252	0.907819230326481	Retinal vascular fractal dimension	2e-07	34743558
rs7566279	rs2126129	0.90674324951163	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs7566279	rs55753056	0.881357311834518	Height	2e-22	30595370
rs7566279	rs11553746	0.879034497010994	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs7566279	rs11553746	0.879034497010994	High density lipoprotein cholesterol levels	2e-07	29083408
rs7566279	rs11553746	0.879034497010994	High density lipoprotein cholesterol levels	7e-15	29083408
rs7566279	rs11553746	0.879034497010994	Large artery stroke	4e-06	28265093
rs7566279	rs7601944	0.873345840504909	Smoking initiation	4e-15	36477530
rs7566279	rs62114548	0.854148958731259	Retinal vascular fractal density	2e-09	34743558
rs7566279	rs60843830	0.853813660972891	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs7566279	rs60843830	0.853813660972891	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs7566279	rs60843830	0.853813660972891	Adventurousness	7e-10	30643258
rs7566279	rs62114538	0.850145369755988	Triglyceride levels	6e-12	34887591
rs7566279	rs17713879	0.845444305706713	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs7566279	rs17713879	0.845444305706713	Smoking initiation	1e-10	36477530
rs7566279	rs17713879	0.845444305706713	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs7566279	rs17713879	0.845444305706713	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs7566279	rs17713879	0.845444305706713	Triglyceride levels	3e-10	34887591
rs7566279	rs17713879	0.845444305706713	Aging (eyeAgeAcceleration)	6e-50	36975205
rs7566279	rs79154857	0.794615069714046	Pulse pressure	5e-08	34594039
rs7566279	rs62114506	0.73728566231881	Gamma glutamyl transpeptidase	3e-14	34594039
rs7566279	rs62114506	0.73728566231881	Apolipoprotein A1 levels	3e-10	32203549
rs7566279	rs62114506	0.73728566231881	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs7566279	rs62114506	0.73728566231881	HDL cholesterol levels	8e-10	36333282
rs757405	rs1557866	1	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs757405	rs1293767	0.897639450963228	Adult asthma	2e-06	27611488
rs757405	rs1293767	0.897639450963228	Adult asthma	9e-07	27611488
rs757405	rs6489882	0.64174960194697	Chronic lymphocytic leukemia	5e-08	28165464
rs757405	rs1859336	0.61982849623932	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs757405	rs10744789	0.610025075807648	Vitamin D levels or COVID-19 (MTAG)	5e-12	37212302
rs757405	rs4767027	0.6033381828865	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs757405	rs2057778	0.600481748899161	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs757405	rs2057778	0.600481748899161	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs757405	rs2057778	0.600481748899161	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7583579	rs7424551	0.601778060391382	Intake of total sugars	7e-08	31005972
rs7584915	rs59937473	0.994118829945565	Protein quantitative trait loci	3e-67	32492067
rs7584915	rs59937473	0.994118829945565	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs7584915	rs17714252	0.984320108298038	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs7584915	rs17714252	0.984320108298038	Retinal vascular fractal dimension	2e-07	34743558
rs7584915	rs55753056	0.959549073316251	Height	2e-22	30595370
rs7584915	rs114976176	0.951333843333627	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs7584915	rs7601944	0.951069589413347	Smoking initiation	4e-15	36477530
rs7584915	rs60843830	0.928318714288607	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs7584915	rs60843830	0.928318714288607	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs7584915	rs60843830	0.928318714288607	Adventurousness	7e-10	30643258
rs7584915	rs62114538	0.927563692110099	Triglyceride levels	6e-12	34887591
rs7584915	rs58461606	0.911450974893904	Blood protein levels	0	30072576
rs7584915	rs7566279	0.907700180178809	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs7584915	rs7595075	0.897384865734062	Waist circumference adjusted for body mass index	2e-09	34021172
rs7584915	rs7595075	0.897384865734062	HDL cholesterol	3e-11	34594039
rs7584915	rs7595075	0.897384865734062	HDL cholesterol levels	6e-13	32203549
rs7584915	rs79716074	0.89361997812584	Plateletcrit	1e-09	32888494
rs7584915	rs79716074	0.89361997812584	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs7584915	rs79716074	0.89361997812584	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs7584915	rs79716074	0.89361997812584	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs7584915	rs17713729	0.890675107969692	Body mass index	2e-09	31669095
rs7584915	rs17713729	0.890675107969692	Serum creatinine levels	4e-14	34594039
rs7584915	rs17713729	0.890675107969692	High density lipoprotein cholesterol levels	7e-17	34887591
rs7584915	rs17713396	0.884100694079612	Blood urea nitrogen levels	3e-21	34272381
rs7584915	rs17713396	0.884100694079612	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs7584915	rs17713396	0.884100694079612	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs7584915	rs6710091	0.882211041697519	Waist circumference adjusted for body mass index	8e-11	31669095
rs7584915	rs6710091	0.882211041697519	HDL cholesterol	5e-08	30275531
rs7584915	rs6710091	0.882211041697519	High density lipoprotein cholesterol levels	3e-24	34887591
rs7584915	rs7605824	0.880206258507322	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs7584915	rs3791221	0.869789911708875	Blood urea nitrogen levels	2e-07	31152163
rs7584915	rs3791221	0.869789911708875	Estimated glomerular filtration rate	2e-10	31152163
rs7584915	rs3791221	0.869789911708875	Estimated glomerular filtration rate	1e-11	31152163
rs7584915	rs3791221	0.869789911708875	Blood urea nitrogen levels	7e-26	34594039
rs7584915	rs2290911	0.847496246283319	Height	5e-07	29782485
rs7584915	rs2290911	0.847496246283319	Large artery stroke	6e-06	28265093
rs7584915	rs2290911	0.847496246283319	Height	8e-112	36224396
rs7584915	rs2126129	0.833978583996032	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs7584915	rs11553746	0.809702127375942	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs7584915	rs11553746	0.809702127375942	High density lipoprotein cholesterol levels	2e-07	29083408
rs7584915	rs11553746	0.809702127375942	High density lipoprotein cholesterol levels	7e-15	29083408
rs7584915	rs11553746	0.809702127375942	Large artery stroke	4e-06	28265093
rs7584915	rs62114548	0.776608260092689	Retinal vascular fractal density	2e-09	34743558
rs7584915	rs17713879	0.775040571187821	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs7584915	rs17713879	0.775040571187821	Smoking initiation	1e-10	36477530
rs7584915	rs17713879	0.775040571187821	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs7584915	rs17713879	0.775040571187821	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs7584915	rs17713879	0.775040571187821	Triglyceride levels	3e-10	34887591
rs7584915	rs17713879	0.775040571187821	Aging (eyeAgeAcceleration)	6e-50	36975205
rs7584915	rs79154857	0.73263456561467	Pulse pressure	5e-08	34594039
rs7584915	rs62114506	0.684069672985259	Gamma glutamyl transpeptidase	3e-14	34594039
rs7584915	rs62114506	0.684069672985259	Apolipoprotein A1 levels	3e-10	32203549
rs7584915	rs62114506	0.684069672985259	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs7584915	rs62114506	0.684069672985259	HDL cholesterol levels	8e-10	36333282
rs7585993	rs73045343	0.652448773075449	Serum total protein level	1e-12	34594039
rs7585993	rs6759004	0.635523213745608	Triptolide cytotoxicity	3e-07	26121980
rs7587037	rs34276187	0.672585828132176	Highest math class taken (MTAG)	2e-08	30038396
rs7587037	rs6705511	0.65416235380541	Self-reported math ability	4e-09	30038396
rs7587037	rs6705511	0.65416235380541	Self-reported math ability (MTAG)	3e-10	30038396
rs7591772	rs777587	0.959586103091845	Proteoglycan 3 levels	6e-29	34648354
rs7591772	rs777587	0.959586103091845	Pappalysin-1 levels	1e-25	34648354
rs7591772	rs12617371	0.941280503657119	Immature fraction of reticulocytes	8e-18	32888494
rs7591772	rs2463097	0.903171985198286	White blood cell count	3e-26	30595370
rs7591772	rs10199672	0.871252379190119	Height	6e-12	34594039
rs7591772	rs10199672	0.871252379190119	Height	2e-12	31562340
rs7591772	rs2593620	0.842762175560794	Serum levels of protein PRG3	5e-14	35078996
rs7591772	rs11685226	0.814353601437937	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs7591772	rs11685226	0.814353601437937	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs7591772	rs2421200	0.811021959414446	Neutrophil count	1e-26	32888493
rs7591772	rs2421200	0.811021959414446	Neutrophil count	1e-25	32888493
rs7591772	rs1177308	0.80541670048666	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs7591772	rs1177308	0.80541670048666	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs7591772	rs7558954	0.803017154197325	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs7591772	rs10169482	0.749361251751528	C-reactive protein levels	4e-09	33462484
rs7591772	rs2950269	0.70975078641563	Eosinophil side fluorescence	3e-18	37596262
rs7591772	rs12616433	0.689749791848073	Eosinophil forward scatter	4e-13	37596262
rs7591772	rs12616433	0.689749791848073	Eosinophil side scatter	2e-18	37596262
rs7595075	rs7595075	1	Waist circumference adjusted for body mass index	2e-09	34021172
rs7595075	rs7595075	1	HDL cholesterol	3e-11	34594039
rs7595075	rs7595075	1	HDL cholesterol levels	6e-13	32203549
rs7595075	rs79716074	0.989753677471562	Plateletcrit	1e-09	32888494
rs7595075	rs79716074	0.989753677471562	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs7595075	rs79716074	0.989753677471562	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs7595075	rs79716074	0.989753677471562	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs7595075	rs17713729	0.986707082428316	Body mass index	2e-09	31669095
rs7595075	rs17713729	0.986707082428316	Serum creatinine levels	4e-14	34594039
rs7595075	rs17713729	0.986707082428316	High density lipoprotein cholesterol levels	7e-17	34887591
rs7595075	rs58461606	0.982716994940685	Blood protein levels	0	30072576
rs7595075	rs17713396	0.979567877244492	Blood urea nitrogen levels	3e-21	34272381
rs7595075	rs17713396	0.979567877244492	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs7595075	rs17713396	0.979567877244492	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs7595075	rs6710091	0.977536264243732	Waist circumference adjusted for body mass index	8e-11	31669095
rs7595075	rs6710091	0.977536264243732	HDL cholesterol	5e-08	30275531
rs7595075	rs6710091	0.977536264243732	High density lipoprotein cholesterol levels	3e-24	34887591
rs7595075	rs7605824	0.975570161109276	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs7595075	rs7566279	0.97456856098759	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs7595075	rs3791221	0.939345323947796	Blood urea nitrogen levels	2e-07	31152163
rs7595075	rs3791221	0.939345323947796	Estimated glomerular filtration rate	2e-10	31152163
rs7595075	rs3791221	0.939345323947796	Estimated glomerular filtration rate	1e-11	31152163
rs7595075	rs3791221	0.939345323947796	Blood urea nitrogen levels	7e-26	34594039
rs7595075	rs2290911	0.933156773039156	Height	5e-07	29782485
rs7595075	rs2290911	0.933156773039156	Large artery stroke	6e-06	28265093
rs7595075	rs2290911	0.933156773039156	Height	8e-112	36224396
rs7595075	rs114976176	0.930065277359219	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs7595075	rs2126129	0.925197806906726	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs7595075	rs59937473	0.901593998029507	Protein quantitative trait loci	3e-67	32492067
rs7595075	rs59937473	0.901593998029507	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs7595075	rs17714252	0.89371215063775	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs7595075	rs17714252	0.89371215063775	Retinal vascular fractal dimension	2e-07	34743558
rs7595075	rs11553746	0.891178106801703	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs7595075	rs11553746	0.891178106801703	High density lipoprotein cholesterol levels	2e-07	29083408
rs7595075	rs11553746	0.891178106801703	High density lipoprotein cholesterol levels	7e-15	29083408
rs7595075	rs11553746	0.891178106801703	Large artery stroke	4e-06	28265093
rs7595075	rs55753056	0.871325038642404	Height	2e-22	30595370
rs7595075	rs7601944	0.86337288642799	Smoking initiation	4e-15	36477530
rs7595075	rs62114548	0.862209946089467	Retinal vascular fractal density	2e-09	34743558
rs7595075	rs62114538	0.840435350239468	Triglyceride levels	6e-12	34887591
rs7595075	rs17713879	0.838753425257464	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs7595075	rs17713879	0.838753425257464	Smoking initiation	1e-10	36477530
rs7595075	rs17713879	0.838753425257464	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs7595075	rs17713879	0.838753425257464	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs7595075	rs17713879	0.838753425257464	Triglyceride levels	3e-10	34887591
rs7595075	rs17713879	0.838753425257464	Aging (eyeAgeAcceleration)	6e-50	36975205
rs7595075	rs60843830	0.832191535528432	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs7595075	rs60843830	0.832191535528432	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs7595075	rs60843830	0.832191535528432	Adventurousness	7e-10	30643258
rs7595075	rs79154857	0.804038460018612	Pulse pressure	5e-08	34594039
rs7595075	rs62114506	0.753681119053721	Gamma glutamyl transpeptidase	3e-14	34594039
rs7595075	rs62114506	0.753681119053721	Apolipoprotein A1 levels	3e-10	32203549
rs7595075	rs62114506	0.753681119053721	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs7595075	rs62114506	0.753681119053721	HDL cholesterol levels	8e-10	36333282
rs7601944	rs7601944	1	Smoking initiation	4e-15	36477530
rs7601944	rs55753056	0.989352616486158	Height	2e-22	30595370
rs7601944	rs59937473	0.954852492431937	Protein quantitative trait loci	3e-67	32492067
rs7601944	rs59937473	0.954852492431937	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs7601944	rs17714252	0.947251988705884	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs7601944	rs17714252	0.947251988705884	Retinal vascular fractal dimension	2e-07	34743558
rs7601944	rs3791221	0.915726987055323	Blood urea nitrogen levels	2e-07	31152163
rs7601944	rs3791221	0.915726987055323	Estimated glomerular filtration rate	2e-10	31152163
rs7601944	rs3791221	0.915726987055323	Estimated glomerular filtration rate	1e-11	31152163
rs7601944	rs3791221	0.915726987055323	Blood urea nitrogen levels	7e-26	34594039
rs7601944	rs114976176	0.915462856674283	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs7601944	rs62114538	0.889648139949407	Triglyceride levels	6e-12	34887591
rs7601944	rs60843830	0.889432694718884	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs7601944	rs60843830	0.889432694718884	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs7601944	rs60843830	0.889432694718884	Adventurousness	7e-10	30643258
rs7601944	rs17713396	0.878274871142706	Blood urea nitrogen levels	3e-21	34272381
rs7601944	rs17713396	0.878274871142706	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs7601944	rs17713396	0.878274871142706	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs7601944	rs58461606	0.876966260079639	Blood protein levels	0	30072576
rs7601944	rs6710091	0.876405149985028	Waist circumference adjusted for body mass index	8e-11	31669095
rs7601944	rs6710091	0.876405149985028	HDL cholesterol	5e-08	30275531
rs7601944	rs6710091	0.876405149985028	High density lipoprotein cholesterol levels	3e-24	34887591
rs7601944	rs7566279	0.873345840504909	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs7601944	rs7595075	0.86337288642799	Waist circumference adjusted for body mass index	2e-09	34021172
rs7601944	rs7595075	0.86337288642799	HDL cholesterol	3e-11	34594039
rs7601944	rs7595075	0.86337288642799	HDL cholesterol levels	6e-13	32203549
rs7601944	rs79716074	0.859722741030318	Plateletcrit	1e-09	32888494
rs7601944	rs79716074	0.859722741030318	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs7601944	rs79716074	0.859722741030318	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs7601944	rs79716074	0.859722741030318	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs7601944	rs17713729	0.85866323562213	Body mass index	2e-09	31669095
rs7601944	rs17713729	0.85866323562213	Serum creatinine levels	4e-14	34594039
rs7601944	rs17713729	0.85866323562213	High density lipoprotein cholesterol levels	7e-17	34887591
rs7601944	rs7605824	0.848417838543746	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs7601944	rs2290911	0.840848833822044	Height	5e-07	29782485
rs7601944	rs2290911	0.840848833822044	Large artery stroke	6e-06	28265093
rs7601944	rs2290911	0.840848833822044	Height	8e-112	36224396
rs7601944	rs2126129	0.828967438912067	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs7601944	rs17713879	0.792486307475073	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs7601944	rs17713879	0.792486307475073	Smoking initiation	1e-10	36477530
rs7601944	rs17713879	0.792486307475073	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs7601944	rs17713879	0.792486307475073	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs7601944	rs17713879	0.792486307475073	Triglyceride levels	3e-10	34887591
rs7601944	rs17713879	0.792486307475073	Aging (eyeAgeAcceleration)	6e-50	36975205
rs7601944	rs11553746	0.773379461037296	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs7601944	rs11553746	0.773379461037296	High density lipoprotein cholesterol levels	2e-07	29083408
rs7601944	rs11553746	0.773379461037296	High density lipoprotein cholesterol levels	7e-15	29083408
rs7601944	rs11553746	0.773379461037296	Large artery stroke	4e-06	28265093
rs7601944	rs62114548	0.746375202502089	Retinal vascular fractal density	2e-09	34743558
rs7601944	rs79154857	0.702265260593528	Pulse pressure	5e-08	34594039
rs7601944	rs62114506	0.678260199832923	Gamma glutamyl transpeptidase	3e-14	34594039
rs7601944	rs62114506	0.678260199832923	Apolipoprotein A1 levels	3e-10	32203549
rs7601944	rs62114506	0.678260199832923	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs7601944	rs62114506	0.678260199832923	HDL cholesterol levels	8e-10	36333282
rs760536	rs11803833	0.906618066224511	Insomnia	5e-10	35835914
rs760536	rs10918585	0.776450370117124	Insomnia	2e-09	35835914
rs7605824	rs7605824	1	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs7605824	rs79716074	0.979623146870325	Plateletcrit	1e-09	32888494
rs7605824	rs79716074	0.979623146870325	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs7605824	rs79716074	0.979623146870325	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs7605824	rs79716074	0.979623146870325	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs7605824	rs7595075	0.975570161109276	Waist circumference adjusted for body mass index	2e-09	34021172
rs7605824	rs7595075	0.975570161109276	HDL cholesterol	3e-11	34594039
rs7605824	rs7595075	0.975570161109276	HDL cholesterol levels	6e-13	32203549
rs7605824	rs7566279	0.968548171681207	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs7605824	rs17713729	0.968509419380304	Body mass index	2e-09	31669095
rs7605824	rs17713729	0.968509419380304	Serum creatinine levels	4e-14	34594039
rs7605824	rs17713729	0.968509419380304	High density lipoprotein cholesterol levels	7e-17	34887591
rs7605824	rs58461606	0.966574034714791	Blood protein levels	0	30072576
rs7605824	rs17713396	0.96144932476189	Blood urea nitrogen levels	3e-21	34272381
rs7605824	rs17713396	0.96144932476189	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs7605824	rs17713396	0.96144932476189	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs7605824	rs6710091	0.959440465855479	Waist circumference adjusted for body mass index	8e-11	31669095
rs7605824	rs6710091	0.959440465855479	HDL cholesterol	5e-08	30275531
rs7605824	rs6710091	0.959440465855479	High density lipoprotein cholesterol levels	3e-24	34887591
rs7605824	rs3791221	0.923637028346039	Blood urea nitrogen levels	2e-07	31152163
rs7605824	rs3791221	0.923637028346039	Estimated glomerular filtration rate	2e-10	31152163
rs7605824	rs3791221	0.923637028346039	Estimated glomerular filtration rate	1e-11	31152163
rs7605824	rs3791221	0.923637028346039	Blood urea nitrogen levels	7e-26	34594039
rs7605824	rs2290911	0.91554762949124	Height	5e-07	29782485
rs7605824	rs2290911	0.91554762949124	Large artery stroke	6e-06	28265093
rs7605824	rs2290911	0.91554762949124	Height	8e-112	36224396
rs7605824	rs114976176	0.914447497372036	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs7605824	rs2126129	0.907688137920993	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs7605824	rs59937473	0.886252251596762	Protein quantitative trait loci	3e-67	32492067
rs7605824	rs59937473	0.886252251596762	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs7605824	rs17714252	0.880336088844923	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs7605824	rs17714252	0.880336088844923	Retinal vascular fractal dimension	2e-07	34743558
rs7605824	rs11553746	0.87993608765608	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs7605824	rs11553746	0.87993608765608	High density lipoprotein cholesterol levels	2e-07	29083408
rs7605824	rs11553746	0.87993608765608	High density lipoprotein cholesterol levels	7e-15	29083408
rs7605824	rs11553746	0.87993608765608	Large artery stroke	4e-06	28265093
rs7605824	rs62114548	0.856972777986691	Retinal vascular fractal density	2e-09	34743558
rs7605824	rs55753056	0.85628861847886	Height	2e-22	30595370
rs7605824	rs7601944	0.848417838543746	Smoking initiation	4e-15	36477530
rs7605824	rs60843830	0.826812330358767	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs7605824	rs60843830	0.826812330358767	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs7605824	rs60843830	0.826812330358767	Adventurousness	7e-10	30643258
rs7605824	rs17713879	0.824099596520275	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs7605824	rs17713879	0.824099596520275	Smoking initiation	1e-10	36477530
rs7605824	rs17713879	0.824099596520275	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs7605824	rs17713879	0.824099596520275	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs7605824	rs17713879	0.824099596520275	Triglyceride levels	3e-10	34887591
rs7605824	rs17713879	0.824099596520275	Aging (eyeAgeAcceleration)	6e-50	36975205
rs7605824	rs62114538	0.823908017511588	Triglyceride levels	6e-12	34887591
rs7605824	rs79154857	0.793551529584367	Pulse pressure	5e-08	34594039
rs7605824	rs62114506	0.738049269459168	Gamma glutamyl transpeptidase	3e-14	34594039
rs7605824	rs62114506	0.738049269459168	Apolipoprotein A1 levels	3e-10	32203549
rs7605824	rs62114506	0.738049269459168	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs7605824	rs62114506	0.738049269459168	HDL cholesterol levels	8e-10	36333282
rs7610312	rs7610312	1	Red blood cell count	5e-09	27863252
rs7610312	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs7610312	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs7610312	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs7610312	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs7610312	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs7610312	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs7610312	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs7610312	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs7610312	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs7610312	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs7610312	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs7610312	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs7610312	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs7610312	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs7610312	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs7610312	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs7610312	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs7610312	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs7610312	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs7610312	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs7610312	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs7610312	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs7610312	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs7610312	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs7610312	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs7610922	rs9835332	0.893783022606341	Height	5e-13	20881960
rs7610922	rs9835332	0.893783022606341	Height	4e-22	25282103
rs7610922	rs7619465	0.893783022606341	Waist circumference adjusted for body mass index	5e-13	34021172
rs7610922	rs4681994	0.893783022606341	General cognitive ability	1e-06	29844566
rs7610922	rs6445804	0.889406916093938	Multi-trait sex score	7e-12	37277458
rs7610922	rs6445804	0.889406916093938	Eczema	1e-08	30595370
rs7610922	rs767602469	0.845190364081594	Hip circumference adjusted for BMI	5e-09	34021172
rs7610922	rs7653344	0.835914092361159	Highest math class taken (MTAG)	5e-14	30038396
rs7610922	rs7653344	0.835914092361159	Self-reported math ability	1e-09	30038396
rs7610922	rs7653344	0.835914092361159	Self-reported math ability (MTAG)	6e-13	30038396
rs7610922	rs7653344	0.835914092361159	Cognitive performance (MTAG)	3e-12	30038396
rs7610922	rs4681724	0.816249966132187	QT interval	4e-10	36050321
rs7610922	rs73079883	0.771151459497618	Multi-trait sex score	5e-08	37277458
rs7610922	rs6773931	0.671069377842304	Height	8e-08	21998595
rs7610922	rs7633694	0.644296308520894	Multi-trait sex score	4e-08	37277458
rs7610922	rs11715144	0.630806417463018	Hip circumference adjusted for BMI	1e-11	34021172
rs7610922	rs7625428	0.630081346175617	Educational attainment (years of education)	1e-11	30038396
rs7610922	rs7625428	0.630081346175617	Educational attainment (MTAG)	5e-14	30038396
rs7611415	rs17648188	0.758839007229293	Hepatocyte growth factor-like protein levels	4e-11	36168886
rs7620012	rs7610312	0.998754420240596	Red blood cell count	5e-09	27863252
rs7620012	rs6775517	0.997513171843502	Hematocrit	1e-17	34594039
rs7620012	rs57700771	0.992533675054664	Red blood cell count	9e-21	30595370
rs7620012	rs11705721	0.977968941165425	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs7620012	rs11130638	0.975522577534433	Hemoglobin concentration	2e-23	32888493
rs7620012	rs34579268	0.968364619868781	Hematocrit	5e-30	32888493
rs7620012	rs34579268	0.968364619868781	Hematocrit	2e-27	32888493
rs7620012	rs34579268	0.968364619868781	Hemoglobin concentration	5e-26	32888493
rs7620012	rs55704295	0.92393320419111	Red blood cell count	8e-26	32888493
rs7620012	rs55704295	0.92393320419111	Red blood cell count	5e-23	32888493
rs7620012	rs55704295	0.92393320419111	Serum total protein level	2e-29	34594039
rs7620012	rs4681679	0.893816459009963	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs7620012	rs11719450	0.867428880762618	Hemoglobin concentration	2e-09	27863252
rs7620012	rs11719450	0.867428880762618	Hemoglobin levels	2e-16	32327693
rs7620012	rs56384862	0.855952025743711	Body mass index	8e-12	29273807
rs7620012	rs56384862	0.855952025743711	Body mass index	3e-06	30108127
rs7620012	rs56384862	0.855952025743711	Hemoglobin levels	1e-16	32327693
rs7620012	rs56384862	0.855952025743711	Body mass index	3e-14	36581621
rs7620012	rs11922478	0.853255768526729	Semaphorin-6B levels	4e-12	34648354
rs7620012	rs55692656	0.836211917546735	vWF levels	3e-08	30586737
rs7620012	rs55692656	0.836211917546735	vWF levels	6e-09	30586737
rs7620012	rs6445969	0.703130628273353	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs7620012	rs11708895	0.699127416139621	Red blood cell count	1e-20	32888494
rs7620012	rs55954186	0.69473127896577	vWF levels	5e-09	30586737
rs7620012	rs55954186	0.69473127896577	vWF levels	9e-09	30586737
rs7620012	rs7431952	0.631469228103101	Hemoglobin levels	1e-12	32327693
rs7624283	rs7610312	0.997507911336935	Red blood cell count	5e-09	27863252
rs7624283	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs7624283	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs7624283	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs7624283	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs7624283	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs7624283	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs7624283	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs7624283	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs7624283	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs7624283	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs7624283	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs7624283	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs7624283	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs7624283	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs7624283	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs7624283	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs7624283	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs7624283	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs7624283	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs7624283	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs7624283	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs7624283	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs7624283	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs7624283	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs7624283	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs762507	rs3213282	0.605686822653265	Low density lipoprotein cholesterol levels	3e-11	32154731
rs7642652	rs7610312	0.998754420240596	Red blood cell count	5e-09	27863252
rs7642652	rs6775517	0.997513171843502	Hematocrit	1e-17	34594039
rs7642652	rs57700771	0.992533675054664	Red blood cell count	9e-21	30595370
rs7642652	rs11705721	0.977968941165425	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs7642652	rs11130638	0.975522577534433	Hemoglobin concentration	2e-23	32888493
rs7642652	rs34579268	0.968364619868781	Hematocrit	5e-30	32888493
rs7642652	rs34579268	0.968364619868781	Hematocrit	2e-27	32888493
rs7642652	rs34579268	0.968364619868781	Hemoglobin concentration	5e-26	32888493
rs7642652	rs55704295	0.92393320419111	Red blood cell count	8e-26	32888493
rs7642652	rs55704295	0.92393320419111	Red blood cell count	5e-23	32888493
rs7642652	rs55704295	0.92393320419111	Serum total protein level	2e-29	34594039
rs7642652	rs4681679	0.893816459009963	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs7642652	rs11719450	0.867428880762618	Hemoglobin concentration	2e-09	27863252
rs7642652	rs11719450	0.867428880762618	Hemoglobin levels	2e-16	32327693
rs7642652	rs56384862	0.855952025743711	Body mass index	8e-12	29273807
rs7642652	rs56384862	0.855952025743711	Body mass index	3e-06	30108127
rs7642652	rs56384862	0.855952025743711	Hemoglobin levels	1e-16	32327693
rs7642652	rs56384862	0.855952025743711	Body mass index	3e-14	36581621
rs7642652	rs11922478	0.853255768526729	Semaphorin-6B levels	4e-12	34648354
rs7642652	rs55692656	0.836211917546735	vWF levels	3e-08	30586737
rs7642652	rs55692656	0.836211917546735	vWF levels	6e-09	30586737
rs7642652	rs6445969	0.703130628273353	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs7642652	rs11708895	0.699127416139621	Red blood cell count	1e-20	32888494
rs7642652	rs55954186	0.69473127896577	vWF levels	5e-09	30586737
rs7642652	rs55954186	0.69473127896577	vWF levels	9e-09	30586737
rs7642652	rs7431952	0.631469228103101	Hemoglobin levels	1e-12	32327693
rs7643057	rs7610312	1	Red blood cell count	5e-09	27863252
rs7643057	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs7643057	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs7643057	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs7643057	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs7643057	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs7643057	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs7643057	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs7643057	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs7643057	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs7643057	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs7643057	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs7643057	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs7643057	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs7643057	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs7643057	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs7643057	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs7643057	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs7643057	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs7643057	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs7643057	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs7643057	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs7643057	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs7643057	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs7643057	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs7643057	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs7647078	rs7610312	0.997507911336935	Red blood cell count	5e-09	27863252
rs7647078	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs7647078	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs7647078	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs7647078	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs7647078	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs7647078	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs7647078	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs7647078	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs7647078	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs7647078	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs7647078	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs7647078	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs7647078	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs7647078	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs7647078	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs7647078	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs7647078	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs7647078	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs7647078	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs7647078	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs7647078	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs7647078	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs7647078	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs7647078	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs7647078	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs7647184	rs7610312	0.997507911336935	Red blood cell count	5e-09	27863252
rs7647184	rs6775517	0.996270689626915	Hematocrit	1e-17	34594039
rs7647184	rs57700771	0.991285016954891	Red blood cell count	9e-21	30595370
rs7647184	rs11705721	0.976750802846984	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs7647184	rs11130638	0.974305051875382	Hemoglobin concentration	2e-23	32888493
rs7647184	rs34579268	0.967156024230531	Hematocrit	5e-30	32888493
rs7647184	rs34579268	0.967156024230531	Hematocrit	2e-27	32888493
rs7647184	rs34579268	0.967156024230531	Hemoglobin concentration	5e-26	32888493
rs7647184	rs55704295	0.922630888282085	Red blood cell count	8e-26	32888493
rs7647184	rs55704295	0.922630888282085	Red blood cell count	5e-23	32888493
rs7647184	rs55704295	0.922630888282085	Serum total protein level	2e-29	34594039
rs7647184	rs4681679	0.892497092737587	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs7647184	rs11719450	0.866103610127891	Hemoglobin concentration	2e-09	27863252
rs7647184	rs11719450	0.866103610127891	Hemoglobin levels	2e-16	32327693
rs7647184	rs56384862	0.854601824873443	Body mass index	8e-12	29273807
rs7647184	rs56384862	0.854601824873443	Body mass index	3e-06	30108127
rs7647184	rs56384862	0.854601824873443	Hemoglobin levels	1e-16	32327693
rs7647184	rs56384862	0.854601824873443	Body mass index	3e-14	36581621
rs7647184	rs11922478	0.851920186570224	Semaphorin-6B levels	4e-12	34648354
rs7647184	rs55692656	0.835074694303985	vWF levels	3e-08	30586737
rs7647184	rs55692656	0.835074694303985	vWF levels	6e-09	30586737
rs7647184	rs6445969	0.7016735902879	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs7647184	rs11708895	0.697657527676995	Red blood cell count	1e-20	32888494
rs7647184	rs55954186	0.693258115806257	vWF levels	5e-09	30586737
rs7647184	rs55954186	0.693258115806257	vWF levels	9e-09	30586737
rs7647184	rs7431952	0.629984220198462	Hemoglobin levels	1e-12	32327693
rs7647987	rs1552244	0.920978139024944	Alzheimer's disease	2e-06	24755620
rs7647987	rs76041173	0.689042866995234	Cysteine-rich with EGF-like domain protein 1 levels (CRELD1.7628.40.3)	8e-149	29875488
rs7660116	rs2130392	0.871515835942713	Kawasaki disease	3e-08	22446962
rs7687399	rs2868708	0.913002023037316	Lymphocyte count	3e-11	34469753
rs7687399	rs2868708	0.913002023037316	White blood cell count	1e-09	30595370
rs7687399	rs6831339	0.909748330358991	High density lipoprotein cholesterol levels	9e-09	34887591
rs7687399	rs6535419	0.864695661088125	Pulse pressure	6e-10	30578418
rs7687399	rs116142917	0.833658788979482	Lymphocyte count	7e-18	32888494
rs7687399	rs6823199	0.823228669315226	Pulse pressure	4e-14	30224653
rs7687399	rs13111599	0.811892637695607	HDL cholesterol levels	3e-09	32203549
rs7687399	rs13111599	0.811892637695607	Apolipoprotein A1 levels	4e-08	32203549
rs7687399	rs11099563	0.751097662260271	High density lipoprotein cholesterol levels	3e-11	34887591
rs7687399	rs28528763	0.736029394712879	White blood cell count	7e-12	32888494
rs7687399	rs4302451	0.731351607254762	Eosinophil counts	2e-09	30595370
rs7687399	rs35895091	0.691415718702079	Cardiovascular disease	1e-07	30595370
rs7687399	rs7662402	0.641666985873621	Brain morphology (MOSTest)	3e-08	35164939
rs7687684	rs6831339	1	High density lipoprotein cholesterol levels	9e-09	34887591
rs7687684	rs2868708	0.996670557915363	Lymphocyte count	3e-11	34469753
rs7687684	rs2868708	0.996670557915363	White blood cell count	1e-09	30595370
rs7687684	rs116142917	0.915238572755671	Lymphocyte count	7e-18	32888494
rs7687684	rs6823199	0.895826456408638	Pulse pressure	4e-14	30224653
rs7687684	rs13111599	0.889525024994145	HDL cholesterol levels	3e-09	32203549
rs7687684	rs13111599	0.889525024994145	Apolipoprotein A1 levels	4e-08	32203549
rs7687684	rs6535419	0.874229728768598	Pulse pressure	6e-10	30578418
rs7687684	rs11099563	0.745403496805278	High density lipoprotein cholesterol levels	3e-11	34887591
rs7687684	rs4302451	0.743813141137588	Eosinophil counts	2e-09	30595370
rs7687684	rs28528763	0.718855802699315	White blood cell count	7e-12	32888494
rs7687684	rs35895091	0.704383113526372	Cardiovascular disease	1e-07	30595370
rs7687684	rs7662402	0.62120795462088	Brain morphology (MOSTest)	3e-08	35164939
rs7697238	rs17007017	0.799224492781043	Conduct disorder	7e-06	20585324
rs7697238	rs34402449	0.764316030654711	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs7697238	rs1550057	0.693809730665077	Conduct disorder	4e-06	20585324
rs7697238	rs1550057	0.693809730665077	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs7698661	rs17007017	0.799224492781043	Conduct disorder	7e-06	20585324
rs7698661	rs34402449	0.76274959296194	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs7698661	rs1550057	0.692318350129907	Conduct disorder	4e-06	20585324
rs7698661	rs1550057	0.692318350129907	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs770192	rs770199	0.896740170955079	Hair color	3e-08	30595370
rs770194	rs770199	0.885309359543265	Hair color	3e-08	30595370
rs770199	rs770199	1	Hair color	3e-08	30595370
rs770204	rs770199	0.943003164612007	Hair color	3e-08	30595370
rs7703341	rs1423357	0.994963944822702	General cognitive ability	9e-06	29844566
rs7703341	rs2432142	0.974922915668223	Neutrophil count	2e-14	32888493
rs7703341	rs2432142	0.974922915668223	White blood cell count	1e-11	32888493
rs7703341	rs38033	0.970097766206101	Blood protein levels	0	30072576
rs7703341	rs27293	0.96428905733583	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs7703341	rs27293	0.96428905733583	Diastolic blood pressure	3e-11	35762941
rs7703341	rs7705093	0.96060532135072	Birdshot chorioretinopathy	2e-09	24957906
rs7703341	rs2910686	0.867118871998665	Neutrophil count	4e-14	32888493
rs7703341	rs2910686	0.867118871998665	Psoriasis	2e-08	23143594
rs7703341	rs2910686	0.867118871998665	Ankylosing spondylitis	5e-17	23749187
rs7703341	rs2910686	0.867118871998665	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs7703341	rs2927608	0.86380638532588	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs7703341	rs2927608	0.86380638532588	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs7703341	rs2927608	0.86380638532588	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs7703341	rs2617439	0.774777724545661	Neutrophil count	8e-11	32888494
rs7703341	rs2549797	0.771945297746188	Systolic blood pressure	7e-07	33230300
rs7703341	rs2549797	0.771945297746188	Diastolic blood pressure	1e-14	33230300
rs7703341	rs2549797	0.771945297746188	Diastolic blood pressure	3e-11	33230300
rs7703341	rs2549797	0.771945297746188	Systolic blood pressure	4e-09	33230300
rs7703341	rs2549782	0.7706881310314	Systolic blood pressure	6e-07	33230300
rs7703341	rs2549782	0.7706881310314	Diastolic blood pressure	1e-14	33230300
rs7703341	rs2549782	0.7706881310314	Diastolic blood pressure	3e-11	33230300
rs7703341	rs2549782	0.7706881310314	Systolic blood pressure	5e-09	33230300
rs7703341	rs1056893	0.7700603899293	Systolic blood pressure	1e-06	33230300
rs7703341	rs1056893	0.7700603899293	Diastolic blood pressure	7e-15	33230300
rs7703341	rs1056893	0.7700603899293	Diastolic blood pressure	2e-11	33230300
rs7703341	rs1056893	0.7700603899293	Systolic blood pressure	7e-09	33230300
rs7703341	rs2549794	0.765298161323202	Crohn's disease	1e-10	21102463
rs7703341	rs2549794	0.765298161323202	Systolic blood pressure	1e-07	33230300
rs7703341	rs2549794	0.765298161323202	Diastolic blood pressure	1e-15	33230300
rs7703341	rs2549794	0.765298161323202	Diastolic blood pressure	2e-12	33230300
rs7703341	rs2549794	0.765298161323202	Systolic blood pressure	4e-10	33230300
rs7703341	rs38029	0.763077791340124	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs7703341	rs1363907	0.76066758945742	Crohn's disease	4e-16	26192919
rs7703341	rs1363907	0.76066758945742	Ulcerative colitis	4e-06	26192919
rs7703341	rs1363907	0.76066758945742	Inflammatory bowel disease	5e-15	26192919
rs7703341	rs1363907	0.76066758945742	Inflammatory bowel disease	6e-13	23128233
rs7703341	rs1363907	0.76066758945742	Inflammatory bowel disease	1e-10	28067908
rs7703341	rs1363907	0.76066758945742	Crohn's disease	1e-14	28067908
rs7703341	rs716848	0.732336843155905	Neutrophil percentage of white cells	2e-09	32888494
rs7703341	rs4869313	0.720712167490722	Pediatric autoimmune diseases	9e-08	26301688
rs7703341	rs1559359	0.714521642919281	Diastolic blood pressure	7e-10	34594039
rs7703341	rs2548532	0.68756310056482	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs7703341	rs4869314	0.667601021761722	Arthritis (juvenile idiopathic)	3e-09	33106285
rs7703341	rs4869314	0.667601021761722	Neutrophil count	1e-10	34594039
rs7703341	rs4869314	0.667601021761722	White blood cell count	2e-07	30595370
rs7703341	rs1974871	0.641106014572923	Granulysin levels	5e-13	34648354
rs7703341	rs1019503	0.63694610210709	Systolic blood pressure	2e-06	33230300
rs7703341	rs1019503	0.63694610210709	Diastolic blood pressure	2e-14	33230300
rs7703341	rs1019503	0.63694610210709	Diastolic blood pressure	4e-11	33230300
rs7703341	rs1019503	0.63694610210709	Systolic blood pressure	1e-08	33230300
rs7703341	rs27660	0.633837855986563	Coronary artery disease	3e-08	35915156
rs7703341	rs3096168	0.629533373884495	Aspartate aminotransferase levels	8e-12	33547301
rs7705093	rs7705093	1	Birdshot chorioretinopathy	2e-09	24957906
rs7705093	rs1423357	0.955767659948791	General cognitive ability	9e-06	29844566
rs7705093	rs2432142	0.936185758727266	Neutrophil count	2e-14	32888493
rs7705093	rs2432142	0.936185758727266	White blood cell count	1e-11	32888493
rs7705093	rs38033	0.932761253508765	Blood protein levels	0	30072576
rs7705093	rs27293	0.925519435880764	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs7705093	rs27293	0.925519435880764	Diastolic blood pressure	3e-11	35762941
rs7705093	rs2910686	0.829221731307697	Neutrophil count	4e-14	32888493
rs7705093	rs2910686	0.829221731307697	Psoriasis	2e-08	23143594
rs7705093	rs2910686	0.829221731307697	Ankylosing spondylitis	5e-17	23749187
rs7705093	rs2910686	0.829221731307697	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs7705093	rs2927608	0.826045876956366	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs7705093	rs2927608	0.826045876956366	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs7705093	rs2927608	0.826045876956366	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs7705093	rs2617439	0.743928413366667	Neutrophil count	8e-11	32888494
rs7705093	rs2549797	0.734856607266745	Systolic blood pressure	7e-07	33230300
rs7705093	rs2549797	0.734856607266745	Diastolic blood pressure	1e-14	33230300
rs7705093	rs2549797	0.734856607266745	Diastolic blood pressure	3e-11	33230300
rs7705093	rs2549797	0.734856607266745	Systolic blood pressure	4e-09	33230300
rs7705093	rs2549794	0.734454866219682	Crohn's disease	1e-10	21102463
rs7705093	rs2549794	0.734454866219682	Systolic blood pressure	1e-07	33230300
rs7705093	rs2549794	0.734454866219682	Diastolic blood pressure	1e-15	33230300
rs7705093	rs2549794	0.734454866219682	Diastolic blood pressure	2e-12	33230300
rs7705093	rs2549794	0.734454866219682	Systolic blood pressure	4e-10	33230300
rs7705093	rs2549782	0.733610904822643	Systolic blood pressure	6e-07	33230300
rs7705093	rs2549782	0.733610904822643	Diastolic blood pressure	1e-14	33230300
rs7705093	rs2549782	0.733610904822643	Diastolic blood pressure	3e-11	33230300
rs7705093	rs2549782	0.733610904822643	Systolic blood pressure	5e-09	33230300
rs7705093	rs1056893	0.732988889035685	Systolic blood pressure	1e-06	33230300
rs7705093	rs1056893	0.732988889035685	Diastolic blood pressure	7e-15	33230300
rs7705093	rs1056893	0.732988889035685	Diastolic blood pressure	2e-11	33230300
rs7705093	rs1056893	0.732988889035685	Systolic blood pressure	7e-09	33230300
rs7705093	rs38029	0.732299758749041	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs7705093	rs1363907	0.729916732034797	Crohn's disease	4e-16	26192919
rs7705093	rs1363907	0.729916732034797	Ulcerative colitis	4e-06	26192919
rs7705093	rs1363907	0.729916732034797	Inflammatory bowel disease	5e-15	26192919
rs7705093	rs1363907	0.729916732034797	Inflammatory bowel disease	6e-13	23128233
rs7705093	rs1363907	0.729916732034797	Inflammatory bowel disease	1e-10	28067908
rs7705093	rs1363907	0.729916732034797	Crohn's disease	1e-14	28067908
rs7705093	rs716848	0.701887917740982	Neutrophil percentage of white cells	2e-09	32888494
rs7705093	rs1559359	0.688557140232811	Diastolic blood pressure	7e-10	34594039
rs7705093	rs4869313	0.687721817084065	Pediatric autoimmune diseases	9e-08	26301688
rs7705093	rs2548532	0.65985087037463	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs7705093	rs4869314	0.632457976380502	Arthritis (juvenile idiopathic)	3e-09	33106285
rs7705093	rs4869314	0.632457976380502	Neutrophil count	1e-10	34594039
rs7705093	rs4869314	0.632457976380502	White blood cell count	2e-07	30595370
rs7705093	rs1974871	0.609024649303833	Granulysin levels	5e-13	34648354
rs7705093	rs27660	0.608692122142801	Coronary artery disease	3e-08	35915156
rs7705093	rs1019503	0.601012485288435	Systolic blood pressure	2e-06	33230300
rs7705093	rs1019503	0.601012485288435	Diastolic blood pressure	2e-14	33230300
rs7705093	rs1019503	0.601012485288435	Diastolic blood pressure	4e-11	33230300
rs7705093	rs1019503	0.601012485288435	Systolic blood pressure	1e-08	33230300
rs7706108	rs2548499	0.918648870190102	Lymphocyte count	9e-14	32888494
rs7706108	rs2648731	0.751559857630931	Type 2 diabetes	7e-12	34594039
rs7706108	rs2648731	0.751559857630931	Type 2 diabetes	3e-19	34594039
rs7706108	rs2648731	0.751559857630931	Lymphocyte count	2e-11	34594039
rs7706108	rs2648731	0.751559857630931	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs7706108	rs2648731	0.751559857630931	Medication use (drugs used in diabetes)	3e-09	34594039
rs7706108	rs13189973	0.601815880813134	Lymphocyte count	2e-16	32888493
rs7716222	rs1423357	0.993292160832705	General cognitive ability	9e-06	29844566
rs7716222	rs2432142	0.97327071302398	Neutrophil count	2e-14	32888493
rs7716222	rs2432142	0.97327071302398	White blood cell count	1e-11	32888493
rs7716222	rs38033	0.970088748897551	Blood protein levels	0	30072576
rs7716222	rs27293	0.962635464471039	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs7716222	rs27293	0.962635464471039	Diastolic blood pressure	3e-11	35762941
rs7716222	rs7705093	0.960580274141199	Birdshot chorioretinopathy	2e-09	24957906
rs7716222	rs2910686	0.865502326732507	Neutrophil count	4e-14	32888493
rs7716222	rs2910686	0.865502326732507	Psoriasis	2e-08	23143594
rs7716222	rs2910686	0.865502326732507	Ankylosing spondylitis	5e-17	23749187
rs7716222	rs2910686	0.865502326732507	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs7716222	rs2927608	0.862195667552224	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs7716222	rs2927608	0.862195667552224	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs7716222	rs2927608	0.862195667552224	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs7716222	rs2617439	0.773461950809437	Neutrophil count	8e-11	32888494
rs7716222	rs2549797	0.770362788255454	Systolic blood pressure	7e-07	33230300
rs7716222	rs2549797	0.770362788255454	Diastolic blood pressure	1e-14	33230300
rs7716222	rs2549797	0.770362788255454	Diastolic blood pressure	3e-11	33230300
rs7716222	rs2549797	0.770362788255454	Systolic blood pressure	4e-09	33230300
rs7716222	rs2549782	0.769106102408256	Systolic blood pressure	6e-07	33230300
rs7716222	rs2549782	0.769106102408256	Diastolic blood pressure	1e-14	33230300
rs7716222	rs2549782	0.769106102408256	Diastolic blood pressure	3e-11	33230300
rs7716222	rs2549782	0.769106102408256	Systolic blood pressure	5e-09	33230300
rs7716222	rs1056893	0.768478601429482	Systolic blood pressure	1e-06	33230300
rs7716222	rs1056893	0.768478601429482	Diastolic blood pressure	7e-15	33230300
rs7716222	rs1056893	0.768478601429482	Diastolic blood pressure	2e-11	33230300
rs7716222	rs1056893	0.768478601429482	Systolic blood pressure	7e-09	33230300
rs7716222	rs2549794	0.763982638939035	Crohn's disease	1e-10	21102463
rs7716222	rs2549794	0.763982638939035	Systolic blood pressure	1e-07	33230300
rs7716222	rs2549794	0.763982638939035	Diastolic blood pressure	1e-15	33230300
rs7716222	rs2549794	0.763982638939035	Diastolic blood pressure	2e-12	33230300
rs7716222	rs2549794	0.763982638939035	Systolic blood pressure	4e-10	33230300
rs7716222	rs38029	0.761765052048952	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs7716222	rs1363907	0.759356007782661	Crohn's disease	4e-16	26192919
rs7716222	rs1363907	0.759356007782661	Ulcerative colitis	4e-06	26192919
rs7716222	rs1363907	0.759356007782661	Inflammatory bowel disease	5e-15	26192919
rs7716222	rs1363907	0.759356007782661	Inflammatory bowel disease	6e-13	23128233
rs7716222	rs1363907	0.759356007782661	Inflammatory bowel disease	1e-10	28067908
rs7716222	rs1363907	0.759356007782661	Crohn's disease	1e-14	28067908
rs7716222	rs716848	0.731038110787276	Neutrophil percentage of white cells	2e-09	32888494
rs7716222	rs4869313	0.71930476318036	Pediatric autoimmune diseases	9e-08	26301688
rs7716222	rs1559359	0.713064063683641	Diastolic blood pressure	7e-10	34594039
rs7716222	rs2548532	0.686381123733422	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs7716222	rs4869314	0.666100859341923	Arthritis (juvenile idiopathic)	3e-09	33106285
rs7716222	rs4869314	0.666100859341923	Neutrophil count	1e-10	34594039
rs7716222	rs4869314	0.666100859341923	White blood cell count	2e-07	30595370
rs7716222	rs1974871	0.639736915473681	Granulysin levels	5e-13	34648354
rs7716222	rs1019503	0.635411494276772	Systolic blood pressure	2e-06	33230300
rs7716222	rs1019503	0.635411494276772	Diastolic blood pressure	2e-14	33230300
rs7716222	rs1019503	0.635411494276772	Diastolic blood pressure	4e-11	33230300
rs7716222	rs1019503	0.635411494276772	Systolic blood pressure	1e-08	33230300
rs7716222	rs27660	0.632765349861023	Coronary artery disease	3e-08	35915156
rs7716222	rs3096168	0.62801475813717	Aspartate aminotransferase levels	8e-12	33547301
rs7719705	rs2617439	0.978627287730126	Neutrophil count	8e-11	32888494
rs7719705	rs2549794	0.963806597626954	Crohn's disease	1e-10	21102463
rs7719705	rs2549794	0.963806597626954	Systolic blood pressure	1e-07	33230300
rs7719705	rs2549794	0.963806597626954	Diastolic blood pressure	1e-15	33230300
rs7719705	rs2549794	0.963806597626954	Diastolic blood pressure	2e-12	33230300
rs7719705	rs2549794	0.963806597626954	Systolic blood pressure	4e-10	33230300
rs7719705	rs38029	0.95941688080861	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs7719705	rs1363907	0.958582890704554	Crohn's disease	4e-16	26192919
rs7719705	rs1363907	0.958582890704554	Ulcerative colitis	4e-06	26192919
rs7719705	rs1363907	0.958582890704554	Inflammatory bowel disease	5e-15	26192919
rs7719705	rs1363907	0.958582890704554	Inflammatory bowel disease	6e-13	23128233
rs7719705	rs1363907	0.958582890704554	Inflammatory bowel disease	1e-10	28067908
rs7719705	rs1363907	0.958582890704554	Crohn's disease	1e-14	28067908
rs7719705	rs716848	0.92833563313485	Neutrophil percentage of white cells	2e-09	32888494
rs7719705	rs2548532	0.865919935548517	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs7719705	rs27660	0.795671981039036	Coronary artery disease	3e-08	35915156
rs7719705	rs1423357	0.79402577307296	General cognitive ability	9e-06	29844566
rs7719705	rs2432142	0.783439017539127	Neutrophil count	2e-14	32888493
rs7719705	rs2432142	0.783439017539127	White blood cell count	1e-11	32888493
rs7719705	rs38033	0.781616229751512	Blood protein levels	0	30072576
rs7719705	rs27293	0.766808531578999	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs7719705	rs27293	0.766808531578999	Diastolic blood pressure	3e-11	35762941
rs7719705	rs7705093	0.758771696443555	Birdshot chorioretinopathy	2e-09	24957906
rs7719705	rs4869313	0.698545558920261	Pediatric autoimmune diseases	9e-08	26301688
rs7719705	rs2927608	0.697453143814792	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs7719705	rs2927608	0.697453143814792	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs7719705	rs2927608	0.697453143814792	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs7719705	rs2910686	0.695149049038479	Neutrophil count	4e-14	32888493
rs7719705	rs2910686	0.695149049038479	Psoriasis	2e-08	23143594
rs7719705	rs2910686	0.695149049038479	Ankylosing spondylitis	5e-17	23749187
rs7719705	rs2910686	0.695149049038479	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs7719705	rs1559359	0.636022735067377	Diastolic blood pressure	7e-10	34594039
rs7719705	rs1974871	0.627087513368797	Granulysin levels	5e-13	34648354
rs7719705	rs2549797	0.619366124098394	Systolic blood pressure	7e-07	33230300
rs7719705	rs2549797	0.619366124098394	Diastolic blood pressure	1e-14	33230300
rs7719705	rs2549797	0.619366124098394	Diastolic blood pressure	3e-11	33230300
rs7719705	rs2549797	0.619366124098394	Systolic blood pressure	4e-09	33230300
rs7719705	rs2549782	0.618360033712037	Systolic blood pressure	6e-07	33230300
rs7719705	rs2549782	0.618360033712037	Diastolic blood pressure	1e-14	33230300
rs7719705	rs2549782	0.618360033712037	Diastolic blood pressure	3e-11	33230300
rs7719705	rs2549782	0.618360033712037	Systolic blood pressure	5e-09	33230300
rs7719705	rs1056893	0.617857662551189	Systolic blood pressure	1e-06	33230300
rs7719705	rs1056893	0.617857662551189	Diastolic blood pressure	7e-15	33230300
rs7719705	rs1056893	0.617857662551189	Diastolic blood pressure	2e-11	33230300
rs7719705	rs1056893	0.617857662551189	Systolic blood pressure	7e-09	33230300
rs7721230	rs7721230	1	Skin color	4e-10	36672889
rs7721944	rs1974871	0.916669349652752	Granulysin levels	5e-13	34648354
rs7721944	rs4869314	0.904823271627218	Arthritis (juvenile idiopathic)	3e-09	33106285
rs7721944	rs4869314	0.904823271627218	Neutrophil count	1e-10	34594039
rs7721944	rs4869314	0.904823271627218	White blood cell count	2e-07	30595370
rs7721944	rs2549782	0.85010077253848	Systolic blood pressure	6e-07	33230300
rs7721944	rs2549782	0.85010077253848	Diastolic blood pressure	1e-14	33230300
rs7721944	rs2549782	0.85010077253848	Diastolic blood pressure	3e-11	33230300
rs7721944	rs2549782	0.85010077253848	Systolic blood pressure	5e-09	33230300
rs7721944	rs2549797	0.85008721562494	Systolic blood pressure	7e-07	33230300
rs7721944	rs2549797	0.85008721562494	Diastolic blood pressure	1e-14	33230300
rs7721944	rs2549797	0.85008721562494	Diastolic blood pressure	3e-11	33230300
rs7721944	rs2549797	0.85008721562494	Systolic blood pressure	4e-09	33230300
rs7721944	rs1056893	0.847874009087815	Systolic blood pressure	1e-06	33230300
rs7721944	rs1056893	0.847874009087815	Diastolic blood pressure	7e-15	33230300
rs7721944	rs1056893	0.847874009087815	Diastolic blood pressure	2e-11	33230300
rs7721944	rs1056893	0.847874009087815	Systolic blood pressure	7e-09	33230300
rs7721944	rs4869313	0.829026994780015	Pediatric autoimmune diseases	9e-08	26301688
rs7721944	rs1559359	0.821332617036965	Diastolic blood pressure	7e-10	34594039
rs7721944	rs2910686	0.803215586138696	Neutrophil count	4e-14	32888493
rs7721944	rs2910686	0.803215586138696	Psoriasis	2e-08	23143594
rs7721944	rs2910686	0.803215586138696	Ankylosing spondylitis	5e-17	23749187
rs7721944	rs2910686	0.803215586138696	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs7721944	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs7721944	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs7721944	rs2927608	0.801880093657109	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs7721944	rs1019503	0.728940392110976	Systolic blood pressure	2e-06	33230300
rs7721944	rs1019503	0.728940392110976	Diastolic blood pressure	2e-14	33230300
rs7721944	rs1019503	0.728940392110976	Diastolic blood pressure	4e-11	33230300
rs7721944	rs1019503	0.728940392110976	Systolic blood pressure	1e-08	33230300
rs7721944	rs3096168	0.723409651088165	Aspartate aminotransferase levels	8e-12	33547301
rs7721944	rs1423357	0.704924641235886	General cognitive ability	9e-06	29844566
rs7721944	rs2432142	0.691024795840694	Neutrophil count	2e-14	32888493
rs7721944	rs2432142	0.691024795840694	White blood cell count	1e-11	32888493
rs7721944	rs38033	0.685525237258851	Blood protein levels	0	30072576
rs7721944	rs27293	0.67549231404753	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs7721944	rs27293	0.67549231404753	Diastolic blood pressure	3e-11	35762941
rs7721944	rs7705093	0.666760272686482	Birdshot chorioretinopathy	2e-09	24957906
rs7726445	rs1423357	0.993285967825322	General cognitive ability	9e-06	29844566
rs7726445	rs2432142	0.976585000930904	Neutrophil count	2e-14	32888493
rs7726445	rs2432142	0.976585000930904	White blood cell count	1e-11	32888493
rs7726445	rs38033	0.971751761686874	Blood protein levels	0	30072576
rs7726445	rs27293	0.965938541743268	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs7726445	rs27293	0.965938541743268	Diastolic blood pressure	3e-11	35762941
rs7726445	rs7705093	0.95896457761629	Birdshot chorioretinopathy	2e-09	24957906
rs7726445	rs2910686	0.868667461483031	Neutrophil count	4e-14	32888493
rs7726445	rs2910686	0.868667461483031	Psoriasis	2e-08	23143594
rs7726445	rs2910686	0.868667461483031	Ankylosing spondylitis	5e-17	23749187
rs7726445	rs2910686	0.868667461483031	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs7726445	rs2927608	0.865352436770287	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs7726445	rs2927608	0.865352436770287	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs7726445	rs2927608	0.865352436770287	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs7726445	rs2617439	0.776306321714294	Neutrophil count	8e-11	32888494
rs7726445	rs2549797	0.773394707940612	Systolic blood pressure	7e-07	33230300
rs7726445	rs2549797	0.773394707940612	Diastolic blood pressure	1e-14	33230300
rs7726445	rs2549797	0.773394707940612	Diastolic blood pressure	3e-11	33230300
rs7726445	rs2549797	0.773394707940612	Systolic blood pressure	4e-09	33230300
rs7726445	rs2549782	0.772136236630038	Systolic blood pressure	6e-07	33230300
rs7726445	rs2549782	0.772136236630038	Diastolic blood pressure	1e-14	33230300
rs7726445	rs2549782	0.772136236630038	Diastolic blood pressure	3e-11	33230300
rs7726445	rs2549782	0.772136236630038	Systolic blood pressure	5e-09	33230300
rs7726445	rs1056893	0.771507844098997	Systolic blood pressure	1e-06	33230300
rs7726445	rs1056893	0.771507844098997	Diastolic blood pressure	7e-15	33230300
rs7726445	rs1056893	0.771507844098997	Diastolic blood pressure	2e-11	33230300
rs7726445	rs1056893	0.771507844098997	Systolic blood pressure	7e-09	33230300
rs7726445	rs2549794	0.766812769771518	Crohn's disease	1e-10	21102463
rs7726445	rs2549794	0.766812769771518	Systolic blood pressure	1e-07	33230300
rs7726445	rs2549794	0.766812769771518	Diastolic blood pressure	1e-15	33230300
rs7726445	rs2549794	0.766812769771518	Diastolic blood pressure	2e-12	33230300
rs7726445	rs2549794	0.766812769771518	Systolic blood pressure	4e-10	33230300
rs7726445	rs38029	0.76459041781779	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs7726445	rs1363907	0.762177181350136	Crohn's disease	4e-16	26192919
rs7726445	rs1363907	0.762177181350136	Ulcerative colitis	4e-06	26192919
rs7726445	rs1363907	0.762177181350136	Inflammatory bowel disease	5e-15	26192919
rs7726445	rs1363907	0.762177181350136	Inflammatory bowel disease	6e-13	23128233
rs7726445	rs1363907	0.762177181350136	Inflammatory bowel disease	1e-10	28067908
rs7726445	rs1363907	0.762177181350136	Crohn's disease	1e-14	28067908
rs7726445	rs716848	0.733810324689119	Neutrophil percentage of white cells	2e-09	32888494
rs7726445	rs4869313	0.722132986758308	Pediatric autoimmune diseases	9e-08	26301688
rs7726445	rs1559359	0.715924175309518	Diastolic blood pressure	7e-10	34594039
rs7726445	rs2548532	0.689025410859739	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs7726445	rs4869314	0.668944411273792	Arthritis (juvenile idiopathic)	3e-09	33106285
rs7726445	rs4869314	0.668944411273792	Neutrophil count	1e-10	34594039
rs7726445	rs4869314	0.668944411273792	White blood cell count	2e-07	30595370
rs7726445	rs1974871	0.642434251553665	Granulysin levels	5e-13	34648354
rs7726445	rs1019503	0.638255285167473	Systolic blood pressure	2e-06	33230300
rs7726445	rs1019503	0.638255285167473	Diastolic blood pressure	2e-14	33230300
rs7726445	rs1019503	0.638255285167473	Diastolic blood pressure	4e-11	33230300
rs7726445	rs1019503	0.638255285167473	Systolic blood pressure	1e-08	33230300
rs7726445	rs27660	0.635275987184695	Coronary artery disease	3e-08	35915156
rs7726445	rs3096168	0.63083498337377	Aspartate aminotransferase levels	8e-12	33547301
rs7729404	rs2098713	0.872347813701339	Telomere length	3e-06	24795349
rs7729404	rs150621	0.844785985482525	Appendicular lean mass	5e-12	31761296
rs7729404	rs757720522	0.746681314313141	Appendicular lean mass	3e-11	31761296
rs7729404	rs158791	0.61611300787495	Height	2e-31	36224396
rs7729404	rs300046	0.612515178005869	Meat-related diet	5e-08	32066663
rs7729404	rs292168	0.607220020588302	Red cell distribution width	3e-10	30595370
rs7731592	rs1423357	0.998317853734593	General cognitive ability	9e-06	29844566
rs7731592	rs2432142	0.979903076448935	Neutrophil count	2e-14	32888493
rs7731592	rs2432142	0.979903076448935	White blood cell count	1e-11	32888493
rs7731592	rs38033	0.976746943504716	Blood protein levels	0	30072576
rs7731592	rs27293	0.961008813147851	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs7731592	rs27293	0.961008813147851	Diastolic blood pressure	3e-11	35762941
rs7731592	rs7705093	0.955739508236385	Birdshot chorioretinopathy	2e-09	24957906
rs7731592	rs2910686	0.870362005985193	Neutrophil count	4e-14	32888493
rs7731592	rs2910686	0.870362005985193	Psoriasis	2e-08	23143594
rs7731592	rs2910686	0.870362005985193	Ankylosing spondylitis	5e-17	23749187
rs7731592	rs2910686	0.870362005985193	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs7731592	rs2927608	0.867037828305154	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs7731592	rs2927608	0.867037828305154	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs7731592	rs2927608	0.867037828305154	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs7731592	rs2617439	0.778949186705388	Neutrophil count	8e-11	32888494
rs7731592	rs2549797	0.775120264357445	Systolic blood pressure	7e-07	33230300
rs7731592	rs2549797	0.775120264357445	Diastolic blood pressure	1e-14	33230300
rs7731592	rs2549797	0.775120264357445	Diastolic blood pressure	3e-11	33230300
rs7731592	rs2549797	0.775120264357445	Systolic blood pressure	4e-09	33230300
rs7731592	rs2549782	0.773862135017138	Systolic blood pressure	6e-07	33230300
rs7731592	rs2549782	0.773862135017138	Diastolic blood pressure	1e-14	33230300
rs7731592	rs2549782	0.773862135017138	Diastolic blood pressure	3e-11	33230300
rs7731592	rs2549782	0.773862135017138	Systolic blood pressure	5e-09	33230300
rs7731592	rs1056893	0.773233913230172	Systolic blood pressure	1e-06	33230300
rs7731592	rs1056893	0.773233913230172	Diastolic blood pressure	7e-15	33230300
rs7731592	rs1056893	0.773233913230172	Diastolic blood pressure	2e-11	33230300
rs7731592	rs1056893	0.773233913230172	Systolic blood pressure	7e-09	33230300
rs7731592	rs2549794	0.769455134167988	Crohn's disease	1e-10	21102463
rs7731592	rs2549794	0.769455134167988	Systolic blood pressure	1e-07	33230300
rs7731592	rs2549794	0.769455134167988	Diastolic blood pressure	1e-15	33230300
rs7731592	rs2549794	0.769455134167988	Diastolic blood pressure	2e-12	33230300
rs7731592	rs2549794	0.769455134167988	Systolic blood pressure	4e-10	33230300
rs7731592	rs38029	0.767227196818797	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs7731592	rs1363907	0.764811637891424	Crohn's disease	4e-16	26192919
rs7731592	rs1363907	0.764811637891424	Ulcerative colitis	4e-06	26192919
rs7731592	rs1363907	0.764811637891424	Inflammatory bowel disease	5e-15	26192919
rs7731592	rs1363907	0.764811637891424	Inflammatory bowel disease	6e-13	23128233
rs7731592	rs1363907	0.764811637891424	Inflammatory bowel disease	1e-10	28067908
rs7731592	rs1363907	0.764811637891424	Crohn's disease	1e-14	28067908
rs7731592	rs716848	0.736419006981026	Neutrophil percentage of white cells	2e-09	32888494
rs7731592	rs4869313	0.723535762300838	Pediatric autoimmune diseases	9e-08	26301688
rs7731592	rs1559359	0.717445956515782	Diastolic blood pressure	7e-10	34594039
rs7731592	rs2548532	0.691399748198845	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs7731592	rs4869314	0.670610948932295	Arthritis (juvenile idiopathic)	3e-09	33106285
rs7731592	rs4869314	0.670610948932295	Neutrophil count	1e-10	34594039
rs7731592	rs4869314	0.670610948932295	White blood cell count	2e-07	30595370
rs7731592	rs1974871	0.643852881496451	Granulysin levels	5e-13	34648354
rs7731592	rs1019503	0.640025319989949	Systolic blood pressure	2e-06	33230300
rs7731592	rs1019503	0.640025319989949	Diastolic blood pressure	2e-14	33230300
rs7731592	rs1019503	0.640025319989949	Diastolic blood pressure	4e-11	33230300
rs7731592	rs1019503	0.640025319989949	Systolic blood pressure	1e-08	33230300
rs7731592	rs27660	0.63743061482558	Coronary artery disease	3e-08	35915156
rs7731592	rs3096168	0.632580506857775	Aspartate aminotransferase levels	8e-12	33547301
rs7733312	rs2617439	0.98039959527516	Neutrophil count	8e-11	32888494
rs7733312	rs2549794	0.965560099206159	Crohn's disease	1e-10	21102463
rs7733312	rs2549794	0.965560099206159	Systolic blood pressure	1e-07	33230300
rs7733312	rs2549794	0.965560099206159	Diastolic blood pressure	1e-15	33230300
rs7733312	rs2549794	0.965560099206159	Diastolic blood pressure	2e-12	33230300
rs7733312	rs2549794	0.965560099206159	Systolic blood pressure	4e-10	33230300
rs7733312	rs38029	0.96116663595415	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs7733312	rs1363907	0.960331138538153	Crohn's disease	4e-16	26192919
rs7733312	rs1363907	0.960331138538153	Ulcerative colitis	4e-06	26192919
rs7733312	rs1363907	0.960331138538153	Inflammatory bowel disease	5e-15	26192919
rs7733312	rs1363907	0.960331138538153	Inflammatory bowel disease	6e-13	23128233
rs7733312	rs1363907	0.960331138538153	Inflammatory bowel disease	1e-10	28067908
rs7733312	rs1363907	0.960331138538153	Crohn's disease	1e-14	28067908
rs7733312	rs716848	0.930047094099796	Neutrophil percentage of white cells	2e-09	32888494
rs7733312	rs2548532	0.86761289675747	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs7733312	rs27660	0.797334246799755	Coronary artery disease	3e-08	35915156
rs7733312	rs1423357	0.795573655065789	General cognitive ability	9e-06	29844566
rs7733312	rs2432142	0.784976259229045	Neutrophil count	2e-14	32888493
rs7733312	rs2432142	0.784976259229045	White blood cell count	1e-11	32888493
rs7733312	rs38033	0.783148002959735	Blood protein levels	0	30072576
rs7733312	rs27293	0.768326143314238	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs7733312	rs27293	0.768326143314238	Diastolic blood pressure	3e-11	35762941
rs7733312	rs7705093	0.760277499553252	Birdshot chorioretinopathy	2e-09	24957906
rs7733312	rs4869313	0.699988700766063	Pediatric autoimmune diseases	9e-08	26301688
rs7733312	rs2927608	0.698886471565233	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs7733312	rs2927608	0.698886471565233	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs7733312	rs2927608	0.698886471565233	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs7733312	rs2910686	0.696579618470093	Neutrophil count	4e-14	32888493
rs7733312	rs2910686	0.696579618470093	Psoriasis	2e-08	23143594
rs7733312	rs2910686	0.696579618470093	Ankylosing spondylitis	5e-17	23749187
rs7733312	rs2910686	0.696579618470093	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs7733312	rs1559359	0.637387962244434	Diastolic blood pressure	7e-10	34594039
rs7733312	rs1974871	0.628442789869964	Granulysin levels	5e-13	34648354
rs7733312	rs2549797	0.620705634762726	Systolic blood pressure	7e-07	33230300
rs7733312	rs2549797	0.620705634762726	Diastolic blood pressure	1e-14	33230300
rs7733312	rs2549797	0.620705634762726	Diastolic blood pressure	3e-11	33230300
rs7733312	rs2549797	0.620705634762726	Systolic blood pressure	4e-09	33230300
rs7733312	rs2549782	0.61969834157098	Systolic blood pressure	6e-07	33230300
rs7733312	rs2549782	0.61969834157098	Diastolic blood pressure	1e-14	33230300
rs7733312	rs2549782	0.61969834157098	Diastolic blood pressure	3e-11	33230300
rs7733312	rs2549782	0.61969834157098	Systolic blood pressure	5e-09	33230300
rs7733312	rs1056893	0.619195369810135	Systolic blood pressure	1e-06	33230300
rs7733312	rs1056893	0.619195369810135	Diastolic blood pressure	7e-15	33230300
rs7733312	rs1056893	0.619195369810135	Diastolic blood pressure	2e-11	33230300
rs7733312	rs1056893	0.619195369810135	Systolic blood pressure	7e-09	33230300
rs7738078	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs7738078	rs1063631	0.893273890466454	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs7738078	rs6928810	0.890092667905038	Platelet distribution width	1e-14	32888494
rs7738078	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs7738078	rs3869132	0.889245789558635	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs7738078	rs9266825	0.864263096403477	Autism spectrum disorder	6e-06	35215271
rs7738078	rs199530775	0.740076610728635	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs7738078	rs55957433	0.740076610728635	Hip circumference adjusted for BMI	3e-08	34021172
rs7738078	rs6934175	0.67384422555715	Psoriatic arthritis	5e-28	30552173
rs7738078	rs17200242	0.664511943065584	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs7738078	rs7751505	0.657706582280067	Pubertal anthropometrics	4e-06	23449627
rs7738078	rs35026345	0.65640936672589	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs7738078	rs72848707	0.655066901958558	HDL cholesterol levels	7e-06	35884923
rs7738078	rs13437088	0.631438004864122	Psoriasis	3e-40	23143594
rs7738078	rs13437082	0.630743556638567	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs7738078	rs13437082	0.630743556638567	Height	5e-08	19343178
rs7738078	rs72657657	0.623149040879308	Hip circumference adjusted for BMI	4e-13	34021172
rs7738696	rs10872649	0.606600660247884	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs7738696	rs10872649	0.606600660247884	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs7738696	rs10872649	0.606600660247884	Right hippocampal volume (body)	1e-10	37337106
rs7739003	rs9469872	0.981656215472806	HDL cholesterol levels	3e-11	36333282
rs7739003	rs11755393	0.980844876191681	Body mass index	3e-26	29273807
rs7739003	rs11755393	0.980844876191681	Systemic lupus erythematosus	2e-12	33493351
rs7739003	rs11755393	0.980844876191681	Systemic lupus erythematosus	2e-06	33493351
rs7739003	rs11755393	0.980844876191681	Systemic lupus erythematosus	1e-07	33493351
rs7739003	rs11755393	0.980844876191681	Systemic lupus erythematosus	2e-08	19838195
rs7739003	rs11755393	0.980844876191681	Body mass index	4e-55	36581621
rs7739003	rs9366863	0.971352163102019	Adult body size	9e-33	32376654
rs7739003	rs9366863	0.971352163102019	Body mass index	2e-44	30595370
rs7739003	rs6941110	0.968211716097332	Sex hormone-binding globulin levels	5e-27	36653534
rs7739003	rs9462030	0.950582196127467	Red cell distribution width	5e-25	32888493
rs7739003	rs9469857	0.941265431184422	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7739003	rs2764208	0.940542668883984	Systemic lupus erythematosus	7e-06	24871463
rs7739003	rs2814949	0.934466288936762	Essential hypertension (time to event)	9e-09	32589924
rs7739003	rs9469899	0.933776826324812	Prostate cancer (advanced)	2e-06	29892016
rs7739003	rs9469899	0.933776826324812	Prostate cancer	5e-09	29892016
rs7739003	rs9469899	0.933776826324812	Prostate cancer	8e-11	33398198
rs7739003	rs9469899	0.933776826324812	Hand grip strength	3e-15	29691431
rs7739003	rs9469899	0.933776826324812	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7739003	rs9469899	0.933776826324812	Graves' disease	4e-10	34594039
rs7739003	rs9469899	0.933776826324812	Coronary artery disease	1e-11	36474045
rs7739003	rs9469899	0.933776826324812	Predicted visceral adipose tissue	2e-20	31501611
rs7739003	rs9469899	0.933776826324812	Medication use (thyroid preparations)	2e-09	31015401
rs7739003	rs9469899	0.933776826324812	Medication use (thyroid preparations)	3e-10	34594039
rs7739003	rs2744944	0.925189632379508	Hypothyroidism	3e-10	34594039
rs7739003	rs2744944	0.925189632379508	High density lipoprotein cholesterol levels	3e-86	34887591
rs7739003	rs2744944	0.925189632379508	Multi-trait sex score	7e-22	37277458
rs7739003	rs2263329	0.90605792406099	HDL cholesterol	6e-35	34594039
rs7739003	rs2263329	0.90605792406099	HDL cholesterol levels	8e-43	32203549
rs7739003	rs2263329	0.90605792406099	High density lipoprotein cholesterol levels	2e-52	34887591
rs7739003	rs9296128	0.892963264256922	Hip circumference adjusted for BMI	4e-13	34021172
rs7739003	rs111868030	0.882318275505166	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7739003	rs9368830	0.85852768007331	HDL cholesterol	4e-21	30275531
rs7739003	rs9368828	0.829831722996626	Body mass index	1e-34	34594039
rs7739003	rs6912327	0.825758221304195	Fasting insulin	5e-06	33402679
rs7739003	rs6912327	0.825758221304195	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7739003	rs112283401	0.802992431348129	Red cell distribution width	4e-27	30595370
rs7739003	rs2744973	0.77510055809948	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7739003	rs2744973	0.77510055809948	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7739003	rs2744973	0.77510055809948	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7739003	rs2744973	0.77510055809948	Multi-trait sex score	6e-20	37277458
rs7739003	rs6940215	0.628021541353883	Insomnia	2e-10	35835914
rs7739003	rs6940215	0.628021541353883	Insomnia	1e-13	35835914
rs7739003	rs6940215	0.628021541353883	Hip circumference adjusted for BMI	8e-10	34021172
rs7739003	rs6940215	0.628021541353883	Multi-trait sex score	2e-23	37277458
rs7739003	rs6940215	0.628021541353883	Multi-trait sex score	4e-23	37277458
rs7739003	rs6457796	0.623641284304566	Insomnia	1e-08	30804565
rs7739003	rs6457796	0.623641284304566	Plateletcrit	9e-11	32888494
rs7739003	rs6457796	0.623641284304566	Systemic lupus erythematosus	3e-22	33272962
rs7739003	rs6457796	0.623641284304566	Body mass index	5e-13	30108127
rs7739003	rs6457796	0.623641284304566	Body mass index	1e-14	26426971
rs7739003	rs6457796	0.623641284304566	Educational attainment	5e-19	35361970
rs7739003	rs9469918	0.605232112941401	Hip circumference adjusted for BMI	8e-09	34021172
rs7739003	rs9469918	0.605232112941401	Hip circumference adjusted for BMI	2e-08	34021172
rs7739003	rs9469918	0.605232112941401	Multi-trait sex score	4e-08	37277458
rs7739766	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7739766	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs7739766	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs7739766	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs7739766	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs7739766	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs7739766	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs7739766	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7739766	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs7739766	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs7739766	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs7739766	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs7739766	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs7739766	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs7739766	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs7739766	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs7739766	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs7739766	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs7739766	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs7739766	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs7739766	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs7739766	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs7739766	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs7739766	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs7739766	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs7739766	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs7739766	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs7739766	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs7739766	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs7739766	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs7739766	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs7739766	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7739766	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs7739766	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs7739766	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7739766	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7739766	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7739766	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs7739766	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs7739766	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7739766	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs7739766	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs7739771	rs9462030	0.962041376960364	Red cell distribution width	5e-25	32888493
rs7739771	rs9469857	0.954213293572495	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7739771	rs2764208	0.953468659123264	Systemic lupus erythematosus	7e-06	24871463
rs7739771	rs9469899	0.945308979745132	Prostate cancer (advanced)	2e-06	29892016
rs7739771	rs9469899	0.945308979745132	Prostate cancer	5e-09	29892016
rs7739771	rs9469899	0.945308979745132	Prostate cancer	8e-11	33398198
rs7739771	rs9469899	0.945308979745132	Hand grip strength	3e-15	29691431
rs7739771	rs9469899	0.945308979745132	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7739771	rs9469899	0.945308979745132	Graves' disease	4e-10	34594039
rs7739771	rs9469899	0.945308979745132	Coronary artery disease	1e-11	36474045
rs7739771	rs9469899	0.945308979745132	Predicted visceral adipose tissue	2e-20	31501611
rs7739771	rs9469899	0.945308979745132	Medication use (thyroid preparations)	2e-09	31015401
rs7739771	rs9469899	0.945308979745132	Medication use (thyroid preparations)	3e-10	34594039
rs7739771	rs9469872	0.918160297978079	HDL cholesterol levels	3e-11	36333282
rs7739771	rs11755393	0.914506748912101	Body mass index	3e-26	29273807
rs7739771	rs11755393	0.914506748912101	Systemic lupus erythematosus	2e-12	33493351
rs7739771	rs11755393	0.914506748912101	Systemic lupus erythematosus	2e-06	33493351
rs7739771	rs11755393	0.914506748912101	Systemic lupus erythematosus	1e-07	33493351
rs7739771	rs11755393	0.914506748912101	Systemic lupus erythematosus	2e-08	19838195
rs7739771	rs11755393	0.914506748912101	Body mass index	4e-55	36581621
rs7739771	rs9366863	0.908167155792052	Adult body size	9e-33	32376654
rs7739771	rs9366863	0.908167155792052	Body mass index	2e-44	30595370
rs7739771	rs9296128	0.90519267285778	Hip circumference adjusted for BMI	4e-13	34021172
rs7739771	rs6941110	0.903568887091945	Sex hormone-binding globulin levels	5e-27	36653534
rs7739771	rs2814949	0.872591452233302	Essential hypertension (time to event)	9e-09	32589924
rs7739771	rs2744944	0.863548022076558	Hypothyroidism	3e-10	34594039
rs7739771	rs2744944	0.863548022076558	High density lipoprotein cholesterol levels	3e-86	34887591
rs7739771	rs2744944	0.863548022076558	Multi-trait sex score	7e-22	37277458
rs7739771	rs2263329	0.846408383040484	HDL cholesterol	6e-35	34594039
rs7739771	rs2263329	0.846408383040484	HDL cholesterol levels	8e-43	32203549
rs7739771	rs2263329	0.846408383040484	High density lipoprotein cholesterol levels	2e-52	34887591
rs7739771	rs111868030	0.822655673149564	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7739771	rs9368830	0.801326416549888	HDL cholesterol	4e-21	30275531
rs7739771	rs9368828	0.778286430150428	Body mass index	1e-34	34594039
rs7739771	rs2744973	0.775626888501588	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7739771	rs2744973	0.775626888501588	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7739771	rs2744973	0.775626888501588	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7739771	rs2744973	0.775626888501588	Multi-trait sex score	6e-20	37277458
rs7739771	rs6912327	0.767167784755893	Fasting insulin	5e-06	33402679
rs7739771	rs6912327	0.767167784755893	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7739771	rs112283401	0.742425501388951	Red cell distribution width	4e-27	30595370
rs7739771	rs9689160	0.608618841343267	Lung function (forced vital capacity)	3e-14	36914875
rs7740278	rs11155671	0.971799362470499	Testicular germ cell tumor	2e-09	28604728
rs7740278	rs4380763	0.958249787826776	Subcortical volume (min-P)	1e-11	32665545
rs7740278	rs1934534	0.957457014135757	Pain (pleiotropy)	2e-08	37844115
rs7740278	rs1934534	0.957457014135757	Pain (pleiotropy)	2e-06	37844115
rs7740278	rs9505982	0.955446828181742	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs7740278	rs80147756	0.918495932435042	HippSubfield lh volume subiculum-head	3e-10	33875891
rs7740278	rs4421206	0.911063327073208	Brain morphology (min-P)	4e-11	32665545
rs7740278	rs9688452	0.891347550408488	Brainstem global volume Whole-brainstem	1e-11	33875891
rs7740278	rs9688452	0.891347550408488	aseg lh volume VentralDC	2e-10	33875891
rs7740278	rs10872649	0.84299143464069	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs7740278	rs10872649	0.84299143464069	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs7740278	rs10872649	0.84299143464069	Right hippocampal volume (body)	1e-10	37337106
rs7740278	rs9322194	0.810482332703351	Brainstem volume	2e-11	31636452
rs7740278	rs7752089	0.809822461281229	Brain morphology (MOSTest)	2e-31	35164939
rs7740278	rs9285521	0.689175221395524	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs7740278	rs12526675	0.638488676256763	Brain morphology (MOSTest)	7e-22	32665545
rs7740278	rs9688809	0.624108312928625	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs7740278	rs34337297	0.621095895535714	Serum levels of protein LRP11	3e-161	35078996
rs7740278	rs10872645	0.620318949521393	Blood protein levels	2e-86	30072576
rs7740278	rs14314	0.619297996800855	Macular thickness	3e-19	30535121
rs7740278	rs14314	0.619297996800855	Vertex-wise sulcal depth	7e-17	34910505
rs7740278	rs14314	0.619297996800855	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs7740278	rs14314	0.619297996800855	Left hippocampal volume (body)	7e-15	37337106
rs7740278	rs14314	0.619297996800855	Left subiculum volume (body)	1e-14	37337106
rs7740278	rs55763431	0.618973844977658	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs7740278	rs9322193	0.618501926151653	Lung cancer	1e-07	27393504
rs7740278	rs9689694	0.617836608907475	Right hippocampal volume (head)	6e-11	37337106
rs7740278	rs9689694	0.617836608907475	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs7740278	rs9689694	0.617836608907475	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs7740278	rs9689694	0.617836608907475	Left hippocampal volume (head)	6e-12	37337106
rs7740278	rs9383843	0.616493795593185	Migraine	1e-09	35115687
rs7740278	rs2095375	0.615926103303159	Serum metabolite levels	1e-20	33031748
rs7740278	rs2095375	0.615926103303159	Serum metabolite levels	1e-20	33031748
rs7740278	rs10872653	0.613658727742065	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs7740278	rs9688867	0.613369906623763	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs7740278	rs9688867	0.613369906623763	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs7741398	rs9366863	0.976905974503215	Adult body size	9e-33	32376654
rs7741398	rs9366863	0.976905974503215	Body mass index	2e-44	30595370
rs7741398	rs2744944	0.974549724767472	Hypothyroidism	3e-10	34594039
rs7741398	rs2744944	0.974549724767472	High density lipoprotein cholesterol levels	3e-86	34887591
rs7741398	rs2744944	0.974549724767472	Multi-trait sex score	7e-22	37277458
rs7741398	rs9469872	0.966624823310536	HDL cholesterol levels	3e-11	36333282
rs7741398	rs2814949	0.965158790147529	Essential hypertension (time to event)	9e-09	32589924
rs7741398	rs2263329	0.949956546490169	HDL cholesterol	6e-35	34594039
rs7741398	rs2263329	0.949956546490169	HDL cholesterol levels	8e-43	32203549
rs7741398	rs2263329	0.949956546490169	High density lipoprotein cholesterol levels	2e-52	34887591
rs7741398	rs11755393	0.941097788423148	Body mass index	3e-26	29273807
rs7741398	rs11755393	0.941097788423148	Systemic lupus erythematosus	2e-12	33493351
rs7741398	rs11755393	0.941097788423148	Systemic lupus erythematosus	2e-06	33493351
rs7741398	rs11755393	0.941097788423148	Systemic lupus erythematosus	1e-07	33493351
rs7741398	rs11755393	0.941097788423148	Systemic lupus erythematosus	2e-08	19838195
rs7741398	rs11755393	0.941097788423148	Body mass index	4e-55	36581621
rs7741398	rs6941110	0.931294938456749	Sex hormone-binding globulin levels	5e-27	36653534
rs7741398	rs111868030	0.92593936088498	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7741398	rs9469857	0.925764553094458	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7741398	rs2764208	0.925002840258633	Systemic lupus erythematosus	7e-06	24871463
rs7741398	rs9462030	0.911849863439748	Red cell distribution width	5e-25	32888493
rs7741398	rs9469899	0.895867919971406	Prostate cancer (advanced)	2e-06	29892016
rs7741398	rs9469899	0.895867919971406	Prostate cancer	5e-09	29892016
rs7741398	rs9469899	0.895867919971406	Prostate cancer	8e-11	33398198
rs7741398	rs9469899	0.895867919971406	Hand grip strength	3e-15	29691431
rs7741398	rs9469899	0.895867919971406	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7741398	rs9469899	0.895867919971406	Graves' disease	4e-10	34594039
rs7741398	rs9469899	0.895867919971406	Coronary artery disease	1e-11	36474045
rs7741398	rs9469899	0.895867919971406	Predicted visceral adipose tissue	2e-20	31501611
rs7741398	rs9469899	0.895867919971406	Medication use (thyroid preparations)	2e-09	31015401
rs7741398	rs9469899	0.895867919971406	Medication use (thyroid preparations)	3e-10	34594039
rs7741398	rs9368830	0.889153655425209	HDL cholesterol	4e-21	30275531
rs7741398	rs9296128	0.876836175886098	Hip circumference adjusted for BMI	4e-13	34021172
rs7741398	rs9368828	0.876056093245606	Body mass index	1e-34	34594039
rs7741398	rs2744973	0.798134559160619	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7741398	rs2744973	0.798134559160619	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7741398	rs2744973	0.798134559160619	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7741398	rs2744973	0.798134559160619	Multi-trait sex score	6e-20	37277458
rs7741398	rs6912327	0.789845886126972	Fasting insulin	5e-06	33402679
rs7741398	rs6912327	0.789845886126972	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7741398	rs112283401	0.764722222010188	Red cell distribution width	4e-27	30595370
rs7741398	rs205262	0.621178036572398	Body mass index	2e-09	26961502
rs7741398	rs205262	0.621178036572398	Walking pace	4e-10	33128006
rs7741398	rs205262	0.621178036572398	Body mass index	8e-13	30108127
rs7741398	rs205262	0.621178036572398	Body mass index	2e-09	25673413
rs7741398	rs205262	0.621178036572398	Body mass index	2e-14	26426971
rs7741398	rs205262	0.621178036572398	BMI in non-smokers	3e-07	28443625
rs7741398	rs205262	0.621178036572398	BMI in non-smokers	6e-09	28443625
rs7741398	rs205262	0.621178036572398	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs7741398	rs205262	0.621178036572398	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs7741398	rs205262	0.621178036572398	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs7741398	rs205262	0.621178036572398	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs7741398	rs205262	0.621178036572398	Gastroesophageal reflux disease	1e-10	34187846
rs7741398	rs205262	0.621178036572398	Body mass index	3e-10	25673413
rs7741398	rs205262	0.621178036572398	Body mass index	2e-10	25673413
rs7741398	rs205262	0.621178036572398	ICD10 M54: Dorsalgia	2e-12	35110524
rs7741398	rs6940215	0.617253492987436	Insomnia	2e-10	35835914
rs7741398	rs6940215	0.617253492987436	Insomnia	1e-13	35835914
rs7741398	rs6940215	0.617253492987436	Hip circumference adjusted for BMI	8e-10	34021172
rs7741398	rs6940215	0.617253492987436	Multi-trait sex score	2e-23	37277458
rs7741398	rs6940215	0.617253492987436	Multi-trait sex score	4e-23	37277458
rs7741398	rs6457796	0.607007233097428	Insomnia	1e-08	30804565
rs7741398	rs6457796	0.607007233097428	Plateletcrit	9e-11	32888494
rs7741398	rs6457796	0.607007233097428	Systemic lupus erythematosus	3e-22	33272962
rs7741398	rs6457796	0.607007233097428	Body mass index	5e-13	30108127
rs7741398	rs6457796	0.607007233097428	Body mass index	1e-14	26426971
rs7741398	rs6457796	0.607007233097428	Educational attainment	5e-19	35361970
rs7741437	rs9469872	0.998394044555158	HDL cholesterol levels	3e-11	36333282
rs7741437	rs11755393	0.972191494663217	Body mass index	3e-26	29273807
rs7741437	rs11755393	0.972191494663217	Systemic lupus erythematosus	2e-12	33493351
rs7741437	rs11755393	0.972191494663217	Systemic lupus erythematosus	2e-06	33493351
rs7741437	rs11755393	0.972191494663217	Systemic lupus erythematosus	1e-07	33493351
rs7741437	rs11755393	0.972191494663217	Systemic lupus erythematosus	2e-08	19838195
rs7741437	rs11755393	0.972191494663217	Body mass index	4e-55	36581621
rs7741437	rs9366863	0.968905389782434	Adult body size	9e-33	32376654
rs7741437	rs9366863	0.968905389782434	Body mass index	2e-44	30595370
rs7741437	rs6941110	0.961014536054212	Sex hormone-binding globulin levels	5e-27	36653534
rs7741437	rs9469857	0.957430241065828	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7741437	rs2764208	0.956688621501686	Systemic lupus erythematosus	7e-06	24871463
rs7741437	rs9462030	0.943249855180756	Red cell distribution width	5e-25	32888493
rs7741437	rs2744944	0.941416618774382	Hypothyroidism	3e-10	34594039
rs7741437	rs2744944	0.941416618774382	High density lipoprotein cholesterol levels	3e-86	34887591
rs7741437	rs2744944	0.941416618774382	Multi-trait sex score	7e-22	37277458
rs7741437	rs2814949	0.932112280228606	Essential hypertension (time to event)	9e-09	32589924
rs7741437	rs9469899	0.926664914053113	Prostate cancer (advanced)	2e-06	29892016
rs7741437	rs9469899	0.926664914053113	Prostate cancer	5e-09	29892016
rs7741437	rs9469899	0.926664914053113	Prostate cancer	8e-11	33398198
rs7741437	rs9469899	0.926664914053113	Hand grip strength	3e-15	29691431
rs7741437	rs9469899	0.926664914053113	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7741437	rs9469899	0.926664914053113	Graves' disease	4e-10	34594039
rs7741437	rs9469899	0.926664914053113	Coronary artery disease	1e-11	36474045
rs7741437	rs9469899	0.926664914053113	Predicted visceral adipose tissue	2e-20	31501611
rs7741437	rs9469899	0.926664914053113	Medication use (thyroid preparations)	2e-09	31015401
rs7741437	rs9469899	0.926664914053113	Medication use (thyroid preparations)	3e-10	34594039
rs7741437	rs2263329	0.918952564094578	HDL cholesterol	6e-35	34594039
rs7741437	rs2263329	0.918952564094578	HDL cholesterol levels	8e-43	32203549
rs7741437	rs2263329	0.918952564094578	High density lipoprotein cholesterol levels	2e-52	34887591
rs7741437	rs9296128	0.90842424848005	Hip circumference adjusted for BMI	4e-13	34021172
rs7741437	rs111868030	0.89768257356005	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7741437	rs9368830	0.856690094205737	HDL cholesterol	4e-21	30275531
rs7741437	rs9368828	0.845024785173927	Body mass index	1e-34	34594039
rs7741437	rs6912327	0.818052127940994	Fasting insulin	5e-06	33402679
rs7741437	rs6912327	0.818052127940994	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7741437	rs112283401	0.795388673802119	Red cell distribution width	4e-27	30595370
rs7741437	rs2744973	0.771660289190377	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7741437	rs2744973	0.771660289190377	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7741437	rs2744973	0.771660289190377	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7741437	rs2744973	0.771660289190377	Multi-trait sex score	6e-20	37277458
rs7741437	rs6940215	0.624379848759855	Insomnia	2e-10	35835914
rs7741437	rs6940215	0.624379848759855	Insomnia	1e-13	35835914
rs7741437	rs6940215	0.624379848759855	Hip circumference adjusted for BMI	8e-10	34021172
rs7741437	rs6940215	0.624379848759855	Multi-trait sex score	2e-23	37277458
rs7741437	rs6940215	0.624379848759855	Multi-trait sex score	4e-23	37277458
rs7741437	rs6457796	0.615403088028926	Insomnia	1e-08	30804565
rs7741437	rs6457796	0.615403088028926	Plateletcrit	9e-11	32888494
rs7741437	rs6457796	0.615403088028926	Systemic lupus erythematosus	3e-22	33272962
rs7741437	rs6457796	0.615403088028926	Body mass index	5e-13	30108127
rs7741437	rs6457796	0.615403088028926	Body mass index	1e-14	26426971
rs7741437	rs6457796	0.615403088028926	Educational attainment	5e-19	35361970
rs7741437	rs205262	0.602339102119846	Body mass index	2e-09	26961502
rs7741437	rs205262	0.602339102119846	Walking pace	4e-10	33128006
rs7741437	rs205262	0.602339102119846	Body mass index	8e-13	30108127
rs7741437	rs205262	0.602339102119846	Body mass index	2e-09	25673413
rs7741437	rs205262	0.602339102119846	Body mass index	2e-14	26426971
rs7741437	rs205262	0.602339102119846	BMI in non-smokers	3e-07	28443625
rs7741437	rs205262	0.602339102119846	BMI in non-smokers	6e-09	28443625
rs7741437	rs205262	0.602339102119846	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs7741437	rs205262	0.602339102119846	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs7741437	rs205262	0.602339102119846	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs7741437	rs205262	0.602339102119846	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs7741437	rs205262	0.602339102119846	Gastroesophageal reflux disease	1e-10	34187846
rs7741437	rs205262	0.602339102119846	Body mass index	3e-10	25673413
rs7741437	rs205262	0.602339102119846	Body mass index	2e-10	25673413
rs7741437	rs205262	0.602339102119846	ICD10 M54: Dorsalgia	2e-12	35110524
rs7742519	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs7742519	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs7742519	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs7742519	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs7742519	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs7742519	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs7742519	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs7742519	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs7742519	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs7742519	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs7742519	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs7742519	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs7742519	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs7742519	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs7742519	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs7742519	rs13437082	0.631513452560533	Height	5e-08	19343178
rs7742519	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs7742652	rs9366863	0.98640321691723	Adult body size	9e-33	32376654
rs7742652	rs9366863	0.98640321691723	Body mass index	2e-44	30595370
rs7742652	rs2814949	0.974550258207417	Essential hypertension (time to event)	9e-09	32589924
rs7742652	rs2744944	0.964974007220799	Hypothyroidism	3e-10	34594039
rs7742652	rs2744944	0.964974007220799	High density lipoprotein cholesterol levels	3e-86	34887591
rs7742652	rs2744944	0.964974007220799	Multi-trait sex score	7e-22	37277458
rs7742652	rs9469872	0.957091433770284	HDL cholesterol levels	3e-11	36333282
rs7742652	rs11755393	0.950313015413274	Body mass index	3e-26	29273807
rs7742652	rs11755393	0.950313015413274	Systemic lupus erythematosus	2e-12	33493351
rs7742652	rs11755393	0.950313015413274	Systemic lupus erythematosus	2e-06	33493351
rs7742652	rs11755393	0.950313015413274	Systemic lupus erythematosus	1e-07	33493351
rs7742652	rs11755393	0.950313015413274	Systemic lupus erythematosus	2e-08	19838195
rs7742652	rs11755393	0.950313015413274	Body mass index	4e-55	36581621
rs7742652	rs2263329	0.94369513984496	HDL cholesterol	6e-35	34594039
rs7742652	rs2263329	0.94369513984496	HDL cholesterol levels	8e-43	32203549
rs7742652	rs2263329	0.94369513984496	High density lipoprotein cholesterol levels	2e-52	34887591
rs7742652	rs6941110	0.940603104421497	Sex hormone-binding globulin levels	5e-27	36653534
rs7742652	rs9462030	0.921226633225148	Red cell distribution width	5e-25	32888493
rs7742652	rs111868030	0.917019400601132	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7742652	rs9469857	0.916621859863398	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7742652	rs2764208	0.915874340163255	Systemic lupus erythematosus	7e-06	24871463
rs7742652	rs9469899	0.905036111416476	Prostate cancer (advanced)	2e-06	29892016
rs7742652	rs9469899	0.905036111416476	Prostate cancer	5e-09	29892016
rs7742652	rs9469899	0.905036111416476	Prostate cancer	8e-11	33398198
rs7742652	rs9469899	0.905036111416476	Hand grip strength	3e-15	29691431
rs7742652	rs9469899	0.905036111416476	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7742652	rs9469899	0.905036111416476	Graves' disease	4e-10	34594039
rs7742652	rs9469899	0.905036111416476	Coronary artery disease	1e-11	36474045
rs7742652	rs9469899	0.905036111416476	Predicted visceral adipose tissue	2e-20	31501611
rs7742652	rs9469899	0.905036111416476	Medication use (thyroid preparations)	2e-09	31015401
rs7742652	rs9469899	0.905036111416476	Medication use (thyroid preparations)	3e-10	34594039
rs7742652	rs9368830	0.897814454059437	HDL cholesterol	4e-21	30275531
rs7742652	rs9296128	0.868176240660314	Hip circumference adjusted for BMI	4e-13	34021172
rs7742652	rs9368828	0.867133462776909	Body mass index	1e-34	34594039
rs7742652	rs2744973	0.807849697235997	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7742652	rs2744973	0.807849697235997	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7742652	rs2744973	0.807849697235997	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7742652	rs2744973	0.807849697235997	Multi-trait sex score	6e-20	37277458
rs7742652	rs6912327	0.799303137926815	Fasting insulin	5e-06	33402679
rs7742652	rs6912327	0.799303137926815	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7742652	rs112283401	0.774034460423479	Red cell distribution width	4e-27	30595370
rs7742652	rs6940215	0.626320440962521	Insomnia	2e-10	35835914
rs7742652	rs6940215	0.626320440962521	Insomnia	1e-13	35835914
rs7742652	rs6940215	0.626320440962521	Hip circumference adjusted for BMI	8e-10	34021172
rs7742652	rs6940215	0.626320440962521	Multi-trait sex score	2e-23	37277458
rs7742652	rs6940215	0.626320440962521	Multi-trait sex score	4e-23	37277458
rs7742652	rs6457796	0.616635544055677	Insomnia	1e-08	30804565
rs7742652	rs6457796	0.616635544055677	Plateletcrit	9e-11	32888494
rs7742652	rs6457796	0.616635544055677	Systemic lupus erythematosus	3e-22	33272962
rs7742652	rs6457796	0.616635544055677	Body mass index	5e-13	30108127
rs7742652	rs6457796	0.616635544055677	Body mass index	1e-14	26426971
rs7742652	rs6457796	0.616635544055677	Educational attainment	5e-19	35361970
rs7742652	rs205262	0.615166896887907	Body mass index	2e-09	26961502
rs7742652	rs205262	0.615166896887907	Walking pace	4e-10	33128006
rs7742652	rs205262	0.615166896887907	Body mass index	8e-13	30108127
rs7742652	rs205262	0.615166896887907	Body mass index	2e-09	25673413
rs7742652	rs205262	0.615166896887907	Body mass index	2e-14	26426971
rs7742652	rs205262	0.615166896887907	BMI in non-smokers	3e-07	28443625
rs7742652	rs205262	0.615166896887907	BMI in non-smokers	6e-09	28443625
rs7742652	rs205262	0.615166896887907	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs7742652	rs205262	0.615166896887907	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs7742652	rs205262	0.615166896887907	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs7742652	rs205262	0.615166896887907	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs7742652	rs205262	0.615166896887907	Gastroesophageal reflux disease	1e-10	34187846
rs7742652	rs205262	0.615166896887907	Body mass index	3e-10	25673413
rs7742652	rs205262	0.615166896887907	Body mass index	2e-10	25673413
rs7742652	rs205262	0.615166896887907	ICD10 M54: Dorsalgia	2e-12	35110524
rs7743746	rs12210271	0.923643041145466	ACE-inhibitor discontinuation	1e-19	35751511
rs7744015	rs10872653	0.996398963379575	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs7744015	rs55763431	0.995508517308269	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs7744015	rs9689694	0.993707610711994	Right hippocampal volume (head)	6e-11	37337106
rs7744015	rs9689694	0.993707610711994	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs7744015	rs9689694	0.993707610711994	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs7744015	rs9689694	0.993707610711994	Left hippocampal volume (head)	6e-12	37337106
rs7744015	rs2095375	0.991013810602254	Serum metabolite levels	1e-20	33031748
rs7744015	rs2095375	0.991013810602254	Serum metabolite levels	1e-20	33031748
rs7744015	rs9383843	0.990119838616633	Migraine	1e-09	35115687
rs7744015	rs10872645	0.988335114239339	Blood protein levels	2e-86	30072576
rs7744015	rs9688867	0.987491421814693	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs7744015	rs9688867	0.987491421814693	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs7744015	rs9688809	0.987491421814693	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs7744015	rs34337297	0.983860681246269	Serum levels of protein LRP11	3e-161	35078996
rs7744015	rs14314	0.97237068229241	Macular thickness	3e-19	30535121
rs7744015	rs14314	0.97237068229241	Vertex-wise sulcal depth	7e-17	34910505
rs7744015	rs14314	0.97237068229241	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs7744015	rs14314	0.97237068229241	Left hippocampal volume (body)	7e-15	37337106
rs7744015	rs14314	0.97237068229241	Left subiculum volume (body)	1e-14	37337106
rs7744015	rs9322193	0.947828234863957	Lung cancer	1e-07	27393504
rs7744015	rs4039600	0.904010090256514	Adenine levels	1e-11	35347128
rs7744015	rs1934534	0.639075075721001	Pain (pleiotropy)	2e-08	37844115
rs7744015	rs1934534	0.639075075721001	Pain (pleiotropy)	2e-06	37844115
rs7744015	rs4380763	0.638554621082928	Subcortical volume (min-P)	1e-11	32665545
rs7744015	rs11155671	0.628128244412566	Testicular germ cell tumor	2e-09	28604728
rs7744015	rs80147756	0.613282304302921	HippSubfield lh volume subiculum-head	3e-10	33875891
rs7744015	rs4421206	0.605718731517047	Brain morphology (min-P)	4e-11	32665545
rs7744454	rs77807794	0.762891094970396	Protein canopy homolog 3 levels	6e-169	34648354
rs7744454	rs115953673	0.762891094970396	Mediator of RNA polymerase II transcription subunit 1 levels	5e-22	34648354
rs7745097	rs9469872	0.98720241099489	HDL cholesterol levels	3e-11	36333282
rs7745097	rs11755393	0.984850809056202	Body mass index	3e-26	29273807
rs7745097	rs11755393	0.984850809056202	Systemic lupus erythematosus	2e-12	33493351
rs7745097	rs11755393	0.984850809056202	Systemic lupus erythematosus	2e-06	33493351
rs7745097	rs11755393	0.984850809056202	Systemic lupus erythematosus	1e-07	33493351
rs7745097	rs11755393	0.984850809056202	Systemic lupus erythematosus	2e-08	19838195
rs7745097	rs11755393	0.984850809056202	Body mass index	4e-55	36581621
rs7745097	rs9366863	0.976860982963086	Adult body size	9e-33	32376654
rs7745097	rs9366863	0.976860982963086	Body mass index	2e-44	30595370
rs7745097	rs6941110	0.973702783416799	Sex hormone-binding globulin levels	5e-27	36653534
rs7745097	rs9462030	0.955940696217343	Red cell distribution width	5e-25	32888493
rs7745097	rs9469857	0.946587798313119	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7745097	rs2764208	0.945856861873276	Systemic lupus erythematosus	7e-06	24871463
rs7745097	rs2814949	0.939888741028689	Essential hypertension (time to event)	9e-09	32589924
rs7745097	rs9469899	0.939150617656352	Prostate cancer (advanced)	2e-06	29892016
rs7745097	rs9469899	0.939150617656352	Prostate cancer	5e-09	29892016
rs7745097	rs9469899	0.939150617656352	Prostate cancer	8e-11	33398198
rs7745097	rs9469899	0.939150617656352	Hand grip strength	3e-15	29691431
rs7745097	rs9469899	0.939150617656352	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7745097	rs9469899	0.939150617656352	Graves' disease	4e-10	34594039
rs7745097	rs9469899	0.939150617656352	Coronary artery disease	1e-11	36474045
rs7745097	rs9469899	0.939150617656352	Predicted visceral adipose tissue	2e-20	31501611
rs7745097	rs9469899	0.939150617656352	Medication use (thyroid preparations)	2e-09	31015401
rs7745097	rs9469899	0.939150617656352	Medication use (thyroid preparations)	3e-10	34594039
rs7745097	rs2744944	0.930563121541505	Hypothyroidism	3e-10	34594039
rs7745097	rs2744944	0.930563121541505	High density lipoprotein cholesterol levels	3e-86	34887591
rs7745097	rs2744944	0.930563121541505	Multi-trait sex score	7e-22	37277458
rs7745097	rs2263329	0.911338067082369	HDL cholesterol	6e-35	34594039
rs7745097	rs2263329	0.911338067082369	HDL cholesterol levels	8e-43	32203549
rs7745097	rs2263329	0.911338067082369	High density lipoprotein cholesterol levels	2e-52	34887591
rs7745097	rs9296128	0.898008968022849	Hip circumference adjusted for BMI	4e-13	34021172
rs7745097	rs111868030	0.887331747144213	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7745097	rs9368830	0.863908938269681	HDL cholesterol	4e-21	30275531
rs7745097	rs9368828	0.83483633935768	Body mass index	1e-34	34594039
rs7745097	rs6912327	0.830416950508655	Fasting insulin	5e-06	33402679
rs7745097	rs6912327	0.830416950508655	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7745097	rs112283401	0.809043683139579	Red cell distribution width	4e-27	30595370
rs7745097	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7745097	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7745097	rs2744973	0.779518782641824	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7745097	rs2744973	0.779518782641824	Multi-trait sex score	6e-20	37277458
rs7745097	rs6940215	0.631797836113969	Insomnia	2e-10	35835914
rs7745097	rs6940215	0.631797836113969	Insomnia	1e-13	35835914
rs7745097	rs6940215	0.631797836113969	Hip circumference adjusted for BMI	8e-10	34021172
rs7745097	rs6940215	0.631797836113969	Multi-trait sex score	2e-23	37277458
rs7745097	rs6940215	0.631797836113969	Multi-trait sex score	4e-23	37277458
rs7745097	rs6457796	0.627184527171391	Insomnia	1e-08	30804565
rs7745097	rs6457796	0.627184527171391	Plateletcrit	9e-11	32888494
rs7745097	rs6457796	0.627184527171391	Systemic lupus erythematosus	3e-22	33272962
rs7745097	rs6457796	0.627184527171391	Body mass index	5e-13	30108127
rs7745097	rs6457796	0.627184527171391	Body mass index	1e-14	26426971
rs7745097	rs6457796	0.627184527171391	Educational attainment	5e-19	35361970
rs7745097	rs9469918	0.602909256276846	Hip circumference adjusted for BMI	8e-09	34021172
rs7745097	rs9469918	0.602909256276846	Hip circumference adjusted for BMI	2e-08	34021172
rs7745097	rs9469918	0.602909256276846	Multi-trait sex score	4e-08	37277458
rs7745097	rs9689160	0.602761401207754	Lung function (forced vital capacity)	3e-14	36914875
rs7745915	rs14314	0.972366829258235	Macular thickness	3e-19	30535121
rs7745915	rs14314	0.972366829258235	Vertex-wise sulcal depth	7e-17	34910505
rs7745915	rs14314	0.972366829258235	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs7745915	rs14314	0.972366829258235	Left hippocampal volume (body)	7e-15	37337106
rs7745915	rs14314	0.972366829258235	Left subiculum volume (body)	1e-14	37337106
rs7745915	rs2095375	0.957273815474007	Serum metabolite levels	1e-20	33031748
rs7745915	rs2095375	0.957273815474007	Serum metabolite levels	1e-20	33031748
rs7745915	rs9383843	0.956398663628019	Migraine	1e-09	35115687
rs7745915	rs55763431	0.952894573474262	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs7745915	rs9689694	0.951126293336113	Right hippocampal volume (head)	6e-11	37337106
rs7745915	rs9689694	0.951126293336113	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs7745915	rs9689694	0.951126293336113	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs7745915	rs9689694	0.951126293336113	Left hippocampal volume (head)	6e-12	37337106
rs7745915	rs10872645	0.949385551015629	Blood protein levels	2e-86	30072576
rs7745915	rs9688867	0.945093583903702	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs7745915	rs9688867	0.945093583903702	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs7745915	rs9688809	0.945093583903702	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs7745915	rs10872653	0.944963376817443	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs7745915	rs34337297	0.941505833989019	Serum levels of protein LRP11	3e-161	35078996
rs7745915	rs9322193	0.908077461139523	Lung cancer	1e-07	27393504
rs7745915	rs4039600	0.864931298525372	Adenine levels	1e-11	35347128
rs7745915	rs1934534	0.628919601490286	Pain (pleiotropy)	2e-08	37844115
rs7745915	rs1934534	0.628919601490286	Pain (pleiotropy)	2e-06	37844115
rs7745915	rs4380763	0.628402609968922	Subcortical volume (min-P)	1e-11	32665545
rs7745915	rs11155671	0.618061041802531	Testicular germ cell tumor	2e-09	28604728
rs7745915	rs80147756	0.603301712341461	HippSubfield lh volume subiculum-head	3e-10	33875891
rs7748203	rs9469872	0.980854703159189	HDL cholesterol levels	3e-11	36333282
rs7748203	rs11755393	0.980052898289887	Body mass index	3e-26	29273807
rs7748203	rs11755393	0.980052898289887	Systemic lupus erythematosus	2e-12	33493351
rs7748203	rs11755393	0.980052898289887	Systemic lupus erythematosus	2e-06	33493351
rs7748203	rs11755393	0.980052898289887	Systemic lupus erythematosus	1e-07	33493351
rs7748203	rs11755393	0.980052898289887	Systemic lupus erythematosus	2e-08	19838195
rs7748203	rs11755393	0.980052898289887	Body mass index	4e-55	36581621
rs7748203	rs9366863	0.970553556312159	Adult body size	9e-33	32376654
rs7748203	rs9366863	0.970553556312159	Body mass index	2e-44	30595370
rs7748203	rs6941110	0.967412944772592	Sex hormone-binding globulin levels	5e-27	36653534
rs7748203	rs9462030	0.94977687859851	Red cell distribution width	5e-25	32888493
rs7748203	rs9469857	0.940462434179581	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7748203	rs2764208	0.939738925342093	Systemic lupus erythematosus	7e-06	24871463
rs7748203	rs2814949	0.933686334550218	Essential hypertension (time to event)	9e-09	32589924
rs7748203	rs9469899	0.932989419591338	Prostate cancer (advanced)	2e-06	29892016
rs7748203	rs9469899	0.932989419591338	Prostate cancer	5e-09	29892016
rs7748203	rs9469899	0.932989419591338	Prostate cancer	8e-11	33398198
rs7748203	rs9469899	0.932989419591338	Hand grip strength	3e-15	29691431
rs7748203	rs9469899	0.932989419591338	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7748203	rs9469899	0.932989419591338	Graves' disease	4e-10	34594039
rs7748203	rs9469899	0.932989419591338	Coronary artery disease	1e-11	36474045
rs7748203	rs9469899	0.932989419591338	Predicted visceral adipose tissue	2e-20	31501611
rs7748203	rs9469899	0.932989419591338	Medication use (thyroid preparations)	2e-09	31015401
rs7748203	rs9469899	0.932989419591338	Medication use (thyroid preparations)	3e-10	34594039
rs7748203	rs2744944	0.924409971023974	Hypothyroidism	3e-10	34594039
rs7748203	rs2744944	0.924409971023974	High density lipoprotein cholesterol levels	3e-86	34887591
rs7748203	rs2744944	0.924409971023974	Multi-trait sex score	7e-22	37277458
rs7748203	rs2263329	0.905280198596544	HDL cholesterol	6e-35	34594039
rs7748203	rs2263329	0.905280198596544	HDL cholesterol levels	8e-43	32203549
rs7748203	rs2263329	0.905280198596544	High density lipoprotein cholesterol levels	2e-52	34887591
rs7748203	rs9296128	0.892156945116647	Hip circumference adjusted for BMI	4e-13	34021172
rs7748203	rs111868030	0.881516482714087	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7748203	rs9368830	0.857809338573682	HDL cholesterol	4e-21	30275531
rs7748203	rs9368828	0.829079602775782	Body mass index	1e-34	34594039
rs7748203	rs6912327	0.824946751619628	Fasting insulin	5e-06	33402679
rs7748203	rs6912327	0.824946751619628	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7748203	rs112283401	0.802191946558805	Red cell distribution width	4e-27	30595370
rs7748203	rs2744973	0.774295715530799	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7748203	rs2744973	0.774295715530799	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7748203	rs2744973	0.774295715530799	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7748203	rs2744973	0.774295715530799	Multi-trait sex score	6e-20	37277458
rs7748203	rs6940215	0.627255714255401	Insomnia	2e-10	35835914
rs7748203	rs6940215	0.627255714255401	Insomnia	1e-13	35835914
rs7748203	rs6940215	0.627255714255401	Hip circumference adjusted for BMI	8e-10	34021172
rs7748203	rs6940215	0.627255714255401	Multi-trait sex score	2e-23	37277458
rs7748203	rs6940215	0.627255714255401	Multi-trait sex score	4e-23	37277458
rs7748203	rs6457796	0.622825080434004	Insomnia	1e-08	30804565
rs7748203	rs6457796	0.622825080434004	Plateletcrit	9e-11	32888494
rs7748203	rs6457796	0.622825080434004	Systemic lupus erythematosus	3e-22	33272962
rs7748203	rs6457796	0.622825080434004	Body mass index	5e-13	30108127
rs7748203	rs6457796	0.622825080434004	Body mass index	1e-14	26426971
rs7748203	rs6457796	0.622825080434004	Educational attainment	5e-19	35361970
rs7748203	rs9469918	0.604719940152806	Hip circumference adjusted for BMI	8e-09	34021172
rs7748203	rs9469918	0.604719940152806	Hip circumference adjusted for BMI	2e-08	34021172
rs7748203	rs9469918	0.604719940152806	Multi-trait sex score	4e-08	37277458
rs7752060	rs9469872	0.987997454410153	HDL cholesterol levels	3e-11	36333282
rs7752060	rs11755393	0.982467199215026	Body mass index	3e-26	29273807
rs7752060	rs11755393	0.982467199215026	Systemic lupus erythematosus	2e-12	33493351
rs7752060	rs11755393	0.982467199215026	Systemic lupus erythematosus	2e-06	33493351
rs7752060	rs11755393	0.982467199215026	Systemic lupus erythematosus	1e-07	33493351
rs7752060	rs11755393	0.982467199215026	Systemic lupus erythematosus	2e-08	19838195
rs7752060	rs11755393	0.982467199215026	Body mass index	4e-55	36581621
rs7752060	rs9366863	0.977650668641976	Adult body size	9e-33	32376654
rs7752060	rs9366863	0.977650668641976	Body mass index	2e-44	30595370
rs7752060	rs6941110	0.971319247876054	Sex hormone-binding globulin levels	5e-27	36653534
rs7752060	rs9462030	0.953562975467101	Red cell distribution width	5e-25	32888493
rs7752060	rs9469857	0.947350756083365	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7752060	rs2764208	0.946618647881069	Systemic lupus erythematosus	7e-06	24871463
rs7752060	rs2814949	0.940666046937796	Essential hypertension (time to event)	9e-09	32589924
rs7752060	rs9469899	0.936806463520527	Prostate cancer (advanced)	2e-06	29892016
rs7752060	rs9469899	0.936806463520527	Prostate cancer	5e-09	29892016
rs7752060	rs9469899	0.936806463520527	Prostate cancer	8e-11	33398198
rs7752060	rs9469899	0.936806463520527	Hand grip strength	3e-15	29691431
rs7752060	rs9469899	0.936806463520527	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7752060	rs9469899	0.936806463520527	Graves' disease	4e-10	34594039
rs7752060	rs9469899	0.936806463520527	Coronary artery disease	1e-11	36474045
rs7752060	rs9469899	0.936806463520527	Predicted visceral adipose tissue	2e-20	31501611
rs7752060	rs9469899	0.936806463520527	Medication use (thyroid preparations)	2e-09	31015401
rs7752060	rs9469899	0.936806463520527	Medication use (thyroid preparations)	3e-10	34594039
rs7752060	rs2744944	0.931333408703444	Hypothyroidism	3e-10	34594039
rs7752060	rs2744944	0.931333408703444	High density lipoprotein cholesterol levels	3e-86	34887591
rs7752060	rs2744944	0.931333408703444	Multi-trait sex score	7e-22	37277458
rs7752060	rs2263329	0.91363111290224	HDL cholesterol	6e-35	34594039
rs7752060	rs2263329	0.91363111290224	HDL cholesterol levels	8e-43	32203549
rs7752060	rs2263329	0.91363111290224	High density lipoprotein cholesterol levels	2e-52	34887591
rs7752060	rs9296128	0.898732266280559	Hip circumference adjusted for BMI	4e-13	34021172
rs7752060	rs111868030	0.888050425014223	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7752060	rs9368830	0.866171684418555	HDL cholesterol	4e-21	30275531
rs7752060	rs9368828	0.837024973165691	Body mass index	1e-34	34594039
rs7752060	rs6912327	0.831084776216686	Fasting insulin	5e-06	33402679
rs7752060	rs6912327	0.831084776216686	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7752060	rs112283401	0.805325025742425	Red cell distribution width	4e-27	30595370
rs7752060	rs2744973	0.781592222627146	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7752060	rs2744973	0.781592222627146	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7752060	rs2744973	0.781592222627146	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7752060	rs2744973	0.781592222627146	Multi-trait sex score	6e-20	37277458
rs7752060	rs6940215	0.63364860564249	Insomnia	2e-10	35835914
rs7752060	rs6940215	0.63364860564249	Insomnia	1e-13	35835914
rs7752060	rs6940215	0.63364860564249	Hip circumference adjusted for BMI	8e-10	34021172
rs7752060	rs6940215	0.63364860564249	Multi-trait sex score	2e-23	37277458
rs7752060	rs6940215	0.63364860564249	Multi-trait sex score	4e-23	37277458
rs7752060	rs6457796	0.626367357649597	Insomnia	1e-08	30804565
rs7752060	rs6457796	0.626367357649597	Plateletcrit	9e-11	32888494
rs7752060	rs6457796	0.626367357649597	Systemic lupus erythematosus	3e-22	33272962
rs7752060	rs6457796	0.626367357649597	Body mass index	5e-13	30108127
rs7752060	rs6457796	0.626367357649597	Body mass index	1e-14	26426971
rs7752060	rs6457796	0.626367357649597	Educational attainment	5e-19	35361970
rs7752060	rs9689160	0.604557427689397	Lung function (forced vital capacity)	3e-14	36914875
rs7752089	rs7752089	1	Brain morphology (MOSTest)	2e-31	35164939
rs7752089	rs10872649	0.932037871546205	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs7752089	rs10872649	0.932037871546205	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs7752089	rs10872649	0.932037871546205	Right hippocampal volume (body)	1e-10	37337106
rs7752089	rs1934534	0.833003017682259	Pain (pleiotropy)	2e-08	37844115
rs7752089	rs1934534	0.833003017682259	Pain (pleiotropy)	2e-06	37844115
rs7752089	rs4380763	0.832224857758033	Subcortical volume (min-P)	1e-11	32665545
rs7752089	rs11155671	0.820938388921372	Testicular germ cell tumor	2e-09	28604728
rs7752089	rs9322194	0.813233844884272	Brainstem volume	2e-11	31636452
rs7752089	rs80147756	0.795009014861863	HippSubfield lh volume subiculum-head	3e-10	33875891
rs7752089	rs4421206	0.788851273497562	Brain morphology (min-P)	4e-11	32665545
rs7752089	rs9505982	0.784101216222178	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs7752089	rs9688452	0.766177796886599	Brainstem global volume Whole-brainstem	1e-11	33875891
rs7752089	rs9688452	0.766177796886599	aseg lh volume VentralDC	2e-10	33875891
rs7752089	rs12526675	0.739440649591775	Brain morphology (MOSTest)	7e-22	32665545
rs7752089	rs2342764	0.716331740057949	Cortical thickness	1e-08	34560273
rs7752089	rs9285521	0.689771780601915	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs7752089	rs56103941	0.665859422922109	Right presubiculum volume (head)	4e-08	37337106
rs7752089	rs12523793	0.626089312167094	Subcortical volume (MOSTest)	4e-24	32665545
rs7752089	rs12523793	0.626089312167094	C-reactive protein levels	3e-08	35459240
rs7752089	rs12523793	0.626089312167094	C-reactive protein levels (MTAG)	2e-08	36376304
rs7752089	rs11155662	0.621432010151701	Vertex-wise cortical thickness	2e-09	34910505
rs7752390	rs9469872	0.987997454410153	HDL cholesterol levels	3e-11	36333282
rs7752390	rs11755393	0.982467199215026	Body mass index	3e-26	29273807
rs7752390	rs11755393	0.982467199215026	Systemic lupus erythematosus	2e-12	33493351
rs7752390	rs11755393	0.982467199215026	Systemic lupus erythematosus	2e-06	33493351
rs7752390	rs11755393	0.982467199215026	Systemic lupus erythematosus	1e-07	33493351
rs7752390	rs11755393	0.982467199215026	Systemic lupus erythematosus	2e-08	19838195
rs7752390	rs11755393	0.982467199215026	Body mass index	4e-55	36581621
rs7752390	rs9366863	0.977650668641976	Adult body size	9e-33	32376654
rs7752390	rs9366863	0.977650668641976	Body mass index	2e-44	30595370
rs7752390	rs6941110	0.971319247876054	Sex hormone-binding globulin levels	5e-27	36653534
rs7752390	rs9462030	0.953562975467101	Red cell distribution width	5e-25	32888493
rs7752390	rs9469857	0.947350756083365	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7752390	rs2764208	0.946618647881069	Systemic lupus erythematosus	7e-06	24871463
rs7752390	rs2814949	0.940666046937796	Essential hypertension (time to event)	9e-09	32589924
rs7752390	rs9469899	0.936806463520527	Prostate cancer (advanced)	2e-06	29892016
rs7752390	rs9469899	0.936806463520527	Prostate cancer	5e-09	29892016
rs7752390	rs9469899	0.936806463520527	Prostate cancer	8e-11	33398198
rs7752390	rs9469899	0.936806463520527	Hand grip strength	3e-15	29691431
rs7752390	rs9469899	0.936806463520527	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7752390	rs9469899	0.936806463520527	Graves' disease	4e-10	34594039
rs7752390	rs9469899	0.936806463520527	Coronary artery disease	1e-11	36474045
rs7752390	rs9469899	0.936806463520527	Predicted visceral adipose tissue	2e-20	31501611
rs7752390	rs9469899	0.936806463520527	Medication use (thyroid preparations)	2e-09	31015401
rs7752390	rs9469899	0.936806463520527	Medication use (thyroid preparations)	3e-10	34594039
rs7752390	rs2744944	0.931333408703444	Hypothyroidism	3e-10	34594039
rs7752390	rs2744944	0.931333408703444	High density lipoprotein cholesterol levels	3e-86	34887591
rs7752390	rs2744944	0.931333408703444	Multi-trait sex score	7e-22	37277458
rs7752390	rs2263329	0.91209497337502	HDL cholesterol	6e-35	34594039
rs7752390	rs2263329	0.91209497337502	HDL cholesterol levels	8e-43	32203549
rs7752390	rs2263329	0.91209497337502	High density lipoprotein cholesterol levels	2e-52	34887591
rs7752390	rs9296128	0.898732266280559	Hip circumference adjusted for BMI	4e-13	34021172
rs7752390	rs111868030	0.891095863403195	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7752390	rs9368830	0.864680351855022	HDL cholesterol	4e-21	30275531
rs7752390	rs9368828	0.835553752965987	Body mass index	1e-34	34594039
rs7752390	rs6912327	0.831084776216686	Fasting insulin	5e-06	33402679
rs7752390	rs6912327	0.831084776216686	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7752390	rs112283401	0.805325025742425	Red cell distribution width	4e-27	30595370
rs7752390	rs2744973	0.780152132292118	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7752390	rs2744973	0.780152132292118	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7752390	rs2744973	0.780152132292118	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7752390	rs2744973	0.780152132292118	Multi-trait sex score	6e-20	37277458
rs7752390	rs6940215	0.63233916902788	Insomnia	2e-10	35835914
rs7752390	rs6940215	0.63233916902788	Insomnia	1e-13	35835914
rs7752390	rs6940215	0.63233916902788	Hip circumference adjusted for BMI	8e-10	34021172
rs7752390	rs6940215	0.63233916902788	Multi-trait sex score	2e-23	37277458
rs7752390	rs6940215	0.63233916902788	Multi-trait sex score	4e-23	37277458
rs7752390	rs6457796	0.625043666735023	Insomnia	1e-08	30804565
rs7752390	rs6457796	0.625043666735023	Plateletcrit	9e-11	32888494
rs7752390	rs6457796	0.625043666735023	Systemic lupus erythematosus	3e-22	33272962
rs7752390	rs6457796	0.625043666735023	Body mass index	5e-13	30108127
rs7752390	rs6457796	0.625043666735023	Body mass index	1e-14	26426971
rs7752390	rs6457796	0.625043666735023	Educational attainment	5e-19	35361970
rs7752390	rs9689160	0.603247208840615	Lung function (forced vital capacity)	3e-14	36914875
rs7752502	rs2475792	0.842862444786723	Neutrophil count	1e-08	34594039
rs7752502	rs2475787	0.830049785440779	Neutrophil count	1e-11	32888493
rs7752502	rs4593336	0.751836969415264	Body mass index	2e-08	36581621
rs7752502	rs10806334	0.728958500978309	White blood cell count	4e-12	32888493
rs7752502	rs10806334	0.728958500978309	Neutrophil count	9e-12	32888493
rs7752502	rs10806334	0.728958500978309	White blood cell count	3e-13	32888493
rs7752522	rs9368830	0.963717438332222	HDL cholesterol	4e-21	30275531
rs7752522	rs9469872	0.887942145272753	HDL cholesterol levels	3e-11	36333282
rs7752522	rs9366863	0.882782717423228	Adult body size	9e-33	32376654
rs7752522	rs9366863	0.882782717423228	Body mass index	2e-44	30595370
rs7752522	rs11755393	0.881704018168647	Body mass index	3e-26	29273807
rs7752522	rs11755393	0.881704018168647	Systemic lupus erythematosus	2e-12	33493351
rs7752522	rs11755393	0.881704018168647	Systemic lupus erythematosus	2e-06	33493351
rs7752522	rs11755393	0.881704018168647	Systemic lupus erythematosus	1e-07	33493351
rs7752522	rs11755393	0.881704018168647	Systemic lupus erythematosus	2e-08	19838195
rs7752522	rs11755393	0.881704018168647	Body mass index	4e-55	36581621
rs7752522	rs6941110	0.872431470511486	Sex hormone-binding globulin levels	5e-27	36653534
rs7752522	rs9462030	0.857064299893611	Red cell distribution width	5e-25	32888493
rs7752522	rs9469857	0.851333400479943	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7752522	rs2764208	0.850748746272164	Systemic lupus erythematosus	7e-06	24871463
rs7752522	rs2814949	0.847264679727539	Essential hypertension (time to event)	9e-09	32589924
rs7752522	rs9469899	0.840034745950353	Prostate cancer (advanced)	2e-06	29892016
rs7752522	rs9469899	0.840034745950353	Prostate cancer	5e-09	29892016
rs7752522	rs9469899	0.840034745950353	Prostate cancer	8e-11	33398198
rs7752522	rs9469899	0.840034745950353	Hand grip strength	3e-15	29691431
rs7752522	rs9469899	0.840034745950353	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7752522	rs9469899	0.840034745950353	Graves' disease	4e-10	34594039
rs7752522	rs9469899	0.840034745950353	Coronary artery disease	1e-11	36474045
rs7752522	rs9469899	0.840034745950353	Predicted visceral adipose tissue	2e-20	31501611
rs7752522	rs9469899	0.840034745950353	Medication use (thyroid preparations)	2e-09	31015401
rs7752522	rs9469899	0.840034745950353	Medication use (thyroid preparations)	3e-10	34594039
rs7752522	rs2744944	0.838794593972064	Hypothyroidism	3e-10	34594039
rs7752522	rs2744944	0.838794593972064	High density lipoprotein cholesterol levels	3e-86	34887591
rs7752522	rs2744944	0.838794593972064	Multi-trait sex score	7e-22	37277458
rs7752522	rs2263329	0.822650621227355	HDL cholesterol	6e-35	34594039
rs7752522	rs2263329	0.822650621227355	HDL cholesterol levels	8e-43	32203549
rs7752522	rs2263329	0.822650621227355	High density lipoprotein cholesterol levels	2e-52	34887591
rs7752522	rs9296128	0.807706004987684	Hip circumference adjusted for BMI	4e-13	34021172
rs7752522	rs111868030	0.801926665340812	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7752522	rs9368828	0.752222895263632	Body mass index	1e-34	34594039
rs7752522	rs6912327	0.748440450444776	Fasting insulin	5e-06	33402679
rs7752522	rs6912327	0.748440450444776	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7752522	rs112283401	0.722655112999146	Red cell distribution width	4e-27	30595370
rs7752522	rs2744973	0.705899008002596	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7752522	rs2744973	0.705899008002596	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7752522	rs2744973	0.705899008002596	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7752522	rs2744973	0.705899008002596	Multi-trait sex score	6e-20	37277458
rs7752522	rs3800458	0.632365857585724	Insomnia	7e-11	35835914
rs7752522	rs3800458	0.632365857585724	Insomnia	2e-12	35835914
rs7754399	rs56103941	0.975797619055237	Right presubiculum volume (head)	4e-08	37337106
rs7754399	rs12523793	0.943306592008487	Subcortical volume (MOSTest)	4e-24	32665545
rs7754399	rs12523793	0.943306592008487	C-reactive protein levels	3e-08	35459240
rs7754399	rs12523793	0.943306592008487	C-reactive protein levels (MTAG)	2e-08	36376304
rs7754399	rs11155662	0.933646489870218	Vertex-wise cortical thickness	2e-09	34910505
rs7754399	rs12526675	0.885546403113708	Brain morphology (MOSTest)	7e-22	32665545
rs7754399	rs2342764	0.820894742749552	Cortical thickness	1e-08	34560273
rs7754399	rs58189451	0.758426371134177	Drinks per week	1e-09	36477530
rs7754399	rs9285521	0.749178880694259	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs7754399	rs7752089	0.658438678524193	Brain morphology (MOSTest)	2e-31	35164939
rs7754399	rs9322194	0.657956736017351	Brainstem volume	2e-11	31636452
rs7754399	rs1125	0.640894265433069	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs7754399	rs1125	0.640894265433069	Vertical cup-disc ratio	8e-14	34077760
rs7754399	rs11155675	0.638359474403794	Brain region volumes	3e-09	31676860
rs7754399	rs10872649	0.632732424215739	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs7754399	rs10872649	0.632732424215739	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs7754399	rs10872649	0.632732424215739	Right hippocampal volume (body)	1e-10	37337106
rs7754399	rs9371201	0.626865814819767	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs7754399	rs4421206	0.619865733778783	Brain morphology (min-P)	4e-11	32665545
rs7754399	rs9688452	0.603242577110133	Brainstem global volume Whole-brainstem	1e-11	33875891
rs7754399	rs9688452	0.603242577110133	aseg lh volume VentralDC	2e-10	33875891
rs7755982	rs2764208	1	Systemic lupus erythematosus	7e-06	24871463
rs7755982	rs9469857	0.994363579966998	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7755982	rs9462030	0.979948846273265	Red cell distribution width	5e-25	32888493
rs7755982	rs9469899	0.96354553338453	Prostate cancer (advanced)	2e-06	29892016
rs7755982	rs9469899	0.96354553338453	Prostate cancer	5e-09	29892016
rs7755982	rs9469899	0.96354553338453	Prostate cancer	8e-11	33398198
rs7755982	rs9469899	0.96354553338453	Hand grip strength	3e-15	29691431
rs7755982	rs9469899	0.96354553338453	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7755982	rs9469899	0.96354553338453	Graves' disease	4e-10	34594039
rs7755982	rs9469899	0.96354553338453	Coronary artery disease	1e-11	36474045
rs7755982	rs9469899	0.96354553338453	Predicted visceral adipose tissue	2e-20	31501611
rs7755982	rs9469899	0.96354553338453	Medication use (thyroid preparations)	2e-09	31015401
rs7755982	rs9469899	0.96354553338453	Medication use (thyroid preparations)	3e-10	34594039
rs7755982	rs9469872	0.958227492160117	HDL cholesterol levels	3e-11	36333282
rs7755982	rs9296128	0.94325488802781	Hip circumference adjusted for BMI	4e-13	34021172
rs7755982	rs11755393	0.933006118158596	Body mass index	3e-26	29273807
rs7755982	rs11755393	0.933006118158596	Systemic lupus erythematosus	2e-12	33493351
rs7755982	rs11755393	0.933006118158596	Systemic lupus erythematosus	2e-06	33493351
rs7755982	rs11755393	0.933006118158596	Systemic lupus erythematosus	1e-07	33493351
rs7755982	rs11755393	0.933006118158596	Systemic lupus erythematosus	2e-08	19838195
rs7755982	rs11755393	0.933006118158596	Body mass index	4e-55	36581621
rs7755982	rs9366863	0.929232788778709	Adult body size	9e-33	32376654
rs7755982	rs9366863	0.929232788778709	Body mass index	2e-44	30595370
rs7755982	rs6941110	0.921417496348263	Sex hormone-binding globulin levels	5e-27	36653534
rs7755982	rs2744944	0.902320101561385	Hypothyroidism	3e-10	34594039
rs7755982	rs2744944	0.902320101561385	High density lipoprotein cholesterol levels	3e-86	34887591
rs7755982	rs2744944	0.902320101561385	Multi-trait sex score	7e-22	37277458
rs7755982	rs2814949	0.893373793948083	Essential hypertension (time to event)	9e-09	32589924
rs7755982	rs2263329	0.879983684454224	HDL cholesterol	6e-35	34594039
rs7755982	rs2263329	0.879983684454224	HDL cholesterol levels	8e-43	32203549
rs7755982	rs2263329	0.879983684454224	High density lipoprotein cholesterol levels	2e-52	34887591
rs7755982	rs111868030	0.85881241867559	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7755982	rs9368830	0.821112992491793	HDL cholesterol	4e-21	30275531
rs7755982	rs9368828	0.811578256757851	Body mass index	1e-34	34594039
rs7755982	rs2744973	0.789742920777674	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7755982	rs2744973	0.789742920777674	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7755982	rs2744973	0.789742920777674	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7755982	rs2744973	0.789742920777674	Multi-trait sex score	6e-20	37277458
rs7755982	rs6912327	0.777573531539846	Fasting insulin	5e-06	33402679
rs7755982	rs6912327	0.777573531539846	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7755982	rs112283401	0.755458408444623	Red cell distribution width	4e-27	30595370
rs7755982	rs9689160	0.61683561435316	Lung function (forced vital capacity)	3e-14	36914875
rs7756009	rs2764208	1	Systemic lupus erythematosus	7e-06	24871463
rs7756009	rs9469857	0.994363579966998	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7756009	rs9462030	0.979948846273265	Red cell distribution width	5e-25	32888493
rs7756009	rs9469899	0.96354553338453	Prostate cancer (advanced)	2e-06	29892016
rs7756009	rs9469899	0.96354553338453	Prostate cancer	5e-09	29892016
rs7756009	rs9469899	0.96354553338453	Prostate cancer	8e-11	33398198
rs7756009	rs9469899	0.96354553338453	Hand grip strength	3e-15	29691431
rs7756009	rs9469899	0.96354553338453	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7756009	rs9469899	0.96354553338453	Graves' disease	4e-10	34594039
rs7756009	rs9469899	0.96354553338453	Coronary artery disease	1e-11	36474045
rs7756009	rs9469899	0.96354553338453	Predicted visceral adipose tissue	2e-20	31501611
rs7756009	rs9469899	0.96354553338453	Medication use (thyroid preparations)	2e-09	31015401
rs7756009	rs9469899	0.96354553338453	Medication use (thyroid preparations)	3e-10	34594039
rs7756009	rs9469872	0.958227492160117	HDL cholesterol levels	3e-11	36333282
rs7756009	rs9296128	0.94325488802781	Hip circumference adjusted for BMI	4e-13	34021172
rs7756009	rs11755393	0.933006118158596	Body mass index	3e-26	29273807
rs7756009	rs11755393	0.933006118158596	Systemic lupus erythematosus	2e-12	33493351
rs7756009	rs11755393	0.933006118158596	Systemic lupus erythematosus	2e-06	33493351
rs7756009	rs11755393	0.933006118158596	Systemic lupus erythematosus	1e-07	33493351
rs7756009	rs11755393	0.933006118158596	Systemic lupus erythematosus	2e-08	19838195
rs7756009	rs11755393	0.933006118158596	Body mass index	4e-55	36581621
rs7756009	rs9366863	0.929232788778709	Adult body size	9e-33	32376654
rs7756009	rs9366863	0.929232788778709	Body mass index	2e-44	30595370
rs7756009	rs6941110	0.921417496348263	Sex hormone-binding globulin levels	5e-27	36653534
rs7756009	rs2744944	0.902320101561385	Hypothyroidism	3e-10	34594039
rs7756009	rs2744944	0.902320101561385	High density lipoprotein cholesterol levels	3e-86	34887591
rs7756009	rs2744944	0.902320101561385	Multi-trait sex score	7e-22	37277458
rs7756009	rs2814949	0.893373793948083	Essential hypertension (time to event)	9e-09	32589924
rs7756009	rs2263329	0.879983684454224	HDL cholesterol	6e-35	34594039
rs7756009	rs2263329	0.879983684454224	HDL cholesterol levels	8e-43	32203549
rs7756009	rs2263329	0.879983684454224	High density lipoprotein cholesterol levels	2e-52	34887591
rs7756009	rs111868030	0.85881241867559	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7756009	rs9368830	0.821112992491793	HDL cholesterol	4e-21	30275531
rs7756009	rs9368828	0.811578256757851	Body mass index	1e-34	34594039
rs7756009	rs2744973	0.789742920777674	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7756009	rs2744973	0.789742920777674	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7756009	rs2744973	0.789742920777674	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7756009	rs2744973	0.789742920777674	Multi-trait sex score	6e-20	37277458
rs7756009	rs6912327	0.777573531539846	Fasting insulin	5e-06	33402679
rs7756009	rs6912327	0.777573531539846	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7756009	rs112283401	0.755458408444623	Red cell distribution width	4e-27	30595370
rs7756009	rs9689160	0.61683561435316	Lung function (forced vital capacity)	3e-14	36914875
rs7757839	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs7757839	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs7757839	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs7757839	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs7757839	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs7757839	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs7757839	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs7757839	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs7757839	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs7757839	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs7757839	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs7757839	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs7757839	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs7757839	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs7757839	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs7757839	rs13437082	0.631513452560533	Height	5e-08	19343178
rs7757839	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs7758082	rs9366863	0.989593473986964	Adult body size	9e-33	32376654
rs7758082	rs9366863	0.989593473986964	Body mass index	2e-44	30595370
rs7758082	rs9469872	0.979223155906725	HDL cholesterol levels	3e-11	36333282
rs7758082	rs11755393	0.97216554178395	Body mass index	3e-26	29273807
rs7758082	rs11755393	0.97216554178395	Systemic lupus erythematosus	2e-12	33493351
rs7758082	rs11755393	0.97216554178395	Systemic lupus erythematosus	2e-06	33493351
rs7758082	rs11755393	0.97216554178395	Systemic lupus erythematosus	1e-07	33493351
rs7758082	rs11755393	0.97216554178395	Systemic lupus erythematosus	2e-08	19838195
rs7758082	rs11755393	0.97216554178395	Body mass index	4e-55	36581621
rs7758082	rs6941110	0.961033074196894	Sex hormone-binding globulin levels	5e-27	36653534
rs7758082	rs2814949	0.952385938151561	Essential hypertension (time to event)	9e-09	32589924
rs7758082	rs9462030	0.943319382561512	Red cell distribution width	5e-25	32888493
rs7758082	rs2744944	0.942988446505634	Hypothyroidism	3e-10	34594039
rs7758082	rs2744944	0.942988446505634	High density lipoprotein cholesterol levels	3e-86	34887591
rs7758082	rs2744944	0.942988446505634	Multi-trait sex score	7e-22	37277458
rs7758082	rs9469857	0.938693871095708	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7758082	rs2764208	0.937961221662211	Systemic lupus erythematosus	7e-06	24871463
rs7758082	rs9469899	0.926694649027276	Prostate cancer (advanced)	2e-06	29892016
rs7758082	rs9469899	0.926694649027276	Prostate cancer	5e-09	29892016
rs7758082	rs9469899	0.926694649027276	Prostate cancer	8e-11	33398198
rs7758082	rs9469899	0.926694649027276	Hand grip strength	3e-15	29691431
rs7758082	rs9469899	0.926694649027276	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7758082	rs9469899	0.926694649027276	Graves' disease	4e-10	34594039
rs7758082	rs9469899	0.926694649027276	Coronary artery disease	1e-11	36474045
rs7758082	rs9469899	0.926694649027276	Predicted visceral adipose tissue	2e-20	31501611
rs7758082	rs9469899	0.926694649027276	Medication use (thyroid preparations)	2e-09	31015401
rs7758082	rs9469899	0.926694649027276	Medication use (thyroid preparations)	3e-10	34594039
rs7758082	rs2263329	0.923618130738164	HDL cholesterol	6e-35	34594039
rs7758082	rs2263329	0.923618130738164	HDL cholesterol levels	8e-43	32203549
rs7758082	rs2263329	0.923618130738164	High density lipoprotein cholesterol levels	2e-52	34887591
rs7758082	rs111868030	0.899374032541085	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7758082	rs9296128	0.890210177635162	Hip circumference adjusted for BMI	4e-13	34021172
rs7758082	rs9368830	0.875978647639277	HDL cholesterol	4e-21	30275531
rs7758082	rs9368828	0.846568603146329	Body mass index	1e-34	34594039
rs7758082	rs6912327	0.818334482335467	Fasting insulin	5e-06	33402679
rs7758082	rs6912327	0.818334482335467	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7758082	rs112283401	0.795668588671549	Red cell distribution width	4e-27	30595370
rs7758082	rs2744973	0.790727212265839	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7758082	rs2744973	0.790727212265839	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7758082	rs2744973	0.790727212265839	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7758082	rs2744973	0.790727212265839	Multi-trait sex score	6e-20	37277458
rs7758082	rs6940215	0.632656094665775	Insomnia	2e-10	35835914
rs7758082	rs6940215	0.632656094665775	Insomnia	1e-13	35835914
rs7758082	rs6940215	0.632656094665775	Hip circumference adjusted for BMI	8e-10	34021172
rs7758082	rs6940215	0.632656094665775	Multi-trait sex score	2e-23	37277458
rs7758082	rs6940215	0.632656094665775	Multi-trait sex score	4e-23	37277458
rs7758082	rs6457796	0.62391996973048	Insomnia	1e-08	30804565
rs7758082	rs6457796	0.62391996973048	Plateletcrit	9e-11	32888494
rs7758082	rs6457796	0.62391996973048	Systemic lupus erythematosus	3e-22	33272962
rs7758082	rs6457796	0.62391996973048	Body mass index	5e-13	30108127
rs7758082	rs6457796	0.62391996973048	Body mass index	1e-14	26426971
rs7758082	rs6457796	0.62391996973048	Educational attainment	5e-19	35361970
rs7758082	rs205262	0.604308053498877	Body mass index	2e-09	26961502
rs7758082	rs205262	0.604308053498877	Walking pace	4e-10	33128006
rs7758082	rs205262	0.604308053498877	Body mass index	8e-13	30108127
rs7758082	rs205262	0.604308053498877	Body mass index	2e-09	25673413
rs7758082	rs205262	0.604308053498877	Body mass index	2e-14	26426971
rs7758082	rs205262	0.604308053498877	BMI in non-smokers	3e-07	28443625
rs7758082	rs205262	0.604308053498877	BMI in non-smokers	6e-09	28443625
rs7758082	rs205262	0.604308053498877	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs7758082	rs205262	0.604308053498877	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs7758082	rs205262	0.604308053498877	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs7758082	rs205262	0.604308053498877	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs7758082	rs205262	0.604308053498877	Gastroesophageal reflux disease	1e-10	34187846
rs7758082	rs205262	0.604308053498877	Body mass index	3e-10	25673413
rs7758082	rs205262	0.604308053498877	Body mass index	2e-10	25673413
rs7758082	rs205262	0.604308053498877	ICD10 M54: Dorsalgia	2e-12	35110524
rs7758082	rs9689160	0.603396649398632	Lung function (forced vital capacity)	3e-14	36914875
rs7759071	rs9369898	0.932442652425511	Homocysteine levels	2e-10	23824729
rs7759071	rs2501968	0.834413439328973	Ischemic stroke	1e-08	34594039
rs7759071	rs1471539	0.832405390246373	Mean reticulocyte volume	1e-10	32888494
rs7759071	rs1471539	0.832405390246373	Mean spheric corpuscular volume	8e-13	32888494
rs7759128	rs9366863	0.984799820066226	Adult body size	9e-33	32376654
rs7759128	rs9366863	0.984799820066226	Body mass index	2e-44	30595370
rs7759128	rs2814949	0.972949639692361	Essential hypertension (time to event)	9e-09	32589924
rs7759128	rs2744944	0.963387775228014	Hypothyroidism	3e-10	34594039
rs7759128	rs2744944	0.963387775228014	High density lipoprotein cholesterol levels	3e-86	34887591
rs7759128	rs2744944	0.963387775228014	Multi-trait sex score	7e-22	37277458
rs7759128	rs9469872	0.955512214283181	HDL cholesterol levels	3e-11	36333282
rs7759128	rs11755393	0.948724069155546	Body mass index	3e-26	29273807
rs7759128	rs11755393	0.948724069155546	Systemic lupus erythematosus	2e-12	33493351
rs7759128	rs11755393	0.948724069155546	Systemic lupus erythematosus	2e-06	33493351
rs7759128	rs11755393	0.948724069155546	Systemic lupus erythematosus	1e-07	33493351
rs7759128	rs11755393	0.948724069155546	Systemic lupus erythematosus	2e-08	19838195
rs7759128	rs11755393	0.948724069155546	Body mass index	4e-55	36581621
rs7759128	rs2263329	0.942137719381755	HDL cholesterol	6e-35	34594039
rs7759128	rs2263329	0.942137719381755	HDL cholesterol levels	8e-43	32203549
rs7759128	rs2263329	0.942137719381755	High density lipoprotein cholesterol levels	2e-52	34887591
rs7759128	rs6941110	0.939042679027898	Sex hormone-binding globulin levels	5e-27	36653534
rs7759128	rs9462030	0.919705774777811	Red cell distribution width	5e-25	32888493
rs7759128	rs111868030	0.915541793747365	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7759128	rs9469857	0.915107360082221	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7759128	rs2764208	0.914362191325346	Systemic lupus erythematosus	7e-06	24871463
rs7759128	rs9469899	0.903511197518135	Prostate cancer (advanced)	2e-06	29892016
rs7759128	rs9469899	0.903511197518135	Prostate cancer	5e-09	29892016
rs7759128	rs9469899	0.903511197518135	Prostate cancer	8e-11	33398198
rs7759128	rs9469899	0.903511197518135	Hand grip strength	3e-15	29691431
rs7759128	rs9469899	0.903511197518135	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7759128	rs9469899	0.903511197518135	Graves' disease	4e-10	34594039
rs7759128	rs9469899	0.903511197518135	Coronary artery disease	1e-11	36474045
rs7759128	rs9469899	0.903511197518135	Predicted visceral adipose tissue	2e-20	31501611
rs7759128	rs9469899	0.903511197518135	Medication use (thyroid preparations)	2e-09	31015401
rs7759128	rs9469899	0.903511197518135	Medication use (thyroid preparations)	3e-10	34594039
rs7759128	rs9368830	0.899265385839741	HDL cholesterol	4e-21	30275531
rs7759128	rs9296128	0.866741710422129	Hip circumference adjusted for BMI	4e-13	34021172
rs7759128	rs9368828	0.865655427796958	Body mass index	1e-34	34594039
rs7759128	rs2744973	0.806545606930039	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7759128	rs2744973	0.806545606930039	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7759128	rs2744973	0.806545606930039	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7759128	rs2744973	0.806545606930039	Multi-trait sex score	6e-20	37277458
rs7759128	rs6912327	0.79798175438986	Fasting insulin	5e-06	33402679
rs7759128	rs6912327	0.79798175438986	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7759128	rs112283401	0.772735299084134	Red cell distribution width	4e-27	30595370
rs7759128	rs6940215	0.625232814095914	Insomnia	2e-10	35835914
rs7759128	rs6940215	0.625232814095914	Insomnia	1e-13	35835914
rs7759128	rs6940215	0.625232814095914	Hip circumference adjusted for BMI	8e-10	34021172
rs7759128	rs6940215	0.625232814095914	Multi-trait sex score	2e-23	37277458
rs7759128	rs6940215	0.625232814095914	Multi-trait sex score	4e-23	37277458
rs7759128	rs6457796	0.615619031302034	Insomnia	1e-08	30804565
rs7759128	rs6457796	0.615619031302034	Plateletcrit	9e-11	32888494
rs7759128	rs6457796	0.615619031302034	Systemic lupus erythematosus	3e-22	33272962
rs7759128	rs6457796	0.615619031302034	Body mass index	5e-13	30108127
rs7759128	rs6457796	0.615619031302034	Body mass index	1e-14	26426971
rs7759128	rs6457796	0.615619031302034	Educational attainment	5e-19	35361970
rs7759128	rs205262	0.614171141316183	Body mass index	2e-09	26961502
rs7759128	rs205262	0.614171141316183	Walking pace	4e-10	33128006
rs7759128	rs205262	0.614171141316183	Body mass index	8e-13	30108127
rs7759128	rs205262	0.614171141316183	Body mass index	2e-09	25673413
rs7759128	rs205262	0.614171141316183	Body mass index	2e-14	26426971
rs7759128	rs205262	0.614171141316183	BMI in non-smokers	3e-07	28443625
rs7759128	rs205262	0.614171141316183	BMI in non-smokers	6e-09	28443625
rs7759128	rs205262	0.614171141316183	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs7759128	rs205262	0.614171141316183	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs7759128	rs205262	0.614171141316183	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs7759128	rs205262	0.614171141316183	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs7759128	rs205262	0.614171141316183	Gastroesophageal reflux disease	1e-10	34187846
rs7759128	rs205262	0.614171141316183	Body mass index	3e-10	25673413
rs7759128	rs205262	0.614171141316183	Body mass index	2e-10	25673413
rs7759128	rs205262	0.614171141316183	ICD10 M54: Dorsalgia	2e-12	35110524
rs7759223	rs1063631	0.89243993556192	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs7759223	rs1063631	0.89243993556192	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs7759223	rs6928810	0.889266905277565	Platelet distribution width	1e-14	32888494
rs7759223	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs7759223	rs3869132	0.888417250473819	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs7759223	rs9266825	0.863388785752485	Autism spectrum disorder	6e-06	35215271
rs7759223	rs199530775	0.742257910001364	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs7759223	rs55957433	0.742257910001364	Hip circumference adjusted for BMI	3e-08	34021172
rs7759223	rs6934175	0.675921974207854	Psoriatic arthritis	5e-28	30552173
rs7759223	rs17200242	0.666572918568088	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs7759223	rs7751505	0.659750033979713	Pubertal anthropometrics	4e-06	23449627
rs7759223	rs35026345	0.658450681246847	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs7759223	rs72848707	0.652690496234301	HDL cholesterol levels	7e-06	35884923
rs7759223	rs13437088	0.633437864038569	Psoriasis	3e-40	23143594
rs7759223	rs13437082	0.632742221721105	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs7759223	rs13437082	0.632742221721105	Height	5e-08	19343178
rs7759223	rs72657657	0.62513475842961	Hip circumference adjusted for BMI	4e-13	34021172
rs7759227	rs9469872	0.990405711342429	HDL cholesterol levels	3e-11	36333282
rs7759227	rs11755393	0.983248753744816	Body mass index	3e-26	29273807
rs7759227	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-12	33493351
rs7759227	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-06	33493351
rs7759227	rs11755393	0.983248753744816	Systemic lupus erythematosus	1e-07	33493351
rs7759227	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-08	19838195
rs7759227	rs11755393	0.983248753744816	Body mass index	4e-55	36581621
rs7759227	rs9366863	0.980050279338797	Adult body size	9e-33	32376654
rs7759227	rs9366863	0.980050279338797	Body mass index	2e-44	30595370
rs7759227	rs6941110	0.972130533054557	Sex hormone-binding globulin levels	5e-27	36653534
rs7759227	rs9462030	0.954406403718491	Red cell distribution width	5e-25	32888493
rs7759227	rs9469857	0.949763837643909	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7759227	rs2764208	0.949033981000713	Systemic lupus erythematosus	7e-06	24871463
rs7759227	rs2814949	0.943009894530421	Essential hypertension (time to event)	9e-09	32589924
rs7759227	rs9469899	0.937611946179886	Prostate cancer (advanced)	2e-06	29892016
rs7759227	rs9469899	0.937611946179886	Prostate cancer	5e-09	29892016
rs7759227	rs9469899	0.937611946179886	Prostate cancer	8e-11	33398198
rs7759227	rs9469899	0.937611946179886	Hand grip strength	3e-15	29691431
rs7759227	rs9469899	0.937611946179886	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7759227	rs9469899	0.937611946179886	Graves' disease	4e-10	34594039
rs7759227	rs9469899	0.937611946179886	Coronary artery disease	1e-11	36474045
rs7759227	rs9469899	0.937611946179886	Predicted visceral adipose tissue	2e-20	31501611
rs7759227	rs9469899	0.937611946179886	Medication use (thyroid preparations)	2e-09	31015401
rs7759227	rs9469899	0.937611946179886	Medication use (thyroid preparations)	3e-10	34594039
rs7759227	rs2744944	0.933676458189598	Hypothyroidism	3e-10	34594039
rs7759227	rs2744944	0.933676458189598	High density lipoprotein cholesterol levels	3e-86	34887591
rs7759227	rs2744944	0.933676458189598	Multi-trait sex score	7e-22	37277458
rs7759227	rs2263329	0.914432373659788	HDL cholesterol	6e-35	34594039
rs7759227	rs2263329	0.914432373659788	HDL cholesterol levels	8e-43	32203549
rs7759227	rs2263329	0.914432373659788	High density lipoprotein cholesterol levels	2e-52	34887591
rs7759227	rs9296128	0.901155780048215	Hip circumference adjusted for BMI	4e-13	34021172
rs7759227	rs111868030	0.890460424513595	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7759227	rs9368830	0.866839594529055	HDL cholesterol	4e-21	30275531
rs7759227	rs9368828	0.8378148480019	Body mass index	1e-34	34594039
rs7759227	rs6912327	0.829083022514325	Fasting insulin	5e-06	33402679
rs7759227	rs6912327	0.829083022514325	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7759227	rs112283401	0.806269190971807	Red cell distribution width	4e-27	30595370
rs7759227	rs2744973	0.782572341748002	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7759227	rs2744973	0.782572341748002	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7759227	rs2744973	0.782572341748002	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7759227	rs2744973	0.782572341748002	Multi-trait sex score	6e-20	37277458
rs7759227	rs6940215	0.634643562406843	Insomnia	2e-10	35835914
rs7759227	rs6940215	0.634643562406843	Insomnia	1e-13	35835914
rs7759227	rs6940215	0.634643562406843	Hip circumference adjusted for BMI	8e-10	34021172
rs7759227	rs6940215	0.634643562406843	Multi-trait sex score	2e-23	37277458
rs7759227	rs6940215	0.634643562406843	Multi-trait sex score	4e-23	37277458
rs7759227	rs6457796	0.626169994896438	Insomnia	1e-08	30804565
rs7759227	rs6457796	0.626169994896438	Plateletcrit	9e-11	32888494
rs7759227	rs6457796	0.626169994896438	Systemic lupus erythematosus	3e-22	33272962
rs7759227	rs6457796	0.626169994896438	Body mass index	5e-13	30108127
rs7759227	rs6457796	0.626169994896438	Body mass index	1e-14	26426971
rs7759227	rs6457796	0.626169994896438	Educational attainment	5e-19	35361970
rs7759227	rs9689160	0.605720875679005	Lung function (forced vital capacity)	3e-14	36914875
rs7759227	rs9469918	0.600168366795112	Hip circumference adjusted for BMI	8e-09	34021172
rs7759227	rs9469918	0.600168366795112	Hip circumference adjusted for BMI	2e-08	34021172
rs7759227	rs9469918	0.600168366795112	Multi-trait sex score	4e-08	37277458
rs7759457	rs12210271	0.92275208903282	ACE-inhibitor discontinuation	1e-19	35751511
rs7762644	rs9469857	0.996776778921405	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7762644	rs2764208	0.995972777577403	Systemic lupus erythematosus	7e-06	24871463
rs7762644	rs9462030	0.982341944636037	Red cell distribution width	5e-25	32888493
rs7762644	rs9469899	0.965886102309356	Prostate cancer (advanced)	2e-06	29892016
rs7762644	rs9469899	0.965886102309356	Prostate cancer	5e-09	29892016
rs7762644	rs9469899	0.965886102309356	Prostate cancer	8e-11	33398198
rs7762644	rs9469899	0.965886102309356	Hand grip strength	3e-15	29691431
rs7762644	rs9469899	0.965886102309356	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7762644	rs9469899	0.965886102309356	Graves' disease	4e-10	34594039
rs7762644	rs9469899	0.965886102309356	Coronary artery disease	1e-11	36474045
rs7762644	rs9469899	0.965886102309356	Predicted visceral adipose tissue	2e-20	31501611
rs7762644	rs9469899	0.965886102309356	Medication use (thyroid preparations)	2e-09	31015401
rs7762644	rs9469899	0.965886102309356	Medication use (thyroid preparations)	3e-10	34594039
rs7762644	rs9469872	0.96054887345204	HDL cholesterol levels	3e-11	36333282
rs7762644	rs9296128	0.945681992424858	Hip circumference adjusted for BMI	4e-13	34021172
rs7762644	rs11755393	0.935272594959748	Body mass index	3e-26	29273807
rs7762644	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-12	33493351
rs7762644	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-06	33493351
rs7762644	rs11755393	0.935272594959748	Systemic lupus erythematosus	1e-07	33493351
rs7762644	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-08	19838195
rs7762644	rs11755393	0.935272594959748	Body mass index	4e-55	36581621
rs7762644	rs9366863	0.931525188678084	Adult body size	9e-33	32376654
rs7762644	rs9366863	0.931525188678084	Body mass index	2e-44	30595370
rs7762644	rs6941110	0.923705176714688	Sex hormone-binding globulin levels	5e-27	36653534
rs7762644	rs2744944	0.904579222323617	Hypothyroidism	3e-10	34594039
rs7762644	rs2744944	0.904579222323617	High density lipoprotein cholesterol levels	3e-86	34887591
rs7762644	rs2744944	0.904579222323617	Multi-trait sex score	7e-22	37277458
rs7762644	rs2814949	0.89561287838885	Essential hypertension (time to event)	9e-09	32589924
rs7762644	rs2263329	0.882234019129751	HDL cholesterol	6e-35	34594039
rs7762644	rs2263329	0.882234019129751	HDL cholesterol levels	8e-43	32203549
rs7762644	rs2263329	0.882234019129751	High density lipoprotein cholesterol levels	2e-52	34887591
rs7762644	rs111868030	0.861138045850585	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7762644	rs9368830	0.823175715403171	HDL cholesterol	4e-21	30275531
rs7762644	rs9368828	0.813764410103364	Body mass index	1e-34	34594039
rs7762644	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7762644	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7762644	rs2744973	0.792134506553775	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7762644	rs2744973	0.792134506553775	Multi-trait sex score	6e-20	37277458
rs7762644	rs6912327	0.779895917756941	Fasting insulin	5e-06	33402679
rs7762644	rs6912327	0.779895917756941	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7762644	rs112283401	0.757749108732694	Red cell distribution width	4e-27	30595370
rs7762644	rs9689160	0.619303726608203	Lung function (forced vital capacity)	3e-14	36914875
rs7763224	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7763224	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs7763224	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs7763224	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs7763224	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs7763224	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs7763224	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs7763224	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7763224	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs7763224	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs7763224	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs7763224	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs7763224	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs7763224	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs7763224	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs7763224	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs7763224	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs7763224	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs7763224	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs7763224	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs7763224	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs7763224	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs7763224	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs7763224	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs7763224	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs7763224	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs7763224	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs7763224	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs7763224	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs7763224	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs7763224	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs7763224	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7763224	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs7763224	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs7763224	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7763224	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7763224	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7763224	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs7763224	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs7763224	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7763224	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs7763224	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs7763718	rs9371533	0.830225987231954	Blood protein levels	4e-286	30072576
rs7763719	rs9371533	0.836316828382318	Blood protein levels	4e-286	30072576
rs7763987	rs9366863	0.976905974503215	Adult body size	9e-33	32376654
rs7763987	rs9366863	0.976905974503215	Body mass index	2e-44	30595370
rs7763987	rs2744944	0.974549724767472	Hypothyroidism	3e-10	34594039
rs7763987	rs2744944	0.974549724767472	High density lipoprotein cholesterol levels	3e-86	34887591
rs7763987	rs2744944	0.974549724767472	Multi-trait sex score	7e-22	37277458
rs7763987	rs9469872	0.966624823310536	HDL cholesterol levels	3e-11	36333282
rs7763987	rs2814949	0.965158790147529	Essential hypertension (time to event)	9e-09	32589924
rs7763987	rs2263329	0.949956546490169	HDL cholesterol	6e-35	34594039
rs7763987	rs2263329	0.949956546490169	HDL cholesterol levels	8e-43	32203549
rs7763987	rs2263329	0.949956546490169	High density lipoprotein cholesterol levels	2e-52	34887591
rs7763987	rs11755393	0.941097788423148	Body mass index	3e-26	29273807
rs7763987	rs11755393	0.941097788423148	Systemic lupus erythematosus	2e-12	33493351
rs7763987	rs11755393	0.941097788423148	Systemic lupus erythematosus	2e-06	33493351
rs7763987	rs11755393	0.941097788423148	Systemic lupus erythematosus	1e-07	33493351
rs7763987	rs11755393	0.941097788423148	Systemic lupus erythematosus	2e-08	19838195
rs7763987	rs11755393	0.941097788423148	Body mass index	4e-55	36581621
rs7763987	rs6941110	0.931294938456749	Sex hormone-binding globulin levels	5e-27	36653534
rs7763987	rs111868030	0.92593936088498	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7763987	rs9469857	0.925764553094458	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7763987	rs2764208	0.925002840258633	Systemic lupus erythematosus	7e-06	24871463
rs7763987	rs9462030	0.911849863439748	Red cell distribution width	5e-25	32888493
rs7763987	rs9469899	0.895867919971406	Prostate cancer (advanced)	2e-06	29892016
rs7763987	rs9469899	0.895867919971406	Prostate cancer	5e-09	29892016
rs7763987	rs9469899	0.895867919971406	Prostate cancer	8e-11	33398198
rs7763987	rs9469899	0.895867919971406	Hand grip strength	3e-15	29691431
rs7763987	rs9469899	0.895867919971406	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7763987	rs9469899	0.895867919971406	Graves' disease	4e-10	34594039
rs7763987	rs9469899	0.895867919971406	Coronary artery disease	1e-11	36474045
rs7763987	rs9469899	0.895867919971406	Predicted visceral adipose tissue	2e-20	31501611
rs7763987	rs9469899	0.895867919971406	Medication use (thyroid preparations)	2e-09	31015401
rs7763987	rs9469899	0.895867919971406	Medication use (thyroid preparations)	3e-10	34594039
rs7763987	rs9368830	0.889153655425209	HDL cholesterol	4e-21	30275531
rs7763987	rs9296128	0.876836175886098	Hip circumference adjusted for BMI	4e-13	34021172
rs7763987	rs9368828	0.876056093245606	Body mass index	1e-34	34594039
rs7763987	rs2744973	0.798134559160619	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7763987	rs2744973	0.798134559160619	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7763987	rs2744973	0.798134559160619	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7763987	rs2744973	0.798134559160619	Multi-trait sex score	6e-20	37277458
rs7763987	rs6912327	0.789845886126972	Fasting insulin	5e-06	33402679
rs7763987	rs6912327	0.789845886126972	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7763987	rs112283401	0.764722222010188	Red cell distribution width	4e-27	30595370
rs7763987	rs205262	0.621178036572398	Body mass index	2e-09	26961502
rs7763987	rs205262	0.621178036572398	Walking pace	4e-10	33128006
rs7763987	rs205262	0.621178036572398	Body mass index	8e-13	30108127
rs7763987	rs205262	0.621178036572398	Body mass index	2e-09	25673413
rs7763987	rs205262	0.621178036572398	Body mass index	2e-14	26426971
rs7763987	rs205262	0.621178036572398	BMI in non-smokers	3e-07	28443625
rs7763987	rs205262	0.621178036572398	BMI in non-smokers	6e-09	28443625
rs7763987	rs205262	0.621178036572398	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs7763987	rs205262	0.621178036572398	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs7763987	rs205262	0.621178036572398	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs7763987	rs205262	0.621178036572398	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs7763987	rs205262	0.621178036572398	Gastroesophageal reflux disease	1e-10	34187846
rs7763987	rs205262	0.621178036572398	Body mass index	3e-10	25673413
rs7763987	rs205262	0.621178036572398	Body mass index	2e-10	25673413
rs7763987	rs205262	0.621178036572398	ICD10 M54: Dorsalgia	2e-12	35110524
rs7763987	rs6940215	0.617253492987436	Insomnia	2e-10	35835914
rs7763987	rs6940215	0.617253492987436	Insomnia	1e-13	35835914
rs7763987	rs6940215	0.617253492987436	Hip circumference adjusted for BMI	8e-10	34021172
rs7763987	rs6940215	0.617253492987436	Multi-trait sex score	2e-23	37277458
rs7763987	rs6940215	0.617253492987436	Multi-trait sex score	4e-23	37277458
rs7763987	rs6457796	0.607007233097428	Insomnia	1e-08	30804565
rs7763987	rs6457796	0.607007233097428	Plateletcrit	9e-11	32888494
rs7763987	rs6457796	0.607007233097428	Systemic lupus erythematosus	3e-22	33272962
rs7763987	rs6457796	0.607007233097428	Body mass index	5e-13	30108127
rs7763987	rs6457796	0.607007233097428	Body mass index	1e-14	26426971
rs7763987	rs6457796	0.607007233097428	Educational attainment	5e-19	35361970
rs7764747	rs1173416	0.990246830834469	Height	2e-59	36224396
rs7764747	rs2842611	0.834886762847869	High density lipoprotein cholesterol levels	5e-09	34887591
rs7764747	rs9450288	0.802450442171776	Height	2e-10	36224396
rs7764846	rs14314	0.987481996076704	Macular thickness	3e-19	30535121
rs7764846	rs14314	0.987481996076704	Vertex-wise sulcal depth	7e-17	34910505
rs7764846	rs14314	0.987481996076704	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs7764846	rs14314	0.987481996076704	Left hippocampal volume (body)	7e-15	37337106
rs7764846	rs14314	0.987481996076704	Left subiculum volume (body)	1e-14	37337106
rs7764846	rs2095375	0.972367820814337	Serum metabolite levels	1e-20	33031748
rs7764846	rs2095375	0.972367820814337	Serum metabolite levels	1e-20	33031748
rs7764846	rs9383843	0.971481116124825	Migraine	1e-09	35115687
rs7764846	rs55763431	0.967942526892945	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs7764846	rs9689694	0.966174398643032	Right hippocampal volume (head)	6e-11	37337106
rs7764846	rs9689694	0.966174398643032	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs7764846	rs9689694	0.966174398643032	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs7764846	rs9689694	0.966174398643032	Left hippocampal volume (head)	6e-12	37337106
rs7764846	rs10872645	0.964410621587431	Blood protein levels	2e-86	30072576
rs7764846	rs9688867	0.960038472581801	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs7764846	rs9688867	0.960038472581801	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs7764846	rs9688809	0.960038472581801	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs7764846	rs10872653	0.9600003517025	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs7764846	rs34337297	0.956485107433086	Serum levels of protein LRP11	3e-161	35078996
rs7764846	rs9322193	0.922726809470044	Lung cancer	1e-07	27393504
rs7764846	rs4039600	0.879753696048718	Adenine levels	1e-11	35347128
rs7764846	rs1934534	0.640935673240993	Pain (pleiotropy)	2e-08	37844115
rs7764846	rs1934534	0.640935673240993	Pain (pleiotropy)	2e-06	37844115
rs7764846	rs4380763	0.640411290585095	Subcortical volume (min-P)	1e-11	32665545
rs7764846	rs11155671	0.62996295031936	Testicular germ cell tumor	2e-09	28604728
rs7764846	rs80147756	0.614959526263484	HippSubfield lh volume subiculum-head	3e-10	33875891
rs7764846	rs4421206	0.607327600685935	Brain morphology (min-P)	4e-11	32665545
rs7764846	rs9505982	0.602173265238806	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs7766485	rs2842611	0.923440358542311	High density lipoprotein cholesterol levels	5e-09	34887591
rs7766485	rs1173416	0.908567811575483	Height	2e-59	36224396
rs7766485	rs9450288	0.880391176664865	Height	2e-10	36224396
rs7768189	rs9469872	0.992779971369624	HDL cholesterol levels	3e-11	36333282
rs7768189	rs11755393	0.966679233142281	Body mass index	3e-26	29273807
rs7768189	rs11755393	0.966679233142281	Systemic lupus erythematosus	2e-12	33493351
rs7768189	rs11755393	0.966679233142281	Systemic lupus erythematosus	2e-06	33493351
rs7768189	rs11755393	0.966679233142281	Systemic lupus erythematosus	1e-07	33493351
rs7768189	rs11755393	0.966679233142281	Systemic lupus erythematosus	2e-08	19838195
rs7768189	rs11755393	0.966679233142281	Body mass index	4e-55	36581621
rs7768189	rs9366863	0.963368938430998	Adult body size	9e-33	32376654
rs7768189	rs9366863	0.963368938430998	Body mass index	2e-44	30595370
rs7768189	rs6941110	0.955495512234789	Sex hormone-binding globulin levels	5e-27	36653534
rs7768189	rs9469857	0.951872141933335	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7768189	rs2764208	0.951129119560764	Systemic lupus erythematosus	7e-06	24871463
rs7768189	rs9462030	0.93773645254385	Red cell distribution width	5e-25	32888493
rs7768189	rs2744944	0.935960213867661	Hypothyroidism	3e-10	34594039
rs7768189	rs2744944	0.935960213867661	High density lipoprotein cholesterol levels	3e-86	34887591
rs7768189	rs2744944	0.935960213867661	Multi-trait sex score	7e-22	37277458
rs7768189	rs2814949	0.926693030978477	Essential hypertension (time to event)	9e-09	32589924
rs7768189	rs9469899	0.921235840987846	Prostate cancer (advanced)	2e-06	29892016
rs7768189	rs9469899	0.921235840987846	Prostate cancer	5e-09	29892016
rs7768189	rs9469899	0.921235840987846	Prostate cancer	8e-11	33398198
rs7768189	rs9469899	0.921235840987846	Hand grip strength	3e-15	29691431
rs7768189	rs9469899	0.921235840987846	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7768189	rs9469899	0.921235840987846	Graves' disease	4e-10	34594039
rs7768189	rs9469899	0.921235840987846	Coronary artery disease	1e-11	36474045
rs7768189	rs9469899	0.921235840987846	Predicted visceral adipose tissue	2e-20	31501611
rs7768189	rs9469899	0.921235840987846	Medication use (thyroid preparations)	2e-09	31015401
rs7768189	rs9469899	0.921235840987846	Medication use (thyroid preparations)	3e-10	34594039
rs7768189	rs2263329	0.913541045075245	HDL cholesterol	6e-35	34594039
rs7768189	rs2263329	0.913541045075245	HDL cholesterol levels	8e-43	32203549
rs7768189	rs2263329	0.913541045075245	High density lipoprotein cholesterol levels	2e-52	34887591
rs7768189	rs9296128	0.902927923471963	Hip circumference adjusted for BMI	4e-13	34021172
rs7768189	rs111868030	0.893744004829709	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7768189	rs9368830	0.85158813092319	HDL cholesterol	4e-21	30275531
rs7768189	rs9368828	0.839809995585497	Body mass index	1e-34	34594039
rs7768189	rs6912327	0.812709712702608	Fasting insulin	5e-06	33402679
rs7768189	rs6912327	0.812709712702608	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7768189	rs112283401	0.79012008233362	Red cell distribution width	4e-27	30595370
rs7768189	rs2744973	0.766405944342314	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7768189	rs2744973	0.766405944342314	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7768189	rs2744973	0.766405944342314	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7768189	rs2744973	0.766405944342314	Multi-trait sex score	6e-20	37277458
rs7768189	rs6940215	0.619504351559988	Insomnia	2e-10	35835914
rs7768189	rs6940215	0.619504351559988	Insomnia	1e-13	35835914
rs7768189	rs6940215	0.619504351559988	Hip circumference adjusted for BMI	8e-10	34021172
rs7768189	rs6940215	0.619504351559988	Multi-trait sex score	2e-23	37277458
rs7768189	rs6940215	0.619504351559988	Multi-trait sex score	4e-23	37277458
rs7768189	rs6457796	0.610361628732661	Insomnia	1e-08	30804565
rs7768189	rs6457796	0.610361628732661	Plateletcrit	9e-11	32888494
rs7768189	rs6457796	0.610361628732661	Systemic lupus erythematosus	3e-22	33272962
rs7768189	rs6457796	0.610361628732661	Body mass index	5e-13	30108127
rs7768189	rs6457796	0.610361628732661	Body mass index	1e-14	26426971
rs7768189	rs6457796	0.610361628732661	Educational attainment	5e-19	35361970
rs7768759	rs9469872	0.98720241099489	HDL cholesterol levels	3e-11	36333282
rs7768759	rs11755393	0.984850809056202	Body mass index	3e-26	29273807
rs7768759	rs11755393	0.984850809056202	Systemic lupus erythematosus	2e-12	33493351
rs7768759	rs11755393	0.984850809056202	Systemic lupus erythematosus	2e-06	33493351
rs7768759	rs11755393	0.984850809056202	Systemic lupus erythematosus	1e-07	33493351
rs7768759	rs11755393	0.984850809056202	Systemic lupus erythematosus	2e-08	19838195
rs7768759	rs11755393	0.984850809056202	Body mass index	4e-55	36581621
rs7768759	rs9366863	0.976860982963086	Adult body size	9e-33	32376654
rs7768759	rs9366863	0.976860982963086	Body mass index	2e-44	30595370
rs7768759	rs6941110	0.973702783416799	Sex hormone-binding globulin levels	5e-27	36653534
rs7768759	rs9462030	0.955940696217343	Red cell distribution width	5e-25	32888493
rs7768759	rs9469857	0.946587798313119	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7768759	rs2764208	0.945856861873276	Systemic lupus erythematosus	7e-06	24871463
rs7768759	rs2814949	0.939888741028689	Essential hypertension (time to event)	9e-09	32589924
rs7768759	rs9469899	0.939150617656352	Prostate cancer (advanced)	2e-06	29892016
rs7768759	rs9469899	0.939150617656352	Prostate cancer	5e-09	29892016
rs7768759	rs9469899	0.939150617656352	Prostate cancer	8e-11	33398198
rs7768759	rs9469899	0.939150617656352	Hand grip strength	3e-15	29691431
rs7768759	rs9469899	0.939150617656352	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7768759	rs9469899	0.939150617656352	Graves' disease	4e-10	34594039
rs7768759	rs9469899	0.939150617656352	Coronary artery disease	1e-11	36474045
rs7768759	rs9469899	0.939150617656352	Predicted visceral adipose tissue	2e-20	31501611
rs7768759	rs9469899	0.939150617656352	Medication use (thyroid preparations)	2e-09	31015401
rs7768759	rs9469899	0.939150617656352	Medication use (thyroid preparations)	3e-10	34594039
rs7768759	rs2744944	0.930563121541505	Hypothyroidism	3e-10	34594039
rs7768759	rs2744944	0.930563121541505	High density lipoprotein cholesterol levels	3e-86	34887591
rs7768759	rs2744944	0.930563121541505	Multi-trait sex score	7e-22	37277458
rs7768759	rs2263329	0.911338067082369	HDL cholesterol	6e-35	34594039
rs7768759	rs2263329	0.911338067082369	HDL cholesterol levels	8e-43	32203549
rs7768759	rs2263329	0.911338067082369	High density lipoprotein cholesterol levels	2e-52	34887591
rs7768759	rs9296128	0.898008968022849	Hip circumference adjusted for BMI	4e-13	34021172
rs7768759	rs111868030	0.887331747144213	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7768759	rs9368830	0.863908938269681	HDL cholesterol	4e-21	30275531
rs7768759	rs9368828	0.83483633935768	Body mass index	1e-34	34594039
rs7768759	rs6912327	0.830416950508655	Fasting insulin	5e-06	33402679
rs7768759	rs6912327	0.830416950508655	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7768759	rs112283401	0.809043683139579	Red cell distribution width	4e-27	30595370
rs7768759	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7768759	rs2744973	0.779518782641824	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7768759	rs2744973	0.779518782641824	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7768759	rs2744973	0.779518782641824	Multi-trait sex score	6e-20	37277458
rs7768759	rs6940215	0.631797836113969	Insomnia	2e-10	35835914
rs7768759	rs6940215	0.631797836113969	Insomnia	1e-13	35835914
rs7768759	rs6940215	0.631797836113969	Hip circumference adjusted for BMI	8e-10	34021172
rs7768759	rs6940215	0.631797836113969	Multi-trait sex score	2e-23	37277458
rs7768759	rs6940215	0.631797836113969	Multi-trait sex score	4e-23	37277458
rs7768759	rs6457796	0.627184527171391	Insomnia	1e-08	30804565
rs7768759	rs6457796	0.627184527171391	Plateletcrit	9e-11	32888494
rs7768759	rs6457796	0.627184527171391	Systemic lupus erythematosus	3e-22	33272962
rs7768759	rs6457796	0.627184527171391	Body mass index	5e-13	30108127
rs7768759	rs6457796	0.627184527171391	Body mass index	1e-14	26426971
rs7768759	rs6457796	0.627184527171391	Educational attainment	5e-19	35361970
rs7768759	rs9469918	0.602909256276846	Hip circumference adjusted for BMI	8e-09	34021172
rs7768759	rs9469918	0.602909256276846	Hip circumference adjusted for BMI	2e-08	34021172
rs7768759	rs9469918	0.602909256276846	Multi-trait sex score	4e-08	37277458
rs7768759	rs9689160	0.602761401207754	Lung function (forced vital capacity)	3e-14	36914875
rs7769403	rs3869132	0.838946475328366	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs7769403	rs3869132	0.838946475328366	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs7769403	rs6928810	0.833914499553637	Platelet distribution width	1e-14	32888494
rs7769403	rs199530775	0.732885043072399	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs7769403	rs55957433	0.732885043072399	Hip circumference adjusted for BMI	3e-08	34021172
rs7769403	rs6934175	0.706145688735985	Psoriatic arthritis	5e-28	30552173
rs7769403	rs9266825	0.704096612105333	Autism spectrum disorder	6e-06	35215271
rs7769403	rs17200242	0.692850719641313	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs7769403	rs9469003	0.65965067650598	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	2e-09	21801394
rs7769403	rs4346874	0.659486653030908	Height	2e-125	36224396
rs7769403	rs1063631	0.642973808243753	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs7769403	rs1063631	0.642973808243753	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs7769820	rs9462030	0.991961796545434	Red cell distribution width	5e-25	32888493
rs7769820	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7769820	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs7769820	rs9469899	0.975314640267064	Prostate cancer (advanced)	2e-06	29892016
rs7769820	rs9469899	0.975314640267064	Prostate cancer	5e-09	29892016
rs7769820	rs9469899	0.975314640267064	Prostate cancer	8e-11	33398198
rs7769820	rs9469899	0.975314640267064	Hand grip strength	3e-15	29691431
rs7769820	rs9469899	0.975314640267064	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7769820	rs9469899	0.975314640267064	Graves' disease	4e-10	34594039
rs7769820	rs9469899	0.975314640267064	Coronary artery disease	1e-11	36474045
rs7769820	rs9469899	0.975314640267064	Predicted visceral adipose tissue	2e-20	31501611
rs7769820	rs9469899	0.975314640267064	Medication use (thyroid preparations)	2e-09	31015401
rs7769820	rs9469899	0.975314640267064	Medication use (thyroid preparations)	3e-10	34594039
rs7769820	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs7769820	rs11755393	0.944425765145638	Body mass index	3e-26	29273807
rs7769820	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-12	33493351
rs7769820	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-06	33493351
rs7769820	rs11755393	0.944425765145638	Systemic lupus erythematosus	1e-07	33493351
rs7769820	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-08	19838195
rs7769820	rs11755393	0.944425765145638	Body mass index	4e-55	36581621
rs7769820	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs7769820	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs7769820	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs7769820	rs6941110	0.932921349732261	Sex hormone-binding globulin levels	5e-27	36653534
rs7769820	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs7769820	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs7769820	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs7769820	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs7769820	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs7769820	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs7769820	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs7769820	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7769820	rs9368830	0.831547762090701	HDL cholesterol	4e-21	30275531
rs7769820	rs9368828	0.805103390346437	Body mass index	1e-34	34594039
rs7769820	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7769820	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7769820	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7769820	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs7769820	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs7769820	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7769820	rs112283401	0.766845687865746	Red cell distribution width	4e-27	30595370
rs7769820	rs9689160	0.628913951683802	Lung function (forced vital capacity)	3e-14	36914875
rs7769961	rs9462030	0.991961796545434	Red cell distribution width	5e-25	32888493
rs7769961	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7769961	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs7769961	rs9469899	0.975314640267064	Prostate cancer (advanced)	2e-06	29892016
rs7769961	rs9469899	0.975314640267064	Prostate cancer	5e-09	29892016
rs7769961	rs9469899	0.975314640267064	Prostate cancer	8e-11	33398198
rs7769961	rs9469899	0.975314640267064	Hand grip strength	3e-15	29691431
rs7769961	rs9469899	0.975314640267064	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7769961	rs9469899	0.975314640267064	Graves' disease	4e-10	34594039
rs7769961	rs9469899	0.975314640267064	Coronary artery disease	1e-11	36474045
rs7769961	rs9469899	0.975314640267064	Predicted visceral adipose tissue	2e-20	31501611
rs7769961	rs9469899	0.975314640267064	Medication use (thyroid preparations)	2e-09	31015401
rs7769961	rs9469899	0.975314640267064	Medication use (thyroid preparations)	3e-10	34594039
rs7769961	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs7769961	rs11755393	0.944425765145638	Body mass index	3e-26	29273807
rs7769961	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-12	33493351
rs7769961	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-06	33493351
rs7769961	rs11755393	0.944425765145638	Systemic lupus erythematosus	1e-07	33493351
rs7769961	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-08	19838195
rs7769961	rs11755393	0.944425765145638	Body mass index	4e-55	36581621
rs7769961	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs7769961	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs7769961	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs7769961	rs6941110	0.932921349732261	Sex hormone-binding globulin levels	5e-27	36653534
rs7769961	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs7769961	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs7769961	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs7769961	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs7769961	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs7769961	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs7769961	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs7769961	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7769961	rs9368830	0.831547762090701	HDL cholesterol	4e-21	30275531
rs7769961	rs9368828	0.805103390346437	Body mass index	1e-34	34594039
rs7769961	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7769961	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7769961	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7769961	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs7769961	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs7769961	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7769961	rs112283401	0.766845687865746	Red cell distribution width	4e-27	30595370
rs7769961	rs9689160	0.628913951683802	Lung function (forced vital capacity)	3e-14	36914875
rs7771778	rs2744944	0.97772874440728	Hypothyroidism	3e-10	34594039
rs7771778	rs2744944	0.97772874440728	High density lipoprotein cholesterol levels	3e-86	34887591
rs7771778	rs2744944	0.97772874440728	Multi-trait sex score	7e-22	37277458
rs7771778	rs9366863	0.973728000941658	Adult body size	9e-33	32376654
rs7771778	rs9366863	0.973728000941658	Body mass index	2e-44	30595370
rs7771778	rs9469872	0.963463921784795	HDL cholesterol levels	3e-11	36333282
rs7771778	rs2814949	0.962001225384388	Essential hypertension (time to event)	9e-09	32589924
rs7771778	rs2263329	0.946821341302302	HDL cholesterol	6e-35	34594039
rs7771778	rs2263329	0.946821341302302	HDL cholesterol levels	8e-43	32203549
rs7771778	rs2263329	0.946821341302302	High density lipoprotein cholesterol levels	2e-52	34887591
rs7771778	rs11755393	0.937981319166221	Body mass index	3e-26	29273807
rs7771778	rs11755393	0.937981319166221	Systemic lupus erythematosus	2e-12	33493351
rs7771778	rs11755393	0.937981319166221	Systemic lupus erythematosus	2e-06	33493351
rs7771778	rs11755393	0.937981319166221	Systemic lupus erythematosus	1e-07	33493351
rs7771778	rs11755393	0.937981319166221	Systemic lupus erythematosus	2e-08	19838195
rs7771778	rs11755393	0.937981319166221	Body mass index	4e-55	36581621
rs7771778	rs6941110	0.928191713112836	Sex hormone-binding globulin levels	5e-27	36653534
rs7771778	rs111868030	0.922831221436726	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7771778	rs9469857	0.922665887654735	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7771778	rs2764208	0.921905089657491	Systemic lupus erythematosus	7e-06	24871463
rs7771778	rs9462030	0.908775064115237	Red cell distribution width	5e-25	32888493
rs7771778	rs9469899	0.892823754630044	Prostate cancer (advanced)	2e-06	29892016
rs7771778	rs9469899	0.892823754630044	Prostate cancer	5e-09	29892016
rs7771778	rs9469899	0.892823754630044	Prostate cancer	8e-11	33398198
rs7771778	rs9469899	0.892823754630044	Hand grip strength	3e-15	29691431
rs7771778	rs9469899	0.892823754630044	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7771778	rs9469899	0.892823754630044	Graves' disease	4e-10	34594039
rs7771778	rs9469899	0.892823754630044	Coronary artery disease	1e-11	36474045
rs7771778	rs9469899	0.892823754630044	Predicted visceral adipose tissue	2e-20	31501611
rs7771778	rs9469899	0.892823754630044	Medication use (thyroid preparations)	2e-09	31015401
rs7771778	rs9469899	0.892823754630044	Medication use (thyroid preparations)	3e-10	34594039
rs7771778	rs9368830	0.886129367065573	HDL cholesterol	4e-21	30275531
rs7771778	rs9296128	0.873811642594267	Hip circumference adjusted for BMI	4e-13	34021172
rs7771778	rs9368828	0.873043527493482	Body mass index	1e-34	34594039
rs7771778	rs2744973	0.798134559160619	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7771778	rs2744973	0.798134559160619	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7771778	rs2744973	0.798134559160619	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7771778	rs2744973	0.798134559160619	Multi-trait sex score	6e-20	37277458
rs7771778	rs6912327	0.786958697974412	Fasting insulin	5e-06	33402679
rs7771778	rs6912327	0.786958697974412	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7771778	rs112283401	0.761881554735598	Red cell distribution width	4e-27	30595370
rs7771778	rs205262	0.618523342531803	Body mass index	2e-09	26961502
rs7771778	rs205262	0.618523342531803	Walking pace	4e-10	33128006
rs7771778	rs205262	0.618523342531803	Body mass index	8e-13	30108127
rs7771778	rs205262	0.618523342531803	Body mass index	2e-09	25673413
rs7771778	rs205262	0.618523342531803	Body mass index	2e-14	26426971
rs7771778	rs205262	0.618523342531803	BMI in non-smokers	3e-07	28443625
rs7771778	rs205262	0.618523342531803	BMI in non-smokers	6e-09	28443625
rs7771778	rs205262	0.618523342531803	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs7771778	rs205262	0.618523342531803	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs7771778	rs205262	0.618523342531803	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs7771778	rs205262	0.618523342531803	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs7771778	rs205262	0.618523342531803	Gastroesophageal reflux disease	1e-10	34187846
rs7771778	rs205262	0.618523342531803	Body mass index	3e-10	25673413
rs7771778	rs205262	0.618523342531803	Body mass index	2e-10	25673413
rs7771778	rs205262	0.618523342531803	ICD10 M54: Dorsalgia	2e-12	35110524
rs7771778	rs6940215	0.614667032340375	Insomnia	2e-10	35835914
rs7771778	rs6940215	0.614667032340375	Insomnia	1e-13	35835914
rs7771778	rs6940215	0.614667032340375	Hip circumference adjusted for BMI	8e-10	34021172
rs7771778	rs6940215	0.614667032340375	Multi-trait sex score	2e-23	37277458
rs7771778	rs6940215	0.614667032340375	Multi-trait sex score	4e-23	37277458
rs7771778	rs6457796	0.604399420540184	Insomnia	1e-08	30804565
rs7771778	rs6457796	0.604399420540184	Plateletcrit	9e-11	32888494
rs7771778	rs6457796	0.604399420540184	Systemic lupus erythematosus	3e-22	33272962
rs7771778	rs6457796	0.604399420540184	Body mass index	5e-13	30108127
rs7771778	rs6457796	0.604399420540184	Body mass index	1e-14	26426971
rs7771778	rs6457796	0.604399420540184	Educational attainment	5e-19	35361970
rs7772549	rs6928810	0.895021499829644	Platelet distribution width	1e-14	32888494
rs7772549	rs1063631	0.890124179561704	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs7772549	rs1063631	0.890124179561704	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs7772549	rs3869132	0.886095797594571	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs7772549	rs3869132	0.886095797594571	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs7772549	rs9266825	0.861288696015309	Autism spectrum disorder	6e-06	35215271
rs7772549	rs199530775	0.737546994763825	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs7772549	rs55957433	0.737546994763825	Hip circumference adjusted for BMI	3e-08	34021172
rs7772549	rs6934175	0.672985262055547	Psoriatic arthritis	5e-28	30552173
rs7772549	rs17200242	0.663643917109277	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs7772549	rs7751505	0.660929819245086	Pubertal anthropometrics	4e-06	23449627
rs7772549	rs35026345	0.65537174858413	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs7772549	rs72848707	0.65131363254979	HDL cholesterol levels	7e-06	35884923
rs7772549	rs13437088	0.631750536871648	Psoriasis	3e-40	23143594
rs7772549	rs13437082	0.631057446687817	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs7772549	rs13437082	0.631057446687817	Height	5e-08	19343178
rs7772549	rs72657657	0.623468014721439	Hip circumference adjusted for BMI	4e-13	34021172
rs7774697	rs9462030	0.99035688450784	Red cell distribution width	5e-25	32888493
rs7774697	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7774697	rs2764208	0.98316776027726	Systemic lupus erythematosus	7e-06	24871463
rs7774697	rs9469899	0.97372510997998	Prostate cancer (advanced)	2e-06	29892016
rs7774697	rs9469899	0.97372510997998	Prostate cancer	5e-09	29892016
rs7774697	rs9469899	0.97372510997998	Prostate cancer	8e-11	33398198
rs7774697	rs9469899	0.97372510997998	Hand grip strength	3e-15	29691431
rs7774697	rs9469899	0.97372510997998	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7774697	rs9469899	0.97372510997998	Graves' disease	4e-10	34594039
rs7774697	rs9469899	0.97372510997998	Coronary artery disease	1e-11	36474045
rs7774697	rs9469899	0.97372510997998	Predicted visceral adipose tissue	2e-20	31501611
rs7774697	rs9469899	0.97372510997998	Medication use (thyroid preparations)	2e-09	31015401
rs7774697	rs9469899	0.97372510997998	Medication use (thyroid preparations)	3e-10	34594039
rs7774697	rs9469872	0.947843420042249	HDL cholesterol levels	3e-11	36333282
rs7774697	rs11755393	0.942863454109952	Body mass index	3e-26	29273807
rs7774697	rs11755393	0.942863454109952	Systemic lupus erythematosus	2e-12	33493351
rs7774697	rs11755393	0.942863454109952	Systemic lupus erythematosus	2e-06	33493351
rs7774697	rs11755393	0.942863454109952	Systemic lupus erythematosus	1e-07	33493351
rs7774697	rs11755393	0.942863454109952	Systemic lupus erythematosus	2e-08	19838195
rs7774697	rs11755393	0.942863454109952	Body mass index	4e-55	36581621
rs7774697	rs9366863	0.937643557564107	Adult body size	9e-33	32376654
rs7774697	rs9366863	0.937643557564107	Body mass index	2e-44	30595370
rs7774697	rs9296128	0.933390553846562	Hip circumference adjusted for BMI	4e-13	34021172
rs7774697	rs6941110	0.931367062468927	Sex hormone-binding globulin levels	5e-27	36653534
rs7774697	rs2814949	0.901583560438718	Essential hypertension (time to event)	9e-09	32589924
rs7774697	rs2744944	0.892271454786639	Hypothyroidism	3e-10	34594039
rs7774697	rs2744944	0.892271454786639	High density lipoprotein cholesterol levels	3e-86	34887591
rs7774697	rs2744944	0.892271454786639	Multi-trait sex score	7e-22	37277458
rs7774697	rs2263329	0.874645285202942	HDL cholesterol	6e-35	34594039
rs7774697	rs2263329	0.874645285202942	HDL cholesterol levels	8e-43	32203549
rs7774697	rs2263329	0.874645285202942	High density lipoprotein cholesterol levels	2e-52	34887591
rs7774697	rs111868030	0.849441761297275	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7774697	rs9368830	0.82862190261866	HDL cholesterol	4e-21	30275531
rs7774697	rs9368828	0.802214254631431	Body mass index	1e-34	34594039
rs7774697	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7774697	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7774697	rs2744973	0.800145420504899	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7774697	rs2744973	0.800145420504899	Multi-trait sex score	6e-20	37277458
rs7774697	rs6912327	0.787674917288877	Fasting insulin	5e-06	33402679
rs7774697	rs6912327	0.787674917288877	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7774697	rs112283401	0.765422105750119	Red cell distribution width	4e-27	30595370
rs7774697	rs9689160	0.626238319892739	Lung function (forced vital capacity)	3e-14	36914875
rs7775716	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs7775716	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs7775716	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs7775716	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs7775716	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs7775716	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs7775716	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs7775716	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs7775716	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs7775716	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs7775716	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs7775716	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs7775716	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs7775716	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs7775716	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs7775716	rs13437082	0.631513452560533	Height	5e-08	19343178
rs7775716	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs777587	rs777587	1	Proteoglycan 3 levels	6e-29	34648354
rs777587	rs777587	1	Pappalysin-1 levels	1e-25	34648354
rs777587	rs12617371	0.928523220158414	Immature fraction of reticulocytes	8e-18	32888494
rs777587	rs2463097	0.890878819993609	White blood cell count	3e-26	30595370
rs777587	rs10199672	0.858876655342343	Height	6e-12	34594039
rs777587	rs10199672	0.858876655342343	Height	2e-12	31562340
rs777587	rs2593620	0.839377073442395	Serum levels of protein PRG3	5e-14	35078996
rs777587	rs11685226	0.822547485090148	Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)	2e-08	33349686
rs777587	rs11685226	0.822547485090148	Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)	4e-08	33349686
rs777587	rs1177308	0.81212280613882	Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)	1e-08	33349686
rs777587	rs1177308	0.81212280613882	Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)	1e-08	33349686
rs777587	rs7558954	0.809726902910783	Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)	4e-08	33349686
rs777587	rs2421200	0.806103088765661	Neutrophil count	1e-26	32888493
rs777587	rs2421200	0.806103088765661	Neutrophil count	1e-25	32888493
rs777587	rs10169482	0.738753446646976	C-reactive protein levels	4e-09	33462484
rs777587	rs2950269	0.7063288726931	Eosinophil side fluorescence	3e-18	37596262
rs777587	rs12616433	0.684548089954624	Eosinophil forward scatter	4e-13	37596262
rs777587	rs12616433	0.684548089954624	Eosinophil side scatter	2e-18	37596262
rs7776219	rs9462030	0.995175518696793	Red cell distribution width	5e-25	32888493
rs7776219	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs7776219	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs7776219	rs9469899	0.978497589843936	Prostate cancer (advanced)	2e-06	29892016
rs7776219	rs9469899	0.978497589843936	Prostate cancer	5e-09	29892016
rs7776219	rs9469899	0.978497589843936	Prostate cancer	8e-11	33398198
rs7776219	rs9469899	0.978497589843936	Hand grip strength	3e-15	29691431
rs7776219	rs9469899	0.978497589843936	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs7776219	rs9469899	0.978497589843936	Graves' disease	4e-10	34594039
rs7776219	rs9469899	0.978497589843936	Coronary artery disease	1e-11	36474045
rs7776219	rs9469899	0.978497589843936	Predicted visceral adipose tissue	2e-20	31501611
rs7776219	rs9469899	0.978497589843936	Medication use (thyroid preparations)	2e-09	31015401
rs7776219	rs9469899	0.978497589843936	Medication use (thyroid preparations)	3e-10	34594039
rs7776219	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs7776219	rs11755393	0.947554267093235	Body mass index	3e-26	29273807
rs7776219	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-12	33493351
rs7776219	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-06	33493351
rs7776219	rs11755393	0.947554267093235	Systemic lupus erythematosus	1e-07	33493351
rs7776219	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-08	19838195
rs7776219	rs11755393	0.947554267093235	Body mass index	4e-55	36581621
rs7776219	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs7776219	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs7776219	rs6941110	0.936033811762549	Sex hormone-binding globulin levels	5e-27	36653534
rs7776219	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs7776219	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs7776219	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs7776219	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs7776219	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs7776219	rs2263329	0.874645285202942	HDL cholesterol	6e-35	34594039
rs7776219	rs2263329	0.874645285202942	HDL cholesterol levels	8e-43	32203549
rs7776219	rs2263329	0.874645285202942	High density lipoprotein cholesterol levels	2e-52	34887591
rs7776219	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs7776219	rs9368830	0.830084187792525	HDL cholesterol	4e-21	30275531
rs7776219	rs9368828	0.803658173339717	Body mass index	1e-34	34594039
rs7776219	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs7776219	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs7776219	rs2744973	0.800145420504899	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs7776219	rs2744973	0.800145420504899	Multi-trait sex score	6e-20	37277458
rs7776219	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs7776219	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs7776219	rs112283401	0.769696819914803	Red cell distribution width	4e-27	30595370
rs7776219	rs9689160	0.627575422825611	Lung function (forced vital capacity)	3e-14	36914875
rs7777044	rs13232536	0.800498778921535	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7777044	rs12539962	0.76576000208387	Colorectal cancer	3e-08	36539618
rs7777044	rs4355658	0.745086551942711	Height	3e-13	36224396
rs7777704	rs13232536	0.79982666305628	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7777704	rs12539962	0.763591555025741	Colorectal cancer	3e-08	36539618
rs7777704	rs4355658	0.745793790955688	Height	3e-13	36224396
rs7781973	rs13232536	0.866114373729245	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7781973	rs4355658	0.847287270885096	Height	3e-13	36224396
rs7781973	rs4304220	0.822428129625689	Height	2e-14	36224396
rs7781973	rs7806956	0.625448832744774	Esophageal squamous cell carcinoma	3e-07	37673066
rs7782126	rs12539962	0.961760679241527	Colorectal cancer	3e-08	36539618
rs7782126	rs7806956	0.672182513897914	Esophageal squamous cell carcinoma	3e-07	37673066
rs7782126	rs4355658	0.659311607293754	Height	3e-13	36224396
rs7782126	rs13232536	0.634799202875174	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7786850	rs4304220	0.867347575367006	Height	2e-14	36224396
rs7786850	rs4355658	0.817717373306373	Height	3e-13	36224396
rs7786850	rs13232536	0.614041555744898	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7786850	rs12539962	0.601093864378622	Colorectal cancer	3e-08	36539618
rs7792129	rs13232536	0.79891771200535	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7792129	rs12539962	0.76431598946043	Colorectal cancer	3e-08	36539618
rs7792129	rs4355658	0.743674188308072	Height	3e-13	36224396
rs7793169	rs4304220	0.868862949321539	Height	2e-14	36224396
rs7793169	rs4355658	0.819206054822882	Height	3e-13	36224396
rs7793169	rs13232536	0.614041555744898	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7793169	rs12539962	0.601093864378622	Colorectal cancer	3e-08	36539618
rs7793313	rs4304220	0.999194389370961	Height	2e-14	36224396
rs7793313	rs13232536	0.725380065936769	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7793313	rs4355658	0.703326394888247	Height	3e-13	36224396
rs7793313	rs13227841	0.611766190898034	Asthma	2e-09	32514122
rs7796554	rs12539962	0.79348756953371	Colorectal cancer	3e-08	36539618
rs7796554	rs4355658	0.783735675598058	Height	3e-13	36224396
rs7796554	rs13232536	0.770818809854786	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7798477	rs4304220	0.859353250026879	Height	2e-14	36224396
rs7798477	rs4355658	0.810875375218172	Height	3e-13	36224396
rs7798477	rs13232536	0.607203943029953	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7798641	rs4304220	0.865032397618909	Height	2e-14	36224396
rs7798641	rs4355658	0.816997126874272	Height	3e-13	36224396
rs7798641	rs13232536	0.612109687548474	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7804928	rs4304220	0.797794532955096	Height	2e-14	36224396
rs7804928	rs4355658	0.747573742745905	Height	3e-13	36224396
rs7804928	rs13232536	0.611831684997624	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7805011	rs4401719	0.614285728428851	Sib-shared facial trait 541; Facial segment 21; 3D morphology of the nose sides	5e-08	33983923
rs7808268	rs4304220	0.866635419320974	Height	2e-14	36224396
rs7808268	rs4355658	0.818438308175868	Height	3e-13	36224396
rs7808268	rs13232536	0.613426149347321	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7808585	rs4304220	0.997583637260812	Height	2e-14	36224396
rs7808585	rs13232536	0.725359533245334	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7808585	rs4355658	0.703188864930741	Height	3e-13	36224396
rs7808585	rs13227841	0.610439369280967	Asthma	2e-09	32514122
rs7809965	rs4304220	0.853976078755604	Height	2e-14	36224396
rs7809965	rs4355658	0.80692993299005	Height	3e-13	36224396
rs7809965	rs13232536	0.614414113970351	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7811317	rs4304220	0.859170561430491	Height	2e-14	36224396
rs7811317	rs4355658	0.810965001005789	Height	3e-13	36224396
rs7811317	rs13232536	0.608383709425369	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7811711	rs4304220	0.85987965520041	Height	2e-14	36224396
rs7811711	rs4355658	0.810247219845347	Height	3e-13	36224396
rs7811711	rs13232536	0.607727705430291	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7812097	rs4355658	0.972954633040682	Height	3e-13	36224396
rs7812097	rs13232536	0.768407273158862	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs7812097	rs12539962	0.694087921573991	Colorectal cancer	3e-08	36539618
rs7812097	rs4304220	0.685860679909428	Height	2e-14	36224396
rs7816480	rs1036385	0.689739937391114	Height	6e-11	36224396
rs7816480	rs2016749	0.646086435824219	Calcium levels	2e-08	34594039
rs7818	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs7818	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs7818	rs9383843	0.999100085712971	Migraine	1e-09	35115687
rs7818	rs55763431	0.995506640298119	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs7818	rs9689694	0.993707895167345	Right hippocampal volume (head)	6e-11	37337106
rs7818	rs9689694	0.993707895167345	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs7818	rs9689694	0.993707895167345	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs7818	rs9689694	0.993707895167345	Left hippocampal volume (head)	6e-12	37337106
rs7818	rs10872645	0.988335410721321	Blood protein levels	2e-86	30072576
rs7818	rs9688867	0.987484746280957	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs7818	rs9688867	0.987484746280957	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs7818	rs9688809	0.987484746280957	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs7818	rs10872653	0.987428985005238	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs7818	rs34337297	0.983863132808358	Serum levels of protein LRP11	3e-161	35078996
rs7818	rs14314	0.981250032026204	Macular thickness	3e-19	30535121
rs7818	rs14314	0.981250032026204	Vertex-wise sulcal depth	7e-17	34910505
rs7818	rs14314	0.981250032026204	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs7818	rs14314	0.981250032026204	Left hippocampal volume (body)	7e-15	37337106
rs7818	rs14314	0.981250032026204	Left subiculum volume (body)	1e-14	37337106
rs7818	rs9322193	0.947826521476432	Lung cancer	1e-07	27393504
rs7818	rs4039600	0.904085337095829	Adenine levels	1e-11	35347128
rs7818	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-08	37844115
rs7818	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-06	37844115
rs7818	rs4380763	0.638343493751961	Subcortical volume (min-P)	1e-11	32665545
rs7818	rs11155671	0.62791813730041	Testicular germ cell tumor	2e-09	28604728
rs7818	rs80147756	0.613057484647013	HippSubfield lh volume subiculum-head	3e-10	33875891
rs7818	rs4421206	0.605487928690632	Brain morphology (min-P)	4e-11	32665545
rs7822193	rs1036385	0.729053114504658	Height	6e-11	36224396
rs7822193	rs2016749	0.682574900309046	Calcium levels	2e-08	34594039
rs7830206	rs1059592	0.664018478378339	Type 2 diabetes	2e-08	32541925
rs7830206	rs751680	0.659152738309869	Insomnia	7e-09	35835914
rs7830206	rs1545837	0.630393285275965	Lung function (FVC)	1e-10	30595370
rs7830206	rs6558173	0.628718385887008	Type 2 diabetes	7e-10	32541925
rs7843828	rs13271626	0.992454186344178	Haemorrhoidal disease	3e-10	33888516
rs7843828	rs11778693	0.971297920798049	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	4e-06	26242244
rs7843828	rs11778693	0.971297920798049	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	8e-06	26242244
rs7843828	rs34269854	0.849462125804243	Lung function (forced vital capacity)	3e-09	36914875
rs7843828	rs746011	0.739124230882888	Triglycerides	2e-10	30275531
rs7843828	rs11781149	0.721759372166859	Refractive error	2e-17	32231278
rs7843828	rs11780207	0.638428307298168	Estimated glomerular filtration rate	2e-13	33462484
rs7843828	rs11780207	0.638428307298168	Serum total protein level	2e-09	33462484
rs7843828	rs11780207	0.638428307298168	Creatinine levels	2e-13	33462484
rs7843828	rs751680	0.627948637247543	Insomnia	7e-09	35835914
rs7843828	rs11782130	0.624798837584499	C-reactive protein levels	9e-09	35459240
rs7843828	rs4592028	0.62156858404381	Non-albumin protein levels	3e-09	33462484
rs7843828	rs1545837	0.610589028891761	Lung function (FVC)	1e-10	30595370
rs7843828	rs2280104	0.600126503974634	Parkinson's disease	3e-08	28892059
rs7843828	rs2280104	0.600126503974634	Parkinson's disease or first degree relation to individual with Parkinson's disease	1e-08	31701892
rs7843828	rs2280104	0.600126503974634	Serum total protein level	3e-12	34594039
rs784882	rs2446066	0.997280245880408	Vertex-wise sulcal depth	1e-10	34910505
rs784882	rs2446066	0.997280245880408	Vertex-wise cortical surface area	2e-13	34910505
rs784882	rs2446066	0.997280245880408	Red blood cell count	1e-10	27863252
rs784882	rs2446066	0.997280245880408	Cortical surface area	3e-08	34560273
rs784882	rs2608301	0.997280245880408	Low density lipoprotein cholesterol levels	2e-12	34887591
rs784882	rs10876448	0.996374463762382	Mean corpuscular hemoglobin	2e-16	32888493
rs784882	rs10876448	0.996374463762382	Reticulocyte count	3e-18	32888494
rs784882	rs10876448	0.996374463762382	Reticulocyte fraction of red cells	1e-10	32888494
rs784882	rs2460882	0.995469219201124	Mean corpuscular volume	3e-15	29403010
rs784882	rs2460882	0.995469219201124	Percentage gas trapping	6e-07	26030696
rs784882	rs12582170	0.965792989766237	Mean corpuscular volume	1e-21	27863252
rs784882	rs12582170	0.965792989766237	Mean corpuscular hemoglobin	7e-37	32888493
rs784882	rs12582170	0.965792989766237	Mean reticulocyte volume	2e-33	32888494
rs784882	rs12582170	0.965792989766237	Mean corpuscular volume	1e-67	32888493
rs784882	rs12582170	0.965792989766237	Mean corpuscular hemoglobin	2e-21	32888494
rs784882	rs12582170	0.965792989766237	Mean corpuscular volume	1e-26	34104963
rs784882	rs111379945	0.768853551216336	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs784882	rs111379945	0.768853551216336	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs784882	rs111379945	0.768853551216336	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs784882	rs79205721	0.619687597188052	Vertex-wise cortical thickness	2e-09	34910505
rs784887	rs10876448	0.925144505213031	Mean corpuscular hemoglobin	2e-16	32888493
rs784887	rs10876448	0.925144505213031	Reticulocyte count	3e-18	32888494
rs784887	rs10876448	0.925144505213031	Reticulocyte fraction of red cells	1e-10	32888494
rs784887	rs2446066	0.924285046414947	Vertex-wise sulcal depth	1e-10	34910505
rs784887	rs2446066	0.924285046414947	Vertex-wise cortical surface area	2e-13	34910505
rs784887	rs2446066	0.924285046414947	Red blood cell count	1e-10	27863252
rs784887	rs2446066	0.924285046414947	Cortical surface area	3e-08	34560273
rs784887	rs2608301	0.924285046414947	Low density lipoprotein cholesterol levels	2e-12	34887591
rs784887	rs2460882	0.922510581777409	Mean corpuscular volume	3e-15	29403010
rs784887	rs2460882	0.922510581777409	Percentage gas trapping	6e-07	26030696
rs784887	rs12582170	0.893815333353552	Mean corpuscular volume	1e-21	27863252
rs784887	rs12582170	0.893815333353552	Mean corpuscular hemoglobin	7e-37	32888493
rs784887	rs12582170	0.893815333353552	Mean reticulocyte volume	2e-33	32888494
rs784887	rs12582170	0.893815333353552	Mean corpuscular volume	1e-67	32888493
rs784887	rs12582170	0.893815333353552	Mean corpuscular hemoglobin	2e-21	32888494
rs784887	rs12582170	0.893815333353552	Mean corpuscular volume	1e-26	34104963
rs784887	rs111379945	0.83397104913541	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs784887	rs111379945	0.83397104913541	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs784887	rs111379945	0.83397104913541	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs784891	rs10876448	0.923362535994204	Mean corpuscular hemoglobin	2e-16	32888493
rs784891	rs10876448	0.923362535994204	Reticulocyte count	3e-18	32888494
rs784891	rs10876448	0.923362535994204	Reticulocyte fraction of red cells	1e-10	32888494
rs784891	rs2446066	0.922505218629653	Vertex-wise sulcal depth	1e-10	34910505
rs784891	rs2446066	0.922505218629653	Vertex-wise cortical surface area	2e-13	34910505
rs784891	rs2446066	0.922505218629653	Red blood cell count	1e-10	27863252
rs784891	rs2446066	0.922505218629653	Cortical surface area	3e-08	34560273
rs784891	rs2608301	0.922505218629653	Low density lipoprotein cholesterol levels	2e-12	34887591
rs784891	rs2460882	0.920727622431039	Mean corpuscular volume	3e-15	29403010
rs784891	rs2460882	0.920727622431039	Percentage gas trapping	6e-07	26030696
rs784891	rs12582170	0.892029420439399	Mean corpuscular volume	1e-21	27863252
rs784891	rs12582170	0.892029420439399	Mean corpuscular hemoglobin	7e-37	32888493
rs784891	rs12582170	0.892029420439399	Mean reticulocyte volume	2e-33	32888494
rs784891	rs12582170	0.892029420439399	Mean corpuscular volume	1e-67	32888493
rs784891	rs12582170	0.892029420439399	Mean corpuscular hemoglobin	2e-21	32888494
rs784891	rs12582170	0.892029420439399	Mean corpuscular volume	1e-26	34104963
rs784891	rs111379945	0.830474279634111	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs784891	rs111379945	0.830474279634111	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs784891	rs111379945	0.830474279634111	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs7874563	rs12985	0.738033182023339	Hematocrit	1e-26	32888493
rs7874563	rs12985	0.738033182023339	Hemoglobin concentration	4e-23	32888493
rs7874563	rs12985	0.738033182023339	Hematocrit	4e-27	32888493
rs7874563	rs12985	0.738033182023339	Hemoglobin concentration	5e-23	32888493
rs7874563	rs12985	0.738033182023339	Hemoglobin	1e-15	34594039
rs7874563	rs12985	0.738033182023339	Hematocrit	2e-16	34594039
rs7874563	rs12985	0.738033182023339	Triglyceride levels	1e-08	34887591
rs7874563	rs10970975	0.606325384941554	Red blood cell count	9e-14	34594039
rs7874563	rs10970975	0.606325384941554	Red blood cell count	6e-21	30595370
rs7896828	rs942810	0.974895837598429	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs7896828	rs942810	0.974895837598429	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs7896828	rs942810	0.974895837598429	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs7896828	rs942810	0.974895837598429	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7896828	rs942810	0.974895837598429	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7896828	rs942810	0.974895837598429	N6-methyllysine levels (advanced age)	2e-11	37118062
rs7896828	rs6584194	0.878888422463278	Metabolite peak levels (QI9680)	2e-135	35995766
rs7896828	rs6584194	0.878888422463278	Metabolite peak levels (QI8984)	5e-11	35995766
rs7896828	rs6584194	0.878888422463278	X-24736 levels	3e-13	36635386
rs7896828	rs4488133	0.79940785888168	Serum metabolite levels	2e-281	23093944
rs7896828	rs4488133	0.79940785888168	Serum metabolite levels	1e-27	23093944
rs7896828	rs4488133	0.79940785888168	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs7896828	rs4488133	0.79940785888168	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs7896828	rs4488133	0.79940785888168	Urine X-12112 levels in chronic kidney disease	0	37277652
rs7896828	rs4488133	0.79940785888168	X-12093 levels	1e-48	24816252
rs7896828	rs4488133	0.79940785888168	X-12092 levels	0	24816252
rs7896828	rs1739	0.798985959733042	Metabolite peak levels (QI7389)	3e-91	35995766
rs7896828	rs1737	0.798242802431249	Arginine levels	3e-24	35995766
rs7896828	rs7072216	0.795121082641203	Metabolite levels	8e-15	21931564
rs7896828	rs7072216	0.795121082641203	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs7896828	rs10883083	0.786413302257217	N2-acetyl,N6-methyllysine levels	0	35347128
rs7896828	rs10883083	0.786413302257217	X-12112 levels	0	35347128
rs7896828	rs10883083	0.786413302257217	Arginine levels	1e-16	35347128
rs7896828	rs10883083	0.786413302257217	Metabolite peak levels (QI8972)	2e-124	35995766
rs7896828	rs10883083	0.786413302257217	Metabolite peak levels (QI5171)	8e-96	35995766
rs7896828	rs2147896	0.786413302257217	Urinary metabolites (H-NMR features)	3e-164	24586186
rs7896828	rs2147896	0.786413302257217	Urinary metabolites (H-NMR features)	8e-30	24586186
rs7896828	rs2147896	0.786413302257217	Urinary metabolites (H-NMR features)	2e-55	24586186
rs7896828	rs2147896	0.786413302257217	Urinary metabolites (H-NMR features)	6e-19	24586186
rs7896828	rs2147896	0.786413302257217	Urinary metabolites (H-NMR features)	4e-34	24586186
rs7896828	rs2147896	0.786413302257217	Trimethylamine levels	4e-144	33283231
rs7896828	rs2147896	0.786413302257217	Serum metabolite levels	1e-15	33031748
rs7896828	rs2147896	0.786413302257217	Serum metabolite levels	4e-226	33031748
rs7896828	rs2147896	0.786413302257217	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs7896828	rs2147896	0.786413302257217	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7896828	rs2147896	0.786413302257217	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7896828	rs2147896	0.786413302257217	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs7896828	rs2147896	0.786413302257217	N6-methyllysine levels	3e-198	33437055
rs7896828	rs2147896	0.786413302257217	N6-methyllysine levels	0	35347128
rs7896828	rs2147896	0.786413302257217	N-methylpipecolate levels	0	35050183
rs7896828	rs2147896	0.786413302257217	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs7896828	rs2147896	0.786413302257217	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs7896828	rs2147896	0.786413302257217	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7896828	rs2147896	0.786413302257217	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7896828	rs2147896	0.786413302257217	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs7896828	rs2147896	0.786413302257217	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7896828	rs2147896	0.786413302257217	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7896828	rs2147896	0.786413302257217	X-12092 levels	4e-191	27073872
rs7896828	rs2147896	0.786413302257217	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7896828	rs2147896	0.786413302257217	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7896828	rs2147896	0.786413302257217	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7896828	rs2147896	0.786413302257217	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7896828	rs2147896	0.786413302257217	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7896828	rs2147896	0.786413302257217	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7896828	rs2147896	0.786413302257217	X-12112 levels	0	36635386
rs7896828	rs2147896	0.786413302257217	N6-methyllysine levels	0	36635386
rs7896828	rs2147896	0.786413302257217	N6,N6-dimethyllysine levels	0	36635386
rs7896828	rs2147896	0.786413302257217	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs7896828	rs2147896	0.786413302257217	N2-acetyl,N6-methyllysine levels	0	36635386
rs7896828	rs10786415	0.786413302257217	N6,N6-dimethyllysine levels	0	35347128
rs7896828	rs10786415	0.786413302257217	N-methylpipecolate levels	0	35347128
rs7896828	rs10786415	0.786413302257217	X-25810 levels	4e-11	36635386
rs7896828	rs942814	0.786413302257217	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs7896828	rs4539242	0.785660498272703	Urinary metabolites (H-NMR features)	2e-20	24586186
rs7896828	rs4539242	0.785660498272703	X-24809 levels	4e-67	33177712
rs7896828	rs4539242	0.785660498272703	X-24983 levels	8e-59	33177712
rs7896828	rs4539242	0.785660498272703	X-12112 levels	4e-63	33177712
rs7896828	rs4539242	0.785660498272703	N-methylpipecolate levels	3e-12	33177712
rs7896828	rs4539242	0.785660498272703	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7896828	rs4539242	0.785660498272703	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7896828	rs4539242	0.785660498272703	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7896828	rs4539242	0.785660498272703	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7896828	rs4539242	0.785660498272703	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7896828	rs4539242	0.785660498272703	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7896828	rs4539242	0.785660498272703	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs7896828	rs7905265	0.782828663098842	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs7896828	rs7905265	0.782828663098842	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs7896828	rs7905265	0.782828663098842	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7896828	rs7905265	0.782828663098842	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7896828	rs7905265	0.782828663098842	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs7896828	rs7905265	0.782828663098842	N6,N6-dimethyllysine levels	2e-132	35995766
rs7896828	rs7905265	0.782828663098842	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs7896828	rs10786414	0.769229883331856	ADMA levels	5e-18	35995766
rs7896828	rs942813	0.759095305246807	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs7896828	rs11598867	0.733382041819916	Urinary metabolites	1e-307	26352407
rs7896828	rs7096654	0.712000264551761	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs7896828	rs7096654	0.712000264551761	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs7896828	rs7096654	0.712000264551761	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs7896828	rs7096654	0.712000264551761	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs7896828	rs6584202	0.631273434113226	Obesity-related traits	4e-07	23251661
rs7897357	rs942810	0.976546903115491	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs7897357	rs942810	0.976546903115491	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs7897357	rs942810	0.976546903115491	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs7897357	rs942810	0.976546903115491	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7897357	rs942810	0.976546903115491	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7897357	rs942810	0.976546903115491	N6-methyllysine levels (advanced age)	2e-11	37118062
rs7897357	rs6584194	0.889521470296141	Metabolite peak levels (QI9680)	2e-135	35995766
rs7897357	rs6584194	0.889521470296141	Metabolite peak levels (QI8984)	5e-11	35995766
rs7897357	rs6584194	0.889521470296141	X-24736 levels	3e-13	36635386
rs7897357	rs4488133	0.799039798813509	Serum metabolite levels	2e-281	23093944
rs7897357	rs4488133	0.799039798813509	Serum metabolite levels	1e-27	23093944
rs7897357	rs4488133	0.799039798813509	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs7897357	rs4488133	0.799039798813509	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs7897357	rs4488133	0.799039798813509	Urine X-12112 levels in chronic kidney disease	0	37277652
rs7897357	rs4488133	0.799039798813509	X-12093 levels	1e-48	24816252
rs7897357	rs4488133	0.799039798813509	X-12092 levels	0	24816252
rs7897357	rs10883083	0.796288449561475	N2-acetyl,N6-methyllysine levels	0	35347128
rs7897357	rs10883083	0.796288449561475	X-12112 levels	0	35347128
rs7897357	rs10883083	0.796288449561475	Arginine levels	1e-16	35347128
rs7897357	rs10883083	0.796288449561475	Metabolite peak levels (QI8972)	2e-124	35995766
rs7897357	rs10883083	0.796288449561475	Metabolite peak levels (QI5171)	8e-96	35995766
rs7897357	rs2147896	0.796288449561475	Urinary metabolites (H-NMR features)	3e-164	24586186
rs7897357	rs2147896	0.796288449561475	Urinary metabolites (H-NMR features)	8e-30	24586186
rs7897357	rs2147896	0.796288449561475	Urinary metabolites (H-NMR features)	2e-55	24586186
rs7897357	rs2147896	0.796288449561475	Urinary metabolites (H-NMR features)	6e-19	24586186
rs7897357	rs2147896	0.796288449561475	Urinary metabolites (H-NMR features)	4e-34	24586186
rs7897357	rs2147896	0.796288449561475	Trimethylamine levels	4e-144	33283231
rs7897357	rs2147896	0.796288449561475	Serum metabolite levels	1e-15	33031748
rs7897357	rs2147896	0.796288449561475	Serum metabolite levels	4e-226	33031748
rs7897357	rs2147896	0.796288449561475	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs7897357	rs2147896	0.796288449561475	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7897357	rs2147896	0.796288449561475	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7897357	rs2147896	0.796288449561475	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs7897357	rs2147896	0.796288449561475	N6-methyllysine levels	3e-198	33437055
rs7897357	rs2147896	0.796288449561475	N6-methyllysine levels	0	35347128
rs7897357	rs2147896	0.796288449561475	N-methylpipecolate levels	0	35050183
rs7897357	rs2147896	0.796288449561475	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs7897357	rs2147896	0.796288449561475	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs7897357	rs2147896	0.796288449561475	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7897357	rs2147896	0.796288449561475	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7897357	rs2147896	0.796288449561475	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs7897357	rs2147896	0.796288449561475	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7897357	rs2147896	0.796288449561475	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7897357	rs2147896	0.796288449561475	X-12092 levels	4e-191	27073872
rs7897357	rs2147896	0.796288449561475	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7897357	rs2147896	0.796288449561475	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7897357	rs2147896	0.796288449561475	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7897357	rs2147896	0.796288449561475	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7897357	rs2147896	0.796288449561475	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7897357	rs2147896	0.796288449561475	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7897357	rs2147896	0.796288449561475	X-12112 levels	0	36635386
rs7897357	rs2147896	0.796288449561475	N6-methyllysine levels	0	36635386
rs7897357	rs2147896	0.796288449561475	N6,N6-dimethyllysine levels	0	36635386
rs7897357	rs2147896	0.796288449561475	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs7897357	rs2147896	0.796288449561475	N2-acetyl,N6-methyllysine levels	0	36635386
rs7897357	rs10786415	0.796288449561475	N6,N6-dimethyllysine levels	0	35347128
rs7897357	rs10786415	0.796288449561475	N-methylpipecolate levels	0	35347128
rs7897357	rs10786415	0.796288449561475	X-25810 levels	4e-11	36635386
rs7897357	rs942814	0.796288449561475	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs7897357	rs4539242	0.795532159050382	Urinary metabolites (H-NMR features)	2e-20	24586186
rs7897357	rs4539242	0.795532159050382	X-24809 levels	4e-67	33177712
rs7897357	rs4539242	0.795532159050382	X-24983 levels	8e-59	33177712
rs7897357	rs4539242	0.795532159050382	X-12112 levels	4e-63	33177712
rs7897357	rs4539242	0.795532159050382	N-methylpipecolate levels	3e-12	33177712
rs7897357	rs4539242	0.795532159050382	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7897357	rs4539242	0.795532159050382	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7897357	rs4539242	0.795532159050382	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7897357	rs4539242	0.795532159050382	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7897357	rs4539242	0.795532159050382	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7897357	rs4539242	0.795532159050382	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7897357	rs4539242	0.795532159050382	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs7897357	rs7072216	0.794737262939503	Metabolite levels	8e-15	21931564
rs7897357	rs7072216	0.794737262939503	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs7897357	rs1739	0.787281948253638	Metabolite peak levels (QI7389)	3e-91	35995766
rs7897357	rs1737	0.786540844693483	Arginine levels	3e-24	35995766
rs7897357	rs7905265	0.782424847272495	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs7897357	rs7905265	0.782424847272495	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs7897357	rs7905265	0.782424847272495	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7897357	rs7905265	0.782424847272495	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7897357	rs7905265	0.782424847272495	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs7897357	rs7905265	0.782424847272495	N6,N6-dimethyllysine levels	2e-132	35995766
rs7897357	rs7905265	0.782424847272495	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs7897357	rs10786414	0.778969627660999	ADMA levels	5e-18	35995766
rs7897357	rs942813	0.768640002505958	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs7897357	rs11598867	0.741599932387402	Urinary metabolites	1e-307	26352407
rs7897357	rs7096654	0.711462420548043	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs7897357	rs7096654	0.711462420548043	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs7897357	rs7096654	0.711462420548043	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs7897357	rs7096654	0.711462420548043	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs7897357	rs6584202	0.623307453017397	Obesity-related traits	4e-07	23251661
rs7905265	rs7905265	1	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs7905265	rs7905265	1	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs7905265	rs7905265	1	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7905265	rs7905265	1	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7905265	rs7905265	1	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs7905265	rs7905265	1	N6,N6-dimethyllysine levels	2e-132	35995766
rs7905265	rs7905265	1	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs7905265	rs10883083	0.98425257612078	N2-acetyl,N6-methyllysine levels	0	35347128
rs7905265	rs10883083	0.98425257612078	X-12112 levels	0	35347128
rs7905265	rs10883083	0.98425257612078	Arginine levels	1e-16	35347128
rs7905265	rs10883083	0.98425257612078	Metabolite peak levels (QI8972)	2e-124	35995766
rs7905265	rs10883083	0.98425257612078	Metabolite peak levels (QI5171)	8e-96	35995766
rs7905265	rs2147896	0.98425257612078	Urinary metabolites (H-NMR features)	3e-164	24586186
rs7905265	rs2147896	0.98425257612078	Urinary metabolites (H-NMR features)	8e-30	24586186
rs7905265	rs2147896	0.98425257612078	Urinary metabolites (H-NMR features)	2e-55	24586186
rs7905265	rs2147896	0.98425257612078	Urinary metabolites (H-NMR features)	6e-19	24586186
rs7905265	rs2147896	0.98425257612078	Urinary metabolites (H-NMR features)	4e-34	24586186
rs7905265	rs2147896	0.98425257612078	Trimethylamine levels	4e-144	33283231
rs7905265	rs2147896	0.98425257612078	Serum metabolite levels	1e-15	33031748
rs7905265	rs2147896	0.98425257612078	Serum metabolite levels	4e-226	33031748
rs7905265	rs2147896	0.98425257612078	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs7905265	rs2147896	0.98425257612078	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7905265	rs2147896	0.98425257612078	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7905265	rs2147896	0.98425257612078	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs7905265	rs2147896	0.98425257612078	N6-methyllysine levels	3e-198	33437055
rs7905265	rs2147896	0.98425257612078	N6-methyllysine levels	0	35347128
rs7905265	rs2147896	0.98425257612078	N-methylpipecolate levels	0	35050183
rs7905265	rs2147896	0.98425257612078	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs7905265	rs2147896	0.98425257612078	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs7905265	rs2147896	0.98425257612078	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7905265	rs2147896	0.98425257612078	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7905265	rs2147896	0.98425257612078	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs7905265	rs2147896	0.98425257612078	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7905265	rs2147896	0.98425257612078	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7905265	rs2147896	0.98425257612078	X-12092 levels	4e-191	27073872
rs7905265	rs2147896	0.98425257612078	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7905265	rs2147896	0.98425257612078	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7905265	rs2147896	0.98425257612078	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7905265	rs2147896	0.98425257612078	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7905265	rs2147896	0.98425257612078	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7905265	rs2147896	0.98425257612078	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7905265	rs2147896	0.98425257612078	X-12112 levels	0	36635386
rs7905265	rs2147896	0.98425257612078	N6-methyllysine levels	0	36635386
rs7905265	rs2147896	0.98425257612078	N6,N6-dimethyllysine levels	0	36635386
rs7905265	rs2147896	0.98425257612078	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs7905265	rs2147896	0.98425257612078	N2-acetyl,N6-methyllysine levels	0	36635386
rs7905265	rs10786415	0.98425257612078	N6,N6-dimethyllysine levels	0	35347128
rs7905265	rs10786415	0.98425257612078	N-methylpipecolate levels	0	35347128
rs7905265	rs10786415	0.98425257612078	X-25810 levels	4e-11	36635386
rs7905265	rs942814	0.98425257612078	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs7905265	rs10786414	0.984249179966026	ADMA levels	5e-18	35995766
rs7905265	rs4539242	0.983429710869166	Urinary metabolites (H-NMR features)	2e-20	24586186
rs7905265	rs4539242	0.983429710869166	X-24809 levels	4e-67	33177712
rs7905265	rs4539242	0.983429710869166	X-24983 levels	8e-59	33177712
rs7905265	rs4539242	0.983429710869166	X-12112 levels	4e-63	33177712
rs7905265	rs4539242	0.983429710869166	N-methylpipecolate levels	3e-12	33177712
rs7905265	rs4539242	0.983429710869166	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7905265	rs4539242	0.983429710869166	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7905265	rs4539242	0.983429710869166	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7905265	rs4539242	0.983429710869166	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7905265	rs4539242	0.983429710869166	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7905265	rs4539242	0.983429710869166	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7905265	rs4539242	0.983429710869166	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs7905265	rs7072216	0.982614628506826	Metabolite levels	8e-15	21931564
rs7905265	rs7072216	0.982614628506826	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs7905265	rs4488133	0.977704345853385	Serum metabolite levels	2e-281	23093944
rs7905265	rs4488133	0.977704345853385	Serum metabolite levels	1e-27	23093944
rs7905265	rs4488133	0.977704345853385	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs7905265	rs4488133	0.977704345853385	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs7905265	rs4488133	0.977704345853385	Urine X-12112 levels in chronic kidney disease	0	37277652
rs7905265	rs4488133	0.977704345853385	X-12093 levels	1e-48	24816252
rs7905265	rs4488133	0.977704345853385	X-12092 levels	0	24816252
rs7905265	rs11598867	0.921553281918623	Urinary metabolites	1e-307	26352407
rs7905265	rs7096654	0.914567774162019	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs7905265	rs7096654	0.914567774162019	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs7905265	rs7096654	0.914567774162019	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs7905265	rs7096654	0.914567774162019	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs7905265	rs942813	0.897664639800967	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs7905265	rs6584194	0.879504157190734	Metabolite peak levels (QI9680)	2e-135	35995766
rs7905265	rs6584194	0.879504157190734	Metabolite peak levels (QI8984)	5e-11	35995766
rs7905265	rs6584194	0.879504157190734	X-24736 levels	3e-13	36635386
rs7905265	rs942810	0.766945561083254	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs7905265	rs942810	0.766945561083254	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs7905265	rs942810	0.766945561083254	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs7905265	rs942810	0.766945561083254	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7905265	rs942810	0.766945561083254	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7905265	rs942810	0.766945561083254	N6-methyllysine levels (advanced age)	2e-11	37118062
rs7905265	rs4345897	0.712352500261406	Urinary metabolites (H-NMR features)	2e-19	24586186
rs7905265	rs4345897	0.712352500261406	Urinary metabolites (H-NMR features)	4e-12	24586186
rs7905265	rs4345897	0.712352500261406	Metabolite levels	2e-91	23281178
rs7905265	rs4345897	0.712352500261406	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	4e-25	37118062
rs7905265	rs4345897	0.712352500261406	N6,N6-dimethyllysine levels (elderly offspring)	4e-17	37118062
rs7905265	rs4345897	0.712352500261406	N6-methyllysine levels (elderly offspring)	1e-41	37118062
rs7905265	rs4345897	0.712352500261406	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs7905265	rs4345897	0.712352500261406	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs7905265	rs4345897	0.712352500261406	N6-methyllysine levels (advanced age)	6e-22	37118062
rs7905265	rs2182169	0.684191825279291	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-23	37118062
rs7905265	rs2182169	0.684191825279291	N6,N6-dimethyllysine levels (elderly offspring)	3e-16	37118062
rs7905265	rs2182169	0.684191825279291	N6-methyllysine levels (elderly offspring)	7e-40	37118062
rs7905265	rs2182169	0.684191825279291	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7905265	rs2182169	0.684191825279291	N6,N6-dimethyllysine levels (advanced age)	4e-09	37118062
rs7905265	rs2182169	0.684191825279291	N6-methyllysine levels (advanced age)	1e-21	37118062
rs7905265	rs6584192	0.680641976218622	Metabolite levels	4e-33	23823483
rs7905265	rs6584192	0.680641976218622	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs7905265	rs6584192	0.680641976218622	N6,N6-dimethyllysine levels (elderly offspring)	2e-16	37118062
rs7905265	rs6584192	0.680641976218622	N6-methyllysine levels (elderly offspring)	3e-41	37118062
rs7905265	rs6584192	0.680641976218622	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs7905265	rs6584192	0.680641976218622	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs7905265	rs6584192	0.680641976218622	N6-methyllysine levels (advanced age)	6e-22	37118062
rs7905265	rs2147895	0.672299956771114	Hydroxyhexadecanoylcarnitine levels	9e-19	35888728
rs7905265	rs2147895	0.672299956771114	Plasma arginine levels in chronic kidney disease	7e-13	37277652
rs7905265	rs2147895	0.672299956771114	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-24	37118062
rs7905265	rs2147895	0.672299956771114	N6,N6-dimethyllysine levels (elderly offspring)	7e-17	37118062
rs7905265	rs2147895	0.672299956771114	N6-methyllysine levels (elderly offspring)	2e-39	37118062
rs7905265	rs2147895	0.672299956771114	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs7905265	rs2147895	0.672299956771114	N6,N6-dimethyllysine levels (advanced age)	2e-09	37118062
rs7905265	rs2147895	0.672299956771114	N6-methyllysine levels (advanced age)	4e-21	37118062
rs7905265	rs2182168	0.667022187038761	Urine X-22162 levels in chronic kidney disease	3e-13	37277652
rs7905265	rs2182168	0.667022187038761	Arginine levels	1e-17	36635386
rs7905265	rs1739	0.619262671779416	Metabolite peak levels (QI7389)	3e-91	35995766
rs7905265	rs1737	0.61855760508477	Arginine levels	3e-24	35995766
rs7905265	rs11189591	0.615885654899834	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs7905265	rs11189591	0.615885654899834	N6,N6-dimethyllysine levels (elderly offspring)	1e-16	37118062
rs7905265	rs11189591	0.615885654899834	N6-methyllysine levels (elderly offspring)	1e-40	37118062
rs7905265	rs11189591	0.615885654899834	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs7905265	rs11189591	0.615885654899834	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs7905265	rs11189591	0.615885654899834	N6-methyllysine levels (advanced age)	6e-22	37118062
rs7909131	rs942810	0.97488472626304	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs7909131	rs942810	0.97488472626304	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs7909131	rs942810	0.97488472626304	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs7909131	rs942810	0.97488472626304	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7909131	rs942810	0.97488472626304	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7909131	rs942810	0.97488472626304	N6-methyllysine levels (advanced age)	2e-11	37118062
rs7909131	rs6584194	0.878973075643994	Metabolite peak levels (QI9680)	2e-135	35995766
rs7909131	rs6584194	0.878973075643994	Metabolite peak levels (QI8984)	5e-11	35995766
rs7909131	rs6584194	0.878973075643994	X-24736 levels	3e-13	36635386
rs7909131	rs4488133	0.799598188847733	Serum metabolite levels	2e-281	23093944
rs7909131	rs4488133	0.799598188847733	Serum metabolite levels	1e-27	23093944
rs7909131	rs4488133	0.799598188847733	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs7909131	rs4488133	0.799598188847733	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs7909131	rs4488133	0.799598188847733	Urine X-12112 levels in chronic kidney disease	0	37277652
rs7909131	rs4488133	0.799598188847733	X-12093 levels	1e-48	24816252
rs7909131	rs4488133	0.799598188847733	X-12092 levels	0	24816252
rs7909131	rs1739	0.797565677982526	Metabolite peak levels (QI7389)	3e-91	35995766
rs7909131	rs1737	0.796824463226439	Arginine levels	3e-24	35995766
rs7909131	rs7072216	0.795319255352342	Metabolite levels	8e-15	21931564
rs7909131	rs7072216	0.795319255352342	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs7909131	rs10883083	0.786617335253353	N2-acetyl,N6-methyllysine levels	0	35347128
rs7909131	rs10883083	0.786617335253353	X-12112 levels	0	35347128
rs7909131	rs10883083	0.786617335253353	Arginine levels	1e-16	35347128
rs7909131	rs10883083	0.786617335253353	Metabolite peak levels (QI8972)	2e-124	35995766
rs7909131	rs10883083	0.786617335253353	Metabolite peak levels (QI5171)	8e-96	35995766
rs7909131	rs2147896	0.786617335253353	Urinary metabolites (H-NMR features)	3e-164	24586186
rs7909131	rs2147896	0.786617335253353	Urinary metabolites (H-NMR features)	8e-30	24586186
rs7909131	rs2147896	0.786617335253353	Urinary metabolites (H-NMR features)	2e-55	24586186
rs7909131	rs2147896	0.786617335253353	Urinary metabolites (H-NMR features)	6e-19	24586186
rs7909131	rs2147896	0.786617335253353	Urinary metabolites (H-NMR features)	4e-34	24586186
rs7909131	rs2147896	0.786617335253353	Trimethylamine levels	4e-144	33283231
rs7909131	rs2147896	0.786617335253353	Serum metabolite levels	1e-15	33031748
rs7909131	rs2147896	0.786617335253353	Serum metabolite levels	4e-226	33031748
rs7909131	rs2147896	0.786617335253353	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs7909131	rs2147896	0.786617335253353	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7909131	rs2147896	0.786617335253353	Urinary metabolite levels in chronic kidney disease	0	31959995
rs7909131	rs2147896	0.786617335253353	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs7909131	rs2147896	0.786617335253353	N6-methyllysine levels	3e-198	33437055
rs7909131	rs2147896	0.786617335253353	N6-methyllysine levels	0	35347128
rs7909131	rs2147896	0.786617335253353	N-methylpipecolate levels	0	35050183
rs7909131	rs2147896	0.786617335253353	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs7909131	rs2147896	0.786617335253353	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs7909131	rs2147896	0.786617335253353	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7909131	rs2147896	0.786617335253353	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7909131	rs2147896	0.786617335253353	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs7909131	rs2147896	0.786617335253353	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7909131	rs2147896	0.786617335253353	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7909131	rs2147896	0.786617335253353	X-12092 levels	4e-191	27073872
rs7909131	rs2147896	0.786617335253353	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7909131	rs2147896	0.786617335253353	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7909131	rs2147896	0.786617335253353	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7909131	rs2147896	0.786617335253353	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7909131	rs2147896	0.786617335253353	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7909131	rs2147896	0.786617335253353	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7909131	rs2147896	0.786617335253353	X-12112 levels	0	36635386
rs7909131	rs2147896	0.786617335253353	N6-methyllysine levels	0	36635386
rs7909131	rs2147896	0.786617335253353	N6,N6-dimethyllysine levels	0	36635386
rs7909131	rs2147896	0.786617335253353	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs7909131	rs2147896	0.786617335253353	N2-acetyl,N6-methyllysine levels	0	36635386
rs7909131	rs10786415	0.786617335253353	N6,N6-dimethyllysine levels	0	35347128
rs7909131	rs10786415	0.786617335253353	N-methylpipecolate levels	0	35347128
rs7909131	rs10786415	0.786617335253353	X-25810 levels	4e-11	36635386
rs7909131	rs942814	0.786617335253353	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs7909131	rs4539242	0.785863398729639	Urinary metabolites (H-NMR features)	2e-20	24586186
rs7909131	rs4539242	0.785863398729639	X-24809 levels	4e-67	33177712
rs7909131	rs4539242	0.785863398729639	X-24983 levels	8e-59	33177712
rs7909131	rs4539242	0.785863398729639	X-12112 levels	4e-63	33177712
rs7909131	rs4539242	0.785863398729639	N-methylpipecolate levels	3e-12	33177712
rs7909131	rs4539242	0.785863398729639	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs7909131	rs4539242	0.785863398729639	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs7909131	rs4539242	0.785863398729639	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs7909131	rs4539242	0.785863398729639	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs7909131	rs4539242	0.785863398729639	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs7909131	rs4539242	0.785863398729639	N6-methyllysine levels (advanced age)	5e-25	37118062
rs7909131	rs4539242	0.785863398729639	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs7909131	rs7905265	0.783036732510353	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs7909131	rs7905265	0.783036732510353	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs7909131	rs7905265	0.783036732510353	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs7909131	rs7905265	0.783036732510353	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs7909131	rs7905265	0.783036732510353	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs7909131	rs7905265	0.783036732510353	N6,N6-dimethyllysine levels	2e-132	35995766
rs7909131	rs7905265	0.783036732510353	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs7909131	rs10786414	0.769450236457547	ADMA levels	5e-18	35995766
rs7909131	rs942813	0.759418469991881	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs7909131	rs11598867	0.732101200528091	Urinary metabolites	1e-307	26352407
rs7909131	rs7096654	0.712274769435294	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs7909131	rs7096654	0.712274769435294	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs7909131	rs7096654	0.712274769435294	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs7909131	rs7096654	0.712274769435294	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs7909131	rs6584202	0.629478144745147	Obesity-related traits	4e-07	23251661
rs7909822	rs6584202	0.995984226838943	Obesity-related traits	4e-07	23251661
rs7909822	rs3830025	0.838436072045397	Resting-state network 3 amplitude (blood oxygenation level dependent) (Attention)	2e-08	36462729
rs7909822	rs3830025	0.838436072045397	Resting-state network 20 amplitude (blood oxygenation level dependent) (Precuneal default mode network)	1e-08	36462729
rs7909822	rs45523432	0.835224242797447	Resting-state network 9 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs7909822	rs7901577	0.682262458788411	Serum metabolite levels	3e-89	33031748
rs7909822	rs942810	0.638810574122663	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs7909822	rs942810	0.638810574122663	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs7909822	rs942810	0.638810574122663	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs7909822	rs942810	0.638810574122663	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7909822	rs942810	0.638810574122663	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs7909822	rs942810	0.638810574122663	N6-methyllysine levels (advanced age)	2e-11	37118062
rs7909822	rs1739	0.630017893774678	Metabolite peak levels (QI7389)	3e-91	35995766
rs7909822	rs1737	0.629501506168997	Arginine levels	3e-24	35995766
rs79205721	rs79205721	1	Vertex-wise cortical thickness	2e-09	34910505
rs79205721	rs2446066	0.617589919422487	Vertex-wise sulcal depth	1e-10	34910505
rs79205721	rs2446066	0.617589919422487	Vertex-wise cortical surface area	2e-13	34910505
rs79205721	rs2446066	0.617589919422487	Red blood cell count	1e-10	27863252
rs79205721	rs2446066	0.617589919422487	Cortical surface area	3e-08	34560273
rs79205721	rs2608301	0.617589919422487	Low density lipoprotein cholesterol levels	2e-12	34887591
rs79205721	rs10876448	0.616889188997008	Mean corpuscular hemoglobin	2e-16	32888493
rs79205721	rs10876448	0.616889188997008	Reticulocyte count	3e-18	32888494
rs79205721	rs10876448	0.616889188997008	Reticulocyte fraction of red cells	1e-10	32888494
rs79205721	rs2460882	0.616188890445325	Mean corpuscular volume	3e-15	29403010
rs79205721	rs2460882	0.616188890445325	Percentage gas trapping	6e-07	26030696
rs7938663	rs1467510	0.867659799120356	Platelet distribution width	1e-14	32888494
rs7938663	rs12276109	0.730314261224761	Severe COVID-19 infection	6e-08	36662838
rs7940353	rs10891301	0.650443021584853	Pyruvate dehydrogenase protein X component, mitochondrial levels	1e-18	34648354
rs7940353	rs2276390	0.640044097988292	Waist-hip ratio	6e-28	30239722
rs7940353	rs603646	0.610110195973292	High density lipoprotein cholesterol levels	3e-08	34887591
rs7945387	rs603646	0.986376918892863	High density lipoprotein cholesterol levels	3e-08	34887591
rs7945387	rs498547	0.851080041772161	General risk tolerance (MTAG)	4e-09	30643258
rs7946257	rs4938354	0.984081075831287	Proprotein convertase subtilisin/kexin type 7 levels	3e-295	36168886
rs7946257	rs1794116	0.914758390865931	Protein CASC4 levels	5e-13	34648354
rs7946257	rs1794116	0.914758390865931	Asialoglycoprotein receptor 1 levels	7e-18	34648354
rs7946257	rs171052	0.892807155294887	Proprotein convertase subtilisin/kexin type 7 level in Chronic kidney disease with hypertension and no diabetes (4459_68)	1e-38	35870639
rs7946257	rs2622935	0.694297625998442	Serum levels of protein CASC4	3e-16	35078996
rs7946257	rs2622935	0.694297625998442	Polypeptide N-acetylgalactosaminyltransferase 1 levels	1e-30	34648354
rs7946257	rs4938353	0.668028946892664	Blood protein levels	2e-14	27532455
rs7946257	rs1060211	0.622012091065975	Diastolic blood pressure	5e-09	35762941
rs7947378	rs4353250	0.982302844046854	Insulin-like growth factor 1 levels	2e-14	33462484
rs7947378	rs4353250	0.982302844046854	Amyloid A serum levels	2e-51	21124955
rs7947378	rs4150575	0.646339221572915	Imidazole lactate levels	1e-10	36635386
rs7951370	rs1467510	0.932114980860384	Platelet distribution width	1e-14	32888494
rs7951370	rs12276109	0.790113893053151	Severe COVID-19 infection	6e-08	36662838
rs7951371	rs1467510	0.9312697188874	Platelet distribution width	1e-14	32888494
rs7951371	rs12276109	0.78944102457772	Severe COVID-19 infection	6e-08	36662838
rs7951976	rs1467510	0.936285702887573	Platelet distribution width	1e-14	32888494
rs7951976	rs12276109	0.793601338209993	Severe COVID-19 infection	6e-08	36662838
rs7955267	rs1859336	0.746740146023313	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7955267	rs6489882	0.745125805537863	Chronic lymphocytic leukemia	5e-08	28165464
rs7955267	rs11066452	0.729558509457063	Blood protein levels	6e-08	30072576
rs7955267	rs4767027	0.713295231427556	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7955267	rs2057778	0.712291996249232	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7955267	rs2057778	0.712291996249232	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7955267	rs2057778	0.712291996249232	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7955267	rs1131476	0.690627990592484	Systemic lupus erythematosus	1e-09	33272962
rs7955267	rs2660	0.690627990592484	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7955267	rs2660	0.690627990592484	COVID-19 (critical illness vs population)	3e-15	37198478
rs7955859	rs7955859	1	Waist-hip index	7e-09	34021172
rs7955859	rs7955859	1	Waist-to-hip ratio adjusted for BMI	4e-09	34021172
rs7955859	rs59864950	0.724107680044515	COVID-19 (covid vs negative)	5e-06	35224516
rs7957666	rs2695294	0.896956883911046	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs7957666	rs2695295	0.896251824017677	Serum levels of protein NAAA	1e-68	35078996
rs7957666	rs2695295	0.896251824017677	Serum levels of protein SMPDL3A	8e-86	35078996
rs7957666	rs2559856	0.894735900177449	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs7957666	rs3809260	0.885598238053051	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs7957666	rs2559851	0.825952183112975	Cathepsin F levels	2e-96	34648354
rs7957666	rs2559851	0.825952183112975	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs7957666	rs2559850	0.712067635581314	Serum levels of protein CTSH	1e-19	35078996
rs7957666	rs2559850	0.712067635581314	Vitamin C levels	6e-20	33203707
rs7957666	rs2559850	0.712067635581314	Cathepsin L2 levels	1e-24	34648354
rs7957666	rs2559850	0.712067635581314	Islet amyloid polypeptide levels	1e-49	34648354
rs7957666	rs2559850	0.712067635581314	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs7958379	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7958379	rs6489882	0.970680553445448	Chronic lymphocytic leukemia	5e-08	28165464
rs7958379	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs7958379	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7958379	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7958379	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7958379	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7958379	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs7958379	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7958379	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs7958379	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs7958379	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs7962345	rs12582170	0.977371546999735	Mean corpuscular volume	1e-21	27863252
rs7962345	rs12582170	0.977371546999735	Mean corpuscular hemoglobin	7e-37	32888493
rs7962345	rs12582170	0.977371546999735	Mean reticulocyte volume	2e-33	32888494
rs7962345	rs12582170	0.977371546999735	Mean corpuscular volume	1e-67	32888493
rs7962345	rs12582170	0.977371546999735	Mean corpuscular hemoglobin	2e-21	32888494
rs7962345	rs12582170	0.977371546999735	Mean corpuscular volume	1e-26	34104963
rs7962345	rs2446066	0.962225529297857	Vertex-wise sulcal depth	1e-10	34910505
rs7962345	rs2446066	0.962225529297857	Vertex-wise cortical surface area	2e-13	34910505
rs7962345	rs2446066	0.962225529297857	Red blood cell count	1e-10	27863252
rs7962345	rs2446066	0.962225529297857	Cortical surface area	3e-08	34560273
rs7962345	rs2608301	0.962225529297857	Low density lipoprotein cholesterol levels	2e-12	34887591
rs7962345	rs10876448	0.961316660969376	Mean corpuscular hemoglobin	2e-16	32888493
rs7962345	rs10876448	0.961316660969376	Reticulocyte count	3e-18	32888494
rs7962345	rs10876448	0.961316660969376	Reticulocyte fraction of red cells	1e-10	32888494
rs7962345	rs2460882	0.960408332703005	Mean corpuscular volume	3e-15	29403010
rs7962345	rs2460882	0.960408332703005	Percentage gas trapping	6e-07	26030696
rs7962345	rs111379945	0.733503268543337	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs7962345	rs111379945	0.733503268543337	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs7962345	rs111379945	0.733503268543337	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs7966314	rs1859336	0.975418064937524	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7966314	rs6489882	0.958065243560148	Chronic lymphocytic leukemia	5e-08	28165464
rs7966314	rs11066452	0.953380704022172	Blood protein levels	6e-08	30072576
rs7966314	rs4767027	0.932657849065299	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7966314	rs2057778	0.92918917446748	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7966314	rs2057778	0.92918917446748	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7966314	rs2057778	0.92918917446748	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7966314	rs1131476	0.904232595033998	Systemic lupus erythematosus	1e-09	33272962
rs7966314	rs2660	0.904232595033998	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7966314	rs2660	0.904232595033998	COVID-19 (critical illness vs population)	3e-15	37198478
rs7966314	rs6489867	0.684956331135011	COVID-19 (critical illness vs population)	1e-09	33307546
rs7966314	rs1557866	0.619706276295214	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs7967461	rs1859336	0.974270923210188	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7967461	rs6489882	0.954628736541852	Chronic lymphocytic leukemia	5e-08	28165464
rs7967461	rs11066452	0.952258866983591	Blood protein levels	6e-08	30072576
rs7967461	rs4767027	0.931559191577056	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7967461	rs2057778	0.928093424195584	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7967461	rs2057778	0.928093424195584	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7967461	rs2057778	0.928093424195584	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7967461	rs1131476	0.903153042130054	Systemic lupus erythematosus	1e-09	33272962
rs7967461	rs2660	0.903153042130054	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7967461	rs2660	0.903153042130054	COVID-19 (critical illness vs population)	3e-15	37198478
rs7967461	rs6489867	0.683991702880807	COVID-19 (critical illness vs population)	1e-09	33307546
rs7967461	rs1557866	0.616873879959745	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs7970837	rs2695294	0.895281016006916	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs7970837	rs2695295	0.894569135489273	Serum levels of protein NAAA	1e-68	35078996
rs7970837	rs2695295	0.894569135489273	Serum levels of protein SMPDL3A	8e-86	35078996
rs7970837	rs2559856	0.893054465640132	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs7970837	rs3809260	0.883934198663481	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs7970837	rs2559851	0.824432971476683	Cathepsin F levels	2e-96	34648354
rs7970837	rs2559851	0.824432971476683	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs7970837	rs2559850	0.712281805017524	Serum levels of protein CTSH	1e-19	35078996
rs7970837	rs2559850	0.712281805017524	Vitamin C levels	6e-20	33203707
rs7970837	rs2559850	0.712281805017524	Cathepsin L2 levels	1e-24	34648354
rs7970837	rs2559850	0.712281805017524	Islet amyloid polypeptide levels	1e-49	34648354
rs7970837	rs2559850	0.712281805017524	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs7970952	rs2695294	0.886455582601488	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	3e-38	29875488
rs7970952	rs2695295	0.885757563293928	Serum levels of protein NAAA	1e-68	35078996
rs7970952	rs2695295	0.885757563293928	Serum levels of protein SMPDL3A	8e-86	35078996
rs7970952	rs2559856	0.884250623318306	N-acylethanolamine-hydrolyzing acid amidase levels	4e-12	28240269
rs7970952	rs3809260	0.875163474653276	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase levels	7e-32	34648354
rs7970952	rs2559851	0.815841006039709	Cathepsin F levels	2e-96	34648354
rs7970952	rs2559851	0.815841006039709	Carbohydrate sulfotransferase 9 levels	3e-12	34648354
rs7970952	rs2559850	0.703893932250687	Serum levels of protein CTSH	1e-19	35078996
rs7970952	rs2559850	0.703893932250687	Vitamin C levels	6e-20	33203707
rs7970952	rs2559850	0.703893932250687	Cathepsin L2 levels	1e-24	34648354
rs7970952	rs2559850	0.703893932250687	Islet amyloid polypeptide levels	1e-49	34648354
rs7970952	rs2559850	0.703893932250687	Glycosyltransferase-like protein LARGE1 levels	1e-17	34648354
rs79716074	rs79716074	1	Plateletcrit	1e-09	32888494
rs79716074	rs79716074	1	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs79716074	rs79716074	1	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs79716074	rs79716074	1	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs79716074	rs7595075	0.989753677471562	Waist circumference adjusted for body mass index	2e-09	34021172
rs79716074	rs7595075	0.989753677471562	HDL cholesterol	3e-11	34594039
rs79716074	rs7595075	0.989753677471562	HDL cholesterol levels	6e-13	32203549
rs79716074	rs17713729	0.982629929266046	Body mass index	2e-09	31669095
rs79716074	rs17713729	0.982629929266046	Serum creatinine levels	4e-14	34594039
rs79716074	rs17713729	0.982629929266046	High density lipoprotein cholesterol levels	7e-17	34887591
rs79716074	rs58461606	0.980693700282243	Blood protein levels	0	30072576
rs79716074	rs7605824	0.979623146870325	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs79716074	rs7566279	0.978619048827281	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs79716074	rs17713396	0.975496010353594	Blood urea nitrogen levels	3e-21	34272381
rs79716074	rs17713396	0.975496010353594	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs79716074	rs17713396	0.975496010353594	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs79716074	rs6710091	0.973467644777114	Waist circumference adjusted for body mass index	8e-11	31669095
rs79716074	rs6710091	0.973467644777114	HDL cholesterol	5e-08	30275531
rs79716074	rs6710091	0.973467644777114	High density lipoprotein cholesterol levels	3e-24	34887591
rs79716074	rs3791221	0.937387421388553	Blood urea nitrogen levels	2e-07	31152163
rs79716074	rs3791221	0.937387421388553	Estimated glomerular filtration rate	2e-10	31152163
rs79716074	rs3791221	0.937387421388553	Estimated glomerular filtration rate	1e-11	31152163
rs79716074	rs3791221	0.937387421388553	Blood urea nitrogen levels	7e-26	34594039
rs79716074	rs2290911	0.929071345012972	Height	5e-07	29782485
rs79716074	rs2290911	0.929071345012972	Large artery stroke	6e-06	28265093
rs79716074	rs2290911	0.929071345012972	Height	8e-112	36224396
rs79716074	rs114976176	0.926179283488751	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs79716074	rs2126129	0.921174984721494	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs79716074	rs59937473	0.899737590508745	Protein quantitative trait loci	3e-67	32492067
rs79716074	rs59937473	0.899737590508745	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs79716074	rs17714252	0.891854730099189	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs79716074	rs17714252	0.891854730099189	Retinal vascular fractal dimension	2e-07	34743558
rs79716074	rs11553746	0.889027013141091	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs79716074	rs11553746	0.889027013141091	High density lipoprotein cholesterol levels	2e-07	29083408
rs79716074	rs11553746	0.889027013141091	High density lipoprotein cholesterol levels	7e-15	29083408
rs79716074	rs11553746	0.889027013141091	Large artery stroke	4e-06	28265093
rs79716074	rs62114548	0.867915061701594	Retinal vascular fractal density	2e-09	34743558
rs79716074	rs55753056	0.86765363520271	Height	2e-22	30595370
rs79716074	rs7601944	0.859722741030318	Smoking initiation	4e-15	36477530
rs79716074	rs62114538	0.836871211657686	Triglyceride levels	6e-12	34887591
rs79716074	rs60843830	0.835870753273051	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs79716074	rs60843830	0.835870753273051	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs79716074	rs60843830	0.835870753273051	Adventurousness	7e-10	30643258
rs79716074	rs17713879	0.834997269468915	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs79716074	rs17713879	0.834997269468915	Smoking initiation	1e-10	36477530
rs79716074	rs17713879	0.834997269468915	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs79716074	rs17713879	0.834997269468915	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs79716074	rs17713879	0.834997269468915	Triglyceride levels	3e-10	34887591
rs79716074	rs17713879	0.834997269468915	Aging (eyeAgeAcceleration)	6e-50	36975205
rs79716074	rs79154857	0.801906908595925	Pulse pressure	5e-08	34594039
rs79716074	rs62114506	0.749540036699701	Gamma glutamyl transpeptidase	3e-14	34594039
rs79716074	rs62114506	0.749540036699701	Apolipoprotein A1 levels	3e-10	32203549
rs79716074	rs62114506	0.749540036699701	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs79716074	rs62114506	0.749540036699701	HDL cholesterol levels	8e-10	36333282
rs7972033	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7972033	rs6489882	0.970680553445448	Chronic lymphocytic leukemia	5e-08	28165464
rs7972033	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs7972033	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7972033	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7972033	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7972033	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7972033	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs7972033	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7972033	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs7972033	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs7972033	rs1557866	0.627359103434099	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs7977345	rs6489882	0.747030827262772	Chronic lymphocytic leukemia	5e-08	28165464
rs7977345	rs1859336	0.744827120709611	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7977345	rs11066452	0.727656527156392	Blood protein levels	6e-08	30072576
rs7977345	rs4767027	0.71140529092709	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7977345	rs2057778	0.71040405690211	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7977345	rs2057778	0.71040405690211	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7977345	rs2057778	0.71040405690211	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7977345	rs1131476	0.688784512820246	Systemic lupus erythematosus	1e-09	33272962
rs7977345	rs2660	0.688784512820246	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7977345	rs2660	0.688784512820246	COVID-19 (critical illness vs population)	3e-15	37198478
rs7980275	rs6489882	0.760425011243846	Chronic lymphocytic leukemia	5e-08	28165464
rs7980275	rs1859336	0.758137916702338	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs7980275	rs11066452	0.740670723842172	Blood protein levels	6e-08	30072576
rs7980275	rs4767027	0.724147878199428	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs7980275	rs2057778	0.723137551234205	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs7980275	rs2057778	0.723137551234205	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs7980275	rs2057778	0.723137551234205	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs7980275	rs1131476	0.701329020139846	Systemic lupus erythematosus	1e-09	33272962
rs7980275	rs2660	0.701329020139846	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs7980275	rs2660	0.701329020139846	COVID-19 (critical illness vs population)	3e-15	37198478
rs7989857	rs7321596	0.99249065457011	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs7989857	rs8002861	0.958569707666156	Leprosy	7e-06	25642632
rs7991226	rs7987940	0.721011400023169	AFP levels	6e-08	36329257
rs7991226	rs9535244	0.648232457117777	Lung function (FVC)	1e-08	30595370
rs7991972	rs8002180	0.913598851196036	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs7991972	rs9590228	0.866285005456835	Height	7e-22	36224396
rs7991972	rs9524869	0.857631410243817	Serum metabolite levels	6e-32	33031748
rs7991972	rs9524869	0.857631410243817	N-acetylcarnosine levels	1e-42	35347128
rs7991972	rs9524869	0.857631410243817	N-acetylcarnosine levels	9e-47	35050183
rs7991972	rs9524869	0.857631410243817	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs7991972	rs9524869	0.857631410243817	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs7991972	rs9524869	0.857631410243817	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs7991972	rs9524869	0.857631410243817	N-acetylcarnosine levels	2e-60	36635386
rs7995283	rs7987940	0.716198871471783	AFP levels	6e-08	36329257
rs7995283	rs9535244	0.650271875549646	Lung function (FVC)	1e-08	30595370
rs7995740	rs2224797	0.752614100570026	Red blood cell count	5e-08	30595370
rs7995740	rs2224797	0.752614100570026	Mean corpuscular hemoglobin	3e-09	30595370
rs7996898	rs9590228	0.994995945945841	Height	7e-22	36224396
rs7996898	rs8002180	0.944219118504524	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs7996898	rs9524869	0.736596131349649	Serum metabolite levels	6e-32	33031748
rs7996898	rs9524869	0.736596131349649	N-acetylcarnosine levels	1e-42	35347128
rs7996898	rs9524869	0.736596131349649	N-acetylcarnosine levels	9e-47	35050183
rs7996898	rs9524869	0.736596131349649	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs7996898	rs9524869	0.736596131349649	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs7996898	rs9524869	0.736596131349649	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs7996898	rs9524869	0.736596131349649	N-acetylcarnosine levels	2e-60	36635386
rs7997223	rs9603222	0.974202690345293	Blood protein levels	2e-12	30072576
rs7997223	rs4424789	0.807944799806497	Periostin levels	2e-19	34648354
rs7997223	rs9547937	0.68903141659889	Serum levels of protein POSTN	6e-18	35078996
rs7999758	rs7999758	1	Height	6e-17	30595370
rs7999758	rs6563739	0.997303504260783	Menarche (age at onset)	2e-11	25231870
rs7999758	rs4598779	0.919053530107906	Height	7e-77	36224396
rs8001475	rs9590228	0.994995945945841	Height	7e-22	36224396
rs8001475	rs8002180	0.944219118504524	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs8001475	rs9524869	0.736596131349649	Serum metabolite levels	6e-32	33031748
rs8001475	rs9524869	0.736596131349649	N-acetylcarnosine levels	1e-42	35347128
rs8001475	rs9524869	0.736596131349649	N-acetylcarnosine levels	9e-47	35050183
rs8001475	rs9524869	0.736596131349649	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs8001475	rs9524869	0.736596131349649	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs8001475	rs9524869	0.736596131349649	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs8001475	rs9524869	0.736596131349649	N-acetylcarnosine levels	2e-60	36635386
rs8002180	rs8002180	1	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs8002180	rs9590228	0.944150856884202	Height	7e-22	36224396
rs8002180	rs9524869	0.783747551889142	Serum metabolite levels	6e-32	33031748
rs8002180	rs9524869	0.783747551889142	N-acetylcarnosine levels	1e-42	35347128
rs8002180	rs9524869	0.783747551889142	N-acetylcarnosine levels	9e-47	35050183
rs8002180	rs9524869	0.783747551889142	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs8002180	rs9524869	0.783747551889142	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs8002180	rs9524869	0.783747551889142	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs8002180	rs9524869	0.783747551889142	N-acetylcarnosine levels	2e-60	36635386
rs8014112	rs8014112	1	Height	9e-54	36224396
rs8026997	rs7173566	0.642208347673562	5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)	6e-16	29875488
rs8026997	rs57141546	0.634522114923896	5-formyltetrahydrofolate cyclo-ligase levels (MTHFS.14107.1.3)	7e-16	29875488
rs8026997	rs4994246	0.625591651791551	5-formyltetrahydrofolate cyclo-ligase levels	5.00000000228973e-315	34648354
rs8032681	rs28373613	0.906147135424403	Height (standard GWA)	8e-12	37106081
rs8032681	rs13379492	0.650768572750287	Lung function (FEV1/FVC)	6e-08	30595370
rs8032681	rs8034216	0.616556409631072	C-reactive protein levels	2e-10	31900758
rs8033816	rs12901247	0.890024844913686	Insular cortex volume	4e-06	31530798
rs8033816	rs2042608	0.7920953023922	Glycemic traits (multi-trait analysis)	3e-09	29743933
rs8033816	rs72749770	0.747684201178409	Low density lipoprotein cholesterol levels	9e-10	32493714
rs8033816	rs72749770	0.747684201178409	Apolipoprotein B levels	2e-09	32203549
rs8033816	rs11635977	0.746067493355287	Height	2e-25	36224396
rs8033816	rs7162536	0.725576127649602	Height	4e-29	34594039
rs8033816	rs731820	0.695469796570295	Height	2e-13	31562340
rs8033816	rs731820	0.695469796570295	Height	2e-12	35831902
rs8033816	rs2162062	0.656498882281674	Height	2e-13	35831902
rs8033816	rs7178540	0.63473495257724	Height	1e-31	36224396
rs8033816	rs933807	0.626398484690796	Fat-free mass	6e-06	30593698
rs8033816	rs933807	0.626398484690796	Fat-free mass	2e-07	30593698
rs8033816	rs933807	0.626398484690796	Fat-free mass	8e-11	30593698
rs8033816	rs7178424	0.607363690793357	Height	6e-09	20881960
rs8033816	rs7178424	0.607363690793357	Height	6e-13	35831902
rs8033816	rs7178424	0.607363690793357	Height	3e-251	36224396
rs8033816	rs17271431	0.605585873258775	Height	2e-11	34594039
rs8033816	rs17205463	0.604555904759229	Serum levels of protein IGF1	8e-08	27329260
rs8033816	rs17205463	0.604555904759229	Appendicular lean mass	4e-43	33097823
rs8033816	rs17205463	0.604555904759229	Height	2e-35	30595370
rs8039105	rs17271340	0.973808871600296	Glycemic traits (multi-trait analysis)	9e-10	29743933
rs8039105	rs8034216	0.959824911441114	C-reactive protein levels	2e-10	31900758
rs8039105	rs17271305	0.938161907881915	Two-hour glucose challenge	1e-07	20081857
rs8039105	rs35967150	0.932804195856606	C-reactive protein levels (MTAG)	1e-08	36376304
rs8039105	rs11634163	0.923173646807998	C-reactive protein	2e-08	34594039
rs8039105	rs11634163	0.923173646807998	Two-hour glucose	3e-14	34059833
rs8039105	rs189400382	0.919971844861845	C-reactive protein levels	1e-08	35459240
rs8039105	rs13379492	0.828812719853799	Lung function (FEV1/FVC)	6e-08	30595370
rs8039105	rs28373613	0.600507947824461	Height (standard GWA)	8e-12	37106081
rs8048410	rs2076435	0.942554594820265	Inguinal hernia	2e-08	35022708
rs8048410	rs2076435	0.942554594820265	Inguinal hernia	2e-09	35022708
rs8048410	rs2235642	0.831167721659371	Coronary artery disease	8e-06	29212778
rs8048410	rs2076438	0.825900731282676	Coronary artery disease	3e-08	33020668
rs8067500	rs409942	0.984053757751021	Total cholesterol levels	8e-06	35884923
rs8067500	rs2654189	0.7285085605642	Eosinophil counts	4e-11	32888494
rs8067500	rs2654189	0.7285085605642	Eosinophil percentage of white cells	6e-12	32888494
rs8067500	rs2654189	0.7285085605642	Eosinophil counts	1e-09	30595370
rs8067500	rs5415	0.720555285907379	Birth weight	5e-06	23202124
rs8067500	rs5415	0.720555285907379	LDL cholesterol levels	1e-06	35884923
rs8067500	rs739669	0.68795361462703	BMI at birth	5e-17	35315439
rs8067500	rs222837	0.631515407513449	Metabolite levels	7e-06	23823483
rs8071834	rs8071834	1	Platelet count	3e-11	34594039
rs8071834	rs712273	0.946158962131152	Red blood cell count	5e-17	32888493
rs8071834	rs8069321	0.873048753111435	Serum albumin levels	2e-09	34594039
rs8071834	rs865923	0.701508952139495	Red blood cell count	2e-14	32888493
rs8071834	rs865923	0.701508952139495	Red blood cell count	1e-10	32888494
rs8071834	rs865923	0.701508952139495	Red blood cell count	1e-11	34594039
rs8071834	rs865923	0.701508952139495	Height	3e-25	30595370
rs8071834	rs865923	0.701508952139495	Red blood cell count	1e-10	30595370
rs8071834	rs854779	0.651044618081013	Height	4e-79	36224396
rs8071834	rs854772	0.60466072316865	Mean corpuscular hemoglobin	3e-12	32888494
rs8074989	rs8077038	0.995618001510414	Educational attainment (MTAG)	4e-10	30038396
rs8074989	rs8077038	0.995618001510414	Highest math class taken (MTAG)	5e-16	30038396
rs8074989	rs12949956	0.972723762315257	Self-reported math ability	3e-11	30038396
rs8074989	rs12949956	0.972723762315257	Self-reported math ability (MTAG)	3e-14	30038396
rs8074989	rs12949956	0.972723762315257	Highest math class taken	8e-12	30038396
rs8074989	rs7211615	0.966617149084095	Heel bone mineral density	1e-08	30595370
rs8074989	rs9894429	0.649509835252423	Eye color traits	9e-14	20463881
rs8074989	rs9894429	0.649509835252423	Body mass index	4e-08	36581621
rs8075345	rs2285583	0.952903838099122	AFP levels	2e-08	36329257
rs8075345	rs178785	0.760009457024182	Lung function (FVC)	5e-09	30595370
rs8075345	rs9897542	0.75931022693478	Total bilirubin levels	8e-11	34594039
rs8075345	rs4792716	0.714702408202522	Body mass index	2e-11	31669095
rs8075345	rs4792716	0.714702408202522	Adult body size	5e-09	32376654
rs8075345	rs1075901	0.712692777221596	Body mass index	4e-13	30239722
rs8075345	rs1075901	0.712692777221596	Body mass index	4e-13	30239722
rs8075345	rs1075901	0.712692777221596	Body mass index (MTAG)	7e-13	36376304
rs8075345	rs1075901	0.712692777221596	Body mass index	4e-14	36581621
rs8075345	rs1075901	0.712692777221596	Body mass index	4e-12	30595370
rs8075345	rs9916868	0.680077058160699	Weight	3e-09	34594039
rs8075345	rs178835	0.639714484117688	C-reactive protein levels	2e-13	31900758
rs8081667	rs2285583	0.981197155556248	AFP levels	2e-08	36329257
rs8081667	rs178785	0.781133631147674	Lung function (FVC)	5e-09	30595370
rs8081667	rs1075901	0.724029804307806	Body mass index	4e-13	30239722
rs8081667	rs1075901	0.724029804307806	Body mass index	4e-13	30239722
rs8081667	rs1075901	0.724029804307806	Body mass index (MTAG)	7e-13	36376304
rs8081667	rs1075901	0.724029804307806	Body mass index	4e-14	36581621
rs8081667	rs1075901	0.724029804307806	Body mass index	4e-12	30595370
rs8081667	rs4792716	0.721985302364727	Body mass index	2e-11	31669095
rs8081667	rs4792716	0.721985302364727	Adult body size	5e-09	32376654
rs8081667	rs9897542	0.714038339749382	Total bilirubin levels	8e-11	34594039
rs8081667	rs178835	0.665839643077079	C-reactive protein levels	2e-13	31900758
rs8081667	rs9916868	0.656300746256817	Weight	3e-09	34594039
rs809474	rs6081731	0.988628661952089	Metabolite levels	6e-06	23823483
rs8102046	rs10419226	0.945529406463662	Esophageal adenocarcinoma	8e-07	24121790
rs8102046	rs10419226	0.945529406463662	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	4e-10	24121790
rs8102046	rs10419226	0.945529406463662	Barrett's esophagus	6e-08	24121790
rs8102046	rs199620551	0.878771547228834	Barrett's esophagus  or Esophageal adenocarcinoma	5e-08	27527254
rs8102046	rs2891698	0.79593403232108	Hiatus hernia	4e-10	36584111
rs8102046	rs2891698	0.79593403232108	Hernia	1e-09	36584111
rs8102046	rs2891698	0.79593403232108	ICD10 K44: Diaphragmatic hernia	3e-13	36076102
rs8102331	rs4808407	0.935878156709861	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs8102813	rs4808407	0.935956809866182	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs8108584	rs1138888	0.786559788868292	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs8108584	rs1138888	0.786559788868292	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs8108584	rs4802157	0.766186273019461	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs8108584	rs2355433	0.664009085802068	Pregnancy-specific beta-1-glycoprotein 3 levels (PSG3.6444.15.3)	2e-163	29875488
rs8108584	rs2355433	0.664009085802068	Pregnancy-specific beta-1-glycoprotein 3 levels	0	34648354
rs8108584	rs2355433	0.664009085802068	Pregnancy-specific beta-1-glycoprotein 5 levels	1e-97	34648354
rs8109272	rs1138888	0.622942614302515	Pregnancy-specific beta-1-glycoprotein 3 level in Chronic kidney disease with hypertension and no diabetes (6444_15)	6e-18	35870639
rs8109272	rs1138888	0.622942614302515	Pregnancy-specific beta-1-glycoprotein 4 levels (PSG4.5649.83.3)	5e-163	29875488
rs8109272	rs4300765	0.617545521916908	Serum levels of protein PSG4	6e-287	35078996
rs8109272	rs4802157	0.616525223221731	Pregnancy-specific beta-1-glycoprotein 4 level in Chronic kidney disease with hypertension and no diabetes (5649_83)	8e-14	35870639
rs8112732	rs4808407	0.936757773982323	Plasma hexadecanedioate (C16-DC) levels in chronic kidney disease	3e-13	37277652
rs8119032	rs11696196	0.61365957517082	Verbal learning (oral presentation)	2e-06	35974141
rs8181292	rs6584202	0.968174513000892	Obesity-related traits	4e-07	23251661
rs8181292	rs3830025	0.850836706183178	Resting-state network 3 amplitude (blood oxygenation level dependent) (Attention)	2e-08	36462729
rs8181292	rs3830025	0.850836706183178	Resting-state network 20 amplitude (blood oxygenation level dependent) (Precuneal default mode network)	1e-08	36462729
rs8181292	rs45523432	0.816936038558332	Resting-state network 9 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs8181292	rs7901577	0.666897006072254	Serum metabolite levels	3e-89	33031748
rs8181292	rs1739	0.641824794169871	Metabolite peak levels (QI7389)	3e-91	35995766
rs8181292	rs1737	0.641298753487985	Arginine levels	3e-24	35995766
rs8181292	rs942810	0.627439544129216	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs8181292	rs942810	0.627439544129216	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs8181292	rs942810	0.627439544129216	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs8181292	rs942810	0.627439544129216	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs8181292	rs942810	0.627439544129216	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs8181292	rs942810	0.627439544129216	N6-methyllysine levels (advanced age)	2e-11	37118062
rs832399	rs33321	0.912235834071706	Height	1e-19	34594039
rs832399	rs832540	0.858033542146071	Coronary artery disease	2e-08	29212778
rs832399	rs10061757	0.720230400274342	Height	4e-30	30595370
rs832399	rs96844	0.647789139253391	Type 2 diabetes	5e-08	30297969
rs832399	rs96844	0.647789139253391	Height	4e-33	36224396
rs832529	rs33321	0.90785991404131	Height	1e-19	34594039
rs832529	rs832540	0.853635406545732	Coronary artery disease	2e-08	29212778
rs832529	rs10061757	0.716326655262089	Height	4e-30	30595370
rs832529	rs96844	0.644901666549392	Type 2 diabetes	5e-08	30297969
rs832529	rs96844	0.644901666549392	Height	4e-33	36224396
rs832533	rs33321	0.971059834748508	Height	1e-19	34594039
rs832533	rs832540	0.915328358735345	Coronary artery disease	2e-08	29212778
rs832533	rs10061757	0.7096155042299	Height	4e-30	30595370
rs832533	rs96844	0.60257312141259	Type 2 diabetes	5e-08	30297969
rs832533	rs96844	0.60257312141259	Height	4e-33	36224396
rs832534	rs33321	0.977160095710592	Height	1e-19	34594039
rs832534	rs832540	0.919559348176917	Coronary artery disease	2e-08	29212778
rs832534	rs10061757	0.711813628418045	Height	4e-30	30595370
rs832534	rs96844	0.607269617489945	Type 2 diabetes	5e-08	30297969
rs832534	rs96844	0.607269617489945	Height	4e-33	36224396
rs832535	rs33321	0.840285554146706	Height	1e-19	34594039
rs832535	rs832540	0.785521682162778	Coronary artery disease	2e-08	29212778
rs832535	rs10061757	0.681359664536309	Height	4e-30	30595370
rs832535	rs33320	0.64483679171969	Height	9e-14	36224396
rs832535	rs2257505	0.643071833835245	Height	8e-192	36224396
rs832536	rs33321	0.976280324613307	Height	1e-19	34594039
rs832536	rs832540	0.916966135324826	Coronary artery disease	2e-08	29212778
rs832536	rs10061757	0.711048233718897	Height	4e-30	30595370
rs832536	rs96844	0.609348501989349	Type 2 diabetes	5e-08	30297969
rs832536	rs96844	0.609348501989349	Height	4e-33	36224396
rs832537	rs33321	0.978028275770804	Height	1e-19	34594039
rs832537	rs832540	0.916966135324826	Coronary artery disease	2e-08	29212778
rs832537	rs10061757	0.711048233718897	Height	4e-30	30595370
rs832537	rs96844	0.609348501989349	Type 2 diabetes	5e-08	30297969
rs832537	rs96844	0.609348501989349	Height	4e-33	36224396
rs832540	rs832540	1	Coronary artery disease	2e-08	29212778
rs832540	rs33321	0.933033047185318	Height	1e-19	34594039
rs832540	rs10061757	0.77112510815175	Height	4e-30	30595370
rs832552	rs10061757	0.859624335743038	Height	4e-30	30595370
rs832552	rs832540	0.802275343333252	Coronary artery disease	2e-08	29212778
rs832552	rs33321	0.745749818387435	Height	1e-19	34594039
rs832564	rs10061757	0.867138424273165	Height	4e-30	30595370
rs832564	rs33321	0.808330920039547	Height	1e-19	34594039
rs832564	rs832540	0.781774207700059	Coronary artery disease	2e-08	29212778
rs832566	rs10061757	0.866332545639335	Height	4e-30	30595370
rs832566	rs33321	0.807571164691785	Height	1e-19	34594039
rs832566	rs832540	0.781042584071083	Coronary artery disease	2e-08	29212778
rs832567	rs9292122	0.88259372727867	Prostate cancer	5e-09	33398198
rs832567	rs702689	0.820102360789905	Vertex-wise sulcal depth	2e-22	34910505
rs832577	rs10061757	0.867138424273165	Height	4e-30	30595370
rs832577	rs33321	0.808330920039547	Height	1e-19	34594039
rs832577	rs832540	0.781774207700059	Coronary artery disease	2e-08	29212778
rs832579	rs10061757	0.878714386216402	Height	4e-30	30595370
rs832579	rs33321	0.742695312005304	Height	1e-19	34594039
rs832579	rs832540	0.719402886299441	Coronary artery disease	2e-08	29212778
rs832579	rs702689	0.662078046798233	Vertex-wise sulcal depth	2e-22	34910505
rs832580	rs10061757	0.879576096398997	Height	4e-30	30595370
rs832580	rs33321	0.743520090324254	Height	1e-19	34594039
rs832580	rs832540	0.720239277693567	Coronary artery disease	2e-08	29212778
rs832580	rs702689	0.662641836078813	Vertex-wise sulcal depth	2e-22	34910505
rs832585	rs10061757	0.929916299551984	Height	4e-30	30595370
rs832585	rs832540	0.749957389060568	Coronary artery disease	2e-08	29212778
rs832585	rs33321	0.741133024779999	Height	1e-19	34594039
rs835341	rs835341	1	Ascending aorta distensibility (MTAG)	8e-09	35922433
rs835341	rs946155	0.705472238915858	Glutathione peroxidase 7 levels (GPX7.8345.27.3)	2e-61	29875488
rs835342	rs835341	0.919342571566883	Ascending aorta distensibility (MTAG)	8e-09	35922433
rs835342	rs946155	0.761228421554249	Glutathione peroxidase 7 levels (GPX7.8345.27.3)	2e-61	29875488
rs8629	rs4304220	0.869576116926952	Height	2e-14	36224396
rs8629	rs4355658	0.818485054235964	Height	3e-13	36224396
rs8629	rs13232536	0.614657395717792	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs8629	rs12539962	0.600485715580277	Colorectal cancer	3e-08	36539618
rs8652	rs111379945	0.826322452753173	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs8652	rs111379945	0.826322452753173	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs8652	rs111379945	0.826322452753173	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs8652	rs10876448	0.632271218496447	Mean corpuscular hemoglobin	2e-16	32888493
rs8652	rs10876448	0.632271218496447	Reticulocyte count	3e-18	32888494
rs8652	rs10876448	0.632271218496447	Reticulocyte fraction of red cells	1e-10	32888494
rs8652	rs2446066	0.631649831948033	Vertex-wise sulcal depth	1e-10	34910505
rs8652	rs2446066	0.631649831948033	Vertex-wise cortical surface area	2e-13	34910505
rs8652	rs2446066	0.631649831948033	Red blood cell count	1e-10	27863252
rs8652	rs2446066	0.631649831948033	Cortical surface area	3e-08	34560273
rs8652	rs2608301	0.631649831948033	Low density lipoprotein cholesterol levels	2e-12	34887591
rs8652	rs2460882	0.629881415034237	Mean corpuscular volume	3e-15	29403010
rs8652	rs2460882	0.629881415034237	Percentage gas trapping	6e-07	26030696
rs8652	rs12582170	0.601436618883873	Mean corpuscular volume	1e-21	27863252
rs8652	rs12582170	0.601436618883873	Mean corpuscular hemoglobin	7e-37	32888493
rs8652	rs12582170	0.601436618883873	Mean reticulocyte volume	2e-33	32888494
rs8652	rs12582170	0.601436618883873	Mean corpuscular volume	1e-67	32888493
rs8652	rs12582170	0.601436618883873	Mean corpuscular hemoglobin	2e-21	32888494
rs8652	rs12582170	0.601436618883873	Mean corpuscular volume	1e-26	34104963
rs865570	rs10061757	0.867945226615215	Height	4e-30	30595370
rs865570	rs33321	0.809091546696033	Height	1e-19	34594039
rs865570	rs832540	0.782506670193324	Coronary artery disease	2e-08	29212778
rs866223	rs10061757	0.969601034333232	Height	4e-30	30595370
rs866223	rs832540	0.785466322265844	Coronary artery disease	2e-08	29212778
rs866223	rs33321	0.729897437153286	Height	1e-19	34594039
rs873687	rs2130392	0.999191196808992	Kawasaki disease	3e-08	22446962
rs875295	rs59864950	0.760156540098966	COVID-19 (covid vs negative)	5e-06	35224516
rs875295	rs17380837	0.75268439334182	Atrial fibrillation	5e-12	30061737
rs875295	rs17380837	0.75268439334182	Hypertrophic cardiomyopathy (sarcomere negative)	4e-07	33495597
rs875295	rs17380837	0.75268439334182	Atrial fibrillation (MTAG)	6e-11	35872910
rs875295	rs7955859	0.750837075522584	Waist-hip index	7e-09	34021172
rs875295	rs7955859	0.750837075522584	Waist-to-hip ratio adjusted for BMI	4e-09	34021172
rs875295	rs113819537	0.69824047380324	Atrial fibrillation	2e-09	29892015
rs875295	rs113819537	0.69824047380324	Atrial fibrillation	7e-09	29892015
rs875295	rs113819537	0.69824047380324	Atrial fibrillation/atrial flutter	6e-10	34594039
rs875295	rs113819537	0.69824047380324	Heart failure (multivariate analysis)	5e-08	36376295
rs875295	rs113819537	0.69824047380324	Atrial fibrillation	3e-16	36653681
rs880245	rs56103941	0.770651459027412	Right presubiculum volume (head)	4e-08	37337106
rs880245	rs12523793	0.734201722641939	Subcortical volume (MOSTest)	4e-24	32665545
rs880245	rs12523793	0.734201722641939	C-reactive protein levels	3e-08	35459240
rs880245	rs12523793	0.734201722641939	C-reactive protein levels (MTAG)	2e-08	36376304
rs880245	rs2342764	0.732450064780636	Cortical thickness	1e-08	34560273
rs880245	rs11155662	0.72646976485445	Vertex-wise cortical thickness	2e-09	34910505
rs880245	rs12526675	0.687265220629959	Brain morphology (MOSTest)	7e-22	32665545
rs880246	rs56103941	0.68646481179649	Right presubiculum volume (head)	4e-08	37337106
rs880246	rs12523793	0.657838449528312	Subcortical volume (MOSTest)	4e-24	32665545
rs880246	rs12523793	0.657838449528312	C-reactive protein levels	3e-08	35459240
rs880246	rs12523793	0.657838449528312	C-reactive protein levels (MTAG)	2e-08	36376304
rs880246	rs11155662	0.644331578461101	Vertex-wise cortical thickness	2e-09	34910505
rs880246	rs7752089	0.63794196770726	Brain morphology (MOSTest)	2e-31	35164939
rs880246	rs9285521	0.620392369503301	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs880246	rs12526675	0.600290230674727	Brain morphology (MOSTest)	7e-22	32665545
rs882897	rs10465746	0.813870005675562	Obesity-related traits	8e-06	23251661
rs882897	rs11580836	0.779165828521921	Body mass index	2e-09	36581621
rs884982	rs400625	0.641109410331363	Posterior-cingulate cortex volume	5e-06	31530798
rs8908	rs61586425	0.646406665714274	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs8908	rs7211615	0.645339279270203	Heel bone mineral density	1e-08	30595370
rs8908	rs8077038	0.622779150743897	Educational attainment (MTAG)	4e-10	30038396
rs8908	rs8077038	0.622779150743897	Highest math class taken (MTAG)	5e-16	30038396
rs8908	rs12949956	0.615738100455642	Self-reported math ability	3e-11	30038396
rs8908	rs12949956	0.615738100455642	Self-reported math ability (MTAG)	3e-14	30038396
rs8908	rs12949956	0.615738100455642	Highest math class taken	8e-12	30038396
rs893156	rs2162062	0.856407774387839	Height	2e-13	35831902
rs893156	rs1436958	0.830787955428697	IgG glycosylation	9e-06	23382691
rs893156	rs7178540	0.823494737852222	Height	1e-31	36224396
rs893156	rs933807	0.81576589936795	Fat-free mass	6e-06	30593698
rs893156	rs933807	0.81576589936795	Fat-free mass	2e-07	30593698
rs893156	rs933807	0.81576589936795	Fat-free mass	8e-11	30593698
rs893156	rs7178424	0.779902959794313	Height	6e-09	20881960
rs893156	rs7178424	0.779902959794313	Height	6e-13	35831902
rs893156	rs7178424	0.779902959794313	Height	3e-251	36224396
rs893156	rs17271431	0.775742536166186	Height	2e-11	34594039
rs893156	rs17205463	0.775154106038341	Serum levels of protein IGF1	8e-08	27329260
rs893156	rs17205463	0.775154106038341	Appendicular lean mass	4e-43	33097823
rs893156	rs17205463	0.775154106038341	Height	2e-35	30595370
rs893156	rs731820	0.76401146408327	Height	2e-13	31562340
rs893156	rs731820	0.76401146408327	Height	2e-12	35831902
rs893156	rs7162536	0.75652066477476	Height	4e-29	34594039
rs893156	rs11635977	0.749362376908022	Height	2e-25	36224396
rs893156	rs72749770	0.716796847930339	Low density lipoprotein cholesterol levels	9e-10	32493714
rs893156	rs72749770	0.716796847930339	Apolipoprotein B levels	2e-09	32203549
rs897944	rs6831339	0.927062930652656	High density lipoprotein cholesterol levels	9e-09	34887591
rs897944	rs2868708	0.923849834775004	Lymphocyte count	3e-11	34469753
rs897944	rs2868708	0.923849834775004	White blood cell count	1e-09	30595370
rs897944	rs116142917	0.84670243803633	Lymphocyte count	7e-18	32888494
rs897944	rs6823199	0.845730731282829	Pulse pressure	4e-14	30224653
rs897944	rs13111599	0.822775159230059	HDL cholesterol levels	3e-09	32203549
rs897944	rs13111599	0.822775159230059	Apolipoprotein A1 levels	4e-08	32203549
rs897944	rs6535419	0.814351343458988	Pulse pressure	6e-10	30578418
rs897944	rs28528763	0.774228366340768	White blood cell count	7e-12	32888494
rs897944	rs4302451	0.720577697596423	Eosinophil counts	2e-09	30595370
rs897944	rs35895091	0.700228417766506	Cardiovascular disease	1e-07	30595370
rs897944	rs11099563	0.693078702524808	High density lipoprotein cholesterol levels	3e-11	34887591
rs9027	rs9322193	0.995534518070988	Lung cancer	1e-07	27393504
rs9027	rs34337297	0.9592597395228	Serum levels of protein LRP11	3e-161	35078996
rs9027	rs10872645	0.949619386050969	Blood protein levels	2e-86	30072576
rs9027	rs55763431	0.949619386050969	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9027	rs9689694	0.947874027556667	Right hippocampal volume (head)	6e-11	37337106
rs9027	rs9689694	0.947874027556667	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9027	rs9689694	0.947874027556667	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9027	rs9689694	0.947874027556667	Left hippocampal volume (head)	6e-12	37337106
rs9027	rs2095375	0.945256628815558	Serum metabolite levels	1e-20	33031748
rs9027	rs2095375	0.945256628815558	Serum metabolite levels	1e-20	33031748
rs9027	rs9383843	0.944383550968151	Migraine	1e-09	35115687
rs9027	rs9688867	0.941789154294014	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9027	rs9688867	0.941789154294014	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9027	rs9688809	0.941789154294014	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9027	rs10872653	0.941776415203266	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9027	rs14314	0.927077146322635	Macular thickness	3e-19	30535121
rs9027	rs14314	0.927077146322635	Vertex-wise sulcal depth	7e-17	34910505
rs9027	rs14314	0.927077146322635	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9027	rs14314	0.927077146322635	Left hippocampal volume (body)	7e-15	37337106
rs9027	rs14314	0.927077146322635	Left subiculum volume (body)	1e-14	37337106
rs9027	rs4039600	0.917205364052737	Adenine levels	1e-11	35347128
rs9027	rs11155671	0.617428704733106	Testicular germ cell tumor	2e-09	28604728
rs9027	rs1934534	0.613519195202609	Pain (pleiotropy)	2e-08	37844115
rs9027	rs1934534	0.613519195202609	Pain (pleiotropy)	2e-06	37844115
rs9027	rs4380763	0.61300535749609	Subcortical volume (min-P)	1e-11	32665545
rs912716	rs9469872	0.997591666762885	HDL cholesterol levels	3e-11	36333282
rs912716	rs11755393	0.9714392678683	Body mass index	3e-26	29273807
rs912716	rs11755393	0.9714392678683	Systemic lupus erythematosus	2e-12	33493351
rs912716	rs11755393	0.9714392678683	Systemic lupus erythematosus	2e-06	33493351
rs912716	rs11755393	0.9714392678683	Systemic lupus erythematosus	1e-07	33493351
rs912716	rs11755393	0.9714392678683	Systemic lupus erythematosus	2e-08	19838195
rs912716	rs11755393	0.9714392678683	Body mass index	4e-55	36581621
rs912716	rs9366863	0.968105638270769	Adult body size	9e-33	32376654
rs912716	rs9366863	0.968105638270769	Body mass index	2e-44	30595370
rs912716	rs2764208	0.960540794481071	Systemic lupus erythematosus	7e-06	24871463
rs912716	rs6941110	0.960210413409491	Sex hormone-binding globulin levels	5e-27	36653534
rs912716	rs9469857	0.956557773971852	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs912716	rs9462030	0.9423881367475	Red cell distribution width	5e-25	32888493
rs912716	rs2744944	0.940628895325189	Hypothyroidism	3e-10	34594039
rs912716	rs2744944	0.940628895325189	High density lipoprotein cholesterol levels	3e-86	34887591
rs912716	rs2744944	0.940628895325189	Multi-trait sex score	7e-22	37277458
rs912716	rs2814949	0.931342848816908	Essential hypertension (time to event)	9e-09	32589924
rs912716	rs9469899	0.925860611908894	Prostate cancer (advanced)	2e-06	29892016
rs912716	rs9469899	0.925860611908894	Prostate cancer	5e-09	29892016
rs912716	rs9469899	0.925860611908894	Prostate cancer	8e-11	33398198
rs912716	rs9469899	0.925860611908894	Hand grip strength	3e-15	29691431
rs912716	rs9469899	0.925860611908894	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs912716	rs9469899	0.925860611908894	Graves' disease	4e-10	34594039
rs912716	rs9469899	0.925860611908894	Coronary artery disease	1e-11	36474045
rs912716	rs9469899	0.925860611908894	Predicted visceral adipose tissue	2e-20	31501611
rs912716	rs9469899	0.925860611908894	Medication use (thyroid preparations)	2e-09	31015401
rs912716	rs9469899	0.925860611908894	Medication use (thyroid preparations)	3e-10	34594039
rs912716	rs2263329	0.918144140309451	HDL cholesterol	6e-35	34594039
rs912716	rs2263329	0.918144140309451	HDL cholesterol levels	8e-43	32203549
rs912716	rs2263329	0.918144140309451	High density lipoprotein cholesterol levels	2e-52	34887591
rs912716	rs9296128	0.907460691616326	Hip circumference adjusted for BMI	4e-13	34021172
rs912716	rs111868030	0.89672309495691	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs912716	rs9368830	0.856091466475765	HDL cholesterol	4e-21	30275531
rs912716	rs9368828	0.84421126632391	Body mass index	1e-34	34594039
rs912716	rs6912327	0.816970782882233	Fasting insulin	5e-06	33402679
rs912716	rs6912327	0.816970782882233	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs912716	rs112283401	0.794320511932889	Red cell distribution width	4e-27	30595370
rs912716	rs2744973	0.770527006968501	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs912716	rs2744973	0.770527006968501	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs912716	rs2744973	0.770527006968501	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs912716	rs2744973	0.770527006968501	Multi-trait sex score	6e-20	37277458
rs912716	rs6940215	0.623177661304694	Insomnia	2e-10	35835914
rs912716	rs6940215	0.623177661304694	Insomnia	1e-13	35835914
rs912716	rs6940215	0.623177661304694	Hip circumference adjusted for BMI	8e-10	34021172
rs912716	rs6940215	0.623177661304694	Multi-trait sex score	2e-23	37277458
rs912716	rs6940215	0.623177661304694	Multi-trait sex score	4e-23	37277458
rs912716	rs6457796	0.613988512137901	Insomnia	1e-08	30804565
rs912716	rs6457796	0.613988512137901	Plateletcrit	9e-11	32888494
rs912716	rs6457796	0.613988512137901	Systemic lupus erythematosus	3e-22	33272962
rs912716	rs6457796	0.613988512137901	Body mass index	5e-13	30108127
rs912716	rs6457796	0.613988512137901	Body mass index	1e-14	26426971
rs912716	rs6457796	0.613988512137901	Educational attainment	5e-19	35361970
rs912716	rs205262	0.600865068481551	Body mass index	2e-09	26961502
rs912716	rs205262	0.600865068481551	Walking pace	4e-10	33128006
rs912716	rs205262	0.600865068481551	Body mass index	8e-13	30108127
rs912716	rs205262	0.600865068481551	Body mass index	2e-09	25673413
rs912716	rs205262	0.600865068481551	Body mass index	2e-14	26426971
rs912716	rs205262	0.600865068481551	BMI in non-smokers	3e-07	28443625
rs912716	rs205262	0.600865068481551	BMI in non-smokers	6e-09	28443625
rs912716	rs205262	0.600865068481551	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs912716	rs205262	0.600865068481551	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs912716	rs205262	0.600865068481551	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs912716	rs205262	0.600865068481551	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs912716	rs205262	0.600865068481551	Gastroesophageal reflux disease	1e-10	34187846
rs912716	rs205262	0.600865068481551	Body mass index	3e-10	25673413
rs912716	rs205262	0.600865068481551	Body mass index	2e-10	25673413
rs912716	rs205262	0.600865068481551	ICD10 M54: Dorsalgia	2e-12	35110524
rs9127	rs1019503	0.68807598602033	Systolic blood pressure	2e-06	33230300
rs9127	rs1019503	0.68807598602033	Diastolic blood pressure	2e-14	33230300
rs9127	rs1019503	0.68807598602033	Diastolic blood pressure	4e-11	33230300
rs9127	rs1019503	0.68807598602033	Systolic blood pressure	1e-08	33230300
rs9127	rs3096168	0.679601835541621	Aspartate aminotransferase levels	8e-12	33547301
rs9127	rs38029	0.663720598323198	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs9127	rs2617439	0.626772058504524	Neutrophil count	8e-11	32888494
rs9127	rs2549794	0.623213317972247	Crohn's disease	1e-10	21102463
rs9127	rs2549794	0.623213317972247	Systolic blood pressure	1e-07	33230300
rs9127	rs2549794	0.623213317972247	Diastolic blood pressure	1e-15	33230300
rs9127	rs2549794	0.623213317972247	Diastolic blood pressure	2e-12	33230300
rs9127	rs2549794	0.623213317972247	Systolic blood pressure	4e-10	33230300
rs9127	rs1363907	0.619035663864428	Crohn's disease	4e-16	26192919
rs9127	rs1363907	0.619035663864428	Ulcerative colitis	4e-06	26192919
rs9127	rs1363907	0.619035663864428	Inflammatory bowel disease	5e-15	26192919
rs9127	rs1363907	0.619035663864428	Inflammatory bowel disease	6e-13	23128233
rs9127	rs1363907	0.619035663864428	Inflammatory bowel disease	1e-10	28067908
rs9127	rs1363907	0.619035663864428	Crohn's disease	1e-14	28067908
rs916337	rs5756090	0.963303887478651	Severe COVID-19 infection	4e-08	36662838
rs916337	rs2227169	0.878582970723232	Severe COVID-19 infection	4e-13	36662838
rs916337	rs1053982	0.859750087489695	Severe COVID-19 infection	9e-06	36662838
rs916337	rs6000172	0.859695373122526	Severe COVID-19 infection	1e-07	36662838
rs916337	rs4821461	0.848856105383115	Severe COVID-19 infection	4e-06	36662838
rs9213	rs114976176	0.936998703082012	Smoking initiation (ever regular vs never regular)	6e-09	30643251
rs9213	rs59937473	0.930347740256184	Protein quantitative trait loci	3e-67	32492067
rs9213	rs59937473	0.930347740256184	Smoking initiation (ever regular vs never regular) (MTAG)	2e-07	30643251
rs9213	rs17714252	0.920673910358943	Cerebrospinal fluid biomarker levels	5e-09	28031287
rs9213	rs17714252	0.920673910358943	Retinal vascular fractal dimension	2e-07	34743558
rs9213	rs17713396	0.916519213656315	Blood urea nitrogen levels	3e-21	34272381
rs9213	rs17713396	0.916519213656315	Estimated glomerular filtration rate (creatinine)	2e-15	34272381
rs9213	rs17713396	0.916519213656315	Estimated glomerular filtration rate (cystatin c)	5e-17	34272381
rs9213	rs7601944	0.915432616370392	Smoking initiation	4e-15	36477530
rs9213	rs6710091	0.914580002990005	Waist circumference adjusted for body mass index	8e-11	31669095
rs9213	rs6710091	0.914580002990005	HDL cholesterol	5e-08	30275531
rs9213	rs6710091	0.914580002990005	High density lipoprotein cholesterol levels	3e-24	34887591
rs9213	rs55753056	0.912362735060887	Height	2e-22	30595370
rs9213	rs7595075	0.906843697382663	Waist circumference adjusted for body mass index	2e-09	34021172
rs9213	rs7595075	0.906843697382663	HDL cholesterol	3e-11	34594039
rs9213	rs7595075	0.906843697382663	HDL cholesterol levels	6e-13	32203549
rs9213	rs79716074	0.902999076496366	Plateletcrit	1e-09	32888494
rs9213	rs79716074	0.902999076496366	Low molecular weight phosphotyrosine protein phosphatase level in Chronic kidney disease with hypertension and no diabetes (3858_5)	6e-148	35870639
rs9213	rs79716074	0.902999076496366	Low molecular weight phosphotyrosine protein phosphatase levels (ACP1.3858.5.1)	0	29875488
rs9213	rs79716074	0.902999076496366	Low molecular weight phosphotyrosine protein phosphatase levels	4e-303	36168886
rs9213	rs17713729	0.902012669537548	Body mass index	2e-09	31669095
rs9213	rs17713729	0.902012669537548	Serum creatinine levels	4e-14	34594039
rs9213	rs17713729	0.902012669537548	High density lipoprotein cholesterol levels	7e-17	34887591
rs9213	rs58461606	0.896254479192878	Blood protein levels	0	30072576
rs9213	rs7566279	0.892422772443065	Low molecular weight phosphotyrosine protein phosphatase levels	0	34648354
rs9213	rs7605824	0.889557318578754	Estimated glomerular filtration rate (creatinine)	5e-20	35710981
rs9213	rs2126129	0.882021599413485	Low molecular weight phosphotyrosine protein phosphatase levels	3e-287	34814699
rs9213	rs3791221	0.877603683206617	Blood urea nitrogen levels	2e-07	31152163
rs9213	rs3791221	0.877603683206617	Estimated glomerular filtration rate	2e-10	31152163
rs9213	rs3791221	0.877603683206617	Estimated glomerular filtration rate	1e-11	31152163
rs9213	rs3791221	0.877603683206617	Blood urea nitrogen levels	7e-26	34594039
rs9213	rs2290911	0.874705636320816	Height	5e-07	29782485
rs9213	rs2290911	0.874705636320816	Large artery stroke	6e-06	28265093
rs9213	rs2290911	0.874705636320816	Height	8e-112	36224396
rs9213	rs62114538	0.867171643498351	Triglyceride levels	6e-12	34887591
rs9213	rs60843830	0.866357743169507	Spherical equivalent (joint analysis main effects and education interaction)	4e-08	27020472
rs9213	rs60843830	0.866357743169507	Spherical equivalent (joint analysis main effects and education interaction)	1e-09	27020472
rs9213	rs60843830	0.866357743169507	Adventurousness	7e-10	30643258
rs9213	rs11553746	0.81458115515062	Low molecular weight phosphotyrosine protein phosphatase levels	1e-257	28240269
rs9213	rs11553746	0.81458115515062	High density lipoprotein cholesterol levels	2e-07	29083408
rs9213	rs11553746	0.81458115515062	High density lipoprotein cholesterol levels	7e-15	29083408
rs9213	rs11553746	0.81458115515062	Large artery stroke	4e-06	28265093
rs9213	rs62114548	0.787058993660326	Retinal vascular fractal density	2e-09	34743558
rs9213	rs17713879	0.762305666544276	Low molecular weight phosphotyrosine protein phosphatase levels	2e-215	28240269
rs9213	rs17713879	0.762305666544276	Smoking initiation	1e-10	36477530
rs9213	rs17713879	0.762305666544276	Blood pressure (pleiotropy model 2 SBP adjusted for estimated causal effects x DBP)	1e-09	34989438
rs9213	rs17713879	0.762305666544276	Blood pressure (pleiotropy model 1 DBP adjusted for estimated causal effects x SBP)	1e-10	34989438
rs9213	rs17713879	0.762305666544276	Triglyceride levels	3e-10	34887591
rs9213	rs17713879	0.762305666544276	Aging (eyeAgeAcceleration)	6e-50	36975205
rs9213	rs79154857	0.739835393337109	Pulse pressure	5e-08	34594039
rs9213	rs62114506	0.707378472747297	Gamma glutamyl transpeptidase	3e-14	34594039
rs9213	rs62114506	0.707378472747297	Apolipoprotein A1 levels	3e-10	32203549
rs9213	rs62114506	0.707378472747297	Liver enzyme levels (gamma-glutamyl transferase)	4e-13	35810165
rs9213	rs62114506	0.707378472747297	HDL cholesterol levels	8e-10	36333282
rs921673	rs11228469	0.639196201405771	Height	6e-181	36224396
rs921673	rs10750840	0.62637233234391	Type 2 diabetes	5e-10	32541925
rs921990	rs10876448	0.887158763030279	Mean corpuscular hemoglobin	2e-16	32888493
rs921990	rs10876448	0.887158763030279	Reticulocyte count	3e-18	32888494
rs921990	rs10876448	0.887158763030279	Reticulocyte fraction of red cells	1e-10	32888494
rs921990	rs2446066	0.886312612565207	Vertex-wise sulcal depth	1e-10	34910505
rs921990	rs2446066	0.886312612565207	Vertex-wise cortical surface area	2e-13	34910505
rs921990	rs2446066	0.886312612565207	Red blood cell count	1e-10	27863252
rs921990	rs2446066	0.886312612565207	Cortical surface area	3e-08	34560273
rs921990	rs2608301	0.886312612565207	Low density lipoprotein cholesterol levels	2e-12	34887591
rs921990	rs2460882	0.884605510718043	Mean corpuscular volume	3e-15	29403010
rs921990	rs2460882	0.884605510718043	Percentage gas trapping	6e-07	26030696
rs921990	rs111379945	0.873700683467375	Dorsomedial frontal area (unadjusted for global measures)	4e-09	36893272
rs921990	rs111379945	0.873700683467375	Parsopercularis area (unadjusted for global measures)	2e-09	36893272
rs921990	rs111379945	0.873700683467375	Precuneus area (unadjusted for global measures)	2e-08	36893272
rs921990	rs12582170	0.856753216362649	Mean corpuscular volume	1e-21	27863252
rs921990	rs12582170	0.856753216362649	Mean corpuscular hemoglobin	7e-37	32888493
rs921990	rs12582170	0.856753216362649	Mean reticulocyte volume	2e-33	32888494
rs921990	rs12582170	0.856753216362649	Mean corpuscular volume	1e-67	32888493
rs921990	rs12582170	0.856753216362649	Mean corpuscular hemoglobin	2e-21	32888494
rs921990	rs12582170	0.856753216362649	Mean corpuscular volume	1e-26	34104963
rs9265800	rs9265742	0.967789850436069	Serum levels of protein CPXM1	4e-12	35078996
rs9266447	rs2596517	0.959771473265918	Hip circumference adjusted for BMI	7e-14	34021172
rs9266447	rs2596484	0.95373012663555	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs9266447	rs2523644	0.879896441245982	Myocardial infarction	5e-07	30226566
rs9266450	rs2596517	0.957912468895729	Hip circumference adjusted for BMI	7e-14	34021172
rs9266450	rs2596484	0.951904662615074	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs9266450	rs2523644	0.878111875605897	Myocardial infarction	5e-07	30226566
rs9266457	rs2596517	0.961803002899657	Hip circumference adjusted for BMI	7e-14	34021172
rs9266457	rs2596484	0.955770865302314	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs9266457	rs2523644	0.881752940760993	Myocardial infarction	5e-07	30226566
rs9266459	rs2596517	0.963758784889081	Hip circumference adjusted for BMI	7e-14	34021172
rs9266459	rs2596484	0.957714415873226	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs9266459	rs2523644	0.883583315634678	Myocardial infarction	5e-07	30226566
rs9266479	rs2596517	0.963758784889081	Hip circumference adjusted for BMI	7e-14	34021172
rs9266479	rs2596484	0.957714415873226	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs9266479	rs2523644	0.883583315634678	Myocardial infarction	5e-07	30226566
rs9266513	rs2596517	0.957740860132188	Hip circumference adjusted for BMI	7e-14	34021172
rs9266513	rs2596484	0.95169031080781	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs9266513	rs2523644	0.878040778765203	Myocardial infarction	5e-07	30226566
rs9266596	rs2523644	0.996198023291095	Myocardial infarction	5e-07	30226566
rs9266596	rs2596517	0.898116089144778	Hip circumference adjusted for BMI	7e-14	34021172
rs9266596	rs2596484	0.888791831673454	Inferior parietal area (unadjusted for global measures)	4e-11	36893272
rs9270602	rs4329147	0.972374804640888	Childhood ear infection	1e-11	28928442
rs9270602	rs4329147	0.972374804640888	Childhood ear infection	1e-11	27182965
rs9270602	rs9270986	0.926095589070154	Myasthenia gravis	6e-08	25643325
rs9270602	rs9271055	0.920657171403839	Height	5e-09	36224396
rs9270602	rs1966002	0.917979632611528	Systemic lupus erythematosus	8e-31	33272962
rs9270602	rs9270984	0.917832687936136	Systemic lupus erythematosus	5e-24	23273568
rs9270602	rs9271082	0.901012667955341	IgA nephropathy	8e-09	34076728
rs9270602	rs4367411	0.855816050130999	Total omega-3 fatty acid levels	7e-09	35692035
rs9270602	rs9271025	0.816106832432933	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270602	rs9271366	0.790108644013519	Ulcerative colitis	7e-06	26278503
rs9270602	rs9271366	0.790108644013519	Multiple sclerosis	7e-184	19525955
rs9270602	rs9271366	0.790108644013519	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270602	rs9271366	0.790108644013519	Ulcerative colitis	1e-18	23511034
rs9270602	rs9271366	0.790108644013519	Immunoglobulin A	3e-33	20694011
rs9270602	rs9271366	0.790108644013519	Multiple sclerosis	4e-17	20598377
rs9270602	rs9271366	0.790108644013519	Crohn's disease	5e-12	23850713
rs9270602	rs9271366	0.790108644013519	Systemic lupus erythematosus	1e-07	19838195
rs9270602	rs3129757	0.79009729793012	Cathepsin L1 levels	9e-17	33067605
rs9270602	rs3129762	0.784848019085335	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270602	rs3135005	0.730446937594332	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270602	rs9271147	0.673527820224617	Albumin levels	2e-15	36329257
rs9270602	rs9270539	0.643089998789983	Systemic lupus erythematosus	4e-36	34076728
rs9270602	rs745475218	0.628660256879202	Allergen component sensitization (Hevea brasiliensis 8)	3e-08	37780799
rs9270602	rs9271100	0.61221701553047	Systemic lupus erythematosus	1e-12	19838193
rs9270602	rs9271100	0.61221701553047	Ulcerative colitis	2e-94	26192919
rs9270602	rs9271100	0.61221701553047	Leprosy	8e-95	25642632
rs9270602	rs9271170	0.609917961716919	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270602	rs9271192	0.608463034236183	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270602	rs9271192	0.608463034236183	Alzheimer's disease	5e-07	31473137
rs9270602	rs9271192	0.608463034236183	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270602	rs9271192	0.608463034236183	Alzheimer's disease (late onset)	3e-12	24162737
rs9270602	rs9271192	0.608463034236183	Alzheimer's disease (late onset)	5e-07	30617256
rs9270602	rs9271060	0.604920991390986	Crohn's disease	1e-22	26891255
rs9270602	rs9270970	0.604130579161257	Systemic lupus erythematosus	4e-26	32771030
rs9270602	rs9271536	0.602045163319254	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9270602	rs9271536	0.602045163319254	SSC-A on CD4+ T cell	9e-14	32929287
rs9270602	rs9271536	0.602045163319254	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9270602	rs9271536	0.602045163319254	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9270602	rs9271536	0.602045163319254	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9270602	rs9271536	0.602045163319254	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9270633	rs4329147	0.882913849197341	Childhood ear infection	1e-11	28928442
rs9270633	rs4329147	0.882913849197341	Childhood ear infection	1e-11	27182965
rs9270633	rs9271055	0.843022585182312	Height	5e-09	36224396
rs9270633	rs9270986	0.843019139825562	Myasthenia gravis	6e-08	25643325
rs9270633	rs9270984	0.838095255997841	Systemic lupus erythematosus	5e-24	23273568
rs9270633	rs1966002	0.838087547147984	Systemic lupus erythematosus	8e-31	33272962
rs9270633	rs9271082	0.822216660922268	IgA nephropathy	8e-09	34076728
rs9270633	rs4367411	0.804709126106533	Total omega-3 fatty acid levels	7e-09	35692035
rs9270633	rs9271025	0.784189559202711	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270633	rs9271366	0.719584491482407	Ulcerative colitis	7e-06	26278503
rs9270633	rs9271366	0.719584491482407	Multiple sclerosis	7e-184	19525955
rs9270633	rs9271366	0.719584491482407	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270633	rs9271366	0.719584491482407	Ulcerative colitis	1e-18	23511034
rs9270633	rs9271366	0.719584491482407	Immunoglobulin A	3e-33	20694011
rs9270633	rs9271366	0.719584491482407	Multiple sclerosis	4e-17	20598377
rs9270633	rs9271366	0.719584491482407	Crohn's disease	5e-12	23850713
rs9270633	rs9271366	0.719584491482407	Systemic lupus erythematosus	1e-07	19838195
rs9270633	rs3129757	0.719506587582902	Cathepsin L1 levels	9e-17	33067605
rs9270633	rs3129762	0.717090682557649	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270633	rs3135005	0.704604868854076	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270633	rs9271147	0.60599909465828	Albumin levels	2e-15	36329257
rs9270643	rs9271366	0.800018994791679	Ulcerative colitis	7e-06	26278503
rs9270643	rs9271366	0.800018994791679	Multiple sclerosis	7e-184	19525955
rs9270643	rs9271366	0.800018994791679	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270643	rs9271366	0.800018994791679	Ulcerative colitis	1e-18	23511034
rs9270643	rs9271366	0.800018994791679	Immunoglobulin A	3e-33	20694011
rs9270643	rs9271366	0.800018994791679	Multiple sclerosis	4e-17	20598377
rs9270643	rs9271366	0.800018994791679	Crohn's disease	5e-12	23850713
rs9270643	rs9271366	0.800018994791679	Systemic lupus erythematosus	1e-07	19838195
rs9270643	rs3129757	0.799978322874793	Cathepsin L1 levels	9e-17	33067605
rs9270643	rs3129762	0.794720145283631	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270643	rs3135005	0.739593952061365	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270643	rs4329147	0.699618169463262	Childhood ear infection	1e-11	28928442
rs9270643	rs4329147	0.699618169463262	Childhood ear infection	1e-11	27182965
rs9270643	rs9271055	0.673566147316407	Height	5e-09	36224396
rs9270643	rs9270986	0.671544934057294	Myasthenia gravis	6e-08	25643325
rs9270643	rs1966002	0.666739009848612	Systemic lupus erythematosus	8e-31	33272962
rs9270643	rs9270984	0.666222295035188	Systemic lupus erythematosus	5e-24	23273568
rs9270643	rs9271082	0.657513669545437	IgA nephropathy	8e-09	34076728
rs9270643	rs4367411	0.642756604117935	Total omega-3 fatty acid levels	7e-09	35692035
rs9270643	rs9271025	0.62175851332915	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270656	rs4329147	0.982024742838177	Childhood ear infection	1e-11	28928442
rs9270656	rs4329147	0.982024742838177	Childhood ear infection	1e-11	27182965
rs9270656	rs9270986	0.935653964328017	Myasthenia gravis	6e-08	25643325
rs9270656	rs9271055	0.930217848813758	Height	5e-09	36224396
rs9270656	rs9270984	0.927421141152692	Systemic lupus erythematosus	5e-24	23273568
rs9270656	rs1966002	0.924851137139859	Systemic lupus erythematosus	8e-31	33272962
rs9270656	rs9271082	0.910453958885106	IgA nephropathy	8e-09	34076728
rs9270656	rs4367411	0.86725627830291	Total omega-3 fatty acid levels	7e-09	35692035
rs9270656	rs9271025	0.824611529601396	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270656	rs9271366	0.795057725039159	Ulcerative colitis	7e-06	26278503
rs9270656	rs9271366	0.795057725039159	Multiple sclerosis	7e-184	19525955
rs9270656	rs9271366	0.795057725039159	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270656	rs9271366	0.795057725039159	Ulcerative colitis	1e-18	23511034
rs9270656	rs9271366	0.795057725039159	Immunoglobulin A	3e-33	20694011
rs9270656	rs9271366	0.795057725039159	Multiple sclerosis	4e-17	20598377
rs9270656	rs9271366	0.795057725039159	Crohn's disease	5e-12	23850713
rs9270656	rs9271366	0.795057725039159	Systemic lupus erythematosus	1e-07	19838195
rs9270656	rs3129757	0.795031728455969	Cathepsin L1 levels	9e-17	33067605
rs9270656	rs3129762	0.789778016546979	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270656	rs3135005	0.735014817005949	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270656	rs9271147	0.676472300415051	Albumin levels	2e-15	36329257
rs9270656	rs9270539	0.631898231562318	Systemic lupus erythematosus	4e-36	34076728
rs9270656	rs9271100	0.618773047119484	Systemic lupus erythematosus	1e-12	19838193
rs9270656	rs9271100	0.618773047119484	Ulcerative colitis	2e-94	26192919
rs9270656	rs9271100	0.618773047119484	Leprosy	8e-95	25642632
rs9270656	rs9271170	0.616425351990034	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270656	rs745475218	0.61571984715256	Allergen component sensitization (Hevea brasiliensis 8)	3e-08	37780799
rs9270656	rs9271192	0.61502151371472	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270656	rs9271192	0.61502151371472	Alzheimer's disease	5e-07	31473137
rs9270656	rs9271192	0.61502151371472	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270656	rs9271192	0.61502151371472	Alzheimer's disease (late onset)	3e-12	24162737
rs9270656	rs9271192	0.61502151371472	Alzheimer's disease (late onset)	5e-07	30617256
rs9270656	rs9271060	0.6114315086291	Crohn's disease	1e-22	26891255
rs9270656	rs9270970	0.610620310557564	Systemic lupus erythematosus	4e-26	32771030
rs9270656	rs9271536	0.606500066629811	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9270656	rs9271536	0.606500066629811	SSC-A on CD4+ T cell	9e-14	32929287
rs9270656	rs9271536	0.606500066629811	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9270656	rs9271536	0.606500066629811	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9270656	rs9271536	0.606500066629811	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9270656	rs9271536	0.606500066629811	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9270656	rs9271429	0.604591651060483	Systemic lupus erythematosus	2e-11	34076728
rs9270656	rs9271209	0.602389313090214	Ulcerative colitis	2e-85	26192919
rs9270700	rs4329147	0.810557439918237	Childhood ear infection	1e-11	28928442
rs9270700	rs4329147	0.810557439918237	Childhood ear infection	1e-11	27182965
rs9270700	rs9270986	0.773351328560473	Myasthenia gravis	6e-08	25643325
rs9270700	rs9270984	0.771161561244142	Systemic lupus erythematosus	5e-24	23273568
rs9270700	rs9271055	0.768778589515884	Height	5e-09	36224396
rs9270700	rs1966002	0.766478706518955	Systemic lupus erythematosus	8e-31	33272962
rs9270700	rs9271082	0.765238744383812	IgA nephropathy	8e-09	34076728
rs9270700	rs4367411	0.738891294577487	Total omega-3 fatty acid levels	7e-09	35692035
rs9270700	rs9271025	0.725493803829886	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270700	rs9271366	0.655501592921433	Ulcerative colitis	7e-06	26278503
rs9270700	rs9271366	0.655501592921433	Multiple sclerosis	7e-184	19525955
rs9270700	rs9271366	0.655501592921433	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270700	rs9271366	0.655501592921433	Ulcerative colitis	1e-18	23511034
rs9270700	rs9271366	0.655501592921433	Immunoglobulin A	3e-33	20694011
rs9270700	rs9271366	0.655501592921433	Multiple sclerosis	4e-17	20598377
rs9270700	rs9271366	0.655501592921433	Crohn's disease	5e-12	23850713
rs9270700	rs9271366	0.655501592921433	Systemic lupus erythematosus	1e-07	19838195
rs9270700	rs3129757	0.655402078868901	Cathepsin L1 levels	9e-17	33067605
rs9270700	rs3129762	0.650908240889837	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270700	rs3135005	0.625798164902771	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270715	rs4329147	0.956136044736393	Childhood ear infection	1e-11	28928442
rs9270715	rs4329147	0.956136044736393	Childhood ear infection	1e-11	27182965
rs9270715	rs9270986	0.923761736332095	Myasthenia gravis	6e-08	25643325
rs9270715	rs9271055	0.918370875850857	Height	5e-09	36224396
rs9270715	rs9270984	0.915595006829043	Systemic lupus erythematosus	5e-24	23273568
rs9270715	rs1966002	0.913050520544075	Systemic lupus erythematosus	8e-31	33272962
rs9270715	rs9271082	0.898783591826537	IgA nephropathy	8e-09	34076728
rs9270715	rs4367411	0.855994658794802	Total omega-3 fatty acid levels	7e-09	35692035
rs9270715	rs9271025	0.820991463908388	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270715	rs9271366	0.781670765295159	Ulcerative colitis	7e-06	26278503
rs9270715	rs9271366	0.781670765295159	Multiple sclerosis	7e-184	19525955
rs9270715	rs9271366	0.781670765295159	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270715	rs9271366	0.781670765295159	Ulcerative colitis	1e-18	23511034
rs9270715	rs9271366	0.781670765295159	Immunoglobulin A	3e-33	20694011
rs9270715	rs9271366	0.781670765295159	Multiple sclerosis	4e-17	20598377
rs9270715	rs9271366	0.781670765295159	Crohn's disease	5e-12	23850713
rs9270715	rs9271366	0.781670765295159	Systemic lupus erythematosus	1e-07	19838195
rs9270715	rs3129757	0.781650554026073	Cathepsin L1 levels	9e-17	33067605
rs9270715	rs3129762	0.776453058611188	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270715	rs3135005	0.724839757496696	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270715	rs9271147	0.664105969419058	Albumin levels	2e-15	36329257
rs9270715	rs9270539	0.611205167811315	Systemic lupus erythematosus	4e-36	34076728
rs9270715	rs9271100	0.609813062038202	Systemic lupus erythematosus	1e-12	19838193
rs9270715	rs9271100	0.609813062038202	Ulcerative colitis	2e-94	26192919
rs9270715	rs9271100	0.609813062038202	Leprosy	8e-95	25642632
rs9270715	rs9271170	0.607486296136764	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270715	rs9271192	0.606097662603418	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270715	rs9271192	0.606097662603418	Alzheimer's disease	5e-07	31473137
rs9270715	rs9271192	0.606097662603418	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270715	rs9271192	0.606097662603418	Alzheimer's disease (late onset)	3e-12	24162737
rs9270715	rs9271192	0.606097662603418	Alzheimer's disease (late onset)	5e-07	30617256
rs9270715	rs9271060	0.602540677765376	Crohn's disease	1e-22	26891255
rs9270715	rs9270970	0.601736580136502	Systemic lupus erythematosus	4e-26	32771030
rs9270717	rs4329147	0.956136044736393	Childhood ear infection	1e-11	28928442
rs9270717	rs4329147	0.956136044736393	Childhood ear infection	1e-11	27182965
rs9270717	rs9270986	0.923761736332095	Myasthenia gravis	6e-08	25643325
rs9270717	rs9271055	0.918370875850857	Height	5e-09	36224396
rs9270717	rs9270984	0.915595006829043	Systemic lupus erythematosus	5e-24	23273568
rs9270717	rs1966002	0.913050520544075	Systemic lupus erythematosus	8e-31	33272962
rs9270717	rs9271082	0.898783591826537	IgA nephropathy	8e-09	34076728
rs9270717	rs4367411	0.855994658794802	Total omega-3 fatty acid levels	7e-09	35692035
rs9270717	rs9271025	0.818572164145536	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270717	rs9271366	0.781670765295159	Ulcerative colitis	7e-06	26278503
rs9270717	rs9271366	0.781670765295159	Multiple sclerosis	7e-184	19525955
rs9270717	rs9271366	0.781670765295159	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270717	rs9271366	0.781670765295159	Ulcerative colitis	1e-18	23511034
rs9270717	rs9271366	0.781670765295159	Immunoglobulin A	3e-33	20694011
rs9270717	rs9271366	0.781670765295159	Multiple sclerosis	4e-17	20598377
rs9270717	rs9271366	0.781670765295159	Crohn's disease	5e-12	23850713
rs9270717	rs9271366	0.781670765295159	Systemic lupus erythematosus	1e-07	19838195
rs9270717	rs3129757	0.781650554026073	Cathepsin L1 levels	9e-17	33067605
rs9270717	rs3129762	0.776453058611188	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270717	rs3135005	0.724839757496696	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270717	rs9271147	0.664105969419058	Albumin levels	2e-15	36329257
rs9270717	rs9270539	0.611205167811315	Systemic lupus erythematosus	4e-36	34076728
rs9270717	rs9271100	0.609813062038202	Systemic lupus erythematosus	1e-12	19838193
rs9270717	rs9271100	0.609813062038202	Ulcerative colitis	2e-94	26192919
rs9270717	rs9271100	0.609813062038202	Leprosy	8e-95	25642632
rs9270717	rs9271170	0.607486296136764	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270717	rs9271192	0.606097662603418	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270717	rs9271192	0.606097662603418	Alzheimer's disease	5e-07	31473137
rs9270717	rs9271192	0.606097662603418	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270717	rs9271192	0.606097662603418	Alzheimer's disease (late onset)	3e-12	24162737
rs9270717	rs9271192	0.606097662603418	Alzheimer's disease (late onset)	5e-07	30617256
rs9270717	rs9271060	0.602540677765376	Crohn's disease	1e-22	26891255
rs9270717	rs9270970	0.601736580136502	Systemic lupus erythematosus	4e-26	32771030
rs9270815	rs9270984	0.951666046185261	Systemic lupus erythematosus	5e-24	23273568
rs9270815	rs9270986	0.949077875912002	Myasthenia gravis	6e-08	25643325
rs9270815	rs9271055	0.946311039771718	Height	5e-09	36224396
rs9270815	rs1966002	0.946311039771718	Systemic lupus erythematosus	8e-31	33272962
rs9270815	rs9271082	0.937057726620796	IgA nephropathy	8e-09	34076728
rs9270815	rs4329147	0.93567592650031	Childhood ear infection	1e-11	28928442
rs9270815	rs4329147	0.93567592650031	Childhood ear infection	1e-11	27182965
rs9270815	rs4367411	0.890200043536902	Total omega-3 fatty acid levels	7e-09	35692035
rs9270815	rs9271025	0.844219313252011	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270815	rs9271366	0.80484497081448	Ulcerative colitis	7e-06	26278503
rs9270815	rs9271366	0.80484497081448	Multiple sclerosis	7e-184	19525955
rs9270815	rs9271366	0.80484497081448	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270815	rs9271366	0.80484497081448	Ulcerative colitis	1e-18	23511034
rs9270815	rs9271366	0.80484497081448	Immunoglobulin A	3e-33	20694011
rs9270815	rs9271366	0.80484497081448	Multiple sclerosis	4e-17	20598377
rs9270815	rs9271366	0.80484497081448	Crohn's disease	5e-12	23850713
rs9270815	rs9271366	0.80484497081448	Systemic lupus erythematosus	1e-07	19838195
rs9270815	rs3129757	0.804815442006949	Cathepsin L1 levels	9e-17	33067605
rs9270815	rs3129762	0.799519831517634	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270815	rs3135005	0.7467392120965	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270815	rs9271147	0.695862586240642	Albumin levels	2e-15	36329257
rs9270815	rs9271060	0.631166534647293	Crohn's disease	1e-22	26891255
rs9270815	rs9271192	0.630897441011232	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270815	rs9271192	0.630897441011232	Alzheimer's disease	5e-07	31473137
rs9270815	rs9271192	0.630897441011232	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270815	rs9271192	0.630897441011232	Alzheimer's disease (late onset)	3e-12	24162737
rs9270815	rs9271192	0.630897441011232	Alzheimer's disease (late onset)	5e-07	30617256
rs9270815	rs9271100	0.630749259207179	Systemic lupus erythematosus	1e-12	19838193
rs9270815	rs9271100	0.630749259207179	Ulcerative colitis	2e-94	26192919
rs9270815	rs9271100	0.630749259207179	Leprosy	8e-95	25642632
rs9270815	rs9270970	0.630326951311706	Systemic lupus erythematosus	4e-26	32771030
rs9270815	rs9271170	0.628363568227098	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270815	rs9271066	0.620639299841268	Takayasu arteritis	2e-11	33308445
rs9270815	rs9271209	0.616081082998838	Ulcerative colitis	2e-85	26192919
rs9270815	rs9271536	0.612511849826958	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9270815	rs9271536	0.612511849826958	SSC-A on CD4+ T cell	9e-14	32929287
rs9270815	rs9271536	0.612511849826958	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9270815	rs9271536	0.612511849826958	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9270815	rs9271536	0.612511849826958	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9270815	rs9271536	0.612511849826958	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9270815	rs9271429	0.610590499274058	Systemic lupus erythematosus	2e-11	34076728
rs9270815	rs9270539	0.604932526395874	Systemic lupus erythematosus	4e-36	34076728
rs9270815	rs9268851	0.60183500999473	Serum levels of protein H6PD	1e-96	35078996
rs9270815	rs9268851	0.60183500999473	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9270880	rs9270984	0.834758280792801	Systemic lupus erythematosus	5e-24	23273568
rs9270880	rs9271055	0.829812143237144	Height	5e-09	36224396
rs9270880	rs9270986	0.829776917235568	Myasthenia gravis	6e-08	25643325
rs9270880	rs1966002	0.824969680113646	Systemic lupus erythematosus	8e-31	33272962
rs9270880	rs4367411	0.824077857024552	Total omega-3 fatty acid levels	7e-09	35692035
rs9270880	rs9271082	0.821265465537332	IgA nephropathy	8e-09	34076728
rs9270880	rs4329147	0.798579483996886	Childhood ear infection	1e-11	28928442
rs9270880	rs4329147	0.798579483996886	Childhood ear infection	1e-11	27182965
rs9270880	rs9271025	0.788789565074746	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270880	rs9271366	0.703402583098999	Ulcerative colitis	7e-06	26278503
rs9270880	rs9271366	0.703402583098999	Multiple sclerosis	7e-184	19525955
rs9270880	rs9271366	0.703402583098999	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270880	rs9271366	0.703402583098999	Ulcerative colitis	1e-18	23511034
rs9270880	rs9271366	0.703402583098999	Immunoglobulin A	3e-33	20694011
rs9270880	rs9271366	0.703402583098999	Multiple sclerosis	4e-17	20598377
rs9270880	rs9271366	0.703402583098999	Crohn's disease	5e-12	23850713
rs9270880	rs9271366	0.703402583098999	Systemic lupus erythematosus	1e-07	19838195
rs9270880	rs3129757	0.700938156332392	Cathepsin L1 levels	9e-17	33067605
rs9270880	rs3129762	0.696225464607224	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270880	rs3135005	0.681322534026596	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270880	rs9271147	0.609703238269081	Albumin levels	2e-15	36329257
rs9270917	rs9270984	0.934789698861009	Systemic lupus erythematosus	5e-24	23273568
rs9270917	rs9270986	0.932187644867319	Myasthenia gravis	6e-08	25643325
rs9270917	rs9271055	0.932158497874135	Height	5e-09	36224396
rs9270917	rs9271082	0.925628699765518	IgA nephropathy	8e-09	34076728
rs9270917	rs1966002	0.924159748263046	Systemic lupus erythematosus	8e-31	33272962
rs9270917	rs4329147	0.890106223382684	Childhood ear infection	1e-11	28928442
rs9270917	rs4329147	0.890106223382684	Childhood ear infection	1e-11	27182965
rs9270917	rs4367411	0.878901269694912	Total omega-3 fatty acid levels	7e-09	35692035
rs9270917	rs9271025	0.833193763941117	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270917	rs9271366	0.794210315939035	Ulcerative colitis	7e-06	26278503
rs9270917	rs9271366	0.794210315939035	Multiple sclerosis	7e-184	19525955
rs9270917	rs9271366	0.794210315939035	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270917	rs9271366	0.794210315939035	Ulcerative colitis	1e-18	23511034
rs9270917	rs9271366	0.794210315939035	Immunoglobulin A	3e-33	20694011
rs9270917	rs9271366	0.794210315939035	Multiple sclerosis	4e-17	20598377
rs9270917	rs9271366	0.794210315939035	Crohn's disease	5e-12	23850713
rs9270917	rs9271366	0.794210315939035	Systemic lupus erythematosus	1e-07	19838195
rs9270917	rs3129757	0.791548122930679	Cathepsin L1 levels	9e-17	33067605
rs9270917	rs3129762	0.786341059223027	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270917	rs3135005	0.741377635802832	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270917	rs9271147	0.675130188027273	Albumin levels	2e-15	36329257
rs9270917	rs9271060	0.619427682592603	Crohn's disease	1e-22	26891255
rs9270917	rs9271192	0.619219810605454	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270917	rs9271192	0.619219810605454	Alzheimer's disease	5e-07	31473137
rs9270917	rs9271192	0.619219810605454	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270917	rs9271192	0.619219810605454	Alzheimer's disease (late onset)	3e-12	24162737
rs9270917	rs9271192	0.619219810605454	Alzheimer's disease (late onset)	5e-07	30617256
rs9270917	rs9271100	0.619053066439421	Systemic lupus erythematosus	1e-12	19838193
rs9270917	rs9271100	0.619053066439421	Ulcerative colitis	2e-94	26192919
rs9270917	rs9271100	0.619053066439421	Leprosy	8e-95	25642632
rs9270917	rs9270970	0.618574910648849	Systemic lupus erythematosus	4e-26	32771030
rs9270917	rs9271170	0.616646479489898	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270917	rs9271066	0.607056745185389	Takayasu arteritis	2e-11	33308445
rs9270917	rs9271209	0.606380229373828	Ulcerative colitis	2e-85	26192919
rs9270917	rs9271429	0.602788120599524	Systemic lupus erythematosus	2e-11	34076728
rs9270917	rs9271536	0.602788120599524	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9270917	rs9271536	0.602788120599524	SSC-A on CD4+ T cell	9e-14	32929287
rs9270917	rs9271536	0.602788120599524	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9270917	rs9271536	0.602788120599524	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9270917	rs9271536	0.602788120599524	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9270917	rs9271536	0.602788120599524	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9270923	rs9270984	0.946683777432502	Systemic lupus erythematosus	5e-24	23273568
rs9270923	rs9270986	0.944054373203476	Myasthenia gravis	6e-08	25643325
rs9270923	rs9271055	0.941333605110403	Height	5e-09	36224396
rs9270923	rs1966002	0.93327762301353	Systemic lupus erythematosus	8e-31	33272962
rs9270923	rs9271082	0.929421196943485	IgA nephropathy	8e-09	34076728
rs9270923	rs4329147	0.898981752294636	Childhood ear infection	1e-11	28928442
rs9270923	rs4329147	0.898981752294636	Childhood ear infection	1e-11	27182965
rs9270923	rs4367411	0.89282744287696	Total omega-3 fatty acid levels	7e-09	35692035
rs9270923	rs9271025	0.844144495094166	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270923	rs9271366	0.799723872459318	Ulcerative colitis	7e-06	26278503
rs9270923	rs9271366	0.799723872459318	Multiple sclerosis	7e-184	19525955
rs9270923	rs9271366	0.799723872459318	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270923	rs9271366	0.799723872459318	Ulcerative colitis	1e-18	23511034
rs9270923	rs9271366	0.799723872459318	Immunoglobulin A	3e-33	20694011
rs9270923	rs9271366	0.799723872459318	Multiple sclerosis	4e-17	20598377
rs9270923	rs9271366	0.799723872459318	Crohn's disease	5e-12	23850713
rs9270923	rs9271366	0.799723872459318	Systemic lupus erythematosus	1e-07	19838195
rs9270923	rs3129757	0.797049580770603	Cathepsin L1 levels	9e-17	33067605
rs9270923	rs3129762	0.791812795352681	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270923	rs3135005	0.744184380299811	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270923	rs9271147	0.684959659176811	Albumin levels	2e-15	36329257
rs9270923	rs9270970	0.633408039022627	Systemic lupus erythematosus	4e-26	32771030
rs9270923	rs9271060	0.630363274336794	Crohn's disease	1e-22	26891255
rs9270923	rs9271100	0.62803103194375	Systemic lupus erythematosus	1e-12	19838193
rs9270923	rs9271100	0.62803103194375	Ulcerative colitis	2e-94	26192919
rs9270923	rs9271100	0.62803103194375	Leprosy	8e-95	25642632
rs9270923	rs9271192	0.626244460316397	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270923	rs9271192	0.626244460316397	Alzheimer's disease	5e-07	31473137
rs9270923	rs9271192	0.626244460316397	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270923	rs9271192	0.626244460316397	Alzheimer's disease (late onset)	3e-12	24162737
rs9270923	rs9271192	0.626244460316397	Alzheimer's disease (late onset)	5e-07	30617256
rs9270923	rs9271170	0.62560306341384	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270923	rs9271066	0.621705569297456	Takayasu arteritis	2e-11	33308445
rs9270923	rs9271209	0.613322569982238	Ulcerative colitis	2e-85	26192919
rs9270923	rs9271536	0.605903152888949	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9270923	rs9271536	0.605903152888949	SSC-A on CD4+ T cell	9e-14	32929287
rs9270923	rs9271536	0.605903152888949	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9270923	rs9271536	0.605903152888949	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9270923	rs9271536	0.605903152888949	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9270923	rs9271536	0.605903152888949	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9270923	rs9271429	0.602108312621606	Systemic lupus erythematosus	2e-11	34076728
rs9270928	rs9270984	0.961403065638163	Systemic lupus erythematosus	5e-24	23273568
rs9270928	rs9270986	0.95874383367409	Myasthenia gravis	6e-08	25643325
rs9270928	rs9271055	0.955993683584516	Height	5e-09	36224396
rs9270928	rs1966002	0.947849555205632	Systemic lupus erythematosus	8e-31	33272962
rs9270928	rs9271082	0.943949730646495	IgA nephropathy	8e-09	34076728
rs9270928	rs4329147	0.91317561854691	Childhood ear infection	1e-11	28928442
rs9270928	rs4329147	0.91317561854691	Childhood ear infection	1e-11	27182965
rs9270928	rs4367411	0.899207019128436	Total omega-3 fatty acid levels	7e-09	35692035
rs9270928	rs9271025	0.860209405627323	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270928	rs9271366	0.812859955465282	Ulcerative colitis	7e-06	26278503
rs9270928	rs9271366	0.812859955465282	Multiple sclerosis	7e-184	19525955
rs9270928	rs9271366	0.812859955465282	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270928	rs9271366	0.812859955465282	Ulcerative colitis	1e-18	23511034
rs9270928	rs9271366	0.812859955465282	Immunoglobulin A	3e-33	20694011
rs9270928	rs9271366	0.812859955465282	Multiple sclerosis	4e-17	20598377
rs9270928	rs9271366	0.812859955465282	Crohn's disease	5e-12	23850713
rs9270928	rs9271366	0.812859955465282	Systemic lupus erythematosus	1e-07	19838195
rs9270928	rs3129757	0.810153829564292	Cathepsin L1 levels	9e-17	33067605
rs9270928	rs3129762	0.804857493270078	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270928	rs3135005	0.751661075902663	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270928	rs9271147	0.696859178991459	Albumin levels	2e-15	36329257
rs9270928	rs9270970	0.64071207651242	Systemic lupus erythematosus	4e-26	32771030
rs9270928	rs9271060	0.639606684266232	Crohn's disease	1e-22	26891255
rs9270928	rs9271100	0.637243782552335	Systemic lupus erythematosus	1e-12	19838193
rs9270928	rs9271100	0.637243782552335	Ulcerative colitis	2e-94	26192919
rs9270928	rs9271100	0.637243782552335	Leprosy	8e-95	25642632
rs9270928	rs9271192	0.635434768630209	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270928	rs9271192	0.635434768630209	Alzheimer's disease	5e-07	31473137
rs9270928	rs9271192	0.635434768630209	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270928	rs9271192	0.635434768630209	Alzheimer's disease (late onset)	3e-12	24162737
rs9270928	rs9271192	0.635434768630209	Alzheimer's disease (late onset)	5e-07	30617256
rs9270928	rs9271170	0.634801530186486	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270928	rs9271066	0.630880561329108	Takayasu arteritis	2e-11	33308445
rs9270928	rs9271209	0.622410451813928	Ulcerative colitis	2e-85	26192919
rs9270928	rs9271536	0.616848330537103	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9270928	rs9271536	0.616848330537103	SSC-A on CD4+ T cell	9e-14	32929287
rs9270928	rs9271536	0.616848330537103	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9270928	rs9271536	0.616848330537103	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9270928	rs9271536	0.616848330537103	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9270928	rs9271536	0.616848330537103	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9270928	rs9271429	0.614926300674119	Systemic lupus erythematosus	2e-11	34076728
rs9270980	rs9270984	0.991616925779876	Systemic lupus erythematosus	5e-24	23273568
rs9270980	rs9270986	0.986103274189104	Myasthenia gravis	6e-08	25643325
rs9270980	rs9271055	0.983307331623531	Height	5e-09	36224396
rs9270980	rs1966002	0.975009826841871	Systemic lupus erythematosus	8e-31	33272962
rs9270980	rs9271082	0.971016064546922	IgA nephropathy	8e-09	34076728
rs9270980	rs4329147	0.926199801319313	Childhood ear infection	1e-11	28928442
rs9270980	rs4329147	0.926199801319313	Childhood ear infection	1e-11	27182965
rs9270980	rs4367411	0.901829826727121	Total omega-3 fatty acid levels	7e-09	35692035
rs9270980	rs9271025	0.870375380488147	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270980	rs9271366	0.837829270050365	Ulcerative colitis	7e-06	26278503
rs9270980	rs9271366	0.837829270050365	Multiple sclerosis	7e-184	19525955
rs9270980	rs9271366	0.837829270050365	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270980	rs9271366	0.837829270050365	Ulcerative colitis	1e-18	23511034
rs9270980	rs9271366	0.837829270050365	Immunoglobulin A	3e-33	20694011
rs9270980	rs9271366	0.837829270050365	Multiple sclerosis	4e-17	20598377
rs9270980	rs9271366	0.837829270050365	Crohn's disease	5e-12	23850713
rs9270980	rs9271366	0.837829270050365	Systemic lupus erythematosus	1e-07	19838195
rs9270980	rs3129757	0.835060857256798	Cathepsin L1 levels	9e-17	33067605
rs9270980	rs3129762	0.829659096664915	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270980	rs3135005	0.775220772879372	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270980	rs9271147	0.714606095117745	Albumin levels	2e-15	36329257
rs9270980	rs9271100	0.659872124854984	Systemic lupus erythematosus	1e-12	19838193
rs9270980	rs9271100	0.659872124854984	Ulcerative colitis	2e-94	26192919
rs9270980	rs9271100	0.659872124854984	Leprosy	8e-95	25642632
rs9270980	rs9271060	0.658251115985151	Crohn's disease	1e-22	26891255
rs9270980	rs9271192	0.658025449254946	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270980	rs9271192	0.658025449254946	Alzheimer's disease	5e-07	31473137
rs9270980	rs9271192	0.658025449254946	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270980	rs9271192	0.658025449254946	Alzheimer's disease (late onset)	3e-12	24162737
rs9270980	rs9271192	0.658025449254946	Alzheimer's disease (late onset)	5e-07	30617256
rs9270980	rs9270970	0.657368047757149	Systemic lupus erythematosus	4e-26	32771030
rs9270980	rs9271170	0.657368047757149	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270980	rs9271066	0.645392172495893	Takayasu arteritis	2e-11	33308445
rs9270980	rs9271209	0.642709010452506	Ulcerative colitis	2e-85	26192919
rs9270980	rs9271536	0.629199056701949	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9270980	rs9271536	0.629199056701949	SSC-A on CD4+ T cell	9e-14	32929287
rs9270980	rs9271536	0.629199056701949	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9270980	rs9271536	0.629199056701949	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9270980	rs9271536	0.629199056701949	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9270980	rs9271536	0.629199056701949	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9270980	rs9271429	0.627249015727026	Systemic lupus erythematosus	2e-11	34076728
rs9270980	rs9271180	0.616034013695382	Alzheimer's disease or educational attainment (pleiotropy)	5e-10	34743297
rs9270980	rs9268851	0.612109678328851	Serum levels of protein H6PD	1e-96	35078996
rs9270980	rs9268851	0.612109678328851	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9270980	rs9271011	0.611554588734038	Leprosy	4e-50	35512355
rs9270980	rs3104376	0.610197330240312	Itch intensity from mosquito bite	2e-28	28199695
rs9270984	rs9270984	1	Systemic lupus erythematosus	5e-24	23273568
rs9270984	rs9270986	0.980564859945092	Myasthenia gravis	6e-08	25643325
rs9270984	rs9271055	0.977771755416565	Height	5e-09	36224396
rs9270984	rs1966002	0.969497688750062	Systemic lupus erythematosus	8e-31	33272962
rs9270984	rs9271082	0.968272417721699	IgA nephropathy	8e-09	34076728
rs9270984	rs4329147	0.920842191552064	Childhood ear infection	1e-11	28928442
rs9270984	rs4329147	0.920842191552064	Childhood ear infection	1e-11	27182965
rs9270984	rs4367411	0.896654740917682	Total omega-3 fatty acid levels	7e-09	35692035
rs9270984	rs9271025	0.867870713791177	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270984	rs9271366	0.832412621625297	Ulcerative colitis	7e-06	26278503
rs9270984	rs9271366	0.832412621625297	Multiple sclerosis	7e-184	19525955
rs9270984	rs9271366	0.832412621625297	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270984	rs9271366	0.832412621625297	Ulcerative colitis	1e-18	23511034
rs9270984	rs9271366	0.832412621625297	Immunoglobulin A	3e-33	20694011
rs9270984	rs9271366	0.832412621625297	Multiple sclerosis	4e-17	20598377
rs9270984	rs9271366	0.832412621625297	Crohn's disease	5e-12	23850713
rs9270984	rs9271366	0.832412621625297	Systemic lupus erythematosus	1e-07	19838195
rs9270984	rs3129757	0.829659096664915	Cathepsin L1 levels	9e-17	33067605
rs9270984	rs3129762	0.824274864002717	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270984	rs3135005	0.772678776615759	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270984	rs9271147	0.714606095117745	Albumin levels	2e-15	36329257
rs9270984	rs9271100	0.653830774801105	Systemic lupus erythematosus	1e-12	19838193
rs9270984	rs9271100	0.653830774801105	Ulcerative colitis	2e-94	26192919
rs9270984	rs9271100	0.653830774801105	Leprosy	8e-95	25642632
rs9270984	rs9271060	0.652225875869986	Crohn's disease	1e-22	26891255
rs9270984	rs9271192	0.651987344270479	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270984	rs9271192	0.651987344270479	Alzheimer's disease	5e-07	31473137
rs9270984	rs9271192	0.651987344270479	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270984	rs9271192	0.651987344270479	Alzheimer's disease (late onset)	3e-12	24162737
rs9270984	rs9271192	0.651987344270479	Alzheimer's disease (late onset)	5e-07	30617256
rs9270984	rs9270970	0.65135373895484	Systemic lupus erythematosus	4e-26	32771030
rs9270984	rs9271170	0.65135373895484	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270984	rs9271066	0.639456536645937	Takayasu arteritis	2e-11	33308445
rs9270984	rs9271209	0.636787410006639	Ulcerative colitis	2e-85	26192919
rs9270984	rs9271536	0.625302001269615	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9270984	rs9271536	0.625302001269615	SSC-A on CD4+ T cell	9e-14	32929287
rs9270984	rs9271536	0.625302001269615	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9270984	rs9271536	0.625302001269615	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9270984	rs9271536	0.625302001269615	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9270984	rs9271536	0.625302001269615	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9270984	rs9271429	0.621417051907328	Systemic lupus erythematosus	2e-11	34076728
rs9270984	rs9268851	0.612109678328851	Serum levels of protein H6PD	1e-96	35078996
rs9270984	rs9268851	0.612109678328851	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9270984	rs9271180	0.610267190067729	Alzheimer's disease or educational attainment (pleiotropy)	5e-10	34743297
rs9270984	rs3104376	0.610197330240312	Itch intensity from mosquito bite	2e-28	28199695
rs9270984	rs9271011	0.605859119829546	Leprosy	4e-50	35512355
rs9270986	rs9270986	1	Myasthenia gravis	6e-08	25643325
rs9270986	rs9271055	0.983347008347586	Height	5e-09	36224396
rs9270986	rs9270984	0.980564859945092	Systemic lupus erythematosus	5e-24	23273568
rs9270986	rs1966002	0.969574734257867	Systemic lupus erythematosus	8e-31	33272962
rs9270986	rs9271082	0.962851975264559	IgA nephropathy	8e-09	34076728
rs9270986	rs4329147	0.929036183433597	Childhood ear infection	1e-11	28928442
rs9270986	rs4329147	0.929036183433597	Childhood ear infection	1e-11	27182965
rs9270986	rs4367411	0.894056437872953	Total omega-3 fatty acid levels	7e-09	35692035
rs9270986	rs9271025	0.862753637377542	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9270986	rs9271366	0.836224464187768	Ulcerative colitis	7e-06	26278503
rs9270986	rs9271366	0.836224464187768	Multiple sclerosis	7e-184	19525955
rs9270986	rs9271366	0.836224464187768	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9270986	rs9271366	0.836224464187768	Ulcerative colitis	1e-18	23511034
rs9270986	rs9271366	0.836224464187768	Immunoglobulin A	3e-33	20694011
rs9270986	rs9271366	0.836224464187768	Multiple sclerosis	4e-17	20598377
rs9270986	rs9271366	0.836224464187768	Crohn's disease	5e-12	23850713
rs9270986	rs9271366	0.836224464187768	Systemic lupus erythematosus	1e-07	19838195
rs9270986	rs3129757	0.830763460368415	Cathepsin L1 levels	9e-17	33067605
rs9270986	rs3129762	0.825390355827359	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9270986	rs3135005	0.773627457163994	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9270986	rs9271147	0.708629106954183	Albumin levels	2e-15	36329257
rs9270986	rs9271100	0.663459886857244	Systemic lupus erythematosus	1e-12	19838193
rs9270986	rs9271100	0.663459886857244	Ulcerative colitis	2e-94	26192919
rs9270986	rs9271100	0.663459886857244	Leprosy	8e-95	25642632
rs9270986	rs9271170	0.660915595490581	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9270986	rs9271192	0.657598286889006	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9270986	rs9271192	0.657598286889006	Alzheimer's disease	5e-07	31473137
rs9270986	rs9271192	0.657598286889006	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9270986	rs9271192	0.657598286889006	Alzheimer's disease (late onset)	3e-12	24162737
rs9270986	rs9271192	0.657598286889006	Alzheimer's disease (late onset)	5e-07	30617256
rs9270986	rs9271060	0.655791400261496	Crohn's disease	1e-22	26891255
rs9270986	rs9270970	0.65490150375889	Systemic lupus erythematosus	4e-26	32771030
rs9270986	rs9271066	0.642943238181825	Takayasu arteritis	2e-11	33308445
rs9270986	rs9271209	0.642240622789455	Ulcerative colitis	2e-85	26192919
rs9270986	rs9271536	0.630684522279287	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9270986	rs9271536	0.630684522279287	SSC-A on CD4+ T cell	9e-14	32929287
rs9270986	rs9271536	0.630684522279287	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9270986	rs9271536	0.630684522279287	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9270986	rs9271536	0.630684522279287	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9270986	rs9271536	0.630684522279287	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9270986	rs9271429	0.626793519935467	Systemic lupus erythematosus	2e-11	34076728
rs9270986	rs9271180	0.61558825686639	Alzheimer's disease or educational attainment (pleiotropy)	5e-10	34743297
rs9270986	rs9268851	0.612119301070884	Serum levels of protein H6PD	1e-96	35078996
rs9270986	rs9268851	0.612119301070884	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9270986	rs9271011	0.60723418440909	Leprosy	4e-50	35512355
rs9270986	rs3104376	0.60606337396463	Itch intensity from mosquito bite	2e-28	28199695
rs9271184	rs9271192	0.943635109584568	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9271184	rs9271192	0.943635109584568	Alzheimer's disease	5e-07	31473137
rs9271184	rs9271192	0.943635109584568	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9271184	rs9271192	0.943635109584568	Alzheimer's disease (late onset)	3e-12	24162737
rs9271184	rs9271192	0.943635109584568	Alzheimer's disease (late onset)	5e-07	30617256
rs9271184	rs9271100	0.9362027883632	Systemic lupus erythematosus	1e-12	19838193
rs9271184	rs9271100	0.9362027883632	Ulcerative colitis	2e-94	26192919
rs9271184	rs9271100	0.9362027883632	Leprosy	8e-95	25642632
rs9271184	rs9271170	0.928927444419315	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9271184	rs9271209	0.915652232721637	Ulcerative colitis	2e-85	26192919
rs9271184	rs9271060	0.909902516589113	Crohn's disease	1e-22	26891255
rs9271184	rs9270970	0.90164841310013	Systemic lupus erythematosus	4e-26	32771030
rs9271184	rs9271180	0.892585229565769	Alzheimer's disease or educational attainment (pleiotropy)	5e-10	34743297
rs9271184	rs9271066	0.891737602596258	Takayasu arteritis	2e-11	33308445
rs9271184	rs9271011	0.857128699783382	Leprosy	4e-50	35512355
rs9271184	rs9270539	0.821404095452852	Systemic lupus erythematosus	4e-36	34076728
rs9271184	rs745475218	0.795123534708758	Allergen component sensitization (Hevea brasiliensis 8)	3e-08	37780799
rs9271184	rs9271176	0.759270123728267	Chronic lymphocytic leukemia	3e-20	28165464
rs9271184	rs9270891	0.747186176630856	Ubiquitin carboxyl-terminal hydrolase 25 levels (USP25.9215.117.3)	6e-35	29875488
rs9271184	rs9270779	0.746003448483443	Heart rate response to exercise	1e-08	29769521
rs9271184	rs9270750	0.671241483423866	Chronic lymphocytic leukemia	6e-16	26956414
rs9271184	rs9270965	0.665790505137861	Narcolepsy (onset before 2009 H1N1 influenza pandemic)	5e-12	24204295
rs9271184	rs9270986	0.627199197882099	Myasthenia gravis	6e-08	25643325
rs9271184	rs9271055	0.625363280797478	Height	5e-09	36224396
rs9271184	rs1966002	0.623408540962475	Systemic lupus erythematosus	8e-31	33272962
rs9271184	rs9270984	0.621696783838955	Systemic lupus erythematosus	5e-24	23273568
rs9271184	rs9271082	0.612348068795755	IgA nephropathy	8e-09	34076728
rs9271191	rs9271055	0.969519633345231	Height	5e-09	36224396
rs9271191	rs1966002	0.969519633345231	Systemic lupus erythematosus	8e-31	33272962
rs9271191	rs9270986	0.9668076298528	Myasthenia gravis	6e-08	25643325
rs9271191	rs9270984	0.966711591922176	Systemic lupus erythematosus	5e-24	23273568
rs9271191	rs9271082	0.954634500787374	IgA nephropathy	8e-09	34076728
rs9271191	rs4329147	0.91289618669388	Childhood ear infection	1e-11	28928442
rs9271191	rs4329147	0.91289618669388	Childhood ear infection	1e-11	27182965
rs9271191	rs4367411	0.883782673923146	Total omega-3 fatty acid levels	7e-09	35692035
rs9271191	rs9271025	0.855365562865051	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9271191	rs3129757	0.830024569442089	Cathepsin L1 levels	9e-17	33067605
rs9271191	rs9271366	0.824693972164723	Ulcerative colitis	7e-06	26278503
rs9271191	rs9271366	0.824693972164723	Multiple sclerosis	7e-184	19525955
rs9271191	rs9271366	0.824693972164723	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9271191	rs9271366	0.824693972164723	Ulcerative colitis	1e-18	23511034
rs9271191	rs9271366	0.824693972164723	Immunoglobulin A	3e-33	20694011
rs9271191	rs9271366	0.824693972164723	Multiple sclerosis	4e-17	20598377
rs9271191	rs9271366	0.824693972164723	Crohn's disease	5e-12	23850713
rs9271191	rs9271366	0.824693972164723	Systemic lupus erythematosus	1e-07	19838195
rs9271191	rs3129762	0.824644071732344	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9271191	rs3135005	0.762873440163794	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9271191	rs9271147	0.707330659839264	Albumin levels	2e-15	36329257
rs9271191	rs9271192	0.665965994906422	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9271191	rs9271192	0.665965994906422	Alzheimer's disease	5e-07	31473137
rs9271191	rs9271192	0.665965994906422	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9271191	rs9271192	0.665965994906422	Alzheimer's disease (late onset)	3e-12	24162737
rs9271191	rs9271192	0.665965994906422	Alzheimer's disease (late onset)	5e-07	30617256
rs9271191	rs9271100	0.651680967216733	Systemic lupus erythematosus	1e-12	19838193
rs9271191	rs9271100	0.651680967216733	Ulcerative colitis	2e-94	26192919
rs9271191	rs9271100	0.651680967216733	Leprosy	8e-95	25642632
rs9271191	rs9271170	0.649205555931013	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9271191	rs9271060	0.644095394537695	Crohn's disease	1e-22	26891255
rs9271191	rs9271209	0.642550069226443	Ulcerative colitis	2e-85	26192919
rs9271191	rs9270970	0.639268704576999	Systemic lupus erythematosus	4e-26	32771030
rs9271191	rs9271066	0.631438655602679	Takayasu arteritis	2e-11	33308445
rs9271191	rs9271536	0.619332593027666	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9271191	rs9271536	0.619332593027666	SSC-A on CD4+ T cell	9e-14	32929287
rs9271191	rs9271536	0.619332593027666	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9271191	rs9271536	0.619332593027666	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9271191	rs9271536	0.619332593027666	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9271191	rs9271536	0.619332593027666	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9271191	rs9271429	0.617399683591964	Systemic lupus erythematosus	2e-11	34076728
rs9271191	rs9271180	0.610121887959714	Alzheimer's disease or educational attainment (pleiotropy)	5e-10	34743297
rs9271191	rs3104376	0.60428721294671	Itch intensity from mosquito bite	2e-28	28199695
rs9271191	rs9268851	0.602682498535378	Serum levels of protein H6PD	1e-96	35078996
rs9271191	rs9268851	0.602682498535378	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9271366	rs9271366	1	Ulcerative colitis	7e-06	26278503
rs9271366	rs9271366	1	Multiple sclerosis	7e-184	19525955
rs9271366	rs9271366	1	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9271366	rs9271366	1	Ulcerative colitis	1e-18	23511034
rs9271366	rs9271366	1	Immunoglobulin A	3e-33	20694011
rs9271366	rs9271366	1	Multiple sclerosis	4e-17	20598377
rs9271366	rs9271366	1	Crohn's disease	5e-12	23850713
rs9271366	rs9271366	1	Systemic lupus erythematosus	1e-07	19838195
rs9271366	rs3129757	0.990625068213502	Cathepsin L1 levels	9e-17	33067605
rs9271366	rs3129762	0.984398019214591	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9271366	rs3135005	0.929249816269998	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9271366	rs9271055	0.838559979320872	Height	5e-09	36224396
rs9271366	rs9270986	0.836224464187768	Myasthenia gravis	6e-08	25643325
rs9271366	rs9270984	0.832412621625297	Systemic lupus erythematosus	5e-24	23273568
rs9271366	rs1966002	0.830452852785127	Systemic lupus erythematosus	8e-31	33272962
rs9271366	rs9271082	0.822390299939463	IgA nephropathy	8e-09	34076728
rs9271366	rs4329147	0.789097537251532	Childhood ear infection	1e-11	28928442
rs9271366	rs4329147	0.789097537251532	Childhood ear infection	1e-11	27182965
rs9271366	rs4367411	0.760296454799756	Total omega-3 fatty acid levels	7e-09	35692035
rs9271366	rs9271025	0.737808641108662	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9271366	rs9271421	0.663508918428329	GDH/6PGL endoplasmic bifunctional protein levels (H6PD.7161.25.3)	5e-29	29875488
rs9271366	rs9268851	0.632070096183797	Serum levels of protein H6PD	1e-96	35078996
rs9271366	rs9268851	0.632070096183797	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9271366	rs9271363	0.610763058714665	Colorectal cancer	9e-20	36539618
rs9271369	rs9271348	0.897274696991784	Rheumatoid arthritis (ACPA-negative)	5e-07	24532677
rs9271369	rs9271348	0.897274696991784	Serum levels of protein KCNE2	7e-13	35078996
rs9271369	rs9271348	0.897274696991784	Height	1e-54	36224396
rs9271370	rs9271348	0.897274696991784	Rheumatoid arthritis (ACPA-negative)	5e-07	24532677
rs9271370	rs9271348	0.897274696991784	Serum levels of protein KCNE2	7e-13	35078996
rs9271370	rs9271348	0.897274696991784	Height	1e-54	36224396
rs9271413	rs3129757	0.984412618612503	Cathepsin L1 levels	9e-17	33067605
rs9271413	rs9271366	0.984398019214591	Ulcerative colitis	7e-06	26278503
rs9271413	rs9271366	0.984398019214591	Multiple sclerosis	7e-184	19525955
rs9271413	rs9271366	0.984398019214591	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9271413	rs9271366	0.984398019214591	Ulcerative colitis	1e-18	23511034
rs9271413	rs9271366	0.984398019214591	Immunoglobulin A	3e-33	20694011
rs9271413	rs9271366	0.984398019214591	Multiple sclerosis	4e-17	20598377
rs9271413	rs9271366	0.984398019214591	Crohn's disease	5e-12	23850713
rs9271413	rs9271366	0.984398019214591	Systemic lupus erythematosus	1e-07	19838195
rs9271413	rs3129762	0.981309835057923	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9271413	rs3135005	0.91747763364198	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9271413	rs9271055	0.825015906297619	Height	5e-09	36224396
rs9271413	rs1966002	0.825015906297619	Systemic lupus erythematosus	8e-31	33272962
rs9271413	rs9270986	0.822710340614583	Myasthenia gravis	6e-08	25643325
rs9271413	rs9270984	0.821589320645251	Systemic lupus erythematosus	5e-24	23273568
rs9271413	rs9271082	0.811676307275362	IgA nephropathy	8e-09	34076728
rs9271413	rs4329147	0.783845838847991	Childhood ear infection	1e-11	28928442
rs9271413	rs4329147	0.783845838847991	Childhood ear infection	1e-11	27182965
rs9271413	rs4367411	0.750191220248034	Total omega-3 fatty acid levels	7e-09	35692035
rs9271413	rs9271025	0.727969652117441	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9271413	rs9271421	0.673109458225568	GDH/6PGL endoplasmic bifunctional protein levels (H6PD.7161.25.3)	5e-29	29875488
rs9271413	rs9268851	0.621756139349083	Serum levels of protein H6PD	1e-96	35078996
rs9271413	rs9268851	0.621756139349083	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9271413	rs9271363	0.606395860369523	Colorectal cancer	9e-20	36539618
rs9271423	rs3129757	0.976632087321249	Cathepsin L1 levels	9e-17	33067605
rs9271423	rs9271366	0.976601740551128	Ulcerative colitis	7e-06	26278503
rs9271423	rs9271366	0.976601740551128	Multiple sclerosis	7e-184	19525955
rs9271423	rs9271366	0.976601740551128	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9271423	rs9271366	0.976601740551128	Ulcerative colitis	1e-18	23511034
rs9271423	rs9271366	0.976601740551128	Immunoglobulin A	3e-33	20694011
rs9271423	rs9271366	0.976601740551128	Multiple sclerosis	4e-17	20598377
rs9271423	rs9271366	0.976601740551128	Crohn's disease	5e-12	23850713
rs9271423	rs9271366	0.976601740551128	Systemic lupus erythematosus	1e-07	19838195
rs9271423	rs3129762	0.973536511905333	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9271423	rs3135005	0.910193688818609	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9271423	rs9271055	0.818390809725618	Height	5e-09	36224396
rs9271423	rs1966002	0.818390809725618	Systemic lupus erythematosus	8e-31	33272962
rs9271423	rs9270986	0.816102416319226	Myasthenia gravis	6e-08	25643325
rs9271423	rs9270984	0.814948964275684	Systemic lupus erythematosus	5e-24	23273568
rs9271423	rs9271082	0.805123699544256	IgA nephropathy	8e-09	34076728
rs9271423	rs4329147	0.774755503814588	Childhood ear infection	1e-11	28928442
rs9271423	rs4329147	0.774755503814588	Childhood ear infection	1e-11	27182965
rs9271423	rs4367411	0.746542386263314	Total omega-3 fatty acid levels	7e-09	35692035
rs9271423	rs9271025	0.724486923644151	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9271423	rs9271421	0.679249668667089	GDH/6PGL endoplasmic bifunctional protein levels (H6PD.7161.25.3)	5e-29	29875488
rs9271423	rs9268851	0.613761367421599	Serum levels of protein H6PD	1e-96	35078996
rs9271423	rs9268851	0.613761367421599	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9271423	rs9271363	0.601409573686075	Colorectal cancer	9e-20	36539618
rs9271466	rs9271055	0.939950472401547	Height	5e-09	36224396
rs9271466	rs9270986	0.9372977179276	Myasthenia gravis	6e-08	25643325
rs9271466	rs1966002	0.937262074659253	Systemic lupus erythematosus	8e-31	33272962
rs9271466	rs9270984	0.937201568011345	Systemic lupus erythematosus	5e-24	23273568
rs9271466	rs9271082	0.925389413248967	IgA nephropathy	8e-09	34076728
rs9271466	rs4329147	0.887163483159926	Childhood ear infection	1e-11	28928442
rs9271466	rs4329147	0.887163483159926	Childhood ear infection	1e-11	27182965
rs9271466	rs4367411	0.861108916166009	Total omega-3 fatty acid levels	7e-09	35692035
rs9271466	rs9271025	0.845370290125324	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9271466	rs9271366	0.808752554947788	Ulcerative colitis	7e-06	26278503
rs9271466	rs9271366	0.808752554947788	Multiple sclerosis	7e-184	19525955
rs9271466	rs9271366	0.808752554947788	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9271466	rs9271366	0.808752554947788	Ulcerative colitis	1e-18	23511034
rs9271466	rs9271366	0.808752554947788	Immunoglobulin A	3e-33	20694011
rs9271466	rs9271366	0.808752554947788	Multiple sclerosis	4e-17	20598377
rs9271466	rs9271366	0.808752554947788	Crohn's disease	5e-12	23850713
rs9271466	rs9271366	0.808752554947788	Systemic lupus erythematosus	1e-07	19838195
rs9271466	rs3129757	0.808694750347298	Cathepsin L1 levels	9e-17	33067605
rs9271466	rs3129762	0.80605393015519	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9271466	rs3135005	0.760177600257021	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9271466	rs9271147	0.675647313203021	Albumin levels	2e-15	36329257
rs9271466	rs9271100	0.629058165971149	Systemic lupus erythematosus	1e-12	19838193
rs9271466	rs9271100	0.629058165971149	Ulcerative colitis	2e-94	26192919
rs9271466	rs9271100	0.629058165971149	Leprosy	8e-95	25642632
rs9271466	rs9271192	0.627268565488017	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9271466	rs9271192	0.627268565488017	Alzheimer's disease	5e-07	31473137
rs9271466	rs9271192	0.627268565488017	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9271466	rs9271192	0.627268565488017	Alzheimer's disease (late onset)	3e-12	24162737
rs9271466	rs9271192	0.627268565488017	Alzheimer's disease (late onset)	5e-07	30617256
rs9271466	rs9271170	0.626629427131769	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9271466	rs9271060	0.623589734270296	Crohn's disease	1e-22	26891255
rs9271466	rs9270970	0.618862994733499	Systemic lupus erythematosus	4e-26	32771030
rs9271466	rs9271429	0.612632943998975	Systemic lupus erythematosus	2e-11	34076728
rs9271466	rs9271536	0.612632943998975	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9271466	rs9271536	0.612632943998975	SSC-A on CD4+ T cell	9e-14	32929287
rs9271466	rs9271536	0.612632943998975	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9271466	rs9271536	0.612632943998975	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9271466	rs9271536	0.612632943998975	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9271466	rs9271536	0.612632943998975	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9271466	rs9271209	0.612418341569087	Ulcerative colitis	2e-85	26192919
rs9271466	rs9271066	0.611181120369355	Takayasu arteritis	2e-11	33308445
rs9271481	rs3129757	0.984398019214591	Cathepsin L1 levels	9e-17	33067605
rs9271481	rs9271366	0.984378531394668	Ulcerative colitis	7e-06	26278503
rs9271481	rs9271366	0.984378531394668	Multiple sclerosis	7e-184	19525955
rs9271481	rs9271366	0.984378531394668	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9271481	rs9271366	0.984378531394668	Ulcerative colitis	1e-18	23511034
rs9271481	rs9271366	0.984378531394668	Immunoglobulin A	3e-33	20694011
rs9271481	rs9271366	0.984378531394668	Multiple sclerosis	4e-17	20598377
rs9271481	rs9271366	0.984378531394668	Crohn's disease	5e-12	23850713
rs9271481	rs9271366	0.984378531394668	Systemic lupus erythematosus	1e-07	19838195
rs9271481	rs3129762	0.978190603523182	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9271481	rs3135005	0.914568644077976	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9271481	rs9271055	0.825069979593344	Height	5e-09	36224396
rs9271481	rs1966002	0.825069979593344	Systemic lupus erythematosus	8e-31	33272962
rs9271481	rs9270986	0.822765548573411	Myasthenia gravis	6e-08	25643325
rs9271481	rs9270984	0.821632024011336	Systemic lupus erythematosus	5e-24	23273568
rs9271481	rs9271082	0.811728316634713	IgA nephropathy	8e-09	34076728
rs9271481	rs4329147	0.783864869695686	Childhood ear infection	1e-11	28928442
rs9271481	rs4329147	0.783864869695686	Childhood ear infection	1e-11	27182965
rs9271481	rs4367411	0.750257424193226	Total omega-3 fatty acid levels	7e-09	35692035
rs9271481	rs9271025	0.730499701243049	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9271481	rs9271421	0.66643026135798	GDH/6PGL endoplasmic bifunctional protein levels (H6PD.7161.25.3)	5e-29	29875488
rs9271481	rs9268851	0.618253398062384	Serum levels of protein H6PD	1e-96	35078996
rs9271481	rs9268851	0.618253398062384	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9271481	rs9271363	0.606561054383262	Colorectal cancer	9e-20	36539618
rs9271525	rs9271055	0.975026779839282	Height	5e-09	36224396
rs9271525	rs9270986	0.972302067818767	Myasthenia gravis	6e-08	25643325
rs9271525	rs9270984	0.97222085112439	Systemic lupus erythematosus	5e-24	23273568
rs9271525	rs1966002	0.969519633345231	Systemic lupus erythematosus	8e-31	33272962
rs9271525	rs9271082	0.960081923647128	IgA nephropathy	8e-09	34076728
rs9271525	rs4329147	0.918225773263043	Childhood ear infection	1e-11	28928442
rs9271525	rs4329147	0.918225773263043	Childhood ear infection	1e-11	27182965
rs9271525	rs4367411	0.888915822388877	Total omega-3 fatty acid levels	7e-09	35692035
rs9271525	rs9271025	0.865324341905346	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9271525	rs9271366	0.832780407301677	Ulcerative colitis	7e-06	26278503
rs9271525	rs9271366	0.832780407301677	Multiple sclerosis	7e-184	19525955
rs9271525	rs9271366	0.832780407301677	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9271525	rs9271366	0.832780407301677	Ulcerative colitis	1e-18	23511034
rs9271525	rs9271366	0.832780407301677	Immunoglobulin A	3e-33	20694011
rs9271525	rs9271366	0.832780407301677	Multiple sclerosis	4e-17	20598377
rs9271525	rs9271366	0.832780407301677	Crohn's disease	5e-12	23850713
rs9271525	rs9271366	0.832780407301677	Systemic lupus erythematosus	1e-07	19838195
rs9271525	rs3129757	0.830024569442089	Cathepsin L1 levels	9e-17	33067605
rs9271525	rs3129762	0.824644071732344	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9271525	rs3135005	0.770456484506878	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs9271525	rs9271147	0.707330659839264	Albumin levels	2e-15	36329257
rs9271525	rs9271100	0.65368651852829	Systemic lupus erythematosus	1e-12	19838193
rs9271525	rs9271100	0.65368651852829	Ulcerative colitis	2e-94	26192919
rs9271525	rs9271100	0.65368651852829	Leprosy	8e-95	25642632
rs9271525	rs9271192	0.651848296452952	Alzheimer's disease or family history of Alzheimer's disease	7e-10	29777097
rs9271525	rs9271192	0.651848296452952	Alzheimer's disease	5e-07	31473137
rs9271525	rs9271192	0.651848296452952	Alzheimer's disease or family history of Alzheimer's disease	4e-08	30617256
rs9271525	rs9271192	0.651848296452952	Alzheimer's disease (late onset)	3e-12	24162737
rs9271525	rs9271192	0.651848296452952	Alzheimer's disease (late onset)	5e-07	30617256
rs9271525	rs9271170	0.651202122425855	Circulating leptin levels in high cardiovascular risk	8e-06	31766143
rs9271525	rs9271060	0.648080428545385	Crohn's disease	1e-22	26891255
rs9271525	rs9270970	0.643234248894565	Systemic lupus erythematosus	4e-26	32771030
rs9271525	rs9271536	0.640793981377393	Epstein-Barr virus VCA p18 antibody levels	7e-21	33204752
rs9271525	rs9271536	0.640793981377393	SSC-A on CD4+ T cell	9e-14	32929287
rs9271525	rs9271536	0.640793981377393	Naive CD4+ T cell %CD4+ T cell	4e-12	32929287
rs9271525	rs9271536	0.640793981377393	Effector Memory CD4+ T cell %T cell	3e-12	32929287
rs9271525	rs9271536	0.640793981377393	Terminally Differentiated CD4+ T cell %CD4+ T cell	8e-17	32929287
rs9271525	rs9271536	0.640793981377393	Terminally Differentiated CD4+ T cell %T cell	3e-18	32929287
rs9271525	rs9271209	0.636634611092879	Ulcerative colitis	2e-85	26192919
rs9271525	rs9271066	0.635364267444926	Takayasu arteritis	2e-11	33308445
rs9271525	rs9271429	0.629042454878224	Systemic lupus erythematosus	2e-11	34076728
rs9271525	rs9271180	0.610121887959714	Alzheimer's disease or educational attainment (pleiotropy)	5e-10	34743297
rs9271525	rs3104376	0.608165329479681	Itch intensity from mosquito bite	2e-28	28199695
rs9271525	rs9268851	0.607815975444863	Serum levels of protein H6PD	1e-96	35078996
rs9271525	rs9268851	0.607815975444863	GDH/6PGL endoplasmic bifunctional protein levels	3e-123	34648354
rs9271525	rs9271011	0.603794362545365	Leprosy	4e-50	35512355
rs9272336	rs9271055	0.716326653247323	Height	5e-09	36224396
rs9272336	rs9270984	0.714202931428902	Systemic lupus erythematosus	5e-24	23273568
rs9272336	rs9270986	0.7119172751893	Myasthenia gravis	6e-08	25643325
rs9272336	rs1966002	0.705398454303166	Systemic lupus erythematosus	8e-31	33272962
rs9272336	rs9271082	0.704249041962403	IgA nephropathy	8e-09	34076728
rs9272336	rs4329147	0.677397307727067	Childhood ear infection	1e-11	28928442
rs9272336	rs4329147	0.677397307727067	Childhood ear infection	1e-11	27182965
rs9272336	rs3104376	0.668771553656065	Itch intensity from mosquito bite	2e-28	28199695
rs9272336	rs4367411	0.66285050472341	Total omega-3 fatty acid levels	7e-09	35692035
rs9272336	rs9271025	0.644634645640803	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9272336	rs9271366	0.640943202806262	Ulcerative colitis	7e-06	26278503
rs9272336	rs9271366	0.640943202806262	Multiple sclerosis	7e-184	19525955
rs9272336	rs9271366	0.640943202806262	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9272336	rs9271366	0.640943202806262	Ulcerative colitis	1e-18	23511034
rs9272336	rs9271366	0.640943202806262	Immunoglobulin A	3e-33	20694011
rs9272336	rs9271366	0.640943202806262	Multiple sclerosis	4e-17	20598377
rs9272336	rs9271366	0.640943202806262	Crohn's disease	5e-12	23850713
rs9272336	rs9271366	0.640943202806262	Systemic lupus erythematosus	1e-07	19838195
rs9272336	rs3129757	0.638617470134077	Cathepsin L1 levels	9e-17	33067605
rs9272336	rs3129762	0.634236782672519	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9272349	rs9271055	0.775650073526141	Height	5e-09	36224396
rs9272349	rs9270986	0.773321723101655	Myasthenia gravis	6e-08	25643325
rs9272349	rs9270984	0.773298985018398	Systemic lupus erythematosus	5e-24	23273568
rs9272349	rs1966002	0.766315550019968	Systemic lupus erythematosus	8e-31	33272962
rs9272349	rs9271082	0.760600168953796	IgA nephropathy	8e-09	34076728
rs9272349	rs4329147	0.734234598822121	Childhood ear infection	1e-11	28928442
rs9272349	rs4329147	0.734234598822121	Childhood ear infection	1e-11	27182965
rs9272349	rs3104376	0.731075433717722	Itch intensity from mosquito bite	2e-28	28199695
rs9272349	rs4367411	0.71092556452431	Total omega-3 fatty acid levels	7e-09	35692035
rs9272349	rs9271366	0.695116552867818	Ulcerative colitis	7e-06	26278503
rs9272349	rs9271366	0.695116552867818	Multiple sclerosis	7e-184	19525955
rs9272349	rs9271366	0.695116552867818	Ulcerative colitis or Crohn's disease	2e-70	21699788
rs9272349	rs9271366	0.695116552867818	Ulcerative colitis	1e-18	23511034
rs9272349	rs9271366	0.695116552867818	Immunoglobulin A	3e-33	20694011
rs9272349	rs9271366	0.695116552867818	Multiple sclerosis	4e-17	20598377
rs9272349	rs9271366	0.695116552867818	Crohn's disease	5e-12	23850713
rs9272349	rs9271366	0.695116552867818	Systemic lupus erythematosus	1e-07	19838195
rs9272349	rs3129757	0.69267340541657	Cathepsin L1 levels	9e-17	33067605
rs9272349	rs3129762	0.687995832118736	Butyrophilin-like protein 9 levels	1e-51	34648354
rs9272349	rs9271025	0.686100726511204	Anti-JC polyomavirus IgG seropositivity	4e-46	34532061
rs9272349	rs3135005	0.642074341099709	Ebbinghaus illusion (overestimation)	2e-09	32939015
rs927904	rs28482086	0.826570042851308	Educational attainment (years of education)	5e-09	30038396
rs927904	rs3931020	0.760655813187154	Resistin levels	6e-12	22843503
rs927904	rs28568334	0.742916927249735	Educational attainment	4e-13	35361970
rs927904	rs277402	0.60568688630026	Heel bone mineral density	2e-09	30048462
rs9285297	rs2224797	0.885629366833941	Red blood cell count	5e-08	30595370
rs9285297	rs2224797	0.885629366833941	Mean corpuscular hemoglobin	3e-09	30595370
rs9285523	rs11155671	0.970991685247979	Testicular germ cell tumor	2e-09	28604728
rs9285523	rs1934534	0.958234298287796	Pain (pleiotropy)	2e-08	37844115
rs9285523	rs1934534	0.958234298287796	Pain (pleiotropy)	2e-06	37844115
rs9285523	rs4380763	0.957438663443902	Subcortical volume (min-P)	1e-11	32665545
rs9285523	rs9505982	0.954690507506435	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9285523	rs80147756	0.91774203568937	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9285523	rs4421206	0.910328822300417	Brain morphology (min-P)	4e-11	32665545
rs9285523	rs9688452	0.890588294542994	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9285523	rs9688452	0.890588294542994	aseg lh volume VentralDC	2e-10	33875891
rs9285523	rs10872649	0.843790176818444	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9285523	rs10872649	0.843790176818444	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9285523	rs10872649	0.843790176818444	Right hippocampal volume (body)	1e-10	37337106
rs9285523	rs7752089	0.810659339395168	Brain morphology (MOSTest)	2e-31	35164939
rs9285523	rs9322194	0.809948972058394	Brainstem volume	2e-11	31636452
rs9285523	rs9285521	0.688768353297021	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9285523	rs12526675	0.638185440683376	Brain morphology (MOSTest)	7e-22	32665545
rs9285523	rs9688809	0.627001937119553	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9285523	rs34337297	0.623978031340988	Serum levels of protein LRP11	3e-161	35078996
rs9285523	rs10872645	0.623199569367605	Blood protein levels	2e-86	30072576
rs9285523	rs14314	0.622180140968882	Macular thickness	3e-19	30535121
rs9285523	rs14314	0.622180140968882	Vertex-wise sulcal depth	7e-17	34910505
rs9285523	rs14314	0.622180140968882	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9285523	rs14314	0.622180140968882	Left hippocampal volume (body)	7e-15	37337106
rs9285523	rs14314	0.622180140968882	Left subiculum volume (body)	1e-14	37337106
rs9285523	rs55763431	0.621851140072483	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9285523	rs9322193	0.621385365363494	Lung cancer	1e-07	27393504
rs9285523	rs9689694	0.620710287091241	Right hippocampal volume (head)	6e-11	37337106
rs9285523	rs9689694	0.620710287091241	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9285523	rs9689694	0.620710287091241	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9285523	rs9689694	0.620710287091241	Left hippocampal volume (head)	6e-12	37337106
rs9285523	rs9383843	0.619364149709951	Migraine	1e-09	35115687
rs9285523	rs2095375	0.61879465068443	Serum metabolite levels	1e-20	33031748
rs9285523	rs2095375	0.61879465068443	Serum metabolite levels	1e-20	33031748
rs9285523	rs10872653	0.616520058813971	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9285523	rs9688867	0.61623693944078	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9285523	rs9688867	0.61623693944078	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9287916	rs8207	0.688929367768922	Monocyte count	1e-10	32888493
rs9287916	rs8207	0.688929367768922	Height	2e-18	36224396
rs9287955	rs6723298	0.682821408027384	Smoking initiation	2e-12	36477530
rs9287955	rs2194492	0.661352195450922	Educational attainment	9e-09	35361970
rs9287955	rs13020443	0.652872841840035	Type 2 diabetes	3e-11	32541925
rs9287956	rs6723298	0.681270056567341	Smoking initiation	2e-12	36477530
rs9287956	rs2194492	0.659838388719788	Educational attainment	9e-09	35361970
rs9287956	rs13020443	0.651398402296612	Type 2 diabetes	3e-11	32541925
rs9292122	rs9292122	1	Prostate cancer	5e-09	33398198
rs9292122	rs702689	0.707965279152431	Vertex-wise sulcal depth	2e-22	34910505
rs9296127	rs9469857	0.960344888079569	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9296127	rs2764208	0.959505875179794	Systemic lupus erythematosus	7e-06	24871463
rs9296127	rs9462030	0.946213530424624	Red cell distribution width	5e-25	32888493
rs9296127	rs9469899	0.93055070308107	Prostate cancer (advanced)	2e-06	29892016
rs9296127	rs9469899	0.93055070308107	Prostate cancer	5e-09	29892016
rs9296127	rs9469899	0.93055070308107	Prostate cancer	8e-11	33398198
rs9296127	rs9469899	0.93055070308107	Hand grip strength	3e-15	29691431
rs9296127	rs9469899	0.93055070308107	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9296127	rs9469899	0.93055070308107	Graves' disease	4e-10	34594039
rs9296127	rs9469899	0.93055070308107	Coronary artery disease	1e-11	36474045
rs9296127	rs9469899	0.93055070308107	Predicted visceral adipose tissue	2e-20	31501611
rs9296127	rs9469899	0.93055070308107	Medication use (thyroid preparations)	2e-09	31015401
rs9296127	rs9469899	0.93055070308107	Medication use (thyroid preparations)	3e-10	34594039
rs9296127	rs9469872	0.925503146277366	HDL cholesterol levels	3e-11	36333282
rs9296127	rs9296128	0.909041345673722	Hip circumference adjusted for BMI	4e-13	34021172
rs9296127	rs11755393	0.901055759212929	Body mass index	3e-26	29273807
rs9296127	rs11755393	0.901055759212929	Systemic lupus erythematosus	2e-12	33493351
rs9296127	rs11755393	0.901055759212929	Systemic lupus erythematosus	2e-06	33493351
rs9296127	rs11755393	0.901055759212929	Systemic lupus erythematosus	1e-07	33493351
rs9296127	rs11755393	0.901055759212929	Systemic lupus erythematosus	2e-08	19838195
rs9296127	rs11755393	0.901055759212929	Body mass index	4e-55	36581621
rs9296127	rs9366863	0.896917092188579	Adult body size	9e-33	32376654
rs9296127	rs9366863	0.896917092188579	Body mass index	2e-44	30595370
rs9296127	rs6941110	0.889168413528812	Sex hormone-binding globulin levels	5e-27	36653534
rs9296127	rs2744944	0.870473764040686	Hypothyroidism	3e-10	34594039
rs9296127	rs2744944	0.870473764040686	High density lipoprotein cholesterol levels	3e-86	34887591
rs9296127	rs2744944	0.870473764040686	Multi-trait sex score	7e-22	37277458
rs9296127	rs2814949	0.861809925182257	Essential hypertension (time to event)	9e-09	32589924
rs9296127	rs2263329	0.849749053734042	HDL cholesterol	6e-35	34594039
rs9296127	rs2263329	0.849749053734042	HDL cholesterol levels	8e-43	32203549
rs9296127	rs2263329	0.849749053734042	High density lipoprotein cholesterol levels	2e-52	34887591
rs9296127	rs9368828	0.84779313520099	Body mass index	1e-34	34594039
rs9296127	rs111868030	0.834894522849575	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9296127	rs2744973	0.824386266353314	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9296127	rs2744973	0.824386266353314	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9296127	rs2744973	0.824386266353314	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9296127	rs2744973	0.824386266353314	Multi-trait sex score	6e-20	37277458
rs9296127	rs9368830	0.792035296933427	HDL cholesterol	4e-21	30275531
rs9296127	rs112283401	0.789807125683663	Red cell distribution width	4e-27	30595370
rs9296127	rs6912327	0.744848614078826	Fasting insulin	5e-06	33402679
rs9296127	rs6912327	0.744848614078826	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9296127	rs9462027	0.622991179810188	Systemic lupus erythematosus	1e-10	27399966
rs9296127	rs9462027	0.622991179810188	Systemic lupus erythematosus	8e-09	26502338
rs9296127	rs9462027	0.622991179810188	Systemic lupus erythematosus	2e-08	28714469
rs9296127	rs9462027	0.622991179810188	Alzheimer's disease or gastroesophageal reflux disease	2e-06	35851147
rs9296128	rs9296128	1	Hip circumference adjusted for BMI	4e-13	34021172
rs9296128	rs9469857	0.94410950115942	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9296128	rs2764208	0.94325488802781	Systemic lupus erythematosus	7e-06	24871463
rs9296128	rs9462030	0.931673955321373	Red cell distribution width	5e-25	32888493
rs9296128	rs9469899	0.914803953979528	Prostate cancer (advanced)	2e-06	29892016
rs9296128	rs9469899	0.914803953979528	Prostate cancer	5e-09	29892016
rs9296128	rs9469899	0.914803953979528	Prostate cancer	8e-11	33398198
rs9296128	rs9469899	0.914803953979528	Hand grip strength	3e-15	29691431
rs9296128	rs9469899	0.914803953979528	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9296128	rs9469899	0.914803953979528	Graves' disease	4e-10	34594039
rs9296128	rs9469899	0.914803953979528	Coronary artery disease	1e-11	36474045
rs9296128	rs9469899	0.914803953979528	Predicted visceral adipose tissue	2e-20	31501611
rs9296128	rs9469899	0.914803953979528	Medication use (thyroid preparations)	2e-09	31015401
rs9296128	rs9469899	0.914803953979528	Medication use (thyroid preparations)	3e-10	34594039
rs9296128	rs9469872	0.909885484027307	HDL cholesterol levels	3e-11	36333282
rs9296128	rs11755393	0.88580748304751	Body mass index	3e-26	29273807
rs9296128	rs11755393	0.88580748304751	Systemic lupus erythematosus	2e-12	33493351
rs9296128	rs11755393	0.88580748304751	Systemic lupus erythematosus	2e-06	33493351
rs9296128	rs11755393	0.88580748304751	Systemic lupus erythematosus	1e-07	33493351
rs9296128	rs11755393	0.88580748304751	Systemic lupus erythematosus	2e-08	19838195
rs9296128	rs11755393	0.88580748304751	Body mass index	4e-55	36581621
rs9296128	rs9366863	0.881494527383526	Adult body size	9e-33	32376654
rs9296128	rs9366863	0.881494527383526	Body mass index	2e-44	30595370
rs9296128	rs6941110	0.873777697661248	Sex hormone-binding globulin levels	5e-27	36653534
rs9296128	rs2744944	0.855275357080456	Hypothyroidism	3e-10	34594039
rs9296128	rs2744944	0.855275357080456	High density lipoprotein cholesterol levels	3e-86	34887591
rs9296128	rs2744944	0.855275357080456	Multi-trait sex score	7e-22	37277458
rs9296128	rs2814949	0.846746338785186	Essential hypertension (time to event)	9e-09	32589924
rs9296128	rs2263329	0.833123103811505	HDL cholesterol	6e-35	34594039
rs9296128	rs2263329	0.833123103811505	HDL cholesterol levels	8e-43	32203549
rs9296128	rs2263329	0.833123103811505	High density lipoprotein cholesterol levels	2e-52	34887591
rs9296128	rs111868030	0.810390339296499	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9296128	rs2744973	0.798863079135444	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9296128	rs2744973	0.798863079135444	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9296128	rs2744973	0.798863079135444	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9296128	rs2744973	0.798863079135444	Multi-trait sex score	6e-20	37277458
rs9296128	rs9368830	0.778158246342176	HDL cholesterol	4e-21	30275531
rs9296128	rs9368828	0.767475189434079	Body mass index	1e-34	34594039
rs9296128	rs6912327	0.729240127036881	Fasting insulin	5e-06	33402679
rs9296128	rs6912327	0.729240127036881	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9296128	rs112283401	0.710537247170967	Red cell distribution width	4e-27	30595370
rs9296131	rs9469872	0.929024535873416	HDL cholesterol levels	3e-11	36333282
rs9296131	rs11755393	0.920598165995655	Body mass index	3e-26	29273807
rs9296131	rs11755393	0.920598165995655	Systemic lupus erythematosus	2e-12	33493351
rs9296131	rs11755393	0.920598165995655	Systemic lupus erythematosus	2e-06	33493351
rs9296131	rs11755393	0.920598165995655	Systemic lupus erythematosus	1e-07	33493351
rs9296131	rs11755393	0.920598165995655	Systemic lupus erythematosus	2e-08	19838195
rs9296131	rs11755393	0.920598165995655	Body mass index	4e-55	36581621
rs9296131	rs9366863	0.918990444478456	Adult body size	9e-33	32376654
rs9296131	rs9366863	0.918990444478456	Body mass index	2e-44	30595370
rs9296131	rs6941110	0.909780830744628	Sex hormone-binding globulin levels	5e-27	36653534
rs9296131	rs9462030	0.897121647445428	Red cell distribution width	5e-25	32888493
rs9296131	rs9469857	0.892612109080675	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9296131	rs2764208	0.891897991313486	Systemic lupus erythematosus	7e-06	24871463
rs9296131	rs2814949	0.883156680219726	Essential hypertension (time to event)	9e-09	32589924
rs9296131	rs9469899	0.879398315507857	Prostate cancer (advanced)	2e-06	29892016
rs9296131	rs9469899	0.879398315507857	Prostate cancer	5e-09	29892016
rs9296131	rs9469899	0.879398315507857	Prostate cancer	8e-11	33398198
rs9296131	rs9469899	0.879398315507857	Hand grip strength	3e-15	29691431
rs9296131	rs9469899	0.879398315507857	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9296131	rs9469899	0.879398315507857	Graves' disease	4e-10	34594039
rs9296131	rs9469899	0.879398315507857	Coronary artery disease	1e-11	36474045
rs9296131	rs9469899	0.879398315507857	Predicted visceral adipose tissue	2e-20	31501611
rs9296131	rs9469899	0.879398315507857	Medication use (thyroid preparations)	2e-09	31015401
rs9296131	rs9469899	0.879398315507857	Medication use (thyroid preparations)	3e-10	34594039
rs9296131	rs2744944	0.875610532303568	Hypothyroidism	3e-10	34594039
rs9296131	rs2744944	0.875610532303568	High density lipoprotein cholesterol levels	3e-86	34887591
rs9296131	rs2744944	0.875610532303568	Multi-trait sex score	7e-22	37277458
rs9296131	rs2263329	0.858435840153904	HDL cholesterol	6e-35	34594039
rs9296131	rs2263329	0.858435840153904	HDL cholesterol levels	8e-43	32203549
rs9296131	rs2263329	0.858435840153904	High density lipoprotein cholesterol levels	2e-52	34887591
rs9296131	rs9296128	0.848317485376507	Hip circumference adjusted for BMI	4e-13	34021172
rs9296131	rs111868030	0.833514010726046	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9296131	rs9368830	0.812499411600032	HDL cholesterol	4e-21	30275531
rs9296131	rs9368828	0.785645645503271	Body mass index	1e-34	34594039
rs9296131	rs6912327	0.783883325001022	Fasting insulin	5e-06	33402679
rs9296131	rs6912327	0.783883325001022	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9296131	rs112283401	0.767386142748683	Red cell distribution width	4e-27	30595370
rs9296131	rs2744973	0.734327627203246	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9296131	rs2744973	0.734327627203246	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9296131	rs2744973	0.734327627203246	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9296131	rs2744973	0.734327627203246	Multi-trait sex score	6e-20	37277458
rs9296132	rs9469872	0.955219429572528	HDL cholesterol levels	3e-11	36333282
rs9296132	rs11755393	0.947877920286333	Body mass index	3e-26	29273807
rs9296132	rs11755393	0.947877920286333	Systemic lupus erythematosus	2e-12	33493351
rs9296132	rs11755393	0.947877920286333	Systemic lupus erythematosus	2e-06	33493351
rs9296132	rs11755393	0.947877920286333	Systemic lupus erythematosus	1e-07	33493351
rs9296132	rs11755393	0.947877920286333	Systemic lupus erythematosus	2e-08	19838195
rs9296132	rs11755393	0.947877920286333	Body mass index	4e-55	36581621
rs9296132	rs9366863	0.945095917865684	Adult body size	9e-33	32376654
rs9296132	rs9366863	0.945095917865684	Body mass index	2e-44	30595370
rs9296132	rs6941110	0.937373851921465	Sex hormone-binding globulin levels	5e-27	36653534
rs9296132	rs9462030	0.920437725527159	Red cell distribution width	5e-25	32888493
rs9296132	rs9469857	0.915928896644464	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9296132	rs2764208	0.915247014296212	Systemic lupus erythematosus	7e-06	24871463
rs9296132	rs2814949	0.908615329618739	Essential hypertension (time to event)	9e-09	32589924
rs9296132	rs9469899	0.903587177448273	Prostate cancer (advanced)	2e-06	29892016
rs9296132	rs9469899	0.903587177448273	Prostate cancer	5e-09	29892016
rs9296132	rs9469899	0.903587177448273	Prostate cancer	8e-11	33398198
rs9296132	rs9469899	0.903587177448273	Hand grip strength	3e-15	29691431
rs9296132	rs9469899	0.903587177448273	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9296132	rs9469899	0.903587177448273	Graves' disease	4e-10	34594039
rs9296132	rs9469899	0.903587177448273	Coronary artery disease	1e-11	36474045
rs9296132	rs9469899	0.903587177448273	Predicted visceral adipose tissue	2e-20	31501611
rs9296132	rs9469899	0.903587177448273	Medication use (thyroid preparations)	2e-09	31015401
rs9296132	rs9469899	0.903587177448273	Medication use (thyroid preparations)	3e-10	34594039
rs9296132	rs2744944	0.89957874329245	Hypothyroidism	3e-10	34594039
rs9296132	rs2744944	0.89957874329245	High density lipoprotein cholesterol levels	3e-86	34887591
rs9296132	rs2744944	0.89957874329245	Multi-trait sex score	7e-22	37277458
rs9296132	rs2263329	0.882411315997203	HDL cholesterol	6e-35	34594039
rs9296132	rs2263329	0.882411315997203	HDL cholesterol levels	8e-43	32203549
rs9296132	rs2263329	0.882411315997203	High density lipoprotein cholesterol levels	2e-52	34887591
rs9296132	rs9296128	0.868988200337383	Hip circumference adjusted for BMI	4e-13	34021172
rs9296132	rs111868030	0.858496874600338	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9296132	rs9368830	0.834280935560731	HDL cholesterol	4e-21	30275531
rs9296132	rs9368828	0.80889255642973	Body mass index	1e-34	34594039
rs9296132	rs6912327	0.802234479995071	Fasting insulin	5e-06	33402679
rs9296132	rs6912327	0.802234479995071	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9296132	rs112283401	0.776946662127433	Red cell distribution width	4e-27	30595370
rs9296132	rs2744973	0.755618643156252	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9296132	rs2744973	0.755618643156252	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9296132	rs2744973	0.755618643156252	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9296132	rs2744973	0.755618643156252	Multi-trait sex score	6e-20	37277458
rs9296132	rs6940215	0.611522736253403	Insomnia	2e-10	35835914
rs9296132	rs6940215	0.611522736253403	Insomnia	1e-13	35835914
rs9296132	rs6940215	0.611522736253403	Hip circumference adjusted for BMI	8e-10	34021172
rs9296132	rs6940215	0.611522736253403	Multi-trait sex score	2e-23	37277458
rs9296132	rs6940215	0.611522736253403	Multi-trait sex score	4e-23	37277458
rs9296132	rs6457796	0.604449824282544	Insomnia	1e-08	30804565
rs9296132	rs6457796	0.604449824282544	Plateletcrit	9e-11	32888494
rs9296132	rs6457796	0.604449824282544	Systemic lupus erythematosus	3e-22	33272962
rs9296132	rs6457796	0.604449824282544	Body mass index	5e-13	30108127
rs9296132	rs6457796	0.604449824282544	Body mass index	1e-14	26426971
rs9296132	rs6457796	0.604449824282544	Educational attainment	5e-19	35361970
rs9314181	rs38033	0.994152413933807	Blood protein levels	0	30072576
rs9314181	rs27293	0.983332329233094	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	7e-09	23603761
rs9314181	rs27293	0.983332329233094	Diastolic blood pressure	3e-11	35762941
rs9314181	rs1423357	0.971026140541252	General cognitive ability	9e-06	29844566
rs9314181	rs2432142	0.959466198494439	Neutrophil count	2e-14	32888493
rs9314181	rs2432142	0.959466198494439	White blood cell count	1e-11	32888493
rs9314181	rs7705093	0.936789208980476	Birdshot chorioretinopathy	2e-09	24957906
rs9314181	rs2910686	0.847099019457154	Neutrophil count	4e-14	32888493
rs9314181	rs2910686	0.847099019457154	Psoriasis	2e-08	23143594
rs9314181	rs2910686	0.847099019457154	Ankylosing spondylitis	5e-17	23749187
rs9314181	rs2910686	0.847099019457154	Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)	2e-21	26974007
rs9314181	rs2927608	0.843861702435685	Endoplasmic reticulum aminopeptidase 2 level in Chronic kidney disease with hypertension and no diabetes (8960_3)	7e-161	35870639
rs9314181	rs2927608	0.843861702435685	Endoplasmic reticulum aminopeptidase 2 levels (ERAP2.8960.3.3)	0	29875488
rs9314181	rs2927608	0.843861702435685	Endoplasmic reticulum aminopeptidase 2 levels	0	34648354
rs9314181	rs38029	0.783315372693566	Smoking initiation (ever regular vs never regular) (MTAG)	8e-07	30643251
rs9314181	rs2617439	0.763279003676691	Neutrophil count	8e-11	32888494
rs9314181	rs2549797	0.752282800212888	Systolic blood pressure	7e-07	33230300
rs9314181	rs2549797	0.752282800212888	Diastolic blood pressure	1e-14	33230300
rs9314181	rs2549797	0.752282800212888	Diastolic blood pressure	3e-11	33230300
rs9314181	rs2549797	0.752282800212888	Systolic blood pressure	4e-09	33230300
rs9314181	rs2549782	0.751030791193721	Systolic blood pressure	6e-07	33230300
rs9314181	rs2549782	0.751030791193721	Diastolic blood pressure	1e-14	33230300
rs9314181	rs2549782	0.751030791193721	Diastolic blood pressure	3e-11	33230300
rs9314181	rs2549782	0.751030791193721	Systolic blood pressure	5e-09	33230300
rs9314181	rs1056893	0.750405625800376	Systolic blood pressure	1e-06	33230300
rs9314181	rs1056893	0.750405625800376	Diastolic blood pressure	7e-15	33230300
rs9314181	rs1056893	0.750405625800376	Diastolic blood pressure	2e-11	33230300
rs9314181	rs1056893	0.750405625800376	Systolic blood pressure	7e-09	33230300
rs9314181	rs2549794	0.749257390940066	Crohn's disease	1e-10	21102463
rs9314181	rs2549794	0.749257390940066	Systolic blood pressure	1e-07	33230300
rs9314181	rs2549794	0.749257390940066	Diastolic blood pressure	1e-15	33230300
rs9314181	rs2549794	0.749257390940066	Diastolic blood pressure	2e-12	33230300
rs9314181	rs2549794	0.749257390940066	Systolic blood pressure	4e-10	33230300
rs9314181	rs1363907	0.744674357439087	Crohn's disease	4e-16	26192919
rs9314181	rs1363907	0.744674357439087	Ulcerative colitis	4e-06	26192919
rs9314181	rs1363907	0.744674357439087	Inflammatory bowel disease	5e-15	26192919
rs9314181	rs1363907	0.744674357439087	Inflammatory bowel disease	6e-13	23128233
rs9314181	rs1363907	0.744674357439087	Inflammatory bowel disease	1e-10	28067908
rs9314181	rs1363907	0.744674357439087	Crohn's disease	1e-14	28067908
rs9314181	rs716848	0.716478990237484	Neutrophil percentage of white cells	2e-09	32888494
rs9314181	rs4869313	0.703354216602425	Pediatric autoimmune diseases	9e-08	26301688
rs9314181	rs1559359	0.696477735761092	Diastolic blood pressure	7e-10	34594039
rs9314181	rs2548532	0.673250754112324	Externalizing behaviour (multivariate analysis)	5e-11	34446935
rs9314181	rs4869314	0.648934612992059	Arthritis (juvenile idiopathic)	3e-09	33106285
rs9314181	rs4869314	0.648934612992059	Neutrophil count	1e-10	34594039
rs9314181	rs4869314	0.648934612992059	White blood cell count	2e-07	30595370
rs9314181	rs1974871	0.624169190249793	Granulysin levels	5e-13	34648354
rs9314181	rs27660	0.620960998866173	Coronary artery disease	3e-08	35915156
rs9314181	rs1019503	0.619076944732003	Systolic blood pressure	2e-06	33230300
rs9314181	rs1019503	0.619076944732003	Diastolic blood pressure	2e-14	33230300
rs9314181	rs1019503	0.619076944732003	Diastolic blood pressure	4e-11	33230300
rs9314181	rs1019503	0.619076944732003	Systolic blood pressure	1e-08	33230300
rs9314181	rs3096168	0.611862403097564	Aspartate aminotransferase levels	8e-12	33547301
rs9315499	rs9547937	0.987465522879599	Serum levels of protein POSTN	6e-18	35078996
rs9315499	rs9603222	0.675798095714415	Blood protein levels	2e-12	30072576
rs9315501	rs9603222	0.970553147377469	Blood protein levels	2e-12	30072576
rs9315501	rs4424789	0.804740302163209	Periostin levels	2e-19	34648354
rs9315501	rs9547937	0.688182005258102	Serum levels of protein POSTN	6e-18	35078996
rs9318364	rs2224797	0.909104756222664	Red blood cell count	5e-08	30595370
rs9318364	rs2224797	0.909104756222664	Mean corpuscular hemoglobin	3e-09	30595370
rs9322188	rs11155671	0.845871960506787	Testicular germ cell tumor	2e-09	28604728
rs9322188	rs4380763	0.833457044544782	Subcortical volume (min-P)	1e-11	32665545
rs9322188	rs1934534	0.832745015444666	Pain (pleiotropy)	2e-08	37844115
rs9322188	rs1934534	0.832745015444666	Pain (pleiotropy)	2e-06	37844115
rs9322188	rs9505982	0.816359092560684	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322188	rs80147756	0.795436685531474	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322188	rs4421206	0.788110596454281	Brain morphology (min-P)	4e-11	32665545
rs9322188	rs9688452	0.770603296370517	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322188	rs9688452	0.770603296370517	aseg lh volume VentralDC	2e-10	33875891
rs9322188	rs10872649	0.733990929993507	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322188	rs10872649	0.733990929993507	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322188	rs10872649	0.733990929993507	Right hippocampal volume (body)	1e-10	37337106
rs9322188	rs9322194	0.715918086977298	Brainstem volume	2e-11	31636452
rs9322188	rs7752089	0.709597688545307	Brain morphology (MOSTest)	2e-31	35164939
rs9322188	rs9285521	0.614411966285234	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322192	rs9322193	0.995539006690242	Lung cancer	1e-07	27393504
rs9322192	rs34337297	0.957533801570571	Serum levels of protein LRP11	3e-161	35078996
rs9322192	rs10872645	0.947904419515069	Blood protein levels	2e-86	30072576
rs9322192	rs55763431	0.947904419515069	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322192	rs9689694	0.946162189958309	Right hippocampal volume (head)	6e-11	37337106
rs9322192	rs9689694	0.946162189958309	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322192	rs9689694	0.946162189958309	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322192	rs9689694	0.946162189958309	Left hippocampal volume (head)	6e-12	37337106
rs9322192	rs2095375	0.943548439127975	Serum metabolite levels	1e-20	33031748
rs9322192	rs2095375	0.943548439127975	Serum metabolite levels	1e-20	33031748
rs9322192	rs9383843	0.942675883393895	Migraine	1e-09	35115687
rs9322192	rs9688867	0.940078859761359	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9322192	rs9688867	0.940078859761359	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9322192	rs9688809	0.940078859761359	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322192	rs10872653	0.940074465899774	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9322192	rs14314	0.92538401208516	Macular thickness	3e-19	30535121
rs9322192	rs14314	0.92538401208516	Vertex-wise sulcal depth	7e-17	34910505
rs9322192	rs14314	0.92538401208516	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322192	rs14314	0.92538401208516	Left hippocampal volume (body)	7e-15	37337106
rs9322192	rs14314	0.92538401208516	Left subiculum volume (body)	1e-14	37337106
rs9322192	rs4039600	0.915562003809783	Adenine levels	1e-11	35347128
rs9322192	rs11155671	0.615899758905025	Testicular germ cell tumor	2e-09	28604728
rs9322192	rs1934534	0.612000014849036	Pain (pleiotropy)	2e-08	37844115
rs9322192	rs1934534	0.612000014849036	Pain (pleiotropy)	2e-06	37844115
rs9322192	rs4380763	0.611486491373142	Subcortical volume (min-P)	1e-11	32665545
rs9322193	rs9322193	1	Lung cancer	1e-07	27393504
rs9322193	rs34337297	0.961856333387432	Serum levels of protein LRP11	3e-161	35078996
rs9322193	rs10872645	0.952199474125302	Blood protein levels	2e-86	30072576
rs9322193	rs55763431	0.952199474125302	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322193	rs9689694	0.95044940828961	Right hippocampal volume (head)	6e-11	37337106
rs9322193	rs9689694	0.95044940828961	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322193	rs9689694	0.95044940828961	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322193	rs9689694	0.95044940828961	Left hippocampal volume (head)	6e-12	37337106
rs9322193	rs2095375	0.947826521476432	Serum metabolite levels	1e-20	33031748
rs9322193	rs2095375	0.947826521476432	Serum metabolite levels	1e-20	33031748
rs9322193	rs9383843	0.946952658176391	Migraine	1e-09	35115687
rs9322193	rs9688867	0.944362213997949	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9322193	rs9688867	0.944362213997949	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9322193	rs9688809	0.944362213997949	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322193	rs10872653	0.9443369194958	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9322193	rs14314	0.929624389777146	Macular thickness	3e-19	30535121
rs9322193	rs14314	0.929624389777146	Vertex-wise sulcal depth	7e-17	34910505
rs9322193	rs14314	0.929624389777146	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322193	rs14314	0.929624389777146	Left hippocampal volume (body)	7e-15	37337106
rs9322193	rs14314	0.929624389777146	Left subiculum volume (body)	1e-14	37337106
rs9322193	rs4039600	0.919677723448607	Adenine levels	1e-11	35347128
rs9322193	rs11155671	0.619729209898932	Testicular germ cell tumor	2e-09	28604728
rs9322193	rs1934534	0.615805006800916	Pain (pleiotropy)	2e-08	37844115
rs9322193	rs1934534	0.615805006800916	Pain (pleiotropy)	2e-06	37844115
rs9322193	rs4380763	0.615290697365256	Subcortical volume (min-P)	1e-11	32665545
rs9322193	rs9505982	0.601318487945432	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322196	rs9505982	0.993544547805291	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322196	rs11155671	0.940522125561972	Testicular germ cell tumor	2e-09	28604728
rs9322196	rs1934534	0.928095045709747	Pain (pleiotropy)	2e-08	37844115
rs9322196	rs1934534	0.928095045709747	Pain (pleiotropy)	2e-06	37844115
rs9322196	rs4380763	0.927300997774675	Subcortical volume (min-P)	1e-11	32665545
rs9322196	rs4421206	0.90312007955201	Brain morphology (min-P)	4e-11	32665545
rs9322196	rs80147756	0.886212919565498	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322196	rs9688452	0.883918760130083	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322196	rs9688452	0.883918760130083	aseg lh volume VentralDC	2e-10	33875891
rs9322196	rs9322194	0.838690745883385	Brainstem volume	2e-11	31636452
rs9322196	rs10872649	0.811651124477041	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322196	rs10872649	0.811651124477041	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322196	rs10872649	0.811651124477041	Right hippocampal volume (body)	1e-10	37337106
rs9322196	rs7752089	0.779829303703556	Brain morphology (MOSTest)	2e-31	35164939
rs9322196	rs9285521	0.71533897463668	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322196	rs12526675	0.627513556419397	Brain morphology (MOSTest)	7e-22	32665545
rs9322196	rs9688809	0.606916402370845	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322196	rs34337297	0.604040941972678	Serum levels of protein LRP11	3e-161	35078996
rs9322196	rs10872645	0.603267312109969	Blood protein levels	2e-86	30072576
rs9322196	rs14314	0.602173265238806	Macular thickness	3e-19	30535121
rs9322196	rs14314	0.602173265238806	Vertex-wise sulcal depth	7e-17	34910505
rs9322196	rs14314	0.602173265238806	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322196	rs14314	0.602173265238806	Left hippocampal volume (body)	7e-15	37337106
rs9322196	rs14314	0.602173265238806	Left subiculum volume (body)	1e-14	37337106
rs9322196	rs55763431	0.60194342559747	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322196	rs9322193	0.601318487945432	Lung cancer	1e-07	27393504
rs9322196	rs9689694	0.600841957866217	Right hippocampal volume (head)	6e-11	37337106
rs9322196	rs9689694	0.600841957866217	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322196	rs9689694	0.600841957866217	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322196	rs9689694	0.600841957866217	Left hippocampal volume (head)	6e-12	37337106
rs9322197	rs34337297	0.975853777533522	Serum levels of protein LRP11	3e-161	35078996
rs9322197	rs9322193	0.975099421140265	Lung cancer	1e-07	27393504
rs9322197	rs10872645	0.966105807800617	Blood protein levels	2e-86	30072576
rs9322197	rs55763431	0.966105807800617	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322197	rs9689694	0.964328236724851	Right hippocampal volume (head)	6e-11	37337106
rs9322197	rs9689694	0.964328236724851	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322197	rs9689694	0.964328236724851	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322197	rs9689694	0.964328236724851	Left hippocampal volume (head)	6e-12	37337106
rs9322197	rs2095375	0.961674174570385	Serum metabolite levels	1e-20	33031748
rs9322197	rs2095375	0.961674174570385	Serum metabolite levels	1e-20	33031748
rs9322197	rs9383843	0.960796612474461	Migraine	1e-09	35115687
rs9322197	rs9688867	0.958235444435805	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9322197	rs9688867	0.958235444435805	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9322197	rs9688809	0.958235444435805	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322197	rs10872653	0.958129719066533	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9322197	rs14314	0.943354755903747	Macular thickness	3e-19	30535121
rs9322197	rs14314	0.943354755903747	Vertex-wise sulcal depth	7e-17	34910505
rs9322197	rs14314	0.943354755903747	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322197	rs14314	0.943354755903747	Left hippocampal volume (body)	7e-15	37337106
rs9322197	rs14314	0.943354755903747	Left subiculum volume (body)	1e-14	37337106
rs9322197	rs4039600	0.929434713752081	Adenine levels	1e-11	35347128
rs9322197	rs11155671	0.635074596364877	Testicular germ cell tumor	2e-09	28604728
rs9322197	rs1934534	0.631057318438715	Pain (pleiotropy)	2e-08	37844115
rs9322197	rs1934534	0.631057318438715	Pain (pleiotropy)	2e-06	37844115
rs9322197	rs4380763	0.630539540525296	Subcortical volume (min-P)	1e-11	32665545
rs9322197	rs9505982	0.617926044154982	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322197	rs80147756	0.602748159602245	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322198	rs11155671	0.972596786806158	Testicular germ cell tumor	2e-09	28604728
rs9322198	rs4380763	0.960629928565859	Subcortical volume (min-P)	1e-11	32665545
rs9322198	rs1934534	0.959835932278713	Pain (pleiotropy)	2e-08	37844115
rs9322198	rs1934534	0.959835932278713	Pain (pleiotropy)	2e-06	37844115
rs9322198	rs9505982	0.95942045301719	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322198	rs80147756	0.917726869729466	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322198	rs4421206	0.913395162093601	Brain morphology (min-P)	4e-11	32665545
rs9322198	rs9688452	0.893646573889388	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322198	rs9688452	0.893646573889388	aseg lh volume VentralDC	2e-10	33875891
rs9322198	rs10872649	0.845238223609163	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322198	rs10872649	0.845238223609163	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322198	rs10872649	0.845238223609163	Right hippocampal volume (body)	1e-10	37337106
rs9322198	rs7752089	0.813493264048428	Brain morphology (MOSTest)	2e-31	35164939
rs9322198	rs9322194	0.812722973789754	Brainstem volume	2e-11	31636452
rs9322198	rs9285521	0.692610157712712	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322198	rs12526675	0.640540207634762	Brain morphology (MOSTest)	7e-22	32665545
rs9322198	rs9688809	0.6259716199647	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322198	rs34337297	0.622954547624865	Serum levels of protein LRP11	3e-161	35078996
rs9322198	rs10872645	0.62217639941969	Blood protein levels	2e-86	30072576
rs9322198	rs14314	0.621153875831965	Macular thickness	3e-19	30535121
rs9322198	rs14314	0.621153875831965	Vertex-wise sulcal depth	7e-17	34910505
rs9322198	rs14314	0.621153875831965	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322198	rs14314	0.621153875831965	Left hippocampal volume (body)	7e-15	37337106
rs9322198	rs14314	0.621153875831965	Left subiculum volume (body)	1e-14	37337106
rs9322198	rs55763431	0.620829213886735	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322198	rs9689694	0.619690219427646	Right hippocampal volume (head)	6e-11	37337106
rs9322198	rs9689694	0.619690219427646	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322198	rs9689694	0.619690219427646	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322198	rs9689694	0.619690219427646	Left hippocampal volume (head)	6e-12	37337106
rs9322198	rs9322193	0.619014979452026	Lung cancer	1e-07	27393504
rs9322198	rs9383843	0.618345324764751	Migraine	1e-09	35115687
rs9322198	rs2095375	0.617776753792053	Serum metabolite levels	1e-20	33031748
rs9322198	rs2095375	0.617776753792053	Serum metabolite levels	1e-20	33031748
rs9322198	rs10872653	0.615505868587064	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9322198	rs9688867	0.615216588865268	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9322198	rs9688867	0.615216588865268	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9322198	rs2342764	0.601079697331469	Cortical thickness	1e-08	34560273
rs9322199	rs9505982	0.964099496407444	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322199	rs11155671	0.961458502990499	Testicular germ cell tumor	2e-09	28604728
rs9322199	rs1934534	0.948792160539893	Pain (pleiotropy)	2e-08	37844115
rs9322199	rs1934534	0.948792160539893	Pain (pleiotropy)	2e-06	37844115
rs9322199	rs4380763	0.947998134475687	Subcortical volume (min-P)	1e-11	32665545
rs9322199	rs80147756	0.906850075698484	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322199	rs4421206	0.900972630122341	Brain morphology (min-P)	4e-11	32665545
rs9322199	rs9688452	0.881426949430299	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322199	rs9688452	0.881426949430299	aseg lh volume VentralDC	2e-10	33875891
rs9322199	rs10872649	0.834728581887992	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322199	rs10872649	0.834728581887992	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322199	rs10872649	0.834728581887992	Right hippocampal volume (body)	1e-10	37337106
rs9322199	rs9322194	0.816579586222717	Brainstem volume	2e-11	31636452
rs9322199	rs7752089	0.803056571675248	Brain morphology (MOSTest)	2e-31	35164939
rs9322199	rs9285521	0.695942014708245	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322199	rs12526675	0.629344796531032	Brain morphology (MOSTest)	7e-22	32665545
rs9322199	rs9688809	0.621869077313897	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322199	rs34337297	0.618879214162067	Serum levels of protein LRP11	3e-161	35078996
rs9322199	rs10872645	0.618102315511363	Blood protein levels	2e-86	30072576
rs9322199	rs14314	0.617067468553409	Macular thickness	3e-19	30535121
rs9322199	rs14314	0.617067468553409	Vertex-wise sulcal depth	7e-17	34910505
rs9322199	rs14314	0.617067468553409	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322199	rs14314	0.617067468553409	Left hippocampal volume (body)	7e-15	37337106
rs9322199	rs14314	0.617067468553409	Left subiculum volume (body)	1e-14	37337106
rs9322199	rs55763431	0.616760082622472	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322199	rs9322193	0.616260266217061	Lung cancer	1e-07	27393504
rs9322199	rs9689694	0.615628488476908	Right hippocampal volume (head)	6e-11	37337106
rs9322199	rs9689694	0.615628488476908	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322199	rs9689694	0.615628488476908	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322199	rs9689694	0.615628488476908	Left hippocampal volume (head)	6e-12	37337106
rs9322199	rs9383843	0.614288542316825	Migraine	1e-09	35115687
rs9322199	rs2095375	0.613723666689898	Serum metabolite levels	1e-20	33031748
rs9322199	rs2095375	0.613723666689898	Serum metabolite levels	1e-20	33031748
rs9322199	rs10872653	0.611467540785509	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9322199	rs9688867	0.611153733520397	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9322199	rs9688867	0.611153733520397	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9322200	rs9505982	0.978336707945183	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322200	rs11155671	0.948912843129171	Testicular germ cell tumor	2e-09	28604728
rs9322200	rs1934534	0.93637483317155	Pain (pleiotropy)	2e-08	37844115
rs9322200	rs1934534	0.93637483317155	Pain (pleiotropy)	2e-06	37844115
rs9322200	rs4380763	0.935582177621877	Subcortical volume (min-P)	1e-11	32665545
rs9322200	rs80147756	0.89453247866556	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322200	rs4421206	0.888620250718484	Brain morphology (min-P)	4e-11	32665545
rs9322200	rs9688452	0.869359305683651	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322200	rs9688452	0.869359305683651	aseg lh volume VentralDC	2e-10	33875891
rs9322200	rs9322194	0.828751676713781	Brainstem volume	2e-11	31636452
rs9322200	rs10872649	0.822748560295471	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322200	rs10872649	0.822748560295471	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322200	rs10872649	0.822748560295471	Right hippocampal volume (body)	1e-10	37337106
rs9322200	rs7752089	0.791036240131646	Brain morphology (MOSTest)	2e-31	35164939
rs9322200	rs9285521	0.706718597948315	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322200	rs12526675	0.61741481106656	Brain morphology (MOSTest)	7e-22	32665545
rs9322200	rs9688809	0.613752822598016	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322200	rs34337297	0.610816786896318	Serum levels of protein LRP11	3e-161	35078996
rs9322200	rs10872645	0.610042361185228	Blood protein levels	2e-86	30072576
rs9322200	rs14314	0.608983139758605	Macular thickness	3e-19	30535121
rs9322200	rs14314	0.608983139758605	Vertex-wise sulcal depth	7e-17	34910505
rs9322200	rs14314	0.608983139758605	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322200	rs14314	0.608983139758605	Left hippocampal volume (body)	7e-15	37337106
rs9322200	rs14314	0.608983139758605	Left subiculum volume (body)	1e-14	37337106
rs9322200	rs55763431	0.608709927312426	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322200	rs9322193	0.608156293906908	Lung cancer	1e-07	27393504
rs9322200	rs9689694	0.607592973574803	Right hippocampal volume (head)	6e-11	37337106
rs9322200	rs9689694	0.607592973574803	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322200	rs9689694	0.607592973574803	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322200	rs9689694	0.607592973574803	Left hippocampal volume (head)	6e-12	37337106
rs9322200	rs9383843	0.606262818309476	Migraine	1e-09	35115687
rs9322200	rs2095375	0.605705253369015	Serum metabolite levels	1e-20	33031748
rs9322200	rs2095375	0.605705253369015	Serum metabolite levels	1e-20	33031748
rs9322200	rs10872653	0.603478326523671	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9322200	rs9688867	0.603116004332505	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9322200	rs9688867	0.603116004332505	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9322203	rs11155671	0.938951647581121	Testicular germ cell tumor	2e-09	28604728
rs9322203	rs4380763	0.925741039662026	Subcortical volume (min-P)	1e-11	32665545
rs9322203	rs1934534	0.924974943987348	Pain (pleiotropy)	2e-08	37844115
rs9322203	rs1934534	0.924974943987348	Pain (pleiotropy)	2e-06	37844115
rs9322203	rs9505982	0.923914234917438	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322203	rs80147756	0.883171138339639	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322203	rs4421206	0.878719687855435	Brain morphology (min-P)	4e-11	32665545
rs9322203	rs9688452	0.859748327993936	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322203	rs9688452	0.859748327993936	aseg lh volume VentralDC	2e-10	33875891
rs9322203	rs10872649	0.811651124477041	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322203	rs10872649	0.811651124477041	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322203	rs10872649	0.811651124477041	Right hippocampal volume (body)	1e-10	37337106
rs9322203	rs7752089	0.779829303703556	Brain morphology (MOSTest)	2e-31	35164939
rs9322203	rs9322194	0.777991502580357	Brainstem volume	2e-11	31636452
rs9322203	rs9285521	0.659364679801652	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322203	rs12526675	0.607247884284249	Brain morphology (MOSTest)	7e-22	32665545
rs9322203	rs9688809	0.601620691349951	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322204	rs9505982	0.975109113824851	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322204	rs11155671	0.950592701523336	Testicular germ cell tumor	2e-09	28604728
rs9322204	rs4380763	0.937273457961983	Subcortical volume (min-P)	1e-11	32665545
rs9322204	rs1934534	0.936499339247785	Pain (pleiotropy)	2e-08	37844115
rs9322204	rs1934534	0.936499339247785	Pain (pleiotropy)	2e-06	37844115
rs9322204	rs80147756	0.896080793171353	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322204	rs4421206	0.894701256894078	Brain morphology (min-P)	4e-11	32665545
rs9322204	rs9688452	0.875465272395248	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322204	rs9688452	0.875465272395248	aseg lh volume VentralDC	2e-10	33875891
rs9322204	rs9322194	0.831220472895433	Brainstem volume	2e-11	31636452
rs9322204	rs10872649	0.824135364726354	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322204	rs10872649	0.824135364726354	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322204	rs10872649	0.824135364726354	Right hippocampal volume (body)	1e-10	37337106
rs9322204	rs7752089	0.795115916547513	Brain morphology (MOSTest)	2e-31	35164939
rs9322204	rs9285521	0.706058536211615	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322204	rs12526675	0.621650067836121	Brain morphology (MOSTest)	7e-22	32665545
rs9322204	rs9688809	0.60973847179092	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322204	rs34337297	0.606829058590251	Serum levels of protein LRP11	3e-161	35078996
rs9322204	rs10872645	0.606055856457561	Blood protein levels	2e-86	30072576
rs9322204	rs14314	0.604984582005888	Macular thickness	3e-19	30535121
rs9322204	rs14314	0.604984582005888	Vertex-wise sulcal depth	7e-17	34910505
rs9322204	rs14314	0.604984582005888	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322204	rs14314	0.604984582005888	Left hippocampal volume (body)	7e-15	37337106
rs9322204	rs14314	0.604984582005888	Left subiculum volume (body)	1e-14	37337106
rs9322204	rs55763431	0.604728269726473	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322204	rs9322193	0.604148023168305	Lung cancer	1e-07	27393504
rs9322204	rs9689694	0.603618557235427	Right hippocampal volume (head)	6e-11	37337106
rs9322204	rs9689694	0.603618557235427	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322204	rs9689694	0.603618557235427	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322204	rs9689694	0.603618557235427	Left hippocampal volume (head)	6e-12	37337106
rs9322204	rs9383843	0.602293245130986	Migraine	1e-09	35115687
rs9322204	rs2095375	0.60173929610655	Serum metabolite levels	1e-20	33031748
rs9322204	rs2095375	0.60173929610655	Serum metabolite levels	1e-20	33031748
rs9322206	rs34337297	0.972335889951472	Serum levels of protein LRP11	3e-161	35078996
rs9322206	rs9322193	0.971548298854235	Lung cancer	1e-07	27393504
rs9322206	rs10872645	0.967910912845265	Blood protein levels	2e-86	30072576
rs9322206	rs55763431	0.962612417588606	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322206	rs9689694	0.960843353466196	Right hippocampal volume (head)	6e-11	37337106
rs9322206	rs9689694	0.960843353466196	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322206	rs9689694	0.960843353466196	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322206	rs9689694	0.960843353466196	Left hippocampal volume (head)	6e-12	37337106
rs9322206	rs2095375	0.9581983179141	Serum metabolite levels	1e-20	33031748
rs9322206	rs2095375	0.9581983179141	Serum metabolite levels	1e-20	33031748
rs9322206	rs9383843	0.957321285130681	Migraine	1e-09	35115687
rs9322206	rs9688867	0.954746797081288	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9322206	rs9688867	0.954746797081288	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9322206	rs9688809	0.954746797081288	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322206	rs10872653	0.954670825562717	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9322206	rs14314	0.939904788895584	Macular thickness	3e-19	30535121
rs9322206	rs14314	0.939904788895584	Vertex-wise sulcal depth	7e-17	34910505
rs9322206	rs14314	0.939904788895584	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322206	rs14314	0.939904788895584	Left hippocampal volume (body)	7e-15	37337106
rs9322206	rs14314	0.939904788895584	Left subiculum volume (body)	1e-14	37337106
rs9322206	rs4039600	0.926157431177939	Adenine levels	1e-11	35347128
rs9322206	rs11155671	0.63716953375434	Testicular germ cell tumor	2e-09	28604728
rs9322206	rs1934534	0.631804949991373	Pain (pleiotropy)	2e-08	37844115
rs9322206	rs1934534	0.631804949991373	Pain (pleiotropy)	2e-06	37844115
rs9322206	rs4380763	0.631285605620178	Subcortical volume (min-P)	1e-11	32665545
rs9322206	rs9505982	0.619925220347511	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322206	rs80147756	0.604748279532371	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322210	rs4421206	0.990353728072038	Brain morphology (min-P)	4e-11	32665545
rs9322210	rs9688452	0.964228605385944	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322210	rs9688452	0.964228605385944	aseg lh volume VentralDC	2e-10	33875891
rs9322210	rs4380763	0.939524340679462	Subcortical volume (min-P)	1e-11	32665545
rs9322210	rs1934534	0.938760619627341	Pain (pleiotropy)	2e-08	37844115
rs9322210	rs1934534	0.938760619627341	Pain (pleiotropy)	2e-06	37844115
rs9322210	rs11155671	0.921431845276782	Testicular germ cell tumor	2e-09	28604728
rs9322210	rs9505982	0.895549555145352	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322210	rs80147756	0.894807178683323	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322210	rs10872649	0.818149316940952	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322210	rs10872649	0.818149316940952	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322210	rs10872649	0.818149316940952	Right hippocampal volume (body)	1e-10	37337106
rs9322210	rs7752089	0.781524653354838	Brain morphology (MOSTest)	2e-31	35164939
rs9322210	rs9322194	0.767826542326843	Brainstem volume	2e-11	31636452
rs9322210	rs9285521	0.710326602085725	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322210	rs12526675	0.698082133134737	Brain morphology (MOSTest)	7e-22	32665545
rs9322210	rs2342764	0.654697185902226	Cortical thickness	1e-08	34560273
rs9322210	rs56103941	0.622822176622141	Right presubiculum volume (head)	4e-08	37337106
rs9322210	rs9688809	0.608479278222665	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322210	rs10872645	0.606208160350354	Blood protein levels	2e-86	30072576
rs9322210	rs34337297	0.605662157601312	Serum levels of protein LRP11	3e-161	35078996
rs9322210	rs14314	0.603728210201737	Macular thickness	3e-19	30535121
rs9322210	rs14314	0.603728210201737	Vertex-wise sulcal depth	7e-17	34910505
rs9322210	rs14314	0.603728210201737	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322210	rs14314	0.603728210201737	Left hippocampal volume (body)	7e-15	37337106
rs9322210	rs14314	0.603728210201737	Left subiculum volume (body)	1e-14	37337106
rs9322210	rs55763431	0.60355769361549	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322210	rs9689694	0.602467608001322	Right hippocampal volume (head)	6e-11	37337106
rs9322210	rs9689694	0.602467608001322	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322210	rs9689694	0.602467608001322	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322210	rs9689694	0.602467608001322	Left hippocampal volume (head)	6e-12	37337106
rs9322210	rs9383843	0.601145350097432	Migraine	1e-09	35115687
rs9322210	rs2095375	0.600601195004103	Serum metabolite levels	1e-20	33031748
rs9322210	rs2095375	0.600601195004103	Serum metabolite levels	1e-20	33031748
rs9322214	rs56103941	0.977404676140372	Right presubiculum volume (head)	4e-08	37337106
rs9322214	rs12523793	0.944892807198539	Subcortical volume (MOSTest)	4e-24	32665545
rs9322214	rs12523793	0.944892807198539	C-reactive protein levels	3e-08	35459240
rs9322214	rs12523793	0.944892807198539	C-reactive protein levels (MTAG)	2e-08	36376304
rs9322214	rs11155662	0.935222807134868	Vertex-wise cortical thickness	2e-09	34910505
rs9322214	rs12526675	0.887069258851911	Brain morphology (MOSTest)	7e-22	32665545
rs9322214	rs2342764	0.820894742749552	Cortical thickness	1e-08	34560273
rs9322214	rs58189451	0.759833270930796	Drinks per week	1e-09	36477530
rs9322214	rs9285521	0.750575964095919	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322214	rs7752089	0.658438678524193	Brain morphology (MOSTest)	2e-31	35164939
rs9322214	rs9322194	0.657956736017351	Brainstem volume	2e-11	31636452
rs9322214	rs11155675	0.639730603406207	Brain region volumes	3e-09	31676860
rs9322214	rs1125	0.639522310565052	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs9322214	rs1125	0.639522310565052	Vertical cup-disc ratio	8e-14	34077760
rs9322214	rs10872649	0.632732424215739	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322214	rs10872649	0.632732424215739	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322214	rs10872649	0.632732424215739	Right hippocampal volume (body)	1e-10	37337106
rs9322214	rs9371201	0.628224760098774	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs9322214	rs4421206	0.619865733778783	Brain morphology (min-P)	4e-11	32665545
rs9322214	rs9688452	0.603242577110133	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322214	rs9688452	0.603242577110133	aseg lh volume VentralDC	2e-10	33875891
rs9322217	rs10872649	0.983995455203051	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9322217	rs10872649	0.983995455203051	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9322217	rs10872649	0.983995455203051	Right hippocampal volume (body)	1e-10	37337106
rs9322217	rs7752089	0.936458374583707	Brain morphology (MOSTest)	2e-31	35164939
rs9322217	rs1934534	0.88359375038876	Pain (pleiotropy)	2e-08	37844115
rs9322217	rs1934534	0.88359375038876	Pain (pleiotropy)	2e-06	37844115
rs9322217	rs4380763	0.8828051773479	Subcortical volume (min-P)	1e-11	32665545
rs9322217	rs11155671	0.866739122368643	Testicular germ cell tumor	2e-09	28604728
rs9322217	rs9322194	0.849257971100374	Brainstem volume	2e-11	31636452
rs9322217	rs80147756	0.845059792349855	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322217	rs4421206	0.840432970116828	Brain morphology (min-P)	4e-11	32665545
rs9322217	rs9505982	0.823615283763187	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9322217	rs9688452	0.81655721803388	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9322217	rs9688452	0.81655721803388	aseg lh volume VentralDC	2e-10	33875891
rs9322217	rs9285521	0.731551251053625	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9322217	rs12526675	0.723393983804812	Brain morphology (MOSTest)	7e-22	32665545
rs9322217	rs2342764	0.67868298268845	Cortical thickness	1e-08	34560273
rs9322217	rs56103941	0.645752410035993	Right presubiculum volume (head)	4e-08	37337106
rs9322217	rs12523793	0.609915816634798	Subcortical volume (MOSTest)	4e-24	32665545
rs9322217	rs12523793	0.609915816634798	C-reactive protein levels	3e-08	35459240
rs9322217	rs12523793	0.609915816634798	C-reactive protein levels (MTAG)	2e-08	36376304
rs9322217	rs11155662	0.606344353739628	Vertex-wise cortical thickness	2e-09	34910505
rs9322224	rs14314	0.988372005308939	Macular thickness	3e-19	30535121
rs9322224	rs14314	0.988372005308939	Vertex-wise sulcal depth	7e-17	34910505
rs9322224	rs14314	0.988372005308939	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9322224	rs14314	0.988372005308939	Left hippocampal volume (body)	7e-15	37337106
rs9322224	rs14314	0.988372005308939	Left subiculum volume (body)	1e-14	37337106
rs9322224	rs2095375	0.973245308741208	Serum metabolite levels	1e-20	33031748
rs9322224	rs2095375	0.973245308741208	Serum metabolite levels	1e-20	33031748
rs9322224	rs9383843	0.97235833757919	Migraine	1e-09	35115687
rs9322224	rs55763431	0.968818154538127	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9322224	rs9689694	0.967048435172407	Right hippocampal volume (head)	6e-11	37337106
rs9322224	rs9689694	0.967048435172407	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9322224	rs9689694	0.967048435172407	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9322224	rs9689694	0.967048435172407	Left hippocampal volume (head)	6e-12	37337106
rs9322224	rs10872645	0.965284127058221	Blood protein levels	2e-86	30072576
rs9322224	rs9688867	0.9609117230211	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9322224	rs9688867	0.9609117230211	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9322224	rs9688809	0.9609117230211	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9322224	rs10872653	0.960869359682457	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9322224	rs34337297	0.957353580435127	Serum levels of protein LRP11	3e-161	35078996
rs9322224	rs9322193	0.923579776560741	Lung cancer	1e-07	27393504
rs9322224	rs4039600	0.880559637692679	Adenine levels	1e-11	35347128
rs9322224	rs1934534	0.640354430267853	Pain (pleiotropy)	2e-08	37844115
rs9322224	rs1934534	0.640354430267853	Pain (pleiotropy)	2e-06	37844115
rs9322224	rs4380763	0.639830520829445	Subcortical volume (min-P)	1e-11	32665545
rs9322224	rs11155671	0.629387565362967	Testicular germ cell tumor	2e-09	28604728
rs9322224	rs80147756	0.614400927383243	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9322224	rs4421206	0.606776686601904	Brain morphology (min-P)	4e-11	32665545
rs9322224	rs9505982	0.601620691349951	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9323443	rs2357176	0.995470414014064	Nevus count or cutaneous melanoma	4e-08	30429480
rs9323443	rs10873172	0.833697783553533	Cutaneous melanoma or hair colour	6e-27	32341527
rs9323443	rs10873172	0.833697783553533	Nevus count or cutaneous melanoma	6e-13	32341527
rs9323443	rs10873172	0.833697783553533	Blond vs. brown/black hair color	6e-15	30531825
rs9323443	rs10873172	0.833697783553533	Cutaneous malignant melanoma	6e-08	32341527
rs9323443	rs10873172	0.833697783553533	Hair color	4e-17	30595370
rs9323443	rs1255908	0.774351744641709	PR interval	8e-14	32439900
rs9323443	rs1255908	0.774351744641709	PR interval	6e-14	32439900
rs9323443	rs12878653	0.715668440833888	Youthful appearance (self-reported)	3e-14	32339537
rs933055	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs933055	rs2095375	1	Serum metabolite levels	1e-20	33031748
rs933055	rs9383843	0.999100085712971	Migraine	1e-09	35115687
rs933055	rs55763431	0.995506640298119	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs933055	rs9689694	0.993707895167345	Right hippocampal volume (head)	6e-11	37337106
rs933055	rs9689694	0.993707895167345	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs933055	rs9689694	0.993707895167345	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs933055	rs9689694	0.993707895167345	Left hippocampal volume (head)	6e-12	37337106
rs933055	rs10872645	0.988335410721321	Blood protein levels	2e-86	30072576
rs933055	rs9688867	0.987484746280957	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs933055	rs9688867	0.987484746280957	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs933055	rs9688809	0.987484746280957	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs933055	rs10872653	0.987428985005238	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs933055	rs34337297	0.983863132808358	Serum levels of protein LRP11	3e-161	35078996
rs933055	rs14314	0.981250032026204	Macular thickness	3e-19	30535121
rs933055	rs14314	0.981250032026204	Vertex-wise sulcal depth	7e-17	34910505
rs933055	rs14314	0.981250032026204	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs933055	rs14314	0.981250032026204	Left hippocampal volume (body)	7e-15	37337106
rs933055	rs14314	0.981250032026204	Left subiculum volume (body)	1e-14	37337106
rs933055	rs9322193	0.947826521476432	Lung cancer	1e-07	27393504
rs933055	rs4039600	0.904085337095829	Adenine levels	1e-11	35347128
rs933055	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-08	37844115
rs933055	rs1934534	0.63886426029342	Pain (pleiotropy)	2e-06	37844115
rs933055	rs4380763	0.638343493751961	Subcortical volume (min-P)	1e-11	32665545
rs933055	rs11155671	0.62791813730041	Testicular germ cell tumor	2e-09	28604728
rs933055	rs80147756	0.613057484647013	HippSubfield lh volume subiculum-head	3e-10	33875891
rs933055	rs4421206	0.605487928690632	Brain morphology (min-P)	4e-11	32665545
rs9342045	rs1173416	0.886079389773667	Height	2e-59	36224396
rs9342045	rs2842611	0.824588595620344	High density lipoprotein cholesterol levels	5e-09	34887591
rs9342045	rs9450288	0.785115068664781	Height	2e-10	36224396
rs9344539	rs2842611	0.916469356938555	High density lipoprotein cholesterol levels	5e-09	34887591
rs9344539	rs1173416	0.901587111923114	Height	2e-59	36224396
rs9344539	rs9450288	0.875084889288302	Height	2e-10	36224396
rs9344540	rs2842611	0.924147447778903	High density lipoprotein cholesterol levels	5e-09	34887591
rs9344540	rs1173416	0.912478685790143	Height	2e-59	36224396
rs9344540	rs9450288	0.876550411417946	Height	2e-10	36224396
rs9348950	rs9366863	0.978512049830449	Adult body size	9e-33	32376654
rs9348950	rs9366863	0.978512049830449	Body mass index	2e-44	30595370
rs9348950	rs2744944	0.972978784303048	Hypothyroidism	3e-10	34594039
rs9348950	rs2744944	0.972978784303048	High density lipoprotein cholesterol levels	3e-86	34887591
rs9348950	rs2744944	0.972978784303048	Multi-trait sex score	7e-22	37277458
rs9348950	rs9469872	0.968223468150989	HDL cholesterol levels	3e-11	36333282
rs9348950	rs2814949	0.963601593032406	Essential hypertension (time to event)	9e-09	32589924
rs9348950	rs2263329	0.948392280440982	HDL cholesterol	6e-35	34594039
rs9348950	rs2263329	0.948392280440982	HDL cholesterol levels	8e-43	32203549
rs9348950	rs2263329	0.948392280440982	High density lipoprotein cholesterol levels	2e-52	34887591
rs9348950	rs11755393	0.942689138910718	Body mass index	3e-26	29273807
rs9348950	rs11755393	0.942689138910718	Systemic lupus erythematosus	2e-12	33493351
rs9348950	rs11755393	0.942689138910718	Systemic lupus erythematosus	2e-06	33493351
rs9348950	rs11755393	0.942689138910718	Systemic lupus erythematosus	1e-07	33493351
rs9348950	rs11755393	0.942689138910718	Systemic lupus erythematosus	2e-08	19838195
rs9348950	rs11755393	0.942689138910718	Body mass index	4e-55	36581621
rs9348950	rs6941110	0.932857605963199	Sex hormone-binding globulin levels	5e-27	36653534
rs9348950	rs9469857	0.927297682758957	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9348950	rs2764208	0.926533589720028	Systemic lupus erythematosus	7e-06	24871463
rs9348950	rs111868030	0.924324267587087	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9348950	rs9462030	0.913372702635674	Red cell distribution width	5e-25	32888493
rs9348950	rs9469899	0.897394731271817	Prostate cancer (advanced)	2e-06	29892016
rs9348950	rs9469899	0.897394731271817	Prostate cancer	5e-09	29892016
rs9348950	rs9469899	0.897394731271817	Prostate cancer	8e-11	33398198
rs9348950	rs9469899	0.897394731271817	Hand grip strength	3e-15	29691431
rs9348950	rs9469899	0.897394731271817	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9348950	rs9469899	0.897394731271817	Graves' disease	4e-10	34594039
rs9348950	rs9469899	0.897394731271817	Coronary artery disease	1e-11	36474045
rs9348950	rs9469899	0.897394731271817	Predicted visceral adipose tissue	2e-20	31501611
rs9348950	rs9469899	0.897394731271817	Medication use (thyroid preparations)	2e-09	31015401
rs9348950	rs9469899	0.897394731271817	Medication use (thyroid preparations)	3e-10	34594039
rs9348950	rs9368830	0.887717610462428	HDL cholesterol	4e-21	30275531
rs9348950	rs9296128	0.878288352324476	Hip circumference adjusted for BMI	4e-13	34021172
rs9348950	rs9368828	0.874536980170018	Body mass index	1e-34	34594039
rs9348950	rs2744973	0.796523927077549	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9348950	rs2744973	0.796523927077549	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9348950	rs2744973	0.796523927077549	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9348950	rs2744973	0.796523927077549	Multi-trait sex score	6e-20	37277458
rs9348950	rs6912327	0.791167784878632	Fasting insulin	5e-06	33402679
rs9348950	rs6912327	0.791167784878632	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9348950	rs112283401	0.766021667885633	Red cell distribution width	4e-27	30595370
rs9348950	rs205262	0.619529000610473	Body mass index	2e-09	26961502
rs9348950	rs205262	0.619529000610473	Walking pace	4e-10	33128006
rs9348950	rs205262	0.619529000610473	Body mass index	8e-13	30108127
rs9348950	rs205262	0.619529000610473	Body mass index	2e-09	25673413
rs9348950	rs205262	0.619529000610473	Body mass index	2e-14	26426971
rs9348950	rs205262	0.619529000610473	BMI in non-smokers	3e-07	28443625
rs9348950	rs205262	0.619529000610473	BMI in non-smokers	6e-09	28443625
rs9348950	rs205262	0.619529000610473	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9348950	rs205262	0.619529000610473	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9348950	rs205262	0.619529000610473	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9348950	rs205262	0.619529000610473	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9348950	rs205262	0.619529000610473	Gastroesophageal reflux disease	1e-10	34187846
rs9348950	rs205262	0.619529000610473	Body mass index	3e-10	25673413
rs9348950	rs205262	0.619529000610473	Body mass index	2e-10	25673413
rs9348950	rs205262	0.619529000610473	ICD10 M54: Dorsalgia	2e-12	35110524
rs9348950	rs6940215	0.618339757937727	Insomnia	2e-10	35835914
rs9348950	rs6940215	0.618339757937727	Insomnia	1e-13	35835914
rs9348950	rs6940215	0.618339757937727	Hip circumference adjusted for BMI	8e-10	34021172
rs9348950	rs6940215	0.618339757937727	Multi-trait sex score	2e-23	37277458
rs9348950	rs6940215	0.618339757937727	Multi-trait sex score	4e-23	37277458
rs9348950	rs6457796	0.608022042542576	Insomnia	1e-08	30804565
rs9348950	rs6457796	0.608022042542576	Plateletcrit	9e-11	32888494
rs9348950	rs6457796	0.608022042542576	Systemic lupus erythematosus	3e-22	33272962
rs9348950	rs6457796	0.608022042542576	Body mass index	5e-13	30108127
rs9348950	rs6457796	0.608022042542576	Body mass index	1e-14	26426971
rs9348950	rs6457796	0.608022042542576	Educational attainment	5e-19	35361970
rs9353330	rs2475792	0.844953757538021	Neutrophil count	1e-08	34594039
rs9353330	rs2475787	0.826208659520809	Neutrophil count	1e-11	32888493
rs9353330	rs4593336	0.749635872149708	Body mass index	2e-08	36581621
rs9353330	rs10806334	0.728101276453366	White blood cell count	4e-12	32888493
rs9353330	rs10806334	0.728101276453366	Neutrophil count	9e-12	32888493
rs9353330	rs10806334	0.728101276453366	White blood cell count	3e-13	32888493
rs9353335	rs1173416	0.639464504546372	Height	2e-59	36224396
rs9353338	rs1173416	0.623894715021369	Height	2e-59	36224396
rs9357181	rs9366863	0.988009408518446	Adult body size	9e-33	32376654
rs9357181	rs9366863	0.988009408518446	Body mass index	2e-44	30595370
rs9357181	rs2814949	0.9729792398285	Essential hypertension (time to event)	9e-09	32589924
rs9357181	rs2744944	0.96340328554858	Hypothyroidism	3e-10	34594039
rs9357181	rs2744944	0.96340328554858	High density lipoprotein cholesterol levels	3e-86	34887591
rs9357181	rs2744944	0.96340328554858	Multi-trait sex score	7e-22	37277458
rs9357181	rs9469872	0.958673406573797	HDL cholesterol levels	3e-11	36333282
rs9357181	rs11755393	0.951904733054754	Body mass index	3e-26	29273807
rs9357181	rs11755393	0.951904733054754	Systemic lupus erythematosus	2e-12	33493351
rs9357181	rs11755393	0.951904733054754	Systemic lupus erythematosus	2e-06	33493351
rs9357181	rs11755393	0.951904733054754	Systemic lupus erythematosus	1e-07	33493351
rs9357181	rs11755393	0.951904733054754	Systemic lupus erythematosus	2e-08	19838195
rs9357181	rs11755393	0.951904733054754	Body mass index	4e-55	36581621
rs9357181	rs6941110	0.942166250755682	Sex hormone-binding globulin levels	5e-27	36653534
rs9357181	rs2263329	0.942128914410229	HDL cholesterol	6e-35	34594039
rs9357181	rs2263329	0.942128914410229	HDL cholesterol levels	8e-43	32203549
rs9357181	rs2263329	0.942128914410229	High density lipoprotein cholesterol levels	2e-52	34887591
rs9357181	rs9462030	0.922750143273034	Red cell distribution width	5e-25	32888493
rs9357181	rs9469857	0.918139000213006	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9357181	rs2764208	0.917389125422034	Systemic lupus erythematosus	7e-06	24871463
rs9357181	rs111868030	0.915405024835497	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9357181	rs9469899	0.906563685830695	Prostate cancer (advanced)	2e-06	29892016
rs9357181	rs9469899	0.906563685830695	Prostate cancer	5e-09	29892016
rs9357181	rs9469899	0.906563685830695	Prostate cancer	8e-11	33398198
rs9357181	rs9469899	0.906563685830695	Hand grip strength	3e-15	29691431
rs9357181	rs9469899	0.906563685830695	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9357181	rs9469899	0.906563685830695	Graves' disease	4e-10	34594039
rs9357181	rs9469899	0.906563685830695	Coronary artery disease	1e-11	36474045
rs9357181	rs9469899	0.906563685830695	Predicted visceral adipose tissue	2e-20	31501611
rs9357181	rs9469899	0.906563685830695	Medication use (thyroid preparations)	2e-09	31015401
rs9357181	rs9469899	0.906563685830695	Medication use (thyroid preparations)	3e-10	34594039
rs9357181	rs9368830	0.89636566310149	HDL cholesterol	4e-21	30275531
rs9357181	rs9296128	0.869613272041354	Hip circumference adjusted for BMI	4e-13	34021172
rs9357181	rs9368828	0.865615372490627	Body mass index	1e-34	34594039
rs9357181	rs2744973	0.806224368804333	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9357181	rs2744973	0.806224368804333	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9357181	rs2744973	0.806224368804333	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9357181	rs2744973	0.806224368804333	Multi-trait sex score	6e-20	37277458
rs9357181	rs6912327	0.800626825361549	Fasting insulin	5e-06	33402679
rs9357181	rs6912327	0.800626825361549	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9357181	rs112283401	0.775335888044034	Red cell distribution width	4e-27	30595370
rs9357181	rs6940215	0.627409968696561	Insomnia	2e-10	35835914
rs9357181	rs6940215	0.627409968696561	Insomnia	1e-13	35835914
rs9357181	rs6940215	0.627409968696561	Hip circumference adjusted for BMI	8e-10	34021172
rs9357181	rs6940215	0.627409968696561	Multi-trait sex score	2e-23	37277458
rs9357181	rs6940215	0.627409968696561	Multi-trait sex score	4e-23	37277458
rs9357181	rs6457796	0.617653829026256	Insomnia	1e-08	30804565
rs9357181	rs6457796	0.617653829026256	Plateletcrit	9e-11	32888494
rs9357181	rs6457796	0.617653829026256	Systemic lupus erythematosus	3e-22	33272962
rs9357181	rs6457796	0.617653829026256	Body mass index	5e-13	30108127
rs9357181	rs6457796	0.617653829026256	Body mass index	1e-14	26426971
rs9357181	rs6457796	0.617653829026256	Educational attainment	5e-19	35361970
rs9357181	rs205262	0.613521344784496	Body mass index	2e-09	26961502
rs9357181	rs205262	0.613521344784496	Walking pace	4e-10	33128006
rs9357181	rs205262	0.613521344784496	Body mass index	8e-13	30108127
rs9357181	rs205262	0.613521344784496	Body mass index	2e-09	25673413
rs9357181	rs205262	0.613521344784496	Body mass index	2e-14	26426971
rs9357181	rs205262	0.613521344784496	BMI in non-smokers	3e-07	28443625
rs9357181	rs205262	0.613521344784496	BMI in non-smokers	6e-09	28443625
rs9357181	rs205262	0.613521344784496	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9357181	rs205262	0.613521344784496	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9357181	rs205262	0.613521344784496	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9357181	rs205262	0.613521344784496	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9357181	rs205262	0.613521344784496	Gastroesophageal reflux disease	1e-10	34187846
rs9357181	rs205262	0.613521344784496	Body mass index	3e-10	25673413
rs9357181	rs205262	0.613521344784496	Body mass index	2e-10	25673413
rs9357181	rs205262	0.613521344784496	ICD10 M54: Dorsalgia	2e-12	35110524
rs9357202	rs9368881	0.993966758812028	Height	2e-21	36224396
rs9357202	rs6931118	0.964190747381805	Lymphocyte count	9e-21	32888494
rs9357202	rs9380522	0.760388172285367	Hypothyroidism	1e-10	30595370
rs9357202	rs4713911	0.748572079258036	Monocyte percentage of white cells	5e-13	32888494
rs9357202	rs12055438	0.687200645204203	Lymphocyte-to-monocyte ratio	5e-18	34469753
rs9357202	rs6457834	0.682203763756823	Autoimmune thyroid disease	6e-13	32581359
rs9357202	rs4713906	0.618331466992532	Multi-trait sex score	8e-09	37277458
rs9362232	rs2842611	0.916469356938555	High density lipoprotein cholesterol levels	5e-09	34887591
rs9362232	rs1173416	0.901587111923114	Height	2e-59	36224396
rs9362232	rs9450288	0.875084889288302	Height	2e-10	36224396
rs9362245	rs1173416	0.623350179018077	Height	2e-59	36224396
rs9366862	rs9366863	0.988786003955939	Adult body size	9e-33	32376654
rs9366862	rs9366863	0.988786003955939	Body mass index	2e-44	30595370
rs9366862	rs9469872	0.959437782688197	HDL cholesterol levels	3e-11	36333282
rs9366862	rs2814949	0.957882853813307	Essential hypertension (time to event)	9e-09	32589924
rs9366862	rs11755393	0.952491819465273	Body mass index	3e-26	29273807
rs9366862	rs11755393	0.952491819465273	Systemic lupus erythematosus	2e-12	33493351
rs9366862	rs11755393	0.952491819465273	Systemic lupus erythematosus	2e-06	33493351
rs9366862	rs11755393	0.952491819465273	Systemic lupus erythematosus	1e-07	33493351
rs9366862	rs11755393	0.952491819465273	Systemic lupus erythematosus	2e-08	19838195
rs9366862	rs11755393	0.952491819465273	Body mass index	4e-55	36581621
rs9366862	rs2744944	0.948449570523015	Hypothyroidism	3e-10	34594039
rs9366862	rs2744944	0.948449570523015	High density lipoprotein cholesterol levels	3e-86	34887591
rs9366862	rs2744944	0.948449570523015	Multi-trait sex score	7e-22	37277458
rs9366862	rs6941110	0.94298124789915	Sex hormone-binding globulin levels	5e-27	36653534
rs9366862	rs2263329	0.929008282832072	HDL cholesterol	6e-35	34594039
rs9366862	rs2263329	0.929008282832072	HDL cholesterol levels	8e-43	32203549
rs9366862	rs2263329	0.929008282832072	High density lipoprotein cholesterol levels	2e-52	34887591
rs9366862	rs9462030	0.923825465393084	Red cell distribution width	5e-25	32888493
rs9366862	rs9469857	0.919240955569893	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9366862	rs2764208	0.918510822302034	Systemic lupus erythematosus	7e-06	24871463
rs9366862	rs9469899	0.907425573054565	Prostate cancer (advanced)	2e-06	29892016
rs9366862	rs9469899	0.907425573054565	Prostate cancer	5e-09	29892016
rs9366862	rs9469899	0.907425573054565	Prostate cancer	8e-11	33398198
rs9366862	rs9469899	0.907425573054565	Hand grip strength	3e-15	29691431
rs9366862	rs9469899	0.907425573054565	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9366862	rs9469899	0.907425573054565	Graves' disease	4e-10	34594039
rs9366862	rs9469899	0.907425573054565	Coronary artery disease	1e-11	36474045
rs9366862	rs9469899	0.907425573054565	Predicted visceral adipose tissue	2e-20	31501611
rs9366862	rs9469899	0.907425573054565	Medication use (thyroid preparations)	2e-09	31015401
rs9366862	rs9469899	0.907425573054565	Medication use (thyroid preparations)	3e-10	34594039
rs9366862	rs111868030	0.904620337099782	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9366862	rs9368830	0.879819047549638	HDL cholesterol	4e-21	30275531
rs9366862	rs9296128	0.871147877459846	Hip circumference adjusted for BMI	4e-13	34021172
rs9366862	rs9368828	0.850225391109643	Body mass index	1e-34	34594039
rs9366862	rs6912327	0.799861995421354	Fasting insulin	5e-06	33402679
rs9366862	rs6912327	0.799861995421354	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9366862	rs2744973	0.795551777273387	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9366862	rs2744973	0.795551777273387	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9366862	rs2744973	0.795551777273387	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9366862	rs2744973	0.795551777273387	Multi-trait sex score	6e-20	37277458
rs9366862	rs112283401	0.777455277474536	Red cell distribution width	4e-27	30595370
rs9366862	rs6940215	0.629052143064024	Insomnia	2e-10	35835914
rs9366862	rs6940215	0.629052143064024	Insomnia	1e-13	35835914
rs9366862	rs6940215	0.629052143064024	Hip circumference adjusted for BMI	8e-10	34021172
rs9366862	rs6940215	0.629052143064024	Multi-trait sex score	2e-23	37277458
rs9366862	rs6940215	0.629052143064024	Multi-trait sex score	4e-23	37277458
rs9366862	rs6457796	0.620160002772668	Insomnia	1e-08	30804565
rs9366862	rs6457796	0.620160002772668	Plateletcrit	9e-11	32888494
rs9366862	rs6457796	0.620160002772668	Systemic lupus erythematosus	3e-22	33272962
rs9366862	rs6457796	0.620160002772668	Body mass index	5e-13	30108127
rs9366862	rs6457796	0.620160002772668	Body mass index	1e-14	26426971
rs9366862	rs6457796	0.620160002772668	Educational attainment	5e-19	35361970
rs9366862	rs205262	0.608401232147416	Body mass index	2e-09	26961502
rs9366862	rs205262	0.608401232147416	Walking pace	4e-10	33128006
rs9366862	rs205262	0.608401232147416	Body mass index	8e-13	30108127
rs9366862	rs205262	0.608401232147416	Body mass index	2e-09	25673413
rs9366862	rs205262	0.608401232147416	Body mass index	2e-14	26426971
rs9366862	rs205262	0.608401232147416	BMI in non-smokers	3e-07	28443625
rs9366862	rs205262	0.608401232147416	BMI in non-smokers	6e-09	28443625
rs9366862	rs205262	0.608401232147416	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9366862	rs205262	0.608401232147416	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9366862	rs205262	0.608401232147416	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9366862	rs205262	0.608401232147416	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9366862	rs205262	0.608401232147416	Gastroesophageal reflux disease	1e-10	34187846
rs9366862	rs205262	0.608401232147416	Body mass index	3e-10	25673413
rs9366862	rs205262	0.608401232147416	Body mass index	2e-10	25673413
rs9366862	rs205262	0.608401232147416	ICD10 M54: Dorsalgia	2e-12	35110524
rs9366863	rs9366863	1	Adult body size	9e-33	32376654
rs9366863	rs9366863	1	Body mass index	2e-44	30595370
rs9366863	rs9469872	0.970483919695282	HDL cholesterol levels	3e-11	36333282
rs9366863	rs11755393	0.963539594764905	Body mass index	3e-26	29273807
rs9366863	rs11755393	0.963539594764905	Systemic lupus erythematosus	2e-12	33493351
rs9366863	rs11755393	0.963539594764905	Systemic lupus erythematosus	2e-06	33493351
rs9366863	rs11755393	0.963539594764905	Systemic lupus erythematosus	1e-07	33493351
rs9366863	rs11755393	0.963539594764905	Systemic lupus erythematosus	2e-08	19838195
rs9366863	rs11755393	0.963539594764905	Body mass index	4e-55	36581621
rs9366863	rs2814949	0.962618453076092	Essential hypertension (time to event)	9e-09	32589924
rs9366863	rs6941110	0.953918635452588	Sex hormone-binding globulin levels	5e-27	36653534
rs9366863	rs2744944	0.953142583205874	Hypothyroidism	3e-10	34594039
rs9366863	rs2744944	0.953142583205874	High density lipoprotein cholesterol levels	3e-86	34887591
rs9366863	rs2744944	0.953142583205874	Multi-trait sex score	7e-22	37277458
rs9366863	rs9462030	0.934589534808786	Red cell distribution width	5e-25	32888493
rs9366863	rs2263329	0.933620128154006	HDL cholesterol	6e-35	34594039
rs9366863	rs2263329	0.933620128154006	HDL cholesterol levels	8e-43	32203549
rs9366863	rs2263329	0.933620128154006	High density lipoprotein cholesterol levels	2e-52	34887591
rs9366863	rs9469857	0.929971672269469	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9366863	rs2764208	0.929232788778709	Systemic lupus erythematosus	7e-06	24871463
rs9366863	rs9469899	0.918139823380352	Prostate cancer (advanced)	2e-06	29892016
rs9366863	rs9469899	0.918139823380352	Prostate cancer	5e-09	29892016
rs9366863	rs9469899	0.918139823380352	Prostate cancer	8e-11	33398198
rs9366863	rs9469899	0.918139823380352	Hand grip strength	3e-15	29691431
rs9366863	rs9469899	0.918139823380352	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9366863	rs9469899	0.918139823380352	Graves' disease	4e-10	34594039
rs9366863	rs9469899	0.918139823380352	Coronary artery disease	1e-11	36474045
rs9366863	rs9469899	0.918139823380352	Predicted visceral adipose tissue	2e-20	31501611
rs9366863	rs9469899	0.918139823380352	Medication use (thyroid preparations)	2e-09	31015401
rs9366863	rs9469899	0.918139823380352	Medication use (thyroid preparations)	3e-10	34594039
rs9366863	rs111868030	0.908999850759808	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9366863	rs9368830	0.886024692197846	HDL cholesterol	4e-21	30275531
rs9366863	rs9296128	0.881494527383526	Hip circumference adjusted for BMI	4e-13	34021172
rs9366863	rs9368828	0.854593927187404	Body mass index	1e-34	34594039
rs9366863	rs6912327	0.809645755191587	Fasting insulin	5e-06	33402679
rs9366863	rs6912327	0.809645755191587	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9366863	rs2744973	0.799413475271135	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9366863	rs2744973	0.799413475271135	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9366863	rs2744973	0.799413475271135	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9366863	rs2744973	0.799413475271135	Multi-trait sex score	6e-20	37277458
rs9366863	rs112283401	0.787098450530365	Red cell distribution width	4e-27	30595370
rs9366863	rs6940215	0.636242549551174	Insomnia	2e-10	35835914
rs9366863	rs6940215	0.636242549551174	Insomnia	1e-13	35835914
rs9366863	rs6940215	0.636242549551174	Hip circumference adjusted for BMI	8e-10	34021172
rs9366863	rs6940215	0.636242549551174	Multi-trait sex score	2e-23	37277458
rs9366863	rs6940215	0.636242549551174	Multi-trait sex score	4e-23	37277458
rs9366863	rs6457796	0.627175681398726	Insomnia	1e-08	30804565
rs9366863	rs6457796	0.627175681398726	Plateletcrit	9e-11	32888494
rs9366863	rs6457796	0.627175681398726	Systemic lupus erythematosus	3e-22	33272962
rs9366863	rs6457796	0.627175681398726	Body mass index	5e-13	30108127
rs9366863	rs6457796	0.627175681398726	Body mass index	1e-14	26426971
rs9366863	rs6457796	0.627175681398726	Educational attainment	5e-19	35361970
rs9366863	rs205262	0.611356737747702	Body mass index	2e-09	26961502
rs9366863	rs205262	0.611356737747702	Walking pace	4e-10	33128006
rs9366863	rs205262	0.611356737747702	Body mass index	8e-13	30108127
rs9366863	rs205262	0.611356737747702	Body mass index	2e-09	25673413
rs9366863	rs205262	0.611356737747702	Body mass index	2e-14	26426971
rs9366863	rs205262	0.611356737747702	BMI in non-smokers	3e-07	28443625
rs9366863	rs205262	0.611356737747702	BMI in non-smokers	6e-09	28443625
rs9366863	rs205262	0.611356737747702	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9366863	rs205262	0.611356737747702	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9366863	rs205262	0.611356737747702	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9366863	rs205262	0.611356737747702	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9366863	rs205262	0.611356737747702	Gastroesophageal reflux disease	1e-10	34187846
rs9366863	rs205262	0.611356737747702	Body mass index	3e-10	25673413
rs9366863	rs205262	0.611356737747702	Body mass index	2e-10	25673413
rs9366863	rs205262	0.611356737747702	ICD10 M54: Dorsalgia	2e-12	35110524
rs9366863	rs9689160	0.606479893230326	Lung function (forced vital capacity)	3e-14	36914875
rs9368828	rs9368828	1	Body mass index	1e-34	34594039
rs9368828	rs9366863	0.854593927187404	Adult body size	9e-33	32376654
rs9368828	rs9366863	0.854593927187404	Body mass index	2e-44	30595370
rs9368828	rs2744944	0.852406821228048	Hypothyroidism	3e-10	34594039
rs9368828	rs2744944	0.852406821228048	High density lipoprotein cholesterol levels	3e-86	34887591
rs9368828	rs2744944	0.852406821228048	Multi-trait sex score	7e-22	37277458
rs9368828	rs9469872	0.846474268217447	HDL cholesterol levels	3e-11	36333282
rs9368828	rs2814949	0.84367902657356	Essential hypertension (time to event)	9e-09	32589924
rs9368828	rs2263329	0.829312627337079	HDL cholesterol	6e-35	34594039
rs9368828	rs2263329	0.829312627337079	HDL cholesterol levels	8e-43	32203549
rs9368828	rs2263329	0.829312627337079	High density lipoprotein cholesterol levels	2e-52	34887591
rs9368828	rs11755393	0.822734322097911	Body mass index	3e-26	29273807
rs9368828	rs11755393	0.822734322097911	Systemic lupus erythematosus	2e-12	33493351
rs9368828	rs11755393	0.822734322097911	Systemic lupus erythematosus	2e-06	33493351
rs9368828	rs11755393	0.822734322097911	Systemic lupus erythematosus	1e-07	33493351
rs9368828	rs11755393	0.822734322097911	Systemic lupus erythematosus	2e-08	19838195
rs9368828	rs11755393	0.822734322097911	Body mass index	4e-55	36581621
rs9368828	rs111868030	0.822241883962006	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9368828	rs6941110	0.813386833065711	Sex hormone-binding globulin levels	5e-27	36653534
rs9368828	rs9469857	0.812310887123721	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9368828	rs2764208	0.811578256757851	Systemic lupus erythematosus	7e-06	24871463
rs9368828	rs9462030	0.799301600448559	Red cell distribution width	5e-25	32888493
rs9368828	rs9469899	0.784531083564841	Prostate cancer (advanced)	2e-06	29892016
rs9368828	rs9469899	0.784531083564841	Prostate cancer	5e-09	29892016
rs9368828	rs9469899	0.784531083564841	Prostate cancer	8e-11	33398198
rs9368828	rs9469899	0.784531083564841	Hand grip strength	3e-15	29691431
rs9368828	rs9469899	0.784531083564841	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9368828	rs9469899	0.784531083564841	Graves' disease	4e-10	34594039
rs9368828	rs9469899	0.784531083564841	Coronary artery disease	1e-11	36474045
rs9368828	rs9469899	0.784531083564841	Predicted visceral adipose tissue	2e-20	31501611
rs9368828	rs9469899	0.784531083564841	Medication use (thyroid preparations)	2e-09	31015401
rs9368828	rs9469899	0.784531083564841	Medication use (thyroid preparations)	3e-10	34594039
rs9368828	rs9368830	0.774546073244933	HDL cholesterol	4e-21	30275531
rs9368828	rs9296128	0.767475189434079	Hip circumference adjusted for BMI	4e-13	34021172
rs9368828	rs2744973	0.758022775303766	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9368828	rs2744973	0.758022775303766	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9368828	rs2744973	0.758022775303766	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9368828	rs2744973	0.758022775303766	Multi-trait sex score	6e-20	37277458
rs9368828	rs112283401	0.727087992420628	Red cell distribution width	4e-27	30595370
rs9368828	rs6912327	0.680068256077029	Fasting insulin	5e-06	33402679
rs9368828	rs6912327	0.680068256077029	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9368830	rs9368830	1	HDL cholesterol	4e-21	30275531
rs9368830	rs9366863	0.886024692197846	Adult body size	9e-33	32376654
rs9368830	rs9366863	0.886024692197846	Body mass index	2e-44	30595370
rs9368830	rs2814949	0.872871957183779	Essential hypertension (time to event)	9e-09	32589924
rs9368830	rs2744944	0.864183867687893	Hypothyroidism	3e-10	34594039
rs9368830	rs2744944	0.864183867687893	High density lipoprotein cholesterol levels	3e-86	34887591
rs9368830	rs2744944	0.864183867687893	Multi-trait sex score	7e-22	37277458
rs9368830	rs9469872	0.858231507139136	HDL cholesterol levels	3e-11	36333282
rs9368830	rs11755393	0.850896311437697	Body mass index	3e-26	29273807
rs9368830	rs11755393	0.850896311437697	Systemic lupus erythematosus	2e-12	33493351
rs9368830	rs11755393	0.850896311437697	Systemic lupus erythematosus	2e-06	33493351
rs9368830	rs11755393	0.850896311437697	Systemic lupus erythematosus	1e-07	33493351
rs9368830	rs11755393	0.850896311437697	Systemic lupus erythematosus	2e-08	19838195
rs9368830	rs11755393	0.850896311437697	Body mass index	4e-55	36581621
rs9368830	rs2263329	0.844692102506487	HDL cholesterol	6e-35	34594039
rs9368830	rs2263329	0.844692102506487	HDL cholesterol levels	8e-43	32203549
rs9368830	rs2263329	0.844692102506487	High density lipoprotein cholesterol levels	2e-52	34887591
rs9368830	rs6941110	0.842906356464362	Sex hormone-binding globulin levels	5e-27	36653534
rs9368830	rs9462030	0.825933046588292	Red cell distribution width	5e-25	32888493
rs9368830	rs111868030	0.822838145356657	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9368830	rs9469857	0.821718979716464	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9368830	rs2764208	0.821112992491793	Systemic lupus erythematosus	7e-06	24871463
rs9368830	rs9469899	0.809552393864725	Prostate cancer (advanced)	2e-06	29892016
rs9368830	rs9469899	0.809552393864725	Prostate cancer	5e-09	29892016
rs9368830	rs9469899	0.809552393864725	Prostate cancer	8e-11	33398198
rs9368830	rs9469899	0.809552393864725	Hand grip strength	3e-15	29691431
rs9368830	rs9469899	0.809552393864725	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9368830	rs9469899	0.809552393864725	Graves' disease	4e-10	34594039
rs9368830	rs9469899	0.809552393864725	Coronary artery disease	1e-11	36474045
rs9368830	rs9469899	0.809552393864725	Predicted visceral adipose tissue	2e-20	31501611
rs9368830	rs9469899	0.809552393864725	Medication use (thyroid preparations)	2e-09	31015401
rs9368830	rs9469899	0.809552393864725	Medication use (thyroid preparations)	3e-10	34594039
rs9368830	rs9296128	0.778158246342176	Hip circumference adjusted for BMI	4e-13	34021172
rs9368830	rs9368828	0.774546073244933	Body mass index	1e-34	34594039
rs9368830	rs2744973	0.724349713506961	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9368830	rs2744973	0.724349713506961	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9368830	rs2744973	0.724349713506961	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9368830	rs2744973	0.724349713506961	Multi-trait sex score	6e-20	37277458
rs9368830	rs6912327	0.717569865465591	Fasting insulin	5e-06	33402679
rs9368830	rs6912327	0.717569865465591	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9368830	rs112283401	0.692329079777226	Red cell distribution width	4e-27	30595370
rs9368830	rs3800458	0.650848587842845	Insomnia	7e-11	35835914
rs9368830	rs3800458	0.650848587842845	Insomnia	2e-12	35835914
rs9368832	rs9366863	0.995988338454092	Adult body size	9e-33	32376654
rs9368832	rs9366863	0.995988338454092	Body mass index	2e-44	30595370
rs9368832	rs9469872	0.966532504744693	HDL cholesterol levels	3e-11	36333282
rs9368832	rs2814949	0.965004084130706	Essential hypertension (time to event)	9e-09	32589924
rs9368832	rs11755393	0.959646948429963	Body mass index	3e-26	29273807
rs9368832	rs11755393	0.959646948429963	Systemic lupus erythematosus	2e-12	33493351
rs9368832	rs11755393	0.959646948429963	Systemic lupus erythematosus	2e-06	33493351
rs9368832	rs11755393	0.959646948429963	Systemic lupus erythematosus	1e-07	33493351
rs9368832	rs11755393	0.959646948429963	Systemic lupus erythematosus	2e-08	19838195
rs9368832	rs11755393	0.959646948429963	Body mass index	4e-55	36581621
rs9368832	rs2744944	0.955499883846003	Hypothyroidism	3e-10	34594039
rs9368832	rs2744944	0.955499883846003	High density lipoprotein cholesterol levels	3e-86	34887591
rs9368832	rs2744944	0.955499883846003	Multi-trait sex score	7e-22	37277458
rs9368832	rs6941110	0.949986664282283	Sex hormone-binding globulin levels	5e-27	36653534
rs9368832	rs2263329	0.935924805252912	HDL cholesterol	6e-35	34594039
rs9368832	rs2263329	0.935924805252912	HDL cholesterol levels	8e-43	32203549
rs9368832	rs2263329	0.935924805252912	High density lipoprotein cholesterol levels	2e-52	34887591
rs9368832	rs9462030	0.930628435576253	Red cell distribution width	5e-25	32888493
rs9368832	rs9469857	0.926012817142676	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9368832	rs2764208	0.925270254625746	Systemic lupus erythematosus	7e-06	24871463
rs9368832	rs9469899	0.914266804809352	Prostate cancer (advanced)	2e-06	29892016
rs9368832	rs9469899	0.914266804809352	Prostate cancer	5e-09	29892016
rs9368832	rs9469899	0.914266804809352	Prostate cancer	8e-11	33398198
rs9368832	rs9469899	0.914266804809352	Hand grip strength	3e-15	29691431
rs9368832	rs9469899	0.914266804809352	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9368832	rs9469899	0.914266804809352	Graves' disease	4e-10	34594039
rs9368832	rs9469899	0.914266804809352	Coronary artery disease	1e-11	36474045
rs9368832	rs9469899	0.914266804809352	Predicted visceral adipose tissue	2e-20	31501611
rs9368832	rs9469899	0.914266804809352	Medication use (thyroid preparations)	2e-09	31015401
rs9368832	rs9469899	0.914266804809352	Medication use (thyroid preparations)	3e-10	34594039
rs9368832	rs111868030	0.911124358285007	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9368832	rs9368830	0.886937373617548	HDL cholesterol	4e-21	30275531
rs9368832	rs9296128	0.877519335683352	Hip circumference adjusted for BMI	4e-13	34021172
rs9368832	rs9368828	0.856761240035975	Body mass index	1e-34	34594039
rs9368832	rs6912327	0.805655768637941	Fasting insulin	5e-06	33402679
rs9368832	rs6912327	0.805655768637941	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9368832	rs2744973	0.801186792855738	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9368832	rs2744973	0.801186792855738	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9368832	rs2744973	0.801186792855738	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9368832	rs2744973	0.801186792855738	Multi-trait sex score	6e-20	37277458
rs9368832	rs112283401	0.783162691107566	Red cell distribution width	4e-27	30595370
rs9368832	rs6940215	0.633724207888394	Insomnia	2e-10	35835914
rs9368832	rs6940215	0.633724207888394	Insomnia	1e-13	35835914
rs9368832	rs6940215	0.633724207888394	Hip circumference adjusted for BMI	8e-10	34021172
rs9368832	rs6940215	0.633724207888394	Multi-trait sex score	2e-23	37277458
rs9368832	rs6940215	0.633724207888394	Multi-trait sex score	4e-23	37277458
rs9368832	rs6457796	0.624430548433788	Insomnia	1e-08	30804565
rs9368832	rs6457796	0.624430548433788	Plateletcrit	9e-11	32888494
rs9368832	rs6457796	0.624430548433788	Systemic lupus erythematosus	3e-22	33272962
rs9368832	rs6457796	0.624430548433788	Body mass index	5e-13	30108127
rs9368832	rs6457796	0.624430548433788	Body mass index	1e-14	26426971
rs9368832	rs6457796	0.624430548433788	Educational attainment	5e-19	35361970
rs9368832	rs205262	0.612512118172211	Body mass index	2e-09	26961502
rs9368832	rs205262	0.612512118172211	Walking pace	4e-10	33128006
rs9368832	rs205262	0.612512118172211	Body mass index	8e-13	30108127
rs9368832	rs205262	0.612512118172211	Body mass index	2e-09	25673413
rs9368832	rs205262	0.612512118172211	Body mass index	2e-14	26426971
rs9368832	rs205262	0.612512118172211	BMI in non-smokers	3e-07	28443625
rs9368832	rs205262	0.612512118172211	BMI in non-smokers	6e-09	28443625
rs9368832	rs205262	0.612512118172211	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9368832	rs205262	0.612512118172211	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9368832	rs205262	0.612512118172211	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9368832	rs205262	0.612512118172211	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9368832	rs205262	0.612512118172211	Gastroesophageal reflux disease	1e-10	34187846
rs9368832	rs205262	0.612512118172211	Body mass index	3e-10	25673413
rs9368832	rs205262	0.612512118172211	Body mass index	2e-10	25673413
rs9368832	rs205262	0.612512118172211	ICD10 M54: Dorsalgia	2e-12	35110524
rs9368832	rs9689160	0.603680883179484	Lung function (forced vital capacity)	3e-14	36914875
rs9368881	rs9368881	1	Height	2e-21	36224396
rs9368881	rs6931118	0.96506181073397	Lymphocyte count	9e-21	32888494
rs9368881	rs9380522	0.75967870099942	Hypothyroidism	1e-10	30595370
rs9368881	rs4713911	0.749449317274817	Monocyte percentage of white cells	5e-13	32888494
rs9368881	rs12055438	0.686561127534471	Lymphocyte-to-monocyte ratio	5e-18	34469753
rs9368881	rs6457834	0.681521352434675	Autoimmune thyroid disease	6e-13	32581359
rs9368881	rs4713906	0.619283753676527	Multi-trait sex score	8e-09	37277458
rs9371207	rs2342764	0.764689702217474	Cortical thickness	1e-08	34560273
rs9371207	rs56103941	0.720945824894381	Right presubiculum volume (head)	4e-08	37337106
rs9371207	rs12526675	0.718641499200377	Brain morphology (MOSTest)	7e-22	32665545
rs9371207	rs12523793	0.684381408535991	Subcortical volume (MOSTest)	4e-24	32665545
rs9371207	rs12523793	0.684381408535991	C-reactive protein levels	3e-08	35459240
rs9371207	rs12523793	0.684381408535991	C-reactive protein levels (MTAG)	2e-08	36376304
rs9371207	rs11155662	0.676639071047711	Vertex-wise cortical thickness	2e-09	34910505
rs9371533	rs9371533	1	Blood protein levels	4e-286	30072576
rs9379314	rs11155671	0.968616921410871	Testicular germ cell tumor	2e-09	28604728
rs9379314	rs4380763	0.955100185175026	Subcortical volume (min-P)	1e-11	32665545
rs9379314	rs1934534	0.954309996172779	Pain (pleiotropy)	2e-08	37844115
rs9379314	rs1934534	0.954309996172779	Pain (pleiotropy)	2e-06	37844115
rs9379314	rs9505982	0.953822135918602	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9379314	rs80147756	0.915368144261389	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9379314	rs4421206	0.912562307821414	Brain morphology (min-P)	4e-11	32665545
rs9379314	rs9688452	0.892874576166482	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9379314	rs9688452	0.892874576166482	aseg lh volume VentralDC	2e-10	33875891
rs9379314	rs10872649	0.839954772768345	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9379314	rs10872649	0.839954772768345	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9379314	rs10872649	0.839954772768345	Right hippocampal volume (body)	1e-10	37337106
rs9379314	rs7752089	0.8125844883248	Brain morphology (MOSTest)	2e-31	35164939
rs9379314	rs9322194	0.811680836922651	Brainstem volume	2e-11	31636452
rs9379314	rs9285521	0.69016683853584	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9379314	rs12526675	0.639326241357188	Brain morphology (MOSTest)	7e-22	32665545
rs9379314	rs9688809	0.620712749897731	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9379314	rs34337297	0.617715184118656	Serum levels of protein LRP11	3e-161	35078996
rs9379314	rs10872645	0.616939908836516	Blood protein levels	2e-86	30072576
rs9379314	rs14314	0.615915909858958	Macular thickness	3e-19	30535121
rs9379314	rs14314	0.615915909858958	Vertex-wise sulcal depth	7e-17	34910505
rs9379314	rs14314	0.615915909858958	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9379314	rs14314	0.615915909858958	Left hippocampal volume (body)	7e-15	37337106
rs9379314	rs14314	0.615915909858958	Left subiculum volume (body)	1e-14	37337106
rs9379314	rs55763431	0.615598741633604	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9379314	rs9322193	0.615117317730485	Lung cancer	1e-07	27393504
rs9379314	rs9689694	0.614466037373558	Right hippocampal volume (head)	6e-11	37337106
rs9379314	rs9689694	0.614466037373558	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9379314	rs9689694	0.614466037373558	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9379314	rs9689694	0.614466037373558	Left hippocampal volume (head)	6e-12	37337106
rs9379314	rs9383843	0.61312716020539	Migraine	1e-09	35115687
rs9379314	rs2095375	0.612561731506417	Serum metabolite levels	1e-20	33031748
rs9379314	rs2095375	0.612561731506417	Serum metabolite levels	1e-20	33031748
rs9379314	rs10872653	0.610303396957318	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9379314	rs9688867	0.610005844029853	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9379314	rs9688867	0.610005844029853	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9379348	rs11155671	0.970189989607598	Testicular germ cell tumor	2e-09	28604728
rs9379348	rs1934534	0.957434334831169	Pain (pleiotropy)	2e-08	37844115
rs9379348	rs1934534	0.957434334831169	Pain (pleiotropy)	2e-06	37844115
rs9379348	rs9505982	0.957078592618826	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9379348	rs4380763	0.956639356047048	Subcortical volume (min-P)	1e-11	32665545
rs9379348	rs80147756	0.915422960761287	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9379348	rs4421206	0.909569774112936	Brain morphology (min-P)	4e-11	32665545
rs9379348	rs9688452	0.889825912079732	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9379348	rs9688452	0.889825912079732	aseg lh volume VentralDC	2e-10	33875891
rs9379348	rs10872649	0.843066926081103	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9379348	rs10872649	0.843066926081103	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9379348	rs10872649	0.843066926081103	Right hippocampal volume (body)	1e-10	37337106
rs9379348	rs9322194	0.813642682346725	Brainstem volume	2e-11	31636452
rs9379348	rs7752089	0.811423473026006	Brain morphology (MOSTest)	2e-31	35164939
rs9379348	rs9285521	0.693544692921981	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9379348	rs12526675	0.637654686252914	Brain morphology (MOSTest)	7e-22	32665545
rs9379348	rs9688809	0.630224864550034	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9379348	rs34337297	0.627195051944199	Serum levels of protein LRP11	3e-161	35078996
rs9379348	rs10872645	0.626414340850923	Blood protein levels	2e-86	30072576
rs9379348	rs14314	0.62539022570245	Macular thickness	3e-19	30535121
rs9379348	rs14314	0.62539022570245	Vertex-wise sulcal depth	7e-17	34910505
rs9379348	rs14314	0.62539022570245	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9379348	rs14314	0.62539022570245	Left hippocampal volume (body)	7e-15	37337106
rs9379348	rs14314	0.62539022570245	Left subiculum volume (body)	1e-14	37337106
rs9379348	rs55763431	0.625062367750286	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9379348	rs9322193	0.624591805955084	Lung cancer	1e-07	27393504
rs9379348	rs9689694	0.623918923082129	Right hippocampal volume (head)	6e-11	37337106
rs9379348	rs9689694	0.623918923082129	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9379348	rs9689694	0.623918923082129	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9379348	rs9689694	0.623918923082129	Left hippocampal volume (head)	6e-12	37337106
rs9379348	rs9383843	0.622569240657774	Migraine	1e-09	35115687
rs9379348	rs2095375	0.62199844621525	Serum metabolite levels	1e-20	33031748
rs9379348	rs2095375	0.62199844621525	Serum metabolite levels	1e-20	33031748
rs9379348	rs10872653	0.619718680121471	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9379348	rs9688867	0.619431570957126	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9379348	rs9688867	0.619431570957126	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9380454	rs9366863	0.976905974503215	Adult body size	9e-33	32376654
rs9380454	rs9366863	0.976905974503215	Body mass index	2e-44	30595370
rs9380454	rs2744944	0.974549724767472	Hypothyroidism	3e-10	34594039
rs9380454	rs2744944	0.974549724767472	High density lipoprotein cholesterol levels	3e-86	34887591
rs9380454	rs2744944	0.974549724767472	Multi-trait sex score	7e-22	37277458
rs9380454	rs9469872	0.966624823310536	HDL cholesterol levels	3e-11	36333282
rs9380454	rs2814949	0.965158790147529	Essential hypertension (time to event)	9e-09	32589924
rs9380454	rs2263329	0.949956546490169	HDL cholesterol	6e-35	34594039
rs9380454	rs2263329	0.949956546490169	HDL cholesterol levels	8e-43	32203549
rs9380454	rs2263329	0.949956546490169	High density lipoprotein cholesterol levels	2e-52	34887591
rs9380454	rs11755393	0.941097788423148	Body mass index	3e-26	29273807
rs9380454	rs11755393	0.941097788423148	Systemic lupus erythematosus	2e-12	33493351
rs9380454	rs11755393	0.941097788423148	Systemic lupus erythematosus	2e-06	33493351
rs9380454	rs11755393	0.941097788423148	Systemic lupus erythematosus	1e-07	33493351
rs9380454	rs11755393	0.941097788423148	Systemic lupus erythematosus	2e-08	19838195
rs9380454	rs11755393	0.941097788423148	Body mass index	4e-55	36581621
rs9380454	rs6941110	0.931294938456749	Sex hormone-binding globulin levels	5e-27	36653534
rs9380454	rs111868030	0.92593936088498	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9380454	rs9469857	0.925764553094458	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9380454	rs2764208	0.925002840258633	Systemic lupus erythematosus	7e-06	24871463
rs9380454	rs9462030	0.911849863439748	Red cell distribution width	5e-25	32888493
rs9380454	rs9469899	0.895867919971406	Prostate cancer (advanced)	2e-06	29892016
rs9380454	rs9469899	0.895867919971406	Prostate cancer	5e-09	29892016
rs9380454	rs9469899	0.895867919971406	Prostate cancer	8e-11	33398198
rs9380454	rs9469899	0.895867919971406	Hand grip strength	3e-15	29691431
rs9380454	rs9469899	0.895867919971406	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9380454	rs9469899	0.895867919971406	Graves' disease	4e-10	34594039
rs9380454	rs9469899	0.895867919971406	Coronary artery disease	1e-11	36474045
rs9380454	rs9469899	0.895867919971406	Predicted visceral adipose tissue	2e-20	31501611
rs9380454	rs9469899	0.895867919971406	Medication use (thyroid preparations)	2e-09	31015401
rs9380454	rs9469899	0.895867919971406	Medication use (thyroid preparations)	3e-10	34594039
rs9380454	rs9368830	0.889153655425209	HDL cholesterol	4e-21	30275531
rs9380454	rs9296128	0.876836175886098	Hip circumference adjusted for BMI	4e-13	34021172
rs9380454	rs9368828	0.876056093245606	Body mass index	1e-34	34594039
rs9380454	rs2744973	0.798134559160619	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9380454	rs2744973	0.798134559160619	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9380454	rs2744973	0.798134559160619	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9380454	rs2744973	0.798134559160619	Multi-trait sex score	6e-20	37277458
rs9380454	rs6912327	0.789845886126972	Fasting insulin	5e-06	33402679
rs9380454	rs6912327	0.789845886126972	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9380454	rs112283401	0.764722222010188	Red cell distribution width	4e-27	30595370
rs9380454	rs205262	0.621178036572398	Body mass index	2e-09	26961502
rs9380454	rs205262	0.621178036572398	Walking pace	4e-10	33128006
rs9380454	rs205262	0.621178036572398	Body mass index	8e-13	30108127
rs9380454	rs205262	0.621178036572398	Body mass index	2e-09	25673413
rs9380454	rs205262	0.621178036572398	Body mass index	2e-14	26426971
rs9380454	rs205262	0.621178036572398	BMI in non-smokers	3e-07	28443625
rs9380454	rs205262	0.621178036572398	BMI in non-smokers	6e-09	28443625
rs9380454	rs205262	0.621178036572398	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9380454	rs205262	0.621178036572398	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9380454	rs205262	0.621178036572398	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9380454	rs205262	0.621178036572398	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9380454	rs205262	0.621178036572398	Gastroesophageal reflux disease	1e-10	34187846
rs9380454	rs205262	0.621178036572398	Body mass index	3e-10	25673413
rs9380454	rs205262	0.621178036572398	Body mass index	2e-10	25673413
rs9380454	rs205262	0.621178036572398	ICD10 M54: Dorsalgia	2e-12	35110524
rs9380454	rs6940215	0.617253492987436	Insomnia	2e-10	35835914
rs9380454	rs6940215	0.617253492987436	Insomnia	1e-13	35835914
rs9380454	rs6940215	0.617253492987436	Hip circumference adjusted for BMI	8e-10	34021172
rs9380454	rs6940215	0.617253492987436	Multi-trait sex score	2e-23	37277458
rs9380454	rs6940215	0.617253492987436	Multi-trait sex score	4e-23	37277458
rs9380454	rs6457796	0.607007233097428	Insomnia	1e-08	30804565
rs9380454	rs6457796	0.607007233097428	Plateletcrit	9e-11	32888494
rs9380454	rs6457796	0.607007233097428	Systemic lupus erythematosus	3e-22	33272962
rs9380454	rs6457796	0.607007233097428	Body mass index	5e-13	30108127
rs9380454	rs6457796	0.607007233097428	Body mass index	1e-14	26426971
rs9380454	rs6457796	0.607007233097428	Educational attainment	5e-19	35361970
rs9380525	rs9368881	0.992253803723827	Height	2e-21	36224396
rs9380525	rs6931118	0.96234627224935	Lymphocyte count	9e-21	32888494
rs9380525	rs9380522	0.756962374332856	Hypothyroidism	1e-10	30595370
rs9380525	rs4713911	0.755479831740748	Monocyte percentage of white cells	5e-13	32888494
rs9380525	rs12055438	0.692342254849654	Lymphocyte-to-monocyte ratio	5e-18	34469753
rs9380525	rs6457834	0.67913385104318	Autoimmune thyroid disease	6e-13	32581359
rs9380525	rs4713906	0.615183150592688	Multi-trait sex score	8e-09	37277458
rs9383546	rs14314	0.921267558906174	Macular thickness	3e-19	30535121
rs9383546	rs14314	0.921267558906174	Vertex-wise sulcal depth	7e-17	34910505
rs9383546	rs14314	0.921267558906174	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9383546	rs14314	0.921267558906174	Left hippocampal volume (body)	7e-15	37337106
rs9383546	rs14314	0.921267558906174	Left subiculum volume (body)	1e-14	37337106
rs9383546	rs2095375	0.907099039233851	Serum metabolite levels	1e-20	33031748
rs9383546	rs2095375	0.907099039233851	Serum metabolite levels	1e-20	33031748
rs9383546	rs9383843	0.906231612921571	Migraine	1e-09	35115687
rs9383546	rs55763431	0.902810974521877	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9383546	rs9689694	0.90116323056609	Right hippocampal volume (head)	6e-11	37337106
rs9383546	rs9689694	0.90116323056609	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9383546	rs9689694	0.90116323056609	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9383546	rs9689694	0.90116323056609	Left hippocampal volume (head)	6e-12	37337106
rs9383546	rs10872645	0.899437881178037	Blood protein levels	2e-86	30072576
rs9383546	rs10872653	0.895368763643173	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9383546	rs9688867	0.895078967895998	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9383546	rs9688867	0.895078967895998	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9383546	rs9688809	0.895078967895998	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9383546	rs34337297	0.891889623598295	Serum levels of protein LRP11	3e-161	35078996
rs9383546	rs9322193	0.859279867425152	Lung cancer	1e-07	27393504
rs9383546	rs4039600	0.819877175442194	Adenine levels	1e-11	35347128
rs9383546	rs4421206	0.603161607967955	Brain morphology (min-P)	4e-11	32665545
rs9383874	rs2342764	0.764689702217474	Cortical thickness	1e-08	34560273
rs9383874	rs56103941	0.720945824894381	Right presubiculum volume (head)	4e-08	37337106
rs9383874	rs12526675	0.718641499200377	Brain morphology (MOSTest)	7e-22	32665545
rs9383874	rs12523793	0.684381408535991	Subcortical volume (MOSTest)	4e-24	32665545
rs9383874	rs12523793	0.684381408535991	C-reactive protein levels	3e-08	35459240
rs9383874	rs12523793	0.684381408535991	C-reactive protein levels (MTAG)	2e-08	36376304
rs9383874	rs11155662	0.676639071047711	Vertex-wise cortical thickness	2e-09	34910505
rs9393173	rs12526675	0.843410866197968	Brain morphology (MOSTest)	7e-22	32665545
rs9393173	rs10872649	0.813206868203549	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9393173	rs10872649	0.813206868203549	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9393173	rs10872649	0.813206868203549	Right hippocampal volume (body)	1e-10	37337106
rs9393173	rs4421206	0.811677038714436	Brain morphology (min-P)	4e-11	32665545
rs9393173	rs9285521	0.807164026701441	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9393173	rs2342764	0.791509458136307	Cortical thickness	1e-08	34560273
rs9393173	rs9688452	0.790134438886263	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9393173	rs9688452	0.790134438886263	aseg lh volume VentralDC	2e-10	33875891
rs9393173	rs9322194	0.781494599663612	Brainstem volume	2e-11	31636452
rs9393173	rs7752089	0.774862722682444	Brain morphology (MOSTest)	2e-31	35164939
rs9393173	rs4380763	0.770014445912743	Subcortical volume (min-P)	1e-11	32665545
rs9393173	rs1934534	0.769388457665309	Pain (pleiotropy)	2e-08	37844115
rs9393173	rs1934534	0.769388457665309	Pain (pleiotropy)	2e-06	37844115
rs9393173	rs11155671	0.754690678705994	Testicular germ cell tumor	2e-09	28604728
rs9393173	rs56103941	0.752781263867529	Right presubiculum volume (head)	4e-08	37337106
rs9393173	rs9505982	0.732647227860347	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9393173	rs80147756	0.728289229277889	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9393173	rs12523793	0.716228503249566	Subcortical volume (MOSTest)	4e-24	32665545
rs9393173	rs12523793	0.716228503249566	C-reactive protein levels	3e-08	35459240
rs9393173	rs12523793	0.716228503249566	C-reactive protein levels (MTAG)	2e-08	36376304
rs9393173	rs11155662	0.7024027979816	Vertex-wise cortical thickness	2e-09	34910505
rs9394952	rs9394952	1	Age-related hearing impairment	3e-11	34108613
rs9394952	rs4714680	0.935479292085823	Height	2e-09	34594039
rs9394952	rs4714680	0.935479292085823	Hip circumference adjusted for BMI	4e-08	34021172
rs9394952	rs1574430	0.714281291390609	Urate levels	3e-14	31578528
rs9394952	rs56401710	0.714281291390609	Urate levels	4e-10	31578528
rs9394952	rs56401710	0.714281291390609	Urate levels	5e-14	31578528
rs9394952	rs56401710	0.714281291390609	Urate levels	5e-30	31578528
rs9394952	rs9369409	0.711470959563724	Waist-hip index	5e-09	34021172
rs9394952	rs9369409	0.711470959563724	Medication use (calcium channel blockers)	3e-10	31015401
rs9394952	rs9369409	0.711470959563724	Waist-to-hip ratio adjusted for BMI	1e-09	34021172
rs9394952	rs9369409	0.711470959563724	Medication use (calcium channel blockers)	4e-17	34594039
rs9394952	rs9369409	0.711470959563724	Waist-hip ratio	8e-15	30595370
rs9394952	rs4714678	0.707648619772867	Systolic blood pressure	1e-17	30487518
rs9394952	rs4714678	0.707648619772867	Mean arterial pressure	9e-16	30487518
rs9394952	rs4714678	0.707648619772867	Urea levels	3e-10	33462484
rs9394952	rs4714678	0.707648619772867	Blood urea nitrogen levels	8e-11	34594039
rs9394952	rs9394951	0.689733746626588	Mean corpuscular volume	1e-16	32888494
rs9394952	rs9394951	0.689733746626588	Mean reticulocyte volume	4e-14	32888494
rs9394952	rs9394951	0.689733746626588	Mean spheric corpuscular volume	1e-17	32888494
rs9394952	rs9394951	0.689733746626588	Medication use (diuretics)	6e-11	31015401
rs9394952	rs9394951	0.689733746626588	Medication use (agents acting on the renin-angiotensin system)	2e-09	31015401
rs9394952	rs9394951	0.689733746626588	Medication use (agents acting on the renin-angiotensin system)	2e-14	34594039
rs9394952	rs9394951	0.689733746626588	Medication use (diuretics)	2e-14	34594039
rs9394952	rs6912283	0.688923505936032	Bioavailable testosterone levels	1e-12	32042192
rs9394952	rs6912283	0.688923505936032	Serum alkaline phosphatase levels	2e-10	33547301
rs9394952	rs6912283	0.688923505936032	Heel bone mineral density	6e-09	30598549
rs9394952	rs6912283	0.688923505936032	Hip index	7e-11	34021172
rs9394952	rs6919440	0.688126825061633	Diastolic blood pressure	1e-11	30487518
rs9394952	rs6919440	0.688126825061633	Systolic blood pressure	5e-09	27618452
rs9394952	rs6919440	0.688126825061633	Mean corpuscular hemoglobin	9e-11	32888493
rs9394952	rs6919440	0.688126825061633	Mean corpuscular volume	1e-14	32888493
rs9394952	rs6919440	0.688126825061633	Platelet count	5e-22	32888493
rs9394952	rs6919440	0.688126825061633	Platelet count	2e-23	32888493
rs9394952	rs6919440	0.688126825061633	Mean corpuscular volume	4e-14	32888493
rs9394952	rs6919440	0.688126825061633	Plateletcrit	3e-09	27863252
rs9394952	rs6919440	0.688126825061633	Hip circumference adjusted for BMI	4e-16	34021172
rs9394952	rs6919440	0.688126825061633	Mean arterial pressure	1e-14	34594039
rs9394952	rs6919440	0.688126825061633	Superior parietal thickness (unadjusted for global measures)	4e-09	36893272
rs9394952	rs2611336	0.687382565187394	Hearing problems	2e-08	37165447
rs9394952	rs4714677	0.68621319687487	Heel bone mineral density	3e-10	30595370
rs9394952	rs9394948	0.686074281286426	Serum uric acid levels	1e-11	29403010
rs9394952	rs9394948	0.686074281286426	Serum uric acid levels	2e-13	30993211
rs9394952	rs2396004	0.684936883797178	Mean corpuscular hemoglobin	1e-12	32888494
rs9394952	rs2396004	0.684936883797178	Chronotype	3e-09	30696823
rs9394952	rs2396004	0.684936883797178	Carnitine levels	4e-11	33414548
rs9394952	rs2396004	0.684936883797178	Total testosterone levels	4e-08	34321204
rs9394952	rs10948071	0.68039883461884	Systolic blood pressure	4e-10	30487518
rs9394952	rs10948071	0.68039883461884	Mean arterial pressure	4e-09	30487518
rs9394952	rs10948071	0.68039883461884	Diastolic blood pressure	1e-06	30487518
rs9394952	rs10948071	0.68039883461884	Pulse pressure	4e-06	30487518
rs9394952	rs10948071	0.68039883461884	Hypertension	1e-06	30487518
rs9394952	rs10948071	0.68039883461884	Age-related hearing impairment (MTAG)	1e-18	32986727
rs9394952	rs10948071	0.68039883461884	Pulse pressure	3e-06	27841878
rs9394952	rs10948071	0.68039883461884	Systolic blood pressure	1e-09	27841878
rs9394952	rs10948071	0.68039883461884	Diastolic blood pressure (cigarette smoking interaction)	1e-10	29455858
rs9394952	rs10948071	0.68039883461884	Systolic blood pressure (cigarette smoking interaction)	8e-21	29455858
rs9394952	rs2254303	0.673379759159224	Pulse pressure	6e-11	30487518
rs9394952	rs2254303	0.673379759159224	Height	3e-18	34594039
rs9394952	rs2254303	0.673379759159224	Height	4e-08	31562340
rs9394952	rs2254303	0.673379759159224	Hearing problems	1e-23	37165447
rs9394952	rs62415384	0.656230142859709	Total testosterone levels	3e-08	32042192
rs9394952	rs62415384	0.656230142859709	Tyrosine levels	2e-11	35213538
rs9394952	rs1214752	0.641844837233931	Coronary artery disease	1e-06	29212778
rs9394952	rs2242416	0.625767320892214	Age-related hearing impairment	1e-17	34108613
rs9394952	rs2242416	0.625767320892214	Body mass index	3e-08	36581621
rs9394952	rs2242416	0.625767320892214	Hearing problems	1e-17	37165447
rs9397357	rs2095375	0.80771642739201	Serum metabolite levels	1e-20	33031748
rs9397357	rs2095375	0.80771642739201	Serum metabolite levels	1e-20	33031748
rs9397357	rs9383843	0.806874588528755	Migraine	1e-09	35115687
rs9397357	rs55763431	0.803628228832836	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9397357	rs9689694	0.802175629498638	Right hippocampal volume (head)	6e-11	37337106
rs9397357	rs9689694	0.802175629498638	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9397357	rs9689694	0.802175629498638	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9397357	rs9689694	0.802175629498638	Left hippocampal volume (head)	6e-12	37337106
rs9397357	rs10872645	0.798940156596517	Blood protein levels	2e-86	30072576
rs9397357	rs10872653	0.796990812080482	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9397357	rs9688867	0.79612492173876	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9397357	rs9688867	0.79612492173876	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9397357	rs9688809	0.79612492173876	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9397357	rs34337297	0.79354212228749	Serum levels of protein LRP11	3e-161	35078996
rs9397357	rs14314	0.790639513582176	Macular thickness	3e-19	30535121
rs9397357	rs14314	0.790639513582176	Vertex-wise sulcal depth	7e-17	34910505
rs9397357	rs14314	0.790639513582176	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9397357	rs14314	0.790639513582176	Left hippocampal volume (body)	7e-15	37337106
rs9397357	rs14314	0.790639513582176	Left subiculum volume (body)	1e-14	37337106
rs9397357	rs9322193	0.765679410227445	Lung cancer	1e-07	27393504
rs9397357	rs4039600	0.732116053978348	Adenine levels	1e-11	35347128
rs9404048	rs9505982	0.97519404911077	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9404048	rs11155671	0.924541978554409	Testicular germ cell tumor	2e-09	28604728
rs9404048	rs4380763	0.911485670898573	Subcortical volume (min-P)	1e-11	32665545
rs9404048	rs1934534	0.910731983194899	Pain (pleiotropy)	2e-08	37844115
rs9404048	rs1934534	0.910731983194899	Pain (pleiotropy)	2e-06	37844115
rs9404048	rs4421206	0.891728962559846	Brain morphology (min-P)	4e-11	32665545
rs9404048	rs9688452	0.872849460627381	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9404048	rs9688452	0.872849460627381	aseg lh volume VentralDC	2e-10	33875891
rs9404048	rs80147756	0.869015801612029	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9404048	rs9322194	0.856088132569919	Brainstem volume	2e-11	31636452
rs9404048	rs10872649	0.796420693607573	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9404048	rs10872649	0.796420693607573	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9404048	rs10872649	0.796420693607573	Right hippocampal volume (body)	1e-10	37337106
rs9404048	rs7752089	0.76736602264852	Brain morphology (MOSTest)	2e-31	35164939
rs9404048	rs9285521	0.726666489382237	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9404048	rs12526675	0.637551300646774	Brain morphology (MOSTest)	7e-22	32665545
rs9404048	rs11155662	0.605756692482995	Vertex-wise cortical thickness	2e-09	34910505
rs9406286	rs9505982	0.973508666178487	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9406286	rs11155671	0.949041222730362	Testicular germ cell tumor	2e-09	28604728
rs9406286	rs4380763	0.935737969996025	Subcortical volume (min-P)	1e-11	32665545
rs9406286	rs1934534	0.934965110040512	Pain (pleiotropy)	2e-08	37844115
rs9406286	rs1934534	0.934965110040512	Pain (pleiotropy)	2e-06	37844115
rs9406286	rs80147756	0.894557377579942	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9406286	rs4421206	0.893169200693034	Brain morphology (min-P)	4e-11	32665545
rs9406286	rs9688452	0.873968388355462	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9406286	rs9688452	0.873968388355462	aseg lh volume VentralDC	2e-10	33875891
rs9406286	rs9322194	0.829641770646195	Brainstem volume	2e-11	31636452
rs9406286	rs10872649	0.822653545360237	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9406286	rs10872649	0.822653545360237	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9406286	rs10872649	0.822653545360237	Right hippocampal volume (body)	1e-10	37337106
rs9406286	rs7752089	0.795061939844803	Brain morphology (MOSTest)	2e-31	35164939
rs9406286	rs9285521	0.705895954660876	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9406286	rs12526675	0.622712698412651	Brain morphology (MOSTest)	7e-22	32665545
rs9406286	rs9688809	0.608739390911716	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9406286	rs34337297	0.60583660335374	Serum levels of protein LRP11	3e-161	35078996
rs9406286	rs10872645	0.605063705788907	Blood protein levels	2e-86	30072576
rs9406286	rs14314	0.603989431900568	Macular thickness	3e-19	30535121
rs9406286	rs14314	0.603989431900568	Vertex-wise sulcal depth	7e-17	34910505
rs9406286	rs14314	0.603989431900568	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9406286	rs14314	0.603989431900568	Left hippocampal volume (body)	7e-15	37337106
rs9406286	rs14314	0.603989431900568	Left subiculum volume (body)	1e-14	37337106
rs9406286	rs55763431	0.603737325452575	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9406286	rs9322193	0.603150456017381	Lung cancer	1e-07	27393504
rs9406286	rs9689694	0.60262941514447	Right hippocampal volume (head)	6e-11	37337106
rs9406286	rs9689694	0.60262941514447	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9406286	rs9689694	0.60262941514447	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9406286	rs9689694	0.60262941514447	Left hippocampal volume (head)	6e-12	37337106
rs9406286	rs9383843	0.601305308447833	Migraine	1e-09	35115687
rs9406286	rs2095375	0.600752259343354	Serum metabolite levels	1e-20	33031748
rs9406286	rs2095375	0.600752259343354	Serum metabolite levels	1e-20	33031748
rs9406346	rs9505982	0.981507594263051	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9406346	rs11155671	0.952173646409928	Testicular germ cell tumor	2e-09	28604728
rs9406346	rs4380763	0.938843859021908	Subcortical volume (min-P)	1e-11	32665545
rs9406346	rs1934534	0.938069173869907	Pain (pleiotropy)	2e-08	37844115
rs9406346	rs1934534	0.938069173869907	Pain (pleiotropy)	2e-06	37844115
rs9406346	rs80147756	0.896080793171353	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9406346	rs4421206	0.891645803165618	Brain morphology (min-P)	4e-11	32665545
rs9406346	rs9688452	0.872438763276229	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9406346	rs9688452	0.872438763276229	aseg lh volume VentralDC	2e-10	33875891
rs9406346	rs9322194	0.832687618190951	Brainstem volume	2e-11	31636452
rs9406346	rs10872649	0.824135364726354	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9406346	rs10872649	0.824135364726354	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9406346	rs10872649	0.824135364726354	Right hippocampal volume (body)	1e-10	37337106
rs9406346	rs7752089	0.792245329240961	Brain morphology (MOSTest)	2e-31	35164939
rs9406346	rs9285521	0.708764462674702	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9406346	rs12526675	0.619109399506293	Brain morphology (MOSTest)	7e-22	32665545
rs9406346	rs9688809	0.612402482740802	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9406346	rs34337297	0.609490694209387	Serum levels of protein LRP11	3e-161	35078996
rs9406346	rs10872645	0.608715396892397	Blood protein levels	2e-86	30072576
rs9406346	rs14314	0.607637804946913	Macular thickness	3e-19	30535121
rs9406346	rs14314	0.607637804946913	Vertex-wise sulcal depth	7e-17	34910505
rs9406346	rs14314	0.607637804946913	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9406346	rs14314	0.607637804946913	Left hippocampal volume (body)	7e-15	37337106
rs9406346	rs14314	0.607637804946913	Left subiculum volume (body)	1e-14	37337106
rs9406346	rs55763431	0.607384898846202	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9406346	rs9322193	0.606796287339517	Lung cancer	1e-07	27393504
rs9406346	rs9689694	0.606273551049203	Right hippocampal volume (head)	6e-11	37337106
rs9406346	rs9689694	0.606273551049203	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9406346	rs9689694	0.606273551049203	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9406346	rs9689694	0.606273551049203	Left hippocampal volume (head)	6e-12	37337106
rs9406346	rs9383843	0.604945325874833	Migraine	1e-09	35115687
rs9406346	rs2095375	0.604390559010409	Serum metabolite levels	1e-20	33031748
rs9406346	rs2095375	0.604390559010409	Serum metabolite levels	1e-20	33031748
rs9406346	rs10872653	0.602174807453241	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9406346	rs9688867	0.601781280893399	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9406346	rs9688867	0.601781280893399	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9407696	rs770199	0.625962618508256	Hair color	3e-08	30595370
rs942810	rs942810	1	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs942810	rs942810	1	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs942810	rs942810	1	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs942810	rs942810	1	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs942810	rs942810	1	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs942810	rs942810	1	N6-methyllysine levels (advanced age)	2e-11	37118062
rs942810	rs6584194	0.872336718709741	Metabolite peak levels (QI9680)	2e-135	35995766
rs942810	rs6584194	0.872336718709741	Metabolite peak levels (QI8984)	5e-11	35995766
rs942810	rs6584194	0.872336718709741	X-24736 levels	3e-13	36635386
rs942810	rs1739	0.808660459174245	Metabolite peak levels (QI7389)	3e-91	35995766
rs942810	rs1737	0.807918529385487	Arginine levels	3e-24	35995766
rs942810	rs4488133	0.783300785879443	Serum metabolite levels	2e-281	23093944
rs942810	rs4488133	0.783300785879443	Serum metabolite levels	1e-27	23093944
rs942810	rs4488133	0.783300785879443	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs942810	rs4488133	0.783300785879443	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs942810	rs4488133	0.783300785879443	Urine X-12112 levels in chronic kidney disease	0	37277652
rs942810	rs4488133	0.783300785879443	X-12093 levels	1e-48	24816252
rs942810	rs4488133	0.783300785879443	X-12092 levels	0	24816252
rs942810	rs10883083	0.780636275950061	N2-acetyl,N6-methyllysine levels	0	35347128
rs942810	rs10883083	0.780636275950061	X-12112 levels	0	35347128
rs942810	rs10883083	0.780636275950061	Arginine levels	1e-16	35347128
rs942810	rs10883083	0.780636275950061	Metabolite peak levels (QI8972)	2e-124	35995766
rs942810	rs10883083	0.780636275950061	Metabolite peak levels (QI5171)	8e-96	35995766
rs942810	rs2147896	0.780636275950061	Urinary metabolites (H-NMR features)	3e-164	24586186
rs942810	rs2147896	0.780636275950061	Urinary metabolites (H-NMR features)	8e-30	24586186
rs942810	rs2147896	0.780636275950061	Urinary metabolites (H-NMR features)	2e-55	24586186
rs942810	rs2147896	0.780636275950061	Urinary metabolites (H-NMR features)	6e-19	24586186
rs942810	rs2147896	0.780636275950061	Urinary metabolites (H-NMR features)	4e-34	24586186
rs942810	rs2147896	0.780636275950061	Trimethylamine levels	4e-144	33283231
rs942810	rs2147896	0.780636275950061	Serum metabolite levels	1e-15	33031748
rs942810	rs2147896	0.780636275950061	Serum metabolite levels	4e-226	33031748
rs942810	rs2147896	0.780636275950061	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs942810	rs2147896	0.780636275950061	Urinary metabolite levels in chronic kidney disease	0	31959995
rs942810	rs2147896	0.780636275950061	Urinary metabolite levels in chronic kidney disease	0	31959995
rs942810	rs2147896	0.780636275950061	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs942810	rs2147896	0.780636275950061	N6-methyllysine levels	3e-198	33437055
rs942810	rs2147896	0.780636275950061	N6-methyllysine levels	0	35347128
rs942810	rs2147896	0.780636275950061	N-methylpipecolate levels	0	35050183
rs942810	rs2147896	0.780636275950061	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs942810	rs2147896	0.780636275950061	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs942810	rs2147896	0.780636275950061	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs942810	rs2147896	0.780636275950061	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942810	rs2147896	0.780636275950061	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs942810	rs2147896	0.780636275950061	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942810	rs2147896	0.780636275950061	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942810	rs2147896	0.780636275950061	X-12092 levels	4e-191	27073872
rs942810	rs2147896	0.780636275950061	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs942810	rs2147896	0.780636275950061	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs942810	rs2147896	0.780636275950061	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs942810	rs2147896	0.780636275950061	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs942810	rs2147896	0.780636275950061	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs942810	rs2147896	0.780636275950061	N6-methyllysine levels (advanced age)	5e-25	37118062
rs942810	rs2147896	0.780636275950061	X-12112 levels	0	36635386
rs942810	rs2147896	0.780636275950061	N6-methyllysine levels	0	36635386
rs942810	rs2147896	0.780636275950061	N6,N6-dimethyllysine levels	0	36635386
rs942810	rs2147896	0.780636275950061	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs942810	rs2147896	0.780636275950061	N2-acetyl,N6-methyllysine levels	0	36635386
rs942810	rs10786415	0.780636275950061	N6,N6-dimethyllysine levels	0	35347128
rs942810	rs10786415	0.780636275950061	N-methylpipecolate levels	0	35347128
rs942810	rs10786415	0.780636275950061	X-25810 levels	4e-11	36635386
rs942810	rs942814	0.780636275950061	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs942810	rs4539242	0.779882910249153	Urinary metabolites (H-NMR features)	2e-20	24586186
rs942810	rs4539242	0.779882910249153	X-24809 levels	4e-67	33177712
rs942810	rs4539242	0.779882910249153	X-24983 levels	8e-59	33177712
rs942810	rs4539242	0.779882910249153	X-12112 levels	4e-63	33177712
rs942810	rs4539242	0.779882910249153	N-methylpipecolate levels	3e-12	33177712
rs942810	rs4539242	0.779882910249153	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs942810	rs4539242	0.779882910249153	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs942810	rs4539242	0.779882910249153	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs942810	rs4539242	0.779882910249153	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs942810	rs4539242	0.779882910249153	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs942810	rs4539242	0.779882910249153	N6-methyllysine levels (advanced age)	5e-25	37118062
rs942810	rs4539242	0.779882910249153	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs942810	rs7072216	0.779080228106588	Metabolite levels	8e-15	21931564
rs942810	rs7072216	0.779080228106588	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs942810	rs7905265	0.766945561083254	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs942810	rs7905265	0.766945561083254	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs942810	rs7905265	0.766945561083254	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs942810	rs7905265	0.766945561083254	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942810	rs7905265	0.766945561083254	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs942810	rs7905265	0.766945561083254	N6,N6-dimethyllysine levels	2e-132	35995766
rs942810	rs7905265	0.766945561083254	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs942810	rs10786414	0.763578976385505	ADMA levels	5e-18	35995766
rs942810	rs942813	0.753820630022569	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs942810	rs11598867	0.752925335048446	Urinary metabolites	1e-307	26352407
rs942810	rs7096654	0.697066455948823	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs942810	rs7096654	0.697066455948823	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs942810	rs7096654	0.697066455948823	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs942810	rs7096654	0.697066455948823	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs942810	rs6584202	0.639058365010731	Obesity-related traits	4e-07	23251661
rs942813	rs942813	1	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs942813	rs10883083	0.912957270246383	N2-acetyl,N6-methyllysine levels	0	35347128
rs942813	rs10883083	0.912957270246383	X-12112 levels	0	35347128
rs942813	rs10883083	0.912957270246383	Arginine levels	1e-16	35347128
rs942813	rs10883083	0.912957270246383	Metabolite peak levels (QI8972)	2e-124	35995766
rs942813	rs10883083	0.912957270246383	Metabolite peak levels (QI5171)	8e-96	35995766
rs942813	rs2147896	0.912957270246383	Urinary metabolites (H-NMR features)	3e-164	24586186
rs942813	rs2147896	0.912957270246383	Urinary metabolites (H-NMR features)	8e-30	24586186
rs942813	rs2147896	0.912957270246383	Urinary metabolites (H-NMR features)	2e-55	24586186
rs942813	rs2147896	0.912957270246383	Urinary metabolites (H-NMR features)	6e-19	24586186
rs942813	rs2147896	0.912957270246383	Urinary metabolites (H-NMR features)	4e-34	24586186
rs942813	rs2147896	0.912957270246383	Trimethylamine levels	4e-144	33283231
rs942813	rs2147896	0.912957270246383	Serum metabolite levels	1e-15	33031748
rs942813	rs2147896	0.912957270246383	Serum metabolite levels	4e-226	33031748
rs942813	rs2147896	0.912957270246383	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs942813	rs2147896	0.912957270246383	Urinary metabolite levels in chronic kidney disease	0	31959995
rs942813	rs2147896	0.912957270246383	Urinary metabolite levels in chronic kidney disease	0	31959995
rs942813	rs2147896	0.912957270246383	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs942813	rs2147896	0.912957270246383	N6-methyllysine levels	3e-198	33437055
rs942813	rs2147896	0.912957270246383	N6-methyllysine levels	0	35347128
rs942813	rs2147896	0.912957270246383	N-methylpipecolate levels	0	35050183
rs942813	rs2147896	0.912957270246383	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs942813	rs2147896	0.912957270246383	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs942813	rs2147896	0.912957270246383	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs942813	rs2147896	0.912957270246383	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942813	rs2147896	0.912957270246383	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs942813	rs2147896	0.912957270246383	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942813	rs2147896	0.912957270246383	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942813	rs2147896	0.912957270246383	X-12092 levels	4e-191	27073872
rs942813	rs2147896	0.912957270246383	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs942813	rs2147896	0.912957270246383	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs942813	rs2147896	0.912957270246383	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs942813	rs2147896	0.912957270246383	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs942813	rs2147896	0.912957270246383	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs942813	rs2147896	0.912957270246383	N6-methyllysine levels (advanced age)	5e-25	37118062
rs942813	rs2147896	0.912957270246383	X-12112 levels	0	36635386
rs942813	rs2147896	0.912957270246383	N6-methyllysine levels	0	36635386
rs942813	rs2147896	0.912957270246383	N6,N6-dimethyllysine levels	0	36635386
rs942813	rs2147896	0.912957270246383	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs942813	rs2147896	0.912957270246383	N2-acetyl,N6-methyllysine levels	0	36635386
rs942813	rs10786415	0.912957270246383	N6,N6-dimethyllysine levels	0	35347128
rs942813	rs10786415	0.912957270246383	N-methylpipecolate levels	0	35347128
rs942813	rs10786415	0.912957270246383	X-25810 levels	4e-11	36635386
rs942813	rs942814	0.912957270246383	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs942813	rs4539242	0.91219488575404	Urinary metabolites (H-NMR features)	2e-20	24586186
rs942813	rs4539242	0.91219488575404	X-24809 levels	4e-67	33177712
rs942813	rs4539242	0.91219488575404	X-24983 levels	8e-59	33177712
rs942813	rs4539242	0.91219488575404	X-12112 levels	4e-63	33177712
rs942813	rs4539242	0.91219488575404	N-methylpipecolate levels	3e-12	33177712
rs942813	rs4539242	0.91219488575404	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs942813	rs4539242	0.91219488575404	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs942813	rs4539242	0.91219488575404	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs942813	rs4539242	0.91219488575404	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs942813	rs4539242	0.91219488575404	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs942813	rs4539242	0.91219488575404	N6-methyllysine levels (advanced age)	5e-25	37118062
rs942813	rs4539242	0.91219488575404	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs942813	rs7072216	0.90991228612558	Metabolite levels	8e-15	21931564
rs942813	rs7072216	0.90991228612558	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs942813	rs4488133	0.90536747748887	Serum metabolite levels	2e-281	23093944
rs942813	rs4488133	0.90536747748887	Serum metabolite levels	1e-27	23093944
rs942813	rs4488133	0.90536747748887	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs942813	rs4488133	0.90536747748887	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs942813	rs4488133	0.90536747748887	Urine X-12112 levels in chronic kidney disease	0	37277652
rs942813	rs4488133	0.90536747748887	X-12093 levels	1e-48	24816252
rs942813	rs4488133	0.90536747748887	X-12092 levels	0	24816252
rs942813	rs7905265	0.897664639800967	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs942813	rs7905265	0.897664639800967	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs942813	rs7905265	0.897664639800967	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs942813	rs7905265	0.897664639800967	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942813	rs7905265	0.897664639800967	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs942813	rs7905265	0.897664639800967	N6,N6-dimethyllysine levels	2e-132	35995766
rs942813	rs7905265	0.897664639800967	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs942813	rs10786414	0.893349287706096	ADMA levels	5e-18	35995766
rs942813	rs11598867	0.857812695859895	Urinary metabolites	1e-307	26352407
rs942813	rs6584194	0.821779625946569	Metabolite peak levels (QI9680)	2e-135	35995766
rs942813	rs6584194	0.821779625946569	Metabolite peak levels (QI8984)	5e-11	35995766
rs942813	rs6584194	0.821779625946569	X-24736 levels	3e-13	36635386
rs942813	rs7096654	0.81420626350067	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs942813	rs7096654	0.81420626350067	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs942813	rs7096654	0.81420626350067	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs942813	rs7096654	0.81420626350067	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs942813	rs942810	0.753820630022569	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs942813	rs942810	0.753820630022569	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs942813	rs942810	0.753820630022569	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs942813	rs942810	0.753820630022569	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs942813	rs942810	0.753820630022569	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs942813	rs942810	0.753820630022569	N6-methyllysine levels (advanced age)	2e-11	37118062
rs942813	rs4345897	0.660979543067477	Urinary metabolites (H-NMR features)	2e-19	24586186
rs942813	rs4345897	0.660979543067477	Urinary metabolites (H-NMR features)	4e-12	24586186
rs942813	rs4345897	0.660979543067477	Metabolite levels	2e-91	23281178
rs942813	rs4345897	0.660979543067477	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	4e-25	37118062
rs942813	rs4345897	0.660979543067477	N6,N6-dimethyllysine levels (elderly offspring)	4e-17	37118062
rs942813	rs4345897	0.660979543067477	N6-methyllysine levels (elderly offspring)	1e-41	37118062
rs942813	rs4345897	0.660979543067477	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs942813	rs4345897	0.660979543067477	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs942813	rs4345897	0.660979543067477	N6-methyllysine levels (advanced age)	6e-22	37118062
rs942813	rs2182169	0.637514785632819	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-23	37118062
rs942813	rs2182169	0.637514785632819	N6,N6-dimethyllysine levels (elderly offspring)	3e-16	37118062
rs942813	rs2182169	0.637514785632819	N6-methyllysine levels (elderly offspring)	7e-40	37118062
rs942813	rs2182169	0.637514785632819	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs942813	rs2182169	0.637514785632819	N6,N6-dimethyllysine levels (advanced age)	4e-09	37118062
rs942813	rs2182169	0.637514785632819	N6-methyllysine levels (advanced age)	1e-21	37118062
rs942813	rs6584192	0.63415827826922	Metabolite levels	4e-33	23823483
rs942813	rs6584192	0.63415827826922	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs942813	rs6584192	0.63415827826922	N6,N6-dimethyllysine levels (elderly offspring)	2e-16	37118062
rs942813	rs6584192	0.63415827826922	N6-methyllysine levels (elderly offspring)	3e-41	37118062
rs942813	rs6584192	0.63415827826922	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs942813	rs6584192	0.63415827826922	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs942813	rs6584192	0.63415827826922	N6-methyllysine levels (advanced age)	6e-22	37118062
rs942813	rs2147895	0.622967713280548	Hydroxyhexadecanoylcarnitine levels	9e-19	35888728
rs942813	rs2147895	0.622967713280548	Plasma arginine levels in chronic kidney disease	7e-13	37277652
rs942813	rs2147895	0.622967713280548	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-24	37118062
rs942813	rs2147895	0.622967713280548	N6,N6-dimethyllysine levels (elderly offspring)	7e-17	37118062
rs942813	rs2147895	0.622967713280548	N6-methyllysine levels (elderly offspring)	2e-39	37118062
rs942813	rs2147895	0.622967713280548	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs942813	rs2147895	0.622967713280548	N6,N6-dimethyllysine levels (advanced age)	2e-09	37118062
rs942813	rs2147895	0.622967713280548	N6-methyllysine levels (advanced age)	4e-21	37118062
rs942813	rs2182168	0.621634465720546	Urine X-22162 levels in chronic kidney disease	3e-13	37277652
rs942813	rs2182168	0.621634465720546	Arginine levels	1e-17	36635386
rs942813	rs1739	0.600943634173753	Metabolite peak levels (QI7389)	3e-91	35995766
rs942814	rs10883083	1	N2-acetyl,N6-methyllysine levels	0	35347128
rs942814	rs10883083	1	X-12112 levels	0	35347128
rs942814	rs10883083	1	Arginine levels	1e-16	35347128
rs942814	rs10883083	1	Metabolite peak levels (QI8972)	2e-124	35995766
rs942814	rs10883083	1	Metabolite peak levels (QI5171)	8e-96	35995766
rs942814	rs2147896	1	Urinary metabolites (H-NMR features)	3e-164	24586186
rs942814	rs2147896	1	Urinary metabolites (H-NMR features)	8e-30	24586186
rs942814	rs2147896	1	Urinary metabolites (H-NMR features)	2e-55	24586186
rs942814	rs2147896	1	Urinary metabolites (H-NMR features)	6e-19	24586186
rs942814	rs2147896	1	Urinary metabolites (H-NMR features)	4e-34	24586186
rs942814	rs2147896	1	Trimethylamine levels	4e-144	33283231
rs942814	rs2147896	1	Serum metabolite levels	1e-15	33031748
rs942814	rs2147896	1	Serum metabolite levels	4e-226	33031748
rs942814	rs2147896	1	Urinary metabolite levels in chronic kidney disease	2e-309	31959995
rs942814	rs2147896	1	Urinary metabolite levels in chronic kidney disease	0	31959995
rs942814	rs2147896	1	Urinary metabolite levels in chronic kidney disease	0	31959995
rs942814	rs2147896	1	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	0	31959995
rs942814	rs2147896	1	N6-methyllysine levels	3e-198	33437055
rs942814	rs2147896	1	N6-methyllysine levels	0	35347128
rs942814	rs2147896	1	N-methylpipecolate levels	0	35050183
rs942814	rs2147896	1	Urine N-methylpipecolate levels in chronic kidney disease	1e-251	37277652
rs942814	rs2147896	1	Plasma X-12112 levels in chronic kidney disease	0	37277652
rs942814	rs2147896	1	Urine N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs942814	rs2147896	1	Urine N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942814	rs2147896	1	Plasma N6-methyllysine levels in chronic kidney disease	0	37277652
rs942814	rs2147896	1	Plasma N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942814	rs2147896	1	Urine N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942814	rs2147896	1	X-12092 levels	4e-191	27073872
rs942814	rs2147896	1	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs942814	rs2147896	1	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs942814	rs2147896	1	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs942814	rs2147896	1	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs942814	rs2147896	1	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs942814	rs2147896	1	N6-methyllysine levels (advanced age)	5e-25	37118062
rs942814	rs2147896	1	X-12112 levels	0	36635386
rs942814	rs2147896	1	N6-methyllysine levels	0	36635386
rs942814	rs2147896	1	N6,N6-dimethyllysine levels	0	36635386
rs942814	rs2147896	1	N2-acetyl,N6,N6-dimethyllysine levels	0	36635386
rs942814	rs2147896	1	N2-acetyl,N6-methyllysine levels	0	36635386
rs942814	rs10786415	1	N6,N6-dimethyllysine levels	0	35347128
rs942814	rs10786415	1	N-methylpipecolate levels	0	35347128
rs942814	rs10786415	1	X-25810 levels	4e-11	36635386
rs942814	rs942814	1	Urine N,N-dimethyl-5-aminovalerate levels in chronic kidney disease	0	37277652
rs942814	rs4539242	0.999168439367004	Urinary metabolites (H-NMR features)	2e-20	24586186
rs942814	rs4539242	0.999168439367004	X-24809 levels	4e-67	33177712
rs942814	rs4539242	0.999168439367004	X-24983 levels	8e-59	33177712
rs942814	rs4539242	0.999168439367004	X-12112 levels	4e-63	33177712
rs942814	rs4539242	0.999168439367004	N-methylpipecolate levels	3e-12	33177712
rs942814	rs4539242	0.999168439367004	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	3e-25	37118062
rs942814	rs4539242	0.999168439367004	N6,N6-dimethyllysine levels (elderly offspring)	2e-17	37118062
rs942814	rs4539242	0.999168439367004	N6-methyllysine levels (elderly offspring)	2e-44	37118062
rs942814	rs4539242	0.999168439367004	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	4e-10	37118062
rs942814	rs4539242	0.999168439367004	N6,N6-dimethyllysine levels (advanced age)	2e-11	37118062
rs942814	rs4539242	0.999168439367004	N6-methyllysine levels (advanced age)	5e-25	37118062
rs942814	rs4539242	0.999168439367004	RBC levels of N6-Methyl-L-lysine	4e-63	36395887
rs942814	rs7072216	0.986739800087918	Metabolite levels	8e-15	21931564
rs942814	rs7072216	0.986739800087918	N-methylpipecolate levels in elite athletes	1e-59	31882771
rs942814	rs7905265	0.98425257612078	Urinary metabolite levels in chronic kidney disease	7e-81	31959995
rs942814	rs7905265	0.98425257612078	Urine 3-methylcytidine levels in chronic kidney disease	3e-14	37277652
rs942814	rs7905265	0.98425257612078	Plasma N2-acetyl,N6-methyllysine levels in chronic kidney disease	0	37277652
rs942814	rs7905265	0.98425257612078	Plasma N2-acetyl,N6,N6-dimethyllysine levels in chronic kidney disease	0	37277652
rs942814	rs7905265	0.98425257612078	Urine N2,N2-dimethylguanosine levels in chronic kidney disease	7e-22	37277652
rs942814	rs7905265	0.98425257612078	N6,N6-dimethyllysine levels	2e-132	35995766
rs942814	rs7905265	0.98425257612078	N6,N6-dimethyllysine levels in chronic kidney disease	1e-60	35120996
rs942814	rs4488133	0.981812255561224	Serum metabolite levels	2e-281	23093944
rs942814	rs4488133	0.981812255561224	Serum metabolite levels	1e-27	23093944
rs942814	rs4488133	0.981812255561224	Urinary metabolite levels in chronic kidney disease	1e-234	31959995
rs942814	rs4488133	0.981812255561224	Urinary metabolite levels in chronic kidney disease	2e-209	31959995
rs942814	rs4488133	0.981812255561224	Urine X-12112 levels in chronic kidney disease	0	37277652
rs942814	rs4488133	0.981812255561224	X-12093 levels	1e-48	24816252
rs942814	rs4488133	0.981812255561224	X-12092 levels	0	24816252
rs942814	rs10786414	0.980137084776573	ADMA levels	5e-18	35995766
rs942814	rs11598867	0.936646612426462	Urinary metabolites	1e-307	26352407
rs942814	rs942813	0.912957270246383	Plasma pyridoxal phosphate to pyridoxal ratio	4e-08	31641590
rs942814	rs7096654	0.899514581295609	Resting-state network 1 amplitude (blood oxygenation level dependent) (Default mode network)	4e-09	36462729
rs942814	rs7096654	0.899514581295609	Resting-state network 16 amplitude (blood oxygenation level dependent) (Executive control)	3e-09	36462729
rs942814	rs7096654	0.899514581295609	Resting-state network 6 amplitude (blood oxygenation level dependent) (Fronto-parietal)	3e-08	36462729
rs942814	rs7096654	0.899514581295609	Resting-state network 13 amplitude (blood oxygenation level dependent) (Language)	2e-08	36462729
rs942814	rs6584194	0.894241137013551	Metabolite peak levels (QI9680)	2e-135	35995766
rs942814	rs6584194	0.894241137013551	Metabolite peak levels (QI8984)	5e-11	35995766
rs942814	rs6584194	0.894241137013551	X-24736 levels	3e-13	36635386
rs942814	rs942810	0.780636275950061	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	9e-19	37118062
rs942814	rs942810	0.780636275950061	N6,N6-dimethyllysine levels (elderly offspring)	2e-13	37118062
rs942814	rs942810	0.780636275950061	N6-methyllysine levels (elderly offspring)	4e-34	37118062
rs942814	rs942810	0.780636275950061	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs942814	rs942810	0.780636275950061	N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs942814	rs942810	0.780636275950061	N6-methyllysine levels (advanced age)	2e-11	37118062
rs942814	rs4345897	0.725228481314342	Urinary metabolites (H-NMR features)	2e-19	24586186
rs942814	rs4345897	0.725228481314342	Urinary metabolites (H-NMR features)	4e-12	24586186
rs942814	rs4345897	0.725228481314342	Metabolite levels	2e-91	23281178
rs942814	rs4345897	0.725228481314342	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	4e-25	37118062
rs942814	rs4345897	0.725228481314342	N6,N6-dimethyllysine levels (elderly offspring)	4e-17	37118062
rs942814	rs4345897	0.725228481314342	N6-methyllysine levels (elderly offspring)	1e-41	37118062
rs942814	rs4345897	0.725228481314342	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs942814	rs4345897	0.725228481314342	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs942814	rs4345897	0.725228481314342	N6-methyllysine levels (advanced age)	6e-22	37118062
rs942814	rs2182169	0.696769770391045	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-23	37118062
rs942814	rs2182169	0.696769770391045	N6,N6-dimethyllysine levels (elderly offspring)	3e-16	37118062
rs942814	rs2182169	0.696769770391045	N6-methyllysine levels (elderly offspring)	7e-40	37118062
rs942814	rs2182169	0.696769770391045	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	1e-07	37118062
rs942814	rs2182169	0.696769770391045	N6,N6-dimethyllysine levels (advanced age)	4e-09	37118062
rs942814	rs2182169	0.696769770391045	N6-methyllysine levels (advanced age)	1e-21	37118062
rs942814	rs6584192	0.69318459578308	Metabolite levels	4e-33	23823483
rs942814	rs6584192	0.69318459578308	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs942814	rs6584192	0.69318459578308	N6,N6-dimethyllysine levels (elderly offspring)	2e-16	37118062
rs942814	rs6584192	0.69318459578308	N6-methyllysine levels (elderly offspring)	3e-41	37118062
rs942814	rs6584192	0.69318459578308	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs942814	rs6584192	0.69318459578308	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs942814	rs6584192	0.69318459578308	N6-methyllysine levels (advanced age)	6e-22	37118062
rs942814	rs2147895	0.684785652644244	Hydroxyhexadecanoylcarnitine levels	9e-19	35888728
rs942814	rs2147895	0.684785652644244	Plasma arginine levels in chronic kidney disease	7e-13	37277652
rs942814	rs2147895	0.684785652644244	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	2e-24	37118062
rs942814	rs2147895	0.684785652644244	N6,N6-dimethyllysine levels (elderly offspring)	7e-17	37118062
rs942814	rs2147895	0.684785652644244	N6-methyllysine levels (elderly offspring)	2e-39	37118062
rs942814	rs2147895	0.684785652644244	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs942814	rs2147895	0.684785652644244	N6,N6-dimethyllysine levels (advanced age)	2e-09	37118062
rs942814	rs2147895	0.684785652644244	N6-methyllysine levels (advanced age)	4e-21	37118062
rs942814	rs2182168	0.679416289117702	Urine X-22162 levels in chronic kidney disease	3e-13	37277652
rs942814	rs2182168	0.679416289117702	Arginine levels	1e-17	36635386
rs942814	rs11189591	0.627750392434333	N2-acetyl,N6,N6-dimethyllysine levels (elderly offspring)	1e-25	37118062
rs942814	rs11189591	0.627750392434333	N6,N6-dimethyllysine levels (elderly offspring)	1e-16	37118062
rs942814	rs11189591	0.627750392434333	N6-methyllysine levels (elderly offspring)	1e-40	37118062
rs942814	rs11189591	0.627750392434333	N2-acetyl,N6,N6-dimethyllysine levels (advanced age)	2e-08	37118062
rs942814	rs11189591	0.627750392434333	N6,N6-dimethyllysine levels (advanced age)	1e-09	37118062
rs942814	rs11189591	0.627750392434333	N6-methyllysine levels (advanced age)	6e-22	37118062
rs942814	rs1739	0.622481884535144	Metabolite peak levels (QI7389)	3e-91	35995766
rs942814	rs1737	0.621776150568137	Arginine levels	3e-24	35995766
rs942848	rs11580836	0.942166744720507	Body mass index	2e-09	36581621
rs942848	rs10465746	0.922673691943645	Obesity-related traits	8e-06	23251661
rs942849	rs11580836	0.941288522184552	Body mass index	2e-09	36581621
rs942849	rs10465746	0.921798149477954	Obesity-related traits	8e-06	23251661
rs9435963	rs2999541	0.979051673290798	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs9435963	rs3007711	0.974839799760727	Electrodermal activity	9e-06	25387706
rs9435963	rs2130525	0.911054446269244	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs9435963	rs7542137	0.825756183193004	Beta-hydroxyisovalerate levels	3e-11	35050183
rs9435963	rs7542137	0.825756183193004	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs9435963	rs7542137	0.825756183193004	3-hydroxysebacate levels	2e-10	36635386
rs9435963	rs10788817	0.77128501820902	Serum metabolite levels	3e-13	24625756
rs9435963	rs10788817	0.77128501820902	Metabolite peak levels (QI2718)	5e-18	35995766
rs9435963	rs10788817	0.77128501820902	3-hydroxylaurate levels	2e-12	36635386
rs9435963	rs10788817	0.77128501820902	Tetradecadienoate (14:2) levels	8e-17	36635386
rs9435963	rs11204914	0.767395197335813	Carnitine C9 levels	1e-13	35995766
rs9435963	rs11204914	0.767395197335813	Metabolite peak levels (QI6204)	1e-32	35995766
rs9435963	rs11204914	0.767395197335813	Metabolite peak levels (QI6252)	2e-32	35995766
rs9435963	rs2279501	0.744303373292105	Serum metabolite levels	3e-14	33031748
rs9435963	rs6685187	0.743637523946469	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs9435963	rs6698740	0.741594091008849	Beta-hydroxyisovalerate levels	1e-13	35347128
rs9435963	rs1060870	0.740166801265491	Serum metabolite levels	1e-11	33031748
rs9435963	rs1060870	0.740166801265491	Serum metabolite levels	1e-15	33031748
rs9435963	rs2338201	0.73082493619494	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs9435963	rs2338201	0.73082493619494	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs9435963	rs2338201	0.73082493619494	Dodecadienoate (12:2) levels	7e-15	36635386
rs9435963	rs56000812	0.69249145644279	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs9435963	rs56078223	0.690333618271437	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs9435963	rs56078223	0.690333618271437	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs9435963	rs10494270	0.684075122504984	Nonaylcarnitine levels	5e-13	26068415
rs9435963	rs2999545	0.680431235057677	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs9435963	rs9943221	0.677287935604267	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs9435963	rs1038747	0.634957098304229	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs9435963	rs6684312	0.620253132749765	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs9435963	rs7523082	0.616672554931173	Metabolite peak levels (QI9845)	2e-14	35995766
rs9435963	rs10888445	0.613492704359061	Beta-hydroxyisovalerate levels	5e-13	36635386
rs9435963	rs7541453	0.611024775898512	Serum metabolite levels	2e-16	33031748
rs9435963	rs7541453	0.611024775898512	Serum metabolite levels	2e-16	33031748
rs9435963	rs7541453	0.611024775898512	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs9435964	rs2999541	0.977366892444071	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs9435964	rs3007711	0.973161128261984	Electrodermal activity	9e-06	25387706
rs9435964	rs2130525	0.909396279982609	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs9435964	rs7542137	0.82571984637431	Beta-hydroxyisovalerate levels	3e-11	35050183
rs9435964	rs7542137	0.82571984637431	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs9435964	rs7542137	0.82571984637431	3-hydroxysebacate levels	2e-10	36635386
rs9435964	rs10788817	0.771147880366233	Serum metabolite levels	3e-13	24625756
rs9435964	rs10788817	0.771147880366233	Metabolite peak levels (QI2718)	5e-18	35995766
rs9435964	rs10788817	0.771147880366233	3-hydroxylaurate levels	2e-12	36635386
rs9435964	rs10788817	0.771147880366233	Tetradecadienoate (14:2) levels	8e-17	36635386
rs9435964	rs11204914	0.76726509132762	Carnitine C9 levels	1e-13	35995766
rs9435964	rs11204914	0.76726509132762	Metabolite peak levels (QI6204)	1e-32	35995766
rs9435964	rs11204914	0.76726509132762	Metabolite peak levels (QI6252)	2e-32	35995766
rs9435964	rs2279501	0.745688086640881	Serum metabolite levels	3e-14	33031748
rs9435964	rs6685187	0.743505544931023	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs9435964	rs6698740	0.741462130548351	Beta-hydroxyisovalerate levels	1e-13	35347128
rs9435964	rs1060870	0.740035258256122	Serum metabolite levels	1e-11	33031748
rs9435964	rs1060870	0.740035258256122	Serum metabolite levels	1e-15	33031748
rs9435964	rs2338201	0.730688662276779	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs9435964	rs2338201	0.730688662276779	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs9435964	rs2338201	0.730688662276779	Dodecadienoate (12:2) levels	7e-15	36635386
rs9435964	rs56000812	0.692812215890143	Urine indoleacetylglycine levels in chronic kidney disease	8e-12	37277652
rs9435964	rs56078223	0.690655029564491	Plasma X-13431 levels in chronic kidney disease	8e-30	37277652
rs9435964	rs56078223	0.690655029564491	Urine X-13431 levels in chronic kidney disease	5e-17	37277652
rs9435964	rs10494270	0.68435172031691	Nonaylcarnitine levels	5e-13	26068415
rs9435964	rs2999545	0.678872235886449	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs9435964	rs9943221	0.677562492799832	Plasma indoleacetylglutamine levels in chronic kidney disease	2e-23	37277652
rs9435964	rs1038747	0.636178098451085	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs9435964	rs6684312	0.620596276596885	Urine X-21827 levels in chronic kidney disease	7e-15	37277652
rs9435964	rs7523082	0.616464897103658	Metabolite peak levels (QI9845)	2e-14	35995766
rs9435964	rs10888445	0.613290872919964	Beta-hydroxyisovalerate levels	5e-13	36635386
rs9435964	rs7541453	0.610806867273193	Serum metabolite levels	2e-16	33031748
rs9435964	rs7541453	0.610806867273193	Serum metabolite levels	2e-16	33031748
rs9435964	rs7541453	0.610806867273193	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs943991	rs4982404	0.970766615389824	Height	1e-24	34594039
rs943991	rs1952151	0.871994567071849	Height	3e-148	36224396
rs943991	rs8019890	0.811121378352317	Appendicular lean mass	2e-38	33097823
rs943991	rs8019890	0.811121378352317	Height (weighted GWA)	2e-07	37106081
rs943991	rs8019890	0.811121378352317	Height (standard GWA)	6e-15	37106081
rs943991	rs8019890	0.811121378352317	Height	2e-39	30595370
rs943991	rs7140850	0.706256392351091	Body surface area	2e-08	36502284
rs9444348	rs2842611	0.704136970662234	High density lipoprotein cholesterol levels	5e-09	34887591
rs9444348	rs1173416	0.685740482709749	Height	2e-59	36224396
rs9444348	rs9450288	0.662305897553303	Height	2e-10	36224396
rs9444351	rs2842611	0.925852818327252	High density lipoprotein cholesterol levels	5e-09	34887591
rs9444351	rs1173416	0.909320527165816	Height	2e-59	36224396
rs9444351	rs9450288	0.881195187740879	Height	2e-10	36224396
rs9444352	rs2842611	0.871529220392683	High density lipoprotein cholesterol levels	5e-09	34887591
rs9444352	rs1173416	0.852798058076374	Height	2e-59	36224396
rs9444352	rs9450288	0.831845350021578	Height	2e-10	36224396
rs9444354	rs2842611	0.924101140359724	High density lipoprotein cholesterol levels	5e-09	34887591
rs9444354	rs1173416	0.903189622996581	Height	2e-59	36224396
rs9444354	rs9450288	0.884134671405087	Height	2e-10	36224396
rs9450273	rs2842611	0.611625766924877	High density lipoprotein cholesterol levels	5e-09	34887591
rs9450273	rs1173416	0.600467809787399	Height	2e-59	36224396
rs9450277	rs2842611	0.650922777234228	High density lipoprotein cholesterol levels	5e-09	34887591
rs9450277	rs1173416	0.632533749977657	Height	2e-59	36224396
rs9450277	rs9450288	0.624708478543871	Height	2e-10	36224396
rs945027	rs2357176	0.994566213860397	Nevus count or cutaneous melanoma	4e-08	30429480
rs945027	rs10873172	0.836092537729997	Cutaneous melanoma or hair colour	6e-27	32341527
rs945027	rs10873172	0.836092537729997	Nevus count or cutaneous melanoma	6e-13	32341527
rs945027	rs10873172	0.836092537729997	Blond vs. brown/black hair color	6e-15	30531825
rs945027	rs10873172	0.836092537729997	Cutaneous malignant melanoma	6e-08	32341527
rs945027	rs10873172	0.836092537729997	Hair color	4e-17	30595370
rs945027	rs1255908	0.778188807400615	PR interval	8e-14	32439900
rs945027	rs1255908	0.778188807400615	PR interval	6e-14	32439900
rs945027	rs12878653	0.714390566019461	Youthful appearance (self-reported)	3e-14	32339537
rs9450285	rs2842611	0.918225634501689	High density lipoprotein cholesterol levels	5e-09	34887591
rs9450285	rs1173416	0.901529323201142	Height	2e-59	36224396
rs9450285	rs9450288	0.87824359321703	Height	2e-10	36224396
rs945028	rs2357176	0.994566213860397	Nevus count or cutaneous melanoma	4e-08	30429480
rs945028	rs10873172	0.836092537729997	Cutaneous melanoma or hair colour	6e-27	32341527
rs945028	rs10873172	0.836092537729997	Nevus count or cutaneous melanoma	6e-13	32341527
rs945028	rs10873172	0.836092537729997	Blond vs. brown/black hair color	6e-15	30531825
rs945028	rs10873172	0.836092537729997	Cutaneous malignant melanoma	6e-08	32341527
rs945028	rs10873172	0.836092537729997	Hair color	4e-17	30595370
rs945028	rs1255908	0.778188807400615	PR interval	8e-14	32439900
rs945028	rs1255908	0.778188807400615	PR interval	6e-14	32439900
rs945028	rs12878653	0.714390566019461	Youthful appearance (self-reported)	3e-14	32339537
rs9450292	rs2842611	0.926607506429491	High density lipoprotein cholesterol levels	5e-09	34887591
rs9450292	rs1173416	0.910104850825755	Height	2e-59	36224396
rs9450292	rs9450288	0.883466801837186	Height	2e-10	36224396
rs9450311	rs2842611	0.921883612302573	High density lipoprotein cholesterol levels	5e-09	34887591
rs9450311	rs1173416	0.913230820922185	Height	2e-59	36224396
rs9450311	rs9450288	0.877349287566552	Height	2e-10	36224396
rs946154	rs946155	0.703735702851367	Glutathione peroxidase 7 levels (GPX7.8345.27.3)	2e-61	29875488
rs946155	rs946155	1	Glutathione peroxidase 7 levels (GPX7.8345.27.3)	2e-61	29875488
rs946155	rs835341	0.705472238915858	Ascending aorta distensibility (MTAG)	8e-09	35922433
rs9462006	rs9469872	0.985594575361965	HDL cholesterol levels	3e-11	36333282
rs9462006	rs9366863	0.984802831061063	Adult body size	9e-33	32376654
rs9462006	rs9366863	0.984802831061063	Body mass index	2e-44	30595370
rs9462006	rs11755393	0.978509137173925	Body mass index	3e-26	29273807
rs9462006	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-12	33493351
rs9462006	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-06	33493351
rs9462006	rs11755393	0.978509137173925	Systemic lupus erythematosus	1e-07	33493351
rs9462006	rs11755393	0.978509137173925	Systemic lupus erythematosus	2e-08	19838195
rs9462006	rs11755393	0.978509137173925	Body mass index	4e-55	36581621
rs9462006	rs6941110	0.967346510074687	Sex hormone-binding globulin levels	5e-27	36653534
rs9462006	rs9462030	0.949582973139464	Red cell distribution width	5e-25	32888493
rs9462006	rs2814949	0.947688155869807	Essential hypertension (time to event)	9e-09	32589924
rs9462006	rs9469857	0.944943071443945	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462006	rs2764208	0.944208717265358	Systemic lupus erythematosus	7e-06	24871463
rs9462006	rs2744944	0.938312541241385	Hypothyroidism	3e-10	34594039
rs9462006	rs2744944	0.938312541241385	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462006	rs2744944	0.938312541241385	Multi-trait sex score	7e-22	37277458
rs9462006	rs9469899	0.932895650652106	Prostate cancer (advanced)	2e-06	29892016
rs9462006	rs9469899	0.932895650652106	Prostate cancer	5e-09	29892016
rs9462006	rs9469899	0.932895650652106	Prostate cancer	8e-11	33398198
rs9462006	rs9469899	0.932895650652106	Hand grip strength	3e-15	29691431
rs9462006	rs9469899	0.932895650652106	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462006	rs9469899	0.932895650652106	Graves' disease	4e-10	34594039
rs9462006	rs9469899	0.932895650652106	Coronary artery disease	1e-11	36474045
rs9462006	rs9469899	0.932895650652106	Predicted visceral adipose tissue	2e-20	31501611
rs9462006	rs9469899	0.932895650652106	Medication use (thyroid preparations)	2e-09	31015401
rs9462006	rs9469899	0.932895650652106	Medication use (thyroid preparations)	3e-10	34594039
rs9462006	rs2263329	0.918988053643494	HDL cholesterol	6e-35	34594039
rs9462006	rs2263329	0.918988053643494	HDL cholesterol levels	8e-43	32203549
rs9462006	rs2263329	0.918988053643494	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462006	rs9296128	0.896314200316187	Hip circumference adjusted for BMI	4e-13	34021172
rs9462006	rs111868030	0.894786239424834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462006	rs9368830	0.871482843035307	HDL cholesterol	4e-21	30275531
rs9462006	rs9368828	0.842133334057305	Body mass index	1e-34	34594039
rs9462006	rs6912327	0.82422154816861	Fasting insulin	5e-06	33402679
rs9462006	rs6912327	0.82422154816861	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462006	rs112283401	0.801473312816332	Red cell distribution width	4e-27	30595370
rs9462006	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462006	rs2744973	0.786385358868946	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462006	rs2744973	0.786385358868946	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462006	rs2744973	0.786385358868946	Multi-trait sex score	6e-20	37277458
rs9462006	rs6940215	0.637903741086296	Insomnia	2e-10	35835914
rs9462006	rs6940215	0.637903741086296	Insomnia	1e-13	35835914
rs9462006	rs6940215	0.637903741086296	Hip circumference adjusted for BMI	8e-10	34021172
rs9462006	rs6940215	0.637903741086296	Multi-trait sex score	2e-23	37277458
rs9462006	rs6940215	0.637903741086296	Multi-trait sex score	4e-23	37277458
rs9462006	rs6457796	0.629218841714412	Insomnia	1e-08	30804565
rs9462006	rs6457796	0.629218841714412	Plateletcrit	9e-11	32888494
rs9462006	rs6457796	0.629218841714412	Systemic lupus erythematosus	3e-22	33272962
rs9462006	rs6457796	0.629218841714412	Body mass index	5e-13	30108127
rs9462006	rs6457796	0.629218841714412	Body mass index	1e-14	26426971
rs9462006	rs6457796	0.629218841714412	Educational attainment	5e-19	35361970
rs9462006	rs9689160	0.608647163734184	Lung function (forced vital capacity)	3e-14	36914875
rs9462006	rs205262	0.60038694747696	Body mass index	2e-09	26961502
rs9462006	rs205262	0.60038694747696	Walking pace	4e-10	33128006
rs9462006	rs205262	0.60038694747696	Body mass index	8e-13	30108127
rs9462006	rs205262	0.60038694747696	Body mass index	2e-09	25673413
rs9462006	rs205262	0.60038694747696	Body mass index	2e-14	26426971
rs9462006	rs205262	0.60038694747696	BMI in non-smokers	3e-07	28443625
rs9462006	rs205262	0.60038694747696	BMI in non-smokers	6e-09	28443625
rs9462006	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9462006	rs205262	0.60038694747696	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9462006	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9462006	rs205262	0.60038694747696	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9462006	rs205262	0.60038694747696	Gastroesophageal reflux disease	1e-10	34187846
rs9462006	rs205262	0.60038694747696	Body mass index	3e-10	25673413
rs9462006	rs205262	0.60038694747696	Body mass index	2e-10	25673413
rs9462006	rs205262	0.60038694747696	ICD10 M54: Dorsalgia	2e-12	35110524
rs9462009	rs9469872	0.987997454410153	HDL cholesterol levels	3e-11	36333282
rs9462009	rs11755393	0.980876296632677	Body mass index	3e-26	29273807
rs9462009	rs11755393	0.980876296632677	Systemic lupus erythematosus	2e-12	33493351
rs9462009	rs11755393	0.980876296632677	Systemic lupus erythematosus	2e-06	33493351
rs9462009	rs11755393	0.980876296632677	Systemic lupus erythematosus	1e-07	33493351
rs9462009	rs11755393	0.980876296632677	Systemic lupus erythematosus	2e-08	19838195
rs9462009	rs11755393	0.980876296632677	Body mass index	4e-55	36581621
rs9462009	rs9366863	0.977650668641976	Adult body size	9e-33	32376654
rs9462009	rs9366863	0.977650668641976	Body mass index	2e-44	30595370
rs9462009	rs6941110	0.969735847144432	Sex hormone-binding globulin levels	5e-27	36653534
rs9462009	rs9462030	0.951991989134682	Red cell distribution width	5e-25	32888493
rs9462009	rs2764208	0.951323450349518	Systemic lupus erythematosus	7e-06	24871463
rs9462009	rs9469857	0.947350756083365	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462009	rs2814949	0.940666046937796	Essential hypertension (time to event)	9e-09	32589924
rs9462009	rs9469899	0.935251159716226	Prostate cancer (advanced)	2e-06	29892016
rs9462009	rs9469899	0.935251159716226	Prostate cancer	5e-09	29892016
rs9462009	rs9469899	0.935251159716226	Prostate cancer	8e-11	33398198
rs9462009	rs9469899	0.935251159716226	Hand grip strength	3e-15	29691431
rs9462009	rs9469899	0.935251159716226	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462009	rs9469899	0.935251159716226	Graves' disease	4e-10	34594039
rs9462009	rs9469899	0.935251159716226	Coronary artery disease	1e-11	36474045
rs9462009	rs9469899	0.935251159716226	Predicted visceral adipose tissue	2e-20	31501611
rs9462009	rs9469899	0.935251159716226	Medication use (thyroid preparations)	2e-09	31015401
rs9462009	rs9469899	0.935251159716226	Medication use (thyroid preparations)	3e-10	34594039
rs9462009	rs2744944	0.931333408703444	Hypothyroidism	3e-10	34594039
rs9462009	rs2744944	0.931333408703444	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462009	rs2744944	0.931333408703444	Multi-trait sex score	7e-22	37277458
rs9462009	rs2263329	0.91209497337502	HDL cholesterol	6e-35	34594039
rs9462009	rs2263329	0.91209497337502	HDL cholesterol levels	8e-43	32203549
rs9462009	rs2263329	0.91209497337502	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462009	rs9296128	0.898732266280559	Hip circumference adjusted for BMI	4e-13	34021172
rs9462009	rs111868030	0.888050425014223	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462009	rs9368830	0.864680351855022	HDL cholesterol	4e-21	30275531
rs9462009	rs9368828	0.835553752965987	Body mass index	1e-34	34594039
rs9462009	rs6912327	0.82664951020816	Fasting insulin	5e-06	33402679
rs9462009	rs6912327	0.82664951020816	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462009	rs112283401	0.803868505588408	Red cell distribution width	4e-27	30595370
rs9462009	rs2744973	0.780152132292118	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462009	rs2744973	0.780152132292118	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462009	rs2744973	0.780152132292118	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462009	rs2744973	0.780152132292118	Multi-trait sex score	6e-20	37277458
rs9462009	rs6940215	0.63233916902788	Insomnia	2e-10	35835914
rs9462009	rs6940215	0.63233916902788	Insomnia	1e-13	35835914
rs9462009	rs6940215	0.63233916902788	Hip circumference adjusted for BMI	8e-10	34021172
rs9462009	rs6940215	0.63233916902788	Multi-trait sex score	2e-23	37277458
rs9462009	rs6940215	0.63233916902788	Multi-trait sex score	4e-23	37277458
rs9462009	rs6457796	0.623721375966438	Insomnia	1e-08	30804565
rs9462009	rs6457796	0.623721375966438	Plateletcrit	9e-11	32888494
rs9462009	rs6457796	0.623721375966438	Systemic lupus erythematosus	3e-22	33272962
rs9462009	rs6457796	0.623721375966438	Body mass index	5e-13	30108127
rs9462009	rs6457796	0.623721375966438	Body mass index	1e-14	26426971
rs9462009	rs6457796	0.623721375966438	Educational attainment	5e-19	35361970
rs9462009	rs9689160	0.603247208840615	Lung function (forced vital capacity)	3e-14	36914875
rs9462010	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462010	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs9462010	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs9462010	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs9462010	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs9462010	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs9462010	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs9462010	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462010	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs9462010	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs9462010	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs9462010	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs9462010	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs9462010	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs9462010	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs9462010	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs9462010	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs9462010	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs9462010	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs9462010	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs9462010	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs9462010	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs9462010	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs9462010	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs9462010	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs9462010	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462010	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs9462010	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs9462010	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs9462010	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs9462010	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462010	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462010	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs9462010	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs9462010	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462010	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462010	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462010	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs9462010	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs9462010	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462010	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs9462010	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs9462011	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462011	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs9462011	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs9462011	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs9462011	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs9462011	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs9462011	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs9462011	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462011	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs9462011	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs9462011	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs9462011	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs9462011	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs9462011	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs9462011	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs9462011	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs9462011	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs9462011	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs9462011	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs9462011	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs9462011	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs9462011	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs9462011	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs9462011	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs9462011	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs9462011	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462011	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs9462011	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs9462011	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs9462011	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs9462011	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462011	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462011	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs9462011	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs9462011	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462011	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462011	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462011	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs9462011	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs9462011	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462011	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs9462011	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs9462015	rs9469857	0.996776778921405	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462015	rs2764208	0.995972777577403	Systemic lupus erythematosus	7e-06	24871463
rs9462015	rs9462030	0.982341944636037	Red cell distribution width	5e-25	32888493
rs9462015	rs9469899	0.965886102309356	Prostate cancer (advanced)	2e-06	29892016
rs9462015	rs9469899	0.965886102309356	Prostate cancer	5e-09	29892016
rs9462015	rs9469899	0.965886102309356	Prostate cancer	8e-11	33398198
rs9462015	rs9469899	0.965886102309356	Hand grip strength	3e-15	29691431
rs9462015	rs9469899	0.965886102309356	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462015	rs9469899	0.965886102309356	Graves' disease	4e-10	34594039
rs9462015	rs9469899	0.965886102309356	Coronary artery disease	1e-11	36474045
rs9462015	rs9469899	0.965886102309356	Predicted visceral adipose tissue	2e-20	31501611
rs9462015	rs9469899	0.965886102309356	Medication use (thyroid preparations)	2e-09	31015401
rs9462015	rs9469899	0.965886102309356	Medication use (thyroid preparations)	3e-10	34594039
rs9462015	rs9469872	0.96054887345204	HDL cholesterol levels	3e-11	36333282
rs9462015	rs9296128	0.94725579215698	Hip circumference adjusted for BMI	4e-13	34021172
rs9462015	rs11755393	0.935272594959748	Body mass index	3e-26	29273807
rs9462015	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-12	33493351
rs9462015	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-06	33493351
rs9462015	rs11755393	0.935272594959748	Systemic lupus erythematosus	1e-07	33493351
rs9462015	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-08	19838195
rs9462015	rs11755393	0.935272594959748	Body mass index	4e-55	36581621
rs9462015	rs9366863	0.931525188678084	Adult body size	9e-33	32376654
rs9462015	rs9366863	0.931525188678084	Body mass index	2e-44	30595370
rs9462015	rs6941110	0.923705176714688	Sex hormone-binding globulin levels	5e-27	36653534
rs9462015	rs2744944	0.904579222323617	Hypothyroidism	3e-10	34594039
rs9462015	rs2744944	0.904579222323617	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462015	rs2744944	0.904579222323617	Multi-trait sex score	7e-22	37277458
rs9462015	rs2814949	0.89561287838885	Essential hypertension (time to event)	9e-09	32589924
rs9462015	rs2263329	0.882234019129751	HDL cholesterol	6e-35	34594039
rs9462015	rs2263329	0.882234019129751	HDL cholesterol levels	8e-43	32203549
rs9462015	rs2263329	0.882234019129751	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462015	rs111868030	0.861138045850585	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462015	rs9368830	0.823175715403171	HDL cholesterol	4e-21	30275531
rs9462015	rs9368828	0.813764410103364	Body mass index	1e-34	34594039
rs9462015	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462015	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462015	rs2744973	0.792134506553775	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462015	rs2744973	0.792134506553775	Multi-trait sex score	6e-20	37277458
rs9462015	rs6912327	0.779895917756941	Fasting insulin	5e-06	33402679
rs9462015	rs6912327	0.779895917756941	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462015	rs112283401	0.757749108732694	Red cell distribution width	4e-27	30595370
rs9462015	rs9689160	0.619303726608203	Lung function (forced vital capacity)	3e-14	36914875
rs9462019	rs9462030	0.991973323084328	Red cell distribution width	5e-25	32888493
rs9462019	rs9469857	0.987176694560192	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462019	rs2764208	0.986389433458688	Systemic lupus erythematosus	7e-06	24871463
rs9462019	rs9469899	0.975286229149324	Prostate cancer (advanced)	2e-06	29892016
rs9462019	rs9469899	0.975286229149324	Prostate cancer	5e-09	29892016
rs9462019	rs9469899	0.975286229149324	Prostate cancer	8e-11	33398198
rs9462019	rs9469899	0.975286229149324	Hand grip strength	3e-15	29691431
rs9462019	rs9469899	0.975286229149324	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462019	rs9469899	0.975286229149324	Graves' disease	4e-10	34594039
rs9462019	rs9469899	0.975286229149324	Coronary artery disease	1e-11	36474045
rs9462019	rs9469899	0.975286229149324	Predicted visceral adipose tissue	2e-20	31501611
rs9462019	rs9469899	0.975286229149324	Medication use (thyroid preparations)	2e-09	31015401
rs9462019	rs9469899	0.975286229149324	Medication use (thyroid preparations)	3e-10	34594039
rs9462019	rs9469872	0.9509390607211	HDL cholesterol levels	3e-11	36333282
rs9462019	rs11755393	0.944352060781661	Body mass index	3e-26	29273807
rs9462019	rs11755393	0.944352060781661	Systemic lupus erythematosus	2e-12	33493351
rs9462019	rs11755393	0.944352060781661	Systemic lupus erythematosus	2e-06	33493351
rs9462019	rs11755393	0.944352060781661	Systemic lupus erythematosus	1e-07	33493351
rs9462019	rs11755393	0.944352060781661	Systemic lupus erythematosus	2e-08	19838195
rs9462019	rs11755393	0.944352060781661	Body mass index	4e-55	36581621
rs9462019	rs9366863	0.940728057758258	Adult body size	9e-33	32376654
rs9462019	rs9366863	0.940728057758258	Body mass index	2e-44	30595370
rs9462019	rs9296128	0.936626672105552	Hip circumference adjusted for BMI	4e-13	34021172
rs9462019	rs6941110	0.932892213958832	Sex hormone-binding globulin levels	5e-27	36653534
rs9462019	rs2814949	0.904596288583152	Essential hypertension (time to event)	9e-09	32589924
rs9462019	rs2744944	0.89528309843648	Hypothyroidism	3e-10	34594039
rs9462019	rs2744944	0.89528309843648	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462019	rs2744944	0.89528309843648	Multi-trait sex score	7e-22	37277458
rs9462019	rs2263329	0.876144094738658	HDL cholesterol	6e-35	34594039
rs9462019	rs2263329	0.876144094738658	HDL cholesterol levels	8e-43	32203549
rs9462019	rs2263329	0.876144094738658	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462019	rs111868030	0.852541106101868	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462019	rs9368830	0.831397247480196	HDL cholesterol	4e-21	30275531
rs9462019	rs9368828	0.805126953855606	Body mass index	1e-34	34594039
rs9462019	rs2744973	0.801904500036379	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462019	rs2744973	0.801904500036379	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462019	rs2744973	0.801904500036379	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462019	rs2744973	0.801904500036379	Multi-trait sex score	6e-20	37277458
rs9462019	rs6912327	0.789357317923654	Fasting insulin	5e-06	33402679
rs9462019	rs6912327	0.789357317923654	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462019	rs112283401	0.767082566425639	Red cell distribution width	4e-27	30595370
rs9462019	rs9689160	0.629562990742547	Lung function (forced vital capacity)	3e-14	36914875
rs9462020	rs9469872	0.990405711342429	HDL cholesterol levels	3e-11	36333282
rs9462020	rs11755393	0.983248753744816	Body mass index	3e-26	29273807
rs9462020	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-12	33493351
rs9462020	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-06	33493351
rs9462020	rs11755393	0.983248753744816	Systemic lupus erythematosus	1e-07	33493351
rs9462020	rs11755393	0.983248753744816	Systemic lupus erythematosus	2e-08	19838195
rs9462020	rs11755393	0.983248753744816	Body mass index	4e-55	36581621
rs9462020	rs9366863	0.980050279338797	Adult body size	9e-33	32376654
rs9462020	rs9366863	0.980050279338797	Body mass index	2e-44	30595370
rs9462020	rs6941110	0.972130533054557	Sex hormone-binding globulin levels	5e-27	36653534
rs9462020	rs9462030	0.954406403718491	Red cell distribution width	5e-25	32888493
rs9462020	rs9469857	0.949763837643909	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462020	rs2764208	0.949033981000713	Systemic lupus erythematosus	7e-06	24871463
rs9462020	rs2814949	0.943009894530421	Essential hypertension (time to event)	9e-09	32589924
rs9462020	rs9469899	0.937611946179886	Prostate cancer (advanced)	2e-06	29892016
rs9462020	rs9469899	0.937611946179886	Prostate cancer	5e-09	29892016
rs9462020	rs9469899	0.937611946179886	Prostate cancer	8e-11	33398198
rs9462020	rs9469899	0.937611946179886	Hand grip strength	3e-15	29691431
rs9462020	rs9469899	0.937611946179886	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462020	rs9469899	0.937611946179886	Graves' disease	4e-10	34594039
rs9462020	rs9469899	0.937611946179886	Coronary artery disease	1e-11	36474045
rs9462020	rs9469899	0.937611946179886	Predicted visceral adipose tissue	2e-20	31501611
rs9462020	rs9469899	0.937611946179886	Medication use (thyroid preparations)	2e-09	31015401
rs9462020	rs9469899	0.937611946179886	Medication use (thyroid preparations)	3e-10	34594039
rs9462020	rs2744944	0.933676458189598	Hypothyroidism	3e-10	34594039
rs9462020	rs2744944	0.933676458189598	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462020	rs2744944	0.933676458189598	Multi-trait sex score	7e-22	37277458
rs9462020	rs2263329	0.914432373659788	HDL cholesterol	6e-35	34594039
rs9462020	rs2263329	0.914432373659788	HDL cholesterol levels	8e-43	32203549
rs9462020	rs2263329	0.914432373659788	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462020	rs9296128	0.901155780048215	Hip circumference adjusted for BMI	4e-13	34021172
rs9462020	rs111868030	0.890460424513595	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462020	rs9368830	0.866839594529055	HDL cholesterol	4e-21	30275531
rs9462020	rs9368828	0.8378148480019	Body mass index	1e-34	34594039
rs9462020	rs6912327	0.829083022514325	Fasting insulin	5e-06	33402679
rs9462020	rs6912327	0.829083022514325	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462020	rs112283401	0.806269190971807	Red cell distribution width	4e-27	30595370
rs9462020	rs2744973	0.782572341748002	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462020	rs2744973	0.782572341748002	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462020	rs2744973	0.782572341748002	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462020	rs2744973	0.782572341748002	Multi-trait sex score	6e-20	37277458
rs9462020	rs6940215	0.634643562406843	Insomnia	2e-10	35835914
rs9462020	rs6940215	0.634643562406843	Insomnia	1e-13	35835914
rs9462020	rs6940215	0.634643562406843	Hip circumference adjusted for BMI	8e-10	34021172
rs9462020	rs6940215	0.634643562406843	Multi-trait sex score	2e-23	37277458
rs9462020	rs6940215	0.634643562406843	Multi-trait sex score	4e-23	37277458
rs9462020	rs6457796	0.626169994896438	Insomnia	1e-08	30804565
rs9462020	rs6457796	0.626169994896438	Plateletcrit	9e-11	32888494
rs9462020	rs6457796	0.626169994896438	Systemic lupus erythematosus	3e-22	33272962
rs9462020	rs6457796	0.626169994896438	Body mass index	5e-13	30108127
rs9462020	rs6457796	0.626169994896438	Body mass index	1e-14	26426971
rs9462020	rs6457796	0.626169994896438	Educational attainment	5e-19	35361970
rs9462020	rs9689160	0.605720875679005	Lung function (forced vital capacity)	3e-14	36914875
rs9462020	rs9469918	0.600168366795112	Hip circumference adjusted for BMI	8e-09	34021172
rs9462020	rs9469918	0.600168366795112	Hip circumference adjusted for BMI	2e-08	34021172
rs9462020	rs9469918	0.600168366795112	Multi-trait sex score	4e-08	37277458
rs9462021	rs9462030	0.991161605706325	Red cell distribution width	5e-25	32888493
rs9462021	rs9469857	0.986362420621675	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462021	rs2764208	0.985572399705324	Systemic lupus erythematosus	7e-06	24871463
rs9462021	rs9469899	0.974512167021756	Prostate cancer (advanced)	2e-06	29892016
rs9462021	rs9469899	0.974512167021756	Prostate cancer	5e-09	29892016
rs9462021	rs9469899	0.974512167021756	Prostate cancer	8e-11	33398198
rs9462021	rs9469899	0.974512167021756	Hand grip strength	3e-15	29691431
rs9462021	rs9469899	0.974512167021756	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462021	rs9469899	0.974512167021756	Graves' disease	4e-10	34594039
rs9462021	rs9469899	0.974512167021756	Coronary artery disease	1e-11	36474045
rs9462021	rs9469899	0.974512167021756	Predicted visceral adipose tissue	2e-20	31501611
rs9462021	rs9469899	0.974512167021756	Medication use (thyroid preparations)	2e-09	31015401
rs9462021	rs9469899	0.974512167021756	Medication use (thyroid preparations)	3e-10	34594039
rs9462021	rs9469872	0.950184689459921	HDL cholesterol levels	3e-11	36333282
rs9462021	rs11755393	0.943625596386269	Body mass index	3e-26	29273807
rs9462021	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-12	33493351
rs9462021	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-06	33493351
rs9462021	rs11755393	0.943625596386269	Systemic lupus erythematosus	1e-07	33493351
rs9462021	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-08	19838195
rs9462021	rs11755393	0.943625596386269	Body mass index	4e-55	36581621
rs9462021	rs9366863	0.939973736176852	Adult body size	9e-33	32376654
rs9462021	rs9366863	0.939973736176852	Body mass index	2e-44	30595370
rs9462021	rs9296128	0.935762261955665	Hip circumference adjusted for BMI	4e-13	34021172
rs9462021	rs6941110	0.932136337001036	Sex hormone-binding globulin levels	5e-27	36653534
rs9462021	rs2814949	0.903864952971577	Essential hypertension (time to event)	9e-09	32589924
rs9462021	rs2744944	0.894545120858599	Hypothyroidism	3e-10	34594039
rs9462021	rs2744944	0.894545120858599	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462021	rs2744944	0.894545120858599	Multi-trait sex score	7e-22	37277458
rs9462021	rs2263329	0.876903422710498	HDL cholesterol	6e-35	34594039
rs9462021	rs2263329	0.876903422710498	HDL cholesterol levels	8e-43	32203549
rs9462021	rs2263329	0.876903422710498	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462021	rs111868030	0.851707403161834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462021	rs9368830	0.832241949897419	HDL cholesterol	4e-21	30275531
rs9462021	rs9368828	0.805831960921872	Body mass index	1e-34	34594039
rs9462021	rs2744973	0.802411285956922	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462021	rs2744973	0.802411285956922	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462021	rs2744973	0.802411285956922	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462021	rs2744973	0.802411285956922	Multi-trait sex score	6e-20	37277458
rs9462021	rs6912327	0.791347099634255	Fasting insulin	5e-06	33402679
rs9462021	rs6912327	0.791347099634255	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462021	rs112283401	0.766192579753087	Red cell distribution width	4e-27	30595370
rs9462021	rs9689160	0.629745752214482	Lung function (forced vital capacity)	3e-14	36914875
rs9462022	rs9462030	0.991961796545434	Red cell distribution width	5e-25	32888493
rs9462022	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462022	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs9462022	rs9469899	0.975314640267064	Prostate cancer (advanced)	2e-06	29892016
rs9462022	rs9469899	0.975314640267064	Prostate cancer	5e-09	29892016
rs9462022	rs9469899	0.975314640267064	Prostate cancer	8e-11	33398198
rs9462022	rs9469899	0.975314640267064	Hand grip strength	3e-15	29691431
rs9462022	rs9469899	0.975314640267064	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462022	rs9469899	0.975314640267064	Graves' disease	4e-10	34594039
rs9462022	rs9469899	0.975314640267064	Coronary artery disease	1e-11	36474045
rs9462022	rs9469899	0.975314640267064	Predicted visceral adipose tissue	2e-20	31501611
rs9462022	rs9469899	0.975314640267064	Medication use (thyroid preparations)	2e-09	31015401
rs9462022	rs9469899	0.975314640267064	Medication use (thyroid preparations)	3e-10	34594039
rs9462022	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs9462022	rs11755393	0.944425765145638	Body mass index	3e-26	29273807
rs9462022	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-12	33493351
rs9462022	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-06	33493351
rs9462022	rs11755393	0.944425765145638	Systemic lupus erythematosus	1e-07	33493351
rs9462022	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-08	19838195
rs9462022	rs11755393	0.944425765145638	Body mass index	4e-55	36581621
rs9462022	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs9462022	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs9462022	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs9462022	rs6941110	0.932921349732261	Sex hormone-binding globulin levels	5e-27	36653534
rs9462022	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs9462022	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs9462022	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462022	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs9462022	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs9462022	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs9462022	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462022	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462022	rs9368830	0.831547762090701	HDL cholesterol	4e-21	30275531
rs9462022	rs9368828	0.805103390346437	Body mass index	1e-34	34594039
rs9462022	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462022	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462022	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462022	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs9462022	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs9462022	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462022	rs112283401	0.766845687865746	Red cell distribution width	4e-27	30595370
rs9462022	rs9689160	0.628913951683802	Lung function (forced vital capacity)	3e-14	36914875
rs9462026	rs9462030	0.994373913660559	Red cell distribution width	5e-25	32888493
rs9462026	rs9469857	0.984761860276752	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462026	rs2764208	0.983972294036617	Systemic lupus erythematosus	7e-06	24871463
rs9462026	rs9469899	0.977693690324335	Prostate cancer (advanced)	2e-06	29892016
rs9462026	rs9469899	0.977693690324335	Prostate cancer	5e-09	29892016
rs9462026	rs9469899	0.977693690324335	Prostate cancer	8e-11	33398198
rs9462026	rs9469899	0.977693690324335	Hand grip strength	3e-15	29691431
rs9462026	rs9469899	0.977693690324335	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462026	rs9469899	0.977693690324335	Graves' disease	4e-10	34594039
rs9462026	rs9469899	0.977693690324335	Coronary artery disease	1e-11	36474045
rs9462026	rs9469899	0.977693690324335	Predicted visceral adipose tissue	2e-20	31501611
rs9462026	rs9469899	0.977693690324335	Medication use (thyroid preparations)	2e-09	31015401
rs9462026	rs9469899	0.977693690324335	Medication use (thyroid preparations)	3e-10	34594039
rs9462026	rs9469872	0.948616480320373	HDL cholesterol levels	3e-11	36333282
rs9462026	rs11755393	0.946752658211181	Body mass index	3e-26	29273807
rs9462026	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-12	33493351
rs9462026	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-06	33493351
rs9462026	rs11755393	0.946752658211181	Systemic lupus erythematosus	1e-07	33493351
rs9462026	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-08	19838195
rs9462026	rs11755393	0.946752658211181	Body mass index	4e-55	36581621
rs9462026	rs9366863	0.938413835677258	Adult body size	9e-33	32376654
rs9462026	rs9366863	0.938413835677258	Body mass index	2e-44	30595370
rs9462026	rs6941110	0.935247375317915	Sex hormone-binding globulin levels	5e-27	36653534
rs9462026	rs9296128	0.934198692532671	Hip circumference adjusted for BMI	4e-13	34021172
rs9462026	rs2814949	0.902335914866459	Essential hypertension (time to event)	9e-09	32589924
rs9462026	rs2744944	0.893023538028903	Hypothyroidism	3e-10	34594039
rs9462026	rs2744944	0.893023538028903	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462026	rs2744944	0.893023538028903	Multi-trait sex score	7e-22	37277458
rs9462026	rs2263329	0.873890090753199	HDL cholesterol	6e-35	34594039
rs9462026	rs2263329	0.873890090753199	HDL cholesterol levels	8e-43	32203549
rs9462026	rs2263329	0.873890090753199	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462026	rs111868030	0.850215739645168	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462026	rs9368830	0.829314976366607	HDL cholesterol	4e-21	30275531
rs9462026	rs9368828	0.80294162376271	Body mass index	1e-34	34594039
rs9462026	rs2744973	0.799489696126742	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462026	rs2744973	0.799489696126742	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462026	rs2744973	0.799489696126742	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462026	rs2744973	0.799489696126742	Multi-trait sex score	6e-20	37277458
rs9462026	rs6912327	0.791347099634255	Fasting insulin	5e-06	33402679
rs9462026	rs6912327	0.791347099634255	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462026	rs112283401	0.770469283630436	Red cell distribution width	4e-27	30595370
rs9462026	rs9689160	0.627068448532794	Lung function (forced vital capacity)	3e-14	36914875
rs9462028	rs9462030	0.994373913660559	Red cell distribution width	5e-25	32888493
rs9462028	rs9469857	0.984761860276752	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462028	rs2764208	0.983972294036617	Systemic lupus erythematosus	7e-06	24871463
rs9462028	rs9469899	0.977693690324335	Prostate cancer (advanced)	2e-06	29892016
rs9462028	rs9469899	0.977693690324335	Prostate cancer	5e-09	29892016
rs9462028	rs9469899	0.977693690324335	Prostate cancer	8e-11	33398198
rs9462028	rs9469899	0.977693690324335	Hand grip strength	3e-15	29691431
rs9462028	rs9469899	0.977693690324335	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462028	rs9469899	0.977693690324335	Graves' disease	4e-10	34594039
rs9462028	rs9469899	0.977693690324335	Coronary artery disease	1e-11	36474045
rs9462028	rs9469899	0.977693690324335	Predicted visceral adipose tissue	2e-20	31501611
rs9462028	rs9469899	0.977693690324335	Medication use (thyroid preparations)	2e-09	31015401
rs9462028	rs9469899	0.977693690324335	Medication use (thyroid preparations)	3e-10	34594039
rs9462028	rs9469872	0.948616480320373	HDL cholesterol levels	3e-11	36333282
rs9462028	rs11755393	0.946752658211181	Body mass index	3e-26	29273807
rs9462028	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-12	33493351
rs9462028	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-06	33493351
rs9462028	rs11755393	0.946752658211181	Systemic lupus erythematosus	1e-07	33493351
rs9462028	rs11755393	0.946752658211181	Systemic lupus erythematosus	2e-08	19838195
rs9462028	rs11755393	0.946752658211181	Body mass index	4e-55	36581621
rs9462028	rs9366863	0.938413835677258	Adult body size	9e-33	32376654
rs9462028	rs9366863	0.938413835677258	Body mass index	2e-44	30595370
rs9462028	rs6941110	0.935247375317915	Sex hormone-binding globulin levels	5e-27	36653534
rs9462028	rs9296128	0.934198692532671	Hip circumference adjusted for BMI	4e-13	34021172
rs9462028	rs2814949	0.902335914866459	Essential hypertension (time to event)	9e-09	32589924
rs9462028	rs2744944	0.893023538028903	Hypothyroidism	3e-10	34594039
rs9462028	rs2744944	0.893023538028903	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462028	rs2744944	0.893023538028903	Multi-trait sex score	7e-22	37277458
rs9462028	rs2263329	0.873890090753199	HDL cholesterol	6e-35	34594039
rs9462028	rs2263329	0.873890090753199	HDL cholesterol levels	8e-43	32203549
rs9462028	rs2263329	0.873890090753199	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462028	rs111868030	0.850215739645168	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462028	rs9368830	0.829314976366607	HDL cholesterol	4e-21	30275531
rs9462028	rs9368828	0.80294162376271	Body mass index	1e-34	34594039
rs9462028	rs2744973	0.799489696126742	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462028	rs2744973	0.799489696126742	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462028	rs2744973	0.799489696126742	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462028	rs2744973	0.799489696126742	Multi-trait sex score	6e-20	37277458
rs9462028	rs6912327	0.791347099634255	Fasting insulin	5e-06	33402679
rs9462028	rs6912327	0.791347099634255	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462028	rs112283401	0.770469283630436	Red cell distribution width	4e-27	30595370
rs9462028	rs9689160	0.627068448532794	Lung function (forced vital capacity)	3e-14	36914875
rs9462030	rs9462030	1	Red cell distribution width	5e-25	32888493
rs9462030	rs9469857	0.980744232505031	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9462030	rs2764208	0.979948846273265	Systemic lupus erythematosus	7e-06	24871463
rs9462030	rs9469899	0.973776846516501	Prostate cancer (advanced)	2e-06	29892016
rs9462030	rs9469899	0.973776846516501	Prostate cancer	5e-09	29892016
rs9462030	rs9469899	0.973776846516501	Prostate cancer	8e-11	33398198
rs9462030	rs9469899	0.973776846516501	Hand grip strength	3e-15	29691431
rs9462030	rs9469899	0.973776846516501	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9462030	rs9469899	0.973776846516501	Graves' disease	4e-10	34594039
rs9462030	rs9469899	0.973776846516501	Coronary artery disease	1e-11	36474045
rs9462030	rs9469899	0.973776846516501	Predicted visceral adipose tissue	2e-20	31501611
rs9462030	rs9469899	0.973776846516501	Medication use (thyroid preparations)	2e-09	31015401
rs9462030	rs9469899	0.973776846516501	Medication use (thyroid preparations)	3e-10	34594039
rs9462030	rs9469872	0.944781064859332	HDL cholesterol levels	3e-11	36333282
rs9462030	rs11755393	0.942982809247869	Body mass index	3e-26	29273807
rs9462030	rs11755393	0.942982809247869	Systemic lupus erythematosus	2e-12	33493351
rs9462030	rs11755393	0.942982809247869	Systemic lupus erythematosus	2e-06	33493351
rs9462030	rs11755393	0.942982809247869	Systemic lupus erythematosus	1e-07	33493351
rs9462030	rs11755393	0.942982809247869	Systemic lupus erythematosus	2e-08	19838195
rs9462030	rs11755393	0.942982809247869	Body mass index	4e-55	36581621
rs9462030	rs9366863	0.934589534808786	Adult body size	9e-33	32376654
rs9462030	rs9366863	0.934589534808786	Body mass index	2e-44	30595370
rs9462030	rs6941110	0.932974160870551	Sex hormone-binding globulin levels	5e-27	36653534
rs9462030	rs9296128	0.931673955321373	Hip circumference adjusted for BMI	4e-13	34021172
rs9462030	rs2814949	0.898605958999402	Essential hypertension (time to event)	9e-09	32589924
rs9462030	rs2744944	0.889288001154867	Hypothyroidism	3e-10	34594039
rs9462030	rs2744944	0.889288001154867	High density lipoprotein cholesterol levels	3e-86	34887591
rs9462030	rs2744944	0.889288001154867	Multi-trait sex score	7e-22	37277458
rs9462030	rs2263329	0.870151884034201	HDL cholesterol	6e-35	34594039
rs9462030	rs2263329	0.870151884034201	HDL cholesterol levels	8e-43	32203549
rs9462030	rs2263329	0.870151884034201	High density lipoprotein cholesterol levels	2e-52	34887591
rs9462030	rs111868030	0.84629716344291	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9462030	rs9368830	0.825933046588292	HDL cholesterol	4e-21	30275531
rs9462030	rs9368828	0.799301600448559	Body mass index	1e-34	34594039
rs9462030	rs2744973	0.796788371990572	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9462030	rs2744973	0.796788371990572	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9462030	rs2744973	0.796788371990572	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9462030	rs2744973	0.796788371990572	Multi-trait sex score	6e-20	37277458
rs9462030	rs6912327	0.791661881740944	Fasting insulin	5e-06	33402679
rs9462030	rs6912327	0.791661881740944	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9462030	rs112283401	0.766497776717205	Red cell distribution width	4e-27	30595370
rs9462030	rs9689160	0.62260414309911	Lung function (forced vital capacity)	3e-14	36914875
rs946504	rs7524908	0.713831944669399	Height	5e-27	30595370
rs946504	rs3828081	0.701172674767744	Cognitive function (immediate memory)	8e-08	35386118
rs9469000	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs9469000	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs9469000	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs9469000	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs9469000	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs9469000	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs9469000	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs9469000	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs9469000	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs9469000	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs9469000	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs9469000	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs9469000	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs9469000	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs9469000	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs9469000	rs13437082	0.631513452560533	Height	5e-08	19343178
rs9469000	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs9469008	rs1063631	0.954947201719153	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs9469008	rs1063631	0.954947201719153	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs9469008	rs9266825	0.922502795643026	Autism spectrum disorder	6e-06	35215271
rs9469008	rs6928810	0.829589454520207	Platelet distribution width	1e-14	32888494
rs9469008	rs3869132	0.828539866728364	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs9469008	rs3869132	0.828539866728364	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs9469008	rs6934175	0.719757575710561	Psoriatic arthritis	5e-28	30552173
rs9469008	rs17200242	0.710305065027428	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs9469008	rs7751505	0.70604413710106	Pubertal anthropometrics	4e-06	23449627
rs9469008	rs35026345	0.704554784669513	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs9469008	rs72848707	0.699753636052241	HDL cholesterol levels	7e-06	35884923
rs9469008	rs13437088	0.678003359881001	Psoriasis	3e-40	23143594
rs9469008	rs13437082	0.677260691460562	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs9469008	rs13437082	0.677260691460562	Height	5e-08	19343178
rs9469008	rs199530775	0.673434244324026	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs9469008	rs55957433	0.673434244324026	Hip circumference adjusted for BMI	3e-08	34021172
rs9469008	rs72657657	0.669271034961939	Hip circumference adjusted for BMI	4e-13	34021172
rs9469835	rs9366863	0.847246316580641	Adult body size	9e-33	32376654
rs9469835	rs9366863	0.847246316580641	Body mass index	2e-44	30595370
rs9469835	rs2814949	0.83420458083285	Essential hypertension (time to event)	9e-09	32589924
rs9469835	rs2744944	0.821494630889944	Hypothyroidism	3e-10	34594039
rs9469835	rs2744944	0.821494630889944	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469835	rs2744944	0.821494630889944	Multi-trait sex score	7e-22	37277458
rs9469835	rs9469872	0.821494630889944	HDL cholesterol levels	3e-11	36333282
rs9469835	rs11755393	0.813935702872279	Body mass index	3e-26	29273807
rs9469835	rs11755393	0.813935702872279	Systemic lupus erythematosus	2e-12	33493351
rs9469835	rs11755393	0.813935702872279	Systemic lupus erythematosus	2e-06	33493351
rs9469835	rs11755393	0.813935702872279	Systemic lupus erythematosus	1e-07	33493351
rs9469835	rs11755393	0.813935702872279	Systemic lupus erythematosus	2e-08	19838195
rs9469835	rs11755393	0.813935702872279	Body mass index	4e-55	36581621
rs9469835	rs2263329	0.811382182659848	HDL cholesterol	6e-35	34594039
rs9469835	rs2263329	0.811382182659848	HDL cholesterol levels	8e-43	32203549
rs9469835	rs2263329	0.811382182659848	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469835	rs6941110	0.809490540696283	Sex hormone-binding globulin levels	5e-27	36653534
rs9469835	rs111868030	0.792792899908736	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469835	rs9462030	0.790555854938866	Red cell distribution width	5e-25	32888493
rs9469835	rs9469857	0.787914601980143	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469835	rs2764208	0.785938715808422	Systemic lupus erythematosus	7e-06	24871463
rs9469835	rs9469899	0.7740853710194	Prostate cancer (advanced)	2e-06	29892016
rs9469835	rs9469899	0.7740853710194	Prostate cancer	5e-09	29892016
rs9469835	rs9469899	0.7740853710194	Prostate cancer	8e-11	33398198
rs9469835	rs9469899	0.7740853710194	Hand grip strength	3e-15	29691431
rs9469835	rs9469899	0.7740853710194	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469835	rs9469899	0.7740853710194	Graves' disease	4e-10	34594039
rs9469835	rs9469899	0.7740853710194	Coronary artery disease	1e-11	36474045
rs9469835	rs9469899	0.7740853710194	Predicted visceral adipose tissue	2e-20	31501611
rs9469835	rs9469899	0.7740853710194	Medication use (thyroid preparations)	2e-09	31015401
rs9469835	rs9469899	0.7740853710194	Medication use (thyroid preparations)	3e-10	34594039
rs9469835	rs9368830	0.753263959393158	HDL cholesterol	4e-21	30275531
rs9469835	rs9296128	0.744792315723447	Hip circumference adjusted for BMI	4e-13	34021172
rs9469835	rs9368828	0.736038574120728	Body mass index	1e-34	34594039
rs9469835	rs2744973	0.696760962015613	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469835	rs2744973	0.696760962015613	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469835	rs2744973	0.696760962015613	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469835	rs2744973	0.696760962015613	Multi-trait sex score	6e-20	37277458
rs9469835	rs6912327	0.68412748219519	Fasting insulin	5e-06	33402679
rs9469835	rs6912327	0.68412748219519	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469835	rs3800458	0.664400229701898	Insomnia	7e-11	35835914
rs9469835	rs3800458	0.664400229701898	Insomnia	2e-12	35835914
rs9469835	rs112283401	0.663438197281891	Red cell distribution width	4e-27	30595370
rs9469856	rs9469857	0.989543793406407	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469856	rs2764208	0.988738867945909	Systemic lupus erythematosus	7e-06	24871463
rs9469856	rs9462030	0.975164897452128	Red cell distribution width	5e-25	32888493
rs9469856	rs9469899	0.958807359162744	Prostate cancer (advanced)	2e-06	29892016
rs9469856	rs9469899	0.958807359162744	Prostate cancer	5e-09	29892016
rs9469856	rs9469899	0.958807359162744	Prostate cancer	8e-11	33398198
rs9469856	rs9469899	0.958807359162744	Hand grip strength	3e-15	29691431
rs9469856	rs9469899	0.958807359162744	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469856	rs9469899	0.958807359162744	Graves' disease	4e-10	34594039
rs9469856	rs9469899	0.958807359162744	Coronary artery disease	1e-11	36474045
rs9469856	rs9469899	0.958807359162744	Predicted visceral adipose tissue	2e-20	31501611
rs9469856	rs9469899	0.958807359162744	Medication use (thyroid preparations)	2e-09	31015401
rs9469856	rs9469899	0.958807359162744	Medication use (thyroid preparations)	3e-10	34594039
rs9469856	rs9469872	0.953504363503026	HDL cholesterol levels	3e-11	36333282
rs9469856	rs9296128	0.938546850923152	Hip circumference adjusted for BMI	4e-13	34021172
rs9469856	rs11755393	0.92834919670856	Body mass index	3e-26	29273807
rs9469856	rs11755393	0.92834919670856	Systemic lupus erythematosus	2e-12	33493351
rs9469856	rs11755393	0.92834919670856	Systemic lupus erythematosus	2e-06	33493351
rs9469856	rs11755393	0.92834919670856	Systemic lupus erythematosus	1e-07	33493351
rs9469856	rs11755393	0.92834919670856	Systemic lupus erythematosus	2e-08	19838195
rs9469856	rs11755393	0.92834919670856	Body mass index	4e-55	36581621
rs9469856	rs9366863	0.924581327301309	Adult body size	9e-33	32376654
rs9469856	rs9366863	0.924581327301309	Body mass index	2e-44	30595370
rs9469856	rs6941110	0.916785081778096	Sex hormone-binding globulin levels	5e-27	36653534
rs9469856	rs2744944	0.897737000774542	Hypothyroidism	3e-10	34594039
rs9469856	rs2744944	0.897737000774542	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469856	rs2744944	0.897737000774542	Multi-trait sex score	7e-22	37277458
rs9469856	rs2814949	0.888814851061705	Essential hypertension (time to event)	9e-09	32589924
rs9469856	rs2263329	0.875455287067743	HDL cholesterol	6e-35	34594039
rs9469856	rs2263329	0.875455287067743	HDL cholesterol levels	8e-43	32203549
rs9469856	rs2263329	0.875455287067743	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469856	rs111868030	0.857313746672353	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469856	rs9368830	0.816751628660009	HDL cholesterol	4e-21	30275531
rs9469856	rs9368828	0.807226942277605	Body mass index	1e-34	34594039
rs9469856	rs2744973	0.785394988011163	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469856	rs2744973	0.785394988011163	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469856	rs2744973	0.785394988011163	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469856	rs2744973	0.785394988011163	Multi-trait sex score	6e-20	37277458
rs9469856	rs6912327	0.774706225623161	Fasting insulin	5e-06	33402679
rs9469856	rs6912327	0.774706225623161	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469856	rs112283401	0.751221377971103	Red cell distribution width	4e-27	30595370
rs9469856	rs9689160	0.615509351753417	Lung function (forced vital capacity)	3e-14	36914875
rs9469857	rs9469857	1	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469857	rs2764208	0.994363579966998	Systemic lupus erythematosus	7e-06	24871463
rs9469857	rs9462030	0.980744232505031	Red cell distribution width	5e-25	32888493
rs9469857	rs9469899	0.964303678467489	Prostate cancer (advanced)	2e-06	29892016
rs9469857	rs9469899	0.964303678467489	Prostate cancer	5e-09	29892016
rs9469857	rs9469899	0.964303678467489	Prostate cancer	8e-11	33398198
rs9469857	rs9469899	0.964303678467489	Hand grip strength	3e-15	29691431
rs9469857	rs9469899	0.964303678467489	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469857	rs9469899	0.964303678467489	Graves' disease	4e-10	34594039
rs9469857	rs9469899	0.964303678467489	Coronary artery disease	1e-11	36474045
rs9469857	rs9469899	0.964303678467489	Predicted visceral adipose tissue	2e-20	31501611
rs9469857	rs9469899	0.964303678467489	Medication use (thyroid preparations)	2e-09	31015401
rs9469857	rs9469899	0.964303678467489	Medication use (thyroid preparations)	3e-10	34594039
rs9469857	rs9469872	0.958971476515971	HDL cholesterol levels	3e-11	36333282
rs9469857	rs9296128	0.94410950115942	Hip circumference adjusted for BMI	4e-13	34021172
rs9469857	rs11755393	0.933717288059645	Body mass index	3e-26	29273807
rs9469857	rs11755393	0.933717288059645	Systemic lupus erythematosus	2e-12	33493351
rs9469857	rs11755393	0.933717288059645	Systemic lupus erythematosus	2e-06	33493351
rs9469857	rs11755393	0.933717288059645	Systemic lupus erythematosus	1e-07	33493351
rs9469857	rs11755393	0.933717288059645	Systemic lupus erythematosus	2e-08	19838195
rs9469857	rs11755393	0.933717288059645	Body mass index	4e-55	36581621
rs9469857	rs9366863	0.929971672269469	Adult body size	9e-33	32376654
rs9469857	rs9366863	0.929971672269469	Body mass index	2e-44	30595370
rs9469857	rs6941110	0.922158003834804	Sex hormone-binding globulin levels	5e-27	36653534
rs9469857	rs2744944	0.903048490448695	Hypothyroidism	3e-10	34594039
rs9469857	rs2744944	0.903048490448695	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469857	rs2744944	0.903048490448695	Multi-trait sex score	7e-22	37277458
rs9469857	rs2814949	0.894090207042686	Essential hypertension (time to event)	9e-09	32589924
rs9469857	rs2263329	0.882234019129751	HDL cholesterol	6e-35	34594039
rs9469857	rs2263329	0.882234019129751	HDL cholesterol levels	8e-43	32203549
rs9469857	rs2263329	0.882234019129751	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469857	rs111868030	0.859637520252733	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469857	rs9368830	0.821718979716464	HDL cholesterol	4e-21	30275531
rs9469857	rs9368828	0.812310887123721	Body mass index	1e-34	34594039
rs9469857	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469857	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469857	rs2744973	0.792134506553775	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469857	rs2744973	0.792134506553775	Multi-trait sex score	6e-20	37277458
rs9469857	rs6912327	0.778459629009136	Fasting insulin	5e-06	33402679
rs9469857	rs6912327	0.778459629009136	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469857	rs112283401	0.759166077209552	Red cell distribution width	4e-27	30595370
rs9469857	rs9689160	0.61797496690874	Lung function (forced vital capacity)	3e-14	36914875
rs9469858	rs9469857	0.997582352024437	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469858	rs2764208	0.99677912492054	Systemic lupus erythematosus	7e-06	24871463
rs9469858	rs9462030	0.983140807806833	Red cell distribution width	5e-25	32888493
rs9469858	rs9469899	0.966667430087757	Prostate cancer (advanced)	2e-06	29892016
rs9469858	rs9469899	0.966667430087757	Prostate cancer	5e-09	29892016
rs9469858	rs9469899	0.966667430087757	Prostate cancer	8e-11	33398198
rs9469858	rs9469899	0.966667430087757	Hand grip strength	3e-15	29691431
rs9469858	rs9469899	0.966667430087757	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469858	rs9469899	0.966667430087757	Graves' disease	4e-10	34594039
rs9469858	rs9469899	0.966667430087757	Coronary artery disease	1e-11	36474045
rs9469858	rs9469899	0.966667430087757	Predicted visceral adipose tissue	2e-20	31501611
rs9469858	rs9469899	0.966667430087757	Medication use (thyroid preparations)	2e-09	31015401
rs9469858	rs9469899	0.966667430087757	Medication use (thyroid preparations)	3e-10	34594039
rs9469858	rs9469872	0.961323796018004	HDL cholesterol levels	3e-11	36333282
rs9469858	rs9296128	0.946492209800938	Hip circumference adjusted for BMI	4e-13	34021172
rs9469858	rs11755393	0.936029189335317	Body mass index	3e-26	29273807
rs9469858	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-12	33493351
rs9469858	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-06	33493351
rs9469858	rs11755393	0.936029189335317	Systemic lupus erythematosus	1e-07	33493351
rs9469858	rs11755393	0.936029189335317	Systemic lupus erythematosus	2e-08	19838195
rs9469858	rs11755393	0.936029189335317	Body mass index	4e-55	36581621
rs9469858	rs9366863	0.932290436890068	Adult body size	9e-33	32376654
rs9469858	rs9366863	0.932290436890068	Body mass index	2e-44	30595370
rs9469858	rs6941110	0.924468849620969	Sex hormone-binding globulin levels	5e-27	36653534
rs9469858	rs2744944	0.905333361761586	Hypothyroidism	3e-10	34594039
rs9469858	rs2744944	0.905333361761586	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469858	rs2744944	0.905333361761586	Multi-trait sex score	7e-22	37277458
rs9469858	rs2814949	0.896360329346663	Essential hypertension (time to event)	9e-09	32589924
rs9469858	rs2263329	0.882985226709218	HDL cholesterol	6e-35	34594039
rs9469858	rs2263329	0.882985226709218	HDL cholesterol levels	8e-43	32203549
rs9469858	rs2263329	0.882985226709218	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469858	rs111868030	0.861914393516153	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469858	rs9368830	0.823864293461377	HDL cholesterol	4e-21	30275531
rs9469858	rs9368828	0.814494197533457	Body mass index	1e-34	34594039
rs9469858	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469858	rs2744973	0.792932896815807	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469858	rs2744973	0.792932896815807	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469858	rs2744973	0.792932896815807	Multi-trait sex score	6e-20	37277458
rs9469858	rs6912327	0.780671203169317	Fasting insulin	5e-06	33402679
rs9469858	rs6912327	0.780671203169317	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469858	rs112283401	0.758513820445014	Red cell distribution width	4e-27	30595370
rs9469858	rs9689160	0.620127800867843	Lung function (forced vital capacity)	3e-14	36914875
rs9469861	rs9469857	0.996776778921405	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469861	rs2764208	0.995972777577403	Systemic lupus erythematosus	7e-06	24871463
rs9469861	rs9462030	0.982341944636037	Red cell distribution width	5e-25	32888493
rs9469861	rs9469899	0.965886102309356	Prostate cancer (advanced)	2e-06	29892016
rs9469861	rs9469899	0.965886102309356	Prostate cancer	5e-09	29892016
rs9469861	rs9469899	0.965886102309356	Prostate cancer	8e-11	33398198
rs9469861	rs9469899	0.965886102309356	Hand grip strength	3e-15	29691431
rs9469861	rs9469899	0.965886102309356	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469861	rs9469899	0.965886102309356	Graves' disease	4e-10	34594039
rs9469861	rs9469899	0.965886102309356	Coronary artery disease	1e-11	36474045
rs9469861	rs9469899	0.965886102309356	Predicted visceral adipose tissue	2e-20	31501611
rs9469861	rs9469899	0.965886102309356	Medication use (thyroid preparations)	2e-09	31015401
rs9469861	rs9469899	0.965886102309356	Medication use (thyroid preparations)	3e-10	34594039
rs9469861	rs9469872	0.96054887345204	HDL cholesterol levels	3e-11	36333282
rs9469861	rs9296128	0.945681992424858	Hip circumference adjusted for BMI	4e-13	34021172
rs9469861	rs11755393	0.935272594959748	Body mass index	3e-26	29273807
rs9469861	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-12	33493351
rs9469861	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-06	33493351
rs9469861	rs11755393	0.935272594959748	Systemic lupus erythematosus	1e-07	33493351
rs9469861	rs11755393	0.935272594959748	Systemic lupus erythematosus	2e-08	19838195
rs9469861	rs11755393	0.935272594959748	Body mass index	4e-55	36581621
rs9469861	rs9366863	0.931525188678084	Adult body size	9e-33	32376654
rs9469861	rs9366863	0.931525188678084	Body mass index	2e-44	30595370
rs9469861	rs6941110	0.923705176714688	Sex hormone-binding globulin levels	5e-27	36653534
rs9469861	rs2744944	0.904579222323617	Hypothyroidism	3e-10	34594039
rs9469861	rs2744944	0.904579222323617	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469861	rs2744944	0.904579222323617	Multi-trait sex score	7e-22	37277458
rs9469861	rs2814949	0.89561287838885	Essential hypertension (time to event)	9e-09	32589924
rs9469861	rs2263329	0.882234019129751	HDL cholesterol	6e-35	34594039
rs9469861	rs2263329	0.882234019129751	HDL cholesterol levels	8e-43	32203549
rs9469861	rs2263329	0.882234019129751	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469861	rs111868030	0.861138045850585	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469861	rs9368830	0.823175715403171	HDL cholesterol	4e-21	30275531
rs9469861	rs9368828	0.813764410103364	Body mass index	1e-34	34594039
rs9469861	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469861	rs2744973	0.792134506553775	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469861	rs2744973	0.792134506553775	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469861	rs2744973	0.792134506553775	Multi-trait sex score	6e-20	37277458
rs9469861	rs6912327	0.779895917756941	Fasting insulin	5e-06	33402679
rs9469861	rs6912327	0.779895917756941	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469861	rs112283401	0.757749108732694	Red cell distribution width	4e-27	30595370
rs9469861	rs9689160	0.620633913312638	Lung function (forced vital capacity)	3e-14	36914875
rs9469861	rs9462027	0.600261280766747	Systemic lupus erythematosus	1e-10	27399966
rs9469861	rs9462027	0.600261280766747	Systemic lupus erythematosus	8e-09	26502338
rs9469861	rs9462027	0.600261280766747	Systemic lupus erythematosus	2e-08	28714469
rs9469861	rs9462027	0.600261280766747	Alzheimer's disease or gastroesophageal reflux disease	2e-06	35851147
rs9469862	rs9469857	0.960344888079569	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469862	rs2764208	0.959505875179794	Systemic lupus erythematosus	7e-06	24871463
rs9469862	rs9462030	0.946213530424624	Red cell distribution width	5e-25	32888493
rs9469862	rs9469899	0.93055070308107	Prostate cancer (advanced)	2e-06	29892016
rs9469862	rs9469899	0.93055070308107	Prostate cancer	5e-09	29892016
rs9469862	rs9469899	0.93055070308107	Prostate cancer	8e-11	33398198
rs9469862	rs9469899	0.93055070308107	Hand grip strength	3e-15	29691431
rs9469862	rs9469899	0.93055070308107	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469862	rs9469899	0.93055070308107	Graves' disease	4e-10	34594039
rs9469862	rs9469899	0.93055070308107	Coronary artery disease	1e-11	36474045
rs9469862	rs9469899	0.93055070308107	Predicted visceral adipose tissue	2e-20	31501611
rs9469862	rs9469899	0.93055070308107	Medication use (thyroid preparations)	2e-09	31015401
rs9469862	rs9469899	0.93055070308107	Medication use (thyroid preparations)	3e-10	34594039
rs9469862	rs9469872	0.925503146277366	HDL cholesterol levels	3e-11	36333282
rs9469862	rs9296128	0.909041345673722	Hip circumference adjusted for BMI	4e-13	34021172
rs9469862	rs11755393	0.901055759212929	Body mass index	3e-26	29273807
rs9469862	rs11755393	0.901055759212929	Systemic lupus erythematosus	2e-12	33493351
rs9469862	rs11755393	0.901055759212929	Systemic lupus erythematosus	2e-06	33493351
rs9469862	rs11755393	0.901055759212929	Systemic lupus erythematosus	1e-07	33493351
rs9469862	rs11755393	0.901055759212929	Systemic lupus erythematosus	2e-08	19838195
rs9469862	rs11755393	0.901055759212929	Body mass index	4e-55	36581621
rs9469862	rs9366863	0.896917092188579	Adult body size	9e-33	32376654
rs9469862	rs9366863	0.896917092188579	Body mass index	2e-44	30595370
rs9469862	rs6941110	0.889168413528812	Sex hormone-binding globulin levels	5e-27	36653534
rs9469862	rs2744944	0.870473764040686	Hypothyroidism	3e-10	34594039
rs9469862	rs2744944	0.870473764040686	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469862	rs2744944	0.870473764040686	Multi-trait sex score	7e-22	37277458
rs9469862	rs2814949	0.861809925182257	Essential hypertension (time to event)	9e-09	32589924
rs9469862	rs2263329	0.849749053734042	HDL cholesterol	6e-35	34594039
rs9469862	rs2263329	0.849749053734042	HDL cholesterol levels	8e-43	32203549
rs9469862	rs2263329	0.849749053734042	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469862	rs9368828	0.84779313520099	Body mass index	1e-34	34594039
rs9469862	rs111868030	0.834894522849575	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469862	rs2744973	0.824386266353314	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469862	rs2744973	0.824386266353314	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469862	rs2744973	0.824386266353314	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469862	rs2744973	0.824386266353314	Multi-trait sex score	6e-20	37277458
rs9469862	rs9368830	0.792035296933427	HDL cholesterol	4e-21	30275531
rs9469862	rs112283401	0.789807125683663	Red cell distribution width	4e-27	30595370
rs9469862	rs6912327	0.744848614078826	Fasting insulin	5e-06	33402679
rs9469862	rs6912327	0.744848614078826	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469862	rs9462027	0.622991179810188	Systemic lupus erythematosus	1e-10	27399966
rs9469862	rs9462027	0.622991179810188	Systemic lupus erythematosus	8e-09	26502338
rs9469862	rs9462027	0.622991179810188	Systemic lupus erythematosus	2e-08	28714469
rs9469862	rs9462027	0.622991179810188	Alzheimer's disease or gastroesophageal reflux disease	2e-06	35851147
rs9469863	rs9469872	0.988807308664001	HDL cholesterol levels	3e-11	36333282
rs9469863	rs11755393	0.981657355692712	Body mass index	3e-26	29273807
rs9469863	rs11755393	0.981657355692712	Systemic lupus erythematosus	2e-12	33493351
rs9469863	rs11755393	0.981657355692712	Systemic lupus erythematosus	2e-06	33493351
rs9469863	rs11755393	0.981657355692712	Systemic lupus erythematosus	1e-07	33493351
rs9469863	rs11755393	0.981657355692712	Systemic lupus erythematosus	2e-08	19838195
rs9469863	rs11755393	0.981657355692712	Body mass index	4e-55	36581621
rs9469863	rs9366863	0.978460111638123	Adult body size	9e-33	32376654
rs9469863	rs9366863	0.978460111638123	Body mass index	2e-44	30595370
rs9469863	rs6941110	0.970546607729113	Sex hormone-binding globulin levels	5e-27	36653534
rs9469863	rs9462030	0.952834858211353	Red cell distribution width	5e-25	32888493
rs9469863	rs9469857	0.94819588033075	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469863	rs2764208	0.94746644361864	Systemic lupus erythematosus	7e-06	24871463
rs9469863	rs2814949	0.941450684903366	Essential hypertension (time to event)	9e-09	32589924
rs9469863	rs9469899	0.936056107974014	Prostate cancer (advanced)	2e-06	29892016
rs9469863	rs9469899	0.936056107974014	Prostate cancer	5e-09	29892016
rs9469863	rs9469899	0.936056107974014	Prostate cancer	8e-11	33398198
rs9469863	rs9469899	0.936056107974014	Hand grip strength	3e-15	29691431
rs9469863	rs9469899	0.936056107974014	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469863	rs9469899	0.936056107974014	Graves' disease	4e-10	34594039
rs9469863	rs9469899	0.936056107974014	Coronary artery disease	1e-11	36474045
rs9469863	rs9469899	0.936056107974014	Predicted visceral adipose tissue	2e-20	31501611
rs9469863	rs9469899	0.936056107974014	Medication use (thyroid preparations)	2e-09	31015401
rs9469863	rs9469899	0.936056107974014	Medication use (thyroid preparations)	3e-10	34594039
rs9469863	rs2744944	0.932124526555203	Hypothyroidism	3e-10	34594039
rs9469863	rs2744944	0.932124526555203	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469863	rs2744944	0.932124526555203	Multi-trait sex score	7e-22	37277458
rs9469863	rs2263329	0.912895693110378	HDL cholesterol	6e-35	34594039
rs9469863	rs2263329	0.912895693110378	HDL cholesterol levels	8e-43	32203549
rs9469863	rs2263329	0.912895693110378	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469863	rs9296128	0.899623963035097	Hip circumference adjusted for BMI	4e-13	34021172
rs9469863	rs111868030	0.888937728686211	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469863	rs9368830	0.865347815677681	HDL cholesterol	4e-21	30275531
rs9469863	rs9368828	0.836343060596943	Body mass index	1e-34	34594039
rs9469863	rs6912327	0.827605193556543	Fasting insulin	5e-06	33402679
rs9469863	rs6912327	0.827605193556543	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469863	rs112283401	0.804811942719288	Red cell distribution width	4e-27	30595370
rs9469863	rs2744973	0.781131472776925	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469863	rs2744973	0.781131472776925	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469863	rs2744973	0.781131472776925	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469863	rs2744973	0.781131472776925	Multi-trait sex score	6e-20	37277458
rs9469863	rs6940215	0.633333210781638	Insomnia	2e-10	35835914
rs9469863	rs6940215	0.633333210781638	Insomnia	1e-13	35835914
rs9469863	rs6940215	0.633333210781638	Hip circumference adjusted for BMI	8e-10	34021172
rs9469863	rs6940215	0.633333210781638	Multi-trait sex score	2e-23	37277458
rs9469863	rs6940215	0.633333210781638	Multi-trait sex score	4e-23	37277458
rs9469863	rs6457796	0.624846626930923	Insomnia	1e-08	30804565
rs9469863	rs6457796	0.624846626930923	Plateletcrit	9e-11	32888494
rs9469863	rs6457796	0.624846626930923	Systemic lupus erythematosus	3e-22	33272962
rs9469863	rs6457796	0.624846626930923	Body mass index	5e-13	30108127
rs9469863	rs6457796	0.624846626930923	Body mass index	1e-14	26426971
rs9469863	rs6457796	0.624846626930923	Educational attainment	5e-19	35361970
rs9469863	rs9689160	0.604409509262181	Lung function (forced vital capacity)	3e-14	36914875
rs9469866	rs9469872	1	HDL cholesterol levels	3e-11	36333282
rs9469866	rs11755393	0.973790640397902	Body mass index	3e-26	29273807
rs9469866	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-12	33493351
rs9469866	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-06	33493351
rs9469866	rs11755393	0.973790640397902	Systemic lupus erythematosus	1e-07	33493351
rs9469866	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-08	19838195
rs9469866	rs11755393	0.973790640397902	Body mass index	4e-55	36581621
rs9469866	rs9366863	0.970483919695282	Adult body size	9e-33	32376654
rs9469866	rs9366863	0.970483919695282	Body mass index	2e-44	30595370
rs9469866	rs6941110	0.96258381097747	Sex hormone-binding globulin levels	5e-27	36653534
rs9469866	rs9469857	0.958971476515971	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469866	rs2764208	0.958227492160117	Systemic lupus erythematosus	7e-06	24871463
rs9469866	rs9462030	0.944781064859332	Red cell distribution width	5e-25	32888493
rs9469866	rs2744944	0.942972684970972	Hypothyroidism	3e-10	34594039
rs9469866	rs2744944	0.942972684970972	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469866	rs2744944	0.942972684970972	Multi-trait sex score	7e-22	37277458
rs9469866	rs2814949	0.933665854372005	Essential hypertension (time to event)	9e-09	32589924
rs9469866	rs9469899	0.92820039426473	Prostate cancer (advanced)	2e-06	29892016
rs9469866	rs9469899	0.92820039426473	Prostate cancer	5e-09	29892016
rs9469866	rs9469899	0.92820039426473	Prostate cancer	8e-11	33398198
rs9469866	rs9469899	0.92820039426473	Hand grip strength	3e-15	29691431
rs9469866	rs9469899	0.92820039426473	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469866	rs9469899	0.92820039426473	Graves' disease	4e-10	34594039
rs9469866	rs9469899	0.92820039426473	Coronary artery disease	1e-11	36474045
rs9469866	rs9469899	0.92820039426473	Predicted visceral adipose tissue	2e-20	31501611
rs9469866	rs9469899	0.92820039426473	Medication use (thyroid preparations)	2e-09	31015401
rs9469866	rs9469899	0.92820039426473	Medication use (thyroid preparations)	3e-10	34594039
rs9469866	rs2263329	0.920478897573699	HDL cholesterol	6e-35	34594039
rs9469866	rs2263329	0.920478897573699	HDL cholesterol levels	8e-43	32203549
rs9469866	rs2263329	0.920478897573699	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469866	rs9296128	0.909885484027307	Hip circumference adjusted for BMI	4e-13	34021172
rs9469866	rs111868030	0.899134497274885	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469866	rs9368830	0.858231507139136	HDL cholesterol	4e-21	30275531
rs9469866	rs9368828	0.846474268217447	Body mass index	1e-34	34594039
rs9469866	rs6912327	0.819382202499493	Fasting insulin	5e-06	33402679
rs9469866	rs6912327	0.819382202499493	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469866	rs112283401	0.796699333730006	Red cell distribution width	4e-27	30595370
rs9469866	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469866	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469866	rs2744973	0.772924967221123	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469866	rs2744973	0.772924967221123	Multi-trait sex score	6e-20	37277458
rs9469866	rs6940215	0.625459662116117	Insomnia	2e-10	35835914
rs9469866	rs6940215	0.625459662116117	Insomnia	1e-13	35835914
rs9469866	rs6940215	0.625459662116117	Hip circumference adjusted for BMI	8e-10	34021172
rs9469866	rs6940215	0.625459662116117	Multi-trait sex score	2e-23	37277458
rs9469866	rs6940215	0.625459662116117	Multi-trait sex score	4e-23	37277458
rs9469866	rs6457796	0.61641252194767	Insomnia	1e-08	30804565
rs9469866	rs6457796	0.61641252194767	Plateletcrit	9e-11	32888494
rs9469866	rs6457796	0.61641252194767	Systemic lupus erythematosus	3e-22	33272962
rs9469866	rs6457796	0.61641252194767	Body mass index	5e-13	30108127
rs9469866	rs6457796	0.61641252194767	Body mass index	1e-14	26426971
rs9469866	rs6457796	0.61641252194767	Educational attainment	5e-19	35361970
rs9469866	rs205262	0.603317711536489	Body mass index	2e-09	26961502
rs9469866	rs205262	0.603317711536489	Walking pace	4e-10	33128006
rs9469866	rs205262	0.603317711536489	Body mass index	8e-13	30108127
rs9469866	rs205262	0.603317711536489	Body mass index	2e-09	25673413
rs9469866	rs205262	0.603317711536489	Body mass index	2e-14	26426971
rs9469866	rs205262	0.603317711536489	BMI in non-smokers	3e-07	28443625
rs9469866	rs205262	0.603317711536489	BMI in non-smokers	6e-09	28443625
rs9469866	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9469866	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9469866	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9469866	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9469866	rs205262	0.603317711536489	Gastroesophageal reflux disease	1e-10	34187846
rs9469866	rs205262	0.603317711536489	Body mass index	3e-10	25673413
rs9469866	rs205262	0.603317711536489	Body mass index	2e-10	25673413
rs9469866	rs205262	0.603317711536489	ICD10 M54: Dorsalgia	2e-12	35110524
rs9469867	rs9469857	0.990345945661013	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469867	rs2764208	0.989543793406407	Systemic lupus erythematosus	7e-06	24871463
rs9469867	rs9462030	0.975958898167286	Red cell distribution width	5e-25	32888493
rs9469867	rs9469899	0.959564190836493	Prostate cancer (advanced)	2e-06	29892016
rs9469867	rs9469899	0.959564190836493	Prostate cancer	5e-09	29892016
rs9469867	rs9469899	0.959564190836493	Prostate cancer	8e-11	33398198
rs9469867	rs9469899	0.959564190836493	Hand grip strength	3e-15	29691431
rs9469867	rs9469899	0.959564190836493	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469867	rs9469899	0.959564190836493	Graves' disease	4e-10	34594039
rs9469867	rs9469899	0.959564190836493	Coronary artery disease	1e-11	36474045
rs9469867	rs9469899	0.959564190836493	Predicted visceral adipose tissue	2e-20	31501611
rs9469867	rs9469899	0.959564190836493	Medication use (thyroid preparations)	2e-09	31015401
rs9469867	rs9469899	0.959564190836493	Medication use (thyroid preparations)	3e-10	34594039
rs9469867	rs9469872	0.954247063217954	HDL cholesterol levels	3e-11	36333282
rs9469867	rs9296128	0.939399878163206	Hip circumference adjusted for BMI	4e-13	34021172
rs9469867	rs11755393	0.929059132987157	Body mass index	3e-26	29273807
rs9469867	rs11755393	0.929059132987157	Systemic lupus erythematosus	2e-12	33493351
rs9469867	rs11755393	0.929059132987157	Systemic lupus erythematosus	2e-06	33493351
rs9469867	rs11755393	0.929059132987157	Systemic lupus erythematosus	1e-07	33493351
rs9469867	rs11755393	0.929059132987157	Systemic lupus erythematosus	2e-08	19838195
rs9469867	rs11755393	0.929059132987157	Body mass index	4e-55	36581621
rs9469867	rs9366863	0.925318901988739	Adult body size	9e-33	32376654
rs9469867	rs9366863	0.925318901988739	Body mass index	2e-44	30595370
rs9469867	rs6941110	0.917524266089316	Sex hormone-binding globulin levels	5e-27	36653534
rs9469867	rs2744944	0.898464072334118	Hypothyroidism	3e-10	34594039
rs9469867	rs2744944	0.898464072334118	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469867	rs2744944	0.898464072334118	Multi-trait sex score	7e-22	37277458
rs9469867	rs2814949	0.889529965897255	Essential hypertension (time to event)	9e-09	32589924
rs9469867	rs2263329	0.876191730836086	HDL cholesterol	6e-35	34594039
rs9469867	rs2263329	0.876191730836086	HDL cholesterol levels	8e-43	32203549
rs9469867	rs2263329	0.876191730836086	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469867	rs111868030	0.856640394457079	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469867	rs9368830	0.817356513258645	HDL cholesterol	4e-21	30275531
rs9469867	rs9368828	0.807958113873507	Body mass index	1e-34	34594039
rs9469867	rs2744973	0.786331822682986	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469867	rs2744973	0.786331822682986	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469867	rs2744973	0.786331822682986	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469867	rs2744973	0.786331822682986	Multi-trait sex score	6e-20	37277458
rs9469867	rs6912327	0.774158705468437	Fasting insulin	5e-06	33402679
rs9469867	rs6912327	0.774158705468437	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469867	rs112283401	0.752094470898845	Red cell distribution width	4e-27	30595370
rs9469867	rs9689160	0.613997249840188	Lung function (forced vital capacity)	3e-14	36914875
rs9469869	rs9469872	1	HDL cholesterol levels	3e-11	36333282
rs9469869	rs11755393	0.973790640397902	Body mass index	3e-26	29273807
rs9469869	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-12	33493351
rs9469869	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-06	33493351
rs9469869	rs11755393	0.973790640397902	Systemic lupus erythematosus	1e-07	33493351
rs9469869	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-08	19838195
rs9469869	rs11755393	0.973790640397902	Body mass index	4e-55	36581621
rs9469869	rs9366863	0.970483919695282	Adult body size	9e-33	32376654
rs9469869	rs9366863	0.970483919695282	Body mass index	2e-44	30595370
rs9469869	rs6941110	0.96258381097747	Sex hormone-binding globulin levels	5e-27	36653534
rs9469869	rs9469857	0.958971476515971	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469869	rs2764208	0.958227492160117	Systemic lupus erythematosus	7e-06	24871463
rs9469869	rs9462030	0.944781064859332	Red cell distribution width	5e-25	32888493
rs9469869	rs2744944	0.942972684970972	Hypothyroidism	3e-10	34594039
rs9469869	rs2744944	0.942972684970972	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469869	rs2744944	0.942972684970972	Multi-trait sex score	7e-22	37277458
rs9469869	rs2814949	0.933665854372005	Essential hypertension (time to event)	9e-09	32589924
rs9469869	rs9469899	0.92820039426473	Prostate cancer (advanced)	2e-06	29892016
rs9469869	rs9469899	0.92820039426473	Prostate cancer	5e-09	29892016
rs9469869	rs9469899	0.92820039426473	Prostate cancer	8e-11	33398198
rs9469869	rs9469899	0.92820039426473	Hand grip strength	3e-15	29691431
rs9469869	rs9469899	0.92820039426473	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469869	rs9469899	0.92820039426473	Graves' disease	4e-10	34594039
rs9469869	rs9469899	0.92820039426473	Coronary artery disease	1e-11	36474045
rs9469869	rs9469899	0.92820039426473	Predicted visceral adipose tissue	2e-20	31501611
rs9469869	rs9469899	0.92820039426473	Medication use (thyroid preparations)	2e-09	31015401
rs9469869	rs9469899	0.92820039426473	Medication use (thyroid preparations)	3e-10	34594039
rs9469869	rs2263329	0.920478897573699	HDL cholesterol	6e-35	34594039
rs9469869	rs2263329	0.920478897573699	HDL cholesterol levels	8e-43	32203549
rs9469869	rs2263329	0.920478897573699	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469869	rs9296128	0.909885484027307	Hip circumference adjusted for BMI	4e-13	34021172
rs9469869	rs111868030	0.899134497274885	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469869	rs9368830	0.858231507139136	HDL cholesterol	4e-21	30275531
rs9469869	rs9368828	0.846474268217447	Body mass index	1e-34	34594039
rs9469869	rs6912327	0.819382202499493	Fasting insulin	5e-06	33402679
rs9469869	rs6912327	0.819382202499493	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469869	rs112283401	0.796699333730006	Red cell distribution width	4e-27	30595370
rs9469869	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469869	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469869	rs2744973	0.772924967221123	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469869	rs2744973	0.772924967221123	Multi-trait sex score	6e-20	37277458
rs9469869	rs6940215	0.625459662116117	Insomnia	2e-10	35835914
rs9469869	rs6940215	0.625459662116117	Insomnia	1e-13	35835914
rs9469869	rs6940215	0.625459662116117	Hip circumference adjusted for BMI	8e-10	34021172
rs9469869	rs6940215	0.625459662116117	Multi-trait sex score	2e-23	37277458
rs9469869	rs6940215	0.625459662116117	Multi-trait sex score	4e-23	37277458
rs9469869	rs6457796	0.61641252194767	Insomnia	1e-08	30804565
rs9469869	rs6457796	0.61641252194767	Plateletcrit	9e-11	32888494
rs9469869	rs6457796	0.61641252194767	Systemic lupus erythematosus	3e-22	33272962
rs9469869	rs6457796	0.61641252194767	Body mass index	5e-13	30108127
rs9469869	rs6457796	0.61641252194767	Body mass index	1e-14	26426971
rs9469869	rs6457796	0.61641252194767	Educational attainment	5e-19	35361970
rs9469869	rs205262	0.603317711536489	Body mass index	2e-09	26961502
rs9469869	rs205262	0.603317711536489	Walking pace	4e-10	33128006
rs9469869	rs205262	0.603317711536489	Body mass index	8e-13	30108127
rs9469869	rs205262	0.603317711536489	Body mass index	2e-09	25673413
rs9469869	rs205262	0.603317711536489	Body mass index	2e-14	26426971
rs9469869	rs205262	0.603317711536489	BMI in non-smokers	3e-07	28443625
rs9469869	rs205262	0.603317711536489	BMI in non-smokers	6e-09	28443625
rs9469869	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9469869	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9469869	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9469869	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9469869	rs205262	0.603317711536489	Gastroesophageal reflux disease	1e-10	34187846
rs9469869	rs205262	0.603317711536489	Body mass index	3e-10	25673413
rs9469869	rs205262	0.603317711536489	Body mass index	2e-10	25673413
rs9469869	rs205262	0.603317711536489	ICD10 M54: Dorsalgia	2e-12	35110524
rs9469870	rs9469872	0.999196675269056	HDL cholesterol levels	3e-11	36333282
rs9469870	rs11755393	0.972990721913365	Body mass index	3e-26	29273807
rs9469870	rs11755393	0.972990721913365	Systemic lupus erythematosus	2e-12	33493351
rs9469870	rs11755393	0.972990721913365	Systemic lupus erythematosus	2e-06	33493351
rs9469870	rs11755393	0.972990721913365	Systemic lupus erythematosus	1e-07	33493351
rs9469870	rs11755393	0.972990721913365	Systemic lupus erythematosus	2e-08	19838195
rs9469870	rs11755393	0.972990721913365	Body mass index	4e-55	36581621
rs9469870	rs9366863	0.969694313630575	Adult body size	9e-33	32376654
rs9469870	rs9366863	0.969694313630575	Body mass index	2e-44	30595370
rs9469870	rs6941110	0.961798834397437	Sex hormone-binding globulin levels	5e-27	36653534
rs9469870	rs9469857	0.958200525766728	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469870	rs2764208	0.957457724317795	Systemic lupus erythematosus	7e-06	24871463
rs9469870	rs9462030	0.944015129149418	Red cell distribution width	5e-25	32888493
rs9469870	rs2744944	0.942194315528525	Hypothyroidism	3e-10	34594039
rs9469870	rs2744944	0.942194315528525	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469870	rs2744944	0.942194315528525	Multi-trait sex score	7e-22	37277458
rs9469870	rs2814949	0.932888731413376	Essential hypertension (time to event)	9e-09	32589924
rs9469870	rs9469899	0.927432322242744	Prostate cancer (advanced)	2e-06	29892016
rs9469870	rs9469899	0.927432322242744	Prostate cancer	5e-09	29892016
rs9469870	rs9469899	0.927432322242744	Prostate cancer	8e-11	33398198
rs9469870	rs9469899	0.927432322242744	Hand grip strength	3e-15	29691431
rs9469870	rs9469899	0.927432322242744	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469870	rs9469899	0.927432322242744	Graves' disease	4e-10	34594039
rs9469870	rs9469899	0.927432322242744	Coronary artery disease	1e-11	36474045
rs9469870	rs9469899	0.927432322242744	Predicted visceral adipose tissue	2e-20	31501611
rs9469870	rs9469899	0.927432322242744	Medication use (thyroid preparations)	2e-09	31015401
rs9469870	rs9469899	0.927432322242744	Medication use (thyroid preparations)	3e-10	34594039
rs9469870	rs2263329	0.919715400872636	HDL cholesterol	6e-35	34594039
rs9469870	rs2263329	0.919715400872636	HDL cholesterol levels	8e-43	32203549
rs9469870	rs2263329	0.919715400872636	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469870	rs9296128	0.909154550515661	Hip circumference adjusted for BMI	4e-13	34021172
rs9469870	rs111868030	0.898408221687105	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469870	rs9368830	0.857460465667157	HDL cholesterol	4e-21	30275531
rs9469870	rs9368828	0.845749212896452	Body mass index	1e-34	34594039
rs9469870	rs6912327	0.818716877807594	Fasting insulin	5e-06	33402679
rs9469870	rs6912327	0.818716877807594	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469870	rs112283401	0.796043720487298	Red cell distribution width	4e-27	30595370
rs9469870	rs2744973	0.77229235489474	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469870	rs2744973	0.77229235489474	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469870	rs2744973	0.77229235489474	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469870	rs2744973	0.77229235489474	Multi-trait sex score	6e-20	37277458
rs9469870	rs6940215	0.624919521547378	Insomnia	2e-10	35835914
rs9469870	rs6940215	0.624919521547378	Insomnia	1e-13	35835914
rs9469870	rs6940215	0.624919521547378	Hip circumference adjusted for BMI	8e-10	34021172
rs9469870	rs6940215	0.624919521547378	Multi-trait sex score	2e-23	37277458
rs9469870	rs6940215	0.624919521547378	Multi-trait sex score	4e-23	37277458
rs9469870	rs6457796	0.615907586835135	Insomnia	1e-08	30804565
rs9469870	rs6457796	0.615907586835135	Plateletcrit	9e-11	32888494
rs9469870	rs6457796	0.615907586835135	Systemic lupus erythematosus	3e-22	33272962
rs9469870	rs6457796	0.615907586835135	Body mass index	5e-13	30108127
rs9469870	rs6457796	0.615907586835135	Body mass index	1e-14	26426971
rs9469870	rs6457796	0.615907586835135	Educational attainment	5e-19	35361970
rs9469870	rs205262	0.602828195364315	Body mass index	2e-09	26961502
rs9469870	rs205262	0.602828195364315	Walking pace	4e-10	33128006
rs9469870	rs205262	0.602828195364315	Body mass index	8e-13	30108127
rs9469870	rs205262	0.602828195364315	Body mass index	2e-09	25673413
rs9469870	rs205262	0.602828195364315	Body mass index	2e-14	26426971
rs9469870	rs205262	0.602828195364315	BMI in non-smokers	3e-07	28443625
rs9469870	rs205262	0.602828195364315	BMI in non-smokers	6e-09	28443625
rs9469870	rs205262	0.602828195364315	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9469870	rs205262	0.602828195364315	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9469870	rs205262	0.602828195364315	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9469870	rs205262	0.602828195364315	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9469870	rs205262	0.602828195364315	Gastroesophageal reflux disease	1e-10	34187846
rs9469870	rs205262	0.602828195364315	Body mass index	3e-10	25673413
rs9469870	rs205262	0.602828195364315	Body mass index	2e-10	25673413
rs9469870	rs205262	0.602828195364315	ICD10 M54: Dorsalgia	2e-12	35110524
rs9469871	rs9469872	0.988799608287437	HDL cholesterol levels	3e-11	36333282
rs9469871	rs11755393	0.981666526164339	Body mass index	3e-26	29273807
rs9469871	rs11755393	0.981666526164339	Systemic lupus erythematosus	2e-12	33493351
rs9469871	rs11755393	0.981666526164339	Systemic lupus erythematosus	2e-06	33493351
rs9469871	rs11755393	0.981666526164339	Systemic lupus erythematosus	1e-07	33493351
rs9469871	rs11755393	0.981666526164339	Systemic lupus erythematosus	2e-08	19838195
rs9469871	rs11755393	0.981666526164339	Body mass index	4e-55	36581621
rs9469871	rs9366863	0.980040193341606	Adult body size	9e-33	32376654
rs9469871	rs9366863	0.980040193341606	Body mass index	2e-44	30595370
rs9469871	rs6941110	0.970533480579797	Sex hormone-binding globulin levels	5e-27	36653534
rs9469871	rs9462030	0.95279619325988	Red cell distribution width	5e-25	32888493
rs9469871	rs9469857	0.948154516053276	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469871	rs2764208	0.947423157749549	Systemic lupus erythematosus	7e-06	24871463
rs9469871	rs2814949	0.943006042709044	Essential hypertension (time to event)	9e-09	32589924
rs9469871	rs9469899	0.936037501286623	Prostate cancer (advanced)	2e-06	29892016
rs9469871	rs9469899	0.936037501286623	Prostate cancer	5e-09	29892016
rs9469871	rs9469899	0.936037501286623	Prostate cancer	8e-11	33398198
rs9469871	rs9469899	0.936037501286623	Hand grip strength	3e-15	29691431
rs9469871	rs9469899	0.936037501286623	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469871	rs9469899	0.936037501286623	Graves' disease	4e-10	34594039
rs9469871	rs9469899	0.936037501286623	Coronary artery disease	1e-11	36474045
rs9469871	rs9469899	0.936037501286623	Predicted visceral adipose tissue	2e-20	31501611
rs9469871	rs9469899	0.936037501286623	Medication use (thyroid preparations)	2e-09	31015401
rs9469871	rs9469899	0.936037501286623	Medication use (thyroid preparations)	3e-10	34594039
rs9469871	rs2744944	0.933665854372005	Hypothyroidism	3e-10	34594039
rs9469871	rs2744944	0.933665854372005	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469871	rs2744944	0.933665854372005	Multi-trait sex score	7e-22	37277458
rs9469871	rs2263329	0.914410275070181	HDL cholesterol	6e-35	34594039
rs9469871	rs2263329	0.914410275070181	HDL cholesterol levels	8e-43	32203549
rs9469871	rs2263329	0.914410275070181	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469871	rs9296128	0.899539497996124	Hip circumference adjusted for BMI	4e-13	34021172
rs9469871	rs111868030	0.890375865799843	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469871	rs9368830	0.866891471704309	HDL cholesterol	4e-21	30275531
rs9469871	rs9368828	0.837778725650444	Body mass index	1e-34	34594039
rs9469871	rs6912327	0.827460063383462	Fasting insulin	5e-06	33402679
rs9469871	rs6912327	0.827460063383462	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469871	rs112283401	0.804668122874813	Red cell distribution width	4e-27	30595370
rs9469871	rs2744973	0.783841158822137	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469871	rs2744973	0.783841158822137	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469871	rs2744973	0.783841158822137	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469871	rs2744973	0.783841158822137	Multi-trait sex score	6e-20	37277458
rs9469871	rs6940215	0.633106674481268	Insomnia	2e-10	35835914
rs9469871	rs6940215	0.633106674481268	Insomnia	1e-13	35835914
rs9469871	rs6940215	0.633106674481268	Hip circumference adjusted for BMI	8e-10	34021172
rs9469871	rs6940215	0.633106674481268	Multi-trait sex score	2e-23	37277458
rs9469871	rs6940215	0.633106674481268	Multi-trait sex score	4e-23	37277458
rs9469871	rs6457796	0.625860010967038	Insomnia	1e-08	30804565
rs9469871	rs6457796	0.625860010967038	Plateletcrit	9e-11	32888494
rs9469871	rs6457796	0.625860010967038	Systemic lupus erythematosus	3e-22	33272962
rs9469871	rs6457796	0.625860010967038	Body mass index	5e-13	30108127
rs9469871	rs6457796	0.625860010967038	Body mass index	1e-14	26426971
rs9469871	rs6457796	0.625860010967038	Educational attainment	5e-19	35361970
rs9469871	rs9689160	0.605382129452609	Lung function (forced vital capacity)	3e-14	36914875
rs9469872	rs9469872	1	HDL cholesterol levels	3e-11	36333282
rs9469872	rs11755393	0.973790640397902	Body mass index	3e-26	29273807
rs9469872	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-12	33493351
rs9469872	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-06	33493351
rs9469872	rs11755393	0.973790640397902	Systemic lupus erythematosus	1e-07	33493351
rs9469872	rs11755393	0.973790640397902	Systemic lupus erythematosus	2e-08	19838195
rs9469872	rs11755393	0.973790640397902	Body mass index	4e-55	36581621
rs9469872	rs9366863	0.970483919695282	Adult body size	9e-33	32376654
rs9469872	rs9366863	0.970483919695282	Body mass index	2e-44	30595370
rs9469872	rs6941110	0.96258381097747	Sex hormone-binding globulin levels	5e-27	36653534
rs9469872	rs9469857	0.958971476515971	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469872	rs2764208	0.958227492160117	Systemic lupus erythematosus	7e-06	24871463
rs9469872	rs9462030	0.944781064859332	Red cell distribution width	5e-25	32888493
rs9469872	rs2744944	0.942972684970972	Hypothyroidism	3e-10	34594039
rs9469872	rs2744944	0.942972684970972	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469872	rs2744944	0.942972684970972	Multi-trait sex score	7e-22	37277458
rs9469872	rs2814949	0.933665854372005	Essential hypertension (time to event)	9e-09	32589924
rs9469872	rs9469899	0.92820039426473	Prostate cancer (advanced)	2e-06	29892016
rs9469872	rs9469899	0.92820039426473	Prostate cancer	5e-09	29892016
rs9469872	rs9469899	0.92820039426473	Prostate cancer	8e-11	33398198
rs9469872	rs9469899	0.92820039426473	Hand grip strength	3e-15	29691431
rs9469872	rs9469899	0.92820039426473	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469872	rs9469899	0.92820039426473	Graves' disease	4e-10	34594039
rs9469872	rs9469899	0.92820039426473	Coronary artery disease	1e-11	36474045
rs9469872	rs9469899	0.92820039426473	Predicted visceral adipose tissue	2e-20	31501611
rs9469872	rs9469899	0.92820039426473	Medication use (thyroid preparations)	2e-09	31015401
rs9469872	rs9469899	0.92820039426473	Medication use (thyroid preparations)	3e-10	34594039
rs9469872	rs2263329	0.920478897573699	HDL cholesterol	6e-35	34594039
rs9469872	rs2263329	0.920478897573699	HDL cholesterol levels	8e-43	32203549
rs9469872	rs2263329	0.920478897573699	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469872	rs9296128	0.909885484027307	Hip circumference adjusted for BMI	4e-13	34021172
rs9469872	rs111868030	0.899134497274885	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469872	rs9368830	0.858231507139136	HDL cholesterol	4e-21	30275531
rs9469872	rs9368828	0.846474268217447	Body mass index	1e-34	34594039
rs9469872	rs6912327	0.819382202499493	Fasting insulin	5e-06	33402679
rs9469872	rs6912327	0.819382202499493	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469872	rs112283401	0.796699333730006	Red cell distribution width	4e-27	30595370
rs9469872	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469872	rs2744973	0.772924967221123	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469872	rs2744973	0.772924967221123	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469872	rs2744973	0.772924967221123	Multi-trait sex score	6e-20	37277458
rs9469872	rs6940215	0.625459662116117	Insomnia	2e-10	35835914
rs9469872	rs6940215	0.625459662116117	Insomnia	1e-13	35835914
rs9469872	rs6940215	0.625459662116117	Hip circumference adjusted for BMI	8e-10	34021172
rs9469872	rs6940215	0.625459662116117	Multi-trait sex score	2e-23	37277458
rs9469872	rs6940215	0.625459662116117	Multi-trait sex score	4e-23	37277458
rs9469872	rs6457796	0.61641252194767	Insomnia	1e-08	30804565
rs9469872	rs6457796	0.61641252194767	Plateletcrit	9e-11	32888494
rs9469872	rs6457796	0.61641252194767	Systemic lupus erythematosus	3e-22	33272962
rs9469872	rs6457796	0.61641252194767	Body mass index	5e-13	30108127
rs9469872	rs6457796	0.61641252194767	Body mass index	1e-14	26426971
rs9469872	rs6457796	0.61641252194767	Educational attainment	5e-19	35361970
rs9469872	rs205262	0.603317711536489	Body mass index	2e-09	26961502
rs9469872	rs205262	0.603317711536489	Walking pace	4e-10	33128006
rs9469872	rs205262	0.603317711536489	Body mass index	8e-13	30108127
rs9469872	rs205262	0.603317711536489	Body mass index	2e-09	25673413
rs9469872	rs205262	0.603317711536489	Body mass index	2e-14	26426971
rs9469872	rs205262	0.603317711536489	BMI in non-smokers	3e-07	28443625
rs9469872	rs205262	0.603317711536489	BMI in non-smokers	6e-09	28443625
rs9469872	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-07	28443625
rs9469872	rs205262	0.603317711536489	BMI (adjusted for smoking behaviour)	3e-09	28443625
rs9469872	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	3e-09	28443625
rs9469872	rs205262	0.603317711536489	Body mass index (joint analysis main effects and smoking interaction)	2e-07	28443625
rs9469872	rs205262	0.603317711536489	Gastroesophageal reflux disease	1e-10	34187846
rs9469872	rs205262	0.603317711536489	Body mass index	3e-10	25673413
rs9469872	rs205262	0.603317711536489	Body mass index	2e-10	25673413
rs9469872	rs205262	0.603317711536489	ICD10 M54: Dorsalgia	2e-12	35110524
rs9469878	rs9462030	0.986396469495239	Red cell distribution width	5e-25	32888493
rs9469878	rs9469857	0.98162271169839	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469878	rs2764208	0.980843972382054	Systemic lupus erythematosus	7e-06	24871463
rs9469878	rs9469899	0.969693418785939	Prostate cancer (advanced)	2e-06	29892016
rs9469878	rs9469899	0.969693418785939	Prostate cancer	5e-09	29892016
rs9469878	rs9469899	0.969693418785939	Prostate cancer	8e-11	33398198
rs9469878	rs9469899	0.969693418785939	Hand grip strength	3e-15	29691431
rs9469878	rs9469899	0.969693418785939	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469878	rs9469899	0.969693418785939	Graves' disease	4e-10	34594039
rs9469878	rs9469899	0.969693418785939	Coronary artery disease	1e-11	36474045
rs9469878	rs9469899	0.969693418785939	Predicted visceral adipose tissue	2e-20	31501611
rs9469878	rs9469899	0.969693418785939	Medication use (thyroid preparations)	2e-09	31015401
rs9469878	rs9469899	0.969693418785939	Medication use (thyroid preparations)	3e-10	34594039
rs9469878	rs9469872	0.945396274049287	HDL cholesterol levels	3e-11	36333282
rs9469878	rs11755393	0.938775218503911	Body mass index	3e-26	29273807
rs9469878	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-12	33493351
rs9469878	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-06	33493351
rs9469878	rs11755393	0.938775218503911	Systemic lupus erythematosus	1e-07	33493351
rs9469878	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-08	19838195
rs9469878	rs11755393	0.938775218503911	Body mass index	4e-55	36581621
rs9469878	rs9366863	0.93678044757816	Adult body size	9e-33	32376654
rs9469878	rs9366863	0.93678044757816	Body mass index	2e-44	30595370
rs9469878	rs9296128	0.9313609762482	Hip circumference adjusted for BMI	4e-13	34021172
rs9469878	rs6941110	0.927420917520423	Sex hormone-binding globulin levels	5e-27	36653534
rs9469878	rs2814949	0.900707833255122	Essential hypertension (time to event)	9e-09	32589924
rs9469878	rs2744944	0.891437282518614	Hypothyroidism	3e-10	34594039
rs9469878	rs2744944	0.891437282518614	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469878	rs2744944	0.891437282518614	Multi-trait sex score	7e-22	37277458
rs9469878	rs2263329	0.872378331837265	HDL cholesterol	6e-35	34594039
rs9469878	rs2263329	0.872378331837265	HDL cholesterol levels	8e-43	32203549
rs9469878	rs2263329	0.872378331837265	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469878	rs111868030	0.84902696100117	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469878	rs9368830	0.82749018605395	HDL cholesterol	4e-21	30275531
rs9469878	rs9368828	0.803011650952733	Body mass index	1e-34	34594039
rs9469878	rs2744973	0.798786568493001	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469878	rs2744973	0.798786568493001	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469878	rs2744973	0.798786568493001	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469878	rs2744973	0.798786568493001	Multi-trait sex score	6e-20	37277458
rs9469878	rs6912327	0.784734837044887	Fasting insulin	5e-06	33402679
rs9469878	rs6912327	0.784734837044887	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469878	rs112283401	0.762529685976814	Red cell distribution width	4e-27	30595370
rs9469878	rs9689160	0.626023600576727	Lung function (forced vital capacity)	3e-14	36914875
rs9469879	rs9462030	0.986396469495239	Red cell distribution width	5e-25	32888493
rs9469879	rs9469857	0.98162271169839	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469879	rs2764208	0.980843972382054	Systemic lupus erythematosus	7e-06	24871463
rs9469879	rs9469899	0.969693418785939	Prostate cancer (advanced)	2e-06	29892016
rs9469879	rs9469899	0.969693418785939	Prostate cancer	5e-09	29892016
rs9469879	rs9469899	0.969693418785939	Prostate cancer	8e-11	33398198
rs9469879	rs9469899	0.969693418785939	Hand grip strength	3e-15	29691431
rs9469879	rs9469899	0.969693418785939	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469879	rs9469899	0.969693418785939	Graves' disease	4e-10	34594039
rs9469879	rs9469899	0.969693418785939	Coronary artery disease	1e-11	36474045
rs9469879	rs9469899	0.969693418785939	Predicted visceral adipose tissue	2e-20	31501611
rs9469879	rs9469899	0.969693418785939	Medication use (thyroid preparations)	2e-09	31015401
rs9469879	rs9469899	0.969693418785939	Medication use (thyroid preparations)	3e-10	34594039
rs9469879	rs9469872	0.945396274049287	HDL cholesterol levels	3e-11	36333282
rs9469879	rs11755393	0.938775218503911	Body mass index	3e-26	29273807
rs9469879	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-12	33493351
rs9469879	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-06	33493351
rs9469879	rs11755393	0.938775218503911	Systemic lupus erythematosus	1e-07	33493351
rs9469879	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-08	19838195
rs9469879	rs11755393	0.938775218503911	Body mass index	4e-55	36581621
rs9469879	rs9366863	0.93678044757816	Adult body size	9e-33	32376654
rs9469879	rs9366863	0.93678044757816	Body mass index	2e-44	30595370
rs9469879	rs9296128	0.9313609762482	Hip circumference adjusted for BMI	4e-13	34021172
rs9469879	rs6941110	0.927420917520423	Sex hormone-binding globulin levels	5e-27	36653534
rs9469879	rs2814949	0.900707833255122	Essential hypertension (time to event)	9e-09	32589924
rs9469879	rs2744944	0.891437282518614	Hypothyroidism	3e-10	34594039
rs9469879	rs2744944	0.891437282518614	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469879	rs2744944	0.891437282518614	Multi-trait sex score	7e-22	37277458
rs9469879	rs2263329	0.872378331837265	HDL cholesterol	6e-35	34594039
rs9469879	rs2263329	0.872378331837265	HDL cholesterol levels	8e-43	32203549
rs9469879	rs2263329	0.872378331837265	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469879	rs111868030	0.84902696100117	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469879	rs9368830	0.82749018605395	HDL cholesterol	4e-21	30275531
rs9469879	rs9368828	0.803011650952733	Body mass index	1e-34	34594039
rs9469879	rs2744973	0.798786568493001	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469879	rs2744973	0.798786568493001	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469879	rs2744973	0.798786568493001	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469879	rs2744973	0.798786568493001	Multi-trait sex score	6e-20	37277458
rs9469879	rs6912327	0.784734837044887	Fasting insulin	5e-06	33402679
rs9469879	rs6912327	0.784734837044887	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469879	rs112283401	0.762529685976814	Red cell distribution width	4e-27	30595370
rs9469879	rs9689160	0.626023600576727	Lung function (forced vital capacity)	3e-14	36914875
rs9469880	rs9462030	0.986396469495239	Red cell distribution width	5e-25	32888493
rs9469880	rs9469857	0.98162271169839	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469880	rs2764208	0.980843972382054	Systemic lupus erythematosus	7e-06	24871463
rs9469880	rs9469899	0.969693418785939	Prostate cancer (advanced)	2e-06	29892016
rs9469880	rs9469899	0.969693418785939	Prostate cancer	5e-09	29892016
rs9469880	rs9469899	0.969693418785939	Prostate cancer	8e-11	33398198
rs9469880	rs9469899	0.969693418785939	Hand grip strength	3e-15	29691431
rs9469880	rs9469899	0.969693418785939	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469880	rs9469899	0.969693418785939	Graves' disease	4e-10	34594039
rs9469880	rs9469899	0.969693418785939	Coronary artery disease	1e-11	36474045
rs9469880	rs9469899	0.969693418785939	Predicted visceral adipose tissue	2e-20	31501611
rs9469880	rs9469899	0.969693418785939	Medication use (thyroid preparations)	2e-09	31015401
rs9469880	rs9469899	0.969693418785939	Medication use (thyroid preparations)	3e-10	34594039
rs9469880	rs9469872	0.945396274049287	HDL cholesterol levels	3e-11	36333282
rs9469880	rs11755393	0.938775218503911	Body mass index	3e-26	29273807
rs9469880	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-12	33493351
rs9469880	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-06	33493351
rs9469880	rs11755393	0.938775218503911	Systemic lupus erythematosus	1e-07	33493351
rs9469880	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-08	19838195
rs9469880	rs11755393	0.938775218503911	Body mass index	4e-55	36581621
rs9469880	rs9366863	0.93678044757816	Adult body size	9e-33	32376654
rs9469880	rs9366863	0.93678044757816	Body mass index	2e-44	30595370
rs9469880	rs9296128	0.9313609762482	Hip circumference adjusted for BMI	4e-13	34021172
rs9469880	rs6941110	0.927420917520423	Sex hormone-binding globulin levels	5e-27	36653534
rs9469880	rs2814949	0.900707833255122	Essential hypertension (time to event)	9e-09	32589924
rs9469880	rs2744944	0.891437282518614	Hypothyroidism	3e-10	34594039
rs9469880	rs2744944	0.891437282518614	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469880	rs2744944	0.891437282518614	Multi-trait sex score	7e-22	37277458
rs9469880	rs2263329	0.872378331837265	HDL cholesterol	6e-35	34594039
rs9469880	rs2263329	0.872378331837265	HDL cholesterol levels	8e-43	32203549
rs9469880	rs2263329	0.872378331837265	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469880	rs111868030	0.84902696100117	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469880	rs9368830	0.82749018605395	HDL cholesterol	4e-21	30275531
rs9469880	rs9368828	0.803011650952733	Body mass index	1e-34	34594039
rs9469880	rs2744973	0.798786568493001	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469880	rs2744973	0.798786568493001	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469880	rs2744973	0.798786568493001	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469880	rs2744973	0.798786568493001	Multi-trait sex score	6e-20	37277458
rs9469880	rs6912327	0.784734837044887	Fasting insulin	5e-06	33402679
rs9469880	rs6912327	0.784734837044887	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469880	rs112283401	0.762529685976814	Red cell distribution width	4e-27	30595370
rs9469880	rs9689160	0.626023600576727	Lung function (forced vital capacity)	3e-14	36914875
rs9469882	rs9462030	0.986396469495239	Red cell distribution width	5e-25	32888493
rs9469882	rs9469857	0.98162271169839	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469882	rs2764208	0.980843972382054	Systemic lupus erythematosus	7e-06	24871463
rs9469882	rs9469899	0.969693418785939	Prostate cancer (advanced)	2e-06	29892016
rs9469882	rs9469899	0.969693418785939	Prostate cancer	5e-09	29892016
rs9469882	rs9469899	0.969693418785939	Prostate cancer	8e-11	33398198
rs9469882	rs9469899	0.969693418785939	Hand grip strength	3e-15	29691431
rs9469882	rs9469899	0.969693418785939	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469882	rs9469899	0.969693418785939	Graves' disease	4e-10	34594039
rs9469882	rs9469899	0.969693418785939	Coronary artery disease	1e-11	36474045
rs9469882	rs9469899	0.969693418785939	Predicted visceral adipose tissue	2e-20	31501611
rs9469882	rs9469899	0.969693418785939	Medication use (thyroid preparations)	2e-09	31015401
rs9469882	rs9469899	0.969693418785939	Medication use (thyroid preparations)	3e-10	34594039
rs9469882	rs9469872	0.945396274049287	HDL cholesterol levels	3e-11	36333282
rs9469882	rs11755393	0.938775218503911	Body mass index	3e-26	29273807
rs9469882	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-12	33493351
rs9469882	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-06	33493351
rs9469882	rs11755393	0.938775218503911	Systemic lupus erythematosus	1e-07	33493351
rs9469882	rs11755393	0.938775218503911	Systemic lupus erythematosus	2e-08	19838195
rs9469882	rs11755393	0.938775218503911	Body mass index	4e-55	36581621
rs9469882	rs9366863	0.93678044757816	Adult body size	9e-33	32376654
rs9469882	rs9366863	0.93678044757816	Body mass index	2e-44	30595370
rs9469882	rs9296128	0.9313609762482	Hip circumference adjusted for BMI	4e-13	34021172
rs9469882	rs6941110	0.927420917520423	Sex hormone-binding globulin levels	5e-27	36653534
rs9469882	rs2814949	0.900707833255122	Essential hypertension (time to event)	9e-09	32589924
rs9469882	rs2744944	0.891437282518614	Hypothyroidism	3e-10	34594039
rs9469882	rs2744944	0.891437282518614	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469882	rs2744944	0.891437282518614	Multi-trait sex score	7e-22	37277458
rs9469882	rs2263329	0.872378331837265	HDL cholesterol	6e-35	34594039
rs9469882	rs2263329	0.872378331837265	HDL cholesterol levels	8e-43	32203549
rs9469882	rs2263329	0.872378331837265	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469882	rs111868030	0.84902696100117	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469882	rs9368830	0.82749018605395	HDL cholesterol	4e-21	30275531
rs9469882	rs9368828	0.803011650952733	Body mass index	1e-34	34594039
rs9469882	rs2744973	0.798786568493001	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469882	rs2744973	0.798786568493001	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469882	rs2744973	0.798786568493001	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469882	rs2744973	0.798786568493001	Multi-trait sex score	6e-20	37277458
rs9469882	rs6912327	0.784734837044887	Fasting insulin	5e-06	33402679
rs9469882	rs6912327	0.784734837044887	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469882	rs112283401	0.762529685976814	Red cell distribution width	4e-27	30595370
rs9469882	rs9689160	0.626023600576727	Lung function (forced vital capacity)	3e-14	36914875
rs9469883	rs9462030	0.991161605706325	Red cell distribution width	5e-25	32888493
rs9469883	rs9469857	0.986362420621675	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469883	rs2764208	0.985572399705324	Systemic lupus erythematosus	7e-06	24871463
rs9469883	rs9469899	0.974512167021756	Prostate cancer (advanced)	2e-06	29892016
rs9469883	rs9469899	0.974512167021756	Prostate cancer	5e-09	29892016
rs9469883	rs9469899	0.974512167021756	Prostate cancer	8e-11	33398198
rs9469883	rs9469899	0.974512167021756	Hand grip strength	3e-15	29691431
rs9469883	rs9469899	0.974512167021756	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469883	rs9469899	0.974512167021756	Graves' disease	4e-10	34594039
rs9469883	rs9469899	0.974512167021756	Coronary artery disease	1e-11	36474045
rs9469883	rs9469899	0.974512167021756	Predicted visceral adipose tissue	2e-20	31501611
rs9469883	rs9469899	0.974512167021756	Medication use (thyroid preparations)	2e-09	31015401
rs9469883	rs9469899	0.974512167021756	Medication use (thyroid preparations)	3e-10	34594039
rs9469883	rs9469872	0.950184689459921	HDL cholesterol levels	3e-11	36333282
rs9469883	rs11755393	0.943625596386269	Body mass index	3e-26	29273807
rs9469883	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-12	33493351
rs9469883	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-06	33493351
rs9469883	rs11755393	0.943625596386269	Systemic lupus erythematosus	1e-07	33493351
rs9469883	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-08	19838195
rs9469883	rs11755393	0.943625596386269	Body mass index	4e-55	36581621
rs9469883	rs9366863	0.939973736176852	Adult body size	9e-33	32376654
rs9469883	rs9366863	0.939973736176852	Body mass index	2e-44	30595370
rs9469883	rs9296128	0.935762261955665	Hip circumference adjusted for BMI	4e-13	34021172
rs9469883	rs6941110	0.932136337001036	Sex hormone-binding globulin levels	5e-27	36653534
rs9469883	rs2814949	0.903864952971577	Essential hypertension (time to event)	9e-09	32589924
rs9469883	rs2744944	0.894545120858599	Hypothyroidism	3e-10	34594039
rs9469883	rs2744944	0.894545120858599	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469883	rs2744944	0.894545120858599	Multi-trait sex score	7e-22	37277458
rs9469883	rs2263329	0.876903422710498	HDL cholesterol	6e-35	34594039
rs9469883	rs2263329	0.876903422710498	HDL cholesterol levels	8e-43	32203549
rs9469883	rs2263329	0.876903422710498	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469883	rs111868030	0.851707403161834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469883	rs9368830	0.832241949897419	HDL cholesterol	4e-21	30275531
rs9469883	rs9368828	0.805831960921872	Body mass index	1e-34	34594039
rs9469883	rs2744973	0.802411285956922	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469883	rs2744973	0.802411285956922	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469883	rs2744973	0.802411285956922	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469883	rs2744973	0.802411285956922	Multi-trait sex score	6e-20	37277458
rs9469883	rs6912327	0.791347099634255	Fasting insulin	5e-06	33402679
rs9469883	rs6912327	0.791347099634255	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469883	rs112283401	0.766192579753087	Red cell distribution width	4e-27	30595370
rs9469883	rs9689160	0.629745752214482	Lung function (forced vital capacity)	3e-14	36914875
rs9469884	rs9462030	0.99035688450784	Red cell distribution width	5e-25	32888493
rs9469884	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469884	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs9469884	rs9469899	0.97372510997998	Prostate cancer (advanced)	2e-06	29892016
rs9469884	rs9469899	0.97372510997998	Prostate cancer	5e-09	29892016
rs9469884	rs9469899	0.97372510997998	Prostate cancer	8e-11	33398198
rs9469884	rs9469899	0.97372510997998	Hand grip strength	3e-15	29691431
rs9469884	rs9469899	0.97372510997998	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469884	rs9469899	0.97372510997998	Graves' disease	4e-10	34594039
rs9469884	rs9469899	0.97372510997998	Coronary artery disease	1e-11	36474045
rs9469884	rs9469899	0.97372510997998	Predicted visceral adipose tissue	2e-20	31501611
rs9469884	rs9469899	0.97372510997998	Medication use (thyroid preparations)	2e-09	31015401
rs9469884	rs9469899	0.97372510997998	Medication use (thyroid preparations)	3e-10	34594039
rs9469884	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs9469884	rs11755393	0.942863454109952	Body mass index	3e-26	29273807
rs9469884	rs11755393	0.942863454109952	Systemic lupus erythematosus	2e-12	33493351
rs9469884	rs11755393	0.942863454109952	Systemic lupus erythematosus	2e-06	33493351
rs9469884	rs11755393	0.942863454109952	Systemic lupus erythematosus	1e-07	33493351
rs9469884	rs11755393	0.942863454109952	Systemic lupus erythematosus	2e-08	19838195
rs9469884	rs11755393	0.942863454109952	Body mass index	4e-55	36581621
rs9469884	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs9469884	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs9469884	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs9469884	rs6941110	0.931367062468927	Sex hormone-binding globulin levels	5e-27	36653534
rs9469884	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs9469884	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs9469884	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469884	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs9469884	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs9469884	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs9469884	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469884	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469884	rs9368830	0.831547762090701	HDL cholesterol	4e-21	30275531
rs9469884	rs9368828	0.805103390346437	Body mass index	1e-34	34594039
rs9469884	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469884	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469884	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469884	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs9469884	rs6912327	0.790564668507463	Fasting insulin	5e-06	33402679
rs9469884	rs6912327	0.790564668507463	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469884	rs112283401	0.765422105750119	Red cell distribution width	4e-27	30595370
rs9469884	rs9689160	0.628913951683802	Lung function (forced vital capacity)	3e-14	36914875
rs9469885	rs9469872	0.988799608287437	HDL cholesterol levels	3e-11	36333282
rs9469885	rs11755393	0.981666526164339	Body mass index	3e-26	29273807
rs9469885	rs11755393	0.981666526164339	Systemic lupus erythematosus	2e-12	33493351
rs9469885	rs11755393	0.981666526164339	Systemic lupus erythematosus	2e-06	33493351
rs9469885	rs11755393	0.981666526164339	Systemic lupus erythematosus	1e-07	33493351
rs9469885	rs11755393	0.981666526164339	Systemic lupus erythematosus	2e-08	19838195
rs9469885	rs11755393	0.981666526164339	Body mass index	4e-55	36581621
rs9469885	rs9366863	0.978449942527939	Adult body size	9e-33	32376654
rs9469885	rs9366863	0.978449942527939	Body mass index	2e-44	30595370
rs9469885	rs6941110	0.970533480579797	Sex hormone-binding globulin levels	5e-27	36653534
rs9469885	rs9462030	0.95279619325988	Red cell distribution width	5e-25	32888493
rs9469885	rs9469857	0.948154516053276	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469885	rs2764208	0.947423157749549	Systemic lupus erythematosus	7e-06	24871463
rs9469885	rs2814949	0.941446746746758	Essential hypertension (time to event)	9e-09	32589924
rs9469885	rs9469899	0.936037501286623	Prostate cancer (advanced)	2e-06	29892016
rs9469885	rs9469899	0.936037501286623	Prostate cancer	5e-09	29892016
rs9469885	rs9469899	0.936037501286623	Prostate cancer	8e-11	33398198
rs9469885	rs9469899	0.936037501286623	Hand grip strength	3e-15	29691431
rs9469885	rs9469899	0.936037501286623	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469885	rs9469899	0.936037501286623	Graves' disease	4e-10	34594039
rs9469885	rs9469899	0.936037501286623	Coronary artery disease	1e-11	36474045
rs9469885	rs9469899	0.936037501286623	Predicted visceral adipose tissue	2e-20	31501611
rs9469885	rs9469899	0.936037501286623	Medication use (thyroid preparations)	2e-09	31015401
rs9469885	rs9469899	0.936037501286623	Medication use (thyroid preparations)	3e-10	34594039
rs9469885	rs2744944	0.932113842451441	Hypothyroidism	3e-10	34594039
rs9469885	rs2744944	0.932113842451441	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469885	rs2744944	0.932113842451441	Multi-trait sex score	7e-22	37277458
rs9469885	rs2263329	0.914410275070181	HDL cholesterol	6e-35	34594039
rs9469885	rs2263329	0.914410275070181	HDL cholesterol levels	8e-43	32203549
rs9469885	rs2263329	0.914410275070181	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469885	rs9296128	0.899539497996124	Hip circumference adjusted for BMI	4e-13	34021172
rs9469885	rs111868030	0.888853154883916	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469885	rs9368830	0.866891471704309	HDL cholesterol	4e-21	30275531
rs9469885	rs9368828	0.837778725650444	Body mass index	1e-34	34594039
rs9469885	rs6912327	0.830416950508655	Fasting insulin	5e-06	33402679
rs9469885	rs6912327	0.830416950508655	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469885	rs112283401	0.804668122874813	Red cell distribution width	4e-27	30595370
rs9469885	rs2744973	0.782399038925958	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469885	rs2744973	0.782399038925958	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469885	rs2744973	0.782399038925958	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469885	rs2744973	0.782399038925958	Multi-trait sex score	6e-20	37277458
rs9469885	rs6940215	0.634416867147106	Insomnia	2e-10	35835914
rs9469885	rs6940215	0.634416867147106	Insomnia	1e-13	35835914
rs9469885	rs6940215	0.634416867147106	Hip circumference adjusted for BMI	8e-10	34021172
rs9469885	rs6940215	0.634416867147106	Multi-trait sex score	2e-23	37277458
rs9469885	rs6940215	0.634416867147106	Multi-trait sex score	4e-23	37277458
rs9469885	rs6457796	0.625860010967038	Insomnia	1e-08	30804565
rs9469885	rs6457796	0.625860010967038	Plateletcrit	9e-11	32888494
rs9469885	rs6457796	0.625860010967038	Systemic lupus erythematosus	3e-22	33272962
rs9469885	rs6457796	0.625860010967038	Body mass index	5e-13	30108127
rs9469885	rs6457796	0.625860010967038	Body mass index	1e-14	26426971
rs9469885	rs6457796	0.625860010967038	Educational attainment	5e-19	35361970
rs9469885	rs9689160	0.605382129452609	Lung function (forced vital capacity)	3e-14	36914875
rs9469886	rs9462030	0.991161605706325	Red cell distribution width	5e-25	32888493
rs9469886	rs9469857	0.986362420621675	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469886	rs2764208	0.985572399705324	Systemic lupus erythematosus	7e-06	24871463
rs9469886	rs9469899	0.974512167021756	Prostate cancer (advanced)	2e-06	29892016
rs9469886	rs9469899	0.974512167021756	Prostate cancer	5e-09	29892016
rs9469886	rs9469899	0.974512167021756	Prostate cancer	8e-11	33398198
rs9469886	rs9469899	0.974512167021756	Hand grip strength	3e-15	29691431
rs9469886	rs9469899	0.974512167021756	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469886	rs9469899	0.974512167021756	Graves' disease	4e-10	34594039
rs9469886	rs9469899	0.974512167021756	Coronary artery disease	1e-11	36474045
rs9469886	rs9469899	0.974512167021756	Predicted visceral adipose tissue	2e-20	31501611
rs9469886	rs9469899	0.974512167021756	Medication use (thyroid preparations)	2e-09	31015401
rs9469886	rs9469899	0.974512167021756	Medication use (thyroid preparations)	3e-10	34594039
rs9469886	rs9469872	0.950184689459921	HDL cholesterol levels	3e-11	36333282
rs9469886	rs11755393	0.943625596386269	Body mass index	3e-26	29273807
rs9469886	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-12	33493351
rs9469886	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-06	33493351
rs9469886	rs11755393	0.943625596386269	Systemic lupus erythematosus	1e-07	33493351
rs9469886	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-08	19838195
rs9469886	rs11755393	0.943625596386269	Body mass index	4e-55	36581621
rs9469886	rs9366863	0.939973736176852	Adult body size	9e-33	32376654
rs9469886	rs9366863	0.939973736176852	Body mass index	2e-44	30595370
rs9469886	rs9296128	0.935762261955665	Hip circumference adjusted for BMI	4e-13	34021172
rs9469886	rs6941110	0.932136337001036	Sex hormone-binding globulin levels	5e-27	36653534
rs9469886	rs2814949	0.903864952971577	Essential hypertension (time to event)	9e-09	32589924
rs9469886	rs2744944	0.894545120858599	Hypothyroidism	3e-10	34594039
rs9469886	rs2744944	0.894545120858599	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469886	rs2744944	0.894545120858599	Multi-trait sex score	7e-22	37277458
rs9469886	rs2263329	0.876903422710498	HDL cholesterol	6e-35	34594039
rs9469886	rs2263329	0.876903422710498	HDL cholesterol levels	8e-43	32203549
rs9469886	rs2263329	0.876903422710498	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469886	rs111868030	0.851707403161834	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469886	rs9368830	0.832241949897419	HDL cholesterol	4e-21	30275531
rs9469886	rs9368828	0.805831960921872	Body mass index	1e-34	34594039
rs9469886	rs2744973	0.802411285956922	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469886	rs2744973	0.802411285956922	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469886	rs2744973	0.802411285956922	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469886	rs2744973	0.802411285956922	Multi-trait sex score	6e-20	37277458
rs9469886	rs6912327	0.791347099634255	Fasting insulin	5e-06	33402679
rs9469886	rs6912327	0.791347099634255	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469886	rs112283401	0.766192579753087	Red cell distribution width	4e-27	30595370
rs9469886	rs9689160	0.629745752214482	Lung function (forced vital capacity)	3e-14	36914875
rs9469887	rs9469872	0.988799608287437	HDL cholesterol levels	3e-11	36333282
rs9469887	rs11755393	0.981666526164339	Body mass index	3e-26	29273807
rs9469887	rs11755393	0.981666526164339	Systemic lupus erythematosus	2e-12	33493351
rs9469887	rs11755393	0.981666526164339	Systemic lupus erythematosus	2e-06	33493351
rs9469887	rs11755393	0.981666526164339	Systemic lupus erythematosus	1e-07	33493351
rs9469887	rs11755393	0.981666526164339	Systemic lupus erythematosus	2e-08	19838195
rs9469887	rs11755393	0.981666526164339	Body mass index	4e-55	36581621
rs9469887	rs9366863	0.978449942527939	Adult body size	9e-33	32376654
rs9469887	rs9366863	0.978449942527939	Body mass index	2e-44	30595370
rs9469887	rs6941110	0.970533480579797	Sex hormone-binding globulin levels	5e-27	36653534
rs9469887	rs9462030	0.95279619325988	Red cell distribution width	5e-25	32888493
rs9469887	rs9469857	0.948154516053276	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469887	rs2764208	0.947423157749549	Systemic lupus erythematosus	7e-06	24871463
rs9469887	rs2814949	0.941446746746758	Essential hypertension (time to event)	9e-09	32589924
rs9469887	rs9469899	0.936037501286623	Prostate cancer (advanced)	2e-06	29892016
rs9469887	rs9469899	0.936037501286623	Prostate cancer	5e-09	29892016
rs9469887	rs9469899	0.936037501286623	Prostate cancer	8e-11	33398198
rs9469887	rs9469899	0.936037501286623	Hand grip strength	3e-15	29691431
rs9469887	rs9469899	0.936037501286623	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469887	rs9469899	0.936037501286623	Graves' disease	4e-10	34594039
rs9469887	rs9469899	0.936037501286623	Coronary artery disease	1e-11	36474045
rs9469887	rs9469899	0.936037501286623	Predicted visceral adipose tissue	2e-20	31501611
rs9469887	rs9469899	0.936037501286623	Medication use (thyroid preparations)	2e-09	31015401
rs9469887	rs9469899	0.936037501286623	Medication use (thyroid preparations)	3e-10	34594039
rs9469887	rs2744944	0.932113842451441	Hypothyroidism	3e-10	34594039
rs9469887	rs2744944	0.932113842451441	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469887	rs2744944	0.932113842451441	Multi-trait sex score	7e-22	37277458
rs9469887	rs2263329	0.914410275070181	HDL cholesterol	6e-35	34594039
rs9469887	rs2263329	0.914410275070181	HDL cholesterol levels	8e-43	32203549
rs9469887	rs2263329	0.914410275070181	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469887	rs9296128	0.899539497996124	Hip circumference adjusted for BMI	4e-13	34021172
rs9469887	rs111868030	0.888853154883916	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469887	rs9368830	0.866891471704309	HDL cholesterol	4e-21	30275531
rs9469887	rs9368828	0.837778725650444	Body mass index	1e-34	34594039
rs9469887	rs6912327	0.830416950508655	Fasting insulin	5e-06	33402679
rs9469887	rs6912327	0.830416950508655	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469887	rs112283401	0.804668122874813	Red cell distribution width	4e-27	30595370
rs9469887	rs2744973	0.782399038925958	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469887	rs2744973	0.782399038925958	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469887	rs2744973	0.782399038925958	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469887	rs2744973	0.782399038925958	Multi-trait sex score	6e-20	37277458
rs9469887	rs6940215	0.634416867147106	Insomnia	2e-10	35835914
rs9469887	rs6940215	0.634416867147106	Insomnia	1e-13	35835914
rs9469887	rs6940215	0.634416867147106	Hip circumference adjusted for BMI	8e-10	34021172
rs9469887	rs6940215	0.634416867147106	Multi-trait sex score	2e-23	37277458
rs9469887	rs6940215	0.634416867147106	Multi-trait sex score	4e-23	37277458
rs9469887	rs6457796	0.625860010967038	Insomnia	1e-08	30804565
rs9469887	rs6457796	0.625860010967038	Plateletcrit	9e-11	32888494
rs9469887	rs6457796	0.625860010967038	Systemic lupus erythematosus	3e-22	33272962
rs9469887	rs6457796	0.625860010967038	Body mass index	5e-13	30108127
rs9469887	rs6457796	0.625860010967038	Body mass index	1e-14	26426971
rs9469887	rs6457796	0.625860010967038	Educational attainment	5e-19	35361970
rs9469887	rs9689160	0.605382129452609	Lung function (forced vital capacity)	3e-14	36914875
rs9469889	rs9462030	0.991961796545434	Red cell distribution width	5e-25	32888493
rs9469889	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469889	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs9469889	rs9469899	0.975314640267064	Prostate cancer (advanced)	2e-06	29892016
rs9469889	rs9469899	0.975314640267064	Prostate cancer	5e-09	29892016
rs9469889	rs9469899	0.975314640267064	Prostate cancer	8e-11	33398198
rs9469889	rs9469899	0.975314640267064	Hand grip strength	3e-15	29691431
rs9469889	rs9469899	0.975314640267064	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469889	rs9469899	0.975314640267064	Graves' disease	4e-10	34594039
rs9469889	rs9469899	0.975314640267064	Coronary artery disease	1e-11	36474045
rs9469889	rs9469899	0.975314640267064	Predicted visceral adipose tissue	2e-20	31501611
rs9469889	rs9469899	0.975314640267064	Medication use (thyroid preparations)	2e-09	31015401
rs9469889	rs9469899	0.975314640267064	Medication use (thyroid preparations)	3e-10	34594039
rs9469889	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs9469889	rs11755393	0.944425765145638	Body mass index	3e-26	29273807
rs9469889	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-12	33493351
rs9469889	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-06	33493351
rs9469889	rs11755393	0.944425765145638	Systemic lupus erythematosus	1e-07	33493351
rs9469889	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-08	19838195
rs9469889	rs11755393	0.944425765145638	Body mass index	4e-55	36581621
rs9469889	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs9469889	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs9469889	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs9469889	rs6941110	0.932921349732261	Sex hormone-binding globulin levels	5e-27	36653534
rs9469889	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs9469889	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs9469889	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469889	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs9469889	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs9469889	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs9469889	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469889	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469889	rs9368830	0.831547762090701	HDL cholesterol	4e-21	30275531
rs9469889	rs9368828	0.805103390346437	Body mass index	1e-34	34594039
rs9469889	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469889	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469889	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469889	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs9469889	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs9469889	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469889	rs112283401	0.766845687865746	Red cell distribution width	4e-27	30595370
rs9469889	rs9689160	0.628913951683802	Lung function (forced vital capacity)	3e-14	36914875
rs9469891	rs9462030	0.991961796545434	Red cell distribution width	5e-25	32888493
rs9469891	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469891	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs9469891	rs9469899	0.975314640267064	Prostate cancer (advanced)	2e-06	29892016
rs9469891	rs9469899	0.975314640267064	Prostate cancer	5e-09	29892016
rs9469891	rs9469899	0.975314640267064	Prostate cancer	8e-11	33398198
rs9469891	rs9469899	0.975314640267064	Hand grip strength	3e-15	29691431
rs9469891	rs9469899	0.975314640267064	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469891	rs9469899	0.975314640267064	Graves' disease	4e-10	34594039
rs9469891	rs9469899	0.975314640267064	Coronary artery disease	1e-11	36474045
rs9469891	rs9469899	0.975314640267064	Predicted visceral adipose tissue	2e-20	31501611
rs9469891	rs9469899	0.975314640267064	Medication use (thyroid preparations)	2e-09	31015401
rs9469891	rs9469899	0.975314640267064	Medication use (thyroid preparations)	3e-10	34594039
rs9469891	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs9469891	rs11755393	0.944425765145638	Body mass index	3e-26	29273807
rs9469891	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-12	33493351
rs9469891	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-06	33493351
rs9469891	rs11755393	0.944425765145638	Systemic lupus erythematosus	1e-07	33493351
rs9469891	rs11755393	0.944425765145638	Systemic lupus erythematosus	2e-08	19838195
rs9469891	rs11755393	0.944425765145638	Body mass index	4e-55	36581621
rs9469891	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs9469891	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs9469891	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs9469891	rs6941110	0.932921349732261	Sex hormone-binding globulin levels	5e-27	36653534
rs9469891	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs9469891	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs9469891	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469891	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs9469891	rs2263329	0.876152008888012	HDL cholesterol	6e-35	34594039
rs9469891	rs2263329	0.876152008888012	HDL cholesterol levels	8e-43	32203549
rs9469891	rs2263329	0.876152008888012	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469891	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469891	rs9368830	0.831547762090701	HDL cholesterol	4e-21	30275531
rs9469891	rs9368828	0.805103390346437	Body mass index	1e-34	34594039
rs9469891	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469891	rs2744973	0.801606201736353	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469891	rs2744973	0.801606201736353	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469891	rs2744973	0.801606201736353	Multi-trait sex score	6e-20	37277458
rs9469891	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs9469891	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469891	rs112283401	0.766845687865746	Red cell distribution width	4e-27	30595370
rs9469891	rs9689160	0.628913951683802	Lung function (forced vital capacity)	3e-14	36914875
rs9469892	rs9469872	0.98640085914586	HDL cholesterol levels	3e-11	36333282
rs9469892	rs11755393	0.980876296632677	Body mass index	3e-26	29273807
rs9469892	rs11755393	0.980876296632677	Systemic lupus erythematosus	2e-12	33493351
rs9469892	rs11755393	0.980876296632677	Systemic lupus erythematosus	2e-06	33493351
rs9469892	rs11755393	0.980876296632677	Systemic lupus erythematosus	1e-07	33493351
rs9469892	rs11755393	0.980876296632677	Systemic lupus erythematosus	2e-08	19838195
rs9469892	rs11755393	0.980876296632677	Body mass index	4e-55	36581621
rs9469892	rs9366863	0.976062312484551	Adult body size	9e-33	32376654
rs9469892	rs9366863	0.976062312484551	Body mass index	2e-44	30595370
rs9469892	rs6941110	0.969735847144432	Sex hormone-binding globulin levels	5e-27	36653534
rs9469892	rs9462030	0.951991989134682	Red cell distribution width	5e-25	32888493
rs9469892	rs9469857	0.945784657482649	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469892	rs2764208	0.945052972111006	Systemic lupus erythematosus	7e-06	24871463
rs9469892	rs2814949	0.939108642528271	Essential hypertension (time to event)	9e-09	32589924
rs9469892	rs9469899	0.935251159716226	Prostate cancer (advanced)	2e-06	29892016
rs9469892	rs9469899	0.935251159716226	Prostate cancer	5e-09	29892016
rs9469892	rs9469899	0.935251159716226	Prostate cancer	8e-11	33398198
rs9469892	rs9469899	0.935251159716226	Hand grip strength	3e-15	29691431
rs9469892	rs9469899	0.935251159716226	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469892	rs9469899	0.935251159716226	Graves' disease	4e-10	34594039
rs9469892	rs9469899	0.935251159716226	Coronary artery disease	1e-11	36474045
rs9469892	rs9469899	0.935251159716226	Predicted visceral adipose tissue	2e-20	31501611
rs9469892	rs9469899	0.935251159716226	Medication use (thyroid preparations)	2e-09	31015401
rs9469892	rs9469899	0.935251159716226	Medication use (thyroid preparations)	3e-10	34594039
rs9469892	rs2744944	0.929783292513884	Hypothyroidism	3e-10	34594039
rs9469892	rs2744944	0.929783292513884	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469892	rs2744944	0.929783292513884	Multi-trait sex score	7e-22	37277458
rs9469892	rs2263329	0.91209497337502	HDL cholesterol	6e-35	34594039
rs9469892	rs2263329	0.91209497337502	HDL cholesterol levels	8e-43	32203549
rs9469892	rs2263329	0.91209497337502	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469892	rs9296128	0.897202379201665	Hip circumference adjusted for BMI	4e-13	34021172
rs9469892	rs111868030	0.886529660697303	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469892	rs9368830	0.866171684418555	HDL cholesterol	4e-21	30275531
rs9469892	rs9368828	0.835553752965987	Body mass index	1e-34	34594039
rs9469892	rs6912327	0.831084776216686	Fasting insulin	5e-06	33402679
rs9469892	rs6912327	0.831084776216686	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469892	rs112283401	0.803868505588408	Red cell distribution width	4e-27	30595370
rs9469892	rs2744973	0.780152132292118	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469892	rs2744973	0.780152132292118	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469892	rs2744973	0.780152132292118	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469892	rs2744973	0.780152132292118	Multi-trait sex score	6e-20	37277458
rs9469892	rs6940215	0.63233916902788	Insomnia	2e-10	35835914
rs9469892	rs6940215	0.63233916902788	Insomnia	1e-13	35835914
rs9469892	rs6940215	0.63233916902788	Hip circumference adjusted for BMI	8e-10	34021172
rs9469892	rs6940215	0.63233916902788	Multi-trait sex score	2e-23	37277458
rs9469892	rs6940215	0.63233916902788	Multi-trait sex score	4e-23	37277458
rs9469892	rs6457796	0.625043666735023	Insomnia	1e-08	30804565
rs9469892	rs6457796	0.625043666735023	Plateletcrit	9e-11	32888494
rs9469892	rs6457796	0.625043666735023	Systemic lupus erythematosus	3e-22	33272962
rs9469892	rs6457796	0.625043666735023	Body mass index	5e-13	30108127
rs9469892	rs6457796	0.625043666735023	Body mass index	1e-14	26426971
rs9469892	rs6457796	0.625043666735023	Educational attainment	5e-19	35361970
rs9469892	rs9689160	0.603247208840615	Lung function (forced vital capacity)	3e-14	36914875
rs9469899	rs9469899	1	Prostate cancer (advanced)	2e-06	29892016
rs9469899	rs9469899	1	Prostate cancer	5e-09	29892016
rs9469899	rs9469899	1	Prostate cancer	8e-11	33398198
rs9469899	rs9469899	1	Hand grip strength	3e-15	29691431
rs9469899	rs9469899	1	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469899	rs9469899	1	Graves' disease	4e-10	34594039
rs9469899	rs9469899	1	Coronary artery disease	1e-11	36474045
rs9469899	rs9469899	1	Predicted visceral adipose tissue	2e-20	31501611
rs9469899	rs9469899	1	Medication use (thyroid preparations)	2e-09	31015401
rs9469899	rs9469899	1	Medication use (thyroid preparations)	3e-10	34594039
rs9469899	rs9462030	0.973776846516501	Red cell distribution width	5e-25	32888493
rs9469899	rs9469857	0.964303678467489	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469899	rs2764208	0.96354553338453	Systemic lupus erythematosus	7e-06	24871463
rs9469899	rs9469872	0.92820039426473	HDL cholesterol levels	3e-11	36333282
rs9469899	rs11755393	0.926155764655461	Body mass index	3e-26	29273807
rs9469899	rs11755393	0.926155764655461	Systemic lupus erythematosus	2e-12	33493351
rs9469899	rs11755393	0.926155764655461	Systemic lupus erythematosus	2e-06	33493351
rs9469899	rs11755393	0.926155764655461	Systemic lupus erythematosus	1e-07	33493351
rs9469899	rs11755393	0.926155764655461	Systemic lupus erythematosus	2e-08	19838195
rs9469899	rs11755393	0.926155764655461	Body mass index	4e-55	36581621
rs9469899	rs2814949	0.922092435107363	Essential hypertension (time to event)	9e-09	32589924
rs9469899	rs9366863	0.918139823380352	Adult body size	9e-33	32376654
rs9469899	rs9366863	0.918139823380352	Body mass index	2e-44	30595370
rs9469899	rs6941110	0.915040259384048	Sex hormone-binding globulin levels	5e-27	36653534
rs9469899	rs9296128	0.914803953979528	Hip circumference adjusted for BMI	4e-13	34021172
rs9469899	rs2744944	0.911237394489752	Hypothyroidism	3e-10	34594039
rs9469899	rs2744944	0.911237394489752	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469899	rs2744944	0.911237394489752	Multi-trait sex score	7e-22	37277458
rs9469899	rs2263329	0.893591195910444	HDL cholesterol	6e-35	34594039
rs9469899	rs2263329	0.893591195910444	HDL cholesterol levels	8e-43	32203549
rs9469899	rs2263329	0.893591195910444	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469899	rs111868030	0.831791207599292	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469899	rs9368830	0.809552393864725	HDL cholesterol	4e-21	30275531
rs9469899	rs9368828	0.784531083564841	Body mass index	1e-34	34594039
rs9469899	rs2744973	0.782641028345457	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469899	rs2744973	0.782641028345457	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469899	rs2744973	0.782641028345457	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469899	rs2744973	0.782641028345457	Multi-trait sex score	6e-20	37277458
rs9469899	rs6912327	0.7742749049301	Fasting insulin	5e-06	33402679
rs9469899	rs6912327	0.7742749049301	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469899	rs112283401	0.752227310371297	Red cell distribution width	4e-27	30595370
rs9469899	rs9689160	0.614041854892826	Lung function (forced vital capacity)	3e-14	36914875
rs9469902	rs9462030	0.995175518696793	Red cell distribution width	5e-25	32888493
rs9469902	rs9469857	0.985558060155015	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469902	rs2764208	0.984767271036896	Systemic lupus erythematosus	7e-06	24871463
rs9469902	rs9469899	0.978497589843936	Prostate cancer (advanced)	2e-06	29892016
rs9469902	rs9469899	0.978497589843936	Prostate cancer	5e-09	29892016
rs9469902	rs9469899	0.978497589843936	Prostate cancer	8e-11	33398198
rs9469902	rs9469899	0.978497589843936	Hand grip strength	3e-15	29691431
rs9469902	rs9469899	0.978497589843936	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469902	rs9469899	0.978497589843936	Graves' disease	4e-10	34594039
rs9469902	rs9469899	0.978497589843936	Coronary artery disease	1e-11	36474045
rs9469902	rs9469899	0.978497589843936	Predicted visceral adipose tissue	2e-20	31501611
rs9469902	rs9469899	0.978497589843936	Medication use (thyroid preparations)	2e-09	31015401
rs9469902	rs9469899	0.978497589843936	Medication use (thyroid preparations)	3e-10	34594039
rs9469902	rs9469872	0.949411048256766	HDL cholesterol levels	3e-11	36333282
rs9469902	rs11755393	0.947554267093235	Body mass index	3e-26	29273807
rs9469902	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-12	33493351
rs9469902	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-06	33493351
rs9469902	rs11755393	0.947554267093235	Systemic lupus erythematosus	1e-07	33493351
rs9469902	rs11755393	0.947554267093235	Systemic lupus erythematosus	2e-08	19838195
rs9469902	rs11755393	0.947554267093235	Body mass index	4e-55	36581621
rs9469902	rs9366863	0.939202875619831	Adult body size	9e-33	32376654
rs9469902	rs9366863	0.939202875619831	Body mass index	2e-44	30595370
rs9469902	rs6941110	0.936033811762549	Sex hormone-binding globulin levels	5e-27	36653534
rs9469902	rs9296128	0.934953504877287	Hip circumference adjusted for BMI	4e-13	34021172
rs9469902	rs2814949	0.903112017724093	Essential hypertension (time to event)	9e-09	32589924
rs9469902	rs2744944	0.893792453246182	Hypothyroidism	3e-10	34594039
rs9469902	rs2744944	0.893792453246182	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469902	rs2744944	0.893792453246182	Multi-trait sex score	7e-22	37277458
rs9469902	rs2263329	0.874645285202942	HDL cholesterol	6e-35	34594039
rs9469902	rs2263329	0.874645285202942	HDL cholesterol levels	8e-43	32203549
rs9469902	rs2263329	0.874645285202942	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469902	rs111868030	0.850932801108693	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469902	rs9368830	0.830084187792525	HDL cholesterol	4e-21	30275531
rs9469902	rs9368828	0.803658173339717	Body mass index	1e-34	34594039
rs9469902	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469902	rs2744973	0.800145420504899	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469902	rs2744973	0.800145420504899	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469902	rs2744973	0.800145420504899	Multi-trait sex score	6e-20	37277458
rs9469902	rs6912327	0.792011528290098	Fasting insulin	5e-06	33402679
rs9469902	rs6912327	0.792011528290098	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469902	rs112283401	0.769696819914803	Red cell distribution width	4e-27	30595370
rs9469902	rs9689160	0.627575422825611	Lung function (forced vital capacity)	3e-14	36914875
rs9469905	rs9469872	0.985599904396389	HDL cholesterol levels	3e-11	36333282
rs9469905	rs11755393	0.983268562275324	Body mass index	3e-26	29273807
rs9469905	rs11755393	0.983268562275324	Systemic lupus erythematosus	2e-12	33493351
rs9469905	rs11755393	0.983268562275324	Systemic lupus erythematosus	2e-06	33493351
rs9469905	rs11755393	0.983268562275324	Systemic lupus erythematosus	1e-07	33493351
rs9469905	rs11755393	0.983268562275324	Systemic lupus erythematosus	2e-08	19838195
rs9469905	rs11755393	0.983268562275324	Body mass index	4e-55	36581621
rs9469905	rs9366863	0.975264237024431	Adult body size	9e-33	32376654
rs9469905	rs9366863	0.975264237024431	Body mass index	2e-44	30595370
rs9469905	rs6941110	0.972105692283998	Sex hormone-binding globulin levels	5e-27	36653534
rs9469905	rs9462030	0.954330418409387	Red cell distribution width	5e-25	32888493
rs9469905	rs9469857	0.944982115878737	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469905	rs2764208	0.944249682195853	Systemic lupus erythematosus	7e-06	24871463
rs9469905	rs2814949	0.938329125452256	Essential hypertension (time to event)	9e-09	32589924
rs9469905	rs9469899	0.937576088518213	Prostate cancer (advanced)	2e-06	29892016
rs9469905	rs9469899	0.937576088518213	Prostate cancer	5e-09	29892016
rs9469905	rs9469899	0.937576088518213	Prostate cancer	8e-11	33398198
rs9469905	rs9469899	0.937576088518213	Hand grip strength	3e-15	29691431
rs9469905	rs9469899	0.937576088518213	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469905	rs9469899	0.937576088518213	Graves' disease	4e-10	34594039
rs9469905	rs9469899	0.937576088518213	Coronary artery disease	1e-11	36474045
rs9469905	rs9469899	0.937576088518213	Predicted visceral adipose tissue	2e-20	31501611
rs9469905	rs9469899	0.937576088518213	Medication use (thyroid preparations)	2e-09	31015401
rs9469905	rs9469899	0.937576088518213	Medication use (thyroid preparations)	3e-10	34594039
rs9469905	rs2744944	0.929004044939223	Hypothyroidism	3e-10	34594039
rs9469905	rs2744944	0.929004044939223	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469905	rs2744944	0.929004044939223	Multi-trait sex score	7e-22	37277458
rs9469905	rs2263329	0.909782766230733	HDL cholesterol	6e-35	34594039
rs9469905	rs2263329	0.909782766230733	HDL cholesterol levels	8e-43	32203549
rs9469905	rs2263329	0.909782766230733	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469905	rs9296128	0.896396395274987	Hip circumference adjusted for BMI	4e-13	34021172
rs9469905	rs111868030	0.887248297550219	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469905	rs9368830	0.86247220588823	HDL cholesterol	4e-21	30275531
rs9469905	rs9368828	0.83333187896658	Body mass index	1e-34	34594039
rs9469905	rs6912327	0.828793738389432	Fasting insulin	5e-06	33402679
rs9469905	rs6912327	0.828793738389432	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469905	rs112283401	0.810361876998339	Red cell distribution width	4e-27	30595370
rs9469905	rs2744973	0.77790857773856	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469905	rs2744973	0.77790857773856	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469905	rs2744973	0.77790857773856	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469905	rs2744973	0.77790857773856	Multi-trait sex score	6e-20	37277458
rs9469905	rs6940215	0.632880969302522	Insomnia	2e-10	35835914
rs9469905	rs6940215	0.632880969302522	Insomnia	1e-13	35835914
rs9469905	rs6940215	0.632880969302522	Hip circumference adjusted for BMI	8e-10	34021172
rs9469905	rs6940215	0.632880969302522	Multi-trait sex score	2e-23	37277458
rs9469905	rs6940215	0.632880969302522	Multi-trait sex score	4e-23	37277458
rs9469905	rs6457796	0.628200807936117	Insomnia	1e-08	30804565
rs9469905	rs6457796	0.628200807936117	Plateletcrit	9e-11	32888494
rs9469905	rs6457796	0.628200807936117	Systemic lupus erythematosus	3e-22	33272962
rs9469905	rs6457796	0.628200807936117	Body mass index	5e-13	30108127
rs9469905	rs6457796	0.628200807936117	Body mass index	1e-14	26426971
rs9469905	rs6457796	0.628200807936117	Educational attainment	5e-19	35361970
rs9469905	rs9689160	0.603733435094497	Lung function (forced vital capacity)	3e-14	36914875
rs9469905	rs9469918	0.601889647134701	Hip circumference adjusted for BMI	8e-09	34021172
rs9469905	rs9469918	0.601889647134701	Hip circumference adjusted for BMI	2e-08	34021172
rs9469905	rs9469918	0.601889647134701	Multi-trait sex score	4e-08	37277458
rs9469909	rs9469872	0.952596328378425	HDL cholesterol levels	3e-11	36333282
rs9469909	rs11755393	0.933593302600081	Body mass index	3e-26	29273807
rs9469909	rs11755393	0.933593302600081	Systemic lupus erythematosus	2e-12	33493351
rs9469909	rs11755393	0.933593302600081	Systemic lupus erythematosus	2e-06	33493351
rs9469909	rs11755393	0.933593302600081	Systemic lupus erythematosus	1e-07	33493351
rs9469909	rs11755393	0.933593302600081	Systemic lupus erythematosus	2e-08	19838195
rs9469909	rs11755393	0.933593302600081	Body mass index	4e-55	36581621
rs9469909	rs9366863	0.923705412932581	Adult body size	9e-33	32376654
rs9469909	rs9366863	0.923705412932581	Body mass index	2e-44	30595370
rs9469909	rs6941110	0.920555254316961	Sex hormone-binding globulin levels	5e-27	36653534
rs9469909	rs9469857	0.911741867456404	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469909	rs2764208	0.910968992657564	Systemic lupus erythematosus	7e-06	24871463
rs9469909	rs9462030	0.902536461723707	Red cell distribution width	5e-25	32888493
rs9469909	rs2744944	0.896874905122449	Hypothyroidism	3e-10	34594039
rs9469909	rs2744944	0.896874905122449	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469909	rs2744944	0.896874905122449	Multi-trait sex score	7e-22	37277458
rs9469909	rs2814949	0.887932934453092	Essential hypertension (time to event)	9e-09	32589924
rs9469909	rs9469899	0.886799380682447	Prostate cancer (advanced)	2e-06	29892016
rs9469909	rs9469899	0.886799380682447	Prostate cancer	5e-09	29892016
rs9469909	rs9469899	0.886799380682447	Prostate cancer	8e-11	33398198
rs9469909	rs9469899	0.886799380682447	Hand grip strength	3e-15	29691431
rs9469909	rs9469899	0.886799380682447	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469909	rs9469899	0.886799380682447	Graves' disease	4e-10	34594039
rs9469909	rs9469899	0.886799380682447	Coronary artery disease	1e-11	36474045
rs9469909	rs9469899	0.886799380682447	Predicted visceral adipose tissue	2e-20	31501611
rs9469909	rs9469899	0.886799380682447	Medication use (thyroid preparations)	2e-09	31015401
rs9469909	rs9469899	0.886799380682447	Medication use (thyroid preparations)	3e-10	34594039
rs9469909	rs2263329	0.876164477820696	HDL cholesterol	6e-35	34594039
rs9469909	rs2263329	0.876164477820696	HDL cholesterol levels	8e-43	32203549
rs9469909	rs2263329	0.876164477820696	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469909	rs9368828	0.869967982380226	Body mass index	1e-34	34594039
rs9469909	rs9296128	0.865804699247957	Hip circumference adjusted for BMI	4e-13	34021172
rs9469909	rs111868030	0.861295893034638	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469909	rs112283401	0.826118576866932	Red cell distribution width	4e-27	30595370
rs9469909	rs9368830	0.815670356956042	HDL cholesterol	4e-21	30275531
rs9469909	rs2744973	0.794021705117346	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469909	rs2744973	0.794021705117346	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469909	rs2744973	0.794021705117346	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469909	rs2744973	0.794021705117346	Multi-trait sex score	6e-20	37277458
rs9469909	rs6912327	0.777368334796605	Fasting insulin	5e-06	33402679
rs9469909	rs6912327	0.777368334796605	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469914	rs9462030	0.983980641312883	Red cell distribution width	5e-25	32888493
rs9469914	rs9469857	0.9744288918798	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469914	rs2764208	0.973649207412322	Systemic lupus erythematosus	7e-06	24871463
rs9469914	rs9469899	0.967330716061871	Prostate cancer (advanced)	2e-06	29892016
rs9469914	rs9469899	0.967330716061871	Prostate cancer	5e-09	29892016
rs9469914	rs9469899	0.967330716061871	Prostate cancer	8e-11	33398198
rs9469914	rs9469899	0.967330716061871	Hand grip strength	3e-15	29691431
rs9469914	rs9469899	0.967330716061871	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469914	rs9469899	0.967330716061871	Graves' disease	4e-10	34594039
rs9469914	rs9469899	0.967330716061871	Coronary artery disease	1e-11	36474045
rs9469914	rs9469899	0.967330716061871	Predicted visceral adipose tissue	2e-20	31501611
rs9469914	rs9469899	0.967330716061871	Medication use (thyroid preparations)	2e-09	31015401
rs9469914	rs9469899	0.967330716061871	Medication use (thyroid preparations)	3e-10	34594039
rs9469914	rs11755393	0.94116109780304	Body mass index	3e-26	29273807
rs9469914	rs11755393	0.94116109780304	Systemic lupus erythematosus	2e-12	33493351
rs9469914	rs11755393	0.94116109780304	Systemic lupus erythematosus	2e-06	33493351
rs9469914	rs11755393	0.94116109780304	Systemic lupus erythematosus	1e-07	33493351
rs9469914	rs11755393	0.94116109780304	Systemic lupus erythematosus	2e-08	19838195
rs9469914	rs11755393	0.94116109780304	Body mass index	4e-55	36581621
rs9469914	rs9469872	0.938392114878059	HDL cholesterol levels	3e-11	36333282
rs9469914	rs9366863	0.928252933840424	Adult body size	9e-33	32376654
rs9469914	rs9366863	0.928252933840424	Body mass index	2e-44	30595370
rs9469914	rs6941110	0.925111926896303	Sex hormone-binding globulin levels	5e-27	36653534
rs9469914	rs9296128	0.924265089409384	Hip circumference adjusted for BMI	4e-13	34021172
rs9469914	rs2814949	0.892357870863913	Essential hypertension (time to event)	9e-09	32589924
rs9469914	rs2744944	0.883117944180871	Hypothyroidism	3e-10	34594039
rs9469914	rs2744944	0.883117944180871	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469914	rs2744944	0.883117944180871	Multi-trait sex score	7e-22	37277458
rs9469914	rs2263329	0.864126810301654	HDL cholesterol	6e-35	34594039
rs9469914	rs2263329	0.864126810301654	HDL cholesterol levels	8e-43	32203549
rs9469914	rs2263329	0.864126810301654	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469914	rs111868030	0.840761090476559	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469914	rs9368830	0.821037948741071	HDL cholesterol	4e-21	30275531
rs9469914	rs9368828	0.793632279330145	Body mass index	1e-34	34594039
rs9469914	rs2744973	0.790556980687368	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469914	rs2744973	0.790556980687368	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469914	rs2744973	0.790556980687368	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469914	rs2744973	0.790556980687368	Multi-trait sex score	6e-20	37277458
rs9469914	rs6912327	0.782391619970774	Fasting insulin	5e-06	33402679
rs9469914	rs6912327	0.782391619970774	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469914	rs112283401	0.760218555868723	Red cell distribution width	4e-27	30595370
rs9469914	rs9689160	0.623532075072339	Lung function (forced vital capacity)	3e-14	36914875
rs9469917	rs9469872	0.983205444781224	HDL cholesterol levels	3e-11	36333282
rs9469917	rs11755393	0.980887318011905	Body mass index	3e-26	29273807
rs9469917	rs11755393	0.980887318011905	Systemic lupus erythematosus	2e-12	33493351
rs9469917	rs11755393	0.980887318011905	Systemic lupus erythematosus	2e-06	33493351
rs9469917	rs11755393	0.980887318011905	Systemic lupus erythematosus	1e-07	33493351
rs9469917	rs11755393	0.980887318011905	Systemic lupus erythematosus	2e-08	19838195
rs9469917	rs11755393	0.980887318011905	Body mass index	4e-55	36581621
rs9469917	rs9366863	0.972880896731738	Adult body size	9e-33	32376654
rs9469917	rs9366863	0.972880896731738	Body mass index	2e-44	30595370
rs9469917	rs6941110	0.969724554798307	Sex hormone-binding globulin levels	5e-27	36653534
rs9469917	rs9462030	0.958247094962924	Red cell distribution width	5e-25	32888493
rs9469917	rs9469857	0.942616606928596	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9469917	rs2764208	0.941883850621884	Systemic lupus erythematosus	7e-06	24871463
rs9469917	rs2814949	0.935995276539578	Essential hypertension (time to event)	9e-09	32589924
rs9469917	rs9469899	0.935234323451031	Prostate cancer (advanced)	2e-06	29892016
rs9469917	rs9469899	0.935234323451031	Prostate cancer	5e-09	29892016
rs9469917	rs9469899	0.935234323451031	Prostate cancer	8e-11	33398198
rs9469917	rs9469899	0.935234323451031	Hand grip strength	3e-15	29691431
rs9469917	rs9469899	0.935234323451031	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9469917	rs9469899	0.935234323451031	Graves' disease	4e-10	34594039
rs9469917	rs9469899	0.935234323451031	Coronary artery disease	1e-11	36474045
rs9469917	rs9469899	0.935234323451031	Predicted visceral adipose tissue	2e-20	31501611
rs9469917	rs9469899	0.935234323451031	Medication use (thyroid preparations)	2e-09	31015401
rs9469917	rs9469899	0.935234323451031	Medication use (thyroid preparations)	3e-10	34594039
rs9469917	rs2744944	0.926677761375104	Hypothyroidism	3e-10	34594039
rs9469917	rs2744944	0.926677761375104	High density lipoprotein cholesterol levels	3e-86	34887591
rs9469917	rs2744944	0.926677761375104	Multi-trait sex score	7e-22	37277458
rs9469917	rs2263329	0.907473651951813	HDL cholesterol	6e-35	34594039
rs9469917	rs2263329	0.907473651951813	HDL cholesterol levels	8e-43	32203549
rs9469917	rs2263329	0.907473651951813	High density lipoprotein cholesterol levels	2e-52	34887591
rs9469917	rs9296128	0.89406371643797	Hip circumference adjusted for BMI	4e-13	34021172
rs9469917	rs111868030	0.883409117807346	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9469917	rs9368830	0.860267032197533	HDL cholesterol	4e-21	30275531
rs9469917	rs9368828	0.831113102054415	Body mass index	1e-34	34594039
rs9469917	rs6912327	0.830941137145856	Fasting insulin	5e-06	33402679
rs9469917	rs6912327	0.830941137145856	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9469917	rs112283401	0.803726259182383	Red cell distribution width	4e-27	30595370
rs9469917	rs2744973	0.777104405580839	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9469917	rs2744973	0.777104405580839	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9469917	rs2744973	0.777104405580839	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9469917	rs2744973	0.777104405580839	Multi-trait sex score	6e-20	37277458
rs9469917	rs6940215	0.62819424457689	Insomnia	2e-10	35835914
rs9469917	rs6940215	0.62819424457689	Insomnia	1e-13	35835914
rs9469917	rs6940215	0.62819424457689	Hip circumference adjusted for BMI	8e-10	34021172
rs9469917	rs6940215	0.62819424457689	Multi-trait sex score	2e-23	37277458
rs9469917	rs6940215	0.62819424457689	Multi-trait sex score	4e-23	37277458
rs9469917	rs6457796	0.62341303827353	Insomnia	1e-08	30804565
rs9469917	rs6457796	0.62341303827353	Plateletcrit	9e-11	32888494
rs9469917	rs6457796	0.62341303827353	Systemic lupus erythematosus	3e-22	33272962
rs9469917	rs6457796	0.62341303827353	Body mass index	5e-13	30108127
rs9469917	rs6457796	0.62341303827353	Body mass index	1e-14	26426971
rs9469917	rs6457796	0.62341303827353	Educational attainment	5e-19	35361970
rs9472049	rs9394952	0.995690755700819	Age-related hearing impairment	3e-11	34108613
rs9472049	rs4714680	0.936322537352492	Height	2e-09	34594039
rs9472049	rs4714680	0.936322537352492	Hip circumference adjusted for BMI	4e-08	34021172
rs9472049	rs1574430	0.713516221950947	Urate levels	3e-14	31578528
rs9472049	rs56401710	0.713516221950947	Urate levels	4e-10	31578528
rs9472049	rs56401710	0.713516221950947	Urate levels	5e-14	31578528
rs9472049	rs56401710	0.713516221950947	Urate levels	5e-30	31578528
rs9472049	rs9369409	0.710702578880068	Waist-hip index	5e-09	34021172
rs9472049	rs9369409	0.710702578880068	Medication use (calcium channel blockers)	3e-10	31015401
rs9472049	rs9369409	0.710702578880068	Waist-to-hip ratio adjusted for BMI	1e-09	34021172
rs9472049	rs9369409	0.710702578880068	Medication use (calcium channel blockers)	4e-17	34594039
rs9472049	rs9369409	0.710702578880068	Waist-hip ratio	8e-15	30595370
rs9472049	rs4714678	0.706881772638578	Systolic blood pressure	1e-17	30487518
rs9472049	rs4714678	0.706881772638578	Mean arterial pressure	9e-16	30487518
rs9472049	rs4714678	0.706881772638578	Urea levels	3e-10	33462484
rs9472049	rs4714678	0.706881772638578	Blood urea nitrogen levels	8e-11	34594039
rs9472049	rs9394951	0.688987916860264	Mean corpuscular volume	1e-16	32888494
rs9472049	rs9394951	0.688987916860264	Mean reticulocyte volume	4e-14	32888494
rs9472049	rs9394951	0.688987916860264	Mean spheric corpuscular volume	1e-17	32888494
rs9472049	rs9394951	0.688987916860264	Medication use (diuretics)	6e-11	31015401
rs9472049	rs9394951	0.688987916860264	Medication use (agents acting on the renin-angiotensin system)	2e-09	31015401
rs9472049	rs9394951	0.688987916860264	Medication use (agents acting on the renin-angiotensin system)	2e-14	34594039
rs9472049	rs9394951	0.688987916860264	Medication use (diuretics)	2e-14	34594039
rs9472049	rs6912283	0.68817677054945	Bioavailable testosterone levels	1e-12	32042192
rs9472049	rs6912283	0.68817677054945	Serum alkaline phosphatase levels	2e-10	33547301
rs9472049	rs6912283	0.68817677054945	Heel bone mineral density	6e-09	30598549
rs9472049	rs6912283	0.68817677054945	Hip index	7e-11	34021172
rs9472049	rs6919440	0.687380854884049	Diastolic blood pressure	1e-11	30487518
rs9472049	rs6919440	0.687380854884049	Systolic blood pressure	5e-09	27618452
rs9472049	rs6919440	0.687380854884049	Mean corpuscular hemoglobin	9e-11	32888493
rs9472049	rs6919440	0.687380854884049	Mean corpuscular volume	1e-14	32888493
rs9472049	rs6919440	0.687380854884049	Platelet count	5e-22	32888493
rs9472049	rs6919440	0.687380854884049	Platelet count	2e-23	32888493
rs9472049	rs6919440	0.687380854884049	Mean corpuscular volume	4e-14	32888493
rs9472049	rs6919440	0.687380854884049	Plateletcrit	3e-09	27863252
rs9472049	rs6919440	0.687380854884049	Hip circumference adjusted for BMI	4e-16	34021172
rs9472049	rs6919440	0.687380854884049	Mean arterial pressure	1e-14	34594039
rs9472049	rs6919440	0.687380854884049	Superior parietal thickness (unadjusted for global measures)	4e-09	36893272
rs9472049	rs2611336	0.686624287461665	Hearing problems	2e-08	37165447
rs9472049	rs4714677	0.685455215227405	Heel bone mineral density	3e-10	30595370
rs9472049	rs9394948	0.68531517561019	Serum uric acid levels	1e-11	29403010
rs9472049	rs9394948	0.68531517561019	Serum uric acid levels	2e-13	30993211
rs9472049	rs2396004	0.684192300572553	Mean corpuscular hemoglobin	1e-12	32888494
rs9472049	rs2396004	0.684192300572553	Chronotype	3e-09	30696823
rs9472049	rs2396004	0.684192300572553	Carnitine levels	4e-11	33414548
rs9472049	rs2396004	0.684192300572553	Total testosterone levels	4e-08	34321204
rs9472049	rs10948071	0.679642326204673	Systolic blood pressure	4e-10	30487518
rs9472049	rs10948071	0.679642326204673	Mean arterial pressure	4e-09	30487518
rs9472049	rs10948071	0.679642326204673	Diastolic blood pressure	1e-06	30487518
rs9472049	rs10948071	0.679642326204673	Pulse pressure	4e-06	30487518
rs9472049	rs10948071	0.679642326204673	Hypertension	1e-06	30487518
rs9472049	rs10948071	0.679642326204673	Age-related hearing impairment (MTAG)	1e-18	32986727
rs9472049	rs10948071	0.679642326204673	Pulse pressure	3e-06	27841878
rs9472049	rs10948071	0.679642326204673	Systolic blood pressure	1e-09	27841878
rs9472049	rs10948071	0.679642326204673	Diastolic blood pressure (cigarette smoking interaction)	1e-10	29455858
rs9472049	rs10948071	0.679642326204673	Systolic blood pressure (cigarette smoking interaction)	8e-21	29455858
rs9472049	rs2254303	0.672626775374474	Pulse pressure	6e-11	30487518
rs9472049	rs2254303	0.672626775374474	Height	3e-18	34594039
rs9472049	rs2254303	0.672626775374474	Height	4e-08	31562340
rs9472049	rs2254303	0.672626775374474	Hearing problems	1e-23	37165447
rs9472049	rs62415384	0.655523441486464	Total testosterone levels	3e-08	32042192
rs9472049	rs62415384	0.655523441486464	Tyrosine levels	2e-11	35213538
rs9472049	rs1214752	0.643737568639917	Coronary artery disease	1e-06	29212778
rs9472049	rs2242416	0.62506538293357	Age-related hearing impairment	1e-17	34108613
rs9472049	rs2242416	0.62506538293357	Body mass index	3e-08	36581621
rs9472049	rs2242416	0.62506538293357	Hearing problems	1e-17	37165447
rs9478848	rs14314	0.836572536456143	Macular thickness	3e-19	30535121
rs9478848	rs14314	0.836572536456143	Vertex-wise sulcal depth	7e-17	34910505
rs9478848	rs14314	0.836572536456143	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9478848	rs14314	0.836572536456143	Left hippocampal volume (body)	7e-15	37337106
rs9478848	rs14314	0.836572536456143	Left subiculum volume (body)	1e-14	37337106
rs9478848	rs2095375	0.823594688458015	Serum metabolite levels	1e-20	33031748
rs9478848	rs2095375	0.823594688458015	Serum metabolite levels	1e-20	33031748
rs9478848	rs9383843	0.82275264022932	Migraine	1e-09	35115687
rs9478848	rs55763431	0.819483696622609	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9478848	rs9689694	0.817987246299505	Right hippocampal volume (head)	6e-11	37337106
rs9478848	rs9689694	0.817987246299505	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9478848	rs9689694	0.817987246299505	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9478848	rs9689694	0.817987246299505	Left hippocampal volume (head)	6e-12	37337106
rs9478848	rs10872645	0.814729223360322	Blood protein levels	2e-86	30072576
rs9478848	rs10872653	0.812670983472209	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9478848	rs9688867	0.81197838650584	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9478848	rs9688867	0.81197838650584	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9478848	rs9688809	0.81197838650584	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9478848	rs34337297	0.809243058380222	Serum levels of protein LRP11	3e-161	35078996
rs9478848	rs9322193	0.782745875571656	Lung cancer	1e-07	27393504
rs9478848	rs4039600	0.747765319201181	Adenine levels	1e-11	35347128
rs9479094	rs4421206	0.987941864604882	Brain morphology (min-P)	4e-11	32665545
rs9479094	rs9688452	0.960249816687386	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9479094	rs9688452	0.960249816687386	aseg lh volume VentralDC	2e-10	33875891
rs9479094	rs4380763	0.937145513588215	Subcortical volume (min-P)	1e-11	32665545
rs9479094	rs1934534	0.936382288984428	Pain (pleiotropy)	2e-08	37844115
rs9479094	rs1934534	0.936382288984428	Pain (pleiotropy)	2e-06	37844115
rs9479094	rs11155671	0.919078379578799	Testicular germ cell tumor	2e-09	28604728
rs9479094	rs80147756	0.897088525065309	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9479094	rs9505982	0.893247987748394	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9479094	rs10872649	0.820338397225349	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9479094	rs10872649	0.820338397225349	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9479094	rs10872649	0.820338397225349	Right hippocampal volume (body)	1e-10	37337106
rs9479094	rs7752089	0.783678066604266	Brain morphology (MOSTest)	2e-31	35164939
rs9479094	rs9322194	0.765760369558016	Brainstem volume	2e-11	31636452
rs9479094	rs9285521	0.708371561698014	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9479094	rs12526675	0.698862594900479	Brain morphology (MOSTest)	7e-22	32665545
rs9479094	rs2342764	0.655470529642136	Cortical thickness	1e-08	34560273
rs9479094	rs56103941	0.623592816451267	Right presubiculum volume (head)	4e-08	37337106
rs9479094	rs9688809	0.610300582983625	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9479094	rs10872645	0.60669796972971	Blood protein levels	2e-86	30072576
rs9479094	rs14314	0.605542209636918	Macular thickness	3e-19	30535121
rs9479094	rs14314	0.605542209636918	Vertex-wise sulcal depth	7e-17	34910505
rs9479094	rs14314	0.605542209636918	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9479094	rs14314	0.605542209636918	Left hippocampal volume (body)	7e-15	37337106
rs9479094	rs14314	0.605542209636918	Left subiculum volume (body)	1e-14	37337106
rs9479094	rs55763431	0.605371421960415	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9479094	rs34337297	0.604825376696012	Serum levels of protein LRP11	3e-161	35078996
rs9479094	rs9689694	0.60427965821124	Right hippocampal volume (head)	6e-11	37337106
rs9479094	rs9689694	0.60427965821124	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9479094	rs9689694	0.60427965821124	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9479094	rs9689694	0.60427965821124	Left hippocampal volume (head)	6e-12	37337106
rs9479094	rs9383843	0.602955359636516	Migraine	1e-09	35115687
rs9479094	rs2095375	0.602410365962116	Serum metabolite levels	1e-20	33031748
rs9479094	rs2095375	0.602410365962116	Serum metabolite levels	1e-20	33031748
rs9479094	rs10872653	0.600233647921779	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9480009	rs10872649	0.991182761470848	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9480009	rs10872649	0.991182761470848	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9480009	rs10872649	0.991182761470848	Right hippocampal volume (body)	1e-10	37337106
rs9480009	rs7752089	0.940396636765247	Brain morphology (MOSTest)	2e-31	35164939
rs9480009	rs1934534	0.884240037554007	Pain (pleiotropy)	2e-08	37844115
rs9480009	rs1934534	0.884240037554007	Pain (pleiotropy)	2e-06	37844115
rs9480009	rs4380763	0.883451982619165	Subcortical volume (min-P)	1e-11	32665545
rs9480009	rs11155671	0.867384540933375	Testicular germ cell tumor	2e-09	28604728
rs9480009	rs9322194	0.851595664895741	Brainstem volume	2e-11	31636452
rs9480009	rs80147756	0.845729590013271	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9480009	rs4421206	0.833738882007628	Brain morphology (min-P)	4e-11	32665545
rs9480009	rs9505982	0.824280359109167	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9480009	rs9688452	0.809920516754819	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9480009	rs9688452	0.809920516754819	aseg lh volume VentralDC	2e-10	33875891
rs9480009	rs9285521	0.726959159290808	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9480009	rs12526675	0.717554109805686	Brain morphology (MOSTest)	7e-22	32665545
rs9480009	rs2342764	0.675709864968964	Cortical thickness	1e-08	34560273
rs9480009	rs56103941	0.642887801917206	Right presubiculum volume (head)	4e-08	37337106
rs9480009	rs12523793	0.608433542190109	Subcortical volume (MOSTest)	4e-24	32665545
rs9480009	rs12523793	0.608433542190109	C-reactive protein levels	3e-08	35459240
rs9480009	rs12523793	0.608433542190109	C-reactive protein levels (MTAG)	2e-08	36376304
rs9480009	rs11155662	0.602334465173527	Vertex-wise cortical thickness	2e-09	34910505
rs9485402	rs11155671	0.810092935066907	Testicular germ cell tumor	2e-09	28604728
rs9485402	rs4380763	0.800659137179905	Subcortical volume (min-P)	1e-11	32665545
rs9485402	rs1934534	0.799937800338076	Pain (pleiotropy)	2e-08	37844115
rs9485402	rs1934534	0.799937800338076	Pain (pleiotropy)	2e-06	37844115
rs9485402	rs9505982	0.783570606450456	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9485402	rs80147756	0.767120469721388	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9485402	rs4421206	0.75605445112374	Brain morphology (min-P)	4e-11	32665545
rs9485402	rs9688452	0.738229995552104	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9485402	rs9688452	0.738229995552104	aseg lh volume VentralDC	2e-10	33875891
rs9485402	rs10872649	0.707647736764409	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9485402	rs10872649	0.707647736764409	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9485402	rs10872649	0.707647736764409	Right hippocampal volume (body)	1e-10	37337106
rs9485402	rs9322194	0.687564507259343	Brainstem volume	2e-11	31636452
rs9485402	rs7752089	0.682283750992371	Brain morphology (MOSTest)	2e-31	35164939
rs9485405	rs11155671	0.955891933050673	Testicular germ cell tumor	2e-09	28604728
rs9485405	rs1934534	0.944834317518188	Pain (pleiotropy)	2e-08	37844115
rs9485405	rs1934534	0.944834317518188	Pain (pleiotropy)	2e-06	37844115
rs9485405	rs4380763	0.942465841496643	Subcortical volume (min-P)	1e-11	32665545
rs9485405	rs9505982	0.941194329511735	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9485405	rs80147756	0.901464230084245	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9485405	rs4421206	0.895613706612643	Brain morphology (min-P)	4e-11	32665545
rs9485405	rs9688452	0.877626458002998	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9485405	rs9688452	0.877626458002998	aseg lh volume VentralDC	2e-10	33875891
rs9485405	rs10872649	0.829583917448709	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9485405	rs10872649	0.829583917448709	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9485405	rs10872649	0.829583917448709	Right hippocampal volume (body)	1e-10	37337106
rs9485405	rs9322194	0.821743339655143	Brainstem volume	2e-11	31636452
rs9485405	rs7752089	0.798039610509484	Brain morphology (MOSTest)	2e-31	35164939
rs9485405	rs9285521	0.702087587464816	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9485405	rs9322193	0.635644931269104	Lung cancer	1e-07	27393504
rs9485405	rs12526675	0.627535684695342	Brain morphology (MOSTest)	7e-22	32665545
rs9485405	rs9688809	0.621035134113701	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9485405	rs10872645	0.618609955516243	Blood protein levels	2e-86	30072576
rs9485405	rs34337297	0.618043114098848	Serum levels of protein LRP11	3e-161	35078996
rs9485405	rs14314	0.616236917160013	Macular thickness	3e-19	30535121
rs9485405	rs14314	0.616236917160013	Vertex-wise sulcal depth	7e-17	34910505
rs9485405	rs14314	0.616236917160013	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9485405	rs14314	0.616236917160013	Left hippocampal volume (body)	7e-15	37337106
rs9485405	rs14314	0.616236917160013	Left subiculum volume (body)	1e-14	37337106
rs9485405	rs55763431	0.615925714564689	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9485405	rs9689694	0.614794026484087	Right hippocampal volume (head)	6e-11	37337106
rs9485405	rs9689694	0.614794026484087	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9485405	rs9689694	0.614794026484087	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9485405	rs9689694	0.614794026484087	Left hippocampal volume (head)	6e-12	37337106
rs9485405	rs9383843	0.61345492367259	Migraine	1e-09	35115687
rs9485405	rs2095375	0.612890001769844	Serum metabolite levels	1e-20	33031748
rs9485405	rs2095375	0.612890001769844	Serum metabolite levels	1e-20	33031748
rs9485405	rs10872653	0.610633691202616	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9485405	rs9688867	0.610326486316519	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9485405	rs9688867	0.610326486316519	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9485408	rs11155671	0.975806902752313	Testicular germ cell tumor	2e-09	28604728
rs9485408	rs4380763	0.962233695928481	Subcortical volume (min-P)	1e-11	32665545
rs9485408	rs1934534	0.961439846419339	Pain (pleiotropy)	2e-08	37844115
rs9485408	rs1934534	0.961439846419339	Pain (pleiotropy)	2e-06	37844115
rs9485408	rs9505982	0.960984470323939	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9485408	rs80147756	0.919265542636776	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9485408	rs4421206	0.91491817608183	Brain morphology (min-P)	4e-11	32665545
rs9485408	rs9688452	0.895176300816421	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9485408	rs9688452	0.895176300816421	aseg lh volume VentralDC	2e-10	33875891
rs9485408	rs10872649	0.846688334478121	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9485408	rs10872649	0.846688334478121	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9485408	rs10872649	0.846688334478121	Right hippocampal volume (body)	1e-10	37337106
rs9485408	rs9322194	0.815502230885224	Brainstem volume	2e-11	31636452
rs9485408	rs7752089	0.813419829880675	Brain morphology (MOSTest)	2e-31	35164939
rs9485408	rs9285521	0.69377665275824	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9485408	rs12526675	0.641605306519562	Brain morphology (MOSTest)	7e-22	32665545
rs9485408	rs9688809	0.62764400998608	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9485408	rs34337297	0.624631289012377	Serum levels of protein LRP11	3e-161	35078996
rs9485408	rs10872645	0.623851361592884	Blood protein levels	2e-86	30072576
rs9485408	rs14314	0.622819500612405	Macular thickness	3e-19	30535121
rs9485408	rs14314	0.622819500612405	Vertex-wise sulcal depth	7e-17	34910505
rs9485408	rs14314	0.622819500612405	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9485408	rs14314	0.622819500612405	Left hippocampal volume (body)	7e-15	37337106
rs9485408	rs14314	0.622819500612405	Left subiculum volume (body)	1e-14	37337106
rs9485408	rs55763431	0.622502497965433	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9485408	rs9322193	0.622014837885711	Lung cancer	1e-07	27393504
rs9485408	rs9689694	0.621363701232172	Right hippocampal volume (head)	6e-11	37337106
rs9485408	rs9689694	0.621363701232172	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9485408	rs9689694	0.621363701232172	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9485408	rs9689694	0.621363701232172	Left hippocampal volume (head)	6e-12	37337106
rs9485408	rs9383843	0.620017125674574	Migraine	1e-09	35115687
rs9485408	rs2095375	0.619448652179028	Serum metabolite levels	1e-20	33031748
rs9485408	rs2095375	0.619448652179028	Serum metabolite levels	1e-20	33031748
rs9485408	rs10872653	0.617178156003887	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9485408	rs9688867	0.616875633366164	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9485408	rs9688867	0.616875633366164	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9485408	rs2342764	0.600828918817829	Cortical thickness	1e-08	34560273
rs9501594	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A level in Chronic kidney disease with hypertension and no diabetes (2730_58)	2e-100	35870639
rs9501594	rs1063631	0.89410837827193	MHC class I polypeptide-related sequence A levels	3e-287	34814699
rs9501594	rs6928810	0.890918957822312	Platelet distribution width	1e-14	32888494
rs9501594	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	1e-91	28240269
rs9501594	rs3869132	0.890074857961092	MHC class I polypeptide-related sequence A levels	5e-16	25147954
rs9501594	rs9266825	0.865137973433832	Autism spectrum disorder	6e-06	35215271
rs9501594	rs199530775	0.740988716009798	MHC class I polypeptide-related sequence B levels (MICB.5102.55.3)	2e-14	29875488
rs9501594	rs55957433	0.740988716009798	Hip circumference adjusted for BMI	3e-08	34021172
rs9501594	rs6934175	0.674745394452775	Psoriatic arthritis	5e-28	30552173
rs9501594	rs17200242	0.665399427664725	alpha-2-macroglobulin receptor-associated protein levels	1e-12	36168886
rs9501594	rs7751505	0.658511556536165	Pubertal anthropometrics	4e-06	23449627
rs9501594	rs35026345	0.657217115148282	CAG-81 sp000435795 abundance in stool	2e-08	35115689
rs9501594	rs72848707	0.65449542788258	HDL cholesterol levels	7e-06	35884923
rs9501594	rs13437088	0.632207845091374	Psoriasis	3e-40	23143594
rs9501594	rs13437082	0.631513452560533	Cerebrospinal fluid biomarker levels	1e-10	28031287
rs9501594	rs13437082	0.631513452560533	Height	5e-08	19343178
rs9501594	rs72657657	0.623916324677882	Hip circumference adjusted for BMI	4e-13	34021172
rs9505823	rs11155671	0.968591478901805	Testicular germ cell tumor	2e-09	28604728
rs9505823	rs1934534	0.955845716257736	Pain (pleiotropy)	2e-08	37844115
rs9505823	rs1934534	0.955845716257736	Pain (pleiotropy)	2e-06	37844115
rs9505823	rs4380763	0.955051480236231	Subcortical volume (min-P)	1e-11	32665545
rs9505823	rs9505982	0.953911573034982	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9505823	rs80147756	0.913873193586203	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9505823	rs4421206	0.908026160122455	Brain morphology (min-P)	4e-11	32665545
rs9505823	rs9688452	0.888297074537249	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9505823	rs9688452	0.888297074537249	aseg lh volume VentralDC	2e-10	33875891
rs9505823	rs10872649	0.84158272799363	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9505823	rs10872649	0.84158272799363	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9505823	rs10872649	0.84158272799363	Right hippocampal volume (body)	1e-10	37337106
rs9505823	rs9322194	0.809288500762629	Brainstem volume	2e-11	31636452
rs9505823	rs7752089	0.808518716379655	Brain morphology (MOSTest)	2e-31	35164939
rs9505823	rs9285521	0.688187548213243	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9505823	rs12526675	0.636365280545655	Brain morphology (MOSTest)	7e-22	32665545
rs9505823	rs9688809	0.626166454822613	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9505823	rs34337297	0.623140376880299	Serum levels of protein LRP11	3e-161	35078996
rs9505823	rs10872645	0.622362803169026	Blood protein levels	2e-86	30072576
rs9505823	rs14314	0.621348036248938	Macular thickness	3e-19	30535121
rs9505823	rs14314	0.621348036248938	Vertex-wise sulcal depth	7e-17	34910505
rs9505823	rs14314	0.621348036248938	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9505823	rs14314	0.621348036248938	Left hippocampal volume (body)	7e-15	37337106
rs9505823	rs14314	0.621348036248938	Left subiculum volume (body)	1e-14	37337106
rs9505823	rs55763431	0.621015211688404	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9505823	rs9322193	0.620556951187034	Lung cancer	1e-07	27393504
rs9505823	rs9689694	0.619874260070144	Right hippocampal volume (head)	6e-11	37337106
rs9505823	rs9689694	0.619874260070144	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9505823	rs9689694	0.619874260070144	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9505823	rs9689694	0.619874260070144	Left hippocampal volume (head)	6e-12	37337106
rs9505823	rs9383843	0.618528961906869	Migraine	1e-09	35115687
rs9505823	rs2095375	0.617959414258828	Serum metabolite levels	1e-20	33031748
rs9505823	rs2095375	0.617959414258828	Serum metabolite levels	1e-20	33031748
rs9505823	rs10872653	0.615684628352917	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9505823	rs9688867	0.615408120045963	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9505823	rs9688867	0.615408120045963	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9505824	rs11155671	0.971814020427767	Testicular germ cell tumor	2e-09	28604728
rs9505824	rs4380763	0.958276062827803	Subcortical volume (min-P)	1e-11	32665545
rs9505824	rs1934534	0.957484726667962	Pain (pleiotropy)	2e-08	37844115
rs9505824	rs1934534	0.957484726667962	Pain (pleiotropy)	2e-06	37844115
rs9505824	rs9505982	0.95698773745613	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9505824	rs4421206	0.915657303754281	Brain morphology (min-P)	4e-11	32665545
rs9505824	rs80147756	0.915368144261389	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9505824	rs9688452	0.895940200896495	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9505824	rs9688452	0.895940200896495	aseg lh volume VentralDC	2e-10	33875891
rs9505824	rs10872649	0.842920415828591	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9505824	rs10872649	0.842920415828591	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9505824	rs10872649	0.842920415828591	Right hippocampal volume (body)	1e-10	37337106
rs9505824	rs7752089	0.815495365193352	Brain morphology (MOSTest)	2e-31	35164939
rs9505824	rs9322194	0.814585443110178	Brainstem volume	2e-11	31636452
rs9505824	rs9285521	0.691505561563633	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9505824	rs12526675	0.64191131022555	Brain morphology (MOSTest)	7e-22	32665545
rs9505824	rs9688809	0.623404030870067	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9505824	rs34337297	0.620403987554827	Serum levels of protein LRP11	3e-161	35078996
rs9505824	rs10872645	0.619626621352508	Blood protein levels	2e-86	30072576
rs9505824	rs14314	0.618596384932292	Macular thickness	3e-19	30535121
rs9505824	rs14314	0.618596384932292	Vertex-wise sulcal depth	7e-17	34910505
rs9505824	rs14314	0.618596384932292	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9505824	rs14314	0.618596384932292	Left hippocampal volume (body)	7e-15	37337106
rs9505824	rs14314	0.618596384932292	Left subiculum volume (body)	1e-14	37337106
rs9505824	rs55763431	0.618282535409484	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9505824	rs9322193	0.617792898435188	Lung cancer	1e-07	27393504
rs9505824	rs9689694	0.617148172459009	Right hippocampal volume (head)	6e-11	37337106
rs9505824	rs9689694	0.617148172459009	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9505824	rs9689694	0.617148172459009	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9505824	rs9689694	0.617148172459009	Left hippocampal volume (head)	6e-12	37337106
rs9505824	rs9383843	0.615806374791431	Migraine	1e-09	35115687
rs9505824	rs2095375	0.615240116562053	Serum metabolite levels	1e-20	33031748
rs9505824	rs2095375	0.615240116562053	Serum metabolite levels	1e-20	33031748
rs9505824	rs10872653	0.612978468509956	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9505824	rs9688867	0.612673837793602	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9505824	rs9688867	0.612673837793602	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9505824	rs2342764	0.602337531120273	Cortical thickness	1e-08	34560273
rs9505826	rs11155671	0.971814020427767	Testicular germ cell tumor	2e-09	28604728
rs9505826	rs4380763	0.958276062827803	Subcortical volume (min-P)	1e-11	32665545
rs9505826	rs1934534	0.957484726667962	Pain (pleiotropy)	2e-08	37844115
rs9505826	rs1934534	0.957484726667962	Pain (pleiotropy)	2e-06	37844115
rs9505826	rs9505982	0.95698773745613	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9505826	rs4421206	0.915657303754281	Brain morphology (min-P)	4e-11	32665545
rs9505826	rs80147756	0.915368144261389	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9505826	rs9688452	0.895940200896495	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9505826	rs9688452	0.895940200896495	aseg lh volume VentralDC	2e-10	33875891
rs9505826	rs10872649	0.842920415828591	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9505826	rs10872649	0.842920415828591	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9505826	rs10872649	0.842920415828591	Right hippocampal volume (body)	1e-10	37337106
rs9505826	rs7752089	0.815495365193352	Brain morphology (MOSTest)	2e-31	35164939
rs9505826	rs9322194	0.814585443110178	Brainstem volume	2e-11	31636452
rs9505826	rs9285521	0.691505561563633	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9505826	rs12526675	0.64191131022555	Brain morphology (MOSTest)	7e-22	32665545
rs9505826	rs9688809	0.623404030870067	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9505826	rs34337297	0.620403987554827	Serum levels of protein LRP11	3e-161	35078996
rs9505826	rs10872645	0.619626621352508	Blood protein levels	2e-86	30072576
rs9505826	rs14314	0.618596384932292	Macular thickness	3e-19	30535121
rs9505826	rs14314	0.618596384932292	Vertex-wise sulcal depth	7e-17	34910505
rs9505826	rs14314	0.618596384932292	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9505826	rs14314	0.618596384932292	Left hippocampal volume (body)	7e-15	37337106
rs9505826	rs14314	0.618596384932292	Left subiculum volume (body)	1e-14	37337106
rs9505826	rs55763431	0.618282535409484	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9505826	rs9322193	0.617792898435188	Lung cancer	1e-07	27393504
rs9505826	rs9689694	0.617148172459009	Right hippocampal volume (head)	6e-11	37337106
rs9505826	rs9689694	0.617148172459009	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9505826	rs9689694	0.617148172459009	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9505826	rs9689694	0.617148172459009	Left hippocampal volume (head)	6e-12	37337106
rs9505826	rs9383843	0.615806374791431	Migraine	1e-09	35115687
rs9505826	rs2095375	0.615240116562053	Serum metabolite levels	1e-20	33031748
rs9505826	rs2095375	0.615240116562053	Serum metabolite levels	1e-20	33031748
rs9505826	rs10872653	0.612978468509956	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9505826	rs9688867	0.612673837793602	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9505826	rs9688867	0.612673837793602	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9505826	rs2342764	0.602337531120273	Cortical thickness	1e-08	34560273
rs9505982	rs9505982	1	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9505982	rs11155671	0.940522125561972	Testicular germ cell tumor	2e-09	28604728
rs9505982	rs4380763	0.927300997774675	Subcortical volume (min-P)	1e-11	32665545
rs9505982	rs1934534	0.926534338165198	Pain (pleiotropy)	2e-08	37844115
rs9505982	rs1934534	0.926534338165198	Pain (pleiotropy)	2e-06	37844115
rs9505982	rs4421206	0.90312007955201	Brain morphology (min-P)	4e-11	32665545
rs9505982	rs80147756	0.884691375304212	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9505982	rs9688452	0.883918760130083	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9505982	rs9688452	0.883918760130083	aseg lh volume VentralDC	2e-10	33875891
rs9505982	rs9322194	0.838690745883385	Brainstem volume	2e-11	31636452
rs9505982	rs10872649	0.816018330501441	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9505982	rs10872649	0.816018330501441	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9505982	rs10872649	0.816018330501441	Right hippocampal volume (body)	1e-10	37337106
rs9505982	rs7752089	0.784101216222178	Brain morphology (MOSTest)	2e-31	35164939
rs9505982	rs9285521	0.71533897463668	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9505982	rs12526675	0.627513556419397	Brain morphology (MOSTest)	7e-22	32665545
rs9505982	rs9688809	0.606916402370845	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9505982	rs34337297	0.604040941972678	Serum levels of protein LRP11	3e-161	35078996
rs9505982	rs10872645	0.603267312109969	Blood protein levels	2e-86	30072576
rs9505982	rs14314	0.602173265238806	Macular thickness	3e-19	30535121
rs9505982	rs14314	0.602173265238806	Vertex-wise sulcal depth	7e-17	34910505
rs9505982	rs14314	0.602173265238806	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9505982	rs14314	0.602173265238806	Left hippocampal volume (body)	7e-15	37337106
rs9505982	rs14314	0.602173265238806	Left subiculum volume (body)	1e-14	37337106
rs9505982	rs55763431	0.60194342559747	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9505982	rs9322193	0.601318487945432	Lung cancer	1e-07	27393504
rs9505982	rs9689694	0.600841957866217	Right hippocampal volume (head)	6e-11	37337106
rs9505982	rs9689694	0.600841957866217	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9505982	rs9689694	0.600841957866217	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9505982	rs9689694	0.600841957866217	Left hippocampal volume (head)	6e-12	37337106
rs9505983	rs34337297	0.966120745828617	Serum levels of protein LRP11	3e-161	35078996
rs9505983	rs10872645	0.96170058716608	Blood protein levels	2e-86	30072576
rs9505983	rs55763431	0.956389148687218	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9505983	rs9689694	0.954584517538495	Right hippocampal volume (head)	6e-11	37337106
rs9505983	rs9689694	0.954584517538495	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9505983	rs9689694	0.954584517538495	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9505983	rs9689694	0.954584517538495	Left hippocampal volume (head)	6e-12	37337106
rs9505983	rs2095375	0.951917507268953	Serum metabolite levels	1e-20	33031748
rs9505983	rs2095375	0.951917507268953	Serum metabolite levels	1e-20	33031748
rs9505983	rs9383843	0.951054004858222	Migraine	1e-09	35115687
rs9505983	rs9688867	0.948644445434086	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9505983	rs9688867	0.948644445434086	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9505983	rs9688809	0.948644445434086	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9505983	rs10872653	0.948319155479283	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9505983	rs4039600	0.938207165331288	Adenine levels	1e-11	35347128
rs9505983	rs14314	0.933781715629307	Macular thickness	3e-19	30535121
rs9505983	rs14314	0.933781715629307	Vertex-wise sulcal depth	7e-17	34910505
rs9505983	rs14314	0.933781715629307	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9505983	rs14314	0.933781715629307	Left hippocampal volume (body)	7e-15	37337106
rs9505983	rs14314	0.933781715629307	Left subiculum volume (body)	1e-14	37337106
rs9505983	rs9322193	0.932257588361468	Lung cancer	1e-07	27393504
rs9505983	rs1934534	0.628234512593661	Pain (pleiotropy)	2e-08	37844115
rs9505983	rs1934534	0.628234512593661	Pain (pleiotropy)	2e-06	37844115
rs9505983	rs4380763	0.627724313787655	Subcortical volume (min-P)	1e-11	32665545
rs9505983	rs11155671	0.617400400303416	Testicular germ cell tumor	2e-09	28604728
rs9505983	rs80147756	0.60027059958187	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9508742	rs7986681	0.682371025134586	Vertex-wise sulcal depth	8e-11	34910505
rs9525867	rs7321596	0.990827937463543	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs9525867	rs8002861	0.956896752068282	Leprosy	7e-06	25642632
rs9525869	rs7321596	0.99249065457011	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs9525869	rs8002861	0.958569707666156	Leprosy	7e-06	25642632
rs9526563	rs7987940	0.717103760189378	AFP levels	6e-08	36329257
rs9526563	rs9535244	0.650791983665097	Lung function (FVC)	1e-08	30595370
rs9532075	rs9547937	0.985912615127934	Serum levels of protein POSTN	6e-18	35078996
rs9532075	rs9603222	0.674594663598107	Blood protein levels	2e-12	30072576
rs9532417	rs7999758	0.993712734808941	Height	6e-17	30595370
rs9532417	rs6563739	0.992818748988152	Menarche (age at onset)	2e-11	25231870
rs9532417	rs4598779	0.916621330743195	Height	7e-77	36224396
rs9533672	rs7321596	0.799787400431078	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs9533672	rs8002861	0.77222270540461	Leprosy	7e-06	25642632
rs9533678	rs7321596	0.99249065457011	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs9533678	rs8002861	0.958569707666156	Leprosy	7e-06	25642632
rs9533685	rs7321596	0.99249065457011	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs9533685	rs8002861	0.958569707666156	Leprosy	7e-06	25642632
rs9547922	rs9547937	0.889700208136245	Serum levels of protein POSTN	6e-18	35078996
rs9547922	rs9603222	0.601964526375592	Blood protein levels	2e-12	30072576
rs9548881	rs7999758	0.950285918701939	Height	6e-17	30595370
rs9548881	rs6563739	0.949427817257086	Menarche (age at onset)	2e-11	25231870
rs9548881	rs4598779	0.876329033275109	Height	7e-77	36224396
rs9548881	rs9943	0.617317000047534	Asthma	4e-09	31959851
rs9548881	rs9603605	0.604006160335857	Menarche (age at onset)	5e-14	30595370
rs9548884	rs4598779	0.918837958773817	Height	7e-77	36224396
rs9548884	rs6563739	0.907931794205301	Menarche (age at onset)	2e-11	25231870
rs9548884	rs7999758	0.907066201323567	Height	6e-17	30595370
rs9548884	rs9532434	0.614901904953499	Eosinophil counts	5e-38	32888493
rs9548884	rs9532434	0.614901904953499	Eosinophil counts	5e-32	32888494
rs9548884	rs9532434	0.614901904953499	Eosinophil counts	8e-36	32888493
rs9548884	rs9532434	0.614901904953499	Eosinophil percentage of white cells	7e-34	32888494
rs9548884	rs9532434	0.614901904953499	Eosinophil percentage of white cells	2e-12	27863252
rs9548884	rs9532434	0.614901904953499	Rheumatoid arthritis	2e-19	33310728
rs9548884	rs9532434	0.614901904953499	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	5e-08	23603761
rs9548884	rs9532434	0.614901904953499	Eosinophil counts	1e-11	27863252
rs9548884	rs9532434	0.614901904953499	Sum eosinophil basophil counts	1e-10	27863252
rs9548884	rs9532434	0.614901904953499	Neutrophil percentage of granulocytes	2e-09	27863252
rs9548884	rs9532434	0.614901904953499	Eosinophil percentage of granulocytes	2e-10	27863252
rs9548884	rs9532434	0.614901904953499	Rheumatoid arthritis	9e-22	36333501
rs9548884	rs9532434	0.614901904953499	Rheumatoid arthritis	5e-15	36333501
rs9548884	rs9532434	0.614901904953499	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	7e-15	36333501
rs9548884	rs9532434	0.614901904953499	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	6e-18	36333501
rs9548884	rs9532434	0.614901904953499	Rheumatoid arthritis	2e-07	36333501
rs9548884	rs9532430	0.614088130269331	Eosinophil counts	9e-16	35935937
rs9548884	rs34270626	0.611984358336711	Asthma	6e-10	32296059
rs9567293	rs7321596	0.759406167536244	Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)	3e-08	31374203
rs9567293	rs8002861	0.732371472316743	Leprosy	7e-06	25642632
rs9584288	rs8002180	0.961509419576607	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs9584288	rs9590228	0.91592120505332	Height	7e-22	36224396
rs9584288	rs9524869	0.811023862410212	Serum metabolite levels	6e-32	33031748
rs9584288	rs9524869	0.811023862410212	N-acetylcarnosine levels	1e-42	35347128
rs9584288	rs9524869	0.811023862410212	N-acetylcarnosine levels	9e-47	35050183
rs9584288	rs9524869	0.811023862410212	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs9584288	rs9524869	0.811023862410212	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs9584288	rs9524869	0.811023862410212	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs9584288	rs9524869	0.811023862410212	N-acetylcarnosine levels	2e-60	36635386
rs9590228	rs9590228	1	Height	7e-22	36224396
rs9590228	rs8002180	0.944150856884202	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs9590228	rs9524869	0.733907506479512	Serum metabolite levels	6e-32	33031748
rs9590228	rs9524869	0.733907506479512	N-acetylcarnosine levels	1e-42	35347128
rs9590228	rs9524869	0.733907506479512	N-acetylcarnosine levels	9e-47	35050183
rs9590228	rs9524869	0.733907506479512	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs9590228	rs9524869	0.733907506479512	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs9590228	rs9524869	0.733907506479512	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs9590228	rs9524869	0.733907506479512	N-acetylcarnosine levels	2e-60	36635386
rs9590229	rs9590228	0.999165192496004	Height	7e-22	36224396
rs9590229	rs8002180	0.944942144724222	X-12244--N-acetylcarnosine levels	8e-23	24816252
rs9590229	rs9524869	0.734681861846541	Serum metabolite levels	6e-32	33031748
rs9590229	rs9524869	0.734681861846541	N-acetylcarnosine levels	1e-42	35347128
rs9590229	rs9524869	0.734681861846541	N-acetylcarnosine levels	9e-47	35050183
rs9590229	rs9524869	0.734681861846541	Urine N-acetylcarnosine levels in chronic kidney disease	5e-23	37277652
rs9590229	rs9524869	0.734681861846541	Plasma N-acetylcarnosine levels in chronic kidney disease	1e-36	37277652
rs9590229	rs9524869	0.734681861846541	Urine argininosuccinate levels in chronic kidney disease	2e-11	37277652
rs9590229	rs9524869	0.734681861846541	N-acetylcarnosine levels	2e-60	36635386
rs9593109	rs2224797	0.887101579192896	Red blood cell count	5e-08	30595370
rs9593109	rs2224797	0.887101579192896	Mean corpuscular hemoglobin	3e-09	30595370
rs9600511	rs2224797	0.895380253818464	Red blood cell count	5e-08	30595370
rs9600511	rs2224797	0.895380253818464	Mean corpuscular hemoglobin	3e-09	30595370
rs9600517	rs2224797	0.881183306476633	Red blood cell count	5e-08	30595370
rs9600517	rs2224797	0.881183306476633	Mean corpuscular hemoglobin	3e-09	30595370
rs9603222	rs9603222	1	Blood protein levels	2e-12	30072576
rs9603222	rs4424789	0.81783398008739	Periostin levels	2e-19	34648354
rs9603222	rs9547937	0.680414352648605	Serum levels of protein POSTN	6e-18	35078996
rs9603605	rs9603605	1	Menarche (age at onset)	5e-14	30595370
rs9603605	rs34394770	0.981993618784535	Psoriasis	5e-08	25903422
rs9603605	rs34394770	0.981993618784535	Psoriasis	3e-08	25903422
rs9603605	rs34394770	0.981993618784535	Height	3e-11	34594039
rs9603605	rs34394770	0.981993618784535	Eosinophil counts	9e-24	34469753
rs9603605	rs9943	0.972159088393456	Asthma	4e-09	31959851
rs9603605	rs9603612	0.946411960787034	Systemic lupus erythematosus or rheumatoid arthritis	3e-13	27193031
rs9603605	rs12875311	0.944392585705994	Height	2e-19	36224396
rs9603605	rs9603608	0.937704150448373	Respiratory diseases	8e-08	30595370
rs9603605	rs7320598	0.929716478221873	Height	5e-16	31562340
rs9603605	rs7320598	0.929716478221873	Rheumatoid arthritis	2e-14	35470158
rs9603605	rs8002731	0.838445488234945	Asthma (adult onset)	4e-10	31669095
rs9603605	rs8002731	0.838445488234945	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	4e-10	35470158
rs9603605	rs9603616	0.820720472120654	Rheumatoid arthritis	2e-12	30423114
rs9603605	rs9603616	0.820720472120654	Rheumatoid arthritis	8e-11	30423114
rs9603605	rs9603616	0.820720472120654	Rheumatoid arthritis	2e-12	24390342
rs9603605	rs9603616	0.820720472120654	Rheumatoid arthritis	3e-11	24390342
rs9603605	rs9603616	0.820720472120654	Asthma	4e-08	34594039
rs9603605	rs11618582	0.820720472120654	Age of onset of adult onset asthma	9e-09	36778051
rs9603605	rs12872801	0.768725447031721	Systemic lupus erythematosus (MTAG)	4e-08	36750564
rs9603605	rs12872801	0.768725447031721	Eosinophil counts	5e-40	30595370
rs9603605	rs7993214	0.757332192104986	Psoriasis	2e-06	18369459
rs9603605	rs7993214	0.757332192104986	Multiple sclerosis	2e-06	24076602
rs9603605	rs7993214	0.757332192104986	Rheumatoid arthritis (ACPA-positive)	5e-06	23143596
rs9603605	rs7993214	0.757332192104986	COVID-19 hospitalization or rheumatoid arthritis (MTAG)	5e-11	36762574
rs9603608	rs9603608	1	Respiratory diseases	8e-08	30595370
rs9603608	rs9603612	0.965092758889146	Systemic lupus erythematosus or rheumatoid arthritis	3e-13	27193031
rs9603608	rs12875311	0.965072725951656	Height	2e-19	36224396
rs9603608	rs9943	0.959351167171319	Asthma	4e-09	31959851
rs9603608	rs7320598	0.958147783427564	Height	5e-16	31562340
rs9603608	rs7320598	0.958147783427564	Rheumatoid arthritis	2e-14	35470158
rs9603608	rs9603605	0.937704150448373	Menarche (age at onset)	5e-14	30595370
rs9603608	rs34394770	0.927967961541499	Psoriasis	5e-08	25903422
rs9603608	rs34394770	0.927967961541499	Psoriasis	3e-08	25903422
rs9603608	rs34394770	0.927967961541499	Height	3e-11	34594039
rs9603608	rs34394770	0.927967961541499	Eosinophil counts	9e-24	34469753
rs9603608	rs8002731	0.867354073596379	Asthma (adult onset)	4e-10	31669095
rs9603608	rs8002731	0.867354073596379	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	4e-10	35470158
rs9603608	rs9603616	0.849377944087833	Rheumatoid arthritis	2e-12	30423114
rs9603608	rs9603616	0.849377944087833	Rheumatoid arthritis	8e-11	30423114
rs9603608	rs9603616	0.849377944087833	Rheumatoid arthritis	2e-12	24390342
rs9603608	rs9603616	0.849377944087833	Rheumatoid arthritis	3e-11	24390342
rs9603608	rs9603616	0.849377944087833	Asthma	4e-08	34594039
rs9603608	rs11618582	0.849377944087833	Age of onset of adult onset asthma	9e-09	36778051
rs9603608	rs12872801	0.797134540123121	Systemic lupus erythematosus (MTAG)	4e-08	36750564
rs9603608	rs12872801	0.797134540123121	Eosinophil counts	5e-40	30595370
rs9603608	rs7993214	0.780507303190627	Psoriasis	2e-06	18369459
rs9603608	rs7993214	0.780507303190627	Multiple sclerosis	2e-06	24076602
rs9603608	rs7993214	0.780507303190627	Rheumatoid arthritis (ACPA-positive)	5e-06	23143596
rs9603608	rs7993214	0.780507303190627	COVID-19 hospitalization or rheumatoid arthritis (MTAG)	5e-11	36762574
rs9603608	rs34270626	0.617199021736396	Asthma	6e-10	32296059
rs9603608	rs9532434	0.608735264115328	Eosinophil counts	5e-38	32888493
rs9603608	rs9532434	0.608735264115328	Eosinophil counts	5e-32	32888494
rs9603608	rs9532434	0.608735264115328	Eosinophil counts	8e-36	32888493
rs9603608	rs9532434	0.608735264115328	Eosinophil percentage of white cells	7e-34	32888494
rs9603608	rs9532434	0.608735264115328	Eosinophil percentage of white cells	2e-12	27863252
rs9603608	rs9532434	0.608735264115328	Rheumatoid arthritis	2e-19	33310728
rs9603608	rs9532434	0.608735264115328	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	5e-08	23603761
rs9603608	rs9532434	0.608735264115328	Eosinophil counts	1e-11	27863252
rs9603608	rs9532434	0.608735264115328	Sum eosinophil basophil counts	1e-10	27863252
rs9603608	rs9532434	0.608735264115328	Neutrophil percentage of granulocytes	2e-09	27863252
rs9603608	rs9532434	0.608735264115328	Eosinophil percentage of granulocytes	2e-10	27863252
rs9603608	rs9532434	0.608735264115328	Rheumatoid arthritis	9e-22	36333501
rs9603608	rs9532434	0.608735264115328	Rheumatoid arthritis	5e-15	36333501
rs9603608	rs9532434	0.608735264115328	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	7e-15	36333501
rs9603608	rs9532434	0.608735264115328	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	6e-18	36333501
rs9603608	rs9532434	0.608735264115328	Rheumatoid arthritis	2e-07	36333501
rs9603608	rs9532430	0.608672466743283	Eosinophil counts	9e-16	35935937
rs9603612	rs9603612	1	Systemic lupus erythematosus or rheumatoid arthritis	3e-13	27193031
rs9603612	rs12875311	0.987936042321529	Height	2e-19	36224396
rs9603612	rs7320598	0.982932332772468	Height	5e-16	31562340
rs9603612	rs7320598	0.982932332772468	Rheumatoid arthritis	2e-14	35470158
rs9603612	rs9603608	0.965092758889146	Respiratory diseases	8e-08	30595370
rs9603612	rs34394770	0.960142692761279	Psoriasis	5e-08	25903422
rs9603612	rs34394770	0.960142692761279	Psoriasis	3e-08	25903422
rs9603612	rs34394770	0.960142692761279	Height	3e-11	34594039
rs9603612	rs34394770	0.960142692761279	Eosinophil counts	9e-24	34469753
rs9603612	rs9943	0.958353738346987	Asthma	4e-09	31959851
rs9603612	rs9603605	0.946411960787034	Menarche (age at onset)	5e-14	30595370
rs9603612	rs8002731	0.877475841080231	Asthma (adult onset)	4e-10	31669095
rs9603612	rs8002731	0.877475841080231	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	4e-10	35470158
rs9603612	rs9603616	0.859357678632703	Rheumatoid arthritis	2e-12	30423114
rs9603612	rs9603616	0.859357678632703	Rheumatoid arthritis	8e-11	30423114
rs9603612	rs9603616	0.859357678632703	Rheumatoid arthritis	2e-12	24390342
rs9603612	rs9603616	0.859357678632703	Rheumatoid arthritis	3e-11	24390342
rs9603612	rs9603616	0.859357678632703	Asthma	4e-08	34594039
rs9603612	rs11618582	0.859357678632703	Age of onset of adult onset asthma	9e-09	36778051
rs9603612	rs12872801	0.808513432557696	Systemic lupus erythematosus (MTAG)	4e-08	36750564
rs9603612	rs12872801	0.808513432557696	Eosinophil counts	5e-40	30595370
rs9603612	rs7993214	0.793613621011409	Psoriasis	2e-06	18369459
rs9603612	rs7993214	0.793613621011409	Multiple sclerosis	2e-06	24076602
rs9603612	rs7993214	0.793613621011409	Rheumatoid arthritis (ACPA-positive)	5e-06	23143596
rs9603612	rs7993214	0.793613621011409	COVID-19 hospitalization or rheumatoid arthritis (MTAG)	5e-11	36762574
rs9603612	rs34270626	0.630264063603957	Asthma	6e-10	32296059
rs9603612	rs9532430	0.621640175123373	Eosinophil counts	9e-16	35935937
rs9603612	rs9532434	0.615787735950635	Eosinophil counts	5e-38	32888493
rs9603612	rs9532434	0.615787735950635	Eosinophil counts	5e-32	32888494
rs9603612	rs9532434	0.615787735950635	Eosinophil counts	8e-36	32888493
rs9603612	rs9532434	0.615787735950635	Eosinophil percentage of white cells	7e-34	32888494
rs9603612	rs9532434	0.615787735950635	Eosinophil percentage of white cells	2e-12	27863252
rs9603612	rs9532434	0.615787735950635	Rheumatoid arthritis	2e-19	33310728
rs9603612	rs9532434	0.615787735950635	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	5e-08	23603761
rs9603612	rs9532434	0.615787735950635	Eosinophil counts	1e-11	27863252
rs9603612	rs9532434	0.615787735950635	Sum eosinophil basophil counts	1e-10	27863252
rs9603612	rs9532434	0.615787735950635	Neutrophil percentage of granulocytes	2e-09	27863252
rs9603612	rs9532434	0.615787735950635	Eosinophil percentage of granulocytes	2e-10	27863252
rs9603612	rs9532434	0.615787735950635	Rheumatoid arthritis	9e-22	36333501
rs9603612	rs9532434	0.615787735950635	Rheumatoid arthritis	5e-15	36333501
rs9603612	rs9532434	0.615787735950635	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	7e-15	36333501
rs9603612	rs9532434	0.615787735950635	Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	6e-18	36333501
rs9603612	rs9532434	0.615787735950635	Rheumatoid arthritis	2e-07	36333501
rs9603612	rs9603618	0.604138126139423	Rheumatoid arthritis (ACPA-positive)	5e-09	24532676
rs9610438	rs6000172	0.928404085201904	Severe COVID-19 infection	1e-07	36662838
rs9610438	rs4821461	0.909111343683328	Severe COVID-19 infection	4e-06	36662838
rs9610438	rs2227169	0.908289630084945	Severe COVID-19 infection	4e-13	36662838
rs9610438	rs1053982	0.89046591008548	Severe COVID-19 infection	9e-06	36662838
rs9610438	rs5756090	0.757240870516549	Severe COVID-19 infection	4e-08	36662838
rs9611440	rs9611441	0.985073091459369	C-reactive protein levels	1e-08	30388399
rs9611440	rs138354	0.977612601870477	Apolipoprotein B levels	8e-09	32203549
rs9611440	rs103197	0.940977862863881	Bipolar disorder (MTAG)	7e-09	34159505
rs9611440	rs5758128	0.903432825951752	Low density lipoprotein cholesterol levels	6e-13	32154731
rs9611440	rs5758128	0.903432825951752	Total cholesterol levels	4e-08	34594039
rs9611441	rs9611441	1	C-reactive protein levels	1e-08	30388399
rs9611441	rs138354	0.989155034375755	Apolipoprotein B levels	8e-09	32203549
rs9611441	rs103197	0.952076029665124	Bipolar disorder (MTAG)	7e-09	34159505
rs9611441	rs5758128	0.913939088956264	Low density lipoprotein cholesterol levels	6e-13	32154731
rs9611441	rs5758128	0.913939088956264	Total cholesterol levels	4e-08	34594039
rs9635310	rs2162062	0.735396281105844	Height	2e-13	35831902
rs9635310	rs1436958	0.692958180122857	IgG glycosylation	9e-06	23382691
rs9635310	rs933807	0.690629995818717	Fat-free mass	6e-06	30593698
rs9635310	rs933807	0.690629995818717	Fat-free mass	2e-07	30593698
rs9635310	rs933807	0.690629995818717	Fat-free mass	8e-11	30593698
rs9637655	rs17007017	0.782196407618056	Conduct disorder	7e-06	20585324
rs9637655	rs34402449	0.745895773736144	Smoking initiation (ever regular vs never regular) (MTAG)	3e-07	30643251
rs9637655	rs1550057	0.67803644029004	Conduct disorder	4e-06	20585324
rs9637655	rs1550057	0.67803644029004	Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome	3e-06	31005965
rs9642920	rs6471393	0.607358760319468	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs9643335	rs6471393	0.607358760319468	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	7e-06	25461247
rs9647786	rs4304220	0.924192218351358	Height	2e-14	36224396
rs9647786	rs13232536	0.723479158427966	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs9647786	rs13227841	0.669759925572447	Asthma	2e-09	32514122
rs9647786	rs4355658	0.647306228542707	Height	3e-13	36224396
rs9678632	rs58588820	0.997599364095019	Total cholesterol levels	1e-09	34887591
rs9678632	rs58588820	0.997599364095019	Total cholesterol levels	8e-11	34887591
rs9678632	rs6547629	0.894656388968167	Height	3e-09	36224396
rs9678632	rs10206961	0.63569919705824	Parental longevity (father's age at death)	2e-06	31484785
rs9688794	rs9505982	0.983952696389212	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9688794	rs11155671	0.933005235861518	Testicular germ cell tumor	2e-09	28604728
rs9688794	rs4380763	0.919878519417271	Subcortical volume (min-P)	1e-11	32665545
rs9688794	rs1934534	0.919120086098325	Pain (pleiotropy)	2e-08	37844115
rs9688794	rs1934534	0.919120086098325	Pain (pleiotropy)	2e-06	37844115
rs9688794	rs4421206	0.900101951216177	Brain morphology (min-P)	4e-11	32665545
rs9688794	rs9688452	0.881093589142322	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9688794	rs9688452	0.881093589142322	aseg lh volume VentralDC	2e-10	33875891
rs9688794	rs80147756	0.87725607670911	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9688794	rs9322194	0.848182802933598	Brainstem volume	2e-11	31636452
rs9688794	rs10872649	0.802908408587306	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9688794	rs10872649	0.802908408587306	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9688794	rs10872649	0.802908408587306	Right hippocampal volume (body)	1e-10	37337106
rs9688794	rs7752089	0.775229879052575	Brain morphology (MOSTest)	2e-31	35164939
rs9688794	rs9285521	0.72089724274936	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9688794	rs12526675	0.636126017163355	Brain morphology (MOSTest)	7e-22	32665545
rs9688794	rs11155662	0.600788806192248	Vertex-wise cortical thickness	2e-09	34910505
rs9688858	rs34337297	0.970595476615989	Serum levels of protein LRP11	3e-161	35078996
rs9688858	rs9322193	0.969783917048309	Lung cancer	1e-07	27393504
rs9688858	rs10872645	0.966175767298822	Blood protein levels	2e-86	30072576
rs9688858	rs55763431	0.960885171812841	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9688858	rs9689694	0.959121383311176	Right hippocampal volume (head)	6e-11	37337106
rs9688858	rs9689694	0.959121383311176	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9688858	rs9689694	0.959121383311176	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9688858	rs9689694	0.959121383311176	Left hippocampal volume (head)	6e-12	37337106
rs9688858	rs2095375	0.956481607255699	Serum metabolite levels	1e-20	33031748
rs9688858	rs2095375	0.956481607255699	Serum metabolite levels	1e-20	33031748
rs9688858	rs9383843	0.955604564778335	Migraine	1e-09	35115687
rs9688858	rs9688867	0.953019471329146	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9688858	rs9688867	0.953019471329146	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9688858	rs9688809	0.953019471329146	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9688858	rs10872653	0.952964633486972	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9688858	rs14314	0.938198425142496	Macular thickness	3e-19	30535121
rs9688858	rs14314	0.938198425142496	Vertex-wise sulcal depth	7e-17	34910505
rs9688858	rs14314	0.938198425142496	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9688858	rs14314	0.938198425142496	Left hippocampal volume (body)	7e-15	37337106
rs9688858	rs14314	0.938198425142496	Left subiculum volume (body)	1e-14	37337106
rs9688858	rs4039600	0.924568090814137	Adenine levels	1e-11	35347128
rs9688858	rs11155671	0.635392899251392	Testicular germ cell tumor	2e-09	28604728
rs9688858	rs1934534	0.630047236847608	Pain (pleiotropy)	2e-08	37844115
rs9688858	rs1934534	0.630047236847608	Pain (pleiotropy)	2e-06	37844115
rs9688858	rs4380763	0.629527893834476	Subcortical volume (min-P)	1e-11	32665545
rs9688858	rs9505982	0.619474471982318	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9688858	rs80147756	0.604319537818448	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9688861	rs11155671	0.97261854342755	Testicular germ cell tumor	2e-09	28604728
rs9688861	rs4380763	0.959078175001066	Subcortical volume (min-P)	1e-11	32665545
rs9688861	rs1934534	0.958286910951392	Pain (pleiotropy)	2e-08	37844115
rs9688861	rs1934534	0.958286910951392	Pain (pleiotropy)	2e-06	37844115
rs9688861	rs9505982	0.957769979523564	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9688861	rs80147756	0.919240937608387	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9688861	rs4421206	0.911778448973451	Brain morphology (min-P)	4e-11	32665545
rs9688861	rs9688452	0.892108732208496	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9688861	rs9688452	0.892108732208496	aseg lh volume VentralDC	2e-10	33875891
rs9688861	rs10872649	0.843645542443413	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9688861	rs10872649	0.843645542443413	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9688861	rs10872649	0.843645542443413	Right hippocampal volume (body)	1e-10	37337106
rs9688861	rs7752089	0.811822192794501	Brain morphology (MOSTest)	2e-31	35164939
rs9688861	rs9322194	0.810893157035408	Brainstem volume	2e-11	31636452
rs9688861	rs9285521	0.690749963183629	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9688861	rs12526675	0.638568024866614	Brain morphology (MOSTest)	7e-22	32665545
rs9688861	rs9688809	0.624239118039083	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9688861	rs34337297	0.621241240556868	Serum levels of protein LRP11	3e-161	35078996
rs9688861	rs10872645	0.620462984180832	Blood protein levels	2e-86	30072576
rs9688861	rs14314	0.61942808309039	Macular thickness	3e-19	30535121
rs9688861	rs14314	0.61942808309039	Vertex-wise sulcal depth	7e-17	34910505
rs9688861	rs14314	0.61942808309039	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9688861	rs14314	0.61942808309039	Left hippocampal volume (body)	7e-15	37337106
rs9688861	rs14314	0.61942808309039	Left subiculum volume (body)	1e-14	37337106
rs9688861	rs55763431	0.619118057253234	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9688861	rs9322193	0.618620903571632	Lung cancer	1e-07	27393504
rs9688861	rs9689694	0.617983790423697	Right hippocampal volume (head)	6e-11	37337106
rs9688861	rs9689694	0.617983790423697	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9688861	rs9689694	0.617983790423697	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9688861	rs9689694	0.617983790423697	Left hippocampal volume (head)	6e-12	37337106
rs9688861	rs9383843	0.616641150375592	Migraine	1e-09	35115687
rs9688861	rs2095375	0.616074939515198	Serum metabolite levels	1e-20	33031748
rs9688861	rs2095375	0.616074939515198	Serum metabolite levels	1e-20	33031748
rs9688861	rs10872653	0.613813480502613	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9688861	rs9688867	0.613502236716709	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9688861	rs9688867	0.613502236716709	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9689084	rs9505982	0.981534292488224	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9689084	rs11155671	0.935286260682962	Testicular germ cell tumor	2e-09	28604728
rs9689084	rs4380763	0.922136061821065	Subcortical volume (min-P)	1e-11	32665545
rs9689084	rs1934534	0.921375779761901	Pain (pleiotropy)	2e-08	37844115
rs9689084	rs1934534	0.921375779761901	Pain (pleiotropy)	2e-06	37844115
rs9689084	rs4421206	0.897790215958853	Brain morphology (min-P)	4e-11	32665545
rs9689084	rs80147756	0.882527561873579	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9689084	rs9688452	0.878772536414614	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9689084	rs9688452	0.878772536414614	aseg lh volume VentralDC	2e-10	33875891
rs9689084	rs9322194	0.844639990777441	Brainstem volume	2e-11	31636452
rs9689084	rs10872649	0.806528372256939	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9689084	rs10872649	0.806528372256939	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9689084	rs10872649	0.806528372256939	Right hippocampal volume (body)	1e-10	37337106
rs9689084	rs7752089	0.771749790108772	Brain morphology (MOSTest)	2e-31	35164939
rs9689084	rs9285521	0.719082710584801	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9689084	rs12526675	0.634503554315788	Brain morphology (MOSTest)	7e-22	32665545
rs9689516	rs9462030	0.991161605706325	Red cell distribution width	5e-25	32888493
rs9689516	rs9469857	0.986362420621675	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9689516	rs2764208	0.985572399705324	Systemic lupus erythematosus	7e-06	24871463
rs9689516	rs9469899	0.974512167021756	Prostate cancer (advanced)	2e-06	29892016
rs9689516	rs9469899	0.974512167021756	Prostate cancer	5e-09	29892016
rs9689516	rs9469899	0.974512167021756	Prostate cancer	8e-11	33398198
rs9689516	rs9469899	0.974512167021756	Hand grip strength	3e-15	29691431
rs9689516	rs9469899	0.974512167021756	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9689516	rs9469899	0.974512167021756	Graves' disease	4e-10	34594039
rs9689516	rs9469899	0.974512167021756	Coronary artery disease	1e-11	36474045
rs9689516	rs9469899	0.974512167021756	Predicted visceral adipose tissue	2e-20	31501611
rs9689516	rs9469899	0.974512167021756	Medication use (thyroid preparations)	2e-09	31015401
rs9689516	rs9469899	0.974512167021756	Medication use (thyroid preparations)	3e-10	34594039
rs9689516	rs9469872	0.950184689459921	HDL cholesterol levels	3e-11	36333282
rs9689516	rs11755393	0.943625596386269	Body mass index	3e-26	29273807
rs9689516	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-12	33493351
rs9689516	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-06	33493351
rs9689516	rs11755393	0.943625596386269	Systemic lupus erythematosus	1e-07	33493351
rs9689516	rs11755393	0.943625596386269	Systemic lupus erythematosus	2e-08	19838195
rs9689516	rs11755393	0.943625596386269	Body mass index	4e-55	36581621
rs9689516	rs9366863	0.939973736176852	Adult body size	9e-33	32376654
rs9689516	rs9366863	0.939973736176852	Body mass index	2e-44	30595370
rs9689516	rs9296128	0.935762261955665	Hip circumference adjusted for BMI	4e-13	34021172
rs9689516	rs6941110	0.932136337001036	Sex hormone-binding globulin levels	5e-27	36653534
rs9689516	rs2814949	0.903864952971577	Essential hypertension (time to event)	9e-09	32589924
rs9689516	rs2744944	0.894545120858599	Hypothyroidism	3e-10	34594039
rs9689516	rs2744944	0.894545120858599	High density lipoprotein cholesterol levels	3e-86	34887591
rs9689516	rs2744944	0.894545120858599	Multi-trait sex score	7e-22	37277458
rs9689516	rs2263329	0.875396108441792	HDL cholesterol	6e-35	34594039
rs9689516	rs2263329	0.875396108441792	HDL cholesterol levels	8e-43	32203549
rs9689516	rs2263329	0.875396108441792	High density lipoprotein cholesterol levels	2e-52	34887591
rs9689516	rs111868030	0.853200374058615	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9689516	rs9368830	0.830777818617479	HDL cholesterol	4e-21	30275531
rs9689516	rs9368828	0.804386143241035	Body mass index	1e-34	34594039
rs9689516	rs2744973	0.800949824982075	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9689516	rs2744973	0.800949824982075	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9689516	rs2744973	0.800949824982075	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9689516	rs2744973	0.800949824982075	Multi-trait sex score	6e-20	37277458
rs9689516	rs6912327	0.788456024158244	Fasting insulin	5e-06	33402679
rs9689516	rs6912327	0.788456024158244	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9689516	rs112283401	0.766192579753087	Red cell distribution width	4e-27	30595370
rs9689516	rs9689160	0.631086542785279	Lung function (forced vital capacity)	3e-14	36914875
rs9689599	rs11155671	0.971789818273642	Testicular germ cell tumor	2e-09	28604728
rs9689599	rs1934534	0.95902427245322	Pain (pleiotropy)	2e-08	37844115
rs9689599	rs1934534	0.95902427245322	Pain (pleiotropy)	2e-06	37844115
rs9689599	rs4380763	0.958228550768841	Subcortical volume (min-P)	1e-11	32665545
rs9689599	rs9505982	0.955494426752104	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9689599	rs80147756	0.916974040888746	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9689599	rs4421206	0.911114699035366	Brain morphology (min-P)	4e-11	32665545
rs9689599	rs9688452	0.891356064123337	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9689599	rs9688452	0.891356064123337	aseg lh volume VentralDC	2e-10	33875891
rs9689599	rs10872649	0.8445524317665	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9689599	rs10872649	0.8445524317665	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9689599	rs10872649	0.8445524317665	Right hippocampal volume (body)	1e-10	37337106
rs9689599	rs7752089	0.811423473026006	Brain morphology (MOSTest)	2e-31	35164939
rs9689599	rs9322194	0.810738596634311	Brainstem volume	2e-11	31636452
rs9689599	rs9285521	0.68952488716706	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9689599	rs12526675	0.638945396937761	Brain morphology (MOSTest)	7e-22	32665545
rs9689599	rs9688809	0.627517801447742	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9689599	rs34337297	0.624490474255146	Serum levels of protein LRP11	3e-161	35078996
rs9689599	rs10872645	0.623711855189654	Blood protein levels	2e-86	30072576
rs9689599	rs14314	0.622693976548039	Macular thickness	3e-19	30535121
rs9689599	rs14314	0.622693976548039	Vertex-wise sulcal depth	7e-17	34910505
rs9689599	rs14314	0.622693976548039	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9689599	rs14314	0.622693976548039	Left hippocampal volume (body)	7e-15	37337106
rs9689599	rs14314	0.622693976548039	Left subiculum volume (body)	1e-14	37337106
rs9689599	rs55763431	0.622362803169026	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9689599	rs9322193	0.621900450018618	Lung cancer	1e-07	27393504
rs9689599	rs9689694	0.621221019653779	Right hippocampal volume (head)	6e-11	37337106
rs9689599	rs9689694	0.621221019653779	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9689599	rs9689694	0.621221019653779	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9689599	rs9689694	0.621221019653779	Left hippocampal volume (head)	6e-12	37337106
rs9689599	rs9383843	0.619874260070144	Migraine	1e-09	35115687
rs9689599	rs2095375	0.619304296382578	Serum metabolite levels	1e-20	33031748
rs9689599	rs2095375	0.619304296382578	Serum metabolite levels	1e-20	33031748
rs9689599	rs10872653	0.617027848640646	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9689599	rs9688867	0.61674781373234	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9689599	rs9688867	0.61674781373234	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9689723	rs4380763	0.992702283104435	Subcortical volume (min-P)	1e-11	32665545
rs9689723	rs1934534	0.991893128010015	Pain (pleiotropy)	2e-08	37844115
rs9689723	rs1934534	0.991893128010015	Pain (pleiotropy)	2e-06	37844115
rs9689723	rs11155671	0.982220186706878	Testicular germ cell tumor	2e-09	28604728
rs9689723	rs80147756	0.949137729258732	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9689723	rs4421206	0.943189427160819	Brain morphology (min-P)	4e-11	32665545
rs9689723	rs9505982	0.93119318478775	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9689723	rs9688452	0.923052023804775	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9689723	rs9688452	0.923052023804775	aseg lh volume VentralDC	2e-10	33875891
rs9689723	rs10872649	0.870915704222649	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9689723	rs10872649	0.870915704222649	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9689723	rs10872649	0.870915704222649	Right hippocampal volume (body)	1e-10	37337106
rs9689723	rs7752089	0.828505949707102	Brain morphology (MOSTest)	2e-31	35164939
rs9689723	rs9322194	0.788852736265746	Brainstem volume	2e-11	31636452
rs9689723	rs9285521	0.673509207366361	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9689723	rs12526675	0.652092662224834	Brain morphology (MOSTest)	7e-22	32665545
rs9689723	rs9688809	0.644779581545914	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9689723	rs34337297	0.641715852853825	Serum levels of protein LRP11	3e-161	35078996
rs9689723	rs10872645	0.640925655170068	Blood protein levels	2e-86	30072576
rs9689723	rs14314	0.639887388364758	Macular thickness	3e-19	30535121
rs9689723	rs14314	0.639887388364758	Vertex-wise sulcal depth	7e-17	34910505
rs9689723	rs14314	0.639887388364758	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9689723	rs14314	0.639887388364758	Left hippocampal volume (body)	7e-15	37337106
rs9689723	rs14314	0.639887388364758	Left subiculum volume (body)	1e-14	37337106
rs9689723	rs55763431	0.639557612334129	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9689723	rs9689694	0.638400994337102	Right hippocampal volume (head)	6e-11	37337106
rs9689723	rs9689694	0.638400994337102	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9689723	rs9689694	0.638400994337102	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9689723	rs9689694	0.638400994337102	Left hippocampal volume (head)	6e-12	37337106
rs9689723	rs9383843	0.63703523881423	Migraine	1e-09	35115687
rs9689723	rs2095375	0.636457861299539	Serum metabolite levels	1e-20	33031748
rs9689723	rs2095375	0.636457861299539	Serum metabolite levels	1e-20	33031748
rs9689723	rs10872653	0.634151801492693	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9689723	rs9688867	0.632499276157096	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9689723	rs9688867	0.632499276157096	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9689723	rs9322193	0.618794355452597	Lung cancer	1e-07	27393504
rs9689723	rs2342764	0.611180655003366	Cortical thickness	1e-08	34560273
rs9689820	rs9462030	0.992772816782388	Red cell distribution width	5e-25	32888493
rs9689820	rs9469857	0.987972909528024	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs9689820	rs2764208	0.987184426748861	Systemic lupus erythematosus	7e-06	24871463
rs9689820	rs9469899	0.976088010907773	Prostate cancer (advanced)	2e-06	29892016
rs9689820	rs9469899	0.976088010907773	Prostate cancer	5e-09	29892016
rs9689820	rs9469899	0.976088010907773	Prostate cancer	8e-11	33398198
rs9689820	rs9469899	0.976088010907773	Hand grip strength	3e-15	29691431
rs9689820	rs9469899	0.976088010907773	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs9689820	rs9469899	0.976088010907773	Graves' disease	4e-10	34594039
rs9689820	rs9469899	0.976088010907773	Coronary artery disease	1e-11	36474045
rs9689820	rs9469899	0.976088010907773	Predicted visceral adipose tissue	2e-20	31501611
rs9689820	rs9469899	0.976088010907773	Medication use (thyroid preparations)	2e-09	31015401
rs9689820	rs9469899	0.976088010907773	Medication use (thyroid preparations)	3e-10	34594039
rs9689820	rs9469872	0.9517336722848	HDL cholesterol levels	3e-11	36333282
rs9689820	rs11755393	0.945151555983629	Body mass index	3e-26	29273807
rs9689820	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-12	33493351
rs9689820	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-06	33493351
rs9689820	rs11755393	0.945151555983629	Systemic lupus erythematosus	1e-07	33493351
rs9689820	rs11755393	0.945151555983629	Systemic lupus erythematosus	2e-08	19838195
rs9689820	rs11755393	0.945151555983629	Body mass index	4e-55	36581621
rs9689820	rs9366863	0.941517151790621	Adult body size	9e-33	32376654
rs9689820	rs9366863	0.941517151790621	Body mass index	2e-44	30595370
rs9689820	rs9296128	0.937381558456179	Hip circumference adjusted for BMI	4e-13	34021172
rs9689820	rs6941110	0.933676577326679	Sex hormone-binding globulin levels	5e-27	36653534
rs9689820	rs2814949	0.905372479297637	Essential hypertension (time to event)	9e-09	32589924
rs9689820	rs2744944	0.896052112029689	Hypothyroidism	3e-10	34594039
rs9689820	rs2744944	0.896052112029689	High density lipoprotein cholesterol levels	3e-86	34887591
rs9689820	rs2744944	0.896052112029689	Multi-trait sex score	7e-22	37277458
rs9689820	rs2263329	0.876899408662782	HDL cholesterol	6e-35	34594039
rs9689820	rs2263329	0.876899408662782	HDL cholesterol levels	8e-43	32203549
rs9689820	rs2263329	0.876899408662782	High density lipoprotein cholesterol levels	2e-52	34887591
rs9689820	rs111868030	0.8532583235175	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs9689820	rs9368830	0.832166605810923	HDL cholesterol	4e-21	30275531
rs9689820	rs9368828	0.805843694938069	Body mass index	1e-34	34594039
rs9689820	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs9689820	rs2744973	0.802560449404375	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs9689820	rs2744973	0.802560449404375	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs9689820	rs2744973	0.802560449404375	Multi-trait sex score	6e-20	37277458
rs9689820	rs6912327	0.790019995220374	Fasting insulin	5e-06	33402679
rs9689820	rs6912327	0.790019995220374	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs9689820	rs112283401	0.767735267176354	Red cell distribution width	4e-27	30595370
rs9689820	rs9689160	0.630070395157481	Lung function (forced vital capacity)	3e-14	36914875
rs9691413	rs4304220	0.858487171106448	Height	2e-14	36224396
rs9691413	rs4355658	0.809886443076537	Height	3e-13	36224396
rs9691413	rs13232536	0.610598273905298	N-acetyl-cadaverine levels in elite athletes	1e-06	31882771
rs9700285	rs11580836	0.943221608810531	Body mass index	2e-09	36581621
rs9700285	rs10465746	0.91189175494495	Obesity-related traits	8e-06	23251661
rs9700285	rs1536166	0.600428119590478	Body mass index	2e-08	30595370
rs9704546	rs10891301	0.834772225194284	Pyruvate dehydrogenase protein X component, mitochondrial levels	1e-18	34648354
rs9704546	rs2276390	0.815207074543764	Waist-hip ratio	6e-28	30239722
rs9704546	rs11214088	0.68592356105565	Gamma glutamyl transpeptidase	4e-11	34594039
rs9711322	rs6705511	0.850181142830701	Self-reported math ability	4e-09	30038396
rs9711322	rs6705511	0.850181142830701	Self-reported math ability (MTAG)	3e-10	30038396
rs9711322	rs34276187	0.842735258919554	Highest math class taken (MTAG)	2e-08	30038396
rs9717327	rs9505982	0.990324660692334	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9717327	rs11155671	0.93738248188329	Testicular germ cell tumor	2e-09	28604728
rs9717327	rs1934534	0.924974943987348	Pain (pleiotropy)	2e-08	37844115
rs9717327	rs1934534	0.924974943987348	Pain (pleiotropy)	2e-06	37844115
rs9717327	rs4380763	0.924182394779027	Subcortical volume (min-P)	1e-11	32665545
rs9717327	rs4421206	0.900051756600031	Brain morphology (min-P)	4e-11	32665545
rs9717327	rs80147756	0.883171138339639	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9717327	rs9688452	0.880879132369966	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9717327	rs9688452	0.880879132369966	aseg lh volume VentralDC	2e-10	33875891
rs9717327	rs9322194	0.838690745883385	Brainstem volume	2e-11	31636452
rs9717327	rs10872649	0.811651124477041	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9717327	rs10872649	0.811651124477041	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9717327	rs10872649	0.811651124477041	Right hippocampal volume (body)	1e-10	37337106
rs9717327	rs7752089	0.779829303703556	Brain morphology (MOSTest)	2e-31	35164939
rs9717327	rs9285521	0.71533897463668	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9717327	rs12526675	0.627513556419397	Brain morphology (MOSTest)	7e-22	32665545
rs9717327	rs9688809	0.604265646174728	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9717327	rs34337297	0.601392526853037	Serum levels of protein LRP11	3e-161	35078996
rs9717327	rs10872645	0.60062099333357	Blood protein levels	2e-86	30072576
rs9747080	rs7211615	0.657376791842914	Heel bone mineral density	1e-08	30595370
rs9747080	rs61586425	0.649655433157536	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs9747080	rs8077038	0.634506323624467	Educational attainment (MTAG)	4e-10	30038396
rs9747080	rs8077038	0.634506323624467	Highest math class taken (MTAG)	5e-16	30038396
rs9747080	rs12949956	0.627345405194521	Self-reported math ability	3e-11	30038396
rs9747080	rs12949956	0.627345405194521	Self-reported math ability (MTAG)	3e-14	30038396
rs9747080	rs12949956	0.627345405194521	Highest math class taken	8e-12	30038396
rs9747104	rs7211615	0.656186492763318	Heel bone mineral density	1e-08	30595370
rs9747104	rs61586425	0.65088889025074	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs9747104	rs8077038	0.633352696675265	Educational attainment (MTAG)	4e-10	30038396
rs9747104	rs8077038	0.633352696675265	Highest math class taken (MTAG)	5e-16	30038396
rs9747104	rs12949956	0.626207566304659	Self-reported math ability	3e-11	30038396
rs9747104	rs12949956	0.626207566304659	Self-reported math ability (MTAG)	3e-14	30038396
rs9747104	rs12949956	0.626207566304659	Highest math class taken	8e-12	30038396
rs9752	rs58588820	0.817572062433027	Total cholesterol levels	1e-09	34887591
rs9752	rs58588820	0.817572062433027	Total cholesterol levels	8e-11	34887591
rs9752	rs6547629	0.73253914275679	Height	3e-09	36224396
rs9765929	rs55763431	1	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9765929	rs9689694	0.998201794182664	Right hippocampal volume (head)	6e-11	37337106
rs9765929	rs9689694	0.998201794182664	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9765929	rs9689694	0.998201794182664	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9765929	rs9689694	0.998201794182664	Left hippocampal volume (head)	6e-12	37337106
rs9765929	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs9765929	rs2095375	0.995506640298119	Serum metabolite levels	1e-20	33031748
rs9765929	rs9383843	0.994608621917206	Migraine	1e-09	35115687
rs9765929	rs10872645	0.99281581932217	Blood protein levels	2e-86	30072576
rs9765929	rs9688867	0.991946733398874	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9765929	rs9688867	0.991946733398874	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9765929	rs9688809	0.991946733398874	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9765929	rs10872653	0.991920973218723	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9765929	rs34337297	0.988337309266227	Serum levels of protein LRP11	3e-161	35078996
rs9765929	rs14314	0.97680053310452	Macular thickness	3e-19	30535121
rs9765929	rs14314	0.97680053310452	Vertex-wise sulcal depth	7e-17	34910505
rs9765929	rs14314	0.97680053310452	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9765929	rs14314	0.97680053310452	Left hippocampal volume (body)	7e-15	37337106
rs9765929	rs14314	0.97680053310452	Left subiculum volume (body)	1e-14	37337106
rs9765929	rs9322193	0.952199474125302	Lung cancer	1e-07	27393504
rs9765929	rs4039600	0.908526761368909	Adenine levels	1e-11	35347128
rs9765929	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-08	37844115
rs9765929	rs1934534	0.641970793150743	Pain (pleiotropy)	2e-06	37844115
rs9765929	rs4380763	0.641447984668751	Subcortical volume (min-P)	1e-11	32665545
rs9765929	rs11155671	0.630994895975767	Testicular germ cell tumor	2e-09	28604728
rs9765929	rs80147756	0.616065401687589	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9765929	rs4421206	0.60846358923055	Brain morphology (min-P)	4e-11	32665545
rs9765929	rs9505982	0.60194342559747	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9766004	rs10872649	0.983995455203051	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9766004	rs10872649	0.983995455203051	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9766004	rs10872649	0.983995455203051	Right hippocampal volume (body)	1e-10	37337106
rs9766004	rs7752089	0.936458374583707	Brain morphology (MOSTest)	2e-31	35164939
rs9766004	rs1934534	0.880556190726822	Pain (pleiotropy)	2e-08	37844115
rs9766004	rs1934534	0.880556190726822	Pain (pleiotropy)	2e-06	37844115
rs9766004	rs4380763	0.879769132888846	Subcortical volume (min-P)	1e-11	32665545
rs9766004	rs11155671	0.86373193844073	Testicular germ cell tumor	2e-09	28604728
rs9766004	rs9322194	0.853698708981912	Brainstem volume	2e-11	31636452
rs9766004	rs80147756	0.842096129760013	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9766004	rs4421206	0.830119307667248	Brain morphology (min-P)	4e-11	32665545
rs9766004	rs9505982	0.820690393265381	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9766004	rs9688452	0.806377780508696	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9766004	rs9688452	0.806377780508696	aseg lh volume VentralDC	2e-10	33875891
rs9766004	rs9285521	0.728809557070136	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9766004	rs12526675	0.720660478334059	Brain morphology (MOSTest)	7e-22	32665545
rs9766004	rs2342764	0.67868298268845	Cortical thickness	1e-08	34560273
rs9766004	rs56103941	0.645752410035993	Right presubiculum volume (head)	4e-08	37337106
rs9766004	rs12523793	0.609915816634798	Subcortical volume (MOSTest)	4e-24	32665545
rs9766004	rs12523793	0.609915816634798	C-reactive protein levels	3e-08	35459240
rs9766004	rs12523793	0.609915816634798	C-reactive protein levels (MTAG)	2e-08	36376304
rs9766004	rs11155662	0.603821725224881	Vertex-wise cortical thickness	2e-09	34910505
rs9766037	rs11155671	0.970988112862525	Testicular germ cell tumor	2e-09	28604728
rs9766037	rs1934534	0.958224294434693	Pain (pleiotropy)	2e-08	37844115
rs9766037	rs1934534	0.958224294434693	Pain (pleiotropy)	2e-06	37844115
rs9766037	rs4380763	0.957429228609911	Subcortical volume (min-P)	1e-11	32665545
rs9766037	rs9505982	0.956299080936574	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9766037	rs80147756	0.916206591643359	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9766037	rs4421206	0.910355624492067	Brain morphology (min-P)	4e-11	32665545
rs9766037	rs9688452	0.8905936467215	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9766037	rs9688452	0.8905936467215	aseg lh volume VentralDC	2e-10	33875891
rs9766037	rs10872649	0.843829134330373	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9766037	rs10872649	0.843829134330373	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9766037	rs10872649	0.843829134330373	Right hippocampal volume (body)	1e-10	37337106
rs9766037	rs9322194	0.814434600874975	Brainstem volume	2e-11	31636452
rs9766037	rs7752089	0.810734523499534	Brain morphology (MOSTest)	2e-31	35164939
rs9766037	rs9285521	0.692962318202393	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9766037	rs12526675	0.638414548462418	Brain morphology (MOSTest)	7e-22	32665545
rs9766037	rs9688809	0.630742450355244	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9766037	rs34337297	0.6277092100293	Serum levels of protein LRP11	3e-161	35078996
rs9766037	rs10872645	0.62692834178327	Blood protein levels	2e-86	30072576
rs9766037	rs14314	0.62590578012174	Macular thickness	3e-19	30535121
rs9766037	rs14314	0.62590578012174	Vertex-wise sulcal depth	7e-17	34910505
rs9766037	rs14314	0.62590578012174	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9766037	rs14314	0.62590578012174	Left hippocampal volume (body)	7e-15	37337106
rs9766037	rs14314	0.62590578012174	Left subiculum volume (body)	1e-14	37337106
rs9766037	rs55763431	0.625575745096128	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9766037	rs9322193	0.625108612471571	Lung cancer	1e-07	27393504
rs9766037	rs9689694	0.624431368293063	Right hippocampal volume (head)	6e-11	37337106
rs9766037	rs9689694	0.624431368293063	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9766037	rs9689694	0.624431368293063	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9766037	rs9689694	0.624431368293063	Left hippocampal volume (head)	6e-12	37337106
rs9766037	rs9383843	0.623081062806035	Migraine	1e-09	35115687
rs9766037	rs2095375	0.622509802901811	Serum metabolite levels	1e-20	33031748
rs9766037	rs2095375	0.622509802901811	Serum metabolite levels	1e-20	33031748
rs9766037	rs10872653	0.62022817774269	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9766037	rs9688867	0.619944159849703	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9766037	rs9688867	0.619944159849703	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9766037	rs4039600	0.60027662736192	Adenine levels	1e-11	35347128
rs9766379	rs9505982	0.9799013288737	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9766379	rs11155671	0.947463022767042	Testicular germ cell tumor	2e-09	28604728
rs9766379	rs4380763	0.934170310072058	Subcortical volume (min-P)	1e-11	32665545
rs9766379	rs1934534	0.933398016184532	Pain (pleiotropy)	2e-08	37844115
rs9766379	rs1934534	0.933398016184532	Pain (pleiotropy)	2e-06	37844115
rs9766379	rs4421206	0.896226987241303	Brain morphology (min-P)	4e-11	32665545
rs9766379	rs80147756	0.891500091787176	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9766379	rs9688452	0.876997275762933	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9766379	rs9688452	0.876997275762933	aseg lh volume VentralDC	2e-10	33875891
rs9766379	rs9322194	0.834042513099067	Brainstem volume	2e-11	31636452
rs9766379	rs10872649	0.819727790495247	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9766379	rs10872649	0.819727790495247	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9766379	rs10872649	0.819727790495247	Right hippocampal volume (body)	1e-10	37337106
rs9766379	rs7752089	0.79219170679751	Brain morphology (MOSTest)	2e-31	35164939
rs9766379	rs9285521	0.708601327423503	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9766379	rs12526675	0.622712698412651	Brain morphology (MOSTest)	7e-22	32665545
rs9766379	rs9688809	0.607410772472132	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9766379	rs34337297	0.604509175980214	Serum levels of protein LRP11	3e-161	35078996
rs9766379	rs10872645	0.603737325452575	Blood protein levels	2e-86	30072576
rs9766379	rs14314	0.602666206145772	Macular thickness	3e-19	30535121
rs9766379	rs14314	0.602666206145772	Vertex-wise sulcal depth	7e-17	34910505
rs9766379	rs14314	0.602666206145772	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9766379	rs14314	0.602666206145772	Left hippocampal volume (body)	7e-15	37337106
rs9766379	rs14314	0.602666206145772	Left subiculum volume (body)	1e-14	37337106
rs9766379	rs55763431	0.602412400513187	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9766379	rs9322193	0.601829706420103	Lung cancer	1e-07	27393504
rs9766379	rs9689694	0.601305308447833	Right hippocampal volume (head)	6e-11	37337106
rs9766379	rs9689694	0.601305308447833	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9766379	rs9689694	0.601305308447833	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9766379	rs9689694	0.601305308447833	Left hippocampal volume (head)	6e-12	37337106
rs9766886	rs11155671	0.971018752266182	Testicular germ cell tumor	2e-09	28604728
rs9766886	rs4380763	0.957488990622834	Subcortical volume (min-P)	1e-11	32665545
rs9766886	rs1934534	0.956698299685774	Pain (pleiotropy)	2e-08	37844115
rs9766886	rs1934534	0.956698299685774	Pain (pleiotropy)	2e-06	37844115
rs9766886	rs9505982	0.956185954025985	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9766886	rs80147756	0.916137652202158	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9766886	rs4421206	0.914871963753326	Brain morphology (min-P)	4e-11	32665545
rs9766886	rs9688452	0.895172891747721	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9766886	rs9688452	0.895172891747721	aseg lh volume VentralDC	2e-10	33875891
rs9766886	rs10872649	0.842161502593192	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9766886	rs10872649	0.842161502593192	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9766886	rs10872649	0.842161502593192	Right hippocampal volume (body)	1e-10	37337106
rs9766886	rs7752089	0.814731561537834	Brain morphology (MOSTest)	2e-31	35164939
rs9766886	rs9322194	0.813796211431402	Brainstem volume	2e-11	31636452
rs9766886	rs9285521	0.690749963183629	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9766886	rs12526675	0.641151434350466	Brain morphology (MOSTest)	7e-22	32665545
rs9766886	rs9688809	0.622891914299499	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9766886	rs34337297	0.619895267467892	Serum levels of protein LRP11	3e-161	35078996
rs9766886	rs10872645	0.619118057253234	Blood protein levels	2e-86	30072576
rs9766886	rs14314	0.618086282560801	Macular thickness	3e-19	30535121
rs9766886	rs14314	0.618086282560801	Vertex-wise sulcal depth	7e-17	34910505
rs9766886	rs14314	0.618086282560801	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9766886	rs14314	0.618086282560801	Left hippocampal volume (body)	7e-15	37337106
rs9766886	rs14314	0.618086282560801	Left subiculum volume (body)	1e-14	37337106
rs9766886	rs55763431	0.617774589551706	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9766886	rs9322193	0.617281556294747	Lung cancer	1e-07	27393504
rs9766886	rs9689694	0.616641150375592	Right hippocampal volume (head)	6e-11	37337106
rs9766886	rs9689694	0.616641150375592	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9766886	rs9689694	0.616641150375592	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9766886	rs9689694	0.616641150375592	Left hippocampal volume (head)	6e-12	37337106
rs9766886	rs9383843	0.615299970433121	Migraine	1e-09	35115687
rs9766886	rs2095375	0.614734173490376	Serum metabolite levels	1e-20	33031748
rs9766886	rs2095375	0.614734173490376	Serum metabolite levels	1e-20	33031748
rs9766886	rs10872653	0.61247436782827	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9766886	rs9688867	0.612166675432639	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9766886	rs9688867	0.612166675432639	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9766886	rs2342764	0.601584924162227	Cortical thickness	1e-08	34560273
rs9767113	rs56103941	0.97980678998649	Right presubiculum volume (head)	4e-08	37337106
rs9767113	rs12523793	0.940990082337941	Subcortical volume (MOSTest)	4e-24	32665545
rs9767113	rs12523793	0.940990082337941	C-reactive protein levels	3e-08	35459240
rs9767113	rs12523793	0.940990082337941	C-reactive protein levels (MTAG)	2e-08	36376304
rs9767113	rs11155662	0.931328704547598	Vertex-wise cortical thickness	2e-09	34910505
rs9767113	rs12526675	0.88924144644435	Brain morphology (MOSTest)	7e-22	32665545
rs9767113	rs2342764	0.82305987203103	Cortical thickness	1e-08	34560273
rs9767113	rs58189451	0.756175372449839	Drinks per week	1e-09	36477530
rs9767113	rs9285521	0.749688027953866	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9767113	rs7752089	0.660069692339415	Brain morphology (MOSTest)	2e-31	35164939
rs9767113	rs9322194	0.65703978833611	Brainstem volume	2e-11	31636452
rs9767113	rs11155675	0.636795924227153	Brain region volumes	3e-09	31676860
rs9767113	rs1125	0.636587340292878	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs9767113	rs1125	0.636587340292878	Vertical cup-disc ratio	8e-14	34077760
rs9767113	rs10872649	0.634285940967278	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9767113	rs10872649	0.634285940967278	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9767113	rs10872649	0.634285940967278	Right hippocampal volume (body)	1e-10	37337106
rs9767113	rs9371201	0.62531888864673	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs9767113	rs4421206	0.621382431406404	Brain morphology (min-P)	4e-11	32665545
rs9767113	rs9688452	0.604720375163409	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9767113	rs9688452	0.604720375163409	aseg lh volume VentralDC	2e-10	33875891
rs9767123	rs4380763	0.984652319682109	Subcortical volume (min-P)	1e-11	32665545
rs9767123	rs1934534	0.983849715646685	Pain (pleiotropy)	2e-08	37844115
rs9767123	rs1934534	0.983849715646685	Pain (pleiotropy)	2e-06	37844115
rs9767123	rs11155671	0.972596786806158	Testicular germ cell tumor	2e-09	28604728
rs9767123	rs80147756	0.941156606248907	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9767123	rs4421206	0.933620529042085	Brain morphology (min-P)	4e-11	32665545
rs9767123	rs9505982	0.921721774278567	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9767123	rs9688452	0.913680670357626	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9767123	rs9688452	0.913680670357626	aseg lh volume VentralDC	2e-10	33875891
rs9767123	rs10872649	0.863170792329116	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9767123	rs10872649	0.863170792329116	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9767123	rs10872649	0.863170792329116	Right hippocampal volume (body)	1e-10	37337106
rs9767123	rs7752089	0.839899778808761	Brain morphology (MOSTest)	2e-31	35164939
rs9767123	rs9322194	0.779663307301533	Brainstem volume	2e-11	31636452
rs9767123	rs9285521	0.663427165921323	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9767123	rs12526675	0.660078641813286	Brain morphology (MOSTest)	7e-22	32665545
rs9767123	rs9688809	0.639546464681815	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9767123	rs34337297	0.636517187236141	Serum levels of protein LRP11	3e-161	35078996
rs9767123	rs10872645	0.635728560111951	Blood protein levels	2e-86	30072576
rs9767123	rs14314	0.6346746455293	Macular thickness	3e-19	30535121
rs9767123	rs14314	0.6346746455293	Vertex-wise sulcal depth	7e-17	34910505
rs9767123	rs14314	0.6346746455293	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9767123	rs14314	0.6346746455293	Left hippocampal volume (body)	7e-15	37337106
rs9767123	rs14314	0.6346746455293	Left subiculum volume (body)	1e-14	37337106
rs9767123	rs55763431	0.634366773603958	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9767123	rs9689694	0.633219519824146	Right hippocampal volume (head)	6e-11	37337106
rs9767123	rs9689694	0.633219519824146	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9767123	rs9689694	0.633219519824146	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9767123	rs9689694	0.633219519824146	Left hippocampal volume (head)	6e-12	37337106
rs9767123	rs9383843	0.631860015385333	Migraine	1e-09	35115687
rs9767123	rs2095375	0.631287313903581	Serum metabolite levels	1e-20	33031748
rs9767123	rs2095375	0.631287313903581	Serum metabolite levels	1e-20	33031748
rs9767123	rs10872653	0.628999930286719	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9767123	rs9688867	0.62732255164427	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9767123	rs9688867	0.62732255164427	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9767123	rs2342764	0.618783589793907	Cortical thickness	1e-08	34560273
rs9767123	rs9322193	0.612328633578436	Lung cancer	1e-07	27393504
rs9767192	rs55763431	0.98750998003992	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9767192	rs9689694	0.985734233849135	Right hippocampal volume (head)	6e-11	37337106
rs9767192	rs9689694	0.985734233849135	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9767192	rs9689694	0.985734233849135	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9767192	rs9689694	0.985734233849135	Left hippocampal volume (head)	6e-12	37337106
rs9767192	rs2095375	0.983065276896949	Serum metabolite levels	1e-20	33031748
rs9767192	rs2095375	0.983065276896949	Serum metabolite levels	1e-20	33031748
rs9767192	rs9383843	0.98217101820761	Migraine	1e-09	35115687
rs9767192	rs10872645	0.980385721588706	Blood protein levels	2e-86	30072576
rs9767192	rs10872653	0.979524403809327	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9767192	rs9688867	0.979490350232176	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9767192	rs9688867	0.979490350232176	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9767192	rs9688809	0.979490350232176	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9767192	rs34337297	0.975948338462044	Serum levels of protein LRP11	3e-161	35078996
rs9767192	rs14314	0.964467425803823	Macular thickness	3e-19	30535121
rs9767192	rs14314	0.964467425803823	Vertex-wise sulcal depth	7e-17	34910505
rs9767192	rs14314	0.964467425803823	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9767192	rs14314	0.964467425803823	Left hippocampal volume (body)	7e-15	37337106
rs9767192	rs14314	0.964467425803823	Left subiculum volume (body)	1e-14	37337106
rs9767192	rs9322193	0.940044470742745	Lung cancer	1e-07	27393504
rs9767192	rs4039600	0.897035227306794	Adenine levels	1e-11	35347128
rs9767192	rs1934534	0.650125120132539	Pain (pleiotropy)	2e-08	37844115
rs9767192	rs1934534	0.650125120132539	Pain (pleiotropy)	2e-06	37844115
rs9767192	rs4380763	0.649595683237329	Subcortical volume (min-P)	1e-11	32665545
rs9767192	rs11155671	0.639067377461872	Testicular germ cell tumor	2e-09	28604728
rs9767192	rs80147756	0.623902591648842	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9767192	rs4421206	0.616193095973264	Brain morphology (min-P)	4e-11	32665545
rs9767192	rs9505982	0.609690799057235	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9767309	rs1934534	0.995941640474453	Pain (pleiotropy)	2e-08	37844115
rs9767309	rs1934534	0.995941640474453	Pain (pleiotropy)	2e-06	37844115
rs9767309	rs4380763	0.995131673493715	Subcortical volume (min-P)	1e-11	32665545
rs9767309	rs11155671	0.976598244626535	Testicular germ cell tumor	2e-09	28604728
rs9767309	rs80147756	0.954712050573477	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9767309	rs4421206	0.944030220065534	Brain morphology (min-P)	4e-11	32665545
rs9767309	rs9505982	0.925768221231163	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9767309	rs9688452	0.917625878058272	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9767309	rs9688452	0.917625878058272	aseg lh volume VentralDC	2e-10	33875891
rs9767309	rs10872649	0.874765724489718	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9767309	rs10872649	0.874765724489718	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9767309	rs10872649	0.874765724489718	Right hippocampal volume (body)	1e-10	37337106
rs9767309	rs7752089	0.832308216900515	Brain morphology (MOSTest)	2e-31	35164939
rs9767309	rs9322194	0.784043542755041	Brainstem volume	2e-11	31636452
rs9767309	rs9285521	0.667831533956461	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9767309	rs12526675	0.65440772644864	Brain morphology (MOSTest)	7e-22	32665545
rs9767309	rs9688809	0.646358878660492	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9767309	rs34337297	0.643284752918591	Serum levels of protein LRP11	3e-161	35078996
rs9767309	rs10872645	0.642494081275194	Blood protein levels	2e-86	30072576
rs9767309	rs14314	0.641460536993591	Macular thickness	3e-19	30535121
rs9767309	rs14314	0.641460536993591	Vertex-wise sulcal depth	7e-17	34910505
rs9767309	rs14314	0.641460536993591	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9767309	rs14314	0.641460536993591	Left hippocampal volume (body)	7e-15	37337106
rs9767309	rs14314	0.641460536993591	Left subiculum volume (body)	1e-14	37337106
rs9767309	rs55763431	0.641124150373489	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9767309	rs9689694	0.639964706358834	Right hippocampal volume (head)	6e-11	37337106
rs9767309	rs9689694	0.639964706358834	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9767309	rs9689694	0.639964706358834	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9767309	rs9689694	0.639964706358834	Left hippocampal volume (head)	6e-12	37337106
rs9767309	rs9383843	0.638597064359943	Migraine	1e-09	35115687
rs9767309	rs2095375	0.638018275670017	Serum metabolite levels	1e-20	33031748
rs9767309	rs2095375	0.638018275670017	Serum metabolite levels	1e-20	33031748
rs9767309	rs10872653	0.635706579594753	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9767309	rs9688867	0.634061555228714	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9767309	rs9688867	0.634061555228714	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9767309	rs9322193	0.614981644438093	Lung cancer	1e-07	27393504
rs9767309	rs2342764	0.612203179248937	Cortical thickness	1e-08	34560273
rs9767554	rs9505982	0.935665474437702	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9767554	rs11155671	0.92747315208799	Testicular germ cell tumor	2e-09	28604728
rs9767554	rs1934534	0.915166867067211	Pain (pleiotropy)	2e-08	37844115
rs9767554	rs1934534	0.915166867067211	Pain (pleiotropy)	2e-06	37844115
rs9767554	rs4380763	0.914375398029422	Subcortical volume (min-P)	1e-11	32665545
rs9767554	rs4421206	0.890156050088259	Brain morphology (min-P)	4e-11	32665545
rs9767554	rs80147756	0.873441869445581	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9767554	rs9688452	0.871209580855556	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9767554	rs9688452	0.871209580855556	aseg lh volume VentralDC	2e-10	33875891
rs9767554	rs10872649	0.799302650897165	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9767554	rs10872649	0.799302650897165	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9767554	rs10872649	0.799302650897165	Right hippocampal volume (body)	1e-10	37337106
rs9767554	rs9322194	0.793743907187277	Brainstem volume	2e-11	31636452
rs9767554	rs7752089	0.766104681181668	Brain morphology (MOSTest)	2e-31	35164939
rs9767554	rs9285521	0.673498078561081	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9767554	rs2342764	0.628486515484007	Cortical thickness	1e-08	34560273
rs9767554	rs12526675	0.619196319574099	Brain morphology (MOSTest)	7e-22	32665545
rs9767554	rs9688809	0.600502045679605	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9767555	rs11155662	0.938604822541009	Vertex-wise cortical thickness	2e-09	34910505
rs9767555	rs56103941	0.937630665118526	Right presubiculum volume (head)	4e-08	37337106
rs9767555	rs12523793	0.93097612695145	Subcortical volume (MOSTest)	4e-24	32665545
rs9767555	rs12523793	0.93097612695145	C-reactive protein levels	3e-08	35459240
rs9767555	rs12523793	0.93097612695145	C-reactive protein levels (MTAG)	2e-08	36376304
rs9767555	rs12526675	0.84892005421008	Brain morphology (MOSTest)	7e-22	32665545
rs9767555	rs2342764	0.78587858969075	Cortical thickness	1e-08	34560273
rs9767555	rs58189451	0.761995496672882	Drinks per week	1e-09	36477530
rs9767555	rs9285521	0.75811043333408	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9767555	rs9322194	0.660672051485363	Brainstem volume	2e-11	31636452
rs9767555	rs7752089	0.627133840927876	Brain morphology (MOSTest)	2e-31	35164939
rs9767555	rs1125	0.625455837053709	Nicotine dependence and major depression (severity of comorbidity)	4e-06	30287806
rs9767555	rs1125	0.625455837053709	Vertical cup-disc ratio	8e-14	34077760
rs9767555	rs11155675	0.621604812345487	Brain region volumes	3e-09	31676860
rs9767555	rs9371201	0.608935124602288	Nicotine dependence and major depression (severity of comorbidity)	7e-06	30287806
rs9767555	rs10872649	0.608059347257002	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9767555	rs10872649	0.608059347257002	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9767555	rs10872649	0.608059347257002	Right hippocampal volume (body)	1e-10	37337106
rs9767727	rs4421206	0.990361617442276	Brain morphology (min-P)	4e-11	32665545
rs9767727	rs9688452	0.962671729165183	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9767727	rs9688452	0.962671729165183	aseg lh volume VentralDC	2e-10	33875891
rs9767727	rs4380763	0.939577227758779	Subcortical volume (min-P)	1e-11	32665545
rs9767727	rs1934534	0.937245971128671	Pain (pleiotropy)	2e-08	37844115
rs9767727	rs1934534	0.937245971128671	Pain (pleiotropy)	2e-06	37844115
rs9767727	rs11155671	0.919928204836243	Testicular germ cell tumor	2e-09	28604728
rs9767727	rs80147756	0.894833141096183	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9767727	rs9505982	0.894043499788015	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9767727	rs10872649	0.816692463335383	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9767727	rs10872649	0.816692463335383	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9767727	rs10872649	0.816692463335383	Right hippocampal volume (body)	1e-10	37337106
rs9767727	rs7752089	0.780067187945739	Brain morphology (MOSTest)	2e-31	35164939
rs9767727	rs9322194	0.75233654528393	Brainstem volume	2e-11	31636452
rs9767727	rs9285521	0.69536590248977	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9767727	rs12526675	0.683147112829426	Brain morphology (MOSTest)	7e-22	32665545
rs9767727	rs2342764	0.640170100474956	Cortical thickness	1e-08	34560273
rs9767727	rs56103941	0.608586661975047	Right presubiculum volume (head)	4e-08	37337106
rs9767727	rs9688809	0.607495368597548	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9767727	rs34337297	0.606010558186291	Serum levels of protein LRP11	3e-161	35078996
rs9767727	rs10872645	0.605229842546747	Blood protein levels	2e-86	30072576
rs9767727	rs14314	0.602748128415318	Macular thickness	3e-19	30535121
rs9767727	rs14314	0.602748128415318	Vertex-wise sulcal depth	7e-17	34910505
rs9767727	rs14314	0.602748128415318	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9767727	rs14314	0.602748128415318	Left hippocampal volume (body)	7e-15	37337106
rs9767727	rs14314	0.602748128415318	Left subiculum volume (body)	1e-14	37337106
rs9767727	rs55763431	0.602581726620042	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9767727	rs9689694	0.60149340022519	Right hippocampal volume (head)	6e-11	37337106
rs9767727	rs9689694	0.60149340022519	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9767727	rs9689694	0.60149340022519	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9767727	rs9689694	0.60149340022519	Left hippocampal volume (head)	6e-12	37337106
rs9767727	rs9383843	0.600172316677313	Migraine	1e-09	35115687
rs9783386	rs4353250	0.945716482470912	Insulin-like growth factor 1 levels	2e-14	33462484
rs9783386	rs4353250	0.945716482470912	Amyloid A serum levels	2e-51	21124955
rs9783386	rs4150575	0.616415855090482	Imidazole lactate levels	1e-10	36635386
rs9787133	rs9787133	1	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs9787133	rs10801690	0.945256757042347	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs9787133	rs7532151	0.933701286784286	Imidazole lactate levels	9e-12	33177712
rs9787133	rs12729558	0.862031361334792	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs9787133	rs10922531	0.746711357476597	Serum metabolite levels	2e-69	33031748
rs9787133	rs2765527	0.688960799081126	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs9787133	rs7530513	0.67752087578048	Height	8e-11	35831902
rs9787133	rs7530513	0.67752087578048	Imidazole lactate levels	8e-166	36635386
rs9787133	rs12144640	0.67752087578048	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs9787133	rs1409152	0.670396524285348	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs9787133	rs1409152	0.670396524285348	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs9787133	rs10801699	0.668623903739804	X-23639 levels	2e-10	36635386
rs9787133	rs1206228892	0.659363489253616	Imidazole lactate levels	5e-186	35050183
rs9787133	rs2810876	0.658883502812038	Imidazole lactate levels	2e-122	35347128
rs9787133	rs10801696	0.658631139268485	Imidazole lactate levels	3e-195	35050183
rs9787133	rs12120164	0.641286483061881	Metabolite peak levels (QI2146)	1e-26	35995766
rs9787377	rs7532151	0.990323901761013	Imidazole lactate levels	9e-12	33177712
rs9787377	rs9787133	0.943132048411873	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs9787377	rs12729558	0.912135711347402	2-hydroxy-4-(methylthio)butanoic acid levels	5e-130	35347128
rs9787377	rs10801690	0.906255456440257	Urinary metabolite levels in chronic kidney disease	6e-13	31959995
rs9787377	rs10922531	0.79129995895409	Serum metabolite levels	2e-69	33031748
rs9787377	rs2765527	0.739481982605983	2-hydroxy-4-(methylthio)butanoic acid levels	3e-205	36635386
rs9787377	rs7530513	0.717228134324492	Height	8e-11	35831902
rs9787377	rs7530513	0.717228134324492	Imidazole lactate levels	8e-166	36635386
rs9787377	rs12144640	0.717228134324492	Kynurenine--oxoglutarate transaminase 3 levels (CCBL2.12682.5.3)	3e-12	29875488
rs9787377	rs1409152	0.711167452331703	Plasma 2-hydroxy-4-(methylthio)butanoic acid levels in chronic kidney disease	9e-85	37277652
rs9787377	rs1409152	0.711167452331703	Kynurenine--oxoglutarate transaminase 3 levels	1e-250	34648354
rs9787377	rs1206228892	0.710070455322364	Imidazole lactate levels	5e-186	35050183
rs9787377	rs2810876	0.709485256346108	Imidazole lactate levels	2e-122	35347128
rs9787377	rs10801699	0.70930893589529	X-23639 levels	2e-10	36635386
rs9787377	rs10801696	0.709294570677693	Imidazole lactate levels	3e-195	35050183
rs9787377	rs12120164	0.680646654060427	Metabolite peak levels (QI2146)	1e-26	35995766
rs9800580	rs11155671	0.975002342838452	Testicular germ cell tumor	2e-09	28604728
rs9800580	rs4380763	0.961431526959028	Subcortical volume (min-P)	1e-11	32665545
rs9800580	rs1934534	0.960637604026419	Pain (pleiotropy)	2e-08	37844115
rs9800580	rs1934534	0.960637604026419	Pain (pleiotropy)	2e-06	37844115
rs9800580	rs9505982	0.95861575348775	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9800580	rs80147756	0.918495932435042	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9800580	rs4421206	0.914156398174817	Brain morphology (min-P)	4e-11	32665545
rs9800580	rs9688452	0.89441116492508	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9800580	rs9688452	0.89441116492508	aseg lh volume VentralDC	2e-10	33875891
rs9800580	rs10872649	0.845963020759206	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9800580	rs10872649	0.845963020759206	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9800580	rs10872649	0.845963020759206	Right hippocampal volume (body)	1e-10	37337106
rs9800580	rs9322194	0.813385373759248	Brainstem volume	2e-11	31636452
rs9800580	rs7752089	0.812728970100812	Brain morphology (MOSTest)	2e-31	35164939
rs9800580	rs9285521	0.691852574617032	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9800580	rs12526675	0.641072567632827	Brain morphology (MOSTest)	7e-22	32665545
rs9800580	rs9688809	0.62545716585142	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9800580	rs34337297	0.622443505544823	Serum levels of protein LRP11	3e-161	35078996
rs9800580	rs10872645	0.621665514016136	Blood protein levels	2e-86	30072576
rs9800580	rs14314	0.620641444992637	Macular thickness	3e-19	30535121
rs9800580	rs14314	0.620641444992637	Vertex-wise sulcal depth	7e-17	34910505
rs9800580	rs14314	0.620641444992637	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9800580	rs14314	0.620641444992637	Left hippocampal volume (body)	7e-15	37337106
rs9800580	rs14314	0.620641444992637	Left subiculum volume (body)	1e-14	37337106
rs9800580	rs55763431	0.620318949521393	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9800580	rs9322193	0.619842929166149	Lung cancer	1e-07	27393504
rs9800580	rs9689694	0.619180883052773	Right hippocampal volume (head)	6e-11	37337106
rs9800580	rs9689694	0.619180883052773	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9800580	rs9689694	0.619180883052773	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9800580	rs9689694	0.619180883052773	Left hippocampal volume (head)	6e-12	37337106
rs9800580	rs9383843	0.617836608907475	Migraine	1e-09	35115687
rs9800580	rs2095375	0.617268501326713	Serum metabolite levels	1e-20	33031748
rs9800580	rs2095375	0.617268501326713	Serum metabolite levels	1e-20	33031748
rs9800580	rs10872653	0.614999466920352	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9800580	rs9688867	0.614707111307114	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9800580	rs9688867	0.614707111307114	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9800580	rs2342764	0.600326763738832	Cortical thickness	1e-08	34560273
rs980417	rs10465746	0.752452162119599	Obesity-related traits	8e-06	23251661
rs980417	rs11580836	0.727298514698963	Body mass index	2e-09	36581621
rs980418	rs10465746	0.751210413956069	Obesity-related traits	8e-06	23251661
rs980418	rs11580836	0.726097218919564	Body mass index	2e-09	36581621
rs9855252	rs10698992	0.652933327820102	von Willebrand factor A domain-containing protein 2 levels	9e-13	34648354
rs986325	rs2548499	0.94509397419678	Lymphocyte count	9e-14	32888494
rs986325	rs2648731	0.752912080825227	Type 2 diabetes	7e-12	34594039
rs986325	rs2648731	0.752912080825227	Type 2 diabetes	3e-19	34594039
rs986325	rs2648731	0.752912080825227	Lymphocyte count	2e-11	34594039
rs986325	rs2648731	0.752912080825227	Type 2 diabetes or schizophrenia (pleiotropy)	6e-09	36329495
rs986325	rs2648731	0.752912080825227	Medication use (drugs used in diabetes)	3e-09	34594039
rs986325	rs13189973	0.615017416823397	Lymphocyte count	2e-16	32888493
rs9881869	rs4681679	0.99867086876754	Systemic lupus erythematosus (MTAG)	3e-11	36750564
rs9881869	rs11719450	0.959062364989163	Hemoglobin concentration	2e-09	27863252
rs9881869	rs11719450	0.959062364989163	Hemoglobin levels	2e-16	32327693
rs9881869	rs56384862	0.945971833827975	Body mass index	8e-12	29273807
rs9881869	rs56384862	0.945971833827975	Body mass index	3e-06	30108127
rs9881869	rs56384862	0.945971833827975	Hemoglobin levels	1e-16	32327693
rs9881869	rs56384862	0.945971833827975	Body mass index	3e-14	36581621
rs9881869	rs6775517	0.897650336959633	Hematocrit	1e-17	34594039
rs9881869	rs7610312	0.893692846376017	Red blood cell count	5e-09	27863252
rs9881869	rs57700771	0.889741492252773	Red blood cell count	9e-21	30595370
rs9881869	rs11705721	0.875271761031879	Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	9e-06	29310926
rs9881869	rs11130638	0.875271761031879	Hemoglobin concentration	2e-23	32888493
rs9881869	rs34579268	0.868845520909068	Hematocrit	5e-30	32888493
rs9881869	rs34579268	0.868845520909068	Hematocrit	2e-27	32888493
rs9881869	rs34579268	0.868845520909068	Hemoglobin concentration	5e-26	32888493
rs9881869	rs55692656	0.836803321248679	vWF levels	3e-08	30586737
rs9881869	rs55692656	0.836803321248679	vWF levels	6e-09	30586737
rs9881869	rs55704295	0.814538559368595	Red blood cell count	8e-26	32888493
rs9881869	rs55704295	0.814538559368595	Red blood cell count	5e-23	32888493
rs9881869	rs55704295	0.814538559368595	Serum total protein level	2e-29	34594039
rs9881869	rs11922478	0.793213773736734	Semaphorin-6B levels	4e-12	34648354
rs9881869	rs6445969	0.781509635010321	Serum 25-Hydroxyvitamin D levels	1e-08	32242144
rs9881869	rs11708895	0.771813792704081	Red blood cell count	1e-20	32888494
rs9881869	rs55954186	0.766933410894765	vWF levels	5e-09	30586737
rs9881869	rs55954186	0.766933410894765	vWF levels	9e-09	30586737
rs9881869	rs7431952	0.702228003591455	Hemoglobin levels	1e-12	32327693
rs9881869	rs9311676	0.637386682769212	Systemic lupus erythematosus	5e-06	27399966
rs9881869	rs9311676	0.637386682769212	Systemic lupus erythematosus	3e-14	26502338
rs9881869	rs9311676	0.637386682769212	Waist circumference adjusted for body mass index	3e-08	34021172
rs9881869	rs9822855	0.627134578173932	Educational attainment	9e-120	35361970
rs9884591	rs2868708	0.95959210817917	Lymphocyte count	3e-11	34469753
rs9884591	rs2868708	0.95959210817917	White blood cell count	1e-09	30595370
rs9884591	rs6831339	0.956322991934123	High density lipoprotein cholesterol levels	9e-09	34887591
rs9884591	rs6535419	0.909313562636612	Pulse pressure	6e-10	30578418
rs9884591	rs116142917	0.882591861484152	Lymphocyte count	7e-18	32888494
rs9884591	rs6823199	0.865552367102365	Pulse pressure	4e-14	30224653
rs9884591	rs13111599	0.853302383592044	HDL cholesterol levels	3e-09	32203549
rs9884591	rs13111599	0.853302383592044	Apolipoprotein A1 levels	4e-08	32203549
rs9884591	rs4302451	0.769135090659365	Eosinophil counts	2e-09	30595370
rs9884591	rs35895091	0.727171661537319	Cardiovascular disease	1e-07	30595370
rs9884591	rs11099563	0.709290800090469	High density lipoprotein cholesterol levels	3e-11	34887591
rs9884591	rs28528763	0.691876542043719	White blood cell count	7e-12	32888494
rs9884591	rs7662402	0.604233216126563	Brain morphology (MOSTest)	3e-08	35164939
rs9890264	rs61586425	0.650878589317474	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs9890264	rs7211615	0.649270809974679	Heel bone mineral density	1e-08	30595370
rs9890264	rs8077038	0.626619690343144	Educational attainment (MTAG)	4e-10	30038396
rs9890264	rs8077038	0.626619690343144	Highest math class taken (MTAG)	5e-16	30038396
rs9890264	rs12949956	0.619546326922979	Self-reported math ability	3e-11	30038396
rs9890264	rs12949956	0.619546326922979	Self-reported math ability (MTAG)	3e-14	30038396
rs9890264	rs12949956	0.619546326922979	Highest math class taken	8e-12	30038396
rs9891938	rs9897542	0.918235549582521	Total bilirubin levels	8e-11	34594039
rs9891938	rs2285583	0.761897423168687	AFP levels	2e-08	36329257
rs9892639	rs61586425	0.646406665714274	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs9892639	rs7211615	0.645339279270203	Heel bone mineral density	1e-08	30595370
rs9892639	rs8077038	0.622779150743897	Educational attainment (MTAG)	4e-10	30038396
rs9892639	rs8077038	0.622779150743897	Highest math class taken (MTAG)	5e-16	30038396
rs9892639	rs12949956	0.615738100455642	Self-reported math ability	3e-11	30038396
rs9892639	rs12949956	0.615738100455642	Self-reported math ability (MTAG)	3e-14	30038396
rs9892639	rs12949956	0.615738100455642	Highest math class taken	8e-12	30038396
rs9905410	rs61586425	0.641720828304765	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs9905410	rs7211615	0.637097968317143	Heel bone mineral density	1e-08	30595370
rs9905410	rs8077038	0.614822329709276	Educational attainment (MTAG)	4e-10	30038396
rs9905410	rs8077038	0.614822329709276	Highest math class taken (MTAG)	5e-16	30038396
rs9905410	rs12949956	0.607910637955509	Self-reported math ability	3e-11	30038396
rs9905410	rs12949956	0.607910637955509	Self-reported math ability (MTAG)	3e-14	30038396
rs9905410	rs12949956	0.607910637955509	Highest math class taken	8e-12	30038396
rs9906358	rs61586425	0.642479745764423	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs9906358	rs7211615	0.637670706133717	Heel bone mineral density	1e-08	30595370
rs9906358	rs8077038	0.615377400890779	Educational attainment (MTAG)	4e-10	30038396
rs9906358	rs8077038	0.615377400890779	Highest math class taken (MTAG)	5e-16	30038396
rs9906358	rs12949956	0.608458102468339	Self-reported math ability	3e-11	30038396
rs9906358	rs12949956	0.608458102468339	Self-reported math ability (MTAG)	3e-14	30038396
rs9906358	rs12949956	0.608458102468339	Highest math class taken	8e-12	30038396
rs9906979	rs61586425	0.644398211758112	Photoreceptor cell layer thickness phenotypes (MTAG)	5e-12	36848389
rs9906979	rs7211615	0.635326871709338	Heel bone mineral density	1e-08	30595370
rs9906979	rs8077038	0.615897284027548	Educational attainment (MTAG)	4e-10	30038396
rs9906979	rs8077038	0.615897284027548	Highest math class taken (MTAG)	5e-16	30038396
rs9906979	rs12949956	0.608788725149067	Self-reported math ability	3e-11	30038396
rs9906979	rs12949956	0.608788725149067	Self-reported math ability (MTAG)	3e-14	30038396
rs9906979	rs12949956	0.608788725149067	Highest math class taken	8e-12	30038396
rs9918189	rs7721230	0.770524993977961	Skin color	4e-10	36672889
rs9932984	rs2076435	0.979333498156414	Inguinal hernia	2e-08	35022708
rs9932984	rs2076435	0.979333498156414	Inguinal hernia	2e-09	35022708
rs9932984	rs2235642	0.860949557725614	Coronary artery disease	8e-06	29212778
rs9932984	rs2076438	0.857082886255086	Coronary artery disease	3e-08	33020668
rs9939655	rs2235642	0.713211499946712	Coronary artery disease	8e-06	29212778
rs9939655	rs2076438	0.710098372598901	Coronary artery disease	3e-08	33020668
rs9939655	rs2076435	0.635619884198224	Inguinal hernia	2e-08	35022708
rs9939655	rs2076435	0.635619884198224	Inguinal hernia	2e-09	35022708
rs9941856	rs400625	0.642463102725978	Posterior-cingulate cortex volume	5e-06	31530798
rs9943281	rs11204914	0.995947128275112	Carnitine C9 levels	1e-13	35995766
rs9943281	rs11204914	0.995947128275112	Metabolite peak levels (QI6204)	1e-32	35995766
rs9943281	rs11204914	0.995947128275112	Metabolite peak levels (QI6252)	2e-32	35995766
rs9943281	rs10788817	0.983043524951993	Serum metabolite levels	3e-13	24625756
rs9943281	rs10788817	0.983043524951993	Metabolite peak levels (QI2718)	5e-18	35995766
rs9943281	rs10788817	0.983043524951993	3-hydroxylaurate levels	2e-12	36635386
rs9943281	rs10788817	0.983043524951993	Tetradecadienoate (14:2) levels	8e-17	36635386
rs9943281	rs6698740	0.97184209674983	Beta-hydroxyisovalerate levels	1e-13	35347128
rs9943281	rs1060870	0.970243654925779	Serum metabolite levels	1e-11	33031748
rs9943281	rs1060870	0.970243654925779	Serum metabolite levels	1e-15	33031748
rs9943281	rs6685187	0.969439414993467	X-12442--5,8-tetradecadienoate levels	3e-26	24816252
rs9943281	rs2338201	0.956817695527244	Dodecadienoate (12:2) (X-21343) levels	3e-12	35050183
rs9943281	rs2338201	0.956817695527244	Tetradecadienoate (14:2) (X-12442) levels	5e-14	35050183
rs9943281	rs2338201	0.956817695527244	Dodecadienoate (12:2) levels	7e-15	36635386
rs9943281	rs2130525	0.838463591342349	Glycine conjugate of C10H14O2 (1) levels	4e-14	36635386
rs9943281	rs7542137	0.825770559002706	Beta-hydroxyisovalerate levels	3e-11	35050183
rs9943281	rs7542137	0.825770559002706	Plasma cis-4-decenoate (10:1n6)* levels in chronic kidney disease	2e-61	37277652
rs9943281	rs7542137	0.825770559002706	3-hydroxysebacate levels	2e-10	36635386
rs9943281	rs2999545	0.822177697645644	Pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) levels	1e-10	36635386
rs9943281	rs7523082	0.809694414296634	Metabolite peak levels (QI9845)	2e-14	35995766
rs9943281	rs10888445	0.805469637254751	Beta-hydroxyisovalerate levels	5e-13	36635386
rs9943281	rs2279501	0.805202196347785	Serum metabolite levels	3e-14	33031748
rs9943281	rs7541453	0.799841841796426	Serum metabolite levels	2e-16	33031748
rs9943281	rs7541453	0.799841841796426	Serum metabolite levels	2e-16	33031748
rs9943281	rs7541453	0.799841841796426	Urine X-24363 levels in chronic kidney disease	7e-27	37277652
rs9943281	rs3007711	0.781716565279048	Electrodermal activity	9e-06	25387706
rs9943281	rs2999541	0.7807985636539	Cis-3,4-methyleneheptanoylcarnitine levels	8e-11	36635386
rs9943281	rs1038747	0.683000982506445	Plasma X-21607 levels in chronic kidney disease	2e-13	37277652
rs9968911	rs4380763	0.975881731437781	Subcortical volume (min-P)	1e-11	32665545
rs9968911	rs1934534	0.975086264906004	Pain (pleiotropy)	2e-08	37844115
rs9968911	rs1934534	0.975086264906004	Pain (pleiotropy)	2e-06	37844115
rs9968911	rs11155671	0.965458420331104	Testicular germ cell tumor	2e-09	28604728
rs9968911	rs4421206	0.961046180433155	Brain morphology (min-P)	4e-11	32665545
rs9968911	rs9688452	0.940970545185919	Brainstem global volume Whole-brainstem	1e-11	33875891
rs9968911	rs9688452	0.940970545185919	aseg lh volume VentralDC	2e-10	33875891
rs9968911	rs9505982	0.939592521371593	S-adenosylhomocysteine (SAH) levels	1e-19	35347128
rs9968911	rs80147756	0.932461078325649	HippSubfield lh volume subiculum-head	3e-10	33875891
rs9968911	rs10872649	0.854732894150133	Hippocampal subfield right CA4 volume (body)	3e-09	37337106
rs9968911	rs10872649	0.854732894150133	Hippocampal right GC-ML-DG volume (body)	3e-08	37337106
rs9968911	rs10872649	0.854732894150133	Right hippocampal volume (body)	1e-10	37337106
rs9968911	rs7752089	0.818200409540227	Brain morphology (MOSTest)	2e-31	35164939
rs9968911	rs9322194	0.796872865220747	Brainstem volume	2e-11	31636452
rs9968911	rs9285521	0.680325910928616	Plasma 5-methylthioadenosine (MTA) levels in chronic kidney disease	3e-17	37277652
rs9968911	rs12526675	0.664716648341654	Brain morphology (MOSTest)	7e-22	32665545
rs9968911	rs9688809	0.633844884473241	Right molecular layer hippocampal volume (head)	7e-09	37337106
rs9968911	rs34337297	0.630853142063424	Serum levels of protein LRP11	3e-161	35078996
rs9968911	rs10872645	0.630066226199853	Blood protein levels	2e-86	30072576
rs9968911	rs14314	0.628995264228293	Macular thickness	3e-19	30535121
rs9968911	rs14314	0.628995264228293	Vertex-wise sulcal depth	7e-17	34910505
rs9968911	rs14314	0.628995264228293	Plasma S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-16	37277652
rs9968911	rs14314	0.628995264228293	Left hippocampal volume (body)	7e-15	37337106
rs9968911	rs14314	0.628995264228293	Left subiculum volume (body)	1e-14	37337106
rs9968911	rs55763431	0.628711256228873	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (6713_4)	8e-28	35870639
rs9968911	rs9689694	0.627574204942369	Right hippocampal volume (head)	6e-11	37337106
rs9968911	rs9689694	0.627574204942369	Hippocampal subfield left CA1 volume (head)	2e-10	37337106
rs9968911	rs9689694	0.627574204942369	Hippocampal subfield right CA1 volume (head)	7e-12	37337106
rs9968911	rs9689694	0.627574204942369	Left hippocampal volume (head)	6e-12	37337106
rs9968911	rs9383843	0.626221511369797	Migraine	1e-09	35115687
rs9968911	rs2095375	0.625653904515199	Serum metabolite levels	1e-20	33031748
rs9968911	rs2095375	0.625653904515199	Serum metabolite levels	1e-20	33031748
rs9968911	rs10872653	0.623386868963867	Urine S-adenosylhomocysteine (SAH) levels in chronic kidney disease	4e-17	37277652
rs9968911	rs2342764	0.62312116741417	Cortical thickness	1e-08	34560273
rs9968911	rs9688867	0.621682415213981	Low-density lipoprotein receptor-related protein 11 level in Chronic kidney disease with hypertension and no diabetes (8330_1)	5e-31	35870639
rs9968911	rs9688867	0.621682415213981	S-adenosylhomocysteine (SAH) levels	2e-26	36635386
rs9968911	rs9322193	0.60674475308181	Lung cancer	1e-07	27393504
rs9971885	rs1859336	0.990525483223381	COVID-19 hospitalization or osteoarthritis (MTAG)	1e-09	37398645
rs9971885	rs6489882	0.973012290739672	Chronic lymphocytic leukemia	5e-08	28165464
rs9971885	rs11066452	0.968154869311565	Blood protein levels	6e-08	30072576
rs9971885	rs4767027	0.947126748808589	2'-5'-oligoadenylate synthase 1 levels (OAS1.10361.25.3)	6e-26	29875488
rs9971885	rs2057778	0.943619787691669	COVID-19 critical illness or age-related macular degeneration (MTAG)	7e-09	36614910
rs9971885	rs2057778	0.943619787691669	COVID-19 hospitalization or age-related macular degeneration (MTAG)	5e-08	36614910
rs9971885	rs2057778	0.943619787691669	COVID-19 infection or age-related macular degeneration (MTAG)	6e-08	36614910
rs9971885	rs1131476	0.918449909381073	Systemic lupus erythematosus	1e-09	33272962
rs9971885	rs2660	0.918449909381073	COVID-19 (hospitalized covid vs population)	3e-17	37198478
rs9971885	rs2660	0.918449909381073	COVID-19 (critical illness vs population)	3e-15	37198478
rs9971885	rs6489867	0.674498960357096	COVID-19 (critical illness vs population)	1e-09	33307546
rs9971885	rs1557866	0.629477186112456	Major depressive disorder or severe COVID-19 (pleiotropy)	2e-09	37426090
rs998278	rs9368830	0.964492395065777	HDL cholesterol	4e-21	30275531
rs998278	rs9469872	0.888653974943008	HDL cholesterol levels	3e-11	36333282
rs998278	rs9366863	0.883491597696554	Adult body size	9e-33	32376654
rs998278	rs9366863	0.883491597696554	Body mass index	2e-44	30595370
rs998278	rs11755393	0.882420879061606	Body mass index	3e-26	29273807
rs998278	rs11755393	0.882420879061606	Systemic lupus erythematosus	2e-12	33493351
rs998278	rs11755393	0.882420879061606	Systemic lupus erythematosus	2e-06	33493351
rs998278	rs11755393	0.882420879061606	Systemic lupus erythematosus	1e-07	33493351
rs998278	rs11755393	0.882420879061606	Systemic lupus erythematosus	2e-08	19838195
rs998278	rs11755393	0.882420879061606	Body mass index	4e-55	36581621
rs998278	rs6941110	0.87313499280941	Sex hormone-binding globulin levels	5e-27	36653534
rs998278	rs9462030	0.857750826443671	Red cell distribution width	5e-25	32888493
rs998278	rs9469857	0.852016502595903	Systemic lupus erythematosus (MTAG)	9e-45	36750564
rs998278	rs2764208	0.851430799433861	Systemic lupus erythematosus	7e-06	24871463
rs998278	rs2814949	0.847962450688264	Essential hypertension (time to event)	9e-09	32589924
rs998278	rs9469899	0.840723204645646	Prostate cancer (advanced)	2e-06	29892016
rs998278	rs9469899	0.840723204645646	Prostate cancer	5e-09	29892016
rs998278	rs9469899	0.840723204645646	Prostate cancer	8e-11	33398198
rs998278	rs9469899	0.840723204645646	Hand grip strength	3e-15	29691431
rs998278	rs9469899	0.840723204645646	Phospholipids to total lipids ratio in large VLDL	4e-09	35213538
rs998278	rs9469899	0.840723204645646	Graves' disease	4e-10	34594039
rs998278	rs9469899	0.840723204645646	Coronary artery disease	1e-11	36474045
rs998278	rs9469899	0.840723204645646	Predicted visceral adipose tissue	2e-20	31501611
rs998278	rs9469899	0.840723204645646	Medication use (thyroid preparations)	2e-09	31015401
rs998278	rs9469899	0.840723204645646	Medication use (thyroid preparations)	3e-10	34594039
rs998278	rs2744944	0.839486072012665	Hypothyroidism	3e-10	34594039
rs998278	rs2744944	0.839486072012665	High density lipoprotein cholesterol levels	3e-86	34887591
rs998278	rs2744944	0.839486072012665	Multi-trait sex score	7e-22	37277458
rs998278	rs2263329	0.823330711739756	HDL cholesterol	6e-35	34594039
rs998278	rs2263329	0.823330711739756	HDL cholesterol levels	8e-43	32203549
rs998278	rs2263329	0.823330711739756	High density lipoprotein cholesterol levels	2e-52	34887591
rs998278	rs9296128	0.80835359873366	Hip circumference adjusted for BMI	4e-13	34021172
rs998278	rs111868030	0.802571893849615	Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile)	4e-08	35589863
rs998278	rs9368828	0.752868087818372	Body mass index	1e-34	34594039
rs998278	rs6912327	0.749038948963331	Fasting insulin	5e-06	33402679
rs998278	rs6912327	0.749038948963331	Triglycerides to total lipids ratio in large VLDL	8e-09	35213538
rs998278	rs112283401	0.723243252195999	Red cell distribution width	4e-27	30595370
rs998278	rs2744973	0.706468308629944	Phospholipids to total lipids ratio in large LDL	8e-09	35213538
rs998278	rs2744973	0.706468308629944	Phospholipids to total lipids ratio in medium HDL	5e-11	35213538
rs998278	rs2744973	0.706468308629944	Free cholesterol to total lipids ratio in medium HDL	6e-15	35213538
rs998278	rs2744973	0.706468308629944	Multi-trait sex score	6e-20	37277458
rs998278	rs3800458	0.633138096312976	Insomnia	7e-11	35835914
rs998278	rs3800458	0.633138096312976	Insomnia	2e-12	35835914
